Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AAAS		ENSG00000094914	"Aladin WD repeat nucleoporin"	Q9NRG9	12	53307456-53324864	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040086	Approved		Approved	"Nuclear membrane,Centrosome,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear membrane"	"Centrosome, Cytosol"	"HPA040086: AB_10805602"	"unprognostic (1.53e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.95e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.44e-2)"	17.0	36.3	12.3	13.8	15.0	19.1	17.1	15.2	15.6	20.3	15.1	19.1	12.3	19.1	7.2	19.3	19.9	9.4	22.7	12.9	13.7	21.7	24.6	14.0	17.6	14.3	14.1	19.2	23.9	18.0	24.8	17.4	14.8	18.4	15.1	12.3	18.5	11.7	22.6	17.3	17.7	16.8	13.7	22.2	21.6	27.3	14.0	25.2	19.4	18.5	21.6	17.8	17.9	17.2	26.1	77.3	63.2	38.0	28.6	32.2	38.9	29.8	31.3	72.6	42.1	54.0	56.7	62.2	47.4	37.3	41.9	37.6	106.4	78.8	42.1	41.0	68.1	49.7	29.9	40.7	26.4	45.5	37.9	28.1	39.4	48.9	44.6	40.4	56.6	56.2	67.6	70.6	30.4	72.8	71.2	46.1	40.0	27.7	53.1	72.1	39.3	69.4	38.2	17.5	32.8	41.3	20.2	46.9	21.0	40.2	61.2	38.8	25.5	34.9	51.1	27.4	32.9	32.5	43.5	54.7	25.6	39.6	40.5	1.0	17.7	10.7	18.4	20.2	20.8	20.0	15.9	16.8	18.8	21.8	21.7	21.4	1.1	10.5	22.5	22.6	17.4	15.2	12.3	15.0	15.2	15.6	12.9	13.7	14.3	14.1	14.8	13.7	14.0	17.2	11.7	12.8	7.8	17.9	15.1	7.4	19.0	26.2	10.2	11.8	13.2	13.0	8.2	17.2	15.4	14.7	16.7	58.4	13.7	9.3	13.7	20.4	12.5	11.9	12.9	11.7	8.4	41.2	7.3	18.3	49.5	14.9	13.3	8.9	8.2	13.1	11.0	12.0	28.5	1.7	6.6	13.1	18.3	12.4	9.3	26.2	17.7	10.6	10.6	5.6	11.6	18.0	15.5	6.6	11.4	8.9	11.0	12.8	20.8	8.1	11.2	18.5	12.6	15.5	19.7	11.0	39.7	34.2	40.5	13.1	7.4	36.5	11.4	14.9	17.2	13.0
AARS1	"AARS, AlaRS, CMT2N"	ENSG00000090861	"Alanyl-tRNA synthetase 1"	P49588	16	70251983-70289707	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Epilepsy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 25.1;Cytotrophoblasts: 63.0;Extravillous trophoblasts: 29.9;Hofbauer cells: 27.1;Syncytiotrophoblasts: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034261, HPA040870, HPA044223"	Supported		Supported	Cytosol		NA	NA		620000	"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB034261: AB_1562673, HPA040870: AB_10794995, HPA044223: AB_2678862"	"unprognostic (1.98e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.02e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.50e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.05e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.83e-3)"	43.7	54.7	60.1	33.4	64.3	7.9	41.4	73.3	88.6	42.1	49.2	48.9	26.0	49.8	49.6	29.5	40.4	22.3	47.9	62.8	71.7	43.6	72.0	45.3	30.0	78.6	68.6	37.3	75.8	74.9	50.1	35.6	84.9	40.0	26.2	59.3	53.3	47.2	62.4	28.8	32.7	47.8	66.3	38.3	51.8	23.8	74.8	36.4	66.6	39.7	35.5	45.9	32.8	83.9	123.7	192.8	52.9	205.7	127.3	115.0	125.7	97.7	135.3	119.7	151.8	162.5	163.2	140.4	127.2	99.3	90.8	137.2	160.5	133.1	170.7	63.2	54.7	135.6	78.0	152.2	348.0	74.4	77.2	133.9	193.8	228.1	508.4	91.4	120.3	209.3	176.0	173.4	91.3	282.0	89.4	85.0	104.3	160.0	108.5	170.4	36.1	317.0	84.7	60.3	67.9	57.3	269.5	62.3	246.1	75.8	197.7	181.3	75.2	85.2	82.9	84.9	78.8	233.8	174.2	258.2	155.4	124.9	175.9	6.5	7.8	2.7	11.9	13.2	13.0	12.8	9.7	11.7	11.9	9.1	11.2	12.2	0.1	22.7	14.1	7.0	8.0	12.6	60.1	64.3	73.3	88.6	62.8	71.7	78.6	68.6	84.9	66.3	74.8	83.9	6.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	63.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	29.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	52.0	0.2	0.0	0.0	0.0
AARS2	"AARSL, bA444E17.1, KIAA1270"	ENSG00000124608	"Alanyl-tRNA synthetase 2, mitochondrial"	Q5JTZ9	6	44298731-44313347	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Cancer-related genes, Cardiomyopathy, Disease variant, Neurodegeneration, Premature ovarian failure, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035636, HPA061396"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria		"HPA035636: AB_10670837, HPA061396: AB_2684502"	"unprognostic (1.56e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.83e-3)"	"unprognostic (5.12e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.02e-1)"	4.7	5.2	6.5	5.6	6.2	5.4	4.9	9.4	6.7	7.6	6.7	5.8	6.5	6.1	3.2	9.2	6.4	4.6	6.0	6.8	5.1	5.7	6.9	4.3	6.0	6.1	5.8	8.3	6.5	5.9	6.3	4.1	6.4	7.0	4.1	5.4	6.2	4.3	4.8	7.2	7.9	4.1	5.4	7.2	5.4	3.7	6.0	6.2	6.2	3.3	5.3	5.6	7.4	6.7	14.6	9.9	13.9	23.8	8.1	7.2	18.3	10.9	5.7	11.2	10.6	11.4	7.1	16.3	16.2	4.8	12.2	10.0	14.7	16.0	4.7	10.9	23.7	18.9	10.6	14.5	4.8	17.9	16.0	5.9	9.8	9.0	10.2	7.3	9.5	21.8	21.0	15.4	6.2	16.0	14.2	15.9	9.9	40.3	9.8	16.4	8.7	10.4	6.7	12.7	32.0	11.4	9.4	10.9	15.5	9.7	9.9	21.6	8.4	12.1	13.5	7.6	13.9	8.8	8.7	16.5	6.8	15.9	22.1	2.2	1.1	0.1	1.3	1.3	2.1	1.5	1.9	1.7	1.0	2.9	1.8	1.7	0.2	1.9	1.4	1.3	1.2	1.3	6.5	6.2	9.4	6.7	6.8	5.1	6.1	5.8	6.4	5.4	6.0	6.7	2.6	6.4	3.3	5.2	3.7	0.6	2.1	1.9	4.0	6.6	2.8	2.7	3.5	5.7	2.8	0.0	12.5	5.0	4.9	3.0	0.0	2.3	10.1	3.5	5.4	3.0	0.0	8.2	5.5	0.4	5.0	3.4	5.1	6.2	0.0	5.9	3.9	2.5	3.3	0.0	9.0	2.2	2.0	2.8	1.8	1.0	4.7	2.5	0.0	1.9	3.9	2.0	4.1	3.0	3.6	1.4	0.7	4.5	6.9	1.6	6.3	1.0	3.0	7.1	0.0	4.7	2.8	4.3	6.1	4.4	0.4	5.3	4.1	4.5	3.7	1.6
AASS	"LKRSDH, LORSDH"	ENSG00000008311	"Aminoadipate-semialdehyde synthase"	Q9UDR5	7	122064583-122144308	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 145.9;Hepatocytes: 113.9;Oligodendrocyte precursor cells: 106.1;Oligodendrocytes: 132.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.5;NTERA-2: 55.3;SuSa: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020637, HPA020728, HPA020734"	Enhanced		Approved	Nucleoplasm,Vesicles,Mitochondria		Yes	No		19000		"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nucleoplasm, Vesicles"	"HPA020637: AB_1844415, HPA020728: AB_1844416, HPA020734: AB_1844417"	"unprognostic (4.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.00e-2)"	"prognostic favorable (9.81e-4)"	"unprognostic (4.48e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.76e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.67e-1)"	9.7	5.9	10.0	1.8	12.2	0.2	8.4	10.3	14.4	8.2	15.5	5.2	0.9	9.5	7.5	3.2	11.7	2.1	9.2	9.4	10.6	13.9	44.3	6.3	1.4	11.6	11.0	25.2	4.8	7.1	3.5	3.2	11.4	5.4	1.4	3.7	3.5	4.8	8.6	2.8	3.6	4.4	10.1	2.9	5.5	2.2	11.0	1.5	4.7	6.2	1.4	6.9	6.2	11.8	0.1	0.0	21.9	41.5	27.3	13.5	9.4	5.4	8.0	7.3	9.1	12.6	0.1	0.0	0.2	6.6	8.3	4.1	33.5	16.8	9.6	0.0	12.2	9.4	4.3	12.5	22.0	0.0	2.9	12.2	0.5	9.2	7.1	18.9	19.8	12.1	2.7	15.5	5.1	0.1	0.9	0.0	55.3	0.1	1.7	11.8	16.3	0.3	5.3	2.4	2.7	0.7	1.5	0.0	5.3	37.8	0.5	0.0	8.1	13.6	3.4	7.0	8.3	3.5	3.0	0.0	4.9	0.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.0	12.2	10.3	14.4	9.4	10.6	11.6	11.0	11.4	10.1	11.0	11.8	16.0	9.6	37.8	145.9	2.1	6.2	9.0	2.8	14.8	7.0	8.7	6.3	9.7	14.3	5.6	14.7	16.7	11.6	1.5	0.6	0.0	2.7	12.2	4.1	24.0	11.7	3.0	5.2	5.0	1.8	3.3	14.4	5.6	7.7	3.8	18.1	24.7	113.9	1.5	11.8	4.4	2.6	2.0	2.2	2.5	7.4	19.0	1.4	12.4	35.6	0.0	8.9	0.0	106.1	132.5	2.3	2.5	24.5	1.6	4.7	5.4	8.6	0.9	3.3	19.7	38.9	15.8	12.4	2.4	7.8	4.7	5.1	2.1	8.0	1.9	4.8
ABCA12	"DKFZP434G232, ICR2B, LI2"	ENSG00000144452	"ATP binding cassette subfamily A member 12"	Q86UK0	2	214931542-215138626	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 5.7;skin 1: 20.7"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 12.9;Suprabasal keratinocytes: 38.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"hTCEpi: 38.7;SK-BR-3: 18.3;T-47d: 9.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"cerebral cortex: 1.0;hippocampal formation: 1.1"	HPA078239			Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	"Vesicles, Plasma membrane"	"Nucleoli, Cytosol"	"HPA078239: AB_2732373"	"unprognostic (6.12e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.52e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (2.50e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.08e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	5.7	0.0	0.1	1.3	0.0	0.3	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.3	0.2	0.2	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	2.8	0.3	3.9	0.1	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	38.7	0.0	2.8	0.0	0.0	0.0	0.0	0.2	0.2	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.4	0.5	0.1	2.7	0.0	18.3	0.0	0.2	9.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	12.9	0.9	6.0	0.0	0.2	1.0	0.5	0.5	0.0	5.1	0.0	0.0	1.1	0.0	3.0	0.0	0.1	2.2	2.6	0.3	0.1	0.0	0.0	1.4	0.0	2.7	0.1	1.5	3.7	0.0	0.5	0.0	0.0	0.4	1.7	2.9	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.6	1.9	0.0	0.7	0.0	1.0	0.0	0.1	3.1	0.2	0.0	0.0	0.2	0.7	0.4	2.2	38.6	3.4	0.0	0.1	0.9	2.7
ABCA2	ABC2	ENSG00000107331	"ATP binding cassette subfamily A member 2"	Q9BZC7	9	137007234-137028922	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"brain: 543.0"	"Cell type enriched"	"Detected in many"	10	"Oligodendrocytes: 388.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 66.4"	"Low region specificity"	"Detected in all"							HPA042886	Approved		Supported	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA042886: AB_2678213"	"unprognostic (1.01e-2)"	"unprognostic (9.21e-3)"	"unprognostic (9.59e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.36e-1)"	9.0	6.0	90.2	4.2	269.7	6.7	6.3	194.3	189.0	5.9	0.0	7.9	3.0	4.3	4.5	3.3	6.2	5.9	9.1	92.4	101.3	7.1	7.4	6.2	4.6	284.9	211.4	3.2	9.3	13.4	23.4	3.1	255.1	7.1	2.2	2.7	8.4	4.7	7.3	6.6	6.5	2.4	135.7	9.5	11.6	2.9	204.9	2.9	15.2	3.5	1.8	5.6	5.3	543.0	8.6	9.2	4.5	18.2	11.1	11.8	7.9	9.5	3.8	4.2	1.5	2.8	10.3	0.4	26.2	10.2	4.1	14.4	2.9	6.9	0.8	6.4	5.9	0.8	26.2	3.5	5.5	13.3	14.5	5.0	6.3	3.0	0.9	15.3	2.4	2.7	2.2	1.5	5.3	25.7	0.1	29.1	2.4	10.9	9.5	13.3	4.6	13.0	2.9	2.0	17.4	20.0	10.1	19.6	7.2	0.3	66.4	17.4	11.9	11.2	6.1	16.0	3.9	0.3	0.2	0.1	19.0	2.6	5.8	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.6	0.2	0.3	90.2	269.7	194.3	189.0	92.4	101.3	284.9	211.4	255.1	135.7	204.9	543.0	7.2	0.0	0.0	26.1	2.3	3.3	1.5	7.1	3.4	12.6	6.2	9.1	5.1	17.2	2.3	1.8	14.6	1.0	24.0	15.2	1.9	2.9	1.0	6.7	4.8	4.7	34.7	6.6	23.4	1.5	1.2	6.4	5.1	6.9	0.0	12.6	6.1	8.6	1.2	37.0	20.8	7.0	2.0	3.5	4.6	1.6	22.1	2.7	5.4	4.7	0.9	12.8	24.7	12.5	388.7	2.3	7.1	23.7	6.7	2.4	11.6	1.4	4.9	7.9	0.0	11.4	4.7	0.5	4.7	1.7	2.7	0.8	13.2	2.8	11.0	1.3
ABCA3	"ABC-C, ABC3, EST111653, LBM180"	ENSG00000167972	"ATP binding cassette subfamily A member 3"	Q99758	16	2275881-2340746	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 91.2"	"Cell type enriched"	"Detected in many"	6	"Alveolar cells type 2: 427.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.6;SCLC-21H: 45.9;T-47d: 76.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007884	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Cytosol"		"HPA007884: AB_1078077"	"unprognostic (2.64e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.61e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.30e-1)"	6.8	8.7	19.1	3.0	20.8	0.7	6.7	10.2	25.5	3.0	0.0	7.9	2.0	3.7	3.5	2.9	4.4	2.7	6.1	23.4	17.1	6.5	1.1	91.2	3.7	20.1	15.8	3.4	13.1	11.2	11.1	4.3	22.2	4.9	1.2	7.4	9.1	4.3	6.2	4.3	3.9	4.6	11.1	3.4	4.9	8.9	19.1	11.3	24.6	3.8	6.5	4.5	2.2	19.7	0.7	21.6	4.1	33.1	0.8	0.0	0.3	5.8	1.4	2.3	2.4	3.0	3.4	0.2	8.4	2.7	2.1	0.6	19.2	0.3	0.8	34.6	12.9	2.2	2.5	0.5	2.9	0.4	3.6	0.3	0.5	0.3	1.1	13.4	32.4	0.2	24.0	0.0	0.1	29.3	0.1	2.4	4.4	5.2	10.4	5.4	0.7	3.8	18.7	0.7	45.9	33.0	4.1	23.4	0.6	1.6	76.5	2.0	9.3	0.2	1.1	9.0	9.8	6.1	2.9	0.1	4.7	11.7	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.4	0.1	0.0	0.0	0.1	19.1	20.8	10.2	25.5	23.4	17.1	20.1	15.8	22.2	11.1	19.1	19.7	4.3	70.5	427.4	30.0	1.1	0.6	0.5	0.2	2.2	20.7	8.4	6.7	6.7	4.3	9.5	18.4	12.5	0.0	2.1	0.3	0.0	5.7	7.7	1.3	0.3	6.3	5.4	0.0	60.3	3.8	0.0	2.7	0.0	2.9	29.7	7.7	5.3	0.7	1.0	18.5	58.6	0.8	4.1	1.2	1.8	3.8	1.8	3.1	1.8	13.1	2.2	7.1	2.1	32.2	37.2	1.9	0.4	3.4	3.6	1.5	0.4	2.0	2.4	12.5	6.6	7.2	2.9	5.1	15.0	1.2	1.6	0.0	3.9	1.3	0.4	0.2
ABCA4	"ABCR, ARMD2, CORD3, FFM, RP19, STGD, STGD1"	ENSG00000198691	"ATP binding cassette subfamily A member 4"	P78363	1	93992834-94121148	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"	Translocase	"Age-related macular degeneration, Cone-rod dystrophy, Disease variant, Retinitis pigmentosa, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"choroid plexus: 144.6;retina: 461.0"	"Group enriched"	"Detected in some"	12	"Cone photoreceptor cells: 450.4;Rod photoreceptor cells: 482.9"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.1"	"Region enriched"	"Detected in some"	6	"hippocampal formation: 9.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;EFO-21: 6.8;HeLa: 2.3;SK-BR-3: 3.0;SuSa: 3.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA064420, HPA078826"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA064420: , HPA078826: "	"unprognostic (1.25e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (2.45e-4)"	"unprognostic (3.77e-2)"	"unprognostic (5.25e-1)"	"unprognostic (3.70e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.17e-9)"	"unprognostic (1.61e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (2.72e-4)"	0.5	0.0	0.4	0.1	0.3	0.0	0.8	1.1	0.7	0.5	144.6	0.2	2.5	0.1	8.4	0.2	0.4	0.1	0.2	9.3	0.1	8.7	0.9	0.3	0.4	0.4	0.5	0.2	0.0	0.0	0.1	0.6	0.2	0.2	0.1	461.0	0.0	1.4	0.1	2.1	2.9	0.0	0.1	0.1	0.1	1.0	1.4	0.3	0.4	0.0	0.1	0.2	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.0	3.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	6.8	0.3	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.4	2.3	0.7	0.4	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.9	0.5	0.0	1.2	0.0	0.1	0.1	0.2	0.2	0.3	0.3	0.0	0.0	0.6	3.0	0.1	3.1	0.3	0.0	0.1	0.2	1.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	1.1	0.7	9.3	0.1	0.4	0.5	0.2	0.1	1.4	0.4	1.2	0.0	1.1	1.3	0.0	0.1	0.2	1.7	0.0	27.9	0.5	1.3	1.1	0.0	1.8	7.3	450.4	0.3	0.0	0.0	0.0	0.0	8.8	0.3	0.1	3.1	0.0	0.0	0.4	0.0	1.5	0.2	0.0	0.9	0.0	0.2	1.4	0.3	0.1	10.1	0.6	16.2	0.0	0.3	0.0	21.9	0.0	0.0	0.0	19.7	0.0	37.3	0.0	0.5	0.0	0.0	0.0	0.4	0.0	2.6	1.3	0.4	2.3	482.9	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.6	0.7
ABCA7	ABCX	ENSG00000064687	"ATP binding cassette subfamily A member 7"	Q8IZY2	19	1039997-1065572	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Phagocytosis, Transport"	Translocase	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.4;pituitary gland: 28.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Bipolar cells: 70.6;Cone photoreceptor cells: 175.2;Extravillous trophoblasts: 303.3;Rod photoreceptor cells: 149.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 20.4;HMC-1: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA041564	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Golgi apparatus, Plasma membrane"	"Cell Junctions"	"HPA041564: AB_2677550"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (7.26e-4)"	"prognostic favorable (1.12e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.68e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.08e-2)"	"unprognostic (3.66e-1)"	"unprognostic (7.88e-2)"	"unprognostic (7.85e-2)"	4.4	3.0	3.4	5.5	3.9	27.4	3.3	4.0	6.1	3.2	11.5	3.8	2.3	1.2	0.2	7.6	2.1	2.1	3.1	3.6	3.7	6.4	4.2	9.5	8.5	5.8	4.5	0.5	7.7	2.7	28.7	1.2	5.3	5.3	1.2	25.5	8.6	1.1	3.8	5.9	10.1	0.5	3.0	26.6	3.8	1.7	4.1	10.0	5.7	0.3	3.2	2.3	2.8	3.2	4.7	6.4	0.5	4.4	7.2	2.2	7.3	0.8	1.0	0.4	0.6	5.2	2.8	13.9	5.6	1.3	0.6	8.0	1.3	6.2	0.4	10.2	2.5	6.7	20.4	5.6	1.8	3.9	40.3	3.8	1.8	0.9	1.2	4.4	1.4	7.7	10.2	6.9	1.3	2.2	4.3	2.2	0.9	3.3	2.5	3.1	0.8	11.6	3.8	6.0	0.3	1.3	8.2	1.9	1.2	1.1	4.6	7.1	2.2	0.4	1.6	3.7	0.8	9.9	6.6	5.7	2.1	7.4	2.0	2.8	1.4	5.9	1.8	1.2	1.1	0.6	0.9	1.2	2.1	0.9	0.8	1.5	3.3	1.1	1.3	7.3	0.4	1.3	3.4	3.9	4.0	6.1	3.6	3.7	5.8	4.5	5.3	3.0	4.1	3.2	4.1	73.7	21.9	8.5	13.2	3.3	0.8	10.7	5.2	70.6	4.8	2.2	6.0	4.3	14.0	5.5	175.2	4.6	9.1	14.7	1.9	2.7	7.3	8.9	1.4	2.9	3.5	13.3	12.9	2.5	303.3	1.5	5.6	6.9	10.1	2.0	2.5	4.9	7.9	15.2	11.5	4.7	16.2	12.6	7.5	4.8	0.0	12.7	0.0	4.7	19.6	13.1	9.2	1.5	2.4	7.0	9.6	0.0	12.0	1.5	1.7	1.3	17.5	149.1	0.0	2.7	2.7	0.7	2.0	6.6	3.4	25.7	12.6	1.0	5.3	1.9
ABCB11	"ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP"	ENSG00000073734	"ATP binding cassette subfamily B member 11"	O95342	2	168915498-169031324	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 80.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 41.7;Alveolar cells type 2: 44.1;Club cells: 19.3;Early spermatids: 16.5;granulocytes: 24.0;Hepatocytes: 20.4"	"Cancer enriched"	"Detected in single"	87	"liver cancer: 6.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.6;RT4: 1.6;TIME: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019035	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 24: NB-4 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA019035: AB_1844429"	"unprognostic (7.78e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.64e-3)"	"unprognostic (3.71e-1)"	"unprognostic (5.26e-6)"	"unprognostic (7.12e-2)"	"unprognostic (1.82e-1)"		"unprognostic (1.94e-1)"	1.5	0.0	0.3	0.1	0.3	0.0	0.6	0.3	0.5	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	80.8	0.0	0.1	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.4	0.1	0.0	0.0	1.1	0.0	0.0	0.3	0.1	0.0	6.2	0.2	0.0	0.0	0.0	0.1	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.4	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.2	0.2	1.0	0.6	0.5	0.3	0.2	0.3	0.0	41.7	44.1	1.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	19.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	16.5	0.1	0.0	1.8	0.0	2.7	0.8	0.0	0.0	6.6	0.0	0.0	24.0	0.0	0.0	20.4	0.0	0.0	0.3	0.0	0.0	0.3	0.0	9.1	0.0	3.8	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.1	0.0	0.0	8.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	2.6	0.2	0.0	0.6
ABCB4	"GBD1, MDR2, MDR3, PFIC-3, PGY3"	ENSG00000005471	"ATP binding cassette subfamily B member 4"	P21439	7	87401696-87480435	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 123.2"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 256.1"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 16.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"memory B-cell: 4.4;naive B-cell: 8.1"	"Lineage enriched"	"Detected in many"	7	"B-cells: 8.1"	"Group enriched"	"Detected in some"	5	"SH-SY5Y: 12.9;WM-115: 25.7"	"Low region specificity"	"Detected in many"							"HPA049395, HPA053288"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Plasma membrane, Actin filaments"	"Focal adhesion sites"	"HPA049395: AB_2680745, HPA053288: AB_2682102"	"unprognostic (7.92e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.47e-1)"	0.7	7.4	0.8	2.5	0.6	0.9	0.5	0.6	0.9	0.3	0.4	1.1	0.4	0.2	0.6	0.6	0.2	0.8	6.6	0.8	0.6	0.6	123.2	0.2	5.9	0.9	0.6	0.4	0.1	0.0	0.2	0.2	1.0	0.5	1.2	0.4	0.6	0.4	7.5	1.4	2.1	0.3	0.6	5.0	0.6	1.0	0.7	0.7	0.5	4.8	5.2	1.2	0.5	0.7	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	12.9	0.0	0.6	2.6	0.5	0.2	0.6	0.0	0.2	1.7	0.1	0.0	0.0	0.0	3.2	0.2	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.2	8.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.8	0.6	0.6	0.9	0.8	0.6	0.9	0.6	1.0	0.6	0.7	0.7	1.3	0.0	0.5	0.3	22.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.0	0.0	1.8	0.0	1.1	0.1	0.2	0.0	0.1	0.6	0.2	0.2	1.0	0.0	0.4	0.6	0.0	0.3	2.0	0.0	0.2	0.0	0.0	3.3	256.1	0.5	38.7	1.8	0.0	0.0	5.0	1.2	0.4	0.0	1.0	10.6	3.7	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.4	0.3	0.0	0.5	0.7	0.0	0.2	0.0	0.6	1.2	1.2	0.2	0.0	0.4	0.1	0.7	0.0	0.2	0.0
ABCB6	"EST45597, MTABC3, umat"	ENSG00000115657	"ATP binding cassette subfamily B member 6 (Langereis blood group)"	Q9NP58	2	219209772-219218994	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Dyskeratosis congenita, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.7;Excitatory neurons: 12.9;Gastric mucus-secreting cells: 5.1;Inhibitory neurons: 10.9;Oligodendrocyte precursor cells: 13.6;Oligodendrocytes: 5.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 65.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046723, HPA058011"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Nucleoplasm, Plasma membrane, Mitochondria, Cytosol"	"HPA046723: AB_10960288, HPA058011: AB_2683578"	"unprognostic (8.04e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (9.45e-7)"	"unprognostic (2.26e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.18e-4)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (1.51e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.30e-1)"	10.2	8.7	4.3	3.4	3.9	10.4	7.6	3.2	4.6	7.7	4.4	6.5	6.9	8.4	8.2	11.4	9.6	7.1	8.5	4.0	5.1	5.2	15.9	5.9	1.9	4.4	4.2	12.9	5.7	4.8	6.0	3.1	6.2	8.0	3.3	3.0	6.2	8.6	30.4	6.8	6.3	7.9	4.1	3.9	7.9	18.0	5.7	2.6	10.7	9.8	2.9	14.9	7.9	5.0	0.3	22.9	4.7	28.8	30.8	11.1	27.6	8.5	7.9	9.2	9.2	35.5	5.0	0.3	42.8	8.6	5.0	49.1	0.6	3.6	3.0	15.0	4.7	36.3	24.9	65.8	37.0	0.0	12.0	16.3	4.2	6.2	0.1	13.9	16.3	4.8	31.4	4.4	6.3	12.0	2.3	0.1	7.2	53.6	9.2	12.3	14.3	1.6	5.1	0.4	16.6	17.8	17.6	41.4	18.7	17.4	12.4	0.8	7.5	12.5	0.5	16.9	10.3	11.2	9.6	0.1	14.0	0.4	17.0	0.7	0.4	0.0	0.7	0.4	0.2	1.0	0.5	0.2	0.3	0.8	1.2	0.8	0.0	0.4	0.3	2.3	0.5	1.0	4.3	3.9	3.2	4.6	4.0	5.1	4.4	4.2	6.2	4.1	5.7	5.0	0.2	0.0	0.0	14.7	0.3	0.3	0.0	0.5	1.2	1.0	0.2	0.0	0.2	0.0	1.3	0.0	0.0	0.2	0.2	0.1	0.0	0.8	1.2	0.3	0.6	0.4	0.0	1.3	12.9	0.0	0.1	0.7	5.1	0.2	0.0	0.5	0.0	0.4	0.1	0.0	10.9	0.3	0.0	0.3	0.4	1.0	0.3	0.3	0.0	3.7	0.0	0.3	0.0	13.6	5.6	0.3	0.0	0.4	0.5	0.0	0.5	0.2	2.2	0.8	0.0	0.4	0.3	1.0	0.3	2.8	0.3	0.3	0.1	0.4	0.2	0.1
ABCB7	"ABC7, ASAT, Atm1p, EST140535"	ENSG00000131269	"ATP binding cassette subfamily B member 7"	O75027	X	75051048-75156732	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034982	Approved		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA034982: AB_10601010"	"unprognostic (1.05e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (5.31e-6)"	"unprognostic (1.95e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.08e-1)"	12.6	13.5	5.0	7.7	5.9	11.1	11.8	8.2	7.6	11.4	9.8	13.8	16.0	10.9	5.0	11.6	11.2	7.4	22.0	5.5	6.1	10.1	14.8	9.8	12.0	6.4	6.0	12.3	9.6	11.0	8.6	7.5	6.2	8.5	9.6	9.8	10.0	6.9	31.4	12.9	11.8	8.8	6.1	10.9	12.3	4.1	5.4	14.0	9.5	22.2	11.1	10.5	10.9	6.8	17.0	16.2	12.2	20.9	14.1	25.5	7.0	8.9	14.6	12.3	22.4	18.5	24.5	25.8	22.8	9.2	21.2	18.8	25.6	18.5	12.0	26.0	33.2	16.8	29.2	17.3	8.2	24.7	13.7	15.9	16.3	12.8	16.7	21.3	23.1	26.2	18.9	31.1	9.8	10.5	24.4	26.1	26.8	26.3	30.5	21.4	26.9	30.5	12.7	13.2	17.7	14.1	27.4	23.5	17.8	20.0	10.2	22.9	10.3	11.3	22.9	23.2	12.4	10.1	27.5	21.2	10.1	35.8	9.4	9.6	26.9	10.0	15.7	25.6	16.6	24.7	16.7	16.7	29.0	28.2	28.7	21.1	2.4	17.5	20.4	18.2	27.2	19.2	5.0	5.9	8.2	7.6	5.5	6.1	6.4	6.0	6.2	6.1	5.4	6.8	12.0	9.6	10.4	48.0	26.6	15.8	14.5	16.0	19.9	10.9	10.9	9.9	46.8	14.3	14.2	11.0	6.2	23.0	19.0	8.2	11.7	17.5	0.4	8.4	12.8	11.9	13.8	26.9	37.9	13.5	11.6	13.9	9.7	10.1	22.2	20.6	9.3	11.8	20.1	25.2	39.0	10.5	8.2	26.1	16.7	0.8	14.6	19.2	10.6	45.0	22.9	12.4	6.2	43.7	46.6	11.6	7.9	13.2	14.3	10.6	15.9	19.9	10.7	7.9	32.9	19.6	13.8	5.5	10.9	16.1	16.1	22.3	14.5	19.2	17.9	11.9
ABCC6	"ARA, EST349056, MLP1, MRP6, PXE, URG7"	ENSG00000091262	"ATP binding cassette subfamily C member 6"	O95255	16	16149565-16223522	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"	Translocase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 134.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 31.5;Distal tubular cells: 45.0;Hepatocytes: 77.9;Proximal enterocytes: 33.7;Proximal tubular cells: 151.1"	"Group enriched"	"Detected in many"	5	"liver cancer: 16.7;renal cancer: 5.0"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	6	"classical monocyte: 3.4"	"Lineage enriched"	"Detected in single"	7	"monocytes: 3.4"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 68.4"	"Not detected"	"Not detected"							HPA038105			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	Nucleoplasm	"HPA038105: AB_2675835"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.09e-1)"	"prognostic favorable (3.82e-4)"	"unprognostic (6.54e-3)"	"unprognostic (3.64e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.41e-1)"	5.6	3.6	0.7	0.3	0.7	0.7	3.8	0.7	1.1	1.0	0.8	5.7	13.2	0.3	0.6	0.3	1.5	2.9	2.6	0.7	0.7	27.4	134.2	7.4	0.0	0.8	0.9	1.0	17.2	2.1	0.9	0.2	0.8	2.9	2.8	0.3	12.7	1.0	4.6	0.4	7.9	0.3	0.7	0.7	6.4	0.4	0.8	0.0	5.6	0.1	0.0	0.4	0.7	0.7	0.0	1.5	0.7	0.0	0.0	0.8	1.8	0.0	0.4	1.0	1.6	7.1	2.3	0.0	0.8	0.0	0.2	0.0	0.7	0.1	0.6	0.0	0.7	1.8	0.2	68.4	0.4	0.0	0.0	2.7	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.2	0.6	0.0	0.0	0.0	0.0	2.3	0.0	0.1	1.0	0.0	0.8	0.1	0.3	8.4	5.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.7	0.7	0.7	1.1	0.7	0.7	0.8	0.9	0.8	0.7	0.8	0.7	0.3	28.9	31.5	2.9	1.9	0.1	0.5	3.2	0.0	1.0	4.3	3.6	3.3	18.6	8.7	9.2	0.0	0.0	0.0	13.7	45.0	2.2	0.5	4.8	1.0	0.8	3.0	2.7	1.0	7.9	0.0	1.7	13.3	1.0	1.3	1.9	1.8	77.9	1.0	0.0	1.1	10.9	0.0	3.5	0.0	0.7	1.5	1.8	1.8	3.7	3.1	1.5	0.0	1.0	0.4	2.2	8.1	5.7	0.3	2.0	33.7	151.1	25.4	0.6	0.0	0.3	1.2	0.4	0.3	0.2	0.9	0.0	1.4	1.8	11.9	0.7
ABCD1	"adrenoleukodystrophy, ALD, ALDP, AMN"	ENSG00000101986	"ATP binding cassette subfamily D member 1"	P33897	X	153724856-153744755	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 19.5;Proximal enterocytes: 39.2;Syncytiotrophoblasts: 27.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 36.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 69.7;PC-3: 50.0;SK-BR-3: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035214	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"HPA035214: "	"unprognostic (1.90e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.57e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.14e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (4.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.23e-2)"	14.6	33.3	3.1	5.4	3.9	4.7	12.5	3.4	3.8	7.5	2.2	14.7	10.6	33.2	1.7	3.7	9.3	3.4	11.9	2.9	3.4	7.0	13.3	7.6	3.9	4.4	3.6	5.4	11.9	2.1	10.0	4.7	4.8	9.9	1.8	0.5	6.2	5.6	20.5	4.4	17.4	4.8	3.1	13.8	7.2	19.0	5.5	4.3	6.0	4.6	1.7	11.9	6.1	4.2	13.2	4.0	2.6	11.2	7.4	3.2	34.3	6.3	6.8	4.2	7.4	2.6	7.1	3.5	69.7	8.6	11.3	1.7	1.6	1.4	0.5	11.8	2.1	10.3	42.1	34.1	9.8	6.4	22.4	6.2	1.7	4.8	0.4	4.4	6.7	4.7	6.0	12.4	5.9	4.7	4.5	6.1	3.3	3.2	50.0	7.8	6.2	5.7	3.2	1.4	2.8	11.5	16.4	49.2	26.4	3.0	3.7	10.8	7.9	5.5	7.4	14.3	7.0	12.2	5.7	8.4	6.9	21.7	7.8	0.4	3.2	2.5	0.8	3.0	4.0	1.0	1.0	1.2	2.7	0.7	1.1	0.8	1.7	0.7	2.8	1.7	0.3	2.5	3.1	3.9	3.4	3.8	2.9	3.4	4.4	3.6	4.8	3.1	5.5	4.2	5.0	0.0	1.1	3.6	3.8	3.2	1.6	1.6	0.6	2.2	2.7	2.8	2.4	2.8	2.2	3.7	2.1	12.2	4.8	9.5	0.0	3.8	0.7	2.0	3.5	3.4	6.0	3.6	0.5	6.9	19.5	4.5	3.6	4.0	0.0	6.9	5.7	6.8	12.6	8.4	0.9	5.0	2.0	15.9	8.4	2.7	4.1	12.3	1.8	0.0	5.9	2.4	0.0	0.0	1.2	5.0	2.1	5.7	2.4	0.8	39.2	2.8	1.2	0.7	6.6	2.3	2.8	3.8	4.8	0.8	1.3	27.4	4.0	7.8	5.5	1.4
ABCD3	"PMP70, PXMP1, ZWS2"	ENSG00000117528	"ATP binding cassette subfamily D member 3"	P28288	1	94418389-94518666	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 126.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032026, HPA032027, CAB032516, CAB075749"	Enhanced		Enhanced	Peroxisomes		NA	NA		12000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Peroxisomes		"CAB032516: AB_2257637, CAB075749: AB_2665755, HPA032026: AB_2674117, HPA032027: AB_10602103"	"unprognostic (1.41e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.16e-5)"	"unprognostic (1.92e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.12e-2)"	"prognostic favorable (4.84e-5)"	"unprognostic (5.45e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-1)"	16.8	18.7	19.8	16.2	23.2	25.1	32.8	22.7	24.3	22.4	22.6	44.6	44.5	14.7	21.2	26.7	16.7	26.8	26.0	18.7	21.8	59.4	126.6	23.3	13.3	22.1	21.2	10.1	28.6	29.6	13.3	14.4	22.7	21.5	40.2	26.3	17.5	27.0	23.5	35.5	46.1	17.7	23.7	11.0	43.5	16.3	21.4	47.5	27.5	29.8	21.2	22.9	16.2	27.3	81.5	37.6	37.8	36.1	28.3	31.0	55.8	41.4	32.0	46.8	51.5	117.5	25.0	49.8	52.1	52.8	50.0	58.2	43.7	53.7	64.9	40.1	36.9	56.7	52.3	102.5	27.5	51.2	17.0	26.2	29.6	54.2	20.8	30.2	29.0	47.0	25.8	29.2	48.6	11.4	86.4	26.8	43.7	61.7	50.7	48.0	78.4	19.4	45.6	122.2	28.5	46.7	71.5	75.2	55.7	28.4	27.7	41.8	28.9	34.5	49.5	61.3	55.9	16.5	16.5	48.4	27.1	25.6	16.4	0.4	3.8	2.9	4.2	4.3	4.0	1.8	3.8	4.9	5.9	1.8	4.5	4.4	0.9	5.9	3.8	1.5	4.6	3.3	19.8	23.2	22.7	24.3	18.7	21.8	22.1	21.2	22.7	23.7	21.4	27.3	16.9	35.3	48.8	64.3	10.2	23.3	16.2	32.8	14.8	27.5	43.7	21.1	39.1	58.6	43.2	42.3	22.9	25.0	12.3	72.1	23.5	22.8	9.0	37.5	16.8	16.4	39.7	8.4	32.7	44.5	12.0	18.3	37.8	30.6	27.9	19.1	18.2	108.9	11.0	33.7	47.5	37.5	26.4	21.9	7.4	8.2	13.7	15.0	16.0	40.3	15.1	78.4	11.3	67.3	96.5	37.5	33.0	24.5	15.4	20.4	75.7	72.3	49.8	26.3	19.7	19.0	17.7	14.5	23.2	21.0	34.0	15.3	15.4	16.7	39.5	32.5
ABCD4	"EST352188, P70R, PMP69, PXMP1L"	ENSG00000119688	"ATP binding cassette subfamily D member 4"	O14678	14	74285269-74303055	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003396	Approved					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 52: Non-specific - Transcription"			"HPA003396: AB_1078078"	"unprognostic (3.92e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.86e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.21e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.45e-3)"	"unprognostic (7.93e-3)"	6.6	4.7	3.0	3.9	3.4	4.6	6.4	4.0	5.4	5.8	2.9	5.4	8.8	4.9	2.1	4.8	8.5	7.7	6.0	3.0	3.3	5.4	7.7	5.8	6.6	4.2	3.4	6.9	6.0	3.8	3.9	7.4	3.7	3.6	4.0	3.3	4.0	3.5	3.9	4.1	8.7	5.2	2.8	6.2	4.5	3.4	3.6	5.5	7.2	2.0	3.8	4.5	4.3	4.5	2.6	3.1	7.9	6.2	6.4	4.3	9.8	3.9	5.6	5.8	6.0	6.5	13.7	4.3	7.4	5.9	3.2	9.2	6.0	5.4	3.0	3.9	3.8	2.3	5.1	5.2	2.1	2.9	4.4	10.4	2.4	4.1	2.8	3.0	9.9	5.4	4.3	1.9	4.5	4.3	7.1	5.6	3.0	5.0	5.9	9.7	11.4	6.3	8.6	8.5	3.7	7.3	5.4	5.3	5.5	3.7	12.3	1.7	9.7	3.6	7.0	3.2	2.5	4.4	4.5	3.3	5.1	4.3	4.5	6.0	1.3	1.8	2.6	1.2	1.7	1.9	2.2	2.9	2.1	1.8	1.2	1.8	1.1	2.6	1.0	4.0	5.2	1.4	3.0	3.4	4.0	5.4	3.0	3.3	4.2	3.4	3.7	2.8	3.6	4.5	50.0	28.9	18.6	32.3	16.7	15.6	14.8	23.0	12.0	46.5	21.4	14.2	9.7	34.3	21.2	20.2	64.6	51.6	28.9	31.4	9.8	25.3	10.3	27.9	23.5	50.2	12.0	9.9	29.6	11.3	19.9	23.0	13.7	20.1	20.3	43.2	44.6	23.3	51.1	32.0	34.7	15.7	18.3	24.8	27.1	7.7	40.4	19.5	21.4	20.6	22.8	36.4	32.0	23.6	38.1	17.9	19.4	25.2	13.3	12.6	60.1	23.9	19.5	55.5	32.9	23.3	19.1	35.8	27.2	10.6	10.7	28.5	23.4	27.9	22.9	16.7
ABCG5	STSL	ENSG00000138075	"ATP binding cassette subfamily G member 5"	Q9H222	2	43812472-43838865	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	69	"intestine: 47.8;liver: 62.0"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 60.3;Paneth cells: 23.9;Proximal enterocytes: 30.9"	"Cancer enriched"	"Detected in some"	23	"liver cancer: 11.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	54	"Hep G2: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.71e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.01e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.97e-2)"	"prognostic favorable (2.60e-5)"	"unprognostic (4.59e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.38e-3)"	"unprognostic (3.07e-4)"	"unprognostic (1.86e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.52e-3)"	"unprognostic (8.29e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.08e-2)"	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	47.8	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.0	62.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.6	5.7	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.1	0.6	0.1	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.7	60.3	0.0	0.0	3.2	2.5	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	1.8	0.0	23.9	0.0	0.0	0.0	30.9	0.0	0.0	0.7	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.7	0.0
ABCG8	GBD4	ENSG00000143921	"ATP binding cassette subfamily G member 8"	Q9H221	2	43831942-43882988	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	40	"intestine: 31.5;liver: 63.4"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 32.0;Proximal enterocytes: 13.8"	"Cancer enriched"	"Detected in some"	30	"liver cancer: 21.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	44	"Hep G2: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA019556	Uncertain		Approved	Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA019556: AB_1844444"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.28e-1)"	"unprognostic (6.14e-3)"	"unprognostic (4.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.86e-3)"	"unprognostic (5.03e-1)"		"unprognostic (1.50e-1)"	0.1	0.0	0.4	0.1	0.3	0.1	0.0	0.2	1.1	0.0	0.0	0.2	29.8	0.1	0.0	0.0	0.2	0.9	0.0	0.2	0.4	0.3	63.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.1	31.5	0.0	0.0	0.1	0.3	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	1.1	0.2	0.4	0.3	0.1	0.4	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	2.8	0.6	1.8	0.0	0.0	0.1	0.0	1.9	0.1	0.0	0.2	0.7	0.6	0.0	2.7	3.6	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.4	32.0	0.0	0.0	2.8	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	5.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.2	0.0
ABHD12	"ABHD12A, BEM46L2, C20orf22, dJ965G21.2, DKFZP434P106"	ENSG00000100997	"Abhydrolase domain containing 12, lysophospholipase"	Q8N2K0	20	25294742-25390835	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase	"Cataract, Deafness, Disease variant, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 315.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026866	Uncertain					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 22: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA026866: AB_1844446"	"prognostic unfavorable (3.81e-5)"	"prognostic favorable (1.30e-5)"	"unprognostic (1.32e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.67e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (7.18e-4)"	"unprognostic (8.51e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.08e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.11e-3)"	29.5	33.0	55.7	27.4	67.3	26.5	26.9	70.0	64.7	32.1	35.9	37.0	47.0	25.3	133.1	50.0	24.8	33.4	30.5	77.3	58.2	45.5	29.8	32.6	30.8	70.9	64.6	30.6	117.8	55.3	42.1	29.6	73.3	35.5	36.4	30.8	36.9	39.9	13.3	52.4	52.8	23.6	66.0	22.0	55.0	19.2	71.8	23.4	80.8	14.8	41.5	37.2	35.1	96.9	67.2	148.3	41.6	50.9	79.6	47.1	93.3	97.0	84.5	73.7	84.6	90.1	93.0	21.8	53.3	77.0	155.1	116.5	44.4	56.8	62.8	22.7	41.9	33.3	46.8	128.4	59.3	33.3	71.6	58.7	42.0	85.4	44.1	95.7	33.2	37.8	25.8	315.3	72.8	142.5	51.8	31.0	29.4	77.8	96.8	39.2	95.3	195.0	43.4	145.7	46.6	39.7	75.4	198.9	133.8	72.3	67.4	47.6	44.6	98.3	63.0	57.1	54.0	38.8	36.1	33.4	61.8	38.7	57.3	15.8	18.8	17.3	9.9	17.0	7.5	3.8	10.2	13.7	17.9	5.1	8.9	8.9	3.6	15.4	17.7	17.0	10.4	8.6	55.7	67.3	70.0	64.7	77.3	58.2	70.9	64.6	73.3	66.0	71.8	96.9	20.7	6.4	6.5	19.2	13.8	17.7	32.0	9.8	19.4	34.5	19.6	19.7	16.6	30.0	13.7	27.6	10.4	91.6	22.2	97.0	27.4	33.7	53.0	24.9	18.1	17.5	34.0	14.5	37.7	34.3	95.2	22.9	35.2	28.3	10.2	26.9	15.0	19.5	114.1	42.1	46.0	28.9	20.3	37.8	43.8	107.1	16.1	62.4	33.8	42.2	58.7	44.1	23.7	50.8	67.5	22.9	77.7	20.7	39.3	31.6	126.7	24.6	13.1	23.3	26.3	13.8	19.5	19.9	37.7	27.2	18.3	130.8	18.0	19.6	33.3	35.2
ABHD5	"CGI-58, NCIE2"	ENSG00000011198	"Abhydrolase domain containing 5, lysophosphatidic acid acyltransferase"	Q8WTS1	3	43690108-43734371	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Cataract, Deafness, Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 205.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 67.8;neutrophil: 42.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 67.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020685, HPA035851, HPA035852"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Cytosol"	Nucleoplasm	"CAB020685: , HPA035851: AB_10671942, HPA035852: AB_10672073"	"unprognostic (2.58e-1)"	"unprognostic (2.73e-1)"	"prognostic favorable (8.89e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.56e-2)"	"unprognostic (4.13e-3)"	"prognostic favorable (9.17e-5)"	"unprognostic (2.48e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.18e-2)"	38.8	12.5	6.7	8.5	8.6	39.6	27.9	10.5	8.9	9.8	6.0	12.3	9.9	5.7	4.1	31.1	5.1	11.6	13.4	6.8	7.4	12.0	21.7	16.4	3.4	9.2	8.2	4.6	16.0	12.2	5.6	10.2	9.1	7.1	7.5	6.3	27.4	8.4	15.0	38.0	10.5	9.3	9.3	9.4	12.1	10.8	8.4	6.8	15.5	18.5	7.9	16.7	16.9	11.9	18.9	6.8	8.2	9.7	32.0	12.8	17.1	77.4	27.1	18.8	14.9	9.4	6.4	16.2	10.9	23.2	15.8	5.8	16.5	18.5	22.6	58.4	13.2	36.6	24.4	7.5	15.7	9.2	13.2	13.0	64.6	31.3	28.5	18.8	33.3	10.8	23.9	14.2	46.9	11.0	7.6	6.9	22.8	16.7	20.4	3.1	24.1	8.6	27.9	40.4	10.6	13.6	36.9	20.5	9.8	9.8	18.9	8.9	19.3	18.1	13.6	35.0	34.5	11.1	34.0	7.7	20.3	17.3	16.0	67.8	14.7	9.5	2.3	7.9	1.7	3.5	1.7	2.7	6.8	4.0	1.6	2.5	42.5	2.0	5.7	1.9	4.8	5.3	6.7	8.6	10.5	8.9	6.8	7.4	9.2	8.2	9.1	9.3	8.4	11.9	117.5	25.6	51.8	12.7	44.8	39.9	27.5	25.9	88.8	11.9	149.9	116.2	10.3	14.3	49.6	27.6	27.1	16.7	80.3	65.0	33.2	57.5	19.5	47.5	49.0	34.6	36.2	69.0	24.1	61.5	24.9	53.7	67.8	114.0	16.5	8.8	18.2	12.7	18.0	3.3	24.1	23.7	34.6	44.1	17.4	17.1	5.3	79.8	7.2	11.2	35.9	11.0	12.3	18.1	28.8	75.2	49.8	5.7	41.8	25.5	98.5	39.8	19.1	17.4	0.0	32.0	46.4	47.3	41.9	111.7	40.9	205.4	42.6	15.2	21.9	71.6
ACACA	"ACAC, ACC, ACC1"	ENSG00000278540	"Acetyl-CoA carboxylase alpha"	Q13085	17	37084992-37406836	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Allosteric enzyme, Ligase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 138.1;Excitatory neurons: 230.7;Inhibitory neurons: 197.8;Oligodendrocyte precursor cells: 181.0;Oligodendrocytes: 186.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013715, HPA036650, HPA063018"	Approved		Supported	"Nucleoli fibrillar center,Actin filaments,Cytosol"		NA	NA		110000	"Cluster 30: Non-specific - Translation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	"Nucleoli fibrillar center, Actin filaments"	"CAB013715: , HPA036650: AB_2675228, HPA063018: AB_2684922"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (8.81e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.89e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.03e-2)"	16.2	25.4	10.8	3.7	10.8	4.9	22.2	9.0	15.8	11.5	11.3	14.4	5.2	12.1	13.8	25.2	10.8	4.8	7.7	9.5	11.2	13.6	23.3	13.3	2.0	11.1	9.9	11.3	10.5	10.9	19.2	3.8	11.1	26.2	6.4	8.0	14.6	9.6	15.1	15.4	9.6	8.0	8.6	7.3	12.6	16.4	10.3	3.7	8.9	3.6	5.5	19.9	14.6	12.3	34.7	7.0	39.8	42.6	54.7	53.2	13.9	15.2	21.3	15.9	27.5	27.4	5.9	5.0	12.0	24.3	39.4	33.9	7.5	51.1	23.7	13.6	23.2	27.3	15.5	28.0	9.2	14.8	5.3	43.4	29.0	40.2	30.0	18.8	27.5	25.1	66.5	3.2	2.1	27.3	16.3	22.8	30.4	21.5	22.1	24.1	25.3	6.4	36.1	38.5	45.0	17.0	27.8	12.3	12.7	34.8	24.9	16.8	23.8	12.7	20.6	17.3	3.9	8.7	11.5	42.0	11.7	12.3	17.2	0.5	0.8	0.1	0.6	1.3	0.6	0.7	0.7	0.7	1.0	1.1	1.1	0.8	0.3	0.6	0.8	0.7	1.0	0.6	10.8	10.8	9.0	15.8	9.5	11.2	11.1	9.9	11.1	8.6	10.3	12.3	6.8	32.1	51.7	138.1	8.0	11.6	20.8	14.8	22.2	17.2	17.3	11.7	8.0	2.8	16.5	11.0	27.1	16.0	7.0	5.3	9.8	6.7	66.3	19.1	15.6	8.3	9.0	10.7	230.7	8.3	7.6	10.4	15.8	15.9	7.0	19.5	6.4	17.3	5.8	23.5	197.8	7.3	14.2	3.8	4.3	51.2	9.9	6.1	10.6	58.1	4.3	18.2	4.1	181.0	186.9	7.2	6.4	15.8	9.3	22.8	4.8	7.0	10.5	11.8	6.6	10.0	7.8	20.8	20.5	27.8	15.9	16.3	6.4	43.2	10.0	22.0
ACADM	"ACAD1, MCAD, MCADH"	ENSG00000117054	"Acyl-CoA dehydrogenase medium chain"	P11310	1	75724431-75787575	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 367.3;skeletal muscle: 380.0;tongue: 475.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 373.1;Distal tubular cells: 344.4;Hepatocytes: 261.2;Proximal tubular cells: 564.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 289.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006198, HPA026542"	Enhanced		Enhanced	Mitochondria		NA	NA		930000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA006198: AB_1078087, HPA026542: AB_1844469"	"unprognostic (9.04e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.09e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.68e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.35e-1)"	"prognostic favorable (3.83e-8)"	"unprognostic (1.27e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.24e-1)"	81.9	82.2	25.2	24.3	25.0	17.3	69.9	26.6	42.2	29.3	30.4	46.8	103.9	20.0	25.3	51.3	30.6	27.8	217.8	24.3	25.9	295.9	367.3	22.6	42.6	26.9	26.8	35.7	35.9	66.3	19.2	16.9	25.8	26.8	49.5	21.2	31.4	26.2	380.0	14.4	75.6	25.5	26.2	27.4	52.8	35.7	25.8	29.7	38.4	475.9	44.3	32.7	21.3	25.2	25.8	20.5	61.0	26.8	53.1	42.1	17.5	48.1	40.4	46.1	38.5	38.3	39.5	289.1	40.7	34.4	39.0	22.8	54.9	41.8	57.8	113.0	25.5	94.4	58.5	58.3	36.4	80.0	23.9	50.7	23.5	39.8	22.8	35.0	36.2	56.6	102.3	60.4	50.5	9.6	96.3	40.6	50.2	80.4	49.5	118.8	83.8	30.6	77.9	70.7	33.8	43.0	38.0	111.6	102.0	43.1	32.7	107.6	20.2	29.9	29.6	26.6	78.1	38.6	62.0	128.1	25.8	67.0	35.3	15.3	14.2	19.3	17.1	20.9	27.3	40.7	17.8	21.5	21.4	24.6	20.3	23.6	0.5	25.0	20.4	23.2	19.5	19.5	25.2	25.0	26.6	42.2	24.3	25.9	26.9	26.8	25.8	26.2	25.8	25.2	42.9	57.7	58.3	29.7	56.5	27.3	41.8	69.0	44.3	39.0	49.0	40.9	373.1	52.9	63.0	58.8	25.0	35.8	39.4	42.6	344.4	37.9	55.4	27.1	32.2	36.2	40.7	67.6	51.6	26.5	19.5	47.6	26.0	25.4	44.9	61.5	43.9	261.2	75.7	30.3	46.7	38.7	63.1	45.6	22.2	24.4	46.9	38.2	51.6	19.7	32.8	53.7	29.9	36.2	36.0	21.2	49.7	45.5	74.9	24.2	88.0	564.8	106.7	30.0	0.0	38.6	43.7	76.3	86.1	46.6	27.0	15.3	39.4	72.5	46.7	35.9
ACADS	"ACAD3, SCAD"	ENSG00000122971	"Acyl-CoA dehydrogenase short chain"	P16219	12	120725774-120740008	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 245.5;skeletal muscle: 158.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 303.1;Hepatocytes: 203.3;Paneth cells: 185.7;Proximal enterocytes: 435.0;Undifferentiated cells: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004799, CAB019284, HPA022271"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"	Mitochondria		"CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472"	"unprognostic (7.14e-2)"	"unprognostic (3.03e-3)"	"unprognostic (8.15e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.11e-3)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.04e-2)"	"prognostic favorable (3.33e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.34e-5)"	50.3	52.7	13.3	11.1	15.4	14.3	40.9	13.6	16.6	11.2	13.7	74.0	84.8	10.2	0.9	14.1	10.2	8.5	90.5	12.3	13.8	51.9	245.5	13.4	6.4	14.6	14.2	8.6	33.1	4.7	9.2	7.5	13.1	13.9	21.3	0.9	19.2	7.2	158.2	13.7	73.2	5.8	14.0	31.6	34.5	20.3	16.0	6.6	21.9	79.7	3.4	18.0	12.7	14.8	3.2	11.4	0.6	9.7	12.9	5.1	11.1	4.7	4.6	6.0	4.5	8.9	8.0	0.3	11.9	3.9	2.7	5.2	6.6	2.1	0.8	16.7	8.2	8.2	3.6	19.3	9.3	0.7	36.0	15.4	3.1	2.6	0.2	1.8	6.1	20.6	6.9	0.1	2.7	6.8	11.7	19.2	2.0	10.6	4.6	8.6	4.2	2.2	11.3	18.2	1.1	6.0	9.7	0.0	15.8	0.9	7.7	13.1	6.9	0.2	4.7	4.5	0.9	15.3	9.3	4.1	10.2	7.0	4.1	8.3	15.3	7.5	13.7	16.3	9.3	6.3	12.2	14.2	13.2	8.9	15.3	14.4	1.4	19.9	10.2	11.0	14.7	12.8	13.3	15.4	13.6	16.6	12.3	13.8	14.6	14.2	13.1	14.0	16.0	14.8	18.8	12.8	13.7	10.1	6.7	6.6	9.5	21.1	4.0	1.0	25.0	14.9	44.0	27.1	13.0	18.4	0.0	78.8	9.8	303.1	50.9	35.2	23.5	12.8	8.2	13.4	45.6	38.5	2.3	32.6	31.3	18.1	28.5	10.8	19.1	12.8	19.2	203.3	55.1	1.7	2.8	105.3	20.3	21.0	8.9	36.5	21.5	15.3	17.8	0.0	26.1	13.6	18.6	3.0	3.6	26.7	185.7	18.0	7.9	8.3	435.0	94.8	7.3	0.6	6.6	13.2	12.7	41.5	8.1	9.4	4.5	75.5	11.9	140.6	185.9	12.7
ACADSB	"ACAD7, SBCAD"	ENSG00000196177	"Acyl-CoA dehydrogenase short/branched chain"	P45954	10	123008979-123058290	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 360.1"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 499.5;Proximal tubular cells: 137.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041458, HPA063555"	Enhanced		Supported	Mitochondria		NA	NA		37000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA041458: AB_2677491, HPA063555: "	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (9.37e-3)"	"prognostic favorable (6.37e-12)"	"unprognostic (2.69e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.14e-2)"	14.8	27.4	8.0	7.1	8.5	3.8	23.9	13.9	10.3	7.8	13.1	15.9	52.4	9.9	7.7	12.6	9.7	7.6	38.5	8.6	6.7	90.2	360.1	12.7	8.2	6.3	7.6	12.8	15.8	33.4	8.8	5.1	6.8	22.7	16.8	12.4	15.7	11.2	42.4	9.8	11.0	8.5	5.9	6.4	14.0	8.4	8.0	7.4	12.3	69.1	10.3	10.8	8.1	8.4	15.4	10.9	7.9	14.5	10.6	13.1	7.0	9.3	18.8	9.2	9.1	9.6	4.9	16.0	6.3	7.9	5.6	6.3	12.5	6.5	15.1	10.6	12.9	8.3	3.3	54.8	7.5	12.0	7.6	9.7	6.5	5.8	5.3	13.5	9.0	13.2	8.1	11.5	11.5	7.1	11.4	9.8	4.8	8.5	6.7	13.4	16.6	5.1	13.1	16.9	1.4	9.1	14.3	4.2	14.4	7.5	12.9	5.8	9.5	4.9	4.4	11.4	11.4	12.9	15.5	8.5	7.6	11.1	3.8	17.4	4.5	11.8	8.8	4.7	10.2	5.5	8.1	7.6	6.4	5.7	7.4	8.3	2.9	8.5	2.9	3.8	7.1	5.7	8.0	8.5	13.9	10.3	8.6	6.7	6.3	7.6	6.8	5.9	8.0	8.4	7.7	28.9	53.1	29.4	11.6	9.3	9.2	8.2	14.2	17.4	58.6	27.8	80.7	37.1	21.1	11.0	10.4	20.1	8.7	11.2	46.9	7.3	7.0	6.8	9.1	8.2	12.1	21.4	39.8	4.8	3.5	10.6	10.7	18.8	3.8	29.1	15.4	499.5	7.3	21.9	49.6	13.7	26.4	17.4	5.9	8.1	13.4	7.1	7.2	12.2	7.9	12.0	7.2	15.6	38.3	4.6	13.1	10.9	9.1	19.8	9.2	137.9	15.2	7.7	19.7	12.3	11.0	8.5	3.7	14.7	13.8	30.1	13.3	18.9	18.3	12.0
ACADVL	"ACAD6, LCACD, VLCAD"	ENSG00000072778	"Acyl-CoA dehydrogenase very long chain"	P49748	17	7217125-7225266	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 850.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019006, HPA020595"	Enhanced		Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA		98000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA019006: AB_1844478, HPA020595: AB_1844479"	"unprognostic (4.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (6.87e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.84e-3)"	197.9	405.2	120.1	78.7	131.0	103.5	142.9	128.4	126.7	110.5	170.6	157.3	306.2	98.5	44.4	181.0	94.0	92.6	576.8	117.8	125.0	215.3	517.4	106.7	52.0	127.5	125.3	80.9	236.5	159.6	189.6	112.0	124.8	133.2	131.6	34.9	158.5	113.9	850.4	135.7	270.6	110.6	118.2	132.2	186.4	75.9	132.0	83.4	159.3	817.1	82.9	137.1	115.3	122.7	193.7	162.5	65.8	92.4	271.2	99.2	135.9	156.5	169.0	136.9	84.5	67.2	155.3	90.4	109.0	260.0	49.7	147.9	43.8	135.5	119.6	295.9	47.1	50.6	120.9	101.1	131.2	49.0	129.5	112.5	122.0	114.7	178.5	212.6	124.8	111.3	73.3	110.2	222.7	65.3	49.6	68.4	34.3	178.4	91.9	70.4	78.3	227.2	305.1	155.0	19.1	47.3	206.8	224.8	110.8	60.6	102.8	74.9	151.5	127.5	101.6	75.9	149.9	104.5	59.1	5.2	230.7	85.7	94.9	24.2	96.1	121.3	39.1	57.8	35.7	25.2	32.5	43.8	99.9	24.6	23.7	29.1	20.2	37.8	39.3	80.4	31.8	79.4	120.1	131.0	128.4	126.7	117.8	125.0	127.5	125.3	124.8	118.2	132.0	122.7	109.9	60.9	81.9	143.3	72.3	87.3	336.0	322.4	91.6	42.0	157.7	104.5	451.4	138.7	206.7	202.3	62.6	482.9	87.7	484.2	185.9	310.8	133.0	87.2	52.7	77.4	179.3	65.2	40.9	77.0	197.8	118.6	406.7	88.5	88.4	121.1	53.6	365.4	182.4	33.7	33.4	251.8	233.9	67.9	94.6	249.9	124.5	101.5	81.8	34.7	274.9	40.7	73.2	23.1	24.5	106.1	388.9	132.8	172.3	369.0	489.8	345.8	144.1	41.3	105.2	88.3	147.4	114.3	47.8	113.8	87.5	663.3	75.5	169.2	316.8	367.5
ACAT1	"ACAT, THIL"	ENSG00000075239	"Acetyl-CoA acetyltransferase 1"	P24752	11	108116695-108147603	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 622.7;liver: 969.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 508.4;Distal tubular cells: 698.5;Hepatocytes: 663.4;Proximal tubular cells: 1484.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 420.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004428, HPA007569"	Enhanced		Enhanced	Mitochondria		NA	NA		1400000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA004428: AB_1078088, HPA007569: AB_1844482"	"unprognostic (3.70e-3)"	"unprognostic (2.23e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.43e-5)"	"unprognostic (3.59e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.06e-2)"	"unprognostic (6.62e-3)"	135.4	151.3	45.2	24.3	45.3	38.4	56.9	47.1	60.1	41.0	91.8	96.3	103.9	44.0	34.1	45.0	39.1	25.6	289.4	42.7	46.8	622.7	969.5	43.7	28.2	44.8	45.2	64.7	110.6	95.9	30.9	24.7	45.2	45.6	85.6	26.2	104.1	60.2	461.1	45.3	53.2	57.1	46.7	29.3	81.9	66.3	45.6	19.1	65.5	410.8	29.7	44.1	34.6	47.7	76.9	57.7	48.2	139.3	155.9	138.7	25.1	71.7	78.8	77.7	91.7	168.1	77.3	41.3	116.8	83.6	119.7	78.1	142.3	70.3	83.3	84.9	114.6	117.4	64.6	163.9	107.6	112.9	64.9	124.6	77.1	69.2	127.4	91.5	85.0	92.3	172.1	61.8	128.6	45.8	57.4	122.4	48.2	103.1	135.0	88.1	96.9	420.4	114.7	50.4	75.7	88.1	111.6	152.7	83.0	37.0	132.2	97.6	87.4	83.2	44.5	73.5	88.8	18.9	57.8	77.7	37.6	233.1	59.6	1.4	17.1	4.7	25.3	25.5	29.9	29.2	28.8	30.0	33.5	13.8	25.5	22.4	1.8	13.4	27.8	11.3	35.7	23.4	45.2	45.3	47.1	60.1	42.7	46.8	44.8	45.2	45.2	46.7	45.6	47.7	50.5	54.5	91.8	17.9	37.2	43.1	52.2	48.9	23.9	30.1	34.6	29.6	508.4	78.6	33.5	104.8	27.1	39.9	29.2	125.0	698.5	43.1	345.7	62.2	42.1	62.5	30.0	74.7	35.1	60.5	41.5	57.1	29.0	25.7	27.8	48.6	99.2	663.4	97.9	38.7	37.8	38.5	97.6	73.6	27.8	65.3	66.5	39.1	58.7	30.0	50.1	39.1	25.7	22.6	26.5	33.8	93.8	82.4	52.7	27.8	51.4	1484.0	101.8	28.8	65.7	54.2	69.2	172.7	27.2	39.2	48.4	25.2	38.1	61.6	84.5	24.4
ACBD5	"DKFZp434A2417, KIAA1996"	ENSG00000107897	"Acyl-CoA binding domain containing 5"	Q5T8D3	10	27168135-27243046	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Transport"		Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011861, HPA012145"	Enhanced		Enhanced	Peroxisomes		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 45: Enterocytes - Digestion"	Peroxisomes		"HPA011861: AB_1844493, HPA012145: AB_1844494"	"prognostic unfavorable (3.33e-4)"	"unprognostic (4.93e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.98e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.46e-2)"	"prognostic favorable (4.68e-5)"	"unprognostic (7.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.37e-3)"	14.6	25.1	31.0	13.5	37.0	18.2	12.3	36.2	37.1	13.2	24.2	20.3	39.8	9.4	9.7	12.0	12.0	15.4	40.4	27.6	33.1	37.3	73.8	14.7	14.7	37.2	34.0	9.9	11.1	31.2	6.4	13.4	38.1	15.2	20.9	36.2	10.3	11.4	31.0	17.3	39.2	8.8	36.7	14.7	21.0	19.3	36.1	12.2	27.8	36.6	12.7	13.5	7.5	38.8	25.8	76.5	17.1	18.0	19.1	17.3	20.1	32.3	12.1	28.1	33.5	19.4	39.9	10.7	27.0	22.4	23.4	21.1	23.2	16.3	23.0	26.2	23.9	16.5	23.1	15.2	20.6	11.0	20.9	16.7	17.7	23.5	12.8	24.9	20.5	16.7	13.6	19.5	35.7	20.0	21.1	9.4	13.1	35.2	10.0	17.4	42.5	20.2	44.1	22.4	21.3	45.5	35.4	38.3	17.9	18.9	18.8	11.5	30.4	27.2	15.2	43.7	25.9	19.4	28.1	20.7	27.4	24.6	12.0	12.5	13.0	10.2	15.3	12.7	15.2	6.4	7.5	12.4	13.0	7.0	5.0	11.0	11.1	10.3	15.1	8.5	7.4	8.0	31.0	37.0	36.2	37.1	27.6	33.1	37.2	34.0	38.1	36.7	36.1	38.8	23.3	25.6	29.9	17.9	16.0	9.7	4.1	14.5	7.4	30.8	14.5	10.8	83.0	15.7	25.2	31.3	25.0	9.6	27.4	22.4	33.2	22.1	43.1	33.7	20.2	18.7	10.2	8.6	20.6	16.2	12.6	16.4	19.4	41.1	12.6	11.5	12.8	56.9	19.0	23.5	26.9	30.4	10.2	25.5	12.5	16.9	16.4	22.4	21.4	15.9	22.4	47.7	29.9	17.6	24.8	17.8	26.1	16.6	14.2	11.7	64.4	48.2	32.7	47.2	19.7	20.9	16.1	41.0	8.3	16.5	15.5	10.4	22.3	27.1	26.5	9.2
ACER3	"APHC, FLJ11238, PHCA"	ENSG00000078124	"Alkaline ceramidase 3"	Q9NUN7	11	76860859-77026797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 335.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070087	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA070087: AB_2732147"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.54e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (7.13e-2)"	"unprognostic (2.35e-3)"	"unprognostic (8.45e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.68e-3)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (5.24e-2)"	"unprognostic (3.37e-1)"	"unprognostic (9.88e-2)"	"unprognostic (7.97e-2)"	10.9	3.0	6.2	4.8	8.5	3.0	5.4	8.5	9.3	5.2	4.0	6.4	6.2	4.2	3.1	6.9	4.1	3.2	3.4	6.3	8.5	4.7	2.5	8.0	4.2	8.6	7.1	2.3	2.9	3.5	2.1	6.2	9.5	4.1	5.5	2.3	4.2	2.3	1.6	2.9	4.6	3.9	8.4	5.6	3.4	6.0	7.3	2.2	3.3	1.2	3.8	4.5	4.4	12.0	7.3	7.7	6.4	7.6	29.2	14.0	5.7	11.2	10.7	8.2	9.2	6.0	7.3	6.4	8.4	8.0	10.3	12.9	10.9	10.6	10.0	8.6	4.3	9.0	4.8	3.6	8.1	9.3	15.0	6.3	5.0	11.8	10.9	4.8	16.8	5.8	6.1	4.2	9.9	5.9	0.7	6.2	3.6	19.3	8.8	4.3	22.8	5.0	6.8	7.2	2.2	5.5	13.9	12.6	3.5	4.9	10.7	5.1	22.2	8.2	6.4	23.3	8.3	3.1	7.1	8.6	5.1	4.7	8.9	0.1	4.3	2.5	0.7	3.1	0.8	1.2	0.5	0.9	4.6	0.4	0.3	0.4	0.9	0.2	2.4	1.5	1.2	1.6	6.2	8.5	8.5	9.3	6.3	8.5	8.6	7.1	9.5	8.4	7.3	12.0	32.4	41.7	35.0	52.9	11.5	31.9	21.4	17.0	33.0	18.8	11.3	11.0	7.5	11.5	27.6	9.2	10.4	13.6	11.3	54.6	7.9	15.5	66.8	6.3	29.0	29.4	2.4	13.5	65.0	17.6	7.5	17.0	26.0	11.5	83.5	30.9	27.8	10.0	44.4	43.7	71.9	30.5	18.3	64.1	67.1	31.7	20.2	64.0	17.8	61.8	40.0	11.3	12.3	159.3	335.1	18.6	37.9	25.9	8.6	15.6	20.0	15.3	12.3	10.0	6.6	17.0	21.0	69.8	25.9	26.3	16.8	26.8	15.2	7.2	20.1	24.1
ACO2	ACONM	ENSG00000100412	"Aconitase 2"	Q99798	22	41447830-41529273	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Lyase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 567.7;skeletal muscle: 660.4;tongue: 695.8"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 374.2;Proximal tubular cells: 285.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001097	Enhanced	Approved	Approved	Mitochondria		NA	NA		2000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA001097: AB_1078092"	"unprognostic (1.95e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.07e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.46e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.12e-2)"	88.8	81.6	154.2	38.6	152.2	32.0	52.4	153.0	190.0	39.5	160.1	94.4	162.9	42.0	26.1	60.4	53.6	36.5	567.7	155.2	153.1	138.9	73.9	40.7	40.5	146.1	145.3	30.8	53.8	233.8	33.6	30.5	147.8	41.2	69.6	46.9	72.0	49.5	660.4	45.5	158.5	43.7	152.5	44.7	110.2	35.1	186.3	38.0	53.7	695.8	43.3	52.5	42.4	159.6	47.2	55.8	56.5	116.3	101.2	69.8	78.7	43.7	60.9	79.0	71.9	81.2	63.5	115.7	72.2	70.6	60.3	109.8	108.8	88.3	42.8	75.8	80.2	51.0	73.7	95.0	86.7	147.8	77.8	120.8	64.4	78.9	83.2	61.7	81.2	61.5	72.9	118.4	65.4	91.7	73.7	47.9	37.0	282.6	115.1	102.3	37.8	162.1	106.8	97.3	37.8	33.9	112.2	128.7	82.0	44.9	74.9	74.7	55.5	60.0	68.7	50.2	45.0	64.7	92.1	80.6	102.0	64.0	66.5	10.3	52.9	18.1	32.0	76.4	29.3	49.4	25.5	34.9	69.0	46.4	29.2	30.8	9.0	39.4	97.1	24.0	41.2	58.6	154.2	152.2	153.0	190.0	155.2	153.1	146.1	145.3	147.8	152.5	186.3	159.6	26.3	25.6	31.8	45.4	49.4	18.7	54.5	102.7	31.3	60.6	28.0	23.2	9.1	64.3	63.5	60.7	81.3	100.3	33.3	190.8	131.0	58.3	14.5	37.2	17.7	26.1	53.2	30.3	28.8	42.6	60.0	24.0	77.5	37.1	40.6	56.7	20.7	64.6	91.5	53.8	34.0	99.1	89.5	35.5	26.4	8.9	24.2	39.2	35.6	7.5	68.3	73.9	34.0	12.1	20.9	43.9	103.5	27.8	63.2	34.4	374.2	285.7	59.2	73.5	59.2	28.6	38.4	26.4	38.2	35.8	16.1	193.2	30.7	54.4	113.6	64.9
ACOX1	PALMCOX	ENSG00000161533	"Acyl-CoA oxidase 1"	Q15067	17	75941507-75979177	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Deafness, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 191.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 199.8;Hepatocytes: 287.4;Proximal enterocytes: 238.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 77.2;neutrophil: 113.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 113.7"	"Cell line enhanced"	"Detected in all"		"BEWO: 96.9;RT4: 129.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021094, HPA021192, HPA021195, HPA028759"	Approved		Approved	Nucleoli,Peroxisomes		NA	NA		96000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Peroxisomes	Nucleoli	"CAB021094: AB_10261667, HPA021192: AB_1844527, HPA021195: AB_1844528, HPA028759: AB_10601352"	"unprognostic (7.47e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.49e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.38e-2)"	"prognostic favorable (5.25e-7)"	"unprognostic (3.39e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.46e-2)"	37.8	18.1	16.1	10.6	18.2	8.8	17.1	17.4	15.1	11.0	21.3	40.9	62.5	9.3	9.8	30.4	9.9	14.9	23.0	14.3	17.5	40.3	191.5	13.6	6.2	16.6	17.9	9.5	39.7	18.8	12.6	17.3	15.9	18.4	27.1	16.1	15.4	11.8	30.1	24.8	51.4	11.1	17.5	10.5	27.4	9.3	20.6	8.3	17.0	29.2	12.1	19.5	12.7	18.9	16.3	24.5	7.2	9.9	34.0	14.4	96.9	11.8	11.3	12.9	14.8	16.4	24.0	9.1	14.0	17.9	12.5	9.9	28.7	12.4	19.2	10.0	9.5	10.9	13.1	47.2	19.4	9.7	7.8	24.0	9.4	15.7	9.2	13.1	32.3	13.6	12.3	8.9	14.0	45.3	26.3	7.0	4.9	36.8	19.8	13.4	21.3	10.2	20.7	129.1	8.7	12.6	30.6	46.5	11.4	21.2	32.6	11.3	20.9	18.2	13.4	15.2	11.5	14.4	11.0	4.0	10.0	9.7	11.4	77.2	18.3	5.2	6.9	14.2	8.2	5.4	6.6	8.8	10.3	4.5	7.2	7.1	113.7	7.2	9.4	9.4	9.3	8.0	16.1	18.2	17.4	15.1	14.3	17.5	16.6	17.9	15.9	17.5	20.6	18.9	28.0	28.9	25.0	25.1	10.8	13.5	15.9	26.1	21.1	27.4	19.4	13.5	47.4	51.5	23.4	23.9	22.9	37.7	12.1	199.8	21.5	22.9	11.6	18.1	16.7	18.8	34.4	21.5	17.8	40.6	46.5	19.8	88.7	24.1	17.1	21.4	21.8	287.4	25.4	18.5	18.8	44.5	24.4	35.4	14.1	7.1	29.8	23.7	14.2	15.0	36.3	61.9	9.2	22.1	18.2	34.2	100.0	47.0	18.3	24.0	238.7	107.8	17.4	28.4	0.0	18.4	17.2	5.5	11.0	28.5	30.3	43.2	13.2	17.1	41.9	31.7
ACOX2	"BRCACOX, BRCOX, THCCox"	ENSG00000168306	"Acyl-CoA oxidase 2"	Q99424	3	58505136-58537283	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 177.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 89.0;Proximal enterocytes: 27.9;Proximal tubular cells: 51.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.4;ASC TERT1: 25.9;fHDF/TERT166: 9.2;Hep G2: 10.8;HSkMC: 17.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA038280, HPA064845"	Enhanced		Approved	Vesicles,Cytosol		No	No		29000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	Cytosol	"HPA038280: AB_10672623, HPA064845: AB_2685368"	"unprognostic (6.62e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.63e-3)"	8.8	8.3	4.1	2.1	4.6	0.1	5.8	4.4	4.5	9.3	16.8	12.9	25.4	9.4	5.8	6.3	10.8	8.2	16.7	4.3	4.5	42.1	177.3	6.2	1.7	5.3	4.8	11.2	4.6	9.6	4.6	3.4	4.4	10.8	8.3	1.8	7.2	9.8	8.2	2.9	21.6	11.2	4.5	1.4	4.0	4.9	4.9	4.0	16.1	17.0	1.2	8.7	6.0	4.1	0.0	0.0	0.2	0.0	16.4	25.9	4.7	3.1	0.2	0.0	0.4	0.8	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	2.3	0.0	0.0	17.4	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	4.6	4.4	4.5	4.3	4.5	5.3	4.8	4.4	4.5	4.9	4.1	1.9	3.2	5.8	11.1	0.6	0.6	7.6	0.5	5.7	0.3	1.3	3.8	14.3	4.3	0.9	3.7	0.0	0.7	0.0	4.2	15.6	0.3	0.1	0.4	1.3	1.6	3.0	2.7	0.6	1.9	0.4	8.6	2.0	0.2	1.3	8.6	6.1	89.0	5.2	1.7	0.6	5.1	0.0	1.9	0.4	1.8	10.8	1.7	0.0	1.0	0.5	10.8	0.0	0.5	0.0	0.4	0.8	8.6	0.1	0.6	27.9	51.0	0.0	0.8	6.6	7.0	5.2	0.4	0.4	3.0	0.3	0.8	0.3	9.6	4.6	3.8
ACP2	LAP	ENSG00000134575	"Acid phosphatase 2, lysosomal"	P11117	11	47239302-47248906	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 89.3;Hofbauer cells: 113.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 69.9"	"Lineage enriched"	"Detected in all"	5	"monocytes: 69.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		12000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (5.27e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.86e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (7.90e-3)"	"unprognostic (2.93e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.64e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.57e-1)"	25.2	36.6	17.3	22.9	17.1	6.4	21.8	17.0	18.5	16.5	22.1	23.3	42.9	15.8	29.8	14.3	14.1	19.6	21.7	19.8	26.0	27.4	80.5	21.4	29.4	20.8	19.6	11.1	45.9	21.3	21.3	28.7	23.1	25.4	18.1	11.9	50.3	18.3	14.0	11.4	31.9	16.9	16.9	29.1	24.8	12.2	22.0	13.7	19.3	14.8	15.3	22.0	13.1	17.2	16.5	33.5	31.9	28.2	28.1	13.6	24.4	26.6	47.1	47.5	49.4	23.3	26.3	4.3	21.9	34.2	14.3	23.7	16.9	24.6	22.5	85.5	29.1	11.1	48.1	24.6	38.4	16.4	27.1	34.1	15.2	24.6	14.5	28.3	34.9	14.1	20.3	33.9	31.5	26.8	13.4	14.2	21.5	24.8	20.0	10.8	43.1	36.2	34.9	37.6	16.7	26.0	36.8	80.1	19.2	16.3	49.0	14.0	21.0	23.9	19.8	31.4	38.4	28.1	40.0	3.6	35.0	8.2	37.6	12.5	16.9	7.2	12.3	69.9	9.4	2.5	7.6	11.1	15.1	1.5	6.6	5.7	2.8	9.7	48.2	0.6	8.3	10.9	17.3	17.1	17.0	18.5	19.8	26.0	20.8	19.6	23.1	16.9	22.0	17.2	13.3	19.2	18.6	6.2	5.6	4.1	9.3	42.2	10.2	14.4	13.5	9.1	9.2	21.5	29.4	18.4	6.2	41.3	2.6	37.6	9.8	50.6	1.8	7.7	15.6	18.3	15.0	13.5	6.9	60.1	33.3	15.3	17.3	12.1	12.0	10.7	45.7	89.3	113.5	11.8	8.9	26.7	22.4	80.0	3.9	3.5	5.0	33.8	24.9	3.7	29.8	20.6	7.2	8.5	4.3	33.5	29.5	10.5	21.1	10.9	55.3	33.4	19.2	11.9	19.7	8.1	14.5	11.8	19.1	9.5	2.4	29.3	5.8	25.2	14.3	8.6
ACP4	ACPT	ENSG00000142513	"Acid phosphatase 4"	Q9BZG2	19	50790415-50795219	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		Hydrolase	"Amelogenesis imperfecta, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 1.2;testis: 3.7"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.5;U-266/84: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 16: U-266 - Nucleosome"					"unprognostic (9.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.00e-3)"	"unprognostic (3.70e-3)"	"unprognostic (7.62e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.89e-3)"	"unprognostic (5.46e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.59e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.37e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	1.5	0.0	0.5	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.9	0.0	0.3	0.2	0.4	0.1	0.2	0.5	0.3	0.1	0.2	0.0	0.5	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.3	0.0	0.2	0.2	0.2	0.1	0.2	2.0	0.2	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.8	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ACP5	"HPAP, TRAP"	ENSG00000102575	"Acid phosphatase 5, tartrate resistant"	P13686	19	11574660-11579008	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 174.1"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 426.9;Hofbauer cells: 426.7;Macrophages: 298.2;Proximal tubular cells: 145.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 200.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 41.1;K-562: 30.4;RPMI-8226: 41.4;SK-MEL-30: 127.6;U-138 MG: 102.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB002584, HPA057655, HPA059463"	Enhanced		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		4000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB002584: AB_564039, HPA057655: AB_2683490, HPA059463: AB_2684028"	"unprognostic (4.27e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.93e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.13e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.66e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	9.4	6.0	2.2	42.4	3.9	9.4	25.6	2.5	21.4	34.7	3.0	46.4	31.9	19.2	7.8	23.4	8.6	26.7	5.1	1.9	3.9	74.0	32.5	174.1	87.1	4.1	3.1	20.3	11.9	2.4	1.3	13.3	6.0	19.6	36.4	20.1	14.3	7.0	1.4	24.9	30.2	13.3	4.1	43.5	38.7	4.0	15.7	25.4	3.0	5.0	43.6	33.1	11.3	5.7	10.2	1.1	0.0	0.2	0.5	0.0	41.1	1.1	25.8	0.0	0.1	0.4	0.3	1.4	1.8	9.0	5.9	0.3	0.0	4.5	0.1	12.1	0.8	0.3	0.0	5.0	1.4	0.1	0.6	0.0	4.1	0.4	0.0	0.0	0.0	0.0	30.4	0.2	0.0	2.3	0.9	1.4	0.8	0.3	0.7	0.4	1.8	41.4	0.0	0.4	0.7	1.0	0.0	0.0	127.6	1.1	0.2	0.4	0.9	102.9	1.2	1.8	0.3	0.7	5.7	0.6	23.7	0.1	4.0	0.4	35.3	76.6	15.8	36.1	8.8	200.1	26.0	19.6	7.3	110.9	35.3	20.2	10.4	13.3	36.3	62.5	67.8	36.4	2.2	3.9	2.5	21.4	1.9	3.9	4.1	3.1	6.0	4.1	15.7	5.7	2.2	9.6	7.8	0.0	75.7	10.3	11.0	21.8	25.0	18.3	14.6	18.4	1.4	15.7	5.7	7.3	18.8	33.4	21.2	7.0	9.8	1.8	0.2	0.7	9.1	30.9	3.0	24.5	0.0	11.3	32.7	19.8	10.7	0.9	63.7	0.8	426.9	8.4	426.7	1.7	0.0	4.7	10.2	106.0	68.6	0.7	1.8	298.2	14.2	1.0	79.8	48.5	8.2	0.0	0.1	4.4	20.4	12.0	33.4	14.5	12.7	145.8	2.5	41.4	0.0	0.4	2.8	0.1	0.2	14.6	11.1	26.1	29.5	0.1	6.7	6.1
ACSF3		ENSG00000176715	"Acyl-CoA synthetase family member 3"	Q4G176	16	89088375-89164121	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 242.9;U-698: 113.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008322			Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 9: Intestine - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	Nucleoplasm	"HPA008322: AB_1845294"	"unprognostic (1.94e-1)"	"unprognostic (3.35e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.87e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (3.76e-5)"	"unprognostic (3.36e-2)"	"prognostic favorable (5.97e-6)"	"unprognostic (2.33e-1)"	"unprognostic (5.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.00e-3)"	8.9	20.5	8.0	15.9	8.2	11.6	9.4	9.9	11.4	9.2	9.6	17.1	30.7	9.6	9.7	10.5	9.5	9.7	9.8	8.0	7.1	11.6	19.2	7.9	21.7	9.1	8.2	8.9	15.6	18.5	7.7	6.1	9.3	8.6	11.4	5.9	13.2	6.5	13.1	10.5	26.4	7.8	7.1	13.3	12.6	7.8	10.6	37.6	9.8	16.5	13.9	10.2	8.7	12.0	12.8	17.8	8.4	14.4	14.5	13.3	19.6	16.5	6.1	16.2	10.4	16.2	20.9	33.2	21.5	14.2	10.5	20.9	8.6	19.4	10.0	12.3	20.6	25.8	16.6	23.8	35.2	8.1	13.3	19.4	22.0	12.4	18.1	18.5	11.7	242.9	36.4	10.1	9.0	32.7	45.6	25.7	9.8	24.8	30.0	53.2	7.2	14.1	15.9	17.2	20.6	15.3	26.6	6.8	26.2	13.5	23.1	28.6	11.6	17.3	12.8	10.2	12.5	11.7	17.3	113.0	15.4	29.8	14.5	7.0	23.0	17.2	22.7	22.8	25.2	29.8	18.5	16.5	21.7	20.6	19.5	17.4	9.0	10.8	21.3	24.6	19.6	17.9	8.0	8.2	9.9	11.4	8.0	7.1	9.1	8.2	9.3	7.1	10.6	12.0	9.2	0.0	11.4	9.4	22.5	3.2	7.6	11.9	4.0	20.2	8.5	7.5	9.1	11.5	15.5	5.5	31.3	11.9	17.5	29.9	15.6	16.1	13.8	10.3	9.3	10.3	16.8	14.3	10.1	10.7	3.8	9.3	17.3	8.1	2.5	44.7	7.9	12.5	18.6	21.9	9.5	19.4	28.5	19.5	14.2	20.4	12.2	14.0	7.2	14.0	18.6	9.3	13.4	9.0	11.2	16.3	20.8	10.1	21.2	8.9	54.7	13.5	10.0	19.0	39.5	11.1	9.7	8.8	8.5	8.2	4.5	7.3	17.0	20.1	31.1	7.4
ACSL4	"ACS4, FACL4, LACS4, MRX63, MRX68"	ENSG00000068366	"Acyl-CoA synthetase long chain family member 4"	O60488	X	109624244-109733403	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase	"Alport syndrome, Deafness, Disease variant, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 184.3;Glandular and luminal cells: 208.8;granulocytes: 633.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 360.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000286, HPA005552"	Supported		Approved	"Golgi apparatus,Mitochondria"		NA	NA		16000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Golgi apparatus"	Mitochondria	"HPA000286: AB_2665966, HPA005552: AB_1078774"	"unprognostic (9.13e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.94e-2)"	"unprognostic (5.32e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.29e-2)"	"prognostic favorable (5.73e-4)"	44.2	40.6	11.9	38.8	14.1	16.2	19.8	13.2	14.8	48.2	5.6	12.7	15.4	19.2	17.7	15.8	13.4	29.2	29.4	16.5	23.7	46.4	13.9	39.0	24.6	17.6	20.8	14.9	11.9	19.8	9.2	21.4	21.3	13.4	13.6	24.7	10.6	15.2	42.6	9.9	13.4	22.0	13.7	22.2	19.3	26.8	14.6	20.3	18.6	16.9	18.5	68.0	10.6	18.9	67.3	21.3	24.2	28.3	97.8	61.6	20.3	94.0	107.6	91.0	97.4	21.1	45.0	46.2	35.4	71.7	100.9	19.4	22.4	92.0	143.0	15.7	23.3	181.4	26.6	223.3	44.8	44.8	360.0	51.4	36.7	103.6	74.0	50.2	71.8	25.5	5.6	54.2	100.7	4.7	40.7	60.7	31.6	15.2	37.2	26.4	45.4	39.6	136.3	20.9	15.2	12.3	109.3	0.4	63.2	49.0	1.9	45.8	128.5	81.1	22.6	129.3	85.9	28.1	31.7	41.2	139.7	97.8	52.2	32.5	10.9	35.0	4.2	15.5	3.2	3.3	3.9	3.5	10.6	3.1	3.0	3.8	29.6	4.0	19.4	4.0	6.7	6.5	11.9	14.1	13.2	14.8	16.5	23.7	17.6	20.8	21.3	13.7	14.6	18.9	27.9	76.9	184.3	29.0	19.5	22.3	25.7	20.0	81.4	44.2	7.3	8.1	37.2	15.7	40.1	73.5	2.1	7.3	18.3	0.8	50.9	27.7	1.4	79.5	27.0	29.8	7.7	26.1	76.7	25.4	36.9	46.0	7.1	208.8	633.8	151.6	18.2	44.2	23.9	6.7	78.3	5.7	2.0	64.9	59.1	4.9	5.6	67.8	16.0	57.1	70.4	10.9	8.2	71.4	116.4	32.3	3.0	10.1	36.1	19.4	0.7	12.4	12.2	16.7	0.0	20.0	27.9	3.7	5.3	10.1	8.1	31.6	25.2	34.9	2.7	18.4
ACSL6	"ACS2, FACL6, KIAA0837, LACS2, LACS5"	ENSG00000164398	"Acyl-CoA synthetase long chain family member 6"	Q9UKU0	5	131949973-132012243	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.6;brain: 32.0;retina: 45.8;testis: 20.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 229.2;Cone photoreceptor cells: 229.4;Erythroid cells: 110.5;Inhibitory neurons: 110.6;Rod photoreceptor cells: 130.0"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 1.8;glioma: 1.9;liver cancer: 0.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.6"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 7.6;U-937: 6.2"									HPA040470	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA040470: AB_10794033"	"unprognostic (1.99e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.89e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.38e-3)"	"unprognostic (5.84e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.57e-2)"	"unprognostic (9.28e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.70e-1)"	0.2	4.2	14.8	1.4	18.3	22.6	0.2	26.3	32.0	0.1	1.2	0.5	4.7	0.1	0.5	0.3	0.2	0.3	1.4	18.6	12.8	1.9	2.0	0.3	2.4	22.2	18.2	0.0	1.1	11.3	4.2	0.6	18.9	0.3	0.3	45.8	0.3	18.0	2.3	0.1	2.4	0.1	13.8	1.1	0.6	20.7	25.0	0.6	0.4	1.4	1.0	0.2	0.1	14.3	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.1	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.1	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.2	6.2	0.3	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.7	1.6	0.0	0.0	1.1	0.5	0.0	0.3	0.0	0.0	0.0	0.3	14.8	18.3	26.3	32.0	18.6	12.8	22.2	18.2	18.9	13.8	25.0	14.3	0.6	25.6	29.2	229.2	1.4	1.9	1.5	0.0	2.2	65.2	2.1	0.4	0.0	1.5	16.1	1.8	229.4	0.3	3.3	0.6	7.9	0.6	43.7	0.3	0.1	3.9	2.4	110.5	70.6	0.2	0.1	4.2	0.0	0.2	10.1	0.2	1.8	8.4	0.1	21.9	110.6	1.8	0.0	1.0	15.9	7.9	0.3	6.4	0.0	15.9	0.9	24.5	0.0	41.7	9.8	0.3	1.6	1.9	0.8	1.1	1.8	0.4	8.1	130.0	0.0	2.3	1.1	45.3	1.7	0.1	1.3	0.3	15.3	0.1	0.4	1.3
ACTN2		ENSG00000077522	"Actinin alpha 2"	P35609	1	236664141-236764631	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	53	"heart muscle: 772.7;skeletal muscle: 2134.7;tongue: 1262.2"	"Cell type enriched"	"Detected in some"	11	"Cardiomyocytes: 1762.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 2.0;HEK 293: 1.3;HSkMC: 5.9;hTEC/SVTERT24-B: 2.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 66.6"	"Region enhanced"	"Detected in all"		"basal ganglia: 44.5"	"HPA006035, HPA008315"	Enhanced		Uncertain	"Actin filaments"		NA	NA		25000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Actin filaments"		"HPA006035: AB_1078095, HPA008315: AB_1844543"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.91e-1)"	"unprognostic (4.32e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-11)"	"unprognostic (1.30e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	0.7	0.2	12.0	0.0	26.3	0.1	0.9	8.0	20.1	0.3	11.0	0.4	0.0	0.5	0.0	21.8	0.5	0.7	772.7	13.2	12.1	0.5	0.3	3.9	0.2	9.7	8.1	1.1	1.6	0.1	0.5	0.1	10.7	16.1	0.0	1.3	18.4	0.1	2134.7	1.3	0.5	1.8	8.0	0.2	3.8	4.2	8.7	0.5	0.7	1262.2	0.1	3.5	0.4	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	1.0	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.1	1.3	0.0	0.0	0.2	0.0	0.0	0.2	5.9	0.0	2.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	26.3	8.0	20.1	13.2	12.1	9.7	8.1	10.7	8.0	8.7	14.2	0.3	0.0	0.6	18.6	0.0	0.3	0.4	0.0	1.2	2.6	0.4	0.5	1762.9	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	8.6	0.5	1.2	10.4	0.0	0.0	40.9	0.7	0.0	43.7	3.6	1.4	0.0	0.1	1.8	0.2	0.1	0.0	11.3	0.0	0.0	0.0	0.3	24.6	0.6	1.2	0.0	11.2	0.0	0.0	0.0	24.6	156.9	0.2	0.0	0.4	0.0	0.2	0.0	1.4	0.0	1.2	0.0	66.3	12.4	3.1	2.0	1.2	0.1	0.0	0.4	0.4	0.0	0.2
ACVR1	"ACVR1A, ACVRLK2, ALK2, SKR1"	ENSG00000115170	"Activin A receptor type 1"	Q04771	2	157736444-157876330	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 6.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007505, HPA046514"	Approved		Uncertain	Nucleoli,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli	Cytosol	"HPA007505: AB_1844752, HPA046514: AB_2732526"	"unprognostic (6.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.65e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (5.17e-4)"	20.8	10.4	17.3	12.9	12.7	1.8	18.8	14.0	15.4	28.1	17.4	16.5	10.9	24.4	32.7	11.3	17.0	24.2	19.7	26.3	12.8	26.4	22.7	17.5	8.8	13.7	12.9	21.2	10.0	8.5	10.9	17.6	13.7	15.1	12.6	6.3	18.8	15.3	21.5	13.9	10.5	34.5	12.6	8.3	14.7	5.2	16.3	7.5	40.5	13.3	8.2	20.9	15.5	11.8	6.1	13.1	14.4	18.5	65.0	70.6	18.9	43.4	71.3	33.7	36.1	10.1	13.4	0.2	18.2	45.6	32.3	16.9	10.5	22.5	36.8	43.0	8.7	25.7	7.2	14.4	54.7	2.0	28.5	89.5	41.4	69.8	84.2	42.8	38.7	6.7	9.5	6.7	45.2	11.1	0.4	0.4	21.4	8.7	21.7	4.1	19.6	5.7	45.4	24.5	12.4	14.9	17.0	9.7	64.5	22.2	5.3	7.0	54.0	50.9	16.8	25.3	17.1	4.7	3.5	0.3	52.2	1.6	58.1	2.9	1.7	0.1	0.5	1.0	0.7	0.8	4.9	1.3	1.3	0.2	1.6	0.7	0.2	1.2	1.4	1.4	6.6	1.1	17.3	12.7	14.0	15.4	26.3	12.8	13.7	12.9	13.7	12.6	16.3	11.8	9.6	9.6	9.0	22.9	1.8	9.8	7.7	12.6	12.5	10.4	8.0	9.8	12.7	11.5	12.4	7.3	0.0	8.4	1.1	4.8	5.9	9.9	1.0	5.9	12.9	17.3	4.2	1.7	34.0	17.8	5.3	20.3	8.2	6.5	5.1	4.2	18.2	13.3	7.0	3.3	34.2	4.5	24.4	13.0	8.7	2.0	20.2	7.6	3.6	106.8	5.5	6.6	2.1	42.3	22.9	17.2	4.1	15.8	6.4	13.0	3.7	15.5	13.6	2.1	13.1	16.3	19.3	0.4	2.7	4.0	7.5	10.5	4.3	3.5	4.3	8.8
ACVR1B	"ActRIB, ACVRLK4, ALK4, SKR2"	ENSG00000135503	"Activin A receptor type 1B"	P36896	12	51951699-51997078	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026126, HPA063761"	Approved		Approved	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB026126: , HPA063761: AB_2685115"	"unprognostic (8.66e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.79e-2)"	16.5	10.3	20.7	10.0	20.8	13.5	13.2	13.6	23.4	13.9	9.1	24.6	28.2	8.8	18.0	20.9	15.3	12.2	10.1	21.5	13.3	34.3	29.9	14.7	6.4	12.5	13.9	9.4	40.7	52.7	14.7	11.1	13.1	14.0	24.4	17.4	32.8	15.3	13.1	45.6	26.1	8.1	9.5	8.8	24.9	15.7	16.1	7.6	11.4	8.8	7.4	12.6	18.8	18.3	11.4	24.3	18.6	10.3	20.9	16.2	10.5	12.6	14.2	13.1	9.9	49.5	17.1	5.0	17.2	13.8	14.6	19.6	17.8	15.2	13.5	7.3	21.0	12.3	5.9	15.6	23.8	19.9	43.8	32.0	19.4	14.8	18.6	13.9	18.7	17.7	13.3	14.9	11.8	23.2	19.1	17.2	18.0	24.0	8.5	10.2	14.4	6.4	37.2	17.0	23.5	19.5	13.6	19.2	9.0	13.1	21.1	12.8	12.0	9.0	13.6	10.2	6.1	9.0	6.8	6.7	9.7	9.4	11.8	2.5	1.2	3.9	0.3	1.8	0.5	0.0	0.3	0.3	0.7	0.2	0.8	0.4	1.0	0.0	2.2	0.3	0.5	0.3	20.7	20.8	13.6	23.4	21.5	13.3	12.5	13.9	13.1	9.5	16.1	18.3	8.0	3.2	13.4	8.1	2.9	18.6	10.1	9.2	23.3	45.3	11.3	8.6	5.9	17.2	12.0	25.8	29.2	0.7	2.0	49.7	3.9	17.7	2.9	12.3	8.1	10.9	24.6	0.8	34.8	14.4	0.8	12.6	19.9	9.0	11.4	9.4	17.9	24.4	4.0	37.0	30.2	28.7	2.0	16.7	5.3	8.4	9.9	10.0	7.2	9.4	10.1	8.8	1.0	21.6	11.3	13.3	22.1	9.4	2.3	15.1	31.8	17.0	15.8	24.5	6.6	17.5	12.2	3.8	16.5	17.7	25.3	0.5	4.6	5.6	24.7	15.5
ACVR2B	ActR-IIB	ENSG00000114739	"Activin A receptor type 2B"	Q13705	3	38453890-38493142	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 5.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 20.9;NTERA-2: 25.9;SuSa: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025115, HPA040384"	Approved					NA	No				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"			"CAB025115: , HPA040384: AB_2732484"	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.75e-1)"	1.1	2.8	3.2	0.6	3.2	0.2	1.7	5.2	2.8	1.9	1.0	1.5	0.9	1.7	1.7	0.7	1.9	0.6	1.4	2.6	3.0	1.8	2.2	1.3	0.7	2.6	3.2	2.9	2.5	3.3	2.0	2.5	2.6	1.3	1.1	6.5	1.7	1.3	6.0	0.7	1.1	0.9	2.3	1.0	1.5	2.5	2.9	4.1	1.6	2.8	0.6	1.4	1.4	3.6	1.1	1.8	20.9	1.8	0.8	0.5	11.2	0.4	0.7	0.4	0.9	3.1	1.4	0.1	1.6	0.5	0.6	1.3	8.1	1.3	1.1	3.2	5.2	5.6	3.5	4.6	1.0	4.0	2.0	0.8	1.2	0.6	2.3	1.3	1.4	8.0	9.4	1.8	0.4	1.7	6.9	2.5	25.9	1.1	0.9	2.2	7.0	1.4	1.3	2.6	4.9	8.5	0.6	3.2	3.0	14.7	1.7	5.2	1.2	0.7	3.3	0.5	1.8	5.0	7.3	1.2	0.7	3.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.2	3.2	5.2	2.8	2.6	3.0	2.6	3.2	2.6	2.3	2.9	3.6	7.0	6.4	6.1	9.4	0.7	4.0	4.6	2.1	4.0	23.0	5.2	5.0	15.0	2.8	3.6	0.0	22.9	8.5	1.3	3.1	0.0	3.6	11.3	8.7	7.0	7.5	7.2	0.4	12.6	3.8	7.6	3.8	2.6	5.3	1.3	17.9	7.9	8.7	2.6	21.9	17.0	4.1	0.0	2.2	6.4	15.8	11.8	2.4	7.2	5.6	0.7	7.6	0.0	15.1	17.2	3.2	5.3	7.9	1.4	5.2	4.8	3.1	7.1	25.4	0.0	9.7	7.7	11.4	17.9	1.8	4.0	6.2	2.6	7.4	4.4	3.9
ACVRL1	"ACVRLK1, ALK1, HHT, HHT2, ORW2"	ENSG00000139567	"Activin A receptor like type 1"	P37023	12	51906908-51923361	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 96.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 107.3;Distal enterocytes: 182.7;Endothelial cells: 84.7;Fibroblasts: 56.0;Hepatic stellate cells: 60.3;Paneth cells: 74.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	19	"classical monocyte: 1.5;myeloid DC: 2.1"	"Group enriched"	"Detected in many"	19	"dendritic cells: 2.1;monocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 61.4;ASC TERT1: 42.1;EFO-21: 61.0;HUVEC TERT2: 200.0;TIME: 161.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007041	Approved				"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA007041: AB_1078097"	"unprognostic (2.50e-1)"	"unprognostic (4.83e-1)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-2)"	"unprognostic (4.98e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.60e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.39e-1)"	"unprognostic (7.98e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.10e-1)"	49.2	12.1	17.1	20.1	14.5	0.6	38.4	15.5	14.9	35.9	10.5	39.2	10.2	28.1	4.3	11.4	32.7	14.3	38.5	13.3	14.6	29.8	3.3	96.3	15.1	17.8	16.7	4.8	12.0	23.6	6.2	83.8	18.7	17.7	28.4	0.7	11.8	13.3	18.2	18.5	28.5	16.2	14.0	29.2	19.1	1.7	22.0	4.6	29.2	15.7	6.1	25.1	25.6	15.0	0.0	0.7	0.4	0.0	61.4	42.1	0.1	3.0	5.6	0.1	0.3	0.3	0.4	0.1	61.0	24.0	0.2	0.0	0.0	0.0	0.1	0.1	2.1	1.4	0.0	0.0	9.0	0.0	1.3	16.8	0.1	0.4	0.0	0.0	200.0	0.0	0.2	0.1	1.1	0.5	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.9	0.0	0.0	0.1	0.4	0.0	4.1	161.2	0.0	0.4	0.7	0.0	0.0	0.1	0.2	0.3	0.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	17.1	14.5	15.5	14.9	13.3	14.6	17.8	16.7	18.7	14.0	22.0	15.0	107.3	3.2	7.9	0.0	0.6	5.2	0.3	0.0	0.6	0.4	1.0	1.3	4.0	0.0	1.3	0.0	0.0	0.6	0.3	182.7	0.0	4.0	0.0	1.4	19.9	84.7	5.4	0.0	0.1	1.4	36.9	56.0	0.5	0.7	0.0	0.0	60.3	0.1	12.0	0.0	0.0	26.4	0.0	30.9	12.4	1.2	11.8	7.8	5.4	25.3	9.9	2.0	0.0	1.0	0.1	0.0	74.7	3.4	0.1	0.6	4.5	0.0	2.8	0.4	39.5	32.9	18.2	0.1	0.8	0.6	5.4	2.6	1.2	0.6	49.3	1.0
ACY1		ENSG00000243989	"Aminoacylase 1"	Q03154	3	51983340-51989197	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"intestine: 181.5;kidney: 449.9;liver: 274.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 31.6;Gastric mucus-secreting cells: 32.6;Proximal enterocytes: 144.8;Proximal tubular cells: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 128.0"									"CAB003695, HPA036174, HPA036175"	Enhanced					NA	NA		23000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB003695: AB_425286, HPA036174: AB_2674988, HPA036175: AB_2674989"	"unprognostic (4.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.70e-2)"	"prognostic favorable (2.93e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.75e-1)"	"unprognostic (7.88e-2)"	"prognostic favorable (6.77e-4)"	19.2	24.0	5.6	7.3	5.7	8.8	20.7	6.4	7.3	13.9	11.6	30.6	181.5	4.3	21.8	10.7	13.0	10.7	14.5	5.1	6.0	449.9	274.9	9.2	7.2	6.5	5.9	4.8	8.7	28.2	4.7	9.7	6.6	14.3	30.5	1.9	16.4	11.1	20.2	8.2	138.2	6.9	6.7	8.1	23.6	3.2	6.1	5.1	21.0	34.6	9.2	12.5	7.1	6.6	15.9	26.2	13.2	34.1	28.9	39.4	40.5	12.6	28.2	29.4	14.9	41.2	67.9	7.2	12.2	22.0	13.2	20.0	14.7	81.2	11.5	21.8	10.7	25.3	13.9	128.0	49.7	19.8	21.0	48.0	67.2	25.4	69.1	25.8	11.5	14.6	47.1	23.9	29.9	35.2	0.6	38.9	23.4	92.1	39.3	8.0	14.1	63.5	74.5	50.8	16.9	18.2	12.6	62.6	29.5	7.5	42.3	27.9	7.1	22.0	21.9	24.8	18.8	61.7	16.9	12.1	28.1	42.9	29.0	9.1	15.7	0.4	10.7	15.1	5.7	7.4	2.6	4.5	21.2	6.1	4.1	4.7	0.0	20.4	6.4	2.8	3.8	9.7	5.6	5.7	6.4	7.3	5.1	6.0	6.5	5.9	6.6	6.7	6.1	6.6	0.5	3.2	3.2	0.0	4.9	0.6	1.0	1.9	17.1	0.2	2.7	1.3	0.2	1.5	2.5	5.5	0.0	3.9	0.3	31.6	9.8	16.6	0.2	0.2	0.9	0.9	2.4	15.8	0.0	8.3	4.5	4.3	32.6	0.6	7.0	0.2	1.1	13.1	1.9	0.0	0.0	11.2	4.1	1.9	0.3	0.8	0.6	4.2	0.0	0.0	9.3	0.8	1.0	0.0	0.0	16.4	23.3	0.0	14.9	0.6	144.8	92.0	1.7	1.1	0.0	0.6	2.0	0.1	0.2	18.5	0.4	4.1	2.6	1.0	14.5	0.4
ADA2	"ADGF, CECR1, IDGFL"	ENSG00000093072	"Adenosine deaminase 2"	Q9NZK5	22	17178790-17258235	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Heparin-binding, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 106.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 27.6;Glandular and luminal cells: 22.0;Hofbauer cells: 57.6;Macrophages: 62.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 23.7;EFO-21: 21.4;HUVEC TERT2: 24.0;Karpas-707: 44.9;MOLT-4: 38.9;U-266/70: 23.8;U-937: 39.6"					"Low region specificity"	"Detected in all"			HPA007888	Uncertain				"Secreted to blood"	NA	NA		58000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA007888: AB_1078495"	"unprognostic (1.03e-3)"	"unprognostic (2.00e-3)"	"unprognostic (6.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.01e-3)"	"unprognostic (4.48e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.26e-4)"	"prognostic favorable (8.91e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.86e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.51e-1)"	14.0	11.3	8.3	39.4	9.9	22.8	17.6	10.6	7.9	22.0	20.5	28.3	18.1	19.9	2.7	12.0	51.5	32.1	39.6	7.8	10.9	14.5	21.1	54.9	47.3	16.3	11.4	12.1	13.9	5.4	22.5	15.2	14.7	15.4	34.3	11.0	15.6	17.1	3.4	4.7	26.1	23.4	13.7	106.3	19.6	18.4	12.9	53.7	16.9	4.3	60.7	34.7	6.5	21.1	0.0	0.0	6.4	0.0	0.2	0.8	0.3	2.3	0.1	0.0	0.0	0.0	23.7	6.0	21.4	7.2	0.0	0.5	0.2	0.0	0.0	0.1	0.0	1.1	0.0	0.1	4.0	0.3	0.3	11.3	0.1	0.0	0.1	0.1	24.0	9.0	0.1	44.9	0.9	0.0	38.9	1.1	17.8	0.0	0.1	1.2	0.0	6.5	0.0	9.3	10.9	0.1	0.1	0.0	0.0	19.1	0.2	9.7	3.0	0.1	0.2	0.0	0.0	23.8	2.3	1.7	0.0	39.6	0.0	17.5	212.9	11.3	34.6	204.9	26.8	25.8	27.4	34.1	139.1	19.7	31.6	32.4	10.5	44.9	176.1	57.4	17.2	170.7	8.3	9.9	10.6	7.9	7.8	10.9	16.3	11.4	14.7	13.7	12.9	21.1	8.7	0.0	16.8	0.0	7.2	0.0	0.0	0.0	0.0	0.0	5.1	4.2	0.0	0.0	11.2	5.5	0.0	0.4	13.7	0.0	7.9	1.7	0.0	27.6	6.6	2.2	0.0	0.0	0.0	5.2	0.9	2.1	0.0	22.0	5.1	12.6	0.0	0.0	57.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	12.4	0.0	0.0	3.1	15.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.8	8.2	3.1	0.0	0.0
ADAM10	"CD156C, HsT18717, kuz, MADM"	ENSG00000137845	"ADAM metallopeptidase domain 10"	O14672	15	58588809-58749791	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 377.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 296.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001709, HPA050670"	Approved		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		690000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Plasma membrane"		"CAB001709: , HPA050670: "	"unprognostic (1.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-3)"	"unprognostic (7.48e-2)"	"prognostic unfavorable (8.46e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (6.69e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.60e-2)"	14.9	8.7	11.4	19.0	18.6	18.7	15.2	20.2	15.0	16.0	9.7	22.2	15.9	16.3	7.7	15.4	13.9	18.9	12.1	12.2	12.7	18.0	16.1	21.0	22.2	18.2	17.6	14.1	8.8	7.9	8.2	29.0	17.5	25.2	17.2	10.8	9.3	12.2	6.1	16.9	17.5	13.3	13.7	29.0	20.3	8.5	15.5	42.7	28.6	7.1	16.4	28.0	10.4	25.2	48.4	88.5	27.6	31.2	34.8	49.8	70.0	39.0	116.0	28.6	39.1	39.9	62.6	22.7	118.0	35.2	49.2	95.9	16.8	43.5	37.0	30.1	19.3	38.7	35.1	42.1	40.8	25.0	103.8	44.4	30.0	19.9	29.2	41.1	55.6	45.0	24.5	57.9	50.4	15.4	89.5	32.0	40.2	15.4	14.6	36.4	91.6	57.1	66.6	121.4	29.9	20.3	44.0	52.8	73.1	60.0	30.4	55.0	41.4	37.1	41.2	296.6	39.6	30.7	70.7	23.5	54.1	50.8	67.3	30.9	36.2	19.2	12.8	41.1	19.2	8.3	12.7	11.6	23.6	9.6	12.7	10.8	51.5	17.7	48.6	10.2	18.2	25.8	11.4	18.6	20.2	15.0	12.2	12.7	18.2	17.6	17.5	13.7	15.5	25.2	60.1	83.3	50.8	83.2	37.9	26.6	30.7	33.3	33.0	22.7	61.6	30.9	40.0	30.0	46.7	80.9	27.1	35.6	69.4	79.0	1.9	56.0	21.2	39.5	56.4	72.5	36.1	20.8	106.1	31.8	57.8	36.1	53.0	74.0	30.3	31.5	71.4	36.2	63.8	45.4	96.2	43.6	36.7	90.1	28.9	19.4	18.0	77.9	46.2	147.1	69.0	30.6	44.3	75.9	377.6	48.9	48.1	17.0	51.0	89.1	45.1	23.7	41.2	33.4	13.1	34.4	42.8	20.3	17.8	39.5	22.3	26.5	51.3	34.1	39.5	83.9
ADAM17	"CD156B, cSVP, TACE"	ENSG00000151694	"ADAM metallopeptidase domain 17"	P78536	2	9488486-9556732	"CD markers, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 154.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010738, HPA051575"	Approved		Supported	Cytosol		NA	NA		300000	"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA010738: AB_1078100, HPA051575: AB_2681539"	"unprognostic (2.28e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.82e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (4.23e-5)"	10.3	5.5	8.7	9.1	8.6	5.8	10.4	7.8	10.6	8.7	9.5	5.4	4.1	7.2	11.4	10.0	6.5	9.0	6.7	8.6	9.4	4.7	4.6	14.6	8.5	9.7	8.3	8.9	4.1	7.9	4.2	20.1	9.4	4.0	6.8	4.5	6.2	6.3	6.9	11.1	6.1	8.6	8.3	9.3	5.1	9.9	9.1	9.6	6.6	6.8	12.7	10.4	7.1	10.4	10.0	18.2	23.2	25.9	45.9	34.7	45.4	8.6	25.4	16.1	24.6	19.2	31.6	33.4	18.1	18.8	42.1	21.9	16.4	29.4	22.6	8.4	12.1	15.8	14.7	13.9	68.0	20.7	17.8	41.2	32.2	25.1	47.5	26.6	46.0	8.7	30.0	12.3	17.3	8.7	8.5	23.4	19.2	13.7	4.6	14.3	21.6	20.5	25.8	18.7	11.7	28.6	14.9	16.5	30.1	27.0	6.6	19.4	29.0	25.5	12.0	19.1	22.1	15.1	17.5	29.6	20.2	11.1	31.1	5.0	3.7	2.8	1.0	3.7	1.9	1.7	0.9	1.1	2.3	0.9	0.9	1.0	5.5	1.2	2.5	0.7	1.1	0.9	8.7	8.6	7.8	10.6	8.6	9.4	9.7	8.3	9.4	8.3	9.1	10.4	53.8	48.1	66.9	19.6	34.5	130.0	48.2	37.0	19.9	25.2	40.8	26.4	3.6	27.1	38.8	31.3	54.2	29.8	37.7	20.7	5.9	23.7	72.1	30.0	32.0	45.1	19.7	16.8	66.7	19.4	45.1	44.1	13.7	51.5	30.9	31.3	41.4	13.5	34.6	10.1	46.2	13.8	12.2	80.4	84.5	16.0	19.0	76.9	40.9	42.2	40.3	12.9	16.5	26.7	41.5	20.9	18.3	16.1	23.2	57.2	12.9	7.0	37.2	41.4	39.5	79.4	27.3	35.7	35.2	33.7	154.7	56.0	30.1	17.7	15.4	104.3
ADAMTS13	"C9orf8, DKFZp434C2322, FLJ42993, MGC118899, MGC118900, TTP, vWF-CP, VWFCP"	ENSG00000160323	"ADAM metallopeptidase with thrombospondin type 1 motif 13"	Q76LX8	9	133414358-133459402	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 63.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 16.0;Early spermatids: 19.3;Excitatory neurons: 12.4;Inhibitory neurons: 12.4;Late spermatids: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA042014, HPA042844, HPA052077"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA	1300000000	120000000	"Cluster 34: Basophils - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA042014: AB_2677798, HPA042844: AB_2678200, HPA052077: "	"unprognostic (1.09e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.75e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.52e-5)"	"unprognostic (1.11e-1)"	"unprognostic (9.91e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.30e-3)"	2.5	2.8	6.9	0.5	7.3	0.6	2.8	7.6	10.0	5.0	5.3	4.3	3.2	4.2	2.9	2.4	5.7	1.2	6.0	7.1	6.2	9.6	63.8	2.8	0.9	7.0	6.7	6.7	6.2	1.5	12.5	0.8	7.1	6.4	0.9	1.1	2.5	1.4	4.3	2.6	4.4	0.6	6.3	2.6	9.8	13.5	7.2	0.8	6.1	1.4	0.5	4.4	3.1	7.1	0.0	0.8	1.9	2.6	1.5	1.3	0.8	0.7	0.5	0.2	0.3	0.3	2.1	0.2	0.9	0.4	0.6	0.3	0.1	0.4	0.1	1.2	1.7	0.2	0.9	0.4	1.1	0.0	0.7	3.6	0.9	0.2	0.7	1.2	0.1	1.3	0.0	0.8	0.3	3.3	0.0	0.9	2.0	1.1	1.1	0.2	0.2	0.9	0.8	0.8	1.3	4.0	1.4	0.6	1.2	3.9	3.7	0.4	0.5	1.5	0.8	0.9	0.0	1.7	0.3	0.3	1.1	0.2	1.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	7.3	7.6	10.0	7.1	6.2	7.0	6.7	7.1	6.3	7.2	7.1	0.9	0.0	2.0	16.0	1.2	0.3	0.3	0.9	0.0	1.7	1.4	1.9	4.2	4.3	2.4	0.0	0.0	0.2	0.2	1.0	1.9	0.6	19.3	3.6	1.6	0.9	1.2	0.0	12.4	0.4	0.3	1.5	4.6	3.3	0.0	3.0	5.0	1.6	0.2	3.3	12.4	1.3	0.0	0.6	0.0	13.6	0.9	0.3	0.0	7.5	0.0	1.7	0.0	2.0	5.5	0.3	3.0	1.5	0.4	0.4	1.5	0.9	0.7	1.8	0.0	0.4	0.7	6.0	3.9	0.3	0.4	0.1	0.5	1.7	0.9	0.3
ADAMTS2	"ADAM-TS2, ADAMTS-3, hPCPNI, NPI, PCINP"	ENSG00000087116	"ADAM metallopeptidase with thrombospondin type 1 motif 2"	O95450	5	179110853-179345461	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 32.2;Excitatory neurons: 17.9;Fibroblasts: 30.7;Hepatic stellate cells: 17.2;Kupffer cells: 71.4;Sertoli cells: 26.3;Smooth muscle cells: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 36.0;ASC TERT1: 35.8;BJ: 31.4;fHDF/TERT166: 39.3;HHSteC: 115.5;HSkMC: 94.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028363, HPA028444"	Uncertain		Approved	"Vesicles,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		2000000		"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Vesicles	"HPA028363: , HPA028444: AB_10601964"	"unprognostic (6.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.85e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.71e-8)"	"unprognostic (1.32e-3)"	"unprognostic (1.03e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.48e-2)"	36.9	10.9	0.8	2.4	4.2	0.3	22.7	0.9	3.5	20.6	0.9	10.5	1.4	21.7	0.5	5.5	15.5	6.1	22.3	0.5	0.9	7.5	15.8	29.6	1.8	4.5	3.3	12.1	5.8	0.4	15.1	9.7	4.2	9.0	1.4	0.2	5.3	1.8	2.9	9.4	11.6	9.1	0.2	38.4	9.3	3.9	2.5	0.4	6.8	0.8	0.6	15.0	16.7	2.2	0.0	0.0	0.1	0.7	36.0	35.8	0.0	31.4	5.4	11.5	12.4	0.1	0.0	0.0	0.2	39.3	0.7	0.1	1.8	0.0	5.1	0.0	1.5	0.0	0.1	2.3	115.5	0.0	0.0	94.4	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.1	0.8	0.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	5.9	1.2	0.1	0.0	0.4	1.9	0.0	10.7	0.0	19.1	3.0	24.5	0.0	0.3	0.0	0.0	0.9	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.8	4.2	0.9	3.5	0.5	0.9	4.5	3.3	4.2	0.2	2.5	2.2	3.3	0.0	1.1	1.6	0.1	2.2	0.4	0.0	2.2	0.3	0.2	5.2	1.5	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.3	0.9	32.2	1.4	0.0	0.0	17.9	0.0	0.3	30.7	0.0	0.8	1.3	6.5	17.2	0.5	5.1	0.0	8.5	0.0	0.0	71.4	4.4	3.4	5.0	10.4	0.0	4.7	0.3	0.1	0.0	3.0	2.4	0.5	0.0	12.8	0.1	0.4	0.0	0.2	0.0	0.0	26.3	4.7	20.4	2.1	4.8	0.2	2.7	0.0	0.4	0.6	0.0	0.1
ADAR	"ADAR1, G1P1, IFI4"	ENSG00000160710	"Adenosine deaminase RNA specific"	P55265	1	154581695-154628013	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing"	"DNA-binding, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003890, HPA051519, CAB056157"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Nucleoplasm	"CAB056157: AB_2665578, HPA003890: AB_1078103, HPA051519: AB_2681520"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.13e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.30e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.94e-2)"	41.9	44.7	30.4	57.2	29.9	47.1	41.1	18.0	35.1	49.4	16.3	42.9	46.4	50.2	26.3	37.9	50.3	45.6	36.1	31.5	40.0	51.7	56.1	54.6	66.1	32.1	33.8	54.9	40.6	62.8	53.9	46.5	34.8	42.8	44.4	47.9	59.4	43.0	18.8	39.9	52.8	56.6	39.2	73.5	40.3	34.4	37.8	85.2	47.1	27.6	65.0	50.5	40.0	25.5	93.2	103.1	84.4	104.8	87.4	88.5	97.8	59.5	132.7	209.8	183.4	87.8	85.3	162.6	97.7	98.7	112.4	85.4	111.9	115.5	109.8	159.1	52.3	84.9	66.2	48.4	96.7	122.8	83.8	86.2	84.7	100.4	104.1	81.2	104.5	112.4	82.4	111.6	72.0	107.8	165.0	43.3	139.7	125.5	74.6	140.1	74.2	131.2	67.6	106.1	84.8	100.2	104.4	167.9	126.2	128.1	113.4	148.2	94.3	67.5	68.5	58.8	71.5	132.9	179.0	177.6	70.2	78.4	81.0	7.8	8.1	15.0	10.8	9.9	10.2	9.0	10.6	11.2	7.8	5.8	9.8	10.0	29.1	8.6	9.4	6.3	9.1	7.4	30.4	29.9	18.0	35.1	31.5	40.0	32.1	33.8	34.8	39.2	37.8	25.5	73.3	83.3	51.2	37.5	80.5	33.3	39.4	39.9	32.5	94.5	43.6	36.6	22.1	45.8	44.0	47.8	95.9	41.2	103.0	73.3	9.8	49.2	4.2	48.9	61.0	86.7	63.1	45.2	44.8	66.9	57.8	49.1	56.6	52.4	62.1	88.6	84.9	93.8	53.5	168.2	53.2	53.9	34.6	104.1	43.9	13.1	73.7	78.0	19.6	32.8	110.2	37.9	126.7	38.2	39.7	69.6	62.7	59.0	87.5	61.1	86.7	42.5	50.0	80.2	52.6	40.1	45.2	11.4	35.0	37.9	40.3	31.5	85.6	66.5	56.2	53.8
ADARB1	"ADAR2, ADAR2a, ADAR2a-L1, ADAR2a-L2, ADAR2a-L3, ADAR2b, ADAR2c, ADAR2d, ADAR2g, DRABA2, DRADA2, hRED1, RED1"	ENSG00000197381	"Adenosine deaminase RNA specific B1"	P78563	21	45073853-45226560	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing"	"Hydrolase, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 62.9;Excitatory neurons: 54.1;Horizontal cells: 69.0;Inhibitory neurons: 85.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 65.8;HHSteC: 65.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029645			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA029645: AB_10602106"	"unprognostic (2.69e-1)"	"unprognostic (7.65e-2)"	"prognostic unfavorable (8.16e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.44e-1)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (4.57e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.38e-2)"	15.4	7.0	14.9	10.3	13.2	5.2	11.4	39.1	26.5	14.7	29.6	35.7	3.0	23.0	6.3	7.4	13.6	8.1	10.1	20.0	17.9	9.5	7.0	35.2	13.4	30.6	17.2	7.8	6.1	9.3	6.1	12.3	30.8	17.9	4.8	28.6	6.8	8.1	13.6	15.9	10.8	11.7	8.7	16.1	19.0	4.5	22.7	5.7	6.6	11.8	8.7	60.4	11.9	12.7	7.0	1.0	5.3	6.2	6.3	4.3	7.2	4.6	7.6	14.4	9.0	10.9	1.1	2.2	12.1	22.6	7.9	0.6	7.8	19.1	15.9	1.7	7.0	15.2	65.8	7.2	65.7	10.5	7.2	23.7	8.1	5.1	14.9	5.4	15.4	20.4	3.5	0.8	42.2	5.1	6.8	10.0	8.6	3.4	10.1	2.0	5.0	7.1	3.2	2.3	30.6	8.2	36.4	1.6	11.6	8.5	3.5	8.2	16.3	4.7	5.7	19.4	17.5	6.6	3.1	1.8	4.3	24.1	25.8	0.7	0.0	2.4	0.4	0.2	0.8	1.0	1.1	0.7	0.0	2.6	0.7	0.6	0.1	0.3	0.2	1.0	0.8	0.2	14.9	13.2	39.1	26.5	20.0	17.9	30.6	17.2	30.8	8.7	22.7	12.7	29.0	0.0	1.1	10.7	12.0	11.1	2.9	3.4	2.8	62.9	6.2	7.1	21.6	1.5	1.9	0.0	12.5	0.5	5.9	0.9	0.0	1.3	2.7	1.6	8.8	21.2	0.0	2.1	54.1	0.5	1.2	9.4	2.6	1.6	8.2	5.5	14.3	6.3	5.9	69.0	85.7	0.9	0.0	3.4	4.9	2.9	3.7	3.2	5.4	37.5	5.0	34.2	2.1	16.1	4.8	1.0	0.1	5.7	4.0	5.5	0.3	2.7	0.7	16.0	0.0	32.9	12.7	11.4	17.7	1.5	7.2	1.0	13.7	1.4	1.2	2.3
ADCY1	"AC1, DFNB44"	ENSG00000164742	"Adenylate cyclase 1"	Q08828	7	45574140-45723116	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, cAMP biosynthesis"	"Calmodulin-binding, Lyase"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.7;liver: 19.2;retina: 53.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 521.3;Excitatory neurons: 147.2;Inhibitory neurons: 117.9;Rod photoreceptor cells: 174.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 22.2;SH-SY5Y: 25.5;SK-MEL-30: 30.1;WM-115: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018364, HPA068274"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria		"CAB018364: AB_2223098, HPA068274: "	"unprognostic (9.41e-3)"	"unprognostic (7.30e-4)"	"unprognostic (9.31e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.74e-6)"	"unprognostic (2.49e-1)"	"unprognostic (7.65e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.23e-1)"	1.9	1.8	13.7	0.3	22.4	0.0	4.7	15.4	33.7	5.3	0.0	0.4	0.2	1.8	0.5	0.6	2.0	0.6	2.9	31.9	0.0	1.9	19.2	0.6	0.4	1.2	0.9	0.9	3.3	1.9	2.6	0.4	1.1	2.8	0.4	53.0	0.3	1.2	7.7	0.4	0.3	0.9	0.0	1.7	1.1	2.8	4.0	0.3	2.4	8.5	0.3	0.8	1.3	24.5	0.8	5.9	2.1	3.2	4.1	0.1	4.0	0.2	0.0	0.8	0.3	0.6	0.0	0.0	0.2	0.2	5.8	1.9	3.8	0.3	0.1	10.7	2.7	0.0	0.0	0.6	0.0	0.2	0.1	4.9	2.8	0.5	22.2	0.0	0.1	8.6	0.3	7.0	0.3	7.1	0.0	0.0	8.3	5.1	0.0	0.0	0.0	11.7	0.0	5.7	13.4	25.5	2.1	0.0	30.1	3.1	2.0	3.5	0.0	0.6	4.2	0.5	3.6	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	22.4	15.4	33.7	31.9	0.0	1.2	0.9	1.1	0.0	4.0	24.5	3.5	0.0	0.0	30.7	0.3	0.3	0.6	0.0	0.0	43.8	10.6	5.7	11.4	2.8	0.0	0.0	521.3	0.1	0.3	0.5	1.9	0.0	2.9	1.0	23.1	10.8	31.2	0.0	147.2	0.9	0.2	4.2	0.0	0.7	0.0	0.2	15.7	52.3	0.3	42.1	117.9	1.0	2.0	3.2	0.4	0.7	1.8	0.2	3.6	17.8	0.0	13.8	0.0	63.3	4.0	0.5	0.1	7.5	0.1	2.6	0.0	0.4	0.0	174.4	0.0	2.3	8.8	0.5	6.8	0.1	0.1	0.0	0.6	0.6	0.6	0.3
ADCY10	"HCA2, RP1-313L4.2, SAC, SACI, Sacy"	ENSG00000143199	"Adenylate cyclase 10"	Q96PN6	1	167809386-167914215	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"liver: 6.1;testis: 17.6"	"Group enriched"	"Detected in some"	7	"Early spermatids: 87.5;Late spermatids: 85.4"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"T-47d: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015243, HPA017749"	Approved					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 34: Spermatids - Unknown function"			"HPA015243: AB_1856540, HPA017749: AB_1856541"	"unprognostic (1.20e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.43e-2)"	"unprognostic (7.83e-5)"	"unprognostic (5.86e-7)"	"unprognostic (4.73e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.59e-1)"	0.1	0.2	1.3	0.0	1.2	0.0	1.0	2.6	2.4	0.2	0.7	0.3	0.3	0.1	0.1	0.1	0.1	0.1	0.2	1.4	0.7	0.4	6.1	0.2	0.0	0.6	0.8	0.1	0.4	0.0	0.1	0.1	0.7	0.4	0.2	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.6	0.1	0.3	17.6	1.2	0.1	0.1	0.0	0.0	0.1	0.1	1.7	0.1	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.2	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.4	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	1.2	2.6	2.4	1.4	0.7	0.6	0.8	0.7	0.6	1.2	1.7	0.1	0.0	0.0	2.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	87.5	0.3	0.2	0.1	0.0	0.0	9.9	0.0	0.7	0.3	0.0	0.1	0.0	0.9	0.7	7.6	0.1	0.0	7.6	0.0	0.0	0.0	0.4	85.4	0.6	0.1	0.0	1.0	0.0	0.0	0.0	3.5	3.6	0.0	0.0	0.4	0.0	0.2	1.1	0.2	0.0	0.0	0.0	0.2	0.4	11.3	0.6	0.1	0.4	1.8	0.0	0.8	0.2	0.2
ADCY3	AC3	ENSG00000138031	"Adenylate cyclase 3"	O60266	2	24819169-24920237	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis, Olfaction, Sensory transduction"	"Calmodulin-binding, Lyase"	Obesity	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 58.4;Sertoli cells: 111.7;Smooth muscle cells: 62.8;Theca cells: 92.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010223	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB010223: AB_630839"	"unprognostic (3.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.39e-3)"	"unprognostic (5.01e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.06e-2)"	"unprognostic (8.43e-2)"	"unprognostic (6.89e-2)"	"unprognostic (8.22e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (1.32e-9)"	"unprognostic (3.74e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.55e-3)"	94.4	17.3	43.5	17.3	55.1	17.7	74.6	36.7	50.1	66.7	28.4	27.5	10.9	56.4	20.5	30.4	62.1	23.0	36.6	43.3	43.4	25.9	6.6	42.5	18.9	41.6	43.8	71.9	15.7	17.0	41.7	83.6	41.1	40.6	15.8	4.2	21.6	33.0	15.2	38.4	34.4	35.3	36.9	30.4	25.0	9.8	50.6	11.4	36.8	20.4	18.1	36.4	48.9	44.9	76.5	40.4	17.2	28.3	84.5	75.4	29.6	32.3	65.9	37.1	37.8	38.6	25.1	26.0	6.2	53.2	51.0	54.5	43.1	54.5	24.0	58.4	55.8	43.0	40.0	1.7	64.0	24.0	24.6	55.7	47.5	36.6	50.8	23.6	33.8	27.9	15.5	49.2	19.3	43.6	17.9	2.1	14.9	39.9	24.4	38.8	75.3	59.5	15.5	38.7	31.6	19.1	45.8	54.2	30.2	13.0	13.5	22.5	33.5	59.7	34.2	39.1	54.1	42.4	101.6	113.6	18.7	39.2	31.4	2.6	1.5	0.0	0.4	1.6	0.3	5.5	0.9	0.5	9.5	6.0	0.7	0.5	0.0	1.2	0.4	9.0	3.4	1.0	43.5	55.1	36.7	50.1	43.3	43.4	41.6	43.8	41.1	36.9	50.6	44.9	14.6	0.0	1.8	17.0	8.2	11.0	4.2	4.1	5.2	3.0	18.6	8.0	2.8	0.0	1.3	1.8	0.0	1.0	5.2	5.0	0.0	0.9	0.3	1.9	42.2	10.6	1.2	5.2	40.1	0.0	2.1	25.5	2.0	2.2	18.4	3.7	5.0	0.3	12.6	0.0	36.8	6.0	2.0	5.4	6.9	3.9	58.4	10.1	7.2	21.5	4.0	1.6	0.0	15.1	33.2	1.0	5.8	29.3	4.9	11.2	8.3	0.2	1.1	2.2	111.7	6.5	62.8	0.4	2.4	4.4	11.8	1.2	7.2	92.9	12.1	3.9
ADCY5	AC5	ENSG00000173175	"Adenylate cyclase 5"	O95622	3	123282296-123449090	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.7;heart muscle: 105.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 75.5;Inhibitory neurons: 44.0;Oligodendrocytes: 89.7;Paneth cells: 59.6;Peritubular cells: 73.7;Sertoli cells: 65.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 15.5;RPMI-8226: 2.7;RPTEC TERT1: 5.2"	"Region enriched"	"Detected in all"	5	"basal ganglia: 388.0"	"Region enriched"	"Detected in all"	6	"basal ganglia: 155.9"	"HPA017730, HPA077682"	Uncertain		Enhanced	"Intermediate filaments"		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"		"HPA017730: AB_1844595, HPA077682: AB_2686851"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-3)"	"unprognostic (7.61e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.27e-3)"	"unprognostic (2.64e-2)"	"prognostic favorable (7.46e-6)"	"unprognostic (1.81e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.97e-4)"	18.9	3.3	25.5	4.9	97.7	0.0	10.6	13.9	43.9	9.8	0.0	35.1	5.2	14.7	5.7	18.8	12.7	10.0	105.2	25.8	15.9	12.8	3.3	4.1	2.3	20.5	18.3	13.2	7.5	0.8	14.3	6.1	17.4	19.8	5.6	4.5	4.0	21.5	2.7	2.6	13.0	18.2	10.8	6.5	21.2	8.2	34.4	1.3	1.9	5.8	3.0	23.2	7.8	30.1	0.0	0.6	1.3	0.1	0.1	0.1	0.3	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.2	2.3	0.5	0.6	0.0	0.0	0.1	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	15.5	0.0	0.0	0.8	0.0	0.1	0.0	0.3	2.7	5.2	0.5	1.8	1.6	0.0	0.5	0.1	1.7	0.0	0.1	0.0	0.1	1.2	0.1	0.2	0.1	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.5	97.7	13.9	43.9	25.8	15.9	20.5	18.3	17.4	10.8	34.4	30.1	0.3	0.0	0.0	8.1	0.1	0.3	0.1	0.2	0.0	21.8	0.4	5.8	75.5	8.6	0.0	7.3	0.0	1.4	0.0	2.6	0.0	15.9	0.9	1.5	7.1	1.8	0.0	0.0	34.0	6.9	4.0	5.2	0.0	4.0	0.0	4.6	3.9	0.1	0.3	0.0	44.0	0.3	0.0	0.0	0.3	3.0	20.5	0.1	0.0	6.5	1.0	1.0	0.0	19.1	89.7	0.4	59.6	73.7	0.0	0.1	0.3	0.8	0.0	2.2	65.7	0.6	21.4	0.8	6.3	0.2	0.9	12.4	0.2	1.0	2.0	0.1
ADCY6	AC6	ENSG00000174233	"Adenylate cyclase 6"	O43306	12	48766194-48789089	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 68.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018365	Approved		Approved	"Golgi apparatus"		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"CAB018365: AB_2257941"	"unprognostic (1.18e-2)"	"unprognostic (2.20e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.68e-2)"	"prognostic unfavorable (8.23e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-3)"	"unprognostic (5.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.48e-2)"	43.2	15.0	8.9	6.1	7.9	1.3	23.7	5.0	9.2	19.3	10.3	26.3	18.7	20.7	19.0	10.3	17.1	13.9	57.2	8.0	11.2	21.1	9.6	13.5	3.9	5.5	5.4	22.3	22.3	20.7	14.6	14.5	6.6	16.3	20.3	5.7	33.5	16.5	12.1	15.3	21.4	13.6	1.9	4.8	25.1	4.0	14.4	2.8	17.9	12.7	3.2	12.3	12.8	6.4	14.0	25.9	30.2	18.9	32.0	15.9	32.0	16.7	17.1	19.8	13.8	45.7	45.3	0.0	37.2	15.3	8.2	10.9	9.2	11.6	7.9	0.1	13.4	12.5	37.8	8.4	17.6	0.0	10.1	20.0	13.6	17.1	6.5	37.9	18.7	0.8	1.7	4.5	15.6	23.1	0.0	0.5	10.3	21.6	12.3	4.6	11.4	7.7	23.4	41.5	4.5	18.4	17.2	68.0	15.2	13.3	53.3	3.5	21.1	18.3	13.1	9.7	7.4	7.0	3.7	0.4	16.9	0.0	8.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.9	7.9	5.0	9.2	8.0	11.2	5.5	5.4	6.6	1.9	14.4	6.4	11.6	0.0	6.4	18.3	0.6	2.7	3.3	7.5	4.0	10.1	22.7	15.0	8.2	7.2	9.8	18.4	20.9	7.4	0.4	38.8	0.0	5.8	0.8	6.8	8.0	8.1	8.4	0.0	17.5	4.0	2.7	7.6	14.3	11.3	1.3	14.6	5.0	7.7	2.5	10.1	18.8	24.9	8.2	0.6	2.8	1.1	11.5	0.7	7.2	7.5	0.6	3.4	0.0	15.1	7.0	9.5	30.3	9.4	0.3	6.3	26.0	2.8	5.8	9.3	19.7	9.5	26.6	1.9	1.7	3.6	2.0	5.1	0.8	13.9	23.7	9.3
ADGRE2	"CD312, EMR2"	ENSG00000127507	"Adhesion G protein-coupled receptor E2"	Q9UHX3	19	14732392-14778560	"CD markers, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Cell adhesion, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 19.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 47.9;Kupffer cells: 69.4;Macrophages: 73.2;monocytes: 49.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 70.0;eosinophil: 74.7;intermediate monocyte: 46.9;neutrophil: 55.7;non-classical monocyte: 89.9"	"Group enriched"	"Detected in many"	9	"granulocytes: 74.7;monocytes: 89.9"	"Cell line enhanced"	"Detected in many"		"HEL: 11.8;HMC-1: 18.3;NB-4: 11.5;RPMI-8226: 8.4;U-937: 14.9"					"Low region specificity"	"Detected in many"			HPA055200			Uncertain	Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	Cytosol	"HPA055200: "	"unprognostic (2.46e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (4.35e-6)"	"unprognostic (1.46e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.01e-1)"	4.9	1.5	1.0	19.4	1.3	6.9	1.8	1.2	2.1	0.9	1.3	1.4	1.9	0.7	0.7	0.9	0.9	2.5	0.5	1.0	1.5	2.1	2.0	4.2	3.0	2.5	1.6	0.1	0.8	1.1	0.5	1.6	2.2	1.1	1.9	0.6	1.0	2.8	0.6	2.0	2.3	1.6	1.1	15.6	1.5	0.4	1.8	2.4	0.6	0.9	2.2	5.4	0.9	2.4	0.3	1.2	0.1	0.2	0.0	0.3	1.2	0.9	1.3	0.0	0.0	0.2	0.2	0.1	0.1	0.7	2.3	1.9	0.3	0.1	0.0	0.2	0.2	11.8	3.8	0.2	0.5	4.3	18.3	0.9	1.6	4.1	0.6	0.1	0.1	1.0	2.7	0.4	1.3	0.5	1.5	11.5	0.4	0.8	0.2	0.1	1.5	8.4	0.0	0.3	0.0	0.2	2.4	2.0	0.4	0.2	0.3	5.4	0.3	0.3	0.2	0.2	0.1	0.2	0.1	0.2	1.1	14.9	0.6	70.0	13.9	74.7	0.2	46.9	0.2	0.2	0.2	0.1	9.3	0.3	0.1	0.2	55.7	3.3	89.9	1.9	0.1	7.3	1.0	1.3	1.2	2.1	1.0	1.5	2.5	1.6	2.2	1.1	1.8	2.4	0.6	3.2	7.7	0.7	1.9	0.0	4.8	0.0	0.6	0.8	1.6	1.5	0.8	0.0	2.5	0.0	0.0	0.2	12.8	0.0	0.0	0.0	2.0	0.7	3.5	1.8	1.2	3.8	0.9	0.0	0.5	1.9	1.1	0.9	47.9	0.1	0.7	0.5	12.8	0.0	1.2	0.1	0.0	69.4	0.0	2.5	0.0	73.2	0.0	0.0	49.2	0.0	2.1	0.5	12.0	0.0	0.2	0.4	2.1	2.4	0.1	0.1	2.2	0.9	0.0	2.0	1.5	0.3	0.5	0.6	0.0	0.4	3.0	0.1	0.1	3.0
ADGRG1	"GPR56, TM7LN4, TM7XN1"	ENSG00000205336	"Adhesion G protein-coupled receptor G1"	Q9Y653	16	57610652-57665580	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein, G-protein coupled receptor, Heparin-binding, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 216.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 222.5;Exocrine glandular cells: 170.7;NK-cells: 208.1;Syncytiotrophoblasts: 186.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 160.3"	"Lineage enriched"	"Detected in many"	5	"T-cells: 160.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 218.4;SK-BR-3: 277.7;SK-MEL-30: 297.8;TIME: 241.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046065	Uncertain				"Secreted to blood"	NA	NA		32000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA046065: AB_2679521"	"unprognostic (4.91e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.26e-3)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (4.87e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.82e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (5.52e-7)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.98e-1)"	50.9	13.2	79.6	12.7	67.7	19.6	50.5	46.9	115.2	36.3	0.0	36.7	26.1	19.7	84.2	46.7	52.2	69.6	36.8	68.7	71.5	158.9	4.2	37.3	5.2	64.6	76.2	5.3	59.8	28.4	17.7	101.3	73.9	31.7	33.4	6.6	92.2	57.5	15.7	87.5	19.3	19.8	54.8	12.3	47.9	45.4	92.5	28.9	216.3	16.9	15.6	37.1	37.8	51.6	41.8	47.1	12.0	0.6	0.0	0.1	127.7	8.5	3.9	14.4	2.6	34.7	218.4	0.2	110.5	8.2	196.1	149.1	0.0	103.4	5.1	1.6	0.0	5.1	56.0	39.3	0.3	0.4	2.1	2.4	143.8	24.5	10.2	15.8	118.1	1.0	0.1	1.2	3.2	51.4	107.3	0.8	1.7	143.3	42.6	3.8	1.4	30.8	209.4	134.9	38.2	1.2	2.0	277.7	297.8	8.4	123.8	0.8	241.4	25.6	38.0	1.5	96.2	0.2	2.1	0.6	200.5	0.7	62.9	2.9	0.8	0.2	160.3	0.5	1.9	0.3	10.5	62.6	0.2	0.1	5.3	45.2	3.3	30.6	0.7	0.3	0.2	37.1	79.6	67.7	46.9	115.2	68.7	71.5	64.6	76.2	73.9	54.8	92.5	51.6	107.7	9.6	11.9	113.9	3.7	0.0	24.1	0.0	11.4	0.9	29.6	27.2	4.3	15.7	21.7	79.1	0.0	222.5	120.4	17.7	27.4	33.9	74.0	24.6	4.3	53.9	20.6	17.7	3.5	170.7	25.1	4.7	29.0	45.2	5.1	88.2	30.0	0.5	22.8	0.0	4.9	23.2	0.0	3.5	0.0	31.3	3.1	6.1	0.0	41.2	1.1	4.8	208.1	85.5	1.3	101.1	12.3	0.0	19.1	15.2	5.6	132.6	16.8	0.5	0.0	1.6	7.1	2.7	0.9	23.0	0.0	186.5	35.1	0.4	24.6	19.5
ADGRG2	"EDDM6, GPR64, HE6, TM7LN2"	ENSG00000173698	"Adhesion G protein-coupled receptor G2"	Q8IZP9	X	18989307-19122637	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 1227.7"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 7.2;Endometrial stromal cells: 5.4;Fibroblasts: 5.3;Gastric mucus-secreting cells: 9.2;Oligodendrocyte precursor cells: 10.1;Oligodendrocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.0;BEWO: 7.3;HeLa: 5.9;NTERA-2: 6.4;RPMI-8226: 4.5;SH-SY5Y: 6.6;U-2197: 14.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA001478, HPA050029"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		22000000		"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA001478: AB_1078923, HPA050029: AB_2680996"	"unprognostic (3.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.63e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.54e-7)"	"unprognostic (6.37e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.35e-1)"	3.9	0.3	0.1	0.9	0.1	0.0	2.0	0.0	1.1	1.0	0.0	0.5	0.5	1.0	1227.7	0.5	16.5	1.6	1.3	0.8	0.7	0.4	0.7	1.3	5.0	0.4	1.5	0.2	1.2	163.4	1.1	0.5	0.6	2.1	0.4	0.9	8.5	3.6	0.2	0.4	1.1	0.4	0.1	2.4	9.0	1.9	0.3	6.6	1.6	1.1	3.7	0.8	1.0	0.2	0.2	6.0	0.0	0.0	0.1	0.9	7.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.4	0.0	5.9	0.2	0.8	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	2.2	6.4	0.0	2.0	0.0	0.0	4.5	0.0	1.2	2.2	6.6	1.5	0.1	0.0	1.1	0.1	0.1	0.1	0.2	0.4	14.6	2.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.8	0.7	0.4	1.5	0.6	0.1	0.3	0.2	0.6	0.0	0.0	3.6	0.1	0.0	0.1	0.0	0.0	0.6	1.2	1.1	1.0	7.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.4	0.1	1.1	5.4	0.6	0.0	0.0	4.4	0.2	0.3	5.3	9.2	3.2	0.0	0.2	1.4	0.4	0.0	3.3	5.0	0.1	0.0	0.0	0.0	0.2	1.2	0.1	0.0	4.7	0.0	4.8	0.0	10.1	7.0	3.1	0.0	1.5	0.0	3.4	0.0	0.1	2.2	0.7	0.0	1.6	0.6	0.1	1.4	0.1	0.0	0.0	0.3	0.3	0.0	0.3
ADGRG6	"FLJ14937, GPR126"	ENSG00000112414	"Adhesion G protein-coupled receptor G6"	Q86SQ4	6	142301854-142446266	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 71.9;placenta: 47.4"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 41.7;Hepatocytes: 143.8;Kupffer cells: 40.5;Pancreatic endocrine cells: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 88.6;Hep G2: 84.8;hTERT-HME1: 81.5;HUVEC TERT2: 161.4;MCF7: 155.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017346	Approved					NA	NA		110000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA017346: AB_1849260"	"unprognostic (1.04e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.00e-2)"	"unprognostic (8.64e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (4.46e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.59e-2)"	5.8	2.8	2.6	4.1	2.3	0.4	5.2	1.6	1.9	3.0	1.9	6.2	17.5	1.1	1.3	11.6	5.2	8.3	4.0	1.8	1.7	7.2	71.9	15.2	1.7	2.4	2.9	1.4	3.2	1.3	0.3	47.4	2.2	3.2	6.4	0.1	9.0	6.5	0.5	14.5	10.2	2.2	2.5	7.5	12.3	2.1	4.6	4.6	1.6	1.2	4.0	15.1	5.6	1.9	17.0	88.6	1.9	9.4	0.5	0.0	0.2	23.1	4.3	17.2	10.7	71.3	51.0	0.0	20.3	13.4	4.9	41.3	2.6	22.1	28.3	0.0	6.8	3.6	14.5	84.8	16.7	14.6	0.0	0.1	34.9	0.4	81.5	10.0	161.4	0.4	0.6	0.1	6.9	155.6	0.3	0.0	0.7	6.2	20.0	0.0	7.7	17.7	9.0	37.9	0.1	0.1	6.8	30.8	14.5	14.1	16.7	0.3	5.6	0.1	7.6	7.7	11.5	0.0	0.1	0.0	0.1	0.1	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.3	1.6	1.9	1.8	1.7	2.4	2.9	2.2	2.5	4.6	1.9	5.1	6.4	5.9	0.0	0.3	0.0	21.9	0.0	18.8	0.0	5.3	2.7	1.9	24.3	8.1	9.2	0.0	5.3	0.0	0.6	0.0	13.2	0.1	0.1	0.5	41.7	0.0	17.0	1.6	5.4	33.5	14.5	32.1	0.5	0.0	0.0	27.1	143.8	2.2	0.0	12.7	3.5	0.0	40.5	0.0	0.6	0.6	8.1	0.0	15.0	0.9	0.0	0.0	0.5	0.3	37.9	8.8	0.4	0.1	18.7	9.5	11.8	2.9	0.0	6.6	0.4	1.3	2.6	5.3	30.2	0.0	13.5	1.6	0.0	1.7	25.0
ADGRV1	"DKFZp761P0710, FEB4, GPR98, KIAA0686, MASS1, USH2C, VLGR1"	ENSG00000164199	"Adhesion G protein-coupled receptor V1"	Q8WXG9	5	90529344-91164437	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Hydrolase, Receptor, Transducer"	"Deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"adrenal gland: 533.0"	"Cell type enriched"	"Detected in many"	8	"Astrocytes: 2207.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 15.5;HAP1: 23.0;K-562: 9.8;NTERA-2: 11.6;SCLC-21H: 11.1;SuSa: 15.0;U-266/70: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067503	Approved		Approved	"Lipid droplets"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Lipid droplets"		"HPA067503: AB_2685856"	"unprognostic (1.29e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.95e-3)"	"unprognostic (7.50e-3)"	"unprognostic (9.73e-7)"	"unprognostic (1.87e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.14e-2)"	0.0	533.0	36.9	0.0	47.8	0.6	3.6	12.7	40.3	0.9	22.4	1.0	0.3	0.1	0.7	2.4	0.2	12.3	0.2	39.1	11.6	21.5	42.3	2.1	0.0	9.4	12.8	0.2	1.5	0.8	15.1	4.1	9.4	1.3	1.0	18.2	2.3	0.2	0.2	2.1	0.5	0.0	7.3	0.3	1.1	1.4	18.3	0.8	17.5	0.0	0.4	10.4	1.9	26.1	0.5	2.1	15.5	0.0	0.0	0.1	0.2	0.3	0.1	0.0	0.0	1.7	0.2	0.3	0.4	0.0	0.4	0.2	23.0	0.2	0.0	1.0	4.3	4.1	2.0	1.4	0.0	0.3	0.1	0.0	4.8	0.0	0.1	0.1	0.0	0.1	9.8	2.6	0.0	2.1	0.1	0.2	11.6	2.9	4.2	0.0	0.4	2.1	0.0	0.5	11.1	2.7	3.4	2.2	0.2	15.0	5.9	0.0	0.8	0.4	1.9	0.5	1.1	13.4	4.1	0.6	0.7	0.2	0.0	3.2	0.9	2.8	1.0	0.7	1.7	1.5	1.1	1.4	0.5	2.9	1.7	0.9	4.6	1.1	0.5	1.2	1.6	0.2	36.9	47.8	12.7	40.3	39.1	11.6	9.4	12.8	9.4	7.3	18.3	26.1	0.4	25.6	26.5	2207.3	0.0	0.0	6.1	0.0	1.8	28.0	15.5	7.4	2.4	2.8	5.6	5.5	264.8	3.0	0.4	0.6	1.9	1.9	43.5	3.3	0.3	1.1	7.3	0.0	54.0	4.2	2.6	1.1	4.6	1.9	0.0	6.7	0.0	12.4	0.2	10.1	21.9	0.4	0.0	0.8	0.0	54.8	0.6	0.5	0.0	51.5	1.2	8.9	1.0	40.2	7.4	1.7	1.2	0.4	0.1	2.1	0.1	24.2	7.3	84.4	0.0	0.3	0.4	3.6	4.5	2.9	0.0	4.1	0.6	0.2	1.2	9.0
ADIPOQ	"ACDC, ACRP30, adiponectin, apM1, GBP28"	ENSG00000181092	"Adiponectin, C1Q and collagen domain containing"	Q15848	3	186842704-186858463	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hormone	"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	28	"adipose tissue: 898.8;breast: 248.9"	"Cell type enhanced"	"Detected in single"		"Distal tubular cells: 1.9"	"Group enriched"	"Detected in some"	8	"breast cancer: 6.5;pancreatic cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	672	"ASC diff: 312.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB046467, HPA051767"	Uncertain				"Secreted to blood"	NA	NA	8360000000	910000000	"Cluster 17: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB046467: AB_1078104, HPA051767: AB_2681598"	"unprognostic (1.76e-2)"									"unprognostic (1.53e-1)"	"unprognostic (2.20e-2)"			"unprognostic (6.99e-3)"	"unprognostic (1.87e-1)"			898.8	8.9	0.1	2.4	0.1	0.2	248.9	0.2	0.1	0.0	0.0	7.7	0.1	0.1	0.0	1.2	0.1	7.6	6.5	0.0	0.0	0.8	0.1	0.1	1.3	0.1	0.0	0.0	6.2	0.1	0.1	0.0	0.1	0.3	6.1	0.1	18.8	0.0	2.3	6.6	8.5	1.2	0.0	0.0	3.9	0.1	0.1	2.2	2.9	20.2	0.0	2.4	0.9	0.3	0.0	0.0	0.0	0.1	312.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADK	AK	ENSG00000156110	"Adenosine kinase"	P55263	10	74151202-74709963	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 151.2"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 245.3;Inhibitory neurons: 287.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032876, HPA038391, HPA038409, HPA075222"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		920000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB032876: AB_2242229, HPA038391: AB_2675990, HPA038409: AB_10675798, HPA075222: "	"unprognostic (1.55e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.93e-4)"	"prognostic favorable (9.91e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.15e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.95e-2)"	23.9	15.5	13.0	16.9	18.7	28.6	27.4	13.5	17.7	17.5	11.6	17.9	16.9	10.8	16.5	47.3	16.5	11.4	27.2	13.9	15.2	35.8	151.2	24.4	22.8	14.0	15.0	8.3	18.8	44.2	14.9	26.6	16.5	14.9	19.5	16.1	20.0	16.0	41.5	33.9	12.4	14.8	14.2	15.0	12.1	15.5	14.1	27.0	38.2	47.1	34.5	24.5	24.7	15.8	177.3	37.4	37.2	50.5	37.1	54.7	88.2	140.8	105.4	103.8	114.5	114.0	172.6	86.3	34.2	57.7	51.3	151.1	44.1	150.1	167.0	59.1	51.3	55.6	59.8	122.8	41.7	87.6	22.5	51.1	95.5	77.4	191.7	79.0	91.2	38.7	41.8	28.4	78.8	101.7	102.5	129.0	9.9	80.0	276.3	100.6	63.7	69.4	117.1	92.7	29.5	33.8	63.6	239.7	49.5	34.7	159.7	69.3	82.8	34.3	67.0	93.2	123.0	40.5	48.3	98.1	65.0	127.6	22.1	2.3	34.2	4.1	12.9	65.5	29.9	103.7	28.2	24.1	83.1	155.0	21.3	19.2	11.1	20.7	80.4	57.6	55.7	36.3	13.0	18.7	13.5	17.7	13.9	15.2	14.0	15.0	16.5	14.2	14.1	15.8	9.8	83.3	75.8	136.5	84.2	94.2	73.5	102.0	105.9	16.3	26.2	26.0	67.8	38.6	72.4	31.3	56.3	136.7	25.9	11.0	92.0	83.2	80.7	40.6	18.8	14.9	10.8	27.7	245.3	67.5	139.5	27.0	23.0	55.6	21.5	9.7	17.2	130.1	39.3	11.8	287.7	12.1	44.7	25.2	50.0	26.9	16.8	33.7	48.0	198.6	44.1	14.1	11.3	140.8	165.4	62.7	10.4	12.0	39.1	92.1	5.0	64.5	33.5	25.0	6.6	20.4	26.0	17.4	14.3	96.7	97.0	107.3	32.7	17.0	20.5	66.3
ADPRS	"ADPRHL2, ARH3, FLJ20446"	ENSG00000116863	"ADP-ribosylserine hydrolase"	Q9NX46	1	36088892-36093932	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	Hydrolase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 79.2;Extravillous trophoblasts: 40.7;Hofbauer cells: 51.6;Syncytiotrophoblasts: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026641, HPA027104, HPA027141"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		54000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA026641: , HPA027104: AB_10601330, HPA027141: AB_1844619"	"unprognostic (3.22e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (3.71e-2)"	"unprognostic (2.63e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (4.37e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.74e-2)"	19.0	36.7	28.4	16.0	30.0	19.7	18.5	31.3	30.3	20.7	33.4	19.6	15.6	17.6	15.0	36.1	33.5	13.3	20.7	28.6	29.1	27.7	22.4	20.6	21.5	32.5	29.7	19.7	17.9	17.6	17.7	20.8	31.2	19.9	12.4	9.1	20.9	16.3	34.4	34.1	16.8	16.4	31.9	23.1	17.6	28.7	29.7	20.9	19.4	21.8	20.2	21.3	22.2	33.9	54.3	22.4	26.2	37.2	23.6	17.1	37.3	39.4	32.9	62.1	60.9	26.8	47.7	38.4	37.5	39.5	32.0	32.9	33.4	60.5	37.0	27.7	41.8	34.9	27.0	36.3	44.4	40.2	19.9	20.3	45.4	56.5	24.5	47.2	39.9	36.2	30.8	30.9	29.6	26.0	40.9	60.5	56.5	31.8	46.0	32.9	27.6	38.8	56.5	43.8	32.1	50.8	28.9	29.9	65.9	34.4	30.9	34.3	27.6	35.7	37.0	50.1	53.0	39.8	41.2	34.2	51.7	39.6	22.4	40.6	58.3	65.8	43.4	74.1	41.5	43.5	47.6	50.8	71.4	51.5	47.7	40.3	57.1	47.9	77.7	44.8	43.4	57.8	28.4	30.0	31.3	30.3	28.6	29.1	32.5	29.7	31.2	31.9	29.7	33.9	3.5	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	79.2	6.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	40.7	6.4	0.0	0.0	0.0	0.0	0.0	0.0	51.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	70.6	1.3	0.0	0.0	0.0
ADSL		ENSG00000239900	"Adenylosuccinate lyase"	P30566	22	40346461-40390463	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Purine biosynthesis"	Lyase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"skeletal muscle: 345.1;tongue: 242.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000525, CAB019285"	Enhanced		Enhanced	Cytosol		NA	NA		440000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"CAB019285: , HPA000525: AB_1078106"	"unprognostic (2.80e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	"prognostic unfavorable (5.81e-8)"	"unprognostic (1.35e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.44e-2)"	29.8	33.9	10.6	31.1	11.2	40.6	33.1	12.5	13.3	30.7	12.9	36.5	22.7	34.9	21.9	29.8	33.5	20.6	47.4	10.9	10.6	33.6	32.1	22.7	46.9	10.5	11.7	33.5	45.2	29.3	22.0	30.2	10.9	23.8	35.4	10.3	25.7	22.3	345.1	22.2	28.8	41.1	10.0	33.5	28.0	29.2	10.5	50.5	29.6	242.3	48.5	36.0	25.2	10.8	98.0	110.2	88.3	124.9	62.6	89.5	106.5	82.0	85.2	187.3	138.1	189.0	51.9	279.0	73.2	102.3	84.9	67.3	203.5	137.4	187.7	75.3	197.5	126.5	98.4	166.5	134.6	423.0	96.3	97.7	76.5	161.5	169.8	91.3	138.9	127.3	153.1	114.3	136.4	105.0	130.2	131.2	152.5	121.3	119.3	195.1	203.6	198.2	118.9	67.8	58.8	54.4	106.2	54.1	170.7	78.5	76.8	134.7	91.2	93.3	173.7	85.3	168.8	109.0	212.6	218.2	80.9	149.5	97.7	29.0	47.2	19.9	35.5	55.2	49.5	34.6	76.1	48.5	68.1	33.5	58.3	45.0	4.1	48.2	49.7	34.4	81.7	62.3	10.6	11.2	12.5	13.3	10.9	10.6	10.5	11.7	10.9	10.0	10.5	10.8	10.0	12.8	10.8	9.4	28.3	18.1	18.8	48.6	23.9	16.1	14.8	15.0	30.0	30.0	20.8	3.7	37.5	85.3	15.5	13.0	7.9	61.3	44.0	5.6	9.2	21.6	13.8	54.6	11.4	43.7	78.9	21.2	21.4	5.6	36.8	8.8	28.9	25.6	60.3	6.7	10.7	24.1	24.4	44.8	26.7	25.2	24.8	22.7	12.4	1.0	41.9	45.1	19.6	9.5	9.8	33.7	15.6	14.3	52.4	21.3	21.4	19.7	12.3	18.1	26.3	38.5	20.8	61.2	82.8	35.7	15.2	33.1	32.2	8.7	37.7	14.1
ADSS1	"ADSSL1, FLJ38602"	ENSG00000185100	"Adenylosuccinate synthase 1"	Q8N142	14	104724229-104747325	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"skeletal muscle: 1273.1;tongue: 609.8"	"Cell type enriched"	"Detected in some"	20	"Cardiomyocytes: 137.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 15.2;MCF7: 14.2;OE19: 23.2;SiHa: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052621	Enhanced					NA	NA		290000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA052621: "	"unprognostic (2.23e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.14e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.78e-2)"	8.1	5.1	3.8	1.0	6.8	0.9	4.4	6.6	5.6	4.1	7.6	3.0	2.7	3.3	4.5	18.5	6.5	5.7	100.2	3.7	6.7	14.8	28.8	3.1	1.1	6.0	6.0	2.7	7.9	7.3	10.0	7.3	6.1	7.6	1.4	10.1	10.7	4.0	1273.1	5.5	2.8	2.3	5.2	2.0	6.5	18.5	5.5	1.0	7.4	609.8	0.8	6.5	5.4	7.7	0.1	3.2	2.4	7.1	1.7	1.1	0.8	0.9	1.3	0.2	0.7	0.2	2.5	0.0	15.2	0.8	0.5	1.3	0.2	0.5	0.6	1.0	0.5	0.1	7.9	1.1	1.8	0.0	6.0	3.2	2.3	0.0	2.6	2.7	0.4	0.3	2.9	0.1	1.2	14.2	0.0	0.7	2.1	23.2	1.3	0.2	0.3	0.9	0.5	1.7	2.0	4.2	23.1	1.0	3.3	1.8	7.1	2.1	0.8	0.1	0.6	1.6	0.1	4.4	3.5	0.0	2.2	1.0	1.5	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.8	6.8	6.6	5.6	3.7	6.7	6.0	6.0	6.1	5.2	5.5	7.7	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	137.4	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.7	6.6	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0
AEBP1	ACLP	ENSG00000106624	"AE binding protein 1"	Q8IUX7	7	44104345-44114562	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, DNA-binding, Repressor"	"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 103.0;Fibroblasts: 263.2;Leydig cells: 151.6;Peritubular cells: 508.9;Smooth muscle cells: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 7.6"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 7.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 141.1;BJ: 193.0;BJ hTERT+: 126.0;fHDF/TERT166: 208.9;JURKAT: 145.0;WM-115: 117.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 57.6"	"CAB009966, HPA047724, HPA063595, HPA064970"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA		2700000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Cytosol"	"CAB009966: AB_2225690, HPA047724: AB_2680132, HPA063595: AB_2685052, HPA064970: AB_2685394"	"unprognostic (1.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (9.31e-9)"	"unprognostic (2.88e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.28e-3)"	190.5	59.9	45.0	59.8	56.0	10.6	153.0	38.6	44.8	312.1	28.0	95.3	19.2	268.8	59.6	65.7	199.8	155.9	156.7	47.3	92.9	68.7	20.3	166.0	45.5	114.7	81.5	253.7	28.9	10.1	43.3	89.0	79.6	112.1	25.0	1.3	50.7	213.5	21.3	84.8	79.1	119.3	74.3	54.4	71.2	40.4	52.1	73.3	83.7	14.1	16.7	138.7	198.0	66.6	0.6	0.0	44.5	0.1	141.1	49.6	1.0	193.0	126.0	21.6	4.5	0.0	0.1	5.3	20.9	208.9	0.2	0.1	2.4	3.5	9.1	0.6	0.0	13.3	0.1	0.0	39.6	0.1	0.3	75.8	0.0	72.9	0.1	1.1	9.7	145.0	8.3	0.3	0.0	0.2	86.9	16.1	19.1	0.0	0.4	71.3	1.7	1.7	5.0	0.0	4.9	25.3	0.1	0.3	85.9	41.9	0.4	14.4	34.1	0.0	86.2	0.5	0.3	1.0	0.9	102.8	0.4	0.2	117.9	0.0	0.0	0.0	0.3	0.0	0.2	1.5	0.2	0.0	0.0	1.4	0.9	0.5	0.0	0.1	0.0	7.6	0.0	0.3	45.0	56.0	38.6	44.8	47.3	92.9	114.7	81.5	79.6	74.3	52.1	66.6	23.6	0.0	2.5	32.3	11.8	34.5	5.7	1.3	1.8	0.8	2.0	14.6	26.4	1.5	1.4	7.3	0.0	2.0	22.7	0.0	0.0	0.9	3.1	3.3	103.0	18.0	0.0	1.3	0.1	0.0	3.3	263.2	8.6	2.9	2.5	33.3	30.4	0.6	3.6	0.0	0.3	0.0	0.0	1.8	42.0	18.0	151.6	3.2	85.4	17.8	1.0	0.2	1.0	6.0	0.3	0.4	0.0	508.9	9.7	16.9	0.0	2.2	2.2	0.8	39.5	23.6	173.4	4.0	4.6	1.5	27.4	3.4	4.8	28.7	0.0	2.4
AFG3L2	"SCA28, SPAX5"	ENSG00000141385	"AFG3 like matrix AAA peptidase subunit 2"	Q9Y4W6	18	12328944-12377227	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004479, HPA004480"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA004479: AB_1078109, HPA004480: AB_1078108"	"unprognostic (1.11e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (1.31e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.00e-2)"	"prognostic favorable (6.05e-14)"	"unprognostic (5.90e-2)"	"unprognostic (9.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.22e-1)"	26.1	25.9	16.4	21.9	17.0	32.4	29.2	18.2	19.0	24.1	30.8	60.8	79.9	22.1	17.5	41.5	23.8	18.3	88.0	17.0	18.7	62.7	51.0	21.8	23.7	17.7	16.6	24.1	41.1	76.0	18.6	23.5	18.8	24.6	54.1	20.3	30.8	24.4	145.4	29.8	58.7	25.4	15.8	18.5	39.1	18.5	19.0	24.3	39.2	155.8	31.0	30.9	19.6	17.6	56.5	56.6	39.7	44.8	45.2	48.6	52.7	61.9	61.1	86.6	63.1	88.1	34.1	161.3	66.3	56.6	76.8	55.6	101.4	71.3	70.3	38.1	43.5	48.5	59.3	83.5	61.1	185.0	69.8	54.3	76.3	82.1	107.7	47.8	64.0	57.0	111.3	92.8	43.6	89.0	66.7	58.5	55.3	277.4	41.9	74.0	125.1	135.2	74.9	123.6	73.7	51.3	97.0	103.8	90.0	50.5	47.8	84.5	49.0	102.4	88.6	98.7	81.7	64.7	80.7	104.1	56.2	71.4	48.0	3.8	16.5	12.4	11.6	17.6	13.9	14.0	13.8	17.9	21.8	10.3	17.2	20.2	1.1	28.4	16.2	11.5	9.5	13.4	16.4	17.0	18.2	19.0	17.0	18.7	17.7	16.6	18.8	15.8	19.0	17.6	24.3	41.7	49.2	23.2	36.6	22.2	45.3	21.5	42.7	50.2	36.5	36.2	74.9	50.1	28.1	35.0	50.1	58.5	29.1	85.2	72.4	39.5	5.5	37.8	52.3	27.7	39.1	61.0	21.1	37.4	37.9	31.2	53.5	46.1	14.5	41.3	21.8	85.6	37.0	30.3	26.8	82.6	18.3	32.6	14.4	5.5	32.9	34.2	23.2	12.2	27.6	26.9	40.2	14.1	17.7	47.8	43.1	30.1	38.8	43.1	88.7	100.0	22.1	58.3	26.3	53.6	26.9	50.9	65.0	75.8	31.3	92.8	28.4	60.8	94.9	38.2
AGA	ASRG	ENSG00000038002	Aspartylglucosaminidase	P20933	4	177430774-177442437	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 77.5;Karpas-707: 111.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031415, HPA031417"	Enhanced				"Intracellular and membrane"	NA	NA		36000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA031415: AB_10603578, HPA031417: AB_10670967"	"unprognostic (8.76e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.11e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (8.61e-4)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (3.79e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.49e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.47e-2)"	9.4	13.3	8.1	9.1	10.4	15.4	21.1	9.8	12.0	9.2	16.2	13.1	9.6	8.6	30.2	15.9	8.4	13.1	7.5	8.4	9.9	15.3	18.7	11.6	12.2	11.4	9.1	10.2	15.1	17.1	6.1	8.4	11.4	11.8	13.1	6.6	14.9	9.8	9.0	20.6	12.4	9.5	9.5	10.3	16.2	13.2	8.6	11.1	15.8	5.8	15.6	10.9	8.2	13.7	5.4	11.9	13.3	18.8	14.9	13.2	9.0	39.5	77.5	20.1	24.8	6.2	26.2	26.9	7.2	30.0	9.7	6.5	11.3	13.0	39.4	17.3	7.5	11.2	11.9	17.3	10.0	19.6	7.4	9.6	22.5	14.7	6.5	18.0	18.7	11.4	10.3	111.6	8.0	14.6	15.9	12.0	5.2	10.5	12.2	5.0	5.4	4.0	20.5	12.9	7.3	16.4	11.9	10.3	32.2	9.9	23.3	39.8	6.1	13.9	12.3	6.6	15.2	21.2	17.4	14.0	22.3	22.0	16.0	26.4	15.3	23.9	15.6	27.5	17.9	13.9	16.6	18.8	14.8	12.9	14.8	21.3	3.3	12.7	35.8	15.8	17.8	15.1	8.1	10.4	9.8	12.0	8.4	9.9	11.4	9.1	11.4	9.5	8.6	13.7	12.6	12.8	13.5	2.6	20.5	24.0	17.4	26.9	12.5	3.9	19.8	16.9	7.5	15.7	21.7	14.7	2.1	26.3	17.6	8.4	5.9	28.2	13.6	8.9	8.5	10.9	5.4	7.8	3.7	31.3	32.0	16.0	13.7	12.5	14.0	13.9	8.2	23.5	23.1	6.7	2.3	18.2	14.2	15.4	23.3	9.2	11.1	15.9	39.2	2.8	23.8	19.1	11.3	3.5	19.3	21.4	9.1	9.8	48.8	13.4	15.1	22.1	10.5	4.8	0.0	8.4	14.1	35.8	36.6	23.7	27.3	22.7	22.5	14.1	13.6	17.7
AGBL1	"CCP4, FLJ32310"	ENSG00000273540	"ATP/GTP binding protein like 1"	Q96MI9	15	86079871-87049169	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Corneal dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"skeletal muscle: 7.8;tongue: 23.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 16.7;Astrocytes: 28.7;Excitatory neurons: 15.6;Inhibitory neurons: 25.6;Oligodendrocyte precursor cells: 47.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA				"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 68: Oligodendrocytes - Mixed function"								"unprognostic (3.70e-2)"	"unprognostic (4.46e-2)"		"unprognostic (1.06e-1)"										0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.7	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.7	0.0	7.8	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.4	0.0	0.0	23.2	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.4	0.0	0.7	1.0	0.3	1.0	0.8	0.3	0.9	0.4	0.4	0.0	3.2	16.7	28.7	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	1.9	0.0	0.0	0.0	47.3	6.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	5.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1
AGBL5	"CCP5, FLJ21839"	ENSG00000084693	"ATP/GTP binding protein like 5"	Q8NDL9	2	27042364-27070622	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"parathyroid gland: 49.9;testis: 192.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 302.7;Late spermatids: 338.0;Spermatocytes: 156.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030981	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Cytokinetic bridge"	"Microtubules, Cytosol"	"HPA030981: AB_10611673"	"unprognostic (1.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.50e-2)"	8.8	16.7	8.4	8.0	7.4	13.6	12.4	7.8	8.2	14.4	9.5	16.2	8.8	14.0	26.0	18.3	20.8	14.3	12.7	7.3	11.3	22.5	7.2	11.2	10.7	8.3	7.8	14.4	15.0	49.9	12.5	11.2	8.9	15.2	11.5	16.3	21.2	16.5	7.1	20.5	9.9	14.6	6.1	8.5	11.8	192.9	9.1	15.6	28.5	6.5	8.6	14.9	7.3	7.5	55.0	34.7	55.4	37.2	11.6	23.0	62.9	10.9	23.5	30.9	31.9	30.2	40.5	30.3	34.0	18.9	43.4	24.6	44.8	49.4	33.9	25.9	66.8	44.5	42.0	65.7	23.6	21.6	14.4	24.4	36.7	27.1	22.0	46.9	32.8	43.5	38.9	23.8	30.3	21.5	63.2	32.3	39.4	39.4	23.7	64.5	62.9	48.0	31.9	13.6	37.1	53.6	21.5	16.7	35.0	53.9	24.9	16.3	16.4	28.6	39.2	13.8	23.9	47.7	27.2	62.4	31.8	24.4	26.1	8.8	1.8	4.5	3.3	1.1	2.5	4.6	4.1	4.6	4.1	2.3	3.6	2.2	1.1	8.5	0.7	2.3	2.8	3.8	8.4	7.4	7.8	8.2	7.3	11.3	8.3	7.8	8.9	6.1	9.1	7.5	3.6	0.0	10.1	5.2	6.3	3.3	8.3	7.2	13.6	5.7	8.6	6.7	6.7	10.0	6.8	9.2	0.0	14.7	1.8	5.9	19.6	8.3	302.7	13.0	3.9	4.9	2.4	11.6	7.9	6.0	7.9	6.4	5.6	5.8	1.3	14.1	6.4	4.1	5.2	0.0	9.1	8.4	6.1	3.1	3.5	338.0	10.5	8.0	7.2	6.5	4.9	6.8	0.0	10.1	10.1	5.0	7.6	11.3	17.1	6.0	6.3	25.0	10.7	10.0	0.0	4.2	7.0	156.8	41.2	16.3	2.7	8.3	5.0	9.4	8.6	10.5
AGK	"FLJ10842, MULK"	ENSG00000006530	"Acylglycerol kinase"	Q53H12	7	141551278-141655244	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Cardiomyopathy, Cataract, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.4;Inhibitory neurons: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 97.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020959, HPA053471"	Supported		Supported	Vesicles,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Mitochondria	Vesicles	"HPA020959: AB_1854206, HPA053471: AB_2682164"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.47e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.24e-3)"	"unprognostic (7.90e-2)"	"unprognostic (9.29e-2)"	"unprognostic (9.65e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.18e-1)"	10.1	14.7	9.4	8.5	10.9	5.6	11.9	8.3	12.8	11.5	10.2	11.8	5.9	11.7	14.5	12.2	12.2	7.8	30.4	11.1	10.8	15.7	14.1	11.6	12.1	8.0	8.8	11.3	10.1	21.5	13.7	10.0	9.0	12.8	13.1	12.7	13.7	11.4	8.6	9.6	12.0	15.4	8.2	16.6	12.2	6.6	10.0	14.0	12.7	10.0	14.7	10.8	11.5	9.0	23.7	25.6	26.7	21.8	21.2	29.4	16.2	23.5	29.3	44.5	50.9	24.7	18.3	26.3	24.0	26.8	40.5	18.7	41.6	32.8	51.0	33.8	32.7	26.1	10.7	18.7	34.1	15.6	12.5	29.9	26.9	36.3	33.1	19.8	34.1	32.3	36.3	36.9	25.3	24.6	47.3	9.1	25.6	19.9	32.4	29.2	4.2	80.1	33.1	20.8	23.3	29.6	24.6	29.7	27.1	26.1	16.3	20.2	19.5	18.9	14.1	23.8	38.1	29.5	31.9	14.4	30.7	9.1	50.4	0.4	7.1	1.2	22.1	13.9	15.3	10.8	17.3	26.0	16.2	6.5	12.8	23.5	1.2	97.3	8.2	6.3	18.9	15.7	9.4	10.9	8.3	12.8	11.1	10.8	8.0	8.8	9.0	8.2	10.0	9.0	8.4	0.0	6.0	22.5	11.4	3.1	5.6	7.9	5.2	11.8	5.5	5.1	18.1	2.8	6.6	12.9	8.4	15.7	15.8	3.0	9.8	6.6	9.9	7.4	9.0	7.5	0.0	11.8	43.4	6.9	8.2	7.7	10.7	6.6	8.2	9.9	4.2	4.1	7.0	15.2	43.0	3.9	12.2	5.1	4.9	12.0	6.8	5.6	7.2	26.2	12.4	11.2	27.8	38.7	37.9	6.1	2.1	10.5	22.1	2.9	2.4	8.2	7.6	17.4	0.0	6.2	8.0	6.2	4.9	11.3	2.7	9.2	15.0	14.2	5.6	3.8
AGL		ENSG00000162688	"Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase"	P35573	1	99850361-99924023	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Glycogen biosynthesis"	"Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 257.6;tongue: 212.0"	"Cell type enhanced"	"Detected in all"		"Muller glia cells: 160.5;Theca cells: 159.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028498, HPA054340"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		450000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA028498: AB_10600975, HPA054340: AB_2682455"	"unprognostic (2.90e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.18e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.10e-3)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.73e-10)"	"unprognostic (6.38e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.13e-2)"	11.9	6.7	4.1	7.1	4.9	6.1	9.1	6.9	5.6	6.1	6.0	10.0	8.8	7.3	7.6	16.4	5.4	5.2	22.8	3.7	5.1	13.3	42.8	5.9	7.3	4.7	5.6	5.9	4.3	17.6	4.5	11.7	4.4	13.8	10.6	23.3	7.7	9.6	257.6	5.3	7.1	9.7	4.9	8.0	7.7	4.7	4.8	7.9	10.5	212.0	8.5	8.9	5.0	5.6	20.4	5.9	7.0	11.4	11.0	10.4	23.4	6.3	9.2	5.5	9.8	22.3	6.8	26.4	11.7	10.8	4.9	11.3	40.5	12.4	10.2	14.2	12.9	15.5	18.9	12.4	7.3	13.7	8.9	12.8	7.9	7.5	6.2	7.5	8.5	9.2	26.3	2.0	5.5	6.2	16.3	4.3	10.9	8.9	7.7	0.0	2.3	1.3	16.3	26.7	17.2	12.1	18.2	17.3	9.9	12.8	12.6	9.0	9.4	6.6	9.3	8.9	6.3	7.3	6.1	30.5	11.7	3.6	3.5	0.0	0.4	1.4	1.5	0.6	1.4	1.0	1.1	1.0	0.9	1.0	1.1	1.1	0.5	2.4	0.3	0.8	1.3	0.8	4.1	4.9	6.9	5.6	3.7	5.1	4.7	5.6	4.4	4.9	4.8	5.6	12.8	22.4	26.8	96.6	28.5	10.6	18.1	24.6	18.2	34.6	18.8	18.0	119.6	18.6	25.8	16.5	54.2	107.9	18.8	23.2	23.5	13.7	1.2	18.8	23.6	13.9	16.8	15.6	45.6	12.9	20.3	28.5	31.1	18.6	10.8	45.0	14.6	111.0	17.9	52.2	56.0	15.8	12.2	19.1	8.8	2.5	10.2	13.5	16.0	23.4	14.1	160.5	21.6	36.2	34.4	17.7	14.3	21.4	20.4	13.0	15.2	19.2	26.0	46.9	6.6	41.4	18.4	8.7	11.9	40.0	9.2	29.1	25.7	159.1	23.5	20.1
AGPAT2	"BSCL, LPAAT-beta"	ENSG00000169692	"1-acylglycerol-3-phosphate O-acyltransferase 2"	O15120	9	136673143-136687457	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Congenital generalized lipodystrophy, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 369.3;liver: 445.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 688.9;Late spermatids: 387.3;Paneth cells: 670.7;Proximal enterocytes: 1298.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 186.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019544	Uncertain					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA019544: AB_1844646"	"unprognostic (3.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.01e-3)"	"unprognostic (9.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.30e-3)"	"unprognostic (5.06e-3)"	"unprognostic (8.98e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.93e-1)"	369.3	38.3	11.4	11.8	9.3	34.2	259.9	8.8	15.9	32.1	13.5	83.2	111.4	26.4	9.6	85.6	29.7	15.7	84.9	9.4	12.6	80.2	445.0	60.9	9.2	11.8	12.3	17.7	129.6	18.4	41.5	8.0	11.3	34.3	12.2	0.9	48.1	12.8	37.4	51.1	119.4	6.7	11.4	39.2	52.0	24.1	13.9	5.5	46.9	10.0	5.3	35.5	36.6	9.6	55.0	75.2	8.9	41.4	63.3	19.8	37.3	35.5	28.5	24.1	18.5	86.0	105.7	17.8	77.8	21.0	38.6	145.1	12.7	22.2	2.8	186.9	57.3	26.5	30.3	19.2	42.6	28.1	62.1	19.0	30.9	20.9	11.0	20.9	12.5	23.6	32.7	2.9	10.4	98.5	1.9	87.4	22.5	101.0	135.0	41.0	31.3	100.3	28.5	33.9	19.5	31.4	45.8	47.6	60.3	6.8	30.6	109.3	24.7	31.5	32.1	10.4	23.0	4.4	0.4	11.8	0.4	59.7	32.1	20.1	88.8	111.8	6.8	83.5	6.5	12.8	5.8	7.9	47.8	22.7	4.6	5.5	61.1	7.2	75.7	65.6	8.1	35.2	11.4	9.3	8.8	15.9	9.4	12.6	11.8	12.3	11.3	11.4	13.9	9.6	25.9	16.0	64.4	0.7	20.2	45.2	60.0	64.0	22.8	3.5	23.4	22.4	39.6	87.2	45.3	73.5	0.0	7.3	30.8	688.9	54.8	155.2	136.4	50.4	17.4	27.9	35.8	8.0	1.9	219.5	37.1	30.1	81.6	63.8	13.4	31.4	31.1	228.0	131.2	40.4	2.6	197.3	126.1	53.4	57.4	387.3	26.8	57.6	136.9	4.7	48.8	14.6	23.7	0.0	0.3	169.5	670.7	20.3	13.4	93.5	1298.3	41.9	46.3	3.8	46.0	15.3	29.8	1.8	27.2	47.5	81.3	6.8	26.6	16.4	207.7	196.2
AGPS	"ADAP-S, ADAS, ADHAPS, ADPS, ALDHPSY"	ENSG00000018510	"Alkylglycerone phosphate synthase"	O00116	2	177392746-177567024	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cataract, Disease variant, Dwarfism, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 262.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030209, HPA030210, HPA030211"	Supported		Supported	Peroxisomes	"Intracellular and membrane"	NA	NA		69000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Peroxisomes		"HPA030209: AB_10600634, HPA030210: AB_10600202, HPA030211: AB_10602195"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (8.62e-6)"	"unprognostic (1.23e-2)"	"unprognostic (7.23e-2)"	"unprognostic (5.41e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (7.74e-2)"	"prognostic favorable (9.45e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.92e-2)"	14.3	9.2	4.4	15.6	6.9	19.6	13.9	7.1	6.9	14.3	4.6	20.1	11.1	14.6	6.5	12.7	9.8	11.3	10.4	4.7	6.6	18.1	19.3	13.7	11.9	8.9	7.0	7.8	11.4	18.5	3.4	13.2	8.2	7.0	21.9	6.4	8.3	8.8	11.7	4.5	13.1	21.1	7.8	8.7	9.9	16.3	6.3	16.1	12.6	12.6	12.8	14.6	5.2	11.9	43.1	36.3	23.3	19.0	32.2	33.2	33.3	29.6	21.9	34.5	34.8	70.6	34.0	58.5	59.5	45.0	46.3	47.5	64.4	45.1	47.8	51.4	16.7	77.6	56.5	75.8	31.9	82.3	63.5	28.6	28.7	58.6	44.6	33.3	75.3	42.1	44.9	26.3	45.7	0.1	59.9	22.4	33.3	42.7	30.9	47.0	65.1	32.7	60.0	65.0	22.0	31.3	66.2	5.8	43.0	58.1	0.4	35.4	70.0	29.4	61.9	26.8	64.2	28.7	59.0	23.6	29.4	43.1	11.8	2.6	3.3	5.8	1.9	4.0	2.9	1.7	3.0	2.4	3.6	1.1	2.7	1.6	1.5	2.8	3.6	0.1	4.3	2.2	4.4	6.9	7.1	6.9	4.7	6.6	8.9	7.0	8.2	7.8	6.3	11.9	20.2	16.0	13.1	29.4	10.7	10.8	6.5	15.5	12.0	11.5	19.2	6.7	20.0	20.0	13.0	14.7	2.1	14.1	15.5	25.6	13.7	20.9	262.2	25.2	17.2	14.0	19.8	20.8	53.0	23.2	20.6	23.0	18.8	25.4	64.1	16.6	11.7	31.0	31.8	15.2	61.7	30.4	16.2	30.0	31.8	41.4	14.6	28.7	14.2	56.2	36.0	12.0	21.6	45.8	83.8	23.9	17.4	13.9	14.1	3.8	15.3	46.5	21.6	7.6	6.6	16.8	16.4	41.7	22.2	16.2	9.8	7.0	19.0	22.7	26.0	6.1
AGRN	AGRIN	ENSG00000188157	Agrin	O00468	1	1020120-1056118	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Differentiation	"Developmental protein"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 94.5;Collecting duct cells: 156.3;Ductal cells: 91.2;Pancreatic endocrine cells: 87.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 205.3;EFO-21: 236.9;HaCaT: 210.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040090	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		20000000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"HPA040090: AB_10805603"	"unprognostic (8.04e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (2.82e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.46e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.31e-2)"	11.4	2.7	8.7	4.3	5.5	2.0	14.7	0.1	13.9	14.4	8.9	10.9	7.9	13.7	1.8	15.6	14.6	7.3	9.9	5.8	0.0	44.0	13.3	19.8	1.6	16.0	1.4	5.5	28.0	3.9	8.3	5.1	6.1	14.4	1.5	0.8	24.8	8.2	4.2	16.5	9.6	2.9	2.2	6.3	13.4	9.7	7.9	2.6	34.7	2.0	1.6	16.2	11.6	9.9	124.3	75.1	11.1	42.7	2.4	3.0	122.1	61.4	19.6	39.7	24.5	60.6	205.3	2.3	236.9	9.6	19.3	210.1	4.1	75.6	4.7	4.4	28.6	0.2	102.1	54.2	17.1	1.8	23.1	10.5	32.2	12.6	27.7	55.9	7.2	1.7	25.7	0.7	3.5	93.0	0.8	17.6	28.4	39.7	54.5	20.1	27.0	18.5	70.0	51.4	2.4	25.9	124.8	129.1	121.9	12.7	114.8	7.4	107.8	47.7	169.0	6.4	50.6	1.2	0.6	3.5	30.4	10.8	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	5.5	0.1	13.9	5.8	0.0	16.0	1.4	6.1	2.2	7.9	9.9	27.4	25.6	8.8	15.0	2.2	15.0	9.2	94.5	19.9	1.4	32.7	39.2	3.1	61.5	42.0	156.3	8.4	1.6	0.9	29.9	1.9	91.2	0.4	37.2	14.0	29.0	6.7	1.7	23.1	16.9	4.8	8.7	17.9	62.7	2.5	7.2	21.8	13.1	4.1	5.0	7.8	11.6	36.7	2.9	10.1	1.0	5.6	4.3	24.9	12.2	15.6	10.5	0.0	15.1	29.6	87.3	17.7	2.6	0.6	22.3	18.1	16.0	33.0	5.3	6.6	3.3	23.3	0.8	11.4	11.7	6.0	1.2	2.9	2.3	18.3	21.2
AGTPBP1	"CCP1, KIAA1035, Nna1"	ENSG00000135049	"ATP/GTP binding protein 1"	Q9UPW5	9	85546539-85742029	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 60.1;brain: 73.4;retina: 46.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 176.7;Inhibitory neurons: 163.0;Oligodendrocytes: 463.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057208, HPA071094"	Approved		Approved	Nucleoli,Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoli, Vesicles"		"HPA057208: AB_2683370, HPA071094: "	"unprognostic (2.15e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.93e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.95e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.26e-3)"	"unprognostic (5.69e-3)"	"unprognostic (6.31e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.25e-1)"	8.4	5.5	31.1	9.5	44.3	60.1	6.2	23.2	36.3	4.7	0.0	5.1	3.7	4.9	3.9	5.3	4.6	5.3	12.2	20.1	30.3	6.9	4.6	14.4	9.4	30.5	28.6	3.6	6.7	7.5	5.3	6.1	31.5	4.7	5.8	46.5	4.1	3.0	16.5	6.2	5.1	6.5	32.0	14.8	5.5	14.1	34.3	12.4	5.8	20.5	8.4	5.7	4.3	73.4	5.1	9.6	27.9	11.1	5.6	6.0	10.6	7.4	6.4	7.4	8.4	5.2	8.6	31.3	6.2	7.7	13.2	2.9	13.0	9.4	6.9	33.6	11.8	5.3	11.5	9.3	11.8	24.5	6.2	5.8	10.8	7.0	23.5	4.8	11.9	15.9	6.7	24.5	3.3	8.0	19.3	14.5	19.3	18.1	6.8	17.3	10.2	9.8	12.8	5.4	33.5	23.7	8.4	9.1	15.4	26.1	3.5	7.8	12.0	4.8	8.5	30.4	8.9	16.7	14.8	14.3	10.1	23.5	9.8	37.4	14.4	12.7	9.0	8.4	8.8	2.3	4.4	7.0	15.6	1.7	3.7	7.0	21.2	6.8	6.7	2.5	5.1	9.6	31.1	44.3	23.2	36.3	20.1	30.3	30.5	28.6	31.5	32.0	34.3	73.4	22.3	64.1	12.8	46.0	14.3	7.9	2.6	2.9	8.0	38.0	4.7	4.8	48.3	0.0	13.8	3.7	102.2	4.1	41.8	4.3	7.9	5.7	52.5	29.3	8.6	12.0	7.7	16.8	176.7	4.0	4.3	6.9	9.2	22.0	27.1	9.2	8.2	3.7	8.1	35.3	163.0	5.6	6.1	35.4	24.1	53.9	1.8	42.8	3.6	61.8	46.6	16.7	47.4	82.9	463.5	5.1	1.2	2.6	26.2	3.8	3.2	9.8	14.7	59.1	13.1	9.3	10.4	46.6	29.2	9.2	10.7	2.9	26.3	6.4	4.7	2.3
AGXT	"AGT, AGT1, AGXT1, PH1, SPAT, SPT"	ENSG00000172482	"Alanine--glyoxylate and serine--pyruvate aminotransferase"	P21549	2	240868824-240880502	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	315	"liver: 2199.2"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 2037.9"	"Cancer enriched"	"Detected in some"	425	"liver cancer: 253.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035370, HPA035371"	Enhanced		Supported	Vesicles		NA	NA		4700000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA035370: AB_10673218, HPA035371: AB_2674593"	"unprognostic (3.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.56e-2)"	"prognostic favorable (5.92e-5)"	"unprognostic (8.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.57e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.37e-1)"		"unprognostic (3.26e-2)"	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	6.9	2199.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	2.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	44.3	0.1	7.3	0.0	0.7	0.0	7.6	23.5	0.1	0.1	0.2	0.0	2.8	9.0	128.4	0.0	1.7	26.7	0.4	0.0	0.4	0.0	0.0	52.5	2037.9	0.2	0.0	0.0	8.1	4.1	53.5	0.0	1.6	0.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.8	0.4	0.0	0.8	1.9	343.9	0.1	0.0	0.0	2.7	0.1	0.1	0.0	0.0	0.0	1.9	5.2	0.1	1.5	0.4
AHCY	SAHH	ENSG00000101444	Adenosylhomocysteinase	P23526	20	34280268-34311802	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 275.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041225, HPA044675"	Approved		Supported	Cytosol		NA	NA		5000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA041225: AB_2677371, HPA044675: AB_2679041"	"unprognostic (3.35e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.10e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.93e-3)"	44.9	56.7	38.5	34.3	41.1	59.3	71.0	41.7	40.1	69.2	45.2	61.8	72.7	55.8	65.7	140.9	75.8	31.1	67.1	38.8	42.8	155.5	187.4	41.5	45.4	42.1	42.2	116.4	161.5	65.5	45.4	39.5	43.3	83.9	58.0	24.6	57.7	49.6	109.3	50.9	54.8	43.6	42.5	39.9	75.8	82.0	42.5	51.7	95.1	63.6	55.9	59.3	66.9	44.6	270.8	345.9	143.6	254.7	163.6	174.8	164.4	108.1	153.9	235.5	186.1	942.0	226.2	417.0	188.0	139.4	152.0	301.2	340.7	606.4	150.3	55.6	207.6	503.9	157.3	612.7	175.5	238.1	158.3	364.1	271.2	146.9	233.8	125.9	162.9	152.0	250.1	102.7	126.8	285.2	313.3	224.2	185.0	343.0	332.7	231.8	364.6	294.1	212.7	188.3	247.8	164.8	216.1	252.6	364.5	112.8	380.3	217.9	104.5	203.3	215.5	104.1	207.6	151.7	239.0	252.3	150.2	144.4	111.3	9.0	32.9	1.0	8.9	60.7	15.0	20.5	13.0	11.5	48.8	19.4	13.8	16.1	2.7	11.6	40.8	55.1	16.4	28.2	38.5	41.1	41.7	40.1	38.8	42.8	42.1	42.2	43.3	42.5	42.5	44.6	13.2	41.7	23.2	5.5	35.3	36.7	88.2	106.1	68.9	11.7	77.6	82.0	47.8	44.3	43.2	27.6	0.0	109.0	31.4	36.6	58.7	73.5	76.5	30.9	110.6	27.1	21.0	60.8	9.0	82.4	165.3	35.6	83.6	42.8	21.0	42.8	19.6	70.4	115.7	11.8	8.4	73.5	30.5	52.2	32.4	187.4	42.6	34.5	26.6	2.8	26.4	42.4	5.2	5.0	16.4	60.4	41.2	40.6	66.2	95.8	51.4	275.0	17.9	15.2	13.1	27.8	34.6	43.5	45.3	100.8	39.5	91.9	19.8	84.3	117.1	82.6
AICDA	"AID, ARP2, CDA2, HIGM2"	ENSG00000111732	"Activation induced cytidine deaminase"	Q9GZX7	12	8602170-8612867	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 15.4"	"Cell type enhanced"	"Detected in single"		"Proximal enterocytes: 2.6"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"memory B-cell: 1.9;naive B-cell: 3.8"	"Lineage enriched"	"Detected in single"	6	"B-cells: 3.8"	"Group enriched"	"Detected in some"	7	"Daudi: 142.5;U-698: 118.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (2.71e-2)"	"unprognostic (1.39e-2)"		"unprognostic (7.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.73e-3)"		"unprognostic (1.11e-1)"	"unprognostic (4.05e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.96e-2)"		"unprognostic (4.04e-6)"	"unprognostic (8.82e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.65e-1)"	0.2	0.1	0.4	3.7	0.3	0.6	0.0	1.2	0.6	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.5	0.3	0.3	0.1	0.0	0.1	0.2	15.4	0.2	0.3	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.1	0.2	0.3	0.0	1.4	0.3	0.8	0.0	0.0	0.7	0.2	0.2	0.3	0.4	0.2	0.0	12.0	0.1	0.1	0.6	0.1	0.0	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	142.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	5.3	0.2	0.1	0.0	2.0	19.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.5	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.1	1.3	0.1	0.1	0.6	0.1	0.4	0.5	0.1	0.0	0.1	118.4	0.0	0.3	0.1	0.5	0.2	0.1	0.1	0.1	0.0	1.9	0.1	0.0	0.1	3.8	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.2	0.4	0.3	1.2	0.6	0.3	0.1	0.2	0.3	0.3	0.0	0.3	0.6	0.2	0.0	0.6	0.0	0.9	0.3	0.6	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.6	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.6	0.2	0.0	0.7	0.0	0.8	0.1	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.1	0.3
AK1		ENSG00000106992	"Adenylate kinase 1"	P00568	9	127866486-127877675	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1346.2;tongue: 783.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 281.3;Late spermatids: 1031.8;Muller glia cells: 287.6;Peritubular cells: 386.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 163.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006456, CAB009893"	Enhanced		Supported	Cytosol		NA	NA		24000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"CAB009893: AB_2225151, HPA006456: AB_1078116"	"unprognostic (6.07e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.74e-2)"	"unprognostic (6.65e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.81e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (2.62e-1)"	"unprognostic (8.40e-3)"	"unprognostic (6.99e-3)"	28.5	34.5	81.3	11.5	79.2	28.4	17.0	87.9	95.1	37.5	145.8	33.8	17.9	14.3	28.5	32.0	342.2	22.5	270.0	79.5	88.5	31.4	26.5	74.6	5.0	97.4	99.8	45.0	14.9	47.0	33.8	7.6	99.0	17.1	39.5	29.0	33.1	35.9	1346.2	14.2	12.1	21.9	105.0	20.8	23.9	63.1	89.4	3.9	34.8	783.3	12.6	19.7	19.4	97.2	56.7	23.6	30.1	40.4	71.2	142.9	27.4	38.3	38.2	66.7	40.4	18.0	34.9	1.5	40.8	79.4	44.1	79.2	0.3	43.1	26.6	9.0	26.1	8.3	65.2	31.6	40.1	0.0	1.0	110.9	81.8	49.9	35.5	36.8	90.3	0.8	33.7	2.3	76.7	53.5	0.1	1.1	10.6	139.7	74.2	1.3	30.0	12.6	44.8	4.1	48.3	30.4	101.0	57.4	29.8	15.3	45.8	33.3	75.9	45.9	18.8	163.8	37.3	3.5	0.6	0.2	57.7	0.3	32.4	0.2	0.0	0.1	0.3	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.0	0.2	0.5	0.2	0.1	0.9	0.0	0.3	81.3	79.2	87.9	95.1	79.5	88.5	97.4	99.8	99.0	105.0	89.4	97.2	12.8	41.7	148.1	25.8	2.6	26.4	17.2	84.5	6.2	54.6	11.5	7.9	49.7	28.6	79.4	7.3	16.7	7.5	5.7	210.1	17.6	116.7	281.3	7.3	8.0	39.8	106.3	97.0	11.1	60.9	46.8	37.3	46.4	4.8	1.3	2.7	49.2	77.3	59.3	48.8	12.0	62.7	120.1	3.7	22.3	1031.8	226.5	7.9	83.6	2.8	2.3	287.6	10.3	4.5	9.7	57.2	132.7	386.3	4.2	14.4	22.8	8.2	186.5	69.5	26.3	107.2	56.4	20.2	16.7	33.6	28.4	13.5	7.1	83.4	65.5	25.3
AK2		ENSG00000004455	"Adenylate kinase 2"	P54819	1	33007940-33080996	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 440.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018479, CAB079913"	Approved		Approved	Mitochondria		NA	NA		1100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB079913: AB_2546087, HPA018479: AB_1844676"	"prognostic favorable (4.37e-4)"	"unprognostic (3.25e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (8.65e-4)"	"unprognostic (3.16e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (7.86e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (4.95e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.56e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.40e-3)"	85.3	88.6	39.9	76.9	45.0	74.3	80.4	44.1	49.0	79.6	49.8	117.2	140.0	58.6	52.1	108.5	65.3	49.0	114.1	38.8	43.8	181.6	172.9	59.3	73.3	48.5	42.8	59.9	78.9	123.6	49.4	68.4	50.4	63.2	114.0	51.0	81.1	55.5	154.2	74.4	139.4	68.1	44.0	57.2	92.7	54.8	44.3	85.9	86.6	122.9	113.4	84.2	76.9	49.3	339.1	153.4	131.6	149.7	94.9	116.6	132.8	185.0	143.5	267.7	280.2	283.2	311.9	602.1	218.4	139.8	204.2	235.4	312.5	327.0	276.6	261.6	229.3	396.2	270.0	219.9	218.2	712.5	222.2	118.1	238.2	232.7	471.2	163.3	190.2	245.7	436.9	230.4	165.0	174.2	273.0	392.8	181.2	337.4	222.4	314.7	222.2	415.6	286.2	205.1	190.8	114.8	205.4	235.0	584.8	151.4	194.5	517.2	138.9	165.5	194.3	259.4	357.5	238.0	324.7	565.7	232.4	664.6	195.5	49.2	158.8	198.0	77.1	145.5	81.8	122.3	72.7	74.0	195.8	105.8	72.9	67.9	42.1	115.3	130.4	154.2	96.8	188.1	39.9	45.0	44.1	49.0	38.8	43.8	48.5	42.8	50.4	44.0	44.3	49.3	60.5	51.3	79.0	19.6	44.0	125.2	101.4	228.1	63.7	21.1	66.5	72.6	106.9	71.4	142.8	112.2	83.4	158.0	37.0	109.6	256.3	120.2	108.3	50.0	42.1	70.7	50.4	50.9	16.2	123.7	164.6	58.0	66.3	47.0	40.0	38.8	41.4	135.5	96.1	8.4	19.7	84.7	89.5	44.8	60.1	42.8	46.9	48.4	87.2	12.2	67.3	22.1	48.4	14.1	22.0	110.5	67.2	44.0	55.7	109.0	236.9	440.0	67.0	41.8	52.6	34.1	108.4	91.0	31.6	88.6	122.7	216.6	40.7	72.2	122.6	120.5
AK7	"CFAP75, FAP75, FLJ32864"	ENSG00000140057	"Adenylate kinase 7"	Q96M32	14	96392128-96489427	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.3"	"Group enriched"	"Detected in many"	4	"Endometrial ciliated cells: 97.9;Respiratory ciliated cells: 137.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	23	"basophil: 9.0"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 17.0;CAPAN-2: 15.1;MCF7: 49.5;REH: 35.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA003543	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA003543: AB_1078117"	"unprognostic (4.18e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.40e-3)"	"prognostic favorable (3.18e-4)"	"unprognostic (4.98e-5)"	"unprognostic (8.41e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.29e-1)"	"unprognostic (9.02e-2)"	"unprognostic (3.65e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.25e-3)"	0.7	2.6	2.0	0.6	3.1	1.5	1.4	1.1	1.7	1.7	13.2	2.1	1.9	2.1	3.9	1.5	24.3	2.6	0.7	2.2	5.2	4.5	1.6	4.2	0.6	6.9	9.4	0.4	2.2	6.9	5.1	0.5	5.6	0.9	1.6	3.0	1.0	1.3	0.3	6.1	1.2	1.1	4.4	3.3	2.8	7.6	5.0	0.5	2.7	0.0	0.4	0.5	1.0	4.2	0.2	4.9	2.0	1.5	0.8	2.6	17.0	0.3	0.6	0.3	0.3	0.5	15.1	0.4	0.3	0.0	0.3	1.9	4.7	0.2	0.1	2.2	0.4	0.4	2.4	0.2	0.8	0.1	0.3	0.2	0.6	2.5	0.1	0.8	0.2	1.4	0.2	0.3	0.3	49.5	0.3	0.3	0.8	2.2	1.0	35.2	0.3	0.4	7.6	0.3	3.1	6.7	1.9	0.6	0.1	1.8	4.2	0.2	0.1	0.4	0.2	0.6	0.2	0.6	2.3	0.2	0.2	0.0	0.7	9.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.2	0.1	0.1	0.3	0.2	0.2	0.0	0.0	0.1	2.0	3.1	1.1	1.7	2.2	5.2	6.9	9.4	5.6	4.4	5.0	4.2	1.6	6.4	4.1	0.7	0.8	1.8	0.9	3.6	1.8	0.2	0.9	0.3	0.4	4.3	12.3	7.3	2.1	0.7	0.1	1.4	3.9	3.2	18.7	97.9	1.7	1.9	1.2	6.9	2.0	1.1	1.7	0.8	5.1	11.6	0.0	0.1	0.7	2.4	0.2	0.0	2.4	0.3	4.1	0.3	0.4	4.1	0.0	0.5	1.8	0.0	0.0	0.6	0.0	0.5	3.7	0.5	0.1	0.0	0.0	0.5	1.0	3.4	137.1	1.8	0.0	0.4	1.6	25.4	9.1	0.7	3.0	2.9	0.2	1.5	1.2	0.6
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 717.5"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 613.3"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 6.6;OE19: 2.9"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		3800000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA044720: AB_2679058, HPA068265: AB_2685966"	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.2	0.0	0.4	41.8	0.0	0.0	0.0	0.3	717.5	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.3	0.2	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	37.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.2	0.0	0.8	0.0	13.5	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	13.6	613.3	0.0	0.0	0.0	0.6	0.0	14.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.2	1.0	1.5	0.0	0.0	0.1	0.0	2.1	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.1
AKT1	"AKT, PKB, PRKBA, RAC, RAC-alpha"	ENSG00000142208	"AKT serine/threonine kinase 1"	P31749	14	104769349-104795751	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Neurogenesis, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 61.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 61.5"	"Cell line enhanced"	"Detected in all"		"MCF7: 558.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002891, CAB003765"	Supported		Supported	Nucleoplasm,Microtubules		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Microtubules	"CAB003765: AB_562035, HPA002891: AB_1078123"	"unprognostic (3.30e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (4.83e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	71.5	102.7	45.9	57.7	45.5	51.2	61.2	43.7	53.2	52.0	50.4	85.0	50.8	59.5	23.2	70.7	53.7	50.0	105.9	45.2	44.3	54.3	97.3	69.2	51.9	50.5	45.7	43.7	94.3	53.0	35.9	55.4	45.0	67.2	39.6	25.1	67.7	73.0	58.1	45.0	53.3	63.4	47.4	63.7	77.8	23.9	48.0	52.4	52.3	64.9	40.3	72.6	48.4	43.3	77.3	150.5	124.6	186.9	95.2	97.7	136.9	142.3	171.5	204.6	163.6	96.8	92.8	91.2	105.5	196.6	102.8	99.4	89.5	131.9	90.1	214.3	36.2	70.6	90.4	103.2	104.6	117.5	178.0	140.0	109.1	102.9	68.1	98.2	154.4	87.5	62.1	102.2	134.1	558.3	145.3	146.8	32.6	153.5	107.2	137.5	111.9	60.5	94.8	189.5	141.2	117.2	117.3	152.2	88.9	56.8	195.7	170.2	123.5	133.2	63.2	192.3	145.1	105.4	52.6	80.7	113.7	96.7	162.0	6.4	9.9	61.5	10.0	10.3	7.2	5.5	8.7	11.4	7.0	7.2	4.6	10.1	22.6	11.0	12.4	10.0	9.0	6.3	45.9	45.5	43.7	53.2	45.2	44.3	50.5	45.7	45.0	47.4	48.0	43.3	45.8	16.0	27.4	16.6	13.7	12.4	20.0	17.3	15.9	26.3	58.0	39.9	16.1	32.9	17.7	22.0	12.5	19.4	54.2	40.9	13.7	23.6	1.9	17.9	28.1	27.5	30.0	11.3	8.2	35.2	31.8	24.0	26.0	24.8	2.5	40.4	23.2	42.9	23.2	42.1	13.0	37.3	22.4	23.3	21.4	3.3	28.6	28.0	10.6	6.5	23.1	51.2	24.7	8.0	9.6	53.3	22.1	30.9	10.3	38.8	23.5	17.9	14.2	26.6	26.3	24.9	29.1	1.8	5.3	16.2	13.9	23.4	23.3	34.0	33.7	33.4
AKT2	PKBβ	ENSG00000105221	"AKT serine/threonine kinase 2"	P31751	19	40230317-40285536	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Diabetes mellitus, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004204, HPA064521"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles, Cytosol"		"CAB004204: AB_626659, HPA064521: AB_2685278"	"unprognostic (6.13e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.05e-6)"	"unprognostic (2.85e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.00e-1)"	62.8	40.0	31.7	37.3	31.3	48.4	38.6	58.3	40.0	49.8	55.1	42.3	24.5	43.5	49.4	42.5	46.1	25.1	40.8	31.5	24.5	52.2	59.2	30.7	38.1	32.0	26.0	53.9	41.9	58.5	47.8	27.6	26.3	41.2	23.3	41.2	32.5	45.0	101.3	39.4	35.6	34.2	22.1	38.1	33.1	29.7	28.0	53.4	100.1	118.7	37.0	39.8	41.5	35.2	66.2	160.1	63.1	61.5	72.0	88.9	32.5	41.7	63.5	87.6	77.9	71.8	60.8	67.4	36.8	96.3	37.2	28.2	66.8	90.0	56.1	62.5	74.3	43.4	116.5	44.7	45.8	50.7	50.5	82.7	53.6	58.6	56.4	71.9	19.0	73.0	57.3	67.5	49.8	54.6	81.1	24.7	31.7	73.7	41.5	54.2	32.1	48.5	68.3	105.7	82.7	49.8	43.3	75.0	35.0	62.5	59.8	64.9	18.8	52.7	51.5	47.3	67.6	61.5	59.0	56.4	52.6	59.7	44.3	5.7	2.6	2.1	2.2	1.2	2.2	1.9	1.8	1.5	1.7	2.9	1.7	2.6	4.0	1.7	1.6	4.9	1.6	1.7	31.7	31.3	58.3	40.0	31.5	24.5	32.0	26.0	26.3	22.1	28.0	35.2	18.1	16.0	15.9	51.2	33.0	23.8	23.9	20.9	26.2	67.6	25.3	23.9	31.2	30.0	18.1	60.7	41.7	31.3	26.0	23.7	21.5	19.7	5.5	26.2	26.7	17.4	19.2	19.1	30.4	30.4	25.2	27.9	20.9	25.8	14.0	44.2	13.9	87.5	22.3	60.6	25.3	20.1	22.4	23.2	17.5	10.5	42.9	20.0	23.2	23.4	21.7	46.2	50.4	41.7	40.6	24.8	16.9	26.7	30.4	29.7	21.8	24.8	24.9	97.4	19.7	29.3	25.0	14.8	15.6	31.1	27.4	38.7	23.1	56.9	23.3	29.4
AKT3	"PKBG, PRKBG, RAC-gamma"	ENSG00000117020	"AKT serine/threonine kinase 3"	Q9Y243	1	243488233-243851079	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.9"	"Group enriched"	"Detected in many"	6	"Astrocytes: 457.4;Excitatory neurons: 756.1;Inhibitory neurons: 514.5;Microglial cells: 414.1;Oligodendrocyte precursor cells: 633.3;Oligodendrocytes: 475.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013090, HPA026441"	Approved		Supported	Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB013090: AB_2533692, HPA026441: AB_1844711"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (9.27e-4)"	19.3	9.7	13.4	6.0	17.0	3.8	15.5	59.9	36.6	20.0	0.0	24.5	2.6	22.7	8.6	5.9	20.3	8.2	11.8	22.8	5.6	11.2	4.7	15.3	5.9	1.2	3.9	26.4	4.5	7.4	13.9	13.1	7.4	15.8	4.9	17.0	5.1	15.6	5.9	6.3	11.8	15.7	0.8	8.1	10.2	9.7	20.3	7.0	14.4	11.5	4.6	18.8	14.8	31.1	30.8	7.2	31.0	0.4	16.9	20.6	13.9	20.8	22.5	11.8	12.9	1.1	13.9	0.5	3.0	28.9	12.1	1.2	16.3	8.5	18.9	9.0	15.3	1.0	1.0	0.3	11.7	0.6	6.5	11.3	0.3	15.5	16.9	30.3	30.2	7.2	0.5	1.1	9.0	0.9	7.6	3.3	14.4	0.3	5.1	4.2	19.7	0.6	4.8	4.1	31.4	41.9	1.3	0.5	40.1	19.1	1.9	21.5	25.6	22.7	17.7	1.1	19.5	4.6	4.6	7.1	19.4	5.2	25.3	1.3	0.8	0.1	0.6	0.1	1.1	0.6	0.6	0.6	0.3	0.8	0.6	0.7	0.7	1.4	0.3	0.5	0.1	0.3	13.4	17.0	59.9	36.6	22.8	5.6	1.2	3.9	7.4	0.8	20.3	31.1	65.4	3.2	2.2	457.4	22.2	2.4	15.0	1.3	17.1	43.6	6.1	5.1	5.4	4.3	2.7	27.6	33.3	11.0	24.4	0.0	0.0	11.6	82.8	1.7	35.5	43.7	0.0	5.0	756.1	1.7	8.0	27.9	2.6	1.1	5.1	29.7	48.2	0.6	2.9	42.1	514.5	0.0	2.0	10.5	12.5	72.8	27.4	9.5	7.2	414.1	8.6	20.1	19.6	633.3	475.9	0.7	0.0	35.3	14.4	27.0	0.0	6.9	0.3	35.0	19.7	40.1	35.6	15.0	14.6	1.7	1.7	12.4	27.8	8.3	0.0	12.2
ALAS2	ASB	ENSG00000158578	"5'-aminolevulinate synthase 2"	P22557	X	55009055-55030977	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"bone marrow: 606.2"	"Cell type enriched"	"Detected in some"	166	"Erythroid cells: 2366.7"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.6"	"Group enriched"	"Detected in some"	93	"HEL: 71.7;K-562: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"				"unprognostic (7.82e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.68e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.89e-1)"	1.9	0.5	0.9	0.4	0.9	606.2	0.6	0.8	2.5	0.2	1.6	0.5	0.6	0.1	0.0	0.8	1.1	0.8	3.4	0.7	0.8	2.5	3.2	5.2	0.3	1.8	1.2	0.4	0.3	0.0	1.2	44.9	1.6	0.2	0.0	0.2	1.0	0.2	0.5	0.6	0.3	0.1	1.6	25.2	0.2	0.2	1.0	1.0	1.2	18.2	0.0	0.6	0.7	1.3	0.1	0.0	0.0	0.8	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.6	71.7	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	85.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.2	0.1	0.4	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.4	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.6	0.0	5.9	0.9	0.9	0.8	2.5	0.7	0.8	1.8	1.2	1.6	1.6	1.0	1.3	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.8	0.0	0.1	0.0	0.3	1.8	2366.7	0.0	0.2	1.8	0.3	0.0	0.1	0.0	0.0	1.4	1.3	2.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	7.3	14.2	1.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.7	1.1	0.0	0.0	0.1
ALDH18A1	"GSAS, P5CS, PYCS, SPG9"	ENSG00000059573	"Aldehyde dehydrogenase 18 family member A1"	P54886	10	95605941-95656711	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	"Kinase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 120.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 80.5;Granulosa cells: 81.6;Proximal enterocytes: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008333, HPA012604"	Approved		Enhanced	Mitochondria		NA	NA		48000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA008333: AB_1078125, HPA012604: AB_1844721"	"unprognostic (5.97e-3)"	"unprognostic (2.08e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (4.20e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.30e-3)"	"unprognostic (7.08e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.60e-9)"	"unprognostic (1.02e-3)"	"unprognostic (6.57e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.43e-2)"	15.3	16.1	12.2	21.2	12.6	16.7	20.2	12.4	13.1	33.4	21.0	51.9	89.3	18.5	30.9	21.0	21.9	25.2	11.5	12.2	13.6	17.7	24.3	10.8	22.0	12.4	14.7	16.7	61.8	33.5	28.2	26.3	13.1	24.2	49.3	11.4	120.1	24.9	4.3	22.4	73.1	26.3	12.7	12.1	40.5	11.7	14.0	17.2	37.5	5.5	26.9	25.2	14.3	13.1	66.5	61.6	57.9	152.7	76.0	72.9	62.2	75.6	112.8	75.1	93.7	124.4	51.6	223.7	68.9	119.7	36.2	85.6	117.1	77.8	84.6	64.0	92.0	71.2	40.5	177.9	49.7	125.6	76.1	77.0	46.8	61.5	119.1	124.5	79.9	82.6	67.5	46.0	57.1	95.0	114.5	80.5	68.6	109.2	60.7	105.9	66.3	76.9	88.3	49.7	57.5	56.9	60.1	47.1	56.9	66.0	70.5	57.9	66.7	31.1	49.0	80.9	88.2	52.4	41.7	135.8	60.4	142.8	40.7	0.1	2.6	0.2	27.3	5.2	28.7	23.0	24.5	28.3	9.6	16.1	20.7	23.1	0.5	26.3	8.3	5.9	25.8	15.5	12.2	12.6	12.4	13.1	12.2	13.6	12.4	14.7	13.1	12.7	14.0	13.1	4.6	6.4	9.2	7.2	12.6	11.2	8.3	8.9	14.2	6.3	15.6	12.4	4.6	11.5	14.3	20.2	0.0	43.9	6.7	80.5	1.9	13.7	1.3	12.7	18.1	8.0	19.8	17.9	15.7	21.1	31.6	16.2	18.8	16.9	8.2	81.6	5.3	27.3	11.5	10.1	13.6	41.3	8.2	3.5	3.8	1.6	9.3	3.5	16.0	11.2	2.6	7.1	8.2	17.6	12.8	11.7	56.4	12.0	30.1	18.4	79.4	8.4	15.2	3.4	0.0	10.5	10.1	8.2	9.9	17.6	8.1	30.2	9.0	10.8	38.7	9.4
ALDH1A3	"ALDH6, RALDH3"	ENSG00000184254	"Aldehyde dehydrogenase 1 family member A3"	P47895	15	100877714-100916626	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 134.5;urinary bladder: 125.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 175.4;Endometrial stromal cells: 247.9;Leydig cells: 194.5;Prostatic glandular cells: 580.3;Urothelial cells: 468.7"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 80.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 363.3;HaCaT: 441.7;HBEC3-KT: 1096.9;hTERT-RPE1: 347.7;U-2197: 619.0;U-87 MG: 484.7;WM-115: 516.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"olfactory bulb: 4.5;spinal cord: 15.8"	"HPA046271, HPA064749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"HPA046271: AB_10965992, HPA064749: AB_2685344"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (6.07e-3)"	83.7	11.4	3.0	41.5	2.7	0.6	30.5	4.7	5.2	37.1	16.2	16.6	15.0	8.2	30.3	28.7	24.9	17.0	12.4	3.1	1.9	8.2	5.3	9.8	3.0	4.8	3.4	6.1	15.0	9.0	7.5	8.4	2.6	134.5	8.9	0.3	93.7	49.3	5.9	3.9	25.2	40.8	2.8	3.1	12.8	16.6	3.3	1.6	2.5	6.9	15.7	125.1	22.3	3.9	363.3	43.5	0.6	0.7	75.0	32.8	1.4	3.2	3.2	1.9	0.8	1.0	285.8	2.6	4.7	97.1	55.7	441.7	8.8	1096.9	6.7	0.1	2.0	1.7	20.1	0.3	25.5	1.4	1.9	23.5	29.8	24.4	4.5	347.7	4.0	0.0	0.7	2.4	1.8	3.8	0.2	1.2	9.0	9.6	316.3	0.7	4.2	2.3	0.2	283.6	0.3	25.4	113.9	94.9	33.3	3.6	9.3	3.2	58.3	0.3	1.0	619.0	14.2	0.7	3.4	1.5	484.7	0.2	516.1	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.0	2.7	4.7	5.2	3.1	1.9	4.8	3.4	2.6	2.8	3.3	3.9	10.0	16.0	6.3	0.3	0.5	0.6	175.4	70.5	4.6	0.0	64.6	18.9	2.0	1.5	141.6	103.0	0.0	9.6	0.9	1.0	3.9	70.5	1.2	20.6	247.9	11.6	3.5	0.0	2.9	1.4	0.5	48.9	1.1	11.7	5.7	0.0	1.8	0.1	1.2	0.0	2.3	2.1	30.5	0.0	1.3	8.5	194.5	3.3	0.0	1.0	0.6	0.0	0.0	36.7	4.6	29.4	0.0	135.4	0.0	580.3	0.1	0.7	78.7	0.0	13.1	20.4	11.5	0.5	0.9	2.9	1.6	4.9	2.0	1.5	0.8	468.7
ALDH3A2	"ALDH10, FALDH, SLS"	ENSG00000072210	"Aldehyde dehydrogenase 3 family member A2"	P51648	17	19648136-19685760	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 288.6"	"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 287.4;Squamous epithelial cells: 232.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 285.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014769, CAB020692"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		32000	"Cluster 14: Monocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Endoplasmic reticulum, Cytosol"		"CAB020692: , HPA014769: AB_1844728"	"unprognostic (1.42e-1)"	"unprognostic (7.62e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"prognostic favorable (3.85e-8)"	"unprognostic (4.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.26e-1)"	75.2	203.0	23.1	15.2	32.5	9.3	34.9	24.8	27.7	49.4	71.7	49.6	68.1	29.4	41.7	131.3	38.3	70.5	44.6	29.0	27.9	173.0	288.6	59.1	14.9	23.3	26.3	32.3	52.3	40.6	21.9	11.8	23.5	75.0	36.5	40.8	61.7	41.5	53.0	207.6	71.8	30.2	25.1	19.4	81.5	26.9	24.8	23.0	75.1	100.9	36.4	24.2	40.5	33.6	27.7	147.0	29.2	58.5	88.7	89.4	19.1	12.3	29.9	24.4	27.6	63.2	52.5	12.3	35.9	50.5	29.3	99.0	59.8	125.2	19.9	36.2	42.5	5.3	120.9	142.8	12.2	30.6	5.4	42.9	137.6	22.9	12.2	49.7	49.2	25.5	2.2	0.6	37.3	45.3	0.7	25.2	32.3	285.4	78.5	38.6	64.1	25.3	17.5	132.3	46.3	30.4	98.9	38.4	35.3	152.2	78.1	35.0	46.7	10.1	28.7	68.8	45.6	11.3	28.6	15.5	47.4	0.3	48.3	0.8	21.1	17.5	6.3	18.3	9.9	5.2	6.0	6.1	20.7	4.9	6.8	6.3	2.2	15.0	20.6	1.3	11.3	11.0	23.1	32.5	24.8	27.7	29.0	27.9	23.3	26.3	23.5	25.1	24.8	33.6	22.1	176.3	86.5	14.7	13.3	57.1	143.9	85.1	287.4	15.3	13.6	24.0	54.1	105.8	86.5	33.1	12.5	12.5	8.2	48.9	43.0	97.5	79.6	47.5	13.4	19.5	16.2	8.2	30.5	52.0	4.6	39.9	87.7	36.9	29.7	34.6	13.6	116.7	24.6	6.7	20.1	27.7	26.4	21.7	15.1	19.5	55.9	23.5	7.2	13.1	25.7	105.9	8.2	19.6	29.1	43.9	28.7	80.5	28.6	104.2	90.6	119.2	59.2	21.4	13.1	70.1	22.1	15.5	24.0	232.6	90.2	1.4	13.2	29.1	46.0	51.4
ALDH4A1	"ALDH4, P5CDh"	ENSG00000159423	"Aldehyde dehydrogenase 4 family member A1"	P30038	1	18871430-18902724	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 200.4;liver: 436.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 78.0;Hepatocytes: 385.1;Proximal tubular cells: 279.4;Syncytiotrophoblasts: 86.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 72.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Hep G2: 83.7;SK-BR-3: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004645, HPA006401, HPA072759"	Enhanced		Supported	Mitochondria		NA	NA		58000	"Cluster 7: Monocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB004645: AB_425775, HPA006401: AB_1844731, HPA072759: "	"unprognostic (1.17e-1)"	"prognostic favorable (5.06e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.34e-2)"	70.8	16.1	73.9	3.9	88.9	11.7	21.6	73.8	95.9	12.6	106.5	6.8	1.6	9.8	4.7	36.3	8.3	5.5	33.0	68.2	73.8	200.4	436.6	6.2	3.4	72.9	82.8	7.3	4.6	23.0	9.7	13.2	70.0	29.5	2.7	6.5	9.1	27.1	74.2	19.2	4.7	7.1	65.6	7.5	12.5	3.2	92.4	11.7	7.1	74.8	4.2	19.3	16.8	66.1	12.7	17.8	9.5	29.2	40.0	5.7	25.2	13.1	7.1	11.8	9.5	13.7	8.9	8.8	16.6	15.6	5.7	34.0	16.7	35.4	4.5	4.8	15.9	5.9	5.0	83.7	12.6	4.4	15.1	15.6	19.2	6.5	6.6	9.0	13.5	14.0	21.0	5.7	8.1	32.3	4.3	20.2	4.7	26.0	10.1	27.9	8.4	10.0	12.1	32.0	19.6	7.6	21.9	85.0	16.1	14.7	38.7	6.3	11.3	10.2	14.0	12.2	4.5	7.1	17.9	2.5	3.4	33.7	13.5	0.0	2.7	1.5	0.6	3.6	0.5	0.8	0.3	0.8	4.4	0.7	0.2	0.5	0.3	0.1	2.0	1.5	0.6	1.5	73.9	88.9	73.8	95.9	68.2	73.8	72.9	82.8	70.0	65.6	92.4	66.1	2.6	0.0	2.8	27.1	4.3	7.5	17.9	12.5	17.6	3.7	9.8	8.5	20.9	34.3	2.9	46.0	10.4	78.0	2.0	2.0	46.9	6.5	0.5	1.1	1.7	3.1	2.4	32.2	1.2	0.9	12.6	3.2	7.7	3.9	4.5	2.1	15.4	385.1	13.8	20.2	1.6	3.6	6.1	17.2	1.4	0.6	1.2	4.7	3.6	1.9	10.9	14.0	1.0	5.5	1.3	2.5	1.8	2.6	4.4	12.0	0.3	279.4	1.7	4.8	6.6	2.6	4.7	2.2	3.9	21.7	5.4	86.6	2.6	4.5	4.0	9.5
ALDH5A1	"SSADH, SSDH"	ENSG00000112294	"Aldehyde dehydrogenase 5 family member A1"	P51649	6	24494867-24537207	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 98.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 90.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 136.6;U-698: 173.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029715, HPA029716"	Enhanced		Supported	Mitochondria		NA	NA		50000	"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA029715: AB_10599994, HPA029716: AB_10601876"	"unprognostic (7.43e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (7.61e-6)"	"unprognostic (2.38e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (3.68e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-2)"	9.4	6.1	27.8	5.9	28.9	4.4	5.2	25.0	32.7	5.4	18.8	8.5	11.8	4.8	3.7	7.3	19.0	5.1	14.5	26.5	32.8	27.8	98.8	6.4	13.6	26.7	35.0	7.3	8.2	19.4	5.8	2.4	27.3	8.2	7.1	11.0	5.2	5.2	57.9	9.5	8.0	3.1	29.4	6.8	7.7	4.5	34.0	26.8	17.0	33.8	12.9	6.7	8.4	24.9	11.5	9.3	6.5	10.1	0.1	0.0	11.7	0.8	2.0	2.4	1.6	35.1	2.5	136.6	21.1	1.0	2.2	0.1	10.5	1.3	1.5	14.7	20.2	20.7	5.9	42.4	1.6	32.2	2.7	1.0	4.4	0.2	0.0	7.1	0.1	34.7	10.4	0.0	1.8	23.3	40.4	19.0	2.7	18.4	5.5	46.1	1.4	1.3	7.7	19.6	11.7	10.5	12.1	1.2	13.2	2.8	19.4	17.5	0.2	1.1	6.7	0.3	7.1	19.4	32.2	173.7	0.2	9.8	1.4	0.3	0.0	0.1	1.0	0.0	1.9	2.2	1.4	1.5	0.1	2.0	3.8	3.4	0.2	0.8	0.1	2.4	0.9	0.7	27.8	28.9	25.0	32.7	26.5	32.8	26.7	35.0	27.3	29.4	34.0	24.9	2.9	16.0	25.3	14.0	9.7	1.7	5.6	8.2	2.2	12.9	7.5	3.4	34.8	11.5	9.4	7.3	16.7	6.1	7.4	6.1	1.9	1.6	0.8	15.2	5.0	3.7	8.4	16.0	18.1	1.0	5.2	3.5	5.6	5.4	7.0	13.5	6.8	90.7	3.9	16.8	32.4	11.7	2.0	3.8	1.8	0.3	3.4	1.7	1.8	8.4	0.2	11.8	3.1	11.6	2.4	1.3	7.7	4.5	12.2	4.1	13.4	26.8	12.8	6.9	0.0	6.9	2.3	1.7	6.6	8.7	3.0	1.9	5.4	8.0	17.0	13.1
ALDH6A1	MMSDH	ENSG00000119711	"Aldehyde dehydrogenase 6 family member A1"	Q02252	14	74056847-74084492	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"kidney: 379.1;liver: 367.1"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 201.5;Hepatocytes: 523.6;Proximal tubular cells: 962.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 43.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 43.2"	"Cell line enhanced"	"Detected in all"		"T-47d: 57.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029072, HPA029073, HPA029074, HPA029075"	Enhanced		Enhanced	Mitochondria		No	No		37000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005"	"unprognostic (1.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.11e-3)"	"prognostic favorable (4.22e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (2.00e-15)"	"unprognostic (4.59e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.12e-1)"	38.7	14.7	58.6	4.8	66.0	3.3	14.4	58.8	59.3	17.3	61.4	15.2	26.6	11.4	9.8	9.8	12.8	9.4	40.3	51.0	54.0	379.1	367.1	9.4	5.1	63.3	54.0	28.3	23.4	37.0	6.6	7.6	55.6	25.4	15.8	15.2	19.8	16.1	27.5	6.2	23.4	9.0	56.4	5.4	24.0	17.1	69.8	5.7	28.3	34.8	5.3	11.4	7.0	62.6	8.9	7.8	11.0	23.5	39.3	19.2	17.5	6.3	11.8	6.8	11.5	17.3	10.2	10.5	13.6	13.5	5.3	4.8	24.9	7.0	14.5	9.5	3.5	5.1	8.0	19.2	45.0	2.7	2.4	28.2	12.0	8.7	20.7	17.0	12.0	23.7	8.1	14.7	4.6	36.2	7.6	4.0	8.7	32.6	5.2	15.1	11.2	14.6	9.2	5.8	4.4	7.0	21.0	21.9	5.7	18.0	57.5	9.6	3.8	7.4	9.0	11.7	2.4	9.3	18.9	10.2	9.9	3.2	7.3	29.1	6.2	43.2	6.9	4.8	10.6	7.2	7.8	8.4	9.2	6.1	9.9	7.0	2.4	9.7	4.2	5.3	6.1	4.9	58.6	66.0	58.8	59.3	51.0	54.0	63.3	54.0	55.6	56.4	69.8	62.6	15.4	38.5	60.4	24.5	11.8	9.2	26.8	10.0	20.5	20.6	28.4	18.9	81.4	67.2	22.9	66.2	4.2	31.0	7.1	18.9	201.5	11.6	23.4	26.2	27.5	27.0	16.9	28.6	5.5	3.1	14.8	25.9	34.7	90.2	7.6	27.1	87.4	523.6	17.7	11.8	10.0	39.3	8.2	26.5	8.9	19.0	28.9	13.4	24.9	1.9	15.8	98.5	9.2	12.5	23.4	4.1	16.3	48.2	8.0	27.6	55.3	962.4	15.4	17.0	13.1	25.6	16.9	11.0	4.2	25.2	7.4	30.6	11.0	10.2	35.7	17.2
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595362	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 162.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 414.1;Proximal tubular cells: 302.1;Syncytiotrophoblasts: 222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 6.4"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 6.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 256.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023296, HPA053675"	Enhanced		Supported	Mitochondria,Cytosol		Yes	No		430000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Cytosol	"HPA023296: AB_1844738, HPA053675: "	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	23.7	38.3	46.6	9.1	47.6	1.8	47.1	43.7	45.8	32.7	40.7	29.5	23.7	25.1	8.8	35.9	28.8	19.1	27.9	44.7	43.2	115.1	162.2	15.7	8.6	43.1	43.5	65.3	27.0	34.0	8.8	44.9	42.6	42.0	27.4	19.7	40.6	27.9	12.2	29.4	21.0	23.6	44.8	7.0	23.6	12.3	44.0	18.3	47.6	26.5	17.1	18.1	20.9	45.2	64.9	41.9	116.6	193.4	95.5	56.4	147.8	76.1	93.4	86.5	110.5	118.6	60.7	0.0	75.5	60.0	36.1	47.1	36.5	256.2	78.8	0.1	44.6	12.3	63.1	102.1	46.3	0.2	0.0	69.0	59.2	67.3	47.7	64.2	70.0	0.0	0.0	0.1	77.1	42.1	2.6	0.3	79.4	47.5	35.2	38.9	131.8	0.0	81.2	48.4	39.4	47.2	0.0	41.1	44.7	89.0	75.2	2.7	86.1	24.8	75.6	28.8	53.1	0.1	0.1	0.4	13.4	0.2	40.6	0.7	0.2	0.1	0.1	0.0	0.2	0.8	0.2	0.1	1.8	0.6	1.2	0.6	0.1	0.1	0.0	6.4	0.0	0.4	46.6	47.6	43.7	45.8	44.7	43.2	43.1	43.5	42.6	44.8	44.0	45.2	17.6	16.0	29.3	99.3	5.0	25.9	59.5	110.0	87.0	23.6	40.6	91.1	39.9	27.1	43.5	42.3	22.9	414.1	3.7	15.2	76.3	43.5	31.4	18.7	44.3	19.1	21.7	5.2	16.0	13.8	107.8	34.0	27.0	21.4	7.0	50.4	18.9	74.6	51.1	25.2	21.5	25.9	20.3	9.4	7.6	41.7	25.4	9.1	55.2	12.2	7.5	102.1	0.0	41.7	30.0	12.6	15.6	37.2	2.0	27.5	23.4	302.1	23.4	13.6	19.7	19.4	25.8	1.0	5.1	59.2	16.1	222.3	4.6	39.3	46.4	50.4
ALDOA		ENSG00000149925	"Aldolase, fructose-bisphosphate A"	P04075	16	30064164-30070457	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease variant, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"skeletal muscle: 26754.8;tongue: 9180.4"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 3267.9;Extravillous trophoblasts: 2322.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004177, CAB006252"	Supported		Approved	Cytosol		NA	NA		640000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"CAB006252: AB_437007, HPA004177: AB_1078128"	"unprognostic (2.63e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.28e-3)"	"prognostic unfavorable (5.79e-5)"	"prognostic unfavorable (7.32e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.19e-3)"	"unprognostic (4.48e-2)"	569.3	696.4	616.8	443.1	697.4	732.5	512.6	617.3	719.7	566.0	617.0	774.1	517.9	533.7	201.0	1302.0	449.7	420.5	2286.1	731.9	652.0	709.0	217.1	425.6	358.2	762.3	654.0	510.4	390.5	943.1	525.1	351.4	763.9	457.7	400.1	465.2	904.9	597.6	26754.8	643.4	488.3	465.2	545.5	417.5	595.0	138.7	657.8	280.9	454.5	9180.4	478.3	761.8	740.3	558.7	2206.1	1620.4	477.9	1542.8	714.6	808.5	1520.8	1297.9	1336.2	1291.6	1603.0	1158.1	1643.6	1487.6	2072.2	1318.6	708.6	1632.6	966.8	2829.1	939.3	658.5	1272.9	1219.3	1202.7	2591.1	1112.5	1793.8	1251.3	1115.7	979.6	1455.4	968.9	2119.7	965.4	686.9	1070.0	951.1	1393.4	3136.7	1100.2	1477.0	1192.8	848.1	1346.6	1613.9	765.2	3353.2	1629.4	1230.5	950.7	668.5	808.6	3368.5	1213.9	591.2	1433.0	1194.7	1162.5	1892.3	750.3	1046.7	1430.0	1861.5	1387.3	1369.3	3524.5	1715.9	1532.9	2050.6	2694.7	2081.7	1008.7	2466.5	1138.1	908.5	1091.7	1047.0	2182.7	877.9	1027.4	996.9	2531.7	819.9	2780.2	824.0	1476.3	4372.2	616.8	697.4	617.3	719.7	731.9	652.0	762.3	654.0	763.9	545.5	657.8	558.7	17.0	12.8	32.4	83.2	281.2	792.0	716.4	3267.9	784.8	387.4	34.4	21.6	1968.4	273.1	1385.1	42.3	118.9	1194.1	107.9	1834.8	111.6	120.9	258.8	15.8	11.8	261.1	323.9	215.8	66.2	76.2	2322.1	329.7	513.3	16.1	196.5	18.7	289.5	102.0	1181.9	733.6	70.0	755.1	1265.4	632.2	715.4	1152.4	380.8	388.8	924.9	50.6	417.7	662.1	328.5	40.2	60.8	126.2	1497.1	405.1	409.4	676.9	1755.7	75.8	700.9	298.9	486.4	680.9	572.9	25.8	123.6	1174.6	684.5	1361.3	294.3	15.2	937.7	1146.2
ALDOB		ENSG00000136872	"Aldolase, fructose-bisphosphate B"	P05062	9	101420560-101449664	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	27	"intestine: 5736.6;kidney: 7181.0;liver: 11160.8"	"Group enriched"	"Detected in some"	4	"Proximal enterocytes: 20078.3;Proximal tubular cells: 7956.0"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 1414.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 21.4;NB-4: 21.0;RPMI-8226: 28.6;SH-SY5Y: 20.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA002198, CAB020827"	Enhanced					NA	NA		560000000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 24: NB-4 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB020827: , HPA002198: AB_1078129"	"unprognostic (6.58e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.79e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.96e-2)"	3.3	1.4	0.4	17.0	0.7	0.0	0.7	1.0	2.3	0.2	0.0	30.1	4073.8	2.8	1.0	0.7	0.4	176.9	1.0	2.4	0.0	7181.0	11160.8	0.5	4.9	0.0	0.0	0.5	292.7	0.0	5.6	0.4	0.0	2.1	5.6	0.3	0.3	0.0	0.4	0.5	5736.6	7.0	0.0	2.0	34.3	1.1	0.0	0.7	0.3	0.0	0.8	0.1	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.5	0.0	4.5	1.8	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	2.2	0.0	1.0	0.0	6.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	0.3	21.0	0.4	0.5	0.0	0.3	4.6	28.6	0.0	0.0	4.3	20.6	2.0	0.0	0.0	0.0	0.0	0.1	1.9	0.1	1.0	7.1	0.3	0.5	0.7	2.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	1.0	2.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	39.4	0.0	0.0	0.3	0.0	1.1	0.0	0.0	1.1	308.8	0.8	150.8	0.0	0.0	0.0	13.5	620.3	4.9	0.0	0.0	0.4	3.6	0.0	50.8	0.5	253.3	0.1	0.0	0.0	0.3	0.0	0.0	49.2	3225.4	0.2	3.3	0.2	464.9	0.0	66.2	0.0	0.0	0.0	38.1	0.0	0.0	3.6	0.3	0.0	0.0	0.3	182.1	997.4	0.0	0.1	0.0	20078.3	7956.0	0.2	0.6	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.3	20.6	0.2	412.7	0.0
ALG1	"CDG1K, HMAT1, HMT-1, Mat-1"	ENSG00000033011	"ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase"	Q9BT22	16	5033923-5087379	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060392	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA060392: AB_2684273"	"unprognostic (1.66e-2)"	"unprognostic (5.18e-1)"	"prognostic favorable (5.79e-4)"	"unprognostic (1.55e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (2.58e-3)"	"unprognostic (3.86e-2)"	11.3	19.6	6.2	12.8	6.6	7.7	9.9	6.1	7.9	12.4	12.7	18.8	15.8	11.0	14.5	11.2	12.4	9.8	8.3	6.5	6.6	12.6	21.0	9.3	12.4	6.3	6.0	8.8	26.8	17.5	10.9	9.5	6.9	10.5	16.3	6.8	18.8	10.6	7.4	8.8	13.1	12.0	5.8	15.0	19.6	20.8	6.5	12.0	11.6	5.5	12.1	12.4	8.3	6.8	24.0	53.7	10.8	25.5	40.7	24.2	26.4	50.6	50.6	46.9	46.4	44.8	72.4	44.4	43.1	48.0	20.7	58.2	30.1	36.2	31.6	42.0	43.3	20.7	40.1	87.1	33.4	37.6	37.3	29.7	26.9	36.2	23.0	18.5	28.7	32.2	29.5	44.7	34.5	50.1	28.9	40.7	51.2	31.7	33.6	48.8	16.0	124.9	28.3	18.7	20.7	21.7	49.3	67.8	27.4	14.3	45.1	29.2	29.8	22.5	25.6	134.7	40.1	39.8	59.3	30.2	20.5	39.8	38.1	11.5	79.9	28.8	87.2	80.6	77.1	72.9	74.9	86.3	86.7	73.9	66.7	75.0	4.3	79.8	80.0	75.6	81.1	126.6	6.2	6.6	6.1	7.9	6.5	6.6	6.3	6.0	6.9	5.8	6.5	6.8	4.6	16.0	6.1	4.2	11.2	2.4	3.4	15.7	5.2	7.4	6.8	6.0	0.7	8.6	14.3	7.3	12.5	16.2	7.2	8.5	3.9	19.5	10.7	5.4	8.1	8.7	13.3	12.0	4.0	28.3	18.7	9.3	13.7	5.5	1.3	8.1	8.6	17.7	21.7	3.3	4.6	21.0	8.2	10.6	2.4	25.5	9.6	7.6	10.6	1.0	9.3	7.5	9.2	3.5	3.4	21.6	11.1	6.8	22.7	4.5	11.8	10.4	11.7	6.3	6.6	5.4	7.1	28.0	16.0	7.7	1.6	8.5	8.6	13.8	18.0	4.4
ALG11	"CDG1P, KIAA0266"	ENSG00000253710	"ALG11 alpha-1,2-mannosyltransferase"	Q2TAA5	13	52012391-52079232	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047214	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"			"HPA047214: AB_10961640"	"unprognostic (9.21e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.02e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.97e-3)"	"unprognostic (8.89e-3)"	"unprognostic (7.47e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.03e-2)"	"unprognostic (9.71e-3)"	10.1	9.5	7.4	8.3	8.4	4.1	12.1	9.5	9.7	12.1	1.9	11.0	10.1	11.0	9.4	7.5	10.8	8.9	10.4	7.5	4.8	14.6	19.2	9.1	8.1	4.8	4.0	11.6	8.6	17.2	2.4	12.7	4.6	12.1	11.8	9.0	10.9	10.9	6.5	7.2	9.7	11.4	2.9	10.1	11.6	6.2	4.7	9.5	16.8	8.8	8.6	8.7	2.5	9.6	6.7	10.5	17.8	15.2	18.6	13.3	14.2	17.7	16.3	12.9	10.3	8.5	14.5	16.2	4.2	18.4	15.8	15.3	18.2	12.0	17.0	16.7	12.9	31.0	8.8	11.4	14.1	28.3	31.0	12.9	17.8	10.1	18.4	14.1	11.5	18.5	17.8	10.4	19.4	5.7	14.7	9.7	19.2	28.8	7.5	15.2	11.9	8.9	16.7	10.8	6.9	15.2	11.9	17.1	11.9	15.0	11.9	20.8	17.8	10.4	11.5	13.6	11.8	9.1	13.5	17.7	6.4	11.7	18.0	13.2	5.4	7.2	7.7	4.5	7.6	5.1	7.0	6.6	6.9	7.1	8.9	8.9	2.2	7.3	12.0	9.8	7.2	4.9	7.4	8.4	9.5	9.7	7.5	4.8	4.8	4.0	4.6	2.9	4.7	9.6	5.3	19.2	8.2	5.5	7.1	2.4	3.2	7.8	8.0	6.8	4.2	3.2	7.5	5.7	9.3	3.7	6.2	3.4	6.2	2.1	1.9	2.9	0.9	5.1	7.3	5.2	3.0	12.6	9.3	2.2	3.9	8.2	9.7	5.4	3.8	6.5	6.1	4.0	2.5	5.0	8.1	2.7	6.1	2.2	3.1	0.5	3.4	3.5	1.8	5.6	2.6	2.8	11.3	13.0	8.9	2.7	1.7	1.2	14.0	2.6	3.5	1.7	13.5	7.5	0.0	4.2	6.4	4.8	3.5	7.8	2.4	4.8	7.2	3.7	2.1	4.0
ALG12	"CDG1G, ECM39"	ENSG00000182858	"ALG12 alpha-1,6-mannosyltransferase"	Q9BV10	22	49900229-49918438	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003076, HPA051665"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA003076: AB_2666777, HPA051665: AB_2681566"	"unprognostic (1.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.39e-3)"	"prognostic favorable (6.09e-4)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.27e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (3.60e-5)"	"unprognostic (1.62e-2)"	"unprognostic (3.00e-2)"	"unprognostic (9.89e-3)"	"unprognostic (6.32e-2)"	6.3	8.0	3.5	7.3	4.5	5.9	6.4	6.2	4.7	7.6	4.9	8.8	11.1	8.3	6.5	8.0	7.6	6.6	8.3	3.9	2.6	10.3	14.5	7.0	5.6	4.5	4.3	7.1	11.4	11.8	6.6	5.4	4.7	9.1	4.1	3.0	12.0	5.6	6.1	7.2	8.9	4.4	3.3	7.2	10.3	4.5	4.9	6.5	11.7	4.5	4.8	7.7	6.8	8.4	8.6	8.5	8.8	14.7	16.4	7.6	9.8	8.8	7.9	10.2	8.2	14.0	12.0	4.6	7.8	7.8	11.1	15.2	10.7	10.4	5.0	7.3	15.9	4.2	14.7	14.1	18.6	10.6	8.9	11.6	10.5	9.9	14.3	11.2	9.9	10.3	5.3	11.2	5.4	19.6	10.4	8.6	8.4	11.3	7.7	17.2	11.0	12.1	10.6	9.6	5.9	9.6	14.0	26.3	11.4	11.7	10.8	9.4	7.7	11.2	8.5	7.9	6.8	9.8	4.9	6.1	12.5	8.0	10.9	21.4	8.7	7.7	11.5	8.5	11.7	4.8	8.9	11.4	7.6	6.4	7.3	8.6	7.1	16.9	10.1	7.7	12.8	8.1	3.5	4.5	6.2	4.7	3.9	2.6	4.5	4.3	4.7	3.3	4.9	8.4	6.8	9.6	3.1	21.5	10.2	4.1	10.2	12.1	9.1	5.2	11.1	10.2	1.2	8.6	10.3	18.4	2.1	20.5	8.5	16.6	3.9	15.9	6.9	6.6	8.0	8.1	6.7	7.4	23.2	13.5	22.4	10.6	11.7	9.2	8.2	7.0	5.3	15.0	18.6	3.3	30.4	12.9	12.2	9.2	5.3	4.3	8.7	8.7	10.6	9.4	9.0	2.9	18.6	17.6	40.4	10.3	9.7	8.2	15.6	11.3	18.8	6.8	5.6	5.2	0.0	8.5	7.7	12.9	9.1	10.4	6.0	26.3	11.9	8.3	16.3	9.1
ALG13	"CDG1S, CXorf45, FLJ23018, GLT28D1, MDS031, TDRD13, YGL047W"	ENSG00000101901	"ALG13 UDP-N-acetylglucosaminyltransferase subunit"	Q9NP73	X	111665811-111760649	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Glycosyltransferase, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Congenital disorder of glycosylation, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002853, HPA005498"	Approved		Approved	Vesicles,Cytosol		NA	NA		11000000	"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles	Cytosol	"HPA002853: AB_1078131, HPA005498: "	"unprognostic (4.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.97e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.62e-3)"	"prognostic unfavorable (1.10e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.45e-2)"	15.1	17.9	10.5	18.8	11.7	16.6	18.3	11.5	19.0	17.2	12.3	18.2	13.7	16.1	20.5	14.7	15.4	16.4	13.2	10.2	13.8	21.0	23.8	13.8	23.4	12.6	12.1	15.8	14.7	23.4	17.9	14.1	13.3	17.7	19.4	11.8	15.6	13.4	9.2	19.4	17.3	17.5	11.4	18.5	15.5	17.4	11.8	17.3	18.2	9.9	20.1	21.3	14.7	16.6	22.3	24.4	21.8	13.8	13.8	19.6	12.3	17.7	18.3	22.4	27.5	24.9	23.1	19.5	33.0	24.7	46.5	12.6	26.1	12.5	23.5	14.4	17.6	10.7	26.1	28.4	20.3	19.5	40.5	23.6	22.8	18.0	38.6	23.3	24.8	21.8	23.9	53.5	22.5	55.8	16.4	17.6	19.9	66.3	33.6	12.8	13.9	26.7	36.6	34.0	13.1	19.1	25.2	15.2	16.3	21.7	13.6	18.5	16.7	19.2	9.7	24.9	34.4	25.8	47.1	31.5	20.5	25.5	15.2	39.5	15.8	16.6	9.5	16.3	9.3	10.6	10.6	9.2	18.5	12.1	13.0	10.8	3.0	4.6	12.9	9.5	14.6	9.6	10.5	11.7	11.5	19.0	10.2	13.8	12.6	12.1	13.3	11.4	11.8	16.6	50.9	16.0	30.8	33.6	127.9	35.2	65.8	53.5	33.6	15.1	33.9	31.6	18.7	22.8	36.0	18.4	10.4	27.3	73.9	39.2	45.0	37.4	21.1	48.2	31.1	37.4	26.5	27.1	64.7	52.1	39.1	34.6	37.2	47.9	109.8	15.7	28.2	28.4	42.5	11.8	57.4	49.0	46.8	39.2	52.3	9.4	21.5	56.1	28.4	83.4	41.8	16.0	29.9	41.7	77.5	58.0	55.6	16.1	60.4	46.9	38.5	55.5	35.3	16.5	26.3	38.7	46.2	32.6	22.4	26.5	35.4	48.7	71.1	28.8	32.8	64.6
ALG2	"CDG1I, CDGIi, FLJ14511, hALPG2, NET38"	ENSG00000119523	"ALG2 alpha-1,3/1,6-mannosyltransferase"	Q9H553	9	99216425-99221942	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041512, HPA041601"	Approved		Approved	"Golgi apparatus"		NA	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA041512: AB_10794380, HPA041601: AB_10794302"	"unprognostic (8.86e-3)"	"unprognostic (4.39e-1)"	"unprognostic (2.37e-1)"	"prognostic favorable (8.44e-5)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.06e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.28e-7)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.81e-1)"	17.7	38.2	13.4	19.4	14.6	23.0	27.1	16.6	18.4	35.1	19.8	24.9	21.9	23.8	74.0	15.1	29.5	26.2	13.4	14.5	15.0	34.3	47.4	24.3	20.8	14.7	16.1	30.2	42.0	37.0	21.8	29.9	15.1	32.8	27.3	15.0	37.9	34.5	15.3	17.9	20.5	24.2	14.8	17.9	25.0	19.2	14.7	16.7	42.3	13.5	27.5	31.7	10.9	16.9	22.9	28.7	22.7	34.4	82.6	52.7	42.0	46.7	75.3	45.6	39.3	34.9	31.2	24.6	18.8	54.3	60.0	85.3	37.9	49.1	45.7	35.2	16.2	14.4	23.7	54.0	99.7	28.2	26.2	61.9	65.2	37.7	72.8	45.8	52.3	15.1	23.2	56.2	44.7	47.8	12.9	29.8	27.6	75.0	39.6	14.0	43.4	38.1	65.2	31.1	22.5	19.3	33.5	63.8	61.6	33.5	24.4	23.3	38.8	31.4	27.9	40.9	28.6	45.8	28.0	10.5	58.6	20.5	16.3	38.7	35.5	22.0	33.7	28.2	49.2	30.8	32.0	33.9	45.1	26.3	27.7	27.4	9.3	38.0	28.4	79.9	38.3	36.0	13.4	14.6	16.6	18.4	14.5	15.0	14.7	16.1	15.1	14.8	14.7	16.9	12.6	12.8	22.9	6.8	22.1	23.3	26.8	56.2	10.2	11.3	22.6	16.6	6.9	32.9	35.8	23.9	2.1	50.3	30.2	20.0	21.5	36.1	28.7	16.9	30.9	19.8	12.5	12.0	8.1	35.2	34.2	30.4	15.3	26.4	7.6	14.1	21.8	55.5	28.1	10.1	8.3	26.3	38.7	25.8	45.4	20.3	26.8	23.0	21.4	10.3	64.2	15.5	15.5	9.5	9.7	31.9	16.0	25.2	47.0	37.3	18.7	36.6	33.1	8.3	6.6	17.2	18.2	22.6	24.6	15.0	23.7	89.2	16.6	25.6	20.8	31.3
ALG3	"CDGS4, D16Ertd36e, Not56, NOT56L"	ENSG00000214160	"ALG3 alpha-1,3- mannosyltransferase"	Q92685	3	184242301-184249548	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 211.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045103	Enhanced					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA045103: AB_10960547"	"unprognostic (3.63e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.63e-1)"	"unprognostic (7.93e-3)"	"prognostic unfavorable (1.58e-5)"	"prognostic unfavorable (8.67e-5)"	"unprognostic (6.18e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.19e-3)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.02e-2)"	22.0	32.6	9.3	15.0	9.3	15.7	19.7	10.8	11.1	18.1	13.9	23.8	16.9	17.5	12.5	30.5	15.1	11.6	19.6	8.8	9.7	18.7	58.0	18.1	13.0	10.6	10.1	12.7	37.1	23.1	14.6	19.6	11.2	19.8	18.3	6.0	26.8	13.7	30.2	24.9	20.4	16.4	10.0	20.8	23.1	25.7	10.7	12.2	18.4	14.8	14.1	22.5	19.8	10.3	77.2	67.6	18.0	59.5	70.2	39.4	59.3	40.6	46.0	54.9	47.3	102.8	50.9	67.6	108.4	50.8	112.0	90.8	64.1	90.0	34.5	49.0	76.7	60.8	49.3	84.7	64.3	99.5	52.4	47.0	74.7	64.8	90.9	29.4	30.0	46.0	60.7	132.6	36.1	95.8	48.5	83.1	55.9	153.3	85.8	49.9	27.5	269.7	63.2	25.7	44.3	36.7	37.6	147.0	67.5	21.8	140.2	54.8	24.3	57.2	36.0	51.2	88.4	72.3	137.8	71.3	51.5	129.2	52.9	0.6	60.9	14.6	35.8	61.1	40.5	31.6	38.3	36.8	71.4	30.8	33.9	33.2	2.0	48.9	51.3	65.3	44.6	41.7	9.3	9.3	10.8	11.1	8.8	9.7	10.6	10.1	11.2	10.0	10.7	10.3	14.2	6.4	18.1	4.6	24.5	25.0	28.3	61.0	26.2	10.4	24.1	20.8	11.7	21.5	43.0	20.2	10.4	79.2	21.0	24.9	7.9	62.3	95.7	9.1	17.7	18.7	14.5	24.4	5.6	63.1	100.4	22.3	25.0	13.5	12.7	16.3	12.5	51.7	69.8	8.4	5.9	33.3	50.8	24.9	15.5	211.5	12.5	25.8	21.4	7.5	21.2	13.7	16.5	7.1	6.3	44.6	22.0	15.1	63.8	47.2	39.4	31.8	16.7	13.0	19.7	9.0	34.6	29.7	34.3	39.4	27.0	65.8	17.6	23.1	45.6	29.1
ALG6		ENSG00000088035	"ALG6 alpha-1,3-glucosyltransferase"	Q9Y672	1	63367575-63438553	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062536, HPA076130"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA062536: AB_2684792, HPA076130: "	"unprognostic (1.21e-1)"	"unprognostic (5.60e-3)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (2.07e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (2.63e-6)"	"unprognostic (1.84e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.41e-1)"	3.5	4.5	1.1	1.1	1.3	1.4	3.4	1.9	1.4	3.7	1.0	3.8	1.1	2.9	1.4	6.1	3.0	0.8	2.1	1.1	1.2	3.0	4.6	2.7	1.9	1.1	1.2	3.2	3.3	1.4	2.0	1.0	1.1	3.1	1.2	1.2	4.3	0.6	2.8	5.1	4.4	0.6	1.1	5.2	3.2	2.2	1.1	2.0	3.1	0.1	1.6	3.1	4.2	1.4	0.5	1.3	1.3	1.2	1.8	1.3	2.6	0.9	0.2	0.3	0.3	2.0	0.6	2.7	1.4	0.7	1.5	1.0	2.0	1.0	1.4	2.4	4.2	2.2	1.5	2.4	0.6	2.8	2.4	0.9	0.6	0.9	0.6	0.7	2.0	2.3	2.2	1.3	1.0	2.5	1.7	2.4	7.6	1.3	2.3	1.8	1.6	2.1	1.6	2.2	1.5	0.8	2.3	3.2	2.3	2.9	0.9	2.1	0.9	0.6	0.6	1.8	1.5	1.7	1.7	1.7	1.2	3.3	2.4	1.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.2	0.3	0.3	0.6	0.5	0.1	0.4	0.3	0.2	0.3	0.2	1.1	1.3	1.9	1.4	1.1	1.2	1.1	1.2	1.1	1.1	1.1	1.4	9.8	9.6	4.8	9.8	12.1	11.0	8.5	24.6	15.4	6.3	8.5	5.5	3.1	12.8	22.1	3.7	4.2	42.1	10.2	6.1	1.9	12.4	2.4	11.2	7.0	8.7	4.2	9.0	19.1	8.9	28.5	8.6	11.2	10.0	8.9	12.2	8.2	11.5	15.5	6.7	19.4	7.8	22.4	7.1	8.8	2.0	6.8	9.1	16.0	4.7	4.8	5.5	13.4	19.1	16.8	6.0	3.6	4.9	11.4	4.9	8.2	7.3	11.7	5.4	6.6	4.5	6.6	16.2	15.3	18.3	11.1	26.8	15.1	10.0	11.5	7.4
ALG8	MGC2840	ENSG00000159063	"ALG8 alpha-1,3-glucosyltransferase"	Q9BVK2	11	78095244-78139660	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 105.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051898	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA051898: AB_2681656"	"unprognostic (1.37e-1)"	"unprognostic (9.24e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.38e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.37e-2)"	22.8	33.0	12.7	13.4	14.3	9.2	25.6	13.9	16.4	18.7	15.4	17.5	13.3	15.9	33.2	19.0	18.8	12.0	17.9	12.9	13.3	24.9	47.1	15.0	14.6	14.1	13.1	22.1	23.8	23.7	19.8	18.7	13.8	19.1	21.8	10.4	21.7	18.0	12.1	16.6	15.5	16.4	13.5	18.3	20.2	43.5	13.1	17.8	22.4	8.9	19.8	18.4	16.0	15.2	27.8	74.4	62.8	56.6	63.7	42.5	37.6	38.6	57.8	68.6	67.4	127.9	102.0	61.4	74.5	51.5	92.3	86.5	87.0	56.5	111.9	46.3	50.8	74.3	56.5	62.2	38.9	71.8	39.6	34.4	36.4	81.8	37.9	37.5	50.3	58.0	98.2	65.8	97.7	38.6	53.3	61.9	81.9	200.5	38.1	63.6	32.6	168.3	70.0	40.4	20.2	44.8	62.0	102.2	29.4	65.6	106.5	50.8	32.0	43.5	50.6	102.5	35.1	46.6	88.0	80.3	26.7	71.4	84.4	1.2	30.0	5.4	25.1	34.5	29.1	37.2	25.5	25.7	34.2	31.3	29.7	26.2	2.6	29.1	39.9	33.1	22.5	27.6	12.7	14.3	13.9	16.4	12.9	13.3	14.1	13.1	13.8	13.5	13.1	15.2	11.9	12.8	11.6	12.4	21.0	10.5	23.3	49.6	26.2	14.7	18.3	16.3	6.9	20.0	35.2	20.2	18.8	53.8	9.1	7.0	5.9	24.4	18.9	11.0	16.9	17.2	7.8	9.9	21.3	25.4	59.5	19.4	11.7	13.8	11.4	36.4	9.3	40.2	31.4	16.8	18.0	15.9	32.6	17.0	10.8	14.0	18.0	15.3	26.6	12.2	12.3	8.2	21.6	13.0	20.7	17.7	6.4	15.8	43.1	16.9	7.7	15.8	21.7	13.5	0.0	14.2	19.6	105.0	37.8	20.9	8.9	32.7	15.2	16.9	16.8	15.2
ALG9	DIBD1	ENSG00000086848	"ALG9 alpha-1,2-mannosyltransferase"	Q9H6U8	11	111782195-111871581	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 26.6;Inhibitory neurons: 31.8;Oligodendrocytes: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA038575	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA038575: AB_10672718"	"unprognostic (1.48e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.34e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.07e-3)"	"unprognostic (5.11e-2)"	"unprognostic (8.75e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (9.15e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.10e-2)"	14.0	9.7	6.3	8.6	7.1	7.8	12.4	8.2	7.8	12.9	6.3	10.9	12.1	11.5	10.9	11.4	9.2	7.9	10.1	6.3	6.6	9.5	13.4	9.6	6.6	6.5	6.8	12.5	19.7	12.7	10.0	9.6	6.7	9.6	10.3	12.0	17.5	11.3	9.1	15.2	10.2	11.1	5.6	8.4	12.0	13.6	6.1	9.8	12.3	8.3	9.2	11.3	11.1	6.4	16.6	16.5	30.7	31.1	19.0	18.0	23.7	20.5	16.5	16.4	17.9	28.7	27.4	27.1	28.7	23.8	21.4	29.8	16.6	25.4	23.4	20.2	12.2	19.7	8.6	21.2	22.0	22.2	13.6	15.5	17.2	17.7	17.8	24.2	16.2	20.2	20.3	41.0	28.4	12.5	22.2	20.3	10.7	23.3	15.9	20.4	26.9	51.5	18.5	13.7	15.0	25.4	18.0	28.0	11.4	21.6	29.0	9.3	16.9	35.0	25.2	17.1	22.6	13.3	10.2	24.4	15.1	27.4	24.7	4.5	3.1	3.8	4.0	4.5	4.7	4.0	4.1	4.6	5.2	3.1	5.8	3.6	1.1	4.2	4.0	5.6	4.5	3.3	6.3	7.1	8.2	7.8	6.3	6.6	6.5	6.8	6.7	5.6	6.1	6.4	3.2	0.0	4.4	21.5	5.9	2.0	1.5	3.2	9.6	8.9	3.8	3.4	5.6	1.5	3.9	7.3	8.4	3.5	4.6	3.2	3.9	7.5	5.1	2.0	5.2	4.1	4.2	6.3	26.6	7.1	12.6	4.7	4.6	3.8	0.0	5.5	2.2	6.8	3.2	15.2	31.8	4.0	4.1	1.9	1.9	4.3	4.7	3.5	0.0	12.2	3.1	4.9	3.1	21.1	31.8	6.5	2.9	3.8	22.8	1.3	4.6	2.3	2.2	9.7	6.6	3.5	5.4	4.2	5.7	8.6	1.6	9.0	5.8	2.5	4.4	0.8
ALKBH8	"MGC10235, TRM9, TRMT9A"	ENSG00000137760	"AlkB homolog 8, tRNA methyltransferase"	Q96BT7	11	107502727-107565742	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Multifunctional enzyme, RNA-binding, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 25.2;Inhibitory neurons: 27.4;Oligodendrocyte precursor cells: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038724, HPA038725, HPA061514"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies"	Nucleoplasm	"HPA038724: AB_2676176, HPA038725: AB_10674838, HPA061514: AB_2684547"	"unprognostic (2.66e-2)"	"unprognostic (3.82e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.45e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.01e-1)"	3.1	2.9	2.4	4.0	3.0	3.3	5.0	2.6	2.8	2.9	1.7	3.0	3.2	3.8	3.2	3.1	2.9	2.8	3.8	2.4	2.6	3.9	4.5	3.6	6.0	2.2	2.6	4.4	2.3	4.1	1.7	3.3	2.5	3.5	3.6	3.3	2.9	3.3	5.1	4.6	2.6	3.6	2.2	4.6	3.3	2.8	2.3	4.6	5.2	4.7	5.9	3.5	2.8	2.3	5.4	6.5	6.6	7.2	3.6	7.9	5.4	10.2	7.5	7.4	8.0	12.1	9.7	12.6	5.8	10.0	10.2	9.6	9.9	8.5	9.6	11.4	6.6	10.6	2.5	5.6	5.3	13.7	12.6	4.9	9.2	9.5	12.0	3.8	9.3	9.9	15.2	4.1	5.9	4.9	12.4	6.8	8.7	10.5	10.6	11.1	10.2	8.7	5.9	5.8	6.0	6.7	5.9	4.4	4.5	4.0	7.2	4.1	8.8	16.1	9.6	5.3	12.9	3.8	4.3	9.7	4.5	9.0	16.1	0.0	1.1	0.3	2.2	2.1	2.1	0.9	1.6	1.9	1.7	1.9	3.0	2.6	0.0	2.8	1.5	1.0	1.8	1.1	2.4	3.0	2.6	2.8	2.4	2.6	2.2	2.6	2.5	2.2	2.3	2.3	4.4	0.0	5.3	4.6	8.5	2.0	1.7	1.5	7.4	5.7	3.2	3.0	11.2	5.7	3.5	1.8	6.2	2.3	3.0	1.3	0.0	1.9	0.4	2.4	4.6	4.2	1.2	4.6	25.2	3.3	2.7	4.3	7.7	2.3	10.1	5.1	2.9	6.6	2.8	1.7	27.4	2.8	2.0	3.8	2.2	0.2	2.8	4.1	3.6	14.0	4.7	3.0	3.1	23.1	14.3	2.7	5.2	4.1	3.8	1.3	1.3	3.6	0.8	3.8	0.0	4.0	3.0	1.8	3.2	6.9	4.1	0.8	6.6	5.2	3.5	0.6
ALOX12	12S-LOX	ENSG00000108839	"Arachidonate 12-lipoxygenase, 12S type"	P18054	17	6996049-7010754	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Hydrolase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 34.6;esophagus: 49.4;vagina: 105.7"	"Cell type enriched"	"Detected in some"	6	"Macrophages: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"A-431: 25.5;HEL: 40.4"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 4.4"					"HPA010691, CAB019287, HPA064819"	Enhanced		Supported	"Nuclear speckles,Vesicles,Cytosol"		NA	NA		49000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Nuclear speckles, Vesicles"	"CAB019287: , HPA010691: AB_1844756, HPA064819: "	"unprognostic (3.61e-3)"	"unprognostic (6.93e-2)"	"unprognostic (7.17e-5)"	"unprognostic (9.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.96e-5)"	"unprognostic (4.01e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.47e-2)"	1.0	1.5	0.9	3.2	1.5	4.7	0.3	0.1	1.4	34.6	0.6	0.4	1.8	2.2	0.0	49.4	1.2	3.1	1.4	0.4	0.4	0.5	0.2	1.1	3.9	1.3	0.7	1.3	1.9	0.0	0.1	1.1	1.0	0.8	0.1	3.1	20.2	0.0	1.6	21.7	2.0	0.2	0.1	3.3	1.1	1.3	1.2	0.0	1.9	0.1	3.8	1.5	105.7	3.4	25.5	4.2	1.9	1.4	0.0	0.0	1.7	1.6	0.0	0.0	0.0	3.7	0.9	1.3	0.9	0.0	1.4	3.2	0.0	0.1	0.0	2.8	3.2	40.4	6.8	2.8	0.1	0.4	6.5	0.0	0.1	0.0	0.0	2.4	0.0	2.8	2.7	1.4	0.0	0.3	0.5	0.9	1.3	0.2	0.8	1.4	0.8	0.7	0.0	3.2	0.1	0.9	0.7	0.8	0.4	2.4	1.5	1.1	4.6	2.2	1.2	2.1	1.1	0.8	0.3	0.7	1.2	3.0	1.0	2.1	0.9	1.8	0.7	0.4	0.5	1.1	0.5	0.7	0.7	0.6	0.2	0.3	4.5	0.7	0.4	1.3	0.3	13.6	0.9	1.5	0.1	1.4	0.4	0.4	1.3	0.7	1.0	0.1	1.2	3.4	0.0	0.0	0.0	2.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	17.3	0.0	1.0	0.8	0.0	0.0	2.5	2.4	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	2.5	1.1	0.0	0.1	0.1	0.0	2.0
ALOX15	15-LOX-1	ENSG00000161905	"Arachidonate 15-lipoxygenase"	P16050	17	4630919-4642294	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 37.2;fallopian tube: 12.7"	"Group enriched"	"Detected in some"	5	"Club cells: 60.3;Langerhans cells: 72.2;Respiratory ciliated cells: 191.8"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 6.6"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	193	"eosinophil: 602.9"	"Lineage enriched"	"Detected in many"	193	"granulocytes: 602.9"	"Group enriched"	"Detected in some"	7	"HMC-1: 15.9;MCF7: 14.7;T-47d: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004962, CAB004963, HPA013859"	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB004962: , CAB004963: , HPA013859: AB_1844758"	"unprognostic (5.31e-4)"	"unprognostic (1.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (8.36e-3)"	"unprognostic (2.22e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.59e-1)"	37.2	0.0	0.6	1.6	2.0	0.5	3.2	0.0	1.3	0.5	0.0	1.6	1.9	0.0	0.4	0.8	12.7	0.6	2.9	0.5	0.5	0.0	0.1	6.6	1.9	0.3	0.2	0.1	0.0	0.0	3.0	0.1	0.3	0.2	1.0	0.0	0.2	0.3	0.0	2.2	3.3	0.6	0.1	1.4	1.0	1.8	0.4	0.8	0.0	0.0	0.6	1.1	0.1	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	14.7	0.0	0.3	1.1	1.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	4.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.2	0.2	602.9	0.0	0.2	0.2	0.1	0.0	0.1	3.1	0.2	0.0	0.1	0.9	0.0	0.1	2.7	0.1	0.4	0.6	2.0	0.0	1.3	0.5	0.5	0.3	0.2	0.3	0.1	0.4	0.4	0.0	0.0	1.1	0.0	0.2	1.5	0.0	13.0	0.0	0.0	1.1	0.1	0.9	11.5	60.3	0.0	0.0	1.8	1.3	0.0	0.0	0.0	19.2	3.0	0.0	0.4	0.0	0.0	0.9	0.0	0.1	3.6	0.0	0.1	1.3	0.0	0.0	0.0	0.6	0.0	0.2	0.0	4.1	0.0	72.2	2.5	0.0	0.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	191.8	0.0	0.0	0.1	3.9	1.2	1.2	0.0	0.9	7.4	0.3	0.0	0.0	0.3
ALOXE3	"E-LOX, eLOX3"	ENSG00000179148	"Arachidonate lipoxygenase 3"	Q9BYJ1	17	8095900-8119047	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Isomerase, Lyase, Oxidoreductase"	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"skin 1: 56.2"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 2.1;Pancreatic endocrine cells: 6.3;Prostatic glandular cells: 1.8;Spermatocytes: 1.8;Spermatogonia: 1.7;Suprabasal keratinocytes: 1.8"	"Group enriched"	"Detected in some"	4	"cervical cancer: 1.1;head and neck cancer: 3.9;melanoma: 1.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.4;HBEC3-KT: 10.1;hTCEpi: 7.3;hTERT-HME1: 13.7;T-47d: 4.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA023120, HPA078597"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"		"HPA023120: AB_10959300, HPA078597: AB_2732385"	"unprognostic (2.40e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.87e-3)"	"unprognostic (2.09e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.06e-2)"		"unprognostic (3.56e-4)"	"unprognostic (3.60e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.66e-5)"	"unprognostic (9.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	0.0	0.0	0.5	0.0	0.3	0.0	1.6	1.9	2.1	0.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.1	0.4	0.2	0.1	0.7	0.1	0.0	0.1	0.3	0.0	0.1	56.2	0.0	0.0	0.1	0.0	0.0	0.8	1.0	0.0	0.0	0.0	1.2	0.0	1.8	0.5	6.4	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.4	0.1	0.5	0.2	0.2	0.1	2.9	0.4	0.8	10.1	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.3	0.1	13.7	0.0	0.0	0.9	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.7	0.0	0.0	4.4	0.0	0.1	0.0	2.1	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	1.9	2.1	0.7	0.4	0.8	0.7	0.7	0.1	1.0	0.5	0.1	0.0	0.0	0.0	0.0	0.3	2.1	1.2	0.0	0.0	0.6	0.5	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.4	0.1	0.1	0.2	0.0	0.0	1.2	0.9	1.2	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	1.7	0.3	1.8	1.1	0.0	0.0	0.0	0.6
ALPK3	"KIAA1330, MAK, Midori"	ENSG00000136383	"Alpha kinase 3"	Q96L96	15	84817356-84873479	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 62.7;skeletal muscle: 195.8;tongue: 59.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 64.1;Exocrine glandular cells: 20.5;Skeletal myocytes: 51.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 14.3;HDLM-2: 10.7;HUVEC TERT2: 15.5;LHCN-M2: 21.2;NTERA-2: 12.9;RH-30: 37.7;THP-1: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA026558	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA026558: AB_1844774"	"unprognostic (2.69e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.95e-7)"	"unprognostic (1.76e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.96e-2)"	"unprognostic (4.87e-2)"	12.5	9.6	1.2	0.9	1.6	0.1	4.4	1.0	2.2	2.2	9.3	7.5	0.6	1.5	5.4	3.0	1.7	1.8	62.7	1.3	3.8	13.5	5.9	5.5	0.6	2.2	3.4	0.8	7.7	11.2	26.1	2.5	4.5	2.4	0.8	2.5	2.6	1.3	195.8	1.0	2.1	3.1	1.6	0.5	5.2	0.9	3.9	0.6	3.6	59.1	0.4	3.6	1.4	1.1	1.8	0.1	0.1	0.2	0.3	0.1	14.3	0.0	0.0	0.0	0.1	0.1	6.3	0.0	0.4	0.0	0.1	1.1	0.0	0.0	0.1	10.7	1.7	1.8	0.3	0.0	0.2	0.0	0.1	1.3	0.2	0.0	0.0	0.1	15.5	0.1	0.0	0.1	21.2	0.9	0.0	0.2	12.9	0.3	0.1	0.0	37.7	0.2	0.0	4.0	0.0	0.2	0.0	2.0	0.1	1.9	0.1	9.6	0.3	0.1	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.6	1.0	2.2	1.3	3.8	2.2	3.4	4.5	1.6	3.9	1.1	3.3	6.4	2.7	2.6	0.2	0.9	0.1	0.6	1.2	4.1	1.3	0.8	64.1	17.2	2.4	9.2	16.7	0.3	0.2	0.5	0.0	2.9	0.3	11.5	1.0	8.7	9.1	0.0	3.0	20.5	0.7	3.8	0.5	8.9	1.3	8.7	1.8	1.7	10.2	0.0	3.4	0.3	0.0	0.3	12.0	0.0	0.0	5.2	3.6	9.4	4.7	1.0	1.0	0.5	0.3	10.4	1.2	0.0	1.5	0.7	0.1	2.2	4.2	3.4	0.0	51.9	8.4	0.5	3.2	0.2	0.1	0.7	0.5	0.2	0.3	1.6
ALPL	"HOPS, TNALP, TNAP, TNSALP"	ENSG00000162551	"Alkaline phosphatase, biomineralization associated"	P05186	1	21509397-21578410	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Biomineralization	Hydrolase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 60.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 92.0;Breast myoepithelial cells: 32.4;Glandular and luminal cells: 43.3;Hepatic stellate cells: 40.7;Hepatocytes: 30.1;Proximal tubular cells: 43.9;Rod photoreceptor cells: 34.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 199.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	90	"neutrophil: 379.1"	"Lineage enriched"	"Detected in many"	139	"granulocytes: 379.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 176.9;hTEC/SVTERT24-B: 141.2;LHCN-M2: 103.7;NTERA-2: 41.2;SCLC-21H: 88.2;SuSa: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007105, HPA008765, CAB020829"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		13000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (3.05e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.70e-3)"	"unprognostic (2.58e-1)"	24.7	60.7	19.5	27.9	16.7	4.2	22.9	18.0	25.8	3.4	26.0	5.0	2.6	5.8	1.3	4.1	10.4	3.9	16.4	17.8	18.8	45.7	56.3	54.9	6.4	21.7	17.7	2.8	3.9	3.3	9.3	3.1	22.4	7.1	1.5	18.8	6.4	9.2	1.1	4.2	7.5	3.5	18.2	45.5	4.7	4.2	21.3	1.5	8.6	5.7	5.9	9.7	3.3	17.3	0.0	0.2	5.2	0.2	0.8	6.6	11.4	0.4	2.4	0.9	1.5	1.0	0.0	2.4	7.7	0.0	0.1	0.1	31.3	0.2	0.6	0.0	2.1	0.0	3.5	3.9	1.8	0.0	0.7	176.9	0.0	141.2	0.5	0.0	0.0	0.0	0.2	0.0	103.7	0.0	0.1	0.0	41.2	0.2	0.0	0.0	3.8	0.2	0.1	0.0	88.2	1.2	0.0	0.1	0.3	48.1	0.2	0.0	0.0	5.2	4.3	0.1	0.0	0.3	0.0	0.1	0.9	0.0	0.8	0.0	0.0	4.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.5	0.0	0.0	379.1	0.0	0.0	0.0	0.0	0.1	19.5	16.7	18.0	25.8	17.8	18.8	21.7	17.7	22.4	18.2	21.3	17.3	25.9	3.2	92.0	0.3	3.8	0.1	0.6	8.2	0.6	2.5	6.6	32.4	2.1	2.8	17.6	0.0	0.0	0.1	0.1	0.0	7.9	0.0	1.4	15.0	2.2	26.5	0.0	5.7	0.9	0.0	0.3	6.8	0.0	43.3	7.6	10.6	40.7	30.1	0.1	1.7	0.3	0.0	12.2	1.6	0.3	8.5	0.3	1.0	0.0	18.7	0.0	6.0	0.0	6.0	0.2	0.0	0.0	0.0	0.3	1.7	0.0	43.9	3.6	34.2	0.0	0.3	5.1	0.4	14.0	0.2	0.4	1.5	1.0	8.0	0.0	0.3
AMACR	"P504S, RACE"	ENSG00000242110	"Alpha-methylacyl-CoA racemase"	Q9UHK6	5	33986165-34008104	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 134.3;liver: 180.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.7;Hepatocytes: 21.6;Late spermatids: 21.6;Proximal tubular cells: 38.5"	"Group enriched"	"Detected in all"	4	"liver cancer: 8.8;prostate cancer: 34.5;renal cancer: 14.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 175.4;U-266/84: 98.0"	"Low region specificity"	"Detected in all"							"CAB001809, HPA019527, HPA020912"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		70000	"Cluster 14: Monocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Plasma membrane"		"CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034"	"unprognostic (8.96e-2)"	"unprognostic (5.20e-3)"	"prognostic favorable (7.11e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.59e-5)"	"unprognostic (1.95e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.32e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	8.6	15.0	5.9	5.0	5.5	3.0	6.4	4.6	6.0	6.5	4.6	40.0	18.0	4.7	9.6	15.6	6.2	20.5	10.1	5.4	7.8	134.3	180.6	9.2	3.6	5.9	6.4	7.8	13.8	13.0	5.7	7.7	6.6	39.3	42.9	12.0	60.7	12.5	19.2	4.9	15.9	7.0	5.8	5.4	34.8	4.3	8.4	4.8	8.3	14.9	5.6	8.8	8.5	5.8	12.7	20.2	11.1	14.3	7.7	11.9	19.1	16.6	12.2	7.6	5.7	66.1	15.1	4.1	8.7	23.6	28.6	5.8	2.8	12.0	7.7	12.7	10.9	9.8	13.7	19.0	5.4	6.0	3.0	18.1	6.0	9.7	3.6	10.7	8.5	8.3	3.8	14.7	22.4	9.6	5.0	7.6	10.0	9.4	32.9	6.0	18.6	6.5	33.2	62.4	6.1	8.7	27.6	19.3	16.9	9.1	14.9	5.9	15.6	24.6	5.4	6.2	13.6	175.4	98.0	7.4	7.0	12.1	18.8	0.3	6.0	9.3	8.3	8.0	7.0	7.1	7.2	6.4	8.9	5.2	6.6	4.8	10.0	8.7	14.2	4.6	7.9	6.0	5.9	5.5	4.6	6.0	5.4	7.8	5.9	6.4	6.6	5.8	8.4	5.8	0.8	3.2	4.1	0.0	2.2	0.4	0.4	0.9	1.8	4.3	1.4	0.9	1.1	8.6	3.7	1.8	0.0	1.0	2.2	19.7	5.9	0.8	8.9	2.3	1.2	3.0	4.2	2.1	0.0	3.8	1.0	2.9	4.1	1.5	0.0	1.2	1.1	21.6	1.1	5.0	0.0	5.1	4.1	0.9	0.2	21.6	0.6	1.2	0.0	0.0	1.5	9.3	3.1	0.0	0.0	2.6	4.5	2.2	1.6	0.6	4.7	38.5	3.1	0.9	0.0	1.7	3.7	0.7	0.7	3.4	0.6	0.3	1.5	1.2	4.4	0.4
AMHR2	"MISR2, MISRII"	ENSG00000135409	"Anti-Mullerian hormone receptor type 2"	Q16671	12	53423855-53431672	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 41.5;ovary: 33.1"	"Group enriched"	"Detected in some"	4	"granulocytes: 26.0;Granulosa cells: 36.1;Theca cells: 94.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"HEL: 40.1;K-562: 22.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"hippocampal formation: 9.4"	"HPA060228, HPA069636"			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 51: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Cytosol"	"HPA060228: AB_2684227, HPA069636: AB_2686163"	"unprognostic (5.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.97e-1)"	0.6	41.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.4	0.1	0.5	0.0	0.3	0.0	0.9	0.4	0.0	0.0	0.2	33.1	12.5	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	4.2	0.1	0.1	0.0	0.0	5.7	0.7	9.1	0.5	0.0	0.0	1.8	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	40.1	0.0	0.8	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	22.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	3.5	2.6	0.0	0.1	1.5	0.0	4.2	0.1	2.1	0.1	2.7	0.0	0.1	26.0	36.1	11.4	0.3	0.1	0.0	0.0	0.0	0.0	1.2	0.0	2.5	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.1	0.3	0.0	0.0	0.3	0.8	94.9	0.1	0.0
AMPD1	"MAD, MADA"	ENSG00000116748	"Adenosine monophosphate deaminase 1"	P23109	1	114673090-114695618	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"skeletal muscle: 559.2;tongue: 211.4"	"Group enriched"	"Detected in some"	6	"Plasma cells: 43.8;Skeletal myocytes: 13.3"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	29	"U-266/70: 8.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026478, HPA028080"	Enhanced				"Intracellular and membrane"	NA	NA		38000	"Cluster 37: B-cells - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 37: Myocytes - Muscle contraction"			"HPA026478: AB_10599969, HPA028080: AB_10600776"	"unprognostic (1.98e-3)"	"unprognostic (1.43e-3)"	"unprognostic (8.75e-3)"	"unprognostic (8.03e-2)"		"unprognostic (1.95e-2)"		"unprognostic (5.61e-3)"	"unprognostic (8.21e-2)"	"unprognostic (4.29e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.36e-5)"	"unprognostic (1.68e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.02e-1)"	0.1	0.1	0.0	0.5	0.0	0.3	3.0	0.0	0.0	0.2	0.0	5.6	16.4	0.2	0.0	5.8	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.0	1.0	0.1	0.3	0.0	0.0	0.0	3.5	5.5	0.0	4.4	0.9	559.2	0.0	7.5	0.1	0.0	1.6	3.7	0.1	0.0	0.4	0.1	211.4	2.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.8	1.9	0.0	0.0	0.0	3.0	4.2	0.0	0.0	0.0	43.8	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1
AMPD2	SPG63	ENSG00000116337	"Adenosine monophosphate deaminase 2"	Q01433	1	109616104-109632051	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Horizontal cells: 52.2;Macrophages: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 19.4;eosinophil: 19.2;intermediate monocyte: 40.7;myeloid DC: 18.9;neutrophil: 61.1;non-classical monocyte: 44.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 18.9;granulocytes: 61.1;monocytes: 44.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027137, HPA045760"	Approved		Enhanced	Cytosol		NA	NA		230000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA027137: AB_2672129, HPA045760: AB_2679443"	"unprognostic (2.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.01e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.78e-10)"	"unprognostic (9.16e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	9.3	17.5	31.2	12.0	41.6	28.6	7.4	22.9	34.7	13.1	36.6	7.5	10.7	11.5	4.1	7.2	13.1	8.8	7.2	34.8	37.0	10.5	16.2	13.4	7.6	34.7	31.7	17.5	10.0	9.4	45.8	7.6	33.6	10.8	4.1	10.5	9.2	12.0	3.3	8.5	10.8	7.1	27.9	19.0	8.6	4.3	39.3	4.9	10.6	1.5	5.9	7.5	11.4	29.0	20.6	22.5	20.5	20.1	18.0	18.7	8.6	25.6	57.2	24.9	25.0	19.1	7.0	10.5	21.8	39.1	16.0	11.3	15.8	20.0	13.4	13.0	20.7	46.0	15.6	19.3	24.9	15.7	45.7	23.3	13.2	32.5	24.1	28.2	26.7	17.0	17.4	13.0	16.0	23.2	26.7	29.0	20.6	17.1	22.9	18.6	15.8	17.3	24.2	8.7	19.3	22.4	17.4	19.8	24.6	5.7	10.4	16.2	16.7	27.7	39.0	33.7	25.4	48.4	28.4	12.1	50.8	25.9	35.1	0.5	19.4	19.2	5.3	40.7	8.0	5.3	5.2	4.9	18.9	2.7	6.4	5.1	61.1	4.3	44.6	2.6	4.0	12.3	31.2	41.6	22.9	34.7	34.8	37.0	34.7	31.7	33.6	27.9	39.3	29.0	3.6	3.2	5.5	13.7	9.4	8.9	5.4	5.0	9.1	41.0	8.8	11.4	3.2	12.8	5.4	0.0	62.6	4.9	10.0	4.2	7.9	9.8	3.5	4.4	9.4	7.1	17.5	5.0	13.3	11.2	8.6	12.6	14.3	5.5	3.8	11.0	6.1	20.5	10.8	52.2	17.6	9.6	2.0	42.1	42.0	1.3	13.1	52.5	5.4	6.5	16.1	10.5	6.2	12.1	10.6	10.3	3.0	21.4	11.1	11.1	6.1	4.5	4.2	7.2	13.1	8.8	10.6	4.2	3.8	7.9	8.1	2.6	15.4	8.5	10.7	4.0
AMPD3		ENSG00000133805	"Adenosine monophosphate deaminase 3"	Q01432	11	10308313-10507579	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 62.9;skeletal muscle: 73.3"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 111.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 44.2;CAPAN-2: 34.6;HMC-1: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038662, HPA047408"	Uncertain		Approved	"Nuclear membrane"		NA	NA		77000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear membrane"		"HPA038662: AB_2676136, HPA047408: AB_2680034"	"unprognostic (2.24e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.44e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.25e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.12e-2)"	4.2	19.6	10.8	20.7	22.5	62.9	3.0	19.1	15.3	6.0	10.8	4.9	6.5	4.2	4.0	7.6	11.1	6.4	2.9	10.4	15.9	7.8	1.8	6.9	17.6	21.1	20.5	2.6	3.3	24.1	18.2	4.1	20.5	7.4	6.6	7.5	6.4	3.5	73.3	15.6	7.8	4.4	14.0	12.1	6.7	1.8	21.4	13.9	3.6	9.3	20.3	9.7	7.9	30.2	14.1	2.0	0.5	0.2	7.1	5.0	0.8	12.4	44.2	3.0	3.1	6.9	34.6	5.1	1.2	5.7	11.9	8.6	0.2	11.8	8.8	12.7	0.5	12.5	1.8	1.0	2.4	17.2	36.0	18.5	17.9	6.0	7.7	7.5	1.4	8.3	19.4	5.3	10.1	0.5	10.2	22.3	1.6	1.1	12.2	3.7	15.9	18.2	0.6	11.5	5.1	2.6	2.7	0.4	0.8	1.0	0.4	5.8	3.4	13.7	0.2	9.6	0.5	4.8	2.9	5.5	15.7	16.9	0.3	9.5	6.4	19.4	2.2	3.9	5.4	7.7	3.3	2.6	4.2	5.3	3.6	2.5	8.4	3.8	1.7	2.7	2.1	2.8	10.8	22.5	19.1	15.3	10.4	15.9	21.1	20.5	20.5	14.0	21.4	30.2	0.5	0.0	3.9	5.2	14.3	12.5	10.6	8.1	4.0	23.6	1.6	1.8	6.3	5.7	9.8	14.7	2.1	0.9	1.6	1.9	17.6	2.9	7.3	14.0	1.7	1.6	10.2	20.2	11.9	1.6	1.5	8.1	3.1	2.9	12.0	0.9	1.1	0.7	14.5	0.0	7.0	3.9	20.3	15.2	7.6	20.6	0.9	18.3	3.6	28.1	14.0	6.5	1.0	5.0	111.8	6.3	3.0	0.0	1.7	26.5	4.9	0.8	24.2	1.3	0.0	12.3	1.9	0.4	0.6	2.2	12.5	1.2	6.6	0.3	2.2	16.8
AMT	"GCST, NKH"	ENSG00000145020	Aminomethyltransferase	P48728	3	49416778-49422685	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 49.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 42.4;Proximal enterocytes: 33.3;Undifferentiated cells: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 7.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 17.1;Hep G2: 47.5;NTERA-2: 8.0;SH-SY5Y: 14.9;SuSa: 9.0"									HPA005566	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	Nucleoplasm	"HPA005566: AB_1844811"	"unprognostic (2.10e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.14e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.29e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.88e-1)"	"prognostic favorable (3.90e-8)"	"unprognostic (4.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.98e-3)"	4.7	12.8	9.8	1.2	10.3	8.8	5.6	10.7	11.7	11.8	13.1	12.2	13.8	6.8	8.2	3.5	10.1	5.8	21.6	9.4	9.6	23.2	49.1	5.4	2.1	9.8	10.2	12.5	19.5	14.2	11.9	2.3	9.8	11.3	11.8	6.5	10.6	8.5	3.1	4.8	12.1	3.7	9.9	6.3	11.1	3.0	10.0	3.8	5.8	4.2	1.5	8.0	6.4	9.9	0.1	0.7	1.4	0.4	0.6	0.0	17.1	0.0	0.4	0.1	0.3	0.5	0.6	0.0	0.2	0.4	0.0	0.3	0.1	0.7	0.1	0.3	0.0	0.0	0.5	47.5	1.8	0.0	0.0	0.6	1.8	0.0	0.7	1.3	0.6	0.2	0.0	0.0	0.2	0.4	0.1	0.1	8.0	0.0	0.2	0.0	0.5	1.0	0.8	0.4	0.0	14.9	0.2	0.0	1.1	9.0	0.1	0.3	0.6	0.1	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	3.2	0.0	1.7	0.0	0.5	0.0	0.0	4.2	0.2	1.2	0.9	0.1	7.9	0.5	0.3	0.0	1.3	9.8	10.3	10.7	11.7	9.4	9.6	9.8	10.2	9.8	9.9	10.0	9.9	1.2	3.2	9.2	11.4	3.6	2.8	12.1	3.1	3.4	17.4	1.2	1.3	21.8	14.3	6.3	0.0	20.9	25.6	1.4	13.8	0.0	0.8	2.5	0.7	1.6	3.2	12.7	8.8	8.7	0.7	8.8	4.5	15.8	1.0	7.6	2.0	3.9	42.4	5.0	8.4	8.5	18.4	2.0	3.8	2.9	1.6	10.5	2.6	5.4	7.5	1.8	26.0	7.2	6.0	6.6	0.6	18.9	6.4	1.1	6.7	33.3	1.1	6.6	19.3	6.6	5.2	3.1	1.9	0.3	2.2	2.7	10.3	3.8	1.0	31.6	10.9
ANK1	"ANK, SPH1"	ENSG00000029534	"Ankyrin 1"	P16157	8	41653220-41896762	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"skeletal muscle: 993.4;tongue: 629.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 164.7;Cone photoreceptor cells: 87.6;Erythroid cells: 250.2;Inhibitory neurons: 176.8;Skeletal myocytes: 51.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"memory B-cell: 9.2;naive B-cell: 7.8;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	4	"B-cells: 9.2;dendritic cells: 3.4"	"Group enriched"	"Detected in many"	4	"HEL: 125.2;K-562: 134.3;RH-30: 160.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004842, HPA056953"	Supported	Supported			"Intracellular and membrane"	NA	NA		4200000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA004842: AB_1844827, HPA056953: AB_2683284"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.76e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-1)"	1.8	1.1	0.4	1.6	2.0	95.2	1.0	34.1	17.3	0.3	0.0	0.5	1.5	0.1	0.1	8.7	0.4	0.8	98.0	0.3	12.5	0.6	0.3	0.7	4.4	26.8	32.6	0.3	0.8	62.1	1.1	2.1	27.1	4.2	0.2	6.3	8.1	0.7	993.4	0.6	0.9	0.3	10.6	2.2	4.4	0.6	8.4	0.7	0.6	629.0	4.0	1.8	0.5	5.4	0.0	16.8	0.5	0.0	0.2	2.9	0.0	4.9	32.8	1.5	0.7	0.1	0.0	7.7	1.5	3.5	0.6	2.8	0.8	0.5	0.7	3.2	0.1	125.2	0.7	0.0	0.1	0.3	0.4	4.2	0.6	0.4	0.0	0.7	0.1	0.0	134.3	2.8	2.1	0.3	0.0	1.6	1.7	0.1	0.1	0.9	160.2	0.8	0.7	0.5	2.2	1.4	0.1	2.3	0.0	5.9	2.0	3.2	0.8	0.5	0.9	27.6	0.2	0.0	0.2	4.7	2.9	0.0	0.0	1.5	0.2	0.0	0.1	0.0	0.4	9.2	0.3	0.4	0.1	7.8	0.0	0.0	0.4	0.1	0.0	3.4	1.0	0.7	0.4	2.0	34.1	17.3	0.3	12.5	26.8	32.6	27.1	10.6	8.4	5.4	5.5	0.0	0.0	1.3	8.3	0.6	1.4	2.2	0.6	15.4	0.3	0.1	164.7	0.0	1.0	0.0	87.6	1.1	0.2	0.1	1.9	0.1	7.0	0.1	0.1	4.6	1.2	250.2	12.9	0.0	0.5	2.9	5.6	0.5	0.0	2.2	0.4	0.1	19.7	3.3	176.8	0.7	2.0	0.8	3.7	6.3	0.3	2.6	0.0	3.7	0.4	1.0	0.0	7.1	2.0	1.1	1.2	0.4	5.7	1.3	0.1	0.3	0.6	5.5	0.0	51.6	5.7	0.2	1.0	0.1	0.0	0.4	1.7	0.1	0.0	1.8
ANK2	"CFAP87, FAP87, LQT4"	ENSG00000145362	"Ankyrin 2"	Q01484	4	112818032-113384221	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 165.7;retina: 191.2;skeletal muscle: 171.7;tongue: 150.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 1101.2;Bipolar cells: 376.6;Cone photoreceptor cells: 479.6;Excitatory neurons: 1282.0;Horizontal cells: 1431.8;Inhibitory neurons: 1060.7;Oligodendrocyte precursor cells: 497.1;Oligodendrocytes: 1351.0;Rod photoreceptor cells: 484.4"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 29.2;ASC TERT1: 32.2;RH-30: 49.6;SH-SY5Y: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008007, CAB015178, HPA035970"	Enhanced	Approved	Supported	"Plasma membrane"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB015178: AB_2242828, HPA008007: AB_2667965, HPA035970: AB_2674893"	"unprognostic (8.33e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (2.41e-6)"	"unprognostic (1.18e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.04e-3)"	31.0	13.6	94.9	11.2	109.0	0.1	18.3	63.1	165.7	31.6	0.0	30.1	8.5	15.8	5.9	12.9	9.6	22.5	119.5	103.9	77.5	110.1	2.4	7.2	9.2	130.2	61.1	27.3	3.2	1.2	19.3	2.1	119.5	7.8	11.4	191.2	6.7	13.3	171.7	8.7	12.7	24.9	51.9	28.3	8.3	9.4	84.8	4.4	9.6	150.5	7.2	9.5	12.3	116.2	0.1	2.9	18.7	5.2	29.2	32.2	0.1	1.5	3.4	0.9	2.6	4.2	0.0	6.9	2.1	5.9	4.1	0.1	11.0	0.6	1.0	2.3	7.3	4.0	0.0	2.9	1.7	1.9	1.2	15.2	3.0	1.2	6.0	3.9	0.0	0.4	0.0	9.3	5.8	0.3	0.2	0.1	9.4	0.1	2.0	0.7	49.6	0.0	0.2	0.0	13.6	24.1	0.2	0.7	8.1	11.7	0.1	1.1	0.0	4.7	2.2	0.4	3.0	6.8	1.8	0.9	20.1	0.6	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.9	109.0	63.1	165.7	103.9	77.5	130.2	61.1	119.5	51.9	84.8	116.2	6.9	0.0	3.9	1101.2	1.1	10.5	0.0	0.0	1.8	376.6	0.2	0.6	188.5	0.0	1.3	20.2	479.6	0.1	0.0	0.0	15.6	0.0	111.2	36.4	6.0	6.4	66.0	0.0	1282.0	1.6	0.1	79.0	2.0	7.2	1.3	81.8	0.0	0.4	1.0	1431.8	1060.7	0.4	8.2	0.0	19.7	49.8	36.4	2.9	17.8	90.9	0.6	44.5	0.0	497.1	1351.0	0.1	5.0	30.1	0.9	0.4	0.1	127.9	0.8	484.4	6.6	24.3	26.5	2.3	1.5	0.8	9.5	0.0	1.9	2.6	0.3	0.2
ANKH	"ANK, CCAL2, CMDJ, CPPDD, HANK, SLC62A1"	ENSG00000154122	"ANKH inorganic pyrophosphate transport regulator"	Q9HCJ1	5	14704800-14871778	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Phosphate transport, Transport"		"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 160.1;Hofbauer cells: 208.8;Inhibitory neurons: 214.5;Oligodendrocytes: 261.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068104			Approved	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA068104: AB_2685954"	"unprognostic (1.15e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (6.58e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.76e-3)"	"unprognostic (1.71e-1)"	"unprognostic (8.66e-2)"	"unprognostic (6.46e-2)"	9.9	10.6	22.1	6.6	23.8	8.0	9.9	33.9	29.3	5.5	26.6	12.8	16.8	7.1	4.9	7.4	7.7	9.4	32.2	22.5	25.5	8.1	21.4	7.1	8.5	25.3	28.2	16.0	15.2	19.2	22.8	8.5	25.1	32.7	11.4	25.1	14.3	9.2	40.9	20.3	15.0	8.5	24.9	6.8	7.3	1.9	26.8	11.5	10.7	37.6	14.1	7.3	7.4	28.8	7.2	5.4	6.7	1.1	13.8	32.3	3.2	6.8	13.7	2.6	2.7	4.3	9.0	16.9	15.7	9.4	6.2	4.6	4.6	7.5	3.0	6.7	11.3	0.4	47.8	11.6	4.6	4.1	1.3	10.2	13.0	8.1	9.2	9.2	5.5	12.3	3.5	35.2	8.7	9.6	6.9	13.3	2.6	9.5	6.0	9.8	3.3	15.3	0.0	2.3	16.4	4.5	33.3	5.3	7.5	6.1	0.3	1.5	5.4	6.9	6.9	11.5	12.6	9.2	9.3	13.0	23.8	15.1	29.0	0.6	0.2	0.0	1.4	0.4	2.3	1.5	2.9	2.3	0.3	1.6	3.3	1.5	0.3	0.3	0.9	0.3	4.6	0.4	22.1	23.8	33.9	29.3	22.5	25.5	25.3	28.2	25.1	24.9	26.8	28.8	50.1	25.6	19.1	64.6	15.4	25.2	79.1	33.7	40.9	58.0	29.7	15.5	73.4	7.2	10.8	7.3	127.2	76.4	21.1	58.2	5.9	1.7	1.2	7.1	14.9	25.4	41.8	69.9	160.1	11.8	6.1	25.6	8.2	16.9	17.7	9.8	12.5	32.7	208.8	20.2	214.5	37.7	8.2	89.3	29.9	1.9	5.0	42.6	10.6	106.8	3.4	20.1	21.6	95.5	261.5	6.8	31.4	31.6	14.7	55.4	44.6	10.2	6.4	50.1	0.0	32.8	12.3	2.3	7.2	10.1	10.7	42.0	25.9	8.6	37.3	22.3
ANO10	"FLJ10375, MGC47890, SCAR10, TMEM16K"	ENSG00000160746	"Anoctamin 10"	Q9NW15	3	43354859-43691594	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 123.3;Excitatory neurons: 77.4;Inhibitory neurons: 97.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016624, HPA051569"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Vesicles	"HPA016624: , HPA051569: AB_2681537"	"unprognostic (1.51e-3)"	"unprognostic (1.38e-2)"	"prognostic favorable (6.70e-4)"	"prognostic favorable (1.11e-4)"	"unprognostic (4.23e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (7.99e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (6.41e-6)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-3)"	"unprognostic (5.71e-2)"	26.6	14.1	17.6	15.1	18.6	33.0	21.8	23.9	20.9	22.3	18.4	39.4	61.1	21.6	13.6	25.3	13.9	19.4	12.7	18.1	21.1	29.9	14.1	16.9	7.6	22.7	22.9	13.9	15.2	23.7	13.9	18.1	23.2	14.2	33.7	10.1	28.6	20.2	15.5	32.0	54.7	28.0	19.6	9.1	13.5	13.0	19.8	7.1	24.5	11.6	9.7	18.1	21.5	24.1	30.6	23.6	26.1	27.4	101.1	53.5	31.2	87.7	141.1	42.0	54.4	16.2	27.5	3.1	27.4	114.8	43.1	16.3	20.6	47.0	52.6	33.6	14.2	39.4	28.7	17.7	43.9	7.2	31.1	50.5	36.3	53.6	71.8	79.4	100.3	18.7	30.8	24.9	95.2	20.8	7.8	5.2	31.3	23.7	28.6	6.3	18.7	10.2	85.5	31.4	6.4	19.4	34.4	27.0	19.8	45.3	59.5	14.5	84.7	66.2	24.4	70.2	40.7	15.7	22.9	1.1	60.2	14.6	44.2	7.4	19.0	1.4	6.7	11.1	3.8	2.7	4.6	4.5	13.1	2.5	3.9	6.0	32.8	9.7	12.7	2.3	5.4	7.0	17.6	18.6	23.9	20.9	18.1	21.1	22.7	22.9	23.2	19.6	19.8	24.1	24.3	6.4	3.2	70.2	4.1	5.6	5.8	6.9	8.0	8.0	18.2	8.4	5.2	8.6	13.2	14.7	0.0	14.4	3.7	38.5	123.3	21.6	2.9	11.8	23.6	17.8	9.6	11.8	77.4	17.8	19.5	10.6	10.2	31.2	2.5	6.8	23.6	10.7	11.6	10.1	97.9	23.8	10.2	9.6	5.3	5.2	5.6	9.1	14.2	69.3	9.2	17.1	5.2	71.4	46.4	11.7	22.1	10.1	2.6	4.4	58.4	19.0	4.0	3.6	6.6	19.1	15.7	17.1	23.6	8.7	6.1	17.1	5.8	6.2	26.9	4.8
ANO3	"C11orf25, DYT23, GENX-3947, TMEM16C"	ENSG00000134343	"Anoctamin 3"	Q9BYT9	11	26188842-26663289	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"brain: 59.2;epididymis: 57.4"	"Cell type enriched"	"Detected in some"	5	"Excitatory neurons: 201.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"basal ganglia: 59.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.9;HDLM-2: 6.8;U-2 OS: 1.6;U-2197: 4.3"	"Region enhanced"	"Detected in all"		"basal ganglia: 158.9"	"Region enriched"	"Detected in all"	7	"basal ganglia: 180.1"	HPA041629	Uncertain					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA041629: AB_10793969"	"unprognostic (7.01e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.94e-1)"	"unprognostic (9.29e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.45e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-4)"	"unprognostic (9.48e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.01e-1)"	3.0	0.8	4.3	0.1	59.2	0.0	0.5	0.0	11.8	0.5	0.0	0.2	0.1	0.1	57.4	0.0	0.2	1.8	0.3	7.7	0.0	1.0	1.1	0.4	0.0	1.1	0.1	0.1	0.3	0.1	0.3	0.0	1.9	0.0	0.1	0.4	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.4	0.0	1.9	0.3	0.1	1.0	0.1	0.0	0.0	0.1	1.7	0.0	0.0	0.4	0.0	1.1	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.3	0.0	0.4	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	59.2	0.0	11.8	7.7	0.0	1.1	0.1	1.9	0.0	0.3	1.7	1.0	0.0	2.0	3.3	0.0	0.0	0.0	0.1	0.0	1.7	0.2	0.0	0.9	0.0	0.2	0.0	14.6	0.2	0.0	0.0	0.0	0.1	12.0	0.5	0.0	0.4	0.0	0.0	201.9	0.0	0.3	0.5	0.0	0.3	0.0	0.0	1.8	0.7	0.0	8.4	4.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	8.4	0.0	0.0	0.0	38.2	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	2.3	0.0	0.0	4.7	3.8	2.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0
ANO5	"GDD1, LGMD2L, TMEM16E"	ENSG00000171714	"Anoctamin 5"	Q75V66	11	21799934-22283357	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Limb-girdle muscular dystrophy, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 24.9;parathyroid gland: 17.0;skeletal muscle: 65.5;tongue: 50.4"	"Group enriched"	"Detected in many"	7	"Astrocytes: 67.9;Cardiomyocytes: 86.2;Excitatory neurons: 166.6;Inhibitory neurons: 136.4;Oligodendrocyte precursor cells: 81.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.9;HAP1: 5.0;HEK 293: 6.6;NTERA-2: 3.5;RPTEC TERT1: 3.2;U-266/84: 3.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA058857	Uncertain					NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA058857: AB_2683835"	"unprognostic (5.25e-3)"	"unprognostic (1.36e-3)"	"unprognostic (2.43e-1)"	"unprognostic (7.67e-3)"	"unprognostic (3.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (8.17e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.54e-4)"	"unprognostic (8.55e-2)"	"prognostic favorable (2.50e-7)"	"unprognostic (3.65e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.77e-4)"	"unprognostic (7.94e-2)"	0.9	4.5	1.9	0.8	3.0	0.0	0.7	0.1	8.9	1.6	3.0	2.6	3.3	1.5	1.3	2.0	0.8	1.7	24.9	4.0	2.2	3.6	2.1	1.2	0.2	2.7	2.1	0.5	3.9	17.0	3.4	0.0	2.2	4.2	3.3	2.1	2.6	4.1	65.5	0.1	2.5	2.7	0.4	0.7	3.0	1.8	2.4	0.2	4.7	50.4	0.3	2.0	0.3	3.4	0.0	4.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.3	1.4	2.5	0.0	0.0	0.0	0.0	3.5	2.6	0.0	0.0	0.0	0.0	3.2	0.1	2.7	2.6	0.0	0.0	0.0	2.1	2.1	1.9	0.0	0.0	1.9	0.0	0.0	2.0	3.7	0.0	2.8	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	3.0	0.1	8.9	4.0	2.2	2.7	2.1	2.2	0.4	2.4	3.4	0.4	0.0	5.9	67.9	0.6	0.3	0.3	0.0	0.0	6.7	2.2	0.6	86.2	1.5	0.0	1.8	0.0	0.1	0.0	7.8	1.9	1.3	5.8	0.4	0.2	3.2	5.4	0.4	166.6	2.7	0.0	3.0	1.5	0.3	0.0	3.0	2.5	5.1	0.5	1.7	136.4	7.1	0.0	0.6	1.4	2.9	0.0	1.6	1.8	14.0	1.9	2.8	0.0	81.4	4.2	1.0	4.4	1.2	0.0	1.4	2.7	3.3	0.7	0.8	0.0	8.1	2.4	11.0	0.9	0.1	0.1	0.0	0.2	1.6	4.6	0.2
ANO6	"DKFZp313M0720, TMEM16F"	ENSG00000177119	"Anoctamin 6"	Q4KMQ2	12	45215987-45482280	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Lipid transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038958	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		47000	"Cluster 14: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 32: U-937 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"HPA038958: AB_10672835"	"prognostic unfavorable (7.56e-5)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.82e-3)"	"unprognostic (7.43e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.41e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.28e-1)"	86.4	25.9	7.4	16.8	8.0	9.8	27.5	7.9	8.4	28.9	13.8	29.9	36.2	38.9	25.6	25.0	27.2	31.6	27.7	7.2	10.5	36.2	56.9	40.2	13.4	10.4	8.5	56.6	25.3	58.8	6.9	50.5	10.1	29.9	15.0	3.6	25.4	37.1	56.0	12.0	51.4	48.4	9.0	16.0	13.8	11.8	9.1	24.9	13.2	46.3	12.8	35.0	16.0	9.3	41.5	44.3	25.7	35.4	119.1	61.7	97.4	57.4	72.5	38.4	36.3	71.9	61.5	21.1	52.2	92.0	34.9	54.0	24.1	32.3	45.6	31.4	16.9	25.0	17.8	62.1	37.8	39.5	19.4	51.7	31.9	33.0	48.7	95.4	52.6	44.5	19.3	34.0	42.7	11.2	41.5	13.2	28.6	0.0	18.0	23.4	33.3	24.4	36.9	63.1	11.7	39.9	59.9	36.8	27.9	67.7	43.3	62.8	70.6	41.2	26.1	41.8	29.3	18.3	21.5	25.8	37.3	122.8	33.4	3.1	5.9	1.4	2.4	6.9	2.5	1.4	2.2	2.0	5.5	1.2	2.0	1.3	0.6	2.3	7.1	2.7	3.0	4.2	7.4	8.0	7.9	8.4	7.2	10.5	10.4	8.5	10.1	9.0	9.1	9.3	65.1	60.9	11.8	54.9	10.0	30.5	20.3	27.7	23.3	1.1	23.0	18.7	23.4	30.0	21.5	18.4	0.0	34.0	14.5	2.5	3.9	38.4	1.3	13.3	32.1	37.5	8.4	8.0	49.8	37.4	28.0	44.2	21.4	26.0	12.7	20.2	52.5	88.3	19.9	0.0	49.0	11.5	12.2	56.3	22.9	3.5	51.3	46.0	17.8	68.4	29.1	8.2	15.5	110.6	3.0	73.3	10.0	40.6	12.2	29.5	70.3	23.4	16.5	0.3	39.5	45.9	52.1	3.5	4.3	25.1	22.0	24.6	17.3	6.7	14.6	30.5
ANXA11	ANX11	ENSG00000122359	"Annexin A11"	P50995	10	80150889-80205572	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division"		"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 443.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004851, HPA027545"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		210000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB004851: AB_626682, HPA027545: AB_1844851"	"unprognostic (1.85e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.35e-3)"	"unprognostic (5.06e-2)"	"unprognostic (8.18e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.01e-3)"	"unprognostic (6.28e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.56e-2)"	"prognostic favorable (6.69e-8)"	"unprognostic (2.69e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.02e-1)"	139.9	29.5	39.0	99.4	40.6	192.9	107.6	27.5	46.8	86.6	52.8	130.3	138.0	74.3	107.5	210.2	109.0	84.8	236.2	47.3	29.0	144.7	47.7	109.5	81.2	26.4	26.6	78.2	95.4	81.8	27.2	91.1	23.9	100.3	120.7	4.8	94.1	81.8	188.9	75.6	137.2	86.0	25.4	76.2	139.3	24.5	24.6	100.2	61.4	166.2	101.7	148.1	102.8	30.4	221.7	195.7	10.4	53.9	220.2	201.1	119.6	149.5	397.3	95.7	98.8	168.7	338.2	13.1	113.6	236.7	8.1	277.7	44.6	136.2	54.2	384.3	76.0	84.4	98.9	131.5	129.4	92.0	212.3	222.9	74.6	57.8	39.4	178.9	143.9	117.9	82.1	163.7	76.8	127.3	119.8	200.9	19.6	211.5	367.7	91.7	14.9	344.0	155.1	191.8	5.1	37.9	65.0	269.9	156.4	83.4	80.6	120.6	160.0	68.7	101.4	157.6	84.4	91.7	145.6	96.0	66.6	155.4	47.4	130.8	66.8	443.8	72.9	52.4	75.0	64.9	92.5	100.5	49.4	54.2	83.7	74.4	231.8	61.3	59.1	78.5	126.5	85.4	39.0	40.6	27.5	46.8	47.3	29.0	26.4	26.6	23.9	25.4	24.6	30.4	150.5	96.1	78.4	17.3	101.4	51.2	266.4	219.4	92.8	1.6	58.8	50.4	293.3	203.0	227.1	220.7	0.0	271.7	137.1	457.7	332.6	429.2	4.5	180.6	49.7	82.7	77.5	29.9	29.5	352.5	309.8	113.1	175.8	265.7	116.1	81.4	91.4	40.8	228.1	3.3	15.5	186.9	97.6	149.7	167.4	9.6	92.9	155.0	90.7	24.4	208.2	38.9	159.6	3.0	2.3	420.6	461.0	92.6	98.2	414.9	367.7	156.8	229.0	2.8	92.1	56.4	137.9	2.8	51.5	98.4	42.1	185.5	131.9	50.8	227.8	581.4
AP000812.4		ENSG00000284922	"Leucine rich transmembrane and O-methyltransferase domain containing"	Q8WZ04	11	72080331-72110782	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Catecholamine metabolism, Hearing, Neurotransmitter degradation"	"Methyltransferase, Transferase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"fallopian tube: 14.1;testis: 9.5"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 2.9;HBEC3-KT: 2.9;MCF7: 3.0"									HPA039949	Approved		Uncertain	Microtubules		NA	NA					"Cluster 40: Non-specific - Basic cellular processes"		Microtubules		"HPA039949: AB_10960708"																		0.1	0.0	0.4	0.0	0.5	0.0	0.2	0.6	1.8	0.0	0.1	0.0	0.0	0.9	0.0	0.0	14.1	0.0	0.0	0.3	0.6	0.4	0.2	0.6	0.0	0.4	0.4	0.2	0.0	0.5		0.0	0.4	0.0	0.1	0.1	0.0	0.2	0.4	0.0	0.2	0.2	0.3	0.2	0.0	9.5	0.4	0.0	0.1	0.0	0.0	0.1		0.6	0.2	0.1	0.0	0.2	0.7	0.2	0.1	0.4	0.5	0.3	1.2	0.2	0.2	0.0	0.1	2.9	0.5	0.6	0.4	2.9	0.3	1.2	0.5	0.5	0.2	0.2	0.0	0.0	0.0	0.8	0.0	1.3	0.4	0.1	0.1	0.6	0.0	0.0	0.4	3.0	0.0	0.0	0.1	1.0	0.0	0.6	0.5	0.2	0.9	0.5	0.3	0.1	0.4	0.3	0.0	0.0	0.9	0.1	0.0	0.2	0.2	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.6	1.8	0.3	0.6	0.4	0.4	0.4	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AP1B1	"ADTB1, AP105A, BAM22, CLAPB2"	ENSG00000100280	"Adaptor related protein complex 1 subunit beta 1"	Q10567	22	29327680-29388583	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 138.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065226, HPA068520"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		660000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	"Vesicles, Cytosol"	"HPA065226: AB_2685438, HPA068520: AB_2685998"	"unprognostic (1.78e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.55e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.24e-6)"	"unprognostic (1.85e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.76e-2)"	30.7	46.7	38.0	47.2	38.3	45.8	26.4	37.3	45.2	22.8	35.6	34.9	43.3	22.7	12.1	63.0	23.5	30.4	23.9	36.1	40.8	34.8	34.8	30.1	57.8	44.2	44.6	17.5	38.3	67.0	39.2	44.8	43.7	38.3	30.1	35.3	40.3	25.9	24.5	47.2	45.6	27.1	41.4	52.6	40.9	24.7	52.7	34.2	29.6	20.5	54.4	39.4	32.2	48.8	84.6	47.5	49.3	50.2	37.0	27.0	60.0	59.8	65.5	71.2	68.2	74.4	33.2	46.1	37.2	68.4	33.0	74.6	71.5	97.6	45.2	58.2	102.0	79.1	60.8	42.0	38.9	114.1	99.9	38.6	36.0	67.5	55.0	33.0	98.7	17.2	54.6	54.9	48.3	93.7	45.5	36.8	37.3	124.8	53.3	89.0	54.3	119.9	50.2	194.5	75.9	52.2	74.0	82.5	36.4	33.5	66.7	49.5	84.6	79.1	48.8	46.0	62.1	60.4	32.5	84.6	56.1	48.1	46.7	0.0	29.3	5.7	9.2	29.2	9.1	16.2	6.3	7.9	28.7	18.2	4.9	5.2	3.0	7.2	31.7	9.0	8.8	24.2	38.0	38.3	37.3	45.2	36.1	40.8	44.2	44.6	43.7	41.4	52.7	48.8	17.8	12.8	16.4	27.7	53.0	7.1	9.3	16.7	16.5	26.3	26.2	20.8	16.1	21.5	16.4	22.0	39.6	52.3	15.1	69.6	23.5	41.2	7.5	16.4	11.6	19.8	21.6	40.0	24.1	40.7	30.1	12.1	33.6	30.1	5.1	13.2	35.3	34.3	138.9	45.4	25.6	24.9	18.3	95.5	24.2	13.1	11.8	65.7	12.4	51.5	29.8	28.4	9.2	16.1	14.0	65.9	33.2	12.4	28.5	17.5	51.2	30.1	14.5	42.1	6.6	17.8	12.7	23.5	17.6	33.0	9.1	68.3	17.0	39.6	36.2	18.1
AP1S1	"AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2"	ENSG00000106367	"Adaptor related protein complex 1 subunit sigma 1"	P61966	7	101154456-101161596	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Ichthyosis, Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 344.4;Proximal enterocytes: 241.3;Proximal tubular cells: 304.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060945	Supported		Supported	"Golgi apparatus,Vesicles"		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus, Vesicles"		"HPA060945: AB_2684393"	"unprognostic (1.98e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.98e-3)"	"unprognostic (8.70e-3)"	"unprognostic (7.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	14.4	24.6	72.2	13.9	75.7	5.8	17.2	43.7	82.6	18.3	34.6	28.6	39.0	16.9	17.0	34.2	13.8	12.8	11.8	85.2	59.6	41.2	36.2	14.7	11.9	53.6	51.9	13.5	21.9	22.8	31.0	15.9	53.4	22.2	22.4	14.6	20.3	9.3	6.4	39.2	30.3	12.7	46.1	20.2	22.0	16.4	62.5	19.1	15.2	8.5	13.6	20.1	19.5	62.7	121.0	87.3	63.3	118.4	42.8	70.4	138.2	76.8	51.1	50.8	52.8	47.3	147.5	24.9	127.5	84.6	97.1	59.0	35.3	116.0	45.6	57.0	56.6	16.8	52.0	61.4	54.2	46.8	87.7	79.1	91.0	49.4	20.6	76.7	76.8	54.1	56.7	103.2	129.9	292.1	40.4	107.8	97.8	177.0	188.2	24.9	27.2	54.6	127.8	88.8	47.5	157.7	40.4	121.1	151.4	101.6	50.7	46.8	79.0	74.1	132.3	27.6	55.2	21.4	51.4	48.4	195.2	50.1	152.9	0.5	3.3	0.3	2.3	3.1	2.2	2.6	3.2	2.5	4.6	2.0	1.9	1.8	1.2	1.3	1.8	5.0	3.3	2.4	72.2	75.7	43.7	82.6	85.2	59.6	53.6	51.9	53.4	46.1	62.5	62.7	34.4	6.4	0.0	2.3	17.9	38.7	29.7	173.0	46.7	30.7	54.8	49.0	1.1	45.8	72.9	55.2	8.4	170.7	19.8	88.4	344.4	128.2	2.5	28.8	34.2	36.7	90.3	16.2	21.2	111.7	101.3	27.7	42.8	31.9	5.7	85.3	28.9	43.0	95.2	30.3	10.3	96.5	116.0	24.8	21.6	3.4	35.1	27.3	53.4	7.5	58.0	34.1	17.5	2.5	9.8	183.3	86.1	21.8	17.4	34.9	241.3	304.8	34.9	22.3	19.7	11.4	38.4	13.1	70.9	51.4	45.5	60.5	19.5	157.4	119.9	38.2
AP2M1	"AP50, CLAPM1, mu2"	ENSG00000161203	"Adaptor related protein complex 2 subunit mu 1"	Q96CW1	3	184174689-184184091	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036849, HPA069870"	Uncertain		Supported	"Plasma membrane"		NA	NA		7500	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"		"HPA036849: AB_10672101, HPA069870: AB_2686217"	"unprognostic (1.16e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.28e-3)"	"unprognostic (4.96e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (9.12e-4)"	"unprognostic (3.80e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.11e-2)"	"unprognostic (9.18e-2)"	"prognostic unfavorable (7.45e-6)"	"unprognostic (2.61e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.28e-1)"	191.8	364.2	233.5	164.7	250.3	231.3	164.6	211.3	257.3	222.8	196.3	232.4	167.5	216.4	104.2	218.1	178.6	166.5	366.2	261.1	249.0	196.0	140.9	180.0	148.2	234.8	211.1	198.6	106.4	224.8	224.9	243.3	248.9	183.2	141.1	230.4	167.2	231.8	181.2	157.2	156.2	243.7	200.9	162.5	156.3	106.4	235.4	158.4	148.0	194.0	157.6	223.7	192.4	225.6	436.3	327.5	275.7	311.8	432.1	450.8	284.3	714.3	412.5	788.5	550.5	355.1	309.9	198.2	851.3	1076.1	516.1	480.0	376.3	482.9	647.1	409.8	470.4	512.2	365.8	317.9	508.9	254.8	311.5	577.0	269.4	501.1	318.5	711.0	595.3	258.3	250.0	377.1	750.1	993.6	330.1	151.2	674.1	388.1	484.7	302.7	351.5	393.7	489.7	389.3	292.0	212.6	561.3	696.4	335.1	427.5	934.4	305.7	645.0	497.1	400.1	492.4	960.2	336.9	318.7	441.6	937.1	369.9	331.7	194.4	294.8	244.9	137.5	238.8	136.2	114.3	127.6	134.0	268.7	112.7	107.7	111.8	127.7	170.2	206.8	134.1	185.4	441.0	233.5	250.3	211.3	257.3	261.1	249.0	234.8	211.1	248.9	200.9	235.4	225.6	146.8	54.5	50.7	41.4	84.8	124.9	177.2	275.1	97.9	174.2	108.0	98.2	195.9	112.9	133.5	114.0	70.9	400.9	117.3	155.9	375.6	243.7	326.6	69.3	131.2	172.2	140.8	277.8	62.0	161.3	327.1	161.5	71.4	78.5	149.1	173.6	182.4	78.0	576.9	277.6	63.4	119.0	201.4	137.1	162.9	347.8	164.7	185.1	199.3	34.7	369.4	199.4	130.7	26.2	46.1	232.1	153.1	214.8	100.2	138.8	253.8	290.7	58.3	125.9	197.2	106.9	278.0	83.3	101.7	128.5	126.6	513.6	102.6	278.1	154.1	185.1
AP2S1	"CLAPS2, FBH3, FBHOk, HHC3"	ENSG00000042753	"Adaptor related protein complex 2 subunit sigma 1"	P53680	19	46838136-46850846	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 991.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (1.34e-1)"	"unprognostic (5.93e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.60e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.11e-2)"	"unprognostic (9.54e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (5.79e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.07e-1)"	"unprognostic (6.05e-2)"	120.2	136.5	110.7	80.6	119.9	126.5	95.9	104.9	138.5	83.0	99.6	91.5	67.3	62.1	41.0	188.9	58.6	46.1	107.5	122.1	117.7	106.8	148.9	90.2	62.4	108.0	103.9	52.3	77.2	51.9	72.4	79.1	111.9	90.8	57.4	27.6	99.8	48.8	101.6	125.8	79.8	60.1	106.0	124.6	85.1	69.2	111.3	67.2	61.5	63.7	67.6	82.9	103.4	112.5	380.3	363.2	181.6	198.7	227.1	248.7	122.2	311.0	383.2	349.2	411.0	277.1	189.3	121.1	168.6	476.2	153.6	178.8	144.9	450.6	263.9	115.1	418.6	210.4	220.6	204.0	306.7	142.1	150.0	317.9	259.0	337.9	281.1	259.0	471.1	199.5	186.1	180.4	331.1	403.2	181.1	1060.2	295.7	341.8	268.8	142.8	167.0	170.8	269.2	299.9	177.2	258.8	239.1	298.4	377.0	113.9	248.6	336.4	343.2	246.0	293.8	135.3	375.7	130.8	302.0	134.8	439.0	292.3	437.6	278.6	640.3	406.6	174.3	708.8	145.2	211.5	167.3	174.5	716.8	198.4	153.1	156.3	204.6	188.5	544.6	431.5	233.8	673.1	110.7	119.9	104.9	138.5	122.1	117.7	108.0	103.9	111.9	106.0	111.3	112.5	129.0	38.5	57.2	10.4	85.9	171.6	103.9	341.6	73.4	39.5	179.0	227.8	79.4	137.2	163.9	95.6	16.7	415.2	100.9	397.7	348.3	215.6	80.7	67.8	106.7	190.6	163.7	250.7	14.6	247.2	257.4	130.2	95.8	82.5	92.7	176.1	396.9	308.4	991.6	45.4	13.3	259.6	164.8	515.0	389.5	232.8	92.6	389.5	200.9	4.7	661.1	109.4	160.6	4.5	14.8	249.8	333.9	95.5	94.8	157.6	442.9	432.4	89.0	42.5	98.6	59.1	173.9	78.9	52.5	252.2	253.3	440.5	87.9	230.6	282.1	164.3
AP4B1	"BETA-4, SPG47"	ENSG00000134262	"Adaptor related protein complex 4 subunit beta 1"	Q9Y6B7	1	113894194-113905201	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028162, HPA028652"	Approved		Approved	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA028162: AB_10610976, HPA028652: AB_10601451"	"unprognostic (8.90e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.01e-2)"	"prognostic unfavorable (8.60e-7)"	"unprognostic (3.45e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (3.73e-6)"	"unprognostic (5.08e-3)"	"unprognostic (7.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.55e-2)"	9.7	8.5	12.5	11.1	13.1	20.5	9.3	14.6	14.6	11.9	10.9	11.5	10.6	9.7	14.2	12.1	11.0	7.0	11.2	13.0	13.0	9.7	8.4	9.5	14.3	11.6	11.4	13.7	14.0	4.8	13.7	5.9	11.8	9.6	12.7	20.0	7.6	6.2	11.7	11.5	12.8	9.1	11.5	20.1	10.4	11.1	13.3	16.1	11.0	9.1	13.9	9.2	10.0	13.3	11.0	9.8	10.0	11.8	15.7	14.1	6.4	10.1	9.8	13.0	14.0	6.8	7.7	21.5	15.9	12.4	6.5	9.7	11.3	13.4	16.5	16.6	9.8	17.6	13.6	8.3	9.5	19.6	17.3	16.1	6.7	25.5	15.3	7.8	22.7	20.9	12.3	18.5	17.6	65.2	15.6	21.6	9.4	7.7	19.0	15.0	19.5	13.3	13.2	5.5	10.2	8.5	10.1	19.1	7.8	9.5	5.7	15.4	21.8	15.0	13.9	17.4	20.8	15.2	15.8	21.3	24.6	26.0	25.1	15.9	10.5	8.6	14.7	10.8	15.6	9.5	11.7	12.6	12.9	11.9	12.7	11.1	1.2	12.2	8.5	9.1	10.4	9.5	12.5	13.1	14.6	14.6	13.0	13.0	11.6	11.4	11.8	11.5	13.3	13.3	7.2	3.2	6.7	7.5	12.3	3.6	3.3	5.4	4.6	6.8	3.2	4.3	8.7	5.7	11.9	3.7	31.3	3.8	12.0	7.8	1.9	7.7	3.6	4.6	4.7	7.6	3.0	18.1	11.4	26.8	3.5	7.0	11.2	5.2	2.5	4.5	7.5	4.1	5.2	8.4	11.6	5.3	6.1	7.3	4.9	2.3	2.8	6.9	7.2	7.5	6.1	4.7	3.1	11.6	10.0	10.9	6.9	4.9	7.4	2.8	6.5	3.3	5.2	21.0	13.1	6.1	6.2	16.4	11.5	5.7	3.7	1.6	14.8	6.4	9.0	3.3
AP4E1	"AP-4-EPSILON, SPG51"	ENSG00000081014	"Adaptor related protein complex 4 subunit epsilon 1"	Q9UPM8	15	50908672-51005895	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041749, HPA041891"	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 59: Non-specific - Transcription"			"HPA041749: AB_10794490, HPA041891: AB_10796462"	"unprognostic (1.72e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.46e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.40e-1)"	"unprognostic (2.03e-2)"	3.7	3.0	2.5	4.4	2.9	3.1	3.0	3.3	2.7	3.7	3.2	3.6	3.0	4.3	2.1	4.7	3.2	2.6	3.9	2.4	2.6	2.8	2.9	3.1	5.5	2.9	2.8	2.9	2.2	5.1	2.4	4.7	2.9	2.7	3.4	3.8	3.3	2.6	8.2	5.4	3.2	4.5	2.6	4.6	2.9	3.9	3.0	6.5	3.8	6.3	4.7	4.0	4.1	3.5	11.5	8.7	6.0	7.1	7.9	12.0	11.7	11.1	8.9	10.7	11.1	10.7	1.8	11.2	4.3	12.5	10.8	13.7	9.0	9.6	12.4	12.3	4.6	9.8	14.5	4.3	11.1	12.1	8.2	12.2	11.6	13.4	21.0	6.6	7.2	8.8	9.1	6.3	14.7	15.4	7.1	6.9	3.9	5.2	4.4	9.7	8.5	6.9	7.9	10.4	4.1	6.7	11.8	8.4	8.7	10.7	7.6	11.7	10.0	15.7	5.8	9.5	15.9	9.6	11.7	14.1	12.3	26.1	7.3	2.7	0.6	0.3	0.8	0.9	0.5	0.5	0.6	0.7	0.6	0.3	0.4	0.9	0.1	0.5	0.5	0.4	0.3	0.4	2.5	2.9	3.3	2.7	2.4	2.6	2.9	2.8	2.9	2.6	3.0	3.5	6.6	6.4	6.1	17.6	8.7	5.7	1.5	3.8	4.0	9.8	4.9	3.7	10.4	2.8	8.4	5.5	18.8	7.3	7.7	7.9	0.0	4.9	2.0	5.9	10.0	7.8	3.0	6.9	26.7	4.8	5.7	4.7	7.1	6.2	10.2	7.2	6.8	8.1	7.2	8.4	27.0	5.3	2.0	17.0	4.1	1.4	5.9	10.2	1.8	25.3	6.5	3.9	8.2	19.1	36.0	10.6	2.4	4.1	9.6	2.2	6.2	3.6	4.8	11.2	6.6	7.1	6.6	10.2	7.7	6.6	7.0	7.3	9.6	4.8	5.5	2.4
AP4M1	"MU-4, MU-ARP2, SPG50"	ENSG00000221838	"Adaptor related protein complex 4 subunit mu 1"	O00189	7	100101549-100110345	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 95.9;Spermatocytes: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066774	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA066774: AB_2685718"	"unprognostic (6.40e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.22e-2)"	"unprognostic (2.24e-3)"	"prognostic unfavorable (7.63e-5)"	"unprognostic (1.58e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.05e-2)"	"unprognostic (7.18e-2)"	"prognostic unfavorable (8.29e-4)"	"unprognostic (6.59e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.46e-1)"	8.4	7.3	9.9	4.7	9.9	4.9	9.6	9.6	12.1	11.4	10.0	15.2	12.5	15.7	6.1	10.3	12.4	8.5	9.8	9.9	10.0	10.3	4.7	8.8	6.3	11.2	10.5	9.3	12.3	7.7	15.4	5.6	10.7	12.3	6.2	6.4	10.1	11.0	10.7	11.7	9.9	8.0	10.0	7.2	12.8	32.6	10.9	6.1	10.9	5.5	4.6	12.4	10.3	10.1	9.3	13.0	13.9	35.4	7.8	17.8	15.8	5.5	9.6	7.1	8.9	10.6	23.7	11.1	25.2	13.4	10.2	9.9	6.1	12.0	3.9	8.9	8.6	6.2	12.7	9.4	16.2	7.2	10.9	15.1	20.5	20.7	12.5	13.7	23.5	14.3	11.9	8.4	24.6	28.7	25.9	14.1	10.9	8.4	13.3	21.8	7.0	13.9	18.0	11.9	24.2	21.1	14.0	40.9	11.9	7.9	18.6	14.0	26.0	21.2	16.9	19.8	9.4	6.2	6.8	16.8	17.7	8.3	18.8	4.3	6.3	9.1	4.5	7.9	4.1	5.3	4.0	5.1	8.7	3.4	1.8	3.2	2.1	3.2	10.8	5.3	4.5	4.3	9.9	9.9	9.6	12.1	9.9	10.0	11.2	10.5	10.7	10.0	10.9	10.1	12.6	16.0	4.6	20.5	10.4	9.4	17.3	17.7	9.1	17.7	14.2	17.8	3.2	20.0	13.3	16.5	52.1	14.7	6.8	17.7	7.9	24.4	69.3	20.3	14.6	12.5	12.1	8.2	9.5	19.0	18.1	12.4	14.8	11.2	3.8	22.8	13.2	3.3	9.9	6.7	7.0	15.6	12.2	7.3	7.7	95.9	14.6	6.9	14.2	10.3	14.5	21.0	8.2	6.0	8.1	19.6	17.7	12.8	5.9	13.7	21.9	11.1	29.5	67.9	13.1	15.3	12.4	84.7	39.5	8.8	8.4	14.0	8.2	16.0	14.2	11.2
AP4S1	"AP47B, CLA20, SPG52"	ENSG00000100478	"Adaptor related protein complex 4 subunit sigma 1"	Q9Y587	14	31025106-31130996	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039963	Approved		Supported	Vesicles		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA039963: AB_10795240"	"unprognostic (4.03e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.00e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (3.79e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.02e-1)"	"prognostic favorable (2.87e-6)"	"unprognostic (2.20e-3)"	"unprognostic (5.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.59e-2)"	4.8	6.3	9.8	6.6	10.6	6.0	5.7	14.1	12.8	6.5	5.6	8.6	3.9	7.7	7.0	4.9	7.3	5.4	8.7	9.5	10.2	7.8	6.2	5.4	8.1	6.3	6.5	10.7	7.9	6.5	8.5	6.7	6.1	6.2	4.1	11.9	5.2	6.7	12.6	4.6	4.4	7.9	5.4	8.0	4.3	18.4	9.0	6.6	8.8	7.2	7.7	6.2	4.8	10.1	9.0	12.6	11.0	3.2	4.4	7.9	8.5	6.0	10.4	9.6	9.5	12.2	14.5	10.6	5.5	7.3	7.2	9.7	7.6	9.4	15.9	9.1	4.4	16.4	5.5	19.0	9.5	14.1	9.2	6.3	5.9	9.6	12.0	6.4	11.7	8.0	8.4	7.0	10.3	12.5	9.7	7.8	13.1	10.5	10.9	10.3	9.8	1.4	10.5	12.4	6.1	6.1	10.7	5.1	16.3	7.3	10.8	6.5	8.8	7.3	6.5	5.0	5.2	8.6	17.0	15.9	4.2	4.4	5.7	3.4	1.3	2.4	2.5	3.5	3.7	3.3	3.8	3.0	1.2	3.4	3.7	4.5	2.6	5.8	2.8	3.3	6.6	1.7	9.8	10.6	14.1	12.8	9.5	10.2	6.3	6.5	6.1	5.4	9.0	10.1	7.1	9.6	7.7	10.7	8.1	3.4	6.5	6.5	1.2	12.1	4.0	4.3	16.5	4.3	3.1	5.5	31.3	9.1	7.6	3.9	5.9	7.6	21.9	5.2	8.8	6.7	6.0	3.8	29.4	4.8	5.3	6.2	7.1	5.8	7.6	7.8	10.8	4.0	7.4	6.7	24.9	3.8	4.1	5.4	4.1	17.0	6.8	6.0	3.6	12.2	7.5	9.3	5.2	25.1	16.4	2.8	6.2	8.6	4.2	4.0	5.0	7.7	8.1	24.4	6.6	8.5	8.1	36.0	8.3	3.0	2.8	11.5	7.3	8.2	4.0	5.2
APCS	"MGC88159, PTX2, SAP"	ENSG00000132703	"Amyloid P component, serum"	P02743	1	159587826-159588865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"liver: 3629.2"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 4141.9"	"Cancer enriched"	"Detected in some"	25	"liver cancer: 826.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB007817, HPA053294"	Supported				"Secreted to blood"	NA	NA	27700000000	39000000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"			"CAB007817: AB_598185, HPA053294: AB_2682104"							"unprognostic (3.19e-3)"				"unprognostic (2.30e-2)"							0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	47.7	0.2	0.0	0.0	1.3	3629.2	0.1	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	388.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.8	0.0	0.0	0.0	2.7	0.0	45.5	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	57.8	4141.9	0.0	0.0	0.0	0.0	0.0	88.9	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0
APOL1	APOL	ENSG00000100342	"Apolipoprotein L1"	O14791	22	36253071-36267530	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 220.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 106.1;Glandular and luminal cells: 216.2;Hepatocytes: 115.6;Pancreatic endocrine cells: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 243.9;HDLM-2: 166.1;HHSteC: 120.3;RPTEC TERT1: 91.1;RT4: 146.8"									"HPA018885, CAB056156"	Supported				"Secreted to blood"	NA	NA	1640000000	9200000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"CAB056156: AB_2665576, HPA018885: AB_1844953"	"unprognostic (1.05e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.07e-3)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (7.43e-6)"	"unprognostic (1.93e-1)"	"unprognostic (3.15e-2)"	"unprognostic (5.05e-3)"	"prognostic favorable (2.01e-5)"	45.3	15.8	8.1	62.5	8.2	4.2	28.4	7.8	9.8	53.8	9.4	32.0	32.7	38.8	17.7	25.7	36.7	69.0	29.5	7.4	8.4	44.5	220.5	59.5	23.1	10.0	8.5	24.8	9.0	4.9	14.1	53.0	9.6	37.5	27.2	0.9	29.7	52.2	11.7	7.1	28.9	65.4	9.0	56.8	64.9	7.9	10.8	24.9	18.0	13.8	23.6	117.7	29.9	8.2	21.6	5.1	0.1	0.6	46.8	44.6	14.2	2.3	9.0	13.7	38.6	0.6	34.4	7.0	243.9	24.8	31.3	5.3	0.0	19.2	3.6	166.1	0.2	6.1	3.2	41.4	120.3	2.4	20.2	8.3	1.7	38.0	0.8	2.0	27.3	1.3	23.8	85.1	2.4	0.2	8.5	2.1	0.6	0.6	0.2	13.6	2.6	3.2	91.1	146.8	1.9	0.1	10.9	5.8	2.1	0.3	0.8	7.8	24.7	29.5	12.4	3.2	1.5	6.5	4.0	1.6	16.0	12.4	4.6	15.6	6.1	5.5	12.6	6.8	10.7	2.6	8.1	11.2	4.3	1.4	4.6	6.3	16.1	22.4	10.3	0.5	5.4	7.2	8.1	8.2	7.8	9.8	7.4	8.4	10.0	8.5	9.6	9.0	10.8	8.2	37.4	57.7	34.3	0.3	7.2	1.7	21.4	73.5	2.8	0.5	6.3	3.0	3.6	15.7	67.1	18.4	2.1	11.0	12.6	31.2	0.0	37.8	0.8	106.1	48.8	41.3	7.7	3.8	0.1	20.0	8.2	27.3	45.9	216.2	11.4	4.3	49.6	115.6	9.1	0.0	0.1	17.7	32.6	15.8	5.3	1.4	27.4	10.9	0.0	7.5	19.4	0.1	36.0	0.0	0.0	105.1	19.9	24.0	15.0	31.2	20.5	2.1	60.5	1.3	6.6	5.5	10.6	0.4	0.4	3.4	2.3	6.7	12.9	1.6	4.6	62.5
APRT		ENSG00000198931	"Adenine phosphoribosyltransferase"	P07741	16	88809339-88811937	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026681	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		1600000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Cytosol"		"HPA026681: AB_1844964"	"unprognostic (5.87e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.72e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.48e-2)"	118.5	161.2	30.1	73.6	30.1	103.1	112.3	32.0	39.5	109.6	39.3	121.0	72.2	81.2	25.5	231.1	87.6	31.4	70.2	29.9	32.0	128.7	190.4	85.8	83.8	32.9	31.3	73.3	169.4	66.1	64.9	37.0	32.1	113.6	40.2	5.1	119.8	44.6	62.7	240.1	106.8	29.8	33.7	128.6	131.8	35.2	35.1	77.2	96.9	23.8	64.5	95.7	153.7	35.7	157.9	228.3	44.9	200.4	54.2	106.0	232.2	117.1	105.0	136.0	52.6	237.6	189.0	145.5	221.9	68.4	65.0	165.3	74.8	195.4	27.5	102.9	417.7	124.3	106.5	253.0	168.1	87.4	97.7	113.1	207.6	109.0	139.4	63.7	172.6	244.6	266.6	107.9	71.4	586.0	242.1	254.7	169.4	169.5	288.8	259.2	69.2	351.5	156.3	107.0	218.2	132.4	223.5	130.7	131.2	41.9	427.9	171.1	111.4	122.5	104.9	99.5	118.0	205.9	186.5	408.8	179.9	228.4	110.5	77.7	544.5	202.8	474.5	473.5	631.7	501.1	612.0	510.3	562.4	517.3	557.8	475.3	31.8	501.8	322.1	731.6	551.8	998.0	30.1	30.1	32.0	39.5	29.9	32.0	32.9	31.3	32.1	33.7	35.1	35.7	146.5	115.4	147.4	5.9	247.0	319.0	320.0	375.7	207.7	19.9	346.2	479.7	46.9	230.2	206.8	92.0	6.2	265.0	262.3	273.1	406.9	404.3	11.8	124.6	180.3	163.1	210.8	150.6	5.1	442.6	401.5	170.3	192.7	148.4	131.9	154.9	147.8	309.6	348.0	15.2	4.4	386.4	160.7	253.9	336.1	35.4	239.9	214.6	297.1	3.7	449.4	78.7	355.3	2.5	7.2	392.3	228.3	135.4	171.6	404.3	349.2	647.9	125.5	20.4	39.5	135.6	186.5	18.4	126.9	358.8	494.7	172.7	285.7	339.5	426.7	385.2
APTX	"AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157"	ENSG00000137074	Aprataxin	Q7Z2E3	9	32886601-33025130	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064930	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nucleoli"		"HPA064930: AB_2685386"	"unprognostic (9.18e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-2)"	"prognostic favorable (6.01e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.50e-2)"	9.7	14.8	14.6	7.0	14.8	11.0	10.4	14.8	20.2	9.1	13.9	10.2	8.6	8.6	7.6	14.7	8.9	4.9	9.9	14.8	15.0	13.6	15.6	9.3	8.1	14.7	14.6	8.5	9.6	12.1	7.6	7.8	15.0	9.6	11.2	8.0	9.0	6.6	9.8	15.3	8.3	8.6	14.2	8.9	9.7	14.7	15.2	9.3	7.0	6.9	11.0	10.4	9.6	15.0	36.2	26.1	18.4	17.1	19.0	17.4	25.6	24.8	26.0	28.7	31.5	35.1	12.7	27.8	14.6	21.1	18.4	19.4	33.7	32.8	35.1	39.2	11.2	17.9	32.5	37.8	24.4	29.4	15.1	23.8	36.3	32.5	37.9	16.9	26.8	20.2	27.0	24.2	26.0	15.6	24.4	43.2	33.5	24.4	29.0	21.2	14.4	21.5	25.2	21.2	15.6	11.1	21.4	18.0	15.5	17.9	23.0	11.4	17.7	16.2	21.1	29.9	25.0	11.1	21.2	27.5	23.4	23.8	13.2	3.3	14.7	13.4	12.2	15.6	15.2	16.3	12.8	14.6	17.6	16.1	16.0	12.1	5.9	23.1	21.7	15.2	17.3	16.1	14.6	14.8	14.8	20.2	14.8	15.0	14.7	14.6	15.0	14.2	15.2	15.0	14.8	19.2	29.0	31.3	16.9	16.7	23.1	32.9	22.2	15.2	17.9	17.0	14.9	21.5	23.1	9.2	10.4	27.7	15.1	12.6	29.4	25.3	55.6	19.7	18.3	13.3	16.8	20.0	27.3	28.2	27.7	15.6	19.4	18.1	16.5	17.8	8.9	21.4	18.8	13.5	29.0	15.3	34.6	14.7	9.9	48.7	13.4	15.0	14.2	15.9	19.3	18.3	15.5	23.6	43.0	31.9	6.8	10.5	28.3	24.0	13.9	31.7	25.4	16.6	13.1	13.5	20.2	42.2	26.9	25.8	21.2	27.9	15.9	20.5	16.3	23.1
AQP2		ENSG00000167580	"Aquaporin 2"	P41181	12	49950737-49958878	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Diabetes insipidus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	92	"kidney: 386.9;seminal vesicle: 212.4"	"Cell type enriched"	"Detected in some"	440	"Collecting duct cells: 4143.6"	"Group enriched"	"Detected in some"	6	"renal cancer: 1.7;stomach cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.4;HEL: 1.1;HMC-1: 2.2;OE19: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046834	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA046834: AB_2679830"	"unprognostic (2.10e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.96e-3)"	"unprognostic (4.48e-3)"	"unprognostic (3.60e-2)"			"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.38e-3)"	"unprognostic (5.92e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.11e-1)"		0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.0	0.0	0.2	1.5	0.0	0.0	386.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.4	212.4	0.0	0.2	0.0	0.0	0.0	0.0	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	4143.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	9.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.1	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0
AQP5		ENSG00000161798	"Aquaporin 5"	P55064	12	49961872-49965682	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 622.6;testis: 222.0"	"Group enriched"	"Detected in many"	7	"Early spermatids: 1542.9;Late spermatids: 4265.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 87.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"OE19: 223.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065008	Enhanced		Approved	"Plasma membrane"		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA065008: AB_2685401"	"unprognostic (4.67e-3)"	"unprognostic (5.00e-2)"	"unprognostic (3.30e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.92e-3)"	"prognostic favorable (1.75e-5)"	"unprognostic (4.13e-3)"	"unprognostic (1.02e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.88e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.69e-4)"	"unprognostic (2.53e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.51e-3)"	"unprognostic (9.11e-3)"	2.9	0.8	2.7	0.1	3.7	0.2	17.1	3.3	2.7	12.9	1.5	0.4	15.3	2.7	0.2	16.5	0.7	2.8	4.0	2.4	2.9	1.9	0.1	7.6	0.0	3.3	3.9	0.2	2.0	3.0	1.2	0.0	3.1	1.3	0.0	1.0	622.6	1.0	0.2	112.7	0.1	0.3	2.6	0.4	52.3	222.0	3.8	0.0	1.6	0.0	0.1	0.3	0.4	2.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.7	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.7	223.2	0.0	10.1	0.0	0.0	0.3	0.0	0.2	0.1	0.8	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.7	3.3	2.7	2.4	2.9	3.3	3.9	3.1	2.6	3.8	2.6	0.5	57.7	3.1	0.0	0.1	1.3	0.5	18.3	0.0	0.8	53.9	48.0	0.3	0.0	56.4	7.3	0.0	0.0	0.1	0.0	0.0	0.1	1542.9	1.5	0.1	1.8	0.0	0.0	0.0	0.2	0.0	1.4	34.7	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	26.4	0.0	1.6	4265.6	28.6	1.7	295.3	0.0	0.0	53.7	0.0	3.0	0.1	7.2	0.0	19.2	0.3	1.6	0.0	0.0	9.7	1.7	19.7	0.0	1.8	403.9	15.9	1.3	0.9	0.0	0.6	18.7	0.0	0.6
ARG1		ENSG00000118520	"Arginase 1"	P05089	6	131470832-131584332	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 1203.5"	"Cell type enriched"	"Detected in some"	22	"Hepatocytes: 991.4"	"Cancer enriched"	"Detected in some"	45	"liver cancer: 167.7"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 44.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 44.9"	"Cell line enhanced"	"Detected in single"		"HL-60: 1.4"	"Region enhanced"	"Detected in single"		"cerebellum: 2.4"	"Low region specificity"	"Detected in all"			"HPA003595, CAB009434, HPA024006, CAB056159, CAB080011"	Enhanced					NA	NA		9500000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"			"CAB009434: AB_2058955, CAB056159: AB_2665582, CAB080011: , HPA003595: AB_1078190, HPA024006: AB_1844987"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.55e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.79e-2)"	2.2	0.2	0.1	0.3	0.2	292.0	4.8	1.0	0.5	0.3	0.2	0.2	0.0	0.1	0.0	2.1	1.9	0.0	0.8	0.3	0.2	0.3	1203.5	6.5	0.3	0.4	0.2	0.2	0.4	0.0	0.2	1.7	0.3	0.3	0.0	0.3	0.9	0.0	0.5	92.8	0.3	0.2	0.1	20.6	0.4	0.1	0.2	1.2	0.5	0.6	0.7	0.2	2.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.0	0.2	0.7	0.3	44.9	0.0	0.9	0.2	9.3	0.4	0.1	0.2	1.0	0.5	0.3	0.2	0.4	0.2	0.3	0.1	0.2	0.2	0.0	0.0	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.1	1.5	0.0	43.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.2	991.4	0.0	0.0	0.1	0.1	0.0	27.6	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1
ARIH1	"ARI, HARI, HHARI, UBCH7BP"	ENSG00000166233	"Ariadne RBR E3 ubiquitin protein ligase 1"	Q9Y4X5	15	72474330-72602987	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 47.8;testis: 42.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003295	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA003295: AB_1845017"	"unprognostic (3.31e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.21e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.43e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.96e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.70e-2)"	8.5	7.9	2.5	10.1	3.9	16.5	6.0	7.0	5.8	6.4	7.1	8.2	9.5	7.5	3.2	6.8	5.4	4.4	11.4	4.4	4.0	5.2	6.2	7.3	4.9	3.4	2.7	9.0	6.6	3.9	5.9	6.5	3.6	5.8	3.3	10.4	4.3	4.8	47.8	7.6	7.4	6.3	3.0	6.0	6.3	42.5	3.8	3.9	5.0	8.5	4.1	7.6	6.5	4.3	17.6	18.0	17.5	10.2	8.9	6.2	20.6	19.3	7.0	8.6	5.9	18.3	14.6	17.2	28.4	8.3	30.3	24.8	18.1	10.1	4.8	30.6	12.4	13.0	22.5	12.4	6.3	19.6	14.4	7.4	3.4	9.5	12.2	8.2	6.4	12.4	13.8	19.7	8.5	11.5	18.9	7.5	18.9	6.3	6.5	21.4	21.3	9.8	4.8	29.0	16.3	18.4	25.1	11.2	31.4	23.0	9.0	22.0	16.7	14.1	19.6	54.8	27.4	20.7	45.2	20.6	9.2	17.5	15.2	1.6	0.2	0.7	0.5	0.4	0.4	0.2	0.3	0.3	0.2	0.6	0.4	0.4	1.0	0.6	0.2	0.3	0.8	0.1	2.5	3.9	7.0	5.8	4.4	4.0	3.4	2.7	3.6	3.0	3.8	4.3	79.5	19.2	37.7	88.5	64.0	66.3	52.7	13.3	76.2	63.3	74.9	53.3	46.9	30.0	25.7	18.4	91.8	18.4	83.3	32.9	3.9	18.4	110.3	108.7	84.8	50.7	46.5	24.8	141.6	18.9	21.8	43.3	63.7	148.4	43.2	43.7	40.0	28.5	19.0	62.2	152.0	31.2	8.2	30.5	42.1	55.4	28.6	67.5	16.0	104.0	24.2	25.7	27.8	129.7	135.1	24.7	19.1	27.4	60.9	55.8	20.8	13.9	33.0	58.8	19.7	96.8	59.9	45.3	32.1	68.8	59.8	40.8	68.3	36.8	27.0	63.7
ARSA		ENSG00000100299	"Arylsulfatase A"	P15289	22	50622754-50628173	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 127.5;Plasma cells: 132.0;Proximal enterocytes: 93.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 80.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005554, CAB025183"	Enhanced		Uncertain	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		5600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	Cytosol	"CAB025183: , HPA005554: AB_1078220"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.07e-2)"	"prognostic favorable (2.96e-5)"	"unprognostic (4.66e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.73e-3)"	28.8	25.1	14.4	15.6	18.0	18.4	27.2	16.8	21.8	21.3	27.5	31.3	30.8	22.4	8.6	28.1	25.1	15.7	33.0	14.9	15.2	31.4	42.8	29.1	19.8	20.0	15.9	11.3	46.7	11.7	34.7	10.9	19.1	28.9	8.2	4.4	39.6	16.2	25.3	17.5	33.8	6.5	16.3	44.5	30.3	54.0	19.4	9.8	32.3	5.1	9.5	23.9	24.7	21.0	8.5	11.0	5.3	10.9	41.8	21.8	13.5	13.0	15.9	5.7	9.3	3.3	12.9	5.3	8.2	22.9	10.8	12.8	1.2	12.3	1.0	2.7	8.0	3.4	14.3	12.5	28.3	5.2	32.7	26.0	24.4	9.5	6.3	19.9	12.8	11.5	3.5	80.4	12.1	9.6	4.6	5.8	1.7	9.0	11.2	4.0	0.4	26.7	9.9	13.5	2.5	8.2	18.2	17.2	10.1	5.1	7.7	6.6	22.1	3.8	15.1	14.9	4.1	18.4	1.9	4.5	11.7	4.3	13.6	10.4	27.7	36.1	17.3	33.3	15.1	10.4	12.4	14.2	22.7	12.5	7.3	10.0	60.4	8.9	43.2	32.1	18.2	16.3	14.4	18.0	16.8	21.8	14.9	15.2	20.0	15.9	19.1	16.3	19.4	21.0	22.8	6.4	12.9	24.5	22.2	4.7	14.0	23.8	18.8	5.3	18.9	13.1	8.0	27.1	15.5	12.9	4.2	11.5	14.0	85.4	1.9	29.4	62.4	24.4	10.3	13.4	36.7	9.7	9.4	21.3	19.9	19.6	41.3	21.3	6.3	15.3	8.2	28.6	36.8	6.7	8.6	30.6	14.2	29.0	9.5	127.5	10.8	29.2	17.8	10.3	28.7	10.3	8.2	8.0	11.9	24.2	75.2	6.0	132.0	10.8	93.9	22.7	21.2	7.2	0.0	6.6	9.9	48.3	4.1	18.3	5.5	13.3	17.2	7.2	25.0	16.1
ARSB		ENSG00000113273	"Arylsulfatase B"	P15848	5	78777209-78986087	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.8;Excitatory neurons: 37.4;Inhibitory neurons: 42.5;Microglial cells: 40.3;Oligodendrocyte precursor cells: 71.4;Oligodendrocytes: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 25.6"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.8;granulocytes: 25.6;monocytes: 8.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037770, HPA037771"	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"		"HPA037770: AB_10671719, HPA037771: AB_10671720"	"unprognostic (1.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.57e-3)"	"unprognostic (9.88e-2)"	"unprognostic (6.54e-3)"	"prognostic unfavorable (3.42e-4)"	6.9	4.5	3.9	8.1	3.9	8.1	2.6	3.1	4.6	5.3	4.2	5.5	3.1	6.4	3.5	4.8	2.9	7.3	8.3	4.7	3.6	21.3	7.6	7.0	5.4	4.6	5.3	2.2	4.6	6.6	2.5	11.5	4.0	5.0	8.2	6.7	3.1	6.6	3.8	2.1	3.6	14.1	4.3	5.2	3.9	2.6	5.2	2.6	4.2	4.3	4.8	8.0	2.3	5.0	5.0	11.3	18.6	6.3	41.9	16.4	16.7	29.2	23.0	18.9	23.0	9.9	8.4	6.5	31.5	25.5	29.0	3.9	7.0	7.4	18.5	55.6	6.2	9.2	11.2	40.1	9.7	10.5	10.4	19.4	2.4	19.7	6.5	15.6	22.4	3.9	2.0	12.9	19.6	9.2	5.8	19.3	5.6	1.1	6.7	7.7	10.9	5.9	12.0	6.2	6.8	15.9	20.3	6.2	12.1	12.7	6.9	26.2	16.2	17.5	10.4	7.6	26.4	14.8	28.0	7.2	21.6	21.4	40.3	19.0	8.3	25.6	1.0	6.7	0.6	2.0	0.4	0.4	7.8	1.3	0.3	0.5	4.6	0.2	5.6	5.7	0.7	2.7	3.9	3.9	3.1	4.6	4.7	3.6	4.6	5.3	4.0	4.3	5.2	5.0	3.9	0.0	2.0	40.8	5.1	0.8	1.4	1.3	0.6	3.7	1.6	1.0	7.2	1.5	0.7	3.7	6.2	2.2	5.5	1.4	3.9	3.7	0.5	1.9	7.2	4.5	1.2	16.2	37.4	9.2	5.1	6.6	2.6	9.0	0.0	6.3	13.6	3.8	16.7	6.7	42.5	6.0	0.0	25.2	14.3	0.5	4.4	15.9	14.2	40.3	16.1	3.6	2.1	71.4	56.2	4.0	3.0	3.8	8.1	2.2	0.5	18.8	2.5	2.7	6.6	5.0	4.4	2.2	3.1	0.7	1.3	2.6	3.4	1.6	2.2	1.3
ARSG	KIAA1001	ENSG00000141337	"Arylsulfatase G"	Q96EG1	17	68259182-68422731	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Deafness, Disease variant, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 30.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 54.2;NK-cells: 42.2;Rod photoreceptor cells: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023245, HPA023285"	Enhanced				"Intracellular and membrane"	NA	NA		4400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA023245: AB_1845056, HPA023285: AB_1845057"	"unprognostic (3.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.02e-2)"	"unprognostic (3.67e-3)"	"unprognostic (4.11e-1)"	"unprognostic (1.14e-3)"	"unprognostic (5.18e-2)"	"unprognostic (5.47e-2)"	"unprognostic (6.11e-7)"	"unprognostic (4.24e-3)"	"prognostic favorable (7.04e-4)"	"unprognostic (1.87e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.49e-1)"	2.6	4.6	1.5	2.9	2.0	3.4	5.5	6.6	2.0	3.5	8.6	2.2	1.1	3.8	30.2	4.4	6.6	2.1	4.9	1.1	2.9	3.0	2.5	2.4	3.9	2.5	3.6	6.2	2.3	1.2	5.3	2.6	3.6	2.0	1.1	7.8	3.3	5.5	3.7	4.5	1.9	2.1	0.7	4.9	2.6	2.1	2.1	2.5	7.5	3.0	3.6	2.0	2.0	1.4	1.4	1.7	1.3	2.1	7.0	4.3	5.7	1.9	5.7	2.7	1.3	0.7	3.2	3.3	4.8	2.5	1.1	0.2	2.2	0.7	1.0	4.8	2.0	1.8	1.8	5.4	5.7	5.1	3.6	1.6	1.3	0.7	2.8	7.2	3.1	5.0	1.0	9.5	1.2	6.2	5.9	4.1	2.0	0.6	1.6	0.2	1.0	8.8	4.1	0.9	7.0	0.6	2.3	5.5	12.1	2.7	13.5	6.1	3.3	4.2	0.4	1.6	0.7	10.5	5.8	5.0	3.3	6.4	1.6	7.1	8.5	6.5	6.3	6.1	4.4	4.0	4.2	6.0	7.7	2.2	4.2	6.0	12.8	4.3	5.2	1.2	4.7	5.4	1.5	2.0	6.6	2.0	1.1	2.9	2.5	3.6	3.6	0.7	2.1	1.4	4.9	3.2	2.7	11.8	7.7	4.0	5.0	4.7	0.0	23.8	9.2	3.8	2.7	8.6	4.8	12.9	54.2	8.1	11.2	3.6	9.8	3.2	0.4	8.7	9.2	8.6	1.8	5.3	18.8	4.7	23.8	24.3	2.6	11.7	3.8	6.4	17.5	3.0	9.2	26.9	26.0	5.2	0.0	6.9	10.7	1.3	13.4	8.4	23.2	12.2	16.0	9.4	42.2	7.1	2.7	2.3	10.9	23.0	11.1	10.0	2.4	12.8	4.3	59.6	6.6	8.7	5.5	1.4	3.6	6.0	3.8	16.8	13.6	9.3	2.3	8.8
ARV1		ENSG00000173409	"ARV1 homolog, fatty acid homeostasis modulator"	Q9H2C2	1	230978981-231000733	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 116.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035709	Approved		Uncertain	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA035709: AB_2674744"	"unprognostic (2.32e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.95e-2)"	"unprognostic (5.66e-2)"	"prognostic favorable (3.27e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.12e-2)"	"unprognostic (9.57e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.82e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-3)"	10.6	18.4	23.4	10.2	24.5	13.9	19.0	26.2	32.8	12.2	25.7	24.6	16.4	9.7	22.9	15.7	14.3	16.4	30.1	24.5	25.6	25.2	26.2	15.0	14.8	25.2	24.1	11.2	17.5	33.3	20.1	11.7	25.0	16.2	25.9	29.0	22.0	15.2	21.7	17.8	17.3	13.1	25.7	13.5	17.1	31.3	25.2	15.0	21.9	24.8	15.3	15.2	11.2	27.7	40.8	43.6	20.8	25.1	29.6	26.4	20.1	19.0	34.0	33.5	38.3	16.3	31.4	11.4	22.7	21.3	20.5	32.3	40.6	25.5	39.2	30.4	55.7	36.8	28.9	22.1	30.5	53.6	27.9	28.0	25.8	18.1	20.9	21.9	22.5	34.7	53.7	30.7	22.2	14.3	22.3	16.4	27.1	43.0	27.1	25.2	32.1	33.1	47.1	33.0	21.2	32.6	22.6	26.6	57.9	5.3	46.6	46.6	13.9	13.4	8.7	23.6	45.9	47.4	44.6	28.9	36.8	45.9	36.7	9.1	8.1	8.5	10.0	12.2	13.9	18.1	11.2	12.4	10.1	11.2	13.7	13.0	2.0	12.7	21.2	14.9	15.4	9.0	23.4	24.5	26.2	32.8	24.5	25.6	25.2	24.1	25.0	25.7	25.2	27.7	13.6	16.0	31.7	10.7	12.6	12.9	22.0	75.8	11.4	18.9	14.8	15.6	32.2	21.5	38.9	29.5	2.1	37.9	12.7	15.8	60.7	24.1	52.6	12.7	10.9	12.7	7.7	58.1	20.2	40.8	14.5	14.5	11.7	9.7	17.1	14.4	15.0	17.3	24.9	38.7	25.6	18.5	34.6	13.3	5.5	22.9	9.3	13.5	24.9	8.4	9.8	33.6	7.2	8.5	19.3	21.5	11.5	16.6	14.7	11.6	17.9	32.5	27.3	20.0	0.0	11.4	15.6	116.7	21.0	20.3	15.2	15.6	11.4	22.0	26.4	20.9
ASAH1	"AC, ACDase, ASAH, FLJ21558, PHP32"	ENSG00000104763	"N-acylsphingosine amidohydrolase 1"	Q13510	8	18055992-18084998	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 573.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 777.0;Hofbauer cells: 921.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 392.8;SK-MEL-30: 590.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005468	Supported				"Intracellular and membrane"	NA	NA		400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"			"HPA005468: AB_1845062"	"unprognostic (1.99e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.15e-3)"	"unprognostic (9.23e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.29e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.03e-2)"	"prognostic favorable (3.08e-8)"	"unprognostic (1.95e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.54e-3)"	"unprognostic (7.36e-3)"	214.3	71.9	50.1	51.6	51.5	107.7	95.8	62.1	50.8	98.5	62.6	84.3	54.7	55.8	131.5	73.2	70.4	99.1	573.9	49.9	66.2	204.0	60.9	190.3	65.9	66.0	59.4	50.1	49.6	117.8	83.6	121.5	69.0	84.3	87.0	79.5	66.6	77.9	66.0	52.6	56.8	61.7	66.3	85.4	61.2	18.2	59.1	26.0	325.5	70.7	57.7	112.8	54.8	102.2	48.1	66.4	25.9	63.3	392.8	46.0	39.2	48.2	67.3	23.0	41.0	35.4	66.1	30.2	60.3	54.5	159.1	62.6	15.0	25.3	28.4	22.9	38.9	134.4	46.7	96.7	107.5	27.7	140.7	100.2	86.5	33.6	22.9	53.2	6.2	50.6	24.3	61.7	67.9	46.0	15.5	48.3	30.3	105.2	40.5	19.4	25.5	41.4	112.0	273.0	40.4	55.0	43.8	145.2	590.5	35.6	47.9	31.3	43.6	30.3	43.1	55.8	23.7	75.5	184.3	22.0	89.5	61.3	24.6	285.2	455.4	318.7	47.6	676.4	43.1	83.9	35.5	36.1	175.1	65.9	40.8	37.9	627.6	60.5	731.4	33.0	43.7	407.2	50.1	51.5	62.1	50.8	49.9	66.2	66.0	59.4	69.0	66.3	59.1	102.2	98.5	317.3	405.0	36.9	92.8	58.6	83.3	103.7	35.3	97.5	105.6	87.8	777.0	100.1	280.9	450.6	45.9	177.4	67.6	83.4	60.7	150.6	2.8	85.7	51.5	79.7	98.1	106.3	49.8	104.1	65.2	122.0	43.3	133.8	257.0	49.3	134.6	50.6	921.2	77.4	53.2	99.3	201.4	564.3	89.9	6.0	88.6	524.6	318.4	56.2	259.2	532.6	53.5	49.8	49.0	64.7	125.5	105.7	87.4	87.8	77.6	304.2	147.3	88.0	177.5	74.5	157.0	14.0	63.6	84.9	64.2	148.2	61.3	53.4	89.7	139.9
ASH1L	"ASH1, ASH1L1, huASH1, KMT2H"	ENSG00000116539	"ASH1 like histone lysine methyltransferase"	Q9NR48	1	155335268-155563162	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004806	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus"		"HPA004806: AB_1845087"	"unprognostic (2.98e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.84e-2)"	"prognostic favorable (3.80e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.94e-1)"	14.1	12.8	21.3	8.5	23.4	11.9	16.8	27.0	25.7	14.4	14.8	13.0	9.7	14.4	20.8	9.2	11.4	9.0	12.6	23.8	19.2	13.9	10.0	10.3	10.9	18.7	19.8	21.3	9.9	18.2	8.4	10.3	18.9	15.7	11.5	26.2	14.8	15.4	30.3	20.4	10.2	12.7	19.3	10.5	11.9	6.8	20.7	12.1	15.8	24.3	9.7	11.7	10.0	23.4	17.2	12.3	9.5	9.4	28.0	22.8	9.6	14.7	13.5	8.3	6.5	10.5	12.3	5.4	14.2	17.0	5.4	19.2	13.6	12.6	13.6	7.6	8.9	8.0	13.2	9.8	14.5	8.8	6.6	16.2	18.0	13.6	15.0	17.1	11.0	6.0	12.3	8.3	18.8	19.0	6.4	8.8	8.3	28.8	13.1	6.1	18.5	10.4	18.6	16.0	9.1	14.3	20.1	25.9	12.9	9.3	16.6	26.6	17.4	13.6	15.8	13.4	17.9	8.0	5.3	8.9	10.7	9.1	13.1	1.0	0.4	0.8	0.7	0.2	0.5	0.9	0.5	0.5	0.2	0.8	0.8	0.5	1.0	0.6	0.1	0.7	0.9	0.2	21.3	23.4	27.0	25.7	23.8	19.2	18.7	19.8	18.9	19.3	20.7	23.4	96.5	60.9	103.2	171.7	108.3	103.9	97.4	52.9	109.3	147.6	75.9	58.3	107.8	50.1	82.7	51.5	202.3	53.6	83.3	76.2	17.6	41.5	25.9	72.0	107.4	77.6	67.5	46.7	220.6	39.8	25.2	93.7	101.4	87.9	81.1	72.3	63.1	39.0	24.6	114.4	211.8	59.0	26.4	42.1	106.9	22.8	102.2	69.1	53.4	203.3	85.2	68.4	89.6	190.5	265.0	37.5	64.8	118.8	110.1	112.0	68.9	31.0	47.1	116.7	98.6	134.4	104.6	85.6	56.1	80.9	112.0	76.2	98.7	87.3	60.2	111.6
ASL	ASAL	ENSG00000126522	"Argininosuccinate lyase"	P04424	7	66075800-66094697	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 396.4"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 294.6;Exocrine glandular cells: 218.6;Hepatocytes: 578.0;Paneth cells: 240.4;Proximal enterocytes: 259.9;Proximal tubular cells: 243.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 52.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB003696, HPA016646"	Enhanced		Approved	Cytosol		NA	NA		12000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB003696: AB_425316, HPA016646: AB_1845096"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.05e-6)"	"unprognostic (4.83e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.40e-3)"	21.7	16.1	5.9	16.7	6.0	23.9	22.0	6.6	8.5	18.2	8.7	53.8	60.7	17.0	6.7	28.7	18.1	27.7	16.9	5.9	8.0	61.2	396.4	27.4	10.3	7.4	7.1	19.7	37.1	15.1	19.8	9.1	9.8	19.5	35.7	2.4	18.3	9.8	8.7	15.1	45.6	10.1	6.2	30.5	43.9	4.5	7.6	5.3	24.9	6.9	8.8	19.3	19.8	6.7	48.4	18.9	11.2	36.7	26.3	18.1	22.1	34.0	31.8	49.5	43.6	43.7	59.0	15.9	53.7	48.5	36.6	13.4	7.1	59.1	11.1	10.5	8.9	18.8	17.9	77.2	48.8	24.0	51.3	38.3	19.5	31.8	51.8	12.5	48.1	11.3	34.4	27.8	25.4	36.6	4.8	28.9	15.8	65.5	26.1	12.1	11.0	51.6	31.9	31.6	18.4	24.3	32.3	109.7	12.3	11.4	46.0	19.7	55.1	53.7	30.8	23.5	45.2	30.2	16.9	19.0	55.0	41.5	49.5	34.2	42.6	50.8	16.9	46.6	15.1	21.8	11.5	13.4	46.2	13.8	8.2	8.5	7.3	73.7	36.1	2.5	23.4	27.3	5.9	6.0	6.6	8.5	5.9	8.0	7.4	7.1	9.8	6.2	7.6	6.7	34.5	19.2	61.4	5.2	20.4	5.5	21.4	24.2	9.1	12.7	24.5	20.4	9.2	124.4	25.8	31.3	22.9	20.7	25.4	294.6	52.8	73.7	4.0	41.2	12.1	30.7	54.0	47.1	9.4	218.6	45.7	14.4	115.7	34.1	44.5	12.0	42.8	578.0	46.0	15.2	9.7	126.5	16.2	41.2	17.6	6.3	9.3	22.3	8.8	1.9	48.3	7.2	34.0	2.5	4.8	118.3	240.4	8.2	23.4	14.9	259.9	243.1	42.8	13.2	13.1	16.9	17.5	3.2	5.7	19.5	4.3	22.3	18.0	13.5	189.4	22.0
ASNS		ENSG00000070669	"Asparagine synthetase (glutamine-hydrolyzing)"	P08243	7	97851677-97872542	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Asparagine biosynthesis"	Ligase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 121.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 233.9;Late spermatids: 217.0;Smooth muscle cells: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 8.9;T-cells: 14.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004924, HPA029318, HPA064737"	Approved		Enhanced	Cytosol		No	No		47000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA004924: AB_2667295, HPA029318: AB_10602389, HPA064737: AB_2685341"	"unprognostic (3.93e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (8.79e-5)"	"prognostic unfavorable (9.42e-6)"	"unprognostic (2.28e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (6.21e-7)"	"unprognostic (5.33e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.33e-1)"	17.3	18.0	49.9	19.5	52.3	13.7	17.8	52.7	66.3	19.9	28.2	24.5	9.7	19.0	31.5	27.0	20.1	11.2	19.4	55.3	51.0	28.9	9.3	25.6	28.8	58.7	43.5	20.8	121.4	26.3	44.1	4.6	59.4	21.5	19.9	35.3	41.6	14.5	8.0	22.9	22.6	18.0	43.6	30.3	46.0	33.3	49.7	13.3	27.5	8.6	25.7	21.7	18.6	63.8	124.6	46.6	51.6	415.9	35.3	57.9	109.1	85.7	62.5	41.6	134.8	64.2	49.3	101.7	45.3	189.8	92.3	57.4	118.2	151.2	102.2	122.4	85.3	31.0	24.6	50.8	347.8	207.1	89.9	106.2	508.8	55.8	361.2	23.5	41.4	94.4	177.1	365.2	76.3	286.5	6.4	54.4	68.1	308.4	125.4	14.0	10.0	282.7	28.4	22.3	218.1	156.7	23.2	136.7	499.0	60.6	57.1	139.1	7.6	21.6	138.5	56.7	40.7	412.6	239.7	401.1	288.7	90.3	220.8	1.9	0.3	0.4	3.6	1.1	4.3	8.9	7.2	3.4	1.5	6.0	10.1	5.5	1.8	2.0	1.0	0.2	14.2	3.3	49.9	52.3	52.7	66.3	55.3	51.0	58.7	43.5	59.4	43.6	49.7	63.8	5.8	9.6	7.2	11.1	14.4	12.4	26.1	20.9	6.2	20.3	9.7	11.2	7.6	7.2	12.3	9.2	25.0	3.1	6.7	10.5	7.9	30.9	233.9	2.9	8.6	6.7	24.4	46.1	51.8	61.6	7.8	8.9	14.3	4.5	8.2	8.8	2.9	1.3	1.1	25.2	48.6	19.6	32.6	1.3	3.2	217.0	9.6	2.1	8.8	5.6	7.3	9.2	5.2	16.1	16.9	36.6	14.7	9.4	19.9	26.1	1.1	3.9	4.5	24.9	6.6	10.2	112.3	3.4	20.2	5.5	10.9	5.6	11.2	6.0	9.9	14.9
ASPA	"ACY2, ASP"	ENSG00000108381	Aspartoacylase	P45381	17	3472374-3503405	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.0;kidney: 38.2"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 49.7;Melanocytes: 46.2;Oligodendrocytes: 217.0;Peritubular cells: 48.2;Proximal enterocytes: 37.5;Proximal tubular cells: 74.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 7.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.4;ASC TERT1: 4.1;CACO-2: 3.8;HSkMC: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022142, HPA022145"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA022142: AB_1845102, HPA022145: AB_1845103"	"unprognostic (4.42e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.57e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.43e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.07e-4)"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.49e-1)"	13.9	4.3	25.9	1.8	46.4	1.8	4.1	27.6	40.9	7.5	14.2	4.3	11.2	4.5	6.0	4.9	5.5	3.6	2.7	25.8	27.7	38.2	15.0	3.5	1.5	30.4	35.4	2.9	1.0	0.8	0.8	3.5	29.5	4.1	4.9	2.8	1.8	5.0	11.9	5.2	15.6	3.1	24.7	5.4	4.4	6.6	42.4	0.6	2.1	15.0	0.7	6.3	4.3	69.0	0.2	0.1	0.5	0.5	5.4	4.1	0.3	0.2	0.1	0.2	0.1	3.8	0.2	0.6	0.2	0.7	0.3	0.3	0.3	0.1	0.2	2.0	0.1	0.4	0.7	0.2	0.5	0.4	0.4	7.5	0.3	0.4	0.1	0.1	0.1	0.4	0.3	1.1	0.2	0.2	0.2	0.6	0.4	0.2	0.3	0.3	0.3	0.6	0.2	1.1	0.4	0.3	1.1	0.3	0.9	0.4	0.3	0.2	0.4	0.6	0.4	0.4	0.3	0.7	0.4	0.4	0.2	0.4	0.5	1.1	0.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.7	0.3	0.1	0.2	0.1	0.0	25.9	46.4	27.6	40.9	25.8	27.7	30.4	35.4	29.5	24.7	42.4	69.0	5.1	9.6	1.5	12.1	0.1	5.2	1.5	1.6	6.2	5.5	2.1	0.8	1.3	2.8	1.0	25.8	0.0	0.0	0.0	0.3	7.9	0.2	5.0	0.1	4.1	1.1	2.4	2.7	0.6	0.2	0.1	15.0	2.0	0.2	0.0	0.1	3.9	11.5	0.2	8.4	0.4	0.8	2.0	0.8	1.5	2.5	49.7	0.8	46.2	3.7	0.0	4.1	0.0	1.5	217.0	0.0	2.5	48.2	0.2	0.4	37.5	74.8	0.1	0.5	0.0	8.5	11.6	11.1	0.6	0.7	1.7	0.1	0.4	28.3	1.8	2.7
ASPH	"BAH, CASQ2BP1, HAAH, JCTN"	ENSG00000198363	"Aspartate beta-hydroxylase"	Q12797	8	61500556-61714640	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 386.9"	"Cell type enhanced"	"Detected in all"		"Muller glia cells: 468.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 34.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 890.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055161, HPA059303"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA		1100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	"Endoplasmic reticulum"		"HPA055161: AB_2682721, HPA059303: AB_2683973"	"unprognostic (8.07e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (6.39e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (8.96e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (2.74e-2)"	386.9	160.3	64.7	50.6	69.2	16.9	106.9	102.3	88.9	65.6	84.4	78.8	45.6	49.3	44.7	71.4	46.9	61.0	111.3	64.5	58.4	59.5	74.9	74.1	20.3	54.0	69.2	62.2	44.7	38.7	36.3	47.9	52.2	48.3	84.9	219.5	101.9	70.2	357.6	35.2	45.5	67.5	44.8	28.6	105.0	16.5	71.8	16.7	97.0	182.7	28.5	112.2	43.8	60.4	460.3	652.3	89.9	55.1	392.1	370.1	31.2	804.0	741.3	336.3	350.1	113.1	594.2	35.3	54.3	474.6	270.3	167.5	56.2	281.1	570.0	13.6	57.0	81.1	372.5	310.3	251.2	12.5	12.9	306.5	61.9	187.6	237.4	657.2	144.8	18.0	22.2	32.1	300.2	97.4	3.3	16.6	51.7	441.6	383.4	22.3	97.0	7.3	206.2	374.0	93.1	32.1	249.9	116.1	101.7	49.0	47.7	22.2	456.7	338.0	174.3	313.0	288.0	20.2	27.1	1.5	890.1	7.5	231.4	1.9	8.3	0.3	2.5	2.9	4.7	5.5	3.5	2.4	10.0	5.0	4.9	2.5	25.4	8.7	1.8	34.0	4.0	4.1	64.7	69.2	102.3	88.9	64.5	58.4	54.0	69.2	52.2	44.8	71.8	60.4	79.1	195.5	244.0	366.6	13.8	47.0	160.7	126.0	68.9	138.3	83.7	58.4	228.6	37.1	157.5	86.5	294.0	118.1	40.3	57.0	15.6	144.2	1.6	51.4	65.8	85.9	116.5	13.0	93.1	180.4	107.1	132.0	73.9	115.4	8.2	34.5	42.8	62.6	72.2	127.9	98.9	215.1	52.9	26.6	44.1	3.1	70.8	48.1	42.7	61.8	20.0	468.8	2.1	154.8	53.5	257.7	32.3	57.6	15.9	148.2	34.3	34.6	66.6	158.8	46.0	114.4	92.7	3.4	16.8	101.7	50.3	48.0	13.6	131.2	67.3	254.2
ASS1	"ASS, CTLN1"	ENSG00000130707	"Argininosuccinate synthase 1"	P00966	9	130444961-130501274	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 1284.8;liver: 2037.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 398.7;Hepatocytes: 1062.0;Proximal enterocytes: 618.2;Proximal tubular cells: 1408.9;Urothelial cells: 413.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	15	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 893.9;HaCaT: 850.4;hTCEpi: 817.8;RPMI-8226: 1444.5;THP-1: 1061.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020896, HPA020934"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		6400000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA020896: AB_1845117, HPA020934: AB_1845118"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (8.14e-9)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.72e-3)"	215.0	146.8	29.6	51.3	29.7	0.2	168.2	25.0	31.0	67.0	61.7	157.2	124.5	111.3	124.8	51.1	166.3	110.2	66.5	31.5	38.3	1284.8	2037.7	52.9	7.5	40.2	42.2	57.2	68.4	11.4	45.0	50.6	51.7	56.2	167.9	6.9	119.4	132.6	74.4	131.3	194.8	61.2	28.4	20.0	53.2	35.9	38.4	7.8	92.3	71.4	15.6	288.7	66.6	25.3	124.5	11.9	13.7	23.1	88.4	223.1	43.6	146.2	893.9	28.2	85.5	52.5	34.0	0.4	95.9	300.2	8.2	850.4	59.9	5.2	19.5	21.7	27.1	0.3	18.3	137.3	305.4	18.3	1.6	148.2	817.8	45.4	81.2	0.3	1.1	384.0	5.3	530.6	28.8	619.8	7.2	262.7	19.2	635.9	26.7	1.7	15.4	1444.5	78.8	61.3	342.4	5.8	515.4	534.7	41.5	53.5	366.1	1061.5	0.4	11.3	68.3	2.3	13.0	88.1	91.5	32.1	219.0	137.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	29.6	29.7	25.0	31.0	31.5	38.3	40.2	42.2	51.7	28.4	38.4	25.3	72.1	25.6	28.6	2.6	21.3	70.5	55.7	179.8	53.5	0.1	23.7	17.3	5.4	138.7	104.4	47.8	0.0	178.5	0.4	398.7	133.1	116.5	1.2	4.7	30.5	68.0	12.0	93.7	2.2	110.5	8.9	21.5	20.4	6.2	5.7	55.5	65.7	1062.0	14.7	0.0	8.0	186.8	24.4	40.1	6.5	7.8	31.1	8.0	3.6	7.5	1.6	10.6	0.0	0.0	0.2	70.8	310.4	124.8	11.7	104.0	618.2	1408.9	32.7	0.4	0.0	18.7	13.4	1.4	2.6	23.5	17.5	144.1	11.5	62.0	165.6	413.2
ATG16L1	"APG16L, ATG16A, ATG16L, FLJ10035, WDR30"	ENSG00000085978	"Autophagy related 16 like 1"	Q676U5	2	233210051-233295674	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012577, HPA063900"	Supported		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA012577: AB_1845155, HPA063900: AB_2685146"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.49e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.93e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.08e-1)"	7.6	7.8	7.0	3.8	7.5	14.3	8.8	7.9	8.4	8.1	12.8	11.1	5.0	9.6	5.5	11.6	7.1	3.3	10.7	7.3	6.6	9.2	15.1	7.6	5.8	6.5	6.3	8.5	8.6	5.3	5.5	4.0	6.9	12.1	5.2	5.6	11.5	4.3	19.9	17.2	11.1	5.2	6.3	11.5	11.1	13.5	6.5	5.9	11.2	6.1	5.2	11.5	8.2	7.7	13.3	12.2	4.9	8.5	12.4	8.0	14.0	11.4	9.3	9.6	8.9	8.9	9.7	3.1	3.7	8.9	14.3	7.7	9.8	6.4	9.8	6.2	7.7	7.1	9.1	14.6	9.1	5.6	9.0	5.3	9.1	11.5	8.7	7.2	9.0	4.7	7.6	2.9	10.2	9.3	6.7	11.2	19.1	14.1	17.6	4.8	10.3	2.6	9.9	8.4	8.8	6.5	7.8	8.5	8.5	7.4	5.3	7.1	10.7	6.2	5.4	9.6	10.3	6.5	3.9	6.1	10.5	5.7	10.2	0.0	1.7	2.9	4.8	1.4	3.7	2.0	3.1	4.4	1.4	2.2	3.5	3.5	1.2	4.1	4.7	0.7	3.8	2.1	7.0	7.5	7.9	8.4	7.3	6.6	6.5	6.3	6.9	6.3	6.5	7.7	6.1	6.4	8.2	5.2	7.4	9.1	4.6	5.2	3.4	8.4	12.0	6.6	5.6	7.2	11.6	5.5	4.2	4.6	20.9	13.9	5.9	8.3	1.2	16.4	10.9	6.4	9.0	3.8	31.0	6.7	6.2	5.2	8.2	31.8	9.5	6.4	6.1	10.2	5.6	1.7	25.6	5.1	6.1	6.3	5.7	1.7	4.1	5.1	10.6	8.4	6.6	7.1	4.1	11.6	21.4	16.8	8.0	3.8	8.1	7.1	9.2	5.6	11.5	19.5	6.6	5.8	6.9	11.0	17.6	7.3	13.2	3.7	19.2	5.1	8.4	6.0
ATG5	"APG5, APG5L, ASP, hAPG5"	ENSG00000057663	"Autophagy related 5"	Q9H1Y0	6	106045423-106325791	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Host-virus interaction, Immunity"		"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034432, CAB037309, HPA042973"	Approved		Approved	Centrosome	"Intracellular and membrane"	NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome		"CAB034432: AB_2243288, CAB037309: AB_796188, HPA042973: AB_2678246"	"unprognostic (1.21e-3)"	"unprognostic (6.53e-3)"	"unprognostic (2.68e-3)"	"unprognostic (4.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.35e-3)"	"prognostic unfavorable (8.84e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.60e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.42e-2)"	12.5	19.2	9.9	6.7	10.2	8.1	15.4	10.5	13.2	15.3	10.7	15.8	12.8	14.9	16.6	12.3	14.7	9.5	9.7	10.3	10.7	14.4	17.7	10.8	8.5	10.0	10.3	14.3	12.1	11.8	7.9	13.2	9.9	15.3	15.2	10.5	11.8	13.1	15.7	8.0	13.1	14.2	9.5	10.6	12.0	8.3	10.2	9.4	17.5	15.2	9.8	13.4	11.9	10.5	14.6	6.0	10.3	14.0	23.2	24.0	10.7	15.4	24.6	22.2	27.2	6.2	8.6	10.2	12.0	23.7	25.0	10.2	15.2	22.2	39.2	4.6	7.3	11.8	6.8	7.8	25.0	14.6	6.0	19.3	24.8	16.1	20.0	29.7	23.9	9.4	17.6	10.0	25.7	6.4	6.0	17.5	11.9	19.4	8.3	6.0	23.7	7.9	24.0	10.3	7.1	6.9	9.4	17.8	14.6	18.6	8.5	27.5	19.8	8.6	4.8	10.1	26.7	4.1	4.2	9.3	31.7	19.6	16.1	4.7	4.8	9.6	2.9	6.1	8.4	5.1	5.6	4.6	5.3	3.3	6.0	5.0	4.1	4.8	8.8	1.9	6.9	3.3	9.9	10.2	10.5	13.2	10.3	10.7	10.0	10.3	9.9	9.5	10.2	10.5	35.8	22.4	18.9	24.2	41.3	26.3	28.5	45.2	25.6	14.8	25.5	26.5	18.1	25.8	36.7	25.8	16.7	47.3	46.5	48.3	29.4	39.6	35.7	33.0	27.4	25.9	19.2	27.0	79.2	44.9	63.8	25.8	42.3	34.5	20.3	20.4	21.8	20.7	38.1	20.2	71.5	38.4	36.7	26.9	32.3	13.7	20.5	33.6	23.2	43.1	44.6	18.3	44.3	43.7	49.1	40.5	59.8	18.0	85.9	40.8	49.2	43.2	30.0	17.9	26.3	23.6	32.1	36.5	39.6	28.5	27.1	66.5	47.3	21.9	36.6	43.0
ATL1	"AD-FSP, FSP1, SPG3, SPG3A"	ENSG00000198513	"Atlastin GTPase 1"	Q8WXF7	14	50532509-50634017	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 138.6;Inhibitory neurons: 95.5;Oligodendrocyte precursor cells: 81.4;Oligodendrocytes: 136.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 22.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 22.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 19.8;SCLC-21H: 17.1;SH-SY5Y: 15.4;SiHa: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027550	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA027550: AB_10600983"	"unprognostic (2.06e-2)"	"unprognostic (7.57e-3)"	"unprognostic (1.82e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.88e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.23e-2)"	4.1	5.6	29.1	3.3	33.2	0.2	11.3	18.8	42.8	5.7	2.2	8.1	3.9	9.0	2.9	5.3	6.5	4.8	2.1	37.1	30.3	4.0	0.3	4.3	1.7	25.2	21.5	10.5	3.7	1.9	7.7	0.5	29.6	8.3	5.6	9.5	13.2	8.6	1.1	9.6	4.9	15.6	24.9	1.1	4.6	8.7	25.0	1.1	2.5	2.2	1.8	6.7	5.3	30.0	1.2	1.1	4.8	4.6	0.3	0.0	3.4	5.7	9.6	6.2	7.4	0.0	4.1	3.7	2.5	0.1	4.5	1.4	8.4	1.1	2.4	19.8	1.8	1.2	0.8	0.3	0.2	0.2	3.1	3.6	1.9	8.6	1.6	0.3	0.4	4.2	0.1	0.5	8.7	0.4	1.2	0.6	4.4	1.4	1.5	0.6	12.1	0.4	1.7	2.5	17.1	15.4	18.9	1.1	0.6	0.0	0.0	2.1	1.3	6.0	4.6	0.0	2.9	0.9	4.7	1.7	3.9	0.2	0.2	22.9	0.1	4.9	2.5	0.0	0.5	3.8	0.9	2.1	1.2	1.1	2.1	4.2	0.3	0.6	0.5	2.8	0.4	2.0	29.1	33.2	18.8	42.8	37.1	30.3	25.2	21.5	29.6	24.9	25.0	30.0	3.0	6.4	2.6	31.6	3.7	5.1	6.2	10.3	6.2	27.8	18.1	16.3	1.9	5.7	6.6	5.5	0.0	0.4	6.7	9.3	0.0	10.6	31.4	4.2	5.4	4.8	7.2	0.4	138.6	13.1	1.1	14.6	5.6	2.3	6.3	1.2	5.0	0.0	1.6	11.8	95.5	1.9	2.0	0.0	3.6	5.7	13.4	5.5	8.8	20.6	1.3	23.0	2.1	81.4	136.7	7.2	6.0	17.0	5.2	3.9	13.2	3.4	14.2	8.6	19.7	4.5	10.8	31.9	5.7	4.1	5.5	0.1	3.8	0.2	3.6	3.3
ATL3	DKFZP564J0863	ENSG00000184743	"Atlastin GTPase 3"	Q6DD88	11	63624087-63671921	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 264.4;Late spermatids: 728.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065702, HPA076616"			Enhanced	"Endoplasmic reticulum"		NA	NA		58000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	"Endoplasmic reticulum"		"HPA065702: AB_2685536, HPA076616: AB_2732318"	"unprognostic (4.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.09e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (4.52e-2)"	"unprognostic (1.11e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.67e-3)"	30.6	18.1	11.6	17.9	16.6	13.2	22.1	14.9	12.6	23.0	22.0	26.0	9.9	24.3	16.5	24.5	20.1	15.9	11.5	9.8	13.9	12.6	17.7	18.8	12.6	19.8	16.4	16.9	15.4	13.3	6.6	14.9	18.9	16.7	16.6	4.0	15.4	20.4	6.3	25.2	13.7	33.2	16.8	16.9	17.4	36.9	15.5	10.8	20.9	9.6	15.4	27.1	19.4	20.6	44.2	39.4	11.7	28.4	59.2	82.5	0.2	53.2	60.0	51.9	35.0	32.9	69.7	26.3	53.8	93.6	40.0	28.3	21.8	34.8	69.8	40.4	5.8	27.9	41.8	0.2	40.7	53.2	39.2	54.0	55.6	69.1	42.8	34.7	56.3	28.5	30.6	70.2	59.6	46.6	19.2	30.7	14.9	14.1	33.7	40.7	29.3	37.8	41.2	29.7	6.3	17.0	174.3	37.6	50.5	14.5	65.7	19.1	79.1	109.0	51.9	105.3	38.3	19.0	29.6	51.4	57.7	33.6	67.1	7.1	8.3	3.7	8.9	11.4	9.8	5.3	7.4	7.3	8.6	4.2	5.9	8.2	3.5	6.9	13.4	4.3	9.3	7.8	11.6	16.6	14.9	12.6	9.8	13.9	19.8	16.4	18.9	16.8	15.5	20.6	56.7	44.8	27.2	16.6	18.8	43.7	45.7	36.4	30.1	4.8	31.9	18.4	8.5	30.0	29.9	33.1	0.0	6.7	28.5	45.2	1.9	41.2	264.4	23.8	46.4	48.2	10.7	29.5	13.5	50.2	20.1	46.2	19.4	63.8	17.1	20.3	49.6	51.3	37.6	5.0	12.1	21.0	28.5	55.3	43.0	728.4	54.3	35.7	42.7	16.9	49.5	12.6	24.7	16.6	35.6	72.7	24.7	67.4	21.0	55.3	27.7	24.7	21.5	8.5	72.3	35.9	55.2	36.0	29.0	32.9	40.6	4.0	28.2	25.6	19.8	50.9
ATM	"ATA, ATC, ATD, ATDC, TEL1, TELO1"	ENSG00000149311	"ATM serine/threonine kinase"	Q13315	11	108222832-108369102	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Neurodegeneration, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 210.6;NK-cells: 339.8;Oligodendrocytes: 217.6;Rod photoreceptor cells: 200.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 78.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000102, HPA067142"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Vesicles	"CAB000102: , HPA067142: AB_2685789"	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.68e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.10e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-1)"	6.2	7.4	8.2	17.5	15.0	16.2	8.5	17.0	12.3	8.7	16.1	6.7	5.2	10.0	9.9	4.0	7.5	8.2	7.0	7.3	11.3	5.8	7.8	7.6	33.7	15.8	13.1	15.8	14.8	9.3	12.1	8.0	17.0	6.3	7.0	20.6	11.4	6.1	4.4	7.5	12.6	6.9	10.3	22.2	8.6	5.2	12.7	18.2	8.8	6.0	25.9	7.1	6.9	28.8	4.3	6.8	14.8	7.6	20.2	29.1	3.1	10.9	13.5	6.4	11.3	7.1	10.3	18.3	14.0	10.2	9.6	7.7	11.6	10.8	9.0	12.3	5.7	15.2	8.7	10.2	10.5	16.4	17.0	18.3	6.3	10.0	21.2	15.2	14.1	16.5	12.4	9.9	14.3	3.4	10.6	18.5	9.8	8.6	7.4	9.7	9.7	24.9	8.1	7.5	9.0	10.5	11.1	4.7	20.6	13.2	9.3	10.1	23.7	15.8	8.4	7.3	9.0	6.2	7.0	78.3	7.0	19.0	18.8	21.3	5.5	4.0	16.5	5.7	11.1	11.6	11.7	12.5	2.6	13.0	21.1	20.4	9.9	9.7	13.3	6.2	6.1	5.3	8.2	15.0	17.0	12.3	7.3	11.3	15.8	13.1	17.0	10.3	12.7	28.8	23.7	38.5	20.8	62.7	146.4	12.6	17.5	21.1	28.5	111.0	19.6	14.2	39.9	12.8	19.5	22.0	210.6	16.9	140.2	4.2	5.9	9.9	19.2	14.4	52.1	25.9	20.4	39.1	70.2	12.3	13.2	39.0	12.8	20.9	13.3	45.9	32.9	23.3	29.1	60.6	82.8	14.9	26.4	96.4	34.0	5.1	39.4	69.2	26.6	178.9	63.2	27.3	339.8	85.5	217.6	7.6	7.6	27.8	96.5	9.1	8.9	11.1	16.0	200.1	26.3	41.4	29.2	31.5	37.4	15.8	12.4	4.2	147.7	52.3	11.5	10.2
ATP11C	"ATPIG, ATPIQ"	ENSG00000101974	"ATPase phospholipid transporting 11C"	Q8NB49	X	139726346-139945276	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 49.8"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 67.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 15.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030830	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA030830: AB_10601336"	"unprognostic (8.94e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.42e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.65e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.18e-2)"	13.4	7.4	3.5	9.0	4.2	6.1	10.4	3.6	4.6	11.8	10.3	10.0	5.6	11.9	9.3	5.1	10.7	8.4	5.4	3.1	4.5	11.8	49.8	7.2	14.8	4.9	4.7	12.7	4.9	5.7	3.7	5.3	5.2	9.8	7.1	2.8	6.0	14.6	3.5	6.0	8.6	10.6	3.9	12.2	7.6	9.7	4.8	11.1	6.1	4.3	8.8	13.6	9.3	4.5	16.9	7.1	14.2	23.3	20.7	27.9	18.0	19.7	26.4	15.6	21.5	6.3	13.4	24.0	43.3	28.2	10.3	13.7	34.6	9.0	24.4	22.1	20.2	12.1	15.2	12.3	23.0	21.4	7.4	18.6	5.9	16.9	14.4	17.3	27.3	18.3	14.0	17.9	20.8	9.1	19.7	14.5	24.1	0.1	13.3	19.5	15.3	20.1	13.1	27.6	11.0	18.3	7.8	0.8	10.6	13.3	5.8	11.7	31.0	21.2	6.9	25.9	27.1	5.1	5.4	18.7	9.7	26.3	10.8	2.4	0.4	0.1	0.4	0.3	0.8	0.9	0.4	0.3	0.4	0.9	0.4	0.7	0.9	1.2	0.6	0.7	0.3	0.2	3.5	4.2	3.6	4.6	3.1	4.5	4.9	4.7	5.2	3.9	4.8	4.5	27.4	16.0	8.4	22.5	14.6	14.5	16.7	6.5	5.7	1.9	8.0	8.9	4.4	2.8	9.2	11.0	0.0	2.3	11.6	7.0	1.9	4.8	13.6	11.5	22.7	32.4	9.1	15.3	1.3	10.1	12.6	17.2	10.7	13.7	9.5	23.6	34.6	46.6	9.4	0.0	26.1	6.4	8.2	37.2	14.4	11.9	14.3	15.3	10.6	45.9	33.9	3.1	7.2	29.1	27.8	7.8	7.2	15.4	13.2	15.8	4.7	7.7	6.8	3.1	0.0	19.3	19.2	67.9	53.1	5.9	13.5	6.7	12.7	11.5	5.2	14.6
ATP13A2	"CLN12, HSA9947, PARK9"	ENSG00000159363	"ATPase cation transporting 13A2"	Q9NQ11	1	16985958-17011928	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuronal ceroid lipofuscinosis, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 112.4"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"plasmacytoid DC: 20.6"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 20.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037038, CAB037111, HPA050910, HPA054717"	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB037038: AB_1840715, CAB037111: AB_1840714, HPA050910: AB_2681269, HPA054717: AB_2682583"	"unprognostic (3.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.33e-7)"	"unprognostic (1.04e-1)"	"unprognostic (9.71e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.84e-3)"	15.3	18.6	49.7	20.2	45.8	11.6	14.3	30.3	81.2	10.6	3.3	15.9	12.7	12.1	6.6	23.6	9.5	9.3	11.6	46.7	66.0	16.6	6.2	17.9	17.7	112.4	60.8	8.7	55.7	12.9	57.0	12.6	110.8	14.3	9.8	22.8	27.4	7.9	17.2	16.5	16.7	8.6	32.0	26.0	19.3	10.3	64.1	9.5	16.7	5.3	10.3	12.9	12.1	44.3	28.3	27.4	14.7	60.8	13.8	12.2	40.8	15.8	15.4	17.1	16.6	48.9	31.4	12.5	65.9	26.9	14.6	43.1	32.1	59.5	6.2	17.2	58.5	43.7	28.0	27.2	17.5	15.6	19.6	10.0	31.6	47.1	36.6	55.0	32.3	32.2	28.2	22.6	70.2	22.2	18.4	8.8	23.2	66.3	20.0	20.0	60.1	50.7	19.0	42.8	40.9	27.4	73.8	87.7	60.2	18.8	29.9	19.6	34.4	18.0	34.5	30.8	33.1	4.8	6.1	14.0	34.6	85.2	30.3	0.0	1.6	0.3	2.6	3.7	2.9	1.3	2.1	2.2	0.4	3.1	1.0	1.5	0.5	2.7	3.6	20.6	1.8	1.4	49.7	45.8	30.3	81.2	46.7	66.0	112.4	60.8	110.8	32.0	64.1	44.3	18.9	0.0	2.2	14.4	8.3	6.5	6.9	5.7	6.2	35.9	16.9	11.3	3.6	7.2	6.8	7.3	35.5	5.8	33.4	44.6	5.9	15.1	1.4	6.7	3.8	14.4	7.7	4.2	53.1	25.1	33.6	6.0	18.8	19.0	8.9	20.5	6.1	3.7	10.4	47.1	61.8	15.0	0.0	17.3	2.8	1.7	5.3	10.1	5.4	11.2	6.1	34.0	8.2	20.1	18.1	57.0	49.0	6.4	5.4	12.3	18.2	5.3	4.3	38.4	0.0	4.6	5.7	13.6	16.4	11.6	5.3	9.3	11.1	4.8	21.7	12.8
ATP13A4	"DKFZp761I1011, FLJ37958"	ENSG00000127249	"ATPase 13A4"	Q4VNC1	3	193398967-193593111	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 64.5;parathyroid gland: 58.4;thyroid gland: 51.9"	"Group enriched"	"Detected in many"	4	"Astrocytes: 409.4;Oligodendrocyte precursor cells: 163.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 23.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051932			Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA051932: "	"unprognostic (4.97e-2)"	"unprognostic (1.50e-3)"	"unprognostic (4.86e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.72e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.29e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.00e-1)"	0.1	0.3	19.5	0.2	20.9	0.2	22.7	18.1	20.1	2.8	28.2	2.0	0.3	0.1	64.5	20.1	2.4	4.6	0.1	18.0	17.0	0.7	0.6	27.3	0.4	18.5	21.5	0.3	5.3	58.4	4.8	0.1	17.9	0.1	3.4	2.5	7.2	2.4	0.5	16.9	0.3	0.1	15.2	0.3	9.6	0.5	21.6	0.3	51.9	0.0	4.8	0.1	6.7	15.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.6	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	19.5	20.9	18.1	20.1	18.0	17.0	18.5	21.5	17.9	15.2	21.6	15.8	0.2	64.1	30.5	409.4	1.1	0.1	0.0	1.7	0.0	1.6	6.1	3.6	0.4	11.5	15.3	0.0	0.0	1.2	0.5	1.6	0.0	3.3	0.4	4.0	0.7	0.1	0.0	0.0	5.8	0.2	0.1	0.2	17.3	6.4	1.3	0.3	1.4	0.1	0.2	1.7	10.9	1.9	0.0	0.3	0.5	1.0	0.0	0.5	1.8	13.1	0.0	0.5	0.0	163.3	20.6	1.3	1.7	0.4	0.2	0.0	0.0	0.4	8.5	1.0	0.0	0.1	0.2	0.7	1.5	2.2	1.6	0.7	0.9	0.1	2.2	0.1
ATP1A2	"FHM2, MHP2"	ENSG00000018625	"ATPase Na+/K+ transporting subunit alpha 2"	P50993	1	160115759-160143591	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 515.9;skeletal muscle: 882.2;tongue: 478.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 515.8;Cardiomyocytes: 158.7;Microglial cells: 141.5;Muller glia cells: 73.0;Oligodendrocyte precursor cells: 94.0;Sertoli cells: 85.5"	"Cancer enriched"	"Detected in many"	18	"glioma: 91.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 51.9;HHSteC: 14.6;RH-30: 16.8;U-87 MG: 10.3"	"Low region specificity"	"Detected in all"							CAB022230	Enhanced					NA	NA		170000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB022230: "	"unprognostic (1.08e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.63e-4)"	"unprognostic (1.70e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.32e-3)"	37.4	4.1	401.5	1.5	480.5	0.0	27.4	419.8	412.8	9.3	164.9	55.8	3.6	5.6	12.5	33.5	14.5	8.0	144.6	337.4	398.5	3.9	1.2	6.4	0.3	429.5	478.8	18.9	1.4	0.3	32.3	3.3	375.3	28.5	8.1	58.5	18.2	28.5	882.2	4.7	15.9	7.8	365.0	1.8	15.7	5.8	515.9	0.6	3.5	478.0	0.5	29.9	9.8	327.7	0.0	0.0	51.9	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	4.6	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	401.5	480.5	419.8	412.8	337.4	398.5	429.5	478.8	375.3	365.0	515.9	327.7	1.4	0.0	0.0	515.8	0.1	0.5	1.6	0.0	0.6	1.3	2.5	0.9	158.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	1.2	11.1	0.0	0.0	5.5	0.0	0.0	4.8	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	1.3	1.4	28.9	0.5	0.0	141.5	0.5	73.0	0.0	94.0	2.5	0.0	0.0	39.5	0.0	0.8	0.0	0.1	0.1	3.9	85.5	54.9	45.8	0.3	0.2	0.2	0.6	0.1	0.1	5.8	0.0	0.6
ATP1A3	DYT12	ENSG00000105409	"ATPase Na+/K+ transporting subunit alpha 3"	P13637	19	41966582-41997497	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Deafness, Disease variant, Dystonia, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 645.2;heart muscle: 157.7;retina: 292.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 418.1;Cone photoreceptor cells: 171.0;Horizontal cells: 213.7;Inhibitory neurons: 119.1;Late spermatids: 115.6;Rod photoreceptor cells: 291.4"	"Cancer enriched"	"Detected in many"	5	"glioma: 21.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 57.7;JURKAT: 36.3;Karpas-707: 35.9;REH: 37.1;SCLC-21H: 128.2;SH-SY5Y: 57.7"									"CAB033630, HPA045367, HPA056446"	Enhanced	Approved				NA	NA		220000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"CAB033630: AB_781528, HPA045367: AB_2679297, HPA056446: AB_2683136"	"unprognostic (1.90e-1)"	"unprognostic (8.65e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.94e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.16e-2)"	"unprognostic (7.66e-2)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (3.44e-4)"	"prognostic favorable (6.15e-5)"	"unprognostic (4.02e-3)"	"prognostic unfavorable (3.02e-6)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.27e-1)"	0.2	18.0	115.4	1.4	126.3	0.6	0.1	76.0	645.2	0.0	0.0	3.6	0.9	0.0	0.0	0.3	0.0	0.2	157.7	165.8	275.3	0.1	0.1	0.2	0.9	390.1	61.8	0.1	0.8	1.2	15.4	0.0	320.4	0.2	0.8	292.4	0.8	0.0	0.2	0.3	1.5	0.8	26.3	0.5	1.3	31.5	174.9	2.1	0.2	1.8	0.6	0.1	0.7	200.7	0.0	2.1	0.7	23.1	0.0	0.1	0.1	0.3	0.0	1.6	1.6	0.8	4.3	57.7	2.6	0.4	5.6	0.5	16.2	0.2	0.6	10.7	3.1	5.0	0.2	0.4	0.0	0.0	18.2	0.0	0.2	0.0	0.3	0.3	0.0	36.3	0.0	35.9	0.4	0.8	10.4	0.1	3.0	8.4	14.3	37.1	18.5	1.8	0.0	0.6	128.2	57.7	0.3	4.2	0.1	0.0	3.4	2.6	0.0	3.0	3.2	0.0	1.1	3.7	2.6	12.7	5.5	20.6	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	115.4	126.3	76.0	645.2	165.8	275.3	390.1	61.8	320.4	26.3	174.9	200.7	0.2	0.0	4.4	9.1	1.1	0.3	0.4	0.0	0.6	418.1	0.3	0.3	19.3	0.0	0.0	0.0	171.0	0.0	3.2	0.8	0.0	0.0	43.7	0.1	0.1	1.4	0.0	0.0	59.1	0.0	0.1	1.0	1.1	0.1	1.3	0.1	0.0	0.0	0.2	213.7	119.1	0.4	0.0	0.0	0.4	115.6	1.8	0.7	0.0	8.4	0.4	40.0	6.2	14.6	11.4	0.0	0.0	0.4	1.0	0.2	0.0	0.1	0.0	291.4	0.0	0.7	0.4	21.2	2.8	0.2	0.3	0.3	3.6	0.4	0.5	0.4
ATP6AP1	"16A, Ac45, ATP6IP1, ATP6S1, CF2, ORF, VATPS1, XAP-3, XAP3"	ENSG00000071553	"ATPase H+ transporting accessory protein 1"	Q15904	X	154428633-154436516	"Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015218	Uncertain					NA	NA		700000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"			"CAB015218: "	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (1.84e-3)"	"unprognostic (4.99e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (7.83e-4)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.26e-8)"	"unprognostic (2.45e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.62e-1)"	56.3	93.5	108.3	43.1	109.2	59.1	56.7	99.6	118.0	59.6	123.6	61.5	48.4	54.2	145.1	85.2	60.0	46.0	92.7	116.2	115.4	104.3	51.4	96.8	46.9	114.0	96.8	63.3	86.6	176.0	110.4	77.9	121.6	85.1	57.0	74.0	87.4	54.8	53.8	83.6	57.4	49.0	104.6	94.7	70.4	47.5	104.2	40.9	81.9	54.4	42.5	63.7	60.9	121.6	110.1	101.6	88.2	146.2	145.7	77.4	162.2	78.5	116.6	122.5	176.1	93.4	135.1	64.7	337.8	177.1	216.5	112.3	133.8	71.9	76.6	58.6	135.1	37.5	113.7	100.0	170.6	60.9	260.2	98.1	126.7	112.4	68.2	139.5	177.0	47.8	45.6	176.4	84.7	158.1	43.6	96.8	32.1	171.0	100.8	66.6	59.1	170.7	139.9	87.3	84.6	89.7	72.6	289.7	159.3	87.3	123.1	157.8	135.5	87.4	79.0	151.1	135.6	256.3	311.8	77.0	104.4	132.8	90.2	246.6	295.1	363.9	147.3	313.8	148.6	91.7	118.4	127.8	376.7	113.6	107.1	117.8	326.9	140.3	255.6	215.9	155.2	216.9	108.3	109.2	99.6	118.0	116.2	115.4	114.0	96.8	121.6	104.6	104.2	121.6	39.4	38.5	57.5	17.0	32.3	30.2	42.7	122.4	25.6	105.8	58.5	42.2	37.7	54.3	102.1	97.5	47.9	145.1	40.1	84.3	19.6	65.4	3.1	52.5	33.7	50.1	89.0	35.8	17.0	52.5	104.5	48.8	36.7	57.4	77.3	51.8	54.3	46.6	246.3	129.5	24.2	59.0	160.7	143.6	88.2	5.5	41.3	130.3	72.9	15.0	79.9	68.4	27.8	22.1	26.4	42.4	67.5	42.5	61.7	34.1	63.7	49.1	112.5	69.2	65.7	35.7	45.5	64.4	10.7	31.6	32.8	196.5	36.3	74.1	54.6	47.2
ATP6AP2	"APT6M8-9, ATP6IP2, ATP6M8-9, M8-9, PRR, RENR"	ENSG00000182220	"ATPase H+ transporting accessory protein 2"	O75787	X	40579372-40606848	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Congenital disorder of glycosylation, Disease variant, Epilepsy, Mental retardation, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 765.1"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 702.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003156	Approved					NA	NA		140000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"HPA003156: AB_1078245"	"unprognostic (1.45e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.01e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.86e-2)"	81.2	71.5	85.6	60.6	86.5	124.4	95.1	76.4	116.9	106.1	72.4	82.9	32.1	86.6	91.3	70.1	75.6	79.7	55.1	90.8	90.2	165.6	96.8	87.3	67.4	80.4	79.8	68.9	53.3	765.1	30.7	106.9	83.4	86.6	89.0	99.3	39.4	97.9	18.4	71.9	47.8	124.7	84.6	69.0	49.1	40.4	87.6	72.0	177.1	40.1	72.5	97.7	41.4	98.7	83.9	117.5	78.7	106.7	472.6	312.4	47.9	182.4	274.1	127.0	152.9	68.0	142.6	48.4	88.1	257.0	141.3	86.6	114.0	136.0	168.2	92.7	97.7	57.5	100.2	66.5	172.0	104.6	111.6	259.6	175.2	154.2	121.4	200.3	168.1	46.1	63.8	130.7	201.7	109.8	45.5	93.7	73.4	140.8	112.7	43.8	132.6	161.6	182.8	96.8	55.2	51.9	185.8	111.7	118.4	284.2	147.8	97.1	172.5	175.0	91.3	207.7	62.8	38.0	70.7	46.2	139.1	93.0	138.5	269.0	511.1	404.8	156.1	364.9	164.3	106.7	157.3	161.9	341.3	110.3	174.8	159.3	255.9	141.2	378.6	124.2	167.2	692.9	85.6	86.5	76.4	116.9	90.8	90.2	80.4	79.8	83.4	84.6	87.6	98.7	102.3	57.7	65.6	36.2	65.4	97.3	135.4	254.3	46.1	155.8	74.1	61.2	30.4	94.4	175.4	138.0	54.2	173.4	109.6	70.3	62.6	146.6	3.6	97.2	115.5	94.7	57.1	62.3	44.8	59.1	106.3	156.5	34.7	124.5	87.5	63.7	96.0	64.0	702.2	188.4	56.3	54.6	349.9	279.5	263.3	9.5	117.4	222.0	149.4	28.1	185.4	193.0	72.1	40.2	40.6	64.0	58.9	151.2	74.8	97.9	61.0	106.4	127.4	93.3	105.2	116.7	138.7	106.7	43.1	60.0	99.9	174.4	100.3	188.2	63.6	121.1
ATP6V0A4	"a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2"	ENSG00000105929	"ATPase H+ transporting V0 subunit a4"	Q9HBG4	7	138706294-138799560	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"kidney: 63.6;salivary gland: 78.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 16.5;Cytotrophoblasts: 13.4;Distal tubular cells: 31.3;Ionocytes: 57.0"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 25.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SK-BR-3: 55.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018029, HPA064555"	Enhanced		Uncertain	Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA018029: AB_1845190, HPA064555: AB_2685284"	"unprognostic (1.99e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.32e-6)"	"unprognostic (4.35e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.10e-2)"	0.2	0.0	0.3	0.0	0.4	0.0	4.7	0.1	0.5	3.7	3.1	0.0	0.1	0.1	1.2	4.9	0.0	0.0	0.0	0.6	0.2	63.6	0.0	0.4	0.0	0.3	0.2	0.0	0.1	1.6	0.1	2.5	0.2	0.9	0.0	0.0	78.4	1.5	0.0	10.2	0.0	0.0	0.2	0.0	0.1	0.2	0.3	0.4	0.0	0.0	3.7	0.1	0.2	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.8	0.1	0.6	0.6	1.8	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.7	5.0	1.9	0.0	0.1	0.0	0.1	0.1	0.6	0.0	4.5	0.2	0.0	0.0	0.1	55.7	1.9	2.9	0.1	0.0	0.2	0.6	1.3	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.5	0.6	0.2	0.3	0.2	0.2	0.2	0.3	0.3	0.0	0.0	1.1	0.3	0.0	0.0	1.1	0.9	0.0	0.0	2.5	1.4	0.5	0.0	1.7	16.5	2.1	13.4	0.3	0.0	31.3	0.0	2.2	0.9	0.1	0.1	0.0	0.0	1.4	0.0	0.7	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	57.0	0.0	0.0	2.8	0.3	0.0	7.2	1.0	0.0	0.0	0.0	6.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.3	4.4	0.1	0.0	0.0	0.1	0.6	0.7	0.0	0.1	5.1	0.2	0.0	0.0	1.3
ATP6V1B1	"ATP6B1, RTA1B, VATB, Vma2, VPP3"	ENSG00000116039	"ATPase H+ transporting V1 subunit B1"	P15313	2	70935900-70965431	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 127.4;salivary gland: 139.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 197.3;Distal tubular cells: 49.0;Ionocytes: 321.4;Syncytiotrophoblasts: 64.9"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 94.7;renal cancer: 23.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 21.6;HaCaT: 20.3;SK-BR-3: 49.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009523, HPA031847"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		No	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear membrane"		"CAB009523: AB_677577, HPA031847: AB_2674072"	"unprognostic (2.28e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.15e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.63e-5)"	"unprognostic (1.97e-2)"	2.2	0.5	0.5	0.2	0.3	0.0	11.8	0.7	0.9	31.1	0.0	0.6	0.5	1.4	1.2	1.6	12.8	0.2	1.1	0.2	0.0	127.4	0.2	1.7	0.5	0.1	0.0	1.2	3.3	0.8	4.2	17.9	0.1	2.0	0.1	3.9	139.8	1.4	0.5	32.5	0.6	0.8	0.0	0.0	0.3	0.3	0.0	0.1	0.3	0.2	0.0	0.6	0.8	0.3	0.4	0.3	0.6	1.3	2.6	3.1	21.6	0.4	0.2	0.0	0.0	0.1	2.0	0.1	0.2	1.2	0.0	20.3	0.7	0.0	0.0	0.5	0.6	0.0	0.3	0.3	0.0	0.0	0.0	1.5	0.1	0.0	0.3	3.1	0.0	0.1	0.0	0.0	0.2	1.2	0.1	0.3	0.0	0.0	0.0	0.1	0.8	0.2	0.4	0.2	0.5	1.5	0.7	49.2	0.1	2.7	0.6	0.0	0.4	0.6	0.2	0.9	0.5	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.7	0.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.7	3.2	0.0	0.3	0.0	0.1	1.3	1.7	0.0	0.9	5.6	3.7	0.4	0.0	13.9	0.0	8.4	197.3	0.1	0.6	49.0	0.1	1.5	0.0	0.1	1.1	0.0	0.0	1.0	0.6	38.3	3.8	0.0	0.1	0.0	0.0	0.0	0.1	11.7	1.7	0.4	0.0	321.4	0.0	0.3	0.1	0.0	0.1	30.2	0.0	0.0	0.5	1.0	1.0	0.1	0.4	0.0	1.2	0.0	0.6	0.3	0.2	2.6	3.8	0.0	1.1	1.0	0.4	1.2	0.0	0.4	64.9	0.1	0.1	0.1	0.6
ATP6V1E1	"ATP6E, ATP6E2, ATP6V1E, P31, Vma4"	ENSG00000131100	"ATPase H+ transporting V1 subunit E1"	P36543	22	17592136-17628749	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 461.8;Proximal tubular cells: 411.3;Syncytiotrophoblasts: 479.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009528, CAB018699, HPA029196"	Enhanced		Approved	Nucleoplasm		NA	NA		34000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB009528: AB_2062678, CAB018699: AB_781534, HPA029196: AB_2672944"	"unprognostic (1.53e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.72e-3)"	"prognostic favorable (4.18e-4)"	"prognostic favorable (7.66e-8)"	"unprognostic (3.81e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.75e-1)"	119.5	165.0	209.8	68.3	220.9	90.4	109.5	214.3	287.3	101.7	200.4	128.9	56.6	112.2	135.8	117.2	96.0	84.7	224.9	231.8	226.9	230.5	85.6	110.3	88.6	220.3	202.3	81.9	59.5	239.9	117.1	113.8	230.8	95.0	99.7	128.4	83.7	126.4	232.8	120.3	83.1	121.0	215.9	99.0	101.8	67.3	218.1	108.2	100.8	178.6	109.5	114.5	97.6	245.6	121.8	108.6	96.4	94.3	314.4	169.6	106.0	159.3	212.0	198.7	228.0	137.3	97.5	76.1	132.8	215.0	251.8	187.9	152.8	140.2	174.9	145.9	173.3	137.1	97.5	182.7	459.9	159.8	226.5	212.9	267.7	192.4	138.7	220.9	170.2	95.0	174.8	150.3	341.9	127.4	136.5	114.5	71.0	269.6	152.6	80.3	140.7	45.7	331.6	189.0	70.3	122.7	146.0	101.0	358.9	187.0	98.6	180.4	146.3	137.5	72.6	174.0	119.2	145.7	275.5	96.3	221.2	76.7	189.3	178.1	106.3	184.7	64.0	100.9	63.0	78.7	64.7	61.5	83.6	59.8	60.8	63.7	137.6	76.0	120.5	81.2	97.7	112.8	209.8	220.9	214.3	287.3	231.8	226.9	220.3	202.3	230.8	215.9	218.1	245.6	66.5	76.9	83.4	13.4	47.1	41.9	77.6	121.8	19.9	54.6	33.9	34.8	126.8	74.4	83.9	138.0	27.1	235.1	63.8	105.2	461.8	143.8	7.6	74.3	56.9	69.3	41.9	49.4	24.9	119.7	143.9	60.8	40.8	79.2	90.5	41.6	72.5	46.8	186.8	53.8	24.4	54.0	116.0	75.1	52.1	17.9	94.1	91.9	80.0	15.0	144.1	94.1	85.5	13.0	31.9	154.7	104.7	97.8	38.3	60.1	65.4	411.3	78.8	50.4	59.2	39.0	74.5	71.7	74.7	34.3	51.6	479.1	54.6	57.6	40.1	93.1
ATP7A	MNK	ENSG00000165240	"ATPase copper transporting alpha"	Q04656	X	77910656-78050395	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"	Translocase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ionocytes: 61.1;Microglial cells: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012887, HPA048107"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 31: Skin - Epidermis development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA012887: AB_1845205, HPA048107: AB_2680266"	"unprognostic (3.14e-2)"	"unprognostic (3.48e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.38e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.52e-1)"	3.0	4.3	1.2	3.6	1.7	5.9	6.3	2.3	2.1	3.9	1.6	3.4	3.9	3.6	5.0	4.9	3.5	3.6	2.5	1.3	2.1	4.4	2.3	4.5	4.1	2.1	2.1	3.6	2.4	7.3	2.5	4.0	3.8	5.3	3.4	3.0	5.1	3.4	1.8	11.1	3.4	3.2	1.1	4.7	5.5	1.6	1.6	4.7	4.6	2.9	4.6	3.9	2.8	2.9	3.2	8.3	5.4	5.5	5.0	5.3	0.9	4.8	6.6	2.8	5.7	1.0	3.6	4.7	6.9	4.8	3.3	3.8	7.1	3.9	5.2	7.0	4.8	2.4	7.8	0.8	6.3	4.1	4.1	5.6	1.6	5.9	1.8	6.5	7.3	4.7	19.6	17.4	5.2	2.8	4.6	1.4	1.5	11.2	1.7	3.7	9.0	15.8	4.6	8.8	1.6	20.4	11.9	2.8	6.0	3.3	2.2	1.3	9.4	3.7	3.6	5.2	1.9	5.6	10.7	5.2	6.0	2.5	5.7	7.1	1.5	4.5	1.8	1.5	0.9	1.8	1.2	1.2	1.0	1.4	1.4	2.1	8.1	1.2	1.9	1.0	0.4	1.0	1.2	1.7	2.3	2.1	1.3	2.1	2.1	2.1	3.8	1.1	1.6	2.9	14.3	0.0	8.4	15.7	12.6	7.4	5.1	5.8	13.1	6.4	17.3	10.0	5.1	1.5	8.2	9.2	4.2	2.0	15.0	4.5	1.9	5.6	0.5	5.3	9.2	9.7	4.8	22.5	11.1	13.6	2.2	9.4	20.4	8.8	9.5	6.4	14.6	3.6	14.3	1.7	12.5	4.8	61.1	11.7	6.7	1.1	7.2	12.6	19.6	44.0	5.5	4.4	11.3	37.7	35.0	6.2	4.1	9.8	10.5	4.8	4.1	5.5	10.2	4.1	32.9	10.3	8.7	1.8	5.4	20.5	16.6	2.2	13.8	6.7	5.2	6.6
ATP7B	WND	ENSG00000123191	"ATPase copper transporting beta"	P35670	13	51930436-52012125	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"	Translocase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 22.9;Early spermatids: 30.2;Excitatory neurons: 24.5;Hepatocytes: 23.6;Inhibitory neurons: 25.4;Late spermatids: 74.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 32.8;CACO-2: 21.1;HEL: 53.0;RPTEC TERT1: 22.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA009137, HPA013187"	Supported		Supported	"Golgi apparatus"		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 36: HEL - Hemostasis"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"HPA009137: AB_2668214, HPA013187: AB_1845206"	"unprognostic (1.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (3.49e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.77e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.40e-1)"	3.6	0.9	1.3	0.6	1.2	2.2	1.7	2.0	2.1	1.8	0.8	2.9	10.6	1.5	0.1	0.7	2.0	7.0	2.1	2.5	1.4	2.2	8.6	1.4	0.3	0.8	1.2	1.9	2.0	6.4	1.2	7.1	1.1	2.0	2.7	3.7	3.0	0.9	1.1	1.0	6.0	1.7	0.5	0.4	4.4	8.4	1.7	0.7	1.2	1.8	0.2	1.6	1.2	0.7	0.8	2.8	5.2	4.5	1.0	0.8	32.8	1.5	0.5	1.6	1.2	21.1	0.1	0.1	0.6	2.7	3.6	0.3	4.0	4.4	1.0	0.4	7.5	53.0	0.5	14.7	1.4	0.6	11.8	1.9	4.7	0.2	2.0	2.1	3.7	3.7	14.4	0.2	1.5	1.0	0.2	0.9	1.7	6.6	1.8	2.0	1.4	0.0	22.5	3.4	3.3	2.2	1.9	2.8	1.8	5.5	8.0	0.5	2.0	0.3	1.7	2.8	0.6	0.6	0.7	0.2	0.1	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	2.0	2.1	2.5	1.4	0.8	1.2	1.1	0.5	1.7	0.7	5.4	6.4	0.0	10.7	0.9	0.4	0.7	1.7	0.0	3.1	2.3	1.8	2.1	4.3	5.2	1.8	22.9	14.3	1.8	6.6	0.0	1.6	30.2	2.4	1.3	2.7	2.4	4.2	24.5	1.0	5.5	2.1	9.2	4.2	0.0	13.3	3.9	23.6	2.3	0.0	25.4	3.4	4.1	0.8	0.3	74.2	2.1	0.2	1.8	15.0	0.2	0.2	0.0	12.1	4.3	2.0	3.0	0.7	0.2	1.3	11.4	2.2	4.3	6.1	6.6	1.0	1.4	2.2	1.7	0.7	0.4	4.5	0.2	0.4	5.0	1.2
ATP8A2	"ATPIB, ML-1"	ENSG00000132932	"ATPase phospholipid transporting 8A2"	Q9NTI2	13	25371974-26025851	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 21.6;pituitary gland: 15.2;retina: 17.2"	"Group enriched"	"Detected in many"	6	"Excitatory neurons: 518.7;Inhibitory neurons: 727.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 19.9;JURKAT: 9.8;MOLT-4: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039926, HPA040033"	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Nucleoplasm	"HPA039926: AB_10794205, HPA040033: AB_2676809"	"unprognostic (3.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.95e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.96e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.20e-5)"	"unprognostic (9.10e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.22e-2)"	0.1	2.1	5.5	0.3	6.7	0.0	0.6	8.0	21.6	0.2	0.0	0.4	0.3	0.6	1.8	0.0	0.0	0.1	0.1	8.7	19.3	0.3	0.0	0.8	0.6	12.8	4.6	0.2	0.6	0.0	15.2	0.2	12.1	0.1	0.2	17.2	0.1	0.0	0.3	0.1	0.3	0.1	0.2	0.3	0.6	2.9	6.6	1.0	0.1	0.1	0.2	0.2	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	19.9	0.1	0.0	0.0	0.0	0.6	0.5	9.8	0.0	0.0	1.7	0.1	3.9	0.0	2.0	0.0	0.7	0.0	2.7	0.9	0.2	0.0	3.2	0.0	0.2	0.2	0.1	0.2	0.0	0.4	0.2	0.0	1.0	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.2	0.1	5.5	6.7	8.0	21.6	8.7	19.3	12.8	4.6	12.1	0.2	6.6	6.8	0.7	0.0	12.2	9.4	0.8	1.0	0.2	0.3	0.0	21.5	1.5	0.3	2.5	1.5	0.4	0.0	95.9	1.5	0.4	0.0	0.0	0.3	39.0	1.2	23.6	2.6	0.0	0.8	518.7	0.0	0.4	1.7	1.1	0.9	5.1	3.7	0.0	0.0	3.2	21.9	727.7	0.0	0.0	0.0	0.7	30.3	0.9	0.3	0.0	9.4	0.0	7.2	1.0	88.4	24.7	0.0	0.0	1.2	0.1	0.2	0.0	1.3	0.3	91.6	13.1	0.3	0.8	19.8	12.5	0.0	0.4	1.1	1.8	10.1	0.1	0.1
ATP8B1	"ATPIC, BRIC, FIC1, PFIC, PFIC1"	ENSG00000081923	"ATPase phospholipid transporting 8B1"	O43520	18	57646426-57803315	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hearing, Lipid transport, Transport"	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 279.7;Intestinal goblet cells: 180.5;Paneth cells: 116.7;Undifferentiated cells: 185.7;Urothelial cells: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 90.2;RT4: 168.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018673, HPA018674"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA018673: AB_1845207, HPA018674: AB_1845208"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (2.60e-4)"	"unprognostic (8.81e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.62e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.30e-3)"	"unprognostic (4.55e-3)"	"prognostic favorable (6.35e-4)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.60e-3)"	9.1	5.4	1.3	8.5	2.0	1.2	9.5	3.6	3.9	16.3	3.0	76.2	30.3	5.9	3.5	14.8	10.6	18.0	4.4	1.7	1.1	6.6	7.7	8.3	2.2	2.1	1.1	2.1	23.3	9.7	2.7	6.9	2.0	17.6	61.7	0.6	20.6	11.5	1.9	8.4	38.2	8.3	1.0	4.6	46.1	0.6	1.9	1.5	22.0	1.8	3.6	30.0	13.0	3.0	32.0	10.7	0.1	0.6	10.5	19.2	11.9	62.6	63.6	67.4	40.4	8.0	24.3	1.5	19.3	90.2	22.3	44.9	0.2	13.9	64.3	0.2	1.1	0.2	2.6	2.5	2.2	0.4	0.6	2.9	12.6	20.8	34.0	39.5	33.0	0.3	0.3	0.7	34.1	15.6	0.1	0.3	0.3	35.5	3.3	0.3	0.2	0.0	7.9	168.1	0.8	0.7	1.3	32.5	0.1	0.5	10.3	0.6	35.3	48.3	2.0	7.7	14.2	0.4	0.4	0.5	1.1	0.4	2.8	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.1	0.2	0.6	0.0	0.2	0.1	0.0	0.0	1.3	2.0	3.6	3.9	1.7	1.1	2.1	1.1	2.0	1.0	1.9	3.0	25.9	19.2	27.0	11.1	4.1	7.8	66.7	20.6	10.2	0.7	28.4	10.4	5.4	27.1	48.9	40.5	0.0	25.6	0.6	279.7	0.0	27.0	2.8	26.3	4.0	30.8	68.4	0.4	61.2	53.1	2.7	7.1	98.4	40.1	4.5	0.9	33.2	19.1	2.4	6.7	11.7	180.5	22.4	2.8	4.0	0.4	0.3	1.0	7.2	37.5	0.9	0.1	0.0	20.6	10.7	38.5	116.7	0.0	0.9	70.8	58.2	0.2	44.7	1.2	13.1	2.8	20.7	0.3	1.5	28.0	16.3	10.9	1.7	2.3	185.7	119.2
ATR	"FRP1, MEC1, SCKL, SCKL1"	ENSG00000175054	"ATR serine/threonine kinase"	Q13535	3	142449007-142578733	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"DNA damage, DNA repair"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 93.0;Inhibitory neurons: 94.4;Microglial cells: 73.1;Oligodendrocyte precursor cells: 65.4;Oligodendrocytes: 71.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054320			Supported	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Golgi apparatus"	"HPA054320: AB_2682448"	"unprognostic (1.47e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.42e-2)"	"prognostic unfavorable (8.39e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.94e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.43e-1)"	3.0	8.6	0.7	4.1	1.1	1.2	3.2	0.9	1.4	3.8	3.7	2.7	1.7	3.3	2.3	3.1	3.3	3.4	2.3	1.2	1.9	3.7	3.6	2.9	4.8	1.5	1.2	2.7	3.8	5.2	3.7	3.1	1.4	3.0	2.9	2.9	3.5	2.5	2.9	2.7	3.1	3.2	1.0	4.2	2.8	5.2	1.2	4.9	5.0	1.4	4.6	4.1	2.7	1.2	28.6	13.2	7.1	7.0	9.6	13.6	8.8	14.8	8.4	10.1	9.7	6.4	6.8	19.9	14.6	10.1	14.6	16.1	10.9	12.8	15.0	7.5	7.9	11.9	8.2	4.1	4.2	20.5	5.3	9.8	4.8	9.5	10.3	5.8	11.6	8.7	8.2	7.5	9.6	7.5	13.9	2.6	7.3	15.6	9.6	11.8	12.5	13.5	6.3	11.1	5.2	5.1	28.6	8.3	8.0	7.8	12.0	5.4	14.6	10.5	4.9	12.3	15.2	10.8	7.4	18.5	13.8	6.5	8.5	0.0	0.3	0.0	0.5	0.4	1.0	0.1	0.3	0.5	0.7	0.3	0.4	0.4	0.0	1.3	0.2	0.2	0.4	0.2	0.7	1.1	0.9	1.4	1.2	1.9	1.5	1.2	1.4	1.0	1.2	1.2	11.5	6.4	10.6	39.2	22.4	4.0	7.2	8.8	14.2	14.1	9.2	6.5	7.6	5.7	10.1	3.7	37.5	7.7	14.9	3.5	0.0	5.9	16.4	18.8	18.6	10.2	7.7	14.5	93.0	4.9	3.6	8.3	14.8	10.3	1.3	16.3	7.9	7.3	6.4	8.4	94.4	4.8	14.2	9.4	4.0	8.7	6.5	12.8	10.6	73.1	12.0	6.0	9.2	65.4	71.9	6.4	1.8	7.2	23.1	8.1	1.9	6.5	25.4	23.6	0.0	14.6	9.8	50.1	18.5	14.7	4.5	5.1	15.1	13.8	7.6	6.1
ATRX	"JMS, MRX52, RAD54, XH2, XNP"	ENSG00000085224	"ATRX chromatin remodeler"	P46100	X	77504880-77786233	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001906, CAB009372, HPA064684, CAB068176"	Supported		Supported	"Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"		"CAB009372: AB_2061023, CAB068176: AB_2665665, HPA001906: AB_1078249, HPA064684: AB_2685321"	"unprognostic (1.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.65e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.69e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.24e-1)"	18.0	15.9	17.3	17.6	20.4	29.9	18.1	32.9	20.4	18.0	21.4	12.7	11.2	21.2	14.8	13.3	11.8	14.7	15.5	19.2	19.8	16.9	13.2	13.4	22.6	15.0	20.1	24.9	13.4	23.2	8.5	16.6	16.6	19.2	13.5	26.8	14.0	14.8	19.1	15.6	10.9	15.6	16.4	22.8	16.5	6.6	22.6	25.7	20.0	26.9	18.6	14.1	9.9	19.7	36.0	55.1	60.1	45.0	31.8	38.1	21.2	29.4	27.3	21.8	25.9	19.6	30.7	48.5	29.9	32.5	39.9	30.0	44.6	18.1	37.5	27.3	30.8	29.3	67.2	16.2	16.1	38.4	10.2	25.5	20.2	32.2	30.4	29.4	41.9	30.3	34.9	53.3	29.3	27.6	30.2	25.0	42.0	17.6	42.5	48.6	76.3	26.0	25.6	46.4	33.1	55.5	60.5	23.1	21.9	37.2	18.6	20.8	55.8	32.8	76.1	34.4	21.0	16.3	52.9	42.1	23.0	30.9	27.8	44.0	10.5	22.7	26.0	13.3	25.2	31.2	24.0	20.9	8.1	32.4	24.6	20.1	33.2	23.2	20.0	20.7	22.2	9.7	17.3	20.4	32.9	20.4	19.2	19.8	15.0	20.1	16.6	16.4	22.6	19.7	201.0	160.3	230.1	157.4	176.6	92.4	112.2	71.3	114.9	220.1	87.8	86.7	277.8	60.1	101.5	71.7	212.7	72.2	176.9	49.0	23.5	91.8	4.7	103.1	195.5	162.8	126.8	105.8	197.8	83.1	51.0	134.3	114.2	137.3	113.1	261.4	97.8	56.7	70.9	158.2	246.9	78.0	69.2	87.0	101.6	12.7	162.4	113.1	62.2	195.8	149.0	112.3	183.4	202.5	237.1	92.0	47.6	208.0	183.9	120.8	49.2	37.2	102.6	245.4	92.1	174.7	160.0	19.8	52.8	78.7	84.4	59.8	158.0	312.4	73.3	112.0
ATXN3	"ATX3, JOS, MJD, SCA3"	ENSG00000066427	"Ataxin 3"	P54252	14	92044496-92106621	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021976, HPA024123, HPA069338"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB021976: , HPA024123: AB_1845133, HPA069338: AB_2686124"	"unprognostic (1.06e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.94e-3)"	"unprognostic (4.22e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.11e-1)"	9.0	5.9	3.8	5.7	4.2	9.9	6.8	4.9	5.0	7.5	3.3	7.3	3.7	6.4	4.3	10.3	6.0	6.5	5.3	3.6	5.0	5.6	9.6	6.8	7.7	6.2	5.7	7.1	4.5	6.4	4.0	7.0	6.2	6.0	6.8	3.9	5.8	5.5	3.3	12.9	4.8	8.6	4.3	5.6	5.2	9.3	4.3	8.0	5.9	5.9	9.8	9.0	8.0	4.9	8.6	16.7	14.6	13.6	20.9	20.1	28.4	9.7	15.4	11.9	16.5	12.3	23.2	17.6	18.5	15.8	14.1	14.6	11.6	21.0	26.3	20.0	3.5	7.4	8.0	18.2	17.3	13.5	12.6	16.5	18.1	20.9	21.8	15.9	18.7	19.4	10.1	12.5	18.2	33.1	14.0	11.9	10.4	28.5	13.6	11.0	27.0	9.9	15.3	19.4	5.3	8.8	23.1	9.5	13.3	19.6	18.1	9.1	10.0	11.7	17.0	7.5	5.2	10.8	19.8	16.2	8.3	12.9	6.9	13.5	14.3	10.8	6.1	16.5	7.4	7.7	7.0	6.9	16.2	10.6	7.8	8.8	12.2	8.7	23.0	9.3	8.1	6.3	3.8	4.2	4.9	5.0	3.6	5.0	6.2	5.7	6.2	4.3	4.3	4.9	55.0	16.0	12.4	33.6	27.6	25.4	28.6	29.8	19.4	35.4	16.9	18.4	19.3	15.7	20.0	42.3	50.1	20.3	31.5	13.8	15.6	25.8	19.8	20.3	34.9	53.0	16.1	30.3	36.1	17.3	29.8	34.6	18.3	22.5	24.6	25.9	49.6	21.1	22.4	26.9	28.6	16.4	12.2	35.1	27.2	26.8	67.7	30.0	23.2	28.1	48.0	20.4	29.9	39.2	51.5	19.6	16.1	65.1	20.1	31.9	16.6	17.7	16.0	46.7	46.0	51.9	38.2	39.1	57.2	21.6	30.3	25.3	28.8	24.8	18.9	28.2
AUH		ENSG00000148090	"AU RNA binding methylglutaconyl-CoA hydratase"	Q13825	9	91213815-91361918	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	"Lyase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 191.7;Inhibitory neurons: 137.0;Oligodendrocytes: 137.5;Proximal tubular cells: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 82.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004171	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA004171: AB_1845215"	"unprognostic (4.10e-2)"	"unprognostic (8.95e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (8.23e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	17.2	41.9	11.8	6.3	12.3	4.8	15.9	16.0	15.3	13.6	17.9	17.2	23.8	10.2	14.2	8.6	12.4	10.7	38.9	12.1	14.3	62.9	26.4	10.3	7.6	14.8	13.6	13.4	25.5	45.4	10.4	16.1	15.2	28.2	17.2	21.4	26.1	14.8	24.2	8.7	20.1	8.6	12.2	8.0	22.7	5.5	14.1	9.0	21.0	29.2	7.7	9.1	9.8	15.0	9.1	8.7	12.0	6.2	14.5	15.5	18.5	8.0	10.0	6.1	7.0	5.0	11.4	10.6	8.1	8.5	18.2	13.0	18.1	10.1	8.7	82.6	15.4	7.3	9.7	29.6	11.1	10.6	7.3	13.1	12.5	4.9	16.8	14.3	7.6	10.7	10.3	15.5	7.2	8.8	14.6	23.8	15.0	22.2	12.5	8.5	9.6	18.6	26.6	4.8	12.2	8.8	11.9	28.3	15.6	27.1	5.2	6.9	7.8	6.1	7.6	9.0	7.8	17.7	16.1	3.6	9.6	8.5	4.2	17.9	5.2	18.2	7.2	3.6	8.1	8.4	7.8	10.4	4.6	11.8	9.6	9.1	7.4	10.8	2.5	6.3	10.8	6.5	11.8	12.3	16.0	15.3	12.1	14.3	14.8	13.6	15.2	12.2	14.1	15.0	9.6	0.0	7.7	75.1	11.2	5.2	24.5	27.7	12.5	18.7	15.8	13.5	37.2	27.1	19.1	27.6	25.0	44.6	11.5	27.0	191.7	29.6	3.1	11.5	11.1	11.1	22.9	28.8	101.2	16.1	28.9	14.2	19.4	16.0	1.3	14.5	11.0	18.3	13.4	13.5	137.0	17.3	38.7	8.9	4.7	1.1	14.3	8.9	12.4	67.5	29.1	9.5	18.6	100.5	137.5	12.5	23.5	11.3	18.4	36.8	59.4	120.0	15.8	34.4	13.1	11.9	11.5	8.7	10.5	16.1	4.1	36.4	12.9	11.6	25.0	24.2
AURKB	"Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5"	ENSG00000178999	"Aurora kinase B"	Q96GD4	17	8204733-8210600	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 44.1;lymphoid tissue: 60.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.5;Erythroid cells: 59.3;Extravillous trophoblasts: 89.1;Granulosa cells: 24.7;Hofbauer cells: 29.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 7.9"	"Group enriched"	"Detected in many"	6	"B-cells: 2.5;T-cells: 7.9"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basal ganglia: 1.3;white matter: 4.0"	"Low region specificity"	"Detected in all"			"CAB005862, HPA037708"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Midbody	"CAB005862: AB_449204, HPA037708: AB_2675623"	"unprognostic (4.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.99e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.47e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.77e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.77e-1)"	1.1	1.2	0.1	14.2	0.2	44.1	1.7	0.2	0.2	3.0	0.1	11.1	12.1	1.6	0.4	18.6	0.6	1.5	0.7	0.1	0.2	0.9	2.0	2.5	36.7	0.1	0.3	0.5	0.6	0.3	0.2	8.2	0.3	0.8	11.0	0.0	2.7	0.3	5.5	9.3	11.6	3.2	0.0	12.0	4.6	1.2	0.4	60.1	0.6	0.0	36.6	3.5	5.9	0.2	196.5	130.9	191.1	93.0	4.2	6.5	73.4	91.7	49.5	186.2	170.6	171.5	57.4	193.3	46.2	37.0	77.0	139.8	140.1	62.6	153.7	84.9	231.3	115.7	78.3	146.1	0.7	62.2	109.2	3.5	2.9	109.4	67.7	18.5	86.5	123.6	73.3	73.4	82.9	92.9	225.1	87.4	119.6	63.9	57.6	149.8	176.1	80.5	41.2	38.2	41.2	59.1	81.7	36.5	61.2	56.5	63.5	41.4	33.9	74.3	75.6	67.6	243.3	53.2	37.7	147.9	35.7	92.9	153.4	0.0	0.4	0.6	0.5	0.3	0.1	1.1	1.3	2.1	0.5	2.5	0.1	0.7	0.9	0.3	0.2	0.2	7.9	0.9	0.1	0.2	0.2	0.2	0.1	0.2	0.1	0.3	0.3	0.0	0.4	0.2	0.3	0.0	0.5	0.0	7.6	4.5	1.8	6.1	0.6	0.0	1.8	2.2	1.4	0.0	2.6	0.0	0.0	40.5	1.8	13.2	0.0	0.4	0.1	0.5	1.6	3.1	0.0	59.3	0.0	0.0	89.1	5.7	6.1	2.1	4.5	24.7	6.1	0.7	29.4	0.0	0.0	10.8	0.0	5.7	7.3	0.2	0.6	5.1	1.8	0.0	0.9	0.0	3.1	0.0	0.1	0.3	2.8	0.0	15.4	1.2	1.5	0.1	0.2	0.0	0.0	0.1	4.8	1.6	7.2	11.8	2.4	9.0	4.3	1.0	22.0	2.8
AURKC	"ARK3, AurC, STK13"	ENSG00000105146	"Aurora kinase C"	Q9UQB9	19	57230802-57235548	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 46.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 150.2;Spermatocytes: 116.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"NTERA-2: 38.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA034859	Uncertain					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA034859: AB_10670298"	"unprognostic (7.27e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.45e-2)"	"unprognostic (8.07e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.20e-5)"	"unprognostic (4.26e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.46e-4)"	1.2	1.1	3.5	1.3	3.7	1.4	2.0	3.8	6.3	0.7	3.0	1.0	0.2	1.3	1.8	1.0	1.1	1.4	1.9	3.5	3.5	1.5	2.7	1.1	3.4	3.7	3.6	0.5	0.9	0.6	1.4	1.9	3.9	0.9	1.3	1.1	0.8	1.4	1.9	1.2	0.8	1.1	3.8	5.0	0.8	46.9	3.7	1.2	1.2	0.5	2.2	1.4	0.8	4.3	0.3	0.1	0.9	0.4	0.3	0.9	0.5	1.7	0.8	1.2	4.4	1.3	0.2	0.1	0.2	0.6	1.0	0.0	0.0	0.9	0.8	0.0	4.9	0.2	0.4	0.0	1.4	0.0	0.3	1.2	0.9	0.9	0.7	1.5	0.8	0.5	0.2	0.0	1.6	0.0	1.5	0.9	38.4	0.2	1.0	0.1	0.3	0.8	0.9	1.7	1.9	0.6	0.0	0.3	0.2	0.1	0.1	1.8	0.4	0.3	5.1	0.4	1.0	1.9	2.7	0.8	1.1	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	3.5	3.7	3.8	6.3	3.5	3.5	3.7	3.6	3.9	3.8	3.7	4.3	1.9	0.0	0.5	0.7	0.1	1.1	0.8	0.9	0.0	2.4	1.2	3.8	1.2	0.0	2.5	1.8	0.0	0.4	0.9	0.7	1.9	2.1	150.2	0.8	0.4	0.8	1.8	0.4	1.3	1.0	0.9	1.0	0.0	0.6	0.0	0.5	1.8	0.6	4.1	0.0	1.3	0.3	0.0	2.6	0.8	28.9	1.5	1.2	5.4	0.0	1.0	1.8	1.0	0.0	0.9	1.3	1.4	0.4	0.6	1.3	0.0	0.5	2.7	1.0	6.6	0.4	0.7	116.8	22.9	0.5	1.1	0.3	0.9	0.5	0.4	1.6
B2M		ENSG00000166710	Beta-2-microglobulin	P61769	15	44711487-44718851	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	Immunity		"Amyloidosis, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 31919.3;NK-cells: 24726.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002572, HPA006361"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	1790000000	2100000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB002572: AB_563434, HPA006361: AB_1078278"	"unprognostic (9.45e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.02e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.02e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.17e-2)"	3160.2	3214.7	697.6	5686.5	705.1	7839.2	2606.9	711.8	1145.0	2539.9	789.6	5139.0	5180.7	2192.2	1735.6	2283.9	1648.3	4948.8	2327.2	651.0	769.9	2462.6	6206.2	6159.2	9311.8	889.5	763.2	1945.7	1310.9	1940.5	318.4	3502.0	815.3	2345.0	5593.5	139.3	5657.1	1784.5	931.7	3015.6	5693.3	2545.3	838.3	7896.1	4878.2	615.6	771.9	4217.4	2340.8	2026.5	5333.4	5753.1	549.4	909.5	1735.4	378.9	226.0	633.6	4348.7	4719.4	1662.5	2045.5	4961.9	3609.7	6561.4	425.3	5417.9	554.8	2567.9	1948.8	2410.2	2537.0	497.2	878.7	1226.2	4762.2	435.9	2956.9	2263.6	600.3	3609.3	2074.5	3328.6	2735.9	609.8	1075.7	1044.4	2442.6	1884.1	965.4	611.9	3649.1	2195.5	476.9	1518.4	3213.8	206.5	629.8	1014.3	2240.2	1926.6	4789.2	2425.5	3486.4	254.1	179.1	1288.4	1571.2	1338.5	394.3	655.3	6180.6	2548.7	4531.4	676.5	5389.2	2193.3	4771.7	7118.6	1683.1	5384.6	3783.6	2567.3	48105.4	18117.1	33178.9	20639.1	17775.0	20836.8	15768.0	23783.0	22245.1	9978.8	11988.4	17122.9	22791.8	50453.6	18779.6	19034.9	12052.6	29659.1	56957.2	697.6	705.1	711.8	1145.0	651.0	769.9	889.5	763.2	815.3	838.3	771.9	909.5	12048.3	3387.8	3505.1	28.7	8472.8	7843.7	3197.1	8420.8	1628.8	33.3	2399.5	2015.2	1068.8	3593.1	5347.4	2100.3	27.1	1354.6	14028.8	8753.6	1038.9	13898.6	43.1	2073.7	2414.0	8385.6	2266.0	2087.2	7.3	9034.5	4397.5	3691.1	1981.7	2282.2	3029.5	1270.6	6835.7	3832.6	11985.7	5.0	22.0	5982.6	8701.4	12536.8	14507.0	158.8	3018.0	10687.9	6744.8	368.2	31919.3	322.0	24726.3	95.0	129.2	10115.7	7085.6	1688.8	11026.6	5300.4	18327.7	3122.5	8367.9	52.5	4016.7	2055.2	4107.1	64.2	72.1	1541.4	8619.8	804.8	14266.2	3229.8	3063.4	8248.6
B3GALNT2	MGC39558	ENSG00000162885	"Beta-1,3-N-acetylgalactosaminyltransferase 2"	Q8NCR0	1	235447190-235504452	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Cone photoreceptor cells: 252.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007846, HPA050662"	Approved		Uncertain	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"HPA007846: , HPA050662: AB_2681209"	"unprognostic (5.50e-2)"	"unprognostic (3.16e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.96e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.19e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.53e-3)"	"unprognostic (8.34e-3)"	4.7	5.4	2.3	2.8	2.2	1.6	4.0	2.5	2.4	5.3	5.7	8.1	3.2	7.3	4.8	8.9	5.5	5.3	6.1	2.4	2.6	3.3	3.2	3.4	2.2	2.4	2.7	5.1	22.3	6.7	3.8	4.3	2.3	7.3	5.3	3.9	6.0	6.6	23.3	6.2	5.1	10.6	2.3	2.7	8.9	5.9	2.5	3.6	7.3	16.7	3.4	7.9	5.4	2.2	15.0	10.4	11.1	16.2	14.2	15.7	21.6	14.1	11.8	9.8	10.0	7.7	13.1	8.2	15.3	15.5	7.0	17.3	21.3	14.8	12.5	14.5	11.7	5.8	12.7	9.3	10.0	17.9	4.3	9.9	9.5	10.4	21.5	7.0	14.1	19.2	10.9	10.9	9.2	7.3	10.0	8.8	15.7	7.9	3.1	10.6	19.9	18.8	6.4	21.1	14.2	16.8	23.7	7.8	12.2	3.9	18.5	15.6	13.1	9.7	13.3	16.6	18.1	11.3	14.8	5.0	6.7	12.1	21.7	1.1	1.1	0.5	0.6	1.6	0.8	0.6	0.6	0.7	2.3	0.5	0.5	0.9	0.2	1.2	1.4	1.9	0.3	0.4	2.3	2.2	2.5	2.4	2.4	2.6	2.4	2.7	2.3	2.3	2.5	2.2	9.6	9.6	5.0	38.8	7.8	31.2	39.0	15.1	36.5	33.1	8.9	6.7	6.7	1.5	9.5	5.5	252.3	20.3	14.6	5.2	0.0	6.9	26.7	20.2	14.8	7.0	9.0	5.0	38.4	7.2	7.0	11.5	10.7	19.9	5.7	11.9	4.6	4.7	3.9	28.6	56.2	6.2	4.1	3.0	16.3	7.3	10.5	6.9	1.8	23.4	11.5	11.2	7.2	29.1	21.7	9.2	5.4	16.1	14.0	27.6	9.7	2.3	8.1	18.4	0.0	21.0	20.5	35.8	40.3	28.5	29.7	22.4	9.0	17.6	7.0	33.1
B3GALT6	beta3GalT6	ENSG00000176022	"Beta-1,3-galactosyltransferase 6"	Q96L58	1	1232237-1235041	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease variant, Dwarfism, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 69.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		14000	"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 52: Non-specific - Transcription"				"unprognostic (9.76e-2)"	"unprognostic (6.97e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (9.89e-2)"	8.7	8.7	8.9	5.6	9.0	1.8	8.4	7.3	9.9	7.6	7.3	6.5	3.9	10.7	3.8	7.2	7.7	3.7	10.1	9.5	10.1	9.9	13.5	6.8	6.2	10.4	9.3	7.0	11.9	7.8	9.3	5.2	8.8	8.0	3.0	2.4	6.4	4.2	9.3	9.2	6.5	4.8	8.3	10.3	7.8	5.4	9.0	5.8	7.7	4.8	3.7	7.6	6.3	9.3	20.4	10.2	17.0	17.9	16.8	11.3	13.2	21.2	17.9	17.4	14.1	9.1	20.3	15.1	12.4	12.7	15.2	17.9	7.4	11.4	10.6	26.8	28.2	28.2	10.1	8.7	17.3	17.6	17.1	10.6	8.3	11.6	11.3	10.5	13.3	17.2	20.0	13.2	18.0	11.6	24.0	31.6	21.9	21.2	37.9	22.8	6.7	12.5	17.4	6.1	69.6	28.6	15.8	18.4	11.4	9.9	15.4	24.9	14.4	17.9	7.9	11.3	30.9	8.2	7.6	14.0	14.1	38.9	20.8	1.3	1.2	0.4	1.6	1.6	2.8	1.4	1.6	1.9	1.7	2.3	1.4	1.7	0.6	2.9	2.0	2.3	0.7	1.0	8.9	9.0	7.3	9.9	9.5	10.1	10.4	9.3	8.8	8.3	9.0	9.3	15.6	12.8	9.9	3.9	13.7	8.4	31.1	3.8	2.2	13.1	15.4	17.5	8.4	11.5	3.4	12.9	4.2	1.7	20.9	3.8	7.9	8.1	0.6	7.6	16.0	12.5	6.0	5.9	3.8	12.7	3.4	10.8	5.1	9.4	0.0	24.7	11.4	13.6	7.3	20.2	5.0	3.7	4.1	12.2	10.3	2.2	2.8	10.5	1.8	1.9	6.9	11.0	18.6	5.5	3.8	11.9	1.0	4.1	9.6	24.5	1.6	10.9	3.0	9.4	0.0	13.6	10.8	1.7	4.1	3.7	12.6	1.4	11.1	33.2	5.3	14.8
B3GAT3	GlcAT-I	ENSG00000149541	"Beta-1,3-glucuronyltransferase 3"	O94766	11	62615296-62622154	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051328	Approved				"Intracellular and membrane"	NA	NA		990000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA051328: AB_2681444"	"unprognostic (1.55e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (4.69e-4)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (5.11e-6)"	"unprognostic (4.94e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.46e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.58e-2)"	28.2	30.0	63.4	17.0	63.8	18.2	27.4	67.0	81.8	33.7	65.9	27.8	17.2	30.0	11.5	21.0	30.0	15.3	23.1	64.0	66.7	52.1	48.7	29.0	26.2	72.3	64.3	32.3	30.7	19.1	55.7	19.1	76.5	37.1	6.9	16.0	25.9	18.2	14.3	33.9	27.8	14.0	63.3	40.0	28.9	23.9	67.1	18.5	30.1	6.8	10.8	30.5	25.7	69.7	36.0	57.3	32.0	55.0	40.0	38.7	23.4	28.3	38.9	26.7	29.4	25.4	52.3	33.4	91.1	29.5	70.6	24.5	30.8	28.7	6.2	71.5	61.3	17.0	25.9	32.8	96.8	21.4	34.8	69.1	47.6	35.0	15.3	42.4	25.3	37.9	51.5	76.7	33.9	89.1	38.1	76.7	47.5	18.9	55.1	36.7	22.5	175.4	55.0	7.2	33.6	53.1	32.6	38.2	134.6	10.6	52.9	41.6	18.6	28.6	20.8	75.2	54.4	79.3	28.7	37.6	82.3	41.0	56.0	32.0	29.3	27.4	21.6	31.8	14.0	18.5	14.9	17.7	25.8	15.3	14.8	17.2	8.6	41.0	33.8	15.5	19.9	16.4	63.4	63.8	67.0	81.8	64.0	66.7	72.3	64.3	76.5	63.3	67.1	69.7	33.2	6.4	13.2	22.2	36.8	19.8	39.0	53.3	51.2	52.3	33.1	44.4	4.2	31.5	26.1	40.5	33.3	77.0	45.3	26.5	15.6	33.8	0.4	20.0	36.3	22.8	25.2	24.4	19.1	46.3	61.3	34.8	25.5	24.1	1.3	45.3	23.2	28.4	67.8	48.8	25.3	23.9	57.0	35.2	17.5	3.2	36.1	34.4	44.4	8.4	45.3	52.5	49.4	14.6	19.5	36.4	31.2	22.6	51.0	30.6	27.3	16.2	15.2	49.6	26.3	22.3	33.7	6.8	25.8	21.9	19.5	43.5	41.7	31.9	28.3	21.0
B4GALNT1	"beta1-4GalNAc-T, GALGT, SPG26"	ENSG00000135454	"Beta-1,4-N-acetyl-galactosaminyltransferase 1"	Q00973	12	57623409-57633239	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 61.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 10.0;Excitatory neurons: 22.0;Horizontal cells: 21.9;Inhibitory neurons: 13.4;Smooth muscle cells: 7.5"	"Cancer enriched"	"Detected in many"	6	"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 67.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008968	Enhanced				"Intracellular and membrane"	NA	NA		35000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA008968: AB_1078253"	"unprognostic (3.18e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.73e-5)"	"unprognostic (1.26e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.18e-14)"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.92e-4)"	1.9	1.1	26.9	1.9	29.7	0.0	0.7	29.3	61.1	1.3	0.6	2.7	0.5	2.1	2.7	0.7	0.7	1.1	3.3	34.9	21.9	0.8	0.4	0.6	0.6	16.7	11.8	0.3	0.3	0.3	1.7	0.4	20.5	2.6	1.2	4.2	1.8	5.0	9.5	0.6	1.2	2.5	8.1	0.6	0.9	0.7	19.1	0.3	1.2	7.2	1.0	1.2	1.6	29.9	7.5	38.2	18.2	38.7	0.3	0.1	0.4	3.0	11.3	19.0	17.5	2.8	21.9	3.0	47.9	13.2	35.9	3.3	15.3	2.1	5.2	67.4	2.6	1.8	10.1	9.9	0.4	3.1	4.1	0.1	0.9	11.0	0.5	6.7	0.2	11.4	8.7	34.8	2.4	13.5	2.5	0.1	13.0	0.9	7.7	0.1	27.1	8.0	0.1	0.1	34.9	12.3	3.1	1.1	0.4	0.9	7.0	3.3	0.0	22.8	28.1	24.0	26.1	37.0	34.0	2.6	28.9	2.3	45.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	26.9	29.7	29.3	61.1	34.9	21.9	16.7	11.8	20.5	8.1	19.1	29.9	0.8	0.0	0.0	2.6	0.0	0.4	0.0	0.0	0.0	10.0	0.0	0.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	1.0	0.8	0.0	0.0	22.0	0.2	0.2	1.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	21.9	13.4	0.0	0.0	0.0	0.3	0.7	2.8	0.1	3.6	2.8	2.6	0.7	0.0	4.5	2.7	0.5	0.0	3.0	0.0	0.1	0.0	0.2	0.0	2.6	6.6	0.6	7.5	1.6	4.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1
B4GALT1	"beta4Gal-T1, GGTB2"	ENSG00000086062	"Beta-1,4-galactosyltransferase 1"	P15291	9	33104082-33167356	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 333.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 215.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 346.6;SiHa: 635.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010806, HPA010807"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		97000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"		"HPA010806: AB_1078255, HPA010807: AB_1078254"	"unprognostic (7.57e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (6.85e-7)"	"unprognostic (1.83e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.93e-3)"	"unprognostic (4.98e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.46e-2)"	52.4	39.2	5.6	43.9	5.1	80.2	91.1	7.3	6.4	64.9	17.9	38.0	21.9	35.7	35.7	49.7	49.3	47.8	55.4	5.4	6.8	42.1	89.4	50.1	33.3	8.6	6.4	77.4	43.9	77.1	21.2	52.9	7.7	38.8	34.3	26.2	70.3	34.0	30.9	35.8	28.1	55.2	8.1	39.7	52.1	38.3	8.3	26.8	60.8	16.7	41.2	79.4	44.9	9.4	99.1	71.8	13.1	18.1	64.9	113.7	235.9	100.6	125.7	59.5	58.8	44.0	112.1	37.8	62.4	147.3	77.2	51.9	13.7	124.5	59.4	346.6	13.6	21.6	277.6	34.1	127.4	17.9	35.0	128.0	218.1	68.0	82.2	127.6	64.0	11.5	24.9	45.5	57.0	86.1	16.3	35.4	8.1	54.1	21.8	21.0	12.2	25.1	177.0	84.6	9.8	12.7	635.5	122.2	25.8	40.4	154.8	32.3	59.9	42.2	49.4	137.2	39.8	7.6	17.9	23.3	131.0	24.2	15.8	30.6	33.2	20.3	45.2	30.5	59.2	87.1	30.4	40.7	23.3	69.9	17.9	23.3	96.5	72.4	24.8	215.3	22.0	24.0	5.6	5.1	7.3	6.4	5.4	6.8	8.6	6.4	7.7	8.1	8.3	9.4	104.4	86.6	71.9	3.3	112.0	141.9	53.0	59.2	75.7	3.8	215.8	66.7	37.2	88.6	59.5	167.3	20.9	94.9	206.2	146.1	15.6	78.2	21.9	108.6	39.7	60.6	8.4	12.8	4.1	125.9	155.8	99.9	80.0	163.7	36.8	19.6	91.1	195.4	53.9	0.0	4.5	64.0	24.4	82.3	333.3	11.1	50.7	129.0	96.0	33.7	31.3	7.7	39.1	3.0	1.0	157.8	57.4	44.4	116.4	89.0	23.9	57.7	33.8	40.1	52.6	80.0	50.8	6.4	13.8	86.1	108.4	173.9	92.7	33.9	41.6	93.2
B4GALT7	"beta4Gal-T7, XGALT-1"	ENSG00000027847	"Beta-1,4-galactosyltransferase 7"	Q9UBV7	5	177600132-177610330	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease variant, Dwarfism, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 132.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042330	Supported					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA042330: AB_10796576"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.97e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.53e-2)"	"unprognostic (4.19e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.00e-2)"	19.0	43.7	21.1	15.3	20.1	24.8	17.0	20.6	25.5	18.4	21.8	15.1	16.9	20.1	12.5	16.6	16.0	12.5	23.4	20.1	21.8	20.2	30.5	13.4	20.1	24.8	25.1	19.8	37.6	24.3	31.5	14.1	24.8	22.5	11.9	5.9	24.2	18.8	20.2	13.6	14.7	11.8	18.5	21.3	21.8	23.9	22.1	10.6	18.5	10.1	11.8	17.9	13.9	18.7	20.2	34.5	14.2	35.6	28.0	20.7	63.7	30.1	31.9	26.9	30.7	32.6	30.8	25.2	54.7	30.9	47.3	22.9	9.8	64.9	11.7	85.4	25.8	13.3	27.5	23.4	40.0	13.8	22.4	31.8	22.7	29.0	23.5	24.7	30.3	16.9	11.8	23.7	27.4	46.0	11.9	17.1	13.9	17.7	50.0	24.1	10.3	27.8	20.6	29.6	12.5	14.4	15.0	29.8	27.6	11.3	19.4	16.3	23.5	34.0	19.5	22.6	30.6	29.5	14.9	18.4	28.8	33.0	31.8	16.8	16.7	9.7	14.0	19.7	12.6	14.4	12.8	12.2	19.3	18.4	11.4	11.3	1.3	11.1	19.4	15.2	9.2	10.9	21.1	20.1	20.6	25.5	20.1	21.8	24.8	25.1	24.8	18.5	22.1	18.7	16.3	3.2	5.6	5.2	24.5	6.6	15.4	27.8	15.9	12.1	16.5	19.3	6.9	12.8	15.8	16.5	4.2	43.8	16.4	13.8	7.9	34.1	13.9	12.5	17.8	15.6	14.5	8.2	4.3	38.9	132.4	21.2	8.2	13.5	10.2	30.0	10.8	15.9	31.7	11.8	6.0	22.2	8.2	17.8	8.9	9.8	14.0	18.8	21.4	3.7	25.6	13.7	13.4	3.0	3.4	34.0	12.4	18.4	52.8	30.7	17.4	19.6	9.3	16.1	0.0	13.9	16.4	14.3	11.3	13.9	8.8	43.9	12.8	33.4	23.3	16.3
BAAT	BAT	ENSG00000136881	"Bile acid-CoA:amino acid N-acyltransferase"	Q14032	9	101354182-101385400	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Serine esterase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"liver: 721.0"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 996.7"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 181.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.4;CACO-2: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021251, HPA021330"	Enhanced		Uncertain	Vesicles		NA	NA		520000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA021251: AB_1845247, HPA021330: AB_2670674"	"unprognostic (2.53e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.97e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.68e-2)"	"prognostic favorable (4.97e-4)"	"unprognostic (2.14e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.43e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.24e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	0.1	0.0	0.5	0.0	0.5	1.2	0.0	0.5	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	17.4	0.1	0.5	0.4	0.3	721.0	0.4	0.0	0.4	0.3	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.8	0.0	3.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.1	0.1	0.1	0.4	0.8	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	1.0	0.5	0.4	0.4	0.3	0.5	0.1	0.3	0.8	0.3	0.0	0.0	0.7	2.4	0.0	0.1	0.0	0.0	1.1	0.3	0.1	0.7	91.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.1	0.0	0.1	0.7	0.0	16.0	9.7	0.2	0.0	0.1	0.0	0.1	0.0	0.0	12.1	996.7	0.0	0.0	7.2	0.0	0.0	18.2	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.0	3.0	0.9	1.8	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.5	0.1	0.3	0.2	0.0	0.0	0.0	1.0	0.1	0.4	0.0
BAP1	"hucep-6, KIAA0272, UCHL2"	ENSG00000163930	"BRCA1 associated protein 1"	Q92560	3	52401008-52410008	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 103.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004322, HPA028814, HPA028815, HPA055560"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"CAB004322: AB_626723, HPA028814: AB_10602393, HPA028815: AB_2672785, HPA055560: AB_2682850"	"unprognostic (1.52e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.41e-3)"	"unprognostic (8.53e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.64e-3)"	"unprognostic (3.30e-3)"	"prognostic favorable (3.29e-7)"	"unprognostic (6.37e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.92e-1)"	45.2	63.5	97.6	25.0	99.2	73.9	42.9	78.9	135.5	39.1	71.4	47.7	21.6	40.5	23.1	59.3	36.0	25.7	57.0	114.1	83.3	57.3	65.2	46.0	29.4	81.2	85.7	43.9	52.7	40.2	36.9	24.6	81.7	50.0	24.1	20.1	43.0	22.5	74.7	73.4	43.4	23.8	79.9	54.2	48.1	140.0	89.2	33.1	49.1	43.5	27.9	44.6	41.7	90.5	39.1	43.1	52.2	44.8	50.1	31.4	59.3	37.8	50.1	62.4	48.0	52.5	35.8	55.7	18.3	54.7	69.3	31.4	55.7	63.0	37.9	55.1	51.4	68.6	94.4	53.2	45.7	65.6	58.5	48.0	80.1	68.5	36.1	33.3	50.3	107.7	59.9	48.3	44.5	33.7	79.1	89.5	58.0	31.0	52.8	33.7	41.7	55.8	37.4	61.2	19.8	63.6	46.1	13.7	56.9	29.2	37.7	90.6	52.5	54.1	49.3	66.0	70.9	71.7	101.6	81.2	58.5	68.2	66.1	2.9	3.2	5.4	5.4	2.8	2.6	3.2	4.3	4.4	2.2	4.1	3.1	4.0	7.4	2.2	2.2	5.6	4.2	2.7	97.6	99.2	78.9	135.5	114.1	83.3	81.2	85.7	81.7	79.9	89.2	90.5	13.5	0.0	16.0	8.1	12.2	31.6	10.5	13.2	23.3	16.6	16.4	12.6	23.6	11.5	10.2	25.8	0.0	14.0	17.7	23.2	11.7	13.5	103.4	9.2	12.4	14.7	10.8	8.2	7.5	16.7	15.8	13.6	14.8	13.6	21.0	18.1	14.6	29.2	12.6	10.1	7.7	16.6	6.1	17.4	10.7	48.0	10.2	12.0	12.4	5.6	15.2	16.1	16.5	7.1	6.7	15.8	16.5	11.7	16.2	11.7	13.3	18.5	8.2	12.3	19.7	14.7	14.2	37.8	13.9	23.0	23.4	12.0	12.2	15.9	19.8	9.6
BAZ1B	"WBSCR10, WBSCR9, WSTF"	ENSG00000009954	"Bromodomain adjacent to zinc finger domain 1B"	Q9UIG0	7	73440406-73522293	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037081, CAB037158, HPA058068"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB037081: AB_477637, CAB037158: AB_477636, HPA058068: "	"unprognostic (1.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	22.6	19.4	24.1	22.1	28.3	24.7	16.7	28.6	25.2	22.5	21.5	23.0	16.0	24.4	17.7	18.0	19.3	16.0	19.6	21.9	26.9	16.8	24.1	20.3	27.9	25.1	26.5	30.8	21.0	27.6	19.2	22.7	24.7	22.6	20.5	28.3	17.1	25.4	28.0	14.2	18.2	24.7	23.8	23.4	18.9	17.3	25.5	40.6	23.8	30.7	29.6	21.9	17.5	29.1	75.6	76.1	102.5	115.3	52.0	55.1	34.1	71.7	54.7	67.4	70.5	62.4	55.6	141.6	16.3	64.1	102.6	51.7	126.1	47.7	100.9	80.3	63.8	84.4	89.3	54.3	57.9	128.8	68.5	39.6	45.5	83.2	101.6	50.4	54.5	75.9	149.9	86.4	76.7	71.7	132.8	59.1	66.7	57.6	56.2	133.1	89.9	94.5	38.5	58.2	102.4	87.2	102.1	112.4	59.8	87.1	69.1	63.6	64.4	116.1	66.5	70.6	123.2	49.7	84.7	235.7	65.9	119.1	107.7	4.0	1.5	1.0	3.0	1.1	2.6	1.2	2.3	2.2	1.1	2.5	1.7	1.9	1.1	2.8	0.8	3.1	2.5	0.9	24.1	28.3	28.6	25.2	21.9	26.9	25.1	26.5	24.7	23.8	25.5	29.1	46.3	76.9	129.8	28.7	52.8	29.8	34.5	16.7	38.1	69.9	28.1	24.6	81.7	27.1	59.0	20.2	43.8	57.3	50.4	33.1	7.9	35.5	8.4	47.4	72.2	53.5	34.7	89.8	35.0	23.1	59.6	58.7	34.7	52.6	51.8	59.5	34.6	59.1	33.0	60.6	35.3	34.6	22.4	33.4	24.8	12.5	61.2	38.7	12.4	34.7	47.3	54.4	61.8	28.6	43.9	26.5	13.6	76.3	65.3	40.5	25.2	12.9	49.2	53.8	32.9	67.1	57.5	75.7	127.0	47.0	25.3	34.6	56.5	46.1	43.3	35.2
BCAP31	"6C6-Ag, BAP31, CDM, DXS1357E"	ENSG00000185825	"B cell receptor associated protein 31"	P51572	X	153700492-153724565	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Protein transport, Transport"		"Deafness, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003906, CAB015350, CAB015424"	Supported	Approved	Enhanced	"Endoplasmic reticulum"		NA	NA		170000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"CAB015350: AB_2243544, CAB015424: AB_781567, HPA003906: AB_1078270"	"unprognostic (1.02e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (9.87e-4)"	"unprognostic (3.25e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	294.1	213.9	171.5	100.9	175.5	151.3	210.9	171.8	213.9	139.5	202.5	157.7	133.3	127.4	228.9	214.0	151.0	118.0	123.5	183.0	192.1	160.7	185.5	144.5	111.8	190.8	187.5	130.9	266.4	193.7	123.5	143.3	195.3	154.6	166.5	63.9	179.7	177.7	81.9	187.3	143.8	155.0	183.4	138.5	129.3	117.3	186.9	99.7	161.4	75.5	134.6	177.9	145.8	185.0	505.5	482.4	128.0	650.6	593.8	179.1	295.3	269.9	287.5	291.6	371.6	386.8	361.9	315.9	1068.1	412.2	373.9	506.8	337.3	518.6	221.0	152.8	436.9	198.4	350.4	323.3	276.4	335.1	373.2	233.8	454.2	282.3	330.1	298.4	372.6	172.0	268.0	528.3	332.7	535.3	187.3	402.5	145.8	704.6	431.7	207.5	152.8	693.2	459.3	546.8	173.3	241.8	111.8	520.6	350.0	200.3	196.2	320.2	380.0	248.9	234.7	338.9	495.1	518.0	1120.1	397.3	460.9	402.6	223.7	630.5	484.2	489.1	507.5	535.7	454.7	436.1	504.5	507.4	420.7	463.6	439.1	474.7	624.5	449.8	632.3	666.9	457.1	1110.8	171.5	175.5	171.8	213.9	183.0	192.1	190.8	187.5	195.3	183.4	186.9	185.0	184.9	112.2	114.1	14.7	97.5	141.9	232.2	374.0	172.4	53.0	127.3	165.7	60.3	134.4	222.8	128.8	45.9	467.5	113.5	194.1	37.2	252.4	7.8	99.7	70.1	165.5	103.2	59.3	16.9	210.0	444.8	103.6	78.5	103.9	95.6	68.5	199.6	216.0	356.2	32.0	12.8	155.1	244.1	148.4	125.6	20.6	105.3	166.2	160.1	17.8	137.5	138.2	111.2	11.6	12.9	247.1	187.4	98.9	120.8	191.8	242.8	170.9	172.6	51.8	157.8	42.9	106.5	310.3	231.3	174.0	130.4	538.1	114.6	120.4	187.0	260.4
BCKDHA	"MSU, OVD1A"	ENSG00000248098	"Branched chain keto acid dehydrogenase E1 subunit alpha"	P12694	19	41397808-41425002	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 26.2;Gastric mucus-secreting cells: 23.4;Plasma cells: 25.0;Squamous epithelial cells: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036640	Supported					NA	NA		7700	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"			"HPA036640: AB_10671964"	"unprognostic (4.50e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.26e-2)"	"prognostic favorable (9.37e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (5.33e-10)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.27e-5)"	"unprognostic (9.66e-2)"	33.8	78.4	32.0	19.3	35.5	32.4	25.2	37.0	39.3	24.6	37.0	20.9	19.9	17.9	14.1	65.1	28.8	15.4	90.4	32.5	35.1	44.3	110.0	22.4	24.5	34.4	33.8	25.4	46.1	56.3	24.0	19.0	36.2	23.8	15.0	21.7	40.9	23.1	110.0	31.8	18.7	12.7	33.9	24.4	52.5	27.1	35.7	27.0	41.7	122.0	21.2	21.7	31.9	40.0	42.7	75.1	14.2	44.1	22.2	12.8	17.1	11.9	25.3	24.4	29.9	18.2	36.0	34.6	23.7	15.1	11.0	17.1	15.0	25.9	12.1	36.0	41.0	27.1	35.2	21.3	51.5	25.5	17.7	27.6	37.6	16.9	38.2	36.0	45.0	50.9	25.9	68.9	17.6	41.5	28.0	20.0	12.8	61.1	21.1	27.1	22.8	89.6	29.8	19.8	32.5	38.6	39.6	84.7	34.1	12.1	45.4	81.0	29.3	22.2	23.0	12.0	22.0	131.9	55.1	34.1	81.8	56.6	24.6	61.4	149.4	59.7	49.5	123.9	56.7	46.0	47.0	49.1	154.6	49.5	43.2	44.9	46.4	82.4	95.5	62.6	63.9	125.6	32.0	35.5	37.0	39.3	32.5	35.1	34.4	33.8	36.2	33.9	35.7	40.0	0.6	0.0	13.1	4.9	10.0	0.3	0.1	2.6	26.2	0.2	1.5	0.4	0.1	1.5	5.3	5.5	0.0	1.9	0.9	3.8	3.9	14.7	0.7	0.5	0.6	2.4	6.1	15.5	5.8	11.8	1.7	3.7	23.4	0.7	5.1	0.4	2.5	2.4	2.7	0.0	6.2	7.6	8.2	2.2	0.8	0.9	0.6	6.6	3.6	3.7	12.4	0.4	5.2	4.0	5.7	8.4	3.8	0.4	25.0	0.2	6.7	2.3	1.2	1.2	0.0	0.2	3.6	1.8	0.9	27.2	0.9	2.1	6.3	0.3	7.3	0.1
BCKDHB		ENSG00000083123	"Branched chain keto acid dehydrogenase E1 subunit beta"	P21953	6	80106647-80346270	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 296.5;Early spermatids: 110.9;Inhibitory neurons: 94.9;Oligodendrocyte precursor cells: 98.5;Oligodendrocytes: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031580, HPA031956"	Approved		Supported	Nucleoplasm,Nucleoli,Mitochondria	"Intracellular and membrane"	Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA031580: AB_10696054, HPA031956: "	"unprognostic (4.23e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.50e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"prognostic favorable (5.54e-9)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.49e-2)"	19.7	10.7	7.3	7.6	8.3	8.2	22.3	11.5	7.8	11.7	11.6	22.5	11.5	9.2	7.1	10.3	11.5	7.8	18.8	8.8	7.0	31.8	78.4	7.3	8.8	10.7	9.2	14.6	12.9	19.7	7.2	4.8	13.1	15.9	20.7	7.9	26.6	11.3	10.9	8.5	12.4	9.4	11.8	6.3	17.6	13.1	8.7	9.1	15.5	15.3	9.1	11.2	7.6	16.0	13.8	5.1	18.8	25.3	18.6	16.1	14.9	9.7	19.8	15.4	21.0	8.3	18.5	38.9	10.1	23.1	18.0	13.6	10.6	12.7	21.5	48.8	15.6	19.4	12.6	11.3	20.7	27.7	8.3	15.6	12.8	10.7	13.3	13.8	18.6	29.8	16.6	33.8	35.0	7.6	10.3	16.3	14.0	30.1	6.5	25.5	58.3	33.8	43.2	20.7	12.6	17.8	16.2	13.4	9.9	20.6	17.3	21.1	8.0	9.2	6.3	8.5	13.0	24.0	25.2	12.9	11.3	20.4	14.2	3.4	4.2	1.0	10.1	5.1	13.3	10.6	8.3	8.5	8.3	12.7	11.0	11.6	0.8	17.4	5.9	12.9	20.3	6.1	7.3	8.3	11.5	7.8	8.8	7.0	10.7	9.2	13.1	11.8	8.7	16.0	8.4	9.6	21.0	296.5	11.5	8.5	12.5	21.1	15.9	7.8	19.6	14.7	29.3	8.6	18.0	5.5	2.1	17.0	9.1	17.5	27.4	8.2	110.9	8.3	10.3	8.0	12.0	10.3	72.0	10.4	8.3	13.7	15.3	17.6	16.5	19.2	11.0	66.5	12.2	3.3	94.9	31.3	10.2	9.1	9.0	13.7	8.7	5.4	16.0	59.0	7.3	15.5	10.3	98.5	101.7	5.4	10.4	8.6	8.4	6.2	11.5	33.1	13.5	8.7	6.6	11.1	9.4	15.2	5.6	20.1	12.4	10.4	9.9	15.5	17.4	10.9
BCKDK		ENSG00000103507	"Branched chain keto acid dehydrogenase kinase"	O14874	16	31106107-31112791	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Autism, Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 95.9;granulocytes: 89.7;monocytes: 115.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017995, HPA056067"	Supported		Supported	Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 4: Macrophages - Innate immune response"	Mitochondria		"HPA017995: AB_1845309, HPA056067: AB_2683024"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.94e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.66e-3)"	"unprognostic (4.85e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.97e-2)"	32.3	56.4	18.4	19.2	18.6	14.5	29.0	17.4	23.8	25.1	18.0	31.4	16.0	27.7	16.7	29.4	24.8	17.9	78.6	18.8	17.8	43.8	76.4	21.7	15.6	20.6	20.7	27.5	70.5	22.9	16.4	15.3	19.3	29.3	12.5	6.3	47.0	21.8	81.3	45.4	24.1	19.5	17.1	30.2	42.0	17.4	18.5	9.8	22.4	69.7	13.6	30.2	24.6	17.5	47.5	49.1	27.1	41.8	32.8	32.5	31.1	40.4	46.3	57.3	55.9	32.1	29.1	41.5	58.9	47.5	28.0	31.4	19.3	65.6	36.5	34.4	60.1	45.2	32.6	59.5	57.5	23.5	41.9	48.3	26.2	49.2	40.6	52.6	62.4	31.1	23.4	39.4	87.7	75.8	22.9	32.4	23.0	20.5	39.1	45.8	39.6	78.8	44.3	30.1	42.1	38.7	31.3	72.4	24.6	22.9	44.5	24.6	41.1	44.2	26.1	45.8	32.2	44.5	15.7	15.1	50.3	33.7	42.6	58.1	115.0	85.2	17.7	97.6	17.2	22.8	16.5	13.9	95.9	19.0	13.6	16.1	89.7	22.8	71.2	19.3	24.5	53.1	18.4	18.6	17.4	23.8	18.8	17.8	20.6	20.7	19.3	17.1	18.5	17.5	27.2	19.2	18.1	5.9	20.0	18.5	24.6	61.0	22.2	11.6	30.9	27.6	39.1	25.8	28.5	20.2	0.0	55.4	9.0	31.5	80.3	68.6	2.5	14.6	24.3	29.2	19.9	16.4	5.1	78.0	71.1	24.9	25.5	20.0	33.0	35.4	25.4	43.8	93.0	11.8	4.4	22.3	42.7	44.5	50.3	7.8	20.8	53.1	12.4	1.9	79.3	22.6	9.2	4.5	4.5	54.8	48.4	25.6	51.7	30.9	66.9	95.2	19.6	9.8	46.0	18.4	33.2	25.8	14.1	25.7	27.4	69.4	12.1	45.5	26.0	27.0
BCO1	"BCDO, BCDO1, BCMO, BCMO1, FLJ10730"	ENSG00000135697	"Beta-carotene oxygenase 1"	Q9HAY6	16	81238689-81291142	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 5.0;intestine: 14.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 6.2;Distal enterocytes: 4.8;Excitatory neurons: 8.0;Intestinal goblet cells: 5.5;Proximal enterocytes: 13.6;Proximal tubular cells: 8.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 11.5;EFO-21: 8.7;HAP1: 3.3;NTERA-2: 4.6;RPTEC TERT1: 8.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA043811			Uncertain	"Actin filaments,Centriolar satellite"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Actin filaments, Centriolar satellite"		"HPA043811: AB_10962487"	"unprognostic (2.78e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.05e-2)"	"unprognostic (8.01e-4)"	"unprognostic (1.65e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.09e-1)"	0.0	0.0	1.8	0.2	1.3	0.0	0.1	0.0	1.2	0.2	5.0	2.6	9.3	0.6	0.2	0.3	0.4	1.2	0.0	2.5	0.2	3.5	0.8	0.2	0.0	0.4	0.4	0.9	0.3	0.0	0.7	0.0	0.1	0.5	3.0	0.2	0.5	1.5	0.1	0.3	14.6	0.3	0.1	0.0	1.9	0.1	0.7	0.2	0.1	0.0	0.0	0.2	0.4	0.6	0.0	11.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	2.3	0.0	8.7	0.0	0.3	0.1	3.3	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.6	0.8	0.0	0.0	0.0	0.0	8.6	0.3	0.3	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.3	0.0	1.2	2.5	0.2	0.4	0.4	0.1	0.1	0.7	0.6	0.0	0.0	0.0	6.2	0.0	0.0	0.3	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	1.8	0.0	0.5	0.0	4.8	0.0	0.6	0.1	0.9	1.1	0.1	1.2	0.0	8.0	0.0	0.0	0.2	0.0	4.0	0.0	0.1	0.4	0.3	0.1	0.0	3.7	5.5	0.0	0.0	0.0	0.3	1.5	0.1	0.0	1.0	0.0	0.0	0.0	2.5	1.0	0.6	2.1	1.2	0.0	0.1	13.6	8.8	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.7	0.0	0.3	0.1	0.0	3.0	0.7
BCS1L	"BCS, BJS, h-BCS, Hs.6719"	ENSG00000074582	"BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone"	Q9Y276	2	218658764-218663443	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Chaperone	"Deafness, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037700, HPA037701"	Supported					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA037700: AB_10794619, HPA037701: AB_10805235"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.28e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.31e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.21e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.38e-2)"	"prognostic favorable (3.31e-4)"	19.9	29.3	24.0	11.5	24.8	12.4	21.3	25.0	25.9	24.9	23.9	22.6	15.9	21.6	14.3	28.2	20.3	10.9	40.8	24.3	25.0	30.5	39.9	16.3	15.5	25.2	25.4	25.2	41.2	17.8	17.4	11.8	26.1	27.2	16.5	13.5	20.8	17.4	32.0	24.2	20.9	16.8	24.5	24.2	25.8	10.1	24.8	9.8	22.1	22.5	14.4	25.5	23.5	26.1	17.1	34.3	19.3	26.8	42.8	28.6	28.9	28.4	15.7	44.9	32.9	92.1	28.0	25.2	40.4	29.1	30.3	46.2	63.0	73.1	25.4	37.2	67.9	40.4	45.5	76.0	49.4	35.6	24.4	36.6	55.0	61.1	79.5	18.4	46.0	35.3	58.3	35.6	41.1	57.7	26.6	48.2	23.7	39.9	43.5	38.3	23.8	40.0	37.6	31.1	41.1	17.9	20.1	48.2	36.9	30.4	25.4	34.9	26.7	33.3	27.7	22.3	39.5	28.1	23.2	43.2	21.1	54.2	32.6	20.1	12.2	10.5	10.3	7.7	11.7	13.5	8.1	9.7	24.6	12.8	9.9	11.9	1.4	7.7	1.1	13.7	13.4	10.2	24.0	24.8	25.0	25.9	24.3	25.0	25.2	25.4	26.1	24.5	24.8	26.1	16.0	9.6	7.5	6.5	6.4	10.6	15.2	29.9	8.6	13.3	13.0	16.0	32.7	20.0	18.3	5.5	6.2	31.4	5.4	9.2	21.5	18.1	1.3	9.2	15.4	13.7	6.1	7.8	3.8	10.1	18.0	13.8	11.2	10.8	11.4	14.6	10.4	11.8	17.4	6.7	3.9	11.0	20.3	5.0	9.0	2.2	9.0	6.6	14.2	2.8	9.2	12.1	11.3	8.0	6.9	11.4	12.7	15.4	9.8	11.6	13.1	22.2	10.7	15.9	6.6	14.7	19.4	5.5	11.6	16.6	9.9	14.5	6.4	18.8	17.0	12.9
BEST1	"BEST, BMD, RP50, VMD2"	ENSG00000167995	"Bestrophin 1"	O76090	11	61950063-61965515	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Transport, Vision"	"Chloride channel, Ion channel"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.3;brain: 41.7"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 272.8"	"Group enriched"	"Detected in some"	6	"glioma: 2.0;melanoma: 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 37.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 37.6"	"Cell line enriched"	"Detected in many"	4	"SK-MEL-30: 71.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057464	Enhanced					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 11: Alveolar cells - Smell perception"			"HPA057464: AB_2683444"	"unprognostic (2.41e-3)"	"unprognostic (3.67e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-10)"	"unprognostic (1.38e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.72e-3)"	9.1	3.7	16.3	8.3	30.5	26.3	5.3	24.9	23.2	5.3	10.2	3.8	1.7	4.1	10.0	2.8	5.9	5.1	5.7	16.5	20.2	3.7	2.6	10.3	2.3	27.9	27.3	4.6	2.5	0.3	3.4	2.4	26.7	4.0	1.0	6.7	2.2	2.0	1.6	2.7	3.9	1.8	19.2	11.0	3.3	5.4	28.6	0.4	2.7	1.4	0.4	5.3	4.7	41.7	0.8	0.8	0.4	0.7	17.7	3.8	1.4	1.0	1.8	0.4	1.3	0.5	0.5	0.1	1.7	1.1	2.0	1.1	0.0	0.0	0.3	0.3	0.2	0.0	6.7	0.9	4.9	0.2	0.5	5.6	1.6	1.9	4.1	1.8	0.0	0.8	0.8	7.6	1.9	0.6	0.1	0.6	0.0	0.8	2.1	0.0	0.1	0.3	0.0	2.0	1.0	0.9	1.6	0.1	71.6	0.8	0.7	2.3	0.2	0.9	0.5	0.7	0.3	10.3	0.8	0.7	4.8	0.6	1.2	2.6	3.9	3.9	0.2	4.6	0.2	0.7	0.2	0.1	2.6	0.2	0.1	0.1	37.6	0.1	5.1	0.4	0.3	1.9	16.3	30.5	24.9	23.2	16.5	20.2	27.9	27.3	26.7	19.2	28.6	41.7	2.7	25.6	59.3	9.1	11.4	36.3	6.3	54.8	18.8	2.0	22.0	7.4	3.3	14.3	57.2	1.8	0.0	14.5	5.6	22.5	0.0	3.8	8.3	5.3	9.0	16.4	10.3	29.0	0.3	3.3	23.4	32.4	9.2	9.0	76.4	1.9	21.0	13.8	37.1	0.0	0.7	10.7	22.4	75.4	272.8	2.9	15.2	49.0	55.2	1.0	14.1	6.0	3.1	17.1	43.0	3.1	21.0	6.8	5.9	11.8	28.0	5.6	37.7	9.6	6.6	16.1	20.8	3.2	4.1	6.2	32.7	20.4	24.5	0.9	11.9	13.2
BIRC3	"API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49"	ENSG00000023445	"Baculoviral IAP repeat containing 3"	Q13489	11	102317450-102339403	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 89.0;lymphoid tissue: 141.5"	"Cell type enhanced"	"Detected in many"		"granulocytes: 554.8;Langerhans cells: 1400.9;monocytes: 1117.0;Proximal enterocytes: 817.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"memory B-cell: 209.0;naive B-cell: 159.9"	"Group enriched"	"Detected in all"	13	"B-cells: 209.0;T-cells: 83.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 146.5;Daudi: 140.7;EFO-21: 74.3;HDLM-2: 140.1;hTERT-HME1: 140.2;U-266/70: 89.2;U-266/84: 85.8"	"Low region specificity"	"Detected in all"							HPA002317	Enhanced	Approved	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cytosol"		"HPA002317: AB_1846748"	"prognostic favorable (3.60e-4)"	"unprognostic (2.89e-1)"	"prognostic favorable (9.35e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (5.83e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.88e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (6.66e-6)"	"unprognostic (6.42e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.85e-2)"	9.0	14.7	2.7	104.8	2.9	26.3	18.4	1.6	3.4	19.1	3.4	24.9	26.6	10.5	3.7	16.0	8.5	51.0	7.7	2.8	3.5	12.6	26.3	24.6	141.5	2.6	2.7	6.6	12.0	4.3	3.6	5.3	2.3	10.6	24.7	0.6	12.7	11.4	2.7	8.1	89.0	10.7	2.5	73.2	54.3	8.2	2.7	59.2	3.9	4.3	134.4	46.9	4.8	3.6	26.4	24.5	0.2	0.4	0.7	3.9	2.4	2.5	17.5	3.3	3.7	4.6	146.5	140.7	74.3	1.4	22.8	13.0	0.1	4.6	7.8	140.1	0.3	0.5	7.3	1.4	30.7	2.4	3.7	3.5	18.1	8.4	140.2	4.9	0.4	10.2	0.5	0.0	3.0	0.1	8.3	1.3	0.3	14.2	1.0	0.1	0.8	6.8	34.3	12.9	0.1	0.3	2.1	2.1	1.8	0.5	6.4	1.8	7.5	25.6	3.4	1.4	28.3	89.2	85.8	48.8	4.0	7.4	3.0	8.6	3.9	2.2	5.8	10.1	9.8	209.0	41.7	14.1	3.6	159.9	28.4	8.3	2.6	9.9	11.0	1.7	83.6	11.9	2.7	2.9	1.6	3.4	2.8	3.5	2.6	2.7	2.3	2.5	2.7	3.6	41.2	144.2	70.8	0.0	420.1	101.2	324.9	267.2	51.2	0.3	26.6	22.9	12.5	134.4	146.9	40.5	0.0	2.0	71.2	142.4	7.9	230.3	1.8	231.3	16.8	101.4	15.0	23.6	1.1	179.7	0.5	63.4	184.5	289.4	554.8	1.8	6.4	4.4	11.7	0.0	3.2	38.0	75.3	25.4	1400.9	2.1	5.0	170.0	192.1	2.8	1117.0	0.5	14.4	0.0	0.4	207.4	281.1	2.2	288.4	455.1	817.3	19.5	88.1	0.0	0.0	60.8	90.9	0.7	0.5	31.8	84.5	0.5	278.0	0.7	49.4	193.3
BLK	MGC10442	ENSG00000136573	"BLK proto-oncogene, Src family tyrosine kinase"	P51451	8	11486894-11564599	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 39.1;lymphoid tissue: 46.7"	"Cell type enriched"	"Detected in some"	11	"B-cells: 116.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"memory B-cell: 183.4;naive B-cell: 131.5"	"Lineage enriched"	"Detected in many"	5	"B-cells: 183.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 106.6;REH: 29.9;RPMI-8226: 38.5;U-698: 48.6;U-87 MG: 22.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB005093, HPA069571"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"CAB005093: AB_2274756, HPA069571: AB_2732137"	"unprognostic (6.50e-5)"	"unprognostic (4.22e-3)"	"unprognostic (5.64e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.98e-6)"	"unprognostic (1.59e-2)"	"unprognostic (8.94e-4)"	"unprognostic (1.02e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (9.05e-6)"	"unprognostic (5.62e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.16e-1)"	0.5	0.1	0.0	9.1	0.0	2.6	0.2	0.0	0.0	0.0	0.0	2.6	0.5	0.1	0.0	1.2	0.2	0.5	0.1	0.0	0.0	1.2	0.7	0.8	29.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.7	0.0	0.7	0.0	0.3	0.0	39.1	0.1	0.0	46.7	2.1	0.1	0.0	2.5	1.2	0.0	27.9	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	29.9	0.0	38.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	5.4	10.2	48.6	22.7	0.0	0.0	0.2	0.1	0.2	2.0	0.0	37.9	183.4	1.4	4.6	0.1	131.5	0.9	0.4	0.7	0.1	0.1	17.5	1.8	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	116.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.1	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	1.0	1.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	4.0	0.1	0.1	0.0
BLM	"BS, RECQ2, RECQL3"	ENSG00000197299	"BLM RecQ like helicase"	P54132	15	90717346-90816166	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.7;lymphoid tissue: 7.9;salivary gland: 7.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 18.3;Oligodendrocyte precursor cells: 58.3;Plasma cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005689	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA005689: AB_1845372"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.89e-2)"	"unprognostic (6.12e-5)"	"unprognostic (2.82e-2)"	"unprognostic (4.55e-3)"	"unprognostic (5.24e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.55e-15)"	"unprognostic (6.53e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	0.3	0.2	0.9	3.6	1.1	5.7	0.5	2.3	0.9	0.1	0.3	1.4	1.0	0.4	0.4	0.6	0.3	0.3	0.3	0.8	1.1	0.1	0.1	0.4	6.4	1.2	1.4	0.1	0.2	0.0	0.6	1.2	1.1	0.1	1.7	2.4	7.8	0.0	0.5	0.4	1.6	0.4	1.0	1.6	1.1	2.2	0.9	7.9	0.3	0.1	6.2	1.0	0.2	1.0	13.0	14.4	20.4	12.6	0.1	0.9	14.6	9.4	3.2	11.1	13.4	11.7	10.1	35.1	5.9	2.6	14.1	20.4	25.7	7.1	15.1	19.1	20.5	36.4	14.8	3.9	0.0	33.7	17.3	0.3	0.1	10.6	4.7	1.3	7.9	16.9	32.7	9.9	11.0	7.4	28.3	14.5	22.2	24.9	4.2	25.4	39.1	14.7	2.3	18.9	14.6	14.7	8.5	11.5	4.8	18.1	7.2	23.4	3.7	8.6	13.6	9.6	21.0	6.4	30.4	39.5	5.6	25.8	15.7	1.7	0.6	2.6	1.6	0.8	2.6	4.6	1.4	2.1	0.7	2.3	1.0	1.1	0.7	3.1	1.0	0.7	3.2	0.9	0.9	1.1	2.3	0.9	0.8	1.1	1.2	1.4	1.1	1.0	0.9	1.0	0.9	3.2	8.9	1.0	12.9	0.3	0.5	0.5	0.6	3.6	1.3	1.0	7.9	0.0	4.2	0.0	2.1	5.5	6.9	2.2	1.9	1.0	2.7	1.3	1.3	2.0	0.0	18.3	0.7	0.7	6.8	1.8	3.6	1.7	13.3	8.1	2.2	0.6	5.7	0.0	8.6	1.3	0.0	7.7	1.3	1.6	0.0	7.7	0.0	7.5	2.7	1.7	10.3	58.3	2.6	1.2	0.3	0.4	20.6	0.7	0.2	0.0	5.4	7.1	0.0	0.9	1.7	17.1	12.9	2.2	0.6	1.0	10.2	0.7	4.0	0.4
BLVRA	BLVR	ENSG00000106605	"Biliverdin reductase A"	P53004	7	43758680-43807342	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 259.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019709, HPA042865, HPA054322"	Approved		Supported	Cytosol		NA	NA		1200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"HPA019709: AB_2670239, HPA042865: AB_10797024, HPA054322: AB_2682450"	"unprognostic (2.47e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.79e-2)"	"unprognostic (2.16e-3)"	"unprognostic (6.45e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.63e-2)"	"prognostic favorable (8.65e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.93e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.63e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.56e-2)"	53.2	28.0	31.4	39.7	33.4	65.6	49.9	32.0	40.1	44.3	31.4	61.4	12.5	38.5	129.9	67.5	40.9	33.4	52.7	32.3	34.7	41.3	14.6	62.7	58.6	34.1	33.6	46.6	23.5	54.9	26.2	28.9	34.2	38.4	19.8	25.4	36.5	46.0	59.7	33.4	27.7	54.1	33.1	82.0	35.3	13.1	34.0	43.0	31.3	69.3	52.6	43.5	40.4	32.0	48.6	92.2	26.2	110.5	55.0	72.7	1.3	32.3	99.3	54.0	65.4	22.2	28.3	0.3	60.6	51.5	190.7	62.1	82.1	81.7	46.2	227.3	56.8	104.1	86.6	138.1	139.5	11.8	37.5	49.9	135.7	57.2	37.8	108.5	92.7	51.1	70.2	55.7	41.4	52.5	37.0	6.3	35.9	11.0	104.7	80.4	45.6	261.4	121.1	26.6	34.0	104.4	65.9	65.1	55.2	46.2	146.7	77.7	57.0	49.3	53.9	21.8	56.0	74.7	63.2	0.2	80.8	46.9	78.4	51.1	291.9	169.2	39.1	374.9	36.7	26.9	75.7	64.9	135.4	17.0	39.7	31.0	26.5	22.4	368.4	20.1	82.2	208.5	31.4	33.4	32.0	40.1	32.3	34.7	34.1	33.6	34.2	33.1	34.0	32.0	22.0	60.9	85.0	7.5	10.7	29.1	64.2	102.4	34.1	18.0	29.6	36.1	59.4	17.2	75.7	35.0	2.1	9.7	9.3	0.3	56.7	52.6	0.7	31.6	20.2	27.3	0.0	74.7	8.4	35.1	8.1	39.7	8.2	41.4	111.5	17.2	24.3	1.9	259.1	8.4	11.5	0.4	59.0	136.5	53.7	1.6	37.0	80.4	46.2	2.8	147.3	36.6	13.4	7.5	4.3	25.2	1.2	29.0	16.6	87.9	7.1	110.5	69.6	13.0	46.0	23.0	50.6	3.0	14.2	52.9	34.4	5.2	23.4	4.9	0.6	48.7
BMP1	"BMP-1, PCOLC"	ENSG00000168487	"Bone morphogenetic protein 1"	P13497	8	22165140-22212326	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor, Hydrolase, Metalloprotease, Protease"	"Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 69.3;Endometrial stromal cells: 52.8;Smooth muscle cells: 43.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014572	Enhanced				"Secreted to extracellular matrix"	NA	NA		9200000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA014572: AB_1845390"	"unprognostic (1.24e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.76e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.75e-3)"	"unprognostic (7.05e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (3.37e-9)"	"unprognostic (2.11e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.34e-2)"	11.7	17.4	3.8	6.3	4.6	1.4	9.0	4.7	4.4	15.6	4.9	8.1	4.8	12.7	3.9	7.0	11.8	9.8	5.9	4.3	3.9	7.7	14.7	8.3	1.7	5.0	4.1	5.9	4.4	3.4	3.4	27.3	4.1	9.6	5.3	0.6	3.7	6.1	3.4	6.2	5.9	14.4	4.3	5.0	4.3	2.4	4.2	1.5	10.0	3.1	1.8	10.4	10.3	4.4	15.2	20.4	7.4	30.2	47.8	41.8	23.2	54.1	50.1	33.8	27.6	5.1	27.4	3.7	32.0	56.9	18.9	51.2	5.1	27.8	6.5	3.6	6.9	6.7	24.5	7.9	31.7	2.9	14.3	49.8	26.5	25.2	11.4	78.3	31.4	5.2	7.1	10.6	19.6	4.6	1.4	3.0	4.7	17.0	8.3	6.4	8.2	15.2	26.7	4.1	2.8	10.6	52.5	3.1	13.4	20.4	5.0	8.3	41.4	17.0	18.4	32.3	23.9	4.0	2.2	0.6	23.8	10.1	28.0	0.0	0.4	0.0	0.6	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.1	3.8	4.6	4.7	4.4	4.3	3.9	5.0	4.1	4.1	4.3	4.2	4.4	12.5	6.4	69.3	5.5	0.8	6.2	5.2	22.6	4.0	2.6	5.0	6.1	4.9	2.8	6.7	5.5	0.0	3.3	3.2	31.9	0.0	25.1	0.7	3.1	52.8	14.1	3.0	0.8	3.5	8.2	9.5	28.7	1.1	5.7	15.2	13.9	14.6	20.1	4.3	1.7	2.7	6.2	0.0	3.4	6.1	1.1	10.2	5.4	10.6	4.7	1.0	2.2	3.1	6.6	6.7	15.3	18.6	10.9	2.8	4.7	13.2	4.1	2.2	1.1	26.3	6.4	43.7	1.5	4.0	6.5	5.3	24.4	3.3	34.2	10.7	8.0
BMPR1B	"ALK6, CDw293"	ENSG00000138696	"Bone morphogenetic protein receptor type 1B"	O00238	4	94757955-95158448	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Chondrogenesis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.1;cervix: 24.7;prostate: 22.4"	"Cell type enriched"	"Detected in many"	7	"Astrocytes: 480.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 32.4;prostate cancer: 24.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 22.0;MCF7: 11.1;SH-SY5Y: 18.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (2.25e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.40e-3)"	"prognostic favorable (2.84e-4)"	"unprognostic (1.57e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-3)"	"unprognostic (7.89e-4)"	"unprognostic (6.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.63e-2)"	0.7	4.6	13.4	0.3	15.4	0.1	1.0	13.5	15.0	24.7	2.1	0.9	0.1	4.4	2.4	0.2	12.5	2.6	0.8	12.5	16.0	7.8	0.8	1.7	0.0	19.3	20.1	6.2	1.1	0.1	1.9	0.7	17.5	22.4	0.2	8.1	1.0	14.2	3.0	0.8	0.1	0.6	15.3	0.9	2.4	3.7	15.6	6.4	0.5	1.1	0.0	0.2	0.5	12.1	0.0	22.0	5.6	0.0	2.3	4.8	0.2	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.2	1.0	0.0	1.3	3.6	8.4	0.1	0.0	4.9	0.0	1.4	0.0	0.6	0.5	0.1	2.7	9.0	2.8	6.2	0.4	0.1	0.0	0.0	0.0	7.1	11.1	0.6	0.1	2.1	0.1	3.2	0.2	3.4	0.1	4.3	0.1	0.2	18.8	0.3	3.2	3.2	0.8	1.7	0.0	0.0	4.0	3.8	0.2	4.3	0.0	0.0	0.0	1.5	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	13.4	15.4	13.5	15.0	12.5	16.0	19.3	20.1	17.5	15.3	15.6	12.1	0.0	6.4	0.0	480.6	0.0	2.7	1.3	13.1	1.2	0.4	3.8	1.0	3.4	2.8	33.4	60.7	0.0	0.0	0.0	0.0	1.9	3.0	1.4	28.5	1.4	1.1	18.4	0.0	51.0	0.4	0.3	1.5	0.0	20.8	0.0	38.6	2.9	0.0	0.1	0.0	2.5	0.0	8.2	0.0	1.2	1.4	3.1	0.4	28.4	22.5	0.0	38.5	0.0	10.1	2.8	0.7	0.0	3.8	0.0	28.5	0.0	0.2	15.7	1.6	0.0	1.7	2.9	1.2	10.6	0.4	2.3	0.0	0.5	4.4	0.0	1.6
BPGM		ENSG00000172331	"Bisphosphoglycerate mutase"	P07738	7	134646811-134679816	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Congenital erythrocytosis, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 87.3"	"Group enriched"	"Detected in all"	4	"Distal tubular cells: 129.1;Erythroid cells: 456.6;Syncytiotrophoblasts: 368.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 118.2;RT4: 186.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016493, HPA028735"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA		81000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA016493: AB_1845414, HPA028735: AB_10600791"	"unprognostic (2.56e-1)"	"prognostic favorable (7.95e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.96e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.67e-3)"	"unprognostic (7.42e-2)"	"unprognostic (5.69e-2)"	"prognostic favorable (1.54e-8)"	"unprognostic (2.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.78e-2)"	11.4	12.6	16.3	9.1	17.1	87.3	12.4	17.9	20.5	12.5	15.8	12.9	8.4	9.6	18.5	26.9	8.5	12.9	13.5	16.5	19.0	35.1	13.1	14.0	11.1	17.9	17.8	7.1	8.4	35.3	18.1	47.0	18.2	13.5	10.0	19.9	17.8	17.9	37.8	10.7	8.0	12.1	19.6	12.5	11.9	14.7	17.7	16.3	11.9	27.0	26.2	39.0	17.2	18.5	14.0	16.3	21.7	29.6	24.3	14.4	21.9	41.3	49.9	15.7	23.2	6.5	18.5	17.1	12.0	23.2	30.9	11.2	23.3	22.7	27.6	118.2	19.9	9.8	15.4	7.8	16.7	18.8	12.4	14.2	20.0	29.7	16.0	24.0	58.0	20.8	28.8	20.9	37.8	6.6	30.7	26.0	22.7	27.7	15.3	23.2	15.5	12.4	36.1	186.8	18.7	31.1	19.3	23.1	21.7	23.1	15.1	11.8	44.7	25.1	6.0	33.7	33.9	33.9	41.2	21.5	43.3	17.7	43.7	61.1	16.4	48.9	23.3	22.2	16.7	19.3	15.0	20.7	17.5	18.9	20.7	21.1	30.2	18.5	23.0	11.4	21.1	23.6	16.3	17.1	17.9	20.5	16.5	19.0	17.9	17.8	18.2	19.6	17.7	18.5	17.6	9.6	25.5	6.5	15.7	39.0	18.5	60.6	10.8	19.2	15.9	18.7	25.0	18.6	52.3	27.6	2.1	44.5	43.0	5.0	129.1	45.9	3.4	10.0	7.0	18.8	13.1	456.6	8.0	18.2	32.7	17.0	4.1	8.5	24.7	6.6	10.0	4.7	15.1	20.2	9.3	4.6	36.7	11.7	10.5	7.2	10.2	11.8	23.2	5.6	15.7	25.6	47.4	7.5	11.6	49.0	4.6	12.0	14.2	26.0	5.5	68.8	50.5	13.5	6.6	12.0	22.1	33.9	21.8	13.5	13.2	368.9	25.0	7.8	4.8	19.2
BPNT2	"FLJ20421, gPAPP, IMPA3, IMPAD1"	ENSG00000104331	"3'(2'), 5'-bisphosphate nucleotidase 2"	Q9NX62	8	56957931-56993867	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.6;Cardiomyocytes: 53.8;Cytotrophoblasts: 18.0;dendritic cells: 16.2;Extravillous trophoblasts: 91.8;Hofbauer cells: 26.6;Syncytiotrophoblasts: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009411	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		480000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA009411: AB_1079138"	"unprognostic (1.62e-2)"	"unprognostic (7.89e-3)"	"unprognostic (6.58e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.05e-1)"	37.6	37.3	14.8	16.1	19.9	12.4	19.3	19.2	19.8	25.5	8.9	17.4	13.3	21.9	16.2	19.1	13.4	16.5	29.4	16.0	17.9	23.4	36.2	17.2	12.3	17.2	17.6	11.8	19.6	35.6	13.7	24.9	17.7	31.0	17.6	19.7	21.9	23.6	37.4	14.3	12.7	25.7	15.3	15.5	16.9	16.5	18.0	15.4	27.1	30.1	13.3	22.4	12.2	29.3	42.4	34.5	26.0	26.9	78.2	53.3	35.7	62.9	60.9	44.1	38.3	17.4	29.2	26.3	47.0	67.3	31.2	33.7	31.8	42.5	65.0	36.4	22.7	51.4	23.0	31.2	48.5	33.0	35.1	43.2	41.6	39.7	63.9	40.8	59.5	24.3	22.5	46.1	48.9	22.1	40.6	19.8	19.2	48.1	12.7	27.9	23.4	29.7	46.0	24.9	10.1	28.1	35.3	42.9	36.3	27.1	38.4	23.9	50.1	59.3	34.2	59.2	45.8	47.5	42.5	27.8	81.0	27.0	37.3	1.8	0.9	0.5	0.9	0.6	0.7	0.7	0.6	0.5	0.7	0.9	0.6	1.1	2.5	3.2	2.6	1.0	0.4	0.3	14.8	19.9	19.2	19.8	16.0	17.9	17.2	17.6	17.7	15.3	18.0	29.3	22.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.8	0.0	0.0	0.0	0.0	18.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	91.8	14.4	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	33.8	1.8	0.0	0.0	0.0
BRCA1	"BRCC1, FANCS, PPP1R53, RNF53"	ENSG00000012048	"BRCA1 DNA repair associated"	P38398	17	43044295-43170245	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"	"Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 42.5;Granulosa cells: 38.2;Spermatocytes: 105.8;Spermatogonia: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 6.8;classical monocyte: 14.7;intermediate monocyte: 4.7;myeloid DC: 10.9;neutrophil: 11.3"	"Group enriched"	"Detected in all"	6	"dendritic cells: 10.9;granulocytes: 11.3;monocytes: 14.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB001946, HPA004840, HPA034966, HPA057371"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"		"CAB001946: , HPA004840: , HPA034966: AB_10795287, HPA057371: AB_2732611"	"unprognostic (7.87e-3)"	"unprognostic (6.97e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.56e-3)"	"unprognostic (4.14e-3)"	"unprognostic (9.62e-3)"	"unprognostic (2.47e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.31e-2)"	3.1	1.8	4.2	7.5	7.2	13.0	3.6	4.7	5.2	2.7	2.7	6.8	3.2	3.1	2.2	4.0	3.7	1.9	3.0	3.6	4.1	2.0	5.6	3.2	10.3	5.6	5.0	2.8	2.8	5.9	2.8	3.8	6.0	2.4	7.4	8.2	3.2	1.6	4.2	6.0	5.1	3.9	3.7	3.9	3.6	13.0	5.5	14.5	7.8	3.7	11.2	2.8	2.4	10.8	44.1	69.1	37.8	30.1	6.0	13.4	36.6	50.6	21.5	41.9	39.3	42.3	33.4	100.8	9.1	19.0	49.0	49.5	51.9	28.3	69.5	46.9	38.0	48.1	54.0	37.1	1.3	86.0	39.9	3.8	4.5	63.1	20.0	10.6	22.3	46.6	73.7	42.2	39.7	30.0	72.0	27.8	20.5	29.1	18.7	49.0	79.8	40.8	15.4	42.1	25.8	27.4	38.8	12.5	19.4	25.5	33.9	39.6	13.8	37.2	29.6	49.0	53.2	20.1	51.2	75.5	29.6	49.6	39.4	6.8	14.7	2.2	1.5	4.7	1.5	1.2	1.5	1.2	10.9	2.1	1.3	1.5	11.3	1.5	2.0	1.7	0.5	17.5	4.2	7.2	4.7	5.2	3.6	4.1	5.6	5.0	6.0	3.7	5.5	10.8	5.0	0.0	2.8	9.4	5.8	2.9	4.5	1.9	1.2	10.3	4.4	5.2	10.1	5.7	3.5	1.8	22.9	12.8	8.1	6.2	0.0	3.0	11.9	14.0	6.3	4.7	0.0	42.5	3.0	1.1	18.2	7.4	6.1	4.2	8.2	38.2	5.3	18.3	10.1	11.8	4.4	7.5	0.0	3.9	2.8	8.0	2.5	6.4	0.0	4.7	4.9	2.4	5.2	3.0	18.7	1.7	2.4	1.5	16.6	2.3	1.1	1.0	10.0	22.8	6.6	13.7	5.5	105.8	73.5	8.2	2.3	4.0	4.7	9.7	12.7	3.4
BRCC3	"BRCC36, C6.1A, CXorf53"	ENSG00000185515	"BRCA1/BRCA2-containing complex subunit 3"	P46736	X	155071420-155123077	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Metalloprotease, Protease"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048737			Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA048737: AB_2680504"	"unprognostic (1.16e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.71e-3)"	"unprognostic (7.14e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.90e-1)"	9.9	12.9	6.8	12.1	6.6	15.6	15.8	9.2	7.7	12.8	6.8	22.3	19.3	9.2	18.5	18.4	11.6	8.4	11.2	6.6	7.0	17.8	13.8	9.8	15.4	5.9	7.1	8.1	11.4	14.7	5.2	14.0	6.7	14.6	23.3	12.9	18.5	10.9	17.8	11.1	16.9	10.6	5.4	11.0	15.6	2.3	7.4	13.4	15.2	17.6	15.5	12.6	6.3	6.6	95.6	45.1	24.4	19.6	20.9	17.7	37.9	35.9	25.8	24.1	52.3	44.0	40.1	84.1	62.8	22.1	36.1	36.3	54.4	33.6	38.0	45.4	42.1	17.7	76.1	41.4	15.8	62.8	25.5	17.3	16.9	35.1	28.5	23.1	30.1	32.2	27.4	24.9	24.6	33.6	25.8	28.8	22.3	101.9	41.9	36.2	43.3	42.0	36.8	36.5	38.0	17.3	25.6	43.6	27.3	31.5	25.2	33.7	31.5	20.4	32.1	27.6	53.8	30.0	56.1	114.5	28.2	61.5	25.3	36.8	18.8	34.0	20.0	22.9	23.4	17.6	19.3	18.2	21.2	16.7	14.8	16.6	10.5	28.4	24.1	13.3	25.4	16.9	6.8	6.6	9.2	7.7	6.6	7.0	5.9	7.1	6.7	5.4	7.4	6.6	12.0	32.1	23.3	16.6	14.0	5.5	7.0	13.8	6.8	13.0	15.0	14.0	27.2	10.0	28.5	7.3	14.6	26.7	17.6	25.5	19.6	22.9	0.6	13.8	13.7	10.6	9.6	17.1	31.9	19.8	26.6	11.3	12.8	15.9	26.6	13.7	8.6	8.6	17.4	8.4	35.2	22.6	16.2	9.5	7.0	1.3	5.9	14.5	5.4	15.9	22.3	12.9	20.6	26.7	29.2	14.7	16.8	12.0	21.1	10.3	16.3	18.0	25.1	14.5	19.7	12.6	22.9	1.2	1.3	26.2	6.5	13.5	14.9	18.3	27.3	8.3
BRIP1	"BACH1, FANCJ, OF"	ENSG00000136492	"BRCA1 interacting protein C-terminal helicase 1"	Q9BX63	17	61679139-61863528	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.2;lymphoid tissue: 5.9;testis: 7.0"	"Group enriched"	"Detected in many"	12	"Early spermatids: 186.2;Late spermatids: 194.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 88.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005474	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes			"Cluster 26: Non-specific - Mitochondria"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear membrane"		"HPA005474: AB_2667333"	"unprognostic (1.88e-1)"	"unprognostic (1.55e-2)"	"prognostic favorable (3.45e-5)"	"unprognostic (6.85e-4)"	"unprognostic (3.09e-1)"	"prognostic favorable (3.62e-4)"	"unprognostic (2.60e-3)"	"unprognostic (5.60e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.75e-2)"	"unprognostic (3.41e-12)"	"unprognostic (1.19e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.62e-3)"	0.3	0.3	0.8	1.7	0.6	7.2	0.9	1.3	0.9	0.4	0.0	1.7	2.0	0.8	0.4	1.5	0.3	0.6	0.1	0.5	0.2	0.3	1.6	0.4	2.8	0.3	0.0	1.1	0.3	0.1	0.0	0.8	0.4	0.4	1.9	0.5	0.4	0.2	0.1	2.0	1.9	0.9	0.0	0.7	0.9	7.0	0.2	5.9	0.3	0.1	3.3	0.7	0.6	0.8	26.6	9.4	25.0	14.1	0.9	2.1	5.5	23.6	13.3	24.6	31.8	9.5	8.0	14.9	5.2	4.9	7.7	9.2	12.8	4.5	33.3	3.8	15.8	15.5	14.4	10.5	0.2	20.3	8.8	0.6	0.4	20.2	5.1	3.4	5.0	14.8	11.6	10.5	14.4	88.9	32.5	6.7	5.3	5.9	7.3	19.7	50.1	7.1	3.0	12.8	10.0	24.2	9.4	3.0	3.3	9.1	8.3	7.3	4.5	36.9	26.5	13.5	26.6	6.3	13.3	16.6	7.3	9.3	8.8	1.0	0.1	0.4	0.1	0.0	0.1	0.5	0.3	0.1	0.1	0.6	0.4	0.2	0.3	0.1	0.1	0.1	1.0	0.1	0.8	0.6	1.3	0.9	0.5	0.2	0.3	0.0	0.4	0.0	0.2	0.8	0.2	0.0	0.5	1.0	1.6	2.3	1.3	0.8	0.6	0.3	1.1	1.8	0.6	0.0	4.0	0.0	0.0	2.0	2.0	1.8	0.0	0.3	186.2	0.7	1.7	0.8	0.0	7.4	4.6	0.2	3.0	2.0	2.0	1.6	0.0	15.5	0.4	3.4	1.7	0.0	3.3	1.8	0.0	0.8	1.1	194.1	1.2	1.0	3.6	2.8	0.6	0.2	1.0	1.5	1.0	0.8	0.1	1.2	4.8	0.4	1.4	0.2	0.8	0.2	0.0	2.5	1.8	12.1	6.0	2.9	0.4	0.3	2.3	2.1	4.7	0.7
BSCL2	"GNG3LG, seipin, SPG17"	ENSG00000168000	"BSCL2 lipid droplet biogenesis associated, seipin"	Q96G97	11	62690275-62709845	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid degradation, Lipid metabolism"		"Congenital generalized lipodystrophy, Diabetes mellitus, Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 292.1;pituitary gland: 237.0"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 35.9;Late spermatids: 53.1;Plasma cells: 86.3;Spermatocytes: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 242.1;RPMI-8226: 176.1;SCLC-21H: 181.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042394	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA042394: AB_10794047"	"unprognostic (7.78e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.41e-1)"	"prognostic favorable (7.55e-5)"	"unprognostic (3.56e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.96e-1)"	24.9	88.1	126.6	7.4	133.2	12.0	26.2	75.0	155.6	38.2	85.4	24.3	10.8	28.4	156.7	24.1	63.7	21.5	18.7	134.9	292.1	50.8	39.3	26.7	15.3	138.1	139.0	32.7	79.4	61.7	237.0	10.0	203.4	35.4	13.3	52.6	66.1	30.3	30.9	25.1	17.2	13.7	83.1	16.2	37.1	190.3	169.3	14.4	37.9	15.5	8.9	17.5	26.1	89.9	18.0	61.7	49.6	83.8	130.8	41.5	7.2	7.2	34.4	13.6	14.5	9.6	26.3	11.9	16.5	25.2	11.8	62.1	5.2	21.8	7.0	30.7	5.0	10.9	33.4	7.8	27.7	9.7	13.5	27.8	16.6	26.9	10.9	19.7	10.8	33.0	7.8	242.1	19.8	44.0	11.4	21.8	132.4	13.9	13.0	21.3	4.2	176.1	65.0	2.4	181.2	29.4	28.2	13.9	25.3	5.7	41.3	15.3	6.5	16.5	3.7	24.5	4.2	32.2	72.5	16.6	82.4	3.2	14.5	26.6	59.2	34.6	24.7	46.2	27.4	27.5	25.5	26.1	42.4	29.7	25.7	27.0	14.2	41.0	40.3	54.3	33.1	43.3	126.6	133.2	75.0	155.6	134.9	292.1	138.1	139.0	203.4	83.1	169.3	89.9	0.8	16.0	5.6	0.0	7.1	1.7	1.0	1.4	35.9	2.5	3.6	2.2	0.2	1.5	1.6	3.7	0.0	2.4	0.9	1.7	3.9	2.0	25.5	4.8	1.5	2.9	0.0	8.8	0.0	1.1	1.9	9.2	20.4	1.5	2.5	0.7	1.4	2.1	1.9	3.3	0.0	1.6	6.1	2.5	3.1	53.1	2.5	6.2	12.4	0.0	0.7	0.8	1.0	0.0	0.0	0.5	1.6	3.0	86.3	0.9	2.5	6.0	23.9	1.2	6.6	1.2	4.1	32.6	18.1	24.7	4.0	1.5	6.5	0.7	1.2	0.5
BSND	"BART, DFNB73"	ENSG00000162399	"Barttin CLCNK type accessory subunit beta"	Q8WZ55	1	54998933-55017172	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Bartter syndrome, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"kidney: 9.4"	"Group enriched"	"Detected in some"	6	"Distal tubular cells: 25.4;Ionocytes: 87.5"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	25	"RPMI-8226: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053836, HPA060617"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA053836: AB_2682277, HPA060617: AB_2732651"	"unprognostic (3.38e-2)"	"unprognostic (9.17e-2)"		"unprognostic (2.27e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.35e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.51e-1)"		"unprognostic (1.78e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.57e-1)"			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	9.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	9.2	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1
BTD		ENSG00000169814	Biotinidase	P43251	3	15601341-15722311	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 95.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052275	Uncertain				"Secreted to blood"	NA	NA		2800000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA052275: AB_2681782"	"unprognostic (6.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.37e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.37e-3)"	"unprognostic (4.26e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (2.60e-9)"	"unprognostic (2.44e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.73e-2)"	25.3	16.7	10.7	8.0	12.7	13.1	16.4	20.2	12.6	13.7	11.0	15.9	46.1	13.2	62.4	9.9	18.3	19.9	10.2	11.5	10.3	37.6	95.9	15.9	9.6	12.0	10.0	25.3	44.1	27.7	5.9	17.0	12.6	19.5	17.0	35.2	16.0	21.1	7.8	9.5	30.7	14.1	10.3	11.3	24.4	18.2	9.9	10.6	26.8	11.4	10.4	14.3	7.5	19.1	9.2	22.0	7.8	7.3	51.7	15.3	39.6	15.4	18.4	16.2	28.3	10.1	21.5	4.1	16.3	31.6	7.1	9.7	5.3	16.7	18.7	7.6	11.7	12.9	28.8	24.8	12.7	8.8	14.7	18.3	16.9	42.9	5.1	39.7	30.5	5.9	8.7	32.3	44.7	11.1	4.5	8.2	8.5	16.9	13.0	5.9	18.4	27.9	16.5	17.7	5.3	11.8	17.9	5.2	24.4	15.1	19.9	11.3	24.3	20.5	13.6	19.1	10.1	8.9	11.4	4.1	21.4	7.7	14.4	74.1	20.7	44.9	22.9	19.6	21.0	14.7	23.3	19.2	21.4	13.1	19.7	15.4	19.8	15.0	15.8	24.9	28.8	16.5	10.7	12.7	20.2	12.6	11.5	10.3	12.0	10.0	12.6	10.3	9.9	19.1	14.9	6.4	11.0	11.8	11.7	5.9	12.4	25.0	6.2	13.5	9.1	7.9	6.0	45.8	16.7	18.4	18.8	25.3	19.7	9.9	5.9	21.1	31.0	9.5	6.0	9.1	7.2	4.0	6.6	28.5	22.4	14.5	9.7	5.7	5.1	8.9	20.3	63.3	14.9	5.0	12.2	8.5	16.2	8.2	5.9	17.9	32.3	9.2	10.6	5.6	8.7	19.2	6.2	27.2	23.9	12.0	17.9	18.0	16.6	6.3	52.1	32.0	19.8	54.1	13.1	8.5	8.6	45.3	7.5	7.7	5.5	23.1	13.6	17.4	8.9	9.5
BUB1B	"Bub1A, BUBR1, MAD3L, SSK1"	ENSG00000156970	"BUB1 mitotic checkpoint serine/threonine kinase B"	O60566	15	40161023-40221123	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.8;lymphoid tissue: 35.7;testis: 22.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 23.5;Spermatocytes: 79.2;Spermatogonia: 26.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA008419			Supported	Cytosol		Yes	Yes			"Cluster 24: B-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA008419: AB_1078308"	"unprognostic (4.40e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.44e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (7.43e-6)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (3.69e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.94e-2)"	0.4	0.5	0.1	6.7	0.1	17.8	1.6	0.3	0.2	1.0	7.7	4.6	4.7	1.2	0.3	5.2	0.6	0.6	0.3	0.3	0.1	0.3	0.4	1.0	12.6	0.0	0.1	0.2	0.2	0.2	0.1	3.4	0.1	0.4	6.0	0.1	0.9	0.2	0.0	3.5	4.1	2.1	0.0	3.1	2.4	22.2	0.2	35.7	0.5	0.0	15.0	1.5	1.7	0.0	66.5	32.8	103.0	41.5	2.5	7.1	33.2	60.9	34.2	64.6	55.7	48.1	25.0	59.7	33.5	22.7	59.0	72.6	98.8	33.2	70.5	51.8	52.1	86.4	83.6	45.5	0.2	79.0	45.7	1.6	2.0	39.2	37.1	12.9	47.7	66.5	76.4	61.7	65.6	22.5	62.5	48.9	70.2	55.6	36.8	66.5	83.7	45.2	19.9	33.1	67.1	40.8	38.0	35.9	13.3	45.1	41.9	40.9	27.6	49.3	51.8	49.2	55.5	32.1	58.2	95.6	26.3	87.8	65.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.2	1.1	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.1	0.1	0.1	0.3	0.2	0.3	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.1	3.2	1.1	0.3	1.8	0.8	0.3	1.0	1.8	0.7	0.9	2.0	0.8	0.0	1.9	0.0	0.0	5.4	0.6	1.8	0.0	0.4	3.0	0.9	1.4	1.0	0.0	23.5	0.7	0.0	6.7	2.4	5.6	2.1	0.0	12.9	1.1	0.3	5.2	0.0	0.7	2.5	0.0	1.9	1.7	3.3	1.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	1.5	0.4	12.6	0.3	0.3	0.1	0.2	0.2	6.6	0.2	1.7	79.2	26.8	6.9	0.3	0.8	1.8	0.8	5.4	0.6
BVES	"HBVES, POP1, POPDC1"	ENSG00000112276	"Blood vessel epicardial substance"	Q8NE79	6	105096822-105137157	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Developmental protein"	"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 27.8;skeletal muscle: 43.9;tongue: 29.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 34.2;Early spermatids: 36.1;Late spermatids: 55.3;Oligodendrocytes: 17.8;Spermatocytes: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 29.7;WM-115: 30.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA014788, HPA018176"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		Yes	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cell Junctions"		"HPA014788: AB_1845504, HPA018176: AB_1845503"	"unprognostic (2.91e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.37e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.29e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.84e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.24e-4)"	2.9	0.7	2.6	2.3	7.1	0.2	1.5	5.8	3.6	2.5	4.6	14.9	1.4	5.8	1.7	5.3	2.8	1.8	27.8	2.7	4.3	1.6	0.3	1.9	0.6	7.3	5.6	1.0	0.6	0.7	2.4	3.5	7.4	5.2	3.3	0.2	1.4	10.0	43.9	0.7	3.0	17.7	5.2	0.3	6.9	11.5	5.2	0.2	1.3	29.3	0.4	9.3	2.2	10.8	1.3	2.0	7.6	1.3	10.9	14.9	3.3	5.8	4.1	8.8	11.6	0.5	0.0	0.0	0.0	10.9	14.7	0.1	3.3	2.0	8.1	0.0	2.8	0.0	1.0	0.3	2.4	0.0	0.6	8.7	6.9	13.6	1.1	6.6	4.0	3.3	0.1	19.3	19.7	0.1	0.2	1.0	1.6	0.0	0.0	5.7	29.7	0.0	0.0	0.0	9.9	17.1	3.7	0.1	7.7	5.5	0.0	20.0	8.9	14.0	0.0	0.0	15.3	1.8	0.8	0.0	8.3	0.0	30.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	2.6	7.1	5.8	3.6	2.7	4.3	7.3	5.6	7.4	5.2	5.2	10.8	2.1	0.0	0.0	1.6	0.0	0.3	0.4	0.1	0.6	0.0	0.4	1.0	34.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	36.1	1.9	4.4	3.1	0.0	0.0	3.3	0.0	0.2	2.6	0.0	6.0	0.0	0.9	2.2	0.1	2.3	0.0	0.6	0.0	0.0	0.0	1.9	55.3	1.2	0.5	0.0	3.7	1.0	0.0	0.0	5.0	17.8	0.1	0.0	3.4	0.0	0.5	0.1	0.1	0.1	0.0	13.1	11.8	4.4	24.4	5.4	0.1	0.9	0.1	0.2	1.3	0.0	0.3
C1QBP	"gC1Q-R, gC1qR, HABP1, p32, SF2p32"	ENSG00000108561	"Complement C1q binding protein"	Q07021	17	5432777-5448830	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Apoptosis, Complement pathway, Host-virus interaction, Immunity, Innate immunity, mRNA processing, mRNA splicing, Ribosome biogenesis, Transcription, Transcription regulation"		"Cancer-related genes, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026483	Supported		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"	NA	NA		410000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"	Mitochondria	"HPA026483: AB_1847108"	"unprognostic (2.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.76e-2)"	"unprognostic (7.47e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.40e-3)"	"unprognostic (6.03e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.08e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.97e-1)"	79.3	135.4	85.5	84.1	85.7	121.2	108.7	91.5	118.3	58.4	119.6	140.3	95.9	66.4	68.3	138.6	74.5	48.7	126.3	89.5	94.3	136.4	134.5	54.7	115.7	89.6	92.3	52.7	72.9	127.7	81.3	75.8	93.2	63.9	141.6	86.7	66.2	73.1	174.2	81.3	78.4	80.9	93.1	73.5	74.3	62.5	90.7	98.5	65.1	160.1	135.6	108.4	73.9	97.3	443.8	671.0	233.0	378.0	169.8	207.7	313.7	330.4	268.5	751.4	458.8	646.8	143.7	941.8	317.8	251.3	271.3	385.8	756.7	448.9	689.8	216.6	1300.5	433.9	312.4	762.2	269.9	535.6	331.0	231.4	404.1	414.6	593.1	181.1	390.0	548.2	526.1	234.4	296.1	308.6	766.4	385.6	525.9	497.2	396.7	601.2	329.1	515.0	440.5	328.7	186.0	348.0	271.4	344.4	483.6	232.1	218.1	267.1	231.1	240.1	219.7	275.9	729.9	122.0	201.2	415.0	229.3	506.2	376.8	68.1	197.6	49.9	217.1	212.0	283.5	330.1	239.0	215.4	389.5	289.8	289.7	245.7	15.5	240.7	166.4	325.4	203.6	432.6	85.5	85.7	91.5	118.3	89.5	94.3	89.6	92.3	93.2	93.1	90.7	97.3	101.6	28.9	30.5	10.7	153.1	243.1	229.0	283.3	165.0	70.5	157.3	209.4	84.8	102.9	107.8	82.8	27.1	323.8	115.0	105.6	313.1	248.0	75.1	106.7	149.9	108.2	79.2	183.1	10.8	205.1	457.9	101.0	94.8	85.9	62.2	131.6	75.3	128.5	202.7	60.6	11.6	190.2	154.6	85.3	129.8	89.5	119.6	101.8	156.5	10.3	170.3	105.2	93.7	11.1	16.1	199.3	128.5	98.6	197.4	255.1	78.9	444.1	65.1	79.9	85.5	101.6	189.1	79.3	237.3	284.4	255.3	179.0	105.5	354.3	364.0	253.8
C2		ENSG00000166278	"Complement C2"	P06681	6	31897785-31945672	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 477.9"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 142.4;Hepatocytes: 380.3;Hofbauer cells: 282.7;Kupffer cells: 99.3"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 100.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 21.1;non-classical monocyte: 25.9"	"Lineage enriched"	"Detected in single"	35	"monocytes: 25.9"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 284.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB016775	Supported				"Secreted to blood"	NA	NA		34000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB016775: "	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (3.27e-2)"	"unprognostic (3.15e-3)"	"prognostic unfavorable (2.64e-7)"	"unprognostic (2.05e-1)"	"unprognostic (4.42e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.55e-2)"	42.6	12.1	0.8	27.6	1.0	3.2	11.7	0.9	1.4	8.1	1.7	14.3	16.7	7.0	1.3	7.6	12.0	23.0	8.5	0.7	1.1	23.2	477.9	80.0	27.8	3.0	2.6	5.3	1.9	0.9	3.8	48.4	3.0	5.4	13.0	0.4	9.1	0.9	2.1	5.8	30.2	23.6	2.1	46.3	12.0	4.1	3.7	5.5	3.3	2.7	12.5	23.6	5.3	2.1	0.3	0.1	0.1	0.6	0.1	0.0	6.8	0.5	0.3	0.4	0.3	0.4	0.3	0.6	3.5	1.0	0.6	0.5	0.1	0.0	0.3	0.2	0.4	0.3	0.4	52.8	1.1	0.1	0.7	2.7	0.3	0.6	0.1	0.6	0.0	0.7	0.5	284.0	0.0	0.0	0.4	0.5	0.3	0.1	0.0	0.2	16.5	3.0	0.0	0.1	0.3	0.3	2.6	0.3	0.2	0.3	0.2	9.5	0.2	0.2	0.7	0.5	0.1	0.9	31.6	2.7	0.8	0.9	0.1	0.1	5.6	0.0	0.1	21.1	0.1	0.0	0.0	0.0	0.7	0.1	0.1	0.1	0.5	0.1	25.9	0.0	0.0	2.2	0.8	1.0	0.9	1.4	0.7	1.1	3.0	2.6	3.0	2.1	3.7	2.1	2.1	25.6	142.4	2.6	1.9	3.3	1.1	2.0	0.6	1.4	1.3	1.3	0.6	25.8	11.2	1.8	0.0	2.1	0.1	1.8	0.0	0.6	0.3	1.5	18.7	1.9	2.4	10.7	6.6	2.7	2.7	19.8	3.1	1.3	3.8	0.2	21.0	380.3	282.7	1.7	6.3	11.3	0.0	99.3	5.0	1.3	6.8	32.6	3.6	7.5	7.3	0.1	0.0	1.0	1.7	4.5	33.1	1.2	0.4	4.0	55.2	35.7	9.4	0.9	0.0	5.6	3.5	0.8	1.4	0.7	2.8	4.0	2.0	0.5	15.8	4.5
C6		ENSG00000039537	"Complement C6"	P13671	5	41142116-41261438	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"liver: 665.9"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 127.2;Hepatocytes: 376.9;Late spermatids: 54.8;Leydig cells: 120.2;Respiratory ciliated cells: 58.0"	"Group enriched"	"Detected in many"	7	"liver cancer: 49.0;pancreatic cancer: 12.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"ASC diff: 4.5;ASC TERT1: 6.2;HSkMC: 16.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA043823, CAB069427"	Enhanced				"Secreted to blood"	NA	NA	45000000000	9200000000		"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB069427: AB_1614336, HPA043823: AB_10960262"	"unprognostic (9.79e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.04e-3)"	"prognostic favorable (4.31e-4)"	"unprognostic (2.69e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"	12.8	1.1	0.2	0.0	0.2	0.0	5.4	0.2	0.1	0.8	1.6	0.8	0.9	0.4	0.9	0.3	43.9	12.0	57.1	0.2	0.6	4.4	665.9	3.2	0.4	0.0	1.7	6.2	42.7	0.1	0.7	2.8	0.2	0.9	0.6	0.0	0.9	0.6	0.6	0.6	1.4	0.9	0.1	0.3	2.2	4.2	0.8	0.6	2.0	0.7	0.5	0.9	0.6	0.6	0.0	0.0	0.0	0.0	4.5	6.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.2	0.6	0.0	1.7	0.2	0.1	0.8	0.6	0.8	0.0	0.0	0.7	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	20.9	127.2	7.5	0.0	0.0	0.0	0.1	0.3	0.0	9.3	11.3	37.5	0.8	0.9	0.0	8.0	1.4	0.4	0.0	6.7	0.0	0.7	0.0	0.1	5.0	376.9	0.0	0.0	2.7	1.0	0.0	9.7	0.3	54.8	120.2	0.2	0.0	0.0	0.0	0.0	0.0	1.0	1.3	0.5	1.3	0.4	0.0	0.0	11.6	0.8	58.0	0.0	0.0	0.2	0.4	0.4	0.1	0.0	0.0	0.0	0.4	0.5	0.6	0.0
C8A		ENSG00000157131	"Complement C8 alpha chain"	P07357	1	56854797-56918223	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	195	"liver: 635.7"	"Cell type enriched"	"Detected in some"	36	"Hepatocytes: 296.4"	"Cancer enriched"	"Detected in single"	279	"liver cancer: 85.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"Hep G2: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		6400000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"										"unprognostic (3.73e-3)"	"unprognostic (2.44e-1)"			"unprognostic (1.28e-1)"			"unprognostic (6.40e-2)"		"unprognostic (9.82e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.1	635.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	5.3	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	296.4	0.0	0.0	0.1	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1
CAD	GATD4	ENSG00000084774	"Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"	P27708	2	27217369-27243943	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Allosteric enzyme, Hydrolase, Ligase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007781, HPA065158, HPA069341"	Supported		Supported	Cytosol		NA	No		260000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"CAB007781: AB_562057, HPA065158: , HPA069341: AB_2686125"	"unprognostic (1.69e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (1.72e-11)"	"unprognostic (1.25e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.93e-3)"	15.0	13.5	12.7	12.4	14.1	9.0	14.9	12.7	15.5	19.8	12.2	16.5	8.5	23.8	9.9	19.2	19.3	7.7	11.6	12.3	12.8	18.0	27.8	12.3	14.9	13.8	13.5	22.3	22.3	5.9	18.7	7.5	14.5	15.2	7.8	5.0	12.3	8.8	10.3	18.7	16.1	11.9	12.7	20.1	14.0	22.2	14.2	11.6	15.8	5.9	10.5	16.9	15.8	15.2	75.2	66.4	28.9	58.4	46.1	37.6	22.9	31.0	21.4	38.3	27.0	75.7	29.2	66.4	27.4	28.5	29.6	41.4	85.7	41.1	28.5	43.8	69.2	95.2	55.0	40.0	23.0	75.7	46.2	28.8	33.1	55.7	63.0	17.8	41.6	60.6	68.3	36.0	34.2	74.8	48.7	112.0	69.7	31.3	49.7	84.0	86.5	69.5	28.6	37.6	57.9	29.1	43.3	30.5	37.4	21.3	23.9	31.3	37.7	57.7	47.5	45.5	63.5	74.0	51.8	135.2	23.3	71.7	51.0	0.0	0.8	0.4	3.1	1.5	2.5	3.4	4.4	5.2	1.9	3.1	2.8	2.8	0.5	2.7	0.9	3.4	5.9	2.0	12.7	14.1	12.7	15.5	12.3	12.8	13.8	13.5	14.5	12.7	14.2	15.2	4.2	3.2	3.9	12.7	5.3	3.7	4.3	5.0	5.7	10.6	7.1	8.6	8.3	10.0	4.7	1.8	16.7	5.9	3.9	3.9	0.0	6.1	1.5	2.9	7.9	5.1	6.6	9.7	5.6	3.7	6.6	7.0	6.1	4.3	4.5	16.9	3.3	6.6	7.7	6.7	5.7	5.8	0.0	3.0	1.9	1.9	6.2	3.6	3.6	6.5	4.7	4.1	5.2	8.5	7.4	5.9	1.9	9.8	7.3	8.0	2.5	2.0	3.5	6.8	0.0	8.2	5.2	5.6	12.1	6.2	3.4	2.2	5.1	9.7	7.5	2.2
CAMK2A	"CAMKA, CaMKIIα, CaMKIINalpha, KIAA0968"	ENSG00000070808	"Calcium/calmodulin dependent protein kinase II alpha"	Q9UQM7	5	150219491-150290291	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 662.9"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 245.8"	"Cancer enriched"	"Detected in single"	13	"glioma: 6.0"	"Region enhanced"	"Detected in many"		"cerebral cortex: 662.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.3;SCLC-21H: 3.0;SuSa: 1.4;U-87 MG: 3.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 1071.1"	"CAB004330, HPA051783, HPA051785, HPA053973"	Supported		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		66000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB004330: AB_626788, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (7.20e-3)"	"unprognostic (6.47e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.85e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.00e-8)"	"unprognostic (2.71e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.36e-3)"	0.2	0.9	161.7	0.2	230.9	0.1	0.1	0.0	662.9	1.2	0.0	1.0	0.1	2.8	0.3	1.3	1.5	0.3	4.8	453.1	0.0	0.7	0.2	0.9	0.0	0.0	0.0	0.4	0.1	0.0	3.5	0.3	0.0	0.8	0.2	1.9	0.7	0.4	95.0	0.7	0.4	2.4	0.0	0.3	0.5	0.1	0.0	0.0	0.1	34.7	0.0	2.0	0.7	99.6	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.8	0.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.9	0.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.7	230.9	0.0	662.9	453.1	0.0	0.0	0.0	0.0	0.0	0.0	99.6	0.0	0.0	0.0	12.1	0.0	3.4	0.0	0.0	0.0	5.1	0.0	0.0	14.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.2	0.0	0.0	245.8	0.0	0.1	2.2	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.0	55.5	0.0	0.0	0.0	0.8	0.3	0.0	0.0	3.6	9.4	0.0	0.4	0.0	8.5	8.1	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.1	0.0	3.6	1.8	0.0	0.3	0.0	1.4	0.3	0.2	0.0	0.0	0.0
CAMK2B	"CAM2, CAMK2, CAMKB, CaMKIIβ"	ENSG00000058404	"Calcium/calmodulin dependent protein kinase II beta"	Q13554	7	44217150-44334577	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 248.8;skeletal muscle: 132.5"	"Cell type enriched"	"Detected in many"	7	"Bipolar cells: 857.4"	"Cancer enhanced"	"Detected in many"		"glioma: 6.0;thyroid cancer: 6.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006849, HPA026307, HPA051783, HPA051785, HPA053973"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		600000	"Cluster 11: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (1.88e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.23e-7)"	"unprognostic (7.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.95e-2)"	0.5	11.3	77.9	0.6	109.0	0.1	1.4	113.0	248.8	0.1	0.0	1.0	1.0	0.2	28.3	1.4	1.1	0.2	65.4	197.6	12.6	1.6	7.7	0.3	1.3	4.4	11.9	0.3	3.8	6.1	51.3	0.1	4.6	3.2	0.4	21.4	1.4	1.6	132.5	1.2	0.9	0.1	3.2	0.3	2.3	2.1	25.9	0.8	20.3	59.2	1.6	0.0	0.3	80.4	0.0	0.8	0.4	0.6	0.0	0.4	0.4	0.3	0.1	0.3	0.0	0.3	0.1	0.2	1.6	0.4	0.1	0.3	0.4	1.4	0.1	2.0	4.5	0.1	0.2	0.2	0.1	0.0	0.9	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.8	0.1	10.1	0.0	0.4	0.2	0.1	4.4	0.2	1.7	0.3	0.0	0.0	75.5	4.0	0.4	0.0	0.0	0.1	3.5	0.3	0.4	0.5	0.7	0.4	0.1	0.9	0.8	0.2	0.2	0.0	0.5	1.0	0.1	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	0.4	0.7	0.3	0.2	0.2	0.2	77.9	109.0	113.0	248.8	197.6	12.6	4.4	11.9	4.6	3.2	25.9	80.4	0.1	0.0	0.0	67.3	0.2	1.1	21.5	0.0	10.8	857.4	3.1	17.5	88.9	2.8	0.0	0.0	45.9	0.1	0.0	0.5	9.8	0.0	0.9	2.3	0.4	1.6	40.7	0.0	111.4	0.0	0.2	2.9	4.1	5.6	4.5	15.4	0.0	4.3	0.2	60.6	90.9	1.5	2.0	0.6	0.4	2.9	1.8	0.5	1.8	5.6	0.0	23.2	0.0	19.6	5.4	0.1	1.2	0.0	0.1	3.3	0.1	1.9	0.0	53.1	0.0	6.9	1.7	0.2	7.8	0.9	0.4	0.3	0.2	0.2	0.3	6.6
CAMK2G	CAMKG	ENSG00000148660	"Calcium/calmodulin dependent protein kinase II gamma"	Q13555	10	73812501-73874591	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Neurogenesis"	"Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 410.7;Cytotrophoblasts: 163.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 133.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 154.8;SK-BR-3: 177.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040656, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		200000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (8.63e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.62e-2)"	22.0	14.0	86.1	17.0	92.6	34.5	15.2	79.9	137.8	24.1	44.1	101.1	34.2	45.2	14.5	34.7	30.6	17.8	11.8	91.3	79.0	19.3	14.5	18.8	16.2	96.1	96.5	12.7	10.3	12.3	14.1	27.3	94.1	31.1	26.1	42.4	22.9	49.6	154.3	17.3	41.5	43.9	91.4	24.9	30.4	6.5	102.5	15.7	13.6	84.8	14.9	58.4	25.8	91.9	35.7	24.6	22.5	43.9	16.7	26.1	26.3	25.8	41.0	31.9	26.1	39.8	37.2	27.4	25.7	32.4	12.4	54.9	17.5	20.5	25.3	24.0	22.2	18.2	20.4	17.8	8.1	24.7	29.1	14.4	17.7	32.5	22.1	50.4	28.3	32.5	19.5	37.9	19.0	25.2	41.7	37.5	16.5	21.3	154.8	36.5	25.3	13.7	17.2	51.5	11.5	28.4	15.0	177.4	11.9	16.5	33.2	15.0	36.7	24.9	40.0	13.4	33.3	11.9	14.9	24.8	26.5	69.2	8.8	31.0	17.9	133.9	23.1	7.9	28.5	13.9	26.3	25.0	23.0	12.7	24.5	24.1	115.8	34.0	15.1	7.9	27.7	17.5	86.1	92.6	79.9	137.8	91.3	79.0	96.1	96.5	94.1	91.4	102.5	91.9	19.3	16.0	11.7	410.7	22.2	9.4	8.7	9.2	14.2	63.3	14.8	16.3	6.7	12.8	15.5	7.3	100.1	163.6	21.3	46.2	13.7	13.3	2.0	6.3	6.4	20.2	23.9	13.3	107.9	19.6	45.2	12.0	14.8	7.5	16.5	20.2	16.4	9.6	27.2	26.9	89.7	24.8	10.2	18.9	16.3	3.1	12.8	15.8	12.4	43.1	18.3	17.7	26.8	61.9	16.9	22.0	65.5	18.8	13.6	8.2	77.1	26.9	10.4	77.0	46.0	11.2	50.8	0.8	13.5	26.5	12.6	81.1	30.3	5.2	32.1	13.7
CAMKMT	"C2orf34, CLNMT"	ENSG00000143919	"Calmodulin-lysine N-methyltransferase"	Q7Z624	2	44361947-44772592	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 155.1;Excitatory neurons: 88.7;Inhibitory neurons: 93.7;Microglial cells: 114.3;Oligodendrocyte precursor cells: 121.2;Oligodendrocytes: 211.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067912			Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA067912: AB_2685922"	"unprognostic (2.28e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.39e-2)"	"prognostic favorable (9.10e-4)"	"unprognostic (1.03e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.85e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.57e-2)"	4.2	5.3	15.9	3.9	21.1	10.2	5.3	19.4	21.1	5.9	17.8	7.0	5.3	4.1	6.5	6.1	4.9	5.7	5.0	15.5	17.1	7.5	4.8	3.9	5.4	17.7	16.4	3.9	9.8	9.8	5.6	3.3	17.3	3.5	6.8	8.5	4.8	3.9	7.8	5.8	5.7	3.9	15.5	3.7	5.8	13.2	17.9	6.2	7.3	3.3	5.4	4.5	4.7	20.4	10.2	6.2	7.4	6.8	8.0	8.1	15.0	7.4	6.0	4.3	5.5	11.9	9.0	9.6	8.6	5.6	5.3	8.3	10.6	13.2	7.6	35.2	13.3	14.2	12.1	22.4	3.1	9.4	9.5	2.6	8.0	5.9	10.9	6.1	6.4	9.9	10.4	17.1	7.1	10.9	17.6	19.1	13.9	24.6	6.1	10.3	8.3	19.4	20.8	11.6	14.0	13.4	7.6	24.1	9.2	7.0	8.8	7.7	7.6	5.5	6.4	6.1	5.9	13.3	11.5	18.2	6.1	16.5	3.9	13.1	8.2	6.2	11.1	6.9	11.5	20.9	11.2	9.7	9.7	14.7	16.9	13.4	5.2	8.7	8.4	10.1	18.3	6.9	15.9	21.1	19.4	21.1	15.5	17.1	17.7	16.4	17.3	15.5	17.9	20.4	5.4	6.4	3.1	155.1	11.0	5.2	7.9	10.9	9.1	5.3	6.6	5.2	2.2	10.0	5.5	9.2	0.0	3.3	6.9	4.5	23.5	13.3	74.3	8.2	7.2	4.0	0.0	13.3	88.7	15.6	4.5	6.2	11.7	10.0	5.7	2.0	3.3	6.3	5.8	1.7	93.7	5.5	20.3	1.9	4.9	39.0	8.1	4.3	10.6	114.3	6.4	20.3	13.4	121.2	211.7	8.6	8.3	5.7	13.3	5.8	7.2	14.5	7.4	3.0	0.0	3.6	5.0	35.5	5.8	10.7	7.4	2.6	9.2	7.9	8.1	6.0
CANT1	"SCAN-1, SHAPY"	ENSG00000171302	"Calcium activated nucleotidase 1"	Q8WVQ1	17	78991716-79009867	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 139.5;Intestinal goblet cells: 155.6;Syncytiotrophoblasts: 101.5;Undifferentiated cells: 100.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 445.4;T-47d: 282.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019627, HPA019639, HPA022818"	Enhanced		Supported	"Golgi apparatus"		NA	Yes		3300000	"Cluster 52: Eosinophils - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"		"HPA019627: AB_1845969, HPA019639: AB_1845970, HPA022818: AB_1845971"	"unprognostic (1.98e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.41e-4)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.21e-4)"	"unprognostic (7.04e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.23e-2)"	15.8	23.9	10.4	24.7	12.4	19.1	25.4	13.6	11.3	32.3	13.8	89.2	51.9	17.4	8.7	44.8	18.2	25.2	17.0	11.1	12.6	16.1	17.3	16.4	15.2	14.6	14.5	14.6	19.6	24.5	17.5	25.9	13.9	71.8	82.8	7.4	62.7	32.4	14.9	14.9	55.5	15.5	13.8	26.5	51.1	20.7	14.5	14.7	13.9	12.4	15.1	16.7	21.7	17.8	106.5	112.1	31.9	46.3	29.7	35.2	38.9	66.0	51.3	66.7	55.9	53.8	99.6	25.3	36.1	46.1	83.0	53.7	27.1	49.8	68.4	43.0	46.4	33.7	34.1	45.9	25.0	33.0	51.6	33.7	32.4	62.7	34.2	40.9	116.1	42.5	42.3	43.2	46.4	58.4	50.2	19.8	22.1	445.4	103.1	27.6	51.8	29.8	29.8	53.5	45.6	45.4	33.9	227.2	50.2	50.3	282.6	38.6	56.6	101.9	90.5	46.4	83.1	48.9	43.8	24.3	64.4	24.9	65.3	6.3	4.0	8.7	5.5	4.4	5.7	3.9	4.3	4.8	3.8	2.5	4.1	4.1	17.4	3.1	3.0	2.7	3.6	4.6	10.4	12.4	13.6	11.3	11.1	12.6	14.6	14.5	13.9	13.8	14.5	17.8	12.6	28.9	20.6	5.9	11.8	16.6	15.3	16.8	6.8	6.4	49.9	16.3	13.3	14.3	15.1	12.9	14.6	36.6	8.9	139.5	3.9	34.7	14.0	10.7	13.1	16.3	51.0	15.2	4.1	28.8	39.4	13.5	38.2	19.0	5.7	20.0	41.7	14.4	24.9	5.0	5.2	155.6	16.2	12.4	9.5	15.7	11.8	14.2	14.2	3.7	18.1	8.1	11.3	5.0	10.2	37.7	55.8	7.5	16.6	33.4	39.4	6.7	9.7	8.7	6.6	9.5	13.3	23.9	5.8	12.0	13.1	101.5	11.1	11.3	100.2	19.4
CAPN1	"CANP, CANPL1, muCANP, muCL"	ENSG00000014216	"Calpain 1"	P07384	11	65180566-65212006	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 276.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 516.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005992	Enhanced		Supported	Cytosol		NA	NA		9100000	"Cluster 46: Basophils - DNA binding"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA005992: AB_1845924"	"unprognostic (2.07e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.33e-1)"	"prognostic favorable (7.06e-8)"	"unprognostic (5.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-1)"	44.8	43.1	27.8	51.9	26.1	66.5	48.4	29.7	30.1	80.9	28.3	78.6	80.4	56.3	27.5	276.2	92.3	55.5	53.1	27.7	33.0	53.1	44.3	56.9	57.0	41.4	31.5	44.5	71.7	36.6	40.8	56.2	43.4	62.1	57.6	9.6	118.7	67.4	84.8	125.1	88.1	45.3	33.9	50.2	65.5	6.1	37.9	49.5	71.5	55.3	86.4	83.4	117.4	27.4	285.6	147.9	42.9	97.2	77.9	104.3	127.0	84.1	144.2	103.0	74.9	94.8	250.2	71.2	136.0	179.3	111.1	409.8	60.9	366.9	32.2	76.4	44.1	170.8	80.4	93.7	76.2	40.6	228.0	107.3	196.8	85.9	43.2	92.6	178.5	50.6	103.1	55.9	87.4	181.8	83.1	130.6	120.5	145.2	133.8	80.7	43.0	43.2	138.1	516.5	76.2	55.7	87.4	331.4	80.3	45.8	142.8	77.9	147.1	73.1	50.5	159.0	38.5	33.8	26.9	86.6	127.5	48.8	82.3	87.6	57.5	77.9	39.4	51.2	31.0	30.8	30.7	35.8	48.4	31.7	17.6	24.9	33.1	34.8	30.4	38.1	35.9	74.8	27.8	26.1	29.7	30.1	27.7	33.0	41.4	31.5	43.4	33.9	37.9	27.4	27.3	25.6	27.9	21.5	39.6	59.9	127.3	120.5	56.9	10.7	44.7	36.6	22.0	74.4	81.0	77.3	20.9	238.5	61.4	184.2	39.2	180.5	0.5	41.9	26.3	31.3	44.3	58.3	15.9	115.8	111.7	39.6	57.6	58.2	46.9	48.6	37.9	36.7	88.7	21.9	15.2	76.9	59.0	51.2	34.0	2.0	43.5	67.1	48.0	14.0	112.7	38.5	61.8	6.6	1.9	179.4	124.1	50.8	17.7	78.6	155.6	34.6	71.1	16.2	39.5	25.3	36.7	0.5	2.8	102.0	68.9	196.6	40.2	35.4	125.3	156.6
CAPN10		ENSG00000142330	"Calpain 10"	Q9HC96	2	240586734-240617705	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004170, HPA056098"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA004170: AB_1078381, HPA056098: AB_2683037"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-2)"	"unprognostic (9.29e-3)"	"unprognostic (6.09e-2)"	"unprognostic (5.44e-3)"	"prognostic favorable (8.47e-5)"	"prognostic unfavorable (4.78e-6)"	"unprognostic (7.48e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.31e-2)"	"prognostic favorable (7.94e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.58e-3)"	10.0	18.6	16.8	6.8	16.2	7.9	9.6	21.0	25.0	11.8	16.5	12.7	13.1	10.7	3.7	14.5	13.7	6.1	24.6	17.9	14.0	23.8	14.7	12.2	10.6	15.6	15.8	13.3	12.6	5.3	18.1	4.5	15.4	14.9	7.1	10.6	10.2	5.3	5.8	12.1	14.0	2.8	12.6	29.8	15.8	17.0	16.7	6.4	13.2	2.8	5.4	11.1	10.0	16.8	8.0	11.2	11.2	9.5	4.5	3.6	19.7	9.9	4.1	6.5	5.9	8.7	18.7	5.9	3.5	3.6	8.9	12.7	3.0	6.6	3.3	23.0	19.8	10.9	20.4	16.0	7.1	7.1	15.3	2.6	4.8	6.7	2.7	6.7	5.2	16.8	12.5	7.3	2.8	7.1	16.2	27.5	17.4	9.5	8.1	15.5	8.1	13.1	9.9	9.8	28.1	22.0	6.3	9.3	13.8	3.5	4.8	9.3	8.6	11.0	9.7	9.5	11.8	16.3	4.2	10.7	10.4	12.8	11.0	1.5	0.9	1.8	1.0	0.6	0.3	1.0	0.6	1.1	0.4	1.1	0.7	0.9	4.1	3.0	0.6	1.2	1.3	0.4	16.8	16.2	21.0	25.0	17.9	14.0	15.6	15.8	15.4	12.6	16.7	16.8	8.9	3.2	6.0	19.6	7.5	4.6	7.2	3.8	6.2	14.9	6.2	5.3	9.5	12.8	4.8	9.2	14.6	5.4	14.2	7.2	7.9	13.0	1.9	14.7	5.7	7.0	11.3	1.7	9.5	9.1	5.2	5.3	4.6	13.8	22.9	11.3	7.5	3.0	6.7	48.8	9.0	6.3	8.2	5.3	1.7	2.6	9.0	7.8	1.8	7.5	7.7	13.4	8.2	7.5	7.2	13.8	4.6	9.4	7.4	10.1	9.9	6.2	9.4	18.6	0.0	5.6	7.6	12.6	7.7	3.7	5.3	5.5	11.3	9.0	6.4	6.9
CAPN3	"CANP3, LGMD2, LGMD2A, nCL-1, p94"	ENSG00000092529	"Calpain 3"	P20807	15	42359498-42412949	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 279.2;skeletal muscle: 905.9;tongue: 377.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 512.5;Late spermatids: 183.6;Melanocytes: 482.0;Oligodendrocytes: 220.2"	"Cancer enriched"	"Detected in some"	10	"melanoma: 9.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	27	"SK-MEL-30: 238.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040052	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA040052: AB_2676821"	"unprognostic (1.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.00e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.11e-4)"	"unprognostic (3.12e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.37e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.91e-4)"	"unprognostic (5.56e-3)"	"unprognostic (2.43e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.38e-1)"	13.5	8.8	136.1	4.0	206.6	47.6	14.1	194.2	243.3	18.8	113.0	13.3	3.1	11.2	163.7	14.5	13.7	4.5	16.1	142.9	159.9	93.6	36.9	21.5	7.0	212.0	194.9	15.7	8.7	2.4	11.3	3.0	212.1	16.0	5.3	7.5	18.6	5.2	905.9	54.9	14.0	4.7	155.2	19.1	8.9	30.8	187.8	3.4	10.7	377.4	5.1	11.7	15.5	279.2	0.5	0.3	0.6	1.1	8.8	6.1	0.6	2.6	1.9	0.5	0.8	1.2	0.5	0.2	0.9	1.6	0.4	3.7	0.4	3.5	0.3	0.9	0.8	0.8	0.8	4.1	0.6	1.0	1.5	4.7	3.7	0.8	0.7	1.5	0.1	0.7	0.2	1.8	0.7	0.1	0.2	1.2	0.4	0.2	0.9	1.1	0.4	1.9	1.9	1.3	0.4	0.1	0.2	0.5	238.0	1.0	0.0	5.4	0.9	0.3	0.4	2.6	0.7	1.5	2.1	0.2	0.4	2.4	1.8	0.5	1.0	0.1	0.7	0.2	0.8	0.3	0.1	0.3	0.5	0.5	0.1	0.9	0.9	0.6	0.1	0.5	0.4	0.6	136.1	206.6	194.2	243.3	142.9	159.9	212.0	194.9	212.1	155.2	187.8	279.2	0.5	12.8	34.5	16.0	2.9	20.1	0.8	2.2	3.4	2.2	0.4	0.3	0.4	1.5	4.4	1.8	2.1	0.7	1.4	2.0	1.9	0.1	512.5	0.5	0.6	2.2	0.0	0.0	4.0	0.0	0.6	1.6	3.6	0.7	1.3	0.4	2.2	8.7	32.7	0.0	5.2	1.8	2.0	4.4	11.6	183.6	5.3	2.9	482.0	13.1	2.5	3.7	2.1	4.5	220.2	0.0	5.4	3.4	0.6	0.9	2.4	59.5	2.6	3.9	0.0	13.8	1.6	15.9	4.7	1.6	8.5	3.3	1.8	1.2	2.3	0.8
CAPN5	"ADNIV, HTRA3, nCL-3, VRNI"	ENSG00000149260	"Calpain 5"	O15484	11	77066961-77126155	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 60.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 170.3;Gastric mucus-secreting cells: 80.0;Intestinal goblet cells: 89.8;Paneth cells: 72.6;Proximal enterocytes: 75.6;Undifferentiated cells: 69.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.3"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"OE19: 106.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033237, HPA072319"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB033237: AB_2069673, HPA072319: AB_2686512"	"unprognostic (6.81e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (3.47e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.35e-3)"	"unprognostic (4.64e-1)"	"unprognostic (3.17e-3)"	"unprognostic (8.58e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.30e-3)"	6.7	12.2	8.5	10.9	7.9	2.7	4.9	6.4	8.6	13.5	3.5	60.5	60.7	10.0	5.7	31.6	10.8	36.3	7.2	8.5	8.7	15.1	52.1	4.8	1.9	11.7	8.2	13.2	5.6	1.0	5.1	2.8	12.5	16.0	49.9	3.8	7.7	8.9	1.6	3.1	52.4	11.3	9.9	3.5	47.9	21.5	7.9	2.8	4.7	1.7	2.7	15.4	10.5	8.1	0.8	12.5	8.6	7.8	32.0	30.4	0.7	11.8	22.9	13.4	10.0	6.9	3.6	0.4	7.7	24.5	14.4	0.5	3.8	1.0	6.4	0.5	0.8	2.1	0.5	0.9	7.9	0.2	0.4	16.1	1.4	22.6	5.2	18.8	14.4	5.1	0.2	0.0	26.9	19.9	1.8	0.3	6.6	106.6	9.3	2.0	27.0	0.4	4.6	16.4	0.5	13.5	1.0	2.7	5.9	5.7	1.7	0.1	23.9	25.4	12.3	34.8	1.3	0.8	1.7	0.1	13.1	0.3	5.7	0.0	0.2	0.0	1.3	0.3	0.1	0.0	0.1	0.5	0.2	0.0	0.6	0.8	0.0	0.0	0.0	0.1	0.0	0.7	8.5	7.9	6.4	8.6	8.5	8.7	11.7	8.2	12.5	9.9	7.9	8.1	1.6	0.0	0.5	4.2	1.0	1.7	0.3	2.2	0.0	3.1	0.5	1.8	1.7	24.3	10.3	23.9	0.0	0.1	3.4	170.3	1.9	10.3	1.1	1.9	5.9	2.4	22.3	5.7	4.6	32.7	0.4	7.6	80.0	3.5	0.0	10.2	2.9	40.4	0.9	1.7	6.7	89.8	10.2	1.6	1.8	1.3	12.5	1.2	7.2	1.0	0.3	5.8	5.2	11.6	0.7	22.4	72.6	4.5	0.9	2.0	75.6	9.9	11.1	2.1	0.0	8.3	4.1	0.5	2.3	2.5	0.9	0.0	1.5	5.3	69.2	2.4
CARS1	CARS	ENSG00000110619	"Cysteinyl-tRNA synthetase 1"	P49589	11	3000922-3057613	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cancer-related genes, Disease variant, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 10.3;Cardiomyocytes: 8.8;Cytotrophoblasts: 22.2;Extravillous trophoblasts: 40.7;Hofbauer cells: 22.0;Syncytiotrophoblasts: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002383, HPA002384, CAB075734, CAB075735, CAB075736, CAB075737"	Enhanced		Enhanced	Cytosol		NA	NA		200000	"Cluster 14: Monocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"CAB075734: AB_2665740, CAB075735: AB_2665741, CAB075736: AB_2665742, CAB075737: AB_2665743, HPA002383: AB_1078399, HPA002384: AB_1846033"	"unprognostic (9.10e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.00e-2)"	"unprognostic (7.97e-2)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.00e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.46e-1)"	22.1	17.4	8.1	12.0	8.5	7.3	19.9	8.7	21.6	13.6	8.4	21.8	12.0	15.9	7.5	19.2	12.8	10.3	13.3	8.2	9.8	13.7	21.1	17.5	12.7	9.6	9.9	8.9	32.8	9.6	18.6	10.3	10.6	12.7	12.8	5.3	20.6	6.8	31.7	23.8	17.4	16.0	9.7	17.2	23.5	16.8	9.9	14.6	17.3	14.7	17.8	18.1	14.9	11.5	29.2	14.0	17.8	55.6	67.3	61.4	16.2	70.0	78.6	46.7	84.1	34.2	64.7	43.1	20.1	88.2	0.0	68.7	58.3	78.6	64.0	123.7	13.5	24.4	23.7	25.8	161.1	50.9	50.2	102.2	64.1	40.1	46.8	0.0	62.3	103.6	42.2	147.0	47.1	41.9	35.7	0.0	65.2	97.9	25.0	17.2	29.7	54.9	0.0	46.1	39.0	49.7	17.1	48.1	80.1	13.3	0.0	0.1	21.8	19.5	18.2	48.2	0.2	107.8	106.8	27.2	0.1	26.6	40.3	16.3	18.6	13.5	20.9	15.4	17.4	10.9	18.3	18.6	19.4	8.5	9.9	16.0	25.4	23.7	37.9	7.5	27.0	19.2	8.1	8.5	8.7	21.6	8.2	9.8	9.6	9.9	10.6	9.7	9.9	11.5	10.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	22.2	8.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	40.7	3.7	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	32.3	1.4	0.0	0.0	0.0
CARS2	FLJ12118	ENSG00000134905	"Cysteinyl-tRNA synthetase 2, mitochondrial"	Q9HA77	13	110641412-110713603	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 221.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 204.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041776	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"HPA041776: AB_2677666"	"unprognostic (2.34e-3)"	"unprognostic (9.50e-2)"	"unprognostic (6.62e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (1.98e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.73e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.71e-2)"	18.3	24.4	8.8	18.9	9.3	28.4	15.0	16.3	13.3	20.3	15.8	20.8	17.5	16.0	13.7	18.6	16.4	11.1	25.9	9.7	9.3	15.4	19.9	16.7	19.3	9.0	9.3	15.3	15.8	15.0	17.6	12.1	9.7	15.2	13.8	9.2	18.9	12.3	45.8	17.6	18.5	12.6	9.2	17.8	17.2	11.2	9.7	12.9	14.3	26.7	14.1	17.7	15.9	10.5	116.0	37.7	21.2	52.6	55.7	51.7	28.7	49.9	45.7	49.6	60.6	53.5	50.7	53.5	68.4	55.4	75.6	61.0	36.6	63.8	40.2	49.2	58.5	33.5	79.6	63.8	58.5	83.0	39.3	66.7	50.7	43.3	51.8	35.5	36.0	40.9	23.2	16.6	71.2	27.2	37.5	27.6	18.4	88.9	36.8	54.2	15.6	22.3	54.2	33.4	37.7	28.9	40.7	62.0	61.1	22.7	29.8	94.0	32.5	41.8	15.6	53.2	51.6	29.0	35.8	32.4	204.5	50.1	41.9	0.0	2.9	0.4	1.1	3.3	1.2	1.8	0.3	0.4	2.4	0.8	1.1	0.5	1.7	0.4	4.6	2.0	0.4	1.1	8.8	9.3	16.3	13.3	9.7	9.3	9.0	9.3	9.7	9.2	9.7	10.5	18.2	9.6	15.9	24.5	24.4	12.9	24.2	10.3	8.6	21.4	21.8	23.4	39.3	18.6	9.5	27.6	25.0	26.7	28.2	17.6	50.9	17.7	66.5	24.1	21.7	13.6	18.7	10.7	29.2	4.7	29.1	21.6	18.8	27.3	16.5	45.3	9.3	26.6	26.9	23.5	25.1	17.7	12.2	31.2	9.0	221.4	20.5	32.8	12.4	24.4	51.4	24.3	14.4	14.1	26.6	12.1	10.8	18.0	18.6	18.2	23.0	38.1	10.6	25.9	6.6	29.2	24.7	8.6	7.5	22.3	13.5	16.8	19.8	44.2	28.5	17.6
CASK	"CAGH39, FGS4, LIN2, TNRC8"	ENSG00000147044	"Calcium/calmodulin dependent serine protein kinase"	O14936	X	41514934-41923554	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 135.8;Oligodendrocyte precursor cells: 447.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 47.1"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 47.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001949, HPA023857"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"CAB001949: , HPA023857: AB_1846035"	"unprognostic (6.30e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (6.11e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.85e-2)"	10.2	11.1	13.6	11.9	12.9	7.3	15.7	12.3	11.1	11.6	12.4	25.3	32.1	11.1	9.4	13.7	10.5	18.5	6.8	14.2	17.1	16.4	13.4	12.2	12.5	13.2	19.4	13.5	12.8	11.8	6.3	16.3	15.7	10.6	27.3	19.8	13.2	8.3	5.0	9.3	31.9	12.0	15.4	12.4	19.8	3.6	25.2	15.4	10.6	6.1	10.4	15.3	8.8	18.0	27.4	32.5	31.4	19.1	21.6	18.6	10.9	23.2	18.7	13.2	12.3	72.3	42.6	0.4	12.0	29.3	23.8	52.3	35.2	23.2	22.8	25.4	20.9	0.6	27.7	26.2	22.1	4.4	3.6	19.8	63.2	25.1	30.1	27.5	11.6	15.3	2.2	21.3	30.2	30.9	8.4	2.2	29.7	37.6	22.6	12.7	79.8	13.2	31.2	54.8	29.7	15.6	43.7	17.7	13.9	52.7	19.0	0.8	14.2	24.4	25.8	22.1	13.3	7.6	5.2	9.5	24.4	3.1	16.9	47.1	1.5	8.7	0.8	1.1	0.8	0.7	0.9	1.3	0.4	0.9	1.2	1.1	1.7	4.3	0.7	0.5	4.5	0.6	13.6	12.9	12.3	11.1	14.2	17.1	13.2	19.4	15.7	15.4	25.2	18.0	13.0	12.8	20.4	101.9	8.8	32.6	42.7	11.1	8.0	42.2	23.7	16.5	7.8	8.6	14.6	7.3	22.9	2.0	12.1	25.8	50.9	13.7	0.9	9.6	24.1	16.0	13.8	0.8	96.6	14.5	0.7	18.8	18.8	11.9	0.0	17.4	8.9	15.0	21.3	50.5	135.8	28.7	14.2	2.8	21.5	1.0	9.9	10.7	10.6	60.0	2.5	9.3	0.0	447.8	59.7	22.1	24.1	9.4	7.0	16.4	35.2	20.9	15.7	25.7	19.7	38.2	20.6	2.9	2.1	13.9	32.5	1.6	26.5	47.7	41.8	33.2
CASP10	"FLICE-2, MCH4"	ENSG00000003400	"Caspase 10"	Q92851	2	201182898-201229406	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 71.3;NK-cells: 44.3;Paneth cells: 44.5;Plasma cells: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 25.3"					"Low region specificity"	"Detected in all"			"CAB003780, HPA017059"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Vesicles	"CAB003780: AB_289592, HPA017059: AB_1846040"	"unprognostic (4.01e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.05e-7)"	"unprognostic (3.23e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.38e-2)"	8.8	2.4	5.7	9.2	5.5	19.5	6.5	4.5	5.8	4.0	4.4	13.2	21.8	3.3	6.2	8.8	5.4	7.4	6.7	4.7	5.1	8.1	6.2	11.5	8.9	6.0	5.0	1.6	4.8	2.3	1.3	9.6	5.8	3.9	13.4	1.3	5.4	3.1	4.9	5.7	18.4	5.1	5.6	22.6	10.2	1.2	7.3	8.7	5.3	2.8	10.4	9.0	5.1	5.4	4.4	3.5	0.3	0.4	0.1	0.3	7.5	0.7	4.6	0.4	1.8	4.6	9.8	0.5	7.0	2.5	1.7	2.9	0.2	2.3	1.3	2.1	4.8	12.2	4.0	15.1	1.6	8.3	12.7	0.5	2.0	5.3	0.4	0.3	25.3	5.1	14.9	17.4	0.4	0.3	15.9	7.8	0.6	6.0	2.4	8.8	0.5	18.4	8.7	6.2	0.2	0.1	4.1	0.2	1.9	3.0	0.2	7.8	10.0	0.4	0.8	3.4	0.2	18.7	12.1	0.5	4.5	6.3	0.2	5.9	11.7	0.7	6.4	16.5	5.6	8.2	5.2	3.6	6.5	7.7	7.2	6.4	2.1	8.5	19.3	6.6	1.2	7.2	5.7	5.5	4.5	5.8	4.7	5.1	6.0	5.0	5.8	5.6	7.3	5.4	20.7	19.2	10.0	0.3	15.8	6.0	2.7	10.6	5.2	0.0	1.3	0.9	1.8	8.6	9.4	9.2	0.0	1.1	20.5	71.3	1.9	16.2	1.2	7.7	7.4	29.7	2.4	14.9	0.3	10.4	0.7	4.2	26.5	12.0	7.6	0.8	26.4	7.1	9.4	0.0	0.5	21.6	4.1	26.6	17.5	0.0	0.6	16.2	7.2	33.7	22.0	0.5	44.3	0.0	0.9	8.6	44.5	0.0	49.7	2.5	26.1	8.7	24.4	0.4	0.0	2.9	2.2	0.1	0.1	6.6	4.5	0.4	12.9	4.1	16.4	10.3
CASP14	"MGC119078, MGC119079, MICE"	ENSG00000105141	"Caspase 14"	P31944	19	15049480-15058293	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Hydrolase, Protease, Thiol protease"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"skin 1: 486.0"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 96.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 62.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"hTCEpi: 49.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010059, HPA027062"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA		3600000		"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Cytosol"	Mitochondria	"CAB010059: AB_626800, HPA027062: AB_2672101"	"unprognostic (1.17e-2)"	"unprognostic (6.44e-3)"		"unprognostic (6.22e-2)"		"unprognostic (2.77e-1)"		"prognostic unfavorable (7.59e-4)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (2.68e-1)"		"unprognostic (4.30e-2)"	"unprognostic (1.99e-1)"		"unprognostic (1.97e-1)"	0.6	0.0	0.1	0.0	0.4	0.4	7.8	0.4	0.2	3.9	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.6	0.1	0.0	0.0	0.3	0.8	0.0	0.1	1.1	4.2	1.4	486.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.0	0.0	0.0	0.0	0.0	19.9	1.0	1.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.9	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.4	0.2	0.2	0.1	0.3	0.1	0.3	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	19.1	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	2.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	96.0	0.7	0.1	0.0	0.0	0.8
CASP8	"Casp-8, FLICE, MACH, MCH5"	ENSG00000064012	"Caspase 8"	Q14790	2	201233443-201287711	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 66.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 107.4;NK-cells: 132.8;Plasma cells: 73.4;T-cells: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001302, CAB002047, HPA005688, HPA006191"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"CAB002047: AB_563465, HPA001302: AB_1846057, HPA005688: AB_1846056, HPA006191: AB_2667535"	"unprognostic (5.21e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.60e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.79e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (1.27e-6)"	"unprognostic (7.67e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.53e-3)"	11.5	10.2	1.7	28.6	2.0	66.6	13.9	1.3	2.1	9.6	4.2	16.1	20.5	8.5	13.2	12.9	14.1	13.2	5.2	2.1	1.8	10.7	14.1	19.6	37.7	3.4	3.0	7.7	7.8	2.9	3.4	9.9	2.7	6.9	17.6	4.6	8.4	7.3	3.3	12.1	26.0	9.9	2.4	37.1	15.9	4.3	2.6	24.4	7.9	3.0	29.7	18.0	8.6	2.4	33.6	26.6	7.7	22.2	20.7	29.7	12.0	13.8	13.2	16.0	26.2	36.1	54.9	3.7	29.6	10.7	28.7	16.2	17.2	16.1	31.3	21.1	15.4	31.0	21.9	35.1	17.1	25.6	33.8	25.9	38.0	30.1	23.9	13.4	15.1	26.9	28.6	69.1	14.7	13.1	32.1	25.9	12.6	17.5	23.7	24.7	15.9	55.4	30.8	35.3	2.3	1.1	17.9	29.8	18.0	7.0	8.0	19.1	19.6	17.3	18.0	9.0	10.9	63.1	30.2	21.2	25.3	33.1	16.6	76.1	39.5	77.1	70.7	51.2	66.0	40.9	57.8	75.9	41.6	24.0	37.0	47.2	153.6	70.6	51.5	18.6	75.0	40.6	1.7	2.0	1.3	2.1	2.1	1.8	3.4	3.0	2.7	2.4	2.6	2.4	8.5	25.6	26.7	0.7	50.0	7.5	13.0	6.1	10.2	2.1	12.9	9.3	2.5	10.0	13.0	5.5	10.4	8.5	107.4	37.0	15.6	12.3	5.9	25.6	8.1	10.1	4.2	10.5	2.5	8.4	12.1	9.5	19.4	27.2	24.6	10.4	5.3	11.7	11.9	0.0	1.3	15.2	4.1	25.3	15.7	1.9	2.5	25.0	7.2	10.3	35.6	0.2	132.8	1.0	0.5	11.2	30.1	0.7	73.4	9.7	22.3	23.6	14.2	0.4	0.0	4.5	3.7	0.8	0.4	13.1	7.7	3.4	86.9	10.6	17.4	12.7
CASQ1	"CASQ, PDIB1"	ENSG00000143318	"Calsequestrin 1"	P31415	1	160190575-160201886	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		"Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	64	"skeletal muscle: 4442.6;tongue: 1892.7"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 17.6;Rod photoreceptor cells: 25.2;Skeletal myocytes: 20.6"	"Cancer enhanced"	"Detected in many"		"glioma: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"BEWO: 19.3;HDLM-2: 38.5;RT4: 67.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007845, CAB015170, HPA026823"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA		270000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Mitochondria"		"CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557"	"unprognostic (1.87e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.65e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.04e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (8.93e-5)"	0.9	0.4	5.1	0.8	6.0	1.5	1.4	4.9	10.0	0.5	3.3	3.3	0.5	1.7	0.3	43.1	1.9	1.2	44.9	6.5	3.1	0.3	0.4	0.7	3.0	3.7	3.9	0.4	0.3	0.2	1.0	6.2	3.2	16.2	0.5	49.7	16.7	5.0	4442.6	1.0	1.9	7.4	3.1	1.3	0.8	5.7	3.6	0.5	0.6	1892.7	1.0	5.7	0.9	6.2	0.0	0.0	0.5	0.0	0.2	0.0	19.3	0.0	0.2	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	38.5	0.4	0.1	0.0	0.0	0.1	0.6	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.7	0.4	0.1	0.0	0.2	0.3	0.2	0.0	67.4	0.0	0.1	0.3	0.2	0.0	3.5	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.7	0.8	0.3	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.1	6.0	4.9	10.0	6.5	3.1	3.7	3.9	3.2	3.1	3.6	6.2	0.1	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.0	1.9	0.7	0.9	17.6	0.0	0.0	0.0	2.1	3.0	0.1	0.0	0.0	0.1	3.0	0.1	0.1	0.2	0.0	0.0	2.0	0.0	4.9	0.3	0.0	0.1	3.8	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.3	0.6	0.6	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	25.2	0.0	20.6	0.6	1.2	1.9	0.0	0.0	4.5	0.1	0.1	0.0	0.3
CATSPER1	CATSPER	ENSG00000175294	"Cation channel sperm associated 1"	Q8NEC5	11	66016752-66026479	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	34	"testis: 17.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 44.0;granulocytes: 99.6;Hofbauer cells: 19.9;monocytes: 27.3;NK-cells: 42.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 16.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.4;EFO-21: 4.0;HEL: 2.8;HMC-1: 5.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"				"unprognostic (2.21e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.44e-3)"	"unprognostic (5.99e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.12e-8)"	"unprognostic (8.79e-3)"	"unprognostic (9.02e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.51e-1)"	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.4	0.3	0.0	4.4	0.0	4.0	0.8	1.4	0.0	0.0	0.8	0.4	0.0	0.0	2.8	0.1	0.0	0.0	0.0	5.1	0.0	0.0	0.3	0.5	0.9	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.3	0.0	1.5	0.1	1.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.2	1.1	2.2	0.1	0.2	0.0	0.0	0.0	0.8	0.3	0.6	16.9	5.8	0.1	0.2	0.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.6	3.7	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.2	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.3	9.6	0.0	0.0	0.4	44.0	0.1	0.1	0.4	0.0	0.8	0.1	0.7	6.0	0.2	0.0	0.0	99.6	0.0	1.4	0.1	19.9	0.0	0.2	0.0	0.0	17.0	12.2	4.3	0.9	15.4	1.8	0.0	27.3	0.0	42.2	0.5	0.0	3.7	0.0	0.4	1.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	1.9	1.2	0.0	0.3	0.4	4.5	0.0	0.0	0.3
CATSPER2		ENSG00000166762	"Cation channel sperm associated 2"	Q96P56	15	43628503-43668118	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.6;retina: 22.8;testis: 15.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 254.4;Early spermatids: 73.6;Rod photoreceptor cells: 221.8;Spermatocytes: 117.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 14.6"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"				"unprognostic (6.88e-3)"	"unprognostic (6.79e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.05e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.48e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.74e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.87e-2)"	"unprognostic (8.23e-5)"	1.2	1.4	2.0	0.8	2.2	4.2	1.8	14.6	4.0	1.3	0.1	2.3	3.3	1.4	5.4	2.4	1.4	0.7	0.9	2.2	0.7	1.4	1.5	1.2	2.0	1.4	0.6	1.6	1.2	4.0	3.2	0.8	1.7	1.6	2.3	22.8	1.6	2.2	1.2	5.4	3.8	0.6	0.1	1.5	1.8	15.5	0.9	0.9	1.9	1.5	1.5	1.7	1.3	3.1	2.0	2.8	1.2	4.4	0.0	0.0	2.0	0.7	1.7	1.2	2.9	0.7	1.1	2.4	1.0	0.5	1.4	4.4	1.1	3.9	1.2	2.0	5.4	7.0	11.2	1.0	1.8	1.6	2.2	0.2	3.0	1.7	4.3	3.2	1.5	4.3	2.8	2.4	0.4	0.5	1.3	2.8	0.4	2.7	1.2	1.9	1.4	1.1	2.4	3.2	2.6	0.9	1.1	1.6	0.1	1.6	3.2	1.5	0.4	3.0	1.3	0.0	1.8	0.4	0.3	5.1	2.1	4.9	1.1	0.1	0.3	0.1	0.3	0.1	0.4	1.1	0.2	0.4	0.2	0.3	0.3	0.7	0.5	0.5	0.3	0.4	0.1	0.0	2.0	2.2	14.6	4.0	2.2	0.7	1.4	0.6	1.7	0.1	0.9	3.1	4.8	0.0	4.5	0.0	4.9	7.0	8.2	8.3	1.8	56.7	6.9	6.9	4.2	5.7	8.0	7.3	254.4	6.0	6.0	3.9	3.9	3.2	73.6	5.2	2.5	6.0	21.5	2.7	0.0	2.7	2.1	3.2	6.1	4.2	9.5	29.7	8.6	3.9	4.3	38.7	0.0	4.6	4.1	5.0	6.5	37.4	6.2	4.5	1.8	0.0	4.5	13.4	7.2	0.0	0.0	2.0	3.3	7.2	1.1	6.7	11.1	4.1	10.8	221.8	0.0	9.3	5.1	117.4	17.1	2.7	8.0	3.0	4.6	5.8	8.5	8.4
CAV1	CAV	ENSG00000105974	"Caveolin 1"	Q03135	7	116524994-116561179	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"Cancer-related genes, Congenital generalized lipodystrophy, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 2160.5;Alveolar cells type 1: 3557.7;Basal keratinocytes: 1375.3;Endothelial cells: 1024.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"basophil: 14.6;memory B-cell: 5.1"	"Group enriched"	"Detected in many"	57	"B-cells: 5.1;granulocytes: 14.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 2140.5;BJ hTERT+: 2371.6;HBEC3-KT: 2333.7;LHCN-M2: 2372.1;U-138 MG: 1894.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 122.1"	"CAB003791, HPA049326"	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"CAB003791: AB_562068, HPA049326: AB_2680714"	"unprognostic (5.98e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.35e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.35e-3)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (7.17e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.79e-3)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.65e-3)"	"unprognostic (2.72e-1)"	"unprognostic (7.40e-2)"	"unprognostic (6.14e-3)"	621.1	17.4	12.7	44.7	15.3	0.6	284.5	14.3	21.6	267.0	11.8	298.8	32.3	190.9	72.5	135.1	152.5	148.2	276.5	12.2	13.9	18.4	26.6	592.0	30.3	15.1	13.4	137.4	24.6	21.4	6.8	449.2	14.6	110.3	93.6	31.4	58.0	175.5	102.9	104.9	89.4	274.2	14.3	199.1	120.8	25.8	16.1	25.2	168.4	184.6	20.3	202.0	124.1	16.2	458.7	344.3	9.5	3.7	1406.6	2140.5	20.6	1055.8	2371.6	566.0	591.2	3.0	652.4	0.1	365.8	1228.5	494.8	828.2	2.2	2333.7	840.3	36.0	19.5	0.4	128.7	0.3	196.9	0.1	2.1	736.9	481.6	805.7	536.0	539.0	1749.9	0.2	0.3	23.4	2372.1	45.2	0.5	0.8	33.7	1.2	173.9	5.2	25.2	251.0	317.0	2.0	1.0	0.6	328.3	20.1	52.3	137.8	1.6	3.9	1349.3	1894.8	212.4	730.6	298.9	96.8	15.8	1.9	758.4	0.9	701.0	14.6	0.0	0.0	0.0	0.0	0.0	5.1	0.1	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	12.7	15.3	14.3	21.6	12.2	13.9	15.1	13.4	14.6	14.3	16.1	16.2	2160.5	3557.7	123.0	0.0	15.8	1375.3	392.0	534.8	316.4	8.3	17.9	190.8	286.6	107.2	342.0	7.3	2.1	64.3	7.0	0.3	5.9	76.8	2.6	17.5	102.3	1024.0	1.8	16.0	0.4	0.7	449.5	326.8	1.5	21.3	13.9	6.3	450.5	5.2	15.0	0.0	0.5	7.0	20.3	11.0	187.1	13.4	377.2	10.7	439.4	19.7	3.7	249.0	0.0	1.0	1.3	43.1	0.1	565.4	56.2	512.7	0.7	0.3	30.6	7.7	558.8	152.4	751.4	2.1	5.7	39.4	610.9	117.0	16.7	59.7	2.4	93.3
CAV3	"LGMD1C, LQT9, VIP-21, VIP21"	ENSG00000182533	"Caveolin 3"	P56539	3	8733802-8841808	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skeletal muscle: 182.7;tongue: 72.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 22.9;Early spermatids: 4.2;Sertoli cells: 6.6;Skeletal myocytes: 11.0"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RH-30: 94.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017518, CAB018557, HPA054488"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	Vesicles	"CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: AB_2682504"	"unprognostic (1.79e-1)"				"unprognostic (1.43e-1)"	"unprognostic (1.40e-2)"		"unprognostic (6.43e-2)"		"unprognostic (8.79e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.38e-3)"		"unprognostic (9.79e-2)"	"unprognostic (1.36e-1)"			0.4	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	5.7	0.1	0.1	27.4	0.1	0.1	0.0	0.0	0.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	2.5	0.2	182.7	0.2	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.2	0.1	72.8	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	11.0	2.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0
CBL	"c-Cbl, CBL2, RNF55"	ENSG00000110395	"Cbl proto-oncogene"	P22681	11	119206298-119313926	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004350, HPA027956"	Enhanced		Approved	Cytosol		NA	NA		67000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB004350: AB_2244054, HPA027956: AB_10601094"	"unprognostic (2.52e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.10e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	6.8	4.0	5.6	9.5	5.7	8.5	5.6	5.3	6.5	5.0	0.2	6.2	3.9	6.5	3.4	5.6	5.6	3.9	4.1	5.3	8.1	4.4	2.7	7.9	10.7	5.8	6.3	3.7	3.8	6.1	2.9	6.4	6.5	4.0	5.0	8.3	3.6	4.6	2.5	5.2	6.6	7.4	5.2	9.9	5.2	18.2	7.9	22.5	4.1	3.2	11.2	5.8	4.9	6.0	10.7	7.6	26.6	16.7	7.8	9.2	16.0	11.2	11.4	10.8	10.2	16.7	12.6	25.1	10.0	14.0	21.7	15.2	18.4	9.4	22.7	14.8	4.7	26.4	6.2	5.1	9.5	30.3	27.9	8.1	10.1	26.7	28.4	11.1	26.3	23.7	21.7	9.9	19.1	11.3	16.2	17.0	14.0	9.2	8.8	17.5	13.5	4.6	9.3	8.2	3.7	11.3	20.9	8.8	7.3	18.1	9.4	24.8	22.8	16.0	11.5	11.6	14.7	3.3	5.3	19.9	6.7	25.4	11.9	0.8	2.4	2.0	0.9	2.8	0.8	1.5	1.1	0.9	2.6	1.2	1.2	1.3	8.6	0.4	2.5	1.4	1.0	0.9	5.6	5.7	5.3	6.5	5.3	8.1	5.8	6.3	6.5	5.2	7.9	6.0	23.2	9.6	8.3	23.5	23.2	18.0	5.9	7.5	19.4	14.0	13.6	11.7	8.8	5.7	6.0	11.0	45.9	6.3	24.0	7.6	1.9	6.1	28.2	9.9	19.6	23.2	8.4	5.7	38.5	6.7	10.5	9.4	9.2	16.8	3.8	20.8	20.0	3.1	16.0	13.5	39.1	4.9	2.0	59.1	43.2	42.0	7.8	41.2	16.0	45.0	46.8	13.2	22.6	26.2	19.6	10.6	11.6	12.8	19.7	8.0	5.1	5.4	4.8	33.3	26.3	11.6	22.7	38.0	36.2	18.5	21.9	7.0	24.9	10.6	5.1	10.9
CBS	HIP4	ENSG00000160200	"Cystathionine beta-synthase"	P35520	21	43053191-43076943	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Allosteric enzyme, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 174.9;pancreas: 99.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 2.3;Cardiomyocytes: 4.9;Hepatocytes: 3.6;Ionocytes: 2.0;Melanocytes: 5.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	51	"neutrophil: 5.0"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 177.5;HAP1: 172.8;HHSteC: 224.1;MCF7: 197.7;RPMI-8226: 197.4"	"Low region specificity"	"Detected in all"							HPA001223	Supported		Approved	Nucleoli,Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	Nucleoli	"HPA001223: AB_1846112"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.68e-4)"	"unprognostic (3.62e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	6.6	2.8	42.5	1.0	39.5	0.2	3.4	58.5	55.3	12.3	29.3	4.8	3.0	4.5	0.0	2.0	5.8	1.2	7.7	41.4	40.3	3.8	174.9	10.2	2.7	42.5	44.6	30.3	99.0	2.5	8.8	1.2	42.7	12.7	0.9	2.5	19.9	1.1	1.1	2.3	7.0	2.3	38.4	1.7	16.5	2.0	48.1	0.7	17.4	1.2	1.4	11.6	6.2	45.4	30.0	17.0	31.3	113.4	48.9	31.5	177.5	39.5	10.0	15.6	15.4	53.7	1.5	0.1	19.2	67.2	0.3	1.5	172.8	13.2	3.1	0.0	20.5	12.3	73.1	63.8	224.1	7.9	19.1	21.7	1.4	16.0	16.4	13.2	38.6	85.6	138.7	118.1	11.1	197.7	16.1	0.1	20.3	65.7	29.4	0.0	0.2	197.4	0.5	15.5	57.8	85.1	78.5	5.4	44.4	18.4	27.0	91.2	5.4	0.8	42.5	0.3	4.8	34.8	30.2	41.2	19.0	11.0	53.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	42.5	39.5	58.5	55.3	41.4	40.3	42.5	44.6	42.7	38.4	48.1	45.4	0.2	0.0	0.5	0.7	0.0	0.4	0.0	2.3	0.0	0.2	0.5	0.1	4.9	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.2	0.8	1.2	0.0	0.1	0.0	0.1	0.0	3.6	0.2	0.0	0.0	0.0	2.0	0.0	1.4	0.0	0.9	0.2	5.4	0.0	0.0	0.5	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.2	1.7	0.1	0.1	0.1	0.0	0.3	0.6	0.0	0.6	0.0	1.0	0.1	0.1	0.0	0.2	0.1
CCDC22	"CXorf37, JM1"	ENSG00000101997	"Coiled-coil domain containing 22"	O60826	X	49235470-49250520	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport, Ubl conjugation pathway"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000229, HPA000888, HPA075980"	Uncertain	Approved	Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 4: Macrophages - Innate immune response"	"Endoplasmic reticulum, Vesicles"		"HPA000229: , HPA000888: AB_1078420, HPA075980: "	"unprognostic (1.24e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.57e-3)"	"unprognostic (3.61e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-3)"	10.3	12.3	9.4	10.1	10.0	18.6	10.3	9.9	10.8	11.7	8.8	12.1	10.4	12.2	5.3	14.2	11.3	6.4	12.8	9.4	9.2	12.3	12.9	10.7	15.0	10.8	9.4	11.2	14.2	8.7	11.2	6.9	10.1	13.5	5.2	4.7	12.3	8.7	17.2	13.8	13.4	6.0	9.6	20.5	12.9	3.8	10.0	13.6	11.0	7.7	8.5	11.9	11.1	10.8	18.8	16.0	9.6	33.5	8.8	8.9	20.4	10.9	7.9	12.0	13.6	16.3	16.0	6.9	15.9	9.7	14.3	15.0	10.6	18.0	4.9	18.1	23.6	7.3	15.6	15.5	14.7	20.8	12.4	8.2	15.2	15.9	8.6	6.1	11.9	13.7	14.7	11.8	8.6	58.3	15.3	24.4	11.2	9.5	23.2	22.0	15.6	30.1	9.4	9.4	11.4	8.8	16.7	19.4	15.0	9.8	30.2	20.2	13.3	15.4	16.5	19.2	11.6	21.2	12.6	12.5	16.8	38.5	12.3	8.6	37.0	23.8	18.3	30.9	20.1	18.9	18.8	21.3	38.2	16.8	16.7	19.6	2.8	10.8	27.1	15.1	21.8	28.0	9.4	10.0	9.9	10.8	9.4	9.2	10.8	9.4	10.1	9.6	10.0	10.8	8.6	0.0	4.4	3.3	15.0	5.6	9.6	13.0	6.2	11.6	7.4	6.1	2.4	15.7	12.0	11.0	6.2	15.2	11.2	12.5	15.6	13.9	0.3	5.8	4.6	7.8	6.7	8.6	3.7	7.3	14.8	7.6	7.1	6.9	11.4	8.6	11.0	7.2	32.0	1.7	2.9	18.2	8.2	14.4	11.9	0.4	8.1	13.8	7.2	1.9	18.0	9.9	9.2	1.0	4.2	8.6	7.6	7.5	10.2	6.2	15.6	12.1	5.6	8.0	6.6	9.1	9.5	0.1	0.9	8.0	6.7	20.2	13.3	11.0	15.7	8.3
CCDC47	GK001	ENSG00000108588	"Coiled-coil domain containing 47"	Q96A33	17	63745255-63776351	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029674, HPA072573, HPA075958"	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"HPA029674: AB_10602703, HPA072573: AB_2686535, HPA075958: "	"unprognostic (6.33e-2)"	"unprognostic (3.26e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.16e-1)"	57.9	67.3	24.3	42.5	33.6	29.0	57.1	28.8	39.2	47.7	46.9	83.4	87.1	39.1	53.7	52.6	43.9	48.2	65.5	29.3	27.9	72.0	102.2	52.7	33.5	28.8	27.4	35.3	59.8	84.6	21.9	54.8	29.9	60.2	80.6	46.9	62.4	52.0	115.3	52.2	78.2	42.1	30.1	35.6	78.5	32.1	26.0	29.9	62.0	83.7	40.5	58.5	29.3	34.3	143.3	133.8	81.4	71.9	112.4	74.0	158.0	141.9	92.6	96.1	112.4	118.7	127.0	112.9	74.3	100.9	110.8	114.3	99.3	88.1	168.9	39.4	101.2	160.9	106.4	117.3	107.6	129.9	81.3	78.5	121.3	132.4	113.2	67.9	81.3	55.3	183.5	95.5	79.4	116.1	100.5	48.1	70.8	179.4	134.0	92.2	157.9	154.6	115.3	161.1	74.2	101.5	95.2	242.8	120.3	103.0	159.8	70.4	104.0	177.6	112.9	130.6	166.0	93.9	119.9	112.8	103.9	81.4	147.3	53.2	59.7	75.6	40.7	61.5	47.9	38.4	39.8	37.9	82.5	31.7	41.1	36.2	47.6	43.4	65.9	54.7	49.0	52.0	24.3	33.6	28.8	39.2	29.3	27.9	28.8	27.4	29.9	30.1	26.0	34.3	96.9	144.2	122.2	16.3	46.6	100.8	108.5	95.9	98.4	40.9	65.9	53.6	129.0	72.9	128.3	60.7	14.6	111.1	59.0	99.8	9.8	115.3	17.9	80.3	73.9	83.9	52.2	76.6	26.2	105.1	98.3	85.3	65.7	126.0	45.5	31.2	68.2	96.3	57.5	57.2	25.9	95.1	83.4	56.9	58.3	11.5	47.8	60.7	39.2	13.1	52.9	55.3	25.7	22.6	25.5	92.0	62.6	56.1	56.0	89.6	87.5	32.6	83.0	27.9	72.3	117.2	92.1	82.0	44.7	90.1	90.8	144.1	42.7	53.0	110.5	83.3
CD151	"PETA-3, RAPH, SFA-1, TSPAN24"	ENSG00000177697	"CD151 molecule (Raph blood group)"	P48509	11	832887-839831	"Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Blood group antigen"	"Deafness, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 716.2;Exocrine glandular cells: 636.7;Pancreatic endocrine cells: 736.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002428, HPA011906"	Supported					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"			"CAB002428: AB_564129, HPA011906: AB_1846245"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.45e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (5.58e-4)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (5.47e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.02e-3)"	"unprognostic (3.31e-1)"	"unprognostic (4.39e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.24e-1)"	"prognostic favorable (6.92e-4)"	"unprognostic (7.83e-2)"	332.4	159.5	54.0	79.7	53.5	25.0	277.8	52.5	67.6	181.6	66.1	219.7	140.6	264.6	103.0	97.5	184.3	132.4	345.8	54.2	65.3	194.3	145.3	240.1	35.4	64.5	57.4	116.2	278.3	85.9	81.1	110.1	60.5	182.9	99.8	9.6	243.5	194.2	113.1	107.0	149.4	255.2	58.3	94.8	187.3	44.8	58.6	15.0	133.5	77.0	30.6	203.1	151.3	58.0	380.0	475.3	71.8	256.3	1088.7	422.8	110.4	587.1	400.4	285.0	241.2	252.6	677.2	0.2	224.0	943.5	388.4	358.4	71.1	498.4	96.1	135.0	236.6	112.8	139.1	193.4	366.7	90.2	157.4	388.6	328.2	164.5	367.8	1089.2	348.8	16.4	135.1	56.3	485.9	196.1	1.9	99.5	48.0	232.9	569.4	20.0	173.7	106.4	642.8	102.1	99.5	111.8	578.9	371.5	121.5	81.6	145.8	102.4	600.0	462.6	209.3	147.5	352.9	62.0	66.5	4.5	437.5	89.7	265.8	24.6	19.1	15.2	5.7	19.3	6.8	3.0	4.7	5.0	11.9	2.0	1.9	3.0	7.3	8.2	24.1	1.8	2.9	10.8	54.0	53.5	52.5	67.6	54.2	65.3	64.5	57.4	60.5	58.3	58.6	58.0	294.4	208.3	79.1	13.1	12.8	70.6	143.2	328.2	60.9	16.6	180.9	203.7	180.0	133.0	159.8	248.3	4.2	222.6	15.6	542.3	19.6	716.2	2.6	60.8	114.6	214.8	127.6	28.6	10.0	636.7	423.8	173.8	236.5	143.7	81.3	103.7	265.2	54.0	130.0	37.0	5.5	388.5	138.4	59.3	70.4	11.3	123.6	81.8	128.1	15.9	75.6	94.8	23.7	3.5	0.7	736.6	477.9	283.2	26.6	307.1	440.6	124.6	52.2	17.0	210.4	96.6	310.3	5.6	13.6	73.4	54.4	185.7	29.7	61.1	289.8	199.6
CD2AP	CMS	ENSG00000198087	"CD2 associated protein"	Q9Y5K6	6	47477789-47627263	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 204.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 9.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003267, HPA003326, CAB004352"	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		NA	NA		58000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Centriolar satellite"	"CAB004352: AB_627009, HPA003267: AB_1078458, HPA003326: AB_1078457"	"unprognostic (5.98e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (7.57e-5)"	14.0	10.5	3.4	15.0	3.4	14.3	17.8	6.3	4.6	18.1	8.8	40.0	56.9	12.0	13.2	19.2	14.1	15.0	7.7	2.7	3.8	34.1	20.2	17.1	15.9	4.3	3.9	6.4	20.2	35.6	6.0	21.6	4.7	19.7	36.9	6.9	17.0	13.5	6.9	18.0	59.5	10.9	4.3	13.7	40.4	9.4	3.9	34.0	18.2	10.3	17.4	30.1	10.1	4.6	58.0	22.5	6.9	14.3	9.4	13.6	54.8	13.9	16.9	18.5	23.3	37.3	39.9	74.5	56.9	18.2	24.0	21.2	23.0	34.7	29.9	29.9	37.2	41.3	18.4	33.6	12.5	23.3	15.4	9.7	32.1	17.7	25.5	35.7	30.1	24.4	73.5	23.2	16.9	18.2	44.6	8.7	20.3	69.6	8.1	23.6	17.6	34.1	115.6	101.7	20.9	8.1	27.9	36.9	27.7	31.1	35.0	14.8	36.2	36.9	30.8	12.0	39.9	17.5	31.3	52.6	39.4	12.4	19.2	1.8	0.5	3.2	1.2	0.4	1.8	0.9	1.0	1.1	1.2	1.0	0.9	1.5	0.1	3.1	0.4	9.9	0.9	0.5	3.4	3.4	6.3	4.6	2.7	3.8	4.3	3.9	4.7	4.3	3.9	4.6	81.7	96.1	67.1	32.0	40.5	32.2	52.1	26.5	39.9	10.0	40.4	26.4	17.2	35.8	68.9	71.7	16.7	53.0	96.1	204.1	21.5	84.6	10.4	97.9	25.0	56.6	55.8	42.9	40.7	98.0	17.1	20.6	101.4	136.7	24.1	28.5	37.5	24.2	17.4	15.2	45.3	97.3	40.7	26.2	12.6	10.5	16.8	30.6	14.2	83.4	18.0	12.5	22.6	28.6	30.8	151.3	114.0	10.9	27.7	89.0	182.3	67.4	60.0	13.0	26.3	34.9	27.8	38.9	27.2	44.2	41.1	40.9	29.4	48.0	68.8	143.6
CD36	"FAT, GP3B, GP4, GPIV, SCARB3"	ENSG00000135218	"CD36 molecule"	P16671	7	80369575-80679277	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Transport"	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1533.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 3219.2;Cardiomyocytes: 623.1;Hofbauer cells: 1369.8;Sertoli cells: 696.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 962.6;intermediate monocyte: 270.6;myeloid DC: 507.1"	"Group enriched"	"Detected in all"	46	"dendritic cells: 507.1;monocytes: 962.6"	"Group enriched"	"Detected in some"	4	"ASC diff: 322.6;HEL: 158.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"spinal cord: 16.9"	"HPA002018, CAB025866, HPA071026"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		5300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"CAB025866: , HPA002018: AB_1078464, HPA071026: AB_2732170"	"unprognostic (7.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (4.47e-4)"	"unprognostic (7.05e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.73e-3)"	1533.6	24.6	3.4	51.7	2.5	148.2	540.4	1.6	2.0	11.6	2.7	40.5	113.6	8.7	38.2	19.6	40.5	84.0	540.9	2.6	6.9	7.0	80.8	131.2	18.8	22.0	21.2	4.0	31.2	25.0	2.0	413.3	15.7	5.0	40.9	0.3	31.9	8.6	248.5	28.6	119.7	39.4	14.0	309.9	31.2	7.7	24.0	22.1	69.1	381.6	7.2	22.2	13.4	3.9	0.0	0.0	1.0	0.2	322.6	3.3	0.7	0.9	10.7	0.1	0.1	0.0	0.0	0.1	0.6	1.4	0.3	0.1	4.3	0.5	0.1	0.6	0.4	158.1	0.5	25.7	0.2	0.1	0.1	31.0	12.6	0.1	0.2	7.7	0.9	0.0	5.8	0.0	1.8	0.2	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.5	0.5	0.1	0.9	1.3	0.8	0.6	0.3	2.7	11.1	19.3	0.4	0.5	0.5	0.6	0.3	0.2	0.8	0.4	0.1	54.3	41.8	12.3	962.6	3.7	1.9	270.6	2.1	3.6	0.6	0.6	507.1	0.5	0.8	0.4	15.8	5.9	72.0	128.3	1.5	692.4	3.4	2.5	1.6	2.0	2.6	6.9	22.0	21.2	15.7	14.0	24.0	3.9	3219.2	6.4	63.1	0.0	7.9	7.4	0.2	3.0	0.6	0.2	189.9	24.8	623.1	4.3	9.8	7.3	0.0	10.1	55.0	0.0	0.0	0.2	11.7	5.0	5.9	303.3	0.0	419.5	6.3	0.0	11.1	69.6	1.1	38.4	15.2	0.6	406.2	9.0	1369.8	0.0	2.2	0.6	8.2	153.7	67.3	3.9	0.6	159.6	16.0	17.8	255.2	0.0	7.2	0.5	1.3	0.1	0.0	0.0	4.2	0.8	9.9	0.4	1.2	0.3	696.8	33.1	452.1	4.6	0.7	0.8	4.7	18.3	5.9	1.9	0.2	0.3
CD74	DHLAG	ENSG00000019582	"CD74 molecule"	P04233	5	150400041-150412969	"Cancer-related genes, CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 5258.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 10167.0;Kupffer cells: 5201.6;Langerhans cells: 23363.4;Macrophages: 7290.2;monocytes: 10305.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 11041.2;intermediate monocyte: 15961.1;memory B-cell: 26889.3;myeloid DC: 23750.6;naive B-cell: 27930.3;non-classical monocyte: 8003.3;plasmacytoid DC: 16940.0"	"Group enriched"	"Detected in all"	6	"B-cells: 27930.3;dendritic cells: 23750.6;monocytes: 15961.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 2171.7;Daudi: 3523.2;HDLM-2: 4787.6;REH: 3026.0;RPMI-8226: 2014.2;U-266/70: 1443.4;U-698: 1978.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002506, HPA010592, CAB079994"	Enhanced		Supported	"Golgi apparatus"		NA	NA		210000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"CAB002506: AB_563630, CAB079994: , HPA010592: AB_1078482"	"prognostic favorable (1.06e-4)"	"unprognostic (1.48e-2)"	"unprognostic (4.80e-3)"	"prognostic favorable (6.53e-6)"	"unprognostic (1.41e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.64e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.24e-2)"	1512.1	976.5	338.1	2741.2	301.9	984.3	1157.2	365.5	474.4	1562.8	429.1	992.3	1826.2	593.6	490.6	618.8	1139.0	1477.9	604.0	306.7	506.8	1271.1	1142.0	3786.3	4995.6	598.7	431.8	464.3	392.4	390.6	469.3	305.7	533.4	556.7	1155.8	58.1	1999.3	911.8	307.2	682.4	2438.8	1014.2	514.2	4897.4	1511.5	207.5	514.4	2160.2	853.5	374.2	5258.9	1557.5	483.5	771.8	35.7	0.3	1.5	2.4	2.3	2.5	11.0	0.0	0.0	0.7	0.6	443.0	2171.7	3523.2	124.2	0.0	9.2	9.4	0.0	0.0	0.1	4787.6	0.0	109.1	1.2	250.2	6.6	9.2	6.5	24.5	0.0	0.8	0.0	0.6	0.0	0.0	8.0	1270.7	0.4	0.0	4.2	14.0	5.3	0.0	0.1	3026.0	5.2	2014.2	9.0	133.5	5.1	8.2	5.5	4.7	94.9	19.2	81.2	414.4	5.6	10.3	9.9	9.0	4.5	1443.4	170.7	1978.6	745.9	154.2	678.6	410.8	11041.2	3996.9	808.7	15961.1	899.9	26889.3	688.4	1188.4	23750.6	27930.3	378.9	646.6	839.6	2378.1	8003.3	16940.0	2157.2	17779.7	338.1	301.9	365.5	474.4	306.7	506.8	598.7	431.8	533.4	514.2	514.4	771.8	2080.4	419.9	2160.4	0.7	10167.0	715.9	154.0	762.2	398.4	1.7	220.3	437.5	69.6	401.7	1063.3	502.1	0.0	28.3	3199.0	139.7	117.4	1264.4	10.4	111.3	11.5	1787.6	242.9	562.5	0.7	527.5	32.6	278.6	538.2	85.5	417.2	113.4	514.7	52.5	4361.8	1.7	0.6	475.7	390.6	5201.6	23363.4	31.3	117.1	7290.2	1197.1	137.7	10305.9	16.8	403.7	0.5	1.4	384.2	487.3	17.7	2068.3	174.9	5034.4	815.8	1153.1	10.0	164.3	45.1	146.7	2.8	12.6	170.9	575.8	41.6	790.7	12.9	450.7	743.4
CD81	"TAPA-1, TAPA1, TSPAN28"	ENSG00000110651	"CD81 molecule"	P60033	11	2376177-2397397	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 1003.1;Endometrial stromal cells: 1050.9;Muller glia cells: 809.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 148.9;naive B-cell: 137.2"	"Lineage enriched"	"Detected in all"	4	"B-cells: 148.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 2960.6;fHDF/TERT166: 1752.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002507, HPA007234"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		400000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Cytosol	"CAB002507: AB_563639, HPA007234: AB_1846333"	"unprognostic (2.96e-1)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.56e-4)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (3.07e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.06e-1)"	892.1	299.1	560.6	270.7	598.4	77.8	773.6	614.8	590.2	952.7	498.9	992.0	150.7	1384.0	960.5	364.3	853.1	534.5	937.9	511.1	615.8	636.6	1175.7	768.4	429.0	665.7	640.8	656.8	449.5	258.3	409.1	441.0	651.1	634.0	234.4	75.9	531.1	1602.0	214.3	511.1	423.1	978.5	694.1	631.3	494.3	316.9	655.1	158.9	564.6	227.6	278.6	749.2	763.4	734.4	337.0	342.0	268.5	413.4	2960.6	1668.4	224.8	621.0	1361.6	490.3	492.2	322.8	1.8	285.4	218.3	1752.6	312.5	430.5	167.3	442.2	199.9	135.6	517.8	43.7	117.1	0.3	976.4	188.2	359.8	1222.3	619.9	201.1	302.1	757.9	476.6	204.0	198.7	484.9	696.4	257.2	160.7	239.1	324.4	304.7	274.2	324.7	135.5	183.3	529.1	223.3	288.8	319.2	198.4	514.4	383.8	214.3	171.0	337.8	641.3	249.0	181.6	471.2	216.6	356.9	88.1	529.1	361.3	111.0	435.0	0.9	3.3	22.9	21.1	5.8	34.4	148.9	14.9	33.0	2.6	137.2	9.2	16.9	1.0	14.7	7.3	7.7	12.0	10.7	560.6	598.4	614.8	590.2	511.1	615.8	665.7	640.8	651.1	694.1	655.1	734.4	1003.1	243.6	270.0	95.0	88.2	179.8	391.8	89.7	26.2	82.7	325.6	452.0	277.4	167.3	102.3	207.8	27.1	21.8	267.1	20.0	35.2	105.7	15.9	365.4	1050.9	344.5	71.9	30.7	19.0	55.1	31.7	560.4	21.4	462.7	81.7	204.0	293.4	603.9	251.5	148.0	32.4	48.2	50.8	232.7	179.7	50.2	389.2	277.6	151.2	60.0	23.0	809.2	45.3	145.8	93.6	61.3	14.7	251.3	50.7	147.6	5.0	29.9	85.8	76.1	118.3	356.9	423.6	15.6	19.4	30.6	164.9	20.1	136.8	379.0	41.5	298.1
CDC14A	"cdc14, Cdc14A1, Cdc14A2, DFNB105, DFNB32"	ENSG00000079335	"Cell division cycle 14A"	Q9UNH5	1	100345001-100520277	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Hearing"	"Hydrolase, Protein phosphatase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 28.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 145.9;Early spermatids: 171.5;Late spermatids: 191.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023783	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023783: AB_1846352"	"unprognostic (3.72e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-4)"	"unprognostic (4.88e-3)"	"unprognostic (6.30e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.66e-2)"	3.6	1.5	3.9	4.6	3.1	15.5	11.3	2.7	4.2	5.4	5.2	6.0	7.3	5.3	2.7	2.2	13.0	3.3	2.3	3.7	4.5	6.3	1.8	5.9	7.2	4.3	4.9	4.6	2.0	6.0	3.6	5.1	3.3	7.6	6.0	5.5	3.4	3.0	2.6	3.8	10.7	4.7	3.5	6.7	5.8	28.2	3.6	6.4	5.8	2.8	4.4	4.4	3.3	3.2	3.3	2.6	8.1	9.3	2.9	2.1	5.7	4.1	2.7	3.9	3.1	8.9	2.7	1.6	3.0	2.4	3.2	2.5	5.6	2.3	4.0	3.4	13.7	5.8	2.3	2.9	1.1	7.8	9.8	1.8	0.6	4.3	1.4	2.0	7.0	3.3	44.7	4.8	5.8	1.4	6.3	8.7	5.1	2.1	3.3	6.8	10.6	1.7	2.8	7.2	1.5	2.7	4.3	4.1	5.6	3.9	1.9	10.0	3.1	2.2	4.9	3.8	2.5	2.4	0.9	2.5	2.7	7.3	1.3	12.2	3.6	9.0	6.9	3.3	12.5	4.5	10.9	8.2	3.5	2.9	10.2	5.5	5.4	4.4	2.3	6.2	6.0	4.1	3.9	3.1	2.7	4.2	3.7	4.5	4.3	4.9	3.3	3.5	3.6	3.2	14.1	3.2	5.5	145.9	10.6	3.7	4.5	1.7	4.6	0.4	15.8	11.0	6.6	0.0	4.4	1.8	4.2	2.7	23.2	18.4	0.0	3.0	171.5	48.3	11.8	13.5	4.8	3.8	4.3	1.9	1.0	7.0	6.6	51.1	15.2	4.8	7.1	1.0	2.8	0.0	1.4	4.0	2.0	5.5	7.3	191.7	5.0	11.1	5.4	51.5	9.3	11.4	6.2	53.8	3.6	3.1	11.2	0.7	13.5	5.2	22.9	2.5	22.5	3.8	0.0	6.2	6.0	2.3	3.6	4.9	2.4	2.2	44.1	3.0	3.7	4.1
CDC42	"CDC42Hs, G25K"	ENSG00000070831	"Cell division cycle 42"	P60953	1	22025511-22101360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004360, HPA069590"	Approved		Supported	"Microtubules,Cytokinetic bridge"		Yes	No		2700000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Microtubules, Cytokinetic bridge"		"CAB004360: AB_627233, HPA069590: AB_2732138"	"unprognostic (9.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.72e-2)"	"prognostic unfavorable (5.28e-5)"	"unprognostic (1.09e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.90e-2)"	"unprognostic (9.41e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.09e-1)"	177.4	116.1	91.7	160.2	96.5	402.9	142.7	100.1	113.8	128.6	98.4	198.2	142.3	131.3	99.8	162.3	124.8	131.7	117.0	95.2	108.8	158.8	153.5	154.1	167.9	115.5	103.7	105.9	82.5	128.4	59.6	170.3	108.4	108.3	185.4	95.9	103.8	107.5	119.9	132.0	156.9	175.0	107.4	157.5	159.9	64.2	102.2	157.7	110.6	120.9	216.8	194.8	114.9	127.1	341.9	146.4	272.2	222.0	295.0	306.4	274.2	347.3	318.8	365.5	336.2	178.0	374.5	253.1	272.8	416.7	136.2	210.7	241.1	369.3	431.1	332.4	180.1	438.1	184.5	225.4	259.1	388.5	350.5	285.6	396.6	341.0	195.2	234.7	535.6	157.8	250.8	273.4	430.2	135.6	242.9	307.5	170.2	242.9	179.3	199.6	297.6	243.3	316.2	301.3	183.4	175.8	293.4	228.7	263.4	296.3	242.3	219.1	466.3	265.3	265.2	349.3	207.8	148.6	355.9	305.8	234.5	419.3	277.6	244.3	200.6	255.1	142.4	282.3	144.3	108.0	152.0	146.7	162.3	103.4	109.5	143.5	308.3	145.0	352.2	107.2	157.4	244.8	91.7	96.5	100.1	113.8	95.2	108.8	115.5	103.7	108.4	107.4	102.2	127.1	502.1	60.9	51.8	20.9	301.0	450.6	385.5	266.0	136.1	119.1	281.1	179.6	86.9	231.6	168.0	312.6	18.8	349.6	470.1	434.9	375.6	441.3	38.0	350.5	356.5	307.7	300.4	243.0	58.5	441.9	499.6	225.2	152.4	425.8	163.6	138.2	277.0	230.9	439.2	106.0	71.0	315.4	187.2	585.4	875.2	41.3	157.8	443.4	423.4	53.4	654.9	102.5	286.3	41.7	72.9	570.5	369.7	177.1	192.9	323.1	283.1	578.2	176.2	65.2	236.7	174.2	308.3	155.3	116.2	176.6	556.6	551.6	379.2	178.6	286.7	469.6
CDK10	PISSLRE	ENSG00000185324	"Cyclin dependent kinase 10"	Q15131	16	89680737-89696354	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007451, HPA059634, HPA067060"	Uncertain		Supported	"Nucleoplasm,Midbody,Midbody ring"		Yes	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Midbody, Midbody ring"	"HPA007451: AB_2732400, HPA059634: AB_2684090, HPA067060: AB_2685772"	"unprognostic (7.89e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.74e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.53e-1)"	"unprognostic (9.06e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.13e-1)"	"prognostic favorable (2.69e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.88e-2)"	"prognostic favorable (3.63e-4)"	30.1	38.5	20.2	10.4	20.4	19.5	26.7	20.3	32.8	49.3	22.0	38.2	22.7	25.9	8.7	35.3	36.3	8.6	27.3	21.0	19.5	52.9	77.0	31.0	14.7	18.6	18.7	43.2	49.2	13.5	55.5	12.5	19.6	39.1	11.3	7.6	24.8	7.5	33.8	32.1	36.1	8.2	17.0	37.5	38.5	17.0	18.4	10.8	54.5	4.1	7.0	32.3	36.5	19.1	27.5	17.8	13.9	5.8	5.7	11.0	14.2	22.3	12.6	15.2	4.9	13.1	21.2	23.9	9.8	19.3	9.1	15.5	5.8	30.8	9.3	5.3	14.1	9.7	21.0	1.7	23.4	15.8	17.1	13.3	10.7	9.3	15.3	10.3	27.0	16.1	25.5	3.2	17.7	36.6	19.5	45.0	28.5	29.7	13.1	26.5	19.0	34.1	27.9	21.2	10.1	29.6	28.0	13.0	6.8	15.2	30.3	25.0	24.1	9.1	26.6	10.1	15.4	11.7	6.4	7.5	16.4	25.0	15.5	5.1	14.0	4.2	14.8	19.7	12.8	7.8	13.2	10.7	18.1	9.0	15.1	12.6	1.5	20.4	15.4	12.4	11.6	11.4	20.2	20.4	20.3	32.8	21.0	19.5	18.6	18.7	19.6	17.0	18.4	19.1	28.2	12.8	26.6	35.3	21.2	15.4	24.2	26.9	23.3	17.2	24.5	25.1	6.5	38.6	20.0	27.6	25.0	28.6	26.7	44.8	43.0	28.6	6.1	20.7	21.9	23.0	67.7	15.4	44.5	12.5	19.8	19.6	85.1	16.9	9.5	40.3	21.8	41.1	18.8	18.5	33.3	49.4	26.4	17.4	16.0	8.8	23.9	17.0	19.6	17.8	15.5	8.5	26.8	24.6	20.0	13.6	41.5	12.4	20.8	30.7	58.3	53.7	28.1	32.3	6.6	11.4	16.3	27.3	28.7	22.4	15.5	27.9	22.0	54.8	58.2	22.9
CDK12	"CRK7, CRKR, CRKRS, KIAA0904"	ENSG00000167258	"Cyclin dependent kinase 12"	Q9NYV4	17	39461486-39564907	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 307.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008038, HPA073305"	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA008038: AB_1078570, HPA073305: "	"unprognostic (2.02e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.00e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.32e-1)"	9.5	7.6	2.5	14.0	1.9	34.3	9.5	8.0	4.0	11.0	4.1	9.8	9.9	10.8	6.0	10.4	9.2	9.2	6.8	1.6	2.9	8.0	12.3	9.2	15.1	3.0	1.7	11.9	8.7	13.0	6.2	11.5	1.6	9.8	10.4	11.7	9.2	9.3	6.7	10.6	10.4	10.0	0.3	12.9	10.3	17.7	3.4	17.9	12.2	7.8	15.3	13.1	9.1	3.3	31.9	40.0	24.9	22.2	17.2	19.0	21.1	28.9	24.7	39.9	29.0	48.1	19.8	45.4	24.6	31.1	38.7	51.8	49.2	36.6	38.4	29.6	38.7	49.7	26.9	36.3	16.4	66.9	33.4	20.4	25.0	48.2	37.6	16.0	24.4	27.7	85.2	30.7	22.9	14.3	57.9	17.7	23.8	16.0	16.9	36.8	50.3	25.7	14.8	38.8	24.6	15.7	37.0	307.8	25.1	34.8	38.5	29.3	26.4	34.5	27.6	24.5	37.9	23.6	18.4	63.5	24.2	28.2	23.0	11.2	2.0	3.2	2.6	1.5	1.8	1.8	1.5	1.7	1.2	3.1	1.7	1.6	7.0	4.5	1.3	2.7	1.2	0.7	2.5	1.9	8.0	4.0	1.6	2.9	3.0	1.7	1.6	0.3	3.4	3.3	41.4	25.6	29.1	50.9	59.0	64.6	58.5	31.2	50.1	46.6	38.1	26.9	14.5	32.9	40.3	38.6	64.6	33.2	59.0	44.6	13.7	30.2	25.1	49.8	63.4	40.6	31.1	39.3	53.9	27.5	29.9	39.2	45.3	63.1	29.1	43.8	32.2	46.3	27.4	35.3	52.9	39.6	42.7	45.9	49.1	17.3	37.3	41.3	26.6	32.8	41.4	27.8	48.4	47.3	53.1	47.9	33.9	33.8	53.5	81.5	33.3	16.7	38.1	65.4	32.9	48.0	48.5	140.2	104.8	53.0	69.0	58.3	59.0	46.0	39.9	84.8
CDK13	"CDC2L, CDC2L5, CHED, KIAA1791"	ENSG00000065883	"Cyclin dependent kinase 13"	Q14004	7	39950121-40099580	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 179.0;Oligodendrocyte precursor cells: 171.9;Oligodendrocytes: 199.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059241	Uncertain		Supported	"Nuclear speckles,Golgi apparatus,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	"Golgi apparatus, Cytosol"	"HPA059241: AB_2683956"	"unprognostic (1.99e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.42e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.53e-2)"	11.4	10.2	8.8	14.6	10.8	28.1	11.1	19.3	9.9	12.8	6.7	11.9	10.5	13.6	14.2	14.7	15.0	12.7	10.4	8.1	10.7	12.7	15.9	12.1	21.7	10.5	8.5	20.1	12.8	17.2	8.0	13.6	8.6	11.2	13.6	19.7	12.9	11.8	11.2	12.0	12.0	12.0	7.2	16.6	12.3	19.0	10.1	19.6	20.6	14.0	20.2	13.4	10.0	14.9	28.4	16.6	28.2	27.0	24.9	24.1	19.3	22.1	23.8	19.8	24.6	17.8	19.1	51.0	12.6	23.4	34.8	33.6	23.4	19.4	29.0	25.3	17.3	22.8	20.0	16.0	23.7	34.8	23.5	14.3	25.5	22.6	30.0	22.6	23.6	23.1	39.0	34.3	20.7	14.7	28.0	24.9	40.8	20.0	19.1	30.5	18.5	20.5	18.5	28.1	20.0	28.8	27.6	59.8	19.9	36.7	24.6	43.0	28.3	27.0	26.0	17.6	30.5	28.3	26.0	41.2	19.8	30.9	35.4	7.8	2.2	4.0	4.1	1.9	2.8	6.4	3.8	3.0	1.3	10.5	3.8	3.9	5.9	4.3	3.1	3.3	3.9	1.3	8.8	10.8	19.3	9.9	8.1	10.7	10.5	8.5	8.6	7.2	10.1	14.9	47.6	44.8	72.0	131.6	49.7	21.4	18.5	15.9	29.0	47.8	36.7	27.7	30.9	25.8	37.1	31.3	70.9	13.7	91.0	23.1	7.9	20.4	13.9	54.3	51.4	30.9	18.7	5.9	179.0	15.4	9.1	31.7	30.1	72.6	17.1	95.5	19.2	23.7	13.2	37.0	166.2	17.6	14.2	23.8	17.4	9.2	26.1	31.6	14.2	145.2	27.9	22.4	53.5	171.9	199.6	28.6	12.9	17.7	50.1	21.8	15.2	12.7	32.8	69.4	6.6	38.5	32.0	36.1	33.4	34.7	26.1	12.2	49.7	56.8	20.1	25.0
CDK5	PSSALRE	ENSG00000164885	"Cyclin dependent kinase 5"	Q00535	7	151053815-151057897	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Lissencephaly, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB008909, HPA064535"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB008909: , HPA064535: AB_2685280"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.25e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-1)"	6.3	16.8	50.2	9.4	53.2	11.2	8.6	44.9	65.8	8.6	40.0	9.3	10.9	6.7	24.9	10.2	8.2	9.5	9.8	57.5	50.9	13.5	12.5	8.3	9.8	48.6	45.3	4.5	9.5	22.8	14.7	8.6	48.4	8.8	9.9	11.3	9.6	10.2	8.5	9.5	8.6	10.4	43.2	9.4	7.9	4.9	50.1	14.2	10.0	7.2	11.6	8.8	6.0	50.9	31.9	40.8	37.3	59.7	48.8	36.1	17.8	24.4	41.7	47.9	40.3	31.2	31.0	34.7	71.3	31.8	63.5	23.5	67.8	40.6	22.6	24.9	43.3	38.2	32.4	30.7	31.6	29.0	64.4	37.9	28.7	39.0	13.5	62.8	38.8	57.6	36.3	24.0	50.7	68.4	76.4	57.9	39.3	57.2	80.5	38.9	14.8	41.5	46.2	27.9	23.0	97.8	30.9	37.7	43.8	36.0	18.6	25.9	22.7	42.2	10.3	31.2	39.2	52.1	61.4	13.7	66.4	46.5	75.8	18.9	39.4	20.1	13.5	46.2	11.1	13.3	12.8	13.6	44.7	12.8	9.8	11.8	5.7	19.9	36.4	26.9	31.9	23.8	50.2	53.2	44.9	65.8	57.5	50.9	48.6	45.3	48.4	43.2	50.1	50.9	7.6	0.0	6.0	1.6	6.2	3.6	8.2	18.0	6.2	12.1	9.6	10.4	3.1	8.6	14.7	11.0	2.1	26.8	5.4	8.0	39.2	21.4	0.8	14.9	10.9	8.9	9.0	12.2	5.8	18.9	12.3	7.6	9.7	9.3	30.5	23.6	7.9	11.1	41.9	0.0	6.4	8.9	18.3	21.9	6.2	1.3	4.7	16.6	10.6	1.9	19.9	12.6	12.3	1.5	3.7	22.8	15.0	11.3	12.4	4.3	20.2	35.7	14.4	7.1	6.6	4.5	13.1	3.9	11.2	11.4	6.3	9.0	7.3	14.2	9.5	9.0
CDK8	K35	ENSG00000132964	"Cyclin dependent kinase 8"	P49336	13	26254104-26405238	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Repressor, Serine/threonine-protein kinase, Transferase"	"Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 118.7;Inhibitory neurons: 175.4;Late spermatids: 100.4;Oligodendrocyte precursor cells: 149.3;Oligodendrocytes: 91.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044721			Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA044721: AB_2679059"	"unprognostic (3.28e-3)"	"unprognostic (2.25e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.12e-1)"	"prognostic favorable (9.23e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.37e-2)"	4.4	2.9	2.2	3.5	2.5	3.2	3.0	7.6	3.0	2.9	1.2	10.5	7.7	4.0	3.2	5.1	2.5	3.9	4.1	3.0	2.7	5.1	5.7	2.9	3.1	2.7	3.0	2.5	7.1	5.1	2.1	5.9	2.4	3.5	6.0	8.5	4.6	6.9	5.0	3.1	7.5	6.6	2.1	2.5	5.0	9.7	2.6	5.9	3.4	5.2	4.1	6.2	2.5	2.1	10.1	8.4	16.5	16.4	8.3	10.2	10.3	19.6	13.2	13.8	10.0	23.8	13.6	10.7	8.3	9.8	11.6	12.2	18.7	12.9	17.2	25.8	10.3	20.5	6.4	8.2	5.8	32.3	11.4	7.5	12.2	10.7	17.3	7.8	10.2	18.1	32.1	0.0	12.5	10.7	25.2	15.1	13.2	15.5	9.9	15.4	15.9	7.6	8.2	9.2	13.6	8.6	8.1	15.1	13.9	12.7	5.5	14.6	10.5	8.8	11.3	16.1	10.4	7.8	15.2	19.3	5.5	13.2	10.7	0.1	0.2	1.0	0.2	0.4	0.4	0.2	0.3	0.4	0.4	0.4	0.4	0.3	0.0	0.2	0.3	0.2	0.2	0.2	2.2	2.5	7.6	3.0	3.0	2.7	2.7	3.0	2.4	2.1	2.6	2.1	6.5	9.6	4.4	63.6	11.2	19.8	7.7	5.9	8.6	20.5	6.4	5.0	5.9	10.0	6.8	1.8	25.0	8.2	9.5	11.7	9.8	8.9	66.4	7.8	7.7	6.6	8.4	9.9	118.7	8.2	9.7	9.4	14.3	7.4	0.0	8.9	6.8	8.0	8.0	18.5	175.4	7.6	10.2	9.1	11.3	100.4	7.8	7.9	8.8	58.1	8.4	7.7	6.2	149.3	91.9	11.5	10.9	8.2	14.4	14.9	18.0	15.3	5.3	17.3	6.6	67.6	10.9	32.9	18.3	12.8	23.9	9.7	10.8	11.2	11.7	16.2
CDK9	"C-2k, CDC2L4, PITALRE, TAK"	ENSG00000136807	"Cyclin dependent kinase 9"	P50750	9	127785679-127790792	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004216, HPA006738"	Supported		Approved	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Cytoplasmic bodies"	"CAB004216: AB_627245, HPA006738: AB_1078493"	"unprognostic (3.60e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.52e-2)"	"unprognostic (8.78e-3)"	44.6	60.8	44.3	23.7	43.7	47.0	40.3	40.8	53.8	55.5	35.4	49.3	19.7	49.3	21.1	35.4	65.6	23.7	40.4	50.8	42.0	44.5	65.1	47.2	35.1	44.7	44.1	88.5	44.4	19.2	67.0	18.7	41.1	44.1	12.2	11.1	29.7	23.3	28.3	38.7	40.9	19.1	42.7	65.6	37.4	44.3	42.1	31.9	42.1	17.1	20.9	38.9	40.5	44.4	22.5	40.5	24.9	27.6	27.6	21.4	32.1	22.9	33.3	23.4	20.9	30.3	25.0	39.5	25.7	26.0	32.1	44.2	16.5	37.3	8.9	34.8	19.0	37.1	45.2	25.3	40.2	36.3	56.5	37.9	44.5	24.8	27.7	30.0	48.5	34.8	32.6	51.7	21.2	60.1	39.5	54.5	55.0	34.3	41.9	112.2	21.2	57.0	34.2	24.9	24.5	29.2	34.5	35.8	20.9	19.3	45.0	33.9	56.4	27.8	30.9	24.1	22.3	92.5	76.4	34.7	26.1	24.4	25.9	4.1	3.7	5.8	10.3	5.1	10.1	3.6	5.7	8.3	4.8	6.6	6.3	7.9	5.4	22.4	7.5	9.9	4.4	3.6	44.3	43.7	40.8	53.8	50.8	42.0	44.7	44.1	41.1	42.7	42.1	44.4	43.1	12.8	12.4	39.8	27.1	24.1	27.6	15.8	18.8	13.9	17.9	10.9	14.1	20.0	10.8	11.0	2.1	22.5	28.5	17.1	15.6	31.3	4.4	26.4	22.7	35.6	19.2	15.4	18.1	37.2	22.3	23.0	24.5	25.3	25.3	18.1	33.5	26.4	23.3	25.2	17.0	12.7	8.2	18.8	23.4	6.2	19.6	24.2	16.0	22.5	44.7	17.5	33.0	12.5	16.8	32.9	13.7	31.2	22.2	28.9	14.5	16.7	20.4	7.9	0.0	21.6	22.1	8.9	22.9	19.9	22.0	51.3	24.7	54.5	13.7	31.4
CDKAL1	FLJ20342	ENSG00000145996	"CDK5 regulatory subunit associated protein 1 like 1"	Q5VV42	6	20534457-21232404	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"tRNA processing"	Transferase	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Astrocytes: 133.2;Excitatory neurons: 159.5;Inhibitory neurons: 134.1;Microglial cells: 198.6;Oligodendrocyte precursor cells: 198.5;Oligodendrocytes: 255.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"SCLC-21H: 188.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (9.64e-2)"	"unprognostic (7.23e-3)"	"unprognostic (8.40e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.25e-3)"	"unprognostic (6.72e-3)"	"unprognostic (1.61e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.79e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-2)"	5.6	4.0	3.6	5.8	5.7	9.5	6.9	7.2	4.3	6.6	5.8	5.2	4.6	8.1	5.8	4.9	6.8	6.3	4.7	3.5	4.9	5.6	5.4	5.5	8.2	6.5	4.9	8.5	5.7	6.5	4.0	6.6	6.5	5.5	6.5	5.3	5.9	4.9	14.0	7.4	5.1	6.4	4.8	7.2	5.8	6.7	4.9	9.6	9.4	9.5	8.6	5.7	5.1	9.0	8.7	5.3	12.1	15.6	6.7	9.0	12.8	9.0	8.2	13.0	17.1	9.8	7.7	20.7	22.0	7.7	14.1	8.6	16.5	9.1	17.3	37.3	9.1	17.7	9.1	13.3	8.7	17.6	11.7	8.2	9.4	12.5	11.5	8.0	12.0	12.6	23.3	8.2	9.7	7.3	22.4	21.0	8.5	8.9	5.8	13.1	16.1	19.5	16.6	9.9	188.5	11.1	10.0	16.0	13.2	10.2	11.7	8.8	11.7	15.2	10.4	6.1	16.8	12.9	36.8	17.7	5.5	9.9	26.0	1.5	3.3	3.1	6.4	5.3	5.3	7.0	6.3	6.5	4.4	6.4	7.7	7.1	1.5	10.3	11.2	4.6	7.4	3.5	3.6	5.7	7.2	4.3	3.5	4.9	6.5	4.9	6.5	4.8	4.9	9.0	13.9	6.4	4.6	133.2	19.5	10.5	10.9	5.2	9.1	8.7	8.7	6.0	9.0	4.3	8.1	7.3	6.2	9.4	12.2	4.6	11.7	8.3	15.4	16.9	13.6	12.2	33.4	6.7	159.5	7.8	10.0	9.4	13.3	18.5	13.3	12.5	8.2	6.4	7.1	11.8	134.1	8.5	14.2	6.1	7.6	6.3	8.7	9.5	3.6	198.6	13.2	6.0	10.3	198.5	255.4	8.8	5.8	4.5	20.8	4.1	5.4	10.7	4.7	10.8	6.6	14.2	9.7	13.3	11.8	9.5	10.5	9.0	17.4	5.0	7.1	6.3
CDKL5	"CFAP247, EIEE2, STK9"	ENSG00000008086	"Cyclin dependent kinase like 5"	O76039	X	18425583-18653629	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 216.6;Horizontal cells: 80.8;Inhibitory neurons: 116.1;Oligodendrocytes: 79.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.7"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"A549: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002847, CAB011577"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 58: Brain - Synaptic function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB011577: AB_727019, HPA002847: AB_1080107"	"unprognostic (7.01e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.25e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.63e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.66e-1)"	"prognostic favorable (5.54e-4)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.99e-1)"	2.0	1.6	4.9	1.1	6.7	2.5	2.5	0.0	11.7	3.9	0.0	1.9	0.9	2.6	1.9	3.5	1.7	1.8	3.8	6.8	0.0	3.5	1.2	4.6	0.8	0.0	2.5	3.8	2.4	2.4	1.7	3.2	0.0	3.6	1.2	12.2	2.2	2.3	1.7	2.2	0.9	2.5	0.0	1.2	2.4	7.1	5.7	1.7	3.0	2.0	1.1	2.7	3.4	5.4	1.1	10.0	2.6	2.2	2.4	3.6	1.7	1.7	3.0	2.0	2.5	3.3	1.5	1.5	0.3	1.0	4.5	0.5	3.2	1.8	4.3	0.4	1.7	0.1	5.5	2.1	1.1	0.2	0.7	1.7	1.9	5.4	4.9	1.3	1.0	1.6	0.2	1.5	2.7	1.0	0.6	0.8	5.2	0.9	2.3	0.6	3.0	0.1	1.8	7.1	0.5	3.2	2.7	0.9	1.5	4.4	1.3	0.4	6.2	2.5	1.7	5.5	1.3	0.3	0.1	0.3	1.4	0.4	3.0	5.7	0.5	1.1	0.3	0.3	0.1	0.1	0.2	0.1	0.1	0.3	0.3	0.2	2.0	0.2	0.3	0.5	0.1	0.1	4.9	6.7	0.0	11.7	6.8	0.0	0.0	2.5	0.0	0.0	5.7	5.4	9.4	25.6	24.8	37.5	2.8	0.9	10.7	0.7	4.6	19.0	7.9	6.3	12.9	5.7	5.3	7.3	33.3	27.4	3.8	1.3	7.9	7.7	34.3	6.5	8.4	6.3	2.4	2.7	216.6	9.6	3.1	7.4	7.7	7.9	1.3	3.9	6.1	3.4	4.2	80.8	116.1	1.6	2.0	4.4	0.5	55.3	5.9	4.9	0.0	34.7	4.6	23.5	0.0	41.7	79.7	8.2	0.8	5.3	4.3	16.2	0.6	8.9	4.0	20.4	32.9	7.2	8.4	5.8	10.1	4.2	1.3	47.3	2.3	5.7	1.8	22.9
CDKN3	"CDI1, KAP"	ENSG00000100526	"Cyclin dependent kinase inhibitor 3"	Q16667	14	54396849-54420218	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 207.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 2630.9;Late spermatids: 659.4;Spermatocytes: 606.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 18.8"	"Group enriched"	"Detected in all"	6	"NK-cells: 6.4;T-cells: 18.8"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005285, HPA039311, HPA058874"			Enhanced	Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"CAB005285: AB_2078884, HPA039311: , HPA058874: AB_2683842"	"unprognostic (3.46e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.73e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.51e-3)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (2.50e-3)"	"unprognostic (2.85e-3)"	"prognostic unfavorable (7.46e-4)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.71e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.31e-2)"	3.4	1.6	2.8	12.2	2.7	43.4	3.4	5.0	4.2	2.2	3.4	13.9	12.4	2.8	0.4	10.2	1.3	2.9	5.3	2.9	3.1	2.0	2.4	2.1	28.4	2.5	2.7	1.3	1.1	0.5	1.6	6.7	3.3	1.6	16.9	2.6	3.3	0.7	3.0	5.9	12.6	7.4	2.1	4.9	5.0	207.0	3.5	30.9	1.7	4.1	30.0	5.8	4.1	2.6	276.7	102.5	74.0	78.2	12.5	15.3	46.5	63.1	97.0	135.8	146.9	81.8	136.5	139.9	44.4	96.7	135.9	195.9	114.6	78.3	245.6	169.5	59.3	65.8	69.0	126.8	10.1	86.2	47.6	5.4	4.9	84.3	138.3	44.4	88.4	129.8	36.1	162.2	159.8	186.9	118.1	67.9	27.9	254.7	216.4	72.7	66.6	29.7	70.5	56.9	30.6	42.0	118.7	67.4	52.5	54.6	142.9	69.4	33.0	59.2	195.8	91.7	155.0	38.6	47.4	91.4	98.6	120.4	110.9	0.0	1.3	1.3	1.6	1.7	0.7	2.1	5.5	4.8	1.8	0.9	2.9	2.3	1.0	6.4	1.2	1.5	18.8	3.1	2.8	2.7	5.0	4.2	2.9	3.1	2.5	2.7	3.3	2.1	3.5	2.6	1.4	0.0	0.0	0.7	10.5	9.3	4.3	9.7	4.6	3.2	6.4	11.6	9.7	0.0	2.4	1.8	2.1	42.6	2.7	7.3	0.0	3.5	2630.9	2.7	3.5	6.8	7.8	125.5	2.5	2.4	35.0	10.2	9.2	3.5	7.0	31.3	6.1	3.1	37.7	5.0	3.9	17.9	4.1	9.8	8.8	659.4	21.5	8.9	1.8	1.0	2.9	1.7	0.0	0.0	0.2	1.9	7.2	10.5	41.0	4.0	3.4	2.8	0.2	2.9	0.0	3.0	20.5	606.9	39.8	22.5	6.5	4.1	8.3	3.9	31.2	5.3
CEL	"BSSL, MODY8"	ENSG00000170835	"Carboxyl ester lipase"	P19835	9	133061981-133071861	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	548	"pancreas: 110578.0"	"Group enriched"	"Detected in many"	10	"Breast glandular cells: 390.7;Exocrine glandular cells: 943.6"	"Cancer enriched"	"Detected in many"	29	"pancreatic cancer: 469.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008023, HPA052701"	Enhanced				"Secreted to digestive system"	NA	NA		110000		"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA008023: AB_1846509, HPA052701: AB_2681921"	"prognostic unfavorable (4.14e-4)"	"unprognostic (2.30e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.98e-1)"	"unprognostic (4.41e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.02e-1)"	10.0	3.0	3.1	2.2	3.2	0.9	10.4	4.8	4.5	6.4	13.5	2.9	21.6	3.2	200.8	7.1	11.1	0.4	22.0	4.1	2.7	7.5	6.4	2.1	4.1	2.9	2.8	57.2	110578.0	0.3	201.7	7.1	3.0	5.1	1.3	1.1	19.9	3.3	2.2	5.5	9.2	0.5	2.5	3.4	18.5	2.5	3.0	1.9	2.5	0.4	0.6	3.4	3.4	3.0	0.3	0.8	3.1	1.9	1.0	0.7	3.1	0.6	0.3	0.4	0.6	0.9	0.6	0.9	1.5	0.6	0.5	2.2	0.7	5.9	0.2	1.9	1.2	1.6	0.5	2.1	0.4	0.7	5.9	1.5	3.8	0.5	0.3	1.3	0.6	7.5	1.0	0.8	0.5	1.3	0.9	3.2	5.2	0.7	1.0	1.8	0.9	0.7	0.4	2.7	5.3	1.3	0.7	0.7	0.3	4.5	1.0	2.9	0.4	1.5	2.0	1.7	0.4	0.4	3.4	0.7	0.0	1.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.2	4.8	4.5	4.1	2.7	2.9	2.8	3.0	2.5	3.0	3.0	1.5	0.0	0.0	1.0	0.7	0.0	1.7	0.8	1.2	1.0	390.7	4.4	2.1	1.5	0.5	0.0	0.0	0.1	1.8	2.5	3.9	1.7	0.5	62.4	0.8	0.9	0.0	0.0	2.0	943.6	0.1	0.4	0.0	1.3	0.0	4.7	0.0	0.1	0.0	0.0	1.4	0.8	26.4	0.0	0.3	3.6	0.3	1.0	0.0	0.0	6.7	0.9	0.0	1.0	0.7	27.7	0.1	0.0	0.0	0.4	10.6	0.1	2.3	0.8	0.0	0.2	1.4	0.2	0.1	2.0	0.3	0.4	0.5	6.0	5.1	3.0
CELA2A	ELA2A	ENSG00000142615	"Chymotrypsin like elastase 2A"	P08217	1	15456728-15472091	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2325	"pancreas: 162732.5"	"Cell type enriched"	"Detected in some"	34	"Exocrine glandular cells: 7828.2"	"Cancer enriched"	"Detected in single"	3818	"pancreatic cancer: 463.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HMC-1: 1.2"														"Secreted to digestive system"	NA	NA		2700000		"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 1: Pancreatic cells - Digestion"				"unprognostic (9.78e-2)"	"unprognostic (3.33e-2)"		"unprognostic (5.60e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.63e-3)"		"unprognostic (2.35e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.94e-9)"	"unprognostic (4.10e-2)"		"unprognostic (3.42e-1)"	"unprognostic (3.55e-2)"	7.9	5.5	0.0	2.6	0.0	1.1	4.4	0.2	0.1	3.9	0.0	2.0	18.5	2.1	0.0	2.3	1.1	0.0	26.9	0.0	0.0	1.6	5.8	1.2	4.3	0.0	0.0	70.0	162732.5	0.0	1.3	10.2	0.0	2.7	0.0	0.0	28.0	0.0	1.6	2.2	8.7	0.0	0.0	2.2	15.4	2.0	0.0	0.0	1.1	0.0	0.0	0.9	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.8	0.1	0.3	0.3	0.3	0.0	0.0	1.1	7828.2	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	20.7	0.0	0.0	0.0	0.1	227.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.1
CELSR1	"ADGRC1, CDHF9, FMI2, HFMI2, ME2"	ENSG00000075275	"Cadherin EGF LAG seven-pass G-type receptor 1"	Q9NYQ6	22	46360834-46537620	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 31.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 41.7;Basal respiratory cells: 28.1;Club cells: 31.1;Endometrial ciliated cells: 31.8;Glandular and luminal cells: 42.6;Respiratory ciliated cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.2;naive B-cell: 1.9"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"A549: 68.4;RPTEC TERT1: 48.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052976, HPA060521"			Enhanced	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		280000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA052976: AB_2682004, HPA060521: AB_2684303"	"unprognostic (5.62e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	0.7	0.8	0.4	3.1	0.9	0.8	7.8	1.5	0.5	9.9	1.2	1.6	0.9	3.7	10.2	11.5	15.4	1.4	3.4	1.0	0.4	17.1	5.2	12.5	5.9	2.4	3.9	0.2	2.6	6.3	2.4	1.0	1.4	5.0	1.8	0.5	12.0	3.9	0.2	31.5	1.6	1.1	1.6	3.3	5.4	1.3	2.2	2.4	3.7	0.1	7.9	3.9	3.7	1.0	22.3	68.4	11.3	10.6	0.0	0.0	6.5	2.3	3.4	2.3	1.3	21.7	21.9	0.2	32.1	1.3	22.0	35.0	7.5	28.7	2.0	0.0	10.2	0.0	25.6	2.0	1.0	3.2	1.8	0.0	43.5	0.0	26.2	31.6	0.4	1.7	0.3	0.4	0.0	38.4	0.1	11.9	4.5	12.1	8.1	0.1	0.1	8.1	48.7	13.5	0.7	0.9	16.1	17.3	3.7	7.9	39.7	16.7	0.9	0.1	0.3	0.0	0.4	10.6	1.1	10.5	15.2	0.1	12.9	0.0	0.0	0.0	0.2	0.1	0.2	2.2	0.1	0.1	0.0	1.9	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.4	0.9	1.5	0.5	1.0	0.4	2.4	3.9	1.4	1.6	2.2	1.0	0.5	41.7	23.5	0.0	5.8	17.1	4.1	28.1	8.0	0.2	14.2	5.2	12.7	2.8	31.1	5.5	0.0	1.9	2.3	0.8	0.0	1.8	2.3	31.8	5.0	5.6	1.2	0.0	1.2	0.7	1.9	1.0	2.6	42.6	0.0	0.6	1.8	1.5	2.4	0.0	1.2	2.8	6.1	0.0	4.1	10.3	0.0	1.1	5.4	1.0	1.1	1.1	0.0	0.5	0.7	4.0	0.3	0.0	1.1	4.3	0.0	8.2	60.3	0.3	0.0	0.1	2.8	0.4	0.6	12.6	15.6	0.8	1.1	0.0	1.7	5.1
CERS3	"LASS3, MGC27091"	ENSG00000154227	"Ceramide synthase 3"	Q8IU89	15	100400395-100544995	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 55.1;skin 1: 64.0;vagina: 30.3"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 18.9;Basal squamous epithelial cells: 39.3;Early spermatids: 23.5;Late spermatids: 17.5;Spermatocytes: 28.2;Squamous epithelial cells: 48.3;Suprabasal keratinocytes: 50.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 14.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"hTCEpi: 65.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006092, HPA024356"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA006092: AB_1079236, HPA024356: AB_1852721"	"unprognostic (5.01e-3)"	"unprognostic (3.43e-2)"	"unprognostic (6.47e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.84e-3)"	"unprognostic (3.23e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.31e-5)"	"unprognostic (2.65e-1)"	"unprognostic (4.74e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.05e-3)"	0.1	0.0	0.1	0.0	0.2	0.2	3.3	0.3	0.2	15.1	0.0	0.0	0.0	0.0	0.5	55.1	0.7	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.6	0.0	0.1	8.4	0.1	0.6	64.0	0.1	0.0	0.0	0.1	0.1	18.3	0.2	0.4	0.1	0.0	16.0	0.3	30.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	1.3	0.0	18.9	5.0	3.9	39.3	0.4	0.1	0.3	0.5	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.5	0.2	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	2.1	17.5	0.6	0.1	0.0	0.0	0.0	0.2	0.0	2.0	1.4	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	28.2	0.7	48.3	50.2	0.0	0.1	0.0	0.0	6.0
CETP	BPIFF	ENSG00000087237	"Cholesteryl ester transfer protein"	P11597	16	56961923-56983845	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Atherosclerosis, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 33.5;liver: 43.0;lymphoid tissue: 59.6;placenta: 36.2"	"Group enriched"	"Detected in some"	6	"Adipocytes: 48.6;Hepatic stellate cells: 75.0;Kupffer cells: 142.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.3;plasmacytoid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 2.3;HUVEC TERT2: 4.7;TIME: 2.8"														"Secreted to blood"	NA	NA	2470000000	360000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (6.52e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.01e-3)"	"unprognostic (4.03e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.05e-3)"	"unprognostic (4.92e-3)"	"unprognostic (7.17e-3)"	"unprognostic (2.62e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.34e-2)"	"unprognostic (9.97e-2)"	33.5	2.0	0.7	3.8	0.7	5.7	6.6	0.7	1.4	0.3	0.7	0.6	0.9	0.7	0.0	0.3	0.3	4.0	0.7	0.6	0.8	3.7	43.0	2.8	43.3	1.1	0.8	0.3	0.5	1.8	3.1	36.2	0.9	0.3	0.5	0.0	0.7	0.5	0.3	0.4	1.9	0.8	0.8	59.6	0.4	0.3	0.9	2.3	5.2	0.3	7.6	1.5	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.8	0.1	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.3	0.1	0.0	0.0	0.1	1.8	2.3	3.2	0.0	1.2	0.7	0.7	0.7	1.4	0.6	0.8	1.1	0.8	0.9	0.8	0.9	0.8	48.6	0.0	1.8	0.0	1.5	0.5	0.0	0.0	0.0	0.1	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	13.4	0.0	5.3	0.1	0.9	0.4	0.2	0.0	0.1	0.0	0.0	75.0	1.3	3.1	0.0	0.1	0.2	0.0	142.0	1.2	0.7	0.0	2.1	0.0	0.0	1.4	0.0	1.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.1	0.6	0.0	0.4	0.0	0.4	1.3	0.0	0.0
CFB	"BF, BFD, H2-Bf"	ENSG00000243649	"Complement factor B"	P00751	6	31945650-31952084	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 2613.2"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 873.6;Exocrine glandular cells: 197.3;Hepatocytes: 284.0;Pancreatic endocrine cells: 318.0;Proximal enterocytes: 139.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 15.0;ASC TERT1: 23.0;EFO-21: 25.1;fHDF/TERT166: 14.1;HSkMC: 19.1;U-87 MG: 10.1"					"Low region specificity"	"Detected in all"			"HPA000951, HPA001817, HPA001832, CAB016381"	Supported		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"	"Secreted to blood"	NA	NA	879000000	120000000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"CAB016381: AB_627562, HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778"	"prognostic favorable (2.76e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.08e-3)"	"unprognostic (8.81e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.68e-2)"	143.7	18.0	3.6	32.8	3.6	0.1	28.5	3.4	9.9	16.3	3.9	22.3	28.1	8.2	14.2	24.1	53.7	0.8	42.6	3.7	3.4	58.7	2613.2	39.2	4.2	4.1	3.7	9.9	51.8	0.2	17.7	5.0	3.8	60.3	14.5	1.4	43.3	0.0	3.0	7.7	73.1	48.3	3.4	12.9	54.5	2.1	3.7	1.9	15.5	0.7	6.7	17.8	9.2	3.6	0.5	1.9	0.1	0.0	15.0	23.0	0.1	0.0	0.2	1.1	0.0	0.1	8.6	0.1	25.1	14.1	0.6	6.0	0.0	1.8	1.2	1.0	0.3	0.7	0.4	0.5	0.0	1.0	0.4	19.1	0.4	0.6	0.5	1.3	0.2	0.1	0.3	0.7	0.1	0.2	0.1	0.3	0.4	0.0	0.4	0.3	0.3	1.3	1.7	0.5	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.2	0.0	3.4	1.2	0.4	0.4	0.7	2.1	1.0	10.1	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.6	3.6	3.4	9.9	3.7	3.4	4.1	3.7	3.8	3.4	3.7	3.6	1.0	0.0	16.9	0.0	2.6	0.8	0.9	64.8	11.4	0.3	4.9	0.9	0.4	44.3	127.3	5.5	0.0	0.1	0.0	3.7	3.9	873.6	0.0	1.9	0.4	3.9	2.4	16.0	0.2	197.3	0.2	34.6	20.9	1.2	0.0	0.0	11.7	284.0	1.0	0.0	0.2	8.5	18.3	19.7	1.0	0.0	2.8	1.1	0.0	5.6	18.1	0.4	0.0	0.0	0.0	318.0	10.6	0.0	0.1	8.6	139.7	17.1	75.4	0.7	0.0	1.0	12.6	0.1	0.1	3.9	1.8	1.6	1.6	0.0	12.4	4.5
CFD	"ADN, DF, PFD"	ENSG00000197766	"Complement factor D"	P00746	19	859664-863641	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1496.7;breast: 993.2"	"Group enriched"	"Detected in many"	6	"Fibroblasts: 9365.5;Leydig cells: 5032.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 297.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 297.6"	"Group enriched"	"Detected in many"	5	"ASC diff: 197.4;THP-1: 342.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	732000000	4400000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (3.00e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.22e-3)"	"unprognostic (6.92e-2)"	"unprognostic (5.28e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.10e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (9.53e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.92e-2)"	"unprognostic (9.75e-2)"	1496.7	33.3	1.5	9.6	1.6	10.7	993.2	1.2	2.4	597.4	3.7	324.8	23.5	58.4	2.4	212.8	258.0	9.6	854.2	1.7	2.3	18.1	8.7	363.3	2.1	3.3	2.3	74.3	41.4	1.7	9.0	14.5	3.6	277.8	10.9	0.6	247.3	6.3	197.0	488.6	248.4	4.0	2.6	28.6	263.8	51.8	2.9	3.6	332.3	26.9	0.8	848.3	729.8	5.8	3.9	5.2	0.6	2.2	197.4	26.2	9.5	0.8	0.0	0.0	0.0	0.8	0.4	0.2	5.7	0.0	0.5	3.0	1.8	0.5	0.0	5.7	14.5	0.5	12.3	3.8	3.6	2.5	4.9	8.7	0.2	0.1	0.0	0.8	0.0	4.5	11.9	0.9	0.0	2.6	0.6	49.2	1.0	4.5	16.1	1.3	0.5	5.2	0.3	1.2	1.8	1.8	5.5	1.9	0.5	0.6	7.5	342.2	0.4	0.2	5.1	2.9	0.6	7.8	4.7	0.4	0.2	20.8	0.2	297.6	41.2	127.8	8.4	55.5	13.2	5.7	4.2	10.2	14.5	1.4	9.7	9.7	112.0	1.3	57.3	1.8	4.7	37.8	1.5	1.6	1.2	2.4	1.7	2.3	3.3	2.3	3.6	2.6	2.9	5.8	857.8	9.6	23.3	0.0	19.2	785.5	49.0	10.1	17.1	2.9	107.3	120.1	55.5	21.5	30.9	18.4	2.1	36.6	40.0	33.1	11.7	7.7	27.1	23.1	593.3	114.8	4.2	8.2	0.2	0.0	32.9	9365.5	113.6	15.9	17.1	0.9	30.4	2.6	272.4	1.7	0.4	8.7	0.0	424.7	1145.2	89.6	5032.4	442.5	642.1	4.7	303.6	1.3	21.6	0.0	0.1	2.9	64.8	283.2	41.0	19.7	4.3	3.4	28.4	6.5	0.0	414.3	530.2	11.4	21.3	28.6	735.9	34.3	82.8	1.2	21.0	233.2
CFI	"C3b-INA, FI, IF, KAF"	ENSG00000205403	"Complement factor I"	P05156	4	109740694-109801999	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1098.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 108.7;Hepatocytes: 592.5;Muller glia cells: 147.8;Proximal tubular cells: 223.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 90.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 106.1;Hep G2: 179.8;HSkMC: 67.4;RPTEC TERT1: 190.6"									"HPA001143, CAB016777, HPA024061"	Supported				"Secreted to blood"	NA	NA		12000000000		"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB016777: , HPA001143: AB_1078555, HPA024061: AB_1847129"	"unprognostic (1.04e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.06e-4)"	45.1	50.2	8.1	12.6	8.2	0.1	17.4	7.7	13.2	36.8	10.4	7.4	38.0	39.2	80.3	9.3	74.0	73.0	25.0	8.3	9.6	224.9	1098.8	50.7	8.9	15.6	10.2	32.1	26.0	3.1	8.4	24.1	10.7	8.3	6.4	53.0	15.0	26.7	3.9	2.7	22.3	24.3	10.5	33.1	14.4	8.8	9.2	2.3	14.5	4.6	7.5	34.1	8.3	10.6	0.0	0.6	0.0	0.3	0.0	0.2	0.1	1.5	1.4	0.1	0.2	0.0	106.1	0.0	32.9	0.0	0.5	0.0	0.0	0.0	0.0	34.8	0.7	0.0	0.4	179.8	6.2	0.3	0.0	67.4	0.0	0.1	0.0	3.6	4.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	190.6	0.5	0.0	0.3	1.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.6	0.0	0.0	0.0	0.1	18.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	8.2	7.7	13.2	8.3	9.6	15.6	10.2	10.7	10.5	9.2	10.6	48.1	12.8	50.9	3.6	4.0	1.0	12.2	15.2	0.6	3.4	2.1	5.6	2.3	108.7	36.2	64.4	2.1	0.1	0.3	1.7	31.3	69.3	0.2	34.1	46.4	57.7	0.0	2.7	0.3	30.9	0.2	34.3	8.2	33.6	3.8	72.1	55.0	592.5	0.7	1.7	0.2	1.9	0.0	16.7	1.5	0.8	16.8	2.0	0.0	4.7	1.6	147.8	0.0	0.0	0.3	30.8	2.4	0.0	0.0	3.8	17.0	223.6	8.4	7.3	0.0	1.3	9.4	1.6	0.5	1.9	1.1	0.3	3.4	18.5	4.1	12.6
CHAT		ENSG00000070748	"Choline O-acetyltransferase"	P28329	10	49609095-49667942	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Acyltransferase, Transferase"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 13.0;placenta: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"NB-4: 20.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 20.6"	"Group enriched"	"Detected in some"	7	"basal ganglia: 6.5;pons: 7.0;spinal cord: 12.0"	"CAB002313, HPA048547, CAB079053"	Supported	Supported				NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 33: Fibroblasts - ECM organization"			"CAB002313: AB_563661, CAB079053: , HPA048547: AB_2680437"					"unprognostic (2.34e-2)"	"unprognostic (6.10e-2)"		"unprognostic (5.28e-2)"		"unprognostic (6.96e-2)"	"unprognostic (2.80e-2)"			"unprognostic (3.98e-1)"	"unprognostic (1.09e-1)"			0.0	0.0	0.6	0.2	2.8	0.0	0.0	0.3	13.0	0.0	0.3	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.1	0.0	0.0	0.0	0.0	7.9	5.1	0.0	0.3	0.0	0.0	5.5	9.4	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.8	20.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	2.8	0.3	13.0	0.1	3.1	7.9	5.1	9.4	1.3	0.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHD1		ENSG00000153922	"Chromodomain helicase DNA binding protein 1"	O14646	5	98853985-98929007	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 69.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022236	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA022236: AB_2670915"	"unprognostic (2.63e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.15e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (7.25e-6)"	"unprognostic (2.69e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.17e-1)"	14.7	10.3	6.9	17.8	7.3	69.6	9.2	17.9	14.1	8.0	8.8	10.5	9.8	12.7	7.0	7.9	8.1	15.0	5.4	6.1	8.3	8.3	13.2	9.4	13.7	9.7	7.7	14.1	10.0	9.4	4.8	14.2	8.8	8.2	10.3	14.9	5.4	7.1	9.7	6.2	9.5	9.0	7.4	15.7	8.2	18.1	7.3	49.6	8.8	9.0	13.8	12.4	5.9	9.3	23.0	20.7	47.5	32.3	15.7	16.1	41.3	23.2	15.1	18.4	23.8	25.9	17.3	19.3	22.0	13.5	29.8	18.6	37.6	25.6	38.2	30.5	28.2	34.2	25.8	19.8	17.3	33.3	25.5	14.0	10.2	32.0	32.2	12.5	22.6	62.0	42.0	28.9	18.7	18.5	66.4	14.4	32.0	7.2	24.8	55.7	33.2	29.2	16.0	21.6	22.1	18.9	29.8	15.4	37.9	24.6	15.0	22.6	25.7	39.3	21.2	24.9	41.6	20.0	22.6	40.0	21.5	32.6	24.2	13.1	7.1	10.1	5.4	6.6	6.9	9.4	5.1	5.3	6.5	8.3	7.0	5.6	14.4	7.4	6.8	4.7	5.9	2.0	6.9	7.3	17.9	14.1	6.1	8.3	9.7	7.7	8.8	7.4	7.3	9.3	87.2	48.1	72.2	35.3	145.3	155.5	99.0	26.6	115.5	39.3	85.9	56.1	29.9	22.8	57.4	36.8	43.8	53.9	203.6	64.0	7.9	36.5	101.0	84.3	114.3	79.5	31.8	40.8	50.9	32.0	38.4	104.6	50.0	107.3	89.2	45.2	40.0	30.6	35.6	33.7	59.8	31.2	16.2	65.8	145.9	19.8	32.3	169.7	67.6	90.9	89.1	20.5	59.8	66.4	72.1	35.3	51.4	19.2	121.0	82.6	28.1	15.5	45.3	49.5	46.0	173.8	113.5	67.1	54.6	74.1	188.5	90.3	148.2	49.9	39.4	75.4
CHD2	"DKFZp547I1315, DKFZp686E01200, DKFZp781D1727, FLJ38614"	ENSG00000173575	"Chromodomain helicase DNA binding protein 2"	O14647	15	92900189-93027996	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060744, HPA060960"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA060744: AB_2684353, HPA060960: AB_2684398"	"unprognostic (1.65e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.85e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.70e-2)"	13.9	12.3	22.7	20.7	25.5	73.5	20.4	42.0	32.7	15.7	32.0	15.2	14.8	19.4	29.1	14.6	16.2	15.6	12.0	21.3	24.7	16.9	15.4	21.6	26.4	29.0	23.3	26.1	19.6	18.2	16.6	20.5	24.5	20.4	14.8	30.8	21.2	13.4	17.4	18.8	18.7	13.3	22.1	23.3	17.7	20.8	25.9	27.0	26.3	14.7	25.4	13.7	16.1	27.6	21.3	11.6	30.6	13.6	17.9	45.3	23.0	19.4	20.0	13.0	16.1	14.5	27.4	5.2	16.1	17.3	22.1	31.1	17.6	19.5	18.0	0.1	10.6	25.3	26.1	12.9	24.6	27.1	19.0	28.7	23.0	15.5	31.1	26.8	22.4	36.7	26.8	57.1	19.9	13.1	14.2	14.0	19.5	10.5	12.6	19.9	27.6	28.4	13.3	28.5	16.8	18.1	34.2	12.3	25.9	30.6	14.1	22.6	36.2	10.7	13.9	9.3	12.8	53.4	23.2	21.6	15.9	15.9	9.4	35.9	10.8	27.7	22.1	6.6	21.8	48.7	21.5	20.5	7.4	39.6	30.1	22.1	53.7	20.6	13.4	27.9	24.9	10.9	22.7	25.5	42.0	32.7	21.3	24.7	29.0	23.3	24.5	22.1	25.9	27.6	59.3	70.5	176.3	182.2	137.8	164.3	112.3	102.3	153.7	71.4	62.6	46.5	42.3	37.1	137.3	46.0	91.8	30.7	116.3	59.6	3.9	36.1	56.5	96.9	61.7	58.6	59.3	65.4	161.5	38.3	28.5	64.5	96.4	189.8	99.3	70.7	25.0	34.9	24.8	57.2	146.2	54.9	91.6	55.1	297.4	39.2	34.8	89.5	96.0	119.9	50.7	34.2	48.4	140.8	155.9	64.2	61.6	37.6	133.0	110.0	39.9	11.5	93.9	82.2	32.9	52.7	64.4	15.3	14.7	125.2	180.7	60.5	153.2	42.9	51.5	143.6
CHD3	"Mi-2a, Mi2-ALPHA, ZFH"	ENSG00000170004	"Chromodomain helicase DNA binding protein 3"	Q12873	17	7884796-7912760	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043368, HPA076524"	Supported		Supported	"Nucleoplasm,Nucleoli,Centriolar satellite"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"	"Centriolar satellite"	"HPA043368: AB_2678448, HPA076524: AB_2686804"	"unprognostic (1.77e-2)"	"unprognostic (8.01e-2)"	"prognostic unfavorable (2.43e-4)"	"prognostic favorable (7.68e-5)"	"unprognostic (1.53e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.25e-3)"	"prognostic favorable (8.36e-4)"	"unprognostic (9.11e-2)"	"unprognostic (8.31e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.90e-3)"	"unprognostic (2.20e-3)"	28.2	29.3	19.9	35.0	27.9	42.7	28.4	0.0	39.9	71.6	0.0	55.3	16.7	63.9	31.2	35.1	56.8	27.8	21.2	35.8	7.0	38.3	5.7	32.4	41.3	4.9	2.4	60.0	34.8	44.7	47.7	16.6	1.1	68.7	22.1	19.0	40.3	38.0	8.0	32.7	34.6	45.0	3.1	31.5	36.3	20.9	8.0	58.2	44.9	9.1	36.7	41.2	42.8	21.4	44.9	108.7	61.6	81.2	72.2	60.9	32.8	51.7	66.1	40.8	43.5	21.1	36.7	122.8	38.3	73.0	34.0	59.6	117.7	52.5	53.0	65.5	67.2	62.7	148.5	2.7	38.3	17.8	112.1	79.2	27.5	55.4	36.9	108.7	76.9	54.1	41.5	2.0	38.8	42.6	48.2	19.6	9.8	45.3	40.3	137.8	82.1	19.3	40.0	107.7	41.9	56.3	126.4	47.9	24.6	16.9	55.7	27.1	99.7	89.4	68.8	22.3	72.5	8.8	1.6	68.3	46.1	47.4	77.6	1.7	2.6	3.3	4.1	1.4	3.6	1.1	4.2	4.0	1.3	1.2	4.6	3.1	2.8	3.2	3.2	3.0	2.5	2.5	19.9	27.9	0.0	39.9	35.8	7.0	4.9	2.4	1.1	3.1	8.0	21.4	20.9	32.1	63.2	10.4	19.6	36.6	47.6	21.1	65.4	60.7	43.8	34.2	14.3	17.2	35.2	80.9	8.4	16.8	57.3	39.8	17.6	22.9	11.3	48.6	51.9	29.4	56.8	19.1	20.6	23.4	20.5	39.9	31.1	70.7	39.9	59.7	22.9	2.7	9.0	45.4	25.2	17.0	12.2	24.7	34.7	18.5	44.4	26.7	8.8	6.5	43.7	12.4	59.8	12.1	2.5	20.9	10.8	57.2	17.4	55.5	10.9	9.7	24.8	17.3	26.3	31.8	43.5	25.5	46.8	52.8	20.5	16.4	62.9	52.0	30.3	60.3
CHD4	"Mi-2b, Mi2-BETA"	ENSG00000111642	"Chromodomain helicase DNA binding protein 4"	Q14839	12	6570082-6614524	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA012008	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA012008: AB_1846633"	"unprognostic (6.11e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.40e-3)"	"unprognostic (8.99e-2)"	"unprognostic (3.36e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.66e-1)"	34.5	45.6	22.9	38.6	30.7	44.4	31.9	24.6	30.1	39.4	20.6	45.7	26.5	47.8	44.9	35.4	37.7	31.1	41.4	19.7	26.1	39.3	31.6	35.3	46.3	27.3	29.2	40.9	37.7	58.3	33.5	42.2	28.0	28.4	35.4	44.9	33.8	44.1	50.0	45.8	35.5	49.9	22.6	39.0	38.5	34.2	29.6	90.7	54.6	38.7	56.6	42.2	34.4	27.4	86.7	79.7	187.6	72.1	76.6	84.7	110.4	92.9	93.4	102.3	93.5	130.6	66.6	184.9	36.0	107.5	66.1	76.0	179.1	104.5	135.7	139.9	92.7	258.5	122.0	83.3	67.1	207.2	119.1	82.9	51.7	99.1	68.7	128.2	122.2	101.6	209.0	91.0	98.7	111.8	196.6	67.8	184.7	82.5	72.7	166.4	114.9	103.6	64.2	101.6	88.8	114.6	121.1	136.0	92.9	205.4	61.3	121.3	114.4	103.4	217.4	76.3	111.5	144.0	91.8	230.2	68.7	125.8	79.5	12.3	6.8	8.7	9.3	7.7	9.6	8.8	8.4	9.3	6.9	11.3	10.6	10.3	10.8	12.2	8.0	14.4	15.9	5.6	22.9	30.7	24.6	30.1	19.7	26.1	27.3	29.2	28.0	22.6	29.6	27.4	68.2	60.9	119.7	56.2	82.8	68.6	47.4	42.4	76.2	109.9	77.5	61.2	132.9	58.6	67.2	88.3	70.9	48.2	106.0	58.1	13.7	84.6	76.4	128.1	153.3	78.9	97.1	64.4	26.1	71.9	46.1	67.7	47.9	123.7	85.9	73.0	56.0	69.2	69.0	139.7	21.4	66.6	54.9	51.9	78.3	59.1	65.9	68.9	48.0	25.3	66.7	71.4	56.7	24.6	55.5	95.8	36.4	74.4	69.0	49.4	45.8	38.3	82.1	57.8	52.6	112.1	98.1	102.6	111.6	78.9	67.6	68.0	85.1	83.7	72.1	47.4
CHD5		ENSG00000116254	"Chromodomain helicase DNA binding protein 5"	Q8TDI0	1	6101787-6180321	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 59.0;pituitary gland: 57.3;testis: 31.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 84.3;Early spermatids: 217.8;Excitatory neurons: 80.4;Horizontal cells: 225.4;Inhibitory neurons: 56.2;Late spermatids: 113.2;Rod photoreceptor cells: 49.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SCLC-21H: 12.9;U-2 OS: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015809			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA015809: "	"unprognostic (5.03e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.47e-3)"	"unprognostic (9.40e-6)"	"unprognostic (1.91e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.64e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.34e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	0.2	4.1	31.8	0.2	40.1	0.0	0.1	0.0	59.0	0.4	0.0	1.1	0.2	0.4	0.0	0.3	0.4	0.1	0.4	34.3	13.6	2.4	0.1	0.3	0.0	3.9	11.1	0.5	0.4	0.9	57.3	0.0	4.4	0.9	0.2	7.9	0.2	2.2	0.2	0.3	0.4	0.1	0.9	0.1	1.0	31.8	10.2	0.3	0.1	0.0	0.0	0.7	0.6	31.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	1.2	0.0	0.1	0.2	1.1	0.0	0.0	0.0	0.0	12.9	0.2	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.1	5.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.8	40.1	0.0	59.0	34.3	13.6	3.9	11.1	4.4	0.9	10.2	31.1	0.0	0.0	0.0	5.5	0.1	0.1	0.1	0.0	0.0	84.3	0.1	0.3	2.1	0.0	0.0	3.7	12.5	0.0	0.1	0.2	0.0	0.0	217.8	0.0	0.2	0.6	0.0	0.0	80.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	225.4	56.2	0.0	0.0	0.0	0.3	113.2	0.9	0.1	0.0	2.8	0.0	2.0	0.0	4.5	3.7	0.3	0.0	0.4	0.0	0.2	0.0	0.1	0.0	49.9	0.0	0.2	0.5	4.5	17.8	0.0	0.4	0.0	0.1	0.1	0.0	0.0
CHD6	"CHD5, dJ620E11.1, FLJ22369, KIAA1335, RIGB"	ENSG00000124177	"Chromodomain helicase DNA binding protein 6"	Q8TD26	20	41402083-41618384	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015543			Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA015543: "	"unprognostic (5.13e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.72e-3)"	"prognostic favorable (3.42e-4)"	"unprognostic (1.17e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.12e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.14e-2)"	7.2	7.7	10.2	6.9	11.4	13.5	12.4	17.5	13.0	9.5	6.0	7.1	4.0	12.7	12.4	6.1	10.0	7.2	8.0	8.5	13.1	7.2	6.8	7.5	8.4	11.7	10.9	16.2	8.1	16.2	7.9	8.4	14.2	12.2	6.1	15.7	8.4	9.3	5.5	8.7	6.1	8.9	7.3	8.2	7.4	7.1	11.0	17.2	13.6	7.8	8.2	8.1	8.8	12.9	8.4	9.8	20.6	9.2	11.5	11.7	13.3	7.2	14.8	12.6	15.2	13.5	6.7	10.0	12.7	12.4	14.2	12.2	12.9	12.4	14.3	3.2	6.3	13.7	9.1	13.2	6.5	10.9	6.6	11.8	11.3	9.2	10.1	13.5	11.0	13.7	11.0	10.4	9.9	23.3	17.3	11.8	6.8	5.2	16.5	13.2	24.2	7.1	7.9	19.3	18.6	12.8	22.1	5.8	14.2	14.9	9.9	8.1	12.7	19.8	9.6	10.0	6.3	9.9	8.6	12.8	8.7	5.2	6.2	20.2	6.0	7.5	8.1	6.1	8.2	8.5	7.0	6.9	5.2	10.6	9.4	8.0	0.9	10.2	10.0	11.4	6.0	2.4	10.2	11.4	17.5	13.0	8.5	13.1	11.7	10.9	14.2	7.3	11.0	12.9	42.2	48.1	30.8	148.2	42.8	18.1	38.6	30.3	37.0	140.4	39.5	34.7	56.6	30.0	34.4	22.0	93.8	34.2	53.3	14.5	21.5	24.4	14.5	50.3	65.3	36.5	60.6	19.6	143.2	15.8	28.2	33.8	19.9	76.0	21.5	65.1	34.2	21.1	16.5	151.4	179.0	35.9	42.7	27.7	44.7	20.3	49.7	27.5	17.8	87.1	40.8	62.2	39.1	182.9	160.6	15.4	16.0	45.5	32.3	30.3	4.1	13.9	35.6	133.8	19.7	71.0	44.4	20.6	61.9	21.8	17.2	32.7	45.5	40.4	24.5	32.9
CHD7	"CRG, FLJ20357, FLJ20361, KIAA1416"	ENSG00000171316	"Chromodomain helicase DNA binding protein 7"	Q9P2D1	8	60678740-60868028	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 241.8;Oligodendrocyte precursor cells: 298.6;Oligodendrocytes: 255.7;Rod photoreceptor cells: 198.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"B-cells: 14.9;granulocytes: 17.6;T-cells: 6.6"	"Cell line enhanced"	"Detected in many"		"AF22: 51.5;SCLC-21H: 46.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053075			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Nucleoli	"HPA053075: AB_2682035"	"unprognostic (3.77e-2)"	"unprognostic (3.28e-3)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (5.34e-5)"	"unprognostic (9.59e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.17e-1)"	3.6	1.9	10.3	3.9	17.2	22.1	3.5	71.5	11.0	2.0	2.5	4.6	4.6	2.2	2.2	4.9	2.3	1.9	3.8	9.4	11.5	3.8	3.2	4.6	5.8	19.7	17.2	1.0	4.4	5.3	6.1	4.3	18.8	2.7	4.0	23.7	3.9	1.7	10.4	5.2	6.4	1.7	11.4	5.6	3.5	2.9	15.6	2.6	4.1	4.1	5.7	3.4	3.2	17.7	8.0	4.0	51.5	9.2	0.1	0.0	16.2	0.4	0.1	1.8	1.6	10.0	7.3	15.5	0.9	0.1	2.3	4.8	26.7	7.9	1.6	5.9	14.3	36.5	7.0	13.2	2.1	11.1	6.5	1.0	5.9	0.0	8.5	3.1	7.7	12.5	2.7	13.4	1.2	8.3	17.5	12.7	35.4	8.1	1.8	36.0	12.1	5.0	4.1	9.1	46.9	23.2	1.4	5.9	14.9	18.0	10.5	10.5	9.0	0.5	8.3	0.5	4.3	14.2	8.7	23.7	3.0	1.2	13.4	14.9	0.4	17.6	3.2	0.2	4.1	10.1	3.6	1.1	0.1	14.9	6.6	2.4	9.3	0.0	0.8	0.8	0.3	0.6	10.3	17.2	71.5	11.0	9.4	11.5	19.7	17.2	18.8	11.4	15.6	17.7	35.9	32.1	17.5	68.6	64.3	30.3	35.9	10.8	9.6	36.3	16.6	14.6	35.8	27.1	20.7	16.5	241.8	8.2	17.4	31.8	1.9	17.7	15.9	34.0	4.1	40.5	87.3	3.8	6.8	11.3	8.6	6.4	28.5	37.6	41.0	39.8	21.4	12.6	14.9	70.7	17.8	39.9	32.6	10.8	10.4	8.9	0.9	13.6	21.4	118.0	13.9	121.3	15.5	298.6	255.7	16.9	27.4	0.4	29.1	42.9	17.4	5.4	20.4	198.5	0.0	49.7	9.8	8.0	12.9	25.5	32.4	6.2	21.4	3.0	34.1	35.8
CHD8	"DUPLIN, HELSNF1, KIAA1564"	ENSG00000100888	"Chromodomain helicase DNA binding protein 8"	Q9HCK8	14	21385194-21456126	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052186, HPA076133"			Enhanced	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA052186: AB_2681754, HPA076133: "	"unprognostic (3.45e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (7.31e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.07e-3)"	12.5	11.9	11.2	13.5	12.5	35.3	14.8	16.3	13.2	12.4	10.5	14.0	9.4	14.8	11.1	14.9	12.9	10.1	12.0	11.1	12.2	11.7	9.6	13.7	18.0	11.4	11.6	17.1	13.6	22.3	13.1	11.7	11.1	13.2	12.3	14.8	13.6	12.1	15.7	22.3	14.7	14.8	11.5	15.8	14.2	12.9	12.5	25.4	14.8	12.7	17.5	12.8	12.9	13.6	31.2	39.6	43.6	20.7	27.7	23.6	24.9	24.4	28.4	36.5	35.4	35.0	26.3	51.4	14.8	33.1	28.4	37.2	54.9	35.1	46.0	39.3	24.2	46.3	27.6	43.5	25.7	64.6	40.4	32.8	27.2	40.9	29.7	28.6	33.4	40.2	32.4	26.7	28.0	33.9	46.1	26.0	33.4	30.9	34.3	42.0	32.9	17.4	27.3	57.9	30.9	30.7	37.5	29.8	21.8	39.7	20.7	30.5	36.4	29.2	23.0	17.8	29.1	30.3	38.4	50.3	12.1	23.2	29.6	9.1	3.8	9.8	5.5	3.8	6.4	4.2	4.9	5.6	2.7	11.2	5.0	4.4	7.9	7.8	6.7	6.1	4.7	2.7	11.2	12.5	16.3	13.2	11.1	12.2	11.4	11.6	11.1	11.5	12.5	13.6	27.6	38.5	56.3	27.4	32.2	12.6	11.3	15.9	23.3	33.3	21.9	22.6	19.6	24.3	32.6	33.1	27.1	14.7	40.0	16.8	1.9	21.8	3.4	32.5	37.9	25.5	27.1	27.8	41.0	23.6	12.3	24.0	27.5	39.5	28.4	41.7	13.9	14.9	17.5	23.5	40.2	16.0	8.2	20.1	9.3	4.1	16.1	25.3	10.6	20.6	27.1	18.9	32.0	29.7	33.1	26.5	13.9	17.7	32.4	16.1	12.0	7.4	28.8	24.3	0.0	32.1	26.2	29.2	25.1	24.6	16.6	12.3	31.4	34.1	16.8	12.7
CHEK2	"bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53"	ENSG00000183765	"Checkpoint kinase 2"	O96017	22	28687743-28742422	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001878, CAB002030"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus"	"CAB002030: AB_563660, HPA001878: AB_1078514"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.08e-3)"	"unprognostic (3.33e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (7.80e-9)"	"unprognostic (2.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.79e-3)"	4.5	6.2	2.4	8.8	2.5	15.4	5.8	2.4	3.7	5.0	2.8	8.8	6.3	4.1	7.3	7.2	3.7	4.7	4.2	2.3	2.8	4.5	6.3	4.4	12.1	2.6	2.6	8.2	2.3	1.3	2.7	7.8	2.8	4.1	10.9	0.4	3.2	3.8	1.3	6.7	7.0	4.8	2.6	6.7	4.1	8.5	2.8	9.4	3.3	1.1	12.0	6.8	5.0	2.9	30.7	9.7	31.1	32.4	10.1	42.7	18.7	15.2	19.9	18.7	27.8	29.1	21.8	36.3	13.0	11.5	21.6	32.1	42.7	29.0	25.0	24.6	31.2	45.3	25.5	46.2	9.4	33.4	38.0	18.6	13.5	25.0	23.0	14.1	25.4	29.4	30.5	33.9	19.8	39.2	24.6	61.5	40.6	41.3	21.6	52.6	18.2	42.7	17.1	11.2	17.8	9.7	16.7	31.4	17.4	22.8	22.6	32.2	7.8	17.1	19.4	14.3	9.1	21.8	28.3	65.4	17.1	34.9	21.0	9.9	4.0	1.2	1.1	8.1	2.4	11.9	2.1	2.1	8.2	7.8	4.0	2.6	0.6	3.4	4.1	6.1	2.8	3.6	2.4	2.5	2.4	3.7	2.3	2.8	2.6	2.6	2.8	2.6	2.8	2.9	2.3	9.6	4.8	2.9	5.5	6.4	5.3	8.3	8.6	1.1	3.2	3.9	1.8	0.0	5.0	1.8	0.0	15.4	1.1	3.8	0.0	1.8	7.0	2.9	10.1	3.0	1.2	11.2	2.9	1.4	13.6	12.4	5.1	7.0	3.8	7.4	2.5	1.3	9.7	0.0	1.2	5.3	8.2	2.4	8.5	1.2	6.2	5.1	1.8	2.8	3.9	0.8	6.2	0.0	1.0	1.0	4.7	4.5	11.4	2.7	3.0	3.9	2.9	1.1	0.0	10.2	3.0	6.7	31.2	8.3	2.3	3.4	3.3	5.7	10.0	4.5
CHKB	"CHETK, CHKL"	ENSG00000100288	"Choline kinase beta"	Q9Y259	22	50578959-50601455	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"	"Congenital muscular dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 19.1;RPMI-8226: 19.8"									HPA018797	Approved		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA018797: AB_1846666"	"unprognostic (6.03e-4)"	"prognostic favorable (4.66e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.70e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.43e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-3)"	14.1	13.0	10.3	0.7	10.3	12.1	13.4	10.5	16.8	10.6	12.2	10.5	3.3	9.5	12.0	11.1	12.0	1.5	11.5	10.1	10.8	13.2	9.4	13.3	4.3	10.5	11.0	8.6	7.7	17.7	14.3	7.2	10.6	12.0	4.8	1.6	11.9	7.2	8.3	11.6	10.7	5.3	10.7	18.1	11.6	14.5	11.0	9.2	12.6	11.7	9.8	11.7	11.1	10.8	4.2	1.3	0.5	1.6	6.7	5.9	10.8	7.3	16.7	4.7	3.1	1.4	2.1	2.1	4.2	3.8	2.4	0.0	1.5	2.0	1.0	0.3	5.4	3.1	2.2	2.3	19.1	2.5	4.8	2.0	6.5	0.6	8.1	4.5	17.1	5.5	1.8	0.3	12.4	5.3	2.0	8.6	0.7	7.0	1.9	3.5	1.8	19.8	11.5	2.0	2.0	3.2	3.0	7.3	5.9	0.2	1.1	2.8	6.9	0.0	1.7	0.0	2.2	7.4	0.0	3.0	2.3	0.4	3.4	12.0	39.5	27.0	26.4	38.4	25.7	24.0	24.2	27.6	35.7	23.6	22.6	20.8	9.6	37.0	26.1	34.1	33.4	32.6	10.3	10.3	10.5	16.8	10.1	10.8	10.5	11.0	10.6	10.7	11.0	10.8	16.7	6.4	28.2	0.0	13.6	4.8	2.3	6.9	8.6	4.8	10.0	7.4	7.7	20.0	12.7	7.3	4.2	8.8	14.0	18.4	3.9	30.6	11.6	3.9	3.4	8.0	15.7	9.0	0.0	23.8	14.1	8.6	19.9	3.3	19.0	2.5	10.4	5.4	14.6	8.4	0.0	19.3	12.2	16.6	9.2	30.5	2.5	10.0	3.6	0.0	48.4	3.3	14.4	0.0	0.0	23.5	24.2	3.0	14.6	2.1	29.3	5.5	11.2	6.0	6.6	2.4	6.8	12.6	10.0	14.5	6.3	8.5	11.2	2.8	17.3	2.2
CHP1	"CHP, p22, p24, Sid470p, SLC9A1BP"	ENSG00000187446	"Calcineurin like EF-hand protein 1"	Q99653	15	41230839-41281887	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	"Protein kinase inhibitor"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 434.4;Distal tubular cells: 389.4;Hepatocytes: 353.6;Proximal enterocytes: 425.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006616	Approved		Approved	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA006616: AB_1857461"	"unprognostic (2.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (9.63e-4)"	"unprognostic (7.29e-2)"	"unprognostic (3.74e-1)"	"prognostic favorable (4.07e-6)"	"unprognostic (2.20e-1)"	"unprognostic (7.46e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.79e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.62e-3)"	"unprognostic (2.04e-1)"	66.9	55.3	22.1	28.0	24.4	58.4	32.8	26.0	26.5	34.0	24.7	113.8	85.4	21.8	34.1	74.5	20.8	48.1	53.2	30.3	32.9	76.1	185.1	52.7	18.6	32.9	31.0	19.1	42.2	54.1	21.6	26.3	35.8	34.3	81.9	20.5	49.9	27.5	81.0	45.5	70.0	27.6	26.9	20.2	112.7	10.7	33.3	20.1	49.8	86.5	41.1	44.8	41.3	28.4	72.4	72.7	28.3	109.0	120.4	113.8	41.0	56.2	69.1	44.8	48.0	66.6	140.4	12.6	59.8	77.7	47.7	89.0	56.0	83.9	51.5	44.8	20.0	50.8	58.1	103.6	93.5	66.5	73.7	116.7	98.8	51.9	53.3	68.0	82.1	37.9	81.2	79.5	52.5	43.5	27.7	72.5	29.0	118.4	35.9	35.9	46.2	34.0	92.5	144.1	17.4	44.3	96.4	178.2	48.7	49.9	101.0	66.3	108.3	47.5	50.3	76.9	36.7	45.0	131.6	59.4	84.9	42.2	44.1	255.5	227.6	274.8	49.5	204.4	51.5	40.2	46.2	50.0	152.1	33.0	29.1	41.4	173.3	56.5	207.4	95.1	60.7	116.5	22.1	24.4	26.0	26.5	30.3	32.9	32.9	31.0	35.8	26.9	33.3	28.4	28.3	44.8	117.3	20.9	26.8	72.3	62.4	48.1	20.5	11.0	101.6	39.2	80.5	243.1	50.7	103.0	10.4	33.3	38.3	434.4	389.4	96.7	52.5	68.0	48.8	39.5	55.6	58.5	24.8	150.6	62.4	38.2	112.7	114.4	37.4	18.9	78.1	353.6	68.5	11.8	21.0	136.2	34.6	170.1	134.8	122.6	29.5	77.1	129.9	19.7	113.4	32.7	36.0	9.5	23.6	173.9	206.4	29.3	24.0	80.1	425.0	231.1	33.7	10.3	26.3	46.6	41.4	13.7	19.3	50.6	108.5	66.9	32.9	65.7	161.4	130.8
CHRNB1	CHRNB	ENSG00000170175	"Cholinergic receptor nicotinic beta 1 subunit"	P11230	17	7445061-7457710	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 158.4;tongue: 57.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 39.0;Skeletal myocytes: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 34.6;RH-30: 71.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA005822, CAB011200"	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 47: Cytotrophoblasts - Unknown function"			"CAB011200: AB_262151, HPA005822: AB_1079484"	"unprognostic (2.89e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-1)"	7.0	30.6	6.9	2.4	7.8	9.1	6.7	7.3	7.5	7.5	8.8	6.3	2.9	6.6	5.1	7.0	5.4	1.9	11.5	6.9	6.9	10.7	16.5	5.1	3.6	7.5	7.0	5.4	16.5	9.1	6.7	6.7	7.3	5.1	2.5	3.2	10.7	3.0	158.4	8.1	5.5	3.2	7.3	7.9	5.2	3.2	7.1	6.5	13.0	57.7	3.9	5.5	7.2	8.1	1.6	2.2	3.8	4.5	6.0	4.0	8.6	1.1	3.8	5.6	4.6	1.3	2.0	6.2	4.0	2.5	2.0	13.6	1.4	25.1	2.0	7.6	4.8	3.5	2.3	8.1	2.6	2.2	8.6	8.8	6.8	3.4	11.0	9.3	3.8	12.0	4.6	3.4	34.6	1.0	6.7	4.1	2.7	1.5	1.1	4.4	71.0	15.8	15.3	1.2	0.6	11.1	2.4	4.0	4.7	5.9	3.9	3.0	3.6	2.3	6.4	1.7	5.0	8.1	9.6	1.7	2.1	4.9	2.1	9.9	5.4	13.6	7.9	6.3	6.1	6.7	8.7	8.0	7.0	7.0	7.0	9.2	1.7	11.0	10.4	5.2	7.9	6.1	6.9	7.8	7.3	7.5	6.9	6.9	7.5	7.0	7.3	7.3	7.1	8.1	8.8	0.0	4.8	4.6	8.9	6.4	3.8	12.6	6.2	3.9	9.3	11.2	9.8	4.3	7.2	9.2	2.1	39.0	17.7	5.2	23.5	16.1	2.2	5.1	7.1	10.1	2.4	3.4	1.4	13.4	9.4	8.1	3.6	7.1	13.3	5.8	10.4	10.8	12.6	15.2	1.5	4.8	14.2	7.2	8.7	2.1	21.8	7.9	12.4	1.0	17.0	14.0	29.9	1.0	5.6	17.3	4.9	17.0	5.8	4.1	10.2	15.5	9.5	7.1	0.0	47.3	8.1	2.8	2.8	6.1	6.5	30.4	11.2	12.1	5.9	3.8
CHRND	ACHRD	ENSG00000135902	"Cholinergic receptor nicotinic delta subunit"	Q07001	2	232525993-232536667	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 57.6"	"Group enriched"	"Detected in some"	10	"Muller glia cells: 4.0;Skeletal myocytes: 4.4"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	49	"RH-30: 99.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA056404, HPA065404"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA056404: AB_2732603, HPA065404: AB_2732734"				"unprognostic (1.69e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.28e-3)"	"unprognostic (7.75e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.90e-1)"		"unprognostic (4.97e-8)"	"unprognostic (7.52e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.46e-1)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	6.3	0.7	0.0	57.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	6.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	99.4	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CHRNE	ACHRE	ENSG00000108556	"Cholinergic receptor nicotinic epsilon subunit"	Q04844	17	4897771-4934438	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"heart muscle: 55.3;pituitary gland: 27.6"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 161.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"HEL: 5.0;HMC-1: 11.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	14	"basal ganglia: 6.3"							NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (2.00e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.35e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.80e-4)"	"unprognostic (7.75e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.39e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.70e-2)"	0.7	0.4	0.1	0.4	0.1	0.7	0.7	0.6	0.4	0.7	0.0	0.3	0.3	0.4	1.3	0.4	0.6	1.0	55.3	0.2	0.1	1.0	3.5	0.8	0.5	0.3	0.0	0.8	1.7	0.2	27.6	0.6	0.1	0.6	0.0	5.1	0.8	0.2	1.8	2.2	0.8	0.2	0.0	1.8	0.5	0.7	0.1	0.1	0.4	2.1	0.2	0.3	0.5	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	5.0	0.0	0.8	0.4	0.0	11.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.2	1.3	2.5	0.4	0.0	0.0	0.1	0.8	0.2	0.4	0.1	0.7	1.1	0.8	0.6	0.1	0.0	0.7	0.1	0.1	0.6	0.4	0.2	0.1	0.3	0.0	0.1	0.0	0.1	0.2	4.9	0.0	0.0	0.3	4.2	1.7	1.4	0.8	1.2	5.0	1.6	2.0	6.5	1.5	0.6	1.8	4.2	0.6	10.2	0.0	1.9	0.3	27.8	0.6	1.1	3.3	0.0	0.0	0.5	0.9	7.3	2.3	1.1	0.8	8.2	1.4	2.9	7.4	3.4	3.3	0.4	0.1	2.0	1.3	13.0	161.5	0.9	9.9	0.0	2.8	5.3	1.1	8.2	0.5	0.7	0.7	0.0	0.4	3.5	1.1	0.0	2.9	0.6	10.0	0.0	0.9	1.1	5.6	8.4	0.2	1.1	11.1	3.5	6.2	0.2	0.7
CHRNG	ACHRG	ENSG00000196811	"Cholinergic receptor nicotinic gamma subunit"	P07510	2	232539692-232548115	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"skeletal muscle: 32.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"HSkMC: 2.7;RH-30: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"				"unprognostic (2.26e-1)"	"unprognostic (8.97e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.38e-1)"	"unprognostic (4.86e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.19e-6)"	"unprognostic (6.13e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.24e-2)"	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.2	0.1	32.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHST11	"C4ST, C4St-1, C4ST1, HSA269537"	ENSG00000171310	"Carbohydrate sulfotransferase 11"	Q9NPF2	12	104455295-104762014	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 39.0;choroid plexus: 59.1"	"Group enriched"	"Detected in many"	4	"Microglial cells: 281.1;Oligodendrocyte precursor cells: 1012.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 12.7;eosinophil: 11.2;neutrophil: 15.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 15.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052828	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		55000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"		"HPA052828: AB_2681966"	"unprognostic (6.35e-2)"	"unprognostic (2.68e-3)"	"unprognostic (2.28e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.64e-3)"	"unprognostic (9.21e-3)"	"unprognostic (3.12e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.44e-2)"	"prognostic unfavorable (7.59e-11)"	"unprognostic (1.64e-2)"	"unprognostic (5.60e-2)"	"unprognostic (5.40e-3)"	"prognostic unfavorable (8.42e-4)"	5.0	10.2	14.5	20.1	13.9	39.0	3.5	11.1	14.1	5.6	59.1	4.2	3.0	11.9	13.3	3.4	3.7	9.4	4.5	15.0	16.0	3.6	3.0	12.2	15.2	17.9	16.4	6.2	4.6	1.3	4.5	15.5	17.1	3.9	4.0	2.2	2.2	8.0	1.1	1.7	6.2	10.9	13.1	12.8	6.3	2.3	17.3	19.5	3.3	1.0	11.7	8.3	3.8	17.5	38.8	18.2	8.2	5.3	20.5	10.0	27.8	3.1	1.2	1.8	1.5	0.0	51.2	0.2	5.6	5.4	42.3	9.9	4.9	20.8	2.2	0.4	7.1	53.2	4.8	0.2	3.1	62.4	60.6	3.7	2.9	32.9	5.4	30.7	13.2	74.4	82.8	13.2	3.5	9.7	47.8	73.1	6.6	0.4	7.0	54.0	27.3	12.9	17.0	0.4	13.6	21.9	2.1	26.3	48.3	7.2	7.7	62.7	29.2	5.7	6.2	29.4	32.3	67.2	75.9	10.6	26.3	43.5	57.7	12.7	1.4	11.2	3.0	1.4	1.7	1.0	1.5	2.2	0.8	2.8	0.7	1.9	15.6	1.6	1.3	2.9	3.2	0.8	14.5	13.9	11.1	14.1	15.0	16.0	17.9	16.4	17.1	13.1	17.3	17.5	8.4	16.0	13.1	142.4	33.8	2.8	18.2	2.6	4.0	3.1	0.5	1.1	5.7	1.5	6.4	5.5	0.0	41.6	45.6	0.1	0.0	4.9	0.9	1.3	24.7	12.9	0.0	36.2	43.8	61.4	12.0	9.5	2.6	0.9	41.3	1.4	18.2	0.5	42.6	10.1	114.4	0.0	0.0	26.8	42.9	2.0	7.5	56.5	3.6	281.1	65.6	2.3	30.9	1012.8	3.5	28.6	0.0	17.0	64.0	3.9	0.0	6.0	8.1	0.6	6.6	1.8	12.8	0.6	2.5	0.9	2.8	26.5	49.0	15.5	0.3	3.7
CHST14	"D4ST-1, D4ST1, HD4ST"	ENSG00000169105	"Carbohydrate sulfotransferase 14"	Q8NCH0	15	40470984-40473158	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase	"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 46.5;Extravillous trophoblasts: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA057697, HPA071601"	Enhanced		Approved	"Golgi apparatus"		NA	NA		20000	"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"		"HPA057697: AB_2683505, HPA071601: AB_2686425"	"unprognostic (5.46e-2)"	"unprognostic (9.23e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.01e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.25e-2)"	14.2	9.6	6.8	7.7	7.5	3.4	13.7	7.0	6.5	22.0	7.3	11.8	4.5	21.6	8.0	8.7	16.5	11.3	13.8	6.2	7.0	10.1	8.8	13.0	8.5	8.0	7.1	21.1	8.1	11.3	14.4	27.0	7.2	14.6	4.6	1.6	11.0	15.4	5.0	9.1	9.9	12.6	7.5	13.6	9.4	7.9	7.0	8.6	15.8	7.4	7.5	16.1	16.1	7.3	26.2	17.1	26.4	71.6	40.4	31.0	43.0	25.2	47.3	43.5	40.9	21.2	12.8	4.3	37.6	42.7	76.7	43.7	23.7	14.2	20.3	31.5	15.0	13.4	16.9	19.8	22.5	5.7	33.4	38.3	11.6	15.4	11.6	47.8	39.2	15.1	13.6	15.0	32.6	20.1	9.6	29.8	17.0	7.9	20.1	26.2	33.4	7.6	29.5	13.3	19.7	30.2	22.2	24.4	8.4	31.9	35.7	23.9	31.9	73.0	27.1	23.3	25.5	30.3	22.6	12.2	32.8	19.6	53.7	7.6	1.1	2.2	2.2	1.1	0.6	0.3	1.1	1.9	2.0	1.1	0.9	0.8	0.1	3.3	0.6	0.7	0.8	0.7	6.8	7.5	7.0	6.5	6.2	7.0	8.0	7.1	7.2	7.5	7.0	7.3	10.6	12.8	1.1	2.0	5.8	3.4	5.4	4.1	9.1	0.6	5.8	9.7	3.2	7.2	4.6	3.7	0.0	46.5	3.5	0.5	0.0	7.7	1.8	3.2	14.5	10.2	2.4	10.7	0.1	4.9	32.4	19.3	0.0	5.6	4.5	14.9	15.4	3.7	9.3	1.7	0.1	1.4	2.0	5.6	3.3	1.3	17.7	5.6	5.4	2.8	3.4	9.8	6.2	2.0	0.5	5.2	0.3	11.7	1.9	3.6	0.2	1.1	3.0	0.8	6.6	11.8	9.2	7.5	1.3	5.6	2.6	13.5	4.9	3.9	1.9	1.3
CHST3	"C6ST, C6ST1"	ENSG00000122863	"Carbohydrate sulfotransferase 3"	Q7LGC8	10	71964395-72013558	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 26.9;Oligodendrocyte precursor cells: 26.7;Oligodendrocytes: 27.1;Skeletal myocytes: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 65.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA047523, HPA055704"	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA		690000		"Cluster 21: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus, Cytosol"		"HPA047523: AB_2680075, HPA055704: AB_2682891"	"unprognostic (1.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.16e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.67e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.54e-3)"	18.4	13.4	10.7	5.5	17.9	0.0	11.4	16.8	11.5	10.7	6.2	11.9	0.9	16.0	3.7	6.4	12.9	4.7	14.3	9.9	12.9	7.9	1.2	7.9	1.6	27.9	18.2	20.6	4.6	1.2	4.6	8.0	19.8	11.1	2.1	2.1	6.4	14.8	17.7	8.7	5.4	17.1	14.0	2.5	14.7	18.1	17.3	4.2	5.5	9.0	1.4	9.4	8.4	25.3	15.4	16.4	8.2	20.3	36.6	14.4	0.3	32.0	30.4	19.3	12.8	14.4	30.1	0.0	21.4	37.9	15.5	19.7	7.4	21.9	15.3	0.4	5.5	0.1	27.8	13.8	18.7	0.0	0.1	19.8	24.9	19.0	25.9	37.3	5.7	0.7	4.7	0.0	20.6	0.4	0.0	0.1	3.5	0.5	5.3	0.2	9.9	0.0	26.9	15.7	0.5	8.1	24.2	0.6	24.1	9.9	1.8	3.1	11.9	23.6	27.1	39.6	65.1	0.0	0.1	0.1	17.2	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	17.9	16.8	11.5	9.9	12.9	27.9	18.2	19.8	14.0	17.3	25.3	23.9	0.0	1.9	14.0	0.1	2.8	4.9	6.1	13.6	0.1	4.3	8.0	10.4	5.7	2.5	7.3	0.0	4.6	0.0	0.1	3.9	9.7	0.8	20.1	24.7	5.6	0.0	0.0	0.2	2.7	2.2	9.3	2.6	17.9	1.3	26.9	13.6	0.3	0.8	0.0	0.3	0.0	2.0	0.6	1.9	3.2	20.5	0.7	8.8	4.7	0.7	6.6	0.0	26.7	27.1	12.7	0.0	21.8	0.0	4.2	0.0	3.6	2.0	0.2	6.6	26.8	13.9	1.0	2.1	7.5	2.4	1.1	0.4	5.5	0.1	1.3
CHSY1	"CSS1, KIAA0990"	ENSG00000131873	"Chondroitin sulfate synthase 1"	Q86X52	15	101175727-101252048	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 216.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"				"unprognostic (7.28e-2)"	"unprognostic (6.39e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (6.33e-5)"	"unprognostic (3.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.91e-3)"	"unprognostic (5.58e-3)"	27.5	18.6	10.3	18.5	9.8	23.0	21.7	9.0	11.8	19.5	14.4	7.7	6.0	17.3	9.5	10.8	14.9	22.7	20.1	9.2	10.3	13.7	10.0	23.6	11.6	14.2	13.8	19.7	7.3	7.4	8.5	46.7	11.9	14.4	8.2	7.0	10.1	11.4	6.5	15.0	7.7	20.0	11.5	13.9	10.4	8.7	12.5	10.5	10.0	7.4	10.3	34.8	14.0	9.8	9.1	11.2	36.8	18.7	18.9	25.0	24.5	21.8	19.2	25.8	26.2	9.7	7.1	22.0	12.7	36.3	16.8	24.7	24.5	27.7	28.2	24.6	12.4	43.4	12.2	11.4	23.3	66.9	42.9	23.2	22.8	22.3	20.1	29.3	30.8	9.7	16.2	216.3	19.7	7.9	9.2	46.3	42.5	17.7	7.9	20.6	36.9	32.8	18.1	17.7	6.4	34.6	23.0	11.1	40.8	29.8	12.6	81.6	26.2	41.9	24.1	20.0	46.5	38.2	94.5	12.7	32.5	62.2	32.0	0.0	1.3	2.9	1.5	0.8	1.7	0.9	0.9	1.6	0.8	1.0	0.5	1.0	4.9	0.7	0.9	0.5	1.8	0.6	10.3	9.8	9.0	11.8	9.2	10.3	14.2	13.8	11.9	11.5	12.5	9.8	55.0	0.0	15.7	27.7	11.4	57.9	20.7	10.1	20.5	10.7	41.9	29.8	9.3	5.7	9.4	16.5	6.2	6.1	14.6	1.6	1.9	5.3	1.2	10.0	33.4	45.8	3.0	12.0	34.2	2.2	28.8	40.0	5.1	13.8	25.9	51.9	60.0	5.4	16.6	38.7	36.1	3.6	10.2	17.8	37.1	2.5	55.0	41.2	26.6	59.0	10.2	9.2	10.3	21.1	24.2	5.5	2.5	47.0	9.3	19.3	1.2	2.4	8.1	7.5	46.0	47.9	53.5	3.9	7.5	10.5	62.5	13.8	15.2	23.0	3.9	10.2
CHUK	"IkBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16"	ENSG00000213341	"Component of inhibitor of nuclear factor kappa B kinase complex"	O15111	10	100188300-100229596	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001402, CAB004240, CAB018564"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB004240: AB_627784, CAB018564: AB_649197, HPA001402: AB_1079125"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.39e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (2.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.22e-1)"	13.5	10.3	6.6	11.7	7.6	19.6	10.8	7.1	8.3	8.4	8.3	11.9	12.8	8.8	9.1	9.7	7.5	9.0	6.8	6.4	9.2	21.0	17.0	10.2	12.7	7.3	7.5	5.6	11.5	14.0	6.5	10.5	7.6	9.6	13.3	8.0	8.8	9.0	14.2	6.9	10.8	11.8	7.7	9.9	11.2	8.3	8.7	14.3	11.1	11.7	12.6	13.6	6.4	8.7	27.7	22.9	23.0	34.4	21.6	19.3	17.6	34.3	33.5	31.3	38.0	25.9	15.9	37.2	19.7	23.5	21.8	26.7	38.7	18.2	34.9	39.8	33.5	24.7	18.0	28.7	18.4	46.2	34.8	15.5	19.1	36.2	35.0	21.8	22.7	30.1	28.5	29.9	34.6	16.7	36.9	28.4	15.0	21.8	16.5	23.7	25.5	17.0	19.9	17.6	13.7	20.3	18.6	14.2	30.9	18.0	28.5	27.8	23.9	19.6	21.9	21.5	39.7	34.9	33.7	35.7	21.3	36.9	15.8	1.0	1.2	2.1	0.9	1.9	1.5	1.6	1.1	1.6	1.4	1.0	1.3	1.5	2.8	1.8	1.3	0.8	1.2	0.5	6.6	7.6	7.1	8.3	6.4	9.2	7.3	7.5	7.6	7.7	8.7	8.7	11.4	12.8	11.5	17.9	10.8	19.8	7.1	5.1	8.0	6.3	7.3	4.8	9.2	7.2	5.9	5.5	2.1	6.5	14.1	12.2	11.7	7.1	7.6	8.9	8.6	8.4	6.0	12.0	22.7	11.8	7.8	6.5	7.7	12.7	8.2	6.2	7.1	14.4	10.6	13.5	21.3	8.0	8.2	16.9	12.7	8.0	6.2	11.7	7.2	19.7	15.6	4.5	9.2	20.6	27.7	10.4	6.0	6.0	18.5	9.6	9.5	20.0	6.4	5.0	19.7	7.8	12.0	16.4	12.9	13.2	19.0	13.8	11.1	10.1	6.6	10.6
CIB1	"CIB, KIP, SIP2-28"	ENSG00000185043	"Calcium and integrin binding 1"	Q99828	15	90229975-90234047	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Angiogenesis, Apoptosis, Cell adhesion, Cell cycle, Cell division, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1385.8;Respiratory ciliated cells: 1103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012991, HPA042413, HPA048825"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane"		"CAB012991: AB_2533205, HPA042413: AB_2732498, HPA048825: AB_2680533"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.73e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (7.56e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.09e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	65.6	163.6	65.4	79.7	69.2	205.5	67.4	67.8	76.5	93.8	96.7	147.9	130.1	44.6	88.1	127.3	146.6	77.4	101.9	62.7	68.8	220.1	195.7	86.7	97.0	70.1	70.3	43.9	214.1	98.3	93.0	38.0	68.7	127.6	138.1	29.1	116.6	72.7	58.8	40.4	128.5	45.3	69.3	117.0	99.3	113.8	69.2	64.4	89.1	42.3	120.9	93.7	68.3	69.3	119.5	261.4	23.8	83.7	98.7	102.7	38.9	123.8	107.2	99.6	87.2	104.7	207.4	34.7	129.7	144.0	125.7	124.2	48.0	141.8	54.0	81.9	114.2	77.5	182.3	175.9	96.2	155.2	71.4	72.2	84.9	91.9	64.6	113.7	129.1	83.7	105.8	53.5	76.4	233.3	118.4	179.4	36.7	223.9	134.0	66.1	62.8	139.7	256.1	199.4	18.7	22.8	168.7	136.5	135.7	41.5	105.3	93.3	81.7	109.6	77.0	132.0	153.2	73.0	122.0	40.3	176.1	174.9	47.8	168.9	201.8	271.3	226.9	248.9	188.0	476.4	269.9	249.4	224.4	418.0	221.5	218.0	118.2	205.7	230.0	149.7	245.8	399.6	65.4	69.2	67.8	76.5	62.7	68.8	70.1	70.3	68.7	69.3	69.2	69.3	77.4	89.8	104.2	14.7	203.7	85.7	253.6	520.1	84.8	12.0	152.0	118.5	86.9	128.7	469.1	183.9	10.4	106.7	198.7	670.9	453.9	372.1	380.8	480.8	101.3	83.9	97.1	62.3	7.7	662.9	117.6	96.5	149.9	222.8	138.8	66.9	79.6	230.1	209.0	3.3	6.6	379.5	463.9	102.5	148.0	1385.8	105.3	180.5	128.1	4.7	187.5	138.4	184.4	5.0	12.2	620.2	794.2	92.6	88.8	699.6	661.4	668.6	1103.6	25.5	39.5	62.3	140.4	160.3	69.0	218.1	67.3	66.1	227.5	91.8	315.5	577.8
CIITA	"C2TA, MHC2TA, NLRA"	ENSG00000179583	"Class II major histocompatibility complex transactivator"	P33076	16	10866222-10943021	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Kinase, Transferase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 57.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 48.8;Langerhans cells: 51.8;Macrophages: 43.8;Microglial cells: 42.2;monocytes: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 29.1;eosinophil: 17.5;intermediate monocyte: 23.5;memory B-cell: 47.3;myeloid DC: 46.2;naive B-cell: 63.3;non-classical monocyte: 29.0;plasmacytoid DC: 48.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 51.1;REH: 89.5;U-266/70: 18.0;U-698: 25.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016084, HPA054757"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB016084: AB_627261, HPA054757: "	"unprognostic (1.45e-3)"	"unprognostic (1.38e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-2)"	9.4	6.5	6.4	39.2	5.9	9.2	7.8	7.3	7.9	10.7	8.9	6.7	20.5	7.3	2.6	5.5	7.4	15.0	5.4	5.4	11.5	7.2	4.7	24.1	57.3	15.0	8.3	3.6	3.9	2.6	3.0	2.6	11.9	4.8	8.2	1.4	12.1	6.9	5.0	8.7	24.8	7.3	11.5	51.2	12.9	2.1	13.0	15.9	5.2	2.4	57.0	9.0	4.1	16.4	0.4	0.4	0.7	0.6	0.1	0.0	0.5	0.2	0.0	0.3	0.4	0.6	12.0	11.2	1.6	0.0	1.7	1.8	0.0	0.0	0.2	51.1	0.6	6.3	2.6	1.3	0.0	0.9	0.9	2.1	0.0	0.2	0.0	1.8	0.0	0.7	0.8	4.1	0.2	0.7	0.6	1.0	0.3	0.4	0.3	89.5	0.6	7.9	0.1	3.6	1.8	0.3	2.1	0.6	2.1	0.6	1.0	3.8	0.5	4.3	0.7	1.2	0.5	18.0	1.4	25.8	16.0	1.1	14.7	0.7	29.1	17.5	0.8	23.5	0.4	47.3	0.3	1.4	46.2	63.3	0.2	0.4	6.8	1.8	29.0	48.3	1.2	5.4	6.4	5.9	7.3	7.9	5.4	11.5	15.0	8.3	11.9	11.5	13.0	16.4	14.5	6.4	19.5	0.3	48.8	2.3	0.3	1.3	1.2	0.8	1.7	2.0	5.3	1.5	1.5	3.7	0.0	0.2	17.9	2.0	0.0	5.5	0.8	1.5	0.4	7.3	2.4	6.9	1.4	2.0	0.3	1.2	4.6	1.4	10.8	7.7	1.4	0.7	8.7	0.0	1.8	1.9	0.0	16.1	51.8	0.0	0.6	43.8	7.2	42.2	51.8	0.2	2.1	0.0	0.3	1.1	0.1	0.0	1.1	0.4	12.3	4.8	5.6	1.6	0.0	1.0	1.2	0.0	0.0	1.0	2.8	0.1	3.0	0.4	1.5	0.5
CILK1	"ICK, KIAA0936, LCK2, MGC46090, MRK"	ENSG00000112144	"Ciliogenesis associated kinase 1"	Q9UPZ9	6	53001279-53061824	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 11.0;Cytotrophoblasts: 20.6;Extravillous trophoblasts: 33.9;Syncytiotrophoblasts: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000791, HPA001113"	Approved		Supported	"Nucleoli fibrillar center"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli fibrillar center"		"HPA000791: AB_2732392, HPA001113: AB_1851385"	"unprognostic (1.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.17e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.12e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-1)"	7.9	17.9	10.2	4.9	11.0	2.7	10.7	8.4	9.7	8.9	5.1	8.7	9.8	8.0	5.5	8.6	7.4	6.9	8.5	6.8	7.8	4.5	7.5	6.3	5.2	9.4	11.6	9.5	5.0	7.3	1.7	12.1	8.8	9.9	10.7	17.4	17.9	7.3	4.0	8.7	10.4	7.4	8.8	5.6	12.9	4.5	14.9	10.1	6.3	5.0	6.2	6.5	5.8	12.8	7.8	2.9	14.6	10.0	8.9	14.0	17.0	6.9	12.4	10.8	12.3	4.1	2.4	5.7	4.0	21.0	3.5	5.0	17.6	7.1	14.2	19.9	7.0	4.2	3.3	22.3	4.5	5.2	5.4	12.5	7.6	4.6	5.3	7.7	10.2	12.1	8.1	22.6	24.9	6.7	5.6	6.4	5.6	27.0	6.3	8.8	6.5	7.5	4.5	5.6	23.6	10.6	6.7	16.3	9.6	14.2	9.5	10.9	8.5	17.2	8.0	6.5	17.1	6.3	4.8	2.2	3.5	5.0	8.5	2.8	1.0	2.2	1.7	0.8	1.5	1.2	1.2	1.4	1.0	1.5	1.4	1.2	0.5	1.1	0.9	1.4	1.7	0.8	10.2	11.0	8.4	9.7	6.8	7.8	9.4	11.6	8.8	8.8	14.9	12.8	6.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	20.6	5.7	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	33.9	5.3	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	58.1	0.8	0.0	0.0	0.0
CIT	"CITK, CRIK, KIAA0949, STK21"	ENSG00000122966	"Citron rho-interacting serine/threonine kinase"	O14578	12	119685791-119877320	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 87.6;Early spermatids: 72.8;Excitatory neurons: 147.0;Inhibitory neurons: 139.8;Oligodendrocyte precursor cells: 82.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019082, HPA048812, HPA075506"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA019082: AB_1846803, HPA048812: AB_2680528, HPA075506: AB_2686752"	"unprognostic (5.64e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.61e-6)"	"unprognostic (6.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.30e-1)"	0.7	2.2	13.5	1.6	26.2	6.3	0.6	0.0	19.9	0.9	0.0	2.1	1.2	0.4	0.0	2.5	0.5	0.5	0.6	15.2	5.4	2.5	0.3	1.8	1.5	0.2	5.0	0.3	0.2	0.1	1.6	1.4	0.4	0.5	2.5	3.4	0.8	0.2	0.5	1.6	1.9	0.9	0.9	3.0	2.2	4.8	14.2	6.8	0.6	0.3	2.3	0.5	1.3	6.6	26.2	20.6	21.7	15.3	2.4	6.3	10.4	22.0	19.1	21.8	16.6	14.5	10.3	18.4	10.0	14.2	9.3	14.6	14.4	9.5	32.1	13.6	7.5	25.7	13.2	7.1	0.3	12.7	20.6	0.9	1.2	23.7	14.8	7.3	15.5	19.9	14.5	15.2	19.5	12.2	22.4	14.0	10.4	8.7	12.5	19.3	39.8	6.3	5.0	11.1	15.5	8.4	31.9	6.5	16.0	9.6	23.2	10.6	11.5	21.9	21.4	17.2	22.7	9.9	12.6	14.2	16.8	12.5	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.5	26.2	0.0	19.9	15.2	5.4	0.2	5.0	0.4	0.9	14.2	6.6	4.1	6.4	13.0	8.5	1.2	3.3	0.7	1.0	0.6	8.2	1.8	1.5	1.8	0.0	5.6	9.2	87.6	3.5	0.6	1.1	0.0	0.2	72.8	2.4	2.1	2.7	1.8	12.8	147.0	0.8	4.8	2.2	3.1	3.6	1.3	10.5	1.1	0.7	3.6	0.0	139.8	4.4	6.1	3.7	0.8	44.1	1.2	2.0	3.6	7.5	0.0	15.4	1.0	82.4	18.7	0.2	0.1	1.2	4.1	0.4	0.8	7.5	1.7	15.2	0.0	0.6	3.3	33.2	4.2	7.7	1.3	1.0	2.2	4.3	4.4	1.0
CLCC1	MCLC	ENSG00000121940	"Chloride channel CLIC like 1"	Q96S66	1	108927361-108963504	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009087, HPA013210"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA009087: AB_1078532, HPA013210: AB_1846895"	"unprognostic (2.95e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (4.32e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.68e-3)"	"unprognostic (9.65e-2)"	14.6	16.5	10.1	11.4	14.3	6.1	16.3	10.6	11.7	17.0	7.8	15.4	13.2	17.0	24.3	9.9	15.1	14.0	18.3	10.7	11.5	11.0	22.2	13.0	10.5	12.8	10.9	18.6	24.8	21.3	18.3	17.7	12.1	20.2	13.2	11.8	22.3	20.0	27.2	10.3	12.7	14.9	11.0	11.5	16.1	7.6	11.8	5.2	21.9	24.8	10.8	15.2	13.4	16.0	44.2	22.3	25.1	45.8	36.7	33.9	35.6	43.8	34.2	30.1	34.2	22.6	21.0	10.8	43.7	33.3	18.5	17.1	23.9	16.1	39.4	38.0	23.2	30.4	24.7	23.5	28.9	28.7	28.2	25.2	21.9	33.2	25.7	28.3	27.1	12.1	38.6	47.7	22.1	18.9	2.3	10.1	21.5	16.6	19.8	24.5	13.1	31.2	24.3	30.5	15.9	22.7	46.9	49.6	38.9	18.9	15.9	19.7	26.7	38.3	27.7	35.1	38.4	32.1	33.3	17.1	44.7	21.8	82.5	4.1	5.6	6.1	5.6	8.4	6.1	6.1	4.5	4.4	5.6	3.2	4.9	4.5	1.4	4.7	12.4	6.4	6.8	4.4	10.1	14.3	10.6	11.7	10.7	11.5	12.8	10.9	12.1	11.0	11.8	16.0	13.3	25.6	20.9	26.8	11.8	3.7	14.0	11.7	1.8	12.3	11.8	9.1	5.9	20.0	18.0	11.0	29.2	28.7	9.0	7.1	0.0	18.6	6.7	8.1	21.3	10.9	3.6	5.9	25.0	21.1	12.8	19.5	10.7	13.5	12.0	16.3	9.7	22.3	13.1	21.9	30.3	9.0	16.2	6.7	5.1	2.8	19.9	9.3	8.8	14.0	12.0	11.4	3.1	35.7	39.3	17.7	3.8	18.8	17.7	17.7	7.2	5.0	14.9	18.9	19.7	18.6	10.7	5.5	5.4	6.4	6.3	18.5	8.4	12.5	9.8	9.9
CLCN1	"ClC-1, CLC1"	ENSG00000188037	"Chloride voltage-gated channel 1"	P35523	7	143316111-143352083	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 65.9"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 149.6"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"HSkMC: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (5.16e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.56e-4)"	"unprognostic (8.71e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.12e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.55e-3)"	"unprognostic (3.57e-2)"	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	65.9	0.0	1.0	0.0	0.0	0.1	0.2	1.0	0.0	0.2	0.0	15.9	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.1	0.8	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	32.9	0.0	0.2	0.1	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.8	149.6	0.0	0.7	0.0	1.0	0.6	0.0	0.0	0.0	0.7	5.7	15.0	0.0	0.0	0.2	0.4	0.1	0.3	0.0	0.0	1.4	0.3	0.1	2.2	0.7	0.1	0.0	0.1	0.1	0.2	2.1
CLCN4	"ClC-4, CLC4"	ENSG00000073464	"Chloride voltage-gated channel 4"	P51793	X	10156975-10237660	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.3;retina: 37.9;skeletal muscle: 45.0;tongue: 34.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 85.0;Cone photoreceptor cells: 102.2;Excitatory neurons: 45.7;Horizontal cells: 52.2;Inhibitory neurons: 54.0;Oligodendrocytes: 76.5;Rod photoreceptor cells: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.6;neutrophil: 2.2"	"Group enriched"	"Detected in many"	6	"B-cells: 2.6;granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"GAMG: 25.3;HEL: 24.3;SCLC-21H: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031313, HPA063637"	Enhanced	Approved	Approved	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA031313: AB_10601358, HPA063637: AB_2685069"	"unprognostic (1.01e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.07e-2)"	"prognostic unfavorable (2.13e-5)"	"unprognostic (2.96e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.99e-2)"	"prognostic favorable (9.55e-4)"	"unprognostic (9.70e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	2.6	2.7	16.2	1.5	27.4	1.8	1.1	28.8	23.1	1.3	5.2	0.9	0.8	0.6	22.6	1.7	2.9	2.1	12.3	19.6	19.7	2.8	3.2	3.0	2.8	27.1	24.1	1.6	2.2	10.8	5.3	1.1	24.5	1.5	0.7	37.9	2.2	1.0	45.0	1.0	0.7	0.7	18.5	2.6	1.5	1.8	26.8	2.6	6.5	34.2	1.8	1.2	0.7	33.3	5.9	4.6	2.7	0.0	1.5	2.5	0.1	0.2	0.0	0.0	0.0	9.1	4.6	5.0	13.0	1.5	25.3	1.4	1.4	2.9	0.2	0.1	5.7	24.3	2.2	3.5	7.3	0.0	0.1	12.9	3.4	7.0	1.5	4.7	9.4	0.0	1.5	0.1	3.3	1.1	0.0	0.2	4.0	7.1	15.3	0.0	4.5	0.0	2.1	0.8	24.1	8.7	8.6	1.1	0.0	2.7	1.7	2.7	7.4	3.1	5.8	15.3	0.6	0.5	12.1	1.8	10.5	0.0	4.5	1.6	0.3	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.4	2.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.3	16.2	27.4	28.8	23.1	19.6	19.7	27.1	24.1	24.5	18.5	26.8	33.3	1.0	9.6	3.1	11.8	4.9	0.5	0.6	2.0	0.0	85.0	1.1	0.4	31.1	8.6	2.2	7.3	102.2	0.2	0.0	0.1	0.0	2.5	0.1	2.6	1.3	3.0	15.0	9.4	45.7	3.6	0.1	4.0	1.1	3.1	1.3	0.7	13.6	5.1	3.1	52.2	54.0	0.6	4.1	4.8	2.3	0.0	0.9	3.4	0.0	15.9	1.0	15.4	0.0	24.6	76.5	4.1	0.1	3.8	0.4	0.8	0.0	2.9	5.3	42.6	0.0	8.7	6.0	0.0	0.5	0.2	0.1	0.3	0.1	2.6	0.3	1.3
CLCN7	"CLC-7, CLC7, OPTA2, PPP1R63"	ENSG00000103249	"Chloride voltage-gated channel 7"	P51798	16	1444934-1475084	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Transport"		"Disease variant, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 74.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043019, HPA043586"	Supported					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"			"HPA043019: AB_10964727, HPA043586: AB_10965322"	"unprognostic (2.69e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.49e-3)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.54e-1)"	18.1	37.3	14.4	16.9	14.2	34.3	17.3	12.8	18.0	18.7	18.0	20.0	16.6	20.3	6.3	12.4	17.0	12.3	16.6	14.2	14.1	21.1	22.0	19.1	18.3	17.9	19.2	15.1	21.8	20.8	21.7	12.4	20.7	16.5	7.1	9.2	16.8	12.0	28.0	23.1	22.7	13.2	11.9	27.3	22.3	19.2	18.0	15.6	23.1	8.3	12.1	16.0	11.9	15.8	14.2	36.9	21.0	33.7	41.3	21.5	34.3	18.9	36.4	35.2	41.5	30.8	51.2	16.3	38.6	23.7	73.8	29.4	18.4	21.0	11.4	26.1	31.5	11.6	37.9	30.0	72.4	29.4	45.1	42.9	28.4	32.1	28.5	23.9	23.0	36.3	48.0	29.2	18.5	28.4	21.3	50.6	21.7	9.0	21.8	96.7	13.3	45.2	16.4	18.2	22.5	24.9	30.8	37.5	120.2	11.8	33.6	78.0	26.3	34.9	16.2	39.1	18.4	47.3	32.1	16.5	28.2	54.3	22.6	0.0	1.6	1.2	0.8	2.7	0.3	1.0	0.4	0.4	1.2	1.0	0.2	0.3	0.3	0.3	3.4	1.1	0.1	1.0	14.4	14.2	12.8	18.0	14.2	14.1	17.9	19.2	20.7	11.9	18.0	15.8	12.6	0.0	7.5	25.1	16.5	7.4	5.5	6.3	9.1	45.0	14.5	12.7	4.4	4.3	8.2	20.2	35.5	10.2	12.3	20.4	1.9	16.2	10.2	14.0	14.9	11.1	12.0	8.0	22.3	17.8	8.9	11.0	18.8	17.9	6.3	24.0	16.8	15.6	36.3	74.0	20.6	14.5	4.1	28.3	11.5	8.6	11.5	29.6	39.2	24.4	22.4	27.3	13.4	8.5	17.9	17.9	7.3	8.2	9.3	9.0	14.5	14.7	7.8	28.1	0.0	9.9	11.9	13.5	10.7	5.6	6.8	15.5	9.4	19.4	15.1	5.2
CLDN1	"ILVASC, SEMP1"	ENSG00000163347	"Claudin 1"	O95832	3	190305707-190322446	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 309.8;skin 1: 288.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 440.1;Basal prostatic cells: 291.1;Prostatic glandular cells: 501.6;Squamous epithelial cells: 298.2;Suprabasal keratinocytes: 836.1;Urothelial cells: 562.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"EFO-21: 658.6;HaCaT: 236.5;hTCEpi: 288.6;RPTEC TERT1: 414.9;RT4: 267.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in some"	12	"spinal cord: 25.4"	"CAB002602, HPA048319"	Enhanced					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB002602: , HPA048319: AB_2680355"	"unprognostic (5.89e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (7.92e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.43e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.22e-1)"	40.8	47.9	1.5	1.2	1.1	0.2	22.7	0.8	1.3	17.7	20.7	1.7	1.1	64.2	31.9	40.9	56.6	15.5	2.5	1.5	1.2	10.5	309.8	9.1	0.5	1.2	2.8	6.3	34.3	0.4	2.4	5.3	1.7	13.6	1.6	0.9	34.0	46.0	1.1	288.2	0.7	126.6	0.7	1.5	1.0	4.3	1.1	9.4	36.2	4.9	44.2	40.4	35.9	1.0	34.0	29.7	0.2	0.1	0.0	0.1	0.0	2.5	52.7	1.1	2.1	17.7	69.1	0.0	658.6	0.3	58.5	236.5	1.5	77.7	6.2	0.9	1.4	0.1	9.3	41.5	49.6	0.4	0.2	0.5	288.6	6.0	87.0	2.4	0.6	0.0	0.1	0.1	0.1	6.5	0.1	0.1	1.5	2.3	5.5	0.0	0.6	0.2	414.9	267.0	0.2	0.0	31.0	5.7	18.4	3.5	53.5	0.5	12.9	0.6	9.9	0.2	1.4	0.7	0.6	1.2	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.8	1.3	1.5	1.2	1.2	2.8	1.7	0.7	1.1	1.0	0.4	12.8	34.7	0.0	0.5	440.1	291.1	217.3	84.2	0.0	35.6	2.0	1.0	170.1	143.2	31.3	0.0	2.4	0.6	0.6	0.0	203.3	0.1	44.4	10.0	7.0	1.8	0.0	0.7	56.3	0.3	29.2	2.0	100.0	1.3	0.4	1.4	188.2	1.0	0.0	1.6	0.3	54.9	3.8	66.5	1.7	15.5	8.5	32.0	0.0	5.7	0.0	0.0	24.6	0.0	139.9	0.0	35.3	0.0	501.6	0.1	4.1	144.6	0.0	0.0	0.3	11.2	0.3	0.8	298.2	836.1	33.8	2.6	5.0	1.0	562.9
CLDN16	"HOMG3, PCLN1"	ENSG00000113946	"Claudin 16"	Q9Y5I7	3	190322541-190412138	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 63.6"	"Cell type enriched"	"Detected in some"	8	"Distal tubular cells: 187.9"	"Group enriched"	"Detected in many"	15	"ovarian cancer: 39.8;thyroid cancer: 29.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	153	"EFO-21: 691.6;RPTEC TERT1: 233.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056020	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA056020: AB_2683011"	"unprognostic (5.01e-2)"	"unprognostic (7.83e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (6.06e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.76e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.15e-1)"	0.1	0.7	0.3	0.2	0.4	0.0	0.2	0.0	0.5	0.1	1.5	0.0	0.0	0.3	0.6	0.5	2.9	0.7	0.0	0.2	0.2	63.6	2.2	0.4	1.5	0.2	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.4	0.9	0.0	3.2	0.0	0.4	0.1	0.1	0.1	0.1	0.3	0.3	9.7	0.0	1.0	0.3	0.2	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	691.6	0.0	0.3	0.7	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	233.2	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	2.2	0.0	0.3	1.4	1.2	3.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.5	0.2	0.2	0.2	0.1	0.2	0.1	0.3	0.6	0.1	0.0	0.0	0.3	0.0	7.0	5.8	2.6	0.6	0.3	0.8	0.3	0.4	4.3	1.6	9.2	0.0	0.4	0.0	0.0	187.9	3.4	2.0	3.0	0.1	0.2	0.0	0.0	5.0	0.4	0.2	0.9	0.0	0.5	1.3	0.3	0.0	1.6	0.1	3.3	3.6	0.0	0.0	0.3	1.2	0.2	0.0	0.4	5.4	2.8	0.0	0.2	0.0	4.0	0.1	0.5	0.0	0.4	0.0	6.7	0.0	0.9	22.1	0.2	0.0	0.8	0.6	0.3	0.3	0.9	12.6	6.2	0.2	0.2	0.0	3.1
CLDN19		ENSG00000164007	"Claudin 19"	Q8N6F1	1	42733093-42740254	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"		"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"choroid plexus: 19.8;kidney: 39.1;placenta: 9.8"	"Cell type enriched"	"Detected in some"	6	"Extravillous trophoblasts: 221.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 3.0;Hep G2: 6.3;SuSa: 3.5"	"Region enhanced"	"Detected in many"		"olfactory bulb: 5.4"	"Region enriched"	"Detected in many"	6	"spinal cord: 41.8"							NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"				"unprognostic (6.23e-4)"	"unprognostic (1.80e-1)"		"unprognostic (1.85e-6)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.22e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"		"unprognostic (3.29e-3)"	0.8	0.1	0.1	0.0	0.1	0.1	1.1	0.4	0.5	0.0	19.8	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.1	1.3	0.0	39.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.8	0.6	0.3	0.0	0.0	0.8	0.7	0.2	0.5	0.1	0.0	0.1	0.0	0.3	0.0	0.1	1.6	0.0	0.9	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.5	1.3	0.0	0.1	0.0	0.6	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.2	8.3	0.3	0.0	0.6	12.9	0.0	12.5	0.0	0.0	33.2	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	221.6	0.7	0.0	0.2	0.0	0.0	0.7	0.0	5.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.0	12.4	0.1	0.2	0.1	0.0
CLDN3	"C7orf1, CPE-R2, CPETR2, HRVP1, RVP1"	ENSG00000165215	"Claudin 3"	O15551	7	73768997-73770270	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 263.1;thyroid gland: 116.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1839.9;Endometrial ciliated cells: 1221.7;Glandular and luminal cells: 1555.7;Intestinal goblet cells: 1471.3;Paneth cells: 2326.0;Proximal enterocytes: 3162.1;Undifferentiated cells: 1266.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 529.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 230.7;PC-3: 47.6;RPMI-8226: 40.5;SCLC-21H: 58.0;T-47d: 105.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.5"	"Region enhanced"	"Detected in many"		"midbrain: 9.7"	HPA014361	Enhanced		Supported	"Cell Junctions"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"		"HPA014361: AB_2668982"	"unprognostic (1.84e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.42e-1)"	"prognostic favorable (3.39e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.18e-2)"	"unprognostic (6.72e-2)"	0.7	0.2	0.2	7.8	0.3	0.2	26.7	4.2	0.3	12.3	37.6	263.1	54.4	7.5	1.4	1.3	29.6	2.2	0.1	1.1	1.2	46.5	40.4	10.7	0.2	1.3	1.9	0.5	96.6	1.5	27.7	1.0	0.6	58.3	17.5	0.4	72.9	8.3	0.1	9.6	169.5	0.8	0.5	0.2	1.4	0.7	0.9	1.0	116.3	0.0	1.2	1.5	0.2	0.2	2.5	3.6	0.0	0.4	0.0	0.0	17.8	0.0	0.0	0.0	0.0	4.2	35.7	0.0	9.9	0.0	0.0	1.0	0.4	0.0	0.0	0.1	4.9	0.0	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	230.7	0.4	1.2	2.1	9.1	47.6	0.1	0.0	40.5	2.1	0.2	58.0	0.7	0.0	33.6	0.0	0.2	105.4	0.0	0.2	0.2	0.6	0.9	0.1	0.2	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	4.2	0.3	1.1	1.2	1.3	1.9	0.6	0.5	0.9	0.2	1.6	38.5	37.8	0.0	13.2	0.1	60.3	43.7	0.0	0.7	289.9	182.5	0.6	287.4	86.3	126.9	4.2	63.9	5.1	1839.9	9.8	297.5	0.0	1221.7	130.5	10.3	606.1	5.3	0.0	19.1	17.7	4.1	16.8	1555.7	28.0	1.5	0.4	40.5	5.1	0.0	0.0	1471.3	116.0	0.3	0.0	0.3	2.5	9.9	10.6	0.0	2.0	11.8	0.0	0.0	0.0	36.7	2326.0	0.0	4.4	433.2	3162.1	58.6	498.4	10.6	0.0	0.0	20.3	0.1	0.3	2.7	0.0	72.4	17.5	0.0	1266.0	607.3
CLDN4	"CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8"	ENSG00000189143	"Claudin 4"	O14493	7	73799542-73832690	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 305.0;urinary bladder: 303.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 3149.1;Glandular and luminal cells: 2298.8;Paneth cells: 2081.0;Prostatic glandular cells: 2184.8;Urothelial cells: 8033.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 358.1;BEWO: 395.0;CAPAN-2: 761.4;MCF7: 400.2;OE19: 402.0;PC-3: 495.0;RT4: 340.2;SK-BR-3: 636.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB002610	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"		"CAB002610: "	"unprognostic (1.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (2.16e-3)"	"unprognostic (5.11e-1)"	"prognostic favorable (3.46e-10)"	"unprognostic (5.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.63e-2)"	2.6	0.4	0.1	23.0	0.0	0.2	69.0	0.8	0.3	61.2	4.8	256.3	126.9	26.7	24.4	305.0	75.8	48.9	0.4	0.2	0.0	116.2	4.8	64.0	1.0	0.4	1.5	1.2	116.2	51.9	13.1	36.3	0.3	82.2	123.3	0.3	204.6	39.1	0.5	180.8	190.6	7.3	0.0	0.7	13.3	0.6	0.2	10.7	111.7	0.3	37.5	303.5	105.7	0.0	358.1	4.4	0.0	1.5	0.0	0.4	395.0	3.3	0.2	0.3	0.4	184.9	761.4	0.6	28.0	0.1	2.6	193.3	0.0	0.5	0.4	0.7	0.4	0.2	20.3	127.0	0.1	0.1	0.9	0.0	1.9	0.1	0.4	0.3	0.0	0.2	0.3	0.7	0.0	400.2	0.7	1.9	0.7	402.0	495.0	0.5	6.9	7.6	92.4	340.2	79.5	1.7	0.4	636.8	0.8	21.6	250.9	0.9	0.5	0.9	13.7	3.1	3.5	0.9	0.7	0.7	0.6	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.3	0.2	0.0	0.4	1.5	0.3	0.0	0.2	0.0	5.1	275.7	230.2	0.0	12.2	16.2	3149.1	641.6	31.3	0.4	1255.2	548.4	0.8	287.4	954.3	218.8	0.0	771.7	18.7	1985.0	13.7	1026.1	0.0	1201.7	231.0	41.3	675.5	0.0	0.2	447.1	739.7	27.0	94.8	2298.8	27.3	0.2	0.4	0.5	76.3	0.0	0.1	1266.9	905.3	0.6	8.6	0.0	2.5	29.3	14.2	0.0	15.6	0.8	0.0	0.0	0.0	950.2	2081.0	0.0	2.5	2184.8	1906.1	21.6	635.6	0.0	0.0	0.1	68.2	0.0	0.2	1068.1	54.0	956.1	40.7	0.1	965.1	8033.4
CLIC2	"CLCNL2, XAP121"	ENSG00000155962	"Chloride intracellular channel 2"	O15247	X	155276211-155334657	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 51.2;Alveolar cells type 1: 89.8;Alveolar cells type 2: 54.9;Endothelial cells: 60.4;Erythroid cells: 70.7;Kupffer cells: 73.5;Langerhans cells: 135.0;monocytes: 71.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 18.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 18.6;myeloid DC: 47.9;non-classical monocyte: 14.2"	"Group enriched"	"Detected in many"	16	"dendritic cells: 47.9;monocytes: 18.6"	"Group enriched"	"Detected in some"	5	"HDLM-2: 103.3;K-562: 60.4;Karpas-707: 53.4;RPMI-8226: 92.2"					"Low region specificity"	"Detected in all"			"HPA047381, HPA060101"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		150000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA047381: AB_2680022, HPA060101: AB_2684204"	"unprognostic (3.27e-2)"	"unprognostic (5.21e-3)"	"unprognostic (9.70e-2)"	"unprognostic (7.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-1)"	23.1	7.1	6.9	16.7	7.8	9.8	16.7	6.9	18.1	20.1	7.6	10.9	8.7	22.6	7.8	9.4	12.5	19.0	14.6	7.1	7.0	5.8	12.8	30.6	30.2	7.7	6.9	21.6	3.5	4.6	4.5	9.3	7.4	4.6	13.6	2.4	6.2	6.3	4.4	6.1	10.3	17.7	7.7	50.1	8.5	3.2	8.5	14.5	31.8	14.3	25.6	15.9	10.7	7.8	0.7	0.0	1.0	0.9	1.0	4.7	0.0	0.2	2.8	0.0	0.4	0.0	0.2	0.1	0.4	0.0	0.2	0.1	0.3	0.0	0.0	103.3	0.5	16.4	0.3	0.0	0.0	0.4	0.6	1.4	0.0	0.0	0.1	0.5	0.1	0.5	60.4	53.4	0.3	0.2	0.1	1.3	0.2	0.1	0.4	0.4	0.0	92.2	0.2	0.2	0.7	0.9	0.0	0.1	0.4	0.2	0.0	1.0	0.0	5.3	1.6	2.0	0.9	3.3	4.6	0.0	2.7	2.6	1.7	0.0	3.5	0.2	0.0	18.6	0.3	0.0	0.1	0.1	47.9	0.0	0.0	0.0	1.4	2.0	14.2	5.2	0.0	2.1	6.9	7.8	6.9	18.1	7.1	7.0	7.7	6.9	7.4	7.7	8.5	7.8	51.2	89.8	54.9	3.9	1.1	13.3	0.8	0.2	2.2	1.2	0.7	1.3	3.2	0.0	5.8	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.5	11.3	60.4	1.2	70.7	8.6	0.2	0.1	25.6	0.5	0.4	3.8	0.5	27.1	1.2	4.7	0.0	7.0	0.6	0.0	73.5	135.0	1.1	13.7	34.5	17.8	8.4	71.4	0.2	0.0	3.0	2.4	0.1	0.0	9.4	2.0	0.5	0.0	0.6	1.5	0.3	6.6	2.5	4.6	0.3	0.3	0.4	13.8	0.0	2.6	5.2	0.1	1.9
CLIC5	DFNB102	ENSG00000112782	"Chloride intracellular channel 5"	Q9NZA1	6	45880827-46080348	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hearing, Ion transport, Sensory transduction, Transport, Vision"	"Chloride channel, Ion channel, Voltage-gated channel"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 102.7;skeletal muscle: 289.7;tongue: 98.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 509.6;Cardiomyocytes: 285.7;Distal enterocytes: 164.2;Late spermatids: 93.8;Proximal enterocytes: 126.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 5.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.5;EFO-21: 9.2;HDLM-2: 4.7;REH: 11.9;U-266/70: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074371			Supported	"Nuclear speckles,Plasma membrane"		NA	NA		400000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Nuclear speckles"	"HPA074371: "	"unprognostic (4.95e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.73e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.46e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.65e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.01e-1)"	18.9	1.5	3.2	4.3	4.4	0.2	6.5	1.5	2.9	19.0	0.5	28.6	20.9	2.1	0.9	2.9	4.5	3.0	102.7	2.1	5.0	54.7	0.3	70.8	1.7	2.1	3.8	0.5	1.1	1.7	3.0	16.5	2.2	2.6	25.8	16.9	2.7	1.4	289.7	1.2	36.6	2.3	1.8	44.5	1.6	1.4	5.5	1.0	7.3	98.3	1.9	2.0	2.6	1.9	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	13.5	0.0	9.2	0.0	0.0	0.3	0.0	0.1	0.0	4.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.1	0.4	1.6	0.0	11.9	0.3	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.4	0.1	0.0	12.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.1	0.1	2.0	1.3	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.0	1.0	0.5	3.2	4.4	1.5	2.9	2.1	5.0	2.1	3.8	2.2	1.8	5.5	1.9	59.6	509.6	30.0	4.6	1.4	0.1	0.1	0.0	1.2	0.3	0.5	0.4	285.7	5.7	26.9	14.7	0.0	0.2	0.7	164.2	0.0	1.7	52.9	4.6	0.5	29.8	13.1	0.4	8.6	0.2	0.1	7.9	0.5	5.7	1.3	0.0	0.7	0.0	0.0	0.0	5.4	23.5	0.0	0.0	0.0	93.8	0.9	0.7	0.0	34.7	0.6	53.8	0.0	0.5	2.9	2.9	51.1	0.7	3.4	3.2	126.0	2.9	11.4	1.8	0.0	6.1	4.3	1.0	0.1	0.1	0.1	2.2	5.8	0.1	13.5	4.3
CLN3	"BTN1, BTS, JNCL"	ENSG00000188603	"CLN3 lysosomal/endosomal transmembrane protein, battenin"	Q13286	16	28474111-28495575	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 315.9;Extravillous trophoblasts: 106.9;Syncytiotrophoblasts: 451.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 178.0;SK-BR-3: 186.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063280	Uncertain					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA063280: AB_2684975"	"unprognostic (2.38e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.06e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.38e-3)"	"unprognostic (8.16e-2)"	"unprognostic (6.27e-2)"	"unprognostic (5.26e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.05e-2)"	18.1	30.5	13.1	19.6	14.2	13.4	21.4	14.2	16.0	16.9	16.5	38.3	21.9	15.9	9.9	22.2	16.0	15.2	11.7	13.2	13.6	21.2	31.9	23.6	13.8	14.6	13.6	16.8	27.7	30.0	8.2	36.9	15.1	17.3	29.2	3.1	34.5	21.0	14.5	24.1	25.7	13.3	13.5	20.4	26.1	7.9	15.6	14.0	24.7	13.8	12.1	19.3	15.6	17.1	23.1	39.2	15.4	38.4	41.1	19.9	178.0	14.8	40.7	28.3	34.9	19.7	52.9	16.0	45.8	24.8	52.0	23.5	25.8	24.7	12.9	38.0	38.5	15.6	24.1	60.6	60.5	23.3	64.7	28.0	66.8	21.9	14.7	26.3	32.9	24.9	30.9	55.0	28.8	61.9	20.7	45.1	21.8	35.3	26.0	37.2	13.4	54.5	30.2	53.0	20.8	19.6	5.7	186.5	18.3	14.0	62.2	32.4	20.2	19.2	10.1	24.9	22.5	58.3	64.2	15.9	28.4	47.3	11.9	63.4	59.8	98.4	57.6	47.6	42.7	24.3	43.6	53.6	63.8	29.3	38.3	40.6	23.8	41.2	38.7	68.1	53.5	46.6	13.1	14.2	14.2	16.0	13.2	13.6	14.6	13.6	15.1	13.5	15.6	17.1	1.2	22.4	15.9	11.1	10.8	0.1	17.2	0.0	23.9	10.9	1.7	0.6	0.0	38.6	6.2	1.8	12.5	315.9	25.8	46.4	0.0	2.2	1.1	1.8	1.3	11.2	17.0	17.5	7.5	0.5	106.9	9.3	20.9	2.6	2.5	7.6	21.0	39.0	70.1	13.5	8.1	39.3	0.0	36.7	0.4	2.5	19.0	17.7	0.0	2.8	17.5	25.0	40.2	7.1	11.4	1.5	43.7	12.4	13.1	10.6	53.1	0.8	1.5	12.1	13.1	9.9	3.5	3.2	8.4	17.1	0.1	451.4	15.9	3.6	50.2	13.3
CLN6	"FLJ20561, HsT18960, nclf"	ENSG00000128973	"CLN6 transmembrane ER protein"	Q9NWW5	15	68206992-68257211	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 181.8;Hofbauer cells: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066046, HPA066759"	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"	"Endoplasmic reticulum"	"Nucleoli, Vesicles"	"HPA066046: AB_2685604, HPA066759: "	"unprognostic (1.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.78e-2)"	11.6	17.6	12.7	14.8	13.0	29.9	11.5	13.3	14.9	11.0	13.2	17.5	14.6	9.8	6.8	16.9	9.8	9.6	9.3	12.1	12.6	20.0	22.7	13.2	16.2	13.3	13.1	6.8	19.1	10.4	10.1	11.6	13.8	12.4	14.9	11.8	14.8	9.2	17.0	14.7	14.6	10.4	12.8	20.7	13.3	10.9	13.0	11.6	12.9	7.3	16.7	10.7	9.6	14.5	38.2	93.1	23.9	33.9	14.5	11.8	57.1	35.3	17.0	42.8	34.9	72.1	60.5	57.6	17.2	21.4	31.7	69.5	69.8	34.5	17.0	38.5	82.3	84.3	66.1	54.3	29.7	95.6	58.1	20.8	11.4	34.7	23.7	9.0	29.1	33.1	56.9	116.0	33.6	103.8	44.0	69.4	57.1	67.3	38.3	42.1	71.8	80.6	36.2	97.0	48.2	20.0	39.5	61.7	34.3	18.0	33.1	95.5	19.3	48.1	55.7	35.8	127.2	81.3	97.3	47.4	30.0	115.4	47.6	0.0	8.8	0.6	3.0	13.0	4.0	2.9	2.2	4.3	5.2	2.3	2.8	1.3	10.5	2.0	16.1	4.4	2.3	3.5	12.7	13.0	13.3	14.9	12.1	12.6	13.3	13.1	13.8	12.8	13.0	14.5	1.4	9.6	6.9	7.2	13.4	20.1	22.0	13.9	14.8	181.8	2.0	1.9	27.4	10.0	9.6	5.5	16.7	42.8	7.1	22.7	0.0	3.3	0.4	1.0	4.8	9.7	15.1	32.8	8.9	1.8	58.4	9.1	8.2	1.4	8.9	5.6	11.0	21.9	88.4	21.9	8.1	20.5	16.2	24.2	14.0	1.4	9.0	11.3	19.6	8.4	12.9	16.9	11.3	5.0	10.2	3.6	26.0	8.2	33.4	23.7	15.6	2.1	3.3	32.7	6.6	7.5	5.6	1.0	19.5	21.1	14.1	21.8	9.5	5.3	35.6	16.3
CLP1	"hClp1, HEAB"	ENSG00000172409	"Cleavage factor polyribonucleotide kinase subunit 1"	Q92989	11	57648188-57661865	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	"Kinase, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057770	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA057770: AB_2683523"	"unprognostic (1.33e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.13e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.82e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.31e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.07e-1)"	8.9	7.4	3.1	10.1	3.6	26.1	9.2	3.9	4.4	7.1	4.4	9.0	8.7	7.7	7.6	9.2	7.3	5.9	6.5	3.3	3.3	8.0	10.1	7.3	10.8	3.3	3.1	6.8	7.4	6.8	4.4	9.2	3.7	5.6	8.6	3.2	6.7	7.1	8.2	9.0	8.4	8.9	3.4	10.0	8.1	8.4	3.3	11.2	7.2	9.3	13.1	8.6	5.0	3.7	21.2	22.2	21.0	21.6	22.3	14.4	19.7	21.4	23.2	30.1	25.8	21.4	18.4	35.1	24.3	18.9	24.2	25.9	29.2	34.5	34.2	24.3	18.0	19.4	13.5	21.7	17.7	28.5	22.2	17.4	24.0	26.9	18.6	11.9	27.7	17.4	30.4	11.9	24.9	14.8	21.8	32.9	31.8	24.3	22.2	21.7	32.1	37.5	16.5	15.0	11.1	22.3	19.1	17.2	28.7	21.7	32.7	23.2	20.0	16.0	21.7	27.7	15.9	18.6	26.4	39.3	17.3	16.3	17.3	31.2	19.0	20.0	15.9	16.4	18.9	15.6	14.1	16.4	19.0	14.3	16.4	14.9	21.7	13.6	15.9	10.8	16.2	12.3	3.1	3.6	3.9	4.4	3.3	3.3	3.3	3.1	3.7	3.4	3.3	3.7	6.1	9.6	5.1	1.0	8.5	19.4	10.7	13.4	16.5	4.3	6.0	6.2	2.4	7.2	10.5	0.0	6.2	16.5	12.7	4.8	9.8	12.9	32.5	6.7	5.7	7.3	2.4	12.2	1.9	11.7	13.9	7.4	3.1	7.1	8.2	4.9	4.2	3.5	11.0	5.0	1.8	3.2	8.2	6.0	6.9	4.1	5.6	5.8	8.8	1.0	15.0	3.3	7.2	2.5	1.4	9.8	4.7	8.6	5.9	4.7	6.2	10.1	6.4	3.1	6.6	10.4	6.9	9.4	12.0	9.3	14.5	13.5	9.7	6.5	4.6	7.8
CLPP		ENSG00000125656	"Caseinolytic mitochondrial matrix peptidase proteolytic subunit"	Q16740	19	6361531-6370242	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 229.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010649	Supported		Supported	Mitochondria		NA	NA		8500	"Cluster 20: T-cells - T-cell receptor"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA010649: AB_1078538"	"unprognostic (2.28e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.17e-3)"	"unprognostic (7.43e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (6.50e-4)"	"unprognostic (1.21e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.86e-3)"	48.6	65.8	52.0	41.5	51.5	42.9	45.1	52.2	63.8	39.1	58.0	46.6	47.4	41.1	17.8	56.1	40.1	20.8	78.0	50.9	52.7	60.5	90.7	39.7	47.7	52.8	52.4	38.5	53.6	36.6	44.5	25.4	49.5	41.0	22.9	15.6	48.3	31.2	146.8	47.5	43.6	25.1	51.8	45.6	55.6	45.2	54.5	45.2	36.1	59.3	35.6	44.6	37.9	53.9	146.7	98.2	61.2	113.9	38.7	54.8	62.4	76.9	59.5	112.2	102.5	87.2	48.9	124.1	122.8	61.3	61.1	83.1	63.5	109.1	38.5	133.8	189.3	95.8	82.2	122.9	106.6	90.7	129.8	73.4	74.4	78.9	82.9	69.7	113.9	188.5	97.5	174.5	72.3	192.8	153.1	104.5	93.2	100.6	207.8	108.6	73.2	206.2	81.2	79.4	99.3	95.9	48.9	123.8	133.0	36.7	67.3	130.6	76.9	70.5	69.7	180.7	156.0	235.4	225.3	137.2	103.5	132.9	117.3	29.4	82.6	47.8	112.0	79.6	133.5	119.5	159.4	139.6	102.4	131.5	138.4	137.4	62.1	126.5	55.5	155.5	207.2	162.6	52.0	51.5	52.2	63.8	50.9	52.7	52.8	52.4	49.5	51.8	54.5	53.9	39.6	22.4	35.2	8.1	45.9	44.9	59.5	90.8	38.1	31.0	47.6	57.9	45.8	55.8	46.2	44.1	12.5	72.2	43.7	56.0	144.8	88.8	105.5	27.6	43.1	51.6	35.3	54.9	5.4	96.6	113.6	42.4	36.2	35.0	26.0	63.1	61.8	89.6	81.3	21.9	7.5	50.9	54.9	38.9	35.0	229.8	42.6	38.7	55.2	4.7	70.6	46.6	46.4	4.5	9.5	101.9	67.7	43.2	82.4	89.5	110.9	189.0	44.5	24.6	13.1	30.0	79.9	67.7	48.1	56.5	37.1	57.7	65.3	95.1	65.4	65.4
CLRN1	"RP61, USH3, USH3A"	ENSG00000163646	"Clarin 1"	P58418	3	150926163-150972727	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hearing, Sensory transduction, Vision"		"Deafness, Disease variant, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 4.9;retina: 12.8"	"Cell type enriched"	"Detected in some"	6	"Muller glia cells: 165.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	30	"NTERA-2: 3.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 5: Muller glia cells - Visual perception"				"unprognostic (1.00e-3)"				"unprognostic (1.26e-1)"					"unprognostic (5.54e-1)"					"unprognostic (9.68e-2)"			0.0	4.9	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	165.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLTC	"CLTCL2, Hc"	ENSG00000141367	"Clathrin heavy chain"	Q00610	17	59619689-59696956	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Cell cycle, Cell division, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010389, CAB011571, CAB017155, HPA059143"	Approved		Enhanced	"Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol"		Yes	No		14000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Endosomes, Lysosomes"	"Mitotic spindle, Cytosol"	"CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: AB_2683924"	"unprognostic (1.56e-1)"	"prognostic unfavorable (7.35e-4)"	"prognostic favorable (7.65e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.02e-4)"	105.4	95.2	42.1	89.7	54.9	96.3	81.6	67.3	103.9	92.3	36.7	121.7	74.1	83.1	126.4	82.1	67.8	88.9	90.7	60.7	65.1	125.5	117.7	82.1	75.5	95.5	52.4	73.2	56.8	186.8	51.6	139.6	95.2	97.8	128.3	163.6	68.6	104.2	88.4	81.3	73.3	121.0	43.8	78.8	91.2	71.3	68.2	76.0	114.1	83.9	86.8	101.1	51.6	55.0	293.3	426.1	207.6	207.0	345.8	280.5	240.0	305.7	321.7	268.2	278.9	264.7	175.2	200.6	340.1	436.4	296.9	186.2	313.6	255.1	356.2	214.4	166.8	328.2	248.8	414.0	262.3	228.5	182.3	266.9	154.6	408.0	262.3	211.4	302.0	99.9	334.4	280.4	429.1	511.1	135.6	65.1	179.6	263.3	248.2	118.7	343.6	244.9	297.5	404.1	184.1	216.7	188.3	122.9	180.4	270.5	290.3	142.3	385.6	492.4	287.9	237.0	317.8	213.3	320.3	181.4	357.7	151.6	305.3	16.6	33.1	21.3	17.5	36.3	21.7	13.7	16.1	19.2	36.5	12.9	13.4	15.0	19.9	18.9	32.5	22.8	22.1	23.3	42.1	54.9	67.3	103.9	60.7	65.1	95.5	52.4	95.2	43.8	68.2	55.0	62.6	99.3	107.9	80.3	46.3	63.9	44.4	75.6	28.5	91.9	58.5	34.7	77.9	71.4	103.3	77.3	60.5	109.1	60.7	184.0	27.4	76.2	23.3	95.5	95.6	79.7	120.6	115.9	137.7	97.7	47.7	84.5	99.4	106.1	68.4	75.5	120.7	185.4	182.5	85.8	135.9	120.7	77.3	195.0	93.2	77.2	74.0	128.3	53.4	79.6	102.8	53.9	38.1	73.4	124.2	106.2	76.1	93.6	83.0	86.3	102.7	132.4	128.0	65.2	78.9	66.0	82.8	52.7	38.0	60.5	79.3	107.9	45.9	81.3	127.8	91.6
CNGA1	"CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49"	ENSG00000198515	"Cyclic nucleotide gated channel subunit alpha 1"	P29973	4	47935977-48016681	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"retina: 264.4"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 1139.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 4.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.2;RT4: 7.2;U-2 OS: 3.0"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.0"	"Not detected"	"Not detected"			HPA076168			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 79: Retina - Phototransduction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA076168: AB_2686781"	"unprognostic (2.68e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.48e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.23e-2)"	3.3	0.4	0.5	0.8	1.4	0.3	1.5	1.6	0.9	1.0	0.6	3.6	2.2	0.4	9.3	9.0	4.1	1.1	0.4	0.7	0.8	2.4	23.5	0.3	0.1	0.4	0.3	0.1	0.8	4.1	0.3	1.0	0.4	2.6	2.4	264.4	4.3	1.7	5.0	5.1	6.3	0.3	0.1	3.4	2.8	0.4	0.7	0.3	0.7	1.3	0.5	3.7	1.9	0.6	2.3	0.9	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	2.0	9.2	0.1	0.5	0.0	2.7	1.4	0.2	0.3	0.1	0.0	0.6	0.0	0.2	0.8	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.9	0.0	0.8	0.7	0.5	0.2	0.9	0.0	0.1	0.4	1.1	2.2	0.1	0.0	0.1	0.4	7.2	0.3	0.0	0.2	0.5	0.1	0.2	0.9	0.0	0.3	0.2	3.0	0.1	0.1	0.7	0.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.3	0.0	0.5	0.0	0.0	0.5	1.4	1.6	0.9	0.7	0.8	0.4	0.3	0.4	0.1	0.7	0.6	7.3	0.0	0.0	0.7	0.1	0.1	1.8	0.5	0.6	97.7	8.7	1.8	0.7	5.7	3.4	62.5	91.8	0.0	0.0	10.6	0.0	10.1	0.4	2.5	0.4	8.7	0.0	2.7	1.2	6.6	0.0	0.3	0.0	3.6	0.0	0.0	0.0	38.0	1.7	45.4	1.1	4.0	0.0	0.8	0.0	0.1	0.3	0.5	0.0	7.5	0.0	163.9	0.0	0.0	0.2	2.1	16.4	0.0	0.0	3.7	24.5	0.4	0.8	1139.7	0.0	0.6	17.1	0.6	1.3	10.3	2.7	0.3	0.2	0.1	4.7	35.1
CNGA3	"ACHM2, CCNC1, CCNCa, CNCG3, CNG3"	ENSG00000144191	"Cyclic nucleotide gated channel subunit alpha 3"	Q16281	2	98346188-98398601	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.7;intestine: 4.2;pituitary gland: 10.1;retina: 5.9"	"Cell type enriched"	"Detected in some"	14	"Cone photoreceptor cells: 43.8"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"U-87 MG: 6.8"	"Group enriched"	"Detected in some"	6	"basal ganglia: 1.8;hypothalamus: 1.9"	"Not detected"	"Not detected"			"HPA049378, CAB079025"	Approved	Approved				NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB079025: , HPA049378: AB_2732551"	"unprognostic (2.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.18e-1)"		"unprognostic (4.17e-4)"		"unprognostic (4.65e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.88e-1)"		"unprognostic (3.85e-3)"	"unprognostic (8.98e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.71e-2)"	0.1	0.0	0.6	0.5	0.5	0.0	0.2	0.2	0.8	0.0	2.9	4.2	1.0	0.0	0.0	1.5	0.4	0.0	0.0	0.7	5.6	0.1	0.0	0.1	0.0	3.4	1.5	0.0	0.3	0.0	10.1	0.0	3.6	0.0	1.1	5.9	0.2	0.2	0.0	0.0	1.3	0.8	5.7	0.0	0.9	0.5	1.3	0.0	0.0	0.0	0.0	0.6	0.1	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.2	0.8	0.7	5.6	3.4	1.5	3.6	5.7	1.3	4.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	43.8	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.1	0.0	0.0	3.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.9	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0
CNGB1	"CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45"	ENSG00000070729	"Cyclic nucleotide gated channel subunit beta 1"	Q14028	16	57882340-57971128	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Olfaction, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"retina: 600.2"	"Group enriched"	"Detected in some"	8	"Cone photoreceptor cells: 331.5;Rod photoreceptor cells: 1111.1"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.5;RPMI-8226: 1.8;SCLC-21H: 5.0;SiHa: 2.9;SK-BR-3: 1.4"	"Region enhanced"	"Detected in some"		"hypothalamus: 4.5"					"HPA039159, HPA060355"			Approved	Vesicles,Cytosol		No	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Vesicles	"HPA039159: AB_10795579, HPA060355: "	"unprognostic (5.52e-3)"	"unprognostic (4.51e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.56e-4)"	"unprognostic (3.08e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.14e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.01e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.57e-2)"	"unprognostic (9.07e-2)"	0.1	2.5	15.5	1.1	13.2	0.2	0.0	0.0	20.4	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.1	0.3	0.0	24.5	24.8	0.0	0.1	0.1	0.2	2.8	3.2	0.0	0.5	0.0	0.2	0.4	4.4	0.0	0.4	600.2	0.0	0.1	0.0	0.2	0.6	0.1	2.4	0.1	0.0	0.4	36.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.0	0.5	0.0	0.0	1.3	0.0	0.1	0.0	0.3	0.9	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.6	5.0	0.0	2.9	1.4	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.2	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	15.5	13.2	0.0	20.4	24.5	24.8	2.8	3.2	4.4	2.4	36.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.4	0.0	61.6	0.3	0.0	1.1	0.0	0.1	0.0	331.5	6.9	0.0	0.0	0.0	0.4	1.6	0.9	0.1	4.2	0.0	0.0	3.2	0.4	0.9	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.4	25.2	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	89.5	0.0	1.0	0.1	0.2	1.1	0.0	0.0	0.2	0.0	0.3	0.0	1111.1	0.0	0.1	0.2	0.5	0.7	0.0	0.0	1.4	0.1	0.1	0.0	0.2
CNGB3	"ACHM1, ACHM3, RMCH"	ENSG00000170289	"Cyclic nucleotide gated channel subunit beta 3"	Q9NQW8	8	86553977-86743675	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease variant, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.1;retina: 13.1"	"Cell type enriched"	"Detected in some"	13	"Cone photoreceptor cells: 158.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"SCLC-21H: 18.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057244	Enhanced					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA057244: AB_2683380"	"unprognostic (5.35e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.82e-1)"	"unprognostic (9.28e-2)"	"unprognostic (2.77e-4)"	"unprognostic (1.40e-4)"	"unprognostic (1.66e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.84e-1)"	0.0	0.0	0.2	0.3	0.3	4.1	0.0	1.2	0.5	0.2	1.7	0.1	0.5	0.2	0.1	0.0	0.9	0.0	0.2	0.3	0.2	0.1	0.0	0.0	0.2	0.1	0.4	0.4	0.6	0.0	0.0	0.1	0.2	0.1	0.0	13.1	0.3	0.0	0.1	1.2	0.1	0.0	0.1	0.1	0.3	2.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	1.3	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.3	0.0	1.0	18.9	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.2	0.5	0.3	0.2	0.1	0.4	0.2	0.1	0.1	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.0	0.0	158.4	0.1	1.3	0.0	0.0	0.0	5.6	0.1	0.6	0.2	0.0	0.0	2.4	0.0	0.0	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	11.4	0.0	0.1	0.0	1.0	0.2	1.5	0.0	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.1	0.1	1.6	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0
CNNM2	ACDP2	ENSG00000148842	"Cyclin and CBS domain divalent metal cation transport mediator 2"	Q9H8M5	10	102918294-103090222	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, Epilepsy, Mental retardation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 37.9;parathyroid gland: 31.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 60.1;Excitatory neurons: 112.6;Inhibitory neurons: 146.9;Oligodendrocyte precursor cells: 92.5;Oligodendrocytes: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059954, HPA071631"			Enhanced	Vesicles		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 16: U-266 - Nucleosome"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA059954: AB_2684177, HPA071631: AB_2686427"	"unprognostic (2.18e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.19e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.80e-2)"	"unprognostic (4.51e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (2.39e-8)"	"unprognostic (2.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.56e-1)"	3.3	11.5	5.1	2.3	5.5	9.3	2.5	7.9	5.7	3.7	37.9	7.0	3.8	3.6	2.1	1.7	4.8	4.1	2.1	4.2	3.3	9.1	4.8	3.8	1.5	4.9	4.8	4.8	3.6	31.6	5.7	8.7	4.7	2.7	6.4	5.0	3.0	3.0	1.6	4.5	4.5	3.7	1.8	2.1	3.3	4.5	4.6	1.8	5.6	1.5	1.1	3.2	2.9	9.7	5.0	8.1	3.1	8.5	7.8	3.2	8.6	2.3	9.7	3.1	3.9	5.8	4.3	1.9	3.5	3.4	6.0	6.3	6.9	4.6	2.4	3.3	12.1	2.8	4.2	11.8	4.6	2.0	3.6	4.2	6.6	3.2	10.7	7.9	1.9	5.5	4.8	10.9	1.8	8.6	2.3	2.2	5.1	4.9	5.0	5.5	4.0	2.4	2.4	2.9	4.5	5.8	5.9	1.3	6.3	9.1	10.4	3.7	1.6	4.2	6.2	3.0	4.2	11.7	14.1	3.6	7.4	6.6	1.7	0.3	0.1	0.1	0.2	0.2	0.2	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.2	1.5	0.0	0.3	0.3	0.1	5.1	5.5	7.9	5.7	4.2	3.3	4.9	4.8	4.7	1.8	4.6	9.7	3.0	6.4	8.4	60.1	7.9	2.4	2.3	1.7	6.8	16.4	3.3	2.4	4.5	2.8	5.6	5.5	12.5	18.8	8.1	46.7	1.9	2.2	10.7	7.4	4.2	4.2	6.7	6.7	112.6	5.4	3.4	6.3	12.8	6.4	3.8	13.7	3.3	6.1	3.8	32.0	146.9	5.0	0.0	3.2	2.5	15.1	3.4	4.7	7.2	39.4	2.3	7.0	2.1	92.5	92.3	2.3	9.0	3.4	6.2	2.0	11.7	5.5	9.5	15.8	13.1	5.7	16.7	15.5	6.9	8.1	4.1	39.8	5.1	3.8	11.6	2.2
CNNM4	"ACDP4, KIAA1592"	ENSG00000158158	"Cyclin and CBS domain divalent metal cation transport mediator 4"	Q6P4Q7	2	96760902-96811874	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Biomineralization, Ion transport, Sensory transduction, Transport, Vision"		"Amelogenesis imperfecta, Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 38.8"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 112.6;Distal enterocytes: 103.4;Rod photoreceptor cells: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017732	Enhanced		Uncertain	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Actin filaments"	"Plasma membrane"	"HPA017732: AB_1847395"	"unprognostic (1.98e-3)"	"unprognostic (8.95e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (3.42e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (8.75e-4)"	"unprognostic (4.75e-3)"	"unprognostic (3.72e-1)"	"unprognostic (8.14e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.06e-1)"	2.8	3.6	5.0	6.1	6.8	4.9	7.0	11.2	5.4	5.8	2.8	32.4	6.2	4.0	4.7	7.1	10.4	4.4	12.5	4.9	4.4	6.8	4.4	8.0	4.6	4.1	4.5	5.1	7.4	6.3	9.1	5.8	4.2	5.7	34.3	38.8	6.8	5.1	24.8	7.2	11.3	4.7	3.5	5.3	12.8	7.9	4.5	3.5	9.5	13.1	4.9	5.5	6.4	5.7	11.1	7.2	5.7	10.5	5.8	3.9	15.6	4.8	6.8	6.9	9.3	13.2	11.8	8.1	13.5	5.0	9.5	14.1	14.9	8.1	6.3	16.3	11.7	6.4	4.8	7.2	8.1	3.1	6.2	3.8	10.0	11.0	6.6	4.6	3.8	8.0	3.3	22.3	3.6	15.7	6.6	4.5	7.5	20.5	9.8	9.7	2.6	9.3	6.9	8.6	26.7	8.0	9.1	45.7	6.8	15.9	22.3	5.3	3.4	4.0	8.9	8.8	5.4	7.7	6.6	4.0	5.9	6.1	7.2	1.2	0.4	0.1	0.8	0.4	0.2	0.9	0.4	0.4	0.6	0.5	0.2	0.5	0.2	0.2	0.7	0.4	0.2	0.3	5.0	6.8	11.2	5.4	4.9	4.4	4.1	4.5	4.2	3.5	4.5	5.7	4.5	38.5	7.7	12.4	6.4	5.7	4.9	4.0	4.6	43.1	14.7	11.2	14.1	4.3	11.6	7.3	112.6	5.4	6.1	103.4	0.0	3.2	4.9	14.3	4.4	4.0	10.1	0.8	9.8	4.2	1.7	3.2	12.2	16.1	1.3	5.9	2.2	3.3	3.3	33.7	8.3	26.4	6.1	5.4	4.8	1.6	0.9	5.9	0.0	8.4	2.3	8.3	2.1	11.1	14.6	5.2	21.3	1.2	4.5	4.1	22.3	1.2	10.6	51.5	0.0	4.6	4.3	4.6	2.5	7.3	4.1	6.7	5.4	6.7	26.5	6.1
CNTN2	"AXT, TAG-1, TAX, TAX1"	ENSG00000184144	"Contactin 2"	Q02246	1	205042937-205078289	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"		Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 248.9"	"Cell type enriched"	"Detected in some"	11	"Oligodendrocytes: 335.5"	"Cancer enriched"	"Detected in some"	9	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 3.9;SCLC-21H: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001397, HPA012497"	Approved				"Secreted in brain"	NA	NA		58000		"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA001397: AB_1847146, HPA012497: AB_1847147"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.52e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.43e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.44e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.73e-7)"	"unprognostic (9.82e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.07e-2)"	0.3	0.5	82.6	0.4	145.4	0.0	0.1	125.7	112.4	0.6	32.4	2.1	0.1	0.0	0.0	0.2	0.1	0.1	0.7	85.2	96.6	0.1	0.0	0.0	0.0	161.6	128.1	0.0	0.1	0.0	8.0	0.0	139.8	0.3	0.5	1.2	0.4	0.6	0.0	0.5	0.9	0.2	110.1	0.1	0.5	6.1	125.7	0.1	0.1	0.0	0.3	0.2	0.7	248.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.6	145.4	125.7	112.4	85.2	96.6	161.6	128.1	139.8	110.1	125.7	248.9	0.4	0.0	0.6	1.3	0.1	0.0	0.0	0.0	0.0	2.4	0.9	1.3	3.7	0.0	0.6	1.8	0.0	0.0	1.2	0.0	0.0	0.6	13.7	0.6	0.5	0.5	0.0	0.0	18.4	0.6	0.0	0.4	0.0	1.2	0.0	2.6	0.0	0.0	0.0	3.3	16.0	0.0	0.0	0.0	0.0	29.0	0.6	0.5	0.0	4.7	0.0	0.2	0.0	9.5	335.5	0.6	0.0	0.0	0.4	0.0	0.0	0.3	1.5	0.8	0.0	0.0	0.3	3.2	0.6	0.0	0.0	0.0	0.5	0.2	0.0	0.2
COASY	"DPCK, NBP, PPAT"	ENSG00000068120	"Coenzyme A synthase"	Q13057	17	42561467-42566277	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022875, HPA022912, HPA023273"	Approved				"Intracellular and membrane"	NA	NA		20000	"Cluster 44: Non-specific - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 40: Granulosa cells - Unknown function"			"HPA022875: AB_1847066, HPA022912: AB_1847067, HPA023273: AB_1847068"	"unprognostic (2.83e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.81e-1)"	"prognostic favorable (2.15e-4)"	"unprognostic (1.01e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (7.54e-5)"	"unprognostic (4.06e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.55e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.16e-1)"	27.4	60.0	24.0	23.1	24.0	29.5	32.8	24.7	28.1	27.6	26.7	35.6	43.3	25.2	17.2	54.4	29.8	16.9	29.4	25.4	23.9	45.6	70.9	30.3	25.0	27.8	24.7	26.0	59.0	39.0	30.3	25.5	28.1	32.4	24.3	13.3	58.5	28.7	38.6	46.6	36.9	17.2	23.8	35.9	47.2	32.4	25.7	27.6	39.0	25.3	25.2	26.8	31.1	24.6	94.2	149.1	27.2	55.2	55.5	34.8	89.2	38.3	52.9	65.8	46.5	85.7	89.2	52.7	65.6	50.4	69.5	146.9	66.1	81.4	43.7	47.6	122.2	52.5	91.2	140.9	70.2	56.4	73.1	51.5	97.8	62.4	66.6	52.4	63.2	70.5	98.7	70.8	46.6	59.2	71.5	87.2	36.7	125.8	75.1	39.1	93.5	88.1	89.9	66.7	63.3	50.1	34.9	37.3	75.4	52.2	158.0	70.4	41.6	68.3	62.3	52.4	40.1	84.6	127.4	31.0	80.9	55.3	47.5	23.3	29.8	26.8	19.7	31.8	20.5	15.8	15.8	19.1	33.6	15.7	15.7	16.3	19.5	21.0	22.5	23.6	18.1	24.0	24.0	24.0	24.7	28.1	25.4	23.9	27.8	24.7	28.1	23.8	25.7	24.6	15.4	6.4	23.8	9.8	24.1	15.0	21.7	49.5	25.6	17.8	38.2	22.9	22.9	40.0	33.3	71.7	0.0	89.4	21.2	53.7	33.2	44.8	4.4	31.5	20.6	20.6	17.4	30.3	5.6	52.5	51.6	18.7	40.2	28.0	10.2	101.2	23.9	94.2	40.3	33.7	5.7	36.7	42.7	23.6	16.1	7.7	14.9	19.9	14.2	4.7	36.2	29.4	20.6	3.5	5.9	38.9	32.4	16.6	25.3	31.2	66.3	94.8	36.5	18.0	26.3	15.2	18.6	46.7	31.1	33.4	17.8	77.2	16.9	36.6	45.1	30.7
COCH	"COCH-5B2, DFNA31, DFNA9"	ENSG00000100473	Cochlin	O43405	14	30874514-30895065	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Hearing		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"pancreas: 502.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 63.0;Horizontal cells: 84.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 71.3"	"Group enriched"	"Detected in some"	12	"memory B-cell: 38.3;naive B-cell: 17.7"	"Lineage enriched"	"Detected in many"	17	"B-cells: 38.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 95.7;Hep G2: 63.8;K-562: 129.1;NB-4: 105.5;SCLC-21H: 111.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 50.8"	HPA065086			Supported	Vesicles	"Secreted in other tissues"	NA	NA		160000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA065086: "	"unprognostic (8.36e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.91e-3)"	"unprognostic (5.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-1)"	3.2	3.7	7.3	2.8	71.3	4.0	3.4	1.4	20.9	17.4	19.0	3.2	0.8	0.6	2.2	0.9	6.2	2.9	1.9	5.6	8.0	5.2	0.5	0.6	11.0	2.9	7.9	0.8	502.0	3.4	10.1	1.9	3.7	48.3	2.2	12.1	3.6	73.4	1.3	15.2	2.6	1.1	6.2	2.6	1.7	5.2	12.5	1.3	1.3	5.0	7.7	2.0	23.0	1.7	0.0	35.3	3.1	0.0	0.6	0.1	21.8	0.2	0.0	6.4	17.1	20.9	1.2	0.4	1.7	0.0	1.3	0.1	22.2	0.0	10.6	0.0	95.7	18.1	7.6	63.8	0.0	1.8	7.3	1.3	0.0	0.6	0.0	0.0	0.3	39.9	129.1	5.1	1.6	0.8	9.2	105.5	11.9	0.1	3.7	26.7	0.0	0.9	1.1	3.4	111.8	30.4	2.6	0.6	0.2	12.1	0.0	48.7	0.9	0.0	0.0	0.3	0.1	5.7	15.8	11.2	0.0	0.0	4.7	0.0	0.6	0.0	0.0	0.0	0.0	38.3	0.3	0.0	0.1	17.7	0.0	0.1	0.2	0.0	0.0	0.0	2.2	1.0	7.3	71.3	1.4	20.9	5.6	8.0	2.9	7.9	3.7	6.2	12.5	1.7	2.0	0.0	0.5	3.6	13.4	19.1	2.3	0.3	0.0	2.7	7.9	1.5	0.8	2.8	0.9	0.0	4.2	6.5	1.3	0.6	1.9	0.5	1.5	2.2	0.8	3.1	17.0	7.4	14.3	63.0	14.3	22.0	1.1	1.0	1.3	1.8	5.0	5.0	3.8	84.1	24.2	0.3	6.1	5.0	25.2	2.0	1.5	2.4	19.6	7.5	2.8	14.5	0.0	6.0	16.5	3.7	4.3	6.0	10.0	3.5	0.2	11.7	0.5	4.0	0.0	2.8	9.0	22.1	20.3	0.1	13.5	6.6	3.3	0.1	0.6	1.7
COLGALT1	"FLJ22329, GLT25D1"	ENSG00000130309	"Collagen beta(1-O)galactosyltransferase 1"	Q8NBJ5	19	17555649-17583162	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 76.2;Hofbauer cells: 91.0;Kupffer cells: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047821	Approved		Approved	Vesicles	"Intracellular and membrane"	No	No		9700	"Cluster 7: Monocytes - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA047821: AB_2680168"	"unprognostic (2.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (2.92e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (3.83e-4)"	38.6	14.3	5.9	38.1	6.9	32.9	27.5	7.9	8.4	31.1	10.6	27.7	16.2	28.4	4.4	17.9	26.5	19.0	22.4	7.1	9.1	12.7	16.3	34.9	29.7	12.1	9.3	23.5	15.8	9.0	10.1	40.9	12.3	15.5	15.2	3.2	15.9	16.3	15.1	23.9	24.7	35.4	7.6	39.5	18.2	11.9	18.9	9.9	14.7	7.5	15.8	28.1	22.8	12.6	103.1	118.0	56.7	79.8	222.3	136.3	90.9	95.9	55.1	121.8	125.9	90.4	159.6	53.0	164.7	166.9	104.2	91.5	58.4	110.6	73.4	29.5	94.9	51.2	147.4	87.9	121.6	123.0	147.8	115.2	97.6	136.7	56.7	49.7	138.8	33.3	105.5	25.8	45.1	45.6	61.9	81.1	43.0	75.8	115.3	65.2	73.8	80.9	26.4	67.2	41.2	29.9	102.8	80.6	97.0	36.7	41.9	177.7	98.7	240.8	67.7	215.3	156.2	45.4	125.1	58.3	142.7	232.4	113.0	1.7	25.7	12.5	5.2	28.1	2.8	3.5	4.8	4.9	18.1	3.3	3.4	5.3	3.6	2.1	20.8	7.0	3.1	14.5	5.9	6.9	7.9	8.4	7.1	9.1	12.1	9.3	12.3	7.6	18.9	12.6	35.0	19.2	23.5	11.1	10.3	19.5	7.0	10.4	10.8	3.7	8.8	9.5	11.2	10.0	15.5	11.0	6.2	7.9	28.6	14.7	0.0	13.1	3.6	8.5	28.5	29.3	5.4	10.3	10.9	8.2	76.2	30.9	20.9	13.6	8.8	20.3	7.9	14.2	91.0	13.5	9.9	15.1	4.1	70.7	24.1	3.1	19.0	59.6	17.8	19.7	26.6	2.3	10.3	6.6	12.8	10.4	7.6	21.8	6.0	9.5	9.5	4.4	8.7	3.6	13.1	9.5	24.3	2.5	13.1	13.8	20.9	8.3	12.0	24.9	18.2	8.4
COQ2	"CL640, FLJ26072"	ENSG00000173085	"Coenzyme Q2, polyprenyltransferase"	Q96H96	4	83261536-83284914	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Disease variant, Neurodegeneration, Parkinsonism, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 37.5"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 50.7;Kupffer cells: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056599, HPA068727"	Approved		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA056599: AB_2683184, HPA068727: AB_2686022"	"unprognostic (8.26e-2)"	"unprognostic (7.40e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.09e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.46e-1)"	6.0	17.0	2.8	8.0	3.2	11.8	5.8	3.5	3.3	7.9	3.6	14.2	9.5	6.3	7.5	10.4	4.4	4.3	15.0	3.0	3.5	5.6	13.6	7.9	6.4	3.6	3.5	6.5	6.5	6.0	4.0	8.4	3.8	6.6	14.2	4.0	7.8	5.0	29.1	10.8	9.1	6.9	4.1	10.1	5.5	3.5	3.9	3.6	5.7	37.5	7.1	7.9	6.5	4.9	26.1	14.7	14.1	27.4	10.5	11.9	9.7	16.1	27.0	29.7	34.4	10.5	38.7	17.2	11.7	28.4	24.6	18.6	23.9	26.0	38.7	17.2	14.8	15.3	22.3	15.4	11.7	31.3	73.5	15.9	16.3	14.2	24.8	8.9	30.7	9.7	10.0	21.4	29.3	27.4	8.6	21.7	10.9	30.6	19.9	14.1	11.4	22.1	45.4	13.8	10.3	6.3	19.0	24.5	9.2	6.7	15.4	18.8	21.0	14.6	14.6	11.1	23.4	5.7	5.2	10.2	29.5	36.8	20.2	2.1	28.8	4.0	2.7	26.8	1.9	6.2	3.0	2.5	21.1	6.9	2.1	3.2	9.8	6.7	33.5	11.2	4.1	13.6	2.8	3.2	3.5	3.3	3.0	3.5	3.6	3.5	3.8	4.1	3.9	4.9	5.4	0.0	4.2	15.7	11.5	6.6	12.4	9.8	4.6	5.9	6.3	5.6	19.5	2.8	10.7	9.2	0.0	25.4	7.1	14.0	31.3	6.7	0.8	7.6	19.5	6.1	4.8	14.1	12.8	10.8	30.0	9.0	6.6	9.2	0.0	17.2	9.3	15.0	50.7	1.7	20.1	15.3	8.2	53.2	7.9	0.8	3.7	25.2	7.2	33.7	21.8	12.6	6.2	25.6	15.6	5.4	15.4	4.9	4.3	12.6	11.0	9.9	6.2	4.8	0.0	7.3	9.7	18.1	19.7	16.7	12.6	12.4	9.6	35.5	26.7	12.9
COQ7	"CAT5, CLK-1"	ENSG00000167186	"Coenzyme Q7, hydroxylase"	Q99807	16	19067614-19080095	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubiquinone biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 40.4;neutrophil: 126.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 126.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067252, HPA071922"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	Nucleoplasm	"HPA067252: AB_2685813, HPA071922: AB_2686473"	"unprognostic (1.37e-1)"	"unprognostic (6.89e-3)"	"unprognostic (1.59e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.44e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.27e-3)"	"unprognostic (2.15e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (8.23e-12)"	"unprognostic (2.19e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.27e-2)"	10.2	13.6	10.7	7.0	11.2	4.8	13.4	10.9	11.6	10.8	12.5	14.1	12.4	15.6	12.3	12.4	15.5	10.7	23.4	11.0	10.8	14.1	12.3	10.0	8.3	10.6	11.3	20.0	10.3	24.4	9.7	10.0	11.1	17.7	13.2	14.0	10.4	14.7	45.8	7.9	11.8	11.6	10.4	10.0	12.8	20.9	11.3	10.3	16.2	44.9	8.4	10.3	8.8	13.1	23.5	24.8	21.1	12.4	11.6	12.2	17.7	13.5	11.0	18.0	18.5	15.9	19.1	17.8	63.9	10.4	19.4	24.5	29.6	16.9	13.0	15.2	29.9	9.5	22.8	49.3	14.4	22.9	20.1	10.3	14.6	16.8	12.2	14.8	14.8	20.9	26.4	16.2	12.9	42.4	24.0	18.4	16.1	9.1	13.1	29.0	23.3	22.8	15.7	15.5	30.4	17.4	12.6	27.4	16.2	10.2	25.2	30.7	16.3	19.0	10.9	14.1	19.7	15.0	26.2	19.7	20.4	13.1	12.5	40.4	11.4	17.8	9.9	10.6	9.4	16.3	8.9	8.7	12.6	15.3	12.2	10.8	126.5	12.9	12.3	15.6	6.2	5.6	10.7	11.2	10.9	11.6	11.0	10.8	10.6	11.3	11.1	10.4	11.3	13.1	13.3	16.0	12.6	6.2	35.5	11.0	26.3	20.9	13.6	31.2	18.3	21.1	21.8	31.5	14.9	16.5	39.6	21.2	28.7	38.1	45.0	25.2	14.8	23.7	16.2	16.1	24.0	4.8	6.0	18.0	17.9	14.9	32.1	23.2	25.4	31.1	20.7	11.1	23.3	20.2	8.8	39.0	30.5	29.4	12.9	8.5	18.6	18.8	10.6	4.7	11.6	39.5	8.2	5.0	9.4	13.2	30.4	13.9	11.6	17.8	71.5	23.7	24.4	53.9	19.7	20.0	20.2	81.3	53.1	12.8	12.4	32.2	23.9	38.2	39.8	24.0
COQ8A	"ADCK3, CABC1, COQ8, SCAR9"	ENSG00000163050	"Coenzyme Q8A"	Q8NI60	1	226940286-226987544	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Kinase, Transferase"	"Disease variant, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skeletal muscle: 1165.1;tongue: 484.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 21.9;Collecting duct cells: 33.1;Ductal cells: 21.2;Exocrine glandular cells: 32.7;Proximal tubular cells: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 82.0;RPMI-8226: 78.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061662			Supported	Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA061662: AB_2684578"	"unprognostic (6.37e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.15e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.62e-1)"	63.9	123.8	7.1	10.3	8.0	26.1	35.8	17.3	8.1	16.5	16.1	30.8	29.9	15.9	0.5	32.2	24.6	19.7	123.5	7.1	5.6	14.4	35.7	9.6	12.7	8.9	5.4	34.1	93.8	6.4	5.3	6.5	9.8	18.5	6.4	1.3	32.7	11.7	1165.1	25.1	18.5	7.2	5.9	14.4	52.8	6.7	5.9	8.6	9.4	484.7	4.3	40.8	13.4	11.5	8.0	14.4	3.3	10.3	11.4	7.3	57.7	3.6	2.9	5.2	6.9	23.0	12.8	24.5	17.9	2.4	2.6	9.2	6.9	8.2	0.8	25.5	82.0	16.7	11.2	38.8	2.5	25.8	9.3	14.2	12.2	4.0	5.4	4.9	2.5	24.7	29.4	19.4	0.7	11.0	15.2	37.3	15.5	62.8	29.5	14.9	17.1	78.6	1.6	5.9	59.9	24.2	7.3	28.7	20.6	3.4	15.1	34.8	2.5	5.9	5.3	8.2	13.3	43.0	40.5	13.1	5.3	29.3	6.0	47.7	23.5	68.4	15.8	17.1	15.3	22.2	15.8	14.6	18.6	26.8	21.5	17.0	43.1	21.2	13.6	8.1	21.5	26.0	7.1	8.0	17.3	8.1	7.1	5.6	8.9	5.4	9.8	5.9	5.9	11.5	11.4	3.2	21.9	0.0	5.8	0.0	0.0	0.0	0.0	0.0	18.1	17.1	0.0	0.0	4.3	33.1	0.0	12.2	10.2	0.0	15.6	21.2	0.0	12.3	8.9	5.4	0.0	0.0	0.0	32.7	10.0	6.3	0.0	9.6	13.9	9.8	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	11.4	0.0	0.0	0.0	0.0	10.8	0.0	0.0	3.2	0.0	0.0	24.8	2.2	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	7.7	5.2	16.0	0.0	0.0
COQ8B	"ADCK4, COQ8, FLJ12229"	ENSG00000123815	"Coenzyme Q8B"	Q96D53	19	40691514-40725784	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 16.5;Endometrial ciliated cells: 16.4;Theca cells: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027229, HPA027277, HPA027279, HPA028303"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA027229: AB_10600100, HPA027277: AB_10599857, HPA027279: AB_10601219, HPA028303: AB_2672551"	"unprognostic (7.57e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.65e-2)"	15.1	25.2	10.1	5.7	10.7	5.9	15.3	10.4	12.8	23.4	10.9	19.4	9.7	22.0	2.3	16.0	29.8	7.6	21.9	9.8	10.6	21.0	25.7	16.4	6.0	10.6	10.8	22.5	20.7	8.4	49.3	3.5	10.3	23.2	2.3	1.3	16.9	7.3	14.4	20.2	17.8	3.8	11.2	18.3	23.9	17.3	10.6	8.8	23.3	8.6	3.3	20.3	18.4	10.5	9.9	39.5	7.9	18.5	7.8	6.1	8.5	6.6	7.8	5.6	5.1	15.4	14.3	13.8	20.0	4.3	7.8	9.8	7.0	10.5	2.0	20.0	10.4	11.6	12.7	6.4	12.1	4.1	19.2	8.4	10.6	5.4	5.4	5.2	7.4	13.7	7.7	8.1	6.0	6.4	4.9	5.7	6.4	11.5	3.6	11.5	13.1	12.4	15.7	17.6	15.1	11.0	12.5	20.4	21.0	4.4	22.8	17.1	9.4	5.1	20.6	3.9	5.5	9.4	9.0	7.3	27.8	5.2	9.1	10.2	9.4	8.7	6.7	9.3	8.3	7.1	5.5	7.8	9.9	5.9	4.6	5.1	9.0	6.9	9.2	4.6	4.9	7.3	10.1	10.7	10.4	12.8	9.8	10.6	10.6	10.8	10.3	11.2	10.6	10.5	8.5	12.8	3.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	11.6	8.0	0.0	0.0	2.5	12.9	0.0	11.1	6.8	0.0	11.7	16.5	0.0	16.4	7.8	1.7	0.0	0.0	0.0	10.9	9.8	5.0	0.0	10.3	1.3	11.7	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	9.5	0.0	0.0	1.2	0.0	0.0	13.0	8.7	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	9.4	3.2	19.8	0.0	0.0
CORIN	"ATC2, CRN, Lrp4, PRSC, TMPRSS10"	ENSG00000145244	"Corin, serine peptidase"	Q9Y5Q5	4	47593999-47838106	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"heart muscle: 56.9"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 69.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC TERT1: 44.0"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.6"	"Low region specificity"	"Detected in some"			HPA070941			Approved	"Nuclear bodies,Plasma membrane,Actin filaments"	"Intracellular and membrane"	Yes	No				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Nuclear bodies, Actin filaments"	"HPA070941: AB_2686324"	"unprognostic (1.05e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.58e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.22e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.33e-2)"	0.4	0.1	0.1	0.1	0.1	0.0	1.0	0.1	0.2	2.1	0.6	0.3	0.1	4.5	0.6	0.9	1.4	4.5	56.9	0.0	0.3	1.0	0.1	1.9	0.0	0.7	0.6	0.5	0.2	1.1	1.9	0.4	0.1	2.3	0.0	0.3	0.4	6.1	0.1	7.5	0.3	0.7	0.1	1.1	0.5	2.5	0.3	0.1	0.1	0.1	0.1	1.2	3.9	0.1	0.0	0.0	0.1	0.3	10.3	44.0	0.0	2.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	2.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	1.4	0.0	0.3	0.2	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.3	0.7	0.6	0.1	0.1	0.3	0.1	0.3	0.0	7.5	1.0	0.0	3.8	0.3	0.0	0.0	1.0	8.3	0.3	69.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.1	1.3	1.0	0.0	0.0	6.5	0.0	0.0	9.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	10.8	0.0	0.0	0.6	5.5	2.0	4.7	0.1	5.4	1.0	0.0	0.7	0.0	2.0	3.9	0.0	0.0	2.6	0.0	0.6	0.0	0.2	0.0	0.3	0.0	0.3	2.3	4.6	4.4	0.1	2.7	0.0	0.6	0.1	0.0	0.3
COX10		ENSG00000006695	"Cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10"	Q12887	17	14069490-14231736	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Heme biosynthesis"	Transferase	"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 44.5;tongue: 44.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 88.2;Late spermatids: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032005, HPA032006"	Supported		Supported	Nucleoli,Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	"Nucleoli, Cytosol"	"HPA032005: AB_10603560, HPA032006: AB_10670554"	"unprognostic (6.17e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.40e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.46e-3)"	"unprognostic (6.46e-2)"	"prognostic favorable (4.32e-6)"	"prognostic favorable (8.73e-4)"	"unprognostic (8.82e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.71e-2)"	7.1	7.5	3.1	5.4	2.9	10.4	6.0	4.1	4.4	5.8	4.3	12.5	12.5	5.2	4.4	10.9	5.6	4.2	27.9	3.3	3.9	11.6	10.6	4.4	5.8	3.8	3.5	4.5	9.9	9.6	3.3	7.0	3.5	5.6	12.3	5.6	7.2	5.5	44.5	7.4	10.1	7.2	3.0	4.8	9.3	21.1	4.0	5.4	6.2	44.3	7.5	8.5	6.6	3.6	10.1	19.7	7.7	11.9	7.7	5.6	19.5	12.3	8.4	21.9	14.6	16.3	6.6	23.5	9.8	13.0	6.8	20.2	16.6	16.3	17.3	13.1	15.7	14.5	12.4	20.0	14.2	15.5	12.3	9.8	19.5	14.0	17.6	7.9	11.4	15.8	20.4	8.2	9.5	13.1	13.5	10.5	12.8	37.6	9.5	10.3	28.8	18.5	15.2	20.1	5.2	9.8	12.0	18.5	16.5	36.1	9.6	9.2	9.9	8.9	8.0	9.9	15.8	10.1	15.6	11.2	14.9	15.7	11.9	3.8	11.3	4.4	9.8	16.1	10.6	13.2	11.3	10.5	14.9	9.2	11.9	11.5	1.2	10.0	13.9	4.6	20.1	11.0	3.1	2.9	4.1	4.4	3.3	3.9	3.8	3.5	3.5	3.0	4.0	3.6	5.9	0.0	14.7	25.8	9.6	9.7	9.5	9.8	14.2	7.5	8.7	7.4	88.2	5.7	7.3	11.0	10.4	19.7	5.7	13.8	41.1	9.1	41.1	9.6	9.6	7.8	12.6	13.3	33.5	8.7	17.5	8.8	16.3	9.4	5.1	7.5	3.9	9.6	10.8	0.0	43.0	16.4	8.2	4.4	4.7	81.0	2.1	6.7	5.4	22.5	6.3	4.6	8.2	34.7	26.9	8.8	11.4	6.8	12.5	8.7	26.6	17.8	5.8	12.2	0.0	5.2	12.5	22.8	19.2	19.4	10.4	16.1	8.6	6.6	18.9	13.7
COX4I1	"COX4, COX4-1"	ENSG00000131143	"Cytochrome c oxidase subunit 4I1"	P13073	16	85798633-85807068	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Oxidoreductase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002485, CAB004080"	Supported		Supported	Mitochondria		NA	NA		55000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB004080: AB_2085427, HPA002485: AB_1078559"	"unprognostic (4.73e-2)"	"unprognostic (9.14e-3)"	"unprognostic (2.65e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.82e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.29e-1)"	"prognostic favorable (2.56e-8)"	"unprognostic (4.23e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.38e-2)"	473.1	393.5	874.4	232.5	881.4	583.2	437.1	896.5	971.9	373.1	882.6	690.5	585.9	301.8	478.8	597.2	355.8	246.9	2047.0	869.5	909.5	632.7	611.2	318.6	412.8	896.4	891.1	366.2	490.4	900.7	362.1	256.7	908.6	377.1	707.7	261.2	421.2	312.3	1333.3	552.5	529.5	301.4	877.2	405.9	650.3	191.1	922.9	479.9	361.5	2063.3	538.7	422.6	420.9	881.0	433.7	677.7	460.2	616.8	823.6	761.2	785.7	379.6	771.2	702.3	346.7	1170.2	636.6	698.6	454.2	610.5	389.9	855.1	657.2	765.3	622.2	238.7	678.1	392.9	554.8	1093.8	741.9	362.9	282.0	893.1	1162.8	579.2	786.0	739.1	746.4	563.6	672.3	280.4	602.5	1510.6	730.9	1116.7	623.0	954.1	796.3	816.9	287.5	616.7	1066.7	840.2	543.2	441.1	807.4	513.2	656.2	489.6	753.2	996.6	529.9	355.5	409.5	330.7	419.0	561.4	562.5	1646.3	542.4	702.2	410.6	633.9	1373.2	805.2	700.3	1199.6	868.1	1302.9	930.5	833.2	1480.8	1231.2	1169.3	968.8	513.9	840.6	1089.3	1105.6	1106.1	2815.9	874.4	881.4	896.5	971.9	869.5	909.5	896.4	891.1	908.6	877.2	922.9	881.0	552.0	275.7	398.1	45.1	925.3	1129.4	1242.3	2031.6	1121.8	280.2	1365.2	1553.2	3479.9	1086.6	942.3	632.7	131.3	1223.1	714.3	1863.5	2752.8	1091.1	539.4	480.5	468.0	629.7	1009.6	524.6	44.0	1316.2	1094.7	591.2	813.0	575.6	521.4	554.3	660.7	1314.7	1602.3	212.0	51.7	1782.5	1125.0	1488.5	1376.5	1155.4	498.9	1010.5	1145.5	35.6	1451.7	562.9	785.8	35.7	65.5	1463.7	1950.7	357.7	726.2	1370.7	3811.3	2936.3	545.4	349.9	355.0	481.8	678.0	358.6	321.7	1721.9	1361.7	1481.9	816.5	1020.3	2147.9	1941.7
COX4I2	"COX4-2, COX4B, COX4L2, COXIV-2, dJ857M17.2"	ENSG00000131055	"Cytochrome c oxidase subunit 4I2"	Q96KJ9	20	31637912-31645006	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 49.1;placenta: 115.4"	"Group enriched"	"Detected in some"	5	"Sertoli cells: 414.2;Smooth muscle cells: 191.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"SH-SY5Y: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (2.64e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.51e-2)"	"prognostic favorable (6.04e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (9.78e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.59e-2)"	19.1	1.1	6.7	1.7	6.7	0.0	15.9	6.5	9.1	4.8	6.1	4.7	1.9	7.5	3.9	5.4	4.9	10.6	39.7	6.5	6.7	10.9	1.1	49.1	4.7	6.8	7.0	2.9	2.3	9.3	2.2	115.4	7.0	10.1	2.7	1.1	3.6	4.7	8.7	4.9	5.8	7.1	6.6	1.7	4.2	1.5	7.0	1.8	14.7	19.4	3.0	7.7	6.7	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	6.7	6.5	9.1	6.5	6.7	6.8	7.0	7.0	6.6	7.0	6.6	55.0	0.0	0.0	0.0	0.5	6.4	0.3	0.0	2.2	0.4	0.9	1.9	2.7	0.0	0.0	0.0	0.0	1.1	0.3	0.1	0.0	0.0	0.2	0.1	0.7	23.5	0.0	0.0	0.0	0.0	0.3	9.5	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	7.5	0.7	3.7	0.5	8.8	2.8	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.7	414.2	4.6	191.6	0.1	1.0	0.8	6.7	2.5	1.0	1.0	0.0	0.3
COX5A		ENSG00000178741	"Cytochrome c oxidase subunit 5A"	P20674	15	74919791-74938083	"Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1749.5;skeletal muscle: 1609.7;tongue: 1735.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1645.3;Distal tubular cells: 1475.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027526	Supported					NA	NA		530000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA027526: AB_10602802"	"unprognostic (7.32e-2)"	"prognostic favorable (2.15e-4)"	"unprognostic (4.06e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.79e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.62e-2)"	"prognostic favorable (6.06e-7)"	"unprognostic (9.78e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.81e-3)"	175.6	176.7	187.1	105.1	189.5	148.5	150.8	231.1	258.1	109.8	201.3	454.2	326.9	98.2	110.7	293.0	89.3	67.8	1749.5	193.1	229.3	373.5	349.6	133.0	125.6	216.1	207.5	71.1	259.3	385.3	141.1	88.0	208.8	118.4	398.2	194.1	211.2	99.2	1609.7	169.0	269.6	95.0	194.8	150.8	306.8	217.8	220.4	150.7	141.5	1735.8	197.9	141.2	146.3	193.8	300.4	309.1	376.8	331.1	227.2	260.2	443.1	262.7	222.3	317.7	294.8	346.0	352.1	700.0	322.0	219.5	387.8	567.7	898.3	368.4	263.7	401.0	906.2	566.6	299.7	436.0	283.9	642.7	335.0	266.6	389.9	198.3	445.1	217.4	377.7	450.0	522.2	429.9	321.2	222.4	558.8	494.6	408.7	575.8	540.1	499.0	369.7	778.4	469.8	472.4	570.5	250.1	396.6	569.2	871.3	407.6	286.3	507.6	274.3	241.4	238.7	303.9	421.1	508.4	1000.3	759.0	258.2	836.1	224.5	332.4	361.5	210.2	198.1	465.6	238.6	296.4	242.4	235.7	452.9	227.3	171.6	198.0	87.4	354.9	432.7	365.2	372.6	426.4	187.1	189.5	231.1	258.1	193.1	229.3	216.1	207.5	208.8	194.8	220.4	193.8	120.7	99.3	119.6	20.5	166.6	158.2	235.3	623.6	151.4	113.4	202.6	313.4	1645.3	221.6	324.0	171.0	39.6	502.8	162.7	987.6	1475.2	407.5	1046.3	199.4	124.3	163.8	461.4	227.3	18.9	436.7	528.2	156.3	247.2	192.8	104.0	143.3	117.8	471.8	571.5	92.5	25.1	890.5	496.4	286.0	209.1	819.6	100.3	238.6	250.8	17.8	413.7	159.9	162.7	15.6	20.2	412.1	817.3	85.7	350.7	319.3	1276.3	921.7	242.7	176.8	92.1	139.6	590.9	523.0	253.6	371.3	159.0	511.0	144.2	216.5	1045.6	393.3
COX6A2		ENSG00000156885	"Cytochrome c oxidase subunit 6A2"	Q02221	16	31427731-31428360	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Oxidoreductase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	46	"heart muscle: 3905.3;skeletal muscle: 6742.0;tongue: 2096.1"	"Cell type enriched"	"Detected in some"	18	"Cardiomyocytes: 4861.8"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 9.3;liver cancer: 2.9;prostate cancer: 3.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	150	"NK-cell: 15.0"	"Lineage enriched"	"Detected in single"	150	"NK-cells: 15.0"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 13.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 16: U-266 - Nucleosome"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (1.66e-1)"	"unprognostic (1.73e-3)"			"unprognostic (2.09e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.68e-2)"		"unprognostic (3.88e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.65e-1)"			1.9	0.9	1.8	0.1	1.3	0.0	2.9	2.3	2.3	0.4	0.2	1.4	1.1	1.0	0.0	74.8	0.9	0.0	3905.3	0.9	2.1	4.5	15.9	3.3	0.4	1.6	2.6	1.2	3.0	2.9	11.9	0.1	7.3	38.9	0.0	1.0	92.1	0.1	6742.0	3.5	1.2	0.0	0.8	0.5	1.3	1.3	2.6	0.5	2.0	2096.1	0.1	0.3	1.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.1	1.8	1.3	2.3	2.3	0.9	2.1	1.6	2.6	7.3	0.8	2.6	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.4	4861.8	2.8	0.0	3.7	0.0	0.0	0.4	0.0	5.9	0.0	0.0	0.0	0.1	48.8	0.0	0.0	0.0	0.4	0.0	96.2	0.0	0.1	0.0	0.2	0.4	75.7	2.9	3.3	0.0	0.1	0.0	1.6	0.0	0.8	0.3	1.3	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.1	1.3	24.9	0.0	4.2	19.7	258.0	53.7	0.2	1.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0
COX8A	"COX, COX8, COX8-2, COX8L, VIII, VIII-L"	ENSG00000176340	"Cytochrome c oxidase subunit 8A"	P10176	11	63974620-63976543	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 2341.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055942	Supported					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA055942: AB_2682979"	"unprognostic (6.93e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.70e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.51e-6)"	"unprognostic (2.70e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.44e-2)"	322.0	443.8	421.6	134.1	435.5	292.0	286.8	470.0	544.7	259.3	524.0	516.1	337.8	236.1	121.2	612.5	246.8	78.4	1287.8	415.9	469.2	771.1	449.9	265.4	119.9	421.5	420.4	248.0	275.7	366.3	373.9	105.7	414.7	316.0	250.2	149.5	362.1	223.8	1523.9	362.0	381.5	132.3	427.7	277.0	467.3	96.7	480.4	206.6	342.9	1005.3	175.8	307.1	331.2	427.9	613.9	803.9	505.6	505.2	213.8	260.8	365.3	317.0	355.2	621.2	480.1	543.1	489.1	290.1	680.8	447.1	581.6	597.7	395.7	550.9	212.5	427.6	687.8	423.2	621.8	650.3	341.4	431.0	527.7	336.7	412.4	497.3	398.6	274.1	391.9	676.2	503.9	613.3	397.7	1600.5	613.8	1461.1	460.7	726.4	1401.4	473.9	406.3	1234.3	512.9	512.7	457.8	645.0	377.1	541.2	816.1	215.0	796.1	459.8	240.7	356.1	481.0	769.2	374.2	760.8	662.4	461.7	462.0	420.9	436.9	764.9	743.9	692.9	407.0	848.8	301.5	398.5	441.6	403.5	867.0	347.3	337.1	369.6	530.6	418.3	794.1	851.2	589.5	723.9	421.6	435.5	470.0	544.7	415.9	469.2	421.5	420.4	414.7	427.7	480.4	427.9	236.7	224.4	259.8	13.7	255.3	294.6	392.2	640.4	385.3	196.8	394.3	458.2	1263.1	424.7	396.1	437.7	73.0	451.2	305.9	1382.7	2341.9	453.1	9.6	271.6	217.2	215.7	721.6	272.9	12.5	483.1	559.6	246.1	395.0	305.1	224.5	209.3	227.4	811.5	927.5	107.7	16.8	1011.7	592.0	535.2	427.0	25.6	239.6	455.4	627.9	11.2	508.9	429.3	416.1	7.5	15.2	562.9	1103.8	221.2	393.2	419.8	1417.0	1658.2	345.2	187.5	157.8	256.0	339.9	74.0	55.5	844.0	370.9	366.9	290.4	203.7	1088.7	593.4
CP		ENSG00000047457	Ceruloplasmin	P00450	3	149162410-149221829	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Copper transport, Ion transport, Transport"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 1871.4"	"Cell type enhanced"	"Detected in many"		"Club cells: 558.1;Glandular and luminal cells: 406.0;Hepatocytes: 1687.2;Muller glia cells: 720.5;Respiratory ciliated cells: 318.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 98.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"EFO-21: 318.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001834, CAB008591"	Supported				"Secreted to blood"	NA	NA	160000000000	440000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB008591: AB_1613734, HPA001834: AB_1078502"	"unprognostic (3.58e-1)"	"unprognostic (4.24e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.14e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.70e-1)"	13.0	2.3	17.9	2.2	18.1	0.9	20.8	18.7	29.8	70.2	129.2	13.0	9.8	14.8	0.0	5.6	8.3	1.1	39.2	17.5	33.0	9.5	1871.4	13.4	18.9	28.1	20.3	0.8	6.5	3.9	28.6	3.4	24.9	7.9	16.4	246.5	39.9	0.9	2.6	13.0	20.8	2.4	19.2	23.1	3.0	1.5	20.1	0.5	16.1	8.3	20.0	23.9	2.3	29.0	0.2	18.8	15.6	0.0	3.3	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	318.8	0.0	29.4	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.4	32.7	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	2.5	5.4	0.0	0.0	0.0	0.4	6.7	16.2	0.0	0.2	0.3	1.0	0.1	0.4	0.0	0.4	0.0	0.2	1.7	0.2	0.2	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.9	18.1	18.7	29.8	17.5	33.0	28.1	20.3	24.9	19.2	20.1	29.0	2.3	19.2	76.6	3.3	10.6	3.3	8.3	28.6	0.6	6.9	14.0	0.6	0.6	65.8	558.1	9.2	6.2	0.1	0.3	0.1	0.0	83.4	0.9	190.5	51.0	12.6	0.0	34.7	1.5	21.4	0.2	16.3	0.0	406.0	2.5	0.1	34.6	1687.2	0.6	5.0	1.4	0.2	8.2	44.6	6.9	1.2	0.3	4.0	0.0	6.5	1.6	720.5	1.0	0.5	2.0	69.3	0.0	0.4	0.3	19.5	0.0	0.3	318.4	24.8	0.0	0.8	15.3	0.0	0.1	0.8	2.6	0.3	4.9	0.1	0.1	79.0
CPA6	CPAH	ENSG00000165078	"Carboxypeptidase A6"	Q8N4T0	8	67422038-67746378	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 2.3;prostate: 2.7;retina: 2.2"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 31.7;Early spermatids: 21.7;Microglial cells: 12.2;Muller glia cells: 22.5;Pancreatic endocrine cells: 21.5;Paneth cells: 12.8;Prostatic glandular cells: 11.3;Urothelial cells: 36.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.5;EFO-21: 1.5;Hep G2: 3.4;OE19: 1.5"	"Region enriched"	"Detected in some"	9	"olfactory bulb: 12.6"	"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"				"unprognostic (2.85e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.23e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.57e-4)"	"unprognostic (9.61e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.41e-2)"	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.3	2.2	0.0	0.2	0.0	0.0	0.2	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	31.7	0.0	5.7	0.2	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	21.7	0.1	0.0	0.1	2.4	0.0	1.6	0.4	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.1	1.7	1.3	2.2	0.0	0.0	0.0	3.2	1.8	0.2	0.0	12.2	0.1	22.5	0.0	3.0	1.3	21.5	12.8	0.0	0.0	11.3	0.0	0.0	0.0	1.0	0.0	0.1	0.3	0.0	0.0	0.8	0.0	0.0	0.6	0.0	5.7	36.6
CPN1		ENSG00000120054	"Carboxypeptidase N subunit 1"	P15169	10	100042193-100081869	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"liver: 81.6"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 37.2"	"Group enriched"	"Detected in some"	12	"liver cancer: 26.6;melanoma: 7.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"SK-MEL-30: 141.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		13000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 15: Hepatocytes - Hemostasis"						"unprognostic (2.97e-2)"	"unprognostic (2.23e-2)"			"unprognostic (3.93e-2)"		"unprognostic (1.64e-1)"		"unprognostic (6.75e-2)"		"unprognostic (2.93e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.63e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	81.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	141.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	37.2	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.6	4.4	0.0	0.0	0.1	0.1	0.0	0.2	0.0
CPOX	"CPO, CPX, HCP"	ENSG00000080819	"Coproporphyrinogen oxidase"	P36551	3	98579446-98593648	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 352.8;Extravillous trophoblasts: 75.9;Oligodendrocytes: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HEL: 166.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015736, HPA054448"			Supported	Mitochondria		No	No		170000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria		"HPA015736: AB_1847194, HPA054448: AB_2682490"	"unprognostic (2.14e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (1.62e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.57e-1)"	8.1	10.0	19.7	11.4	28.2	44.1	7.2	24.0	31.7	9.1	13.5	10.0	21.2	10.1	7.2	16.1	7.4	8.1	8.6	19.5	22.4	6.5	35.3	7.5	12.3	30.8	24.9	10.7	7.2	9.5	5.4	18.0	29.8	8.4	12.0	4.5	7.6	7.9	11.2	13.1	15.2	9.0	24.5	9.5	9.4	4.7	25.1	12.8	7.1	9.8	12.3	8.1	10.9	41.8	47.9	22.9	19.9	35.4	36.5	26.9	56.6	30.0	21.7	30.7	34.7	38.2	14.7	5.0	33.1	16.2	33.6	34.1	24.9	32.8	51.9	15.4	21.6	166.4	12.9	49.9	18.5	35.7	37.8	21.2	27.0	29.0	12.0	35.9	29.6	20.2	32.2	20.9	29.1	14.8	36.2	30.4	23.4	26.6	41.0	25.4	45.0	22.1	26.2	19.8	13.1	13.0	32.0	10.9	96.2	22.1	16.7	22.5	24.9	45.1	44.0	26.1	22.4	31.6	26.8	26.7	44.6	38.3	33.7	0.0	0.6	0.0	0.3	0.3	0.7	0.5	0.6	0.8	0.5	0.5	0.2	0.8	0.0	0.6	0.2	0.3	0.3	0.2	19.7	28.2	24.0	31.7	19.5	22.4	30.8	24.9	29.8	24.5	25.1	41.8	6.4	3.2	8.7	9.1	5.6	7.4	3.9	7.3	11.4	4.3	6.0	4.6	8.0	7.2	4.2	3.7	8.4	23.9	6.5	7.9	1.9	3.7	0.1	5.2	8.6	7.4	8.4	352.8	17.7	1.7	75.9	9.4	10.2	5.0	1.3	7.0	11.7	36.4	12.7	0.0	12.3	9.1	4.1	11.3	10.0	0.2	7.5	11.4	12.4	11.2	12.7	5.8	3.1	13.0	99.1	3.2	4.1	7.9	10.4	5.2	9.4	6.3	5.0	5.0	13.1	6.4	7.2	0.3	6.1	12.2	10.2	10.7	12.7	9.7	9.9	4.2
CPT1C	"CATL1, CPT1P, CPTIC, FLJ23809"	ENSG00000169169	"Carnitine palmitoyltransferase 1C"	Q8TCG5	19	49690898-49713731	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.2;pituitary gland: 28.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 43.4;Excitatory neurons: 34.0;Horizontal cells: 32.0;Inhibitory neurons: 28.1;Late spermatids: 29.7;Oligodendrocyte precursor cells: 21.1"	"Cancer enriched"	"Detected in many"	5	"glioma: 9.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 40.2;AN3-CA: 33.2;SCLC-21H: 27.4;SH-SY5Y: 70.1;U-87 MG: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014529, HPA063621"	Approved		Approved	Centrosome		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Centrosome		"HPA014529: AB_1847206, HPA063621: AB_2732706"	"unprognostic (1.09e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.03e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.36e-1)"	"unprognostic (1.92e-10)"	"unprognostic (9.44e-4)"	"unprognostic (3.35e-2)"	"unprognostic (3.91e-1)"	"unprognostic (4.72e-3)"	3.4	5.3	14.0	1.6	14.8	0.0	2.1	8.5	19.1	6.5	18.8	2.6	1.3	8.1	2.3	1.0	4.9	4.4	3.8	19.2	15.6	1.7	0.8	2.1	1.3	10.1	9.2	5.1	1.4	1.4	28.4	0.7	10.3	3.4	0.6	12.4	1.0	2.5	0.7	1.0	1.8	4.6	4.9	4.9	1.5	3.5	12.9	0.2	2.4	0.2	0.6	2.7	3.7	14.4	0.0	0.0	40.2	33.2	14.0	11.0	0.0	12.6	25.2	16.2	22.4	0.7	0.0	0.8	0.0	12.7	2.0	3.0	0.0	0.0	8.5	0.6	0.1	0.0	0.1	0.0	22.7	0.0	0.0	12.7	0.0	13.3	0.1	4.3	22.2	0.1	0.1	0.0	0.9	0.7	0.2	0.0	1.8	2.7	8.8	0.0	0.0	0.0	0.9	0.0	27.4	70.1	0.1	0.1	0.0	0.6	0.1	0.1	18.3	1.0	0.2	7.7	6.7	0.2	3.2	0.4	29.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	14.8	8.5	19.1	19.2	15.6	10.1	9.2	10.3	4.9	12.9	14.4	3.8	0.0	0.0	7.5	0.4	2.2	3.1	0.5	3.4	43.4	0.9	1.3	1.4	1.5	0.0	0.0	16.7	1.1	0.3	0.1	0.0	0.0	8.9	0.5	14.1	7.4	0.0	0.0	34.0	0.0	4.4	6.0	0.0	1.2	0.0	1.9	5.0	0.1	0.3	32.0	28.1	0.1	0.0	0.9	1.2	29.7	3.4	0.8	0.0	7.5	0.0	18.3	0.0	21.1	14.9	0.3	0.0	13.2	1.4	2.1	0.0	0.0	0.0	19.1	0.0	5.8	6.3	3.1	7.0	1.0	1.8	1.1	0.7	4.4	0.2	1.6
CRAT	CAT1	ENSG00000095321	"Carnitine O-acetyltransferase"	P43155	9	129094142-129111189	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 227.5;tongue: 201.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 181.2;Late spermatids: 521.8;Proximal enterocytes: 136.4;Spermatocytes: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019230, HPA020260, HPA022815"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA		8100	"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA019230: AB_1847212, HPA020260: AB_1847210, HPA022815: AB_2732427"	"unprognostic (5.13e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.36e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.03e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.65e-2)"	36.1	51.3	26.4	5.4	26.6	9.0	29.2	27.0	33.8	31.7	27.5	36.1	33.0	24.8	4.0	37.3	23.1	6.6	68.2	25.1	27.8	46.9	151.2	15.2	3.2	28.8	28.2	23.0	107.1	26.3	12.3	6.6	30.6	42.2	4.2	1.7	32.8	8.9	227.5	29.6	37.2	6.8	26.7	15.2	34.0	146.4	30.2	3.1	21.5	201.3	1.6	31.3	27.5	24.4	0.1	39.3	10.7	21.3	13.4	25.9	17.0	15.0	16.6	18.9	12.0	7.8	14.0	1.5	9.2	25.9	23.2	6.7	2.2	4.9	7.2	23.6	0.3	7.3	19.1	30.4	34.1	0.0	26.1	26.3	0.0	15.7	0.9	15.8	26.2	7.2	3.6	5.7	20.0	9.1	0.5	15.9	2.8	32.0	18.0	16.8	21.8	12.2	18.0	0.6	4.2	12.1	0.0	7.1	4.8	3.4	49.7	5.5	22.6	23.0	1.6	32.1	15.4	25.5	22.6	0.1	28.8	4.2	16.8	1.6	8.4	3.5	3.2	5.5	6.7	1.5	4.4	4.3	8.6	1.3	2.6	3.1	1.1	4.4	5.6	3.9	4.5	6.1	26.4	26.6	27.0	33.8	25.1	27.8	28.8	28.2	30.6	26.7	30.2	24.4	10.5	6.4	3.7	5.5	4.9	3.2	4.7	10.8	0.6	1.5	9.7	8.1	57.8	21.5	8.2	3.7	2.1	45.9	6.0	64.5	17.6	22.6	181.2	3.5	15.7	12.9	15.5	17.4	5.3	22.4	55.6	19.3	16.8	9.9	7.0	12.9	14.6	65.7	20.7	1.7	6.1	23.6	14.2	13.9	10.5	521.8	22.1	12.4	5.4	6.5	8.3	15.5	6.2	3.5	4.0	11.6	47.6	24.5	9.6	9.3	136.4	52.0	2.8	1.3	6.6	10.5	15.7	123.5	8.6	57.4	4.5	50.3	7.6	20.1	29.3	13.8
CREBBP	"CBP, KAT3A, RSTS, RTS"	ENSG00000005339	"CREB binding protein"	Q92793	16	3725054-3880713	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004212, HPA055861"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Nuclear bodies"	"CAB004212: AB_626817, HPA055861: AB_2682948"	"unprognostic (1.17e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.09e-2)"	"unprognostic (9.59e-3)"	"unprognostic (6.98e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.24e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.23e-2)"	17.4	10.6	5.8	17.1	5.2	52.9	16.8	25.4	11.5	20.9	3.7	18.8	12.5	26.5	12.4	16.5	22.4	16.6	14.4	5.9	3.1	12.0	14.3	15.9	17.6	8.9	6.8	37.3	29.7	18.5	11.3	16.9	2.9	16.1	14.1	13.8	17.2	16.2	29.6	21.0	16.4	19.6	0.4	21.0	16.3	33.2	7.9	29.1	23.3	28.9	20.7	16.6	16.5	6.4	12.3	31.0	39.3	17.4	23.5	23.1	20.4	17.4	28.9	29.2	28.2	28.2	22.4	33.7	20.1	33.3	18.7	23.2	45.7	14.2	32.9	57.5	18.5	26.6	29.2	17.9	26.0	26.9	36.5	20.7	14.2	32.5	38.9	18.0	22.3	17.0	30.9	44.8	16.0	42.0	17.9	13.0	32.3	11.7	12.7	83.4	31.1	26.1	11.2	16.2	32.6	21.5	29.5	28.7	16.8	25.3	25.6	25.9	34.7	35.5	35.2	18.4	16.0	20.8	24.3	63.7	7.2	15.8	25.6	1.9	1.1	0.9	1.7	1.5	0.8	3.7	0.8	1.3	0.7	2.1	0.8	1.1	6.7	1.4	2.9	1.5	0.8	0.9	5.8	5.2	25.4	11.5	5.9	3.1	8.9	6.8	2.9	0.4	7.9	6.4	48.1	44.8	51.6	91.1	38.3	56.2	31.0	16.0	27.3	34.2	34.4	25.7	41.2	40.0	28.0	11.0	25.0	17.4	50.1	31.2	5.9	20.9	43.0	37.2	56.4	35.7	15.0	33.4	88.7	20.3	11.3	39.5	32.1	63.5	30.4	53.1	32.5	29.5	20.9	28.6	89.8	25.3	18.3	44.0	42.8	80.2	56.5	49.0	17.8	87.1	52.5	34.5	43.3	111.6	101.2	27.5	19.5	51.1	35.6	39.8	25.2	10.9	28.2	17.6	46.0	75.8	44.9	35.1	42.2	34.6	58.8	30.8	44.2	36.2	24.6	44.2
CRELD1	"AVSD2, CIRRIN"	ENSG00000163703	"Cysteine rich with EGF like domains 1"	Q96HD1	3	9933816-9945406	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 110.3;hTERT-RPE1: 77.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026964	Uncertain		Approved	Nucleoli,Cytosol	"Intracellular and membrane"	NA	NA		19000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Nucleoli	"HPA026964: AB_10602210"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (3.03e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.31e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.78e-2)"	32.7	37.3	63.6	11.4	63.5	9.3	24.8	69.1	94.4	27.7	59.1	57.5	14.0	31.3	17.0	18.0	34.9	16.5	73.2	63.9	65.7	43.0	57.1	27.5	12.4	64.7	63.0	32.5	27.6	22.7	70.9	17.9	66.3	47.6	12.1	16.4	26.3	34.5	48.9	20.1	25.9	22.2	58.6	28.6	35.6	23.6	65.5	10.5	67.6	26.4	9.2	33.6	24.4	68.2	6.4	8.1	19.3	8.8	30.1	17.6	110.3	26.7	8.0	6.1	11.7	11.1	20.7	8.4	57.6	17.7	27.7	4.5	10.4	17.6	4.9	15.2	9.2	7.3	15.2	28.2	68.7	3.3	29.3	21.7	32.3	15.2	13.6	77.2	28.8	11.1	9.5	10.4	6.1	15.5	3.6	19.3	5.7	30.1	6.6	4.8	3.1	21.6	25.9	9.9	6.9	26.7	12.6	10.3	24.3	27.5	27.9	17.0	21.7	12.1	19.5	16.2	6.3	10.7	14.2	15.2	27.3	7.8	13.0	12.3	10.2	9.3	11.9	9.8	12.2	7.9	8.9	11.5	6.9	8.7	11.3	10.4	1.8	13.8	12.9	12.3	7.2	9.5	63.6	63.5	69.1	94.4	63.9	65.7	64.7	63.0	66.3	58.6	65.5	68.2	24.7	19.2	17.5	43.4	14.1	9.7	26.2	48.5	15.9	21.5	17.5	15.0	41.9	31.5	24.0	16.5	16.7	23.7	15.1	10.9	7.9	19.6	6.8	10.3	7.0	20.2	27.0	7.8	38.0	4.4	11.5	20.1	19.4	12.9	21.0	18.8	19.2	14.9	20.6	32.0	37.1	19.1	38.7	8.8	9.0	10.1	32.0	10.0	12.4	15.0	13.9	18.3	27.8	14.6	21.7	8.7	20.4	26.4	15.3	31.4	18.8	11.1	13.2	15.8	26.3	11.0	17.1	68.0	26.5	9.6	12.4	22.2	15.4	11.2	15.4	20.2
CRPPA	"hCG_1745121, ISPD, Nip"	ENSG00000214960	"CDP-L-ribitol pyrophosphorylase A"	A4D126	7	16087525-16502504	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"choroid plexus: 27.0"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 8.0;Cytotrophoblasts: 3.5;Extravillous trophoblasts: 10.6;Syncytiotrophoblasts: 2.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	29	"basophil: 13.8"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 13.8"	"Cell line enhanced"	"Detected in many"		"HEL: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053554			Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA053554: AB_2682185"	"unprognostic (4.65e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.07e-1)"	"prognostic favorable (1.38e-11)"	"unprognostic (4.01e-2)"	"unprognostic (1.78e-4)"	"unprognostic (6.26e-2)"	"unprognostic (2.79e-1)"	1.1	1.2	1.3	0.8	1.8	1.6	0.9	0.7	3.7	1.3	27.0	1.0	0.6	1.0	0.5	0.5	0.9	1.1	2.6	3.8	1.1	2.9	4.1	1.0	1.4	0.8	0.8	0.7	1.5	1.1	0.7	1.0	0.8	1.0	1.2	1.2	1.2	0.8	1.5	1.2	0.6	1.2	0.2	0.9	3.5	2.2	3.2	1.2	0.8	1.3	1.4	1.1	0.5	2.0	0.4	2.2	1.0	1.6	1.0	1.3	6.8	1.5	1.4	1.5	1.3	2.2	1.9	4.3	3.2	2.7	0.9	2.5	1.2	0.0	2.9	1.5	0.9	9.6	1.4	0.7	1.5	1.9	2.4	2.2	0.8	1.6	0.4	0.9	1.2	3.0	3.2	0.2	4.2	0.7	3.0	1.2	1.8	1.1	0.5	1.1	1.9	0.2	2.1	0.8	1.5	0.9	1.4	2.1	1.7	2.5	1.6	2.0	2.0	1.9	1.5	0.4	1.7	0.4	0.0	4.8	1.5	2.3	2.2	13.8	0.1	0.4	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.4	0.3	0.2	0.4	0.4	0.1	0.3	0.1	0.0	1.3	1.8	0.7	3.7	3.8	1.1	0.8	0.8	0.8	0.2	3.2	2.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	3.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	10.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0
CRYM	DFNA40	ENSG00000103316	"Crystallin mu"	Q14894	16	21238874-21303083	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.7;heart muscle: 175.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 126.0;Ionocytes: 114.0;Muller glia cells: 640.7;Proximal tubular cells: 190.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 14.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	21	"plasmacytoid DC: 82.0"	"Lineage enriched"	"Detected in many"	21	"dendritic cells: 82.0"	"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 100.3"	"Group enriched"	"Detected in all"	11	"amygdala: 124.0;basal ganglia: 275.1;cerebral cortex: 124.7;hippocampal formation: 324.3;white matter: 128.4"	"Low region specificity"	"Detected in all"			"HPA019086, HPA030619"	Enhanced		Supported	Cytosol		NA	NA		150000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA019086: AB_1847260, HPA030619: AB_2673551"	"unprognostic (1.32e-1)"	"unprognostic (2.93e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.11e-3)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.31e-1)"	1.9	0.8	37.4	0.9	78.7	1.0	2.7	40.6	62.2	3.7	13.6	6.9	1.6	1.0	0.2	7.6	1.1	7.0	175.3	54.0	31.6	64.4	14.2	8.5	1.1	13.9	19.8	0.3	1.8	8.9	55.6	0.4	15.6	35.4	8.4	54.7	20.6	0.2	13.4	4.1	2.6	0.3	14.1	0.3	1.3	5.1	20.5	0.3	0.4	0.9	3.8	21.8	3.6	31.3	0.2	4.0	0.0	0.0	0.2	0.4	0.7	0.0	2.1	0.1	0.2	0.2	0.2	0.3	1.0	0.0	1.8	0.6	5.4	0.0	0.0	0.0	0.8	23.2	0.1	2.3	0.0	0.1	2.2	0.8	0.0	0.8	1.0	0.0	0.0	0.5	0.0	0.4	0.7	0.3	0.0	0.9	9.7	1.6	0.1	0.1	0.0	0.5	100.3	0.1	3.7	5.2	0.2	0.1	2.6	4.8	0.1	0.0	0.0	0.5	0.7	6.8	0.0	0.2	0.0	0.5	16.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.1	3.9	0.0	0.0	0.3	0.0	0.0	82.0	0.0	1.2	37.4	78.7	40.6	62.2	54.0	31.6	13.9	19.8	15.6	14.1	20.5	31.3	0.3	0.0	20.1	5.2	4.1	2.3	25.4	16.3	0.0	6.3	0.4	11.7	126.0	2.8	56.1	14.7	4.2	0.0	11.4	7.1	17.6	0.1	19.7	3.2	1.5	3.0	13.1	4.8	43.8	0.0	0.0	7.1	6.1	7.7	1.3	1.3	0.4	8.3	0.1	1.7	5.9	20.6	114.0	1.6	0.7	12.4	0.0	1.5	33.8	10.3	0.7	640.7	0.0	7.1	6.6	0.4	2.8	0.0	0.3	19.0	7.5	190.1	19.9	26.2	0.0	0.2	4.3	6.7	7.3	0.2	1.3	0.1	1.1	0.1	8.2	68.0
CSGALNACT1	"ChGn, CSGalNAcT-1, FLJ11264"	ENSG00000147408	"Chondroitin sulfate N-acetylgalactosaminyltransferase 1"	Q8TDX6	8	19404161-19758029	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 86.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 494.3;Excitatory neurons: 144.4;Granulosa cells: 214.1;Microglial cells: 224.9;Oligodendrocyte precursor cells: 355.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 22.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 62.6"	"Group enriched"	"Detected in all"	5	"B-cells: 44.5;granulocytes: 24.9;T-cells: 62.6"	"Cell line enhanced"	"Detected in many"		"A549: 57.8;BJ hTERT+: 32.3;GAMG: 22.9;RPTEC TERT1: 39.6;U-2197: 36.8;U-87 MG: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA068462			Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Golgi apparatus"	"HPA068462: "	"unprognostic (8.90e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.17e-3)"	"unprognostic (9.78e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.22e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.02e-2)"	19.4	12.5	20.3	8.8	15.7	11.1	7.4	4.8	18.3	18.0	0.7	4.7	3.5	7.0	5.4	31.2	11.8	16.1	35.8	16.3	11.5	6.0	2.8	11.7	7.6	6.3	11.2	57.0	7.9	11.4	3.0	38.8	7.6	31.8	2.5	2.5	6.8	9.8	5.8	4.8	4.7	12.3	6.7	8.7	6.9	2.8	8.9	11.7	86.7	11.0	8.8	23.4	8.1	10.7	2.1	57.8	0.5	0.0	9.3	2.1	7.9	1.4	32.3	0.3	0.3	3.1	1.0	0.0	0.3	0.0	22.9	0.7	0.0	0.0	0.4	7.5	0.4	0.2	16.2	1.9	4.1	0.0	0.1	0.9	1.6	0.7	0.3	0.4	11.6	0.2	0.0	0.1	0.1	2.6	2.9	0.2	0.3	8.3	1.7	0.3	0.1	0.0	39.6	1.6	0.2	0.3	17.2	6.9	2.4	1.5	0.1	0.4	1.0	1.1	1.3	36.8	0.9	0.3	0.0	0.0	26.0	3.4	11.4	0.1	2.9	24.9	5.6	0.1	0.6	44.5	25.7	8.5	2.8	15.9	44.6	11.6	15.6	8.4	0.4	4.2	62.6	11.7	20.3	15.7	4.8	18.3	16.3	11.5	6.3	11.2	7.6	6.7	8.9	10.7	33.3	3.2	1.1	494.3	27.3	4.5	7.4	0.2	0.6	0.3	4.1	0.8	45.8	0.0	0.9	12.9	10.4	1.9	6.2	0.0	1.9	5.7	6.9	7.5	1.2	38.5	3.0	3.2	144.4	1.7	14.6	20.9	2.0	2.0	0.0	214.1	26.7	0.2	15.8	18.5	76.5	0.0	16.2	27.4	6.5	7.4	5.3	14.1	12.4	224.9	3.5	1.0	6.2	355.9	4.6	3.1	0.0	12.0	21.3	21.8	0.0	0.1	1.5	1.0	6.6	2.1	12.0	0.7	0.1	0.5	3.1	8.3	9.6	77.0	0.1	2.8
CSNK1D	"CKID, CKIdelta, HCKID"	ENSG00000141551	"Casein kinase 1 delta"	P48730	17	82239023-82273731	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 312.5;Late spermatids: 775.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015410	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"	Nucleoplasm	"CAB015410: AB_831049"	"unprognostic (1.07e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (2.38e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.38e-6)"	"unprognostic (8.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.00e-2)"	"prognostic favorable (9.62e-5)"	"unprognostic (2.23e-3)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.52e-3)"	"unprognostic (4.74e-2)"	46.7	57.0	36.9	28.9	36.9	25.9	42.3	34.4	37.9	45.3	30.3	57.1	35.1	56.6	26.7	50.8	45.3	24.8	42.4	39.0	40.2	45.5	40.9	45.3	30.8	37.2	37.6	43.1	47.5	43.1	54.2	30.2	36.3	51.8	20.0	15.1	48.6	36.8	88.9	36.4	50.9	29.0	36.3	56.3	49.3	60.7	42.6	34.0	44.7	38.7	22.8	49.0	37.0	32.9	60.3	70.9	39.5	54.7	50.8	53.9	77.7	85.1	54.4	61.0	56.8	58.6	49.4	55.0	66.3	62.5	64.8	57.1	37.4	88.3	48.9	47.0	90.5	68.5	53.4	63.7	146.9	56.9	50.4	81.9	61.5	41.6	61.3	76.0	90.0	39.5	78.5	28.4	58.5	70.6	73.7	59.3	42.2	71.3	108.6	62.6	48.7	49.7	64.8	93.4	48.5	87.4	100.4	85.5	97.7	54.3	61.5	73.0	95.6	86.9	77.3	76.2	67.0	61.0	32.1	58.4	69.5	48.1	64.7	8.8	20.8	27.4	12.3	21.3	11.8	11.1	9.6	12.1	20.1	9.0	8.1	8.7	50.4	15.3	20.3	9.6	9.2	15.4	36.9	36.9	34.4	37.9	39.0	40.2	37.2	37.6	36.3	36.3	42.6	32.9	65.8	48.1	54.3	36.6	81.1	56.6	116.0	58.3	52.9	46.5	59.8	51.2	19.7	31.5	65.7	42.3	27.1	61.8	101.0	105.2	33.2	71.6	312.5	69.6	54.0	54.2	46.2	32.4	24.4	69.6	95.2	42.8	87.1	93.2	60.1	45.3	42.5	33.6	65.3	95.9	21.2	62.8	67.1	51.5	83.8	775.6	30.1	75.7	28.4	24.4	65.8	28.7	79.3	24.6	21.2	87.7	83.2	40.3	80.9	90.8	94.3	43.8	66.6	54.4	39.5	78.6	57.5	55.1	29.6	44.2	48.3	126.6	87.6	46.7	56.7	118.6
CSNK2A1	"Cka1, Cka2"	ENSG00000101266	"Casein kinase 2 alpha 1"	P68400	20	472498-543835	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB020680, HPA059206, HPA061698, CAB069395"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB020680: , CAB069395: AB_1611912, HPA059206: AB_2683948, HPA061698: AB_2732667"	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.44e-2)"	"unprognostic (8.28e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (4.11e-6)"	"unprognostic (4.08e-2)"	"unprognostic (3.89e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.47e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.37e-2)"	36.1	32.6	20.9	38.6	23.2	34.0	35.9	28.2	29.6	36.5	29.3	48.3	39.1	35.8	26.6	50.0	39.9	31.3	54.0	25.7	21.0	41.0	31.8	31.6	41.2	20.6	21.1	41.5	46.9	59.1	21.2	42.4	21.1	35.8	40.7	32.9	41.1	37.7	110.5	34.2	40.5	39.1	18.8	30.2	49.5	65.2	22.3	51.6	39.6	86.4	46.6	47.4	28.5	27.3	209.5	170.4	152.9	96.0	61.1	103.8	103.5	117.9	116.1	125.8	139.5	178.5	120.0	179.1	74.2	90.1	179.1	147.8	162.1	167.4	187.2	62.6	57.7	247.3	44.7	177.7	102.5	228.1	51.3	99.5	173.3	105.8	316.0	122.2	139.5	146.4	248.9	112.6	123.8	64.2	262.0	73.7	227.4	173.4	97.6	149.8	140.5	140.9	112.9	128.5	163.9	132.3	97.2	184.0	174.8	120.7	120.4	83.9	142.7	136.0	118.4	90.0	178.5	120.6	311.8	174.1	65.8	119.5	138.6	40.5	23.8	28.7	18.2	32.3	22.4	23.0	18.0	17.6	31.5	22.5	17.9	17.4	14.9	25.1	33.5	25.7	20.4	20.8	20.9	23.2	28.2	29.6	25.7	21.0	20.6	21.1	21.1	18.8	22.3	27.3	50.7	64.1	84.6	51.9	46.1	41.0	40.0	43.8	45.5	49.4	42.1	36.1	59.4	41.5	75.8	44.1	31.3	42.2	50.5	43.5	41.1	68.5	135.5	67.6	77.0	44.5	35.2	59.3	65.6	50.6	54.4	46.3	40.2	75.7	63.8	108.6	27.1	31.1	33.2	60.6	69.3	41.8	46.8	39.2	30.3	140.0	41.0	45.3	14.2	51.5	61.7	38.6	37.0	73.9	73.6	66.6	34.4	36.9	49.6	57.2	43.2	68.8	65.5	27.8	52.6	43.6	56.8	94.2	68.7	52.3	50.2	61.4	38.9	81.2	40.6	59.4
CSTB	"CST6, EPM1, PME, STFB"	ENSG00000160213	"Cystatin B"	P04080	21	43772511-43776330	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"esophagus: 11304.7"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 5910.7;Club cells: 4352.8;Hofbauer cells: 2827.7;Squamous epithelial cells: 4910.2;Urothelial cells: 3198.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 2798.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017380, CAB047320, HPA058557"	Enhanced		Supported	Nucleoli,Cytosol		NA	NA		8700000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoli	"CAB047320: , HPA017380: AB_1847414, HPA058557: AB_2683755"	"unprognostic (1.69e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.05e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (6.66e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.88e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	224.3	165.6	254.1	141.6	253.6	73.8	161.9	255.4	314.6	585.8	275.2	243.8	122.9	90.1	175.0	11304.7	154.1	150.7	192.2	252.8	263.0	144.7	189.4	290.1	176.4	258.4	257.8	136.1	116.2	154.4	70.1	132.1	259.6	137.3	194.7	78.9	738.3	138.6	100.1	256.9	135.6	110.4	257.5	125.8	249.9	71.7	262.8	268.2	147.9	197.4	1484.9	611.8	1001.9	262.9	1573.6	495.5	146.3	188.1	874.5	742.6	379.6	310.1	431.0	230.7	230.6	401.6	868.6	123.0	245.8	570.1	1814.0	260.5	384.4	405.7	153.5	529.0	388.4	332.4	385.3	473.8	753.0	85.5	267.1	754.5	439.6	621.2	314.7	389.3	331.2	111.8	276.9	681.1	359.7	431.4	100.1	267.6	336.0	1052.6	791.5	169.7	80.5	1472.0	669.1	2798.2	141.8	121.6	420.2	229.2	928.8	75.7	210.4	214.0	426.3	347.7	162.7	305.5	211.8	148.5	347.4	251.1	1432.5	430.2	242.3	390.1	505.5	313.1	242.9	840.3	224.5	198.5	315.4	255.4	766.1	172.7	221.0	217.6	445.6	152.4	1322.9	93.4	406.9	475.2	254.1	253.6	255.4	314.6	252.8	263.0	258.4	257.8	259.6	257.5	262.8	262.9	210.1	176.3	298.4	43.4	140.5	385.3	460.6	5910.7	191.2	69.8	317.8	345.1	105.7	268.8	4352.8	415.6	35.5	310.4	126.5	803.9	538.1	588.4	10.4	388.8	205.1	307.8	239.3	61.4	17.0	488.2	1199.4	238.6	297.7	458.8	228.2	131.5	250.6	464.5	2827.7	67.3	18.4	308.6	1462.8	483.4	1256.2	40.8	381.1	806.9	471.4	24.4	915.9	160.6	255.4	11.1	32.4	810.9	735.6	330.2	167.7	674.3	524.9	469.9	1997.3	72.9	118.3	86.5	320.0	33.7	111.7	4910.2	596.0	402.5	202.8	170.9	367.2	3198.3
CTDP1	FCP1	ENSG00000060069	"CTD phosphatase subunit 1"	Q9Y5B0	18	79679803-79754510	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cataract, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 113.1;Late spermatids: 123.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032641, HPA040394, HPA070389"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Vesicles	"CAB032641: AB_2261235, HPA040394: AB_10794029, HPA070389: AB_2732155"	"unprognostic (1.71e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (6.43e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (5.51e-5)"	"unprognostic (5.16e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.74e-2)"	9.3	7.4	3.8	7.2	3.9	13.7	8.9	3.3	4.2	7.8	4.1	11.1	7.2	10.4	1.4	10.7	8.1	4.0	7.2	3.3	3.3	7.9	9.5	9.3	8.7	5.3	4.2	5.0	9.0	3.3	6.9	4.2	4.0	8.2	3.1	1.5	9.5	3.9	11.9	20.5	10.9	3.1	3.3	13.5	9.9	22.2	4.0	6.5	8.0	3.1	3.7	9.6	8.6	4.4	13.4	14.0	7.7	11.0	6.0	5.0	25.9	9.6	6.1	7.6	7.5	9.4	8.0	17.2	4.2	5.6	9.1	16.4	6.6	8.8	3.1	16.9	12.4	8.5	6.6	12.9	8.7	37.6	20.5	8.4	8.3	8.1	3.8	4.6	9.2	12.2	11.2	8.1	3.0	11.5	25.4	29.5	12.7	4.2	19.1	20.7	10.1	20.0	5.6	13.1	12.0	12.4	10.2	9.8	13.9	5.8	8.0	21.7	12.9	12.9	19.4	5.3	9.7	7.4	27.6	16.1	11.0	18.8	9.3	0.0	0.4	3.2	0.5	0.4	0.4	0.2	0.4	0.8	0.6	0.1	0.5	0.3	1.0	1.1	0.4	0.1	0.1	0.2	3.8	3.9	3.3	4.2	3.3	3.3	5.3	4.2	4.0	3.3	4.0	4.4	7.4	0.0	4.1	3.6	9.2	8.5	5.0	4.0	11.4	9.5	7.7	6.5	3.8	4.3	4.5	3.7	14.6	8.8	24.2	20.0	1.9	5.4	113.1	18.6	8.0	7.5	6.0	13.5	7.7	7.2	8.0	4.8	19.9	24.0	7.0	7.8	6.4	5.7	8.8	23.5	6.6	16.6	6.1	7.5	9.5	123.2	7.8	13.8	7.2	6.5	6.5	6.5	19.6	3.0	8.9	10.2	14.9	10.5	15.2	11.8	10.0	6.8	9.6	14.8	0.0	5.9	7.4	18.0	10.5	10.5	10.1	19.0	18.3	8.0	11.7	12.6
CTH		ENSG00000116761	"Cystathionine gamma-lyase"	P32929	1	70411218-70439851	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Calmodulin-binding, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 122.9;ovary: 34.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 38.0;Hepatocytes: 141.6"	"Group enriched"	"Detected in all"	5	"liver cancer: 30.0;testis cancer: 8.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 39.7;Karpas-707: 63.8;SK-MEL-30: 85.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021591, HPA023300"	Enhanced					NA	NA		220000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA021591: AB_1847321, HPA023300: AB_1847322"	"unprognostic (3.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.76e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.45e-3)"	"prognostic favorable (8.69e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.05e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.97e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.26e-1)"	4.3	12.9	3.4	1.3	3.1	3.4	2.9	3.3	4.0	2.5	4.5	5.1	5.2	2.2	1.6	4.5	3.8	1.8	2.4	3.3	3.6	13.5	122.9	3.1	0.9	3.4	3.7	34.4	17.0	1.4	2.9	1.1	3.4	4.3	6.2	8.1	2.5	2.1	3.6	1.2	5.3	1.3	2.7	1.0	7.4	4.1	3.7	0.6	7.7	2.9	1.3	2.2	1.9	3.2	10.2	1.5	7.1	10.0	8.5	4.8	15.0	4.3	4.1	3.8	15.7	3.2	6.4	5.8	3.4	3.1	9.3	4.9	27.3	3.1	7.2	17.3	5.9	7.0	5.1	9.4	39.7	7.8	1.7	7.5	24.4	7.5	8.8	1.5	3.2	11.9	14.0	63.8	2.2	3.2	2.7	1.9	7.2	4.2	5.9	3.0	3.7	16.2	7.3	0.1	3.9	3.3	6.6	7.7	85.7	13.3	2.6	4.6	1.1	1.2	7.7	5.7	4.1	23.8	15.3	3.1	9.8	16.1	3.1	0.8	0.3	0.1	1.2	0.2	2.1	2.2	1.1	1.7	0.5	1.7	3.2	1.5	0.4	0.2	0.2	0.7	0.3	0.6	3.4	3.1	3.3	4.0	3.3	3.6	3.4	3.7	3.4	2.7	3.7	3.2	2.8	6.4	5.6	16.6	6.7	2.5	8.0	2.2	6.2	9.4	6.2	5.8	1.9	5.7	2.5	5.5	10.4	0.8	5.5	16.1	11.7	1.8	27.2	38.0	6.4	3.3	3.0	7.4	7.8	4.2	1.8	13.6	14.8	19.7	0.0	1.9	3.9	141.6	1.2	0.0	7.4	7.9	2.0	3.5	5.7	5.2	1.2	4.7	19.6	1.9	0.0	4.4	0.0	7.1	4.2	6.4	12.9	4.1	10.8	4.0	11.1	29.2	0.7	11.6	0.0	2.8	17.7	1.4	0.6	4.8	2.0	0.8	11.2	4.5	9.1	3.8
CTNND1	"CTNND, KIAA0384, p120, p120cas, p120ctn"	ENSG00000198561	"Catenin delta 1"	O60716	11	57753243-57819546	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway"		"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 305.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.9;intermediate monocyte: 9.5;myeloid DC: 6.3;non-classical monocyte: 5.6"	"Group enriched"	"Detected in many"	19	"dendritic cells: 6.3;monocytes: 9.5"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB003837, HPA015954, HPA015955"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"		"CAB003837: AB_562066, HPA015954: AB_2669326, HPA015955: AB_1846068"	"unprognostic (1.06e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.87e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.52e-3)"	"unprognostic (4.17e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.75e-1)"	"prognostic favorable (3.54e-4)"	"unprognostic (7.17e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.33e-2)"	72.6	48.8	29.6	34.8	28.1	5.9	83.3	28.2	33.0	86.0	50.0	107.9	97.8	70.8	49.3	209.7	58.4	56.3	49.0	26.6	26.8	77.9	82.6	83.9	19.0	34.8	30.6	49.3	120.0	76.1	57.7	106.0	32.5	78.9	102.0	23.5	121.8	57.1	26.8	129.4	104.9	54.8	32.3	51.5	105.4	44.3	38.0	24.4	98.6	19.9	48.4	83.5	111.9	33.5	156.6	106.4	70.2	63.3	46.1	71.6	141.7	65.1	78.8	58.5	55.6	88.5	163.9	1.0	113.2	72.5	50.9	201.7	58.8	97.4	71.1	1.0	21.9	32.0	35.8	109.9	52.6	5.0	52.7	70.0	133.5	67.1	73.5	103.8	197.2	1.7	55.1	0.4	55.1	48.0	1.7	13.9	54.7	101.2	56.5	0.7	67.4	1.3	90.2	171.0	4.9	40.1	91.5	133.6	113.1	176.3	138.9	6.1	166.0	59.6	50.3	53.2	34.6	1.2	0.9	2.3	53.2	3.4	111.5	0.0	4.9	0.1	0.0	9.5	0.2	0.2	0.0	0.1	6.3	0.3	0.0	0.0	0.2	0.4	5.6	1.4	0.1	1.1	29.6	28.1	28.2	33.0	26.6	26.8	34.8	30.6	32.5	32.3	38.0	33.5	116.2	147.4	84.0	0.0	8.8	117.1	96.9	82.9	126.9	21.0	101.5	70.5	17.5	125.8	96.6	141.6	39.6	94.0	2.3	305.5	13.7	106.7	14.1	91.1	58.5	98.6	86.2	21.3	0.0	97.2	85.6	34.5	165.1	139.4	32.4	61.1	91.8	127.6	44.4	15.2	0.0	160.7	52.9	64.3	55.5	10.5	28.3	46.4	48.0	0.0	28.5	30.2	2.1	0.0	0.0	141.8	169.3	38.4	5.0	116.9	179.6	57.6	88.2	26.4	26.3	32.3	38.1	37.0	21.1	285.1	200.5	90.8	6.2	39.9	127.0	194.6
CTNS	"CTNS-LSB, PQLC4, SLC66A4"	ENSG00000040531	"Cystinosin, lysosomal cystine transporter"	O60931	17	3636459-3663103	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Melanin biosynthesis, Protein transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 35.5;Late spermatids: 29.3;Theca cells: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 34.3;granulocytes: 27.9;monocytes: 10.4"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 144.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046947			Supported	"Vesicles,Intermediate filaments"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	"Vesicles, Intermediate filaments"		"HPA046947: AB_2679872"	"unprognostic (1.64e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.25e-2)"	"unprognostic (8.39e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.28e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.62e-3)"	"prognostic favorable (6.39e-5)"	"unprognostic (8.40e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	10.3	19.5	9.5	10.0	17.0	10.2	9.6	13.5	12.1	20.3	12.1	8.3	12.2	11.3	6.4	8.7	10.3	13.1	10.5	10.8	10.3	15.2	15.9	11.6	10.0	16.5	16.8	12.1	27.0	13.6	9.6	12.9	18.0	10.8	7.2	6.8	12.0	11.6	15.3	19.2	11.0	8.6	10.9	12.1	15.0	24.8	13.2	8.8	9.2	7.4	9.5	9.1	9.4	28.0	17.6	37.0	22.6	18.2	34.5	16.9	13.0	19.6	28.8	21.1	26.0	21.0	16.0	10.2	17.8	11.6	55.9	40.1	19.8	12.1	12.6	144.3	33.7	10.8	32.2	19.3	46.5	8.0	81.3	23.8	14.2	20.2	15.4	28.1	22.2	18.7	12.6	15.9	16.6	15.1	7.8	7.9	9.8	12.2	16.8	16.4	9.3	23.0	15.3	16.2	3.9	17.2	19.2	24.4	20.3	19.0	17.1	7.7	24.2	17.2	11.6	40.3	13.3	12.4	20.0	4.2	28.1	7.8	11.8	27.9	10.4	21.8	3.0	6.9	4.9	5.8	4.0	5.7	9.7	4.9	4.5	5.5	3.1	5.2	7.1	34.3	4.3	7.3	9.5	17.0	13.5	12.1	10.8	10.3	16.5	16.8	18.0	10.9	13.2	28.0	4.4	3.2	2.2	6.5	4.8	1.7	3.5	2.5	4.0	1.6	6.3	5.0	5.2	5.7	2.7	12.9	10.4	6.1	5.2	3.6	0.0	6.7	35.5	5.7	4.4	5.3	2.4	4.0	3.4	6.4	7.1	6.0	7.7	4.3	8.2	6.7	9.3	7.6	25.2	5.0	3.4	2.5	4.1	7.2	5.9	29.3	9.6	12.1	5.4	3.7	10.0	6.5	3.1	5.5	11.1	6.4	3.3	12.8	4.5	6.5	3.2	9.5	7.0	3.9	6.6	3.7	3.5	19.7	8.7	2.9	2.4	8.5	3.3	30.9	1.8	3.2
CTPS1	"CTPS, GATD5"	ENSG00000171793	"CTP synthase 1"	P17812	1	40979688-41012565	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Pyrimidine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 73.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017111, HPA051322"	Enhanced		Approved	"Actin filaments,Cytosol"		NA	Yes		150000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol	"Actin filaments"	"CAB017111: , HPA051322: AB_2681441"	"unprognostic (6.60e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.89e-2)"	9.1	8.1	4.8	11.1	4.7	6.8	6.7	4.0	5.8	9.3	7.9	8.7	4.4	23.6	5.7	14.9	11.1	10.6	5.3	4.9	5.3	12.4	73.4	7.6	12.4	4.6	4.9	3.4	4.7	47.6	0.0	7.8	5.8	13.5	12.0	2.4	50.6	24.8	7.7	4.6	8.4	51.9	4.7	5.0	4.1	14.7	4.9	17.3	4.8	7.6	17.8	17.7	0.3	5.0	77.8	68.5	95.3	60.5	22.9	30.9	138.5	138.8	57.0	141.2	92.0	131.5	66.6	149.8	55.6	61.7	39.4	38.6	91.5	97.0	139.5	66.5	78.0	87.3	72.3	43.3	87.8	128.0	56.8	34.0	49.2	148.5	103.0	23.0	64.1	102.2	84.7	51.5	99.4	42.9	125.0	38.1	126.8	66.4	81.3	100.9	120.0	93.7	71.4	69.4	118.4	61.7	79.2	77.7	33.9	90.8	30.1	152.9	53.5	78.2	119.6	61.7	167.2	36.8	50.8	134.5	59.8	84.5	97.4	0.0	3.5	0.0	3.6	6.5	5.7	5.2	4.1	4.3	11.0	4.0	3.7	6.1	0.0	6.9	5.9	11.9	6.3	3.4	4.8	4.7	4.0	5.8	4.9	5.3	4.6	4.9	5.8	4.7	4.9	5.0	5.4	6.4	18.4	4.9	10.9	8.0	14.3	9.1	9.6	12.5	4.6	4.7	5.7	21.5	7.0	5.5	6.2	15.4	26.4	2.2	1.9	19.2	32.4	4.7	10.8	8.5	3.0	22.5	14.1	17.2	26.4	8.7	7.1	7.3	1.3	15.8	2.2	29.0	11.0	11.8	18.7	3.4	6.1	2.8	6.2	27.9	10.8	6.8	1.8	7.5	8.7	5.4	7.2	7.1	10.3	19.3	1.1	24.8	15.1	19.3	25.2	12.8	2.8	4.3	39.5	9.3	17.5	11.1	40.6	11.8	7.4	5.6	9.9	20.7	5.8	7.3
CTRC	"CLCR, ELA4"	ENSG00000162438	"Chymotrypsin C"	Q99895	1	15438442-15449242	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	3927	"pancreas: 25708.5"	"Cell type enriched"	"Detected in some"	9	"Exocrine glandular cells: 6566.4"	"Cancer enriched"	"Detected in some"	168	"pancreatic cancer: 236.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046920	Enhanced				"Secreted to digestive system"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"		"Cluster 1: Pancreatic cells - Digestion"			"HPA046920: AB_2679865"	"unprognostic (2.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.55e-11)"	"unprognostic (4.98e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-3)"	6.5	1.2	0.2	0.2	0.2	0.7	2.9	0.7	0.3	2.7	0.2	1.2	1.1	1.3	0.1	1.9	0.8	0.0	2.3	0.3	0.1	1.2	3.5	1.0	0.3	0.1	0.1	5.6	25708.5	0.0	1.5	0.7	0.2	1.8	0.0	0.1	2.1	0.0	1.0	2.1	1.7	0.0	0.0	2.0	2.3	1.0	0.2	0.0	1.0	0.0	0.0	0.6	1.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.1	0.0	0.0	0.2	0.2	0.7	0.3	0.3	0.1	0.1	0.1	0.2	0.0	0.2	0.2	0.2	0.0	0.5	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	17.3	0.0	0.6	1.0	0.7	0.0	0.0	0.2	6566.4	0.1	0.2	0.0	2.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.9	0.0	0.0	1.1	1.8	0.0	24.3	0.0	1.0	0.0	0.0	673.8	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.0	0.0	1.3	3.5	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.3
CTSA	"GSL, PPGB"	ENSG00000064601	"Cathepsin A"	P10619	20	45890144-45898824	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 368.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 445.6;Proximal enterocytes: 301.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 856.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024930, HPA031068, HPA072487"	Enhanced		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		28000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"CAB024930: , HPA031068: AB_10601205, HPA072487: "	"unprognostic (8.61e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (6.33e-2)"	"unprognostic (9.53e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.40e-2)"	80.4	368.3	56.8	75.3	58.1	75.6	61.9	63.6	65.6	47.6	96.0	178.6	100.9	55.1	39.0	60.4	39.3	89.7	97.2	59.7	63.8	188.1	95.7	90.9	61.6	62.6	59.1	62.2	52.9	104.4	43.8	76.4	61.4	38.5	170.4	44.0	61.3	48.4	56.0	95.2	109.2	67.3	59.4	108.5	63.3	33.5	70.2	23.0	47.4	61.7	58.8	82.8	49.2	68.4	111.9	114.1	17.6	89.2	856.5	438.6	47.0	150.3	424.0	169.6	217.5	214.4	291.8	24.1	176.2	299.9	638.1	168.6	55.9	105.6	95.7	47.6	53.6	54.3	53.4	375.9	187.3	98.0	240.9	349.0	123.6	107.9	22.5	421.9	190.1	28.2	61.0	355.1	186.9	232.1	25.8	82.4	19.4	172.6	272.1	37.8	107.3	135.7	138.2	96.7	36.9	37.8	263.2	450.3	444.4	51.5	108.5	141.8	172.5	335.0	76.2	178.9	123.7	162.1	238.5	15.7	599.3	128.6	142.4	480.7	305.9	530.5	44.9	168.8	185.5	42.0	75.6	78.3	102.4	25.7	26.6	39.8	152.4	81.2	120.1	40.6	155.4	378.1	56.8	58.1	63.6	65.6	59.7	63.8	62.6	59.1	61.4	59.4	70.2	68.4	53.7	35.3	32.6	26.1	38.2	24.2	38.9	88.8	17.6	58.4	18.4	15.9	12.6	65.8	64.1	71.7	60.5	104.1	27.5	445.6	39.2	246.0	3.3	22.3	39.5	56.0	54.0	22.1	20.4	166.4	109.2	86.8	29.6	62.4	9.5	50.8	102.1	67.9	297.1	47.1	25.2	74.5	95.6	177.1	25.1	4.8	32.9	273.1	112.1	12.2	135.6	86.6	37.0	7.1	10.2	135.0	216.0	27.4	41.9	18.6	301.8	245.8	34.2	46.1	26.3	33.7	54.5	15.3	31.9	24.0	22.9	144.1	49.1	91.3	113.9	36.2
CTSB		ENSG00000164733	"Cathepsin B"	P07858	8	11842524-11869533	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 2744.5;Kupffer cells: 1774.9;Macrophages: 1224.3"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 1446.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 390.6;classical monocyte: 610.1;intermediate monocyte: 467.3;myeloid DC: 287.4;non-classical monocyte: 307.6;plasmacytoid DC: 410.1"	"Group enriched"	"Detected in all"	6	"dendritic cells: 410.1;granulocytes: 390.6;monocytes: 610.1"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1607.5;fHDF/TERT166: 1436.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000457, HPA018156, HPA048998"	Enhanced		Supported	Nucleoli,Vesicles	"Secreted to blood"	NA	NA		100000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Nucleoli	"CAB000457: , HPA018156: AB_1846069, HPA048998: "	"unprognostic (5.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.12e-2)"	"prognostic favorable (5.76e-4)"	"prognostic unfavorable (9.02e-4)"	443.9	304.5	65.6	399.7	71.2	87.0	249.0	65.9	77.2	583.2	101.0	312.4	120.8	379.2	116.9	421.6	368.4	230.6	447.0	64.7	95.5	420.6	497.2	428.9	289.6	100.4	90.8	169.1	135.4	79.6	156.8	253.2	107.4	255.5	159.3	33.6	437.3	156.6	237.4	184.7	260.2	316.1	91.9	521.1	194.3	33.2	204.5	60.9	1150.7	99.3	104.0	431.9	477.8	159.2	66.6	283.4	4.0	94.9	657.3	754.5	128.3	885.0	1607.5	258.4	299.5	10.3	294.4	1.5	32.2	1436.1	419.3	279.5	65.3	157.1	195.6	25.9	52.6	58.8	10.0	397.1	479.2	7.7	73.7	296.4	532.2	327.2	427.3	611.5	33.4	20.2	81.7	260.7	194.6	62.5	6.5	23.1	16.3	839.7	91.3	33.6	39.3	202.7	2.6	121.1	4.9	68.6	165.1	68.6	514.6	110.1	97.8	68.7	922.4	766.5	111.9	129.9	259.3	182.7	178.5	4.8	432.5	22.9	249.4	390.6	610.1	90.6	26.3	467.3	35.4	44.1	79.0	31.5	287.4	38.8	48.3	21.5	97.8	31.3	307.6	410.1	78.7	703.7	65.6	71.2	65.9	77.2	64.7	95.5	100.4	90.8	107.4	91.9	204.5	159.2	87.7	109.0	171.4	17.6	54.8	54.7	441.6	563.2	54.7	55.2	94.1	74.5	320.1	165.8	331.7	114.0	41.7	279.4	122.4	147.9	27.4	294.6	15.6	105.8	240.1	163.0	154.7	210.2	36.2	238.2	341.7	155.0	44.4	183.5	179.4	105.9	204.2	239.5	2744.5	58.9	42.8	94.2	158.7	1774.9	436.5	18.5	76.4	1224.3	161.9	70.3	373.1	117.4	24.7	19.1	12.9	363.9	154.0	92.9	47.3	295.5	198.6	351.8	180.8	40.0	39.5	39.4	149.9	10.8	21.0	160.3	40.5	649.6	56.0	32.1	139.6	321.4
CTSC	"DPP1, PALS, PLS"	ENSG00000109861	"Cathepsin C"	P53634	11	88265069-88359684	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 900.7;Club cells: 471.8;Hofbauer cells: 1100.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1078.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025364, HPA066610, HPA068434"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	No	No		19000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"CAB025364: , HPA066610: AB_2685694, HPA068434: AB_2685989"	"unprognostic (4.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (9.30e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.07e-2)"	173.2	60.7	9.9	185.1	9.6	71.7	63.4	11.1	24.9	77.9	14.2	143.1	121.0	43.9	28.5	63.3	54.0	182.0	38.5	9.5	10.1	234.7	82.0	272.6	243.7	14.0	11.9	22.1	52.2	42.4	39.3	253.3	13.3	26.0	191.5	3.7	131.6	28.9	18.8	29.6	128.8	88.9	11.5	197.2	73.6	22.8	19.5	63.7	43.6	31.9	140.6	176.3	43.3	21.3	80.3	75.9	27.6	69.9	103.7	286.1	218.4	626.5	1078.4	372.8	270.3	194.7	361.3	117.3	278.9	365.2	84.3	133.6	50.4	269.2	341.9	204.7	82.8	144.5	188.0	233.5	140.2	188.9	108.7	419.1	198.8	284.5	697.4	302.1	377.6	122.3	155.3	145.4	54.8	14.8	89.1	295.1	172.2	551.5	244.9	113.6	30.7	227.0	451.3	106.6	8.8	66.8	81.2	114.9	80.6	185.4	27.9	152.7	149.3	23.5	190.5	156.8	364.6	61.9	81.0	122.9	56.8	435.8	122.4	85.5	203.8	309.7	230.1	415.6	194.9	47.2	99.6	198.2	209.9	26.3	49.5	115.3	215.0	200.5	582.9	425.0	162.7	243.3	9.9	9.6	11.1	24.9	9.5	10.1	14.0	11.9	13.3	11.5	19.5	21.3	78.6	22.4	88.1	0.3	40.8	30.1	7.3	900.7	33.6	1.5	15.9	14.6	4.4	52.9	471.8	40.5	0.0	414.1	330.6	37.9	29.4	29.8	1.6	13.4	135.6	94.8	11.4	29.7	3.0	90.6	159.2	114.4	39.8	21.2	75.3	25.5	26.4	15.8	1100.6	0.0	8.2	19.4	158.7	344.7	200.7	7.9	198.5	391.7	48.0	61.8	185.4	0.5	299.7	13.6	0.4	44.8	72.3	25.6	78.5	8.5	20.2	166.4	93.7	0.8	59.2	4.4	150.8	3.0	11.1	43.3	27.1	227.3	170.6	286.7	44.9	16.1
CTSD	"CLN10, CPSD"	ENSG00000117984	"Cathepsin D"	P07339	11	1752752-1764573	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"	"Alzheimer disease, Cancer-related genes, Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 1475.9;Hofbauer cells: 3763.5;Macrophages: 1512.6;Proximal enterocytes: 1699.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 2596.6;hTERT-RPE1: 2780.1;SK-BR-3: 2488.5"									"CAB000109, HPA003001"	Supported				"Secreted to blood"	NA	NA		370000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"CAB000109: , HPA003001: AB_1078404"	"unprognostic (9.95e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.65e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.86e-2)"	"prognostic favorable (4.93e-5)"	"unprognostic (8.98e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.60e-1)"	318.6	734.6	147.0	204.9	181.9	499.0	244.0	186.0	156.5	270.8	672.7	298.0	387.6	170.7	82.8	319.4	171.6	438.4	444.1	187.8	223.6	691.6	464.8	539.6	241.0	247.6	206.6	130.7	284.8	137.3	131.5	180.7	228.6	138.2	153.4	48.3	422.1	231.7	590.3	340.9	398.3	105.0	188.9	442.0	287.2	88.9	334.4	78.1	182.1	178.2	123.1	296.4	307.5	367.1	204.6	578.9	51.4	246.2	586.5	206.3	112.1	149.4	362.2	161.8	182.8	147.5	2596.6	49.2	376.8	285.8	1265.6	1072.2	63.7	142.6	35.8	206.7	222.9	70.4	92.5	196.5	736.2	171.4	787.7	350.9	621.6	82.5	136.9	2780.1	128.2	62.1	89.2	267.6	263.3	832.6	47.0	110.9	153.1	719.7	247.9	62.5	72.5	191.2	586.6	610.8	84.2	94.8	173.3	2488.5	535.0	68.6	1022.8	232.6	170.3	556.8	92.9	79.0	216.7	432.0	382.3	26.8	867.7	468.6	509.6	211.2	578.7	170.1	156.5	309.9	90.6	28.8	72.1	110.3	144.5	18.8	82.5	107.4	319.5	192.3	265.2	120.3	89.2	489.1	147.0	181.9	186.0	156.5	187.8	223.6	247.6	206.6	228.6	188.9	334.4	367.1	139.3	112.2	228.6	48.3	62.8	72.0	223.5	473.2	71.7	168.6	108.9	113.8	251.9	314.5	459.5	548.1	110.5	211.7	156.1	1475.9	109.5	911.4	3.3	118.1	67.4	128.3	159.6	132.6	18.3	370.1	165.0	157.0	237.5	203.4	474.3	119.4	695.7	678.9	3763.5	264.2	25.2	418.2	498.5	1187.8	67.5	14.6	108.4	1512.6	227.7	20.6	382.6	179.0	256.4	27.2	42.2	392.3	832.5	128.2	122.5	111.7	1699.4	311.8	270.3	102.1	111.7	70.7	135.2	26.6	63.5	141.2	82.1	471.3	155.0	96.0	399.1	357.8
CTSF	"CATSF, CLN13"	ENSG00000174080	"Cathepsin F"	Q9UBX1	11	66563464-66568879	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 320.9;Muller glia cells: 196.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 23.1;SK-MEL-30: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002141, HPA031431"	Approved		Supported	"Endoplasmic reticulum,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		5800000	"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Endoplasmic reticulum, Plasma membrane"	"CAB002141: AB_563471, HPA031431: "	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.12e-2)"	"prognostic favorable (8.92e-7)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.42e-1)"	57.8	70.0	68.1	0.8	76.3	0.3	62.2	74.5	74.0	78.8	90.2	76.7	3.0	89.2	21.9	15.6	70.8	10.0	100.2	63.2	74.2	46.9	66.0	32.9	3.6	75.0	70.3	99.1	31.7	20.0	43.3	3.8	68.4	53.5	3.5	26.2	55.7	17.1	91.9	44.4	29.5	12.2	77.2	25.0	54.3	109.7	71.0	3.0	40.6	27.6	3.0	56.6	58.7	86.6	0.0	17.0	3.1	5.4	14.2	8.6	3.4	13.0	11.4	6.3	2.3	0.0	2.2	0.0	21.3	10.4	0.0	1.2	6.8	2.6	4.8	3.7	0.0	0.5	7.0	0.0	9.9	0.3	4.4	22.3	9.1	0.8	1.6	13.7	3.8	2.0	5.4	1.6	5.2	4.6	0.1	1.7	0.9	3.7	9.7	0.0	0.0	1.5	7.1	0.3	4.3	6.9	23.1	0.3	59.5	0.3	7.4	0.6	3.3	1.8	2.9	1.5	1.2	21.2	0.2	0.0	2.2	0.0	2.9	0.0	0.4	0.3	3.9	0.6	4.1	1.5	3.5	4.6	0.6	1.4	6.4	4.1	0.1	4.6	0.2	0.9	1.3	2.2	68.1	76.3	74.5	74.0	63.2	74.2	75.0	70.3	68.4	77.2	71.0	86.6	36.6	12.8	15.6	31.3	5.9	39.8	62.4	8.5	37.5	107.9	45.3	80.6	57.9	41.5	7.4	36.8	41.7	31.6	9.6	0.6	15.6	13.1	163.3	1.7	22.8	27.2	12.0	11.4	26.5	7.5	9.5	118.1	8.2	5.3	9.5	52.1	56.0	67.8	14.9	134.6	31.3	3.1	18.3	21.5	32.8	320.9	145.7	13.1	156.5	12.2	3.1	196.6	17.5	21.6	29.4	5.9	3.2	121.9	12.9	50.5	1.3	44.7	3.3	77.9	78.9	62.0	45.9	169.6	43.3	3.6	25.3	23.7	9.5	30.7	4.3	32.9
CTSK	"CTSO, CTSO2, PKND, PYCD"	ENSG00000143387	"Cathepsin K"	P43235	1	150794880-150809577	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 420.6"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 372.4;Langerhans cells: 123.6;Leydig cells: 119.0;Melanocytes: 97.8;Peritubular cells: 149.7;Theca cells: 80.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebral cortex: 18.1"	"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.8"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.8"	"Group enriched"	"Detected in many"	9	"ASC diff: 2284.0;ASC TERT1: 813.2;BJ hTERT+: 1949.1"	"Low region specificity"	"Detected in all"							HPA050346			Supported	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA050346: AB_2681101"	"unprognostic (1.48e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.61e-3)"	"unprognostic (5.08e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (7.12e-5)"	"unprognostic (6.07e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.41e-2)"	224.1	12.5	2.7	33.1	2.8	3.1	227.7	2.9	18.1	420.6	16.4	68.6	13.8	334.0	44.9	46.0	74.0	299.2	35.8	2.7	2.6	12.7	9.0	36.4	42.1	2.7	2.7	78.4	10.6	6.1	14.6	18.9	2.6	34.1	61.8	6.9	53.3	38.0	15.7	219.8	63.8	141.6	2.8	20.2	41.7	15.1	2.7	12.3	34.7	46.3	48.7	210.5	176.2	2.9	0.7	0.3	1.4	0.8	2284.0	813.2	1.0	55.2	1949.1	3.3	8.3	0.3	0.3	0.4	0.6	129.8	0.0	0.6	0.3	0.4	1.2	0.4	0.4	1.4	0.5	0.0	11.0	0.2	1.3	156.5	1.7	50.5	0.7	137.6	4.2	0.6	0.4	1.4	1.5	1.4	0.0	3.0	10.2	1.0	0.0	0.2	0.1	0.1	3.2	0.1	0.6	2.9	0.4	0.0	29.3	3.9	1.0	1.5	1.0	0.7	0.5	0.6	0.6	2.3	1.7	3.6	184.1	0.0	9.9	0.0	1.8	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.4	0.6	2.7	2.8	2.9	18.1	2.7	2.6	2.7	2.7	2.6	2.8	2.7	2.9	17.9	3.2	4.6	2.6	1.1	68.8	0.5	1.6	2.2	12.1	3.7	9.5	2.0	1.5	3.9	3.7	4.2	1.3	2.8	1.5	0.0	1.0	0.9	2.5	59.0	10.2	1.2	0.8	5.0	0.2	2.5	372.4	11.2	3.8	0.0	77.5	14.6	0.5	21.4	3.3	7.7	1.6	8.2	4.6	123.6	4.4	119.0	8.7	97.8	7.5	4.9	2.7	3.1	7.1	2.5	1.4	1.4	149.7	0.8	1.0	1.4	0.1	2.2	7.7	13.1	4.5	33.9	1.4	1.0	2.6	59.1	1.0	5.4	80.9	1.0	0.7
CX3CR1	"CCRL1, CMKBRL1, CMKDR1, GPR13, V28"	ENSG00000168329	"C-X3-C motif chemokine receptor 1"	P49238	3	39263495-39281735	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	"G-protein coupled receptor, Receptor, Transducer"	"Age-related macular degeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.4"	"Group enriched"	"Detected in some"	5	"Microglial cells: 177.1;NK-cells: 350.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 21.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 449.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	21	"RPMI-8226: 589.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032478, HPA046587"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"CAB032478: AB_638830, HPA046587: AB_2679708"	"unprognostic (2.00e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.42e-2)"	"unprognostic (6.52e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.59e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.12e-1)"	2.3	3.8	6.2	6.9	6.4	1.1	5.1	8.6	6.0	2.7	1.7	1.1	1.2	2.7	4.2	0.8	6.1	2.6	2.4	7.7	8.4	2.5	2.0	9.9	2.1	17.3	14.8	1.6	0.7	4.5	1.0	4.6	18.9	3.5	1.1	0.5	7.6	7.2	6.5	2.3	0.9	3.5	21.5	11.9	1.4	1.8	17.4	2.0	2.4	2.2	5.3	2.4	0.3	26.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.2	6.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	24.5	0.0	0.2	0.2	0.5	0.1	0.0	0.0	0.2	0.1	589.8	0.0	0.0	0.1	0.1	0.0	8.1	0.0	0.2	0.1	16.5	0.0	0.0	0.1	0.1	0.0	0.5	1.0	0.1	0.0	28.6	0.0	7.7	99.6	1.8	264.0	261.2	3.4	0.8	55.9	145.2	94.4	0.7	19.0	122.4	20.8	39.7	449.2	7.1	1.5	232.7	6.2	6.4	8.6	6.0	7.7	8.4	17.3	14.8	18.9	21.5	17.4	26.4	0.8	0.0	0.5	0.7	0.7	0.5	0.0	0.0	0.0	0.0	0.8	3.8	0.4	0.0	0.6	0.0	0.0	0.0	44.3	0.0	0.0	0.0	0.2	0.2	0.1	3.5	0.0	2.1	0.3	0.0	0.0	0.3	0.0	0.0	5.1	0.1	0.7	0.3	4.1	0.0	0.6	0.0	0.0	15.0	28.0	0.3	0.3	43.2	0.0	177.1	50.3	0.1	350.1	2.0	0.4	0.0	0.0	0.0	1.4	0.0	0.0	0.4	0.7	0.2	6.6	0.4	1.3	0.7	0.2	0.0	0.6	0.0	22.6	0.1	0.1	0.0
CYB561	"CYB561A1, FRRS2"	ENSG00000008283	"Cytochrome b561"	P49447	17	63432304-63446354	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Transport"	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 74.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"pons: 124.7"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 432.2;SK-BR-3: 209.2;T-47d: 168.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014753	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"			"HPA014753: AB_1847364"	"prognostic unfavorable (8.89e-5)"	"unprognostic (2.90e-1)"	"unprognostic (4.01e-1)"	"prognostic favorable (2.95e-5)"	"unprognostic (1.81e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.91e-2)"	"unprognostic (8.97e-2)"	"unprognostic (6.38e-2)"	"unprognostic (8.09e-3)"	"unprognostic (1.16e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.89e-1)"	14.8	125.6	22.2	12.3	24.4	4.1	32.8	6.8	23.1	45.0	70.6	26.4	36.6	12.3	57.2	51.9	55.8	17.3	16.2	20.4	33.2	24.5	21.0	30.9	8.3	17.2	23.2	9.4	118.0	76.1	74.1	16.2	124.7	63.3	21.1	9.8	85.0	37.8	6.0	37.3	31.9	9.2	9.8	8.7	48.1	6.0	28.0	3.5	40.8	4.6	12.8	16.4	27.4	17.9	99.3	31.9	2.6	20.5	11.5	52.7	43.3	10.3	12.0	12.3	4.9	29.2	96.9	0.2	23.0	75.5	3.3	83.1	20.3	8.0	4.8	26.1	8.7	12.7	20.4	2.0	21.7	1.3	4.3	8.6	84.1	11.2	1.5	17.9	23.9	0.1	41.2	17.7	4.0	140.3	0.5	4.9	20.9	80.5	49.9	0.3	0.2	31.0	40.0	49.8	73.7	432.2	26.0	209.2	10.4	7.3	168.6	6.2	3.6	25.9	29.4	60.6	3.1	0.4	0.4	0.1	22.6	5.1	14.0	0.3	2.0	0.2	19.2	5.7	24.6	0.6	14.4	13.2	2.1	0.6	1.3	4.2	5.2	20.3	7.7	0.1	0.0	5.8	22.2	24.4	6.8	23.1	20.4	33.2	17.2	23.2	124.7	9.8	28.0	17.9	14.6	28.9	37.8	3.6	3.5	16.4	23.7	16.0	26.2	6.1	37.4	24.6	12.8	20.0	36.7	23.9	0.0	25.1	7.0	22.2	3.9	41.1	6.9	74.5	12.5	18.3	21.6	3.4	14.1	50.5	29.2	15.0	30.1	53.9	15.9	7.3	11.4	11.1	4.7	0.0	10.7	31.7	18.3	7.0	9.8	6.2	3.7	4.1	3.6	9.4	6.0	5.2	2.1	0.5	0.6	30.8	11.4	3.4	15.3	41.6	32.1	11.9	68.5	26.8	6.6	5.1	7.6	6.9	7.2	34.2	27.8	24.8	11.4	0.4	26.2	22.6
CYB5R3	DIA1	ENSG00000100243	"Cytochrome b5 reductase 3"	P00387	22	42617840-42649392	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 830.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001566	Approved		Supported	"Endoplasmic reticulum"		NA	NA		1500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum"		"HPA001566: AB_1078601"	"unprognostic (4.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (2.13e-5)"	"unprognostic (2.45e-1)"	"unprognostic (8.22e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.24e-2)"	404.4	310.5	147.1	87.4	152.9	82.7	272.2	145.7	189.9	237.3	115.0	192.4	94.8	248.4	58.8	152.4	174.0	139.5	374.3	138.7	163.9	182.9	279.4	201.3	76.3	194.7	174.2	218.3	89.1	62.0	137.4	107.8	169.9	181.4	74.9	27.3	149.8	239.3	203.0	233.6	138.1	200.2	154.8	101.4	182.0	142.7	156.7	54.0	157.8	140.5	72.3	216.7	210.0	160.2	125.5	78.6	126.6	78.6	830.9	654.7	74.4	359.2	330.0	262.2	232.4	104.0	95.6	58.8	156.6	668.8	113.8	112.4	85.3	178.0	133.7	63.9	187.3	83.6	127.3	202.4	211.0	118.4	149.5	397.4	138.1	188.9	124.5	190.8	220.0	74.0	73.5	296.3	361.9	137.9	116.8	108.4	51.0	129.2	142.7	84.9	153.8	131.3	202.0	90.6	56.1	73.2	118.6	113.2	134.0	92.6	90.6	112.0	340.9	282.0	175.3	192.3	137.9	78.3	91.2	72.4	328.8	67.8	237.9	126.3	104.0	300.3	75.9	135.3	76.6	110.1	72.8	83.9	154.0	102.7	50.8	54.0	53.8	63.5	176.7	140.8	95.0	86.4	147.1	152.9	145.7	189.9	138.7	163.9	194.7	174.2	169.9	154.8	156.7	160.2	238.5	86.6	62.2	17.0	51.7	110.1	95.5	184.8	27.3	16.7	52.3	73.2	106.4	105.8	100.9	60.7	4.2	110.0	37.0	90.5	49.0	216.4	4.8	51.4	82.9	161.5	83.7	113.9	12.3	107.0	199.3	183.4	38.2	65.4	62.8	57.8	180.2	230.4	108.3	16.8	16.1	45.8	142.4	50.6	112.0	17.0	253.9	67.7	176.1	25.3	112.5	91.0	33.0	7.1	26.4	156.8	85.6	280.6	36.7	82.3	116.9	110.8	53.3	18.4	190.7	62.5	202.5	23.8	45.5	57.5	112.7	117.9	43.0	233.1	55.2	96.4
CYBA	p22-PHOX	ENSG00000051523	"Cytochrome b-245 alpha chain"	P13498	16	88643289-88651054	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Transport"	Oxidoreductase	"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 742.0;lymphoid tissue: 693.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 1632.1;Hofbauer cells: 2171.9;Kupffer cells: 1734.2;Macrophages: 1682.8;monocytes: 1688.5;NK-cells: 1805.4;Plasma cells: 1990.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 733.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 1058.3;RPMI-8226: 1631.2;THP-1: 1231.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009492	Enhanced					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB009492: AB_2090309"	"prognostic favorable (8.19e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (4.75e-5)"	"unprognostic (2.42e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.88e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (1.91e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.63e-2)"	149.9	68.0	40.3	344.4	41.8	742.0	93.3	46.0	58.0	81.9	62.4	200.9	196.6	60.8	38.5	80.9	95.4	122.5	93.2	38.6	55.0	187.7	71.5	234.6	333.8	73.8	49.3	40.0	108.6	13.4	40.6	54.9	64.1	75.2	79.9	1.8	116.7	26.6	41.8	39.4	245.3	51.3	65.4	693.1	236.0	10.4	62.4	87.1	136.5	19.9	192.8	144.6	74.1	92.2	2.5	663.0	2.6	1.5	1.3	0.4	329.5	155.7	77.3	39.3	24.1	447.2	819.6	510.5	420.7	56.4	0.0	250.5	21.4	0.9	5.8	146.1	564.1	99.0	217.7	694.9	75.7	156.3	397.6	80.7	0.0	1.6	0.3	1.9	23.9	103.6	278.5	567.5	3.2	1058.3	147.9	822.3	106.2	248.7	1.5	437.9	1.6	1631.2	324.9	490.9	84.2	76.5	482.7	78.8	138.5	60.8	1.4	1231.3	129.8	1.5	6.1	1.8	2.2	362.9	459.9	543.6	195.5	464.9	53.4	120.2	103.8	733.7	76.7	150.1	55.8	109.8	36.7	70.4	107.0	110.7	28.9	36.7	192.3	36.4	143.3	196.3	41.2	47.3	40.3	41.8	46.0	58.0	38.6	55.0	73.8	49.3	64.1	65.4	62.4	92.2	157.8	16.0	12.4	0.0	1290.9	119.4	233.4	420.8	53.5	0.4	131.7	133.2	12.8	368.9	487.1	285.1	2.1	45.3	1632.1	807.2	127.2	636.8	4.2	219.5	137.5	137.1	230.5	162.7	0.2	155.3	299.0	184.8	285.4	312.5	279.0	104.3	317.0	23.9	2171.9	0.0	0.2	540.3	233.9	1734.2	1370.8	14.0	50.1	1682.8	1152.6	32.8	1688.5	1.6	1805.4	1.0	0.2	682.8	1045.8	21.4	1990.6	191.8	390.4	1057.4	529.7	2.7	59.2	44.0	164.3	0.9	15.6	75.2	85.7	118.2	838.6	20.5	805.2	436.9
CYBB	"CGD, GP91-PHOX, NOX2"	ENSG00000165168	"Cytochrome b-245 beta chain"	P04839	X	37780059-37813461	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"	"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 160.9;lymphoid tissue: 158.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 157.2;Kupffer cells: 456.0;Macrophages: 469.3;monocytes: 396.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 276.3;intermediate monocyte: 261.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 90.9;granulocytes: 110.5;monocytes: 276.3"	"Group enriched"	"Detected in some"	5	"Daudi: 52.8;NB-4: 64.2;REH: 54.6;RPMI-8226: 210.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051227	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA051227: AB_2681395"	"unprognostic (5.83e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.32e-2)"	"unprognostic (5.73e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.72e-2)"	40.5	28.4	5.5	158.9	5.3	160.9	15.2	6.5	5.5	12.3	12.4	22.3	19.3	9.3	4.3	8.9	9.9	26.2	8.0	4.7	9.1	8.0	27.5	91.5	97.1	15.1	9.6	6.9	4.0	4.4	2.5	54.6	13.3	6.7	30.6	1.7	7.0	9.7	3.7	2.2	22.3	55.5	12.5	89.0	17.2	4.7	11.1	18.3	5.3	5.5	73.2	46.8	2.3	24.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	52.8	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.4	3.6	0.6	0.0	0.0	3.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.1	64.2	0.2	0.0	0.3	54.6	0.0	210.4	0.0	0.1	0.4	0.1	0.0	0.4	0.0	0.0	0.1	20.0	0.0	0.0	0.1	0.1	0.2	0.6	1.6	3.4	0.0	8.9	0.0	2.2	276.3	110.5	0.4	261.6	0.5	39.6	0.3	0.4	62.8	32.8	0.3	0.2	19.2	0.6	237.1	90.9	0.9	162.5	5.5	5.3	6.5	5.5	4.7	9.1	15.1	9.6	13.3	12.5	11.1	24.0	2.4	25.6	25.4	0.7	99.9	1.0	0.1	0.0	0.6	0.1	1.0	3.0	11.0	2.8	13.0	1.8	0.0	0.9	82.7	2.0	0.0	0.0	0.6	0.2	0.1	8.1	0.0	5.2	1.6	0.4	1.1	4.4	4.1	0.1	7.6	0.1	5.0	3.2	157.2	1.7	1.6	0.7	0.0	456.0	25.0	0.7	0.6	469.3	1.8	76.8	396.6	0.1	14.4	0.0	0.1	0.1	0.5	0.0	13.6	0.0	0.6	0.5	7.3	0.7	13.1	1.6	1.2	0.0	0.6	1.9	1.3	1.8	7.5	0.0	1.3	0.1
CYC1	UQCR4	ENSG00000179091	"Cytochrome c1"	P08574	8	144095039-144097525	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 730.0;tongue: 724.9"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 817.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 1125.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001247	Supported		Approved	Mitochondria		NA	NA		45000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA001247: AB_1078602"	"unprognostic (3.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.92e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (5.89e-6)"	"unprognostic (6.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.13e-2)"	84.7	173.2	92.1	62.4	97.2	104.4	72.7	115.4	103.8	71.4	102.4	162.6	171.2	75.9	35.7	155.5	67.8	39.5	527.7	92.3	105.3	152.6	180.4	56.7	55.8	99.8	96.9	63.6	101.2	163.3	58.2	45.8	103.1	67.8	111.0	42.0	104.4	70.0	730.0	106.5	127.5	59.9	94.9	70.1	139.6	38.9	106.9	63.4	64.8	724.9	61.0	92.0	86.5	99.6	172.0	381.4	98.9	208.4	80.5	88.5	189.6	96.7	116.7	240.2	156.9	269.4	208.2	241.0	210.8	129.8	116.2	247.3	217.9	191.2	89.8	148.2	289.2	259.7	306.5	250.4	143.1	154.7	162.5	129.4	234.9	153.2	301.4	80.6	141.3	163.7	240.4	208.2	127.7	616.8	292.0	143.5	115.1	476.8	1125.5	253.7	132.4	422.1	199.7	273.0	263.3	117.2	267.8	365.7	200.0	54.0	302.5	233.2	108.8	152.1	321.6	169.6	299.7	229.1	179.7	183.8	193.2	261.9	198.4	185.7	340.4	95.7	131.6	360.4	139.8	208.7	108.1	141.5	444.1	180.3	104.9	134.6	32.7	187.8	278.8	251.0	158.2	397.1	92.1	97.2	115.4	103.8	92.3	105.3	99.8	96.9	103.1	94.9	106.9	99.6	77.0	19.2	29.3	23.5	94.0	156.1	191.9	394.8	62.6	113.6	110.7	102.6	402.3	181.6	156.0	79.1	81.3	263.6	61.7	516.1	817.8	239.9	81.2	59.1	68.1	88.0	146.4	130.6	14.4	289.1	257.1	102.8	144.8	60.2	59.7	89.2	62.4	239.4	246.3	87.5	21.6	390.4	272.6	104.8	139.4	88.6	88.9	101.4	179.7	12.2	208.4	115.2	92.7	12.1	17.5	290.6	332.5	90.7	149.9	237.9	570.0	468.6	86.1	100.9	72.3	109.4	250.6	83.1	116.7	212.9	163.7	236.8	63.8	197.5	602.6	258.3
CYLD	"CYLD1, KIAA0849, USPL2"	ENSG00000083799	"CYLD lysine 63 deubiquitinase"	Q9NQC7	16	50742050-50801935	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 94.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 136.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011713, HPA050095"	Approved		Supported	"Nucleoplasm,Centriolar satellite"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Centriolar satellite"	Nucleoplasm	"CAB011713: AB_731794, HPA050095: AB_2681013"	"unprognostic (9.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.24e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (8.42e-2)"	14.3	22.0	23.9	38.8	23.5	94.3	13.6	17.9	18.2	13.0	22.3	16.3	16.1	15.1	12.1	23.3	11.0	20.5	20.1	17.3	23.3	14.2	21.0	21.5	53.4	21.3	27.8	15.4	15.2	23.0	15.4	15.4	23.6	16.3	19.3	22.0	18.9	16.0	34.3	15.2	16.2	16.8	21.6	39.0	19.9	38.3	32.7	35.6	24.9	20.5	48.4	24.1	12.9	24.2	26.9	8.3	9.4	10.6	14.3	21.0	8.7	39.1	56.7	39.9	23.4	6.9	12.5	30.7	13.7	38.3	43.4	10.3	11.3	23.7	58.7	136.6	16.6	15.5	15.3	5.8	29.1	15.4	69.5	23.0	18.6	48.1	50.1	37.7	16.3	21.3	6.6	26.1	56.4	4.0	14.4	22.3	10.1	8.5	13.3	13.4	18.8	29.4	12.9	9.1	12.0	9.2	33.1	11.2	9.8	14.3	11.0	18.9	18.6	67.2	15.4	23.4	15.9	68.0	68.4	33.2	49.3	16.7	14.7	64.6	15.2	38.3	18.1	17.7	21.8	17.2	27.1	24.5	18.3	11.1	24.4	19.4	32.3	25.7	18.8	11.0	37.3	19.5	23.9	23.5	17.9	18.2	17.3	23.3	21.3	27.8	23.6	21.6	32.7	24.2	28.8	44.8	31.8	31.6	87.7	120.1	59.5	32.2	40.9	89.2	35.5	26.0	34.4	21.5	32.9	18.4	93.8	6.8	84.1	28.3	5.9	20.0	48.2	22.5	24.9	36.0	31.1	26.1	51.9	19.1	4.4	37.3	22.4	47.1	80.5	21.4	27.8	25.5	21.5	67.3	54.7	10.7	30.5	40.0	127.6	31.3	25.4	66.4	74.7	57.1	63.7	23.3	70.0	51.8	119.2	18.0	22.4	21.1	79.7	66.4	15.4	13.9	23.3	48.3	6.6	54.2	30.5	59.2	15.2	64.3	155.6	4.1	119.5	21.3	14.8	66.7
CYP11B2	"ALDOS, CPN2, CYP11B, CYP11BL, P-450C18, P450aldo"	ENSG00000179142	"Cytochrome P450 family 11 subfamily B member 2"	P19099	8	142910559-142917843	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism, Steroidogenesis"	"Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	603	"adrenal gland: 179.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049171, HPA049565, HPA056348, HPA057752"	Supported		Uncertain	Mitochondria		NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"		"Cluster 43: Cardiomyocytes - Nuclear processes"	Mitochondria		"HPA049171: AB_2680661, HPA049565: , HPA056348: AB_2683104, HPA057752: AB_2683516"																		0.0	179.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP1B1	"CP1B, GLC3A"	ENSG00000138061	"Cytochrome P450 family 1 subfamily B member 1"	Q16678	2	38066973-38109902	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism, Steroid metabolism"	"Lyase, Monooxygenase, Oxidoreductase"	"Disease variant, Glaucoma, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Peritubular cells: 170.8;Prostatic glandular cells: 747.6;Urothelial cells: 498.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"classical monocyte: 156.9"	"Lineage enriched"	"Detected in many"	24	"monocytes: 156.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 128.7;ASC TERT1: 136.8;HSkMC: 551.3;hTERT-RPE1: 128.9;SiHa: 270.0;U-87 MG: 142.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"spinal cord: 34.6"	"CAB011705, HPA026863"	Approved		Uncertain	Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"CAB011705: AB_731810, HPA026863: AB_10600900"	"unprognostic (7.25e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (1.87e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (2.76e-4)"	28.4	12.0	2.7	31.9	6.2	2.0	29.4	1.6	8.9	34.9	10.4	3.7	2.2	41.0	19.5	7.6	44.9	23.8	29.2	2.5	2.3	24.1	7.0	16.8	11.6	3.6	2.9	5.6	7.2	0.9	14.8	4.5	3.0	34.7	2.1	1.2	4.3	39.2	3.4	6.3	5.8	35.1	3.6	27.3	15.9	8.0	7.3	28.3	8.7	5.5	1.9	35.0	6.7	1.5	7.0	71.9	2.3	0.0	128.7	136.8	0.4	0.6	4.4	1.3	12.3	0.2	30.1	0.0	19.1	17.8	3.1	58.7	0.3	4.0	2.3	5.5	3.8	0.0	21.2	0.0	36.0	0.2	0.1	551.3	55.3	30.7	1.4	128.9	0.0	0.3	0.7	0.2	0.7	29.2	0.3	22.5	7.5	10.4	14.2	0.1	0.0	0.2	13.4	0.9	0.5	2.1	270.0	38.8	0.0	7.5	49.4	10.8	0.0	1.1	0.2	107.9	0.1	0.3	0.2	0.0	142.2	0.1	11.8	1.6	156.9	0.0	0.1	23.2	0.0	0.1	0.1	0.0	1.5	0.0	0.1	0.1	6.5	0.1	18.6	0.7	0.1	70.2	2.7	6.2	1.6	8.9	2.5	2.3	3.6	2.9	3.0	3.6	7.3	1.5	56.8	19.2	66.3	0.0	1.7	17.7	118.4	86.9	8.0	0.7	18.3	42.0	3.4	0.0	79.7	46.0	0.0	0.3	1.1	0.9	15.6	6.0	15.1	11.7	100.4	103.8	1.8	0.0	4.5	0.5	0.8	114.1	3.6	28.2	3.8	0.1	7.5	12.2	12.6	0.0	0.3	1.3	4.1	103.0	50.6	12.1	159.7	112.2	17.8	64.6	140.1	1.6	3.1	0.0	0.2	0.6	0.1	170.8	0.3	747.6	0.1	1.6	11.2	0.5	19.7	4.5	32.7	12.6	2.6	2.4	14.2	0.3	2.4	1.3	1.0	498.7
CYP21A2	"CA21H, CAH1, CPS1, CYP21, CYP21B, P450c21B"	ENSG00000231852	"Cytochrome P450 family 21 subfamily A member 2"	P08686	6	32038327-32041644	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Steroidogenesis	"Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	46	"adrenal gland: 2041.7"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 15.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HDLM-2: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048979, HPA053371"	Enhanced					NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA048979: AB_2680584, HPA053371: AB_2682131"	"unprognostic (1.03e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.76e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.67e-7)"	"unprognostic (7.39e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.82e-1)"	2.0	2041.7	0.0	0.0	0.0	0.0	1.5	0.0	0.6	1.9	0.0	2.5	0.0	1.5	0.6	0.6	2.4	0.0	2.9	0.0	0.0	7.0	44.8	0.8	0.0	0.0	0.0	4.3	0.9	0.0	1.9	0.0	0.0	1.9	0.0	0.0	4.0	0.0	0.3	0.7	1.1	0.0	0.0	5.5	0.8	0.8	0.0	0.0	2.3	0.0	0.0	2.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.4	2.4	0.5	0.3	1.5	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.1	0.8	0.9	1.8	0.0	0.1	0.0	0.0	1.6	0.0	0.2	1.3	0.4	0.0	15.9	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.6	0.1	1.8	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	2.0	1.2	0.6	0.0	0.3	0.6	0.6	0.4	0.0	0.0	0.0	0.3	1.0	0.0	0.0
CYP24A1	"CP24, CYP24, P450-CC24"	ENSG00000019186	"Cytochrome P450 family 24 subfamily A member 1"	Q07973	20	54153446-54173986	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"endometrium 1: 14.9;kidney: 35.3;lymphoid tissue: 10.5;placenta: 10.0;urinary bladder: 28.7"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 48.3;Basal respiratory cells: 142.7;Basal squamous epithelial cells: 74.0;Club cells: 47.0;Proximal tubular cells: 61.3;Urothelial cells: 36.7"	"Cancer enhanced"	"Detected in many"		"lung cancer: 18.3;urothelial cancer: 21.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"A549: 411.5;Hep G2: 122.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA022261, HPA063771"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA022261: AB_1847427, HPA063771: AB_2685120"	"unprognostic (1.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.69e-3)"	"unprognostic (3.30e-1)"	"unprognostic (2.30e-2)"		"unprognostic (1.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.12e-1)"	0.0	0.0	0.2	0.4	0.4	0.0	3.7	0.0	0.3	1.7	0.0	0.0	0.1	14.9	0.2	3.8	0.2	0.0	0.0	0.1	1.8	35.3	0.4	0.7	0.2	0.4	2.0	0.0	0.0	0.0	0.2	10.0	0.3	2.9	0.0	0.0	0.3	2.0	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.2	1.3	0.0	10.5	28.7	1.3	0.2	0.5	411.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	12.6	0.0	3.2	0.0	0.9	15.8	0.0	0.1	0.1	0.0	0.0	0.0	6.5	122.6	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	7.0	1.3	0.0	2.6	0.6	0.0	0.1	0.1	0.0	0.0	0.0	16.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.1	1.8	0.4	2.0	0.3	0.1	0.6	0.2	0.0	0.0	0.0	0.0	1.3	22.8	48.3	142.7	74.0	0.0	11.0	8.6	0.4	0.0	47.0	0.0	0.0	0.1	0.1	0.1	5.9	0.1	0.0	0.7	0.5	0.3	0.0	0.0	0.2	0.0	0.1	2.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	9.8	0.0	61.3	13.1	0.0	0.0	0.0	0.6	0.0	0.0	3.3	19.6	0.1	0.1	0.0	0.2	36.7
CYP27A1	"CP27, CTX, CYP27"	ENSG00000135929	"Cytochrome P450 family 27 subfamily A member 1"	Q02318	2	218781749-218815293	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"liver: 594.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 404.3;Hofbauer cells: 148.9;Proximal enterocytes: 206.3"	"Group enriched"	"Detected in all"	4	"liver cancer: 176.9;melanoma: 85.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 151.5;neutrophil: 126.3"	"Group enriched"	"Detected in many"	21	"granulocytes: 126.3;monocytes: 151.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 299.6;HSkMC: 54.7;RPTEC TERT1: 78.5;SK-MEL-30: 103.6;WM-115: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059155	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria	Cytosol	"HPA059155: AB_2683933"	"prognostic favorable (1.05e-4)"	"unprognostic (4.21e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.71e-3)"	"unprognostic (1.31e-2)"	"prognostic favorable (8.62e-6)"	"unprognostic (6.04e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.25e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	23.1	50.3	45.2	15.7	59.0	1.3	21.8	57.0	59.3	27.6	75.6	27.6	77.8	19.8	11.6	11.9	34.0	19.1	30.7	42.2	49.3	46.4	594.4	71.7	24.6	63.0	56.1	32.6	8.3	18.5	29.6	6.2	62.7	41.8	20.7	22.5	40.4	29.5	37.9	17.5	81.9	13.2	50.6	13.0	13.8	12.6	58.8	23.6	12.6	49.2	28.0	24.3	23.2	69.2	0.2	0.0	2.7	0.2	4.6	3.3	0.4	1.9	11.7	3.9	7.8	13.7	0.8	0.0	4.3	7.6	0.2	0.1	0.0	0.0	1.7	1.4	1.0	0.0	0.4	299.6	16.2	0.4	0.3	54.7	0.5	0.1	0.0	12.8	5.9	0.0	0.3	0.1	8.3	0.0	0.0	0.2	2.3	0.3	0.5	0.1	2.4	0.5	78.5	0.2	0.2	0.2	0.1	0.0	103.6	2.4	1.6	2.2	5.9	0.0	0.2	0.1	6.0	0.0	0.0	0.1	0.1	0.3	42.9	0.0	151.5	0.4	0.2	17.1	0.3	0.7	0.2	0.5	6.5	0.0	0.1	0.0	126.3	0.0	1.2	0.8	0.0	44.1	45.2	59.0	57.0	59.3	42.2	49.3	63.0	56.1	62.7	50.6	58.8	69.2	10.6	3.2	28.9	33.6	0.9	5.2	52.4	8.5	21.6	15.3	12.7	18.8	5.1	17.2	11.3	3.7	27.1	0.7	0.5	37.0	9.8	12.1	1.0	12.6	4.3	10.3	24.5	8.4	2.2	12.0	0.7	35.4	2.6	14.8	2.5	1.9	19.6	404.3	148.9	10.1	3.9	20.0	4.1	18.2	5.1	1.0	47.5	104.3	49.8	15.0	92.4	28.7	0.0	26.7	108.5	9.7	44.0	26.7	0.0	43.3	206.3	76.9	21.4	14.1	0.0	12.8	7.2	0.7	0.1	3.2	3.1	1.2	2.3	1.2	30.3	20.4
CYP27B1	"CYP1, P450c1, PDDR, VDD1"	ENSG00000111012	"Cytochrome P450 family 27 subfamily B member 1"	O15528	12	57762334-57768986	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 15.2;thyroid gland: 5.7"	"Group enriched"	"Detected in many"	5	"Exocrine glandular cells: 22.1;monocytes: 22.8;Proximal tubular cells: 36.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 13.6;RH-30: 22.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (8.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.75e-3)"	"unprognostic (4.10e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (5.67e-3)"	0.3	0.9	0.3	0.7	0.3	0.8	0.8	0.3	0.4	0.2	0.3	0.4	0.4	0.2	0.6	0.4	0.2	0.5	0.1	0.3	0.3	15.2	0.6	0.5	0.9	0.3	0.3	0.2	1.6	1.0	0.4	0.3	0.3	0.3	0.6	3.3	0.5	0.2	0.1	0.6	0.5	0.1	0.3	0.2	0.5	0.4	0.3	0.2	5.7	0.0	0.7	2.2	0.2	0.5	2.8	0.4	0.0	0.3	0.2	0.4	1.1	0.1	3.1	1.0	0.3	3.7	1.0	2.0	0.1	0.4	0.3	3.3	0.5	5.9	3.1	0.6	0.4	0.9	0.0	1.0	0.3	1.2	2.5	0.5	1.9	0.8	13.6	1.2	0.4	2.6	1.3	1.2	0.4	0.4	0.4	1.1	1.3	2.8	2.3	0.8	22.6	1.7	0.5	0.3	0.7	0.8	2.0	0.4	0.1	0.1	1.7	2.3	0.2	0.2	1.6	1.1	0.4	1.4	1.2	0.4	1.2	2.6	1.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.5	0.5	0.0	0.0	0.7	3.0	5.2	1.3	1.1	0.6	0.7	5.1	2.7	0.7	2.8	1.9	0.0	2.1	0.1	0.0	0.6	1.9	2.0	0.9	1.1	0.5	0.5	0.0	0.0	0.3	22.1	0.4	0.6	0.0	1.7	4.5	0.4	0.4	0.3	2.3	0.0	0.2	0.6	0.0	0.3	0.8	0.0	0.0	1.5	0.0	0.0	22.8	0.6	0.0	0.0	0.1	5.4	0.1	0.4	1.7	1.4	0.5	36.9	0.6	5.2	0.0	1.5	1.1	0.3	0.7	1.3	2.7	0.1	0.5	0.4	0.9	0.6
CYP2R1		ENSG00000186104	"Cytochrome P450 family 2 subfamily R member 1"	Q6VVX0	11	14877440-14892231	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 176.3;Late spermatids: 106.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 26.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042949	Approved				"Intracellular and membrane"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA042949: AB_2678237"	"unprognostic (1.62e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.23e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.44e-2)"	2.5	1.8	1.6	3.1	1.9	3.0	4.1	4.9	2.4	2.6	0.5	3.7	4.6	2.2	3.2	4.6	1.8	1.6	2.2	1.6	2.1	1.8	2.2	2.5	3.0	1.7	1.5	2.0	5.2	1.5	2.6	1.0	1.8	2.8	3.3	3.3	4.5	1.4	2.8	6.9	4.4	1.5	1.5	3.0	5.0	4.3	1.6	2.4	1.9	1.6	2.9	3.0	3.3	2.3	6.1	3.7	3.6	1.5	1.5	2.5	0.0	2.1	1.1	1.2	1.3	4.3	6.8	7.6	1.6	0.4	4.7	0.0	1.2	2.8	0.5	6.3	5.8	3.4	4.7	0.3	5.4	5.9	3.4	2.4	10.6	0.0	4.4	1.1	1.4	9.3	5.1	26.0	0.8	1.6	6.5	11.9	3.4	4.4	3.5	4.6	2.6	11.6	1.4	0.7	3.0	4.7	4.5	5.4	5.2	2.3	4.0	2.2	3.8	3.6	4.4	2.2	2.7	12.8	16.1	9.0	5.0	7.6	3.3	2.4	2.0	1.6	3.0	1.9	4.7	1.6	2.5	1.9	1.7	2.8	3.5	3.0	0.3	2.1	2.3	2.0	3.6	1.2	1.6	1.9	4.9	2.4	1.6	2.1	1.7	1.5	1.8	1.5	1.6	2.3	4.4	12.8	4.8	8.5	15.4	5.9	13.9	9.3	12.5	1.9	7.0	5.8	4.3	8.6	7.4	5.5	6.2	0.3	9.8	10.1	5.9	8.1	176.3	1.9	3.3	6.7	6.7	4.6	13.1	16.9	0.2	4.4	14.8	3.9	3.8	7.8	5.0	6.0	5.9	1.7	18.4	5.5	0.0	7.6	12.6	106.7	2.1	7.7	14.2	13.1	6.1	5.0	13.4	14.6	13.3	11.3	2.9	4.1	11.9	6.4	12.6	6.2	2.8	5.0	13.1	3.2	4.9	23.8	20.2	20.4	6.7	0.0	16.4	6.7	8.8	6.1
CYP2U1	"SPG49, SPG56"	ENSG00000155016	"Cytochrome P450 family 2 subfamily U member 1"	Q7Z449	4	107931549-107953461	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 84.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 30.2;Inhibitory neurons: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041622, HPA046754, HPA064827"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA041622: AB_2677583, HPA046754: AB_2679787, HPA064827: AB_2685362"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.19e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.02e-1)"	"prognostic favorable (2.75e-5)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	7.7	6.4	6.6	4.0	8.3	0.5	4.5	7.6	7.3	5.1	10.1	5.8	3.4	6.6	3.6	3.5	7.8	5.6	7.7	6.5	8.7	5.3	5.9	5.7	6.3	9.0	7.9	9.5	2.3	10.7	4.7	2.4	8.2	9.9	3.9	5.8	3.4	8.7	3.6	2.7	4.7	10.2	8.1	7.6	3.2	3.0	8.0	84.9	3.6	7.2	4.7	4.7	3.8	9.5	4.0	1.9	5.2	9.5	28.6	13.4	0.8	16.8	25.3	10.2	15.7	0.1	2.5	10.8	1.1	10.1	7.8	0.2	8.1	6.4	15.4	3.0	2.5	2.3	3.5	0.5	11.3	3.2	0.0	15.3	5.3	4.7	3.2	20.8	4.0	12.0	0.1	5.0	8.4	2.9	11.8	0.0	5.4	0.4	4.7	6.5	6.3	0.1	3.3	6.7	10.0	7.6	4.2	7.3	18.6	4.3	3.6	1.5	10.6	6.5	0.8	9.3	6.9	21.1	21.2	3.4	5.5	0.0	7.4	0.0	0.1	0.3	0.4	0.5	0.3	0.8	0.3	0.4	0.9	1.1	0.7	0.5	0.0	0.7	2.8	1.1	0.0	0.2	6.6	8.3	7.6	7.3	6.5	8.7	9.0	7.9	8.2	8.1	8.0	9.5	5.5	3.2	3.9	18.6	12.9	1.1	4.6	2.2	15.4	4.1	2.8	5.8	6.2	1.5	2.4	9.2	4.2	0.4	10.1	1.4	0.0	0.9	13.2	6.9	6.3	5.8	3.0	1.7	30.2	2.0	0.3	12.6	3.1	6.2	4.5	2.5	8.6	7.3	2.3	1.7	34.3	1.2	0.0	6.2	3.3	9.5	17.7	4.7	19.6	5.6	3.7	9.5	1.0	20.1	12.1	0.4	0.1	17.7	4.2	1.5	9.9	3.0	8.6	3.1	0.0	20.0	8.1	1.0	4.2	2.0	1.4	0.3	3.6	5.1	3.1	0.8
CYP3A4	CYP3A3	ENSG00000160868	"Cytochrome P450 family 3 subfamily A member 4"	P08684	7	99756960-99784248	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 3796.2"	"Group enriched"	"Detected in some"	40	"Hepatocytes: 2612.9;Proximal enterocytes: 1685.2"	"Cancer enriched"	"Detected in some"	240	"liver cancer: 351.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;NB-4: 2.2;RPMI-8226: 3.4;SCLC-21H: 1.3;SH-SY5Y: 2.0"					"Low region specificity"	"Detected in all"			"CAB033671, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 24: NB-4 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	Vesicles	"CAB033671: AB_782375, HPA072245: , HPA075539: "	"unprognostic (4.55e-2)"	"unprognostic (8.95e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.07e-3)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.89e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.82e-2)"	0.3	3.8	0.1	1.1	0.3	0.0	0.3	0.0	0.8	0.1	0.0	4.6	797.6	0.6	0.2	0.4	0.1	0.6	0.1	0.1	0.0	4.9	3796.2	0.1	0.9	0.0	0.0	0.1	43.4	0.0	1.0	0.0	0.0	0.2	2.2	0.4	0.3	0.0	2.4	1.9	853.0	0.0	0.0	0.1	1.1	1.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.8	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	2.2	0.2	0.0	0.0	0.0	0.8	3.4	0.0	0.1	1.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.3	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	2.2	0.4	0.8	0.2	0.0	0.0	0.0	0.0	0.4	32.9	0.0	0.0	0.0	0.3	0.0	5.6	0.0	0.1	0.4	0.0	0.0	1.4	0.0	26.7	0.6	0.9	0.0	0.0	0.0	0.1	0.0	0.0	30.0	2612.9	0.0	0.0	0.6	29.6	2.0	52.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.1	38.9	0.0	0.0	0.6	1685.2	3.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.9	0.1	2.3	0.5	16.1	1.1
CYP4F2		ENSG00000186115	"Cytochrome P450 family 4 subfamily F member 2"	P78329	19	15878023-15898077	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 80.2;kidney: 40.9;liver: 166.7"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 139.7;Proximal enterocytes: 204.6"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 29.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	19	"basophil: 8.1"	"Lineage enriched"	"Detected in single"	82	"granulocytes: 8.1"	"Cell line enriched"	"Detected in single"	4	"Hep G2: 3.8"					"Low region specificity"	"Detected in all"			"HPA014048, HPA017265, HPA058960"	Supported				"Intracellular and membrane"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA014048: AB_1847452, HPA017265: AB_1847451, HPA058960: AB_2683862"	"unprognostic (7.46e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.55e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.69e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.89e-1)"		"unprognostic (7.79e-3)"	0.0	0.0	0.1	0.1	0.1	1.1	0.2	0.1	0.3	0.1	0.5	2.2	79.9	0.0	25.8	0.2	0.0	3.3	0.0	0.2	0.1	40.9	166.7	0.0	0.1	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.1	6.6	0.9	0.0	0.0	0.1	0.0	0.8	80.2	0.0	0.3	0.1	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.4	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.5	4.3	0.0	0.0	0.0	0.0	0.0	12.3	1.9	0.1	5.8	0.0	0.0	0.1	1.8	5.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	1.4	139.7	0.0	0.0	0.0	8.9	0.0	3.8	0.0	18.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.5	204.6	37.7	0.0	0.0	0.0	0.0	0.7	0.1	0.4	0.0	0.1	0.0	0.2	0.1	5.6	0.2
CYP4V2	CYP4AH1	ENSG00000145476	"Cytochrome P450 family 4 subfamily V member 2"	Q6ZWL3	4	186191567-186213463	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sensory transduction, Vision"	"Monooxygenase, Oxidoreductase"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 113.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 103.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 15.2;SK-MEL-30: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029122	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nuclear speckles"		"HPA029122: AB_10601806"	"unprognostic (1.65e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (5.86e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (6.66e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.05e-1)"	"unprognostic (6.49e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (1.49e-7)"	"unprognostic (3.25e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.14e-2)"	7.4	16.4	5.1	5.2	6.8	2.1	5.7	5.6	5.0	8.6	17.9	9.6	16.5	5.6	2.6	5.0	6.1	14.7	9.2	4.8	5.1	33.9	113.5	10.8	5.6	5.3	6.0	5.7	15.6	33.4	3.7	3.5	5.3	8.2	11.9	14.2	7.0	7.5	4.5	1.3	16.7	7.1	5.4	11.2	6.2	3.2	5.6	6.5	17.3	5.0	4.9	6.4	2.3	6.3	3.4	1.8	0.8	0.0	15.2	6.3	0.2	4.4	9.9	1.7	1.9	0.0	13.0	1.1	0.5	3.5	5.9	1.6	1.9	1.7	0.3	6.0	2.2	4.7	0.8	0.5	5.6	2.6	1.9	5.8	0.8	1.9	1.0	5.9	0.1	6.4	1.4	14.3	6.8	2.9	3.6	1.3	1.5	1.6	0.0	3.1	0.7	1.0	7.4	6.1	4.0	4.9	1.1	0.0	27.5	0.3	2.6	4.6	4.1	3.6	0.7	3.5	1.6	0.1	0.0	0.5	10.9	11.0	4.7	0.0	0.6	0.0	1.8	1.9	1.0	0.4	1.4	1.8	0.7	1.0	1.3	1.3	0.0	0.8	3.1	1.3	1.1	0.9	5.1	6.8	5.6	5.0	4.8	5.1	5.3	6.0	5.3	5.4	5.6	6.3	9.0	6.4	11.5	31.3	13.8	2.5	4.5	5.1	9.6	33.6	9.3	7.2	18.8	42.9	8.7	14.7	31.3	2.0	9.6	14.7	9.8	24.2	2.7	6.7	5.1	7.7	16.9	16.4	15.4	22.4	2.1	14.2	12.8	7.6	7.0	6.5	8.9	103.7	13.5	5.0	23.4	16.5	2.0	14.8	6.0	2.1	5.0	11.3	3.6	6.5	3.5	52.2	4.1	15.6	11.0	9.6	9.0	6.4	12.3	3.8	47.2	28.5	11.9	27.4	0.0	10.1	10.6	8.9	6.3	6.8	3.1	1.0	17.2	6.7	10.5	5.7
CYP7B1	SPG5A	ENSG00000172817	"Cytochrome P450 family 7 subfamily B member 1"	O75881	8	64587763-64798737	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Disease variant, Hereditary spastic paraplegia, Intrahepatic cholestasis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 93.7;Oligodendrocyte precursor cells: 94.5;Oligodendrocytes: 119.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"basophil: 2.5;eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 2.5"	"Group enriched"	"Detected in some"	4	"HSkMC: 16.5;SH-SY5Y: 5.5;WM-115: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017761	Uncertain					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA017761: AB_1847455"	"unprognostic (3.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.89e-3)"	"unprognostic (1.07e-1)"	"unprognostic (5.80e-3)"	"unprognostic (3.80e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.11e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.00e-1)"	"unprognostic (3.04e-3)"	"unprognostic (6.75e-3)"	8.4	5.4	5.7	5.6	11.4	0.3	6.3	8.2	6.6	5.7	8.6	2.3	1.8	2.8	2.0	7.3	2.7	5.8	3.6	5.3	6.8	7.9	21.5	4.6	2.4	11.8	7.3	4.2	6.7	11.4	0.8	0.5	11.4	4.4	3.5	1.9	4.6	5.6	0.2	5.9	1.8	4.3	8.4	9.2	2.4	1.7	8.1	2.1	12.2	1.7	2.9	7.9	3.0	27.2	1.5	0.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.6	5.5	0.0	0.0	2.2	0.8	0.0	1.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	2.5	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.7	11.4	8.2	6.6	5.3	6.8	11.8	7.3	11.4	8.4	8.1	27.2	3.3	0.0	3.4	93.7	0.1	10.6	6.6	1.0	7.4	4.9	4.2	5.5	3.0	2.8	0.9	7.3	2.1	0.1	0.4	0.0	3.9	4.4	7.4	0.2	6.9	2.1	1.8	1.3	29.3	4.9	0.2	15.9	0.5	0.1	12.7	0.6	2.5	8.2	0.2	3.3	30.6	0.5	0.0	0.3	4.9	8.6	5.9	0.5	17.8	30.0	1.0	6.9	0.0	94.5	119.2	1.2	0.0	4.9	0.0	4.2	0.0	2.9	0.8	0.5	13.1	1.1	16.8	4.1	3.4	6.2	12.6	0.0	1.3	7.6	0.0	3.1
DAG1	"156DAG, A3a, AGRNR, DAG"	ENSG00000173402	"Dystroglycan 1"	Q14118	3	49468703-49535618	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 207.9;Skeletal myocytes: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 280.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001960, CAB016353, HPA070563"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		84000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Plasma membrane"	Nucleoplasm	"CAB001960: , CAB016353: AB_627292, HPA070563: "	"unprognostic (1.58e-1)"	"unprognostic (5.14e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.27e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.59e-4)"	"unprognostic (9.22e-2)"	"unprognostic (1.99e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-2)"	25.2	22.0	31.5	17.9	32.6	5.4	26.6	30.7	30.7	26.2	25.5	38.8	24.0	32.1	16.2	28.3	31.8	26.4	68.9	30.1	28.9	28.1	43.0	31.8	9.4	33.3	31.4	24.6	51.4	44.3	18.6	77.0	28.6	29.5	30.6	9.8	31.8	37.9	93.8	28.5	24.0	45.9	30.2	12.6	32.0	26.9	34.1	10.5	25.5	95.7	14.3	27.8	22.0	31.2	92.3	92.4	61.9	152.3	80.3	38.8	280.9	63.9	93.7	108.0	69.0	74.2	96.0	13.0	62.2	103.2	87.6	168.4	55.6	81.2	67.2	12.7	18.6	9.6	84.3	87.2	35.5	11.2	17.4	33.3	72.5	100.3	33.3	96.7	97.1	15.3	14.5	9.8	31.2	75.5	10.1	8.1	66.4	110.0	31.2	5.5	60.5	22.3	82.5	126.4	21.8	45.2	74.8	206.0	105.5	170.3	171.6	22.8	51.8	39.1	63.9	76.0	91.4	11.0	24.2	8.1	50.4	12.6	245.9	2.3	1.2	0.7	1.1	1.3	1.2	1.2	0.9	0.9	0.7	1.0	1.0	1.0	2.2	1.1	2.5	1.3	0.7	1.4	31.5	32.6	30.7	30.7	30.1	28.9	33.3	31.4	28.6	30.2	34.1	31.2	19.0	54.5	18.4	32.0	4.0	14.3	8.0	31.7	17.1	7.4	36.1	46.4	56.6	30.0	20.6	35.0	4.2	116.4	5.8	37.3	1.9	32.4	30.0	30.2	17.3	20.9	33.0	14.3	15.6	79.6	118.4	26.1	37.8	37.9	7.0	207.9	16.8	59.9	21.2	3.3	16.5	29.7	14.2	8.6	7.0	20.0	21.5	6.3	33.8	9.4	5.6	27.1	5.2	19.6	10.7	57.2	21.4	36.9	5.1	14.4	18.9	7.6	23.2	8.7	46.0	326.1	36.2	7.1	19.9	19.0	17.0	95.9	5.9	10.0	29.2	10.2
DAO	"DAAO, DAMOX"	ENSG00000110887	"D-amino acid oxidase"	P14920	12	108858932-108901043	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 71.4;kidney: 90.3;liver: 149.9"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 46.1;Proximal tubular cells: 86.8"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 13.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.1"	"Group enriched"	"Detected in some"	10	"cerebellum: 66.4;pons and medulla: 20.2"	"Low region specificity"	"Detected in all"			"HPA038653, HPA038654"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA038653: AB_10673016, HPA038654: AB_10673285"	"unprognostic (1.50e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.59e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.13e-2)"	"prognostic favorable (4.11e-4)"	"unprognostic (3.44e-3)"	"unprognostic (8.96e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.17e-1)"	0.1	0.0	0.9	0.0	6.9	0.0	0.0	71.4	1.6	0.0	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	3.3	90.3	149.9	0.2	0.0	41.9	14.8	0.0	0.2	0.0	0.0	0.0	29.5	0.0	2.0	12.0	0.0	0.0	0.0	0.0	0.0	0.1	44.0	0.1	0.1	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	59.1	0.0	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	6.9	71.4	1.6	0.8	3.3	41.9	14.8	29.5	44.0	4.3	59.1	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.0	1.8	0.0	0.7	0.0	4.6	3.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	46.1	0.2	0.0	1.2	0.0	0.0	0.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.7	0.0	0.5	0.1	0.0	1.2	0.0	0.0	0.0	0.0	86.8	0.0	7.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.4	0.0	0.2	0.0
DARS1	DARS	ENSG00000115866	"Aspartyl-tRNA synthetase 1"	P14868	2	135905881-135986100	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 85.1;Cytotrophoblasts: 115.4;Extravillous trophoblasts: 157.9;Hofbauer cells: 94.2;Syncytiotrophoblasts: 136.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020451, HPA029804, HPA029805"	Enhanced		Enhanced	Cytosol		NA	NA		210000	"Cluster 30: Non-specific - Translation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA020451: AB_1847479, HPA029804: AB_10599178, HPA029805: AB_10601994"	"unprognostic (6.13e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.54e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (2.39e-6)"	"unprognostic (2.98e-3)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (6.00e-3)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (1.04e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.00e-1)"	37.5	42.1	30.1	41.2	31.2	34.0	48.7	33.3	52.1	34.7	28.0	38.5	23.5	38.4	22.8	46.0	37.8	25.8	42.3	29.5	35.2	47.3	44.2	27.8	48.3	32.6	31.2	47.2	36.1	38.4	24.6	44.4	35.6	33.6	26.6	87.1	32.5	36.5	82.8	40.2	28.0	39.3	34.0	32.3	33.3	17.8	30.7	63.1	43.4	60.1	55.4	40.0	36.4	35.3	201.6	77.0	73.4	66.3	61.0	78.1	141.6	99.8	92.6	92.2	91.1	163.0	84.0	210.0	159.8	78.4	86.6	111.7	94.9	114.9	170.3	95.6	86.0	134.0	76.8	185.6	83.9	188.3	90.8	84.5	75.6	109.1	99.8	122.9	46.8	106.3	131.6	66.0	66.6	87.3	139.2	117.4	77.8	85.3	66.9	179.3	157.9	139.0	91.8	76.9	40.3	89.6	75.0	63.5	74.8	72.2	66.8	118.2	38.2	86.0	87.4	64.5	92.8	194.9	123.3	250.2	144.1	132.3	51.0	33.7	85.4	51.2	115.2	82.6	174.7	219.9	172.6	151.4	133.7	198.8	175.2	154.2	31.7	171.9	67.4	130.4	168.9	153.3	30.1	31.2	33.3	52.1	29.5	35.2	32.6	31.2	35.6	34.0	30.7	35.3	29.4	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.1	0.0	0.0	0.0	0.0	115.4	20.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	157.9	18.2	0.0	0.0	0.0	0.0	0.0	0.0	94.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	136.4	4.4	0.0	0.0	0.0
DARS2	"FLJ10514, mtAspRS"	ENSG00000117593	"Aspartyl-tRNA synthetase 2, mitochondrial"	Q6PI48	1	173824653-173858808	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026506, HPA026528"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria	Nucleoplasm	"HPA026506: AB_1847482, HPA026528: AB_1847483"	"unprognostic (3.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.05e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (1.74e-4)"	"unprognostic (3.30e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.73e-3)"	8.8	9.8	3.1	7.6	3.5	5.4	7.5	3.7	4.3	7.1	11.5	14.6	8.7	4.3	4.7	6.4	5.2	4.8	8.4	3.1	3.8	19.9	13.5	5.7	9.2	3.3	3.6	4.4	5.7	15.5	2.9	7.6	3.4	5.3	15.4	5.2	5.2	5.0	5.6	3.4	10.4	5.6	3.5	6.2	9.3	6.2	3.9	10.6	7.6	13.5	12.0	6.7	4.1	3.7	74.8	50.5	26.3	18.7	24.0	34.2	38.6	32.3	30.0	49.2	37.0	47.5	68.2	41.6	45.2	27.2	31.3	77.5	86.6	56.5	66.7	48.6	41.5	35.2	22.7	31.8	24.0	30.9	30.8	23.2	25.3	50.9	44.5	15.4	49.8	30.5	74.7	31.0	39.6	19.9	38.8	16.1	60.2	83.0	63.2	44.3	40.6	78.2	43.7	24.9	40.4	34.2	36.3	79.6	51.3	47.0	84.5	39.7	21.2	22.9	35.3	32.6	52.5	21.7	60.4	46.3	13.3	33.3	51.5	3.9	4.4	3.3	3.8	7.0	5.4	6.0	3.4	3.2	6.4	4.4	3.8	2.6	0.2	3.5	5.0	2.5	3.9	3.5	3.1	3.5	3.7	4.3	3.1	3.8	3.3	3.6	3.4	3.5	3.9	3.7	3.7	3.2	3.1	7.2	5.7	1.8	4.1	3.1	6.2	2.3	3.3	2.5	12.6	4.3	4.2	5.5	0.0	9.7	3.1	4.8	7.9	3.9	2.5	3.9	4.9	4.5	4.2	9.4	5.3	2.7	16.0	3.9	7.1	4.5	5.7	4.5	1.8	5.4	10.3	3.3	6.5	5.2	0.0	4.4	2.2	1.5	3.1	5.1	1.8	8.4	5.6	2.9	3.1	4.0	5.1	3.8	1.9	1.5	7.1	2.6	5.9	7.1	3.0	2.7	0.0	6.2	4.0	8.9	7.1	8.0	1.6	4.2	4.4	9.2	7.2	2.9
DBT	"BCKAD-E2, BCKDH-E2, BCOADC-E2"	ENSG00000137992	"Dihydrolipoamide branched chain transacylase E2"	P11182	1	100186919-100249834	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease variant, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 65.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026481, HPA026485, HPA026533"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA026481: AB_1847504, HPA026485: AB_1847505, HPA026533: AB_1847506"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (8.79e-12)"	"unprognostic (1.63e-1)"	"unprognostic (3.77e-1)"	"unprognostic (9.67e-2)"	"unprognostic (9.92e-2)"	11.1	13.6	4.4	5.9	5.2	4.6	11.8	4.3	4.9	11.3	3.7	9.2	8.0	8.2	6.0	12.8	11.1	6.3	25.9	4.2	5.0	30.3	43.4	7.4	7.5	5.6	4.6	11.1	15.4	19.4	2.3	10.0	4.5	15.9	10.2	5.9	12.8	11.2	13.4	7.4	7.1	8.0	4.6	6.1	17.3	4.7	5.2	9.9	17.2	19.2	8.9	9.4	4.0	7.1	18.5	8.2	9.5	17.4	23.9	17.6	20.6	13.1	12.3	13.9	15.6	17.7	7.4	17.1	18.3	9.3	8.1	18.7	20.3	17.7	16.8	18.2	11.5	12.1	16.3	9.5	18.0	16.1	6.1	18.2	18.1	10.6	17.9	11.4	12.4	17.9	20.9	19.2	11.1	4.9	14.4	4.1	18.6	14.8	18.4	14.1	30.3	14.2	15.3	15.9	15.8	8.7	27.5	25.4	23.7	16.7	20.9	11.9	10.8	12.1	7.6	15.9	11.0	12.7	14.1	9.1	13.8	10.7	5.3	2.1	1.2	0.8	2.2	1.5	2.4	1.9	2.0	1.9	1.2	2.1	1.8	1.9	1.1	2.0	1.4	1.3	1.5	1.1	4.4	5.2	4.3	4.9	4.2	5.0	5.6	4.6	4.5	4.6	5.2	7.1	9.6	22.4	36.4	29.0	9.6	6.8	6.5	9.8	13.6	22.2	11.9	8.5	65.9	18.6	11.3	12.9	39.6	19.8	10.9	11.4	50.9	10.0	0.8	18.5	20.5	11.7	9.1	8.2	24.0	8.5	11.6	11.3	15.8	15.4	2.5	19.6	15.4	53.2	8.7	15.2	25.2	12.0	14.2	8.8	5.0	1.7	15.2	7.3	3.6	3.7	10.3	14.5	12.3	22.1	26.1	6.4	6.0	21.1	7.1	9.4	9.9	32.1	18.0	22.4	6.6	15.0	12.9	2.8	6.1	18.7	7.2	8.2	9.7	17.3	15.1	5.5
DCPS	"HINT-5, HINT5, HSL1, HSPC015"	ENSG00000110063	"Decapping enzyme, scavenger"	Q96C86	11	126304060-126350005	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 50.7"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 101.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 46.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 79.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039632, HPA058597"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		1200000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA039632: AB_10794200, HPA058597: AB_2683770"	"unprognostic (1.45e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.40e-2)"	8.3	11.4	2.8	7.4	4.0	12.1	8.5	5.0	4.5	10.9	8.1	10.1	4.7	11.0	4.1	11.3	8.6	16.0	9.9	3.9	3.2	13.5	50.7	9.0	12.1	3.3	3.4	9.2	12.1	3.5	8.2	4.0	2.9	8.1	5.9	6.3	12.0	5.3	14.6	11.3	9.4	5.5	2.7	17.3	8.7	6.1	3.6	8.9	7.5	5.8	9.6	13.3	9.2	3.4	13.9	8.5	10.2	19.8	7.9	11.2	8.9	6.5	10.3	11.5	10.8	17.5	29.1	19.5	28.0	12.2	7.5	16.2	14.4	24.4	5.9	35.8	7.1	27.1	9.9	14.7	18.8	33.3	25.4	12.5	14.0	16.0	17.6	5.9	14.1	17.0	11.6	34.8	11.2	21.6	21.1	41.5	8.0	79.8	28.7	13.7	13.8	40.6	11.4	15.1	16.1	11.0	20.3	21.1	15.8	6.3	33.8	22.1	9.3	18.7	7.3	8.9	13.7	13.4	14.6	20.0	6.0	51.0	46.7	4.2	10.5	4.3	9.3	15.2	7.8	13.0	8.5	9.7	16.6	8.6	6.4	6.7	1.3	8.9	15.3	46.6	15.4	8.9	2.8	4.0	5.0	4.5	3.9	3.2	3.3	3.4	2.9	2.7	3.6	3.4	14.2	12.8	11.2	6.2	31.2	6.9	16.4	38.7	8.0	6.7	12.2	17.1	5.0	47.1	18.8	42.3	0.0	39.9	35.3	6.4	56.7	19.7	8.1	11.1	12.1	12.4	7.3	14.5	5.8	29.2	43.8	15.9	11.2	23.2	17.1	9.8	8.6	31.4	29.2	3.3	6.0	12.0	28.5	14.1	11.7	2.2	17.1	16.8	17.8	2.8	15.3	10.1	22.6	2.5	4.6	17.1	14.9	18.4	101.1	8.7	6.1	15.0	15.7	9.4	19.7	10.8	14.6	14.8	24.9	18.3	8.9	27.1	24.3	16.2	14.4	24.0
DCXR	"DCR, HCR2, KIDCR, P34H, SDR20C1"	ENSG00000169738	"Dicarbonyl and L-xylulose reductase"	Q7Z4W1	17	82035136-82037709	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Xylose metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"liver: 1851.6"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 812.0;Hepatocytes: 3510.3;Proximal tubular cells: 2919.4"	"Group enriched"	"Detected in all"	5	"liver cancer: 305.9;prostate cancer: 163.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 365.2;MCF7: 446.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023371, HPA023863"	Enhanced		Uncertain	Nucleoli,Microtubules		NA	NA		4000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli, Microtubules"		"HPA023371: AB_1847530, HPA023863: AB_1847531"	"unprognostic (3.33e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (4.70e-4)"	"unprognostic (1.72e-1)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.10e-2)"	106.7	43.9	93.1	15.2	95.3	25.3	107.6	102.5	111.1	52.0	84.4	49.6	29.2	39.5	281.3	96.6	59.2	10.8	132.7	87.6	100.7	239.9	1851.6	61.0	16.6	102.4	98.0	70.0	71.6	46.1	63.9	20.2	105.9	138.0	20.9	9.7	103.4	33.6	187.3	87.6	44.4	10.4	91.8	35.8	167.0	44.8	105.9	26.1	60.7	80.6	19.6	48.9	62.1	94.9	50.3	68.2	32.8	56.4	123.2	31.8	80.4	25.0	33.9	68.5	48.4	122.0	21.3	100.3	47.4	35.9	9.4	57.4	59.6	52.6	24.1	21.4	145.9	96.9	48.8	365.2	143.2	75.6	114.5	44.6	62.2	22.7	79.8	16.0	41.1	61.1	112.4	76.3	36.5	446.2	63.7	184.1	35.0	242.9	71.3	57.9	42.0	135.3	53.3	71.9	85.5	51.0	35.5	287.5	46.0	19.7	213.4	74.5	20.5	36.6	45.0	48.9	48.2	73.7	56.2	50.2	31.4	83.0	26.7	49.5	92.6	77.9	66.5	92.0	64.1	86.8	83.0	64.7	151.3	99.2	117.7	85.4	47.2	108.9	88.1	121.6	98.9	110.1	93.1	95.3	102.5	111.1	87.6	100.7	102.4	98.0	105.9	91.8	105.9	94.9	29.0	51.3	198.2	16.6	133.6	58.5	200.3	113.5	109.8	16.0	301.8	269.2	120.7	183.0	123.4	178.4	18.8	372.1	116.6	152.9	812.0	41.4	6.0	67.0	50.9	44.6	54.7	335.7	4.7	42.6	450.6	65.0	151.4	102.3	64.7	62.7	138.5	3510.3	164.7	21.9	9.0	170.4	189.2	165.7	65.6	22.6	70.8	82.3	179.7	1.9	52.8	145.1	78.2	5.5	10.5	30.4	135.7	47.4	98.6	215.2	158.9	2919.4	55.4	26.5	19.7	40.6	79.6	10.3	48.2	219.9	73.2	342.6	135.7	118.6	154.6	178.8
DDOST	"GATD6, KIAA0115, OST, OST48, WBP1"	ENSG00000244038	"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit"	P39656	1	20651767-20661544	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 350.7;Syncytiotrophoblasts: 349.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009746, HPA046841, HPA052867"	Supported		Supported	"Endoplasmic reticulum"		NA	NA		120000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB009746: AB_2092075, HPA046841: AB_2679834, HPA052867: AB_2681977"	"unprognostic (8.57e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.57e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (4.88e-4)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (2.70e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-1)"	"prognostic unfavorable (9.05e-7)"	"unprognostic (1.07e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.07e-1)"	98.1	132.7	44.6	108.5	46.4	191.4	111.9	44.9	46.3	130.7	64.1	161.4	119.4	115.8	224.5	113.2	137.4	98.2	123.4	47.2	53.7	100.6	137.2	104.4	104.6	48.1	45.3	139.5	259.8	112.7	119.1	183.3	46.9	99.8	165.7	42.1	151.7	130.4	80.0	87.3	108.4	122.8	46.1	113.1	139.0	83.4	52.4	84.0	185.6	66.4	121.6	119.3	92.8	51.4	366.0	206.7	178.8	533.9	347.4	359.8	376.6	286.1	545.9	435.5	445.3	278.9	678.8	275.8	501.8	447.0	238.7	292.7	250.4	334.3	321.3	257.0	256.3	235.7	138.5	375.0	513.2	377.5	618.8	371.6	370.2	365.2	439.5	522.8	504.1	180.5	116.3	445.0	266.5	251.1	179.6	308.2	196.5	529.8	214.2	164.5	238.6	492.2	358.7	150.4	133.0	238.3	294.0	299.1	413.5	257.1	237.8	566.8	260.2	249.7	279.6	435.1	274.6	586.1	677.5	195.6	409.4	489.4	342.0	272.0	268.3	257.3	255.6	284.2	270.3	230.4	218.1	239.9	389.7	207.8	203.1	209.6	63.8	266.1	251.4	320.1	256.0	490.6	44.6	46.4	44.9	46.3	47.2	53.7	48.1	45.3	46.9	46.1	52.4	51.4	62.0	35.3	72.3	7.5	93.6	50.2	95.8	200.6	47.3	18.3	70.0	62.5	22.1	77.2	120.0	35.0	29.2	350.7	92.9	52.5	39.2	162.5	29.9	44.7	71.9	65.2	71.8	49.6	10.9	148.3	270.0	102.8	74.5	71.6	79.1	113.2	55.3	74.4	140.8	16.8	9.4	152.6	79.3	66.8	78.8	13.9	74.6	74.5	85.4	6.5	96.4	54.1	87.6	15.6	10.7	93.5	89.7	60.9	320.5	68.9	69.1	54.3	78.9	24.6	46.0	42.5	103.3	136.0	171.3	55.1	53.6	349.7	78.5	122.9	133.7	84.3
DDX11	"CHL1, CHLR1, KRG2, WABS"	ENSG00000013573	"DEAD/H-box helicase 11"	Q96FC9	12	31073860-31104799	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA065197	Supported		Supported	Nucleoplasm,Nucleoli		No	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"HPA065197: AB_2685430"	"unprognostic (6.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.79e-3)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.23e-8)"	"unprognostic (1.89e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.03e-3)"	5.9	6.4	6.0	10.2	6.8	29.2	7.2	6.9	7.3	10.7	7.1	9.6	8.0	7.5	4.3	9.5	8.0	5.9	5.3	6.0	6.1	9.2	9.3	6.1	13.2	6.9	6.4	11.0	17.5	5.8	9.4	5.4	6.9	10.0	10.1	6.6	8.6	5.3	10.6	16.7	13.4	3.6	6.1	13.8	9.6	8.8	6.7	24.0	8.0	6.6	11.1	6.9	9.8	6.9	36.5	35.0	42.2	34.5	5.8	11.0	58.7	21.8	10.4	25.2	28.5	44.1	58.6	49.2	23.9	10.8	23.6	35.0	31.7	28.9	21.3	43.4	66.6	47.4	71.0	25.4	2.1	37.4	35.0	11.9	13.0	32.6	24.8	16.9	12.6	55.2	26.6	103.3	17.6	30.9	64.5	60.7	84.0	39.9	19.5	55.0	53.3	66.2	13.3	38.5	30.2	21.7	23.4	33.2	10.4	65.0	27.3	25.5	8.2	22.0	42.1	42.2	40.0	39.4	29.6	95.3	24.6	32.5	20.3	0.0	1.3	0.8	2.0	1.2	1.5	2.5	1.9	1.5	1.5	2.6	2.0	2.6	0.5	2.2	4.4	2.4	2.0	1.3	6.0	6.8	6.9	7.3	6.0	6.1	6.9	6.4	6.9	6.1	6.7	6.9	10.1	3.2	9.5	1.6	9.0	6.0	4.0	6.0	2.2	9.4	8.3	7.1	2.5	4.3	6.0	0.0	14.6	7.6	8.8	7.8	0.0	2.0	1.7	5.5	8.9	5.4	0.0	15.3	2.5	3.3	7.5	5.7	9.7	7.4	5.7	15.6	6.1	7.7	5.2	8.4	3.6	6.5	10.2	4.1	5.4	1.3	7.2	4.4	7.2	3.7	3.5	2.7	4.1	1.5	1.7	3.2	2.7	4.5	17.2	6.0	2.3	1.4	6.7	25.8	0.0	4.9	4.8	5.3	18.0	5.5	6.5	2.6	8.4	4.1	9.5	5.1
DDX3X	"DBX, DDX14, DDX3, HLP2"	ENSG00000215301	"DEAD-box helicase 3 X-linked"	O00571	X	41333348-41364472	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 887.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059585"	Supported	Supported	Approved	Nucleoplasm,Cytosol		NA	NA		260000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: AB_2684073"	"unprognostic (2.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.95e-1)"	"unprognostic (4.77e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.93e-2)"	164.7	123.2	28.7	113.3	29.9	146.1	99.8	31.9	37.3	102.4	38.8	85.6	80.7	123.4	39.1	107.6	108.8	111.0	96.4	27.0	36.0	110.5	130.6	103.5	118.7	33.6	29.8	108.1	76.9	133.0	52.5	107.3	34.2	68.7	75.8	81.9	72.9	64.8	126.9	91.2	81.6	145.1	32.4	103.2	84.4	43.0	30.9	169.6	104.3	112.5	111.5	153.3	97.7	34.7	230.5	225.6	236.3	122.3	273.6	211.1	136.4	150.6	239.3	167.1	132.3	238.8	141.4	2.5	103.9	185.8	212.4	149.4	292.2	235.0	248.3	130.2	232.9	132.6	237.6	152.1	140.5	253.8	236.4	159.1	150.9	278.4	270.3	204.1	258.3	131.5	258.4	134.5	158.9	157.8	163.0	83.2	212.2	121.3	114.2	187.8	223.3	182.6	143.7	279.1	147.1	220.0	352.3	184.3	194.3	248.9	158.9	172.4	224.5	159.6	166.3	178.7	188.2	153.6	194.0	215.7	161.5	156.1	151.5	50.8	39.0	30.7	23.3	35.3	33.5	21.0	23.3	26.3	34.7	13.0	25.4	25.3	54.0	30.7	39.4	11.7	24.8	37.8	28.7	29.9	31.9	37.3	27.0	36.0	33.6	29.8	34.2	32.4	30.9	34.7	466.5	86.6	150.0	66.9	280.1	264.3	160.5	63.7	191.8	77.1	295.1	237.6	158.0	81.5	96.5	58.8	131.3	94.6	415.2	231.1	43.0	64.3	370.6	261.1	237.7	238.5	183.7	113.0	43.8	85.6	95.1	191.8	178.9	290.1	165.5	180.6	144.2	174.5	123.1	60.6	47.1	161.4	71.2	208.7	269.1	887.5	66.5	319.0	128.1	47.8	112.2	90.0	79.3	44.7	63.1	114.1	156.7	62.8	241.8	145.0	234.9	87.3	102.5	127.1	72.3	351.4	210.1	30.6	57.7	212.6	333.4	172.9	342.4	144.8	129.1	225.8
DDX3Y	DBY	ENSG00000067048	"DEAD-box helicase 3 Y-linked"	O15523	Y	12904108-12920478	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 96.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 275.5;Late spermatids: 575.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebral cortex: 31.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 153.7;HEL: 156.8;U-266/84: 133.1;U-698: 112.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059583"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059583: "			"unprognostic (3.89e-2)"		"unprognostic (1.70e-1)"	"prognostic favorable (4.70e-5)"	"unprognostic (6.50e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.22e-2)"		"unprognostic (4.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.87e-2)"	29.0	26.1	2.8	15.2	2.9	96.0	20.7	5.5	31.8	0.0	6.6	25.8	12.0	0.0	26.8	18.5	0.0	18.7	19.1	2.7	5.5	23.7	22.0	27.4	9.6	2.8	3.3	0.1	14.8	12.4	25.1	22.1	3.2	33.6	24.0	23.6	18.5	31.3	19.9	20.2	25.9	0.0	2.3	26.5	19.8	70.1	3.8	0.0	22.0	28.1	23.6	22.0	0.0	4.6	0.7	28.3	0.0	0.0	0.0	0.0	20.0	69.3	49.9	35.9	44.0	0.2	0.0	153.7	0.1	69.5	0.0	0.0	0.0	0.0	63.2	38.8	0.0	156.8	0.0	46.5	34.2	0.1	0.1	37.4	43.4	0.0	0.0	0.0	0.0	15.2	0.2	0.1	43.1	0.2	61.8	0.2	27.1	0.0	0.0	0.0	18.0	28.2	38.2	41.5	44.5	0.1	0.1	0.2	51.4	43.5	0.0	36.5	49.1	55.0	0.3	0.1	45.8	78.7	133.1	112.8	6.9	0.1	0.0	1.5	3.8	3.2	4.4	3.9	4.0	3.2	3.3	3.7	4.9	2.7	3.9	3.5	3.5	3.4	2.4	1.4	3.0	3.2	2.8	2.9	5.5	31.8	2.7	5.5	2.8	3.3	3.2	2.3	3.8	4.6	0.1	48.1	75.8	10.1	58.0	94.1	92.7	37.5	89.4	53.8	0.0	0.0	26.0	10.0	41.2	9.2	41.7	38.3	13.3	5.6	5.9	13.9	275.5	0.0	0.0	56.5	16.0	24.6	19.7	0.2	18.9	63.4	56.1	0.0	92.9	0.0	42.1	9.1	20.1	42.1	15.7	9.3	10.2	64.1	127.5	575.3	38.8	58.2	26.6	5.6	27.8	53.7	26.8	4.0	5.7	5.0	8.8	39.5	54.7	70.8	10.5	13.9	101.2	49.3	19.7	56.2	39.2	67.2	70.1	43.8	80.4	37.8	66.2	0.0	8.1	75.0
DDX41	"ABS, MGC8828"	ENSG00000183258	"DEAD-box helicase 41"	Q9UJV9	5	177511577-177516961	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017911, HPA048803"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"HPA017911: AB_1847558, HPA048803: AB_2680527"	"unprognostic (2.52e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavorable (2.21e-6)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.75e-1)"	26.5	29.0	15.1	28.7	16.1	22.3	25.4	13.1	21.9	26.1	13.7	26.5	24.8	25.2	16.8	33.7	30.6	18.3	18.9	17.8	14.2	26.8	27.1	24.5	24.7	15.8	13.7	28.6	23.5	31.2	18.0	22.8	16.0	22.3	19.3	14.6	28.7	19.1	43.4	35.0	28.7	20.1	12.8	26.7	26.7	17.9	16.2	24.3	29.0	20.3	25.0	24.8	27.6	16.4	62.1	71.4	42.4	44.9	43.4	45.2	125.1	58.4	35.1	47.1	36.1	107.7	61.3	67.2	83.3	57.6	67.6	47.8	57.2	128.5	33.2	175.4	68.0	90.5	70.8	66.5	52.5	89.3	82.3	48.7	47.0	45.3	59.0	43.5	53.4	68.1	72.3	50.0	55.6	135.5	80.6	45.9	62.0	59.0	61.3	72.7	48.1	86.2	50.5	78.8	45.0	41.9	64.6	83.2	56.5	27.1	54.6	110.2	51.3	74.4	42.8	43.6	87.6	49.6	75.9	120.1	81.3	100.1	47.0	14.3	31.4	22.3	18.3	28.5	23.5	17.0	18.3	16.8	27.2	14.4	14.6	18.8	9.2	25.8	31.4	11.2	18.8	25.6	15.1	16.1	13.1	21.9	17.8	14.2	15.8	13.7	16.0	12.8	16.2	16.4	17.0	25.6	17.8	7.8	20.6	21.0	22.9	37.9	18.2	16.9	17.5	16.5	9.0	25.8	24.3	9.2	2.1	46.6	22.9	22.9	41.1	42.1	11.2	16.1	16.5	22.3	11.4	25.2	6.0	39.6	63.2	17.6	17.3	19.2	29.8	21.3	16.1	18.0	48.8	8.4	6.4	27.0	18.3	23.5	15.4	22.9	14.9	22.2	12.4	4.7	34.6	23.9	20.6	5.0	3.9	33.5	23.9	21.1	23.2	19.0	29.5	40.1	20.5	10.3	13.1	14.5	29.0	24.5	26.7	26.2	20.3	37.5	19.0	25.6	31.0	22.7
DDX58	"DKFZp434J1111, FLJ13599, RIG-1, RIG-I, RIG1"	ENSG00000107201	"DExD/H-box helicase 58"	O95786	9	32455302-32526208	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"BJ hTERT+ SV40 Large T+: 79.0;BJ hTERT+ SV40 Large T+ RasG12V: 76.0;GAMG: 22.8"									"CAB012643, HPA047193, HPA073217"	Approved		Supported	"Plasma membrane,Cytosol"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"CAB012643: , HPA047193: AB_2679978, HPA073217: "	"unprognostic (1.10e-1)"	"unprognostic (4.65e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.15e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	6.3	4.9	3.5	7.5	2.9	1.3	6.0	3.0	4.3	7.1	3.1	6.3	2.9	5.6	4.7	6.4	4.4	6.0	4.1	2.7	3.6	5.5	6.3	7.1	7.4	5.2	3.7	4.6	5.7	2.5	5.2	5.7	4.0	4.2	5.3	2.3	10.0	3.5	4.8	7.8	7.1	5.7	6.5	9.2	4.8	2.8	3.6	15.6	4.3	1.7	5.2	5.1	5.3	2.9	4.3	2.4	2.5	2.2	7.5	6.4	2.7	2.1	14.6	79.0	76.0	2.4	1.4	0.4	2.7	2.7	22.8	2.8	2.3	1.3	11.4	7.4	0.9	1.1	2.4	3.5	5.0	1.4	4.5	4.9	1.3	6.9	1.3	4.2	14.3	1.5	1.8	1.0	6.6	0.6	3.8	12.4	1.8	0.6	2.0	2.4	3.1	0.0	11.6	0.6	2.0	0.3	1.7	1.7	12.6	1.7	3.5	0.9	13.4	1.5	0.9	1.7	1.1	0.0	0.3	0.9	2.6	3.3	2.1	0.0	0.1	0.3	0.2	0.1	0.3	0.2	0.3	0.0	0.0	0.2	0.2	0.2	1.3	0.4	0.2	0.0	0.2	0.0	3.5	2.9	3.0	4.3	2.7	3.6	5.2	3.7	4.0	6.5	3.6	2.9	41.7	22.4	8.8	20.5	13.9	4.2	5.1	7.2	13.6	4.1	5.8	5.1	5.1	5.7	6.7	1.8	2.1	5.6	13.9	13.8	0.0	19.5	2.7	12.9	8.7	23.6	3.0	5.7	10.4	12.2	7.6	13.9	21.9	20.3	5.1	16.8	9.3	6.7	5.6	6.7	13.2	4.6	4.1	7.3	4.6	0.4	6.5	11.6	0.0	39.4	12.3	6.4	21.6	31.2	17.5	16.2	7.7	6.0	9.1	4.9	16.9	7.2	7.3	2.5	6.6	16.8	13.1	0.5	2.3	10.9	5.4	2.5	17.8	10.4	2.6	5.3
DDX59	"DKFZP564B1023, ZNHIT5"	ENSG00000118197	"DEAD-box helicase 59"	Q5T1V6	1	200623896-200669907	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047166	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Actin filaments"		"HPA047166: AB_2679966"	"unprognostic (1.99e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.43e-3)"	"unprognostic (4.16e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (9.02e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.66e-2)"	"unprognostic (5.98e-2)"	15.4	16.1	13.5	14.2	15.4	33.1	26.5	17.1	18.8	16.2	15.6	14.2	10.2	17.6	20.0	13.5	15.5	12.2	13.3	14.0	14.7	16.4	17.8	14.5	17.0	16.0	15.0	17.6	18.8	15.0	11.3	18.7	17.3	15.2	15.0	17.4	14.4	13.2	32.8	26.2	14.3	14.1	16.3	22.4	12.1	11.0	15.1	22.0	16.2	20.1	16.9	15.0	14.7	17.8	17.5	20.1	22.6	19.0	10.1	17.4	49.9	19.1	17.4	20.5	16.5	6.3	20.2	17.9	9.5	15.7	16.4	16.2	13.0	19.4	14.5	56.8	13.3	13.6	26.4	18.6	20.2	19.5	24.0	18.8	29.1	15.4	41.7	16.7	15.9	24.8	17.4	25.9	20.1	20.0	12.0	29.0	23.8	10.5	16.3	10.1	15.5	34.7	21.9	19.8	13.8	35.7	30.8	31.7	35.6	28.8	27.3	27.3	14.4	17.1	9.5	16.8	20.0	19.5	27.2	23.5	16.3	12.2	30.0	33.3	12.4	24.7	15.1	11.1	12.4	14.9	12.5	13.8	10.6	14.8	12.7	11.8	22.9	16.4	22.0	11.8	19.8	10.2	13.5	15.4	17.1	18.8	14.0	14.7	16.0	15.0	17.3	16.3	15.1	17.8	22.5	19.2	20.1	8.8	19.9	16.2	13.1	16.1	24.5	4.3	10.0	13.2	18.4	7.2	10.6	7.3	2.1	22.2	14.6	9.8	15.6	8.8	2.4	14.6	13.3	16.7	1.2	10.5	4.5	8.2	28.0	14.9	6.6	12.8	20.8	7.1	14.3	7.3	13.0	6.7	6.1	11.0	14.2	12.0	13.0	1.1	8.1	16.1	5.4	8.4	18.5	8.3	25.7	19.1	10.3	8.8	7.9	13.5	13.1	12.0	8.0	11.6	10.8	6.7	0.0	22.8	15.7	14.2	20.0	12.9	15.6	43.8	18.9	9.3	8.5	11.1
DDX6	"HLR2, RCK, Rck/p54"	ENSG00000110367	"DEAD-box helicase 6"	P26196	11	118747763-118791164	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004668, HPA024201, HPA026644"	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA		19000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	"Cytoplasmic bodies"	Cytosol	"CAB004668: AB_436960, HPA024201: AB_10603562, HPA026644: AB_1847582"	"unprognostic (1.26e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-2)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (3.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.58e-2)"	"unprognostic (4.55e-2)"	31.5	28.4	29.1	34.9	36.0	69.0	34.9	50.7	31.9	33.2	12.7	30.0	23.7	30.5	30.5	33.1	29.1	23.6	37.2	31.5	35.4	30.6	34.2	27.3	49.0	28.4	29.3	48.8	30.7	28.3	17.3	31.6	25.2	32.9	27.9	48.7	32.4	29.2	43.2	27.2	26.2	30.6	29.9	45.4	29.9	28.8	37.1	54.9	37.5	41.9	60.9	30.0	21.9	36.6	33.9	50.4	73.6	71.7	64.0	64.8	47.2	45.6	62.0	43.0	40.4	72.1	50.9	77.6	47.1	78.8	44.3	53.2	88.8	69.1	69.0	62.7	17.4	154.5	30.8	57.1	42.0	110.9	55.8	67.1	49.5	63.5	100.8	54.8	69.1	53.2	72.5	110.4	59.2	96.8	81.0	52.1	53.3	50.1	33.6	89.3	59.2	60.1	50.1	92.7	48.7	63.9	84.7	67.2	28.5	56.2	79.2	44.2	81.2	67.2	38.4	39.8	47.6	34.1	47.8	91.7	26.8	52.2	59.2	13.8	4.8	13.2	10.2	6.2	12.3	12.1	10.0	10.8	5.1	12.0	12.2	11.0	19.0	8.3	12.4	7.1	9.9	6.8	29.1	36.0	50.7	31.9	31.5	35.4	28.4	29.3	25.2	29.9	37.1	36.6	84.6	60.9	57.9	37.9	140.1	30.2	75.2	31.3	69.4	82.2	49.8	43.2	116.9	42.9	41.4	44.1	50.1	38.4	184.0	58.6	31.3	32.2	4.2	77.3	81.5	64.6	85.7	88.2	57.3	35.5	36.5	55.6	42.3	91.7	52.5	54.2	61.8	41.5	38.3	62.2	60.9	59.8	42.7	66.9	44.3	10.5	54.0	70.1	33.8	68.4	75.9	90.0	119.4	50.3	80.9	51.2	57.0	45.1	106.0	49.8	57.2	41.3	35.9	91.3	39.5	92.6	69.7	71.1	76.8	73.4	30.5	76.5	130.2	48.8	53.1	78.2
DECR1	"DECR, SDR18C1"	ENSG00000104325	"2,4-dienoyl-CoA reductase 1"	Q16698	8	90001405-90053633	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 290.1;liver: 272.3"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 399.2;Proximal tubular cells: 485.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 81.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023160, HPA023162, HPA023238"	Enhanced		Supported	Mitochondria,Cytosol		No	No		120000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587"	"prognostic unfavorable (1.49e-4)"	"unprognostic (5.76e-3)"	"unprognostic (8.37e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.79e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (6.06e-4)"	60.2	136.8	12.4	9.6	14.4	24.9	54.4	12.5	14.4	29.4	22.2	65.0	20.2	28.0	14.9	52.6	26.1	7.4	290.1	12.7	13.2	103.5	272.3	34.2	15.0	12.2	13.1	35.5	44.4	13.2	32.6	5.9	12.1	28.6	18.8	8.0	42.8	6.5	121.8	43.3	61.0	9.1	12.5	47.1	44.5	52.3	15.4	10.2	33.0	34.4	13.9	31.1	35.8	12.8	13.1	7.9	19.6	16.1	8.0	17.3	5.2	13.2	12.9	5.9	8.2	2.8	13.4	7.7	5.3	15.1	4.1	6.8	7.7	11.1	11.0	12.6	1.2	18.4	13.6	14.5	11.6	8.7	4.4	12.0	7.0	7.6	10.7	10.1	17.4	16.5	21.3	15.5	20.7	16.3	12.5	7.6	1.5	9.1	24.9	7.4	5.8	13.4	23.4	43.9	1.3	10.6	13.0	81.1	7.7	1.1	10.7	7.4	20.1	11.4	6.2	12.9	6.0	10.5	7.5	12.8	8.6	12.0	10.8	3.9	9.1	6.2	7.1	10.2	7.9	7.4	6.9	8.6	8.8	4.6	8.1	7.8	15.2	3.9	9.3	3.9	9.6	5.8	12.4	14.4	12.5	14.4	12.7	13.2	12.2	13.1	12.1	12.5	15.4	12.8	66.1	76.9	59.4	72.5	52.9	41.3	70.6	180.2	35.3	11.4	51.1	57.4	268.3	82.9	96.4	71.7	2.1	50.2	57.6	119.0	399.2	137.8	165.3	68.2	65.5	60.0	104.8	77.4	27.2	92.5	49.0	60.2	61.2	40.6	50.0	81.3	47.8	244.8	115.1	32.0	55.9	105.9	116.0	95.2	82.7	52.6	85.4	85.1	85.4	29.0	107.1	52.5	74.2	66.9	35.0	87.5	111.6	51.6	67.8	30.3	250.3	485.2	69.0	7.6	72.3	54.5	61.7	157.5	24.6	68.6	41.1	41.0	64.4	135.1	139.6	86.8
DEGS1	"DEGS-1, Des-1, DES1, FADS7, MLD"	ENSG00000143753	"Delta 4-desaturase, sphingolipid 1"	O15121	1	224175756-224193441	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skin 1: 535.6"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 246.0;Cytotrophoblasts: 281.8;Suprabasal keratinocytes: 320.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA076422			Supported	Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 61: Skin - Cornification"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA076422: AB_2686799"	"unprognostic (2.34e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.48e-2)"	"prognostic unfavorable (7.74e-5)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (4.29e-5)"	"unprognostic (7.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.83e-7)"	"unprognostic (2.87e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (2.53e-4)"	60.3	31.0	30.3	44.9	33.1	69.5	61.9	35.0	36.2	53.4	42.5	50.8	47.0	44.5	29.5	48.6	34.4	40.5	43.8	31.3	35.6	38.1	35.7	49.1	48.0	36.6	35.2	27.1	22.5	31.5	34.8	128.7	35.9	83.2	27.2	20.8	38.7	58.6	20.9	535.6	33.4	70.9	37.9	38.7	38.6	22.7	34.0	34.2	52.3	23.3	50.9	48.4	72.7	44.5	72.8	50.7	65.2	49.5	275.7	181.1	51.2	201.1	223.8	137.5	164.2	47.1	55.2	58.0	252.4	181.0	82.4	76.3	76.5	67.9	153.0	84.2	141.5	41.7	51.1	29.2	167.9	84.2	86.1	177.4	153.6	125.5	69.9	143.0	140.4	31.4	62.8	61.8	181.2	27.5	43.2	46.9	83.3	40.0	76.1	38.8	92.4	37.5	181.1	19.8	42.3	69.8	106.6	169.4	110.4	118.8	57.1	123.4	125.7	133.4	41.4	153.1	197.5	44.5	55.3	52.8	141.9	41.7	154.2	104.6	61.4	120.3	30.9	67.8	59.8	58.2	52.7	43.3	104.4	74.3	40.7	37.0	67.7	43.9	48.7	34.9	59.0	52.8	30.3	33.1	35.0	36.2	31.3	35.6	36.6	35.2	35.9	37.9	34.0	44.5	71.7	83.3	29.3	13.4	69.9	246.0	44.0	33.6	89.4	31.2	40.7	38.4	20.8	10.0	19.8	11.0	14.6	281.8	40.5	4.0	13.7	34.9	27.9	54.0	90.2	66.7	14.9	18.7	17.4	43.3	48.3	77.7	21.4	146.1	106.5	21.3	55.6	20.8	93.0	18.5	20.4	6.2	34.6	57.8	90.5	13.6	63.0	72.8	69.4	20.6	57.1	26.0	10.3	25.6	32.1	29.5	5.9	79.4	50.1	44.2	20.1	29.7	20.1	18.4	105.2	42.7	89.1	84.3	44.0	50.4	320.4	198.9	58.9	43.7	6.6	13.7
DGAT1	"ARGP1, DGAT"	ENSG00000185000	"Diacylglycerol O-acyltransferase 1"	O75907	8	144314584-144326910	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 40.6"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 213.5;Proximal enterocytes: 700.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 18.4;PC-3: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032853	Enhanced		Approved	"Nucleoli,Nucleoli rim,Endoplasmic reticulum"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum"	"Nucleoli, Nucleoli rim"	"CAB032853: AB_2090798"	"unprognostic (9.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-3)"	15.0	24.7	4.6	1.8	4.6	5.1	11.8	5.5	5.6	6.1	4.1	16.7	37.0	5.6	1.0	8.6	5.1	2.0	11.7	4.7	4.1	7.9	16.5	6.9	1.8	4.5	4.6	4.3	6.5	3.9	6.5	1.5	4.2	6.6	4.2	1.6	7.4	2.4	11.7	6.9	40.6	1.6	4.1	9.3	8.7	14.7	4.4	2.3	7.4	3.5	1.4	6.7	6.4	4.5	5.2	4.9	2.2	4.1	3.5	1.5	2.9	3.4	3.1	2.9	2.0	11.2	3.1	2.1	12.4	1.9	1.6	4.0	1.8	4.3	0.6	3.7	5.1	3.3	4.2	18.4	2.5	1.0	3.4	2.1	3.2	2.0	2.1	2.1	2.3	7.3	2.9	5.2	1.9	3.7	6.8	4.1	1.1	10.9	21.2	7.7	0.9	3.4	2.8	2.5	2.6	4.2	4.7	5.2	2.3	0.8	2.9	3.3	2.0	1.6	5.6	3.6	2.8	2.3	0.6	0.8	1.8	6.3	3.2	0.0	0.4	0.7	0.2	0.3	0.4	0.1	0.2	0.2	0.5	0.1	0.1	0.0	0.5	0.0	0.4	0.2	0.1	0.2	4.6	4.6	5.5	5.6	4.7	4.1	4.5	4.6	4.2	4.1	4.4	4.5	34.0	16.0	19.0	15.7	8.5	8.0	12.5	6.3	4.0	24.6	21.6	16.0	20.8	12.8	8.7	18.4	29.2	11.3	17.6	213.5	1.9	9.4	19.2	12.3	13.7	26.5	23.4	17.7	11.2	11.9	10.3	9.3	48.4	21.3	7.0	23.9	12.5	57.4	18.8	18.5	12.8	93.6	4.1	25.5	11.8	25.8	6.8	22.8	5.4	8.4	9.2	21.3	4.1	17.6	7.0	13.3	113.4	6.8	18.8	8.1	700.1	7.4	5.6	23.6	0.0	11.9	12.3	27.7	17.4	12.3	9.2	16.4	12.3	41.1	108.0	20.7
DGKE	"DAGK6, DGK"	ENSG00000153933	"Diacylglycerol kinase epsilon"	P52429	17	56834107-56869567	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 34.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 181.1;Cone photoreceptor cells: 189.7;Inhibitory neurons: 90.0;Rod photoreceptor cells: 165.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 84.8;MOLT-4: 30.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017167	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Cytosol"		"HPA017167: AB_1847638"	"unprognostic (1.19e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.92e-5)"	"unprognostic (4.20e-2)"	"unprognostic (4.87e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.69e-3)"	4.1	2.2	5.4	4.5	6.9	3.1	3.0	9.4	7.4	4.9	7.7	4.9	2.6	6.5	4.2	2.6	4.8	4.6	2.9	5.8	8.1	2.6	2.8	5.2	5.0	3.3	4.7	3.5	3.9	4.1	6.2	2.7	3.4	4.1	3.3	34.5	2.5	3.3	1.2	1.9	4.4	4.3	2.7	6.9	3.7	6.5	6.9	9.8	4.0	2.2	4.3	3.8	4.2	5.8	3.5	3.3	3.0	0.3	0.6	1.0	1.4	5.8	4.7	3.9	4.5	7.7	4.2	5.1	7.0	3.1	1.9	4.2	7.2	3.2	7.8	16.5	9.5	6.6	8.9	5.1	3.3	12.7	8.9	1.9	4.0	4.1	8.0	3.6	5.4	14.7	5.5	84.8	4.8	5.1	30.3	7.1	2.3	4.6	10.0	9.4	12.4	12.2	3.9	7.6	4.7	3.2	4.7	2.5	0.2	1.9	5.3	6.0	5.0	1.1	5.4	1.7	0.9	11.3	25.3	3.4	3.3	7.3	0.3	0.1	0.2	0.0	1.0	0.1	0.7	0.9	0.6	0.7	0.2	0.3	0.7	0.9	0.3	0.7	0.2	0.8	1.7	0.3	5.4	6.9	9.4	7.4	5.8	8.1	3.3	4.7	3.4	2.7	6.9	5.8	51.2	3.2	6.0	10.4	11.3	8.9	13.5	3.1	21.6	181.1	5.0	6.3	6.3	10.0	4.0	16.5	189.7	6.6	16.3	5.6	0.0	7.4	18.3	9.0	9.9	30.6	11.3	2.1	66.0	4.7	3.0	6.9	9.7	19.3	0.0	13.1	29.3	4.0	2.2	8.4	90.0	7.7	8.2	5.0	9.3	9.2	4.4	7.4	3.6	32.8	6.3	18.6	14.4	32.6	14.4	6.0	6.4	5.3	15.1	21.3	1.9	0.1	2.8	165.4	6.6	11.8	10.7	28.5	20.7	9.7	6.7	3.4	18.9	5.7	5.8	13.4
DGUOK	dGK	ENSG00000114956	"Deoxyguanosine kinase"	Q16854	2	73926826-73958961	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034766, HPA057246"	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA034766: AB_10669850, HPA057246: AB_2683381"	"unprognostic (3.40e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.10e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (8.69e-7)"	"unprognostic (3.86e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.98e-2)"	"prognostic favorable (7.47e-4)"	20.8	30.0	37.1	20.3	39.2	27.1	28.1	36.5	48.4	23.0	36.8	25.0	17.7	23.1	34.4	21.8	31.3	19.4	23.0	38.5	42.8	24.6	30.5	17.7	36.8	37.9	37.7	30.0	16.3	11.0	41.3	21.5	39.1	24.5	29.1	34.5	19.8	22.5	17.1	26.5	20.2	21.9	37.9	25.9	21.0	32.8	38.8	36.3	22.6	17.7	40.9	22.2	20.9	38.8	45.1	72.5	74.4	67.9	47.8	53.8	37.1	29.3	56.0	66.7	61.1	91.2	51.5	83.0	27.4	42.1	74.1	34.7	85.4	57.1	79.3	47.1	53.6	65.8	25.4	107.5	70.5	62.1	66.0	49.7	51.3	50.4	58.9	48.6	48.3	91.4	67.2	37.0	78.8	54.4	59.6	101.2	76.7	60.5	53.9	73.8	73.1	59.7	55.8	49.6	85.0	82.6	27.9	28.2	77.1	35.5	34.0	34.8	45.3	43.3	68.8	37.8	52.6	32.3	31.4	86.1	62.2	65.9	95.1	129.8	70.9	138.7	62.3	87.3	72.4	108.5	77.0	69.6	81.6	114.5	98.6	79.6	56.4	79.4	84.7	91.3	79.9	91.3	37.1	39.2	36.5	48.4	38.5	42.8	37.9	37.7	39.1	37.9	38.8	38.8	72.5	32.1	42.8	14.7	103.4	74.2	138.7	249.6	88.2	52.3	85.0	128.1	19.1	78.6	108.6	60.7	6.2	159.4	89.7	58.9	84.1	102.6	12.3	82.3	69.1	74.1	113.1	67.1	17.5	149.1	165.4	88.3	40.2	82.6	57.6	87.4	76.1	69.9	90.9	52.2	21.1	100.1	158.7	88.3	112.3	15.1	93.5	80.2	110.3	15.9	151.9	89.5	118.4	12.5	27.2	173.0	88.1	86.9	70.2	146.2	88.2	119.7	87.2	40.4	92.1	55.3	89.3	105.3	129.4	88.3	83.3	124.5	101.4	124.5	104.9	142.9
DHCR24	"DCE, KIAA0018, seladin-1"	ENSG00000116133	"24-dehydrocholesterol reductase"	Q15392	1	54849627-54887195	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 1129.5;liver: 623.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 298.1;Alveolar cells type 2: 682.3;Hepatocytes: 1091.4;Theca cells: 442.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1031.9"	"Low region specificity"	"Detected in all"							"HPA017981, CAB037247, HPA063005"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB037247: AB_796187, HPA017981: AB_2732422, HPA063005: AB_2684919"	"unprognostic (2.88e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.99e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (1.69e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (3.35e-1)"	"unprognostic (7.82e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.97e-2)"	58.3	1129.5	35.7	19.8	58.5	1.6	104.8	125.3	73.0	54.9	30.4	55.6	62.2	13.1	1.6	296.1	60.4	42.2	18.0	55.9	63.9	48.6	623.5	215.9	9.4	216.2	91.3	28.5	30.5	157.9	17.0	21.6	158.9	128.6	40.5	15.8	136.2	8.3	197.7	247.6	29.6	12.6	129.3	134.1	98.9	74.2	87.9	10.1	15.4	11.1	33.9	13.5	103.9	280.7	342.1	58.5	210.6	257.1	1031.9	219.0	50.5	94.8	160.3	130.7	268.6	341.6	210.2	55.3	191.5	82.4	427.4	319.2	250.5	501.3	118.3	8.3	159.6	303.3	131.8	421.7	168.9	126.7	68.2	161.0	429.0	397.6	74.7	66.7	67.2	124.5	224.7	0.2	50.2	143.5	25.8	111.4	592.0	90.7	164.2	0.3	54.2	166.3	735.3	257.1	144.5	53.2	185.0	337.5	123.1	221.6	441.5	143.3	62.2	45.3	130.0	66.1	183.9	22.7	55.0	91.2	32.8	215.3	60.4	5.1	1.5	0.7	6.0	1.8	0.3	3.7	2.5	2.6	5.2	1.3	2.2	2.9	0.0	2.7	0.7	3.0	0.4	4.4	35.7	58.5	125.3	73.0	55.9	63.9	216.2	91.3	158.9	129.3	87.9	280.7	6.2	298.1	682.3	12.4	13.3	31.5	17.3	150.6	79.1	9.7	87.9	33.1	15.3	145.8	205.2	68.0	0.0	35.2	6.4	133.3	3.9	55.3	22.9	14.5	5.8	13.5	24.0	71.6	14.5	76.5	34.4	17.5	38.7	44.7	32.2	26.4	111.0	1091.4	28.0	5.0	8.7	39.2	69.2	68.9	8.2	77.2	14.0	9.4	14.2	1.9	6.8	3.6	2.1	5.5	62.6	48.6	27.7	7.9	1.8	52.4	22.6	14.4	136.3	6.4	0.0	1.5	23.2	5.4	14.7	145.4	80.4	30.6	10.6	442.4	35.2	45.2
DHCR7	SLOS	ENSG00000172893	"7-dehydrocholesterol reductase"	Q9UBM7	11	71428193-71452868	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 161.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 77.9;Granulosa cells: 81.3;Hepatocytes: 156.1;Theca cells: 103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044280	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"HPA044280: AB_10794893"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-3)"	"unprognostic (8.57e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.45e-2)"	"prognostic favorable (6.93e-7)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (5.67e-4)"	23.7	97.2	28.1	13.0	35.4	46.7	36.3	42.4	37.0	16.2	15.6	21.1	48.1	10.6	59.2	42.2	12.5	8.9	28.8	28.8	35.8	16.3	161.1	21.8	6.0	55.3	38.8	54.4	16.6	24.4	18.4	8.3	55.8	21.6	14.4	8.7	27.8	7.1	13.6	68.2	19.3	9.9	34.4	9.6	19.1	31.0	38.0	4.7	11.9	13.2	9.4	7.9	22.7	58.9	126.4	112.3	106.7	118.9	49.0	75.8	33.7	50.9	134.1	43.1	114.5	419.8	401.5	87.1	79.0	48.6	376.2	235.9	128.8	276.7	44.5	33.5	98.7	33.4	89.3	183.1	127.8	63.7	15.6	89.2	122.1	159.3	108.4	34.6	63.8	112.7	159.6	180.7	43.2	341.1	52.4	72.6	154.1	124.9	67.4	46.9	150.6	377.3	162.3	187.3	144.7	53.9	48.4	157.6	113.9	51.4	153.2	34.5	60.4	11.5	62.4	3.7	61.5	59.3	78.7	95.8	33.8	110.9	48.9	5.6	2.1	1.9	10.5	1.4	12.6	6.5	8.9	9.8	2.8	5.4	11.0	13.0	1.1	5.8	1.5	7.1	6.0	6.9	28.1	35.4	42.4	37.0	28.8	35.8	55.3	38.8	55.8	34.4	38.0	58.9	7.1	3.2	19.1	7.2	7.1	0.8	10.1	77.9	3.4	8.4	21.8	14.9	13.1	15.7	39.2	22.0	12.5	15.5	11.9	9.9	7.9	36.9	0.1	3.9	1.5	11.8	9.5	5.2	3.2	49.9	27.6	12.8	11.7	9.3	0.0	81.3	7.9	156.1	11.9	0.0	4.5	12.3	54.9	3.8	3.3	1.7	8.4	5.6	5.4	1.0	5.8	21.2	4.1	5.0	14.7	26.7	11.5	4.9	10.0	16.5	8.9	3.8	7.6	8.7	13.1	3.9	9.0	0.5	7.0	11.9	1.1	54.2	13.8	103.6	15.0	9.5
DHDDS	"DS, FLJ13102, hCIT, HDS, RP59"	ENSG00000117682	"Dehydrodolichyl diphosphate synthase subunit"	Q86SQ9	1	26432282-26471306	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Transferase	"Disease variant, Epilepsy, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 256.5;Early spermatids: 99.1;Rod photoreceptor cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026721, HPA026727"	Uncertain		Uncertain	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"		"HPA026721: AB_1847643, HPA026727: AB_1847644"	"unprognostic (1.11e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (6.71e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.81e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.40e-2)"	"prognostic favorable (4.08e-7)"	"unprognostic (9.42e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.95e-1)"	57.3	19.6	12.3	18.9	11.8	12.4	22.7	32.5	14.0	14.6	14.6	37.3	19.1	13.5	38.5	26.3	12.9	15.9	19.8	12.8	13.3	25.5	22.0	13.9	17.6	15.5	16.9	11.4	18.5	39.8	20.9	12.6	18.8	14.1	38.8	37.8	43.3	14.0	13.5	21.2	18.2	18.4	9.0	14.1	23.3	12.3	14.1	14.1	19.1	11.8	20.8	18.1	14.4	12.2	34.2	24.8	20.6	23.8	36.1	28.2	28.4	54.9	33.4	44.0	41.6	37.4	34.6	38.4	33.3	57.2	30.0	24.1	25.4	42.8	42.9	22.7	13.9	38.0	66.9	30.8	39.3	41.4	51.5	40.3	27.6	59.1	32.2	29.4	51.2	26.7	27.3	41.0	39.7	19.4	23.1	20.2	26.3	53.1	36.2	25.3	33.4	31.2	25.4	28.8	24.4	19.4	36.4	38.0	26.6	26.8	29.8	20.9	63.0	30.1	26.3	60.4	32.0	48.1	72.4	39.5	43.0	54.0	26.8	9.4	16.1	9.6	13.8	23.6	9.8	13.2	9.0	9.1	13.6	10.2	7.4	10.9	13.0	10.1	23.1	11.5	8.3	10.5	12.3	11.8	32.5	14.0	12.8	13.3	15.5	16.9	18.8	9.0	14.1	12.2	9.4	9.6	7.8	7.8	13.5	4.6	9.6	12.0	10.8	29.6	9.6	7.4	15.5	15.7	13.8	14.7	256.5	18.3	13.7	76.3	11.7	19.3	99.1	11.6	12.9	11.1	20.9	5.7	26.9	14.5	23.4	11.1	33.6	20.0	19.0	14.4	10.0	13.2	24.5	15.2	28.5	46.3	14.2	11.5	7.1	23.4	10.5	10.5	10.6	10.3	34.4	16.3	14.4	9.0	11.4	17.6	40.3	7.5	18.7	10.6	24.7	29.3	11.5	106.1	0.0	8.4	14.5	13.2	13.5	12.4	5.1	25.4	10.3	15.8	26.0	12.2
DHPS	MIG13	ENSG00000095059	"Deoxyhypusine synthase"	P49366	19	12675717-12681880	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hypusine biosynthesis"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014461, HPA029413"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA014461: AB_1847651, HPA029413: AB_10602217"	"unprognostic (4.17e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.83e-2)"	30.6	43.2	44.6	23.9	48.1	21.7	29.6	51.0	57.5	35.7	50.0	40.9	28.0	33.2	15.6	29.5	38.6	20.1	41.0	46.5	48.6	34.2	41.0	29.6	32.7	46.4	45.1	40.6	49.7	47.0	52.8	19.7	50.0	34.8	29.5	69.1	34.1	27.9	92.6	41.3	32.8	29.1	47.7	31.6	44.2	16.0	45.9	45.2	28.7	70.5	34.7	36.7	33.1	56.2	70.8	50.8	80.8	41.5	34.2	57.7	18.6	44.0	64.9	82.8	82.9	35.4	33.8	71.7	49.4	48.2	75.6	41.0	55.7	63.0	57.4	64.2	37.8	48.8	51.4	47.1	43.8	57.2	72.1	47.2	74.8	49.7	85.2	82.9	59.1	141.5	45.1	49.5	61.5	137.0	105.1	83.3	64.2	90.3	85.1	65.8	29.1	106.6	63.5	34.6	106.7	144.4	44.0	64.2	76.0	48.1	59.0	96.5	29.8	94.4	38.2	93.5	69.2	160.0	184.9	49.9	59.7	66.2	94.5	37.0	58.8	82.7	51.0	54.1	53.0	86.2	59.0	52.8	63.4	82.1	77.7	56.8	18.2	64.2	72.8	64.9	77.6	70.0	44.6	48.1	51.0	57.5	46.5	48.6	46.4	45.1	50.0	47.7	45.9	56.2	40.3	41.7	30.7	10.1	54.8	55.6	79.2	93.0	38.7	75.8	48.3	64.5	8.6	37.1	49.1	33.1	45.9	47.1	52.2	35.2	86.1	53.7	20.9	38.2	24.5	35.0	41.3	26.7	11.9	37.6	55.1	35.0	33.6	27.9	24.1	46.0	30.4	34.6	42.8	42.1	12.5	60.8	79.3	37.6	42.5	27.5	45.1	35.3	49.8	6.5	62.7	115.2	53.5	8.0	14.7	48.7	70.1	34.6	51.1	73.3	87.9	84.1	49.6	129.2	46.0	39.6	53.8	33.3	62.3	39.7	51.0	71.8	51.1	37.4	54.3	71.0
DHTKD1	"CMT2Q, DKFZP762M115, KIAA1630, MGC3090"	ENSG00000181192	"Dehydrogenase E1 and transketolase domain containing 1"	Q96HY7	10	12068954-12123221	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 129.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 227.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 102.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037949, HPA037950, HPA066098"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA037949: AB_2675752, HPA037950: AB_10673650, HPA066098: AB_2685617"	"unprognostic (3.76e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.02e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (3.43e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.88e-3)"	10.7	8.4	8.1	6.8	10.4	3.8	8.4	12.6	8.5	8.8	11.9	10.1	7.6	6.2	6.8	7.5	6.1	5.3	13.2	7.6	8.5	42.7	129.5	5.4	8.5	9.5	8.6	10.0	18.0	12.7	5.6	7.7	9.5	12.9	10.8	7.5	13.1	5.7	18.7	5.6	6.9	5.7	8.8	7.8	10.9	4.7	9.1	10.5	11.6	23.1	9.7	6.3	6.1	11.4	27.0	20.4	29.8	23.8	18.2	10.8	35.9	13.3	8.6	23.4	20.6	13.1	15.7	19.3	4.3	8.4	10.8	37.4	31.6	10.4	26.6	10.9	14.2	10.6	7.7	10.1	17.8	4.2	3.8	13.3	7.9	13.7	5.5	9.2	13.0	23.1	16.7	15.1	6.3	52.3	14.4	7.7	16.7	24.9	4.7	24.3	9.7	16.5	15.2	6.4	7.7	34.9	26.3	46.3	15.4	31.7	102.2	15.2	5.8	7.5	5.4	15.8	9.9	13.4	10.3	12.6	9.7	7.4	12.8	23.8	6.8	15.4	4.2	9.2	4.5	13.0	3.2	2.7	11.9	9.9	3.1	4.1	19.4	14.3	17.0	17.3	5.7	4.9	8.1	10.4	12.6	8.5	7.6	8.5	9.5	8.6	9.5	8.8	9.1	11.4	6.9	12.8	38.8	21.5	21.3	5.2	6.7	5.3	10.2	13.3	13.7	8.3	31.1	28.6	7.8	16.5	10.4	35.4	23.2	14.6	19.6	10.9	3.5	8.8	17.3	8.1	11.3	21.9	12.8	11.1	25.1	8.1	21.9	20.8	8.8	45.2	11.0	227.4	10.3	26.9	17.3	18.0	4.1	15.3	10.1	4.2	12.5	13.5	5.4	17.8	13.4	10.4	8.2	15.6	20.5	12.4	9.6	12.0	22.6	9.6	9.4	62.5	5.2	19.2	13.1	10.6	7.4	6.7	3.8	16.2	6.0	13.5	8.4	21.8	16.6	7.8
DHX16	"DBP2, DDX16, Prp2, PRPF2"	ENSG00000204560	"DEAH-box helicase 16"	O60231	6	30653119-30673006	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 92.7;Spermatocytes: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051455	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA051455: AB_2681491"	"unprognostic (7.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (9.77e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.73e-3)"	24.3	28.2	5.4	13.8	6.3	11.3	26.0	6.3	6.8	27.7	8.3	29.5	18.8	25.5	8.6	27.2	26.6	11.3	26.6	5.3	6.0	34.9	36.5	25.4	18.1	6.3	5.9	26.2	35.0	16.0	28.6	10.5	6.4	30.1	10.3	14.4	32.0	12.8	45.0	28.8	37.5	12.5	5.2	40.3	28.3	46.8	6.6	17.1	38.2	17.6	12.7	24.8	26.8	6.4	31.9	17.9	20.3	38.7	26.8	15.7	27.0	33.0	30.7	47.6	44.3	35.8	15.9	25.5	24.2	31.1	39.6	34.0	47.0	24.1	35.5	35.4	15.5	27.2	25.5	17.9	21.4	65.9	40.4	17.6	22.7	47.3	30.1	16.5	16.9	36.9	44.4	29.3	26.7	29.0	22.4	20.8	21.4	20.9	12.1	38.5	17.4	28.2	18.4	24.0	27.9	19.7	30.8	37.4	32.0	20.3	29.5	24.7	11.8	31.2	21.3	27.4	46.3	29.9	49.9	20.2	15.7	36.8	40.4	10.5	11.2	18.6	7.4	14.7	9.5	7.7	9.1	7.9	11.1	5.9	7.4	5.8	11.4	14.8	16.4	9.8	7.4	7.5	5.4	6.3	6.3	6.8	5.3	6.0	6.3	5.9	6.4	5.2	6.6	6.4	13.0	22.4	20.9	4.6	16.9	10.8	11.7	11.3	16.5	13.9	10.0	9.9	14.6	10.0	20.2	5.5	39.6	19.2	14.4	18.3	9.8	15.7	92.7	25.2	18.0	11.8	6.0	14.9	4.3	18.6	20.1	11.6	26.5	15.8	42.3	11.1	8.6	9.7	13.9	5.0	4.1	14.6	8.2	12.6	12.8	49.3	14.3	14.4	5.4	5.6	20.3	11.6	15.5	2.5	5.2	22.9	23.1	12.4	22.1	9.3	18.0	9.8	31.4	51.1	19.7	16.2	19.2	86.9	32.6	14.7	10.7	19.2	19.5	11.4	12.8	9.5
DHX30	"DDX30, FLJ11214, KIAA0890"	ENSG00000132153	"DExH-box helicase 30"	Q7L2E3	3	47802909-47850195	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ribosome biogenesis"	"Helicase, Hydrolase, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034806	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	Cytosol	"HPA034806: AB_10601364"	"unprognostic (2.00e-1)"	"unprognostic (8.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.42e-2)"	"prognostic favorable (1.37e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.22e-1)"	22.6	24.6	23.7	17.1	23.3	22.2	22.9	21.4	26.3	26.4	24.8	26.8	16.2	27.6	10.4	23.6	24.8	14.9	28.8	23.5	22.4	26.8	25.2	21.3	20.1	24.0	23.5	27.9	24.1	28.9	32.1	17.5	24.6	26.6	10.9	12.7	21.6	18.2	37.1	27.6	22.3	15.9	20.3	27.3	25.2	54.2	23.8	23.3	24.8	21.0	14.3	25.2	22.8	24.2	21.9	52.3	54.5	56.2	24.6	20.2	35.3	39.0	33.4	65.1	46.5	56.9	42.6	66.4	32.0	37.0	51.2	30.3	73.7	52.1	23.1	49.6	86.1	59.6	76.0	58.6	40.7	56.0	58.3	33.0	33.4	68.1	49.7	28.4	44.0	57.5	82.0	40.6	31.8	57.1	82.2	59.3	60.7	30.2	84.0	44.6	30.6	62.2	32.0	53.6	41.6	61.6	39.6	54.1	31.1	25.0	38.5	58.8	32.2	40.6	51.0	46.7	73.9	56.2	75.3	61.8	42.8	48.3	49.9	14.1	10.7	7.8	16.2	10.6	12.4	10.4	12.4	16.3	13.9	8.7	11.7	12.7	1.6	9.6	11.6	7.9	15.3	14.7	23.7	23.3	21.4	26.3	23.5	22.4	24.0	23.5	24.6	20.3	23.8	24.2	31.1	38.5	46.7	30.7	34.7	18.1	25.7	38.7	39.3	49.0	34.6	35.6	38.1	32.9	34.1	51.5	43.8	41.7	33.1	37.6	66.5	37.8	129.5	59.2	31.7	32.4	40.1	38.5	32.8	36.3	22.8	26.7	42.3	33.2	23.5	40.7	27.5	50.8	35.9	58.9	36.6	25.8	40.7	29.6	17.6	123.8	24.8	24.4	19.6	13.1	32.5	46.3	28.8	22.1	28.7	46.0	41.0	30.1	39.9	28.6	40.5	83.5	49.9	52.8	32.9	27.3	28.6	145.4	50.2	33.5	19.9	29.6	29.7	36.6	38.5	26.3
DHX37	"DDX37, Dhr1, KIAA1517, MGC2695, MGC4322"	ENSG00000150990	"DEAH-box helicase 37"	Q8IY37	12	124946825-124989131	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047607	Approved		Approved	"Nuclear membrane"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear membrane"		"HPA047607: AB_2680101"	"unprognostic (1.83e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (9.54e-10)"	"unprognostic (2.38e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.16e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.73e-1)"	4.3	3.2	2.9	6.8	3.4	8.8	3.6	3.0	3.6	3.5	1.4	3.4	4.4	3.8	1.3	4.7	3.4	2.8	3.6	2.9	2.5	3.3	3.0	2.8	7.4	4.1	3.6	4.5	6.6	2.6	1.6	2.9	3.4	3.3	1.6	0.5	4.3	2.6	10.8	4.0	3.8	2.5	3.0	5.2	3.9	2.6	3.2	4.6	3.2	4.9	3.9	5.0	3.6	4.3	17.3	45.5	5.2	21.9	6.7	6.6	27.4	13.8	7.3	19.5	11.6	44.7	9.4	37.5	24.6	11.4	19.7	21.9	19.8	15.6	4.5	32.7	38.2	23.0	13.8	23.7	13.4	27.7	30.5	8.8	10.8	24.3	4.0	7.2	10.0	17.4	44.4	7.5	7.5	23.9	29.5	28.5	39.2	15.1	36.4	31.4	11.0	21.5	8.6	22.6	17.6	11.1	14.0	16.3	16.0	5.1	19.3	19.5	13.1	16.1	20.2	20.0	27.6	31.6	33.2	44.0	15.1	22.2	27.2	0.0	1.5	0.0	1.6	1.7	1.4	1.8	1.3	1.6	1.4	1.4	0.9	1.4	0.0	0.9	0.8	1.1	0.7	1.4	2.9	3.4	3.0	3.6	2.9	2.5	4.1	3.6	3.4	3.0	3.2	4.3	5.5	3.2	5.2	3.3	10.3	4.2	3.4	2.8	4.0	3.5	6.2	5.3	3.8	2.8	4.1	0.0	0.0	4.1	6.7	8.8	3.9	4.8	1.7	5.3	9.6	5.7	9.0	5.0	3.0	6.2	6.0	4.8	8.2	7.8	6.3	9.3	2.2	6.2	5.4	13.5	2.0	7.1	6.1	7.2	2.5	2.0	5.3	4.9	0.0	1.9	6.6	2.2	6.2	3.0	4.0	9.0	2.2	2.6	9.2	4.9	2.8	4.7	4.1	2.1	6.6	7.1	3.8	1.5	5.6	8.0	4.0	2.9	7.7	5.9	9.3	4.0
DHX38	"DDX38, hPrp16, KIAA0224, PRP16, PRPF16"	ENSG00000140829	"DEAH-box helicase 38"	Q92620	16	72093613-72112912	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041347, HPA041604"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA041347: AB_10796571, HPA041604: AB_2677577"	"unprognostic (2.38e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.32e-3)"	"unprognostic (8.50e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.68e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.40e-2)"	25.8	18.7	22.4	22.8	24.4	39.7	23.8	22.2	24.7	25.1	25.9	24.8	19.6	25.5	10.7	24.2	23.8	15.0	27.0	21.5	21.6	19.6	24.0	23.9	27.8	23.2	23.2	30.6	20.2	22.9	19.3	18.6	22.5	20.9	16.1	13.2	21.1	14.4	39.9	27.6	27.3	17.6	22.2	30.4	22.5	21.3	23.5	24.2	22.8	21.4	23.1	23.7	22.9	25.0	38.5	55.0	39.4	21.9	33.4	25.8	51.1	33.6	32.6	49.1	37.8	66.4	37.5	50.5	29.2	50.9	27.0	48.6	46.3	45.8	38.0	25.3	50.0	38.7	48.9	92.5	30.8	46.9	66.7	35.6	41.2	66.1	47.4	25.9	42.9	35.7	58.9	22.9	30.6	112.8	43.9	53.1	49.7	23.9	30.9	55.8	27.1	49.9	24.0	35.6	35.6	38.9	43.8	20.3	24.5	22.5	36.8	38.4	49.4	46.6	40.8	34.8	37.3	56.2	47.6	96.7	43.9	32.1	37.5	7.1	6.2	7.1	11.3	8.3	9.8	8.1	6.8	8.2	6.2	6.0	7.4	7.9	6.4	8.8	5.1	5.5	8.6	5.5	22.4	24.4	22.2	24.7	21.5	21.6	23.2	23.2	22.5	22.2	23.5	25.0	22.5	25.6	34.3	13.7	24.4	12.2	11.0	9.5	20.5	30.7	12.0	13.6	8.6	20.0	22.0	14.7	16.7	15.0	33.3	28.5	0.0	14.5	9.0	19.3	23.0	22.3	30.5	16.8	6.7	20.6	14.3	17.1	28.1	23.6	43.0	24.0	15.0	13.6	14.9	30.3	6.1	24.8	6.1	15.2	13.9	11.0	28.9	20.3	8.8	5.6	16.9	17.9	19.6	8.0	11.1	23.7	17.1	25.2	22.4	12.7	21.1	8.6	19.0	35.3	19.7	25.6	19.1	25.5	17.8	18.5	12.8	20.4	28.2	20.6	23.4	12.6
DICER1	"Dicer, HERNA, K12H4.8-LIKE, KIAA0928, MNG1"	ENSG00000100697	"Dicer 1, ribonuclease III"	Q9UPY3	14	95086228-95158010	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing"	"Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 418.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000694, CAB068185"	Approved		Supported	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB068185: AB_2665650, HPA000694: AB_1078661"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.75e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.52e-3)"	"unprognostic (5.73e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.74e-2)"	15.6	7.9	6.7	14.0	22.5	10.8	15.1	12.3	11.4	13.3	7.4	13.0	7.5	12.7	8.3	15.0	12.4	8.7	9.9	7.2	14.0	10.7	12.8	14.9	11.0	19.1	16.0	14.3	12.6	11.5	10.6	18.7	18.5	12.5	10.9	19.3	12.4	10.1	19.2	13.0	11.6	11.5	11.6	12.1	10.1	13.2	20.3	8.5	14.7	16.2	12.0	12.7	14.5	39.4	18.6	19.4	40.7	12.0	7.2	14.5	26.4	15.5	10.7	11.3	11.1	25.4	12.5	20.9	16.1	16.0	10.4	21.2	31.6	13.9	20.5	35.9	14.6	36.5	10.1	16.0	6.7	22.6	18.0	12.2	10.1	12.3	20.8	8.0	16.1	15.7	15.7	16.6	16.9	21.8	24.1	6.8	9.3	11.0	10.2	16.0	31.9	12.2	8.2	30.9	31.9	16.4	16.2	13.4	15.2	19.2	18.0	12.4	16.4	8.1	14.4	14.0	16.9	18.9	31.7	31.4	8.0	14.5	13.1	1.4	1.1	0.8	0.3	1.4	0.7	0.7	0.6	0.4	0.8	0.7	0.5	0.3	3.9	0.5	3.2	0.4	0.7	0.4	6.7	22.5	12.3	11.4	7.2	14.0	19.1	16.0	18.5	11.6	20.3	39.4	69.4	54.5	53.7	88.8	45.7	27.4	49.5	29.9	40.5	98.2	50.7	29.1	36.4	41.5	47.3	46.0	56.3	46.6	36.9	44.0	5.9	33.4	23.3	37.4	54.2	52.0	46.1	33.4	99.7	23.1	22.8	45.6	33.1	50.1	12.0	35.5	42.1	60.1	48.8	107.7	112.2	29.7	24.4	104.2	24.8	15.5	54.3	82.3	23.2	81.5	84.6	33.5	33.0	109.1	418.6	33.2	28.0	52.6	39.2	62.5	27.1	25.9	38.6	73.8	32.9	64.3	41.9	45.5	56.1	63.0	27.6	25.7	31.7	35.9	33.9	62.1
DLAT	"DLTA, E2, PDC-E2"	ENSG00000150768	"Dihydrolipoamide S-acetyltransferase"	P10515	11	112025408-112064404	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 89.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 100.5;Distal tubular cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003782, HPA040786, HPA062766"	Supported		Supported	Mitochondria		NA	NA		44000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB003782: , HPA040786: AB_2677136, HPA062766: AB_2684864"	"unprognostic (4.57e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (6.19e-6)"	"unprognostic (7.68e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.70e-2)"	"prognostic unfavorable (7.49e-5)"	"unprognostic (8.68e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.23e-3)"	"unprognostic (6.25e-2)"	"prognostic favorable (1.95e-14)"	"unprognostic (5.82e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.15e-2)"	24.7	16.5	7.7	13.3	8.3	7.9	14.5	9.5	9.3	11.0	10.4	24.7	18.3	10.0	13.4	19.5	13.0	8.5	69.4	8.1	11.1	33.8	15.5	11.7	16.1	8.3	8.9	9.5	6.8	31.7	8.5	13.1	9.7	14.5	26.0	10.8	16.8	14.8	75.4	10.3	16.5	13.4	8.2	9.9	14.3	9.9	9.4	12.7	20.2	89.4	18.2	14.2	8.1	8.0	18.7	16.4	28.2	34.4	41.6	30.5	26.5	26.6	18.2	34.8	38.7	52.8	56.7	85.4	46.0	28.7	42.6	41.0	65.7	34.2	38.9	27.3	30.2	51.9	17.9	39.2	29.0	64.9	26.6	36.9	37.7	32.0	35.2	24.2	33.9	41.7	88.4	42.6	41.2	16.6	25.4	66.9	30.3	58.6	35.4	45.4	38.0	93.3	64.4	21.4	51.2	27.8	30.7	93.4	20.5	30.9	67.4	42.9	17.8	29.1	29.1	29.1	33.0	11.1	19.4	127.5	7.7	73.0	22.7	9.1	3.8	3.0	4.3	5.8	5.4	5.6	4.9	5.1	5.8	4.0	5.6	5.1	0.3	4.7	6.1	4.5	5.8	5.0	7.7	8.3	9.5	9.3	8.1	11.1	8.3	8.9	9.7	8.2	9.4	8.0	7.6	12.8	14.5	15.3	13.8	11.2	9.2	18.2	14.2	8.1	9.2	5.8	100.5	15.7	13.2	11.0	0.0	21.2	6.4	26.3	74.3	18.7	3.9	15.8	11.6	9.6	17.3	18.1	18.0	11.4	39.6	11.7	11.7	12.1	3.8	13.5	7.5	15.5	18.7	8.4	24.4	17.8	24.4	8.8	7.5	3.2	6.2	9.5	17.8	9.4	16.7	10.4	4.1	11.1	19.7	14.1	9.2	10.9	19.4	7.0	19.0	37.6	30.3	11.1	0.0	14.2	19.9	25.1	18.3	21.1	9.8	17.4	8.5	26.3	26.7	9.3
DLD	"DLDH, E3, GCSL, LAD, OGDC-E3"	ENSG00000091140	"Dihydrolipoamide dehydrogenase"	P09622	7	107891162-107931730	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 357.0"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 356.2;Distal tubular cells: 226.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044849	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		10000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA044849: AB_2679111"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (7.35e-2)"	"prognostic favorable (7.58e-9)"	"unprognostic (4.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.18e-1)"	108.7	98.9	22.7	42.1	23.7	54.0	49.0	27.1	29.1	36.3	35.6	109.0	81.8	45.3	21.2	94.1	34.3	48.5	264.1	23.1	29.5	153.3	112.8	39.3	50.1	27.1	27.4	30.0	49.2	136.7	27.8	43.1	26.6	45.7	99.3	35.0	50.2	50.3	295.0	38.9	71.9	67.7	24.9	38.4	80.5	31.3	25.7	43.2	64.2	357.0	67.5	66.1	32.7	23.4	171.4	134.5	74.8	127.9	104.6	91.4	88.4	96.5	80.8	110.6	86.2	159.5	95.5	165.9	159.6	103.0	177.7	110.9	150.2	135.8	166.1	111.1	88.4	116.9	175.6	116.7	80.3	194.7	116.0	104.8	97.6	116.4	63.4	72.3	134.0	137.0	298.5	119.7	121.8	188.1	161.8	138.9	87.4	206.0	98.2	113.1	117.8	225.9	151.8	250.8	92.3	99.9	156.3	262.1	143.9	149.9	100.5	165.8	87.9	120.7	97.3	238.1	149.4	89.3	187.1	114.6	115.0	204.1	130.2	132.7	63.9	136.0	46.9	81.6	49.4	37.8	46.8	46.8	87.2	38.5	47.9	50.5	39.9	68.1	116.9	29.9	49.0	64.2	22.7	23.7	27.1	29.1	23.1	29.5	27.1	27.4	26.6	24.9	25.7	23.4	26.7	28.9	20.7	14.7	26.3	31.4	42.7	124.7	31.3	47.1	24.0	19.2	356.2	51.5	70.5	79.1	22.9	110.2	27.3	56.1	226.9	69.3	10.2	27.6	26.2	32.2	30.6	53.9	23.9	55.9	62.7	36.3	36.7	28.0	26.6	35.3	26.0	86.8	69.2	21.9	25.3	44.1	114.0	41.0	26.5	7.3	23.3	37.5	37.4	15.9	62.2	36.0	38.1	21.1	16.7	42.6	51.4	42.2	30.7	24.3	60.0	178.9	55.5	45.5	26.3	28.4	44.8	55.2	51.5	48.0	32.4	108.4	29.5	73.7	78.7	39.2
DLG4	"PSD-95, PSD95, SAP-90, SAP90"	ENSG00000132535	"Discs large MAGUK scaffold protein 4"	P78352	17	7187187-7219841	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 112.4;pituitary gland: 62.8;retina: 223.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 41.8;Cone photoreceptor cells: 102.2;Rod photoreceptor cells: 62.6"	"Cancer enhanced"	"Detected in all"		"glioma: 13.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 40.0;hTERT-RPE1: 45.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001999, CAB002000, HPA010122, HPA071006"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB001999: , CAB002000: , HPA010122: AB_1855169, HPA071006: "	"unprognostic (7.08e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.72e-2)"	"prognostic favorable (8.82e-6)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.77e-3)"	13.1	19.1	41.9	9.3	49.6	3.6	10.0	32.1	112.4	23.5	0.0	18.5	4.9	23.1	6.9	6.3	20.7	10.8	19.6	86.3	17.5	10.3	7.1	14.7	4.4	7.2	0.4	30.3	6.3	7.2	62.8	8.9	5.6	16.6	3.5	223.2	7.2	12.8	6.1	4.7	8.4	11.1	0.0	13.9	10.3	18.9	7.7	8.7	11.0	2.8	2.9	13.3	16.4	36.2	0.5	15.2	29.4	9.1	8.4	14.6	1.5	14.1	12.5	10.8	11.3	0.7	4.0	2.4	6.4	12.1	1.6	1.8	1.1	6.7	3.3	17.6	6.0	9.4	35.1	1.4	8.0	0.3	40.0	17.5	0.9	7.7	11.0	45.5	11.5	10.1	3.1	10.1	15.2	1.0	9.3	5.1	3.8	0.8	1.6	10.5	1.6	1.0	6.6	0.3	12.4	10.5	0.4	0.8	2.6	7.0	6.5	7.2	16.4	30.6	12.6	7.4	7.8	1.5	0.9	2.1	19.3	6.9	8.5	0.4	0.2	0.1	0.2	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.4	0.0	0.1	41.9	49.6	32.1	112.4	86.3	17.5	7.2	0.4	5.6	0.0	7.7	36.2	3.4	0.0	1.5	14.0	1.5	2.7	2.2	1.8	6.2	41.8	4.8	3.7	3.2	1.5	2.2	3.7	102.2	0.6	3.3	0.4	0.0	0.9	1.8	2.4	9.5	7.0	15.0	0.8	22.8	0.2	0.4	5.5	2.0	3.2	7.0	3.4	10.0	2.2	3.9	20.2	17.5	0.8	4.1	11.0	10.3	1.3	7.2	7.8	3.6	8.4	5.5	11.1	0.0	4.5	4.2	0.2	0.1	10.1	0.2	1.7	1.3	0.3	3.0	62.6	0.0	1.4	4.5	6.5	2.9	3.2	1.8	0.5	1.1	6.8	0.5	1.1
DLST	"DLTS, KGD2, OGDC-E2"	ENSG00000119689	"Dihydrolipoamide S-succinyltransferase"	P36957	14	74881891-74903743	"Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003010	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA		70000	"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA003010: AB_1078679"	"unprognostic (1.62e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.45e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.13e-12)"	"unprognostic (3.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.55e-3)"	64.5	85.5	33.5	32.3	34.7	75.0	59.6	35.8	34.7	62.1	43.8	63.3	58.7	47.5	43.2	62.9	46.1	36.2	129.0	30.8	35.1	100.4	78.4	48.5	36.9	35.8	34.5	45.8	44.8	78.8	35.4	44.8	34.3	41.3	59.3	37.1	46.5	43.5	144.7	64.3	58.3	52.1	33.6	46.1	57.7	29.3	37.3	42.5	42.9	224.2	45.7	58.0	49.7	32.5	79.1	81.1	63.7	45.4	98.1	110.6	97.5	106.3	107.8	106.8	99.0	80.9	88.1	81.0	44.3	118.1	48.1	87.8	109.0	105.6	112.0	61.5	43.3	68.4	66.3	74.8	101.4	49.5	45.4	114.0	90.5	103.8	126.7	95.5	106.1	36.6	53.4	55.6	110.3	112.0	59.0	69.7	55.0	146.6	79.0	73.8	93.8	46.7	125.8	100.8	75.5	64.1	100.6	129.4	71.3	54.2	121.7	70.5	90.8	63.8	83.2	79.5	74.0	38.7	43.7	73.4	93.9	47.9	68.8	3.0	1.3	2.3	2.1	2.0	1.8	1.6	1.9	1.6	2.1	1.0	1.5	2.2	1.3	3.5	1.8	2.8	2.0	1.5	33.5	34.7	35.8	34.7	30.8	35.1	35.8	34.5	34.3	33.6	37.3	32.5	24.2	6.4	4.8	14.0	22.7	26.4	23.5	19.7	21.6	19.1	25.1	20.4	28.5	21.5	10.1	20.2	31.3	41.0	27.7	41.9	56.7	37.8	7.3	10.9	20.4	19.8	14.8	22.5	21.9	25.7	38.8	25.6	30.5	18.9	21.0	19.4	23.2	43.6	32.1	13.5	24.6	31.8	12.2	20.9	19.0	6.2	18.0	18.8	23.2	13.1	27.1	10.0	20.6	18.6	18.5	44.3	28.0	20.7	20.0	28.2	49.8	73.3	8.7	20.8	26.3	18.3	24.0	12.1	15.3	34.2	28.4	79.5	23.1	19.3	40.5	27.7
DMGDH		ENSG00000132837	"Dimethylglycine dehydrogenase"	Q9UI17	5	78997564-79236038	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	18	"kidney: 169.4;liver: 283.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 40.6;Hepatocytes: 104.2;Late spermatids: 33.1;Proximal tubular cells: 83.9"	"Group enriched"	"Detected in some"	12	"liver cancer: 15.6;renal cancer: 12.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.6;Hep G2: 7.6;hTEC/SVTERT24-B: 2.2;Karpas-707: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036441, HPA036442, HPA077849"	Enhanced		Supported	Mitochondria		NA	NA		680000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: AB_2686859"	"unprognostic (3.11e-2)"	"unprognostic (3.36e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.52e-3)"	"prognostic favorable (5.32e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.07e-4)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.17e-5)"	"unprognostic (2.03e-2)"	"unprognostic (9.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	8.4	4.5	1.5	0.3	1.7	0.0	2.2	1.4	1.6	1.4	3.0	1.3	0.2	2.8	12.2	1.4	1.3	2.1	1.9	1.5	2.4	169.4	283.8	0.4	0.2	1.5	1.9	2.2	1.8	0.6	2.9	0.1	2.0	1.8	0.4	1.5	0.4	1.8	2.4	0.6	0.6	1.7	1.4	0.1	1.0	2.3	2.9	0.3	4.8	1.5	0.3	1.2	0.5	1.6	0.0	0.0	0.0	0.3	0.3	0.8	0.3	0.2	3.6	0.8	1.4	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	7.6	1.9	0.0	0.0	1.7	2.1	2.2	1.6	1.5	0.0	0.8	0.0	2.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	1.4	1.6	1.5	2.4	1.5	1.9	2.0	1.4	2.9	1.6	1.3	0.0	1.1	19.9	2.9	0.1	0.5	1.0	1.8	1.9	1.4	1.8	1.0	2.8	0.8	9.2	2.1	0.3	1.9	0.7	19.6	0.4	40.6	2.6	5.0	1.2	1.2	6.1	5.8	0.7	0.1	2.7	3.6	2.7	0.0	4.1	1.8	104.2	0.1	0.0	1.5	1.2	4.1	1.6	0.4	33.1	2.5	1.7	0.0	4.7	0.2	4.3	3.1	4.5	3.3	0.8	1.4	2.6	4.5	0.9	1.6	83.9	4.7	3.7	0.0	1.7	0.7	4.9	5.3	1.8	0.3	0.3	2.9	4.4	0.9	0.8
DMPK	"DM, DM1, DM1PK, DMK, MDPK, MT-PK"	ENSG00000104936	"DM1 protein kinase"	Q09013	19	45769709-45782552	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 44.1;Sertoli cells: 59.2;Smooth muscle cells: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 85.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 8.7"	"HPA007164, HPA008905"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	Vesicles	"HPA007164: AB_1078687, HPA008905: AB_1078685"	"unprognostic (7.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.46e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (9.39e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.24e-3)"	24.2	68.3	22.1	17.5	24.0	3.0	19.1	22.2	33.1	42.8	25.6	121.5	15.8	92.7	5.3	33.4	61.2	13.9	171.3	21.8	21.6	20.3	8.8	29.8	5.2	24.0	23.8	31.1	34.3	2.9	37.9	8.8	22.3	56.4	4.8	4.1	18.6	37.6	173.6	12.3	34.6	59.9	21.9	17.8	51.7	13.2	23.8	4.2	21.7	143.2	1.3	69.1	34.3	21.3	11.7	16.7	13.5	10.7	13.4	12.9	10.5	26.1	22.2	10.5	8.8	2.2	6.6	2.9	2.8	32.9	9.2	15.1	3.0	1.5	2.2	12.4	16.6	0.8	22.6	1.4	12.6	0.1	5.4	22.8	8.0	6.4	1.7	24.2	3.6	2.1	8.6	8.0	15.4	13.7	1.6	3.8	8.8	4.8	3.3	5.0	85.1	6.4	4.7	11.5	10.2	13.5	13.6	27.6	9.3	4.8	28.6	5.5	8.4	9.2	10.4	8.3	15.0	16.8	11.5	2.9	9.5	1.3	13.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	24.0	22.2	33.1	21.8	21.6	24.0	23.8	22.3	21.9	23.8	21.3	10.5	0.0	2.2	44.1	3.7	8.0	8.1	3.8	5.7	5.7	9.6	9.9	3.7	4.3	3.2	3.7	8.4	2.7	4.2	4.7	1.9	2.7	1.5	8.7	8.6	7.9	10.1	0.4	16.4	17.3	2.0	8.4	8.2	6.3	0.0	9.7	9.3	1.5	0.8	5.0	12.4	8.2	8.2	1.6	9.8	1.8	7.2	0.8	7.2	10.3	0.4	2.6	5.2	26.7	10.0	5.8	4.5	23.3	3.1	4.0	3.8	31.7	7.1	7.4	59.2	27.6	34.9	7.2	6.4	10.1	6.8	1.6	4.5	5.4	5.1	4.6
DMXL2	"DFNA71, KIAA0856, RC3"	ENSG00000104093	"Dmx like 2"	Q8TDJ6	15	51447711-51622833	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Diabetes mellitus, Disease variant, Epilepsy, Hypogonadotropic hypogonadism, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 138.9;Inhibitory neurons: 122.9;Kupffer cells: 96.1;Macrophages: 106.3;monocytes: 84.9;Oligodendrocyte precursor cells: 96.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.8;intermediate monocyte: 2.2;neutrophil: 2.2;non-classical monocyte: 2.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.2;monocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"U-937: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039375	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA039375: AB_10673610"	"unprognostic (5.66e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.67e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.70e-2)"	5.3	4.7	4.1	11.1	4.7	17.1	3.4	4.0	7.3	4.6	8.1	6.5	9.2	4.4	13.9	1.9	5.2	4.5	3.1	8.9	2.8	5.7	4.5	6.8	4.7	2.5	1.1	4.1	5.4	8.0	8.4	7.2	3.0	2.7	7.5	16.3	5.4	2.5	1.1	1.7	7.1	5.3	0.0	6.5	5.3	9.0	4.2	4.7	4.2	1.7	2.6	6.0	2.8	2.4	9.1	11.7	12.6	7.3	5.3	9.1	3.1	6.9	7.5	6.5	8.5	1.7	4.4	0.0	3.3	4.1	12.5	4.8	8.1	4.8	8.7	10.6	3.9	3.6	10.6	2.1	4.9	20.6	5.8	4.2	3.9	8.4	3.7	6.8	4.5	10.9	8.3	0.8	6.7	10.0	8.9	19.2	9.2	4.3	3.8	7.9	10.3	13.5	3.4	18.1	18.0	7.8	7.3	4.1	8.5	11.0	6.9	21.9	5.7	7.8	5.3	11.0	8.2	16.0	25.2	0.0	9.2	44.0	7.4	0.0	2.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	2.2	0.0	2.7	0.3	0.0	0.4	4.1	4.7	4.0	7.3	8.9	2.8	2.5	1.1	3.0	0.0	4.2	2.4	5.2	3.2	15.7	68.6	2.1	3.1	2.5	4.1	4.6	41.4	4.9	2.0	8.4	1.5	6.7	7.3	64.6	5.7	13.1	22.7	1.9	3.0	2.5	11.6	18.9	5.4	28.1	0.8	138.9	3.8	4.9	8.7	28.5	5.5	10.8	10.6	5.7	6.0	36.5	58.9	122.9	13.3	2.0	96.1	16.4	3.5	6.5	106.3	3.6	50.6	84.9	8.6	1.0	96.5	50.7	5.2	17.4	9.1	2.1	2.5	24.9	8.1	18.7	31.9	6.6	8.1	8.7	37.2	30.3	2.8	1.7	3.8	3.6	9.1	15.9	2.7
DNA2	"DNA2L, KIAA0083"	ENSG00000138346	"DNA replication helicase/nuclease 2"	P51530	10	68414064-68472121	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Disease variant, Dwarfism, Mental retardation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 33.2;Excitatory neurons: 14.1;Inhibitory neurons: 15.5;Oligodendrocytes: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"NK-cell: 1.8"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037487, HPA057526"	Approved		Supported	Mitochondria		No	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria		"HPA037487: AB_10672493, HPA057526: AB_2683456"	"unprognostic (1.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.60e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.50e-5)"	"unprognostic (3.36e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.09e-10)"	"unprognostic (3.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.23e-2)"	1.3	0.9	1.9	2.8	2.1	4.6	1.8	2.5	3.6	1.4	1.0	2.3	2.1	1.1	0.9	1.9	0.9	0.9	1.8	1.8	1.9	2.6	4.2	1.8	5.2	2.3	1.9	1.2	1.6	0.4	1.5	1.6	2.4	1.9	2.8	5.3	1.6	0.4	1.6	1.8	3.2	1.1	1.6	2.1	1.9	2.9	2.1	8.1	1.0	0.9	4.2	1.4	1.4	3.2	25.6	13.0	29.0	20.7	3.2	2.2	20.4	12.4	10.3	17.4	21.2	31.1	16.1	26.1	4.6	3.8	6.7	15.2	16.8	6.5	20.7	16.2	12.6	15.8	8.5	12.3	0.9	27.7	16.4	1.8	2.6	12.3	3.6	4.5	7.9	17.0	23.6	22.8	10.1	9.0	42.8	19.8	20.5	10.9	24.0	33.1	20.0	8.4	7.5	11.7	13.1	15.7	16.9	21.4	4.2	20.1	16.5	11.6	3.4	6.6	20.5	8.5	23.8	11.5	13.9	38.3	5.7	26.1	8.9	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	1.8	0.0	0.0	0.1	0.0	1.9	2.1	2.5	3.6	1.8	1.9	2.3	1.9	2.4	1.6	2.1	3.2	1.0	6.4	1.1	4.9	1.3	2.3	0.9	1.7	2.8	2.5	2.3	1.4	10.5	2.8	1.1	1.8	6.2	3.9	2.2	1.7	0.0	0.8	2.2	2.0	1.4	2.0	1.2	33.2	14.1	0.9	4.8	2.0	2.6	2.8	0.0	6.0	0.7	4.6	2.2	0.0	15.5	1.8	0.0	1.3	0.7	3.7	0.6	1.5	0.0	4.7	0.5	0.5	2.1	5.5	18.4	0.7	0.1	0.7	7.4	2.5	2.4	0.6	0.8	4.3	0.0	2.4	1.1	9.1	12.2	4.7	1.7	1.2	1.6	0.7	3.7	1.0
DNAJC6	"KIAA0473, PARK19"	ENSG00000116675	"DnaJ heat shock protein family (Hsp40) member C6"	O75061	1	65248219-65415871	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Chaperone, Hydrolase, Protein phosphatase"	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 81.5;retina: 52.8"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1038.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 5.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 62.1;HEL: 165.8;K-562: 65.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031182, HPA054917"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA031182: AB_10611957, HPA054917: AB_2682641"	"unprognostic (6.99e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.19e-1)"	"unprognostic (7.94e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.87e-4)"	"unprognostic (2.98e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.14e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.67e-3)"	1.5	11.1	34.7	0.9	43.3	4.7	1.1	33.7	46.9	0.8	0.0	2.1	1.0	0.6	0.4	0.3	1.1	1.0	8.9	42.1	48.0	7.7	0.4	1.5	0.2	60.2	51.3	0.5	2.1	1.0	12.6	7.4	67.6	1.1	1.7	52.8	0.7	0.7	0.4	1.1	1.0	0.9	27.2	2.1	1.7	2.2	42.0	0.8	1.7	0.8	0.3	1.1	0.9	81.5	10.4	2.8	0.1	4.4	2.1	0.5	23.4	20.1	33.1	32.6	31.7	2.7	0.5	9.9	1.7	8.3	8.0	2.5	14.6	3.3	25.8	62.1	6.9	165.8	5.1	0.6	0.2	5.6	3.9	2.7	2.2	3.3	13.8	6.0	0.7	8.0	65.5	1.2	6.6	1.9	2.1	0.0	6.5	0.0	2.2	0.0	4.9	0.4	23.7	0.0	39.4	27.0	11.9	15.5	5.4	37.4	7.5	0.3	6.5	4.8	3.3	0.6	5.9	6.0	4.1	3.0	13.4	4.1	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.7	43.3	33.7	46.9	42.1	48.0	60.2	51.3	67.6	27.2	42.0	81.5	0.8	0.0	0.5	49.3	0.5	1.3	0.4	0.5	0.0	30.4	0.6	0.3	28.0	2.8	0.2	0.0	14.6	8.9	1.5	0.4	1.9	0.8	2.0	1.8	0.5	3.7	7.2	19.4	237.4	0.7	2.1	5.8	1.5	3.0	0.0	0.6	0.4	0.1	1.2	52.2	237.6	1.9	2.0	0.0	0.8	1.9	0.0	0.7	7.2	18.7	1.1	4.1	0.0	136.7	1038.1	0.4	0.2	0.0	0.9	1.7	0.0	7.2	1.2	21.6	0.0	0.2	8.5	1.7	2.5	0.0	0.3	7.4	0.6	6.9	0.6	0.2
DNASE1	DNL1	ENSG00000213918	"Deoxyribonuclease 1"	P24855	16	3611728-3680143	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	"Actin-binding, Endonuclease, Hydrolase, Nuclease"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 34.5;kidney: 34.2"	"Cell type enriched"	"Detected in many"	11	"Proximal enterocytes: 715.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA010703	Enhanced		Supported	Vesicles	"Secreted in other tissues"	NA	NA		420000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA010703: AB_10600806"	"unprognostic (5.18e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.69e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.14e-4)"	4.6	5.0	5.1	6.6	5.6	4.3	4.6	13.4	6.4	9.8	6.9	6.1	29.7	5.2	5.0	7.1	6.8	2.7	5.5	5.8	4.9	34.2	5.9	4.9	10.0	6.0	5.2	7.5	23.6	2.7	16.3	4.2	6.6	11.6	5.0	4.4	4.9	2.5	3.7	7.8	34.5	2.7	3.2	9.2	11.2	9.2	5.8	9.4	7.4	1.3	8.7	6.0	8.5	9.7	2.9	6.5	11.4	5.9	3.3	2.8	5.2	4.7	0.8	3.7	5.3	8.0	6.9	12.3	3.6	0.7	7.8	4.8	4.2	1.3	3.9	5.5	6.4	4.4	11.3	5.4	1.7	2.9	9.6	2.3	4.8	5.0	1.2	5.8	2.5	10.3	11.2	5.0	3.2	12.3	6.3	13.6	6.9	8.7	3.6	14.9	5.3	5.7	3.1	2.5	8.1	7.6	3.5	10.5	1.9	5.7	10.4	7.7	3.4	6.8	5.0	4.3	2.5	4.8	7.5	21.4	1.7	5.7	6.6	2.7	1.1	3.2	1.5	0.7	1.0	1.4	1.2	1.3	0.6	2.1	1.3	1.8	5.0	1.0	0.7	1.1	1.4	0.5	5.1	5.6	13.4	6.4	5.8	4.9	6.0	5.2	6.6	3.2	5.8	9.7	4.9	9.6	10.3	27.1	9.1	2.7	8.6	3.1	10.8	27.3	5.5	4.8	6.0	4.3	9.7	16.5	22.9	8.6	9.3	11.8	56.7	5.3	19.3	9.8	10.0	7.7	14.3	7.6	20.5	11.0	4.1	7.4	13.3	8.4	2.5	23.3	7.5	1.8	3.9	25.2	22.0	38.6	20.3	5.0	4.2	52.4	8.4	4.4	1.8	15.9	13.2	8.6	30.9	22.1	20.6	5.3	61.4	7.9	7.2	12.4	715.5	2.4	9.1	17.9	0.0	13.6	6.3	28.5	24.5	5.8	3.8	6.2	12.2	10.4	33.4	6.3
DNM1	DNM	ENSG00000106976	"Dynamin 1"	Q05193	9	128191655-128255248	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, Motor protein"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 319.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 112.4;Cone photoreceptor cells: 89.6;Excitatory neurons: 176.1;Inhibitory neurons: 182.2;Rod photoreceptor cells: 78.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 319.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 126.9;U-87 MG: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005920, HPA049910"	Enhanced					NA	NA		8800		"Cluster 10: Brain - Neuronal signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB005920: , HPA049910: AB_2680948"	"unprognostic (3.25e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.34e-3)"	"unprognostic (3.95e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.62e-3)"	"unprognostic (6.30e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-3)"	22.2	7.9	99.8	3.7	129.1	2.0	13.2	13.6	319.5	30.8	0.0	8.0	1.9	8.8	2.4	5.5	9.4	13.4	7.8	140.1	15.9	14.1	5.3	4.6	2.4	50.7	4.1	2.5	8.4	4.1	33.6	2.5	36.6	9.0	2.7	68.3	9.0	3.0	3.2	15.0	9.0	5.3	0.0	1.0	5.0	4.9	10.0	0.9	5.2	4.0	1.8	10.6	21.6	123.1	8.7	126.9	11.3	2.8	3.6	36.8	0.6	8.0	18.9	15.7	6.5	1.7	2.6	0.2	10.7	16.7	0.6	15.3	1.8	0.8	8.6	0.1	12.1	8.3	19.5	0.5	2.6	1.1	5.6	9.8	0.2	12.4	0.2	15.2	0.0	7.3	3.1	0.5	0.0	3.6	0.7	2.7	12.2	2.2	23.1	15.6	0.4	3.9	2.4	0.0	16.1	27.1	27.1	0.8	1.2	1.4	0.3	11.2	0.6	0.5	34.8	36.2	16.6	1.0	0.4	0.8	46.8	0.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.8	129.1	13.6	319.5	140.1	15.9	50.7	4.1	36.6	0.0	10.0	123.1	2.2	0.0	0.0	18.9	0.9	7.9	1.7	0.3	8.0	112.4	2.9	3.9	2.0	5.7	0.8	0.0	89.6	0.3	0.2	0.4	1.9	0.8	0.9	1.3	19.0	1.8	0.0	0.0	176.1	0.9	0.4	24.3	2.6	1.4	1.3	2.8	0.7	0.6	10.6	50.5	182.2	0.9	0.0	0.6	10.5	1.0	2.8	9.2	3.6	22.5	1.3	10.7	0.0	33.7	14.3	0.6	5.0	1.5	0.7	0.8	2.5	5.3	1.1	78.4	0.0	2.1	3.8	1.0	1.8	2.5	7.5	0.8	1.6	2.1	1.6	0.8
DNM1L	"DRP1, DVLP, DYMPLE, HDYNIV, VPS1"	ENSG00000087470	"Dynamin 1 like"	O00429	12	32679200-32745650	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Biological rhythms, Endocytosis, Necrosis"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009952, HPA039324"	Approved		Enhanced	Vesicles,Cytosol		NA	NA		2000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Vesicles	"CAB009952: AB_2093533, HPA039324: AB_2676443"	"unprognostic (2.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (6.27e-6)"	"unprognostic (8.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.17e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.57e-2)"	23.2	23.2	25.3	23.5	27.5	40.0	21.1	27.7	32.3	18.4	15.7	24.0	18.6	23.6	23.9	28.6	19.8	17.5	38.9	28.4	26.1	27.9	14.2	16.7	20.9	22.5	22.0	20.0	13.5	40.5	25.3	23.9	23.6	27.0	22.7	44.9	16.0	28.7	43.8	18.3	16.8	32.0	22.2	18.8	17.3	36.0	21.6	21.4	22.4	57.2	24.8	29.9	18.5	26.6	66.8	62.3	64.3	68.3	51.2	52.7	123.2	72.0	55.4	67.2	61.7	80.6	48.0	87.3	50.0	65.8	66.9	57.8	69.2	80.3	79.3	46.6	57.6	102.3	57.2	48.2	41.7	72.5	50.1	48.6	37.4	70.7	66.1	63.5	81.1	41.4	74.4	37.5	75.3	21.7	29.1	61.7	138.2	41.0	30.8	48.6	125.0	61.5	56.5	79.1	57.1	59.3	76.3	51.8	56.7	129.4	59.7	49.0	74.0	57.3	54.4	135.3	68.2	26.1	75.8	86.3	55.6	47.0	43.5	7.4	10.0	3.2	5.6	15.6	6.9	7.0	6.2	6.1	18.8	6.0	7.3	8.4	1.8	8.1	15.6	5.6	7.3	7.9	25.3	27.5	27.7	32.3	28.4	26.1	22.5	22.0	23.6	22.2	21.6	26.6	42.5	38.5	38.4	82.6	36.0	30.0	34.7	28.0	44.3	80.9	32.5	29.2	82.8	20.0	33.3	25.8	131.3	30.0	53.8	26.7	31.3	34.8	63.9	38.8	55.8	42.0	30.5	28.4	139.4	25.1	63.7	41.0	23.9	59.4	50.7	48.8	26.4	16.0	30.8	126.2	150.0	24.9	34.6	27.5	30.7	78.0	26.8	43.3	14.2	44.0	45.6	59.0	34.0	99.5	121.7	45.7	14.4	30.5	48.5	42.8	11.4	23.3	22.8	164.8	19.7	55.0	55.5	79.3	52.3	39.6	27.6	36.0	42.2	26.0	31.5	36.4
DNM2	"CMT2M, CMTDI1, CMTDIB, DI-CMTB, DYN2, DYNII"	ENSG00000079805	"Dynamin 2"	P50570	19	10718079-10833488	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Phagocytosis"	"Hydrolase, Motor protein"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 242.8;Paneth cells: 177.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054246	Supported		Approved	"Golgi apparatus,Cytosol"		NA	NA		230000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus, Cytosol"		"HPA054246: AB_2682427"	"unprognostic (2.30e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (8.91e-4)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.75e-2)"	"unprognostic (5.35e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.40e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	55.1	69.9	50.5	63.2	77.8	125.7	46.1	74.1	64.1	49.0	38.8	105.8	65.9	42.2	25.3	67.6	42.5	40.5	87.2	52.3	57.4	72.8	57.2	87.0	62.4	82.7	78.9	36.6	68.2	38.9	41.9	51.3	79.8	47.4	83.9	30.7	55.0	55.7	108.1	92.8	99.6	35.1	60.3	81.0	98.6	55.1	72.9	58.6	47.6	82.8	65.4	64.6	54.5	101.6	116.4	92.8	67.6	54.6	67.6	65.4	86.5	75.1	70.5	108.8	91.7	94.2	74.7	83.2	132.2	81.5	52.5	99.4	92.6	82.1	90.8	103.1	72.4	160.1	81.7	107.1	82.9	87.8	146.5	67.8	62.4	83.5	77.9	66.2	107.3	84.9	131.5	139.1	68.0	140.1	126.3	85.7	76.6	138.3	109.7	125.6	72.6	95.7	71.3	171.1	97.1	63.8	86.6	73.6	54.2	74.9	58.8	106.2	99.6	120.7	40.5	172.0	102.7	112.7	127.3	77.9	89.9	134.0	61.0	3.5	3.5	7.0	4.0	6.2	3.8	2.5	3.0	4.4	4.2	2.1	1.7	3.0	6.5	8.9	8.4	8.4	3.8	4.1	50.5	77.8	74.1	64.1	52.3	57.4	82.7	78.9	79.8	60.3	72.9	101.6	37.8	32.1	22.3	24.8	48.8	23.2	17.1	13.8	22.2	28.8	19.7	16.3	30.3	14.3	25.7	51.5	22.9	25.7	57.2	242.8	50.9	35.2	48.4	32.2	17.9	33.1	21.6	38.1	29.2	32.0	106.9	19.5	168.7	39.7	19.0	36.8	20.3	22.8	49.1	43.7	31.1	106.9	14.2	28.0	39.6	98.0	16.8	55.2	19.6	60.9	43.4	17.2	39.1	23.1	90.9	45.2	177.3	27.8	92.2	20.2	90.7	38.8	18.0	26.3	26.3	18.7	27.6	15.0	12.3	26.6	31.5	31.7	46.4	40.7	82.5	22.8
DNMT3A		ENSG00000119772	"DNA methyltransferase 3 alpha"	Q9Y6K1	2	25227855-25342590	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 127.2;Horizontal cells: 95.9;Rod photoreceptor cells: 143.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 59.6;REH: 59.5;SH-SY5Y: 71.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009469, HPA026588"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB009469: AB_2093990, HPA026588: AB_1847812"	"unprognostic (2.38e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (8.38e-2)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-2)"	5.6	9.0	8.9	9.8	12.6	8.7	6.2	9.3	10.7	9.1	2.4	11.3	6.7	9.3	8.7	6.0	7.5	6.3	5.9	8.8	7.9	11.3	5.3	7.3	11.1	9.0	7.6	13.0	8.3	4.2	11.5	15.7	8.6	7.2	6.6	15.4	6.2	5.9	21.0	4.9	8.9	7.1	5.2	13.4	8.5	5.2	9.4	20.6	6.9	10.2	9.0	7.3	6.2	11.3	1.6	8.1	34.6	8.3	3.8	2.7	45.2	1.9	2.2	4.7	3.8	21.1	13.2	0.0	4.7	4.7	3.5	2.2	3.8	5.2	2.8	5.7	4.3	14.7	12.8	25.4	8.8	2.9	7.6	8.2	2.6	6.0	2.2	9.1	19.5	34.0	18.0	2.9	3.5	20.6	33.7	36.5	59.6	14.3	4.2	59.5	32.5	3.8	2.9	3.4	18.6	71.5	2.7	19.6	6.2	29.5	2.1	16.2	6.8	5.4	4.7	1.0	2.5	5.6	5.1	19.6	2.2	8.4	5.5	2.8	1.0	2.1	2.7	1.7	4.0	1.3	1.7	2.4	1.3	1.6	4.6	3.9	2.5	5.5	2.7	2.3	1.9	1.2	8.9	12.6	9.3	10.7	8.8	7.9	9.0	7.6	8.6	5.2	9.4	11.3	18.5	6.4	13.1	28.1	11.0	5.2	10.2	6.6	5.7	73.3	12.1	9.8	15.8	5.7	9.9	20.2	127.2	40.6	15.3	6.3	5.9	16.9	1.6	13.3	19.1	20.5	13.1	15.8	49.4	9.8	10.7	16.4	9.7	10.7	37.4	37.3	11.0	6.4	23.2	95.9	43.2	11.4	2.0	14.2	3.9	1.9	19.3	13.7	7.2	38.4	7.4	20.6	13.4	36.7	63.4	9.3	9.4	15.4	9.8	12.4	6.2	6.6	7.3	143.5	19.7	15.1	14.3	2.8	14.6	8.1	2.6	32.2	19.6	26.1	12.1	10.2
DNMT3B		ENSG00000088305	"DNA methyltransferase 3 beta"	Q9UBC3	20	32762385-32809356	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 5.3;Extravillous trophoblasts: 5.2;Horizontal cells: 5.0;Inhibitory neurons: 6.8;Sertoli cells: 6.6"	"Cancer enriched"	"Detected in all"	25	"testis cancer: 111.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 245.7;CACO-2: 95.8;HEL: 100.7;K-562: 98.6;NTERA-2: 333.9;SuSa: 174.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001595, HPA001803, CAB069896"	Enhanced		Supported	Nucleoplasm		NA	Yes				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB069896: AB_2094115, HPA001595: AB_1847814, HPA001803: "	"unprognostic (7.65e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (3.42e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.39e-4)"	"unprognostic (4.18e-3)"	"unprognostic (8.60e-3)"	"unprognostic (8.48e-2)"	"unprognostic (6.79e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (6.62e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.55e-2)"	0.8	0.6	1.2	0.8	1.5	3.6	1.3	2.4	1.6	1.3	1.0	0.7	0.8	1.0	3.1	0.8	0.7	0.8	1.0	1.2	1.6	1.7	1.2	0.7	0.9	1.4	1.3	0.8	6.0	1.1	0.6	2.0	1.3	0.8	0.7	3.0	1.2	0.6	0.5	3.8	0.8	0.9	1.0	1.0	0.9	5.8	1.4	3.7	1.7	0.2	0.9	1.3	1.1	1.4	3.9	5.3	27.0	6.2	0.5	2.1	245.7	3.5	2.4	3.6	3.8	95.8	4.3	10.0	9.7	1.7	4.3	2.2	17.6	1.7	3.0	1.2	14.0	100.7	3.3	18.5	0.9	4.6	9.7	2.3	1.9	5.5	1.1	1.8	6.6	6.2	98.6	2.7	1.4	15.7	15.6	86.1	333.9	8.8	3.2	15.4	4.5	2.3	9.1	4.2	8.6	5.7	5.9	8.5	2.5	174.4	5.8	5.5	1.6	5.5	12.3	2.8	2.6	5.9	2.8	3.8	2.6	27.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	1.5	2.4	1.6	1.2	1.6	1.4	1.3	1.3	1.0	1.4	1.4	1.6	0.0	1.5	3.9	0.1	0.9	0.2	0.3	0.6	2.1	1.5	1.3	1.3	0.0	0.8	0.0	2.1	5.3	0.3	0.2	0.0	1.3	0.1	0.8	0.9	1.6	0.0	4.6	1.1	0.6	5.2	1.2	0.5	2.2	0.0	1.3	0.7	0.6	0.8	5.0	6.8	0.3	0.0	0.3	0.3	1.0	0.0	0.7	0.0	1.9	0.1	0.8	0.0	1.5	1.3	1.0	0.1	0.4	1.3	0.3	0.1	1.3	0.1	2.5	6.6	0.3	0.9	0.1	2.6	0.9	1.3	4.8	0.3	0.8	0.6	0.1
DOLK	"DK1, KIAA1094, TMEM15"	ENSG00000175283	"Dolichol kinase"	Q9UPQ8	9	128945530-128947603	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066767, HPA068706"			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA066767: AB_2732751, HPA068706: AB_2732118"	"unprognostic (6.35e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (5.53e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (6.88e-5)"	"unprognostic (6.13e-3)"	9.6	14.3	6.6	6.3	6.3	1.5	7.8	6.7	6.7	7.4	8.6	7.5	7.6	9.3	13.5	8.6	8.9	7.9	10.5	6.5	7.1	9.1	10.5	9.1	6.8	6.9	7.6	6.7	14.5	16.8	5.9	9.3	7.3	10.0	6.6	4.4	12.0	10.0	6.7	9.9	7.5	9.4	6.5	8.0	10.6	14.5	7.6	5.1	7.8	7.1	6.6	8.6	5.9	6.8	11.7	42.5	14.8	22.0	42.6	22.2	20.0	23.7	38.1	28.5	21.0	33.7	17.9	6.4	12.3	34.6	40.3	80.3	20.3	29.6	14.7	10.7	17.8	8.0	27.4	24.5	43.0	8.8	13.5	31.1	27.0	30.8	16.8	16.7	28.1	9.1	19.7	10.0	31.3	56.9	7.3	7.3	19.0	33.0	26.0	7.2	19.5	25.1	25.7	17.3	13.5	15.1	31.4	25.6	14.1	13.7	44.8	11.4	23.6	25.6	9.2	32.5	19.8	9.4	25.0	6.4	24.2	8.0	19.9	2.7	15.4	6.9	11.2	15.3	10.1	11.8	9.9	12.3	16.6	12.5	12.8	13.2	2.2	13.0	21.2	9.3	16.8	10.5	6.6	6.3	6.7	6.7	6.5	7.1	6.9	7.6	7.3	6.5	7.6	6.8	8.5	6.4	4.1	2.9	2.6	1.8	3.6	13.9	4.6	9.1	4.4	4.3	3.5	10.0	10.9	7.3	8.4	25.6	3.5	5.2	0.0	15.7	15.1	5.9	7.2	9.2	1.2	3.6	1.2	14.2	16.4	8.1	5.1	3.6	1.3	7.5	16.1	9.2	13.5	5.0	2.2	3.5	12.2	5.2	2.7	3.7	12.2	2.9	3.6	1.9	2.8	10.7	5.2	2.5	1.7	11.1	7.5	6.0	1.5	4.4	7.5	9.0	11.4	7.1	0.0	7.0	15.7	33.8	15.1	3.3	1.3	18.2	2.3	15.8	5.7	2.1
DPAGT1	"ALG7, CDG-Ij, D11S366, DGPT, DPAGT, DPAGT2, GPT"	ENSG00000172269	"Dolichyl-phosphate N-acetylglucosaminephosphotransferase 1"	Q9H3H5	11	119096503-119108331	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053878	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA053878: AB_2682288"	"unprognostic (1.66e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.76e-1)"	"unprognostic (7.83e-3)"	"unprognostic (6.50e-2)"	"unprognostic (8.53e-3)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (2.52e-1)"	"unprognostic (3.95e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.08e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.87e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.57e-2)"	11.3	14.1	13.0	13.7	13.3	9.1	14.8	13.9	22.4	16.1	17.6	17.7	16.8	10.2	21.8	12.4	17.3	14.5	8.6	13.5	14.1	12.8	21.2	11.4	11.5	14.2	14.4	9.0	27.1	18.6	4.4	15.8	14.2	14.3	20.0	7.4	27.8	16.3	5.6	9.0	14.9	17.7	13.4	9.8	14.4	4.8	14.6	8.2	15.5	8.5	14.3	16.8	6.2	14.9	22.0	39.2	22.2	55.7	60.0	37.0	24.6	33.7	38.3	25.7	32.2	43.4	88.3	41.5	62.8	45.4	57.7	77.1	42.0	60.7	31.1	29.4	23.8	83.5	14.1	51.6	50.7	53.9	47.4	40.3	48.7	62.4	85.3	29.9	53.3	25.2	51.7	84.1	50.9	67.7	19.5	39.9	22.5	148.3	49.4	26.2	26.6	61.3	60.3	44.7	23.0	30.1	30.7	99.3	17.1	32.3	116.8	19.4	29.1	57.3	24.5	30.3	23.7	19.6	32.2	13.9	14.3	68.3	48.9	28.4	35.7	4.4	25.2	35.5	28.4	24.5	20.1	24.8	43.3	25.6	16.6	15.8	3.0	20.7	32.7	37.5	19.6	20.2	13.0	13.3	13.9	22.4	13.5	14.1	14.2	14.4	14.2	13.4	14.6	14.9	11.5	6.4	8.1	7.2	10.7	13.3	15.2	34.4	13.1	6.1	18.4	12.1	5.0	14.3	22.8	14.7	14.6	34.2	9.6	10.3	3.9	32.9	0.9	15.6	12.3	16.0	10.2	8.6	7.3	13.3	44.4	11.0	14.3	11.2	12.7	12.7	15.7	23.1	28.8	3.3	5.7	19.8	32.6	13.0	11.4	1.9	14.0	14.1	8.8	5.6	20.9	6.2	13.4	7.5	5.4	13.9	11.1	8.2	33.2	14.5	19.3	11.3	37.2	4.6	0.0	6.0	10.7	6.8	10.3	14.1	12.5	23.5	10.0	15.9	20.7	12.9
DPH1	"DPH2L, DPH2L1, OVCA1"	ENSG00000108963	"Diphthamide biosynthesis 1"	Q9BZG8	17	2030137-2043898	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Dwarfism, Ectodermal dysplasia, Hypotrichosis, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 19.4;Gastric mucus-secreting cells: 21.4;Plasma cells: 12.0;Squamous epithelial cells: 13.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069750, HPA073864"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Cell Junctions"	"HPA069750: AB_2686188, HPA073864: "	"unprognostic (5.54e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (1.78e-5)"	"unprognostic (2.74e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.40e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.41e-1)"	24.5	32.3	13.1	6.0	12.8	5.3	22.2	16.8	17.7	29.1	10.7	26.8	8.0	28.8	5.6	19.8	31.0	9.1	19.2	13.7	11.9	28.0	36.3	16.6	7.5	10.3	10.9	26.6	32.0	14.2	59.3	8.5	10.3	36.2	6.2	12.4	23.7	11.0	42.3	29.3	20.8	8.9	10.1	24.3	27.0	20.3	11.7	6.7	28.6	13.7	6.0	24.2	22.3	11.5	15.4	24.9	6.3	16.0	22.2	14.2	18.7	19.3	26.8	29.7	18.7	24.1	11.6	29.0	23.6	52.5	11.2	11.6	20.7	21.1	15.9	9.0	52.4	6.3	10.5	13.1	19.4	8.3	10.2	20.3	20.3	22.7	19.0	20.5	13.9	16.8	23.4	11.2	11.9	18.2	14.7	4.8	6.5	17.3	25.9	16.6	5.7	22.0	13.3	8.0	13.1	15.2	17.4	17.9	17.2	6.9	25.9	6.8	10.1	19.4	10.1	26.2	16.7	10.3	8.3	6.8	20.3	10.8	8.5	0.8	4.5	0.8	8.0	6.1	8.9	8.8	6.5	7.4	7.7	7.2	9.6	6.9	0.3	6.7	4.5	5.5	10.2	5.2	13.1	12.8	16.8	17.7	13.7	11.9	10.3	10.9	10.3	10.1	11.7	11.5	0.9	3.2	9.2	1.3	9.3	0.4	0.9	0.5	19.4	2.1	0.8	0.8	1.5	0.0	2.7	0.0	2.1	1.4	0.9	0.6	0.0	0.5	1.2	1.5	1.2	1.7	0.0	9.0	4.0	0.6	0.9	4.5	21.4	0.8	2.5	1.0	0.7	0.0	0.6	1.7	3.7	0.8	0.0	0.0	0.8	1.5	0.6	3.9	0.0	1.0	0.4	0.9	2.1	1.5	1.4	0.0	0.2	0.4	12.0	0.5	0.5	0.5	3.0	2.8	0.0	1.3	3.2	1.2	0.5	13.0	0.3	1.4	5.4	1.3	0.4	0.6
DPM1	"CDGIE, MPDS"	ENSG00000000419	"Dolichyl-phosphate mannosyltransferase subunit 1, catalytic"	O60762	20	50934867-50958555	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051818	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA051818: AB_2681624"	"unprognostic (2.21e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (1.10e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.02e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.74e-1)"	40.9	53.4	23.0	34.3	23.9	59.3	42.7	24.4	31.9	31.5	26.1	38.6	36.9	39.4	47.6	45.3	32.6	36.1	60.6	24.4	24.5	47.0	63.1	29.7	56.0	23.3	22.8	38.7	48.6	43.0	25.4	45.1	23.5	34.3	42.7	27.2	38.5	31.0	57.3	34.6	39.0	37.4	23.8	37.1	38.1	39.7	23.1	43.9	48.4	55.2	53.6	51.6	33.3	27.6	139.9	55.4	83.6	50.5	72.1	80.8	92.1	52.6	62.1	102.9	80.7	252.1	110.2	84.1	112.9	71.1	141.9	156.2	68.5	129.0	103.9	40.7	53.9	87.7	69.5	171.2	101.6	141.4	50.5	70.0	187.0	71.5	73.7	66.4	80.1	89.0	135.3	104.2	103.3	61.3	127.6	148.9	85.3	131.8	124.8	69.7	120.7	112.6	102.6	83.4	62.5	68.5	135.8	203.8	189.1	64.2	138.8	164.5	66.1	130.8	109.2	76.6	112.6	74.2	99.7	122.0	143.7	92.4	60.4	13.5	16.3	17.6	16.4	18.5	20.0	17.9	18.6	17.9	20.3	16.1	20.0	22.4	20.0	19.1	18.6	21.7	19.5	16.1	23.0	23.9	24.4	31.9	24.4	24.5	23.3	22.8	23.5	23.8	23.1	27.6	36.8	19.2	42.3	27.1	37.3	116.5	143.4	248.4	29.0	11.7	37.1	24.9	48.8	35.8	119.5	31.3	2.1	153.1	46.4	31.7	117.4	75.9	207.8	49.3	38.0	53.0	23.4	30.7	35.6	73.8	104.9	53.7	18.8	57.5	74.3	25.1	49.2	67.9	87.9	5.0	31.0	52.5	144.5	42.0	58.4	43.8	56.8	36.7	49.8	18.7	65.8	27.3	43.3	20.1	34.2	70.5	50.2	51.6	33.2	73.7	40.7	96.4	135.7	12.6	72.3	50.4	71.5	109.9	103.6	32.0	105.6	245.4	47.8	36.5	55.3	125.9
DPP10	"DPL2, DPPY, DPRP3"	ENSG00000175497	"Dipeptidyl peptidase like 10"	Q8N608	2	114442299-115845780	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 10.7;brain: 20.2;pancreas: 17.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 4634.9;Excitatory neurons: 3067.4;Inhibitory neurons: 3258.7;Oligodendrocyte precursor cells: 990.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.1;HAP1: 6.2;HMC-1: 4.3;JURKAT: 3.4;NTERA-2: 3.7;RT4: 6.7;SCLC-21H: 9.7;SH-SY5Y: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048767	Uncertain					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA048767: AB_2680515"	"unprognostic (1.19e-1)"		"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.29e-1)"		"unprognostic (2.03e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.33e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.22e-2)"	0.2	10.7	12.4	0.3	20.2	0.1	0.0	0.0	16.6	0.3	0.0	2.2	1.2	0.4	0.0	0.0	0.1	0.8	0.1	19.3	0.5	0.2	0.1	0.2	0.0	1.9	3.1	0.0	17.3	0.0	0.8	0.8	2.0	0.0	2.8	4.1	0.2	0.0	0.0	0.1	1.2	0.8	4.5	0.0	1.0	1.0	6.0	0.0	0.6	0.0	0.0	0.3	0.0	11.7	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	6.7	9.7	3.9	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	20.2	0.0	16.6	19.3	0.5	1.9	3.1	2.0	4.5	6.0	11.7	0.0	0.0	0.0	4634.9	0.0	0.0	0.0	0.0	0.6	21.7	0.0	0.0	1.5	4.3	0.6	0.0	0.0	1.5	0.0	2.3	0.0	0.0	12.4	0.1	0.1	0.1	4.2	2.1	3067.4	2.7	10.2	0.5	0.0	0.3	0.0	5.8	0.7	0.0	0.3	5.0	3258.7	1.4	0.0	0.0	0.0	5.7	0.3	0.0	1.8	58.1	0.0	1.4	0.0	990.7	48.3	0.8	1.9	0.0	0.0	0.0	0.2	0.2	0.0	0.7	0.0	0.0	0.1	1.6	2.6	0.3	0.0	4.4	0.0	0.4	3.2	0.0
DPP6	"DPL1, DPPX"	ENSG00000130226	"Dipeptidyl peptidase like 6"	P42658	7	153887097-154894285	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.0;endometrium 1: 58.2"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 673.4;Inhibitory neurons: 1195.9;Oligodendrocyte precursor cells: 1947.8"	"Cancer enriched"	"Detected in some"	11	"glioma: 12.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"NTERA-2: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050509	Enhanced	Supported				NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA050509: AB_2681150"	"unprognostic (1.29e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.83e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.04e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.85e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.61e-3)"	"unprognostic (6.11e-2)"	0.6	8.2	16.5	0.2	24.5	0.1	0.5	32.0	34.5	5.8	0.0	19.8	0.5	58.2	2.5	0.3	5.2	0.1	0.2	42.7	21.6	5.3	0.0	1.4	0.1	54.0	24.5	0.7	3.9	0.0	10.8	0.2	53.1	0.3	1.6	11.1	0.1	8.9	6.0	3.6	3.4	19.9	8.6	4.7	7.8	7.3	32.2	1.9	17.1	0.9	0.0	0.3	1.1	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	11.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.6	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.0	16.5	24.5	32.0	34.5	42.7	21.6	54.0	24.5	53.1	8.6	32.2	14.8	0.1	0.0	0.0	147.9	0.0	3.3	0.4	0.0	0.0	27.0	0.4	1.3	7.4	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	13.4	0.9	21.6	0.4	10.3	0.0	673.4	4.0	0.0	2.1	0.0	0.5	0.0	0.0	0.0	0.0	0.2	32.0	1195.9	0.4	0.0	0.0	0.0	18.4	1.2	0.2	16.0	22.5	0.0	17.1	0.0	1947.8	290.8	0.3	0.0	3.8	0.0	0.1	0.1	0.4	0.8	6.1	0.0	0.7	0.9	1.2	4.0	0.0	1.6	0.0	0.2	0.0	0.0	0.2
DPYS	DHPase	ENSG00000147647	Dihydropyrimidinase	Q14117	8	104330324-104467055	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	39	"kidney: 199.6;liver: 477.6"	"Group enriched"	"Detected in some"	12	"Hepatocytes: 459.5;Proximal tubular cells: 518.8"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 57.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024785, HPA070814"	Enhanced					NA	NA		820000		"Cluster 85: Liver - Metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA024785: AB_1847856, HPA070814: "	"unprognostic (1.54e-3)"	"unprognostic (2.33e-1)"		"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.16e-4)"	"unprognostic (1.56e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.86e-1)"	8.6	2.8	0.6	0.1	0.6	0.0	0.4	0.2	1.7	1.2	0.2	0.2	0.0	0.1	0.6	0.1	0.7	6.5	0.1	0.6	0.5	199.6	477.6	0.6	0.3	0.5	0.7	0.2	0.1	0.6	0.2	0.6	0.6	4.4	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.3	0.1	0.9	1.2	5.1	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.2	1.7	0.6	0.5	0.5	0.7	0.6	0.3	1.2	0.5	0.1	0.0	0.0	1.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	40.0	0.0	20.2	0.0	0.0	0.0	0.0	27.4	0.1	12.8	0.3	0.1	1.0	0.0	16.0	11.2	0.0	0.0	1.8	0.0	0.3	0.0	0.4	11.7	459.5	1.4	0.0	4.6	0.0	0.0	11.1	0.3	13.5	0.9	10.6	0.0	14.0	0.4	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.7	0.0	518.8	0.0	0.1	0.0	0.0	0.0	1.2	1.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0
DRAM2	"MGC54289, PRO180, RP5-1180E21.1, TMEM77, WWFQ154"	ENSG00000156171	"DNA damage regulated autophagy modulator 2"	Q6UX65	1	111117163-111140203	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"		"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018036, HPA061701"	Supported		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus, Vesicles"		"HPA018036: AB_1858134, HPA061701: AB_2684590"	"unprognostic (9.38e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.16e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (3.45e-5)"	"unprognostic (6.57e-3)"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.69e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.77e-3)"	38.0	23.1	13.9	33.1	14.5	17.9	26.8	17.7	19.9	23.1	22.7	26.7	28.6	17.7	17.6	15.0	30.1	36.4	23.7	13.5	15.2	26.5	24.9	25.0	55.3	15.6	14.9	24.3	25.6	28.3	4.6	41.2	16.2	17.8	30.7	16.9	25.8	16.7	16.6	17.9	26.3	17.0	15.5	45.3	23.4	10.3	15.0	27.8	22.0	23.6	50.3	29.4	4.2	17.8	38.0	12.9	24.0	10.8	57.3	56.2	23.4	28.7	29.9	24.7	24.9	12.5	38.2	28.7	17.2	25.6	12.1	37.4	30.5	24.0	31.9	26.8	25.6	16.8	18.4	16.4	41.4	19.4	15.4	38.5	41.4	18.3	38.4	53.6	29.9	29.1	34.1	19.6	30.1	19.6	16.6	28.8	14.5	43.3	13.2	11.1	40.0	14.0	42.5	25.8	19.1	18.2	16.8	52.4	80.1	33.1	16.7	84.6	24.8	20.6	13.8	16.2	18.9	25.7	9.6	29.8	33.4	34.7	29.6	41.7	47.3	11.5	14.2	61.0	19.4	65.7	17.5	15.3	45.1	54.1	22.3	19.0	7.2	25.0	49.8	28.6	17.7	35.5	13.9	14.5	17.7	19.9	13.5	15.2	15.6	14.9	16.2	15.5	15.0	17.8	34.5	12.8	12.0	17.3	146.2	47.0	54.4	82.5	34.1	11.6	53.6	43.9	29.7	32.9	53.1	44.1	2.1	98.1	38.9	41.2	43.0	59.2	8.5	51.7	19.5	36.4	13.2	28.6	20.6	46.6	102.3	39.2	24.5	17.6	23.6	18.5	42.8	26.0	183.1	20.2	31.7	45.7	77.3	189.4	97.8	7.8	33.5	110.3	81.8	39.4	89.0	27.1	56.7	31.7	42.6	41.9	64.3	24.8	54.7	46.3	88.4	80.4	95.8	10.1	39.5	26.4	32.5	4.7	14.6	40.8	53.0	73.3	38.6	26.3	43.7	70.1
DSE	"DS-Epi1, DSEPI, SART2"	ENSG00000111817	"Dermatan sulfate epimerase"	Q9UL01	6	116254173-116444861	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 112.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 5.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA014764	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"			"HPA014764: AB_1856587"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (6.19e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.10e-2)"	27.8	10.7	3.6	26.8	4.5	18.4	18.3	3.9	4.4	13.8	10.4	7.7	6.4	10.5	8.3	13.7	14.6	14.9	12.4	3.2	4.3	8.6	11.3	15.3	16.4	7.0	5.8	13.8	3.8	11.1	6.0	23.1	5.6	8.5	8.0	3.5	6.9	10.2	6.9	13.8	9.0	15.0	4.6	18.6	6.4	6.1	8.5	10.3	6.6	10.7	9.7	19.7	14.3	5.9	32.7	7.0	23.6	22.2	62.0	40.7	26.5	37.6	88.2	46.4	67.4	0.2	8.9	0.9	3.3	66.3	46.4	60.8	3.3	88.7	60.1	33.9	14.6	2.2	9.8	0.3	69.0	1.5	1.7	86.8	37.4	51.5	50.0	24.0	27.7	8.3	0.8	14.4	22.4	1.0	4.4	1.8	12.7	0.2	1.8	5.6	21.6	15.6	30.4	2.2	7.8	5.9	36.4	0.1	0.8	16.2	0.3	3.9	10.5	46.4	13.4	11.8	30.6	3.1	1.1	1.6	24.6	4.0	5.5	0.4	2.0	0.1	0.6	2.5	0.3	2.0	0.5	0.3	5.9	2.1	0.6	0.3	1.6	0.1	1.6	2.7	0.1	0.8	3.6	4.5	3.9	4.4	3.2	4.3	7.0	5.8	5.6	4.6	8.5	5.9	9.4	16.0	4.1	64.9	15.4	52.0	26.4	42.2	78.6	6.3	7.4	10.7	8.3	2.8	20.7	3.7	0.0	2.9	16.5	0.3	7.9	4.8	52.2	11.0	21.9	15.4	1.2	11.4	46.8	8.5	7.0	73.7	3.6	3.1	22.8	100.9	56.4	5.7	39.8	1.7	48.9	0.6	8.2	83.6	77.1	24.9	55.0	112.2	10.6	51.5	79.4	3.4	5.2	73.4	86.4	13.6	0.4	30.1	8.9	32.0	0.4	7.7	30.3	3.0	32.9	16.4	33.4	6.1	5.5	76.6	39.9	4.9	14.0	17.2	1.0	51.0
DSTYK	"DustyPK, KIAA0472, RIP5, RIPK5, SPG23"	ENSG00000133059	"Dual serine/threonine and tyrosine protein kinase"	Q6XUX3	1	205142505-205211702	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 89.2;Melanocytes: 90.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044140	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"			"HPA044140: AB_10965031"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (8.73e-5)"	4.5	7.2	11.5	3.8	11.1	19.2	6.7	11.5	12.1	6.4	6.8	6.0	2.7	7.9	5.8	5.5	7.2	4.5	4.9	11.8	11.3	7.5	2.2	6.1	4.0	13.5	10.7	11.1	4.5	13.1	5.5	6.0	13.7	5.6	3.6	13.5	4.4	6.9	9.6	12.0	4.1	7.1	9.9	6.2	4.2	5.1	11.5	6.2	6.8	6.8	4.5	5.2	5.4	13.5	9.9	6.3	6.6	8.1	9.5	15.9	4.7	12.0	12.1	12.4	8.4	2.9	5.3	7.3	3.5	20.6	6.9	6.9	7.3	7.8	12.4	3.5	7.8	13.3	8.1	3.1	8.5	3.7	6.8	9.4	11.6	12.7	12.0	14.7	9.2	5.2	17.4	4.8	10.0	6.8	2.9	3.3	7.2	1.8	7.4	2.6	12.1	6.5	8.4	6.1	3.7	7.2	10.3	10.5	34.5	7.7	7.8	4.9	9.2	7.7	7.7	11.8	8.2	4.8	3.7	4.1	9.0	5.1	28.2	8.1	1.9	3.6	2.4	1.5	2.3	1.5	1.8	2.0	1.7	1.7	2.6	1.9	2.7	2.8	1.0	1.2	1.1	1.0	11.5	11.1	11.5	12.1	11.8	11.3	13.5	10.7	13.7	9.9	11.5	13.5	15.8	28.9	15.5	26.4	15.3	14.9	7.2	10.5	14.2	48.0	14.5	13.6	13.6	12.8	15.1	16.5	33.3	6.8	15.1	3.8	5.9	12.5	11.3	16.3	37.7	16.1	12.7	31.6	35.1	9.1	6.1	19.4	8.2	11.6	24.1	43.2	28.5	6.9	8.8	89.2	36.6	6.2	6.1	23.6	15.6	25.2	16.4	11.4	90.7	21.5	20.6	45.1	23.7	17.1	43.0	10.6	5.0	18.0	11.1	10.7	6.1	6.9	24.7	37.3	26.3	22.4	16.4	22.3	13.0	10.1	13.9	2.6	15.1	27.8	7.5	6.7
DTNA	"D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3"	ENSG00000134769	"Dystrobrevin alpha"	Q9Y4J8	18	34493290-34891844	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 461.9;choroid plexus: 120.6;heart muscle: 150.0;skeletal muscle: 166.9;tongue: 209.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1756.1;Excitatory neurons: 506.0;Inhibitory neurons: 650.9;Oligodendrocyte precursor cells: 491.6;Oligodendrocytes: 367.4"	"Cancer enriched"	"Detected in many"	9	"glioma: 28.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 37.7;NTERA-2: 42.0;SCLC-21H: 51.9;U-87 MG: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015196, HPA071177"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Intermediate filaments"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cell Junctions, Intermediate filaments"	Nucleoplasm	"CAB015196: AB_2261797, HPA071177: "	"unprognostic (1.57e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.13e-3)"	"unprognostic (7.82e-6)"	"unprognostic (5.03e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.35e-4)"	"unprognostic (6.89e-2)"	"prognostic favorable (2.64e-7)"	"unprognostic (6.08e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.27e-5)"	11.6	6.6	252.7	5.4	248.2	0.8	9.6	243.3	260.1	5.4	120.6	22.4	3.9	8.1	20.5	22.9	11.7	9.4	150.0	250.1	423.0	2.3	2.2	6.6	2.3	461.9	326.9	7.0	18.1	2.4	10.8	4.1	360.4	23.6	7.6	19.8	11.3	25.3	166.9	2.7	8.4	19.4	308.1	4.8	6.8	6.1	269.2	0.5	12.3	209.9	2.0	32.0	5.2	331.0	0.7	0.5	17.3	0.0	9.5	25.1	2.6	3.2	14.8	0.6	1.7	3.8	0.2	0.1	8.9	1.9	15.3	1.1	2.1	7.5	1.8	0.0	10.7	0.1	0.9	5.7	7.1	0.2	0.2	19.2	1.8	11.9	4.5	14.2	6.7	0.1	2.4	1.9	3.8	37.7	0.1	0.2	42.0	0.6	8.1	0.1	7.7	24.1	0.9	0.3	51.9	6.9	0.0	1.7	4.9	23.8	21.8	6.3	0.5	16.7	9.9	0.3	5.2	1.3	2.0	1.0	52.5	0.0	8.4	1.0	0.7	0.0	0.8	0.0	1.1	0.8	1.5	1.1	3.5	0.7	1.6	1.3	0.3	0.8	0.0	0.1	4.3	1.0	252.7	248.2	243.3	260.1	250.1	423.0	461.9	326.9	360.4	308.1	269.2	331.0	5.1	0.0	1.1	1756.1	0.1	1.5	0.1	0.8	0.0	18.3	22.2	12.3	134.3	27.1	1.4	0.0	6.2	0.1	0.4	0.0	5.9	12.6	3.1	7.0	2.6	6.4	0.0	0.0	506.0	25.1	0.1	5.7	0.0	0.4	0.0	2.3	0.0	0.2	9.0	1.7	650.9	0.1	4.1	4.0	21.5	3.7	5.9	8.0	5.4	105.9	0.9	34.0	0.0	491.6	367.4	8.0	0.0	0.4	0.0	1.8	0.1	2.0	7.1	3.8	13.1	22.7	17.3	0.9	4.8	0.2	1.0	0.0	0.2	0.3	0.2	0.2
DUOX2	"LNOX2, P138-TOX, P138(TOX), THOX2"	ENSG00000140279	"Dual oxidase 2"	Q9NRD8	15	45092650-45114172	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Hydrogen peroxide, Thyroid hormones biosynthesis"	"Oxidoreductase, Peroxidase"	"Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 290.2;thyroid gland: 75.7;urinary bladder: 92.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 159.3;Ductal cells: 225.2;Exocrine glandular cells: 125.5;Gastric mucus-secreting cells: 85.1;Pancreatic endocrine cells: 411.7;Urothelial cells: 110.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 60.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"HaCaT: 6.3"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.2"	"Not detected"	"Not detected"									NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"				"unprognostic (3.19e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.77e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.59e-3)"	"unprognostic (7.11e-2)"	"unprognostic (5.32e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.62e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.63e-2)"	0.5	1.4	0.0	21.5	0.1	0.0	0.6	0.1	0.3	2.8	0.0	11.6	1.5	0.2	3.1	21.5	0.5	290.2	0.8	0.1	0.1	0.7	0.8	2.5	0.1	0.2	0.6	0.5	1.2	0.2	0.1	0.0	0.1	11.8	5.5	0.0	4.6	1.9	0.0	4.9	8.3	2.7	0.1	0.0	42.3	1.4	0.1	0.0	75.7	0.0	4.2	92.8	21.7	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	6.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.3	0.1	48.1	36.9	0.0	3.0	1.9	5.2	11.7	1.8	0.4	0.6	0.6	1.9	54.3	31.5	0.0	0.0	0.1	0.0	159.3	0.0	225.2	0.6	1.0	0.5	5.6	1.2	0.0	0.1	125.5	0.0	5.1	85.1	3.5	32.8	0.1	0.4	0.1	0.1	0.0	0.1	10.1	4.1	0.0	0.4	0.3	0.3	3.9	0.0	0.0	5.2	0.2	0.0	0.0	0.1	411.7	45.5	0.0	0.8	4.5	2.9	0.0	43.4	0.3	0.0	0.2	2.7	0.9	1.0	3.6	1.8	0.0	4.6	0.1	34.7	110.4
DUSP6	"MKP-3, PYST1"	ENSG00000139318	"Dual specificity phosphatase 6"	Q16828	12	89347235-89352501	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 226.2"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 246.8;granulocytes: 456.9;Kupffer cells: 266.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 97.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1636.7"	"Group enriched"	"Detected in all"	13	"granulocytes: 1636.7;monocytes: 842.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 427.6;NB-4: 325.8;SK-MEL-30: 253.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017566, HPA053188, HPA064692"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Cytosol"		"CAB017566: AB_647991, HPA053188: , HPA064692: "	"unprognostic (7.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.77e-2)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-1)"	113.9	24.7	12.0	63.7	12.9	178.7	50.8	10.0	28.5	39.4	29.8	47.3	24.8	26.2	14.2	34.8	36.6	75.5	30.9	19.8	11.6	58.9	143.3	88.2	42.3	12.6	12.1	14.2	17.9	34.6	17.8	74.1	12.4	18.8	56.1	6.8	226.2	22.9	8.5	17.4	52.1	43.2	12.7	71.0	28.7	6.9	16.0	47.7	77.4	40.2	27.2	76.4	13.8	13.6	6.4	6.2	127.0	427.6	108.1	89.9	0.2	47.5	58.3	9.5	6.8	38.7	6.8	0.0	11.2	20.5	17.9	51.4	0.5	118.4	13.0	0.5	0.8	20.0	1.4	61.4	75.7	86.3	210.9	18.4	40.4	81.5	75.5	94.9	214.4	2.6	0.0	20.4	29.3	3.1	2.9	325.8	78.7	149.5	102.7	216.6	15.5	8.3	129.3	129.7	2.4	88.7	1.1	0.6	253.0	43.3	6.4	46.8	59.0	30.6	0.8	5.8	22.8	3.7	18.5	0.5	126.5	60.0	200.3	1636.7	558.9	247.2	9.8	842.3	4.5	2.7	2.7	3.5	97.0	11.6	1.6	3.2	230.5	14.8	841.0	12.2	6.7	455.2	12.0	12.9	10.0	28.5	19.8	11.6	12.6	12.1	12.4	12.7	16.0	13.6	182.9	102.5	246.8	12.4	18.0	90.9	79.4	97.4	38.7	2.1	30.3	85.5	11.1	81.5	80.5	180.3	33.3	72.6	36.1	58.3	17.6	12.6	1.6	67.4	14.1	159.8	19.2	6.6	19.6	14.0	4.2	54.5	19.4	134.2	456.9	24.2	177.8	130.2	49.6	1.7	3.8	13.2	46.8	266.7	61.2	1.7	1.5	193.2	12.4	33.7	198.9	8.7	20.6	24.6	2.4	17.1	45.7	3.4	16.2	26.1	17.0	27.5	21.2	2.4	26.3	21.4	29.7	2.6	7.0	14.7	24.7	49.3	42.3	3.5	22.0	61.4
DUX4		ENSG00000260596	"Double homeobox 4"	Q9UBX2	4	190173774-190185942	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.0"	"Group enriched"	"Detected in some"	26	"Early spermatids: 4.9;Late spermatids: 5.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.5;U-2 OS: 2.2;U-266/70: 4.7;U-266/84: 6.9;U-698: 1.5"	"Low region specificity"	"Detected in some"							HPA058451			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli"	"Golgi apparatus, Cytosol"	"HPA058451: AB_2683722"																		0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	2.2	0.4	0.0	4.7	6.9	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DYRK1A	"DYRK, DYRK1, MNBH"	ENSG00000157540	"Dual specificity tyrosine phosphorylation regulated kinase 1A"	Q13627	21	37365573-37526358	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 156.7;Inhibitory neurons: 158.4;Microglial cells: 176.1;Oligodendrocyte precursor cells: 158.3;Oligodendrocytes: 157.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015323, HPA015810"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Nucleoli fibrillar center"	"HPA015323: AB_1847922, HPA015810: AB_1847921"	"unprognostic (2.71e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.39e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.40e-2)"	23.1	20.4	17.8	22.5	19.9	71.4	22.3	29.9	20.7	23.9	22.2	22.2	18.7	26.6	22.0	18.8	22.6	19.9	28.9	21.3	19.2	19.9	19.8	22.3	30.1	12.1	14.7	29.6	21.5	27.8	20.2	23.0	13.3	18.8	21.6	27.8	21.3	19.2	49.4	24.2	21.7	24.1	12.8	30.4	22.8	29.9	18.6	45.8	25.7	45.2	26.7	24.3	21.1	20.9	23.5	18.2	36.3	25.6	17.1	18.8	32.7	20.8	26.0	20.3	22.0	25.7	19.7	31.7	13.8	37.0	27.1	15.8	27.3	21.2	24.4	49.7	11.6	93.6	30.9	16.1	26.5	36.9	32.3	18.7	24.3	26.5	41.2	23.5	22.3	44.2	36.4	70.4	22.2	23.6	49.3	25.9	38.5	24.1	10.8	62.8	19.7	29.6	22.3	30.4	36.5	20.4	47.1	31.6	33.2	12.2	29.9	34.8	27.8	27.6	8.3	17.2	17.4	47.7	41.6	44.9	22.0	41.8	30.7	3.1	0.5	0.8	1.2	0.8	0.7	1.1	1.3	1.0	0.7	1.0	1.4	1.3	2.3	0.5	1.1	1.3	1.3	0.3	17.8	19.9	29.9	20.7	21.3	19.2	12.1	14.7	13.3	12.8	18.6	20.9	36.8	19.2	25.5	114.3	28.8	37.5	24.1	15.7	18.2	32.7	28.3	18.0	73.0	20.0	23.0	11.0	27.1	10.3	43.0	30.1	0.0	13.5	29.7	44.2	39.3	31.9	21.4	26.1	156.7	14.6	12.4	25.2	21.4	71.4	24.7	35.9	27.1	18.1	15.8	47.1	158.4	18.8	14.2	25.0	27.7	22.2	16.1	32.4	24.9	176.1	18.8	16.4	21.6	158.3	157.2	21.2	22.4	19.5	33.8	29.8	17.1	9.9	27.9	21.8	13.1	38.4	32.5	15.3	24.7	24.6	31.7	15.3	36.8	21.3	19.3	37.2
DYRK1B	MIRK	ENSG00000105204	"Dual specificity tyrosine phosphorylation regulated kinase 1B"	Q9Y463	19	39825350-39834201	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 131.3;testis: 83.8"	"Group enriched"	"Detected in many"	12	"Early spermatids: 179.4;Late spermatids: 580.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028522, HPA028786"	Uncertain		Supported	"Nucleoplasm,Mitotic chromosome"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Mitotic chromosome"	"HPA028522: AB_2672656, HPA028786: AB_10670831"	"unprognostic (2.22e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.67e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (8.83e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.88e-2)"	9.5	19.6	4.8	2.7	4.8	4.7	10.9	4.1	6.2	12.5	4.8	12.4	5.3	11.9	7.8	11.7	13.8	3.3	20.0	4.7	3.6	16.2	7.5	8.8	4.6	3.5	3.4	11.6	10.3	6.5	31.5	2.7	3.6	13.0	2.1	4.1	14.3	3.3	131.3	14.8	10.2	2.6	1.2	14.0	12.1	83.8	3.6	5.2	16.5	49.9	2.5	11.4	10.5	3.0	0.4	9.3	8.8	6.2	4.9	4.6	0.7	2.9	1.8	2.6	2.3	0.9	3.6	1.4	11.0	3.4	0.1	3.2	1.3	2.0	2.3	5.4	7.8	0.6	5.9	0.9	4.1	0.3	1.9	6.2	1.2	0.8	2.9	8.6	0.6	3.5	1.5	2.0	0.4	4.7	2.1	0.8	2.2	2.7	2.1	1.0	0.2	0.6	5.7	2.2	12.7	14.5	4.5	4.4	0.2	4.6	4.4	0.5	4.5	1.1	2.0	1.0	0.9	3.2	1.1	1.0	7.4	0.9	0.4	0.7	1.6	1.8	3.0	1.7	3.6	2.4	2.0	3.1	1.9	1.6	1.0	1.7	2.5	3.3	1.6	4.5	2.2	1.7	4.8	4.8	4.1	6.2	4.7	3.6	3.5	3.4	3.6	1.2	3.6	3.0	6.0	0.0	0.6	6.2	10.9	3.4	3.8	8.4	10.2	15.2	9.0	6.1	6.1	7.2	3.4	16.5	20.9	2.1	21.7	10.3	9.8	13.1	179.4	15.4	6.7	7.3	20.4	19.8	4.6	4.3	1.7	5.1	7.7	10.1	1.3	11.9	12.1	3.9	5.9	10.1	6.3	9.8	10.2	8.2	3.0	580.2	7.2	4.7	5.4	7.5	5.7	8.3	10.3	5.0	3.2	9.7	9.7	5.3	5.0	4.8	11.5	17.4	10.7	13.0	0.0	11.1	4.8	30.1	13.4	6.1	2.8	1.4	10.8	20.2	7.4	3.6
DYSF	"FER1L1, LGMD2B"	ENSG00000135636	Dysferlin	O75923	2	71453722-71686768	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 95.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 30.5;Endothelial cells: 43.7;Excitatory neurons: 34.7;Hepatic stellate cells: 32.2;Kupffer cells: 27.1;Oligodendrocytes: 62.7;Syncytiotrophoblasts: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	7	"neutrophil: 27.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 27.0"	"Group enriched"	"Detected in many"	5	"hTERT-RPE1: 31.9;HUVEC TERT2: 85.5;LHCN-M2: 75.3;RH-30: 78.5;TIME: 58.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002510, HPA017071, HPA021945"	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Centriolar satellite"		"CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928"	"unprognostic (1.04e-1)"	"unprognostic (7.66e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.43e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.97e-3)"	10.1	1.7	1.0	11.5	1.1	31.6	4.3	4.1	7.7	1.9	0.7	7.0	2.0	2.3	0.5	7.4	3.2	4.6	16.8	0.2	3.8	3.6	6.5	8.3	3.7	14.8	5.1	1.3	1.5	2.3	1.5	21.1	13.7	3.3	2.5	0.5	1.3	4.8	95.3	1.2	3.1	10.2	2.0	21.4	2.5	1.1	10.2	2.3	4.6	32.3	0.9	6.9	1.8	1.8	1.1	0.0	3.3	3.0	0.0	0.0	6.1	0.1	0.8	2.2	1.5	0.4	1.0	0.0	12.1	0.1	3.4	2.5	0.0	1.2	1.1	0.0	0.0	0.2	0.2	0.0	0.3	0.1	0.0	1.5	0.0	2.3	10.6	31.9	85.5	0.2	8.4	0.0	75.3	0.0	0.0	5.8	8.1	0.0	0.9	0.0	78.5	0.0	2.6	0.2	0.0	0.0	4.1	0.7	0.1	7.9	0.3	0.8	58.1	0.3	3.8	0.2	1.1	0.0	0.0	0.0	0.0	13.3	0.0	0.0	4.1	0.1	0.5	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	27.0	0.4	0.1	0.0	0.0	1.4	1.0	1.1	4.1	7.7	0.2	3.8	14.8	5.1	13.7	2.0	10.2	1.8	30.5	3.2	8.1	1.0	1.0	2.4	0.0	0.1	0.0	1.1	0.3	0.6	24.0	0.0	1.3	0.0	0.0	8.1	0.7	0.1	0.0	0.4	4.8	0.7	1.3	43.7	0.0	2.7	34.7	0.2	3.8	2.2	0.0	9.3	2.5	0.3	32.2	13.4	11.4	0.0	13.0	0.2	0.0	27.1	3.0	6.0	0.6	10.2	0.0	16.9	5.8	0.1	0.0	2.5	62.7	0.1	0.0	0.7	0.1	0.2	0.0	2.1	0.7	0.2	6.6	5.2	5.5	0.6	1.1	0.1	1.6	66.2	1.1	0.9	0.0	0.1
EARS2	"KIAA1970, MSE1, mtGlnRS"	ENSG00000103356	"Glutamyl-tRNA synthetase 2, mitochondrial"	Q5JPH6	16	23520754-23557731	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043289, HPA043633"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA043289: AB_10963932, HPA043633: AB_10959901"	"unprognostic (3.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.20e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (8.09e-2)"	"prognostic favorable (3.16e-6)"	"unprognostic (2.48e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.29e-2)"	3.7	7.6	3.3	1.2	3.5	1.5	4.0	2.7	4.0	2.9	3.6	3.7	1.1	3.7	3.0	5.2	3.0	1.0	5.3	3.3	3.6	4.9	9.9	3.1	1.8	3.3	2.5	3.3	5.6	4.8	3.5	2.5	2.6	3.0	2.3	1.9	4.6	1.4	4.2	5.6	2.9	2.0	1.5	3.3	4.1	3.8	3.5	2.5	4.3	3.8	2.4	3.3	3.3	3.2	2.6	8.3	2.4	4.8	2.9	3.8	3.9	3.2	3.1	3.6	2.4	5.0	2.9	4.8	2.6	3.3	1.8	2.9	9.6	6.4	4.7	2.9	7.7	2.4	5.3	7.1	2.4	3.4	2.1	3.2	4.4	2.4	4.7	4.5	1.4	5.2	7.0	2.5	2.6	5.5	2.1	2.3	7.5	4.4	2.8	4.1	4.5	8.0	5.5	3.8	5.0	4.1	2.1	5.0	2.7	6.3	5.9	3.0	2.3	3.1	2.1	3.1	3.4	5.1	3.7	3.4	4.1	4.0	4.3	0.1	0.8	0.0	1.0	1.5	1.6	0.8	1.4	1.1	1.7	1.0	1.3	1.1	0.4	1.8	1.1	1.6	1.7	1.3	3.3	3.5	2.7	4.0	3.3	3.6	3.3	2.5	2.6	1.5	3.5	3.2	1.8	9.6	5.9	5.2	3.8	2.2	4.0	4.0	4.0	3.8	6.2	4.7	11.6	2.8	2.9	3.7	2.1	15.1	2.3	2.5	5.9	7.0	2.9	3.3	4.9	3.2	5.4	9.4	8.3	3.5	12.3	4.3	4.1	3.4	5.7	6.5	3.6	11.4	7.1	8.4	7.9	4.3	2.0	3.2	2.5	2.5	2.5	3.4	5.4	3.7	5.3	2.6	4.1	4.0	4.7	3.7	1.7	1.9	8.8	4.9	1.6	8.6	5.3	3.9	0.0	2.7	3.4	5.8	9.8	6.5	3.0	11.4	3.3	12.6	6.2	3.2
EBP	"CDPX2, CHO2, CPX, CPXD"	ENSG00000147155	"EBP cholestenol delta-isomerase"	Q15125	X	48521799-48528716	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Isomerase	"Cataract, Disease variant, Dwarfism, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 328.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 674.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003130	Approved		Supported	"Endoplasmic reticulum"		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"HPA003130: AB_1078717"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.04e-2)"	"unprognostic (5.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.36e-1)"	10.2	73.3	16.7	17.1	17.2	48.3	17.4	18.5	17.8	19.4	22.0	50.6	85.5	11.0	17.3	41.3	14.3	10.5	32.5	16.8	18.7	44.0	328.5	24.4	18.8	24.4	16.6	12.7	26.0	44.0	7.2	8.2	24.2	40.6	57.5	10.7	25.0	11.7	9.5	27.8	54.2	14.9	15.8	16.9	31.6	14.2	15.9	28.2	14.4	10.6	32.7	14.1	23.3	16.0	224.5	96.4	107.4	77.0	74.5	39.2	50.5	48.2	43.6	64.3	93.9	169.9	382.7	115.9	35.2	41.3	83.5	230.3	217.5	293.8	49.8	85.8	149.7	50.1	115.2	139.3	57.8	179.2	138.2	51.3	108.6	112.9	86.4	22.5	46.5	98.1	77.6	119.5	50.7	163.7	119.1	199.9	118.2	88.3	199.1	93.8	10.3	363.7	175.6	68.8	110.0	59.6	175.4	122.6	31.2	91.5	122.9	71.1	46.6	33.1	56.2	132.9	63.1	47.5	72.1	107.7	78.7	239.7	40.6	96.1	37.7	97.1	129.4	53.4	104.5	71.5	90.5	116.7	53.5	57.2	76.5	99.7	7.3	63.9	57.2	105.4	103.1	93.6	16.7	17.2	18.5	17.8	16.8	18.7	24.4	16.6	24.2	15.8	15.9	16.0	15.2	32.1	49.8	2.9	38.9	37.1	58.2	245.6	23.3	23.8	57.8	26.2	49.9	77.2	116.6	53.3	8.4	55.9	74.5	140.3	39.2	91.7	10.5	30.5	14.7	26.1	30.0	48.8	7.4	239.1	113.0	21.4	36.2	56.5	40.6	41.2	27.1	674.6	65.0	8.4	10.3	96.8	93.6	30.2	36.0	11.8	13.4	31.9	37.4	4.7	34.8	19.3	101.0	5.0	5.1	156.7	137.3	14.7	54.4	46.4	171.9	99.7	34.8	23.3	13.1	12.5	23.6	8.7	22.7	47.6	45.5	37.5	57.1	128.7	149.1	71.1
ECE1	ECE	ENSG00000117298	"Endothelin converting enzyme 1"	P42892	1	21217247-21345572	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Hirschsprung disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 164.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 29.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 673.8;TIME: 588.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001490, HPA013616"	Enhanced					NA	NA		1300000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA001490: AB_1078718, HPA013616: AB_1847963"	"unprognostic (7.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-2)"	87.3	123.2	26.5	47.7	29.4	48.1	79.4	23.0	30.1	61.4	12.6	71.0	30.1	42.4	10.0	26.7	46.9	36.8	70.9	21.3	33.7	38.1	54.0	72.1	35.7	34.4	25.7	71.0	91.8	125.0	47.4	66.5	30.4	53.1	34.7	14.7	33.6	25.1	19.8	34.3	46.1	42.3	21.2	48.5	43.3	22.7	28.1	21.1	51.4	33.2	34.9	58.8	43.8	27.5	93.0	60.1	77.9	38.3	111.0	116.4	44.1	135.4	236.8	72.9	66.6	44.1	275.8	34.0	323.6	138.8	157.7	38.4	32.6	64.9	63.5	83.0	27.2	48.7	89.9	34.8	144.3	7.1	11.8	61.6	74.3	112.6	55.8	199.2	673.8	27.6	10.0	17.7	62.9	19.4	14.6	11.4	23.2	26.3	46.5	17.5	45.0	49.2	114.0	17.0	26.4	63.1	134.3	79.2	57.4	42.5	55.9	20.2	588.7	160.7	77.9	73.3	79.9	26.4	49.0	39.1	332.6	16.5	196.6	0.2	8.4	3.3	2.9	10.0	4.2	6.1	6.1	4.6	0.7	4.1	4.0	2.7	29.8	1.5	7.8	2.8	8.6	7.2	26.5	29.4	23.0	30.1	21.3	33.7	34.4	25.7	30.4	21.2	28.1	27.5	164.0	19.2	7.5	46.4	25.1	20.3	19.7	81.6	18.8	5.0	71.3	44.7	18.9	10.0	54.7	23.9	0.0	6.0	12.4	105.8	5.9	25.8	1.5	19.6	35.2	106.1	25.2	20.2	19.2	56.7	35.0	51.8	20.9	51.8	18.4	35.4	97.1	36.0	3.3	0.0	14.8	13.0	57.0	9.6	14.3	4.2	43.5	17.3	7.2	31.9	25.5	50.4	8.2	13.6	22.5	100.4	106.5	55.3	29.4	34.9	45.7	7.5	24.2	4.4	39.5	72.7	47.5	1.3	5.9	8.5	16.1	10.5	17.9	80.6	21.6	40.8
ECEL1	"DINE, XCE"	ENSG00000171551	"Endothelin converting enzyme like 1"	O95672	2	232479827-232487834	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 106.9;ovary: 99.7;pituitary gland: 27.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 33.5;Muller glia cells: 100.3;Peritubular cells: 21.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 106.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AN3-CA: 44.1;HeLa: 21.8"	"Region enhanced"	"Detected in many"		"hypothalamus: 70.7"	"Low region specificity"	"Detected in many"			"HPA067560, HPA069756, HPA077424"	Approved	Supported	Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA067560: , HPA069756: , HPA077424: "	"unprognostic (1.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.39e-1)"	"unprognostic (4.62e-3)"	"unprognostic (2.80e-1)"	"unprognostic (9.96e-4)"	"unprognostic (7.56e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.89e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.24e-5)"	"unprognostic (3.09e-2)"	"unprognostic (3.68e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.45e-2)"	1.8	10.0	5.2	1.0	5.5	0.0	1.7	1.2	31.6	1.0	3.4	0.8	0.1	2.2	0.0	0.4	3.5	0.5	0.2	0.5	106.9	4.1	2.5	0.4	0.3	20.9	11.3	99.7	0.7	1.2	27.6	0.3	17.1	0.4	0.0	13.4	0.6	1.5	3.0	0.6	0.4	1.4	2.4	4.5	0.9	1.9	44.2	0.2	1.4	0.0	0.4	0.4	1.1	4.5	0.0	0.1	0.1	44.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.4	0.0	0.2	0.0	0.6	0.0	0.0	0.0	4.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	3.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	5.5	1.2	31.6	0.5	106.9	20.9	11.3	17.1	2.4	44.2	4.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	33.5	0.5	0.3	1.1	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.2	1.1	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.2	1.5	0.1	0.0	0.0	0.0	100.3	0.0	0.0	0.0	0.1	0.0	21.1	0.0	0.0	0.0	0.1	0.0	3.7	0.0	1.0	2.3	0.5	1.6	0.0	0.0	0.0	0.1	0.6	0.0	0.1
EGLN1	"C1orf12, HIFPH2, PHD2, SM-20, ZMYND6"	ENSG00000135766	"Egl-9 family hypoxia inducible factor 1"	Q9GZT9	1	231363751-231422287	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Congenital erythrocytosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 190.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 29.1"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 29.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022129	Approved					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA022129: AB_1848046"	"unprognostic (4.20e-1)"	"prognostic unfavorable (2.99e-7)"	"unprognostic (8.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.81e-2)"	32.8	35.6	37.5	18.1	40.8	20.0	23.9	38.8	43.2	26.3	31.6	30.0	34.0	30.8	24.5	33.6	24.2	28.2	58.7	39.9	37.2	38.8	56.5	19.1	21.1	41.6	39.0	37.5	40.0	39.0	9.3	42.6	36.8	23.8	26.1	49.9	22.0	30.3	190.7	48.6	35.5	27.6	40.9	27.6	19.1	17.1	43.4	16.7	25.5	153.4	21.3	27.0	12.0	40.9	54.2	59.9	17.5	33.7	44.8	29.4	15.8	22.7	42.2	36.3	49.4	41.3	48.0	15.5	41.7	42.4	31.7	25.1	26.8	30.1	61.0	18.6	42.5	6.7	23.5	37.7	31.5	38.5	8.1	25.4	27.5	24.9	34.2	58.6	49.3	18.5	33.9	37.9	38.3	12.2	8.9	14.4	18.4	33.4	21.0	20.0	21.7	22.7	48.0	23.4	15.9	45.3	32.9	41.4	83.1	11.2	22.4	112.8	54.3	44.3	20.8	40.5	47.2	65.7	46.4	14.7	60.4	14.0	59.4	4.2	0.5	3.1	1.2	1.0	0.7	0.7	0.9	0.8	0.8	0.7	1.0	1.8	29.1	1.6	1.8	0.7	0.5	0.4	37.5	40.8	38.8	43.2	39.9	37.2	41.6	39.0	36.8	40.9	43.4	40.9	64.7	19.2	23.2	36.6	19.8	58.5	15.0	10.7	33.0	32.3	19.4	13.3	111.9	67.2	11.6	18.4	37.5	16.2	16.6	57.6	35.2	37.8	1.2	18.5	20.2	60.6	12.7	8.2	43.9	36.2	34.2	25.9	15.3	21.2	10.1	55.6	28.9	70.6	16.9	62.2	52.6	24.6	16.2	24.1	45.3	5.0	16.1	29.8	26.6	44.0	19.0	56.9	12.3	46.3	48.3	36.6	30.9	23.0	23.9	15.1	43.2	52.3	13.5	44.0	19.7	36.4	36.6	13.1	20.9	24.9	57.5	10.4	24.9	16.0	23.5	21.3
EHHADH	ECHD	ENSG00000113790	"Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase"	Q08426	3	185190624-185281990	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Multifunctional enzyme, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	11	"kidney: 144.3;liver: 344.5"	"Group enriched"	"Detected in many"	10	"Hepatocytes: 289.0;Proximal tubular cells: 147.1"	"Group enriched"	"Detected in all"	7	"liver cancer: 42.2;renal cancer: 25.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036401, HPA042021"	Enhanced					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036401: AB_10670165, HPA042021: AB_2677801"	"unprognostic (1.20e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.80e-1)"	10.8	4.3	2.1	3.0	2.9	1.2	4.1	3.9	2.7	3.5	9.2	14.2	21.5	2.8	3.5	5.5	3.6	4.4	10.7	2.1	3.1	144.3	344.5	4.3	2.1	3.2	4.1	2.6	9.9	7.8	1.5	3.2	3.0	6.3	10.8	1.6	5.7	2.2	1.7	4.5	12.9	3.7	2.5	3.7	10.4	2.7	3.1	2.1	6.5	5.6	2.8	3.6	2.1	2.8	12.3	5.0	1.4	0.0	7.3	6.1	1.5	5.7	1.8	3.7	4.1	21.9	7.5	0.0	22.1	5.7	1.4	5.8	0.0	4.8	7.6	16.2	5.2	8.6	1.3	22.5	4.7	1.0	0.2	8.7	6.0	3.7	3.4	5.0	5.5	0.0	5.7	6.1	7.2	6.4	0.2	5.1	3.0	4.3	6.3	0.0	9.9	0.5	15.4	6.8	4.4	6.4	11.2	6.4	10.5	12.1	23.7	10.1	2.6	2.4	3.6	1.9	0.5	1.7	5.6	0.5	0.8	3.9	4.0	0.1	0.9	0.0	0.6	0.8	0.4	0.5	0.4	0.9	2.4	0.0	0.6	1.0	0.0	1.2	0.8	1.0	0.6	0.4	2.1	2.9	3.9	2.7	2.1	3.1	3.2	4.1	3.0	2.5	3.1	2.8	4.9	16.0	10.9	20.9	4.5	1.5	1.4	1.9	1.2	0.7	3.2	2.3	19.2	17.2	3.9	20.2	4.2	8.9	0.4	17.8	19.6	2.1	0.2	6.5	5.1	3.9	7.7	9.7	4.9	6.8	2.9	1.6	8.6	3.1	0.0	6.1	13.6	289.0	4.4	0.0	5.7	12.8	0.0	10.5	1.0	0.7	0.6	2.7	3.6	4.7	9.4	1.9	0.0	3.5	8.0	3.7	9.3	0.4	0.8	2.5	15.0	147.1	4.0	1.2	0.0	1.1	2.4	3.7	4.2	4.9	0.4	1.4	2.2	3.6	10.8	1.8
EI24	"EPG4, PIG8, TP53I8"	ENSG00000149547	"EI24 autophagy associated transmembrane protein"	O14681	11	125569280-125584684	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 461.9"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 575.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 760.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047165, HPA051029"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Cytosol"	"Golgi apparatus"	"HPA047165: AB_2679965, HPA051029: AB_2681317"	"unprognostic (2.04e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.38e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.01e-1)"	53.4	32.6	61.1	36.2	62.5	23.2	72.6	59.7	72.4	51.3	59.8	77.8	49.6	46.2	57.4	80.8	50.8	46.3	55.7	60.2	61.5	61.0	248.4	45.0	28.4	60.2	62.5	42.4	101.8	461.9	30.6	48.5	60.2	49.6	80.4	39.4	75.3	58.0	119.5	70.2	49.3	62.5	62.4	30.5	59.7	33.1	64.4	35.3	40.5	104.6	42.3	78.9	48.4	61.0	156.6	115.6	129.5	160.5	207.7	155.9	162.4	159.6	116.8	104.3	93.4	178.9	303.4	158.0	264.0	146.5	110.8	176.1	199.0	326.8	135.2	42.0	142.6	760.9	77.2	179.9	154.1	170.9	78.4	147.5	292.7	157.4	230.2	102.8	223.9	85.1	351.1	61.1	149.4	113.8	79.0	96.4	173.6	398.3	139.5	113.9	155.4	132.8	177.0	272.4	120.1	116.9	187.1	215.5	63.4	212.3	436.4	165.7	195.2	133.8	93.3	94.7	128.7	39.7	84.8	200.5	58.5	256.1	182.2	4.3	7.0	5.9	7.2	6.7	7.2	8.4	5.7	9.0	10.9	6.3	8.1	6.7	0.8	6.5	4.9	14.5	9.1	5.3	61.1	62.5	59.7	72.4	60.2	61.5	60.2	62.5	60.2	62.4	64.4	61.0	73.5	32.1	38.3	13.4	34.8	120.6	130.3	132.6	120.1	58.9	148.8	100.6	61.9	124.4	69.5	110.3	37.5	166.9	32.4	66.4	144.8	178.6	31.1	34.4	59.3	87.1	98.4	102.7	25.1	181.8	201.2	80.1	87.7	46.5	27.3	76.2	74.6	575.0	110.5	82.4	24.0	115.3	105.8	49.8	96.1	49.7	71.4	40.9	90.7	11.2	40.9	107.1	50.4	13.0	23.0	182.1	67.6	72.2	79.1	270.0	68.5	122.7	43.9	36.9	46.0	60.8	80.1	95.9	112.3	176.3	181.4	140.1	31.0	71.3	135.7	189.4
EIF2AK1	"HRI, KIAA1369"	ENSG00000086232	"Eukaryotic translation initiation factor 2 alpha kinase 1"	Q9BQI3	7	6022247-6059175	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Protein synthesis inhibitor, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Cytotrophoblasts: 219.1;Erythroid cells: 422.0;Syncytiotrophoblasts: 371.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016496, CAB022082, HPA061675"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	Cytosol	"CAB022082: , HPA016496: AB_1848057, HPA061675: AB_2684583"	"unprognostic (7.15e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.70e-2)"	"unprognostic (9.69e-3)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.06e-2)"	27.2	39.4	28.1	27.7	28.9	105.9	35.9	30.6	36.1	29.0	34.9	48.8	37.1	25.0	37.4	30.4	31.0	23.8	33.8	28.1	30.6	43.8	65.1	30.3	35.2	30.5	28.9	29.3	44.3	78.0	25.9	52.3	31.6	35.0	47.3	29.0	46.8	24.2	38.3	33.3	37.2	23.8	29.1	26.6	49.1	19.5	29.8	43.6	39.3	34.4	40.4	27.2	22.4	33.7	144.5	90.5	71.2	108.8	66.4	59.6	92.4	73.0	66.8	64.2	80.8	83.7	96.2	112.5	77.4	81.3	115.5	100.4	93.1	67.1	82.2	69.8	140.3	115.9	91.6	127.3	54.3	100.8	102.0	48.1	82.8	60.7	64.9	67.7	69.4	88.1	189.0	106.8	61.4	146.5	55.6	128.6	88.5	84.6	99.7	120.0	74.6	134.0	82.3	70.3	87.3	156.5	139.3	186.6	63.8	98.6	141.0	122.4	65.9	37.0	134.2	65.3	78.2	106.5	114.8	115.6	73.9	129.8	108.7	11.1	6.9	17.3	8.2	5.5	5.6	12.3	6.5	9.3	6.9	9.5	7.5	6.6	3.7	10.2	6.2	6.0	8.9	4.8	28.1	28.9	30.6	36.1	28.1	30.6	30.5	28.9	31.6	29.1	29.8	33.7	23.1	38.5	43.7	14.4	42.8	23.8	34.9	34.3	41.5	29.7	52.5	34.9	49.6	45.8	37.7	44.1	16.7	219.1	52.5	57.1	66.5	55.0	8.8	59.5	42.3	27.5	38.5	422.0	21.8	44.8	82.1	29.7	64.7	48.1	20.8	44.9	21.0	63.2	53.8	32.0	21.9	68.7	54.9	39.0	29.9	16.1	34.5	65.2	24.9	13.1	62.8	46.4	70.0	19.1	26.9	53.0	47.0	37.6	60.1	43.3	47.5	66.1	48.3	26.5	13.1	32.0	26.0	33.7	34.5	45.5	22.4	371.0	38.0	57.1	52.7	32.3
EIF2AK2	"EIF2AK1, PKR, PPP1R83, PRKR"	ENSG00000055332	"Eukaryotic translation initiation factor 2 alpha kinase 2"	P19525	2	37099210-37157522	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003845, HPA019795, HPA063893"	Approved		Enhanced	Cytosol		NA	NA		44000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB003845: AB_562332, HPA019795: AB_1848060, HPA063893: AB_2685144"	"unprognostic (1.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.77e-3)"	"unprognostic (8.42e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.65e-2)"	"unprognostic (5.32e-2)"	11.1	9.0	7.2	10.5	8.1	30.1	8.6	7.4	9.5	9.8	8.6	8.8	7.6	10.5	8.0	6.3	8.3	9.5	6.3	7.8	11.1	8.5	7.7	8.9	8.0	10.9	8.1	10.8	7.4	11.1	6.6	11.2	10.9	10.1	8.6	6.6	17.7	8.4	4.5	4.6	9.9	11.1	15.6	11.9	9.5	3.3	13.0	11.7	10.0	5.8	7.1	8.0	5.9	8.7	38.4	22.1	16.7	17.4	21.5	28.3	20.1	21.2	29.1	56.3	41.1	23.0	23.2	27.4	27.0	29.8	66.2	27.4	24.2	27.1	29.5	45.7	12.0	33.8	19.2	18.7	17.9	32.2	0.2	22.5	13.1	23.7	19.3	17.7	18.0	10.7	19.1	23.6	20.3	13.4	35.5	17.0	15.8	8.4	10.8	27.6	40.9	12.1	15.3	18.7	14.1	20.4	32.0	24.0	50.7	12.7	9.2	9.0	31.4	25.7	24.9	15.1	36.2	19.0	30.8	0.3	15.9	20.0	23.1	10.7	5.3	6.3	5.4	7.9	5.2	5.3	4.5	5.2	4.8	4.2	3.0	4.3	15.7	6.5	8.0	3.1	6.5	2.1	7.2	8.1	7.4	9.5	7.8	11.1	10.9	8.1	10.9	15.6	13.0	8.7	94.5	67.3	34.0	25.1	35.9	19.5	42.3	33.0	31.3	38.8	26.6	26.0	29.9	32.9	46.0	22.0	14.6	47.8	44.8	32.2	21.5	40.2	2.4	55.8	68.7	76.3	15.0	36.0	39.6	48.5	89.2	52.6	22.4	41.7	41.1	93.5	33.5	21.9	38.2	47.1	42.9	24.0	16.2	29.9	20.8	4.2	57.2	50.7	21.4	48.7	47.1	50.9	45.3	51.3	16.8	54.7	21.8	84.2	46.0	39.5	33.6	33.0	48.9	24.8	39.5	60.5	45.9	2.4	5.5	22.5	10.1	40.8	40.0	61.3	28.6	40.5
EIF2AK3	"PEK, PERK"	ENSG00000172071	"Eukaryotic translation initiation factor 2 alpha kinase 3"	Q9NZJ5	2	88556741-88627464	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Stress response, Translation regulation, Unfolded protein response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 19.6"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 46.8;U-266/70: 44.0;U-698: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009204, HPA015737"	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB009204: AB_2230863, HPA015737: AB_1848062"	"unprognostic (7.25e-3)"	"unprognostic (5.35e-2)"	"unprognostic (3.03e-3)"	"unprognostic (9.32e-2)"	"unprognostic (9.39e-3)"	"unprognostic (3.25e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.46e-3)"	"unprognostic (9.84e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.92e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.90e-3)"	3.3	3.1	0.8	4.0	1.1	2.6	1.6	1.6	1.4	2.3	1.6	4.7	6.2	1.9	1.0	1.6	1.3	1.4	1.5	0.8	1.5	2.0	1.9	1.8	3.2	1.0	1.2	1.9	19.6	3.4	1.1	3.2	0.9	4.0	1.8	0.1	9.7	1.2	2.0	1.4	5.0	0.9	1.5	3.1	12.3	1.0	1.2	1.3	3.5	0.0	2.3	1.9	1.8	2.1	8.7	3.3	1.2	4.3	2.8	2.0	15.9	12.4	1.1	0.7	2.1	3.5	2.9	46.8	8.0	1.3	3.1	7.2	1.6	1.3	1.1	25.3	7.1	4.6	1.7	2.0	1.1	3.9	12.3	0.1	1.5	0.7	2.0	0.8	1.4	4.9	3.0	8.7	0.6	4.4	5.5	2.2	6.2	2.7	7.2	25.1	7.0	8.2	1.3	5.0	5.6	9.9	6.3	6.5	8.2	1.7	2.2	4.4	3.9	2.5	5.5	10.8	7.1	44.0	24.4	31.0	4.6	4.2	6.2	0.0	0.1	0.1	0.3	0.0	0.2	1.0	0.2	0.8	0.1	1.9	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.8	1.1	1.6	1.4	0.8	1.5	1.0	1.2	0.9	1.5	1.2	2.1	9.2	9.6	7.5	14.7	43.8	20.3	8.9	7.2	26.7	8.4	14.7	8.9	8.2	17.2	7.2	12.9	8.4	4.1	13.4	14.0	0.0	3.7	0.1	18.4	18.3	7.6	13.7	1.7	31.3	6.5	6.9	15.2	40.2	39.2	1.3	4.4	8.9	11.8	4.6	1.7	39.0	30.1	14.2	5.1	41.2	0.7	7.5	27.7	32.0	21.5	3.9	3.0	9.2	20.1	26.2	7.0	7.7	5.7	121.3	13.0	5.4	2.9	7.7	2.3	0.0	13.4	9.4	3.1	3.6	23.8	18.3	6.7	12.8	3.5	6.8	16.6
EIF2AK4	"GCN2, KIAA1338"	ENSG00000128829	"Eukaryotic translation initiation factor 2 alpha kinase 4"	Q9P2K8	15	39934115-40035591	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Activation of host autophagy by virus, Adaptive immunity, Antiviral defense, Cell cycle, Growth arrest, Host-virus interaction, Immunity, Neurogenesis, Stress response, Translation regulation"	"Activator, Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, tRNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 66.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011811	Approved		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 15: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA011811: AB_2668543"	"unprognostic (3.10e-1)"	"unprognostic (4.78e-3)"	"unprognostic (5.97e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.11e-3)"	20.1	14.6	21.5	12.2	22.4	18.7	17.6	27.2	23.7	14.6	16.8	15.5	11.3	30.5	15.4	16.0	16.1	17.0	17.7	21.2	22.0	13.4	21.3	16.9	16.9	20.3	20.2	17.1	14.1	17.7	24.1	19.0	20.5	19.8	12.9	13.1	13.9	11.5	18.9	19.0	11.3	15.6	18.9	15.7	15.2	8.9	22.1	13.1	21.8	11.0	11.6	17.2	12.4	28.9	37.1	17.5	30.3	46.3	49.0	81.7	28.9	51.0	58.1	40.8	40.0	25.2	15.6	19.6	25.9	69.3	54.7	38.6	41.1	61.4	56.6	92.8	20.4	41.6	30.8	30.7	42.1	25.6	27.8	65.3	41.2	39.0	69.8	57.3	58.0	40.5	31.3	18.1	81.7	12.3	21.7	34.6	18.8	32.8	38.2	25.4	42.2	33.1	51.4	24.7	16.1	24.4	36.4	22.2	32.3	29.5	30.7	43.4	61.6	54.3	40.9	27.3	33.6	24.6	47.8	6.0	38.1	34.4	77.4	11.6	10.8	8.6	6.8	14.1	5.7	7.1	7.6	7.9	17.6	9.2	8.3	8.2	3.3	8.5	20.5	66.5	5.8	4.9	21.5	22.4	27.2	23.7	21.2	22.0	20.3	20.2	20.5	18.9	22.1	28.9	47.9	16.0	31.1	28.7	29.3	12.0	27.5	17.8	43.3	29.9	45.0	45.2	32.3	32.9	21.4	16.5	12.5	37.5	32.2	21.1	13.7	23.7	1.5	19.3	52.7	35.3	14.4	37.4	42.7	25.4	34.8	36.5	23.4	27.0	24.1	35.0	22.9	27.8	30.7	28.6	53.9	25.9	12.2	33.7	55.4	4.3	42.3	52.1	32.0	29.0	41.1	30.4	16.5	30.2	26.3	47.6	16.2	39.9	115.6	30.7	6.4	18.2	12.9	23.9	46.0	43.6	35.6	8.6	29.8	47.0	14.5	15.2	18.2	64.0	29.6	18.4
EIF2S3	"EIF2, EIF2G, EIF2gamma"	ENSG00000130741	"Eukaryotic translation initiation factor 2 subunit gamma"	P41091	X	24054946-24078810	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Hydrolase, Initiation factor"	"Disease variant, Epilepsy, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											CAB012471	Approved					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"			"CAB012471: AB_873547"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.46e-3)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.66e-3)"	"unprognostic (6.94e-3)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (5.44e-6)"	"unprognostic (4.88e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-1)"	65.5	51.8	31.9	71.8	33.5	76.2	82.9	35.7	35.4	78.0	42.5	67.2	66.4	83.8	45.0	62.5	79.9	53.3	57.1	31.4	33.0	69.6	74.6	50.7	113.3	35.9	32.2	131.3	94.8	49.6	30.1	46.4	35.7	51.7	66.3	46.9	69.7	41.7	66.7	71.8	53.0	74.3	35.8	72.1	66.7	18.6	34.8	97.6	69.9	51.8	111.6	66.4	65.6	41.4	261.0	256.0	110.3	182.7	113.5	235.5	73.2	142.3	127.4	114.8	130.6	290.8	174.3	449.5	141.0	104.9	251.9	165.1	344.7	271.3	140.8	147.8	203.7	177.2	467.8	164.3	126.2	304.0	219.4	206.9	169.2	129.6	269.7	152.9	166.2	176.0	275.4	176.0	127.7	124.8	170.6	278.8	268.2	118.1	146.5	169.5	215.2	271.4	155.4	241.5	60.2	130.8	232.3	224.7	239.8	205.5	289.6	205.1	140.2	97.1	66.7	177.3	125.3	156.6	322.4	240.9	120.9	193.1	113.7	64.4	141.1	27.9	84.9	151.9	147.8	156.0	148.8	113.9	123.9	120.6	187.5	156.6	51.2	106.3	132.6	97.4	124.2	127.2	31.9	33.5	35.7	35.4	31.4	33.0	35.9	32.2	35.7	35.8	34.8	41.4	76.5	44.8	54.5	48.0	187.6	126.6	98.0	51.8	145.1	25.3	128.4	91.2	49.1	74.4	49.0	40.5	25.0	59.6	127.5	35.2	111.6	67.9	0.5	67.3	109.4	67.5	44.9	92.5	19.0	57.6	122.1	72.3	78.5	90.9	100.8	84.6	84.3	58.8	89.1	20.2	20.1	65.0	32.6	138.9	91.9	3.5	67.7	109.7	55.2	36.5	134.5	30.4	78.2	23.6	31.4	59.5	68.9	61.3	99.3	70.2	72.3	135.2	40.6	33.3	72.3	85.0	87.4	10.2	21.9	130.7	151.2	71.0	117.9	76.2	100.4	92.9
EIF3F	"eIF3-epsilon, eIF3-p47, EIF3S5"	ENSG00000175390	"Eukaryotic translation initiation factor 3 subunit F"	O00303	11	7970251-8001862	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis, Ubl conjugation pathway"	"Hydrolase, Initiation factor, Protease, Thiol protease"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049250	Approved					NA	NA		83000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"			"HPA049250: AB_2680692"	"unprognostic (1.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.61e-1)"	"unprognostic (8.36e-2)"	"unprognostic (8.78e-2)"	225.1	160.8	7.8	10.2	7.4	21.7	216.8	8.6	7.6	249.1	5.1	248.9	10.5	206.8	10.1	227.3	213.3	16.7	186.2	7.6	6.6	165.8	160.3	157.0	24.7	7.9	6.8	353.9	361.3	8.0	126.6	11.7	7.7	170.0	12.6	15.5	175.5	12.9	374.0	333.1	188.6	21.2	6.7	201.6	238.9	132.7	7.3	11.8	153.7	12.8	25.4	218.7	212.9	8.2	23.6	9.3	12.7	11.3	23.5	52.6	39.9	16.1	28.1	20.3	19.4	9.6	23.0	70.4	6.7	15.7	9.1	12.5	9.9	27.7	20.4	23.1	32.4	24.8	9.5	11.1	38.7	26.9	10.0	32.2	32.7	7.9	18.7	18.6	20.7	12.6	21.5	16.1	22.2	9.6	15.8	25.5	13.1	9.5	22.6	17.7	17.3	22.4	11.0	15.8	29.2	50.6	15.2	6.7	19.3	7.7	11.9	18.6	19.3	9.5	11.0	6.9	11.7	11.8	21.1	29.0	6.4	16.8	12.6	37.5	92.4	41.7	81.5	99.7	112.1	174.6	130.5	96.4	130.9	161.6	155.4	114.5	11.7	95.8	93.6	87.7	177.6	246.5	7.8	7.4	8.6	7.6	7.6	6.6	7.9	6.8	7.7	6.7	7.3	8.2	179.9	109.0	145.4	11.1	355.2	349.1	364.1	411.0	266.9	72.2	271.6	285.6	96.8	264.5	197.2	79.1	52.1	631.3	283.7	121.1	293.5	277.0	424.5	113.8	204.9	218.3	210.2	221.7	11.5	442.8	670.6	216.3	139.7	112.1	164.8	335.7	256.6	170.6	344.2	45.4	10.9	262.0	140.4	423.1	398.1	913.3	246.0	263.4	247.3	8.4	471.1	141.5	362.5	7.5	18.8	322.2	242.2	196.7	237.6	247.4	312.9	286.9	115.1	87.1	98.6	222.4	374.3	197.0	124.8	358.3	440.4	563.4	319.3	264.8	392.2	426.0
EIF4A3	"DDX48, EIF4AIII, Fal1, KIAA0111"	ENSG00000141543	"Eukaryotic translation initiation factor 4A3"	P38919	17	80134369-80147151	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, rRNA processing, Translation regulation, Transport"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021878	Supported		Supported	Nucleoplasm		NA	NA		280000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA021878: AB_1848090"	"unprognostic (7.24e-2)"	"unprognostic (7.33e-3)"	"prognostic favorable (3.57e-5)"	"unprognostic (1.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.68e-5)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (3.71e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.81e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.91e-3)"	65.8	81.4	19.0	49.1	21.1	185.8	44.2	21.5	27.2	51.2	22.8	44.3	38.6	46.6	38.8	81.9	54.7	40.1	38.0	22.3	21.0	45.1	42.6	44.0	67.0	19.9	19.5	66.5	37.0	58.5	41.1	52.9	20.3	38.7	47.5	32.3	42.4	32.6	37.3	64.8	38.9	42.6	22.7	47.6	41.4	42.8	20.0	78.2	37.0	34.9	74.7	83.4	55.1	24.7	237.2	208.9	140.5	103.8	105.5	63.2	114.4	119.3	91.0	177.7	141.4	223.7	110.3	221.4	67.9	112.9	126.4	152.2	194.9	136.2	195.0	71.5	192.3	142.5	159.3	244.3	103.1	253.8	133.4	98.7	68.7	149.5	119.4	71.8	147.2	128.7	189.8	140.2	105.3	178.9	224.8	132.8	145.0	223.8	190.0	168.5	282.7	172.2	85.8	196.5	186.1	100.1	170.9	334.2	151.9	130.1	219.3	166.7	100.5	108.7	138.6	159.9	200.3	104.4	86.2	403.2	88.0	158.7	113.3	126.1	167.0	137.4	101.1	174.6	131.2	142.4	128.2	119.4	200.0	119.8	116.9	115.2	98.7	132.9	143.4	326.0	158.2	232.6	19.0	21.1	21.5	27.2	22.3	21.0	19.9	19.5	20.3	22.7	20.0	24.7	117.9	41.7	48.0	6.8	135.1	283.1	273.4	212.9	107.0	23.3	77.0	109.2	61.5	38.6	107.8	29.5	16.7	140.1	165.7	75.4	64.6	85.6	33.2	132.9	109.2	70.5	60.3	24.4	4.1	115.2	225.1	144.3	149.4	248.2	92.6	42.6	32.2	27.0	108.5	6.7	4.3	83.2	89.5	63.4	255.0	12.1	67.1	199.6	103.2	10.3	67.9	48.6	23.7	5.5	7.6	86.6	83.1	49.7	118.6	96.0	47.9	65.0	61.4	32.5	85.5	109.7	207.8	99.4	123.2	77.6	299.1	261.9	138.4	98.0	77.7	252.5
ELAC2	"FLJ10530, HPC2"	ENSG00000006744	"ElaC ribonuclease Z 2"	Q9BQ52	17	12991612-13018065	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Endonuclease, Hydrolase, Nuclease"	"Disease variant, Primary mitochondrial disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 394.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019535	Approved		Supported	Nucleoplasm		NA	NA		9500	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA019535: AB_1848106"	"unprognostic (4.24e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (3.24e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.98e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.09e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.70e-2)"	30.7	35.8	13.7	23.0	14.6	22.7	24.6	14.7	14.3	21.7	18.0	28.7	23.1	24.7	17.1	31.9	25.8	21.1	38.1	13.8	15.0	28.6	32.5	19.8	28.0	16.4	14.6	19.8	23.1	33.8	12.5	23.5	15.3	26.4	32.7	22.5	20.4	33.6	60.2	23.8	21.1	33.6	17.1	28.8	24.8	28.1	13.4	28.4	25.8	35.7	37.6	24.6	18.2	22.1	76.4	102.1	69.8	81.5	53.3	53.9	44.9	75.4	59.6	119.8	79.8	84.3	34.8	127.7	84.9	69.9	45.0	96.6	133.6	80.6	113.5	65.7	163.7	73.0	82.1	54.7	40.7	64.7	99.4	47.3	70.6	88.2	80.5	51.4	88.3	71.5	108.0	34.8	88.7	58.0	112.0	58.3	62.2	132.9	80.7	84.1	122.2	82.2	62.0	59.2	37.5	54.6	97.4	61.0	39.2	394.4	59.1	26.2	82.7	152.3	47.6	57.0	116.3	24.7	51.6	53.3	57.6	64.2	54.6	26.9	31.1	19.2	41.6	41.2	43.4	37.7	39.1	40.7	48.4	34.4	39.7	36.2	4.7	53.5	46.8	30.1	53.4	46.3	13.7	14.6	14.7	14.3	13.8	15.0	16.4	14.6	15.3	17.1	13.4	22.1	11.6	6.4	10.8	6.8	18.0	10.3	10.1	16.7	16.5	11.3	12.5	10.8	28.3	12.8	12.9	16.5	2.1	59.3	15.6	13.2	19.6	27.4	6.4	13.0	13.1	14.1	8.4	24.0	9.8	26.0	32.6	16.6	17.3	14.2	9.5	30.4	11.7	28.4	28.2	11.8	9.2	13.5	24.4	14.2	7.0	5.7	10.5	10.0	14.2	3.7	14.7	16.1	14.4	7.1	10.6	25.9	16.6	21.4	21.6	13.5	15.2	19.5	12.2	14.6	52.6	10.1	14.9	26.4	24.4	22.2	14.5	33.5	15.9	59.0	20.7	8.2
ELOVL1	Ssc1	ENSG00000066322	"ELOVL fatty acid elongase 1"	Q9BW60	1	43363398-43368074	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033426, HPA056557"	Enhanced		Supported	"Endoplasmic reticulum"		NA	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Endoplasmic reticulum"		"CAB033426: AB_2099896, HPA056557: AB_2683173"	"unprognostic (5.23e-2)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (8.00e-2)"	"unprognostic (8.45e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (2.79e-7)"	"unprognostic (4.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-1)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.00e-2)"	78.5	54.7	77.2	39.8	115.6	52.9	66.6	121.1	116.9	57.1	61.4	63.9	51.6	46.5	30.6	176.6	38.9	42.4	47.2	76.8	93.2	59.7	45.8	59.6	40.1	152.0	110.1	28.9	55.4	46.2	27.2	51.0	140.7	58.7	48.6	8.4	72.7	48.8	24.1	201.9	55.4	50.8	114.8	57.1	70.6	18.6	107.7	22.2	66.8	28.0	55.7	68.5	86.8	165.7	108.0	119.5	22.6	44.8	148.4	138.2	70.2	125.2	154.5	153.5	122.4	105.9	182.5	73.9	94.3	193.6	130.3	119.4	79.7	152.2	93.2	94.6	53.9	96.6	77.3	77.1	128.2	84.2	98.0	106.2	168.2	180.9	198.4	114.8	155.0	27.7	68.1	54.8	178.5	79.5	19.9	69.5	33.5	136.9	120.2	43.6	59.9	89.7	195.5	128.7	27.4	28.8	73.7	258.4	105.8	66.8	121.2	82.4	132.2	129.7	82.5	161.2	161.3	26.6	31.2	35.4	127.8	85.2	120.1	134.9	189.6	172.7	105.1	180.0	93.4	109.0	98.4	103.2	212.8	94.2	63.5	88.0	133.0	114.7	179.6	148.8	113.8	203.1	77.2	115.6	121.1	116.9	76.8	93.2	152.0	110.1	140.7	114.8	107.7	165.7	44.0	19.2	12.5	7.5	28.1	15.6	25.9	61.1	29.6	5.7	60.3	37.5	4.7	34.3	40.2	40.5	10.4	93.4	36.0	114.0	7.9	91.5	3.4	22.9	26.3	43.6	19.2	67.8	3.8	100.1	127.4	26.1	48.4	45.2	21.0	52.6	24.7	16.7	74.9	3.3	3.4	33.8	46.8	46.3	37.5	4.6	20.2	41.5	12.4	7.5	92.5	13.7	32.0	3.0	66.1	133.3	63.9	25.6	19.0	44.7	66.0	23.3	14.5	9.5	19.7	10.0	39.7	8.4	11.2	70.1	31.0	95.9	31.5	50.8	47.2	49.2
ELOVL5	"dJ483K16.1, HELO1, SCA38"	ENSG00000012660	"ELOVL fatty acid elongase 5"	Q9NYP7	6	53267398-53349179	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017042, HPA047752, HPA054197"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 35: Glandular cells - Unknown function"	"Endoplasmic reticulum"		"CAB017042: , HPA047752: AB_2680147, HPA054197: AB_2682413"	"unprognostic (7.33e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (1.58e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (2.76e-2)"	242.4	134.7	51.3	74.9	67.0	114.6	199.2	74.6	79.2	48.9	49.4	40.0	28.3	39.8	49.7	28.4	46.0	51.3	37.8	50.8	65.3	38.9	108.9	68.4	106.7	80.7	69.0	32.3	15.4	24.3	28.5	40.2	74.5	128.0	18.3	36.5	24.8	103.0	9.9	32.9	47.5	52.4	67.7	56.1	22.8	82.5	65.8	107.3	45.1	19.5	102.4	67.1	27.0	98.9	137.2	98.1	168.0	309.0	436.0	250.8	71.3	155.8	174.2	123.2	171.5	87.4	154.5	154.4	110.3	163.3	193.1	78.9	168.0	142.6	183.7	131.2	117.5	153.1	85.0	122.9	239.0	122.2	107.2	233.6	109.8	123.6	153.9	124.5	139.1	301.4	194.2	87.3	90.3	14.9	364.4	107.9	91.2	5.2	73.6	139.9	115.3	54.3	232.7	80.6	155.7	107.1	129.3	66.9	135.2	108.7	152.3	112.9	133.0	134.7	118.5	242.2	208.8	72.8	72.1	116.2	70.2	173.6	97.8	47.6	49.2	183.7	34.9	34.9	56.5	88.4	58.1	42.7	77.9	101.5	27.8	26.3	261.5	36.7	45.0	20.4	110.0	50.6	51.3	67.0	74.6	79.2	50.8	65.3	80.7	69.0	74.5	67.7	65.8	98.9	48.6	80.1	50.7	75.4	118.3	52.4	108.2	36.8	44.3	11.6	177.3	70.9	23.3	21.5	40.2	12.9	2.1	25.3	55.5	2.1	15.6	34.9	94.2	37.4	53.2	54.4	25.0	77.0	25.8	36.1	58.2	54.8	3.1	66.4	99.0	28.4	39.3	88.7	35.5	8.4	29.8	1.6	16.2	57.3	114.6	181.0	20.8	55.5	48.0	39.4	53.5	83.2	39.1	49.3	111.2	27.8	1.4	32.0	45.2	169.2	21.9	48.4	58.5	6.0	65.7	27.3	77.5	27.0	18.9	35.7	60.9	31.2	97.2	60.0	4.4	73.4
EMC1	KIAA0090	ENSG00000127463	"ER membrane protein complex subunit 1"	Q8N766	1	19215660-19251527	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048904	Approved					NA	NA		14000	"Cluster 27: Non-specific - Gene expression"	"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA048904: AB_2680552"	"unprognostic (9.46e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.31e-3)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (5.98e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.19e-2)"	"prognostic unfavorable (1.43e-4)"	15.4	11.2	10.1	11.7	11.6	9.2	11.1	11.7	14.0	12.2	2.1	12.8	8.7	12.2	13.1	10.7	12.0	8.2	12.5	11.8	16.0	10.8	15.5	12.0	9.0	8.3	9.5	14.1	10.6	16.3	10.0	24.0	11.3	13.2	14.1	51.9	10.7	11.0	19.9	11.6	9.1	18.9	5.1	9.7	11.0	13.1	12.4	9.4	14.0	14.3	10.5	11.7	9.8	8.8	41.1	36.5	40.3	105.4	63.6	49.3	78.3	65.1	60.8	88.3	86.8	38.4	92.5	36.5	84.1	100.6	57.1	45.4	56.7	73.0	102.1	31.0	29.6	44.0	46.3	45.5	46.2	56.9	50.7	52.7	46.4	104.6	86.2	82.2	75.6	31.2	55.1	53.7	69.1	23.5	23.3	27.9	24.4	47.2	33.9	34.4	49.7	64.2	35.8	18.8	49.6	33.9	71.5	37.0	54.6	47.2	40.5	35.3	67.3	79.5	51.7	61.2	75.2	29.7	67.0	46.3	75.4	73.5	108.4	5.2	12.7	3.1	8.1	9.6	9.0	6.2	8.1	9.2	12.6	7.0	8.0	8.0	0.5	21.7	12.8	6.1	6.2	9.1	10.1	11.6	11.7	14.0	11.8	16.0	8.3	9.5	11.3	5.1	12.4	8.8	13.0	16.0	14.6	8.1	12.4	11.6	10.1	16.9	8.0	20.3	11.2	11.7	15.7	11.5	10.5	22.0	10.4	40.4	9.9	11.4	0.0	14.3	1.2	10.0	18.0	16.1	19.7	6.9	12.9	8.5	41.0	19.2	9.7	15.0	8.2	23.2	14.3	25.6	19.4	15.2	14.5	11.4	14.2	12.3	7.3	2.6	14.9	11.5	10.6	8.4	12.0	19.0	4.1	15.1	10.9	10.6	9.4	14.3	14.5	10.3	6.4	9.0	7.8	63.4	6.6	20.1	13.5	12.9	19.3	13.0	9.2	36.0	8.9	18.6	12.7	6.7
ENO3		ENSG00000108515	"Enolase 3"	P13929	17	4948092-4957131	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	26	"skeletal muscle: 14758.3;tongue: 10771.0"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 582.2;Skeletal myocytes: 248.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 263.8;HeLa: 120.0;HMC-1: 115.1;RH-30: 170.2;RPMI-8226: 96.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000793, HPA068284, HPA068721"	Enhanced		Supported	"Plasma membrane,Cytosol"		Yes	No		86000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA000793: AB_1078742, HPA068284: , HPA068721: AB_2732119"	"unprognostic (7.35e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (7.33e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.50e-2)"	7.8	5.5	3.8	15.6	3.9	20.4	8.0	7.1	4.3	6.6	5.0	8.0	20.1	7.2	7.1	173.8	7.4	2.6	499.8	3.5	3.7	10.3	108.0	8.6	13.0	4.3	5.0	6.0	5.5	4.0	7.9	6.3	4.6	47.3	3.0	5.0	116.8	3.1	14758.3	8.3	15.6	2.8	4.1	16.9	10.1	9.3	4.3	5.8	10.3	10771.0	4.9	5.6	5.0	4.9	12.0	25.5	11.3	10.7	9.1	2.2	27.6	21.0	2.7	1.5	1.3	12.8	8.1	21.9	25.8	1.9	3.5	15.4	3.8	1.9	1.0	263.8	24.3	21.9	120.0	18.9	3.7	6.8	115.1	14.4	3.8	2.1	4.1	9.8	1.4	24.8	10.2	39.0	4.9	6.6	7.9	26.5	14.8	3.3	10.6	34.6	170.2	96.9	3.1	7.9	7.1	27.1	13.6	11.4	14.7	7.6	10.2	7.0	6.5	12.1	21.3	5.4	16.0	27.6	16.8	18.2	6.7	20.8	12.2	31.4	28.5	50.4	36.8	41.5	24.8	24.5	30.8	34.4	37.6	20.1	20.0	32.2	34.4	34.9	47.6	29.9	43.2	83.6	3.8	3.9	7.1	4.3	3.5	3.7	4.3	5.0	4.6	4.1	4.3	4.9	1.2	0.0	1.8	2.3	2.7	2.0	1.2	2.1	4.0	6.6	3.0	3.0	582.2	0.0	2.2	5.5	4.2	5.4	3.2	2.9	0.0	1.5	1.8	0.9	1.6	7.3	0.0	3.8	0.2	0.8	3.8	17.3	4.6	2.2	8.2	2.4	2.2	56.2	4.5	3.3	0.2	2.2	2.0	3.5	6.7	3.7	0.3	4.3	1.8	0.0	78.3	1.9	4.1	1.0	0.5	1.8	1.9	0.4	2.3	1.2	6.6	9.5	0.3	2.5	6.6	248.4	55.8	7.9	7.5	2.1	1.8	3.3	4.5	1.1	2.6	0.8
ENPP1	"M6S1, NPPS, PC-1, PCA1, PDNP1"	ENSG00000197594	"Ectonucleotide pyrophosphatase/phosphodiesterase 1"	P22413	6	131808016-131895155	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins"	Biomineralization	Hydrolase	"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 80.2;Fibroblasts: 56.9;Hepatocytes: 111.6;Peritubular cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 34.1;LHCN-M2: 21.1;U-138 MG: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032904, HPA062066"	Enhanced				"Secreted - unknown location"	NA	NA		4400000	"Cluster 48: NK-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB032904: AB_2099635, HPA062066: AB_2684674"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.22e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.28e-3)"	8.4	3.1	0.4	1.4	0.5	0.1	7.1	0.7	0.4	7.1	0.4	2.3	1.8	22.1	7.4	2.3	6.9	1.2	1.6	0.4	0.7	4.2	31.9	0.8	1.4	1.2	1.4	8.3	28.5	27.8	10.9	44.0	0.9	3.4	2.0	0.5	4.2	5.8	2.7	1.7	1.3	10.2	0.8	1.9	1.7	1.6	1.0	2.2	20.1	3.2	0.8	2.7	4.9	0.8	0.0	1.3	1.2	0.1	34.1	5.3	0.0	9.2	9.4	3.5	9.5	4.1	1.1	0.0	0.8	5.9	7.2	0.0	1.3	0.2	14.8	0.3	1.8	0.0	1.1	12.0	1.0	0.0	4.2	8.8	0.4	9.6	0.4	4.1	4.3	0.7	0.0	1.8	21.1	2.6	0.0	0.0	7.9	1.6	1.3	0.0	10.2	0.3	0.2	0.4	3.4	0.0	0.2	1.3	4.2	5.7	3.9	0.0	2.9	27.6	1.0	1.9	9.1	3.4	0.0	0.0	12.6	0.0	3.5	0.6	0.0	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.7	0.2	0.0	0.0	0.3	1.6	0.1	0.1	0.0	0.0	0.4	0.5	0.7	0.4	0.4	0.7	1.2	1.4	0.9	0.8	1.0	0.8	2.6	0.0	1.7	0.3	1.5	1.5	9.9	0.0	0.6	4.5	28.7	19.9	6.4	5.7	0.1	1.8	0.0	3.0	1.2	16.7	5.9	0.3	4.8	3.9	80.2	4.1	0.0	8.0	3.5	10.6	2.1	56.9	6.1	3.2	0.0	9.4	3.3	111.6	4.6	1.7	10.5	12.7	0.0	2.9	5.9	6.7	25.1	3.9	1.8	12.2	0.2	3.6	0.0	21.6	1.6	5.2	3.9	70.0	0.4	2.3	6.7	25.2	0.1	0.5	13.1	12.6	18.8	4.1	2.2	0.1	1.3	6.2	2.6	1.9	2.5	1.7
ENTPD1	"ATPDase, CD39, NTPDase-1, SPG64"	ENSG00000138185	"Ectonucleoside triphosphate diphosphohydrolase 1"	P49961	10	95711779-95877266	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		Hydrolase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.1;Kupffer cells: 110.4;Langerhans cells: 161.3;Microglial cells: 217.4;monocytes: 112.2;Plasma cells: 80.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 17.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 102.2"	"Group enriched"	"Detected in all"	4	"dendritic cells: 31.9;granulocytes: 102.2;monocytes: 41.0"	"Group enriched"	"Detected in many"	7	"HDLM-2: 147.5;Karpas-707: 135.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002494, HPA014067, CAB079986"	Enhanced		Uncertain	Microtubules		NA	NA		19000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Microtubules		"CAB002494: AB_563557, CAB079986: , HPA014067: AB_1848178"	"unprognostic (1.14e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.67e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.45e-3)"	"unprognostic (6.31e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (5.33e-5)"	"unprognostic (9.79e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (7.89e-4)"	"unprognostic (5.09e-2)"	11.8	8.3	5.9	24.7	5.5	27.5	10.8	5.0	6.3	17.5	5.0	14.3	9.3	28.0	19.3	19.2	14.0	27.7	8.5	5.3	6.3	7.6	5.4	16.1	20.2	7.1	6.5	5.5	2.8	3.4	3.9	11.4	7.7	11.2	12.8	6.8	6.0	18.1	4.0	6.3	11.7	49.7	6.2	21.5	7.3	4.5	7.5	6.8	20.0	8.7	25.6	30.6	11.0	6.3	1.4	2.7	5.4	7.1	0.1	0.1	5.0	4.5	1.2	0.0	0.0	4.0	1.6	8.2	3.1	0.0	5.3	2.2	0.0	0.0	0.0	147.5	5.2	7.2	4.0	4.3	0.0	12.5	4.1	0.1	0.0	0.6	0.0	2.4	18.2	2.0	5.3	135.4	0.1	4.4	4.7	5.8	5.9	3.6	2.8	15.3	2.4	4.4	1.7	2.2	5.1	6.2	3.6	3.7	3.9	3.6	5.5	5.9	3.9	3.9	2.8	3.8	5.3	21.6	7.2	0.6	4.3	13.9	2.7	0.7	41.0	102.2	0.6	27.2	1.1	13.7	1.6	1.1	31.9	11.4	0.6	0.6	49.4	1.5	6.7	2.1	13.1	15.5	5.9	5.5	5.0	6.3	5.3	6.3	7.1	6.5	7.7	6.2	7.5	6.3	19.6	0.0	1.1	74.1	40.9	8.9	0.3	0.0	0.6	1.4	0.8	1.5	10.1	0.0	0.7	1.8	2.1	0.6	3.7	0.3	1.9	0.0	10.3	0.6	3.6	60.6	0.0	4.4	2.8	2.0	1.9	15.7	6.1	0.6	3.8	0.3	31.4	0.8	26.6	0.0	5.2	0.1	0.0	110.4	161.3	7.3	0.6	62.1	16.0	217.4	112.2	0.4	0.0	20.6	5.0	0.2	1.2	3.0	80.1	0.5	0.1	0.3	0.8	0.8	6.6	1.0	22.7	10.1	4.4	0.8	11.2	15.7	26.9	15.1	1.0	0.5
EOGT	"AER61, C3orf64, FLJ33770"	ENSG00000163378	"EGF domain specific O-linked N-acetylglucosamine transferase"	Q5NDL2	3	68975217-69013684	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Peritubular cells: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 86.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019460	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA019460: AB_1844628"	"unprognostic (2.62e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.96e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.18e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (8.97e-5)"	"unprognostic (7.41e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-1)"	19.4	9.1	7.2	12.8	7.2	5.9	19.5	6.7	10.9	14.0	22.4	25.8	7.4	29.9	9.8	17.5	18.5	17.8	28.5	7.1	7.0	10.2	5.7	28.7	8.2	7.7	7.6	11.6	12.6	5.0	9.3	22.3	8.0	27.9	8.6	8.8	16.4	33.7	20.0	9.7	11.4	25.4	7.8	10.0	15.5	8.9	7.8	11.1	7.9	15.2	8.8	24.7	13.7	7.5	19.0	7.1	12.5	14.4	16.6	32.2	8.6	25.4	31.5	16.0	21.0	9.1	10.2	1.1	3.8	28.1	13.6	6.0	8.3	32.3	19.9	62.3	5.6	20.2	15.5	13.5	18.7	11.5	8.2	26.8	29.4	20.6	25.1	19.4	86.2	0.8	5.9	11.1	53.7	5.5	2.0	3.8	13.5	6.2	3.5	0.8	12.4	8.2	13.9	43.4	1.2	6.3	29.1	1.7	23.5	12.8	6.0	15.9	44.6	40.6	13.4	5.1	24.3	6.0	20.5	9.3	16.3	17.1	23.8	5.4	1.5	0.0	2.0	1.4	2.3	1.1	3.0	4.3	2.4	0.7	2.5	2.7	0.2	2.4	0.5	0.4	6.6	1.3	7.2	7.2	6.7	10.9	7.1	7.0	7.7	7.6	8.0	7.8	7.8	7.5	29.6	12.8	10.3	14.0	3.5	7.1	11.4	13.2	16.5	2.2	7.5	11.7	20.7	4.3	14.5	1.8	16.7	0.9	3.1	5.1	0.0	4.6	16.5	15.3	7.5	23.7	6.0	3.8	11.2	8.2	5.3	9.3	9.2	15.4	0.0	9.4	20.3	3.6	6.7	0.0	21.4	4.5	2.0	6.8	9.8	15.1	3.1	8.6	8.8	30.9	6.5	1.4	1.0	9.5	12.2	12.4	3.4	40.6	5.4	8.3	2.1	1.9	13.2	5.6	0.0	26.8	15.2	5.5	2.5	14.8	4.5	0.8	7.0	6.9	3.4	8.6
EP300	"KAT3B, p300"	ENSG00000100393	"E1A binding protein p300"	Q09472	22	41092592-41180077	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000146, HPA003128, HPA004112"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB000146: AB_2533138, HPA003128: AB_1078745, HPA004112: AB_1078746"	"unprognostic (7.67e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.54e-2)"	"prognostic favorable (7.45e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-2)"	15.7	13.7	6.8	17.7	8.9	65.1	14.2	20.5	10.8	16.0	6.1	16.6	13.6	17.2	13.5	16.3	16.4	14.2	11.5	7.1	9.4	13.1	15.5	14.7	17.6	10.6	7.8	23.9	18.0	23.2	13.4	19.3	7.7	15.0	14.5	17.8	15.0	15.6	20.4	18.9	16.0	16.4	5.3	17.0	14.5	19.6	8.6	27.2	20.2	23.4	17.9	15.4	14.8	11.2	31.6	21.7	35.4	23.0	22.2	23.3	32.3	15.0	21.8	21.0	21.0	27.8	12.0	32.7	12.2	28.4	18.7	24.1	48.1	20.8	23.5	30.5	32.2	24.4	25.4	22.3	26.9	59.3	26.5	24.8	22.2	30.0	27.0	19.3	24.9	18.7	26.3	43.9	18.3	12.5	16.2	18.9	27.5	38.3	15.2	33.7	16.7	21.3	20.3	40.4	11.3	11.9	51.1	26.0	25.6	29.5	17.8	33.9	31.3	20.3	24.8	16.3	20.8	28.5	14.1	47.9	16.3	17.4	21.5	3.6	1.7	1.6	1.6	1.9	1.5	2.2	1.7	1.7	2.1	1.4	1.4	1.1	4.9	2.7	1.0	1.6	1.4	1.2	6.8	8.9	20.5	10.8	7.1	9.4	10.6	7.8	7.7	5.3	8.6	11.2	45.4	67.3	49.2	58.1	53.8	24.6	22.9	11.6	40.9	44.6	35.1	25.8	31.6	38.6	15.8	25.8	35.5	18.4	63.2	37.0	3.9	16.1	15.3	55.1	56.4	36.2	24.7	60.4	71.8	18.7	17.9	32.0	27.5	72.5	25.3	36.1	32.9	29.2	18.4	25.2	73.6	24.2	2.0	60.7	25.7	6.4	28.9	60.5	8.8	45.9	52.0	27.7	40.2	81.4	80.3	25.8	28.9	30.5	51.2	30.8	20.2	10.8	22.8	30.9	26.3	47.6	36.7	22.8	31.2	35.3	25.9	30.2	46.0	36.7	23.7	36.3
EPB41	"4.1R, EL1"	ENSG00000159023	"Erythrocyte membrane protein band 4.1"	P11171	1	28887091-29120046	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"	"Actin-binding, Calmodulin-binding"	"Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 80.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 151.6;Cone photoreceptor cells: 137.6;Erythroid cells: 187.1;Rod photoreceptor cells: 171.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 42.2"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 136.3;K-562: 136.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"cerebellum: 105.6"	"HPA028076, HPA028096, HPA028412, HPA028414"	Supported		Supported	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No		1100000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cell Junctions"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366"	"unprognostic (2.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (5.00e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (5.01e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	11.0	10.2	1.8	21.9	18.3	63.3	14.1	42.2	6.0	14.5	4.9	23.6	17.7	10.2	5.3	16.6	6.3	15.0	9.7	1.2	4.7	12.7	21.7	15.1	37.4	8.2	5.6	16.3	18.8	15.5	4.7	7.2	8.5	15.0	23.1	80.0	19.1	9.1	15.9	15.3	23.3	9.9	3.5	22.9	27.0	10.4	4.7	69.0	15.2	13.8	37.0	15.5	1.9	3.0	27.0	6.9	62.3	29.4	5.2	0.8	19.5	6.9	10.1	8.4	10.5	16.8	31.2	49.1	17.2	9.2	13.5	11.9	78.7	6.6	8.6	86.4	23.8	136.3	19.7	28.6	10.1	45.8	88.2	1.7	18.4	8.2	13.8	19.9	14.1	73.5	136.5	36.2	0.1	8.8	72.3	30.4	62.0	44.1	10.0	110.9	28.2	68.3	7.7	33.3	78.0	60.5	19.7	19.2	43.3	21.7	14.7	18.2	1.2	0.3	13.3	12.9	13.4	52.5	72.4	85.2	12.1	47.8	6.8	33.3	3.2	21.4	12.9	1.1	15.4	17.2	18.3	14.1	4.4	13.6	22.1	12.7	44.2	10.9	1.5	4.4	28.9	15.3	1.8	18.3	42.2	6.0	1.2	4.7	8.2	5.6	8.5	3.5	4.7	3.0	25.3	19.2	71.7	20.2	58.2	10.5	8.6	7.8	15.4	151.6	20.0	12.2	21.5	20.0	16.8	16.5	137.6	2.4	75.3	26.5	17.6	17.1	16.4	11.3	4.1	15.1	41.6	187.1	76.3	18.7	4.2	7.9	29.6	29.1	24.1	24.9	17.5	30.0	7.1	21.9	61.7	29.0	16.2	23.7	9.0	22.7	2.1	32.4	0.0	78.7	29.3	15.7	85.5	7.5	4.8	28.6	20.3	2.2	46.7	12.2	32.8	13.4	15.2	171.4	13.1	2.8	8.5	39.3	55.7	14.9	16.8	4.1	71.6	4.2	33.0	12.6
EPHA3	"ETK, ETK1, HEK, HEK4, TYRO4"	ENSG00000044524	"EPH receptor A3"	P29320	3	89107621-89482134	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 31.5"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 70.6;Inhibitory neurons: 106.6;Microglial cells: 103.0;Oligodendrocytes: 48.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AF22: 197.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010462, HPA069390"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear membrane, Plasma membrane, Cytosol"	"Nucleoplasm, Actin filaments"	"CAB010462: AB_2099218, HPA069390: "	"unprognostic (1.48e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (3.28e-7)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.20e-2)"	5.4	1.0	2.1	1.8	1.3	0.0	2.3	0.2	3.8	12.3	0.1	3.8	2.3	5.5	0.2	3.2	1.3	18.8	8.2	2.2	0.7	1.3	4.9	2.4	3.6	3.3	0.9	4.1	2.1	1.0	0.9	20.1	4.0	31.5	6.2	8.0	2.2	7.1	0.8	0.7	2.4	7.9	0.8	0.9	2.5	1.0	1.7	1.0	11.0	6.3	3.2	14.3	6.4	2.2	0.0	0.0	197.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	11.2	0.2	0.7	0.0	2.4	0.0	0.0	11.8	0.0	0.0	1.7	2.0	0.0	3.9	0.0	0.0	0.6	0.0	2.5	0.1	0.3	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.1	0.0	0.5	0.1	0.1	36.1	0.1	0.0	0.0	1.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.3	0.2	3.8	2.2	0.7	3.3	0.9	4.0	0.8	1.7	2.2	2.2	0.0	0.0	5.5	0.0	0.5	0.3	0.0	0.6	6.4	0.0	0.1	2.4	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.5	1.8	0.0	0.0	70.6	0.0	0.1	18.1	0.5	0.0	0.0	0.0	1.1	0.0	0.1	20.2	106.6	0.0	0.0	0.0	0.7	1.6	2.1	0.1	0.0	103.0	0.0	4.7	0.0	2.5	48.0	0.0	0.0	8.2	0.0	0.1	0.0	0.0	0.0	18.7	6.6	0.7	19.2	0.1	0.0	0.3	0.3	0.5	0.2	1.3	0.0	0.1
EPHB2	"DRT, EPHT3, ERK, Hek5, Tyro5"	ENSG00000133216	"EPH receptor B2"	P29323	1	22710839-22921500	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.3"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 45.1;Enteroendocrine cells: 48.7;Intestinal goblet cells: 61.1;Oligodendrocytes: 76.3;Pancreatic endocrine cells: 63.7;Undifferentiated cells: 97.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 86.5;HUVEC TERT2: 74.2;TIME: 79.2;U-251 MG: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013647, HPA071200"	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	No	No		380000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 9: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Nucleoplasm	"CAB013647: , HPA071200: AB_2686360"	"unprognostic (2.47e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (4.98e-4)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.46e-2)"	3.1	1.6	2.1	9.2	3.7	0.5	1.6	4.1	4.2	2.5	0.0	22.6	21.0	1.8	1.9	0.6	4.4	3.7	3.3	2.2	4.3	3.8	0.4	1.8	2.9	5.7	4.5	10.6	3.9	6.1	2.9	4.0	4.8	1.9	23.3	2.9	1.5	3.0	0.2	0.9	21.8	3.3	5.0	2.4	1.7	1.8	5.4	1.2	7.3	0.3	1.7	4.4	1.0	8.2	43.4	17.2	17.2	27.7	1.6	1.5	0.0	10.0	0.5	27.3	5.7	6.3	16.6	0.6	20.2	4.0	86.5	39.6	10.8	52.8	7.7	0.1	4.1	0.0	1.9	0.1	16.5	0.0	4.3	5.3	17.5	48.7	0.3	25.4	74.2	2.4	1.8	0.1	5.7	6.4	1.1	0.3	4.0	49.0	11.2	5.3	18.0	0.8	14.7	4.0	18.0	19.3	17.4	0.7	0.2	1.5	1.1	0.5	79.2	11.5	29.6	29.4	69.5	0.0	0.2	0.1	21.8	0.9	0.5	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	3.7	4.1	4.2	2.2	4.3	5.7	4.5	4.8	5.0	5.4	8.2	0.4	3.2	0.0	5.5	0.3	0.8	1.7	20.5	0.0	15.4	0.1	0.1	1.3	7.2	8.6	0.0	0.0	0.5	0.1	24.3	0.0	45.1	2.6	1.0	0.8	1.2	48.7	0.0	34.1	8.0	2.8	5.0	1.1	2.4	0.0	0.5	0.4	0.4	9.6	6.7	32.3	61.1	6.1	7.6	1.4	0.8	0.9	7.2	0.0	21.5	0.7	18.4	0.0	5.5	76.3	63.7	12.6	0.7	0.3	2.3	5.5	0.2	1.7	1.8	0.0	0.6	2.1	0.5	3.5	0.0	0.4	1.1	0.3	0.2	97.2	1.1
EPHB4	"HTK, Tyro11"	ENSG00000196411	"EPH receptor B4"	P54760	7	100802565-100827523	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Angiogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 68.5;Hepatic stellate cells: 113.2;Syncytiotrophoblasts: 206.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 2.0;neutrophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB013537	Uncertain					NA	NA		1400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB013537: "	"prognostic unfavorable (8.56e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.33e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.51e-3)"	"unprognostic (6.63e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (8.84e-4)"	26.4	49.8	5.0	8.0	4.3	5.6	32.6	4.6	4.8	45.6	6.8	20.7	8.3	61.5	3.8	24.7	27.1	18.0	26.1	4.1	4.1	28.3	33.3	28.2	5.8	5.5	5.1	36.0	26.8	10.1	6.3	35.5	5.3	28.9	10.2	0.3	24.2	22.4	7.7	35.8	17.5	22.2	5.1	47.9	21.4	12.3	6.3	3.1	17.6	13.3	4.9	17.3	28.1	4.8	37.7	33.1	32.5	94.2	20.4	13.0	94.7	14.1	31.2	22.3	29.0	27.4	28.3	4.8	63.6	15.3	31.3	38.2	14.3	38.3	11.9	6.2	25.6	1.3	19.0	43.2	11.8	0.7	0.9	15.3	56.7	14.2	33.1	24.8	84.0	1.5	71.9	1.8	18.4	66.4	0.7	15.0	54.7	56.3	47.5	51.4	15.6	8.9	28.6	19.9	0.2	27.4	22.0	10.4	22.1	45.1	26.1	6.7	71.3	27.6	42.6	51.3	21.4	0.2	0.8	1.7	4.0	12.0	51.2	0.0	2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	4.3	0.0	0.1	0.1	0.0	0.7	5.0	4.3	4.6	4.8	4.1	4.1	5.5	5.1	5.3	5.1	6.3	4.8	47.1	9.6	12.6	1.6	1.9	20.5	10.3	13.9	15.9	0.1	22.0	19.7	5.7	7.2	8.5	5.5	0.0	68.5	1.1	9.1	0.0	12.3	28.5	4.8	21.8	51.2	3.0	10.8	0.3	6.6	11.2	6.5	12.8	8.0	1.3	10.7	113.2	22.4	9.0	0.0	0.2	17.4	8.2	4.1	3.4	9.9	8.1	1.3	3.6	1.9	1.5	1.7	0.0	0.0	1.0	20.6	7.6	4.1	1.4	13.3	1.3	4.0	4.2	0.2	6.6	5.7	6.3	1.4	10.2	12.1	17.8	206.5	1.2	2.9	19.9	8.0
EPHX1	EPHX	ENSG00000143819	"Epoxide hydrolase 1"	P07099	1	225810124-225845563	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Aromatic hydrocarbons catabolism, Detoxification"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 1178.6;liver: 1705.1"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 349.9;Hepatocytes: 757.6;Theca cells: 1042.6"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 1047.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"ASC diff: 1161.8;SiHa: 413.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020593, HPA048847"	Enhanced					NA	NA		160000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"HPA020593: AB_10601373, HPA048847: AB_2680538"	"unprognostic (2.85e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (7.02e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (8.10e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.88e-2)"	245.8	1178.6	233.5	23.6	252.5	22.7	163.7	239.0	249.3	188.3	345.8	82.0	102.2	108.1	97.6	159.6	153.8	96.5	94.0	221.3	233.7	110.7	1705.1	146.8	39.1	225.3	234.9	329.1	536.1	147.7	105.8	32.9	223.6	113.2	52.5	30.7	143.6	128.1	142.5	71.5	52.8	109.6	210.1	55.7	99.9	74.3	258.4	25.9	171.1	95.6	33.4	135.4	140.4	227.2	32.1	202.3	12.3	108.5	1161.8	120.2	24.3	29.7	49.2	28.1	35.1	38.8	293.6	1.3	128.7	147.3	30.6	38.1	32.7	16.8	12.1	7.8	46.5	21.8	83.5	282.7	129.8	12.9	15.1	109.2	40.0	74.6	6.3	116.5	22.1	13.4	14.5	27.3	50.4	30.3	13.5	31.0	61.6	178.1	79.4	27.8	15.2	92.9	91.1	132.5	98.3	13.0	413.0	192.1	51.3	32.1	131.7	43.5	46.8	41.9	35.4	54.5	59.0	9.1	38.9	4.1	63.5	14.2	59.5	0.0	2.6	0.1	0.2	0.7	0.4	0.1	0.3	0.2	0.6	0.2	0.5	0.3	0.2	0.7	0.3	0.9	0.3	0.8	233.5	252.5	239.0	249.3	221.3	233.7	225.3	234.9	223.6	210.1	258.4	227.2	196.9	0.0	14.0	41.1	5.7	19.6	121.8	244.2	74.0	8.8	29.7	27.4	1.2	102.9	255.5	51.5	29.2	46.6	3.4	34.5	17.6	95.3	10.2	142.9	32.2	82.7	10.8	7.0	3.1	73.0	7.6	175.6	30.5	93.4	5.7	349.9	88.2	757.6	149.1	1.7	5.0	17.5	103.7	30.9	28.7	28.4	311.3	25.8	42.7	23.4	9.6	99.2	0.0	7.1	19.4	45.5	27.2	159.1	9.5	40.4	63.4	128.9	174.3	10.1	223.5	29.3	146.9	4.4	5.1	129.0	17.6	22.8	4.7	1042.6	31.5	108.5
EPM2A	"LD, LDE"	ENSG00000112425	"EPM2A glucan phosphatase, laforin"	O95278	6	145382535-145736023	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease variant, Epilepsy, Glycogen storage disease, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.8;tongue: 79.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.9;Early spermatids: 33.0;Excitatory neurons: 30.4;Inhibitory neurons: 50.7;Oligodendrocyte precursor cells: 56.8;Oligodendrocytes: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.2"	"Low region specificity"	"Detected in all"							"HPA053643, HPA055468"			Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA053643: AB_2797247, HPA055468: AB_2797252"	"unprognostic (2.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-4)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.08e-7)"	"unprognostic (4.12e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.23e-1)"	5.8	6.0	11.4	1.5	11.7	1.8	3.2	11.9	17.8	3.1	7.3	17.2	3.2	6.0	4.3	9.3	4.4	3.6	24.4	11.6	12.6	8.5	5.7	3.0	3.3	11.9	11.5	5.7	2.4	5.2	3.8	1.5	11.1	6.1	2.9	12.1	3.1	8.8	76.8	2.1	3.8	6.3	10.3	2.1	5.3	3.0	11.5	4.8	3.9	79.5	2.6	9.8	2.7	13.3	1.3	2.1	3.4	6.6	8.6	2.3	1.6	3.1	3.8	2.9	3.5	1.7	1.7	23.2	2.7	3.8	3.5	1.8	1.3	1.6	2.6	9.3	1.9	3.6	2.5	2.7	4.8	12.7	2.4	2.0	7.0	1.7	0.7	3.8	2.0	5.0	1.8	5.4	3.8	3.1	8.4	3.2	3.9	3.2	1.9	4.8	3.1	6.7	2.5	1.8	6.3	6.4	5.5	3.3	7.8	3.1	1.9	7.3	4.6	2.9	1.1	2.7	2.6	4.1	4.6	8.6	2.6	2.8	4.8	0.0	0.0	0.0	0.1	0.5	0.4	0.4	0.4	0.3	0.3	0.4	0.4	0.9	0.1	1.9	0.1	0.3	0.0	0.3	11.4	11.7	11.9	17.8	11.6	12.6	11.9	11.5	11.1	10.3	11.5	13.3	3.9	6.4	1.5	66.9	4.4	0.9	1.0	0.8	0.6	8.4	3.5	2.2	27.8	2.8	2.2	1.8	6.2	1.0	1.9	0.2	11.7	1.0	33.0	1.9	3.6	2.2	1.2	4.4	30.4	2.3	0.7	2.3	1.1	1.4	2.5	6.0	1.4	6.6	2.3	30.3	50.7	1.5	2.0	3.3	1.4	19.8	3.1	3.1	7.2	15.9	1.7	7.9	2.1	56.8	60.1	1.2	1.7	2.2	1.7	1.5	0.5	7.1	2.2	6.3	0.0	6.2	2.4	4.9	1.6	0.8	0.4	0.4	1.8	5.1	1.2	0.3
EPRS1	"EARS, EPRS, GLUPRORS, PARS, QARS, QPRS"	ENSG00000136628	"Glutamyl-prolyl-tRNA synthetase 1"	P07814	1	219968600-220046530	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Aminoacyl-tRNA synthetase, Ligase, Multifunctional enzyme, RNA-binding"	"Disease variant, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.3;Cardiomyocytes: 84.7;Cytotrophoblasts: 40.8;Extravillous trophoblasts: 59.3;Hofbauer cells: 42.6;Syncytiotrophoblasts: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026490, HPA030052"	Enhanced		Enhanced	Cytosol		NA	NA		360000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA026490: AB_1855979, HPA030052: AB_10601466"	"prognostic unfavorable (7.25e-4)"	"unprognostic (1.19e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.13e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.62e-4)"	28.8	24.7	18.1	34.4	19.6	26.6	35.7	22.8	24.8	30.5	17.6	36.1	27.7	25.6	25.2	30.6	26.2	20.6	31.8	17.7	21.8	31.6	27.9	24.3	36.5	21.6	20.5	34.7	49.0	54.5	22.5	23.8	22.9	23.6	39.0	43.8	83.4	26.4	52.2	28.9	29.7	32.5	22.4	27.4	35.9	20.5	21.7	34.8	43.0	55.9	42.5	30.4	18.6	27.8	125.9	78.4	55.7	152.3	114.9	126.7	138.0	160.1	111.7	102.1	113.4	93.3	98.1	239.3	86.7	170.4	41.3	130.3	140.9	129.4	136.2	117.9	88.9	130.2	97.6	80.2	125.1	217.6	106.7	92.1	161.7	130.3	161.6	84.8	113.4	113.2	228.0	182.9	100.8	61.8	94.7	53.1	107.4	146.8	159.6	98.5	98.0	236.2	92.8	54.4	128.6	101.3	93.7	152.6	166.5	78.9	141.2	235.1	101.1	48.3	88.1	149.6	151.1	122.8	150.1	197.1	111.4	153.9	156.4	8.8	17.8	10.0	19.7	24.6	27.8	21.0	19.7	22.1	23.2	18.5	22.0	22.9	0.6	22.5	22.1	7.6	20.8	17.2	18.1	19.6	22.8	24.8	17.7	21.8	21.6	20.5	22.9	22.4	21.7	27.8	22.3	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.7	0.0	0.0	0.0	0.0	40.8	14.1	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	59.3	17.1	0.0	0.0	0.0	0.0	0.0	0.0	42.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	36.5	2.6	0.0	0.0	0.0
EPX	"EPO, EPP, EPX-PEN"	ENSG00000121053	"Eosinophil peroxidase"	P11678	17	58192726-58205174	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"bone marrow: 33.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.5;Inhibitory neurons: 1.2;Microglial cells: 1.0;Oligodendrocyte precursor cells: 2.0;Oligodendrocytes: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	23	"eosinophil: 2.2"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.2"	"Cell line enriched"	"Detected in some"	68	"NB-4: 248.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA076792	Enhanced					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA076792: "	"unprognostic (5.67e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.36e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.34e-3)"	"unprognostic (4.83e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.71e-4)"	"unprognostic (7.38e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.73e-1)"	0.0	0.1	0.0	0.2	0.2	33.7	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.4	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.3	0.0	0.1	0.5	0.1	0.0	0.0	1.3	0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	3.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.2	248.2	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.1	0.2	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ERBB3	"HER3, LCCS2"	ENSG00000065361	"Erb-b2 receptor tyrosine kinase 3"	P21860	12	56076799-56103505	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 254.3;Oligodendrocytes: 187.0;Paneth cells: 184.6;Proximal enterocytes: 240.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 2.4;neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 116.4;OE19: 119.1;RT4: 89.7;SK-BR-3: 106.5;SK-MEL-30: 149.5;T-47d: 122.2;WM-115: 153.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025331, HPA045396, HPA070524"	Approved		Supported	"Plasma membrane,Actin filaments"	"Secreted - unknown location"	NA	NA		450000	"Cluster 17: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Actin filaments"	"CAB025331: , HPA045396: AB_2679312, HPA070524: "	"unprognostic (2.97e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.31e-3)"	"unprognostic (2.66e-2)"	"unprognostic (9.89e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.76e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.07e-2)"	2.4	2.6	34.4	8.0	69.2	0.9	56.5	45.9	62.0	20.9	10.9	62.9	88.5	5.5	12.3	82.0	12.1	30.6	9.0	39.2	43.1	36.2	98.6	29.3	0.6	59.4	54.4	1.6	57.0	23.8	2.4	13.0	54.7	37.8	64.1	1.3	83.0	18.2	2.4	75.7	82.5	3.8	36.2	0.6	74.7	2.3	55.9	1.0	9.4	1.7	12.5	21.8	44.2	104.9	39.8	2.1	3.2	1.4	0.2	0.1	63.2	3.9	7.2	4.5	4.1	20.4	70.4	0.2	0.8	1.0	0.6	32.2	5.0	7.7	2.3	0.7	3.0	0.1	1.1	116.4	0.1	0.1	0.5	1.3	9.3	0.7	0.3	0.7	0.1	0.8	2.6	1.0	0.4	71.6	0.4	1.3	10.4	119.1	1.9	0.4	7.4	2.1	7.9	89.7	3.3	1.3	2.6	106.5	149.5	9.1	122.2	0.7	0.3	0.5	4.0	1.9	0.5	0.9	0.6	0.6	0.4	0.3	153.4	2.4	0.1	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.4	1.0	0.4	0.2	0.2	0.3	0.1	34.4	69.2	45.9	62.0	39.2	43.1	59.4	54.4	54.7	36.2	55.9	104.9	0.8	118.6	81.0	1.0	1.5	18.2	15.3	21.6	19.4	1.5	106.4	47.8	1.9	171.6	74.6	35.0	2.1	52.6	2.0	254.3	1.9	60.1	1.3	36.1	10.9	2.7	93.1	2.7	0.7	88.1	84.6	4.5	96.4	95.9	1.3	0.7	5.0	112.0	6.1	0.0	2.0	145.2	40.7	1.9	3.7	0.5	1.5	1.5	55.2	1.0	1.7	7.7	0.0	49.8	187.0	94.8	184.6	0.0	0.3	103.3	240.2	30.0	54.8	1.1	6.6	4.5	3.4	9.5	13.4	87.7	36.9	100.6	2.5	0.1	136.9	135.4
ERCC2	"EM9, MAG, MGC102762, MGC126218, MGC126219, XPD"	ENSG00000104884	"ERCC excision repair 2, TFIIH core complex helicase subunit"	P18074	19	45349837-45370918	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Chromosome partition, DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 34.1;Spermatocytes: 30.5;Theca cells: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005375, HPA038057, HPA069266"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 43: Testis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Cytosol	"CAB005375: AB_2100152, HPA038057: AB_2675810, HPA069266: AB_2686104"	"unprognostic (1.10e-1)"	"unprognostic (5.48e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.47e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.45e-2)"	6.8	13.0	10.5	6.9	10.3	4.8	6.5	8.4	11.7	7.5	8.4	7.5	4.9	9.7	3.2	6.3	8.0	4.1	7.0	10.8	9.3	7.6	9.0	5.8	5.8	10.6	9.9	7.8	7.7	7.7	9.7	4.5	9.6	6.7	4.0	3.1	7.3	6.7	11.7	7.2	6.6	6.9	8.1	8.1	7.5	13.9	10.1	5.3	8.4	6.3	5.2	7.5	5.9	8.9	28.0	13.3	27.1	38.4	16.3	19.4	15.2	38.8	27.4	50.2	40.2	32.6	18.6	10.0	21.6	39.9	19.1	14.0	19.1	32.9	18.5	24.4	31.8	16.9	26.8	35.4	33.3	27.1	28.4	22.4	5.6	55.8	31.9	28.2	29.1	28.8	41.8	10.9	34.8	14.7	16.1	17.9	12.7	27.2	24.6	30.3	19.4	8.3	14.0	24.9	15.8	17.1	34.2	23.9	13.6	20.6	22.8	35.4	37.9	46.4	25.3	19.9	88.0	24.9	15.8	14.2	13.8	16.4	21.2	0.0	17.2	6.5	9.1	18.0	11.9	9.1	8.9	8.9	21.8	6.5	8.2	8.7	0.5	15.6	14.9	10.4	9.8	12.1	10.5	10.3	8.4	11.7	10.8	9.3	10.6	9.9	9.6	8.1	10.1	8.9	4.2	6.4	3.4	6.2	5.8	6.2	5.5	8.6	4.6	0.0	6.1	4.3	6.7	8.6	8.7	5.5	0.0	10.5	4.1	5.9	13.7	10.7	4.7	3.3	4.5	5.5	7.2	5.5	2.9	8.2	12.1	6.8	6.1	3.8	0.0	34.1	7.9	12.3	11.5	0.0	3.1	8.5	4.1	8.2	4.2	2.8	6.5	6.3	3.6	1.0	4.2	0.0	5.2	5.0	1.4	8.1	3.1	7.9	7.5	4.2	4.1	13.0	7.5	0.0	0.0	3.5	9.9	30.5	13.1	5.1	5.7	4.8	4.7	29.1	8.8	3.2
ERCC3	"BTF2, RAD25, XPB"	ENSG00000163161	"ERCC excision repair 3, TFIIH core complex helicase subunit"	P19447	2	127257290-127294166	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037153, HPA046077"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"CAB037153: AB_796181, HPA046077: AB_2679527"	"unprognostic (2.31e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.85e-2)"	"prognostic unfavorable (1.62e-7)"	"unprognostic (2.74e-1)"	"unprognostic (9.13e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (4.30e-6)"	"unprognostic (3.71e-1)"	"unprognostic (8.50e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.92e-2)"	24.4	25.9	15.0	14.5	16.0	19.8	24.4	15.1	16.5	32.2	19.6	28.9	9.6	27.0	11.6	22.7	28.9	14.2	23.4	16.6	14.9	22.8	22.2	22.1	21.6	15.7	14.8	29.5	23.8	26.3	33.8	13.6	16.0	27.4	13.8	4.4	23.2	16.8	35.3	27.7	24.3	21.5	15.1	32.6	23.7	29.8	15.6	26.6	25.0	25.6	22.4	27.2	26.4	15.2	45.9	30.8	37.8	40.6	40.6	27.8	46.4	41.3	52.9	65.1	62.5	48.1	32.9	34.5	33.2	37.8	41.7	40.2	57.7	43.3	56.1	54.4	51.4	43.6	35.8	51.0	30.5	38.1	45.4	28.9	39.8	75.7	32.4	41.5	42.4	44.3	43.0	22.1	41.7	45.1	54.8	42.2	55.0	29.2	47.3	44.5	42.7	28.8	36.4	42.2	45.2	49.2	35.3	52.6	55.0	42.4	28.7	43.0	34.1	39.2	45.2	35.8	49.7	39.2	81.5	54.0	34.3	18.0	42.8	8.0	11.5	8.8	18.2	12.0	18.4	13.7	13.1	15.7	16.9	12.7	17.7	12.2	3.5	25.0	9.9	13.6	20.5	15.5	15.0	16.0	15.1	16.5	16.6	14.9	15.7	14.8	16.0	15.1	15.6	15.2	12.2	22.4	14.6	24.8	17.7	7.6	9.5	20.6	21.1	0.0	13.0	11.6	13.0	5.7	25.4	7.3	0.0	18.6	18.9	6.1	1.9	13.7	9.0	22.9	13.9	12.2	6.1	3.8	22.3	14.9	12.2	16.6	18.8	13.1	10.1	17.1	15.4	8.6	14.6	0.0	23.5	10.0	14.2	12.5	7.6	5.1	16.4	10.7	8.8	10.3	12.3	0.0	14.4	18.1	22.4	15.5	7.3	12.8	16.4	7.4	6.3	8.5	45.2	0.0	13.1	17.6	13.3	41.1	31.0	11.3	9.5	14.6	15.7	12.3	10.6	8.5
ERLIN1	"C10orf69, Erlin-1, KE04, SPFH1, SPG62"	ENSG00000107566	"ER lipid raft associated 1"	O75477	10	100150094-100186033	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 114.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA011252	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Endoplasmic reticulum"		"HPA011252: AB_1853965"	"unprognostic (3.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (1.26e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.99e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.10e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.93e-1)"	29.4	14.2	8.6	21.4	10.5	76.2	21.4	9.5	10.1	27.5	10.3	37.0	40.4	21.8	17.6	32.8	31.6	16.3	11.0	9.6	9.4	27.2	114.1	19.1	14.5	8.6	8.2	30.4	19.2	19.4	5.4	42.2	9.0	17.7	38.2	10.8	15.1	16.4	8.6	22.5	30.2	22.4	8.8	16.6	36.8	28.0	9.0	15.6	26.2	13.6	21.2	28.6	19.1	9.7	97.4	95.3	46.9	86.3	113.5	107.9	96.8	148.7	138.3	120.2	137.5	64.0	109.9	42.6	59.7	139.9	100.5	98.5	42.6	90.0	164.1	26.1	38.8	36.7	38.5	83.5	47.6	128.4	39.4	62.6	53.6	105.8	129.2	114.9	90.1	43.5	36.8	25.2	130.2	40.7	33.5	65.9	33.8	66.2	40.4	28.3	77.2	31.6	53.9	37.6	19.1	31.1	85.6	23.6	56.0	53.8	59.3	109.0	101.7	118.7	92.4	72.4	160.8	19.6	35.2	57.1	105.6	204.8	60.6	8.1	20.4	24.4	10.5	15.1	9.3	7.4	7.9	8.6	16.3	6.7	8.1	10.9	15.0	9.9	11.9	4.1	5.6	9.7	8.6	10.5	9.5	10.1	9.6	9.4	8.6	8.2	9.0	8.8	9.0	9.7	28.2	0.0	11.5	5.2	6.4	15.8	11.3	16.1	12.5	4.6	13.4	12.3	4.8	5.7	14.6	14.7	6.2	20.6	6.4	31.5	0.0	9.9	28.9	16.3	19.5	18.8	13.2	19.1	16.2	10.9	62.7	17.1	20.4	20.9	8.2	19.7	13.6	77.6	14.3	3.3	14.8	27.5	0.0	14.4	7.2	12.9	15.2	12.9	10.6	12.2	13.3	5.9	6.2	15.6	21.0	9.5	19.8	7.9	4.7	12.7	25.6	12.6	30.2	6.2	0.0	14.3	11.8	50.9	15.4	20.6	20.3	24.8	6.6	19.6	27.6	15.6
ERLIN2	"C8orf2, Erlin-2, NET32, SPFH2, SPG18"	ENSG00000147475	"ER lipid raft associated 2"	O94905	8	37736601-37758422	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002025, CAB014894"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum"		"CAB014894: , HPA002025: AB_1080077"	"unprognostic (5.82e-3)"	"unprognostic (2.45e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (3.39e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.67e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.78e-3)"	"prognostic favorable (6.67e-6)"	"unprognostic (4.78e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.33e-1)"	20.3	17.8	15.7	14.6	17.3	14.4	25.0	16.5	16.8	20.0	27.2	24.2	17.7	21.2	32.3	17.9	30.1	19.8	17.8	14.2	16.3	40.4	40.8	15.5	11.5	18.0	18.5	30.8	26.2	41.4	8.3	21.2	17.7	25.4	25.0	21.6	29.4	23.8	18.9	15.3	23.6	19.5	17.9	14.6	24.9	17.0	15.6	14.7	46.5	14.1	12.6	16.8	10.3	18.6	39.0	38.5	43.0	31.4	47.3	33.9	47.2	59.1	51.9	31.8	33.2	20.1	50.8	18.9	95.8	63.4	30.3	41.4	31.2	48.4	46.8	11.2	24.2	27.8	22.7	22.7	31.5	17.8	34.1	43.3	49.1	46.3	48.1	39.6	30.7	17.2	51.1	17.7	47.4	18.3	25.8	14.7	45.9	53.8	17.7	17.9	29.9	15.2	42.8	41.9	7.7	20.7	39.3	12.6	35.6	50.1	62.0	27.1	31.1	30.9	26.4	56.8	31.1	24.3	41.0	24.2	55.0	28.4	40.7	1.3	6.5	13.4	4.4	7.0	3.6	4.5	2.7	3.5	5.4	2.3	4.1	3.8	6.1	2.5	9.6	7.6	5.5	3.1	15.7	17.3	16.5	16.8	14.2	16.3	18.0	18.5	17.7	17.9	15.6	18.6	14.7	12.8	14.3	21.5	7.1	9.7	10.0	18.5	13.1	25.2	24.9	20.7	30.2	25.8	22.8	33.1	20.9	17.9	6.0	19.0	9.8	23.8	21.3	31.3	18.5	13.6	11.4	8.0	3.7	22.1	27.0	18.8	17.3	27.8	3.8	14.4	17.5	41.0	20.6	16.8	6.4	24.3	20.3	23.9	6.6	16.8	11.8	16.1	14.2	7.5	12.3	23.5	5.2	11.6	16.7	18.8	17.4	17.7	16.8	15.2	25.4	19.8	47.6	18.7	19.7	19.1	14.8	47.4	18.5	21.9	7.4	15.7	7.1	12.9	25.4	12.8
ETHE1	"HSCO, YF13H12"	ENSG00000105755	"ETHE1 persulfide dioxygenase"	O95571	19	43506719-43527230	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 256.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1037.7;Paneth cells: 788.4;Proximal enterocytes: 376.3;Undifferentiated cells: 447.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 222.6;OE19: 360.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028360, HPA029028, HPA029029"	Enhanced		Enhanced	Mitochondria		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA028360: AB_10599297, HPA029028: AB_10602092, HPA029029: AB_10601998"	"unprognostic (8.04e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (7.75e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.72e-3)"	"unprognostic (2.73e-2)"	24.4	27.9	16.1	34.8	17.0	45.8	26.7	16.5	17.3	28.7	15.8	256.1	85.5	18.3	29.8	81.0	20.6	21.0	18.8	15.6	17.4	40.4	52.7	30.5	23.4	17.3	17.2	13.5	28.9	16.1	19.1	26.3	16.6	27.1	226.6	3.2	40.1	18.5	22.8	27.2	77.0	35.6	17.1	27.8	37.8	3.0	18.2	19.8	24.1	21.9	41.7	34.4	39.1	17.2	54.1	68.9	14.1	49.6	75.1	50.9	5.5	82.1	222.6	69.8	71.1	21.1	54.3	0.2	60.0	79.8	22.2	42.9	20.6	123.4	19.6	26.2	6.2	13.8	29.7	59.2	34.0	19.3	18.4	52.2	95.1	26.9	76.0	92.2	52.0	49.8	9.0	87.6	35.1	35.7	22.2	18.9	3.8	360.5	32.9	26.6	6.1	12.0	153.0	110.9	0.2	16.6	20.8	74.8	50.6	23.6	22.4	34.3	41.6	10.9	46.9	13.1	15.3	23.1	20.2	1.4	48.4	83.8	57.7	24.2	63.3	1.6	41.1	34.5	48.3	20.5	47.6	39.4	95.8	7.5	36.4	35.0	2.1	29.3	22.8	17.9	50.4	40.2	16.1	17.0	16.5	17.3	15.6	17.4	17.3	17.2	16.6	17.1	18.2	17.2	32.0	22.4	23.4	3.9	25.5	34.5	82.2	242.5	57.5	9.8	85.8	95.2	9.8	47.1	84.5	55.2	0.0	191.6	38.0	1037.7	54.8	71.7	0.9	31.0	41.2	44.9	63.7	17.4	6.2	63.6	95.7	42.1	53.5	68.2	38.0	12.6	42.1	89.2	115.1	5.0	6.8	324.2	79.3	105.0	78.5	2.1	17.7	74.6	80.0	3.7	78.5	11.7	63.8	4.0	5.6	102.7	788.4	16.1	34.9	75.0	376.3	136.4	23.1	5.8	19.7	32.0	45.1	2.1	6.2	82.8	23.2	92.5	50.4	15.8	447.5	146.5
EXT1	"LGCR, LGS, ttv"	ENSG00000182197	"Exostosin glycosyltransferase 1"	Q16394	8	117794490-118111826	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease variant, Hereditary multiple exostoses, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 229.6;Inhibitory neurons: 421.4;Microglial cells: 144.3;Oligodendrocyte precursor cells: 162.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 95.5;fHDF/TERT166: 82.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044394	Uncertain					NA	Yes		17000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA044394: AB_10963838"	"unprognostic (1.29e-2)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.19e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.70e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.31e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.27e-2)"	"unprognostic (9.84e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.85e-1)"	5.1	4.2	2.0	5.2	2.5	1.1	4.3	2.3	2.3	7.6	3.9	7.7	14.1	4.9	2.9	5.5	3.8	5.8	7.0	3.4	1.3	3.8	13.3	7.9	3.0	1.1	2.1	5.0	5.5	3.3	1.8	11.1	1.0	5.0	8.2	2.7	3.2	7.7	1.5	7.8	11.7	6.1	1.4	5.1	5.3	2.4	1.2	3.0	5.2	2.4	3.8	11.8	4.2	1.9	29.3	8.5	13.5	5.5	22.8	23.0	5.9	51.5	95.5	40.9	39.4	10.0	3.1	0.5	24.8	82.1	24.0	19.8	5.0	31.4	55.7	12.5	9.9	1.5	5.9	6.5	10.0	0.0	1.6	10.8	10.8	38.8	38.5	47.7	28.1	2.9	0.9	7.4	18.7	3.2	1.8	0.2	4.6	13.7	10.1	0.0	4.1	1.3	23.1	7.6	4.5	4.0	8.0	3.9	9.2	32.6	5.3	0.5	32.0	35.2	28.7	32.0	15.8	5.5	5.1	2.4	36.5	0.0	9.2	0.1	0.4	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.4	0.2	0.3	0.1	2.0	2.5	2.3	2.3	3.4	1.3	1.1	2.1	1.0	1.4	1.2	1.9	21.1	19.2	6.0	127.3	3.0	54.8	23.0	27.7	10.2	23.6	7.8	10.8	6.5	24.3	13.7	7.3	14.6	6.5	5.1	49.2	0.0	37.3	1.8	17.7	37.1	25.9	4.8	1.7	229.6	20.1	3.9	32.6	11.7	18.2	7.0	108.3	16.8	32.9	2.5	10.1	421.4	25.5	4.1	37.9	13.9	2.7	17.4	9.6	19.6	144.3	8.1	5.9	4.1	162.8	101.8	27.4	16.1	36.1	5.3	19.3	44.9	4.9	14.2	22.4	0.0	17.1	36.4	0.6	5.1	12.6	47.3	12.2	4.2	35.0	26.3	26.8
EXT2	SOTV	ENSG00000151348	"Exostosin glycosyltransferase 2"	Q93063	11	44095673-44251962	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease variant, Epilepsy, Hereditary multiple exostoses, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078409			Supported	"Golgi apparatus"		NA	NA		39000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA078409: AB_2686884"	"unprognostic (5.87e-2)"	"unprognostic (3.05e-3)"	"unprognostic (3.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.77e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (5.36e-6)"	"unprognostic (7.07e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.36e-2)"	33.5	22.8	14.4	22.1	15.4	11.2	29.3	15.4	16.3	36.1	17.5	29.1	26.5	43.1	33.3	20.1	33.7	28.1	27.3	15.6	18.1	26.5	26.9	27.9	16.0	15.5	16.0	33.5	26.5	28.9	20.1	61.9	15.5	29.8	28.7	20.9	26.7	30.2	16.2	25.8	31.0	49.3	14.7	21.6	23.8	21.6	19.4	15.2	27.6	18.4	17.3	29.7	28.5	16.1	57.9	71.6	38.3	121.5	170.4	124.2	60.8	181.1	198.0	93.1	125.1	51.2	36.5	40.4	82.1	188.8	98.5	90.0	41.0	114.0	110.0	83.2	71.5	38.4	33.7	39.7	67.5	37.5	76.6	97.7	73.4	56.3	86.6	108.8	132.7	34.8	50.0	63.9	68.4	40.3	25.9	22.3	43.8	67.1	70.9	32.3	116.1	21.1	53.9	49.1	30.9	35.5	118.1	41.4	28.1	67.0	69.8	37.2	137.8	127.4	90.6	133.1	111.4	33.4	46.0	30.4	84.7	27.9	140.0	15.2	17.5	19.4	20.9	17.7	23.5	9.0	16.5	19.3	21.3	8.8	15.4	15.2	3.4	26.3	12.8	7.4	14.2	15.5	14.4	15.4	15.4	16.3	15.6	18.1	15.5	16.0	15.5	14.7	19.4	16.1	24.5	16.0	10.6	41.4	8.7	15.2	17.3	22.0	10.8	11.5	11.0	11.4	10.2	8.6	13.5	12.9	14.6	34.3	10.6	21.1	5.9	33.5	43.2	7.9	17.1	19.2	1.8	6.7	64.3	23.7	37.0	32.3	7.7	11.5	6.3	22.7	22.9	18.3	18.3	13.5	63.3	12.9	12.2	10.8	7.2	23.0	27.4	10.4	5.4	28.1	10.2	17.4	7.2	50.3	51.8	24.0	14.9	28.6	7.0	23.6	31.6	8.2	8.1	15.0	19.7	15.8	20.7	51.2	24.4	10.2	12.6	35.3	9.2	12.2	15.0	15.3
EXTL3	"botv, REGR"	ENSG00000012232	"Exostosin like glycosyltransferase 3"	O43909	8	28600469-28755599	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025387	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 38: Heart - Muscle contraction"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"CAB025387: "	"unprognostic (1.35e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.19e-3)"	"unprognostic (9.83e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (4.25e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.19e-3)"	"prognostic favorable (2.47e-5)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.39e-2)"	10.8	16.5	11.3	7.2	12.0	3.8	6.3	7.6	13.7	8.9	5.8	11.1	5.5	13.8	5.4	12.3	11.3	7.9	31.1	14.7	10.4	7.0	6.2	8.6	5.4	10.7	14.3	10.0	11.9	18.9	10.3	13.8	7.2	8.5	5.4	11.2	8.1	11.8	20.8	11.1	6.7	17.9	8.9	8.6	9.0	10.3	23.4	6.4	7.7	22.7	4.8	10.6	7.2	12.7	45.3	33.6	70.1	37.0	18.8	18.5	15.6	33.7	32.6	20.3	16.4	28.9	15.9	12.2	46.6	40.1	28.2	29.7	34.5	55.1	22.4	8.9	18.9	17.2	15.7	14.3	9.8	8.6	46.9	22.2	36.7	15.9	14.6	16.9	44.3	17.4	16.2	15.4	16.5	8.5	15.5	4.7	49.2	13.3	13.6	18.4	31.3	7.1	31.2	29.0	15.2	26.6	14.3	8.6	17.3	22.0	8.4	9.4	34.9	26.6	62.7	25.4	28.9	7.9	17.9	13.5	22.5	10.3	23.7	3.0	1.3	2.0	1.7	0.9	0.8	0.3	0.7	0.9	1.3	0.4	0.5	0.4	5.7	0.5	1.4	1.1	0.3	0.8	11.3	12.0	7.6	13.7	14.7	10.4	10.7	14.3	7.2	8.9	23.4	12.7	6.3	3.2	4.4	10.4	2.4	5.0	2.9	8.7	6.8	17.5	4.8	4.2	26.8	7.2	5.0	1.8	25.0	3.7	7.1	4.9	3.9	9.7	32.0	4.2	7.0	7.3	4.2	1.3	20.0	10.6	16.9	6.5	4.1	5.9	5.7	3.0	8.2	9.0	4.4	8.4	19.0	2.4	2.0	6.6	2.5	10.1	9.9	6.1	5.4	16.9	5.7	6.7	23.7	13.0	16.6	12.3	2.4	14.3	4.2	6.3	2.1	3.5	4.9	16.2	26.3	8.4	9.6	4.3	9.1	4.3	3.0	2.2	4.5	8.6	3.1	3.1
EYA1	BOR	ENSG00000104313	"EYA transcriptional coactivator and phosphatase 1"	Q99502	8	71197433-71592025	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 18.7;parathyroid gland: 23.7"	"Cell type enriched"	"Detected in some"	11	"Astrocytes: 214.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 27.6;RH-30: 21.3;RPMI-8226: 9.5;SH-SY5Y: 51.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 20.7"	HPA028917			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nuclear bodies"		"HPA028917: AB_2672826"	"unprognostic (3.74e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.91e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-12)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.81e-4)"	"unprognostic (1.25e-2)"	0.6	0.6	2.8	0.1	7.8	0.0	0.2	0.5	2.1	5.1	18.7	0.1	0.1	0.1	0.1	0.4	2.0	0.3	4.5	1.3	2.5	0.1	0.0	0.4	0.0	2.1	4.9	0.2	0.0	23.7	10.8	0.0	2.3	12.0	0.2	0.4	0.8	4.0	2.8	0.0	0.2	0.2	0.0	0.1	0.8	0.8	4.6	11.7	0.6	2.5	0.1	2.6	4.3	0.6	0.2	0.0	6.4	27.6	0.0	0.0	0.0	0.2	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	1.6	0.0	0.0	4.7	0.0	2.2	0.0	0.0	0.5	0.0	6.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	0.0	2.0	0.0	1.5	0.0	21.3	9.5	0.0	0.0	2.2	51.4	0.0	0.0	1.6	5.9	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	6.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	7.8	0.5	2.1	1.3	2.5	2.1	4.9	2.3	0.0	4.6	0.6	0.2	0.0	0.0	214.5	0.0	0.1	0.0	6.4	0.6	0.1	0.0	0.1	8.8	0.0	7.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	4.4	3.1	0.1	0.2	0.0	0.0	1.3	0.0	0.5	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	13.5	0.0	2.0	0.0	0.0	6.4	0.3	0.0	0.0	11.2	0.0	0.1	0.0	18.6	0.6	0.0	0.0	0.4	0.0	0.1	0.0	0.3	10.5	0.2	0.0	0.2	0.5	0.8	1.0	1.1	0.1	0.5	0.0	1.4	0.0	0.1
EYA4	"CMD1J, DFNA10"	ENSG00000112319	"EYA transcriptional coactivator and phosphatase 4"	O95677	6	133240598-133532128	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Cardiomyopathy, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 27.6;tongue: 21.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 46.0;Inhibitory neurons: 139.0;Oligodendrocytes: 79.2;Skeletal myocytes: 26.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 25.4;GAMG: 25.6;HeLa: 74.3;RH-30: 23.8;U-87 MG: 24.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004805, HPA038771, HPA038772"	Enhanced		Approved	Nucleoplasm		No	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA004805: AB_10669750, HPA038771: AB_10671865, HPA038772: AB_10673119"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-9)"	"unprognostic (1.64e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.44e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.27e-4)"	"unprognostic (1.82e-3)"	"unprognostic (6.67e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.51e-2)"	1.1	2.5	2.6	0.1	1.9	0.0	0.4	2.2	1.9	2.6	13.3	0.2	0.2	0.5	1.2	0.4	7.4	0.5	5.8	2.3	1.2	5.0	0.0	1.8	0.1	5.6	7.9	1.2	0.2	0.0	0.8	0.0	4.5	5.7	0.2	0.1	0.2	11.8	27.6	0.0	0.1	0.3	4.5	0.4	0.4	3.0	3.3	6.6	2.1	21.3	0.5	2.2	2.3	4.9	0.0	25.4	2.4	0.0	0.0	0.0	0.0	0.0	20.4	0.5	2.9	0.1	0.1	0.1	19.6	0.0	25.6	0.0	15.4	6.7	0.0	0.0	20.2	2.8	74.3	0.0	0.6	0.0	6.8	5.1	0.0	14.4	4.5	3.4	0.0	0.0	0.0	10.7	8.1	0.0	0.0	0.0	0.0	0.3	1.6	0.3	23.8	0.0	0.0	3.9	3.7	4.1	0.2	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	18.4	7.2	3.4	0.0	24.6	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.9	2.2	1.9	2.3	1.2	5.6	7.9	4.5	4.5	3.3	4.9	0.3	12.8	1.8	2.6	0.0	0.1	0.1	13.3	0.0	0.0	0.0	0.0	14.4	0.0	6.7	46.0	0.0	0.0	0.0	0.1	0.0	0.1	4.4	0.1	0.1	0.5	1.8	0.0	4.8	0.2	0.0	2.9	0.0	0.1	0.0	1.5	0.4	0.1	0.0	0.0	139.0	0.0	8.2	1.0	0.0	2.6	0.6	0.2	0.0	2.8	7.2	0.0	0.0	1.5	79.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	4.8	0.0	0.0	26.2	3.3	7.9	7.1	0.0	0.0	0.0	0.1	1.5	0.0	0.2
FAH		ENSG00000103876	"Fumarylacetoacetate hydrolase"	P16930	15	80152490-80186946	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 301.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 266.8;Proximal tubular cells: 305.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 23.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 34.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 316.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041370, HPA044093"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		220000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA041370: AB_2677438, HPA044093: AB_2678806"	"unprognostic (3.15e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.19e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.98e-2)"	99.2	65.4	16.0	7.0	17.1	20.0	59.0	16.6	21.1	19.2	15.1	13.8	14.6	19.3	50.4	15.2	23.0	9.7	20.3	16.3	18.8	65.0	301.5	20.0	5.7	17.9	19.6	26.4	9.9	18.4	16.8	7.8	16.9	16.6	11.9	1.6	14.8	13.6	31.0	10.9	16.8	13.5	17.2	19.1	14.2	20.8	17.4	6.7	14.5	27.7	5.8	16.4	15.8	17.5	20.1	34.4	13.5	17.0	60.2	62.2	32.9	24.3	56.8	26.2	22.3	22.0	35.9	0.4	39.0	52.6	36.8	29.1	46.8	59.6	25.1	12.5	28.5	166.6	18.0	112.1	316.6	79.6	88.8	107.5	37.1	22.9	39.7	84.2	37.4	38.3	71.1	35.7	50.3	31.0	22.3	42.0	9.9	15.5	37.6	12.2	19.3	123.4	77.0	25.2	0.7	8.3	27.4	76.7	77.9	21.6	58.3	55.0	126.1	46.8	30.0	25.5	42.7	32.7	69.5	13.8	99.6	187.5	26.9	34.5	18.8	3.3	9.6	8.1	2.3	0.1	2.4	6.0	25.3	0.1	3.1	2.7	1.3	5.7	8.4	1.9	2.5	9.7	16.0	17.1	16.6	21.1	16.3	18.8	17.9	19.6	16.9	17.2	17.4	17.5	3.0	3.2	13.8	9.8	4.1	6.8	17.5	30.8	15.4	0.4	19.1	13.7	15.5	21.5	12.5	33.1	0.0	37.9	4.9	9.3	52.8	9.3	7.5	3.0	16.2	3.2	4.2	24.4	0.4	3.5	14.1	16.6	3.6	4.0	41.9	6.3	8.9	266.8	72.5	0.0	2.5	13.0	24.4	21.4	6.6	13.5	9.9	30.5	19.6	1.0	5.7	7.3	3.1	2.5	0.6	4.5	12.8	7.9	5.2	9.7	54.1	305.5	5.3	0.4	0.0	9.2	11.2	1.5	2.1	18.2	5.7	22.0	7.7	8.7	22.4	16.4
FAM20C	"DKFZp547D065, DMP4, G-CK, IMAGE:4942737"	ENSG00000177706	"FAM20C golgi associated secretory pathway kinase"	Q8IXL6	7	192571-260772	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	Biomineralization	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 55.2;Hepatocytes: 94.0;Hofbauer cells: 54.9;Peritubular cells: 56.4;Proximal tubular cells: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 55.3;hTERT-RPE1: 39.9;U-87 MG: 36.0;WM-115: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019823			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted in other tissues"	NA	NA		240000000		"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Nucleoplasm	"HPA019823: AB_1848389"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.47e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (9.40e-6)"	"unprognostic (1.97e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.83e-3)"	32.5	14.8	7.0	7.3	5.7	1.5	32.8	5.0	7.0	19.4	0.8	44.3	4.5	19.4	2.1	14.3	20.2	5.9	30.2	4.3	5.0	34.9	56.5	27.9	1.1	12.5	9.7	20.3	13.4	1.6	18.3	2.6	6.7	29.9	1.4	1.1	20.3	3.6	30.7	14.7	23.3	6.8	6.4	8.9	38.9	7.8	12.6	0.6	19.6	6.3	0.6	36.8	15.1	6.2	19.6	6.4	0.3	10.3	11.8	20.3	0.0	17.4	23.2	7.9	5.9	0.9	10.1	0.0	9.3	21.8	10.4	14.9	1.1	0.6	1.6	4.5	0.6	0.0	3.1	3.4	8.8	0.0	1.0	55.3	1.6	0.3	0.7	39.9	5.0	0.0	0.0	0.0	1.8	1.9	0.0	0.7	8.9	0.1	0.3	2.3	0.5	0.0	4.9	0.0	4.4	0.2	17.2	0.0	2.3	1.1	9.7	6.5	14.6	10.3	5.3	7.7	5.3	0.0	0.0	0.0	36.0	1.0	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	5.7	5.0	7.0	4.3	5.0	12.5	9.7	6.7	6.4	12.6	6.2	5.0	6.4	5.1	11.8	1.2	10.1	2.3	4.5	1.8	26.9	27.6	18.7	9.9	21.5	1.0	55.2	0.0	0.5	4.6	3.4	5.9	1.8	0.0	4.1	19.0	4.5	11.9	0.4	7.4	4.8	0.5	22.6	13.7	9.5	3.8	3.1	9.3	94.0	54.9	1.7	17.0	5.3	2.0	24.4	9.8	2.6	16.1	34.5	1.8	5.6	10.8	17.1	0.0	8.5	15.3	6.3	3.7	56.4	0.1	6.6	33.7	48.7	3.4	9.0	13.1	8.7	17.3	0.3	1.0	3.5	8.1	0.5	0.9	0.6	9.0	1.9
FAN1	"KIAA1018, MTMR15"	ENSG00000198690	"FANCD2 and FANCI associated nuclease 1"	Q9Y2M0	15	30890559-30943108	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048198			Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA048198: AB_2680311"	"unprognostic (7.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.67e-2)"	"prognostic favorable (1.42e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.29e-1)"	6.2	8.5	9.3	0.9	9.5	0.5	6.7	9.4	9.7	10.1	9.3	10.7	0.9	9.2	6.6	6.5	9.0	1.2	8.8	8.9	9.5	9.5	9.6	5.5	0.8	9.7	9.8	11.8	12.7	5.9	11.4	3.0	10.0	11.5	2.0	2.7	9.8	1.4	18.7	10.8	7.3	2.4	9.5	6.8	8.6	8.9	9.9	4.4	10.0	7.3	0.7	9.3	9.7	10.0	5.2	9.9	3.6	1.9	12.4	9.3	0.8	4.4	2.1	4.7	5.0	4.5	1.7	0.6	7.6	3.6	7.4	9.2	4.7	9.4	5.0	4.2	1.4	1.3	5.5	1.9	4.8	1.2	1.9	2.8	7.3	3.0	7.3	7.2	3.4	5.7	4.7	6.1	4.7	0.6	8.6	3.1	2.2	11.5	2.8	7.0	12.0	2.3	6.7	2.3	4.5	4.6	9.2	5.6	3.0	8.8	4.4	3.3	3.3	9.4	3.0	5.0	3.4	7.4	8.7	1.1	4.1	1.9	1.1	0.0	0.1	0.0	1.4	0.3	2.0	1.2	1.2	0.7	0.9	1.5	1.8	1.1	0.0	1.8	4.3	1.1	1.4	0.7	9.3	9.5	9.4	9.7	8.9	9.5	9.7	9.8	10.0	9.5	9.9	10.0	9.1	16.0	8.4	21.2	5.4	4.1	5.8	4.9	9.6	17.0	11.2	9.8	17.0	0.0	10.7	9.2	20.9	6.5	3.5	7.6	9.8	4.5	11.9	10.2	12.9	8.8	7.8	6.9	23.7	2.9	2.2	8.4	8.6	9.0	8.8	15.5	6.8	13.4	3.7	26.9	25.5	11.0	8.2	5.4	2.5	7.1	10.5	3.9	5.4	15.0	3.4	14.9	7.2	13.6	44.2	3.6	6.4	6.8	7.0	6.0	4.2	8.0	13.6	23.5	6.6	9.4	7.6	20.9	16.4	7.2	2.4	4.1	5.3	9.2	10.3	3.7
FANCL	"FAAP43, FLJ10335, PHF9, Pog"	ENSG00000115392	"FA complementation group L"	Q9NW38	2	58159243-58241372	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 81.4;Oligodendrocytes: 188.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033842, HPA036685, HPA036686"	Supported		Approved	"Nuclear bodies,Vesicles"		NA	Yes			"Cluster 19: B-cells - Humoral immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"	Vesicles	"CAB033842: AB_1122766, HPA036685: AB_10672474, HPA036686: AB_10670844"	"unprognostic (3.02e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.81e-7)"	"unprognostic (4.71e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.08e-3)"	"prognostic favorable (7.80e-5)"	8.5	35.3	39.4	11.0	49.5	15.1	19.5	35.3	39.4	18.6	27.2	12.1	11.5	19.9	18.4	11.5	13.9	12.0	13.0	34.1	45.1	12.2	21.7	9.6	14.8	51.6	40.3	24.8	14.5	14.0	44.3	12.5	55.4	14.7	14.8	24.6	18.7	10.7	9.1	17.9	12.8	13.5	40.9	16.8	13.1	19.1	41.2	13.2	17.1	9.1	12.6	11.7	14.6	68.6	48.6	35.0	69.4	34.0	11.9	15.1	36.9	34.8	21.5	33.8	43.5	30.9	59.4	33.4	43.8	11.4	46.3	27.5	39.0	26.4	56.0	78.8	61.7	54.8	49.5	42.1	13.0	53.3	29.0	11.8	12.4	24.8	9.7	29.9	27.0	23.5	51.9	29.6	23.2	24.6	18.9	65.8	75.2	77.4	7.2	35.2	52.5	26.1	29.9	47.2	78.1	39.3	49.5	20.2	33.8	37.0	18.7	35.4	15.9	30.0	45.0	22.3	39.0	30.4	20.6	19.7	63.7	35.7	46.6	3.2	3.0	4.9	3.7	5.6	3.0	9.1	3.2	4.2	5.9	9.3	1.0	2.3	0.8	7.6	4.3	5.3	4.8	2.2	39.4	49.5	35.3	39.4	34.1	45.1	51.6	40.3	55.4	40.9	41.2	68.6	16.7	19.2	20.0	18.6	9.4	10.3	13.9	26.1	11.4	16.6	12.5	15.4	16.4	8.6	16.1	9.2	4.2	29.1	4.8	7.2	11.7	9.7	2.5	11.1	15.8	14.8	9.0	14.5	45.0	4.2	14.0	12.2	15.3	6.2	10.8	25.8	13.2	12.5	10.9	8.4	38.4	15.0	30.5	6.3	4.6	3.6	10.8	7.0	26.6	34.7	6.8	22.8	3.1	81.4	188.9	4.6	13.3	14.3	9.7	6.2	21.7	5.7	23.2	18.7	13.1	10.8	12.4	52.6	37.9	9.5	6.8	7.4	5.6	13.2	16.0	9.3
FANCM	"FAAP250, KIAA1596"	ENSG00000187790	"FA complementation group M"	Q8IYD8	14	45135930-45200890	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 65.5;Late spermatids: 206.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055144			Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA055144: AB_2682715"	"unprognostic (8.40e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.99e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.13e-2)"	1.9	1.6	0.8	2.2	1.6	5.6	2.8	1.9	2.2	2.0	0.3	1.6	1.3	2.4	2.2	1.9	1.6	1.8	1.3	1.0	0.9	1.8	1.5	1.7	3.3	1.0	0.8	2.9	1.1	1.5	0.8	1.9	1.2	1.6	1.8	2.8	1.4	1.9	1.6	2.6	1.2	1.9	0.7	2.3	1.4	7.6	1.1	4.1	1.5	2.3	2.6	1.5	1.5	1.2	8.2	7.0	8.1	7.5	6.4	3.5	6.5	10.3	4.1	8.1	10.1	11.3	6.2	10.6	5.8	2.6	4.5	10.6	9.5	4.4	11.0	7.6	5.4	5.1	7.8	6.4	1.1	13.0	6.1	2.2	1.6	8.1	5.1	1.8	7.1	6.6	9.1	8.9	6.9	8.1	9.5	9.2	3.2	6.3	11.6	9.0	12.7	4.5	3.4	5.8	7.3	1.9	9.4	7.6	4.0	5.1	8.0	6.0	5.6	11.8	11.0	10.6	8.1	4.4	8.7	10.3	2.3	7.9	7.0	6.6	0.7	2.5	2.0	2.0	1.1	4.3	1.3	0.7	0.6	2.0	2.0	1.7	1.0	1.1	0.9	1.7	1.0	0.6	0.8	1.6	1.9	2.2	1.0	0.9	1.0	0.8	1.2	0.7	1.1	1.2	6.5	0.0	3.1	9.8	8.3	2.7	1.1	1.9	4.6	6.3	3.9	2.4	8.3	1.5	3.1	1.8	2.1	7.6	5.6	1.7	0.0	2.2	65.5	3.5	5.8	5.1	0.0	12.8	21.0	2.7	3.5	4.6	5.1	3.0	1.3	9.4	5.7	1.7	3.5	3.3	15.6	1.6	4.1	3.8	2.9	206.1	9.0	4.0	3.6	18.7	5.9	4.8	3.1	20.1	22.7	2.4	0.8	5.3	8.4	0.8	1.5	1.9	1.1	6.9	6.6	4.7	6.0	26.5	14.0	4.4	1.8	2.3	5.6	9.5	3.2	0.7
FAR1	"FLJ22728, MLSTD2, SDR10E1"	ENSG00000197601	"Fatty acyl-CoA reductase 1"	Q8WVX9	11	13668668-13732346	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Cataract, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 437.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017322	Approved		Supported	Peroxisomes		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Peroxisomes		"HPA017322: AB_1848424"	"unprognostic (3.96e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.27e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.37e-3)"	21.1	16.2	19.3	23.0	36.0	74.9	20.6	34.3	31.5	23.8	24.5	32.9	38.7	24.7	24.9	50.9	17.7	13.7	20.0	22.6	29.7	14.0	5.0	20.2	20.5	48.4	29.9	19.9	21.3	29.1	15.6	24.6	44.1	20.5	37.6	32.6	18.2	15.4	15.2	12.2	21.1	30.7	37.3	20.5	62.0	20.8	32.1	16.5	19.8	18.6	23.9	28.4	30.0	94.8	79.5	50.6	49.1	38.4	45.9	52.6	26.7	69.2	27.6	50.0	52.7	53.5	66.4	100.9	30.2	55.5	74.3	84.3	73.2	69.9	76.1	30.0	59.4	43.4	44.8	0.2	44.1	87.9	33.7	40.2	70.3	36.2	107.7	36.9	49.6	50.2	68.9	29.3	41.5	39.9	65.5	26.3	25.8	100.1	72.6	56.9	62.6	28.4	48.4	126.4	37.7	27.3	65.5	61.6	34.4	56.2	37.8	54.1	62.1	68.5	58.2	63.7	58.4	16.4	59.6	84.7	43.4	26.4	42.4	10.4	24.9	28.0	7.7	21.3	5.4	3.5	3.7	6.6	28.5	5.5	3.3	5.5	38.9	9.1	18.2	4.4	5.3	7.7	19.3	36.0	34.3	31.5	22.6	29.7	48.4	29.9	44.1	37.3	32.1	94.8	38.6	35.3	21.1	80.0	24.2	32.2	24.2	21.5	41.5	46.0	27.6	20.3	24.1	5.7	26.2	22.0	41.7	25.7	40.2	59.8	5.9	12.8	100.8	21.1	36.5	31.4	36.0	38.5	146.0	25.9	18.5	26.8	114.7	26.2	38.7	23.3	29.6	2.5	33.9	47.1	113.5	28.8	26.4	53.5	57.0	181.3	26.8	48.8	35.6	71.2	54.8	20.6	20.6	93.5	437.2	29.3	43.4	25.6	36.1	30.8	23.3	8.7	18.7	50.4	26.3	29.3	29.3	41.6	32.3	116.9	19.9	9.9	25.8	17.0	47.7	42.0
FARS2	"dJ236A3.1, FARS1, mtPheRS"	ENSG00000145982	"Phenylalanyl-tRNA synthetase 2, mitochondrial"	O95363	6	5261044-5829192	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 110.4;Early spermatids: 77.4;Excitatory neurons: 217.0;Inhibitory neurons: 122.6;Late spermatids: 78.8;Microglial cells: 106.8;Oligodendrocyte precursor cells: 186.5;Oligodendrocytes: 122.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018148, HPA028836"	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA018148: AB_1848426, HPA028836: AB_10601377"	"unprognostic (2.73e-1)"	"unprognostic (4.08e-3)"	"prognostic favorable (5.14e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.34e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.31e-3)"	"unprognostic (7.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (1.24e-6)"	"unprognostic (2.81e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.57e-1)"	9.4	12.0	8.1	9.6	10.9	11.7	11.0	6.1	10.8	8.8	22.9	10.6	7.4	9.2	7.3	9.8	14.9	6.8	16.0	8.4	9.6	14.2	14.4	9.6	12.4	5.8	6.7	7.8	10.3	13.2	9.8	8.9	6.5	7.3	11.3	6.8	8.4	8.6	19.7	11.4	7.9	9.8	6.1	9.8	9.9	11.7	10.8	12.5	14.4	17.9	11.0	8.8	8.9	8.6	14.2	13.4	14.1	14.7	17.1	20.5	11.6	15.1	17.9	19.4	19.2	18.0	10.7	19.7	23.1	14.9	18.9	13.9	18.2	23.9	20.2	59.5	12.2	7.9	11.0	16.1	8.9	18.9	11.4	16.5	24.0	21.9	15.8	11.4	23.6	21.8	23.7	4.5	14.6	14.5	20.6	21.2	8.7	21.7	12.9	20.0	17.6	38.9	18.7	16.4	23.9	11.8	14.1	11.0	17.6	18.4	22.1	20.6	13.7	20.7	9.4	12.3	19.8	9.3	34.2	10.9	11.6	11.1	26.6	0.1	14.7	5.2	23.1	16.7	20.3	20.0	20.5	21.2	26.0	17.5	22.3	22.1	1.1	24.6	11.9	15.5	28.0	17.6	8.1	10.9	6.1	10.8	8.4	9.6	5.8	6.7	6.5	6.1	10.8	8.6	10.4	9.6	13.7	110.4	15.7	14.8	18.5	17.7	10.2	8.8	8.9	12.1	18.4	12.8	8.5	9.2	2.1	19.5	10.5	6.9	27.4	14.6	77.4	10.2	7.6	10.9	10.7	13.9	217.0	12.9	20.9	10.5	13.3	7.2	22.2	14.3	11.4	12.0	15.8	0.0	122.6	9.4	14.2	12.5	11.6	78.8	6.2	17.4	5.4	106.8	9.4	14.2	8.2	186.5	122.4	7.8	8.6	7.2	16.1	6.6	7.4	30.7	19.3	11.1	0.0	10.1	10.8	19.2	9.4	13.3	13.2	10.7	16.2	24.2	11.9	13.2
FARSB	"FARSLB, FRSB, PheHB"	ENSG00000116120	"Phenylalanyl-tRNA synthetase subunit beta"	Q9NSD9	2	222566899-222656092	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036677, HPA036678, HPA061398"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		28000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA036677: AB_2675242, HPA036678: AB_10673504, HPA061398: AB_2684504"	"unprognostic (9.95e-3)"	"unprognostic (1.86e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (6.45e-10)"	"unprognostic (8.89e-3)"	"unprognostic (4.51e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.25e-4)"	12.8	10.9	9.5	7.6	10.0	8.0	12.8	10.4	11.3	13.1	6.5	14.7	9.1	13.5	6.5	20.7	11.9	3.9	16.7	10.2	10.7	11.8	14.1	9.4	7.4	9.6	9.4	14.3	15.6	8.0	13.2	5.0	10.8	11.2	11.1	10.0	10.4	6.1	31.9	14.9	10.8	8.1	8.4	9.7	13.9	13.5	9.9	7.7	9.7	13.2	8.3	13.1	13.7	9.4	31.1	17.8	20.7	27.2	18.0	26.3	31.0	31.0	19.2	29.4	23.9	45.3	16.6	15.3	22.7	22.6	24.7	25.8	39.7	34.7	43.0	22.8	20.7	35.1	18.9	28.8	27.9	51.9	14.0	17.6	27.0	33.9	51.2	10.5	28.3	26.4	53.5	30.3	36.1	28.9	31.2	29.2	26.6	37.0	22.0	30.2	49.4	49.8	24.5	19.9	33.4	11.2	12.9	22.4	27.6	24.7	20.9	21.3	15.8	25.5	21.1	37.8	38.5	14.8	15.5	54.5	20.8	34.0	27.2	0.5	7.6	1.2	9.6	9.4	14.3	15.1	12.8	11.9	14.4	12.7	16.4	14.2	0.9	17.4	11.3	7.2	12.5	13.7	9.5	10.0	10.4	11.3	10.2	10.7	9.6	9.4	10.8	8.4	9.9	9.4	10.2	6.4	6.4	21.2	25.2	12.4	19.5	32.7	19.4	17.9	16.3	18.0	28.6	5.7	18.5	22.0	4.2	37.0	7.5	18.1	35.2	24.7	57.5	17.3	15.8	13.3	20.9	24.2	50.2	30.4	43.3	18.0	32.6	18.6	5.1	21.8	7.5	17.8	27.4	3.3	56.7	19.9	20.3	10.1	9.7	73.1	15.2	11.8	7.2	26.2	11.3	13.2	15.5	38.7	38.2	22.8	11.3	19.9	27.3	18.1	9.9	31.0	16.8	19.5	6.6	17.6	34.4	67.4	33.7	28.8	14.2	22.2	16.9	24.3	45.8	14.3
FBH1	"Fbx18, FBXO18, FLJ14590"	ENSG00000134452	"F-box DNA helicase 1"	Q8NFZ0	10	5890203-5937594	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 22.4;Distal tubular cells: 21.5;Granulosa cells: 23.6;Syncytiotrophoblasts: 32.0;Theca cells: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002844	Supported					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA002844: AB_1078829"	"unprognostic (3.14e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.35e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.98e-3)"	"prognostic unfavorable (7.73e-7)"	"unprognostic (1.89e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.69e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.54e-2)"	28.7	38.8	17.5	22.8	20.3	24.6	26.8	17.7	19.1	32.4	25.7	30.4	24.6	34.3	21.3	24.0	36.4	23.0	44.5	17.2	18.0	25.2	28.8	27.6	27.6	17.7	18.2	30.7	21.9	28.5	26.1	26.6	18.0	28.6	24.2	14.8	24.3	25.8	30.3	30.4	29.7	30.1	17.8	35.3	27.6	24.7	19.2	40.2	25.2	27.4	27.2	28.8	27.1	19.0	31.8	34.0	31.3	34.4	70.4	46.3	28.1	35.9	24.6	34.8	38.8	40.4	28.3	29.6	23.0	52.5	16.7	46.3	42.6	38.2	31.3	32.2	31.5	28.6	27.3	34.8	48.2	14.2	26.4	58.2	36.4	44.2	19.4	44.0	59.7	39.7	50.9	30.4	37.3	48.1	34.5	20.9	14.3	54.7	18.9	37.6	14.8	49.9	34.0	25.5	17.7	26.6	36.8	33.1	50.8	35.7	33.7	28.5	37.9	22.1	24.7	59.1	28.1	30.9	26.1	16.3	29.8	20.7	15.8	0.0	2.1	3.3	1.9	1.7	1.3	3.0	2.0	2.5	2.0	4.1	2.5	1.8	1.3	4.6	1.3	4.0	6.2	1.7	17.5	20.3	17.7	19.1	17.2	18.0	17.7	18.2	18.0	17.8	19.2	19.0	22.4	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	15.6	16.1	0.0	0.0	0.0	7.3	0.0	20.3	9.3	0.0	21.5	16.8	0.0	11.4	19.0	7.1	0.0	0.0	0.0	15.1	19.4	9.8	0.0	14.9	0.0	23.6	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	10.3	0.0	0.0	0.0	0.0	18.3	0.0	0.0	3.2	0.0	0.0	20.9	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	32.0	4.4	27.9	0.0	0.0
FBP1	FBP	ENSG00000165140	"Fructose-bisphosphatase 1"	P09467	9	94603133-94640249	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 324.4;kidney: 297.8;liver: 893.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 500.4;Macrophages: 238.6;Proximal enterocytes: 1095.0;Proximal tubular cells: 864.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 404.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HaCaT: 75.2;MCF7: 243.4;OE19: 54.5;RT4: 157.0;U-698: 170.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005857, HPA012513, CAB033869"	Enhanced		Approved	Mitochondria		NA	NA		21000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB033869: AB_1121520, HPA005857: AB_1848445, HPA012513: AB_1848446"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (6.94e-3)"	"unprognostic (4.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (6.86e-7)"	"unprognostic (6.91e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.64e-5)"	13.7	27.4	1.6	12.7	1.8	15.0	41.4	1.8	5.7	19.9	2.6	29.8	324.4	3.6	15.8	2.7	7.1	34.4	2.9	1.5	2.2	297.8	893.2	165.9	6.8	3.6	2.6	1.1	41.4	107.9	8.6	3.0	2.9	25.8	30.5	0.7	53.2	28.9	1.3	8.1	258.1	8.8	2.6	12.2	85.6	2.5	3.2	2.2	16.8	0.9	7.8	70.8	6.7	3.8	0.5	0.1	0.3	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.6	3.8	0.0	0.3	0.8	0.1	75.2	0.1	0.0	0.1	0.0	0.3	0.6	2.9	1.3	0.0	1.5	18.8	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.2	0.3	0.2	243.4	0.1	4.4	1.1	54.5	9.5	0.0	0.9	1.9	0.0	157.0	0.7	5.6	0.6	44.5	0.0	0.9	26.7	7.7	0.2	0.1	1.0	0.8	0.0	0.3	1.1	170.4	0.0	1.4	0.1	63.3	68.4	404.3	7.9	162.3	11.7	3.0	4.6	4.6	90.1	3.2	16.2	8.3	12.1	15.4	90.7	32.1	2.3	33.1	1.6	1.8	1.8	5.7	1.5	2.2	3.6	2.6	2.9	2.6	3.2	3.8	2.8	76.9	182.8	0.0	10.3	0.8	8.9	0.7	0.0	0.1	62.4	24.3	0.7	102.9	41.0	62.5	0.0	11.1	14.8	26.1	111.6	21.5	0.1	4.0	0.4	4.8	31.9	24.4	0.9	62.7	1.7	5.4	102.4	5.2	47.4	16.0	12.1	500.4	177.6	0.0	0.8	61.4	0.0	79.9	32.1	1.5	1.5	238.6	12.4	1.9	20.1	2.6	8.2	0.5	0.3	24.0	77.6	4.1	18.3	11.9	1095.0	864.1	9.1	0.2	6.6	0.6	2.0	0.6	1.3	0.8	1.0	10.1	12.1	0.5	90.4	68.1
FCSK	"FLJ39408, FUK"	ENSG00000157353	"Fucose kinase"	Q8N0W3	16	70454595-70480274	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.7;Cardiomyocytes: 4.2;Cytotrophoblasts: 5.5;Extravillous trophoblasts: 3.0;Hofbauer cells: 5.0;Syncytiotrophoblasts: 5.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041971	Approved		Approved	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles		"HPA041971: AB_10795648"	"unprognostic (4.55e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.82e-3)"	"unprognostic (4.85e-2)"	"prognostic favorable (8.91e-4)"	"unprognostic (2.49e-2)"	"unprognostic (9.68e-2)"	"unprognostic (8.89e-2)"	"prognostic favorable (8.38e-4)"	3.9	7.2	5.4	5.4	7.1	5.0	4.9	8.2	7.7	5.6	7.5	7.5	10.1	4.9	2.4	5.6	5.5	3.8	4.3	5.3	5.0	8.9	8.2	4.8	5.4	6.4	4.6	6.6	8.3	9.1	9.8	3.6	5.7	6.3	3.9	2.9	5.9	4.4	5.5	7.2	7.4	3.1	4.5	6.4	6.6	4.5	5.7	3.8	7.9	2.3	2.8	4.8	4.8	11.1	3.4	4.6	2.5	5.8	1.5	1.8	10.0	1.8	2.8	2.2	3.0	4.2	10.0	2.3	8.8	1.7	0.7	4.8	1.8	4.7	1.6	4.4	6.5	2.9	8.9	4.5	3.7	3.8	2.3	3.0	5.4	2.1	4.4	3.3	4.3	4.6	5.9	2.6	1.8	10.3	4.6	9.2	1.6	5.5	2.7	7.0	0.6	10.4	5.9	5.5	4.0	5.3	10.1	3.7	5.3	1.9	14.8	7.5	5.0	1.8	2.4	4.0	2.2	9.5	5.1	4.8	3.3	3.8	4.2	0.2	1.9	0.8	1.9	1.0	1.6	0.8	1.9	1.9	1.1	1.5	2.6	1.2	1.6	1.2	1.2	1.3	1.4	1.2	5.4	7.1	8.2	7.7	5.3	5.0	6.4	4.6	5.7	4.5	5.7	11.1	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	5.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.2	0.2	0.0	0.0	0.0
FDFT1	SQS	ENSG00000079459	"Farnesyl-diphosphate farnesyltransferase 1"	P37268	8	11795573-11839304	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 479.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Daudi: 133.1;RPMI-8226: 361.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008874	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"		"HPA008874: AB_1078844"	"unprognostic (2.33e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (4.92e-5)"	"unprognostic (1.29e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.57e-1)"	"prognostic favorable (6.59e-9)"	"unprognostic (2.28e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.06e-1)"	69.1	126.7	8.2	6.7	14.9	15.0	69.5	13.1	11.6	93.3	7.4	113.4	6.7	80.2	2.9	165.7	59.4	3.2	62.9	10.0	11.7	71.3	118.3	88.0	6.0	29.9	14.1	66.9	58.6	2.0	51.2	4.2	23.1	64.5	5.8	5.4	141.7	3.1	160.3	129.0	92.2	4.9	15.4	50.4	113.2	118.7	15.3	3.2	45.9	6.9	4.5	70.4	107.8	31.9	19.1	8.1	28.8	19.4	3.8	5.7	10.9	19.2	10.6	7.4	8.6	8.1	14.1	133.1	3.9	3.2	34.6	17.8	10.6	24.7	8.2	13.1	17.2	9.6	11.1	21.7	7.4	5.5	13.0	11.2	6.0	13.2	4.7	5.3	2.1	24.5	12.1	60.0	4.6	11.1	16.7	12.9	27.1	9.0	5.3	14.9	11.3	361.0	11.9	61.5	9.6	11.2	4.3	11.2	35.9	12.3	11.6	6.8	11.3	5.1	21.6	3.1	5.8	17.0	30.2	26.3	7.5	18.7	19.7	52.1	19.5	25.5	23.1	23.6	20.7	60.5	25.3	24.5	29.1	45.6	25.7	23.3	22.3	26.7	15.1	27.9	45.7	43.9	8.2	14.9	13.1	11.6	10.0	11.7	29.9	14.1	23.1	15.4	15.3	31.9	31.1	54.5	164.1	67.6	78.0	52.5	94.0	479.6	87.6	17.7	79.6	49.8	78.5	101.5	325.8	79.1	14.6	266.2	49.4	134.8	88.0	165.6	294.4	55.0	20.9	45.2	79.1	113.2	29.3	284.4	153.3	37.1	64.2	68.1	57.0	86.2	22.1	221.8	94.1	11.8	25.6	117.4	284.8	41.9	32.2	228.8	77.0	54.3	101.4	38.4	97.1	61.9	55.6	30.2	95.6	163.6	108.4	53.4	50.0	101.3	87.0	74.9	142.6	21.0	52.6	13.8	74.4	215.5	76.1	112.5	88.8	175.0	55.7	131.4	100.4	167.2
FDXR	"ADR, ADXR"	ENSG00000161513	"Ferredoxin reductase"	P22570	17	74862497-74873031	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Oxidoreductase	"Deafness, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"adrenal gland: 343.1"	"Group enriched"	"Detected in many"	7	"Granulosa cells: 329.3;Theca cells: 794.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 89.5;Hep G2: 173.5"					"Low region specificity"	"Detected in all"			"CAB008597, CAB009818, HPA044393, HPA053673"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"CAB008597: AB_1615557, CAB009818: AB_2102601, HPA044393: AB_2678927, HPA053673: AB_2682225"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-3)"	"unprognostic (7.51e-2)"	"prognostic favorable (2.38e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.13e-1)"	3.9	343.1	6.9	2.4	8.4	2.2	3.8	7.8	8.1	7.8	8.6	9.7	4.6	6.7	5.1	26.0	12.9	4.1	6.0	6.6	6.7	6.5	14.9	5.3	2.9	7.6	7.9	20.5	12.9	5.9	4.1	3.0	7.5	6.7	3.2	0.5	7.1	4.4	7.7	16.4	5.6	2.3	7.4	33.9	7.6	45.6	7.0	4.7	6.0	1.7	2.5	6.2	10.5	7.5	12.5	65.6	9.6	10.8	6.8	9.1	89.5	14.8	15.9	8.6	17.1	18.3	10.8	29.6	2.6	6.2	4.8	24.9	6.9	18.4	2.5	27.9	15.2	22.6	10.6	173.5	19.0	5.0	75.1	29.2	20.3	9.1	3.1	7.0	43.9	10.9	36.1	4.8	13.4	53.4	19.7	10.6	5.5	11.8	14.5	10.6	16.4	16.2	7.1	21.0	5.2	12.1	10.0	21.7	11.2	10.9	47.4	4.7	20.5	5.9	51.9	9.4	7.4	12.7	2.3	6.5	16.1	7.7	20.6	1.7	6.0	5.0	5.6	4.5	5.0	4.8	5.1	6.8	7.3	2.4	4.4	5.4	2.0	10.3	3.4	1.4	15.4	5.2	6.9	8.4	7.8	8.1	6.6	6.7	7.6	7.9	7.5	7.4	7.0	7.5	4.0	3.2	3.9	7.5	8.2	9.7	17.8	42.6	17.1	4.9	6.6	8.4	3.8	5.7	23.3	9.2	4.2	53.2	2.8	18.6	5.9	11.1	6.5	28.2	4.3	4.6	7.1	4.0	1.4	7.9	18.9	12.9	13.7	3.5	5.7	329.3	12.5	13.9	23.1	3.3	2.2	13.1	36.7	6.2	2.7	14.9	5.9	4.6	5.4	1.0	3.9	11.4	8.2	3.0	1.3	9.0	16.9	4.5	7.1	5.2	24.9	21.7	73.6	5.1	0.0	6.2	18.3	6.3	6.1	33.7	18.2	46.1	8.6	794.1	20.3	17.4
FECH		ENSG00000066926	Ferrochelatase	P22830	18	57544377-57586702	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Distal tubular cells: 156.5;Erythroid cells: 479.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 32.7;K-562: 31.4;U-266/70: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044100, HPA048177"	Approved					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA044100: AB_2678809, HPA048177: AB_2680300"	"unprognostic (2.30e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.59e-3)"	"unprognostic (6.85e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.86e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.36e-1)"	"prognostic favorable (2.38e-10)"	"unprognostic (1.10e-1)"	"unprognostic (8.30e-2)"	"unprognostic (4.05e-3)"	"unprognostic (3.58e-2)"	9.3	14.7	5.2	1.9	6.3	39.6	8.8	4.7	6.3	7.8	5.8	10.0	1.8	9.2	2.9	12.0	7.6	2.6	17.0	4.8	5.2	20.9	22.0	6.5	1.9	6.3	5.3	8.4	9.2	4.3	8.9	3.2	7.2	9.5	2.4	3.6	9.0	2.4	32.2	8.4	7.2	2.8	5.3	10.0	8.4	4.7	5.3	5.0	9.7	7.4	1.8	9.9	8.5	9.7	5.3	15.1	4.3	8.2	2.6	7.4	4.2	4.5	3.4	2.9	4.0	7.3	3.0	4.8	4.3	6.8	3.9	3.5	4.2	3.8	3.7	6.6	19.0	29.5	12.8	10.5	4.9	17.7	32.7	5.4	4.0	4.0	1.4	4.2	5.3	8.0	31.4	10.9	2.1	10.1	7.8	3.8	4.3	1.9	8.7	6.3	19.7	4.7	8.6	19.1	2.5	8.4	4.8	7.4	3.4	2.5	4.6	2.8	6.8	3.3	1.9	1.4	3.2	33.4	12.4	6.3	3.5	5.6	3.9	3.7	3.8	8.1	4.5	5.0	3.2	2.4	3.0	4.9	6.6	1.0	2.8	3.3	0.6	6.9	5.2	4.3	3.2	3.8	5.2	6.3	4.7	6.3	4.8	5.2	6.3	5.3	7.2	5.3	5.3	9.7	4.9	6.4	10.6	10.4	5.6	2.5	6.7	8.6	5.2	3.8	7.8	6.1	24.5	15.7	7.2	5.5	4.2	36.6	15.4	6.7	156.5	16.4	0.4	6.6	7.9	7.3	2.4	479.7	20.3	16.3	16.5	10.3	4.6	9.7	16.5	11.8	4.2	26.3	33.4	8.4	14.6	4.1	8.2	10.6	4.9	1.1	9.9	12.7	1.8	12.2	15.4	15.1	9.2	12.1	45.5	12.4	6.4	7.2	12.5	6.5	7.0	18.2	9.8	4.1	0.0	9.0	6.8	4.1	5.5	14.2	3.1	24.2	8.1	19.1	5.7	5.0
FES	FPS	ENSG00000182511	"FES proto-oncogene, tyrosine kinase"	P07332	15	90883695-90895776	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 83.4;lymphoid tissue: 110.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 46.8;Hofbauer cells: 48.7;Kupffer cells: 92.3;Macrophages: 51.9;monocytes: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 315.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 162.6;granulocytes: 315.8;monocytes: 151.7"	"Cell line enhanced"	"Detected in many"		"HEL: 63.5;HL-60: 56.9;HMC-1: 116.6;NB-4: 76.1;THP-1: 110.8;U-937: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001376	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	Vesicles	"HPA001376: AB_1078847"	"unprognostic (1.07e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.05e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-1)"	30.8	8.0	9.4	20.2	8.8	83.4	21.3	9.6	10.8	18.1	9.6	12.5	5.8	15.7	2.4	5.9	19.0	14.0	19.6	8.3	8.7	18.9	25.2	30.9	13.8	11.1	9.2	13.5	7.8	2.3	5.6	16.3	10.1	17.9	4.6	1.5	58.3	8.0	6.1	8.0	12.5	10.7	10.4	110.9	9.6	4.5	10.9	4.2	16.0	7.0	5.7	15.1	13.5	9.8	0.4	0.8	0.8	10.3	3.1	8.8	17.9	2.9	0.1	5.1	2.9	2.6	0.1	6.8	0.5	6.0	0.2	1.5	1.7	0.3	1.6	3.3	1.1	63.5	0.0	11.9	6.8	56.9	116.6	8.8	0.1	7.6	0.0	0.0	31.2	9.4	1.8	0.2	0.0	21.3	1.8	76.1	3.2	2.5	0.0	8.6	0.1	0.1	0.0	0.2	0.4	0.1	0.0	2.8	2.3	2.9	0.1	110.8	24.9	0.2	10.4	0.2	0.2	0.1	8.0	2.5	0.3	48.0	2.4	64.4	151.7	315.8	0.5	88.6	0.4	5.2	0.3	0.4	162.6	4.1	0.2	0.3	100.5	51.4	39.8	65.0	0.2	81.5	9.4	8.8	9.6	10.8	8.3	8.7	11.1	9.2	10.1	10.4	10.9	9.8	46.8	3.2	5.8	3.6	5.0	3.8	5.4	0.5	0.6	0.2	4.1	3.8	3.4	8.6	0.5	1.8	0.0	5.3	25.6	0.6	3.9	7.3	1.7	2.0	4.2	29.1	3.0	8.0	2.8	4.3	4.2	9.0	2.0	4.2	29.2	10.7	20.0	15.0	48.7	0.0	0.2	2.0	2.0	92.3	27.9	8.4	9.0	51.9	7.2	5.6	57.8	2.5	26.8	2.0	0.3	2.1	2.0	10.1	4.0	3.1	0.7	1.5	0.2	1.9	13.1	4.6	12.9	4.4	15.9	1.0	2.8	4.5	6.7	3.3	3.7	5.2
FGF23		ENSG00000118972	"Fibroblast growth factor 23"	Q9GZV9	12	4368227-4379712	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters"	Differentiation	"Growth factor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"brain: 126.3;choroid plexus: 104.9"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 10.4;Early spermatids: 6.6;Hepatic stellate cells: 13.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 10.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 10.8"	"Cell line enhanced"	"Detected in some"		"AF22: 1.9;HBEC3-KT: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA	56800		"Cluster 42: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 23: Spermatids - Flagellum & Golgi organization"							"unprognostic (1.31e-1)"						"unprognostic (2.18e-2)"				"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"			0.2	0.1	74.8	0.1	73.5	0.5	0.2	73.8	126.3	0.0	104.9	0.2	0.3	0.3	1.2	0.2	0.3	0.1	5.0	74.1	74.1	0.2	4.1	0.2	0.2	73.8	86.6	0.2	0.1	0.1	0.0	0.2	77.8	0.1	0.6	2.3	0.5	0.0	1.2	0.3	0.1	0.3	72.9	0.5	0.2	0.5	73.3	0.1	0.1	0.3	0.6	0.1	0.0	78.6	0.0	0.0	1.9	0.6	0.9	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.7	0.1	0.0	0.3	0.1	0.4	0.2	1.4	0.0	0.0	0.2	0.0	0.3	0.2	0.5	0.4	0.1	0.5	0.0	0.9	1.1	0.1	0.1	0.0	0.1	0.8	0.0	0.0	0.2	0.5	0.5	0.1	0.0	0.3	0.0	0.3	0.2	0.4	0.4	0.3	0.0	0.6	0.1	0.3	0.4	0.3	0.0	0.7	0.1	0.5	0.1	0.0	0.0	0.1	0.4	0.1	0.4	10.8	1.4	2.0	1.6	1.5	1.9	1.8	1.5	1.2	1.2	1.9	1.7	1.7	4.8	2.2	2.5	1.9	1.6	1.1	74.8	73.5	73.8	126.3	74.1	74.1	73.8	86.6	77.8	72.9	73.3	78.6	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.9	1.5	0.0	0.0	10.4	0.1	0.3	0.0	0.0	0.0	6.6	0.0	0.2	0.5	0.0	0.0	0.8	0.0	0.1	0.4	0.0	0.1	0.0	0.0	13.6	0.0	0.2	1.7	0.3	0.0	0.0	0.6	0.3	1.8	0.3	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.3	0.2	0.5	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.2
FGR	"c-fgr, p55c-fgr, SRC2"	ENSG00000000938	"FGR proto-oncogene, Src family tyrosine kinase"	P09769	1	27612064-27635185	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 207.8;lung: 86.5;lymphoid tissue: 141.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 182.2;Langerhans cells: 63.8;Macrophages: 155.9;monocytes: 159.7;NK-cells: 259.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Daudi: 86.0;U-266/70: 153.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002024	Enhanced		Approved	"Plasma membrane,Aggresome"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Aggresome	"HPA002024: AB_1078503"	"unprognostic (2.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.32e-2)"	"unprognostic (9.74e-3)"	"unprognostic (6.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.12e-3)"	25.0	6.8	12.8	62.2	11.9	207.8	16.0	11.9	19.1	7.6	11.5	6.0	3.9	8.1	1.7	5.2	15.6	12.7	8.7	11.4	12.3	7.5	10.8	86.5	27.5	13.6	12.7	2.9	5.8	1.6	2.7	7.9	14.5	7.2	4.0	0.7	6.6	2.4	3.2	4.5	10.1	16.3	12.5	141.1	5.9	2.5	17.2	8.4	7.4	6.5	20.0	17.8	7.3	12.6	0.0	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	86.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	1.7	29.3	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	3.8	5.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	153.1	2.1	6.5	0.0	19.5	0.0	30.8	381.4	229.4	189.5	469.1	11.3	54.0	15.8	89.1	196.1	84.0	8.0	78.4	272.9	264.5	405.2	9.0	1.2	494.1	12.8	11.9	11.9	19.1	11.4	12.3	13.6	12.7	14.5	12.5	17.2	12.6	8.6	6.4	20.0	0.0	24.9	2.8	0.6	0.2	0.0	0.0	0.4	0.6	1.6	1.5	5.7	1.8	0.0	0.5	55.2	0.0	0.0	0.0	0.3	0.1	0.2	14.9	0.0	7.4	0.2	0.2	0.7	2.7	1.5	0.1	13.3	0.1	6.8	1.9	56.8	0.0	0.1	0.0	0.0	182.2	63.8	0.7	0.3	155.9	1.8	6.5	159.7	0.1	259.5	1.0	0.4	0.0	1.2	0.0	4.2	0.4	0.0	0.7	1.5	0.0	0.0	0.7	0.6	0.2	0.5	0.5	1.1	1.0	28.0	0.0	0.0	2.5
FH		ENSG00000091483	"Fumarate hydratase"	P07954	1	241497603-241519755	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Tricarboxylic acid cycle"	Lyase	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 276.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 173.5;Early spermatids: 226.0;Syncytiotrophoblasts: 166.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017785, HPA025770, HPA025948, HPA027341"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA		1800000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB017785: , HPA025770: AB_10599603, HPA025948: AB_10602177, HPA027341: AB_10601222"	"unprognostic (1.03e-2)"	"unprognostic (3.82e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.76e-7)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.24e-2)"	43.4	75.2	30.4	31.0	33.3	31.4	37.3	33.5	42.0	28.9	43.9	66.8	68.2	36.9	26.1	51.1	27.9	23.7	179.0	33.9	33.1	101.8	276.4	26.4	30.0	31.8	31.0	24.9	38.1	95.0	31.1	32.1	32.1	33.5	69.0	58.8	42.0	38.4	213.4	40.3	59.1	42.0	32.4	30.1	53.6	44.4	32.7	31.3	34.6	229.3	40.4	37.5	33.7	33.0	129.2	105.6	97.9	89.0	93.9	110.0	154.9	155.7	121.1	171.6	107.1	152.2	78.0	81.1	100.3	119.9	75.0	178.4	151.7	115.8	148.4	93.5	48.9	76.3	102.2	131.4	84.1	180.2	66.7	80.2	70.7	96.6	108.0	60.2	107.2	175.8	236.3	101.7	126.9	64.3	156.6	120.1	104.5	186.2	223.6	127.4	107.2	365.7	167.4	107.6	125.4	108.4	131.1	153.3	104.0	67.2	117.1	120.9	106.5	76.6	98.9	137.0	264.0	90.3	103.7	97.3	85.7	203.5	112.6	11.9	22.8	4.9	16.1	33.3	21.0	27.2	18.8	15.1	46.7	25.1	22.3	21.1	1.3	18.3	29.1	23.1	23.8	16.7	30.4	33.3	33.5	42.0	33.9	33.1	31.8	31.0	32.1	32.4	32.7	33.0	17.1	38.5	30.2	9.4	25.0	20.0	24.6	69.5	17.1	24.7	19.9	17.5	173.5	35.8	40.0	23.9	14.6	101.6	13.7	44.0	78.2	60.4	226.0	25.4	23.5	18.6	18.0	37.7	12.7	45.0	58.7	25.5	26.5	25.4	19.0	24.9	13.6	80.4	50.7	35.3	14.9	40.6	48.8	18.5	14.4	37.4	23.9	23.9	24.9	8.4	27.9	35.0	10.3	8.0	14.4	29.4	35.7	26.7	41.3	19.0	66.1	86.0	29.2	39.1	39.5	27.7	67.9	84.7	47.1	32.1	18.6	166.1	14.9	48.4	74.2	22.8
FHIT	"AP3Aase, FRA3B"	ENSG00000189283	"Fragile histidine triad diadenosine triphosphatase"	P49789	3	59747277-61251459	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Hydrolase	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 94.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 609.8;Inhibitory neurons: 450.5;Microglial cells: 337.3;Oligodendrocyte precursor cells: 1086.7;Oligodendrocytes: 1111.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"naive CD4 T-cell: 87.6"	"Lineage enriched"	"Detected in all"	12	"T-cells: 87.6"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 17.5;U-266/70: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002684, HPA018840, HPA018909"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane"		NA	NA		12000	"Cluster 32: T-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoli fibrillar center, Plasma membrane"		"CAB002684: , HPA018840: AB_1848538, HPA018909: AB_1848537"	"unprognostic (2.36e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.77e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (1.54e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.80e-2)"	5.6	24.4	13.7	6.2	18.3	8.0	9.0	13.0	17.3	5.4	94.0	6.9	6.4	3.5	6.9	5.0	6.6	9.8	15.8	19.7	16.4	24.9	9.6	4.7	7.6	18.9	17.0	6.8	13.0	18.1	7.9	3.0	18.9	5.3	5.8	7.6	8.5	4.7	10.6	8.1	5.3	4.7	15.0	5.0	8.6	5.5	15.9	12.1	11.7	7.2	5.3	6.7	4.2	19.8	0.1	0.0	1.4	0.0	0.6	0.1	2.5	0.1	0.2	0.1	0.0	2.7	4.2	4.0	0.7	0.1	3.0	0.0	12.7	3.2	0.0	2.2	5.0	3.3	2.0	6.4	3.3	8.7	0.1	9.1	5.2	0.2	6.9	0.3	0.0	3.7	2.5	11.9	0.2	3.6	15.2	6.7	1.2	12.2	0.9	11.3	0.0	17.5	15.3	2.0	2.9	4.3	1.5	9.9	10.1	5.3	0.4	0.2	0.0	1.7	0.4	0.1	2.4	34.6	11.3	0.0	4.0	0.1	1.9	6.8	4.6	0.5	2.2	2.9	1.4	4.1	17.2	1.8	5.7	3.1	87.6	15.6	0.8	7.2	1.3	5.8	20.5	11.9	13.7	18.3	13.0	17.3	19.7	16.4	18.9	17.0	18.9	15.0	15.9	19.8	4.1	6.4	10.6	609.8	19.7	7.6	20.7	30.0	46.7	12.6	41.2	31.2	10.0	38.6	17.5	27.6	58.4	42.0	12.4	6.9	78.2	19.1	45.8	14.6	7.9	7.0	7.7	17.7	276.6	4.7	8.5	10.1	18.3	19.0	5.7	25.7	14.6	23.4	20.9	30.3	450.5	12.9	22.4	10.2	7.1	163.0	19.3	12.9	12.4	337.3	8.6	19.7	6.2	1086.7	1111.0	9.7	15.0	9.8	23.8	12.0	20.7	126.6	12.4	20.7	0.0	10.7	6.2	19.1	7.5	33.7	11.2	32.7	11.5	23.0	20.1	18.8
FITM2	"C20orf142, dJ881L22.2, FIT2"	ENSG00000197296	"Fat storage inducing transmembrane protein 2"	Q8N6M3	20	44302840-44311202	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid metabolism"	Hydrolase	"Deafness, Disease variant, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"heart muscle: 67.4"	"Cell type enriched"	"Detected in many"	9	"Cardiomyocytes: 153.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (2.92e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.19e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (8.98e-12)"	"unprognostic (2.07e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.38e-3)"	"unprognostic (2.49e-3)"	11.4	11.1	4.8	2.9	5.0	1.2	7.0	5.7	6.3	4.2	5.9	5.2	4.3	4.0	8.7	3.3	3.7	3.2	67.4	4.8	5.9	7.9	6.4	4.1	2.2	6.9	5.9	4.6	7.4	13.6	5.2	1.9	7.4	6.4	6.0	6.7	6.5	4.4	9.2	5.7	3.9	5.3	4.2	2.6	4.6	3.8	5.4	1.7	6.3	16.8	2.6	4.5	3.1	4.7	7.2	10.9	4.5	6.6	31.4	12.8	4.6	11.5	8.4	8.9	4.9	13.5	5.1	4.9	6.5	13.0	14.3	15.8	5.7	7.7	9.6	1.4	2.7	1.6	6.5	22.9	6.6	3.1	4.0	9.7	17.2	6.2	4.7	4.9	6.4	3.1	2.7	14.2	9.1	22.4	1.2	3.4	1.1	10.8	13.9	1.9	8.4	4.9	5.1	6.7	2.7	3.2	24.4	13.5	10.3	2.0	16.5	2.4	7.9	28.2	12.6	16.6	6.8	5.2	14.4	1.3	12.6	4.9	14.4	0.7	1.0	0.6	1.1	1.0	1.2	0.6	1.2	0.9	1.0	0.6	2.0	1.6	0.4	1.4	0.8	0.6	1.2	0.9	4.8	5.0	5.7	6.3	4.8	5.9	6.9	5.9	7.4	4.2	5.4	4.7	2.8	6.4	9.7	1.3	3.6	6.9	3.5	2.8	1.2	6.4	5.0	3.4	153.9	11.5	4.3	5.5	6.2	2.0	1.0	5.1	1.9	5.2	4.6	2.2	5.0	4.4	9.1	0.8	2.3	8.6	3.5	9.4	4.1	2.1	0.0	4.4	8.2	14.1	3.4	6.7	2.1	4.8	0.0	3.8	2.2	1.2	7.8	1.7	7.2	1.0	2.3	6.6	2.1	4.0	0.9	5.7	4.1	7.5	3.1	3.1	5.9	6.2	4.0	5.9	0.0	5.6	6.3	9.1	6.0	2.7	8.1	1.5	2.1	16.3	9.2	2.2
FKBP10	"FKBP6, FKBP65, FLJ20683, FLJ22041, FLJ23833, hFKBP65"	ENSG00000141756	"FKBP prolyl isomerase 10"	Q96AY3	17	41812680-41823213	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Isomerase, Rotamase"	"Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 79.1;Fibroblasts: 100.0;Sertoli cells: 59.2;Smooth muscle cells: 65.3;Theca cells: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 551.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051171, HPA057021"	Enhanced		Approved	Mitochondria	"Intracellular and membrane"	NA	NA		110000	"Cluster 22: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Mitochondria		"HPA051171: AB_2681371, HPA057021: AB_2683312"	"unprognostic (8.30e-2)"	"prognostic unfavorable (4.16e-4)"	"unprognostic (9.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.34e-2)"	"unprognostic (5.77e-2)"	"prognostic unfavorable (3.43e-5)"	"prognostic unfavorable (4.99e-4)"	39.4	39.5	20.9	27.1	22.2	0.5	33.5	21.7	26.1	64.0	22.0	29.1	7.6	61.5	16.9	13.9	50.9	46.0	45.6	20.3	22.1	17.7	7.8	37.8	10.9	24.6	21.6	58.4	15.1	48.5	56.7	60.7	22.2	32.6	10.8	6.0	14.7	30.8	7.6	20.4	19.1	55.6	21.9	14.3	18.5	9.0	24.2	4.9	34.9	9.3	4.4	42.2	39.1	21.6	0.7	119.6	110.7	363.3	379.3	441.7	92.0	490.4	497.4	185.6	159.0	62.1	4.8	0.3	6.6	551.9	45.9	0.8	66.7	133.4	77.9	33.0	99.9	48.6	132.1	181.0	411.4	0.0	0.6	476.1	0.5	150.3	115.5	352.6	158.8	0.0	1.9	16.7	157.0	163.2	0.3	0.1	85.4	258.0	38.3	9.9	125.2	15.7	31.7	0.1	26.7	92.1	0.7	349.3	166.0	137.4	54.1	3.1	181.0	219.0	111.5	145.8	76.0	0.8	0.2	0.3	299.7	0.0	213.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	20.9	22.2	21.7	26.1	20.3	22.1	24.6	21.6	22.2	21.9	24.2	21.6	14.9	0.0	4.8	38.2	0.2	8.5	11.5	2.7	1.2	0.6	10.8	13.2	2.3	1.5	1.4	0.0	0.0	6.1	0.2	0.1	0.0	8.7	0.7	3.0	79.1	34.9	0.0	0.0	0.3	4.7	30.8	100.0	1.5	4.6	0.0	32.9	30.4	0.0	4.7	15.2	0.3	1.3	0.0	0.0	9.7	2.9	46.9	1.5	16.0	15.0	0.0	32.0	0.0	17.1	0.1	2.2	0.1	44.8	0.5	8.2	0.0	0.0	0.1	1.1	59.2	35.2	65.3	0.9	7.6	0.5	5.1	11.9	2.1	54.0	0.6	1.6
FKBP14	"FKBP22, FLJ20731"	ENSG00000106080	"FKBP prolyl isomerase 14"	Q9NWM8	7	30010587-30026702	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Isomerase, Rotamase"	"Deafness, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013329, HPA026829"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA013329: AB_1848613, HPA026829: AB_10601651"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.12e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (6.06e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-3)"	"prognostic unfavorable (4.25e-4)"	6.5	5.1	3.4	7.0	3.5	4.3	6.4	5.4	3.6	9.9	3.1	4.7	3.0	8.5	10.0	4.7	4.3	6.0	6.8	3.2	3.2	3.1	3.2	4.1	3.1	3.3	3.1	5.4	5.8	6.2	7.7	7.9	3.0	6.8	4.8	7.2	4.3	7.5	2.1	4.7	2.9	13.9	3.0	2.7	4.0	2.2	3.5	1.8	3.3	3.2	3.2	8.9	3.8	3.5	7.0	5.2	14.4	33.6	36.8	46.8	6.5	34.9	32.7	12.0	23.3	4.4	4.3	2.4	16.0	31.0	14.7	14.8	8.1	12.8	23.9	1.3	11.6	5.6	9.2	13.1	18.6	4.0	9.3	29.4	13.1	20.9	24.6	28.2	27.0	3.6	9.2	5.0	21.8	2.9	2.1	4.9	7.5	7.7	9.2	0.1	9.6	8.2	11.8	6.1	3.8	12.5	12.2	27.5	8.8	17.0	6.2	5.3	21.7	12.6	14.6	21.8	14.0	7.6	8.3	4.2	18.0	3.8	40.2	0.5	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.4	0.2	0.0	0.6	0.2	0.1	3.4	3.5	5.4	3.6	3.2	3.2	3.3	3.1	3.0	3.0	3.5	3.5	13.5	19.2	16.0	7.2	7.9	27.4	22.0	15.8	35.9	16.3	13.3	13.0	15.7	5.7	11.7	18.4	27.1	11.6	9.4	5.3	1.9	7.4	0.4	30.4	44.3	12.9	1.2	6.5	19.4	3.7	27.3	40.0	15.3	40.0	2.5	9.1	8.6	6.5	6.0	15.2	12.7	9.7	8.2	2.5	11.2	0.4	13.1	5.7	10.6	10.3	3.6	26.5	2.1	11.6	16.6	5.7	19.0	20.7	43.8	17.8	3.3	2.7	6.0	21.4	6.6	13.8	20.4	1.4	3.4	27.5	18.3	15.7	6.0	20.8	6.1	28.0
FLAD1	"FAD1, PP591"	ENSG00000160688	"Flavin adenine dinucleotide synthetase 1"	Q8NFF5	1	154983338-154993111	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028476, HPA028486, HPA028563"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA028476: AB_10599974, HPA028486: AB_10600206, HPA028563: AB_10602286"	"unprognostic (2.64e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.32e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.51e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (1.67e-2)"	"unprognostic (5.06e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.17e-2)"	21.9	21.1	19.2	17.0	20.5	14.2	23.5	20.2	20.7	20.4	19.7	22.8	20.1	19.8	20.5	26.1	19.1	11.8	28.7	20.1	19.5	21.7	32.8	17.7	22.8	20.2	20.3	15.5	18.9	18.0	15.1	14.3	20.6	24.3	18.9	9.8	21.0	13.7	34.1	32.9	24.9	17.7	19.6	30.1	22.0	19.0	20.6	16.0	22.5	32.0	23.0	22.6	21.1	21.0	33.4	52.4	32.8	56.1	27.9	20.5	62.1	24.7	20.5	35.2	30.2	46.9	40.1	38.5	48.8	23.0	18.3	42.6	63.4	51.3	23.0	40.6	47.5	31.4	42.8	33.7	38.1	46.0	39.1	29.5	65.9	40.2	42.8	17.0	41.5	40.4	51.4	30.3	30.2	71.8	31.9	32.0	71.7	72.2	53.8	52.8	16.2	88.7	33.9	45.8	54.9	75.6	38.7	86.2	50.0	63.0	74.0	68.6	26.4	21.9	30.1	28.6	39.6	47.5	63.7	66.9	26.4	36.8	36.1	29.8	35.3	23.7	34.5	33.0	38.9	39.0	31.9	33.8	37.7	34.2	29.1	28.9	7.8	26.1	41.4	38.3	37.9	37.6	19.2	20.5	20.2	20.7	20.1	19.5	20.2	20.3	20.6	19.6	20.6	21.0	12.2	9.6	10.6	9.8	19.3	26.5	18.1	37.1	23.3	15.7	16.4	15.9	39.4	20.0	22.6	25.8	6.2	42.5	16.9	22.1	31.3	24.4	25.3	15.4	12.0	14.1	12.0	19.0	8.2	28.2	42.6	12.1	25.0	12.6	8.8	21.2	11.7	27.0	27.6	15.2	6.3	20.8	28.5	18.1	11.1	77.6	10.2	14.8	14.2	5.6	34.7	23.3	32.0	4.5	8.2	25.4	14.9	9.8	18.3	26.1	30.3	32.9	19.3	17.2	6.6	9.7	18.3	22.9	20.6	25.7	27.6	36.0	20.2	23.1	25.4	20.0
FLNA	"ABP-280, FLN, FLN1, OPD1, OPD2"	ENSG00000196924	"Filamin A"	P21333	X	154348524-154374634	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation"	Actin-binding	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 1203.7;intestine: 1462.2"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 500.6;Sertoli cells: 420.7;Smooth muscle cells: 459.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000356, HPA000368, HPA001016, HPA001115, HPA002925"	Enhanced	Approved	Enhanced	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		730000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Actin filaments, Cytosol"		"CAB000356: , HPA000368: AB_2797215, HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869"	"unprognostic (1.39e-1)"	"unprognostic (9.40e-3)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (5.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.88e-4)"	267.4	55.9	14.4	223.2	18.5	157.9	164.2	15.2	43.0	392.1	54.7	1462.2	89.9	1203.7	35.5	454.7	609.4	137.9	108.4	14.8	23.0	70.5	21.2	238.9	65.0	39.9	19.9	236.7	50.5	13.4	30.5	79.2	24.4	369.2	86.9	9.0	80.3	617.2	49.7	124.7	354.6	706.6	21.1	102.7	508.0	33.7	34.0	48.1	85.6	31.2	38.1	1053.9	286.4	21.5	947.2	719.2	246.7	316.1	209.8	278.4	400.9	614.0	680.1	552.5	489.8	469.2	169.4	80.5	1551.4	966.4	970.1	528.3	224.0	538.1	152.7	333.6	77.8	262.2	914.9	159.7	375.9	309.3	324.9	266.1	126.1	825.5	327.0	533.8	417.1	94.9	74.7	538.7	401.3	210.7	148.5	93.1	258.3	97.9	470.9	147.8	221.2	71.6	197.2	193.4	52.9	119.7	515.8	80.2	381.1	187.3	79.1	96.3	1016.6	625.2	586.8	640.0	1147.1	333.7	212.8	162.3	580.3	202.4	638.7	7.6	24.9	11.8	32.6	23.1	21.2	10.2	15.6	29.2	22.4	4.6	6.0	14.3	3.6	10.5	34.2	2.7	20.7	56.2	14.4	18.5	15.2	43.0	14.8	23.0	39.9	19.9	24.4	21.1	34.0	21.5	105.1	57.7	38.7	30.0	76.9	124.3	85.9	127.8	85.4	3.5	40.9	153.5	34.5	38.6	26.1	35.0	0.0	24.6	257.7	2.6	1.9	272.0	2.1	33.8	186.3	107.0	1.8	39.7	11.8	133.1	90.9	137.9	13.3	55.8	26.0	334.5	81.8	4.3	120.3	11.8	8.6	2.5	22.4	141.0	263.0	13.7	122.4	227.7	88.9	30.9	207.9	39.4	270.8	8.0	2.6	347.4	1.5	500.6	98.7	96.1	1.9	3.0	9.1	4.3	420.7	118.3	459.3	4.1	8.9	48.8	73.6	20.0	172.3	134.7	3.3	35.3
FLNB	"ABP-278, FH1, FLN1L, LRS1, TABP, TAP"	ENSG00000136068	"Filamin B"	O75369	3	58008400-58172251	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Differentiation, Myogenesis"	"Actin-binding, Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 344.9;Pancreatic endocrine cells: 385.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 17.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 523.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004747, HPA004886, CAB019322"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Actin filaments,Cytosol"		NA	NA		20000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Golgi apparatus, Actin filaments, Cytosol"	"CAB019322: , HPA004747: AB_1848599, HPA004886: AB_1848600"	"unprognostic (1.29e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (9.23e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (4.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.33e-1)"	74.6	63.1	42.8	22.3	51.3	7.4	90.4	50.9	52.4	45.5	57.1	122.2	52.8	75.5	120.3	57.7	75.9	19.6	47.2	40.1	41.6	96.7	71.5	49.9	24.4	54.4	52.3	68.9	83.2	59.9	38.1	48.0	52.6	124.4	74.4	10.2	64.0	51.4	16.3	91.3	92.7	36.2	48.1	55.3	70.2	30.4	50.0	74.8	91.1	17.8	23.8	114.7	58.6	58.3	134.4	225.0	22.3	32.9	14.8	25.0	385.7	49.0	39.3	106.6	108.4	227.1	223.1	21.9	18.1	172.9	172.8	215.9	42.1	311.5	103.0	121.6	20.8	18.4	192.7	110.5	107.8	16.2	63.1	40.2	132.1	148.5	448.3	125.2	365.4	94.7	30.9	6.6	67.0	29.2	49.3	38.5	34.5	146.6	192.1	21.6	5.8	18.7	143.8	224.6	24.7	23.1	247.3	132.6	27.4	160.9	110.3	44.6	523.3	27.8	84.5	334.1	175.6	4.8	1.7	17.0	102.2	29.2	29.9	10.1	0.3	5.0	0.5	0.8	2.7	4.1	1.7	0.8	1.4	1.6	5.1	3.8	0.2	7.3	1.5	17.9	2.0	1.5	42.8	51.3	50.9	52.4	40.1	41.6	54.4	52.3	52.6	48.1	50.0	58.3	133.7	51.3	30.2	3.9	11.0	50.6	42.9	73.2	29.0	3.3	86.6	43.4	10.0	57.2	62.0	47.8	39.6	28.7	36.8	344.9	0.0	93.8	15.6	103.6	24.4	92.9	49.2	10.3	34.1	67.1	207.1	28.8	88.7	133.8	24.7	34.4	151.3	52.0	14.6	1.7	34.3	82.8	38.7	11.3	12.2	22.4	16.1	11.1	5.4	22.5	11.6	9.1	2.1	25.1	40.9	385.7	161.0	27.8	3.4	115.2	157.3	6.5	76.1	10.6	0.0	4.4	25.9	4.4	6.9	46.4	51.7	49.8	9.9	84.6	93.0	88.4
FLNC	"ABP-280, ABPL, FLN2"	ENSG00000128591	"Filamin C"	Q14315	7	128830406-128859274	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 635.2;skeletal muscle: 1384.8;tongue: 442.6"	"Cell type enriched"	"Detected in many"	26	"Cardiomyocytes: 1892.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 393.6;fHDF/TERT166: 180.2;hTEC/SVTERT24-B: 190.6;U-2 OS: 163.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA006135, HPA071007"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		26000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA006135: AB_1848602, HPA071007: "	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (2.17e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (5.68e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (3.73e-5)"	13.1	3.4	5.8	25.9	11.5	0.0	5.9	11.5	9.9	16.9	3.0	215.4	9.4	96.6	4.6	40.3	35.4	13.8	635.2	5.9	16.7	2.8	1.1	12.5	0.6	52.1	11.1	9.4	2.1	3.2	1.6	2.4	29.9	71.1	9.8	0.5	16.5	100.7	1384.8	8.9	40.3	114.4	51.7	0.7	65.6	2.2	19.1	0.3	4.3	442.6	0.2	162.7	21.3	49.8	0.1	0.8	4.2	0.1	34.4	41.2	4.1	393.6	73.6	109.2	52.3	124.0	1.0	0.1	64.7	180.2	44.9	0.1	23.7	0.9	64.4	0.2	13.1	0.1	20.2	0.1	43.2	0.0	0.2	78.0	0.1	190.6	0.1	44.2	69.0	0.3	49.0	0.2	75.8	0.0	0.0	1.5	64.5	0.1	22.6	0.1	127.5	1.0	0.1	0.0	2.1	7.0	0.7	0.1	0.3	88.0	0.4	1.6	144.6	38.2	163.5	10.1	0.2	0.1	0.0	0.3	129.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	11.5	11.5	9.9	5.9	16.7	52.1	11.1	29.9	51.7	19.1	49.8	3.6	3.2	0.5	0.7	0.0	3.7	0.3	0.1	1.2	0.6	0.3	1.3	1892.3	0.0	1.9	1.8	0.0	0.4	0.2	0.5	0.0	0.7	0.4	1.8	5.0	31.4	0.0	0.0	0.2	0.2	3.0	31.6	0.0	2.9	0.0	0.6	1.8	0.0	0.9	0.0	1.1	0.3	0.0	0.0	6.9	0.9	5.3	0.5	5.4	0.0	0.0	0.1	0.0	0.0	5.8	2.6	0.1	10.5	1.2	2.7	0.0	1.1	0.0	0.2	0.0	71.8	38.1	0.3	1.0	0.2	4.5	1.9	1.0	0.1	0.2	1.0
FLVCR1	"AXPC1, FLVCR, MFSD7B, PCA, SLC49A1"	ENSG00000162769	"FLVCR heme transporter 1"	Q9Y5Y0	1	212858275-212899363	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Erythrocyte maturation, Transport"	Receptor	"Disease variant, Neurodegeneration, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.4"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046646	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 45: Enterocytes - Digestion"	"Cell Junctions"		"HPA046646: AB_2679735"	"unprognostic (2.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.88e-2)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (7.15e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-2)"	"unprognostic (7.29e-3)"	2.1	2.4	3.4	3.1	2.8	6.2	3.1	5.0	3.7	2.9	2.7	3.4	9.7	2.5	4.9	2.1	2.4	2.0	1.6	3.2	4.4	2.4	1.8	2.4	2.9	4.5	4.1	2.4	2.6	3.6	6.9	2.4	5.3	3.4	2.8	7.0	1.9	1.8	1.0	2.9	19.4	1.7	2.5	2.6	4.8	2.8	4.3	2.6	2.2	0.6	2.2	2.3	2.3	4.2	8.4	11.0	16.8	5.1	2.8	3.4	31.3	2.4	1.8	4.8	2.9	16.1	15.2	9.1	4.4	1.7	10.2	12.5	18.2	5.4	4.7	5.4	8.0	5.4	10.4	14.9	3.2	14.5	8.4	2.7	3.5	5.2	6.6	2.5	3.8	6.4	14.7	7.4	3.2	3.2	4.1	7.2	55.3	11.1	7.7	9.0	15.4	10.6	6.0	8.0	18.1	12.7	11.2	11.1	10.4	13.8	18.2	6.7	2.2	2.3	5.6	7.7	11.2	4.6	9.9	10.8	3.5	8.3	2.9	0.5	0.2	1.5	0.2	0.1	0.2	0.2	0.3	0.2	0.1	0.3	0.3	0.3	0.7	0.2	0.2	0.4	0.4	0.0	3.4	2.8	5.0	3.7	3.2	4.4	4.5	4.1	5.3	2.5	4.3	4.2	6.7	12.8	16.0	12.4	8.3	14.3	8.8	6.9	9.6	24.0	10.3	9.5	4.1	14.3	12.1	20.2	35.5	3.9	6.8	13.7	1.9	5.5	4.7	7.0	7.8	9.3	32.4	9.5	28.8	13.4	6.7	8.8	17.3	7.6	7.0	20.1	10.0	9.2	6.5	16.8	39.4	10.6	10.2	10.1	9.6	6.8	6.2	9.0	5.4	9.4	10.5	5.8	4.1	24.1	28.7	8.9	12.0	2.6	6.5	11.9	73.7	4.6	10.1	31.8	6.6	18.0	7.2	10.4	6.8	7.0	9.2	2.5	8.3	5.1	8.2	4.3
FLVCR2	"C14orf58, CCT, FLJ20371, MFSD7C, SLC49A2"	ENSG00000119686	"FLVCR heme transporter 2"	Q9UPI3	14	75578620-75663214	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 75.6;Kupffer cells: 44.9;Late spermatids: 142.5;Microglial cells: 41.2;Proximal enterocytes: 50.4;Syncytiotrophoblasts: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 14.0;intermediate monocyte: 14.6;myeloid DC: 7.6;non-classical monocyte: 11.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.6;monocytes: 14.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 53.8;ASC TERT1: 23.2;BEWO: 73.5;MCF7: 26.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037984	Enhanced					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA037984: AB_10672733"	"unprognostic (2.42e-1)"	"unprognostic (4.85e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.44e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.80e-2)"	"prognostic favorable (2.53e-5)"	"unprognostic (6.69e-2)"	"unprognostic (9.94e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.16e-1)"	5.1	13.6	3.5	9.3	3.7	5.4	2.5	3.2	3.8	2.1	16.2	8.4	17.4	1.0	1.4	2.9	1.9	3.5	2.2	2.9	2.7	11.3	20.5	16.2	5.3	4.7	3.7	2.2	0.6	2.1	3.4	10.3	3.9	2.3	7.1	0.7	12.7	1.7	8.3	5.7	24.4	4.2	5.2	13.8	0.9	21.1	4.8	1.2	3.2	1.6	5.0	4.9	2.6	5.5	3.7	2.8	0.8	4.0	53.8	23.2	73.5	0.7	3.1	3.3	2.6	6.2	0.4	0.0	0.2	0.2	5.4	0.4	9.8	0.2	1.3	19.3	0.6	0.1	2.8	13.3	4.3	0.1	0.6	10.9	7.7	4.0	2.4	0.1	0.8	0.3	0.2	0.5	10.1	26.4	0.2	1.9	1.6	1.1	4.4	0.1	2.6	0.0	3.5	5.1	0.0	0.1	2.0	8.1	1.6	4.6	4.5	10.1	8.8	4.0	1.4	2.0	0.1	0.6	1.1	0.0	11.4	2.5	0.7	0.0	14.0	0.7	0.4	14.6	1.1	0.0	1.1	0.3	7.6	0.1	0.8	0.2	0.5	0.5	11.8	0.1	1.6	4.1	3.5	3.7	3.2	3.8	2.9	2.7	4.7	3.7	3.9	5.2	4.8	5.5	0.3	6.4	6.4	2.6	0.5	0.6	0.3	0.4	0.6	0.0	1.5	0.6	0.8	0.0	3.2	3.7	0.0	23.2	1.7	14.0	0.0	0.1	75.6	2.1	3.9	2.5	0.0	0.0	0.2	0.2	31.0	2.2	0.0	2.7	1.3	0.2	1.8	21.1	16.4	0.0	0.2	2.2	4.1	44.9	5.6	142.5	3.4	19.0	0.0	41.2	10.1	1.3	2.1	0.0	0.2	0.1	3.2	1.9	0.5	0.8	50.4	7.0	0.3	0.3	0.0	0.4	0.3	2.4	1.3	0.2	0.9	54.5	1.2	2.3	5.5	0.2
FMO3	FMOII	ENSG00000007933	"Flavin containing dimethylaniline monoxygenase 3"	P31513	1	171090901-171117819	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	41	"liver: 1123.3"	"Cell type enriched"	"Detected in some"	13	"Hepatocytes: 412.3"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 94.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 34.6;ASC TERT1: 26.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013750	Enhanced					NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"HPA013750: AB_1848968"	"unprognostic (1.87e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.31e-3)"	"prognostic favorable (3.46e-4)"	"prognostic favorable (5.60e-5)"	"unprognostic (2.95e-1)"	"unprognostic (9.34e-2)"	"unprognostic (3.02e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.27e-2)"	27.2	12.4	2.5	0.9	2.7	0.4	6.8	2.5	3.6	1.2	2.3	1.4	1.8	1.3	3.0	5.1	13.3	1.8	4.2	2.3	2.6	14.0	1123.3	18.7	4.9	5.0	2.7	0.3	4.5	4.2	4.3	0.2	3.1	1.1	0.7	0.1	5.1	0.4	4.6	4.3	2.2	1.6	4.0	0.4	3.9	0.5	2.8	1.4	2.6	3.1	9.1	1.0	0.9	2.6	0.0	0.0	0.0	0.0	34.6	26.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	7.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.7	2.5	3.6	2.3	2.6	5.0	2.7	3.1	4.0	2.8	2.6	2.7	12.8	0.5	0.0	0.7	0.4	0.4	2.7	0.0	0.0	0.1	0.3	0.4	7.2	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	0.0	4.7	0.0	29.5	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	6.8	412.3	0.0	0.0	0.0	0.0	4.1	9.5	0.8	0.0	0.3	0.1	1.8	1.0	0.0	0.5	0.0	7.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	22.7	0.2	6.6	1.3	6.3	0.4	0.1	0.4	0.4	0.0	0.8	0.2	0.0	0.1
FOLR1	"FOLR, FRα"	ENSG00000110195	"Folate receptor alpha"	P15328	11	72189558-72196323	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Transport	Receptor	Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 480.2;fallopian tube: 187.2;lung: 193.5;salivary gland: 219.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 496.8;Alveolar cells type 2: 213.3;Breast glandular cells: 211.3;Club cells: 276.3;Collecting duct cells: 318.2;Cytotrophoblasts: 462.2;Proximal tubular cells: 366.0;Syncytiotrophoblasts: 259.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 259.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HeLa: 444.2;RPTEC TERT1: 476.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077030			Approved	"Nuclear membrane"	"Secreted to blood"	NA	NA	448000	140000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"	"Nuclear membrane"		"HPA077030: "	"unprognostic (3.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.18e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	0.1	1.7	2.7	0.2	1.8	0.1	28.3	11.8	1.8	123.5	480.2	0.5	0.3	1.9	7.6	3.4	187.2	2.4	0.6	14.1	4.1	153.0	0.2	193.5	0.0	5.7	7.8	0.7	7.1	17.5	8.1	36.2	3.8	1.5	0.4	0.5	219.5	15.2	0.1	2.5	0.4	0.2	3.2	0.2	33.0	0.2	7.7	0.2	45.9	0.0	0.4	0.1	0.1	2.7	0.2	0.2	0.0	0.2	0.0	0.0	64.7	0.1	0.1	0.1	0.1	44.5	46.0	0.0	45.5	0.8	0.0	0.9	2.4	2.1	0.2	0.1	1.4	1.0	444.2	1.3	0.0	0.0	0.1	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.5	0.1	0.1	2.2	0.7	0.0	0.5	15.1	0.0	476.5	0.0	0.1	3.0	1.4	7.1	0.1	38.5	65.7	0.5	0.0	0.0	8.4	0.3	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.8	11.8	1.8	14.1	4.1	5.7	7.8	3.8	3.2	7.7	2.7	1.0	496.8	213.3	0.0	1.3	0.9	7.9	80.3	0.0	0.0	211.3	62.9	0.2	34.3	276.3	318.2	0.0	462.2	1.1	0.0	133.1	14.3	0.1	33.6	2.3	3.4	1.8	0.0	0.0	1.4	110.9	4.3	9.7	33.7	5.1	0.0	0.0	0.0	29.5	0.0	0.0	0.1	87.5	0.0	0.4	0.0	0.6	3.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	6.7	0.0	0.0	0.0	6.3	0.0	366.0	149.1	0.1	0.0	0.1	6.3	0.0	0.5	3.2	0.1	259.0	2.2	0.3	0.3	10.4
FRMD7	"FLJ43346, NYS, NYS1"	ENSG00000165694	"FERM domain containing 7"	Q6ZUT3	X	132076990-132128020	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Neurogenesis		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"endometrium 1: 2.9;kidney: 2.7;smooth muscle: 2.2"	"Cell type enriched"	"Detected in single"	19	"Distal tubular cells: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-87 MG: 1.5"	"Region enriched"	"Detected in many"	28	"olfactory bulb: 65.7"	"Region enriched"	"Detected in single"	86	"olfactory bulb: 21.3"	HPA000886	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA000886: AB_1079269"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"			"unprognostic (1.36e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.54e-2)"			"unprognostic (3.00e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	2.9	0.5	0.0	0.5	0.0	0.1	0.1	0.1	2.7	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FTCD		ENSG00000160282	"Formimidoyltransferase cyclodeaminase"	O95954	21	46136262-46155579	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	"Lyase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 939.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 131.5;Early spermatids: 104.7;Hepatocytes: 444.9;Late spermatids: 124.3;Proximal tubular cells: 395.1"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 87.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"Hep G2: 92.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020073, HPA030928, HPA030929, HPA036114"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	NA		1600000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Plasma membrane"	"HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-5)"	"unprognostic (2.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.78e-5)"	"unprognostic (1.80e-1)"	"prognostic favorable (5.78e-4)"	"unprognostic (3.80e-2)"	"unprognostic (3.60e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.10e-1)"	0.4	1.7	5.4	0.2	6.8	0.0	0.4	3.6	8.4	1.3	3.0	1.3	1.3	1.2	0.4	0.3	0.9	0.1	1.6	4.9	4.7	155.7	939.8	0.2	0.2	4.6	3.9	3.0	4.0	0.0	3.4	0.0	5.6	4.2	0.0	0.0	0.2	0.6	0.4	0.3	1.7	0.0	3.5	0.5	0.5	13.9	4.4	0.0	0.9	0.0	0.0	1.3	1.0	5.5	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	3.1	0.0	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.6	0.6	0.0	92.9	0.0	0.6	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.9	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.4	0.5	0.0	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	5.4	6.8	3.6	8.4	4.9	4.7	4.6	3.9	5.6	3.5	4.4	5.5	0.0	0.0	0.0	1.0	8.1	0.1	0.0	0.0	0.0	1.3	0.2	0.5	1.5	131.5	0.0	9.2	0.0	0.0	0.1	0.0	46.9	0.0	104.7	0.1	0.4	1.8	0.0	61.5	10.5	0.0	0.0	0.6	0.0	0.2	0.0	0.6	30.4	444.9	0.1	3.3	5.9	0.1	0.0	28.9	0.0	124.3	3.1	1.6	0.0	1.0	0.0	0.2	0.0	1.0	18.5	0.0	0.1	2.6	0.0	0.5	0.3	395.1	0.0	0.4	0.0	0.2	0.5	39.2	17.9	0.2	0.4	0.0	3.6	0.1	0.2	0.1
FTO	"ALKBH9, KIAA1752, MGC5149"	ENSG00000140718	"FTO alpha-ketoglutarate dependent dioxygenase"	Q9C0B1	16	53701692-54158512	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase, Transferase"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 173.3;Excitatory neurons: 226.1;Inhibitory neurons: 240.7;Oligodendrocyte precursor cells: 210.6;Oligodendrocytes: 282.5;Respiratory ciliated cells: 182.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017123, HPA041086, HPA068695"	Enhanced		Supported	Vesicles,Cytosol		No	No		540000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Vesicles	"CAB017123: , HPA041086: AB_2677293, HPA068695: AB_2732117"	"unprognostic (9.74e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.30e-3)"	"unprognostic (6.11e-3)"	24.4	33.6	31.8	12.5	36.6	8.2	36.3	30.1	37.7	25.8	31.0	22.2	7.7	26.9	21.4	17.2	25.3	21.6	27.1	35.2	39.5	25.0	17.4	36.8	15.0	29.2	31.3	27.2	20.7	40.6	26.2	20.1	31.9	20.0	14.1	38.4	18.9	23.9	33.1	21.4	12.5	29.9	30.5	16.4	15.0	8.3	33.8	17.0	27.5	23.0	14.8	21.9	18.5	43.9	15.1	26.8	35.0	35.9	67.3	50.4	11.5	35.6	32.2	29.3	8.5	16.8	19.3	34.4	38.2	46.3	16.6	21.7	32.4	34.9	42.5	16.0	25.5	15.5	33.6	31.7	46.2	12.5	17.1	55.9	36.5	26.6	32.5	36.6	44.1	25.1	15.2	8.4	48.1	11.8	28.0	19.2	18.1	15.5	17.5	42.2	52.9	32.3	44.6	12.3	43.0	29.7	40.4	23.6	10.8	33.7	31.1	29.3	42.4	36.4	23.9	19.8	22.1	15.9	13.9	35.0	33.9	22.9	28.7	14.9	17.9	9.7	25.6	22.7	32.4	17.6	24.4	25.9	23.8	17.4	22.5	24.4	2.9	26.4	16.5	9.5	26.6	23.1	31.8	36.6	30.1	37.7	35.2	39.5	29.2	31.3	31.9	30.5	33.8	43.9	15.1	80.1	62.0	173.3	10.3	12.4	10.0	8.6	13.6	22.8	69.1	39.5	22.3	15.7	54.4	7.3	12.5	9.3	10.2	4.8	7.9	9.0	39.1	11.0	18.3	17.4	6.6	9.7	226.1	5.7	7.4	23.1	9.7	9.9	25.9	16.8	11.0	13.8	9.2	16.8	240.7	6.6	10.2	9.0	13.2	69.9	14.3	11.8	10.6	134.0	5.5	19.6	10.3	210.6	282.5	5.5	5.0	15.1	18.7	6.0	4.5	15.8	182.7	14.1	13.1	21.6	16.8	3.5	3.4	11.0	9.1	5.1	12.9	17.8	6.3	7.9
FTSJ1	"CDLIV, JM23, MRX44, MRX9, SPB1, TRM7, TRMT7"	ENSG00000068438	"FtsJ RNA 2'-O-methyltransferase 1"	Q9UET6	X	48476021-48486364	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 75.7;Pancreatic endocrine cells: 60.1;Plasma cells: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002718	Approved		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA002718: AB_1078914"	"unprognostic (2.56e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (1.95e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.96e-3)"	"unprognostic (2.06e-3)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (5.24e-10)"	"unprognostic (2.61e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.23e-1)"	14.6	15.2	5.7	14.5	6.8	16.0	13.8	6.5	9.0	16.0	5.2	10.2	8.2	13.8	4.6	14.9	12.1	8.6	11.4	6.6	6.7	10.1	9.8	13.3	16.2	6.0	6.2	12.7	16.8	12.4	12.2	8.4	6.2	10.3	7.7	5.7	15.4	12.8	14.8	14.2	10.2	12.3	6.2	13.7	13.7	9.8	5.8	14.8	14.3	10.9	13.4	14.3	14.1	6.6	75.9	51.1	19.1	76.4	27.1	27.9	31.3	36.0	34.3	51.4	40.5	30.8	102.6	43.6	26.3	55.4	32.4	49.8	38.3	127.3	23.1	33.4	36.3	27.8	62.5	35.5	75.8	38.5	67.4	26.0	63.0	64.8	63.2	28.5	36.4	49.2	24.1	35.2	67.4	42.6	50.4	27.3	43.2	32.1	86.6	40.4	62.7	91.2	48.3	25.4	26.0	25.5	57.4	31.1	27.5	22.1	35.7	21.7	35.8	40.6	54.9	85.3	44.9	47.6	39.8	31.4	89.6	71.3	43.6	19.5	23.7	19.1	34.6	27.1	43.0	27.2	29.5	35.4	28.3	31.5	26.8	34.5	3.4	30.3	27.8	19.1	30.2	27.8	5.7	6.8	6.5	9.0	6.6	6.7	6.0	6.2	6.2	6.2	5.8	6.6	15.1	6.4	11.0	3.9	20.6	12.7	11.4	30.7	14.2	4.5	8.5	8.8	6.7	4.3	23.8	7.3	2.1	5.3	19.7	6.6	17.6	21.2	49.5	11.1	11.8	13.4	5.4	14.7	4.4	18.2	28.7	12.4	16.3	15.2	8.8	9.2	6.4	5.9	17.0	3.3	4.3	11.3	10.2	8.4	10.6	75.7	10.8	11.0	5.4	5.6	8.9	5.7	19.6	3.0	5.8	60.1	2.7	8.6	59.5	17.0	4.8	11.3	14.0	6.5	13.1	9.6	16.7	7.5	10.1	15.0	10.9	5.7	17.0	10.7	9.4	26.5
FUCA1		ENSG00000179163	"Alpha-L-fucosidase 1"	P04066	1	23845077-23868290	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 181.7;Distal enterocytes: 226.6;Paneth cells: 221.0;Proximal enterocytes: 210.9;Syncytiotrophoblasts: 200.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 165.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046542, HPA056371"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		60000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA046542: AB_2679691, HPA056371: AB_2683108"	"unprognostic (6.94e-3)"	"unprognostic (6.53e-2)"	"unprognostic (2.68e-3)"	"prognostic favorable (2.45e-4)"	"unprognostic (5.64e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.99e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (5.70e-13)"	"unprognostic (3.75e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.13e-3)"	34.2	34.4	8.3	49.8	8.2	7.7	26.3	8.3	11.2	54.5	23.8	124.2	90.3	20.7	113.0	17.0	51.1	46.6	20.6	8.3	10.5	78.2	104.8	55.1	168.2	9.5	8.8	23.8	23.9	56.9	17.6	72.6	9.6	50.2	140.7	5.7	40.8	60.4	15.8	14.9	81.3	26.7	9.3	71.8	63.9	27.7	10.8	26.8	70.6	17.7	94.1	74.9	13.2	12.8	15.9	10.6	2.2	31.9	4.2	0.3	11.0	16.6	34.4	17.1	31.6	14.5	165.1	23.9	40.9	21.3	18.8	9.4	15.3	35.4	22.4	16.9	25.6	19.7	9.2	32.7	14.2	2.0	62.7	15.3	19.7	6.2	8.1	55.2	6.9	13.3	9.3	0.5	20.6	17.5	5.0	17.7	5.4	48.1	16.9	26.9	0.2	26.2	63.5	40.5	10.9	10.6	47.9	18.5	26.2	17.9	13.6	7.8	1.8	5.8	9.0	38.9	5.6	28.5	31.0	8.5	14.5	58.9	9.5	54.8	100.4	51.9	27.2	99.9	23.1	23.8	19.5	22.9	44.0	14.1	18.9	22.0	12.8	44.6	91.1	25.4	21.4	64.8	8.3	8.2	8.3	11.2	8.3	10.5	9.5	8.8	9.6	9.3	10.8	12.8	12.9	25.6	28.6	4.2	10.5	3.6	27.4	99.3	6.8	4.4	22.2	10.4	5.6	40.0	77.8	84.6	0.0	181.7	13.9	226.6	15.6	64.1	61.0	31.5	2.8	11.6	10.8	20.6	5.8	50.3	24.2	16.7	33.1	13.3	8.2	11.1	25.7	42.7	156.4	0.0	6.3	44.4	44.7	121.0	13.5	24.4	23.3	85.4	8.8	2.8	29.6	13.0	10.3	4.0	4.7	34.9	221.0	19.5	8.7	23.6	210.9	40.2	53.7	5.0	6.6	16.7	13.2	109.0	24.8	8.5	2.8	200.6	11.2	34.6	79.5	40.3
FUT8		ENSG00000033170	"Fucosyltransferase 8"	Q9BYC5	14	65410592-65744121	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 64.3"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1019.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 15.6;NK-cells: 14.8;T-cells: 10.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017129, HPA043410"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB017129: , HPA043410: AB_2678467"	"unprognostic (1.67e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.33e-3)"	"unprognostic (8.09e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	7.9	8.2	21.0	11.9	38.2	3.6	10.5	44.1	28.2	6.9	0.0	11.4	17.5	9.0	5.3	6.8	15.6	11.1	4.7	20.4	27.7	6.9	3.4	8.1	11.7	32.8	29.9	7.3	9.9	9.6	4.6	17.3	29.3	5.8	11.6	8.3	42.6	10.5	2.5	5.3	17.4	11.0	29.4	10.2	31.8	16.4	29.7	11.3	8.4	6.3	18.6	13.3	4.5	64.3	115.9	22.5	12.6	110.6	49.5	38.4	61.6	35.9	64.8	30.3	32.6	16.9	44.8	30.7	29.2	40.1	79.4	9.0	29.9	11.4	45.6	124.2	11.0	33.5	7.2	23.0	26.8	7.6	23.9	96.0	6.8	39.3	19.4	124.4	69.6	17.1	14.1	28.8	20.8	60.8	36.6	16.7	14.7	59.6	66.6	26.9	10.3	17.2	46.5	33.1	23.4	16.6	20.8	9.8	8.0	70.6	10.2	12.9	141.8	34.5	36.0	15.3	30.5	47.3	18.5	74.3	68.6	13.6	11.1	0.7	2.0	0.7	3.6	0.9	3.8	15.6	6.2	5.6	2.6	8.3	6.6	6.6	0.3	14.8	1.4	2.6	10.0	2.9	21.0	38.2	44.1	28.2	20.4	27.7	32.8	29.9	29.3	29.4	29.7	64.3	19.0	12.8	32.5	227.5	43.1	12.1	7.4	11.5	17.1	10.1	18.3	11.7	5.9	8.6	18.9	12.9	4.2	45.5	8.3	5.9	0.0	9.1	37.9	9.9	14.6	16.0	5.4	15.8	169.0	31.7	28.1	22.7	78.0	10.2	7.6	3.3	14.6	3.5	13.0	8.4	166.4	26.5	2.0	12.2	8.6	15.3	12.8	10.2	1.8	70.3	3.6	27.8	9.2	138.7	1019.1	54.7	10.3	13.5	124.3	8.8	24.5	8.4	15.3	9.1	0.0	14.3	13.2	34.6	26.8	7.4	9.8	14.1	18.9	10.6	21.7	7.2
FXN	"CyaY, FA, FARR, FRDA, X25"	ENSG00000165060	Frataxin	Q16595	9	69035751-69079076	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Heme biosynthesis, Ion transport, Iron storage, Iron transport, Transport"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 69.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022164, HPA068304"	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Mitochondria	Cytosol	"CAB022164: , HPA068304: AB_2685970"	"unprognostic (3.38e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.37e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.74e-2)"	10.3	20.1	8.9	7.8	9.2	29.1	10.1	9.7	8.9	9.3	11.7	10.4	7.4	12.1	12.1	9.5	10.2	5.3	27.0	9.0	10.4	12.9	46.3	7.1	9.8	9.8	10.2	17.6	15.1	22.2	8.1	9.1	9.8	10.2	12.3	4.1	11.7	13.6	25.5	5.2	7.7	13.3	9.5	12.6	10.1	10.7	9.9	5.4	10.4	19.8	10.4	12.3	7.9	10.4	27.0	22.1	34.2	17.0	15.7	23.1	34.3	18.6	16.3	28.0	21.2	11.8	16.6	45.9	14.0	19.5	28.8	28.6	41.8	42.6	34.9	53.9	47.5	66.2	14.1	87.2	26.7	48.7	27.7	25.7	33.7	27.8	29.9	9.6	37.7	28.0	50.3	43.9	26.1	25.6	14.0	21.0	47.5	53.1	42.8	32.7	24.0	32.0	32.2	21.5	26.9	12.1	19.2	12.5	20.7	24.3	14.1	14.4	22.7	18.0	32.0	24.1	27.6	11.6	11.4	27.8	8.5	39.7	18.5	8.1	39.9	0.4	48.6	45.4	37.5	36.3	48.0	48.4	42.8	22.7	61.6	59.8	1.9	60.8	36.2	33.2	43.3	49.5	8.9	9.2	9.7	8.9	9.0	10.4	9.8	10.2	9.8	9.5	9.9	10.4	11.0	3.2	11.5	13.1	19.9	9.7	19.8	36.6	14.8	6.8	16.9	20.8	38.2	10.0	10.5	14.7	4.2	39.9	14.9	4.9	21.5	17.5	2.4	11.7	22.5	16.9	7.2	56.1	14.2	14.7	22.3	14.7	14.3	8.7	7.0	15.4	11.0	69.0	33.4	0.0	18.6	15.3	18.3	22.1	16.1	6.3	15.8	13.9	17.8	9.4	18.3	7.6	28.8	6.6	10.8	15.0	3.7	13.2	42.0	17.1	5.8	27.2	7.4	1.6	13.1	10.1	19.8	5.1	32.3	29.8	8.1	14.6	17.1	27.9	17.5	14.1
FZD2		ENSG00000180340	"Frizzled class receptor 2"	Q14332	17	44557484-44561262	"Cancer-related genes, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 10.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Kupffer cells: 9.8;Leydig cells: 23.3;Peritubular cells: 18.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.1;myeloid DC: 1.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 1.8;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 53.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA057667	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"	"Cell Junctions"	"HPA057667: AB_2683497"	"unprognostic (6.94e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.83e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.45e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.19e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-3)"	1.5	1.6	1.0	1.4	1.5	0.2	1.3	0.9	1.2	5.9	10.5	1.8	0.9	5.3	1.3	0.9	3.8	1.8	2.8	1.1	1.3	2.8	0.2	2.9	0.8	1.3	1.9	3.3	1.5	2.1	1.1	3.6	2.0	1.7	0.4	0.7	1.0	1.9	0.4	0.6	1.6	1.5	1.3	2.1	1.2	1.5	1.4	0.3	2.4	0.7	0.7	2.0	2.5	1.6	12.9	37.7	38.3	13.8	8.7	6.4	0.4	39.5	30.4	53.4	38.2	28.4	6.2	0.0	8.9	13.9	13.1	5.5	3.6	2.8	30.2	2.9	7.2	1.7	6.6	0.1	7.7	0.2	7.5	10.7	2.8	9.6	8.8	40.8	1.8	4.9	2.5	0.3	20.9	5.9	6.7	3.6	26.8	0.1	6.7	18.1	8.6	1.9	7.7	0.6	3.8	10.9	5.2	1.1	2.3	32.4	14.6	8.4	0.7	24.1	17.5	4.4	22.6	0.8	0.7	3.0	4.0	2.4	11.3	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.2	1.0	1.5	0.9	1.2	1.1	1.3	1.3	1.9	2.0	1.3	1.4	1.6	0.5	19.2	0.0	1.6	0.6	0.6	0.3	0.9	0.0	0.0	0.9	2.9	1.9	0.0	0.2	1.8	0.0	1.6	1.8	0.0	0.0	0.3	0.6	1.1	8.4	0.7	1.2	1.3	0.0	1.8	0.5	5.9	0.0	1.5	0.0	1.4	0.7	0.0	4.8	0.0	0.0	0.3	0.0	9.8	6.0	0.4	23.3	5.6	0.0	6.5	6.2	6.0	0.0	0.0	0.2	0.7	0.0	18.0	0.3	0.1	0.0	0.3	0.2	0.4	0.0	0.4	5.3	0.3	1.2	0.3	0.4	2.3	0.2	2.4	0.0	0.0
FZD4	"CD344, EVR1"	ENSG00000174804	"Frizzled class receptor 4"	Q9ULV1	11	86945679-86955395	"CD markers, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 120.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 83.0;Collecting duct cells: 36.8;Endothelial cells: 51.2;Hepatic stellate cells: 99.6;Sertoli cells: 32.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 22.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 63.6;Hep G2: 85.2;HSkMC: 46.0;HUVEC TERT2: 93.6;TIME: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042328, HPA074833"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Nucleoplasm	"HPA042328: AB_10962494, HPA074833: AB_2686716"	"unprognostic (6.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.87e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (8.60e-5)"	"unprognostic (1.05e-2)"	"unprognostic (9.96e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.97e-1)"	120.1	9.5	6.7	5.8	6.2	0.3	55.6	5.1	7.3	12.5	7.8	14.9	2.8	12.2	7.6	6.5	16.3	11.5	27.4	5.6	5.9	27.1	14.6	32.9	6.2	6.5	6.3	12.9	9.5	6.4	8.7	11.7	7.0	12.5	6.3	1.1	12.2	30.2	31.5	5.9	8.8	13.4	5.6	14.1	14.1	5.1	8.5	3.9	18.1	40.6	4.6	10.5	9.5	5.9	1.3	1.1	2.7	5.2	63.6	16.5	3.7	8.4	7.6	3.2	3.3	7.1	0.9	0.0	1.8	2.6	4.4	2.8	3.1	1.3	2.5	0.2	2.1	2.8	2.3	85.2	18.9	0.0	0.1	46.0	0.5	2.8	0.5	7.5	93.6	0.1	3.9	0.4	2.2	2.2	0.0	0.0	3.9	7.5	18.8	0.1	4.8	0.2	9.0	13.7	0.6	0.8	3.5	1.0	1.4	5.6	12.0	0.0	46.3	7.8	5.1	9.2	1.7	0.4	1.3	0.0	1.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	6.2	5.1	7.3	5.6	5.9	6.5	6.3	7.0	5.6	8.5	5.9	83.0	0.0	1.3	9.8	0.5	1.5	0.5	1.3	2.2	0.7	5.5	3.2	8.3	7.2	2.0	36.8	10.4	0.2	0.5	1.0	3.9	0.5	0.7	0.4	2.7	51.2	0.0	2.7	8.1	1.6	0.2	17.7	4.1	0.5	0.0	9.1	99.6	14.1	0.2	0.0	3.4	1.3	0.0	6.7	1.8	2.2	9.3	0.6	0.0	10.3	0.0	0.2	2.1	3.0	0.7	1.0	0.1	6.8	0.3	1.4	0.7	9.4	2.1	0.2	32.9	14.4	26.6	0.3	3.2	1.3	0.6	0.3	0.4	16.6	1.1	0.2
FZD6	Hfz6	ENSG00000164930	"Frizzled class receptor 6"	O60353	8	103298433-103332866	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 73.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 4.0"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 127.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017991	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"HPA017991: AB_1849138"	"unprognostic (8.22e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (1.20e-6)"	"unprognostic (3.62e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.92e-2)"	"unprognostic (7.54e-2)"	11.7	10.6	3.0	4.2	2.8	1.0	15.1	3.1	4.3	14.2	5.7	7.0	5.7	13.0	9.5	18.7	23.5	10.6	9.1	2.9	3.0	14.5	4.0	18.6	5.1	3.8	3.1	5.4	11.2	25.3	9.8	15.1	3.8	12.6	7.0	4.6	11.7	10.3	2.0	24.0	4.6	9.3	3.0	4.0	7.4	3.6	3.3	10.0	22.3	5.6	9.9	21.6	10.2	3.2	59.8	11.0	29.6	0.0	7.9	20.6	17.1	31.0	34.1	27.2	17.6	6.2	47.8	0.0	51.4	29.7	9.1	90.3	16.8	65.7	51.0	13.5	18.0	31.4	12.2	8.5	93.4	0.0	0.0	23.0	127.6	29.4	91.5	67.1	58.2	7.0	3.2	27.0	31.5	25.5	29.8	2.7	6.7	4.7	20.6	2.3	12.3	0.0	59.1	39.5	10.0	7.9	44.8	22.8	59.9	15.8	0.0	11.6	4.1	6.1	32.0	24.9	32.7	6.4	3.7	13.3	18.0	0.0	40.4	0.0	0.0	0.1	0.2	0.0	0.0	0.5	0.8	0.4	0.3	0.5	0.9	0.4	0.0	4.0	0.0	0.1	0.4	0.2	3.0	2.8	3.1	4.3	2.9	3.0	3.8	3.1	3.8	3.0	3.3	3.2	38.3	25.6	22.5	10.1	2.8	46.9	15.9	51.1	42.7	4.1	16.1	12.7	4.8	8.6	35.4	12.9	2.1	22.7	2.1	4.9	0.0	11.7	9.6	51.0	5.8	42.0	5.3	6.7	19.9	8.2	7.1	7.0	14.8	73.6	0.0	11.2	13.9	3.7	2.4	6.7	7.3	7.4	26.4	1.0	5.1	2.9	1.2	1.3	14.2	16.9	0.7	11.8	1.0	8.5	3.6	9.5	3.2	1.5	8.6	13.4	2.8	7.1	53.8	4.8	0.0	1.6	7.7	7.0	0.8	41.9	44.6	14.6	3.0	1.7	5.6	23.2
G6PC	"G6PC1, G6PT, GSD1a"	ENSG00000131482	"Glucose-6-phosphatase catalytic subunit"	P35575	17	42900797-42914438	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	Gluconeogenesis	Hydrolase	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 75.1;liver: 286.7"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 246.2;Proximal enterocytes: 176.2"	"Cancer enriched"	"Detected in some"	72	"liver cancer: 151.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052324	Enhanced					NA	NA				"Cluster 85: Liver - Metabolism"		"Cluster 2: Hepatocytes - Metabolism"			"HPA052324: AB_2681790"				"unprognostic (4.23e-2)"	"unprognostic (1.49e-2)"		"prognostic favorable (5.42e-5)"				"unprognostic (8.37e-2)"		"prognostic favorable (3.79e-5)"	"unprognostic (4.79e-2)"	"unprognostic (6.46e-2)"		"unprognostic (2.56e-3)"	0.0	0.0	0.1	0.1	0.2	0.4	0.0	0.4	0.2	0.0	0.2	0.1	19.7	0.0	0.1	0.0	0.0	4.1	0.0	0.2	0.1	75.1	286.7	0.0	0.1	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	30.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.2	0.1	0.3	0.2	0.2	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	28.6	0.0	1.8	0.0	0.0	0.0	0.0	1.9	0.7	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	2.5	246.2	0.1	0.0	0.0	2.1	0.0	3.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	176.2	43.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.2
G6PC3	UGRP	ENSG00000141349	"Glucose-6-phosphatase catalytic subunit 3"	Q9BUM1	17	44070735-44076344	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Gluconeogenesis	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067052			Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA067052: AB_2685771"	"unprognostic (9.13e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (1.11e-4)"	"unprognostic (1.88e-3)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (9.61e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.87e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.49e-2)"	56.7	97.2	64.8	22.5	67.8	16.0	55.6	70.5	79.3	47.6	88.8	42.1	28.7	55.4	63.9	37.1	45.6	23.9	61.9	65.3	77.5	75.2	26.4	42.9	19.3	74.9	86.9	44.3	56.5	66.7	95.1	25.8	96.1	59.5	18.2	17.1	48.7	40.6	54.3	26.8	39.6	23.0	67.9	45.2	51.4	55.1	72.7	15.2	71.1	26.4	12.0	48.7	37.7	72.4	40.0	231.7	73.7	128.5	77.9	58.3	55.3	45.0	86.9	96.2	64.4	97.1	62.3	88.9	62.8	95.1	65.4	67.4	53.5	92.1	44.5	46.4	86.0	49.3	142.5	182.4	84.1	46.1	59.8	77.3	44.3	93.1	62.3	59.6	79.3	35.9	51.5	109.6	72.5	112.1	22.4	71.4	99.3	48.7	133.5	45.6	48.4	207.5	137.6	93.6	92.7	83.0	49.1	57.4	59.3	82.9	158.6	45.1	87.6	98.8	53.1	26.8	63.5	74.0	56.2	26.1	110.3	38.2	128.9	3.0	33.1	7.9	9.9	43.4	12.1	12.1	8.0	9.1	54.2	13.9	9.7	12.9	1.4	17.5	26.3	74.5	8.5	16.9	64.8	67.8	70.5	79.3	65.3	77.5	74.9	86.9	96.1	67.9	72.7	72.4	22.3	3.2	12.9	5.2	10.4	2.5	17.3	31.8	8.0	10.5	20.7	21.5	6.4	21.5	25.2	40.5	12.5	64.3	17.1	12.4	13.7	59.3	5.0	18.9	22.1	26.0	22.9	9.7	2.8	49.4	41.1	25.0	16.8	20.1	18.3	20.2	18.5	7.1	58.7	5.0	4.5	14.1	24.4	21.6	12.2	6.2	20.2	20.9	14.2	0.0	21.8	30.7	10.3	8.0	5.5	33.6	13.6	23.0	27.2	19.5	20.5	36.0	24.6	8.3	13.1	15.3	21.4	31.5	26.7	14.3	2.6	42.5	7.0	43.9	19.7	17.2
G6PD	G6PD1	ENSG00000160211	"Glucose-6-phosphate dehydrogenase"	P11413	X	154531391-154547572	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 105.9"	"Cell type enhanced"	"Detected in many"		"monocytes: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 412.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 412.7"	"Cell line enhanced"	"Detected in all"		"A549: 2333.8;MCF7: 883.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000247, HPA000834"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		No	No		2400000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Centriolar satellite"	"HPA000247: AB_1078978, HPA000834: AB_1078977"	"unprognostic (1.73e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (9.45e-13)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.25e-2)"	40.7	39.1	19.9	30.2	21.8	105.9	31.9	20.5	28.3	20.6	20.0	13.9	13.1	21.6	13.3	54.3	19.3	46.5	14.3	21.3	22.7	12.7	6.5	29.4	28.9	25.4	22.2	24.1	13.0	9.6	27.5	13.7	24.5	12.2	13.1	26.1	21.2	14.4	4.2	21.3	12.4	25.6	19.7	26.9	18.1	54.0	26.1	26.2	45.9	5.1	37.2	33.8	22.4	21.9	168.5	2333.8	49.7	189.7	207.2	281.7	43.5	116.0	341.7	120.0	205.8	111.2	61.9	110.9	174.1	274.3	475.9	146.3	79.3	202.5	60.3	111.4	55.0	116.8	517.2	244.6	401.6	117.8	373.5	136.6	58.5	233.9	49.8	185.6	252.5	79.8	69.6	46.3	218.4	883.9	77.5	93.0	35.3	549.5	172.2	74.9	28.4	120.5	357.1	210.9	49.6	62.0	115.9	444.5	99.9	65.0	67.1	99.4	289.8	73.1	250.0	102.5	181.8	58.2	80.0	189.8	200.6	77.5	150.9	166.1	84.9	412.7	50.3	72.1	32.1	16.0	13.7	36.7	40.1	17.0	16.5	28.2	137.4	69.3	63.5	18.9	18.7	72.8	19.9	21.8	20.5	28.3	21.3	22.7	25.4	22.2	24.5	19.7	26.1	21.9	7.9	0.0	17.0	4.6	21.5	12.5	24.3	46.6	8.6	6.2	14.6	8.6	1.1	14.3	22.9	11.0	18.8	29.6	58.9	25.5	29.4	39.3	10.3	7.7	13.7	13.2	9.5	37.7	2.9	29.3	41.2	19.6	23.4	10.7	37.5	26.1	18.2	1.6	45.6	33.7	2.3	11.5	24.4	58.2	26.0	20.8	26.1	56.6	19.6	5.6	112.3	13.6	83.4	3.5	3.7	31.0	11.4	16.1	21.6	23.9	18.5	18.3	10.9	32.5	6.6	7.5	23.6	10.9	32.8	34.4	13.8	36.3	33.8	11.6	13.5	30.5
GAD1	GAD	ENSG00000128683	"Glutamate decarboxylase 1"	Q99259	2	170813213-170861151	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Decarboxylase, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"brain: 98.5;parathyroid gland: 46.3;retina: 29.7"	"Group enriched"	"Detected in many"	8	"Inhibitory neurons: 392.8;Oligodendrocyte precursor cells: 146.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 20.1;HEL: 64.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"olfactory bulb: 547.6"	"CAB004415, HPA048871, HPA058412, CAB078176"	Enhanced	Supported	Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Plasma membrane, Cytosol"		"CAB004415: AB_627650, CAB078176: AB_2665792, HPA048871: , HPA058412: AB_2683710"	"unprognostic (1.28e-1)"	"prognostic favorable (7.31e-4)"	"unprognostic (1.87e-2)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.97e-7)"	"unprognostic (1.51e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.27e-4)"	"unprognostic (6.75e-2)"	"unprognostic (9.18e-3)"	"unprognostic (6.90e-5)"	"unprognostic (2.93e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.08e-3)"	0.2	3.0	22.1	0.0	29.9	3.3	0.1	15.5	33.0	1.0	0.0	0.0	0.0	1.6	4.3	0.4	0.2	0.1	0.0	17.1	98.5	4.8	0.1	0.2	0.1	12.4	41.6	0.2	0.2	46.3	5.0	0.4	17.6	0.8	0.1	29.7	0.1	0.3	0.0	0.2	0.1	0.0	12.7	0.1	0.0	3.2	31.1	0.8	0.1	0.0	0.2	0.6	0.4	14.2	18.2	0.7	0.0	7.3	0.0	0.0	0.1	0.4	0.0	2.6	1.7	4.6	6.7	0.0	0.9	0.5	2.9	20.1	2.3	0.6	1.6	2.8	13.4	64.5	6.0	0.2	0.0	0.3	1.1	0.0	5.5	0.0	2.3	0.6	0.1	0.5	17.0	0.3	0.8	1.5	0.0	0.0	8.1	9.7	6.7	1.0	4.6	0.4	8.5	9.4	6.7	2.1	12.6	0.0	3.5	0.6	0.2	0.0	0.0	12.0	1.7	2.4	7.0	0.0	0.0	0.1	11.5	3.2	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	29.9	15.5	33.0	17.1	98.5	12.4	41.6	17.6	12.7	31.1	14.2	0.0	0.0	0.0	14.7	0.0	0.3	2.1	7.7	2.2	32.5	0.1	0.1	1.3	0.0	3.6	0.0	10.4	0.0	0.0	0.2	7.9	4.5	5.6	4.4	0.4	0.4	3.0	5.5	2.6	5.6	0.1	0.2	0.0	2.9	0.0	5.5	0.0	0.0	4.0	5.0	392.8	0.3	2.0	0.8	0.4	6.2	0.6	0.5	0.0	7.5	0.0	4.9	0.0	146.8	7.6	2.9	0.0	0.0	0.1	0.9	0.0	0.0	4.7	6.0	0.0	0.0	1.2	4.4	7.7	0.6	0.1	0.5	0.0	0.1	0.1	0.4
GALC		ENSG00000054983	Galactosylceramidase	P54803	14	87837820-87993665	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism, Sphingolipid metabolism"	"Glycosidase, Hydrolase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 68.4;Kupffer cells: 72.1;Late spermatids: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 84.3;HMC-1: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022196	Approved				"Intracellular and membrane"	NA	NA		53000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB022196: "	"unprognostic (1.27e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.44e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-2)"	15.0	17.2	20.0	14.9	23.3	23.2	13.3	22.1	26.1	12.0	20.8	15.1	33.3	11.1	12.2	6.6	20.7	18.4	13.5	18.5	21.6	21.3	12.1	23.9	11.7	23.0	22.6	15.8	10.8	9.4	9.8	16.8	23.9	14.3	17.3	18.4	8.1	9.3	8.0	9.1	34.4	9.6	22.3	15.4	16.4	24.0	20.8	9.7	24.5	12.9	7.9	13.6	7.5	30.6	0.0	19.5	7.2	0.0	23.8	21.3	0.0	9.1	17.9	8.3	9.9	10.8	84.3	5.3	26.4	8.7	0.0	1.3	0.0	1.0	10.2	2.7	0.6	29.8	0.7	0.0	19.5	0.1	78.4	20.7	6.6	5.6	0.0	3.4	22.6	0.0	10.0	3.9	14.4	1.9	0.0	4.5	6.5	35.4	2.2	0.0	0.5	0.3	13.4	7.8	6.7	15.6	24.6	4.0	0.2	17.2	20.4	20.5	19.7	0.0	12.9	5.6	0.2	4.2	8.0	0.0	2.3	6.8	19.2	25.3	15.2	34.2	11.1	16.6	24.0	2.5	8.3	10.8	8.9	1.2	6.0	7.0	11.9	16.3	13.4	1.6	5.3	11.7	20.0	23.3	22.1	26.1	18.5	21.6	23.0	22.6	23.9	22.3	20.8	30.6	11.3	25.6	19.0	26.8	8.0	8.4	5.6	9.4	3.4	10.1	9.1	5.2	9.2	10.0	8.9	14.7	12.5	6.2	27.6	15.3	3.9	9.8	51.6	17.3	10.9	11.4	6.1	13.7	17.8	11.4	12.7	15.2	7.7	5.8	68.4	15.9	18.2	6.1	26.6	3.3	21.2	10.2	4.1	72.1	11.8	77.9	16.1	25.0	10.6	8.4	26.7	7.3	40.2	33.2	42.6	14.1	20.0	10.1	9.3	6.1	15.9	6.7	22.1	10.4	0.0	9.8	10.6	14.9	10.0	3.5	11.5	6.6	21.2	12.9	16.7	7.9
GALE	SDR1E1	ENSG00000117308	UDP-galactose-4-epimerase	Q14376	1	23795599-23800781	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	Isomerase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 122.4"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 276.8;Intestinal goblet cells: 149.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070023			Approved	"Golgi apparatus,Cytosol"		NA	NA		16000	"Cluster 27: Non-specific - Gene expression"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus, Cytosol"		"HPA070023: "	"unprognostic (1.65e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (2.68e-4)"	"unprognostic (1.41e-2)"	8.9	12.8	12.3	16.0	12.5	6.0	12.8	12.2	17.7	22.3	11.5	58.6	54.6	6.7	12.7	63.1	16.6	31.5	7.1	12.5	12.5	34.0	61.2	20.6	7.5	12.5	12.3	4.6	15.2	15.5	6.7	17.8	12.4	11.0	60.0	6.3	59.7	16.4	4.3	9.7	38.3	10.8	12.6	17.6	122.4	8.7	13.2	8.0	4.7	5.4	15.8	20.9	22.2	12.6	60.3	71.5	27.8	44.5	9.8	13.9	26.9	40.7	53.4	68.6	50.9	65.3	195.4	14.3	54.7	23.5	91.9	65.8	24.5	101.8	51.5	29.4	16.2	40.6	34.4	71.6	102.0	18.4	11.6	30.1	53.4	63.4	156.8	69.2	59.5	30.1	45.9	3.8	49.5	64.5	29.0	19.5	7.8	83.1	67.7	33.6	27.1	18.5	112.7	41.4	10.7	24.1	73.9	66.7	70.6	31.1	47.9	14.5	33.7	52.0	74.9	52.0	50.3	18.5	46.4	18.9	53.0	74.5	27.8	1.7	13.5	3.0	8.5	29.3	8.5	5.4	5.0	6.9	19.0	1.7	5.8	4.1	3.4	37.3	37.1	5.2	9.5	8.8	12.3	12.5	12.2	17.7	12.5	12.5	12.5	12.3	12.4	12.6	13.2	12.6	9.6	12.8	49.3	6.8	7.5	7.6	18.8	110.4	6.2	17.2	26.7	10.9	3.5	37.1	90.6	40.5	16.7	54.1	7.4	131.8	35.2	67.6	21.5	19.9	9.1	14.3	12.1	8.2	9.4	114.8	106.3	14.0	276.8	36.2	10.8	17.4	10.8	38.3	99.3	8.4	10.8	149.5	73.2	5.7	6.8	5.0	4.7	12.5	24.9	5.6	19.4	21.2	7.2	4.5	2.1	92.0	109.0	3.4	9.4	24.9	78.6	89.5	37.0	14.8	0.0	3.7	13.1	14.5	9.7	19.6	4.8	96.3	7.6	99.6	73.8	46.0
GALK1	GALK	ENSG00000108479	"Galactokinase 1"	P51570	17	75751594-75765236	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Kinase, Transferase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 126.4"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 100.1;Hepatocytes: 116.7;Proximal enterocytes: 139.4;Proximal tubular cells: 122.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 42.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007094, HPA016960"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		57000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Golgi apparatus"	"HPA007094: AB_1078939, HPA016960: AB_1849430"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (3.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (1.62e-5)"	18.6	12.5	5.9	7.8	6.7	5.6	17.1	6.4	8.4	17.5	5.9	12.5	20.6	16.5	1.0	24.4	14.9	4.3	19.7	6.0	6.6	32.0	126.4	18.7	7.4	7.9	6.3	13.7	31.2	10.6	5.7	5.8	7.5	13.3	2.0	0.7	20.0	5.7	8.6	20.6	18.3	3.9	7.0	24.5	17.6	16.0	6.8	6.1	11.6	3.6	3.4	13.0	17.8	8.2	20.4	65.2	4.9	20.7	6.8	16.6	16.7	16.9	14.3	16.8	15.8	35.4	4.2	31.2	19.5	9.3	12.6	11.9	5.0	4.4	1.9	14.2	39.3	20.1	25.1	62.4	22.1	13.0	41.9	15.3	6.9	8.5	3.5	8.5	39.1	16.9	15.9	21.2	11.7	77.3	38.6	44.7	4.7	9.8	32.3	43.6	50.1	50.9	9.8	7.3	9.9	26.1	14.6	35.8	35.0	3.8	29.8	20.9	33.4	24.3	22.3	21.7	14.6	44.4	12.4	8.2	26.7	30.3	18.3	7.2	77.2	23.0	23.0	67.8	20.8	27.7	18.5	21.2	70.1	18.9	10.0	14.5	53.1	16.2	55.6	93.3	23.6	40.8	5.9	6.7	6.4	8.4	6.0	6.6	7.9	6.3	7.5	7.0	6.8	8.2	42.1	16.0	12.9	3.3	17.7	8.7	10.0	4.4	7.4	7.3	22.4	20.6	22.6	22.8	10.6	12.9	0.0	48.4	16.3	8.4	68.4	28.5	1.3	4.9	24.5	23.5	8.4	9.0	1.5	55.2	100.1	25.3	10.2	8.6	27.9	16.6	29.3	116.7	56.1	3.3	1.7	20.9	22.4	49.0	25.2	5.6	31.1	33.3	39.2	0.0	42.3	19.2	20.6	2.5	1.6	19.3	49.6	24.0	29.1	5.7	139.4	122.0	4.0	6.1	6.6	19.2	20.8	1.7	22.1	16.6	12.5	42.3	14.9	6.1	28.2	9.2
GALM		ENSG00000143891	"Galactose mutarotase"	Q96C23	2	38666081-38741237	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 86.5;kidney: 120.2"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 97.8;Proximal enterocytes: 161.1;Proximal tubular cells: 222.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 68.3"	"Group enriched"	"Detected in all"	5	"granulocytes: 39.1;T-cells: 68.3"	"Cell line enhanced"	"Detected in many"		"Hep G2: 62.7;Karpas-707: 71.1;U-266/70: 76.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035472, HPA035473, HPA064835"	Enhanced		Approved	Nucleoplasm		NA	NA		620000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA035472: AB_10669906, HPA035473: AB_2674642, HPA064835: AB_2732723"	"unprognostic (5.02e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.63e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.45e-2)"	"prognostic favorable (9.06e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.34e-1)"	"prognostic favorable (1.32e-4)"	9.0	86.5	5.2	12.2	5.1	3.8	10.4	6.0	6.1	9.3	8.3	34.7	71.4	8.1	23.0	5.8	35.8	16.5	13.0	4.9	4.8	120.2	72.5	14.3	16.0	5.4	6.1	15.5	15.0	21.3	3.0	7.7	5.4	10.2	33.3	4.4	8.7	20.8	13.1	3.8	52.8	10.4	5.7	6.6	14.9	4.4	7.0	11.0	15.1	12.3	10.2	10.8	6.4	6.0	0.2	27.1	8.1	0.0	27.3	15.4	14.9	3.2	10.3	7.5	12.2	32.4	14.4	10.9	18.9	15.3	14.5	4.3	11.7	0.7	14.5	49.5	19.3	5.9	7.1	62.7	10.0	2.4	0.4	11.1	0.4	17.5	0.0	10.5	8.2	0.0	17.2	71.1	13.9	0.9	23.4	41.0	12.4	59.2	8.6	15.2	0.6	21.3	9.3	45.1	1.5	11.2	0.1	18.9	14.7	10.2	9.0	5.4	3.4	2.5	0.5	18.6	1.0	76.4	54.3	0.3	17.9	7.0	0.3	39.1	4.8	4.2	21.5	3.3	31.8	6.8	33.1	31.2	10.3	4.7	11.7	10.2	11.3	5.5	0.7	0.8	68.3	11.9	5.2	5.1	6.0	6.1	4.9	4.8	5.4	6.1	5.4	5.7	7.0	6.0	9.7	28.9	11.0	13.4	10.0	6.6	6.7	3.4	10.8	3.6	7.8	4.2	23.4	24.3	6.5	69.9	0.0	23.6	19.0	83.2	25.4	12.1	1.4	28.5	11.6	10.0	13.2	8.2	2.3	15.1	31.4	16.1	17.9	10.1	7.0	16.8	14.6	48.1	94.8	3.3	1.4	40.5	4.1	18.6	43.6	1.3	20.2	34.7	17.8	4.7	9.9	38.2	18.6	0.5	1.3	6.8	64.5	97.8	14.7	5.7	161.1	222.1	14.8	6.8	6.6	16.6	10.4	1.0	2.3	3.2	6.0	6.3	44.0	43.3	80.4	5.7
GALNS	"GALNAC6S, GAS"	ENSG00000141012	"Galactosamine (N-acetyl)-6-sulfatase"	P34059	16	88813734-88856970	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Dwarfism, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 11.3;granulocytes: 31.3;monocytes: 17.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026404, HPA042433, HPA074225"	Supported		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 18: U-2197 - ECM organization"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"CAB026404: , HPA042433: AB_2732499, HPA074225: "	"unprognostic (3.16e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.03e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (4.15e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.12e-3)"	"unprognostic (4.24e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.84e-2)"	9.2	12.8	9.4	9.3	10.0	22.2	6.3	10.0	11.5	9.1	22.1	10.0	10.6	7.4	14.5	8.8	11.4	9.7	11.0	10.6	12.0	8.6	8.1	10.4	7.4	12.6	16.4	6.7	5.0	8.6	11.9	8.6	12.0	7.7	6.1	3.3	8.3	4.7	6.4	8.4	10.6	7.1	10.8	9.1	8.1	26.3	11.3	4.8	9.1	3.6	5.6	9.0	9.1	12.0	5.7	42.7	6.2	43.4	47.1	22.4	41.9	17.9	27.3	19.1	14.7	22.7	36.8	7.1	37.1	29.2	28.8	33.0	9.0	14.2	11.4	4.7	13.8	4.5	17.0	13.2	31.5	3.6	28.5	31.4	26.9	21.4	6.0	27.0	16.4	7.8	9.9	4.1	11.3	33.3	9.2	15.0	14.2	14.3	19.6	19.6	5.4	12.1	11.9	13.2	15.8	12.2	42.4	4.0	21.9	14.4	27.3	32.5	31.3	41.8	31.5	43.2	10.0	4.3	4.5	12.6	45.2	29.7	25.4	1.4	17.4	31.3	4.5	12.5	3.9	3.0	2.5	4.0	11.3	1.3	2.5	3.1	21.7	4.0	9.6	4.7	4.6	8.5	9.4	10.0	10.0	11.5	10.6	12.0	12.6	16.4	12.0	10.8	11.3	12.0	4.8	16.0	4.8	9.4	5.9	6.5	7.3	27.7	9.1	5.0	6.8	5.0	8.4	4.3	11.0	3.7	6.2	9.9	8.5	16.8	3.9	5.7	21.0	27.2	9.6	7.2	12.0	1.3	7.6	3.7	14.0	13.8	6.1	8.9	1.3	11.9	7.5	6.4	18.7	25.2	10.4	6.8	8.2	13.2	6.3	37.3	7.2	11.3	7.2	2.8	18.2	8.8	14.4	4.0	9.8	5.6	13.6	6.8	9.9	6.7	17.3	5.9	35.1	10.0	6.6	9.4	9.0	51.3	42.8	6.3	5.7	15.9	7.9	16.5	10.1	6.8
GALNT11	GalNAc-T11	ENSG00000178234	"Polypeptide N-acetylgalactosaminyltransferase 11"	Q8NCW6	7	152025674-152122340	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Notch signaling pathway"	"Glycosyltransferase, Transferase"	Heterotaxy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 408.0;kidney: 229.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 131.1;Inhibitory neurons: 130.7;Proximal tubular cells: 196.7"	"Cancer enhanced"	"Detected in all"		"renal cancer: 30.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039330	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039330: AB_10795249"	"unprognostic (6.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (9.54e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.56e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.24e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.51e-2)"	32.4	25.4	27.9	15.2	30.7	12.7	29.0	24.1	29.3	23.7	408.0	21.9	14.5	23.8	24.6	26.3	22.4	26.1	26.4	39.1	25.1	229.5	19.9	27.5	16.1	20.8	23.9	28.1	84.1	58.0	24.4	45.8	21.6	32.3	17.6	40.6	22.8	25.6	28.4	23.8	15.0	24.2	16.9	20.5	22.0	11.8	30.3	23.8	34.4	26.0	17.8	24.2	24.0	27.0	28.9	25.4	36.8	41.2	83.1	81.3	37.7	22.6	25.6	18.6	17.4	20.7	29.7	0.1	57.8	36.8	51.8	13.3	17.6	31.9	22.8	23.5	26.3	5.8	23.4	18.2	27.3	26.2	29.3	72.1	40.3	15.5	13.0	32.3	34.1	19.9	29.5	0.2	47.0	24.9	22.7	23.6	30.4	45.1	20.2	0.1	16.1	0.9	61.1	43.8	32.6	43.3	37.5	18.0	31.0	39.0	26.8	22.3	31.1	24.8	8.8	31.6	25.1	8.4	11.4	0.5	51.6	25.1	86.6	10.2	12.7	13.5	28.1	15.2	27.8	9.5	15.4	25.8	13.0	5.7	13.1	19.9	6.6	26.2	21.3	4.0	12.7	14.4	27.9	30.7	24.1	29.3	39.1	25.1	20.8	23.9	21.6	16.9	30.3	27.0	28.7	12.8	25.2	44.4	12.9	10.5	24.6	20.5	13.1	123.9	23.5	20.7	30.7	15.7	16.1	35.0	27.1	84.0	49.1	8.7	60.7	17.8	4.8	31.5	38.8	22.8	22.8	7.8	131.1	18.7	13.5	33.8	11.7	57.1	14.5	26.0	22.1	15.8	25.3	75.7	130.7	10.0	8.2	19.7	12.5	3.5	19.9	21.7	17.8	46.9	18.0	37.8	43.3	54.3	42.0	13.0	8.3	36.1	20.3	26.3	9.6	196.7	21.2	39.4	0.0	36.3	25.0	38.7	27.5	24.7	11.8	36.3	29.1	24.3	9.3	19.1
GALNT12	GalNAc-T12	ENSG00000119514	"Polypeptide N-acetylgalactosaminyltransferase 12"	Q8IXK2	9	98807670-98850081	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 74.7;intestine: 55.8;stomach 1: 54.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 101.2;Intestinal goblet cells: 142.4;Undifferentiated cells: 42.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 128.4;U-2197: 160.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA048292, HPA071076"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		47000	"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA048292: AB_2680343, HPA071076: "	"unprognostic (7.85e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.97e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.71e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (9.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.60e-3)"	"unprognostic (6.87e-2)"	5.0	2.0	1.2	7.7	1.3	2.2	3.4	6.5	1.8	8.7	4.3	55.3	34.2	3.7	74.7	19.6	7.5	10.5	1.2	1.1	1.4	4.8	0.4	11.7	3.2	2.6	1.4	0.4	13.6	6.3	3.4	2.6	2.7	4.6	55.8	0.6	25.5	4.3	1.3	3.4	27.1	14.0	1.1	2.2	54.8	4.6	1.5	3.3	14.7	0.6	6.1	11.9	4.6	1.6	5.4	4.1	3.4	13.5	10.0	7.8	0.0	1.4	2.1	2.0	4.6	0.8	21.6	0.0	5.0	0.9	12.2	38.0	2.9	1.3	1.6	26.2	1.7	2.4	0.2	0.0	0.5	1.6	0.5	3.8	0.9	6.4	0.0	2.7	2.3	19.3	30.2	0.0	0.6	13.9	2.6	4.7	16.7	128.4	5.6	6.5	0.3	0.1	2.3	7.7	12.4	1.1	0.5	30.6	3.0	7.7	4.5	4.5	4.3	0.0	0.3	160.9	0.0	2.1	4.8	2.3	37.1	0.0	0.9	0.0	0.0	0.5	0.3	0.0	0.6	0.0	0.4	0.2	0.0	0.1	0.6	0.3	0.0	0.6	0.0	0.1	0.0	0.1	1.2	1.3	6.5	1.8	1.1	1.4	2.6	1.4	2.7	1.1	1.5	1.6	1.3	3.2	25.7	2.0	2.3	2.4	1.3	8.3	1.2	2.4	0.4	0.1	1.0	18.6	16.9	11.0	16.7	1.0	2.6	101.2	0.0	11.2	1.8	4.8	1.6	1.6	19.9	1.3	7.4	25.4	1.7	12.5	32.1	8.7	2.5	2.4	0.0	0.0	2.3	0.0	5.7	142.4	2.0	0.3	3.9	1.4	2.1	3.9	0.0	3.7	0.2	0.8	3.1	3.5	7.0	32.0	36.5	7.5	1.7	7.4	21.9	2.7	16.9	0.2	0.0	0.7	1.5	5.9	10.5	9.9	1.3	1.1	4.5	5.1	42.5	11.1
GALNT17	"GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17"	ENSG00000185274	"Polypeptide N-acetylgalactosaminyltransferase 17"	Q6IS24	7	71132144-71713600	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.0;choroid plexus: 46.0;heart muscle: 43.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Endometrial stromal cells: 7.4;Fibroblasts: 1.5;Granulosa cells: 1.7;Theca cells: 2.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 8.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 14.3;NTERA-2: 10.8;RPMI-8226: 12.6;SK-BR-3: 45.7;SuSa: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013624, HPA047986"	Approved		Uncertain	"Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus"		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Golgi apparatus"	"Nucleoli, Nuclear bodies"	"HPA013624: AB_1858787, HPA047986: "	"unprognostic (2.79e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.41e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (4.60e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.63e-3)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.92e-1)"	"unprognostic (7.94e-3)"	3.2	8.7	30.5	1.9	37.9	0.0	2.0	35.9	51.2	4.0	46.0	16.6	0.3	16.6	3.1	9.3	8.7	2.5	43.5	55.0	3.2	5.7	0.4	9.3	0.0	2.1	3.8	31.6	10.1	1.2	13.3	0.2	3.0	14.7	1.0	3.3	3.3	8.2	4.7	2.2	3.9	8.3	0.0	3.4	2.4	5.0	11.2	2.6	10.1	2.9	1.5	21.2	3.3	24.8	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.7	0.0	0.0	45.7	0.0	14.1	0.0	0.0	0.0	0.0	3.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.5	37.9	35.9	51.2	55.0	3.2	2.1	3.8	3.0	0.0	11.2	24.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.0	0.1	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0
GALNT2	GalNAc-T2	ENSG00000143641	"Polypeptide N-acetylgalactosaminyltransferase 2"	Q10471	1	230057990-230282122	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 133.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 429.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011222	Supported		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		13000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA011222: AB_1849446"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (1.15e-2)"	"unprognostic (1.35e-2)"	"unprognostic (8.70e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (8.48e-8)"	"unprognostic (2.93e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (2.79e-13)"	"unprognostic (3.79e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.89e-1)"	32.9	49.6	17.0	34.8	19.9	13.9	21.9	15.2	16.7	24.7	22.0	28.9	19.5	27.1	6.9	21.0	22.4	21.2	27.4	15.8	18.6	18.5	100.1	27.1	14.0	23.0	19.5	39.2	68.1	9.9	13.6	27.6	18.3	21.4	12.4	19.8	22.1	14.3	67.4	14.7	23.6	25.0	15.3	17.4	33.1	19.7	25.1	42.8	19.0	27.4	11.2	33.4	19.5	15.5	79.5	103.7	59.9	71.4	112.4	95.3	122.8	146.3	90.0	58.4	55.6	45.2	146.5	20.0	106.2	77.7	135.9	150.7	39.9	123.0	48.6	200.1	52.0	60.7	217.2	50.9	60.9	23.4	114.8	136.9	59.8	78.0	30.9	127.3	69.2	110.1	77.0	29.6	65.6	21.8	122.3	23.9	82.1	52.8	97.7	134.3	85.5	61.7	57.4	92.9	18.9	70.1	148.4	7.9	91.0	31.7	46.5	43.5	165.3	56.7	107.9	129.5	118.0	97.9	60.3	44.4	146.1	46.3	429.7	1.5	10.7	3.6	4.4	9.3	3.2	3.4	2.6	4.5	7.8	5.8	2.5	5.0	3.2	2.8	10.2	13.2	3.3	7.7	17.0	19.9	15.2	16.7	15.8	18.6	23.0	19.5	18.3	15.3	25.1	15.5	18.6	16.0	21.3	71.5	32.1	15.3	20.0	52.8	20.5	30.8	13.8	10.7	13.6	18.6	30.1	23.9	33.3	7.3	21.7	24.1	5.9	49.7	47.2	18.7	15.4	17.9	16.8	27.6	67.3	133.0	123.4	36.1	21.4	24.5	13.3	20.5	19.6	98.8	24.9	28.6	82.0	18.9	4.1	42.4	9.7	24.6	35.8	28.9	24.9	106.8	44.0	10.9	18.6	72.9	44.6	88.5	21.6	29.3	109.0	23.5	17.9	19.2	23.5	73.5	13.1	33.1	25.4	3.4	14.0	16.6	8.0	16.6	21.2	32.8	17.6	29.9
GALNT3	"GalNAc-T3, HFTC, HHS"	ENSG00000115339	"Polypeptide N-acetylgalactosaminyltransferase 3"	Q14435	2	165747588-165794659	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 77.3"	"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 152.8;Pancreatic endocrine cells: 188.1;Prostatic glandular cells: 155.7;Urothelial cells: 274.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 50.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 85.4;HaCaT: 108.3;HBEC3-KT: 69.2;hTCEpi: 88.2;OE19: 201.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA007613	Enhanced		Supported	"Golgi apparatus"		NA	NA		440000	"Cluster 46: Basophils - DNA binding"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"		"HPA007613: AB_1078941"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (1.16e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (4.10e-4)"	"unprognostic (4.13e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.57e-1)"	1.5	1.7	1.7	8.4	2.1	54.0	26.0	2.7	1.8	29.3	4.3	48.9	43.5	5.2	9.3	27.4	38.8	32.2	0.6	1.8	3.4	10.9	2.4	14.0	3.7	4.5	5.2	6.8	26.2	6.9	9.8	6.4	3.3	25.2	53.2	3.7	55.3	8.2	0.3	15.3	39.5	2.5	7.0	20.1	77.3	25.8	1.9	3.3	25.4	0.4	12.3	17.3	12.6	5.4	61.5	0.0	0.6	0.2	0.1	2.6	43.0	18.3	7.7	6.6	16.0	32.0	85.4	0.4	0.1	0.0	0.1	108.3	0.0	69.2	13.5	1.3	13.0	0.0	14.9	0.3	0.3	14.5	0.4	0.5	88.2	0.0	30.3	2.1	0.1	2.9	0.0	55.0	5.0	42.7	0.5	5.6	0.1	201.1	7.8	0.2	0.0	1.7	17.8	42.0	6.5	0.1	0.3	49.6	16.8	1.9	21.7	0.9	0.5	0.1	1.0	0.1	0.3	34.4	16.3	1.3	0.2	14.0	0.6	50.5	6.8	32.2	10.2	9.0	7.5	6.6	3.1	5.8	11.4	6.0	1.0	3.4	25.2	10.6	13.8	17.3	5.6	6.2	1.7	2.1	2.7	1.8	1.8	3.4	4.5	5.2	3.3	7.0	1.9	5.4	1.0	12.8	34.4	7.8	13.6	38.0	107.9	36.5	29.6	0.6	45.0	26.8	0.4	35.8	45.9	66.2	0.0	8.5	37.7	68.6	3.9	70.2	127.5	91.8	5.2	2.9	23.4	1.3	10.5	113.2	22.5	2.3	102.4	70.5	45.7	0.7	1.1	0.6	8.2	0.0	5.1	152.8	28.5	1.9	12.4	14.1	2.5	8.3	16.0	1.0	7.5	16.1	15.5	27.6	1.4	188.1	46.5	0.4	29.7	155.7	32.6	3.1	89.3	1.0	6.6	0.6	4.3	71.5	1.1	42.4	41.3	11.2	14.4	1.2	61.8	274.4
GALT		ENSG00000213930	"Galactose-1-phosphate uridylyltransferase"	P07902	9	34638133-34651035	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Nucleotidyltransferase, Transferase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 50.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004868, HPA005729"	Enhanced		Approved	Cytosol		NA	NA		260000	"Cluster 37: B-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA004868: AB_1079130, HPA005729: AB_1079131"	"unprognostic (2.38e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (3.11e-5)"	"unprognostic (9.68e-2)"	"prognostic favorable (6.25e-6)"	"unprognostic (7.90e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.75e-2)"	6.7	14.0	5.3	6.7	5.9	8.1	6.3	5.5	6.5	6.9	4.6	8.5	18.3	6.9	5.3	5.3	7.8	6.8	10.4	5.2	6.3	10.0	50.0	6.6	12.0	5.5	5.7	8.2	7.5	13.0	6.1	9.2	5.3	6.4	6.7	6.3	12.3	7.5	10.2	15.2	16.5	4.0	4.5	9.7	8.1	2.4	6.1	7.8	8.2	7.6	7.7	5.3	6.1	4.7	5.5	7.5	6.8	2.4	9.0	9.2	7.8	4.2	12.1	4.3	5.1	9.5	4.8	6.1	4.2	5.2	1.6	2.9	1.3	11.8	0.8	9.7	4.8	2.5	14.7	9.8	8.7	1.4	2.9	12.6	7.4	2.7	3.6	9.3	10.6	8.3	2.3	6.4	7.3	5.1	5.4	10.3	2.3	6.7	1.3	8.4	5.9	3.3	12.5	7.8	1.6	5.7	5.0	9.8	5.4	5.0	9.2	8.2	1.6	1.7	3.4	3.4	0.0	3.9	2.4	1.3	4.1	4.4	10.8	16.5	23.7	11.7	15.4	21.5	21.3	24.8	25.2	21.1	21.5	13.2	15.3	14.8	4.6	29.0	20.4	18.2	30.0	17.6	5.3	5.9	5.5	6.5	5.2	6.3	5.5	5.7	5.3	4.5	6.1	4.7	12.6	6.4	21.2	10.7	19.0	21.7	13.4	19.3	19.4	44.0	10.5	12.1	25.7	14.3	15.4	16.5	47.9	72.5	13.9	17.3	29.4	18.3	7.6	7.8	11.8	14.6	16.3	13.7	9.1	7.3	36.3	18.3	9.2	8.0	20.3	24.7	23.6	69.9	24.1	47.1	12.5	17.0	26.4	15.5	8.7	36.8	18.3	12.4	21.4	5.6	15.9	18.7	34.0	6.0	3.7	6.9	37.5	13.9	10.7	4.7	67.1	46.3	11.1	38.5	6.6	11.2	12.2	4.8	6.6	8.6	20.2	59.1	25.5	27.4	20.4	9.2
GARS1	"CMT2D, DSMAV, GARS, GlyRS, SMAD1"	ENSG00000106105	"Glycyl-tRNA synthetase 1"	P41250	7	30580533-30634033	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Hydrolase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 34.1;Cytotrophoblasts: 47.0;Extravillous trophoblasts: 70.0;Hofbauer cells: 44.3;Syncytiotrophoblasts: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017896, HPA019097"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	NA	NA		560000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA017896: AB_1849478, HPA019097: AB_1849480"	"prognostic unfavorable (1.02e-4)"	"unprognostic (2.46e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavorable (8.95e-5)"	"unprognostic (7.31e-3)"	"unprognostic (4.76e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.45e-2)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (3.92e-1)"	"unprognostic (3.40e-2)"	"unprognostic (6.32e-2)"	"prognostic unfavorable (3.04e-5)"	34.2	31.0	33.3	43.3	36.5	32.0	31.7	34.2	46.2	32.6	49.9	39.8	27.6	29.1	37.3	53.8	23.3	29.9	32.9	38.6	45.7	42.7	46.0	34.0	47.2	38.1	34.7	26.7	78.5	58.1	36.5	39.9	42.0	26.8	48.6	46.9	36.1	29.3	48.1	43.4	26.0	49.8	33.2	22.3	47.4	51.5	43.4	40.7	51.5	45.0	67.3	54.0	29.4	35.2	231.4	119.8	103.4	364.5	191.9	286.8	172.0	332.4	330.5	184.0	369.8	159.5	115.4	375.9	96.2	443.1	281.6	174.5	262.6	230.2	327.7	92.9	82.5	182.6	84.8	141.1	604.0	267.6	149.8	272.5	391.9	265.8	304.9	128.1	241.6	354.1	350.2	465.4	296.7	154.7	216.8	204.3	259.6	222.4	183.4	114.0	90.1	299.0	219.5	109.1	117.9	177.4	88.1	261.5	509.2	182.8	225.3	409.3	208.2	82.2	262.9	164.9	217.9	403.8	390.8	445.9	289.4	398.8	392.9	40.0	27.0	24.1	22.9	35.8	27.4	21.0	26.0	28.8	35.8	16.3	25.2	30.2	5.2	20.9	41.7	18.5	31.9	23.9	33.3	36.5	34.2	46.2	38.6	45.7	38.1	34.7	42.0	33.2	43.4	35.2	10.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	47.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	70.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	44.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	39.8	2.0	0.0	0.0	0.0
GATM	AGAT	ENSG00000171766	"Glycine amidinotransferase"	P50440	15	45361124-45402327	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"kidney: 2099.3;liver: 2804.2;pancreas: 2935.3"	"Group enriched"	"Detected in many"	8	"Hepatocytes: 1495.2;Proximal tubular cells: 3703.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 135.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 11.0;myeloid DC: 6.6;naive B-cell: 5.4;plasmacytoid DC: 6.8"	"Group enriched"	"Detected in many"	5	"B-cells: 11.0;dendritic cells: 6.8"	"Group enriched"	"Detected in many"	4	"RH-30: 210.1;RT4: 55.8;U-266/70: 126.3;U-266/84: 165.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026077	Enhanced		Supported	Mitochondria		NA	NA		600000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA026077: AB_1849528"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.80e-1)"	14.4	21.4	133.9	12.4	138.4	1.8	25.4	152.5	216.5	9.9	94.3	19.6	175.5	8.4	10.5	25.1	11.6	47.7	57.2	131.1	140.9	2099.3	2804.2	7.3	18.4	148.0	135.4	165.2	2935.3	2.7	8.3	74.7	153.4	12.4	11.5	7.5	57.5	15.1	142.5	137.6	110.2	14.5	149.2	33.6	99.2	78.2	140.4	12.6	63.0	46.9	29.7	18.0	15.5	181.2	12.9	6.5	4.4	0.6	0.1	0.2	0.8	0.1	0.1	0.0	0.2	1.4	21.4	34.4	1.0	0.0	5.7	2.2	17.0	0.6	0.4	1.9	0.3	2.8	0.4	0.3	0.8	20.7	2.6	0.8	0.7	0.0	0.4	0.0	0.3	7.8	0.4	0.7	0.2	0.6	2.2	0.6	11.2	31.3	0.0	0.5	210.1	1.5	3.5	55.8	23.5	4.1	6.9	0.4	1.2	2.1	2.9	23.7	0.0	0.0	0.5	0.2	6.3	126.3	165.5	0.8	1.6	0.3	1.0	0.0	1.1	0.3	0.2	1.6	0.0	11.0	0.0	0.2	6.6	5.4	0.0	1.4	0.0	0.1	0.6	6.8	0.0	1.0	133.9	138.4	152.5	216.5	131.1	140.9	148.0	135.4	153.4	149.2	140.4	181.2	2.4	3.2	1.1	67.3	42.3	54.3	14.9	5.2	5.7	8.1	16.9	9.5	35.5	228.8	5.4	71.7	0.0	1.0	0.8	3.1	295.4	58.2	8.8	1.3	0.4	7.3	0.0	29.3	6.8	290.0	1.2	19.8	69.8	2.7	3.8	219.5	23.9	1495.2	89.6	8.4	3.3	3.1	2.0	80.3	80.3	18.3	4.4	50.6	23.2	20.6	3.1	19.1	2.1	57.3	196.3	97.3	3.9	3.4	7.2	6.4	98.4	3703.0	1.9	3.8	6.6	38.4	16.8	22.0	9.7	16.0	133.7	1.8	17.6	4.1	3.4	20.4
GBA	"GBA1, GLUC"	ENSG00000177628	"Glucosylceramidase beta"	P04062	1	155234452-155244699	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism"	"Glycosidase, Glycosyltransferase, Hydrolase, Transferase"	"Disease variant, Gaucher disease, Ichthyosis, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 65.2;Syncytiotrophoblasts: 59.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006667, CAB037171, CAB037289"	Supported				"Intracellular and membrane"	NA	NA		470000	"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"			"CAB037171: AB_1078958, CAB037289: AB_1078957, HPA006667: AB_1078979"	"unprognostic (6.03e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.00e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.04e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.94e-2)"	23.9	37.9	22.5	24.8	24.4	41.7	25.1	25.9	24.3	26.7	27.4	35.1	23.9	22.9	50.2	27.6	20.5	28.3	19.1	26.1	27.7	33.6	33.7	28.3	19.9	27.3	28.0	16.9	33.4	103.1	43.8	39.2	36.2	23.3	39.8	12.4	26.8	33.6	9.1	33.4	22.5	29.7	25.0	29.0	22.7	8.8	29.2	19.7	37.7	13.6	28.0	27.1	21.9	29.5	38.0	72.2	25.1	34.2	254.8	55.8	29.3	65.4	230.4	95.3	119.0	43.2	135.7	26.3	70.4	153.7	152.0	76.2	35.9	46.4	50.3	55.5	25.1	21.8	45.1	23.2	73.6	25.8	87.0	73.4	38.2	199.7	30.2	100.2	85.6	22.2	23.4	42.9	113.5	82.6	32.5	11.9	16.3	61.9	51.2	26.8	41.9	108.1	63.9	29.0	23.9	33.5	57.4	136.4	145.3	45.6	102.6	63.3	65.7	71.7	31.7	91.9	53.7	86.2	78.6	20.4	126.6	23.4	56.4	21.4	36.0	15.3	20.8	35.8	13.2	11.1	15.7	13.8	22.4	7.8	11.0	11.7	28.9	11.6	37.2	12.5	23.4	23.3	22.5	24.4	25.9	24.3	26.1	27.7	27.3	28.0	36.2	25.0	29.2	29.5	6.8	3.2	5.1	3.3	8.8	6.0	5.8	9.5	4.6	4.0	12.7	6.5	8.8	17.2	8.1	12.9	2.1	30.7	6.2	36.1	3.9	30.5	1.4	12.3	9.7	12.2	14.6	7.4	3.4	32.4	27.9	18.6	20.9	17.9	7.0	7.9	17.2	23.2	65.2	5.0	2.7	11.6	4.1	33.3	9.9	2.8	9.9	26.8	26.6	1.0	22.8	11.7	12.3	0.5	3.3	29.5	15.8	9.1	19.8	6.7	28.6	20.6	8.5	6.0	0.0	9.4	21.6	22.5	12.5	8.6	4.4	59.4	8.5	6.0	10.4	6.5
GBA2	"AD035, DKFZp762K054, KIAA1605, SPG46"	ENSG00000070610	"Glucosylceramidase beta 2"	Q9HCG7	9	35736866-35749228	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism"	"Glycosidase, Glycosyltransferase, Hydrolase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 114.7;Rod photoreceptor cells: 102.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024026	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024026: AB_1849530"	"unprognostic (3.34e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.99e-2)"	"unprognostic (8.69e-2)"	"prognostic favorable (6.00e-4)"	"unprognostic (9.01e-3)"	"prognostic favorable (1.24e-11)"	"unprognostic (7.62e-3)"	"unprognostic (2.94e-1)"	"unprognostic (7.69e-2)"	"prognostic favorable (6.60e-4)"	39.3	45.7	48.5	23.2	47.5	16.3	39.9	52.8	53.7	46.4	63.3	83.5	54.2	44.6	26.9	36.3	44.2	26.3	83.3	47.2	54.2	84.4	65.9	54.1	24.6	54.1	56.2	39.8	54.1	37.2	65.5	24.7	56.1	60.2	41.0	71.1	50.0	27.7	75.8	39.3	89.7	22.9	45.1	58.5	63.9	30.8	58.9	18.3	61.7	43.7	21.6	53.0	40.9	48.7	18.1	29.3	39.6	38.4	18.8	11.4	40.0	24.1	18.8	23.9	25.0	32.8	14.1	19.3	17.1	14.7	51.5	18.4	38.2	16.2	12.0	27.5	26.2	20.8	87.8	35.6	20.8	31.2	49.4	19.8	29.8	20.3	21.1	57.9	63.4	18.9	20.7	36.0	22.6	18.0	8.5	32.0	41.2	36.6	45.7	15.5	16.0	16.3	33.3	41.9	32.2	43.0	13.5	33.3	24.5	48.1	22.8	27.8	44.6	25.8	30.9	22.4	29.9	24.2	16.5	16.0	32.3	11.3	20.5	11.1	2.9	2.0	3.8	3.9	2.5	3.7	3.7	4.7	2.8	4.7	2.2	1.9	3.2	2.4	2.5	4.4	2.8	2.2	48.5	47.5	52.8	53.7	47.2	54.2	54.1	56.2	56.1	45.1	58.9	48.7	12.7	12.8	8.0	45.1	11.2	7.4	18.2	9.4	6.2	77.5	15.0	10.8	13.7	17.2	14.5	27.6	114.7	11.1	16.6	71.7	21.5	10.5	14.1	10.0	8.1	16.0	35.8	17.2	23.5	12.0	10.2	8.0	46.4	13.8	14.0	18.7	30.7	20.1	9.2	52.2	26.4	35.8	16.2	12.8	10.7	24.3	12.5	10.7	12.4	8.4	13.3	16.2	12.3	18.1	20.2	15.1	57.6	9.8	11.7	15.8	87.4	17.8	17.9	102.9	13.1	12.2	12.2	9.2	5.7	8.8	9.9	22.2	9.4	11.3	41.4	26.3
GBE1		ENSG00000114480	"1,4-alpha-glucan branching enzyme 1"	Q04446	3	81489703-81761645	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Glycosyltransferase, Transferase"	"Disease variant, Glycogen storage disease, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 149.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 287.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038073, HPA038074, HPA038075"	Enhanced		Approved	Cytosol		NA	NA		6500000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA038073: AB_10673040, HPA038074: AB_10672403, HPA038075: AB_10674545"	"unprognostic (3.10e-1)"	"unprognostic (1.02e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.19e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.36e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.83e-3)"	"unprognostic (3.78e-3)"	73.9	53.8	4.5	14.9	5.7	19.7	38.6	7.1	8.2	14.2	14.2	11.8	13.2	17.3	14.2	18.1	13.8	13.0	55.6	6.2	8.2	41.4	108.6	17.2	8.6	10.7	18.7	14.2	14.2	19.1	10.4	25.6	10.3	13.2	13.8	22.0	15.5	14.9	149.1	14.4	11.5	21.8	7.0	12.0	11.1	7.9	7.4	11.4	19.6	56.6	13.2	19.2	13.9	7.4	61.3	36.2	11.9	168.7	287.6	216.8	21.5	99.1	140.1	58.1	97.6	7.1	15.6	67.9	42.7	122.5	34.5	7.1	9.9	45.7	135.4	32.3	6.4	21.2	70.0	22.8	197.5	72.2	17.8	161.2	33.2	93.5	95.5	144.9	130.5	8.0	17.0	38.0	191.1	17.8	12.5	92.7	12.0	16.8	58.0	22.9	53.6	81.1	41.4	20.5	6.0	7.9	64.6	18.7	20.9	17.2	13.3	58.9	183.4	118.9	28.1	84.7	92.8	174.8	21.4	24.6	194.1	47.8	49.8	7.5	11.8	15.6	5.2	10.8	5.1	11.6	5.6	5.7	13.8	12.5	6.4	6.6	11.4	13.5	11.8	4.8	5.1	6.5	4.5	5.7	7.1	8.2	6.2	8.2	10.7	18.7	10.3	7.0	7.4	7.4	49.7	16.0	12.4	31.3	14.9	30.7	22.2	36.8	27.3	18.6	7.5	5.5	60.2	15.7	21.9	31.3	0.0	30.3	8.4	9.5	41.1	32.1	36.2	16.3	15.2	32.0	22.1	4.6	52.4	25.4	74.0	34.9	6.6	14.7	43.1	16.0	15.4	75.2	26.3	30.3	47.4	8.7	12.2	12.9	21.3	16.9	17.4	17.3	24.9	87.1	16.3	10.4	7.2	49.3	63.0	37.8	5.8	13.2	12.8	17.7	11.3	50.8	25.0	17.8	32.9	45.8	26.7	6.9	7.3	20.6	21.3	54.9	8.7	34.2	8.3	14.5
GCDH	ACAD5	ENSG00000105607	"Glutaryl-CoA dehydrogenase"	Q92947	19	12891160-12914207	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 115.5;Proximal tubular cells: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043252, HPA048492"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA043252: AB_2678390, HPA048492: AB_2680418"	"unprognostic (2.46e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.79e-3)"	"unprognostic (8.07e-3)"	"unprognostic (8.20e-3)"	"unprognostic (3.14e-2)"	"prognostic favorable (7.28e-5)"	"prognostic favorable (3.35e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.03e-2)"	"unprognostic (7.50e-3)"	"unprognostic (7.46e-2)"	"prognostic favorable (6.79e-8)"	"unprognostic (7.09e-3)"	"unprognostic (3.42e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.59e-1)"	16.8	17.8	20.2	11.2	22.4	13.0	15.6	22.1	23.3	10.2	21.8	13.2	11.8	12.6	8.6	14.0	15.2	8.4	29.3	19.2	19.4	24.5	89.1	9.3	16.8	20.7	20.9	16.8	15.5	11.5	10.6	5.4	21.0	13.6	8.5	5.5	20.0	11.5	30.5	10.1	13.0	8.2	19.9	12.8	18.6	4.5	20.9	17.8	11.9	27.1	11.9	14.9	9.9	22.7	22.9	14.1	15.0	27.5	21.4	9.8	13.8	17.2	11.1	21.6	15.7	26.9	10.8	33.0	31.9	10.5	10.8	15.6	20.8	16.4	10.6	28.6	22.8	21.0	24.6	33.1	24.8	43.7	18.8	13.8	19.9	15.3	16.1	8.8	18.1	44.4	51.8	11.4	10.7	28.9	51.7	41.7	16.7	22.0	36.1	48.2	15.3	68.9	12.6	12.1	32.3	18.9	22.8	22.6	16.7	9.6	17.8	29.3	13.3	18.0	12.9	29.9	18.2	59.5	32.2	34.6	11.0	50.7	15.4	13.9	13.9	8.5	18.8	12.1	18.8	18.1	23.2	21.0	24.0	19.5	30.9	23.8	3.1	38.8	9.8	14.7	21.4	20.0	20.2	22.4	22.1	23.3	19.2	19.4	20.7	20.9	21.0	19.9	20.9	22.7	6.0	3.2	5.3	25.5	21.2	7.9	14.5	13.3	11.4	14.2	17.3	10.8	10.0	22.8	8.6	11.0	25.0	16.2	17.2	11.6	52.8	14.0	2.6	7.7	10.0	7.3	15.6	60.4	7.1	11.2	21.5	10.2	12.8	10.9	7.0	19.5	13.6	115.5	21.5	8.4	7.4	13.8	16.2	14.4	5.0	1.8	13.1	9.9	17.8	5.6	20.7	18.6	18.6	14.6	15.1	10.2	9.7	12.8	25.4	11.3	17.4	147.8	7.2	12.3	0.0	13.7	9.8	8.3	7.4	13.4	5.3	16.3	20.9	33.0	20.6	12.1
GCH1	"DYT14, DYT5, DYT5a, GCH, GTPCH1"	ENSG00000131979	"GTP cyclohydrolase 1"	P30793	14	54842008-54902826	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	"Allosteric enzyme, Hydrolase"	"Disease variant, Dystonia, Parkinsonism, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.4;liver: 36.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 212.5;Hepatocytes: 94.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 11.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 23.5;Daudi: 25.0;JURKAT: 23.0;SH-SY5Y: 50.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 12.7"	HPA028612	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028612: AB_10602135"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.97e-1)"	"prognostic favorable (8.69e-4)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (6.67e-4)"	2.4	6.0	2.1	8.1	3.0	31.4	1.8	1.1	2.0	0.4	1.5	2.4	9.4	0.4	0.2	3.5	1.2	0.4	1.9	1.9	4.8	4.6	36.7	4.1	7.0	3.5	16.1	0.5	2.6	0.9	1.8	0.3	8.4	1.5	2.4	0.1	1.7	1.0	0.4	2.2	7.5	1.1	2.4	6.9	2.8	1.2	7.8	3.8	0.8	0.2	2.0	3.3	1.4	2.0	4.7	0.6	1.3	7.1	0.0	0.0	23.5	0.0	2.0	2.4	2.9	1.4	1.0	25.0	6.9	0.2	5.8	4.0	4.9	1.5	0.1	10.9	5.2	0.6	0.3	3.1	8.4	0.0	1.9	0.3	0.7	1.2	0.1	0.0	0.7	23.0	2.8	0.0	0.0	5.0	15.1	0.3	0.4	6.5	8.2	9.6	2.8	0.0	2.9	1.6	11.6	50.9	3.3	2.4	1.6	0.4	2.9	1.5	0.3	0.1	4.0	9.9	3.8	10.5	8.4	7.8	3.1	8.4	0.0	0.0	2.6	0.2	2.8	5.3	2.1	0.7	1.0	1.5	2.8	1.9	2.5	1.3	0.3	1.8	11.1	0.1	2.1	1.2	2.1	3.0	1.1	2.0	1.9	4.8	3.5	16.1	8.4	2.4	7.8	2.0	19.2	3.2	4.8	0.7	33.4	74.6	30.9	23.6	17.6	0.0	19.4	13.2	6.5	4.3	13.6	5.5	2.1	1.9	50.9	21.8	7.9	8.7	0.5	16.8	5.8	19.8	212.5	10.1	3.8	9.4	44.3	15.3	43.8	29.3	0.0	0.3	6.8	94.6	6.1	0.0	5.9	22.7	4.1	28.0	33.3	0.6	0.3	55.8	10.6	15.9	29.5	0.7	29.9	0.5	0.8	11.0	13.6	4.9	14.4	20.5	17.1	48.6	6.9	0.4	0.0	12.5	7.5	2.2	6.7	20.8	76.1	4.2	41.8	11.9	12.2	39.0
GCK	"HK4, MODY2"	ENSG00000106633	Glucokinase	P35557	7	44143213-44198170	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 12.6;choroid plexus: 7.4;heart muscle: 8.8;liver: 21.5;pituitary gland: 23.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.0;Cardiomyocytes: 4.9;Fibroblasts: 5.2;Horizontal cells: 5.0;Smooth muscle cells: 3.7"	"Cancer enhanced"	"Detected in some"		"liver cancer: 4.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.3;naive CD4 T-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 6.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007034, HPA007093"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"		"HPA007034: AB_1079050, HPA007093: AB_1079051"	"unprognostic (3.09e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.64e-7)"	"unprognostic (8.00e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.11e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.53e-1)"	0.8	0.3	8.9	0.3	8.3	0.2	0.7	8.1	9.5	2.8	7.4	0.5	0.1	1.2	0.8	0.4	1.2	0.5	8.8	8.2	11.0	1.2	21.5	0.4	0.2	9.0	9.9	1.4	1.8	0.1	23.9	1.6	9.1	1.2	0.2	1.0	0.3	0.7	0.2	0.7	0.5	0.3	8.3	0.6	0.6	0.4	12.6	0.1	0.5	0.1	0.2	1.1	2.0	7.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.5	0.0	0.7	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	1.2	1.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.6	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.3	2.3	0.7	0.1	0.1	0.3	2.0	0.4	0.8	0.1	0.0	0.1	0.0	0.3	8.9	8.3	8.1	9.5	8.2	11.0	9.0	9.9	9.1	8.3	12.6	7.9	0.3	0.0	0.0	0.7	0.3	1.1	0.7	0.0	1.2	5.0	0.1	0.8	4.9	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	1.3	0.5	2.4	0.0	1.8	0.0	0.2	5.2	0.0	0.0	0.0	2.4	0.0	0.4	0.7	5.0	2.4	0.0	0.0	0.0	0.7	0.3	0.9	0.1	0.0	1.0	0.0	2.8	0.0	0.5	1.0	0.1	0.1	2.2	0.2	1.7	0.0	0.1	0.0	0.8	0.0	0.6	3.7	0.5	1.1	0.0	0.1	0.8	0.3	0.5	0.0	0.7
GCLC	"GCS, GLCL, GLCLC"	ENSG00000001084	"Glutamate-cysteine ligase catalytic subunit"	P48506	6	53497341-53616970	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.1"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 220.7;Urothelial cells: 144.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A549: 205.4;Hep G2: 178.2;OE19: 287.5;RT4: 189.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009569, HPA036359, HPA036360"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		5800000	"Cluster 15: NK-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789"	"unprognostic (8.41e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.94e-3)"	"unprognostic (4.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.23e-2)"	"prognostic favorable (3.83e-6)"	"unprognostic (3.78e-2)"	"unprognostic (8.91e-2)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.30e-2)"	26.7	18.3	18.5	16.6	24.9	37.8	27.2	18.1	23.3	9.5	14.1	22.8	41.9	19.2	10.8	37.0	62.9	32.1	16.4	16.8	18.9	34.1	152.1	10.9	26.2	18.4	19.7	8.5	15.9	18.3	4.8	9.1	20.4	26.9	26.0	14.4	13.1	15.8	11.4	18.8	32.2	16.0	18.2	39.1	32.9	11.3	22.5	13.7	30.0	14.5	24.0	63.7	14.5	36.0	31.3	205.4	16.5	39.1	19.4	8.6	22.1	15.5	24.9	11.4	13.3	30.5	70.7	59.1	28.7	14.1	86.9	43.3	50.7	112.5	15.3	46.9	31.4	39.6	38.3	178.2	22.1	52.8	23.5	13.5	46.6	12.8	56.8	15.0	17.7	50.9	22.4	18.2	5.6	32.9	45.5	20.9	30.6	287.5	19.2	14.9	10.2	52.1	37.0	189.8	47.5	23.3	25.9	40.9	27.8	23.8	28.2	24.6	24.6	10.2	35.5	26.0	23.4	24.1	39.9	34.0	25.6	37.0	17.5	1.2	0.5	0.3	0.5	0.9	0.4	0.8	0.5	1.1	2.3	0.5	0.3	0.6	0.2	4.2	1.0	1.6	0.9	0.3	18.5	24.9	18.1	23.3	16.8	18.9	18.4	19.7	20.4	18.2	22.5	36.0	17.1	0.0	2.4	36.9	12.7	34.8	61.6	56.6	47.3	14.4	23.7	13.6	20.9	38.6	47.4	0.0	25.0	6.4	22.9	22.1	11.7	14.6	2.2	34.8	14.9	14.1	220.7	113.2	22.4	12.8	8.6	13.6	43.8	69.8	2.5	50.9	10.4	118.5	22.7	8.4	30.4	19.4	40.7	87.2	10.9	1.5	6.5	32.1	8.8	24.4	10.6	12.5	17.5	30.2	84.1	15.9	13.2	9.4	10.4	88.3	18.2	27.1	66.5	5.0	13.1	14.0	13.5	3.1	9.2	72.6	24.9	7.8	14.9	26.6	14.8	144.8
GCNT2	"bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3"	ENSG00000111846	"Glucosaminyl (N-acetyl) transferase 2 (I blood group)"	Q8N0V5	6	10492223-10629368	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 13.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Endometrial ciliated cells: 79.1;Glandular and luminal cells: 105.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 44.2;Hep G2: 19.7;SK-MEL-30: 17.1;SuSa: 21.4"	"Region enriched"	"Detected in all"	4	"basal ganglia: 61.1"	"Low region specificity"	"Detected in all"			HPA026776	Approved		Approved	"Golgi apparatus"		No	No		750000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"		"HPA026776: AB_1849573"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.28e-4)"	"unprognostic (3.96e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.54e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	0.6	0.3	0.7	1.0	0.6	0.3	10.1	2.5	1.1	4.2	4.5	3.6	5.2	1.4	0.2	1.4	0.8	1.5	6.6	0.8	1.1	5.7	5.1	3.9	1.8	1.2	1.0	0.3	1.3	0.4	1.4	2.6	1.4	13.5	2.0	0.3	4.2	0.3	0.7	1.4	5.8	1.6	0.9	1.5	5.9	2.5	0.9	0.5	1.2	1.8	2.4	1.0	0.7	1.0	6.3	4.9	1.5	4.8	0.0	0.0	9.6	0.0	4.1	1.1	0.5	11.0	5.2	3.5	44.2	0.0	3.2	0.3	0.4	5.1	2.9	3.1	1.8	0.5	2.6	19.7	0.0	1.7	4.7	0.0	0.0	0.5	0.0	2.4	9.1	0.0	0.4	0.0	0.4	0.0	0.0	4.0	4.4	0.0	3.6	0.2	3.8	6.0	16.0	2.9	4.0	1.2	0.0	14.4	17.1	21.4	0.3	0.8	6.4	0.8	0.5	0.0	5.0	0.1	0.0	2.4	0.8	0.3	2.3	1.9	1.1	0.5	0.1	0.8	0.0	0.7	0.1	0.1	0.8	0.4	0.1	0.2	0.1	0.2	0.2	0.2	0.0	0.3	0.7	0.6	2.5	1.1	0.8	1.1	1.2	1.0	1.4	0.9	0.9	1.0	1.4	76.9	32.4	1.0	9.5	4.6	6.6	15.5	9.6	5.1	30.5	16.1	18.4	2.8	28.6	7.3	0.0	27.9	6.4	15.5	11.7	2.9	4.3	79.1	5.5	11.0	2.4	25.9	0.7	24.7	2.1	2.0	16.8	105.5	2.5	0.0	12.8	32.0	15.8	3.3	11.8	5.6	6.1	7.7	9.4	8.2	0.3	7.8	49.8	52.5	11.1	2.4	0.0	18.6	1.1	12.0	11.9	0.0	1.0	16.6	44.3	13.4	27.9	0.6	0.0	0.7	2.2	6.2	27.6	11.2	1.7	10.9	3.1	0.0	16.3	8.1
GFER	"ALR, ERV1, HERV1, HPO1, HPO2, HSS"	ENSG00000127554	"Growth factor, augmenter of liver regeneration"	P55789	16	1984193-1987749	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Oxidoreductase"	"Cataract, Deafness, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 183.7;Early spermatids: 168.7;Proximal enterocytes: 371.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041227, HPA063553"	Approved		Enhanced	Mitochondria,Cytosol	"Secreted to blood"	NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	"Mitochondria, Cytosol"		"HPA041227: AB_10795538, HPA063553: AB_2685038"	"unprognostic (5.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.93e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.09e-2)"	17.7	21.2	19.6	13.8	19.0	18.2	17.8	21.6	23.1	14.2	17.9	32.8	42.7	16.6	6.6	17.5	16.0	13.5	29.8	19.0	19.7	21.9	45.9	15.3	20.9	21.5	21.1	11.3	53.7	29.6	18.1	12.2	20.9	19.6	25.4	7.7	28.8	13.1	40.9	14.5	45.2	10.9	18.8	21.9	24.7	38.5	20.6	10.5	15.9	30.4	16.9	19.4	12.8	20.6	27.2	44.1	35.6	29.2	14.7	28.9	43.5	28.6	31.2	44.2	35.6	63.7	46.1	15.2	39.7	24.2	25.7	39.8	27.3	42.4	27.9	44.7	46.6	20.9	44.3	73.4	26.6	32.1	37.9	18.9	32.5	38.8	34.6	27.8	21.1	32.7	33.0	51.3	32.6	66.1	34.9	33.9	54.9	23.9	39.7	74.5	26.8	50.7	45.5	21.9	30.5	28.9	39.3	91.2	34.5	18.2	43.4	33.6	19.1	42.8	45.0	24.0	54.3	79.1	48.3	45.7	14.2	21.5	36.7	3.8	16.2	13.4	11.2	13.9	11.4	23.5	14.9	18.5	11.6	17.8	13.6	9.5	1.4	10.7	17.4	5.1	24.9	10.6	19.6	19.0	21.6	23.1	19.0	19.7	21.5	21.1	20.9	18.8	20.6	20.6	18.0	3.2	6.7	2.3	32.5	15.9	19.9	21.1	17.6	10.8	32.7	27.6	17.4	27.1	16.6	9.2	0.0	43.4	23.0	183.7	35.2	44.0	168.7	24.0	11.4	17.9	27.2	17.0	3.4	80.8	57.8	17.7	16.8	18.7	12.7	22.8	20.7	59.1	45.9	8.4	3.2	60.3	26.4	39.3	24.8	123.7	17.4	24.7	23.2	1.0	39.6	12.6	39.1	1.5	3.3	57.3	100.3	12.4	39.6	21.7	371.7	84.6	33.3	11.5	13.1	15.8	18.5	41.9	26.7	17.3	14.8	37.5	27.4	26.7	68.7	26.0
GFPT1	"GFA, GFAT, GFAT1, GFPT"	ENSG00000198380	"Glutamine--fructose-6-phosphate transaminase 1"	Q06210	2	69319780-69387250	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms"	"Aminotransferase, Transferase"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 184.2;Intestinal goblet cells: 244.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047240			Approved	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		NA	NA		93000	"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Nucleoli"	"Nucleoli fibrillar center"	"HPA047240: "	"unprognostic (4.38e-3)"	"unprognostic (8.20e-2)"	"prognostic favorable (7.13e-5)"	"unprognostic (2.97e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.84e-2)"	"unprognostic (5.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.58e-1)"	31.2	17.9	6.6	21.5	6.5	15.0	22.4	5.5	7.1	37.8	31.5	74.3	38.4	15.6	41.6	16.4	24.3	32.5	24.8	7.0	11.0	21.6	23.1	17.0	10.6	4.9	10.5	12.0	33.7	26.2	18.9	36.0	10.8	36.7	76.6	10.4	42.4	25.9	10.2	6.0	41.2	23.2	5.3	9.5	64.3	46.6	8.0	10.2	91.8	13.9	15.9	21.8	9.2	6.8	46.6	42.7	34.7	20.9	107.7	75.8	73.5	97.1	94.5	44.7	59.3	109.5	50.5	31.7	31.9	92.9	61.4	22.6	47.1	28.6	73.6	38.4	18.4	38.2	25.0	94.5	123.0	27.9	17.9	47.8	132.5	88.7	158.8	55.5	43.4	29.8	34.8	58.3	85.2	30.9	31.3	22.9	37.0	116.7	27.4	28.2	79.1	18.3	70.6	42.0	25.2	11.9	35.2	52.4	93.7	73.5	22.7	17.2	61.8	37.2	62.3	64.6	47.5	39.5	32.2	25.4	65.7	18.3	46.9	9.2	3.5	4.9	7.5	4.3	7.0	6.4	6.5	8.3	4.7	3.6	6.3	6.2	1.2	5.2	5.2	4.4	5.0	4.2	6.6	6.5	5.5	7.1	7.0	11.0	4.9	10.5	10.8	5.3	8.0	6.8	14.6	51.3	49.5	15.7	29.8	28.4	21.6	31.7	26.7	13.7	50.6	16.5	43.1	42.9	54.5	44.1	12.5	28.6	30.3	184.2	17.6	34.1	123.9	54.4	54.1	17.2	75.1	3.8	49.2	89.5	70.3	37.6	110.1	60.0	24.1	19.2	17.9	53.6	17.0	6.7	56.3	244.0	16.2	10.0	31.4	23.7	23.3	16.0	53.4	27.2	28.1	10.6	13.4	42.7	43.8	66.0	83.3	28.2	82.1	72.3	62.5	30.0	89.7	14.0	19.7	21.6	41.8	134.1	45.3	20.3	21.0	34.3	33.4	15.7	135.3	56.3
GGT1	"CD224, D22S672, D22S732, GGT"	ENSG00000100031	"Gamma-glutamyltransferase 1"	P19440	22	24594811-24629005	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis, Lipid metabolism"	"Acyltransferase, Hydrolase, Protease, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 174.8;liver: 115.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 80.1;Cholangiocytes: 48.6;Distal enterocytes: 54.1;Ductal cells: 82.6;Hepatocytes: 40.8;Proximal enterocytes: 111.7;Proximal tubular cells: 62.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 37.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 103.6;Karpas-707: 165.8;OE19: 169.5;RPMI-8226: 210.3;RPTEC TERT1: 203.2"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA		3600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (8.13e-3)"	"unprognostic (4.76e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (4.55e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (4.83e-4)"	"unprognostic (1.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.10e-2)"	3.3	2.4	5.5	6.4	6.7	12.0	24.7	7.0	7.5	28.7	5.1	20.3	84.7	3.0	72.0	3.3	3.3	47.1	7.2	5.1	5.1	174.8	115.7	42.6	5.4	7.2	6.6	3.2	63.1	0.2	5.5	2.4	7.8	48.8	11.0	1.6	9.9	21.6	1.9	4.1	80.4	2.2	5.9	13.3	31.3	18.4	7.1	6.5	15.9	0.4	6.2	5.7	4.3	9.2	1.0	79.7	1.0	0.3	0.0	0.5	2.2	0.5	1.7	0.8	1.0	11.7	18.3	1.0	16.2	0.1	14.8	11.0	6.2	0.8	0.5	103.6	12.3	0.6	40.8	64.3	5.5	1.5	33.2	2.1	0.9	2.5	1.7	1.4	0.5	19.0	8.4	165.8	1.0	1.7	1.6	52.4	6.4	169.5	0.7	0.7	6.8	210.3	203.2	2.9	0.5	1.2	0.4	33.3	0.8	22.2	32.4	39.6	6.4	10.6	9.3	46.6	0.9	48.2	18.4	0.7	19.0	58.7	0.5	4.8	12.3	0.2	1.0	6.0	2.9	2.2	5.0	2.4	6.5	0.2	0.6	1.4	15.9	4.9	4.0	0.1	6.5	5.6	5.5	6.7	7.0	7.5	5.1	5.1	7.2	6.6	7.8	5.9	7.1	9.2	0.2	80.1	22.8	3.3	2.8	0.8	0.1	0.3	4.6	0.5	5.9	2.3	0.7	48.6	4.9	1.8	0.0	1.4	0.7	54.1	1.9	82.6	1.8	1.2	0.6	0.7	1.2	5.3	4.4	8.1	0.4	3.9	15.3	5.1	5.7	0.1	1.8	40.8	4.9	0.0	4.1	4.4	4.1	2.5	1.7	6.7	0.0	2.9	1.8	1.0	5.8	2.5	0.0	1.5	5.7	20.9	20.1	0.4	12.8	2.0	111.7	62.9	1.6	0.1	0.0	0.1	1.0	0.6	0.8	0.4	0.4	0.8	4.0	0.0	6.5	0.1
GHSR		ENSG00000121853	"Growth hormone secretagogue receptor"	Q92847	3	172443291-172448456	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"hippocampal formation: 3.8;hypothalamus: 15.1;thalamus: 3.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hypothalamus: 3.3"	"Low region specificity"	"Detected in all"									NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"														"unprognostic (1.27e-1)"			"unprognostic (3.31e-2)"				0.0	0.2	0.7	0.1	0.5	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	15.1	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	3.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.6	3.8	15.1	1.3	0.2	0.8	0.3	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GJA3	"CX46, CZP3"	ENSG00000121743	"Gap junction protein alpha 3"	Q9Y6H8	13	20138255-20161052	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 7.8;parathyroid gland: 4.0;placenta: 2.5"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 13.6"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 1.3;melanoma: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 4.4;CAPAN-2: 7.7;HL-60: 6.6;U-266/84: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014821	Supported					NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA014821: AB_2669097"	"unprognostic (2.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.04e-2)"	"unprognostic (6.87e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.52e-2)"	"unprognostic (7.70e-2)"	"unprognostic (4.02e-2)"	"unprognostic (9.65e-8)"	"unprognostic (2.87e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-2)"	"unprognostic (8.04e-3)"	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	7.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	1.2	0.1	0.0	0.1	0.0	1.0	0.0	0.2	0.0	4.4	0.2	0.0	3.7	0.1	1.1	0.0	0.5	3.5	0.6	0.7	0.4	7.7	0.0	0.1	1.3	1.2	0.1	2.5	2.1	0.5	0.2	1.9	1.8	0.0	0.0	0.0	6.6	0.0	0.2	1.2	0.1	0.3	0.0	0.0	2.8	0.5	0.0	0.1	0.0	0.0	0.0	0.5	0.1	1.5	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	3.7	0.1	0.8	1.4	0.0	0.0	0.0	1.5	0.2	1.7	4.7	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.2	0.0	0.0	0.0	13.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	2.7	0.3	0.0	0.0	0.1	0.0	0.0	0.1
GJA5	CX40	ENSG00000265107	"Gap junction protein alpha 5"	P36382	1	147756199-147773362	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Atrial fibrillation, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 36.7;placenta: 85.4"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 135.3;Extravillous trophoblasts: 345.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SK-BR-3: 133.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB013080, HPA071370"	Enhanced					NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB013080: AB_2533263, HPA071370: "	"unprognostic (1.25e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.88e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.27e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.44e-1)"	"unprognostic (4.41e-2)"	"unprognostic (3.43e-2)"	"unprognostic (8.93e-2)"	18.6	2.2	2.5	6.0	3.4	0.0	10.5	2.4	4.1	5.5	2.6	4.7	3.4	10.8	2.3	4.8	8.2	6.3	36.7	2.4	2.2	17.1	1.2	26.4	1.7	2.8	2.6	4.0	2.6	3.4	0.5	85.4	2.5	4.0	4.1	0.2	1.6	9.4	2.1	1.4	5.9	8.2	2.6	3.9	3.0	2.9	2.7	0.6	5.3	8.9	2.3	7.4	3.8	2.7	1.8	0.0	0.3	0.0	0.0	0.0	5.7	4.4	2.2	2.2	0.5	0.1	0.2	0.0	1.4	0.7	0.0	0.3	0.0	9.3	3.5	0.0	0.3	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.1	13.1	0.0	0.1	0.1	0.2	133.8	0.0	12.2	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.4	2.4	4.1	2.4	2.2	2.8	2.6	2.5	2.6	2.7	2.7	14.3	3.2	4.2	0.0	1.0	0.0	0.0	0.0	0.6	0.0	0.2	1.5	17.7	0.0	0.0	3.7	0.0	135.3	0.1	0.0	0.0	0.0	7.6	0.1	0.3	14.7	0.0	0.0	0.0	0.0	345.3	3.7	0.0	0.1	0.0	19.9	37.9	0.0	15.8	0.0	0.0	0.0	0.0	0.6	0.0	9.8	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	39.5	0.5	11.1	4.3	0.4	0.2	0.3	31.1	0.5	0.1	0.0	0.1
GJA8	"CAE, CAE1, CX50, CZP1"	ENSG00000121634	"Gap junction protein alpha 8"	P48165	1	147902795-147909269	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	46	"testis: 5.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 14.6;Spermatocytes: 39.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA014715, HPA062940"	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA014715: AB_2732411, HPA062940: AB_2732693"										"unprognostic (3.73e-2)"					"unprognostic (2.35e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GJB1	"CMTX, CMTX1, CX32"	ENSG00000169562	"Gap junction protein beta 1"	P08034	X	71212811-71225516	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 100.9;liver: 335.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 114.4;Hepatocytes: 286.4;Proximal enterocytes: 118.8;Proximal tubular cells: 68.9;Undifferentiated cells: 66.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 163.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 143.2;SK-MEL-30: 155.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012994	Uncertain					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB012994: AB_2533228"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.85e-6)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.97e-2)"	0.1	0.0	27.1	3.7	63.2	0.0	6.4	76.5	37.6	8.8	12.7	33.9	44.0	1.7	22.5	0.3	27.4	41.5	0.0	27.3	40.9	42.9	335.7	2.4	0.0	90.6	64.4	0.1	83.0	0.0	0.1	0.0	76.0	11.6	23.8	0.0	37.7	7.5	0.0	0.9	34.4	1.8	50.0	0.1	16.4	10.2	56.9	0.0	0.1	0.1	0.0	0.4	0.1	100.9	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	25.5	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.3	0.0	5.1	0.2	0.0	0.2	0.0	0.0	155.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	27.1	63.2	76.5	37.6	27.3	40.9	90.6	64.4	76.0	50.0	56.9	100.9	0.0	0.0	4.8	0.3	0.8	0.6	0.7	0.5	0.0	0.0	7.7	2.4	0.1	114.4	2.7	9.2	0.0	0.0	0.1	50.2	9.8	34.1	0.3	8.2	3.4	0.6	9.6	8.0	0.2	58.9	0.0	0.1	15.8	29.0	4.5	0.0	3.3	286.4	0.0	0.0	0.2	29.4	2.0	4.8	0.4	0.4	0.3	0.8	23.2	0.0	0.6	0.0	0.0	1.0	51.3	32.3	53.4	0.4	0.0	2.6	118.8	68.9	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	1.0	0.0	66.1	2.8
GJB2	"CX26, DFNA3, DFNB1, NSRD1"	ENSG00000165474	"Gap junction protein beta 2"	P29033	13	20187463-20192938	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Disease variant, Ectodermal dysplasia, Ichthyosis, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 328.1;esophagus: 812.1;vagina: 519.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 69.8;Basal respiratory cells: 237.4;Basal squamous epithelial cells: 55.8;Ionocytes: 50.8;Squamous epithelial cells: 160.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 447.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 144.6;hTCEpi: 105.4;OE19: 76.9;RT4: 169.9"	"Low region specificity"	"Detected in all"							"CAB013093, HPA014362"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"CAB013093: AB_2533903, HPA014362: "	"unprognostic (2.21e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (4.45e-4)"	"unprognostic (9.77e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.69e-3)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (2.53e-6)"	"unprognostic (5.78e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.93e-3)"	2.0	0.7	1.3	6.7	1.2	3.8	3.7	2.4	3.1	328.1	5.3	20.8	12.9	2.9	3.4	812.1	0.9	14.0	0.4	1.1	1.7	9.8	47.5	0.7	0.4	1.8	1.7	0.3	1.3	0.1	4.1	0.2	1.7	1.2	17.4	0.0	145.2	0.3	0.4	73.0	10.6	2.6	1.7	0.2	8.1	1.2	7.6	12.5	1.7	1.2	90.4	27.9	519.8	1.6	8.7	0.6	0.0	0.2	0.0	2.9	1.7	0.0	0.0	0.0	0.0	1.3	144.6	0.0	0.7	0.1	1.1	28.9	5.3	14.4	0.1	12.6	1.8	0.1	0.1	0.3	0.0	0.0	5.1	2.4	105.4	1.9	19.5	0.0	0.0	2.1	0.1	10.7	0.2	1.4	1.3	0.0	0.3	76.9	14.4	0.2	0.0	8.3	0.2	169.9	0.1	0.0	0.3	0.1	0.3	1.9	2.2	0.4	0.0	0.2	0.0	2.5	22.2	8.7	9.6	0.0	17.1	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	2.4	3.1	1.1	1.7	1.8	1.7	1.7	1.7	7.6	1.6	0.1	3.2	0.0	2.0	0.6	69.8	16.1	237.4	55.8	0.0	1.3	1.3	0.5	4.3	37.3	1.8	0.0	0.1	0.0	28.0	0.0	4.4	1.5	5.0	1.5	1.3	4.2	0.0	0.0	9.8	0.2	1.7	4.1	19.1	0.0	0.0	0.0	25.2	0.6	0.0	0.0	6.1	50.8	0.6	13.3	1.3	0.0	3.9	1.8	0.0	4.6	0.0	0.0	0.0	0.0	9.2	13.3	0.0	2.7	8.6	10.7	17.5	7.5	0.0	0.0	0.1	4.7	0.8	2.1	160.9	28.7	0.1	0.9	0.0	25.0	21.7
GJB3	"CX31, DFNA2, EKV"	ENSG00000188910	"Gap junction protein beta 3"	O75712	1	34781214-34786369	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 77.8;skin 1: 145.0"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 138.4;Basal prostatic cells: 71.9;Basal respiratory cells: 43.6;Pancreatic endocrine cells: 119.8;Prostatic glandular cells: 63.4;Squamous epithelial cells: 91.9;Suprabasal keratinocytes: 170.6;Urothelial cells: 171.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 58.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 88.8;CAPAN-2: 121.7;HaCaT: 99.4;HBEC3-KT: 84.9;hTCEpi: 136.8;OE19: 54.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074472			Supported	"Vesicles,Cell Junctions"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Cell Junctions"		"HPA074472: AB_2686694"	"unprognostic (1.34e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.21e-4)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (4.50e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.46e-2)"	0.3	0.2	1.3	1.7	0.6	0.0	5.5	1.1	1.0	8.9	0.0	4.2	0.2	0.3	2.8	77.8	1.1	7.0	0.1	0.6	0.0	0.5	1.5	0.6	0.5	0.2	0.0	0.1	0.3	0.0	0.1	1.4	0.1	4.0	5.0	0.0	8.9	1.7	0.6	145.0	1.3	0.1	0.0	0.0	5.9	0.8	0.1	0.8	0.2	0.0	12.9	11.9	26.4	0.2	88.8	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	121.7	0.0	11.6	0.1	0.1	99.4	0.0	84.9	0.0	0.1	0.0	0.3	5.0	0.0	0.0	0.0	0.0	0.0	136.8	0.0	35.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.4	54.2	22.3	0.0	0.0	0.0	40.8	33.0	0.0	0.0	13.1	0.9	0.0	0.1	1.0	0.1	0.0	0.1	5.7	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	1.1	1.0	0.6	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	3.2	0.0	0.0	0.0	138.4	71.9	43.6	16.5	0.0	2.0	1.3	0.4	1.5	15.5	5.5	0.0	0.3	0.0	18.3	0.0	14.6	0.0	4.1	0.4	1.7	1.8	0.0	0.2	7.3	0.2	1.7	3.1	8.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	6.1	0.0	12.5	0.0	0.0	0.4	14.2	0.0	0.0	0.0	0.0	0.0	0.0	119.8	8.1	0.0	0.0	63.4	0.5	0.0	10.1	0.0	0.0	0.0	2.1	0.1	0.3	91.9	170.6	0.1	0.5	0.0	19.1	171.0
GJB4	CX30.3	ENSG00000189433	"Gap junction protein beta 4"	Q9NTQ9	1	34759740-34762327	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 43.1"	"Group enriched"	"Detected in some"	4	"Basal prostatic cells: 31.1;Pancreatic endocrine cells: 37.0;Urothelial cells: 102.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 9.0;HaCaT: 12.2;HBEC3-KT: 8.3;hTCEpi: 5.7;OE19: 4.5;RPTEC TERT1: 4.8;RT4: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055112, HPA073904"	Enhanced		Supported	"Cell Junctions"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"		"HPA055112: AB_2682699, HPA073904: "	"unprognostic (3.30e-2)"	"prognostic favorable (5.48e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.65e-1)"	"prognostic unfavorable (3.24e-5)"	"unprognostic (3.73e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.52e-4)"	"unprognostic (5.42e-2)"	0.0	0.0	0.0	0.3	0.1	0.0	2.6	0.0	0.2	0.7	0.0	0.2	0.0	0.0	5.5	2.3	0.2	4.8	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.3	0.0	0.5	1.0	0.2	43.1	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.1	0.0	2.3	7.9	1.4	0.0	9.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	1.3	0.0	0.1	12.2	0.0	8.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	4.8	5.9	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	31.1	13.9	1.2	0.0	0.3	0.1	0.1	0.0	5.7	0.0	0.0	0.1	0.1	0.3	0.0	3.7	0.0	0.3	0.0	0.2	1.8	0.0	0.0	0.6	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	37.0	1.3	0.0	0.0	12.9	0.1	0.0	6.8	0.0	0.0	0.0	0.7	0.0	0.0	3.5	6.0	0.3	0.1	0.0	0.4	102.6
GK	"GK1, GKD"	ENSG00000198814	"Glycerol kinase"	P32189	X	30653359-30731462	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 90.7;kidney: 107.7;liver: 79.2"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 139.2;Macrophages: 133.4;Proximal enterocytes: 144.2;Proximal tubular cells: 161.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	8	"neutrophil: 178.4"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 178.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 37.4;Hep G2: 46.4"	"Low region specificity"	"Detected in all"							HPA060687	Supported					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"			"HPA060687: AB_2684343"	"unprognostic (8.78e-3)"	"unprognostic (8.41e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.56e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.58e-2)"	"prognostic favorable (3.24e-9)"	"unprognostic (1.59e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.57e-3)"	"unprognostic (4.11e-3)"	8.8	9.8	3.1	51.5	2.8	6.6	4.8	3.7	17.2	4.8	8.4	13.0	86.6	3.6	12.3	9.6	7.7	23.8	4.8	2.3	4.1	107.7	79.2	19.7	10.6	7.2	4.2	2.6	4.5	14.0	5.4	8.2	6.8	3.6	10.9	10.3	11.2	2.2	2.6	6.3	90.7	4.4	3.6	10.1	6.2	2.9	14.5	5.4	6.6	3.1	14.5	30.2	2.7	8.0	4.5	3.5	4.5	7.7	2.7	10.4	1.8	10.6	37.4	7.6	8.6	5.8	4.1	12.6	1.7	4.1	6.9	0.3	8.5	3.5	10.1	8.2	9.6	7.5	6.6	46.4	17.2	14.2	15.4	6.3	4.9	24.2	22.3	1.9	6.0	9.6	4.0	17.3	2.1	6.2	11.0	14.6	7.5	4.9	4.0	15.0	7.1	13.1	5.7	14.8	4.8	6.1	9.4	9.4	21.5	4.5	10.6	10.1	2.3	5.5	2.3	0.3	4.9	9.1	10.7	12.5	9.5	9.1	5.6	5.0	22.8	7.9	1.7	7.2	1.3	3.1	3.1	2.2	14.2	5.6	1.8	1.9	178.4	4.8	9.1	4.2	11.5	6.2	3.1	2.8	3.7	17.2	2.3	4.1	7.2	4.2	6.8	3.6	14.5	8.0	2.0	16.0	27.4	19.6	15.8	6.9	12.3	12.6	4.6	3.2	9.4	3.9	4.3	12.8	22.5	7.3	16.7	1.2	5.6	54.7	35.2	21.9	61.5	15.1	2.7	3.8	12.1	6.3	41.5	11.1	1.1	12.4	20.9	1.7	14.5	6.9	3.6	38.1	34.8	5.0	37.2	14.7	0.0	26.6	139.2	29.9	1.2	133.4	14.2	10.3	42.6	29.1	3.1	28.6	19.6	10.6	39.9	2.2	12.4	17.0	144.2	161.1	47.7	17.7	0.0	9.2	7.0	15.3	1.7	14.7	16.9	0.8	15.7	3.7	11.0	26.8
GLA	GALA	ENSG00000102393	"Galactosidase alpha"	P06280	X	101393273-101408012	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 229.9;Plasma cells: 171.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 328.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000237, HPA000966"	Enhanced				"Intracellular and membrane"	NA	NA		1300000	"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA000237: AB_1078968, HPA000966: AB_1078969"	"unprognostic (7.27e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (5.62e-5)"	"unprognostic (2.53e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.73e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (1.13e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.21e-1)"	15.6	21.5	5.2	12.7	5.4	25.1	26.7	6.6	6.9	13.8	6.2	13.0	22.4	10.9	17.5	9.3	15.2	11.8	9.9	5.6	6.2	15.6	12.7	17.2	13.2	7.0	7.3	9.2	6.7	31.7	9.9	22.1	7.3	7.9	15.3	6.9	10.0	39.3	6.2	9.2	13.5	15.4	6.5	13.2	9.3	3.8	6.9	12.0	7.9	6.5	15.6	14.7	9.1	8.1	30.5	117.9	30.8	31.9	68.9	26.8	13.8	34.1	51.9	63.5	176.3	64.7	45.9	33.6	70.0	35.3	151.8	70.3	65.9	38.3	53.8	19.3	47.1	18.3	87.9	78.4	19.2	26.7	328.1	24.3	11.3	72.9	21.6	17.4	50.9	18.2	28.6	71.2	60.8	52.3	24.4	53.7	48.2	72.5	46.4	18.2	39.5	81.5	95.1	61.9	11.5	19.4	78.6	34.6	30.9	54.4	15.2	51.2	29.9	20.7	23.8	52.6	27.0	23.0	26.3	25.4	36.9	39.9	23.1	22.5	37.3	11.9	6.9	38.5	9.0	8.8	5.6	8.8	29.8	9.0	5.6	6.9	21.6	5.6	40.6	10.9	7.3	20.4	5.2	5.4	6.6	6.9	5.6	6.2	7.0	7.3	7.3	6.5	6.9	8.1	31.5	16.0	10.2	3.3	65.8	30.2	32.6	23.7	45.5	4.0	34.0	23.2	7.7	4.3	19.3	11.0	6.2	38.4	25.5	26.5	17.6	22.5	3.9	57.6	19.5	30.8	33.9	12.6	3.2	18.7	26.3	66.1	39.8	97.6	31.0	9.6	8.9	7.1	93.0	8.4	3.9	15.9	20.3	28.5	229.9	0.9	11.1	115.7	88.9	4.7	30.3	17.5	14.4	3.0	3.9	14.4	25.3	18.0	171.4	20.5	30.9	9.5	29.9	5.3	6.6	22.6	70.8	6.4	5.8	31.0	23.7	75.5	33.2	19.8	19.2	27.9
GLB1	"EBP, ELNR1"	ENSG00000170266	"Galactosidase beta 1"	P16278	3	32996609-33097202	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 857.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008382, HPA040610, HPA069503"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		2700000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Golgi apparatus"	"CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142"	"unprognostic (1.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.02e-3)"	"unprognostic (9.66e-3)"	"unprognostic (9.61e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.85e-2)"	22.0	36.1	12.1	27.8	13.0	21.9	20.5	12.5	14.8	33.4	16.0	43.5	43.0	21.9	103.6	15.4	28.2	32.0	15.5	12.5	14.8	46.0	48.2	42.7	25.8	14.3	12.9	21.4	30.8	59.4	18.5	53.8	15.4	23.2	45.6	14.9	25.3	29.3	7.7	15.8	31.0	30.6	12.4	24.4	35.5	13.5	13.5	17.5	52.8	10.8	23.0	31.8	16.2	15.1	37.4	63.6	39.8	48.3	241.9	123.7	857.2	59.1	157.6	73.7	95.1	91.3	86.5	17.9	50.9	120.9	53.9	35.1	38.1	75.5	53.7	104.9	33.0	69.9	35.3	47.4	124.3	50.5	69.9	144.9	70.2	67.0	39.2	144.1	116.5	24.7	64.3	67.0	81.8	44.6	29.6	31.6	26.4	78.0	27.0	24.7	26.4	86.6	78.4	54.4	12.0	40.3	75.0	120.2	74.4	69.3	80.3	130.2	67.7	46.8	32.2	65.2	50.1	53.2	87.9	5.9	99.6	71.2	36.7	43.9	146.2	86.4	29.2	125.8	40.4	37.9	34.3	31.8	166.5	35.6	17.9	21.8	56.6	26.0	92.1	35.1	77.1	91.9	12.1	13.0	12.5	14.8	12.5	14.8	14.3	12.9	15.4	12.4	13.5	15.1	8.7	19.2	25.3	39.2	18.6	6.0	13.6	60.1	10.8	11.3	11.5	7.5	9.1	34.3	43.3	27.6	6.2	100.1	14.1	41.9	27.4	53.5	24.8	18.7	16.0	17.4	16.9	20.6	46.7	35.4	55.3	29.2	26.0	27.1	26.6	20.6	19.6	39.7	79.5	5.0	46.0	23.5	40.7	43.9	13.9	5.0	15.2	41.7	14.2	23.4	64.6	16.5	10.3	27.2	24.2	28.1	43.4	21.1	19.8	9.9	36.2	33.1	31.0	16.2	13.1	12.9	16.3	1.0	6.6	10.1	3.4	49.1	18.7	51.0	32.0	12.1
GLDC	"GCSP, NKH"	ENSG00000178445	"Glycine decarboxylase"	P23378	9	6532467-6645729	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 173.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 31.3;Cytotrophoblasts: 79.0;Extravillous trophoblasts: 41.6;Hepatocytes: 120.5;Oligodendrocyte precursor cells: 52.3;Proximal tubular cells: 31.6;Syncytiotrophoblasts: 46.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 41.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 235.7;CACO-2: 58.2;HMC-1: 45.6;RPTEC TERT1: 95.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002318, HPA052887"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		740000	"Cluster 37: B-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Nucleoplasm	"HPA002318: AB_1849700, HPA052887: AB_2681980"	"unprognostic (6.73e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.50e-2)"	"prognostic unfavorable (5.24e-5)"	"unprognostic (1.50e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.17e-2)"	0.3	0.3	15.3	1.4	15.5	0.5	0.8	14.7	23.7	0.4	12.9	1.0	0.8	0.4	5.2	3.2	0.7	0.8	0.1	14.8	14.4	38.2	173.5	1.0	1.6	14.0	13.6	0.3	0.1	0.0	4.9	15.2	13.4	0.5	0.4	1.6	1.1	1.0	1.3	4.5	0.8	0.0	13.1	1.2	1.0	3.5	15.8	0.0	5.1	0.1	1.2	1.1	0.1	15.3	0.6	4.9	2.1	25.6	0.2	0.4	235.7	0.1	0.0	0.0	0.1	58.2	0.5	0.3	5.6	0.1	0.7	0.4	0.0	0.7	0.2	1.2	13.4	0.2	0.3	38.3	0.0	0.1	45.6	0.0	0.1	1.8	0.3	1.0	9.0	4.3	0.0	0.5	1.2	1.5	0.9	0.2	27.5	4.6	3.8	1.3	0.0	0.5	95.4	1.0	22.6	11.7	0.0	21.4	0.3	13.9	5.3	0.1	3.0	0.6	0.6	2.6	1.3	1.1	34.4	0.1	0.8	2.4	5.1	0.4	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.3	15.3	15.5	14.7	23.7	14.8	14.4	14.0	13.6	13.4	13.1	15.8	15.3	0.2	0.0	0.0	17.6	1.9	0.0	0.0	0.2	1.2	0.4	1.5	0.6	0.7	11.5	0.1	31.3	0.0	79.0	0.2	0.0	5.9	0.0	12.6	5.4	0.5	0.6	0.0	0.0	21.6	0.2	41.6	0.3	0.0	10.7	0.0	1.1	2.2	120.5	7.0	0.0	15.9	0.0	0.0	2.8	0.3	10.8	0.3	0.4	0.0	1.9	0.0	9.6	0.0	52.3	1.8	0.1	0.0	0.0	15.1	0.0	0.0	31.6	0.0	0.4	0.0	1.7	0.8	4.5	5.1	0.4	0.0	46.0	0.8	0.0	0.0	0.1
GLE1	"GLE1L, hGLE1, LCCS1"	ENSG00000119392	"GLE1 RNA export mediator"	Q53GS7	9	128504719-128542288	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 77.0;Late spermatids: 58.1;Spermatocytes: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041689, HPA043538, HPA061560"	Supported		Supported	"Nuclear membrane,Nucleoli"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear membrane"	Nucleoli	"HPA041689: AB_2677617, HPA043538: AB_2678539, HPA061560: AB_2684560"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.49e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.00e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.99e-3)"	"unprognostic (5.64e-2)"	11.6	14.0	9.2	15.7	9.2	15.1	15.7	12.4	11.3	13.0	13.4	17.4	16.2	11.6	10.8	16.4	14.1	7.8	14.9	8.9	8.8	14.1	16.3	12.3	20.4	8.7	9.2	16.2	9.5	17.6	14.1	9.2	8.6	11.8	18.3	16.5	11.1	12.4	22.5	19.1	15.8	12.9	8.4	15.2	12.9	32.0	9.3	25.9	13.3	12.4	22.2	12.8	12.3	8.9	29.6	54.5	26.2	44.9	25.3	25.5	34.6	29.2	24.9	40.2	28.4	36.8	20.1	59.6	23.0	33.0	38.6	101.4	45.9	41.7	34.5	56.9	29.8	30.6	57.8	34.6	28.5	49.9	38.8	18.1	39.7	45.6	48.5	22.3	22.9	54.7	44.7	51.0	46.7	68.6	49.5	35.2	22.2	79.1	46.7	49.8	64.2	79.0	27.3	26.1	30.9	23.1	71.3	42.7	25.9	21.1	78.9	34.9	17.0	42.5	28.1	50.2	41.2	50.9	131.9	45.9	39.9	37.5	46.8	40.0	21.1	24.4	22.1	26.0	18.1	13.4	17.2	20.0	22.1	20.5	15.2	17.7	18.0	27.4	27.5	13.0	22.3	19.8	9.2	9.2	12.4	11.3	8.9	8.8	8.7	9.2	8.6	8.4	9.3	8.9	4.0	9.6	9.0	11.1	11.4	6.5	5.3	10.4	8.6	7.6	8.8	7.6	13.0	5.7	7.2	7.3	8.4	16.1	6.9	13.2	5.9	11.7	77.0	12.2	7.4	3.6	5.4	12.0	14.0	6.2	11.7	7.6	10.2	9.4	9.5	10.9	4.6	14.2	15.7	10.1	15.5	12.7	8.2	15.1	5.7	58.1	10.2	13.5	3.6	10.3	20.0	8.9	15.5	18.1	15.5	8.3	8.0	6.4	13.4	6.1	16.3	13.7	12.6	8.6	13.1	7.7	7.3	51.3	25.5	14.4	6.8	13.3	12.1	7.1	14.1	5.4
GLRB		ENSG00000109738	"Glycine receptor beta"	P48167	4	157076125-157172090	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.5;parathyroid gland: 33.0"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 168.6;Inhibitory neurons: 110.7;Oligodendrocyte precursor cells: 110.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 28.6;hTERT-RPE1: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052363	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA052363: AB_2681800"	"unprognostic (7.36e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.59e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (4.89e-4)"	"unprognostic (4.32e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.66e-2)"	4.7	7.0	16.5	1.1	17.7	0.2	10.6	7.4	35.5	9.0	4.5	3.3	0.6	2.9	5.2	1.0	7.3	3.2	11.1	18.0	12.9	3.8	1.2	3.1	0.3	9.4	6.9	1.2	15.2	33.0	7.5	2.6	10.8	6.2	0.9	8.5	19.5	4.7	3.3	1.8	1.4	3.7	5.7	0.0	2.9	1.6	9.8	1.1	1.0	4.9	0.2	1.4	1.5	13.5	8.0	3.4	9.5	28.6	18.0	7.2	0.0	16.0	10.1	7.6	14.4	0.0	24.0	0.0	3.7	16.2	9.4	0.0	7.2	2.5	14.3	0.0	9.7	5.0	3.8	0.3	8.1	6.2	0.0	6.4	2.2	13.4	1.9	37.8	6.9	5.1	0.0	0.0	14.1	0.0	0.8	0.0	0.6	0.0	2.3	0.0	13.0	0.0	20.6	1.5	10.3	6.1	0.0	7.3	1.2	1.4	6.8	1.6	10.5	4.5	13.2	7.6	15.3	0.0	0.0	0.0	10.7	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	16.5	17.7	7.4	35.5	18.0	12.9	9.4	6.9	10.8	5.7	9.8	13.5	0.5	0.0	1.1	26.1	0.0	1.1	0.9	3.1	1.2	10.8	7.8	4.8	13.9	4.3	3.5	0.0	2.1	0.4	0.4	0.1	0.0	8.8	0.3	6.9	3.4	2.1	0.0	1.7	168.6	1.8	0.0	3.9	0.0	2.0	1.3	7.0	3.3	0.0	0.1	1.7	110.7	0.0	4.1	0.3	1.9	0.3	0.3	0.1	3.6	15.9	0.6	13.2	0.0	110.1	31.5	1.5	0.0	3.4	0.0	0.6	0.0	0.5	10.4	2.2	0.0	8.5	2.2	1.3	3.3	0.4	0.3	0.1	0.1	1.3	0.1	0.2
GLS	"GLS1, KIAA0838"	ENSG00000115419	Glutaminase	O94925	2	190880821-190965552	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cataract, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 316.8"	"Cell type enhanced"	"Detected in all"		"Collecting duct cells: 391.8;Excitatory neurons: 427.1;Proximal tubular cells: 539.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 907.3;RPTEC TERT1: 419.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036223	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	No	No		92000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036223: AB_10669984"	"unprognostic (7.45e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.51e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.12e-1)"	37.0	77.4	38.5	45.7	50.5	28.7	32.0	40.5	74.6	31.0	35.6	32.0	92.2	28.8	26.6	16.8	25.1	41.8	34.7	55.5	35.9	316.8	11.7	55.6	68.0	44.7	19.8	28.9	36.9	62.0	19.9	35.8	52.5	20.8	30.1	81.8	20.4	31.2	15.8	28.5	103.4	36.9	12.0	49.3	18.7	16.2	24.1	41.7	35.7	23.6	57.9	36.5	23.6	44.8	43.6	47.2	32.4	43.1	99.7	68.9	84.0	126.8	95.7	90.6	103.1	58.1	42.1	88.5	907.3	269.3	46.1	55.6	58.0	50.0	131.5	219.8	37.7	147.3	69.1	72.2	90.8	87.2	66.5	62.9	51.0	71.2	48.4	90.1	119.3	36.7	69.3	175.2	203.3	22.8	59.2	83.7	86.9	25.7	76.7	74.2	83.7	77.4	419.2	78.9	44.9	46.8	172.8	37.9	169.2	115.1	14.9	53.0	85.3	129.4	94.5	65.9	156.8	56.2	138.9	122.1	46.7	70.6	105.5	6.4	1.0	1.9	3.7	1.5	6.5	3.4	4.4	4.8	1.6	3.8	4.5	5.5	2.1	2.8	1.1	3.6	4.1	1.1	38.5	50.5	40.5	74.6	55.5	35.9	44.7	19.8	52.5	12.0	24.1	44.8	81.0	189.1	122.5	61.0	89.3	174.5	44.7	15.6	60.9	93.5	51.8	49.5	38.2	35.8	28.4	391.8	210.6	4.4	128.0	100.6	50.9	21.4	6.6	33.7	66.8	68.3	59.2	17.9	427.1	24.5	15.6	66.0	46.4	97.9	36.8	48.2	63.5	4.3	29.1	26.9	270.5	36.7	14.2	31.2	230.0	7.3	28.6	84.3	88.9	143.4	68.4	11.9	55.6	163.3	146.9	29.8	92.9	43.2	118.4	70.1	165.9	539.1	17.0	111.9	19.7	71.6	76.0	11.3	12.9	61.7	162.8	4.0	114.0	97.8	43.6	56.7
GLUD1	"GDH, GLUD"	ENSG00000148672	"Glutamate dehydrogenase 1"	P00367	10	87050202-87094843	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 816.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 294.1;Hepatocytes: 402.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 555.0"	"Low region specificity"	"Detected in all"							"HPA042492, HPA044839, HPA061369"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		23000000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494"	"unprognostic (1.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.81e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.57e-3)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.44e-6)"	"unprognostic (2.29e-1)"	"unprognostic (4.23e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.27e-2)"	70.1	93.0	217.2	44.8	219.0	29.2	96.4	180.4	216.8	50.2	135.8	63.4	80.9	48.1	30.0	77.0	47.4	53.3	75.6	193.3	223.2	249.2	816.4	57.7	42.9	220.9	222.9	71.6	66.2	39.0	37.1	58.8	202.3	110.5	61.5	90.2	55.6	53.2	51.1	84.2	88.6	53.3	223.2	46.4	57.0	22.3	254.6	44.8	68.1	64.4	59.2	68.1	55.6	202.3	127.1	100.3	77.1	131.5	143.0	174.5	84.0	97.7	167.8	92.4	100.5	233.0	120.6	141.5	77.8	143.4	53.0	194.7	101.4	98.5	98.0	102.7	79.8	69.0	55.9	555.0	318.1	163.2	95.5	121.3	181.5	103.2	304.9	140.3	112.0	109.3	70.7	124.0	101.0	92.1	148.1	145.7	88.2	136.9	79.8	110.4	98.3	93.1	267.4	101.8	39.7	73.9	87.8	68.8	126.1	73.9	94.3	112.8	112.4	47.8	42.5	98.2	101.0	73.6	81.4	167.5	115.3	182.8	29.3	9.1	14.2	9.7	8.3	11.1	10.3	9.8	11.2	10.1	15.9	11.3	9.9	8.0	1.2	13.6	16.0	5.9	12.6	6.5	217.2	219.0	180.4	216.8	193.3	223.2	220.9	222.9	202.3	223.2	254.6	202.3	49.3	22.4	23.9	294.1	56.6	106.0	57.5	32.2	105.3	22.5	83.3	38.2	60.2	57.2	47.3	60.7	37.5	95.7	45.6	56.1	156.5	32.5	14.2	37.3	44.0	54.1	39.4	52.6	35.8	33.8	63.8	89.0	86.2	59.7	43.2	33.6	50.7	402.3	69.1	15.2	38.0	49.5	36.7	74.1	184.5	26.0	88.0	81.4	104.9	42.2	50.6	140.0	39.1	48.7	42.9	50.2	38.3	90.7	75.7	103.4	124.2	175.5	21.6	68.9	65.7	41.3	55.9	11.4	8.6	189.5	122.3	47.6	84.6	70.9	49.6	107.3
GLUL	GLNS	ENSG00000135821	"Glutamate-ammonia ligase"	P15104	1	182378098-182392206	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Ligase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1443.6"	"Group enriched"	"Detected in all"	4	"Late spermatids: 8544.2;Muller glia cells: 6247.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 365.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 656.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 656.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1150.8;ASC TERT1: 807.6;HSkMC: 702.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007316, HPA007571, CAB008636"	Approved		Supported	"Plasma membrane,Mitochondria,Cytosol"		NA	NA		150000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Mitochondria, Cytosol"	"Plasma membrane"	"CAB008636: AB_1616669, HPA007316: AB_888438, HPA007571: AB_1078980"	"prognostic favorable (4.81e-4)"	"unprognostic (1.52e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.53e-3)"	753.5	76.0	694.3	156.9	746.5	232.9	573.5	717.5	1237.1	161.4	583.2	157.8	24.4	116.7	115.7	218.7	224.3	105.4	129.7	676.6	764.7	65.3	280.7	221.7	75.2	891.0	783.7	303.0	204.7	32.3	70.5	176.6	767.0	103.4	92.5	891.1	233.5	96.0	1443.6	231.4	148.2	124.1	725.0	216.4	648.2	87.1	811.4	97.0	257.4	472.0	103.2	185.5	292.0	810.4	26.4	10.8	117.2	0.2	1150.8	807.6	86.0	44.1	141.7	25.9	23.4	64.1	26.7	22.4	46.3	85.5	23.8	59.3	51.8	309.4	21.5	61.2	143.3	296.5	47.6	124.8	61.1	132.6	227.2	702.1	363.3	32.9	384.6	39.1	52.8	71.7	254.3	13.3	92.6	15.0	208.2	126.5	87.3	36.8	55.0	74.3	31.3	38.6	45.8	114.0	79.7	52.5	12.4	157.3	17.4	93.3	153.1	165.9	39.7	0.9	1.9	0.8	10.1	4.8	3.4	0.4	22.3	73.9	5.0	396.5	153.4	409.4	42.3	145.8	17.6	11.5	29.9	35.5	80.0	17.8	15.3	25.3	656.8	27.2	130.5	43.7	13.0	172.0	694.3	746.5	717.5	1237.1	676.6	764.7	891.0	783.7	767.0	725.0	811.4	810.4	127.8	125.0	173.8	599.4	37.6	134.7	533.8	1190.7	260.0	105.6	166.6	99.1	216.2	171.6	855.3	82.8	52.1	161.7	113.4	118.3	74.3	124.2	1491.3	140.2	150.0	191.5	325.9	319.7	3.4	116.6	65.9	404.4	388.4	124.6	786.3	88.0	152.8	597.1	798.0	43.7	22.0	256.7	451.6	907.2	614.1	8544.2	487.4	687.4	136.9	74.9	112.7	6247.0	42.2	38.2	330.0	108.1	105.3	375.0	38.7	421.0	10.3	46.6	569.9	176.0	92.1	481.5	218.5	48.2	63.6	186.5	128.3	235.3	108.6	53.3	173.3	1420.5
GLYCTK	"HBEBP2, HBEBP4"	ENSG00000168237	"Glycerate kinase"	Q8IVS8	3	52287089-52295257	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 275.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 183.0;Proximal enterocytes: 105.2;Proximal tubular cells: 83.0"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 52.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006913	Approved		Approved	"Golgi apparatus,Cytosol,Rods & Rings"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Golgi apparatus, Rods & Rings"	"HPA006913: AB_1078993"	"unprognostic (1.51e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.64e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.00e-3)"	14.8	8.3	1.0	4.5	0.9	6.7	9.3	0.5	1.5	2.9	0.9	11.4	22.4	3.2	0.6	3.8	2.7	2.2	4.4	0.9	1.2	24.9	275.1	4.2	4.6	1.4	0.9	2.4	5.9	2.5	2.9	2.2	1.2	3.7	3.6	0.6	3.1	1.0	3.6	1.9	21.7	1.6	0.4	8.9	8.5	2.3	1.2	2.3	4.1	1.0	3.2	3.3	2.5	1.2	2.9	5.8	3.4	1.2	15.7	2.4	1.8	2.4	2.6	4.6	3.9	12.1	2.4	6.7	1.6	2.7	3.7	1.6	1.7	7.8	0.8	2.0	1.8	9.3	7.5	16.2	1.7	2.8	5.0	2.4	3.5	7.6	3.2	2.1	10.2	5.2	2.4	4.5	3.6	1.9	5.9	2.7	1.5	14.2	4.2	1.9	2.5	11.1	5.8	3.9	1.9	1.9	2.6	1.4	3.0	1.0	3.2	1.7	3.8	3.5	4.1	2.4	6.1	5.1	3.9	5.4	2.7	4.9	2.2	2.2	5.2	6.6	5.6	2.8	2.6	4.4	4.2	4.9	5.6	2.6	3.3	4.3	4.4	3.6	3.5	3.4	6.6	3.7	1.0	0.9	0.5	1.5	0.9	1.2	1.4	0.9	1.2	0.4	1.2	1.2	5.4	6.4	3.2	0.7	8.2	0.4	3.2	4.1	1.8	1.6	2.1	1.4	1.6	18.6	3.0	9.2	0.0	7.9	9.2	18.4	19.6	5.4	0.3	4.4	2.7	8.3	23.4	26.5	0.6	6.2	5.3	2.9	27.0	8.6	1.3	3.4	14.6	183.0	13.2	0.0	0.4	15.8	2.0	16.6	2.4	0.0	1.2	9.1	3.6	1.0	7.7	1.2	9.2	0.5	0.7	4.0	40.6	0.0	13.5	2.8	105.2	83.0	2.4	1.5	0.0	2.7	2.7	1.8	8.3	2.1	1.3	11.1	9.3	7.7	24.9	4.3
GMPPB	KIAA1851	ENSG00000173540	"GDP-mannose pyrophosphorylase B"	Q9Y5P6	3	49716844-49723973	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 130.2;Syncytiotrophoblasts: 79.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA014657	Uncertain					NA	NA		38000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA014657: AB_1849852"	"unprognostic (3.48e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.77e-2)"	"prognostic favorable (6.19e-6)"	"unprognostic (1.01e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (5.01e-3)"	"unprognostic (5.73e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	14.5	30.1	6.1	16.1	6.0	11.8	15.3	5.7	6.6	20.8	9.2	23.1	14.5	18.6	14.5	26.3	19.5	9.5	18.2	6.0	6.3	17.5	44.2	21.4	13.0	6.7	6.5	14.0	57.4	10.1	39.4	7.5	6.1	27.9	12.2	4.1	35.4	14.7	13.4	14.9	21.8	9.4	6.1	27.9	26.2	9.6	6.8	9.3	26.3	5.7	13.0	15.9	16.8	5.9	31.8	27.0	21.0	12.3	15.6	10.8	21.7	36.1	17.1	29.0	26.1	18.7	21.5	17.6	15.8	18.1	22.2	16.7	18.6	29.0	10.6	17.2	14.5	13.5	27.2	21.5	31.1	19.0	19.6	8.2	15.1	40.0	34.8	11.3	24.8	20.2	10.4	32.0	16.3	20.3	27.3	11.7	12.2	22.5	34.3	9.2	12.5	30.4	16.3	24.0	13.8	16.0	15.7	36.5	12.5	10.6	20.6	13.9	21.9	25.7	25.0	33.4	38.8	33.7	11.1	13.6	25.4	14.7	28.6	22.1	15.6	6.7	18.3	21.3	18.6	22.7	15.9	19.3	14.7	22.5	11.8	14.6	4.0	11.3	21.8	61.8	12.0	14.8	6.1	6.0	5.7	6.6	6.0	6.3	6.7	6.5	6.1	6.1	6.8	5.9	7.3	9.6	17.2	1.6	35.4	0.8	22.8	0.7	2.8	3.7	34.1	14.1	4.5	15.7	3.8	18.4	2.1	28.5	28.5	43.6	29.4	39.8	10.0	18.3	14.3	10.7	16.7	9.9	0.8	50.6	67.2	15.5	34.7	17.8	0.0	11.2	9.3	28.4	39.0	6.7	0.8	55.9	0.0	10.7	1.7	10.0	15.5	13.7	1.8	1.0	40.9	5.8	19.6	1.0	0.4	31.9	27.1	7.5	130.2	40.9	29.2	25.7	14.4	6.2	0.0	5.3	12.2	22.9	12.6	14.7	1.7	79.5	14.7	13.1	32.8	37.1
GMPS	GATD7	ENSG00000163655	"Guanine monophosphate synthase"	P49915	3	155870650-155944020	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	Ligase	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 100.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 272.7;Late spermatids: 193.6;Spermatocytes: 171.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046630			Approved	Cytosol		No	No		50000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA046630: AB_2679727"	"unprognostic (3.89e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (5.54e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (8.73e-7)"	"unprognostic (1.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.79e-2)"	18.8	20.7	7.2	20.0	7.7	44.6	24.1	22.7	11.0	21.2	7.9	19.7	15.8	20.6	16.0	22.1	17.1	14.0	17.9	6.8	8.5	15.9	22.6	18.2	27.0	7.8	6.8	17.0	26.4	23.1	11.5	20.8	8.3	17.4	22.5	10.1	20.9	17.5	20.0	25.0	16.7	23.4	6.3	19.2	18.0	100.3	8.0	32.3	20.3	16.7	29.4	23.3	19.9	8.8	241.0	93.1	123.0	101.1	49.0	77.0	118.9	99.8	91.6	128.2	128.8	170.5	156.2	171.7	116.1	77.1	98.1	114.6	105.7	104.2	175.0	101.1	81.8	183.2	63.7	92.8	55.9	188.5	68.7	57.3	62.9	99.4	150.5	68.2	79.9	91.3	131.7	63.8	96.8	160.1	153.9	99.4	118.5	130.4	68.3	149.2	145.8	207.5	66.3	103.5	73.3	68.0	111.0	156.0	101.8	83.9	163.6	122.3	56.9	84.4	68.5	121.0	204.3	88.8	58.5	288.5	84.8	137.4	77.0	23.7	16.1	11.5	24.7	20.2	29.1	16.0	23.6	22.3	26.1	11.6	23.3	22.3	2.2	29.3	29.5	14.2	27.1	17.5	7.2	7.7	22.7	11.0	6.8	8.5	7.8	6.8	8.3	6.3	8.0	8.8	23.8	19.2	20.2	19.6	21.5	39.9	47.4	43.9	22.8	22.0	19.5	18.5	16.4	15.7	28.4	7.3	2.1	44.1	21.6	8.3	25.4	33.8	272.7	14.3	37.5	29.9	7.2	68.5	40.9	29.5	56.2	32.4	19.9	18.4	28.6	34.0	22.1	11.6	29.9	21.9	41.6	19.7	26.4	18.5	27.1	193.6	23.0	25.2	23.2	22.5	31.7	17.8	30.9	30.2	31.6	21.3	11.9	24.8	21.9	50.6	17.8	22.8	17.3	8.7	19.7	28.6	65.2	171.2	65.5	29.0	38.2	30.8	30.4	63.2	26.8	42.4
GNA11	"FBH, FBH2, FHH2, HHC2"	ENSG00000088256	"G protein subunit alpha 11"	P29992	19	3094362-3123999	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		Transducer	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 330.6;Proximal enterocytes: 323.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048886	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 45: Enterocytes - Digestion"			"HPA048886: AB_2680544"	"unprognostic (4.64e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (2.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.26e-2)"	"unprognostic (7.85e-3)"	"unprognostic (2.43e-1)"	"prognostic favorable (1.48e-11)"	"unprognostic (1.05e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.02e-1)"	33.5	32.5	36.4	16.2	31.2	8.3	32.6	53.8	35.3	31.7	18.9	66.7	117.5	42.4	12.7	28.7	44.5	20.0	51.7	33.5	27.3	40.4	26.2	34.7	7.5	30.3	29.6	32.5	33.9	26.3	29.8	22.3	28.6	40.4	38.7	11.0	33.3	47.1	54.2	34.4	139.3	28.7	26.6	21.4	34.9	50.6	31.3	8.5	32.9	39.2	7.0	38.8	27.0	31.1	56.1	31.2	27.9	48.5	41.7	28.4	30.9	53.8	53.7	71.8	57.8	41.7	27.3	12.0	29.2	76.4	43.6	39.0	37.8	42.7	44.3	30.1	21.9	3.3	35.7	23.6	42.2	3.8	11.8	36.9	36.8	48.4	29.2	36.9	57.8	3.4	27.8	1.9	49.1	25.8	3.0	14.4	20.5	38.4	29.4	23.2	26.4	11.9	33.8	40.8	66.0	40.7	38.3	45.2	27.2	18.9	33.3	7.9	50.0	45.7	33.3	85.4	73.5	1.3	3.9	7.9	33.0	2.9	52.3	2.5	1.4	0.3	0.7	0.7	0.8	0.9	0.5	0.6	0.2	1.1	1.2	0.9	5.1	0.5	1.5	2.3	0.1	0.3	36.4	31.2	53.8	35.3	33.5	27.3	30.3	29.6	28.6	26.6	31.3	31.1	62.3	32.1	24.1	5.2	3.5	32.6	9.5	15.4	13.6	22.7	43.2	47.9	17.8	35.8	12.6	27.6	37.5	13.2	2.4	330.6	7.9	21.4	45.2	26.9	23.0	33.9	54.6	5.2	8.8	25.4	13.5	25.3	29.6	26.1	4.5	24.1	58.2	28.5	9.0	45.4	11.3	84.1	26.4	9.1	16.4	20.0	50.1	5.1	23.2	11.2	1.1	29.0	0.0	7.1	14.1	36.1	96.0	80.5	1.2	16.0	323.0	18.9	35.4	15.8	19.7	28.5	30.5	23.7	8.9	20.6	41.2	20.4	2.0	22.1	94.9	13.4
GNAS	"GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI"	ENSG00000087460	"GNAS complex locus"	"O95467, P63092, P84996, Q5JWF2"	20	58839718-58911192	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Transducer	"Cancer-related genes, Cushing syndrome, Disease variant, Dwarfism, Obesity, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 1886.1;Late spermatids: 1756.9;Skeletal myocytes: 1998.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010337, HPA018122, HPA027478, HPA028386"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.90e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.53e-3)"	"unprognostic (8.01e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (8.76e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.36e-1)"	784.8	1215.3	1564.4	512.6	1524.7	887.4	578.9	1413.1	1768.3	828.5	1373.3	657.1	492.4	611.4	1253.8	883.1	742.9	672.7	1990.6	1557.3	2716.9	625.0	651.1	640.3	769.2	1710.5	1949.4	766.5	1917.7	1799.4	1153.6	884.6	1963.4	577.3	607.3	731.2	2943.9	594.4	2400.4	526.8	527.3	782.4	1598.4	606.6	587.1	357.9	1882.0	854.4	3432.2	2813.1	800.0	687.1	239.3	1483.9	215.6	897.3	1501.9	663.3	2691.8	1822.3	1200.1	1219.1	1635.0	1937.3	1201.8	2480.5	1446.7	911.9	1670.3	2314.3	1305.6	976.1	1499.0	2195.3	1540.9	401.4	784.6	984.9	1651.7	2232.7	1420.7	641.6	483.0	1566.4	1113.6	875.1	1399.1	1561.0	1669.7	1100.6	692.0	1294.6	1319.1	4131.0	1759.5	1452.8	487.9	214.0	894.4	1436.7	1287.3	1589.4	2165.5	1315.8	1818.3	3853.2	2157.6	2117.1	1354.2	1921.8	1570.0	1581.7	1343.3	2210.2	1477.0	688.5	1452.3	1314.0	993.3	1583.2	900.0	473.7	1107.1	217.9	96.7	114.2	68.9	127.3	80.0	103.2	73.4	74.8	129.2	93.6	65.8	82.6	103.4	95.6	150.3	174.9	92.7	100.9	1564.4	1524.7	1413.1	1768.3	1557.3	2716.9	1710.5	1949.4	1963.4	1598.4	1882.0	1483.9	982.6	221.2	258.8	192.0	310.8	130.4	182.0	130.0	205.5	397.8	465.6	684.4	1025.3	237.4	212.2	261.1	56.3	832.6	390.8	357.3	444.1	233.9	734.9	487.7	515.7	518.3	463.1	252.1	232.5	228.9	342.0	380.9	196.3	685.0	138.6	542.3	380.1	256.4	379.1	1886.1	439.7	327.2	181.0	380.4	405.7	1756.9	265.3	437.1	222.3	236.1	204.0	1367.2	137.0	194.5	166.6	339.9	300.0	197.1	309.7	268.1	273.7	153.6	218.0	222.0	210.4	1998.0	560.4	226.0	73.6	240.5	117.8	1211.7	301.8	860.9	304.4	316.5
GNB1		ENSG00000078369	"G protein subunit beta 1"	P62873	1	1785285-1891117	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"retina: 2629.0"	"Cell type enriched"	"Detected in all"	5	"Rod photoreceptor cells: 1373.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040736	Supported		Approved	"Golgi apparatus,Plasma membrane"		NA	NA		1900000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 79: Retina - Phototransduction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Golgi apparatus"	"HPA040736: AB_2677106"	"unprognostic (9.49e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (3.61e-6)"	"unprognostic (1.99e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.27e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.90e-2)"	178.1	123.8	167.9	179.9	212.3	147.6	119.7	147.8	234.4	124.3	87.1	165.7	173.7	127.1	90.8	126.7	114.4	110.9	119.6	228.3	172.0	125.1	103.3	146.7	160.0	159.5	153.2	130.2	105.9	148.2	106.8	141.1	169.5	118.3	123.1	2629.0	120.6	118.9	66.8	111.8	208.2	156.1	131.6	142.6	129.7	99.0	168.9	167.3	113.6	97.1	145.6	152.6	102.7	203.9	373.2	344.2	400.2	280.4	222.4	242.4	154.4	515.4	339.9	456.2	355.2	282.8	361.8	385.5	369.3	522.5	258.6	192.0	405.5	373.5	411.4	595.9	199.2	375.0	308.2	325.6	279.1	227.7	394.4	216.4	256.6	437.2	402.9	306.1	376.8	298.8	236.8	337.8	440.0	230.3	501.9	177.4	230.8	190.0	275.0	482.9	308.7	306.4	310.8	227.5	489.9	556.5	477.1	306.6	420.5	272.8	214.8	305.9	579.4	399.3	267.5	314.8	379.1	227.1	432.8	888.7	341.4	470.1	230.5	11.4	13.3	21.9	9.9	16.4	9.1	9.0	9.9	11.2	13.3	9.6	6.7	7.2	22.1	12.8	17.5	22.7	12.5	8.2	167.9	212.3	147.8	234.4	228.3	172.0	159.5	153.2	169.5	131.6	168.9	203.9	172.0	70.5	42.6	57.5	67.9	86.3	51.6	47.4	33.0	149.8	65.3	57.8	60.6	52.9	42.4	75.4	175.2	44.2	124.4	140.9	46.9	88.0	29.1	93.3	112.9	131.6	122.9	40.3	102.4	100.5	99.4	77.8	52.0	121.6	53.8	101.9	95.3	60.3	100.8	180.0	101.9	95.5	40.7	152.7	114.6	33.8	76.1	128.0	53.4	115.2	119.5	250.3	73.2	70.9	110.1	175.4	91.0	88.0	75.3	100.5	167.6	67.4	41.1	1373.7	78.9	71.0	105.9	68.8	67.1	51.6	101.7	36.4	74.5	83.7	83.0	94.1
GNE	"IBM2, Uae1"	ENSG00000159921	"Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase"	Q9Y223	9	36214441-36277042	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Allosteric enzyme, Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"intestine: 48.4;liver: 90.5;salivary gland: 55.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 59.3;Hepatocytes: 119.3;Intestinal goblet cells: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 107.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007045, HPA027258"	Approved		Supported	Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"HPA007045: AB_1079003, HPA027258: AB_1849873"	"unprognostic (7.54e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-3)"	"unprognostic (7.28e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.78e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.88e-3)"	"unprognostic (4.20e-2)"	"prognostic favorable (9.28e-11)"	"unprognostic (2.90e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.72e-2)"	11.9	9.0	5.5	8.7	7.4	15.5	15.8	8.9	6.5	11.3	7.9	34.0	4.3	10.3	3.5	11.6	9.1	7.4	7.7	5.5	7.3	10.0	90.5	6.8	7.3	7.7	7.3	14.8	10.2	6.1	4.8	14.2	8.9	15.3	48.4	8.0	55.3	7.2	7.9	3.8	7.6	11.7	6.6	6.2	4.6	4.8	7.1	6.2	6.9	15.3	9.5	14.2	7.5	10.5	9.9	44.4	20.1	17.1	22.5	22.4	29.9	13.5	17.9	19.5	25.1	10.5	32.6	13.5	14.2	24.2	50.5	3.9	15.3	4.6	21.8	25.1	1.4	11.0	26.0	15.2	15.4	0.2	31.2	14.4	4.6	32.0	30.6	14.3	8.4	20.7	14.4	27.3	19.3	1.8	19.1	6.3	11.8	6.7	23.7	15.5	16.3	3.8	107.7	19.4	16.7	15.2	13.7	5.3	12.6	7.1	4.8	12.0	12.2	12.7	12.9	15.5	12.2	11.7	26.0	7.0	17.0	9.8	18.2	0.2	0.5	0.2	0.7	0.6	0.5	0.6	0.9	0.8	0.4	0.9	1.0	1.2	0.3	0.7	0.8	0.6	0.4	0.6	5.5	7.4	8.9	6.5	5.5	7.3	7.7	7.3	8.9	6.6	7.1	10.5	9.7	9.6	10.0	9.4	7.1	1.9	3.1	6.7	1.8	8.4	8.2	7.5	6.7	10.0	16.9	9.2	6.2	8.6	4.3	59.3	1.9	10.4	3.4	7.2	12.1	6.3	11.5	7.8	12.8	6.0	9.5	8.3	2.6	10.6	10.1	9.1	7.1	119.3	2.9	11.8	15.6	88.1	16.2	7.8	4.4	2.4	10.8	5.4	1.8	5.6	6.1	1.9	2.1	32.2	28.2	5.3	20.3	6.4	7.9	6.9	2.9	2.2	18.8	6.9	13.1	10.0	6.3	1.8	2.7	1.2	1.6	19.8	5.7	2.3	26.8	13.4
GNMT		ENSG00000124713	"Glycine N-methyltransferase"	Q14749	6	42960754-42963880	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"liver: 296.5;pancreas: 600.1"	"Cell type enriched"	"Detected in many"	10	"Hepatocytes: 842.9"	"Group enriched"	"Detected in many"	20	"liver cancer: 69.6;prostate cancer: 49.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 8.5;SCLC-21H: 9.5;T-47d: 6.1"	"Region enriched"	"Detected in some"	4	"cerebellum: 15.7"	"Low region specificity"	"Detected in many"			HPA027501	Enhanced		Approved	Cytosol		NA	NA		390000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA027501: AB_1849879"	"unprognostic (1.53e-2)"	"unprognostic (8.02e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.24e-3)"	"unprognostic (3.91e-2)"	"unprognostic (6.40e-4)"	"prognostic favorable (1.86e-4)"	"unprognostic (4.08e-6)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.92e-2)"	0.9	0.9	2.3	1.3	2.5	3.8	7.1	2.8	2.4	0.8	2.0	0.7	0.2	0.8	2.2	0.6	1.3	0.5	4.7	2.2	2.2	0.9	296.5	2.0	1.0	1.1	1.0	1.9	600.1	0.2	8.4	0.4	1.1	20.3	0.3	2.2	9.8	1.2	1.8	0.9	1.6	0.5	0.9	2.9	50.8	0.7	1.9	1.8	1.9	0.4	1.2	0.8	0.7	2.1	0.4	0.3	1.4	3.9	0.4	0.1	0.2	0.3	1.6	0.6	0.9	0.0	0.1	1.3	0.1	0.3	0.7	0.4	0.2	0.2	0.2	1.6	1.2	1.0	0.9	8.5	0.0	0.9	1.8	0.3	0.0	0.3	0.1	0.9	0.0	3.0	1.2	1.5	0.2	1.8	1.6	3.0	0.1	0.4	0.4	1.4	1.3	0.8	0.6	0.2	9.5	1.3	0.1	1.3	0.6	0.4	6.1	2.8	0.3	0.7	0.7	0.4	0.8	1.0	1.0	1.1	0.1	1.6	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.5	0.0	0.0	0.7	0.0	0.1	2.3	2.5	2.8	2.4	2.2	2.2	1.1	1.0	1.1	0.9	1.9	2.1	0.3	0.0	2.2	5.5	2.8	0.3	5.2	0.7	0.0	1.7	10.2	14.7	5.4	24.3	0.2	1.8	0.0	0.1	1.7	0.0	3.9	0.5	0.2	1.6	0.2	2.2	0.0	77.9	18.4	0.9	0.1	0.3	0.5	0.8	0.0	2.6	24.3	842.9	0.7	1.7	18.2	0.0	6.1	28.9	0.7	0.1	0.9	1.1	0.0	11.2	0.3	0.2	0.0	7.1	4.7	0.6	0.0	2.6	0.5	17.9	0.3	3.4	4.6	0.3	0.0	0.2	0.6	0.6	0.7	0.0	0.1	0.1	3.0	0.0	0.2	1.9
GNPAT	"DAP-AT, DAPAT, DHAPAT"	ENSG00000116906	"Glyceronephosphate O-acyltransferase"	O15228	1	231241207-231277973	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cataract, Disease variant, Dwarfism, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (8.87e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.07e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (8.29e-6)"	"unprognostic (5.69e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.68e-1)"	22.4	26.9	21.6	20.5	24.0	17.3	21.7	23.9	28.2	18.3	25.2	30.0	30.0	20.3	23.7	22.1	27.9	18.2	44.9	22.0	23.5	25.7	30.9	18.7	23.6	24.1	22.5	22.5	29.5	22.6	17.9	19.4	23.3	22.8	24.8	17.0	26.4	20.9	101.9	23.6	28.1	26.4	23.6	18.5	26.9	32.0	23.2	27.5	20.8	84.1	25.8	21.5	17.0	26.1	39.8	43.6	60.4	46.1	48.7	71.4	40.7	32.9	37.1	34.1	39.1	56.1	48.3	57.0	40.4	49.5	35.9	41.9	40.6	44.7	50.0	64.8	37.2	41.2	41.4	81.7	49.4	70.9	31.4	50.1	53.8	35.5	39.6	44.5	81.2	56.0	61.1	53.3	71.7	13.1	63.6	41.0	97.1	112.0	49.5	68.7	81.0	66.9	42.7	29.2	40.0	57.1	55.2	30.7	49.1	23.8	53.7	110.7	42.8	34.5	32.1	50.5	83.3	68.2	93.6	65.1	49.8	58.8	65.3	34.1	36.4	37.3	23.7	37.1	27.2	35.1	30.6	31.3	36.4	37.7	26.4	24.4	14.3	26.9	50.3	17.2	37.9	29.8	21.6	24.0	23.9	28.2	22.0	23.5	24.1	22.5	23.3	23.6	23.2	26.1	17.7	25.6	20.8	19.9	32.3	13.5	19.5	23.1	16.5	23.3	14.9	12.6	55.8	30.0	21.2	27.6	39.6	25.3	20.1	16.4	17.6	41.5	70.3	21.5	19.4	21.4	28.2	13.2	18.9	43.4	19.2	19.5	21.4	14.1	11.4	30.1	19.2	26.9	27.4	11.8	18.6	21.0	22.4	24.8	18.3	119.2	25.4	21.8	12.4	15.9	38.7	22.7	26.8	17.1	29.2	40.2	30.3	26.7	30.1	24.9	41.7	28.0	30.8	24.2	19.7	16.5	22.4	50.9	31.5	18.8	13.9	12.4	24.5	19.7	30.1	19.0
GNPTAB	"GNPTA, KIAA1208, MGC4170"	ENSG00000111670	"N-acetylglucosamine-1-phosphate transferase subunits alpha and beta"	Q3T906	12	101745499-101830959	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Transferase	"Cancer-related genes, Disease variant, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 192.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014558, HPA042343"	Approved		Supported	"Golgi apparatus"		NA	NA		160000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"HPA014558: AB_2732409, HPA042343: "	"unprognostic (6.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.71e-3)"	"prognostic favorable (8.48e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.98e-2)"	11.9	7.9	18.8	16.2	22.2	23.9	16.4	14.4	20.0	17.4	2.7	29.6	14.2	11.8	6.2	15.6	8.8	14.8	21.5	22.7	10.8	14.5	9.4	27.0	20.6	8.5	11.1	7.2	11.3	23.0	8.4	14.8	9.7	20.1	30.3	13.0	54.3	13.0	16.4	25.1	16.2	15.9	8.9	19.0	21.3	10.4	12.4	34.1	13.9	25.9	17.8	19.3	12.0	13.3	18.2	17.5	6.4	10.9	52.3	24.8	19.6	25.4	52.3	24.7	32.2	13.5	12.4	38.1	17.9	35.1	20.1	23.2	29.8	32.8	38.4	18.1	15.6	16.3	15.4	19.3	9.7	15.0	31.7	19.3	17.7	23.5	13.8	61.4	44.0	30.0	25.9	11.0	23.4	27.8	45.6	21.0	22.0	22.6	12.5	10.6	32.6	51.2	39.5	46.8	13.6	11.2	42.3	29.7	60.7	23.5	30.6	9.8	43.6	23.1	12.5	19.6	14.4	30.0	32.9	21.5	26.4	21.8	14.6	8.6	3.8	4.4	18.8	3.6	6.2	3.0	4.0	10.3	7.1	4.9	5.1	7.9	1.4	17.0	4.6	6.9	3.3	3.7	18.8	22.2	14.4	20.0	22.7	10.8	8.5	11.1	9.7	8.9	12.4	13.3	25.3	60.9	65.0	35.9	42.1	16.8	32.9	16.2	17.1	23.6	25.2	18.9	43.5	18.6	27.8	22.0	25.0	25.7	107.3	68.3	7.9	10.3	0.6	25.3	23.7	21.1	18.0	19.5	84.5	15.1	15.0	18.9	33.1	61.6	122.8	24.6	10.4	9.7	46.7	8.4	83.8	29.6	24.4	46.7	17.6	3.8	17.1	41.2	42.7	30.0	43.5	26.9	192.6	135.2	19.8	15.7	129.3	12.8	63.9	28.1	17.7	13.8	10.0	37.0	0.0	18.6	14.9	12.4	33.0	26.7	14.3	8.8	63.4	30.6	49.7	46.5
GNS		ENSG00000135677	"Glucosamine (N-acetyl)-6-sulfatase"	P15586	12	64713445-64759431	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 198.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 228.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013695, CAB026011, HPA048508"	Enhanced				"Intracellular and membrane"	NA	NA		510000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"CAB026011: , HPA013695: AB_1849741, HPA048508: AB_2680423"	"unprognostic (8.07e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (7.76e-4)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.04e-1)"	106.1	174.7	18.0	56.4	19.9	25.4	51.9	20.4	21.3	58.9	80.7	35.3	34.6	49.5	38.5	26.2	43.8	63.7	52.9	17.2	26.4	132.0	56.2	71.5	41.0	30.0	23.3	64.3	24.1	76.8	23.0	80.2	25.5	38.5	36.9	25.1	32.9	47.7	30.1	26.3	41.4	69.2	22.5	51.2	34.6	31.8	27.3	20.5	72.8	29.0	26.9	63.7	27.6	31.2	41.0	61.3	50.7	81.4	240.0	145.2	108.8	92.0	213.5	108.4	117.1	55.9	53.3	17.4	117.0	117.8	133.3	33.1	49.1	52.6	119.5	51.4	36.6	41.4	45.4	36.4	109.3	30.6	346.2	139.6	62.9	111.5	49.3	342.0	200.1	24.7	28.8	117.2	156.8	32.6	8.1	17.9	19.4	102.8	53.2	23.8	77.3	53.7	91.5	116.2	33.7	37.3	119.6	56.6	82.4	65.8	102.2	40.4	185.1	104.5	54.8	101.8	54.4	112.1	143.4	14.9	151.1	58.4	72.1	51.7	136.9	27.5	29.3	158.4	21.9	13.0	15.9	22.6	78.2	10.0	16.4	16.4	56.6	18.4	228.5	19.3	13.0	101.9	18.0	19.9	20.4	21.3	17.2	26.4	30.0	23.3	25.5	22.5	27.3	31.2	52.6	48.1	31.7	19.2	11.0	16.6	8.4	14.8	11.4	10.5	28.4	17.0	59.9	22.8	24.2	103.0	18.8	24.3	18.8	24.2	1.9	36.2	24.4	26.5	25.5	50.6	41.9	15.4	25.0	15.1	19.7	40.2	12.2	32.9	48.1	36.3	58.5	57.9	81.0	16.8	31.3	16.6	18.3	198.8	46.5	24.5	34.8	107.8	16.0	27.2	79.0	20.1	13.4	15.1	19.9	20.0	15.7	37.2	16.0	17.2	60.9	64.3	42.8	7.5	6.6	23.1	24.9	11.3	7.8	10.5	12.9	29.1	13.2	30.0	18.2	19.2
GOLGA5	"golgin-84, GOLIM5, ret-II, rfg5"	ENSG00000066455	"Golgin A5"	Q8TBA6	14	92794305-92839947	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000992, HPA063876"	Enhanced	Supported	Supported	"Golgi apparatus"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA000992: AB_1079009, HPA063876: AB_2685140"	"unprognostic (2.06e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.49e-2)"	26.0	23.3	21.4	18.2	23.7	10.4	33.1	22.4	26.4	32.2	23.9	26.4	23.3	21.9	54.2	25.0	19.2	24.0	21.5	20.8	22.3	25.5	54.3	22.4	18.8	22.6	22.4	20.6	32.2	33.6	23.5	28.2	23.1	31.2	32.5	15.8	32.4	25.8	26.9	23.3	22.9	26.0	22.6	19.1	32.9	34.3	22.1	16.9	33.2	20.0	23.3	24.1	19.6	25.9	32.4	29.4	25.9	23.7	53.1	71.4	44.3	43.9	80.4	41.9	49.2	21.8	43.4	21.0	35.1	70.2	29.2	33.4	23.1	35.9	56.6	25.8	11.2	19.9	14.0	29.3	61.5	23.3	31.8	55.1	63.7	29.5	60.6	46.2	42.0	21.8	17.7	27.3	46.5	60.1	18.1	19.6	16.1	70.2	31.0	13.9	37.9	21.1	42.8	38.9	18.4	26.0	40.0	29.6	45.7	35.7	51.0	25.6	35.0	23.9	15.6	31.3	22.2	33.3	27.6	18.2	54.9	18.2	40.8	10.4	10.0	23.6	10.3	13.0	11.8	9.5	10.4	10.6	9.9	9.5	9.2	8.1	8.8	8.7	11.9	9.1	12.9	6.7	21.4	23.7	22.4	26.4	20.8	22.3	22.6	22.4	23.1	22.6	22.1	25.9	18.7	28.9	26.3	8.8	15.7	7.8	11.2	17.9	16.5	7.5	16.2	11.9	26.8	8.6	19.6	14.7	12.5	23.7	17.2	23.8	29.4	25.3	31.6	17.6	24.6	16.7	22.3	15.8	17.6	32.7	32.0	21.7	33.1	25.7	9.5	29.7	13.9	33.5	15.4	25.2	15.6	31.6	4.1	14.7	10.3	18.5	23.0	14.6	12.4	15.0	18.2	15.6	16.5	14.6	21.9	28.9	12.0	25.2	29.2	19.4	19.9	24.2	18.7	10.7	26.3	18.0	19.3	34.1	37.0	16.5	11.4	50.3	15.9	15.6	16.5	16.5
GOPC	"CAL, dJ94G16.2, FIG, GOPC1, PIST"	ENSG00000047932	"Golgi associated PDZ and coiled-coil motif containing"	Q9HD26	6	117560269-117602542	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019477, HPA024018"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA019477: AB_1849890, HPA024018: AB_1849891"	"unprognostic (2.48e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.22e-2)"	"unprognostic (6.77e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.01e-2)"	15.5	14.2	14.6	15.8	14.9	7.1	20.2	15.6	18.0	23.4	11.0	18.7	12.2	23.5	18.0	12.1	17.4	16.3	22.1	15.9	13.3	14.5	16.4	13.6	19.9	12.5	12.5	25.6	12.7	22.1	16.1	19.9	13.1	16.2	20.3	13.5	14.3	17.3	15.8	18.7	15.0	18.4	13.6	16.9	14.9	17.7	12.6	21.0	23.9	17.4	17.2	15.1	14.7	16.8	14.1	15.0	19.1	25.6	40.1	47.9	30.3	57.1	41.7	30.6	31.5	23.1	15.5	42.2	24.3	32.4	60.4	31.2	37.2	27.6	42.8	21.2	20.8	38.7	39.9	37.5	42.4	52.2	24.8	57.4	74.9	22.8	65.7	60.6	26.5	29.0	36.7	16.8	62.2	12.9	21.8	40.3	16.5	24.0	16.0	33.0	37.0	30.8	23.3	12.9	26.7	21.0	57.6	19.7	15.8	36.3	14.3	49.7	31.8	2.2	27.9	28.5	62.6	29.9	28.8	35.4	37.9	43.4	23.9	10.5	4.2	3.2	6.7	3.9	9.3	7.9	7.1	7.1	5.5	7.7	8.2	8.5	2.9	9.2	4.7	9.2	7.7	4.1	14.6	14.9	15.6	18.0	15.9	13.3	12.5	12.5	13.1	13.6	12.6	16.8	43.2	22.4	22.7	46.4	33.4	46.7	25.1	63.9	46.7	59.2	47.0	67.3	46.2	34.3	32.2	20.2	22.9	77.0	28.6	40.4	27.4	27.9	35.1	30.4	77.4	38.1	33.6	26.5	52.9	25.6	62.4	48.3	30.1	30.6	31.1	50.4	35.0	38.7	38.5	74.0	46.2	65.2	24.4	24.2	22.9	13.7	42.3	27.0	28.4	32.8	24.1	39.3	35.0	73.9	64.5	21.1	40.9	42.2	38.7	40.3	20.9	27.1	35.3	35.9	32.9	50.0	44.3	115.6	51.4	36.7	59.8	52.3	38.7	43.3	37.7	27.3
GOT2	"KAT4, KATIV, KYAT4, mitAAT"	ENSG00000125166	"Glutamic-oxaloacetic transaminase 2"	P00505	16	58707131-58734342	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Lipid transport, Transport"	"Aminotransferase, Transferase"	"Cancer-related genes, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 698.4;tongue: 726.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 341.9;Hepatocytes: 176.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018139, HPA058537"	Enhanced				"Intracellular and membrane"	NA	NA		2800000	"Cluster 13: T-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA018139: AB_1849903, HPA058537: "	"unprognostic (1.50e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.63e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (1.61e-4)"	"prognostic favorable (5.75e-5)"	"unprognostic (1.12e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.00e-1)"	"prognostic favorable (2.90e-9)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.22e-1)"	19.6	73.9	52.4	27.4	55.9	21.1	36.3	62.5	66.9	34.1	129.4	57.6	37.4	36.5	66.3	66.9	46.7	24.1	313.2	57.9	59.3	88.0	321.4	25.2	35.6	60.6	51.0	29.4	33.2	98.6	46.7	24.7	62.5	59.0	65.0	91.4	47.7	65.7	698.4	41.1	35.7	46.7	50.1	28.5	54.9	28.9	58.7	35.9	42.6	726.8	57.0	57.0	45.1	61.0	137.2	182.4	93.8	114.8	66.6	59.8	122.0	101.4	108.8	197.6	107.7	158.9	120.1	302.3	117.3	114.6	86.5	195.5	203.2	199.2	250.1	83.1	182.0	81.4	92.1	179.3	84.2	132.3	71.9	58.4	110.9	125.2	108.2	112.4	201.8	141.9	167.0	30.6	102.2	122.5	164.0	128.0	127.7	90.8	338.0	177.8	142.7	291.1	187.9	197.7	148.2	107.6	195.2	208.5	74.8	84.2	105.5	42.7	82.3	71.4	129.3	56.2	132.4	69.9	68.6	247.4	76.7	130.9	73.8	4.6	20.6	7.4	28.3	16.9	43.7	26.5	33.1	34.1	34.7	22.3	30.1	28.4	1.8	30.2	18.4	30.0	48.7	31.2	52.4	55.9	62.5	66.9	57.9	59.3	60.6	51.0	62.5	50.1	58.7	61.0	15.1	9.6	15.8	11.8	19.8	32.0	37.0	39.4	34.1	34.5	27.5	16.3	341.9	22.8	22.5	36.8	77.2	42.6	11.8	42.6	56.7	50.8	4.0	30.4	20.0	23.8	20.5	39.3	24.7	42.5	38.8	21.1	30.1	25.4	14.5	37.5	23.2	176.1	39.1	20.2	27.1	33.5	26.4	17.0	15.1	8.1	18.0	13.5	24.9	5.6	12.7	16.1	8.2	11.6	17.6	40.3	13.3	22.6	39.2	38.2	27.6	63.2	17.5	48.9	0.0	15.2	24.0	11.9	15.0	68.9	30.0	23.7	17.4	36.4	54.4	69.6
GPD1		ENSG00000167588	"Glycerol-3-phosphate dehydrogenase 1"	P21695	12	50103982-50111313	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 609.9;skeletal muscle: 577.1"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 99.1;Proximal enterocytes: 247.0;Proximal tubular cells: 298.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC diff: 134.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044620, HPA058621"	Enhanced					NA	NA		4700000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA044620: AB_10796803, HPA058621: "	"unprognostic (2.65e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.19e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-2)"	609.9	4.7	9.1	1.6	16.8	0.2	229.2	22.7	12.8	0.3	5.5	6.4	76.4	0.2	5.3	4.9	0.5	16.6	9.2	10.1	14.2	149.3	147.6	18.4	1.0	32.6	18.3	0.3	7.2	13.0	1.3	0.0	26.5	1.3	3.3	1.0	33.0	1.3	577.1	10.2	76.9	1.3	32.7	0.4	3.3	0.8	18.4	1.5	2.7	215.7	0.4	4.1	1.0	49.4	0.1	0.2	0.1	0.1	134.0	0.0	0.3	0.1	0.0	0.0	0.0	27.0	0.1	0.4	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.6	0.1	0.6	25.2	0.0	0.2	0.0	0.3	0.2	0.1	0.3	0.1	0.0	0.7	0.7	0.3	0.0	0.2	0.1	0.4	0.1	3.7	0.0	0.2	0.2	30.2	0.2	0.0	0.6	0.2	0.0	1.5	1.0	0.0	1.8	0.0	0.0	0.0	0.3	0.2	0.1	0.6	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	16.8	22.7	12.8	10.1	14.2	32.6	18.3	26.5	32.7	18.4	49.4	3.4	3.2	3.2	0.0	2.4	0.0	0.2	0.3	0.6	3.2	3.4	3.7	5.8	11.5	1.8	5.5	8.4	0.0	0.0	3.0	43.0	0.9	0.1	0.5	0.1	0.2	1.2	5.3	0.2	0.7	0.0	0.8	4.1	0.2	0.0	0.1	1.1	99.1	2.3	3.3	0.2	9.7	0.0	1.0	0.4	0.0	0.0	5.2	1.8	0.0	1.0	2.8	0.0	0.0	4.0	0.6	8.0	0.0	0.0	0.1	247.0	298.4	0.4	1.7	0.0	7.0	1.1	0.0	0.0	0.8	0.4	0.0	1.2	0.0	10.6	0.2
GPD1L	KIAA0089	ENSG00000152642	"Glycerol-3-phosphate dehydrogenase 1 like"	Q8N335	3	32105689-32168709	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Brugada syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 158.4;tongue: 253.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 154.1;Distal enterocytes: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 136.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (1.23e-1)"	"unprognostic (3.12e-2)"	"prognostic favorable (7.05e-4)"	"unprognostic (2.63e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (1.35e-5)"	"prognostic favorable (5.71e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.33e-15)"	"unprognostic (1.50e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.31e-3)"	"unprognostic (5.51e-3)"	39.0	44.7	18.2	8.3	20.1	6.9	30.6	17.2	21.2	22.8	27.1	40.1	26.5	11.6	9.8	40.9	19.1	9.2	124.8	21.2	20.5	34.2	2.8	31.3	9.0	19.2	18.6	16.6	21.6	32.8	5.9	20.8	19.3	59.9	36.7	9.8	22.0	41.2	158.4	10.3	29.0	16.6	20.5	12.8	29.7	6.1	18.3	6.8	40.3	253.1	10.2	31.0	12.9	21.9	11.1	10.0	3.5	15.3	49.3	11.9	136.1	8.8	3.1	9.2	7.1	10.7	5.2	19.4	13.2	6.2	11.3	12.6	23.4	9.3	11.6	8.3	21.4	11.3	13.2	16.8	12.4	29.4	39.3	35.5	12.1	8.9	12.5	9.4	16.3	15.7	8.0	6.1	7.3	15.1	12.6	11.0	2.1	27.6	44.8	23.1	15.7	40.0	14.6	66.8	15.1	15.0	6.7	61.1	25.0	4.8	38.7	14.1	8.6	10.5	4.9	16.3	23.6	4.3	2.0	19.3	24.0	22.3	6.0	0.5	2.8	5.7	3.3	3.2	8.0	1.5	4.1	4.0	5.6	1.2	2.5	3.7	1.4	7.4	2.1	4.4	8.8	2.8	18.2	20.1	17.2	21.2	21.2	20.5	19.2	18.6	19.3	20.5	18.3	21.9	10.2	28.9	41.8	1.3	4.1	4.6	5.3	3.5	8.6	4.1	20.3	10.7	154.1	2.8	18.6	9.2	2.1	36.4	10.8	75.2	39.2	2.0	8.0	5.3	4.4	10.5	7.8	6.9	23.1	3.7	6.1	10.5	17.3	9.2	39.3	9.8	13.2	0.7	10.0	1.7	23.7	21.3	26.4	6.3	5.7	20.7	5.9	4.4	8.8	24.4	2.3	32.9	7.2	3.0	11.1	4.3	21.6	12.8	8.7	13.8	33.9	18.4	15.0	3.9	0.0	8.0	8.7	0.8	2.1	32.3	7.0	27.1	10.4	3.3	26.9	8.5
GPHN	KIAA1385	ENSG00000171723	Gephyrin	Q9NQX3	14	66507407-67181803	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	"Multifunctional enzyme, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 62.4"	"Group enriched"	"Detected in many"	4	"Astrocytes: 493.0;Excitatory neurons: 686.5;Inhibitory neurons: 866.7;Oligodendrocyte precursor cells: 576.1;Oligodendrocytes: 597.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003116, CAB004419, HPA024694"	Enhanced		Approved	Vesicles,Cytosol		NA	NA		6900	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Cytosol	"CAB004419: AB_627670, HPA003116: AB_1078963, HPA024694: AB_1849616"	"unprognostic (8.37e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.89e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.49e-2)"	"unprognostic (8.54e-2)"	"prognostic favorable (5.25e-12)"	"unprognostic (9.81e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (4.61e-5)"	13.8	11.1	35.5	3.5	36.0	2.6	13.4	48.4	54.1	9.7	20.9	11.8	7.4	9.9	11.6	12.2	11.1	6.2	17.1	36.1	37.6	25.3	62.4	9.3	3.8	32.7	35.3	8.9	23.9	11.7	13.6	3.6	32.3	11.3	10.1	23.1	9.4	6.6	24.5	15.2	9.0	6.2	32.4	6.7	14.7	6.2	34.6	5.8	11.9	13.8	4.3	11.4	10.7	39.5	39.9	8.8	13.7	15.9	14.2	17.5	9.5	11.1	5.7	12.7	12.2	2.8	17.9	0.0	1.8	7.7	5.5	13.1	17.0	19.9	18.9	15.0	14.9	15.8	9.4	22.3	7.8	9.1	15.8	13.3	13.8	2.9	16.0	4.8	11.8	13.8	9.3	14.2	7.1	19.2	11.9	22.2	5.0	28.3	17.0	0.0	32.5	13.2	16.7	7.5	25.8	10.3	10.2	31.6	12.4	3.3	18.5	11.5	6.7	14.1	24.8	11.3	13.0	22.8	9.1	0.3	10.5	0.8	11.2	0.0	0.7	0.3	2.0	1.2	3.2	1.2	2.5	1.7	1.1	1.9	1.7	1.6	0.0	1.3	1.0	1.5	3.0	0.7	35.5	36.0	48.4	54.1	36.1	37.6	32.7	35.3	32.3	32.4	34.6	39.5	11.5	6.4	13.1	493.0	11.8	4.7	9.2	5.8	27.9	34.3	12.4	6.7	12.7	8.6	10.8	1.8	52.1	3.9	3.5	8.6	13.7	4.0	3.8	7.2	13.5	10.7	6.0	7.6	686.5	5.3	2.3	8.7	19.9	13.6	0.0	3.9	15.7	47.6	3.7	43.7	866.7	15.0	8.2	5.8	1.7	5.0	11.1	4.5	1.8	148.0	1.3	8.9	1.0	576.1	597.5	3.1	7.8	5.7	15.1	11.5	7.1	20.1	2.4	34.9	0.0	12.5	11.8	11.8	8.9	26.7	5.8	2.1	7.9	9.0	10.4	6.5
GPI	"AMF, NLK"	ENSG00000105220	"Glucose-6-phosphate isomerase"	P06744	19	34359480-34402413	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Gluconeogenesis, Glycolysis"	"Cytokine, Growth factor, Isomerase"	"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 331.0;Late spermatids: 1127.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018655, HPA024305, CAB040563, HPA052171"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	No	No		86000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748"	"unprognostic (1.03e-1)"	"unprognostic (8.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.52e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.88e-2)"	196.9	283.2	83.4	74.5	101.9	222.8	129.0	67.7	130.5	95.0	84.8	162.9	113.7	92.4	27.2	197.8	88.8	87.1	407.2	108.5	73.6	196.8	222.6	91.2	66.4	73.5	58.5	97.0	84.2	166.3	147.2	47.5	69.3	94.4	84.3	156.1	105.1	61.0	416.6	120.1	126.5	78.4	34.0	102.2	122.5	95.9	83.2	50.1	100.8	374.6	76.0	147.9	121.5	95.8	572.9	596.1	58.7	433.3	167.5	121.9	134.1	183.4	132.4	206.3	253.7	314.9	169.6	303.5	311.4	177.9	149.1	343.7	337.7	437.0	259.4	461.0	105.1	382.1	252.3	310.8	108.4	517.6	259.3	173.7	136.6	289.0	132.7	273.3	209.3	230.5	210.3	261.8	140.2	319.2	245.5	133.5	158.0	421.3	174.6	242.7	149.1	649.4	254.1	275.4	304.9	185.8	331.9	634.3	131.7	100.5	144.4	161.7	171.9	80.8	185.5	256.7	312.8	535.5	383.7	318.4	287.4	372.3	170.6	188.8	93.2	331.3	80.4	141.2	99.1	59.9	73.7	93.1	101.0	50.5	61.8	72.8	7.4	58.0	180.3	31.6	83.4	123.4	83.4	101.9	67.7	130.5	108.5	73.6	73.5	58.5	69.3	34.0	83.2	95.8	34.2	28.9	40.0	98.9	43.8	25.9	30.1	104.5	42.7	98.8	34.1	27.2	232.5	42.9	51.4	57.0	75.0	44.5	41.6	76.7	115.4	101.7	331.0	35.9	41.2	38.0	63.7	46.7	121.8	66.9	69.2	47.1	109.1	58.0	23.4	36.1	42.8	89.5	89.6	237.2	127.2	75.8	50.8	52.9	40.5	1127.2	37.0	58.1	35.6	17.8	44.4	32.6	23.7	43.7	87.7	77.6	39.4	30.5	77.1	31.5	111.8	103.0	33.1	68.3	19.7	44.3	65.0	7.8	22.3	139.1	32.8	39.3	64.3	74.8	126.9	37.2
GPR101		ENSG00000165370	"G protein-coupled receptor 101"	Q96P66	X	137023929-137033995	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	143	"brain: 14.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 12.4;cerebral cortex: 4.4;hypothalamus: 14.3;thalamus: 7.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hypothalamus: 38.3"	"Low region specificity"	"Detected in many"			HPA001084	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA001084: AB_1078920"																		0.0	0.0	2.1	0.0	12.4	0.0	0.0	0.3	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.3	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	12.4	0.3	4.4	0.1	14.3	1.3	0.6	1.5	1.2	7.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR143	OA1	ENSG00000101850	"G protein-coupled receptor 143"	P51810	X	9725346-9786297	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Albinism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.2;choroid plexus: 14.4"	"Group enriched"	"Detected in many"	8	"Cytotrophoblasts: 40.6;Melanocytes: 126.3"	"Cancer enriched"	"Detected in all"	9	"melanoma: 84.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"basophil: 3.1"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 3.1"	"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 159.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003648	Enhanced					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA003648: AB_2667028"	"unprognostic (4.60e-2)"	"prognostic favorable (8.73e-4)"	"unprognostic (7.43e-3)"	"unprognostic (5.41e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.78e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.18e-2)"	"unprognostic (8.40e-2)"	"prognostic favorable (2.45e-5)"	"unprognostic (2.75e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.59e-2)"	0.6	1.1	10.6	0.1	13.0	0.0	1.7	11.8	11.5	2.0	14.4	1.4	0.5	3.2	5.3	2.4	2.8	0.9	0.1	10.8	13.1	4.6	1.7	1.0	0.5	12.6	14.2	3.3	1.2	2.9	2.7	6.1	12.3	2.6	1.4	0.9	3.3	4.4	0.0	8.9	0.5	1.0	11.4	0.0	0.7	0.8	13.1	1.8	3.2	0.0	1.6	1.1	1.1	12.2	1.9	0.4	4.6	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.2	0.0	0.4	0.1	0.2	1.1	0.1	0.1	0.3	0.0	0.2	0.6	2.3	0.0	3.4	0.1	1.6	0.0	0.0	24.2	6.7	0.0	0.0	0.0	0.0	12.1	0.0	0.1	11.1	0.0	0.1	0.0	0.1	0.1	22.2	3.2	0.9	0.0	0.3	0.0	159.6	10.8	1.9	0.0	4.6	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.4	3.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	10.6	13.0	11.8	11.5	10.8	13.1	12.6	14.2	12.3	11.4	13.1	12.2	0.1	0.0	0.0	9.8	0.2	5.5	1.3	1.8	2.2	0.5	2.1	1.7	0.9	0.0	4.9	7.3	0.0	40.6	0.0	0.8	1.9	4.9	0.2	1.7	1.6	1.5	0.0	0.0	0.6	0.6	2.1	1.0	0.0	1.3	0.0	1.8	2.9	0.3	4.8	0.0	0.3	0.8	2.0	0.0	1.6	1.8	1.8	0.1	126.3	1.0	0.0	1.2	0.0	0.5	0.6	1.2	0.2	6.4	0.0	1.8	0.2	5.0	3.2	0.2	0.0	0.0	0.7	0.2	1.3	4.2	0.6	10.1	0.7	1.0	2.0	1.8
GPR68	OGR1	ENSG00000119714	"G protein-coupled receptor 68"	Q15743	14	91232532-91253925	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Amelogenesis imperfecta, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 12.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 8.0;Hofbauer cells: 17.3;Langerhans cells: 22.6;NK-cells: 12.3;T-cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 22.9"	"Group enriched"	"Detected in many"	9	"NK-cells: 20.2;T-cells: 22.9"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 9.0;U-87 MG: 28.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (3.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"prognostic favorable (3.06e-5)"	"unprognostic (3.20e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.84e-2)"	"unprognostic (9.63e-2)"	"unprognostic (9.42e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.31e-9)"	"unprognostic (1.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.78e-3)"	3.7	1.0	2.5	5.7	1.9	1.4	2.3	3.6	4.9	2.2	0.8	3.1	1.8	1.3	0.5	8.7	1.0	3.7	2.4	1.8	3.3	3.1	1.0	4.9	5.9	2.2	2.6	0.3	0.7	0.9	12.2	3.1	3.7	2.7	1.5	0.2	3.8	0.4	0.7	6.2	2.9	2.0	0.2	4.2	5.7	2.1	2.7	1.2	1.7	0.2	2.8	7.5	3.9	1.4	0.2	0.1	0.6	0.0	0.0	0.9	0.6	1.1	0.6	0.0	0.0	0.2	1.0	0.9	0.4	9.0	0.0	1.0	0.0	0.1	0.2	0.3	0.1	0.0	0.1	0.2	0.0	0.6	4.1	0.4	0.1	4.8	0.0	4.4	0.4	2.9	5.8	0.8	3.9	1.2	0.8	6.4	0.1	0.0	0.1	0.3	0.3	0.2	0.1	0.3	3.1	4.4	0.1	0.1	0.0	0.2	1.5	0.4	2.8	6.1	0.1	1.1	0.4	1.0	1.3	0.2	28.6	1.1	0.1	0.0	0.1	0.1	22.9	0.0	13.8	0.5	5.0	13.5	0.2	0.4	0.6	4.5	2.3	20.2	0.0	0.0	8.7	4.1	2.5	1.9	3.6	4.9	1.8	3.3	2.2	2.6	3.7	0.2	2.7	1.4	1.1	0.0	4.8	0.3	0.7	3.6	0.2	4.2	0.6	0.5	0.8	0.8	1.7	0.0	1.0	0.0	0.0	0.1	8.0	0.1	0.0	0.0	5.4	0.5	0.2	6.9	0.0	2.7	4.1	0.2	0.1	4.3	0.0	0.3	0.0	0.1	0.4	0.0	17.3	0.0	2.1	0.0	0.0	0.0	22.6	1.6	0.3	3.0	3.6	0.0	0.6	0.0	12.3	1.0	0.3	2.9	0.0	4.5	1.3	0.1	0.0	0.4	0.4	0.2	0.0	0.1	1.1	3.4	0.4	0.9	3.0	0.7	13.1	0.2	0.0	0.3
GPR88		ENSG00000181656	"G protein-coupled receptor 88"	Q9GZN0	1	100538139-100542021	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 93.9"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.1;Excitatory neurons: 1.8;Hepatocytes: 2.2"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 12.0"	"Region enriched"	"Detected in many"	7	"basal ganglia: 93.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HSkMC: 1.6;SCLC-21H: 2.0"	"Region enriched"	"Detected in many"	10	"basal ganglia: 718.8"	"Region enriched"	"Detected in many"	42	"basal ganglia: 273.1"	HPA007488		Approved				NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA007488: AB_2667844"	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.37e-3)"	"unprognostic (5.41e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.03e-2)"	"unprognostic (7.76e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.93e-4)"	"unprognostic (1.85e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.35e-2)"	0.4	0.3	4.8	0.3	93.9	0.0	7.2	0.1	14.4	0.1	0.1	0.9	0.3	0.1	0.0	0.1	0.1	0.0	0.2	3.1	2.6	0.1	8.9	0.1	0.1	10.1	1.4	2.6	0.0	1.0	1.1	0.0	1.0	0.3	0.3	0.3	0.4	0.0	0.2	0.0	0.4	0.1	0.9	10.5	0.2	0.1	7.5	0.2	0.1	0.2	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	93.9	0.1	14.4	3.1	2.6	10.1	1.4	1.0	0.9	7.5	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPT2	ALT2	ENSG00000166123	"Glutamic--pyruvic transaminase 2"	Q8TD30	16	46884362-46931289	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 267.4;skeletal muscle: 176.4;tongue: 184.5"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 64.3;Hepatocytes: 123.9;Syncytiotrophoblasts: 83.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.3;naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Hep G2: 159.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051514	Approved		Approved	Mitochondria		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA051514: AB_2681516"	"unprognostic (1.65e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.12e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.86e-1)"	"unprognostic (3.54e-3)"	"unprognostic (3.18e-1)"	56.8	10.4	51.6	4.0	49.9	3.8	17.0	49.1	56.9	5.2	38.4	7.7	1.7	3.7	31.4	77.8	7.6	9.8	7.9	51.3	45.7	23.5	103.7	2.1	4.3	69.8	45.9	2.3	267.4	8.3	13.0	3.1	63.9	24.2	4.9	6.9	48.8	10.9	176.4	37.8	3.9	3.1	60.2	2.3	58.6	15.0	54.9	7.7	7.6	184.5	13.4	2.7	7.7	64.5	42.6	19.0	23.8	90.6	32.7	7.0	43.1	28.9	10.9	30.7	19.2	65.3	17.6	29.9	24.7	20.7	15.6	33.6	43.3	42.8	20.4	14.0	21.1	10.5	10.8	159.9	22.4	75.6	9.5	15.2	37.0	30.0	46.3	20.3	15.1	56.1	8.7	23.3	10.3	75.8	15.1	62.9	25.3	52.2	54.2	0.3	26.3	71.1	12.4	21.0	73.7	37.7	14.9	76.4	39.0	9.4	19.6	67.6	11.3	21.1	40.9	14.2	23.4	110.2	36.9	87.1	32.6	48.3	11.7	0.4	0.2	0.0	0.1	0.0	0.0	1.3	0.0	0.1	0.4	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	51.6	49.9	49.1	56.9	51.3	45.7	69.8	45.9	63.9	60.2	54.9	64.5	1.3	6.4	3.4	54.9	4.8	15.9	4.9	6.8	64.3	14.5	6.7	8.4	14.9	8.6	9.1	18.4	22.9	9.2	0.3	10.2	11.7	7.0	9.6	12.2	7.2	2.3	13.1	5.2	16.7	30.2	44.8	7.5	37.2	37.5	3.8	14.9	5.0	123.9	3.8	6.7	18.8	13.4	6.1	3.2	7.3	22.9	4.7	2.3	8.8	1.0	1.1	42.5	1.0	13.6	26.0	25.6	5.2	15.4	7.9	12.4	2.0	38.6	5.4	5.9	0.0	5.2	3.6	2.5	17.3	53.1	16.3	83.3	1.4	2.6	6.3	4.2
GPX4	"MCSP, PHGPx"	ENSG00000167468	"Glutathione peroxidase 4"	P36969	19	1103926-1106791	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Oxidoreductase, Peroxidase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 18580.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008630, HPA047224, HPA058546"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA		150000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"CAB008630: AB_1616685, HPA047224: AB_2679990, HPA058546: AB_2683749"	"unprognostic (8.42e-3)"	"prognostic favorable (7.18e-4)"	"unprognostic (8.14e-3)"	"prognostic favorable (1.84e-5)"	"unprognostic (1.00e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.53e-3)"	"unprognostic (8.49e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.96e-2)"	927.8	535.3	415.1	127.4	428.7	178.0	733.3	440.7	519.1	280.8	478.7	249.0	259.0	188.4	318.9	220.4	199.2	196.6	426.0	419.2	450.3	536.5	687.8	307.9	216.4	430.9	448.3	260.3	157.9	285.5	398.4	147.2	454.1	322.1	110.9	167.5	304.9	193.8	672.3	290.4	236.2	87.9	418.2	213.2	219.0	1403.5	444.0	158.7	291.5	399.7	182.5	319.0	245.2	429.1	258.1	286.8	405.8	863.0	1202.1	706.0	449.3	199.3	713.5	371.1	375.9	590.5	339.8	92.8	211.8	405.8	313.5	283.1	239.7	289.3	180.5	522.3	436.5	175.0	246.9	849.2	697.4	207.6	269.4	707.3	432.1	188.3	314.7	665.9	527.1	317.5	249.4	225.7	311.1	660.4	353.8	354.9	386.2	569.7	458.9	482.8	55.3	271.3	408.9	629.9	348.3	220.6	390.5	366.1	422.1	246.7	358.1	498.0	450.9	392.3	257.4	680.6	254.6	786.5	582.0	224.3	369.4	412.2	230.9	578.9	539.6	564.4	219.8	405.4	256.9	352.7	319.7	230.7	404.0	309.9	339.4	245.0	265.1	196.6	462.2	278.8	310.3	841.7	415.1	428.7	440.7	519.1	419.2	450.3	430.9	448.3	454.1	418.2	444.0	429.1	415.9	179.5	189.7	21.2	281.7	510.0	525.8	1188.1	512.2	332.2	845.1	868.2	264.6	316.0	600.6	472.6	98.0	562.5	231.3	479.1	1592.6	515.8	4209.7	546.8	326.3	268.7	397.1	215.0	24.5	368.7	1327.3	536.1	99.9	442.3	346.1	242.6	322.0	826.2	1184.1	208.6	33.1	328.7	671.4	583.1	1304.8	18580.2	384.9	735.2	677.7	21.5	1786.8	502.6	192.6	13.6	35.4	484.0	507.9	312.9	189.2	694.7	1861.9	3024.7	800.9	246.0	243.3	244.6	587.1	1310.8	202.4	357.7	467.0	978.1	281.0	186.7	336.4	662.6
GPX7	"FLJ14777, GPX6, NPGPx"	ENSG00000116157	"Glutathione peroxidase 7"	Q96SL4	1	52602371-52609051	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 43.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 68.6;HEL: 63.9;REH: 76.4;RPMI-8226: 130.0;THP-1: 101.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (5.87e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.43e-3)"	"unprognostic (3.18e-1)"	"unprognostic (5.64e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.42e-2)"	"unprognostic (8.18e-2)"	"unprognostic (4.17e-1)"	"unprognostic (2.48e-3)"	"prognostic unfavorable (2.26e-5)"	"unprognostic (1.14e-2)"	"unprognostic (9.24e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.44e-2)"	8.4	7.9	4.8	12.4	5.0	18.3	11.9	5.2	5.4	11.6	9.3	9.4	3.3	13.1	7.3	4.3	9.1	13.4	10.8	4.6	5.9	6.9	5.3	6.8	16.5	5.2	5.1	8.9	11.5	8.5	12.5	29.3	5.0	8.7	5.5	1.7	5.9	9.7	12.1	5.0	6.0	10.8	5.0	8.1	5.0	5.5	5.0	15.9	17.1	11.5	14.0	12.4	6.9	4.9	0.1	0.0	18.1	33.9	6.6	19.1	0.1	12.5	0.7	14.8	15.3	12.2	0.0	0.1	9.8	68.6	0.0	0.0	29.0	0.0	8.1	0.0	0.2	63.9	3.6	11.3	23.9	0.0	0.0	44.4	0.0	2.5	0.0	0.0	22.9	0.4	0.0	0.0	28.2	0.0	3.3	33.5	31.5	0.0	0.0	76.4	0.0	130.0	1.3	0.0	13.7	27.0	33.3	0.0	21.9	3.0	0.0	101.1	1.4	0.0	3.7	3.8	0.1	0.1	0.0	47.9	0.0	0.2	11.3	0.2	1.7	5.4	22.6	0.4	31.8	32.0	34.6	27.1	5.4	35.2	44.5	29.0	0.9	31.6	0.2	73.7	27.6	21.4	4.8	5.0	5.2	5.4	4.6	5.9	5.2	5.1	5.0	5.0	5.0	4.9	8.4	3.2	5.5	1.0	16.1	2.2	9.0	8.3	1.2	1.0	7.1	13.6	3.9	12.8	6.5	3.7	0.0	22.8	9.2	0.2	5.9	11.1	6.9	8.2	43.7	12.4	1.2	6.7	1.6	15.6	19.8	30.5	0.5	6.5	1.3	25.8	15.4	3.8	12.3	5.0	2.7	1.2	2.0	1.9	0.7	6.6	15.2	6.0	7.2	4.7	5.0	8.3	9.2	4.5	2.0	4.7	0.7	13.5	25.2	5.7	0.0	3.0	7.0	0.6	13.1	13.3	14.5	10.8	12.1	1.9	3.3	15.6	10.9	19.3	0.6	4.9
GRHPR	"GLXR, PH2"	ENSG00000137106	"Glyoxylate and hydroxypyruvate reductase"	Q9UBQ7	9	37422666-37436990	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 652.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 864.6;Proximal tubular cells: 817.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022971, HPA078575"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		2700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA022971: AB_1849975, HPA078575: "	"prognostic favorable (7.00e-5)"	"unprognostic (6.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-3)"	"unprognostic (5.78e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.39e-9)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	58.9	143.1	72.6	35.5	83.9	40.5	55.7	84.1	74.3	53.0	76.1	60.5	63.5	58.5	62.6	62.5	51.0	36.6	107.6	69.7	76.4	156.5	652.5	42.9	55.8	76.3	76.2	63.4	64.2	49.1	35.7	35.2	77.6	50.7	35.4	20.8	74.8	46.4	168.5	64.2	51.4	42.8	75.9	41.7	60.7	37.9	78.4	34.7	43.4	146.4	51.5	52.9	51.8	89.4	111.7	157.7	87.5	81.0	80.1	86.4	87.7	86.2	114.3	115.8	125.2	60.3	47.2	106.5	50.0	105.3	85.8	49.3	51.7	113.5	69.3	140.3	62.8	61.6	144.1	107.5	124.3	58.7	61.6	104.2	97.2	67.6	87.4	98.0	102.2	67.5	116.1	42.9	104.2	85.3	58.9	60.8	53.5	101.1	67.5	55.4	62.1	59.1	155.9	63.0	36.3	64.3	74.4	143.8	84.1	79.1	80.1	75.7	109.7	63.5	100.4	44.0	76.9	33.1	27.4	70.8	90.8	33.5	95.7	45.0	64.7	33.9	39.3	66.9	32.7	61.6	40.8	44.6	70.3	65.6	39.6	33.9	14.5	64.5	56.7	63.4	57.8	52.0	72.6	83.9	84.1	74.3	69.7	76.4	76.3	76.2	77.6	75.9	78.4	89.4	50.7	57.7	30.2	24.2	37.5	43.3	52.5	87.3	41.5	39.0	53.7	65.7	103.7	177.3	53.8	51.5	20.9	152.6	33.9	65.3	248.4	78.0	14.9	38.4	65.4	47.9	62.2	54.7	10.3	89.0	93.0	67.7	52.0	44.8	50.1	93.3	67.5	864.6	110.8	23.5	11.0	79.7	71.2	82.9	45.8	16.0	74.6	49.2	80.0	14.0	71.1	102.8	33.0	16.1	44.9	73.8	56.9	98.6	30.1	46.4	135.6	817.7	36.0	29.1	78.9	54.3	71.8	22.3	19.0	74.6	56.3	88.9	32.5	233.3	80.9	48.1
GRIA3	"GluA3, GLUR3, GLURC, MRX94"	ENSG00000125675	"Glutamate ionotropic receptor AMPA type subunit 3"	P42263	X	123184153-123490915	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.6;retina: 17.8"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 468.4;Horizontal cells: 198.5;Inhibitory neurons: 396.3;Oligodendrocyte precursor cells: 385.0"	"Cancer enriched"	"Detected in some"	11	"glioma: 10.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 23.8;BJ hTERT+: 34.5;fHDF/TERT166: 45.9;U-2197: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058659, HPA073344"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA058659: AB_2683791, HPA073344: "	"unprognostic (2.14e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.94e-3)"	"unprognostic (5.09e-2)"	"unprognostic (4.29e-4)"	"unprognostic (2.42e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.05e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	0.8	10.3	20.0	0.3	25.3	0.1	1.4	1.3	31.6	6.7	0.0	0.7	0.3	2.1	3.6	0.4	1.5	1.2	2.0	29.0	4.0	2.5	7.7	0.3	0.5	1.9	3.4	4.1	1.7	0.0	1.0	0.4	1.4	1.7	0.8	17.8	0.2	1.9	0.2	0.5	0.5	1.9	4.5	0.1	2.0	0.7	6.4	0.2	0.2	0.1	0.8	0.6	2.8	20.9	0.0	0.0	0.0	0.0	2.2	0.4	0.0	23.8	34.5	0.4	0.9	0.0	0.0	0.0	0.0	45.9	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	6.6	0.0	15.1	0.2	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.0	25.3	1.3	31.6	29.0	4.0	1.9	3.4	1.4	4.5	6.4	20.9	0.1	0.0	0.0	27.4	0.0	0.3	0.0	0.8	0.6	13.6	0.2	0.0	1.6	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.1	0.3	8.7	0.3	0.0	0.0	468.4	0.2	0.1	6.4	1.1	0.2	0.0	0.1	0.4	6.1	0.1	198.5	396.3	0.0	0.0	0.0	1.5	0.3	9.3	0.2	1.8	14.0	0.0	1.9	0.0	385.0	67.6	0.3	0.0	4.1	0.0	0.4	0.0	6.2	0.1	3.8	0.0	0.2	4.5	0.0	0.1	0.0	1.0	0.1	0.1	0.7	0.0	0.0
GRIP1		ENSG00000155974	"Glutamate receptor interacting protein 1"	Q9Y3R0	12	66347431-67069162	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 16.4"	"Cell type enriched"	"Detected in many"	7	"Inhibitory neurons: 2829.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"myeloid DC: 4.9"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 4.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 44.4;HaCaT: 48.7;REH: 30.7;RT4: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038856	Uncertain					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA038856: AB_10673297"	"unprognostic (6.25e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.00e-2)"	"unprognostic (4.14e-1)"	"unprognostic (2.82e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.27e-4)"	"unprognostic (8.57e-3)"	0.5	4.3	8.5	2.7	6.6	0.5	3.0	0.0	14.2	1.2	0.0	3.1	1.1	3.5	4.7	7.3	4.2	1.6	2.7	3.9	12.4	3.3	0.3	0.8	0.7	0.7	7.6	1.2	2.0	16.4	3.3	8.2	2.2	4.6	1.7	4.8	6.0	9.3	1.0	9.8	1.9	2.8	0.0	2.6	0.8	6.2	3.0	0.7	5.0	0.6	1.3	2.6	2.0	3.7	11.1	10.1	17.7	2.1	0.0	0.0	44.4	3.2	0.0	5.4	2.5	0.3	3.3	1.4	4.2	0.0	9.5	48.7	4.9	3.3	2.4	0.0	12.0	0.0	0.1	0.3	0.0	1.2	0.1	0.0	8.0	0.0	0.8	8.3	0.0	8.0	0.0	0.1	0.0	4.0	0.4	0.4	16.1	1.4	3.6	30.7	0.1	0.6	5.6	31.0	10.8	1.4	14.8	7.1	1.4	11.3	8.7	1.8	0.0	0.0	12.7	0.1	9.0	1.5	0.3	1.0	12.0	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.1	0.1	0.2	0.0	1.0	0.0	0.3	0.0	0.1	8.5	6.6	0.0	14.2	3.9	12.4	0.7	7.6	2.2	0.0	3.0	3.7	0.1	0.0	1.1	74.7	0.1	13.3	2.3	2.9	2.2	5.5	4.1	2.4	3.4	1.5	1.7	7.3	0.0	7.8	0.7	0.3	0.0	2.2	38.5	8.1	2.2	0.4	1.8	0.0	390.2	1.5	4.3	1.1	0.0	13.7	0.0	2.3	0.0	0.0	1.0	47.1	2829.7	0.7	0.0	2.4	1.6	34.0	0.6	2.1	7.2	20.6	1.0	0.5	0.0	158.3	44.4	1.9	0.5	0.7	0.1	3.8	0.2	0.4	1.1	1.8	0.0	1.0	0.6	0.3	1.2	2.3	17.8	16.6	0.8	1.2	0.7	3.1
GRK1	"GPRK1, RHOK, RK"	ENSG00000185974	"G protein-coupled receptor kinase 1"	Q15835	13	113667219-113737736	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	50	"retina: 42.6"	"Group enriched"	"Detected in some"	16	"Cone photoreceptor cells: 56.3;Rod photoreceptor cells: 84.9"	"Cancer enriched"	"Detected in single"	5	"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035200, HPA059376"	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA035200: AB_2674515, HPA059376: AB_2683996"	"unprognostic (7.93e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.24e-5)"	"unprognostic (1.76e-3)"	"unprognostic (1.53e-1)"		"unprognostic (3.59e-2)"		"unprognostic (2.21e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.18e-2)"	"unprognostic (6.11e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	56.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRM1	"GPRC1A, mGlu1, MGLUR1, PPP1R85"	ENSG00000152822	"Glutamate metabotropic receptor 1"	Q13255	6	146027646-146437601	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 27.6"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 215.5;Inhibitory neurons: 138.8;Rod photoreceptor cells: 124.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 27.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015701	Approved	Supported	Approved	Vesicles		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA015701: AB_1853917"	"unprognostic (1.04e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.77e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.48e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.76e-2)"	0.0	0.0	3.3	0.0	3.6	0.0	0.0	27.6	6.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	7.3	2.3	0.7	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.6	27.6	6.8	7.3	2.3	0.0	3.1	0.9	0.0	7.7	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	3.7	0.0	0.0	1.8	16.7	0.0	0.0	0.0	1.9	0.0	8.5	0.1	0.0	0.2	0.0	0.0	215.5	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.6	6.7	138.8	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	3.7	0.0	4.0	0.0	8.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	124.9	0.0	0.0	0.1	1.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRM6	"CSNB1B, GPRC1F, mGlu6, MGLUR6"	ENSG00000113262	"Glutamate metabotropic receptor 6"	O15303	5	178977587-178996206	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Receptor, Transducer"	"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	57	"retina: 42.6"	"Cell type enriched"	"Detected in some"	31	"Bipolar cells: 440.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014511	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 56: Bipolar cells - Visual perception"			"HPA014511: AB_2669025"	"unprognostic (1.85e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.25e-3)"	"unprognostic (7.72e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.12e-3)"	"unprognostic (6.27e-2)"	"unprognostic (3.34e-4)"	"unprognostic (2.58e-1)"	"unprognostic (3.36e-4)"	"unprognostic (1.23e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.59e-3)"	"unprognostic (1.97e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.7	0.0	0.1	0.3	0.0	42.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.4	0.3	0.1	0.0	440.5	0.1	0.0	1.9	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	1.0	0.2	0.4	0.6	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	3.3	0.4	0.0	0.0	0.0	0.9	1.1	0.0	0.1	0.0	0.0	0.6	4.2	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	14.2	0.0	0.3	0.2	0.9	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1
GSDME	"DFNA5, ICERE-1"	ENSG00000105928	"Gasdermin E"	O60443	7	24698355-24757940	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Necrosis		"Deafness, Non-syndromic deafness, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 168.1;Distal tubular cells: 41.1;Extravillous trophoblasts: 26.5;Hofbauer cells: 39.9;Syncytiotrophoblasts: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 9.0;myeloid DC: 5.9;naive B-cell: 8.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011326, CAB019306"	Approved		Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB019306: , HPA011326: AB_1847629"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.48e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.90e-2)"	13.5	7.8	16.4	2.9	16.7	0.5	7.6	13.3	18.0	17.3	9.2	6.4	7.7	24.8	15.3	3.6	14.3	8.5	9.7	18.1	15.0	13.3	4.5	4.4	5.8	19.4	18.7	16.9	2.6	7.3	7.0	35.0	16.1	7.5	2.4	6.3	3.1	21.1	7.8	3.0	26.8	15.1	16.5	1.8	3.9	12.9	14.1	5.8	14.5	5.2	3.8	15.0	10.1	26.6	31.4	21.7	9.6	41.2	51.4	28.6	16.4	24.1	63.6	24.5	34.3	22.9	1.1	0.5	20.6	66.4	81.7	20.5	5.8	105.4	42.8	0.1	2.1	0.8	39.3	48.0	43.0	0.1	1.5	31.3	75.3	43.5	103.1	73.0	42.3	13.8	3.0	5.2	55.3	0.4	1.9	0.8	10.2	0.1	15.7	0.2	33.6	0.0	74.5	21.9	0.4	60.0	36.5	0.6	42.3	24.3	2.2	2.8	27.9	23.1	39.7	31.6	29.2	2.4	0.6	15.5	69.8	0.1	5.8	0.0	1.9	0.0	0.0	0.2	0.0	9.0	0.1	0.0	5.9	8.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	16.4	16.7	13.3	18.0	18.1	15.0	19.4	18.7	16.1	16.5	14.1	26.6	1.0	6.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.1	3.9	0.0	0.0	0.6	5.5	0.0	168.1	0.0	0.0	41.1	1.9	0.0	0.7	16.9	1.3	0.0	0.0	0.0	0.9	26.5	4.3	0.0	1.0	0.0	4.8	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	8.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	8.8	1.5	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	104.7	0.7	0.9	0.0	0.0
GSTZ1	"GSTZ1-1, MAAI, MAI"	ENSG00000100577	"Glutathione S-transferase zeta 1"	O43708	14	77320996-77331597	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Isomerase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 263.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 373.2;Late spermatids: 398.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 182.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004701	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		340000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 62: Liver - Hemostasis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	Nucleoplasm	"HPA004701: AB_1078990"	"prognostic favorable (4.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (7.90e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.92e-2)"	13.9	34.7	11.1	9.7	12.5	9.3	23.2	13.2	16.3	12.7	10.5	21.9	22.5	10.8	22.1	26.9	14.9	11.9	14.3	10.5	12.3	24.5	263.1	7.8	13.5	12.6	11.7	6.5	20.1	26.4	13.3	11.2	12.8	21.1	21.7	5.1	24.1	9.6	47.4	22.1	15.6	7.9	12.3	12.1	18.9	57.8	11.9	14.0	19.5	37.3	17.4	11.9	13.8	14.0	18.8	39.0	27.6	19.9	17.1	23.9	45.8	11.4	11.9	21.6	30.9	13.0	45.2	43.5	14.9	13.6	13.4	24.1	18.9	22.5	20.7	23.2	21.0	20.8	13.3	26.9	26.3	7.8	15.8	22.1	24.0	12.4	20.8	12.0	18.6	24.7	17.5	37.0	14.5	182.1	12.2	16.4	8.2	64.1	30.3	20.2	29.5	34.2	32.5	24.0	30.2	26.2	26.0	49.1	35.6	15.5	81.2	11.1	13.8	17.0	52.5	18.9	8.6	28.2	32.7	35.2	41.9	11.3	20.8	13.4	15.5	9.9	2.6	22.2	2.4	8.2	4.6	3.7	20.7	10.4	3.9	3.1	1.6	5.1	20.1	15.0	7.9	7.4	11.1	12.5	13.2	16.3	10.5	12.3	12.6	11.7	12.8	12.3	11.9	14.0	6.1	6.4	9.6	6.5	13.5	13.4	19.8	26.2	15.9	7.3	36.1	34.2	13.0	47.1	19.0	9.2	4.2	91.4	7.5	34.9	46.9	45.0	125.8	19.4	15.6	11.1	28.8	30.3	2.9	68.0	62.5	15.0	33.1	27.0	3.8	25.7	15.4	373.2	44.6	16.8	3.3	45.7	20.3	38.1	10.9	398.1	11.8	19.0	17.8	3.7	30.4	26.4	4.1	2.0	9.2	41.8	37.4	6.0	13.2	19.8	72.9	77.8	15.0	11.9	0.0	12.3	13.2	51.3	29.4	38.0	14.1	76.2	6.7	55.8	50.3	30.3
GUCA1B	"GCAP2, RP48"	ENSG00000112599	"Guanylate cyclase activator 1B"	Q9UMX6	6	42183284-42194956	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Sensory transduction, Vision"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	99	"retina: 466.0"	"Group enriched"	"Detected in some"	4	"Astrocytes: 23.2;Cone photoreceptor cells: 83.4;Oligodendrocytes: 28.2;Rod photoreceptor cells: 53.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.3;U-698: 3.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA055479	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA055479: AB_2732598"	"unprognostic (1.61e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.14e-6)"	"unprognostic (5.39e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.57e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.28e-7)"	"unprognostic (4.50e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.59e-3)"	1.5	0.9	3.5	0.8	3.6	1.3	1.4	3.8	4.1	2.3	2.2	1.3	0.3	1.9	1.0	0.8	2.3	0.2	1.6	3.2	3.2	1.0	1.9	1.1	0.7	3.3	3.2	2.7	0.9	0.2	1.0	0.4	3.6	1.5	0.5	466.0	1.1	0.5	2.6	2.8	1.4	1.0	3.0	2.1	0.8	2.6	3.5	1.0	1.0	0.9	0.9	1.1	1.4	4.6	0.1	0.6	1.3	0.5	1.0	0.9	0.3	0.5	0.8	0.8	0.7	1.1	0.4	1.6	0.8	0.1	0.2	0.4	1.4	0.2	1.4	1.3	0.6	0.4	0.1	0.2	0.4	1.5	0.5	0.3	4.3	0.8	1.1	0.4	0.1	1.2	1.0	1.5	0.2	1.3	0.6	1.0	0.0	0.3	0.3	0.2	0.8	0.1	0.8	0.5	0.6	0.9	0.0	0.2	0.1	0.2	0.1	0.9	0.0	0.2	1.7	0.6	0.7	2.7	1.3	3.9	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	3.5	3.6	3.8	4.1	3.2	3.2	3.3	3.2	3.6	3.0	3.5	4.6	0.2	0.0	0.0	23.2	0.0	0.3	0.1	0.0	0.0	4.0	0.2	0.1	0.3	0.0	0.0	0.0	83.4	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.3	0.3	0.0	0.0	8.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	6.7	11.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.8	2.8	0.1	8.1	0.0	11.6	28.2	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	53.0	0.0	0.5	0.4	0.5	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.2
GUCY1A1	"GC-SA3, GUC1A3, GUCY1A3"	ENSG00000164116	"Guanylate cyclase 1 soluble subunit alpha 1"	Q02108	4	155666726-155737059	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 38.4;Alveolar cells type 2: 56.1;Breast glandular cells: 37.4;Breast myoepithelial cells: 24.9;Distal tubular cells: 19.6;Ductal cells: 21.8;Smooth muscle cells: 49.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 8.2;non-classical monocyte: 10.1;plasmacytoid DC: 11.5"	"Group enriched"	"Detected in many"	35	"dendritic cells: 11.5;monocytes: 10.1;NK-cells: 8.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.8;HEK 293: 5.5;Karpas-707: 9.7;MOLT-4: 18.5;RPTEC TERT1: 12.1;RT4: 14.2;SH-SY5Y: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010887, HPA056004, HPA058617"	Uncertain		Supported	Nucleoplasm		NA	NA		7100	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"CAB010887: AB_259901, HPA056004: AB_2683007, HPA058617: AB_2732624"	"unprognostic (4.81e-3)"	"unprognostic (2.60e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (1.85e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-3)"	14.4	7.8	10.1	17.0	24.1	1.2	15.4	2.8	14.0	14.5	0.1	27.1	8.7	16.1	6.2	7.5	9.5	12.6	33.7	12.7	8.0	15.6	8.0	21.0	8.5	5.3	10.0	5.6	13.1	31.4	3.9	25.9	4.5	25.8	10.3	17.0	5.3	13.9	5.1	2.5	9.2	28.9	8.7	14.1	8.6	1.2	10.2	7.5	7.2	18.7	9.2	7.3	6.6	8.5	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	6.8	0.0	0.0	0.0	5.5	1.3	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	3.6	0.0	9.7	0.0	0.0	18.5	0.0	0.0	0.0	0.2	4.1	0.0	3.0	12.1	14.2	2.5	8.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.0	2.3	0.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.1	8.2	10.1	11.5	0.0	1.0	10.1	24.1	2.8	14.0	12.7	8.0	5.3	10.0	4.5	8.7	10.2	8.5	38.4	9.6	56.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	37.4	24.9	0.0	0.0	6.8	11.0	0.0	0.4	1.7	0.0	19.6	21.8	0.0	5.5	9.7	10.9	0.0	0.0	0.0	2.0	0.3	8.3	0.0	15.2	3.8	3.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	12.9	2.2	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0
GUCY2D	"CORD6, CYGD, GUC1A4, GUC2D, LCA, LCA1, retGC, RETGC-1, ROS-GC1"	ENSG00000132518	"Guanylate cyclase 2D, retinal"	Q02846	17	8002615-8020342	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"cGMP biosynthesis, Sensory transduction, Vision"	Lyase	"Cone-rod dystrophy, Congenital stationary night blindness, Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"retina: 34.2"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 62.6;Rod photoreceptor cells: 58.3"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	31	"plasmacytoid DC: 8.0"	"Lineage enriched"	"Detected in single"	50	"dendritic cells: 8.0"	"Cell line enriched"	"Detected in some"	5	"JURKAT: 5.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"									NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 79: Retina - Phototransduction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"				"unprognostic (3.57e-4)"	"unprognostic (5.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.75e-5)"	"unprognostic (5.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.44e-1)"	"unprognostic (7.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.07e-1)"	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	34.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.4	1.3	5.2	5.7	2.1	1.4	3.8	1.9	0.0	1.4	0.0	62.6	1.2	2.7	0.0	1.9	0.1	6.9	0.2	0.1	0.1	0.0	0.0	0.5	0.0	0.7	0.1	0.0	0.6	0.0	0.1	0.0	1.2	1.1	0.0	0.4	0.0	0.0	0.6	0.0	14.9	0.0	0.6	0.0	0.0	0.8	6.1	0.0	0.0	0.1	0.1	0.0	0.4	0.0	1.1	0.0	0.4	0.1	58.3	0.0	0.0	0.0	0.4	0.1	2.4	0.3	2.2	0.1	0.0	0.2	0.5
GUSB		ENSG00000169919	"Glucuronidase beta"	P08236	7	65960684-65982215	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 213.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036322, HPA036323"	Approved		Supported	Vesicles	"Intracellular and membrane"	NA	NA		330000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA036322: AB_10670796, HPA036323: AB_2675059"	"unprognostic (1.54e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.98e-1)"	"unprognostic (5.06e-1)"	"unprognostic (1.45e-1)"	28.4	18.2	11.0	22.3	12.3	84.2	80.9	12.0	16.1	26.7	14.3	38.2	36.1	26.2	41.8	16.4	24.6	27.6	19.6	10.7	11.5	25.1	104.0	35.7	25.6	13.2	12.2	19.9	33.6	30.3	12.6	48.2	13.2	20.2	41.9	9.7	32.9	21.2	10.9	18.8	29.8	19.1	11.9	34.0	38.1	19.5	13.0	22.7	27.7	14.4	24.0	27.3	15.4	13.5	67.0	26.5	25.2	56.3	80.9	49.1	35.3	21.3	56.8	45.0	42.1	37.0	67.8	30.9	32.3	26.8	24.1	27.5	16.5	25.1	26.8	27.3	34.1	41.5	40.9	27.3	39.7	89.6	67.1	33.4	26.7	26.3	33.3	54.5	39.3	18.0	63.2	213.5	30.5	50.3	34.2	92.0	17.9	103.0	21.0	34.4	55.9	172.4	29.4	42.8	36.2	32.7	55.6	129.1	72.3	29.9	71.1	88.8	28.5	55.3	49.3	21.8	53.6	119.6	151.9	50.0	41.0	116.3	68.3	26.0	80.1	65.7	32.0	103.0	28.4	27.7	24.7	28.4	80.5	22.6	16.8	19.5	13.2	46.6	93.5	34.2	34.5	51.4	11.0	12.3	12.0	16.1	10.7	11.5	13.2	12.2	13.2	11.9	13.0	13.5	53.1	51.3	58.7	10.1	33.0	18.0	32.0	51.9	29.0	12.2	26.1	19.9	12.2	48.6	48.9	29.5	8.4	81.9	32.6	52.2	5.9	41.1	59.1	28.9	26.5	39.7	43.0	47.1	12.3	30.3	61.2	49.5	49.5	49.4	36.8	38.3	37.9	72.7	126.4	16.8	10.6	51.6	30.5	88.1	33.2	46.7	43.2	78.0	39.2	14.0	44.8	28.0	20.6	8.5	14.2	29.4	49.5	28.6	87.5	25.3	50.6	26.8	43.2	20.1	26.3	27.1	26.0	49.6	31.0	16.0	14.8	66.9	32.2	24.4	44.3	29.6
GYG1	GYG	ENSG00000163754	"Glycogenin 1"	P46976	3	148991408-149031775	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	Transferase	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 560.0;tongue: 357.6"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 229.8;Early spermatids: 251.2;Late spermatids: 368.8;Spermatocytes: 296.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030497, HPA073229"	Supported		Approved	Vesicles		NA	NA		30000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA030497: AB_10602326, HPA073229: "	"unprognostic (2.68e-2)"	"unprognostic (6.31e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (6.15e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.79e-2)"	40.3	31.1	30.1	31.3	32.2	219.8	33.8	33.1	39.4	36.5	28.7	152.2	16.7	64.1	38.7	53.6	52.6	23.9	117.8	29.9	44.0	29.0	18.6	41.1	24.8	37.0	39.7	43.8	42.7	25.2	31.5	23.0	39.0	47.3	25.6	34.3	39.7	64.4	560.0	21.2	37.7	68.1	35.9	59.2	50.7	115.1	33.6	18.0	21.1	357.6	23.0	86.1	30.8	38.3	62.7	39.8	29.0	32.6	78.5	81.7	39.5	90.2	74.4	128.3	119.2	52.3	62.2	0.1	43.5	105.1	68.4	18.8	76.7	39.8	128.6	21.1	33.3	47.6	16.7	59.9	70.7	49.1	68.8	45.1	63.8	42.7	53.3	66.8	74.7	30.7	29.8	109.8	74.7	110.3	9.6	38.9	34.9	48.3	32.2	26.7	43.8	89.3	35.7	57.6	23.7	11.3	47.6	64.6	54.4	27.3	64.4	51.4	62.9	65.4	19.4	47.4	66.9	98.7	59.1	44.4	55.1	74.3	21.7	22.7	58.1	42.4	39.4	59.6	73.1	15.9	25.7	41.3	64.0	14.0	13.8	23.5	27.0	44.3	67.9	25.3	39.4	50.1	30.1	32.2	33.1	39.4	29.9	44.0	37.0	39.7	39.0	35.9	33.6	38.3	27.7	12.8	11.1	16.3	28.3	12.1	22.4	27.7	12.5	9.4	22.5	17.1	229.8	15.7	21.9	33.1	18.8	36.5	50.4	9.9	27.4	43.4	251.2	7.9	15.2	32.6	14.4	12.2	9.8	77.6	47.2	45.0	17.3	9.5	18.3	19.7	45.3	13.5	95.3	6.7	11.3	19.0	26.4	87.1	26.3	368.8	53.1	56.2	40.9	6.5	56.2	132.1	36.0	11.6	5.4	31.6	14.3	76.8	104.1	45.9	15.0	17.3	16.1	7.0	65.7	35.8	50.3	296.7	52.2	23.1	14.9	29.3	61.2	33.8	15.2	19.6
GYS1	"GSY, GYS"	ENSG00000104812	"Glycogen synthase 1"	P13807	19	48968130-48993310	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 118.5;skeletal muscle: 319.4;tongue: 201.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007793, HPA041598"	Enhanced		Approved	Microtubules,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Microtubules, Cytosol"		"CAB007793: AB_562291, HPA041598: AB_2677571"	"unprognostic (3.37e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.83e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (4.04e-2)"	"unprognostic (6.76e-2)"	"unprognostic (5.87e-3)"	"unprognostic (3.81e-2)"	32.4	26.3	17.9	16.2	18.8	46.0	23.7	26.4	23.3	17.1	22.2	21.7	15.3	18.8	8.9	38.2	18.7	10.1	118.5	19.7	17.6	21.8	14.9	16.0	15.5	22.2	20.9	19.7	13.6	15.7	15.5	11.3	19.6	27.4	14.7	19.2	22.2	15.5	319.4	20.7	19.9	16.7	16.4	18.5	23.2	6.1	20.2	14.7	15.9	201.6	14.4	24.3	23.2	18.3	67.3	26.3	19.0	26.3	43.2	16.9	37.6	45.5	31.7	46.8	54.3	25.8	21.3	28.0	27.0	44.7	12.4	46.6	32.0	57.7	40.6	17.4	46.5	23.1	33.3	23.1	24.3	25.4	15.9	41.8	27.2	30.2	25.4	40.5	39.8	28.8	16.4	36.1	59.4	25.4	31.8	21.9	10.2	29.0	29.8	26.6	33.2	27.5	46.7	70.6	11.8	16.4	40.5	52.1	10.4	25.2	27.7	26.1	31.0	57.1	22.0	26.1	50.5	29.8	33.1	13.5	58.3	22.2	13.1	7.7	9.4	6.6	7.0	5.3	8.6	5.2	6.0	6.5	13.4	3.9	4.7	4.4	3.7	10.6	8.0	7.2	8.6	7.1	17.9	18.8	26.4	23.3	19.7	17.6	22.2	20.9	19.6	16.4	20.2	18.3	3.5	0.0	14.2	21.9	5.9	5.1	3.7	11.7	11.4	4.2	7.3	5.5	67.9	2.8	5.8	0.0	16.7	7.6	6.8	13.2	0.0	8.1	0.3	6.9	8.9	7.1	7.2	4.8	14.7	6.9	31.7	5.0	12.8	11.9	4.5	6.7	9.7	5.2	8.3	0.0	16.6	9.2	4.1	7.0	5.7	0.7	5.3	7.2	7.2	4.7	9.8	3.3	10.3	8.5	6.9	11.8	8.2	5.7	9.7	5.4	9.2	6.0	6.2	11.7	0.0	5.0	7.3	1.3	2.9	15.3	4.1	4.0	5.2	3.8	11.7	3.3
GYS2		ENSG00000111713	"Glycogen synthase 2"	P54840	12	21536107-21604847	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"liver: 173.8"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 63.6"	"Cancer enriched"	"Detected in single"	29	"liver cancer: 12.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039482	Approved					NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"			"HPA039482: AB_10795107"	"unprognostic (7.22e-3)"	"unprognostic (2.85e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.68e-2)"	"unprognostic (3.16e-1)"	"prognostic favorable (7.62e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.66e-4)"	3.1	0.0	0.1	0.0	0.0	0.0	1.0	0.1	0.1	2.4	0.0	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.2	0.0	0.0	0.2	173.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	5.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.9	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.4	63.6	0.0	0.0	7.7	0.0	6.1	1.6	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	5.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
H6PD	"GDH, H6PDH"	ENSG00000049239	"Hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase"	O95479	1	9234774-9271337	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 164.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 68.9;ASC TERT1: 78.9;HSkMC: 77.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004824, HPA005440"	Approved		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		140000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA004824: AB_1079037, HPA005440: AB_1079036"	"unprognostic (4.83e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.16e-2)"	"unprognostic (7.35e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.95e-1)"	29.0	30.5	7.5	12.6	11.6	9.7	23.0	8.2	9.0	22.6	18.8	15.1	11.2	25.7	14.4	13.5	28.3	12.6	18.9	6.4	7.8	11.5	94.5	20.3	12.4	14.4	10.8	44.9	18.9	10.6	12.7	14.1	11.4	19.5	9.1	4.2	56.2	13.1	48.3	35.7	16.8	16.6	9.6	14.5	18.7	8.1	11.4	13.1	14.7	21.0	11.4	16.7	16.5	10.9	9.9	8.0	6.8	25.5	68.9	78.9	6.4	9.8	24.0	7.1	10.9	1.5	20.1	10.9	11.2	15.3	9.1	10.3	1.8	4.8	10.3	32.8	2.2	0.0	2.8	6.7	38.6	3.5	4.1	77.7	9.1	17.2	11.1	15.6	32.9	5.9	2.9	18.2	14.0	5.7	3.9	8.2	3.7	7.5	4.6	1.2	0.9	9.3	9.1	4.0	2.3	12.0	12.9	10.0	12.0	4.7	7.5	17.4	32.9	24.3	3.9	6.2	2.8	24.1	7.6	2.5	40.8	15.6	15.7	1.6	2.3	0.3	1.6	2.4	1.3	1.3	1.2	1.5	1.0	1.6	1.2	1.1	1.5	1.2	2.3	1.4	1.1	1.5	7.5	11.6	8.2	9.0	6.4	7.8	14.4	10.8	11.4	9.6	11.4	10.9	24.1	25.6	29.5	17.9	10.1	14.3	13.2	16.9	18.8	19.6	10.3	8.3	17.5	58.6	18.8	20.2	27.1	11.2	9.1	16.6	0.0	22.9	0.8	11.2	36.0	19.8	7.8	9.0	8.4	21.3	8.5	33.6	5.6	15.5	3.8	29.9	19.6	164.0	12.1	16.8	9.1	15.1	8.2	25.4	11.4	2.9	48.1	14.2	12.4	13.1	51.6	10.4	19.6	16.6	18.6	20.0	17.0	36.9	4.5	17.2	23.1	7.4	19.1	10.9	0.0	50.5	11.7	4.6	5.5	10.5	12.8	5.9	11.6	26.1	23.6	14.2
HAAO		ENSG00000162882	"3-hydroxyanthranilate 3,4-dioxygenase"	P46952	2	42767089-42792593	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 295.8"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 209.8;Proximal enterocytes: 236.8;Proximal tubular cells: 162.7"	"Group enriched"	"Detected in all"	5	"liver cancer: 46.5;renal cancer: 13.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 23.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 23.2;granulocytes: 19.2;monocytes: 17.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.0;Hep G2: 49.4;REH: 9.9;THP-1: 9.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036394, HPA042024"	Enhanced					NA	NA		580000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036394: AB_10673131, HPA042024: AB_2677803"	"unprognostic (6.97e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.23e-3)"	"prognostic favorable (5.77e-4)"	"unprognostic (6.20e-2)"	"unprognostic (7.58e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.03e-1)"	8.7	5.4	1.8	5.9	2.1	4.1	12.9	2.1	2.5	16.0	3.3	13.2	23.1	10.5	14.5	6.0	10.6	6.1	7.0	1.8	2.3	41.8	295.8	5.7	6.1	2.0	2.5	14.0	26.3	2.9	4.5	8.5	2.3	10.1	11.6	0.3	3.8	11.3	2.4	5.0	40.8	4.7	2.1	5.4	9.6	1.8	2.1	4.0	5.8	3.2	4.5	15.8	9.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	4.6	14.0	0.1	0.0	0.1	0.6	0.0	0.0	4.7	0.0	0.8	0.0	1.4	5.6	0.0	49.4	0.4	1.9	0.1	2.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	2.6	0.2	0.0	9.9	1.1	0.3	0.0	0.0	0.1	0.0	0.6	1.0	0.0	1.3	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	7.9	17.4	19.2	0.0	10.5	0.0	3.5	0.0	0.0	23.2	3.9	0.0	0.1	5.5	0.7	2.9	7.7	0.0	5.6	1.8	2.1	2.1	2.5	1.8	2.3	2.0	2.5	2.3	2.1	2.1	2.3	2.5	0.0	1.1	3.6	3.5	4.0	6.3	2.3	14.8	0.1	2.9	7.6	0.6	14.3	1.6	1.8	0.0	1.1	2.9	18.3	17.6	7.4	0.0	0.6	8.1	1.9	6.7	12.0	3.4	13.3	0.5	18.0	1.5	0.3	30.4	1.2	4.6	209.8	21.3	0.0	2.2	14.9	0.0	13.5	4.9	0.2	12.5	8.7	5.4	8.4	8.4	3.6	1.0	5.5	1.0	4.8	28.7	10.5	0.5	2.1	236.8	162.7	0.5	0.3	13.1	37.7	13.8	0.4	0.7	6.0	4.8	1.2	1.2	2.2	25.5	2.7
HABP2	"FSAP, HABP, HGFAL, PHBP"	ENSG00000148702	"Hyaluronan binding protein 2"	Q14520	10	113550837-113589602	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 437.3"	"Group enriched"	"Detected in some"	5	"Cholangiocytes: 124.4;Hepatocytes: 221.4"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 92.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"OE19: 64.7;RPTEC TERT1: 50.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019518	Uncertain				"Secreted to blood"	NA	NA	20200000000	4400000000		"Cluster 62: Liver - Hemostasis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA019518: AB_1850467"	"unprognostic (3.89e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (9.78e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.77e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.62e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.22e-1)"	"unprognostic (9.05e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.9	0.9	0.0	0.0	3.1	2.9	1.7	0.0	2.2	36.0	3.8	0.1	0.0	14.2	437.3	0.8	0.0	0.0	0.0	0.0	17.3	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.1	12.1	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	64.7	0.0	0.0	0.1	0.0	50.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	2.3	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	124.4	0.0	1.8	0.0	0.0	0.0	0.0	3.9	31.4	0.5	10.8	0.8	0.4	0.0	5.3	1.0	3.9	0.0	0.0	17.9	6.5	0.0	0.0	5.3	221.4	1.0	0.0	0.0	0.2	0.0	5.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	12.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.1
HACD1	"CAP, PTPLA"	ENSG00000165996	"3-hydroxyacyl-CoA dehydratase 1"	B0YJ81	10	17589032-17617374	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Developmental protein, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 73.0"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 143.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"T-reg: 55.7"	"Lineage enriched"	"Detected in many"	12	"T-cells: 55.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (2.73e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.10e-1)"	"unprognostic (5.67e-3)"	"unprognostic (4.21e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.49e-2)"	9.7	7.0	3.1	5.0	3.5	8.0	8.8	10.7	4.6	6.8	2.9	31.9	2.8	22.1	3.3	7.8	10.3	3.6	73.0	3.0	6.5	5.0	1.6	9.7	1.3	5.5	5.2	4.3	2.7	0.5	3.7	1.6	5.0	11.9	3.8	2.3	2.7	16.7	36.5	3.0	6.9	25.4	2.4	1.7	15.0	3.5	4.7	2.6	7.6	16.5	1.2	18.1	6.8	8.4	29.3	24.6	6.8	33.4	30.1	5.8	0.6	40.5	24.4	51.9	48.5	16.4	34.6	0.2	5.9	66.4	74.5	7.1	17.3	12.3	28.6	19.1	10.4	67.1	18.4	45.6	39.0	0.3	4.8	14.0	17.2	29.9	11.6	39.8	10.1	35.1	0.6	1.3	69.0	21.0	50.4	6.7	14.6	2.2	6.6	44.7	7.1	0.8	20.5	5.6	7.5	19.1	34.6	0.6	58.9	21.2	24.2	16.7	9.8	30.3	17.4	18.7	18.8	0.9	0.8	0.3	22.3	7.7	4.3	4.7	0.9	0.7	1.2	0.1	0.3	0.4	5.0	1.0	3.0	1.3	0.9	0.7	2.6	3.3	0.3	1.5	55.7	1.3	3.1	3.5	10.7	4.6	3.0	6.5	5.5	5.2	5.0	2.4	4.7	8.4	2.4	28.9	15.0	0.3	0.4	0.0	23.1	0.0	8.0	0.8	6.9	21.6	143.7	10.0	2.5	31.3	0.0	0.5	4.4	0.4	3.9	16.5	11.1	5.6	8.0	5.4	3.6	29.2	10.4	8.0	1.9	7.1	8.2	12.4	6.3	17.5	20.7	1.0	5.4	0.0	11.7	2.5	0.0	2.2	0.0	2.7	1.8	3.6	0.0	5.6	0.8	0.5	1.0	2.5	31.8	15.6	0.8	0.7	0.6	23.9	0.5	2.3	0.7	0.6	0.0	5.7	32.5	7.4	5.2	17.7	0.0	3.0	2.9	10.8	3.5	6.2
HACE1	KIAA1320	ENSG00000085382	"HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1"	Q8IYU2	6	104728094-104859919	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 30.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 45.9;Excitatory neurons: 118.8;Inhibitory neurons: 84.2;Microglial cells: 45.9;Oligodendrocyte precursor cells: 64.3;Oligodendrocytes: 74.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046071			Supported	"Nuclear bodies,Endoplasmic reticulum"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"	"Nuclear bodies"	"HPA046071: AB_2679524"	"unprognostic (6.32e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.22e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.75e-1)"	3.7	3.2	2.7	2.2	4.4	2.9	3.1	5.0	4.8	3.9	0.4	2.6	2.1	3.9	1.1	5.3	3.3	3.1	3.3	3.1	2.5	6.2	1.6	3.6	2.2	1.9	2.6	3.8	1.9	7.2	1.5	30.6	2.3	3.7	1.8	11.5	2.9	4.1	2.2	2.5	2.1	4.0	1.4	2.5	2.4	10.4	3.1	3.9	4.5	4.1	2.4	3.3	2.9	5.8	3.9	2.7	11.3	14.3	6.6	8.8	13.3	7.7	11.9	4.8	7.2	2.5	2.3	2.2	3.4	5.9	8.1	2.6	2.8	5.3	10.0	9.1	7.2	7.7	2.5	3.4	6.6	6.8	2.5	5.9	4.7	6.2	5.2	6.3	8.0	9.2	7.6	2.4	9.6	2.8	5.1	4.1	5.0	2.9	2.6	8.0	12.8	0.9	3.8	6.6	6.1	9.1	4.2	4.3	2.3	7.3	2.7	9.2	8.5	3.9	3.2	10.5	7.4	3.5	4.1	7.6	4.0	6.4	7.1	0.0	0.6	0.7	1.2	1.0	1.3	0.9	1.1	1.1	0.6	0.8	1.2	0.9	0.1	0.8	0.5	0.8	0.4	0.5	2.7	4.4	5.0	4.8	3.1	2.5	1.9	2.6	2.3	1.4	3.1	5.8	11.6	3.2	1.1	42.4	5.1	4.7	2.3	2.3	5.2	11.6	5.3	3.7	6.7	1.5	3.9	5.5	45.9	10.6	4.1	1.5	1.9	1.6	6.2	2.7	6.2	12.9	1.8	3.0	118.8	1.5	5.4	7.1	5.6	3.4	1.3	7.1	4.2	2.6	5.7	16.8	84.2	2.0	0.0	4.1	2.4	4.6	6.2	3.5	1.8	45.9	4.3	6.1	8.2	64.3	74.6	1.4	2.9	3.8	3.7	1.6	3.8	5.7	2.6	31.7	6.6	6.4	6.6	13.2	3.5	5.3	4.7	6.3	6.2	2.9	1.9	1.9
HADHA	"GBP, LCEH, LCHAD, MTPA"	ENSG00000084754	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha"	P40939	2	26190635-26244672	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 502.5"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 527.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015536, HPA056070"	Approved		Enhanced	Mitochondria		NA	NA		470000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Mitochondria		"HPA015536: AB_1850473, HPA056070: AB_2683026"	"unprognostic (2.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.87e-3)"	"unprognostic (2.64e-2)"	105.0	125.3	57.7	31.1	60.7	46.3	94.9	65.0	69.6	72.6	59.1	108.4	115.0	61.8	30.7	90.1	60.1	32.4	330.2	52.8	61.9	99.0	156.7	66.9	35.3	64.4	62.2	77.8	101.4	95.0	57.4	39.2	64.2	60.2	76.1	14.9	77.9	33.4	502.5	95.7	106.2	57.4	61.8	68.4	93.8	49.0	62.4	46.7	59.5	300.7	58.5	79.1	73.6	67.2	105.7	88.1	58.4	90.8	221.1	139.9	51.5	80.6	84.7	78.5	67.7	114.7	104.1	71.7	50.2	138.4	78.6	66.8	103.4	152.6	72.5	139.1	103.6	103.3	86.2	197.9	73.3	132.2	69.2	142.7	101.6	112.4	109.3	82.8	127.7	70.4	140.2	133.2	101.1	128.2	63.4	137.7	50.1	77.5	134.1	52.9	128.5	143.7	90.3	125.3	41.9	85.1	94.6	104.6	102.4	44.5	52.2	125.8	127.1	48.8	70.7	69.9	58.0	44.8	86.5	113.4	77.6	150.2	56.2	22.5	84.0	33.5	31.8	92.3	39.1	40.5	36.8	38.7	80.8	31.2	42.6	40.1	20.9	38.8	86.1	31.3	50.9	89.9	57.7	60.7	65.0	69.6	52.8	61.9	64.4	62.2	64.2	61.8	62.4	67.2	122.4	89.8	99.0	47.0	101.2	89.0	137.5	139.9	97.3	35.6	89.7	96.4	349.9	82.9	128.0	77.3	52.1	182.0	95.1	242.1	131.0	120.8	39.2	73.3	121.1	99.1	91.4	155.9	22.8	108.5	94.7	96.1	100.4	85.5	139.9	140.3	84.3	185.1	163.0	20.2	28.2	156.5	89.5	136.8	106.0	74.3	92.6	145.0	81.8	12.2	170.7	65.4	93.7	30.7	37.4	90.0	195.6	84.2	90.4	76.2	527.4	182.5	84.8	62.3	52.6	129.9	109.6	147.9	54.9	136.5	103.3	129.2	100.5	154.7	216.7	104.4
HADHB	MTPB	ENSG00000138029	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta"	P55084	2	26243170-26290465	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 793.3;skeletal muscle: 950.6;tongue: 1097.1"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1167.5;Distal tubular cells: 520.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037539, HPA037540, HPA066099"	Enhanced		Supported	Mitochondria		No	No		61000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA037539: AB_10671374, HPA037540: AB_2675531, HPA066099: AB_2685618"	"unprognostic (5.15e-2)"	"unprognostic (8.72e-2)"	"unprognostic (8.21e-2)"	"unprognostic (8.67e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.59e-2)"	"unprognostic (7.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (1.37e-9)"	"unprognostic (2.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.68e-2)"	127.0	224.7	120.6	51.1	135.4	58.8	91.3	146.4	138.1	65.2	128.0	110.7	224.2	55.9	73.7	101.3	68.8	64.3	793.3	109.0	138.1	231.4	324.8	64.7	54.9	135.9	141.6	78.4	83.7	209.5	48.1	65.6	139.6	77.1	113.2	63.0	104.8	75.0	950.6	74.4	184.4	79.0	141.4	75.8	109.0	67.1	143.3	53.1	90.8	1097.1	62.5	89.2	64.1	152.8	108.2	83.2	56.6	102.2	342.1	190.1	57.9	89.0	134.6	89.0	86.8	100.5	101.7	53.9	60.8	145.3	100.1	82.8	95.2	124.8	109.2	121.1	83.1	123.6	44.9	194.2	145.9	100.6	90.0	183.7	201.6	92.7	149.0	151.0	168.2	81.0	105.2	83.9	189.5	78.0	57.1	190.7	39.8	160.2	89.0	61.7	188.3	103.2	183.3	148.9	27.2	93.7	151.7	169.8	239.5	68.5	105.4	177.9	118.0	83.5	86.9	79.3	65.1	62.6	101.1	94.7	95.5	158.4	84.4	95.7	168.1	66.4	45.2	150.3	57.6	65.5	61.3	56.6	154.2	49.7	55.8	51.3	72.7	88.2	123.3	51.8	94.7	135.6	120.6	135.4	146.4	138.1	109.0	138.1	135.9	141.6	139.6	141.4	143.3	152.8	106.5	48.1	36.5	63.0	48.3	62.1	136.5	183.3	49.5	29.3	49.5	52.3	1167.5	104.4	107.7	97.5	56.3	227.9	42.4	129.5	520.4	124.0	93.4	59.5	49.0	75.2	74.9	85.2	32.7	57.2	75.2	79.5	53.0	60.2	62.8	94.2	69.9	277.6	139.6	13.5	33.0	93.4	114.0	98.1	67.4	99.7	56.5	78.1	88.9	27.2	110.2	65.0	32.0	35.2	47.5	58.4	134.8	62.8	37.1	60.5	376.0	321.1	73.5	80.0	72.3	72.9	80.7	120.4	49.4	53.8	54.7	186.6	45.2	194.0	113.5	110.3
HAL	HIS	ENSG00000084110	"Histidine ammonia-lyase"	P42357	12	95972662-95996365	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"liver: 198.2;skin 1: 61.1"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 129.6"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 23.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basophil: 56.9;neutrophil: 73.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 73.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;NB-4: 2.8;THP-1: 11.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038547, HPA038548"	Enhanced		Approved	Cytosol		NA	NA		280000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol		"HPA038547: AB_10669541, HPA038548: AB_10673175"	"unprognostic (3.39e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.87e-2)"	1.4	0.3	0.1	2.9	0.1	11.5	2.2	0.1	0.4	0.8	0.1	0.5	0.6	0.4	0.0	1.0	0.7	0.6	0.3	0.1	0.1	0.3	198.2	2.3	0.5	0.1	0.1	0.2	0.9	0.1	3.0	0.4	0.1	0.2	0.4	0.0	0.6	0.1	0.2	61.1	0.8	0.5	0.0	7.6	0.4	0.1	0.1	0.5	0.2	0.6	1.4	0.5	1.4	0.2	0.4	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.4	0.4	0.0	0.6	0.3	0.2	0.1	0.2	0.3	0.0	0.1	0.1	0.0	0.1	2.8	0.9	0.1	0.4	0.2	0.1	0.0	0.1	0.6	0.1	0.3	0.3	0.0	0.0	0.0	0.0	11.4	0.1	0.1	0.1	0.1	0.1	0.4	0.5	0.1	0.0	1.7	0.0	56.9	15.1	2.4	0.0	5.7	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	73.3	0.7	13.6	0.3	0.2	4.4	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.0	1.1	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.7	2.8	0.3	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.1	3.2	2.0	0.4	0.0	9.7	0.2	0.2	0.7	0.1	0.5	15.0	0.0	0.1	2.5	129.6	0.3	0.0	0.1	0.1	0.0	7.7	0.8	0.0	0.0	3.5	0.0	0.0	6.3	0.0	1.0	0.0	0.0	0.0	1.3	0.0	0.4	0.2	1.2	0.7	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	2.8	0.0	0.6	0.0	0.3	0.1
HAMP	"HEPC, HFE2B, LEAP-1, LEAP1"	ENSG00000105697	"Hepcidin antimicrobial peptide"	P81172	19	35280716-35285143	"Disease related genes, Human disease related genes, Potential drug targets, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide, Hormone"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 2054.8"	"Cell type enriched"	"Detected in many"	17	"Hepatocytes: 3227.7"	"Group enriched"	"Detected in many"	12	"glioma: 6.5;liver cancer: 16.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"myeloid DC: 1.5;plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.6"	"Cell line enriched"	"Detected in some"	440	"Hep G2: 448.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	1900000	10000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (5.53e-2)"	"unprognostic (5.02e-4)"	"unprognostic (2.10e-3)"	"unprognostic (4.69e-3)"	"unprognostic (5.35e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.92e-2)"	"unprognostic (9.36e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.61e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.68e-7)"	"unprognostic (4.11e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.77e-2)"	1.0	1.2	17.7	2.0	17.6	5.4	1.5	17.4	30.4	2.3	20.8	0.8	0.9	0.3	0.6	0.5	2.8	0.6	415.0	17.8	20.2	1.1	2054.8	3.2	4.0	48.0	24.9	3.2	88.0	0.4	5.8	2.3	25.8	2.7	0.0	4.2	1.2	1.3	1.2	1.1	0.5	1.0	21.5	1.1	1.1	0.7	18.7	0.1	0.4	0.2	4.4	1.6	0.2	21.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.7	448.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.7	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.4	0.0	4.6	0.0	0.0	17.7	17.6	17.4	30.4	17.8	20.2	48.0	24.9	25.8	21.5	18.7	21.0	0.8	0.0	0.0	0.0	5.7	0.5	1.5	0.0	0.0	0.0	26.2	8.0	1.7	30.0	0.6	0.0	0.0	0.9	0.6	0.1	0.0	0.4	0.0	1.9	1.0	13.7	0.0	89.7	0.2	99.0	1.2	0.4	10.7	1.8	75.7	0.7	45.3	3227.7	187.9	0.0	0.0	0.7	0.0	63.2	1.2	0.0	0.0	28.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1	22.6	0.1	0.0	0.1	4.2	0.0	0.1	0.0	0.6	0.0	0.2	0.6	0.0	0.0	0.0	18.6	0.7	4.3	0.5	0.2	2.2
HARS1	"HARS, HisRS, USH3B"	ENSG00000170445	"Histidyl-tRNA synthetase 1"	P12081	5	140673035-140691537	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Charcot-Marie-Tooth disease, Deafness, Disease variant, Neurodegeneration, Neuropathy, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 41.4;dendritic cells: 11.5;Extravillous trophoblasts: 48.6;Hofbauer cells: 35.7;Syncytiotrophoblasts: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036539	Approved		Enhanced	Cytosol		NA	NA		190000	"Cluster 27: Non-specific - Gene expression"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA036539: AB_10669796"	"unprognostic (9.35e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (1.96e-7)"	"unprognostic (6.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.36e-1)"	31.6	39.9	64.8	27.1	67.0	24.3	29.3	64.9	88.7	32.9	57.9	39.2	21.8	34.5	27.1	42.9	30.8	21.0	38.3	67.8	72.2	30.7	47.3	27.2	29.6	71.2	69.9	31.3	40.8	37.1	60.0	18.5	72.8	33.0	29.6	18.5	29.2	32.0	56.7	53.9	28.6	35.2	62.1	32.2	36.0	25.6	77.4	32.2	27.1	33.4	36.8	34.3	32.0	71.9	66.8	94.3	55.5	120.5	68.9	74.9	57.9	104.8	75.0	118.6	109.4	174.8	54.1	88.4	90.3	118.3	94.3	66.6	85.9	169.2	111.6	74.5	105.0	63.7	115.4	111.8	86.3	101.1	49.8	80.4	51.5	129.0	72.6	69.5	122.1	52.2	56.5	68.6	125.6	111.0	71.8	100.6	43.3	52.3	60.9	65.4	82.0	70.9	97.0	82.2	86.5	83.7	86.1	121.5	84.2	54.9	89.5	55.5	100.3	107.8	41.6	61.5	144.7	68.5	90.5	89.4	82.8	83.1	76.1	16.2	31.2	24.0	61.0	46.3	54.2	34.9	54.1	57.6	48.5	34.6	58.1	55.4	8.1	59.3	54.9	34.3	51.3	56.7	64.8	67.0	64.9	88.7	67.8	72.2	71.2	69.9	72.8	62.1	77.4	71.9	9.6	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	41.4	11.5	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	48.6	6.1	0.0	0.0	0.0	0.0	0.0	0.0	35.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	36.0	1.7	0.0	0.0	0.0
HARS2	"HARSL, HARSR, HO3"	ENSG00000112855	"Histidyl-tRNA synthetase 2, mitochondrial"	P49590	5	140691430-140699305	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035941, HPA075303"	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA035941: AB_10671237, HPA075303: "	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.15e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.30e-3)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (7.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.31e-2)"	19.6	24.6	14.0	13.8	14.2	14.4	18.9	13.7	14.2	22.0	16.8	23.5	16.6	19.5	15.0	20.0	18.4	9.8	27.9	14.0	14.2	23.3	19.3	16.0	15.1	14.1	14.0	21.1	15.6	20.8	20.8	14.2	14.4	20.2	22.3	11.5	17.5	13.4	35.0	21.1	20.9	14.0	13.8	26.9	20.4	14.8	14.3	15.2	19.0	28.4	16.1	21.1	20.6	15.7	20.9	46.2	19.6	50.6	21.9	28.6	32.3	26.3	29.8	36.1	31.4	42.7	25.5	26.3	41.3	29.3	35.5	25.9	27.3	49.4	33.2	26.6	22.4	19.1	45.3	28.6	20.9	26.1	27.1	27.0	32.9	35.3	39.7	29.4	26.5	27.4	18.0	24.1	35.6	26.6	25.7	32.1	22.6	15.7	28.9	25.8	19.9	26.8	33.9	48.1	27.0	38.9	38.1	61.0	54.2	28.5	54.0	25.5	32.5	32.4	17.8	18.2	35.2	23.6	37.0	25.2	25.4	29.5	32.9	37.7	13.1	28.6	19.1	18.9	21.1	16.9	18.4	19.2	14.9	14.8	19.0	20.6	15.1	29.3	15.0	12.1	20.1	13.3	14.0	14.2	13.7	14.2	14.0	14.2	14.1	14.0	14.4	13.8	14.3	15.7	8.6	3.2	5.8	2.6	12.3	3.4	3.7	7.8	9.6	5.5	5.9	5.5	20.4	7.2	7.8	5.5	0.0	20.3	6.6	8.5	13.7	14.9	1.1	5.3	8.0	9.7	7.7	9.9	5.5	16.1	18.7	6.3	13.3	6.4	2.5	11.8	9.7	7.2	10.0	0.0	4.8	8.7	18.3	8.2	6.2	2.3	9.3	7.4	3.6	2.8	12.8	8.3	3.1	6.0	6.2	18.3	12.1	10.5	9.6	4.1	7.2	9.0	8.6	5.6	0.0	4.4	7.0	8.9	14.4	9.5	4.0	14.4	8.0	11.2	11.7	4.4
HAS2		ENSG00000170961	"Hyaluronan synthase 2"	Q92819	8	121612116-121641440	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 22.7;urinary bladder: 20.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 54.1;Fibroblasts: 62.1;Langerhans cells: 28.9;Melanocytes: 30.2;Smooth muscle cells: 30.7;Urothelial cells: 89.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HBF TERT88: 157.8;hTEC/SVTERT24-B: 153.8;LHCN-M2: 206.5;U-138 MG: 396.9;U-251 MG: 123.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA052060			Approved	"Nuclear speckles"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"		"HPA052060: AB_2681712"	"unprognostic (7.01e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.57e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-7)"	"unprognostic (1.47e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.54e-3)"	22.7	0.3	0.6	9.0	0.5	0.1	5.3	0.6	0.5	0.7	0.1	4.1	2.8	0.8	1.2	1.6	1.7	7.8	4.0	0.5	1.5	1.1	2.9	3.7	1.6	1.6	2.1	0.2	0.9	0.2	0.3	2.3	1.3	1.1	5.6	0.0	1.0	0.2	0.5	2.3	5.2	3.9	1.1	0.1	2.0	1.8	1.3	0.8	0.7	0.9	0.9	20.5	0.6	0.9	0.3	2.8	0.0	0.4	4.7	11.8	0.0	23.5	17.3	29.9	51.2	0.2	0.4	0.1	0.0	20.8	0.0	4.2	0.0	0.0	157.8	0.1	0.6	0.0	0.6	0.0	19.9	0.0	0.0	31.0	0.0	153.8	14.1	0.7	0.0	0.0	0.0	0.0	206.5	0.3	0.0	0.0	0.4	0.0	3.4	0.0	26.6	0.0	0.0	2.0	0.0	0.4	10.0	0.0	5.6	9.0	0.2	0.3	0.0	396.9	1.4	37.7	123.7	0.0	0.0	0.0	8.5	0.1	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.6	0.5	0.5	1.5	1.6	2.1	1.3	1.1	1.3	0.9	2.2	0.0	0.0	0.0	0.0	16.3	54.1	1.8	0.6	0.0	0.1	0.4	1.2	0.0	0.2	3.7	0.0	0.2	0.2	1.6	0.0	0.9	19.0	0.1	3.5	7.2	1.2	0.0	0.1	0.0	0.0	62.1	1.1	0.1	13.4	0.0	0.7	0.0	0.3	0.0	0.2	2.3	0.0	0.0	28.9	3.4	1.8	0.7	30.2	0.0	0.0	0.0	0.0	16.1	0.2	1.6	1.9	0.0	0.0	11.0	0.0	0.1	0.0	0.0	0.0	6.9	30.7	0.3	0.1	0.6	11.9	0.1	1.5	0.0	3.9	89.3
HCCS	"CCHL, MLS"	ENSG00000004961	"Holocytochrome c synthase"	P53701	X	11111301-11123086	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002946	Approved		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"HPA002946: AB_1079041"	"prognostic unfavorable (8.69e-5)"	"unprognostic (6.89e-3)"	"unprognostic (8.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.44e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (9.18e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (6.17e-8)"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.93e-2)"	13.9	16.1	6.2	13.7	6.7	20.5	12.6	7.0	8.4	8.4	8.4	21.6	23.1	9.6	7.6	19.3	8.5	10.8	39.0	7.4	6.8	17.6	22.9	11.5	15.6	6.7	6.2	8.3	9.9	25.1	8.3	13.1	6.4	9.5	21.6	13.5	15.2	10.0	64.4	17.6	20.2	12.5	6.2	14.5	15.3	10.2	6.7	13.0	10.8	57.0	17.1	22.3	11.6	6.1	54.3	60.5	31.8	28.5	25.6	25.2	29.2	52.0	43.0	67.8	57.5	70.7	38.5	34.3	26.3	46.1	80.8	49.8	63.2	51.8	70.5	30.8	48.0	34.1	80.8	38.6	47.3	40.9	39.4	24.2	37.4	67.9	46.5	37.9	49.1	26.1	63.1	41.1	46.3	72.5	28.0	31.4	51.5	36.6	70.1	27.3	59.9	65.4	44.0	44.8	20.9	24.2	54.8	58.7	38.2	66.7	45.6	27.1	48.7	42.4	23.6	110.4	47.0	26.9	29.0	47.8	35.5	28.8	42.7	25.6	47.8	30.1	20.2	66.4	19.0	39.0	19.6	18.2	62.2	34.7	17.1	22.1	13.1	19.1	57.4	56.2	23.5	19.0	6.2	6.7	7.0	8.4	7.4	6.8	6.7	6.2	6.4	6.2	6.7	6.1	15.5	6.4	4.8	2.3	20.8	54.8	53.2	57.0	22.8	5.3	16.1	13.7	49.3	17.2	33.3	16.5	0.0	32.9	12.4	44.6	50.9	34.9	13.7	19.0	10.4	21.0	10.8	32.8	3.8	29.3	37.9	17.1	12.8	16.7	13.3	10.4	15.7	18.5	41.8	8.4	4.5	19.2	67.1	21.0	44.1	2.3	13.4	23.5	24.9	1.9	27.9	13.0	7.2	2.0	2.7	68.4	31.9	10.5	18.4	63.5	46.4	36.0	28.9	7.1	6.6	12.5	20.1	24.4	28.4	21.8	46.0	40.9	12.0	15.6	30.2	88.6
HCK	JTK9	ENSG00000101336	"HCK proto-oncogene, Src family tyrosine kinase"	P08631	20	32052197-32101856	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Exocytosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Phagocytosis"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 112.1"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 150.7;Kupffer cells: 155.5;Langerhans cells: 89.2;Macrophages: 170.1;Microglial cells: 52.5;monocytes: 222.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"classical monocyte: 575.0;eosinophil: 707.8;intermediate monocyte: 1059.1;myeloid DC: 336.3;neutrophil: 801.3;non-classical monocyte: 1251.7"	"Group enriched"	"Detected in all"	16	"dendritic cells: 336.3;granulocytes: 801.3;monocytes: 1251.7"	"Group enriched"	"Detected in some"	9	"THP-1: 69.3;U-937: 199.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB005195, HPA035534, HPA063768"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	"Plasma membrane, Cytosol"	"CAB005195: AB_631619, HPA035534: , HPA063768: AB_2685118"	"unprognostic (6.22e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.98e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (4.92e-2)"	"unprognostic (4.42e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.12e-1)"	24.8	9.2	4.7	100.0	5.0	55.2	6.0	5.5	6.0	5.5	13.7	12.8	15.2	3.1	2.6	6.7	7.6	14.4	4.8	4.7	6.2	4.7	14.1	46.0	38.6	9.9	6.8	2.5	4.5	2.1	3.1	20.9	8.3	4.0	13.6	0.5	5.1	4.7	1.6	5.8	17.8	25.3	8.1	112.1	6.7	2.3	8.4	14.5	2.8	6.9	39.3	32.8	4.1	12.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.9	0.0	0.1	0.1	1.3	0.0	0.0	0.1	0.0	4.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	15.6	0.0	0.1	0.1	4.9	0.4	0.0	0.0	0.4	0.2	0.6	0.0	0.0	0.3	0.0	0.5	0.0	0.2	0.7	0.0	69.3	0.0	0.0	0.3	0.0	0.1	1.9	0.3	10.3	0.0	199.6	0.0	6.4	575.0	707.8	1.1	1059.1	1.3	48.4	1.1	1.1	336.3	43.0	1.1	0.9	801.3	11.0	1251.7	30.4	1.2	566.4	4.7	5.0	5.5	6.0	4.7	6.2	9.9	6.8	8.3	8.1	8.4	12.0	0.6	6.4	14.0	0.0	17.1	3.1	4.0	0.2	0.6	0.1	0.4	1.3	2.0	1.5	3.9	7.3	0.0	0.9	12.1	0.2	1.9	0.1	2.5	0.1	0.1	3.7	1.8	1.7	1.2	0.6	0.9	1.3	4.6	0.1	6.3	0.1	1.1	2.3	150.7	0.0	1.0	0.5	22.4	155.5	89.2	0.3	0.0	170.1	1.8	52.5	222.0	0.0	4.1	1.5	0.6	0.0	0.0	0.0	0.7	0.5	0.1	0.3	1.5	0.1	0.0	0.6	0.5	0.2	0.3	0.2	1.1	1.6	3.0	0.2	0.9	3.7
HCN1	"BCNG-1, BCNG1, HAC-2"	ENSG00000164588	"Hyperpolarization activated cyclic nucleotide gated potassium channel 1"	O60741	5	45254948-45696498	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"brain: 7.2;retina: 17.6"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 671.7;Inhibitory neurons: 766.5;Rod photoreceptor cells: 199.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 7.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"WM-115: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019195	Enhanced					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA019195: AB_2670094"	"unprognostic (1.30e-1)"		"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.24e-3)"			"unprognostic (6.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.63e-3)"	"unprognostic (4.11e-3)"		"unprognostic (6.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.68e-3)"		0.0	0.4	1.8	0.0	2.5	0.1	0.0	2.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.5	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.5	2.4	7.2	2.5	1.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	24.5	0.0	0.1	0.1	0.0	0.0	29.4	0.0	0.0	7.4	0.0	0.0	0.0	133.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	671.7	0.7	0.0	0.6	0.0	0.1	0.0	0.6	0.0	0.0	0.0	6.7	766.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.5	0.0	14.8	0.0	21.1	14.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	199.4	0.0	0.3	0.1	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3
HCN4		ENSG00000138622	"Hyperpolarization activated cyclic nucleotide gated potassium channel 4"	Q9Y3Q4	15	73319859-73368958	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Brugada syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"brain: 8.5;heart muscle: 8.4;testis: 7.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 29.4;Late spermatids: 49.5"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 3.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CACO-2: 1.7;HDLM-2: 1.1;NTERA-2: 4.9;SuSa: 1.2;U-2 OS: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA073174	Approved					NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA073174: "	"unprognostic (2.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.14e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.05e-5)"	"unprognostic (5.56e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (7.95e-2)"	0.0	0.4	3.6	0.0	0.7	0.0	0.0	2.2	1.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	8.4	1.0	2.8	0.0	0.0	0.0	0.0	5.0	4.2	0.0	0.1	0.0	0.5	0.0	4.6	0.1	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.0	2.5	0.0	0.1	7.2	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.7	2.2	1.8	1.0	2.8	5.0	4.2	4.6	2.5	8.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	29.4	0.6	0.0	0.2	1.8	0.0	1.5	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	49.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.3	1.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HECW2	"KIAA1301, NEDL2"	ENSG00000138411	"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2"	Q9P2P5	2	196189099-196593684	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 331.5;Hepatic stellate cells: 99.2;Inhibitory neurons: 375.4;Oligodendrocyte precursor cells: 143.2;Oligodendrocytes: 460.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.7;non-classical monocyte: 3.7"	"Group enriched"	"Detected in many"	8	"granulocytes: 4.7;monocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 30.1;hTEC/SVTERT24-B: 16.3;HUVEC TERT2: 20.9;SCLC-21H: 31.6;TIME: 26.3;U-138 MG: 21.7"	"Low region specificity"	"Detected in all"							HPA034609	Enhanced					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA034609: AB_10669993"	"unprognostic (2.65e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.00e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.63e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (8.05e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.48e-2)"	4.1	1.5	2.4	1.2	3.5	0.1	1.7	4.4	6.1	2.2	0.0	0.4	0.4	0.8	0.3	3.1	3.5	2.1	8.1	3.3	0.0	1.6	2.7	5.3	2.0	1.1	0.8	0.2	0.6	4.3	1.2	7.4	2.1	0.4	0.4	2.7	0.9	0.5	1.4	0.8	0.5	1.3	0.0	6.0	0.9	3.5	1.7	0.8	3.8	3.5	2.4	1.0	0.6	8.2	0.1	1.4	2.3	0.0	1.4	4.2	1.6	2.7	7.3	2.1	2.6	0.3	0.1	1.4	0.5	13.4	3.3	3.2	0.9	0.1	4.5	30.1	1.6	0.0	2.3	0.2	0.2	0.5	0.3	1.0	1.3	16.3	5.7	4.1	20.9	0.0	0.2	0.1	6.7	1.8	0.0	0.7	2.5	0.2	1.0	0.0	0.5	0.0	0.1	0.0	31.6	2.5	2.0	0.5	0.0	0.4	0.1	0.2	26.3	21.7	1.4	4.6	0.7	0.2	0.0	1.3	5.4	0.1	0.2	0.1	0.3	0.8	0.0	1.1	0.0	0.4	0.0	0.0	0.4	0.5	0.0	0.0	4.7	0.0	3.7	0.0	0.0	0.1	2.4	3.5	4.4	6.1	3.3	0.0	1.1	0.8	2.1	0.0	1.7	8.2	61.2	0.0	12.1	12.7	3.6	2.2	0.3	0.1	3.4	9.5	1.1	0.8	18.7	0.0	0.1	0.0	0.0	0.2	0.7	0.6	0.0	0.1	11.1	0.4	1.6	34.2	2.4	0.0	331.5	0.0	0.3	4.2	0.5	0.3	1.3	4.9	99.2	1.5	0.1	0.0	375.4	0.6	0.0	7.2	3.0	5.3	0.0	1.4	3.6	14.0	1.2	12.0	0.0	143.2	460.7	0.1	0.0	2.6	3.4	0.4	0.0	0.1	1.0	1.1	0.0	1.2	2.2	0.5	6.1	9.2	1.6	0.1	1.4	0.7	0.1	0.6
HEPACAM	"FLJ25530, GLIALCAM"	ENSG00000165478	"Hepatic and glial cell adhesion molecule"	Q14CZ8	11	124919205-124936412	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Cell cycle, Growth arrest, Growth regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 222.6;choroid plexus: 79.7"	"Group enriched"	"Detected in some"	9	"Astrocytes: 184.8;Oligodendrocyte precursor cells: 72.9;Oligodendrocytes: 163.2"	"Cancer enriched"	"Detected in some"	12	"glioma: 29.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	30	"Hep G2: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017613, CAB025486"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"CAB025486: , HPA017613: AB_1850595"	"unprognostic (3.22e-3)"	"unprognostic (1.06e-2)"		"unprognostic (1.64e-1)"	"unprognostic (6.41e-2)"		"unprognostic (1.47e-1)"		"unprognostic (9.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.06e-6)"	"unprognostic (2.62e-1)"	"unprognostic (3.21e-1)"			15.6	0.3	172.8	0.2	203.3	0.0	2.5	170.4	162.1	0.2	79.7	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.2	163.2	156.1	0.1	16.2	0.0	0.2	222.6	182.8	0.0	0.0	0.0	0.8	0.0	183.6	0.2	0.2	1.8	0.2	0.5	0.1	0.0	0.2	0.1	205.7	0.0	0.1	0.2	182.0	0.0	0.0	0.3	0.6	0.0	0.1	212.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	25.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.2	172.8	203.3	170.4	162.1	163.2	156.1	222.6	182.8	183.6	205.7	182.0	212.2	0.1	0.0	0.0	184.8	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	11.2	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.6	0.0	15.5	0.0	72.9	163.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
HEPHL1	DKFZp686F22190	ENSG00000181333	"Hephaestin like 1"	Q6MZM0	11	94021354-94114208	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 4.5;lymphoid tissue: 9.5;skin 1: 3.8;vagina: 4.5"	"Cell type enriched"	"Detected in some"	5	"Basal keratinocytes: 10.5"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 20.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 1.4;HBEC3-KT: 2.6"	"Region enriched"	"Detected in single"	12	"olfactory bulb: 1.2"	"Not detected"	"Not detected"			HPA031517	Uncertain					NA	NA		260000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"			"HPA031517: AB_10603769"	"unprognostic (9.16e-2)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-6)"	"unprognostic (3.17e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.71e-2)"	"unprognostic (5.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.25e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	9.5	0.0	4.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.4	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	10.5	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	1.8	0.0	0.6	0.0	0.1	0.0	0.0	1.4	0.0	0.1	0.1	0.0	0.4	1.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0
HERC1	"p532, p619"	ENSG00000103657	"HECT and RLD domain containing E3 ubiquitin protein ligase family member 1"	Q15751	15	63608618-63833948	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transport, Ubl conjugation pathway"	"Guanine-nucleotide releasing factor, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 458.8;Inhibitory neurons: 338.0;Oligodendrocytes: 201.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049749	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA049749: AB_2680866"	"unprognostic (9.72e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (4.87e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.89e-3)"	"prognostic favorable (3.66e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.36e-6)"	"unprognostic (2.87e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.04e-3)"	"unprognostic (3.94e-1)"	10.5	7.4	8.6	10.3	10.1	27.4	12.7	14.1	20.3	13.0	5.2	11.8	5.3	10.8	6.5	8.1	7.6	9.6	15.2	9.3	0.0	9.1	9.1	10.6	13.7	1.7	0.3	18.5	8.4	22.7	8.8	10.3	1.8	8.6	9.2	18.3	8.8	10.3	30.4	12.1	9.9	12.4	0.0	15.2	10.2	11.5	0.0	25.6	14.0	29.3	12.8	9.2	7.9	22.7	13.5	17.1	19.1	6.6	33.3	21.1	6.4	10.3	13.4	10.7	12.3	10.9	5.3	19.8	9.3	19.8	9.7	14.5	31.2	9.0	14.6	15.4	9.6	42.5	26.4	7.8	5.3	31.6	25.1	15.3	8.5	15.1	14.5	9.3	22.7	13.3	44.0	8.6	9.4	21.7	11.3	6.5	9.3	10.4	8.7	12.2	20.6	11.6	4.4	32.9	17.0	8.4	18.2	12.5	10.5	23.0	6.1	12.7	23.6	13.6	12.6	11.9	13.6	9.4	17.4	13.3	7.8	23.3	4.9	24.4	3.8	8.7	4.9	3.4	3.7	5.9	5.5	4.6	3.4	9.5	5.5	5.4	13.5	2.9	6.7	7.5	7.8	1.8	8.6	10.1	14.1	20.3	9.3	0.0	1.7	0.3	1.8	0.0	0.0	22.7	66.0	6.4	39.5	113.0	44.2	14.9	10.6	16.1	17.1	65.3	19.7	17.1	64.8	17.2	19.9	22.0	66.7	8.8	66.1	11.4	1.9	11.0	28.7	13.5	24.0	44.5	10.2	47.5	458.8	14.1	15.1	28.5	34.7	17.8	50.6	36.5	47.2	21.0	16.2	85.8	338.0	13.1	10.2	43.2	27.4	14.3	27.7	39.2	19.6	137.7	36.0	29.9	35.0	160.4	201.5	11.7	14.7	39.9	44.9	12.7	12.5	15.7	16.6	55.0	6.6	34.4	36.0	43.5	31.3	17.1	15.3	8.9	61.1	31.9	14.4	12.1
HERC2	"D15F37S1, jdf2, p528"	ENSG00000128731	"HECT and RLD domain containing E3 ubiquitin protein ligase 2"	O95714	15	28111040-28322179	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 54.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017188, HPA048389, HPA074166"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Plasma membrane"	"CAB017188: , HPA048389: AB_2680382, HPA074166: "	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.64e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.74e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.60e-2)"	"prognostic favorable (1.41e-7)"	"unprognostic (7.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.71e-1)"	5.3	5.7	2.5	2.3	2.9	4.0	4.9	1.5	3.1	5.5	3.0	9.3	2.6	7.6	1.7	5.2	6.1	2.2	7.4	2.3	1.1	3.7	3.7	5.1	2.3	2.0	1.8	8.3	6.1	5.4	6.3	2.7	2.7	4.4	2.8	5.3	4.8	2.9	14.2	5.3	6.1	3.7	0.4	4.3	6.3	4.8	2.7	4.4	5.8	9.3	2.4	5.6	5.0	6.2	8.5	16.5	11.2	4.7	9.2	6.9	3.2	6.0	7.1	7.6	7.3	8.6	1.1	8.5	7.2	10.4	11.5	8.5	12.0	5.9	5.6	5.2	7.8	54.0	20.2	2.9	3.5	12.8	4.1	5.7	4.5	9.0	11.2	4.9	10.2	7.0	21.2	3.4	7.3	3.9	2.9	4.3	3.4	6.4	7.1	10.2	16.0	0.7	2.6	18.2	12.3	7.1	14.6	4.1	4.5	5.8	4.8	14.8	15.3	14.0	9.2	5.5	9.1	2.2	3.3	7.7	6.5	5.9	7.6	0.1	0.2	0.1	0.3	0.0	0.1	0.2	0.1	0.1	0.2	0.4	0.2	0.1	0.0	0.1	0.1	0.6	0.2	0.1	2.5	2.9	1.5	3.1	2.3	1.1	2.0	1.8	2.7	0.4	2.7	6.2	56.2	22.4	23.5	68.9	34.3	16.4	15.3	18.1	27.9	107.9	39.1	31.2	66.6	21.5	23.6	64.4	148.0	25.9	28.5	31.8	1.9	28.7	13.0	35.0	55.8	73.3	28.1	67.9	88.9	30.4	15.5	34.3	43.3	29.6	3.8	135.0	38.9	36.7	19.0	122.8	82.9	32.1	16.2	22.3	20.7	15.8	56.2	22.1	69.4	84.3	26.9	41.0	45.3	65.9	89.7	36.6	30.8	52.3	56.6	20.5	31.1	19.8	19.6	142.9	65.7	46.0	43.2	72.5	66.4	38.3	21.0	17.8	30.0	62.7	35.5	11.5
HEXA		ENSG00000213614	"Hexosaminidase subunit alpha"	P06865	15	72340924-72376420	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 234.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018082, HPA054583"	Supported		Supported	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		20000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Cytosol	"HPA018082: , HPA054583: AB_2682531"	"unprognostic (1.51e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (5.63e-8)"	"unprognostic (6.58e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.98e-1)"	"unprognostic (7.05e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	49.8	56.1	18.3	37.6	21.1	110.0	58.5	20.4	21.6	73.8	28.5	55.1	49.8	42.6	164.6	24.8	47.8	76.7	54.3	19.9	20.1	90.1	79.4	84.2	54.2	23.0	21.3	39.3	30.6	54.0	26.3	102.0	24.6	45.3	67.0	32.1	45.0	53.3	22.1	21.8	41.2	59.5	21.7	54.7	45.1	35.6	27.0	38.1	76.5	33.2	42.4	71.6	19.7	29.9	39.8	66.4	27.8	53.8	223.6	253.1	39.7	54.8	274.1	115.3	182.8	34.6	282.7	32.9	50.9	110.0	59.9	77.1	74.5	34.6	72.5	26.5	30.0	41.4	60.4	60.9	172.9	99.9	113.1	216.7	101.3	50.4	89.3	210.3	107.4	48.4	65.1	197.6	156.0	33.9	21.7	50.0	16.0	128.9	0.3	22.3	60.6	75.3	129.1	61.6	23.8	26.4	136.5	126.6	307.3	56.1	23.4	123.9	54.1	171.9	70.7	160.1	59.3	104.7	151.8	33.4	62.1	130.4	85.3	24.2	84.6	60.1	43.8	35.7	38.7	41.1	28.8	38.9	98.0	38.0	22.5	33.2	8.1	51.3	13.3	37.3	28.2	63.0	18.3	21.1	20.4	21.6	19.9	20.1	23.0	21.3	24.6	21.7	27.0	29.9	68.9	64.1	62.4	19.9	46.3	22.2	33.3	94.3	19.4	42.4	28.6	30.4	26.9	30.0	68.0	66.2	106.3	150.2	54.2	36.6	60.7	88.3	20.6	27.2	30.2	50.8	47.2	19.1	22.7	38.0	68.0	78.7	42.8	40.6	29.9	49.9	43.5	42.9	234.3	26.9	24.7	46.3	81.4	92.8	75.0	13.7	74.3	118.1	94.3	24.4	60.3	38.4	82.4	20.6	26.7	39.1	74.6	44.8	37.7	33.0	68.5	66.7	37.5	56.9	46.0	24.5	31.7	24.3	32.3	13.5	15.6	157.6	36.7	45.2	50.6	27.5
HEXB		ENSG00000049860	"Hexosaminidase subunit beta"	P07686	5	74640023-74722647	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 466.5;Hofbauer cells: 340.2;Syncytiotrophoblasts: 493.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 746.0;GAMG: 646.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055409, HPA056010"	Enhanced				"Intracellular and membrane"	NA	NA		40000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA055409: AB_2682808, HPA056010: AB_2683008"	"unprognostic (3.45e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (3.36e-8)"	"unprognostic (2.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.64e-2)"	92.2	72.0	22.1	59.7	25.3	59.9	83.0	22.3	32.5	97.6	39.4	105.0	99.0	71.5	321.4	38.5	66.7	99.0	84.3	23.1	26.2	81.6	137.5	111.3	47.0	23.8	22.9	62.4	103.6	94.2	46.6	319.4	24.7	98.7	116.9	33.6	123.4	54.0	43.3	54.3	75.4	76.1	23.2	64.7	88.4	19.6	28.2	29.1	89.6	38.4	40.4	94.6	64.1	30.4	147.3	111.0	39.4	131.8	746.0	232.3	122.3	173.5	590.4	175.0	375.2	130.6	194.5	0.0	133.0	152.2	646.3	115.2	43.2	185.2	228.7	79.2	72.6	19.1	101.4	101.5	216.5	16.2	152.3	206.7	108.0	180.7	121.3	275.9	204.5	47.3	54.3	236.9	194.9	145.7	19.8	36.6	36.8	142.7	47.8	43.9	56.2	191.8	119.8	130.4	24.5	30.4	134.2	92.6	180.0	68.8	99.1	108.6	118.5	112.1	26.6	207.8	165.6	102.6	191.3	0.9	257.9	143.6	209.8	86.2	343.2	99.1	69.3	129.9	80.7	45.2	56.1	64.0	310.8	28.1	52.6	51.3	125.2	42.4	82.5	93.4	73.2	269.0	22.1	25.3	22.3	32.5	23.1	26.2	23.8	22.9	24.7	23.2	28.2	30.4	49.6	41.7	38.4	5.9	31.5	44.0	82.8	103.2	21.6	10.2	26.3	27.6	19.8	82.9	63.8	29.5	8.4	466.5	32.8	68.2	19.6	151.3	1.3	21.0	21.4	56.2	22.8	23.1	32.2	125.6	175.4	107.2	33.6	26.9	69.8	19.8	74.3	70.1	340.2	10.1	24.3	56.7	107.8	127.3	134.3	3.4	85.1	168.8	72.9	17.8	114.2	35.4	29.9	22.6	13.3	65.8	54.8	72.2	71.5	74.2	99.5	79.6	36.3	16.3	46.0	32.6	49.5	0.3	1.4	23.8	32.5	493.6	35.3	31.4	81.8	71.0
HFM1	"FLJ36760, FLJ39011, MER3, SEC63D1"	ENSG00000162669	"Helicase for meiosis 1"	A2PYH4	1	91260766-91404856	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	Meiosis	"Helicase, Hydrolase"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 9.3;testis: 13.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 50.9;Inhibitory neurons: 38.4;Oligodendrocyte precursor cells: 90.5;Spermatocytes: 58.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.2;AN3-CA: 2.8;K-562: 3.0;SH-SY5Y: 2.1;U-266/70: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035036, HPA035557"			Supported	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Golgi apparatus, Vesicles"		"HPA035036: AB_2797224, HPA035557: AB_10696507"	"unprognostic (1.35e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.43e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.75e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.76e-4)"	"unprognostic (2.81e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.77e-4)"	"unprognostic (9.59e-2)"	0.4	0.3	1.0	0.1	1.0	0.2	0.4	5.1	1.0	0.9	0.0	0.5	0.3	2.3	1.1	0.1	0.8	0.2	0.6	0.7	1.6	0.7	0.1	0.2	0.1	1.7	1.6	3.9	0.7	0.1	9.3	0.5	1.1	0.6	0.3	4.5	0.5	1.1	1.5	0.1	0.2	0.9	1.1	0.4	0.2	13.8	1.6	0.1	1.6	1.1	0.2	0.4	0.3	1.3	0.0	0.1	5.2	2.8	0.0	0.1	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.3	0.1	1.6	0.0	0.0	0.2	1.0	0.0	0.0	0.0	1.7	2.1	0.0	0.0	0.7	1.4	0.0	0.5	0.0	0.0	0.5	0.5	0.1	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	5.1	1.0	0.7	1.6	1.7	1.6	1.1	1.1	1.6	1.3	0.2	0.0	1.1	50.9	0.0	0.0	0.0	0.0	0.6	3.9	0.1	0.3	3.1	0.0	0.0	0.0	6.2	0.5	0.0	0.0	0.0	0.4	17.8	0.2	1.9	0.4	0.0	2.5	17.6	0.2	0.2	0.6	0.0	0.0	0.0	5.9	0.0	0.0	0.1	0.0	38.4	0.0	0.0	0.0	0.0	5.0	4.1	0.0	0.0	10.3	0.0	2.4	0.0	90.5	9.5	0.1	0.0	2.2	0.0	0.1	0.0	0.0	0.0	6.2	0.0	2.0	1.4	58.9	15.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0
HGD	"AKU, HGO"	ENSG00000113924	"Homogentisate 1,2-dioxygenase"	Q93099	3	120628172-120682269	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"kidney: 200.3;liver: 752.6"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 103.7;Endometrial ciliated cells: 113.9;Glandular and luminal cells: 127.8;Hepatocytes: 534.7;Proximal tubular cells: 477.5"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 119.8"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 55.8;EFO-21: 82.7;Hep G2: 186.6;OE19: 328.0;RPTEC TERT1: 212.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"HPA047374, HPA052359"	Enhanced		Approved	"Golgi apparatus"		NA	NA		700000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA047374: AB_2680019, HPA052359: AB_2681798"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.65e-3)"	"unprognostic (7.20e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.43e-1)"	0.4	0.3	0.4	2.5	1.9	0.5	12.5	0.6	0.8	27.4	1.5	16.7	31.6	3.1	13.0	0.4	4.2	61.7	0.3	0.5	0.4	200.3	752.6	0.8	0.4	0.4	0.4	0.2	31.2	7.0	0.2	0.2	0.4	44.5	20.3	0.7	4.2	4.2	0.1	0.9	25.6	0.5	0.4	0.6	25.5	0.1	0.5	0.7	55.1	0.2	0.1	0.2	0.1	0.6	0.0	12.3	4.6	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	55.8	10.7	0.1	82.7	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.2	186.6	0.0	0.4	1.0	0.0	0.2	0.1	0.0	0.1	0.1	0.4	0.0	0.3	0.5	0.0	0.0	0.2	0.3	328.0	0.0	0.1	0.3	0.1	212.2	0.0	0.2	0.2	0.2	0.9	0.0	0.0	0.2	1.0	0.6	0.1	0.9	0.2	0.1	0.0	0.3	0.5	0.2	0.8	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.3	0.4	1.9	0.6	0.8	0.5	0.4	0.4	0.4	0.4	0.4	0.5	0.6	0.1	0.0	2.0	0.3	5.9	0.0	0.4	0.6	0.0	0.3	7.5	1.7	0.3	81.5	4.9	27.6	2.1	0.0	0.3	18.5	103.7	7.2	0.2	113.9	17.1	1.2	43.8	24.0	3.2	17.8	0.0	0.4	19.4	127.8	1.3	0.0	16.4	534.7	0.2	0.0	0.6	16.0	2.0	16.1	0.0	0.0	0.0	21.3	0.0	1.9	2.0	4.2	0.0	0.0	0.5	12.1	35.6	0.0	0.0	12.9	54.6	477.5	4.1	0.2	0.0	0.2	1.1	0.1	0.0	0.0	0.0	0.0	3.8	0.4	9.1	0.4
HGF	"DFNB39, F-TCF, HGFB, HPTA, SF"	ENSG00000019991	"Hepatocyte growth factor"	P14210	7	81699010-81770438	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Serine protease homolog"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"placenta: 311.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 23.8;Fibroblasts: 95.8;Hepatic stellate cells: 25.0;Muller glia cells: 36.2;Smooth muscle cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 94.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 94.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 171.6;HHSteC: 135.8;HL-60: 82.4;hTEC/SVTERT24-B: 87.4;Karpas-707: 240.7;U-87 MG: 62.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010333, HPA040360, HPA044088"	Approved				"Secreted to blood"	NA	NA	4110000	14000	"Cluster 10: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 33: Fibroblasts - ECM organization"			"CAB010333: AB_647965, HPA040360: AB_2676939, HPA044088: AB_2678804"	"unprognostic (5.24e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.45e-5)"	"unprognostic (1.66e-1)"	"unprognostic (9.28e-3)"	"unprognostic (3.28e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (5.59e-4)"	"unprognostic (7.90e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.06e-2)"	7.9	19.8	1.6	6.3	3.3	12.3	5.2	1.5	7.8	7.2	1.8	4.4	2.6	8.1	3.6	2.9	5.4	16.6	4.7	2.9	3.6	11.8	30.3	19.5	2.2	3.6	2.3	1.8	2.1	2.1	2.4	311.9	4.3	7.2	3.4	14.2	2.4	6.4	0.8	0.9	2.3	7.1	1.8	6.5	3.9	2.4	2.9	1.5	5.6	3.9	1.5	10.4	6.3	3.3	0.0	0.0	0.1	0.0	21.6	171.6	0.1	0.7	33.4	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.1	6.0	0.0	0.0	135.8	82.4	0.4	41.4	0.0	87.4	0.3	0.0	2.2	0.0	0.1	240.7	0.6	0.0	0.0	56.4	0.0	0.0	0.2	0.8	0.0	7.5	0.0	0.0	0.2	9.3	0.0	0.1	0.0	0.2	0.0	3.5	0.4	2.0	0.0	0.1	0.0	0.1	0.0	0.0	62.6	16.9	0.1	94.0	15.2	3.9	0.0	18.7	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	3.2	0.0	17.3	1.0	0.0	4.3	1.6	3.3	1.5	7.8	2.9	3.6	3.6	2.3	4.3	1.8	2.9	3.3	6.2	0.0	4.1	16.3	0.0	1.0	0.2	0.0	1.8	0.2	0.3	0.5	1.3	1.5	0.6	0.0	0.0	5.6	0.0	0.0	0.0	0.0	15.2	1.0	23.8	6.2	0.0	2.1	0.3	0.0	4.9	95.8	0.5	0.9	1.3	0.0	25.0	0.5	18.4	0.0	22.4	0.0	0.0	12.5	1.9	2.3	18.3	14.0	1.8	7.5	10.5	36.2	1.0	0.0	0.1	0.0	0.0	10.9	0.3	0.4	0.0	0.0	0.0	0.7	13.1	0.9	26.2	0.2	0.3	0.3	0.1	12.0	0.6	1.3	0.0	0.4
HGSNAT	"FLJ32731, HGNAT, TMEM76"	ENSG00000165102	"Heparan-alpha-glucosaminide N-acetyltransferase"	Q68CP4	8	43140464-43202855	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease variant, Mucopolysaccharidosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029578	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"			"HPA029578: AB_10602423"	"unprognostic (5.35e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (3.94e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.54e-3)"	"unprognostic (5.02e-2)"	"prognostic favorable (6.33e-5)"	"unprognostic (2.55e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.45e-2)"	32.3	20.0	13.1	17.5	13.0	21.7	27.8	10.6	13.5	35.0	13.8	25.4	18.4	30.1	30.6	24.0	29.0	25.9	23.3	13.3	17.6	20.0	26.6	24.5	11.7	13.3	12.0	35.9	29.9	22.7	30.7	28.4	13.2	26.9	17.2	12.5	25.9	23.3	14.4	35.4	20.9	25.1	11.4	17.6	23.2	7.6	15.8	11.3	26.9	17.6	15.7	25.2	28.7	13.0	27.4	36.0	8.9	18.0	71.7	53.8	13.3	30.5	36.2	21.8	19.3	5.1	39.2	14.8	20.5	42.9	15.2	15.5	4.0	18.5	12.7	6.4	6.9	16.3	22.2	8.1	23.0	3.7	2.5	36.2	25.9	11.7	24.9	34.5	39.2	7.0	7.5	22.1	40.4	10.0	14.8	7.2	8.0	16.3	5.4	1.6	16.1	7.7	36.1	22.8	4.7	14.0	39.0	12.6	17.4	19.0	43.7	20.9	46.3	33.2	5.4	20.9	12.7	17.9	18.2	6.1	26.8	6.3	20.8	0.2	8.8	9.4	2.7	5.4	3.0	1.9	2.3	2.8	15.8	2.1	1.7	1.9	3.2	8.8	8.6	2.0	1.7	5.0	13.1	13.0	10.6	13.5	13.3	17.6	13.3	12.0	13.2	11.4	15.8	13.0	39.1	16.0	31.9	48.0	26.7	18.0	19.5	22.6	8.6	50.6	23.9	21.7	10.5	28.6	17.8	51.5	50.1	39.2	30.1	27.2	3.9	26.7	0.5	23.5	42.1	37.8	24.1	15.3	61.8	28.1	39.4	34.3	32.6	36.5	8.2	51.2	49.6	23.5	29.2	25.2	76.3	28.0	18.3	34.3	58.8	3.2	35.1	43.3	19.6	44.0	33.5	13.5	34.0	50.8	43.8	29.9	17.0	31.6	19.8	20.7	31.4	9.9	23.5	39.6	26.3	30.2	28.2	1.1	3.0	22.3	21.2	30.1	25.0	37.4	21.7	17.7
HIBCH		ENSG00000198130	"3-hydroxyisobutyryl-CoA hydrolase"	Q6NVY1	2	190189735-190344193	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 230.2;Proximal tubular cells: 376.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036540, HPA036541, HPA067080"	Enhanced		Enhanced	Mitochondria		NA	NA		74000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036540: AB_10673355, HPA036541: AB_2675182, HPA067080: "	"unprognostic (3.60e-3)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.88e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (1.04e-10)"	"unprognostic (1.34e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.18e-3)"	34.0	60.1	40.6	17.4	49.2	14.5	28.5	40.5	60.3	33.4	51.0	37.5	55.9	28.1	29.1	34.9	22.5	22.3	28.7	40.7	47.7	142.2	129.0	13.9	20.5	43.9	43.1	18.6	27.2	58.2	19.1	18.6	44.9	25.5	40.9	38.4	20.9	23.2	49.2	58.7	33.9	18.3	45.0	17.8	25.6	21.7	43.3	16.8	31.7	38.5	21.9	23.7	26.6	72.6	23.5	16.1	37.0	23.8	29.9	27.6	16.9	23.1	11.4	20.8	22.1	46.8	20.2	33.3	36.1	18.1	17.0	44.4	33.2	30.7	29.5	47.0	25.1	44.5	37.7	41.4	10.7	31.8	16.7	19.8	17.8	24.3	4.8	32.3	31.6	30.4	55.2	30.3	20.8	18.2	34.3	33.6	11.1	30.2	30.2	42.4	24.8	83.8	43.8	68.4	27.9	24.0	18.0	27.2	66.8	47.2	32.0	21.3	26.5	22.8	20.8	16.1	15.8	18.7	45.2	30.9	20.7	27.4	18.6	27.8	11.9	26.4	19.5	14.2	21.3	43.5	21.8	21.0	20.9	34.7	22.9	29.6	6.0	32.0	11.3	26.7	37.0	12.7	40.6	49.2	40.5	60.3	40.7	47.7	43.9	43.1	44.9	45.0	43.3	72.6	23.3	22.4	25.8	129.3	29.8	56.0	131.4	74.9	34.1	35.3	39.1	24.1	28.6	42.9	51.3	36.8	102.2	53.6	18.8	53.5	115.4	27.4	230.2	48.0	21.4	33.3	37.8	13.0	46.4	29.4	22.3	27.7	29.6	39.3	10.2	41.1	89.3	117.4	35.3	25.2	51.5	31.4	71.2	15.7	11.7	62.9	34.8	15.9	46.2	52.5	14.1	35.5	39.1	104.0	141.1	15.6	26.6	45.5	23.3	27.9	32.4	376.2	47.6	50.5	39.5	29.9	26.2	18.0	29.4	45.5	40.6	20.0	30.7	61.7	62.7	67.8
HK1		ENSG00000156515	"Hexokinase 1"	P19367	10	69269984-69401884	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycolysis, Immunity, Inflammatory response, Innate immunity"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, Mental retardation, Neurodegeneration, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 374.0;Horizontal cells: 304.5;Late spermatids: 1034.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007043, HPA007044, CAB010052"	Supported		Supported	Mitochondria		NA	NA		560000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"CAB010052: AB_627721, HPA007043: AB_1850652, HPA007044: AB_1079049"	"unprognostic (8.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.86e-2)"	47.0	24.4	61.0	45.0	65.7	60.3	40.6	58.0	76.6	54.7	64.2	60.1	13.1	41.3	11.2	129.9	37.0	25.7	150.8	69.1	62.7	49.2	8.5	48.1	34.1	56.7	59.8	19.9	12.3	25.0	44.9	49.3	71.1	52.9	31.9	147.6	67.1	53.1	193.5	102.6	29.2	49.8	40.0	40.3	61.6	77.2	53.5	44.9	71.0	146.7	47.6	74.3	80.9	54.1	101.6	56.6	74.2	71.1	81.0	60.4	47.1	98.3	256.5	128.5	138.0	16.3	11.0	7.3	75.8	165.9	92.9	86.2	69.9	220.0	122.0	67.5	54.5	250.0	58.3	1.1	91.7	5.1	181.2	91.5	125.8	184.5	407.6	160.8	135.4	36.8	424.5	51.3	178.7	167.7	29.7	13.1	113.8	51.7	247.0	44.8	45.0	0.6	88.7	117.4	75.7	88.7	112.6	215.4	65.2	104.3	117.7	16.5	140.4	190.5	86.4	106.5	139.6	61.1	42.8	17.4	247.3	130.4	56.1	68.7	88.8	44.6	41.5	125.2	69.0	33.5	47.9	47.6	81.0	19.9	41.7	33.9	20.9	31.2	135.4	9.1	58.1	110.4	61.0	65.7	58.0	76.6	69.1	62.7	56.7	59.8	71.1	40.0	53.5	54.1	26.1	25.6	32.4	38.2	26.5	48.3	50.5	37.8	43.9	83.9	33.1	21.7	130.6	4.3	34.2	27.6	54.2	70.6	14.6	30.3	13.7	28.6	374.0	32.6	28.0	37.9	18.7	104.8	53.8	30.6	93.3	30.3	41.3	34.5	23.4	72.6	26.7	1.1	49.4	304.5	49.8	28.7	44.7	41.7	21.9	1034.1	15.2	51.3	37.4	29.0	35.3	32.9	20.6	14.1	3.5	54.6	11.1	18.4	19.1	29.1	0.7	1.1	30.7	95.5	19.7	22.2	43.1	5.3	6.2	86.0	51.7	118.9	30.5	28.3	19.3	43.5
HLA-A		ENSG00000206503	"Major histocompatibility complex, class I, A"	P04439	6	29941260-29945884	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 3747.8;Proximal enterocytes: 5267.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 1363.9;fHDF/TERT166: 360.3;HBEC3-KT: 366.7;RPMI-8226: 372.1;U-266/70: 344.6"									CAB078470			Supported	"Golgi apparatus,Plasma membrane"		NA	NA		170000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Golgi apparatus"	"CAB078470: AB_10985125"	"unprognostic (1.56e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.34e-2)"	"prognostic favorable (9.59e-4)"	"unprognostic (3.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.42e-2)"	"prognostic favorable (6.47e-4)"	"unprognostic (2.96e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.54e-2)"	635.4	714.2	15.0	34.8	15.5	137.7	566.7	14.7	36.5	504.9	18.0	737.5	278.3	476.1	181.1	366.8	390.3	239.9	473.4	14.6	17.0	687.0	392.0	1007.3	132.0	19.1	15.8	338.8	200.0	18.5	406.5	52.1	16.5	370.9	94.6	9.9	364.1	1.2	246.5	673.3	959.1	14.5	16.8	1413.1	442.2	132.6	18.0	138.9	531.9	14.5	178.3	412.3	466.8	18.3	1363.9	35.0	0.0	0.0	205.9	193.7	1.4	1.4	2.5	2.1	2.3	0.2	0.1	4.0	0.6	360.3	179.1	31.2	0.2	366.7	0.5	3.1	13.5	237.5	9.5	7.4	11.2	0.5	14.4	2.0	0.0	2.5	1.1	0.6	0.2	177.8	0.4	1.4	0.5	0.0	1.1	24.3	2.9	0.2	4.1	27.5	2.5	372.1	246.7	276.5	0.6	12.4	29.3	0.2	11.8	82.8	1.6	30.4	5.8	18.7	0.8	5.8	4.0	344.6	92.6	77.7	0.4	199.9	0.2	321.6	119.0	182.7	164.7	95.5	134.8	96.9	125.4	146.3	18.6	64.3	86.5	119.2	248.7	133.1	109.6	54.6	222.2	191.9	15.0	15.5	14.7	36.5	14.6	17.0	19.1	15.8	16.5	16.8	18.0	18.3	1622.4	371.8	478.6	22.9	1316.2	856.4	886.2	1417.5	228.8	30.8	289.6	188.5	147.4	936.5	952.5	503.9	6.2	18.3	1879.4	2631.8	88.0	3747.8	52.2	239.4	374.0	1717.8	955.2	499.4	3.6	1310.0	18.5	743.5	853.7	556.2	603.0	253.3	1266.2	276.4	1840.9	37.0	19.3	1755.3	1265.4	1575.0	1124.0	95.6	704.6	1419.1	635.0	67.5	3258.0	170.4	3201.9	49.3	16.1	1802.9	2452.4	484.1	1110.7	1026.6	5267.3	294.9	609.6	24.4	558.8	397.3	579.2	197.4	23.8	216.5	947.7	31.7	2234.9	1021.3	1225.4	1262.8
HLCS	HCS	ENSG00000159267	"Holocarboxylase synthetase"	P50747	21	36748626-36990236	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Ligase, Multifunctional enzyme"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 86.2;Inhibitory neurons: 99.7;Oligodendrocyte precursor cells: 79.9;Oligodendrocytes: 80.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017379	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA017379: AB_1850768"	"prognostic unfavorable (7.72e-4)"	"unprognostic (2.41e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.44e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.85e-3)"	"unprognostic (3.02e-1)"	5.0	5.1	4.9	4.2	5.5	3.3	7.4	9.1	5.8	5.1	9.4	4.7	4.2	4.0	7.0	6.1	5.3	4.2	3.7	6.3	5.4	6.4	10.6	4.9	3.7	5.9	4.6	3.8	7.6	10.6	8.8	4.1	6.3	8.9	4.4	6.1	8.5	6.6	13.3	2.8	4.9	4.5	4.1	3.1	5.7	5.7	5.4	3.3	10.7	6.2	4.3	5.4	2.8	5.5	23.8	10.4	13.0	9.6	14.8	13.7	13.3	13.0	12.7	7.1	7.0	10.8	11.0	10.6	6.4	21.4	13.0	8.2	5.9	11.6	5.5	21.0	9.2	16.4	9.6	6.7	14.9	8.6	11.0	10.2	17.0	10.6	23.6	15.5	9.0	12.0	19.7	31.9	17.4	14.2	4.6	5.4	21.8	16.7	11.3	7.1	7.5	11.2	10.8	24.8	8.3	9.9	16.7	8.8	14.8	10.0	16.2	9.1	10.5	9.1	2.7	8.9	7.8	25.6	19.8	7.1	14.6	11.1	10.7	1.9	0.8	0.8	3.6	2.0	2.9	1.2	1.9	2.3	0.8	1.3	2.4	2.2	1.2	4.8	5.1	1.9	1.6	1.8	4.9	5.5	9.1	5.8	6.3	5.4	5.9	4.6	6.3	4.1	5.4	5.5	3.0	9.6	12.5	46.4	4.1	3.3	9.2	5.3	6.8	12.8	9.4	7.4	4.5	8.6	8.4	12.9	22.9	8.9	5.1	3.5	7.9	7.8	5.6	8.0	8.0	3.8	6.0	7.4	86.2	8.1	5.4	5.1	9.7	8.0	5.7	7.9	4.2	18.5	4.6	18.5	99.7	5.2	4.1	5.1	2.1	4.3	4.4	4.0	0.0	45.9	3.2	5.6	8.2	79.9	80.1	9.0	2.9	7.2	4.2	7.8	8.0	6.1	9.2	14.2	0.0	9.0	6.8	5.2	11.5	8.7	4.0	5.1	5.5	11.1	5.4	6.9
HMBS	"PBGD, PORC, UPS"	ENSG00000256269	"Hydroxymethylbilane synthase"	P08397	11	119084866-119093549	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"bone marrow: 170.8"	"Cell type enriched"	"Detected in many"	15	"Erythroid cells: 935.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006114, HPA050659"	Supported		Approved	"Lipid droplets"		NA	NA		21000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Lipid droplets"		"HPA006114: AB_1079067, HPA050659: AB_2681206"	"unprognostic (6.24e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.42e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.90e-3)"	"unprognostic (3.91e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.11e-2)"	10.3	15.9	9.3	9.3	10.4	170.8	9.4	11.5	10.4	7.9	10.1	13.7	12.5	10.2	11.9	14.4	7.7	4.0	17.3	9.1	10.0	12.3	22.8	8.8	9.2	10.7	10.2	3.8	16.2	9.2	8.5	10.6	10.6	8.6	14.9	5.9	9.9	8.6	30.4	10.5	10.1	10.5	10.4	15.2	11.7	5.7	10.7	7.6	8.9	23.9	11.9	9.6	8.0	12.6	40.0	59.9	27.7	47.5	21.6	27.2	41.7	31.1	34.8	45.0	38.2	74.4	60.2	59.4	68.3	40.1	42.0	53.7	41.6	60.1	28.2	42.0	42.4	97.2	22.5	55.0	40.8	37.6	31.2	29.8	38.0	71.5	53.1	18.7	21.5	55.9	154.6	25.7	35.9	158.4	36.3	72.6	32.1	72.8	36.5	41.9	27.8	59.5	45.3	36.2	31.1	41.4	24.6	38.4	29.3	19.3	64.7	52.3	20.0	33.0	25.5	32.9	36.0	14.2	16.7	36.6	22.7	47.4	40.0	48.5	38.5	4.4	13.6	35.2	17.8	21.4	12.5	15.1	52.8	24.4	19.7	14.7	1.3	11.5	22.2	35.1	14.2	26.6	9.3	10.4	11.5	10.4	9.1	10.0	10.7	10.2	10.6	10.4	10.7	12.6	5.2	9.6	9.0	4.2	12.1	7.9	11.0	26.7	13.6	5.6	14.5	16.8	13.7	18.6	12.8	11.0	27.1	57.8	12.1	12.4	19.6	25.6	1.7	5.8	10.4	6.2	13.2	935.9	3.8	31.2	61.1	9.0	5.6	5.8	2.5	6.3	4.6	23.7	29.1	10.1	5.7	19.1	14.2	13.0	10.4	3.0	5.9	9.5	14.2	1.9	15.3	7.5	8.2	4.5	8.6	23.3	13.0	8.6	25.0	14.5	9.2	24.5	13.6	25.9	0.0	8.6	11.7	1.7	32.0	18.8	8.1	23.3	6.1	16.7	31.0	10.5
HMGCL	HL	ENSG00000117305	"3-hydroxy-3-methylglutaryl-CoA lyase"	P35914	1	23801885-23838620	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 322.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 172.4;Proximal tubular cells: 216.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004727	Enhanced				"Intracellular and membrane"	NA	NA		34000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA004727: AB_1079074"	"unprognostic (8.24e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (7.67e-4)"	"unprognostic (1.23e-3)"	"unprognostic (5.47e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.05e-1)"	"unprognostic (8.24e-2)"	"prognostic favorable (5.07e-8)"	"unprognostic (1.72e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.39e-3)"	27.5	63.0	26.3	16.8	27.5	7.5	25.8	27.5	28.3	27.5	33.0	53.3	45.7	20.2	47.2	32.8	35.6	26.3	42.5	24.6	26.9	115.5	322.5	23.6	21.7	28.0	26.2	21.6	33.4	60.2	26.3	19.9	27.7	31.7	52.9	16.1	30.3	27.9	63.7	25.5	40.0	23.3	27.4	26.8	40.9	17.9	30.1	23.4	40.5	70.2	25.1	28.6	24.2	29.6	28.5	16.0	17.7	13.4	70.6	53.5	6.8	22.0	38.3	23.3	28.2	10.2	53.7	14.8	44.3	34.6	19.0	22.4	21.3	35.7	25.2	30.4	16.1	19.8	13.8	23.5	90.9	7.8	12.7	62.4	52.0	30.8	58.5	62.5	32.2	27.4	20.6	20.3	43.3	29.3	12.2	15.3	4.6	77.4	22.1	17.2	14.5	27.9	55.4	14.5	14.8	13.2	28.6	10.8	49.3	23.3	33.9	19.3	24.3	19.3	11.6	35.5	9.7	28.7	15.2	13.3	47.7	28.7	23.0	103.5	67.0	66.0	36.3	66.0	39.8	45.9	39.1	42.1	58.0	51.2	39.6	37.7	25.5	54.4	77.5	43.9	45.5	61.7	26.3	27.5	27.5	28.3	24.6	26.9	28.0	26.2	27.7	27.4	30.1	29.6	19.9	12.8	25.7	14.0	16.3	5.9	29.9	54.3	9.6	24.6	19.9	17.1	33.7	41.5	30.6	49.7	18.8	43.0	10.0	48.1	119.3	57.7	2.3	25.0	17.5	22.5	9.0	18.7	4.3	24.0	27.3	20.8	30.5	23.1	17.7	29.7	30.4	172.4	61.6	35.3	5.3	49.5	28.5	23.5	7.7	3.6	21.8	23.5	21.4	8.4	41.4	37.1	24.7	6.0	12.5	31.2	53.8	24.5	8.3	29.4	70.9	216.8	31.5	25.5	6.6	17.1	21.6	6.6	5.4	13.8	6.5	41.3	15.2	65.6	48.9	24.3
HMGCS2		ENSG00000134240	"3-hydroxy-3-methylglutaryl-CoA synthase 2"	P54868	1	119748002-119768905	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 2434.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 327.2;Hepatocytes: 1118.3;Intestinal goblet cells: 226.8;Paneth cells: 177.7;Undifferentiated cells: 282.3"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 441.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 113.6;RT4: 201.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027423, HPA027442, CAB032906"	Enhanced		Approved	Mitochondria		NA	NA		830000		"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.62e-2)"		"unprognostic (1.49e-2)"	"prognostic favorable (2.43e-7)"	"unprognostic (9.68e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (3.43e-5)"	"unprognostic (9.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.54e-3)"	1.0	0.3	0.0	7.3	0.0	0.0	222.4	0.0	0.0	0.1	5.2	366.7	165.6	1.4	0.4	4.3	0.4	4.3	36.6	0.0	0.1	64.9	2434.1	2.2	0.1	0.0	0.1	0.1	20.1	0.1	0.1	0.4	0.0	34.0	228.0	0.1	50.8	0.6	6.9	14.2	151.8	23.7	0.0	0.6	101.2	35.6	0.0	0.4	0.6	3.1	0.0	36.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	113.6	0.1	0.2	0.7	0.7	0.0	201.6	0.1	0.8	0.6	0.0	0.0	0.1	7.6	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	10.8	0.0	2.4	0.1	3.7	0.0	1.2	0.0	18.8	5.6	8.7	42.9	0.1	31.3	0.0	0.8	0.0	327.2	0.0	0.0	1.9	0.6	0.1	1.1	73.1	24.0	0.0	0.0	0.2	0.2	66.8	1.4	4.5	19.5	16.4	1118.3	0.2	0.0	0.0	226.8	0.0	26.1	0.7	3.9	1.5	0.2	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	177.7	0.0	0.0	6.3	12.4	0.9	0.0	0.0	6.6	0.0	0.1	0.4	0.5	1.9	0.3	9.4	2.2	0.1	282.3	26.5
HMOX1	"bK286B10, HO-1"	ENSG00000100292	"Heme oxygenase 1"	P09601	22	35380361-35394214	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 612.2"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 327.1;Extravillous trophoblasts: 285.2;Hofbauer cells: 494.9;Kupffer cells: 954.1;Macrophages: 271.5;Syncytiotrophoblasts: 502.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 98.8;intermediate monocyte: 238.8;non-classical monocyte: 329.2"	"Lineage enriched"	"Detected in all"	7	"monocytes: 329.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 869.1;GAMG: 631.2;U-138 MG: 506.2;U-87 MG: 489.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000635, CAB017444"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane"		NA	NA		170000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Plasma membrane"		"CAB017444: AB_10617276, HPA000635: AB_1079089"	"unprognostic (3.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.42e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.54e-2)"	150.2	48.9	40.9	64.6	48.8	99.3	20.6	42.4	66.3	28.2	46.4	35.2	106.0	10.4	7.6	48.4	40.7	52.6	18.2	40.6	46.6	96.2	136.5	113.6	57.2	52.3	46.5	139.0	41.7	7.4	9.6	72.2	56.3	6.7	31.1	1.7	15.1	4.0	107.1	74.1	64.5	38.7	45.9	612.2	19.9	17.8	60.7	25.1	11.3	21.4	49.4	46.2	29.2	56.2	12.2	179.1	1.8	37.7	170.9	49.6	869.1	83.2	57.6	42.9	48.6	82.1	11.3	0.1	18.3	83.3	631.2	10.1	11.4	1.9	16.1	308.6	9.2	4.3	51.5	179.3	218.9	11.5	54.8	146.3	4.2	282.3	19.7	74.6	130.9	0.5	0.0	87.4	152.5	6.9	0.2	4.3	18.1	130.4	20.7	1.2	15.6	28.4	35.2	104.5	2.7	2.4	215.8	19.1	15.5	92.5	8.9	3.0	44.3	506.2	22.1	82.5	82.5	53.5	77.0	9.3	489.4	5.7	8.6	11.3	98.8	7.7	1.1	238.8	0.4	24.8	0.7	1.7	44.6	2.9	0.1	0.5	47.1	5.3	329.2	1.1	1.8	70.9	40.9	48.8	42.4	66.3	40.6	46.6	52.3	46.5	56.3	45.9	60.7	56.2	19.3	3.2	19.0	0.0	11.5	16.4	27.5	11.0	10.8	0.0	25.0	9.1	2.9	24.3	10.5	5.5	0.0	50.5	3.5	59.1	21.5	13.6	2.1	39.6	12.9	327.1	16.0	5.7	0.2	1.5	285.2	64.1	9.2	74.6	11.4	98.4	23.6	23.6	494.9	0.0	0.4	8.3	18.3	954.1	175.8	4.1	31.1	271.5	35.6	1.9	184.7	0.4	9.2	0.5	1.4	8.3	26.1	5.3	2.5	110.6	61.5	157.9	7.1	0.6	0.0	40.8	52.7	0.9	4.4	5.5	15.6	502.0	6.8	6.9	6.1	118.3
HNMT		ENSG00000150540	"Histamine N-methyltransferase"	P50135	2	137964020-138016364	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 245.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 299.3;Kupffer cells: 263.7;Proximal tubular cells: 268.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	21	"classical monocyte: 110.9;intermediate monocyte: 89.8;myeloid DC: 68.3;non-classical monocyte: 52.2"	"Group enriched"	"Detected in many"	23	"dendritic cells: 68.3;monocytes: 110.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 227.2;HSkMC: 87.9;RT4: 117.1;SuSa: 107.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035480, HPA035481, HPA073754"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA		130000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Cytosol"	Centrosome	"HPA035480: AB_2674645, HPA035481: AB_10672094, HPA073754: "	"unprognostic (1.32e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (5.24e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (4.68e-4)"	70.4	18.2	13.0	41.7	13.3	12.6	62.3	13.1	18.8	57.3	19.2	53.9	29.3	62.8	27.1	17.5	34.5	68.7	21.7	15.6	19.1	109.7	245.9	49.0	35.1	16.0	15.3	91.0	29.0	40.2	9.5	46.8	18.1	37.0	56.4	6.1	30.5	44.3	5.9	17.4	29.1	33.1	16.1	37.5	29.1	10.3	14.5	8.2	14.6	11.9	16.4	49.7	24.5	22.2	0.7	0.9	5.6	14.6	61.9	64.6	0.4	3.9	6.2	0.4	2.3	29.7	15.7	0.9	50.2	17.0	0.8	1.1	11.9	0.0	0.1	0.7	4.9	0.2	44.5	227.2	28.0	0.3	0.6	87.9	0.1	21.5	0.0	4.7	15.9	0.1	0.5	0.7	47.4	3.7	0.0	0.5	28.1	39.3	5.6	0.5	1.5	0.2	67.9	117.1	0.1	0.8	22.1	28.4	0.1	107.9	1.0	53.2	4.8	4.8	11.8	6.2	16.3	0.4	0.3	0.7	20.9	27.8	3.3	1.3	110.9	0.7	0.5	89.8	0.3	1.8	0.2	0.2	68.3	0.5	0.3	0.4	3.9	0.5	52.2	1.5	0.7	32.6	13.0	13.3	13.1	18.8	15.6	19.1	16.0	15.3	18.1	16.1	14.5	22.2	15.5	28.9	44.1	9.4	5.0	35.6	81.5	64.6	30.7	0.7	78.1	65.4	2.2	133.0	88.9	60.7	0.0	54.9	2.6	59.4	123.3	122.1	1.5	28.3	50.6	9.4	16.4	16.8	16.8	48.0	81.6	54.2	20.9	115.3	0.0	17.4	19.2	165.7	299.3	0.0	13.8	67.8	24.4	263.7	97.2	4.2	131.4	127.4	56.9	31.9	122.0	25.5	4.1	45.8	14.3	71.0	108.6	105.3	0.2	39.8	31.9	268.3	38.4	0.8	78.9	55.2	55.7	0.5	0.9	33.2	25.9	37.6	4.0	43.9	83.5	126.1
HOGA1	"C10orf65, DHDPS2, DHDPSL, FLJ37472, NPL2"	ENSG00000241935	"4-hydroxy-2-oxoglutarate aldolase 1"	Q86XE5	10	97584323-97612802	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 51.8;liver: 54.8"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 35.8;Distal tubular cells: 29.4;Hepatocytes: 43.3;Late spermatids: 18.4;Proximal tubular cells: 98.0"	"Group enriched"	"Detected in many"	5	"liver cancer: 4.5;renal cancer: 9.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.8;EFO-21: 9.7;Hep G2: 26.1;RPTEC TERT1: 31.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039466	Approved					NA	NA		16000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039466: AB_2676522"	"unprognostic (6.44e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-3)"	"unprognostic (4.72e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.80e-2)"	"prognostic favorable (9.08e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.94e-3)"	"unprognostic (7.20e-4)"	4.1	8.3	5.8	0.2	7.4	0.4	1.9	9.3	5.0	0.7	11.4	0.2	0.3	1.1	3.7	1.0	2.0	2.5	21.1	4.4	6.5	51.8	54.8	1.4	0.3	8.2	9.2	0.2	15.3	5.7	3.6	0.1	8.3	1.1	0.1	0.8	1.7	2.1	3.4	1.5	0.3	0.5	7.3	0.4	0.2	0.9	7.9	0.3	1.8	12.1	0.2	0.4	0.9	10.3	0.3	3.7	0.1	7.8	1.5	0.3	0.1	0.1	0.2	0.0	0.0	3.0	0.2	0.3	9.7	0.2	0.5	2.6	0.0	0.2	0.1	0.1	4.0	0.1	1.4	26.1	1.1	0.2	0.1	0.3	0.7	0.1	0.1	1.9	0.4	0.1	0.0	0.4	0.6	1.6	0.1	0.1	0.2	0.2	0.0	0.1	0.6	0.4	31.5	0.6	0.6	1.0	0.1	1.3	0.5	0.2	2.8	0.0	0.2	0.8	0.2	0.3	0.2	0.5	0.9	0.1	2.0	0.1	0.1	0.6	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.1	0.4	0.2	0.2	1.0	0.2	0.2	0.3	0.2	0.1	5.8	7.4	9.3	5.0	4.4	6.5	8.2	9.2	8.3	7.3	7.9	10.3	0.0	0.0	0.0	7.2	1.5	0.1	0.7	0.5	1.8	0.4	0.1	0.4	6.0	35.8	0.2	9.2	0.0	0.1	0.0	0.1	29.4	5.9	3.8	1.8	0.1	0.0	0.0	0.0	1.3	0.2	0.0	0.2	0.0	0.5	0.0	0.1	0.4	43.3	0.1	1.7	1.2	0.0	0.0	1.3	0.0	18.4	0.0	0.8	1.8	1.0	0.0	2.0	0.0	1.5	12.3	0.5	0.1	0.0	0.0	0.1	0.0	98.0	3.2	0.3	0.0	4.5	0.9	0.0	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.2
HP		ENSG00000257017	Haptoglobin	P00738	16	72054505-72061055	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Immunity"	"Antibiotic, Antimicrobial, Antioxidant, Serine protease homolog"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	91	"liver: 61113.6"	"Cell type enriched"	"Detected in many"	43	"Hepatocytes: 59512.7"	"Cancer enriched"	"Detected in many"	81	"liver cancer: 1297.4"	"Region enhanced"	"Detected in all"		"medulla oblongata: 29.7"	"Group enriched"	"Detected in many"	5	"classical monocyte: 49.3;eosinophil: 80.2"	"Group enriched"	"Detected in many"	7	"granulocytes: 80.2;monocytes: 49.3"	"Group enriched"	"Detected in some"	5	"Hep G2: 232.2;HSkMC: 121.4"									"CAB003787, HPA047750, HPA066795"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	998000000000	100000000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"CAB003787: , HPA047750: AB_2680146, HPA066795: "	"unprognostic (6.38e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.07e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.30e-2)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (6.94e-13)"	"unprognostic (4.34e-4)"	"unprognostic (1.80e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.49e-2)"	673.1	11.4	1.3	26.9	1.7	231.5	34.2	1.4	2.9	71.9	3.6	3.6	1.5	3.5	2.9	5.3	74.6	1.3	146.7	1.4	1.4	19.8	61113.6	91.3	1.7	29.7	2.0	9.9	7.6	0.2	49.9	2.5	3.7	7.3	0.6	0.7	6.1	0.2	5.0	3.4	4.4	4.5	2.3	72.0	6.2	2.1	8.3	2.7	6.3	0.4	3.0	3.8	3.3	5.9	0.0	0.0	0.0	0.0	6.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	8.5	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	11.2	0.2	232.2	0.3	33.3	6.2	121.4	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	2.0	0.4	2.6	0.0	0.0	1.1	23.6	0.0	0.0	0.1	0.0	0.0	16.2	0.0	0.0	0.0	0.0	6.8	5.1	0.0	0.8	0.0	0.0	3.9	0.0	14.1	0.0	12.7	0.0	6.2	49.3	80.2	0.0	2.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	14.2	0.0	2.1	0.0	0.0	15.2	1.3	1.7	1.4	2.9	1.4	1.4	29.7	2.0	3.7	2.3	8.3	5.9	0.4	19.2	228.7	1.6	96.1	0.1	0.7	1.9	0.0	0.4	0.4	0.3	66.6	1085.2	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	56.7	0.0	1128.3	0.0	10.4	0.1	45.5	0.0	1.3	3.8	0.4	1038.7	59512.7	2.3	0.0	0.0	0.2	4.1	1381.4	0.0	0.5	10.2	7.8	1.8	0.0	0.3	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	1.5	7.5	0.2	0.0	2.6	1.8	0.0	0.0	0.1	0.3	0.1	90.3	0.0	0.3	0.1
HPCA	DYT2	ENSG00000121905	Hippocalcin	P84074	1	32885994-32898441	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 517.5"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 198.3;Early spermatids: 155.4;Late spermatids: 119.7"	"Cancer enriched"	"Detected in many"	9	"glioma: 8.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"SCLC-21H: 4.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basal ganglia: 1309.6;hippocampal formation: 990.7"	"CAB012340, HPA043245"	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"CAB012340: AB_2120209, HPA043245: AB_2678385"	"unprognostic (4.60e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.72e-3)"	"unprognostic (5.18e-2)"	"unprognostic (9.08e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.85e-3)"	0.2	0.4	99.4	0.0	517.5	0.0	0.1	50.3	322.2	0.7	37.5	0.7	0.1	0.5	0.0	0.1	0.3	0.2	0.3	326.8	52.2	0.3	0.2	0.1	0.0	43.0	54.8	0.6	0.5	0.3	1.8	0.0	41.6	0.5	0.4	18.4	0.1	0.1	0.2	0.1	0.4	0.2	54.8	0.1	0.2	3.6	105.8	0.0	0.4	0.0	0.0	0.2	0.4	82.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.6	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	4.9	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.4	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.4	517.5	50.3	322.2	326.8	52.2	43.0	54.8	41.6	54.8	105.8	82.6	0.1	0.0	0.0	3.6	0.0	0.0	1.4	0.5	0.0	198.3	0.4	0.9	0.4	0.0	0.1	0.0	6.2	0.1	0.1	1.7	0.0	0.3	155.4	0.0	0.4	0.3	18.0	0.0	21.9	0.5	0.3	0.7	0.0	0.1	0.0	0.9	0.0	0.0	0.1	13.5	7.8	2.8	0.0	0.0	0.0	119.7	1.2	0.1	0.0	2.8	0.0	9.1	0.0	4.5	3.7	0.3	5.9	0.4	0.0	1.3	2.0	2.0	0.2	19.3	0.0	0.1	0.5	4.2	8.5	0.1	0.3	0.1	0.0	0.0	2.2	1.4
HPGD	SDR36C1	ENSG00000164120	"15-hydroxyprostaglandin dehydrogenase"	P15428	4	174490175-174523154	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 235.0;urinary bladder: 376.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 457.8;Extravillous trophoblasts: 701.7;granulocytes: 864.5;Proximal enterocytes: 500.6;Urothelial cells: 922.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 52.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 123.7;T-reg: 45.0"	"Group enriched"	"Detected in many"	73	"granulocytes: 123.7;T-cells: 45.0"	"Cell line enhanced"	"Detected in many"		"A549: 157.8;ASC diff: 110.6;HEL: 355.0;OE19: 102.1;RT4: 565.7;SuSa: 121.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004919, HPA005679"	Enhanced		Supported	Nucleoplasm,Cytosol		No	NA		20000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoplasm	"HPA004919: AB_1079081, HPA005679: AB_1079080"	"unprognostic (1.23e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (3.20e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.37e-4)"	"unprognostic (2.33e-2)"	9.2	16.5	1.0	11.4	0.7	2.7	159.9	0.5	1.2	32.2	8.7	60.9	152.2	45.5	36.5	81.6	13.4	24.9	1.6	1.2	2.8	60.2	210.8	91.0	5.5	1.4	2.0	1.1	2.6	85.3	2.1	99.1	1.0	10.2	57.4	1.0	7.7	4.0	2.5	39.8	117.3	63.7	0.8	10.3	235.0	1.6	2.2	12.2	1.7	3.0	26.6	376.0	83.0	0.7	0.0	157.8	0.0	0.0	110.6	5.4	0.4	0.0	0.0	0.0	0.4	45.1	0.2	0.1	0.0	0.0	0.2	14.2	16.0	0.0	0.0	0.3	2.9	355.0	10.8	0.3	0.0	2.1	0.9	5.6	2.6	0.0	0.1	0.1	0.0	22.6	0.2	0.0	0.0	0.3	1.2	0.3	1.4	102.1	7.4	16.3	0.3	1.3	36.2	565.7	0.9	0.4	0.0	1.3	3.5	121.3	0.1	0.0	0.3	0.0	0.2	0.1	0.0	28.4	0.0	0.1	0.3	0.2	0.0	123.7	0.3	16.6	9.9	0.0	15.6	0.4	5.2	4.5	0.7	0.2	1.6	4.0	1.3	1.1	0.0	0.0	45.0	3.0	1.0	0.7	0.5	1.2	1.2	2.8	1.4	2.0	1.0	0.8	2.2	0.7	3.4	16.0	33.0	0.0	4.3	17.3	80.8	6.9	45.5	3.3	14.5	6.7	0.8	35.8	23.6	22.0	0.0	48.5	38.5	457.8	21.5	7.4	1.4	5.7	5.4	18.2	8.4	17.2	0.8	94.5	701.7	25.3	196.7	36.4	864.5	1.5	13.9	245.7	21.4	0.0	9.7	60.7	0.0	14.8	19.5	0.5	19.9	29.2	76.5	5.6	2.9	0.0	10.3	0.0	4.1	42.4	254.7	0.0	50.2	76.8	500.6	131.1	4.4	0.8	0.0	2.4	3.7	0.5	1.0	53.4	22.4	56.6	42.7	65.0	58.9	922.8
HR	"ALUNC, AU"	ENSG00000168453	"HR lysine demethylase and nuclear receptor corepressor"	O43593	8	22114419-22133384	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Oxidoreductase"	"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 20.9;skin 1: 52.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 91.4;Cone photoreceptor cells: 33.3;Distal enterocytes: 27.5;Gastric mucus-secreting cells: 26.5;Paneth cells: 31.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 21.2;HaCaT: 81.7;OE19: 39.9;SiHa: 28.8;T-47d: 30.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054888			Supported	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA054888: AB_2682630"	"unprognostic (9.11e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.68e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-2)"	2.4	1.0	4.3	1.8	6.7	0.0	2.7	7.8	14.5	3.8	0.0	9.0	4.8	1.6	0.1	20.9	1.1	1.3	2.3	3.1	4.8	0.6	0.4	0.8	0.3	11.3	9.0	0.6	0.5	0.0	2.7	0.1	12.0	3.8	3.2	1.8	5.1	4.2	0.7	52.7	4.7	1.5	2.4	0.5	7.7	5.3	8.8	0.6	4.3	0.9	1.2	3.0	11.7	11.5	1.9	21.2	0.0	0.0	0.2	0.6	0.1	0.1	0.1	0.0	0.0	0.0	2.6	0.0	20.7	1.5	1.0	81.7	0.0	2.0	0.0	0.0	0.0	0.0	17.8	0.1	4.7	0.0	0.1	4.1	12.9	0.0	1.4	1.3	0.0	2.1	0.0	0.2	0.0	12.7	1.5	0.3	0.0	39.9	16.3	1.9	0.0	0.5	0.3	5.7	1.0	4.7	28.8	6.4	6.5	0.3	30.0	0.0	0.0	0.4	17.2	0.0	0.9	0.0	0.0	0.0	0.2	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	6.7	7.8	14.5	3.1	4.8	11.3	9.0	12.0	2.4	8.8	11.5	1.9	0.0	0.0	1.3	0.0	12.0	4.5	4.3	10.8	91.4	4.0	3.9	2.7	0.0	1.4	1.8	33.3	0.1	0.1	27.5	0.0	0.1	0.3	1.6	1.2	0.6	7.8	0.0	8.7	0.7	0.2	2.1	26.5	2.1	0.0	0.3	1.8	0.3	0.0	10.1	3.9	8.1	0.0	0.0	2.1	1.9	3.4	0.1	21.4	0.0	0.0	3.2	0.0	2.0	9.2	0.3	31.2	7.2	0.0	3.0	11.0	0.1	1.3	8.8	0.0	5.8	3.3	0.1	0.3	15.5	17.8	0.8	0.3	0.2	19.5	6.8
HRAS	HRAS1	ENSG00000174775	"HRas proto-oncogene, GTPase"	P01112	11	532242-537287	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 145.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002015, HPA049830, HPA070222"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"CAB002015: , HPA049830: AB_2680903, HPA070222: "	"unprognostic (3.06e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.49e-3)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.88e-3)"	"unprognostic (9.85e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.38e-1)"	28.1	24.6	64.6	3.5	67.2	2.9	27.0	62.1	86.8	30.4	58.3	34.3	2.8	23.6	12.5	80.1	18.9	3.6	56.8	64.4	64.6	33.8	21.8	27.1	4.3	65.6	65.3	20.0	20.5	13.1	38.2	9.0	66.9	38.3	6.9	10.2	27.3	12.3	59.0	69.9	19.5	8.9	64.2	20.6	24.2	16.5	64.8	9.2	20.5	25.2	10.2	34.5	44.2	65.4	59.0	105.6	44.2	25.6	22.2	17.5	39.6	49.9	25.1	64.5	29.5	62.4	29.7	20.4	10.9	63.2	60.7	43.7	46.0	114.1	19.3	19.5	108.4	6.6	43.7	56.1	38.5	13.9	12.0	28.3	118.0	42.0	51.5	19.6	31.5	34.3	29.7	32.3	40.9	110.6	34.0	50.5	26.5	39.9	94.5	31.6	40.7	18.2	47.0	33.2	87.6	43.7	25.5	55.4	17.9	31.5	43.3	14.8	35.4	47.3	44.7	16.4	39.7	20.3	17.7	15.4	39.1	17.0	38.3	0.0	0.5	0.6	0.8	0.7	0.4	0.3	0.9	0.8	0.7	2.0	0.9	0.3	0.0	0.1	4.0	0.9	1.5	0.2	64.6	67.2	62.1	86.8	64.4	64.6	65.6	65.3	66.9	64.2	64.8	65.4	51.3	12.8	10.7	9.1	18.0	131.2	101.7	25.4	82.0	46.0	38.8	75.7	25.2	22.8	11.2	35.0	18.8	78.8	21.5	72.2	74.3	35.2	1.6	36.1	28.6	32.0	29.3	11.2	9.8	37.4	63.4	25.9	33.6	34.1	2.5	26.8	22.9	17.4	39.9	48.8	10.6	26.5	4.1	11.7	38.4	7.9	17.1	21.3	64.0	10.3	12.8	50.8	11.3	4.0	12.3	48.2	30.9	23.0	26.5	61.2	30.8	54.6	20.0	37.6	32.9	20.3	40.3	5.4	21.4	118.1	145.9	78.1	22.0	18.8	26.2	106.4
HSD17B3	SDR12C2	ENSG00000130948	"Hydroxysteroid 17-beta dehydrogenase 3"	P37058	9	96235306-96302176	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase	"Disease variant, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 15.1;testis: 36.7"	"Group enriched"	"Detected in some"	6	"Leydig cells: 108.1;Oligodendrocytes: 93.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 2.3;HEL: 1.0;U-2 OS: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056833	Enhanced		Approved	Vesicles		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA056833: AB_2683252"	"unprognostic (2.78e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.08e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.26e-4)"	"unprognostic (3.45e-1)"	"unprognostic (5.48e-8)"	"unprognostic (8.47e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.11e-2)"	1.6	0.8	3.1	0.2	4.3	0.0	1.7	3.4	5.9	3.1	2.4	2.7	0.5	1.5	0.9	0.7	3.5	0.2	2.1	3.1	3.6	4.7	15.1	1.8	0.0	4.3	3.9	1.4	4.2	0.0	1.7	0.1	4.2	3.2	0.1	0.7	1.0	0.1	0.5	0.9	3.7	0.0	3.3	0.9	1.4	36.7	4.2	0.1	10.0	0.1	0.0	1.6	1.8	5.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.0	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.1	4.3	3.4	5.9	3.1	3.6	4.3	3.9	4.2	3.3	4.2	5.4	0.0	0.0	0.0	15.3	0.2	0.0	0.1	0.8	0.0	0.2	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.2	4.0	0.2	0.0	0.4	1.8	0.0	0.5	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	2.5	0.0	0.0	0.5	0.5	0.0	0.0	0.4	14.4	108.1	1.1	0.0	4.7	0.1	0.6	0.0	1.0	93.2	0.2	0.1	12.8	0.0	0.1	0.6	0.0	0.5	0.2	0.0	0.1	0.5	1.9	1.8	0.0	0.3	0.1	0.0	0.0	0.3	0.0
HSD17B4	"DBP, MFE-2, SDR8C1"	ENSG00000133835	"Hydroxysteroid 17-beta dehydrogenase 4"	P51659	5	119452473-119637199	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Oxidoreductase"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 320.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 225.1;Oligodendrocytes: 221.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 75.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021302, HPA021311, HPA021479"	Enhanced		Enhanced	Peroxisomes		NA	NA		450000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Peroxisomes		"HPA021302: AB_1844350, HPA021311: AB_1844351, HPA021479: AB_1844352"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.85e-1)"	"prognostic favorable (6.31e-6)"	"unprognostic (1.60e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-3)"	74.4	85.0	37.2	41.9	50.2	19.7	44.4	51.1	50.0	68.8	47.2	64.5	79.3	34.1	53.0	50.9	39.1	52.5	68.6	34.9	50.7	84.4	320.0	75.6	33.2	50.6	49.5	34.8	55.2	75.5	26.5	53.4	49.2	56.8	65.9	27.2	44.9	79.0	59.8	51.8	87.6	39.5	44.7	36.6	53.8	20.9	49.9	31.9	133.9	52.8	39.7	57.7	31.5	56.3	68.8	59.8	104.1	143.7	261.8	120.3	57.9	63.4	80.3	57.3	103.0	49.4	112.8	84.4	128.0	70.6	81.0	68.7	77.0	144.4	84.3	94.6	79.8	118.1	62.0	96.9	65.8	38.0	169.9	110.0	56.3	64.9	54.7	69.3	103.9	59.4	41.0	48.9	64.2	64.0	59.2	23.6	82.1	161.1	43.1	68.7	103.0	104.8	92.2	192.7	81.1	70.6	149.0	23.4	78.7	93.3	88.7	68.2	67.6	52.7	38.1	66.5	53.1	26.3	55.3	32.6	63.7	104.4	56.7	75.5	27.3	49.9	6.5	15.5	7.3	11.1	5.8	5.3	21.3	10.3	5.5	5.2	4.9	6.9	17.1	13.8	4.1	12.2	37.2	50.2	51.1	50.0	34.9	50.7	50.6	49.5	49.2	44.7	49.9	56.3	38.9	73.7	125.2	47.3	28.2	14.9	42.5	43.2	24.5	19.7	31.1	22.1	76.4	64.3	52.3	36.8	14.6	64.3	19.1	40.0	84.1	39.9	8.8	29.0	48.9	32.3	33.0	42.1	92.9	35.8	29.3	35.6	48.4	35.8	68.4	25.3	32.2	225.1	77.9	15.2	102.8	45.8	22.4	51.8	13.8	13.4	34.5	46.7	8.8	49.6	85.7	47.3	9.2	78.4	221.5	20.5	29.6	51.1	23.1	24.8	85.7	65.4	33.8	18.6	6.6	29.2	32.2	30.6	22.7	34.7	17.2	65.0	15.7	57.2	55.3	39.7
HSD3B7	"C(27)-3BETA-HSD, SDR11E3"	ENSG00000099377	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7"	Q9H2F3	16	30985207-30989147	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	Oxidoreductase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 136.5"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 42.5;Hepatocytes: 68.9;Hofbauer cells: 53.9;Proximal enterocytes: 45.3;Proximal tubular cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"basophil: 61.8;eosinophil: 27.3"	"Lineage enriched"	"Detected in many"	38	"granulocytes: 61.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 91.0;Hep G2: 66.2;HMC-1: 98.1;U-2197: 96.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015965, HPA050521, HPA060847"	Approved		Enhanced	"Lipid droplets"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Lipid droplets"		"HPA015965: , HPA050521: AB_2681155, HPA060847: AB_2684379"	"unprognostic (5.41e-3)"	"unprognostic (4.14e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (1.60e-6)"	"unprognostic (2.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.79e-1)"	27.3	25.7	5.7	10.9	6.2	4.4	17.1	14.7	9.1	8.5	3.5	15.9	19.5	9.5	2.1	12.3	9.4	11.5	11.7	5.9	5.9	27.7	136.5	11.2	8.4	6.3	5.4	8.6	25.6	8.0	5.4	4.5	6.6	8.2	5.8	1.6	10.0	4.5	7.0	18.5	18.4	9.8	5.6	16.3	11.1	6.0	7.1	2.8	6.3	4.5	5.5	13.9	8.7	6.9	20.3	23.2	2.4	11.5	7.9	28.5	1.4	24.8	38.7	4.8	10.0	1.7	34.4	1.2	8.1	30.3	0.8	6.1	2.2	3.6	2.4	91.0	5.4	1.6	18.6	66.2	7.4	0.5	98.1	13.7	6.0	23.1	4.6	11.2	2.2	1.2	4.9	1.0	18.3	43.6	0.6	14.4	1.9	8.5	3.2	2.5	7.8	22.3	15.1	1.3	8.4	4.1	3.2	15.9	2.2	1.1	31.1	1.6	11.5	10.0	2.8	96.1	2.7	1.6	15.4	1.1	39.1	2.5	0.8	61.8	1.4	27.3	0.1	0.1	0.1	0.1	0.1	0.0	1.6	0.2	0.0	0.1	1.2	0.5	0.0	0.6	0.0	0.7	5.7	6.2	14.7	9.1	5.9	5.9	6.3	5.4	6.6	5.6	7.1	6.9	7.6	3.2	4.2	3.3	1.2	7.9	2.6	4.1	4.0	0.7	13.6	9.8	1.7	27.1	2.2	14.7	0.0	2.0	0.5	10.8	15.6	42.5	37.5	1.9	7.1	11.1	7.8	4.8	0.2	30.3	3.5	26.0	8.2	4.2	9.5	9.0	6.8	68.9	53.9	1.7	0.4	11.4	6.1	7.3	15.9	2.2	6.5	11.4	14.2	0.0	12.8	2.1	0.0	0.5	1.2	20.7	14.0	5.3	1.9	1.8	45.3	46.7	1.3	0.5	13.1	9.4	6.3	0.8	1.2	4.9	12.6	1.4	1.7	6.5	23.5	2.8
HSPA5	"BiP, GRP78"	ENSG00000044574	"Heat shock protein family A (Hsp70) member 5"	P11021	9	125234853-125241382	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction"	"Chaperone, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1327.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005221, HPA038845, HPA038846"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		790000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB005221: AB_631616, HPA038845: AB_10673477, HPA038846: AB_10673478"	"unprognostic (3.98e-2)"	"unprognostic (2.50e-3)"	"unprognostic (6.64e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.54e-3)"	"unprognostic (6.02e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.11e-3)"	"unprognostic (4.50e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.96e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.66e-2)"	211.2	170.2	83.7	276.1	91.7	856.2	147.2	101.8	107.3	202.9	112.0	181.6	166.5	183.6	379.1	150.7	177.9	130.6	284.0	90.2	126.8	168.7	327.8	182.8	145.4	105.8	107.0	142.1	260.7	223.3	182.7	311.3	120.2	192.8	183.7	105.1	211.0	167.5	87.6	143.2	175.8	205.2	111.4	129.8	177.9	173.5	101.7	116.2	692.8	85.2	180.0	197.7	105.1	163.9	593.4	380.3	480.2	631.3	505.6	592.0	1152.8	1047.6	728.2	675.9	778.5	558.4	1093.4	649.5	644.7	682.4	1564.0	732.5	403.3	839.4	684.7	403.7	213.8	396.7	392.9	945.1	2692.4	547.4	730.2	363.6	1515.2	551.3	2309.4	728.1	1065.6	129.0	291.9	870.3	482.2	382.6	249.7	297.8	559.1	1327.5	362.2	233.2	492.4	1061.2	608.4	352.7	248.5	448.0	648.1	653.4	1079.3	715.5	694.3	378.0	791.8	439.5	433.0	462.7	484.2	939.0	994.7	551.2	1070.4	435.9	689.0	455.5	366.3	305.3	384.7	361.8	390.0	209.0	276.7	360.1	322.0	173.9	224.6	277.2	280.9	362.9	252.5	349.5	213.6	758.2	83.7	91.7	101.8	107.3	90.2	126.8	105.8	107.0	120.2	111.4	101.7	163.9	227.1	185.9	273.5	38.5	254.0	292.9	1225.2	573.2	192.9	97.3	193.7	166.2	803.4	97.2	416.9	112.2	352.3	505.9	408.7	426.5	45.0	415.0	86.2	372.1	402.2	247.9	508.8	82.3	19.7	258.4	955.2	455.5	258.4	467.4	334.2	304.6	147.4	379.4	449.4	63.9	34.6	508.2	195.3	133.4	271.0	50.3	175.2	261.6	181.5	30.0	135.0	134.6	80.3	29.7	41.1	313.7	408.3	174.5	1041.5	360.8	196.9	121.2	267.6	176.6	118.3	245.9	673.8	435.7	204.3	167.4	236.4	1327.5	323.8	243.0	376.4	795.4
HSPD1	"GroEL, HSP60, SPG13"	ENSG00000144381	"Heat shock protein family D (Hsp60) member 1"	P10809	2	197486584-197516737	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, Isomerase"	"Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 790.6"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 1737.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001523, CAB002775, HPA050025, CAB072816"	Supported		Enhanced	Mitochondria		NA	NA		18000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"CAB002775: , CAB072816: , HPA001523: AB_1079028, HPA050025: AB_2680995"	"unprognostic (2.79e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.21e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.91e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.47e-2)"	"unprognostic (7.83e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.10e-2)"	179.4	790.6	188.6	128.3	191.6	110.6	168.8	204.9	401.9	96.9	217.8	170.0	158.1	90.8	89.3	124.5	132.6	69.1	145.0	184.3	198.6	374.9	462.6	136.6	149.2	199.6	198.5	167.6	219.0	159.2	116.0	148.6	205.3	104.5	195.1	71.8	93.9	93.6	162.7	83.3	148.7	104.5	195.1	94.6	155.4	57.6	198.6	99.3	138.7	176.7	172.7	144.6	92.3	201.4	559.7	650.1	541.3	496.9	373.6	389.2	786.5	573.2	304.7	686.1	495.6	2219.1	326.2	1724.4	730.0	304.1	834.2	538.4	2232.9	633.2	943.0	417.0	888.2	1209.8	984.8	2562.8	353.2	1331.4	349.1	445.5	717.1	599.5	1053.2	471.4	542.6	919.1	1535.3	606.8	501.7	690.4	853.6	1304.2	1086.4	735.2	1424.9	1000.1	679.7	1235.5	709.5	539.7	716.5	400.8	582.0	608.5	771.0	1116.3	425.0	789.4	242.2	405.8	570.4	532.8	910.0	331.1	861.4	1399.5	485.7	795.3	456.7	12.1	52.3	11.4	36.4	81.8	71.7	63.8	59.6	54.3	84.6	54.0	81.0	70.3	11.0	62.6	72.1	49.4	51.8	70.6	188.6	191.6	204.9	401.9	184.3	198.6	199.6	198.5	205.3	195.1	198.6	201.4	216.4	166.7	172.5	38.8	220.4	246.6	1737.2	247.5	264.0	75.8	216.0	263.1	239.2	195.9	287.9	79.1	256.5	825.7	197.7	213.7	375.6	235.0	6.2	322.2	304.5	233.9	274.6	241.6	31.9	145.9	419.8	356.0	215.6	445.2	299.5	407.1	63.1	312.5	328.0	95.9	47.2	302.2	166.8	88.6	479.3	12.8	130.5	381.9	163.7	30.0	138.5	125.7	68.0	20.6	35.6	171.4	163.2	113.6	322.9	705.9	160.1	797.1	328.6	117.1	85.5	199.0	471.7	88.5	106.0	262.4	207.1	1001.2	467.2	1017.4	512.1	861.5
HTRA1	"ARMD7, HtrA, IGFBP5-protease, PRSS11"	ENSG00000166033	"HtrA serine peptidase 1"	Q92743	10	122458551-122514907	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding, Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 269.3;Granulosa cells: 731.6;Horizontal cells: 625.9;Muller glia cells: 373.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 2417.8;ASC TERT1: 889.4;fHDF/TERT166: 862.3;HSkMC: 1581.4;LHCN-M2: 1238.2;U-87 MG: 1004.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036655	Approved		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	24800000	7600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"		"HPA036655: AB_10671966"	"unprognostic (3.84e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.71e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.83e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (7.90e-7)"	"unprognostic (7.12e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.62e-6)"	246.0	81.3	382.1	37.0	436.6	0.5	202.8	422.6	595.7	352.1	316.2	154.8	20.8	197.1	247.1	57.8	122.9	301.2	114.7	377.7	411.4	230.9	226.4	69.9	39.9	427.1	447.0	425.5	55.9	111.8	184.1	281.9	425.3	85.7	51.8	243.6	101.1	114.5	31.1	130.5	73.5	152.3	382.1	54.2	87.3	19.5	423.6	21.2	78.8	80.9	27.3	137.3	188.3	464.2	0.3	45.6	19.4	5.7	2417.8	889.4	0.8	108.3	196.8	44.4	23.6	0.2	0.6	0.0	29.0	862.3	68.6	12.8	7.6	124.4	6.2	0.1	4.9	0.1	65.4	0.3	123.7	0.1	0.9	1581.4	444.6	25.8	205.3	503.6	207.1	0.0	0.1	1.5	1238.2	22.3	0.1	0.7	20.9	0.2	67.6	0.2	1.3	0.4	282.6	2.2	1.2	3.9	272.1	0.2	122.2	91.4	8.6	0.2	136.0	309.9	4.5	141.3	94.1	0.2	0.1	0.3	1004.6	0.2	148.5	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	382.1	436.6	422.6	595.7	377.7	411.4	427.1	447.0	425.3	382.1	423.6	464.2	55.1	22.4	6.9	116.5	0.9	44.1	32.5	10.8	23.9	53.3	5.4	31.2	26.4	14.3	0.9	64.4	54.2	30.9	1.3	0.0	0.0	2.0	3.5	11.3	76.5	107.0	0.0	2.7	2.2	4.6	164.6	269.3	4.6	14.4	1.3	731.6	57.8	157.8	51.3	625.9	31.2	0.3	8.2	18.1	59.9	4.2	31.7	22.0	46.2	86.2	8.5	373.8	0.0	193.0	112.5	2.7	1.3	77.5	1.9	8.7	0.2	22.6	10.1	150.3	6.6	63.3	140.5	0.2	0.7	7.0	30.5	87.7	7.2	2.5	0.6	11.9
HTRA2	"OMI, PARK13, PRSS25"	ENSG00000115317	"HtrA serine peptidase 2"	O43464	2	74529725-74533332	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	Apoptosis	"Hydrolase, Protease, Serine protease"	"Disease variant, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 118.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004004, HPA006602, HPA027366"	Uncertain		Supported	Mitochondria		NA	NA		260000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"CAB004004: AB_326421, HPA006602: AB_2667622, HPA027366: AB_1851301"	"unprognostic (3.09e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (7.77e-8)"	"unprognostic (2.12e-3)"	"unprognostic (4.18e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.15e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-2)"	11.4	8.6	8.1	8.1	8.7	11.1	6.8	9.1	9.7	7.1	7.7	6.4	6.9	6.9	1.0	6.0	7.1	4.7	9.4	8.1	8.3	8.1	6.5	6.6	7.8	8.6	8.5	10.9	7.4	9.4	4.7	6.3	8.3	4.8	3.3	2.5	8.5	5.3	14.5	5.4	7.9	5.3	8.2	9.9	6.4	6.2	9.6	9.1	6.8	9.0	4.8	6.5	5.8	9.2	19.1	14.7	14.7	12.6	21.3	9.0	30.1	17.0	10.3	10.3	7.0	21.1	8.5	16.6	12.9	10.7	26.0	19.7	12.0	19.6	2.4	34.0	31.4	33.3	10.8	19.0	19.8	15.3	22.4	9.9	13.7	18.4	19.5	18.4	14.2	23.5	43.9	24.9	9.7	14.1	22.0	31.1	10.0	22.8	37.7	15.8	37.0	17.1	9.6	8.2	15.1	17.7	8.9	18.6	32.5	7.3	9.3	13.2	10.6	19.2	19.7	33.4	35.3	29.5	10.2	9.8	13.6	23.4	13.0	5.8	7.0	4.0	4.8	5.7	5.8	11.0	4.8	4.1	8.6	9.9	4.3	4.1	2.6	5.0	4.5	4.5	5.7	5.5	8.1	8.7	9.1	9.7	8.1	8.3	8.6	8.5	8.3	8.2	9.6	9.2	30.7	0.0	4.8	6.2	27.3	20.6	19.7	33.8	13.6	12.0	17.4	21.7	0.9	21.5	15.7	11.0	0.0	24.7	25.8	12.5	35.2	32.4	30.8	11.9	18.1	29.6	9.0	118.5	6.3	17.7	37.8	23.3	11.2	12.9	27.3	20.9	22.9	12.7	31.5	10.1	6.3	12.3	20.3	10.7	19.4	48.9	24.8	14.6	30.2	2.8	26.3	20.2	30.9	5.5	7.5	26.1	16.8	20.7	36.0	21.3	24.8	36.8	13.5	16.3	26.3	18.7	56.5	64.3	43.3	16.7	22.0	20.2	20.6	27.1	20.0	15.7
HUWE1	"Ib772, KIAA0312, UREB1"	ENSG00000086758	"HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1"	Q7Z6Z7	X	53532096-53686728	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Granulosa cells: 507.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002548, CAB022718"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		73000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB022718: , HPA002548: AB_1080489"	"unprognostic (4.73e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.89e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	37.7	46.1	55.6	21.1	57.4	26.7	37.4	57.6	69.6	39.8	42.0	49.4	17.6	45.6	52.6	48.4	40.7	18.5	57.1	62.6	61.3	45.2	41.8	36.1	26.6	58.7	67.8	54.0	45.9	43.2	54.2	24.0	73.2	38.4	22.7	40.0	38.9	28.6	101.0	59.3	40.2	28.8	49.1	42.5	45.5	43.0	65.1	41.2	42.9	58.1	30.3	44.6	40.2	57.2	166.8	100.4	64.0	45.4	109.2	64.8	78.5	48.8	62.6	50.2	52.3	77.0	52.2	86.6	32.3	89.4	90.4	77.8	145.6	81.8	68.3	125.6	64.6	69.1	91.9	60.5	100.2	104.5	40.6	62.4	59.8	120.8	137.6	49.7	88.3	66.4	70.3	54.5	66.3	102.4	57.0	58.2	87.7	45.4	71.3	52.0	87.9	52.8	84.0	113.3	53.1	38.4	137.7	60.5	44.1	118.7	87.0	50.1	113.8	46.0	65.8	66.5	62.9	47.3	50.2	73.1	49.2	100.1	67.6	2.8	2.3	4.3	3.3	1.9	4.0	2.4	3.1	3.5	3.3	2.4	2.2	2.2	1.9	3.5	3.8	3.5	2.9	1.9	55.6	57.4	57.6	69.6	62.6	61.3	58.7	67.8	73.2	49.1	65.1	57.2	41.4	51.3	46.1	70.2	41.9	30.1	32.6	30.4	44.9	57.8	37.0	35.6	110.4	37.1	35.4	40.5	50.1	31.0	40.0	29.2	1.9	42.8	28.6	45.6	59.8	38.3	47.6	47.7	94.4	35.4	34.8	38.6	57.1	69.6	22.1	507.7	32.9	48.1	24.8	82.4	85.8	28.1	18.3	31.4	30.8	32.8	28.3	34.1	26.6	59.0	43.7	22.6	35.0	83.9	95.3	49.3	20.5	39.1	50.9	44.1	27.1	14.7	35.7	33.3	13.1	69.6	56.4	34.5	44.6	53.3	41.6	37.9	46.7	114.1	31.7	42.0
HYAL1	"HYAL-1, LUCA1"	ENSG00000114378	"Hyaluronidase 1"	Q12794	3	50299890-50312381	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 201.6;lymphoid tissue: 95.1"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 30.0;Hepatic stellate cells: 33.2;Hepatocytes: 137.1;Proximal tubular cells: 58.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 37.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"Hep G2: 100.9;SK-BR-3: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002112	Uncertain				"Secreted to blood"	NA	NA		590000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA002112: AB_1857412"	"unprognostic (1.39e-1)"	"unprognostic (8.68e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.56e-11)"	"unprognostic (4.51e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.90e-2)"	11.4	21.5	5.0	2.8	4.5	0.3	9.2	6.4	6.3	10.8	18.3	6.8	3.4	8.2	0.8	5.5	7.3	13.2	68.2	4.5	4.0	49.4	201.6	30.7	1.8	5.4	4.8	3.0	9.4	19.9	3.3	2.4	5.6	4.6	2.9	3.1	7.3	2.9	15.0	21.1	6.0	5.9	3.5	95.1	19.4	1.7	5.8	0.8	8.3	19.0	1.2	4.8	12.3	4.7	2.9	1.8	0.4	0.9	0.6	0.7	0.5	0.1	0.3	0.1	0.4	11.4	3.1	0.0	0.8	0.6	0.6	6.6	0.2	0.4	0.0	0.1	0.0	0.3	8.6	100.9	4.4	0.7	0.7	3.9	13.8	0.1	0.4	0.8	2.9	0.3	0.3	0.5	0.4	0.6	0.1	0.3	0.6	7.1	0.6	0.0	0.2	0.3	5.9	0.4	0.2	2.1	0.2	28.0	0.3	2.4	2.0	0.3	1.9	0.6	0.6	0.6	0.3	0.2	0.3	0.4	0.4	0.6	0.3	1.3	0.4	1.5	0.3	0.1	0.8	0.4	0.3	0.4	0.2	0.5	0.6	0.4	3.1	0.3	0.3	0.5	0.4	0.1	5.0	4.5	6.4	6.3	4.5	4.0	5.4	4.8	5.6	3.5	5.8	4.7	18.1	19.2	18.5	1.6	0.3	2.9	0.4	3.3	0.0	1.0	0.3	0.1	20.8	30.0	2.0	11.0	4.2	0.1	0.0	2.5	23.5	16.5	8.2	0.2	0.9	25.8	1.8	2.7	3.1	14.4	0.1	3.3	19.4	0.2	0.0	0.6	33.2	137.1	0.1	0.0	3.1	1.4	0.0	4.4	0.9	7.7	2.1	0.9	0.0	7.5	0.0	0.4	0.0	1.5	1.6	12.1	0.3	1.2	0.0	0.2	0.4	58.2	0.9	0.5	6.6	1.2	4.3	0.4	1.1	0.9	3.1	0.7	0.9	7.4	0.9	1.7
HYOU1	"Grp170, HSP12A, ORP150"	ENSG00000149428	"Hypoxia up-regulated 1"	Q9Y4L1	11	119044188-119057227	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Stress response"	Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 201.9"	"Cell type enhanced"	"Detected in all"		"Plasma cells: 118.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 35.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 418.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049296	Approved				"Intracellular and membrane"	NA	NA		130000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA049296: AB_2680702"	"unprognostic (2.97e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.46e-2)"	"prognostic favorable (2.58e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.81e-1)"	"unprognostic (8.98e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (5.10e-5)"	"unprognostic (3.86e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (1.38e-2)"	38.2	48.5	30.7	27.1	32.2	18.6	31.0	28.3	34.1	37.2	25.5	40.9	18.1	44.6	51.2	47.4	40.8	14.0	56.5	32.9	41.0	63.0	201.9	47.7	17.4	32.6	34.5	36.1	165.9	18.8	100.1	19.9	34.2	47.9	21.3	11.9	46.3	20.7	19.1	25.0	39.0	19.0	28.5	47.6	60.3	85.7	35.2	21.7	87.2	8.4	20.9	39.9	31.7	32.9	40.5	34.5	77.2	224.4	41.2	19.7	107.7	56.1	38.0	63.1	47.2	105.0	103.0	85.3	418.9	40.7	122.1	59.5	71.5	69.3	53.8	92.8	26.1	151.8	32.6	76.7	187.7	88.6	73.5	23.9	91.1	55.2	185.3	57.9	100.2	57.2	53.5	136.8	33.9	97.8	59.4	49.6	55.5	83.2	33.6	63.1	55.9	144.3	48.6	67.8	45.7	70.0	80.4	103.8	53.3	65.5	78.8	82.9	75.0	59.9	46.4	27.2	77.5	88.1	64.0	61.2	53.8	76.2	135.6	4.4	4.5	2.2	11.7	6.1	12.6	5.4	6.4	8.7	5.0	4.0	4.0	6.1	1.3	7.6	4.4	35.9	5.5	4.7	30.7	32.2	28.3	34.1	32.9	41.0	32.6	34.5	34.2	28.5	35.2	32.9	16.4	9.6	14.1	6.2	22.7	17.8	18.5	17.5	14.2	11.5	28.5	21.1	12.4	15.7	16.8	25.8	43.8	11.2	36.6	35.3	9.8	20.7	74.0	20.4	29.1	20.0	35.8	17.0	12.0	18.8	26.6	21.0	39.8	38.1	15.8	43.1	13.9	49.9	22.2	25.2	13.7	52.1	18.3	8.2	21.6	38.8	13.1	17.8	23.2	5.6	15.5	8.7	17.5	4.5	9.3	31.4	24.2	13.5	118.7	44.4	14.9	17.6	16.7	14.5	13.1	16.4	15.6	27.8	29.1	16.2	19.9	19.3	20.8	14.8	27.3	24.7
IARS1	"IARS, ILRS"	ENSG00000196305	"Isoleucyl-tRNA synthetase 1"	P41252	9	92210207-92293756	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 47.6;Cytotrophoblasts: 29.8;Extravillous trophoblasts: 31.7;Hofbauer cells: 17.2;Syncytiotrophoblasts: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029806	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		100000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA029806: AB_10601818"	"unprognostic (1.32e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (4.98e-7)"	"unprognostic (2.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.76e-3)"	22.2	24.3	6.3	28.8	5.8	13.2	27.4	8.8	11.5	26.4	10.7	29.1	17.9	32.5	15.1	31.8	27.7	16.1	32.2	6.8	10.7	28.4	19.6	18.9	28.3	5.9	7.3	20.4	40.1	52.3	11.7	27.7	8.6	27.7	33.3	25.2	25.5	31.6	43.1	21.7	16.2	42.6	3.6	19.7	31.4	20.0	5.2	27.5	64.6	47.2	37.6	28.2	11.7	6.9	150.7	154.9	83.3	132.2	110.5	142.2	126.8	156.4	146.2	118.8	138.5	52.2	99.0	216.0	54.9	231.4	130.5	194.9	254.4	197.9	149.3	126.1	97.9	135.3	128.3	62.8	235.6	181.3	90.6	134.1	194.9	208.9	348.9	78.3	123.6	230.1	229.2	189.8	145.0	79.3	173.2	31.6	139.7	294.5	143.3	116.2	129.3	103.0	72.9	72.6	110.2	91.5	118.2	117.0	128.8	87.8	95.2	94.4	101.3	89.5	104.6	149.3	119.1	134.8	156.4	99.5	218.7	133.3	173.3	2.8	5.9	0.7	11.9	7.0	16.4	13.9	11.8	11.9	12.7	9.7	12.8	12.7	0.5	19.5	6.3	4.8	10.9	9.0	6.3	5.8	8.8	11.5	6.8	10.7	5.9	7.3	8.6	3.6	5.2	6.9	7.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.6	0.0	0.0	0.0	0.0	29.8	7.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	31.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	17.4	1.1	0.0	0.0	0.0
IARS2	FLJ10326	ENSG00000067704	"Isoleucyl-tRNA synthetase 2, mitochondrial"	Q9NSE4	1	220094132-220148041	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cataract, Deafness, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024212, HPA024594, HPA024596"	Enhanced		Enhanced	Mitochondria		NA	NA		35000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA024212: AB_1851363, HPA024594: AB_1851368, HPA024596: AB_1851370"	"unprognostic (2.15e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (9.24e-5)"	"unprognostic (9.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.27e-3)"	55.8	49.8	19.9	33.3	21.1	18.3	41.8	23.5	25.4	35.3	37.8	54.2	43.4	31.8	31.4	47.9	41.4	30.5	60.0	20.0	21.8	65.5	83.8	31.0	38.8	22.7	22.2	39.0	33.6	80.5	16.0	40.7	25.0	36.1	54.8	34.8	40.0	37.5	92.9	40.5	40.4	39.4	21.6	28.4	39.1	30.1	22.3	31.8	39.7	85.7	43.1	35.6	30.0	22.9	137.2	125.6	70.7	69.9	104.2	104.4	169.6	81.4	86.9	87.9	70.7	121.7	138.8	125.6	107.1	101.4	68.0	129.3	99.0	101.5	100.9	87.5	119.3	62.6	94.6	137.8	64.6	100.4	64.9	76.0	101.3	95.4	97.6	84.7	86.9	79.9	156.9	70.7	116.7	75.9	79.8	72.0	92.1	106.2	82.1	69.5	140.7	202.2	126.2	90.4	38.0	106.6	123.2	188.2	130.3	80.6	218.5	111.9	89.8	86.1	71.6	117.0	138.4	60.0	98.9	90.8	91.3	77.3	97.6	33.8	24.6	22.8	23.0	27.7	30.8	23.6	24.9	30.3	29.2	18.3	27.8	25.6	4.7	28.3	22.3	10.6	29.9	26.7	19.9	21.1	23.5	25.4	20.0	21.8	22.7	22.2	25.0	21.6	22.3	22.9	66.4	35.3	38.0	15.7	30.7	20.1	28.6	44.1	34.7	28.6	40.1	39.4	144.3	22.8	42.9	29.5	25.0	79.0	31.5	54.2	11.7	47.7	20.0	63.8	48.3	43.7	36.2	29.6	17.3	65.4	55.5	37.0	32.1	44.3	19.6	41.3	37.5	99.6	45.9	20.2	22.7	55.4	28.5	51.0	11.2	6.8	37.3	35.9	19.6	15.0	46.1	34.6	27.8	16.6	31.5	67.4	44.9	42.5	33.1	34.1	38.4	36.1	62.0	35.5	46.0	46.3	39.0	44.6	44.1	63.5	26.6	71.7	31.0	54.4	69.9	27.6
IDS	"ID2S, SIDS"	ENSG00000010404	"Iduronate 2-sulfatase"	P22304	X	149476988-149521096	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 323.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"amygdala: 194.3;basal ganglia: 212.9;cerebral cortex: 323.4;hippocampal formation: 320.5;white matter: 109.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA078003	Approved				"Intracellular and membrane"	NA	NA		17000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 24: Non-specific - Transcription regulation"			"HPA078003: "	"unprognostic (9.88e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.52e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.76e-3)"	"unprognostic (3.61e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.87e-1)"	32.7	43.3	194.3	29.5	212.9	47.6	27.9	0.0	323.4	37.5	0.0	35.7	21.1	35.1	43.5	26.1	35.7	26.3	42.2	320.5	25.7	22.7	15.8	40.5	31.0	9.7	9.4	45.4	23.3	57.0	67.8	16.3	3.1	29.4	20.8	48.6	24.7	41.0	25.1	37.1	27.9	30.5	0.2	34.1	23.0	6.1	32.3	17.2	27.2	38.9	36.0	32.8	31.5	109.4	46.4	50.7	19.6	12.7	22.1	40.9	9.2	26.6	67.8	23.3	43.9	10.2	32.7	110.0	69.6	38.3	49.1	22.6	21.3	40.5	30.1	40.8	17.7	11.5	14.7	5.7	17.8	18.8	101.3	21.4	19.6	50.9	33.1	95.5	37.8	20.2	5.7	76.6	34.7	57.9	19.6	9.3	17.5	28.8	34.3	12.4	19.4	20.7	27.8	10.5	28.9	67.6	9.8	22.1	32.0	33.2	6.9	7.9	44.3	29.9	31.3	50.1	70.8	54.5	47.3	79.3	138.0	44.3	22.1	117.5	56.9	171.7	70.9	63.0	53.2	35.2	43.1	54.0	48.7	27.0	28.4	42.9	261.1	37.2	73.9	36.8	74.0	63.0	194.3	212.9	0.0	323.4	320.5	25.7	9.7	9.4	3.1	0.2	32.3	109.4	53.7	99.3	64.4	55.8	150.9	33.1	60.6	44.0	20.5	178.3	43.2	43.8	44.1	27.1	58.9	82.8	45.9	34.2	158.5	66.9	21.5	50.2	1.3	59.8	36.8	44.7	168.4	19.6	232.3	74.0	25.7	78.3	31.1	49.5	226.2	25.5	60.3	33.0	44.0	222.1	243.7	29.0	73.2	94.8	109.8	3.7	72.7	98.4	51.6	63.7	120.9	55.0	146.2	39.2	95.8	85.0	50.3	89.5	98.8	71.3	74.6	22.3	112.4	59.5	59.2	68.1	65.2	3.5	6.6	22.2	43.8	143.0	183.9	16.4	17.1	96.9
IDUA	"MPS1, MPSI"	ENSG00000127415	Alpha-L-iduronidase	P35475	4	986997-1004564	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025901, HPA046979, HPA054254"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		170000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"CAB025901: , HPA046979: AB_2679888, HPA054254: AB_2682429"	"unprognostic (3.62e-2)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.64e-2)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (2.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"prognostic favorable (8.04e-5)"	13.5	17.6	3.4	2.2	3.4	2.9	16.1	9.2	7.5	17.5	2.9	10.3	3.6	15.4	2.4	9.9	16.3	3.7	11.6	3.8	1.5	15.9	13.6	13.9	3.5	3.2	2.1	17.0	21.0	2.8	17.2	1.7	2.4	18.5	1.8	1.8	16.6	4.5	3.7	8.9	14.3	2.0	1.0	18.9	17.1	5.6	2.9	3.4	17.0	0.7	1.3	12.0	13.9	2.6	1.8	0.4	0.0	1.1	12.7	3.6	5.3	10.7	8.5	1.2	1.7	0.6	6.4	0.8	10.7	5.0	1.0	0.5	0.1	0.3	0.4	6.1	0.6	1.0	0.8	0.1	5.8	0.8	4.6	9.3	3.1	0.6	0.0	3.4	1.0	0.7	0.6	0.0	1.6	0.0	2.2	2.5	0.8	11.9	5.5	2.7	0.0	1.1	3.5	0.9	0.1	3.3	0.3	0.0	5.7	1.3	1.2	2.3	9.3	9.0	1.6	2.6	1.2	29.0	1.4	0.4	7.8	3.3	1.8	0.0	1.5	0.0	1.4	1.2	1.8	0.1	1.1	0.9	1.8	0.2	1.3	0.7	0.0	1.5	1.7	1.1	0.6	0.5	3.4	3.4	9.2	7.5	3.8	1.5	3.2	2.1	2.4	1.0	2.9	2.6	8.7	6.4	5.0	4.9	5.2	3.6	11.5	1.1	8.6	2.0	8.5	9.1	2.6	1.5	1.5	7.3	4.2	0.4	4.3	5.0	0.0	1.6	0.9	4.1	9.0	4.9	10.7	1.3	4.4	2.4	1.7	13.4	16.8	6.0	2.5	8.2	6.1	2.6	6.5	0.0	2.9	4.2	0.0	5.0	3.6	0.9	19.6	7.3	5.4	1.0	1.6	1.1	4.1	5.5	3.3	1.4	6.9	10.5	15.7	7.7	6.9	1.4	1.4	2.1	0.0	5.5	4.4	3.7	1.6	4.7	1.8	0.4	5.6	4.7	4.3	7.9
IFIH1	"Hlcd, IDDM19, MDA-5, MDA5"	ENSG00000115267	"Interferon induced with helicase C domain 1"	Q9BYX4	2	162267074-162318684	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 38.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 55.6;Late spermatids: 53.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 62.3;BJ hTERT+ SV40 Large T+ RasG12V: 71.5;Karpas-707: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002656	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA002656: AB_1079344"	"unprognostic (2.85e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.65e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.41e-2)"	"unprognostic (7.29e-2)"	6.2	6.4	3.1	12.7	4.3	38.1	5.9	3.2	3.0	6.5	4.4	7.4	13.1	6.4	4.3	7.5	7.2	9.5	5.1	2.3	3.3	5.6	8.5	10.9	11.7	7.2	3.4	7.0	7.1	8.1	5.9	8.3	5.0	5.5	6.8	1.1	17.5	4.7	1.7	5.0	10.0	5.7	8.1	16.4	9.6	2.4	4.2	10.9	6.0	3.2	9.7	6.4	5.2	4.4	6.7	0.3	0.2	0.0	7.4	6.0	2.8	1.2	17.7	62.3	71.5	1.2	16.7	13.3	10.5	1.0	31.9	8.5	1.1	9.8	6.3	35.4	4.5	7.1	0.8	2.8	5.0	8.2	6.4	5.3	4.8	8.9	1.7	6.5	4.9	6.9	0.3	38.9	1.0	12.5	9.3	6.4	0.0	5.4	3.8	7.5	0.0	18.8	5.9	7.3	0.4	0.1	3.7	20.7	34.0	0.3	5.7	7.1	4.1	1.9	1.7	1.1	2.7	15.2	26.8	1.9	3.5	6.5	5.6	4.4	11.5	4.4	6.6	12.5	9.2	12.4	8.2	7.2	11.1	12.8	6.7	6.9	15.2	4.0	12.7	1.6	10.3	7.8	3.1	4.3	3.2	3.0	2.3	3.3	7.2	3.4	5.0	8.1	4.2	4.4	24.7	32.1	12.0	4.6	20.1	6.8	11.2	7.7	6.2	0.0	4.8	5.2	5.0	12.8	11.1	7.3	0.0	6.4	10.2	10.9	5.9	18.7	55.6	17.3	7.9	22.3	15.7	8.2	2.8	18.7	17.5	8.8	10.7	20.2	13.3	10.4	13.6	6.5	14.4	0.0	0.7	11.5	8.2	12.8	8.7	53.3	13.7	20.0	5.4	28.1	23.9	7.3	10.3	0.5	4.0	13.4	10.1	13.2	16.0	9.1	11.8	4.8	17.5	0.1	0.0	10.9	4.9	1.6	1.3	10.2	5.8	3.4	13.1	6.9	6.7	11.1
IGHMBP2	"CATF1, CMT2S, HCSA, HMN6, SMARD1, SMUBP2, ZFAND7"	ENSG00000132740	"Immunoglobulin mu DNA binding protein 2"	P38935	11	68903863-68940602	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase, Ribonucleoprotein, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 94.6;Late spermatids: 46.9;Spermatocytes: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004092, HPA060994"			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA004092: , HPA060994: AB_2684406"	"unprognostic (1.17e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.59e-3)"	"unprognostic (4.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.29e-8)"	"unprognostic (1.69e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.18e-2)"	5.2	4.0	1.2	2.5	1.3	6.0	5.4	0.7	1.7	7.0	0.1	11.8	1.5	7.8	0.6	5.5	6.7	1.7	5.2	1.6	1.2	4.4	6.3	5.1	3.3	0.8	0.4	6.1	5.2	2.8	4.0	2.0	0.7	6.3	1.5	1.4	6.4	3.1	8.5	7.7	6.3	2.6	0.5	5.7	6.2	15.4	0.6	4.3	4.9	3.8	1.7	6.3	5.8	1.1	5.1	7.3	4.0	7.4	3.6	3.1	5.2	5.8	3.9	7.8	4.6	14.5	7.0	7.3	9.7	3.3	6.9	8.0	5.8	4.9	1.8	8.3	6.2	6.6	9.6	5.6	5.5	6.5	7.4	1.8	4.9	9.2	4.6	4.5	4.6	11.1	10.6	4.6	2.3	5.1	11.1	8.9	2.3	7.9	10.3	9.4	5.7	7.6	3.3	5.9	8.6	5.4	7.4	6.1	16.6	3.0	9.3	6.0	6.6	5.3	3.8	7.7	6.6	6.0	6.3	6.9	5.3	6.1	5.1	0.0	2.0	0.8	1.5	1.8	1.3	1.0	0.9	1.0	1.8	0.6	0.5	0.7	0.6	0.1	1.1	0.3	0.6	1.3	1.2	1.3	0.7	1.7	1.6	1.2	0.8	0.4	0.7	0.5	0.6	1.1	6.6	6.4	7.7	7.5	5.7	5.7	3.8	3.5	6.2	9.1	5.6	3.8	6.3	8.6	6.1	1.8	20.9	4.9	10.2	6.0	1.9	5.1	94.6	7.0	8.1	6.4	3.0	9.3	7.4	5.1	4.4	5.5	6.1	14.0	7.0	10.7	3.3	6.1	5.8	11.8	6.4	4.1	2.0	3.5	4.3	46.9	7.8	7.2	1.8	5.6	7.3	6.6	9.2	6.0	5.2	6.5	8.4	7.2	5.8	7.5	3.9	2.9	3.8	10.1	0.0	5.1	10.1	51.6	7.1	5.3	6.7	6.7	8.0	4.6	7.1	6.3
IL1RAPL1	"IL1R8, IL1RAPL, MRX10, MRX21, MRX34, OPHN4, TIGIRR-2"	ENSG00000169306	"Interleukin 1 receptor accessory protein like 1"	Q9NZN1	X	28587446-29956718	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Receptor"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	73	"brain: 33.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1315.7;Inhibitory neurons: 2598.6;Oligodendrocyte precursor cells: 1954.3;Oligodendrocytes: 6420.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"white matter: 33.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"GAMG: 8.7;WM-115: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (2.51e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.25e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.95e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.74e-4)"	"unprognostic (2.29e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.58e-3)"	0.1	0.0	3.9	0.0	12.1	0.0	0.1	1.9	8.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.4	3.3	4.0	0.0	0.2	0.0	0.0	7.8	4.5	0.3	0.1	0.0	0.0	0.1	5.7	0.2	0.1	0.2	0.0	0.2	0.4	0.0	0.2	0.0	3.9	0.0	0.1	0.1	8.5	0.0	0.1	0.1	0.0	0.3	0.0	33.4	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.2	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	12.1	1.9	8.1	3.3	4.0	7.8	4.5	5.7	3.9	8.5	33.4	0.5	0.0	0.5	64.6	0.0	0.1	0.2	0.0	0.6	2.4	0.0	0.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1315.7	0.0	0.0	1.6	0.0	0.0	26.1	0.1	0.0	0.0	0.1	0.0	2598.6	0.0	0.0	0.0	0.9	0.2	0.3	0.0	1.8	42.2	0.0	0.3	0.0	1954.3	6420.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.7	1.5	0.0	0.1	0.1	1.1	0.4	0.1	0.0
IMMP2L	"IMMP2L-IT1, IMP2"	ENSG00000184903	"Inner mitochondrial membrane peptidase subunit 2"	Q96T52	7	110662644-111562517	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 247.8;Distal tubular cells: 160.4;Excitatory neurons: 365.4;Inhibitory neurons: 373.9;Microglial cells: 455.3;Oligodendrocyte precursor cells: 273.9;Oligodendrocytes: 233.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026711	Approved		Approved	Mitochondria		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA026711: AB_1851760"	"unprognostic (2.55e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (1.89e-5)"	"unprognostic (5.64e-3)"	"unprognostic (1.00e-1)"	"unprognostic (4.17e-1)"	"unprognostic (5.68e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.71e-1)"	19.2	14.2	10.4	5.1	12.5	5.2	15.7	9.6	11.7	12.4	14.2	14.6	7.6	15.3	11.9	8.0	16.0	8.5	13.1	11.9	12.2	34.0	25.7	8.1	7.5	11.3	11.3	19.5	12.1	20.1	8.0	9.0	11.3	19.0	8.2	9.2	11.1	21.1	27.3	10.2	12.9	14.2	10.9	8.4	11.8	9.9	11.4	8.9	23.5	25.1	7.5	12.5	10.5	13.1	17.5	10.3	6.1	25.1	15.8	16.0	10.7	11.8	11.9	7.7	8.1	5.1	19.8	28.4	31.4	10.2	14.3	9.6	6.6	23.6	12.7	17.9	6.7	9.7	44.2	14.0	24.2	18.2	1.1	27.9	30.7	3.3	21.4	35.0	10.2	26.2	32.0	21.4	5.9	12.3	24.4	20.3	6.0	33.2	15.8	5.1	50.0	15.0	28.0	7.3	7.0	22.1	5.1	23.8	67.3	17.2	9.6	10.4	6.5	11.8	12.3	11.9	14.4	12.2	3.5	17.4	12.9	8.4	63.1	15.9	9.1	2.9	10.5	11.9	19.4	28.5	18.3	12.3	17.0	38.7	25.0	17.6	0.5	47.0	17.3	21.3	12.4	8.1	10.4	12.5	9.6	11.7	11.9	12.2	11.3	11.3	11.3	10.9	11.4	13.1	22.3	19.2	13.2	247.8	20.4	32.9	34.4	41.4	39.9	11.3	35.3	39.4	19.5	15.7	23.9	47.8	8.4	22.4	11.9	3.1	160.4	30.1	8.4	10.4	12.6	15.3	19.3	21.9	365.4	8.1	27.1	19.5	12.8	12.0	3.8	11.3	11.7	23.8	11.7	8.4	373.9	7.0	28.5	4.9	14.1	5.6	49.4	6.1	21.4	455.3	10.1	16.3	1.0	273.9	233.7	10.8	6.8	35.0	9.2	36.2	25.5	66.8	13.3	15.6	13.1	19.5	46.7	24.2	12.8	28.0	26.6	16.3	12.6	18.7	11.7	22.1
IMPA1	IMPA	ENSG00000133731	"Inositol monophosphatase 1"	P29218	8	81656914-81686331	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037489	Approved					NA	No		310000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA037489: AB_10671757"	"unprognostic (1.78e-1)"	"unprognostic (3.59e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.68e-2)"	"unprognostic (7.78e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.42e-1)"	"unprognostic (5.41e-3)"	12.8	11.3	12.7	12.7	13.3	27.0	10.2	11.8	15.8	8.9	14.8	26.9	23.5	10.4	11.7	20.7	11.8	11.8	25.8	14.6	12.6	16.4	31.3	10.2	17.6	10.9	13.4	13.5	8.6	15.5	10.1	8.2	13.0	11.0	28.4	18.2	8.3	8.1	14.1	5.1	23.2	18.0	12.4	11.2	14.7	38.2	12.1	19.6	21.8	29.0	16.3	14.0	10.5	15.1	12.5	34.6	23.3	17.2	14.0	21.9	9.8	35.7	26.5	31.3	36.7	16.3	20.1	47.2	27.5	26.2	45.6	9.4	27.1	12.0	41.3	50.7	26.5	35.7	19.2	20.8	23.8	36.7	35.0	20.3	17.6	24.9	48.2	30.2	35.2	35.6	32.8	38.7	30.6	8.7	46.1	18.4	10.1	32.2	37.2	21.2	16.9	19.2	31.7	43.5	9.3	38.7	23.9	6.2	41.3	39.6	20.4	27.4	26.4	24.9	32.8	19.8	44.1	45.2	58.5	67.4	29.4	20.7	35.9	50.5	6.6	29.4	13.6	10.3	16.8	20.3	13.5	14.9	7.5	13.7	14.0	16.8	11.2	20.5	11.8	12.0	19.6	9.5	12.7	13.3	11.8	15.8	14.6	12.6	10.9	13.4	13.0	12.4	12.1	15.1	22.2	16.0	12.7	15.3	25.7	13.8	16.9	16.8	28.5	15.8	8.5	6.9	38.3	21.5	17.3	9.2	14.6	9.7	29.4	54.4	31.3	16.2	4.0	23.2	19.7	16.5	21.5	11.6	19.4	20.3	11.0	16.1	12.2	17.3	33.0	11.5	13.9	32.9	14.3	25.2	12.5	19.8	18.3	16.2	13.1	8.2	15.5	16.4	12.4	12.2	21.9	23.4	13.4	14.1	14.0	19.0	62.3	15.1	18.1	14.4	30.4	30.7	25.1	15.9	13.1	15.5	17.0	78.4	19.2	26.9	8.7	3.0	26.2	18.7	22.3	21.3
INPP5E	"CORS1, JBTS1, pharbin, PPI5PIV"	ENSG00000148384	"Inositol polyphosphate-5-phosphatase E"	Q9NRR6	9	136428619-136439845	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase	"Ciliopathy, Disease variant, Joubert syndrome, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065758	Approved		Approved	"Golgi apparatus,Focal adhesion sites"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus, Focal adhesion sites"		"HPA065758: AB_2685554"	"unprognostic (1.99e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.00e-1)"	"unprognostic (6.92e-2)"	"unprognostic (9.60e-3)"	"unprognostic (3.21e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.65e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (2.03e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.66e-2)"	12.1	10.8	15.0	6.9	15.0	6.4	11.7	15.3	19.9	15.1	11.3	13.1	5.7	15.2	2.3	10.6	17.6	5.3	13.7	14.0	14.3	13.3	12.2	11.9	8.2	15.1	13.3	16.2	10.8	6.6	14.3	5.7	15.5	12.3	3.3	7.4	9.5	5.3	8.5	11.2	11.7	5.6	11.4	20.8	8.9	20.1	14.8	6.4	15.1	3.8	4.7	12.2	12.0	13.9	8.9	10.3	12.6	13.2	6.5	7.1	14.9	10.7	5.7	7.4	5.1	12.5	6.0	10.8	10.5	11.1	11.9	25.2	6.2	8.6	2.8	36.8	25.4	8.5	27.1	8.4	10.3	9.5	11.9	10.9	8.8	9.8	7.2	10.3	8.9	14.8	14.5	14.0	7.0	22.3	11.4	19.9	8.1	5.3	16.0	21.1	8.7	8.3	7.4	9.8	14.1	12.2	10.4	8.5	7.6	7.6	15.1	15.6	11.8	24.1	9.4	10.1	18.2	11.6	10.6	4.5	12.0	7.8	9.7	0.0	0.1	0.5	0.5	0.0	0.3	0.7	0.6	0.4	0.1	0.4	0.2	0.4	0.1	0.0	0.0	0.2	0.7	0.1	15.0	15.0	15.3	19.9	14.0	14.3	15.1	13.3	15.5	11.4	14.8	13.9	14.7	3.2	6.9	17.0	5.0	5.5	1.8	2.6	5.7	7.4	6.5	6.9	5.0	7.2	3.4	3.7	2.1	2.3	7.6	4.0	1.9	4.8	0.9	11.8	8.1	7.4	6.1	0.8	12.2	5.6	2.8	5.7	3.6	6.8	8.9	8.3	6.1	3.8	3.2	15.2	12.9	2.6	6.1	3.5	3.5	1.3	7.5	3.7	5.4	6.5	3.5	8.9	1.0	8.5	8.5	6.7	1.6	5.7	2.5	3.3	3.4	2.4	10.0	10.8	0.0	5.5	7.5	15.3	9.1	5.4	4.8	0.8	5.3	5.6	3.9	1.6
INPP5K	SKIP	ENSG00000132376	"Inositol polyphosphate-5-phosphatase K"	Q9BT40	17	1494577-1516742	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cataract, Congenital muscular dystrophy, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 96.1;Late spermatids: 345.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (7.47e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (8.91e-2)"	"prognostic favorable (2.33e-5)"	"unprognostic (3.25e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.77e-2)"	"prognostic favorable (1.47e-6)"	"unprognostic (4.71e-2)"	"unprognostic (9.35e-3)"	"unprognostic (3.01e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.04e-1)"	34.7	15.2	25.8	12.9	26.0	34.5	29.2	25.3	30.2	19.5	61.5	19.6	10.2	17.0	13.1	17.9	15.3	10.7	28.9	29.8	25.7	16.7	15.0	27.3	18.6	26.9	26.9	17.8	21.9	13.7	14.8	18.6	26.9	19.6	12.7	15.9	18.1	12.9	40.5	30.1	19.4	12.0	25.4	22.8	19.1	20.4	26.9	25.8	30.4	25.2	19.7	18.2	17.9	27.0	14.9	24.0	9.2	18.4	22.5	13.2	12.1	12.0	23.6	15.8	19.6	15.7	9.1	14.6	23.2	22.2	12.5	19.4	22.1	9.6	14.3	35.3	33.0	8.6	18.1	5.9	31.3	7.9	17.0	16.2	24.0	15.8	16.1	10.0	25.3	25.3	9.4	25.9	10.6	12.5	24.5	7.1	3.9	23.9	14.6	19.0	6.7	14.6	12.8	10.3	7.1	18.0	10.2	21.6	24.3	13.0	17.9	7.3	16.2	13.6	13.3	19.8	16.8	12.9	23.4	7.4	14.7	9.1	17.3	104.3	42.2	74.3	48.7	41.9	39.7	27.5	44.5	50.2	36.2	24.4	37.5	41.1	74.7	42.3	66.6	27.0	75.1	62.5	25.8	26.0	25.3	30.2	29.8	25.7	26.9	26.9	26.9	25.4	26.9	27.0	26.1	32.1	14.1	8.5	20.6	30.0	15.7	10.8	18.8	7.8	15.6	12.2	35.8	8.6	11.0	23.9	2.1	13.9	27.5	26.0	13.7	19.4	96.1	10.3	6.9	27.0	17.4	25.2	5.4	24.3	16.4	15.5	13.3	17.4	19.7	7.7	28.5	10.2	11.9	20.2	5.9	17.3	14.2	18.4	19.0	345.7	11.5	13.8	32.0	2.8	37.1	23.1	27.8	2.5	7.0	27.1	23.4	7.5	18.0	13.3	33.2	11.2	6.4	7.9	19.7	12.6	15.3	35.5	20.4	18.1	30.3	31.1	27.2	5.8	13.5	17.4
INPPL1	SHIP2	ENSG00000165458	"Inositol polyphosphate phosphatase like 1"	O15357	11	72223701-72239147	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Immunity"	"Actin-binding, Hydrolase"	"Cancer-related genes, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 344.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037601	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Golgi apparatus"	"HPA037601: AB_10672281"	"unprognostic (2.68e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (2.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.07e-1)"	45.2	56.4	39.0	34.4	43.4	51.3	44.7	41.3	40.5	63.8	47.3	87.5	35.9	56.1	18.2	34.6	61.3	33.7	73.6	33.2	42.5	60.0	36.6	61.8	36.8	53.9	43.2	68.6	55.7	36.4	60.5	39.7	45.8	68.7	23.3	14.9	53.8	39.5	116.6	31.4	57.1	33.4	45.0	66.1	60.8	24.2	48.8	19.3	67.7	43.0	23.2	59.9	43.4	41.2	28.7	62.1	71.5	49.8	35.4	41.1	122.5	118.9	61.2	80.6	49.6	84.3	72.2	79.5	125.6	101.7	57.8	106.7	60.4	37.6	28.0	101.9	59.1	84.8	344.5	31.9	68.1	56.1	176.7	58.2	39.1	78.0	31.4	100.5	44.2	29.3	59.7	34.7	45.1	78.8	42.1	224.9	67.7	20.7	93.7	185.0	161.0	18.2	94.8	48.6	33.8	48.6	133.9	85.1	182.8	36.6	88.8	106.0	74.5	86.4	96.7	129.9	43.1	94.5	17.5	80.1	24.7	51.7	47.2	2.5	3.5	3.3	1.9	2.0	1.7	0.9	1.6	1.3	2.4	1.0	1.1	1.6	2.3	2.2	3.6	1.8	1.5	1.8	39.0	43.4	41.3	40.5	33.2	42.5	53.9	43.2	45.8	45.0	48.8	41.2	13.9	3.2	12.8	47.0	8.1	7.1	4.9	10.8	14.2	1.7	20.3	17.3	13.6	11.5	11.7	12.9	27.1	27.9	9.1	28.3	1.9	11.6	1.5	14.6	16.3	11.2	22.7	5.7	2.6	12.5	15.4	10.8	24.5	25.5	7.6	21.0	8.9	12.5	21.7	10.1	2.2	16.4	18.3	27.6	16.2	2.1	9.9	29.8	10.6	18.7	17.6	16.8	14.4	15.1	6.1	14.9	17.5	13.9	7.8	7.8	15.2	16.2	10.2	17.2	6.6	12.9	14.5	1.4	4.9	6.7	4.8	32.4	11.6	10.1	21.8	5.4
IRAK3	IRAK-M	ENSG00000090376	"Interleukin 1 receptor associated kinase 3"	Q9Y616	12	66189195-66254622	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"			Asthma	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 83.3;Kupffer cells: 123.0;Macrophages: 126.3;Microglial cells: 114.3;monocytes: 96.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 12.7;classical monocyte: 23.4;intermediate monocyte: 24.2;myeloid DC: 11.5;neutrophil: 12.9;non-classical monocyte: 42.0"	"Group enriched"	"Detected in many"	12	"dendritic cells: 11.5;granulocytes: 12.9;monocytes: 42.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.9;ASC TERT1: 21.1;HEL: 22.9;HL-60: 30.8;NB-4: 25.1;THP-1: 37.3;U-937: 26.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043097	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA043097: AB_10795612"	"unprognostic (7.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (8.52e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (5.58e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.23e-2)"	18.7	3.8	3.7	12.4	4.1	78.1	11.6	4.1	7.5	9.3	5.4	4.6	1.3	4.0	3.0	3.8	8.0	6.9	7.9	3.2	4.7	3.5	2.8	19.0	4.1	5.6	5.7	3.2	2.5	0.9	8.9	6.8	6.5	5.3	2.8	0.4	6.2	5.6	2.6	3.4	5.6	5.4	5.0	27.5	6.9	1.8	5.6	2.7	5.0	4.6	3.9	8.4	6.6	5.1	0.0	0.0	0.4	0.0	25.9	21.1	0.0	2.9	0.0	1.5	2.3	0.0	2.2	0.0	1.4	5.3	0.0	0.0	3.2	0.0	1.3	0.0	0.0	22.9	1.4	0.0	13.4	30.8	4.0	13.5	0.1	1.2	0.0	0.0	7.6	0.0	0.0	0.0	1.0	0.0	0.0	25.1	1.3	0.0	0.0	0.0	6.4	0.0	0.1	3.3	0.1	0.0	11.6	0.0	1.2	0.1	0.1	37.3	8.2	0.0	0.0	0.0	0.0	0.9	0.2	2.2	0.0	26.8	0.0	12.7	23.4	4.3	0.0	24.2	0.0	0.1	0.0	0.0	11.5	0.7	0.0	0.0	12.9	1.8	42.0	0.1	0.6	7.3	3.7	4.1	4.1	7.5	3.2	4.7	5.6	5.7	6.5	5.0	5.6	5.1	83.3	9.6	19.4	1.3	2.3	1.5	4.8	27.5	6.2	0.3	2.5	1.8	2.8	0.0	46.9	3.7	0.0	0.2	14.8	0.5	0.0	0.6	6.4	0.5	7.5	38.5	0.0	9.7	0.4	1.2	0.4	22.3	18.3	0.5	27.3	0.5	36.4	1.2	9.4	0.0	5.6	1.1	36.7	123.0	12.1	5.3	7.2	126.3	5.4	114.3	96.9	0.2	3.1	2.0	0.6	4.9	0.1	11.3	9.1	1.6	0.0	0.2	35.1	0.1	0.0	18.1	10.2	0.8	1.8	1.2	1.3	0.3	3.5	12.5	0.7	2.5
IRAK4	NY-REN-64	ENSG00000198001	"Interleukin 1 receptor associated kinase 4"	Q9NWZ3	12	43758944-43789543	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 56.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016685, CAB022077"	Uncertain		Approved	Nucleoli,Microtubules,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Microtubules	"Nucleoli, Cytosol"	"CAB016685: AB_1618505, CAB022077: "	"unprognostic (2.76e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.47e-2)"	"prognostic favorable (3.46e-5)"	"unprognostic (6.15e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.44e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.00e-3)"	"unprognostic (6.29e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (4.42e-5)"	8.6	6.5	4.0	13.6	4.6	10.0	8.9	4.5	5.1	7.9	5.1	7.9	9.1	6.8	7.0	10.5	7.0	8.8	5.4	3.9	4.6	8.0	9.2	8.5	17.5	5.5	4.7	5.6	15.1	6.9	6.2	8.3	5.4	7.5	8.4	12.3	8.4	7.0	3.0	13.3	11.9	7.2	4.8	18.6	10.5	5.8	4.9	18.5	10.9	3.2	16.3	7.8	7.9	5.3	9.3	6.8	4.7	6.2	16.5	27.6	6.7	12.9	9.1	10.0	9.1	5.8	8.7	15.8	12.4	10.7	6.6	7.5	5.3	8.3	14.2	22.8	4.9	15.2	5.2	3.7	9.4	21.2	17.7	14.7	12.7	12.7	7.4	17.4	15.0	15.1	14.4	11.6	27.8	5.1	18.6	11.7	1.7	0.0	7.9	12.2	5.8	8.4	7.8	8.8	3.4	3.3	6.3	7.9	6.2	6.4	9.9	18.5	13.4	12.2	2.3	15.1	9.0	14.0	19.4	13.7	12.7	56.2	6.9	20.8	4.0	8.7	6.1	4.6	6.3	3.3	4.9	5.3	3.7	4.4	4.4	4.8	7.9	7.9	5.9	5.1	6.7	4.6	4.0	4.6	4.5	5.1	3.9	4.6	5.5	4.7	5.4	4.8	4.9	5.3	24.1	19.2	15.6	5.2	36.5	10.8	11.3	10.7	17.1	5.8	15.2	11.2	4.5	17.2	11.3	33.1	20.9	14.9	52.1	15.7	21.5	12.7	18.4	14.1	12.4	17.3	3.6	12.0	2.9	17.8	8.4	13.7	33.6	15.2	22.1	10.7	16.1	8.7	16.9	8.4	3.4	11.9	14.2	24.7	20.2	23.2	12.5	25.1	10.6	20.6	28.2	9.9	60.8	2.5	14.7	13.3	7.2	11.3	33.2	8.9	18.6	13.8	9.5	27.2	6.6	9.5	11.0	28.2	12.5	17.2	11.8	27.9	41.1	15.0	9.2	13.5
IRF2BPL	"C14orf4, EAP1, KIAA1865"	ENSG00000119669	"Interferon regulatory factor 2 binding protein like"	Q9H1B7	14	77024543-77028708	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA050862, HPA061333"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA050862: AB_2681258, HPA061333: AB_2684481"	"unprognostic (5.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (8.78e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.51e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.55e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	26.1	25.3	12.2	9.2	13.9	5.6	28.5	13.4	12.0	20.1	12.8	32.4	6.9	25.8	5.1	13.3	33.7	6.5	22.6	14.1	21.1	28.7	19.1	20.9	6.2	15.2	14.8	32.4	17.5	19.8	22.6	7.9	10.9	18.4	3.3	7.3	19.2	10.1	16.8	25.2	15.1	8.0	12.6	19.0	18.8	13.5	19.0	9.7	18.7	4.2	3.3	26.4	18.2	9.4	15.4	13.2	32.2	36.3	9.6	8.8	45.8	15.9	13.0	4.4	5.9	6.2	24.8	5.4	11.3	13.6	12.4	23.6	5.6	11.8	3.7	25.8	19.1	6.9	13.0	8.5	12.5	1.9	29.7	11.8	9.1	7.8	6.8	34.8	6.0	10.9	10.4	59.4	5.7	42.2	21.0	14.5	14.5	6.6	68.2	4.4	9.1	13.0	15.6	22.4	24.9	36.0	22.5	23.2	42.5	8.6	16.1	3.4	10.4	20.2	19.5	6.8	10.3	22.9	26.3	9.0	31.3	4.7	25.8	1.7	1.4	1.3	2.8	1.9	2.7	1.4	2.5	2.6	1.3	1.6	2.0	2.3	9.0	5.9	2.3	10.7	2.6	0.8	12.2	13.9	13.4	12.0	14.1	21.1	15.2	14.8	10.9	12.6	19.0	9.4	71.4	22.4	14.3	5.9	40.2	73.7	32.5	22.5	115.5	57.1	54.6	41.5	19.5	32.9	11.6	64.4	29.2	22.8	58.9	10.8	37.2	19.6	1.3	25.3	26.0	44.0	47.6	10.8	8.2	19.0	49.7	47.8	12.2	25.6	26.6	15.2	55.6	60.5	33.3	10.1	8.6	14.7	16.2	54.7	78.9	4.0	30.1	26.6	35.6	9.4	10.0	57.8	38.1	8.5	4.8	17.8	7.0	34.3	21.1	30.0	6.7	23.1	13.8	10.4	39.5	56.4	83.2	1.6	50.5	54.2	50.6	46.0	39.0	27.5	12.8	20.6
ITCH	AIP4	ENSG00000078747	"Itchy E3 ubiquitin protein ligase"	Q96J02	20	34363241-34540748	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 139.7;Oligodendrocytes: 260.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021126, HPA049032, CAB072824, CAB072825"	Supported		Enhanced	Nucleoplasm,Vesicles		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Vesicles	"CAB072824: , CAB072825: , HPA021126: AB_1851941, HPA049032: AB_2680607"	"unprognostic (2.51e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.21e-1)"	19.5	16.2	13.7	18.1	27.1	27.3	20.0	19.6	17.7	24.5	17.7	21.6	20.2	19.4	16.6	42.8	15.7	17.0	20.2	14.7	15.9	23.3	55.6	18.7	21.4	19.8	20.0	18.8	16.5	23.1	7.8	25.6	21.0	19.6	23.5	25.6	18.7	19.9	17.2	14.0	20.9	21.5	15.9	20.4	20.9	38.5	20.2	23.2	26.3	21.7	25.7	30.6	14.8	45.7	55.5	34.6	35.2	25.9	38.3	57.4	42.7	43.5	52.0	56.2	54.0	101.5	83.8	26.7	42.1	55.6	73.9	66.2	54.9	92.3	66.2	20.8	17.9	78.3	28.2	59.3	43.9	32.6	34.4	31.7	46.2	44.4	72.2	49.8	41.7	40.6	45.5	45.7	46.2	26.5	49.2	18.8	16.9	35.6	44.2	40.9	76.3	63.6	34.7	91.2	21.4	16.4	82.0	32.7	51.0	33.9	38.3	31.1	39.5	61.5	36.0	42.8	33.3	36.2	40.5	40.0	41.0	21.6	38.0	4.6	6.7	7.0	12.0	7.0	12.5	9.2	4.2	6.1	4.9	7.8	3.7	5.7	20.2	7.6	4.9	14.3	5.8	4.3	13.7	27.1	19.6	17.7	14.7	15.9	19.8	20.0	21.0	15.9	20.2	45.7	26.1	12.8	21.8	56.5	33.1	15.0	23.9	11.7	25.6	19.5	15.1	8.5	25.0	12.8	25.6	31.3	25.0	17.5	46.1	28.8	5.9	12.8	59.0	26.5	34.6	20.7	12.0	26.5	85.0	16.3	21.2	24.2	33.1	36.1	19.0	17.9	18.2	53.0	15.8	15.2	72.3	16.9	10.2	24.3	26.7	139.7	22.4	31.4	26.6	68.4	30.0	38.2	43.3	79.4	260.0	22.6	23.7	15.4	50.3	25.8	21.1	26.8	23.5	26.0	13.1	21.4	22.0	40.6	25.5	30.4	16.2	46.9	30.8	12.3	11.9	40.6
ITGA6	CD49f	ENSG00000091409	"Integrin subunit alpha 6"	P23229	2	172427354-172506459	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 327.2;Basal keratinocytes: 244.7;Urothelial cells: 247.6"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 144.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 22.9"	"Group enriched"	"Detected in many"	28	"granulocytes: 22.9;NK-cells: 7.1;T-cells: 12.8"	"Cell line enhanced"	"Detected in many"		"BJ: 326.2;HaCaT: 356.8;HBEC3-KT: 705.8;hTCEpi: 298.9;hTERT-HME1: 301.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009009, HPA012696, HPA027582"	Enhanced					NA	NA		3300000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB009009: AB_2128038, HPA012696: AB_1851822, HPA027582: AB_10602606"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-3)"	"unprognostic (9.34e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (2.35e-11)"	"unprognostic (3.35e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.21e-3)"	45.9	8.3	20.1	27.8	16.7	5.8	55.6	16.6	20.3	64.3	42.8	65.4	74.2	43.1	9.5	25.1	25.3	37.2	29.2	17.2	20.9	42.7	8.8	29.3	18.7	20.8	18.8	5.6	42.0	14.0	6.2	76.8	19.3	24.4	62.4	7.3	81.0	30.8	27.7	46.6	67.4	39.0	20.5	41.2	66.1	26.1	25.0	33.9	21.1	42.6	21.4	55.0	26.8	16.5	77.5	64.8	26.7	49.1	1.4	0.9	146.3	326.2	34.6	32.1	20.0	36.2	141.3	0.7	90.9	86.8	73.8	356.8	17.7	705.8	58.1	0.7	16.6	1.9	64.8	58.7	4.8	21.4	2.4	6.2	298.9	2.0	301.4	32.9	209.6	40.8	0.3	5.5	41.6	3.7	5.9	17.8	48.2	214.2	54.5	1.1	82.3	1.6	48.0	106.6	0.8	3.4	61.2	0.1	69.7	28.0	13.1	1.4	97.9	44.9	41.1	84.2	56.8	4.8	3.6	1.9	1.7	7.2	185.0	4.4	0.2	22.9	5.3	0.0	10.7	0.2	6.7	6.4	0.1	0.5	12.8	5.9	0.7	7.1	0.0	0.0	8.1	4.3	20.1	16.7	16.6	20.3	17.2	20.9	20.8	18.8	19.3	20.5	25.0	16.5	327.2	9.6	19.5	88.5	8.8	244.7	236.4	43.4	88.8	1.4	55.0	72.8	32.5	22.8	10.5	27.6	56.3	103.8	14.4	139.6	5.9	34.4	31.2	82.5	34.8	196.0	57.4	1.7	4.0	62.1	26.5	20.8	219.7	149.3	8.2	103.4	11.7	21.5	25.5	1.7	6.1	128.8	20.3	3.2	20.8	46.8	4.1	10.0	51.6	119.9	1.7	1.3	29.9	1.5	8.8	127.9	104.2	2.6	109.0	184.8	54.5	52.2	9.2	13.9	0.0	11.8	18.4	7.7	20.2	141.5	84.0	22.3	30.1	44.0	146.3	247.6
ITGA7		ENSG00000135424	"Integrin subunit alpha 7"	Q13683	12	55684568-55716043	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Cell shape"	"Integrin, Receptor"	"Congenital muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 262.3"	"Group enriched"	"Detected in many"	6	"Astrocytes: 87.5;Cardiomyocytes: 124.5;Sertoli cells: 164.3;Skeletal myocytes: 65.8;Smooth muscle cells: 110.6"	"Cancer enhanced"	"Detected in all"		"glioma: 35.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"hTERT-RPE1: 309.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008427	Uncertain		Approved	"Nuclear speckles,Vesicles,Plasma membrane"		NA	NA		1200000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	"Nuclear speckles, Vesicles"	"HPA008427: AB_1851823"	"unprognostic (4.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.02e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.57e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (2.85e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.10e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (9.59e-5)"	133.4	8.2	18.5	18.5	21.2	1.8	69.0	15.9	30.2	28.7	16.1	97.8	17.7	45.5	12.3	23.9	56.1	30.8	157.9	34.5	17.8	11.5	10.2	15.5	6.4	21.2	21.1	19.1	5.1	6.1	12.6	1.9	20.3	33.9	8.9	2.4	14.9	37.3	262.3	16.0	27.4	95.2	16.4	10.2	35.2	8.9	23.8	3.4	26.1	154.1	3.3	46.5	25.5	21.0	0.2	4.1	7.5	12.3	66.5	13.4	0.7	5.4	8.7	11.7	11.8	8.4	6.5	2.3	7.4	3.4	0.9	1.1	5.1	0.3	10.0	0.2	3.8	0.8	2.8	3.2	0.5	0.3	2.7	19.1	0.2	64.2	0.3	309.1	0.2	2.2	0.9	1.6	37.8	5.3	0.3	3.1	20.9	1.7	0.4	0.1	28.7	0.6	0.2	0.2	0.9	2.8	0.6	0.2	48.0	4.0	0.9	13.9	0.0	1.3	12.4	0.8	8.4	3.2	2.2	0.9	57.8	8.2	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.5	21.2	15.9	30.2	34.5	17.8	21.2	21.1	20.3	16.4	23.8	21.0	11.9	0.0	0.0	87.5	0.3	1.9	0.5	0.1	0.6	2.4	1.2	3.4	124.5	2.8	0.0	1.8	4.2	0.0	0.3	0.7	0.0	0.3	0.3	1.1	1.2	9.5	7.7	0.4	17.6	0.0	0.1	5.0	0.5	1.1	0.0	6.2	0.7	1.4	0.6	0.0	9.4	1.8	0.0	1.9	2.7	0.1	6.5	2.2	3.6	9.4	0.0	3.4	0.0	6.6	3.7	0.3	0.1	6.4	0.1	0.8	2.6	0.8	0.1	0.6	164.3	65.8	110.6	4.1	2.9	0.7	2.3	0.1	0.5	0.3	0.9	0.3
ITK	"EMT, LYK, PSCTK2"	ENSG00000113263	"IL2 inducible T cell kinase"	Q08881	5	157142933-157255185	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"lymphoid tissue: 57.9"	"Group enriched"	"Detected in some"	6	"dendritic cells: 51.7;granulocytes: 31.8;NK-cells: 42.2;Plasma cells: 34.0;T-cells: 115.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	23	"gdT-cell: 39.6;MAIT T-cell: 26.4;memory CD4 T-cell: 55.6;memory CD8 T-cell: 54.9;naive CD4 T-cell: 78.2;naive CD8 T-cell: 65.0;NK-cell: 29.3;T-reg: 73.2"	"Group enriched"	"Detected in many"	23	"NK-cells: 29.3;T-cells: 78.2"	"Group enriched"	"Detected in some"	10	"JURKAT: 62.2;MOLT-4: 23.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043670			Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA043670: "	"unprognostic (2.08e-3)"	"unprognostic (6.57e-4)"	"unprognostic (5.06e-3)"	"unprognostic (4.96e-5)"	"unprognostic (1.52e-2)"	"unprognostic (1.12e-4)"	"unprognostic (8.45e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.52e-6)"	"unprognostic (3.64e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.26e-2)"	1.0	0.3	0.0	15.9	0.0	3.7	0.9	0.0	0.0	1.0	0.0	1.4	0.7	0.4	0.0	1.4	0.4	4.2	0.2	0.0	0.0	0.3	1.6	3.1	29.3	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.4	1.5	0.0	0.3	0.1	0.0	0.2	4.0	0.5	0.0	10.5	3.1	0.5	0.0	57.9	0.5	0.0	24.6	3.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	3.9	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	62.2	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	39.6	0.0	26.4	0.0	55.6	54.9	0.1	0.0	78.2	65.0	1.3	29.3	2.3	0.1	73.2	44.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	6.2	0.0	4.0	2.7	0.6	0.0	0.0	0.0	0.4	0.4	0.9	0.0	0.6	1.8	0.0	0.1	51.7	0.1	0.0	0.1	8.5	0.2	0.3	0.8	0.0	1.7	0.2	0.0	0.0	1.1	7.7	0.4	31.8	0.1	1.8	1.0	0.0	0.0	0.2	0.0	0.0	1.6	5.1	6.7	0.0	2.9	1.8	1.0	2.8	0.0	42.2	0.0	0.1	0.0	0.0	0.0	34.0	0.3	0.0	0.4	0.0	0.0	0.0	1.0	1.0	0.0	0.0	0.2	3.4	0.1	115.7	0.0	0.1	0.6
ITM2B	"BRI, BRI2, BRICD2B, E25B, E3-16"	ENSG00000136156	"Integral membrane protein 2B"	Q9Y287	13	48232612-48270357	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Amyloidosis, Deafness, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 4375.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 4375.2"	"Cell line enhanced"	"Detected in all"		"HMC-1: 731.2;RPTEC TERT1: 1718.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029292, HPA071992"	Enhanced		Enhanced	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		5800000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus, Vesicles"		"HPA029292: AB_10601917, HPA071992: AB_2686480"	"unprognostic (4.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.87e-2)"	"prognostic favorable (3.73e-5)"	"unprognostic (4.38e-2)"	"unprognostic (4.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.22e-1)"	510.2	367.4	286.9	172.5	301.0	125.6	323.8	328.6	489.0	416.1	406.6	260.1	289.2	388.8	1171.8	399.9	305.4	257.5	381.0	320.1	339.2	1306.3	391.2	376.1	236.7	334.9	308.0	507.2	179.6	233.7	290.5	573.8	304.4	312.5	191.4	174.4	408.7	386.2	164.7	399.6	287.4	232.5	373.6	435.2	312.8	121.4	308.8	188.3	386.1	206.2	187.4	305.1	402.2	394.8	67.6	51.8	73.1	116.3	348.5	254.5	119.2	215.0	202.2	87.5	100.6	29.1	248.3	16.6	168.8	121.6	48.5	214.1	61.3	107.0	107.4	69.9	147.3	137.9	29.0	99.0	138.5	140.6	731.2	113.4	149.1	45.1	62.0	375.7	131.2	78.3	24.5	90.9	174.8	29.6	200.4	310.1	266.0	116.5	103.6	100.1	100.5	73.6	1718.9	268.6	26.2	119.5	154.5	110.2	111.0	306.0	74.0	119.4	180.5	62.9	73.8	95.7	85.4	72.9	59.6	2.5	78.0	75.3	155.3	3091.4	864.5	2737.9	387.4	661.3	512.5	235.3	523.1	476.4	428.9	245.3	551.3	466.8	4375.2	356.5	692.7	196.2	563.4	1723.5	286.9	301.0	328.6	489.0	320.1	339.2	334.9	308.0	304.4	373.6	308.8	394.8	1380.0	695.5	300.4	174.6	408.6	862.4	1661.1	2606.2	1006.2	653.1	460.1	573.5	384.8	722.0	1121.9	1991.8	187.7	1164.3	448.2	754.2	545.9	910.2	23.6	751.8	802.2	1166.2	283.3	307.0	114.2	682.9	2362.8	1334.0	302.8	1177.2	578.0	421.2	1319.7	557.3	2117.8	353.3	142.6	503.2	1129.1	1569.8	900.6	76.7	1867.0	1381.5	681.3	252.0	1415.7	1634.9	425.3	174.4	237.9	515.7	788.3	2011.6	445.4	922.5	1259.3	2748.9	795.6	219.4	1222.7	602.4	1022.9	143.6	256.4	1384.6	1149.6	1471.5	723.2	665.5	440.9	1613.4
ITPA	"C20orf37, dJ794I6.3, HLC14-06-P"	ENSG00000125877	"Inosine triphosphatase"	Q9BY32	20	3208868-3223870	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022824, HPA073963"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA022824: AB_1851960, HPA073963: "	"unprognostic (1.58e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.84e-1)"	26.2	37.1	16.7	21.2	17.5	26.4	25.0	16.9	20.0	24.8	18.2	25.3	27.0	24.0	13.0	43.9	29.9	16.7	20.8	18.2	16.8	34.2	28.2	22.4	27.6	17.0	16.5	21.2	21.9	24.2	13.0	19.8	17.0	20.3	19.2	6.9	26.4	16.1	26.5	33.6	23.2	18.5	17.3	27.0	27.1	12.3	18.0	24.8	33.5	15.1	21.4	24.1	25.7	18.5	118.2	91.1	44.0	49.1	29.7	42.7	30.9	50.9	72.4	65.9	58.8	75.0	106.6	52.5	46.9	48.7	65.7	101.9	62.3	79.8	46.6	32.9	91.6	123.9	39.1	117.6	55.5	54.5	41.4	41.5	60.3	64.4	40.9	28.6	52.5	39.5	88.7	34.2	62.6	55.2	66.0	156.5	77.2	132.1	89.6	61.4	60.7	135.0	96.7	39.2	67.4	80.9	41.4	154.0	106.3	19.3	60.1	94.2	37.9	76.5	42.4	51.7	116.0	52.0	68.4	94.2	32.9	102.8	83.0	32.8	61.5	22.9	47.7	78.2	41.7	48.9	43.6	49.0	74.5	50.2	32.4	39.5	3.4	64.5	56.9	70.7	61.0	48.0	16.7	17.5	16.9	20.0	18.2	16.8	17.0	16.5	17.0	17.3	18.0	18.5	29.4	22.4	47.0	15.3	38.0	40.1	50.5	93.2	56.9	20.4	48.8	58.3	9.8	34.3	59.3	44.1	14.6	74.4	45.9	37.5	58.7	104.2	2.7	51.8	64.4	29.4	27.5	24.6	12.0	105.1	128.2	41.8	48.4	60.9	42.5	49.7	29.3	32.1	116.6	5.0	9.2	53.1	54.9	42.4	54.0	3.7	31.1	49.0	40.9	5.6	90.3	21.0	41.2	14.1	21.5	102.2	59.9	22.2	34.5	53.5	51.6	94.5	37.9	24.5	19.7	35.4	45.0	16.8	17.6	58.8	49.2	56.2	47.2	53.3	79.9	66.0
ITPR1	"ACV, Insp3r1, IP3R1, PPP1R94, SCA15, SCA16, SCA29"	ENSG00000150995	"Inositol 1,4,5-trisphosphate receptor type 1"	Q14643	3	4493345-4847840	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 290.2;Inhibitory neurons: 183.1;Microglial cells: 84.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 49.9"	"Immune cell enhanced"	"Detected in many"		"naive B-cell: 13.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 76.4;HEL: 41.1;HeLa: 74.9;HMC-1: 40.0;U-87 MG: 56.7"	"Region enhanced"	"Detected in all"		"cerebellum: 697.2"	"Region enhanced"	"Detected in all"		"cerebellum: 208.8"	"HPA014765, HPA016487"	Approved		Approved	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA014765: AB_1851843, HPA016487: AB_1851842"	"unprognostic (1.92e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (2.40e-1)"	10.6	12.0	1.8	11.8	12.0	7.2	17.3	49.9	20.1	11.5	15.6	19.5	4.5	36.5	10.0	10.6	27.1	14.1	10.1	5.9	0.0	13.9	3.9	13.7	11.2	0.0	0.5	25.3	6.7	45.3	16.0	8.0	0.0	21.7	6.3	3.9	16.1	27.9	3.0	5.0	11.5	24.5	0.0	9.2	11.1	4.5	0.0	10.3	31.7	5.3	10.5	27.9	11.8	6.1	0.4	4.1	1.0	3.0	27.7	1.9	11.8	0.9	0.5	1.3	0.8	1.3	1.2	14.5	0.6	1.9	6.5	0.1	2.2	2.6	2.1	76.4	3.2	41.1	74.9	3.5	27.4	17.7	40.0	9.2	4.0	5.8	1.1	7.6	7.2	8.4	7.9	13.9	3.7	1.8	7.2	3.0	2.1	0.5	9.7	4.2	1.0	1.1	1.7	5.5	0.7	19.5	5.4	4.3	4.3	0.9	2.6	20.6	13.5	1.8	4.3	3.7	2.3	17.7	12.0	9.6	56.7	17.0	2.7	5.8	2.0	1.5	2.3	0.9	1.7	6.7	1.6	1.6	2.2	13.4	2.7	1.6	1.8	1.8	0.9	4.7	1.4	1.1	1.8	12.0	49.9	20.1	5.9	0.0	0.0	0.5	0.0	0.0	0.0	6.1	30.1	0.0	31.4	24.8	49.7	3.8	6.1	6.3	11.4	4.0	40.0	29.7	8.0	2.8	11.2	9.2	0.0	0.5	17.8	0.3	3.9	2.4	5.4	9.1	11.9	31.2	3.5	8.4	290.2	5.1	0.5	21.5	20.4	12.7	26.5	22.6	36.0	2.0	4.7	1.7	183.1	1.3	2.0	12.9	17.4	7.9	30.1	23.9	7.2	84.3	14.2	4.3	6.2	25.1	12.7	1.5	1.2	52.6	8.8	5.4	0.3	3.9	13.1	1.5	39.5	8.8	28.2	1.5	2.9	4.9	3.1	1.0	25.7	22.0	0.8	3.3
IVD	ACAD2	ENSG00000128928	"Isovaleryl-CoA dehydrogenase"	P26440	15	40405485-40435947	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 135.0;Theca cells: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041391, HPA044250"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA041391: AB_2677449, HPA044250: AB_2678875"	"unprognostic (9.30e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (1.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (2.91e-9)"	"unprognostic (1.40e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.46e-3)"	25.8	80.5	35.1	14.5	40.8	15.9	45.3	35.6	40.8	29.4	39.5	31.6	24.3	26.4	29.0	16.0	35.0	21.5	61.7	34.0	41.5	59.1	145.4	24.3	19.6	40.2	38.8	43.3	27.4	39.2	58.3	15.3	37.5	42.1	27.2	13.0	31.8	36.8	55.7	8.6	26.8	23.8	37.9	27.9	46.7	25.0	44.5	16.8	119.2	55.4	19.5	31.1	20.8	45.3	20.9	11.9	22.9	38.9	35.9	32.9	1.0	27.6	32.7	39.4	24.0	36.5	16.0	0.8	57.7	43.4	32.6	20.8	45.9	46.6	30.1	36.4	34.0	52.1	36.2	38.9	64.6	22.0	48.5	45.3	18.5	23.5	55.3	46.3	38.8	60.4	2.5	2.4	42.1	27.1	27.3	38.9	17.8	1.3	33.0	41.2	32.6	27.9	45.2	51.6	37.3	21.5	38.2	83.4	18.7	21.5	69.0	117.6	27.6	29.9	20.2	23.6	24.9	54.5	38.5	1.0	30.9	22.8	28.4	17.0	24.8	36.7	33.3	36.1	31.0	27.5	18.5	26.6	58.8	27.6	18.5	26.7	2.3	39.4	73.1	89.2	26.9	24.3	35.1	40.8	35.6	40.8	34.0	41.5	40.2	38.8	37.5	37.9	44.5	45.3	13.1	28.9	54.5	27.4	19.0	2.3	21.0	17.3	13.1	26.0	27.5	22.2	88.0	45.8	29.9	44.1	14.6	20.3	34.0	17.9	95.9	19.7	5.4	21.4	31.0	18.6	19.7	21.3	15.3	14.9	7.3	20.2	29.6	19.9	34.7	46.5	21.4	135.0	28.1	16.8	16.6	24.4	14.2	18.3	6.2	7.4	20.5	18.6	5.4	21.5	28.8	26.0	26.8	25.1	21.4	14.8	9.4	24.8	10.0	16.6	22.0	97.3	29.3	19.9	19.7	25.0	18.2	16.1	3.7	17.4	0.6	9.9	18.0	105.7	35.4	11.9
IYD	"C6orf71, DEHAL1, dJ422F24.1"	ENSG00000009765	"Iodotyrosine deiodinase"	Q6PHW0	6	150368892-150405969	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"thyroid gland: 472.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 23.7;Hepatocytes: 25.1;Intestinal goblet cells: 21.8;Paneth cells: 22.5;Proximal enterocytes: 89.1;Proximal tubular cells: 35.4"	"Cancer enriched"	"Detected in many"	20	"thyroid cancer: 80.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"CACO-2: 1.3;OE19: 3.0;SK-BR-3: 3.2"	"Group enriched"	"Detected in some"	13	"hippocampal formation: 7.4;thalamus: 2.4"	"Low region specificity"	"Detected in all"			HPA059627	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA059627: AB_2684086"	"unprognostic (3.73e-4)"	"unprognostic (2.93e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-2)"	"prognostic favorable (6.22e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.07e-9)"	"unprognostic (9.79e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.18e-2)"	0.1	0.0	0.4	0.6	0.3	0.3	0.5	0.6	0.6	0.1	0.2	6.4	18.1	0.2	0.6	0.0	0.0	8.9	0.5	0.3	0.1	26.6	33.6	0.7	0.5	0.5	0.4	0.0	0.4	0.0	0.0	0.0	0.6	0.2	6.5	0.2	0.1	0.0	0.0	0.2	19.6	0.2	0.0	0.1	2.0	0.2	0.5	0.0	472.7	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	3.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	3.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.6	0.5	0.3	0.2	0.4	0.2	0.2	0.1	0.1	0.0	0.4	0.2	0.2	1.9	0.7	0.2	0.3	0.2	1.3	0.4	0.3	0.6	0.6	0.3	0.1	0.5	0.4	0.6	0.0	0.5	0.5	0.7	3.2	7.8	0.0	0.0	0.1	0.6	0.2	0.0	0.1	0.3	0.4	0.8	14.3	8.9	0.0	0.0	0.1	0.0	23.7	1.9	0.3	0.0	0.9	0.3	0.4	3.6	2.7	0.1	0.2	0.0	0.7	0.0	2.2	1.3	0.1	1.1	25.1	0.1	0.0	0.1	21.8	0.0	0.0	1.2	0.1	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	22.5	0.0	0.0	1.0	89.1	35.4	3.6	1.3	0.0	1.7	0.3	0.1	0.1	0.0	0.4	0.3	0.9	0.4	11.5	0.7
JPH2	JP-2	ENSG00000149596	"Junctophilin 2"	Q9BR39	20	44106590-44187188	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 85.2;skeletal muscle: 120.4"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 64.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 15.3;EFO-21: 15.0;fHDF/TERT166: 19.1;HeLa: 12.6;SiHa: 12.9"	"Low region specificity"	"Detected in some"							HPA052646	Approved					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA052646: AB_2681899"	"unprognostic (1.57e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.61e-4)"	"unprognostic (4.71e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.45e-3)"	"unprognostic (6.87e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.73e-2)"	"unprognostic (4.76e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.10e-2)"	6.0	1.9	0.5	4.5	0.6	0.1	5.7	0.4	0.7	15.1	0.7	63.3	2.1	51.6	2.9	11.9	30.0	3.5	85.2	0.4	0.5	1.4	0.3	5.2	0.2	1.1	1.1	3.9	0.3	0.1	1.2	3.8	0.8	23.8	4.5	0.2	5.8	22.1	120.4	3.8	11.8	27.5	0.9	1.3	16.0	0.8	0.6	0.1	1.5	48.3	0.1	40.5	10.6	0.7	7.5	0.8	0.4	0.0	0.3	0.4	1.5	2.2	4.1	5.4	2.3	15.3	5.9	0.0	15.0	19.1	6.1	10.5	0.0	0.5	2.1	0.0	0.0	0.0	12.6	0.1	0.1	0.3	0.0	0.7	1.1	2.7	3.7	3.3	0.0	0.0	0.0	0.0	7.3	4.3	0.0	0.2	0.3	0.0	0.9	1.7	3.4	0.0	0.4	0.1	0.0	0.1	12.9	3.1	0.1	8.6	10.8	0.1	0.3	2.4	2.7	0.5	4.7	0.1	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.4	0.7	0.4	0.5	1.1	1.1	0.8	0.9	0.6	0.7	0.2	0.0	0.0	0.3	0.0	6.6	0.5	0.9	0.0	0.0	0.4	5.1	64.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.9	0.0	0.0	0.8	0.0	0.5	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.2	0.0	6.6	15.9	12.8	0.0	1.5	0.0	2.0	0.5	0.1	0.0	0.2	0.1
JPH3	"CAGL237, HDL2, JP-3, JP3, TNRC22"	ENSG00000154118	"Junctophilin 3"	Q8WXH2	16	87601835-87698156	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 59.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 24.4;Cone photoreceptor cells: 22.9;Early spermatids: 41.1;Excitatory neurons: 33.2;Horizontal cells: 50.5;Inhibitory neurons: 28.7;Late spermatids: 14.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Group enriched"	"Detected in all"	5	"amygdala: 17.1;basal ganglia: 24.6;cerebral cortex: 59.1;hippocampal formation: 42.7;white matter: 20.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 6.5;NTERA-2: 5.7;SH-SY5Y: 7.2;SiHa: 5.0;U-2 OS: 22.5"	"Low region specificity"	"Detected in all"							HPA076304			Approved	Nucleoplasm,Cytosol		Yes	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA076304: AB_2686793"	"unprognostic (8.97e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.82e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.28e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.36e-2)"	0.2	1.3	17.1	0.2	24.6	0.0	0.1	1.1	59.1	0.7	0.0	1.1	0.1	0.2	0.0	0.6	0.4	0.0	0.1	42.7	5.6	0.0	0.1	0.1	0.0	6.4	5.8	0.1	0.3	0.0	14.1	0.0	1.1	0.2	0.0	1.8	0.0	0.3	0.0	0.1	0.5	0.0	1.1	0.1	0.5	1.4	1.1	0.0	0.1	0.0	0.0	0.1	0.3	20.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	3.0	0.0	0.9	0.0	1.2	0.0	0.0	0.1	0.9	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.5	0.0	0.0	5.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	7.2	5.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	24.6	1.1	59.1	42.7	5.6	6.4	5.8	1.1	1.1	1.1	20.6	0.0	0.0	0.0	2.3	0.1	0.0	0.2	0.0	0.0	24.4	0.0	0.0	3.7	0.0	0.0	0.0	22.9	0.0	0.0	0.1	0.0	0.0	41.1	0.0	0.0	0.8	0.0	0.0	33.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.2	0.0	0.1	50.5	28.7	0.0	0.0	0.0	0.0	14.4	0.3	0.0	0.0	0.0	0.0	1.3	0.0	10.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.6	0.0	0.2	0.1	1.1	3.7	0.0	0.0	0.1	0.1	0.5	0.0	0.1
KARS1	"DFNB89, KARS, KARS2"	ENSG00000065427	"Lysyl-tRNA synthetase 1"	Q15046	16	75627474-75648643	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Deafness, Disease variant, Neurodegeneration, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 90.7;Cytotrophoblasts: 122.7;Extravillous trophoblasts: 143.3;Hofbauer cells: 89.5;Syncytiotrophoblasts: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041345, HPA041550"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		82000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Plasma membrane"	"HPA041345: AB_10795589, HPA041550: AB_10794520"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (6.24e-3)"	"unprognostic (8.97e-3)"	"unprognostic (1.18e-1)"	"unprognostic (9.11e-3)"	"unprognostic (8.71e-3)"	"unprognostic (8.46e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	68.5	49.6	45.5	71.6	47.3	86.1	83.0	46.9	63.2	60.3	50.6	75.8	62.4	53.9	75.1	72.5	69.5	50.4	96.0	45.6	48.3	72.2	76.8	53.1	88.3	46.9	47.5	74.9	86.5	76.7	51.5	62.2	46.8	55.2	85.6	69.6	79.6	60.6	213.4	67.3	62.6	69.6	46.8	57.6	66.2	98.9	47.4	96.6	65.3	186.8	107.8	92.1	55.0	48.1	164.2	187.0	133.5	185.4	140.1	140.3	262.4	135.0	164.9	290.2	217.0	332.8	209.0	292.4	145.4	180.8	138.4	229.4	272.0	246.7	314.4	86.0	139.8	161.4	153.1	348.5	255.8	245.5	174.1	166.4	173.8	257.4	414.6	147.7	240.0	253.5	273.4	68.5	222.5	378.0	254.1	262.2	284.3	238.4	135.9	329.2	120.0	358.4	235.4	136.3	200.2	162.9	339.5	122.8	152.2	144.8	166.1	229.2	133.8	159.8	164.9	123.6	196.7	145.1	178.6	696.6	139.5	206.5	199.7	88.6	112.7	130.0	110.7	155.7	202.6	109.5	137.1	132.0	135.7	91.6	126.6	117.1	24.9	127.6	163.1	85.7	155.5	160.5	45.5	47.3	46.9	63.2	45.6	48.3	46.9	47.5	46.8	46.8	47.4	48.1	14.2	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.7	0.0	0.0	0.0	0.0	122.7	10.1	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	143.3	14.4	0.0	0.0	0.0	0.0	0.0	0.0	89.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	110.0	2.1	0.0	0.0	0.0
KAT2B	"GCN5, GCN5L, P/CAF, PCAF"	ENSG00000114166	"Lysine acetyltransferase 2B"	Q92831	3	20040446-20154404	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 165.2;Oligodendrocyte precursor cells: 418.2;Oligodendrocytes: 175.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002470, CAB004526, HPA055839, HPA073897"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"CAB004526: AB_2128417, HPA002470: , HPA055839: AB_2682938, HPA073897: "	"unprognostic (2.91e-2)"	"unprognostic (6.85e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.83e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.13e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.63e-2)"	17.9	9.9	38.7	15.4	46.5	48.0	10.3	39.1	40.3	14.9	33.8	13.8	17.7	12.3	8.1	27.4	11.7	12.6	35.9	34.4	42.2	16.6	39.3	16.2	22.4	41.7	44.9	27.7	18.7	51.0	10.2	13.7	43.0	14.5	12.5	33.9	37.6	13.0	60.2	14.3	21.5	13.6	37.1	19.8	13.9	2.7	42.2	23.6	14.4	56.1	20.1	11.9	15.1	45.1	2.7	6.9	3.8	6.2	15.1	14.2	8.8	8.8	13.0	9.1	13.3	2.1	4.5	24.0	3.6	16.7	11.5	2.0	9.4	2.8	7.6	21.8	9.0	21.0	10.7	0.7	7.1	3.2	26.2	6.1	5.0	7.9	5.1	16.0	8.8	5.8	13.7	32.9	13.0	3.3	7.0	6.4	1.6	6.7	6.8	9.1	7.1	5.1	12.4	14.2	1.9	4.1	4.9	7.9	30.5	5.9	8.2	14.2	8.5	15.3	6.1	5.8	10.1	12.3	27.6	5.7	13.9	13.8	33.0	0.6	0.4	1.3	1.5	0.7	1.5	0.4	1.3	1.1	0.4	0.8	0.4	0.8	2.4	0.5	0.5	1.2	2.2	0.3	38.7	46.5	39.1	40.3	34.4	42.2	41.7	44.9	43.0	37.1	42.2	45.1	15.5	32.1	20.8	165.2	11.9	8.5	11.3	2.2	3.4	14.6	5.5	5.0	64.1	4.3	10.4	5.5	4.2	7.3	19.5	16.6	11.7	3.8	3.8	6.4	5.7	14.6	11.5	52.2	22.4	4.4	1.1	11.7	3.6	13.1	10.8	12.3	20.7	33.6	7.7	15.2	32.1	7.3	4.1	22.8	23.3	1.8	6.5	16.0	17.8	52.5	11.1	14.8	14.4	418.2	175.4	3.3	2.4	5.3	19.9	7.1	24.7	6.2	12.7	11.9	6.6	25.2	9.0	0.8	1.4	10.0	12.9	9.9	23.5	2.9	3.8	8.0
KAT6A	"MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220"	ENSG00000083168	"Lysine acetyltransferase 6A"	Q92794	8	41929479-42051994	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase"	"Cancer-related genes, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017023, HPA063266, HPA065052"	Supported		Supported	"Nucleoli,Nuclear speckles,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"	"Nucleoli, Cytosol"	"CAB017023: , HPA063266: AB_2684973, HPA065052: AB_2685414"	"unprognostic (3.51e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.27e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	14.4	7.1	8.6	15.4	12.7	38.2	12.3	20.1	10.5	13.7	9.7	10.2	9.6	15.6	8.6	13.4	12.0	11.2	9.1	9.1	12.8	9.1	10.0	16.7	16.8	12.7	12.4	21.5	11.7	18.0	6.7	14.9	12.9	11.0	10.6	18.1	9.6	9.7	13.1	16.6	12.1	13.5	8.2	15.7	11.3	11.4	10.1	27.0	14.2	16.0	17.2	12.0	10.7	16.7	19.6	23.2	34.8	21.8	17.8	20.3	9.8	15.4	20.6	17.9	14.2	16.3	11.5	33.4	13.4	19.0	19.5	17.3	27.3	18.6	23.2	16.1	14.4	60.4	14.2	10.3	14.8	27.3	23.6	17.1	19.1	20.4	24.8	14.5	18.8	29.7	36.6	24.2	16.0	10.4	59.9	9.4	12.8	20.4	8.1	37.7	39.1	9.9	11.0	27.1	17.6	16.7	15.8	12.4	13.8	15.8	26.3	12.9	25.5	21.6	15.3	21.1	15.5	16.8	22.1	33.8	12.6	14.1	17.3	2.5	0.8	1.8	1.6	0.9	1.6	1.4	1.6	2.1	0.6	1.6	1.9	1.8	5.1	1.9	0.9	1.1	1.9	1.2	8.6	12.7	20.1	10.5	9.1	12.8	12.7	12.4	12.9	8.2	10.1	16.7	87.5	35.3	34.9	64.0	54.0	50.3	24.2	15.5	18.2	54.8	31.7	25.5	23.7	18.6	25.3	12.9	54.2	14.4	61.5	23.2	3.9	14.2	2.6	30.3	47.5	56.7	24.7	31.2	62.8	11.8	17.0	32.4	21.4	44.8	35.4	31.9	43.5	25.3	17.0	58.9	76.6	24.9	10.2	44.2	34.5	4.8	28.3	43.7	23.2	120.9	30.3	27.9	61.8	93.5	129.2	15.7	20.2	23.0	38.7	30.7	22.9	10.6	22.8	44.9	19.7	49.3	34.6	37.8	37.0	23.0	61.2	21.1	61.4	19.7	19.3	27.2
KAT6B	"Morf, MOZ2, MYST4, qkf, querkopf, ZC2HC6B"	ENSG00000156650	"Lysine acetyltransferase 6B"	Q8WYB5	10	74824927-75032624	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006104	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"		"HPA006104: AB_1079445"	"unprognostic (4.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.32e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.78e-2)"	"prognostic favorable (4.82e-4)"	"unprognostic (2.52e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.15e-1)"	7.6	6.3	5.0	3.1	5.6	8.8	7.3	5.6	5.3	10.5	2.0	9.6	3.2	9.2	5.2	6.9	8.3	3.8	7.5	5.7	4.0	4.3	4.6	6.5	4.4	3.1	3.5	12.2	8.6	10.5	7.4	4.4	3.0	6.5	4.1	6.4	7.3	4.3	11.8	8.0	8.1	6.0	3.0	5.4	9.3	7.8	5.6	9.8	7.3	6.0	4.1	9.1	8.9	4.9	4.7	4.4	8.0	6.9	6.2	9.2	4.1	4.1	7.5	3.4	3.6	3.4	5.3	9.8	2.1	7.1	3.5	3.8	4.2	3.3	5.6	4.2	6.8	3.6	3.9	4.5	4.5	8.6	2.4	5.9	5.3	4.5	6.9	10.5	3.8	7.7	3.9	9.0	4.2	4.7	8.2	4.3	5.0	4.9	25.7	12.7	4.3	2.4	2.3	2.3	4.2	6.9	4.1	7.4	3.7	2.8	4.5	3.2	4.7	4.6	5.5	3.1	3.8	6.4	8.1	6.4	5.0	8.9	1.3	1.7	1.3	1.6	2.3	1.0	2.6	2.2	1.9	2.1	1.1	2.8	2.9	2.6	1.8	4.4	1.1	1.7	1.7	1.0	5.0	5.6	5.6	5.3	5.7	4.0	3.1	3.5	3.0	3.0	5.6	4.9	34.5	44.8	53.7	90.1	48.1	19.9	20.8	16.3	74.6	52.8	36.7	27.3	53.9	12.8	29.3	9.2	68.8	10.4	51.8	22.5	9.8	12.7	6.2	41.1	72.7	24.9	23.8	32.0	130.2	18.0	10.6	44.4	57.6	50.8	41.7	68.0	18.9	16.0	11.0	43.7	131.2	21.7	12.2	12.3	15.0	8.3	42.3	24.1	14.2	41.2	13.6	45.5	42.2	101.0	92.1	10.5	19.4	40.3	62.5	21.0	17.8	10.2	28.6	52.5	26.3	55.3	44.1	33.1	32.2	46.6	17.5	22.7	59.7	27.1	17.5	23.5
KCNE5	KCNE1L	ENSG00000176076	"Potassium voltage-gated channel subfamily E regulatory subunit 5"	Q9UJ90	X	109623700-109625172	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Alport syndrome, Deafness, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.8;skeletal muscle: 4.0;tongue: 4.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.6;Erythroid cells: 3.8;monocytes: 9.4;Muller glia cells: 5.3;Peritubular cells: 3.8"	"Group enriched"	"Detected in some"	8	"glioma: 7.9;testis cancer: 2.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.5;hTEC/SVTERT24-B: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042316			Uncertain	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA042316: AB_10795397"	"unprognostic (5.33e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.62e-3)"	"unprognostic (7.83e-2)"	"unprognostic (5.64e-6)"	"unprognostic (5.10e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.37e-3)"	1.1	0.8	3.2	0.1	5.4	1.6	0.5	9.4	2.7	0.2	0.7	0.1	0.0	0.0	0.1	0.1	0.0	0.4	0.7	2.7	6.6	0.7	0.2	0.4	0.0	6.3	9.8	0.5	0.1	0.0	0.3	0.2	6.9	0.3	0.0	0.2	0.2	0.3	4.0	0.1	0.1	0.1	4.0	0.9	0.1	0.3	7.8	2.3	0.1	4.9	0.0	0.3	0.2	4.6	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.3	0.3	0.0	0.8	0.3	0.0	0.1	1.0	1.1	0.7	0.0	0.0	1.5	0.2	0.5	2.0	0.5	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.4	0.5	0.0	0.9	0.4	0.7	0.3	0.3	0.9	0.2	0.2	0.1	0.4	0.4	0.1	0.0	0.3	0.0	0.3	0.8	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	3.2	5.4	9.4	2.7	2.7	6.6	6.3	9.8	6.9	4.0	7.8	4.6	0.1	0.0	1.1	4.6	0.1	0.0	0.0	0.0	1.2	0.0	0.3	1.1	0.6	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.3	0.0	0.5	0.1	0.2	0.0	3.8	0.1	0.4	1.2	1.4	0.0	0.5	1.3	0.7	1.1	0.0	0.6	0.0	0.1	0.0	0.0	2.0	0.0	0.0	1.2	2.1	0.0	1.0	9.4	5.3	0.0	0.0	0.0	0.3	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.4	0.0	0.0	0.1	0.0	0.8	0.2	0.1	0.0	0.1
KCNH1	"eag, eag1, h-eag, hEAG, Kv10.1"	ENSG00000143473	"Potassium voltage-gated channel subfamily H member 1"	O95259	1	210676823-211134165	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 17.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 533.5;Inhibitory neurons: 261.0;Oligodendrocytes: 116.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 6.2;RH-30: 10.1;RPTEC TERT1: 6.0;SH-SY5Y: 12.9;SK-MEL-30: 12.9;T-47d: 9.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 34.0;cerebellum: 19.1;cerebral cortex: 23.9;hippocampal formation: 17.9;olfactory bulb: 8.9"	"HPA014551, HPA019445, HPA076421"	Enhanced		Supported	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA014551: AB_2669038, HPA019445: AB_1852118, HPA076421: "	"unprognostic (9.12e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.63e-1)"	"unprognostic (6.70e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.70e-2)"	0.2	0.9	6.8	0.4	9.2	0.0	0.2	9.5	17.9	0.7	2.7	0.5	0.3	0.4	0.2	0.1	0.6	0.2	0.0	11.2	5.3	0.1	0.1	0.0	0.0	4.8	4.4	0.1	0.2	0.0	0.7	0.3	4.0	0.5	0.3	0.3	0.1	0.1	0.2	0.1	0.8	0.2	4.0	0.0	0.5	1.5	4.9	0.2	0.1	0.6	0.0	0.2	0.4	8.3	0.0	2.1	0.4	0.1	0.0	0.1	0.1	1.0	0.2	2.1	2.4	0.0	0.0	0.0	0.0	1.4	2.4	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	6.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	10.1	0.0	6.0	0.0	0.4	12.9	2.4	0.2	12.9	1.7	9.2	0.0	0.0	1.6	0.2	2.0	1.2	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.8	9.2	9.5	17.9	11.2	5.3	4.8	4.4	4.0	4.0	4.9	8.3	0.2	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	11.2	0.2	2.8	0.1	0.0	0.0	533.5	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	261.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	7.5	0.0	0.0	0.0	19.1	116.6	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNJ13	"Kir1.4, Kir7.1, LCA16"	ENSG00000115474	"Potassium inwardly rectifying channel subfamily J member 13"	O60928	2	232765802-232776565	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cataract, Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"choroid plexus: 159.5;intestine: 91.3"	"Group enriched"	"Detected in some"	4	"Muller glia cells: 54.8;Proximal enterocytes: 217.4;Undifferentiated cells: 68.1"	"Cancer enriched"	"Detected in some"	5	"melanoma: 5.9"	"Group enriched"	"Detected in many"	4	"cerebellum: 7.3;hippocampal formation: 8.0;thalamus: 5.3;white matter: 3.4"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"U-2197: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051609			Approved	"Nuclear membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nuclear membrane"		"HPA051609: "	"unprognostic (4.29e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.03e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-2)"		"unprognostic (2.26e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.11e-2)"	0.1	0.1	0.4	0.0	1.3	0.4	0.1	7.3	1.1	0.1	159.5	0.1	7.9	0.1	0.3	0.1	0.0	2.2	0.1	8.0	0.4	3.3	0.2	0.1	0.2	1.3	0.8	0.2	0.8	15.8	0.2	0.0	1.3	0.1	0.0	13.7	0.2	1.1	0.1	3.2	91.3	0.1	0.4	0.1	2.3	0.5	5.3	0.1	7.0	0.0	0.0	0.1	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.3	0.0	0.2	0.2	0.1	0.0	1.9	0.3	0.3	0.3	0.0	0.4	0.2	0.6	0.2	0.1	0.3	0.7	0.3	0.3	0.4	0.4	0.3	1.0	0.0	0.4	1.3	7.3	1.1	8.0	0.4	1.3	0.8	1.3	0.4	5.3	3.4	0.1	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.5	0.5	0.0	0.0	1.8	0.0	0.0	0.2	0.1	1.9	0.0	3.0	0.7	0.3	0.2	0.0	0.0	1.1	1.3	0.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	25.7	0.0	0.0	0.0	0.6	0.0	0.1	21.4	0.0	0.0	54.8	0.0	1.5	2.0	0.0	8.8	0.0	0.0	0.1	217.4	0.2	0.0	1.7	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.0	68.1	0.0
KCNJ5	"CIR, GIRK4, KATP1, Kir3.4, LQT13"	ENSG00000120457	"Potassium inwardly rectifying channel subfamily J member 5"	P48544	11	128891356-128921163	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cancer-related genes, Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 64.3;pancreas: 20.4"	"Cell type enriched"	"Detected in many"	4	"Hofbauer cells: 48.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"HBEC3-KT: 13.3"	"Group enriched"	"Detected in many"	6	"basal ganglia: 2.9;hypothalamus: 6.8;midbrain: 1.9;thalamus: 3.6"	"Low region specificity"	"Detected in all"			"HPA014722, HPA017353, CAB022569"	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"			"CAB022569: , HPA014722: AB_1852133, HPA017353: AB_1852135"	"unprognostic (2.01e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.56e-3)"	"unprognostic (5.81e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.54e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.23e-2)"	1.5	64.3	1.2	0.6	0.9	0.4	0.9	0.6	2.0	1.3	0.2	0.8	0.8	0.3	0.9	1.0	0.9	2.2	8.5	0.7	3.2	5.4	0.4	5.9	1.6	3.7	1.7	0.9	20.4	1.3	11.9	7.3	2.7	1.3	0.7	1.0	0.9	9.6	0.4	0.4	0.5	0.6	1.7	13.6	2.3	1.1	7.9	5.8	0.5	0.4	0.5	1.5	0.4	3.9	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.1	0.3	13.3	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	1.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	1.2	0.9	0.6	2.0	0.7	3.2	3.7	1.7	2.7	1.7	7.9	3.9	0.2	0.0	10.0	0.3	0.2	1.5	2.2	4.7	0.0	2.7	0.2	1.4	7.6	0.0	0.3	1.8	0.0	0.8	0.1	0.0	0.0	0.1	2.3	0.2	0.2	0.6	0.0	0.0	0.2	3.9	0.7	1.1	0.0	0.3	0.0	0.2	0.4	0.1	48.3	1.7	3.1	0.0	0.0	2.2	2.9	7.8	0.9	10.9	3.6	3.7	1.2	0.3	3.1	0.5	0.1	0.8	0.0	0.7	0.3	0.6	0.0	0.1	0.3	1.4	0.0	0.9	0.2	0.9	0.5	0.5	1.7	1.2	0.6	2.3	0.0	0.6
KCNJ6	"BIR1, GIRK2, hiGIRK2, KATP2, KCNJ7, Kir3.2"	ENSG00000157542	"Potassium inwardly rectifying channel subfamily J member 6"	P48051	21	37607373-38121345	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Congenital generalized lipodystrophy, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 24.2"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 152.6;Horizontal cells: 245.6;Inhibitory neurons: 146.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	6	"cerebral cortex: 10.3;hippocampal formation: 10.6;midbrain: 24.2"	"Immune cell enhanced"	"Detected in some"		"basophil: 2.2;eosinophil: 1.3"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 2.2"	"Cell line enriched"	"Detected in some"	7	"LHCN-M2: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 62: Horizontal cells - Visual perception"				"unprognostic (1.43e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.75e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.96e-10)"	"unprognostic (2.42e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.21e-1)"	0.0	0.1	2.3	0.1	2.7	0.1	0.0	1.6	10.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.6	1.9	0.0	0.0	0.1	0.2	1.9	24.2	0.0	0.4	0.0	1.7	0.4	2.2	0.2	0.0	1.0	0.0	0.0	0.4	0.1	0.1	0.0	1.2	0.2	0.4	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.7	0.3	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.9	1.6	0.0	0.0	0.0	3.5	0.1	29.2	0.1	0.0	0.0	0.3	0.0	2.8	0.0	0.1	1.0	4.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.3	0.1	0.1	0.2	4.3	1.2	0.0	0.0	0.0	0.0	2.2	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.1	0.0	0.0	2.3	2.7	1.6	10.3	10.6	1.9	1.9	24.2	2.2	1.2	1.8	1.5	0.2	0.0	1.1	2.3	0.0	0.1	0.4	0.1	0.0	25.4	0.2	0.3	34.3	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.4	0.1	0.2	1.6	41.4	0.0	152.6	0.0	0.4	0.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	245.6	146.2	1.8	2.0	0.0	0.0	0.0	0.6	0.0	3.6	16.9	0.0	1.2	0.0	38.2	1.5	0.6	0.0	0.0	0.0	0.3	0.2	0.0	0.1	2.6	0.0	0.2	1.1	0.0	1.7	0.0	0.1	0.3	0.1	0.0	0.4	0.4
KCNK18	"K2p18.1, TRESK, TRESK-2, TRESK2, TRIK"	ENSG00000186795	"Potassium two pore domain channel subfamily K member 18"	Q7Z418	10	117197489-117210299	"Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"choroid plexus: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA044739	Uncertain					NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"					"HPA044739: AB_10795008"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNK4	"K2p4.1, TRAAK"	ENSG00000182450	"Potassium two pore domain channel subfamily K member 4"	Q9NYG8	11	64291302-64300031	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	28	"brain: 6.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.9;Endometrial stromal cells: 9.8;Excitatory neurons: 9.0;Extravillous trophoblasts: 3.6;Horizontal cells: 3.3;Muller glia cells: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 36: Stromal cells - Cell proliferation"								"unprognostic (1.85e-1)"					"unprognostic (1.58e-1)"				"unprognostic (1.21e-1)"	"unprognostic (2.84e-1)"			0.0	0.0	5.7	0.0	4.1	0.0	0.0	0.5	6.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.1	0.7	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	4.1	0.5	6.9	6.1	0.7	0.6	0.6	0.6	0.0	1.3	3.2	0.0	0.0	0.0	2.9	0.0	0.5	0.0	0.0	0.0	0.9	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	9.8	0.1	0.0	0.0	9.0	0.0	3.6	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	3.3	2.4	0.0	0.0	0.0	0.9	0.0	0.0	1.0	0.0	1.0	0.0	4.4	0.0	0.5	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.1	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0
KCNQ2	"BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2"	ENSG00000075043	"Potassium voltage-gated channel subfamily Q member 2"	O43526	20	63400208-63472677	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 91.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.5;Excitatory neurons: 61.7;Horizontal cells: 13.5;Inhibitory neurons: 37.5;Oligodendrocyte precursor cells: 50.8;Spermatogonia: 28.3"	"Cancer enriched"	"Detected in some"	9	"glioma: 8.7"	"Group enriched"	"Detected in many"	4	"amygdala: 55.7;basal ganglia: 37.2;cerebellum: 27.8;cerebral cortex: 91.9;hippocampal formation: 68.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 21.2;AN3-CA: 35.0;NTERA-2: 19.3;SCLC-21H: 67.8;SH-SY5Y: 119.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016642, HPA057112"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"		"HPA016642: AB_1855555, HPA057112: AB_2683339"	"unprognostic (2.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-4)"	"unprognostic (8.21e-6)"	"unprognostic (6.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.96e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.43e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.70e-2)"	0.0	6.2	55.7	0.1	37.2	0.0	0.0	27.8	91.9	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.3	0.3	0.2	68.1	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.0	1.1	0.0	19.1	0.0	0.1	1.6	0.0	2.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	10.6	1.0	0.0	0.0	0.0	0.0	0.0	0.1	12.9	0.0	0.0	21.2	35.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.6	0.0	8.3	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	19.3	0.5	0.2	0.0	0.0	0.1	0.0	0.0	67.8	119.3	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	55.7	37.2	27.8	91.9	68.1	0.0	2.6	0.0	0.1	0.0	1.0	12.9	0.6	0.0	0.0	7.2	0.1	0.1	0.0	0.0	0.0	5.7	0.0	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	16.5	0.0	0.1	1.0	0.0	0.0	61.7	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.5	37.5	0.2	0.0	0.0	0.0	8.1	0.6	0.1	0.0	1.0	0.0	0.9	0.0	50.8	2.1	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	2.5	0.0	0.1	0.1	7.4	28.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0
KCNQ3	"EBN2, Kv7.3"	ENSG00000184156	"Potassium voltage-gated channel subfamily Q member 3"	O43525	8	132120859-132481095	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 23.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 501.5;Inhibitory neurons: 485.6;Microglial cells: 502.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 6.6;JURKAT: 3.8;RPMI-8226: 2.8;U-2 OS: 4.3;U-87 MG: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (2.90e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.65e-5)"	"unprognostic (2.32e-1)"	"unprognostic (4.60e-2)"	"unprognostic (5.57e-6)"	"unprognostic (5.82e-2)"	"unprognostic (7.32e-2)"	"unprognostic (6.09e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.71e-4)"	"unprognostic (1.14e-3)"	"unprognostic (3.52e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.50e-2)"	1.3	1.4	9.9	0.5	21.2	0.0	0.9	0.0	23.7	0.3	0.0	0.4	0.2	0.2	0.1	0.1	0.3	0.3	0.7	9.1	4.7	0.7	0.0	1.9	0.1	4.7	8.1	0.1	0.9	0.2	1.9	0.2	7.4	0.4	0.2	2.5	0.3	0.6	0.0	0.4	0.6	0.5	0.0	0.5	0.1	0.2	16.0	0.5	0.5	0.0	0.2	0.4	0.4	8.7	0.2	0.1	0.0	0.0	0.3	1.0	0.0	0.3	1.1	0.0	0.0	0.0	1.0	0.0	1.2	1.5	2.5	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.7	6.6	0.1	0.0	3.8	0.0	0.1	0.9	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	2.8	1.6	0.0	1.3	1.2	0.4	0.0	0.0	0.2	0.0	1.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	21.2	0.0	23.7	9.1	4.7	4.7	8.1	7.4	0.0	16.0	8.7	0.4	0.0	14.0	84.5	0.2	0.3	0.0	0.0	0.0	6.7	1.3	0.6	4.6	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	4.3	1.6	0.3	4.2	2.7	0.0	0.0	501.5	6.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	485.6	0.7	0.0	0.3	1.6	2.9	0.0	2.1	0.0	502.2	0.6	0.4	0.0	117.1	31.2	1.8	0.0	0.0	0.0	0.1	4.6	1.6	0.8	0.6	0.0	0.0	2.7	0.0	0.5	0.1	0.1	0.0	0.4	0.1	1.2	0.1
KCNQ4	"DFNA2, Kv7.4"	ENSG00000117013	"Potassium voltage-gated channel subfamily Q member 4"	P56696	1	40783787-40840452	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Hearing, Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5.1;intestine: 5.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 5.1;Inhibitory neurons: 9.7;Muller glia cells: 4.2;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 5.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.8;HEK 293: 2.2;K-562: 2.6;MCF7: 1.4;REH: 1.3;THP-1: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA018305	Uncertain					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA018305: AB_1855556"	"unprognostic (1.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.43e-3)"	"unprognostic (4.59e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.40e-2)"	"unprognostic (5.18e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.44e-2)"	0.9	0.1	0.1	0.3	0.6	0.0	0.6	0.2	1.7	0.9	2.4	5.4	0.4	2.8	0.1	1.0	2.3	0.3	0.6	0.2	0.2	0.1	0.1	0.5	0.0	0.7	5.1	0.5	0.4	0.2	0.3	0.5	0.7	1.1	0.3	0.4	1.4	1.1	3.2	0.6	1.2	1.5	0.8	0.0	1.3	0.2	0.1	0.3	0.2	1.0	0.0	2.3	0.7	2.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	2.2	0.9	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	2.6	0.0	0.0	1.4	0.3	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.2	0.0	1.1	0.2	0.0	0.6	0.2	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	1.7	0.2	0.2	0.7	5.1	0.7	0.8	0.1	2.0	0.3	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.4	1.8	1.5	2.1	0.0	0.0	0.0	2.1	0.1	0.0	0.5	0.0	1.2	0.2	0.2	0.1	0.3	1.8	0.8	5.1	0.2	0.0	0.2	0.0	0.4	0.0	0.3	0.0	0.0	2.2	0.0	9.7	1.2	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	4.2	0.0	2.5	1.5	0.6	0.5	0.7	0.3	0.2	0.0	0.0	0.0	0.3	6.6	2.0	2.8	0.2	0.7	1.0	0.4	0.0	0.0	0.1	1.1	0.1
KCNQ5	Kv7.5	ENSG00000185760	"Potassium voltage-gated channel subfamily Q member 5"	Q9NR82	6	72621792-73198853	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 28.3;skeletal muscle: 21.1;tongue: 12.2"	"Group enriched"	"Detected in some"	30	"Excitatory neurons: 2136.7;Inhibitory neurons: 862.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 28.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 34.9;HEL: 23.2;HL-60: 31.5;U-251 MG: 23.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016655	Approved		Approved	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA016655: AB_1855557"	"unprognostic (4.91e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.09e-2)"	"unprognostic (8.55e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.39e-3)"	0.1	1.6	1.2	1.3	7.5	5.1	0.4	0.0	28.3	0.4	0.0	0.4	0.2	0.1	0.0	0.9	0.3	0.3	0.2	4.3	0.0	0.1	0.2	0.3	2.2	17.4	1.0	0.1	0.1	0.0	0.2	0.4	19.4	1.3	0.3	0.2	1.2	0.9	21.1	0.1	0.7	0.3	0.0	1.1	0.3	1.2	0.0	1.7	4.7	12.2	2.0	0.9	0.6	4.6	4.4	1.1	0.0	0.2	0.0	1.5	0.0	34.9	5.2	5.1	4.3	0.0	0.0	21.2	0.0	11.9	0.4	0.7	0.1	2.1	6.1	0.3	7.2	23.2	0.1	0.0	0.9	31.5	0.0	0.3	0.8	14.5	14.9	3.3	0.0	0.0	1.4	14.2	10.2	0.1	0.0	13.5	1.3	0.0	7.1	0.0	1.1	14.4	1.9	0.0	5.8	2.7	0.0	0.1	13.7	0.2	4.3	2.3	0.0	21.0	9.2	0.1	23.4	14.8	0.4	9.3	0.2	14.9	1.2	0.3	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.4	0.1	0.3	0.3	0.3	0.0	0.6	0.0	0.0	0.0	0.0	1.2	7.5	0.0	28.3	4.3	0.0	17.4	1.0	19.4	0.0	0.0	4.6	0.0	0.0	0.0	38.8	7.6	0.3	3.6	0.7	5.2	0.3	0.4	0.5	3.6	0.0	0.1	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	5.5	2136.7	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	862.4	0.0	0.0	0.0	1.5	1.6	0.0	0.2	1.8	49.6	0.0	0.1	1.0	30.2	26.7	0.0	0.0	0.0	7.6	5.7	0.0	0.0	0.0	0.2	0.0	6.0	0.8	0.5	0.5	0.8	0.3	0.3	2.8	0.0	0.0	0.7
KCNT1	"KCa4.1, KIAA1422, SLACK, Slo2.2"	ENSG00000107147	"Potassium sodium-activated channel subfamily T member 1"	Q5JUK3	9	135702185-135795508	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 37.1;lymphoid tissue: 15.8;skeletal muscle: 13.4"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 60.1;Inhibitory neurons: 55.0;Theca cells: 21.2"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.8"	"Region enhanced"	"Detected in many"		"cerebral cortex: 37.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 2.5;RPMI-8226: 1.8;SCLC-21H: 3.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 42.8"	HPA059880	Uncertain					NA	NA				"Cluster 47: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA059880: AB_2684149"	"unprognostic (1.50e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.98e-13)"	"unprognostic (9.26e-2)"	"unprognostic (7.73e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.89e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.89e-7)"	"unprognostic (9.15e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.66e-2)"	0.4	0.1	3.9	0.1	7.9	0.1	0.3	1.9	37.1	0.3	0.0	0.3	0.1	0.1	0.1	0.2	0.6	0.2	1.2	4.2	0.0	0.0	0.1	0.3	0.0	4.5	0.0	5.0	0.1	0.0	8.7	0.3	2.8	0.1	0.0	0.4	0.2	0.0	13.4	0.1	0.2	0.0	0.0	15.8	0.5	0.9	0.0	0.0	0.1	8.2	0.0	0.2	0.2	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.8	1.8	0.0	0.0	3.7	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	7.9	1.9	37.1	4.2	0.0	4.5	0.0	2.8	0.0	0.0	12.5	0.0	0.0	0.0	3.6	0.1	0.0	0.3	0.0	0.0	1.3	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	60.1	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	55.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.3	0.0	3.5	2.7	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.6	0.0	5.1	1.1	0.3	1.0	0.0	0.0	0.0	0.1	21.2	0.0	0.0
KCNT2	"KCa4.2, SLICK, SLO2.1"	ENSG00000162687	"Potassium sodium-activated channel subfamily T member 2"	Q6UVM3	1	196225779-196609225	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ovary: 3.8"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 220.2;Inhibitory neurons: 240.5;Oligodendrocyte precursor cells: 310.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 3.2;hTERT-RPE1: 9.0;SCLC-21H: 7.5;SH-SY5Y: 5.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051218	Uncertain		Approved	Vesicles		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA051218: AB_2681392"	"unprognostic (5.06e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.10e-6)"	"unprognostic (1.22e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.18e-1)"	"unprognostic (9.56e-3)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.67e-5)"	"unprognostic (3.30e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.72e-3)"	1.0	0.6	0.9	0.1	2.0	0.0	0.4	0.0	2.0	0.4	0.3	0.5	0.2	0.3	0.4	1.0	0.5	1.4	1.8	2.5	3.3	0.3	2.8	1.8	0.1	0.0	0.2	3.8	0.1	0.0	0.9	0.2	0.0	1.0	0.5	0.1	0.5	0.6	0.1	0.3	0.4	0.5	0.6	0.2	0.5	1.1	1.0	0.1	1.1	0.8	0.1	0.8	0.4	0.5	0.0	0.1	1.8	0.0	0.2	0.2	0.0	0.0	1.0	0.1	1.8	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.9	0.0	3.2	0.0	0.0	1.2	0.0	0.4	0.1	9.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	2.4	0.0	0.1	0.0	0.1	0.0	0.0	0.5	7.5	5.6	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.0	0.0	2.0	2.5	3.3	0.0	0.2	0.0	0.6	1.0	0.5	0.8	41.7	1.1	6.8	0.0	0.4	0.2	0.0	0.6	0.0	0.0	0.1	1.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.2	0.8	0.0	0.0	220.2	0.0	0.0	9.3	0.0	0.0	0.0	6.1	2.5	6.2	0.0	0.0	240.5	0.0	0.0	0.0	0.7	3.3	6.5	0.0	1.8	58.1	0.0	0.0	0.0	310.7	6.1	0.0	0.0	4.9	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.4	4.0	0.6	0.2	0.0	0.0	0.0	0.0	3.9	0.0	0.2
KCNV2	Kv8.2	ENSG00000168263	"Potassium voltage-gated channel modifier subfamily V member 2"	Q8TDN2	9	2717510-2730037	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	59	"retina: 289.1"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 515.0;Rod photoreceptor cells: 530.1"	"Cancer enriched"	"Detected in single"	78	"testis cancer: 6.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031131	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA031131: AB_10609996"	"unprognostic (5.06e-2)"	"unprognostic (1.47e-3)"	"unprognostic (3.45e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.96e-8)"	"unprognostic (3.01e-1)"	"unprognostic (4.90e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.06e-2)"	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.1	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.9	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	289.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.9	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.1	1.3	0.9	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	49.6	0.0	0.0	0.2	0.0	0.0	0.0	515.0	0.0	0.0	0.0	0.0	0.0	81.5	0.0	0.0	2.3	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	1.3	0.0	0.0	0.0	0.0	25.3	0.6	0.0	0.0	0.0	0.0	69.1	0.0	0.5	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	530.1	13.1	0.0	0.0	7.4	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KDM1A	"AOF2, BHC110, KDM1, KIAA0601, LSD1"	ENSG00000004487	"Lysine demethylase 1A"	O60341	1	23019443-23083689	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Oxidoreductase, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005884, HPA053660"	Supported		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		7700	"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB005884: AB_443964, HPA053660: AB_2682220"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (6.31e-4)"	"unprognostic (1.50e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (4.47e-12)"	"unprognostic (1.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.39e-1)"	25.7	30.8	24.7	23.5	25.8	48.1	30.6	26.5	27.0	33.1	20.4	31.6	26.4	36.0	46.9	35.0	34.2	25.3	26.1	25.3	28.2	24.7	22.3	24.5	34.7	19.8	22.0	41.4	36.2	51.2	41.5	31.5	21.0	32.2	33.8	30.9	36.6	29.4	47.3	38.2	29.2	30.1	21.2	25.2	29.3	86.9	27.4	55.8	28.5	34.0	37.2	34.6	31.5	21.8	128.1	64.7	180.8	160.7	47.0	59.5	128.4	53.1	66.4	106.0	93.7	61.2	120.5	94.5	74.1	87.6	53.7	139.5	169.5	101.0	133.3	86.3	102.7	133.0	105.7	150.6	59.6	103.7	56.0	55.6	71.4	112.8	78.9	93.0	134.1	171.7	148.0	43.4	76.3	75.9	227.3	79.2	118.3	70.8	93.0	214.7	119.1	64.1	89.0	81.0	225.0	169.9	239.4	62.4	80.2	126.1	62.7	76.2	109.5	47.0	78.4	88.1	73.6	55.6	47.1	109.3	49.2	120.4	68.3	2.0	2.5	4.3	4.1	4.3	3.4	7.4	3.5	3.8	3.1	2.1	4.5	4.9	0.2	3.0	5.5	6.8	4.4	1.4	24.7	25.8	26.5	27.0	25.3	28.2	19.8	22.0	21.0	21.2	27.4	21.8	18.7	19.2	29.1	33.6	15.9	18.6	27.1	19.9	33.0	27.5	20.4	22.1	24.4	11.5	19.0	23.9	27.1	31.6	18.1	15.7	17.6	35.4	43.5	45.9	49.3	20.4	22.8	29.7	51.1	24.7	57.2	24.8	23.4	44.4	12.0	49.5	16.8	17.2	15.0	15.2	51.2	24.9	22.4	15.1	19.7	20.3	21.5	20.2	12.4	30.0	28.1	19.3	12.3	50.3	30.4	28.1	13.5	23.0	28.9	26.3	17.2	15.7	29.5	19.8	0.0	22.2	25.0	131.8	67.1	36.1	12.8	16.6	15.4	34.3	27.6	20.5
KDM3B	"C5orf7, JMJD1B, KIAA1082, NET22"	ENSG00000120733	"Lysine demethylase 3B"	Q7LBC6	5	138352685-138437028	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016610, HPA057202"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 12: NES - Nervous system development"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA016610: AB_1852004, HPA057202: AB_2683367"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"prognostic favorable (6.67e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.60e-2)"	21.7	19.4	22.6	16.9	23.0	25.4	25.3	22.2	22.8	22.7	21.1	23.9	18.6	23.0	28.3	21.2	24.2	14.2	20.0	21.3	20.7	21.4	14.5	19.3	23.0	23.4	22.7	30.8	20.3	34.2	16.5	20.5	21.5	21.8	24.0	36.3	22.2	25.9	41.5	28.1	23.4	20.8	21.9	26.0	21.6	19.4	23.9	35.9	23.2	27.1	29.4	24.8	19.9	21.8	24.3	32.4	65.0	58.7	27.2	23.3	47.0	15.6	27.1	30.0	33.5	35.7	27.2	46.3	27.9	30.3	41.0	24.3	53.2	37.8	32.6	30.3	29.3	39.2	28.6	27.1	25.4	32.2	43.3	26.9	39.0	22.1	26.7	23.2	34.6	29.3	31.8	26.1	34.3	30.3	46.4	41.0	31.0	34.1	13.7	53.1	48.5	30.9	40.4	31.6	32.7	35.9	27.0	28.0	25.7	93.2	27.3	43.5	31.9	17.9	17.4	19.3	28.8	32.8	16.7	40.2	12.5	45.6	25.6	0.2	2.9	4.2	2.3	2.2	3.2	2.3	2.7	3.0	2.5	2.0	2.5	2.3	5.5	4.2	2.3	3.0	1.7	1.3	22.6	23.0	22.2	22.8	21.3	20.7	23.4	22.7	21.5	21.9	23.9	21.8	22.8	16.0	15.7	43.1	22.1	15.9	13.7	15.1	20.5	21.3	29.1	29.5	33.2	17.2	17.0	22.0	29.2	13.4	24.0	26.8	0.0	16.0	6.1	22.8	19.9	18.9	21.0	25.4	40.9	16.8	10.7	18.5	17.9	24.2	13.3	26.3	18.2	23.0	17.6	23.5	39.1	26.4	18.3	39.2	18.3	2.8	21.1	27.9	16.0	50.6	27.0	17.3	16.5	41.7	56.9	19.9	28.0	23.0	16.2	21.2	20.9	16.1	25.6	31.9	26.3	21.8	18.7	13.0	15.5	26.2	21.6	10.9	19.1	17.1	24.6	21.0
KDM5A	"JARID1A, RBBP2"	ENSG00000073614	"Lysine demethylase 5A"	P29375	12	280057-389320	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 45.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006201			Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear bodies"	Cytosol	"HPA006201: AB_1079160"	"unprognostic (2.75e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.81e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.77e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.60e-2)"	"unprognostic (7.69e-2)"	8.1	8.7	5.8	11.4	8.3	45.5	11.1	11.6	8.5	8.6	10.0	8.2	7.2	9.7	7.1	8.9	7.6	8.0	5.2	6.2	6.5	7.8	9.9	8.8	15.3	6.8	5.7	11.0	9.4	10.1	4.2	11.8	6.5	8.6	9.9	9.6	6.7	7.3	5.5	12.5	7.3	9.4	6.0	13.5	8.8	21.1	6.7	21.6	9.1	7.6	14.4	8.7	7.2	15.0	14.4	25.3	18.3	14.2	16.1	15.2	20.3	12.5	16.5	18.4	19.8	15.2	17.0	24.0	3.9	21.0	16.0	13.3	19.2	14.2	21.9	37.9	15.9	29.3	26.5	9.0	13.0	38.6	22.1	16.6	13.1	22.6	29.9	18.8	18.8	21.0	17.9	32.7	15.7	9.7	27.9	11.0	28.4	12.3	7.9	25.7	47.5	11.4	8.8	32.6	7.0	20.5	24.5	11.0	13.0	25.0	11.9	24.0	26.0	12.0	17.0	13.6	21.1	11.5	13.6	53.7	15.5	16.5	18.0	64.5	21.8	44.4	31.4	25.0	32.3	27.1	24.6	25.9	22.8	32.0	26.3	22.8	63.0	35.8	28.9	32.0	20.9	22.5	5.8	8.3	11.6	8.5	6.2	6.5	6.8	5.7	6.5	6.0	6.7	15.0	53.1	64.1	61.6	61.7	80.6	33.0	22.2	30.1	48.9	69.0	35.3	27.9	38.2	31.5	39.0	35.0	116.7	48.8	103.3	51.3	3.9	37.4	96.8	60.2	72.8	51.6	69.7	51.3	71.7	31.6	34.7	47.2	39.8	99.8	54.4	106.9	42.8	30.9	30.2	87.5	59.1	40.0	40.7	52.5	37.5	32.5	48.4	63.9	26.6	57.1	82.9	48.3	105.0	68.3	85.9	38.7	37.0	55.7	73.1	32.4	33.6	11.8	40.2	71.9	59.2	64.0	59.9	137.1	104.8	50.1	47.6	71.1	80.1	67.5	40.1	42.0
KDM5B	"CT31, JARID1B, PLU-1, PPP1R98, RBBP2H1A"	ENSG00000117139	"Lysine demethylase 5B"	Q9UGL1	1	202724495-202808487	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 62.3"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 243.6;Spermatocytes: 390.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027179, HPA053723, CAB068193"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB068193: AB_2665696, HPA027179: AB_1851987, HPA053723: AB_2682241"	"unprognostic (1.19e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.02e-2)"	"unprognostic (3.23e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.79e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.56e-2)"	"unprognostic (4.13e-1)"	9.1	7.7	1.5	2.6	2.2	14.1	9.9	5.8	4.8	14.7	7.9	10.6	2.1	12.6	3.3	21.0	9.9	2.9	6.0	4.6	1.5	6.2	4.6	10.8	2.2	0.8	0.4	12.8	8.3	2.6	6.9	4.7	0.2	10.6	2.2	17.8	12.5	2.4	4.7	24.3	8.6	3.1	1.0	7.4	8.7	62.3	1.2	4.1	8.4	0.8	2.1	10.9	15.7	2.3	9.9	2.4	14.0	9.8	7.2	6.6	23.7	6.2	9.4	6.2	6.4	2.2	8.8	0.1	5.7	7.9	2.3	11.8	9.0	8.3	5.4	0.5	12.8	7.7	2.4	1.9	5.5	17.7	8.9	9.4	12.1	7.0	7.2	10.1	11.7	7.3	20.9	0.3	4.9	6.3	5.8	16.4	21.9	4.3	28.0	18.7	0.1	0.4	6.5	10.7	10.7	23.4	14.7	7.9	8.7	15.7	16.6	10.5	12.8	8.2	5.8	1.4	5.2	2.3	1.1	8.2	6.0	5.5	4.1	44.6	6.4	19.6	7.7	4.8	4.6	10.9	8.9	4.3	4.2	17.4	9.6	6.0	34.4	12.9	10.4	6.6	7.2	3.9	1.5	2.2	5.8	4.8	4.6	1.5	0.8	0.4	0.2	1.0	1.2	2.3	24.5	89.8	38.5	46.7	22.2	64.4	34.8	53.0	84.2	35.5	57.1	50.0	9.5	11.5	53.6	16.5	62.6	41.8	12.4	23.7	5.9	47.6	191.6	65.2	71.8	31.9	43.6	50.2	75.8	22.3	34.3	42.7	47.9	69.5	27.1	28.6	17.2	10.9	7.7	15.2	53.5	38.1	44.7	15.1	21.9	243.6	36.4	15.5	26.6	40.3	11.3	69.8	10.3	39.7	42.5	45.4	21.8	32.7	25.8	43.1	15.2	8.2	61.9	138.6	32.9	22.8	40.2	390.9	71.0	95.9	116.2	82.4	21.2	61.5	30.2	55.6
KDM5C	"DXS1272E, JARID1C, MRX13, SMCX, XE169"	ENSG00000126012	"Lysine demethylase 5C"	P41229	X	53191321-53225422	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038244, HPA046147"			Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA038244: AB_2675911, HPA046147: AB_2679555"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.00e-1)"	22.3	29.0	19.2	28.2	19.7	34.8	22.7	23.0	21.7	35.5	22.2	25.5	26.0	35.5	14.8	35.2	33.2	17.1	22.7	19.6	20.1	21.1	24.1	27.2	33.4	19.8	19.0	39.9	26.4	33.8	31.4	23.8	19.0	23.8	15.4	24.6	29.4	18.5	51.0	34.2	28.2	26.9	16.8	30.9	25.8	13.5	20.9	44.2	27.6	25.5	26.5	25.9	35.4	20.8	45.3	60.4	63.6	49.0	43.2	39.1	45.2	27.7	32.2	36.8	34.0	41.3	28.9	41.8	35.0	36.7	103.2	39.5	72.6	59.1	27.8	31.6	107.9	40.6	66.7	29.6	52.9	48.5	77.6	31.0	42.8	72.0	87.7	52.3	55.2	34.2	80.8	27.2	27.3	57.9	35.9	55.4	54.1	23.3	56.3	40.1	37.8	45.9	23.5	42.6	47.6	61.4	84.0	76.8	32.2	58.4	53.9	42.3	37.8	40.6	35.0	36.9	27.2	39.0	34.2	31.5	52.6	56.9	30.8	0.9	1.2	0.8	1.6	1.1	1.4	1.2	1.0	1.6	0.9	0.8	1.2	0.8	1.4	0.8	1.2	1.3	1.3	1.2	19.2	19.7	23.0	21.7	19.6	20.1	19.8	19.0	19.0	16.8	20.9	20.8	17.6	12.8	14.9	33.0	17.8	12.1	10.5	12.1	14.8	24.7	19.7	15.0	10.0	11.5	15.2	7.3	25.0	13.1	21.2	32.2	3.9	15.0	0.8	28.2	25.2	17.7	31.2	17.2	36.1	21.9	15.1	14.2	21.4	35.7	13.3	25.5	15.0	25.5	14.4	25.2	37.0	25.8	16.2	18.2	8.8	2.6	14.6	17.1	14.2	27.2	14.9	9.8	16.5	31.2	49.2	26.4	26.3	15.8	17.0	17.9	22.1	5.8	16.4	16.9	0.0	17.2	16.8	10.3	15.8	16.2	15.9	20.8	18.0	22.6	18.9	21.6
KDM6A	UTX	ENSG00000147050	"Lysine demethylase 6A"	O15550	X	44873188-45112779	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 116.2;Oligodendrocyte precursor cells: 118.1;Oligodendrocytes: 264.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000568, HPA001165, HPA002111"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"	"Intracellular and membrane"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA000568: AB_1858705, HPA001165: AB_1080541, HPA002111: AB_1858704"	"unprognostic (1.73e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.58e-3)"	"unprognostic (8.22e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.16e-2)"	9.6	8.0	6.7	4.5	7.6	19.4	10.6	7.2	10.6	15.7	6.5	9.1	6.2	14.0	5.1	11.1	14.0	3.4	6.6	6.8	6.9	6.8	10.4	10.8	8.0	7.3	6.8	17.2	10.8	6.4	8.6	3.9	7.3	7.7	4.1	3.8	10.5	3.1	10.4	18.4	13.0	4.1	7.1	14.1	12.5	12.2	7.0	12.9	9.4	6.1	5.3	9.8	15.2	9.9	7.3	5.8	7.0	9.3	5.0	6.8	15.7	4.9	4.2	4.0	4.1	10.4	5.2	4.6	3.2	3.5	10.1	13.9	6.5	5.4	3.9	7.6	10.8	2.4	4.5	5.2	3.7	2.6	13.2	2.6	6.4	8.2	6.6	5.1	4.2	5.3	6.4	10.1	2.4	6.0	6.9	13.6	6.8	4.2	7.4	6.4	7.1	1.4	3.8	9.2	6.2	4.4	18.2	6.8	10.7	14.1	8.5	0.0	3.0	5.4	5.2	5.2	3.6	5.5	8.8	5.6	4.0	3.3	3.3	7.3	1.7	1.5	1.9	3.5	2.1	1.9	2.5	2.8	3.1	1.2	2.5	2.4	2.8	2.8	3.0	1.7	2.2	2.0	6.7	7.6	7.2	10.6	6.8	6.9	7.3	6.8	7.3	7.1	7.0	9.9	23.2	6.4	10.6	92.1	26.0	26.1	14.3	9.4	38.1	7.7	16.8	12.1	12.8	12.8	10.9	7.3	14.6	4.5	26.1	24.6	0.0	8.4	1.5	26.4	25.5	13.1	13.1	16.8	88.3	7.5	7.9	14.2	23.0	39.7	2.5	27.3	6.4	17.6	7.0	25.2	74.0	14.0	6.1	9.1	13.8	2.0	6.5	19.9	10.6	116.2	12.6	6.8	6.2	118.1	264.6	9.1	17.4	7.2	31.4	14.2	22.6	3.7	8.9	9.7	6.6	20.9	17.0	14.1	12.5	29.3	26.3	10.9	27.4	10.6	13.1	17.1
KDM6B	"JMJD3, KIAA0346"	ENSG00000132510	"Lysine demethylase 6B"	O15054	17	7834217-7854796	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Inflammatory response"	"Chromatin regulator, Dioxygenase, Oxidoreductase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 393.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 3.6;neutrophil: 8.9"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 8.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037988	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"		"HPA037988: AB_10672502"	"unprognostic (3.43e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.89e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.42e-2)"	"prognostic favorable (6.07e-4)"	"unprognostic (5.73e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (1.85e-1)"	33.6	13.3	3.1	20.0	2.4	35.5	12.6	12.5	22.9	12.2	3.4	15.4	14.3	14.0	3.4	13.6	17.1	15.6	17.7	3.2	4.5	14.6	15.2	27.4	8.0	4.8	3.2	29.7	17.1	7.9	21.8	6.8	3.3	14.5	4.1	6.2	12.0	6.2	12.4	16.4	17.5	5.5	1.4	20.7	17.7	16.1	5.0	16.4	15.9	8.2	4.6	19.8	12.4	6.2	4.9	7.0	12.5	19.0	4.6	3.4	16.2	3.8	5.4	2.7	2.8	9.3	3.6	11.4	4.5	3.0	3.9	12.2	5.8	5.1	1.6	4.7	4.5	5.3	6.7	6.2	13.0	7.2	15.6	5.3	8.0	6.1	5.1	7.2	4.8	11.8	8.8	4.8	1.2	7.7	10.6	6.5	6.4	4.9	3.9	11.9	2.9	3.2	5.1	7.7	6.6	21.4	4.8	11.5	10.3	7.3	6.4	8.9	2.3	4.0	7.1	7.0	5.5	5.6	1.2	3.9	5.3	4.2	8.1	3.6	0.6	1.1	0.3	0.4	0.3	0.3	0.2	0.1	0.3	0.5	0.3	0.4	8.9	0.1	0.2	0.7	0.1	0.4	3.1	2.4	12.5	22.9	3.2	4.5	4.8	3.2	3.3	1.4	5.0	6.2	135.5	25.6	33.6	6.2	158.8	214.4	122.2	30.8	156.0	45.2	113.7	70.9	10.8	42.9	32.4	7.3	31.3	15.1	127.6	47.8	1.9	28.0	29.2	88.2	67.1	80.5	79.9	8.4	9.0	25.1	15.9	85.4	73.4	181.6	178.6	44.8	34.2	22.7	23.4	38.7	10.9	62.5	18.3	50.4	393.1	10.7	16.4	219.2	56.9	4.7	25.6	13.2	9.2	5.5	1.9	58.4	49.1	13.9	70.7	99.6	53.9	9.8	20.5	17.1	19.7	181.2	83.0	20.1	19.3	138.1	188.0	52.0	104.1	22.0	46.2	86.6
KDSR	"DHSR, FVT1, SDR35C1"	ENSG00000119537	"3-ketodihydrosphingosine reductase"	Q06136	18	63327726-63367228	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant, Palmoplantar keratoderma, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 90.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003673, HPA044884"	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB003673: AB_425440, HPA044884: AB_2679131"	"unprognostic (4.44e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.56e-2)"	"unprognostic (5.88e-3)"	"unprognostic (7.50e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.81e-2)"	"prognostic favorable (9.53e-6)"	"unprognostic (3.32e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.16e-3)"	32.3	22.4	12.8	8.1	19.9	4.8	25.4	19.5	16.7	26.9	12.3	24.6	7.0	22.7	20.8	22.4	18.9	12.6	20.7	12.7	16.4	20.1	36.7	21.5	7.0	20.6	17.7	21.3	15.7	13.1	12.1	8.5	20.0	16.3	7.4	7.0	22.8	11.6	16.7	44.5	15.1	13.3	17.6	8.4	16.4	6.1	16.6	7.1	17.2	8.9	6.8	23.9	23.4	22.4	14.9	6.5	6.7	7.5	52.6	39.0	13.0	48.8	29.7	10.5	13.9	2.7	10.0	15.1	20.3	19.1	17.4	64.6	8.7	27.3	12.8	28.6	14.5	11.6	8.7	3.4	40.1	22.0	7.8	37.4	50.7	16.8	47.9	19.3	10.5	9.9	9.5	21.0	28.1	6.2	23.6	9.7	8.0	3.7	23.5	15.5	19.7	21.9	29.0	9.6	8.5	16.4	23.4	11.3	21.9	8.8	6.1	12.1	24.9	44.0	10.6	14.8	21.3	90.4	44.9	8.7	33.2	13.0	13.4	0.1	5.2	0.5	6.5	8.1	26.6	5.7	13.6	10.2	8.0	4.7	9.3	6.1	1.3	14.2	3.9	3.8	19.1	5.3	12.8	19.9	19.5	16.7	12.7	16.4	20.6	17.7	20.0	17.6	16.6	22.4	53.1	35.3	49.1	21.9	30.1	158.6	131.7	47.0	122.3	37.4	63.4	63.6	27.7	62.9	43.5	38.6	27.1	58.8	15.6	34.6	15.6	50.7	1.0	43.9	53.0	48.1	20.4	17.4	19.1	36.7	70.4	82.0	26.5	64.9	26.0	52.3	51.8	88.3	36.4	40.4	24.2	31.8	42.7	32.2	47.7	6.5	71.1	39.9	56.9	14.0	31.5	56.5	13.4	21.6	57.0	47.4	44.6	70.7	24.5	104.3	43.4	39.6	41.2	41.1	32.9	73.7	48.4	1.3	5.2	89.7	143.1	91.4	37.7	51.1	40.3	94.7
KHK		ENSG00000138030	Ketohexokinase	P50053	2	27086747-27100762	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"intestine: 121.2;kidney: 104.4;liver: 180.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 428.5;Proximal enterocytes: 1858.7;Proximal tubular cells: 1019.7"	"Group enriched"	"Detected in all"	7	"liver cancer: 62.2;renal cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 32.8;Hep G2: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007040	Enhanced		Approved	Vesicles,Cytosol		NA	NA		620000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Vesicles	"HPA007040: AB_1079185"	"unprognostic (8.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.62e-8)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.02e-2)"	2.2	4.6	4.2	3.0	4.3	1.7	2.0	7.1	5.9	2.6	1.2	4.2	112.4	3.8	0.6	2.4	4.3	1.3	1.4	4.8	3.9	104.4	180.5	1.6	1.9	5.4	4.0	3.6	9.4	2.6	1.4	0.5	5.5	1.6	1.2	1.5	4.4	1.4	3.8	2.4	121.2	1.9	3.6	2.0	2.9	3.2	3.8	0.7	1.1	2.0	1.2	1.8	2.3	4.7	25.0	18.5	2.8	11.0	2.0	0.5	2.5	1.7	1.1	2.3	1.4	9.0	5.3	3.7	5.8	0.1	2.6	10.7	9.4	3.1	0.8	8.8	17.2	32.8	5.2	48.0	1.1	4.6	3.7	0.1	1.3	2.7	0.2	1.2	2.1	5.1	5.9	6.1	0.2	16.0	5.4	3.6	4.0	22.3	7.2	18.9	1.4	20.9	2.7	3.0	10.2	15.8	3.6	6.2	6.9	1.0	2.7	2.0	1.9	0.7	3.6	1.6	6.5	7.5	14.4	6.3	3.0	10.7	1.8	0.0	5.4	0.3	4.1	3.1	5.5	3.8	6.6	6.0	4.9	3.6	4.7	5.8	0.5	4.9	1.4	6.1	4.7	4.9	4.2	4.3	7.1	5.9	4.8	3.9	5.4	4.0	5.5	3.6	3.8	4.7	6.5	3.2	3.7	1.6	6.8	3.6	2.6	0.8	6.8	3.6	4.7	5.8	1.8	20.0	1.0	40.5	2.1	4.1	1.3	7.4	129.1	3.2	1.2	0.1	0.6	5.5	6.0	15.6	3.4	3.0	3.6	2.4	3.6	0.3	4.5	2.9	9.7	428.5	8.3	6.7	2.7	89.6	4.1	11.9	2.0	6.2	1.8	10.8	8.8	0.0	1.9	9.8	4.1	2.5	2.3	2.1	95.7	1.5	8.0	0.7	1858.7	1019.7	0.0	5.4	0.0	5.0	5.0	1.1	5.8	4.6	6.8	9.4	6.8	0.8	82.6	2.2
KIDINS220	ARMS	ENSG00000134313	"Kinase D interacting substrate 220"	Q9ULH0	2	8721081-8837630	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Neurogenesis		"Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 322.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014790	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA014790: AB_1852460"	"unprognostic (3.58e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.33e-2)"	"prognostic favorable (9.64e-4)"	"unprognostic (1.68e-1)"	"unprognostic (9.21e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.39e-2)"	"prognostic favorable (9.29e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-1)"	21.2	21.6	20.9	14.5	40.6	24.4	19.6	34.9	27.5	22.3	21.6	19.6	11.4	29.3	15.3	15.1	16.6	17.7	21.9	22.1	28.9	22.1	15.7	23.6	13.1	43.9	31.5	37.7	18.8	42.8	16.9	21.4	43.4	20.0	16.5	38.0	14.5	18.0	14.5	16.7	13.8	23.6	35.7	17.1	16.5	10.6	32.0	21.6	20.0	16.7	12.3	16.7	17.9	73.9	13.5	21.3	41.8	26.8	51.4	33.9	21.9	26.2	21.6	16.4	15.0	21.5	13.5	25.2	26.1	39.4	31.5	22.5	37.9	16.1	24.0	36.4	25.7	22.7	15.9	22.6	36.3	23.6	29.9	35.3	24.9	26.1	33.7	25.1	25.9	21.6	44.7	30.8	29.2	14.8	24.2	12.7	22.7	22.3	18.8	22.7	30.7	12.7	21.7	25.4	35.4	59.3	20.8	20.7	23.6	21.7	13.3	26.6	34.4	36.1	19.0	36.6	28.5	22.4	21.1	33.5	21.1	31.2	28.1	4.1	3.4	4.2	3.6	3.9	2.6	1.9	2.6	3.0	2.7	1.8	2.7	3.1	5.3	3.2	4.6	1.8	2.4	2.2	20.9	40.6	34.9	27.5	22.1	28.9	43.9	31.5	43.4	35.7	32.0	73.9	57.1	99.3	115.7	129.6	25.2	32.8	27.6	25.1	19.9	86.2	31.3	25.0	40.2	25.8	48.6	29.5	139.7	21.5	35.0	33.9	0.0	33.3	1.3	32.3	77.8	51.8	43.3	36.4	108.3	23.6	10.0	55.0	39.8	53.1	35.4	144.0	47.8	30.9	28.8	154.8	149.2	23.4	44.7	52.7	46.0	5.9	69.6	45.9	24.9	60.9	44.2	60.5	34.0	162.3	322.2	29.0	29.8	65.5	27.3	25.7	24.5	10.5	34.4	58.0	6.6	65.4	54.2	28.1	23.4	26.4	29.5	10.9	40.2	52.1	23.9	36.0
KISS1R	"AXOR12, GPR54, HOT7T175"	ENSG00000116014	"KISS1 receptor"	Q969F8	19	917287-921005	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 8.5"	"Cell type enriched"	"Detected in some"	9	"Extravillous trophoblasts: 41.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 15.7;RPMI-8226: 37.4;SCLC-21H: 7.4;SH-SY5Y: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA007156, HPA071913"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"	Vesicles	"HPA007156: , HPA071913: AB_2686471"	"unprognostic (1.54e-1)"	"unprognostic (3.01e-2)"	"unprognostic (9.42e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.46e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.17e-2)"	"prognostic unfavorable (3.33e-6)"	"unprognostic (1.87e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.05e-2)"	0.0	0.0	2.9	0.1	1.8	0.0	0.0	0.9	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	3.8	0.3	0.1	0.1	0.1	4.0	2.2	0.0	1.3	0.3	1.1	0.1	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.0	0.4	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.3	4.1	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	15.7	0.0	0.0	0.3	0.1	0.0	0.6	1.2	0.4	1.0	0.0	37.4	0.0	0.0	7.4	20.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	2.9	1.8	0.9	3.4	1.3	3.8	4.0	2.2	3.9	1.0	8.5	0.8	0.1	0.0	0.0	0.0	1.0	0.1	0.1	0.5	0.0	1.1	1.2	1.4	0.5	0.0	0.2	0.0	0.0	0.4	0.2	0.1	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.2	41.9	0.1	0.0	0.4	0.0	0.1	0.0	0.1	0.7	0.0	0.7	0.0	0.0	0.0	1.5	0.0	0.0	0.3	1.8	0.0	0.0	0.2	1.0	0.0	0.0	0.1	0.0	0.0	4.2	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.4	0.0	0.3	0.3	0.3	1.6	0.9	0.2	0.1	0.2
KL		ENSG00000133116	Klotho	Q9UEF7	13	33016423-33066143	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Glycosidase, Hormone, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 47.1;kidney: 128.7;parathyroid gland: 135.2"	"Cell type enriched"	"Detected in some"	7	"Proximal tubular cells: 123.3"	"Group enriched"	"Detected in many"	6	"prostate cancer: 5.9;renal cancer: 17.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HMC-1: 2.4;SK-BR-3: 4.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 13.3;cerebral cortex: 6.7;hippocampal formation: 7.4;medulla oblongata: 4.2"						"Secreted to blood"	NA	NA	510000			"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.32e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-4)"	"unprognostic (3.06e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (4.44e-4)"	"unprognostic (9.46e-2)"	"prognostic favorable (1.29e-9)"	"unprognostic (4.76e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.07e-1)"	3.3	1.4	0.9	0.8	3.1	0.1	2.5	0.8	1.5	1.8	47.1	2.1	2.7	1.2	8.8	1.1	0.8	1.3	1.1	4.2	1.1	128.7	0.4	3.5	1.0	0.5	0.5	0.1	1.2	135.2	0.3	30.4	0.5	8.0	0.9	0.0	0.8	2.5	0.7	0.6	2.6	1.2	0.6	2.4	2.0	0.5	0.8	0.5	1.3	1.5	0.5	1.6	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.1	0.8	1.5	4.2	1.1	0.5	0.5	0.5	0.6	0.8	0.5	15.8	0.0	0.5	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.6	0.3	1.0	0.0	0.7	12.9	0.0	0.2	0.0	0.4	5.9	0.0	1.8	0.1	2.5	10.2	16.3	0.4	1.2	0.0	0.1	1.6	0.0	0.1	0.0	0.1	1.1	0.2	2.8	0.0	0.5	1.1	0.0	0.9	1.0	0.8	0.3	1.9	0.0	6.5	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	3.6	1.8	123.3	0.7	0.0	0.0	1.1	2.3	1.4	0.5	0.0	0.1	0.1	1.1	0.1	1.9	0.1
KLK4	"EMSP, EMSP1, KLK-L1, PRSS17, PSTS"	ENSG00000167749	"Kallikrein related peptidase 4"	Q9Y5K2	19	50906352-50910738	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization	"Hydrolase, Protease, Serine protease"	"Amelogenesis imperfecta, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	32	"prostate: 286.4"	"Cell type enriched"	"Detected in some"	15	"Prostatic glandular cells: 106.1"	"Cancer enriched"	"Detected in many"	55	"prostate cancer: 463.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 6.4;HaCaT: 7.9;OE19: 7.3;SK-BR-3: 5.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"spinal cord: 4.5"	HPA051839	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 51: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 35: Glandular cells - Unknown function"			"HPA051839: AB_2681632"	"unprognostic (3.58e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.66e-3)"	"unprognostic (3.11e-2)"	"unprognostic (4.35e-1)"	"unprognostic (3.18e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.69e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-3)"	"unprognostic (3.27e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.34e-1)"	0.4	2.9	0.4	1.5	0.3	1.1	1.7	1.7	1.2	6.5	0.0	3.0	7.3	4.4	1.1	2.1	0.6	1.0	0.1	0.3	0.8	0.6	1.2	0.3	0.8	1.6	0.8	0.1	0.9	1.0	0.0	0.3	1.6	286.4	3.6	0.5	4.8	2.7	3.5	8.9	5.1	0.3	0.5	0.3	1.9	1.2	0.6	0.1	3.8	1.3	0.8	1.2	0.2	0.5	4.1	1.6	0.2	0.2	0.0	0.0	3.5	0.0	0.0	0.0	0.0	3.5	6.4	0.4	0.3	0.1	0.2	7.9	0.0	4.2	0.0	1.1	1.1	1.3	3.8	1.4	0.0	1.4	1.7	0.0	1.9	0.0	0.0	0.2	0.0	0.3	0.7	3.3	0.0	1.0	0.1	2.0	0.1	7.3	0.3	0.3	0.4	0.9	0.0	2.6	0.0	0.4	0.3	5.1	0.0	0.2	4.0	0.3	0.9	0.2	0.2	1.0	0.2	2.0	0.9	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	1.7	1.2	0.3	0.8	1.6	0.8	1.6	0.5	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.3	3.6	0.0	0.0	0.6	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	2.6	0.1	0.0	0.0	0.1	0.2	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.7	0.0	0.0	0.0	0.4	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	106.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.6	0.0	0.0	3.3	1.0	2.6
KMT2A	"ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1"	ENSG00000118058	"Lysine methyltransferase 2A"	Q03164	11	118436490-118526832	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017794, CAB024270, HPA044910"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB017794: , CAB024270: , HPA044910: AB_2679141"	"unprognostic (6.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.56e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.52e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.90e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	9.9	6.7	8.0	8.5	8.6	19.5	9.9	21.2	9.3	10.3	1.6	10.8	5.4	10.7	8.2	6.8	10.3	6.4	6.5	7.4	9.6	6.7	6.0	10.5	12.4	6.3	6.3	21.2	11.1	9.8	10.2	5.6	6.6	9.2	6.4	23.9	9.4	8.4	7.4	10.4	9.8	7.6	3.2	9.7	8.2	5.3	7.0	14.1	9.9	8.4	11.3	10.7	9.3	11.9	17.9	8.6	20.1	14.5	11.1	16.1	6.2	8.7	11.8	9.0	9.6	17.3	11.4	23.1	15.9	10.8	14.6	16.0	22.9	7.2	17.9	26.0	10.0	45.7	8.9	9.3	6.1	28.5	7.8	7.2	7.4	20.3	24.0	8.9	12.8	13.3	32.8	18.8	9.2	12.7	18.2	12.7	13.6	6.6	13.7	13.8	21.9	6.9	9.8	13.8	18.0	11.8	22.0	6.7	3.9	9.8	11.9	9.1	20.4	14.1	12.7	9.4	14.7	5.1	4.4	15.6	4.7	17.6	8.3	2.1	0.6	1.9	1.6	0.6	1.6	2.5	1.8	1.5	0.3	1.8	1.8	1.2	0.5	2.0	0.7	1.4	1.7	0.4	8.0	8.6	21.2	9.3	7.4	9.6	6.3	6.3	6.6	3.2	7.0	11.9	87.1	70.5	65.8	93.4	83.4	86.9	67.6	29.4	64.9	158.1	76.8	73.9	44.5	40.0	32.2	38.6	152.2	13.9	81.0	26.2	3.9	33.0	10.1	62.1	101.4	74.4	66.4	67.3	146.0	25.6	10.2	65.6	44.4	85.2	29.0	57.5	60.0	27.3	16.8	195.2	170.1	29.6	20.3	37.0	63.7	5.8	66.8	44.8	42.7	62.8	49.9	98.9	78.2	106.6	131.9	28.2	20.1	78.6	83.3	88.3	22.7	10.5	52.7	152.4	65.7	113.4	84.6	25.5	30.7	46.3	80.6	6.0	102.8	55.8	30.6	64.8
KMT2B	"CXXC10, HRX2, KIAA0304, MLL1B, MLL2, MLL4, TRX2, WBP7"	ENSG00000272333	"Lysine methyltransferase 2B"	Q9UMN6	19	35717973-35738878	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 64.5;Rod photoreceptor cells: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006487			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA006487: AB_1080587"	"unprognostic (1.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.95e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.33e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.63e-3)"	"unprognostic (9.47e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	11.6	10.1	15.4	9.8	15.7	14.3	11.8	17.2	22.9	12.9	12.2	13.6	9.8	14.1	4.4	12.8	13.1	6.8	8.4	14.7	14.8	10.3	10.0	12.1	14.5	15.4	14.4	16.1	16.0	5.1	14.5	5.8	14.7	13.4	3.9	5.8	13.3	5.8	16.1	18.8	14.5	4.5	12.4	15.6	12.7	22.5	15.9	9.3	16.6	5.0	6.8	12.6	12.0	16.0	16.7	36.7	11.1	17.3	6.0	4.3	11.0	6.7	4.7	7.3	5.0	25.3	7.4	15.5	11.8	5.1	8.5	10.8	11.3	5.2	4.2	21.2	13.6	29.7	20.2	24.4	8.6	17.4	26.1	6.9	9.4	8.9	10.7	6.9	5.7	13.5	22.5	15.8	6.4	34.1	15.9	24.4	12.0	18.8	9.2	19.8	8.9	7.6	7.8	21.3	14.0	10.0	13.5	20.6	11.3	7.9	11.8	21.3	12.5	16.3	17.0	10.5	17.4	22.2	15.7	12.4	8.5	18.8	12.2	0.3	0.4	0.4	1.0	0.1	0.5	0.4	0.6	0.7	0.3	0.7	0.6	0.9	1.8	0.5	0.2	2.1	0.8	0.4	15.4	15.7	17.2	22.9	14.7	14.8	15.4	14.4	14.7	12.4	15.9	16.0	24.6	9.6	15.4	13.7	18.6	12.7	10.0	6.2	9.6	64.5	16.1	14.6	9.2	8.6	6.3	9.2	52.1	6.5	27.4	25.2	0.0	6.4	2.8	17.9	31.6	15.6	20.3	7.4	11.7	7.7	6.1	12.4	27.5	26.0	5.1	30.5	11.0	11.2	8.4	35.3	11.8	14.1	6.1	11.8	7.1	4.7	8.1	13.4	5.4	7.5	9.5	25.7	19.6	7.5	10.0	8.4	16.7	12.4	17.9	19.6	13.9	5.0	6.7	71.2	0.0	25.0	17.3	26.5	38.5	11.9	12.9	9.4	20.6	30.7	16.3	14.8
KMT2C	"HALR, KIAA1506, MLL3"	ENSG00000055609	"Lysine methyltransferase 2C"	Q8NEZ4	7	152134922-152436641	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 363.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 15.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074736			Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA074736: AB_2686709"	"unprognostic (7.75e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (8.01e-6)"	"unprognostic (1.78e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.64e-1)"	12.7	11.2	16.7	7.3	25.7	16.4	12.9	16.7	15.7	15.3	5.5	13.1	5.7	14.3	13.7	14.1	11.9	7.7	10.2	13.0	18.9	8.9	10.4	12.7	8.1	25.3	19.4	16.8	18.5	12.4	12.1	10.3	20.6	9.3	7.6	21.7	14.2	9.0	25.9	17.6	12.8	7.5	12.2	12.2	15.2	13.4	19.1	16.1	14.6	16.9	9.5	11.3	12.7	28.6	13.4	6.1	11.6	11.7	19.0	13.9	10.2	4.7	6.4	5.0	5.5	10.9	4.7	22.4	8.9	11.3	9.2	5.2	14.3	7.5	9.2	12.7	6.5	14.0	7.3	4.5	8.9	22.9	12.8	6.6	9.1	7.1	8.2	7.2	8.4	9.7	22.5	15.0	11.7	12.7	14.8	11.1	6.8	8.5	7.9	9.5	12.3	8.4	5.8	10.9	19.6	12.8	13.4	15.8	6.3	10.6	4.6	15.7	12.8	8.0	4.4	9.0	8.9	15.3	7.7	22.4	10.7	14.7	8.4	6.1	3.0	4.4	1.9	2.7	1.6	6.9	2.0	1.5	1.4	3.9	1.9	1.4	15.2	2.2	2.6	3.7	1.3	0.8	16.7	25.7	16.7	15.7	13.0	18.9	25.3	19.4	20.6	12.2	19.1	28.6	62.4	76.9	71.9	292.8	75.0	89.1	38.3	31.5	62.0	89.0	59.6	35.2	65.8	44.3	72.4	46.0	173.0	38.0	61.9	61.7	5.9	37.6	32.1	94.4	92.1	58.9	67.9	55.5	180.7	33.1	51.7	58.3	89.2	200.5	65.2	52.8	56.7	46.0	33.7	80.8	172.2	53.5	42.7	54.7	79.6	17.3	67.4	90.5	42.7	202.4	77.1	57.7	59.8	299.6	363.2	37.6	49.0	60.2	90.3	53.6	36.3	14.7	46.9	73.0	26.3	83.0	55.5	42.3	33.9	80.9	96.3	127.2	76.8	54.8	39.1	61.4
KMT2D	"ALR, CAGL114, MLL2, MLL4, TNRC21"	ENSG00000167548	"Lysine methyltransferase 2D"	O14686	12	49018978-49060794	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035977	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA035977: AB_10670673"	"unprognostic (8.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.14e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.07e-2)"	"unprognostic (6.91e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.60e-2)"	19.9	21.9	14.0	17.0	14.4	62.1	20.3	14.7	18.1	20.2	3.8	21.3	13.2	26.9	14.4	25.5	24.1	11.7	23.7	12.1	9.1	18.2	20.5	25.1	17.5	9.3	8.2	25.3	33.2	22.9	25.4	16.2	8.6	19.2	14.7	48.0	22.1	16.2	44.9	30.4	27.9	15.5	3.1	36.6	25.5	23.6	12.7	29.0	26.5	21.9	17.2	19.4	19.4	13.4	32.3	31.9	31.0	24.7	29.3	20.4	32.6	17.3	17.1	20.3	10.9	54.8	14.1	33.4	21.2	23.9	14.0	21.5	38.1	19.9	17.7	22.4	26.7	47.2	37.7	29.9	20.5	59.1	43.2	18.4	25.8	30.7	32.0	27.3	31.8	33.2	55.1	19.2	23.7	37.4	26.8	48.0	29.9	45.4	25.0	37.4	22.4	12.0	18.1	37.2	24.6	21.2	28.1	25.5	19.5	26.1	24.0	44.1	49.8	15.5	30.7	14.5	30.5	24.8	20.9	31.7	17.1	28.0	12.5	0.5	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	1.5	0.5	0.0	0.2	0.0	0.1	14.0	14.4	14.7	18.1	12.1	9.1	9.3	8.2	8.6	3.1	12.7	13.4	12.9	9.6	19.1	17.6	13.3	14.0	7.8	8.1	14.2	26.8	12.1	7.1	7.8	12.8	10.9	18.4	52.1	8.2	15.3	12.3	1.9	6.3	2.8	10.7	12.7	13.2	13.1	16.0	17.4	6.0	6.0	8.8	24.5	13.1	8.2	23.3	17.9	13.0	9.8	21.9	16.5	10.0	6.1	15.7	18.4	2.4	9.6	15.4	10.6	15.0	14.9	6.4	17.5	12.5	19.8	8.8	9.5	10.9	10.1	11.0	13.3	4.5	9.0	38.4	6.6	14.4	12.5	6.5	3.8	18.9	17.6	11.4	15.3	10.8	10.3	9.6
KMT5B	"CGI-85, SUV420H1"	ENSG00000110066	"Lysine methyltransferase 5B"	Q4FZB7	11	68154863-68213828	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 128.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063648			Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA063648: AB_2685073"	"unprognostic (5.82e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.36e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (9.30e-4)"	18.6	16.5	16.3	15.7	17.5	28.5	27.5	26.2	17.6	20.2	17.3	22.3	22.8	26.2	19.0	17.2	18.2	15.0	15.9	15.8	17.2	19.7	22.4	18.1	19.2	16.1	16.3	22.4	22.8	20.6	15.6	22.3	15.6	22.0	21.6	33.4	23.4	16.3	16.9	21.7	21.8	20.7	14.8	17.2	20.7	20.7	16.1	27.0	31.0	16.7	20.4	16.5	17.6	21.3	25.3	18.8	37.6	24.5	8.6	21.4	40.8	17.7	12.3	21.7	12.8	59.7	39.6	20.5	30.2	24.4	21.4	13.0	26.2	20.6	31.6	23.2	15.1	19.4	21.9	24.7	31.0	27.7	25.6	21.3	41.6	26.2	27.3	20.0	21.8	20.3	29.3	23.4	18.7	52.2	19.6	28.9	40.4	50.4	13.9	31.9	29.4	55.4	16.2	24.2	32.7	39.1	27.5	27.4	128.7	20.3	35.1	17.9	23.1	29.2	38.9	22.5	18.4	29.5	13.8	43.0	18.4	17.3	31.8	10.0	3.7	16.5	4.4	5.2	3.1	3.2	4.6	5.4	3.5	3.8	5.3	4.8	10.9	9.6	5.3	5.4	4.1	2.8	16.3	17.5	26.2	17.6	15.8	17.2	16.1	16.3	15.6	14.8	16.1	21.3	39.8	60.9	61.3	0.0	32.9	0.0	42.3	0.0	50.7	50.0	45.8	34.7	0.0	25.8	25.4	25.8	12.5	27.4	37.6	32.6	21.5	27.9	22.0	42.6	46.3	31.7	25.5	31.4	0.0	32.7	29.6	26.3	37.2	44.3	22.7	40.7	30.0	37.7	17.9	63.9	0.0	26.6	0.0	32.4	0.0	21.0	28.0	27.7	0.0	0.0	38.2	29.6	43.3	0.0	0.0	37.1	25.7	31.6	34.8	43.7	36.4	22.7	32.1	39.6	32.9	44.8	28.6	45.8	58.9	38.0	0.0	51.7	30.7	31.8	25.1	53.6
KRAS	"KRAS1, KRAS2"	ENSG00000133703	"KRAS proto-oncogene, GTPase"	P01116	12	25205246-25250936	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Cardiomyopathy, Deafness, Disease variant, Ectodermal dysplasia, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049830	Approved					NA	NA		3300000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA049830: AB_2680903"	"unprognostic (2.24e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.08e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (6.42e-2)"	"prognostic favorable (2.75e-5)"	"unprognostic (1.95e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.81e-2)"	"unprognostic (9.97e-2)"	11.8	9.1	11.0	16.2	12.2	27.8	10.0	11.7	12.3	9.5	4.6	22.0	14.0	11.0	6.8	19.3	7.4	13.1	8.6	12.5	12.0	11.7	15.3	13.2	17.9	8.5	9.7	8.0	12.6	11.1	5.7	17.0	8.7	11.8	23.0	22.7	11.9	8.3	7.6	13.6	19.5	13.6	8.1	12.0	20.3	8.9	12.9	17.2	10.8	10.3	17.4	16.2	11.4	8.6	15.9	14.3	39.4	20.7	14.1	19.9	68.9	17.3	22.8	18.0	21.9	51.5	30.7	38.7	10.4	32.0	23.4	18.6	44.9	17.3	34.3	26.7	15.0	37.6	17.6	15.6	15.8	32.8	25.6	18.1	25.5	21.9	20.2	33.6	27.1	28.7	28.0	17.3	27.6	14.1	46.8	56.6	87.6	25.3	7.4	43.4	39.9	59.9	27.2	22.4	11.2	32.4	20.5	24.9	21.8	97.4	28.9	26.9	28.1	18.7	24.8	38.2	22.0	16.4	28.5	41.9	15.4	20.0	15.0	31.2	8.1	13.7	11.6	16.4	7.9	10.7	10.1	13.1	7.9	10.5	13.8	12.4	19.2	11.2	22.4	7.8	7.6	5.8	11.0	12.2	11.7	12.3	12.5	12.0	8.5	9.7	8.7	8.1	12.9	8.6	73.7	48.1	32.1	16.6	90.8	100.9	96.4	57.2	72.3	63.4	59.9	38.0	16.3	64.3	53.6	38.6	73.0	94.2	66.0	161.9	58.7	77.5	3.9	45.4	40.8	77.3	78.8	60.2	42.0	91.8	21.4	50.1	98.4	53.4	24.1	26.6	77.8	56.9	51.5	92.5	45.3	92.9	36.7	53.9	83.7	5.9	40.7	75.3	62.2	28.1	82.9	41.7	49.4	19.6	16.6	114.2	104.7	51.6	85.0	130.1	63.0	52.3	42.5	65.8	26.3	53.7	52.2	53.0	40.3	93.0	155.7	139.1	83.0	36.5	96.7	176.9
KYNU		ENSG00000115919	Kynureninase	Q16719	2	142877657-143055833	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 88.4;urinary bladder: 51.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 136.1;Club cells: 109.6;Ionocytes: 114.0;Langerhans cells: 190.5;Macrophages: 122.9;monocytes: 248.0;Syncytiotrophoblasts: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"classical monocyte: 109.4;intermediate monocyte: 142.7;memory B-cell: 73.6;myeloid DC: 111.2;naive B-cell: 51.3;non-classical monocyte: 123.4;plasmacytoid DC: 77.7"	"Group enriched"	"Detected in many"	19	"B-cells: 73.6;dendritic cells: 111.2;monocytes: 142.7"	"Cell line enhanced"	"Detected in many"		"A549: 185.2;GAMG: 298.5;HeLa: 195.5;Hep G2: 128.3;hTEC/SVTERT24-B: 106.5;U-87 MG: 314.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA031686	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		590000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"HPA031686: AB_2673995"	"unprognostic (2.58e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.58e-3)"	"unprognostic (4.88e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.64e-1)"	5.2	4.0	2.4	24.4	2.1	10.8	30.8	2.7	4.5	4.0	3.6	2.4	1.1	2.5	1.3	6.7	1.2	9.8	1.2	2.0	1.6	18.6	88.4	13.5	15.0	2.8	1.7	0.4	0.9	0.8	1.2	7.3	3.3	0.9	2.9	1.5	1.8	0.7	0.7	1.3	3.0	4.8	0.5	8.9	5.8	16.6	6.6	3.9	2.3	0.3	28.9	51.5	3.4	2.1	0.2	185.2	0.3	0.4	0.4	0.6	0.5	0.4	5.1	0.2	0.2	3.3	2.7	11.9	0.5	0.1	298.5	0.7	0.1	0.2	0.2	0.6	0.2	4.3	195.5	128.3	2.4	0.4	0.8	17.3	15.0	106.5	0.6	0.2	0.2	0.3	0.5	1.1	1.7	96.7	0.2	11.8	0.7	0.2	0.9	0.2	0.9	0.4	3.2	96.0	0.5	0.3	102.2	15.2	1.0	1.0	50.9	26.5	1.5	5.9	0.5	89.1	0.3	0.7	0.3	0.3	314.5	22.2	0.6	0.7	109.4	2.4	0.5	142.7	0.4	73.6	0.6	0.3	111.2	51.3	0.5	0.3	5.8	1.8	123.4	77.7	0.6	49.2	2.4	2.1	2.7	4.5	2.0	1.6	2.8	1.7	3.3	0.5	6.6	2.1	3.0	3.2	2.7	0.7	46.8	4.0	0.5	136.1	0.0	0.5	5.8	0.9	1.6	7.2	109.6	3.7	4.2	3.3	16.1	0.7	5.9	14.5	46.3	1.5	1.1	5.1	0.0	2.5	1.3	9.5	2.3	1.8	20.4	15.7	0.0	0.0	2.5	49.1	38.8	10.1	0.9	0.0	114.0	64.7	190.5	42.8	1.8	122.9	1.8	29.0	248.0	0.2	1.0	0.5	0.8	59.6	1.1	0.4	5.1	1.1	0.0	44.4	21.1	0.6	6.6	0.5	3.9	47.8	8.0	1.5	3.1	104.7	2.2	0.1	1.0	22.6
L2HGDH	"C14orf160, FLJ12618"	ENSG00000087299	"L-2-hydroxyglutarate dehydrogenase"	Q9H9P8	14	50237563-50312229	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 56.3;Excitatory neurons: 60.5;Inhibitory neurons: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065409, HPA069708"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA065409: AB_2685485, HPA069708: AB_2686179"	"unprognostic (1.74e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.33e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (9.75e-10)"	"unprognostic (1.24e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-2)"	4.6	2.5	2.9	2.2	2.9	2.7	3.7	6.1	5.5	2.3	1.3	4.3	4.7	2.4	3.0	5.1	3.1	2.0	5.2	2.7	2.5	19.6	12.6	1.8	2.6	1.2	2.4	2.5	3.9	6.1	2.3	1.7	1.1	3.3	5.0	11.4	2.8	3.2	15.5	5.1	3.6	2.5	1.2	1.3	4.3	3.9	2.4	3.0	4.8	14.7	3.4	2.4	2.3	4.1	24.3	16.6	6.8	6.6	3.3	2.2	19.1	7.9	4.4	12.2	14.3	26.8	10.8	19.0	9.0	3.2	9.7	17.4	20.6	8.2	13.5	15.2	11.9	41.1	10.9	3.7	3.1	14.7	13.7	2.0	5.2	8.1	7.0	3.1	5.3	19.3	14.7	11.6	3.2	29.0	16.7	6.7	9.9	20.6	17.6	15.6	22.0	14.8	11.4	28.0	13.8	9.9	23.3	17.5	10.4	9.0	22.9	4.0	5.0	7.7	21.5	9.0	10.6	10.5	25.6	26.3	4.3	7.3	8.8	8.6	0.4	0.9	0.9	0.1	2.2	0.8	1.1	1.0	0.6	0.6	1.3	1.7	0.5	1.7	0.1	1.0	1.6	0.5	2.9	2.9	6.1	5.5	2.7	2.5	1.2	2.4	1.1	1.2	2.4	4.1	1.9	41.7	19.2	16.6	5.1	3.7	2.7	2.1	8.6	15.5	3.9	2.2	14.7	2.8	20.4	12.9	56.3	6.4	6.1	4.8	15.6	3.8	35.1	5.2	2.8	4.6	7.8	7.4	60.5	4.2	6.6	5.3	7.7	5.6	18.9	6.0	2.9	14.2	2.1	11.8	61.4	4.3	0.0	2.7	0.6	8.8	2.5	3.3	1.8	13.1	2.4	6.1	7.2	20.6	18.9	2.5	3.6	4.5	3.3	2.7	6.0	21.7	18.4	40.3	0.0	5.8	3.9	14.3	12.6	10.5	6.3	4.9	5.0	4.6	7.6	2.1
LACC1	"C13orf31, FAMIN, FLJ38725"	ENSG00000179630	"Laccase domain containing 1"	Q8IV20	13	43879284-43893932	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.4"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 3.0;eosinophil: 3.1;intermediate monocyte: 5.2;myeloid DC: 2.7;non-classical monocyte: 8.0"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.7;granulocytes: 3.1;monocytes: 8.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 37.1;TIME: 118.2"	"Low region specificity"	"Detected in all"							"CAB034228, HPA040150, HPA044211"	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"CAB034228: AB_1564163, HPA040150: AB_10963540, HPA044211: AB_10961258"	"unprognostic (2.48e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.54e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.90e-2)"	"unprognostic (6.41e-3)"	"unprognostic (4.43e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.78e-2)"	"unprognostic (6.06e-3)"	"unprognostic (2.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.30e-1)"	"unprognostic (9.36e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.18e-1)"	6.4	6.6	12.7	12.2	22.3	1.9	5.4	10.8	20.6	4.5	6.8	10.3	9.9	3.9	3.2	6.8	3.2	9.8	10.1	11.7	13.6	4.8	7.2	6.4	8.8	13.9	14.5	3.4	3.5	9.9	2.8	6.1	15.2	5.4	13.3	0.8	4.6	4.9	1.4	4.8	13.8	5.8	12.5	7.2	6.8	9.4	17.3	6.5	3.5	1.2	8.3	11.1	2.9	27.4	4.7	2.5	1.3	0.0	2.7	12.3	9.5	10.3	25.7	2.8	3.9	5.3	10.5	9.9	2.3	13.8	6.0	6.7	0.3	2.9	4.5	6.6	1.7	12.3	2.6	1.9	12.5	2.9	37.1	16.3	8.5	10.3	12.6	3.4	5.9	1.1	0.0	7.1	6.4	2.3	0.3	3.7	0.9	2.6	2.2	2.3	0.0	5.2	7.4	5.5	1.6	2.5	3.4	1.2	4.9	6.8	1.5	6.2	118.2	3.5	1.1	18.8	0.1	0.0	0.0	2.4	10.0	3.7	8.0	1.0	3.0	3.1	0.7	5.2	0.8	0.8	0.6	0.6	2.7	1.0	0.2	0.3	0.1	0.4	8.0	0.5	0.8	1.0	12.7	22.3	10.8	20.6	11.7	13.6	13.9	14.5	15.2	12.5	17.3	27.4	4.6	12.8	6.8	1.0	5.9	5.7	8.4	8.1	3.4	0.5	5.1	4.6	24.2	4.3	7.8	11.0	0.0	6.5	1.0	7.6	1.9	5.5	1.3	5.1	3.4	7.4	5.4	1.7	2.1	3.8	4.3	4.5	2.0	8.5	8.2	9.7	5.0	5.1	15.3	0.0	6.2	4.4	6.1	17.6	10.3	3.1	2.1	24.2	1.8	1.9	7.8	2.0	1.0	2.0	39.2	8.0	11.2	1.5	0.5	11.4	10.5	8.2	7.2	0.2	6.6	5.3	6.0	17.1	16.7	8.4	10.2	9.2	4.3	4.6	6.7	10.2
LAMP2	CD107b	ENSG00000005893	"Lysosomal associated membrane protein 2"	P13473	X	120426148-120469365	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Autophagy		"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 507.2;Syncytiotrophoblasts: 402.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 556.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 556.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005272, HPA029100"	Supported		Supported	Vesicles		NA	NA		520000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"CAB005272: AB_647855, HPA029100: AB_10795022"	"unprognostic (2.99e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-2)"	"unprognostic (4.84e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.53e-3)"	54.2	68.7	80.3	38.3	144.2	62.8	56.3	109.1	135.5	64.9	52.7	39.2	44.3	44.3	55.1	79.4	44.1	69.6	45.3	81.6	101.8	85.5	129.9	54.2	34.1	113.0	112.6	49.1	57.8	64.2	32.2	47.9	120.6	62.2	35.0	32.6	102.1	55.1	111.6	67.2	42.4	42.8	100.5	39.5	51.8	26.2	100.9	59.3	61.7	67.4	36.6	43.4	63.3	211.7	53.8	47.5	40.1	49.7	367.0	140.9	91.5	79.3	130.4	77.1	134.4	42.7	90.3	47.9	73.1	132.7	236.2	84.9	56.7	67.2	125.5	43.6	37.2	35.8	46.4	54.3	148.1	158.9	73.2	151.5	114.8	108.1	75.1	188.6	107.5	32.5	42.1	122.9	117.2	79.3	45.3	80.2	29.0	63.7	42.6	35.1	65.3	73.1	102.3	36.9	14.0	22.6	99.7	93.0	196.5	57.4	64.7	173.0	122.5	114.1	58.7	176.2	261.5	68.5	78.6	30.2	131.4	182.4	284.4	30.6	114.9	224.1	27.1	97.1	20.6	17.1	24.3	24.5	64.2	22.5	23.4	21.8	556.6	31.8	96.2	33.4	33.4	66.3	80.3	144.2	109.1	135.5	81.6	101.8	113.0	112.6	120.6	100.5	100.9	211.7	75.7	73.7	53.8	52.2	29.8	100.9	92.5	262.7	64.9	17.6	74.0	58.3	37.3	173.0	155.3	66.2	14.6	163.7	44.3	52.1	39.2	217.7	3.3	103.4	74.1	69.9	36.6	14.1	32.4	70.6	128.3	113.7	38.7	168.1	17.7	46.7	87.8	176.8	208.0	18.5	40.7	32.6	134.3	133.1	80.4	8.6	113.7	135.5	131.6	33.7	132.7	116.3	50.4	57.3	507.2	62.5	54.4	109.9	66.6	100.8	97.5	154.7	75.6	11.5	39.5	176.8	61.7	6.4	13.7	78.8	136.2	402.4	34.5	71.0	34.8	92.9
LARS1	"FLJ10595, FLJ21788, HSPC192, LARS, LEUS, RNTLS"	ENSG00000133706	"Leucyl-tRNA synthetase 1"	Q9P2J5	5	146110566-146182696	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 26.8;Cardiomyocytes: 135.7;Cytotrophoblasts: 39.2;Extravillous trophoblasts: 40.3;Hofbauer cells: 36.7;Smooth muscle cells: 22.7;Syncytiotrophoblasts: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036424, HPA040881"	Supported		Approved	"Nuclear bodies,Cytosol"		NA	NA		110000	"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear bodies, Cytosol"		"HPA036424: AB_10670102, HPA040881: AB_2677185"	"unprognostic (2.20e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.39e-1)"	"prognostic unfavorable (3.78e-5)"	"unprognostic (8.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (2.96e-2)"	35.4	37.0	40.0	26.6	42.0	20.2	46.3	42.8	48.9	33.9	44.0	34.4	18.4	33.9	35.4	35.0	34.8	18.7	38.5	40.4	44.3	34.6	25.6	26.4	29.7	42.3	42.9	37.2	49.7	34.7	37.0	22.2	41.8	35.6	34.8	34.7	40.0	28.3	70.6	31.7	28.1	33.4	43.1	35.7	29.8	23.9	43.2	32.7	34.7	58.8	34.8	35.6	30.9	46.2	56.1	59.5	65.9	125.9	88.0	95.7	102.5	45.5	57.8	71.4	92.4	66.1	59.8	67.8	32.7	91.2	72.6	52.9	107.2	116.5	106.4	45.2	88.2	65.5	76.0	58.5	122.7	101.4	51.9	83.7	153.6	92.0	173.3	73.2	87.7	108.0	67.4	121.3	83.4	56.9	102.8	116.1	126.8	63.8	86.8	75.0	62.0	101.9	73.6	44.1	77.7	97.3	50.2	111.6	221.2	76.6	103.1	159.3	63.4	61.2	44.3	56.7	89.4	79.3	82.3	86.3	89.8	164.1	79.1	1.1	11.8	5.4	14.5	19.2	19.6	18.9	16.6	14.9	21.2	15.5	21.2	21.9	0.7	19.2	16.7	16.6	19.6	14.9	40.0	42.0	42.8	48.9	40.4	44.3	42.3	42.9	41.8	43.1	43.2	46.2	26.8	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	135.7	0.0	0.0	0.0	0.0	39.2	13.5	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	40.3	16.6	0.0	0.0	0.0	0.0	0.0	0.0	36.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	33.0	2.8	0.0	0.0	0.0
LARS2	"KIAA0028, LEURS, MGC26121, mtLeuRS"	ENSG00000011376	"Leucyl-tRNA synthetase 2, mitochondrial"	Q15031	3	45388561-45554726	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 28.7;Excitatory neurons: 35.4;Inhibitory neurons: 37.8;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035951, HPA045450, HPA066085"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Nucleoplasm	"HPA035951: AB_10672997, HPA045450: AB_2679328, HPA066085: AB_2685612"	"unprognostic (3.89e-1)"	"unprognostic (3.89e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.02e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.19e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-1)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.32e-11)"	"unprognostic (2.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.07e-2)"	3.3	4.7	9.5	3.4	10.3	2.4	3.9	10.1	11.7	3.7	9.2	6.9	3.9	4.6	4.3	4.2	4.5	3.0	5.5	9.3	10.5	7.5	8.1	2.9	4.3	9.5	10.2	3.8	2.4	12.3	3.7	4.2	9.5	4.3	6.9	4.2	3.6	4.2	6.2	3.6	2.9	4.4	9.2	3.2	3.6	2.2	11.5	6.9	4.5	6.4	4.8	5.0	3.7	8.5	6.3	11.2	10.7	9.3	11.8	13.0	11.1	11.6	15.7	24.7	16.2	20.3	8.8	13.8	8.9	18.0	18.2	5.8	49.0	30.4	16.0	9.5	12.7	12.9	13.6	18.4	12.1	20.9	4.4	19.0	16.8	26.0	12.5	13.1	14.9	19.5	25.1	5.5	19.0	9.7	21.1	11.6	28.4	15.0	21.9	8.9	9.8	16.9	23.6	18.8	7.6	9.7	17.3	7.9	11.8	13.5	14.6	14.7	9.1	12.1	8.3	8.5	12.3	5.3	12.3	15.4	14.0	16.9	9.5	0.0	0.6	0.6	1.2	0.9	1.5	1.0	0.7	1.1	1.2	0.5	0.8	1.0	0.3	1.9	0.8	1.0	0.6	0.7	9.5	10.3	10.1	11.7	9.3	10.5	9.5	10.2	9.5	9.2	11.5	8.5	3.9	0.0	2.0	28.7	4.8	1.1	1.5	1.8	3.4	5.5	3.2	2.8	9.0	1.5	1.8	5.5	4.2	5.0	3.5	4.4	5.9	2.9	0.6	7.6	5.7	4.2	4.8	5.2	35.4	2.7	5.2	3.2	6.6	4.9	1.3	9.8	2.2	7.7	5.4	1.7	37.8	4.5	0.0	2.9	1.3	1.2	1.2	2.6	1.8	19.7	2.3	4.0	2.1	22.6	25.2	3.2	7.0	2.2	5.0	1.9	2.6	2.4	2.9	4.7	0.0	3.1	2.9	0.7	2.4	4.8	1.3	2.9	3.2	8.3	6.8	1.7
LBR	"DHCR14B, TDRD18"	ENSG00000143815	"Lamin B receptor"	Q14739	1	225401502-225428925	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"DNA-binding, Oxidoreductase, Receptor"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 248.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062236	Enhanced		Supported	"Nuclear membrane"		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nuclear membrane"		"HPA062236: AB_2684721"	"unprognostic (2.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (7.30e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.45e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.78e-1)"	28.6	9.1	8.8	53.2	9.7	95.7	17.1	9.3	11.9	27.3	9.2	61.4	40.7	47.0	44.4	29.7	31.8	21.7	10.0	8.5	10.1	19.4	47.3	19.2	81.6	12.0	9.8	19.4	16.9	5.6	6.5	27.6	11.2	23.8	46.2	5.3	11.1	36.7	9.8	13.8	39.9	41.4	10.2	41.5	28.2	20.5	9.5	105.5	11.8	12.8	70.7	32.3	23.0	13.1	122.2	42.0	154.9	69.3	64.8	39.7	77.3	31.2	39.2	65.0	69.0	87.2	207.2	248.4	66.6	32.8	38.6	88.8	114.2	32.9	98.5	142.2	107.1	61.4	40.4	81.5	39.9	274.7	105.5	34.3	21.3	58.9	52.0	33.1	82.9	117.4	189.6	164.6	44.4	16.3	254.9	156.6	140.6	121.8	14.2	164.9	141.4	234.0	75.6	52.7	40.6	53.4	52.7	39.6	26.6	68.2	53.3	181.0	50.5	17.6	91.7	49.3	115.9	56.6	83.0	274.5	24.3	120.5	61.2	83.6	44.3	67.3	43.6	31.6	50.9	39.0	43.5	48.8	38.4	39.5	42.4	52.9	211.4	41.3	25.2	21.5	61.9	69.8	8.8	9.7	9.3	11.9	8.5	10.1	12.0	9.8	11.2	10.2	9.5	13.1	98.1	28.9	36.4	13.4	86.4	27.0	33.4	17.3	21.6	4.5	11.9	11.0	8.5	48.6	34.4	31.3	6.2	40.5	98.3	33.4	5.9	23.6	1.2	31.5	31.0	53.1	27.0	248.9	10.5	19.8	23.9	29.0	29.0	53.9	10.1	24.0	48.5	73.6	44.4	11.8	14.3	43.0	12.2	88.5	18.1	3.4	33.8	71.7	26.6	19.7	56.0	11.6	82.4	37.2	34.1	20.6	24.6	32.4	74.0	32.9	19.3	26.0	26.0	10.4	39.5	13.9	46.6	21.0	26.7	68.4	35.5	11.1	81.3	13.2	73.8	36.7
LCAT		ENSG00000213398	"Lecithin-cholesterol acyltransferase"	P04180	16	67939750-67944131	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 283.0"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 219.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 76.5;Hep G2: 62.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 29.2"	HPA044767			Approved	Nucleoplasm	"Secreted to blood"	NA	NA	6470000000	6400000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 15: Hepatocytes - Hemostasis"	Nucleoplasm		"HPA044767: AB_2756312"	"unprognostic (3.34e-2)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (5.43e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (4.21e-8)"	"unprognostic (6.42e-2)"	"unprognostic (4.26e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (9.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.90e-3)"	29.5	20.8	29.3	8.3	29.8	4.2	27.2	56.7	37.5	41.4	37.8	30.6	5.0	28.7	9.1	13.4	26.1	11.5	42.0	28.5	32.3	33.2	283.0	36.1	7.5	41.9	32.7	28.5	17.7	8.0	17.5	17.8	31.6	40.0	4.8	2.8	16.9	18.6	13.2	32.0	17.8	12.3	31.9	23.3	16.5	11.3	33.4	9.4	43.2	8.9	4.4	27.5	27.3	32.0	5.7	9.0	13.0	14.8	11.1	15.6	76.5	21.9	9.3	14.5	10.2	29.5	6.8	3.1	4.0	31.9	5.3	19.4	3.1	30.0	8.9	1.5	7.9	3.9	22.8	62.9	15.2	0.7	10.3	27.1	27.9	30.0	10.4	19.5	10.8	8.7	8.7	1.2	10.5	9.1	3.7	9.5	8.6	1.1	5.0	4.0	14.1	3.3	4.1	9.6	0.5	6.7	33.1	1.6	3.9	26.5	18.6	6.0	20.6	18.5	28.8	20.7	8.1	17.7	5.2	8.3	8.9	2.5	16.5	0.9	0.4	1.9	0.3	0.0	0.4	0.4	0.2	0.3	0.1	0.6	0.4	0.1	1.0	0.4	0.1	0.3	0.0	0.0	29.3	29.8	56.7	37.5	28.5	32.3	41.9	32.7	31.6	31.9	33.4	32.0	16.5	9.6	4.8	27.4	1.1	9.4	4.1	4.6	6.8	0.4	1.9	5.5	7.9	5.7	3.3	3.7	2.1	7.7	1.3	0.1	0.0	1.7	0.2	2.1	6.0	8.0	1.2	14.3	0.1	1.0	3.4	7.3	1.1	1.6	1.3	5.4	10.8	219.5	2.4	0.0	0.1	0.0	4.1	6.6	3.8	1.3	8.7	2.4	7.2	6.5	3.0	7.7	1.0	4.5	1.4	2.1	0.0	8.6	1.9	4.3	0.0	0.4	4.4	0.6	13.1	7.6	10.4	0.9	1.4	0.9	2.6	12.2	1.6	4.1	0.1	1.7
LCT		ENSG00000115850	Lactase	P09848	2	135787850-135837184	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	187	"intestine: 225.5"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.4;Breast myoepithelial cells: 3.3;Early spermatids: 1.3;Proximal enterocytes: 2.8;Undifferentiated cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"JURKAT: 2.5;MOLT-4: 4.9;RPMI-8226: 9.7"	"Region enriched"	"Detected in some"	15	"hippocampal formation: 15.7"	"Not detected"	"Not detected"									NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (2.21e-2)"	"unprognostic (1.65e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.39e-2)"	"unprognostic (8.03e-4)"	"unprognostic (3.55e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.64e-4)"	"unprognostic (4.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.02e-1)"	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	225.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136.3	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.0	4.9	0.8	0.0	0.0	0.0	1.1	0.0	9.7	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.3	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0
LDHD		ENSG00000166816	"Lactate dehydrogenase D"	Q86WU2	16	75111860-75116780	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 85.6;liver: 135.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 37.3;Distal enterocytes: 80.2;Distal tubular cells: 37.2;Hepatocytes: 88.6;Proximal tubular cells: 118.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 32.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 11.1"	"Group enriched"	"Detected in many"	45	"granulocytes: 11.1;monocytes: 4.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 11.4;HMC-1: 14.4;T-47d: 29.1;U-266/70: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041766, HPA048639, HPA066148"	Enhanced		Approved	Cytosol		No	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA041766: AB_2677660, HPA048639: AB_2680473, HPA066148: AB_2685626"	"unprognostic (8.75e-2)"	"unprognostic (3.68e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.01e-1)"	"prognostic favorable (2.95e-14)"	"unprognostic (4.10e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.20e-1)"	24.9	14.4	17.7	2.1	19.7	0.7	11.7	20.5	22.6	5.4	34.1	27.2	8.8	3.5	1.1	10.8	5.5	3.0	85.6	16.1	18.9	36.1	135.5	4.9	0.8	20.8	20.2	16.4	18.7	17.0	11.8	0.7	22.4	8.1	9.7	1.3	21.3	3.2	68.7	5.8	5.7	1.2	17.0	1.1	23.1	1.7	19.3	0.5	10.6	52.7	0.6	2.6	3.7	17.5	0.7	2.1	0.0	0.2	1.6	1.4	6.1	0.2	0.1	0.2	0.2	2.8	2.6	0.1	2.1	0.9	1.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.8	11.4	2.6	0.0	14.4	2.0	0.3	0.0	0.0	0.6	0.1	0.4	0.7	2.5	0.0	5.3	0.1	0.8	1.4	2.7	1.3	0.0	0.0	7.8	1.4	0.1	0.0	0.0	0.2	5.2	0.3	0.7	29.1	3.3	0.0	0.0	0.2	0.0	0.0	11.5	0.6	0.0	1.9	0.1	0.0	11.1	2.2	0.6	0.0	3.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.8	17.7	19.7	20.5	22.6	16.1	18.9	20.8	20.2	22.4	17.0	19.3	17.5	1.6	0.0	6.7	7.8	1.0	0.6	1.8	2.2	0.6	0.5	6.5	2.4	37.3	11.5	2.3	11.0	0.0	2.1	0.1	80.2	37.2	2.3	0.4	2.2	0.3	1.7	3.0	2.7	1.0	6.2	1.2	2.3	32.6	3.8	10.2	2.1	4.2	88.6	7.2	1.7	1.4	11.0	0.0	6.0	1.0	0.6	0.0	3.0	5.4	1.9	2.0	12.0	0.0	1.0	3.2	3.0	28.3	0.0	0.8	2.1	2.4	118.1	2.0	1.4	0.0	4.1	1.3	0.0	0.7	3.6	0.3	3.1	1.0	1.8	15.7	1.5
LFNG	SCDO3	ENSG00000106003	"LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	Q8NES3	7	2512529-2529177	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 74.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 40.3;Enteroendocrine cells: 87.4;monocytes: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.7;OE19: 46.4;RH-30: 46.0;U-2 OS: 49.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069130	Approved		Approved	"Nuclear membrane,Golgi apparatus"	"Intracellular and membrane"	NA	NA		880000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	"Nuclear membrane"	"HPA069130: AB_2686091"	"unprognostic (4.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (6.36e-4)"	"unprognostic (1.85e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.15e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.16e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.28e-2)"	16.7	6.5	23.3	17.3	25.9	9.8	13.7	29.3	22.4	9.9	11.1	23.1	15.5	9.4	2.2	11.4	6.1	11.8	13.1	17.4	30.1	9.0	2.5	14.4	18.6	34.1	35.6	1.8	74.4	3.0	3.7	6.5	24.8	17.1	12.0	3.0	33.4	4.6	4.6	58.2	17.2	5.8	25.0	20.9	37.8	4.2	38.1	5.8	6.7	3.6	10.8	12.2	13.8	23.6	1.5	14.3	18.4	2.5	2.0	1.7	1.2	5.4	2.8	4.7	5.9	6.0	37.7	1.1	16.7	14.8	8.1	27.1	2.9	5.1	2.3	8.6	0.6	4.3	7.7	3.2	0.1	6.2	7.7	3.3	12.6	7.8	0.8	3.2	1.9	0.3	0.7	0.2	3.6	34.5	0.1	8.7	22.4	46.4	10.3	1.8	46.0	2.9	1.8	4.5	16.9	4.2	6.2	1.4	0.3	4.7	10.2	7.3	4.5	10.5	49.7	0.4	15.4	0.2	0.0	1.4	11.8	16.4	2.0	6.3	5.3	12.7	1.8	6.9	2.0	1.1	1.7	0.9	2.3	2.0	1.8	1.8	2.8	1.3	6.6	0.6	4.2	1.7	23.3	25.9	29.3	22.4	17.4	30.1	34.1	35.6	24.8	25.0	38.1	23.6	23.3	6.4	6.0	18.9	15.6	6.8	2.5	10.6	3.4	8.5	5.3	12.4	3.6	5.7	2.8	0.0	0.0	0.1	40.3	23.1	0.0	1.2	0.1	2.4	8.5	16.0	87.4	2.7	0.0	6.4	0.3	5.7	30.5	1.2	17.7	0.1	13.9	0.6	7.0	0.0	0.1	34.5	6.1	30.4	13.8	0.5	1.8	30.6	3.6	11.2	38.2	31.3	19.6	1.5	0.1	21.7	3.1	0.0	12.6	2.2	8.8	0.4	1.2	0.8	0.0	0.6	5.0	0.3	3.1	0.6	4.0	0.0	15.9	0.5	15.3	0.7
LGR4	GPR48	ENSG00000205213	"Leucine rich repeat containing G protein-coupled receptor 4"	Q9BXB1	11	27365961-27472790	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Differentiation, Immunity, Innate immunity, Spermatogenesis, Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 204.4;Distal enterocytes: 123.3;Glandular and luminal cells: 137.7;Syncytiotrophoblasts: 128.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 83.5;RPTEC TERT1: 100.4;U-2197: 82.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030267, HPA054350"	Uncertain		Approved	"Centriolar satellite"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Centriolar satellite"		"HPA030267: AB_10610004, HPA054350: "	"unprognostic (5.27e-3)"	"unprognostic (5.18e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.10e-1)"	"prognostic favorable (2.00e-7)"	"unprognostic (5.01e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.76e-1)"	16.4	16.8	10.2	8.1	10.2	2.4	16.1	13.0	9.2	7.5	10.2	36.8	22.6	10.2	13.3	13.7	10.2	9.0	19.4	7.8	10.5	51.5	55.7	3.2	1.5	14.1	10.4	22.9	59.7	6.4	6.8	34.4	12.8	15.4	36.8	44.4	18.1	16.1	14.4	18.3	24.7	13.2	13.4	11.7	31.0	13.9	10.1	4.4	15.2	8.2	3.0	10.1	11.7	18.0	28.3	50.7	49.5	5.7	4.5	3.1	56.0	15.7	14.8	13.8	11.8	7.6	0.5	0.1	10.1	21.2	23.2	45.8	83.5	31.1	23.5	0.2	37.0	15.3	28.4	36.1	1.4	1.6	0.1	4.1	19.5	9.5	21.0	57.0	7.0	0.0	4.5	0.1	5.7	9.0	0.1	2.7	47.9	76.3	20.4	0.2	33.8	3.3	100.4	12.1	0.7	6.0	7.7	45.7	4.6	37.6	15.1	23.4	22.6	10.2	8.2	82.6	14.6	18.9	15.2	0.0	17.3	0.0	6.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	10.2	13.0	9.2	7.8	10.5	14.1	10.4	12.8	13.4	10.1	18.0	1.7	3.2	0.5	204.4	1.4	30.3	13.5	33.1	38.7	18.6	17.2	14.1	26.6	24.3	15.4	44.1	25.0	55.1	0.4	123.3	3.9	21.4	7.1	75.4	11.5	3.9	16.8	3.4	35.6	50.7	29.2	14.5	43.3	137.7	0.0	78.6	3.6	60.7	8.1	25.2	51.6	47.1	20.3	5.3	5.7	2.2	5.0	1.6	7.2	15.0	2.1	109.8	0.0	36.7	62.1	31.4	48.8	17.0	0.6	11.7	37.9	19.4	14.5	14.8	6.6	6.9	13.0	1.3	1.4	36.8	21.9	128.6	1.8	6.3	55.5	19.7
LHFPL5	"DFNB67, dJ510O8.8, MGC33835, Tmhs"	ENSG00000197753	"LHFPL tetraspan subfamily member 5"	Q8TAF8	6	35797206-35845397	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.8;epididymis: 12.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 13.5;Excitatory neurons: 8.0;Glandular and luminal cells: 2.8;Inhibitory neurons: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029421, HPA055110"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles		"HPA029421: , HPA055110: AB_2682697"	"unprognostic (2.35e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"		"unprognostic (4.89e-3)"		"unprognostic (2.96e-3)"	"unprognostic (2.46e-2)"		"unprognostic (1.47e-8)"	"unprognostic (5.53e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.41e-1)"	0.9	1.1	4.1	2.7	4.6	18.8	0.8	4.8	5.6	0.3	0.3	0.9	3.0	1.5	12.4	1.3	0.6	1.7	0.7	3.6	2.6	0.6	0.8	1.0	2.8	0.0	0.3	1.1	5.6	0.3	0.5	1.3	0.2	1.0	0.7	8.2	2.4	0.4	1.4	7.6	2.5	0.3	0.0	2.2	1.7	1.5	1.9	0.5	1.4	0.2	0.6	0.6	0.0	2.7	2.3	1.5	3.0	3.1	0.2	0.6	4.6	1.6	0.3	0.1	0.4	2.7	2.0	3.6	1.2	0.6	1.9	2.9	0.2	0.8	0.3	1.6	2.6	3.2	5.3	4.0	0.0	3.4	2.2	0.5	0.3	0.3	0.4	2.1	0.2	3.6	3.1	5.1	0.9	1.9	2.5	6.2	2.6	0.7	1.5	2.2	1.1	2.0	0.7	5.6	3.4	1.9	1.6	2.3	1.0	2.9	2.4	1.9	2.6	3.1	1.7	2.5	2.4	3.2	3.0	3.1	1.1	3.6	1.6	2.9	0.6	0.5	0.3	0.3	0.3	0.5	0.3	0.3	0.1	0.9	0.4	0.5	3.3	0.6	0.4	0.7	0.4	0.1	4.1	4.6	4.8	5.6	3.6	2.6	0.0	0.3	0.2	0.0	1.9	2.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.3	0.7	0.3	0.0	0.4	8.0	0.2	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0
LHFPL6	"LHFP, MGC22429"	ENSG00000183722	"LHFPL tetraspan subfamily member 6"	Q9Y693	13	39209116-39603528	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 195.2;Endometrial stromal cells: 78.1;Extravillous trophoblasts: 156.9;Fibroblasts: 113.0;Smooth muscle cells: 131.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"myeloid DC: 6.2;plasmacytoid DC: 2.1"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 6.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 255.1;HSkMC: 186.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058975	Approved		Approved	Nucleoli		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli		"HPA058975: AB_2683866"	"unprognostic (6.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.45e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (1.20e-7)"	"unprognostic (4.41e-3)"	"unprognostic (5.25e-2)"	"unprognostic (7.75e-2)"	"prognostic unfavorable (2.30e-4)"	143.2	55.1	46.3	18.6	49.9	1.1	128.7	59.2	45.2	51.6	57.2	51.7	10.8	78.8	47.5	37.0	88.9	74.5	99.7	45.6	57.3	31.9	14.2	82.6	39.1	54.9	56.8	49.6	17.2	18.2	26.9	134.6	51.4	30.8	16.7	11.9	34.7	36.9	32.1	37.9	29.0	68.9	47.8	30.4	27.9	20.4	64.3	17.0	64.2	89.2	17.6	49.1	48.3	44.3	11.5	4.0	118.3	5.1	255.1	115.1	51.6	61.8	88.3	30.8	23.1	0.5	11.6	17.5	1.3	86.6	40.0	17.3	15.0	36.2	25.3	16.9	17.2	47.3	3.7	0.0	26.7	0.8	0.9	186.4	4.7	27.7	45.7	27.6	29.1	1.1	0.0	0.1	59.9	9.9	0.0	14.5	8.8	0.2	15.8	7.7	51.3	0.1	20.9	15.0	0.7	3.8	5.6	7.2	16.8	67.4	6.7	0.1	54.3	77.9	11.7	24.4	33.9	0.9	0.0	48.9	32.4	0.2	57.2	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.3	46.3	49.9	59.2	45.2	45.6	57.3	54.9	56.8	51.4	47.8	64.3	44.3	195.2	3.2	12.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	4.4	28.6	0.0	0.0	9.9	0.0	0.0	5.0	1.4	0.0	1.9	0.6	0.0	2.7	78.1	32.0	0.0	0.0	0.0	0.6	156.9	113.0	0.0	2.8	2.5	22.1	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	3.6	2.2	0.0	0.0	0.0	131.6	0.0	0.0	0.0	0.0	6.2	1.2	45.8	0.0	0.0
LIAS	LAS	ENSG00000121897	"Lipoic acid synthetase"	O43766	4	39459004-39485109	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 86.0;Late spermatids: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018842, HPA019076"	Approved	Supported	Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Mitochondria	"HPA018842: AB_1852864, HPA019076: AB_1852866"	"unprognostic (3.61e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.80e-2)"	"prognostic favorable (4.11e-7)"	"unprognostic (9.41e-3)"	"unprognostic (2.35e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.98e-2)"	5.4	7.5	5.9	3.0	6.5	6.6	5.7	7.6	9.8	5.1	5.9	6.4	5.5	4.6	5.3	6.7	6.1	3.6	11.1	6.2	6.7	8.7	8.6	2.9	5.1	6.3	6.4	10.0	6.8	6.5	4.0	3.3	6.8	4.1	6.4	5.4	4.3	3.1	27.2	5.7	5.2	5.2	5.5	3.6	6.3	9.8	6.2	4.3	4.2	21.0	4.2	5.8	4.7	8.3	5.7	4.5	5.4	5.2	11.5	11.4	4.8	6.6	3.7	6.1	4.1	6.8	7.8	20.8	7.3	2.5	15.2	4.9	15.9	9.1	8.0	2.4	4.0	8.8	2.3	7.0	10.4	19.1	5.5	10.8	14.6	7.1	22.4	13.4	7.0	12.7	21.1	5.2	7.5	3.6	10.9	24.9	7.3	15.3	14.2	9.1	15.2	12.9	7.1	2.9	6.0	4.8	3.8	4.9	22.5	7.6	5.6	8.8	2.6	4.7	10.6	6.3	15.5	9.9	15.8	14.3	7.2	22.2	4.0	2.5	6.4	3.9	5.7	7.6	12.7	10.0	8.1	8.0	6.2	7.6	16.2	11.6	3.4	7.7	5.6	5.5	5.7	4.7	5.9	6.5	7.6	9.8	6.2	6.7	6.3	6.4	6.8	5.5	6.2	8.3	11.0	9.6	12.6	14.0	12.9	9.7	11.6	17.4	12.0	25.8	15.7	17.3	20.1	17.2	12.7	18.4	10.4	24.0	22.6	12.9	21.5	13.2	86.0	11.2	15.8	10.3	18.1	12.4	11.9	6.4	18.2	10.4	9.2	10.3	17.7	19.0	11.4	19.0	17.5	10.1	18.8	13.5	18.3	13.5	7.8	100.1	10.2	11.4	1.8	6.5	17.6	15.4	16.5	14.6	22.9	10.3	10.1	12.4	5.8	6.6	18.3	32.6	14.1	26.7	0.0	10.8	20.5	64.9	25.1	13.7	9.2	9.6	14.2	19.0	18.4	8.8
LIG4		ENSG00000174405	"DNA ligase 4"	P49917	13	108207439-108218368	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001334, HPA057325"	Approved		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Cytoplasmic bodies"	"HPA001334: AB_1078689, HPA057325: AB_2732608"	"unprognostic (9.93e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.03e-3)"	7.2	8.3	6.3	8.6	6.5	3.9	5.6	6.1	9.0	4.0	8.7	5.7	7.2	4.4	8.5	4.2	4.5	6.8	6.7	7.1	10.2	8.2	12.0	6.9	11.0	6.8	6.6	5.8	3.8	11.3	5.2	5.8	6.8	5.6	6.6	23.1	4.6	5.2	7.1	5.3	7.0	6.6	6.1	8.3	7.8	9.8	7.1	21.8	7.7	6.5	8.3	6.9	2.3	7.9	15.5	5.8	15.3	10.2	12.4	13.3	5.4	14.9	11.2	11.2	13.3	6.9	6.7	26.0	11.9	9.8	13.7	6.3	10.2	9.9	19.2	15.4	9.8	12.3	13.8	3.6	14.8	16.6	12.5	12.3	16.3	10.8	9.6	10.7	13.5	47.0	4.4	4.7	17.4	8.3	27.7	12.1	3.9	12.6	3.6	25.1	6.0	4.2	14.6	9.7	9.6	9.9	3.3	9.0	11.7	11.7	7.7	25.4	20.1	6.6	7.2	7.5	13.5	12.4	8.7	41.7	25.4	9.4	15.2	0.6	1.6	4.8	1.1	2.5	1.6	1.6	1.2	1.2	1.4	2.2	1.2	1.7	2.2	1.9	8.3	1.0	1.8	1.0	6.3	6.5	6.1	9.0	7.1	10.2	6.8	6.6	6.8	6.1	7.1	7.9	5.6	9.6	9.5	13.4	9.2	2.7	2.8	4.9	3.4	10.7	4.9	2.8	11.6	1.5	10.0	1.8	8.4	2.3	7.3	7.9	9.8	5.3	11.6	8.3	5.7	4.3	9.6	0.4	16.6	7.5	1.0	4.2	7.7	6.0	3.8	3.6	4.6	9.8	5.8	18.5	16.1	5.3	2.0	7.5	3.9	5.1	2.8	7.4	1.8	10.3	9.3	7.3	4.1	13.6	24.9	8.9	6.3	6.0	6.2	2.5	3.5	6.3	21.9	13.6	13.1	4.6	3.8	19.1	4.4	4.0	5.7	1.8	4.1	8.7	2.9	3.7
LIMK1	LIMK	ENSG00000106683	"LIM domain kinase 1"	P53667	7	74082933-74122525	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 77.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 27.6;Horizontal cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 136.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028516, HPA073571"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 4: Macrophages - Innate immune response"	"Nuclear speckles, Cytosol"		"HPA028516: AB_10601751, HPA073571: "	"unprognostic (1.45e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (4.95e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (6.63e-8)"	"unprognostic (4.14e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.79e-2)"	11.1	10.5	31.1	18.7	32.7	6.8	9.4	28.3	77.9	21.4	0.2	8.9	6.6	13.1	3.5	11.3	7.3	10.1	9.4	35.0	43.8	10.8	4.6	13.2	23.5	75.5	40.0	13.2	11.4	5.8	13.9	7.3	73.0	12.3	4.1	4.0	17.9	8.2	23.7	11.4	12.1	7.1	31.8	22.3	9.2	15.6	59.1	8.1	11.2	7.8	18.2	13.1	14.7	38.3	47.4	37.2	27.2	45.4	35.1	47.0	20.0	28.8	27.3	22.6	25.4	21.3	45.6	30.2	12.7	35.5	76.9	28.1	10.1	17.8	8.6	53.7	18.6	23.2	13.1	24.6	40.5	17.2	81.4	46.8	15.6	18.5	9.6	68.3	34.4	20.9	15.1	9.0	28.8	41.4	14.8	31.4	52.1	16.6	23.7	21.1	43.3	18.2	26.5	10.1	10.7	25.2	18.6	43.7	23.5	29.7	13.9	15.4	41.1	36.0	33.7	94.5	47.7	10.2	12.5	54.9	136.5	12.4	25.2	0.1	6.1	3.5	1.8	6.0	1.4	3.4	0.4	1.2	7.0	1.7	0.1	0.5	0.5	5.8	3.8	0.7	0.3	3.3	31.1	32.7	28.3	77.9	35.0	43.8	75.5	40.0	73.0	31.8	59.1	38.3	2.9	3.2	2.7	7.5	14.4	2.9	5.2	6.6	1.8	6.6	7.7	6.9	3.4	7.2	3.8	1.8	2.1	2.5	11.9	2.9	0.0	6.6	1.2	2.7	9.7	4.1	2.4	0.4	15.4	6.5	6.3	9.2	3.1	5.1	5.7	27.6	3.3	2.1	25.0	35.3	20.8	2.7	0.0	13.5	10.8	2.2	7.2	15.6	3.6	6.5	14.9	3.5	22.6	6.6	2.4	13.5	2.3	6.0	10.0	9.0	0.3	2.8	3.1	3.3	0.0	5.3	4.5	3.4	11.5	1.8	3.1	3.7	11.1	6.9	2.4	7.2
LINGO1	"FLJ14594, LERN1, LRRN6A"	ENSG00000169783	"Leucine rich repeat and Ig domain containing 1"	Q96FE5	15	77613027-77820900	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 271.0;Excitatory neurons: 271.6;Horizontal cells: 132.9;Inhibitory neurons: 220.5;Microglial cells: 167.7;Oligodendrocyte precursor cells: 240.8;Oligodendrocytes: 324.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"amygdala: 37.4;basal ganglia: 43.9;cerebral cortex: 56.1;hippocampal formation: 49.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 23.9;AN3-CA: 20.1;HAP1: 30.2;HEK 293: 21.0;MCF7: 13.5;NTERA-2: 56.9;SuSa: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074653	Enhanced		Supported	"Plasma membrane"		NA	NA		25000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"		"HPA074653: AB_2686706"	"unprognostic (1.06e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (3.23e-7)"	"unprognostic (2.07e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.59e-2)"	3.9	1.1	37.4	1.2	43.9	0.0	3.5	0.0	56.1	4.6	0.0	2.2	1.5	4.5	2.2	0.9	2.7	2.1	11.8	49.1	0.0	4.2	0.8	1.0	0.7	0.0	0.0	2.3	2.5	4.1	1.9	6.7	0.0	1.6	0.8	16.2	3.2	2.0	0.8	2.8	1.7	4.6	0.0	3.3	1.4	5.3	0.2	0.3	2.2	1.4	0.3	2.3	2.9	4.6	0.0	2.1	23.9	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.4	0.0	0.4	0.1	30.2	0.0	0.0	0.0	21.0	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	13.5	0.0	0.0	56.9	1.3	0.0	0.0	0.0	0.5	0.0	0.0	4.2	1.2	0.1	2.4	4.9	21.6	0.3	0.4	2.1	0.0	5.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	43.9	0.0	56.1	49.1	0.0	0.0	0.0	0.0	0.0	0.2	4.6	2.1	0.0	0.0	271.0	0.0	0.3	0.1	0.0	0.0	21.8	0.7	0.3	7.3	1.5	0.0	0.0	2.1	0.1	0.0	1.8	0.0	0.3	8.6	0.8	3.7	2.3	0.0	0.0	271.6	0.2	0.2	1.8	0.0	0.2	0.0	14.9	4.2	0.0	0.3	132.9	220.5	0.3	0.0	0.0	0.0	16.5	0.3	0.1	3.6	167.7	0.0	51.1	0.0	240.8	324.2	0.2	7.7	0.4	0.0	0.0	0.0	0.0	0.0	19.5	26.3	0.0	21.9	0.2	3.1	0.0	0.1	0.3	0.1	0.5	0.2	0.0
LIPA	"CESD, LAL"	ENSG00000107798	"Lipase A, lysosomal acid type"	P38571	10	89213569-89414557	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 398.4"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 515.0;Kupffer cells: 714.8;Macrophages: 303.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 167.3;intermediate monocyte: 355.1;myeloid DC: 123.6;non-classical monocyte: 198.5"	"Group enriched"	"Detected in all"	6	"dendritic cells: 123.6;monocytes: 355.1"	"Cell line enhanced"	"Detected in many"		"A-431: 354.4;AN3-CA: 367.8;ASC TERT1: 450.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034892, HPA057052"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA		280000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"CAB034892: AB_784329, HPA057052: AB_2683322"	"unprognostic (1.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.71e-2)"	76.0	46.3	43.5	66.7	65.2	39.8	47.8	64.1	74.4	54.0	39.0	67.7	167.6	38.8	21.7	28.6	37.8	83.5	24.2	43.5	53.1	44.9	218.9	169.5	159.3	74.7	55.5	32.7	21.4	68.9	12.7	79.1	82.2	30.7	72.0	12.6	22.5	33.8	11.8	18.7	227.5	47.7	65.4	398.4	34.3	13.4	57.0	44.5	31.6	22.5	45.5	58.4	19.3	115.5	354.4	49.4	30.7	367.8	343.5	450.8	10.0	171.4	194.8	65.5	121.5	18.6	176.6	63.9	34.0	264.4	73.7	338.7	13.8	92.8	53.6	86.1	34.7	25.1	19.1	81.5	87.6	48.8	48.9	190.4	69.2	72.9	40.6	88.2	14.9	45.4	0.3	108.5	58.3	28.2	45.7	34.6	22.7	62.4	60.0	26.4	39.0	60.5	69.2	50.9	10.5	21.8	41.4	49.9	133.9	20.4	64.4	65.8	26.2	58.8	15.5	132.1	44.6	60.0	65.7	25.8	71.4	112.9	82.1	4.2	167.3	16.9	40.0	355.1	40.6	31.9	35.8	38.8	123.6	33.4	36.7	40.4	7.1	29.8	198.5	25.0	38.2	159.6	43.5	65.2	64.1	74.4	43.5	53.1	74.7	55.5	82.2	65.4	57.0	115.5	75.5	41.7	33.8	11.1	35.9	17.7	30.3	58.1	25.6	5.4	16.1	14.1	9.6	45.8	31.9	33.1	0.0	34.8	31.4	2.8	21.5	35.1	6.8	11.4	20.4	56.7	21.8	27.4	34.4	36.2	32.9	34.6	21.4	15.5	28.5	10.8	54.7	66.7	515.0	16.8	15.1	8.9	40.7	714.8	69.0	2.7	11.5	303.1	48.0	30.0	71.7	33.1	29.9	15.1	143.0	19.3	12.0	21.8	15.4	11.3	161.0	14.0	28.8	2.2	6.6	19.7	21.0	5.1	13.8	31.9	12.5	20.0	33.1	17.6	9.1	24.0
LIPC	"HL, HTGL"	ENSG00000166035	"Lipase C, hepatic type"	P11150	15	58410569-58569844	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"liver: 171.0"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 161.7"	"Group enriched"	"Detected in some"	14	"liver cancer: 20.4;renal cancer: 10.4"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	7	"granulocytes: 1.6;NK-cells: 1.5;T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.5;EFO-21: 6.1;Hep G2: 24.4;HMC-1: 6.8;MOLT-4: 5.5;U-2197: 18.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		5500000	"Cluster 10: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.76e-2)"	"unprognostic (9.15e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.15e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.93e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.27e-2)"	0.4	0.1	0.5	0.3	0.5	0.2	1.5	0.8	0.9	0.4	0.0	0.6	1.8	0.2	0.9	0.6	1.0	0.8	0.5	0.6	0.3	6.0	171.0	0.3	0.7	0.8	0.7	0.8	2.5	0.0	1.5	0.4	1.0	0.1	0.8	0.1	0.2	0.9	0.0	0.6	0.8	0.1	0.6	0.8	0.5	0.1	0.4	2.1	1.2	0.3	0.2	1.6	0.3	1.2	0.0	0.0	0.0	0.0	0.3	1.0	0.1	0.1	0.8	0.0	0.0	8.5	0.0	0.0	6.1	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	3.0	0.0	24.4	0.5	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.2	0.1	5.5	0.8	0.0	0.1	0.0	1.1	0.3	0.0	2.6	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	18.4	0.0	0.1	0.0	0.1	0.2	0.5	0.0	1.6	0.1	0.0	1.3	0.1	1.8	0.0	0.3	0.9	0.1	0.0	0.4	1.3	0.2	1.5	0.2	0.0	0.9	1.1	0.5	0.5	0.8	0.9	0.6	0.3	0.8	0.7	1.0	0.6	0.4	1.2	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	2.2	0.8	11.5	0.7	3.7	0.0	0.0	0.9	1.2	5.9	7.8	0.0	0.4	0.5	1.2	0.0	2.7	6.1	3.7	0.1	2.9	0.5	2.7	0.0	0.2	4.2	161.7	0.1	0.0	4.3	0.0	0.0	3.8	0.8	0.1	0.3	0.3	1.8	16.9	0.6	0.0	3.1	0.0	12.9	0.2	0.0	0.0	0.0	0.2	0.3	15.7	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.3	0.6	0.0	1.1	1.2	0.0	0.1
LIPE	HSL	ENSG00000079435	"Lipase E, hormone sensitive type"	Q05469	19	42401514-42427388	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid degradation, Lipid metabolism, Steroid metabolism, Sterol metabolism"	Hydrolase	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 834.5;breast: 524.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 76.1;Early spermatids: 127.8;Late spermatids: 236.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"ASC diff: 136.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006567, CAB017700"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"CAB017700: AB_2135504, HPA006567: AB_2667618"	"unprognostic (4.24e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.11e-1)"	"unprognostic (9.44e-2)"	"prognostic favorable (1.15e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.63e-10)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.34e-3)"	834.5	45.1	22.7	7.7	71.7	5.0	524.7	77.2	41.5	5.1	0.6	10.9	5.3	6.4	1.2	8.6	5.8	3.7	32.5	23.8	42.6	7.7	1.5	3.7	7.3	100.3	73.9	4.9	6.2	4.7	6.9	2.9	90.0	7.1	1.4	2.0	17.2	2.6	19.7	23.6	24.4	2.6	44.0	14.4	8.5	68.6	57.1	6.9	9.6	23.3	3.7	14.2	7.7	116.9	12.7	9.6	6.0	2.3	136.8	1.3	0.1	5.8	3.1	9.2	8.5	2.3	4.6	20.6	6.3	1.8	4.5	5.6	3.7	11.5	1.0	4.0	6.1	5.8	5.3	0.2	2.7	0.1	13.9	1.2	10.7	1.5	2.1	1.3	2.6	8.5	2.7	12.8	1.2	0.1	14.8	0.5	0.8	9.7	2.7	12.2	1.1	6.9	2.6	13.1	8.5	8.8	5.1	5.7	5.6	0.3	1.5	7.5	4.7	2.5	7.8	1.1	5.3	9.7	8.5	15.6	6.3	0.7	8.7	11.0	8.6	3.8	2.5	4.7	2.3	3.4	3.2	3.7	3.6	4.5	2.8	2.5	1.5	3.6	2.7	2.9	3.0	3.1	22.7	71.7	77.2	41.5	23.8	42.6	100.3	73.9	90.0	44.0	57.1	116.9	76.1	0.0	3.3	4.2	8.1	4.1	12.1	2.4	4.6	11.0	4.8	2.9	2.5	0.0	2.0	1.8	10.4	0.1	4.8	1.3	1.9	8.0	127.8	0.9	3.4	10.2	0.0	5.3	4.6	2.7	0.1	2.0	3.6	1.5	0.0	6.6	17.9	0.0	0.6	8.4	6.7	2.0	6.1	2.2	2.4	236.5	3.1	0.8	5.4	4.7	0.9	4.0	6.2	6.0	37.9	1.8	0.7	1.5	3.0	6.7	18.4	1.5	0.8	13.9	0.0	7.2	2.1	39.4	13.1	2.5	2.4	0.0	5.1	5.2	2.9	10.7
LIPT2		ENSG00000175536	"Lipoyl(octanoyl) transferase 2"	A6NK58	11	74490519-74493724	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Ligase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 12.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 55.4;Late spermatids: 29.4;Proximal tubular cells: 17.7;Spermatocytes: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040249	Approved					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA040249: AB_10795275"	"unprognostic (8.80e-2)"	"unprognostic (9.67e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.11e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (6.11e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.35e-1)"	1.3	2.0	1.8	1.6	2.0	2.1	2.4	1.8	1.8	1.5	1.2	2.1	3.7	1.6	3.2	1.8	3.2	1.9	1.5	1.6	1.8	4.6	3.1	1.7	2.2	2.4	1.9	3.4	2.9	2.1	2.1	2.1	2.4	1.8	2.3	1.9	2.1	2.7	8.0	1.6	3.6	0.6	1.8	2.1	3.5	12.3	2.8	2.7	3.0	7.1	2.2	1.7	1.2	3.3	2.1	3.3	6.6	3.1	2.1	0.4	6.9	0.8	1.5	3.3	2.3	9.8	3.0	11.5	4.0	0.6	8.0	3.2	2.8	1.9	1.2	2.2	2.6	4.0	3.2	2.9	2.9	4.4	5.0	1.4	2.2	2.2	2.2	1.5	0.2	12.7	3.0	4.1	1.3	4.0	6.6	6.1	4.9	13.0	2.6	4.3	7.0	3.7	2.6	7.3	5.5	3.6	5.6	2.0	8.1	6.2	5.6	3.2	0.6	1.0	2.1	1.5	1.8	5.7	5.8	9.3	0.6	2.7	2.9	0.1	4.7	7.5	5.5	3.0	7.6	10.6	7.3	6.6	5.3	10.5	13.3	10.9	1.1	8.4	3.4	6.3	3.7	4.8	1.8	2.0	1.8	1.8	1.6	1.8	2.4	1.9	2.4	1.8	2.8	3.3	0.6	0.0	0.0	1.0	2.5	0.8	1.1	2.9	4.0	0.9	1.7	1.9	1.1	2.8	1.4	3.7	0.0	13.2	0.7	0.9	5.9	2.6	55.4	1.5	0.7	1.0	0.0	4.0	0.3	4.4	14.1	1.4	2.0	1.1	0.0	1.9	2.2	4.2	5.4	3.3	0.2	3.1	4.1	1.3	0.0	29.4	1.8	2.3	1.8	0.0	0.7	9.8	2.1	0.5	1.1	2.8	0.5	1.2	0.8	1.0	4.3	17.7	1.9	1.6	0.0	1.3	0.9	46.7	10.7	2.9	0.6	8.1	1.4	3.0	3.1	0.3
LMAN1	"ERGIC-53, ERGIC53, F5F8D, FMFD1, gp58, MCFD1, MR60"	ENSG00000074695	"Lectin, mannose binding 1"	P49257	18	59327823-59359265	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 502.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002320, CAB037163"	Supported		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA		18000000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	"Endoplasmic reticulum"	"CAB037163: AB_532237, HPA002320: AB_1079256"	"unprognostic (5.64e-2)"	"unprognostic (8.96e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.05e-2)"	"unprognostic (3.71e-3)"	36.0	43.3	14.8	39.4	16.4	21.7	43.8	16.9	19.4	66.0	20.1	34.1	45.7	46.1	52.9	31.1	48.8	31.9	42.6	13.8	19.4	64.5	181.1	33.6	28.4	17.1	16.0	43.3	53.1	74.3	32.7	54.8	17.4	58.4	39.3	40.0	69.0	43.7	33.3	20.3	49.1	37.7	16.2	27.4	59.3	21.2	16.0	32.1	86.5	41.1	34.8	40.1	21.2	20.4	90.6	52.7	55.1	46.4	125.6	215.6	110.7	159.6	227.9	105.7	140.5	52.7	85.2	16.0	110.7	191.0	75.7	108.1	79.0	90.5	191.0	61.7	50.4	52.5	65.4	109.5	148.9	183.6	77.0	144.7	106.8	102.5	208.1	198.1	108.1	54.3	89.7	173.6	104.2	24.5	53.5	37.9	37.8	45.8	64.5	60.0	100.1	176.0	58.9	67.6	37.5	40.9	80.6	78.0	91.6	76.8	57.8	70.8	89.8	170.5	59.9	55.2	94.0	131.6	71.3	76.2	179.1	96.0	142.6	6.0	2.5	0.7	7.3	3.7	10.0	7.1	7.9	7.7	3.5	5.1	7.5	7.7	0.3	10.0	2.1	8.8	9.6	4.0	14.8	16.4	16.9	19.4	13.8	19.4	17.1	16.0	17.4	16.2	16.0	20.4	120.0	102.5	97.1	15.0	104.0	69.8	120.3	213.5	84.8	39.2	104.5	97.2	134.6	71.4	171.2	80.9	106.3	149.3	86.7	32.8	21.5	130.6	28.1	117.5	203.7	97.7	51.6	49.6	17.2	84.6	304.8	162.4	106.0	200.7	33.6	96.9	75.0	394.0	80.2	58.9	22.1	181.4	107.8	41.9	40.1	10.3	110.6	52.5	67.6	22.5	53.5	76.8	54.6	20.1	33.5	71.6	45.5	85.4	502.1	214.1	95.5	75.6	164.7	66.7	65.7	95.4	142.3	47.2	65.1	80.7	57.0	231.2	69.5	149.6	89.7	129.5
LMBRD1	"bA810I22.1, C6orf209, cblF, FLJ11240"	ENSG00000168216	"LMBR1 domain containing 1"	Q9NUN5	6	69672757-69867236	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Endocytosis, Gastrulation, Host-virus interaction, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 21.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016491, HPA019547"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA016491: , HPA019547: AB_2281256"	"unprognostic (1.44e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (7.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.68e-2)"	33.3	49.4	10.3	11.5	10.8	4.2	31.4	20.7	17.0	28.9	13.3	26.4	13.5	22.5	27.7	25.7	26.3	16.0	27.7	11.1	11.5	53.0	42.9	27.9	12.1	13.6	11.9	34.5	36.5	31.7	26.5	17.2	12.3	19.1	20.5	10.7	33.2	20.0	28.8	28.1	28.6	12.7	11.4	21.8	29.6	10.4	10.2	9.1	35.1	13.1	16.8	30.1	29.4	16.1	3.8	3.8	6.0	10.2	16.5	23.7	17.9	2.2	7.1	2.6	5.6	4.8	8.2	6.5	9.2	8.8	5.8	7.5	3.8	9.8	2.4	16.3	11.9	6.2	4.9	7.8	13.7	3.4	8.7	7.6	9.6	0.8	5.7	19.1	7.4	5.5	9.4	6.1	6.0	8.1	2.5	4.7	4.6	8.5	4.8	0.3	15.4	37.8	17.0	13.8	5.5	8.5	0.9	7.0	13.3	3.0	4.6	25.3	1.1	3.9	4.6	4.3	2.8	8.8	5.5	2.8	2.3	4.0	12.3	6.5	2.2	3.9	2.0	2.5	2.5	12.1	2.9	1.9	1.7	21.0	3.1	2.3	11.4	2.6	4.8	2.2	3.7	2.1	10.3	10.8	20.7	17.0	11.1	11.5	13.6	11.9	12.3	11.4	10.2	16.1	49.7	64.1	38.3	82.3	93.4	29.1	41.9	45.2	71.2	73.7	39.2	25.4	40.6	50.1	56.0	58.8	110.5	69.6	36.2	79.0	19.6	49.0	28.8	48.3	22.7	41.1	18.7	18.5	119.2	49.6	59.2	56.1	36.7	61.7	40.5	15.7	44.6	60.5	42.1	55.5	144.6	37.6	44.7	66.9	36.3	9.3	35.4	52.0	32.0	79.6	49.3	56.3	28.8	122.2	156.6	42.0	51.0	33.8	82.7	19.6	78.7	64.1	65.5	90.8	26.3	36.4	33.9	22.5	16.9	43.4	38.1	77.4	43.2	26.9	31.7	34.2
LNPK	"KIAA1715, LNP, LNP1, Ul"	ENSG00000144320	"Lunapark, ER junction formation factor"	Q9C0E8	2	175923882-176002839	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 19.3;Endometrial stromal cells: 24.6;Hofbauer cells: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-138 MG: 159.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014205	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA		15000	"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"	Nucleoplasm	"HPA014205: AB_2234186"	"unprognostic (4.93e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.35e-3)"	"unprognostic (3.43e-2)"	13.5	8.9	6.3	7.7	10.1	30.1	9.8	10.2	8.7	12.0	4.2	12.0	7.6	8.6	6.2	13.1	6.3	7.7	12.2	7.6	13.2	8.2	14.4	6.7	7.2	11.3	9.2	10.7	5.5	15.6	6.0	6.1	14.1	10.1	10.2	24.1	6.4	8.2	34.1	12.1	7.5	9.6	11.3	5.9	7.8	24.5	9.3	14.0	8.8	26.8	7.9	7.6	9.2	19.0	24.5	12.3	28.3	40.1	58.5	36.1	14.3	70.8	33.7	32.2	45.1	17.0	28.2	24.4	39.4	31.5	42.3	26.5	26.9	18.9	44.6	37.5	27.4	27.6	14.8	15.2	13.8	47.2	32.9	29.9	17.5	31.4	15.4	26.4	6.0	19.3	28.9	31.5	44.9	16.0	31.4	18.8	9.2	24.9	23.4	31.3	28.6	18.0	13.6	22.2	32.6	32.9	31.3	17.5	24.1	26.6	26.2	15.4	9.2	159.0	23.6	53.9	33.7	18.5	36.6	20.3	49.4	15.2	30.4	3.7	4.2	7.9	4.9	4.8	5.8	4.3	4.2	5.4	3.9	3.3	4.2	6.7	3.4	6.5	4.5	4.4	7.8	3.4	6.3	10.1	10.2	8.7	7.6	13.2	11.3	9.2	14.1	11.3	9.3	19.0	10.8	19.2	13.6	0.0	4.4	0.0	0.0	0.0	0.0	0.0	19.3	15.0	0.0	0.0	6.2	16.5	0.0	5.7	14.5	0.0	5.9	14.0	0.0	10.1	24.6	3.5	0.0	0.0	0.0	9.6	17.3	12.8	0.0	12.7	11.4	10.6	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	3.3	0.0	0.0	9.1	8.7	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	8.3	7.2	12.0	0.0	0.0
LONP1	"hLON, LonHS, PIM1, PRSS15"	ENSG00000196365	"Lon peptidase 1, mitochondrial"	P36776	19	5691834-5720572	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Hydrolase, Protease, Serine protease"	"Cataract, Deafness, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 196.2"	"Cell type enhanced"	"Detected in all"		"Theca cells: 85.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002034, HPA002192"	Supported		Enhanced	Nucleoplasm,Mitochondria		No	No		7900	"Cluster 6: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA002034: AB_2756304, HPA002192: AB_1079695"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.66e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	30.4	196.2	31.5	22.2	32.7	23.7	27.2	34.6	42.8	24.4	39.9	27.9	22.6	25.2	14.1	27.7	22.6	15.4	76.0	30.8	35.7	43.2	79.1	25.6	24.1	37.6	35.8	26.6	38.2	35.2	41.5	18.5	37.9	26.4	13.2	13.0	30.8	16.6	69.3	28.9	25.5	14.7	30.8	29.5	33.7	24.2	37.2	17.5	34.6	40.7	14.5	28.2	22.4	33.0	108.4	111.0	35.6	114.0	41.4	29.2	110.4	67.2	52.7	71.0	86.0	96.3	37.7	134.3	91.4	70.6	68.0	45.0	92.1	81.1	34.2	80.0	78.0	74.5	97.5	127.6	190.4	169.7	74.9	55.0	114.6	67.5	132.6	34.1	57.5	183.9	200.9	259.4	33.0	71.8	85.5	101.6	127.6	43.6	143.1	89.4	50.9	146.6	39.3	63.9	94.2	94.1	59.4	85.2	242.2	24.9	50.3	211.9	41.2	36.0	39.2	100.7	99.2	272.3	182.6	121.4	161.7	185.0	66.2	4.5	2.4	0.5	3.4	3.7	2.3	4.0	3.1	3.4	2.6	3.7	3.8	2.6	0.3	2.7	1.5	3.9	2.7	1.7	31.5	32.7	34.6	42.8	30.8	35.7	37.6	35.8	37.9	30.8	37.2	33.0	12.6	6.4	13.1	18.3	14.1	8.3	11.1	14.9	11.4	26.9	14.2	12.7	19.8	15.7	14.3	27.6	6.2	28.8	8.4	40.1	46.9	33.9	6.5	24.0	16.3	15.3	11.4	17.1	13.5	28.0	31.9	13.3	29.6	25.6	5.7	51.1	11.4	47.0	30.8	21.9	17.4	26.4	22.4	14.6	8.6	6.3	12.8	16.4	14.2	9.4	17.8	24.9	8.2	10.6	15.7	26.0	16.8	17.3	17.6	16.8	27.5	50.2	17.0	26.5	19.7	17.9	24.7	12.0	14.4	11.0	10.7	35.0	10.7	85.0	35.1	11.4
LOX		ENSG00000113083	"Lysyl oxidase"	P28300	5	122063195-122078413	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase	"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 27.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 67.1;Club cells: 38.4;Early spermatids: 41.9;Endometrial stromal cells: 34.0;Extravillous trophoblasts: 44.2;Fibroblasts: 79.1;Peritubular cells: 39.1;Smooth muscle cells: 32.7"	"Cancer enhanced"	"Detected in all"		"renal cancer: 39.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 777.3;fHDF/TERT166: 1790.7;HSkMC: 356.3;U-138 MG: 475.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA043930			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		550000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA043930: AB_2678736"	"unprognostic (5.10e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-3)"	"unprognostic (8.92e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (3.93e-8)"	"unprognostic (1.11e-3)"	"unprognostic (9.92e-2)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (3.32e-4)"	27.9	2.4	0.4	6.8	0.4	0.2	17.6	0.5	0.9	10.8	0.8	4.2	3.8	6.2	1.7	5.6	8.9	18.8	23.9	0.3	0.4	4.5	2.1	13.6	3.3	1.3	1.4	5.4	3.3	0.9	1.2	8.1	0.8	4.1	4.5	1.1	3.2	2.6	1.9	12.4	3.7	10.0	1.2	2.6	4.4	1.4	0.5	0.9	6.9	2.1	1.4	14.1	4.8	1.0	0.8	0.2	2.0	0.9	168.7	185.2	0.1	777.3	205.3	73.2	246.4	0.5	0.3	0.1	16.5	1790.7	3.7	0.2	4.5	3.5	196.4	0.1	2.0	0.0	16.3	9.3	203.4	0.4	0.1	356.3	4.4	137.6	7.4	329.3	95.3	0.1	0.0	0.1	83.6	0.0	0.1	0.3	6.4	0.1	1.9	0.1	7.4	0.9	4.9	0.5	0.5	4.2	72.1	0.1	12.9	29.8	0.6	0.6	6.8	475.5	23.2	272.8	9.3	0.0	0.1	0.2	207.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.5	0.9	0.3	0.4	1.3	1.4	0.8	1.2	0.5	1.0	20.0	9.6	1.1	0.0	0.2	7.8	1.9	67.1	0.0	0.6	1.3	1.1	2.1	0.0	38.4	0.0	0.0	0.8	0.1	0.0	0.0	7.2	41.9	8.4	34.0	9.4	0.0	0.0	0.3	0.6	44.2	79.1	0.0	6.6	0.0	0.1	10.8	0.5	2.2	1.7	2.0	0.0	2.0	0.8	21.6	5.0	14.0	1.3	5.4	1.9	0.6	0.0	0.0	0.0	0.0	1.3	0.0	39.1	0.3	2.8	0.0	0.1	8.3	1.7	19.7	1.1	32.7	0.8	0.6	1.8	10.7	4.8	1.1	0.4	0.1	0.9
LOXL3		ENSG00000115318	"Lysyl oxidase like 3"	P58215	2	74532258-74555690	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Inflammatory response"	Oxidoreductase	"Deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.0;Hofbauer cells: 17.9;Kupffer cells: 12.5;Macrophages: 12.3;Microglial cells: 30.0;Muller glia cells: 10.6;Oligodendrocyte precursor cells: 11.6;Sertoli cells: 19.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 15.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 11.7;non-classical monocyte: 9.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 143.4;HDLM-2: 110.7;U-138 MG: 245.9;WM-115: 549.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035281	Approved				"Secreted to extracellular matrix"	NA	NA		200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA035281: AB_10601766"	"unprognostic (7.54e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.34e-3)"	"unprognostic (4.55e-3)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.97e-8)"	"unprognostic (1.22e-2)"	"unprognostic (7.33e-3)"	"unprognostic (7.09e-2)"	"unprognostic (3.38e-2)"	6.8	5.3	4.5	7.8	4.7	14.3	3.0	4.5	5.3	5.1	3.8	7.3	4.0	7.4	1.7	3.2	4.9	6.5	8.2	4.5	5.6	2.0	1.5	4.6	4.1	7.0	5.0	2.9	1.1	1.7	2.7	15.9	6.3	3.3	3.7	4.9	1.6	4.0	1.3	2.0	3.9	8.1	5.6	8.9	2.7	2.6	7.0	1.4	2.2	1.5	2.3	5.2	4.0	7.3	1.6	0.3	21.8	3.7	17.1	20.6	4.5	71.0	143.4	33.8	31.8	25.6	1.3	0.1	0.9	73.1	1.6	1.1	2.8	1.8	19.8	110.7	1.0	17.6	1.8	0.2	5.7	0.6	16.7	22.6	0.2	90.6	3.8	12.0	0.7	0.8	0.8	2.8	6.4	4.1	0.2	6.5	12.0	0.8	0.7	2.0	3.1	0.3	0.3	1.2	11.2	12.8	0.6	1.1	14.7	3.2	2.3	1.3	0.3	245.9	8.2	1.4	0.9	1.4	0.5	0.1	92.5	6.8	549.6	0.1	6.0	0.3	0.0	11.7	0.0	0.1	0.1	0.0	3.5	0.1	0.0	0.0	2.5	0.0	9.3	0.4	0.0	2.6	4.5	4.7	4.5	5.3	4.5	5.6	7.0	5.0	6.3	5.6	7.0	7.3	0.9	0.0	0.5	14.0	0.3	0.9	0.2	0.6	0.6	0.9	0.4	0.8	0.3	1.5	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.8	0.0	0.2	4.8	1.2	0.0	0.4	0.4	0.0	1.5	7.1	0.0	0.5	1.3	0.7	0.4	0.1	17.9	1.7	4.2	0.1	0.0	12.5	2.5	0.7	5.0	12.3	0.0	30.0	4.8	10.6	1.0	11.6	0.6	0.3	0.0	4.5	0.1	0.3	0.0	0.1	0.0	0.9	19.7	1.6	5.3	0.6	0.8	0.1	0.1	0.8	0.4	0.2	0.0	0.2
LPAR6	"P2RY5, P2Y5"	ENSG00000139679	"Lysophosphatidic acid receptor 6"	P43657	13	48389567-48444704	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 266.1;Basal squamous epithelial cells: 327.2;Early spermatids: 334.0;Langerhans cells: 703.7;Late spermatids: 321.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 21.6;HUVEC TERT2: 35.3;MOLT-4: 20.0"	"Low region specificity"	"Detected in all"							HPA028934	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"			"HPA028934: AB_2672833"	"unprognostic (1.19e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.82e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.57e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (6.22e-4)"	"unprognostic (1.07e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (6.54e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.94e-2)"	41.0	26.5	14.5	26.8	14.7	6.1	43.0	15.2	27.1	41.9	18.3	22.1	15.0	28.7	39.5	81.8	22.2	35.5	24.9	14.0	15.8	26.2	23.2	34.6	45.6	19.0	16.4	14.9	8.7	9.7	15.9	77.7	18.0	60.7	27.6	5.8	59.7	32.2	9.0	33.9	21.7	27.1	18.2	40.2	21.6	8.1	16.7	36.4	24.3	20.8	41.1	40.8	75.1	21.0	0.1	2.1	21.6	0.1	7.0	8.6	0.2	4.5	12.7	0.9	2.5	0.0	6.4	0.0	0.1	4.9	0.0	12.7	0.6	7.2	0.4	0.0	4.3	0.2	0.2	15.9	4.6	0.1	0.1	11.5	12.4	0.5	7.0	0.0	35.3	7.0	0.0	0.3	4.2	0.0	20.0	6.3	8.6	0.4	5.9	16.9	0.0	0.2	5.9	13.1	0.0	0.1	0.0	0.1	4.5	13.2	2.2	0.1	9.1	2.4	0.0	0.2	1.1	0.0	0.0	0.0	0.7	1.1	7.8	1.3	71.9	0.3	24.6	112.0	13.6	1.2	70.0	29.4	26.0	0.5	49.3	15.6	5.9	6.9	103.6	1.1	83.9	58.2	14.5	14.7	15.2	27.1	14.0	15.8	19.0	16.4	18.0	18.2	16.7	21.0	266.1	3.2	9.7	4.9	5.8	120.6	196.3	155.7	327.2	1.7	30.5	30.5	5.8	17.2	76.2	5.5	0.0	0.8	22.2	4.9	0.0	10.4	334.0	10.1	20.7	140.1	21.4	8.8	1.8	4.1	0.8	23.6	16.8	12.8	7.6	5.8	136.0	2.9	82.9	0.0	1.8	4.9	42.7	74.0	703.7	321.7	22.7	111.9	49.8	177.1	76.4	11.3	18.6	5.0	2.0	6.7	4.1	15.8	6.3	107.1	3.0	25.5	49.4	1.5	13.1	5.4	13.3	2.5	1.7	182.7	142.9	0.8	52.3	14.0	9.6	143.5
LPIN1	KIAA0188	ENSG00000134324	"Lipin 1"	Q14693	2	11677595-11827409	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 193.5;tongue: 137.2"	"Cell type enriched"	"Detected in all"	5	"Late spermatids: 1705.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024591, HPA038021"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Plasma membrane"	"HPA024591: , HPA038021: AB_10669514"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.02e-1)"	36.2	15.0	29.0	14.9	30.6	8.6	36.7	24.2	24.9	25.1	21.9	16.7	11.9	16.6	19.0	40.5	15.6	13.0	20.1	21.0	32.1	14.9	27.0	16.1	22.3	31.8	38.2	31.5	9.9	23.1	34.2	11.7	35.3	13.7	8.5	14.8	27.3	14.1	193.5	13.4	19.7	13.0	14.1	14.8	14.9	57.4	35.0	16.1	14.6	137.2	26.3	19.9	23.1	18.8	16.2	18.0	15.9	34.9	71.4	77.9	7.8	22.2	38.7	14.0	24.3	6.9	15.4	8.2	2.9	18.6	41.6	17.3	17.4	49.2	12.8	32.9	9.8	20.3	11.5	9.7	25.1	14.1	90.1	71.1	21.7	57.9	22.6	41.7	28.0	19.6	27.4	68.3	10.4	6.4	13.5	12.0	16.2	5.5	18.9	18.1	28.6	52.0	36.9	10.0	42.8	33.6	8.0	19.7	51.9	15.0	4.9	7.9	19.5	22.1	19.9	14.4	19.0	108.0	92.0	15.2	31.3	24.7	16.6	11.2	2.9	13.4	10.3	2.3	11.2	7.3	9.9	10.1	2.7	5.1	8.6	7.2	1.1	9.5	2.3	10.3	12.2	3.7	29.0	30.6	24.2	24.9	21.0	32.1	31.8	38.2	35.3	14.1	35.0	18.8	15.6	22.4	56.8	167.8	46.1	19.1	45.1	12.6	18.8	48.6	32.8	22.9	59.6	31.5	43.9	11.0	85.5	8.7	68.0	21.2	7.9	23.0	338.4	27.8	44.4	25.8	36.2	9.7	55.7	28.0	6.0	28.8	19.4	76.5	35.4	13.1	17.5	48.7	8.9	48.8	71.7	25.2	22.4	15.7	39.4	1705.8	119.0	25.5	17.8	21.5	15.4	14.7	66.9	41.7	43.5	36.5	29.7	179.8	76.0	34.9	5.4	4.8	52.0	49.0	32.9	32.4	18.4	20.6	19.7	5.5	11.9	12.3	73.2	26.6	16.3	31.3
LPIN2	KIAA0249	ENSG00000101577	"Lipin 2"	Q92539	18	2916994-3013144	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase	"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 165.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 154.4;Granulosa cells: 323.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"granulocytes: 23.4;NK-cells: 12.5;T-cells: 12.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015223, HPA017857, HPA030550"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Plasma membrane, Actin filaments"	"CAB015223: , HPA017857: AB_1852904, HPA030550: AB_2673519"	"unprognostic (7.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (8.01e-4)"	"unprognostic (9.85e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.15e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-2)"	9.7	9.3	17.9	21.2	19.9	19.8	9.8	14.6	17.4	9.7	16.6	13.9	62.8	9.8	6.7	10.0	9.5	25.7	7.2	16.1	24.2	26.4	165.8	21.2	24.3	22.7	22.0	13.2	16.4	13.5	10.9	15.7	24.2	9.0	12.5	10.7	7.4	8.0	2.7	3.6	39.9	9.6	15.6	20.3	28.1	22.0	28.8	18.9	12.1	3.0	19.2	9.9	6.0	14.3	8.7	12.0	17.1	6.6	31.7	27.4	10.5	17.4	22.8	18.9	16.9	16.7	7.1	5.4	10.8	30.2	30.2	0.2	13.8	6.3	13.2	11.2	2.7	13.3	10.0	19.4	27.2	11.2	17.0	27.4	4.6	18.5	17.2	28.2	23.4	14.8	12.8	3.5	28.2	7.2	15.0	12.0	5.7	13.7	13.1	26.7	14.0	23.2	17.6	20.0	14.4	10.2	18.4	9.1	6.8	10.7	0.0	18.0	31.2	25.3	28.7	31.7	14.6	5.0	7.9	12.3	22.1	12.2	8.1	8.7	2.4	7.8	11.8	1.5	12.1	1.0	9.2	7.2	1.0	1.7	9.1	6.3	23.4	12.5	0.8	1.5	9.2	3.2	17.9	19.9	14.6	17.4	16.1	24.2	22.7	22.0	24.2	15.6	28.8	14.3	17.7	67.3	44.0	55.2	20.4	5.6	9.8	8.5	5.7	35.7	12.1	11.2	11.2	154.4	23.9	38.6	14.6	25.2	41.9	45.3	17.6	11.8	3.3	48.2	33.3	18.9	14.9	138.1	26.3	19.0	11.3	25.4	103.0	64.4	12.6	323.0	19.2	131.1	23.1	116.1	65.6	36.8	16.2	26.8	8.9	11.0	22.7	31.1	8.8	79.6	31.2	16.7	59.8	37.7	21.0	22.2	21.6	31.2	16.1	21.2	92.4	54.9	17.1	16.7	6.6	16.6	20.1	26.5	73.0	0.6	2.0	49.5	58.9	20.3	14.0	14.1
LRAT	LCA14	ENSG00000121207	"Lecithin retinol acyltransferase"	O95237	4	154626945-154753120	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction, Vision"	"Acyltransferase, Transferase"	"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6"	"Cell type enriched"	"Detected in many"	6	"Granulosa cells: 104.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"NTERA-2: 15.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA070726			Uncertain	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	"Endoplasmic reticulum"	"HPA070726: "	"unprognostic (3.64e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-4)"	"unprognostic (4.49e-6)"	"unprognostic (6.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.98e-1)"	0.2	0.2	0.6	0.2	0.7	0.5	0.4	0.7	2.6	0.2	1.6	0.5	1.2	0.1	0.3	0.0	0.2	0.5	0.1	0.7	1.2	0.1	2.1	0.3	0.1	1.0	1.1	0.3	0.8	0.2	0.2	0.1	1.3	0.4	0.1	1.0	0.1	0.5	0.8	0.4	1.6	0.1	0.7	0.1	0.3	0.8	0.7	0.0	1.5	0.0	0.1	0.1	0.1	0.9	0.5	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.3	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	15.3	0.0	0.0	0.0	0.0	0.1	1.4	0.4	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.6	1.9	0.1	0.1	0.6	0.1	0.1	0.1	0.1	1.5	0.2	0.1	0.1	0.8	0.2	0.2	0.2	0.1	2.2	0.6	0.7	0.7	2.6	0.7	1.2	1.0	1.1	1.3	0.7	0.7	0.9	0.2	0.0	4.4	4.6	0.1	1.1	4.4	4.0	0.6	0.5	8.6	9.1	0.3	11.5	1.7	0.0	0.0	0.1	0.3	0.8	3.9	1.2	15.2	0.9	0.5	0.3	0.0	0.0	2.2	0.8	0.1	1.5	2.0	2.2	0.0	104.4	1.4	2.2	0.1	0.0	0.6	0.9	2.0	0.8	2.8	3.2	0.0	0.3	5.4	0.0	0.0	3.9	0.0	1.0	2.2	1.2	0.0	0.0	0.0	2.4	12.3	1.0	0.9	0.8	0.0	1.4	8.1	10.5	4.7	1.4	1.1	0.3	0.6	0.0	1.2	0.6
LRP1	"A2MR, APOER, APR, CD91, IGFBP-3R, IGFBP3R1, LRP, LRP1A"	ENSG00000123384	"LDL receptor related protein 1"	Q07954	12	57128483-57213361	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Endocytosis	"Developmental protein, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 109.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 273.4;Hepatocytes: 188.4;Leydig cells: 233.3;Peritubular cells: 184.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"classical monocyte: 4.3;intermediate monocyte: 2.2;myeloid DC: 1.6;non-classical monocyte: 2.4"	"Group enriched"	"Detected in many"	21	"dendritic cells: 1.6;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 484.8;ASC TERT1: 488.4;fHDF/TERT166: 222.2;HSkMC: 318.5;hTERT-RPE1: 248.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004182, CAB018621, HPA022903"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		180000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Nucleoplasm	"CAB018621: AB_627893, HPA004182: AB_2667163, HPA022903: AB_10602426"	"unprognostic (1.65e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.33e-2)"	"unprognostic (3.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (2.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (1.29e-5)"	109.2	14.1	21.3	29.0	36.3	8.2	40.0	30.2	19.7	32.3	8.0	24.1	23.2	36.9	6.2	19.3	30.3	31.5	35.5	16.7	21.9	5.7	35.0	34.0	4.9	46.0	31.5	71.0	10.7	7.8	10.2	39.8	27.9	13.8	11.2	9.9	20.3	20.2	13.0	20.4	18.4	28.9	27.1	13.6	15.1	7.3	48.9	5.6	17.6	23.5	2.7	25.5	29.3	27.6	7.7	14.5	30.4	24.2	484.8	488.4	91.2	85.3	109.0	27.5	26.7	26.9	12.4	0.4	10.4	222.2	6.0	33.6	5.3	8.7	9.7	0.7	1.3	0.4	17.9	56.4	66.5	0.5	14.6	318.5	3.1	61.8	7.2	248.7	1.7	1.1	0.4	1.3	87.2	1.7	0.2	0.4	34.8	11.0	8.8	3.2	171.0	1.6	1.9	2.2	1.4	16.4	19.0	0.6	13.2	42.0	2.9	1.2	1.2	96.0	35.0	53.9	5.2	1.1	0.1	0.2	167.4	0.1	18.7	0.0	4.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	1.6	21.3	36.3	30.2	19.7	16.7	21.9	46.0	31.5	27.9	27.1	48.9	27.6	24.6	12.8	8.4	113.6	3.2	24.0	11.9	28.7	19.9	29.2	4.9	19.3	14.8	15.7	14.7	1.8	0.0	87.5	1.1	81.7	0.0	7.4	1.9	9.7	111.4	13.0	4.2	0.8	39.3	1.8	53.0	273.4	49.5	4.2	6.3	36.9	11.0	188.4	73.8	8.4	41.6	14.1	6.1	145.3	28.6	8.4	233.3	102.9	28.4	89.9	48.8	154.7	1.0	173.4	6.6	14.7	27.2	184.3	4.4	5.5	86.0	2.1	15.1	7.3	39.5	129.7	77.0	1.6	2.4	35.4	16.1	125.9	4.2	11.4	25.0	12.3
LRP2	"DBS, gp330"	ENSG00000081479	"LDL receptor related protein 2"	P98164	2	169127109-169362534	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Hearing, Neurogenesis, Transport"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 70.5;kidney: 34.8;parathyroid gland: 44.7;retina: 29.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 87.6;Cytotrophoblasts: 63.2;Oligodendrocytes: 300.1;Proximal tubular cells: 283.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 29.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"AF22: 39.4;CACO-2: 64.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA005980, HPA064792"	Enhanced		Approved	Vesicles,Mitochondria		No	NA		74000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Mitochondria"		"HPA005980: AB_1079278, HPA064792: AB_2685353"	"unprognostic (1.87e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.38e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (1.37e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.62e-2)"	1.5	0.0	5.5	0.0	23.4	0.1	9.6	18.9	13.5	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.2	7.5	14.6	34.8	0.3	1.2	0.0	30.5	17.5	0.0	0.0	44.7	0.1	7.5	31.9	0.0	0.0	29.3	0.9	0.0	0.1	0.1	0.0	0.0	14.5	0.0	0.0	0.2	18.7	0.0	17.3	0.0	0.0	0.0	0.0	70.5	0.0	0.0	39.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	64.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	23.4	18.9	13.5	7.5	14.6	30.5	17.5	31.9	14.5	18.7	70.5	0.2	6.4	43.7	1.0	3.0	0.3	0.2	0.0	0.0	2.8	22.9	15.1	2.1	2.8	2.5	3.7	87.6	63.2	0.2	0.0	17.6	0.0	3.1	0.1	0.1	0.5	0.0	0.0	1.8	0.0	2.2	1.8	0.0	0.1	2.5	0.0	0.0	0.8	5.1	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	2.5	0.0	1.9	0.0	33.1	0.0	1.5	300.1	0.0	0.0	0.0	0.0	0.0	0.0	283.9	2.2	19.5	0.0	0.0	0.3	0.1	0.8	0.0	0.0	23.1	1.7	0.0	0.0	0.2
LRP4	"CLSS, LRP-4, MEGF7, SOST2"	ENSG00000134569	"LDL receptor related protein 4"	O75096	11	46856717-46918642	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Endocytosis, Wnt signaling pathway"	"Developmental protein, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 46.7;skin 1: 31.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 123.1;Cone photoreceptor cells: 41.7;Distal enterocytes: 31.1;Oligodendrocyte precursor cells: 137.2;Oligodendrocytes: 31.3"	"Group enriched"	"Detected in all"	4	"colorectal cancer: 12.2;endometrial cancer: 8.6;glioma: 13.2;testis cancer: 15.6;thyroid cancer: 28.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 21.3;SuSa: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011934, HPA012300"	Approved		Uncertain	Nucleoplasm,Nucleoli,Mitochondria		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA011934: AB_1853286, HPA012300: AB_1853288"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.39e-2)"	"unprognostic (9.73e-3)"	"unprognostic (5.29e-4)"	"unprognostic (8.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.59e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.90e-3)"	"unprognostic (6.79e-2)"	0.7	1.4	23.3	0.9	30.5	0.0	1.5	19.1	21.3	2.3	0.0	4.8	3.4	1.6	0.9	1.8	1.4	2.0	6.9	24.2	16.0	0.7	0.2	2.9	0.1	46.7	23.0	4.6	2.2	5.6	2.6	2.6	19.8	2.1	3.4	7.9	1.7	2.3	4.4	31.6	4.9	1.5	21.3	3.9	7.8	1.1	30.9	1.5	2.4	7.7	0.3	0.9	1.4	25.6	0.1	9.6	21.3	6.5	13.4	3.7	4.9	1.0	1.9	2.8	3.2	2.8	0.0	0.0	1.4	11.4	3.1	3.9	12.0	7.5	2.2	0.0	10.3	1.0	3.8	6.8	2.8	0.1	1.9	4.5	4.2	4.4	1.1	2.5	2.5	2.6	0.9	0.0	1.6	0.8	0.2	0.3	11.9	0.0	0.9	1.6	7.3	0.0	0.3	2.8	0.1	14.2	1.2	0.0	3.4	16.2	0.3	0.5	0.2	5.7	3.5	6.5	2.1	0.0	0.0	0.4	4.3	0.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	30.5	19.1	21.3	24.2	16.0	46.7	23.0	19.8	21.3	30.9	25.6	0.2	0.0	1.9	123.1	0.0	8.2	2.7	2.4	10.8	0.5	0.3	1.9	6.2	0.0	1.9	1.8	41.7	2.6	0.0	31.1	1.9	0.0	0.5	1.0	4.7	1.0	0.0	0.0	19.7	0.4	0.4	5.0	3.1	4.4	5.1	1.6	1.8	0.4	0.2	0.0	18.6	2.8	0.0	0.0	0.4	0.0	1.8	0.2	1.8	15.0	0.6	9.3	0.0	137.2	31.3	0.3	3.0	1.2	0.0	1.0	8.0	0.3	1.1	2.7	0.0	12.4	0.9	0.2	0.8	2.3	10.9	1.4	0.2	8.4	3.3	0.8
LRRC8A	"FLJ10337, KIAA1437, LRRC8, SWELL1"	ENSG00000136802	"Leucine rich repeat containing 8 VRAC subunit A"	Q8IWT6	9	128882133-128918039	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 192.0;Prostatic glandular cells: 207.0;Urothelial cells: 328.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 163.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"				"unprognostic (6.33e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.38e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.80e-2)"	"prognostic unfavorable (3.83e-4)"	"unprognostic (3.53e-1)"	"prognostic favorable (5.27e-5)"	"unprognostic (3.69e-1)"	"unprognostic (8.77e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.02e-2)"	31.4	17.4	68.2	16.2	69.4	17.3	27.3	69.4	77.1	30.8	44.6	31.4	9.7	36.3	7.3	71.7	23.5	23.3	32.0	57.2	67.9	18.2	28.9	42.4	9.3	76.7	77.2	18.8	21.2	32.4	13.7	23.1	67.9	29.3	8.5	13.4	28.1	25.5	13.9	35.2	17.3	29.1	63.9	16.2	25.0	11.8	82.6	9.9	25.6	18.4	10.1	32.7	44.2	52.4	35.1	54.2	32.0	27.5	73.6	28.3	40.4	39.8	26.2	24.1	17.1	24.1	73.2	12.8	43.6	43.3	30.1	163.8	19.9	87.5	11.3	13.1	16.4	11.5	33.4	29.2	49.8	13.8	20.3	22.1	60.9	42.7	50.8	48.6	84.1	17.5	25.8	12.4	31.8	30.3	15.6	13.2	95.9	58.3	58.4	21.4	37.0	20.6	37.9	17.3	19.2	39.9	44.4	27.3	15.8	23.9	19.9	10.2	149.4	69.9	30.2	29.9	58.8	14.4	36.5	15.5	38.7	10.3	41.3	0.7	0.7	1.9	3.9	1.1	1.8	1.2	1.9	2.5	1.0	0.9	1.9	1.8	1.4	3.5	0.3	1.6	3.5	1.0	68.2	69.4	69.4	77.1	57.2	67.9	76.7	77.2	67.9	63.9	82.6	52.4	98.8	16.0	15.6	57.1	7.5	105.7	192.0	91.6	113.3	13.1	38.3	29.2	31.3	17.2	73.6	7.3	6.2	13.8	17.4	31.9	0.0	28.9	6.9	22.0	50.5	57.4	16.1	13.7	11.8	21.2	17.6	27.5	24.5	47.0	6.3	35.1	55.6	16.5	6.1	25.2	14.2	28.7	24.4	5.0	17.4	4.5	23.0	9.9	26.6	12.2	5.1	41.3	36.0	8.5	9.7	78.1	23.0	44.4	13.5	207.0	10.9	8.1	33.2	10.2	65.7	38.2	35.2	3.2	8.6	91.6	145.1	20.8	15.5	9.6	14.5	328.5
LRRK2	"DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2"	ENSG00000188906	"Leucine rich repeat kinase 2"	Q5S007	12	40196744-40369285	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Differentiation"	"GTPase activation, Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lung: 52.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 502.2;Excitatory neurons: 92.0;monocytes: 133.1;Oligodendrocyte precursor cells: 256.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 17.1;thyroid cancer: 22.7"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	8	"neutrophil: 58.2"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 58.2"	"Cell line enhanced"	"Detected in some"		"A549: 4.6;ASC TERT1: 5.6;BJ hTERT+: 3.2;RPTEC TERT1: 7.8;T-47d: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014293, CAB037160"	Approved		Supported	Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"CAB037160: AB_1840989, HPA014293: AB_1853353"	"unprognostic (2.67e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.10e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.02e-6)"	"unprognostic (2.55e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.01e-3)"	"unprognostic (5.21e-3)"	4.8	3.1	1.1	10.1	1.9	9.0	2.6	0.9	2.1	5.1	1.2	4.3	0.6	4.8	1.9	7.0	4.1	6.2	3.9	1.3	1.1	10.9	5.6	52.4	6.8	1.7	1.1	5.4	3.6	8.4	2.1	1.2	1.4	2.6	1.8	1.5	3.5	2.0	5.5	2.1	3.6	4.0	1.1	10.8	2.1	0.8	1.2	2.5	2.9	7.9	5.4	4.5	5.5	1.9	0.0	4.6	0.0	0.0	2.3	5.6	0.0	1.3	3.2	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.1	0.0	0.6	0.4	0.0	2.1	0.4	0.0	0.0	2.5	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.3	0.0	0.5	2.7	0.1	3.1	1.5	1.0	0.4	0.5	0.6	0.4	0.0	0.0	0.0	1.3	0.0	1.7	0.0	7.2	2.2	0.0	5.2	0.0	1.8	0.0	0.0	2.1	1.7	0.0	0.0	58.2	0.0	6.9	0.3	0.0	1.3	1.1	1.9	0.9	2.1	1.3	1.1	1.7	1.1	1.4	1.1	1.2	1.9	7.4	32.1	502.2	17.3	29.9	2.4	1.8	0.4	2.8	8.6	1.3	1.4	7.8	5.7	17.3	27.6	0.0	0.0	1.9	0.0	1.9	1.3	0.5	0.4	2.6	7.0	0.0	2.1	92.0	2.7	0.1	16.1	0.5	0.4	13.9	2.7	13.2	8.2	4.6	47.1	28.0	0.0	0.0	55.8	8.7	1.2	19.0	52.2	12.4	73.1	133.1	8.6	3.1	256.9	3.1	0.8	1.1	12.0	2.8	0.6	0.0	22.5	3.4	1.0	0.0	22.5	4.8	0.3	1.0	12.6	3.1	0.4	3.4	11.2	0.0	0.7
LRSAM1	"CMT2P, FLJ31641, RIFLE, TAL"	ENSG00000148356	"Leucine rich repeat and sterile alpha motif containing 1"	Q6UWE0	9	127451489-127503499	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.0;Excitatory neurons: 28.6;Inhibitory neurons: 26.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021403, HPA021844, CAB037304"	Supported		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB037304: AB_2138198, HPA021403: AB_1853366, HPA021844: AB_1853368"	"unprognostic (8.83e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.48e-3)"	"unprognostic (4.15e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.72e-2)"	"prognostic favorable (6.78e-6)"	"unprognostic (1.27e-1)"	"prognostic favorable (5.72e-4)"	"unprognostic (1.94e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.33e-2)"	7.2	9.8	8.6	3.4	8.6	2.0	7.3	7.3	12.5	10.7	5.2	16.5	3.4	9.0	5.9	8.7	7.8	3.9	17.3	8.8	8.8	9.0	8.8	7.4	4.5	11.1	7.6	10.7	5.7	6.9	9.0	3.4	11.4	9.1	2.6	2.3	7.5	5.6	13.5	21.2	9.1	5.0	7.0	9.5	9.5	4.3	7.9	3.4	8.8	7.2	3.2	12.3	10.2	9.0	5.7	10.8	4.8	10.7	9.8	9.1	8.3	5.3	8.1	10.0	7.6	8.9	5.9	9.8	5.9	9.9	3.6	18.7	7.8	13.3	3.8	11.5	5.3	5.2	9.0	10.2	9.4	6.2	7.3	6.1	7.9	6.1	12.2	10.7	11.2	7.6	4.8	7.6	4.5	17.6	3.9	4.5	4.7	17.4	9.3	7.1	5.6	18.4	11.5	5.1	9.8	9.2	4.1	12.6	8.8	4.3	26.5	3.2	10.2	4.6	5.6	4.2	2.5	6.2	7.9	1.1	9.1	4.5	2.6	18.5	4.8	21.3	3.7	6.5	4.7	3.7	2.8	3.5	6.1	2.7	1.1	1.4	4.0	1.3	6.8	3.6	2.3	3.8	8.6	8.6	7.3	12.5	8.8	8.8	11.1	7.6	11.4	7.0	7.9	9.0	5.3	9.6	3.9	32.0	5.1	1.1	3.1	2.9	4.6	6.7	5.2	5.0	20.4	4.3	7.3	0.0	6.2	5.0	5.3	6.0	5.9	7.1	0.6	3.6	4.7	4.8	1.2	2.5	28.6	1.4	2.1	4.9	12.2	4.6	9.5	6.6	3.3	7.1	6.3	11.8	26.9	5.8	14.2	5.6	3.7	1.2	2.8	7.4	3.6	10.3	7.4	4.7	3.1	18.1	21.0	4.7	5.0	5.3	3.9	5.0	6.6	5.8	6.0	5.2	0.0	5.1	6.0	5.7	3.6	5.8	2.7	7.0	5.6	3.9	4.8	3.3
LSS	OSC	ENSG00000160285	"Lanosterol synthase"	P48449	21	46188141-46228824	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Isomerase	"Cataract, Disease variant, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 132.0;Oligodendrocytes: 158.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 234.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032060, HPA032062, CAB034116"	Supported					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 15: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB034116: AB_2138611, HPA032060: AB_10671085, HPA032062: AB_2674134"	"unprognostic (2.78e-3)"	"unprognostic (8.53e-3)"	"unprognostic (6.95e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.34e-2)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (3.07e-4)"	29.3	38.9	20.0	10.8	30.8	5.7	22.3	38.9	33.5	20.8	7.1	22.9	28.5	26.6	12.1	39.7	18.0	9.0	25.1	15.7	26.2	10.7	54.8	24.1	9.4	62.3	40.7	30.3	19.4	12.2	25.9	8.0	65.7	24.0	10.7	6.8	16.1	12.4	29.0	27.6	17.4	12.2	28.4	7.6	23.3	17.5	40.4	12.3	10.2	19.5	8.0	20.2	19.6	58.7	70.4	22.2	70.9	30.6	94.1	90.6	20.3	26.8	186.4	32.1	62.7	73.9	54.4	15.4	22.3	51.7	234.6	32.7	63.2	110.9	12.9	14.9	34.5	37.7	38.6	48.3	85.5	13.7	25.1	89.0	41.4	59.7	25.6	22.2	26.9	72.1	37.4	87.3	27.8	23.8	29.9	19.7	115.4	11.3	20.1	34.9	21.9	92.2	82.8	38.1	41.4	36.7	31.4	24.0	27.5	30.6	38.0	33.7	40.8	37.9	30.2	33.8	21.1	31.8	29.5	30.6	39.7	59.4	16.6	4.6	2.1	2.2	4.0	1.8	2.8	3.1	2.9	4.9	2.4	1.5	2.4	3.6	0.0	1.7	1.5	5.0	1.4	3.6	20.0	30.8	38.9	33.5	15.7	26.2	62.3	40.7	65.7	28.4	40.4	58.7	13.8	12.8	36.8	66.6	7.2	37.0	3.8	30.2	8.0	16.0	15.3	8.0	13.7	14.3	18.7	11.0	4.2	3.7	11.8	10.4	0.0	10.5	6.5	6.6	16.4	10.3	19.7	16.8	21.2	17.2	6.7	19.7	13.3	14.6	3.8	20.6	11.4	132.0	9.7	23.5	24.2	11.6	16.2	7.5	13.7	6.6	21.1	4.9	21.4	21.5	12.0	7.5	5.2	22.1	158.8	14.0	2.7	13.5	6.3	16.2	5.0	4.1	11.0	16.4	0.0	9.8	8.5	20.3	18.1	12.6	54.0	6.3	7.9	18.0	10.9	4.6
LTC4S	MGC33147	ENSG00000213316	"Leukotriene C4 synthase"	Q16873	5	179793980-179796647	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Leukotriene biosynthesis, Lipid biosynthesis, Lipid metabolism"	"Lyase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"granulocytes: 327.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 20.2;eosinophil: 63.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 63.1"	"Cell line enriched"	"Detected in some"	11	"HMC-1: 102.0"					"Low region specificity"	"Detected in many"			HPA044688			Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Endoplasmic reticulum, Cytosol"	"HPA044688: "	"unprognostic (8.94e-2)"	"unprognostic (2.40e-2)"			"unprognostic (9.35e-3)"		"unprognostic (3.57e-2)"	"unprognostic (1.24e-2)"		"unprognostic (9.40e-2)"	"unprognostic (4.53e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.62e-1)"	8.9	6.9	1.1	0.5	0.8	2.3	5.5	1.5	1.3	4.2	0.7	3.3	0.7	5.7	0.0	3.1	11.8	0.3	12.4	1.0	1.4	7.1	1.9	7.7	0.2	2.1	1.5	5.7	2.0	0.2	3.5	0.4	1.4	4.8	0.2	0.0	4.3	0.8	1.0	3.1	3.2	0.4	2.9	6.1	3.0	1.5	2.6	0.0	5.9	0.0	0.1	4.8	4.0	4.7	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.9	8.9	0.2	0.4	0.3	0.6	102.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.1	6.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	3.2	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	1.0	0.1	20.2	0.5	63.1	0.8	0.6	3.0	0.3	2.1	1.5	8.6	0.2	0.4	1.0	0.3	4.7	0.0	0.4	0.2	0.6	1.1	0.8	1.5	1.3	1.0	1.4	2.1	1.5	1.4	2.9	2.6	4.7	32.3	0.0	3.2	2.9	2.3	9.9	9.6	11.2	14.8	0.4	26.4	38.6	0.0	14.3	6.2	14.7	0.0	10.4	5.0	0.6	1.9	5.9	0.3	4.0	1.5	49.5	3.0	2.1	0.8	2.4	1.9	8.3	3.1	5.6	327.4	0.5	72.1	0.9	41.5	0.0	0.7	1.7	0.0	20.8	46.3	0.9	16.4	53.9	1.8	28.1	2.0	0.1	2.1	1.0	1.5	1.9	0.5	47.4	10.0	3.7	2.2	54.8	5.8	0.5	0.0	0.8	1.6	0.1	0.7	5.2	7.0	3.0	10.0	1.5	3.1	10.0
LTK	TYK1	ENSG00000062524	"Leukocyte receptor tyrosine kinase"	P29376	15	41503637-41513887	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.2;lung: 15.1;salivary gland: 11.8"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 25.3;Gastric mucus-secreting cells: 18.8;Hepatic stellate cells: 11.4;Intestinal goblet cells: 7.9;Proximal enterocytes: 15.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"MAIT T-cell: 5.7;plasmacytoid DC: 5.0"	"Group enriched"	"Detected in many"	10	"dendritic cells: 5.0;T-cells: 5.7"	"Cell line enhanced"	"Detected in some"		"HEL: 5.0;NB-4: 9.7;RH-30: 4.6;THP-1: 14.7"	"Low region specificity"	"Detected in many"							HPA059545			Approved	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA059545: AB_2684057"	"unprognostic (9.47e-4)"	"unprognostic (5.52e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.12e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.74e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.81e-3)"	"unprognostic (9.36e-3)"	"unprognostic (5.36e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	0.8	0.6	1.0	1.4	1.6	4.6	0.5	1.2	1.8	0.9	0.6	5.2	12.5	0.2	0.0	0.3	0.4	2.4	1.7	1.3	0.7	4.0	2.9	15.1	1.2	0.6	0.6	0.1	0.3	0.6	0.7	10.4	0.7	0.4	5.7	0.1	11.8	0.3	1.8	1.4	13.2	0.3	0.6	5.5	9.9	2.5	0.8	0.4	0.7	0.0	2.1	0.7	0.7	0.9	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.1	0.6	0.8	1.2	2.2	0.0	0.0	0.0	0.6	0.0	0.0	2.6	0.0	0.4	0.2	1.3	5.0	0.1	0.0	2.0	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.0	1.9	0.0	1.8	0.0	0.0	9.7	0.4	1.8	0.2	0.2	4.6	0.1	0.0	0.0	0.4	2.9	0.1	0.2	0.0	2.6	0.2	14.7	0.0	0.0	0.2	0.1	0.0	0.3	0.2	0.2	0.0	0.5	0.8	0.0	0.0	0.0	0.4	0.0	5.7	0.5	0.3	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.1	1.0	1.6	1.2	1.8	1.3	0.7	0.6	0.6	0.7	0.6	0.8	0.9	0.3	0.0	0.0	0.3	1.6	0.1	0.0	0.4	0.0	0.0	0.2	0.1	0.8	2.8	0.9	0.0	0.0	0.3	5.5	25.3	0.0	0.0	2.8	0.1	0.4	1.8	1.8	3.2	2.9	0.2	1.5	0.2	18.8	0.2	0.0	0.3	11.4	0.5	0.1	0.0	0.2	7.9	0.0	1.9	0.6	2.1	0.0	0.4	3.6	0.0	0.4	0.0	1.0	0.5	0.4	0.7	5.5	0.0	2.7	0.0	15.3	0.0	5.6	0.0	0.0	0.3	0.5	2.2	1.2	0.0	0.1	0.4	4.0	0.0	3.8	0.0
LYN	JTK8	ENSG00000254087	"LYN proto-oncogene, Src family tyrosine kinase"	P07948	8	55879835-56014169	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 73.8;lymphoid tissue: 85.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 237.5;Kupffer cells: 183.7;Macrophages: 226.0;monocytes: 182.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 64.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 198.4;HMC-1: 193.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001231, CAB004492"	Enhanced		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		770000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus, Plasma membrane"	Vesicles	"CAB004492: AB_627897, HPA001231: AB_1079286"	"unprognostic (7.87e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.74e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	17.2	7.3	3.9	79.2	4.0	73.8	9.2	7.4	8.7	11.0	7.8	14.2	36.3	6.2	4.8	8.6	10.0	23.5	5.4	4.4	5.5	5.9	14.9	28.2	49.2	9.4	7.2	3.6	9.5	6.3	4.8	23.5	8.3	5.6	13.3	8.9	17.0	9.7	1.6	3.7	31.6	14.2	7.2	85.4	13.3	3.1	9.0	10.4	10.6	4.4	53.1	29.7	5.7	11.2	47.2	24.6	6.9	0.7	0.5	0.0	43.6	34.6	54.7	21.0	15.7	18.0	15.5	41.2	15.0	12.1	15.3	19.3	22.2	23.8	14.6	70.0	19.8	198.4	6.9	5.5	4.0	20.6	193.4	0.8	7.8	0.6	13.6	13.1	27.2	0.0	98.3	90.2	3.0	3.3	0.1	21.5	38.6	72.9	2.1	3.3	9.6	5.0	9.8	24.9	4.5	74.8	17.3	0.1	7.5	44.9	3.4	41.4	33.1	0.0	10.0	0.1	15.0	26.4	13.2	102.4	1.5	38.8	1.7	4.5	12.2	22.7	1.6	28.3	1.3	15.9	0.3	0.6	10.3	16.1	0.2	0.7	64.4	4.3	49.1	16.2	0.0	5.0	3.9	4.0	7.4	8.7	4.4	5.5	9.4	7.2	8.3	7.2	9.0	11.2	21.0	35.3	37.5	27.7	237.5	5.4	23.8	32.4	4.6	6.3	10.3	7.0	2.2	18.6	44.5	9.2	2.1	2.9	130.0	14.5	0.0	21.8	0.9	14.6	26.2	28.1	6.0	40.4	1.1	53.0	65.2	13.6	18.8	15.9	72.8	0.5	22.9	13.2	126.6	0.0	2.5	14.1	14.2	183.7	96.1	2.4	3.4	226.0	5.4	92.8	182.6	54.3	94.7	13.0	1.7	40.7	13.3	1.2	58.9	62.9	26.0	2.1	40.9	2.6	19.7	3.7	6.4	1.2	2.1	4.9	5.8	38.7	25.0	62.5	17.1	82.4
LYZ		ENSG00000090382	Lysozyme	P61626	12	69348381-69354234	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase"	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 10588.1;salivary gland: 21115.5;stomach 1: 8941.1"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 3106.1;Kupffer cells: 2841.2;Langerhans cells: 4859.1;Macrophages: 4870.7;monocytes: 7063.0;Pancreatic endocrine cells: 3152.5"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 976.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 25266.2;myeloid DC: 14438.7"	"Group enriched"	"Detected in all"	20	"dendritic cells: 14438.7;monocytes: 25266.2"	"Cell line enriched"	"Detected in many"	13	"OE19: 12130.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000055, HPA048284, HPA066182"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	NA	NA	1500000000	1500000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Actin filaments"	Nucleoplasm	"CAB000055: AB_2341230, HPA048284: AB_2680339, HPA066182: AB_2732741"	"unprognostic (8.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (7.45e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.62e-2)"	95.8	27.8	3.5	802.1	4.0	10588.1	128.2	3.7	18.5	156.2	11.4	309.0	3605.0	65.7	4.2	106.3	33.9	1054.6	34.8	2.6	4.3	32.4	138.0	1355.2	739.7	8.0	7.3	20.4	63.1	13.8	7.2	91.3	12.2	40.2	273.8	4.4	21115.5	21.8	34.0	58.7	1322.2	123.9	5.4	621.0	8941.1	21.8	10.9	321.8	27.8	36.4	652.8	428.5	16.2	11.7	0.6	0.1	0.0	0.2	0.0	0.0	4.8	0.0	0.0	0.0	0.3	9.5	6.5	4.2	1.5	0.0	3.6	1.2	0.0	0.0	0.2	1.2	0.1	62.4	1.0	960.4	0.0	110.6	50.5	0.0	0.1	0.0	0.0	0.2	0.0	0.3	7.7	0.3	0.0	0.2	2.6	109.5	2.3	12130.8	0.2	1.6	1.4	16.7	0.3	0.5	0.8	3.6	0.5	0.1	0.5	0.7	0.0	489.0	0.6	0.0	2.6	2.3	0.9	2.6	1.1	1.2	0.1	518.5	0.0	443.4	25266.2	298.2	32.6	4798.4	52.3	100.5	20.1	22.7	14438.7	20.8	20.0	17.8	1007.7	108.1	880.1	301.2	31.1	25392.1	3.5	4.0	3.7	18.5	2.6	4.3	8.0	7.3	12.2	5.4	10.9	11.7	24.0	86.6	285.8	0.0	80.8	57.2	1.7	1.2	1.2	0.3	1205.7	32.3	0.2	734.9	51.1	27.6	0.0	5.6	39.6	32.1	0.0	55.1	1.9	2.6	1.9	25.1	12.5	264.6	0.2	547.3	9.4	26.8	3106.1	2.9	123.6	0.5	29.6	25.4	887.1	0.0	0.2	112.4	0.0	2841.2	4859.1	17.4	4.1	4870.7	53.4	0.0	7063.0	0.1	176.1	0.0	0.3	3152.5	600.5	2.2	9.0	2.7	41.8	6.6	33.8	1.0	39.5	7.4	9.9	0.7	3.9	1.5	38.2	8.5	50.6	0.3	111.4	38.3
MACF1	"ABP620, ACF7, FLJ45612, FLJ46776, KIAA0465, KIAA1251, MACF"	ENSG00000127603	"Microtubule actin crosslinking factor 1"	Q9UPN3	1	39081316-39487177	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	Actin-binding	"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 1079.0;Cone photoreceptor cells: 779.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013713, HPA068064, HPA068103"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA		25000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cell Junctions, Actin filaments"		"HPA013713: AB_10600821, HPA068064: AB_2685946, HPA068103: AB_2685953"	"unprognostic (2.71e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.40e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.98e-1)"	"prognostic favorable (2.77e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.22e-2)"	69.1	62.5	172.0	27.7	197.5	36.2	54.6	174.6	181.6	65.9	119.1	148.6	18.6	130.3	48.7	46.4	92.0	46.4	127.0	159.7	166.1	85.7	63.8	183.6	35.9	190.2	179.0	92.6	51.2	96.9	69.3	34.6	182.9	68.2	25.1	121.2	57.7	41.6	73.0	121.0	62.6	54.2	155.6	84.9	71.3	50.2	193.2	39.3	73.3	55.2	22.8	80.3	62.7	185.3	48.1	54.9	66.7	29.3	53.8	47.3	29.8	62.2	79.4	38.0	33.7	34.3	56.5	24.4	64.6	84.0	62.1	30.6	12.5	45.7	51.2	43.5	33.1	34.0	43.4	56.5	66.0	30.8	15.9	37.0	46.5	105.1	54.3	83.5	104.7	52.0	63.2	25.7	137.0	16.0	23.3	52.7	95.8	20.0	31.7	38.5	89.6	4.5	206.0	50.8	38.2	38.6	24.9	17.2	62.5	76.3	7.5	37.9	115.1	61.6	48.5	28.8	101.9	19.4	19.7	28.8	101.0	32.6	55.2	7.5	1.3	3.8	12.2	2.7	5.9	2.2	5.8	7.8	1.8	3.8	4.7	6.1	1.3	6.5	2.9	2.5	3.0	2.0	172.0	197.5	174.6	181.6	159.7	166.1	190.2	179.0	182.9	155.6	193.2	185.3	135.3	150.6	128.2	1079.0	68.7	154.4	74.9	43.0	60.3	387.7	52.5	50.9	246.1	61.5	70.7	80.9	779.8	52.6	120.5	35.4	0.0	113.3	9.6	140.6	124.4	164.3	36.1	57.6	320.6	114.6	62.1	108.2	65.2	180.1	77.7	194.3	132.1	47.9	52.1	117.8	367.5	27.2	22.4	59.7	46.3	11.8	43.8	74.8	71.2	342.9	59.0	107.8	158.6	494.6	410.7	193.5	17.7	112.5	81.0	89.7	22.5	20.6	71.3	398.5	105.2	95.5	136.7	62.6	33.7	43.5	191.5	69.9	131.2	76.5	19.7	78.8
MACROD1	LRP16	ENSG00000133315	"Mono-ADP ribosylhydrolase 1"	Q9BQ69	11	63998558-64166113	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 290.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 137.0;Proximal tubular cells: 333.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 73.8;RPMI-8226: 145.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041031, HPA071075"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA041031: AB_10794435, HPA071075: AB_2686341"	"unprognostic (1.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.15e-1)"	"prognostic favorable (4.68e-6)"	"unprognostic (2.45e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.86e-2)"	14.9	14.1	6.4	1.3	5.9	2.8	17.3	6.8	12.7	15.6	5.9	21.3	5.7	13.8	0.9	18.6	15.3	2.2	111.6	6.4	8.2	55.1	50.2	10.4	1.1	8.6	7.9	21.6	49.5	4.1	11.8	1.6	8.8	19.6	1.4	1.2	30.1	5.5	290.1	26.0	10.7	1.1	6.6	6.5	27.2	4.7	9.1	1.0	32.0	58.9	0.5	17.4	16.8	7.4	12.7	5.7	1.9	10.2	1.7	1.0	10.9	7.5	3.2	5.3	5.1	5.3	33.2	44.9	25.4	0.6	2.6	29.8	1.9	0.1	0.6	3.6	21.9	16.8	23.3	29.7	6.1	13.8	1.8	2.5	3.4	0.6	1.7	4.5	1.8	14.7	15.2	8.5	1.1	73.8	20.1	45.1	5.5	4.3	24.4	18.7	11.5	145.4	1.8	0.7	15.7	31.2	5.7	40.3	41.4	0.2	29.8	1.0	2.9	4.9	7.4	7.0	0.8	17.8	3.1	7.4	3.4	13.4	4.6	0.0	0.0	0.0	0.4	0.2	0.4	0.1	0.4	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	6.4	5.9	6.8	12.7	6.4	8.2	8.6	7.9	8.8	6.6	9.1	7.4	19.4	0.0	4.6	6.8	7.1	28.0	39.8	7.5	57.5	15.1	46.2	45.0	32.5	30.0	8.6	42.3	0.0	35.6	1.3	34.6	137.0	20.8	7.1	19.0	13.3	11.9	22.9	8.0	7.1	40.4	16.1	15.9	20.9	22.7	0.0	41.6	9.7	45.3	11.7	11.8	12.4	55.2	8.2	6.9	5.1	26.8	24.8	7.2	39.2	4.7	2.4	16.9	1.0	13.6	6.9	19.2	35.2	14.3	12.9	37.6	23.0	333.4	3.1	20.6	19.7	55.7	19.1	8.2	32.5	46.3	37.1	23.9	6.1	18.8	67.9	49.8
MAGI2	"ACVRIP1, AIP1, ARIP1, KIAA0705, MAGI-2"	ENSG00000187391	"Membrane associated guanylate kinase, WW and PDZ domain containing 2"	Q86UL8	7	78017055-79453667	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.1"	"Group enriched"	"Detected in many"	7	"Astrocytes: 1765.2;Excitatory neurons: 2453.9;Inhibitory neurons: 2438.2;Oligodendrocyte precursor cells: 1208.9;Oligodendrocytes: 4001.5"	"Cancer enriched"	"Detected in many"	5	"glioma: 7.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"Karpas-707: 81.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013650	Approved					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA013650: AB_1853501"	"unprognostic (4.32e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-4)"	"unprognostic (5.04e-2)"	"unprognostic (3.33e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (4.34e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.01e-2)"	4.0	5.9	11.9	1.1	16.4	0.8	3.1	0.0	27.1	4.3	0.0	3.8	1.8	4.1	3.6	2.1	3.9	3.0	2.6	14.1	0.0	5.3	1.4	2.8	0.7	0.7	1.3	8.2	3.3	12.5	6.9	1.2	0.0	8.5	1.6	11.6	1.6	8.1	1.9	1.3	2.0	2.5	0.0	1.9	2.2	3.6	10.8	0.6	6.5	2.3	0.4	4.4	3.0	17.0	0.1	0.6	19.5	0.3	4.0	6.2	0.3	3.5	6.4	0.7	1.0	0.1	0.3	0.1	0.1	2.2	2.6	0.3	1.1	0.1	0.9	1.0	0.8	0.3	0.5	1.1	5.8	0.5	1.0	4.7	0.3	0.4	0.2	3.6	0.9	0.7	0.6	81.9	1.7	0.8	0.2	0.4	4.3	0.7	0.2	0.3	0.2	1.4	0.2	0.3	2.9	4.9	0.8	0.3	1.9	2.9	0.4	0.6	1.1	2.8	1.0	7.6	0.5	0.4	0.0	0.2	1.8	0.1	1.2	0.8	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.1	0.2	0.9	0.2	0.2	0.3	0.1	0.0	11.9	16.4	0.0	27.1	14.1	0.0	0.7	1.3	0.0	0.0	10.8	17.0	7.9	9.6	12.5	1765.2	0.3	1.0	1.3	0.6	6.2	29.3	3.2	6.7	7.5	4.3	3.3	1.8	20.9	0.4	0.7	1.6	5.9	0.4	25.1	9.1	18.3	5.8	2.4	0.0	2453.9	1.0	0.1	11.0	0.5	4.5	0.0	11.6	2.2	2.0	0.2	47.1	2438.2	1.6	0.0	0.0	0.3	32.5	6.5	1.0	1.8	327.9	0.0	24.5	0.0	1208.9	4001.5	0.4	1.5	19.9	0.5	3.5	1.1	1.7	2.1	23.3	13.1	11.0	12.8	4.8	0.9	1.3	1.0	0.4	0.7	8.9	1.4	0.7
MAGT1	"DKFZp564K142, IAP, MRX95, OST3B, SLC58A1"	ENSG00000102158	"Magnesium transporter 1"	Q9H0U3	X	77825747-77895593	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 145.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049851	Approved				"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA049851: AB_2680913"	"prognostic unfavorable (1.30e-4)"	"unprognostic (3.32e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.81e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (8.98e-4)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.66e-1)"	25.3	22.6	12.9	24.2	19.4	20.8	36.5	17.2	17.4	39.4	14.4	28.3	25.7	27.5	53.7	25.6	25.9	25.1	37.5	13.0	16.4	41.9	71.2	26.8	22.5	20.9	18.5	23.6	31.9	38.4	18.5	36.4	21.9	33.5	27.0	5.2	34.6	28.0	17.1	18.3	26.2	24.3	16.6	23.5	29.4	11.3	17.9	21.0	78.0	21.9	23.5	29.1	18.2	27.0	62.5	34.1	41.7	48.8	75.0	49.3	64.8	66.9	67.4	51.7	56.5	45.6	99.5	45.6	90.9	71.7	53.3	56.4	88.4	50.8	80.0	32.3	55.4	30.6	46.2	42.5	66.6	64.9	31.1	45.3	43.5	64.6	56.7	55.1	74.0	31.2	36.5	123.2	64.7	40.4	36.2	23.9	56.1	64.6	41.3	43.3	72.5	84.7	61.9	45.8	14.1	26.3	91.6	64.8	58.0	43.6	43.8	35.3	75.2	45.6	51.1	71.7	33.2	44.8	103.1	58.1	49.7	60.5	61.0	15.3	12.9	13.7	17.2	19.7	18.4	12.5	15.6	16.6	11.1	10.7	14.9	17.7	11.0	18.6	21.0	22.2	12.8	15.7	12.9	19.4	17.2	17.4	13.0	16.4	20.9	18.5	21.9	16.6	17.9	27.0	50.2	41.7	53.6	9.8	37.3	33.0	55.3	51.6	24.5	5.2	39.1	25.1	53.4	42.9	51.6	40.5	4.2	33.3	43.4	44.8	3.9	35.3	2.2	23.7	38.9	40.7	22.7	33.0	6.1	34.9	59.3	43.7	33.1	58.0	30.4	24.5	43.2	145.6	42.3	1.7	6.3	39.6	32.6	49.8	46.1	2.5	30.7	45.1	33.8	15.9	33.9	17.1	18.6	13.6	28.0	36.2	37.2	27.1	87.4	65.4	31.2	32.0	20.7	5.2	19.7	38.7	31.2	6.6	16.7	36.5	45.6	81.3	36.0	31.2	26.0	69.4
MAK	"dJ417M14.2, RP62"	ENSG00000111837	"Male germ cell associated kinase"	P20794	6	10762723-10838553	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"retina: 118.9"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 369.1;Early spermatids: 119.7;Rod photoreceptor cells: 330.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	9	"neutrophil: 6.3"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 6.3"	"Cell line enhanced"	"Detected in single"		"HDLM-2: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 79: Retina - Phototransduction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"				"unprognostic (1.23e-3)"	"unprognostic (8.77e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.73e-2)"	"unprognostic (6.59e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.59e-2)"	0.3	0.1	0.2	0.6	0.0	0.6	0.4	1.5	0.4	0.3	5.4	0.0	0.1	0.4	0.0	0.2	5.4	0.4	0.1	0.1	0.0	0.2	0.0	0.7	0.1	0.7	0.9	0.1	0.2	4.6	0.8	0.1	0.1	0.2	0.0	118.9	0.2	0.0	0.1	0.3	0.1	0.0	0.2	0.7	0.3	4.7	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.4	0.7	0.0	0.3	0.2	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.0	0.4	0.1	0.1	0.0	0.4	0.1	0.1	0.0	0.1	1.3	0.4	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.1	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.4	0.6	0.3	0.3	0.3	0.3	0.1	0.3	0.2	0.3	0.4	0.3	0.5	6.3	0.2	0.6	0.3	0.1	0.1	0.2	0.0	1.5	0.4	0.1	0.0	0.7	0.9	0.1	0.2	0.2	0.4	2.1	0.0	6.4	16.3	1.5	0.4	2.3	0.8	2.8	14.6	4.0	3.9	0.9	0.0	5.3	3.7	369.1	0.5	0.5	0.1	0.0	0.4	119.7	43.3	1.7	1.8	0.0	1.3	45.6	0.2	1.0	2.2	1.1	3.8	2.5	0.3	1.1	0.1	0.2	5.0	39.4	0.0	2.0	0.6	0.7	47.1	0.6	1.3	1.8	12.2	1.3	23.6	0.0	30.7	21.5	0.1	0.0	0.4	1.0	1.1	0.0	0.1	48.9	330.1	0.0	5.4	1.5	15.2	5.5	0.7	0.4	0.8	0.8	0.3	0.0	0.8
MALT1	"MLT, PCASP1"	ENSG00000172175	"MALT1 paracaspase"	Q9UDY8	18	58671465-58754477	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Ubl conjugation pathway"	"Hydrolase, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 88.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004494, HPA048432"	Enhanced		Approved	"Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoli fibrillar center"	Cytosol	"CAB004494: AB_627909, HPA048432: AB_2680389"	"unprognostic (3.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.67e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.00e-2)"	7.1	2.5	2.9	11.2	2.8	10.5	6.3	4.8	3.6	7.7	4.2	5.1	3.6	5.4	4.2	12.5	5.1	5.8	5.4	3.1	4.1	6.7	6.9	7.3	21.1	3.2	2.6	5.3	4.0	5.3	4.7	4.0	3.0	11.5	5.5	8.7	5.8	3.8	8.3	9.4	7.7	4.2	3.0	11.5	4.6	8.2	4.1	15.6	5.3	2.8	23.1	7.1	9.6	3.6	11.4	16.0	16.8	5.2	3.1	6.7	9.2	19.7	12.1	15.7	12.6	13.8	13.5	27.0	10.3	24.0	11.1	12.0	10.8	7.6	20.8	17.0	6.8	9.7	9.0	21.8	4.0	20.1	11.4	4.0	12.2	11.8	10.4	6.6	3.4	7.7	15.3	42.3	9.6	3.3	4.7	9.7	6.3	4.1	7.1	14.8	11.5	19.7	88.9	2.8	2.5	4.5	11.7	6.0	9.3	12.0	5.1	12.2	5.7	22.6	9.1	7.1	20.8	38.5	54.4	16.3	10.6	15.6	9.9	0.3	0.5	0.2	0.7	0.7	0.6	1.1	1.4	0.8	0.7	2.1	1.0	0.8	0.3	0.5	0.5	1.3	0.8	0.4	2.9	2.8	4.8	3.6	3.1	4.1	3.2	2.6	3.0	3.0	4.1	3.6	35.0	22.4	19.2	24.2	67.8	33.0	32.3	4.8	26.2	14.7	13.6	11.0	14.4	10.0	7.0	11.0	85.5	6.2	53.2	11.1	3.9	16.6	12.7	10.4	17.5	31.1	6.7	0.8	61.3	8.5	6.0	15.7	13.7	24.7	31.7	28.1	10.4	11.1	11.8	55.5	42.9	8.6	8.2	21.0	96.5	8.0	10.2	55.9	12.4	34.7	79.5	26.2	20.6	52.3	11.9	16.2	21.9	7.2	42.2	46.6	8.0	30.7	5.8	18.1	19.7	16.1	12.9	40.1	35.6	25.4	24.7	9.0	55.2	5.7	10.7	38.1
MAN1B1	"ERManI, MANA-ER, MRT15"	ENSG00000177239	"Mannosidase alpha class 1B member 1"	Q9UKM7	9	137086985-137109183	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051516	Approved		Uncertain	Vesicles		NA	NA		940000	"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA051516: AB_2681518"	"unprognostic (1.21e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.25e-3)"	"unprognostic (4.67e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.44e-3)"	25.3	32.2	21.3	12.1	21.2	9.1	25.1	21.1	32.9	22.6	26.3	24.1	15.5	20.7	20.4	32.1	22.0	20.1	27.3	22.4	23.1	31.8	39.6	23.0	15.4	22.6	22.7	28.0	36.0	20.0	32.6	21.4	25.2	26.1	9.9	3.6	34.2	15.2	17.6	32.6	22.9	12.1	21.7	28.7	25.6	28.3	22.9	13.8	27.1	9.9	10.1	22.0	21.9	22.8	22.8	50.7	18.2	49.9	67.0	57.7	57.0	37.9	78.4	48.6	43.7	24.9	67.4	20.0	118.8	64.7	69.2	74.3	11.0	36.3	9.1	27.7	17.3	8.7	41.2	33.2	59.6	16.0	33.1	65.1	66.9	29.1	25.1	67.1	32.4	26.5	24.5	32.7	36.4	45.0	16.7	37.8	23.5	67.3	50.0	9.7	30.6	63.9	41.6	11.3	20.4	18.3	55.2	55.9	38.7	9.6	63.5	31.5	46.5	69.6	25.9	52.9	43.6	13.0	11.1	13.3	84.6	19.9	61.6	17.9	31.2	27.0	32.4	34.4	30.2	19.1	25.1	30.4	36.0	16.4	24.3	25.0	9.0	31.0	42.2	26.6	34.5	32.1	21.3	21.2	21.1	32.9	22.4	23.1	22.6	22.7	25.2	21.7	22.9	22.8	18.8	19.2	27.3	23.5	18.3	11.6	12.6	33.0	12.0	20.7	23.5	21.7	10.3	14.3	21.5	25.8	16.7	53.2	24.3	39.1	7.9	32.0	5.8	21.5	16.4	19.7	30.5	14.3	13.0	32.0	72.4	26.9	23.4	20.3	21.0	47.8	25.0	25.2	32.1	30.3	10.2	28.1	22.4	22.9	17.4	6.8	21.1	21.8	23.2	11.2	29.3	16.0	16.5	6.6	12.8	27.6	25.0	21.8	25.4	9.0	35.9	15.9	24.9	19.3	13.1	19.4	20.2	16.1	28.4	16.3	16.2	45.4	21.5	41.1	25.6	8.2
MAN2B1	"LAMAN, MANB"	ENSG00000104774	"Mannosidase alpha class 2B member 1"	O00754	19	12646511-12666742	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 32.8;Plasma cells: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 201.8;intermediate monocyte: 178.8;myeloid DC: 158.8;non-classical monocyte: 138.4;plasmacytoid DC: 187.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 187.5;monocytes: 201.8"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041530, HPA053404"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		3200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Vesicles"		"HPA041530: AB_10795639, HPA053404: "	"unprognostic (6.63e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (4.00e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.51e-1)"	35.8	21.4	5.3	54.6	6.4	83.6	24.8	6.6	5.9	19.6	18.5	30.3	31.0	21.8	9.0	19.8	19.9	28.4	16.0	4.9	7.4	17.3	23.7	46.8	52.1	10.3	6.7	16.7	39.7	16.6	9.9	24.6	9.5	20.5	22.6	1.6	35.2	14.9	12.1	28.9	33.6	20.2	8.9	70.1	32.7	6.4	9.7	23.1	16.3	9.4	39.3	35.6	16.7	12.4	52.4	26.3	26.4	31.3	85.8	57.3	74.0	37.9	79.2	33.1	32.4	21.3	21.4	56.9	44.9	30.4	9.4	40.1	13.6	25.6	15.7	28.5	41.6	19.8	13.6	34.9	43.5	131.6	130.2	68.5	49.2	18.5	23.3	35.6	31.7	21.1	25.6	41.9	17.8	40.9	17.9	74.2	21.9	26.2	32.8	40.8	36.1	28.8	38.9	59.8	8.2	25.5	37.7	32.0	63.0	15.8	49.4	80.0	42.0	44.8	18.4	44.0	36.2	55.4	65.5	28.0	30.4	127.5	51.2	12.2	201.8	29.7	31.9	178.8	35.4	32.9	28.9	29.0	158.8	26.4	15.4	15.9	29.4	13.2	138.4	187.5	30.7	150.3	5.3	6.4	6.6	5.9	4.9	7.4	10.3	6.7	9.5	8.9	9.7	12.4	1.6	6.4	7.5	8.5	25.1	3.6	2.0	2.7	14.2	2.6	1.9	1.0	0.9	2.8	2.0	1.8	0.0	2.5	20.5	2.0	1.9	1.7	3.7	1.4	2.5	3.1	1.8	9.4	7.8	2.3	2.8	7.2	20.9	1.3	1.3	3.4	1.8	0.8	8.4	0.0	6.4	0.9	0.0	15.4	24.7	11.1	3.7	32.8	1.8	17.8	11.0	1.5	9.2	3.5	13.4	1.5	2.5	4.5	78.1	2.5	3.8	1.5	3.9	4.0	13.1	2.3	2.0	0.6	1.6	11.5	3.3	2.7	9.4	2.7	2.0	2.0
MANBA		ENSG00000109323	"Mannosidase beta"	O00462	4	102630770-102760994	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Macrophages: 74.0;Microglial cells: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 16.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.3;granulocytes: 16.6;monocytes: 9.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.5;hTCEpi: 13.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053478	Approved		Supported	Vesicles		NA	NA		15000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 57: B-cells - Immune response"	Vesicles		"HPA053478: AB_2682165"	"unprognostic (2.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.13e-1)"	7.1	12.4	1.9	1.5	2.4	7.0	6.4	4.7	2.2	6.5	2.2	6.7	1.6	6.1	0.2	3.8	6.3	1.3	6.6	1.1	2.1	4.8	4.7	10.5	2.1	3.8	2.9	8.8	8.3	3.0	5.0	3.7	4.7	4.3	1.1	2.7	8.9	2.0	3.0	4.5	8.5	2.4	3.0	12.0	9.1	1.6	3.5	1.2	7.1	0.1	2.0	8.1	5.8	3.7	2.9	1.4	0.6	1.6	15.5	12.1	0.9	1.1	6.9	1.8	4.1	1.7	1.0	3.6	1.4	2.7	3.9	1.0	3.0	2.2	1.1	2.2	0.7	3.0	1.1	0.7	2.7	2.8	8.2	3.7	13.7	7.6	3.4	8.9	3.0	1.2	3.6	2.0	3.4	1.4	2.0	2.3	1.3	1.9	1.1	1.9	1.6	0.6	3.4	2.3	1.4	0.5	1.4	1.9	1.5	5.4	4.5	1.8	0.2	2.0	1.3	9.3	1.2	1.3	5.8	0.5	3.1	1.5	1.6	4.0	6.8	16.6	0.4	6.1	0.7	1.7	0.0	0.7	5.3	2.1	0.4	0.6	6.1	1.8	9.1	1.2	0.5	3.1	1.9	2.4	4.7	2.2	1.1	2.1	3.8	2.9	4.7	3.0	3.5	3.7	6.4	32.1	35.6	24.5	45.4	5.9	8.4	13.2	12.0	6.2	11.6	8.1	14.6	14.3	13.5	9.2	6.2	42.3	14.3	5.1	1.9	8.1	2.8	6.9	6.9	8.1	1.8	19.7	36.4	2.7	7.3	13.8	25.5	12.8	34.8	5.5	10.4	17.7	43.6	6.7	66.5	10.5	2.0	58.5	29.6	1.6	9.0	74.0	0.0	111.5	52.8	5.2	17.5	31.2	66.8	5.5	17.3	19.9	17.5	7.5	5.2	9.8	5.8	7.5	0.0	10.8	6.7	0.2	1.4	12.6	4.5	22.6	16.9	12.6	11.2	9.7
MAP2K3	"MAPKK3, MEK3, MKK3, PRKMK3"	ENSG00000034152	"Mitogen-activated protein kinase kinase 3"	P46734	17	21284672-21315232	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 212.4"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 325.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018548	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		28000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"CAB018548: AB_631927"	"unprognostic (2.31e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.77e-1)"	47.3	32.5	12.9	35.3	12.1	212.4	30.7	17.6	23.2	22.7	22.6	33.1	49.0	17.1	14.5	62.7	29.9	40.0	66.7	11.5	14.4	45.7	95.7	67.5	34.0	13.6	14.3	12.6	33.6	17.9	37.1	28.9	14.2	28.9	24.1	6.0	45.3	16.5	132.7	53.1	41.0	22.5	14.3	60.4	42.8	6.2	15.8	20.9	24.0	74.6	41.1	54.1	33.4	17.0	75.5	73.9	9.7	44.5	57.7	36.6	36.3	113.0	121.8	88.3	80.5	82.9	46.6	68.1	44.7	178.3	74.2	72.4	31.0	100.5	62.1	69.5	56.9	39.2	42.0	76.1	18.2	51.9	76.7	28.5	28.2	120.6	35.9	27.7	40.0	38.6	7.7	33.2	74.7	74.1	25.5	49.3	28.1	134.1	42.3	53.0	62.2	50.0	50.5	77.4	26.3	9.4	41.7	45.9	82.0	95.7	22.5	17.7	36.8	83.0	68.4	90.1	73.9	39.8	21.8	88.1	80.2	44.3	44.1	54.1	49.3	77.8	35.9	72.1	31.1	33.3	29.1	33.6	49.6	25.5	17.9	24.1	145.6	15.3	104.7	35.4	44.5	35.6	12.9	12.1	17.6	23.2	11.5	14.4	13.6	14.3	14.2	14.3	15.8	17.0	44.2	38.5	53.6	2.6	51.5	258.0	188.4	57.0	97.9	7.1	69.3	51.3	21.9	44.3	50.5	22.0	4.2	73.3	117.4	109.1	74.3	99.1	1.5	130.5	44.8	49.4	120.4	325.0	7.2	79.8	82.0	43.7	68.3	237.8	94.0	11.5	22.1	73.1	49.0	18.5	8.0	77.0	28.5	59.4	278.7	1.8	12.2	118.1	87.2	4.7	48.3	17.3	35.0	5.5	2.0	129.1	135.3	16.6	85.2	158.7	60.8	44.2	40.4	7.4	0.0	61.9	42.4	1.1	5.3	97.3	218.1	67.0	62.6	10.5	58.5	255.7
MAP3K20	"MLK7, MLTK, MLTKalpha, MLTKbeta, MRK, ZAK"	ENSG00000091436	"Mitogen-activated protein kinase kinase kinase 20"	Q9NYL2	2	173075435-173268015	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 261.9;tongue: 279.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 57.5;Alveolar cells type 2: 57.7;Cytotrophoblasts: 52.6;Endometrial stromal cells: 96.7;Granulosa cells: 100.7;Smooth muscle cells: 83.2;Theca cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 15.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 15.5;monocytes: 9.4"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 176.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017205	Approved		Supported	Cytosol		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA017205: AB_1858933"	"unprognostic (2.90e-2)"	"unprognostic (9.99e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.63e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.83e-2)"	"unprognostic (9.27e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (3.41e-6)"	"unprognostic (2.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.19e-2)"	71.0	11.4	9.5	20.5	9.7	4.7	21.4	10.3	8.5	44.9	15.7	65.8	13.0	76.4	18.6	50.0	48.0	31.4	195.7	9.3	12.1	7.5	25.2	22.5	9.8	13.8	14.7	69.5	11.7	49.3	3.8	27.6	11.2	44.0	20.9	2.5	12.4	57.1	261.9	14.1	19.2	75.0	11.1	12.5	31.5	10.6	12.5	11.5	16.4	279.7	10.2	56.1	21.2	9.4	34.6	28.6	22.0	29.1	62.7	92.5	13.8	121.9	94.7	55.9	59.6	19.5	22.2	26.5	31.2	122.5	48.8	22.9	33.1	64.6	124.2	52.0	22.0	43.3	30.5	4.1	24.8	39.3	43.8	74.7	27.2	105.2	164.2	46.3	37.5	28.5	19.8	4.9	36.8	14.8	24.8	19.0	12.2	28.9	16.0	36.2	45.0	0.1	13.6	19.6	12.9	12.4	47.0	11.3	19.7	35.6	12.9	20.9	37.9	176.3	71.4	53.1	27.9	0.1	0.1	5.5	126.2	10.6	18.9	0.2	9.4	0.0	1.0	8.3	1.0	1.6	0.8	1.7	15.5	2.5	0.0	0.8	2.6	0.5	8.2	0.3	0.8	3.4	9.5	9.7	10.3	8.5	9.3	12.1	13.8	14.7	11.2	11.1	12.5	9.4	57.5	38.5	57.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	20.0	44.4	0.0	0.0	7.4	11.0	0.0	52.6	2.3	0.0	1.9	43.9	0.0	36.7	96.7	14.1	0.0	0.0	0.0	27.6	21.9	36.5	0.0	35.6	5.1	100.7	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	15.5	0.0	0.0	0.0	0.0	38.6	0.0	0.0	1.4	0.0	0.0	1.9	13.1	0.0	0.0	0.0	83.2	0.0	0.0	0.0	0.0	21.6	3.6	70.5	0.0	0.0
MAP3K7	"MEKK7, TAK1"	ENSG00000135341	"Mitogen-activated protein kinase kinase kinase 7"	O43318	6	90513573-90587072	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 137.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007633, HPA075335"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Nuclear speckles, Plasma membrane"	"HPA007633: AB_1079359, HPA075335: "	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.17e-1)"	11.8	12.5	13.1	12.5	15.1	8.7	14.3	15.6	17.3	14.3	11.7	11.6	9.2	16.6	16.5	10.6	11.0	12.7	16.9	14.7	14.9	11.4	11.6	10.4	16.4	15.3	13.7	15.8	9.7	16.3	13.0	17.4	15.8	14.9	10.9	23.5	12.1	13.3	16.9	13.9	9.8	14.0	15.3	17.6	10.8	9.9	13.8	20.8	14.7	18.4	16.8	14.3	12.2	22.4	16.7	14.4	41.3	35.6	29.5	39.1	29.0	32.7	37.7	28.8	36.1	18.6	15.5	36.9	20.4	35.6	25.6	17.3	26.3	25.5	48.7	19.0	27.7	32.9	19.9	24.9	30.8	36.9	24.4	32.5	30.5	28.2	34.2	33.1	27.4	31.8	67.0	29.3	41.8	20.3	17.2	31.2	34.0	25.7	18.0	29.3	73.9	18.0	24.2	18.4	20.8	29.5	22.9	15.6	24.8	32.2	15.5	64.7	26.5	23.3	14.7	21.6	30.9	25.9	24.7	15.8	35.7	39.7	35.0	18.2	11.5	18.4	12.8	15.9	14.5	13.0	12.3	12.5	14.6	9.9	13.7	13.4	11.5	17.9	17.6	8.9	20.8	13.4	13.1	15.1	15.6	17.3	14.7	14.9	15.3	13.7	15.8	15.3	13.8	22.4	16.1	16.0	26.9	47.0	24.3	36.3	20.8	19.5	21.6	23.3	17.9	12.3	31.0	14.3	16.9	16.5	27.1	31.8	17.8	12.4	7.9	17.6	3.6	10.9	19.8	21.2	12.1	14.1	85.7	20.9	34.6	23.2	16.3	14.8	13.9	25.9	25.7	20.7	24.3	28.6	63.8	13.7	20.3	27.3	24.6	3.2	26.8	21.7	21.4	36.5	35.2	19.6	16.5	50.8	137.2	20.1	9.1	41.0	18.8	30.1	11.1	16.6	21.4	21.5	19.7	28.0	18.5	25.9	24.9	21.3	37.2	48.4	22.7	18.1	15.1	24.8
MAP3K9	"MEKK9, MLK1, PRKE1"	ENSG00000006432	"Mitogen-activated protein kinase kinase kinase 9"	P80192	14	70722526-70809534	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.7;retina: 9.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 49.6;Inhibitory neurons: 58.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000942	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli"		"HPA000942: AB_1079360"	"unprognostic (1.20e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.75e-5)"	"unprognostic (2.58e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.23e-6)"	"unprognostic (5.71e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.35e-1)"	0.2	1.0	3.3	1.0	4.6	0.7	1.3	10.7	22.7	0.9	0.4	1.5	1.5	0.4	1.5	5.1	1.0	0.4	0.5	4.0	3.2	1.4	0.7	1.9	1.4	8.6	3.0	0.6	2.2	2.7	1.1	0.6	7.7	0.9	1.5	9.6	1.7	0.5	0.8	4.0	1.4	0.2	0.3	0.9	1.6	5.5	10.0	0.9	2.7	0.4	3.6	0.7	1.8	6.8	22.3	10.5	2.0	2.5	0.0	0.0	6.7	0.5	0.3	2.1	1.9	7.8	8.6	4.5	2.8	0.1	4.7	10.3	6.5	12.8	2.2	3.0	1.7	0.2	4.1	5.2	0.3	0.5	0.9	0.1	6.5	1.5	12.7	3.7	0.0	4.1	1.7	1.0	0.5	9.4	3.7	0.5	4.2	9.0	4.5	1.3	3.9	0.9	4.6	10.9	13.8	3.0	6.3	7.7	1.2	3.7	6.9	0.8	0.0	0.0	8.5	0.0	3.5	2.2	5.6	2.4	3.4	0.4	1.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.2	0.2	0.0	0.0	0.2	0.0	3.3	4.6	10.7	22.7	4.0	3.2	8.6	3.0	7.7	0.3	10.0	6.8	0.3	6.4	13.4	6.8	3.9	8.7	13.7	9.4	6.8	17.7	11.2	4.8	2.3	14.3	12.4	7.3	12.5	2.8	1.7	5.7	1.9	6.1	19.8	7.4	0.7	0.8	8.4	0.0	49.6	4.8	1.6	1.0	4.1	8.5	1.3	1.8	1.1	4.8	1.2	30.3	58.1	4.0	4.1	0.8	1.9	20.0	0.6	0.8	3.6	5.6	0.4	3.2	0.0	8.5	1.3	11.1	3.9	0.0	2.8	15.8	2.6	2.8	7.1	12.7	0.0	0.8	1.3	8.0	8.4	12.6	9.1	4.0	3.7	6.0	5.8	27.9
MAPK10	"JNK3, p493F12, p54bSAPK, PRKM10"	ENSG00000109339	"Mitogen-activated protein kinase 10"	P53779	4	85990007-86594625	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 91.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 902.0;Excitatory neurons: 1018.9;Inhibitory neurons: 727.8;Late spermatids: 400.5;Oligodendrocyte precursor cells: 596.6;Oligodendrocytes: 302.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	6	"AF22: 155.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022625	Approved					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB022625: "	"unprognostic (2.46e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.05e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.59e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.81e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.02e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.22e-3)"	"prognostic favorable (5.57e-4)"	26.1	15.6	45.2	5.1	61.6	14.5	7.4	25.4	91.3	17.5	23.5	5.7	3.6	14.5	18.8	9.8	15.8	13.8	6.9	60.4	24.9	20.4	3.2	8.6	5.2	29.0	36.2	14.7	7.4	10.3	25.5	4.3	31.4	22.4	5.4	18.3	4.7	24.2	2.6	4.6	5.1	15.5	24.9	7.4	6.6	26.4	39.2	3.4	20.5	4.2	4.6	14.0	18.4	55.6	2.9	4.9	155.0	4.8	4.1	3.6	5.6	3.2	2.9	2.7	1.2	3.3	4.4	7.1	5.1	1.9	3.8	9.4	1.8	4.2	4.3	4.9	4.0	5.7	7.3	4.6	3.6	2.7	3.1	4.1	1.9	3.7	5.0	5.5	3.5	4.8	5.2	27.9	1.7	3.5	4.4	3.1	8.8	0.7	3.2	4.9	4.0	2.5	10.7	16.9	9.2	8.4	3.3	5.9	2.2	5.0	8.8	3.3	7.5	6.3	6.4	3.0	2.7	8.2	5.1	4.4	9.9	3.5	3.8	3.3	0.7	1.2	0.8	0.7	1.0	1.3	0.7	1.0	0.6	1.1	1.0	1.4	4.4	1.2	0.7	1.2	1.2	0.9	45.2	61.6	25.4	91.3	60.4	24.9	29.0	36.2	31.4	24.9	39.2	55.6	4.3	22.4	33.8	902.0	1.6	0.8	15.7	5.5	4.0	26.1	3.2	3.7	1.6	8.6	12.8	22.0	6.2	0.3	0.1	0.0	11.7	2.4	219.5	61.1	25.1	1.3	2.4	0.0	1018.9	0.0	0.5	16.9	2.0	7.1	2.5	6.2	1.1	0.0	0.3	38.7	727.8	0.0	4.1	0.3	0.0	400.5	26.4	1.5	1.8	185.5	0.0	15.7	0.0	596.6	302.8	2.0	0.0	54.9	0.1	7.6	0.0	22.6	68.9	10.8	6.6	7.2	18.5	10.5	5.5	1.3	1.0	0.1	0.9	28.5	0.0	22.6
MAPK12	"ERK6, p38gamma, PRKM12, SAPK-3, SAPK3"	ENSG00000188130	"Mitogen-activated protein kinase 12"	P53778	22	50245450-50261716	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"skeletal muscle: 279.7;tongue: 120.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 23.1;Astrocytes: 22.9;Endothelial cells: 15.8;Hepatic stellate cells: 20.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 31.6"	"Low region specificity"	"Detected in all"			"CAB025483, HPA054562"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles"	Cytosol	"CAB025483: , HPA054562: AB_2682524"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.90e-3)"	"unprognostic (3.16e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.70e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-6)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.28e-3)"	11.0	2.3	15.6	3.8	16.5	1.3	7.9	15.5	21.2	11.4	9.2	4.7	3.5	19.0	9.8	6.3	11.2	4.4	15.7	15.1	16.5	10.7	1.4	6.8	4.1	17.1	14.9	10.6	1.8	4.3	25.1	4.1	14.6	10.0	1.1	1.4	4.3	6.9	279.7	1.5	4.4	8.6	14.6	4.3	5.0	4.6	15.2	0.9	3.2	120.9	1.4	6.0	5.9	13.9	23.2	13.9	5.3	16.3	12.4	13.5	7.5	17.5	15.1	28.2	18.3	19.6	7.2	45.1	23.4	19.6	16.8	15.4	24.3	3.4	5.5	12.8	34.0	29.2	46.7	24.9	37.7	28.4	54.5	29.8	6.0	7.2	0.0	16.8	33.2	4.0	26.3	38.5	13.4	12.8	0.0	35.4	15.9	7.6	22.5	41.4	14.2	43.9	17.5	3.0	18.0	6.5	13.3	0.5	22.1	4.2	7.1	29.6	18.7	28.5	26.1	6.6	11.2	9.3	7.3	24.5	7.2	24.7	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	15.6	16.5	15.5	21.2	15.1	16.5	17.1	14.9	14.6	14.6	15.2	13.9	23.1	0.0	3.2	22.9	1.6	0.8	0.7	3.3	1.2	5.5	1.2	1.3	8.8	4.3	0.8	0.0	0.0	0.3	0.9	0.3	1.9	0.5	0.3	0.6	10.0	15.8	1.8	1.7	9.8	0.0	2.8	5.3	2.6	0.7	10.8	0.6	20.7	0.9	6.3	1.7	6.5	0.2	8.2	2.2	0.8	1.9	6.5	2.2	0.0	6.5	0.6	8.1	0.0	5.0	0.9	0.5	0.0	3.8	2.8	3.6	0.4	8.0	0.9	2.2	6.6	3.3	3.0	0.7	12.1	0.8	0.6	0.4	2.2	3.2	0.3	0.2
MAPKAPK3	"3pK, MAPKAP3, MK-3, MK3"	ENSG00000114738	"MAPK activated protein kinase 3"	Q16644	3	50611520-50649291	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 106.5;heart muscle: 256.3;skeletal muscle: 224.2;tongue: 284.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 226.6;Hofbauer cells: 102.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 142.8;granulocytes: 126.3;monocytes: 341.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058275			Supported	Nucleoplasm		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA058275: AB_2683663"	"unprognostic (6.46e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (8.08e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.96e-2)"	"unprognostic (8.77e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.90e-8)"	"unprognostic (2.15e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.69e-1)"	15.3	43.3	18.0	29.8	19.6	106.5	15.8	19.2	19.2	15.0	21.3	19.7	30.2	11.3	10.3	49.6	15.1	12.1	256.3	18.0	19.7	40.0	18.7	28.2	21.7	23.6	20.5	14.2	36.2	47.2	23.5	13.9	22.5	18.4	20.0	4.7	27.7	12.6	224.2	53.4	24.2	15.9	21.6	25.3	27.6	9.2	21.1	42.0	41.2	284.3	24.2	20.3	22.2	21.6	99.6	30.3	12.4	35.9	18.4	45.7	27.9	23.8	33.7	35.7	30.3	47.1	90.2	39.8	23.5	79.5	88.5	34.6	85.9	92.7	31.9	88.3	22.3	209.5	40.6	43.5	36.8	152.1	106.4	36.9	57.0	83.1	112.2	35.6	31.9	70.2	59.7	25.4	76.1	40.5	65.3	153.3	46.4	34.6	127.0	28.5	29.9	60.1	165.5	56.2	23.0	16.5	21.3	58.9	27.7	20.6	37.8	93.4	23.8	28.1	64.5	146.4	59.5	17.2	33.7	33.1	148.3	234.7	11.8	45.3	169.5	126.3	27.6	271.6	27.3	15.1	30.9	32.1	142.8	8.8	23.9	27.8	104.4	42.1	341.5	91.2	28.0	132.6	18.0	19.6	19.2	19.2	18.0	19.7	23.6	20.5	22.5	21.6	21.1	21.6	3.5	9.6	14.0	8.5	8.6	11.3	26.9	14.0	19.4	1.1	15.3	12.3	226.6	15.7	10.4	11.0	0.0	6.0	38.1	16.2	64.6	45.6	34.5	3.4	2.7	7.1	6.0	19.1	0.3	30.4	7.4	14.9	11.7	5.4	36.2	8.3	5.3	14.2	102.1	0.0	0.7	15.4	10.2	68.0	23.9	86.2	7.2	59.4	7.2	0.0	76.6	17.1	41.2	0.5	2.0	76.2	15.6	3.4	12.7	30.9	30.7	35.4	5.7	2.3	26.3	9.7	12.0	4.1	4.6	34.2	20.2	5.1	24.3	22.0	28.2	33.5
MARCHF6	"MARCH-VI, MARCH6, RNF176, TEB4"	ENSG00000145495	"Membrane associated ring-CH-type finger 6"	O60337	5	10353695-10440388	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 38.5;Cardiomyocytes: 102.5;Cytotrophoblasts: 54.4;dendritic cells: 25.8;Extravillous trophoblasts: 30.0;Hofbauer cells: 36.4;Syncytiotrophoblasts: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040841, HPA063246"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Endoplasmic reticulum"		"HPA040841: AB_2677162, HPA063246: AB_2684970"	"unprognostic (3.31e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.80e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.06e-2)"	"unprognostic (9.52e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.94e-2)"	"unprognostic (5.58e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.57e-1)"	"unprognostic (8.50e-3)"	22.1	25.5	16.1	20.3	23.7	76.5	25.9	28.3	20.7	20.1	2.9	26.9	32.8	22.7	25.5	20.9	24.9	24.5	30.8	22.0	30.4	34.1	32.5	25.1	24.7	13.7	17.5	36.0	39.3	62.4	20.8	22.8	16.9	22.7	19.8	36.6	25.6	23.8	48.4	24.8	30.3	18.9	13.8	28.2	30.2	29.9	27.9	32.3	29.3	51.8	23.3	23.7	18.6	33.5	37.4	55.1	90.1	69.9	50.6	40.4	73.7	57.7	53.7	48.9	61.8	52.8	97.0	39.4	85.4	54.4	67.2	52.3	48.2	37.7	65.4	82.9	43.0	50.7	179.7	36.2	35.6	61.4	54.6	47.4	40.6	49.0	53.1	50.0	45.8	41.4	62.1	85.1	45.0	42.4	33.1	47.2	32.8	29.9	38.5	50.9	37.6	57.0	38.0	72.4	38.7	56.0	107.2	57.9	38.4	41.3	48.2	32.5	44.8	58.4	56.8	29.1	43.7	59.3	94.1	55.7	43.1	40.7	42.8	15.6	7.4	12.6	11.2	8.4	12.8	11.7	10.8	11.0	6.3	9.6	12.5	12.4	12.1	9.1	11.1	5.0	10.4	9.1	16.1	23.7	28.3	20.7	22.0	30.4	13.7	17.5	16.9	13.8	27.9	33.5	38.5	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.5	0.0	0.0	0.0	0.0	54.4	25.8	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	30.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	36.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	81.3	5.8	0.0	0.0	0.0
MARK1	"MARK, PAR-1C"	ENSG00000116141	"Microtubule affinity regulating kinase 1"	Q9P0L2	1	220528136-220664461	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 73.8;Excitatory neurons: 171.3;Inhibitory neurons: 170.1;Oligodendrocyte precursor cells: 167.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 11.3;RT4: 33.7;SuSa: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007421, HPA008061"	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA007421: AB_1079311, HPA008061: AB_1079310"	"unprognostic (1.51e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.72e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (4.59e-2)"	"prognostic favorable (2.23e-5)"	"unprognostic (6.62e-2)"	"unprognostic (4.27e-2)"	"unprognostic (9.56e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.74e-2)"	6.3	1.8	6.9	1.4	7.1	0.0	4.9	6.4	10.0	4.6	8.4	5.4	0.4	4.2	9.7	4.8	3.3	1.7	8.0	7.4	6.7	2.3	0.3	3.1	0.5	6.4	6.8	1.7	0.9	2.4	6.9	1.1	7.4	3.0	1.2	9.3	3.7	4.0	2.2	2.5	2.5	3.9	5.7	1.3	2.8	6.9	6.5	1.4	4.3	3.5	1.9	5.3	5.1	6.4	0.4	0.0	5.4	1.1	0.0	0.0	1.8	1.6	2.2	1.8	2.5	0.0	0.0	0.0	0.0	0.0	2.5	2.5	11.3	6.0	1.0	0.0	8.4	0.0	2.3	0.0	0.0	0.7	0.8	0.9	4.7	0.0	3.0	0.8	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	8.1	5.5	1.8	0.0	7.4	0.0	0.0	33.7	6.4	6.2	0.3	0.3	0.5	12.2	0.5	0.0	0.0	0.0	2.4	4.0	7.1	0.0	0.0	0.0	1.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	7.1	6.4	10.0	7.4	6.7	6.4	6.8	7.4	5.7	6.5	6.4	3.2	0.0	0.5	73.8	0.5	3.4	2.6	10.0	13.1	28.6	1.6	3.8	21.9	0.0	4.7	3.7	31.3	2.1	0.0	0.7	0.0	1.6	7.3	19.3	6.4	3.4	9.0	0.0	171.3	0.0	2.3	6.3	2.6	35.5	0.0	13.6	3.3	0.0	0.3	10.1	170.1	0.4	4.1	0.3	1.5	3.6	2.1	0.2	0.0	15.0	0.0	12.3	0.0	167.9	45.9	0.1	0.0	6.4	0.6	4.8	1.5	0.2	4.1	11.9	0.0	6.9	17.5	17.4	5.1	13.1	3.3	1.0	0.4	1.1	0.9	4.8
MARK3	"CTAK1, KP78, PAR-1A"	ENSG00000075413	"Microtubule affinity regulating kinase 3"	P27448	14	103385377-103503831	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	32	"eosinophil: 101.5"	"Lineage enriched"	"Detected in all"	32	"granulocytes: 101.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024652	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"			"HPA024652: AB_1853582"	"unprognostic (6.86e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.48e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (2.29e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.60e-1)"	34.6	52.5	14.9	23.0	15.9	53.2	27.5	16.0	22.1	29.8	15.1	34.8	20.4	31.3	26.7	39.8	36.8	20.8	71.5	14.5	14.8	38.7	30.8	38.3	24.9	15.1	15.0	33.7	46.7	33.8	32.0	22.8	16.2	30.5	21.3	23.2	29.2	24.2	71.0	27.3	31.8	30.8	15.0	42.6	46.5	38.4	14.7	31.0	33.2	42.7	26.2	32.1	28.5	15.6	28.1	33.3	52.8	34.7	64.3	43.6	40.9	54.9	56.8	66.3	62.4	23.3	46.2	36.3	31.9	52.5	27.0	51.5	58.3	56.6	81.2	39.4	28.0	46.8	34.9	30.8	123.5	53.4	27.2	56.1	51.5	53.1	105.0	51.9	61.0	33.0	45.4	77.1	51.2	61.6	34.9	38.4	42.0	57.7	56.0	44.9	56.2	30.1	54.1	52.3	44.5	43.1	59.0	36.6	52.1	58.7	50.8	47.1	50.2	34.8	23.4	62.1	48.4	44.4	67.0	42.1	41.5	40.8	48.0	0.3	1.5	101.5	1.4	1.1	0.9	1.5	2.2	2.8	1.8	0.6	2.4	1.6	2.3	1.4	1.1	1.2	3.1	0.7	14.9	15.9	16.0	22.1	14.5	14.8	15.1	15.0	16.2	15.0	14.7	15.6	38.0	57.7	79.1	154.1	43.6	44.2	57.2	28.7	33.0	78.7	26.3	21.7	74.6	47.1	45.2	38.6	162.6	33.3	47.9	36.6	11.7	46.8	38.0	47.5	63.7	50.9	31.2	187.1	153.5	42.0	31.0	47.3	52.0	62.1	48.2	128.7	63.9	30.1	30.2	58.9	145.0	32.3	30.5	40.4	63.0	52.4	60.9	42.6	37.4	70.3	57.5	34.4	61.8	138.2	172.3	60.4	34.0	59.0	55.9	67.4	34.6	21.5	36.8	86.7	32.9	38.9	44.1	74.6	72.4	36.1	52.1	49.1	54.8	98.9	33.7	114.6
MARS1	"CMT2U, MARS, MetRS, SPG70"	ENSG00000166986	"Methionyl-tRNA synthetase 1"	P56192	12	57475445-57517569	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 11.9;Cytotrophoblasts: 29.5;Extravillous trophoblasts: 22.0;Hofbauer cells: 19.3;Syncytiotrophoblasts: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 738.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004125, CAB017097"	Supported	Approved	Enhanced	Cytosol		NA	NA		23000	"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"CAB017097: , HPA004125: AB_1079312"	"prognostic unfavorable (1.73e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (4.55e-7)"	"unprognostic (8.47e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.06e-2)"	35.9	47.2	63.1	35.9	65.2	31.6	31.5	62.0	83.6	30.8	61.6	47.6	21.5	40.7	39.0	54.3	30.1	19.3	50.5	67.5	67.5	55.7	60.6	42.7	34.5	64.2	65.5	24.2	64.4	40.7	58.9	27.3	68.1	38.7	29.6	39.6	39.6	34.0	48.5	33.0	37.3	41.3	63.5	53.9	53.2	50.7	65.6	32.6	40.0	33.1	44.4	44.8	33.6	67.9	110.6	149.6	99.7	171.9	107.1	64.6	180.2	149.0	178.4	158.1	168.6	162.9	119.0	192.3	97.6	187.2	98.3	119.4	226.0	196.4	166.2	167.4	96.9	136.7	52.8	89.4	238.1	207.7	147.5	96.2	302.9	181.5	467.5	76.6	114.8	238.1	212.9	400.3	112.1	150.4	187.9	148.1	184.8	173.0	162.3	155.5	738.3	200.0	117.0	86.4	131.6	134.0	79.8	120.9	215.8	109.6	161.0	260.7	86.9	57.5	162.8	82.8	91.6	357.5	395.8	232.5	139.7	154.8	199.1	29.9	29.8	39.3	35.1	53.6	31.7	24.4	23.4	32.0	57.9	14.7	20.0	27.4	14.5	30.0	45.6	55.9	26.3	34.2	63.1	65.2	62.0	83.6	67.5	67.5	64.2	65.5	68.1	63.5	65.6	67.9	5.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	29.5	7.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	22.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	38.0	1.2	0.0	0.0	0.0
MARS2	"mtMetRS, SPAX3"	ENSG00000247626	"Methionyl-tRNA synthetase 2, mitochondrial"	Q96GW9	2	197705369-197708395	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 17.1;Suprabasal keratinocytes: 18.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035589, HPA035590"	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 28: Keratinocytes - Keratinization"			"HPA035589: AB_10601870, HPA035590: AB_2674693"	"unprognostic (2.12e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (3.50e-4)"	"prognostic favorable (1.12e-4)"	"unprognostic (2.99e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.86e-3)"	"prognostic favorable (6.14e-5)"	"unprognostic (1.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.47e-2)"	"unprognostic (8.74e-2)"	3.0	4.7	1.8	4.7	2.9	3.6	4.1	3.0	3.0	1.8	1.4	5.4	4.7	1.9	1.4	4.9	2.3	2.2	4.1	2.1	2.5	4.0	5.7	2.0	6.5	2.7	2.7	1.6	5.3	4.1	0.9	2.5	3.2	2.0	5.0	1.7	3.1	1.7	4.8	3.2	3.7	2.5	2.5	4.5	3.3	1.9	2.7	3.2	3.1	6.0	6.6	4.2	2.2	4.1	6.9	8.2	7.7	13.0	7.2	3.5	14.5	5.2	4.1	9.8	7.3	21.1	6.3	43.4	7.6	3.0	5.2	12.8	27.2	11.2	10.3	11.8	15.9	26.7	9.7	18.7	6.8	39.7	12.3	3.7	14.0	6.6	11.3	2.6	6.5	12.6	31.7	15.1	5.6	11.7	20.3	18.7	13.3	16.1	20.6	20.7	8.1	30.7	11.8	12.2	13.6	6.5	6.5	17.5	11.9	10.0	7.5	13.8	5.2	8.0	6.3	6.1	15.4	10.0	8.0	35.7	6.0	23.8	7.5	0.0	2.5	0.7	4.3	4.0	5.0	2.7	3.5	3.9	4.0	3.0	5.6	6.3	0.1	8.6	1.9	2.8	6.6	3.6	1.8	2.9	3.0	3.0	2.1	2.5	2.7	2.7	3.2	2.5	2.7	4.1	0.7	0.0	1.1	0.7	5.3	17.1	6.2	2.6	9.1	1.7	3.3	1.4	1.9	0.0	1.8	3.7	0.0	1.8	2.1	3.7	5.9	2.1	2.8	0.6	1.7	2.2	0.0	7.2	1.7	1.8	1.3	1.6	3.1	0.9	4.5	1.5	1.1	7.7	2.6	0.0	1.7	1.6	0.0	2.2	4.2	0.8	1.5	0.8	5.4	2.8	1.7	1.6	0.0	1.5	2.0	1.2	2.4	0.4	2.1	3.1	1.1	4.4	1.3	2.3	0.0	2.5	3.1	3.5	2.7	7.3	18.9	0.8	3.9	4.1	5.4	4.8
MARVELD2	"DFNB49, FLJ30532, MRVLDC2, TRIC"	ENSG00000152939	"MARVEL domain containing 2"	Q8N4S9	5	69415065-69444330	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 15.7"	"Cell type enhanced"	"Detected in many"		"Urothelial cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.5;CAPAN-2: 24.1;HaCaT: 18.9;RT4: 21.1;SCLC-21H: 26.7;T-47d: 18.3"	"Region enriched"	"Detected in some"	8	"cerebellum: 7.9"	"Low region specificity"	"Detected in all"			"HPA018119, HPA061726"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"		"HPA018119: AB_2669771, HPA061726: AB_2684595"	"unprognostic (4.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.84e-13)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.82e-1)"	0.3	0.2	0.5	0.9	0.5	0.2	4.0	0.5	0.6	2.1	3.2	5.7	7.7	1.1	1.3	6.9	3.9	2.9	0.4	0.5	0.5	8.0	10.7	5.6	0.1	0.7	0.7	0.1	9.3	4.6	2.9	1.8	0.7	3.0	6.2	0.3	4.6	2.6	0.0	4.3	7.7	0.4	0.4	0.2	8.1	1.5	0.7	1.0	15.7	0.0	1.3	3.0	3.4	0.7	10.8	3.5	0.1	0.0	0.0	0.0	29.5	0.2	0.2	0.2	0.7	14.1	24.1	0.1	2.0	1.8	0.0	18.9	0.0	14.0	0.5	0.2	5.8	0.0	1.1	7.8	1.7	0.0	0.1	0.4	15.3	0.1	1.9	0.7	0.9	0.1	0.0	0.1	0.0	9.8	0.0	0.0	1.8	6.3	0.3	0.0	0.1	0.5	10.0	21.1	26.7	0.0	2.3	2.0	0.3	4.3	18.3	0.0	1.5	0.0	0.1	0.0	0.0	0.1	3.5	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.5	0.5	0.6	0.5	0.5	0.7	0.7	0.7	0.4	0.7	0.7	1.0	22.4	26.5	0.7	1.0	5.0	22.2	14.8	10.2	0.3	15.5	8.5	2.8	35.8	23.1	16.5	2.1	22.9	0.2	31.4	17.6	25.1	5.8	33.5	3.4	4.1	16.8	3.4	0.5	25.8	8.2	1.1	17.9	30.4	1.3	3.7	5.0	37.9	1.9	0.0	0.4	23.1	18.3	0.6	0.9	3.2	0.0	0.6	1.8	1.0	7.8	0.5	0.0	0.5	0.6	25.0	29.7	0.0	0.6	25.5	33.5	6.1	38.4	0.6	0.0	0.8	1.5	4.1	2.4	19.4	6.5	12.0	0.9	2.9	25.6	46.9
MAS1		ENSG00000130368	"MAS1 proto-oncogene, G protein-coupled receptor"	P04201	6	159890988-159917447	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"brain: 9.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;B-cells: 2.0;Cone photoreceptor cells: 2.1;Rod photoreceptor cells: 2.1;Urothelial cells: 1.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 5.1;hippocampal formation: 9.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"HMC-1: 7.5"	"Group enriched"	"Detected in many"	22	"amygdala: 38.5;basal ganglia: 26.6;cerebral cortex: 32.4;hippocampal formation: 64.6;white matter: 18.1"	"Group enriched"	"Detected in some"	4	"amygdala: 5.2;cerebral cortex: 8.0;hippocampal formation: 15.1"	HPA079325	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA079325: "	"unprognostic (3.31e-1)"	"unprognostic (2.25e-3)"		"unprognostic (2.91e-1)"	"unprognostic (2.22e-3)"	"unprognostic (8.15e-3)"		"unprognostic (7.05e-2)"		"unprognostic (1.88e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.48e-5)"	"unprognostic (1.69e-1)"	"unprognostic (7.67e-2)"	"unprognostic (6.28e-1)"		0.0	0.0	1.7	0.0	0.7	0.3	0.0	0.0	5.1	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.7	0.0	5.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	3.2	0.6	0.0	2.0	0.0	1.4	0.0	0.0	1.2	0.1	0.3	0.8	0.0	0.6	0.0	2.1	0.2	0.2	0.0	0.0	0.0	0.1	0.4	0.3	0.8	0.0	0.0	0.1	0.0	0.3	0.7	0.0	0.3	0.0	0.4	1.1	0.4	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.9	0.7	0.0	0.0	0.5	0.7	1.0	0.0	0.0	0.1	0.0	0.7	0.0	1.4	0.0	0.3	0.0	2.1	0.0	1.3	1.0	0.4	0.5	0.0	0.0	0.3	0.5	0.2	0.2	1.9
MASP1	"CRARF, MASP, PRSS5"	ENSG00000127241	"Mannan binding lectin serine peptidase 1"	P48740	3	187217282-187291980	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 120.0;heart muscle: 116.1;liver: 183.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 28.1;Cardiomyocytes: 38.1;Cholangiocytes: 20.0;Endometrial stromal cells: 30.6;Fibroblasts: 16.4;Hepatic stellate cells: 23.2;Hepatocytes: 65.8"	"Group enriched"	"Detected in some"	9	"glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BJ: 133.3;BJ hTERT+: 498.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001617, HPA009641"	Supported		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	No	NA	8670000000	1900000000		"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA001617: AB_1079314, HPA009641: AB_1079313"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.25e-6)"	"prognostic favorable (2.20e-4)"	"unprognostic (9.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.29e-1)"	6.3	3.6	9.4	1.3	9.4	0.0	2.8	12.9	7.0	120.0	4.9	57.5	1.9	88.4	3.3	11.1	17.7	5.1	116.1	10.4	27.0	4.8	183.4	6.0	1.0	19.2	16.5	2.7	0.2	0.3	1.0	9.0	15.3	46.0	5.6	0.0	2.3	52.2	37.5	6.3	7.5	44.4	22.2	0.8	1.6	0.5	14.6	0.2	3.2	18.9	4.3	9.9	61.5	32.0	0.0	0.0	0.3	0.4	15.7	17.3	0.1	133.3	498.3	1.8	0.9	0.0	0.0	0.1	0.0	40.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	2.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.2	0.0	0.0	5.4	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	9.4	12.9	7.0	10.4	27.0	19.2	16.5	15.3	22.2	14.6	32.0	1.1	0.0	1.8	28.1	0.2	2.9	0.1	0.2	0.0	0.0	0.0	0.0	38.1	20.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.9	0.7	30.6	2.0	0.0	0.0	0.2	0.0	0.3	16.4	0.0	0.7	0.0	0.2	23.2	65.8	0.4	0.0	0.9	0.0	0.0	1.9	3.7	7.5	2.5	0.3	1.8	1.0	0.0	0.0	0.0	10.1	0.2	0.0	0.0	0.7	0.1	0.1	0.0	2.4	0.0	0.0	0.0	5.4	4.5	0.0	0.0	0.2	1.7	0.1	0.5	5.1	0.0	0.1
MASP2	MASP1P1	ENSG00000009724	"Mannan binding lectin serine peptidase 2"	O00187	1	11026523-11047239	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	64	"liver: 476.5"	"Cell type enriched"	"Detected in some"	52	"Hepatocytes: 658.6"	"Cancer enriched"	"Detected in some"	71	"liver cancer: 41.9"	"Region enriched"	"Detected in single"	9	"cerebellum: 6.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 16.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029313, HPA029314"	Uncertain		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	340000000	820000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"HPA029313: AB_10669654, HPA029314: AB_10670029"	"unprognostic (7.00e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.26e-3)"	"prognostic favorable (1.60e-4)"	"unprognostic (2.92e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.90e-3)"	"unprognostic (8.30e-4)"	"unprognostic (7.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-4)"	2.1	1.2	0.0	1.7	0.0	7.4	2.2	6.4	0.7	2.4	0.0	2.7	1.6	2.8	0.0	1.2	2.7	1.2	1.3	0.1	0.0	1.0	476.5	1.8	2.7	0.0	0.0	2.9	2.9	0.0	2.3	0.6	0.2	1.6	0.0	6.9	2.5	0.0	5.1	5.3	3.4	0.0	0.0	2.5	2.4	1.5	0.0	0.0	1.9	0.0	0.0	2.1	1.6	0.4	0.5	0.3	2.6	1.6	0.0	0.1	0.4	0.7	0.0	0.0	0.0	1.2	1.0	2.3	0.6	0.0	0.5	0.7	0.0	0.0	0.0	0.6	2.3	1.3	2.7	16.4	0.0	2.0	1.5	0.0	0.0	0.1	0.0	1.8	0.0	1.7	0.7	0.5	0.0	0.5	0.6	1.1	0.3	0.2	0.7	1.6	0.9	0.6	0.0	1.3	1.7	0.7	0.9	0.4	0.4	1.6	0.6	1.2	1.2	0.9	0.5	0.8	0.5	0.5	0.9	1.5	0.5	1.7	0.4	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	6.4	0.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	4.6	1.1	0.9	0.2	0.0	0.6	0.2	0.2	0.0	0.5	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.9	0.0	5.3	9.5	0.0	0.0	0.1	0.0	0.1	1.3	0.0	8.2	658.6	0.1	0.0	8.3	0.0	0.0	12.6	0.3	0.0	0.0	0.0	1.8	1.9	0.0	0.1	0.0	8.0	10.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.7	0.4	0.0	0.7	0.2	0.0	0.0	0.4	0.6	0.0	0.8	0.1	0.0	0.1
MAST1	"KIAA0973, SAST"	ENSG00000105613	"Microtubule associated serine/threonine kinase 1"	Q9Y2H9	19	12833951-12874952	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 37.7;pituitary gland: 23.3;retina: 15.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 24.7;Cone photoreceptor cells: 43.8;Excitatory neurons: 64.7;Inhibitory neurons: 70.3;Oligodendrocyte precursor cells: 22.1;Rod photoreceptor cells: 20.4"	"Cancer enhanced"	"Detected in many"		"glioma: 3.5"	"Region enhanced"	"Detected in many"		"cerebral cortex: 37.7"	"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.3;SCLC-21H: 40.5;SH-SY5Y: 20.2;U-266/70: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028181, HPA073106"	Enhanced		Supported	Vesicles,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Cytosol	"HPA028181: AB_10603872, HPA073106: AB_2732218"	"unprognostic (6.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.83e-5)"	"unprognostic (1.72e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.89e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.19e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.96e-1)"	0.0	2.2	6.5	0.3	12.1	0.3	0.1	7.3	37.7	0.2	0.0	1.2	0.3	0.0	0.0	0.2	0.1	0.2	0.2	8.3	2.4	0.1	0.6	0.1	0.1	11.2	1.1	0.3	0.6	0.5	23.3	0.0	9.5	0.2	0.1	15.4	0.2	0.0	0.0	3.7	0.4	0.0	0.0	0.1	0.6	5.0	1.2	0.8	0.1	0.0	0.0	0.2	0.3	3.0	3.6	1.6	1.5	23.3	0.0	0.0	1.9	0.2	0.1	0.3	0.9	0.8	1.5	5.8	2.6	0.0	3.9	0.1	6.8	0.1	0.1	4.1	4.5	0.5	5.8	2.6	0.0	1.3	1.2	0.5	0.1	0.8	0.7	1.3	0.0	15.2	5.2	3.0	0.0	0.8	2.4	0.6	6.9	0.6	7.2	15.9	4.6	8.3	0.3	0.2	40.5	20.2	0.8	1.4	4.3	1.2	3.8	2.1	0.0	2.8	4.2	3.1	0.8	16.7	14.5	3.7	5.1	3.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	6.5	12.1	7.3	37.7	8.3	2.4	11.2	1.1	9.5	0.0	1.2	3.0	0.5	0.0	2.4	7.8	0.2	0.9	1.6	0.6	0.6	24.7	0.8	2.5	1.0	0.0	0.3	0.0	43.8	0.6	0.4	0.6	0.0	0.4	14.0	0.2	0.2	1.3	0.0	0.0	64.7	0.5	0.6	1.3	0.0	0.3	1.3	0.5	1.1	0.5	0.2	15.2	70.3	0.1	0.0	1.0	1.2	8.2	0.6	0.7	5.4	6.5	0.1	3.7	0.0	22.1	3.0	0.3	2.5	1.2	0.0	1.0	0.9	0.2	1.0	20.4	0.0	2.0	0.5	8.0	5.2	0.7	1.4	0.3	1.0	0.4	0.7	1.2
MASTL	"FLJ14813, Gwl, THC2"	ENSG00000120539	"Microtubule associated serine/threonine kinase like"	Q96GX5	10	27154824-27187953	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 24.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027175, HPA054273"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA027175: AB_1853591, HPA054273: AB_2682433"	"unprognostic (4.10e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (2.19e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (4.81e-5)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (1.71e-6)"	"unprognostic (1.55e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.79e-1)"	5.0	3.9	1.7	6.2	1.9	18.7	5.3	2.3	2.3	3.8	2.1	4.1	4.4	3.9	4.5	5.9	3.0	3.9	2.5	1.9	2.0	3.9	4.9	4.0	8.9	2.0	2.0	3.4	3.3	6.0	3.1	6.5	2.1	3.1	5.2	2.7	4.1	3.0	2.3	6.0	4.3	4.5	1.6	4.6	4.7	6.5	2.0	10.4	4.7	2.2	7.1	4.5	4.3	2.3	29.4	22.0	43.8	15.5	6.2	9.1	25.4	43.3	18.0	68.4	83.8	26.7	27.2	22.4	16.1	18.4	33.5	26.8	27.9	16.0	48.2	20.2	26.5	26.9	14.5	15.5	3.8	10.4	19.8	5.6	7.5	41.6	7.9	9.0	14.7	18.2	21.1	49.9	41.5	17.9	34.8	11.2	32.0	15.9	8.9	22.2	71.9	18.9	17.4	10.6	19.2	26.8	26.0	17.6	19.1	28.1	17.2	21.4	12.6	17.0	36.3	44.0	37.4	5.9	10.3	34.7	18.3	31.1	14.8	0.2	1.8	1.7	0.7	1.7	1.1	1.1	0.9	0.7	1.0	1.6	0.9	0.8	2.3	1.0	1.8	1.1	1.6	0.8	1.7	1.9	2.3	2.3	1.9	2.0	2.0	2.0	2.1	1.6	2.0	2.3	4.3	6.4	7.8	2.6	7.4	11.0	4.9	4.4	4.0	1.7	4.2	4.8	3.0	2.8	7.0	1.8	0.0	8.6	10.1	7.0	0.0	4.0	3.0	9.7	5.3	4.6	4.2	7.8	4.3	2.5	24.9	7.3	6.1	17.9	12.7	6.9	2.5	2.5	5.8	3.3	4.3	3.7	4.1	7.8	19.3	1.7	3.1	11.3	0.0	3.7	5.1	1.8	3.1	3.5	4.9	4.4	2.9	2.6	7.1	5.0	2.8	1.9	4.0	1.0	0.0	3.8	5.3	14.9	14.1	10.9	9.9	6.2	11.6	5.4	4.5	6.6
MAT1A	"MAT, MATA1, SAMS, SAMS1"	ENSG00000151224	"Methionine adenosyltransferase 1A"	Q00266	10	80271820-80289658	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"liver: 1346.5"	"Cell type enriched"	"Detected in some"	55	"Hepatocytes: 5534.4"	"Cancer enriched"	"Detected in many"	54	"liver cancer: 209.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"Hep G2: 94.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA048627	Supported					NA	NA		1900000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA048627: AB_2680465"	"unprognostic (6.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.11e-16)"	"unprognostic (8.59e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.98e-2)"	0.5	0.5	0.4	0.1	0.8	0.0	0.4	0.1	0.5	0.2	0.9	0.2	0.2	0.1	57.5	0.1	1.2	0.0	0.2	0.2	0.2	0.9	1346.5	0.4	0.1	0.6	0.8	6.3	43.8	0.1	0.8	0.1	0.4	0.0	0.0	0.0	0.3	1.9	0.0	4.2	0.0	0.2	0.8	0.5	0.2	3.7	0.2	0.4	0.4	0.0	0.0	0.5	0.1	0.2	6.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.3	0.0	3.2	0.1	0.0	0.0	0.0	0.3	0.5	1.6	0.0	94.9	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	2.1	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	1.0	0.2	0.0	0.5	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.1	0.5	0.2	0.2	0.6	0.8	0.4	0.8	0.2	0.2	0.0	0.0	0.5	0.0	8.8	2.0	0.1	0.4	0.0	0.0	0.2	0.6	0.7	67.2	0.9	1.8	0.0	0.0	0.0	0.0	1.9	0.1	23.9	3.0	0.0	5.3	0.0	69.5	0.1	4.6	0.0	0.0	0.0	0.2	0.0	7.6	76.8	5534.4	0.1	0.0	0.0	0.0	0.0	100.4	0.6	5.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.4	0.0	0.1	0.0	0.6	10.2	0.0	0.0	0.0	0.2	2.7	0.3	0.0	2.7	0.0	6.0	1.0	0.0	0.0
MBOAT7	"BB1, hMBOA-7, LENG4, LPLAT"	ENSG00000125505	"Membrane bound O-acyltransferase domain containing 7"	Q96N66	19	54173412-54189882	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 108.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	9	"basophil: 157.3;eosinophil: 265.9;neutrophil: 239.1"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 265.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 216.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055967	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA055967: AB_2682990"	"unprognostic (1.89e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (5.55e-6)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (5.36e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (1.31e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.95e-1)"	"prognostic favorable (4.31e-4)"	14.9	108.4	17.6	13.4	14.8	13.1	13.7	0.0	21.4	19.0	0.0	27.8	27.0	19.0	6.6	20.6	20.1	9.2	12.8	17.6	34.4	19.2	16.0	23.6	4.8	24.9	27.8	23.0	21.0	18.9	22.8	6.9	29.2	17.3	5.3	1.0	18.6	20.2	7.9	21.1	25.3	4.4	2.7	26.6	19.9	36.3	28.7	3.2	15.9	1.1	2.3	32.5	18.1	4.8	66.8	43.2	3.8	50.8	21.0	15.4	57.1	90.5	42.6	32.9	49.2	22.1	64.3	11.3	46.5	34.4	10.9	111.9	0.3	26.1	9.0	16.1	54.6	12.8	30.0	12.6	18.9	29.0	216.2	31.0	17.9	17.3	9.8	44.1	46.0	11.0	51.6	42.2	9.2	32.2	10.9	22.7	22.0	21.1	60.1	28.4	7.3	24.9	47.0	71.1	2.3	14.3	57.3	37.0	16.3	4.2	34.5	2.8	73.1	49.4	16.0	12.1	40.8	17.4	31.0	6.4	66.1	25.8	27.9	157.3	22.5	265.9	2.2	11.8	3.3	1.8	3.2	1.7	24.8	1.5	1.1	1.7	239.1	7.8	7.0	7.0	1.9	8.6	17.6	14.8	0.0	21.4	17.6	34.4	24.9	27.8	29.2	2.7	28.7	4.8	11.8	12.8	26.4	11.4	11.3	13.9	66.4	29.2	14.8	15.4	31.1	19.8	8.4	31.5	23.2	44.1	6.2	43.5	15.2	88.8	5.9	52.2	1.1	28.7	22.1	18.5	42.5	13.9	18.7	33.1	52.2	16.3	10.7	26.4	76.8	25.3	15.0	22.7	32.2	30.3	13.6	49.6	16.2	36.8	38.1	4.3	19.3	52.5	8.8	8.4	48.9	24.6	3.1	5.5	9.3	28.6	43.0	15.4	9.3	44.5	101.1	14.5	28.5	8.5	39.5	7.7	19.6	5.1	15.0	17.9	21.6	51.6	23.0	46.3	46.6	47.2
MBTPS1	"KIAA0091, PCSK8, S1P, SKI-1"	ENSG00000140943	"Membrane bound transcription factor peptidase, site 1"	Q14703	16	84053761-84116942	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Protease, Serine protease"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 318.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056109	Supported					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA056109: AB_2683040"	"unprognostic (1.50e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (2.21e-5)"	"unprognostic (2.62e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.63e-2)"	"unprognostic (6.88e-2)"	45.8	33.7	12.7	26.2	16.4	24.6	42.8	17.6	13.3	41.2	18.1	38.7	26.0	40.8	25.6	28.2	45.6	32.2	44.6	13.1	17.8	36.7	27.5	35.5	27.5	6.3	8.0	49.4	36.4	58.5	38.8	37.1	8.9	37.3	33.7	108.7	42.4	40.3	18.9	27.8	26.4	41.2	5.9	30.1	30.7	19.6	16.5	33.4	53.9	35.6	29.9	35.2	21.3	8.6	49.4	61.3	53.8	75.2	124.2	100.1	42.2	81.2	124.4	70.2	52.6	43.7	71.0	47.0	82.0	117.3	55.8	52.9	50.2	56.3	77.9	42.6	55.9	34.4	55.8	61.3	59.9	84.2	72.7	103.6	79.9	64.8	55.5	100.3	92.4	62.2	45.6	40.3	43.1	85.0	46.6	46.4	50.3	27.7	43.2	59.6	28.7	34.1	56.1	40.2	41.0	51.2	156.9	42.9	62.1	58.3	134.3	76.4	99.0	72.3	52.5	43.7	38.7	50.5	102.6	90.5	52.6	50.6	45.2	8.0	16.3	15.0	16.3	13.8	16.8	11.3	14.0	15.4	12.8	9.6	16.9	15.3	4.5	17.0	11.6	7.1	9.6	18.3	12.7	16.4	17.6	13.3	13.1	17.8	6.3	8.0	8.9	5.9	16.5	8.6	54.3	48.1	50.7	27.1	33.5	13.8	24.2	25.9	19.9	68.4	62.2	56.1	50.5	44.3	41.9	25.8	166.8	24.4	41.0	28.9	11.7	24.1	0.9	70.4	67.8	39.8	34.9	19.4	50.4	27.5	21.4	48.4	23.0	92.7	29.1	103.1	36.0	33.8	16.7	84.1	53.5	26.6	28.5	21.0	10.8	5.5	53.4	23.3	19.6	36.5	22.5	44.4	29.9	57.8	39.0	30.2	24.8	50.4	59.3	30.1	20.3	17.5	56.4	318.6	26.3	60.9	42.2	12.6	24.2	23.4	15.8	21.6	34.3	75.5	33.8	28.6
MBTPS2	"KFSD, S2P"	ENSG00000012174	"Membrane bound transcription factor peptidase, site 2"	O43462	X	21839617-21885423	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Metalloprotease, Protease"	"Disease variant, Ichthyosis, Osteogenesis imperfecta, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA005494, CAB009486"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Mitochondria, Cytosol"		"CAB009486: AB_2140370, HPA005494: AB_1079329"	"unprognostic (7.97e-3)"	"unprognostic (9.12e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.05e-2)"	8.6	10.6	3.5	5.2	4.0	1.7	8.8	7.8	4.9	7.5	4.5	5.1	5.2	9.7	6.0	5.8	7.3	6.7	7.7	3.7	4.1	9.4	18.7	5.5	5.0	4.4	4.1	12.5	7.3	11.0	3.8	11.6	4.9	10.5	6.0	8.8	6.6	8.5	7.1	3.7	4.2	10.1	4.1	4.8	5.8	4.1	4.2	4.9	9.0	9.1	4.7	6.8	4.0	6.1	16.9	34.5	16.1	16.5	19.8	24.4	7.7	24.4	24.7	22.7	19.7	13.8	22.5	14.6	12.4	26.2	44.4	15.4	22.4	14.0	27.9	10.9	17.8	7.2	19.7	11.4	27.1	15.6	6.8	23.2	14.8	34.3	25.1	23.0	17.8	8.4	20.3	15.8	26.1	10.5	6.4	8.1	15.0	8.8	25.1	7.9	29.8	16.4	15.7	8.4	3.9	32.8	34.3	21.5	30.5	21.3	28.9	13.2	21.2	28.4	6.6	41.9	18.5	19.1	26.0	6.9	31.6	6.4	28.0	0.0	2.2	0.8	2.2	2.5	2.0	1.9	1.6	2.0	3.6	1.7	2.2	2.6	0.2	2.6	2.6	2.4	3.2	1.7	3.5	4.0	7.8	4.9	3.7	4.1	4.4	4.1	4.9	4.1	4.2	6.1	5.5	9.6	11.5	16.6	5.8	5.5	4.8	7.0	8.0	11.8	7.5	5.1	13.3	8.6	7.1	7.3	18.8	7.0	2.2	3.8	0.0	5.9	0.3	4.0	11.5	5.6	2.4	2.1	16.8	8.9	7.1	10.8	6.1	3.7	10.8	14.5	7.5	18.7	9.4	30.3	25.0	3.4	12.2	9.2	4.0	1.9	10.5	4.8	10.6	11.2	5.0	7.3	3.1	21.6	22.2	6.1	2.4	13.2	9.1	7.4	4.9	7.2	10.7	14.5	0.0	8.6	8.3	2.7	1.5	6.5	2.7	4.8	5.1	12.3	4.3	4.9
MCCC1	MCCA	ENSG00000078070	"Methylcrotonoyl-CoA carboxylase 1"	Q96RQ3	3	183015218-183116075	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 153.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008310	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA008310: AB_1853620"	"unprognostic (4.01e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.59e-3)"	"unprognostic (3.46e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.82e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.65e-2)"	"prognostic favorable (3.68e-4)"	"unprognostic (4.73e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	37.9	22.6	9.5	9.5	10.9	13.9	33.2	9.9	13.4	12.3	13.8	17.4	16.1	10.1	14.6	17.6	12.2	11.9	34.2	9.2	9.3	58.8	59.3	17.9	11.7	9.5	9.1	17.2	31.2	18.7	8.4	6.3	10.6	15.1	18.6	10.8	18.0	13.4	21.9	12.2	13.8	10.6	9.3	11.8	21.7	9.1	11.1	16.0	18.9	26.3	15.5	26.5	9.4	13.3	43.1	16.5	10.3	10.6	42.6	19.1	20.4	19.5	26.4	21.1	23.5	22.9	17.1	47.6	31.0	17.2	35.8	22.0	15.4	12.9	26.4	16.6	17.0	40.0	18.3	23.9	28.7	27.5	22.0	21.6	14.5	10.0	23.3	14.0	28.6	40.7	22.7	24.7	23.6	35.4	27.1	15.9	11.2	66.3	17.9	22.4	22.6	60.1	32.2	67.2	22.0	16.4	75.3	100.1	21.1	10.7	153.9	37.8	14.0	15.8	12.5	12.8	28.6	24.3	48.8	48.2	16.8	38.4	15.2	14.4	13.3	25.0	10.7	15.6	12.3	17.9	14.1	11.8	26.6	15.4	14.7	13.1	2.1	25.4	16.8	17.3	9.6	10.7	9.5	10.9	9.9	13.4	9.2	9.3	9.5	9.1	10.6	9.3	11.1	13.3	6.2	9.6	53.9	44.7	14.6	7.0	20.1	17.9	15.9	13.0	10.6	9.5	32.8	31.5	20.2	27.6	10.4	35.4	6.3	7.2	33.2	25.3	5.4	11.0	10.2	6.6	6.0	10.9	66.6	17.2	5.4	10.3	21.4	21.9	7.6	19.0	6.1	36.5	16.5	8.4	56.9	13.6	16.2	11.1	8.6	5.5	8.7	10.5	7.2	44.0	10.5	12.0	4.1	47.7	61.6	13.4	15.8	10.5	12.5	10.4	13.5	40.6	21.4	11.2	6.6	11.6	9.6	8.1	4.4	22.3	5.8	28.3	10.1	24.3	20.5	21.7
MCCC2	MCCB	ENSG00000131844	"Methylcrotonoyl-CoA carboxylase 2"	Q9HCC0	5	71587288-71658706	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 120.5"	"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 107.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 81.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038300, HPA038301, HPA061546"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA038300: AB_2675941, HPA038301: AB_10670661, HPA061546: AB_2684557"	"unprognostic (2.39e-1)"	"unprognostic (6.89e-3)"	"prognostic favorable (3.62e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.07e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.43e-8)"	"unprognostic (1.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (3.47e-2)"	21.3	47.6	13.4	13.5	13.7	6.0	60.0	12.4	15.5	21.3	24.9	30.5	27.2	14.4	38.9	25.4	17.2	15.2	54.9	12.0	13.1	73.3	120.5	13.4	17.8	14.8	13.4	14.2	24.6	32.8	14.1	14.2	14.8	48.2	35.9	12.2	28.2	20.6	34.4	19.8	20.7	11.7	16.3	15.6	25.8	8.6	16.0	14.2	44.6	35.4	21.5	27.0	15.0	18.4	38.5	52.4	21.4	82.5	22.4	23.0	36.9	16.4	29.4	35.7	25.7	91.1	46.9	90.4	62.8	25.9	28.0	30.8	37.8	58.8	44.3	47.6	45.6	48.2	24.7	100.5	39.2	24.4	42.8	29.5	30.1	32.6	25.8	15.8	31.7	24.9	63.2	31.6	24.9	103.0	0.3	42.9	29.0	33.2	27.2	46.3	64.5	130.9	92.5	66.9	32.9	36.7	80.1	111.8	38.8	10.1	92.7	59.6	22.7	14.4	22.1	26.1	49.9	22.4	46.2	54.6	23.7	66.3	36.6	2.0	8.4	1.9	6.5	13.5	8.5	9.7	8.4	7.4	19.4	9.9	8.3	9.1	1.3	14.7	8.1	8.1	12.1	8.3	13.4	13.7	12.4	15.5	12.0	13.1	14.8	13.4	14.8	16.3	16.0	18.4	9.1	16.0	23.6	27.4	26.8	13.3	17.5	20.2	22.2	12.6	54.9	28.3	61.5	20.0	22.3	16.5	6.2	48.5	17.6	26.3	21.5	20.6	4.3	94.0	24.0	15.1	29.5	13.9	22.2	18.2	23.0	13.1	30.1	107.0	12.7	22.7	9.7	93.1	18.0	3.3	21.6	22.8	8.2	12.1	11.2	9.8	13.7	14.0	12.4	11.2	17.9	15.4	20.6	30.2	28.0	15.3	17.0	20.3	27.2	29.6	23.6	59.1	17.7	10.8	6.6	15.2	9.0	4.2	12.0	35.9	13.8	63.6	17.9	30.9	33.9	20.9
MCEE	"GLOD2, MCE"	ENSG00000124370	"Methylmalonyl-CoA epimerase"	Q96PE7	2	71109684-71130239	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 92.0;Proximal tubular cells: 77.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035196			Approved	Nucleoli	"Intracellular and membrane"	No	No		29000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoli		"HPA035196: AB_10601871"	"unprognostic (7.65e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (4.76e-4)"	"prognostic favorable (5.78e-4)"	"unprognostic (4.86e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-3)"	"unprognostic (8.59e-2)"	"unprognostic (9.40e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.38e-2)"	17.8	30.0	8.9	12.3	9.7	9.1	32.7	10.5	12.5	22.1	15.4	20.1	20.1	13.1	30.5	26.3	14.8	14.2	35.9	8.9	9.4	33.7	69.8	13.7	14.7	9.5	9.1	18.5	36.1	35.6	24.1	17.6	9.9	23.9	23.9	12.3	42.8	17.8	36.5	28.4	16.9	12.2	9.7	16.0	23.5	6.0	9.4	13.3	14.1	61.7	15.5	16.5	21.9	11.7	12.1	5.2	10.6	7.6	34.3	46.6	30.2	18.5	23.3	9.2	13.9	14.7	14.8	18.7	5.5	18.5	7.0	12.5	12.4	9.6	9.5	17.1	10.7	12.7	16.3	42.5	19.5	14.5	10.3	31.3	13.5	6.2	12.3	20.5	10.6	14.6	17.1	31.9	9.1	15.5	10.9	16.9	9.6	33.1	14.6	12.8	12.3	35.2	14.8	10.4	11.9	8.8	6.9	40.1	18.1	12.1	31.7	13.4	13.7	10.6	8.3	10.9	7.5	30.7	13.1	20.0	17.5	23.7	9.9	20.3	23.2	27.6	15.4	25.6	21.9	21.6	19.3	15.5	19.9	16.7	17.6	15.0	6.1	16.5	25.3	23.9	35.3	14.6	8.9	9.7	10.5	12.5	8.9	9.4	9.5	9.1	9.9	9.7	9.4	11.7	11.1	25.6	13.4	13.7	12.8	8.5	10.5	18.4	21.6	2.6	37.5	27.3	75.2	25.8	18.2	5.5	2.1	36.2	11.2	14.0	92.0	13.3	1.1	17.2	16.2	9.0	9.0	12.0	13.3	18.4	36.8	23.3	17.3	20.2	0.0	5.2	12.8	73.0	15.1	5.0	14.5	32.5	18.3	10.4	8.7	1.0	29.2	9.4	14.2	14.0	9.1	7.3	5.2	16.1	20.8	9.6	16.2	17.7	42.0	11.0	35.0	77.1	19.4	8.6	26.3	12.7	17.9	3.7	5.1	25.6	20.9	11.4	10.1	16.9	23.0	11.9
MCFD2	"F5F8D, LMAN1IP, SDNSF"	ENSG00000180398	"Multiple coagulation factor deficiency 2, ER cargo receptor complex subunit"	Q8NI22	2	46901870-46941855	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 253.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022410, HPA034593"	Supported				"Intracellular and membrane"	NA	NA		1200000	"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"			"CAB022410: , HPA034593: AB_2674239"	"unprognostic (1.16e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.98e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.93e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.64e-4)"	52.0	155.5	41.3	35.6	43.1	34.7	55.1	38.1	40.3	50.4	69.5	32.2	32.5	54.5	42.1	45.9	41.9	44.9	42.3	41.3	46.8	59.4	111.8	45.0	32.1	33.5	41.3	79.2	104.1	52.5	38.7	70.1	41.6	54.0	26.9	83.3	149.7	82.9	83.3	26.0	33.4	52.5	28.0	44.6	33.9	30.9	48.6	30.8	121.0	84.6	34.2	41.2	29.2	34.7	147.7	86.9	74.7	59.7	151.5	215.1	115.4	248.4	254.1	129.4	116.8	116.9	109.4	96.4	297.7	294.7	154.3	81.8	67.0	127.0	207.7	64.5	67.2	101.9	87.1	182.5	236.5	94.8	158.6	163.2	77.8	206.7	178.7	247.9	210.8	28.0	199.3	56.0	266.8	48.7	56.9	67.6	63.9	102.3	84.1	68.3	133.2	106.7	80.3	59.3	23.9	62.2	93.1	46.9	116.0	86.3	33.1	80.6	341.1	298.3	130.5	97.0	164.2	42.0	43.8	76.4	320.2	88.0	100.8	27.2	21.4	29.7	9.6	23.3	12.2	12.5	10.9	10.2	18.4	12.8	14.3	9.8	12.0	9.9	18.3	16.9	9.7	14.0	41.3	43.1	38.1	40.3	41.3	46.8	33.5	41.3	41.6	28.0	48.6	34.7	50.8	105.8	89.1	16.6	29.6	48.2	56.5	65.3	36.5	69.3	64.4	48.5	70.3	38.6	68.8	47.8	39.6	75.5	25.4	26.6	21.5	88.6	144.3	76.4	60.2	64.7	26.8	28.2	19.6	178.5	64.5	70.1	20.4	69.9	50.5	44.1	53.9	155.1	54.5	38.7	23.8	28.5	18.3	40.5	31.3	113.7	62.7	39.2	12.4	7.5	33.8	253.2	12.3	16.1	16.2	152.7	23.1	59.5	43.8	82.4	42.2	41.3	69.6	51.3	65.7	63.9	55.4	48.9	32.6	39.6	44.9	102.1	23.4	74.3	22.8	75.8
MCM2	"BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030"	ENSG00000073111	"Minichromosome maintenance complex component 2"	P49736	3	127598410-127622436	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 67.7;lymphoid tissue: 37.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 63.3;Erythroid cells: 65.6;Extravillous trophoblasts: 28.8;Spermatogonia: 25.9;Syncytiotrophoblasts: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB000303, HPA031450, HPA031495, HPA031496"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		120000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905"	"unprognostic (2.43e-1)"	"prognostic favorable (4.66e-4)"	"unprognostic (4.44e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.51e-7)"	"unprognostic (8.43e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.82e-1)"	3.1	3.4	2.0	16.4	1.9	67.7	6.2	2.5	1.9	5.3	0.6	9.2	8.1	5.0	2.4	11.0	7.6	2.5	6.4	1.9	1.8	3.4	6.3	3.4	26.8	2.3	1.9	6.4	3.0	3.7	2.4	17.0	2.6	5.0	10.2	3.5	4.7	2.8	9.4	10.6	8.6	5.3	2.0	9.6	5.7	12.3	2.0	37.6	4.8	5.8	26.0	4.2	5.4	2.4	133.6	110.3	122.4	102.1	7.0	14.4	110.5	65.2	42.3	129.9	146.9	177.7	84.7	136.0	65.2	32.3	113.6	105.6	204.8	76.1	79.1	127.2	127.1	227.4	134.8	131.1	4.4	214.3	102.4	8.2	8.4	86.1	13.1	15.3	40.6	160.7	116.0	123.7	47.4	169.0	229.0	156.2	172.5	108.3	90.7	242.4	165.1	203.3	26.9	97.9	143.0	106.8	175.8	48.9	16.7	45.7	111.9	165.3	20.3	104.2	87.9	128.4	91.7	127.1	163.5	362.6	73.2	159.7	41.0	0.0	0.6	0.3	4.4	1.4	5.5	9.7	3.9	5.4	2.9	8.1	3.6	4.7	0.9	6.5	0.4	3.7	11.2	3.5	2.0	1.9	2.5	1.9	1.9	1.8	2.3	1.9	2.6	2.0	2.0	2.4	1.2	3.2	2.0	0.7	8.5	4.6	2.6	4.6	2.2	2.5	4.1	5.3	8.3	0.0	3.9	0.0	0.0	63.3	1.8	4.8	0.0	5.3	0.9	5.2	3.5	2.9	3.6	65.6	0.3	1.9	28.8	4.2	6.6	4.8	1.3	18.8	1.4	1.7	18.2	0.0	0.4	8.2	0.0	1.6	3.2	0.7	1.8	2.7	1.8	0.0	9.2	2.1	0.0	0.0	0.7	2.1	1.7	1.5	20.5	0.8	1.1	0.8	7.4	2.1	0.0	2.6	4.1	8.1	25.9	7.1	3.0	33.5	6.3	3.8	13.8	2.3
MCM3AP	"GANP, KIAA0572, Map80, SAC3"	ENSG00000160294	"Minichromosome maintenance complex component 3 associated protein"	O60318	21	46235133-46286297	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Immunity, mRNA transport, Protein transport, Translocation, Transport"	"Acyltransferase, Transferase"	"Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021527, HPA032103"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane, Cytosol"	Nucleoplasm	"HPA021527: AB_1853626, HPA032103: AB_2674152"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.76e-3)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.28e-1)"	16.8	12.0	10.0	20.3	11.5	19.7	13.6	8.9	10.7	14.7	17.0	15.1	14.0	16.5	8.3	14.3	15.2	14.2	15.1	8.5	7.8	13.0	9.7	16.0	21.0	10.8	10.4	17.6	15.4	16.9	9.2	16.3	9.5	14.2	15.0	12.8	13.7	13.4	41.3	13.8	16.1	17.1	9.4	19.6	15.4	14.1	11.0	21.7	16.0	28.7	21.5	13.6	11.2	14.6	38.0	36.3	41.8	45.5	33.1	41.4	38.0	40.8	48.1	37.1	30.2	33.1	21.9	53.6	32.9	43.2	40.3	21.9	55.9	34.0	32.7	55.7	50.8	87.9	35.0	25.9	29.6	40.6	47.7	31.7	28.7	51.2	35.2	25.4	40.7	31.7	107.3	39.6	43.3	21.1	43.5	26.8	72.3	40.0	30.2	56.3	26.6	48.9	17.8	34.1	35.2	37.6	52.4	33.7	39.0	31.5	46.0	41.2	51.6	39.1	29.7	33.1	31.0	71.8	86.2	33.0	35.3	38.0	51.8	0.6	2.0	1.6	2.3	1.9	2.4	1.1	1.3	2.6	1.9	1.6	1.2	1.3	1.2	1.1	1.1	1.6	1.8	2.1	10.0	11.5	8.9	10.7	8.5	7.8	10.8	10.4	9.5	9.4	11.0	14.6	17.3	9.6	18.9	28.1	21.3	7.0	7.1	9.0	22.2	21.8	13.8	13.0	4.7	14.3	12.7	11.0	20.9	11.4	20.6	17.5	1.9	11.3	3.5	16.8	23.7	14.8	12.0	18.5	28.0	14.2	11.7	12.8	27.0	17.7	8.8	20.1	11.7	18.6	15.4	16.8	34.2	19.2	10.2	19.7	8.4	4.3	18.3	18.6	10.6	34.7	24.3	9.3	16.5	37.2	35.3	15.9	8.6	14.3	21.6	14.0	13.8	6.6	15.5	21.7	19.7	17.9	12.9	19.7	15.0	21.2	10.4	9.3	19.1	16.0	17.9	7.9
MCM4	"CDC21, CDC54, hCdc21, MGC33310, P1-Cdc21"	ENSG00000104738	"Minichromosome maintenance complex component 4"	P33991	8	47960185-47978160	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 153.2;Erythroid cells: 60.8;Late spermatids: 77.9;Spermatocytes: 65.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004497, HPA004873, HPA031052"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		140000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB004497: AB_627916, HPA004873: AB_1079337, HPA031052: AB_2673712"	"unprognostic (4.55e-2)"	"unprognostic (3.16e-3)"	"prognostic favorable (2.19e-4)"	"prognostic unfavorable (2.84e-5)"	"unprognostic (7.71e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.12e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.40e-1)"	6.5	8.8	4.8	21.7	4.8	63.2	16.0	5.7	5.2	7.7	1.8	17.7	13.3	6.9	4.6	22.4	9.7	5.6	14.5	5.2	3.5	8.2	9.2	6.3	38.7	3.6	4.2	7.1	5.5	7.7	4.1	18.3	3.9	5.6	21.3	12.3	8.8	4.9	13.4	24.2	16.7	9.2	4.2	8.1	10.6	41.6	4.8	47.0	6.5	15.8	41.8	11.8	10.9	5.2	184.0	139.6	188.1	83.2	20.7	36.6	102.8	122.6	99.8	178.5	190.3	156.6	181.1	229.8	70.3	72.1	119.2	143.2	278.7	128.2	199.8	64.2	190.4	371.8	133.3	169.2	5.4	189.7	82.0	20.3	24.1	147.8	54.3	28.6	72.0	136.8	216.2	167.0	129.9	155.6	435.5	141.5	241.2	246.5	54.2	266.6	159.6	139.2	64.9	168.1	209.0	97.8	325.6	133.6	46.3	117.7	154.9	110.5	45.1	138.1	125.4	144.5	131.9	54.7	104.6	347.2	114.8	185.7	131.5	2.3	1.8	1.1	4.0	3.1	2.0	3.9	3.8	5.4	3.9	1.6	3.3	2.7	0.1	4.1	3.5	1.5	10.2	3.6	4.8	4.8	5.7	5.2	5.2	3.5	3.6	4.2	3.9	4.2	4.8	5.2	3.3	0.0	6.3	3.3	6.5	21.7	11.1	9.0	13.6	12.2	9.0	7.7	25.1	1.5	8.4	5.5	10.4	36.7	5.8	12.1	3.9	8.0	153.2	11.0	7.9	6.7	6.7	60.8	5.0	6.0	40.2	10.6	11.2	13.4	1.3	24.9	2.2	3.2	12.3	16.8	5.7	13.9	4.1	2.9	6.5	77.9	5.3	7.9	3.6	1.9	2.4	7.0	3.1	4.0	2.9	4.5	4.8	3.0	22.3	7.7	5.6	3.0	13.1	16.7	0.0	9.5	11.4	65.8	39.9	19.1	19.0	29.8	9.0	11.7	26.2	9.7
MCM5	CDC46	ENSG00000100297	"Minichromosome maintenance complex component 5"	P33992	22	35400134-35425431	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 138.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 147.8;Erythroid cells: 96.6;monocytes: 137.7;Syncytiotrophoblasts: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000101, HPA000845, HPA052880"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		44000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: AB_2681979"	"unprognostic (6.71e-2)"	"prognostic favorable (2.81e-6)"	"unprognostic (5.29e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.78e-4)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.53e-1)"	15.2	7.1	5.8	49.1	10.4	138.7	14.4	8.3	7.4	14.5	5.8	20.2	19.6	16.3	3.3	25.1	13.7	9.6	8.9	5.8	7.0	9.1	14.9	14.8	70.1	10.3	7.7	25.6	12.6	10.3	5.3	25.2	9.6	10.2	16.7	2.3	13.9	9.6	13.3	17.6	28.3	12.2	8.1	47.3	17.9	20.6	9.0	58.9	12.1	8.0	53.6	12.7	15.6	12.3	213.0	147.5	115.7	118.8	11.0	22.2	100.6	138.1	71.2	199.4	188.3	98.9	102.4	137.9	78.8	70.5	83.6	103.8	116.0	108.3	64.4	112.7	212.6	198.3	141.5	203.7	3.9	414.0	172.4	12.3	9.7	120.0	32.4	18.4	88.7	124.5	124.0	201.2	76.9	172.7	341.8	137.9	154.9	143.4	86.7	379.6	164.8	173.0	39.4	120.1	88.2	94.8	188.3	75.4	41.8	60.9	78.8	155.6	54.1	201.3	153.1	127.2	145.4	111.9	150.2	265.2	130.9	153.5	157.6	66.5	59.8	43.4	49.5	69.6	35.8	127.5	43.1	53.1	77.8	106.1	34.0	39.0	28.4	65.5	81.2	88.8	96.6	77.1	5.8	10.4	8.3	7.4	5.8	7.0	10.3	7.7	9.6	8.1	9.0	12.3	8.1	6.4	7.3	1.3	49.5	10.6	13.6	12.1	8.6	1.5	9.2	10.8	3.5	8.6	6.0	7.3	0.0	147.8	30.4	12.0	5.9	19.8	2.8	6.2	4.1	11.8	3.5	96.6	0.3	12.7	77.1	11.2	18.8	9.0	15.2	65.7	13.2	5.3	53.1	1.7	0.4	16.6	4.1	24.0	29.4	5.1	10.8	28.4	7.2	7.5	137.7	5.7	13.4	3.0	6.0	11.0	8.6	6.0	49.3	4.0	6.5	5.7	4.8	3.7	19.7	8.8	14.5	16.1	58.8	14.9	6.3	82.2	19.4	8.5	34.6	9.8
MCM8	"C20orf154, dJ967N21.5, MGC119522, MGC119523, MGC12866, MGC4816, REC"	ENSG00000125885	"Minichromosome maintenance 8 homologous recombination repair factor"	Q9UJA3	20	5950652-5998977	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 71.8;Spermatogonia: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											"HPA045141, HPA066433"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA045141: AB_2679230, HPA066433: "	"unprognostic (6.55e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (5.78e-2)"	"prognostic unfavorable (9.30e-8)"	"unprognostic (5.21e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.47e-1)"	2.9	2.9	3.0	4.6	4.1	10.2	2.8	6.8	4.4	4.0	4.2	3.9	3.6	3.1	2.1	3.7	3.2	1.7	3.3	3.1	3.4	2.4	1.8	2.4	7.5	2.9	3.1	2.6	3.1	2.0	1.6	3.3	3.1	3.6	3.2	5.3	2.9	1.8	6.9	4.7	3.7	2.1	2.6	3.6	3.3	13.4	3.1	9.0	2.4	4.6	6.5	3.4	3.6	5.8	48.6	33.0	27.7	30.3	4.6	6.6	27.4	38.1	12.3	26.6	32.0	35.4	27.6	48.3	11.3	10.2	51.5	50.9	46.1	25.7	47.9	13.4	21.5	49.3	16.8	27.9	0.9	56.6	7.4	2.5	3.8	47.2	17.6	5.3	12.3	28.7	56.7	45.8	27.1	12.3	27.6	30.0	40.3	25.3	21.6	34.8	50.9	18.6	5.0	15.3	21.6	23.2	40.0	36.3	22.5	28.6	27.1	16.4	9.6	51.5	43.2	28.2	56.8	20.1	53.8	82.2	9.6	33.5	43.4	1.0	0.1	0.4	0.4	0.1	0.7	0.3	0.2	0.4	0.0	0.3	0.2	0.4	0.4	0.4	0.2	0.4	0.5	0.1	3.0	4.1	6.8	4.4	3.1	3.4	2.9	3.1	3.1	2.6	3.1	5.8	3.3	0.0	4.4	1.6	6.0	2.3	3.0	1.9	4.6	7.3	2.1	2.8	10.3	7.2	2.4	12.9	16.7	7.2	4.2	5.8	0.0	1.9	8.5	4.9	3.5	4.2	4.2	14.9	3.7	2.8	6.3	5.0	3.1	5.4	1.3	24.4	2.9	1.9	4.5	6.7	2.9	4.0	6.1	2.8	4.6	3.2	3.7	3.7	1.8	2.8	0.3	3.7	8.2	3.5	6.6	3.6	3.9	3.0	9.2	3.3	4.7	2.4	4.0	11.5	6.6	5.7	4.8	71.8	37.1	5.0	2.6	4.0	6.0	3.0	6.3	2.2
MCM9	"C6orf61, dJ329L24.3, FLJ20170, MCMDC1, MGC35304"	ENSG00000111877	"Minichromosome maintenance 9 homologous recombination repair factor"	Q9NXL9	6	118813442-118935162	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.0;Microglial cells: 40.3;Oligodendrocyte precursor cells: 35.7;Oligodendrocytes: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031137	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA031137: AB_10602027"	"unprognostic (3.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.61e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.95e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.79e-2)"	5.7	4.4	2.5	5.7	3.3	12.7	7.0	2.4	2.9	6.8	3.5	5.1	4.9	5.3	10.2	6.5	5.8	3.7	3.4	2.2	2.5	6.6	5.0	5.2	7.5	3.2	3.2	5.1	6.9	5.3	4.6	7.0	3.1	6.8	5.7	4.1	7.5	4.7	2.6	6.5	5.8	4.2	2.8	6.3	4.9	5.7	3.0	8.0	8.0	2.1	7.1	5.8	6.9	3.7	4.2	6.5	10.3	11.8	4.2	4.8	7.3	3.9	7.1	5.4	6.8	5.2	6.7	12.1	4.5	6.2	3.9	12.5	7.1	4.7	7.2	7.5	10.1	11.4	9.5	5.5	3.0	11.7	7.3	5.2	5.7	6.0	7.3	3.7	5.5	8.0	12.9	6.3	4.2	9.4	10.0	9.4	4.7	7.3	3.1	8.3	7.0	4.2	5.4	7.9	8.5	6.0	6.9	5.7	3.7	2.9	7.3	15.8	6.0	4.3	3.7	2.9	5.7	7.8	7.2	13.9	5.5	8.7	5.6	4.3	2.6	4.4	2.2	2.7	1.8	1.5	1.4	2.3	2.9	1.4	1.7	1.6	2.9	4.8	1.7	2.1	3.5	2.1	2.5	3.3	2.4	2.9	2.2	2.5	3.2	3.2	3.1	2.8	3.0	3.7	6.6	6.4	6.7	32.0	10.8	2.9	3.8	2.9	7.4	3.5	6.4	4.1	6.0	2.8	4.4	7.3	10.4	11.8	7.6	7.2	3.9	3.0	2.9	7.4	6.0	6.3	7.2	4.6	16.8	2.8	3.4	5.0	9.2	6.9	7.0	8.1	2.9	3.9	3.5	1.7	15.2	6.0	6.1	5.5	2.8	2.6	3.7	7.4	0.0	40.3	6.3	1.6	11.3	35.7	39.7	2.7	5.6	4.1	10.9	3.9	6.8	3.3	10.6	5.6	0.0	5.7	5.8	6.3	4.6	8.6	2.0	7.3	9.8	4.7	4.1	4.3
MCOLN1	"ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1"	ENSG00000090674	"Mucolipin 1"	Q9GZU1	19	7522624-7534009	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Ion channel"	"Disease variant, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 109.4;Kupffer cells: 117.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 117.5;classical monocyte: 45.2;eosinophil: 105.7;intermediate monocyte: 95.5;neutrophil: 41.1;non-classical monocyte: 105.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 117.5;monocytes: 105.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031763, CAB032637, HPA069495"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: "	"unprognostic (5.51e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.07e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (5.60e-5)"	"unprognostic (1.36e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.83e-1)"	21.2	37.4	6.4	9.2	6.5	10.4	15.3	7.0	8.4	11.7	8.3	13.6	8.3	11.6	2.7	11.0	12.2	10.1	15.7	7.0	7.4	11.7	14.7	20.3	13.2	8.2	7.4	10.0	9.9	10.2	21.7	15.9	9.0	8.7	5.6	5.0	12.3	6.1	22.2	20.8	12.1	8.1	7.1	48.2	12.8	5.6	8.2	6.2	8.5	11.7	4.1	15.8	10.9	9.9	11.6	11.7	5.6	19.1	32.0	10.3	16.1	21.2	16.9	25.2	21.6	9.0	10.0	6.5	25.5	14.5	22.2	5.3	9.5	7.3	7.4	12.7	21.1	5.8	11.0	7.3	28.0	6.6	24.5	14.5	16.8	24.1	4.2	7.9	10.7	14.2	10.9	27.9	14.7	3.9	9.1	6.6	12.6	6.1	24.8	12.6	9.4	13.8	9.6	9.9	14.4	17.8	9.1	15.8	26.8	6.1	9.6	11.4	13.5	12.0	6.9	48.8	16.0	21.5	35.5	4.7	19.2	9.2	18.4	117.5	45.2	105.7	7.7	95.5	6.3	4.2	6.5	6.3	19.2	4.1	6.0	6.5	41.1	10.3	105.1	21.1	10.0	17.1	6.4	6.5	7.0	8.4	7.0	7.4	8.2	7.4	9.0	7.1	8.2	9.9	15.1	3.2	2.6	5.9	8.0	13.4	6.5	16.9	10.2	27.3	15.9	15.0	2.3	15.7	8.1	31.3	22.9	11.6	12.1	32.0	1.9	23.7	4.8	5.0	19.8	14.1	16.8	21.7	10.6	23.1	20.0	16.0	9.7	6.5	1.3	22.2	13.6	13.6	109.4	58.9	8.0	10.0	22.4	117.1	32.2	17.0	16.4	70.6	21.4	7.5	18.0	23.0	16.5	7.5	11.4	23.4	19.3	15.8	8.0	5.6	21.8	12.3	6.5	44.1	6.6	11.2	14.8	10.3	14.7	8.9	17.3	29.6	8.7	17.3	9.4	4.8
MCTP2	"FLJ11175, FLJ33303"	ENSG00000140563	"Multiple C2 and transmembrane domain containing 2"	Q6DN12	15	94231538-94483952	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 72.8;NK-cells: 97.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 6.8"	"Immune cell enhanced"	"Detected in many"		"neutrophil: 32.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 20.8;HMC-1: 16.4;U-698: 22.4;U-87 MG: 24.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051176, HPA070541"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA051176: AB_2681373, HPA070541: AB_2686277"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.15e-4)"	"unprognostic (3.57e-2)"	"unprognostic (2.66e-3)"	"unprognostic (3.45e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (2.18e-5)"	"unprognostic (5.87e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.76e-3)"	"unprognostic (9.41e-2)"	4.1	3.8	1.0	6.6	1.8	18.0	2.9	0.0	6.8	5.4	0.8	10.6	6.9	1.8	8.6	3.9	4.1	4.5	0.6	1.1	2.8	2.3	1.5	8.7	6.1	0.0	0.3	1.6	5.7	3.5	7.3	19.3	1.0	5.4	12.2	2.6	5.9	4.1	0.1	3.6	6.4	1.6	0.0	21.1	4.7	1.0	1.3	3.0	5.5	0.4	6.2	6.6	3.7	0.6	3.6	0.0	0.1	0.0	0.0	0.0	2.5	1.9	1.1	0.3	0.1	2.4	4.4	10.3	0.5	0.1	0.1	8.0	0.1	6.6	0.0	2.1	0.8	20.8	2.9	1.2	1.4	4.4	16.4	1.1	7.8	0.1	8.2	0.0	0.0	3.6	0.8	5.9	0.0	0.0	2.0	11.4	0.8	3.6	3.7	4.7	0.1	4.0	0.5	10.7	1.9	0.4	0.2	3.4	1.3	0.8	0.0	0.3	0.2	0.1	1.7	0.0	0.0	12.0	0.3	22.4	24.1	11.1	1.2	6.6	0.8	12.1	6.1	0.2	3.0	3.5	1.7	2.8	0.0	3.6	0.7	2.7	32.1	10.9	0.9	0.3	0.1	1.9	1.0	1.8	0.0	6.8	1.1	2.8	0.0	0.3	1.0	0.0	1.3	0.6	1.1	3.2	18.6	1.0	38.9	4.2	12.9	8.6	22.8	15.6	3.8	4.3	1.1	7.2	13.2	3.7	0.0	17.0	72.8	39.4	0.0	3.4	4.0	6.5	3.4	1.8	15.6	35.7	15.6	4.7	7.3	7.8	5.6	6.6	36.2	0.3	1.4	1.4	9.6	0.0	10.3	43.8	8.2	8.7	2.1	4.8	0.3	11.1	1.8	25.3	4.7	0.1	97.9	0.0	0.7	4.2	24.6	0.0	45.8	14.2	18.1	1.9	8.7	0.6	0.0	2.5	1.6	3.4	2.5	15.0	2.3	24.5	26.6	0.5	21.5	19.6
MDH1		ENSG00000014641	"Malate dehydrogenase 1"	P40925	2	63588609-63607197	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1349.1;tongue: 1843.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1926.9;Proximal tubular cells: 1428.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027296, CAB047333, HPA054276"	Uncertain		Supported	Centrosome,Cytosol		NA	NA		49000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Centrosome, Cytosol"		"CAB047333: , HPA027296: AB_10611118, HPA054276: AB_2682434"	"unprognostic (1.01e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.80e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.05e-1)"	274.6	213.6	235.9	86.7	249.7	79.1	137.9	245.9	353.6	89.6	230.2	167.7	154.7	82.0	161.3	125.3	114.5	87.2	1349.1	253.2	261.5	371.6	266.3	89.8	131.9	248.5	218.3	80.4	69.9	411.8	107.2	92.5	253.3	125.5	190.9	240.7	122.0	142.0	792.5	87.7	133.1	171.5	215.7	71.6	192.6	70.5	259.1	170.4	125.5	1843.8	165.4	131.5	62.8	237.7	268.2	219.5	257.8	173.2	369.6	280.9	282.3	215.1	295.9	300.6	304.1	252.5	215.4	355.2	112.8	264.1	358.8	214.3	303.0	355.0	425.5	207.6	253.1	337.0	173.2	376.8	202.1	384.1	223.9	277.7	241.3	271.5	152.7	236.2	235.3	308.1	183.7	217.3	395.1	157.8	300.6	317.5	158.0	376.3	266.5	235.2	349.7	310.5	460.9	251.0	249.9	153.6	182.5	257.7	384.1	205.6	191.9	341.9	149.6	220.3	211.9	187.1	252.9	264.6	264.8	407.6	266.2	312.2	184.1	271.3	186.3	200.2	202.7	267.8	218.8	258.5	236.6	224.6	241.0	258.5	230.3	221.6	28.1	214.6	253.4	184.3	320.9	321.2	235.9	249.7	245.9	353.6	253.2	261.5	248.5	218.3	253.3	215.7	259.1	237.7	44.4	60.9	54.3	54.9	78.7	81.6	109.4	562.9	50.7	165.4	81.0	86.7	1926.9	95.8	227.2	134.3	70.9	248.7	78.4	128.4	630.0	186.2	12.4	116.1	72.6	61.0	62.8	62.9	120.2	108.1	257.0	134.7	112.7	68.8	80.5	95.0	36.0	153.2	397.0	122.8	130.0	115.9	380.5	85.2	65.8	15.1	100.0	98.4	177.9	43.1	155.0	136.3	73.2	51.3	58.8	91.3	99.8	109.1	82.1	48.8	177.4	1428.3	224.5	164.1	59.2	68.3	167.8	58.0	65.6	82.7	84.0	149.5	84.3	137.4	167.8	102.6
MDM2	"HDM2, MGC5370"	ENSG00000135679	"MDM2 proto-oncogene"	Q00987	12	68808177-68850686	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 257.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 504.6;U-698: 517.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000086, CAB016303, CAB079977"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"CAB000086: AB_563872, CAB016303: AB_627920, CAB079977: "	"unprognostic (1.16e-1)"	"prognostic favorable (3.23e-4)"	"unprognostic (6.16e-2)"	"prognostic favorable (4.51e-7)"	"unprognostic (7.25e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.95e-2)"	14.0	11.6	5.4	10.4	10.0	28.6	11.9	7.4	7.6	13.9	28.0	20.7	6.4	9.5	7.1	13.0	14.1	12.0	6.8	3.8	7.4	9.5	26.9	14.3	13.8	9.9	8.5	10.8	14.3	10.9	5.0	16.4	9.2	11.3	21.9	14.2	9.6	11.5	18.6	10.9	7.5	12.4	6.0	11.4	10.0	6.6	9.2	15.6	15.4	12.9	17.0	15.1	10.8	12.8	18.7	42.1	43.5	22.6	55.9	51.5	223.4	49.7	50.3	26.2	41.5	26.8	8.4	188.6	13.5	34.7	7.3	11.0	31.4	504.6	42.1	51.0	22.0	35.3	36.0	115.0	55.7	32.6	31.0	77.8	46.5	101.5	69.4	26.9	73.7	32.1	37.1	45.4	50.8	28.0	43.1	10.7	36.9	10.1	8.2	149.4	31.7	16.2	16.0	146.0	34.3	20.2	32.0	25.0	11.3	88.8	58.3	21.4	82.3	20.2	38.0	16.8	18.5	68.2	47.7	517.6	31.3	12.8	81.2	6.1	5.4	5.2	4.1	4.1	3.7	4.7	3.5	4.1	3.0	5.4	3.6	3.5	19.2	3.7	7.2	3.9	4.1	3.6	5.4	10.0	7.4	7.6	3.8	7.4	9.9	8.5	9.2	6.0	9.2	12.8	23.1	32.1	56.3	26.1	36.4	15.6	30.5	42.6	22.8	26.8	21.4	17.1	20.9	24.3	75.8	25.8	33.3	47.5	32.1	19.3	13.7	19.5	2.5	257.4	34.5	22.0	25.1	29.9	28.8	24.2	28.0	31.9	28.5	74.8	32.9	33.2	15.7	45.0	18.3	30.3	32.9	23.4	32.6	49.0	25.0	2.9	19.3	44.9	12.4	37.5	35.4	27.8	10.3	25.6	71.8	22.4	20.1	15.1	117.7	39.8	15.8	21.3	141.7	35.3	19.7	30.0	32.4	17.3	20.0	59.5	22.0	94.3	31.8	49.4	20.9	82.0
MECOM	"EVI1, KMT8E, MDS1, MDS1-EVI1, PRDM3"	ENSG00000085276	"MDS1 and EVI1 complex locus"	Q03112	3	169083499-169663775	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 73.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 184.8;Collecting duct cells: 125.0;Gastric mucus-secreting cells: 111.1;Glandular and luminal cells: 107.7;Microglial cells: 346.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 55.5;RPTEC TERT1: 71.2;RT4: 119.6;TIME: 53.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046537	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA046537: AB_2679689"	"unprognostic (4.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.27e-3)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.60e-3)"	"unprognostic (6.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.37e-3)"	16.0	0.9	7.3	7.3	7.2	1.4	12.3	8.5	7.3	21.3	2.4	24.9	19.8	17.3	4.4	13.5	23.4	8.3	13.0	4.9	6.3	41.3	1.4	25.5	1.5	9.1	7.2	2.3	23.3	1.7	4.2	17.4	8.9	6.9	30.0	1.8	8.8	8.0	4.3	2.6	10.2	8.0	4.1	6.2	73.3	3.0	8.1	2.0	5.7	12.0	5.3	30.4	7.5	6.3	25.8	0.7	0.9	0.2	3.7	2.7	1.1	3.7	4.2	1.1	2.2	10.7	26.1	0.9	39.1	0.6	5.5	13.4	10.2	15.7	3.1	1.4	16.6	16.7	7.6	1.1	0.4	0.3	5.1	5.7	2.2	1.0	12.1	12.0	55.5	1.4	13.0	1.8	10.3	9.8	0.9	0.4	1.7	13.5	6.6	9.8	13.1	0.3	71.2	119.6	1.0	3.1	1.3	6.7	0.3	1.5	7.1	1.1	53.4	9.7	6.6	2.5	16.9	1.4	0.7	0.9	4.8	1.0	1.6	0.9	0.4	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.3	0.4	0.5	1.6	0.1	0.0	7.3	7.2	8.5	7.3	4.9	6.3	9.1	7.2	8.9	4.1	8.1	6.3	80.2	60.9	184.8	16.0	0.6	2.2	33.3	29.4	10.2	0.0	1.2	0.9	11.4	2.8	69.6	125.0	0.0	1.1	0.1	25.5	52.8	1.6	10.4	71.9	5.8	70.5	19.9	7.4	10.3	75.4	0.2	4.8	111.1	107.7	9.5	0.8	69.3	0.2	0.0	0.0	9.1	29.0	20.3	0.6	1.9	3.2	0.3	2.6	1.8	346.6	1.0	0.0	0.0	6.0	13.8	49.8	19.3	0.0	0.3	13.9	6.2	0.7	53.2	0.1	0.0	1.4	5.7	3.0	1.2	39.4	1.4	0.4	1.3	0.5	53.9	45.4
MECR	"CGI-63, ETR1, FASN2B, NRBF1"	ENSG00000116353	"Mitochondrial trans-2-enoyl-CoA reductase"	Q9BV79	1	29192657-29230942	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 42.1"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 82.5;Rod photoreceptor cells: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA022018, HPA022030, HPA028740"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA022018: AB_1853714, HPA022030: AB_1853716, HPA028740: AB_10601133"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.06e-2)"	"unprognostic (8.66e-2)"	"prognostic favorable (5.81e-6)"	"unprognostic (7.01e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (5.29e-4)"	14.7	14.6	5.1	1.7	5.1	1.8	13.4	3.3	6.2	10.2	3.1	10.3	1.4	12.9	2.5	12.5	9.4	1.3	24.8	6.0	3.9	14.1	15.8	7.3	2.0	5.2	4.0	10.0	8.9	4.5	7.2	3.5	5.4	7.9	2.6	9.9	12.3	3.0	42.1	15.4	7.2	3.1	3.2	6.7	11.1	7.6	4.3	1.4	8.3	5.8	2.1	9.6	9.6	5.2	3.9	4.5	3.2	4.6	2.9	2.5	6.8	3.7	3.8	4.7	3.9	2.3	5.6	7.3	5.1	3.7	1.3	3.0	5.4	6.3	4.0	4.4	6.9	6.4	3.4	4.1	6.6	6.1	1.9	4.3	5.9	3.1	11.0	3.8	3.5	6.9	5.8	4.2	4.7	4.5	3.9	2.9	6.5	5.8	4.3	3.5	4.2	9.3	5.9	2.4	5.1	4.5	4.1	4.7	7.0	4.4	2.3	5.4	3.8	2.4	2.9	4.1	4.7	2.7	2.2	5.0	3.9	8.4	5.2	0.1	2.2	0.0	1.5	2.1	4.1	2.2	1.6	1.7	1.9	1.1	2.3	1.6	0.3	2.9	1.6	2.5	2.4	1.2	5.1	5.1	3.3	6.2	6.0	3.9	5.2	4.0	5.4	3.2	4.3	5.2	8.8	12.8	3.9	14.7	9.1	5.6	15.6	26.9	7.4	12.8	12.0	14.6	19.8	21.5	21.4	20.2	10.4	46.0	3.8	7.4	41.1	24.3	40.8	19.7	13.6	9.1	7.8	10.1	25.1	19.7	42.4	12.8	4.6	12.8	5.7	17.5	7.1	19.7	20.8	8.4	20.3	9.4	12.2	6.0	5.1	82.5	13.7	5.3	16.0	3.7	10.8	14.5	10.3	11.6	15.2	16.3	8.0	10.9	10.3	20.6	10.9	46.0	11.3	68.5	13.1	13.2	12.9	8.5	16.1	14.0	7.4	27.9	6.0	25.8	18.3	20.5
MELK	KIAA0175	ENSG00000165304	"Maternal embryonic leucine zipper kinase"	Q14680	9	36572862-36677683	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.0;lymphoid tissue: 21.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 16.1;Erythroid cells: 15.2;Extravillous trophoblasts: 44.1;Spermatocytes: 23.2;Spermatogonia: 21.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"T-reg: 1.7"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA017214	Uncertain					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA017214: AB_1853798"	"unprognostic (5.03e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.42e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.91e-7)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (8.86e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.35e-1)"	0.9	0.5	0.0	5.7	0.0	10.0	1.4	0.0	0.1	1.3	0.0	6.8	5.2	1.0	0.0	7.9	0.3	0.6	0.2	0.0	0.0	0.3	0.7	0.9	10.0	0.0	0.1	0.2	0.3	0.1	0.0	5.3	0.1	0.3	8.5	0.0	1.2	0.1	0.0	3.4	4.4	2.4	0.0	2.0	3.2	9.2	0.3	21.0	0.3	0.1	11.7	1.7	2.3	0.0	123.4	62.1	81.6	48.5	11.1	18.8	47.1	88.8	62.2	121.5	148.2	47.8	47.3	40.9	27.8	43.8	106.5	41.0	71.7	55.5	133.1	112.3	28.6	32.0	69.1	48.1	4.3	50.2	39.0	6.9	9.8	93.9	53.0	15.6	62.2	61.9	41.7	63.2	100.9	40.9	63.1	23.4	65.1	55.1	47.9	57.4	54.9	25.8	37.7	40.7	55.1	40.8	47.4	45.3	28.6	45.2	38.0	23.7	30.8	65.4	81.8	56.1	82.3	12.3	47.9	60.7	41.2	36.8	91.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	1.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.7	1.9	4.6	0.9	3.5	0.0	0.0	0.9	0.8	0.4	0.0	2.0	0.0	0.0	16.1	0.7	4.5	0.0	1.1	2.8	2.9	1.4	1.3	0.0	15.2	0.8	1.1	44.1	3.3	4.6	2.1	0.0	7.8	1.4	0.7	10.1	0.0	0.7	4.7	4.1	1.6	3.0	2.7	1.2	1.9	0.0	0.0	3.1	0.0	2.1	1.0	0.4	1.7	2.7	0.0	10.2	0.5	0.6	0.1	2.0	0.0	0.0	0.0	3.7	23.2	21.3	9.3	1.7	8.9	2.7	0.7	8.9	2.3
MERTK	"c-Eyk, mer, RP38, Tyro12"	ENSG00000153208	"MER proto-oncogene, tyrosine kinase"	Q12866	2	111898607-112029561	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease variant, Proto-oncogene, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 162.6;Kupffer cells: 119.8;Macrophages: 46.5;Microglial cells: 124.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 8.6;non-classical monocyte: 5.5"	"Lineage enriched"	"Detected in single"	50	"monocytes: 8.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 35.1;Hep G2: 39.9;HUVEC TERT2: 38.4;RT4: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036196, HPA075622"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol"		Yes	NA		65000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Endoplasmic reticulum, Midbody, Cytosol"	"HPA036196: AB_10670676, HPA075622: AB_2686759"	"unprognostic (2.17e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.74e-4)"	"unprognostic (6.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.72e-1)"	"prognostic favorable (4.43e-5)"	"unprognostic (5.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.05e-2)"	20.1	59.8	22.8	13.5	28.0	1.5	15.3	18.0	29.3	12.6	44.7	10.9	12.3	11.5	26.3	8.4	15.5	12.0	7.0	22.0	22.5	11.4	21.0	13.6	13.1	23.5	22.3	12.6	9.9	21.2	15.5	20.1	22.4	14.1	7.9	16.6	6.4	16.3	3.2	6.4	14.3	14.4	18.4	30.6	13.9	17.2	30.1	6.8	10.1	4.6	8.9	13.6	9.4	22.0	1.0	1.7	7.6	17.3	0.4	0.2	12.3	0.0	0.2	1.0	1.7	35.1	2.2	0.1	8.1	0.1	7.9	0.2	10.2	0.0	1.4	1.5	5.5	7.0	0.0	39.9	0.3	0.2	1.5	0.5	0.0	8.9	0.6	4.0	38.4	1.5	2.2	3.5	2.9	1.8	0.0	9.1	4.8	1.1	6.0	2.9	2.1	3.0	19.4	23.4	0.3	7.2	0.2	0.5	3.2	2.7	0.0	0.4	5.8	1.0	3.4	0.1	0.0	3.1	4.8	0.1	0.0	1.4	0.0	0.0	0.6	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.5	0.1	0.0	0.2	22.8	28.0	18.0	29.3	22.0	22.5	23.5	22.3	22.4	18.4	30.1	22.0	8.8	3.2	27.7	162.6	1.7	1.7	2.9	0.3	1.8	0.6	2.1	4.3	2.7	2.8	6.4	0.0	2.1	3.3	0.4	1.2	1.9	1.1	2.3	8.0	4.7	10.2	0.0	0.4	5.0	1.0	1.1	3.2	0.5	12.1	0.0	3.8	28.5	9.2	25.5	0.0	7.0	2.0	0.0	119.8	1.8	2.7	5.0	46.5	0.0	124.6	1.5	7.7	0.0	10.6	0.6	1.2	1.9	6.8	10.8	2.9	4.4	1.9	1.5	11.3	6.6	1.5	9.2	0.6	1.5	0.6	1.3	18.9	1.3	3.5	1.9	1.6
MEX3C	"FLJ38871, RKHD2, RNF194"	ENSG00000176624	"Mex-3 RNA binding family member C"	Q5U5Q3	18	51174550-51218333	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 118.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 555.3;Late spermatids: 514.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040603	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA040603: AB_10805714"	"unprognostic (1.09e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.88e-2)"	"unprognostic (8.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (8.49e-5)"	"unprognostic (4.34e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.17e-1)"	17.6	13.5	9.1	17.0	9.9	49.4	17.4	12.5	12.3	16.4	9.0	13.5	12.6	17.6	10.4	15.5	14.0	18.6	10.8	10.5	9.8	11.9	14.0	13.7	23.6	10.5	10.0	23.5	14.7	17.9	1.7	16.1	10.6	11.5	14.1	14.8	9.6	12.2	9.7	9.2	13.4	20.1	10.7	22.3	13.3	118.4	9.3	40.9	16.1	17.1	26.6	20.2	2.4	11.6	23.8	19.6	71.2	26.8	27.7	36.8	49.6	32.8	37.4	18.9	22.2	33.6	17.3	53.0	13.2	44.2	30.4	44.6	27.9	42.7	31.0	43.0	12.5	10.7	19.1	29.0	44.5	75.2	22.3	28.2	46.5	26.9	76.4	47.0	41.8	36.0	11.3	95.7	40.0	18.0	63.8	24.3	32.1	13.3	15.0	61.7	36.5	46.7	31.1	9.5	34.8	39.1	30.4	12.4	117.7	54.3	13.5	34.3	43.2	46.3	30.9	15.1	28.1	64.5	12.4	87.2	32.9	31.3	110.7	9.7	1.2	1.5	2.3	1.0	2.0	1.9	2.4	2.4	1.4	1.1	0.9	2.3	0.4	3.4	0.7	1.1	2.0	1.4	9.1	9.9	12.5	12.3	10.5	9.8	10.5	10.0	10.6	10.7	9.3	11.6	25.2	19.2	5.0	6.8	18.6	38.2	10.3	12.4	11.4	12.6	25.9	23.2	14.5	14.3	11.2	3.7	20.9	5.2	56.6	9.0	5.9	12.1	555.3	18.9	22.7	30.0	6.7	7.4	8.0	8.5	7.0	18.2	6.1	34.9	12.7	79.3	10.4	7.6	7.7	11.8	7.9	9.4	12.2	10.9	20.5	514.0	16.1	13.8	19.6	5.6	8.2	10.0	34.0	14.1	13.3	16.5	3.9	15.1	20.6	15.4	9.1	9.3	6.4	14.8	0.0	30.2	17.7	14.4	14.2	18.1	45.9	4.2	24.2	14.9	11.5	19.6
MFN2	"CMT2A2, CPRP1, KIAA0214, MARF"	ENSG00000116688	"Mitofusin 2"	O95140	1	11980181-12015211	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy, Unfolded protein response"	Hydrolase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 270.4;skeletal muscle: 310.5;tongue: 337.6"	"Cell type enriched"	"Detected in all"	7	"Cardiomyocytes: 336.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030554, CAB079902"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB079902: AB_2724683, HPA030554: AB_10603018"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.38e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.55e-1)"	"prognostic favorable (2.36e-8)"	"unprognostic (4.69e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.12e-1)"	34.7	31.4	39.9	20.9	42.4	26.7	31.8	39.1	41.4	29.3	17.4	59.7	41.9	37.0	12.7	57.3	26.2	21.8	270.4	34.7	43.0	36.5	58.5	31.1	19.8	41.1	44.8	27.0	22.5	76.7	28.7	27.6	40.6	36.3	38.1	35.0	32.2	62.3	310.5	58.9	46.3	41.2	43.5	31.5	44.9	25.4	48.8	26.1	56.1	337.6	30.4	51.2	36.2	40.5	93.6	54.0	52.6	72.7	59.7	47.2	58.8	76.0	66.1	96.5	72.6	88.7	51.8	68.8	74.8	92.6	60.6	80.5	101.7	156.1	90.6	60.6	75.4	94.5	81.8	54.2	53.8	114.2	51.9	57.0	105.1	133.1	124.5	40.1	66.2	26.4	106.1	53.6	69.7	30.2	60.2	15.2	39.7	57.8	77.4	68.2	95.8	58.5	44.9	61.4	68.2	44.6	88.4	81.0	74.6	41.4	43.8	49.2	71.2	63.1	58.3	88.4	71.2	59.0	86.4	120.7	69.0	99.6	69.8	10.4	11.5	7.6	8.9	14.0	10.2	6.7	6.7	7.9	9.7	4.8	5.0	6.2	16.2	6.2	18.3	4.2	8.1	15.7	39.9	42.4	39.1	41.4	34.7	43.0	41.1	44.8	40.6	43.5	48.8	40.5	18.1	22.4	15.8	16.6	10.2	22.8	9.4	18.9	19.9	26.7	17.4	16.4	336.9	7.2	14.9	14.7	12.5	15.1	12.5	39.2	21.5	13.6	4.7	8.9	12.1	18.5	18.0	32.4	21.5	20.4	15.5	17.3	17.3	12.8	10.8	12.8	11.7	46.3	16.0	30.3	24.5	22.2	18.3	23.9	9.7	8.0	7.2	19.1	17.8	8.4	17.3	14.6	8.2	11.1	16.7	18.5	16.8	15.1	10.9	13.9	41.8	14.3	12.9	21.0	13.1	16.0	16.5	25.9	15.6	25.1	30.1	25.2	10.3	12.5	26.4	16.6
MFSD2A	"FLJ14490, MFSD2"	ENSG00000168389	"Major facilitator superfamily domain containing 2A"	Q8NA29	1	39955112-39969968	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Symport, Transport"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 96.9;liver: 162.0;skin 1: 87.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 136.2;Hepatocytes: 299.6;Proximal enterocytes: 235.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"classical monocyte: 13.2;intermediate monocyte: 6.6;myeloid DC: 14.7;plasmacytoid DC: 24.3"	"Group enriched"	"Detected in many"	12	"dendritic cells: 24.3;monocytes: 13.2"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 52.0;THP-1: 169.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043107	Uncertain		Approved	"Plasma membrane,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Plasma membrane, Cytoplasmic bodies"	"HPA043107: AB_10794387"	"unprognostic (2.20e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.22e-6)"	"unprognostic (9.26e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.33e-4)"	6.3	1.4	34.0	3.4	31.7	8.4	13.4	34.8	36.0	4.8	22.2	7.2	14.6	8.5	96.9	12.5	3.5	2.3	1.4	30.9	33.4	5.8	162.0	36.1	2.3	38.5	33.8	2.2	0.6	0.7	8.0	17.1	38.6	2.4	5.0	2.6	4.0	79.2	0.5	87.8	32.0	3.5	32.8	1.5	1.9	33.9	37.2	1.6	7.5	0.1	3.6	20.2	14.1	33.1	6.2	2.7	12.5	18.9	8.7	1.6	0.0	5.9	11.2	12.8	15.1	0.8	3.4	38.0	3.4	3.0	8.8	15.0	12.4	21.8	9.8	4.9	6.0	4.6	0.1	0.1	28.8	6.8	21.8	9.7	13.3	52.0	21.5	2.3	3.1	11.5	0.0	9.5	5.7	0.8	10.6	10.4	10.1	21.4	4.7	7.4	18.5	8.7	2.1	17.9	4.4	6.7	4.5	31.7	3.0	1.1	1.5	169.8	2.0	2.7	5.3	9.5	24.9	1.8	3.5	8.5	28.9	26.0	9.2	0.0	13.2	1.4	0.1	6.6	0.2	1.5	0.1	0.2	14.7	0.2	0.0	0.1	0.7	0.2	1.2	24.3	0.0	3.6	34.0	31.7	34.8	36.0	30.9	33.4	38.5	33.8	38.6	32.8	37.2	33.1	0.5	19.2	136.2	3.3	6.3	52.8	21.2	40.0	51.2	2.0	6.3	2.3	0.6	12.8	30.8	16.5	0.0	0.5	5.7	62.2	0.0	3.4	1.0	25.8	5.5	22.9	1.2	5.7	1.5	24.8	7.6	9.7	24.5	61.8	17.2	0.1	7.1	299.6	6.7	0.0	1.3	34.5	12.2	9.8	43.3	2.7	0.6	16.1	0.0	38.4	5.5	38.8	0.0	0.0	1.6	27.2	39.3	0.4	5.0	13.9	235.1	6.1	33.9	2.7	0.0	5.0	3.3	1.0	1.3	49.3	54.8	52.5	3.3	0.1	20.7	26.6
MFSD8	"CLN7, MGC33302"	ENSG00000164073	"Major facilitator superfamily domain containing 8"	Q8NHS3	4	127917799-127966034	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044802	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	Vesicles	Nucleoplasm	"HPA044802: AB_10963221"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.61e-3)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.21e-4)"	4.6	5.7	1.3	6.8	1.3	2.6	6.9	1.9	1.6	6.2	1.1	6.8	10.0	5.6	3.9	5.4	5.5	4.8	3.8	1.1	1.7	6.4	10.0	4.8	5.4	1.4	1.3	6.8	8.1	9.1	7.1	5.9	1.5	5.5	8.2	4.6	5.8	4.4	3.7	5.9	7.6	5.8	1.1	7.3	6.4	3.9	0.8	5.2	7.0	4.4	7.9	5.3	5.9	2.2	10.9	7.3	9.5	4.6	7.2	6.9	7.0	8.3	10.3	10.2	10.5	5.2	14.3	5.2	14.5	14.3	14.8	7.8	10.2	7.4	14.4	10.8	7.9	5.7	9.1	8.0	9.4	6.0	6.6	8.3	2.7	8.6	7.7	5.0	10.6	6.6	9.5	5.9	14.6	8.9	5.0	1.9	1.7	11.8	5.2	5.3	0.6	4.7	7.5	13.9	8.5	2.9	9.0	12.0	3.5	6.4	5.6	5.1	6.7	2.9	3.1	10.7	7.8	12.5	22.1	9.6	10.3	5.3	8.8	1.9	1.6	2.8	2.5	2.4	2.4	2.5	2.7	2.2	1.6	1.1	2.4	2.6	2.5	2.4	3.7	2.2	3.4	1.2	1.3	1.3	1.9	1.6	1.1	1.7	1.4	1.3	1.5	1.1	0.8	2.2	9.5	12.8	14.1	17.0	18.8	3.2	4.9	8.5	10.2	17.2	8.1	5.3	3.0	5.7	14.0	16.5	20.9	12.5	17.9	7.2	1.9	8.5	10.4	7.7	7.2	7.2	4.2	3.8	32.1	7.0	7.3	8.6	11.7	8.2	12.7	18.4	8.9	10.1	7.6	11.8	34.9	6.8	10.2	8.5	3.3	14.7	9.3	6.5	3.6	27.2	10.5	8.6	20.6	20.6	24.6	7.8	9.5	9.4	19.9	5.4	11.1	6.3	12.1	24.9	6.6	5.8	6.6	12.6	8.4	8.9	5.7	22.0	13.7	11.4	7.3	4.8
MGAT2	GNT-II	ENSG00000168282	"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase"	Q10469	14	49620799-49623481	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043721, HPA056824"	Approved		Supported	"Golgi apparatus"		NA	Yes		5100000	"Cluster 44: Non-specific - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA043721: AB_2678636, HPA056824: AB_2683248"	"unprognostic (1.20e-2)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (2.84e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.44e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.59e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-2)"	16.8	17.6	5.9	24.3	5.8	10.3	13.3	6.9	6.8	17.4	9.0	23.6	23.1	12.7	21.7	11.8	11.9	15.2	11.7	5.6	6.7	14.2	40.7	13.8	25.3	6.4	6.3	13.1	23.8	8.2	7.9	22.0	6.6	14.1	21.9	8.2	15.8	13.7	5.0	9.3	22.5	16.0	6.9	20.2	21.0	24.3	7.2	16.4	13.3	5.6	25.1	20.9	8.8	7.3	63.5	30.7	23.2	39.2	53.6	51.7	15.1	68.6	67.7	62.2	55.8	37.5	47.1	63.7	56.9	62.9	36.0	49.5	32.9	39.7	66.7	65.5	29.1	40.7	21.7	37.2	42.3	94.5	91.2	39.8	31.2	36.8	51.8	45.5	75.5	31.4	31.7	170.4	66.3	24.2	32.9	60.1	23.8	22.2	49.1	36.7	67.1	55.6	49.3	36.2	24.0	25.6	49.3	12.9	39.8	22.2	39.1	63.6	78.9	56.1	60.8	41.1	49.6	182.8	94.6	56.7	27.3	46.5	38.6	49.4	38.6	39.3	36.6	34.1	39.3	25.1	33.3	33.1	39.9	15.9	19.3	26.8	11.6	22.3	39.8	47.2	31.6	44.8	5.9	5.8	6.9	6.8	5.6	6.7	6.4	6.3	6.6	6.9	7.2	7.3	17.4	12.8	8.6	2.0	31.7	15.7	25.7	28.8	14.2	13.7	15.5	8.9	0.1	24.3	18.0	11.0	4.2	26.4	46.9	34.6	9.8	31.0	7.9	12.5	20.7	20.8	12.1	19.0	3.0	34.4	40.3	24.3	13.7	11.7	17.1	27.7	27.1	63.0	37.2	18.5	4.3	20.5	40.7	34.5	28.8	6.0	17.4	26.3	21.4	2.8	40.6	16.7	63.8	6.0	4.5	36.5	25.1	22.2	77.1	27.0	26.7	15.2	23.5	15.8	6.6	15.8	34.6	56.4	13.0	15.2	14.1	5.3	31.5	23.2	20.0	25.5
MIA2	"cTAGE-5A, cTAGE-5B, cTAGE-5C, cTAGE-5D, CTAGE5, FLJ22404, MEA6, MGEA, MGEA11, MGEA6, TALI"	ENSG00000150527	"MIA SH3 domain ER export factor 2"	Q96PC5	14	39230231-39388513	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 138.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 44.1;Ductal cells: 42.9;Endometrial ciliated cells: 78.7;Exocrine glandular cells: 42.7;Glandular and luminal cells: 93.5;Pancreatic endocrine cells: 41.3;Proximal tubular cells: 61.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 125.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000387, HPA000922, HPA054066, HPA055459"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"		"HPA000387: AB_1078582, HPA000922: AB_1078581, HPA054066: AB_2682368, HPA055459: AB_2682819"	"unprognostic (2.62e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.27e-4)"	"unprognostic (3.21e-4)"	"unprognostic (2.63e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.93e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.97e-2)"	12.1	26.6	5.6	16.8	6.9	23.6	22.1	5.8	7.9	29.7	58.0	30.8	80.4	15.7	40.2	26.9	22.2	30.3	16.6	9.4	6.5	78.4	138.9	15.5	16.2	5.6	4.7	9.6	43.6	40.5	15.5	11.2	6.4	21.1	34.6	12.8	52.5	19.2	54.5	9.9	78.4	12.3	4.1	14.5	45.3	21.0	5.1	14.3	46.7	20.7	19.8	16.2	17.2	7.1	23.0	25.1	10.4	18.5	20.6	23.2	14.5	13.3	13.9	9.3	9.6	19.7	125.4	27.5	40.1	15.0	18.9	34.1	12.7	15.0	11.0	21.4	10.6	17.2	11.5	106.1	48.2	23.2	30.7	14.4	83.7	9.2	69.2	59.0	15.3	31.8	16.6	68.3	14.0	22.1	14.9	18.9	12.0	87.2	20.8	15.2	18.3	34.9	42.7	24.7	8.7	5.1	31.0	32.5	20.4	13.1	31.2	24.8	24.3	14.1	9.2	10.4	8.8	38.7	35.7	27.2	7.9	14.5	12.0	40.9	16.3	25.9	15.4	18.0	14.0	11.7	11.6	14.4	17.8	13.1	14.2	13.2	34.5	14.6	21.0	12.3	11.8	11.8	5.6	6.9	5.8	7.9	9.4	6.5	5.6	4.7	6.4	4.1	5.1	7.1	26.7	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	33.1	19.9	0.0	5.7	0.0	44.1	0.0	5.6	35.9	0.8	7.9	42.9	0.5	78.7	30.7	7.1	0.0	0.0	0.1	42.7	5.0	4.6	0.0	93.5	0.0	10.3	0.0	3.8	7.6	0.0	0.1	1.8	0.0	0.0	0.0	0.6	0.0	12.7	0.0	0.0	23.8	0.0	1.0	0.0	0.0	41.3	0.0	0.0	8.1	0.0	6.6	61.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	7.0	13.6	20.0	0.2	0.0
MIB1	"DIP-1, KIAA1323, MIB, ZZANK2, ZZZ6"	ENSG00000101752	"Mindbomb E3 ubiquitin protein ligase 1"	Q86YT6	18	21704957-21870953	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 121.2;Oligodendrocytes: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"REH: 121.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019100, CAB037044"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Vesicles	"CAB037044: AB_1841007, HPA019100: AB_1853934"	"unprognostic (1.38e-1)"	"unprognostic (6.92e-2)"	"unprognostic (7.29e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.66e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.70e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.33e-3)"	"unprognostic (4.91e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.85e-2)"	8.1	6.3	9.1	6.0	9.1	4.9	11.2	9.2	8.5	11.0	8.0	7.1	5.1	13.0	9.5	8.0	7.1	8.6	6.0	8.4	9.2	11.1	10.4	7.2	7.6	9.5	10.2	11.7	8.1	9.8	5.2	11.0	8.6	10.1	7.0	8.3	8.4	8.5	5.8	9.1	5.2	10.2	10.1	7.2	7.6	8.7	10.3	11.5	13.6	7.0	7.9	8.4	8.2	9.6	19.9	7.6	36.4	25.8	19.5	23.0	9.0	15.6	17.2	10.8	15.6	11.3	7.1	16.9	14.1	21.4	11.8	13.2	21.4	21.0	24.4	22.4	10.4	18.8	9.7	15.9	15.8	38.3	7.8	14.8	23.0	12.6	32.0	16.0	27.8	6.6	26.5	47.5	17.2	9.5	18.9	14.7	9.5	12.2	10.2	121.1	30.3	42.5	18.7	16.9	12.1	30.1	26.8	12.4	13.9	18.6	8.8	25.1	23.9	27.8	14.2	11.7	21.1	25.6	9.5	25.4	11.8	24.1	16.9	0.7	0.3	0.1	0.2	0.1	0.2	0.2	0.3	0.2	0.1	0.1	0.2	0.1	0.3	0.5	0.1	0.2	0.4	0.1	9.1	9.1	9.2	8.5	8.4	9.2	9.5	10.2	8.6	10.1	10.3	9.6	35.7	48.1	22.7	68.2	11.9	21.9	15.1	19.8	24.5	28.8	24.1	19.7	18.1	25.8	31.8	16.5	25.0	13.3	18.2	20.8	3.9	13.4	7.0	29.0	59.2	30.8	24.0	23.1	106.7	12.9	7.5	33.1	10.2	32.4	14.5	16.8	24.3	30.0	12.9	15.2	92.6	17.1	26.4	17.2	16.2	5.6	20.5	14.2	26.6	67.5	19.4	17.7	15.5	121.2	109.6	18.8	7.0	24.8	18.1	48.5	8.7	15.9	30.6	14.5	0.0	35.4	26.9	26.2	12.0	23.4	24.6	25.3	14.5	21.8	10.4	25.3
MICU1	"CALC, CBARA1, EFHA3, FLJ12684"	ENSG00000107745	"Mitochondrial calcium uptake 1"	Q9BPX6	10	72367327-72626191	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"		Allergen	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 185.5;Inhibitory neurons: 205.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037479, HPA037480"	Approved		Supported	Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA037479: AB_2675495, HPA037480: AB_10696934"	"unprognostic (8.18e-2)"	"unprognostic (6.98e-3)"	"unprognostic (6.71e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.91e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.38e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.23e-2)"	"prognostic favorable (4.66e-7)"	"unprognostic (1.70e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.35e-2)"	"unprognostic (6.70e-2)"	30.9	55.3	34.4	21.2	37.2	34.2	26.4	51.4	47.1	28.8	27.8	30.1	37.4	36.5	23.8	20.7	34.6	32.3	43.9	37.8	32.2	105.3	116.7	29.6	20.1	32.2	30.7	41.6	20.0	43.3	24.4	23.6	33.7	24.8	32.9	31.5	20.8	22.3	72.2	29.0	32.7	38.4	29.0	27.0	43.3	20.2	30.4	26.1	22.9	76.9	21.6	30.8	21.7	34.1	42.2	71.8	45.4	53.3	70.8	66.6	20.6	45.8	101.6	65.7	89.8	42.2	77.2	56.8	37.3	63.5	54.0	49.1	57.7	40.7	76.9	51.9	46.6	38.3	37.1	61.2	56.4	53.3	40.1	66.6	36.2	72.4	66.5	90.4	57.7	53.4	60.0	64.5	77.6	37.9	46.7	49.9	19.0	45.0	17.3	50.5	60.9	37.4	80.8	31.0	34.8	49.8	54.2	65.9	42.0	45.2	39.3	50.5	36.2	32.6	50.1	65.7	38.4	33.9	62.6	39.2	65.1	69.6	22.5	21.5	60.0	110.8	16.8	49.8	14.7	15.1	14.7	15.5	26.0	17.5	14.4	12.0	48.8	15.2	54.5	16.5	15.3	35.4	34.4	37.2	51.4	47.1	37.8	32.2	32.2	30.7	33.7	29.0	30.4	34.1	30.4	54.5	36.0	47.7	23.4	9.9	16.0	22.6	14.2	31.9	25.3	19.6	35.8	25.8	38.3	35.0	20.9	20.7	16.9	25.9	80.3	35.6	10.7	42.0	43.0	22.7	14.4	25.0	185.5	26.7	18.8	31.1	45.9	48.2	18.3	31.5	23.9	60.4	34.8	16.8	205.9	24.4	16.2	36.9	13.4	12.5	26.8	40.1	12.4	64.6	38.0	51.3	10.3	146.8	97.5	51.4	24.9	25.9	25.0	10.7	29.3	110.7	34.0	33.8	6.6	29.0	27.2	54.5	40.0	14.2	14.2	21.5	19.0	73.4	23.6	14.2
MID1	"FXY, OS, RNF59, TRIM18"	ENSG00000101871	"Midline 1"	O15344	X	10445310-10833654	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 129.3;Basal squamous epithelial cells: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 156.1;AF22: 132.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002878, HPA003715"	Approved		Uncertain	"Golgi apparatus,Centriolar satellite,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Centriolar satellite"	"Golgi apparatus, Cytosol"	"HPA002878: , HPA003715: AB_1079384"	"unprognostic (1.99e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.25e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.12e-3)"	"unprognostic (5.88e-2)"	5.9	2.5	6.9	5.0	7.7	1.7	5.3	17.2	5.0	7.0	6.5	17.3	5.7	8.9	4.9	7.0	6.4	6.8	9.3	7.0	4.9	7.3	4.2	6.5	2.2	3.6	10.4	4.4	3.5	2.8	4.2	6.2	4.9	10.4	10.6	12.3	4.9	12.9	0.7	2.9	5.8	12.3	2.1	1.0	3.8	3.6	8.2	2.3	4.2	2.2	3.1	11.7	6.2	4.4	33.2	156.1	132.5	16.7	8.1	9.2	14.6	16.2	17.8	19.7	20.7	31.0	9.7	10.6	6.5	21.9	58.4	22.5	11.0	15.1	23.0	1.3	11.0	2.7	24.3	1.1	2.8	0.3	1.2	12.1	7.0	16.1	15.8	20.4	23.1	5.1	2.1	3.2	9.6	8.0	5.3	0.5	32.7	5.1	10.0	3.9	28.9	0.4	18.7	36.2	7.1	3.5	7.4	23.5	10.1	42.7	19.2	0.2	13.7	7.2	1.0	34.1	17.0	2.8	1.2	0.4	13.5	0.3	31.3	0.5	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.7	0.0	0.1	0.4	0.0	0.1	6.9	7.7	17.2	5.0	7.0	4.9	3.6	10.4	4.9	2.1	8.2	4.4	16.5	35.3	20.7	129.3	0.7	21.4	31.5	24.7	82.6	10.7	8.5	13.2	4.8	8.6	19.6	23.9	18.8	9.1	1.3	22.6	1.9	13.4	2.2	39.8	8.9	25.4	12.1	2.7	15.5	8.7	26.9	16.2	10.7	38.5	1.3	13.4	69.9	4.0	1.5	69.0	44.3	9.0	2.0	2.5	5.8	7.9	30.1	1.2	3.6	23.4	0.0	37.0	0.0	66.4	59.2	7.3	17.2	41.3	0.2	8.2	11.3	1.5	19.3	2.9	6.6	3.7	3.3	0.3	2.4	36.1	10.1	20.0	0.8	9.7	20.0	49.2
MID2	"FXY2, MRX101, RNF60, TRIM1"	ENSG00000080561	"Midline 2"	Q9UJV3	X	107825755-107931637	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 14.5;Inhibitory neurons: 21.5;Urothelial cells: 11.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	6	"T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 41.5;Karpas-707: 35.5;MCF7: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (8.28e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.69e-4)"	"unprognostic (6.40e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.87e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.07e-1)"	"unprognostic (3.77e-1)"	"unprognostic (5.97e-3)"	11.2	9.2	5.2	3.9	6.1	0.4	7.2	4.4	4.2	8.3	4.2	6.0	1.8	9.4	8.0	13.6	8.8	7.7	3.1	3.5	12.1	6.0	5.4	6.4	4.4	7.4	7.1	9.3	9.6	12.9	3.2	4.4	9.1	10.3	3.6	14.8	11.1	9.6	12.9	9.6	2.6	15.8	6.3	3.8	4.4	2.1	9.0	2.3	13.2	18.5	5.2	10.6	7.5	4.8	8.4	7.1	0.2	11.2	8.8	12.3	0.1	5.9	15.0	5.0	3.6	0.6	1.5	0.0	7.5	11.7	8.3	5.2	4.1	12.1	1.1	0.0	5.5	0.0	4.2	0.0	13.5	0.0	0.0	8.0	13.3	0.1	14.5	9.1	41.5	0.5	0.0	35.5	5.6	26.8	0.1	0.0	1.2	0.3	13.0	0.0	3.2	0.0	6.3	7.5	0.6	0.0	12.6	0.5	18.6	3.9	4.6	0.5	8.2	0.0	2.1	9.9	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.3	0.0	0.8	1.4	0.0	0.2	1.6	1.1	0.0	0.0	0.0	0.0	0.1	0.4	5.2	6.1	4.4	4.2	3.5	12.1	7.4	7.1	9.1	6.3	9.0	4.8	3.1	3.2	0.0	8.1	0.4	3.1	3.3	0.9	4.0	1.9	2.3	1.8	0.6	1.5	1.1	0.0	0.0	0.0	0.3	0.3	1.9	1.8	1.1	1.0	1.7	2.6	0.0	0.0	14.5	1.5	0.0	1.5	1.1	1.5	0.0	0.3	2.2	1.8	0.1	0.0	21.5	0.2	0.0	0.0	0.0	1.4	0.0	0.2	3.6	7.5	0.0	0.8	0.0	8.0	7.4	1.1	0.0	0.7	1.1	4.2	0.5	0.8	2.3	3.9	0.0	1.9	2.1	0.2	0.4	3.9	3.7	0.0	1.7	0.8	0.4	11.4
MIF	"GIF, GLIF"	ENSG00000240972	"Macrophage migration inhibitory factor"	P14174	22	23894383-23895227	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Isomerase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 2032.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 4974.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003868, CAB005284"	Approved		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	No	No	13800000	5000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"CAB005284: AB_648587, HPA003868: AB_1079290"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-1)"	233.3	467.9	195.8	119.5	200.0	146.0	223.3	209.3	450.0	235.0	204.3	194.3	98.9	205.3	49.8	514.2	219.4	20.9	290.8	245.2	289.7	530.3	484.6	208.2	61.5	225.2	224.7	223.7	255.7	127.8	368.0	100.4	217.2	318.7	35.2	23.8	233.6	132.8	99.3	302.5	171.7	43.4	250.8	204.5	230.7	113.5	204.2	65.0	274.0	19.5	46.2	255.8	316.7	369.4	1698.3	605.3	122.2	499.0	58.9	111.3	590.7	581.2	154.7	298.9	382.1	526.4	364.4	761.3	499.8	83.1	115.2	788.1	155.0	546.8	51.5	642.2	4974.4	286.2	534.6	1126.5	225.3	1077.2	758.6	230.9	354.9	173.8	103.5	248.8	241.3	589.4	466.9	540.1	122.2	1476.0	827.0	2345.5	532.8	488.6	2365.8	1040.4	127.9	2398.8	294.7	179.6	1080.9	1290.4	380.3	531.9	1374.7	37.6	671.2	442.6	424.7	232.5	1227.9	127.3	9.9	1647.2	732.5	1020.9	967.5	484.6	477.9	484.2	543.5	443.5	872.4	579.5	1250.8	1527.9	1221.7	983.3	796.9	1378.9	1040.4	928.4	166.8	1158.9	383.3	977.1	1258.3	1803.3	195.8	200.0	209.3	450.0	245.2	289.7	225.2	224.7	217.2	250.8	204.2	369.4	161.2	157.0	199.4	21.5	433.4	672.2	295.5	1134.8	1027.2	28.3	856.0	778.2	0.3	479.0	489.1	693.4	2.1	462.7	171.3	317.9	1649.4	859.0	190.5	733.7	485.3	248.5	348.9	455.7	17.1	377.7	885.0	336.2	606.5	844.3	180.3	192.2	261.6	885.2	278.8	21.9	24.1	432.5	697.8	207.7	505.2	153.9	336.1	232.6	773.7	19.7	217.0	59.5	155.5	17.6	52.8	649.9	360.4	302.8	1337.1	269.8	476.8	2032.7	404.6	33.2	138.1	338.1	349.7	21.3	124.2	1511.3	758.8	686.0	386.3	227.6	473.0	256.1
MINPP1	MIPP	ENSG00000107789	"Multiple inositol-polyphosphate phosphatase 1"	Q9UNW1	10	87504875-87553461	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 288.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026859	Approved				"Intracellular and membrane"	NA	NA		370000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA026859: AB_1853961"	"unprognostic (9.15e-2)"	"unprognostic (8.76e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.20e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.55e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.54e-2)"	"unprognostic (6.50e-3)"	"prognostic unfavorable (6.98e-5)"	"unprognostic (2.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.01e-2)"	8.5	21.3	6.6	7.2	6.7	31.1	9.4	6.9	9.1	8.8	9.4	12.6	17.6	7.0	10.0	3.6	8.5	8.4	5.8	6.8	8.0	17.5	29.1	8.3	7.7	6.4	6.8	8.8	11.9	9.0	8.1	18.9	6.4	11.7	12.9	11.9	6.9	7.6	4.9	9.1	13.6	7.6	6.9	6.9	8.5	7.9	7.7	8.1	11.6	5.7	7.0	8.6	5.7	7.4	18.6	28.1	28.1	40.9	46.4	38.1	23.2	29.5	51.1	28.8	38.3	15.0	35.5	16.4	27.0	35.9	19.4	28.2	29.9	27.1	33.2	37.1	35.7	41.1	10.4	55.7	34.6	18.0	36.0	33.7	34.7	32.6	19.5	52.5	37.0	14.3	24.5	75.9	34.4	13.8	11.9	25.6	20.0	14.2	20.2	0.0	15.8	11.0	38.5	10.4	10.2	31.5	28.1	5.9	51.5	31.5	16.7	14.7	32.4	18.3	21.9	22.1	28.7	24.5	27.1	4.2	29.3	26.8	13.7	10.5	10.8	4.9	11.5	13.8	10.1	8.7	10.8	13.0	14.3	8.2	10.2	11.4	0.7	11.7	12.5	8.2	17.3	10.5	6.6	6.7	6.9	9.1	6.8	8.0	6.4	6.8	6.4	6.9	7.7	7.4	11.7	6.4	12.8	9.1	8.1	2.8	8.3	25.5	8.0	14.4	9.0	4.3	4.9	15.7	16.2	7.3	2.1	20.4	4.9	14.0	5.9	17.2	15.9	7.1	13.4	10.5	13.1	288.9	18.3	16.7	19.2	17.9	7.1	6.7	24.7	17.8	16.4	58.3	12.9	10.1	20.8	25.5	20.3	16.0	5.8	4.0	9.3	8.7	10.6	7.5	11.7	11.1	10.3	25.6	19.1	10.5	17.2	8.2	18.6	6.8	17.1	26.0	19.0	14.8	0.0	4.8	11.1	10.6	12.1	4.0	3.4	8.1	8.2	13.7	11.6	4.4
MIPEP	MIP	ENSG00000027001	"Mitochondrial intermediate peptidase"	Q99797	13	23730189-23889400	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 108.0;Oligodendrocytes: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 64.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030676, HPA031669, HPA031670"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA030676: AB_10598907, HPA031669: AB_10600986, HPA031670: AB_10602198"	"unprognostic (2.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.75e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-1)"	"prognostic favorable (7.66e-12)"	"unprognostic (1.62e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.90e-3)"	6.3	9.6	3.7	6.2	4.3	5.3	11.1	3.2	5.0	7.5	13.4	12.9	8.8	7.2	12.4	11.5	17.3	7.7	18.4	14.4	4.0	25.4	12.0	7.1	5.1	4.0	5.0	5.4	8.2	14.6	5.4	4.7	4.6	10.9	13.1	6.1	9.7	8.7	13.9	21.4	7.6	7.8	4.0	4.3	8.6	9.8	3.7	6.0	11.1	16.9	7.8	7.7	6.4	4.9	14.6	16.1	7.8	18.4	17.4	23.4	16.6	10.3	16.0	15.1	12.7	21.7	28.1	17.0	10.2	8.4	13.3	35.8	18.1	21.6	18.8	9.9	11.5	7.4	7.0	18.8	14.3	17.5	3.9	11.6	26.4	15.7	13.9	12.7	19.2	12.7	14.5	2.7	24.0	10.8	12.6	9.8	10.8	64.8	16.1	13.8	21.0	14.8	33.7	9.6	18.2	6.1	11.0	17.8	21.8	9.8	18.3	9.7	10.7	9.2	7.6	15.3	11.2	2.6	4.0	9.1	15.9	8.8	11.7	0.0	3.0	1.3	7.4	3.7	9.3	8.7	7.1	6.8	6.5	7.2	6.7	6.7	0.0	10.3	12.0	5.5	5.2	4.0	3.7	4.3	3.2	5.0	14.4	4.0	4.0	5.0	4.6	4.0	3.7	4.9	2.5	16.0	8.6	18.9	5.9	39.9	7.7	13.8	6.2	3.6	6.2	5.8	108.0	11.5	12.6	9.2	6.2	9.8	2.4	8.2	29.4	23.4	8.2	26.0	8.5	5.4	6.0	4.6	43.8	10.6	9.3	8.0	7.1	8.5	2.5	4.2	3.6	5.9	9.7	15.2	47.5	7.1	14.2	3.5	5.0	7.4	6.8	4.3	5.4	12.2	3.4	5.5	5.2	18.1	62.8	8.6	7.0	8.6	4.9	7.5	6.6	25.6	46.3	11.4	0.0	7.3	5.7	9.7	19.0	10.1	42.3	5.1	4.0	8.9	13.6	5.6
MKRN3	"D15S9, MGC88288, RNF63, ZFP127, ZNF127"	ENSG00000179455	"Makorin ring finger protein 3"	Q13064	15	23565674-23630075	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.1;retina: 8.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 13.8;Cone photoreceptor cells: 25.0;Horizontal cells: 6.7;Oligodendrocyte precursor cells: 6.0;Oligodendrocytes: 9.0;Rod photoreceptor cells: 7.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"JURKAT: 26.3;K-562: 30.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029494	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029494: AB_10603873"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.05e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.91e-2)"	"unprognostic (9.78e-2)"	0.3	0.1	4.5	0.4	7.7	1.8	0.5	4.8	6.7	0.1	2.4	0.5	0.2	0.4	1.6	3.4	3.1	0.1	0.1	5.2	5.1	0.3	0.1	0.2	0.7	7.0	6.1	0.2	0.4	0.0	1.1	3.3	7.0	0.3	0.1	8.9	3.1	0.2	0.8	0.4	0.3	0.1	4.0	0.6	0.2	2.4	6.6	2.4	0.2	0.8	0.8	0.2	0.2	14.1	8.5	2.9	6.1	5.6	0.0	0.0	13.0	0.9	0.0	4.3	4.5	14.7	0.0	0.1	0.1	0.0	11.8	12.5	2.4	0.0	2.7	0.1	0.5	15.3	17.0	0.9	0.4	18.6	10.2	0.6	0.0	5.8	0.0	2.8	0.0	26.3	30.6	12.9	3.5	0.0	20.3	7.3	0.0	9.6	12.1	10.7	2.5	7.5	0.0	0.1	1.6	4.4	0.0	7.7	0.1	0.2	4.2	5.2	0.1	13.5	9.9	0.9	9.6	16.8	24.5	8.6	7.9	0.1	0.1	0.6	0.2	0.1	0.6	0.0	0.3	0.2	0.2	0.4	0.0	0.2	0.6	2.3	0.4	0.1	0.1	0.3	0.1	0.3	4.5	7.7	4.8	6.7	5.2	5.1	7.0	6.1	7.0	4.0	6.6	14.1	0.0	0.0	0.0	0.7	0.1	0.5	1.2	0.0	0.0	13.8	0.3	0.0	0.7	0.0	0.1	0.0	25.0	0.8	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.7	0.4	0.0	0.0	0.0	0.6	0.5	0.0	0.1	1.8	1.0	0.1	3.4	0.0	6.0	9.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.2	7.4	0.0	0.7	1.6	2.6	0.9	1.8	0.0	0.5	0.2	0.1	0.0	0.4
MLC1	"KIAA0027, LVM, MLC, VL"	ENSG00000100427	"Modulator of VRAC current 1"	Q15049	22	50059391-50085426	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 262.7;choroid plexus: 145.6"	"Cell type enriched"	"Detected in some"	6	"Astrocytes: 115.6"	"Cancer enriched"	"Detected in some"	69	"glioma: 122.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 20.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 228.2;NB-4: 219.8;THP-1: 401.5;U-266/70: 131.6;U-266/84: 120.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003040	Enhanced		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA003040: AB_1079387"	"unprognostic (2.68e-2)"	"unprognostic (5.46e-6)"	"unprognostic (5.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.42e-3)"	"unprognostic (9.54e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.51e-3)"	"unprognostic (8.39e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.92e-1)"	0.3	0.1	239.3	0.7	235.7	36.4	0.1	212.7	261.8	3.0	145.6	0.1	0.4	0.3	1.0	0.1	1.8	1.0	0.6	225.8	234.5	0.1	0.4	1.6	0.3	262.7	243.1	0.3	0.1	0.0	1.1	2.3	221.8	4.8	0.0	4.1	0.1	1.4	0.1	1.0	0.1	0.2	231.9	2.2	0.2	3.8	231.5	0.5	0.1	0.0	0.5	0.4	11.9	217.2	0.4	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	68.1	0.0	0.0	0.1	228.2	68.4	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	1.8	219.8	0.3	0.0	0.1	24.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	401.5	0.0	0.0	0.2	0.1	0.3	131.6	120.2	0.4	0.3	35.7	2.2	0.0	1.1	0.0	3.9	6.8	0.1	0.1	0.3	1.6	0.9	0.0	0.1	1.8	0.1	20.2	9.2	0.2	0.1	4.0	239.3	235.7	212.7	261.8	225.8	234.5	262.7	243.1	221.8	231.9	231.5	217.2	0.0	0.0	0.5	115.6	0.3	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.1	17.2	0.0	0.0	0.0	1.1	0.1	0.4	0.1	0.0	7.8	0.4	0.0	0.1	2.4	0.0	0.1	1.3	4.4	0.4	0.0	3.5	0.0	0.5	0.0	0.0	0.3	0.0	0.7	0.0	0.6	1.8	7.5	0.6	16.3	18.6	0.5	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.3	2.7	0.1	0.0	0.0
MLYCD	"hMCD, MCD"	ENSG00000103150	"Malonyl-CoA decarboxylase"	O95822	16	83899115-83951445	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 21.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 97.5;Cone photoreceptor cells: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031625	Enhanced					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA031625: AB_10602028"	"unprognostic (6.23e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.84e-4)"	"unprognostic (2.33e-1)"	"prognostic favorable (2.61e-7)"	"unprognostic (2.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.56e-2)"	"unprognostic (1.51e-3)"	2.5	2.1	1.9	1.0	2.5	0.4	1.4	1.5	2.4	1.1	2.7	1.7	1.7	1.3	1.2	1.0	1.4	0.7	9.5	1.7	1.9	2.7	5.7	1.2	1.2	2.5	2.5	1.9	5.1	2.0	1.2	0.9	2.0	1.2	1.7	2.4	2.1	1.5	8.2	1.0	1.4	1.2	1.6	1.0	2.5	1.3	3.2	1.0	1.5	21.5	0.9	1.6	0.9	2.5	0.6	1.9	1.6	1.9	2.5	0.9	2.9	0.8	1.2	0.7	0.4	0.9	1.5	0.1	2.4	1.2	2.6	1.5	1.4	0.6	0.7	0.8	1.9	0.9	0.8	1.9	3.0	1.2	2.1	1.1	1.4	0.4	0.4	1.3	0.8	1.4	1.4	0.4	1.1	2.4	0.7	2.7	1.6	2.7	0.4	2.2	1.1	1.1	1.6	1.1	1.4	0.9	3.0	1.1	2.4	2.1	3.4	2.5	0.6	1.8	0.3	1.0	0.2	2.1	1.3	2.0	1.0	0.9	1.9	0.5	0.1	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.9	2.5	1.5	2.4	1.7	1.9	2.5	2.5	2.0	1.6	3.2	2.5	6.1	6.4	7.3	8.5	10.9	2.0	7.4	1.5	4.6	25.2	7.2	5.2	97.5	17.2	5.5	23.9	125.1	20.2	10.6	12.9	31.3	5.7	4.6	10.4	6.9	8.2	10.2	9.1	3.1	5.5	11.1	10.5	15.3	8.7	5.7	20.1	12.8	46.2	12.3	16.8	6.2	15.2	4.1	10.1	2.0	8.6	14.6	8.2	3.6	3.7	7.7	14.7	27.8	12.5	8.2	6.7	13.1	19.5	6.5	10.4	19.4	19.4	2.4	53.3	6.6	19.0	8.1	12.1	14.4	5.2	2.0	8.2	9.0	17.5	17.1	8.6
MMAB	"cblB, CFAP23"	ENSG00000139428	"Metabolism of cobalamin associated B"	Q96EY8	12	109553715-109573580	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 103.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 225.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039017	Supported		Approved	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 15: Hepatocytes - Hemostasis"	Mitochondria		"HPA039017: AB_10673603"	"unprognostic (1.16e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.22e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.58e-1)"	"prognostic favorable (1.55e-4)"	"unprognostic (4.90e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.65e-2)"	15.5	51.2	17.8	6.3	18.3	5.8	15.8	18.8	26.9	12.4	18.6	15.8	13.0	10.7	21.2	29.1	13.0	6.0	30.0	17.0	18.8	32.8	103.6	14.9	6.2	22.2	19.0	18.9	23.0	9.8	20.5	4.9	21.3	26.5	7.9	7.3	17.1	6.3	21.1	18.2	14.0	5.6	19.0	12.4	17.7	12.6	18.9	5.5	22.1	16.2	6.5	14.1	14.7	22.9	32.2	22.3	22.2	17.6	8.8	17.7	11.3	7.1	16.2	10.3	10.8	25.8	29.5	21.0	19.9	8.0	19.1	32.9	14.6	54.9	4.6	8.2	60.9	8.6	15.9	42.1	31.3	18.4	7.2	24.0	33.5	22.2	9.7	12.3	9.7	16.4	27.5	15.5	7.3	74.7	16.6	29.2	27.3	3.3	31.6	13.6	8.7	53.9	45.3	30.3	34.1	14.8	15.8	29.2	12.7	6.2	60.5	50.5	5.4	8.6	3.6	6.1	10.4	11.9	9.6	24.0	19.0	22.2	23.9	7.4	7.2	1.0	15.3	10.0	12.2	13.6	11.1	12.1	11.3	17.8	15.2	14.6	1.9	11.2	10.9	9.2	5.8	10.3	17.8	18.3	18.8	26.9	17.0	18.8	22.2	19.0	21.3	19.0	18.9	22.9	25.1	35.3	80.8	9.8	20.4	10.3	33.1	105.6	17.1	32.9	59.6	47.0	52.3	60.1	68.9	42.3	29.2	55.4	15.2	33.6	150.6	49.7	41.3	23.8	10.0	22.1	33.0	34.1	6.4	71.3	37.6	24.7	28.5	16.5	16.5	34.3	28.5	225.3	34.8	104.3	8.5	50.4	71.2	20.4	10.2	82.9	40.4	13.5	26.6	4.7	25.1	30.6	30.9	6.6	21.5	29.7	30.0	30.5	18.1	31.8	61.9	143.6	62.1	29.7	13.1	17.9	26.3	26.0	15.8	44.7	19.7	61.8	16.1	121.1	56.6	30.3
MMACHC	"cblC, DKFZP564I122"	ENSG00000132763	"Metabolism of cobalamin associated C"	Q9Y4U1	1	45500300-45513382	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Oxidoreductase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 17.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027394, HPA027399, HPA027402"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA027394: AB_10601669, HPA027399: AB_10601987, HPA027402: AB_2672255"	"unprognostic (3.34e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.03e-3)"	"unprognostic (3.14e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.08e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.58e-2)"	2.0	3.1	3.3	1.7	5.3	1.2	3.5	5.1	4.2	2.9	2.3	3.7	3.3	1.7	3.0	2.8	3.5	1.3	6.9	3.4	5.1	3.5	17.4	1.2	1.8	4.1	5.6	3.5	2.9	5.5	1.3	1.5	3.9	2.0	4.4	2.1	5.0	2.4	10.8	2.0	2.4	2.3	3.5	1.6	2.3	4.3	5.6	2.2	2.3	6.6	2.0	1.7	1.5	6.0	7.7	3.9	6.6	10.0	6.1	3.7	8.1	5.9	3.9	10.5	9.4	8.3	4.7	12.0	7.4	4.9	2.0	6.2	12.3	14.0	9.6	3.3	11.4	9.4	6.5	9.2	5.8	13.5	3.3	5.3	7.8	11.6	12.6	3.7	5.1	12.5	10.8	6.7	8.1	8.2	9.1	4.3	10.9	8.8	8.9	11.1	2.7	13.2	6.2	6.0	10.5	5.4	8.8	14.5	19.3	4.9	8.3	4.6	2.3	7.3	9.9	8.3	3.3	9.9	8.5	6.9	5.3	6.4	6.9	2.3	0.5	0.5	0.5	0.8	0.8	0.7	0.7	0.4	0.6	0.6	1.3	0.6	0.9	0.8	2.7	1.3	0.4	0.4	3.3	5.3	5.1	4.2	3.4	5.1	4.1	5.6	3.9	3.5	5.6	6.0	1.1	3.2	5.5	1.6	2.1	0.1	1.8	0.8	5.7	1.3	2.7	1.5	9.8	4.3	2.2	1.8	0.0	3.7	0.6	2.8	5.9	1.3	1.0	3.6	4.8	1.5	4.2	4.8	2.6	1.4	4.3	3.6	7.1	3.2	2.5	2.9	2.5	22.9	3.3	3.3	2.7	3.2	2.0	3.2	0.9	1.2	1.8	2.7	0.0	0.0	0.6	1.4	3.1	1.5	5.3	1.8	2.3	1.5	10.4	1.7	2.0	4.6	1.2	5.2	0.0	5.0	2.4	7.4	2.1	11.5	0.1	2.7	2.4	3.9	5.8	1.8
MMP13	CLG3	ENSG00000137745	"Matrix metallopeptidase 13"	P45452	11	102942995-102955732	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"urinary bladder: 12.9"	"Cell type enriched"	"Detected in some"	12	"Basal respiratory cells: 426.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 70.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 17.9;PC-3: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB002742	Supported				"Secreted to extracellular matrix"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB002742: "	"unprognostic (8.98e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.59e-3)"		"unprognostic (1.32e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.69e-1)"	"unprognostic (7.55e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.73e-8)"	"unprognostic (2.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.33e-2)"	0.1	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	12.9	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	17.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.0	0.0	6.7	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	2.4	1.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.7	426.0	0.0	0.0	0.0	0.0	0.2	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	6.8	0.0	0.0	0.0	2.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	15.8
MMP14	MT1-MMP	ENSG00000157227	"Matrix metallopeptidase 14"	P50281	14	22836560-22849041	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 244.0;Pancreatic endocrine cells: 144.7;Syncytiotrophoblasts: 122.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 923.8;HHSteC: 794.2;HSkMC: 887.0;hTERT-RPE1: 925.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009918, HPA051432"	Approved		Approved	"Intermediate filaments,Cytosol"		No	No		1400000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	"Intermediate filaments"	"CAB009918: AB_2250767, HPA051432: AB_2681484"	"unprognostic (1.34e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-3)"	"unprognostic (5.91e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.82e-3)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (5.02e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.41e-3)"	151.5	31.7	5.6	59.9	5.0	1.6	101.5	5.7	7.5	181.3	61.8	77.2	39.5	167.3	19.0	92.1	82.1	148.2	41.3	6.6	7.2	35.9	13.2	91.8	24.8	11.9	8.4	90.2	36.0	65.3	14.2	118.9	9.2	59.9	36.6	9.6	78.1	45.5	18.8	127.5	69.4	106.0	7.3	30.8	57.7	11.7	13.2	13.0	50.0	16.1	30.8	103.9	111.1	10.6	90.6	1.2	26.3	2.0	923.8	651.6	455.9	270.1	606.4	93.3	158.5	21.3	337.4	0.9	146.4	301.9	24.6	216.3	0.3	262.2	99.7	1.1	0.6	37.2	1.7	5.0	794.2	0.4	1.3	887.0	148.7	334.7	288.3	925.5	492.9	0.6	0.8	2.1	185.1	0.7	0.4	79.4	14.7	17.7	52.4	2.1	96.0	0.2	61.4	148.1	0.3	0.6	187.3	0.3	574.2	104.4	1.0	79.5	436.8	724.9	53.7	198.2	329.6	0.8	1.6	1.1	410.9	0.6	396.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	5.0	5.7	7.5	6.6	7.2	11.9	8.4	9.2	7.3	13.2	10.6	13.9	12.8	3.0	2.0	3.4	34.0	23.4	105.4	39.3	0.0	14.1	17.5	4.7	50.1	42.2	7.3	0.0	105.6	0.3	19.9	11.7	63.0	0.4	16.1	81.6	35.2	7.8	0.0	0.0	28.7	244.0	84.0	25.5	14.8	3.8	9.3	32.9	2.7	89.5	0.0	0.0	24.5	34.6	20.2	32.7	2.4	72.1	38.0	37.4	4.7	21.5	14.3	0.0	0.5	0.1	144.7	33.0	54.9	0.3	21.8	19.9	11.7	46.8	0.8	39.5	11.1	73.9	0.8	0.8	33.7	34.2	122.7	2.5	15.6	18.6	37.9
MMP19	"MMP18, RASI-1"	ENSG00000123342	"Matrix metallopeptidase 19"	Q99542	12	55835433-55842966	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins"	"Angiogenesis, Collagen degradation, Differentiation"	"Developmental protein, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 58.5"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 54.4;Fibroblasts: 52.8;Hofbauer cells: 30.8;Kupffer cells: 35.7;Langerhans cells: 100.7;Macrophages: 61.2"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"thalamus: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"BEWO: 75.6"	"Region enriched"	"Detected in many"	5	"olfactory bulb: 7.2"	"Low region specificity"	"Detected in all"			HPA070804			Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		2100000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum, Vesicles"		"HPA070804: AB_2686315"	"unprognostic (2.61e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.77e-3)"	"unprognostic (2.01e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (8.56e-9)"	"unprognostic (5.06e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.73e-2)"	"unprognostic (4.00e-2)"	58.5	3.6	0.0	11.4	0.1	0.7	18.3	0.0	0.3	10.4	0.5	7.3	1.2	20.7	0.5	2.3	17.2	25.6	8.8	0.1	0.1	5.7	2.7	25.4	2.8	0.1	0.1	11.9	7.2	0.5	0.8	10.8	0.2	3.3	3.3	0.1	3.1	2.3	0.9	5.5	8.7	8.7	0.1	27.4	9.6	0.4	1.3	2.9	4.4	0.6	6.9	9.6	6.2	0.1	1.5	0.0	0.2	0.0	7.8	12.4	75.6	10.1	10.6	3.9	4.4	0.6	0.6	0.0	0.0	12.8	0.3	0.0	0.0	3.0	4.0	0.8	0.0	0.0	0.3	0.1	6.5	0.0	0.6	12.1	0.4	1.9	2.4	6.2	0.7	0.0	0.2	0.1	11.2	0.0	0.0	0.2	0.3	0.0	0.2	0.0	2.8	0.0	1.7	4.7	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.2	15.7	2.2	5.0	0.2	0.3	0.1	0.0	0.0	8.4	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.2	0.1	1.3	0.1	2.8	0.0	4.6	0.7	1.3	7.1	0.3	1.9	0.6	0.4	0.3	0.3	0.7	11.5	3.3	0.0	4.2	18.6	0.7	0.0	0.0	0.3	0.5	2.4	20.8	1.5	0.0	0.0	0.2	0.5	54.4	52.8	1.1	1.7	2.5	0.4	3.6	0.7	30.8	0.0	0.2	0.1	0.0	35.7	100.7	0.9	5.9	61.2	12.4	1.9	22.5	0.4	0.0	0.0	0.3	0.1	0.0	5.3	1.0	0.3	0.0	0.1	1.5	1.7	0.0	3.8	7.6	0.2	0.2	1.0	4.3	18.7	0.9	0.2	0.0	0.4
MMP2	"CLG4, CLG4A, TBE-1"	ENSG00000087245	"Matrix metallopeptidase 2"	P08253	16	55389700-55506691	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 1062.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 222.4;Extravillous trophoblasts: 467.9;Fibroblasts: 815.9;Leydig cells: 340.2;Peritubular cells: 419.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 5619.3;ASC TERT1: 1623.2;hTERT-RPE1: 6400.4;U-87 MG: 1812.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001939, CAB002788"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA	1600000000	220000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB002788: , HPA001939: AB_1079395"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.36e-3)"	"unprognostic (4.81e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.59e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.59e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (4.63e-2)"	518.9	68.3	3.9	135.1	4.0	1.2	328.9	4.9	7.8	514.1	9.4	173.8	57.4	453.6	192.6	121.5	190.6	1062.9	212.8	3.6	5.3	43.7	15.6	279.7	28.1	7.6	4.9	271.1	42.8	13.8	14.7	225.0	5.4	116.8	171.3	11.4	124.1	137.5	60.8	455.6	177.3	468.5	6.7	58.3	134.0	49.6	8.6	19.8	113.5	66.1	30.3	660.8	238.1	10.0	6.5	3.9	192.0	2.4	5619.3	1623.2	312.7	501.4	1146.1	99.4	79.0	0.2	2.1	0.5	391.7	891.0	37.0	54.2	1.2	4.6	57.0	0.7	0.9	0.7	12.9	3.0	530.6	0.4	14.8	1396.8	1.7	512.4	4.4	6400.4	651.1	0.5	0.7	2.4	334.7	0.0	0.4	8.2	152.4	0.5	1.6	0.4	46.1	0.9	16.1	7.6	3.2	345.0	93.3	0.8	2.1	849.0	1.6	36.0	924.6	1546.0	144.9	300.5	66.9	1.0	0.6	2.2	1812.3	28.3	289.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	4.0	4.9	7.8	3.6	5.3	7.6	4.9	5.4	6.7	8.6	10.0	38.4	0.0	0.5	0.0	0.0	122.1	14.1	48.8	9.1	30.5	3.1	16.8	4.4	0.0	3.1	11.0	0.0	5.6	0.5	0.1	0.0	2.5	12.5	7.7	222.4	46.9	28.2	0.0	0.0	0.4	467.9	815.9	12.2	5.4	0.0	0.0	13.2	0.1	28.2	1.7	0.2	0.1	2.0	1.6	180.7	40.2	340.2	11.8	128.1	27.2	0.0	7.7	0.0	5.0	0.0	9.3	0.0	419.0	2.8	5.6	0.0	0.2	1.1	2.5	13.1	80.0	65.3	1.2	2.8	6.6	102.3	17.2	10.3	35.2	0.0	4.4
MMP20		ENSG00000137674	"Matrix metallopeptidase 20"	O60882	11	102576832-102625332	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Amelogenesis imperfecta"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	7	"Early spermatids: 91.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"OE19: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"	NA	NA					"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (4.62e-3)"		"unprognostic (2.61e-2)"	"unprognostic (1.68e-3)"		"unprognostic (1.75e-1)"		"unprognostic (2.13e-1)"		"unprognostic (3.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.58e-5)"	"unprognostic (6.10e-2)"		"unprognostic (2.35e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	12.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	6.6	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.4
MMP21		ENSG00000154485	"Matrix metallopeptidase 21"	Q8N119	10	125753580-125775821	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	Heterotaxy	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	14	"epididymis: 53.9"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 1.9;Granulosa cells: 1.4;Microglial cells: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted to extracellular matrix"	NA	NA				"Cluster 68: Epididymis - Unknown function"		"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (1.32e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.89e-2)"	"unprognostic (3.62e-2)"	"unprognostic (9.70e-8)"	"unprognostic (1.30e-2)"	"unprognostic (7.69e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.18e-1)"	0.2	0.3	0.4	0.6	0.7	0.7	0.2	1.7	0.7	0.2	0.2	0.2	0.5	0.5	53.9	0.5	0.4	0.7	0.8	0.5	0.4	0.1	0.3	0.2	1.0	0.3	0.3	3.7	0.7	0.0	0.1	0.1	0.2	0.5	0.1	1.8	1.2	0.2	0.3	1.2	0.4	0.2	0.1	0.6	0.4	1.0	0.5	0.0	0.5	0.0	0.2	0.2	0.0	0.9	0.4	0.2	0.6	0.4	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.4	0.1	0.9	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.3	0.0	0.2	0.2	0.3	0.3	0.0	0.3	0.2	0.1	0.1	0.0	0.3	0.1	0.2	0.2	0.0	0.0	0.2	0.1	0.1	0.2	0.5	0.2	0.2	0.3	0.5	0.4	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	1.7	0.7	0.5	0.4	0.3	0.3	0.2	0.1	0.5	0.9	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	1.4	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.5	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0
MMP3	"STMY, STMY1"	ENSG00000149968	"Matrix metallopeptidase 3"	P08254	11	102835801-102843609	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 90.7;salivary gland: 286.1"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 20.4;Basal respiratory cells: 25.8;Early spermatids: 24.2;Extravillous trophoblasts: 13.4;Fibroblasts: 17.9;Prostatic glandular cells: 11.9;Smooth muscle cells: 10.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 59.9"	"Region enriched"	"Detected in some"	4	"thalamus: 7.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"BJ: 1545.7;BJ hTERT+: 4229.3;fHDF/TERT166: 1846.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hippocampal formation: 3.2"	HPA007875	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA	2540000	460000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA007875: AB_1079396"	"unprognostic (2.27e-1)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (1.63e-3)"	"unprognostic (5.11e-3)"	"unprognostic (3.78e-1)"	"unprognostic (5.11e-2)"	"unprognostic (5.26e-6)"	"unprognostic (3.46e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.09e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-15)"	"unprognostic (3.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.34e-1)"	90.7	0.1	0.3	20.1	0.4	0.0	36.6	0.2	1.6	0.3	0.1	6.1	2.4	38.1	0.2	0.8	0.2	1.9	0.2	0.4	1.6	0.4	1.6	0.3	0.0	0.4	0.4	0.1	0.3	0.1	0.9	0.4	0.3	2.2	2.3	0.0	286.1	2.2	39.6	63.7	4.5	1.6	0.3	0.0	10.5	0.1	7.3	0.1	2.6	0.4	1.3	13.9	0.5	0.3	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1545.7	4229.3	27.0	8.7	0.1	0.2	0.0	0.0	1846.6	96.9	0.0	0.1	0.1	45.1	0.0	0.0	0.0	0.0	1.0	0.7	0.0	0.0	4.6	0.2	122.0	5.3	0.0	0.0	0.0	0.2	0.3	4.7	0.0	0.0	0.0	0.2	0.4	0.9	0.0	0.2	0.0	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.9	0.0	0.3	0.0	140.5	13.1	1.6	0.5	0.0	0.0	0.2	56.8	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	1.6	0.4	1.6	0.4	0.4	0.3	0.3	7.3	0.3	0.0	3.2	0.0	0.0	0.0	8.4	20.4	25.8	0.0	0.0	0.1	0.1	0.3	4.3	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.8	24.2	0.0	0.3	0.5	0.0	0.0	0.2	1.4	13.4	17.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.1	0.0	2.2	1.2	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.5	4.0	0.0	0.0	11.9	1.0	0.9	0.1	0.0	0.0	1.8	10.2	0.0	1.8	0.0	3.4	0.3	0.6	0.0	0.8	7.4
MOCOS	"FLJ20733, HMCS, MOS"	ENSG00000075643	"Molybdenum cofactor sulfurase"	Q96EN8	18	36187497-36272157	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 10.3;liver: 16.0"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 18.8;Hepatocytes: 39.4;Proximal enterocytes: 22.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 40.7;hTERT-HME1: 49.7;SiHa: 54.9;SK-MEL-30: 38.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039412, HPA047958"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria	Cytosol	"HPA039412: AB_2676496, HPA047958: AB_2680225"	"unprognostic (3.07e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.84e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.91e-2)"	"prognostic unfavorable (3.03e-12)"	"unprognostic (8.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.35e-2)"	2.0	10.3	0.3	0.9	0.3	0.3	2.5	0.5	0.5	0.9	0.5	1.6	6.1	0.8	1.9	3.8	1.7	1.4	0.3	0.4	0.4	1.2	16.0	1.6	0.2	1.2	0.3	6.4	0.8	2.3	2.0	1.0	1.3	1.3	1.6	0.7	1.8	3.3	0.6	2.0	6.4	0.6	0.2	0.3	1.6	0.9	0.6	0.1	1.2	0.4	1.2	2.7	0.7	0.3	14.3	4.8	0.2	0.1	4.3	5.5	2.9	8.2	4.6	3.9	10.0	3.1	4.4	0.1	2.5	13.4	1.0	8.6	2.9	12.9	5.4	2.4	2.3	0.2	13.5	11.8	14.6	0.1	3.8	8.7	40.7	15.2	49.7	0.5	0.6	0.1	4.9	0.1	6.2	3.6	0.0	0.1	0.8	3.4	4.1	0.0	0.1	0.0	5.5	18.5	0.1	1.2	54.9	3.3	38.8	0.9	2.5	0.2	2.7	3.0	3.7	6.7	1.4	0.1	0.1	0.1	7.8	0.1	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.5	0.5	0.4	0.4	1.2	0.3	1.3	0.2	0.6	0.3	0.9	12.8	5.0	0.3	0.9	0.6	1.4	3.7	1.8	0.3	4.5	1.9	1.0	4.3	6.4	0.0	2.1	0.5	0.2	2.2	0.0	3.1	7.2	5.9	3.4	0.8	3.0	0.0	0.9	12.4	4.3	2.4	1.5	18.8	0.0	2.0	0.4	39.4	0.6	0.0	1.1	3.1	6.1	0.6	2.6	3.2	1.8	1.0	3.6	4.7	11.9	6.6	0.0	1.0	0.3	4.6	2.3	9.1	0.9	2.3	22.4	0.2	4.5	0.5	0.0	6.5	1.2	0.1	0.3	5.1	1.3	2.3	0.5	2.7	4.5	2.2
MOCS1	MOCOD	ENSG00000124615	"Molybdenum cofactor synthesis 1"	Q9NZB8	6	39899578-39934551	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 33.7;Hepatocytes: 36.2;Sertoli cells: 78.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 40.4;JURKAT: 51.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045783, HPA058177, HPA075505"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA045783: AB_10960058, HPA058177: AB_2683629, HPA075505: AB_2686751"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.07e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (6.07e-5)"	"unprognostic (5.34e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.21e-2)"	33.7	9.5	14.6	3.2	17.9	0.0	26.8	16.8	14.7	8.8	11.2	11.7	16.2	10.0	10.1	6.7	10.3	5.5	22.0	12.7	16.0	20.4	40.3	22.9	4.5	17.4	18.8	9.0	11.9	9.6	5.3	35.6	16.2	5.3	5.6	3.0	6.1	7.5	25.7	7.3	12.7	9.2	15.6	2.6	7.6	3.2	17.3	3.3	16.0	45.0	3.4	10.0	6.6	16.4	0.0	2.1	7.0	11.4	19.3	7.2	15.2	8.7	15.0	12.1	10.0	40.4	0.1	0.0	8.4	7.4	7.0	0.4	8.2	9.8	8.7	0.0	8.6	0.0	0.0	13.7	12.2	0.0	3.1	12.0	3.7	7.9	4.2	7.2	10.1	51.1	8.4	0.7	11.7	5.0	16.0	0.0	7.9	0.1	4.6	0.0	6.3	1.1	7.6	8.2	6.1	8.5	0.0	4.2	7.0	6.3	5.2	1.4	16.2	12.2	9.8	7.7	4.1	0.0	1.7	0.0	1.3	0.0	4.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.5	0.0	0.3	0.0	0.0	0.0	0.2	14.6	17.9	16.8	14.7	12.7	16.0	17.4	18.8	16.2	15.6	17.3	16.4	5.7	6.4	1.5	6.2	0.1	0.6	0.6	0.7	1.2	1.6	9.3	6.5	11.6	8.6	0.3	9.2	12.5	33.7	0.5	3.6	5.9	4.4	0.8	0.9	1.6	3.3	0.0	0.0	3.2	4.1	2.3	4.3	1.1	1.4	1.3	6.3	3.3	36.2	2.9	3.3	2.6	3.5	0.0	2.8	1.0	1.8	3.7	0.4	1.8	2.8	0.0	4.6	0.0	1.0	4.4	1.0	9.1	3.0	1.3	0.2	13.2	17.8	0.0	2.2	78.9	3.9	20.3	1.6	1.9	1.2	1.1	6.2	0.3	0.8	5.5	0.6
MOCS2	"MOCO1, MOCS2A, MOCS2B"	ENSG00000164172	"Molybdenum cofactor synthesis 2"	"O96007, O96033"	5	53095679-53110063	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 573.2;Proximal tubular cells: 281.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037679, HPA037680"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Nuclear speckles"	"HPA037679: AB_2675604, HPA037680: AB_10673635"	"unprognostic (3.27e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.68e-6)"	"unprognostic (1.04e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.86e-2)"	48.7	79.4	79.1	24.9	84.9	9.1	42.1	80.3	107.6	34.7	74.4	41.9	40.8	30.0	45.9	35.2	26.5	31.3	87.0	84.3	86.3	114.8	126.2	28.2	26.1	79.2	80.5	43.5	42.4	89.6	30.5	35.9	82.4	36.8	32.3	59.3	48.9	44.9	109.3	16.6	40.2	34.4	85.6	23.6	37.2	26.0	88.0	28.3	55.4	111.8	25.2	30.8	24.6	87.4	79.4	62.7	42.9	109.9	85.0	83.2	51.6	99.5	91.9	74.4	89.8	79.7	56.5	76.7	143.5	69.9	127.1	45.0	91.7	96.7	117.2	19.6	84.8	61.7	58.2	75.9	94.4	65.0	43.0	65.1	41.7	91.7	83.5	81.0	85.1	101.4	58.7	44.2	129.5	115.5	72.7	31.8	37.0	34.2	130.1	36.0	93.0	67.0	144.1	56.6	29.4	33.7	69.4	57.3	72.9	56.9	107.2	15.4	55.6	76.9	81.0	69.1	120.5	49.4	84.8	91.5	106.7	16.8	125.1	14.5	21.8	15.6	36.9	26.9	46.2	37.5	42.7	42.8	29.8	40.5	55.3	49.2	3.8	43.5	25.4	27.8	44.9	28.9	79.1	84.9	80.3	107.6	84.3	86.3	79.2	80.5	82.4	85.6	88.0	87.4	51.7	54.5	29.7	14.4	23.5	13.4	40.1	48.5	19.9	30.2	55.7	50.5	122.9	62.9	37.9	69.9	27.1	95.4	19.4	18.2	573.2	43.7	7.3	22.6	29.0	37.6	26.4	18.7	19.1	43.7	37.3	55.7	19.9	26.8	10.1	38.8	26.0	132.6	41.3	6.7	18.4	22.7	44.7	31.2	20.1	14.6	50.7	28.7	23.2	6.5	12.2	67.5	29.9	4.5	11.9	22.1	18.2	68.8	26.7	34.5	65.7	281.7	32.9	21.7	32.9	73.8	49.4	46.7	62.9	37.5	15.6	32.3	25.8	64.2	30.9	34.5
MOGS	"CWH41, DER7, GCS1"	ENSG00000115275	"Mannosyl-oligosaccharide glucosidase"	Q13724	2	74461057-74465410	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 222.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011322, HPA011969"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		1500000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA011322: AB_2668483, HPA011969: AB_1849579"	"unprognostic (5.66e-2)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.91e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (2.34e-6)"	"unprognostic (1.48e-2)"	"unprognostic (2.66e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.21e-2)"	"unprognostic (4.36e-1)"	"prognostic unfavorable (2.79e-8)"	"unprognostic (1.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.59e-3)"	18.4	18.3	8.1	20.2	9.1	8.5	18.6	9.0	13.3	19.2	9.2	22.8	41.7	18.3	5.5	22.5	20.0	14.4	16.9	8.3	9.0	20.9	34.3	24.9	21.6	9.4	8.7	18.6	42.3	21.5	21.7	34.5	9.9	23.3	13.4	9.6	31.1	14.6	21.3	24.9	29.7	11.4	9.3	31.7	35.5	19.0	8.9	19.8	21.9	16.2	18.1	20.1	19.1	9.8	53.1	46.2	23.5	29.6	55.3	38.9	90.1	38.7	58.3	59.8	58.2	81.9	58.7	45.2	34.9	36.3	46.7	50.6	40.2	43.3	32.5	46.7	39.9	20.3	14.4	68.6	54.9	49.8	46.6	25.6	77.1	41.9	39.0	62.2	68.4	27.8	39.6	51.6	28.5	58.8	32.3	62.0	42.6	64.1	22.5	35.5	57.4	74.1	38.0	19.5	19.7	29.2	15.5	84.8	62.7	21.8	38.7	34.3	40.1	26.5	49.7	36.3	56.5	66.5	36.5	22.7	46.9	49.3	39.0	6.7	2.4	1.9	2.6	1.5	3.3	1.2	2.3	2.5	2.1	1.9	1.4	1.6	0.4	8.4	3.3	2.1	3.3	1.7	8.1	9.1	9.0	13.3	8.3	9.0	9.4	8.7	9.9	9.3	8.9	9.8	13.9	6.4	15.9	16.3	22.0	15.8	21.8	20.8	18.2	14.9	18.9	12.8	8.6	24.3	21.3	23.9	18.8	39.5	34.6	18.7	5.9	21.9	65.6	12.4	12.2	13.3	13.9	16.4	13.9	26.1	50.5	12.3	40.8	17.4	4.5	20.9	17.9	25.6	19.9	6.7	12.1	25.7	20.3	12.9	14.8	222.0	15.2	17.9	10.6	12.2	25.5	7.0	30.9	11.1	10.7	22.3	19.7	7.2	43.6	22.7	37.7	7.4	17.7	14.1	13.1	9.4	12.7	13.0	5.1	15.2	17.3	52.0	21.2	16.5	23.3	19.6
MPC1	"BRP44L, CGI-129, dJ68L15.3, SLC54A1"	ENSG00000060762	"Mitochondrial pyruvate carrier 1"	Q9Y5U8	6	166364919-166383013	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 739.7;tongue: 559.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 950.0;Distal tubular cells: 1721.8;Proximal tubular cells: 573.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045119, HPA055790"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA045119: AB_10960421, HPA055790: AB_2682923"	"unprognostic (3.30e-2)"	"prognostic favorable (1.45e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.64e-2)"	"prognostic favorable (4.79e-11)"	"unprognostic (4.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.45e-2)"	61.7	39.6	105.9	33.4	119.5	57.0	52.8	129.7	153.1	52.4	108.0	97.7	84.8	35.7	44.8	71.5	34.7	41.7	739.7	101.2	127.8	259.9	411.2	44.6	44.3	119.2	123.9	43.4	66.0	141.8	38.1	23.7	119.5	43.5	89.9	57.3	87.7	42.3	319.4	40.9	63.8	38.5	117.1	35.0	96.1	22.2	121.5	48.6	82.9	559.2	44.2	47.4	34.9	132.4	25.6	7.5	31.3	107.7	88.4	49.8	45.2	29.1	47.1	45.1	43.9	38.8	17.9	53.6	50.9	45.4	36.1	24.5	47.0	36.7	31.9	36.1	79.0	27.5	35.4	132.6	36.6	104.9	34.1	40.0	51.0	36.8	26.7	13.7	36.9	80.8	94.2	84.1	28.6	40.5	73.1	193.7	16.1	148.0	35.5	39.1	51.7	134.9	85.4	20.5	96.7	85.7	33.6	145.8	34.0	25.9	34.5	154.3	25.3	25.7	26.8	91.6	30.0	55.8	42.2	46.3	23.5	127.0	42.1	60.7	60.0	90.1	41.7	98.3	39.4	33.1	48.5	45.1	72.2	25.4	44.7	43.3	54.6	40.5	128.5	43.0	69.1	49.8	105.9	119.5	129.7	153.1	101.2	127.8	119.2	123.9	119.5	117.1	121.5	132.4	56.1	118.6	48.0	64.6	51.7	45.6	44.2	83.6	29.0	61.1	74.2	79.1	950.0	187.3	67.6	106.7	10.4	22.0	54.2	219.1	1721.8	89.3	66.8	73.7	50.7	51.7	37.2	72.6	49.0	140.3	78.3	74.1	63.7	93.2	71.0	28.0	47.5	391.0	121.4	48.8	74.7	122.1	166.8	89.6	81.7	10.2	66.5	80.3	129.9	20.6	104.7	199.9	58.7	32.2	108.0	65.2	125.0	89.9	114.5	32.0	162.0	573.6	46.3	66.7	92.1	76.9	80.4	163.2	79.6	67.3	55.8	24.4	58.4	39.9	146.7	53.6
MPI		ENSG00000178802	"Mannose phosphate isomerase"	P34949	15	74890005-74902219	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 70.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007200	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		350000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Plasma membrane"	"HPA007200: AB_1854079"	"unprognostic (1.38e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.65e-3)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (2.39e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.58e-2)"	18.9	50.5	45.4	16.7	47.3	11.7	20.1	52.2	49.2	23.9	41.1	31.8	45.6	23.6	35.3	27.7	27.8	16.0	44.8	46.6	47.9	31.2	39.1	14.9	20.9	55.5	50.1	30.6	31.8	31.1	22.9	16.2	56.2	27.5	31.4	33.6	23.7	22.9	52.2	16.5	33.0	22.5	45.7	23.0	20.9	26.2	50.0	23.2	23.2	70.9	24.2	24.2	19.5	47.1	27.2	36.9	29.8	34.0	66.7	32.2	26.0	22.8	37.2	38.4	53.4	36.7	35.0	38.3	48.6	33.6	30.6	65.9	60.0	66.7	36.2	29.4	74.9	68.8	35.3	39.9	47.5	32.0	19.4	43.1	16.9	36.2	64.4	58.1	52.9	45.2	23.4	30.7	50.1	23.2	34.6	14.2	16.4	40.9	31.0	35.0	28.0	94.9	45.5	30.4	55.7	24.4	26.7	47.5	28.7	43.5	65.3	21.9	24.1	22.9	19.4	17.3	22.6	75.0	48.4	25.1	47.9	45.8	17.1	2.3	16.2	5.7	28.2	17.0	37.0	27.4	38.3	32.6	23.0	31.9	56.0	40.8	2.7	43.1	15.5	19.1	53.1	29.0	45.4	47.3	52.2	49.2	46.6	47.9	55.5	50.1	56.2	45.7	50.0	47.1	5.6	6.4	15.0	7.8	10.8	1.9	7.6	16.4	5.2	23.4	9.2	10.7	54.1	7.2	10.9	14.7	4.2	31.8	9.1	28.3	15.6	19.6	18.9	5.6	9.2	9.6	10.8	4.2	4.9	8.8	11.4	10.9	6.1	8.5	15.2	13.3	6.1	18.8	23.9	35.3	6.1	19.0	8.2	7.2	2.2	31.3	11.1	6.6	3.6	3.7	9.7	20.7	12.3	2.0	6.9	12.2	33.2	8.6	11.8	7.2	70.1	31.4	7.8	16.7	6.6	8.2	10.1	34.5	9.0	9.1	2.7	16.3	11.1	21.0	16.4	6.2
MPO		ENSG00000005381	Myeloperoxidase	P05164	17	58269855-58280935	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	61	"bone marrow: 4023.1"	"Cell type enriched"	"Detected in some"	30	"Erythroid cells: 87.4"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.1"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 6.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	94	"HL-60: 3517.4;NB-4: 4589.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000059, HPA021147, HPA061464"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	No	NA	576000000	24000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles	Nucleoplasm	"CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531"	"unprognostic (1.91e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.05e-2)"	0.5	0.4	0.8	0.6	0.6	4023.1	0.3	0.6	1.1	0.0	0.3	0.2	0.0	0.2	1.1	0.1	0.1	0.3	1.1	0.8	0.7	0.2	1.8	8.4	1.7	0.9	1.0	0.1	0.1	0.0	1.5	1.4	0.9	0.2	0.2	0.4	66.3	0.1	1.1	4.3	0.2	0.3	0.8	21.7	0.1	0.4	0.8	10.9	0.3	0.3	0.2	0.5	0.1	0.7	0.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	3517.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4589.9	0.0	0.0	0.0	5.3	3.2	0.6	0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	4.0	0.0	0.0	6.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.1	7.5	0.8	0.6	0.6	1.1	0.8	0.7	0.9	1.0	0.9	0.8	0.8	0.7	0.0	0.0	0.5	0.7	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.9	0.0	0.5	0.1	0.0	0.1	0.0	87.4	0.3	0.2	0.9	0.7	0.0	0.0	0.0	0.0	0.7	0.3	0.9	0.0	0.2	0.0	0.0	1.2	0.0	1.3	0.0	2.9	0.0	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.1	0.3	0.1	0.0	0.1	0.6	0.0	0.0	0.0
MPST	"MST, TST2, TUM1"	ENSG00000128309	"Mercaptopyruvate sulfurtransferase"	P25325	22	37019635-37029821	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 390.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 553.6;Hepatocytes: 578.6;Paneth cells: 621.4;Proximal enterocytes: 1322.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001240	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		2900000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	Cytosol	"HPA001240: AB_1079408"	"unprognostic (7.18e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.98e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (5.89e-4)"	58.0	57.3	25.3	10.0	32.3	36.5	51.0	29.0	31.0	40.9	29.8	102.4	106.5	34.7	0.6	91.5	42.9	16.6	64.2	22.9	23.4	71.4	390.7	43.5	8.8	34.0	27.5	81.7	106.4	4.8	14.7	9.1	29.7	45.3	17.0	0.5	43.5	9.6	89.7	82.3	93.0	7.0	26.0	22.1	70.3	51.7	31.4	4.5	24.8	23.1	6.0	48.3	62.3	35.1	44.0	50.4	24.2	50.0	27.8	17.2	38.1	23.4	20.6	24.8	33.2	48.6	18.9	68.7	33.0	16.7	16.7	29.9	20.9	33.8	3.6	41.4	119.2	26.5	21.3	115.6	87.5	29.0	35.6	30.0	64.2	16.1	15.1	22.8	50.6	33.1	48.0	19.3	7.0	33.8	2.6	97.5	45.7	56.7	52.2	73.6	28.8	51.9	25.5	14.0	12.4	92.9	15.6	23.9	46.6	12.2	26.0	45.6	39.8	21.3	60.1	23.9	16.0	33.3	16.8	21.0	7.7	34.7	11.1	48.5	71.9	54.7	31.0	27.5	42.4	24.9	20.1	26.4	104.0	25.0	2.7	10.4	21.9	87.8	12.7	16.3	44.3	35.4	25.3	32.3	29.0	31.0	22.9	23.4	34.0	27.5	29.7	26.0	31.4	35.1	21.3	35.3	61.9	14.7	25.1	81.6	80.4	120.3	70.6	4.5	81.4	83.4	29.4	243.1	70.0	60.7	0.0	61.9	20.3	553.6	133.1	146.4	191.1	38.5	46.8	42.6	108.6	122.6	1.1	148.3	119.1	52.8	87.1	72.5	17.2	140.3	108.5	578.6	77.5	3.3	1.9	363.1	85.5	84.6	77.6	115.1	91.0	62.7	58.7	3.7	60.7	24.8	56.7	4.5	14.9	117.9	621.4	84.7	65.7	77.7	1322.1	469.8	13.4	2.8	46.0	34.4	36.0	101.3	11.5	133.7	152.9	50.1	26.6	57.7	397.5	110.6
MPV17	SYM1	ENSG00000115204	"Mitochondrial inner membrane protein MPV17"	P39210	2	27309492-27325680	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"unprognostic (9.34e-3)"	"unprognostic (2.70e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (6.99e-6)"	"unprognostic (1.05e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.59e-3)"	"unprognostic (2.52e-1)"	"unprognostic (5.10e-3)"	"unprognostic (4.62e-2)"	50.2	86.5	56.4	37.8	58.1	31.3	39.9	59.1	58.4	36.0	59.3	32.5	25.0	37.9	47.7	32.6	37.7	36.7	78.2	56.3	59.1	48.6	22.6	39.1	43.2	58.8	57.1	43.7	33.2	70.0	38.9	35.0	58.1	34.1	34.1	26.7	35.9	35.0	18.3	32.0	27.5	57.7	56.9	37.1	29.1	15.5	60.3	46.0	51.6	30.0	48.1	44.9	28.1	63.2	74.1	68.2	49.7	42.6	202.7	237.0	46.6	70.8	143.6	67.2	60.7	55.0	52.0	41.5	72.8	97.2	124.0	61.3	64.1	134.1	69.5	56.9	63.7	79.5	58.8	105.6	125.4	47.3	48.7	229.3	116.3	118.6	169.4	94.3	100.2	49.8	77.0	77.1	113.9	107.4	46.9	71.5	55.7	106.7	69.1	64.6	73.2	85.2	149.2	58.5	33.1	107.2	37.6	43.7	82.1	49.3	49.0	60.6	88.6	67.0	68.8	83.4	76.4	108.1	106.1	130.4	109.2	105.4	76.1	59.5	93.7	42.9	59.3	81.4	64.4	84.5	60.5	67.4	120.5	73.6	58.0	67.8	7.8	76.0	81.7	87.4	81.4	92.1	56.4	58.1	59.1	58.4	56.3	59.1	58.8	57.1	58.1	56.9	60.3	63.2	36.0	25.6	29.3	10.7	26.3	17.2	32.8	69.2	33.0	20.5	49.5	52.8	48.9	18.6	46.5	33.1	8.4	51.1	26.3	8.8	64.6	43.3	27.4	17.3	32.6	35.9	16.8	21.6	18.4	24.3	60.2	37.5	12.2	17.5	42.5	28.7	28.2	9.9	116.9	8.4	22.7	15.0	59.0	28.5	24.0	34.2	35.4	33.7	40.9	8.4	38.1	38.9	28.8	13.6	15.5	20.7	12.9	35.0	31.4	32.1	17.6	87.1	36.7	12.7	0.0	30.1	30.8	15.5	21.2	33.9	18.8	59.4	22.2	41.8	17.7	30.7
MRAS	"M-RAs, R-RAS3, RRAS3"	ENSG00000158186	"Muscle RAS oncogene homolog"	O14807	3	138347648-138405534	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 202.3;heart muscle: 132.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 121.7;Distal tubular cells: 58.7;Theca cells: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"non-classical monocyte: 25.0"	"Lineage enriched"	"Detected in many"	9	"monocytes: 25.0"	"Cell line enhanced"	"Detected in many"		"BJ: 92.9;EFO-21: 113.7;fHDF/TERT166: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042728	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	Vesicles	"HPA042728: AB_10796582"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.63e-3)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.69e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.78e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.23e-2)"	91.9	67.7	112.7	10.8	130.6	1.7	46.7	118.2	105.5	17.3	48.9	24.2	3.3	28.7	7.1	7.9	26.4	12.0	132.9	105.6	132.8	22.9	5.5	18.4	5.2	126.1	135.9	48.6	5.7	8.2	17.7	10.6	112.9	15.3	4.1	15.9	13.4	15.0	80.4	12.2	8.7	23.2	110.3	12.2	12.0	9.6	202.3	4.9	26.4	48.0	3.3	29.1	12.1	97.8	0.8	7.9	15.8	24.5	59.6	29.2	40.0	92.9	16.0	7.3	8.2	3.3	3.1	0.3	113.7	70.4	18.6	0.1	9.0	1.8	6.1	7.7	3.1	0.5	4.8	20.1	15.9	0.0	1.9	41.5	5.9	0.7	1.4	13.6	1.3	0.0	10.7	0.8	31.4	3.7	0.0	20.4	19.1	0.0	2.7	1.1	33.8	0.2	30.4	2.0	18.6	42.0	62.8	0.7	45.9	10.9	16.1	37.7	0.6	23.7	25.3	24.3	2.4	0.1	1.0	1.2	21.4	0.1	11.4	0.2	2.1	0.0	0.0	4.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.3	0.8	25.0	0.1	0.0	0.8	112.7	130.6	118.2	105.5	105.6	132.8	126.1	135.9	112.9	110.3	202.3	97.8	8.9	9.6	1.5	54.2	0.8	2.2	3.0	3.4	1.2	5.6	28.8	34.8	121.7	2.8	3.5	9.2	10.4	20.1	0.2	0.0	58.7	8.6	11.6	1.0	21.4	14.5	1.8	0.0	25.5	3.2	3.2	23.0	2.0	1.5	6.3	35.2	12.8	1.6	26.3	28.6	20.6	0.0	2.0	15.1	18.4	40.0	23.3	18.2	28.4	20.6	12.2	24.3	0.0	28.6	11.0	3.8	0.0	34.3	0.1	3.3	0.0	27.5	1.3	9.6	6.6	20.8	18.9	7.3	18.6	0.4	1.0	14.4	0.8	59.1	0.0	0.6
MSMO1	"DESP4, ERG25, SC4MOL"	ENSG00000052802	"Methylsterol monooxygenase 1"	Q15800	4	165327667-165343164	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 575.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 532.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 416.2;Karpas-707: 412.3;RPTEC TERT1: 399.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055073, HPA056127"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"HPA055073: , HPA056127: AB_2683045"	"unprognostic (5.76e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (3.35e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.28e-1)"	"prognostic favorable (9.21e-4)"	"unprognostic (2.39e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.40e-1)"	18.3	95.2	36.7	20.9	48.2	10.4	66.2	45.1	47.5	57.1	37.4	39.2	75.7	19.1	97.0	145.7	20.9	21.7	18.5	43.9	59.2	52.6	575.6	70.3	20.7	90.5	58.4	25.7	22.6	42.9	18.4	22.9	78.6	58.9	32.9	26.1	34.7	12.1	5.5	82.5	38.1	16.5	45.0	11.0	31.5	52.8	48.4	13.4	22.4	6.5	27.0	20.2	67.0	61.1	89.1	21.7	198.8	36.4	97.7	312.0	37.5	35.3	159.0	44.7	123.4	41.5	372.9	43.4	20.6	43.1	416.2	71.7	101.6	366.3	49.4	37.7	63.0	20.0	20.0	127.6	194.9	35.8	26.8	192.6	237.6	163.6	100.6	61.1	58.8	55.7	35.3	412.3	74.6	45.7	32.6	58.2	115.6	46.9	21.0	16.8	21.8	132.3	399.5	102.5	39.7	30.0	54.5	77.9	33.9	121.7	36.1	44.7	67.6	20.6	36.1	18.5	24.7	75.9	86.5	58.6	43.9	36.0	28.5	13.7	8.6	8.8	34.0	11.6	25.4	40.6	31.8	31.4	15.0	37.6	34.3	35.6	6.1	24.9	20.5	19.3	31.0	29.2	36.7	48.2	45.1	47.5	43.9	59.2	90.5	58.4	78.6	45.0	48.4	61.1	16.9	51.3	168.0	70.5	28.9	36.1	70.1	189.2	21.6	33.8	81.9	23.0	10.7	40.0	160.0	69.9	27.1	55.6	20.7	130.8	35.2	67.9	6.4	27.6	12.2	30.4	60.7	53.9	33.6	71.7	87.0	24.1	35.2	44.4	47.7	83.0	27.8	532.0	28.3	35.3	22.8	72.8	170.9	28.0	11.5	7.0	24.8	18.3	32.0	10.3	23.6	27.2	17.5	42.7	49.6	86.8	85.7	18.8	10.9	138.3	46.0	38.4	103.2	50.4	19.7	5.6	35.1	8.7	15.4	84.6	115.1	123.0	22.3	136.1	36.9	129.0
MSRB3	"DFNB74, DKFZp686C1178, FLJ36866"	ENSG00000174099	"Methionine sulfoxide reductase B3"	Q8IXL7	12	65278643-65491430	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 2801.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 41.6"	"Lineage enhanced"	"Detected in many"		"granulocytes: 41.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 126.1;hTERT-RPE1: 110.6;U-937: 106.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014432	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA014432: AB_1854146"	"unprognostic (1.40e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (2.86e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.33e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (8.85e-8)"	"unprognostic (3.29e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (2.17e-4)"	44.9	10.7	12.9	20.9	13.6	21.2	26.3	12.5	12.8	29.5	18.8	108.0	11.9	85.8	20.1	63.0	41.4	33.2	90.8	11.9	18.3	10.1	3.8	30.6	5.7	15.9	15.2	16.9	5.8	3.2	6.8	25.2	13.8	52.7	27.8	12.5	10.8	103.0	104.0	9.7	25.6	123.9	14.6	13.6	36.2	5.8	18.2	4.1	14.5	69.2	3.9	60.9	23.7	11.8	8.8	19.2	16.4	75.9	71.6	63.0	0.5	87.0	92.9	33.2	19.8	0.7	1.0	0.0	18.3	126.1	10.5	1.9	7.7	22.1	30.0	0.2	15.9	0.0	16.7	0.9	46.6	47.1	0.3	33.4	11.9	28.1	39.0	110.6	68.2	0.1	0.3	0.3	76.8	2.9	0.0	11.0	5.4	0.2	10.4	0.2	22.0	0.5	7.5	1.0	0.4	7.9	30.0	1.8	21.9	16.8	14.1	44.5	78.9	42.3	22.8	19.5	34.2	8.0	6.7	0.2	11.5	106.7	26.9	15.0	0.6	41.6	0.2	0.9	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.2	6.8	8.3	0.4	10.8	0.1	1.4	12.9	13.6	12.5	12.8	11.9	18.3	15.9	15.2	13.8	14.6	18.2	11.8	55.3	12.8	3.4	76.7	0.8	6.4	16.4	11.4	4.0	22.7	2.2	45.3	2801.7	4.3	1.2	3.7	0.0	0.4	8.3	0.0	0.0	9.3	5.7	0.9	16.7	154.2	0.0	17.4	37.1	1.0	0.4	108.8	1.1	0.4	2.5	7.4	28.2	0.2	0.5	21.9	56.6	0.0	0.0	0.0	13.7	2.2	12.5	4.0	10.6	62.8	1.6	44.4	2.1	37.7	1.4	1.6	0.0	116.6	0.3	14.8	0.0	0.4	6.8	10.6	105.2	37.7	218.7	4.2	4.7	0.8	4.5	0.7	2.4	10.3	0.0	2.9
MST1R	"CD136, CDw136, PTK8, RON, SEA"	ENSG00000164078	"Macrophage stimulating 1 receptor"	Q04912	3	49887002-49903873	"CD markers, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 62.3;stomach 1: 42.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 25.6;Distal enterocytes: 53.9;Gastric mucus-secreting cells: 108.6;Intestinal goblet cells: 25.7;Pancreatic endocrine cells: 31.2;Paneth cells: 30.3;Proximal enterocytes: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 39.3;CAPAN-2: 98.8;HaCaT: 56.3;HBEC3-KT: 59.4;hTCEpi: 83.4;RT4: 67.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA007657, HPA008180, CAB008972"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291"	"unprognostic (3.84e-3)"	"unprognostic (3.86e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.00e-3)"	"prognostic favorable (2.33e-5)"	5.1	0.3	1.1	5.1	1.1	0.2	3.8	1.1	1.7	5.7	1.3	26.5	25.2	1.3	1.2	17.5	1.7	11.4	3.2	1.1	0.9	3.4	1.1	9.5	2.5	0.9	0.8	1.0	5.8	0.1	2.7	0.8	0.9	4.7	20.1	0.2	5.4	1.0	1.3	62.3	23.9	2.0	0.8	1.6	42.6	8.4	0.9	8.8	3.4	0.7	5.6	9.2	11.5	1.0	39.3	14.4	0.1	0.6	0.0	0.0	2.2	0.5	0.1	0.0	0.0	4.1	98.8	1.7	8.8	0.5	0.1	56.3	0.0	59.4	0.0	0.9	1.0	0.1	25.9	0.9	0.9	0.0	1.2	0.3	83.4	0.2	11.7	0.2	0.1	0.2	0.8	0.3	0.0	5.1	0.1	0.1	0.3	33.1	34.6	2.9	0.0	1.1	35.8	67.9	1.0	0.1	11.5	22.6	0.2	0.1	17.7	0.9	0.3	0.0	0.3	0.3	0.1	0.5	0.2	0.2	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	1.1	1.1	1.7	1.1	0.9	0.9	0.8	0.9	0.8	0.9	1.0	1.6	25.6	10.3	0.7	1.0	8.8	2.2	14.2	6.8	0.0	2.8	2.5	1.0	0.0	10.6	0.0	0.0	0.1	0.2	53.9	0.0	6.4	15.4	2.9	0.8	0.6	4.2	0.0	1.1	10.0	0.4	0.8	108.6	5.3	0.0	0.1	0.0	0.0	0.1	0.0	1.1	25.7	2.0	0.0	1.4	10.5	0.3	0.5	0.0	1.0	0.6	0.0	1.0	2.0	0.1	31.2	30.3	0.0	0.5	2.2	27.6	0.1	7.6	0.0	0.0	0.5	0.9	1.3	1.5	3.2	4.7	0.0	0.5	0.0	20.1	6.2
MT-CO1	"COI, COX1, MTCO1"	ENSG00000198804	"Mitochondrially encoded cytochrome c oxidase I"	P00395	MT	5904-7445	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"	Translocase	"Deafness, Disease variant, Leber hereditary optic neuropathy, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 222644.8;heart muscle: 255389.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 107039.5;Hepatocytes: 59794.3;Proximal enterocytes: 98329.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 54167.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016241, HPA069328"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB016241: AB_2229888, HPA069328: AB_2686122"	"unprognostic (4.39e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.31e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.20e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.44e-2)"	22006.8	46968.9	171347.0	8727.7	151652.8	11321.8	17952.5	132201.9	222644.8	10440.9	179120.2	42606.0	27505.7	11582.9	14226.0	20791.8	10700.5	11452.7	255389.3	151507.6	137459.2	63061.8	96575.5	12744.7	9111.4	176794.8	152802.2	8124.5	19467.4	41236.2	7420.2	10527.8	168465.9	12427.0	28389.7	12503.0	23260.1	17753.2	147209.5	26849.0	35366.3	13146.2	138626.1	16284.7	44852.9	10932.5	176888.2	7461.1	14056.3	184587.7	8381.2	17415.3	10559.7	131378.4	5837.6	8554.3	11384.1	12431.0	25510.2	11563.1	12037.2	12867.2	4284.9	3189.4	5257.4	10383.6	18320.5	15138.9	6040.7	9857.6	3118.2	21430.9	1326.6	11407.4	4515.1	7226.0	8040.6	9130.6	54167.9	19725.4	3521.2	5336.1	11055.5	13603.9	11589.8	3149.9	6917.5	14668.4	3902.1	8485.5	5916.3	10551.1	9525.6	14037.0	4378.4	23591.9	2905.0	7814.2	6900.5	5664.0	3401.6	9177.9	15910.6	15016.1	5414.7	7189.1	4466.7	17018.9	8305.7	13626.1	9809.7	17703.3	15637.8	12617.8	8438.9	12565.9	6642.1	4951.2	5072.9	3542.6	6235.7	13711.8	6294.4	5305.8	9759.2	3824.6	3085.1	4907.9	3420.5	5374.6	3047.3	3425.6	3444.6	5567.3	3080.8	3911.2	1900.4	3759.1	5775.1	4847.5	2947.7	3929.0	171347.0	151652.8	132201.9	222644.8	151507.6	137459.2	176794.8	152802.2	168465.9	138626.1	176888.2	131378.4	3924.0	2900.6	3897.1	0.0	13282.9	9769.7	9713.9	22625.0	20857.7	0.0	12033.2	11841.6	107039.5	30777.5	16135.4	19596.3	0.0	0.0	9288.4	40726.1	4255.4	7191.4	1555.3	13044.7	9033.9	7847.9	7514.7	45610.3	0.0	5089.4	0.0	6305.3	19235.7	25645.6	3832.6	20400.0	25951.4	59794.3	0.0	0.0	0.0	24302.1	19071.0	45533.4	7744.0	7398.4	11696.4	12124.7	6894.2	0.0	15180.0	0.0	8901.3	0.0	0.0	6410.5	23865.9	8490.1	13829.3	9441.3	98329.8	33652.6	10474.0	0.0	13614.6	11019.8	9403.5	12096.5	14338.7	27110.9	11475.1	0.0	11502.4	15179.6	27138.6	21770.7
MT-CO2	"CO2, COX2, MTCO2"	ENSG00000198712	"Mitochondrially encoded cytochrome c oxidase II"	P00403	MT	7586-8269	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 164780.5;heart muscle: 210840.8"	"Cell type enriched"	"Detected in many"	13	"Cardiomyocytes: 709929.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 73985.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016243, HPA051505, HPA054758"	Enhanced					NA	NA		240000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB016243: AB_2066366, HPA051505: AB_2681511, HPA054758: AB_2682595"	"unprognostic (2.67e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.57e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (2.89e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.72e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (1.25e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.72e-3)"	27287.7	50118.4	114427.0	5960.9	114629.6	9211.1	23112.5	102567.5	164780.5	8637.9	123709.0	47542.8	18239.3	10045.0	10813.1	24529.5	11015.1	5914.4	210840.8	108795.0	110116.5	112074.1	105449.6	14032.6	6314.3	129884.9	115346.3	7950.6	24515.9	29782.0	16861.9	10397.8	125082.8	25688.4	24989.1	8983.3	21379.6	12907.0	93258.6	22997.0	36121.9	9693.6	102620.8	18194.3	45409.4	14516.5	123032.8	6034.4	16877.7	109930.2	7889.2	21068.8	13184.5	102646.5	6276.2	9796.4	12777.6	12396.3	25548.5	9745.3	9393.2	7927.6	6429.8	4420.4	6584.3	10616.0	13681.5	12924.1	6467.6	11751.8	4522.1	23074.6	1724.1	16319.1	5925.8	10089.3	8726.0	9297.7	73985.8	20756.8	5543.0	7919.2	9987.0	14433.8	23568.7	2276.3	8072.8	14337.8	4979.3	12668.7	8862.9	12216.0	12212.6	13490.3	5804.8	22519.7	3353.4	12256.7	6160.6	5998.2	3899.6	10866.7	17578.2	17096.2	4758.2	7830.6	6527.3	15842.4	11881.3	18742.2	11084.6	31596.4	12345.0	10576.0	9043.3	10116.0	5740.6	6151.2	6563.0	7590.8	5638.0	15586.1	7129.7	20953.0	13541.7	15753.7	5586.8	8887.6	6782.0	11844.8	6189.5	6338.9	6316.7	10947.0	6386.1	7947.1	5329.9	6846.5	10055.3	8426.1	5367.4	7670.7	114427.0	114629.6	102567.5	164780.5	108795.0	110116.5	129884.9	115346.3	125082.8	102620.8	123032.8	102646.5	4337.7	1445.5	1999.8	0.0	11825.3	6754.0	8961.4	22171.6	22140.9	0.0	11994.6	16742.4	709929.9	18464.2	10323.3	18597.6	0.0	0.0	7569.1	29582.2	3709.5	3684.4	1119.7	12108.5	6979.9	16215.0	6396.9	27238.9	0.0	4873.7	0.0	10942.5	19089.4	20683.3	2144.6	17185.5	15141.7	53416.5	0.0	0.0	0.0	17158.1	14290.0	26774.7	4814.0	5284.9	7663.3	9292.7	5140.4	0.0	7967.0	0.0	6828.1	0.0	0.0	4709.1	15133.6	5123.0	14109.6	5949.4	40280.5	22569.2	7617.1	0.0	7060.4	9361.8	14171.2	7120.5	8965.1	26952.2	6702.8	0.0	8863.0	13639.8	19371.4	14261.8
MT-CO3	"CO3, COIII, COX3, MTCO3"	ENSG00000198938	"Mitochondrially encoded cytochrome c oxidase III"	P00414	MT	9207-9990	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		Translocase	"Disease variant, Leber hereditary optic neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 189825.4;heart muscle: 231090.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 98114.9;Proximal enterocytes: 47697.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 47821.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042788	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA042788: AB_10793985"	"unprognostic (2.38e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.93e-1)"	"prognostic favorable (2.01e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.05e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.33e-2)"	27612.7	53681.0	106768.6	6403.7	100201.0	11914.6	26962.2	92217.9	189825.4	9972.2	122787.3	41553.8	21299.6	10118.8	12166.4	23137.6	10414.1	8134.8	231090.6	101700.1	98402.0	135745.7	93934.0	11738.0	7309.6	111323.1	103274.0	9356.4	21307.1	30833.6	18098.1	9332.4	106050.0	25270.8	25404.7	14193.4	21229.0	16620.0	98348.0	28350.1	31017.2	10682.4	91790.3	14201.4	41772.3	19009.4	106894.6	5959.0	20136.7	138793.4	9366.6	19763.5	13535.9	91700.3	6374.2	7329.2	11033.5	15732.2	21484.7	8772.8	6020.3	8032.3	4753.9	3111.6	4736.6	9884.1	9176.0	14020.9	3392.6	6719.8	3380.0	16891.6	1769.9	9653.6	5455.7	4794.4	7644.1	7478.3	47821.5	16704.0	4327.8	4505.2	9419.7	8504.4	13400.6	3422.1	5046.7	10915.4	5848.3	7900.3	6047.2	13759.0	10367.7	12916.5	4589.9	25941.9	2461.0	9979.3	5226.1	4852.9	3482.9	10181.9	19232.2	10970.2	4917.9	6797.0	3741.8	4032.3	8135.9	15244.2	8471.0	19585.6	9432.2	5152.8	8782.1	9756.5	5388.8	5622.3	3881.6	8183.5	5151.5	14362.6	3475.8	2863.0	4714.1	2004.7	1562.3	1885.5	1896.8	2933.1	1703.2	1823.0	1927.4	3253.5	2137.7	2759.1	3629.6	2089.5	1920.3	1612.4	1186.9	2432.3	106768.6	100201.0	92217.9	189825.4	101700.1	98402.0	111323.1	103274.0	106050.0	91790.3	106894.6	91700.3	2817.9	1910.3	2767.0	0.0	9010.7	8343.8	9724.5	21550.3	14394.8	0.0	8643.0	8027.7	98114.9	20354.3	11786.8	16547.0	0.0	0.0	5698.3	25285.3	4368.9	5152.0	1929.0	10274.3	6922.4	7282.3	6805.3	29321.2	0.0	6670.2	0.0	5902.5	8605.1	22503.2	2090.9	20302.5	15810.3	44494.8	0.0	0.0	0.0	19209.5	11157.0	28166.3	5603.1	9286.2	11579.8	7637.7	5553.1	0.0	9746.7	0.0	6001.1	0.0	0.0	5901.3	16542.9	7809.0	8204.1	6813.7	47697.3	33390.3	6427.3	0.0	12142.0	15068.6	7967.9	11927.7	12469.2	17772.8	8480.1	0.0	7584.6	21335.3	22667.3	15127.4
MT-ND2	"MTND2, NAD2, ND2"	ENSG00000198763	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2"	P03891	MT	4470-5511	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Alzheimer disease, Amyloidosis, Disease variant, Leber hereditary optic neuropathy, Leigh syndrome, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 101525.8;heart muscle: 130517.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 77734.8;Proximal enterocytes: 33797.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"basophil: 16754.8"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 16754.8"	"Cell line enhanced"	"Detected in all"		"HeLa: 23544.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (5.82e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.77e-1)"	"unprognostic (4.79e-2)"	"unprognostic (9.56e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.38e-3)"	"unprognostic (4.55e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.92e-2)"	"unprognostic (4.35e-2)"	25741.8	33190.5	71860.8	2728.1	75185.8	2871.9	21730.1	67030.8	101525.8	7501.8	71811.2	22574.5	7339.4	7298.5	8093.3	11090.4	9270.8	2863.6	130517.4	67583.8	74656.1	57055.4	53965.1	9461.4	2469.7	81497.3	77858.3	7800.1	20642.6	9848.0	12388.5	5446.8	84069.6	17166.0	8141.9	5436.2	13468.5	5444.8	45903.7	15500.0	20333.4	3554.4	65578.7	8952.9	31183.1	11451.9	75256.7	2049.2	10704.5	50400.1	2830.9	14131.4	8428.2	66998.7	2964.9	3166.9	2774.5	4699.2	9795.6	1730.7	2618.5	2678.9	669.9	703.1	875.8	4014.2	3860.6	4185.9	2486.9	1936.7	1150.4	5147.5	444.4	3349.6	1504.2	3675.8	2270.9	4845.1	23544.1	6585.1	1999.7	4760.9	5392.4	2886.1	5969.8	1726.7	1692.0	2488.5	1049.4	2269.3	3606.2	3978.3	1701.5	3480.4	2711.2	7603.4	1396.2	3068.2	2045.4	2352.3	1554.8	3525.9	5071.4	4465.8	1728.4	2059.3	1159.0	3501.0	4372.7	4402.7	5412.1	5417.8	3333.0	2606.6	3230.5	3719.5	3483.2	2577.9	2356.8	3637.4	1695.0	4006.5	1196.1	16754.8	1658.1	2709.0	872.0	1066.1	1373.3	1568.7	1012.2	1099.7	632.5	1625.8	1212.2	1558.3	2355.9	1158.8	1341.7	1171.9	716.1	804.2	71860.8	75185.8	67030.8	101525.8	67583.8	74656.1	81497.3	77858.3	84069.6	65578.7	75256.7	66998.7	1855.6	919.9	759.8	0.0	3886.7	2666.7	7962.2	3116.2	2155.8	0.0	2560.5	3948.5	77734.8	10211.5	2425.9	6232.9	0.0	0.0	2313.0	13115.0	1807.8	1793.7	1314.5	4100.0	2322.6	4025.7	3175.3	10585.1	0.0	3677.8	0.0	2629.4	2366.5	5225.2	1865.9	7033.2	9394.0	19067.5	0.0	0.0	0.0	10974.6	1947.0	14566.9	1814.8	6327.6	9064.4	3148.2	1657.8	0.0	4768.9	0.0	3602.5	0.0	0.0	2565.3	9271.1	4538.8	1959.6	4228.6	33797.5	12714.8	3449.0	0.0	7283.9	6341.5	3547.2	5465.6	4872.6	1826.5	2455.7	0.0	3694.7	2538.3	10272.4	7385.5
MT-ND3	"MTND3, NAD3, ND3"	ENSG00000198840	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3"	P03897	MT	10059-10404	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 184151.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 37883.1;Proximal enterocytes: 23257.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 23280.2;HeLa: 21694.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063296	Enhanced		Uncertain	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"HPA063296: AB_2684978"	"unprognostic (1.71e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (4.63e-5)"	"unprognostic (2.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.65e-3)"	31356.6	42036.1	79316.1	3483.1	80070.8	4077.5	25368.6	75454.6	124729.8	8985.8	81148.8	26406.1	11478.9	8410.1	8217.8	12712.6	10495.3	3610.0	184151.1	75602.8	85299.8	84244.0	72988.4	9018.3	3610.8	89729.0	83678.9	9439.2	26008.9	14199.5	13387.4	6281.1	85648.8	23996.0	10095.2	6318.4	14787.5	8355.4	70313.2	16879.7	21792.1	4960.7	71704.7	11407.9	36122.2	10815.9	84470.1	3654.8	14626.9	73367.5	3934.1	18841.5	10373.7	74059.9	3324.0	5255.7	3450.6	3399.1	23280.2	4613.0	2871.7	2717.2	1592.1	1441.9	1616.6	7973.2	5004.1	3408.8	4095.7	3519.2	2600.2	6710.1	1504.4	5941.5	2461.9	4945.3	7153.7	3371.4	21694.2	13369.3	3629.0	5018.8	4874.1	8076.0	10704.2	2416.7	2704.4	8547.3	2285.4	3853.4	2711.1	3864.5	2747.1	10748.2	2646.2	6609.3	1779.4	9407.1	4824.1	2262.5	3389.7	3164.0	8729.4	8962.3	1417.0	3058.9	1310.8	2587.7	5763.8	8928.3	6011.6	7960.5	3898.6	2207.0	3378.3	3876.8	2982.9	1492.1	2128.5	7735.7	1794.0	2976.6	1284.1	2263.7	612.4	386.5	336.6	346.8	441.9	672.5	393.0	417.4	321.5	686.4	568.4	769.3	968.2	447.0	335.5	312.1	262.5	353.1	79316.1	80070.8	75454.6	124729.8	75602.8	85299.8	89729.0	83678.9	85648.8	71704.7	84470.1	74059.9	4254.0	701.9	879.1	0.0	6320.6	1987.5	2507.9	1722.8	5384.4	0.0	3350.4	5821.1	37883.1	9781.1	1560.8	5041.1	0.0	0.0	5039.9	14324.8	1164.1	1320.8	1023.5	11751.2	6030.4	3302.6	2852.4	14390.0	0.0	2870.2	0.0	3063.4	6039.9	17552.8	1453.7	17373.9	10407.8	20920.6	0.0	0.0	0.0	11328.3	870.8	16584.4	1757.6	5643.0	9133.7	4877.6	1858.7	0.0	4964.0	0.0	2775.5	0.0	0.0	2194.1	9034.9	4865.3	6343.6	1554.6	23257.1	8457.2	2113.9	0.0	7001.2	6561.9	3856.1	5442.6	3706.2	3801.0	1888.8	0.0	4844.1	3423.5	10381.8	2314.6
MT-ND4	"LHON, MTND4, NAD4, ND4"	ENSG00000198886	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4"	P03905	MT	10760-12137	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Dystonia, Leber hereditary optic neuropathy, MELAS syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 196536.0"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 253563.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 13456.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 41594.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053928	Approved		Supported	Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA053928: AB_2682313"	"unprognostic (8.39e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.50e-3)"	"unprognostic (8.16e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.01e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.24e-2)"	23701.9	43566.1	86386.5	4193.8	83474.8	3652.7	19363.5	76852.9	119139.4	8711.6	100909.6	30312.4	11021.5	10764.3	6795.9	15885.7	10624.6	4622.9	196536.0	81116.7	85290.4	76204.1	101401.1	11855.8	3820.4	102081.7	90689.2	8957.6	21476.2	15709.9	12834.3	7692.4	97098.9	22214.5	15007.9	14112.1	17508.5	11691.2	61489.1	18268.8	25046.6	7116.7	75024.9	12782.7	39594.1	13571.1	91494.4	3233.7	14785.3	70605.7	4913.1	19417.4	10309.3	74806.7	4251.7	4285.9	5449.6	8075.1	12523.6	3123.1	3808.6	4184.0	1603.2	958.4	1834.2	6555.4	4688.4	7428.4	3608.7	3590.8	1396.3	7685.0	496.1	6777.9	1691.7	4330.2	2654.6	4592.7	41594.9	11166.3	1884.9	4672.8	5223.9	5330.2	7007.6	1403.3	4977.9	8925.4	2344.4	3683.1	3908.9	8930.2	3461.9	9508.0	1848.1	10481.0	1551.2	3650.3	2876.4	2481.0	1712.1	4518.2	6770.1	8938.3	1999.0	2694.8	2434.3	7967.3	4267.8	9600.3	5601.2	10888.7	6532.2	3851.7	3726.9	5232.7	3330.8	5307.6	2292.6	3407.7	2514.1	7881.4	2100.8	13456.8	3334.1	7103.1	1902.0	2192.8	2614.3	3555.5	2129.5	2285.7	1616.0	3624.4	2452.9	3095.1	2513.1	2106.5	2329.2	2112.6	1668.2	1840.0	86386.5	83474.8	76852.9	119139.4	81116.7	85290.4	102081.7	90689.2	97098.9	75024.9	91494.4	74806.7	3065.0	1269.2	1516.1	0.0	6183.3	4404.5	9073.3	7719.8	2713.0	0.0	6210.4	6965.6	253563.4	15377.3	4975.3	12806.1	0.0	0.0	4005.7	20185.0	2435.8	2924.2	1109.7	6731.7	4298.6	9316.2	5090.0	20898.0	0.0	4058.3	0.0	5843.3	5601.5	11920.4	2188.6	15486.9	13931.3	35046.7	0.0	0.0	0.0	14557.8	5771.7	22254.8	3452.7	5132.5	8834.9	4749.3	3799.3	0.0	6280.7	0.0	4212.2	0.0	0.0	3710.0	12363.2	5788.3	3409.4	5872.9	28978.7	17714.1	4527.9	0.0	6310.9	8264.3	7732.9	6461.4	6003.0	3008.8	4937.6	0.0	5125.3	7671.5	15595.2	11405.7
MT-ND4L	"MTND4L, NAD4L, ND4L"	ENSG00000212907	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L"	P03901	MT	10470-10766	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Leber hereditary optic neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 132930.7;heart muscle: 145078.7"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 30444.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 50775.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075648			Approved	Centrosome,Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	Centrosome	"HPA075648: AB_2686760"	"unprognostic (5.81e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.91e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.04e-2)"	"unprognostic (4.63e-3)"	"unprognostic (6.61e-2)"	"unprognostic (7.38e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.97e-2)"	"unprognostic (5.68e-2)"	20104.7	29874.0	85794.9	4122.5	86270.4	3115.3	14930.3	82985.5	132930.7	6880.0	93989.2	20616.6	9025.8	7679.7	5976.7	10820.3	7752.4	4365.8	145078.7	84214.9	90415.7	46912.7	74928.5	8462.2	2787.1	92948.1	87984.2	6729.2	16038.2	20410.6	9234.3	5840.3	89012.2	16438.2	14044.5	15747.5	12913.6	12715.8	58998.5	13345.9	17015.9	6979.3	79192.1	7285.6	28192.3	9561.4	87700.1	4435.4	11270.7	103082.4	4852.1	15113.7	7437.4	83632.8	4598.0	4121.5	7308.1	7468.2	25088.0	5217.1	3223.3	9523.0	2384.3	1468.4	2651.9	6894.3	4080.7	11229.9	3809.7	6497.0	2387.4	8496.5	1155.8	10210.3	2895.1	4454.2	4711.8	8095.9	50775.4	13024.1	3671.8	8429.4	6965.0	9229.0	10159.4	2792.9	9675.2	10923.1	2983.6	5697.7	4556.7	7771.2	5412.1	8124.5	3199.8	10639.4	1846.3	4811.8	4953.4	1842.5	3155.8	5025.1	7636.0	9464.9	2208.4	2971.3	4666.2	7283.7	3197.8	15599.0	5199.9	10420.1	9592.2	3792.1	4708.5	5630.1	3738.0	6985.1	3552.9	6053.5	2725.1	11018.8	1816.1	16170.2	4327.0	8286.8	2536.0	2849.6	3435.6	4233.2	2723.9	2939.9	2282.7	4618.7	3206.8	4006.1	2010.3	2906.4	2817.9	2884.1	2096.4	2551.4	85794.9	86270.4	82985.5	132930.7	84214.9	90415.7	92948.1	87984.2	89012.2	79192.1	87700.1	83632.8	503.6	224.4	217.6	0.0	2303.6	228.5	254.2	170.4	5991.6	0.0	764.0	886.3	30444.3	1464.1	438.4	323.7	0.0	0.0	449.8	1428.3	90.1	152.9	52.8	870.1	618.8	942.3	256.6	3302.0	0.0	342.2	0.0	1129.2	5335.9	1186.3	479.3	1394.0	1520.3	4413.7	0.0	0.0	0.0	727.8	99.7	1977.9	193.5	286.1	417.2	1043.8	256.1	0.0	312.9	0.0	133.9	0.0	0.0	284.5	867.0	230.9	4395.8	129.7	1228.2	589.4	582.7	0.0	348.4	711.2	1052.8	247.0	207.4	5256.4	242.2	0.0	1387.0	308.6	573.4	207.9
MT-ND5	"MTND5, NAD5, ND5"	ENSG00000198786	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5"	P03915	MT	12337-14148	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 25147.7;heart muscle: 26116.9;skeletal muscle: 25697.4"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 35040.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 10198.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (2.87e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.09e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.29e-3)"	"unprognostic (4.78e-2)"	"prognostic favorable (7.31e-5)"	"unprognostic (9.93e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.68e-2)"	5288.6	4777.7	18907.8	1742.2	18307.4	1525.5	2456.7	14400.2	21432.3	1614.3	22368.1	4280.6	4135.2	1972.7	2508.1	2717.8	3030.2	2040.5	26116.9	16370.1	20521.2	8014.5	10041.3	2683.6	1180.6	25147.7	20794.2	1886.3	2631.6	4813.1	1528.8	1691.5	23065.0	2812.7	2879.0	3264.8	2819.2	2163.8	25697.4	6657.3	4780.7	2643.7	13881.7	2014.4	6673.9	1678.5	21024.6	794.7	2059.1	19444.2	1541.4	3557.5	1537.7	13870.1	1615.8	1671.5	1998.7	1937.9	5903.9	1530.3	1075.8	3208.3	492.5	355.1	583.1	2472.6	2051.0	3865.3	1590.5	1510.4	397.3	3350.6	191.2	1685.7	583.4	2182.3	1281.4	2840.4	10198.2	4239.2	678.8	2010.7	2824.3	2305.4	1315.5	401.6	951.8	1933.5	725.2	1233.3	1056.8	1794.8	1216.3	3046.1	757.3	2453.4	397.5	910.2	903.0	1432.9	938.2	1668.7	2083.2	3132.2	595.0	904.1	1496.1	2636.3	894.4	3001.9	1927.1	2979.2	5094.9	2013.2	1403.2	2409.7	1271.9	678.8	1246.0	1066.9	1077.4	1780.4	897.7	2851.8	1521.7	874.2	771.4	980.3	922.8	979.1	753.9	839.2	746.5	1096.6	729.2	869.0	446.2	785.1	1039.5	890.3	628.6	492.0	18907.8	18307.4	14400.2	21432.3	16370.1	20521.2	25147.7	20794.2	23065.0	13881.7	21024.6	13870.1	773.3	628.2	594.2	0.0	1707.9	895.1	1050.1	1005.5	3261.6	0.0	1003.4	1025.1	35040.8	2566.4	934.5	1156.8	0.0	0.0	977.0	3181.2	283.7	804.1	109.5	3130.4	2025.6	1614.3	782.9	3776.6	0.0	936.6	0.0	1437.2	3609.6	5212.8	862.1	2987.5	2623.3	6597.7	0.0	0.0	0.0	1776.8	583.9	3664.2	661.9	528.9	1057.5	1364.5	608.3	0.0	1303.9	0.0	756.0	0.0	0.0	1327.8	2211.7	848.6	2674.2	753.3	4484.5	2410.8	1282.0	0.0	696.8	1941.5	1558.6	652.2	521.9	3002.4	973.6	0.0	1527.8	1560.9	1650.5	1506.6
MT-ND6	"MTND6, NAD6, ND6"	ENSG00000198695	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6"	P03923	MT	14149-14673	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Dystonia, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 35802.7;skeletal muscle: 57879.2"	"Cell type enriched"	"Detected in many"	13	"Cardiomyocytes: 15756.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 20826.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (1.96e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.03e-3)"	"unprognostic (6.02e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.06e-3)"	"unprognostic (2.91e-1)"	"prognostic favorable (8.91e-6)"	"unprognostic (3.64e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.92e-2)"	7945.8	6310.2	5769.7	3186.7	3927.7	3253.0	3096.2	2199.5	5682.5	2191.3	13970.3	6452.8	7840.8	3145.2	54.5	5822.6	5447.4	3433.9	35802.7	4361.1	7820.0	9569.5	11697.0	4598.5	2503.1	13167.2	11029.3	2126.9	4152.4	69.3	1372.8	953.0	13713.7	2509.5	97.7	4313.6	4084.0	40.6	57879.2	15225.1	8006.6	51.8	1229.7	4205.8	10030.4	1993.1	8318.4	40.9	2562.5	243.6	43.1	5236.3	1897.2	1060.7	3305.7	2595.3	2255.7	2869.4	371.0	34.6	1614.6	4329.1	8.9	13.9	14.2	3553.8	3233.4	6999.5	2873.3	117.5	423.7	4781.1	25.1	79.1	23.3	4178.5	1966.3	4217.6	20826.9	10361.0	29.7	2704.1	3805.1	64.4	103.3	103.9	86.4	2123.1	23.2	1445.3	1855.2	2671.0	94.5	6976.5	836.0	3680.9	492.5	1868.7	1267.3	2002.7	1440.3	3034.3	60.9	9493.6	926.2	1476.3	2250.2	3898.6	1876.3	3559.0	3037.2	5182.3	8822.6	2473.6	2088.6	3550.5	1766.8	906.6	2600.9	1705.0	1682.9	2680.8	1473.8	2089.0	1092.3	645.1	733.4	881.5	840.2	1047.3	776.1	800.0	582.8	1016.1	760.2	870.6	453.3	752.2	963.0	790.6	635.2	365.4	5769.7	3927.7	2199.5	5682.5	4361.1	7820.0	13167.2	11029.3	13713.7	1229.7	8318.4	1060.7	31.2	83.3	62.2	0.0	328.4	16.8	55.8	75.1	1210.0	0.0	52.2	31.2	15756.5	273.1	107.1	128.8	0.0	0.0	78.9	125.6	17.6	32.6	8.2	154.1	132.5	478.6	30.1	797.7	0.0	35.3	0.0	396.2	886.9	247.7	98.0	130.6	385.8	699.5	0.0	0.0	0.0	59.8	44.7	518.3	20.1	33.4	62.4	214.3	33.8	0.0	66.3	0.0	48.4	0.0	0.0	25.6	69.9	45.1	1055.4	152.0	76.1	175.7	111.0	0.0	59.2	121.6	423.9	31.7	60.5	1160.0	20.5	0.0	266.3	58.1	78.4	117.0
MTAP	"c86fus, MSAP"	ENSG00000099810	"Methylthioadenosine phosphorylase"	Q13126	9	21802636-21937651	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046915, CAB080036, CAB080037"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		3000000	"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB080036: AB_11128130, CAB080037: AB_11129069, HPA046915: AB_2679862"	"unprognostic (1.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.78e-1)"	"unprognostic (6.16e-2)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (9.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.27e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	5.9	6.5	4.1	5.4	4.8	5.8	8.5	4.2	5.7	7.8	7.6	6.7	4.8	8.8	7.1	8.8	7.1	4.9	7.0	3.8	4.0	6.9	10.9	5.8	6.3	5.0	4.5	12.1	6.6	8.4	2.8	8.9	5.1	7.2	8.0	3.9	6.5	7.0	4.5	7.0	5.9	9.0	4.0	7.3	7.2	2.9	5.4	6.8	7.2	5.4	7.3	10.1	7.4	6.0	30.4	1.0	23.0	19.0	19.4	19.0	28.3	42.3	21.0	21.9	24.3	21.7	14.6	15.3	13.4	21.1	16.3	15.2	24.4	59.5	36.8	0.3	19.8	0.3	56.8	28.8	18.6	24.5	26.3	23.5	0.1	38.6	42.6	24.4	22.6	0.5	0.3	20.1	21.9	3.1	26.8	0.7	27.5	14.7	35.2	0.4	18.0	26.0	18.3	0.4	14.4	15.3	14.4	17.1	21.1	17.9	10.9	0.6	23.8	0.3	15.7	0.2	34.4	13.7	25.5	30.0	0.2	24.3	12.0	1.2	5.6	0.2	3.6	4.5	6.1	5.9	5.3	4.2	6.9	8.4	4.6	4.2	0.7	6.7	2.9	6.3	3.2	2.7	4.1	4.8	4.2	5.7	3.8	4.0	5.0	4.5	5.1	4.0	5.4	6.0	18.8	22.4	19.8	26.1	16.3	14.1	58.4	22.4	16.5	0.0	20.2	23.9	22.4	24.3	27.9	14.7	0.0	52.3	11.4	6.8	15.6	38.6	77.9	28.8	28.5	14.9	9.6	19.1	14.8	28.0	80.0	18.7	15.3	40.6	10.8	30.0	17.5	22.2	27.1	0.0	9.1	14.3	30.5	25.5	11.1	14.8	14.9	15.1	10.6	48.7	15.0	0.0	10.3	40.7	32.9	41.5	6.8	14.7	13.7	45.0	9.2	19.5	19.1	0.0	13.1	20.6	23.1	1.3	13.9	35.1	13.1	22.6	15.1	33.0	20.7	62.9
MTFMT	FMT1	ENSG00000103707	"Mitochondrial methionyl-tRNA formyltransferase"	Q96DP5	15	65001512-65029639	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	Transferase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040710	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA040710: AB_10794879"	"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.28e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (3.31e-8)"	"unprognostic (2.75e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.85e-2)"	1.6	2.2	2.6	0.7	2.9	1.9	1.6	3.8	3.1	2.4	4.0	2.5	1.5	2.5	1.5	2.2	2.6	0.9	4.3	2.5	3.4	2.4	3.5	1.5	1.3	2.5	2.2	2.7	1.4	1.7	2.2	0.8	2.5	2.8	1.5	1.6	1.8	1.3	3.0	1.7	2.2	1.7	1.9	2.3	2.0	1.5	2.9	1.0	1.7	1.5	1.2	2.5	2.1	2.6	1.4	1.9	1.8	3.2	2.5	1.7	1.7	1.3	2.2	1.6	1.5	1.2	1.5	4.7	1.7	2.3	2.7	4.0	3.3	2.2	1.5	1.9	2.8	1.9	1.9	1.3	2.9	2.7	0.6	2.3	2.8	0.9	1.9	2.2	1.5	4.2	2.3	2.2	2.4	1.9	2.3	3.1	2.4	4.0	3.6	2.0	2.5	2.2	2.7	1.6	1.8	1.8	3.1	2.7	2.5	2.2	1.6	2.0	2.8	1.9	1.9	2.4	2.6	1.9	3.1	1.8	1.7	4.6	1.9	3.7	3.3	2.6	4.8	3.1	4.8	4.8	4.7	5.0	6.0	4.7	5.1	5.4	16.5	4.5	2.2	10.1	5.4	2.3	2.6	2.9	3.8	3.1	2.5	3.4	2.5	2.2	2.5	1.9	2.9	2.6	8.5	3.2	9.7	17.0	11.8	3.3	15.2	19.1	14.8	0.0	7.0	7.7	15.8	10.0	10.5	3.7	0.0	11.4	18.1	10.5	25.4	11.8	1.7	7.8	11.6	8.2	7.8	9.4	49.8	10.0	11.7	11.8	8.6	7.0	8.8	8.0	12.8	12.2	16.5	0.0	44.2	8.9	2.0	12.2	12.2	1.7	15.5	9.7	8.8	27.2	7.1	0.0	11.3	19.1	12.9	10.3	15.9	15.4	10.3	16.7	17.5	25.1	5.1	0.0	0.0	12.5	14.5	13.3	20.7	10.7	4.5	8.9	10.1	11.4	15.7	14.5
MTHFR		ENSG00000177000	"Methylenetetrahydrofolate reductase"	P42898	1	11785723-11806455	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"	"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 44.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063389, HPA076180, HPA077255"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"		"HPA063389: AB_2685001, HPA076180: , HPA077255: "	"unprognostic (3.25e-2)"	"unprognostic (8.19e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (3.97e-5)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.69e-2)"	"prognostic favorable (4.81e-5)"	"unprognostic (3.10e-1)"	"prognostic favorable (2.12e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.80e-2)"	12.3	11.3	7.1	10.8	10.3	28.9	10.2	12.8	8.8	9.0	5.0	11.1	10.8	8.9	53.5	10.3	12.3	10.1	23.9	10.4	6.2	12.8	13.1	16.8	12.3	9.9	7.0	19.7	11.4	6.6	17.7	7.1	9.4	10.2	8.7	12.6	6.8	6.7	17.9	13.4	14.7	10.8	5.1	18.3	14.6	10.9	8.0	7.9	16.3	16.8	12.2	10.3	7.9	8.9	2.2	9.4	10.9	12.3	10.2	15.1	2.0	5.2	14.6	6.0	5.1	8.1	13.2	18.0	3.6	7.5	16.3	4.1	8.1	7.7	2.4	9.3	6.8	13.4	13.3	3.2	13.7	7.4	16.4	13.6	6.1	8.0	6.4	10.0	10.7	17.2	44.1	11.0	6.7	3.3	8.2	3.5	3.6	9.5	3.0	8.9	6.0	20.3	8.8	11.7	10.5	17.6	8.1	7.8	10.9	6.2	12.9	11.7	8.5	6.0	4.9	7.2	1.6	6.4	9.4	32.8	7.6	16.8	5.6	0.7	2.3	1.1	2.7	4.3	0.9	1.6	0.8	1.4	1.7	2.3	1.2	1.4	2.5	2.0	6.1	0.9	0.6	1.6	7.1	10.3	12.8	8.8	10.4	6.2	9.9	7.0	9.4	5.1	8.0	8.9	15.9	25.6	48.0	8.1	18.3	8.4	6.8	11.9	15.9	0.0	17.9	10.8	37.0	11.5	13.0	27.6	0.0	5.1	6.0	44.2	1.9	8.9	18.2	32.0	25.8	16.9	12.1	29.5	15.8	25.3	3.3	21.0	52.5	55.5	8.2	10.7	37.5	23.4	22.2	0.0	15.2	18.0	6.1	39.3	39.9	42.4	18.3	32.1	12.4	16.9	26.5	0.0	20.6	9.0	13.3	21.9	20.6	9.1	10.3	10.2	36.0	17.2	12.3	0.0	19.7	22.8	23.3	6.8	5.2	15.0	9.2	2.9	10.6	21.3	18.6	9.6
MTHFS	HsT19268	ENSG00000136371	"Methenyltetrahydrofolate synthetase"	P49914	15	79833585-79897379	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 253.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 205.5;monocytes: 150.8;Proximal tubular cells: 201.6;Syncytiotrophoblasts: 253.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 134.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 134.1;monocytes: 49.1"	"Low cell line specificity"	"Detected in many"											"HPA008067, HPA054177"	Approved		Supported	Cytosol		NA	NA		13000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA008067: AB_1078882, HPA054177: AB_2682405"	"unprognostic (4.57e-2)"	"unprognostic (9.76e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (9.13e-3)"	"prognostic favorable (1.29e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (2.04e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.90e-1)"	21.9	19.8	8.0	4.6	8.2	5.0	19.0	9.6	12.7	9.9	6.9	12.0	13.7	9.0	10.3	10.1	9.4	7.0	19.0	8.0	9.2	53.1	253.4	17.8	6.4	8.7	9.3	8.6	32.8	26.3	21.5	8.3	9.1	19.5	6.4	5.9	13.6	5.5	20.2	6.2	14.5	6.2	8.8	14.9	19.5	12.1	8.7	10.6	15.9	11.1	10.8	12.4	9.9	9.1	12.6	35.8	5.0	2.6	15.8	12.0	11.9	8.8	13.0	16.4	10.5	34.5	22.4	15.1	25.1	15.5	15.0	19.5	31.9	10.7	15.4	14.7	28.4	14.8	22.9	39.8	25.3	7.8	0.8	17.5	27.8	8.1	23.0	19.6	7.4	16.0	28.8	12.0	17.4	36.0	10.2	36.1	15.6	51.4	17.0	10.8	17.2	25.8	35.1	34.3	8.9	4.8	25.1	14.2	43.8	20.0	17.3	13.0	3.3	5.7	11.1	3.6	7.1	6.8	20.2	17.8	3.3	25.9	6.2	17.5	25.7	73.5	9.4	35.3	12.4	13.5	13.7	12.9	12.3	11.1	16.5	12.6	134.1	17.8	49.1	13.3	15.7	19.1	8.0	8.2	9.6	12.7	8.0	9.2	8.7	9.3	9.1	8.8	8.7	9.1	11.3	19.2	44.0	0.0	20.7	10.7	9.9	63.0	35.9	0.0	25.5	32.5	0.7	58.6	34.3	22.0	0.0	68.1	10.1	10.0	64.6	55.8	2.2	11.9	7.8	10.5	17.6	36.6	0.0	75.7	37.1	13.5	39.8	11.0	8.8	7.2	21.8	205.5	45.7	0.0	0.0	18.7	24.4	22.1	34.8	3.8	13.7	29.3	21.4	0.0	150.8	0.0	35.0	0.0	0.0	75.3	35.9	15.8	13.3	13.3	101.7	201.6	29.9	0.0	13.1	8.4	10.5	6.7	8.5	21.1	8.1	253.8	22.2	9.2	24.9	7.7
MTM1		ENSG00000171100	"Myotubularin 1"	Q13496	X	150568621-150673143	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 52.2;Oligodendrocytes: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010008, HPA010665"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA010008: AB_1079426, HPA010665: AB_1079425"	"unprognostic (3.66e-3)"	"unprognostic (8.43e-3)"	"unprognostic (3.52e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.74e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.59e-2)"	"prognostic favorable (7.40e-7)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.46e-1)"	6.8	11.1	7.4	9.7	8.3	11.3	7.6	8.0	8.4	5.7	6.1	19.8	11.7	6.5	8.4	7.5	9.6	7.1	7.3	6.9	8.5	12.9	18.4	11.2	12.4	7.8	8.6	11.7	4.9	16.0	3.8	6.3	8.0	8.0	19.2	5.4	6.3	10.7	11.8	8.2	12.1	6.9	7.7	11.9	7.8	11.5	8.8	8.4	11.2	10.1	9.7	7.1	4.7	8.8	14.3	6.1	8.5	3.1	7.5	7.3	5.4	6.1	8.5	7.0	7.9	4.7	7.3	22.2	11.4	8.3	21.9	9.9	6.1	11.5	8.6	6.4	5.2	5.6	5.4	15.0	5.8	25.2	19.1	4.5	14.3	5.7	11.9	6.9	9.4	9.3	3.9	19.8	8.8	4.5	6.9	25.2	4.3	13.4	7.4	8.0	4.9	4.5	11.7	6.9	2.2	2.4	5.5	11.3	8.5	11.9	4.1	35.2	8.2	5.0	3.1	12.4	7.1	4.2	10.0	20.3	6.0	14.8	8.0	34.8	9.5	27.9	2.0	10.8	6.8	8.0	9.6	7.3	12.0	10.6	9.0	5.4	11.6	14.6	9.8	7.4	12.2	7.1	7.4	8.3	8.0	8.4	6.9	8.5	7.8	8.6	8.0	7.7	8.8	8.8	9.9	9.6	20.0	52.2	13.9	15.2	8.3	5.8	2.2	0.0	5.8	3.9	15.0	4.3	6.0	3.7	0.0	2.1	8.4	33.0	1.9	3.4	35.6	7.7	5.0	11.5	9.6	7.4	44.0	4.3	2.8	6.6	8.2	4.8	8.8	3.3	16.4	13.2	8.0	0.0	41.5	17.7	2.0	16.3	10.4	18.8	6.2	13.0	5.4	24.4	12.0	0.0	0.0	27.6	47.7	4.7	9.5	12.8	8.0	6.8	11.2	14.7	13.4	0.0	0.0	5.2	6.9	5.1	4.1	4.9	19.0	7.3	12.8	4.8	13.8	9.7
MTMR2	"CMT4B, KIAA1073"	ENSG00000087053	"Myotubularin related protein 2"	Q13614	11	95821766-95925315	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 120.1;Oligodendrocytes: 226.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049831	Approved		Supported	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA049831: AB_2680904"	"unprognostic (1.71e-2)"	"unprognostic (2.55e-3)"	"unprognostic (7.81e-3)"	"unprognostic (4.16e-1)"	"unprognostic (4.18e-3)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (1.61e-8)"	"unprognostic (3.23e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.03e-3)"	14.7	9.3	11.0	11.2	16.8	4.4	11.8	16.3	18.3	12.2	12.2	12.9	7.1	12.3	6.2	14.7	12.4	14.3	13.5	10.8	14.3	16.4	4.3	12.3	9.5	15.1	14.4	11.5	7.8	12.7	6.4	24.5	15.8	16.1	13.9	18.6	20.5	11.4	6.2	8.2	8.3	18.0	13.5	8.6	13.0	31.0	14.1	15.1	9.9	8.9	12.1	15.2	10.4	22.4	24.1	25.3	54.1	39.2	19.2	29.0	47.5	43.3	37.9	42.4	37.8	57.3	47.1	16.2	50.3	45.5	35.9	30.9	47.7	48.2	38.9	30.8	21.3	31.5	55.0	33.0	42.8	59.3	26.7	24.0	31.2	56.6	54.5	41.8	64.4	35.4	44.7	14.2	39.6	17.9	29.0	27.2	46.6	59.0	34.9	23.2	32.2	16.8	43.9	125.0	35.6	40.6	43.6	36.4	19.2	35.1	27.6	26.5	64.4	47.7	45.1	34.4	41.1	13.1	42.4	14.3	20.4	15.6	50.6	9.8	3.9	1.7	12.4	4.7	13.4	5.8	7.9	15.7	7.6	4.9	4.0	11.3	0.9	14.1	7.2	3.7	8.1	7.8	11.0	16.8	16.3	18.3	10.8	14.3	15.1	14.4	15.8	13.5	14.1	22.4	19.6	3.2	8.6	28.7	9.6	10.3	15.0	9.0	8.6	0.0	8.0	6.7	17.3	0.0	11.6	9.2	0.0	9.0	8.8	9.1	9.8	17.8	74.8	18.1	14.1	20.2	16.2	12.8	69.8	16.9	34.3	17.0	9.7	8.7	19.0	49.1	11.0	1.0	12.5	0.0	37.5	9.8	24.4	10.3	8.2	120.1	11.1	8.3	3.6	40.3	6.8	0.0	14.4	63.8	226.6	17.7	4.7	12.0	7.0	15.1	6.0	29.3	17.0	0.0	32.9	7.9	29.0	46.8	19.2	15.4	6.0	9.0	8.8	12.9	10.6	15.6
MTPAP	"FLJ10486, PAPD1, SPAX4, TENT6"	ENSG00000107951	"Mitochondrial poly(A) polymerase"	Q9NVV4	10	30309801-30374448	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, Transcription"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 36.8"	"Cell type enriched"	"Detected in many"	7	"Early spermatids: 240.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038620, HPA058232"	Approved		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria		"HPA038620: AB_10673015, HPA058232: AB_2683646"	"unprognostic (2.76e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.56e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.28e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.39e-2)"	8.9	7.4	4.9	10.3	4.8	36.8	9.7	12.6	6.7	6.1	3.1	9.6	10.6	9.0	6.2	8.3	6.6	5.2	8.8	4.8	4.3	9.6	10.6	6.3	10.7	3.4	3.5	8.2	10.0	8.4	2.7	9.6	3.9	7.2	11.0	7.1	8.0	4.9	13.2	8.4	9.0	9.1	3.2	9.3	7.1	5.1	3.6	9.2	10.2	12.0	10.3	8.1	5.2	6.2	26.0	25.3	15.8	23.0	15.2	14.2	20.6	17.6	6.2	17.7	18.4	27.0	35.4	36.9	12.3	11.7	16.3	29.7	31.1	20.7	21.6	18.7	24.0	37.3	23.7	27.5	16.0	24.6	28.2	14.3	19.0	19.9	11.7	9.8	19.6	34.0	41.2	28.1	13.5	21.8	29.8	21.8	10.8	19.5	13.3	29.6	27.9	34.4	16.2	17.1	25.9	20.8	16.0	16.4	24.7	14.8	15.8	15.6	18.7	18.4	23.8	26.0	19.8	6.2	16.3	50.8	15.9	44.5	6.6	27.4	25.2	27.3	21.7	35.0	23.0	20.8	20.4	21.1	33.0	17.1	21.6	22.0	4.2	25.1	27.9	17.3	23.1	13.1	4.9	4.8	12.6	6.7	4.8	4.3	3.4	3.5	3.9	3.2	3.6	6.2	12.2	9.6	7.4	9.1	11.2	25.2	13.9	7.4	4.6	0.0	9.8	9.8	16.7	15.7	9.2	3.7	0.0	13.1	13.9	8.1	19.6	9.6	240.7	9.9	14.8	12.9	4.2	16.6	12.7	9.1	12.0	12.7	7.7	12.5	5.1	18.8	12.5	14.6	14.7	0.0	14.5	15.6	6.1	15.8	13.6	34.3	12.2	10.8	8.8	8.4	14.8	0.0	5.2	4.5	14.4	8.9	5.2	16.6	5.3	14.1	8.7	14.2	8.6	0.0	13.1	14.7	10.8	25.3	19.5	11.4	24.9	11.5	8.8	12.6	18.4	16.6
MTRR	cblE	ENSG00000124275	"5-methyltetrahydrofolate-homocysteine methyltransferase reductase"	Q9UBK8	5	7851186-7906025	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 70.1;Late spermatids: 99.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038113	Supported		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Cytosol"	"Intermediate filaments"	"HPA038113: AB_10671520"	"unprognostic (1.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (6.60e-4)"	"unprognostic (2.56e-2)"	"unprognostic (5.82e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.11e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-1)"	11.2	10.6	5.1	9.5	11.2	5.7	6.3	10.1	10.9	7.2	3.4	8.3	8.9	11.7	12.3	9.3	9.6	11.8	14.4	6.5	9.0	18.7	19.4	13.1	11.1	10.9	10.4	11.4	11.9	12.8	6.7	10.8	10.6	9.0	10.1	19.2	10.5	7.1	28.9	9.1	10.2	12.0	8.2	6.7	6.7	7.1	9.3	7.5	9.0	32.9	10.6	14.4	5.5	20.0	19.3	18.1	10.2	20.0	34.0	13.6	25.1	31.1	18.5	16.5	15.4	27.8	15.1	32.6	27.9	24.6	27.4	11.8	17.0	14.2	27.9	22.9	15.8	14.6	62.0	15.3	21.9	23.4	6.8	18.3	11.4	24.6	18.4	20.4	10.4	8.0	21.9	24.2	9.8	4.2	14.2	11.7	7.3	29.4	19.0	12.4	9.5	14.1	16.2	16.0	14.0	2.5	51.6	33.7	28.6	18.1	10.7	17.5	14.6	31.9	19.7	24.1	22.7	34.7	13.5	27.3	23.1	50.5	19.1	5.3	4.0	3.0	4.1	5.5	7.0	3.3	6.5	5.7	3.6	3.3	4.1	3.6	0.1	3.1	4.4	2.3	9.1	3.3	5.1	11.2	10.1	10.9	6.5	9.0	10.9	10.4	10.6	8.2	9.3	20.0	7.7	16.0	70.1	10.1	11.1	16.3	9.4	4.6	12.0	0.0	9.7	5.1	12.9	5.7	9.0	9.2	0.0	9.9	11.4	11.0	21.5	10.2	50.1	10.0	10.7	8.0	9.6	12.4	25.4	5.5	8.9	11.8	9.2	6.7	10.2	6.5	8.6	19.3	7.7	0.0	20.8	9.1	0.0	11.1	9.4	99.2	10.5	9.7	1.8	15.0	8.1	0.0	7.2	20.1	50.9	7.2	6.0	11.7	26.5	14.3	8.7	28.9	10.1	0.0	6.6	10.7	10.1	17.4	13.1	10.5	20.6	11.2	13.8	11.8	9.4	8.7
MUSK		ENSG00000030304	"Muscle associated receptor tyrosine kinase"	O15146	9	110668779-110806558	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation	"Developmental protein, Kinase, Muscle protein, Receptor, Transferase, Tyrosine-protein kinase"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 6.2;skeletal muscle: 4.1"	"Cell type enhanced"	"Detected in some"		"Late spermatids: 4.8;Leydig cells: 5.3;Oligodendrocytes: 17.0;Peritubular cells: 19.5;Skeletal myocytes: 23.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"LHCN-M2: 24.7;RH-30: 23.7"	"Region enhanced"	"Detected in some"		"basal ganglia: 5.0"	"Not detected"	"Not detected"									NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (6.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.20e-2)"		"unprognostic (1.50e-2)"		"unprognostic (2.46e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.58e-2)"	"unprognostic (6.03e-5)"	"unprognostic (4.58e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.11e-2)"	0.1	0.2	1.5	1.7	3.0	0.0	0.0	0.8	1.5	0.0	1.6	1.9	1.1	0.0	0.0	1.4	0.0	1.1	1.5	1.2	1.1	0.0	0.3	1.0	0.6	2.7	6.2	0.1	0.1	0.0	0.0	0.3	1.7	0.2	2.5	0.0	0.1	0.0	4.1	0.1	2.4	0.5	2.9	0.0	1.3	1.6	2.0	0.1	0.0	2.0	2.0	1.2	0.0	4.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.5	0.0	0.2	0.0	23.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.0	0.8	1.5	1.2	1.1	2.7	6.2	1.7	2.9	2.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.3	0.1	0.0	0.0	1.3	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	4.8	5.3	0.0	0.0	1.9	0.0	0.0	0.0	2.5	17.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.1	0.5	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0
MUTYH	MYH	ENSG00000132781	"MutY DNA glycosylase"	Q9UIF7	1	45329163-45340893	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA008732	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA008732: AB_1854219"	"unprognostic (6.30e-3)"	"unprognostic (7.12e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (4.76e-8)"	"unprognostic (2.80e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.05e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (7.25e-5)"	"unprognostic (3.50e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.57e-2)"	"unprognostic (5.49e-3)"	5.0	5.0	11.9	5.5	12.7	6.7	5.3	16.7	15.6	7.6	10.6	6.0	6.4	6.3	4.6	5.1	5.7	4.2	4.0	11.6	11.9	7.0	5.9	4.4	7.7	12.8	12.4	7.3	5.1	5.1	5.9	6.4	12.7	5.8	5.6	4.9	4.5	5.0	5.6	5.9	6.1	3.6	11.7	7.8	5.8	3.3	12.2	9.8	6.6	4.7	7.0	5.9	5.8	14.4	7.9	6.9	15.5	10.5	11.3	8.4	26.6	5.7	7.4	11.8	9.2	14.3	11.2	22.5	9.0	3.6	9.5	11.3	8.7	11.0	5.4	18.1	7.0	10.2	11.4	10.5	10.0	9.4	7.1	4.6	10.3	16.0	25.7	3.1	8.6	28.6	17.5	7.4	5.0	13.3	27.3	8.7	39.6	19.5	7.9	36.2	12.6	12.3	6.1	14.6	14.5	11.8	11.3	8.7	18.2	20.1	6.7	11.1	4.9	8.3	6.2	7.2	8.2	11.6	14.6	13.3	8.0	14.6	7.5	1.6	7.0	2.9	11.5	11.8	17.2	8.1	11.8	11.5	8.1	8.0	12.7	12.2	1.4	8.8	9.1	6.5	13.4	8.6	11.9	12.7	16.7	15.6	11.6	11.9	12.8	12.4	12.7	11.7	12.2	14.4	10.0	0.0	5.6	17.0	12.1	6.9	10.7	8.1	6.2	15.6	6.7	8.8	3.2	1.5	6.9	7.3	2.1	40.2	8.8	16.5	3.9	6.5	0.9	3.2	5.1	7.6	7.8	6.7	4.0	5.3	14.3	7.5	16.8	3.2	10.8	8.4	5.7	4.3	10.0	5.0	7.0	15.1	12.2	4.0	10.2	1.6	10.8	5.6	7.2	8.4	8.2	12.0	10.3	11.6	12.7	3.8	16.4	12.0	7.5	9.5	12.9	12.2	8.6	20.1	13.1	8.7	7.6	10.5	11.2	5.2	5.4	22.2	13.9	9.5	13.5	8.0
MVD	MPD	ENSG00000167508	"Mevalonate diphosphate decarboxylase"	P53602	16	88651935-88663161	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 147.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041404, HPA048250"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA		170000	"Cluster 15: NK-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	"Cell Junctions"	"HPA041404: AB_2677457, HPA048250: AB_2680329"	"unprognostic (1.67e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.42e-1)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.89e-1)"	"unprognostic (9.56e-2)"	"unprognostic (9.26e-3)"	"unprognostic (8.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.00e-2)"	20.3	51.1	24.2	15.7	27.5	7.0	16.4	26.2	37.5	30.5	19.3	32.3	35.1	20.3	2.2	77.8	13.5	4.9	22.8	24.7	27.8	28.8	78.8	31.0	12.3	32.4	27.8	19.6	25.3	8.3	18.9	6.3	39.3	23.5	4.2	3.4	25.1	6.5	27.2	52.3	26.6	5.7	24.0	24.6	31.5	42.3	24.7	7.0	21.1	8.3	6.8	17.6	36.9	25.6	50.6	34.2	52.4	33.1	18.1	38.7	29.5	25.1	26.0	17.7	14.6	86.1	119.7	24.4	39.8	15.7	63.7	72.8	25.0	133.1	4.9	15.7	38.3	17.8	18.2	127.0	35.9	11.6	11.8	30.9	24.6	46.6	13.5	8.7	18.0	58.0	51.7	13.1	10.2	115.9	39.3	56.6	61.5	17.7	31.3	40.2	15.0	62.3	49.8	33.0	52.2	17.9	62.0	13.3	18.5	11.4	67.8	51.3	39.0	14.7	29.8	27.2	14.2	34.9	17.6	83.2	17.9	55.7	25.7	5.6	12.6	2.4	26.8	13.7	20.4	16.1	18.0	17.9	15.0	22.6	13.2	16.6	1.8	28.3	15.4	28.0	20.4	15.4	24.2	27.5	26.2	37.5	24.7	27.8	32.4	27.8	39.3	24.0	24.7	25.6	17.2	25.6	48.2	22.2	21.5	15.2	12.9	106.3	4.0	27.2	26.5	14.1	16.7	21.5	56.9	20.2	6.2	20.2	79.6	117.5	25.4	30.8	61.6	17.7	10.0	15.8	32.9	26.5	23.4	62.3	29.2	15.5	41.8	26.5	16.5	27.4	20.7	147.2	38.6	23.5	17.0	75.3	32.6	25.5	21.6	96.2	8.1	20.3	21.4	6.5	32.2	16.5	55.6	11.1	14.5	30.0	79.4	9.1	46.3	20.1	47.1	22.6	21.5	18.1	6.6	7.0	20.7	50.8	13.0	13.8	21.6	48.8	36.3	35.5	65.2	20.6
MVK	"LRBP, MK"	ENSG00000110921	"Mevalonate kinase"	Q03426	12	109573255-109598125	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Kinase, Transferase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 60.5;Horizontal cells: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016961, HPA044110"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Vesicles, Cytosol"		"HPA016961: AB_1854220, HPA044110: "	"unprognostic (3.10e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.73e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.28e-1)"	7.9	29.8	12.7	6.1	13.7	8.3	14.7	16.7	15.0	14.5	9.6	11.2	13.9	7.3	10.2	45.5	6.3	5.3	9.4	11.1	13.2	32.1	69.1	11.4	6.9	36.1	15.5	10.7	10.0	11.5	11.6	5.4	38.6	12.3	8.6	7.3	13.7	7.0	12.1	33.3	9.8	5.0	15.3	6.7	11.8	28.5	15.3	4.2	15.1	8.8	9.1	9.5	20.1	24.4	30.1	25.0	29.9	13.7	11.2	27.3	14.4	9.5	21.7	30.0	32.8	31.4	33.8	17.7	7.8	11.7	48.1	36.0	31.6	50.0	13.2	19.0	18.1	9.9	15.7	53.7	31.5	11.1	13.0	27.2	42.1	48.8	13.6	12.6	20.9	19.0	18.7	17.4	13.6	34.5	12.0	34.6	22.6	14.9	32.3	10.5	22.1	37.0	67.4	40.9	25.1	18.7	19.8	58.7	14.0	11.0	59.7	21.1	14.1	13.2	14.5	12.0	12.8	13.3	20.6	28.2	16.1	29.2	16.6	1.0	6.9	4.0	12.6	6.5	11.3	9.4	7.4	12.4	8.6	14.1	10.9	8.3	1.6	11.0	4.6	7.0	7.6	6.4	12.7	13.7	16.7	15.0	11.1	13.2	36.1	15.5	38.6	15.3	15.3	24.4	6.1	12.8	12.4	6.8	8.3	4.7	5.2	39.7	4.6	12.4	13.1	11.0	5.7	11.5	25.8	14.7	18.8	33.0	7.3	10.4	21.5	15.6	60.5	5.8	2.3	7.1	9.0	4.8	5.1	18.1	15.3	6.8	9.7	5.1	1.3	14.7	6.4	32.7	15.6	62.2	5.2	7.8	10.2	3.4	2.2	42.5	8.1	4.8	7.2	3.7	10.3	10.6	10.3	4.0	15.3	13.2	3.2	7.2	4.1	5.5	16.4	52.4	13.5	12.2	6.6	4.0	8.2	33.9	16.8	12.0	8.5	47.9	6.1	44.8	11.1	4.6
MYLK	"MLCK, MLCK1, MYLK1, smMLCK"	ENSG00000065534	"Myosin light chain kinase"	Q15746	3	123610049-123884332	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 1700.3;smooth muscle: 2137.7"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 728.5;Hepatocytes: 208.7;Peritubular cells: 690.5;Sertoli cells: 276.1;Smooth muscle cells: 448.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 200.0;BJ hTERT+: 298.2;fHDF/TERT166: 260.2;hTERT-RPE1: 202.7;RPTEC TERT1: 291.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020789, HPA031677, HPA048055"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		NA	NA		1500000	"Cluster 34: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Actin filaments"	"Plasma membrane"	"CAB020789: , HPA031677: AB_10794617, HPA048055: AB_2732543"	"unprognostic (2.80e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (5.26e-3)"	"unprognostic (9.60e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (4.46e-4)"	143.6	57.4	37.6	188.7	64.8	3.3	163.4	72.1	42.4	281.3	14.1	551.5	110.9	669.2	232.9	420.6	289.8	250.4	33.6	33.6	46.7	64.4	67.2	85.2	33.6	104.6	64.8	95.9	15.3	11.6	2.6	70.2	99.3	907.6	299.1	13.6	140.1	1700.3	10.0	20.1	125.1	2137.7	55.6	89.5	122.7	50.5	52.2	8.0	22.2	14.9	19.1	505.7	84.8	112.1	14.4	38.4	10.8	7.8	10.8	1.9	4.7	200.0	298.2	137.3	92.1	8.1	7.4	0.6	42.5	260.2	67.0	4.8	5.2	1.8	149.0	0.2	0.7	102.4	0.9	28.9	56.1	0.6	9.8	36.9	3.5	24.4	34.4	202.7	8.9	1.3	1.2	0.5	90.9	1.7	0.2	2.5	12.0	0.5	5.1	13.5	6.8	36.7	291.9	8.5	1.4	6.4	21.8	1.9	3.1	25.0	1.0	0.3	33.4	39.5	13.9	10.3	30.7	3.4	4.2	0.3	104.0	1.0	9.6	7.4	1.6	0.4	0.1	0.2	0.0	0.2	0.0	0.0	3.5	0.1	0.2	0.1	5.0	0.0	0.0	3.3	0.2	20.9	37.6	64.8	72.1	42.4	33.6	46.7	104.6	64.8	99.3	55.6	52.2	112.1	45.9	16.0	38.3	43.4	2.5	20.5	27.2	24.8	1.2	2.9	19.9	728.5	25.2	37.1	5.7	27.6	125.1	0.8	3.5	88.1	3.9	6.0	40.7	45.9	46.6	56.9	11.4	3.2	25.2	3.9	0.8	40.1	3.1	54.4	2.5	3.2	45.3	208.7	4.9	3.3	3.4	3.9	8.2	7.9	37.0	33.8	104.7	20.8	19.6	8.4	1.2	4.7	0.0	5.5	37.0	4.0	18.7	690.5	3.3	8.6	14.2	17.2	17.6	19.9	276.1	5.6	448.7	4.7	4.6	1.3	20.2	2.5	3.2	4.5	4.2	3.7
MYLK2	"KMLC, MLCK2, skMLCK"	ENSG00000101306	"Myosin light chain kinase 2"	Q9H1R3	20	31819308-31834689	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"skeletal muscle: 732.0"	"Cell type enriched"	"Detected in some"	5	"Skeletal myocytes: 15.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.1;RH-30: 10.5;RPMI-8226: 8.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA059704, HPA059890"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Endoplasmic reticulum"		"HPA059704: AB_2684108, HPA059890: AB_2684153"	"unprognostic (1.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.84e-2)"	"unprognostic (5.27e-2)"	"prognostic favorable (4.00e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.38e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.25e-11)"	"unprognostic (2.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.70e-2)"	0.1	0.0	0.6	0.1	0.6	0.4	0.1	0.6	0.7	0.0	0.5	0.2	0.0	0.1	0.1	4.7	0.1	0.0	0.3	0.6	0.6	0.0	0.0	0.1	0.0	0.6	0.7	0.1	5.5	0.0	0.1	0.0	0.7	1.1	0.0	0.0	2.4	0.0	732.0	0.6	0.1	0.1	0.6	0.3	0.2	0.2	0.7	0.2	0.2	60.3	0.0	0.0	0.0	0.6	0.3	0.0	0.7	0.6	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.2	0.2	0.5	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.3	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	1.3	0.8	0.5	0.1	4.1	0.1	0.6	0.5	0.3	0.5	0.0	0.3	0.6	10.5	8.8	0.0	0.1	0.5	0.5	2.7	0.1	0.0	0.1	0.1	0.1	2.1	0.2	0.7	0.4	2.4	0.0	0.8	0.2	0.1	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	0.7	0.6	0.6	0.6	0.7	0.7	0.6	0.7	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
MYMK	"TMEM226, TMEM8C"	ENSG00000187616	"Myomaker, myoblast fusion factor"	A6NI61	9	133514586-133528612	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Myogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	32	"HSkMC: 15.2;RH-30: 7.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA051846, HPA055785"	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA051846: AB_2681636, HPA055785: AB_2682920"						"unprognostic (9.17e-3)"	"unprognostic (8.63e-2)"	"unprognostic (3.76e-1)"		"unprognostic (1.13e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.37e-1)"	"unprognostic (9.32e-2)"			"unprognostic (1.91e-1)"		0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.4	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.5	0.2	0.1	0.5	0.2	0.4	0.2	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
MYO3A	DFNB30	ENSG00000095777	"Myosin IIIA"	Q8NEV4	10	25934229-26212532	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"retina: 15.5;testis: 5.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 156.6;Late spermatids: 58.2;Muller glia cells: 74.8;Spermatocytes: 31.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 1.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CAPAN-2: 1.2;HEK 293: 1.5;SCLC-21H: 1.4;U-2 OS: 2.4;U-698: 6.3"	"Not detected"	"Not detected"							"HPA051893, HPA075413"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytoplasmic bodies"		No	No				"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"	"Actin filaments, Cytoplasmic bodies"	"Plasma membrane"	"HPA051893: , HPA075413: "	"unprognostic (5.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.37e-2)"		"unprognostic (5.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-3)"	"unprognostic (7.96e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.69e-2)"	0.1	0.1	0.4	0.0	1.8	0.1	0.1	0.0	0.8	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.6	0.3	0.0	0.1	0.0	0.6	0.5	0.0	0.7	0.0	0.5	0.0	0.5	0.1	0.3	15.5	0.0	0.1	0.0	0.7	0.1	0.0	0.2	0.0	0.2	5.2	0.3	0.2	0.2	0.1	0.2	0.0	0.3	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.8	0.0	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.0	0.8	0.1	0.6	0.6	0.5	0.5	0.2	0.3	0.3	0.2	0.0	0.5	2.0	0.1	1.8	0.3	0.0	0.0	0.9	0.6	0.3	0.6	0.0	2.5	0.0	0.0	0.0	0.0	0.2	1.9	0.8	156.6	0.6	0.1	0.3	1.8	0.0	2.2	0.0	0.4	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	5.9	0.4	0.0	0.0	0.0	58.2	1.2	0.1	0.0	1.9	0.0	74.8	0.0	1.0	0.4	0.2	0.0	1.2	0.0	0.3	0.0	1.0	0.0	3.9	0.0	0.0	2.4	31.7	14.2	2.4	1.0	0.0	0.0	0.0	0.4	0.3
MYSM1	KIAA1915	ENSG00000162601	"Myb like, SWIRM and MPN domains 1"	Q5VVJ2	1	58643440-58700077	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, DNA-binding, Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 106.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054291, HPA057306"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA054291: AB_2682438, HPA057306: "	"unprognostic (2.95e-3)"	"unprognostic (3.64e-2)"	"unprognostic (3.20e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (5.09e-5)"	"unprognostic (8.12e-3)"	"unprognostic (9.63e-3)"	"unprognostic (5.72e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-2)"	11.2	7.5	4.0	4.4	3.9	12.5	12.0	4.3	5.9	11.9	4.2	11.8	5.4	10.6	6.2	10.0	10.2	3.1	10.5	4.1	3.9	7.2	8.0	10.1	6.3	3.9	3.7	13.2	12.1	5.9	8.7	4.4	3.9	9.6	4.4	8.4	11.8	4.1	10.0	10.5	12.6	3.6	3.7	11.4	9.9	4.4	3.9	5.3	11.5	3.1	4.9	9.3	11.1	4.4	10.1	2.6	5.0	6.7	6.0	7.2	10.5	5.9	5.6	5.1	3.9	5.3	4.2	10.3	1.8	3.8	4.8	7.4	7.7	2.1	11.0	6.2	4.3	11.3	2.1	5.1	7.4	19.6	9.7	5.4	5.9	7.5	3.8	6.1	1.2	4.2	12.6	6.3	6.8	2.6	7.8	16.3	11.4	3.5	3.5	7.3	16.4	6.1	4.6	3.8	5.8	6.6	4.4	9.4	13.9	9.0	3.1	10.6	4.9	9.3	4.6	6.4	11.3	10.8	5.8	13.9	5.8	13.7	11.6	0.9	0.3	0.1	0.3	0.4	0.2	0.4	0.3	0.3	0.1	0.3	0.5	0.4	1.0	0.1	0.5	0.4	0.4	0.1	4.0	3.9	4.3	5.9	4.1	3.9	3.9	3.7	3.9	3.7	3.9	4.4	36.5	22.4	33.7	47.7	26.0	19.1	22.8	13.5	30.7	19.5	25.6	21.0	28.2	10.0	35.1	11.0	25.0	8.4	36.6	22.1	15.6	8.8	3.9	22.1	34.8	25.4	16.2	14.1	87.4	9.4	5.7	20.8	19.9	36.9	56.3	30.1	23.9	16.3	11.3	18.5	58.2	17.0	24.4	13.9	14.2	6.3	12.8	22.2	8.8	35.6	21.3	12.7	22.6	58.3	106.9	12.7	13.1	17.3	29.5	19.3	19.2	8.8	21.2	27.8	26.3	28.8	21.5	15.5	20.6	25.0	18.5	11.4	30.8	22.0	18.5	26.4
NAA10	"ARD1, ARD1A, DXS707, TE2"	ENSG00000102030	"N-alpha-acetyltransferase 10, NatA catalytic subunit"	P41227	X	153929225-153935080	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006269, HPA030711"	Supported		Supported	Nucleoli,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoli	"CAB006269: AB_425759, HPA030711: AB_2673579"	"unprognostic (7.57e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (3.29e-8)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.48e-3)"	38.4	39.5	19.6	17.2	20.1	13.2	34.6	20.4	27.2	26.5	19.2	34.1	15.3	32.3	15.1	40.5	24.4	10.3	56.3	20.0	21.8	34.1	35.9	26.0	19.7	20.8	20.3	23.8	45.8	13.7	22.5	12.5	20.8	27.6	10.2	7.3	25.3	12.2	98.4	30.9	24.9	18.1	20.4	28.8	35.9	9.1	21.2	10.2	21.7	24.9	15.3	35.9	26.8	20.4	133.4	136.0	25.8	83.0	36.7	36.9	71.2	46.3	28.6	63.8	57.0	88.5	41.0	102.0	147.6	38.7	79.2	63.0	57.9	56.8	23.9	42.1	255.2	36.8	85.8	91.3	49.1	71.4	76.8	28.8	62.2	57.9	59.1	30.7	72.0	39.2	75.1	41.5	41.6	172.8	115.0	106.4	42.9	124.4	189.0	90.1	65.7	111.5	47.7	59.7	54.0	65.7	18.7	71.0	113.7	23.9	38.4	58.8	41.1	25.6	88.5	89.5	142.0	86.3	107.2	196.0	34.7	91.0	75.5	35.3	53.1	81.3	60.0	65.3	78.1	75.2	63.4	65.6	69.4	77.7	37.4	56.7	49.8	64.7	76.0	75.9	102.9	70.6	19.6	20.1	20.4	27.2	20.0	21.8	20.8	20.3	20.8	20.4	21.2	20.4	126.9	9.6	30.2	27.1	76.0	70.1	66.1	90.6	68.3	29.5	82.6	113.8	45.1	47.1	52.8	38.6	12.5	125.9	77.0	94.5	95.9	121.1	2.9	46.0	60.7	98.7	58.1	78.9	18.6	149.9	179.0	57.3	76.5	43.4	67.9	64.2	77.8	78.7	123.1	37.0	14.6	92.2	54.9	66.5	96.0	12.5	46.6	66.4	119.2	9.4	84.8	37.9	85.5	14.1	19.1	144.6	75.2	46.6	104.3	136.9	91.5	197.0	40.2	30.4	65.7	56.6	98.3	7.6	33.1	120.7	90.5	108.8	74.8	97.7	110.3	85.9
NADK2	"C5orf33, FLJ30596, MNADK, NADKD1"	ENSG00000152620	"NAD kinase 2, mitochondrial"	Q4G0N4	5	36192589-36242279	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"liver: 328.0"	"Group enriched"	"Detected in many"	5	"Astrocytes: 105.4;Early spermatids: 324.5;Hepatocytes: 211.9;Late spermatids: 154.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 36.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038366, HPA038367, HPA061492"	Enhanced		Supported	Mitochondria		NA	NA		30000	"Cluster 24: B-cells - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria		"HPA038366: AB_2675977, HPA038367: AB_10672743, HPA061492: AB_2684538"	"unprognostic (1.15e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.06e-3)"	"unprognostic (8.84e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.75e-2)"	13.6	20.1	26.6	9.3	23.3	10.6	15.4	21.9	24.2	13.7	14.0	13.9	16.6	13.3	7.9	10.4	12.7	11.9	20.2	22.2	27.1	23.2	328.0	8.4	9.5	25.4	27.4	19.6	26.9	10.7	5.5	16.9	25.3	19.0	13.8	11.2	13.0	16.2	29.4	6.6	12.9	14.2	31.0	8.6	17.1	18.2	25.3	10.3	17.3	29.8	11.4	27.9	8.8	30.3	21.5	14.6	22.4	23.5	32.2	27.2	27.5	19.5	13.2	17.5	13.2	41.4	27.4	74.3	14.0	23.3	23.0	14.9	20.0	14.3	24.2	21.2	16.3	22.0	43.1	23.9	22.7	46.5	8.0	28.9	22.5	21.6	29.9	22.4	18.4	30.2	52.0	27.8	18.0	9.0	42.3	18.2	10.7	18.1	19.2	40.2	51.6	15.8	24.2	18.2	8.7	20.1	102.0	32.4	10.5	16.7	22.9	39.8	15.1	34.1	18.2	27.0	23.9	23.7	30.3	23.2	14.5	57.2	14.2	8.2	1.2	1.1	1.3	1.4	1.8	1.3	1.9	1.5	2.3	5.3	1.6	1.4	0.1	6.7	3.3	1.2	2.1	1.4	26.6	23.3	21.9	24.2	22.2	27.1	25.4	27.4	25.3	31.0	25.3	30.3	9.6	3.2	6.9	105.4	7.5	6.8	6.8	5.4	6.2	5.7	18.3	11.2	29.3	25.8	7.1	5.5	8.4	9.2	9.6	7.4	25.4	5.0	324.5	6.1	9.4	6.8	7.2	13.7	23.8	9.5	8.9	12.5	5.6	7.1	1.3	10.0	12.1	211.9	8.9	3.3	18.3	11.7	4.1	10.4	9.6	154.9	19.9	6.4	14.2	11.2	3.7	16.9	5.2	21.1	23.6	6.9	8.8	23.0	14.3	14.9	6.6	23.1	7.2	5.4	0.0	11.6	13.5	35.1	11.0	7.7	5.7	7.3	6.9	26.4	11.6	12.3
NADSYN1	FLJ10631	ENSG00000172890	"NAD synthetase 1"	Q6IA69	11	71453109-71524107	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017798, HPA038523, HPA038524"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 45: Enterocytes - Digestion"	Vesicles	"Golgi apparatus, Cytosol"	"CAB017798: , HPA038523: AB_2676060, HPA038524: AB_2676061"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.17e-6)"	"unprognostic (1.19e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (4.12e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (5.10e-4)"	29.5	34.1	18.8	24.1	20.4	67.6	26.2	18.5	21.2	30.4	20.3	48.6	39.5	26.0	24.2	56.3	31.2	25.8	20.3	17.8	18.3	33.2	49.8	35.3	33.3	22.4	19.6	27.6	29.5	13.4	36.0	16.5	21.0	45.3	36.0	6.9	32.9	22.8	11.0	31.1	51.1	19.3	18.8	58.4	34.3	25.6	21.7	27.9	31.8	5.1	28.2	43.4	33.4	24.4	15.9	37.8	12.0	21.6	35.0	50.6	32.4	29.7	27.2	15.4	17.0	32.4	25.7	13.4	33.1	35.3	20.7	55.2	15.9	42.6	8.2	27.9	12.8	22.2	27.6	36.3	43.3	45.1	40.9	72.0	65.8	19.9	17.8	34.9	54.6	24.2	11.9	18.5	21.9	49.7	22.4	29.9	7.0	69.6	21.3	27.5	37.2	13.5	37.8	72.1	8.9	12.7	21.2	27.9	56.0	17.9	24.9	24.4	66.2	16.7	14.2	30.9	11.8	24.3	11.0	11.7	29.9	25.6	12.0	6.1	28.0	17.3	15.3	25.0	12.7	12.2	13.5	13.8	31.1	9.2	8.8	11.4	17.7	16.3	22.6	23.0	17.7	21.4	18.8	20.4	18.5	21.2	17.8	18.3	22.4	19.6	21.0	18.8	21.7	24.4	12.6	22.4	32.3	4.2	24.0	6.2	17.8	18.4	26.2	7.8	13.5	10.9	8.3	12.8	19.8	11.0	4.2	17.4	27.3	65.3	3.9	16.5	22.6	21.1	11.1	15.6	23.4	20.2	5.1	17.3	14.5	12.8	51.0	19.7	22.1	23.1	13.9	16.7	20.1	13.5	5.8	30.3	16.2	23.2	18.5	60.9	9.3	25.4	8.8	8.4	25.8	5.9	29.9	7.5	18.5	20.0	55.8	10.1	18.0	17.9	73.3	16.2	16.5	7.3	13.1	9.6	9.8	15.9	5.0	38.3	12.8	17.2	22.3	17.1	43.7	24.2
NAGA	D22S674	ENSG00000198951	Alpha-N-acetylgalactosaminidase	P17050	22	42058334-42070842	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 65.0;Hofbauer cells: 91.6;Kupffer cells: 64.4;monocytes: 65.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 202.5;intermediate monocyte: 249.1;myeloid DC: 195.2;non-classical monocyte: 257.9;plasmacytoid DC: 119.8"	"Group enriched"	"Detected in all"	6	"dendritic cells: 195.2;monocytes: 257.9"	"Cell line enhanced"	"Detected in all"		"HMC-1: 190.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000649	Enhanced				"Intracellular and membrane"	NA	NA		2200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA000649: AB_1079448"	"unprognostic (3.74e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.92e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.53e-1)"	21.4	12.7	9.3	32.3	10.4	20.1	13.4	10.3	10.1	20.6	17.0	26.1	20.4	17.2	12.4	17.2	20.0	22.1	16.0	8.9	11.5	14.9	31.9	27.1	20.8	13.9	10.8	17.0	11.4	39.2	11.7	42.8	12.6	18.2	26.7	7.7	17.3	18.6	7.7	13.4	24.2	28.3	12.2	20.3	16.6	9.0	12.0	13.9	15.1	12.3	19.0	24.8	13.7	14.4	27.8	14.0	21.7	38.9	37.0	41.9	15.9	22.4	45.7	37.9	39.2	31.4	39.9	13.5	13.5	49.1	22.9	19.2	16.7	27.4	22.3	31.0	21.2	33.5	20.1	21.5	21.5	28.1	190.4	28.9	23.8	34.0	14.4	19.5	63.4	11.6	12.4	56.0	30.2	32.3	10.4	11.5	5.8	25.3	18.5	23.0	11.0	24.2	29.4	32.7	6.7	7.7	29.8	27.0	29.3	19.1	40.4	50.9	34.4	26.6	31.8	17.1	20.7	30.9	33.3	10.9	28.3	52.7	33.4	36.5	202.5	25.1	13.6	249.1	13.8	10.5	14.1	12.7	195.2	6.9	9.2	8.4	9.9	18.8	257.9	119.8	18.3	121.0	9.3	10.4	10.3	10.1	8.9	11.5	13.9	10.8	12.6	12.2	12.0	14.4	6.5	9.6	6.7	4.6	8.2	3.3	9.4	10.9	5.7	2.8	6.7	6.2	4.2	4.3	11.3	7.3	8.4	46.1	11.0	27.3	3.9	15.4	15.8	5.6	8.8	11.2	6.0	12.4	1.1	8.1	65.0	13.8	6.1	10.2	9.5	3.2	9.3	33.6	91.6	0.0	2.0	15.0	6.1	64.4	36.3	17.9	7.2	52.5	19.6	12.2	65.8	5.9	6.2	0.5	2.0	13.0	23.9	6.8	22.2	6.0	40.0	9.8	15.7	6.4	19.7	6.1	10.0	10.7	5.2	7.1	3.4	58.3	6.9	6.5	15.4	10.0
NAGLU	NAG	ENSG00000108784	N-acetyl-alpha-glucosaminidase	P54802	17	42536241-42544449	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Charcot-Marie-Tooth disease, Disease variant, Mucopolysaccharidosis, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038815	Supported				"Intracellular and membrane"	NA	NA		270000000	"Cluster 37: B-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"			"HPA038815: AB_10697398"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.48e-2)"	"prognostic favorable (4.17e-4)"	"prognostic unfavorable (6.59e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.68e-2)"	"prognostic favorable (6.90e-4)"	"unprognostic (8.07e-2)"	"prognostic favorable (2.58e-6)"	"unprognostic (2.25e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.62e-1)"	41.6	37.9	12.5	14.8	21.6	20.3	35.3	16.6	16.7	31.1	28.7	25.1	24.3	34.7	12.8	19.5	27.6	27.4	20.1	12.0	15.0	39.3	59.3	30.8	24.0	18.0	19.2	35.2	63.8	21.3	22.5	26.1	20.1	28.3	16.4	3.1	37.7	18.4	16.0	25.1	30.9	13.8	14.2	40.7	35.1	8.7	19.5	17.1	37.6	9.7	13.4	28.9	23.9	30.0	16.0	55.3	10.8	24.6	106.6	34.5	36.4	24.0	56.9	24.9	31.7	14.9	40.4	20.3	23.7	37.4	54.7	38.3	9.7	11.7	5.5	15.8	20.2	11.2	31.3	31.8	35.3	13.3	27.7	41.4	17.8	13.6	16.9	27.3	32.8	3.6	16.6	39.3	27.9	38.9	2.2	23.0	12.6	34.6	7.0	8.7	23.6	47.2	33.1	36.1	16.2	24.4	12.9	17.6	20.4	15.6	82.1	14.1	25.8	59.3	9.7	23.8	15.7	52.6	25.8	17.6	35.9	14.4	43.1	1.1	2.4	1.9	2.5	1.8	2.4	2.4	1.0	1.3	2.1	1.8	1.8	1.4	1.1	2.1	2.9	2.8	0.2	1.1	12.5	21.6	16.6	16.7	12.0	15.0	18.0	19.2	20.1	14.2	19.5	30.0	14.1	12.8	7.8	17.3	9.0	2.8	6.1	3.9	2.2	15.5	14.2	8.9	3.8	18.6	4.9	18.4	4.2	23.8	11.4	21.1	3.9	18.4	0.3	5.8	14.5	12.2	6.7	4.4	2.3	33.2	14.5	26.4	27.0	12.1	2.5	40.1	24.3	43.7	37.6	15.2	3.1	17.6	0.0	26.0	3.5	2.4	19.9	19.0	16.0	10.3	5.9	13.2	8.2	6.0	19.2	15.8	5.4	12.8	12.9	10.7	23.0	31.8	3.7	6.7	6.6	18.0	12.8	0.4	6.0	6.1	3.4	18.5	6.0	74.6	15.0	6.0
NAGPA	"APAA, UCE"	ENSG00000103174	"N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase"	Q9UK23	16	5024844-5034141	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064055	Approved					NA	NA		7800000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 52: Non-specific - Transcription"			"HPA064055: AB_2685183"	"unprognostic (9.93e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.30e-3)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (1.05e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.51e-3)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (2.67e-5)"	"unprognostic (1.26e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.02e-1)"	6.3	7.0	20.3	5.7	21.6	6.2	5.5	17.9	29.6	5.5	17.6	8.8	6.5	6.6	2.6	6.4	4.8	3.4	5.4	23.6	18.3	8.2	9.0	5.7	6.4	19.2	18.0	3.6	6.2	4.8	5.4	4.1	18.5	5.7	3.0	0.6	5.4	3.3	6.1	6.7	9.8	3.4	17.8	11.8	9.4	3.3	19.6	3.5	5.7	2.4	2.8	6.4	5.1	20.9	2.5	9.7	1.6	10.4	4.0	5.0	10.8	7.1	12.7	9.3	11.2	8.0	19.9	1.0	8.8	9.6	15.8	7.3	4.4	7.8	2.6	11.8	13.3	3.6	5.7	53.1	12.7	8.8	14.6	7.7	8.1	6.0	2.7	11.0	14.6	8.8	11.5	14.1	5.5	11.3	4.0	23.6	5.0	6.3	10.2	10.4	3.7	19.3	5.8	3.9	4.0	5.6	5.6	14.2	15.1	1.4	9.7	10.5	11.0	9.9	7.2	24.0	5.3	6.9	6.3	2.3	4.6	13.1	8.3	3.9	39.3	10.4	17.9	35.0	14.2	17.3	17.1	15.4	50.5	14.2	14.0	13.2	1.2	10.6	23.6	12.9	16.3	20.1	20.3	21.6	17.9	29.6	23.6	18.3	19.2	18.0	18.5	17.8	19.6	20.9	8.1	0.0	2.7	7.8	15.0	2.9	4.7	4.5	7.4	14.7	5.2	5.1	3.1	8.6	4.7	5.5	31.3	13.3	10.2	21.8	1.9	11.3	0.4	3.0	3.7	8.4	1.2	9.1	44.5	8.5	14.9	4.6	28.1	4.1	1.3	8.9	9.7	7.7	27.2	16.8	21.5	13.6	2.0	24.9	8.6	1.0	8.1	20.6	3.6	2.8	24.0	4.5	18.6	4.0	6.9	9.5	18.4	6.4	13.2	4.1	28.9	9.0	3.2	13.8	0.0	4.3	4.8	4.4	8.4	8.8	2.4	9.4	12.1	5.8	12.4	3.2
NAGS	"AGAS, ARGA, NAT7"	ENSG00000161653	"N-acetylglutamate synthase"	Q8N159	17	44004622-44009068	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Urea cycle"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 15.9;liver: 48.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 21.7;Proximal enterocytes: 44.2;Proximal tubular cells: 20.7;Spermatocytes: 16.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 12.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.5;HHSteC: 5.2;TIME: 7.1;U-87 MG: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027300			Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA027300: AB_2672207"	"unprognostic (1.51e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.19e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	0.9	0.7	2.0	0.5	1.2	0.0	1.4	0.9	2.0	0.8	0.0	2.4	15.9	0.8	1.8	1.4	0.7	0.4	1.2	1.0	3.5	4.9	48.2	1.9	0.3	2.0	1.4	0.6	0.3	3.3	0.5	0.1	2.2	1.1	0.5	0.0	1.0	1.4	0.2	1.0	13.6	0.1	1.3	0.4	0.4	0.6	3.6	0.1	4.4	0.2	0.1	0.4	1.0	1.0	2.9	0.1	0.0	0.4	0.0	5.5	0.1	0.5	0.1	0.1	0.2	1.7	0.7	0.0	1.1	0.0	0.1	1.3	0.1	1.5	0.3	0.2	0.7	0.1	0.2	2.2	5.2	0.0	0.0	3.2	0.0	0.7	0.0	0.6	1.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	1.5	2.7	0.0	0.3	0.0	0.1	0.0	2.1	0.0	0.9	0.0	0.0	0.2	0.2	0.0	7.1	2.5	0.7	0.2	0.6	0.1	0.1	0.1	10.0	0.0	0.3	0.8	0.5	0.7	0.9	0.4	0.7	0.3	0.6	0.8	0.5	0.3	0.3	0.4	0.3	0.2	0.8	0.1	0.5	0.3	2.0	1.2	0.9	2.0	1.0	3.5	2.0	1.4	2.2	1.3	3.6	1.0	1.8	3.2	4.2	0.0	0.9	1.5	0.9	1.9	6.8	0.4	3.5	4.8	2.6	2.8	2.9	12.9	0.0	0.9	1.1	10.5	7.9	1.9	5.8	0.5	0.2	2.3	7.2	0.0	0.0	4.2	1.9	0.9	2.0	0.2	0.0	0.3	0.7	21.7	1.1	0.0	0.3	3.8	4.1	1.9	5.3	5.3	1.5	2.1	0.0	1.0	6.1	1.0	3.1	0.0	0.0	5.1	11.1	0.7	0.0	0.6	44.2	20.7	1.1	0.5	0.0	0.2	0.9	16.0	2.5	1.0	0.9	0.4	1.4	0.7	6.6	0.6
NALCN	"bA430M15.1, CanIon, VGCNL1"	ENSG00000102452	"Sodium leak channel, non-selective"	Q8IZF0	13	101053776-101416508	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.1"	"Group enriched"	"Detected in some"	10	"Astrocytes: 125.4;Excitatory neurons: 265.8;Inhibitory neurons: 277.4;Oligodendrocyte precursor cells: 324.7;Oligodendrocytes: 477.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"basophil: 2.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 14.2;HHSteC: 14.4;hTERT-RPE1: 11.0;TIME: 19.8;U-87 MG: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031889, HPA031890, HPA031958"	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA031889: AB_10669638, HPA031890: AB_10696056, HPA031958: AB_10601039"	"unprognostic (4.66e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.78e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.37e-3)"	"unprognostic (8.11e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.58e-5)"	"unprognostic (1.77e-3)"	"unprognostic (5.44e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	0.5	4.3	7.5	0.4	9.8	0.6	2.7	6.4	10.3	1.5	0.0	0.4	0.6	0.5	1.5	0.2	1.0	2.3	3.3	8.6	10.2	0.3	1.2	1.1	0.3	8.2	5.8	2.8	1.3	2.9	6.8	3.0	7.0	0.3	0.6	6.1	0.8	1.0	0.3	0.5	0.5	0.5	6.8	0.4	0.7	0.6	8.3	0.0	2.4	0.2	0.1	0.5	0.2	13.1	0.1	7.8	1.4	0.2	0.7	0.3	0.1	0.8	0.8	1.8	0.4	0.2	8.9	0.0	0.3	3.6	0.8	14.2	0.0	2.2	5.5	0.0	1.2	0.4	3.8	0.1	14.4	0.2	0.3	0.4	0.5	1.7	4.6	11.0	8.2	0.1	0.1	0.4	5.9	0.0	0.1	0.0	0.4	1.3	1.8	0.0	0.0	0.0	4.6	1.9	1.2	0.6	0.1	0.0	0.8	0.9	0.2	0.1	19.8	0.4	0.1	0.3	1.8	0.1	0.1	0.1	11.4	0.1	0.3	2.6	0.1	0.2	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.1	0.5	0.2	0.1	0.2	0.1	0.1	7.5	9.8	6.4	10.3	8.6	10.2	8.2	5.8	7.0	6.8	8.3	13.1	0.1	0.0	0.0	125.4	0.0	0.3	0.0	0.3	0.6	15.4	3.5	4.6	6.2	0.0	0.1	0.0	6.2	1.0	0.0	0.0	0.0	0.8	4.5	0.1	0.2	0.6	0.0	0.0	265.8	0.2	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	26.9	277.4	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	23.4	0.0	2.0	0.0	324.7	477.4	0.3	0.0	1.9	0.0	0.0	0.0	0.1	0.0	2.6	0.0	3.6	0.5	0.2	0.8	0.0	0.1	0.5	0.0	0.1	0.0	0.0
NANS	SAS	ENSG00000095380	"N-acetylneuraminate synthase"	Q9NR45	9	98056732-98083077	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Intestinal goblet cells: 362.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019223	Approved		Enhanced	Nucleoplasm		No	No		410000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 4: Stomach - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA019223: AB_1854298"	"unprognostic (2.95e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.24e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.79e-1)"	39.4	28.9	16.2	49.3	15.0	67.8	36.5	13.8	18.2	49.9	29.8	133.5	52.2	28.5	33.5	51.4	29.4	34.2	46.3	15.1	17.0	32.8	67.0	45.9	59.5	16.2	17.2	26.2	67.6	20.4	42.5	31.7	18.4	106.4	129.2	8.3	120.0	19.7	34.2	29.2	47.8	29.0	15.1	53.3	76.1	27.2	17.2	18.8	27.3	17.4	60.5	47.5	41.5	17.2	387.9	111.8	32.5	94.5	64.0	68.8	70.5	120.9	93.7	96.3	78.3	134.8	53.6	118.1	57.2	133.3	101.9	134.1	61.0	103.6	80.0	95.7	91.0	70.3	128.4	271.9	176.3	80.3	55.3	58.4	69.1	102.9	116.4	111.8	104.3	57.9	129.9	119.8	71.2	265.0	54.1	114.9	56.2	277.5	143.3	103.4	89.0	121.5	78.2	116.6	65.7	34.4	77.8	414.4	107.2	35.8	137.6	85.3	274.2	74.8	72.5	193.4	125.8	110.7	99.3	45.7	88.4	95.9	59.6	30.9	190.9	29.5	34.9	237.6	53.4	55.6	45.5	36.8	194.7	54.9	48.8	33.7	77.4	38.9	217.0	178.8	58.3	91.4	16.2	15.0	13.8	18.2	15.1	17.0	16.2	17.2	18.4	15.1	17.2	17.2	46.7	28.9	54.9	3.6	57.0	70.1	134.0	183.0	30.7	11.4	61.6	45.5	25.3	42.9	206.3	22.0	18.8	86.7	50.2	234.3	70.5	49.4	42.8	63.4	37.9	63.4	64.9	18.7	6.7	100.7	159.2	50.6	99.4	55.8	43.8	29.5	34.2	33.6	160.0	10.1	7.2	362.7	95.6	67.7	107.6	71.5	32.3	89.8	129.9	6.5	53.1	14.1	14.4	2.0	3.1	70.9	181.0	26.4	141.1	213.6	66.5	68.3	204.5	8.0	13.1	32.9	91.3	10.5	21.9	42.0	61.7	150.8	50.6	44.6	260.1	223.3
NARS2	"DFNB94, FLJ23441, SLM5"	ENSG00000137513	"Asparaginyl-tRNA synthetase 2, mitochondrial"	Q96I59	11	78435968-78574874	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026793	Supported		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA026793: AB_1848833"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.79e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.62e-3)"	"prognostic favorable (1.39e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.22e-6)"	"unprognostic (8.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.60e-1)"	7.3	11.9	10.7	6.8	12.3	6.2	11.1	12.4	13.3	9.6	19.8	11.3	10.3	9.1	11.2	8.1	9.9	7.0	11.7	10.4	11.7	19.0	23.5	7.6	9.6	11.7	13.9	11.4	10.6	11.4	7.6	8.0	13.1	10.8	10.9	13.4	10.7	7.3	23.5	7.2	9.7	7.4	11.3	7.4	9.9	7.5	11.4	11.7	11.5	19.6	9.7	8.7	8.1	12.3	16.7	22.8	23.5	15.4	16.1	13.5	19.5	13.5	13.1	20.6	16.9	39.4	17.4	40.9	34.1	8.7	19.8	21.5	39.9	26.3	28.3	27.0	21.3	28.9	17.3	33.7	13.3	31.3	10.1	9.4	16.8	18.1	32.0	18.3	17.9	33.7	44.5	11.0	23.1	19.4	32.7	50.3	25.6	67.3	27.3	33.6	38.2	55.5	27.2	23.0	27.8	17.5	20.1	25.4	35.5	25.1	24.1	12.3	10.9	27.7	32.8	32.0	23.1	18.1	33.1	91.1	5.4	27.7	19.2	9.5	9.3	4.4	11.1	10.4	13.8	17.6	12.8	12.5	16.6	15.0	18.5	16.7	2.0	20.3	12.8	12.7	10.5	10.3	10.7	12.3	12.4	13.3	10.4	11.7	11.7	13.9	13.1	11.3	11.4	12.3	5.8	19.2	26.4	27.7	14.5	13.5	14.2	12.0	12.5	5.2	9.4	6.5	8.8	5.7	10.3	5.5	2.1	20.0	4.4	4.0	29.4	9.5	13.1	10.1	7.4	6.6	12.0	9.2	34.7	7.3	23.6	9.0	10.2	9.0	8.2	14.0	2.5	19.8	12.4	0.0	45.1	8.3	22.4	6.3	11.6	5.4	7.8	6.3	17.8	45.0	2.9	6.3	4.1	42.7	47.7	7.5	9.9	4.9	14.6	17.5	7.0	28.9	10.2	9.0	6.6	7.5	8.8	8.6	19.5	12.0	13.8	15.3	7.8	9.0	14.6	10.7
NAT8L	"FLJ37478, Hcml3, Shati"	ENSG00000185818	"N-acetyltransferase 8 like"	Q8N9F0	4	2059327-2069089	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adipose tissue: 43.5;brain: 99.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 126.7;Excitatory neurons: 46.0;Horizontal cells: 80.8;Inhibitory neurons: 37.6;Muller glia cells: 25.0"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 20.8;SCLC-21H: 25.8;SK-MEL-30: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040677			Approved	Mitochondria		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria		"HPA040677: AB_2732486"	"unprognostic (1.32e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.63e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.78e-3)"	"unprognostic (7.24e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.35e-2)"	43.5	0.7	56.1	0.1	46.4	0.0	1.6	42.9	99.0	0.0	0.6	0.2	0.1	0.3	1.3	0.1	0.9	0.1	0.8	45.8	29.0	5.3	0.0	0.0	0.2	52.3	46.4	0.2	2.3	0.9	1.8	0.1	57.5	1.0	0.1	3.7	2.3	1.6	5.7	1.0	0.2	0.2	33.0	0.3	0.4	9.0	88.8	0.2	0.3	2.5	0.0	0.0	0.0	38.9	0.1	9.2	4.9	10.0	0.9	0.0	5.7	0.2	0.0	0.2	0.0	4.1	0.3	0.0	1.9	0.0	1.5	0.1	11.1	0.0	0.1	0.0	13.2	0.1	2.1	6.6	1.5	14.5	6.9	0.0	0.2	0.0	0.0	1.8	0.0	3.4	11.5	0.0	0.4	6.2	0.2	20.8	14.1	0.0	4.1	0.7	2.3	0.4	0.2	0.5	25.8	8.6	6.6	0.0	21.4	0.8	0.7	8.3	0.0	0.0	3.3	0.1	5.6	0.0	0.0	0.2	0.0	6.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	56.1	46.4	42.9	99.0	45.8	29.0	52.3	46.4	57.5	33.0	88.8	38.9	0.5	0.0	0.0	126.7	0.0	0.3	0.0	0.0	0.0	14.5	1.4	2.2	2.6	0.0	0.0	1.8	6.2	0.0	5.4	0.0	0.0	4.6	1.1	1.7	0.1	0.4	1.8	0.0	46.0	0.6	0.1	0.2	0.0	1.0	0.0	21.9	0.0	0.0	0.8	80.8	37.6	0.0	0.0	0.0	0.3	3.8	0.0	0.7	10.6	17.8	0.0	25.0	0.0	23.1	15.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.8	0.5	1.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1
NAXD	"CARKD, FLJ10769, LP3298"	ENSG00000213995	"NAD(P)HX dehydratase"	Q8IW45	13	110615545-110639996	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 34.8;Distal tubular cells: 39.2;Extravillous trophoblasts: 26.7;Granulosa cells: 27.6;Syncytiotrophoblasts: 30.9;Theca cells: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010551	Approved					NA	NA		390000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"			"HPA010551: AB_1848669"	"unprognostic (1.24e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.79e-2)"	"prognostic favorable (3.15e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.36e-3)"	"prognostic favorable (4.63e-5)"	"unprognostic (2.19e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.62e-2)"	17.3	37.1	44.0	16.0	43.7	8.2	19.4	43.6	46.3	16.7	40.8	23.1	22.9	18.7	26.6	23.4	22.6	21.3	26.4	45.7	42.8	24.9	65.4	18.8	20.8	45.9	45.0	39.0	36.2	28.4	22.4	23.3	44.5	25.8	19.7	14.3	22.8	28.9	31.9	30.5	23.0	21.7	43.9	21.8	30.3	24.2	46.2	18.3	25.4	33.6	17.1	17.3	15.0	45.2	36.0	15.7	28.1	24.3	29.8	23.6	35.4	27.9	22.7	24.6	26.2	43.9	35.1	7.3	28.4	21.7	25.3	28.1	16.3	24.4	16.0	31.6	27.4	22.5	47.9	23.5	34.2	29.3	20.2	29.1	42.4	19.8	17.7	32.5	21.9	31.8	19.6	0.2	22.3	30.0	23.1	48.4	21.2	64.4	17.2	8.2	14.4	5.9	30.3	30.1	42.5	28.6	16.8	75.4	21.6	18.5	39.7	54.4	25.3	17.1	14.3	0.1	22.4	25.6	18.7	0.3	27.7	8.7	28.9	0.0	8.3	0.8	9.6	9.0	6.3	8.4	9.6	8.9	10.4	8.2	9.9	9.1	1.0	9.2	6.5	10.1	10.5	8.3	44.0	43.7	43.6	46.3	45.7	42.8	45.9	45.0	44.5	43.9	46.2	45.2	9.3	19.2	12.7	0.0	2.5	0.0	0.0	0.0	0.0	0.0	14.2	11.3	0.0	0.0	9.9	22.0	0.0	34.8	5.4	0.0	39.2	15.0	0.0	7.3	10.5	4.0	0.0	0.0	0.0	11.8	26.7	6.2	0.0	8.8	1.3	27.6	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	10.3	0.0	0.0	0.0	0.0	11.6	0.0	0.0	2.1	0.0	0.0	22.4	8.7	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	30.9	2.1	24.4	0.0	0.0
NAXE	"AIBP, APOA1BP, MGC119143, MGC119144, MGC119145, YJEFN1"	ENSG00000163382	"NAD(P)HX epimerase"	Q8NCW5	1	156591756-156609507	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins"	"Lipid transport, Transport"	Isomerase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 136.7;Distal tubular cells: 201.5;Ductal cells: 112.8;Exocrine glandular cells: 100.1;Proximal tubular cells: 219.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043766, HPA048164"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA		3300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Vesicles, Cytosol"	"HPA043766: AB_2678660, HPA048164: AB_2680294"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (7.38e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.08e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.15e-2)"	"unprognostic (8.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-1)"	47.1	74.8	61.0	20.9	63.7	22.2	47.9	66.1	69.6	56.8	71.1	62.9	45.5	68.8	88.7	58.0	59.5	26.5	111.1	60.9	64.3	83.8	86.5	43.6	27.0	62.7	64.8	46.5	69.7	104.7	70.0	23.7	61.8	62.5	41.6	17.4	53.9	48.3	71.8	55.8	48.3	39.7	64.7	43.2	67.5	40.8	63.5	30.6	59.8	68.2	34.3	55.0	47.8	70.5	114.2	155.4	43.9	84.4	64.0	43.8	55.5	29.5	62.3	69.5	72.6	130.6	76.8	62.4	113.4	52.5	55.9	111.1	49.4	99.0	47.5	81.2	98.5	58.1	76.2	86.1	75.1	60.0	60.9	44.2	123.7	87.9	81.9	53.4	95.4	104.7	54.7	70.1	71.6	209.6	83.3	98.0	43.1	158.1	118.2	87.7	40.2	212.6	93.0	93.6	114.7	102.9	90.4	172.4	141.6	66.4	178.3	117.5	51.1	45.1	64.8	64.6	70.6	180.1	110.3	53.0	63.1	37.0	70.4	25.4	96.3	52.9	121.2	111.3	121.3	236.2	109.4	124.3	89.1	186.5	122.8	114.9	11.4	141.3	89.1	225.7	110.1	186.6	61.0	63.7	66.1	69.6	60.9	64.3	62.7	64.8	61.8	64.7	63.5	70.5	29.5	41.7	32.9	0.0	14.8	0.0	0.0	0.0	0.0	0.0	87.5	96.0	0.0	0.0	23.5	68.0	0.0	136.7	28.7	0.0	201.5	112.8	0.0	27.3	29.9	18.4	0.0	0.0	0.0	100.1	43.1	27.2	0.0	32.0	5.1	53.5	0.0	0.0	92.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	40.8	0.0	0.0	0.0	0.0	91.0	0.0	0.0	6.2	0.0	0.0	219.6	11.7	0.0	0.0	0.0	24.5	0.0	0.0	0.0	0.0	81.3	13.4	48.1	0.0	0.0
NCOA1	"bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1"	ENSG00000084676	"Nuclear receptor coactivator 1"	Q15788	2	24491914-24770702	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 467.5;Excitatory neurons: 313.0;Inhibitory neurons: 421.8;Microglial cells: 341.9;Oligodendrocyte precursor cells: 459.4;Oligodendrocytes: 305.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 81.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019402, HPA070213, HPA070520"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB019402: AB_2196189, HPA070213: AB_2686235, HPA070520: AB_2686276"	"unprognostic (2.73e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.60e-2)"	"unprognostic (2.36e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.15e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.92e-2)"	16.6	15.1	24.0	13.3	25.4	17.3	17.3	24.6	28.2	18.6	13.6	15.9	20.9	19.0	12.8	17.6	15.7	14.0	15.3	29.6	19.5	18.9	15.0	16.0	15.3	17.7	19.2	26.6	17.4	30.0	16.6	17.1	16.0	15.2	16.6	47.3	16.0	20.2	33.4	15.7	18.9	19.0	19.5	16.3	12.5	19.9	21.8	26.1	11.8	36.1	16.3	14.9	15.5	22.3	14.1	10.3	17.7	9.2	19.2	17.3	26.9	7.4	14.7	9.1	8.1	9.6	5.9	10.2	3.1	13.5	17.4	3.4	10.7	6.3	9.8	48.6	15.5	36.5	4.1	4.1	12.0	16.9	29.1	27.9	9.4	8.8	7.1	11.3	9.4	12.9	22.6	16.5	14.0	9.4	15.1	6.0	8.5	8.2	6.8	11.8	81.5	5.1	9.9	18.9	16.2	12.8	17.1	10.2	7.4	9.3	12.3	8.6	10.2	15.2	11.9	10.5	7.5	18.8	17.5	17.2	8.6	10.5	7.7	10.6	3.3	7.0	3.4	2.6	3.8	1.6	3.0	3.8	2.5	2.4	2.9	3.5	13.8	3.5	2.9	5.2	3.7	2.0	24.0	25.4	24.6	28.2	29.6	19.5	17.7	19.2	16.0	19.5	21.8	22.3	41.0	38.5	31.5	467.5	16.7	30.5	11.6	7.8	14.2	96.5	32.3	26.7	41.9	17.2	22.8	14.7	52.1	13.1	47.0	39.0	7.9	16.5	29.7	14.6	37.6	34.9	25.2	29.9	313.0	26.6	18.1	39.8	19.9	28.4	20.2	52.9	36.8	22.8	17.9	62.2	421.8	20.7	20.3	29.8	30.3	7.4	47.2	37.7	19.6	341.9	34.7	66.7	78.2	459.4	305.8	20.1	33.5	43.2	14.3	15.7	30.4	12.5	16.9	71.6	39.5	116.9	34.4	37.7	37.6	16.6	31.0	5.3	33.4	27.2	24.1	21.7
NDST1	"HSST, NST1"	ENSG00000070614	"N-deacetylase and N-sulfotransferase 1"	P52848	5	150485818-150558211	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Multifunctional enzyme, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 1.4;classical monocyte: 5.5;eosinophil: 3.6;intermediate monocyte: 1.7;myeloid DC: 4.2;neutrophil: 5.4;non-classical monocyte: 4.7"	"Group enriched"	"Detected in many"	10	"dendritic cells: 4.2;granulocytes: 5.4;monocytes: 5.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060532	Approved					NA	NA		1400000	"Cluster 14: Monocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA060532: AB_2684310"	"unprognostic (1.36e-1)"	"unprognostic (5.54e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (1.77e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (4.97e-3)"	"unprognostic (6.92e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.08e-2)"	37.2	22.7	39.4	14.0	45.1	7.6	28.6	43.8	38.9	16.0	3.9	17.6	12.5	17.3	7.9	38.8	14.7	15.2	26.8	30.8	30.7	15.4	42.6	34.3	7.3	62.6	48.8	23.0	39.7	20.5	6.7	12.2	50.3	14.5	9.5	13.9	37.4	16.8	23.6	34.2	17.4	19.2	47.8	43.4	16.0	14.5	51.5	4.2	22.9	13.0	9.9	14.1	18.7	60.0	32.4	28.3	46.1	56.4	45.3	44.9	46.3	58.1	75.9	56.8	84.8	84.1	33.3	22.0	57.6	116.8	91.0	54.4	25.1	118.0	37.6	2.6	38.9	26.0	18.5	13.2	33.5	19.5	45.5	61.6	48.1	68.7	31.0	56.9	78.3	12.9	25.3	7.8	56.3	27.5	2.3	6.2	21.6	9.1	33.0	37.6	38.4	9.8	33.4	32.5	13.8	48.3	35.2	108.5	46.3	32.7	58.3	4.8	38.8	96.4	86.2	42.3	48.3	17.1	4.7	8.1	79.2	30.1	38.0	1.4	5.5	3.6	0.1	1.7	0.0	0.4	0.0	0.4	4.2	0.1	0.0	0.2	5.4	0.0	4.7	0.3	0.0	2.8	39.4	45.1	43.8	38.9	30.8	30.7	62.6	48.8	50.3	47.8	51.5	60.0	29.8	38.5	8.7	23.8	1.9	5.7	3.5	14.4	6.2	11.6	29.9	15.4	11.5	17.2	9.6	16.5	8.4	8.6	0.5	20.9	1.9	10.4	0.7	5.5	7.7	35.5	1.2	3.2	12.0	10.5	11.3	11.0	2.0	6.8	1.3	20.4	31.8	47.5	7.7	13.5	11.7	5.3	8.2	14.4	7.6	1.9	12.5	8.7	10.6	16.9	7.4	12.1	0.0	12.1	39.7	18.8	6.6	32.0	3.7	7.9	17.8	8.8	3.8	11.3	0.0	8.7	11.5	0.7	1.6	17.4	12.4	4.5	1.2	11.8	5.8	5.3
NDUFAF7	"C2orf56, MidA, PRO1853"	ENSG00000003509	"NADH:ubiquinone oxidoreductase complex assembly factor 7"	Q7L592	2	37231631-37253403	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.8"	"Group enriched"	"Detected in all"	4	"Early spermatids: 196.6;Late spermatids: 109.6;Spermatocytes: 118.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045217	Uncertain					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 43: Testis - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA045217: AB_10960395"	"unprognostic (6.38e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.48e-4)"	"prognostic favorable (3.08e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.88e-2)"	"unprognostic (8.12e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.73e-2)"	"unprognostic (8.67e-3)"	6.2	12.7	6.7	5.4	7.1	6.0	6.0	7.7	7.8	8.0	6.2	12.1	4.6	7.8	8.0	5.6	6.0	5.9	15.5	7.3	6.6	9.3	10.6	5.5	6.9	6.5	6.5	7.0	5.7	8.2	6.8	5.9	6.8	6.6	5.9	10.0	5.7	5.4	20.4	4.9	5.7	7.3	5.8	6.6	6.2	38.8	6.2	8.2	5.1	24.4	5.9	6.7	6.1	7.1	20.2	10.6	13.2	11.6	8.3	17.6	7.3	6.6	10.5	11.1	14.1	22.9	8.5	17.1	8.1	6.0	18.9	14.8	16.2	8.3	13.1	11.9	12.1	12.6	13.1	21.1	10.2	12.6	6.1	13.8	13.6	9.1	5.6	11.8	17.4	6.4	15.5	11.1	6.7	7.4	12.6	13.5	17.3	15.9	9.5	11.3	10.2	14.4	15.4	7.4	13.7	11.0	8.2	13.9	14.3	18.6	8.4	4.9	3.4	9.2	12.3	11.6	12.1	9.7	6.0	19.8	13.4	16.9	7.9	3.0	4.3	2.6	4.1	3.7	1.8	4.7	3.6	3.5	5.3	4.1	3.5	3.1	2.7	4.1	2.7	4.2	4.6	2.0	6.7	7.1	7.7	7.8	7.3	6.6	6.5	6.5	6.8	5.8	6.2	7.1	10.9	9.6	10.0	12.7	15.5	4.8	9.5	12.3	11.4	18.1	6.4	5.6	13.4	2.8	8.4	11.0	22.9	15.0	16.1	3.7	17.6	10.5	196.6	6.6	12.1	9.4	2.4	6.5	30.5	6.3	10.8	9.7	8.6	7.2	7.6	11.9	7.5	5.6	9.4	11.8	26.9	5.5	12.2	7.3	7.8	109.6	13.4	9.4	3.6	15.0	10.5	7.6	10.3	13.6	15.4	8.8	2.0	16.6	9.3	5.9	7.7	14.8	11.3	21.8	6.6	10.1	18.0	118.4	14.4	7.4	4.0	11.5	13.6	16.1	6.2	6.3
NDUFS1	CI-75k	ENSG00000023228	"NADH:ubiquinone oxidoreductase core subunit S1"	P28331	2	206114817-206159509	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 181.7;skeletal muscle: 221.6;tongue: 225.2"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 582.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064605, CAB070844"	Enhanced		Supported	Mitochondria		NA	NA		48000	"Cluster 14: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB070844: , HPA064605: AB_2685297"	"prognostic unfavorable (3.85e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.22e-3)"	"unprognostic (5.01e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.75e-1)"	"unprognostic (3.72e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.47e-12)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.73e-2)"	27.1	61.6	8.3	13.3	10.8	13.2	23.8	14.9	16.1	19.5	39.7	35.3	29.9	19.3	10.8	36.2	16.3	10.5	181.7	10.7	13.7	48.0	51.8	18.3	12.6	10.1	10.1	14.6	19.2	47.2	20.2	14.4	11.7	15.8	30.0	24.4	27.7	15.6	221.6	26.6	26.1	16.4	9.2	16.8	37.1	20.8	14.2	15.6	17.9	225.2	16.9	22.4	22.4	12.5	28.3	27.6	39.2	28.6	35.8	28.9	45.4	40.4	43.4	66.0	47.6	72.0	32.1	31.7	34.8	50.8	65.5	38.5	52.9	39.2	58.2	14.6	24.9	63.5	65.1	64.9	37.0	46.2	27.5	35.3	22.5	51.9	40.4	29.6	52.3	39.3	69.8	31.1	43.6	35.2	38.5	30.7	36.5	47.2	48.6	38.3	54.7	55.1	54.7	50.7	38.1	29.8	46.7	45.1	67.1	53.3	39.8	44.2	40.1	36.2	32.0	35.8	39.1	29.8	38.4	46.9	36.3	37.5	37.8	14.1	12.9	15.7	12.4	15.2	9.6	9.6	10.8	11.8	14.7	9.0	9.6	11.1	9.2	12.5	22.5	7.8	15.9	9.5	8.3	10.8	14.9	16.1	10.7	13.7	10.1	10.1	11.7	9.2	14.2	12.5	32.4	60.9	33.0	45.1	23.8	16.2	21.7	40.8	30.1	97.1	19.3	14.0	582.5	48.6	42.8	38.6	120.9	48.4	18.8	74.5	93.9	44.2	14.5	49.8	49.8	36.6	51.0	42.0	67.8	28.2	33.7	42.3	48.4	54.5	37.3	42.3	29.3	94.5	34.0	117.8	72.8	47.9	54.9	31.2	10.7	7.0	33.5	27.7	30.2	28.1	37.2	62.7	27.8	45.2	41.6	32.1	46.4	44.8	31.0	19.9	77.8	102.3	53.5	81.5	32.9	55.2	60.8	58.2	49.5	40.8	16.6	52.5	23.7	71.5	69.9	26.6
NDUFS2	CI-49	ENSG00000158864	"NADH:ubiquinone oxidoreductase core subunit S2"	O75306	1	161197104-161214723	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 464.8;tongue: 633.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055140, HPA061953"	Enhanced		Supported	Mitochondria		NA	NA		25000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA055140: AB_2682713, HPA061953: AB_2684646"	"unprognostic (2.13e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.47e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.32e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-1)"	60.2	98.2	38.7	37.4	41.6	39.5	49.6	46.4	48.8	40.2	76.6	96.5	102.4	41.4	33.4	62.0	52.5	36.8	273.7	40.5	47.5	137.0	177.4	48.5	42.4	49.5	40.7	51.6	47.7	156.5	35.8	41.6	53.1	45.7	101.8	36.2	53.5	49.0	464.8	51.4	81.5	58.6	41.6	43.6	73.3	29.5	47.9	48.3	45.0	633.7	60.1	57.5	40.0	49.2	101.8	129.4	95.2	104.0	115.1	102.8	77.0	85.7	105.8	139.6	107.5	143.9	98.5	108.4	168.1	113.0	81.3	135.9	129.1	131.8	122.1	84.2	108.0	105.9	109.5	136.5	117.7	116.0	105.3	147.2	112.3	121.1	137.2	96.8	160.5	115.4	139.9	72.7	132.5	93.5	81.7	58.4	175.3	288.5	116.5	72.0	83.3	172.0	157.8	109.4	97.2	152.0	93.0	237.0	151.5	116.4	221.7	342.2	108.6	84.5	66.3	65.5	123.7	125.2	172.0	95.1	123.6	109.3	105.4	150.0	159.3	85.7	82.0	193.2	82.6	81.4	86.6	86.3	217.8	68.4	86.6	88.1	86.7	93.5	190.7	128.7	130.8	167.5	38.7	41.6	46.4	48.8	40.5	47.5	49.5	40.7	53.1	41.6	47.9	49.2	70.5	35.3	45.7	30.7	47.1	38.9	52.4	277.8	52.9	74.6	58.9	50.7	232.6	74.4	148.4	77.3	31.3	146.8	47.6	187.5	332.6	184.3	11.3	43.5	57.0	67.5	72.0	78.9	28.0	143.2	111.3	69.7	80.5	41.3	69.7	99.7	65.7	206.5	150.5	92.5	30.1	122.6	242.1	87.8	42.0	7.8	43.5	66.5	83.6	14.0	97.9	57.0	35.0	18.1	48.3	147.7	105.1	33.4	49.5	25.6	221.9	345.5	103.0	57.3	46.0	41.9	176.6	42.0	27.5	68.8	43.3	158.4	50.0	192.0	172.5	57.5
NDUFS3	CI-30	ENSG00000213619	"NADH:ubiquinone oxidoreductase core subunit S3"	O75489	11	47565336-47584562	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 292.3"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 405.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004484, CAB034894"	Enhanced		Supported	"Nuclear bodies,Mitochondria"		NA	NA		14000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nuclear bodies"	"CAB034894: AB_2151118, HPA004484: AB_1079464"	"unprognostic (2.18e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.01e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.13e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.75e-3)"	"unprognostic (7.73e-2)"	"prognostic favorable (2.61e-6)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.17e-3)"	52.4	91.3	47.4	16.5	52.6	44.1	50.7	55.6	50.2	43.5	59.4	97.5	53.8	49.7	26.2	78.7	42.6	18.1	210.3	49.3	51.9	94.2	96.2	40.5	25.5	48.8	49.3	37.3	56.7	53.6	67.5	17.6	49.4	44.0	52.7	23.5	60.9	27.5	292.3	66.2	69.4	26.6	50.3	55.5	81.4	48.2	54.7	33.8	49.7	194.2	33.3	51.4	52.0	47.7	37.7	68.7	59.8	62.9	48.8	52.3	48.2	35.0	60.3	84.6	80.4	103.6	65.1	81.8	34.8	49.7	63.0	64.9	81.7	61.8	69.4	44.2	137.2	49.5	90.6	106.5	49.7	121.5	62.1	50.1	46.6	32.0	52.2	37.5	55.3	69.2	73.7	57.1	57.7	118.6	87.0	164.9	83.6	109.6	97.7	100.7	81.8	68.7	76.4	60.2	63.9	47.1	43.4	76.9	83.5	35.2	84.4	118.2	37.0	49.3	56.4	57.0	80.4	61.2	93.5	91.8	50.1	94.9	51.3	38.3	69.3	48.9	43.2	79.8	46.4	60.6	45.2	47.5	83.3	59.2	42.4	46.0	18.4	45.6	66.7	89.3	61.3	90.3	47.4	52.6	55.6	50.2	49.3	51.9	48.8	49.3	49.4	50.3	54.7	47.7	54.7	54.5	42.6	23.5	54.6	65.6	67.4	217.5	62.6	45.6	60.2	72.5	176.9	81.5	108.5	69.9	41.7	122.0	70.8	183.1	405.0	113.0	132.3	56.8	58.6	60.0	84.7	73.8	12.7	111.3	116.5	60.8	81.1	40.5	57.7	67.1	58.5	126.3	195.9	60.6	14.5	162.8	173.0	66.9	59.3	63.2	67.4	62.8	119.2	7.5	83.9	117.9	58.7	12.5	13.1	91.7	109.3	69.2	69.8	53.0	257.8	297.0	109.7	59.5	105.2	55.5	154.8	85.5	74.7	115.3	75.9	89.1	55.5	128.3	210.7	85.3
NDUFS7	"CI-20, FLJ45860, FLJ46880, PSST"	ENSG00000115286	"NADH:ubiquinone oxidoreductase core subunit S7"	O75251	19	1383527-1395589	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 665.9"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 812.0;Proximal tubular cells: 774.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"				"unprognostic (7.36e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (5.30e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.99e-3)"	"unprognostic (8.12e-2)"	"prognostic favorable (4.90e-7)"	"unprognostic (2.95e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.34e-2)"	52.9	51.3	78.2	31.2	96.8	33.8	33.8	116.0	120.6	32.1	86.6	50.0	104.2	31.2	5.2	62.2	28.8	17.6	170.7	72.6	92.3	67.9	68.2	30.2	36.7	103.6	85.5	31.7	89.6	43.9	50.2	19.9	108.2	34.1	9.8	5.7	75.6	26.3	665.9	37.9	73.8	10.5	95.6	41.8	53.0	58.9	88.5	19.3	32.1	159.4	11.4	36.7	37.7	120.2	127.0	109.3	17.5	77.6	16.0	20.3	68.8	52.0	19.3	39.4	39.0	155.3	52.8	146.2	71.4	13.0	9.7	85.4	17.3	44.1	1.0	157.6	143.2	47.0	113.1	125.7	53.4	76.5	90.1	27.2	47.4	17.7	0.0	13.2	40.2	110.5	103.1	196.6	13.6	130.0	138.6	77.0	67.5	40.8	141.0	144.6	36.3	254.9	23.6	86.9	105.7	89.5	48.5	117.8	158.6	2.1	84.0	118.1	72.3	67.3	49.5	85.5	100.0	326.9	218.4	121.5	110.9	159.0	70.4	176.5	299.0	143.8	166.6	342.4	147.5	249.4	161.6	159.7	354.9	235.6	151.8	146.9	75.6	160.6	308.0	276.8	241.8	193.2	78.2	96.8	116.0	120.6	72.6	92.3	103.6	85.5	108.2	95.6	88.5	120.2	98.5	80.1	92.5	14.0	117.7	89.9	98.4	275.0	100.2	74.3	116.7	146.0	77.1	158.7	167.0	145.3	50.1	225.2	75.0	482.1	812.0	161.8	443.2	69.2	74.2	88.4	175.4	94.9	13.8	163.3	197.1	92.2	162.1	66.2	111.7	99.4	72.5	243.9	333.4	52.2	15.1	332.9	248.2	188.4	129.7	414.5	83.9	154.6	261.5	7.5	182.1	111.2	111.2	14.6	57.0	121.1	346.7	74.1	155.2	81.0	616.5	774.9	122.4	81.9	72.3	105.0	120.2	268.8	134.9	266.2	106.0	186.8	100.9	128.8	410.8	138.7
NDUFS8	"CI-23k, TYKY"	ENSG00000110717	"NADH:ubiquinone oxidoreductase core subunit S8"	O00217	11	68030617-68036644	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 833.5;Late spermatids: 797.2;Proximal tubular cells: 927.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018524, HPA067429"	Enhanced		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA018524: AB_1854355, HPA067429: "	"unprognostic (2.90e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.81e-1)"	"prognostic favorable (3.27e-8)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (9.45e-2)"	99.2	308.4	141.2	38.8	153.2	56.2	87.7	157.2	180.4	73.2	172.3	142.0	81.4	89.2	27.2	115.3	81.3	29.1	468.2	144.2	152.0	188.6	152.0	73.1	42.2	149.6	144.9	68.2	97.7	74.6	130.6	33.6	145.8	118.2	36.7	49.5	96.2	66.7	406.4	93.0	84.4	39.0	142.2	76.9	137.8	104.7	154.0	40.3	101.8	275.5	30.1	94.4	76.0	150.2	152.9	366.4	94.6	137.0	70.9	63.5	132.4	102.3	88.5	155.6	118.9	338.4	159.6	118.4	186.8	85.9	134.6	181.2	108.8	128.4	53.1	139.4	264.9	107.2	217.1	186.3	171.8	99.1	112.1	80.5	126.5	111.1	124.8	82.0	106.2	159.9	110.3	121.1	99.2	358.6	219.2	216.9	125.2	377.7	308.0	154.4	95.9	384.9	192.8	123.3	125.5	102.2	75.7	171.7	392.3	66.5	245.6	105.9	84.1	155.6	133.9	224.8	148.8	165.2	188.5	99.7	252.3	121.8	111.2	84.7	220.1	124.0	182.4	232.0	170.1	183.3	154.6	165.5	309.4	156.3	146.2	164.2	20.7	309.6	131.7	324.3	202.2	232.4	141.2	153.2	157.2	180.4	144.2	152.0	149.6	144.9	145.8	142.2	154.0	150.2	88.7	89.8	90.1	18.6	92.3	85.4	95.5	284.3	104.7	83.4	147.2	156.7	301.9	143.0	164.9	213.3	54.2	279.6	97.8	301.0	833.5	200.8	225.7	101.1	74.8	85.3	205.0	149.8	13.6	199.3	165.9	109.6	147.3	79.7	95.8	156.5	73.5	231.7	276.6	50.5	19.3	277.2	240.1	124.1	108.0	797.2	100.6	128.7	163.7	13.1	187.4	143.6	128.8	12.1	15.4	173.7	194.9	108.0	157.8	118.6	337.1	927.8	120.8	118.7	59.2	81.2	208.6	105.9	72.7	209.7	116.2	172.4	102.7	278.7	318.2	139.1
NDUFV1	CI-51K	ENSG00000167792	"NADH:ubiquinone oxidoreductase core subunit V1"	P49821	11	67605653-67612554	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 526.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 482.4;Proximal tubular cells: 499.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045211, HPA075051"	Enhanced		Supported	Mitochondria,Cytosol		No	No		37000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA045211: AB_10962830, HPA075051: AB_2686732"	"unprognostic (4.57e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.84e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.03e-2)"	"prognostic favorable (7.49e-10)"	"unprognostic (1.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	95.0	126.5	87.6	52.5	93.7	72.5	90.9	105.6	107.1	93.9	104.8	142.3	124.5	85.2	33.8	114.0	84.6	47.1	400.2	91.6	97.0	188.4	187.0	77.1	66.7	103.3	91.5	101.9	117.2	169.8	84.5	46.7	110.4	77.4	73.7	81.6	90.2	73.2	526.2	117.7	96.6	51.1	86.9	98.8	132.0	76.0	104.9	51.6	107.6	440.5	62.8	88.1	88.6	99.9	132.9	133.6	68.8	141.3	85.6	83.4	130.6	84.1	76.4	122.2	82.6	256.8	155.3	241.9	167.3	69.2	99.7	176.8	146.1	126.4	38.4	125.2	114.9	100.0	189.1	127.9	119.0	136.9	106.9	126.7	119.0	100.4	88.0	76.9	109.3	173.9	180.9	192.6	75.8	190.2	163.1	268.0	68.5	295.3	168.8	184.5	135.8	399.1	99.3	95.3	109.9	104.6	104.3	347.4	275.3	46.0	177.4	138.0	90.7	118.9	88.8	172.3	87.5	187.7	116.8	122.6	138.0	144.6	117.7	39.0	72.8	38.1	65.1	83.4	71.6	59.8	55.0	63.2	110.7	60.1	50.2	63.7	13.1	104.0	51.2	73.0	78.1	77.0	87.6	93.7	105.6	107.1	91.6	97.0	103.3	91.5	110.4	86.9	104.9	99.9	54.6	60.9	75.0	33.3	76.2	80.3	95.9	187.6	77.4	68.7	82.1	94.4	482.4	61.5	120.7	86.5	50.1	203.5	72.8	235.7	397.2	114.9	74.0	43.1	47.5	56.7	98.5	85.0	32.9	112.1	158.8	82.4	137.1	55.2	61.4	99.6	56.4	136.2	136.5	63.9	36.5	155.9	152.5	68.8	81.4	222.7	65.6	68.4	113.8	13.1	81.0	89.3	60.8	19.1	34.6	70.1	122.8	59.0	146.6	55.0	199.4	499.2	80.3	78.5	46.0	90.8	136.9	100.7	83.3	127.0	80.6	189.1	79.3	145.9	274.8	111.7
NDUFV2	CI-24k	ENSG00000178127	"NADH:ubiquinone oxidoreductase core subunit V2"	P19404	18	9102630-9134345	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 606.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003404, HPA077896"	Supported		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No		7600	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA003404: AB_1079466, HPA077896: AB_2686866"	"unprognostic (1.18e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.95e-3)"	97.4	171.6	94.3	69.2	97.4	149.8	101.7	106.8	139.7	63.9	106.0	124.2	102.3	69.7	91.1	142.6	64.0	68.7	419.3	96.7	106.0	180.7	404.2	88.6	105.0	105.9	104.4	52.4	111.6	136.7	72.1	73.7	105.9	88.5	119.8	129.9	97.4	72.4	606.9	94.7	100.5	80.6	103.7	86.4	133.8	79.6	102.7	90.2	72.7	538.3	105.1	122.1	76.5	104.6	136.5	139.8	159.1	148.4	116.6	164.0	133.4	165.4	266.5	217.7	205.5	265.1	109.4	209.4	149.5	158.6	200.3	66.9	157.5	175.5	208.8	104.6	136.6	133.0	135.3	364.8	133.6	373.8	159.2	139.2	144.3	134.9	146.2	156.8	239.3	184.3	216.5	644.0	204.6	171.6	263.5	328.9	131.4	750.5	172.3	124.5	118.2	794.2	354.3	218.7	167.0	122.3	164.6	188.0	220.3	113.6	174.2	282.8	145.8	273.4	194.3	198.8	223.0	180.4	292.3	237.1	195.4	166.0	181.0	250.8	161.8	194.2	118.1	196.1	148.3	237.6	176.9	140.5	237.9	201.1	153.5	142.7	76.0	124.2	187.9	315.1	231.9	231.8	94.3	97.4	106.8	139.7	96.7	106.0	105.9	104.4	105.9	103.7	102.7	104.6	107.3	80.1	145.8	17.6	143.1	148.0	319.0	629.4	159.4	101.2	165.0	167.3	69.9	178.7	339.5	150.8	87.6	344.1	146.6	211.0	876.5	415.2	271.5	160.3	108.2	117.3	106.5	165.4	32.9	531.4	323.3	122.0	144.3	183.9	120.3	109.7	96.4	351.5	313.5	94.2	37.3	201.7	480.1	115.7	267.1	186.2	122.1	170.2	231.3	17.8	293.2	167.1	96.8	32.2	46.5	530.3	201.2	102.0	244.9	554.3	349.9	810.6	293.4	184.2	105.2	124.0	196.3	217.4	175.0	226.5	147.6	289.4	165.7	266.7	227.3	469.0
NEDD4L	"KIAA0439, NEDD4-2, RSP5"	ENSG00000049759	"NEDD4 like E3 ubiquitin protein ligase"	Q96PU5	18	58044226-58401540	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 253.2;Excitatory neurons: 280.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 29.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"T-reg: 5.1"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.1"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 146.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024618	Approved				"Intracellular and membrane"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA024618: AB_1854362"	"unprognostic (2.56e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.26e-2)"	"unprognostic (9.24e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.55e-15)"	"unprognostic (2.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.49e-3)"	"unprognostic (4.75e-2)"	11.2	16.8	20.9	6.7	34.4	27.0	25.8	25.1	31.3	7.6	0.7	38.8	18.7	5.3	10.0	12.0	9.1	9.5	26.9	32.3	16.2	53.4	36.5	47.9	4.1	10.9	18.4	6.4	60.5	13.6	28.4	12.0	10.4	64.2	42.8	20.5	27.5	20.4	34.0	11.2	33.8	6.2	8.6	7.9	51.5	7.8	16.7	4.5	17.4	13.1	7.9	19.4	5.9	16.3	70.7	24.5	14.6	20.9	5.1	2.1	49.8	19.2	88.2	48.6	74.6	28.6	37.1	15.1	57.7	7.4	51.3	50.3	19.5	86.1	100.8	34.9	15.5	10.6	14.3	111.3	2.4	0.5	6.0	13.0	54.6	66.4	78.8	39.1	4.0	13.2	18.7	6.3	20.0	16.2	1.0	1.0	12.2	26.7	33.3	14.3	20.1	17.6	47.0	88.7	17.5	5.0	16.1	5.1	146.1	28.3	29.4	5.6	28.8	131.5	38.5	7.5	83.4	8.3	15.3	9.5	27.6	10.8	10.8	0.7	0.3	1.2	0.2	0.3	0.5	0.8	0.6	0.1	0.1	0.3	0.3	0.2	0.2	0.3	0.1	0.1	5.1	0.3	20.9	34.4	25.1	31.3	32.3	16.2	10.9	18.4	10.4	8.6	16.7	16.3	6.0	253.2	144.8	110.4	5.1	112.8	161.2	34.0	86.6	18.1	99.5	65.9	47.8	64.3	112.8	62.5	173.0	13.0	3.6	144.5	49.0	35.7	22.6	64.0	7.3	14.7	45.2	57.9	280.9	49.2	4.7	9.5	114.7	75.0	3.8	4.7	17.5	41.3	7.3	62.2	173.3	201.5	101.7	8.4	8.2	6.6	3.4	13.3	14.2	88.1	7.3	45.2	2.1	11.1	105.0	49.9	145.3	17.7	12.7	126.9	127.3	91.6	72.7	10.0	0.0	34.3	6.0	1.1	12.5	62.3	53.0	80.0	6.6	8.2	72.9	155.5
NEK1	"KIAA1901, NY-REN-55"	ENSG00000137601	"NIMA related kinase 1"	Q96PY6	4	169392809-169612627	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Ciliopathy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 162.6;Excitatory neurons: 126.3;Inhibitory neurons: 170.5;Oligodendrocytes: 196.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020873, HPA040413"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Centriolar satellite"	"HPA020873: AB_10671583, HPA040413: AB_10671169"	"unprognostic (4.10e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.42e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.46e-1)"	6.0	6.1	5.1	4.9	6.8	4.2	5.2	7.1	5.3	7.6	2.7	4.0	3.2	7.3	2.8	4.6	9.3	6.1	6.9	3.5	8.8	5.9	4.2	4.6	5.3	7.5	7.7	9.4	4.0	6.5	2.9	4.3	7.6	6.7	4.4	8.7	4.2	6.0	3.3	2.3	3.5	6.6	7.6	5.1	4.9	11.8	5.3	6.8	7.9	4.6	4.6	5.6	2.8	7.7	5.8	2.5	10.0	11.0	15.5	17.1	3.3	11.9	10.6	9.3	8.8	3.3	6.7	15.4	2.2	10.4	9.0	1.9	9.7	10.1	10.5	16.9	6.5	10.3	10.4	3.9	9.0	10.6	7.9	13.7	5.9	9.5	16.7	19.1	9.3	14.5	18.6	28.2	12.1	3.7	13.6	4.6	3.3	3.6	6.0	8.4	6.5	4.9	9.7	6.8	11.0	12.5	8.6	4.2	8.1	7.7	5.3	4.6	11.2	6.0	5.4	6.2	8.1	11.3	18.6	11.6	9.7	5.1	10.7	5.1	0.9	0.9	1.9	1.5	2.2	2.0	1.5	1.2	0.7	2.0	2.2	2.3	0.6	1.1	0.7	1.6	1.6	0.7	5.1	6.8	7.1	5.3	3.5	8.8	7.5	7.7	7.6	7.6	5.3	7.7	12.2	12.8	16.4	162.6	34.2	9.6	15.8	12.1	21.1	21.8	11.3	12.7	37.2	4.3	17.8	18.4	29.2	20.8	17.0	6.4	17.6	10.4	109.7	67.2	21.6	13.2	7.2	26.7	126.3	6.2	8.6	25.0	17.3	23.7	18.3	20.1	9.7	7.8	10.7	18.5	170.5	5.6	20.3	7.0	7.4	48.2	23.6	14.5	5.4	53.4	6.6	26.1	15.5	115.1	196.1	8.9	4.0	31.6	23.2	6.9	5.3	9.6	68.4	24.9	13.1	32.8	25.5	67.9	37.3	21.3	6.3	29.6	22.0	26.0	6.3	9.2
NEK10	FLJ32685	ENSG00000163491	"NIMA related kinase 10"	Q6ZWH5	3	27110085-27369460	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 36.6;tongue: 20.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 87.6;Early spermatids: 123.5;Endometrial ciliated cells: 59.3;Excitatory neurons: 131.4;Inhibitory neurons: 130.2;Late spermatids: 61.7;Respiratory ciliated cells: 104.2"	"Cancer enriched"	"Detected in single"	5	"breast cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 6.0;LHCN-M2: 8.2;U-2 OS: 6.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038941	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles	Nucleoplasm	"HPA038941: AB_10673600"	"prognostic favorable (4.20e-4)"	"unprognostic (2.17e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.14e-1)"	0.2	0.3	3.0	0.3	5.3	0.3	14.0	0.0	9.4	1.4	3.3	2.0	2.5	0.8	8.3	1.8	11.0	1.4	3.3	9.6	5.0	1.7	2.5	2.4	0.5	3.3	5.7	0.7	0.7	0.4	3.4	0.1	2.7	1.7	0.5	6.2	0.3	1.2	12.4	0.3	0.8	0.3	2.3	0.4	1.0	36.6	6.1	0.5	0.7	20.0	0.6	1.2	0.2	0.9	0.8	1.6	0.8	0.9	0.6	1.5	0.3	6.0	0.9	1.6	1.4	0.0	0.4	0.5	1.4	2.5	1.1	0.1	0.4	0.4	1.7	1.1	0.6	0.1	3.4	2.9	0.1	0.3	0.8	1.8	0.4	2.5	0.1	2.0	1.1	3.4	0.1	0.6	8.2	0.1	0.6	0.4	0.5	0.2	0.2	0.8	0.3	0.2	3.0	0.5	0.1	0.2	0.9	0.3	0.4	0.5	4.8	0.3	0.7	4.3	6.8	0.2	0.6	0.2	0.2	0.4	3.6	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.0	5.3	0.0	9.4	9.6	5.0	3.3	5.7	2.7	2.3	6.1	0.9	1.5	6.4	0.0	11.4	0.3	0.3	0.3	3.2	0.0	14.5	25.8	7.4	12.9	4.3	9.3	1.8	87.6	0.0	0.8	0.2	0.0	0.4	123.5	59.3	1.3	2.4	0.0	0.0	131.4	0.0	0.3	3.1	0.0	7.7	0.0	1.1	0.7	1.3	0.2	0.0	130.2	0.4	12.2	1.0	0.8	61.7	1.8	1.1	0.0	32.8	0.1	1.0	1.0	20.6	12.9	0.2	2.7	1.2	0.1	1.9	2.1	0.3	104.2	19.1	0.0	14.9	2.4	32.2	2.2	0.1	0.4	0.0	1.1	3.7	0.6	0.4
NEK2	"NEK2A, NLK1, PPP1R111, RP67"	ENSG00000117650	"NIMA related kinase 2"	P51955	1	211658657-211675630	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 17.9;lymphoid tissue: 19.2;testis: 67.1"	"Group enriched"	"Detected in many"	4	"Early spermatids: 76.1;Spermatocytes: 244.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.7"	"Low region specificity"	"Detected in all"			"CAB017530, HPA064967"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"		"CAB017530: AB_1126558, HPA064967: AB_2685393"	"unprognostic (1.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (9.47e-6)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.49e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.21e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.71e-1)"	0.7	0.4	0.5	5.3	0.4	17.9	1.5	0.9	0.6	1.1	0.6	5.9	7.4	1.3	0.5	4.4	2.2	0.8	0.4	0.5	0.3	0.3	0.7	0.7	9.0	0.4	0.2	0.4	0.1	0.1	0.0	3.2	0.3	2.5	7.6	1.5	0.8	0.2	0.4	4.3	6.9	2.0	0.2	1.7	2.7	67.1	0.6	19.2	0.4	0.2	10.6	1.3	1.6	0.9	86.0	60.5	45.3	32.6	2.6	4.5	49.7	32.4	30.1	55.4	47.5	32.3	81.7	45.1	15.2	25.2	35.1	44.5	39.9	24.2	69.6	69.5	33.2	21.6	51.4	44.2	0.4	43.2	28.3	1.4	2.9	42.9	45.9	13.4	36.3	45.2	59.9	76.9	56.0	23.6	47.3	28.8	43.0	55.0	30.5	46.2	69.2	68.7	19.7	24.2	41.0	45.0	46.6	51.5	39.3	38.4	79.4	25.1	19.0	27.6	54.1	54.8	88.3	31.6	62.6	59.6	24.1	32.6	46.8	1.2	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.0	0.4	0.3	0.2	0.7	1.5	0.1	0.2	1.6	0.3	0.5	0.4	0.9	0.6	0.5	0.3	0.4	0.2	0.3	0.2	0.6	0.9	0.1	0.0	0.5	0.3	1.7	2.9	0.7	3.8	0.6	11.3	1.9	2.2	0.5	0.0	2.9	0.0	0.0	9.4	0.8	1.9	0.0	0.2	76.1	15.2	0.7	0.8	0.0	39.6	0.8	0.2	14.1	1.4	5.6	1.5	0.0	3.6	3.6	0.7	5.8	3.3	0.0	3.2	10.2	2.5	1.1	39.0	2.5	2.1	0.0	0.0	0.0	1.6	2.1	0.0	0.1	0.0	2.5	0.7	5.4	0.7	2.1	0.1	5.2	1.8	6.6	0.0	1.5	244.2	26.1	8.6	1.7	1.4	2.0	0.9	9.5	1.4
NEK8	NPHP9	ENSG00000160602	"NIMA related kinase 8"	Q86SG6	17	28725897-28743455	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Ciliopathy, Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 14.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040661, HPA040679"	Approved		Approved	"Nuclear speckles,Microtubules,Mitotic spindle"		Yes	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Microtubules	"Nuclear speckles, Mitotic spindle"	"HPA040661: AB_10794065, HPA040679: AB_10796226"	"unprognostic (2.63e-1)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (6.25e-2)"	"unprognostic (2.23e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"prognostic favorable (4.52e-4)"	"unprognostic (7.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.87e-3)"	"unprognostic (4.61e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.67e-3)"	1.5	3.1	1.7	3.3	1.9	1.7	2.4	1.4	1.9	2.5	3.8	2.4	3.0	1.5	3.2	2.5	3.9	2.0	1.0	1.4	1.6	9.1	5.2	3.3	5.8	2.0	1.7	1.9	4.5	2.9	4.4	2.6	1.7	4.0	2.2	0.6	3.7	2.6	0.5	3.1	4.2	1.2	1.6	5.8	3.4	3.8	1.9	2.7	7.2	0.4	5.0	2.6	2.2	2.3	2.1	3.4	3.5	2.8	1.9	2.1	10.9	0.9	2.1	1.3	1.7	5.4	5.0	13.1	3.5	2.8	2.5	3.8	5.2	4.8	1.3	3.5	6.4	2.9	5.8	10.1	3.3	1.8	3.7	4.8	1.8	2.5	5.8	1.8	0.9	1.9	4.3	1.3	1.5	4.7	1.9	3.4	3.3	3.7	1.0	4.9	2.3	5.9	7.0	5.7	6.4	1.5	3.0	6.3	1.6	4.7	9.3	2.4	0.8	1.3	2.2	1.6	1.0	1.5	1.8	8.9	2.0	1.6	3.1	3.3	0.9	1.2	0.7	0.5	0.8	2.8	0.6	0.7	0.1	4.2	0.7	1.0	0.4	1.3	1.1	14.8	0.5	0.8	1.7	1.9	1.4	1.9	1.4	1.6	2.0	1.7	1.7	1.6	1.9	2.3	2.7	9.6	19.3	3.9	22.9	2.8	9.2	8.3	7.4	2.8	10.1	14.1	1.7	12.8	11.6	25.8	8.4	17.6	19.1	14.9	7.9	5.8	9.5	12.8	6.0	2.9	10.3	7.0	0.7	6.0	9.2	3.9	6.1	15.2	26.6	3.2	3.3	9.4	3.9	1.7	0.5	14.4	10.2	5.0	2.7	2.0	3.4	4.4	3.6	2.8	4.0	2.6	3.1	1.5	1.6	3.9	17.2	2.6	7.2	8.6	13.4	4.3	14.3	1.8	0.0	11.7	3.0	19.9	11.4	8.8	1.6	11.1	4.9	7.8	15.9	4.2
NEK9	"DKFZp434D0935, MGC16714, Nek8, NERCC, NERCC1"	ENSG00000119638	"NIMA related kinase 9"	Q8TD19	14	75079353-75127344	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001405	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"			"HPA001405: AB_1079467"	"unprognostic (1.00e-1)"	"unprognostic (5.37e-2)"	"unprognostic (9.97e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.60e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.57e-2)"	24.2	18.5	6.7	18.6	8.4	11.8	17.3	7.5	7.9	24.3	9.0	14.3	15.5	26.0	10.5	17.8	25.2	17.9	37.2	6.1	7.8	18.4	21.0	18.8	21.0	8.2	7.7	35.8	16.0	34.2	3.1	21.2	7.9	23.5	16.3	16.5	12.4	28.1	43.6	8.1	16.9	32.2	7.5	19.7	13.1	20.4	7.7	28.3	19.7	36.9	23.5	16.3	2.9	9.1	21.3	30.8	44.8	45.4	86.3	88.8	37.9	32.4	54.6	29.7	29.4	25.5	24.7	52.7	0.1	54.2	23.1	31.8	45.0	27.0	38.5	38.2	16.8	23.0	27.3	17.3	48.6	10.8	26.8	76.6	32.8	31.8	26.7	71.6	46.1	36.2	23.8	31.4	40.2	4.8	35.5	11.5	21.9	43.3	18.8	53.5	49.4	23.9	21.3	28.2	19.5	41.3	39.5	19.3	30.0	50.4	41.7	37.6	46.3	30.2	12.7	31.5	15.8	34.3	36.5	49.6	24.9	24.8	26.4	3.4	3.5	3.1	2.5	3.4	4.0	1.3	2.4	2.3	5.0	1.9	3.1	2.8	1.2	3.3	2.5	1.1	1.5	2.9	6.7	8.4	7.5	7.9	6.1	7.8	8.2	7.7	7.9	7.5	7.7	9.1	15.3	12.8	30.2	49.3	21.2	8.8	7.7	6.6	21.1	16.8	14.5	12.4	55.7	12.8	14.8	11.0	35.5	17.4	11.1	10.2	7.9	6.9	11.9	13.3	23.1	17.6	5.4	16.2	31.3	4.9	16.2	18.1	10.7	10.4	16.4	36.8	17.9	30.3	13.9	13.5	35.9	10.7	6.1	18.6	11.8	8.3	24.8	17.0	3.6	30.9	16.0	12.0	15.5	41.2	59.5	5.3	11.7	26.4	14.7	7.4	13.1	8.4	17.4	23.1	0.0	18.9	16.7	28.8	13.9	17.4	10.2	14.0	16.5	20.8	10.5	5.6
NEU1	NEU	ENSG00000204386	"Neuraminidase 1"	Q99519	6	31857659-31862905	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 197.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"GAMG: 5.4;U-266/84: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015634, HPA021506"	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA		180000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Cell Junctions"	"HPA015634: AB_1854386, HPA021506: AB_1854385"	"unprognostic (3.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-3)"	"unprognostic (8.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.13e-3)"	23.9	57.2	0.7	0.4	0.8	0.0	22.4	2.5	1.2	21.2	1.2	25.1	0.7	19.5	0.0	14.9	16.8	1.0	22.5	0.7	0.6	43.7	29.9	28.9	0.3	0.8	0.5	20.3	35.9	0.3	33.0	0.2	0.8	26.5	0.0	1.6	38.6	0.0	21.3	20.1	24.3	0.1	0.3	25.3	29.8	8.2	1.0	0.0	31.8	0.0	0.0	23.2	16.2	1.7	0.3	0.2	0.8	1.4	1.8	0.4	0.7	0.2	0.2	0.3	0.3	1.5	0.6	0.7	0.4	0.1	5.4	0.3	2.2	0.0	0.4	2.5	0.3	0.6	0.9	1.2	1.4	0.9	1.8	1.0	0.2	1.4	0.7	0.2	0.6	0.9	1.1	1.2	0.5	0.3	0.6	0.0	0.6	0.5	0.4	0.9	0.4	0.9	1.0	0.4	0.7	0.4	0.2	0.3	0.7	0.9	0.9	0.5	0.7	1.1	0.8	0.7	0.6	3.7	9.6	0.9	1.7	0.4	0.4	1.3	0.3	0.4	0.2	0.3	0.1	0.2	0.2	0.1	0.2	0.6	0.2	0.3	3.0	0.3	0.2	0.3	0.2	0.1	0.7	0.8	2.5	1.2	0.7	0.6	0.8	0.5	0.8	0.3	1.0	1.7	65.7	25.6	46.3	5.2	57.0	34.3	48.5	45.0	39.9	26.4	87.7	55.8	29.0	51.5	54.8	47.8	25.0	62.8	100.5	83.7	9.8	114.2	0.8	29.3	53.5	42.8	113.5	4.6	6.3	59.6	57.8	73.8	32.6	60.8	67.9	17.4	30.7	34.5	170.9	10.1	7.6	39.9	79.3	63.0	65.9	1.4	27.7	93.0	71.2	9.4	25.8	48.8	9.2	5.0	4.0	34.4	88.1	23.3	81.7	89.0	115.0	59.9	29.2	32.7	26.3	60.8	43.7	5.4	10.0	29.3	41.6	197.0	81.7	40.3	41.1	34.6
NGLY1	"FLJ11005, PNG-1, PNG1"	ENSG00000151092	"N-glycanase 1"	Q96IV0	3	25718944-25790039	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 594.1;Late spermatids: 963.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036825	Approved				"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA036825: AB_10672231"	"unprognostic (3.65e-2)"	"unprognostic (8.65e-2)"	"prognostic favorable (1.17e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (1.96e-6)"	"unprognostic (2.20e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.73e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.23e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.07e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.89e-2)"	10.8	13.7	6.9	15.1	7.1	25.6	15.6	10.0	9.2	12.3	10.5	17.9	14.6	9.7	16.2	12.3	11.5	9.8	16.1	7.5	8.0	17.8	22.4	11.4	25.9	8.1	9.2	11.8	15.9	11.6	5.9	11.9	8.2	14.2	20.6	13.5	14.9	9.9	49.5	9.8	15.4	12.1	6.7	15.5	15.3	55.8	9.1	27.4	13.6	38.1	25.3	16.1	9.9	8.6	27.6	24.2	12.8	27.4	23.5	22.7	15.0	21.6	20.4	29.7	25.5	14.8	20.9	64.3	24.5	19.9	28.3	12.1	45.5	14.0	39.2	27.8	18.5	49.9	15.1	24.8	29.0	48.3	25.7	20.3	17.5	33.6	31.5	32.2	31.3	32.8	47.9	49.1	30.3	11.7	60.7	26.8	17.4	33.2	43.5	54.2	16.5	54.6	27.1	31.1	8.3	9.5	35.1	33.3	23.3	24.0	31.1	40.6	15.7	15.5	20.1	27.5	29.9	60.4	60.7	48.8	25.1	52.8	18.1	48.8	19.7	27.8	22.9	19.4	26.0	42.2	23.2	23.5	31.6	33.4	21.8	23.6	18.3	45.0	16.0	65.1	19.0	20.7	6.9	7.1	10.0	9.2	7.5	8.0	8.1	9.2	8.2	6.7	9.1	8.6	24.3	19.2	17.3	34.0	84.1	12.6	23.7	25.0	16.5	22.3	19.8	16.8	30.3	27.1	21.4	5.5	12.5	40.5	74.7	25.0	35.2	30.6	594.1	20.0	19.4	20.9	7.2	26.9	51.7	44.2	31.7	19.2	17.3	19.2	20.8	77.7	17.5	25.1	23.4	11.8	64.2	29.3	14.2	22.2	63.6	963.6	14.9	33.6	24.9	31.9	30.0	20.7	45.3	54.3	59.4	27.2	27.3	15.8	87.1	27.8	26.0	38.2	25.2	22.7	0.0	26.0	17.9	105.7	52.7	18.8	13.8	56.6	41.1	26.3	30.3	20.6
NHLRC1	"bA204B7.2, EPM2B"	ENSG00000187566	"NHL repeat containing E3 ubiquitin protein ligase 1"	Q6VVB1	6	18120440-18122677	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	Transferase	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 5.0;Exocrine glandular cells: 3.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 6.8;K-562: 6.1;SCLC-21H: 6.1"	"Low region specificity"	"Detected in all"							HPA066030			Uncertain	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 15: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA066030: "	"unprognostic (1.61e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.95e-2)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (6.95e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.39e-1)"	"unprognostic (7.17e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.77e-2)"	"prognostic favorable (5.30e-4)"	1.2	1.4	2.0	0.8	2.3	1.1	2.0	1.5	2.6	0.8	0.8	1.5	1.4	0.8	2.6	1.1	1.4	0.6	1.8	2.4	1.9	0.8	4.1	1.2	0.6	2.5	1.8	1.4	1.8	1.2	1.2	0.5	2.7	1.2	1.3	2.0	2.3	1.0	2.6	3.8	1.9	0.8	1.6	1.1	1.3	0.7	2.0	1.0	1.6	1.5	0.8	0.9	0.8	3.6	2.6	1.5	0.6	0.0	1.3	1.2	0.0	2.6	0.8	0.9	0.5	0.1	2.1	0.0	6.8	1.9	0.2	3.0	0.0	1.7	0.7	0.1	0.9	0.4	1.0	0.1	2.0	0.0	1.7	2.1	2.5	1.0	0.9	0.6	2.1	0.0	6.1	0.1	2.1	2.8	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.1	1.4	2.8	6.1	0.1	5.3	4.3	1.6	0.6	3.1	1.7	0.4	0.2	1.3	1.8	0.1	0.1	0.0	0.1	0.1	0.0	2.6	0.5	4.4	0.4	0.6	4.9	0.8	2.3	1.1	0.5	4.7	1.3	1.5	1.0	0.3	1.6	2.3	0.6	1.3	1.8	2.0	2.3	1.5	2.6	2.4	1.9	2.5	1.8	2.7	1.6	2.0	3.6	0.8	0.0	2.2	0.3	0.2	1.9	1.4	1.4	1.8	0.4	1.5	2.0	0.9	1.5	2.3	0.0	0.0	0.4	0.0	0.2	0.0	2.9	0.0	0.6	1.3	0.3	3.5	5.0	1.0	3.7	0.0	0.8	1.5	0.5	1.3	0.8	0.4	1.1	1.2	0.0	0.7	0.3	0.0	0.8	0.6	0.0	0.6	1.5	1.8	1.0	0.5	1.1	0.0	1.5	1.2	2.0	0.3	0.0	0.0	0.2	0.6	1.2	0.8	1.0	0.0	0.3	0.8	0.2	0.2	1.3	1.8	0.4	0.1	1.1	0.5	0.5
NIPA1	"MGC35570, SLC57A1, SPG6"	ENSG00000170113	"NIPA magnesium transporter 1"	Q7RTP0	15	22773063-22829789	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 36.2;Inhibitory neurons: 33.8;Oligodendrocytes: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023269	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA023269: AB_1854485"	"unprognostic (1.64e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.42e-2)"	"unprognostic (6.25e-2)"	"unprognostic (6.32e-2)"	"unprognostic (6.95e-2)"	"unprognostic (8.80e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.66e-2)"	3.1	4.2	27.7	3.7	36.9	1.2	2.8	36.8	38.1	3.7	17.9	4.6	6.5	2.2	2.1	4.3	2.5	4.8	3.5	22.8	28.7	6.2	5.7	4.7	5.3	35.4	36.9	1.5	5.7	8.7	3.6	3.5	33.8	6.7	4.3	6.2	3.6	3.4	2.5	4.9	6.6	2.6	36.1	4.2	6.4	4.3	36.0	8.2	7.3	3.5	5.5	3.2	3.5	40.2	14.9	17.4	5.4	12.4	6.9	5.6	3.8	17.6	12.7	8.5	7.1	13.3	7.4	6.9	13.5	7.3	17.4	9.7	16.0	4.6	10.1	40.2	9.8	10.8	10.8	11.4	8.3	0.1	20.8	1.7	15.2	5.5	9.2	13.6	8.2	15.2	8.4	11.3	4.8	5.6	5.9	9.7	5.9	15.9	18.2	12.1	7.7	5.4	13.0	14.9	15.2	15.4	13.2	1.6	16.7	7.0	10.3	13.8	15.4	23.9	12.2	10.1	27.2	12.7	13.6	12.4	12.3	0.0	15.6	0.4	0.1	0.2	0.6	0.0	0.6	0.9	0.7	0.6	0.5	1.1	0.4	0.3	0.3	0.3	0.0	3.9	0.8	0.3	27.7	36.9	36.8	38.1	22.8	28.7	35.4	36.9	33.8	36.1	36.0	40.2	5.9	12.8	5.9	14.4	7.4	8.8	4.0	5.9	2.2	4.1	4.4	3.0	4.3	15.7	5.2	5.5	6.2	2.6	10.5	9.9	3.9	5.7	3.3	3.6	2.4	5.9	3.0	4.0	36.2	11.6	2.1	4.5	10.2	5.7	0.0	4.1	4.6	6.0	4.1	5.0	33.8	7.1	2.0	4.4	6.9	4.2	2.1	2.9	5.4	4.7	3.8	4.7	4.1	15.6	65.2	17.7	6.8	3.0	7.2	8.6	11.8	5.8	6.2	6.6	19.7	3.0	3.6	3.4	8.5	4.2	14.9	1.5	7.1	1.6	7.5	7.3
NIPAL4	ICHYN	ENSG00000172548	"NIPA like domain containing 4"	Q0D2K0	5	157460213-157474722	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	Receptor	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.7;skin 1: 61.2"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 29.7;Basal prostatic cells: 9.8;Oligodendrocytes: 21.0;Squamous epithelial cells: 9.8;Suprabasal keratinocytes: 42.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.0;urothelial cancer: 11.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"memory B-cell: 1.6;naive B-cell: 4.8"	"Lineage enriched"	"Detected in single"	37	"B-cells: 4.8"	"Group enriched"	"Detected in some"	8	"hTCEpi: 31.7;RT4: 108.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038259	Approved					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 28: Keratinocytes - Keratinization"			"HPA038259: AB_10672510"	"unprognostic (6.74e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.55e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.28e-9)"	"unprognostic (3.12e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.18e-2)"	"prognostic favorable (6.82e-4)"	0.4	0.0	3.5	2.0	9.7	3.4	2.2	8.5	7.1	5.9	1.1	3.7	0.3	1.2	0.1	15.1	0.1	0.5	1.5	3.9	6.2	0.0	0.0	0.7	0.4	12.4	8.7	0.0	0.0	0.0	0.5	0.6	10.5	1.5	0.6	0.1	1.9	1.4	0.2	61.2	0.9	1.1	7.6	0.2	2.5	0.1	8.0	0.4	0.3	0.0	5.8	11.5	15.1	18.7	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.4	0.1	1.1	0.0	0.0	0.7	0.4	0.0	6.3	0.3	2.7	0.6	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.3	31.7	0.0	1.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	108.1	0.0	0.4	0.0	0.0	0.0	8.5	1.6	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.5	9.7	8.5	7.1	3.9	6.2	12.4	8.7	10.5	7.6	8.0	18.7	0.0	0.0	0.5	0.0	2.4	29.7	9.8	0.6	2.2	0.6	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.7	0.3	0.0	1.1	1.8	0.0	0.0	0.0	0.0	0.0	21.0	0.1	0.0	0.0	0.3	3.8	0.0	0.0	0.1	1.1	0.0	5.2	0.3	0.0	0.1	9.8	42.1	0.0	0.2	0.0	0.0	4.4
NKAIN2	"FAM77B, TCBA1"	ENSG00000188580	"Sodium/potassium transporting ATPase interacting 2"	Q5VXU1	6	123803865-124825640	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	6	"brain: 56.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1721.6;Inhibitory neurons: 636.4;Oligodendrocytes: 2869.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	19	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;Daudi: 3.0;HEL: 6.4;Karpas-707: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045860			Approved	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA045860: AB_10983192"	"unprognostic (3.09e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.67e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.63e-1)"	0.9	0.4	24.2	0.1	33.6	0.7	0.3	30.1	39.3	0.3	9.8	1.0	0.0	0.1	0.3	0.2	0.3	0.2	1.1	29.2	25.3	0.1	0.2	0.2	0.2	40.7	28.0	0.1	0.1	0.0	1.8	0.1	37.4	0.2	0.1	6.6	0.3	0.2	2.9	0.1	0.3	0.3	34.8	0.1	0.2	0.4	28.8	0.5	0.1	3.4	0.2	0.5	0.3	56.8	0.0	0.0	1.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	6.4	0.0	0.0	0.4	0.0	0.0	1.2	0.1	0.0	0.3	0.1	0.0	0.0	0.0	10.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	33.6	30.1	39.3	29.2	25.3	40.7	28.0	37.4	34.8	28.8	56.8	0.5	0.0	0.0	97.3	0.0	0.1	0.0	0.2	0.0	3.0	0.0	0.1	1.3	0.0	0.1	0.0	2.1	0.2	0.0	0.0	0.0	0.1	1.7	0.2	0.1	0.3	1.8	2.1	1721.6	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.1	47.1	636.4	0.1	0.0	0.0	0.0	0.0	0.3	1.0	0.0	47.8	0.0	15.8	0.0	19.1	2869.5	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.2	1.1	0.0	0.8	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1
NLGN1	KIAA1070	ENSG00000169760	"Neuroligin 1"	Q8N2Q7	3	173396284-174286644	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Biological rhythms, Cell adhesion"		"Autism, Autism spectrum disorder, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.0;retina: 13.8"	"Group enriched"	"Detected in many"	31	"Excitatory neurons: 1484.7;Inhibitory neurons: 1700.0;Oligodendrocyte precursor cells: 4004.1;Oligodendrocytes: 1261.9"	"Group enriched"	"Detected in some"	9	"glioma: 3.8;melanoma: 2.2;renal cancer: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 25.9;HUVEC TERT2: 24.9;RH-30: 26.2;WM-115: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006572, HPA006680, CAB033261"	Enhanced		Uncertain	"Nuclear bodies,Plasma membrane"	"Intracellular and membrane"	NA	NA		82000		"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nuclear bodies"	"CAB033261: AB_2151659, HPA006572: , HPA006680: AB_1854400"	"unprognostic (2.81e-1)"	"unprognostic (9.86e-2)"	"unprognostic (3.08e-5)"	"unprognostic (7.52e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.67e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.07e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.81e-2)"	"unprognostic (2.41e-3)"	"unprognostic (5.37e-2)"	2.0	1.0	12.6	0.5	10.8	0.0	0.7	31.0	12.1	3.1	0.0	2.0	0.2	2.1	2.5	2.5	3.0	1.6	3.2	12.5	15.2	2.9	0.0	0.4	0.2	5.3	5.4	1.3	0.8	0.7	1.8	0.5	4.0	2.2	0.9	13.8	0.3	3.0	0.2	0.3	0.6	2.7	4.4	0.0	0.8	7.0	20.5	0.2	0.9	1.0	0.1	2.9	1.3	7.2	0.1	0.0	6.1	0.0	11.8	12.4	0.0	5.2	12.8	0.6	0.8	0.0	0.5	0.0	0.2	25.9	4.7	0.0	3.7	0.0	1.3	0.0	6.0	1.7	0.1	0.0	0.0	0.0	0.0	9.7	0.1	0.0	0.0	10.0	24.9	0.0	0.0	1.7	0.1	0.0	0.0	0.0	7.2	0.0	1.7	0.0	26.2	6.4	4.7	0.1	2.5	1.7	0.0	0.0	12.3	1.1	0.6	0.0	3.1	13.5	1.3	9.9	11.6	11.7	0.0	0.0	4.6	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	10.8	31.0	12.1	12.5	15.2	5.3	5.4	4.0	4.4	20.5	7.2	0.3	0.0	0.5	66.6	0.0	0.8	0.4	0.0	0.6	14.3	0.1	0.0	4.4	0.0	0.0	3.7	4.2	0.3	0.0	0.0	0.0	0.3	55.9	0.6	12.4	0.8	0.0	0.0	1484.7	0.0	0.2	8.2	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	1700.0	0.0	0.0	0.0	0.3	12.5	25.7	0.4	14.2	60.9	0.0	24.9	0.0	4004.1	1261.9	0.1	0.0	14.3	0.0	2.6	0.0	8.5	0.0	10.3	6.6	2.9	2.1	0.4	1.6	0.1	0.9	0.1	0.1	1.6	0.0	0.3
NLGN4X	"HLNX, KIAA1260, NLGN, NLGN4"	ENSG00000146938	"Neuroligin 4 X-linked"	Q8N0W4	X	5840637-6228867	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"		"Asperger syndrome, Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5;lymphoid tissue: 14.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 113.9;Excitatory neurons: 162.2;Inhibitory neurons: 236.8;Oligodendrocyte precursor cells: 702.7"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 2.7;glioma: 8.5;testis cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 55.6;NTERA-2: 44.1;SuSa: 42.7"									HPA001651	Approved					NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA001651: AB_1079470"	"unprognostic (2.21e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.10e-3)"	"unprognostic (7.16e-4)"	"unprognostic (6.70e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	3.4	1.3	8.8	1.8	10.1	0.0	2.2	9.8	12.7	5.1	0.0	3.4	1.3	2.3	0.4	0.7	2.0	2.5	4.5	14.8	28.5	0.3	1.3	1.1	0.8	6.5	5.6	11.6	0.4	5.2	1.7	3.6	4.4	1.1	1.9	9.2	0.8	1.9	0.3	0.6	2.6	3.7	1.6	2.2	1.1	2.6	8.9	14.3	0.7	0.2	0.5	2.1	1.4	4.2	0.0	0.0	55.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	7.4	0.0	44.1	0.0	0.1	0.0	0.0	0.1	4.1	11.5	2.7	3.5	0.0	0.1	0.0	42.7	5.7	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	10.1	9.8	12.7	14.8	28.5	6.5	5.6	4.4	1.6	8.9	4.2	12.1	0.0	0.5	113.9	0.3	0.3	0.1	0.2	0.0	15.0	5.2	3.4	2.8	0.0	0.1	0.0	25.0	3.7	0.1	0.0	0.0	0.0	0.1	19.7	69.5	2.5	0.0	0.0	162.2	0.0	2.4	9.6	0.0	33.2	0.0	2.2	1.8	0.0	0.6	0.0	236.8	0.0	0.0	0.3	0.5	0.7	18.0	0.3	14.2	4.7	0.0	12.5	0.0	702.7	68.3	0.0	0.0	29.7	0.1	0.0	0.0	0.1	0.7	3.3	13.1	18.4	5.0	2.0	5.5	0.2	0.6	3.6	0.5	8.8	0.0	0.3
NMNAT1	"LCA9, NMNAT, PNAT1"	ENSG00000173614	"Nicotinamide nucleotide adenylyltransferase 1"	Q9HAN9	1	9943428-9985501	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"	"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059447	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nuclear bodies"		"HPA059447: AB_2684022"	"unprognostic (1.94e-1)"	"unprognostic (3.81e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.45e-3)"	"unprognostic (4.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.57e-1)"	"prognostic favorable (3.85e-14)"	"unprognostic (3.11e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.47e-3)"	"unprognostic (5.16e-2)"	5.2	7.4	5.4	4.4	6.0	2.5	5.7	4.8	7.7	5.4	9.2	9.0	6.0	3.8	5.8	5.2	4.8	3.4	10.7	5.1	5.2	8.2	7.8	3.2	4.3	5.6	5.4	2.9	4.9	8.2	3.8	3.7	5.5	4.5	9.0	5.3	5.2	5.4	23.3	5.7	6.1	5.0	4.7	5.0	4.4	4.3	5.9	4.2	7.3	16.9	4.6	4.0	3.6	7.2	4.6	5.4	7.5	7.1	13.4	12.2	1.8	9.1	7.2	10.3	6.7	2.4	7.7	4.8	5.7	12.9	4.5	4.6	9.4	12.4	11.0	10.4	4.8	7.6	3.0	7.6	11.4	6.7	7.7	13.3	14.2	12.1	17.4	9.5	10.2	10.4	9.7	3.1	10.9	8.0	3.8	4.4	0.9	10.2	10.2	4.2	4.7	2.7	11.9	2.5	5.4	2.8	11.8	9.7	10.4	3.8	3.5	7.2	10.2	4.1	3.3	8.7	4.2	4.5	4.3	4.5	7.1	13.8	8.6	7.5	3.7	3.2	1.6	2.6	0.8	4.9	1.6	1.9	3.3	2.3	1.4	1.8	9.1	2.5	3.9	3.2	1.5	1.8	5.4	6.0	4.8	7.7	5.1	5.2	5.6	5.4	5.5	4.7	5.9	7.2	5.6	3.2	4.4	10.1	3.7	2.3	5.6	14.3	2.2	7.7	6.1	5.1	14.4	4.3	7.3	7.3	6.2	10.1	3.7	18.8	23.5	9.1	7.8	5.5	8.1	7.9	3.0	2.1	13.0	6.9	4.7	5.7	4.1	6.1	4.5	9.2	7.5	9.0	12.9	10.1	14.3	7.6	12.2	10.3	2.7	3.7	6.5	7.2	5.4	4.7	13.5	9.6	12.3	6.0	13.2	6.0	6.2	6.4	0.9	5.9	19.0	14.3	8.6	7.1	6.6	5.9	5.1	17.3	8.3	3.6	1.8	9.0	3.6	13.1	14.5	4.8
NOTCH1	TAN1	ENSG00000148400	"Notch receptor 1"	P46531	9	136494433-136546048	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Angiogenesis, Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 56.2;Astrocytes: 67.3;Hepatic stellate cells: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 47.0;HDLM-2: 32.3;HMC-1: 39.7;MOLT-4: 72.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008112, CAB022466, HPA067168"	Supported		Approved	Nucleoplasm		NA	NA		29000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB008112: AB_2153490, CAB022466: , HPA067168: AB_2685795"	"unprognostic (1.77e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.50e-3)"	"unprognostic (8.78e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.84e-2)"	18.2	4.2	10.4	4.9	16.1	4.3	15.0	12.1	9.3	14.3	0.0	19.8	4.3	12.7	0.2	16.3	11.9	0.9	14.9	8.6	5.5	11.8	9.2	22.2	3.0	13.5	12.3	5.1	14.0	0.7	6.3	2.6	9.8	15.4	0.6	0.6	10.7	3.1	5.0	24.2	14.2	1.3	9.7	24.8	10.0	2.5	13.9	4.0	11.2	1.2	0.9	14.2	16.5	14.0	8.8	10.6	4.0	2.6	0.0	0.4	17.7	3.3	0.4	1.4	0.4	1.8	0.9	13.3	10.3	1.3	1.6	47.0	1.0	8.6	0.1	32.3	2.0	5.5	6.1	0.6	2.1	6.9	39.7	0.3	16.7	1.4	1.9	0.7	9.0	3.7	3.6	1.1	0.0	9.0	72.3	13.1	8.4	2.9	7.7	15.7	9.2	19.3	0.6	4.2	0.0	0.7	6.1	4.3	3.4	1.0	3.2	10.4	22.7	5.0	9.3	5.9	4.3	2.4	2.6	4.1	3.7	5.0	26.1	0.2	0.4	0.6	0.3	0.1	0.1	0.1	0.1	0.5	0.3	0.0	0.1	0.3	2.3	0.7	0.1	0.1	0.1	0.5	10.4	16.1	12.1	9.3	8.6	5.5	13.5	12.3	9.8	9.7	13.9	14.0	56.2	9.6	21.9	67.3	8.4	24.9	12.3	35.1	23.9	0.8	10.7	12.4	11.0	5.7	16.3	1.8	2.1	1.1	14.2	11.8	0.0	5.1	0.3	12.3	9.9	53.2	2.4	5.2	0.3	4.0	2.2	6.4	1.1	17.3	34.9	1.0	68.2	7.7	9.3	1.7	0.4	14.8	18.3	10.1	17.5	0.3	1.2	15.2	7.2	18.7	14.3	46.6	24.7	33.7	19.6	2.1	11.5	0.7	5.7	8.4	4.1	3.4	3.8	2.0	6.6	14.7	18.4	0.2	3.3	20.6	29.8	1.1	15.0	1.4	28.8	15.6
NOX1	"GP91-2, MOX1, NOH-1, NOH1"	ENSG00000007952	"NADPH oxidase 1"	Q9Y5S8	X	100843324-100874359	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"intestine: 71.7"	"Group enriched"	"Detected in some"	8	"Distal enterocytes: 45.8;Intestinal goblet cells: 21.4;Paneth cells: 29.1;Undifferentiated cells: 64.8"	"Cancer enriched"	"Detected in many"	18	"colorectal cancer: 82.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"CACO-2: 30.9;OE19: 11.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (8.31e-2)"	"unprognostic (2.07e-3)"	"prognostic favorable (9.71e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.55e-3)"	"unprognostic (5.48e-3)"	"unprognostic (8.68e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-3)"	0.3	0.5	0.0	2.9	0.0	0.0	0.1	0.1	0.1	0.1	0.0	58.9	0.5	0.3	0.0	0.5	0.2	0.7	0.1	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.3	71.7	0.3	0.2	2.4	0.1	0.7	1.6	1.6	0.0	0.1	0.1	0.2	0.1	0.3	0.4	0.0	0.0	1.3	0.0	0.0	0.4	1.1	0.4	0.4	0.2	0.0	0.3	0.3	0.0	0.0	0.0	30.9	0.4	0.4	0.7	0.0	0.2	0.7	0.0	0.0	0.0	0.4	1.4	0.5	0.6	0.9	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.4	0.3	0.0	0.3	1.3	1.2	0.8	11.6	1.1	0.7	0.7	0.5	0.0	1.1	0.5	0.6	0.7	0.3	0.7	0.3	0.2	1.0	0.3	0.4	0.3	0.5	0.8	0.3	0.7	0.3	0.8	1.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	45.8	0.0	0.0	0.0	0.0	0.0	0.3	4.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	29.1	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	64.8	0.6
NPC1	SLC65A1	ENSG00000141458	"NPC intracellular cholesterol transporter 1"	O15118	18	23506184-23586506	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease variant, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 110.6"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 182.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 70.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 273.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026618, CAB070132, HPA077445"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Vesicles"		"CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: "	"unprognostic (1.74e-1)"	"unprognostic (1.53e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.26e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.08e-3)"	17.5	76.7	35.1	16.9	69.6	42.6	20.0	55.3	47.8	16.7	28.6	13.7	14.5	16.7	15.0	20.5	13.4	15.3	11.5	41.1	44.3	16.8	15.2	29.0	20.4	73.3	55.8	16.0	11.9	72.6	15.0	27.8	66.6	13.1	12.0	28.0	36.8	13.2	22.9	24.3	17.8	15.1	49.8	17.1	20.4	13.7	55.8	12.2	11.8	14.1	15.6	15.8	18.0	110.6	21.5	41.4	17.8	29.3	55.8	44.6	40.7	37.3	81.1	38.8	84.3	28.1	30.7	18.4	28.0	55.0	132.8	59.3	22.6	63.2	35.2	15.0	17.9	6.8	35.7	63.2	79.2	25.0	28.5	42.2	61.3	81.7	273.2	76.8	40.3	20.7	20.1	47.5	44.2	32.4	10.6	14.9	12.5	24.4	37.3	15.3	28.1	45.0	88.8	51.9	7.5	14.5	44.6	62.0	54.3	27.7	15.9	19.5	50.0	81.1	15.3	32.4	32.3	29.7	97.1	12.2	177.7	21.8	37.1	4.4	9.0	8.8	29.7	8.7	20.5	5.0	12.4	20.7	4.0	6.7	5.5	15.0	7.9	10.5	13.8	70.9	17.4	10.6	35.1	69.6	55.3	47.8	41.1	44.3	73.3	55.8	66.6	49.8	55.8	110.6	18.4	25.6	56.1	32.7	9.6	9.3	34.1	16.5	8.0	6.7	10.5	9.4	4.4	11.5	21.8	9.2	18.8	15.1	61.0	24.8	0.0	11.2	1.2	23.3	12.2	16.4	3.6	2.5	23.8	15.1	7.8	13.0	15.3	53.9	10.8	31.6	6.8	9.8	28.9	3.3	20.2	7.3	2.0	11.9	6.5	1.5	9.0	21.0	12.4	59.0	7.2	15.1	25.7	39.2	182.0	34.4	22.6	10.5	15.6	41.5	8.3	5.4	10.0	12.7	0.0	10.3	14.4	13.9	25.1	17.6	14.5	23.8	19.1	52.4	7.6	64.0
NPC2	"EDDM1, HE1, NP-C2"	ENSG00000119655	"NPC intracellular cholesterol transporter 2"	P61916	14	74476192-74494177	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease variant, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	21	"epididymis: 16783.1"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 2034.2;Hofbauer cells: 2898.5;Kupffer cells: 2035.4"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 769.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 668.7;classical monocyte: 1300.7;intermediate monocyte: 1772.7;myeloid DC: 587.8;neutrophil: 674.2;non-classical monocyte: 1252.1;plasmacytoid DC: 2113.2"	"Group enriched"	"Detected in all"	5	"dendritic cells: 2113.2;granulocytes: 674.2;monocytes: 1772.7"	"Cell line enhanced"	"Detected in all"		"ASC diff: 1619.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000835, CAB032888"	Enhanced				"Secreted to blood"	NA	NA		53000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"CAB032888: AB_2157036, HPA000835: AB_1079499"	"unprognostic (1.27e-3)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.83e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (6.67e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.11e-3)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.97e-1)"	"prognostic favorable (6.55e-4)"	"unprognostic (1.42e-1)"	260.1	297.0	127.1	261.3	145.4	305.3	221.3	152.2	190.6	284.5	434.0	259.7	201.7	196.7	16783.1	185.0	170.0	356.0	215.1	118.1	156.9	322.4	202.4	786.0	360.3	185.7	145.6	283.1	219.9	241.3	197.5	263.1	179.2	164.2	220.8	48.6	221.9	261.3	58.7	181.6	193.3	180.5	151.1	305.6	206.8	156.8	172.1	134.4	444.7	114.7	241.9	347.4	187.9	195.5	297.2	199.3	124.8	179.4	1619.3	498.6	404.8	194.1	707.1	200.9	398.9	351.7	420.3	78.6	141.6	181.9	372.6	595.9	170.0	405.5	188.6	120.4	126.3	29.6	96.7	296.2	348.6	51.0	548.4	467.7	388.9	173.7	336.9	930.2	298.1	87.0	32.9	601.4	224.0	106.9	70.1	75.9	52.9	489.0	307.9	39.5	219.1	281.6	511.1	735.0	5.5	91.3	296.3	120.3	298.0	359.6	205.2	225.7	268.9	291.9	342.0	396.1	188.2	253.7	452.5	24.2	292.1	168.4	163.4	668.7	1300.7	274.1	92.2	1772.7	87.9	295.2	126.5	92.3	587.8	241.8	120.9	100.5	674.2	99.5	1252.1	2113.2	187.8	1304.5	127.1	145.4	152.2	190.6	118.1	156.9	185.7	145.6	179.2	151.1	172.1	195.5	154.9	381.4	2034.2	11.1	160.2	374.9	557.8	1074.2	170.2	9.9	138.6	220.5	55.4	163.0	626.9	331.1	22.9	228.3	664.0	301.0	305.2	500.4	90.9	123.8	168.5	276.5	119.7	65.4	2.1	279.4	803.3	318.1	61.7	161.0	341.4	104.2	447.3	195.6	2898.5	8.4	3.8	264.8	832.1	2035.4	750.9	69.6	566.7	1462.6	602.9	6.5	790.5	167.4	117.4	7.5	24.4	368.3	405.1	291.9	287.4	357.9	298.1	969.0	393.3	25.1	131.5	118.3	155.9	268.1	166.7	182.6	320.7	210.4	109.9	330.0	298.5	521.6
NPHS1	"CNF, NPHN"	ENSG00000161270	"NPHS1 adhesion molecule, nephrin"	O60500	19	35825372-35869287	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Myogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"kidney: 41.5;pancreas: 22.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.0;Early spermatids: 13.5;Endometrial ciliated cells: 4.5;Fibroblasts: 5.1;Glandular and luminal cells: 12.1;Late spermatids: 6.9"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.1;JURKAT: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB035555	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"CAB035555: "	"unprognostic (3.42e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.47e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.83e-5)"	"unprognostic (4.30e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	0.3	0.0	0.4	0.6	0.9	0.2	0.0	0.8	0.4	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	41.5	0.1	0.0	3.9	0.4	0.4	0.0	22.8	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.3	0.7	0.6	0.7	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.8	0.4	0.4	0.2	0.4	0.4	0.5	0.1	0.6	0.7	0.3	0.0	0.5	0.0	0.2	0.8	0.8	0.0	0.6	5.0	0.3	0.3	1.0	0.0	0.0	3.7	0.0	0.0	0.2	0.0	0.0	0.3	13.5	4.5	0.4	0.7	0.0	0.0	0.7	2.4	0.0	5.1	0.0	12.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	2.1	6.9	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0	0.4	0.5	0.8	0.4	0.1	0.4	0.0	0.3	0.0	0.1	0.3
NPHS2	"PDCN, SRN1"	ENSG00000116218	"NPHS2 stomatin family member, podocin"	Q9NP85	1	179550539-179575952	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	140	"kidney: 255.0"	"Group enriched"	"Detected in some"	7	"Collecting duct cells: 20.2;Early spermatids: 9.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"NTERA-2: 1.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB037267, HPA049486"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 29: Early spermatids - Spermatogenesis"			"CAB037267: AB_261982, HPA049486: AB_2680788"													"unprognostic (6.77e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.86e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	255.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0
NPSR1	"GPR154, GPRA, PGR14"	ENSG00000187258	"Neuropeptide S receptor 1"	Q6W5P4	7	34658218-34878332	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	Asthma	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.6"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.1;Early spermatids: 4.4;Excitatory neurons: 3.8;Inhibitory neurons: 2.2;Late spermatids: 2.1;Oligodendrocyte precursor cells: 1.0"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 2.3;pancreatic cancer: 2.0;stomach cancer: 2.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HAP1: 1.0"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 6.2"							NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"					"unprognostic (3.56e-1)"	"unprognostic (9.34e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.00e-2)"		"unprognostic (9.35e-2)"			"unprognostic (6.34e-3)"			"unprognostic (2.85e-1)"	"unprognostic (1.36e-2)"		"unprognostic (2.08e-2)"	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.2	0.4	1.6	0.6	1.1	0.3	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.0
NRAS	N-ras	ENSG00000213281	"NRAS proto-oncogene, GTPase"	P01111	1	114704469-114716771	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010157, HPA049830, CAB079912"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"		"CAB010157: AB_632073, CAB079912: AB_2784586, HPA049830: AB_2680903"	"unprognostic (4.75e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.11e-2)"	"unprognostic (8.59e-3)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.03e-7)"	"unprognostic (7.76e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (6.60e-3)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.33e-2)"	19.0	9.1	10.3	25.7	11.2	58.5	18.0	11.5	12.3	12.5	8.6	27.8	21.5	12.4	7.8	20.7	10.3	17.2	8.3	10.2	12.2	20.9	24.9	18.5	30.4	12.3	12.1	9.6	11.4	9.0	4.3	28.3	12.3	11.4	26.6	6.6	10.9	7.1	7.7	19.8	22.5	14.1	11.7	18.6	21.8	9.6	11.4	39.0	16.1	7.8	29.7	22.2	8.6	13.4	93.7	24.9	65.2	24.9	26.4	56.3	46.5	43.5	48.4	79.5	89.0	50.4	33.9	70.4	56.3	58.9	55.4	26.0	88.2	70.6	113.4	96.5	34.2	47.8	34.5	60.2	52.3	120.0	71.0	51.1	56.1	91.5	66.2	25.0	102.8	54.6	77.3	78.5	71.0	248.9	83.5	46.4	111.0	30.2	17.9	62.9	116.0	44.1	70.6	49.5	39.4	59.0	44.7	36.4	107.1	75.4	31.9	96.2	79.2	43.3	82.2	81.5	90.3	137.7	101.6	81.6	86.4	64.6	159.0	38.7	12.8	12.6	11.7	19.2	10.5	12.8	9.3	11.6	12.6	10.5	9.9	12.9	3.4	15.5	17.6	9.6	13.4	13.1	10.3	11.2	11.5	12.3	10.2	12.2	12.3	12.1	12.3	11.7	11.4	13.4	22.7	16.0	16.5	8.1	25.9	30.7	31.2	23.1	15.4	5.2	18.5	13.6	5.6	18.6	19.3	22.0	8.4	22.4	27.7	49.2	13.7	34.1	3.9	22.9	24.7	29.2	24.6	31.6	5.8	31.5	50.4	16.1	29.0	38.0	31.1	22.2	33.2	29.7	49.2	5.0	5.2	28.1	30.5	44.9	30.7	5.9	8.1	30.4	23.2	9.4	41.6	7.8	22.6	5.0	8.1	51.4	32.9	6.4	39.6	30.6	28.1	39.4	23.1	3.3	6.6	12.8	15.3	7.3	15.4	24.6	36.2	31.2	21.9	13.8	28.8	40.2
NRXN1	"Hs.22998, KIAA0578"	ENSG00000179915	"Neurexin 1"	"P58400, Q9ULB1"	2	49918503-51225575	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Angiogenesis, Cell adhesion"		"Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 145.0"	"Group enriched"	"Detected in many"	5	"Astrocytes: 4025.1;Excitatory neurons: 3206.3;Inhibitory neurons: 2116.2;Oligodendrocyte precursor cells: 4897.8"	"Cancer enriched"	"Detected in single"	8	"glioma: 3.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.3"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071400			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		1400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA071400: AB_2732180"	"unprognostic (7.01e-2)"	"unprognostic (9.96e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.74e-4)"	"unprognostic (2.46e-1)"	"unprognostic (8.95e-2)"		"unprognostic (2.02e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-2)"	"unprognostic (6.37e-4)"	"unprognostic (2.85e-2)"	"unprognostic (6.68e-7)"	"unprognostic (3.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.99e-3)"	1.1	2.0	40.9	1.1	60.9	0.3	0.8	145.0	74.4	2.2	0.0	11.3	0.9	1.1	3.0	2.0	0.8	1.2	5.2	62.7	16.8	0.4	0.5	0.4	0.3	0.0	2.2	0.9	1.4	0.0	6.0	0.0	7.2	2.8	2.6	7.2	2.4	8.4	0.2	0.9	2.6	1.0	4.7	0.2	2.3	5.6	15.7	1.2	0.6	0.8	0.2	2.3	3.1	22.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	31.3	1.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2	3.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	40.9	60.9	145.0	74.4	62.7	16.8	0.0	2.2	7.2	4.7	15.7	22.0	0.1	0.0	0.0	4025.1	0.0	0.0	0.3	0.0	3.4	116.0	3.1	3.7	19.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.9	0.1	201.6	0.1	2.8	1.0	1.8	0.0	3206.3	0.0	0.0	2.3	0.0	0.1	0.0	0.2	3.3	0.2	0.1	77.4	2116.2	0.0	0.0	0.0	0.6	103.4	2.5	0.6	1.8	174.3	0.0	22.7	0.0	4897.8	678.0	0.2	0.0	0.7	1.4	0.5	0.0	0.2	0.0	9.7	0.0	2.5	1.3	13.3	5.8	0.6	0.1	0.3	0.1	0.1	0.0	0.1
NSD1	"ARA267, FLJ22263, KMT3B, STO"	ENSG00000165671	"Nuclear receptor binding SET domain protein 1"	Q96L73	5	177133025-177300213	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048431, HPA070333, HPA073705"	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"		"HPA048431: AB_2680388, HPA070333: AB_2686255, HPA073705: AB_2732239"	"unprognostic (3.48e-2)"	"unprognostic (7.46e-2)"	"unprognostic (7.14e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.68e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.77e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.32e-2)"	8.7	7.2	8.9	12.0	13.4	21.2	10.9	26.2	10.4	11.1	9.8	10.1	8.4	11.5	10.3	11.4	10.1	8.0	9.1	7.7	10.0	10.6	6.6	9.2	13.7	9.7	10.8	12.3	11.3	12.8	9.0	10.7	12.2	9.3	10.8	11.9	10.4	9.6	13.6	12.0	9.4	12.0	6.6	11.3	8.9	23.2	12.0	20.2	15.5	11.5	14.7	9.3	7.9	17.5	20.5	25.9	26.0	22.8	12.5	16.1	0.9	18.2	17.9	24.6	22.8	5.7	16.6	41.7	19.9	24.8	22.7	17.0	41.9	40.0	29.7	72.9	25.9	18.6	29.5	0.2	20.7	40.4	21.2	15.2	23.6	29.4	27.3	17.5	36.4	26.0	25.9	14.3	25.2	42.3	28.3	13.1	28.5	13.7	22.5	31.0	3.4	12.9	15.9	24.4	31.6	21.9	46.7	20.1	13.8	24.1	20.2	33.0	27.4	17.1	25.0	11.0	22.6	16.7	15.7	29.5	9.9	19.3	18.7	14.7	9.0	10.5	7.2	6.1	6.0	8.5	6.1	5.0	7.2	10.3	7.5	6.0	18.6	11.3	12.2	9.4	6.4	3.4	8.9	13.4	26.2	10.4	7.7	10.0	9.7	10.8	12.2	6.6	12.0	17.5	37.4	22.4	31.4	84.9	71.7	17.0	32.8	27.2	34.1	94.4	29.8	25.7	44.5	34.3	35.0	55.2	150.1	43.6	66.1	19.7	17.6	27.8	31.9	27.1	65.7	36.4	41.9	48.3	107.0	21.2	23.7	32.7	41.8	41.9	41.7	64.0	33.5	19.9	27.7	89.2	110.3	25.6	12.2	36.8	25.7	50.3	51.0	47.1	16.0	115.2	75.0	29.2	95.8	140.8	157.5	23.7	31.0	33.1	55.8	29.4	33.6	19.2	17.3	112.3	52.6	42.9	36.1	83.7	62.1	41.8	20.6	35.4	62.0	55.9	28.2	30.0
NSD2	"KMT3G, MMSET, WHSC1"	ENSG00000109685	"Nuclear receptor binding SET domain protein 2"	O96028	4	1871393-1982207	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 20.3;Granulosa cells: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015801, CAB068246, CAB068247"	Enhanced		Supported	Nucleoplasm		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"CAB068246: AB_2665690, CAB068247: AB_2665689, HPA015801: AB_1858830"	"unprognostic (3.70e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (3.24e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (3.89e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.15e-2)"	10.1	8.4	12.7	16.5	13.0	54.9	9.9	23.6	15.2	9.4	0.8	19.6	18.6	10.7	7.3	13.6	8.4	8.3	15.8	11.8	11.5	9.8	8.3	12.6	25.4	9.8	8.6	7.7	13.5	12.0	13.8	12.2	12.0	9.7	22.5	28.5	11.6	8.4	16.7	11.6	18.3	12.4	4.4	14.1	12.5	37.2	12.6	59.8	17.4	13.7	24.3	9.7	9.2	14.9	124.0	58.6	168.3	71.2	17.5	26.5	44.2	98.2	85.4	115.2	128.8	44.6	141.4	117.5	31.4	78.0	158.5	50.2	114.4	74.3	195.0	58.3	47.7	151.3	81.7	25.5	18.6	89.5	74.9	9.9	19.8	101.2	89.9	60.1	92.2	123.4	81.7	132.2	95.8	42.1	243.3	99.7	68.8	60.1	77.1	137.8	106.7	42.9	45.4	57.4	115.6	82.7	78.4	29.2	31.7	71.4	68.9	52.2	64.9	109.0	87.4	72.8	188.1	54.1	72.9	113.7	66.0	81.9	108.0	4.0	1.1	1.3	1.0	0.8	1.1	0.9	1.5	1.2	1.2	1.7	1.1	0.8	3.4	1.2	0.5	2.1	2.9	0.7	12.7	13.0	23.6	15.2	11.8	11.5	9.8	8.6	12.0	4.4	12.6	14.9	12.6	12.8	18.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	15.3	9.1	0.0	0.0	8.1	12.9	0.0	15.7	7.2	0.0	3.9	10.4	0.0	13.0	11.7	6.3	0.0	0.0	0.0	7.1	10.0	6.0	0.0	20.3	2.5	69.3	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	5.7	0.0	0.0	0.0	0.0	11.4	0.0	0.0	4.9	0.0	0.0	4.0	7.3	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	3.4	5.2	3.7	0.0	0.0
NSD3	"FLJ20353, KMT3F, WHISTLE, WHSC1L1"	ENSG00000147548	"Nuclear receptor binding SET domain protein 3"	Q9BZ95	8	38269704-38382272	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 173.8;Syncytiotrophoblasts: 130.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005659, CAB013721, HPA018893"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	Nucleoplasm	"CAB013721: , HPA005659: AB_1080596, HPA018893: AB_1858833"	"unprognostic (6.21e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (5.06e-2)"	"unprognostic (5.60e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.60e-2)"	22.4	14.4	10.0	24.8	13.7	60.2	23.4	28.4	20.5	24.0	0.7	22.4	24.1	22.9	17.4	22.9	23.5	24.5	13.7	12.8	22.3	20.0	16.6	20.6	35.3	3.1	4.8	36.4	20.1	24.8	17.3	33.5	5.3	20.9	26.6	23.3	19.9	24.3	14.4	19.8	26.7	19.8	0.1	26.9	29.0	14.4	10.4	38.3	27.6	16.0	31.0	23.3	23.1	18.7	62.1	34.9	58.7	39.9	40.3	46.0	43.4	50.8	55.9	43.1	49.7	18.8	33.6	73.5	45.5	35.0	41.7	36.4	47.0	40.6	61.0	29.4	27.6	93.6	28.6	22.1	41.2	41.7	32.5	24.9	40.4	39.0	78.6	40.3	50.1	79.8	67.9	47.4	41.5	22.3	122.8	35.4	40.0	48.0	16.4	55.5	64.1	23.4	30.3	47.3	33.0	44.6	41.4	35.8	35.3	37.5	45.1	31.4	48.3	44.5	46.0	67.0	30.3	41.9	53.8	69.2	37.6	41.3	33.0	37.4	11.8	21.9	17.2	5.6	11.0	43.1	25.5	15.5	9.3	60.7	31.9	13.7	57.9	19.6	3.6	12.6	43.4	7.3	10.0	13.7	28.4	20.5	12.8	22.3	3.1	4.8	5.3	0.1	10.4	18.7	75.1	67.3	57.3	0.0	57.8	0.0	0.0	0.0	0.0	0.0	73.4	69.1	0.0	0.0	30.3	51.5	0.0	101.6	101.9	0.0	23.5	73.0	0.0	109.1	81.3	28.0	0.0	0.0	0.0	61.0	173.8	33.1	0.0	97.5	8.8	99.7	0.0	0.0	44.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	49.7	0.0	0.0	0.0	0.0	64.7	0.0	0.0	48.9	0.0	0.0	31.7	34.2	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	130.8	55.6	81.7	0.0	0.0
NSDHL	"H105e3, SDR31E1, XAP104"	ENSG00000147383	"NAD(P) dependent steroid dehydrogenase-like"	Q15738	X	152830967-152869729	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease variant, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 53.0;Hepatocytes: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000248, HPA000571"	Enhanced		Enhanced	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"	"Lipid droplets"	"HPA000248: AB_1079507, HPA000571: AB_1079506"	"unprognostic (1.84e-1)"	"prognostic favorable (5.65e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (1.03e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.63e-1)"	"prognostic favorable (6.09e-5)"	"unprognostic (3.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.79e-2)"	24.0	38.8	13.2	10.2	12.6	8.9	20.2	14.2	13.3	20.3	13.7	13.9	17.6	13.6	44.5	51.7	14.9	7.9	22.4	13.7	14.3	14.9	50.4	12.9	9.1	16.8	15.4	10.3	10.6	12.9	8.8	10.3	18.5	14.8	13.5	10.4	16.7	21.3	10.1	22.6	24.2	12.5	13.4	9.5	13.8	8.9	15.2	9.9	13.3	10.9	18.1	12.1	24.1	15.1	135.6	48.9	65.5	33.8	54.9	41.5	36.2	26.3	35.2	46.9	59.3	68.5	71.7	67.0	86.0	35.9	174.2	67.6	85.5	122.1	41.3	22.0	49.5	27.9	44.7	70.3	39.8	27.6	21.1	51.1	46.3	92.2	23.0	20.2	44.2	28.7	46.4	29.1	36.1	60.1	27.3	35.8	26.0	67.4	58.1	19.9	47.4	54.6	98.9	55.7	23.4	26.5	23.4	34.6	28.4	44.9	23.1	35.0	38.7	21.6	35.4	52.3	51.0	40.9	29.4	114.9	40.0	42.4	20.8	21.0	19.6	18.7	16.3	18.7	16.4	19.1	16.1	14.1	19.4	15.1	11.6	12.7	2.2	19.7	14.2	17.4	20.4	15.2	13.2	12.6	14.2	13.3	13.7	14.3	16.8	15.4	18.5	13.4	15.2	15.1	7.1	12.8	16.7	5.9	6.3	10.8	12.8	53.0	10.8	4.3	11.7	6.1	25.0	15.7	29.0	12.9	0.0	21.5	6.1	9.6	9.8	20.1	13.3	15.5	6.6	9.2	6.0	13.0	2.2	20.3	22.0	9.0	8.2	15.5	8.2	14.0	7.5	55.0	18.6	1.7	2.2	10.2	26.4	8.7	9.6	8.0	8.4	7.9	5.4	1.0	11.0	10.6	7.2	2.5	5.7	21.4	11.9	9.1	11.3	10.4	25.2	16.5	25.4	6.2	0.0	5.9	12.5	3.7	7.8	19.4	12.1	18.6	5.3	25.1	11.2	16.4
NSUN2	"FLJ20303, Misu, MRT5, TRM4"	ENSG00000037474	"NOP2/Sun RNA methyltransferase 2"	Q08J23	5	6599239-6633291	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis, tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037896	Supported		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA		110000	"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA037896: AB_10670532"	"unprognostic (3.99e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (8.56e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.44e-3)"	"unprognostic (5.12e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.48e-2)"	"prognostic unfavorable (5.69e-5)"	"unprognostic (1.98e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.70e-2)"	21.6	16.0	10.4	29.1	10.9	28.2	38.6	11.3	13.4	16.2	12.0	24.7	20.8	18.2	19.5	24.1	17.7	17.8	23.0	10.8	11.3	16.4	36.7	19.5	34.3	11.2	10.6	18.0	20.0	24.9	11.5	19.8	11.2	20.7	27.7	10.9	17.9	17.0	39.0	22.7	20.4	22.4	10.4	23.0	21.4	18.9	11.8	26.5	18.0	30.2	36.8	29.3	15.0	13.2	97.6	85.8	49.9	45.4	31.7	36.1	112.9	72.5	48.6	84.4	71.5	113.0	75.6	170.6	74.0	63.8	101.6	70.7	102.1	90.6	114.6	115.1	73.4	100.8	199.0	67.0	44.8	176.8	77.4	40.2	67.5	91.8	80.5	33.6	60.6	70.3	132.3	66.3	79.9	71.1	93.2	89.3	80.0	69.3	101.3	121.1	50.5	54.7	61.7	112.1	45.8	65.4	184.4	101.2	79.1	65.0	85.0	84.2	66.6	66.8	82.0	68.4	111.1	51.2	100.1	159.9	52.9	143.9	77.6	16.2	18.6	21.2	21.1	22.4	27.9	22.4	22.1	25.0	21.5	20.6	23.2	23.5	3.9	24.4	21.2	20.2	17.0	17.0	10.4	10.9	11.3	13.4	10.8	11.3	11.2	10.6	11.2	10.4	11.8	13.2	13.2	19.2	17.6	27.7	26.3	37.7	16.4	15.7	21.6	6.2	15.5	14.2	18.7	17.2	30.3	18.4	14.6	20.1	17.1	16.2	9.8	19.6	3.1	11.2	12.9	16.2	14.9	22.3	37.2	15.3	21.2	14.5	17.9	14.1	20.8	17.8	10.0	33.9	14.4	3.3	30.2	16.5	16.2	18.5	21.1	2.9	13.1	16.4	16.0	20.6	21.9	7.2	21.6	24.1	45.4	24.8	14.8	14.3	23.0	18.9	10.2	9.8	17.4	7.3	6.6	20.2	15.4	14.9	17.7	30.1	30.5	23.1	20.7	17.2	19.8	17.0
NT5C2	"cN-II, GMP, NT5B, PNT5, SPG45, SPG65"	ENSG00000076685	"5'-nucleotidase, cytosolic II"	P49902	10	103087185-103277605	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Allosteric enzyme, Hydrolase"	"Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 141.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003751	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA003751: AB_1854664"	"unprognostic (8.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.87e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.41e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.50e-1)"	24.6	27.0	25.0	19.0	27.2	29.7	23.0	27.3	28.5	37.6	36.8	27.3	9.9	18.8	17.3	67.1	26.5	16.4	28.5	25.2	28.8	32.5	27.8	30.8	18.3	26.9	29.5	32.4	22.0	21.7	34.0	17.9	27.2	32.4	16.7	47.3	46.4	18.4	51.6	19.9	20.4	13.4	26.4	32.8	22.3	30.8	27.2	28.6	55.4	18.1	24.5	33.3	42.7	28.6	148.4	52.5	32.6	67.5	27.2	33.2	18.2	66.0	64.7	29.9	32.4	34.6	91.7	49.2	47.7	45.6	27.6	62.8	23.4	33.8	38.3	40.3	21.6	38.7	21.1	39.6	48.5	64.2	21.0	50.4	34.1	28.0	24.8	57.5	25.6	19.4	29.4	36.4	54.5	73.8	53.7	64.6	34.6	43.2	68.6	102.6	30.0	19.6	43.3	72.5	10.0	24.9	35.8	25.9	50.3	33.7	39.2	38.1	30.5	20.5	24.8	39.7	51.7	32.9	71.6	85.5	23.9	64.6	7.8	29.5	16.5	31.3	10.0	18.8	10.3	8.9	8.4	8.7	14.7	5.2	6.7	8.0	27.4	14.4	23.0	9.6	9.3	10.5	25.0	27.2	27.3	28.5	25.2	28.8	26.9	29.5	27.2	26.4	27.2	28.6	16.2	83.3	34.9	141.7	17.2	7.4	29.0	26.9	5.7	24.4	13.9	13.6	2.6	18.6	60.4	27.6	45.9	19.4	23.3	48.7	11.7	28.5	103.7	29.5	17.1	19.8	11.5	12.4	79.8	26.0	11.7	17.5	25.5	46.2	8.8	18.2	13.9	17.4	19.9	47.1	83.6	17.6	18.3	29.8	14.2	61.9	24.8	27.1	26.6	78.7	25.9	85.5	16.5	70.4	107.5	57.9	23.1	13.5	21.0	35.7	11.7	15.3	44.1	59.1	32.9	22.9	21.7	25.3	20.5	22.9	7.5	35.0	16.6	15.8	18.0	80.5
NT5C3A	"cN-III, hUMP1, NT5C3, p36, P5'N-1, PN-I, POMP, PSN1, UMPH, UMPH1"	ENSG00000122643	"5'-nucleotidase, cytosolic IIIA"	Q9H0P0	7	33014114-33062797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.4"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 191.0;Paneth cells: 186.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010520, HPA010630, HPA029058"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		10000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	"Endoplasmic reticulum, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA010520: , HPA010630: AB_2668319, HPA029058: AB_10601380"	"unprognostic (7.50e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (9.37e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.43e-3)"	12.4	14.3	11.4	26.1	11.4	32.6	21.3	15.2	15.6	12.6	10.8	51.9	40.0	16.9	14.3	18.6	15.9	23.4	16.6	11.5	11.5	22.4	11.8	17.6	30.8	11.1	11.8	13.4	21.4	9.7	7.5	16.3	11.5	12.3	51.0	20.4	9.7	10.0	87.4	28.7	37.3	13.2	12.7	22.9	27.0	9.5	12.0	22.5	17.1	51.0	45.8	23.8	14.4	13.1	42.2	27.6	25.2	29.6	21.2	16.1	20.3	44.8	30.5	29.2	38.9	19.9	115.1	100.4	27.7	29.6	48.3	63.8	28.3	30.8	40.4	16.2	36.2	54.7	36.5	28.7	23.3	55.6	36.9	21.7	23.8	35.9	63.0	16.4	22.2	33.2	43.3	24.8	37.3	29.9	25.0	87.8	27.8	47.1	31.2	25.9	22.9	60.0	87.8	39.8	28.1	37.0	31.1	52.4	66.6	24.5	35.2	33.5	19.8	25.1	20.9	42.6	55.7	50.6	69.0	54.8	20.6	34.9	42.5	112.5	25.9	82.5	26.6	32.7	30.6	64.0	34.2	30.8	22.1	63.6	34.5	29.1	103.8	28.2	39.2	20.6	56.2	37.9	11.4	11.4	15.2	15.6	11.5	11.5	11.1	11.8	11.5	12.7	12.0	13.1	39.1	22.4	13.7	30.7	85.1	46.8	40.9	85.3	47.8	23.9	22.6	18.9	16.9	32.9	40.4	16.5	41.7	36.9	42.5	191.0	29.4	34.4	5.7	40.9	21.0	40.8	119.6	127.1	45.3	79.0	31.6	35.2	42.8	21.4	17.7	38.3	30.0	18.9	25.0	1.7	49.4	98.9	40.7	31.2	23.5	5.0	33.8	111.4	26.6	29.0	37.0	23.4	55.6	48.2	52.4	48.3	186.6	22.2	43.8	45.7	91.8	84.8	53.7	27.1	13.1	30.7	24.9	46.4	24.0	35.5	38.9	28.3	53.7	23.3	71.0	65.9
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 112.6;retina: 94.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 58.0;Oligodendrocyte precursor cells: 61.3;Pancreatic endocrine cells: 124.8;Rod photoreceptor cells: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 33.0;naive CD8 T-cell: 30.7"	"Group enriched"	"Detected in many"	41	"B-cells: 33.0;T-cells: 30.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 807.8;LHCN-M2: 934.3;TIME: 546.2;U-87 MG: 821.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		3000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (1.92e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.78e-1)"	20.7	6.0	9.8	11.9	11.9	0.6	14.1	11.2	10.7	112.6	14.9	29.4	40.1	49.4	6.3	8.6	20.7	17.2	8.7	8.5	11.3	17.2	54.8	6.8	9.6	11.7	14.1	39.3	1.8	1.8	11.8	25.3	13.0	13.3	31.9	94.4	6.6	34.2	2.1	6.4	20.9	73.9	14.7	13.0	8.1	10.4	12.7	5.2	23.7	9.8	11.3	15.8	28.5	12.1	48.9	26.0	42.9	0.8	95.1	302.4	0.4	306.1	332.7	147.5	275.2	0.4	469.6	0.0	107.3	270.2	379.0	24.5	0.1	308.0	348.8	0.8	0.1	0.1	7.3	6.0	47.5	0.2	0.7	77.4	3.7	302.0	191.3	807.8	124.9	0.3	0.3	1.4	934.3	8.3	0.0	0.2	0.8	8.2	34.6	1.5	9.5	1.3	323.1	21.8	0.3	5.5	3.8	18.8	104.9	2.2	0.4	8.3	546.2	120.6	0.9	152.9	506.8	22.7	15.3	0.5	821.7	0.4	385.3	0.0	0.0	0.5	3.7	0.0	6.4	23.7	4.2	11.7	0.0	33.0	4.1	30.7	0.5	0.7	0.0	0.1	1.7	6.4	9.8	11.9	11.2	10.7	8.5	11.3	11.7	14.1	13.0	14.7	12.7	12.1	6.4	0.0	5.8	36.9	21.6	5.2	1.7	6.1	2.8	4.4	1.2	0.3	1.7	27.1	4.8	1.8	10.4	0.6	2.2	49.2	3.9	3.8	0.6	19.3	20.8	20.5	0.0	0.0	1.6	4.1	2.5	39.4	11.2	58.0	0.0	0.1	49.6	33.7	1.3	0.0	2.1	27.7	0.0	3.5	8.2	1.3	13.1	2.1	7.2	11.2	0.5	9.1	0.0	61.3	0.7	124.8	46.0	25.6	3.6	1.5	8.3	27.6	4.8	81.6	0.0	3.3	9.6	0.0	0.3	0.6	4.8	15.2	5.0	0.1	18.0	9.6
NTHL1	"NTH1, OCTS3"	ENSG00000065057	"Nth like DNA glycosylase 1"	P78549	16	2039815-2047866	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase, Lyase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	10	"Hepatocytes: 866.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025152	Supported					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"			"CAB025152: "	"unprognostic (1.06e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.62e-2)"	11.7	9.3	13.8	6.2	14.7	4.7	11.0	14.8	19.7	15.5	11.1	16.8	6.6	15.4	3.1	11.3	13.8	6.0	15.8	13.5	14.2	9.8	21.9	10.7	8.4	15.4	13.9	16.1	9.9	4.8	11.5	5.6	15.6	11.2	5.6	1.8	16.0	11.5	9.7	9.3	11.1	5.3	13.6	16.7	13.2	8.7	15.2	7.6	9.6	6.8	5.9	11.8	12.5	14.2	29.8	74.2	20.8	32.2	8.5	15.9	22.8	12.1	13.2	23.1	14.6	53.0	28.8	63.0	25.2	10.7	15.1	26.2	26.1	29.0	4.0	28.9	63.3	19.5	47.7	60.9	11.5	22.4	22.3	13.2	14.9	12.3	13.2	15.4	33.4	37.0	22.2	22.6	9.0	34.9	33.9	88.3	46.2	37.3	47.3	80.8	22.0	103.5	17.2	10.7	43.9	43.5	13.2	41.0	25.4	7.6	29.6	23.5	12.9	19.9	21.5	17.5	23.1	30.3	38.0	26.9	8.8	31.7	24.9	4.2	15.0	3.4	14.4	26.0	16.2	37.5	17.3	16.7	25.7	32.8	12.8	15.4	0.7	19.1	22.5	26.3	34.0	14.4	13.8	14.7	14.8	19.7	13.5	14.2	15.4	13.9	15.6	13.6	15.2	14.2	47.2	28.9	27.5	2.9	12.9	8.7	16.4	21.6	8.0	8.8	18.9	23.4	14.1	44.3	28.3	3.7	0.0	10.5	8.1	75.6	17.6	16.3	8.1	20.4	19.5	36.5	67.4	26.7	3.0	9.1	18.3	17.6	16.3	23.3	5.7	20.5	51.0	866.4	13.4	6.7	3.6	85.3	54.9	25.5	17.6	23.8	33.8	9.3	21.4	2.8	9.7	10.7	18.6	3.0	4.9	12.1	81.6	25.2	16.0	6.4	12.8	28.8	23.5	8.1	13.1	8.1	23.6	5.4	32.0	11.7	10.1	2.7	12.2	20.6	56.8	21.0
NUP107	NUP84	ENSG00000111581	"Nucleoporin 107"	P57740	12	68686951-68745809	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 89.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031679			Uncertain	"Nucleoplasm,Nuclear membrane,Centrosome"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nuclear membrane, Centrosome"	"HPA031679: AB_2673992"	"unprognostic (2.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.10e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"prognostic unfavorable (3.12e-9)"	"unprognostic (4.03e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (1.28e-6)"	"unprognostic (3.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.96e-1)"	15.4	11.1	5.0	17.9	6.3	24.0	17.8	8.2	6.0	12.9	6.3	13.0	10.3	16.7	14.3	10.7	13.5	9.3	11.4	4.6	5.0	10.6	11.8	12.8	25.8	5.6	5.7	16.3	9.3	11.8	6.8	13.8	5.5	12.0	16.2	14.7	10.3	12.2	11.7	15.8	12.9	14.0	5.4	15.8	11.0	20.9	5.5	25.6	10.3	12.1	25.5	12.4	10.7	7.6	53.1	66.8	77.8	56.7	22.6	28.6	84.1	56.6	32.4	83.0	68.9	67.6	43.7	96.3	53.7	27.2	36.9	59.4	88.4	41.7	109.8	90.8	65.6	110.1	46.2	57.4	14.2	97.9	35.6	15.2	19.4	66.5	43.2	29.0	50.3	54.9	133.7	67.3	52.8	64.3	81.3	85.2	85.8	20.3	64.6	81.9	93.6	57.8	36.1	55.3	45.7	46.9	62.7	46.5	34.4	60.4	69.8	46.7	31.1	45.0	45.8	53.0	69.9	29.2	62.2	115.2	34.7	70.2	54.2	10.5	9.2	14.4	17.7	12.5	23.4	18.7	17.5	19.3	10.2	18.7	21.5	19.5	2.4	30.5	23.2	8.1	20.0	11.8	5.0	6.3	8.2	6.0	4.6	5.0	5.6	5.7	5.5	5.4	5.5	7.6	18.3	12.8	17.7	13.7	38.1	17.3	18.4	28.1	25.0	23.8	12.5	11.4	13.5	12.8	18.9	9.2	18.8	30.7	30.3	12.2	11.7	22.8	45.3	12.6	18.2	20.6	8.5	64.4	23.8	17.6	30.8	19.6	16.3	10.2	15.8	35.6	15.4	7.0	17.5	13.5	20.1	12.6	42.7	13.9	16.2	9.6	38.8	18.3	19.6	15.9	27.0	16.7	36.0	21.6	34.3	22.1	9.9	21.8	22.9	19.4	10.5	6.4	21.9	29.6	13.1	18.4	18.2	89.4	51.9	18.7	17.6	14.1	27.0	24.5	16.8	12.5
NUP133	FLJ10814	ENSG00000069248	"Nucleoporin 133"	Q8WUM0	1	229440259-229508341	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059767	Approved		Supported	"Nuclear membrane"		NA	NA		6300	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane"		"HPA059767: AB_2684123"	"unprognostic (2.05e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.30e-2)"	12.3	10.7	9.2	11.2	10.8	12.6	15.8	13.1	11.9	11.7	7.5	11.2	8.6	14.4	11.2	10.6	13.9	8.6	15.2	9.2	9.2	12.2	10.1	10.8	14.3	9.5	9.0	16.5	10.0	17.9	9.9	15.1	9.8	11.7	11.4	19.1	10.0	11.8	17.9	13.4	9.6	13.2	10.1	11.6	9.8	13.0	8.9	16.8	13.8	14.3	15.4	11.1	10.4	14.5	30.6	24.3	37.0	19.2	26.0	27.8	71.9	24.8	25.1	36.0	32.4	28.8	29.4	44.1	20.9	24.8	16.1	39.4	51.8	26.3	38.4	26.8	64.2	26.7	23.6	21.8	20.9	54.8	20.8	21.8	19.4	25.9	30.8	25.0	30.5	37.1	61.2	20.6	28.6	13.7	40.8	23.4	55.6	42.7	21.8	39.1	38.5	43.6	20.3	26.6	31.7	39.3	36.9	22.9	27.6	18.0	35.7	42.8	26.8	16.3	19.9	28.5	37.3	19.7	26.1	46.8	18.6	31.2	34.6	5.5	5.7	4.4	5.6	5.7	7.0	5.8	5.9	6.2	7.1	4.4	5.9	6.3	1.9	5.5	10.2	4.0	5.9	5.2	9.2	10.8	13.1	11.9	9.2	9.2	9.5	9.0	9.8	10.1	8.9	14.5	10.4	9.6	18.9	26.4	19.9	9.1	6.8	10.1	13.6	16.5	9.9	8.5	21.2	14.3	10.7	14.7	8.4	21.4	11.5	4.4	5.9	8.3	1.5	10.9	8.7	10.3	10.2	21.7	48.9	8.5	13.8	13.8	15.8	8.4	7.6	17.1	11.7	12.0	9.8	16.8	44.1	7.5	8.2	13.6	8.6	3.7	12.5	10.8	7.2	25.3	13.4	12.4	5.2	28.1	60.2	7.0	4.9	12.0	19.0	6.7	4.7	7.9	13.1	12.3	0.0	16.3	10.7	12.6	18.2	14.6	10.7	18.3	13.6	11.8	9.0	6.6
NUP155	"KIAA0791, N155"	ENSG00000113569	"Nucleoporin 155"	O75694	5	37288137-37371106	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Atrial fibrillation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 70.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.6;Late spermatids: 104.5;Spermatocytes: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037775	Enhanced		Enhanced	"Nuclear membrane"	"Intracellular and membrane"	NA	NA		28000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"		"HPA037775: AB_10671885"	"unprognostic (1.10e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (1.35e-6)"	"unprognostic (2.18e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	5.3	3.4	1.9	6.7	2.7	15.2	7.4	5.1	2.5	5.2	3.3	5.6	4.9	6.0	2.7	6.5	5.2	4.0	4.0	2.1	2.5	4.6	5.7	4.2	8.3	2.5	2.4	6.3	4.8	8.1	2.1	8.1	2.9	5.2	6.9	6.6	4.4	4.2	4.3	5.1	4.5	6.6	2.5	5.7	5.0	70.8	2.8	12.6	6.1	5.9	9.8	5.7	3.5	4.0	40.6	31.7	33.7	50.0	10.3	15.1	120.8	32.2	16.9	43.1	31.4	46.9	32.5	46.0	14.4	20.9	46.7	32.2	57.5	31.7	67.0	30.4	32.3	35.8	109.6	21.9	13.0	60.0	24.0	11.1	13.0	66.5	33.5	11.8	23.2	20.4	65.8	23.8	29.0	19.9	32.4	16.3	32.0	24.8	28.4	38.3	106.1	36.5	9.7	38.5	40.6	27.8	74.0	31.4	18.1	23.8	38.8	23.5	20.2	51.5	42.9	39.3	49.5	26.8	47.9	60.0	24.1	53.0	39.9	4.3	2.0	3.5	3.3	4.2	5.6	3.9	3.1	2.9	2.9	2.9	3.0	3.5	0.6	4.5	3.1	2.0	2.4	2.7	1.9	2.7	5.1	2.5	2.1	2.5	2.5	2.4	2.9	2.5	2.8	4.0	11.1	3.2	6.8	11.8	15.5	10.5	6.5	6.5	10.8	8.0	8.0	5.0	11.0	2.8	9.6	3.7	6.2	14.3	9.8	5.2	0.0	6.0	64.6	6.9	11.0	9.6	1.2	10.7	12.4	6.1	20.4	9.0	9.2	7.1	5.1	15.1	13.9	9.7	7.9	5.0	12.6	8.7	12.2	8.9	8.0	104.5	11.1	7.0	0.0	7.5	5.7	3.9	8.2	15.1	16.7	8.2	3.8	10.1	12.7	7.6	3.9	4.1	11.4	14.5	0.0	11.5	10.5	48.2	21.1	10.8	11.6	7.5	9.9	10.6	11.3	4.9
NUP160	"FLJ22583, KIAA0197"	ENSG00000030066	"Nucleoporin 160"	Q12769	11	47778087-47848555	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		15000	"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"				"unprognostic (8.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-1)"	13.3	9.5	5.1	17.3	6.6	20.0	16.5	9.4	6.5	13.5	8.6	12.1	11.8	17.6	11.4	11.0	15.5	10.9	8.7	5.1	6.2	14.2	14.5	14.0	20.6	6.4	6.2	19.6	14.7	16.3	9.9	20.7	6.1	12.7	14.9	15.2	11.7	11.5	11.1	12.6	11.5	16.5	5.8	15.1	10.8	14.5	5.9	30.9	16.9	9.3	21.6	14.6	11.7	9.2	24.4	31.7	52.2	36.6	30.3	34.8	67.3	30.7	22.7	40.8	46.8	40.3	36.2	33.2	20.3	28.0	41.0	52.1	96.5	30.4	45.3	29.1	66.7	36.6	131.3	44.1	20.2	108.1	24.0	27.4	18.7	29.0	56.5	16.6	32.5	52.9	103.7	45.5	22.0	41.9	72.9	47.6	78.4	53.7	33.1	86.2	78.3	29.8	20.9	42.2	43.0	49.0	72.8	35.6	27.6	45.7	44.6	41.1	22.1	44.6	38.4	75.2	41.7	19.7	19.9	83.8	22.0	45.2	45.2	8.6	7.5	13.3	9.9	9.5	13.6	15.3	11.7	10.8	12.3	14.8	15.4	11.5	4.3	9.7	6.8	16.3	9.8	7.1	5.1	6.6	9.4	6.5	5.1	6.2	6.4	6.2	6.1	5.8	5.9	9.2	15.0	22.4	18.8	39.5	31.0	22.9	35.7	18.6	20.5	24.8	14.8	11.2	7.8	12.8	19.4	20.2	43.8	33.1	31.4	10.3	15.6	17.7	27.6	17.9	16.3	17.9	19.2	19.6	35.2	16.7	30.4	19.2	15.3	20.3	19.7	23.3	19.2	12.0	15.2	6.7	50.1	14.6	20.3	10.1	19.8	11.5	24.2	14.4	10.6	44.0	15.7	19.7	24.7	61.9	53.8	16.4	8.6	21.8	21.8	32.9	10.9	10.5	15.0	48.4	19.7	19.6	17.2	18.2	22.0	16.4	27.7	30.8	25.3	20.5	15.7	34.8
NUP188	KIAA0169	ENSG00000095319	"Nucleoporin 188"	Q5SRE5	9	128947699-129007096	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Cataract, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 45.9;Spermatocytes: 52.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061750, HPA063942"	Approved		Uncertain	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA061750: AB_2684602, HPA063942: AB_2685156"	"unprognostic (4.64e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.20e-5)"	"unprognostic (9.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.81e-3)"	"unprognostic (3.53e-3)"	13.1	15.5	9.5	16.2	10.9	21.4	11.9	13.1	10.0	15.6	10.0	14.8	7.5	13.1	8.0	23.7	11.9	9.4	13.6	9.0	9.7	10.4	9.9	16.7	18.0	11.4	11.1	11.4	12.0	13.1	14.9	11.8	11.8	13.5	11.5	13.7	13.9	9.8	15.7	21.4	13.4	13.9	9.3	16.8	13.6	56.6	10.9	27.3	12.6	10.3	20.4	16.1	15.6	11.7	33.6	62.6	50.8	69.7	37.7	37.2	45.4	45.9	35.9	82.1	54.4	76.3	26.2	58.2	16.7	50.7	52.9	96.6	115.2	56.8	61.0	47.1	55.5	51.9	113.3	60.8	23.9	89.6	50.2	26.0	26.3	86.5	43.8	24.1	47.8	74.1	116.0	40.3	58.8	84.6	77.3	36.5	68.2	63.8	59.4	69.9	109.8	59.2	25.5	37.3	71.2	34.3	118.8	44.7	17.1	37.2	49.3	32.7	39.0	67.7	48.2	69.2	83.5	34.1	67.9	76.9	39.5	56.3	51.2	8.2	4.8	1.7	7.5	8.9	9.7	4.9	6.4	7.4	6.8	4.3	6.4	7.0	0.6	5.4	5.2	2.9	8.3	6.8	9.5	10.9	13.1	10.0	9.0	9.7	11.4	11.1	11.8	9.3	10.9	11.7	9.6	0.0	12.6	15.7	10.4	6.5	6.6	6.4	5.7	16.2	7.6	7.6	3.5	10.0	5.9	5.5	45.9	8.0	8.6	6.0	1.9	6.1	14.5	7.9	13.2	9.4	9.1	8.6	11.3	6.5	6.5	9.5	9.7	12.2	6.3	24.0	11.0	5.0	8.4	20.2	13.1	7.2	6.1	4.7	6.1	5.7	9.6	8.1	1.8	12.2	5.3	6.8	9.2	12.5	13.0	9.0	2.3	11.7	8.3	10.1	3.3	2.5	6.3	24.4	26.3	18.2	7.1	52.9	37.8	13.6	11.2	8.6	9.4	12.5	7.4	8.2
NUP205	"C7orf14, KIAA0225"	ENSG00000155561	"Nucleoporin 205"	Q92621	7	135557917-135648757	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		24000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"				"unprognostic (3.64e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.66e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (1.90e-7)"	"unprognostic (2.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.35e-2)"	7.5	6.7	2.0	13.1	3.3	10.7	11.5	6.7	2.6	8.9	3.8	10.0	8.0	10.7	7.2	11.0	10.4	6.4	4.9	1.7	3.1	8.0	6.6	8.4	15.0	2.7	2.7	11.8	6.1	15.1	5.2	11.0	3.2	8.7	12.3	14.8	11.8	9.0	8.0	9.6	8.3	12.7	2.6	10.3	9.0	11.6	3.2	21.8	8.4	8.0	17.3	9.9	6.9	4.4	66.4	52.8	69.5	68.2	16.2	26.6	45.4	41.0	31.5	62.4	69.1	55.1	46.8	84.2	31.7	24.6	63.0	50.1	88.5	46.0	80.1	41.9	63.3	48.9	52.1	25.1	12.2	96.5	37.0	14.5	20.5	61.4	40.8	21.9	47.3	58.9	115.6	39.1	47.6	45.0	105.0	29.4	107.0	51.6	46.3	77.6	64.6	66.6	18.8	52.4	69.3	70.4	67.8	54.8	31.8	52.4	31.6	36.5	38.6	51.0	25.3	62.7	79.5	28.7	57.2	112.3	51.7	74.3	70.1	1.6	1.3	0.4	2.4	3.1	2.8	2.3	2.9	2.5	3.0	2.1	2.3	2.7	0.5	2.9	1.7	1.9	2.9	1.4	2.0	3.3	6.7	2.6	1.7	3.1	2.7	2.7	3.2	2.6	3.2	4.4	7.9	12.8	13.4	24.8	15.3	13.0	6.8	10.3	11.4	6.3	8.6	5.2	5.3	7.2	10.6	16.5	12.5	13.1	7.5	8.2	3.9	7.8	0.9	7.4	8.1	9.3	9.1	21.3	22.7	9.6	9.3	9.4	13.3	8.4	8.2	18.5	7.9	10.7	10.3	5.0	24.1	10.4	6.1	14.1	11.7	2.4	8.1	12.2	10.6	17.8	11.4	4.9	3.1	26.2	23.3	11.9	6.4	7.5	17.4	10.3	3.9	4.6	12.4	9.7	0.0	12.6	8.2	14.5	10.8	14.8	15.5	7.7	11.9	6.1	10.9	9.4
NUP214	"CAIN, CAN, D9S46E, N214"	ENSG00000126883	"Nucleoporin 214"	P35658	9	131125586-131234663	"Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 124.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 281.4;Granulosa cells: 169.2;Kupffer cells: 274.8;Late spermatids: 404.3;monocytes: 224.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 425.3;neutrophil: 1259.6"	"Group enriched"	"Detected in all"	5	"granulocytes: 1259.6;monocytes: 425.3"	"Cell line enhanced"	"Detected in all"		"K-562: 260.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		46000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (1.30e-1)"	"unprognostic (9.51e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.10e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.95e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.39e-5)"	"unprognostic (5.49e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	29.0	21.2	17.0	18.5	20.9	42.0	26.0	19.1	23.2	21.1	17.7	23.1	11.8	21.1	17.5	33.0	22.6	12.3	26.1	18.0	18.2	43.8	32.0	22.7	15.1	20.9	19.6	22.1	32.8	16.0	21.5	14.4	20.1	21.9	13.4	15.2	21.3	12.2	24.0	28.9	23.8	13.0	17.0	68.8	25.6	124.2	20.4	41.8	22.0	13.1	15.4	21.2	22.1	26.3	23.1	31.3	28.1	15.4	20.2	25.1	26.9	20.9	20.4	24.7	20.2	25.2	17.0	36.7	16.8	29.6	26.5	50.1	35.2	24.0	32.6	26.4	16.0	25.7	45.7	45.5	18.3	37.4	23.3	20.7	21.9	31.0	27.5	16.9	25.1	23.2	260.6	20.5	28.0	39.4	52.8	41.8	27.7	30.2	27.1	17.8	35.2	36.4	25.0	24.8	21.4	24.8	35.5	30.0	17.3	18.4	41.0	90.3	23.5	44.9	25.2	30.1	31.6	18.8	49.7	39.0	22.3	20.7	28.2	53.2	425.3	174.5	6.7	181.7	8.1	13.5	8.4	6.4	162.2	11.8	6.5	7.5	1259.6	10.2	154.8	16.9	5.2	211.2	17.0	20.9	19.1	23.2	18.0	18.2	20.9	19.6	20.1	17.0	20.4	26.3	24.3	19.2	17.9	46.7	27.8	8.7	11.3	11.4	20.5	31.0	14.7	14.6	21.3	10.0	15.6	23.9	45.9	13.2	31.2	18.6	9.8	10.4	281.4	17.3	20.1	18.6	20.4	20.4	39.7	15.2	11.8	17.8	20.4	18.8	8.8	169.2	21.4	14.5	81.2	16.8	41.1	16.6	22.4	274.8	35.3	404.3	23.3	120.6	10.6	50.6	224.1	14.9	33.0	41.2	75.8	13.8	7.7	20.3	23.4	14.3	15.0	9.1	19.8	32.3	6.6	24.4	36.3	90.8	49.8	16.5	10.9	10.9	22.4	23.0	17.6	11.3
NUP37	"FLJ22618, MGC5585"	ENSG00000075188	"Nucleoporin 37"	Q8NFH4	12	102073103-102120120	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056300, HPA073708"	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA056300: AB_2683092, HPA073708: AB_2686629"	"unprognostic (1.42e-3)"	"unprognostic (5.39e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.72e-4)"	"prognostic unfavorable (7.70e-6)"	"unprognostic (2.48e-3)"	"unprognostic (2.37e-3)"	"unprognostic (7.77e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.67e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.64e-1)"	11.3	14.2	4.1	17.1	4.4	22.7	19.5	5.1	7.8	12.8	2.4	20.1	13.0	11.9	21.5	18.9	19.0	10.9	17.6	4.8	4.5	15.2	13.0	11.6	28.1	3.5	2.8	12.1	8.7	17.4	5.9	16.9	3.4	13.7	23.8	10.9	11.7	13.8	17.5	13.4	14.9	17.7	2.4	12.0	12.9	15.1	4.3	25.7	16.4	15.5	33.5	17.7	9.6	6.3	105.5	74.5	64.2	29.6	51.7	68.4	144.6	64.8	61.0	99.8	68.0	97.4	55.5	70.1	45.4	50.9	68.9	76.2	113.5	101.2	124.4	98.5	65.2	75.6	37.2	86.4	66.0	107.5	22.8	53.4	43.5	78.3	57.3	66.7	83.3	91.2	135.5	25.8	93.9	71.6	79.9	87.9	63.4	96.8	117.2	51.9	92.0	52.8	79.0	76.1	33.6	24.0	49.8	52.7	50.3	72.1	90.7	61.7	27.2	35.7	39.4	51.0	91.1	38.5	78.9	119.4	41.9	86.1	61.8	67.8	24.0	28.3	21.4	29.3	23.2	31.2	25.7	21.9	30.2	28.2	23.0	26.1	7.0	23.9	24.9	25.3	45.4	22.5	4.1	4.4	5.1	7.8	4.8	4.5	3.5	2.8	3.4	2.4	4.3	6.3	12.3	6.4	14.3	8.8	22.6	11.3	20.9	63.8	17.1	8.0	10.5	11.7	9.5	14.3	28.2	16.5	8.4	68.1	17.7	9.1	25.4	24.0	2.9	21.6	17.6	17.2	6.0	38.7	5.8	20.0	92.3	19.9	12.2	11.8	7.6	21.2	13.6	10.0	35.6	3.3	7.3	16.0	22.4	15.2	8.4	6.3	19.6	13.5	7.2	5.6	20.5	18.9	13.4	11.1	12.6	17.2	10.6	18.8	34.1	10.7	11.5	24.6	39.3	20.1	19.7	8.6	18.3	49.0	42.4	25.5	9.5	40.2	18.8	31.9	26.5	16.8
NUP62	"DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, p62, SNDI"	ENSG00000213024	"Nucleoporin 62"	P37198	19	49906825-49929763	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 119.2;Late spermatids: 315.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005435, CAB020724"	Supported		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes		31000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"	Nucleoplasm	"CAB020724: , HPA005435: AB_1079510"	"unprognostic (2.26e-1)"	"unprognostic (4.06e-2)"	"unprognostic (9.92e-2)"	"unprognostic (9.68e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (2.50e-7)"	"unprognostic (2.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.97e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (5.71e-12)"	"unprognostic (3.89e-3)"	"unprognostic (3.62e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.27e-3)"	19.9	29.4	14.2	37.3	13.2	27.1	18.9	18.4	15.9	22.5	14.0	22.5	23.7	27.6	11.0	25.0	24.8	18.4	20.4	13.9	15.7	18.5	31.7	19.4	38.3	15.5	14.2	29.8	21.0	18.0	22.8	22.4	15.8	19.9	21.1	11.1	21.8	17.5	33.7	23.4	24.3	27.7	13.6	29.8	19.4	50.4	14.7	41.9	16.3	24.5	37.7	24.6	20.1	16.9	126.7	115.5	88.8	74.0	26.0	30.0	79.7	92.8	65.8	99.3	98.8	79.8	71.9	141.2	51.7	60.8	65.9	73.6	108.3	62.1	96.1	211.6	112.0	109.8	59.4	72.6	30.9	108.8	106.8	28.6	44.8	62.0	54.8	44.1	71.5	82.7	138.6	135.5	69.2	59.7	196.7	83.6	82.0	117.4	102.8	170.3	99.9	120.3	46.9	93.7	96.2	68.8	88.2	103.8	46.3	63.8	78.8	51.5	53.0	150.2	85.3	49.1	155.4	96.3	295.9	132.5	62.2	90.1	113.9	12.3	33.4	6.7	17.7	34.7	24.1	15.1	17.6	19.6	33.1	14.9	11.9	15.4	5.2	22.0	20.1	29.0	17.2	22.1	14.2	13.2	18.4	15.9	13.9	15.7	15.5	14.2	15.8	13.6	14.7	16.9	16.8	25.6	22.4	0.0	28.4	34.2	16.5	16.0	21.1	11.4	23.7	26.0	15.4	21.5	18.3	9.2	6.2	37.0	24.4	24.9	9.8	23.7	113.5	19.2	23.9	27.7	21.6	39.1	0.0	16.3	48.4	19.5	20.4	25.6	23.4	30.4	30.4	13.3	49.5	63.9	0.0	27.0	16.2	36.1	119.2	315.1	24.8	41.5	21.4	0.0	77.1	19.1	22.6	0.0	0.0	22.9	22.8	23.0	23.3	24.1	20.6	16.1	19.2	16.3	19.7	18.0	16.0	71.0	39.3	20.0	32.0	21.8	24.4	17.2	33.4	16.6
NUP85	"FLJ12549, NUP75"	ENSG00000125450	"Nucleoporin 85"	Q9BW27	17	75205659-75235758	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061910, HPA062595"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA061910: AB_2684634, HPA062595: AB_2684801"	"unprognostic (2.30e-1)"	"unprognostic (5.10e-2)"	"unprognostic (5.12e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (1.73e-7)"	"unprognostic (3.46e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (1.03e-3)"	"unprognostic (2.16e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.11e-1)"	20.9	12.9	15.2	18.6	15.7	20.8	20.0	21.8	17.0	21.5	15.4	18.7	15.8	20.8	16.1	20.5	20.9	11.6	16.4	15.6	14.7	18.9	22.1	18.7	26.5	15.8	15.1	20.8	18.7	12.1	12.7	19.0	16.0	18.9	21.0	11.2	16.7	14.3	16.7	23.9	20.5	19.6	14.9	25.3	16.9	22.2	15.3	33.2	18.0	14.1	27.0	17.9	19.5	17.0	66.5	74.0	53.4	37.3	20.3	31.5	74.0	47.3	37.4	108.5	101.7	63.2	61.4	61.1	26.6	41.1	70.5	55.9	88.8	50.6	96.1	19.3	70.1	51.0	83.3	56.3	16.6	52.8	40.7	30.3	30.5	76.1	32.8	24.9	84.7	49.0	63.3	38.1	53.8	73.0	100.2	64.8	40.0	82.2	67.4	68.9	115.1	55.5	42.1	47.5	40.6	38.5	58.2	73.7	42.5	59.4	83.3	59.1	30.8	80.2	74.4	52.5	76.3	23.6	21.0	79.2	41.4	47.3	50.6	8.1	24.9	21.5	16.1	22.6	22.9	16.1	17.5	15.9	20.5	21.5	17.0	12.8	8.2	16.7	16.5	22.5	16.6	17.3	15.2	15.7	21.8	17.0	15.6	14.7	15.8	15.1	16.0	14.9	15.3	17.0	13.2	6.4	12.5	7.2	13.9	6.1	8.9	19.1	6.2	7.8	10.3	7.5	9.0	8.6	15.0	7.3	10.4	23.0	11.7	9.1	7.9	16.0	3.7	11.1	13.6	15.0	7.7	16.2	13.5	19.4	22.1	13.8	9.7	10.3	11.4	13.0	21.0	23.1	23.0	6.7	9.9	11.0	16.2	13.3	7.2	3.9	14.3	13.7	8.8	10.3	15.8	4.8	22.6	3.5	10.6	18.3	7.5	9.8	8.6	7.9	8.8	11.7	11.8	8.8	32.9	7.9	19.2	24.9	29.3	7.3	7.1	12.7	10.9	7.4	13.3	8.0
NUP88	MGC8530	ENSG00000108559	"Nucleoporin 88"	Q99567	17	5360963-5419676	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 146.0;Spermatocytes: 147.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002209, HPA021816"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB002209: AB_564128, HPA021816: AB_1854725"	"unprognostic (3.46e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.94e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	11.8	12.0	4.2	16.3	3.8	20.8	15.2	7.5	6.0	10.8	3.3	13.2	9.9	10.4	16.4	12.1	12.4	8.0	12.2	3.9	3.9	15.2	27.3	9.4	26.4	4.1	4.0	8.5	10.2	15.3	9.0	10.9	4.3	11.5	19.3	9.6	13.2	10.3	31.2	12.9	11.7	13.7	3.6	14.8	12.3	49.3	3.8	24.1	14.6	21.6	32.9	15.1	9.0	4.2	46.2	50.0	44.0	33.3	18.3	20.0	40.2	35.8	29.0	58.7	52.0	41.5	17.8	88.6	13.3	33.1	38.1	43.5	73.6	39.6	74.7	22.7	48.6	40.0	42.7	32.5	24.8	31.8	34.6	14.3	28.2	43.7	71.3	24.5	41.0	34.3	42.3	22.2	46.5	24.3	46.7	23.4	41.2	46.4	23.9	44.1	48.5	38.7	30.7	22.3	17.5	33.9	44.0	20.4	28.1	33.7	22.9	37.3	26.8	26.4	28.3	27.1	66.9	15.0	19.4	39.5	31.3	36.3	37.4	5.4	7.6	4.3	12.4	12.2	12.3	39.1	13.3	15.0	10.9	35.7	14.3	15.9	0.9	21.1	14.3	12.2	17.6	11.5	4.2	3.8	7.5	6.0	3.9	3.9	4.1	4.0	4.3	3.6	3.8	4.2	6.9	12.8	17.8	10.1	38.0	22.2	31.5	13.5	14.2	13.3	8.9	6.2	10.7	11.5	18.1	16.5	16.7	30.1	19.3	15.2	11.7	27.9	146.0	26.1	15.0	11.5	13.8	28.6	22.9	25.4	24.8	12.2	15.3	47.2	7.6	14.9	9.3	16.5	11.4	10.1	20.4	10.1	14.2	7.9	12.3	38.0	15.2	10.6	3.6	11.2	19.4	7.8	26.8	13.0	17.8	23.3	15.4	10.9	9.4	21.7	9.9	7.5	11.5	11.0	13.1	19.5	20.5	147.5	61.8	15.8	17.0	36.0	17.9	13.6	17.6	42.8
NUP93	KIAA0095	ENSG00000102900	"Nucleoporin 93"	Q8N1F7	16	56730118-56850286	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017937	Uncertain					NA	NA		38000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA017937: AB_1854726"	"unprognostic (6.31e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.78e-3)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (9.18e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.22e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.68e-2)"	"unprognostic (3.74e-2)"	17.9	13.9	13.2	21.3	17.4	52.7	15.5	6.8	23.9	15.3	0.2	17.7	9.9	16.9	12.4	22.3	15.3	12.4	14.2	30.6	10.7	12.8	9.3	15.3	27.7	10.7	9.3	14.9	14.2	14.8	10.8	19.1	9.9	17.7	18.1	31.7	12.2	12.7	20.0	21.6	14.5	19.5	8.3	24.2	15.2	39.8	11.4	34.1	34.3	14.2	30.3	17.1	16.1	11.5	71.3	84.5	71.6	81.0	25.9	34.8	81.0	58.7	48.2	156.2	100.1	119.4	66.1	107.7	60.4	54.9	54.2	120.6	143.3	90.1	149.8	34.0	81.3	72.6	64.7	97.3	35.0	96.7	82.8	29.3	35.7	104.2	64.7	31.6	90.8	95.3	87.8	22.3	72.3	52.4	136.2	81.1	92.1	44.2	95.4	163.9	129.4	108.9	53.1	47.8	66.6	44.1	159.1	54.6	47.3	77.4	43.0	57.9	55.3	68.1	74.0	57.8	67.5	35.0	60.7	190.2	47.4	88.5	67.5	19.3	49.9	195.7	38.9	77.2	45.2	45.4	28.3	40.9	60.9	45.4	28.7	41.0	11.8	51.8	77.5	28.7	39.7	47.4	13.2	17.4	6.8	23.9	30.6	10.7	10.7	9.3	9.9	8.3	11.4	11.5	11.3	6.4	12.3	17.6	13.4	12.0	13.6	20.7	6.2	68.6	9.0	7.6	11.8	1.5	20.2	9.2	10.4	21.1	9.4	8.6	11.7	24.6	11.7	10.9	8.8	16.5	4.9	33.2	51.1	25.5	31.7	12.8	13.7	10.6	17.2	22.3	10.8	7.2	26.6	38.7	49.4	11.2	24.4	17.8	23.8	7.7	23.3	17.3	16.0	33.7	30.3	11.7	8.2	18.1	22.1	21.4	7.2	13.5	8.1	16.5	3.6	11.0	13.0	20.8	13.1	11.4	27.9	54.6	62.2	14.3	16.1	10.3	13.5	22.3	15.3	18.0
NUP98	"NUP96, Nup98-96, Nup98-Nup96"	ENSG00000110713	"Nucleoporin 98 and 96 precursor"	P52948	11	3671083-3797792	"Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 118.7;Late spermatids: 158.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.41e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.71e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.08e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	22.9	14.7	7.2	25.1	8.4	76.0	25.3	15.1	12.4	21.8	13.8	21.1	17.8	22.2	20.7	23.1	20.8	21.6	20.8	7.2	8.8	19.3	31.9	23.4	27.6	9.8	10.5	28.4	24.0	25.7	16.7	25.6	8.3	21.9	23.6	23.2	23.3	22.3	41.9	21.2	17.7	23.4	7.1	21.9	17.6	78.4	9.1	34.4	29.1	31.0	30.6	32.7	18.6	12.7	81.2	63.7	51.7	54.5	54.7	46.1	44.5	57.9	67.7	78.3	69.9	69.4	97.4	80.6	26.0	68.6	77.1	85.5	90.0	56.1	105.6	56.7	67.0	86.4	51.7	48.1	46.1	111.1	67.5	51.9	37.6	41.8	75.2	33.7	61.9	88.3	109.3	60.6	82.5	33.2	110.2	36.3	64.5	87.8	48.4	65.9	62.6	37.8	43.4	63.4	46.8	31.5	83.4	64.9	38.1	52.0	40.5	43.4	45.9	59.9	51.1	67.5	53.0	37.0	67.0	83.5	41.0	46.5	64.4	40.5	11.7	23.3	15.0	15.0	15.1	12.8	14.7	13.5	14.3	10.8	16.1	14.4	35.2	9.7	9.5	3.9	20.1	13.3	7.2	8.4	15.1	12.4	7.2	8.8	9.8	10.5	8.3	7.1	9.1	12.7	24.7	28.9	25.2	32.7	37.4	49.8	36.3	12.6	34.7	14.9	28.2	24.5	19.5	22.8	20.1	7.3	16.7	22.2	41.6	18.8	3.9	12.2	118.7	32.1	30.4	22.5	21.5	42.5	43.6	11.8	17.5	22.7	42.3	62.0	18.3	16.3	15.7	23.6	16.8	15.2	43.7	15.1	6.1	19.8	51.1	158.6	17.1	29.3	16.0	25.3	24.9	11.1	12.3	31.7	44.4	13.2	16.1	14.3	36.3	25.1	11.8	9.0	16.6	14.1	32.9	36.9	23.2	56.2	31.0	30.3	50.4	46.5	44.5	13.7	19.5	32.5
NUS1	"C6orf68, MGC7199, NgBR, TANGO14"	ENSG00000153989	"NUS1 dehydrodolichyl diphosphate synthase subunit"	Q96E22	6	117675469-117710727	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Angiogenesis, Differentiation, Lipid metabolism"	"Developmental protein, Receptor, Transferase"	"Congenital disorder of glycosylation, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027504	Supported		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	"Plasma membrane"	"HPA027504: AB_10603124"	"unprognostic (1.21e-2)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (1.09e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.26e-3)"	"unprognostic (1.42e-3)"	"unprognostic (2.42e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.97e-2)"	17.8	20.0	12.1	22.2	13.0	19.4	22.2	11.4	15.5	60.3	16.1	19.8	16.5	20.6	28.4	15.7	18.4	16.1	11.7	12.9	13.8	28.4	31.6	18.2	21.4	10.8	12.5	16.5	20.4	29.8	11.9	21.6	11.9	20.6	20.3	12.5	30.5	17.6	10.0	11.1	17.6	18.7	11.7	17.8	24.2	12.6	13.5	18.5	35.4	12.6	20.6	23.5	11.7	12.4	27.1	19.5	41.3	46.4	40.7	52.9	101.0	48.3	50.1	39.5	45.1	44.6	29.5	63.4	51.1	44.7	50.0	24.0	62.1	47.2	73.0	47.9	57.0	72.8	31.5	80.2	62.6	92.8	41.2	46.6	52.5	43.3	87.7	40.3	41.3	46.5	88.4	54.9	59.7	30.5	43.9	58.8	48.0	36.9	35.3	41.7	29.7	45.7	79.0	26.6	48.7	38.5	29.1	37.4	36.9	45.6	23.8	95.9	36.4	24.3	30.1	39.2	70.5	75.6	60.8	66.8	57.6	70.0	49.7	1.9	1.3	0.8	1.3	1.4	1.9	1.1	1.6	1.8	1.5	1.0	1.3	1.7	0.1	1.9	2.5	3.8	1.7	1.0	12.1	13.0	11.4	15.5	12.9	13.8	10.8	12.5	11.9	11.7	13.5	12.4	18.7	0.0	22.3	30.3	28.5	60.5	41.9	32.6	19.4	15.3	26.6	13.7	6.3	15.7	24.0	25.8	10.4	26.8	38.1	26.4	27.4	23.4	16.0	15.7	28.9	24.3	13.1	19.1	33.4	30.2	63.6	22.8	38.2	21.4	31.1	15.8	28.2	39.7	35.3	15.2	37.1	29.3	20.3	37.0	42.2	14.0	18.0	30.2	32.0	20.6	28.4	8.3	24.7	35.7	36.5	37.4	22.7	20.3	57.5	73.1	18.6	33.6	23.1	9.6	6.6	21.3	25.9	24.9	25.4	25.7	56.1	57.9	26.2	14.5	26.1	77.5
NXN	"FLJ12614, NRX"	ENSG00000167693	Nucleoredoxin	Q6DKJ4	17	799310-979776	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein, Oxidoreductase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 99.2"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 91.5;Microglial cells: 87.1;Urothelial cells: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 100.7;HHSteC: 106.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023566	Approved		Approved	Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA023566: AB_1854737"	"unprognostic (1.68e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.05e-3)"	16.9	7.5	14.5	8.7	13.1	1.1	19.0	12.1	15.0	41.3	21.9	70.0	5.4	47.2	11.6	27.2	29.1	13.7	16.0	13.5	13.2	14.4	9.5	24.6	5.0	13.6	14.9	14.8	33.6	2.6	6.8	14.5	14.0	39.7	4.6	8.9	20.7	25.0	99.2	24.9	19.8	23.1	12.8	6.4	28.3	9.6	17.1	13.1	12.9	35.7	13.8	43.4	42.5	12.3	14.3	21.2	81.5	52.8	5.3	1.1	4.5	44.6	29.3	46.1	73.3	50.4	14.8	0.6	83.6	57.5	10.8	100.7	52.9	83.2	36.3	0.6	30.9	0.2	12.7	44.8	106.1	0.3	2.3	32.2	75.6	6.0	36.0	9.3	41.9	11.3	7.4	0.0	12.3	5.8	2.9	1.0	39.2	42.3	1.4	6.2	2.1	0.3	32.9	20.6	20.9	13.6	21.1	0.1	1.1	50.3	14.9	13.0	0.0	1.0	19.1	0.4	12.5	7.5	5.2	0.4	0.4	1.7	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.2	0.0	14.5	13.1	12.1	15.0	13.5	13.2	13.6	14.9	14.0	12.8	17.1	12.3	36.5	32.1	11.7	13.4	0.9	17.5	53.6	18.8	12.0	2.6	7.6	12.4	8.6	2.8	13.2	3.7	33.3	0.4	0.4	0.1	0.0	3.5	25.1	20.2	52.1	34.7	1.8	2.7	6.9	24.6	0.7	23.0	1.1	12.6	1.3	1.0	14.6	8.2	6.3	5.0	10.7	0.0	0.0	0.3	8.8	91.5	15.5	1.9	7.2	87.1	0.6	11.4	0.0	23.1	3.3	5.9	0.0	7.2	0.4	36.0	0.0	0.5	15.5	18.0	13.1	14.5	19.2	13.1	10.1	13.1	12.4	0.4	1.5	27.2	0.0	59.0
OAT	HOGA	ENSG00000065154	"Ornithine aminotransferase"	P04181	10	124397303-124418976	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 781.8"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 1222.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033576, HPA040098, HPA064742"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		12000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	Nucleoplasm	"CAB033576: AB_2298892, HPA040098: AB_10793955, HPA064742: AB_2685343"	"unprognostic (1.61e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.43e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.00e-2)"	60.0	119.6	69.4	40.8	71.2	106.4	150.1	74.6	97.4	99.7	75.4	75.6	750.0	82.5	63.7	105.0	56.0	68.7	52.3	71.2	78.7	114.6	162.5	42.7	38.1	76.5	72.0	77.0	36.1	46.1	53.5	65.0	85.2	74.3	67.2	51.1	225.4	94.6	58.2	71.6	781.8	97.8	73.6	34.1	70.1	56.2	73.3	30.2	67.7	60.0	69.1	58.9	63.8	81.7	241.5	42.8	27.5	98.7	272.4	260.8	93.4	142.2	288.0	124.2	135.2	110.5	30.8	0.5	101.0	241.8	118.0	249.4	126.5	265.7	134.0	42.4	174.9	268.1	28.1	82.7	139.9	0.4	169.3	172.1	134.5	111.9	129.5	204.9	147.1	48.4	470.8	50.0	175.5	62.6	72.1	15.3	55.1	73.2	59.6	66.3	104.5	65.3	119.8	3.9	57.3	60.9	89.7	235.1	209.5	156.6	78.6	65.8	114.3	70.5	65.3	117.9	90.2	42.4	47.6	64.6	97.4	72.0	34.4	38.0	39.6	36.0	28.8	35.3	31.2	15.2	24.0	30.5	44.3	16.2	29.5	29.8	40.0	16.9	37.2	9.4	24.6	29.6	69.4	71.2	74.6	97.4	71.2	78.7	76.5	72.0	85.2	73.6	73.3	81.7	49.0	19.2	49.7	37.9	44.7	151.3	144.0	362.8	185.5	35.2	154.2	163.7	21.8	18.6	182.7	35.0	27.1	120.8	80.3	38.2	90.1	34.6	30.4	37.0	90.4	37.7	43.1	317.0	31.8	13.4	90.5	124.2	55.5	40.6	43.8	32.2	37.5	152.2	66.2	43.7	33.4	104.1	197.4	31.8	68.1	15.2	104.1	56.7	85.4	17.8	34.8	37.4	18.6	22.1	41.9	12.6	74.6	120.0	32.9	82.6	1222.6	196.4	76.4	24.4	78.9	106.1	115.1	46.3	33.2	161.8	126.0	48.2	65.0	92.4	214.5	82.2
OBSCN	"ARHGEF30, KIAA1556, KIAA1639, UNC89"	ENSG00000154358	"Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF"	Q5VST9	1	228208044-228378876	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 481.3"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 155.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 10.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA021186, HPA065801"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		4500000	"Cluster 7: Monocytes - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA021186: AB_1854761, HPA065801: "	"unprognostic (8.47e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.99e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (5.30e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-2)"	3.5	2.5	2.4	1.4	18.4	1.6	3.7	10.4	4.4	8.1	18.1	5.2	0.7	3.7	1.8	4.6	5.1	1.1	78.5	0.9	2.7	6.6	1.3	8.9	2.1	4.3	2.7	8.6	5.4	1.1	13.6	0.9	2.4	9.9	0.5	0.8	9.4	1.7	481.3	4.7	5.4	0.5	1.0	9.3	5.2	1.9	6.3	4.9	7.5	112.8	1.3	3.2	7.4	0.1	1.7	2.8	3.6	3.7	0.2	0.2	4.6	1.6	0.7	1.7	1.4	2.1	1.3	3.2	5.4	0.7	0.7	2.1	1.3	2.2	0.3	2.0	3.4	1.7	10.5	0.1	1.2	2.4	2.2	1.4	0.6	0.4	0.5	5.1	0.5	7.0	3.2	0.0	0.3	1.8	3.3	3.5	4.9	0.6	2.1	4.4	0.0	1.9	1.8	1.4	1.7	6.3	0.6	3.9	1.0	0.8	3.4	4.0	1.0	0.0	5.1	0.3	0.5	2.5	0.5	4.7	0.0	0.8	2.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.1	2.4	18.4	10.4	4.4	0.9	2.7	4.3	2.7	2.4	1.0	6.3	0.1	1.5	0.0	5.5	1.6	2.4	2.2	6.6	7.7	23.9	4.2	7.3	11.9	155.8	4.3	4.5	5.5	10.4	0.1	1.9	0.7	11.7	3.6	4.9	3.9	3.7	3.1	0.0	3.0	3.9	0.5	0.5	5.7	3.1	11.3	7.0	1.8	1.4	0.5	0.1	0.0	5.3	2.7	4.1	0.3	1.0	4.5	3.1	1.1	1.8	5.6	0.5	7.9	4.1	1.5	1.7	0.8	1.1	4.5	1.5	3.8	0.6	4.1	1.3	3.2	0.0	22.9	6.1	1.0	4.1	9.4	1.7	1.2	5.4	6.2	1.2	3.6
OCA2	"BEY, BEY1, BEY2, D15S12, EYCL, EYCL2, EYCL3, P"	ENSG00000104044	"OCA2 melanosomal transmembrane protein"	Q04671	15	27754875-28099315	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Albinism, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"choroid plexus: 28.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 30.9;Inhibitory neurons: 40.8;Melanocytes: 42.7;Peritubular cells: 14.7"	"Cancer enriched"	"Detected in many"	17	"melanoma: 19.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SK-MEL-30: 24.6"	"Low region specificity"	"Detected in some"							HPA036402			Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Cytosol	"HPA036402: "	"unprognostic (6.07e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (4.60e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.20e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.28e-2)"	0.3	0.0	1.8	0.1	1.8	0.0	0.3	0.1	1.8	1.2	28.1	0.1	0.0	0.2	0.3	2.2	1.1	0.0	0.3	1.4	1.8	0.3	0.1	0.6	1.8	0.5	0.9	0.3	0.0	0.0	0.8	1.5	0.6	0.6	0.0	0.0	0.8	1.0	0.2	6.4	0.2	0.0	0.0	1.1	0.1	1.9	2.4	0.4	4.2	0.0	0.7	0.2	2.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.1	5.6	0.0	0.0	24.6	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.8	0.1	1.8	1.4	1.8	0.5	0.9	0.6	0.0	2.4	1.0	0.0	0.0	0.0	0.7	0.0	2.0	0.1	0.1	0.6	0.0	0.0	0.4	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.4	5.6	0.2	0.1	0.0	0.0	30.9	0.0	0.1	1.4	0.0	2.8	0.0	2.3	0.0	0.0	0.1	0.0	40.8	0.1	0.0	0.0	0.9	3.0	9.3	0.1	42.7	0.0	0.0	0.0	0.0	2.5	0.8	0.0	1.2	14.7	0.0	0.0	0.0	0.1	2.0	0.0	0.0	1.0	0.8	4.2	4.9	6.1	0.9	0.1	0.1	0.4	0.1	0.2
OCLN	PPP1R115	ENSG00000197822	Occludin	Q16625	5	69492292-69558104	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 31.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 109.0;Glandular and luminal cells: 119.7;Urothelial cells: 224.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in many"		"A-431: 23.3;CAPAN-2: 39.8;HaCaT: 33.4;RPTEC TERT1: 25.7;SK-BR-3: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005933, CAB013075, CAB068212, CAB068213, CAB068214"	Enhanced		Supported	"Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cell Junctions"		"CAB013075: AB_2533101, CAB068212: AB_2665711, CAB068213: AB_2665712, CAB068214: AB_2665713, HPA005933: AB_1079520"	"unprognostic (2.28e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.25e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (6.59e-11)"	"unprognostic (2.83e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.35e-1)"	1.2	0.7	6.2	1.6	6.5	1.8	7.8	7.2	6.7	6.8	22.2	11.0	10.3	2.1	4.0	11.6	7.5	8.5	1.5	5.9	5.4	11.0	18.8	15.1	0.6	9.3	7.7	2.3	20.2	8.3	3.4	3.9	8.3	3.5	11.2	2.3	6.7	4.6	0.6	11.3	10.0	0.6	5.4	2.1	15.2	2.4	6.5	0.9	31.4	0.6	2.8	5.0	7.9	7.4	23.3	4.5	0.6	0.9	0.6	0.9	15.1	0.3	1.6	2.5	3.3	20.7	39.8	0.5	5.9	1.1	8.3	33.4	7.2	4.3	7.8	0.3	12.2	2.4	1.1	9.8	0.3	1.2	2.5	0.1	6.4	4.1	1.0	1.6	1.4	3.1	0.1	0.4	0.1	22.4	1.5	1.2	3.1	8.0	2.1	0.2	6.0	1.1	25.7	22.2	2.7	2.8	0.3	27.2	0.9	5.0	14.7	4.0	1.2	0.4	7.7	1.8	2.7	0.5	0.4	0.3	0.3	0.3	0.6	1.0	0.2	0.5	0.2	0.1	0.2	0.3	0.2	0.1	0.1	0.4	0.2	0.2	2.7	0.5	0.1	0.4	0.1	0.1	6.2	6.5	7.2	6.7	5.9	5.4	9.3	7.7	8.3	5.4	6.5	7.4	4.8	109.0	67.3	1.6	3.2	3.7	60.8	7.6	1.8	5.7	49.7	16.9	1.4	64.3	51.0	25.8	14.6	30.3	3.6	94.1	9.8	65.6	1.9	78.5	12.1	10.7	26.3	2.5	1.3	61.6	2.5	5.8	46.4	119.7	2.5	6.5	18.2	48.3	3.0	6.7	1.1	45.1	16.2	12.9	1.2	1.6	3.1	2.4	1.8	16.9	3.9	2.8	1.0	0.5	1.5	64.6	61.8	1.5	1.1	101.5	42.3	10.5	63.0	6.3	13.1	3.3	4.4	4.7	8.2	29.5	15.5	16.4	4.3	0.7	47.9	224.0
OCRL	"Dent-2, OCRL1"	ENSG00000122126	"OCRL inositol polyphosphate-5-phosphatase"	Q01968	X	129539849-129592561	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Hydrolase	"Cataract, Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 3.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.2;monocytes: 3.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012495	Approved		Approved	"Microtubules,Centriolar satellite,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Microtubules, Centriolar satellite"	"HPA012495: AB_1851804"	"prognostic unfavorable (2.93e-5)"	"unprognostic (3.17e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.34e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.08e-3)"	"unprognostic (2.56e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.10e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	13.9	23.8	12.4	4.7	13.2	5.0	12.7	5.3	13.6	14.9	27.2	16.4	8.0	19.4	16.1	11.6	16.7	8.3	10.7	13.1	20.3	9.5	15.7	10.0	2.8	9.6	14.0	28.4	13.0	34.6	25.6	11.2	17.4	18.5	12.4	9.9	11.0	21.3	14.8	12.4	12.2	15.0	7.6	7.9	14.5	24.6	18.6	4.4	16.8	6.7	3.0	22.8	12.3	8.6	19.3	20.5	17.0	18.7	29.3	24.1	17.1	28.5	22.3	28.2	26.3	14.2	13.3	1.5	46.7	24.1	33.0	11.6	30.5	20.9	29.2	0.1	21.5	5.8	18.5	14.1	21.1	5.7	0.6	20.7	27.3	28.3	27.3	27.7	21.2	8.4	7.9	13.6	28.7	24.2	4.3	8.2	6.2	24.4	30.9	4.2	17.6	11.5	16.1	19.1	20.5	26.1	13.5	18.0	14.6	21.5	13.2	10.0	19.3	23.0	10.6	24.6	29.1	3.8	3.3	3.7	16.2	21.4	18.8	0.0	1.0	0.0	0.1	1.1	0.3	0.1	0.0	0.0	1.2	0.1	0.2	0.1	0.1	0.0	3.6	0.4	0.0	0.4	12.4	13.2	5.3	13.6	13.1	20.3	9.6	14.0	17.4	7.6	18.6	8.6	6.7	3.2	7.8	14.4	2.6	4.7	3.4	5.4	3.4	9.9	9.3	5.6	10.3	4.3	8.8	18.4	6.2	6.4	0.3	14.4	3.9	5.3	31.2	4.9	6.9	6.4	17.5	3.8	20.0	3.6	5.4	7.8	11.7	6.1	0.0	17.0	8.2	11.5	5.0	13.5	23.1	11.8	6.1	11.8	4.0	8.9	23.0	5.8	8.8	21.5	4.3	9.6	0.0	17.6	21.0	8.5	8.3	34.3	1.4	5.9	15.7	5.2	5.4	7.2	0.0	4.5	6.0	6.8	14.6	8.3	7.4	5.7	1.0	7.6	12.2	8.4
OGG1	"HMMH, HOGG1, MUTM, OGH1"	ENSG00000114026	"8-oxoguanine DNA glycosylase"	O15527	3	9749944-9788219	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027514, CAB047301"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"CAB047301: , HPA027514: AB_10602189"	"unprognostic (6.95e-2)"	"unprognostic (7.82e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.24e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (7.83e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.43e-3)"	"unprognostic (9.66e-3)"	"unprognostic (4.23e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (2.06e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.59e-1)"	12.6	13.8	18.6	13.2	18.3	12.2	12.8	20.5	19.6	18.2	12.5	14.8	18.9	17.1	10.3	9.6	16.9	8.4	11.8	19.6	15.8	30.3	20.7	10.7	26.2	18.8	16.7	22.5	10.6	6.6	10.8	8.6	17.9	15.7	8.1	12.1	12.2	10.1	7.2	9.6	17.2	9.8	16.2	15.2	12.4	8.6	17.5	13.5	13.1	8.0	21.2	15.3	14.3	17.4	11.3	20.7	20.3	13.1	19.9	22.3	38.4	14.5	14.8	21.6	25.6	19.9	10.8	68.5	9.5	18.3	34.1	10.8	12.1	15.9	9.0	25.1	17.6	33.9	32.5	29.3	20.7	13.3	20.9	22.3	20.0	37.4	16.0	17.4	27.3	9.6	11.0	10.9	20.9	21.3	10.7	13.2	11.0	10.3	29.3	7.8	13.7	22.4	12.4	5.7	9.0	15.9	18.4	15.2	11.5	10.4	23.7	22.9	17.5	21.9	22.7	17.2	24.0	10.7	16.9	35.9	17.4	37.9	13.7	15.1	10.9	20.7	18.7	9.0	18.4	13.9	15.8	15.3	9.8	16.5	12.1	11.5	2.9	27.0	7.3	15.9	21.0	10.9	18.6	18.3	20.5	19.6	19.6	15.8	18.8	16.7	17.9	16.2	17.5	17.4	9.5	0.0	3.4	15.3	16.7	5.5	8.9	8.3	9.1	20.9	6.7	7.4	2.3	10.0	4.9	9.2	35.5	6.4	16.5	9.0	11.7	7.7	0.9	5.0	12.2	10.4	18.0	22.3	11.2	6.7	10.1	11.7	6.1	4.4	2.5	10.0	10.0	11.8	18.0	8.4	9.2	8.8	6.1	9.0	5.8	1.8	14.3	9.3	7.2	10.3	15.8	11.3	27.8	13.0	9.9	8.8	11.0	13.5	10.0	5.2	47.1	86.3	4.1	34.7	26.3	11.1	10.3	10.2	21.5	5.0	4.5	4.0	12.9	12.0	14.0	5.4
OGT	"FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1"	ENSG00000147162	"O-linked N-acetylglucosamine (GlcNAc) transferase"	O15294	X	71533104-71575892	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	"Chromatin regulator, Glycosyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030751, HPA030752, HPA030753, HPA030754, CAB034099"	Approved		Supported	"Nucleoplasm,Plasma membrane"		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Plasma membrane"	"CAB034099: AB_2157067, HPA030751: AB_10600217, HPA030752: AB_10601445, HPA030753: AB_2673594, HPA030754: AB_2673595"	"unprognostic (1.37e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (3.40e-2)"	"prognostic favorable (1.97e-4)"	"unprognostic (9.56e-3)"	"unprognostic (1.96e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.74e-3)"	"prognostic unfavorable (2.36e-6)"	"unprognostic (2.99e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.03e-3)"	"prognostic favorable (6.85e-7)"	59.3	55.9	39.7	38.3	42.4	61.5	62.7	43.3	51.6	72.7	40.1	62.5	30.6	56.0	62.2	52.8	76.4	26.4	55.5	43.9	35.5	61.6	45.8	70.7	71.9	36.1	35.8	85.5	102.4	24.3	46.9	26.4	37.9	75.4	39.6	36.9	64.1	27.1	62.8	68.6	86.4	24.5	36.1	122.8	67.4	19.0	36.2	57.2	70.7	39.2	57.8	55.7	67.4	44.3	40.5	37.0	47.1	41.5	49.6	45.6	31.6	30.3	54.3	32.1	49.1	39.3	45.4	47.9	20.7	37.3	33.3	49.1	52.0	29.5	39.4	41.1	53.4	30.4	98.6	28.5	37.6	62.9	48.1	43.6	59.2	35.1	65.7	55.5	30.5	100.7	31.1	160.4	31.1	34.3	48.9	75.2	31.6	35.5	49.8	47.8	52.7	62.1	50.0	45.9	24.1	21.2	46.9	30.9	30.2	35.5	22.8	42.4	35.5	34.6	27.9	36.6	17.9	43.5	33.5	56.5	24.4	65.0	21.6	2.8	4.6	2.0	7.5	5.7	6.8	7.4	6.3	6.2	6.1	6.2	7.2	7.4	1.9	10.4	5.7	6.2	6.2	5.6	39.7	42.4	43.3	51.6	43.9	35.5	36.1	35.8	37.9	36.1	36.2	44.3	31.1	35.3	85.2	52.9	67.2	88.1	37.9	23.5	58.6	26.5	49.6	34.0	42.8	20.0	31.1	49.7	8.4	15.8	130.7	31.1	9.8	14.4	2.4	32.1	49.8	39.8	34.9	51.3	110.7	14.4	8.5	47.5	54.6	53.3	27.8	26.4	45.7	27.5	16.1	40.4	94.6	37.3	22.4	60.9	69.7	4.8	53.4	45.8	35.6	71.2	51.6	11.3	51.5	92.0	97.9	17.6	34.9	29.7	147.2	53.8	34.8	15.1	28.0	21.8	32.9	44.8	42.2	2.5	6.1	63.3	84.1	10.9	82.1	62.0	34.0	50.8
OPA1	"FLJ12460, KIAA0567, MGM1, NPG, NTG"	ENSG00000198836	"OPA1 mitochondrial dynamin like GTPase"	O60313	3	193593144-193697811	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Sensory transduction, Vision"	Hydrolase	"Cardiomyopathy, Deafness, Disease variant, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036926, HPA036927"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA		10000	"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Mitochondria"		"HPA036926: AB_10671247, HPA036927: AB_2675388"	"unprognostic (2.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (1.62e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.44e-5)"	"unprognostic (3.48e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (2.92e-1)"	"unprognostic (4.75e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.21e-1)"	15.0	12.0	14.3	7.6	17.4	25.6	12.8	15.2	19.5	10.4	9.4	18.9	16.8	10.9	9.1	14.6	8.1	10.2	39.3	18.6	17.4	18.3	20.9	8.5	11.8	16.4	15.4	8.4	10.1	23.1	3.8	11.7	16.8	12.3	16.6	9.6	11.7	13.3	24.2	11.9	13.8	13.5	12.4	9.3	14.6	6.3	15.2	12.7	13.9	44.5	12.4	13.0	5.1	13.7	58.9	18.8	18.2	20.2	15.8	25.0	19.3	27.5	26.2	30.0	29.0	45.2	19.3	38.6	58.1	27.0	27.3	37.3	32.7	31.7	53.5	46.5	25.7	67.9	16.7	23.1	24.9	55.8	29.8	28.4	27.6	30.0	40.9	18.5	26.2	15.7	28.4	37.0	30.2	46.5	21.9	30.9	25.8	33.9	59.9	27.8	40.1	41.6	22.7	36.1	39.8	24.2	41.8	46.3	29.5	14.1	60.3	43.5	26.3	27.7	20.8	29.3	58.7	33.1	41.3	74.0	30.5	43.7	28.4	9.7	7.3	7.1	5.8	8.2	5.5	6.8	5.5	5.6	7.8	5.1	5.6	6.0	2.7	4.7	17.3	4.0	6.6	5.2	14.3	17.4	15.2	19.5	18.6	17.4	16.4	15.4	16.8	12.4	15.2	13.7	24.8	16.0	24.0	72.1	27.5	15.9	16.4	17.4	24.5	19.5	20.9	13.5	135.2	22.8	20.1	18.4	31.3	19.0	24.6	31.4	17.6	19.3	7.7	20.3	25.2	23.8	23.4	86.3	106.8	24.0	14.9	24.6	31.1	26.1	19.6	25.6	14.3	39.1	17.9	21.9	106.7	20.6	10.2	25.6	14.7	13.5	15.8	28.1	21.4	58.1	22.9	14.6	11.3	87.4	98.1	28.9	12.1	14.7	29.3	18.7	24.6	34.1	19.6	23.4	6.6	21.3	26.2	15.1	16.6	34.3	22.4	17.9	22.3	28.2	26.7	22.1
OPLAH	"5-Opase, OPLA"	ENSG00000178814	"5-oxoprolinase, ATP-hydrolysing"	O14841	8	144051266-144063965	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 66.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 115.7;Late spermatids: 231.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.1;neutrophil: 1.1"	"Group enriched"	"Detected in many"	9	"granulocytes: 1.1;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 33.9;BEWO: 21.0;Hep G2: 18.8;PC-3: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026562, HPA028260, HPA052429"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA		34000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"		"HPA026562: AB_1854804, HPA028260: AB_10601383, HPA052429: AB_2681830"	"unprognostic (7.89e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.87e-3)"	"unprognostic (2.04e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.62e-1)"	"prognostic favorable (1.53e-6)"	"unprognostic (4.03e-3)"	"unprognostic (4.33e-1)"	"unprognostic (3.54e-2)"	"unprognostic (8.24e-2)"	9.2	14.8	3.3	1.9	5.6	2.7	8.6	8.1	3.7	6.4	5.7	15.0	13.8	4.8	0.6	15.6	4.2	2.5	35.1	2.9	2.7	15.8	34.3	6.4	0.8	12.2	5.6	5.7	10.0	6.7	3.2	1.3	12.5	8.9	2.2	0.3	11.2	5.7	34.2	13.3	12.2	1.1	3.9	9.1	19.7	66.5	5.3	0.3	5.9	15.4	0.5	4.8	9.5	6.5	4.2	4.2	0.4	33.9	1.5	3.1	21.0	2.1	1.3	1.2	0.7	8.1	7.8	0.0	6.8	3.8	0.0	5.5	1.0	3.1	0.1	1.1	0.0	1.4	7.0	18.8	10.5	0.1	0.0	4.4	13.8	1.4	0.0	0.0	0.2	5.8	5.1	0.0	0.0	4.8	0.3	3.3	2.8	6.5	26.2	0.4	0.0	5.6	3.6	5.1	1.2	0.1	0.0	1.4	0.1	0.4	8.8	4.6	0.2	0.0	5.5	0.0	1.4	1.1	1.5	1.1	0.5	1.1	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.4	3.3	5.6	8.1	3.7	2.9	2.7	12.2	5.6	12.5	3.9	5.3	6.5	1.1	3.2	3.2	9.1	0.8	2.0	2.8	4.4	3.4	1.1	6.1	6.1	2.9	7.2	4.7	9.2	0.0	1.7	0.2	37.6	11.7	3.8	115.7	2.6	2.7	1.1	1.2	0.0	0.2	2.7	2.7	2.7	18.3	5.5	0.0	6.0	2.2	25.1	2.4	0.0	0.3	10.0	4.1	6.0	0.5	231.7	2.5	3.4	0.0	1.0	2.1	4.3	0.0	0.5	2.6	3.6	13.1	3.8	0.6	1.9	23.8	13.3	2.2	0.1	0.0	3.6	2.2	3.1	2.3	7.2	1.8	2.5	0.6	10.2	18.2	3.0
OPN1LW	"CBBM, CBP, COD5, RCP"	ENSG00000102076	"Opsin 1, long wave sensitive"	P04000	X	154144243-154159032	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2568	"retina: 256.7"	"Cell type enriched"	"Detected in some"	20	"Cone photoreceptor cells: 725.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 9: Photoreceptor cells - Phototransduction"													"unprognostic (6.05e-2)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	256.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	725.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPN1MW	"CBBM, CBD, COD5, GCP, OPN1MW1"	ENSG00000268221	"Opsin 1, medium wave sensitive"	P04001	X	154182596-154196861	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	133	"retina: 13.3"	"Cell type enriched"	"Detected in single"	111	"Cone photoreceptor cells: 33.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 9: Photoreceptor cells - Phototransduction"																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
OPN1SW	"BCP, BOP, CBT"	ENSG00000128617	"Opsin 1, short wave sensitive"	P03999	7	128772485-128775794	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	84	"retina: 41.0"	"Cell type enriched"	"Detected in some"	12	"Cone photoreceptor cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"LHCN-M2: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA013562, HPA014083"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nuclear bodies, Cytokinetic bridge, Cytosol"	"HPA013562: AB_2668850, HPA014083: AB_2668938"	"unprognostic (2.88e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (8.50e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (2.26e-8)"	"prognostic unfavorable (5.98e-8)"	"unprognostic (2.53e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (9.33e-4)"	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	41.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPTN	"FIP-2, FIP2, GLC1E, HIP7, HYPL, NRP, TFIIIA-INTP"	ENSG00000123240	Optineurin	Q96CV9	10	13099449-13138308	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Host-virus interaction, Immunity, Innate immunity"		"Amyotrophic lateral sclerosis, Disease variant, Glaucoma, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"skeletal muscle: 879.4;tongue: 394.5"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 933.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003279, HPA003360, CAB019303"	Approved		Enhanced	Cytosol		NA	NA		370000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"CAB019303: , HPA003279: AB_1079527, HPA003360: AB_1079528"	"unprognostic (2.84e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.79e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.58e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.15e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.14e-1)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (7.62e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	92.7	90.4	45.7	35.8	53.5	50.1	64.0	45.9	55.9	52.3	36.8	55.4	63.2	39.7	21.9	61.8	37.7	41.6	105.7	54.9	49.2	72.3	73.8	58.9	45.7	48.0	53.9	92.1	35.4	33.1	33.8	57.5	52.9	34.1	57.2	48.8	46.3	41.4	879.4	77.9	69.6	43.4	44.3	57.3	56.1	72.8	45.4	30.1	27.1	394.5	37.6	43.8	56.3	49.0	83.3	23.1	12.8	17.8	171.4	175.6	15.2	97.6	110.7	72.1	119.0	41.1	108.1	0.7	37.6	134.3	113.2	75.6	17.3	93.5	54.8	192.9	9.2	17.2	32.1	22.0	175.4	0.6	59.5	94.6	72.6	69.2	71.8	177.9	62.4	23.8	21.5	123.7	98.7	17.6	8.3	2.3	5.2	22.4	10.3	1.4	25.5	8.5	87.9	57.6	2.8	13.6	84.9	25.0	64.3	49.9	54.6	11.4	171.6	58.8	28.9	81.0	27.5	63.3	23.5	0.6	88.3	14.3	11.4	47.9	2.5	0.3	56.1	1.5	43.3	18.0	71.2	65.8	0.5	11.7	28.0	34.5	1.7	51.2	3.8	5.2	109.6	30.2	45.7	53.5	45.9	55.9	54.9	49.2	48.0	53.9	52.9	44.3	45.4	49.0	68.2	67.3	29.4	18.6	25.9	74.4	46.6	104.5	67.2	38.7	30.5	32.9	237.7	68.6	81.3	31.3	18.8	112.8	89.8	199.8	33.2	135.5	281.9	36.0	38.6	82.4	42.6	126.5	48.9	114.0	39.8	91.6	88.7	37.4	70.8	92.8	47.8	30.9	31.6	90.9	26.6	106.4	65.1	15.1	26.0	933.6	95.7	14.5	90.7	25.3	36.6	36.4	119.4	13.6	28.1	166.3	186.9	103.4	86.3	92.3	209.9	162.4	73.7	103.4	111.7	63.1	106.6	102.0	13.7	58.1	77.9	75.4	107.5	166.3	44.1	75.0
ORAI1	"CRACM1, FLJ14466, TMEM142A"	ENSG00000276045	"ORAI calcium release-activated calcium modulator 1"	Q96D31	12	121626550-121642677	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 60.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 92.3;NK-cells: 88.6;Theca cells: 86.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 81.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016583	Approved					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA016583: AB_1848720"	"unprognostic (2.22e-2)"	"unprognostic (3.78e-3)"	"unprognostic (7.82e-3)"	"unprognostic (8.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.00e-2)"	"prognostic favorable (4.30e-4)"	"unprognostic (1.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-2)"	10.8	5.4	4.4	9.6	4.6	8.8	10.9	5.2	6.8	7.3	22.1	10.6	20.8	7.6	0.0	8.7	7.7	3.3	9.3	3.8	4.9	11.2	12.3	15.5	12.0	5.5	4.9	6.7	8.1	8.7	2.6	4.5	5.5	6.4	0.3	0.0	15.6	2.6	60.1	46.6	13.8	2.2	5.4	23.1	12.5	11.5	5.1	6.1	10.4	14.0	2.8	11.1	7.8	5.1	18.3	42.0	3.4	16.9	4.0	4.9	18.4	20.5	2.9	8.8	4.7	33.1	16.2	13.3	31.4	3.1	11.8	30.2	3.4	13.7	0.0	41.9	7.8	23.9	6.8	16.6	10.1	18.5	43.7	2.0	5.1	14.4	0.9	4.9	12.9	30.0	16.8	6.9	2.3	41.4	46.1	81.7	19.6	10.3	35.7	16.8	7.9	20.5	5.0	13.4	16.4	3.3	10.7	11.7	17.5	0.2	29.3	11.6	23.5	21.0	8.4	28.6	15.9	9.4	8.7	5.6	15.7	25.9	19.1	9.4	6.3	8.2	18.6	5.4	13.9	6.3	15.4	18.8	7.5	9.0	14.3	12.5	6.9	7.5	5.2	1.9	13.7	7.6	4.4	4.6	5.2	6.8	3.8	4.9	5.5	4.9	5.5	5.4	5.1	5.1	32.0	28.9	16.4	1.0	41.0	22.6	10.1	3.4	6.8	2.1	48.4	22.9	4.2	18.6	10.3	1.8	4.2	3.7	92.3	8.4	1.9	13.3	3.4	14.1	11.1	40.6	2.4	23.8	0.3	19.5	15.2	9.5	8.6	17.4	7.0	24.0	43.2	17.9	38.6	0.0	0.5	9.3	2.0	28.2	65.0	11.8	13.4	42.8	21.4	4.7	27.2	5.8	88.6	3.0	1.5	29.5	6.3	9.4	30.5	14.8	17.2	12.1	6.3	6.9	0.0	6.3	10.8	1.7	6.0	6.9	37.4	7.8	70.3	86.0	20.1	10.7
OSGEP	"GCPL1, KAE1, OSGEP1, PRSMG1, TCS3"	ENSG00000092094	"O-sialoglycoprotein endopeptidase"	Q9NPF4	14	20446401-20455089	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Acyltransferase, Transferase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039751	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Plasma membrane"	"HPA039751: AB_10794754"	"prognostic favorable (1.48e-4)"	"unprognostic (4.15e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.80e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (4.64e-6)"	"unprognostic (4.83e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.91e-2)"	5.7	6.3	6.1	3.8	6.2	6.1	7.0	6.4	7.3	6.8	6.8	7.6	3.8	6.4	8.5	6.0	6.1	6.6	8.1	6.0	6.3	5.8	11.1	6.2	9.3	6.4	6.1	5.3	5.6	7.4	5.2	6.7	6.4	4.9	7.0	4.1	5.3	8.3	10.5	4.7	6.2	5.6	6.5	8.4	6.4	2.4	6.3	9.9	7.6	9.9	10.1	8.2	4.9	6.9	10.3	17.2	5.6	16.2	9.9	6.6	17.6	8.0	11.3	21.1	20.1	21.5	12.3	21.1	10.3	11.0	9.0	8.6	17.9	17.6	14.1	16.8	19.1	14.8	12.2	32.1	7.4	24.3	19.7	5.3	5.2	26.1	14.0	4.6	14.3	18.8	14.0	12.1	17.6	21.0	25.0	11.8	9.1	31.5	31.8	35.3	10.3	12.4	12.8	11.7	21.3	4.2	15.4	16.0	11.9	3.3	9.7	23.7	6.1	8.7	21.2	11.3	10.7	3.4	18.0	31.7	5.0	36.1	11.0	9.3	29.2	38.5	18.8	27.9	17.4	28.7	19.7	17.2	44.5	38.1	15.9	17.4	13.8	20.9	23.3	16.9	19.2	24.6	6.1	6.2	6.4	7.3	6.0	6.3	6.4	6.1	6.4	6.5	6.3	6.9	27.1	35.3	34.9	16.3	46.0	11.5	20.9	26.2	14.2	37.8	24.0	25.1	17.2	15.7	29.1	23.9	37.5	66.3	31.8	22.5	35.2	24.7	3.1	19.2	18.3	24.1	26.9	19.6	23.0	29.8	47.0	23.4	28.1	16.3	25.9	24.6	25.7	19.3	65.8	10.1	24.1	24.2	22.4	30.7	32.8	3.0	19.3	34.2	21.4	7.5	28.4	31.0	32.0	16.6	17.0	20.0	30.6	21.4	26.2	10.9	42.2	39.7	25.5	51.5	13.1	24.6	23.9	7.8	16.9	22.0	11.5	46.1	26.8	37.3	31.6	17.4
OSTM1	"GL, HSPC019"	ENSG00000081087	"Osteoclastogenesis associated transmembrane protein 1"	Q86WC4	6	108041409-108165854	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			Osteopetrosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Melanocytes: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010851	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No		210000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Cytosol	"Nucleoplasm, Vesicles"	"HPA010851: AB_1079533"	"prognostic unfavorable (4.36e-4)"	"unprognostic (4.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.72e-3)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (9.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.34e-6)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.77e-1)"	26.1	19.1	4.7	17.9	5.2	5.7	9.8	5.1	5.8	10.4	33.1	12.2	7.9	13.7	9.0	12.7	9.5	12.5	19.2	5.3	9.2	15.6	13.1	16.2	14.7	6.0	7.6	7.5	5.8	15.3	8.3	14.1	7.9	13.8	11.1	17.6	8.9	16.7	11.8	9.8	9.0	23.3	5.3	18.3	8.5	10.1	7.4	13.7	10.7	11.5	13.5	16.9	7.0	8.3	6.0	17.2	20.1	29.4	59.0	19.0	28.6	42.8	42.7	30.7	50.4	10.0	9.8	13.7	34.4	30.0	82.5	11.1	20.2	14.6	47.0	31.6	15.7	28.9	10.9	12.8	45.6	32.1	64.6	28.1	35.7	37.7	30.0	28.2	15.8	15.2	23.3	48.7	50.3	8.4	7.1	7.3	8.0	7.1	13.0	11.4	29.1	7.5	22.0	15.7	2.2	11.8	34.7	8.7	79.9	26.6	10.0	45.8	19.3	26.7	9.8	59.7	61.4	18.6	34.4	11.9	78.9	21.3	60.3	31.4	20.2	22.8	20.3	29.4	21.5	14.7	16.9	22.3	17.8	8.6	15.6	19.8	29.8	22.0	43.5	12.9	22.6	27.0	4.7	5.2	5.1	5.8	5.3	9.2	6.0	7.6	7.9	5.3	7.4	8.3	28.5	9.6	19.0	26.4	26.0	46.7	19.8	11.7	21.6	28.3	10.0	7.0	24.8	12.8	9.4	12.9	10.4	21.7	32.3	21.9	1.9	12.4	12.0	7.5	15.7	20.7	4.2	4.6	36.6	22.9	33.9	24.4	15.8	9.6	24.1	6.9	26.7	13.2	52.8	28.6	40.1	5.8	6.1	46.5	29.5	5.4	14.3	43.1	151.2	20.6	25.6	23.7	40.2	21.1	36.6	16.8	17.0	28.6	25.0	17.9	7.6	25.5	9.8	17.5	26.3	18.5	29.6	28.0	18.7	12.4	31.1	61.2	29.5	23.7	3.3	16.0
OTC	OTCase	ENSG00000036473	"Ornithine carbamoyltransferase"	P00480	X	38352586-38421446	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	124	"intestine: 112.4;liver: 377.8"	"Group enriched"	"Detected in some"	5	"Hepatic stellate cells: 38.9;Hepatocytes: 99.6;Proximal enterocytes: 82.0;Undifferentiated cells: 25.3"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 59.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000243, HPA000570"	Enhanced		Supported	Mitochondria		NA	NA		2200000		"Cluster 85: Liver - Metabolism"		"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA000243: AB_1079535, HPA000570: AB_1079534"			"unprognostic (6.93e-2)"		"unprognostic (2.48e-1)"		"unprognostic (1.89e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.19e-2)"			"unprognostic (7.70e-3)"	"unprognostic (5.61e-2)"			1.2	0.0	0.2	0.5	0.3	0.0	0.2	0.3	0.4	0.4	0.1	5.0	112.4	0.7	0.0	0.4	0.5	0.4	0.3	0.2	0.3	0.1	377.8	0.9	0.1	0.3	0.3	0.1	1.7	0.0	0.0	0.0	0.4	0.0	2.5	0.1	0.1	0.1	0.0	0.0	87.4	0.5	0.3	0.0	1.9	0.4	0.3	0.0	0.3	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.4	0.2	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.0	0.0	1.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	7.4	0.1	0.0	1.7	1.2	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	38.9	99.6	0.0	0.0	0.5	8.3	0.0	3.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.9	0.0	0.0	0.0	82.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.3	0.0	25.3	0.0
OTUD6B	"CGI-77, DUBA5"	ENSG00000155100	"OTU deubiquitinase 6B"	Q8N6M0	8	91070196-91087095	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024046, HPA024503, HPA024772"	Approved	Approved	Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA024046: AB_10600925, HPA024503: AB_1854845, HPA024772: AB_1854846"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.78e-3)"	"unprognostic (4.91e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.78e-2)"	"unprognostic (5.71e-2)"	6.6	6.2	5.7	6.3	6.1	5.9	7.2	5.9	8.6	5.2	5.0	5.3	4.2	6.0	4.6	6.4	4.2	3.9	6.5	5.4	6.1	5.4	5.4	4.7	7.4	6.2	6.2	5.3	4.6	4.0	3.5	8.0	6.3	5.8	5.4	3.1	4.3	4.7	10.2	6.4	4.4	5.5	6.3	5.0	4.3	6.4	5.9	5.7	6.0	9.2	6.1	6.3	5.4	7.5	27.6	11.1	12.8	10.4	6.4	5.6	14.5	19.1	7.4	19.1	12.6	8.6	16.6	25.6	9.0	10.2	7.6	9.1	26.4	16.1	31.6	21.6	16.9	34.5	11.7	8.3	13.3	18.7	21.0	7.2	9.8	14.0	35.5	11.6	17.5	19.4	36.5	19.1	18.9	9.6	31.7	17.5	8.1	20.3	27.3	19.4	11.2	28.9	18.9	15.1	3.5	14.6	2.6	55.9	22.7	16.3	25.5	11.8	15.8	12.3	17.2	20.6	20.5	17.1	29.5	37.2	16.8	26.2	23.1	1.7	1.9	1.1	1.5	2.7	2.0	2.0	1.4	1.7	2.6	1.8	2.1	1.9	0.2	3.4	2.1	4.0	0.8	1.0	5.7	6.1	5.9	8.6	5.4	6.1	6.2	6.2	6.3	6.3	5.9	7.5	11.9	9.6	11.3	9.8	13.7	23.2	6.5	4.0	10.8	13.0	6.5	5.2	14.3	8.6	9.2	1.8	33.3	10.8	16.5	5.1	9.8	4.8	0.9	10.6	9.9	10.9	10.8	8.2	18.0	4.9	10.0	9.0	7.7	8.6	18.4	10.7	8.9	11.7	8.1	11.8	15.5	4.9	4.1	8.7	12.5	2.2	9.6	8.3	3.6	12.2	10.2	12.2	11.3	18.6	21.6	6.6	3.7	4.1	12.0	8.9	2.8	8.2	8.8	15.3	0.0	8.2	9.6	3.2	7.0	12.5	18.2	6.7	10.7	9.9	6.4	5.9
OTULIN	"FAM105B, FLJ34884"	ENSG00000154124	"OTU deubiquitinase with linear linkage specificity"	Q96BN8	5	14664664-14699850	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 26.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051074	Uncertain		Approved	"Plasma membrane,Mitochondria"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria	"Plasma membrane"	"HPA051074: AB_2681334"	"unprognostic (4.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (2.59e-7)"	"unprognostic (2.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.02e-2)"	5.0	3.9	4.8	9.6	6.3	26.8	4.6	5.9	4.9	5.5	6.2	4.7	7.6	3.6	2.6	8.0	3.5	4.7	6.7	4.9	5.0	4.4	12.3	6.4	12.5	6.6	5.6	4.8	6.8	3.8	3.6	6.5	6.4	6.3	4.6	4.6	5.7	3.3	5.2	11.8	5.8	4.8	5.6	7.1	4.3	7.1	5.8	11.2	4.1	5.5	13.5	5.7	6.9	7.1	10.0	11.5	11.2	12.8	10.0	10.3	12.3	9.8	6.9	13.8	10.2	15.4	7.2	18.0	18.9	6.4	19.9	11.1	14.1	12.9	9.2	31.1	11.6	12.9	36.3	8.3	8.8	12.4	21.2	6.0	15.2	11.3	9.4	7.6	11.8	14.9	13.0	27.8	10.0	6.1	12.4	10.6	6.9	10.5	12.0	18.8	10.0	7.1	8.9	10.1	5.1	8.3	35.1	7.8	7.6	13.5	8.5	14.1	11.1	17.8	20.0	13.4	13.2	12.4	20.6	20.3	10.1	23.2	9.3	0.2	0.6	1.1	0.3	0.7	1.0	0.3	0.8	1.1	1.0	1.6	0.5	1.3	0.7	0.3	1.1	0.8	1.7	0.3	4.8	6.3	5.9	4.9	4.9	5.0	6.6	5.6	6.4	5.6	5.8	7.1	20.3	3.2	11.5	23.5	24.6	0.0	23.2	0.0	26.2	11.9	12.8	11.7	15.0	10.0	4.3	5.5	14.6	15.1	70.6	21.1	7.9	5.5	9.4	20.6	28.1	13.3	9.5	13.7	18.5	5.8	10.3	10.1	16.8	24.0	10.2	14.0	6.4	36.9	13.9	8.4	19.5	15.7	0.0	18.9	0.0	4.2	10.5	25.0	0.0	38.4	17.1	10.4	26.8	16.6	31.7	8.0	13.3	6.4	38.5	25.9	14.1	15.1	5.1	31.4	0.0	11.5	10.2	29.7	28.8	23.7	0.0	14.2	35.8	7.6	15.6	23.1
OXCT1	"OXCT, SCOT"	ENSG00000083720	"3-oxoacid CoA-transferase 1"	P55809	5	41730065-41870425	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 245.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 243.7;Distal tubular cells: 187.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 238.7;SiHa: 319.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012047, HPA061425"	Enhanced		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA		440000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA012047: AB_1854857, HPA061425: AB_2684515"	"unprognostic (4.26e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (7.42e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.62e-1)"	"prognostic favorable (1.86e-8)"	"unprognostic (2.66e-2)"	"unprognostic (9.99e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.28e-3)"	52.7	15.8	30.4	16.6	34.9	13.3	18.5	23.9	32.7	13.5	15.9	19.2	8.3	14.9	17.6	26.8	12.4	15.2	245.9	36.2	27.1	53.1	1.3	8.0	21.7	19.5	21.4	13.8	5.3	48.6	14.7	5.0	20.0	25.5	21.1	23.6	18.9	29.8	28.5	23.1	12.8	36.6	19.3	11.0	34.2	13.2	25.7	76.8	27.3	42.6	25.9	15.1	13.8	24.5	35.3	1.6	27.9	33.6	84.7	45.0	0.1	62.1	38.9	50.3	30.4	5.7	23.5	91.2	15.0	47.5	25.8	20.5	77.5	55.9	58.5	78.5	9.1	63.9	238.7	11.9	36.8	125.8	20.9	42.7	15.3	49.3	82.2	24.6	46.4	81.6	13.3	114.0	58.1	4.5	105.5	6.1	6.4	0.0	24.5	82.8	78.9	68.7	41.7	2.9	27.9	28.8	319.5	0.3	38.3	2.5	0.4	27.4	28.3	39.7	51.9	68.6	50.6	18.6	16.5	3.6	59.9	90.9	30.9	1.4	1.4	4.7	11.6	1.5	13.8	10.0	11.5	12.7	6.3	7.5	13.6	10.9	0.4	11.3	2.5	2.4	21.5	6.6	30.4	34.9	23.9	32.7	36.2	27.1	19.5	21.4	20.0	19.3	25.7	24.5	8.4	6.4	9.2	37.5	19.2	14.8	11.7	12.4	17.6	14.1	18.8	14.2	243.7	7.2	14.3	11.0	2.1	7.0	18.3	5.0	187.9	5.4	19.1	11.7	18.8	9.8	13.2	23.1	71.5	0.7	11.9	21.3	20.4	31.2	9.5	8.7	6.8	0.3	38.2	13.5	84.2	18.6	12.2	1.3	7.0	8.6	6.2	5.2	16.0	26.2	4.4	11.8	10.3	66.4	46.8	4.8	5.3	7.5	31.3	12.1	2.9	27.4	5.6	21.6	13.1	9.7	24.6	35.6	19.7	27.6	21.6	6.8	26.6	8.6	18.1	9.0
P3H1	"GROS1, LEPRE1, LEPRECAN, MGC117314"	ENSG00000117385	"Prolyl 3-hydroxylase 1"	Q32P28	1	42746335-42767084	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 47.9;Extravillous trophoblasts: 56.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 193.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012113, HPA016980"	Approved		Approved	Nucleoli,Vesicles	"Intracellular and membrane"	NA	NA		18000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	Nucleoli	"HPA012113: AB_2668626, HPA016980: AB_2669498"	"unprognostic (3.24e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.37e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.95e-7)"	"unprognostic (5.41e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.41e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.60e-3)"	12.4	11.1	3.6	8.7	3.5	6.1	10.2	3.6	4.4	13.4	7.3	8.3	2.4	13.8	6.1	4.4	9.8	12.0	9.1	3.8	3.8	7.2	13.3	11.6	5.1	5.2	3.5	12.8	6.8	5.9	15.5	37.4	3.8	7.5	5.4	1.3	6.7	5.9	3.0	7.6	7.4	20.3	3.4	11.5	6.7	15.2	3.8	7.6	7.6	3.9	5.1	12.3	8.5	3.6	8.7	22.3	48.7	115.0	112.8	85.4	20.1	101.8	131.9	71.9	121.7	11.3	18.8	13.0	79.7	193.0	29.2	7.8	20.9	25.9	49.2	19.5	26.3	30.5	32.2	32.6	65.2	30.9	34.0	73.8	17.4	72.6	30.9	102.4	102.9	18.3	17.5	16.1	49.0	4.7	20.6	17.8	53.1	4.7	16.0	19.9	71.9	17.7	38.2	4.9	10.2	17.3	62.5	1.7	45.8	85.2	3.7	127.0	85.1	53.8	47.2	43.4	41.2	14.5	17.5	11.9	61.5	41.5	77.0	5.0	18.9	16.8	8.3	20.4	8.8	4.1	6.3	7.0	23.6	3.3	5.1	5.3	1.8	17.8	26.3	10.9	12.4	9.3	3.6	3.5	3.6	4.4	3.8	3.8	5.2	3.5	3.8	3.4	3.8	3.6	13.7	3.2	2.3	5.9	10.5	0.0	6.4	0.0	6.2	10.2	4.5	6.5	5.0	7.2	0.6	11.0	25.0	47.9	11.1	0.4	0.0	11.5	17.1	3.2	30.1	16.4	6.1	11.3	12.9	7.6	56.6	34.4	3.6	4.4	1.3	28.8	16.8	11.3	17.6	15.2	10.8	2.5	0.0	8.7	0.0	10.8	19.3	11.7	0.0	9.4	10.5	3.5	6.2	9.5	6.9	7.4	2.0	16.1	11.2	3.4	1.7	1.9	0.7	22.1	0.0	17.2	22.3	30.6	18.8	3.5	0.0	17.5	9.6	27.0	1.9	4.5
P3H2	"FLJ10718, LEPREL1, MLAT4"	ENSG00000090530	"Prolyl 3-hydroxylase 2"	Q8IVL5	3	189956728-190122437	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 80.3;Granulosa cells: 124.1;Microglial cells: 91.8;Theca cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	22	"plasmacytoid DC: 28.9"	"Lineage enriched"	"Detected in single"	90	"dendritic cells: 28.9"	"Cell line enhanced"	"Detected in many"		"GAMG: 120.2;HaCaT: 109.9;RPTEC TERT1: 109.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007890, HPA013355, HPA013611"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Vesicles, Cytosol"	"HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: "	"unprognostic (4.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.76e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.97e-2)"	"unprognostic (7.75e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.01e-2)"	4.9	41.6	2.8	4.9	3.1	1.0	6.5	3.0	3.1	17.0	1.8	24.0	2.7	17.6	18.5	11.0	8.0	4.8	8.8	3.3	4.8	51.3	7.0	28.7	2.4	7.6	4.7	16.1	3.6	2.3	8.2	9.2	6.7	37.6	10.4	19.3	4.9	26.5	1.2	17.8	6.7	32.4	5.2	54.8	23.9	4.2	4.9	5.2	3.0	1.7	2.0	11.9	19.9	8.3	46.9	18.2	35.1	0.2	0.6	1.4	42.1	48.7	19.3	7.8	12.6	15.0	18.0	0.1	27.1	8.6	120.2	109.9	0.1	65.3	16.3	0.4	6.2	0.1	12.1	0.3	35.4	0.2	0.3	16.9	21.4	15.2	5.4	73.5	1.4	0.1	0.1	0.4	12.3	1.1	0.1	0.4	11.0	31.3	3.7	0.1	7.1	2.8	109.8	77.5	2.5	0.3	66.1	3.7	29.3	51.1	0.1	0.7	24.4	45.9	16.8	0.4	8.9	3.4	0.2	0.5	10.6	0.2	60.2	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.1	0.0	28.9	0.0	0.2	2.8	3.1	3.0	3.1	3.3	4.8	7.6	4.7	6.7	5.2	4.9	8.3	5.7	48.1	80.3	19.2	1.0	0.0	7.7	0.0	13.6	2.3	1.6	9.9	1.0	2.8	3.1	44.1	4.2	42.0	9.5	19.8	5.9	4.7	19.6	2.0	27.3	10.5	0.0	2.7	55.6	0.8	14.7	10.3	8.6	1.5	1.3	124.1	32.5	0.8	11.4	10.1	60.4	0.5	0.0	3.2	0.0	14.9	4.7	5.6	0.0	91.8	0.8	44.5	0.0	43.7	4.4	30.6	1.9	0.0	0.2	15.1	0.0	26.2	0.0	1.2	0.0	10.9	45.2	0.5	0.9	13.5	0.0	38.6	0.7	74.3	2.1	3.9
P4HA2	C-P4Halpha(II)	ENSG00000072682	"Prolyl 4-hydroxylase subunit alpha 2"	O15460	5	132190147-132295315	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 115.6;Endometrial stromal cells: 96.9;Skeletal myocytes: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HHSteC: 324.2;U-87 MG: 323.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA016997, HPA027824, CAB062557"	Enhanced		Enhanced	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	No	No		13000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum, Vesicles"		"CAB062557: AB_2665641, HPA016997: AB_2669501, HPA027824: AB_2672402"	"unprognostic (1.30e-3)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (2.56e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.62e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.93e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (2.77e-7)"	"unprognostic (2.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (3.12e-4)"	17.4	11.7	11.9	16.1	12.1	2.4	12.3	11.4	28.4	29.5	42.2	28.7	22.6	31.1	76.7	19.6	29.6	19.9	40.6	14.4	17.2	80.0	10.5	31.5	2.5	11.4	14.3	8.6	70.7	10.9	19.9	35.1	19.1	10.8	32.7	7.8	32.5	17.1	13.0	16.7	26.8	52.6	10.0	8.7	20.5	9.7	16.8	11.3	20.7	22.9	8.3	22.9	22.3	12.2	57.0	34.9	11.2	57.2	149.2	173.7	61.1	261.9	223.7	108.9	265.0	78.9	50.3	1.5	71.8	283.3	120.5	70.2	33.2	136.5	172.7	41.5	11.9	0.6	48.1	49.0	324.2	0.0	33.9	104.6	193.1	128.8	117.4	162.7	59.1	0.1	21.2	3.6	134.0	23.2	0.2	0.5	3.0	53.7	27.2	0.9	3.6	9.8	31.1	11.0	5.4	15.8	67.7	22.3	47.9	84.1	28.4	3.7	88.9	171.7	63.5	51.0	57.1	24.4	28.1	11.8	323.4	0.4	48.3	0.0	0.4	0.0	0.8	0.3	0.7	0.0	0.4	0.1	0.2	0.0	0.0	0.1	1.0	0.9	0.0	0.3	0.0	0.2	11.9	12.1	11.4	28.4	14.4	17.2	11.4	14.3	19.1	10.0	16.8	12.2	13.0	35.3	10.3	7.5	1.1	16.8	43.6	115.6	23.9	11.6	9.5	9.5	13.3	8.6	36.9	11.0	22.9	2.6	0.3	43.2	5.9	68.3	1.4	26.7	96.9	12.2	15.0	0.0	7.7	71.8	70.2	61.6	12.8	28.0	5.7	11.1	9.3	7.8	7.6	0.0	7.7	18.6	32.6	1.3	5.5	2.0	8.1	4.4	30.2	2.8	2.6	6.8	0.0	1.5	1.2	81.9	41.0	5.3	3.0	19.6	41.4	44.6	71.9	5.2	26.3	109.4	47.6	23.0	29.1	6.8	9.8	7.5	4.8	10.4	13.8	15.3
P4HB	"DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PO4DB, PO4HB, PROHB"	ENSG00000185624	"Prolyl 4-hydroxylase subunit beta"	P07237	17	81843159-81860856	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Chaperone, Isomerase"	"Craniosynostosis, Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1856.8;pancreas: 2446.9"	"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 1077.9;Extravillous trophoblasts: 1349.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012463, HPA018884"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	No	No		110000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB012463: , HPA018884: AB_1854896"	"unprognostic (9.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.14e-3)"	"unprognostic (7.75e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (2.30e-11)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.19e-3)"	266.5	507.8	34.6	209.8	35.7	517.1	225.5	39.1	35.7	272.0	59.6	258.4	640.2	206.5	133.0	618.7	183.4	202.0	318.4	31.7	50.2	270.7	1856.8	301.3	104.0	48.9	37.1	187.8	2446.9	144.3	330.0	334.3	40.8	335.8	173.6	23.3	948.1	184.2	328.5	370.4	554.7	179.8	39.8	428.6	539.2	68.8	58.7	89.3	244.8	150.8	137.9	233.7	322.9	43.7	690.3	580.7	236.8	687.5	813.4	726.7	593.6	1038.5	1081.1	741.9	934.5	550.4	576.9	264.4	501.8	1120.2	407.5	464.1	248.8	647.4	254.1	145.8	320.5	355.2	362.9	953.6	1010.8	1146.4	613.4	618.8	494.8	478.2	596.7	843.0	1250.1	182.1	273.6	978.2	559.5	566.4	260.5	723.2	157.7	791.0	463.8	261.8	342.5	614.0	453.2	492.8	248.7	301.1	586.1	1693.1	808.1	289.6	855.3	1601.2	644.1	980.5	503.1	574.3	586.6	743.5	407.9	204.8	1372.0	591.3	825.4	198.3	268.1	163.0	202.6	154.4	209.8	83.9	138.9	165.7	174.7	68.1	74.9	114.6	72.9	157.0	115.3	311.5	105.6	372.4	34.6	35.7	39.1	35.7	31.7	50.2	48.9	37.1	40.8	39.8	58.7	43.7	122.3	102.5	162.1	23.2	151.4	120.1	163.6	371.0	140.6	59.2	283.0	170.8	24.1	247.4	211.7	112.2	33.3	790.2	208.9	420.7	41.1	671.9	43.5	78.4	196.8	153.9	199.9	140.9	15.3	1077.9	1349.1	272.5	388.9	209.1	99.1	210.4	190.2	840.7	435.9	62.2	16.2	610.9	189.2	186.9	125.5	64.9	141.4	180.3	136.9	20.6	263.3	122.7	230.7	13.6	19.6	575.2	465.6	112.1	664.3	310.6	914.2	105.0	91.3	54.3	157.8	103.4	226.7	83.4	94.1	302.3	144.6	1001.2	138.8	378.4	475.4	220.8
P4HTM	"EGLN4, FLJ20262, HIFPH4, P4H-TM, PH-4, PH4, PHD4"	ENSG00000178467	"Prolyl 4-hydroxylase, transmembrane"	Q9NXG6	3	48989889-49007153	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 155.3;Respiratory ciliated cells: 169.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007199	Supported		Uncertain	Vesicles,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Vesicles, Cytosol"		"HPA007199: AB_1855272"	"unprognostic (1.95e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.47e-2)"	"prognostic favorable (8.18e-4)"	"unprognostic (7.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-2)"	"prognostic favorable (3.28e-5)"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.60e-2)"	"unprognostic (9.65e-3)"	13.3	37.1	50.6	4.9	53.3	5.9	12.4	44.3	67.9	18.4	89.7	14.7	12.1	17.6	18.7	8.2	39.8	11.2	26.2	53.5	57.3	29.8	11.9	15.7	6.5	52.2	49.6	20.0	38.5	39.4	75.9	11.0	51.5	18.5	7.4	16.4	19.6	16.8	15.2	10.1	13.0	7.4	45.8	10.7	25.1	23.6	53.3	5.5	26.5	11.3	3.8	12.8	13.1	49.6	8.6	27.9	4.8	0.1	15.5	17.6	0.4	16.8	24.6	13.2	14.8	6.3	55.6	8.1	15.8	21.6	10.5	4.8	12.5	6.6	4.1	30.4	19.5	0.0	42.1	0.0	38.6	8.3	0.2	11.0	6.3	13.4	1.1	51.4	15.0	0.1	0.0	37.9	6.5	48.1	1.2	1.0	6.8	52.6	31.2	0.0	0.0	53.5	24.4	15.9	20.9	0.2	17.7	25.0	0.1	1.1	20.1	13.1	9.9	8.0	6.1	19.9	14.5	50.0	28.6	0.1	54.9	0.7	7.1	8.0	9.0	5.9	6.7	3.5	9.6	8.4	12.3	11.7	9.4	15.9	13.0	8.3	0.8	5.9	4.5	1.6	17.0	6.0	50.6	53.3	44.3	67.9	53.5	57.3	52.2	49.6	51.5	45.8	53.3	49.6	15.1	22.4	17.3	36.2	16.1	9.2	34.6	41.1	12.5	72.9	28.7	23.0	12.0	41.5	44.0	46.0	87.6	31.4	13.4	27.4	19.6	38.3	138.4	106.4	23.7	12.6	80.9	12.4	55.7	39.1	9.9	28.1	48.9	31.2	22.9	31.6	15.4	8.5	16.8	117.8	48.6	40.4	65.1	6.3	12.8	155.3	30.4	13.0	12.4	20.6	11.3	58.4	14.4	17.1	32.3	23.6	51.8	25.9	28.9	24.4	56.2	30.4	169.4	72.5	19.7	32.9	24.7	32.5	7.0	12.9	10.4	26.1	25.0	23.9	40.9	31.2
PACS2	"KIAA0602, PACS1L"	ENSG00000179364	"Phosphofurin acidic cluster sorting protein 2"	Q86VP3	14	105300563-105398147	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 136.6;skeletal muscle: 98.5"	"Cell type enhanced"	"Detected in all"		"Horizontal cells: 97.6;Oligodendrocytes: 169.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077892			Approved	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA077892: AB_2686865"	"unprognostic (4.31e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (1.18e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.56e-4)"	"unprognostic (2.08e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.30e-1)"	22.4	16.1	48.4	10.6	101.5	9.0	18.7	104.4	61.3	18.1	4.7	24.6	10.9	21.0	5.4	11.2	19.0	11.2	23.8	43.2	58.0	12.4	6.9	16.1	8.5	136.6	110.6	20.0	28.8	11.7	21.6	8.8	119.6	15.0	6.6	12.2	16.3	11.5	98.5	12.6	14.2	10.0	80.8	16.0	17.4	19.8	106.1	9.4	14.1	46.1	5.5	19.3	14.1	126.8	17.5	23.8	21.9	20.7	21.5	20.6	25.9	13.0	15.0	11.0	9.6	10.4	32.5	19.0	21.5	20.0	14.1	19.7	13.5	18.7	7.9	23.7	11.0	8.7	10.0	15.6	28.1	7.1	15.0	24.1	17.5	7.7	17.7	13.9	20.1	18.9	5.4	17.2	9.7	54.9	12.1	9.5	8.5	22.1	19.4	26.5	13.3	12.1	9.3	39.7	49.0	25.8	12.4	11.1	19.4	13.7	28.1	13.2	30.8	16.2	7.2	25.6	13.1	22.3	15.6	7.2	24.6	12.8	16.1	0.0	0.6	0.1	0.3	1.1	0.6	0.0	0.3	0.4	1.1	0.2	0.1	0.4	0.1	1.0	1.9	2.3	0.8	0.4	48.4	101.5	104.4	61.3	43.2	58.0	136.6	110.6	119.6	80.8	106.1	126.8	28.3	9.6	14.7	41.1	3.3	9.1	7.5	7.1	8.0	30.5	15.1	14.4	21.4	8.6	12.6	5.5	12.5	4.3	15.1	21.5	13.7	13.9	77.1	13.8	15.7	21.1	13.1	4.2	29.7	23.0	3.2	15.5	20.4	18.3	1.3	28.8	19.2	10.8	17.6	97.6	41.0	14.6	8.2	15.7	23.0	78.7	17.4	17.1	26.6	30.9	8.4	17.0	7.2	23.1	169.3	14.2	12.6	16.6	7.1	9.0	19.3	12.3	7.7	23.4	6.6	20.6	14.2	18.3	14.6	8.1	8.4	3.4	8.0	30.6	19.5	8.0
PADI3	PDI3	ENSG00000142619	"Peptidyl arginine deiminase 3"	Q9ULW8	1	17249098-17284233	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 17.0;urinary bladder: 25.6"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Ionocytes: 6.1;Squamous epithelial cells: 1.1;Urothelial cells: 7.9"	"Cancer enriched"	"Detected in many"	4	"urothelial cancer: 48.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 14.0;RT4: 17.4;T-47d: 12.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043739	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Nucleoplasm	"HPA043739: AB_10959466"	"unprognostic (4.47e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.05e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.10e-3)"	"unprognostic (5.88e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.47e-4)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.55e-11)"	"unprognostic (2.40e-2)"	"unprognostic (4.73e-3)"		"unprognostic (2.64e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	17.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.9	3.4	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	25.6	3.6	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	14.0	0.0	1.4	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	17.4	0.0	0.0	0.0	2.5	0.1	0.1	12.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.2	0.0	7.9
PADI4	"PAD, PADI5, PDI4, PDI5"	ENSG00000159339	"Peptidyl arginine deiminase 4"	Q9UM07	1	17308195-17364004	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"bone marrow: 105.1;lymphoid tissue: 29.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 8.3;granulocytes: 12.6;Macrophages: 14.6;monocytes: 22.3;NK-cells: 20.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"basophil: 79.9;classical monocyte: 71.3;eosinophil: 97.5;neutrophil: 183.0"	"Group enriched"	"Detected in all"	9	"granulocytes: 183.0;monocytes: 71.3"	"Cell line enhanced"	"Detected in some"		"HEL: 1.2;RPMI-8226: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA017007, HPA042825"	Enhanced					NA	NA		29000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA017007: AB_1854921, HPA042825: AB_2678189"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-2)"	"unprognostic (8.49e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.80e-1)"	1.8	0.1	0.2	0.7	0.4	105.1	0.3	0.2	0.8	0.1	0.2	0.1	0.1	0.1	0.0	0.4	1.0	0.4	1.1	0.3	0.2	0.5	1.7	7.9	0.3	0.3	0.1	0.1	0.3	0.0	0.2	0.5	0.3	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.4	0.0	29.9	0.4	0.1	0.1	1.6	0.3	0.3	0.2	0.7	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	79.9	71.3	97.5	0.4	5.7	0.2	1.1	0.5	0.7	13.9	1.8	2.6	4.5	183.0	4.5	1.8	6.2	0.4	35.8	0.2	0.4	0.2	0.8	0.3	0.2	0.3	0.1	0.3	0.0	0.1	0.4	0.0	0.0	3.7	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.6	0.6	0.0	0.0	12.6	0.1	0.0	0.4	0.2	0.0	0.4	0.0	0.0	3.3	0.4	0.2	0.0	14.6	0.0	0.0	22.3	0.0	20.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	4.0	0.0	0.0	0.1	2.3	0.1	0.0	0.0
PADI6		ENSG00000276747	"Peptidyl arginine deiminase 6"	Q6TGC4	1	17372196-17401699	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"white matter: 2.4"	"Not detected"	"Not detected"									NA	NA			"Cluster 28: Myeloid DCs - Unknown function"			"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (1.19e-1)"					"unprognostic (4.36e-2)"			"unprognostic (3.02e-2)"				"unprognostic (6.56e-2)"		"unprognostic (1.23e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.7	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
PAK1		ENSG00000149269	"P21 (RAC1) activated kinase 1"	Q13153	11	77322017-77474635	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Exocytosis"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 219.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	9	"classical monocyte: 182.2;eosinophil: 292.7;intermediate monocyte: 177.7;myeloid DC: 264.3;neutrophil: 431.8;non-classical monocyte: 202.6"	"Group enriched"	"Detected in all"	11	"dendritic cells: 264.3;granulocytes: 431.8;monocytes: 202.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003565, CAB005312"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"		NA	NA		560000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"CAB005312: AB_2160720, HPA003565: AB_1854935"	"unprognostic (1.15e-2)"	"unprognostic (3.23e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (6.62e-2)"	"unprognostic (8.19e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.52e-2)"	12.7	13.4	32.4	33.9	44.5	59.0	18.2	13.9	57.7	21.1	0.0	43.2	43.1	20.9	29.8	21.4	21.9	30.9	9.4	58.3	8.0	26.1	14.5	16.8	20.4	19.2	12.2	21.1	17.5	20.5	20.7	14.7	19.4	19.1	46.5	25.1	19.9	19.7	87.0	16.2	45.7	27.0	0.9	29.3	41.2	25.7	17.1	29.1	40.6	18.8	23.1	27.7	20.7	30.0	39.9	26.7	56.7	25.5	22.8	37.6	45.9	44.6	32.1	42.0	48.7	38.7	52.8	36.3	16.0	39.4	54.4	20.2	40.2	47.8	65.5	41.4	32.6	38.2	17.6	2.3	15.3	64.3	53.5	28.2	28.8	49.2	73.1	36.6	10.1	41.3	25.5	61.2	77.6	2.9	42.3	30.2	84.5	166.2	22.5	62.6	72.3	1.4	10.6	32.9	24.6	23.9	23.6	9.7	19.5	55.0	45.4	29.0	0.9	27.3	47.5	148.9	37.9	165.7	92.4	23.4	23.0	42.5	30.6	2.5	182.2	292.7	11.2	177.7	9.4	16.8	8.4	10.7	264.3	12.9	7.4	14.5	431.8	28.4	202.6	22.9	7.3	92.3	32.4	44.5	13.9	57.7	58.3	8.0	19.2	12.2	19.4	0.9	17.1	30.0	3.1	3.2	20.5	24.2	23.9	11.9	33.3	28.2	23.9	51.6	25.1	19.7	6.2	35.8	30.8	25.8	8.4	25.4	10.2	78.6	45.0	32.4	38.8	37.3	13.5	3.2	37.8	30.5	219.1	56.3	53.5	24.0	45.9	39.7	132.2	35.2	3.6	11.4	49.8	1.7	118.5	50.8	28.5	59.6	152.9	28.3	14.3	80.0	30.2	54.4	121.7	14.9	10.3	53.3	70.7	50.9	57.9	13.2	28.6	28.7	47.9	55.7	39.0	6.4	13.1	13.8	25.2	50.4	53.8	23.6	10.4	95.0	19.3	10.3	52.8	33.2
PAK3	"bPAK, hPAK3, MRX30, MRX47"	ENSG00000077264	"P21 (RAC1) activated kinase 3"	O75914	X	110944285-111227361	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Allosteric enzyme, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 31.9;pancreas: 42.7;pituitary gland: 13.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 104.1;Excitatory neurons: 364.0;Inhibitory neurons: 323.5;Oligodendrocyte precursor cells: 165.9;Peritubular cells: 81.3"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.7"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 10.8;HAP1: 9.9;HDLM-2: 12.4;NTERA-2: 9.7;SCLC-21H: 12.4;SH-SY5Y: 7.7;U-2197: 7.6;U-251 MG: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044791, HPA060219"	Approved		Approved	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA044791: , HPA060219: AB_2684223"	"unprognostic (1.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.27e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.63e-3)"	"unprognostic (7.29e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.89e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-2)"	1.0	5.2	16.9	1.6	16.2	0.1	5.2	0.0	17.6	2.3	0.0	0.7	0.2	5.4	5.8	0.7	2.5	1.6	0.3	17.8	31.9	0.7	0.2	0.9	1.7	1.6	0.0	6.2	42.7	0.1	13.7	0.6	6.0	3.4	0.7	7.0	2.2	4.8	1.6	1.3	0.5	4.7	0.4	2.0	2.0	2.6	13.2	0.6	6.2	0.4	0.8	0.9	0.7	2.8	0.0	0.7	1.4	0.0	0.0	0.0	0.0	0.3	0.4	1.1	0.0	0.0	0.0	0.0	10.8	1.2	1.6	0.0	9.9	0.6	1.3	12.4	0.4	0.0	1.3	0.0	0.0	0.0	0.4	0.3	0.0	0.1	2.2	5.7	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.2	9.7	0.0	2.2	0.1	4.3	0.0	0.8	0.0	12.4	7.7	0.0	0.4	0.0	6.6	0.0	0.0	0.0	0.7	4.7	7.6	13.6	0.1	0.1	0.1	1.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.9	16.2	0.0	17.6	17.8	31.9	1.6	0.0	6.0	0.4	13.2	2.8	0.9	3.2	1.1	16.0	0.6	0.3	13.3	0.2	0.0	104.1	6.9	10.4	1.0	20.0	0.7	0.0	0.0	0.3	0.2	0.2	0.0	4.7	4.4	1.0	10.8	2.3	3.6	0.0	364.0	13.1	0.4	10.3	10.2	1.7	1.3	21.9	1.4	0.2	0.2	6.7	323.5	0.3	0.0	0.3	5.7	7.0	34.2	1.1	0.0	17.8	0.7	27.5	1.0	165.9	12.0	5.3	0.0	81.3	1.0	1.7	0.0	0.6	0.0	6.0	0.0	1.6	7.8	1.4	1.4	0.3	1.1	6.7	2.4	29.2	0.3	0.9
PANK2	"C20orf48, FLJ11729, HARP, HSS, NBIA1, PKAN"	ENSG00000125779	"Pantothenate kinase 2"	Q9BZ23	20	3888839-3929887	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Coenzyme A biosynthesis"	"Kinase, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008440	Approved		Supported	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA008440: AB_1079559"	"unprognostic (4.50e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.00e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (2.75e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.81e-1)"	13.0	12.3	14.5	16.8	13.7	20.9	12.2	15.3	15.9	11.9	14.1	11.4	8.4	11.0	11.3	20.0	16.3	12.1	8.7	15.5	13.5	15.7	18.3	14.1	18.5	12.7	14.1	12.9	10.3	10.9	8.9	15.3	13.3	12.0	14.2	10.3	11.9	10.7	9.6	11.7	11.6	13.7	12.7	14.9	9.1	25.9	13.9	16.8	15.4	11.2	22.0	15.6	9.9	12.4	39.3	29.4	33.7	18.6	39.3	32.6	15.0	25.6	34.2	38.3	48.3	40.8	25.4	34.6	10.6	34.9	70.2	34.9	34.7	57.3	49.3	8.8	9.8	47.4	22.7	80.2	33.3	33.6	15.9	28.7	26.4	39.7	28.7	17.0	36.0	23.3	34.7	30.5	42.5	11.7	30.0	30.3	28.8	22.9	19.5	20.3	46.0	22.4	26.2	45.7	36.2	16.7	30.0	44.3	78.1	32.6	23.6	28.1	24.6	47.7	17.8	60.7	43.3	14.0	50.8	23.3	15.0	30.7	34.2	3.0	10.5	3.4	3.6	11.1	3.5	3.8	3.7	3.4	8.5	4.5	4.1	3.4	5.9	6.8	9.4	3.0	5.9	4.0	14.5	13.7	15.3	15.9	15.5	13.5	12.7	14.1	13.3	12.7	13.9	12.4	23.8	19.2	11.7	23.8	29.2	25.5	17.5	12.0	41.5	22.0	15.8	17.3	9.8	7.2	13.4	14.7	25.0	29.4	38.6	14.4	23.5	19.4	83.1	24.1	20.6	26.7	20.3	42.7	28.6	17.8	36.0	21.1	24.5	24.1	7.6	20.1	26.0	14.0	33.8	35.3	25.3	12.7	10.2	52.8	37.9	17.3	21.1	34.3	19.6	29.0	55.0	14.1	35.0	23.1	17.7	15.9	12.8	22.6	33.2	20.9	15.1	20.6	20.2	21.1	6.6	14.1	23.1	54.6	25.9	37.7	24.3	18.6	31.6	21.2	15.0	20.0
PANX1	"MRS1, PX1, UNQ2529"	ENSG00000110218	"Pannexin 1"	Q96RD7	11	94128841-94181968	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Differentiation, Ion transport, Oogenesis, Transport"	"Calcium channel, Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 102.0;Suprabasal keratinocytes: 72.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016930	Uncertain		Enhanced	"Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane"		"HPA016930: AB_1854954"	"unprognostic (1.65e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.16e-1)"	"unprognostic (7.02e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (7.09e-5)"	"unprognostic (1.79e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (1.15e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.26e-3)"	11.4	7.2	5.1	12.1	5.2	4.1	6.4	1.2	5.5	7.9	2.7	8.4	5.4	8.5	5.2	7.9	5.2	11.5	9.9	5.0	7.1	6.9	16.8	10.2	6.4	2.1	2.9	7.1	7.4	4.4	4.7	9.7	3.3	7.7	7.2	3.1	6.0	7.0	20.8	8.3	5.8	12.8	2.8	5.8	7.4	9.9	4.9	8.1	8.7	10.8	7.0	21.9	6.5	2.7	24.6	10.2	26.2	16.0	23.9	32.3	17.1	29.8	63.0	25.1	30.7	26.2	37.6	7.8	27.3	30.5	46.1	50.5	20.9	49.2	25.2	33.6	10.9	36.0	10.2	13.5	23.1	18.7	31.0	25.7	33.9	32.8	29.2	16.1	21.2	20.1	23.8	27.5	28.3	7.8	31.3	4.4	21.0	19.7	18.2	36.7	35.0	9.7	16.3	24.0	11.0	31.9	20.9	11.9	14.4	13.3	25.2	9.5	15.4	49.5	25.5	16.4	29.9	4.5	18.2	12.6	20.6	19.0	32.2	3.2	4.0	0.3	2.1	2.2	2.4	1.3	1.7	2.3	2.7	1.2	1.6	1.7	0.2	2.6	1.4	0.4	2.9	3.2	5.1	5.2	1.2	5.5	5.0	7.1	2.1	2.9	3.3	2.8	4.9	2.7	3.8	0.0	8.7	4.6	6.6	102.0	12.3	14.9	13.6	1.3	4.5	2.0	4.7	4.3	4.7	1.8	0.0	12.8	5.3	4.7	0.0	15.7	5.3	9.1	13.0	6.8	2.4	5.2	8.9	18.2	32.4	17.5	7.1	13.9	9.5	4.0	2.2	8.1	20.5	0.0	15.4	4.1	0.0	3.1	21.6	3.9	4.4	11.5	17.8	8.4	3.7	1.1	1.0	9.5	5.8	26.1	3.4	3.8	7.4	10.2	2.6	2.1	6.2	1.1	0.0	16.9	10.6	1.7	8.2	8.3	72.2	23.8	6.6	10.1	4.2	12.7
PAPSS2	ATPSK2	ENSG00000198682	"3'-phosphoadenosine 5'-phosphosulfate synthase 2"	O95340	10	87659613-87747705	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 135.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 240.4;Distal enterocytes: 202.4;Hepatocytes: 111.5;Proximal enterocytes: 181.3;Theca cells: 96.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 4.0;myeloid DC: 2.1;non-classical monocyte: 7.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.1;monocytes: 7.7"	"Cell line enhanced"	"Detected in many"		"BJ: 189.8;fHDF/TERT166: 473.2;HHSteC: 196.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071224, HPA075267"	Enhanced		Approved	Mitochondria		No	No		16000	"Cluster 7: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"HPA071224: AB_2686366, HPA075267: "	"unprognostic (3.98e-3)"	"unprognostic (7.06e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (3.50e-2)"	"prognostic favorable (6.58e-4)"	"unprognostic (1.14e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (3.46e-3)"	33.3	135.2	6.3	26.6	7.0	2.0	20.9	6.2	9.5	17.8	6.2	79.9	29.5	8.5	3.1	10.2	12.4	20.7	11.6	5.8	6.2	23.8	77.0	70.4	11.0	6.9	6.6	27.5	26.1	2.1	3.0	58.5	7.5	6.7	64.3	2.3	16.4	3.4	4.7	3.5	61.8	16.7	6.8	8.5	9.2	11.7	8.0	3.0	21.3	8.7	14.8	16.6	11.5	7.2	19.9	20.0	6.4	0.3	129.4	164.8	0.3	189.8	157.7	110.4	79.9	1.0	4.1	0.1	9.8	473.2	3.5	8.5	13.9	13.3	125.2	0.2	10.0	8.8	13.4	0.1	196.5	0.2	3.8	58.7	0.3	63.7	5.2	135.6	94.2	1.4	0.0	89.4	79.2	74.1	0.1	0.7	7.4	4.8	24.1	0.4	0.1	0.4	117.5	8.7	0.9	1.6	92.5	3.3	1.1	12.6	13.5	5.3	120.0	38.2	22.5	131.5	13.9	0.3	1.0	0.3	18.3	0.2	0.2	0.0	1.1	0.0	0.0	4.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.6	0.0	7.7	0.0	0.0	0.8	6.3	7.0	6.2	9.5	5.8	6.2	6.9	6.6	7.5	6.8	8.0	7.2	49.5	240.4	38.2	3.6	2.6	2.3	0.9	18.0	1.8	0.2	11.5	4.7	4.4	8.6	13.8	9.2	0.0	0.5	0.8	202.4	13.7	6.4	1.2	2.6	18.7	23.2	12.6	5.2	22.2	30.2	0.8	36.1	15.3	11.6	0.0	20.3	36.0	111.5	11.5	0.0	27.6	26.5	4.1	29.8	50.7	0.8	17.4	51.0	1.8	30.0	5.2	1.3	0.0	21.6	1.0	19.4	46.1	5.3	3.1	2.1	181.3	9.8	3.4	0.0	13.1	1.0	20.4	1.2	0.7	1.1	1.3	1.4	1.7	96.4	74.3	1.1
PARK7	"DJ-1, DJ1, GATD2"	ENSG00000116288	"Parkinsonism associated deglycase"	Q99497	1	7954291-7985505	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Fertilization, Inflammatory response, Stress response"	"Chaperone, Hydrolase, Protease, RNA-binding"	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004190, CAB005870"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		35000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"CAB005870: AB_444361, HPA004190: AB_1079566"	"unprognostic (6.88e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.68e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.43e-2)"	249.4	373.6	283.5	213.7	290.0	205.0	235.7	292.9	403.4	201.1	327.7	252.5	145.8	212.2	278.0	161.0	203.2	162.9	388.0	285.5	296.6	311.0	397.6	181.6	269.2	289.6	286.0	234.2	308.5	387.6	283.6	174.1	291.7	234.9	194.9	273.8	240.9	185.6	771.4	127.1	170.5	199.1	295.2	188.2	234.2	139.6	288.1	217.9	286.3	541.8	249.7	226.5	171.2	299.7	537.0	452.5	467.1	523.2	459.8	442.6	218.4	476.7	434.4	450.4	360.3	419.9	549.4	633.1	534.2	505.1	328.6	367.1	483.2	625.3	579.3	574.5	526.2	683.0	678.6	674.5	403.8	662.9	418.6	421.3	262.4	459.8	547.4	359.2	478.2	340.1	676.8	471.7	633.0	485.0	474.3	868.7	376.1	653.6	465.4	366.7	598.0	888.7	714.7	269.7	527.7	447.4	470.4	728.0	798.4	370.1	414.9	503.7	459.3	412.8	344.6	395.5	539.5	452.8	788.4	938.8	551.5	1002.9	606.4	298.4	590.2	394.0	484.7	553.7	459.2	483.6	478.2	577.3	717.4	374.6	406.8	466.8	202.5	551.1	456.9	1378.2	874.4	1060.8	283.5	290.0	292.9	403.4	285.5	296.6	289.6	286.0	291.7	295.2	288.1	299.7	243.6	131.4	157.1	23.2	211.8	208.9	402.4	677.7	200.9	196.2	342.0	381.8	453.3	257.4	318.5	248.3	79.2	553.0	382.3	131.1	851.0	504.3	32.1	272.1	263.9	241.7	238.0	177.1	19.5	478.4	612.1	302.3	146.3	195.9	206.5	291.2	183.1	368.1	435.1	186.7	22.9	279.6	484.2	204.5	304.5	53.6	358.2	258.9	359.3	21.5	605.4	816.4	327.5	18.1	36.0	378.9	186.9	378.7	269.7	523.4	227.1	941.5	327.8	235.5	276.1	277.8	342.6	288.2	302.2	220.4	143.8	469.6	244.4	535.3	312.2	433.1
PARN	DAN	ENSG00000140694	"Poly(A)-specific ribonuclease"	O95453	16	14435700-14632728	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006314, CAB011673, HPA012010"	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"CAB011673: AB_778216, HPA006314: AB_1079567, HPA012010: AB_1854976"	"unprognostic (2.54e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (2.99e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.09e-2)"	16.6	20.2	10.8	13.9	12.1	9.2	15.9	11.7	11.4	17.2	12.0	19.3	11.8	19.1	24.7	15.6	16.0	13.4	14.8	10.6	14.0	12.7	16.4	14.2	21.2	11.7	11.9	16.4	16.5	21.1	16.3	15.6	11.9	16.1	16.8	7.0	15.3	17.1	16.8	17.9	16.1	18.0	11.3	15.7	16.2	18.1	12.6	21.6	20.6	9.7	23.4	19.3	16.0	13.5	28.0	39.9	17.6	22.9	32.9	33.2	20.3	24.4	32.4	29.8	28.3	21.9	28.7	56.2	63.1	32.3	25.3	30.4	46.7	32.3	41.0	42.9	29.4	28.8	24.2	53.2	35.5	46.0	36.2	32.5	38.5	32.0	43.1	25.5	22.5	32.6	28.5	29.9	32.5	44.9	36.7	33.1	26.0	28.2	16.7	56.2	36.1	57.1	23.1	17.1	18.7	16.9	53.4	29.6	36.3	28.6	31.6	28.0	21.2	31.5	15.8	16.4	26.9	32.5	31.0	63.5	34.6	30.8	35.8	8.9	8.0	15.8	8.6	13.2	7.7	16.0	10.4	12.4	13.6	9.4	14.2	14.4	6.2	15.0	15.6	8.3	19.1	7.1	10.8	12.1	11.7	11.4	10.6	14.0	11.7	11.9	11.9	11.3	12.6	13.5	18.0	32.1	39.1	37.9	26.2	7.1	7.8	9.7	21.6	13.0	13.4	14.0	22.3	7.2	11.8	11.0	8.4	29.2	24.7	13.6	11.7	14.2	14.1	15.2	20.5	15.2	14.9	20.4	48.0	12.9	23.2	19.5	21.9	21.7	2.5	19.2	11.7	15.6	14.8	8.4	48.2	14.3	6.1	14.2	5.8	6.3	21.1	18.2	10.6	54.4	35.8	10.3	52.5	38.2	72.4	15.2	10.6	17.7	23.0	7.1	12.2	10.8	19.2	10.8	19.7	13.1	15.0	70.5	70.5	20.0	8.2	22.4	21.5	20.1	13.4	4.8
PARS2	DKFZp727A071	ENSG00000162396	"Prolyl-tRNA synthetase 2, mitochondrial"	Q7L3T8	1	54756898-54764523	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 9.8;Early spermatids: 11.0;Spermatocytes: 10.5;Spermatogonia: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028308, HPA028314, HPA028518"	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center, Mitochondria"		"HPA028308: AB_2672553, HPA028314: AB_10603981, HPA028518: AB_2672653"	"unprognostic (1.95e-1)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.26e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.79e-3)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (6.48e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.24e-6)"	"unprognostic (2.72e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.64e-2)"	1.3	2.9	2.5	1.9	3.0	0.2	2.7	2.8	3.1	2.7	3.0	4.0	2.7	2.5	3.2	2.7	4.4	1.6	3.0	2.6	2.6	4.2	3.4	1.4	2.0	2.5	2.7	4.8	2.3	4.7	2.1	2.5	2.7	2.3	3.6	2.0	3.3	2.8	4.4	2.9	2.1	2.0	2.7	1.8	2.5	4.8	2.7	2.6	2.9	5.5	2.4	2.1	2.0	3.0	4.4	7.2	4.6	6.0	5.5	4.6	10.3	3.7	4.5	6.4	4.6	8.3	2.8	7.7	5.6	3.3	9.3	6.9	8.3	5.8	4.7	5.0	7.5	7.4	4.0	6.2	8.5	4.3	2.5	5.0	8.8	8.3	7.4	5.5	4.8	8.4	13.2	1.0	4.9	4.6	6.1	5.7	10.6	8.3	9.1	4.6	9.0	9.0	5.4	3.2	4.7	4.8	5.3	6.9	9.7	8.7	3.9	5.5	2.6	4.8	4.9	6.8	4.7	7.3	6.6	3.0	3.6	5.1	2.8	1.2	5.3	4.5	4.8	7.7	5.9	4.9	5.3	5.3	7.3	5.5	7.8	5.3	0.5	7.4	10.7	5.9	8.2	5.0	2.5	3.0	2.8	3.1	2.6	2.6	2.5	2.7	2.7	2.7	2.7	3.0	0.6	0.0	1.1	0.3	1.0	0.6	0.9	2.0	1.8	2.6	1.3	1.9	1.5	2.8	1.8	0.0	0.0	7.0	0.2	2.4	9.8	4.5	11.0	1.1	1.4	0.8	0.0	0.0	0.9	2.8	3.9	1.3	1.5	0.6	0.0	2.9	0.0	2.3	3.1	5.0	1.1	2.8	0.0	1.2	0.3	6.8	3.7	0.8	0.0	2.8	1.1	3.2	0.0	0.5	1.6	1.9	1.5	3.0	0.3	1.8	1.5	6.5	1.0	1.9	0.0	1.3	1.1	10.5	11.5	2.0	1.0	3.3	0.7	5.1	3.5	0.8
PC	PCB	ENSG00000173599	"Pyruvate carboxylase"	P11498	11	66848417-66958386	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Lipid biosynthesis, Lipid metabolism"	"Ligase, Multifunctional enzyme"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.0"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 201.9;Late spermatids: 53.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 37.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033742, HPA043922, HPA058765"	Enhanced		Enhanced	Mitochondria		Yes	No		200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 15: Hepatocytes - Hemostasis"	Mitochondria		"CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (7.86e-5)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.22e-5)"	"unprognostic (8.58e-3)"	"unprognostic (5.67e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.05e-1)"	60.9	23.7	35.7	2.9	35.5	3.5	28.4	36.6	35.8	3.7	17.5	4.7	6.5	3.8	1.8	9.3	3.2	2.8	4.3	32.4	41.0	23.3	148.0	2.6	1.3	43.4	40.1	5.1	4.9	18.2	8.6	4.4	37.6	7.2	2.8	2.4	35.3	9.3	12.1	4.7	7.7	1.4	37.8	1.5	9.1	10.7	49.0	2.0	4.6	6.6	2.0	2.9	4.4	37.0	6.1	19.3	6.5	17.2	25.4	8.9	6.6	3.4	15.5	6.9	7.5	8.8	6.0	0.0	7.4	6.0	9.6	6.8	7.7	39.5	1.5	2.8	11.0	10.3	57.4	41.2	21.0	0.1	10.8	40.2	10.1	5.8	12.4	4.4	5.7	14.3	17.4	0.0	2.1	44.6	9.2	4.6	12.0	15.1	16.2	8.3	13.0	3.2	5.7	1.9	15.2	21.0	33.6	18.0	15.5	4.8	14.6	2.7	6.3	7.8	6.6	8.8	4.7	3.5	4.8	0.1	7.7	5.7	6.7	0.0	1.3	0.0	0.5	0.3	0.5	0.0	0.1	0.5	0.9	0.2	0.9	0.5	0.1	0.1	0.1	0.3	0.5	0.7	35.7	35.5	36.6	35.8	32.4	41.0	43.4	40.1	37.6	37.8	49.0	37.0	0.9	0.0	3.0	26.4	1.4	1.3	1.6	9.1	2.8	5.6	4.8	5.8	4.4	11.5	3.0	3.7	2.1	17.4	0.6	27.6	1.9	3.1	18.4	2.3	7.1	1.5	9.0	28.0	18.5	1.8	4.2	3.2	5.6	3.0	8.9	16.0	4.6	201.9	12.3	0.0	18.6	5.0	0.0	7.0	1.8	53.2	0.6	1.8	5.4	7.5	18.9	9.4	2.1	10.1	16.7	2.3	8.5	4.1	0.1	3.1	23.6	39.0	1.5	4.8	0.0	2.2	2.2	11.2	4.7	4.1	0.6	25.4	1.2	6.0	6.4	1.3
PCBD1	"DCOH, PCBD, PCD"	ENSG00000166228	"Pterin-4 alpha-carbinolamine dehydratase 1"	P61457	10	70882280-70888565	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis, Transcription, Transcription regulation"	"Activator, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 429.5"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 453.9;Hepatocytes: 603.7;Proximal tubular cells: 877.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 527.8;Hep G2: 527.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037575, HPA061723"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		170000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 15: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA037575: AB_10671761, HPA061723: AB_2684594"	"unprognostic (1.02e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.39e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.95e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.38e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.43e-3)"	77.3	102.9	115.0	31.0	111.8	21.8	67.9	111.9	140.7	58.0	114.1	83.9	54.4	48.2	91.2	54.3	111.5	47.4	152.3	109.3	136.9	165.1	429.5	57.9	31.1	125.4	138.5	64.2	174.9	135.1	61.5	33.4	139.4	73.8	88.3	48.6	49.9	78.4	109.7	25.7	64.0	75.6	119.7	25.6	84.8	20.0	131.8	25.8	86.3	109.1	35.8	69.3	39.2	118.9	158.3	374.3	21.4	223.8	80.9	76.0	29.4	50.0	84.5	77.7	61.6	527.8	270.3	32.2	141.4	56.3	57.9	101.7	138.9	81.3	53.2	86.2	251.9	28.6	57.5	527.1	84.9	28.5	99.2	74.1	88.5	76.5	35.8	114.1	212.3	19.9	57.1	2.8	55.2	270.2	3.5	94.7	30.1	420.5	346.0	15.1	29.7	103.6	328.6	164.7	94.0	158.8	41.5	277.1	111.5	59.9	81.1	53.8	86.2	12.7	102.9	18.9	123.8	1.1	6.7	1.1	68.3	93.1	19.5	0.2	24.8	8.7	19.6	47.1	15.3	25.7	25.8	28.3	49.6	10.9	8.4	17.1	1.6	19.6	34.4	35.8	41.1	18.7	115.0	111.8	111.9	140.7	109.3	136.9	125.4	138.5	139.4	119.7	131.8	118.9	25.5	41.7	91.5	8.5	25.9	49.8	169.1	88.2	103.0	39.0	197.9	249.6	151.5	138.7	86.0	187.6	6.2	124.6	18.5	113.8	453.9	185.0	2.3	138.7	49.3	40.8	176.4	36.2	4.9	169.9	81.6	82.2	86.6	175.3	31.1	64.6	37.9	603.7	180.3	35.3	8.5	313.3	65.1	79.9	55.7	11.2	67.4	73.1	78.2	5.6	68.0	153.0	22.6	9.0	4.6	154.8	164.7	95.5	35.1	212.7	232.1	877.7	78.4	33.2	85.5	57.2	63.3	4.4	12.3	147.8	45.7	77.6	32.6	95.9	230.2	187.5
PCCA		ENSG00000175198	"Propionyl-CoA carboxylase subunit alpha"	P05165	13	100089015-100530437	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 218.2"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 152.8;Excitatory neurons: 152.8;Inhibitory neurons: 166.5;Microglial cells: 217.4;Oligodendrocyte precursor cells: 200.6;Oligodendrocytes: 182.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 167.0;SCLC-21H: 91.1;U-937: 131.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041716, HPA047792"	Enhanced		Supported	Mitochondria		NA	NA		290000	"Cluster 27: Non-specific - Gene expression"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Mitochondria		"HPA041716: AB_2677635, HPA047792: AB_2680156"	"unprognostic (1.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (7.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.32e-2)"	35.4	56.3	29.0	12.4	29.8	6.2	25.8	55.5	34.6	22.3	44.4	37.5	13.2	14.9	218.2	19.4	17.4	11.6	35.4	28.6	26.3	111.7	104.3	12.0	8.0	28.9	27.4	19.9	27.6	25.7	12.3	21.3	31.1	25.9	27.6	25.2	26.9	16.9	17.6	18.6	18.0	13.7	30.3	17.2	40.9	9.2	33.9	11.4	20.4	27.2	6.4	21.3	17.5	38.7	10.6	18.5	29.8	9.9	27.9	24.2	16.6	10.2	15.4	9.5	9.0	23.0	13.9	0.8	15.2	10.1	12.0	11.8	9.1	14.1	15.6	17.5	10.1	24.6	12.7	49.7	15.4	1.2	11.3	22.4	15.2	8.8	14.6	23.0	19.6	13.0	9.8	13.4	17.1	11.6	2.6	54.8	18.6	37.2	8.1	21.4	12.9	17.3	167.0	20.5	91.1	10.9	7.0	38.4	17.9	31.9	27.9	43.1	14.3	9.6	8.0	6.7	7.3	13.1	12.9	0.4	18.4	131.6	6.9	1.6	9.1	1.7	4.5	11.2	5.9	3.6	2.8	4.2	13.5	2.3	3.9	4.9	1.1	8.7	12.3	1.1	6.5	5.2	29.0	29.8	55.5	34.6	28.6	26.3	28.9	27.4	31.1	30.3	33.9	38.7	11.3	3.2	8.7	152.8	6.6	1.9	29.1	12.7	8.6	15.5	13.5	8.8	10.5	52.9	14.8	20.2	29.2	25.7	4.3	20.7	99.7	19.7	17.6	76.5	22.4	12.0	3.6	3.4	152.8	8.4	6.9	12.9	12.2	72.9	14.0	20.7	12.1	48.8	11.8	28.6	166.5	12.4	12.2	14.2	2.2	12.0	8.7	8.2	5.4	217.4	6.0	11.5	10.3	200.6	182.5	5.8	17.5	13.5	9.4	11.2	13.2	86.9	13.2	31.7	13.1	12.3	10.1	7.2	6.2	10.6	3.8	30.2	6.4	17.6	27.6	19.2
PCCB		ENSG00000114054	"Propionyl-CoA carboxylase subunit beta"	P05166	3	136250340-136337896	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 202.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 316.7;Late spermatids: 159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036939, HPA036940"	Enhanced				"Intracellular and membrane"	NA	NA		120000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA036939: AB_10671366, HPA036940: AB_10669779"	"unprognostic (2.74e-1)"	"unprognostic (7.88e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.47e-7)"	"unprognostic (2.43e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.50e-1)"	"unprognostic (4.13e-1)"	34.4	75.1	23.3	15.2	33.6	37.9	27.5	31.4	29.3	17.5	35.5	43.6	38.1	13.8	13.9	26.3	19.2	17.0	94.6	23.6	28.5	88.9	202.1	14.8	16.2	31.1	29.4	12.1	32.0	57.0	15.6	19.6	30.4	23.7	41.9	17.2	23.6	21.7	83.8	15.1	27.5	22.6	27.1	12.7	26.1	38.8	29.8	21.1	37.9	91.4	20.7	20.5	11.4	47.8	64.8	45.8	42.4	64.4	30.2	34.5	75.4	33.0	35.5	49.1	69.6	67.9	44.7	80.3	89.4	46.6	44.0	35.1	50.3	44.0	69.4	47.8	43.0	140.8	49.5	101.4	66.4	107.3	60.2	40.8	41.4	31.0	69.4	30.5	56.1	131.6	104.5	41.0	38.0	123.1	109.3	63.1	36.0	96.8	40.9	29.3	34.6	116.6	89.9	69.4	84.0	62.9	84.4	48.9	77.5	35.2	98.3	62.9	42.0	24.5	26.0	69.2	29.6	78.3	70.0	66.9	34.9	41.7	29.9	7.3	29.5	7.5	22.6	30.8	25.4	21.7	14.7	23.2	44.6	19.8	15.1	18.7	2.7	25.9	28.7	38.5	14.8	22.6	23.3	33.6	31.4	29.3	23.6	28.5	31.1	29.4	30.4	27.1	29.8	47.8	5.6	9.6	14.0	16.0	9.2	4.1	9.4	37.9	3.4	16.0	12.5	5.3	51.1	8.6	28.4	20.2	10.4	57.1	8.0	15.1	39.2	24.6	316.7	14.1	9.5	8.1	9.1	53.2	16.5	14.0	27.1	13.6	14.8	14.1	29.2	18.1	9.3	76.3	35.1	11.8	22.7	15.1	24.4	11.7	5.2	159.0	13.7	11.4	19.6	16.9	16.5	11.8	10.3	22.1	50.9	14.4	16.7	10.9	22.6	10.4	19.2	97.3	23.6	13.2	13.1	13.6	13.1	11.3	29.0	16.2	3.3	50.9	9.9	52.8	25.1	12.2
PCK1	PEPCK-C	ENSG00000124253	"Phosphoenolpyruvate carboxykinase 1"	P35558	20	57561080-57568121	"Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Kinase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 432.1;liver: 681.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 703.8;Distal tubular cells: 588.9;Hepatocytes: 1184.0;Proximal enterocytes: 2209.9;Proximal tubular cells: 3547.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 99.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"ASC diff: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006277, HPA006507, CAB017027"	Approved					NA	NA		840000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB017027: , HPA006277: AB_1079579, HPA006507: AB_1079578"	"unprognostic (3.50e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.60e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.43e-2)"		"unprognostic (1.84e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.47e-5)"	"unprognostic (1.03e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.21e-1)"	59.2	1.1	0.8	1.7	0.8	0.0	29.8	0.7	1.6	0.0	0.6	57.8	110.4	1.2	0.2	0.4	0.9	5.0	1.0	0.7	1.4	432.1	681.4	0.2	0.3	0.7	0.9	1.6	0.4	0.0	21.1	0.3	0.8	0.2	79.8	0.5	1.1	0.2	0.4	0.9	143.9	2.9	0.6	0.3	0.9	0.0	1.3	0.1	0.8	6.5	0.0	0.8	0.1	0.8	0.0	0.0	0.0	0.0	20.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.7	1.6	0.7	1.4	0.7	0.9	0.8	0.6	1.3	0.8	0.7	0.0	0.0	0.0	21.3	0.1	0.0	0.0	15.9	0.3	0.7	0.6	1.0	61.5	0.6	90.1	0.0	0.1	0.1	703.8	588.9	0.6	0.1	1.3	1.5	2.7	53.9	40.2	0.0	0.0	0.0	2.3	19.9	8.5	8.9	0.1	29.6	1184.0	0.0	3.3	0.0	293.6	0.0	22.6	0.0	0.0	0.0	12.8	0.0	1.9	0.0	9.9	0.0	0.0	0.0	0.1	285.5	0.0	0.0	0.0	2209.9	3547.9	0.0	0.4	0.0	0.3	6.0	0.0	0.1	10.3	0.3	0.3	10.2	1.5	348.5	0.1
PCK2	"PEPCK, PEPCK2"	ENSG00000100889	"Phosphoenolpyruvate carboxykinase 2, mitochondrial"	Q16822	14	24094053-24110598	"Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"intestine: 196.1;kidney: 99.1;liver: 374.1"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 309.3;Proximal enterocytes: 752.6;Proximal tubular cells: 237.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 91.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 104.7;hTCEpi: 104.7;SK-MEL-30: 103.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB018734, HPA051162, HPA053502"	Enhanced		Enhanced	Mitochondria		NA	NA		3500000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.17e-1)"	25.5	10.7	3.2	8.0	3.9	4.5	21.1	3.8	3.3	6.8	3.4	44.8	196.1	5.8	3.1	20.0	5.9	4.5	5.8	3.1	3.9	99.1	374.1	16.5	8.7	4.6	4.2	3.0	34.8	17.4	8.0	2.8	4.1	9.1	19.2	2.7	18.6	7.1	2.6	12.6	136.3	3.8	4.0	21.7	16.0	19.7	3.9	3.7	18.9	1.2	7.5	10.8	10.0	4.3	17.6	9.8	2.7	18.1	11.0	10.5	46.0	21.5	25.6	17.4	28.4	16.1	19.9	44.6	2.6	33.4	5.6	25.4	18.0	28.1	13.8	22.8	0.8	8.0	5.0	84.2	104.7	15.8	33.4	12.9	104.7	10.6	26.5	5.0	14.0	50.6	23.4	79.3	6.4	74.6	4.0	7.6	3.1	39.4	13.0	8.7	10.5	26.0	5.3	26.7	11.3	18.2	16.5	21.2	103.9	2.6	28.5	24.1	2.7	3.8	19.7	5.6	6.0	53.2	18.6	11.0	10.6	24.5	9.6	0.3	11.6	3.5	4.0	21.6	4.1	11.4	4.5	4.5	15.3	7.3	2.7	2.5	1.3	2.2	22.0	2.5	9.1	6.1	3.2	3.9	3.8	3.3	3.1	3.9	4.6	4.2	4.1	4.0	3.9	4.3	4.8	12.8	28.5	1.3	17.9	3.3	10.2	12.3	5.7	4.7	8.6	5.2	1.8	18.6	8.0	18.4	0.0	4.7	4.3	91.2	35.2	18.9	60.1	1.6	5.2	5.6	9.1	24.4	0.5	76.3	14.3	7.4	16.8	4.5	1.3	1.6	13.2	309.3	63.8	0.0	0.9	60.8	18.3	25.8	5.7	30.8	3.4	16.4	7.2	1.0	22.9	5.8	7.2	0.0	0.1	29.0	87.8	3.0	13.3	7.6	752.6	237.1	4.8	5.5	0.0	3.4	18.7	19.8	1.0	9.1	4.8	3.0	7.6	6.8	72.0	15.0
PCSK1	"NEC1, PC1, PC3, SPC3"	ENSG00000175426	"Proprotein convertase subtilisin/kexin type 1"	P29120	5	96390333-96434143	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 68.3"	"Cell type enriched"	"Detected in some"	4	"Enteroendocrine cells: 224.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 12.1"	"Group enriched"	"Detected in all"	5	"cerebral cortex: 19.1;hypothalamus: 68.3;pons: 30.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 22.6;U-138 MG: 19.0;U-87 MG: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA048564, HPA079656"	Approved				"Secreted in other tissues"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA048564: AB_2680444, HPA079656: "	"unprognostic (1.86e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.20e-5)"	"prognostic unfavorable (9.13e-5)"	"unprognostic (8.47e-4)"	"unprognostic (1.46e-1)"	"unprognostic (5.84e-3)"	"unprognostic (4.71e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.89e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.90e-6)"	"unprognostic (5.25e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.37e-3)"	1.7	6.3	5.5	4.7	3.7	0.1	1.4	1.0	19.1	0.9	0.0	2.4	5.2	0.1	0.0	0.1	0.2	0.2	0.8	3.0	68.3	0.4	0.0	0.3	0.1	6.6	7.7	0.4	7.6	0.0	12.1	0.0	30.0	0.4	2.3	8.7	2.7	0.1	0.3	1.1	3.6	0.6	4.0	0.1	5.7	0.1	6.6	0.2	1.9	0.0	0.0	2.0	0.5	5.3	0.0	0.0	0.3	0.0	2.3	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	1.0	3.8	0.0	0.0	0.1	0.0	0.1	0.1	0.8	2.4	0.0	0.0	0.0	0.0	2.0	1.0	0.4	0.1	0.2	0.9	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	3.3	0.0	0.0	0.4	0.0	0.0	1.2	19.0	0.6	0.3	0.2	0.0	0.0	0.1	15.8	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	3.7	1.0	19.1	3.0	68.3	6.6	7.7	30.0	4.0	6.6	5.3	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	1.8	13.2	0.0	0.0	0.7	0.0	0.0	0.0	2.1	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.2	0.2	224.6	0.0	54.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	4.0	10.7	2.0	0.0	0.4	1.6	0.0	0.0	0.0	4.7	0.0	0.5	0.0	3.5	4.9	1.5	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.9	0.0	1.7	1.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.7	0.0
PCYT1A	"CT, CTPCT, PCYT1"	ENSG00000161217	"Phosphate cytidylyltransferase 1, choline, alpha"	P49585	3	196214222-196287957	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"	"Cone-rod dystrophy, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 215.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035428	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA035428: AB_10602045"	"unprognostic (8.58e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (8.52e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.41e-2)"	31.4	24.4	15.2	30.0	16.0	45.3	21.0	16.6	15.8	16.7	17.8	25.7	60.3	19.1	13.9	31.0	15.6	20.7	46.4	15.5	21.1	18.3	20.7	22.5	22.9	18.8	18.0	15.8	16.8	22.7	12.9	20.1	18.5	16.6	22.9	14.4	19.3	18.6	73.8	43.0	49.1	23.0	17.5	25.9	24.2	22.4	18.1	18.1	17.2	42.1	26.8	21.0	19.8	17.1	92.6	36.6	25.8	37.2	52.2	53.9	37.0	68.2	47.1	59.2	51.8	92.3	32.8	23.9	215.2	78.1	60.2	71.4	40.5	52.1	50.4	42.1	28.6	68.6	40.6	39.5	45.2	34.3	56.7	47.4	40.0	55.9	39.6	35.4	63.0	21.0	38.3	53.3	58.1	79.6	19.9	17.3	21.4	55.7	53.0	34.5	31.0	37.5	35.7	53.6	25.4	18.3	44.5	79.5	44.2	32.8	114.1	37.2	88.5	45.5	25.2	61.8	92.7	45.8	101.1	44.1	69.6	43.8	56.9	9.6	9.2	10.4	8.8	9.3	7.5	7.2	6.5	9.7	9.1	6.3	4.2	6.3	21.0	9.4	11.0	5.9	14.9	5.2	15.2	16.0	16.6	15.8	15.5	21.1	18.8	18.0	18.5	17.5	18.1	17.1	24.7	16.0	25.7	15.3	19.9	14.5	9.4	19.7	14.2	15.9	14.1	9.4	70.1	20.0	17.5	14.7	25.0	11.9	27.3	36.4	13.7	24.8	76.3	17.8	22.9	23.2	22.1	12.2	20.4	22.9	17.7	17.0	23.4	15.6	20.8	16.1	26.7	35.6	37.4	8.4	22.7	24.2	6.1	34.6	27.1	67.6	19.9	33.9	19.6	20.6	39.4	13.1	39.1	16.1	17.6	24.6	21.1	28.2	27.2	12.0	67.2	23.2	33.9	12.8	26.3	15.0	19.0	46.0	13.2	30.0	21.5	18.6	25.6	25.5	23.8	12.2
PCYT2	ET	ENSG00000185813	"Phosphate cytidylyltransferase 2, ethanolamine"	Q99447	17	81900958-81911432	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 165.7;testis: 261.7"	"Group enriched"	"Detected in many"	7	"Early spermatids: 763.2;Late spermatids: 2829.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 218.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023033, HPA023034"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		84000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA023033: AB_1855094, HPA023034: AB_1855095"	"unprognostic (4.05e-3)"	"unprognostic (4.39e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"prognostic favorable (4.29e-6)"	"unprognostic (1.19e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.47e-2)"	29.7	16.8	40.0	9.5	40.1	12.1	25.2	44.4	45.8	14.9	30.4	25.5	63.9	18.0	13.5	26.3	23.9	9.9	47.7	41.2	37.7	44.0	165.7	21.3	12.0	47.0	43.0	20.9	25.3	20.2	14.4	12.0	47.3	24.2	16.7	8.6	22.3	12.1	33.5	16.3	43.0	9.6	41.3	12.8	35.4	261.7	41.0	13.5	16.2	29.3	11.9	21.2	15.1	44.0	42.6	23.9	18.8	53.1	91.8	48.0	27.9	29.9	63.2	40.7	48.0	94.0	43.0	14.8	16.0	31.1	75.3	34.5	28.6	55.1	23.5	4.5	24.3	32.1	33.3	218.2	97.8	32.5	26.0	39.8	31.4	36.8	28.4	14.5	38.6	44.0	60.6	29.6	30.8	35.7	39.3	40.1	15.1	147.2	25.9	25.4	20.2	52.4	49.2	78.8	23.9	21.9	22.4	121.7	29.0	36.5	33.9	75.3	26.1	30.0	19.7	22.9	25.0	19.3	9.1	15.3	31.2	42.8	29.9	1.5	2.4	0.9	4.6	2.6	3.0	4.2	5.5	4.7	4.5	5.6	4.5	4.6	0.7	3.3	2.1	4.4	3.6	3.1	40.0	40.1	44.4	45.8	41.2	37.7	47.0	43.0	47.3	41.3	41.0	44.0	11.5	0.0	17.3	15.0	11.1	5.4	8.1	11.7	6.8	12.5	25.1	11.0	17.0	62.9	9.6	25.8	0.0	73.1	21.0	41.6	119.3	19.5	763.2	29.0	7.5	8.7	13.9	47.8	5.3	18.3	39.7	7.7	36.2	15.8	9.5	39.6	21.8	166.0	24.1	16.8	4.6	29.1	20.3	11.8	3.3	2829.0	27.7	8.1	33.8	0.0	14.7	26.7	22.6	3.5	12.2	17.8	18.8	25.9	13.4	11.4	144.4	130.3	29.4	10.6	26.3	6.2	11.5	253.1	18.1	16.5	5.7	50.8	13.6	34.4	48.7	7.7
PDE6G	"PDEG, RP57"	ENSG00000185527	"Phosphodiesterase 6G"	P18545	17	81650459-81663112	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	99	"retina: 2050.3"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 4448.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"basophil: 127.0;NK-cell: 220.2"	"Group enriched"	"Detected in all"	6	"granulocytes: 127.0;NK-cells: 220.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 5.2;NB-4: 5.8;NTERA-2: 8.9;REH: 11.9;SuSa: 6.2"	"Region enhanced"	"Detected in some"		"hippocampal formation: 4.7"	"Not detected"	"Not detected"			HPA045118	Supported		Uncertain	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 46: Photoreceptor cells - Phototransduction"	Vesicles		"HPA045118: AB_2732517"	"unprognostic (6.16e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.85e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.94e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.14e-1)"	1.5	0.3	0.0	4.7	0.1	7.8	0.9	0.2	0.5	1.0	0.2	1.6	0.6	0.2	0.1	0.8	0.7	2.5	0.4	0.1	0.7	2.1	4.2	3.0	20.6	0.1	0.2	0.0	0.0	0.1	0.1	12.0	0.2	0.2	1.0	2050.3	0.5	0.4	1.2	0.3	1.6	0.9	0.1	19.9	1.7	0.8	0.3	8.3	0.4	0.3	7.1	3.0	0.1	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.3	0.1	0.2	0.0	0.9	0.0	0.0	0.0	0.0	5.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.4	2.8	0.2	0.1	0.2	0.4	0.3	0.0	5.8	8.9	0.0	0.0	11.9	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.1	0.1	6.2	0.1	0.8	1.2	0.2	0.0	0.0	0.1	0.1	0.6	0.9	0.4	3.1	0.1	127.0	18.1	30.5	4.1	26.2	1.3	2.7	0.8	2.3	28.9	5.1	2.1	7.4	2.4	220.2	15.5	2.9	0.1	13.5	0.0	0.1	0.2	0.5	0.1	0.7	0.1	0.2	0.2	0.1	0.3	0.2	0.3	0.0	0.6	0.3	1.1	0.9	0.0	0.0	0.6	422.5	0.3	0.4	0.2	0.0	0.0	5.5	517.1	0.2	4.3	0.1	1.9	0.4	0.8	1.5	0.3	27.2	0.0	1.7	0.2	0.2	0.4	0.2	0.0	0.5	23.6	0.1	2.9	0.2	22.6	262.5	0.1	0.2	0.0	4.8	8.0	2.3	0.0	4.4	3.6	0.0	13.3	709.0	11.3	0.0	0.1	0.2	0.0	0.0	0.8	0.1	0.1	1.0	0.0	4448.6	0.0	0.1	0.1	1.1	0.2	0.3	1.4	0.3	1.7	2.1	0.0	0.1
PDE6H		ENSG00000139053	"Phosphodiesterase 6H"	Q13956	12	14973042-14981865	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	226	"retina: 911.3"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 831.9;Rod photoreceptor cells: 218.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"AN3-CA: 1.0"	"Low region specificity"	"Detected in single"							HPA045118	Supported		Uncertain	Vesicles		NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles		"HPA045118: AB_2732517"					"unprognostic (1.47e-3)"										"unprognostic (1.07e-2)"			0.0	0.4	0.3	0.0	0.4	4.0	0.0	0.1	1.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	911.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.1	1.0	0.3	2.3	0.3	0.4	0.5	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.9	0.0	0.0	0.1	0.0	0.0	0.0	831.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.5	0.0	21.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	23.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.6	81.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	218.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0
PDHA1	PDHA	ENSG00000131828	"Pyruvate dehydrogenase E1 subunit alpha 1"	P08559	X	19343893-19361718	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 508.8;tongue: 770.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 479.9;Distal tubular cells: 354.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931"	"unprognostic (5.71e-3)"	"unprognostic (2.46e-3)"	"unprognostic (5.71e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.90e-2)"	"unprognostic (8.68e-2)"	"prognostic favorable (1.13e-7)"	"unprognostic (3.72e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.06e-2)"	93.0	69.0	62.1	37.9	66.9	88.1	63.1	66.2	91.5	55.9	84.4	112.6	87.0	53.1	78.9	76.8	49.1	29.3	508.8	68.2	67.0	174.1	118.3	47.2	36.6	64.5	62.7	50.6	83.4	161.0	48.7	43.1	65.0	48.4	104.4	90.1	109.7	63.4	459.0	60.9	82.1	51.8	59.6	49.3	121.8	24.0	67.4	52.3	64.5	770.2	59.1	61.7	56.1	71.1	124.9	151.4	107.9	114.2	102.3	77.7	131.6	83.8	74.6	170.2	130.7	216.6	78.2	212.2	60.6	102.0	226.7	159.0	334.2	145.8	178.1	70.1	186.1	104.8	264.0	194.2	107.8	170.3	82.8	100.9	132.8	157.3	154.4	85.6	105.3	129.8	94.2	87.2	120.7	164.5	142.7	173.5	110.0	227.4	261.7	145.2	180.9	260.3	298.0	125.1	59.7	62.6	134.1	167.8	158.1	229.8	177.1	118.1	65.4	87.6	78.6	240.9	108.6	73.3	82.0	140.5	82.4	117.2	77.4	99.9	87.4	65.3	72.3	119.9	88.9	103.4	69.4	79.5	115.7	82.1	67.7	72.0	15.5	98.1	109.1	76.9	84.4	89.6	62.1	66.9	66.2	91.5	68.2	67.0	64.5	62.7	65.0	59.6	67.4	71.1	34.1	44.8	44.4	18.6	30.7	29.8	59.7	135.4	25.0	59.0	37.0	29.3	479.9	87.2	74.8	152.6	33.3	105.0	32.5	73.0	354.1	88.8	2.5	41.2	33.7	36.8	41.9	55.8	21.2	59.8	120.7	49.2	49.5	36.9	42.6	39.7	18.2	76.3	73.2	25.2	24.6	64.4	71.2	26.8	30.5	4.1	35.4	32.5	56.9	9.4	40.8	49.0	26.8	13.0	11.5	47.4	52.5	40.6	43.3	47.1	88.6	213.7	33.1	69.1	32.9	37.5	51.7	51.1	25.3	45.2	33.4	133.4	31.6	25.4	130.3	55.8
PDHB	PDHE1B	ENSG00000168291	"Pyruvate dehydrogenase E1 subunit beta"	P11177	3	58427630-58433857	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 299.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 300.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033794, HPA036744, HPA036745"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No		61000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.98e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (2.79e-8)"	"unprognostic (2.67e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.85e-2)"	59.9	76.5	48.7	42.2	50.2	25.7	42.9	53.9	62.7	43.3	63.6	56.8	42.5	38.5	44.6	57.4	37.7	35.9	175.0	49.7	52.3	100.8	110.7	36.4	53.1	51.7	49.4	26.5	36.4	88.8	44.1	57.0	51.5	48.5	60.4	30.7	45.9	52.1	272.6	36.8	37.6	63.8	51.6	42.8	53.9	42.3	53.1	53.1	40.8	299.4	56.0	49.7	35.9	54.3	66.5	90.9	92.3	69.8	91.7	111.1	110.4	81.6	101.3	117.9	120.6	165.1	62.6	140.3	44.9	103.8	109.0	37.6	113.2	74.9	90.0	81.7	83.0	125.4	163.7	126.0	92.5	103.0	67.9	97.9	67.7	95.5	55.8	137.5	103.1	114.2	65.9	61.5	129.5	63.1	98.2	107.8	127.2	69.2	101.3	46.3	71.8	136.1	188.1	89.1	63.7	70.2	75.6	107.2	85.4	131.3	159.0	108.7	76.3	62.9	83.7	66.8	94.2	85.2	129.9	99.2	96.2	120.8	60.7	57.8	98.9	98.7	83.2	115.1	87.9	102.2	81.7	80.5	141.1	103.4	90.9	82.4	19.6	129.4	109.7	94.7	113.2	124.1	48.7	50.2	53.9	62.7	49.7	52.3	51.7	49.4	51.5	51.6	53.1	54.3	57.8	60.9	34.5	5.9	45.3	27.9	40.7	142.0	26.7	31.8	29.4	31.6	300.6	48.6	96.0	35.0	25.0	174.1	35.3	41.0	230.9	95.9	76.3	37.0	37.3	58.0	58.0	22.5	10.9	72.2	101.6	54.1	29.6	34.2	39.3	48.5	46.1	76.1	84.6	57.2	13.3	50.4	162.8	37.9	26.6	16.9	60.3	37.2	56.9	9.4	76.5	61.7	70.0	9.0	13.6	55.9	43.0	51.1	38.8	19.1	45.8	146.8	70.7	45.9	65.7	30.8	72.3	98.2	88.3	42.8	29.8	157.2	44.7	224.4	53.0	37.7
PDK3		ENSG00000067992	"Pyruvate dehydrogenase kinase 3"	Q15120	X	24465270-24550466	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 71.6;Excitatory neurons: 92.8;Inhibitory neurons: 78.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046583, HPA072492"	Approved		Supported	Nucleoli,Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Nucleoli	"HPA046583: AB_2679707, HPA072492: AB_2686526"	"unprognostic (5.41e-3)"	"unprognostic (5.43e-3)"	"unprognostic (5.35e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-3)"	"unprognostic (5.38e-2)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.51e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.43e-3)"	4.4	2.0	4.4	5.6	6.2	8.9	8.8	1.4	7.5	3.5	2.5	6.1	8.2	2.8	10.9	3.9	5.9	3.2	7.4	13.2	4.7	8.8	4.7	5.0	7.9	2.6	4.2	4.8	2.9	6.7	5.8	4.1	2.4	4.6	5.3	6.0	11.1	2.9	1.4	6.8	8.3	4.5	0.9	7.7	6.9	11.6	9.1	6.3	2.3	1.8	8.0	4.2	4.1	4.2	11.5	5.2	4.2	8.0	0.2	0.0	5.0	3.4	2.4	4.1	6.9	0.5	13.9	10.4	2.3	0.8	11.6	2.1	12.3	8.4	10.4	9.7	6.0	5.3	6.1	3.3	1.4	4.6	5.8	0.9	3.6	1.1	1.2	0.5	6.8	10.9	0.9	16.5	0.5	20.9	9.4	6.0	8.1	12.2	5.6	5.0	8.0	17.3	4.1	21.4	2.6	4.0	17.9	8.0	5.5	7.3	9.6	1.9	0.1	3.3	3.6	5.8	4.2	11.0	8.9	12.9	8.7	7.7	6.4	13.3	15.4	37.9	11.8	19.6	16.5	7.5	9.1	10.3	12.2	7.3	7.6	8.6	57.6	13.3	18.8	3.5	8.3	12.4	4.4	6.2	1.4	7.5	13.2	4.7	2.6	4.2	2.4	0.9	9.1	4.2	3.9	3.2	2.0	19.6	15.2	4.6	9.5	13.5	30.1	3.5	11.1	8.1	6.6	1.5	5.2	1.8	0.0	5.5	16.6	4.2	3.9	4.3	71.6	2.1	2.9	3.8	4.2	14.3	92.8	5.1	32.1	4.9	5.6	2.8	5.7	4.9	5.3	5.3	15.0	8.4	78.0	2.9	10.2	19.8	7.4	35.9	3.7	17.4	16.0	35.6	10.3	3.7	25.7	19.6	14.0	2.1	0.3	5.7	19.0	5.9	13.3	14.2	2.4	3.5	0.0	2.0	10.6	10.2	8.3	6.8	4.4	17.8	18.2	9.7	4.1	8.4
PDP1	"PDH, PDP, PPM2A, PPM2C"	ENSG00000164951	"Pyruvate dehyrogenase phosphatase catalytic subunit 1"	Q9P0J1	8	93857807-93926068	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 80.0;Early spermatids: 144.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"amygdala: 14.2;basal ganglia: 20.1;cerebral cortex: 41.7;hippocampal formation: 23.4;white matter: 18.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 117.8;hTERT-RPE1: 117.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018483, HPA019081, HPA021152"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635"	"prognostic unfavorable (8.61e-5)"	"unprognostic (4.62e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.25e-1)"	"prognostic favorable (8.42e-9)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.67e-1)"	10.6	62.6	14.2	10.5	20.1	14.4	16.1	0.0	41.7	14.2	1.2	8.9	7.2	15.5	17.0	14.2	12.2	19.4	49.2	23.4	0.0	12.8	4.2	12.6	12.9	0.0	2.3	19.3	19.9	29.9	5.4	13.8	0.0	10.3	12.4	14.1	11.7	9.4	72.9	4.3	7.6	11.2	0.0	13.2	11.7	26.7	3.0	11.6	18.8	16.9	12.4	14.0	6.8	18.5	25.7	12.0	25.9	10.9	21.0	37.9	8.6	19.3	21.7	22.1	25.8	12.7	90.3	13.9	63.8	30.8	117.8	54.4	11.0	16.1	32.8	1.5	5.6	6.6	15.7	4.5	23.9	3.3	9.0	24.5	31.5	37.7	59.8	117.1	50.9	12.4	2.4	22.8	27.6	6.0	20.3	10.3	12.1	26.8	15.4	4.8	15.5	2.6	15.3	17.0	2.4	11.4	12.7	1.4	61.8	20.9	4.0	3.9	90.9	27.5	17.2	63.8	23.3	12.6	5.8	12.1	34.2	11.7	25.1	6.4	27.9	14.5	9.2	25.3	8.9	15.6	15.1	12.0	22.5	17.9	8.9	7.8	3.1	5.4	41.1	3.7	34.9	18.0	14.2	20.1	0.0	41.7	23.4	0.0	0.0	2.3	0.0	0.0	3.0	18.5	10.7	12.8	7.8	15.0	18.0	13.0	12.7	36.3	68.9	38.3	11.6	7.0	80.0	14.3	35.6	16.5	8.4	4.3	13.7	27.5	5.9	33.3	144.2	33.3	14.9	15.0	10.2	1.3	73.6	14.0	3.9	20.8	16.3	70.2	6.3	3.7	12.5	3.3	6.3	10.1	23.4	5.5	10.2	19.2	19.1	28.1	11.5	19.9	10.6	19.7	22.4	18.8	10.3	13.0	8.5	24.5	9.6	13.5	8.1	15.6	4.9	11.4	30.5	11.5	6.6	35.4	13.1	10.1	11.4	26.5	10.9	4.4	19.3	7.1	10.7	23.9
PDSS1	"COQ1, COQ1A, TPRT, TPT"	ENSG00000148459	"Decaprenyl diphosphate synthase subunit 1"	Q5T2R2	10	26697701-26746798	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.1;lymphoid tissue: 13.8"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 32.5;Proximal enterocytes: 29.8;Undifferentiated cells: 29.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038032, HPA042741"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA038032: AB_10670650, HPA042741: AB_2678139"	"unprognostic (1.41e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (6.79e-3)"	"unprognostic (5.43e-2)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (2.47e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.93e-3)"	"unprognostic (8.85e-2)"	"unprognostic (9.83e-2)"	"unprognostic (6.36e-2)"	2.1	1.4	0.8	5.3	0.9	5.8	2.3	2.6	1.4	1.8	0.6	14.1	19.1	1.9	1.3	4.3	1.5	1.6	2.8	0.8	0.8	6.2	3.6	2.2	4.0	0.8	0.9	1.7	1.3	2.2	0.8	2.4	0.9	1.5	15.1	1.9	1.8	1.3	5.7	1.4	15.3	2.9	0.8	1.8	2.8	2.8	0.9	13.8	1.2	9.5	4.7	3.1	2.2	1.1	15.6	11.8	8.9	16.3	2.9	5.4	12.2	14.0	3.6	20.0	13.7	18.3	8.4	35.0	7.2	7.0	7.6	19.2	28.6	21.8	16.7	14.7	23.6	30.4	9.9	13.6	4.3	20.3	11.6	6.8	9.2	19.0	5.0	3.5	10.7	22.8	28.4	9.3	14.4	24.9	64.6	14.7	17.9	24.9	11.3	29.6	25.1	25.5	12.0	7.3	25.7	15.8	13.5	27.6	15.9	9.2	9.9	23.7	6.8	11.1	17.9	22.9	22.5	3.6	14.1	25.6	10.9	51.3	8.7	0.0	2.8	0.5	0.4	2.3	1.0	0.2	0.8	0.6	2.6	2.4	1.6	0.7	0.1	0.4	1.2	0.7	0.0	0.7	0.8	0.9	2.6	1.4	0.8	0.8	0.8	0.9	0.9	0.8	0.9	1.1	3.6	0.0	0.0	18.9	4.8	6.9	3.6	5.7	8.0	2.9	4.4	5.1	2.2	5.7	3.9	3.7	4.2	7.7	4.9	11.7	7.9	6.1	12.0	2.1	3.8	2.7	10.8	8.4	16.9	3.9	12.4	3.4	10.2	3.3	0.0	3.7	1.8	4.5	8.8	1.7	32.5	13.0	6.1	5.3	2.7	4.1	2.1	7.7	1.8	5.6	6.2	1.2	1.0	6.6	6.5	5.6	9.8	2.6	9.1	3.7	29.8	26.3	2.1	4.9	0.0	4.1	6.5	12.5	9.4	13.6	3.1	6.3	4.8	4.6	29.8	3.3
PDSS2	"bA59I9.3, C6orf210, COQ1B"	ENSG00000164494	"Decaprenyl diphosphate synthase subunit 2"	Q86YH6	6	107152562-107459564	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Cancer-related genes, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 82.4;Oligodendrocyte precursor cells: 72.9;Oligodendrocytes: 74.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029685, HPA029686"	Approved		Supported	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA029685: AB_10600219, HPA029686: AB_10602309"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.44e-1)"	"prognostic favorable (5.74e-5)"	"unprognostic (5.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (3.75e-7)"	"unprognostic (2.25e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.11e-2)"	7.9	17.9	4.6	6.3	5.2	9.0	8.1	6.1	5.7	9.2	6.8	12.4	9.3	6.8	6.5	8.6	8.6	8.7	13.9	4.6	5.2	21.6	27.1	8.0	7.6	4.9	4.7	9.1	8.4	13.2	8.5	6.8	5.0	14.6	13.2	6.0	15.3	7.4	12.5	6.3	9.6	8.5	4.7	6.7	9.6	7.7	5.3	8.1	13.3	13.7	7.1	7.6	6.1	6.1	7.6	10.0	8.3	13.2	14.2	18.0	19.2	13.1	16.5	12.4	11.8	10.0	10.8	14.4	11.7	14.7	13.1	10.2	20.3	16.5	16.7	9.1	9.8	14.4	11.4	16.9	15.0	18.5	11.1	13.5	19.1	19.5	15.3	10.8	13.1	16.5	20.7	19.0	12.2	9.3	5.4	19.7	5.3	17.3	12.7	9.7	7.4	11.7	15.2	10.2	8.2	7.1	9.0	15.4	19.7	9.0	12.7	22.3	8.3	8.8	5.2	12.4	11.4	5.3	6.8	11.3	16.3	27.4	16.3	3.2	5.1	2.8	3.7	5.9	5.9	4.7	3.8	4.7	7.0	5.5	5.0	4.8	0.6	3.6	9.9	3.3	5.5	3.4	4.6	5.2	6.1	5.7	4.6	5.2	4.9	4.7	5.0	4.7	5.3	6.1	11.4	16.0	19.1	64.9	12.3	4.2	13.8	11.7	13.6	8.2	9.7	8.3	17.4	12.8	13.9	14.7	2.1	26.9	8.3	15.1	35.2	12.7	37.3	16.3	9.3	8.4	10.3	8.0	53.5	14.5	17.3	9.5	8.2	10.9	14.0	11.9	7.5	32.6	11.8	6.7	67.3	15.3	14.2	9.8	5.1	12.7	5.3	10.2	7.2	82.4	8.5	11.8	6.2	72.9	74.5	13.7	14.4	9.4	13.0	12.2	14.2	40.8	21.0	11.5	26.3	8.7	7.9	21.7	11.5	14.3	5.8	11.9	9.8	13.4	17.0	12.5
PDYN	"ADCA, PENKB, SCA23"	ENSG00000101327	Prodynorphin	P01213	20	1978757-1994285	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Neurotransmitter, Opioid peptide"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 47.0"	"Group enriched"	"Detected in some"	83	"Early spermatids: 47.8;Late spermatids: 119.0"	"Group enriched"	"Detected in some"	29	"glioma: 2.6;ovarian cancer: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"THP-1: 1.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 152.2;hypothalamus: 60.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 132.2"	"HPA053342, CAB079777"	Enhanced	Supported			"Secreted in brain"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"CAB079777: , HPA053342: AB_2682121"					"unprognostic (7.00e-2)"				"unprognostic (1.07e-1)"	"unprognostic (1.40e-1)"					"unprognostic (3.73e-2)"			0.0	0.0	43.2	0.1	31.1	0.0	0.0	0.0	43.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.0	17.6	0.0	0.0	0.0	0.0	1.8	4.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	21.0	0.0	0.0	8.3	9.2	0.2	0.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.2	31.1	0.0	43.1	47.0	17.6	1.8	4.1	0.2	21.0	9.2	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	119.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PEPD		ENSG00000124299	"Peptidase D"	P12955	19	33386950-33521791	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Collagen degradation"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 209.5;kidney: 277.7"	"Group enriched"	"Detected in all"	4	"Proximal enterocytes: 833.0;Proximal tubular cells: 1278.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015599, HPA072045"	Enhanced		Approved	Nucleoplasm		NA	NA		860000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA015599: AB_1855192, HPA072045: AB_2732194"	"unprognostic (1.39e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.96e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.50e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	53.2	56.0	28.5	26.9	35.5	14.3	43.6	35.6	30.5	36.9	33.5	44.2	180.5	49.7	9.9	42.8	34.2	31.2	24.3	28.7	30.9	277.7	117.8	38.1	30.7	36.2	30.8	35.9	27.1	29.3	42.5	21.9	36.3	23.6	14.8	11.8	33.6	22.9	35.6	43.1	209.5	24.5	34.6	38.2	33.6	18.3	33.4	20.8	37.0	23.2	21.3	40.1	28.2	43.4	43.2	118.7	26.4	53.1	114.9	44.9	80.6	37.4	65.3	45.6	52.7	104.7	34.2	18.8	53.5	73.2	33.9	11.2	39.5	28.5	23.4	51.3	50.4	107.7	24.6	108.3	91.6	29.6	128.8	63.6	29.0	38.2	18.3	27.8	56.4	34.4	22.7	49.4	44.2	54.3	19.0	11.7	46.2	79.6	48.8	45.3	41.0	51.2	39.4	108.8	40.3	106.4	64.2	31.3	62.5	18.2	25.1	36.3	56.6	48.3	46.6	62.3	41.8	45.2	59.1	13.1	49.5	48.2	65.8	113.7	117.2	8.3	75.5	123.6	65.5	49.6	74.0	69.8	100.6	50.5	47.1	55.6	6.1	55.6	92.5	31.0	76.1	119.6	28.5	35.5	35.6	30.5	28.7	30.9	36.2	30.8	36.3	34.6	33.4	43.4	56.9	22.4	27.4	11.4	29.0	19.4	32.9	36.0	11.4	33.3	16.2	24.4	13.3	52.9	23.8	73.5	4.2	21.4	32.6	17.6	197.6	77.2	8.0	15.0	20.1	50.7	17.3	25.4	19.9	44.2	67.3	38.6	18.3	13.0	57.6	41.9	52.8	180.3	227.2	62.2	14.9	35.6	30.5	59.7	40.9	13.2	49.4	75.3	67.6	15.9	102.2	73.6	34.0	21.6	24.3	33.8	79.3	60.5	31.5	22.9	833.0	1278.3	27.1	33.7	39.5	37.0	43.1	10.2	44.5	34.3	20.3	30.4	33.7	48.7	44.6	22.2
PEX1	"ZWS, ZWS1"	ENSG00000127980	"Peroxisomal biogenesis factor 1"	O43933	7	92487020-92528520	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis, Protein transport, Transport"		"Amelogenesis imperfecta, Deafness, Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020235	Approved		Supported	Peroxisomes		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Peroxisomes		"HPA020235: AB_1855224"	"unprognostic (4.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.81e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.17e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.35e-3)"	"unprognostic (4.90e-2)"	5.8	6.9	2.6	6.0	4.7	4.1	8.7	4.6	4.3	6.4	2.5	8.6	6.6	6.7	11.2	6.1	5.6	4.7	8.9	2.4	3.1	14.2	13.0	5.3	6.9	3.5	3.5	6.8	8.8	11.7	6.3	4.2	4.1	7.8	9.5	13.2	9.1	7.0	9.1	7.9	8.1	5.4	2.8	6.0	8.2	6.7	3.0	7.9	8.6	9.9	6.7	5.6	5.8	6.3	8.3	8.9	14.4	24.6	8.9	7.6	13.0	5.4	7.1	6.3	9.1	5.5	8.7	12.2	12.0	6.3	9.6	8.4	11.0	9.9	10.0	12.7	9.7	5.8	9.5	7.0	6.2	10.6	6.4	8.2	8.6	9.4	12.7	8.0	9.9	12.6	21.9	17.2	10.1	15.5	21.3	10.4	10.0	12.3	8.3	15.0	16.0	15.3	8.8	12.0	10.6	17.1	12.4	34.3	10.8	20.2	7.1	4.4	8.1	6.0	8.1	23.0	5.7	18.9	15.9	16.7	5.7	6.2	9.8	0.8	1.1	1.8	2.5	1.8	2.5	3.0	2.6	2.8	1.2	2.8	2.9	3.3	0.9	4.7	2.2	0.7	2.8	1.1	2.6	4.7	4.6	4.3	2.4	3.1	3.5	3.5	4.1	2.8	3.0	6.3	14.2	28.9	18.4	26.1	14.1	5.9	8.4	8.1	10.8	43.5	11.7	12.6	29.7	5.7	13.1	5.5	35.5	9.0	13.6	17.2	9.8	6.6	7.3	22.6	14.7	11.6	13.9	12.4	30.0	7.5	3.9	11.6	21.9	14.2	8.8	20.5	8.2	14.2	5.4	40.4	45.7	12.0	8.2	7.6	3.1	4.8	14.3	8.4	7.2	13.1	12.7	14.2	14.4	23.6	55.2	6.0	11.3	15.1	11.6	9.6	16.5	19.2	32.4	42.9	6.6	15.5	12.6	36.6	14.4	11.2	7.7	8.3	12.0	11.8	15.2	7.7
PEX10	RNF69	ENSG00000157911	"Peroxisomal biogenesis factor 10"	O60683	1	2403964-2413797	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 194.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049458, HPA049755"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA049458: AB_2680775, HPA049755: AB_2680867"	"prognostic favorable (4.50e-6)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.16e-6)"	"unprognostic (4.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-1)"	14.9	28.9	22.2	2.2	24.3	3.1	13.9	23.5	25.7	10.8	19.7	11.3	6.7	11.4	8.5	17.2	10.0	4.2	16.1	20.6	21.6	18.1	22.0	8.8	4.3	25.4	22.6	12.8	19.8	10.4	18.5	3.8	22.1	16.1	4.4	4.6	14.3	6.9	18.6	14.0	9.6	4.1	23.4	10.2	12.7	22.0	23.3	3.7	13.1	10.2	3.4	12.9	11.3	25.3	18.6	16.9	13.2	7.4	7.9	9.7	11.5	9.6	10.9	14.2	11.3	27.2	13.9	10.8	27.1	11.9	8.7	12.1	11.6	16.3	8.1	16.8	21.9	8.5	17.2	55.3	16.4	14.2	4.2	9.0	9.3	10.8	16.0	10.4	13.9	12.5	9.9	7.4	14.7	26.2	9.1	6.0	9.6	8.0	31.3	7.8	13.8	18.9	17.8	6.3	18.2	15.3	13.0	8.2	29.2	7.1	8.3	3.5	14.8	6.7	5.9	17.2	10.8	19.0	7.6	8.6	17.6	10.9	6.1	1.6	5.8	1.7	3.8	8.7	4.4	5.9	3.3	5.1	9.4	4.9	3.8	3.0	0.6	3.6	7.6	7.8	2.1	4.2	22.2	24.3	23.5	25.7	20.6	21.6	25.4	22.6	22.1	23.4	23.3	25.3	12.8	3.2	4.4	3.3	9.5	8.8	13.7	15.4	15.9	16.8	16.4	15.4	1.1	11.5	8.9	14.7	0.0	26.7	6.7	8.3	35.2	26.8	51.7	8.5	9.0	11.2	13.2	9.2	5.1	30.3	25.2	11.5	12.8	10.3	0.0	22.8	7.5	10.5	22.9	13.5	5.6	10.3	12.2	11.2	7.2	194.7	10.5	9.6	23.2	2.8	18.7	45.2	8.2	8.0	6.7	21.0	7.7	13.5	14.9	14.6	17.5	27.8	8.6	14.8	0.0	15.5	10.9	28.9	22.8	22.4	6.1	27.5	6.9	30.2	14.6	14.1
PEX12		ENSG00000108733	"Peroxisomal biogenesis factor 12"	O00623	17	35574795-35578863	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 17.2;Spermatocytes: 21.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069386	Enhanced					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA069386: AB_2686135"	"unprognostic (1.45e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.64e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (2.60e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	3.9	6.8	6.7	3.6	7.2	1.5	5.5	7.9	9.1	5.3	6.7	3.4	3.6	4.3	10.7	3.4	5.6	3.2	9.1	6.8	7.1	8.2	9.0	3.4	4.8	6.8	6.9	8.2	4.0	7.8	4.7	4.7	6.8	5.7	2.9	4.6	5.5	6.9	10.3	4.2	3.5	3.5	7.3	3.9	3.9	6.8	7.0	3.2	7.7	10.8	4.5	3.7	2.7	8.4	2.8	3.7	5.4	4.4	11.0	9.9	3.9	7.3	8.3	6.0	6.3	3.2	3.0	6.4	11.6	4.1	4.9	7.3	6.6	4.8	5.2	2.3	8.7	4.7	3.8	5.9	12.8	6.7	1.2	9.2	9.2	3.7	10.9	7.7	4.6	5.2	7.5	6.6	7.2	2.9	7.9	3.8	2.2	6.3	5.8	3.8	9.3	6.4	7.1	4.2	4.0	4.0	4.6	3.0	9.6	6.5	7.4	3.7	3.7	5.6	3.5	6.3	4.9	13.3	9.9	7.5	6.0	5.1	5.2	2.2	1.5	3.0	1.8	1.1	3.2	2.3	3.0	1.8	1.7	2.6	4.1	3.5	1.0	2.0	1.2	1.7	2.4	1.4	6.7	7.2	7.9	9.1	6.8	7.1	6.8	6.9	6.8	7.3	7.0	8.4	2.7	3.2	0.5	6.5	3.3	0.6	1.9	1.3	1.8	2.1	2.4	2.2	6.3	0.0	2.7	3.7	0.0	6.7	1.4	1.3	3.9	3.5	17.2	1.9	2.3	3.9	1.2	0.8	1.3	1.1	4.1	2.6	2.6	1.5	2.5	2.0	3.3	5.4	2.9	1.7	1.9	1.7	2.0	2.6	0.6	3.0	3.1	1.5	1.8	1.0	0.9	8.3	1.0	4.5	2.8	2.2	1.0	1.5	0.5	2.4	2.7	3.3	1.8	2.2	0.0	2.6	3.7	21.0	10.2	1.4	1.3	5.2	2.8	3.0	2.2	1.3
PEX13		ENSG00000162928	"Peroxisomal biogenesis factor 13"	Q92968	2	61017225-61051990	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 125.8;Urothelial cells: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032141, HPA032142, CAB032689"	Enhanced		Supported	Peroxisomes		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 85: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Peroxisomes		"CAB032689: AB_2162137, HPA032141: AB_2674176, HPA032142: AB_10669676"	"unprognostic (2.44e-3)"	"unprognostic (4.10e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (5.42e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.63e-2)"	9.5	8.0	6.6	6.7	7.1	7.4	11.1	9.7	9.2	10.2	10.2	10.2	10.2	9.2	7.5	10.2	6.6	8.8	11.9	6.8	7.4	13.6	25.0	9.3	6.8	6.7	7.1	11.0	11.8	9.6	7.4	9.3	6.8	14.6	10.7	8.8	8.7	5.8	14.6	7.9	9.8	8.1	6.6	6.7	10.1	14.9	7.1	7.3	13.7	13.6	6.7	13.8	9.1	7.7	15.5	11.3	15.7	20.3	14.8	11.5	24.2	15.9	12.3	10.6	10.8	16.9	22.9	10.0	16.7	15.6	19.9	22.8	14.1	19.2	20.0	9.9	9.7	9.2	15.1	28.0	17.5	13.9	10.8	14.2	28.9	14.5	22.3	16.2	19.4	11.3	22.8	8.7	16.3	14.1	10.4	16.6	17.2	28.6	11.2	11.1	17.4	12.7	20.3	38.2	17.7	12.2	17.7	23.7	14.9	18.5	15.8	7.1	15.3	20.2	27.0	11.8	13.6	14.2	11.6	25.0	12.7	14.0	14.5	12.4	3.9	5.9	5.0	3.9	4.7	5.4	5.8	5.5	5.1	4.1	6.1	4.6	3.7	5.5	5.0	4.5	5.4	3.9	6.6	7.1	9.7	9.2	6.8	7.4	6.7	7.1	6.8	6.6	7.1	7.7	12.9	19.2	19.1	14.0	13.8	51.2	35.1	61.9	25.6	11.9	23.0	13.2	21.9	28.6	53.0	22.0	8.4	36.9	13.4	27.6	25.4	28.8	125.8	24.5	16.1	15.1	2.4	9.9	18.8	28.5	43.1	14.5	12.8	28.8	8.2	15.6	13.6	49.3	20.9	16.8	16.8	14.5	36.7	14.6	25.9	28.7	9.6	14.8	16.0	25.3	19.3	12.6	18.6	14.1	19.4	23.2	13.2	11.7	9.9	43.9	28.8	33.2	38.7	15.0	6.6	11.6	18.8	66.8	26.4	21.8	50.3	68.7	15.0	11.4	18.1	112.0
PEX14		ENSG00000142655	"Peroxisomal biogenesis factor 14"	O75381	1	10472288-10630758	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"		"Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 67.3;Syncytiotrophoblasts: 64.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046104, HPA049231"	Supported		Supported	"Nucleoli fibrillar center,Peroxisomes"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Peroxisomes	"Nucleoli fibrillar center"	"HPA046104: AB_2679539, HPA049231: AB_2680683"	"unprognostic (7.23e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.05e-3)"	"unprognostic (9.67e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.75e-2)"	15.9	13.9	15.5	9.5	15.3	7.8	16.2	11.7	21.8	15.5	10.7	16.8	15.1	17.1	6.4	20.9	13.7	9.3	19.6	15.8	13.6	15.8	33.0	14.3	10.5	14.1	13.1	14.9	11.2	11.8	14.1	11.8	13.8	26.4	8.2	28.1	16.8	23.8	22.6	18.6	16.2	8.5	12.2	12.6	13.8	14.0	14.3	9.7	14.0	11.3	8.6	48.8	17.6	16.0	22.5	21.1	17.2	19.2	12.3	11.6	11.2	25.2	20.8	27.4	26.1	22.4	40.1	16.4	24.9	19.4	16.3	26.3	17.9	24.6	12.9	23.1	30.3	20.4	22.6	31.2	18.8	23.0	27.3	14.2	19.2	20.7	19.0	16.3	17.9	21.2	32.2	16.3	12.4	18.7	21.9	30.4	17.7	17.2	24.6	23.5	14.5	23.3	21.7	14.8	20.5	23.5	24.4	20.2	23.9	13.2	18.4	16.2	17.7	19.9	21.5	19.6	22.0	23.3	20.4	32.3	21.8	31.2	21.7	1.4	2.2	4.6	4.5	1.6	2.8	2.2	2.3	3.4	2.7	2.0	2.9	2.8	0.3	2.6	1.5	2.8	3.0	2.4	15.5	15.3	11.7	21.8	15.8	13.6	14.1	13.1	13.8	12.2	14.3	16.0	5.9	9.6	2.0	32.0	9.2	7.1	13.9	29.2	4.0	15.1	8.3	6.9	8.4	4.3	12.3	9.2	27.1	49.7	11.3	14.1	7.9	17.2	5.9	10.6	4.9	7.8	9.0	4.6	42.0	14.7	18.7	8.1	4.1	7.4	6.3	7.8	8.2	51.1	22.7	18.5	48.4	9.7	14.2	9.0	3.1	3.1	8.1	8.0	12.4	28.1	19.9	21.2	10.3	29.7	29.9	18.2	12.3	5.7	14.7	10.8	29.7	18.5	23.5	67.3	6.6	4.5	11.0	7.1	12.8	7.1	8.1	64.7	9.8	8.3	12.0	13.5
PEX16		ENSG00000121680	"Peroxisomal biogenesis factor 16"	Q9Y5Y5	11	45909663-45918812	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043286	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 1: Pancreatic cells - Digestion"			"HPA043286: AB_10794179"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.53e-1)"	"unprognostic (9.06e-3)"	"unprognostic (9.06e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.75e-3)"	"unprognostic (5.72e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (9.06e-4)"	23.4	27.1	22.3	10.9	23.8	20.3	22.2	23.4	24.4	18.2	16.6	20.6	21.3	18.7	6.3	21.3	18.9	10.1	17.0	23.0	22.7	26.7	50.2	16.2	16.6	26.2	23.6	18.3	40.0	10.1	32.0	6.7	23.2	21.7	5.1	4.4	21.6	9.7	18.1	27.2	25.3	6.0	21.9	24.5	27.6	25.8	23.6	11.8	21.8	7.5	8.6	20.1	18.0	26.0	15.0	19.9	6.7	16.8	11.0	13.2	19.4	11.6	15.2	15.5	12.0	22.6	10.7	25.6	15.0	10.9	14.7	27.2	6.9	23.0	3.7	22.4	23.6	16.7	28.8	20.1	34.8	24.9	33.8	21.3	20.1	9.4	15.1	9.1	17.0	21.9	13.4	29.6	10.7	42.0	21.3	32.5	15.1	28.7	20.0	18.4	16.8	29.4	10.0	26.5	17.0	22.7	13.3	27.1	24.5	4.2	40.4	21.1	13.6	14.8	19.0	36.9	21.5	47.1	33.1	16.2	16.2	14.7	16.2	35.3	44.1	36.8	47.9	51.0	44.9	57.0	48.9	49.6	47.8	50.5	44.4	46.7	32.2	44.9	38.6	44.7	61.1	46.1	22.3	23.8	23.4	24.4	23.0	22.7	26.2	23.6	23.2	21.9	23.6	26.0	25.1	3.2	5.4	3.9	35.7	16.6	24.4	47.6	19.4	15.7	25.9	22.4	3.8	22.8	25.1	14.7	10.4	39.9	31.9	45.8	50.9	37.3	25.9	19.7	13.8	21.5	28.1	25.9	4.8	88.7	22.2	15.7	17.9	20.3	21.0	16.2	21.8	68.6	34.2	15.2	5.1	26.5	30.5	37.7	19.7	32.6	19.3	20.0	21.4	3.7	46.6	28.8	26.8	5.0	10.6	55.9	49.2	14.3	27.1	26.1	90.5	68.1	26.4	18.0	32.9	16.8	24.4	27.2	15.4	21.6	21.0	64.0	33.0	19.9	29.6	28.2
PEX19	"D1S2223E, HK33, PMP1, PMPI, PXF, PXMP1"	ENSG00000162735	"Peroxisomal biogenesis factor 19"	P40855	1	160276807-160286348	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044837, HPA051966"	Supported		Supported	Peroxisomes		NA	NA		7900	"Cluster 34: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Peroxisomes		"HPA044837: AB_10962496, HPA051966: AB_2681677"	"unprognostic (1.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.80e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.92e-5)"	"unprognostic (3.46e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.24e-2)"	79.3	25.7	21.1	14.5	22.5	12.3	36.5	22.2	23.5	20.3	15.6	22.6	19.4	18.2	25.0	24.9	22.9	19.6	39.4	21.5	22.7	33.1	109.1	21.6	16.6	22.3	23.5	23.6	17.2	40.4	15.0	21.9	23.5	28.0	23.2	30.9	21.3	26.6	66.2	18.2	18.8	16.7	22.1	16.7	20.0	16.8	22.7	21.0	34.3	84.8	20.5	23.9	15.2	24.5	31.2	18.9	69.8	22.4	59.8	57.8	53.0	25.3	51.3	44.6	35.3	35.1	37.2	37.8	40.9	37.3	26.3	29.7	34.2	44.0	35.3	32.3	17.3	26.6	26.5	36.3	46.9	48.6	32.6	84.7	51.0	60.0	38.6	35.8	32.2	51.4	40.8	27.9	50.0	17.8	37.0	15.8	50.3	38.6	48.2	45.7	34.4	45.5	45.8	61.8	23.2	38.3	98.3	49.5	37.4	71.3	48.1	48.2	24.8	26.5	31.1	29.9	30.1	42.5	57.9	68.6	43.1	20.9	38.9	9.1	5.5	5.0	5.8	8.9	4.2	5.0	2.8	3.5	5.5	1.9	4.0	3.7	2.2	4.7	6.6	3.4	4.2	2.3	21.1	22.5	22.2	23.5	21.5	22.7	22.3	23.5	23.5	22.1	22.7	24.5	16.4	9.6	20.6	9.1	12.7	9.9	21.0	15.4	13.1	18.8	18.9	16.4	45.6	20.0	11.3	16.5	10.4	30.0	6.9	25.4	49.0	22.6	6.6	12.0	13.7	13.6	11.4	15.6	8.6	14.8	51.2	18.4	13.3	12.0	16.5	15.6	20.0	60.1	30.1	25.2	9.0	11.5	0.0	15.7	7.0	3.1	21.8	15.0	21.4	6.5	24.9	39.0	12.3	6.0	11.5	20.2	17.2	29.3	9.5	18.5	29.8	40.7	11.8	12.7	32.9	14.6	16.2	17.8	25.3	15.0	9.9	38.7	12.5	18.2	15.7	25.2
PEX2	"PAF-1, PMP35, PXMP3, RNF72, ZWS3"	ENSG00000164751	"Peroxisomal biogenesis factor 2"	P28328	8	76980258-77001044	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 133.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010983, HPA011410, HPA027729"	Approved		Supported	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles		"HPA010983: , HPA011410: AB_1854922, HPA027729: AB_10610416"	"unprognostic (6.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.48e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.09e-3)"	39.8	45.9	33.1	33.5	36.6	35.8	53.9	34.2	45.6	40.7	38.6	43.1	39.8	33.3	42.4	32.9	41.8	31.9	39.7	32.1	35.1	53.6	43.7	36.5	39.4	37.3	34.5	33.3	39.0	57.7	27.2	24.7	37.6	44.2	39.6	66.5	50.9	83.4	61.8	24.5	41.0	35.3	37.3	36.5	48.3	22.1	34.5	48.8	53.2	44.6	35.7	35.7	31.3	43.3	88.2	29.3	46.9	47.9	50.7	63.2	24.5	64.4	75.3	49.9	55.2	18.4	76.9	50.2	93.6	59.9	39.7	33.3	33.1	50.1	61.2	93.3	28.5	61.1	26.0	28.3	33.9	51.5	46.5	70.9	43.5	37.8	45.6	77.0	55.3	79.3	34.4	46.7	53.9	26.4	90.4	30.1	27.2	126.4	26.3	16.5	37.4	42.1	59.9	61.6	16.7	43.0	41.9	192.0	36.9	39.8	58.7	36.1	54.7	44.4	58.1	57.7	32.4	86.0	53.8	87.9	56.5	26.7	50.2	179.9	55.6	102.6	57.2	58.0	51.2	46.1	39.6	46.5	46.3	50.5	51.6	49.3	38.6	83.1	67.8	46.8	48.6	71.7	33.1	36.6	34.2	45.6	32.1	35.1	37.3	34.5	37.6	37.3	34.5	43.3	28.0	48.1	25.2	32.3	29.7	18.1	31.0	57.8	28.5	28.9	38.9	33.1	27.2	28.6	38.4	27.6	12.5	42.8	38.3	30.2	133.1	52.3	5.6	36.5	19.9	20.7	28.9	25.6	11.9	49.1	24.8	29.8	20.4	22.2	18.3	20.2	25.7	36.7	26.6	13.5	15.2	37.5	48.8	39.1	22.4	7.3	29.5	26.8	28.4	16.9	36.3	68.4	53.5	31.7	45.9	42.0	28.2	35.7	41.7	36.3	43.3	61.4	36.6	34.4	6.6	34.9	24.6	13.7	20.8	28.6	21.0	34.8	37.6	27.7	30.0	43.0
PEX26	FLJ20695	ENSG00000215193	"Peroxisomal biogenesis factor 26"	Q7Z412	22	18077923-18105396	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 198.7;Proximal enterocytes: 91.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											CAB070429	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB070429: AB_11154363"	"unprognostic (2.25e-1)"	"unprognostic (5.75e-3)"	"prognostic favorable (9.92e-4)"	"unprognostic (1.77e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.10e-4)"	"unprognostic (1.59e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (1.38e-4)"	"unprognostic (3.17e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.49e-1)"	7.5	5.8	7.3	7.8	6.2	12.1	6.7	3.7	6.8	4.9	5.8	16.9	19.2	5.5	5.3	7.5	6.0	5.3	5.8	7.9	5.3	7.5	7.3	5.0	7.3	8.4	7.8	5.4	8.0	9.2	4.2	5.0	7.0	5.3	13.1	3.1	6.4	5.6	6.3	5.6	19.9	5.4	6.3	8.1	9.3	3.1	8.3	7.3	6.9	4.1	6.7	6.0	3.9	5.5	18.3	8.7	10.2	9.2	10.5	6.6	18.8	11.8	12.2	12.8	10.5	15.2	15.1	11.3	10.8	17.5	11.2	18.7	15.9	16.5	10.9	19.0	12.4	19.4	12.3	12.8	10.0	26.0	23.6	8.2	12.7	17.3	16.2	6.1	15.2	11.1	21.2	8.1	12.7	22.0	22.8	8.8	13.2	24.9	15.7	17.6	8.6	4.1	14.8	20.6	17.7	15.5	17.1	12.0	16.3	8.2	19.3	9.7	20.4	23.6	10.2	12.8	12.4	21.4	15.8	16.6	10.9	12.3	17.1	1.2	1.7	1.4	2.0	1.1	1.9	1.4	1.8	2.6	1.5	2.0	2.0	1.3	1.2	2.7	2.6	3.1	0.8	1.0	7.3	6.2	3.7	6.8	7.9	5.3	8.4	7.8	7.0	6.3	8.3	5.5	10.5	6.4	10.3	1.3	14.7	13.5	14.8	9.3	8.6	24.5	12.4	7.2	29.3	25.8	13.8	7.3	43.8	11.9	18.0	198.7	5.9	24.7	1.0	16.3	16.2	17.6	24.5	11.1	4.9	23.6	9.8	13.0	20.9	18.6	12.0	19.8	18.9	33.0	15.2	30.3	5.6	22.9	6.1	20.4	10.7	2.8	12.5	11.0	0.0	2.8	20.4	9.2	22.6	4.5	4.3	31.6	51.8	11.7	11.8	20.4	91.7	21.7	11.5	25.5	13.1	18.8	9.6	9.4	10.1	13.7	17.6	9.3	13.9	21.4	29.4	18.7
PEX3		ENSG00000034693	"Peroxisomal biogenesis factor 3"	P56589	6	143450805-143490616	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042830, HPA058006"	Supported		Approved	Nucleoplasm,Peroxisomes		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Peroxisomes"		"HPA042830: AB_10794918, HPA058006: AB_2683576"	"unprognostic (3.52e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (3.80e-4)"	"unprognostic (1.87e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.12e-1)"	8.7	38.4	4.4	7.6	4.8	3.2	11.8	4.5	5.6	11.7	7.3	7.5	6.0	9.8	12.5	17.8	9.6	7.3	12.6	4.2	5.3	18.3	24.4	7.9	8.8	3.6	3.4	10.7	6.7	24.4	9.0	9.4	3.9	11.7	6.2	10.0	10.6	11.2	11.6	12.8	7.4	8.9	3.9	7.2	9.7	12.2	3.6	8.3	15.5	9.6	9.5	8.9	13.4	7.5	21.4	4.6	11.0	21.1	17.8	15.6	12.2	17.8	13.8	23.7	28.3	31.5	12.8	31.7	21.1	17.4	27.8	17.3	14.4	23.9	30.8	19.4	16.5	22.8	10.2	20.0	15.0	38.7	9.6	18.1	16.6	22.4	17.2	10.3	13.0	18.5	21.1	15.7	24.0	14.1	20.2	15.3	6.1	12.6	18.2	15.3	22.2	14.0	28.0	9.2	15.3	5.3	23.0	19.3	14.7	9.5	10.2	12.7	10.3	16.7	15.9	26.9	20.9	10.7	16.4	36.1	21.1	26.0	13.3	12.9	6.3	6.4	15.5	10.1	17.2	23.2	16.3	15.5	9.9	18.6	21.1	20.7	1.0	15.6	13.4	10.6	21.2	9.8	4.4	4.8	4.5	5.6	4.2	5.3	3.6	3.4	3.9	3.9	3.6	7.5	13.1	16.0	14.4	23.8	19.7	26.6	12.7	19.2	14.8	14.5	9.9	11.8	14.8	5.7	19.0	9.2	4.2	41.7	9.0	4.1	19.6	12.3	12.6	15.2	10.4	12.0	6.0	5.9	61.0	9.5	11.6	13.5	10.2	13.1	25.3	9.6	13.6	20.5	11.5	16.8	67.4	5.4	16.2	7.6	6.6	4.9	13.7	6.0	8.8	28.1	8.0	15.4	10.3	40.7	59.6	9.6	2.3	11.3	18.1	6.6	8.2	28.8	27.2	12.1	6.6	12.2	13.6	80.0	18.5	20.2	34.8	58.7	13.7	20.9	7.6	8.5
PEX6	"PAF-2, PXAAA1"	ENSG00000124587	"Peroxisomal biogenesis factor 6"	Q13608	6	42963865-42979181	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Amelogenesis imperfecta, Deafness, Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 76.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025924, HPA074179"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA025924: AB_1855230, HPA074179: "	"unprognostic (7.32e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.55e-1)"	11.6	20.5	24.9	9.2	25.2	9.5	12.1	23.9	27.7	19.1	25.5	16.3	9.3	15.5	7.7	16.4	22.7	9.6	18.7	25.1	25.5	16.5	27.7	10.0	14.5	27.2	25.5	26.1	76.2	15.2	24.3	9.6	24.2	21.6	7.8	9.9	14.8	11.4	23.4	14.0	16.3	9.6	23.9	17.5	16.3	16.2	25.1	14.7	19.8	15.0	10.4	17.3	15.7	25.2	35.0	16.4	8.1	30.6	29.6	28.3	8.4	6.0	9.4	4.8	10.0	10.5	10.1	14.1	8.2	14.3	20.5	32.2	28.7	31.1	5.0	27.6	15.2	4.7	24.4	6.2	20.0	4.8	9.4	35.5	35.5	19.9	5.5	39.1	24.7	18.9	25.2	14.1	10.7	3.9	12.7	15.8	10.0	78.8	14.3	26.8	14.3	5.8	12.3	10.0	25.4	11.1	5.6	21.9	32.7	13.1	43.2	21.2	14.0	15.2	2.9	7.5	14.0	21.0	19.8	19.7	5.2	24.6	12.4	1.3	1.3	2.1	1.2	1.1	2.1	1.0	1.8	2.5	1.9	1.9	2.2	2.1	0.8	2.0	0.7	1.0	0.9	1.1	24.9	25.2	23.9	27.7	25.1	25.5	27.2	25.5	24.2	23.9	25.1	25.2	5.6	6.4	2.6	19.9	5.6	5.0	10.2	6.2	10.8	15.2	11.8	12.7	4.1	10.0	5.6	7.3	2.1	11.4	5.4	10.2	13.7	2.8	2.5	17.6	10.6	5.8	5.4	1.7	24.6	1.5	6.7	9.2	11.2	9.1	0.0	19.8	8.6	14.1	5.8	21.9	22.4	8.5	6.1	9.7	3.2	3.6	14.6	5.4	8.8	9.4	4.5	11.8	9.2	13.0	16.6	1.9	10.4	9.4	3.1	6.3	15.1	13.9	14.3	7.0	0.0	13.0	6.6	7.3	2.6	6.3	5.5	7.4	7.8	26.1	10.5	6.6
PEX7	"PTS2R, RD"	ENSG00000112357	"Peroxisomal biogenesis factor 7"	O00628	6	136822564-136913934	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cataract, Deafness, Disease variant, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049202	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Vesicles"		"HPA049202: AB_2680674"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (4.01e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.88e-2)"	"prognostic favorable (1.85e-10)"	"unprognostic (3.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-1)"	5.2	14.8	4.6	2.0	4.8	3.8	11.9	6.0	5.2	6.8	5.1	7.9	5.3	4.2	17.2	7.3	8.7	4.5	11.7	4.2	4.2	15.6	9.1	4.9	3.2	4.3	4.4	5.0	26.9	17.1	6.0	4.1	4.5	10.4	8.4	6.9	10.6	6.4	10.7	11.2	4.7	3.3	4.4	3.3	15.6	10.0	4.7	3.7	11.0	9.8	3.3	5.4	6.7	5.5	4.4	4.3	4.4	6.2	6.6	9.8	2.4	6.1	8.9	7.5	7.4	4.9	6.0	1.5	11.3	8.3	8.5	5.3	3.3	13.8	9.8	5.7	7.5	6.4	4.3	0.9	13.9	8.1	5.3	9.6	13.1	5.4	7.9	8.7	5.4	12.0	13.0	5.2	10.6	13.4	3.5	7.9	5.0	13.9	8.3	4.8	3.4	5.7	17.4	6.4	8.3	10.6	6.5	9.0	8.4	4.9	5.8	7.7	2.5	4.8	1.7	7.3	5.3	6.9	5.1	0.0	4.2	6.4	4.9	2.9	1.3	2.2	0.7	1.0	0.7	1.5	1.3	1.6	2.3	1.0	2.4	1.5	0.9	1.6	1.9	1.8	2.3	0.9	4.6	4.8	6.0	5.2	4.2	4.2	4.3	4.4	4.5	4.4	4.7	5.5	4.9	3.2	9.4	10.7	6.3	12.1	14.9	16.5	9.1	9.1	19.5	13.8	18.7	11.5	14.7	11.0	8.4	19.6	2.3	11.6	60.7	16.5	12.5	18.7	6.4	5.6	10.3	15.8	12.4	22.7	21.0	6.8	10.2	11.1	14.0	7.9	6.1	7.0	12.4	0.0	14.7	21.8	30.5	5.7	6.2	10.2	9.0	6.4	14.2	5.6	11.9	20.8	4.1	17.6	19.9	16.7	13.2	9.8	3.7	16.0	15.0	38.3	16.1	9.9	6.6	5.7	8.2	30.6	16.7	15.4	18.2	17.1	6.6	24.3	17.2	17.4
PFKM	"PFK-1, PFKX, PPP1R122"	ENSG00000152556	"Phosphofructokinase, muscle"	P08237	12	48105139-48146404	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 1570.1;tongue: 1393.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 345.9;Horizontal cells: 121.1;Muller glia cells: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002117	Approved		Approved	"Endoplasmic reticulum"		NA	NA		410000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Endoplasmic reticulum"		"HPA002117: AB_1855245"	"unprognostic (4.60e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (5.85e-6)"	"unprognostic (4.97e-1)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (5.93e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.29e-3)"	"unprognostic (6.73e-2)"	"prognostic favorable (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.30e-2)"	18.7	54.2	50.4	11.0	50.9	8.0	15.0	58.1	59.3	28.2	50.1	34.2	10.4	36.1	14.3	38.6	29.2	15.9	298.6	49.4	63.3	46.0	8.4	14.9	8.0	54.5	51.1	45.1	10.9	136.2	36.5	12.0	58.7	29.0	16.1	85.5	29.2	39.0	1570.1	14.4	16.0	35.1	46.1	11.8	23.0	50.7	62.1	9.3	21.5	1393.9	10.2	27.7	19.2	43.4	32.9	30.6	98.4	87.5	97.2	72.5	20.2	85.4	80.2	77.1	54.4	76.3	40.5	192.9	69.6	44.1	44.9	36.0	90.1	91.2	70.9	5.5	43.9	54.7	64.7	1.9	54.3	2.9	30.9	102.1	50.4	69.2	107.3	125.1	85.9	3.7	64.6	91.7	71.5	25.8	69.5	5.1	67.7	36.0	93.9	115.7	55.7	141.3	48.4	32.5	111.5	82.6	51.0	75.9	86.5	78.7	80.3	11.2	75.8	34.0	46.5	49.5	72.1	52.8	145.3	106.4	62.4	6.8	28.5	0.3	2.9	7.8	2.1	2.5	0.9	8.8	3.5	2.1	5.6	8.3	4.3	2.4	0.7	2.1	2.1	0.9	3.5	3.1	50.4	50.9	58.1	59.3	49.4	63.3	54.5	51.1	58.7	46.1	62.1	43.4	8.6	16.0	8.4	30.3	6.9	7.4	21.7	22.1	15.9	43.3	5.6	9.1	345.9	12.8	10.8	22.0	43.8	2.8	0.9	3.4	66.5	10.6	43.1	5.5	18.0	17.3	9.1	8.6	23.2	2.5	3.8	27.1	6.6	2.4	1.3	17.3	13.9	2.7	4.1	121.1	30.0	9.1	34.6	3.8	3.7	27.0	30.7	4.3	55.2	3.7	11.3	125.7	4.1	15.6	3.4	3.5	1.9	47.8	4.6	7.9	2.7	30.6	11.2	51.1	26.3	37.6	24.5	52.1	14.4	9.2	5.3	2.5	3.3	24.0	10.1	9.7
PGAM2	PGAM-M	ENSG00000164708	"Phosphoglycerate mutase 2"	P15259	7	44062727-44065567	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 1132.9;skeletal muscle: 4350.5;tongue: 1754.5"	"Group enriched"	"Detected in many"	6	"Early spermatids: 539.1;Late spermatids: 1891.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 65.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043801, HPA050314, HPA060173"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		38000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA043801: , HPA050314: AB_2732558, HPA060173: AB_2684215"																		4.1	3.7	32.9	0.1	37.7	0.1	2.9	40.9	43.1	2.8	28.9	2.1	2.0	1.8	0.7	58.9	2.3	2.4	1132.9	29.3	45.0	10.6	1.8	2.0	0.3	33.8	39.8	2.0	2.1	4.0	13.5	0.1	46.0	16.5	0.3	4.3	33.6	0.6	4350.5	1.8	1.3	0.5	30.8	1.2	1.7	193.9	46.8	23.9	5.1	1754.5	0.5	0.7	1.9	39.8	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	65.8	7.0	0.0	0.3	0.4	0.1	0.7	0.0	0.0	0.0	0.2	0.1	0.0	1.0	0.7	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	32.9	37.7	40.9	43.1	29.3	45.0	33.8	39.8	46.0	30.8	46.8	39.8	0.7	0.0	0.0	6.8	1.2	1.1	0.3	0.1	0.6	15.6	0.2	0.6	0.0	0.0	0.3	0.0	10.4	0.0	0.0	0.2	80.3	0.1	539.1	4.0	0.4	1.5	22.9	0.0	0.1	0.5	0.0	0.6	1.5	5.6	0.0	0.4	0.0	0.3	0.0	0.0	0.7	0.4	4.1	0.3	1.4	1891.7	7.8	1.5	1.8	1.9	0.0	5.6	0.0	1.0	0.5	0.3	1.2	6.0	1.4	0.2	0.4	9.2	0.1	4.6	26.3	78.3	18.6	187.6	7.0	0.2	0.6	0.0	0.6	0.1	0.2	0.5
PGAP2	"CWH43-N, FRAG1, MRT17, MRT21"	ENSG00000148985	"Post-GPI attachment to proteins 2"	Q9UHJ9	11	3797724-3826371	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"GPI-anchor biosynthesis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"epididymis: 216.2"	"Group enriched"	"Detected in all"	4	"Cytotrophoblasts: 74.9;Early spermatids: 147.6;Late spermatids: 296.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063099	Approved		Approved	Microtubules		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Microtubules		"HPA063099: AB_2684940"	"unprognostic (1.94e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.18e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.66e-3)"	"unprognostic (4.13e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.67e-2)"	8.9	14.9	16.4	6.4	17.5	9.5	11.5	15.9	18.2	13.7	17.0	13.9	18.4	8.3	216.2	34.9	19.2	7.6	21.7	16.6	16.3	13.9	30.9	16.2	10.4	17.8	16.6	11.2	28.9	17.6	15.1	14.2	17.2	16.7	13.3	9.2	18.4	33.4	11.4	48.0	16.0	7.6	16.3	11.3	14.1	28.5	17.3	13.1	19.4	9.5	13.5	10.9	18.8	20.9	27.1	36.3	17.2	15.8	15.2	28.9	27.3	10.9	9.4	15.6	14.2	31.1	46.6	29.0	12.3	8.0	9.4	44.1	27.6	30.2	15.5	35.5	30.9	17.7	14.7	38.4	10.7	23.0	22.0	22.8	41.9	11.6	39.3	10.2	18.0	38.4	38.4	41.8	16.6	39.9	28.0	19.3	32.4	56.7	21.5	44.0	2.0	27.8	30.0	31.6	22.7	22.5	19.7	52.0	12.3	20.1	43.2	9.6	16.5	9.9	9.2	23.8	6.8	26.2	31.3	21.6	12.9	15.3	19.1	3.0	6.4	5.9	9.1	9.2	11.0	11.4	13.2	11.3	9.7	12.7	17.3	11.8	18.2	10.7	9.2	6.6	13.3	8.8	16.4	17.5	15.9	18.2	16.6	16.3	17.8	16.6	17.2	16.3	17.3	20.9	8.4	12.8	10.6	7.5	10.6	31.7	15.1	23.3	33.6	14.1	19.2	18.0	13.7	11.5	13.0	12.9	22.9	74.9	5.2	11.4	1.9	15.6	147.6	11.7	6.6	9.0	3.0	13.2	15.4	21.3	18.4	7.6	10.2	14.7	8.8	13.4	3.6	14.6	16.0	3.3	19.1	10.5	10.2	5.0	8.0	296.8	8.7	5.5	5.4	4.7	8.9	9.3	8.2	10.6	23.0	14.2	9.3	6.8	12.2	9.1	39.8	10.2	15.2	9.5	6.6	11.0	7.2	17.7	21.6	31.1	28.6	29.3	9.4	11.8	20.1	13.0
PGK1		ENSG00000102144	"Phosphoglycerate kinase 1"	P00558	X	77910739-78129295	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 1126.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010065, HPA045385, HPA073644, HPA073656"	Approved					NA	NA		170000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB010065: AB_628116, HPA045385: AB_2679306, HPA073644: AB_2732231, HPA073656: AB_2732235"	"prognostic unfavorable (7.05e-8)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.21e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.65e-6)"	"prognostic unfavorable (2.74e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.66e-2)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (5.66e-2)"	"unprognostic (2.99e-1)"	"unprognostic (8.99e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.90e-2)"	"unprognostic (6.57e-2)"	120.7	141.8	87.3	149.0	94.1	252.8	89.1	103.2	119.0	100.2	117.2	127.4	123.4	72.3	73.0	154.1	79.3	110.1	247.4	92.7	109.2	233.5	143.8	117.1	139.0	104.8	95.1	61.9	61.1	188.8	30.0	138.6	109.5	92.8	143.1	298.8	93.2	101.8	452.0	92.6	119.1	116.7	102.4	97.2	86.1	29.2	111.1	158.3	105.6	266.7	189.6	148.4	49.4	101.3	943.0	426.7	139.7	283.8	236.1	190.0	331.3	469.2	324.0	402.9	670.0	390.2	287.7	373.9	473.7	326.5	479.5	397.6	624.8	729.3	800.7	229.8	246.6	290.3	657.8	341.8	258.0	671.8	309.2	238.5	302.2	366.7	192.7	646.1	418.8	361.9	308.5	553.4	557.4	371.2	593.5	506.0	433.3	628.5	800.7	421.8	374.4	1157.0	423.8	385.4	208.0	286.6	486.3	409.0	422.9	352.6	214.8	347.9	340.2	428.1	294.3	433.4	329.0	609.5	1221.7	391.5	1207.0	750.5	286.6	170.6	360.2	321.1	121.9	382.0	135.9	128.4	144.3	132.9	333.7	101.2	130.9	140.7	281.9	140.3	527.0	130.2	168.4	606.0	87.3	94.1	103.2	119.0	92.7	109.2	104.8	95.1	109.5	102.4	111.1	101.3	166.3	150.6	168.6	20.2	174.8	144.3	272.2	1126.6	122.3	211.3	72.4	67.2	480.4	140.2	436.9	174.7	77.2	298.4	200.6	196.5	471.6	715.8	19.3	123.7	112.4	182.3	102.4	95.9	32.5	236.4	746.4	131.3	95.3	145.1	195.5	98.1	139.6	200.2	499.0	309.6	37.0	164.3	518.8	298.4	188.8	12.1	94.8	310.4	167.2	25.3	499.3	245.7	131.8	20.1	21.9	510.2	149.9	127.2	214.8	118.3	221.5	566.0	235.6	188.8	124.9	84.0	191.8	8.8	57.4	138.4	119.1	349.6	251.9	278.7	203.5	225.8
PGM1		ENSG00000079739	"Phosphoglucomutase 1"	P36871	1	63593411-63660245	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase	"Congenital disorder of glycosylation, Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 1559.1;tongue: 788.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 238.4;Extravillous trophoblasts: 185.9;Hepatocytes: 214.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004666, HPA024190, HPA024637, HPA046329"	Enhanced		Supported	Cytosol		NA	NA		21000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: AB_2679625"	"unprognostic (2.50e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (8.74e-5)"	"unprognostic (7.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.74e-3)"	113.7	70.8	31.6	20.7	34.7	21.5	57.4	34.3	38.4	33.9	53.1	58.9	60.8	22.9	19.2	49.3	17.0	30.3	178.9	31.4	34.0	52.2	279.8	42.6	14.7	44.7	34.1	51.0	112.2	65.3	31.8	26.9	32.7	46.6	49.9	22.6	41.8	49.7	1559.1	30.6	55.1	41.4	31.9	14.7	30.6	11.1	36.5	14.3	27.5	788.0	19.4	38.4	22.1	30.2	113.4	47.0	17.3	57.0	111.0	81.4	138.6	45.7	61.8	48.9	79.0	38.8	51.3	35.8	93.2	71.2	107.4	26.5	24.0	96.3	55.9	44.0	32.1	75.3	72.6	40.3	91.6	66.8	4.3	103.4	60.7	57.1	88.5	129.8	29.6	36.3	0.1	46.3	78.8	6.9	19.6	36.7	78.3	3.4	73.9	26.8	80.0	11.8	70.0	35.3	10.4	66.7	100.0	103.0	157.4	78.6	32.4	25.2	3.1	71.6	36.0	64.0	39.4	29.1	45.5	57.8	117.0	58.0	31.5	46.0	33.2	49.2	40.5	22.4	32.7	22.4	23.5	31.0	48.4	11.8	21.0	24.7	38.7	43.9	21.2	13.9	20.4	35.4	31.6	34.7	34.3	38.4	31.4	34.0	44.7	34.1	32.7	31.9	36.5	30.2	8.4	93.0	29.4	48.3	16.9	17.8	29.0	58.8	47.8	9.2	33.8	21.8	139.2	48.6	24.2	16.5	10.4	76.6	14.2	81.8	88.0	55.9	32.0	8.2	12.1	12.7	13.1	5.7	17.9	238.4	185.9	37.0	27.0	13.5	5.1	134.3	15.0	214.4	24.6	0.0	26.3	47.5	20.3	17.0	10.8	8.5	22.1	13.5	26.6	4.7	32.8	75.8	29.9	32.2	9.8	70.5	31.6	38.0	40.4	29.2	90.2	74.8	17.0	11.4	13.1	53.4	25.5	5.6	10.1	57.3	18.2	58.8	19.0	20.2	81.5	19.0
PGM3	"AGM1, DKFZP434B187, PAGM"	ENSG00000013375	"Phosphoglucomutase 3"	O95394	6	83161150-83193936	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004998, HPA029759, HPA029760"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		220000	"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Cytosol"		"CAB004998: AB_425591, HPA029759: AB_10600305, HPA029760: AB_10601109"	"prognostic unfavorable (8.78e-4)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.45e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.09e-3)"	"unprognostic (6.72e-3)"	"unprognostic (3.11e-1)"	"prognostic favorable (9.96e-4)"	"unprognostic (4.00e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.39e-7)"	"unprognostic (2.21e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.22e-3)"	23.6	21.0	12.0	18.1	12.9	9.3	18.0	20.2	15.2	24.4	19.6	18.0	15.8	17.1	34.5	12.3	13.4	24.6	14.3	9.7	10.5	13.6	38.3	16.8	11.2	10.9	10.2	22.7	46.1	13.3	28.2	47.5	13.1	51.0	23.4	26.8	35.8	20.3	6.7	10.9	18.2	18.5	6.6	11.5	24.9	32.3	11.1	8.2	25.6	8.6	15.2	19.0	12.3	15.9	35.1	23.4	41.8	51.0	68.9	72.9	48.9	118.1	82.9	55.2	83.3	60.1	16.1	18.3	24.7	112.3	53.0	20.1	38.4	49.5	104.6	14.6	37.8	22.7	41.9	105.0	77.6	22.6	11.2	46.2	40.1	96.6	120.0	55.5	64.6	12.1	74.9	19.6	61.0	39.1	3.7	14.7	18.8	31.8	31.6	16.2	92.5	11.3	42.0	36.0	16.9	26.3	34.8	28.5	20.9	61.8	27.0	25.5	94.2	38.3	21.2	74.9	60.5	36.5	16.1	13.0	29.7	17.7	58.4	10.8	4.1	2.7	2.6	3.5	3.9	4.6	2.8	3.4	3.6	2.5	4.5	4.7	1.8	3.5	4.5	4.2	2.1	2.3	12.0	12.9	20.2	15.2	9.7	10.5	10.9	10.2	13.1	6.6	11.1	15.9	14.3	28.9	27.7	14.4	13.0	15.8	29.2	28.5	5.7	16.4	19.9	15.0	6.8	15.7	36.1	11.0	10.4	32.4	12.7	15.9	7.9	31.7	67.7	17.0	35.1	13.8	16.1	6.9	25.1	49.6	71.1	46.1	23.9	36.4	5.1	25.4	14.3	32.6	17.6	8.4	29.4	35.5	18.3	6.0	8.7	20.9	33.5	8.6	10.6	15.9	10.1	25.9	2.1	41.2	36.8	37.9	19.7	18.4	44.1	56.5	16.1	23.2	22.2	21.1	6.6	22.1	26.6	75.5	34.2	11.6	15.6	64.4	10.1	12.2	17.6	25.6
PHEX	"HPDR, HPDR1, HYP, HYP1, PEX, XLH"	ENSG00000102174	"Phosphate regulating endopeptidase homolog X-linked"	P78562	X	22032325-22251310	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	Biomineralization	"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 2.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 45.3;Granulosa cells: 161.7"	"Cancer enriched"	"Detected in some"	4	"thyroid cancer: 5.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	37	"plasmacytoid DC: 4.8"	"Lineage enriched"	"Detected in single"	37	"dendritic cells: 4.8"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 3.7;HUVEC TERT2: 2.8;PC-3: 3.0;TIME: 3.1;U-87 MG: 6.5;WM-115: 2.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"									NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (2.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.84e-8)"	"unprognostic (1.18e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (7.68e-2)"	0.0	0.0	1.0	0.5	1.0	0.0	0.7	1.8	0.7	0.9	0.4	0.3	0.5	2.0	0.1	0.2	0.1	0.9	0.0	0.8	2.2	0.1	0.0	2.7	1.5	1.6	1.6	1.6	0.0	0.0	0.2	0.1	1.9	0.6	0.0	0.3	0.2	0.4	0.0	0.1	0.6	1.5	1.8	0.4	0.0	0.1	1.3	0.3	1.0	0.3	0.9	0.2	0.3	2.1	0.2	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.1	0.8	0.0	0.1	0.1	0.0	3.7	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	1.3	0.7	0.7	2.1	0.1	2.8	0.2	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.6	0.0	0.4	0.1	0.1	0.1	0.2	1.5	0.5	0.4	1.8	0.0	3.1	0.6	0.1	0.4	0.5	0.0	0.0	0.0	6.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	1.0	1.0	1.8	0.7	0.8	2.2	1.6	1.6	1.9	1.8	1.3	2.1	0.0	0.0	0.0	3.9	0.8	0.0	5.8	2.3	0.0	0.4	3.0	1.8	0.5	0.0	1.6	0.0	0.0	0.2	45.3	0.7	0.0	0.9	0.4	1.3	1.4	0.2	0.0	0.0	2.2	1.2	0.1	2.9	0.0	1.8	0.0	161.7	0.0	0.0	0.0	16.8	1.9	0.5	4.1	0.0	0.4	0.3	1.8	1.2	1.8	0.0	0.0	0.6	0.0	1.5	0.5	0.8	0.0	0.0	0.3	1.8	8.2	0.9	4.5	0.5	0.0	2.1	2.6	0.1	0.4	0.1	0.1	0.8	0.4	18.9	0.4	3.3
PHF8	"JHDM1F, KDM7B, KIAA1111, ZNF422"	ENSG00000172943	"PHD finger protein 8"	Q9UPP1	X	53936676-54048958	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, Oxidoreductase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 70.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 57.9;Spermatogonia: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038779, HPA062015"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA038779: AB_10675950, HPA062015: AB_2684658"	"unprognostic (6.35e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (3.74e-5)"	11.6	8.1	8.3	13.3	11.1	16.2	13.8	9.5	10.3	13.9	20.0	11.6	10.3	14.1	70.6	13.4	14.1	9.2	9.8	7.8	11.2	9.7	28.7	13.5	16.3	10.1	9.4	19.3	17.8	10.8	13.9	13.2	11.2	16.0	9.6	14.6	12.8	18.3	11.0	13.1	14.2	9.4	8.1	13.9	12.7	40.1	10.2	18.6	13.2	7.8	15.8	14.1	13.5	13.3	16.1	14.0	20.4	19.9	12.2	9.6	33.3	12.0	10.4	12.9	11.4	15.7	12.8	23.4	6.9	10.8	13.9	16.5	51.1	10.3	13.7	36.4	23.8	14.2	18.1	15.8	9.6	22.4	25.6	10.9	14.0	15.0	20.2	9.7	12.0	24.3	18.7	33.2	7.6	16.1	30.6	16.9	37.2	11.0	19.6	29.7	22.5	22.9	8.9	19.2	29.2	14.5	31.6	20.5	10.5	31.2	20.5	15.5	14.3	10.3	14.5	19.2	10.0	25.1	25.4	28.3	12.2	27.9	11.3	6.1	2.7	4.4	3.2	4.8	5.1	2.3	3.3	3.9	2.9	3.1	2.5	2.8	4.4	3.5	3.2	2.3	5.3	3.4	8.3	11.1	9.5	10.3	7.8	11.2	10.1	9.4	11.2	8.1	10.2	13.3	9.5	9.6	10.3	17.3	11.2	8.9	9.4	4.5	15.4	13.7	13.9	8.1	7.8	5.7	5.4	9.2	12.5	13.9	14.1	8.3	0.0	5.1	54.9	34.5	11.3	11.3	5.4	5.2	19.7	4.6	4.7	6.9	10.7	40.2	14.0	15.0	7.9	39.4	6.8	8.4	22.0	8.8	10.2	11.8	6.4	31.4	9.3	11.6	3.6	20.6	9.2	6.1	9.2	27.2	30.0	4.4	9.4	6.4	14.4	10.9	9.2	3.7	16.5	15.3	6.6	11.6	9.2	57.9	58.7	15.2	9.8	12.2	13.5	6.3	8.3	14.7
PHGDH	"PDG, PGDH, SERA"	ENSG00000092621	"Phosphoglycerate dehydrogenase"	O43175	1	119648411-119744218	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 135.0;Exocrine glandular cells: 136.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD8 T-cell: 25.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 975.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003681, HPA021241, HPA024031, CAB068216"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1100000	"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB003681: AB_425928, CAB068216: AB_2665666, HPA021241: AB_1855299, HPA024031: AB_1855300"	"unprognostic (2.30e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (1.48e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (9.80e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.45e-3)"	"unprognostic (8.80e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.78e-3)"	51.4	3.0	113.6	9.4	125.3	11.4	30.1	130.7	125.9	46.1	89.1	27.2	7.6	25.4	79.6	56.6	49.3	7.6	22.4	108.8	128.8	40.9	126.0	18.0	14.9	121.8	113.9	46.1	171.1	103.9	23.7	13.2	122.4	52.6	7.0	7.5	156.2	33.5	2.6	92.5	13.3	15.0	117.0	6.5	41.7	40.3	115.8	34.0	29.5	4.3	13.3	35.8	62.9	153.6	156.8	35.2	148.0	444.6	64.9	82.8	286.1	101.0	209.3	132.9	257.6	195.7	28.6	0.1	58.1	270.5	16.6	205.6	216.8	224.6	83.9	1.1	162.1	29.1	151.3	153.3	135.7	214.3	1.7	147.6	338.6	146.8	142.2	83.0	100.1	519.7	71.4	443.9	66.8	380.9	222.8	90.1	440.0	93.3	274.6	228.0	181.1	24.8	9.6	120.4	160.8	146.0	65.9	63.9	975.9	103.9	164.8	505.7	0.9	38.3	172.1	207.3	134.8	294.0	79.9	246.1	456.9	328.2	302.7	5.3	1.1	0.2	4.7	0.3	0.2	11.1	2.4	8.2	5.3	4.0	13.0	25.2	2.2	1.8	0.3	2.6	4.5	6.3	113.6	125.3	130.7	125.9	108.8	128.8	121.8	113.9	122.4	117.0	115.8	153.6	5.3	3.2	12.6	31.6	10.0	51.9	118.1	24.2	42.7	0.7	29.7	38.0	2.1	128.7	12.5	20.2	2.1	49.9	2.2	1.6	135.0	60.2	51.2	15.6	3.8	6.9	1.8	5.5	0.3	136.1	54.0	58.7	8.6	12.2	5.7	30.9	3.6	96.1	9.2	0.0	0.6	3.6	18.3	2.2	4.3	116.9	67.7	6.5	56.9	2.8	11.0	82.4	0.0	14.1	32.3	35.6	2.0	127.9	27.4	62.1	0.2	118.4	24.7	3.4	13.1	11.2	48.8	20.0	19.4	57.5	77.1	25.3	5.9	71.4	3.2	56.8
PHKG2		ENSG00000156873	"Phosphorylase kinase catalytic subunit gamma 2"	P15735	16	30748293-30761176	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 130.1"	"Group enriched"	"Detected in many"	5	"Early spermatids: 397.0;Late spermatids: 1576.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065618, HPA068751"			Supported	Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA065618: AB_2685520, HPA068751: AB_2686025"	"unprognostic (7.63e-3)"	"prognostic favorable (7.90e-4)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.81e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (6.45e-2)"	"unprognostic (1.25e-2)"	"prognostic favorable (8.02e-4)"	"unprognostic (6.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	9.0	15.8	17.5	11.5	16.9	30.0	9.9	17.1	18.7	10.0	15.9	12.9	11.0	10.1	9.5	10.2	11.7	8.2	12.1	18.9	16.4	14.7	19.1	10.0	12.5	17.7	17.2	8.3	9.7	18.9	15.9	7.8	18.8	14.7	12.0	8.9	11.5	12.0	13.2	14.6	12.0	9.9	16.0	12.9	13.8	130.1	17.5	11.6	13.6	8.8	12.7	10.1	9.2	16.2	24.7	16.3	13.1	16.2	11.8	9.4	29.8	17.2	24.6	22.1	25.1	13.5	12.6	21.0	19.3	17.1	11.5	24.0	13.5	21.5	17.6	11.4	38.2	11.9	28.8	38.7	18.1	18.1	16.9	12.9	11.2	21.4	9.9	10.7	22.8	15.3	16.1	11.7	16.3	55.5	22.3	27.1	18.0	17.6	18.0	29.4	20.0	28.2	25.7	27.2	17.5	11.9	13.5	38.1	16.6	11.8	30.1	15.5	13.6	14.4	15.1	17.2	16.0	24.1	14.4	14.8	27.3	35.2	11.4	44.0	55.8	114.9	37.8	56.5	30.9	21.1	27.1	38.8	52.0	21.5	24.2	27.7	44.7	63.8	42.3	46.1	43.3	49.0	17.5	16.9	17.1	18.7	18.9	16.4	17.7	17.2	18.8	16.0	17.5	16.2	10.4	12.8	21.7	13.7	18.5	21.0	15.2	28.7	22.8	8.8	21.8	17.1	15.9	10.0	32.0	18.4	10.4	29.6	32.2	32.1	27.4	11.9	397.0	35.8	13.0	10.0	16.3	20.2	14.7	24.4	41.5	11.8	44.4	38.8	13.3	16.1	10.4	24.1	28.2	20.2	14.5	21.4	26.4	19.1	27.2	1576.6	17.4	26.4	12.4	11.2	40.3	13.7	39.1	9.0	8.1	19.6	18.5	23.3	20.5	31.5	27.8	47.3	33.0	9.9	0.0	8.9	14.8	180.5	22.9	20.5	23.0	75.5	25.9	20.8	27.0	16.9
PHYH	"PAHX, PHYH1, RD"	ENSG00000107537	"Phytanoyl-CoA 2-hydroxylase"	O14832	10	13277796-13302412	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Cataract, Deafness, Disease variant, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 667.8;skeletal muscle: 483.6;tongue: 412.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 258.6;Proximal tubular cells: 414.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 110.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007598, HPA011796"	Enhanced					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA007598: AB_1855334, HPA011796: AB_1855335"	"unprognostic (5.78e-2)"	"unprognostic (3.83e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.09e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.24e-1)"	"prognostic favorable (7.28e-12)"	"unprognostic (2.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.19e-1)"	57.9	66.5	22.9	9.5	23.7	8.2	32.2	23.5	28.3	28.8	31.7	46.5	58.7	22.1	16.7	22.9	16.7	28.2	126.5	21.7	24.1	191.4	667.8	17.3	7.5	21.6	24.4	36.8	48.2	56.7	20.9	19.3	22.8	22.5	37.2	28.2	33.7	25.4	483.6	17.5	55.8	23.2	22.7	12.8	44.2	15.1	26.0	5.6	56.0	412.7	5.4	27.0	14.8	23.6	17.2	35.2	15.6	22.5	110.7	69.9	12.4	17.2	23.9	19.4	19.1	9.1	30.3	0.9	12.9	29.0	47.0	7.8	20.5	20.2	11.8	41.4	10.7	14.9	9.3	36.6	54.8	2.5	26.8	50.3	28.9	21.0	8.4	22.7	18.7	16.8	8.4	32.2	45.5	16.3	9.2	12.1	14.4	49.4	12.6	15.7	24.1	5.8	40.6	21.9	5.3	16.8	64.8	1.4	32.9	12.5	64.8	44.2	6.4	29.5	10.6	36.4	11.8	36.6	26.3	3.3	38.3	18.9	11.6	16.3	18.7	8.2	8.0	14.2	17.6	11.0	9.9	10.4	15.8	5.6	12.5	12.7	0.8	4.4	11.2	14.4	10.5	12.3	22.9	23.7	23.5	28.3	21.7	24.1	21.6	24.4	22.8	22.7	26.0	23.6	53.6	12.8	19.2	8.5	14.5	11.9	27.6	19.1	6.2	47.0	22.6	24.5	258.6	77.2	19.7	35.0	22.9	137.8	20.5	72.9	144.8	40.6	33.1	18.5	29.0	29.7	31.8	15.2	7.1	19.6	34.3	41.3	41.8	26.8	30.4	28.3	25.0	145.5	55.4	21.9	5.6	57.4	46.8	21.0	22.0	45.4	25.4	25.3	17.8	4.7	10.3	69.3	7.2	2.5	2.4	16.7	46.0	37.6	15.1	11.9	141.9	414.6	19.6	41.8	19.7	30.2	37.5	12.5	1.6	7.3	13.4	83.9	25.2	103.3	46.9	18.1
PHYKPL	"AGXT2L2, MGC15875"	ENSG00000175309	"5-phosphohydroxy-L-lysine phospho-lyase"	Q8IUZ5	5	178208471-178232802	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036461, HPA063608"	Approved		Approved	Mitochondria		Yes	No		160000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA036461: AB_10670717, HPA063608: AB_2685059"	"unprognostic (3.29e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.02e-3)"	"prognostic unfavorable (3.82e-5)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.41e-3)"	23.2	10.6	7.4	16.4	8.2	14.9	14.0	6.8	8.6	12.3	8.3	23.9	20.7	14.3	15.8	11.1	13.9	14.4	15.5	6.7	8.3	17.5	42.2	15.8	24.5	11.4	8.3	12.5	15.6	13.7	5.2	16.3	10.0	13.7	30.8	3.4	13.8	12.0	19.6	10.7	24.8	18.5	7.6	17.2	15.5	5.9	9.5	25.1	19.7	18.7	23.6	13.7	9.6	11.7	9.6	3.8	9.0	3.6	21.6	17.4	13.9	5.6	6.2	7.6	11.8	9.7	11.7	13.0	18.4	17.6	9.7	6.2	7.7	14.3	8.5	24.0	8.7	15.6	18.0	7.1	35.1	9.2	11.4	19.6	15.0	9.3	22.4	14.9	24.9	18.6	11.8	26.7	11.3	13.1	13.1	5.5	1.9	11.5	12.4	9.1	4.3	25.0	13.4	8.3	5.7	5.4	9.2	5.2	9.4	10.2	5.5	7.4	9.9	7.8	7.0	5.1	6.2	18.8	5.5	7.2	2.2	9.2	5.2	16.7	41.7	36.9	20.3	46.8	20.4	28.4	22.2	22.9	53.4	26.3	27.3	22.2	9.2	23.7	47.2	70.9	28.6	33.2	7.4	8.2	6.8	8.6	6.7	8.3	11.4	8.3	10.0	7.6	9.5	11.7	23.1	19.2	14.3	31.6	63.0	10.7	43.1	16.1	25.0	21.9	17.2	14.5	17.4	37.1	13.0	23.9	25.0	18.4	72.5	96.1	19.6	24.6	21.7	13.2	27.7	26.2	19.2	30.7	20.7	18.6	20.2	33.4	76.9	13.8	12.7	38.4	31.1	30.1	31.7	15.2	17.9	40.8	6.1	37.1	22.9	55.3	42.6	43.3	24.9	36.5	61.1	25.0	70.0	29.1	45.2	15.1	64.5	25.2	51.4	30.3	119.2	43.1	13.6	26.4	13.1	34.5	23.6	37.2	25.9	14.6	10.4	22.0	58.9	36.3	39.2	36.6
PI4KA	"PI4K-ALPHA, pi4K230, PIK4CA"	ENSG00000241973	"Phosphatidylinositol 4-kinase alpha"	P42356	22	20707691-20859417	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 209.1;Inhibitory neurons: 127.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009092, HPA075515"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Plasma membrane"	"CAB009092: AB_2164033, HPA075515: AB_2686753"	"unprognostic (8.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.01e-3)"	"unprognostic (3.19e-2)"	"prognostic favorable (5.24e-4)"	"unprognostic (2.08e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (7.22e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.50e-1)"	18.8	21.6	45.2	19.2	61.0	24.1	16.8	2.1	74.4	20.4	9.6	23.7	15.8	24.2	9.9	14.3	19.5	13.5	21.5	65.3	9.0	21.3	25.2	19.1	20.5	14.6	4.8	21.4	18.7	34.5	25.2	17.9	14.5	19.5	14.9	27.7	16.5	16.9	23.6	15.1	22.9	21.9	0.0	21.0	26.0	25.7	8.6	34.3	18.0	15.9	18.0	22.2	16.9	43.3	24.5	20.2	17.4	26.3	48.7	29.1	24.9	21.6	32.6	31.3	30.4	15.9	10.2	45.6	12.6	43.9	30.7	21.1	33.4	20.9	19.0	38.9	50.9	47.1	27.1	18.3	24.3	47.0	36.1	26.2	12.9	26.7	14.7	20.4	25.8	13.8	130.2	37.6	24.6	33.8	41.6	16.0	13.8	43.4	20.6	41.1	38.1	8.5	17.3	38.3	42.6	31.0	28.4	32.6	22.6	24.3	27.6	21.3	26.2	56.4	29.1	21.1	18.5	28.6	31.3	35.8	37.4	33.2	24.1	2.1	3.7	5.3	3.2	3.8	3.1	3.4	3.6	3.9	2.5	3.4	3.6	5.0	5.1	7.0	3.3	8.5	4.3	2.2	45.2	61.0	2.1	74.4	65.3	9.0	14.6	4.8	14.5	0.0	8.6	43.3	13.0	12.8	30.4	65.6	14.7	10.1	6.5	7.6	9.6	35.8	17.2	14.4	30.2	20.0	10.5	7.3	47.9	17.8	21.5	19.7	1.9	9.7	36.5	10.3	17.9	15.5	19.2	12.4	209.1	6.3	19.6	15.6	38.7	15.8	12.0	13.8	11.4	19.7	20.1	37.0	127.4	16.7	10.2	21.0	12.6	25.3	19.9	20.2	10.6	39.4	10.9	23.1	16.5	50.3	88.4	8.9	9.7	24.0	15.5	10.1	23.8	10.3	9.6	25.4	26.3	14.5	19.3	35.3	29.6	14.1	9.8	20.0	15.3	26.1	14.3	8.9
PIEZO1	"FAM38A, KIAA0233"	ENSG00000103335	"Piezo type mechanosensitive ion channel component 1"	Q92508	16	88715338-88785220	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Pancreatic endocrine cells: 85.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 270.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA047185	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA047185: AB_2679973"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (4.39e-2)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (3.51e-2)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (8.89e-7)"	"unprognostic (2.04e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.74e-1)"	79.0	26.4	15.2	20.5	16.0	29.8	65.1	16.5	19.0	30.7	10.4	86.7	7.7	40.4	0.5	48.4	38.1	9.0	29.4	12.9	13.8	57.2	48.2	67.2	14.8	25.0	17.6	15.8	21.9	5.2	6.8	18.6	22.5	49.4	4.8	1.7	33.3	11.2	6.8	48.8	41.1	14.3	17.6	55.2	38.0	5.2	17.4	7.2	32.4	4.3	5.9	65.3	40.4	21.2	42.0	42.1	6.5	31.3	27.6	30.0	155.2	99.9	43.9	36.1	14.0	61.3	68.5	34.2	68.2	48.4	18.0	88.4	13.9	36.0	7.3	33.8	56.0	58.3	77.9	49.4	41.6	26.4	9.3	24.6	19.4	28.3	23.3	21.3	43.9	56.1	80.4	42.8	21.2	270.1	32.7	91.2	14.7	19.7	25.7	77.7	9.3	86.9	16.4	61.1	12.8	3.4	130.5	68.0	17.8	6.5	93.0	76.5	120.1	86.0	49.6	58.4	51.6	8.7	21.1	21.2	67.9	46.5	52.2	1.8	5.0	3.3	8.1	9.7	7.8	2.3	6.0	5.5	9.7	3.1	1.0	2.5	0.1	1.0	13.1	1.7	5.0	3.9	15.2	16.0	16.5	19.0	12.9	13.8	25.0	17.6	22.5	17.6	17.4	21.2	69.1	73.7	19.8	27.1	14.3	19.1	12.9	27.6	5.2	2.2	23.5	16.3	5.0	10.0	17.1	58.8	16.7	6.7	16.8	19.3	0.0	37.3	1.6	6.2	15.4	45.0	21.0	12.6	0.4	21.7	30.5	13.7	25.0	9.9	8.8	0.7	55.3	22.0	23.6	3.3	0.5	29.5	10.2	16.8	19.0	1.0	5.6	21.8	16.0	21.5	15.6	1.5	3.1	16.6	5.0	85.9	18.0	2.6	30.8	48.3	8.1	5.5	9.7	4.1	0.0	30.3	9.0	0.3	2.0	18.9	15.9	5.1	21.6	5.6	12.0	21.8
PIEZO2	"C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771"	ENSG00000154864	"Piezo type mechanosensitive ion channel component 2"	Q9H5I5	18	10666483-11149569	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 58.3"	"Cell type enriched"	"Detected in many"	10	"Oligodendrocytes: 399.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.1;BJ hTERT+ SV40 Large T+: 16.9;BJ hTERT+ SV40 Large T+ RasG12V: 23.1;HeLa: 38.1;U-266/70: 23.0;U-698: 16.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA015986, HPA031974, HPA040616"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"		"HPA015986: AB_1848395, HPA031974: AB_10603675, HPA040616: AB_2677043"	"unprognostic (1.36e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.34e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (9.57e-7)"	"unprognostic (1.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.83e-2)"	1.2	0.5	7.3	1.3	20.2	0.4	1.7	14.7	14.4	1.0	0.1	3.9	0.3	0.6	1.6	5.1	1.1	5.3	0.3	7.9	8.7	1.1	4.1	6.6	0.9	18.2	14.4	0.7	1.8	0.5	0.9	0.0	18.2	3.0	1.4	0.1	0.3	2.9	0.1	1.1	1.1	2.1	8.5	2.7	1.6	1.2	16.8	0.8	1.5	0.2	0.6	5.3	0.7	58.3	0.0	1.8	15.1	0.0	0.0	0.0	0.0	0.8	4.4	16.9	23.1	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	10.6	0.0	0.5	0.0	38.1	8.8	5.2	0.0	0.1	0.1	0.3	4.3	1.2	0.1	5.2	0.6	0.0	0.3	2.7	0.0	0.3	0.0	4.5	6.7	0.0	0.0	0.0	7.0	0.0	5.3	12.7	0.0	0.1	0.0	0.8	6.7	0.0	4.5	0.0	0.0	5.8	0.3	0.9	23.0	0.2	16.2	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	20.2	14.7	14.4	7.9	8.7	18.2	14.4	18.2	8.5	16.8	58.3	3.3	0.0	5.3	2.0	0.0	0.8	0.3	0.0	0.0	0.0	2.3	0.8	1.6	10.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	31.7	0.2	0.2	9.9	0.0	0.0	2.5	0.2	0.0	11.2	2.6	0.0	5.1	0.1	17.2	5.9	1.0	0.0	37.0	0.0	0.0	3.2	0.8	11.9	0.0	0.6	0.0	9.4	0.0	0.0	0.0	2.0	399.6	0.1	0.0	0.0	0.4	0.1	0.0	0.1	7.3	0.0	6.6	0.9	4.5	0.3	1.4	0.2	0.9	0.4	0.6	32.9	0.0	0.1
PIGA	GPI3	ENSG00000165195	"Phosphatidylinositol glycan anchor biosynthesis class A"	P37287	X	15319452-15335554	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 83.5;Suprabasal keratinocytes: 55.0;Urothelial cells: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 22.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001174	Approved					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"			"HPA001174: AB_2666220"	"unprognostic (1.15e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.99e-3)"	"unprognostic (2.24e-2)"	"unprognostic (7.37e-3)"	"unprognostic (3.93e-3)"	"prognostic unfavorable (7.64e-4)"	"unprognostic (1.85e-3)"	"unprognostic (5.97e-3)"	"unprognostic (2.24e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.18e-2)"	2.1	2.9	2.2	2.9	2.7	9.2	3.1	2.0	3.6	2.8	0.8	3.7	1.9	3.0	3.5	5.1	2.8	3.7	2.0	1.6	1.8	3.8	4.5	6.7	3.5	2.8	2.7	2.4	4.0	3.3	0.6	3.6	2.2	2.7	3.7	4.5	4.6	1.7	1.3	1.4	2.4	2.5	2.2	2.0	2.8	2.6	2.3	4.0	4.4	1.3	4.7	10.3	1.9	5.8	14.5	8.3	9.1	5.0	2.6	2.8	7.0	3.7	5.7	7.4	7.3	9.2	6.5	6.6	2.9	2.9	9.0	5.8	14.3	11.4	12.6	6.1	9.5	5.5	11.0	5.8	4.5	8.8	2.9	3.3	8.1	10.0	16.0	2.4	5.0	5.2	6.4	7.0	5.1	9.2	9.0	3.4	4.7	5.5	8.2	3.0	12.4	10.7	5.6	9.4	6.2	9.4	6.9	6.8	14.4	8.7	6.6	7.4	4.2	6.2	2.4	14.0	7.3	5.4	7.2	9.9	9.4	5.6	7.9	22.9	3.8	4.3	2.6	6.3	3.7	3.0	4.1	2.6	3.9	2.1	3.8	2.9	5.2	1.8	8.6	2.6	4.1	2.7	2.2	2.7	2.0	3.6	1.6	1.8	2.8	2.7	2.2	2.2	2.3	5.8	6.4	19.2	83.5	6.8	7.2	29.6	41.9	10.6	13.6	3.5	13.2	10.5	6.9	5.7	20.1	3.7	0.0	6.3	7.4	8.4	11.7	7.6	5.4	30.8	9.8	7.9	10.7	9.3	2.2	5.8	10.2	12.7	17.9	45.6	33.6	3.0	3.6	4.4	8.8	3.3	2.0	5.0	2.0	8.4	43.4	4.4	3.1	18.1	28.4	2.8	3.6	4.2	4.1	1.0	7.7	8.3	5.1	3.0	5.5	32.0	2.1	6.6	19.8	3.0	13.1	10.6	16.3	2.7	3.7	35.5	55.0	28.0	11.7	2.9	6.0	62.2
PIGK	"GPI8, hGPI8"	ENSG00000142892	"Phosphatidylinositol glycan anchor biosynthesis class K"	Q92643	1	77088989-77219430	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056383, HPA057040"	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA056383: AB_2683109, HPA057040: AB_2683319"	"unprognostic (2.43e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.19e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.12e-3)"	9.8	12.4	5.2	6.3	6.6	8.8	12.4	6.1	9.4	9.7	5.7	8.5	6.9	9.5	9.7	6.5	9.3	10.0	14.1	6.0	6.4	17.7	13.2	9.2	8.8	5.9	5.5	9.6	9.6	16.3	6.5	6.4	6.2	11.2	9.3	9.8	9.5	8.8	7.0	4.8	7.3	10.7	6.8	9.8	8.9	6.0	5.5	8.5	16.3	9.8	7.5	9.3	4.2	9.8	12.3	14.2	11.5	14.7	64.1	48.1	18.6	24.4	33.1	25.0	35.6	11.8	12.2	10.7	24.4	43.1	29.7	10.8	14.8	20.8	45.2	22.1	15.1	14.6	13.8	11.1	14.4	32.5	12.4	29.2	11.1	26.7	22.9	29.9	37.4	13.2	18.0	35.6	39.0	8.3	10.3	13.2	10.4	13.7	23.4	12.0	33.7	13.3	31.9	8.9	9.7	9.1	23.2	20.8	27.1	18.9	10.0	18.5	21.5	40.1	15.6	21.9	25.0	16.1	23.7	10.7	29.8	40.5	16.2	7.2	3.0	5.8	5.8	3.4	6.0	3.7	6.0	5.0	5.7	3.2	7.5	6.8	1.5	7.4	3.5	3.9	9.8	4.7	5.2	6.6	6.1	9.4	6.0	6.4	5.9	5.5	6.2	6.8	5.5	9.8	17.7	9.6	9.1	16.3	14.4	9.6	15.2	23.7	5.2	14.2	21.0	14.2	23.0	18.6	18.3	40.5	2.1	16.0	14.1	9.7	3.9	20.8	2.1	15.6	15.5	18.1	10.8	16.4	51.4	21.1	35.7	29.3	6.6	14.1	17.7	14.7	20.3	29.3	20.3	8.4	40.2	12.4	24.4	14.5	13.9	3.7	19.6	11.9	19.6	26.2	9.2	17.6	18.6	40.7	78.2	11.9	8.5	27.4	41.7	10.1	9.3	23.3	25.3	12.4	52.6	16.3	24.1	75.8	30.2	9.4	11.9	15.2	15.5	12.7	12.7	11.5
PIGL		ENSG00000108474	"Phosphatidylinositol glycan anchor biosynthesis class L"	Q9Y2B2	17	16217191-16351797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"GPI-anchor biosynthesis"	Hydrolase	"Deafness, Disease variant, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 46.7;Inhibitory neurons: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012739	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	No	No			"Cluster 32: T-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA012739: AB_1855367"	"unprognostic (3.07e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.70e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.39e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavorable (2.57e-4)"	"prognostic unfavorable (1.47e-4)"	"unprognostic (3.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.75e-3)"	9.6	8.6	8.0	6.3	8.4	5.6	10.1	9.7	10.4	8.6	8.5	8.8	10.6	8.3	11.8	8.1	8.9	6.1	5.6	7.8	8.5	9.0	14.3	7.7	7.8	7.8	7.8	10.4	10.2	6.1	10.4	6.3	8.2	9.8	8.4	6.3	8.2	6.1	5.3	11.4	10.1	5.9	7.6	7.8	10.5	8.7	8.2	6.4	10.1	3.3	8.3	7.8	8.1	9.4	12.5	16.3	11.4	9.3	16.0	15.2	4.6	6.3	8.0	10.8	19.5	17.2	15.4	6.6	13.7	6.7	6.9	17.4	14.7	8.2	15.0	13.1	38.3	12.3	13.6	21.9	17.3	5.0	7.4	12.5	20.3	19.1	22.0	10.9	13.0	20.1	14.6	7.3	8.6	11.1	9.3	11.6	4.5	25.2	8.3	9.0	9.7	15.6	12.3	6.6	6.0	8.5	6.7	4.9	14.6	29.9	5.4	4.5	7.6	9.1	6.0	6.6	19.8	5.5	0.2	10.3	12.2	12.5	6.2	0.0	2.7	4.7	4.6	2.6	4.1	3.7	6.3	3.7	2.0	2.8	6.4	5.5	0.0	4.8	1.8	5.3	5.4	2.5	8.0	8.4	9.7	10.4	7.8	8.5	7.8	7.8	8.2	7.6	8.2	9.4	8.5	9.6	21.0	19.2	10.0	4.5	9.2	9.1	11.4	11.5	9.8	9.8	2.4	7.2	13.0	12.9	10.4	15.6	9.3	7.3	5.9	6.3	3.0	7.7	11.4	6.6	7.8	11.6	46.7	7.5	8.0	8.8	11.7	6.9	5.1	14.0	5.0	10.5	5.2	6.7	45.3	11.2	10.2	3.5	4.3	2.9	7.8	5.9	3.6	26.2	3.6	5.2	9.2	24.6	34.9	9.4	9.7	11.3	12.2	8.3	9.8	5.9	10.6	12.2	0.0	9.1	7.3	16.1	8.3	7.5	6.0	9.6	11.8	9.4	12.6	10.4
PIK3C2A	PI3K-C2alpha	ENSG00000011405	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha"	O00443	11	17077730-17207983	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Endocytosis, Exocytosis"	"Kinase, Transferase"	"Cataract, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 217.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037641, HPA037642"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Vesicles, Cytosol"	"HPA037641: AB_10671878, HPA037642: AB_10697081"	"unprognostic (2.35e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-1)"	22.5	13.7	16.3	12.3	25.9	9.4	15.9	22.5	14.6	16.1	17.4	13.2	14.9	18.0	15.7	15.4	14.5	19.0	12.4	10.5	14.0	23.5	15.5	16.6	11.3	16.6	16.1	14.1	12.3	43.6	10.3	23.1	17.0	16.4	13.0	22.4	11.8	14.8	6.4	12.3	11.8	18.3	13.8	13.0	18.0	19.3	19.6	9.4	30.7	12.1	10.9	14.9	12.0	15.8	53.8	24.1	39.6	24.8	28.0	28.3	35.3	33.2	35.7	23.9	33.2	58.9	6.0	15.6	16.2	28.6	39.1	34.8	31.9	25.4	42.1	13.5	27.6	9.8	28.4	23.3	30.6	12.3	14.9	22.2	17.5	23.6	45.8	22.2	57.7	9.9	23.4	14.7	18.6	16.6	6.6	7.7	22.6	30.1	18.5	6.9	41.1	11.0	29.6	47.0	23.2	20.5	50.6	21.4	23.2	33.0	12.7	12.3	72.5	19.1	27.4	50.1	20.4	5.9	14.1	12.8	22.8	11.3	22.6	1.7	1.5	1.1	1.7	1.0	1.1	1.4	1.3	1.3	2.1	1.5	1.7	1.0	2.3	1.8	3.2	1.4	0.9	0.6	16.3	25.9	22.5	14.6	10.5	14.0	16.6	16.1	17.0	13.8	19.6	15.8	93.2	76.9	62.0	217.4	25.0	35.3	26.1	18.7	24.5	49.1	34.7	25.0	29.7	25.8	33.1	36.8	70.9	29.6	29.5	22.6	19.6	19.8	35.9	51.8	35.1	87.6	28.7	11.2	57.0	25.1	17.9	28.6	45.3	72.4	32.2	22.8	106.7	32.4	19.2	35.3	81.1	23.5	18.3	46.3	33.1	18.6	25.7	27.0	19.6	69.3	19.6	73.0	17.5	62.8	79.4	26.1	13.1	31.2	29.9	42.7	15.2	22.4	26.4	40.4	39.5	33.7	35.1	52.6	26.8	23.5	34.0	143.5	25.3	25.1	20.7	37.3
PIKFYVE	"FAB1, KIAA0981, MGC40423, p235, PIP5K, PIP5K3, ZFYVE29"	ENSG00000115020	"Phosphoinositide kinase, FYVE-type zinc finger containing"	Q9Y2I7	2	208266255-208358746	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 82.0;Oligodendrocyte precursor cells: 80.9;Oligodendrocytes: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042604	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"HPA042604: AB_10796580"	"unprognostic (1.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.04e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (6.82e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.05e-2)"	10.4	7.9	7.6	12.0	7.6	28.8	8.1	14.3	9.3	9.1	10.5	6.1	6.0	9.3	11.9	6.3	6.4	7.2	7.4	7.7	7.3	10.6	10.5	7.8	17.4	8.0	7.4	10.0	22.2	11.1	6.0	9.7	6.9	11.5	7.4	17.3	6.5	8.0	6.5	8.2	7.3	8.9	7.4	15.1	8.0	14.0	8.9	19.3	12.2	9.0	16.1	8.2	5.8	11.1	8.0	7.9	18.3	14.3	18.1	21.4	8.5	9.6	19.5	11.1	15.0	11.3	6.6	9.2	9.8	16.6	21.7	8.0	16.1	10.8	18.8	7.9	10.1	33.0	15.6	10.2	13.7	29.5	28.5	16.0	11.5	13.0	24.1	18.5	18.3	24.1	22.7	16.1	14.0	3.4	26.9	22.1	15.2	6.1	5.9	9.9	14.2	12.7	14.2	11.5	5.8	13.8	10.6	6.8	19.2	21.4	4.3	31.3	21.2	13.8	9.2	9.4	9.0	11.2	14.2	19.2	11.1	25.2	13.9	0.9	0.5	0.4	0.9	0.4	0.5	4.4	1.2	1.4	0.5	3.2	0.9	1.1	0.7	3.2	0.7	1.2	0.9	0.3	7.6	7.6	14.3	9.3	7.7	7.3	8.0	7.4	6.9	7.4	8.9	11.1	18.8	25.6	16.2	58.8	82.0	15.3	6.7	7.8	25.6	21.9	10.5	6.6	17.5	11.5	10.6	11.0	16.7	8.1	14.4	8.1	5.9	5.4	10.4	11.3	19.4	18.8	18.6	25.5	72.6	4.3	5.7	15.7	16.3	21.7	36.1	18.0	18.2	19.4	14.4	10.1	67.9	9.6	4.1	29.9	32.5	8.3	18.6	28.5	10.6	48.7	19.1	13.5	16.5	80.9	81.7	8.5	5.9	13.5	10.3	18.1	14.3	9.9	9.2	19.7	13.1	15.4	18.9	30.5	23.0	14.8	15.3	7.3	21.5	13.3	8.8	11.4
PINK1	"BRPK, PARK6"	ENSG00000158828	"PTEN induced kinase 1"	Q9BXM7	1	20633458-20651511	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Autophagy	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 384.4;tongue: 392.3"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 151.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 8.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001931, CAB026191"	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB026191: , HPA001931: AB_1079620"	"unprognostic (3.73e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.06e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (1.11e-16)"	"unprognostic (2.68e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.08e-1)"	50.7	127.2	119.3	13.7	103.4	13.0	41.9	104.6	110.9	37.9	73.0	62.3	32.3	43.9	18.8	48.8	34.4	23.5	153.4	106.6	107.0	56.8	76.8	30.1	10.8	118.5	127.8	30.1	52.7	66.5	33.4	21.3	118.3	37.1	15.0	29.4	55.0	29.7	384.4	55.3	35.2	20.0	124.9	27.9	46.7	94.8	132.1	12.3	41.6	392.3	8.3	47.4	42.7	95.0	49.9	22.2	10.3	29.6	34.6	32.8	10.7	68.2	67.9	32.4	56.1	7.7	39.3	11.7	52.6	69.9	75.4	22.5	15.0	36.2	16.0	14.0	56.8	5.9	60.3	12.1	26.8	6.3	17.7	30.8	38.5	40.6	13.9	36.2	21.3	10.7	14.5	14.5	23.6	21.2	9.2	14.1	4.6	12.9	72.2	7.9	18.0	9.4	20.1	11.5	37.8	14.8	74.4	24.2	20.8	12.3	8.0	21.6	32.6	29.1	14.9	49.2	9.7	16.7	3.6	5.4	63.1	17.9	14.0	3.6	1.6	3.7	0.8	1.1	1.0	0.2	0.7	1.1	0.5	1.4	0.5	0.8	8.1	0.6	3.9	1.0	1.5	0.6	119.3	103.4	104.6	110.9	106.6	107.0	118.5	127.8	118.3	124.9	132.1	95.0	38.7	22.4	19.2	16.3	9.1	15.7	36.0	7.9	10.8	50.1	31.5	24.4	1.1	37.1	9.2	44.1	37.5	26.3	9.2	107.4	80.3	24.0	77.7	22.3	16.1	48.5	20.0	56.0	27.2	28.0	31.8	27.4	12.2	26.4	0.0	36.7	84.3	110.5	23.7	28.6	24.4	30.2	12.2	27.1	16.3	151.4	35.4	22.7	21.4	25.3	10.1	69.7	12.3	8.5	14.3	56.6	67.9	56.8	27.0	67.5	66.9	109.2	7.6	69.0	85.5	30.9	32.2	120.8	24.6	19.3	24.0	34.2	10.6	34.2	24.4	47.9
PIP5K1C	"KIAA0589, LCCS3, PIP5Kgamma"	ENSG00000186111	"Phosphatidylinositol-4-phosphate 5-kinase type 1 gamma"	O60331	19	3630183-3700468	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Chemotaxis, Endocytosis, Exocytosis, Phagocytosis"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"U-2197: 75.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017168	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Cytosol"		"HPA017168: AB_1855395"	"unprognostic (1.20e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.36e-3)"	"prognostic favorable (7.28e-5)"	"unprognostic (7.03e-2)"	"unprognostic (4.02e-3)"	"unprognostic (5.80e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.57e-3)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.51e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	22.1	15.6	30.7	11.5	36.6	3.4	19.2	19.4	66.4	24.0	0.0	62.2	8.6	44.9	7.6	20.3	29.8	8.2	32.2	40.2	5.0	15.8	8.7	22.6	6.5	13.3	7.7	22.2	18.0	10.7	20.6	11.2	12.9	33.9	4.5	13.2	18.1	25.1	17.7	16.0	24.1	16.0	0.0	22.4	29.7	61.4	19.5	5.3	21.1	4.8	4.2	39.4	24.7	33.2	18.9	18.0	13.4	18.0	25.5	21.0	20.3	36.1	22.4	15.2	12.3	16.1	5.2	7.8	13.6	39.0	16.5	16.4	6.5	11.7	6.2	28.7	11.9	9.0	15.0	13.1	22.0	9.4	26.7	23.7	9.9	12.4	4.1	9.9	25.6	11.5	14.1	13.5	14.4	15.7	11.2	6.6	14.4	6.8	24.6	21.4	7.2	11.2	11.5	15.9	13.7	12.0	18.7	10.1	11.1	16.6	7.9	14.1	57.3	21.3	11.8	75.1	17.0	16.0	14.3	3.5	27.6	19.2	15.0	1.0	0.7	0.0	0.7	0.5	0.2	0.6	0.5	0.4	0.8	0.3	0.2	0.4	0.5	0.5	0.8	0.5	0.4	0.6	30.7	36.6	19.4	66.4	40.2	5.0	13.3	7.7	12.9	0.0	19.5	33.2	20.3	6.4	5.0	8.8	6.2	5.4	3.0	6.1	7.4	56.8	9.6	6.6	7.5	7.2	3.0	16.5	37.5	7.8	10.6	12.2	1.9	7.9	11.6	6.4	29.0	22.1	8.4	2.1	30.6	7.1	7.4	10.7	7.1	11.6	1.3	10.7	16.1	4.0	15.7	30.3	17.9	9.7	6.1	19.6	13.2	24.0	14.9	15.5	5.4	22.5	15.0	14.3	11.3	9.0	6.8	12.1	13.2	24.0	5.7	4.4	7.2	6.4	4.1	26.8	13.1	8.4	10.4	18.6	11.8	7.8	6.8	16.4	8.0	11.9	7.2	5.3
PJVK	DFNB59	ENSG00000204311	Pejvakin	Q0ZLH3	2	178451346-178462102	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 20.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 9.1;Distal tubular cells: 3.9;Granulosa cells: 6.1;Theca cells: 4.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 2.8"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.8"	"Cell line enhanced"	"Detected in many"		"SuSa: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042621			Approved	Mitochondria		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA042621: AB_10797503"	"unprognostic (4.01e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-1)"	"unprognostic (7.21e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.60e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.90e-3)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.06e-3)"	3.0	1.8	6.9	1.3	7.2	1.4	4.8	6.9	10.7	2.7	6.9	1.9	1.2	3.9	7.3	1.2	2.8	2.9	1.4	7.0	7.0	3.2	2.8	1.5	1.9	7.6	7.3	7.1	1.3	1.1	4.1	1.2	7.5	2.8	1.2	6.4	2.7	3.0	3.5	4.2	1.4	2.0	7.3	1.4	1.2	20.7	7.1	1.2	2.5	0.9	1.7	1.9	1.4	7.7	0.2	1.8	2.3	1.9	3.0	3.1	1.2	1.5	1.4	1.2	2.0	0.7	3.1	2.1	1.5	0.9	1.0	0.9	1.7	1.0	0.9	0.7	0.6	0.7	2.9	0.4	3.0	0.6	0.2	3.2	2.2	1.4	3.2	3.8	1.5	4.1	0.4	1.3	1.5	0.5	2.1	1.3	2.8	0.2	0.8	2.7	1.7	1.3	2.0	1.0	1.6	1.3	0.5	0.3	0.6	6.8	0.7	0.7	1.0	1.5	0.6	0.4	0.1	4.3	2.8	0.7	0.7	1.1	0.6	0.1	0.1	0.0	0.1	0.1	0.2	0.3	0.2	0.1	0.0	0.5	0.5	0.3	0.4	0.2	0.0	2.8	0.0	0.0	6.9	7.2	6.9	10.7	7.0	7.0	7.6	7.3	7.5	7.3	7.1	7.7	1.6	6.4	9.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.0	2.4	0.0	0.0	1.8	1.8	0.0	1.1	0.5	0.0	3.9	1.4	0.0	1.8	2.6	0.4	0.0	0.0	0.0	0.9	0.5	1.4	0.0	1.6	0.0	6.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	4.7	0.0	0.0
PKD1	"PBP, Pc-1, TRPP1"	ENSG00000008710	"Polycystin 1, transient receptor potential channel interacting"	P98161	16	2088708-2135898	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"		"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 72.4"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 138.1;Horizontal cells: 119.5;Inhibitory neurons: 101.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 65.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB046448	Approved					NA	NA		840000		"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"			"CAB046448: AB_2163360"	"unprognostic (1.95e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (7.43e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-1)"	"prognostic favorable (3.35e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (3.38e-5)"	"unprognostic (7.86e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.81e-1)"	14.8	9.5	7.9	4.9	10.4	3.9	13.7	65.4	32.1	22.1	0.0	40.3	3.8	30.6	2.0	11.3	25.9	3.7	23.9	9.6	1.6	7.5	8.9	13.4	3.4	16.2	1.7	23.8	10.4	2.3	72.4	3.7	12.6	19.9	1.5	7.4	10.4	8.7	47.7	16.8	15.3	6.1	0.1	9.9	19.1	10.3	4.7	2.8	10.3	8.3	1.5	24.5	15.5	4.9	4.2	8.9	4.8	10.9	8.2	8.8	9.3	14.2	5.9	4.0	4.0	8.0	3.1	6.3	8.9	7.3	4.3	10.4	1.4	2.1	1.5	7.4	7.1	3.9	25.8	3.2	16.1	5.4	7.8	8.2	7.0	7.5	4.6	5.6	3.1	6.6	5.7	6.2	2.6	6.9	7.7	16.5	4.3	1.7	6.6	21.6	7.7	9.6	2.1	2.8	19.9	22.2	12.9	8.5	8.9	1.7	7.0	18.3	7.4	12.7	10.3	9.6	10.5	9.0	4.3	7.0	7.1	5.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	10.4	65.4	32.1	9.6	1.6	16.2	1.7	12.6	0.1	4.7	4.9	21.3	12.8	12.2	61.7	6.9	24.3	10.3	14.7	30.7	79.8	15.4	18.9	26.4	4.3	10.9	9.2	41.7	6.0	11.2	13.6	9.8	5.2	51.9	16.0	32.1	17.1	30.5	4.8	138.1	3.1	4.0	30.4	8.2	16.9	8.2	21.3	15.7	24.2	5.2	119.5	101.0	17.6	4.1	7.2	12.6	10.6	27.7	7.8	23.2	18.7	6.2	36.4	11.3	38.2	29.5	4.5	5.9	45.9	9.0	10.3	8.9	7.7	32.9	35.2	32.9	41.4	25.2	10.1	15.8	26.0	20.0	3.1	10.9	10.1	14.2	6.9
PKD1L1	PRO19563	ENSG00000158683	"Polycystin 1 like 1, transient receptor potential channel interacting"	Q8TDX9	7	47740202-47948466	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	Heterotaxy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 9.1;Astrocytes: 13.4;Early spermatids: 11.8;Excitatory neurons: 25.7;Inhibitory neurons: 37.9;Microglial cells: 15.0;Oligodendrocyte precursor cells: 11.6;Oligodendrocytes: 17.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"T-47d: 5.9;U-266/70: 14.7;U-266/84: 5.7"	"Not detected"	"Not detected"							"HPA020422, HPA022424"	Uncertain					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA020422: AB_1855434, HPA022424: AB_1855435"	"unprognostic (5.47e-2)"	"unprognostic (5.33e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.88e-4)"	"unprognostic (1.88e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.90e-1)"	1.7	0.1	1.1	0.4	0.9	1.1	0.5	2.1	1.9	0.2	0.0	0.4	0.9	0.3	0.6	0.4	0.3	0.4	2.6	0.4	1.3	0.3	0.8	0.4	0.9	0.5	0.7	0.3	0.3	0.1	0.4	0.6	0.7	0.3	0.5	1.7	0.4	0.1	2.8	0.5	0.4	0.4	0.1	0.3	0.4	1.5	0.8	1.5	0.4	3.3	0.6	0.6	0.1	1.1	0.4	0.7	0.6	0.8	0.1	0.0	1.2	0.3	0.2	0.2	0.4	0.8	0.4	0.3	0.3	0.4	0.4	0.8	0.5	0.6	0.6	0.2	0.4	0.3	0.3	0.8	0.0	0.5	0.3	0.2	0.1	0.3	0.2	0.2	1.1	0.4	0.4	1.1	0.5	0.2	0.3	0.3	0.4	0.0	0.2	0.2	0.3	0.3	0.1	0.7	0.5	0.4	0.5	0.3	0.4	0.5	5.9	0.1	0.1	0.5	1.1	0.2	0.3	14.7	5.7	0.5	0.2	0.2	0.3	0.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.1	0.2	0.1	0.1	1.1	0.9	2.1	1.9	0.4	1.3	0.5	0.7	0.7	0.1	0.8	1.1	9.1	0.0	0.0	13.4	0.3	0.1	0.0	0.0	0.0	3.1	0.1	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.8	0.5	0.1	3.7	0.0	0.0	25.7	0.2	0.2	1.7	0.0	0.3	0.0	0.2	2.2	0.1	1.4	1.7	37.9	0.7	0.0	0.3	0.0	5.3	0.3	0.2	0.0	15.0	0.0	0.5	0.0	11.6	17.1	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	1.5	0.0	0.4	0.2	1.4	0.6	0.0	0.0	0.0	0.1	0.3	0.8	0.0
PKD2	"Pc-2, PC2, PKD4, TRPP2"	ENSG00000118762	"Polycystin 2, transient receptor potential cation channel"	Q13563	4	88007635-88077777	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Potassium transport, Transport, Wnt signaling pathway"	"Calcium channel, Ion channel, Potassium channel, Voltage-gated channel"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 129.1;Inhibitory neurons: 148.6;Microglial cells: 95.5;Oligodendrocyte precursor cells: 178.9;Oligodendrocytes: 219.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 137.2;BJ hTERT+: 207.1;fHDF/TERT166: 166.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004544, HPA015794, HPA055297"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"	Cytosol	"CAB004544: AB_672377, HPA015794: AB_1855437, HPA055297: "	"unprognostic (2.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.51e-1)"	30.7	24.2	9.6	13.9	12.2	10.7	18.6	10.0	12.0	40.0	7.3	32.5	10.7	61.1	14.7	12.7	39.3	26.9	19.7	9.0	8.9	48.6	15.0	22.2	11.5	10.4	11.2	47.7	14.8	27.9	9.0	24.5	10.0	23.3	13.2	14.0	9.7	39.2	5.8	10.3	14.8	53.7	9.1	10.9	20.0	10.3	11.9	7.6	16.4	11.7	8.7	20.6	18.4	14.6	7.4	40.8	44.9	23.2	101.8	67.6	13.3	137.2	207.1	62.9	62.2	2.0	12.8	4.0	29.3	166.4	24.0	9.1	8.1	20.4	54.5	21.2	7.1	6.6	21.8	4.3	56.5	16.2	12.9	56.4	9.1	49.4	26.4	85.6	28.8	7.6	0.9	10.9	55.5	14.4	11.4	7.7	23.4	5.3	6.7	21.5	26.8	6.0	55.6	17.2	9.0	20.1	25.5	1.2	32.5	45.0	9.7	12.1	44.7	59.1	12.9	16.8	18.8	8.7	2.9	4.4	35.2	2.5	55.3	1.4	0.1	0.2	0.2	0.2	0.4	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.2	0.3	0.1	0.4	0.1	0.1	9.6	12.2	10.0	12.0	9.0	8.9	10.4	11.2	10.0	9.1	11.9	14.6	14.8	3.2	6.3	59.4	3.5	7.4	5.3	7.4	23.3	16.7	7.4	11.3	7.1	18.6	7.2	69.9	10.4	10.4	2.7	0.6	0.0	14.0	0.3	10.3	41.7	19.2	6.7	13.5	129.1	3.8	3.4	42.0	2.0	11.1	1.3	12.7	21.4	10.6	12.2	26.9	148.6	3.4	4.1	5.0	6.8	1.1	23.0	9.8	23.2	95.5	9.5	17.3	4.1	178.9	219.4	2.2	4.6	50.8	3.1	6.5	3.9	17.0	12.3	1.9	26.3	53.0	31.5	0.8	3.8	13.3	6.7	2.7	6.1	11.5	2.8	3.4
PKDCC	"SgK493, Vlk"	ENSG00000162878	"Protein kinase domain containing, cytoplasmic"	Q504Y2	2	42048021-42058517	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	"Differentiation, Osteogenesis, Protein transport, Transport"	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 85.5"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 71.9;Fibroblasts: 55.4;Leydig cells: 137.6;Peritubular cells: 112.1;Rod photoreceptor cells: 95.9;Theca cells: 135.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 85.9;ASC diff: 61.7;CACO-2: 101.0;HHSteC: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026427, HPA026442, HPA026526"	Approved				"Secreted to blood"	NA	NA		80000		"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"			"HPA026427: AB_10600773, HPA026442: AB_10601237, HPA026526: AB_10602416"	"unprognostic (6.77e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.18e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.73e-3)"	"unprognostic (2.58e-3)"	25.7	11.3	3.1	4.9	3.8	0.8	16.1	0.8	6.2	31.8	6.4	20.3	10.7	25.7	2.1	2.2	24.2	3.3	37.6	4.8	1.0	10.7	6.9	16.5	2.1	1.5	1.6	50.1	7.0	1.1	6.8	3.6	1.3	12.2	5.7	5.3	20.7	5.8	85.5	3.8	13.7	9.8	1.4	9.6	9.6	14.8	2.1	6.4	5.1	27.7	1.4	32.5	17.4	4.7	0.0	5.5	14.0	85.9	61.7	0.7	5.3	0.2	0.0	1.2	1.5	101.0	0.2	0.0	0.3	1.7	1.8	0.0	1.3	0.0	0.0	8.1	3.5	0.2	3.3	27.0	53.7	0.0	1.2	5.7	0.3	0.2	0.0	0.6	0.7	0.0	1.2	0.0	0.3	0.3	0.0	0.3	23.8	6.8	1.7	0.0	27.3	0.0	0.0	0.0	2.8	5.1	1.3	0.0	0.2	16.3	0.1	0.7	0.0	0.6	2.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.8	0.8	6.2	4.8	1.0	1.5	1.6	1.3	1.4	2.1	4.7	28.8	19.2	0.5	4.2	0.3	3.2	0.2	0.0	0.0	4.7	1.3	2.0	9.2	1.5	0.0	1.8	16.7	0.5	0.6	22.8	0.0	2.1	1.1	6.0	31.4	3.1	71.9	0.0	22.8	1.3	1.3	55.4	2.6	26.3	0.0	4.5	2.9	2.7	0.6	0.0	3.3	18.6	0.0	0.6	3.1	5.4	137.6	0.6	1.8	3.7	0.0	21.3	0.0	10.1	1.8	1.9	16.0	112.1	0.0	0.8	15.2	3.9	0.0	95.9	13.1	14.2	15.1	0.7	1.7	0.0	1.8	0.3	0.8	135.4	35.9	0.1
PKLR		ENSG00000143627	"Pyruvate kinase L/R"	P30613	1	155289293-155301438	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 19.6;kidney: 25.1;liver: 92.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.3;Erythroid cells: 22.1;Hepatocytes: 16.3;Late spermatids: 23.0;Proximal enterocytes: 14.8;Proximal tubular cells: 48.9"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 56.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"K-562: 107.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.6"	"Not detected"	"Not detected"			"HPA006653, CAB034376, CAB034378"	Enhanced		Approved	Cytosol		No	NA		5200000		"Cluster 85: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: AB_2667632"	"unprognostic (9.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-3)"	0.0	0.0	0.0	0.0	0.1	19.6	0.0	0.7	0.1	0.0	0.0	0.4	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	25.1	92.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.2	7.2	0.0	0.0	0.1	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	11.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.5	0.2	0.2	0.3	0.0	0.4	0.0	0.1	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.4	1.5	0.0	1.8	0.0	0.0	0.0	0.6	0.0	0.0	9.3	0.2	0.3	0.1	0.0	22.1	1.2	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.7	16.3	0.2	0.0	1.2	0.9	0.0	0.0	0.0	23.0	0.0	0.3	0.0	1.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	14.8	48.9	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0
PLA2G4A	"cPLA2-alpha, PLA2G4"	ENSG00000116711	"Phospholipase A2 group IVA"	P47712	1	186828949-186988981	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Glycerol metabolism, Leukotriene biosynthesis, Lipid biosynthesis, Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 87.2;seminal vesicle: 48.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 33.4;Glandular and luminal cells: 28.1;Microglial cells: 115.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 6.8;eosinophil: 7.8;intermediate monocyte: 8.4;myeloid DC: 7.7;non-classical monocyte: 4.0;plasmacytoid DC: 3.1"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.7;granulocytes: 7.8;monocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 52.4;OE19: 84.4;RPMI-8226: 73.4;U-2197: 66.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010050, HPA050062, HPA054206"	Approved		Supported	Vesicles,Cytosol		NA	NA		35000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Cytosol	Vesicles	"CAB010050: AB_631312, HPA050062: AB_2681002, HPA054206: AB_2682417"	"prognostic favorable (9.07e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.26e-2)"	9.9	12.7	2.4	6.3	3.4	4.8	6.5	2.8	3.7	14.5	3.2	11.9	11.1	10.2	11.7	7.5	24.9	6.2	6.3	2.4	3.3	10.8	2.1	5.9	5.3	4.4	3.5	6.4	7.6	87.2	2.0	5.8	4.0	8.8	8.1	0.8	6.3	48.3	0.5	9.5	8.2	10.5	4.1	6.6	5.3	2.8	3.1	1.5	2.6	2.1	2.9	29.1	8.4	3.9	0.0	39.7	0.2	0.0	23.8	9.5	0.0	1.5	15.1	1.8	3.2	0.3	15.5	0.0	0.0	0.0	6.8	2.8	24.6	7.4	0.8	12.5	0.6	7.6	52.4	0.0	14.7	11.1	3.8	5.4	5.0	19.5	4.0	2.4	16.5	3.4	16.7	5.9	0.0	0.0	0.0	0.0	2.1	84.4	5.1	0.0	0.0	73.4	0.1	5.4	0.2	0.0	5.9	2.0	7.3	0.7	0.8	15.0	3.3	14.3	1.9	66.3	3.2	2.3	0.0	0.0	5.3	32.4	20.7	0.2	6.8	7.8	0.0	8.4	0.2	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.6	1.1	4.0	3.1	0.0	1.7	2.4	3.4	2.8	3.7	2.4	3.3	4.4	3.5	4.0	4.1	3.1	3.9	0.6	0.0	1.1	0.3	0.2	21.4	4.3	4.6	10.2	0.2	2.9	2.9	2.3	0.0	4.9	0.0	0.0	0.1	3.2	1.6	1.9	2.1	0.9	33.4	1.7	6.6	1.2	3.0	8.1	0.0	0.1	11.2	7.1	28.1	10.8	3.3	1.1	0.2	6.6	0.0	5.8	2.6	2.0	7.9	8.3	1.3	10.5	11.5	5.4	115.2	3.7	0.0	1.0	2.0	0.4	1.7	7.3	14.7	0.0	2.3	2.0	0.3	2.3	0.5	0.0	1.2	5.0	0.6	0.3	5.2	8.9	0.0	1.0	1.2	4.8	13.4
PLA2G5		ENSG00000127472	"Phospholipase A2 group V"	P39877	1	20028179-20091911	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism, Phagocytosis, Phospholipid degradation, Phospholipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 132.7;ovary: 47.6"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 75.3;Cone photoreceptor cells: 70.9;Leydig cells: 81.4;Peritubular cells: 73.4;Sertoli cells: 263.0;Smooth muscle cells: 63.1"	"Group enriched"	"Detected in many"	5	"glioma: 13.0;prostate cancer: 3.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2197: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053361	Approved				"Secreted in other tissues"	NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA053361: AB_2682127"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.70e-3)"	"unprognostic (6.00e-5)"	"unprognostic (2.87e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.97e-3)"	8.9	1.5	8.7	1.4	10.9	0.0	3.4	10.5	14.4	1.2	22.1	33.7	0.7	1.8	0.9	4.4	6.4	2.0	132.7	9.1	9.7	0.1	6.1	8.0	0.6	10.2	10.9	47.6	0.9	0.0	0.8	4.7	9.2	14.9	2.3	18.9	2.7	7.7	0.5	1.7	3.0	3.3	9.5	1.6	6.3	10.1	11.8	0.0	2.4	0.3	1.2	17.6	1.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	10.9	10.5	14.4	9.1	9.7	10.2	10.9	9.2	9.5	11.8	8.6	0.7	0.0	0.5	25.8	0.0	0.4	0.0	0.0	0.0	11.6	0.2	1.3	75.3	0.0	0.0	0.0	70.9	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	5.1	0.0	0.0	0.2	0.0	0.1	30.8	0.0	0.0	0.0	6.7	10.8	0.1	0.3	0.0	0.2	0.0	0.0	1.2	0.7	4.9	81.4	0.5	0.0	1.9	0.0	30.8	0.0	0.5	0.1	0.0	0.0	73.4	0.0	1.3	0.0	0.0	0.0	32.1	263.0	0.5	63.1	0.6	0.7	0.0	0.4	0.3	0.1	0.0	0.0	0.1
PLA2G6	"iPLA2, iPLA2beta, NBIA2, PARK14, PNPLA9"	ENSG00000184381	"Phospholipase A2 group VI"	O60733	22	38111495-38214778	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Lipid metabolism, Phospholipid metabolism"	"Calmodulin-binding, Hydrolase"	"Disease variant, Dystonia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 28.5;Spermatocytes: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 39.1;HMC-1: 25.6;U-266/70: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001171	Approved		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Centriolar satellite, Cytosol"		"HPA001171: AB_1079145"	"unprognostic (5.26e-2)"	"prognostic favorable (7.29e-4)"	"unprognostic (8.74e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.67e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.37e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.55e-4)"	20.0	22.2	14.1	4.6	16.6	12.2	19.5	15.2	20.3	24.9	12.3	11.4	9.2	17.8	10.6	10.3	26.2	13.2	9.5	14.3	13.7	24.0	13.3	10.4	8.5	17.2	15.0	24.3	16.1	6.7	17.7	4.1	19.5	24.9	2.8	8.3	15.9	9.2	10.7	17.2	12.5	3.4	15.3	17.1	13.2	42.1	15.4	11.7	51.8	4.4	4.6	13.2	14.4	25.5	0.8	1.3	2.6	6.3	8.0	5.5	9.8	0.9	1.0	0.5	1.2	3.2	2.4	5.9	6.7	1.3	0.9	3.5	2.2	2.5	0.3	9.2	11.1	39.1	3.4	3.5	3.1	2.6	25.6	13.3	3.7	2.3	4.6	6.6	0.8	11.7	8.0	13.3	0.7	3.1	8.5	3.0	3.4	2.7	1.3	6.5	1.2	6.1	2.8	5.9	7.1	1.9	1.9	3.1	6.7	3.9	4.1	2.4	0.6	2.1	4.5	0.9	0.6	20.6	2.7	4.0	4.0	3.2	2.0	1.4	0.1	0.0	1.0	0.0	0.7	0.5	1.0	1.5	0.4	0.3	0.4	1.2	0.6	3.7	0.2	1.3	1.6	0.7	14.1	16.6	15.2	20.3	14.3	13.7	17.2	15.0	19.5	15.3	15.4	25.5	5.6	3.2	2.7	19.9	4.6	3.1	3.5	4.0	4.6	9.9	7.4	6.5	2.0	4.3	5.0	12.9	4.2	3.3	11.1	11.3	0.0	2.1	28.5	9.5	4.4	3.1	11.4	7.4	6.4	1.0	2.7	3.3	11.2	8.7	0.0	10.6	3.6	3.5	1.7	15.2	5.9	8.6	2.0	1.0	0.8	18.3	5.9	2.1	1.8	4.7	2.3	4.9	8.2	4.5	25.2	1.1	12.6	3.8	4.7	2.9	21.9	1.9	7.6	7.5	6.6	2.6	3.4	44.5	7.7	4.1	3.4	4.9	6.6	6.8	8.4	2.1
PLA2G7	"LDL-PLA2, PAFAH"	ENSG00000146070	"Phospholipase A2 group VII"	Q13093	6	46704201-46735693	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase	"Asthma, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.2;placenta: 23.3"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 372.2;Macrophages: 140.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 37.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 43.4"	"Group enriched"	"Detected in many"	49	"dendritic cells: 14.1;monocytes: 43.4"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.7;PC-3: 3.4;RT4: 1.6;U-2 OS: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	7380000	290000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (3.63e-3)"	"unprognostic (2.82e-3)"	"unprognostic (8.69e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.26e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.08e-2)"	4.5	3.1	1.6	22.9	3.6	2.8	2.6	2.7	4.5	2.5	0.4	7.5	4.1	4.8	1.1	0.6	1.9	6.0	0.6	2.6	1.4	0.3	6.9	7.2	26.8	3.9	2.6	1.1	0.8	21.0	2.1	23.3	4.2	13.1	10.3	0.6	1.4	2.6	0.4	3.6	3.3	2.8	2.6	27.2	2.9	0.9	8.9	4.9	20.2	0.0	10.0	11.1	0.3	7.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.9	0.7	0.0	0.0	0.0	0.1	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	3.4	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.4	0.4	0.4	0.0	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.6	0.3	43.4	0.3	0.1	9.2	0.3	0.3	0.0	0.0	14.1	0.0	0.0	0.1	0.5	0.0	0.5	0.3	0.0	11.9	1.6	3.6	2.7	4.5	2.6	1.4	3.9	2.6	4.2	2.6	8.9	7.4	0.5	0.0	1.3	0.3	3.6	0.8	4.4	0.0	0.0	0.2	0.3	4.3	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.6	0.1	1.6	50.3	0.6	3.5	0.0	7.1	0.0	5.1	1.8	0.0	1.5	0.0	0.0	0.0	0.0	372.2	1.7	4.8	0.3	0.0	24.6	4.9	0.1	0.0	140.9	10.6	11.2	29.3	0.3	0.0	6.0	0.3	0.3	0.0	0.0	0.1	6.9	0.0	0.1	0.0	0.1	0.0	0.9	0.6	0.1	0.0	0.1	0.1	3.1	0.8	8.9	0.2	3.8
PLAU	"UPA, URK"	ENSG00000122861	"Plasminogen activator, urokinase"	P00749	10	73909177-73917496	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 103.8;urinary bladder: 128.5"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 635.9;Basal respiratory cells: 237.3;Pancreatic endocrine cells: 613.9;Prostatic glandular cells: 695.0;Urothelial cells: 869.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"myeloid DC: 1.1;neutrophil: 2.1;plasmacytoid DC: 2.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.0;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 856.0;LHCN-M2: 822.4;RPTEC TERT1: 3100.7;U-251 MG: 869.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA070796	Supported		Uncertain	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	647000	88000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus, Vesicles"		"HPA070796: "	"unprognostic (1.96e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (2.26e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (2.83e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.77e-2)"	57.6	4.8	2.5	41.7	2.7	36.2	17.6	2.7	8.9	9.3	4.4	13.1	11.9	22.0	16.7	14.4	10.3	28.5	23.1	2.4	2.9	103.8	5.0	22.0	14.3	3.8	2.9	2.3	10.1	8.3	2.9	36.5	5.4	9.1	18.2	0.3	17.3	13.7	10.8	25.5	13.7	23.4	3.3	40.6	15.7	3.7	4.7	5.9	17.9	18.9	7.2	128.5	16.2	4.7	171.1	88.9	36.8	1.7	3.1	59.5	2.0	101.9	461.6	40.0	62.2	2.3	856.0	0.1	184.0	14.5	416.9	114.1	0.9	165.8	44.8	9.9	0.0	0.1	4.4	1.7	72.6	15.6	32.3	158.7	20.2	271.4	103.7	447.0	114.7	1.0	1.1	0.9	822.4	0.2	0.2	22.7	10.8	0.3	244.5	0.4	112.6	0.9	3100.7	130.6	0.1	0.2	0.3	4.0	2.4	25.4	1.2	22.9	300.6	3.5	20.3	21.6	869.8	0.2	1.3	1.6	216.0	25.5	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.1	0.0	0.0	2.0	0.0	0.1	2.5	2.7	2.7	8.9	2.4	2.9	3.8	2.9	5.4	3.3	4.7	4.7	29.0	3.2	4.6	0.3	1.4	37.3	635.9	237.3	19.9	0.0	3.0	24.4	2.5	0.0	103.6	29.5	0.0	28.0	1.6	0.6	68.4	62.7	0.5	50.7	22.2	46.4	3.5	0.0	0.2	21.3	21.7	69.7	0.0	68.9	31.1	0.1	3.9	0.0	39.8	0.0	0.3	0.1	140.4	4.0	33.1	1.3	2.5	53.4	7.2	4.7	23.8	0.0	0.0	0.5	0.2	613.9	0.3	0.0	0.5	695.0	0.0	1.4	35.4	0.0	6.6	27.6	65.2	0.0	0.2	60.6	29.5	17.5	4.7	0.6	1.7	869.6
PLCB1	"KIAA0581, PLC-I, PLC154"	ENSG00000182621	"Phospholipase C beta 1"	Q9NQ66	20	8077251-8968360	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 563.5;Excitatory neurons: 2569.1;Inhibitory neurons: 1774.0;Oligodendrocyte precursor cells: 783.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 74.3"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 45.5;Hep G2: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004275, CAB005334, HPA034743, HPA057910"	Enhanced		Approved	"Plasma membrane"		NA	NA		6600	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"CAB004275: AB_628118, CAB005334: AB_632196, HPA034743: AB_2674311, HPA057910: AB_2683552"	"unprognostic (2.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.12e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.12e-1)"	9.3	8.9	11.7	5.7	52.3	4.8	7.6	0.0	74.3	8.2	0.0	18.1	7.2	9.3	3.5	5.4	9.6	8.5	11.7	17.4	0.0	13.2	4.3	5.0	1.8	0.0	0.1	3.7	14.7	44.3	4.3	19.6	0.0	13.4	4.1	7.1	29.0	18.8	14.4	2.6	5.7	8.1	0.0	3.6	8.0	3.0	9.8	6.8	3.8	11.0	0.9	15.9	6.7	23.8	0.2	1.2	4.8	0.3	8.7	16.1	6.3	20.2	13.1	5.2	3.1	45.5	5.0	2.2	8.2	3.9	0.3	0.0	3.7	0.0	3.8	0.0	4.4	1.0	3.5	68.7	2.2	1.1	0.7	1.1	0.8	7.1	0.0	6.5	10.6	13.0	7.1	26.0	0.1	6.2	1.0	3.3	15.0	10.6	6.6	14.7	0.0	12.1	4.0	16.8	16.9	7.2	0.1	4.1	0.9	17.1	19.9	6.6	1.9	16.8	7.5	1.3	12.7	19.4	24.5	33.9	8.6	12.6	29.5	0.3	1.3	1.2	1.4	0.3	2.0	0.1	0.4	0.5	0.1	0.2	0.2	0.4	0.8	1.1	0.1	0.3	0.1	0.2	11.7	52.3	0.0	74.3	17.4	0.0	0.0	0.1	0.0	0.0	9.8	23.8	74.8	0.0	3.4	563.5	1.1	1.9	20.8	2.3	8.0	7.6	8.1	23.2	26.9	7.2	2.6	16.5	0.0	2.4	16.8	1.3	33.2	1.2	9.9	42.1	5.1	54.6	0.0	6.5	2569.1	13.4	2.8	25.8	3.6	83.6	1.3	0.2	26.4	2.8	0.8	1.7	1774.0	2.1	0.0	8.2	1.2	4.3	3.4	9.1	7.2	211.7	12.2	18.2	15.5	783.1	34.8	1.8	0.5	3.8	6.1	20.2	0.1	9.4	9.9	4.1	0.0	7.4	13.3	4.7	5.6	2.5	1.7	1.8	15.4	1.1	1.2	18.9
PLCB4		ENSG00000101333	"Phospholipase C beta 4"	Q15147	20	9068763-9481242	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.6;salivary gland: 57.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 105.9;Horizontal cells: 164.9;Inhibitory neurons: 113.8;Microglial cells: 183.6;Oligodendrocyte precursor cells: 168.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.5"	"Region enhanced"	"Detected in all"		"cerebellum: 55.6"	"Immune cell enriched"	"Detected in single"	18	"plasmacytoid DC: 3.0"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 3.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 91.4;hTERT-HME1: 45.9;LHCN-M2: 77.6;OE19: 48.2;RPTEC TERT1: 96.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007951	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 21: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Microtubules	Nucleoplasm	"HPA007951: AB_2667944"	"unprognostic (3.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (1.44e-2)"	"unprognostic (9.72e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.75e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.45e-2)"	6.3	7.2	8.6	3.4	3.7	0.5	7.0	55.6	6.3	4.6	31.0	20.5	2.6	8.2	24.4	9.0	15.0	5.9	17.9	2.5	10.8	3.0	0.3	5.4	1.7	13.4	17.8	2.1	2.1	0.7	8.2	6.5	12.0	9.7	17.9	15.1	57.4	6.1	2.7	4.6	4.2	9.1	5.3	1.3	14.4	2.4	23.3	4.5	32.7	6.8	2.3	8.2	5.3	6.5	0.0	15.1	7.9	0.0	0.0	0.4	0.1	35.8	9.5	10.9	6.1	3.4	2.6	0.0	0.6	91.4	39.0	0.1	2.3	7.6	14.7	0.0	5.3	3.8	5.7	0.0	1.6	0.0	0.0	2.3	3.0	12.7	45.9	18.7	0.1	0.0	4.3	0.4	77.6	5.0	0.0	0.0	8.8	48.2	10.4	0.0	0.0	0.7	96.9	5.8	25.5	18.4	0.0	23.8	15.1	10.5	19.2	0.2	0.5	11.2	0.9	1.2	14.2	0.0	0.0	0.0	1.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.0	8.6	3.7	55.6	6.3	2.5	10.8	13.4	17.8	12.0	5.3	23.3	6.5	37.8	6.4	0.5	60.1	0.3	2.4	3.8	1.5	2.2	82.9	5.7	5.3	72.6	0.0	8.9	5.5	0.0	0.0	4.5	17.9	0.0	0.7	1.4	46.2	4.6	40.4	42.0	0.0	105.9	0.2	0.0	9.0	18.8	53.5	0.0	36.6	1.8	0.0	0.1	164.9	113.8	36.4	14.2	0.0	2.1	1.2	1.5	0.8	7.2	183.6	0.6	2.9	0.0	168.9	2.9	7.1	9.7	20.7	0.2	8.5	2.1	1.2	39.5	6.6	13.1	10.5	36.0	1.5	2.0	0.5	1.0	0.1	1.4	4.8	40.4	2.5
PLCD1		ENSG00000187091	"Phospholipase C delta 1"	P51178	3	38007496-38029642	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 89.5;Theca cells: 53.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 25.3;fHDF/TERT166: 26.3;hTCEpi: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009913, HPA020107, HPA021677"	Approved		Approved	Microtubules		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Microtubules		"CAB009913: AB_2163388, HPA020107: AB_1855318, HPA021677: AB_1855319"	"unprognostic (1.75e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.24e-1)"	"prognostic favorable (9.25e-11)"	"unprognostic (1.50e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.88e-2)"	14.8	12.9	14.3	4.6	16.1	4.3	10.6	15.4	15.6	15.9	9.7	15.7	4.9	11.5	4.2	26.2	9.8	5.6	7.2	12.8	19.0	10.1	5.4	11.3	6.6	20.3	18.5	12.7	6.0	3.9	9.3	3.8	19.6	9.1	10.1	2.8	13.0	8.8	2.9	18.5	8.3	5.6	19.4	7.2	8.3	32.6	16.9	9.1	8.3	4.1	6.6	15.7	19.0	21.9	1.0	2.7	9.4	2.6	25.3	22.2	2.8	2.8	11.1	4.2	6.4	1.0	2.3	0.6	1.4	26.3	2.9	15.0	4.8	3.0	1.3	3.9	1.2	0.5	1.7	4.7	14.7	0.0	1.6	18.0	31.6	12.9	1.7	9.4	8.2	2.2	16.3	1.3	9.6	1.2	2.2	1.1	2.4	5.5	2.7	0.9	1.3	3.6	5.1	5.0	0.1	2.6	0.8	12.4	3.2	3.1	2.7	1.2	4.4	2.5	6.3	6.7	0.1	5.2	2.2	0.6	6.4	0.1	1.3	14.6	2.7	0.2	13.0	3.7	15.2	1.3	16.9	12.8	3.8	0.6	10.1	7.9	9.9	5.9	2.2	2.0	16.6	7.4	14.3	16.1	15.4	15.6	12.8	19.0	20.3	18.5	19.6	19.4	16.9	21.9	5.2	3.2	7.5	22.9	3.6	2.8	12.4	9.6	8.0	0.9	5.4	6.1	4.7	8.6	7.3	9.2	2.1	1.8	4.2	89.5	3.9	11.4	1.7	3.3	11.3	8.1	4.9	3.6	1.9	3.0	5.1	10.2	6.6	3.8	4.5	3.6	20.0	4.1	4.0	3.3	2.3	28.3	10.2	3.8	14.5	3.6	12.8	4.3	1.8	3.7	3.4	13.3	1.0	7.1	2.2	4.1	34.7	14.3	5.9	13.2	10.0	5.8	6.2	1.7	6.6	5.4	7.2	3.1	3.7	12.6	5.8	0.8	7.4	53.4	11.3	14.7
PLCE1	"KIAA1516, NPHS3, PLCE"	ENSG00000138193	"Phospholipase C epsilon 1"	Q9P212	10	93993931-94332823	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 70.5;Astrocytes: 69.5;Distal enterocytes: 79.6;Inhibitory neurons: 83.9;Muller glia cells: 82.7;Oligodendrocyte precursor cells: 123.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015597, HPA015598"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA015597: AB_1855321, HPA015598: AB_1855322"	"unprognostic (4.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.73e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.30e-2)"	3.8	2.6	4.5	2.8	4.1	0.2	2.7	3.1	5.6	8.0	7.0	12.6	4.0	9.0	5.3	1.7	4.4	2.5	12.4	3.9	4.7	8.4	0.7	7.3	0.7	3.9	4.8	3.9	14.7	0.8	4.4	2.9	4.0	3.8	7.5	7.3	2.3	5.4	4.1	1.1	5.2	4.2	3.2	6.2	8.3	2.0	5.4	0.5	9.8	6.3	0.6	5.6	5.6	4.2	4.0	6.7	1.8	1.1	0.7	3.2	1.9	2.8	0.6	0.3	0.4	5.3	1.3	0.8	1.3	2.3	1.3	2.6	2.2	0.4	0.6	0.4	2.3	0.5	4.0	0.5	0.0	0.9	0.3	1.8	0.0	1.1	0.0	6.8	0.0	0.4	0.5	0.3	4.2	0.3	0.8	0.9	0.7	7.9	5.0	0.1	3.9	0.2	0.2	10.3	0.9	1.5	3.3	3.6	0.7	4.1	3.5	0.6	0.6	3.0	5.9	2.0	4.4	0.6	0.3	0.4	3.5	1.1	2.2	0.1	0.1	0.0	0.3	0.2	0.2	0.5	0.3	0.2	0.1	0.7	0.5	0.4	0.1	0.2	0.2	0.2	0.1	0.1	4.5	4.1	3.1	5.6	3.9	4.7	3.9	4.8	4.0	3.2	5.4	4.2	8.2	70.5	5.4	69.5	7.0	8.2	9.7	6.8	2.2	12.2	3.6	3.6	34.7	4.3	12.3	0.0	0.0	3.7	2.9	79.6	1.9	1.1	20.7	26.7	18.4	9.7	1.8	0.0	3.1	6.4	2.5	15.3	29.6	10.6	0.0	7.2	4.2	1.6	0.7	6.7	83.9	9.7	4.1	2.4	5.2	5.3	12.2	1.3	7.2	5.6	1.2	82.7	4.1	123.1	2.4	4.2	54.8	23.3	0.9	7.5	11.0	2.5	10.6	18.7	6.6	30.8	37.7	3.7	8.0	1.7	7.4	1.9	4.3	3.7	41.1	10.5
PLCG2		ENSG00000197943	"Phospholipase C gamma 2"	P16885	16	81739097-81962685	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 706.3;choroid plexus: 347.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 187.0;Bipolar cells: 224.8;Muller glia cells: 221.7;Rod photoreceptor cells: 196.2"	"Cancer enhanced"	"Detected in all"		"renal cancer: 9.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 183.3;HMC-1: 84.2;REH: 75.1;U-698: 403.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004280, HPA020099, HPA020100"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		8200	"Cluster 5: Granulocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Cytosol"	Nucleoplasm	"CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325"	"unprognostic (2.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (6.71e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	"prognostic favorable (4.88e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.40e-3)"	9.0	4.2	69.4	33.0	141.3	30.3	8.5	706.3	105.2	5.0	347.5	8.6	17.3	8.6	22.5	4.6	5.5	13.4	4.3	40.1	122.6	23.4	14.3	9.4	66.8	301.3	122.7	1.6	3.9	2.8	1.2	8.2	207.3	2.8	7.0	0.5	7.1	3.4	1.9	4.0	19.4	8.8	241.5	34.8	8.7	2.0	283.3	10.0	6.9	3.6	72.0	10.1	3.9	437.2	1.4	3.2	0.6	2.9	0.2	0.2	4.0	0.3	0.4	2.3	0.8	0.9	8.1	183.3	30.1	0.2	7.4	4.2	4.0	0.5	1.4	1.4	2.1	22.1	0.4	0.3	1.2	22.3	84.2	0.3	1.8	1.3	1.0	0.3	4.2	8.1	2.5	15.0	0.4	5.7	2.6	55.5	3.1	2.3	1.3	75.1	0.1	23.7	0.5	3.9	1.4	0.4	5.0	1.6	1.5	3.9	3.3	67.7	1.1	0.4	3.2	0.4	0.6	35.2	61.4	403.4	0.3	30.0	1.6	9.4	12.1	76.2	1.9	16.1	0.9	51.1	0.6	2.9	10.7	49.6	0.8	1.9	65.7	41.3	36.8	7.0	0.5	6.9	69.4	141.3	706.3	105.2	40.1	122.6	301.3	122.7	207.3	241.5	283.3	437.2	187.0	12.8	54.0	0.0	138.3	2.9	1.6	2.3	1.8	224.8	139.5	113.0	7.2	28.6	13.1	16.5	104.3	13.6	94.0	0.4	13.7	2.6	20.5	65.5	88.0	61.7	21.5	23.2	0.7	0.0	2.2	30.6	16.8	86.6	40.4	29.0	37.1	43.2	27.7	101.0	0.8	2.7	65.1	47.4	9.4	30.7	11.1	46.7	8.8	95.5	21.8	221.7	47.4	2.0	1.3	0.1	9.8	4.9	138.6	3.5	5.5	5.9	6.9	196.2	6.6	28.0	51.9	4.8	2.9	3.0	2.3	11.1	48.2	8.7	1.9	6.5
PLCZ1	"NYD-SP27, PLCzeta"	ENSG00000139151	"Phospholipase C zeta 1"	Q86YW0	12	18683169-18738100	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fertilization, Lipid degradation, Lipid metabolism"	"Developmental protein, Hydrolase, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"testis: 42.3"	"Group enriched"	"Detected in some"	47	"Early spermatids: 647.0;Late spermatids: 316.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"amygdala: 3.1"	"Not detected"	"Not detected"									NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"				"unprognostic (1.95e-1)"					"unprognostic (2.79e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.87e-2)"			"unprognostic (1.39e-2)"		"unprognostic (1.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.4	0.0	0.4	0.2	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.1	0.0	0.2	0.0	0.4	42.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	647.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	316.3	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	10.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLD1		ENSG00000075651	"Phospholipase D1"	Q13393	3	171600404-171810950	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 86.8"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 519.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 57.5;SK-MEL-30: 31.1;TIME: 50.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004527, HPA042396, HPA066938"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	Nucleoplasm	"CAB004527: AB_677324, HPA042396: AB_2677977, HPA066938: "	"unprognostic (3.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (5.82e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.58e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.23e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.76e-6)"	7.8	26.4	9.2	6.6	24.7	7.8	7.5	18.4	13.6	10.4	4.5	14.6	46.9	6.2	2.8	33.0	6.4	86.8	24.4	10.5	14.3	12.0	33.7	4.7	9.1	24.8	22.0	24.2	21.2	1.6	2.3	10.7	23.5	3.4	14.7	0.5	13.8	6.0	2.5	29.2	43.9	4.8	14.7	15.7	8.2	5.0	19.0	4.1	3.7	6.8	10.8	5.1	12.4	41.4	4.5	7.2	3.7	1.4	11.2	12.6	7.7	2.3	9.9	3.5	4.3	1.1	6.4	0.0	17.0	0.9	24.0	15.2	0.6	2.0	5.7	3.6	3.2	4.2	11.5	26.1	4.9	7.3	18.9	4.9	10.9	4.2	2.0	10.0	57.5	1.2	2.8	0.0	0.9	1.3	0.0	6.4	0.8	11.9	5.1	0.2	1.5	0.1	8.9	1.8	0.1	0.1	7.9	4.7	31.1	5.1	9.0	9.7	50.7	1.5	5.7	4.0	2.5	9.6	8.2	0.1	6.7	8.6	1.9	8.3	1.8	2.3	0.3	1.1	2.6	0.0	0.2	0.6	0.6	0.0	0.0	0.1	1.0	2.2	0.4	0.0	0.8	0.6	9.2	24.7	18.4	13.6	10.5	14.3	24.8	22.0	23.5	14.7	19.0	41.4	7.7	0.0	4.7	2.0	0.9	7.1	3.4	11.0	10.8	0.4	4.9	5.6	33.6	57.2	11.1	1.8	0.0	3.0	1.9	37.5	3.9	8.4	13.1	1.0	4.8	7.4	4.2	6.3	8.9	3.4	3.7	15.7	27.0	1.3	27.9	10.4	6.4	15.9	20.0	0.0	12.1	23.6	6.1	13.2	2.4	9.5	10.5	10.2	12.4	98.4	5.4	0.0	1.0	12.5	519.6	2.4	18.3	4.5	3.4	0.7	38.3	48.0	9.9	0.1	19.7	3.8	8.4	6.1	5.3	93.5	34.9	2.3	2.3	12.1	17.8	4.7
PLD3	HU-K4	ENSG00000105223	"Phospholipase D family member 3"	Q8IV08	19	40348456-40380439	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response"	"Exonuclease, Hydrolase, Nuclease"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 711.9"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 688.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 1727.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 1727.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012800, CAB020812"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA		450000	"Cluster 10: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Endoplasmic reticulum, Cytosol"	Nucleoplasm	"CAB020812: , HPA012800: AB_1855330"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.60e-2)"	"prognostic favorable (6.44e-4)"	"unprognostic (4.34e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.42e-2)"	169.3	200.0	143.3	78.4	159.7	48.3	138.4	46.0	229.7	139.4	54.0	131.4	71.7	155.7	84.7	84.9	133.5	96.7	206.1	202.5	294.4	130.2	121.3	181.5	98.1	132.4	128.5	199.0	151.0	105.9	711.9	123.4	137.9	133.4	49.2	51.4	138.7	106.2	105.1	120.5	105.3	79.1	63.8	197.0	126.5	77.7	197.7	44.3	120.8	82.3	41.4	126.2	126.0	129.6	85.6	257.8	163.7	259.1	444.2	210.2	124.5	206.5	208.6	146.4	166.6	49.4	93.8	36.9	211.0	180.9	47.8	39.3	39.9	81.2	63.5	138.4	145.3	39.9	82.1	63.2	302.7	16.8	435.1	402.5	167.0	112.1	76.6	244.2	125.0	59.3	142.5	144.5	106.7	111.5	29.5	79.6	107.4	138.7	52.8	37.0	124.5	154.2	75.2	63.2	116.7	193.9	99.0	60.6	113.8	169.5	83.6	283.2	222.3	122.8	58.5	105.6	47.0	148.9	173.3	38.8	197.7	66.2	77.9	1727.4	256.7	378.7	75.0	129.5	62.0	34.4	59.5	67.7	235.0	28.1	60.8	61.3	25.7	102.3	64.2	34.7	64.5	208.6	143.3	159.7	46.0	229.7	202.5	294.4	132.4	128.5	137.9	63.8	197.7	129.6	66.7	32.1	69.6	59.4	27.0	35.4	93.6	263.1	39.9	101.5	45.9	61.2	22.0	45.8	90.4	57.0	33.3	158.2	27.2	42.5	21.5	52.5	8.7	32.0	49.8	53.9	72.8	18.7	99.1	58.3	107.2	158.8	38.2	31.5	60.3	134.7	88.2	43.1	688.4	121.1	113.4	41.3	126.1	280.9	59.1	15.7	151.6	261.3	92.5	50.6	54.2	94.1	35.0	53.3	70.2	54.3	42.6	143.7	85.8	57.9	78.8	37.1	35.2	47.6	19.7	73.1	59.7	24.2	67.9	32.4	33.4	195.9	28.8	114.1	41.6	68.2
PLK1	PLK	ENSG00000166851	"Polo like kinase 1"	P53350	16	23677656-23690367	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.0;lymphoid tissue: 43.9;testis: 33.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 32.3;Early spermatids: 123.7;Erythroid cells: 38.3;Extravillous trophoblasts: 55.9;Spermatocytes: 79.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"T-reg: 5.6"	"Lineage enriched"	"Detected in many"	5	"T-cells: 5.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051638, HPA053229"	Approved					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA051638: AB_2681561, HPA053229: AB_2682084"	"unprognostic (7.21e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.98e-3)"	"unprognostic (4.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (2.70e-7)"	"prognostic unfavorable (2.28e-5)"	"unprognostic (2.55e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.33e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.26e-2)"	1.4	1.5	2.3	13.4	2.3	32.0	1.5	2.5	3.2	2.3	2.0	9.6	10.4	1.2	0.4	13.9	1.0	1.4	1.0	2.3	2.1	1.4	1.9	1.9	27.8	2.3	2.3	1.3	1.1	0.2	1.2	6.4	2.2	1.2	10.1	1.2	2.4	0.3	1.0	5.7	9.2	4.0	2.0	9.1	6.2	33.1	2.5	43.9	0.9	0.4	30.0	2.8	4.0	2.8	199.9	207.5	166.2	90.9	5.2	11.7	92.8	111.0	74.5	172.5	127.0	184.3	131.0	99.1	56.3	76.5	90.1	112.8	229.5	93.5	206.1	139.5	128.0	125.2	163.4	257.1	1.7	147.5	133.7	4.8	5.2	124.7	125.2	21.6	127.9	127.5	200.7	133.9	134.8	187.8	139.8	151.4	189.5	82.1	103.5	217.2	111.7	160.0	49.3	43.9	94.3	65.3	126.8	88.9	55.8	94.4	114.4	92.1	65.1	82.7	102.7	79.9	194.1	93.2	156.8	173.6	69.3	127.7	137.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8	0.3	0.3	0.0	0.0	0.0	0.4	0.9	0.0	0.0	5.6	1.4	2.3	2.3	2.5	3.2	2.3	2.1	2.3	2.3	2.2	2.0	2.5	2.8	0.6	3.2	0.0	3.3	7.6	1.3	1.2	6.5	0.0	1.4	1.7	2.3	0.6	0.0	1.4	0.0	4.2	32.3	0.4	5.5	0.0	0.8	123.7	3.4	1.3	2.5	0.0	38.3	3.1	0.8	55.9	4.7	10.2	1.8	1.3	19.9	3.3	1.1	20.8	0.0	2.3	7.3	4.1	6.9	3.2	13.9	1.2	7.2	0.0	2.8	0.4	1.1	0.0	1.5	2.3	1.2	0.3	0.7	23.0	2.0	1.5	0.1	1.3	1.3	0.0	2.3	6.1	79.5	13.5	12.2	1.8	3.8	2.5	1.2	17.9	2.0
PLK4	"Sak, STK18"	ENSG00000142731	"Polo like kinase 4"	O00444	4	127880893-127899224	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 22.6;lymphoid tissue: 14.4;testis: 22.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 65.9;Late spermatids: 87.5;Spermatocytes: 53.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017327, HPA035026, HPA043198"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Centrosome, Cytosol"		"HPA017327: AB_2669584, HPA035026: AB_10602080, HPA043198: AB_2732504"	"unprognostic (2.44e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (7.46e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.06e-5)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.44e-3)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.22e-11)"	"unprognostic (2.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.93e-2)"	1.0	1.1	0.4	4.9	0.5	22.6	2.0	0.2	0.7	0.9	0.1	3.5	2.8	1.5	0.6	3.2	1.3	1.1	0.5	0.5	0.6	0.6	0.8	0.9	7.4	0.5	0.5	1.0	0.4	0.6	0.2	3.6	0.4	0.9	4.3	2.1	0.9	0.9	0.1	2.3	2.9	1.8	0.4	1.6	2.0	22.6	0.6	14.4	0.9	0.7	7.3	1.3	1.4	0.4	26.1	12.1	44.3	22.9	1.5	4.2	20.1	24.9	17.6	32.4	33.3	17.0	26.1	34.9	9.0	13.9	26.3	16.7	31.6	19.9	49.6	27.4	13.1	31.6	20.0	16.0	0.5	45.2	35.9	1.4	2.0	29.7	13.6	5.9	25.3	26.3	37.5	45.2	27.6	18.2	69.9	20.1	20.7	26.3	13.6	36.0	30.9	12.1	10.8	16.4	24.4	20.0	15.8	14.2	7.6	18.7	11.5	19.3	11.0	25.3	24.4	17.4	31.4	23.1	27.4	49.0	13.0	33.7	28.7	0.0	0.1	0.4	0.4	0.2	0.3	0.1	0.5	0.5	0.2	0.2	0.1	0.6	0.0	0.4	0.1	0.1	1.2	0.2	0.4	0.5	0.2	0.7	0.5	0.6	0.5	0.5	0.4	0.4	0.6	0.4	1.6	0.0	0.6	0.0	1.6	1.7	0.9	1.7	1.2	1.8	1.0	0.9	0.9	0.0	0.6	1.8	0.0	6.0	1.9	2.0	0.0	0.6	65.9	4.7	1.0	1.0	2.4	19.6	0.8	0.4	12.9	1.6	4.1	2.0	1.3	7.5	0.4	0.5	3.7	0.0	0.8	3.3	6.1	1.3	0.6	87.5	2.8	1.5	0.0	1.0	1.2	1.1	1.0	1.0	1.2	0.1	0.5	0.4	8.7	0.7	0.5	0.6	3.7	0.8	0.0	0.4	3.6	53.5	13.4	6.8	0.9	3.8	2.1	0.8	4.5	1.7
PLN	"CMD1P, PLB"	ENSG00000198523	Phospholamban	P26678	6	118548296-118561716	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 1563.4;skeletal muscle: 507.3"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 2452.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"CAB005597, HPA026900"	Enhanced					NA	NA				"Cluster 38: Heart - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB005597: AB_2252716, HPA026900: AB_1855314"	"unprognostic (2.49e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.96e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.35e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.98e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (2.98e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (5.59e-4)"	40.1	12.3	1.5	12.3	3.0	0.6	15.9	2.9	4.0	31.7	2.0	148.7	13.6	121.7	21.8	43.9	81.9	92.2	1563.4	1.6	1.6	15.0	1.2	15.4	2.7	1.8	2.0	20.4	3.2	1.3	1.5	0.3	1.8	35.1	24.4	0.2	5.3	37.0	507.3	8.3	41.6	128.4	1.5	3.0	34.1	4.3	2.2	1.0	12.7	230.2	0.9	44.1	22.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.0	2.9	4.0	1.6	1.6	1.8	2.0	1.8	1.5	2.2	2.0	4.5	0.0	0.0	0.3	0.2	4.2	0.2	0.0	1.2	1.8	0.4	0.6	2452.8	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	108.2	0.2	0.7	21.4	0.0	0.0	1.0	0.0	0.0	49.1	0.5	0.1	0.0	0.1	0.7	0.1	0.1	0.0	0.9	0.0	0.0	0.0	4.7	25.0	0.9	0.4	3.6	1.0	0.0	0.0	0.0	2.0	1.1	0.1	0.0	11.7	0.0	0.7	0.0	0.0	0.0	0.3	276.1	16.7	248.0	9.2	0.8	0.3	1.6	0.0	0.8	0.0	0.0	0.4
PLOD1	"LH1, LLH, PLOD"	ENSG00000083444	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1"	Q02809	1	11934205-11975538	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 236.8;Sertoli cells: 105.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049137, HPA055799"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		3600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA049137: AB_2680649, HPA055799: AB_2682924"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.21e-3)"	"unprognostic (5.43e-2)"	"unprognostic (7.53e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.15e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (1.91e-12)"	"unprognostic (2.79e-1)"	"unprognostic (7.12e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.43e-4)"	58.1	34.6	46.3	35.2	51.2	16.1	41.2	48.6	56.6	65.4	46.4	47.3	37.7	65.0	30.5	21.3	51.1	42.0	71.2	44.5	47.4	45.5	78.1	44.4	15.4	49.6	50.8	54.4	39.0	36.9	29.6	83.8	52.4	34.7	23.2	10.6	75.9	40.6	40.5	27.2	35.6	78.4	44.8	31.5	35.5	11.6	52.2	7.9	34.9	41.6	12.9	42.4	36.0	53.1	112.5	91.4	51.3	239.7	343.4	190.6	39.0	330.4	436.1	170.4	287.1	105.2	71.5	63.1	339.5	367.3	125.9	93.4	75.6	115.6	115.6	66.2	78.3	34.0	136.6	137.3	212.5	21.9	162.7	234.0	59.7	206.2	81.9	573.3	305.0	14.8	97.6	30.9	180.2	71.1	5.7	58.6	22.9	115.4	131.6	25.8	100.0	141.0	98.7	24.3	19.2	77.7	137.3	97.4	164.8	80.4	48.3	55.9	298.7	190.1	141.6	236.3	161.9	71.4	123.7	38.7	425.1	75.5	316.8	0.0	40.3	2.0	17.3	34.4	3.1	1.7	3.0	8.4	32.7	3.4	1.2	6.4	35.5	5.4	32.3	4.9	2.0	22.6	46.3	51.2	48.6	56.6	44.5	47.4	49.6	50.8	52.4	44.8	52.2	53.1	19.4	0.0	7.9	9.4	3.7	7.0	8.0	22.8	8.0	5.7	17.9	17.5	18.3	8.6	8.6	11.0	2.1	39.7	8.7	14.8	3.9	30.3	1.0	11.0	62.2	33.9	8.4	3.0	4.2	9.8	236.8	47.5	17.3	24.8	0.0	20.4	36.8	37.1	46.3	6.7	5.8	12.5	4.1	26.5	8.3	2.4	44.4	16.3	10.6	15.9	17.9	7.9	15.5	3.0	9.8	22.4	15.4	24.5	19.4	8.0	41.5	16.7	4.5	3.1	105.2	77.2	47.3	0.5	3.3	7.4	5.1	33.7	5.5	37.1	16.6	3.9
PLOD2	LH2	ENSG00000152952	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2"	O00469	3	146069440-146163653	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 130.9;Basal respiratory cells: 115.1;Distal enterocytes: 143.7;Extravillous trophoblasts: 130.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 636.0;hTERT-RPE1: 723.8;U-87 MG: 566.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025898, HPA069126"	Approved		Uncertain	Nucleoli,Cytosol	"Intracellular and membrane"	NA	NA		21000		"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoli, Cytosol"		"CAB025898: , HPA069126: "	"unprognostic (8.68e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.29e-3)"	"prognostic unfavorable (7.64e-10)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (2.97e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (4.99e-11)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (6.07e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.41e-3)"	63.1	20.1	13.4	35.6	14.5	1.1	18.6	15.1	17.2	10.2	19.4	36.2	42.2	23.5	13.4	18.2	11.4	41.5	22.1	13.3	15.1	26.1	57.3	12.9	3.8	23.1	18.1	20.5	18.7	16.5	7.9	80.6	16.3	13.2	29.9	56.6	9.5	16.2	3.0	3.9	35.0	46.8	17.8	5.4	20.1	8.5	20.6	10.5	90.0	3.9	5.5	25.7	10.0	17.6	134.5	94.3	29.0	9.5	102.5	109.6	73.2	465.5	141.6	247.7	463.0	7.2	13.4	0.0	88.8	79.5	113.1	27.8	34.0	400.5	636.0	0.6	53.5	33.3	84.3	66.9	262.5	0.1	0.6	192.9	56.5	215.2	104.1	723.8	347.7	0.1	45.1	1.8	441.6	48.8	0.3	0.6	18.5	0.3	40.0	0.2	19.2	0.6	105.0	6.5	14.5	0.5	370.3	39.4	39.9	135.1	107.5	4.2	440.4	304.2	92.2	97.8	280.7	138.9	20.9	0.5	566.5	0.4	55.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	13.4	14.5	15.1	17.2	13.3	15.1	23.1	18.1	16.3	17.8	20.6	17.6	29.1	16.0	11.4	130.9	0.4	7.0	6.4	115.1	30.1	17.1	23.7	10.2	14.3	44.3	47.0	27.6	35.5	9.2	0.3	143.7	9.8	64.5	0.5	35.4	13.8	24.3	19.8	4.6	22.8	53.1	130.6	68.1	19.9	38.7	0.0	42.7	21.0	65.2	5.1	0.0	46.4	19.5	22.4	1.0	2.5	1.2	13.1	3.0	14.2	21.5	0.7	53.8	0.0	64.3	6.0	82.4	48.8	4.9	1.3	8.9	50.5	8.2	33.0	24.7	19.7	36.9	47.2	11.0	18.0	27.5	5.5	18.7	1.0	24.5	25.1	5.6
PLOD3	LH3	ENSG00000106397	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3"	O60568	7	101205977-101218420	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Dioxygenase, Glycosyltransferase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"melanoma: 115.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 20.3;monocytes: 22.5;T-cells: 12.6"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 695.6;WM-115: 680.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001236	Uncertain				"Secreted to extracellular matrix"	NA	NA		1600000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 15: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA001236: AB_1855474"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.91e-5)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.11e-3)"	"unprognostic (8.00e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.87e-2)"	41.9	27.3	43.6	22.9	53.2	19.6	32.8	54.9	58.5	33.3	46.8	37.8	25.7	38.9	11.7	12.2	32.5	18.8	42.6	43.6	46.3	36.3	54.1	37.5	14.6	61.1	52.3	26.3	41.8	21.5	27.1	35.0	58.9	24.2	15.3	3.9	19.4	18.6	15.3	19.1	35.9	26.0	49.4	35.3	30.0	12.9	51.7	8.0	25.3	11.8	7.5	35.2	25.2	71.9	71.7	62.4	27.1	168.2	116.2	83.9	51.4	125.5	135.9	122.7	88.6	98.0	89.0	5.6	140.2	211.4	100.7	83.0	50.0	72.0	31.2	37.8	23.8	7.2	70.7	97.3	157.6	31.5	57.4	90.8	67.6	71.6	55.4	120.2	110.9	4.6	68.4	695.6	84.2	194.5	3.4	72.1	53.5	120.5	94.9	21.8	35.1	108.3	42.0	19.1	21.2	116.0	81.1	116.2	288.1	66.8	21.9	105.2	100.5	188.1	94.9	228.1	155.0	38.5	75.9	5.2	112.4	74.2	680.2	0.0	18.1	4.4	12.6	21.8	10.9	3.7	9.3	8.3	16.5	2.2	4.1	4.5	1.8	3.6	22.5	20.3	6.7	9.5	43.6	53.2	54.9	58.5	43.6	46.3	61.1	52.3	58.9	49.4	51.7	71.9	34.1	22.4	8.7	11.1	9.7	8.9	10.8	18.9	8.0	5.7	8.1	9.1	16.1	21.5	8.7	25.8	14.6	20.4	22.0	37.6	1.9	40.2	0.6	10.8	29.9	28.5	16.2	19.1	11.9	31.6	71.6	34.2	17.9	20.5	19.7	25.9	26.7	18.3	50.1	8.4	10.8	18.0	4.1	23.3	18.3	2.1	26.1	23.2	62.2	4.7	18.9	7.7	12.3	10.1	33.4	36.1	37.8	14.7	19.7	8.0	45.8	8.8	9.3	7.3	19.7	14.3	29.8	8.9	12.4	1.9	4.8	18.9	12.5	18.4	27.3	5.2
PMM2	"CDG1, CDG1a, CDGS, PMI, PMI1"	ENSG00000140650	"Phosphomannomutase 2"	O15305	16	8788823-8849325	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	8	"basophil: 210.5"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 210.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040852, HPA063649"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		21000	"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA040852: AB_10794069, HPA063649: AB_2685074"	"unprognostic (8.62e-3)"	"unprognostic (8.00e-3)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.14e-3)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (1.22e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.02e-2)"	18.5	18.3	3.3	15.1	4.6	6.4	16.7	3.3	4.2	13.7	8.4	26.0	25.0	10.6	11.9	29.0	10.7	10.6	13.2	3.8	3.5	16.7	51.8	13.8	13.7	3.6	3.7	7.5	36.5	10.2	12.1	15.5	3.5	14.2	26.0	1.5	22.6	7.4	9.7	16.2	21.3	12.5	3.5	14.0	19.6	4.5	3.9	9.6	11.3	5.9	14.2	21.7	15.7	3.6	26.1	56.5	12.3	32.7	21.8	33.7	27.4	39.8	47.3	38.8	41.6	42.5	31.5	41.0	16.3	69.4	20.2	35.1	25.3	48.5	39.2	30.7	29.0	13.6	33.0	73.8	40.4	36.9	31.6	50.4	33.7	41.1	37.9	18.1	40.1	24.5	18.9	39.6	26.0	68.3	37.9	33.9	52.8	60.0	35.8	47.2	27.4	82.8	43.5	45.0	23.5	43.7	32.7	71.4	23.9	19.5	46.4	31.7	47.7	27.8	31.5	76.6	39.5	48.2	43.3	51.5	23.4	45.5	38.0	210.5	16.5	3.2	7.9	13.0	11.7	9.5	7.0	10.2	12.1	7.8	7.7	7.5	26.5	6.2	8.4	10.9	5.7	10.9	3.3	4.6	3.3	4.2	3.8	3.5	3.6	3.7	3.5	3.5	3.9	3.6	16.5	16.0	24.1	12.7	18.4	3.8	11.6	7.7	14.8	4.7	10.6	9.5	3.1	4.3	28.8	0.0	14.6	8.9	11.9	11.2	9.8	16.3	0.9	15.9	32.0	11.7	7.7	9.0	29.3	28.5	11.9	16.6	23.9	38.5	22.8	12.9	2.5	12.8	5.5	1.7	26.1	21.2	2.0	4.7	1.7	0.9	6.2	10.4	1.8	21.5	9.6	2.5	9.2	22.6	21.6	23.3	9.7	2.2	49.5	12.6	12.3	17.4	16.8	9.0	0.0	13.5	9.8	2.0	4.2	27.0	4.1	10.7	16.0	13.1	12.6	14.9
PMP22	"CMT1A, GAS3, HMSNIA, HNPP, Sp110"	ENSG00000109099	"Peripheral myelin protein 22"	Q01453	17	15229773-15272292	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes, Charcot-Marie-Tooth disease, Deafness, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 404.1;Hofbauer cells: 558.3;Leydig cells: 324.3;Melanocytes: 343.3;Proximal enterocytes: 580.6;Skeletal myocytes: 288.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 32.2;eosinophil: 43.0;plasmacytoid DC: 23.8"	"Group enriched"	"Detected in many"	22	"dendritic cells: 23.8;granulocytes: 43.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 383.5;HMC-1: 263.7;SuSa: 333.9;WM-115: 448.8"														"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (3.00e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.63e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.33e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.83e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.08e-2)"	275.6	45.4	113.6	55.1	161.0	4.9	184.5	153.2	140.7	192.2	77.9	212.2	41.7	142.1	36.5	68.2	163.4	106.5	167.6	113.5	129.0	53.5	11.7	208.4	27.8	163.3	144.2	102.9	22.8	10.8	26.3	201.9	159.9	81.2	74.7	6.5	77.5	80.6	252.4	112.7	239.1	122.0	135.0	27.9	96.2	20.7	141.1	17.3	95.3	127.0	21.8	208.9	157.4	216.7	7.0	44.1	61.9	62.2	383.5	167.1	12.6	60.5	68.8	58.7	38.0	48.7	1.1	0.1	7.0	172.3	22.7	0.7	74.0	1.1	15.4	0.2	13.9	4.3	76.7	17.2	201.8	0.1	263.7	126.9	1.1	32.6	1.8	72.1	66.1	2.8	24.5	0.8	33.2	6.1	0.2	2.0	3.5	4.0	74.7	22.0	39.3	0.0	44.6	4.8	0.1	40.6	16.6	0.6	134.2	333.9	0.2	0.5	81.4	12.7	45.7	216.9	62.0	0.5	0.1	0.3	84.7	0.1	448.8	32.2	1.4	43.0	0.0	0.9	0.0	0.0	0.0	0.0	7.6	0.1	0.0	0.1	0.2	0.1	0.2	23.8	0.0	0.9	113.6	161.0	153.2	140.7	113.5	129.0	163.3	144.2	159.9	135.0	141.1	216.7	86.6	28.9	11.5	50.9	2.8	90.1	6.7	6.1	9.6	1.4	43.0	82.7	68.4	4.3	7.4	0.0	0.0	8.8	2.5	9.1	3.9	4.5	17.7	20.1	118.6	148.0	4.8	10.1	3.7	3.3	23.1	404.1	2.6	11.0	119.7	25.0	88.5	0.9	558.3	0.0	1.8	23.8	0.0	23.4	116.8	11.0	324.3	93.0	343.3	29.0	11.8	61.6	0.0	46.8	217.1	1.7	25.2	246.4	1.9	4.9	580.6	0.7	3.0	2.2	230.1	288.8	141.1	3.0	4.8	3.0	103.0	19.0	8.7	49.2	17.9	5.2
PMPCA	"Alpha-MPP, CLA1, INPP5E, KIAA0123, SCAR2"	ENSG00000165688	"Peptidase, mitochondrial processing subunit alpha"	Q10713	9	136410641-136423761	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"			"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021648, HPA063735"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA021648: AB_1855491, HPA063735: AB_2685108"	"unprognostic (9.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.32e-2)"	"prognostic favorable (8.00e-5)"	"unprognostic (9.47e-3)"	"prognostic favorable (2.14e-6)"	"unprognostic (4.27e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.54e-2)"	29.2	58.1	27.0	20.6	27.6	31.4	27.1	27.0	34.6	29.2	36.8	32.2	24.8	26.8	10.4	34.5	27.5	17.9	73.2	28.0	27.3	37.3	110.8	25.4	27.1	27.1	27.6	29.3	28.8	26.9	38.8	20.8	27.9	31.8	15.3	8.8	28.4	16.1	69.2	37.6	30.6	15.3	25.6	38.2	35.3	37.8	27.9	21.4	29.4	50.0	17.0	28.0	27.8	26.7	48.7	87.7	41.8	84.5	30.8	45.0	63.2	49.3	39.6	67.2	48.9	101.1	56.5	67.4	50.5	50.3	36.2	110.2	77.9	72.0	30.0	97.2	92.8	54.6	113.2	123.6	53.9	71.7	44.9	66.3	48.9	52.6	27.0	38.2	58.0	61.2	140.2	43.4	42.6	132.1	68.1	90.1	85.4	86.2	82.2	83.0	59.1	149.9	46.3	33.9	85.4	56.1	66.6	92.9	58.6	28.6	127.6	95.5	48.2	47.8	50.7	39.8	63.8	26.2	37.4	73.5	62.9	61.3	43.9	37.4	50.5	36.5	53.2	51.9	51.4	52.5	49.0	57.2	61.7	48.8	57.9	50.2	11.9	67.2	51.5	31.4	52.7	62.2	27.0	27.6	27.0	34.6	28.0	27.3	27.1	27.6	27.9	25.6	27.9	26.7	17.3	16.0	26.7	14.7	24.2	27.5	40.2	65.0	27.9	24.7	19.3	15.2	35.9	15.7	32.8	22.0	22.9	103.1	22.5	28.0	49.0	32.9	24.6	25.6	23.5	21.7	20.8	23.5	13.8	30.7	50.4	23.7	21.9	26.2	24.7	44.2	19.6	57.2	37.8	18.5	11.4	24.2	44.7	19.2	14.6	15.8	19.0	17.4	16.0	6.5	21.0	22.9	14.4	8.5	8.0	31.6	20.9	22.6	26.6	22.6	25.6	46.9	22.6	27.4	39.5	22.4	27.9	37.7	42.4	23.2	26.9	103.8	21.7	77.0	38.6	28.5
PMPCB	"MPPB, MPPP52"	ENSG00000105819	"Peptidase, mitochondrial processing subunit beta"	O75439	7	103297435-103329511	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040674, HPA074168"	Approved		Enhanced	Mitochondria		No	No		19000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA040674: AB_10961998, HPA074168: AB_2686671"	"prognostic favorable (2.79e-4)"	"unprognostic (3.11e-1)"	"unprognostic (7.18e-3)"	"unprognostic (3.03e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.67e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.42e-3)"	"prognostic favorable (2.95e-8)"	"unprognostic (2.59e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.39e-2)"	30.8	42.0	16.9	22.3	18.2	53.5	32.5	18.9	22.1	33.3	24.7	33.4	38.0	29.9	26.2	27.7	29.3	25.1	44.9	18.8	18.1	47.4	46.1	22.6	36.4	16.5	16.6	35.4	41.1	39.7	22.4	25.8	17.6	31.5	33.2	25.4	30.6	28.1	34.8	33.2	32.4	26.3	17.2	28.2	35.8	26.7	17.4	30.2	33.4	38.2	33.9	29.3	28.4	19.9	30.2	42.8	49.9	69.4	28.5	57.1	38.0	26.7	45.6	54.3	62.8	47.7	33.7	76.9	41.7	47.9	58.0	37.5	59.7	43.2	49.2	26.4	69.4	26.4	74.0	61.6	35.0	35.0	30.6	53.4	40.5	41.8	39.6	51.3	28.8	55.9	52.5	77.9	48.5	71.1	59.2	82.0	59.2	60.4	52.4	42.7	34.3	79.4	50.3	54.2	62.2	76.5	37.3	108.6	55.8	49.5	45.3	49.1	24.9	48.3	57.9	85.1	52.3	57.4	79.9	61.8	35.7	59.3	38.2	16.7	19.3	13.2	18.3	21.4	20.1	25.9	21.1	18.5	24.7	19.3	26.1	21.7	5.7	17.9	19.7	12.6	30.2	22.3	16.9	18.2	18.9	22.1	18.8	18.1	16.5	16.6	17.6	17.2	17.4	19.9	32.0	32.1	36.9	27.1	54.5	36.7	68.2	123.2	51.8	31.6	41.3	37.3	70.4	41.5	70.7	27.6	22.9	125.6	55.9	35.8	72.4	75.6	106.3	38.4	37.0	37.1	27.1	65.8	36.8	73.2	61.3	42.5	35.7	35.0	60.2	49.9	31.1	53.7	54.6	23.5	33.9	48.1	75.3	49.4	30.7	24.0	51.9	42.4	26.6	18.7	92.5	35.8	58.7	35.7	44.4	59.7	45.4	49.7	56.1	35.2	60.4	127.5	58.2	37.9	65.7	48.6	73.5	125.4	56.4	47.1	37.5	124.9	55.9	63.3	59.1	62.2
PMVK	"HUMPMKI, PMK, PMKA"	ENSG00000163344	"Phosphomevalonate kinase"	Q15126	1	154924740-154936719	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 266.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029900	Approved					NA	NA		15000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA029900: AB_10601390"	"unprognostic (2.52e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.47e-2)"	"unprognostic (8.22e-2)"	"prognostic favorable (9.70e-4)"	"unprognostic (1.41e-1)"	"unprognostic (8.76e-2)"	"prognostic favorable (4.96e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.10e-1)"	39.9	56.4	99.0	29.8	100.1	15.3	35.0	97.9	108.9	33.4	95.0	39.9	45.9	25.9	17.7	77.7	37.2	17.2	63.1	93.9	96.4	53.8	91.9	30.1	34.6	98.6	97.4	35.8	41.6	58.2	60.3	23.7	96.0	32.4	22.2	19.8	34.0	27.1	79.1	69.2	44.2	27.7	96.4	45.7	40.5	26.6	102.3	27.9	31.5	47.4	36.8	31.9	37.9	99.8	51.8	72.9	46.7	72.5	43.6	30.9	48.5	40.5	29.3	38.9	37.0	30.6	101.0	75.1	75.9	49.3	40.5	49.4	65.3	63.9	17.8	103.3	28.9	34.1	104.1	29.0	40.0	51.4	29.3	36.3	58.7	70.2	49.6	19.5	40.0	65.9	36.8	221.7	41.3	108.3	40.8	51.0	41.0	121.7	95.0	60.3	29.8	171.1	66.1	38.4	37.7	91.1	44.1	75.7	51.9	35.0	146.7	91.1	32.7	35.8	29.2	84.4	62.1	174.0	153.2	131.8	58.9	83.9	46.7	28.0	80.9	91.8	68.2	205.6	110.1	114.8	93.1	70.6	93.6	111.1	59.1	59.1	6.9	59.7	219.4	96.5	134.3	80.0	99.0	100.1	97.9	108.9	93.9	96.4	98.6	97.4	96.0	96.4	102.3	99.8	22.7	57.7	37.5	9.4	42.2	69.8	105.9	95.8	51.8	38.5	67.1	68.3	57.3	78.6	42.2	53.3	8.4	235.7	31.5	65.0	266.1	69.6	9.0	45.0	28.5	29.8	66.4	35.6	5.1	71.3	108.1	45.1	46.9	44.2	22.2	49.8	39.3	146.9	141.0	37.0	7.0	78.9	67.1	67.9	49.5	13.5	42.6	47.8	65.8	3.7	49.5	119.1	41.2	8.0	11.8	61.7	61.7	47.8	58.8	53.7	219.3	246.1	22.1	27.4	32.9	46.0	48.4	51.3	51.3	81.0	90.5	227.7	45.1	162.6	79.9	76.2
PNKP	PNK	ENSG00000039650	"Polynucleotide kinase 3'-phosphatase"	Q96T60	19	49859882-49878351	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease variant, Epilepsy, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006782	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"HPA006782: AB_1855496"	"prognostic favorable (9.18e-4)"	"unprognostic (1.87e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.68e-3)"	18.9	45.1	12.0	21.0	12.9	26.4	21.2	12.8	16.2	21.1	24.2	21.6	16.0	21.3	13.5	19.4	22.9	10.6	23.9	14.4	11.9	27.3	22.4	22.2	17.5	14.0	14.0	23.7	28.6	16.7	36.8	11.1	14.3	25.3	13.1	10.1	21.6	12.4	18.5	17.8	22.8	11.5	12.8	37.2	25.0	21.2	13.3	12.3	31.9	7.8	15.3	19.4	18.0	14.1	27.5	17.4	19.1	27.2	15.8	13.4	28.6	43.4	21.2	18.7	17.7	17.5	34.2	18.4	13.6	13.6	11.3	23.5	6.1	25.9	10.9	22.3	27.2	30.0	36.7	14.8	12.2	25.8	36.3	13.2	13.0	17.9	11.0	16.9	26.3	23.4	14.9	34.3	24.7	18.8	28.7	23.5	16.0	28.3	37.4	24.3	15.9	34.7	21.0	68.5	20.6	33.4	19.3	52.5	9.2	14.5	10.2	14.8	36.0	37.6	24.9	9.6	35.8	38.7	16.5	13.0	33.8	12.3	30.8	1.8	12.3	16.7	9.2	11.5	7.9	9.1	7.8	7.3	9.8	12.2	5.7	5.0	23.4	3.9	18.1	5.5	9.1	5.8	12.0	12.9	12.8	16.2	14.4	11.9	14.0	14.0	14.3	12.8	13.3	14.1	23.6	16.0	23.6	5.9	47.2	13.4	35.4	29.9	25.6	40.9	28.1	23.7	11.1	21.5	19.1	20.2	81.3	44.5	37.7	40.0	23.5	42.5	15.0	25.2	28.5	26.6	30.5	17.1	6.0	39.9	35.1	19.1	31.6	28.0	29.1	54.6	35.0	20.1	39.5	33.7	6.0	31.7	24.4	27.7	19.0	32.9	59.4	26.8	14.2	8.4	46.1	18.4	96.8	6.0	5.7	44.6	22.3	44.8	40.4	33.6	27.1	36.1	33.8	73.9	19.7	17.9	20.1	19.4	28.9	23.3	13.1	49.3	39.2	83.0	34.1	35.6
PNPLA1	"dJ50J22.1, FLJ38755"	ENSG00000180316	"Patatin like phospholipase domain containing 1"	Q8N8W4	6	36243203-36313955	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 23.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.9;granulocytes: 4.5;Oligodendrocyte precursor cells: 1.5;Proximal enterocytes: 1.5;Proximal tubular cells: 3.8;Suprabasal keratinocytes: 3.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basophil: 69.8;eosinophil: 18.9"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 69.8"	"Cell line enriched"	"Detected in some"	4	"U-937: 17.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (3.57e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.95e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.65e-2)"	0.1	0.2	0.1	0.6	0.2	4.3	0.6	0.3	0.4	0.3	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	4.7	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.2	23.9	0.9	0.2	0.1	0.7	1.7	1.0	0.2	0.1	0.1	0.0	0.1	0.2	0.6	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	17.6	0.0	69.8	4.0	18.9	0.0	2.2	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.2	6.2	0.1	1.1	0.0	0.0	1.1	0.1	0.2	0.3	0.4	0.1	0.1	0.2	0.0	0.2	0.1	0.2	0.3	0.0	0.0	0.0	1.0	0.0	0.9	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.2	4.5	0.7	0.0	0.0	0.2	0.0	1.2	0.4	0.0	0.0	0.3	1.3	0.0	0.1	0.0	0.0	0.7	0.0	0.0	1.5	0.7	0.1	0.0	0.0	0.0	0.1	1.5	3.8	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	3.7	0.1	0.0	0.4	0.2	0.2
PNPLA2	"ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2"	ENSG00000177666	"Patatin like phospholipase domain containing 2"	Q96AD5	11	818914-825573	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 508.1;breast: 361.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 194.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055173, HPA062602, HPA075175"	Approved		Enhanced	"Nucleoplasm,Lipid droplets"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"	Nucleoplasm	"HPA055173: AB_2682725, HPA062602: AB_2684804, HPA075175: "	"unprognostic (2.11e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.68e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.46e-1)"	"unprognostic (4.09e-1)"	"unprognostic (2.07e-2)"	508.1	75.3	11.9	9.2	14.0	43.1	361.4	13.6	18.8	42.2	13.4	58.1	19.3	49.2	2.8	39.9	50.8	9.5	171.3	11.9	14.0	61.9	58.4	57.3	8.1	17.5	11.8	50.5	75.4	9.6	46.3	8.4	16.8	46.6	4.8	1.3	81.1	16.7	194.6	71.8	74.7	6.4	12.6	51.2	71.3	32.1	12.8	10.9	55.3	64.3	4.1	64.8	44.5	15.3	33.9	26.0	5.3	14.0	194.4	17.2	34.1	35.3	28.1	21.6	19.1	22.3	33.3	19.9	20.4	26.7	13.6	30.0	8.1	14.6	6.6	25.9	71.5	27.6	11.2	36.3	63.3	19.2	33.4	33.9	18.7	14.5	16.7	22.3	17.7	14.5	23.8	19.9	19.5	20.0	25.8	42.3	15.2	34.3	55.1	24.6	11.5	45.7	21.4	7.7	19.6	26.0	65.3	55.0	21.9	3.4	23.7	22.0	32.5	19.3	15.0	12.7	16.3	75.2	49.8	16.7	48.4	27.0	13.8	11.5	9.5	22.1	3.7	6.1	3.6	4.7	4.8	5.4	6.1	4.1	5.4	4.4	8.2	4.0	7.1	7.0	4.2	4.7	11.9	14.0	13.6	18.8	11.9	14.0	17.5	11.8	16.8	12.6	12.8	15.3	78.1	6.4	11.8	12.7	63.5	44.2	69.2	34.2	42.1	14.0	79.5	67.1	45.5	61.5	65.2	51.5	8.4	70.2	50.8	151.8	33.2	65.1	22.1	58.0	31.8	51.8	51.5	52.6	8.9	65.3	32.0	37.4	204.4	114.3	11.4	42.2	100.6	50.6	29.2	11.8	7.5	96.1	20.3	27.6	29.0	6.2	48.4	46.6	42.7	16.9	29.6	32.2	21.6	5.5	13.8	142.2	170.7	39.1	92.0	78.5	166.8	45.0	31.3	9.0	65.7	64.4	50.7	33.5	23.9	53.7	41.2	169.4	53.3	182.2	43.6	195.5
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923792-43964488	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 31.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 35.9;Cone photoreceptor cells: 18.8;Hepatocytes: 42.3;Rod photoreceptor cells: 37.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 16.7;LHCN-M2: 19.3"	"Region enhanced"	"Detected in many"		"cerebellum: 12.2"	"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoli	"Mitochondria, Cytosol"	"HPA058058: AB_2683590"	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	2.6	0.2	0.6	0.5	0.8	0.1	1.6	0.1	1.2	0.6	5.9	0.1	0.8	0.3	0.1	0.2	0.9	0.4	0.2	1.2	0.7	4.5	31.0	0.8	0.3	1.7	1.8	0.3	0.0	0.2	0.0	0.3	2.0	0.0	0.1	6.4	0.7	0.0	1.7	5.8	0.5	0.0	0.2	0.4	0.2	0.4	1.3	0.1	0.1	0.1	0.2	0.0	0.3	0.6	5.1	1.6	16.7	6.8	4.6	5.2	0.5	3.1	1.8	4.1	8.8	5.0	9.0	0.0	2.5	5.2	2.4	4.3	10.6	5.0	3.4	0.0	0.9	0.3	4.5	9.4	7.5	0.0	0.3	6.0	3.8	13.2	0.6	7.0	0.5	0.2	0.0	0.0	19.3	0.7	0.3	0.0	11.5	0.6	0.0	0.1	8.9	0.2	1.7	0.2	1.5	0.1	3.4	1.4	4.8	2.9	5.3	5.8	0.6	1.6	4.9	0.1	0.1	0.1	0.0	0.0	14.3	0.1	6.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.8	0.1	1.2	1.2	0.7	1.7	1.8	2.0	0.2	1.3	0.6	0.4	0.0	0.0	4.2	0.2	0.4	0.5	2.4	0.0	35.9	0.5	0.1	1.3	10.0	1.4	0.0	18.8	0.0	0.2	0.2	0.0	0.4	0.0	1.5	0.5	0.4	1.8	0.0	1.9	0.0	0.1	0.5	0.0	3.6	0.0	1.9	0.7	42.3	0.7	0.0	1.2	0.8	0.0	2.8	0.3	0.3	0.3	0.9	1.8	0.0	0.0	1.1	0.0	0.0	0.8	2.6	0.0	0.7	0.0	0.7	0.4	5.0	0.1	37.3	0.0	1.0	0.8	0.6	0.6	0.0	0.1	0.0	0.2	1.6	0.4	0.4
PNPLA4	"DXS1283E, GS2, iPLA2eta"	ENSG00000006757	"Patatin like phospholipase domain containing 4"	P41247	X	7898247-7927739	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 95.9;Proximal tubular cells: 126.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA003656	Approved				"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA003656: AB_1079033"	"unprognostic (2.97e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.17e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (5.29e-4)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.42e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.27e-1)"	"prognostic favorable (2.23e-12)"	"unprognostic (5.23e-2)"	"unprognostic (6.71e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.12e-1)"	20.8	27.6	11.9	9.7	12.6	8.7	22.6	12.0	11.8	13.9	16.9	15.4	18.9	14.0	18.1	21.0	24.7	9.4	42.1	11.1	14.2	41.2	40.1	9.8	10.8	12.1	13.5	22.4	28.8	25.2	13.5	8.0	12.4	12.8	12.3	16.8	26.9	10.8	77.9	15.0	11.4	12.1	12.5	9.4	19.5	7.8	15.6	16.3	29.9	66.0	10.2	8.9	13.3	11.9	44.7	18.1	2.8	44.4	0.9	0.5	11.9	13.7	1.5	23.0	14.1	18.1	16.1	13.9	0.1	4.5	0.3	25.7	0.0	45.6	39.2	0.4	32.0	10.0	32.8	38.6	28.6	17.8	14.1	29.5	45.7	11.7	27.3	5.5	16.2	0.3	39.9	0.5	0.3	11.8	0.3	17.2	46.9	30.7	38.0	0.3	0.2	15.6	30.6	20.3	25.3	12.7	41.2	16.8	23.7	49.7	26.1	13.0	9.4	0.2	11.4	35.5	0.2	20.3	0.3	27.0	0.2	0.1	3.7	7.4	11.4	9.7	6.1	13.5	7.0	14.7	8.7	6.7	22.2	16.7	11.3	10.8	0.7	11.9	12.5	16.3	6.0	9.3	11.9	12.6	12.0	11.8	11.1	14.2	12.1	13.5	12.4	12.5	15.6	11.9	10.7	9.6	12.5	3.3	8.2	11.9	16.7	46.0	17.6	11.3	38.2	33.5	55.0	20.0	24.3	20.2	0.0	28.7	7.8	31.2	95.9	34.2	3.1	35.9	20.6	10.6	19.8	15.6	2.8	48.7	21.3	14.6	13.7	15.5	8.2	17.3	13.2	62.1	28.7	10.1	3.6	30.6	38.7	9.2	10.2	3.7	16.4	12.1	17.8	1.0	13.3	36.1	6.2	2.5	1.0	39.8	25.1	20.3	14.2	15.3	47.6	126.4	31.0	15.0	6.6	6.6	14.6	22.2	21.4	24.0	16.8	14.0	6.4	49.0	32.3	16.0
PNPLA6	"iPLA2delta, NTE, SPG39, sws"	ENSG00000032444	"Patatin like phospholipase domain containing 6"	Q8IY17	19	7534004-7561764	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant, Dwarfism, Hereditary spastic paraplegia, Hypogonadotropic hypogonadism, Mental retardation, Neurodegeneration, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 73.4;Late spermatids: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007522, HPA064773"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum, Cytosol"		"HPA007522: AB_1079649, HPA064773: "	"unprognostic (2.73e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.78e-1)"	"prognostic favorable (5.25e-4)"	"unprognostic (3.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (3.36e-1)"	"prognostic favorable (7.53e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.17e-1)"	17.9	27.3	18.3	26.2	23.2	26.1	16.4	14.7	31.5	20.2	12.6	25.7	26.9	20.8	5.3	20.4	16.8	13.7	20.7	21.9	16.3	25.6	21.9	40.4	19.5	23.4	20.3	18.8	16.4	15.6	32.7	13.6	25.6	21.4	8.4	10.6	15.8	12.8	33.5	17.5	29.6	14.5	10.1	41.9	19.2	36.4	23.7	10.9	22.7	19.5	8.9	24.6	17.4	23.6	32.4	80.1	14.7	36.1	25.5	37.0	34.3	42.2	41.9	31.4	28.8	18.6	43.7	27.3	69.1	55.3	19.7	40.8	13.1	39.4	16.3	68.5	29.2	17.7	41.8	13.9	29.2	20.2	53.0	31.6	22.2	41.8	23.8	49.2	62.7	31.4	14.9	36.5	28.6	15.7	22.2	26.0	16.2	15.5	71.7	17.3	9.0	31.9	27.9	31.2	19.0	32.5	34.9	15.7	45.6	20.4	14.1	27.6	67.0	38.5	22.1	53.3	44.2	42.6	30.1	12.2	64.2	23.2	36.7	15.7	11.3	37.6	5.4	20.0	5.5	6.5	3.8	5.7	12.1	4.3	3.3	4.5	3.2	7.9	35.0	3.8	6.9	8.8	18.3	23.2	14.7	31.5	21.9	16.3	23.4	20.3	25.6	10.1	23.7	23.6	12.6	6.4	12.0	16.6	11.9	4.8	4.1	9.3	8.6	12.1	10.9	8.3	10.0	15.7	10.1	33.1	27.1	18.2	14.4	48.5	1.9	15.8	73.4	8.2	7.2	13.5	17.4	25.4	14.0	7.1	15.5	7.3	14.8	10.7	12.0	19.5	13.6	20.2	27.4	21.9	16.1	14.6	10.2	68.3	16.0	106.1	9.6	42.4	8.8	15.0	23.6	9.2	21.6	9.0	16.4	9.5	17.9	7.5	8.8	4.9	67.0	12.1	14.4	16.5	0.0	7.1	7.7	60.8	10.5	8.5	5.5	12.4	15.9	10.0	20.9	3.6
PNPLA8	"IPLA2-2, IPLA2G, iPLA2gamma"	ENSG00000135241	"Patatin like phospholipase domain containing 8"	Q9NP80	7	108470417-108569666	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 236.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020083	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA020083: AB_1851849"	"unprognostic (4.48e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.61e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.86e-6)"	"unprognostic (3.16e-2)"	"unprognostic (3.64e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.24e-1)"	27.8	47.3	23.6	17.9	25.1	82.9	20.2	21.6	29.6	19.4	22.1	14.1	11.8	17.9	17.7	21.1	11.6	21.4	25.3	24.0	26.5	30.0	34.6	17.5	18.0	23.5	23.3	14.7	13.9	28.4	16.5	26.6	23.4	18.0	15.1	24.4	11.9	17.7	35.9	15.0	10.7	20.9	24.9	17.7	15.6	15.5	22.9	18.6	24.3	34.7	22.1	29.1	12.7	26.5	28.6	12.8	22.1	19.7	47.7	32.7	32.4	26.6	47.2	21.6	35.8	12.4	16.0	15.9	33.1	26.4	43.4	10.6	37.9	17.1	32.6	24.2	10.1	11.0	19.3	9.1	34.8	7.6	21.7	29.8	31.7	29.2	26.9	23.4	29.5	17.7	13.0	44.5	27.2	18.9	18.0	18.3	9.8	17.9	17.8	6.5	23.3	34.3	25.9	35.9	18.3	25.3	25.8	27.4	32.7	27.7	11.6	12.6	24.2	35.1	15.7	52.8	15.0	37.4	41.5	23.9	33.4	11.4	23.2	21.9	29.8	26.2	14.6	32.8	17.8	28.6	14.2	14.6	29.2	27.3	15.4	14.7	24.5	22.9	43.4	11.6	19.1	22.9	23.6	25.1	21.6	29.6	24.0	26.5	23.5	23.3	23.4	24.9	22.9	26.5	64.5	41.7	49.3	66.3	91.3	92.9	124.0	42.2	55.2	64.0	45.7	35.9	49.7	8.6	51.2	23.9	18.8	58.0	72.7	44.3	93.9	32.0	52.3	124.9	67.3	57.1	57.1	50.7	42.4	37.8	37.5	76.6	45.3	236.1	71.7	19.0	23.2	44.3	32.2	32.0	42.9	27.8	67.1	45.5	90.0	47.4	32.0	113.8	55.2	23.4	43.5	42.9	18.6	38.2	41.3	29.6	38.6	39.5	76.8	80.1	16.7	41.0	62.0	32.5	19.7	88.9	63.9	18.6	23.1	60.5	135.7	130.2	69.1	43.7	22.9	122.7
PNPO	PDXPO	ENSG00000108439	"Pyridoxamine 5'-phosphate oxidase"	Q9NVS9	17	47941506-47949308	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridoxine biosynthesis"	Oxidoreductase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 88.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 62.6;Hepatocytes: 53.4;Proximal tubular cells: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023204, HPA027776"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		450000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 15: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA023204: AB_1855506, HPA027776: AB_10601246"	"unprognostic (1.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.65e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.47e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.74e-1)"	7.3	15.8	16.5	6.2	15.9	3.5	10.6	16.7	22.0	7.0	12.9	8.8	10.2	5.0	11.6	10.7	10.1	6.6	13.2	16.0	21.9	35.1	88.8	6.4	6.9	19.1	21.2	5.8	10.9	26.6	9.2	7.0	20.6	8.0	8.6	5.4	10.4	7.8	21.1	6.7	9.6	6.1	16.5	7.2	8.6	6.6	20.6	5.8	17.8	19.6	7.7	6.7	7.3	14.3	37.9	30.9	2.4	5.8	15.3	11.7	0.0	12.2	7.7	14.0	11.9	51.1	27.6	35.2	57.4	12.7	5.5	22.0	19.4	34.7	20.3	43.4	16.4	24.6	13.9	53.6	16.3	22.6	16.6	15.4	26.9	25.8	32.7	13.1	18.0	26.1	24.4	12.2	16.5	28.3	25.3	7.8	4.5	37.4	37.1	18.8	10.4	26.2	40.2	19.5	12.1	9.5	11.2	18.6	10.7	8.5	32.4	9.1	19.1	22.6	12.8	22.2	26.2	27.8	34.0	19.0	18.4	19.2	11.7	2.5	12.3	2.8	7.2	17.7	8.2	6.7	6.3	7.6	13.5	5.3	8.2	8.1	1.1	7.9	11.9	9.8	7.0	10.3	16.5	15.9	16.7	22.0	16.0	21.9	19.1	21.2	20.6	16.5	20.6	14.3	7.6	12.8	13.9	7.5	3.9	1.5	6.7	5.0	5.7	1.1	16.2	14.4	1.9	18.6	6.8	12.9	4.2	8.4	7.8	7.3	62.6	18.2	0.8	11.2	6.4	5.9	3.6	7.4	4.2	15.6	1.9	5.3	4.6	13.3	12.7	8.8	6.4	53.4	17.2	3.3	6.2	11.6	2.0	11.4	2.4	0.9	9.9	10.6	1.8	2.8	8.6	7.1	3.1	2.5	3.2	15.0	8.9	6.0	4.9	9.0	20.2	86.3	5.9	1.9	0.0	4.1	3.8	0.7	1.3	7.2	2.3	6.3	4.7	19.5	15.4	5.0
PNPT1	"DFNB70, old-35, OLD35, PNPase"	ENSG00000138035	"Polyribonucleotide nucleotidyltransferase 1"	Q8TCS8	2	55634061-55693863	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, Transport"	"Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, RNA-binding, Transferase"	"Deafness, Disease variant, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033424, HPA034602, HPA034603"	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria	Cytosol	"CAB033424: AB_2299801, HPA034602: AB_2674243, HPA034603: AB_10603130"	"unprognostic (9.09e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (1.95e-7)"	"unprognostic (1.88e-1)"	"unprognostic (5.93e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (2.19e-2)"	"unprognostic (2.11e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	6.7	5.9	5.4	4.0	7.0	7.4	5.7	6.4	7.7	5.2	6.4	5.7	3.3	6.4	4.5	4.6	5.7	3.0	6.6	4.8	6.5	5.6	5.2	5.0	4.3	6.9	6.0	4.8	7.8	4.9	5.0	2.9	7.1	4.4	5.2	5.5	5.0	3.2	11.5	5.9	5.3	4.2	5.7	6.2	5.8	3.2	6.3	3.4	5.2	5.9	3.3	5.6	4.5	9.0	9.0	4.3	6.5	2.9	4.7	7.8	8.4	12.2	7.7	19.8	13.1	13.5	4.2	17.9	5.4	5.8	6.2	7.1	8.3	10.1	9.5	6.3	16.3	10.2	5.9	7.0	11.8	25.0	6.4	8.6	6.9	8.4	7.0	4.7	6.4	7.3	11.5	4.2	8.0	4.4	15.4	17.9	15.5	9.3	8.1	15.2	10.9	16.6	8.6	5.2	15.2	9.6	4.4	14.3	17.0	5.6	3.8	11.4	6.4	4.6	3.9	4.2	13.5	18.9	1.3	3.8	9.2	21.1	8.3	3.3	3.4	4.0	4.2	2.8	2.4	3.1	1.7	4.1	1.3	5.6	3.4	3.9	3.4	2.2	2.7	4.1	1.4	2.9	5.4	7.0	6.4	7.7	4.8	6.5	6.9	6.0	7.1	5.7	6.3	9.0	25.1	48.1	57.0	23.8	21.6	24.2	23.1	17.5	29.0	41.3	12.6	11.2	25.6	15.7	46.8	20.2	58.4	19.9	14.2	7.7	9.8	18.6	25.6	27.9	28.9	24.4	10.2	17.4	48.4	16.0	23.3	25.3	14.8	14.3	58.7	21.8	11.7	14.7	15.4	30.3	48.1	12.8	26.4	12.2	17.7	4.8	17.4	26.7	16.0	17.8	16.5	23.9	13.4	34.2	97.7	15.8	11.4	18.4	23.1	26.0	7.6	19.8	38.5	58.6	26.3	31.7	22.3	43.4	20.7	25.7	20.2	12.3	24.7	58.2	18.6	17.6
POFUT1	"FUT12, KIAA0180, O-Fuc-T, O-FUT"	ENSG00000101346	"Protein O-fucosyltransferase 1"	Q9H488	20	32207880-32238658	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Fucose metabolism, Notch signaling pathway"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 20.9"	"Lineage enriched"	"Detected in all"	5	"monocytes: 20.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054519, HPA059935"	Approved		Approved	Centrosome	"Intracellular and membrane"	NA	NA		60000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Centrosome		"HPA054519: AB_2682515, HPA059935: AB_2684171"	"unprognostic (6.61e-2)"	"unprognostic (4.10e-3)"	"unprognostic (8.83e-2)"	"unprognostic (5.51e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.65e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.86e-3)"	17.6	10.8	7.9	11.7	8.4	10.5	16.5	7.2	7.7	15.2	9.1	20.0	20.4	14.9	14.4	12.4	20.4	11.4	17.5	7.7	7.3	16.1	30.9	12.2	9.1	9.3	8.3	20.0	13.8	23.8	9.1	16.4	8.0	14.5	19.1	5.9	13.0	18.1	12.8	13.7	24.0	18.1	8.0	9.4	11.1	9.5	8.1	10.5	18.9	14.0	10.0	14.0	10.9	8.2	47.1	37.2	31.5	34.7	52.9	51.4	58.8	47.8	56.2	78.8	51.3	111.9	62.1	31.7	69.8	53.5	87.2	51.2	30.5	59.0	68.0	16.5	19.2	47.1	32.1	51.2	41.2	41.0	28.9	45.4	45.7	59.7	38.8	33.5	44.6	30.0	36.3	17.6	55.6	23.1	28.4	31.4	16.2	45.2	59.4	23.3	83.6	29.5	24.2	30.7	20.6	26.5	109.5	30.0	41.0	24.0	44.7	48.5	38.8	113.4	42.2	71.8	82.4	21.4	29.3	28.7	68.5	139.9	73.0	4.3	5.4	2.6	3.2	15.1	3.6	3.2	2.8	3.0	4.6	2.6	3.6	2.5	1.0	2.0	20.9	3.4	3.3	4.2	7.9	8.4	7.2	7.7	7.7	7.3	9.3	8.3	8.0	8.0	8.1	8.2	7.8	9.6	9.5	11.1	5.2	2.9	4.7	8.6	5.2	3.1	7.2	7.1	13.4	8.6	7.9	7.3	2.1	15.2	5.7	17.5	1.9	10.0	0.9	7.1	10.8	9.3	12.0	9.2	9.0	10.4	28.2	12.0	9.2	13.6	5.1	13.1	13.9	39.8	10.7	8.4	9.0	13.4	2.0	8.1	3.8	1.7	10.5	6.5	5.4	6.5	9.3	5.2	3.1	11.1	9.6	9.6	11.9	14.3	8.2	6.7	31.7	5.3	7.2	4.3	13.1	11.1	9.4	2.9	7.3	9.7	1.7	7.7	5.0	26.0	19.0	4.1
POGLUT1	"9630046K23Rik, C3orf9, hCLP46, KDELCL1, KTELC1, MDS010, MDSRP, MGC32995, Rumi"	ENSG00000163389	"Protein O-glucosyltransferase 1"	Q8NBL1	3	119468963-119494708	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Gastrulation	"Developmental protein, Glycosyltransferase, Transferase"	"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 81.2;monocytes: 151.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037855, HPA037856"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Endoplasmic reticulum"		"HPA037855: AB_10672728, HPA037856: AB_2732477"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.02e-7)"	"unprognostic (3.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (2.23e-4)"	6.8	7.2	5.9	7.8	6.1	3.1	7.7	6.0	8.2	7.1	6.9	6.8	4.2	9.0	7.8	5.6	6.0	4.7	5.9	5.9	7.2	5.7	6.6	5.6	10.8	6.6	6.5	5.5	7.9	9.5	4.9	8.2	6.6	5.4	7.2	4.2	4.6	11.6	3.2	10.0	7.8	10.4	6.1	9.0	5.4	2.5	7.2	9.7	5.6	3.4	10.8	8.5	6.3	6.7	10.8	7.1	11.7	13.1	29.5	16.8	8.6	16.7	16.7	12.3	18.4	11.5	6.9	16.5	22.2	21.4	10.6	11.9	15.9	16.8	20.4	14.4	10.6	19.3	11.1	12.9	19.1	21.3	21.7	17.5	9.6	13.3	18.0	15.7	15.5	11.2	10.5	19.7	13.9	10.9	12.5	20.7	12.4	18.6	13.8	12.2	12.2	24.0	11.6	13.9	12.7	20.0	8.1	4.9	13.4	11.7	13.2	17.8	19.7	13.1	8.0	3.8	8.9	27.1	25.2	21.7	11.1	20.6	18.8	2.9	16.4	13.9	16.2	15.7	18.7	13.9	18.2	17.0	20.7	10.1	21.1	20.0	1.2	29.5	10.8	11.5	22.3	15.0	5.9	6.1	6.0	8.2	5.9	7.2	6.6	6.5	6.6	6.1	7.2	6.7	19.1	0.0	6.2	11.4	15.7	16.8	7.3	17.4	16.5	13.6	9.7	8.5	5.2	14.3	10.1	20.2	6.2	10.6	17.1	5.2	0.0	6.9	0.7	5.5	19.3	16.1	9.5	8.4	32.7	5.3	14.7	14.5	9.2	7.0	17.7	11.3	13.6	12.5	8.4	5.0	31.6	11.7	22.4	11.9	81.2	0.2	8.7	16.6	12.4	6.5	151.4	10.3	21.6	23.6	25.8	5.0	8.3	17.0	14.1	8.0	8.5	6.0	6.5	13.0	13.1	16.7	13.4	1.5	1.5	13.9	14.9	6.6	15.5	17.4	13.9	5.9
POLD1	"CDC2, POLD"	ENSG00000062822	"DNA polymerase delta 1, catalytic subunit"	P28340	19	50384204-50418018	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Paneth cells: 51.3;Spermatogonia: 25.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004375, HPA046524"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB004375: AB_675487, HPA046524: AB_2679684"	"unprognostic (2.45e-1)"	"unprognostic (7.02e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (2.87e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.08e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.01e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.70e-2)"	5.6	5.1	3.2	9.2	3.7	26.3	6.3	4.5	3.8	7.6	2.5	8.9	5.4	8.4	0.4	10.7	6.5	2.1	5.8	2.7	2.7	6.5	6.4	9.5	11.2	5.1	3.7	7.1	7.9	2.3	4.7	5.9	4.1	6.1	2.2	1.9	7.4	2.6	5.6	9.2	10.1	2.3	3.5	12.8	6.2	13.3	4.1	11.0	9.8	1.5	5.2	5.9	7.7	4.4	52.1	77.9	27.9	22.4	3.0	2.8	45.6	34.0	9.6	30.0	34.9	42.4	39.2	84.6	19.4	7.1	13.9	45.1	27.4	25.1	6.8	64.4	145.0	66.1	73.0	54.6	3.7	67.0	57.7	6.4	7.1	26.1	6.5	6.0	14.2	58.2	77.4	54.3	9.1	40.6	92.2	110.6	48.7	25.3	55.4	105.4	62.2	67.7	7.4	44.9	39.3	38.6	33.0	35.9	8.8	10.1	21.1	50.7	17.4	21.4	70.7	22.0	56.5	60.0	91.3	76.3	21.2	66.9	20.8	1.3	4.3	1.5	4.3	5.6	4.0	6.0	4.0	3.5	3.9	5.4	4.0	3.9	0.6	4.2	6.9	7.1	3.1	4.0	3.2	3.7	4.5	3.8	2.7	2.7	5.1	3.7	4.1	3.5	4.1	4.4	3.5	3.2	3.9	0.7	8.7	6.4	2.3	3.5	3.4	4.0	4.3	5.3	3.4	2.8	3.8	3.7	6.2	19.2	3.8	12.2	0.0	4.8	1.9	2.8	1.6	3.4	7.2	15.2	1.2	4.0	15.0	4.1	3.1	3.0	0.0	9.5	1.1	2.2	15.1	0.0	0.9	7.4	0.0	5.7	5.3	1.9	3.1	5.8	5.4	1.0	4.8	1.2	6.2	1.5	2.2	4.7	51.3	5.3	10.6	2.8	6.3	2.8	3.0	4.3	0.0	3.5	4.0	11.5	25.6	5.5	5.3	7.7	5.4	3.4	14.3	1.3
POLG	"POLG1, POLGA"	ENSG00000140521	"DNA polymerase gamma, catalytic subunit"	P54098	15	89305198-89334861	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease variant, Epilepsy, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056821, HPA078482"	Approved		Supported	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Mitochondria		"HPA056821: AB_2683247, HPA078482: "	"unprognostic (1.87e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.65e-3)"	"unprognostic (1.58e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.45e-1)"	13.3	11.1	6.8	4.0	5.0	2.6	12.0	4.8	6.3	12.0	4.5	13.3	5.5	12.9	0.4	14.6	11.2	0.9	13.8	6.1	3.5	10.1	12.9	13.8	3.0	9.0	5.8	10.8	10.7	2.9	8.4	2.5	6.5	10.5	0.9	1.4	12.3	2.2	25.0	16.0	14.5	1.3	5.4	16.2	11.9	5.4	5.7	7.3	10.5	10.9	2.4	12.2	12.7	6.3	8.0	17.0	6.7	10.0	7.7	1.6	16.4	16.4	2.7	7.9	5.9	28.0	10.9	14.4	33.6	5.9	16.9	11.8	14.3	4.8	0.9	35.8	31.3	19.4	19.5	11.1	10.8	21.3	33.6	2.4	8.7	7.0	3.0	8.3	12.2	26.8	19.5	5.4	6.1	22.8	16.3	16.5	8.7	13.7	8.2	18.2	13.7	17.4	3.2	19.2	24.5	6.9	26.8	9.6	16.8	6.0	7.7	10.8	17.3	12.8	15.6	28.5	14.2	17.0	9.4	18.6	9.5	14.3	11.6	3.3	4.3	6.1	5.5	4.0	4.3	2.0	4.6	6.8	6.0	3.0	3.7	4.4	1.8	5.0	3.5	4.1	3.3	5.3	6.8	5.0	4.8	6.3	6.1	3.5	9.0	5.8	6.5	5.4	5.7	6.3	15.7	12.8	11.9	11.4	17.2	12.2	11.0	10.7	9.1	7.6	12.0	10.3	19.0	11.5	9.5	11.0	2.1	15.0	33.8	17.2	9.8	10.4	1.3	8.4	9.4	12.4	5.4	9.0	12.9	10.9	15.8	11.9	21.4	11.3	8.2	14.8	14.6	17.8	12.7	3.3	9.9	24.9	4.1	18.5	14.7	1.5	14.3	17.2	19.6	8.4	21.8	6.1	30.9	9.5	11.9	11.4	15.9	10.5	16.8	17.7	10.5	7.5	7.8	6.4	6.6	13.3	12.9	9.2	11.1	11.8	11.9	21.8	21.7	14.8	17.6	15.5
POLH	"RAD30A, XP-V"	ENSG00000170734	"DNA polymerase eta"	Q9Y253	6	43576185-43620523	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"	"Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 91.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006721, HPA026762"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA006721: AB_1847785, HPA026762: AB_10601248"	"unprognostic (1.79e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.11e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.18e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.50e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.02e-2)"	5.0	3.8	2.3	6.9	2.7	4.2	4.8	5.1	2.9	5.9	5.3	7.0	4.6	4.2	3.6	5.5	5.5	4.3	3.7	2.2	2.2	4.7	5.6	5.7	12.9	2.7	2.2	4.7	5.4	3.7	3.2	4.0	2.7	4.7	7.2	7.4	4.0	3.8	8.5	8.5	4.4	6.3	1.8	5.6	4.6	10.6	2.5	12.9	6.8	4.7	14.2	4.8	4.3	3.6	46.7	9.7	13.5	19.9	17.6	29.1	33.0	48.6	13.9	26.2	29.2	12.0	7.9	48.9	12.0	17.6	7.6	11.4	13.1	28.6	31.5	25.9	10.0	15.3	31.6	35.5	13.4	26.8	19.2	19.5	33.4	21.5	11.3	10.6	24.3	14.5	24.0	29.6	33.0	15.0	23.9	6.4	4.2	33.2	7.2	25.1	14.3	11.8	9.9	34.6	15.1	5.4	14.5	12.9	7.3	15.4	17.9	10.8	36.2	23.6	24.4	12.2	25.2	28.0	21.3	91.1	11.8	14.5	27.3	4.1	1.7	2.7	4.2	1.6	3.8	5.0	3.5	3.1	1.3	4.9	2.8	3.0	1.7	4.2	1.6	2.6	4.6	2.0	2.3	2.7	5.1	2.9	2.2	2.2	2.7	2.2	2.7	1.8	2.5	3.6	3.1	12.8	8.2	12.1	15.1	4.7	3.2	4.8	19.4	6.3	3.4	3.3	2.3	5.7	6.5	3.7	10.4	2.4	5.2	6.3	5.9	2.1	11.4	10.2	4.8	2.8	5.4	5.7	14.8	0.9	2.8	5.3	8.2	9.0	0.0	6.1	1.4	2.4	1.7	0.0	15.3	2.2	4.1	2.2	2.2	7.3	3.4	3.0	1.8	6.5	3.2	2.6	2.1	10.1	13.4	1.9	4.5	3.0	12.7	2.2	3.1	2.3	5.4	9.4	0.0	7.0	5.0	25.9	6.7	13.0	3.0	1.9	8.8	5.6	3.0	2.3
POLQ	POLH	ENSG00000051341	"DNA polymerase theta"	O75417	3	121431427-121546641	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;lymphoid tissue: 4.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 16.4;Excitatory neurons: 9.5;Granulosa cells: 12.6;Inhibitory neurons: 7.8;Plasma cells: 12.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 2.5"	HPA053359			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA053359: "	"unprognostic (1.59e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.23e-3)"	"unprognostic (3.09e-5)"	"unprognostic (8.55e-3)"	"unprognostic (1.09e-4)"	"unprognostic (2.86e-1)"	"unprognostic (5.59e-5)"	"unprognostic (2.06e-3)"	"unprognostic (0.00e+0)"	"prognostic favorable (1.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.76e-2)"	0.1	0.2	0.0	1.6	0.1	6.0	0.4	1.0	0.2	0.2	0.0	1.2	1.2	0.2	0.0	2.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.2	2.8	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	2.0	0.0	0.3	0.0	0.0	1.4	0.9	0.4	0.0	0.8	0.5	2.2	0.0	4.5	0.0	0.0	2.3	0.3	0.5	0.0	18.2	12.1	10.2	7.2	0.9	1.2	9.2	8.5	3.2	9.7	12.9	9.8	6.6	21.5	3.7	4.6	11.7	14.0	12.2	5.4	16.4	6.3	6.7	13.8	8.0	6.1	0.1	15.1	12.1	0.2	0.4	8.9	5.4	1.7	4.9	7.9	9.3	15.9	10.3	7.1	13.7	8.8	9.7	5.5	5.9	11.4	12.2	7.6	3.1	10.3	5.5	5.0	9.8	5.2	3.4	8.8	4.8	14.8	3.8	8.6	11.2	3.4	11.1	8.0	6.9	21.8	4.1	11.0	6.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	1.6	0.7	0.9	0.5	0.6	0.0	0.9	0.6	0.6	1.6	0.0	2.0	0.0	0.0	3.1	0.6	1.6	0.0	0.1	0.4	0.9	1.0	0.5	0.0	16.4	9.5	0.0	3.3	1.2	4.6	1.0	0.0	12.6	0.0	0.2	2.3	0.0	7.8	1.6	2.0	1.3	1.2	0.7	0.3	1.7	0.0	1.0	0.6	0.4	0.0	1.5	1.3	0.2	1.2	0.0	12.2	0.5	0.2	0.1	2.4	0.2	0.0	0.1	1.0	6.8	3.4	4.9	0.1	0.3	1.8	0.9	3.2	0.8
POLR1A	"DKFZP586M0122, FLJ21915, RPA1, RPA190, RPO1-4"	ENSG00000068654	"RNA polymerase I subunit A"	O95602	2	86020216-86106155	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010145, HPA031513, HPA049700"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments"		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"	"Nucleoplasm, Intermediate filaments"	"CAB010145: AB_675814, HPA031513: AB_2673916, HPA049700: AB_2680856"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (3.70e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.31e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (7.20e-2)"	5.4	5.7	3.7	5.8	4.0	4.9	4.5	3.1	4.7	4.9	4.0	4.9	4.1	8.2	3.0	6.0	5.2	2.9	5.8	3.9	3.6	4.6	5.0	4.0	4.6	3.4	3.6	5.2	5.2	7.1	4.9	5.0	3.3	4.5	5.0	3.5	3.9	5.1	10.8	5.5	3.8	6.9	2.7	3.8	4.5	6.2	4.4	6.2	4.5	7.4	4.9	5.2	4.2	4.3	18.5	41.1	18.0	34.7	17.2	13.7	25.9	16.6	10.9	23.2	14.4	51.9	14.2	41.9	17.2	17.0	22.7	20.9	46.6	24.4	20.6	17.6	24.0	36.2	18.0	35.1	12.1	34.8	18.7	10.5	15.0	34.6	26.7	8.8	18.2	19.0	48.8	10.3	16.2	16.4	25.8	15.1	32.7	24.4	26.8	30.7	39.5	19.6	10.5	29.7	27.7	14.6	18.3	23.8	12.7	12.3	14.0	12.0	29.3	28.0	22.2	24.3	33.8	14.5	15.3	35.7	14.6	29.3	25.3	0.5	0.4	0.0	0.7	0.6	0.9	0.5	0.3	0.6	0.4	0.6	0.3	0.4	0.1	0.5	0.5	0.7	0.1	0.4	3.7	4.0	3.1	4.7	3.9	3.6	3.4	3.6	3.3	2.7	4.4	4.3	4.9	3.2	9.1	13.4	8.8	4.2	4.9	5.3	12.0	12.4	6.2	5.5	11.1	8.6	4.7	9.2	16.7	6.3	7.2	5.1	3.9	6.0	3.0	5.4	13.8	6.5	9.6	10.9	19.7	4.9	5.4	7.7	8.2	6.9	6.3	11.0	4.2	8.3	12.5	11.8	18.1	6.7	2.0	3.1	3.5	1.7	6.2	5.5	5.4	6.5	3.3	4.2	6.2	20.1	18.2	6.6	3.0	5.3	10.1	9.1	3.5	3.4	5.2	9.7	0.0	14.3	6.2	5.0	7.2	13.4	2.7	3.8	7.5	12.4	10.4	4.0
POLR3A	"C160, hRPC155, RPC1, RPC155"	ENSG00000148606	"RNA polymerase III subunit A"	O14802	10	77969251-78029515	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 75.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037926	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA037926: AB_10672400"	"unprognostic (6.83e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.76e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.64e-6)"	"unprognostic (3.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.11e-2)"	4.3	6.0	6.6	5.2	7.1	3.9	6.2	6.7	7.9	5.1	4.7	4.8	5.1	5.5	7.5	5.0	4.8	3.7	4.9	8.1	3.7	5.2	5.6	4.0	5.7	5.5	3.4	6.5	5.4	6.8	10.4	6.1	5.5	5.8	5.7	12.8	5.0	4.5	11.5	6.7	4.7	5.6	2.2	5.1	4.7	6.0	4.0	7.6	5.6	8.7	6.3	5.0	4.8	6.5	14.2	16.3	17.4	28.8	11.2	14.2	11.6	16.0	20.7	20.2	19.8	22.1	10.0	17.6	9.7	14.0	11.5	15.7	30.3	17.5	24.4	13.0	22.2	14.2	13.6	26.6	10.5	24.6	11.5	12.2	12.3	35.9	33.0	19.4	18.0	14.1	26.8	10.6	19.9	10.6	18.7	15.6	19.0	11.0	75.1	17.5	11.0	11.5	10.0	8.6	15.5	20.0	15.4	28.3	16.6	15.5	21.0	12.7	19.8	12.9	12.5	14.2	32.0	16.4	18.6	21.0	23.0	25.4	6.4	5.4	2.6	1.5	3.5	3.1	3.5	2.6	2.8	3.4	2.4	3.2	2.5	3.0	1.5	3.4	2.9	2.6	4.6	1.9	6.6	7.1	6.7	7.9	8.1	3.7	5.5	3.4	5.5	2.2	4.0	6.5	8.5	0.0	9.1	17.0	8.7	9.9	5.1	5.3	11.4	28.3	9.6	8.3	11.7	8.6	9.5	0.0	64.6	8.0	12.6	6.1	1.9	7.0	1.6	8.3	14.4	8.1	7.2	11.6	26.4	6.2	6.9	8.2	8.2	8.9	6.3	15.7	5.3	9.5	5.5	15.2	26.3	10.2	0.0	6.9	3.7	1.2	13.1	5.9	1.8	10.3	7.8	13.0	12.3	16.1	18.7	8.1	8.3	8.2	11.2	4.7	8.0	5.0	10.4	31.5	6.6	13.6	8.3	12.5	18.0	10.1	9.1	4.1	7.8	13.7	8.6	3.6
POLR3B	"C128, FLJ10388, RPC2"	ENSG00000013503	"RNA polymerase III subunit B"	Q9NW08	12	106357748-106510198	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036466	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA036466: AB_10671842"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.09e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.24e-2)"	4.5	8.7	3.1	4.8	4.4	5.2	5.0	4.3	4.6	4.7	3.7	5.3	4.2	4.6	5.2	8.6	5.1	3.6	5.8	3.4	2.9	6.8	9.0	4.7	4.1	2.2	2.3	7.5	4.9	11.1	2.4	6.7	2.3	5.6	5.7	6.2	4.7	4.0	6.5	11.0	3.4	5.4	2.7	3.3	5.4	6.1	3.2	4.7	6.0	8.3	5.6	4.9	4.3	3.6	16.2	7.6	16.4	7.8	13.9	13.1	22.9	21.9	13.0	15.2	11.6	14.0	4.4	20.6	7.7	14.2	5.6	14.8	19.5	19.2	18.5	16.6	13.1	15.7	10.1	12.0	9.2	26.1	17.0	11.7	13.4	15.1	17.3	10.3	11.5	9.8	24.5	6.5	11.2	12.0	19.1	8.7	17.8	11.9	28.5	11.6	9.8	13.5	8.6	21.8	17.3	9.6	13.6	18.2	13.4	10.8	17.0	7.9	11.0	8.3	10.0	13.6	13.1	8.1	22.4	30.3	3.8	15.9	9.2	5.6	2.0	1.5	2.0	2.2	2.7	2.1	2.2	2.2	2.6	1.3	3.0	1.9	1.3	2.1	2.2	0.9	2.7	1.7	3.1	4.4	4.3	4.6	3.4	2.9	2.2	2.3	2.3	2.7	3.2	3.6	2.4	0.0	9.2	14.4	4.7	1.8	1.7	4.5	4.6	6.0	3.4	3.7	10.3	2.8	7.0	5.5	6.2	11.0	3.8	3.8	1.9	5.1	7.1	3.9	7.0	3.3	4.2	3.8	22.3	4.6	9.3	4.4	9.2	3.9	5.1	4.8	3.6	11.0	3.1	3.3	24.1	5.6	2.0	1.6	0.3	5.2	3.7	2.4	3.6	9.4	1.0	2.4	2.1	17.1	22.4	3.8	1.1	4.9	4.9	1.5	1.7	3.4	7.2	7.2	6.6	6.9	4.1	16.5	10.9	8.9	3.0	7.4	4.1	7.2	5.1	1.2
POMGNT2	"AGO61, C3orf39, FLJ14566, GTDC2"	ENSG00000144647	"Protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)"	Q8NAT1	3	43079232-43106079	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034870, HPA040989"	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"			"HPA034870: AB_10602701, HPA040989: AB_2677238"	"unprognostic (2.37e-3)"	"unprognostic (8.22e-2)"	"prognostic favorable (8.13e-5)"	"unprognostic (2.57e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.26e-5)"	"unprognostic (8.71e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.95e-2)"	"unprognostic (4.01e-1)"	"prognostic favorable (4.00e-7)"	"unprognostic (4.98e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.57e-1)"	11.0	13.5	22.1	4.2	21.0	20.7	9.9	22.6	23.1	19.4	19.8	14.9	3.6	50.7	11.3	7.5	30.9	9.0	19.1	22.6	20.8	12.8	9.2	10.2	3.1	21.7	21.0	30.4	15.3	17.7	19.1	5.5	24.9	15.2	2.9	9.0	13.8	14.5	31.5	11.7	7.1	19.7	18.1	6.0	13.8	14.8	26.7	5.5	11.8	18.6	2.3	15.2	13.6	17.8	20.0	14.9	8.5	26.0	32.0	8.2	13.5	5.6	10.0	19.5	22.7	18.2	13.7	0.0	20.6	10.2	23.6	0.4	14.0	16.3	8.5	0.1	39.2	14.0	11.1	17.4	12.1	9.9	15.9	9.5	11.9	13.2	7.7	7.7	7.6	29.7	11.6	0.1	7.6	11.8	18.1	2.6	18.7	12.4	27.7	7.0	6.0	12.3	11.6	14.4	13.4	12.2	11.8	9.4	10.9	5.7	17.8	8.6	3.6	15.7	21.9	23.3	23.3	14.5	23.2	0.1	20.2	19.6	17.0	0.0	0.5	0.5	3.0	0.4	2.7	1.9	1.9	1.9	0.6	0.9	2.3	1.9	0.0	1.0	0.4	0.6	1.7	1.0	22.1	21.0	22.6	23.1	22.6	20.8	21.7	21.0	24.9	18.1	26.7	17.8	4.1	3.2	2.0	11.8	2.6	8.0	2.8	3.8	6.8	15.3	8.2	7.5	17.0	10.0	3.4	14.7	8.4	3.4	3.2	2.4	5.9	9.9	10.4	6.9	6.6	3.9	6.0	28.4	13.2	10.7	5.3	14.3	4.6	2.5	0.0	12.6	5.0	6.6	6.2	10.1	14.1	1.9	4.1	4.2	4.8	24.5	19.9	3.7	5.4	3.7	1.1	10.1	5.2	15.6	7.4	5.5	2.0	29.3	3.1	4.4	1.4	5.2	9.2	5.2	13.1	8.5	8.3	10.0	19.0	6.0	11.6	1.8	3.6	3.2	2.7	2.2
POMK	"FLJ23356, SgK196"	ENSG00000185900	"Protein O-mannose kinase"	Q9H5K3	8	43093498-43131180	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.5"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 6.9;Inhibitory neurons: 6.8;Microglial cells: 7.5;Oligodendrocyte precursor cells: 5.5;Oligodendrocytes: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA013321	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"			"HPA013321: AB_2668809"	"unprognostic (1.66e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.10e-2)"	2.3	2.8	11.6	2.5	12.6	6.8	3.8	6.0	14.5	4.1	0.0	3.3	1.6	2.3	7.2	1.9	2.4	1.9	1.3	12.3	7.9	2.0	3.3	2.6	4.0	8.8	7.6	2.6	3.3	2.6	0.9	3.1	9.1	5.0	3.6	5.9	2.4	2.4	2.8	5.8	1.8	2.6	6.1	3.9	3.2	3.6	11.1	4.9	3.1	2.7	4.1	2.7	0.8	8.8	7.8	9.1	9.2	24.4	8.8	6.6	9.1	4.3	4.7	6.1	6.1	8.4	13.8	9.2	7.7	7.1	2.5	8.2	13.5	11.7	7.9	2.0	4.3	19.2	6.2	15.6	8.3	6.1	9.9	8.7	15.2	11.1	10.8	4.6	9.1	10.1	4.6	15.9	9.7	5.3	14.5	18.6	19.8	11.2	1.7	8.7	10.2	4.1	19.1	11.3	6.5	8.2	12.4	7.5	10.0	10.7	14.9	9.6	9.8	11.6	12.8	11.8	8.1	5.8	11.6	11.7	5.7	6.3	16.0	2.2	0.9	0.8	0.8	0.8	0.9	0.5	0.8	0.8	1.4	1.2	1.0	1.1	2.8	0.9	1.5	2.4	1.2	0.6	11.6	12.6	6.0	14.5	12.3	7.9	8.8	7.6	9.1	6.1	11.1	8.8	0.6	0.0	0.5	2.9	0.7	0.4	0.1	0.3	1.8	1.6	0.3	0.3	0.3	0.0	1.3	0.0	0.0	0.4	1.0	0.5	0.0	0.2	0.0	0.7	1.9	0.3	0.0	0.4	6.9	0.0	0.8	0.6	1.5	1.0	0.0	1.2	0.0	0.3	0.2	0.0	6.8	0.3	0.0	0.3	0.0	0.0	0.6	0.8	1.8	7.5	1.3	0.3	2.1	5.5	6.5	0.2	0.0	0.0	1.5	0.2	0.5	0.1	0.0	1.0	0.0	0.2	0.6	0.3	1.1	2.3	0.1	0.5	0.9	0.6	0.5	0.2
POMT1	LGMD2K	ENSG00000130714	"Protein O-mannosyltransferase 1"	Q9Y6A1	9	131502789-131523806	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 64.5;Spermatocytes: 71.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065252			Uncertain	"Golgi apparatus"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"		"HPA065252: AB_2685445"	"unprognostic (2.00e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.76e-3)"	"unprognostic (2.84e-1)"	"prognostic favorable (3.90e-5)"	"unprognostic (8.36e-2)"	"prognostic favorable (4.68e-5)"	"unprognostic (2.41e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-1)"	15.7	20.9	16.6	7.6	16.7	6.6	16.2	18.4	21.0	21.1	15.0	24.8	9.0	17.1	7.2	15.2	18.4	9.3	24.5	25.5	16.0	25.5	24.4	15.6	8.3	16.0	16.2	25.6	25.9	15.5	31.3	9.7	16.5	28.4	6.5	8.1	20.1	8.7	32.9	17.5	19.9	7.1	14.2	22.2	20.4	63.7	16.9	7.1	19.0	13.4	5.4	16.5	17.1	15.5	9.8	17.4	10.5	26.4	19.3	13.5	24.5	12.1	17.0	21.3	14.1	15.8	14.7	2.5	16.9	26.4	8.6	24.1	17.3	16.6	5.9	16.2	21.6	4.2	28.5	7.8	23.1	13.1	10.5	10.8	10.0	12.3	5.0	17.6	15.1	16.4	13.4	15.6	23.2	27.6	15.8	25.2	6.7	9.6	21.1	15.7	13.8	24.6	18.1	1.5	15.0	14.1	25.1	26.8	13.0	5.8	31.4	17.7	20.9	13.8	2.2	28.6	10.3	7.3	7.0	5.2	8.7	29.1	13.0	0.0	2.8	3.4	5.2	3.0	7.7	1.9	5.0	5.3	4.0	2.6	4.8	3.6	0.6	3.2	2.9	2.4	5.2	4.0	16.6	16.7	18.4	21.0	25.5	16.0	16.0	16.2	16.5	14.2	16.9	15.5	5.9	9.6	16.0	18.6	7.1	4.5	4.9	7.2	5.7	13.2	7.8	8.6	9.7	10.0	8.7	12.9	8.4	20.8	6.5	12.9	1.9	10.7	64.5	9.6	7.3	8.0	7.8	1.3	21.5	6.7	12.9	9.0	9.2	9.9	2.5	15.1	11.0	10.1	10.8	21.9	25.9	8.4	10.2	5.4	5.9	33.0	8.7	5.6	5.4	15.9	7.5	12.3	5.2	18.6	11.1	8.1	6.0	10.1	6.8	4.9	14.2	7.5	6.8	16.6	6.6	7.5	7.2	71.6	9.6	5.7	3.0	17.5	9.0	6.2	9.1	2.6
POMT2	LGMD2N	ENSG00000009830	"Protein O-mannosyltransferase 2"	Q9UKY4	14	77274956-77320883	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 37.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 27.1;Oligodendrocytes: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003663	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 43: Testis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA003663: AB_1079655"	"unprognostic (2.15e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (7.10e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.89e-3)"	"unprognostic (1.94e-3)"	"unprognostic (8.50e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.75e-3)"	"unprognostic (3.46e-2)"	5.8	12.4	13.2	4.1	14.9	2.5	5.7	13.5	13.4	8.0	12.5	6.7	2.6	6.7	9.8	5.5	5.8	4.0	7.9	12.7	13.1	10.8	9.3	5.6	1.8	14.6	14.6	6.1	8.8	8.6	12.6	7.0	13.4	7.8	3.3	5.6	6.3	6.9	19.1	4.7	4.9	4.6	13.7	5.6	5.9	37.5	14.4	2.9	10.9	8.4	1.9	7.9	5.3	15.4	15.6	19.4	18.6	21.1	13.0	10.3	14.8	13.4	10.8	19.3	16.6	9.6	13.6	4.6	10.6	12.6	27.1	17.1	8.8	13.3	13.5	6.9	12.1	2.8	8.9	7.9	15.8	3.2	8.9	10.5	13.9	18.3	17.8	13.6	11.5	4.5	7.4	10.5	13.0	30.7	5.4	15.0	5.3	21.4	16.2	5.3	18.0	4.1	20.4	11.3	15.6	15.2	8.7	14.6	11.3	12.0	15.1	6.5	9.6	14.6	22.8	17.1	12.0	6.8	14.5	2.1	7.4	4.8	13.2	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.1	13.2	14.9	13.5	13.4	12.7	13.1	14.6	14.6	13.4	13.7	14.4	15.4	3.2	6.4	2.8	27.1	2.0	3.1	2.7	3.4	2.8	7.5	7.2	7.6	4.3	4.3	1.6	1.8	16.7	6.0	1.2	6.5	0.0	7.6	14.3	5.8	6.7	3.1	18.0	0.0	12.9	7.5	10.2	6.1	4.1	7.0	2.5	6.4	2.5	5.7	5.5	8.4	14.5	3.2	2.0	2.2	2.6	17.2	1.8	2.4	1.8	9.4	2.3	5.9	0.0	20.1	30.5	5.5	3.2	4.1	2.1	5.2	2.5	3.6	5.1	15.1	0.0	6.2	5.0	11.3	8.2	5.2	1.8	5.7	1.2	13.9	3.6	1.9
PON1	"ESA, PON"	ENSG00000005421	"Paraoxonase 1"	P27169	7	95297676-95324532	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	103	"liver: 531.8"	"Cell type enriched"	"Detected in some"	23	"Hepatocytes: 440.0"	"Cancer enriched"	"Detected in some"	78	"liver cancer: 97.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001610	Approved				"Secreted to blood"	NA	NA	96000000000	17000000000		"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"			"HPA001610: AB_1079656"	"unprognostic (2.02e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.70e-1)"		"prognostic favorable (7.24e-7)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.97e-2)"	"unprognostic (6.74e-9)"	"unprognostic (1.09e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.54e-3)"	0.0	4.1	0.6	0.0	0.5	0.0	0.1	0.6	0.6	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.5	0.6	0.2	531.8	0.1	0.0	0.5	0.5	0.6	0.1	0.0	0.8	0.0	0.5	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.3	0.6	5.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.6	0.6	0.5	0.6	0.5	0.5	0.5	0.3	0.6	0.6	0.0	0.0	1.5	7.2	1.1	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.6	18.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.4	3.0	13.5	0.2	0.2	0.0	0.2	0.0	0.3	0.0	0.1	8.9	440.0	0.0	0.0	0.2	0.2	0.0	13.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	2.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	1.6	0.5	0.4	0.2	0.0	0.1	0.0	0.6	0.5	0.3	0.1
POP1		ENSG00000104356	"POP1 homolog, ribonuclease P/MRP subunit"	Q99575	8	98117293-98159835	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066194			Supported	Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA066194: AB_2732742"	"prognostic unfavorable (2.54e-4)"	"unprognostic (9.42e-2)"	"unprognostic (5.96e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (1.26e-6)"	"prognostic unfavorable (9.88e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.96e-1)"	2.1	1.6	1.7	3.5	1.5	1.5	2.1	3.4	2.3	1.4	1.2	1.9	1.5	1.7	1.4	3.0	1.8	1.3	1.6	1.3	1.2	2.0	1.9	1.6	3.6	1.1	1.4	2.9	1.7	1.7	1.5	1.2	1.1	1.5	4.8	2.4	1.4	1.3	1.7	3.0	1.6	1.8	0.8	2.1	1.9	3.1	1.6	2.6	1.5	1.2	4.4	2.5	1.5	1.8	21.9	12.9	13.8	12.8	4.8	3.3	9.1	18.3	15.2	18.7	13.8	13.4	13.8	15.3	25.6	12.9	9.0	14.3	40.3	18.2	18.9	11.1	17.0	30.0	10.2	9.2	2.1	16.4	18.4	2.8	3.3	20.8	8.2	5.7	14.8	7.2	17.0	13.5	17.7	17.4	23.8	8.3	10.4	25.1	17.6	19.4	7.5	11.0	13.5	11.5	32.8	7.7	8.4	14.2	6.4	7.9	19.2	6.0	18.4	16.3	11.6	20.8	36.5	13.3	13.6	32.7	12.8	17.3	14.6	9.4	5.1	3.9	7.4	5.7	6.0	4.9	5.4	5.0	5.0	8.1	6.8	6.5	0.8	3.8	2.9	6.2	4.9	2.1	1.7	1.5	3.4	2.3	1.3	1.2	1.1	1.4	1.1	0.8	1.6	1.8	2.3	3.2	3.9	10.7	4.7	3.7	8.2	3.8	4.0	7.0	2.5	2.3	3.9	0.0	3.8	5.5	0.0	4.1	4.1	2.7	5.9	8.8	13.8	2.4	6.4	4.2	0.0	5.0	17.7	5.9	3.4	5.8	6.6	2.9	1.3	5.9	1.8	5.4	3.4	1.7	19.0	1.7	2.0	2.4	0.8	3.0	5.3	3.3	0.0	3.7	7.9	2.7	10.3	8.5	11.0	7.8	1.0	4.5	5.2	4.8	1.1	8.5	2.6	9.5	6.6	4.0	6.1	7.7	19.1	9.8	2.4	3.0	4.4	6.1	3.9	5.1
POR	"CYPOR, FLJ26468"	ENSG00000127948	"Cytochrome p450 oxidoreductase"	P16435	7	75899200-75986855	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Congenital adrenal hyperplasia, Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 313.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 489.2;Proximal enterocytes: 274.2;Theca cells: 647.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 328.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004372, HPA010136"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		12000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Vesicles"	Cytosol	"CAB004372: AB_627391, HPA010136: AB_1079657"	"unprognostic (1.89e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.94e-2)"	"unprognostic (9.89e-2)"	53.4	197.4	19.9	32.1	20.7	17.9	44.7	14.1	18.6	42.0	15.5	35.9	105.2	32.1	29.4	53.6	50.2	37.0	43.3	20.7	30.2	38.1	313.3	55.0	19.9	22.2	24.5	52.2	44.5	77.6	71.4	46.3	20.9	31.8	21.9	12.7	29.9	113.1	56.2	43.8	92.4	28.2	16.9	43.8	41.5	25.5	34.7	38.0	131.3	68.1	23.2	36.6	42.3	15.3	59.6	133.0	57.0	106.3	212.9	79.8	98.0	24.4	79.3	44.7	62.3	100.7	257.0	56.1	21.9	53.1	151.8	28.3	76.0	38.4	19.6	48.1	57.9	26.0	36.9	189.4	146.5	26.2	45.5	163.9	47.4	59.2	43.2	36.3	42.3	27.1	79.1	24.0	40.8	90.9	29.0	49.4	71.7	92.9	74.8	41.0	37.6	61.1	50.0	72.8	59.3	57.4	65.4	328.4	91.0	32.6	94.0	44.2	38.6	41.7	45.8	63.6	48.7	23.8	38.3	39.0	59.3	39.8	54.9	65.9	42.6	60.4	20.6	39.6	17.1	11.0	17.5	19.4	45.6	11.2	17.1	14.7	53.8	25.9	30.2	12.5	19.3	36.6	19.9	20.7	14.1	18.6	20.7	30.2	22.2	24.5	20.9	16.9	34.7	15.3	34.3	38.5	39.7	23.2	17.1	17.1	29.4	172.3	13.1	31.4	20.5	14.0	10.9	54.3	201.4	73.5	12.5	99.9	26.0	97.7	1.9	65.0	27.6	62.1	28.0	27.1	19.8	11.8	10.1	29.4	95.0	40.1	67.8	46.6	24.7	121.4	32.2	489.2	67.8	15.2	17.1	41.7	124.1	35.2	16.1	9.5	75.8	47.3	12.4	11.2	20.5	25.9	12.3	11.6	8.8	27.9	102.0	112.5	17.0	20.7	274.2	31.7	178.6	23.0	65.7	32.7	46.9	21.3	30.8	18.2	14.6	193.2	25.4	647.6	44.5	45.9
PORCN	"DHOF, MG61, por, PORC, PPN"	ENSG00000102312	"Porcupine O-acyltransferase"	Q9H237	X	48508962-48520814	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 37.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 68.5;Club cells: 44.2;Pancreatic endocrine cells: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 176.9;LHCN-M2: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049215, HPA058413"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA049215: , HPA058413: AB_2683711"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.35e-1)"	5.2	37.3	8.7	3.3	8.3	2.9	4.7	7.0	10.6	9.1	4.5	6.3	2.3	7.1	2.1	10.8	5.8	4.6	11.5	11.2	7.0	3.7	1.5	4.6	3.6	7.1	6.6	4.3	3.5	9.8	4.7	2.4	7.2	4.5	1.6	7.4	4.9	11.6	7.6	5.9	3.7	4.6	6.2	4.5	5.2	5.1	7.7	2.3	6.3	3.5	3.3	6.2	7.1	7.8	13.1	15.6	3.8	26.6	15.9	9.4	1.6	3.7	7.7	5.8	3.9	1.8	19.7	1.1	15.9	8.3	6.5	17.3	5.5	176.9	1.8	8.3	1.8	2.2	9.0	3.8	23.4	2.0	22.5	12.2	20.6	16.8	36.0	13.5	5.3	6.4	1.0	12.1	60.8	3.7	2.0	2.8	4.9	4.0	10.4	4.0	4.6	20.5	9.8	5.1	4.2	6.5	30.8	5.9	5.9	2.5	6.7	1.0	3.3	15.0	7.8	36.4	6.8	10.4	6.3	1.5	43.0	4.9	8.7	16.9	5.5	6.8	10.8	4.9	8.5	3.2	7.1	9.0	6.8	3.5	4.7	7.1	1.1	8.4	4.3	3.6	4.9	4.7	8.7	8.3	7.0	10.6	11.2	7.0	7.1	6.6	7.2	6.2	7.7	7.8	5.4	6.4	2.8	5.2	3.8	4.0	5.3	68.5	8.0	15.4	2.9	4.6	3.4	4.3	44.2	16.5	18.8	0.3	7.3	0.8	1.9	6.9	0.2	13.4	3.5	5.7	6.0	1.3	7.8	9.9	1.3	5.0	3.6	17.8	5.7	3.9	5.0	0.7	3.5	8.4	7.6	2.9	12.2	2.7	4.5	0.1	5.6	2.5	3.6	2.8	3.1	10.1	10.3	6.0	2.8	36.4	1.8	4.1	6.3	2.5	0.2	0.7	8.7	15.5	6.6	4.0	4.8	2.9	4.9	4.2	3.8	8.2	6.9	7.5	1.5	6.6
PPA2	FLJ20459	ENSG00000138777	"Inorganic pyrophosphatase 2"	Q9H2U2	4	105369077-105474067	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030888, HPA031671, HPA031672"	Supported		Approved	Mitochondria		NA	NA		150000	"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA030888: AB_2673646, HPA031671: AB_10603986, HPA031672: AB_2673988"	"prognostic unfavorable (2.98e-4)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.60e-4)"	"unprognostic (9.26e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.54e-2)"	"prognostic favorable (1.27e-11)"	"unprognostic (3.69e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	7.4	12.8	23.8	9.0	24.6	22.0	12.0	24.3	53.7	7.4	29.5	17.4	14.2	7.4	12.5	10.8	8.4	8.0	27.5	23.7	26.3	20.7	14.8	7.5	8.3	24.4	24.3	5.8	11.8	11.7	7.7	7.4	24.5	13.3	14.0	13.6	13.8	5.7	27.6	12.2	13.8	6.8	24.0	9.9	12.6	6.3	25.4	7.0	11.5	35.5	8.7	8.1	6.7	26.6	20.6	8.5	18.5	32.3	11.3	9.1	12.9	10.2	15.7	14.6	9.9	22.2	30.4	15.6	14.5	9.7	11.3	9.5	39.2	18.7	17.0	23.6	11.8	13.5	13.7	19.9	9.3	36.7	13.6	9.7	19.6	9.9	7.9	15.4	14.6	28.4	22.3	22.0	12.5	26.2	32.5	26.6	13.9	42.4	28.3	28.2	10.9	17.9	49.7	14.7	17.8	10.7	7.8	48.9	19.0	10.7	24.8	32.1	6.9	9.2	19.2	8.9	20.0	19.0	27.3	18.4	17.5	18.6	14.1	27.0	20.9	15.4	21.0	30.1	18.6	28.5	21.7	23.7	49.9	22.6	21.1	23.9	9.5	36.4	26.4	25.9	23.4	23.5	23.8	24.6	24.3	53.7	23.7	26.3	24.4	24.3	24.5	24.0	25.4	26.6	26.7	9.6	67.3	86.2	37.6	50.0	82.4	205.0	38.1	29.7	64.8	40.9	63.3	45.8	126.2	33.1	16.7	119.0	25.9	73.3	264.1	114.0	113.7	42.3	35.3	36.3	65.7	70.2	138.2	120.1	98.5	31.1	37.2	42.3	45.6	26.4	24.3	64.2	83.5	21.9	134.6	104.6	142.4	42.9	86.1	126.4	27.7	47.1	76.5	74.9	50.5	39.2	30.9	169.9	145.7	65.0	90.4	32.4	41.9	68.1	112.2	285.4	90.7	22.6	39.5	46.3	43.6	50.8	10.8	59.1	57.7	84.7	34.3	72.1	138.0	94.6
PPCS	FLJ11838	ENSG00000127125	"Phosphopantothenoylcysteine synthetase"	Q9HAB8	1	42456117-42473385	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 397.2;Proximal tubular cells: 316.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031361, HPA031363"	Approved		Approved	Mitochondria		NA	NA		17000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA031361: AB_10602150, HPA031363: AB_2673844"	"unprognostic (1.49e-1)"	"unprognostic (6.71e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.84e-3)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (5.96e-5)"	"unprognostic (2.71e-1)"	"unprognostic (7.79e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.30e-2)"	51.0	62.7	28.2	34.6	29.3	27.1	65.0	29.8	34.6	44.2	36.8	63.5	58.0	35.8	71.0	48.4	31.7	43.1	42.5	28.6	32.0	88.1	99.6	39.8	43.5	30.1	28.8	30.2	66.9	59.8	27.8	38.0	29.1	52.3	58.0	22.4	59.3	44.2	45.9	47.0	56.4	29.0	31.6	42.2	64.7	15.0	29.9	27.8	64.8	40.4	38.2	43.3	40.1	32.9	83.4	34.3	17.2	28.8	52.3	55.0	72.1	40.7	43.3	49.1	44.2	30.7	93.3	22.6	80.7	46.2	30.3	48.8	11.5	62.5	40.3	66.2	35.1	39.9	34.7	31.3	72.5	39.9	69.4	48.8	98.9	35.8	62.4	58.2	48.3	29.9	16.9	17.0	50.5	47.3	20.4	40.1	22.6	70.0	49.8	22.6	18.8	45.3	106.2	70.7	23.0	25.0	47.9	113.2	129.4	50.2	56.7	167.8	31.1	28.2	41.1	42.9	46.5	58.6	37.3	17.5	12.6	44.4	61.0	298.8	231.5	325.6	114.5	245.4	135.2	171.5	141.1	128.0	195.9	182.4	149.5	132.9	159.5	185.6	237.2	135.8	160.9	262.8	28.2	29.3	29.8	34.6	28.6	32.0	30.1	28.8	29.1	31.6	29.9	32.9	61.0	57.7	84.1	5.9	62.6	23.3	42.3	99.4	42.7	12.1	91.3	100.2	104.3	84.4	90.8	64.4	6.2	172.2	52.6	129.2	397.2	96.5	3.5	66.7	43.9	48.7	31.3	29.0	7.4	136.8	131.0	52.9	61.7	59.3	57.0	52.8	44.6	120.1	107.4	11.8	7.0	124.9	103.7	84.4	44.3	4.6	60.6	76.3	81.8	6.5	127.0	64.8	79.3	8.0	8.7	98.5	125.2	63.6	41.8	51.7	159.7	316.3	63.2	28.0	26.3	26.2	48.9	10.3	20.8	66.3	36.2	134.6	62.5	103.2	101.2	60.1
PPIB	"B, CYP-S1, CYPB, OI9, PPIase, SCYLP"	ENSG00000166794	"Peptidylprolyl isomerase B"	P23284	15	64155740-64163134	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Isomerase, Rotamase"	"Disease variant, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 1473.7;Plasma cells: 2242.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011487, HPA012720"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Secreted to blood"	No	No		33000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"	Nucleoplasm	"CAB011487: AB_443295, HPA012720: AB_1847399"	"unprognostic (3.00e-3)"	"unprognostic (5.65e-3)"	"unprognostic (2.81e-1)"	"prognostic favorable (1.56e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.02e-11)"	"unprognostic (7.05e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-2)"	375.5	377.5	230.7	449.5	240.3	571.9	361.9	247.9	259.2	611.5	257.2	401.0	365.0	383.9	899.0	298.8	401.5	379.2	262.0	229.7	256.9	312.3	737.4	351.1	344.5	258.1	241.4	386.2	644.2	345.4	416.8	515.2	255.1	375.7	411.3	72.3	513.1	488.6	62.2	205.5	334.3	482.4	247.0	360.5	375.0	110.0	254.9	315.6	672.8	91.1	346.4	510.9	295.6	262.6	675.6	847.9	736.7	1666.7	2577.0	1492.3	641.9	1570.3	2108.3	1248.7	1472.3	1242.6	1223.1	653.6	1227.4	2513.0	1235.3	1067.7	1384.6	1080.4	641.1	406.2	491.0	914.5	915.3	1643.7	2682.9	915.0	778.1	1374.2	1149.4	725.9	1751.3	1516.7	1539.2	301.1	645.9	2174.7	966.0	1102.6	280.6	1404.9	625.1	1879.0	529.5	520.6	784.1	3347.9	1312.7	1062.6	410.5	647.7	726.0	1224.5	1194.2	1086.0	727.6	2767.0	927.6	1213.7	975.8	679.2	1079.4	1152.5	1269.5	693.4	1129.0	1478.0	1238.2	716.7	712.5	491.7	929.6	547.3	931.8	827.8	645.0	762.4	930.9	541.4	411.3	558.0	347.5	668.1	369.3	2643.5	569.3	1512.3	230.7	240.3	247.9	259.2	229.7	256.9	258.1	241.4	255.1	247.0	254.9	262.6	389.3	125.0	209.0	16.6	375.3	160.2	426.2	614.6	234.5	34.5	264.3	303.8	0.8	270.2	328.7	272.2	31.3	625.9	560.0	271.0	90.1	665.1	19.0	295.8	910.1	285.0	297.0	172.6	10.2	566.4	1473.7	627.8	441.4	494.2	181.2	540.4	322.7	473.2	630.1	45.4	15.8	603.9	205.4	216.9	333.4	29.5	456.3	316.6	281.1	19.7	299.1	149.1	368.7	35.2	37.0	435.1	338.9	393.1	2242.6	569.3	338.6	287.4	168.2	43.7	230.1	204.3	445.6	38.4	76.6	337.0	144.8	1118.9	352.3	674.0	477.2	422.3
PPIP5K2	"CFAP160, DFNB100, HISPPD1, KIAA0433, VIP2"	ENSG00000145725	"Diphosphoinositol pentakisphosphate kinase 2"	O43314	5	103120149-103212799	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Hearing	"Kinase, Transferase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 160.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037895, HPA038442"	Approved		Approved	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA037895: AB_2675724, HPA038442: AB_10673173"	"unprognostic (2.18e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.59e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (8.80e-2)"	15.7	19.1	6.8	22.0	7.9	51.6	25.1	18.9	13.9	22.2	5.8	28.1	18.3	20.6	21.2	17.1	14.5	20.4	19.5	6.7	8.9	20.3	29.2	16.2	25.5	15.4	11.9	26.1	26.7	23.0	18.1	16.7	15.1	16.3	25.5	19.2	17.1	15.4	4.2	17.2	16.5	18.4	6.1	23.9	22.5	15.1	7.3	27.9	23.3	7.7	24.5	17.8	13.9	10.7	27.4	25.3	50.8	65.2	40.8	53.4	47.8	63.5	39.3	34.2	47.6	20.9	48.3	67.6	56.2	60.9	52.7	16.5	43.9	33.2	57.5	53.7	23.5	84.7	44.3	33.4	29.0	72.1	70.4	34.5	23.4	52.0	46.1	31.2	40.0	42.5	84.9	57.0	53.1	21.3	60.9	44.6	55.4	12.7	64.4	58.6	46.7	89.3	36.8	31.5	29.6	40.1	43.5	39.9	40.7	34.0	33.5	48.9	42.7	55.8	25.7	56.0	45.1	38.1	87.3	91.3	31.5	116.0	51.2	41.7	21.5	39.6	13.0	22.9	15.8	19.5	12.6	14.2	25.6	16.1	16.1	17.0	19.7	17.8	32.4	15.5	12.3	11.1	6.8	7.9	18.9	13.9	6.7	8.9	15.4	11.9	15.1	6.1	7.3	10.7	35.8	48.1	23.1	49.3	39.3	13.6	12.8	13.7	31.9	38.5	26.1	26.4	48.9	18.6	29.6	16.5	45.9	12.7	35.7	29.7	5.9	11.6	5.6	25.4	44.7	28.7	16.3	70.7	88.4	17.0	19.2	33.0	33.6	30.6	43.6	49.2	14.6	20.6	30.6	16.8	160.3	24.2	16.2	39.5	22.4	6.7	29.5	43.3	12.4	49.6	47.5	14.5	27.8	62.8	67.0	16.9	19.1	23.7	56.6	12.1	13.3	22.6	25.1	25.2	6.6	30.3	28.1	39.7	21.6	31.6	15.8	26.0	31.6	38.7	30.1	12.6
PPM1D	"PP2C-DELTA, Wip1"	ENSG00000170836	"Protein phosphatase, Mg2+/Mn2+ dependent 1D"	O15297	17	60600183-60666280	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022277, HPA061848"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA022277: AB_1858839, HPA061848: "	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.98e-1)"	4.4	2.4	2.7	2.2	5.2	5.9	3.9	14.8	4.6	4.5	5.0	3.1	2.9	4.3	2.9	3.5	3.7	3.1	2.9	3.3	3.4	2.8	2.8	3.6	2.7	4.0	3.5	6.3	3.3	2.3	2.4	5.9	4.7	3.1	3.5	6.4	3.1	2.2	4.0	2.9	2.7	3.0	3.4	3.8	2.7	5.5	3.7	4.4	2.9	3.1	2.3	2.8	4.0	9.1	3.8	6.9	7.5	6.4	5.0	3.1	10.7	5.8	3.6	3.4	4.9	7.1	2.0	9.9	4.5	3.7	1.3	3.4	4.9	2.2	4.6	1.9	11.1	7.4	6.7	8.1	4.2	2.9	5.3	2.7	3.6	5.1	3.0	2.8	7.9	4.1	5.4	4.0	3.7	34.4	8.1	4.4	3.5	3.4	5.2	9.5	9.6	6.6	3.1	4.2	10.5	7.4	7.1	2.4	1.6	8.0	2.8	3.9	5.7	4.7	12.5	3.5	3.3	6.7	7.7	7.3	1.7	2.9	3.8	9.9	16.1	18.0	7.6	12.5	6.8	8.9	6.3	7.0	16.0	6.2	6.8	7.0	24.7	8.6	8.1	7.0	10.6	9.8	2.7	5.2	14.8	4.6	3.3	3.4	4.0	3.5	4.7	3.4	3.7	9.1	40.9	32.1	7.7	15.0	23.1	21.0	6.2	3.3	52.3	13.1	14.2	9.8	6.3	8.6	4.6	5.5	4.2	17.6	19.4	15.0	3.9	6.6	68.9	14.0	15.5	25.2	14.4	14.1	19.6	6.6	6.4	14.7	10.2	15.6	1.3	7.2	23.6	4.2	8.8	3.3	20.8	11.4	6.1	21.4	19.2	12.8	13.7	16.1	3.6	28.1	12.3	7.0	6.2	20.6	38.6	5.4	10.2	7.5	24.5	7.8	8.7	5.1	3.6	10.4	0.0	12.1	14.0	43.8	15.0	34.4	18.0	38.6	18.1	6.0	11.5	7.7
PPM1K	"BDP, DKFZp761G058, hPTMP, PP2Ckappa, PP2Cm"	ENSG00000163644	"Protein phosphatase, Mg2+/Mn2+ dependent 1K"	Q8N3J5	4	88257620-88284769	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 92.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 512.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 58.0;Karpas-707: 48.6;U-698: 48.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020066, HPA020862, HPA023891"	Approved		Supported	Mitochondria		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA020066: AB_1855628, HPA020862: AB_1855629, HPA023891: AB_1855630"	"unprognostic (2.38e-2)"	"unprognostic (5.86e-2)"	"unprognostic (7.42e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.25e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.28e-1)"	5.3	8.5	23.3	14.9	26.3	9.9	14.5	22.5	31.2	19.4	22.0	5.9	4.4	32.7	7.6	11.2	21.5	8.9	92.5	26.5	23.9	17.8	7.6	9.7	25.6	19.9	22.3	32.5	11.1	12.5	9.9	9.7	22.9	16.2	6.0	14.2	11.8	7.1	14.2	2.6	10.4	26.6	22.1	18.9	8.0	19.9	27.7	15.2	7.9	11.5	25.8	8.9	11.7	33.2	4.6	1.5	5.7	10.1	8.3	10.9	2.3	7.2	13.0	23.3	27.4	11.6	1.1	58.0	7.7	4.6	11.5	0.5	17.0	5.4	9.1	44.9	7.1	10.8	5.0	10.8	6.6	14.6	5.3	7.2	2.7	14.5	12.5	4.9	4.2	25.4	15.5	48.6	7.0	6.5	20.3	7.9	3.4	3.5	2.3	10.8	9.3	21.9	8.1	2.0	4.4	3.9	4.6	0.5	5.4	9.6	23.2	3.9	0.8	8.3	4.2	2.8	4.1	15.6	15.0	48.3	9.1	11.7	14.0	24.7	9.9	8.1	39.4	12.0	51.4	102.9	37.1	39.9	18.6	113.5	36.3	44.2	3.2	27.6	3.6	131.3	46.9	24.5	23.3	26.3	22.5	31.2	26.5	23.9	19.9	22.3	22.9	22.1	27.7	33.2	20.7	48.1	12.4	105.4	124.8	9.8	15.8	5.7	29.6	109.5	42.8	25.7	512.1	8.6	13.7	49.7	18.8	11.5	153.0	0.8	156.5	7.0	7.9	9.7	37.2	27.2	9.6	34.3	89.5	6.2	3.2	42.9	8.2	20.0	19.0	32.2	24.7	30.2	28.9	85.8	145.6	16.5	4.1	14.5	16.4	10.5	23.9	27.5	21.4	40.3	75.6	21.8	80.3	100.0	54.7	4.6	9.2	31.6	82.7	32.1	8.2	47.6	19.5	14.8	26.3	38.5	36.4	38.2	22.9	71.4	5.4	2.9	70.1	45.4	4.1	6.7
PPOX	"PPO, VP"	ENSG00000143224	"Protoporphyrinogen oxidase"	P50336	1	161166056-161178013	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 65.9;Respiratory ciliated cells: 84.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030123	Uncertain		Approved	Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	"Vesicles, Cytosol"	"HPA030123: AB_10603987"	"unprognostic (1.17e-1)"	"unprognostic (4.73e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.64e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.18e-3)"	"unprognostic (7.12e-3)"	"prognostic unfavorable (9.89e-4)"	"unprognostic (6.12e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.80e-2)"	9.3	17.1	24.2	3.5	24.5	25.2	10.3	25.2	38.2	14.5	24.7	12.7	3.9	10.9	8.3	8.9	22.0	4.7	13.1	24.4	24.7	15.5	11.5	8.6	5.7	25.0	25.0	13.8	10.8	7.2	13.7	6.5	24.6	13.4	3.9	12.6	8.7	7.7	7.6	11.2	8.5	6.6	25.0	13.6	10.9	6.9	24.0	5.0	11.9	5.6	5.2	11.6	9.6	25.4	10.0	8.0	12.7	8.5	10.4	9.3	3.5	5.9	5.7	7.5	10.3	10.4	9.3	7.4	14.3	5.3	4.1	6.3	9.8	8.8	7.1	4.6	20.3	9.0	18.9	23.9	8.6	3.0	4.6	7.6	11.0	6.3	9.4	9.4	14.7	7.0	22.8	11.2	5.6	9.2	12.0	8.6	8.2	11.2	18.8	13.6	8.2	16.7	15.1	4.2	9.8	14.7	6.6	10.3	12.0	14.6	19.9	9.5	5.7	6.5	7.1	6.5	7.5	19.4	15.3	10.5	6.8	6.0	4.9	6.3	7.2	5.3	10.4	7.6	7.2	9.0	7.8	7.6	10.4	8.2	6.8	6.9	2.9	12.0	5.2	6.6	16.1	7.8	24.2	24.5	25.2	38.2	24.4	24.7	25.0	25.0	24.6	25.0	24.0	25.4	10.9	3.2	13.7	10.4	9.8	12.0	8.3	16.6	9.1	18.0	12.1	14.1	10.1	4.3	15.6	7.3	22.9	21.4	10.6	3.6	21.5	9.5	9.8	39.1	5.9	8.3	6.0	65.9	5.9	5.6	9.4	9.1	5.1	4.6	6.3	12.3	8.9	6.1	9.3	15.2	7.5	7.3	26.4	4.7	8.4	12.1	10.2	8.0	1.8	5.6	8.1	10.4	8.2	9.0	8.9	6.3	3.8	6.8	16.9	3.2	6.6	17.2	84.4	20.9	6.6	9.6	15.6	12.8	9.3	7.2	14.9	10.4	10.6	11.1	7.5	6.2
PPP1CB	"MP, PP-1B, PP1B, PP1beta, PP1c, PPP1beta"	ENSG00000213639	"Protein phosphatase 1 catalytic subunit beta"	P62140	2	28751640-28802940	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 985.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022558, HPA065425, CAB069426"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3800000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022558: , CAB069426: , HPA065425: AB_2685489"	"unprognostic (2.90e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.52e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.26e-2)"	90.9	75.2	55.8	74.7	73.5	119.1	110.5	55.6	74.9	148.6	67.8	109.2	84.8	138.4	104.0	245.7	113.5	103.1	185.2	54.3	73.8	84.4	70.5	73.3	60.4	73.9	61.2	92.7	76.2	126.9	45.9	74.8	74.5	149.1	92.9	70.8	114.6	123.4	386.0	73.7	76.0	159.7	71.8	65.8	81.7	47.6	63.5	71.3	78.8	262.8	91.1	118.0	104.1	88.2	186.0	114.6	391.1	121.7	130.8	121.0	227.0	97.7	110.6	92.2	91.0	102.6	106.9	147.5	119.2	101.5	102.7	111.4	112.6	129.9	109.8	235.9	58.2	111.3	130.1	111.5	284.3	127.8	50.5	93.5	181.3	100.1	207.8	97.4	113.8	77.0	103.6	140.4	123.3	93.2	136.9	110.3	128.3	141.8	89.8	132.2	344.9	112.7	304.3	220.6	106.7	131.3	151.4	166.2	136.2	111.4	80.4	70.6	137.6	122.6	134.6	89.3	119.0	100.4	171.0	299.8	130.1	135.0	93.5	72.4	59.4	84.9	39.8	96.7	50.8	38.6	59.3	46.8	65.4	31.6	51.8	58.8	103.6	61.4	115.2	49.8	74.3	52.8	55.8	73.5	55.6	74.9	54.3	73.8	73.9	61.2	74.5	71.8	63.5	88.2	172.2	93.0	80.6	59.4	147.8	492.1	176.7	101.5	64.9	62.4	208.0	117.0	352.1	112.9	124.1	310.8	27.1	129.6	210.4	324.5	244.6	297.0	514.0	330.2	245.7	129.3	283.0	200.2	68.5	210.5	202.1	147.8	78.5	258.9	146.6	91.2	137.8	108.7	114.7	163.2	71.8	144.2	111.9	182.6	985.1	406.2	196.7	238.1	336.2	59.0	137.9	116.6	55.6	64.3	68.4	236.8	181.3	302.0	100.9	364.9	106.6	227.4	213.3	65.2	631.1	225.8	264.8	55.2	66.6	135.6	458.0	392.9	237.7	65.8	154.4	498.9
PPP2CA	"PP2AC, PP2Calpha"	ENSG00000113575	"Protein phosphatase 2 catalytic subunit alpha"	P67775	5	134194332-134226073	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Meiosis	"Hydrolase, Protein phosphatase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003848, HPA043236"	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB003848: AB_562203, HPA043236: AB_2678379"	"unprognostic (1.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.59e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.57e-1)"	47.9	53.1	52.1	42.9	55.1	124.8	46.6	60.6	66.3	38.9	44.9	51.4	46.1	46.6	36.1	71.5	39.0	44.6	90.1	57.8	53.5	57.3	62.1	39.4	58.6	48.6	51.4	30.0	44.3	87.1	26.1	52.2	53.7	37.8	47.1	58.6	36.5	40.4	75.3	54.1	44.5	57.8	54.7	40.0	41.3	34.7	53.6	92.4	48.1	73.1	76.7	75.4	41.0	59.5	157.0	128.8	180.8	97.9	92.1	98.2	126.2	144.1	123.3	214.8	215.4	249.1	119.6	136.5	131.7	134.4	242.9	79.7	175.6	208.6	250.2	123.9	100.1	96.9	142.4	156.5	136.3	97.1	84.2	91.7	141.5	169.0	166.6	107.0	153.5	135.1	97.2	99.1	165.1	112.5	154.9	95.0	98.9	123.6	77.3	136.5	179.6	132.6	130.0	173.4	142.9	99.6	148.9	55.1	166.9	179.7	112.2	112.3	109.2	123.3	69.1	99.6	206.5	88.5	171.6	217.0	83.2	125.9	130.3	43.0	64.7	75.6	46.8	63.1	59.2	53.1	53.2	62.5	77.3	54.7	60.6	57.2	71.3	75.5	67.0	41.5	72.4	95.8	52.1	55.1	60.6	66.3	57.8	53.5	48.6	51.4	53.7	54.7	53.6	59.5	58.7	51.3	47.6	27.1	103.3	239.0	187.4	90.1	121.8	43.9	93.6	53.0	111.2	55.8	63.1	57.0	22.9	152.1	89.0	68.7	107.6	109.7	34.6	85.8	83.2	81.1	87.1	89.0	36.6	87.6	171.3	78.0	77.5	106.1	62.2	44.6	51.8	65.9	111.4	50.5	35.7	62.0	69.2	88.2	194.6	29.8	38.5	95.8	104.9	24.4	115.6	62.9	51.5	36.7	48.9	101.7	56.6	45.5	120.9	143.3	64.9	114.8	53.0	31.4	19.7	76.8	97.6	91.4	85.8	112.4	234.4	309.8	110.6	53.3	69.7	176.7
PPP3CA	"CALN, CALNA, CNA1, PPP2B"	ENSG00000138814	"Protein phosphatase 3 catalytic subunit alpha"	Q08209	4	101023409-101348278	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"	"Craniosynostosis, Disease variant, Dwarfism, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 144.1"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 933.8;Inhibitory neurons: 403.0;Oligodendrocyte precursor cells: 348.3"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 98.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012778, CAB018581"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		94000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB018581: AB_2168324, HPA012778: AB_1855660"	"unprognostic (6.66e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.74e-2)"	24.7	17.5	48.5	15.7	144.1	17.2	20.5	63.2	125.6	17.0	0.0	19.5	11.6	11.8	13.1	14.4	13.8	13.3	9.2	97.4	25.0	11.2	17.0	19.9	14.7	14.6	11.0	17.9	9.4	8.9	9.0	13.0	15.7	66.0	16.1	27.6	22.2	38.4	51.2	22.9	12.9	15.5	24.7	14.5	22.4	10.6	23.9	12.8	13.2	29.0	18.3	20.7	16.0	54.3	48.3	33.8	9.3	18.0	50.4	37.9	15.8	51.9	47.8	19.8	21.6	18.3	59.0	22.4	20.9	47.6	25.6	23.5	33.3	69.6	34.9	56.0	15.1	35.4	45.8	25.2	36.8	59.0	17.8	39.6	35.6	45.3	51.4	39.1	38.8	14.5	14.4	61.1	33.5	58.0	12.2	44.2	15.4	55.7	20.7	22.1	83.2	26.5	20.0	38.3	71.5	26.2	43.1	35.4	24.6	12.5	32.3	33.4	42.1	48.7	54.8	44.7	34.7	28.5	31.5	40.1	26.6	31.5	13.1	82.5	31.0	73.5	35.7	33.1	41.6	74.1	33.2	34.8	28.2	62.8	15.5	31.0	123.7	65.1	45.1	51.9	25.3	21.1	48.5	144.1	63.2	125.6	97.4	25.0	14.6	11.0	15.7	24.7	23.9	54.3	143.3	76.9	58.6	284.1	96.8	168.8	36.2	29.5	34.7	89.8	93.8	51.8	25.0	38.6	21.9	31.3	39.6	39.6	81.4	60.0	33.2	21.3	3.2	39.3	56.2	100.8	127.4	32.0	933.8	31.6	84.0	75.6	59.1	42.8	35.4	22.1	53.2	39.7	38.3	18.5	403.0	44.2	14.2	61.8	135.3	8.4	65.0	58.2	92.5	281.1	64.3	21.2	56.7	348.3	139.1	53.3	115.4	60.9	63.8	127.6	23.9	51.9	25.3	82.9	13.1	66.9	67.5	12.7	26.5	27.9	172.0	27.5	69.1	76.2	55.9	39.5
PPT1	"CLN1, INCL, PPT"	ENSG00000131238	"Palmitoyl-protein thioesterase 1"	P50897	1	40072710-40097260	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 251.9;Kupffer cells: 315.8;Langerhans cells: 328.8;Macrophages: 271.3;monocytes: 227.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 1254.3;eosinophil: 624.2;intermediate monocyte: 1006.3;myeloid DC: 1091.1;neutrophil: 683.9;non-classical monocyte: 815.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 1091.1;granulocytes: 683.9;monocytes: 1254.3"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 1082.7;THP-1: 1449.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021546	Supported		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		240000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"		"HPA021546: AB_1855667"	"unprognostic (5.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (6.98e-8)"	"unprognostic (1.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.08e-2)"	69.8	59.4	92.9	92.7	95.6	117.5	95.7	100.4	135.9	70.1	106.1	50.5	32.1	72.7	60.1	45.1	55.4	57.1	45.3	93.6	101.2	75.8	54.1	128.5	93.9	97.0	96.7	68.6	42.6	79.2	39.0	74.8	99.6	73.4	58.8	89.4	56.8	63.2	21.3	40.3	39.2	95.3	101.6	177.0	45.1	37.6	99.1	78.0	60.0	37.1	75.1	79.1	34.7	113.5	115.6	62.5	93.7	81.0	106.5	92.1	209.8	68.4	127.9	153.0	183.3	350.1	270.5	140.1	118.1	65.2	112.2	209.5	154.9	112.7	163.6	186.4	151.4	100.3	127.2	155.5	137.5	233.7	158.9	103.1	107.5	108.7	126.4	79.7	190.9	108.8	167.7	247.0	80.6	168.1	109.8	88.3	258.3	163.9	93.8	116.0	263.7	226.1	89.2	152.0	114.1	96.9	247.9	1082.7	298.6	111.7	199.3	1449.6	85.2	100.7	147.1	70.7	174.9	161.2	383.8	133.9	109.4	408.7	155.5	85.7	1254.3	624.2	122.2	1006.3	137.9	118.8	171.5	131.3	1091.1	118.6	227.0	168.3	683.9	100.3	815.7	101.8	204.1	1586.9	92.9	95.6	100.4	135.9	93.6	101.2	97.0	96.7	99.6	101.6	99.1	113.5	45.2	28.9	47.7	19.9	33.3	39.6	77.1	30.8	34.7	46.6	55.3	37.5	15.7	41.5	40.0	38.6	16.7	51.7	28.9	4.7	5.9	59.0	64.8	13.8	46.4	49.6	19.9	40.1	28.4	42.1	66.5	56.6	14.8	18.2	84.9	34.6	47.5	9.3	251.9	25.2	39.2	8.1	20.3	315.8	328.8	87.6	31.4	271.3	67.6	31.9	227.2	120.3	28.8	27.6	22.7	22.2	6.0	39.5	34.2	42.4	3.2	18.5	32.3	37.0	19.7	30.5	49.3	17.5	33.0	19.1	27.3	41.2	43.5	39.4	11.4	35.6
PRDM16	"KIAA1675, KMT8F, MEL1, MGC166915, PFM13"	ENSG00000142611	"PR/SET domain 16"	Q9HAZ2	1	3069168-3438621	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 16.2"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 173.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	16	"NK-cell: 2.4"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.8;HHSteC: 2.0;hTERT-RPE1: 6.7;MCF7: 1.6;OE19: 3.5"	"Region enriched"	"Detected in many"	5	"basal ganglia: 15.7"	"Low region specificity"	"Detected in many"			"HPA050343, HPA060467"			Supported	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA050343: AB_2681099, HPA060467: AB_2684287"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.15e-3)"	"unprognostic (5.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.07e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.80e-6)"	"unprognostic (2.14e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (4.06e-2)"	1.6	0.2	3.7	0.5	4.8	0.0	1.1	0.1	4.1	1.3	16.2	1.1	7.4	1.0	2.1	0.3	1.4	1.1	5.4	2.8	0.6	6.8	0.2	2.5	0.5	0.5	1.7	1.5	5.8	0.9	0.6	0.1	0.9	0.7	0.2	0.0	0.4	2.2	0.4	0.5	2.6	0.2	0.0	2.1	9.3	0.7	4.1	0.1	8.0	0.6	0.3	0.9	1.1	1.5	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.3	0.0	0.2	0.0	0.2	0.0	1.3	0.0	0.0	0.1	1.8	0.0	0.0	0.3	2.0	0.0	0.7	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	3.7	4.8	0.1	4.1	2.8	0.6	0.5	1.7	0.9	0.0	4.1	1.5	4.5	35.3	10.5	173.7	0.1	0.6	0.3	2.1	0.6	0.1	0.2	0.3	5.2	22.8	6.3	7.3	0.0	0.0	0.1	0.2	5.9	10.0	0.3	0.2	0.0	2.1	5.4	0.8	1.2	4.9	4.2	0.6	30.5	0.4	0.0	0.3	0.0	0.0	0.0	1.7	1.0	0.9	0.0	0.0	0.4	0.2	1.5	0.1	0.0	14.0	0.0	1.4	0.0	6.6	1.8	7.1	0.8	1.9	0.1	0.8	0.5	0.2	1.9	0.3	0.0	3.3	9.0	0.3	1.8	0.2	0.0	0.0	0.4	0.0	1.5	0.2
PRDM6	"KMT8C, PRISM"	ENSG00000061455	"PR/SET domain 6"	Q9NQX0	5	123089241-123194266	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 4.9;urinary bladder: 9.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 15.0;Endometrial stromal cells: 6.5;Excitatory neurons: 7.9;Fibroblasts: 10.7;Late spermatids: 7.1;Oligodendrocytes: 11.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;HEK 293: 5.2;HEL: 1.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"spinal cord: 2.3"	HPA030324	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA030324: AB_10670032"	"unprognostic (2.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.12e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-7)"	"unprognostic (9.30e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-4)"	"unprognostic (1.27e-1)"	0.7	0.1	0.2	0.3	0.2	0.0	0.6	0.2	0.3	0.9	0.6	4.9	0.2	0.7	0.1	0.6	0.4	3.3	0.5	0.1	0.2	0.3	0.1	2.9	0.0	0.3	0.4	1.9	0.3	0.1	0.3	4.2	0.4	1.3	1.0	0.2	0.1	0.1	0.1	0.2	0.6	0.7	0.3	0.0	0.6	0.3	0.2	0.0	0.8	0.2	0.2	9.0	0.6	0.3	0.0	0.0	0.0	0.3	0.3	0.4	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.7	0.0	0.0	0.1	5.2	1.1	0.5	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.2	0.0	0.8	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.1	0.2	0.3	0.4	0.4	0.3	0.2	0.3	0.5	0.0	0.0	15.0	0.0	1.9	0.1	0.0	0.0	1.0	0.6	0.3	1.4	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.1	3.3	0.6	6.5	0.5	0.0	0.0	7.9	0.2	0.3	10.7	0.0	0.5	0.0	2.4	0.0	0.5	0.8	0.0	6.4	0.1	0.0	0.8	3.5	7.1	2.1	0.4	3.6	4.7	0.8	0.2	0.0	3.0	11.0	0.1	0.0	1.2	0.1	0.2	0.0	0.8	0.2	1.0	0.0	0.7	2.2	2.3	4.4	0.2	1.3	0.4	0.4	6.1	0.0	0.1
PREPL	KIAA0436	ENSG00000138078	"Prolyl endopeptidase like"	Q4J6C6	2	44316281-44361862	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 243.1;Inhibitory neurons: 219.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063238	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA063238: AB_2684967"	"unprognostic (5.60e-3)"	"unprognostic (9.81e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.22e-1)"	"unprognostic (8.53e-2)"	"unprognostic (5.98e-3)"	"unprognostic (4.38e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.75e-1)"	26.2	50.9	64.6	18.4	67.4	5.5	31.9	42.9	133.1	35.9	27.5	24.4	26.1	47.2	70.9	22.9	33.6	28.4	62.7	73.1	93.1	62.5	21.6	24.5	17.4	45.3	26.0	49.8	25.2	54.4	52.5	21.4	41.7	37.3	29.4	123.8	26.2	33.1	34.3	22.3	27.9	34.1	34.0	23.1	26.4	28.2	53.4	19.1	61.3	51.3	17.9	23.6	23.9	58.4	41.2	31.7	35.3	45.3	55.7	58.0	26.8	45.1	34.6	32.0	27.4	34.1	28.4	52.3	61.2	47.5	36.6	34.6	50.6	33.0	61.0	48.7	36.2	35.5	24.2	26.3	40.0	35.8	32.5	37.9	64.6	61.8	50.1	62.9	31.4	24.3	45.6	72.6	43.6	22.2	39.1	17.4	33.4	52.8	35.1	30.1	42.8	38.0	61.4	24.0	58.3	46.5	28.9	30.6	67.4	33.9	41.4	27.6	32.8	56.3	32.1	44.6	31.0	40.2	28.2	34.3	65.9	40.1	42.5	6.9	4.4	3.5	7.9	4.9	11.2	8.5	7.3	8.5	6.3	7.0	10.7	8.7	1.3	11.1	4.3	2.9	8.8	5.8	64.6	67.4	42.9	133.1	73.1	93.1	45.3	26.0	41.7	34.0	53.4	58.4	16.3	32.1	37.4	83.2	34.0	13.0	16.0	13.2	21.6	89.1	33.4	26.7	88.1	32.9	21.1	64.4	47.9	8.7	30.0	20.4	39.2	17.4	21.1	40.1	36.7	18.7	33.0	13.9	243.1	23.6	4.9	29.5	28.1	32.1	13.3	21.9	16.8	32.8	11.6	144.7	219.9	24.2	18.3	13.5	7.5	10.0	35.4	14.2	17.8	55.3	12.8	41.4	32.0	81.4	126.2	13.6	20.8	33.1	21.8	16.3	12.2	38.8	35.5	63.2	19.7	44.5	27.2	29.2	28.7	16.3	14.8	8.8	29.1	26.0	17.1	10.7
PRF1	"HPLH2, P1, PFP"	ENSG00000180644	"Perforin 1"	P14222	10	70597348-70602759	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Cytolysis		"Cancer-related genes, Disease variant, Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 28.6;lung: 16.5;lymphoid tissue: 49.4"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 542.1;NK-cells: 1231.7;T-cells: 265.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 900.4;MAIT T-cell: 628.8;memory CD8 T-cell: 499.1;naive CD8 T-cell: 313.0;NK-cell: 656.8"	"Group enriched"	"Detected in all"	50	"NK-cells: 656.8;T-cells: 900.4"	"Cell line enriched"	"Detected in some"	11	"HDLM-2: 240.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002436, HPA037940"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2100000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB002436: AB_563955, HPA037940: AB_2675747"	"unprognostic (6.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (1.87e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (6.98e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.69e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (7.38e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.97e-3)"	"unprognostic (5.22e-3)"	5.0	2.0	0.7	7.6	0.7	28.6	2.7	0.7	1.3	1.3	1.3	2.2	2.3	3.5	1.1	1.9	1.9	4.2	2.2	0.6	0.6	1.7	6.3	16.5	20.3	1.4	0.7	1.0	1.0	0.5	0.9	2.7	1.0	1.5	1.4	0.0	2.3	1.2	2.6	0.9	5.2	2.0	1.3	49.4	4.7	0.6	1.0	5.8	2.6	1.5	4.9	3.8	1.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	240.1	0.0	1.4	0.0	7.4	0.0	0.3	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	22.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	5.2	1.9	0.9	900.4	1.7	628.8	4.0	125.8	499.1	2.0	3.5	52.1	313.0	15.4	656.8	2.6	2.9	108.8	587.5	0.7	0.7	0.7	1.3	0.6	0.6	1.4	0.7	1.0	1.3	1.0	1.0	3.1	3.2	13.6	0.0	4.4	0.4	0.1	0.0	0.6	0.0	0.5	0.5	0.8	1.5	2.5	0.0	0.0	0.2	542.1	0.1	0.0	0.3	0.0	0.2	0.3	1.9	0.0	19.0	0.0	0.0	0.1	2.1	7.7	0.4	8.8	0.0	10.8	2.7	0.1	0.0	0.0	0.0	0.0	7.8	2.3	0.0	0.0	5.7	0.0	1.9	7.4	0.0	1231.7	0.0	0.1	0.0	0.0	0.0	88.5	0.1	0.1	1.6	1.5	0.0	0.0	1.1	0.8	0.0	0.0	0.5	0.9	0.7	265.4	0.0	0.1	0.0
PRKACA	PKACa	ENSG00000072062	"Protein kinase cAMP-activated catalytic subunit alpha"	P17612	19	14091688-14118084	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 310.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 116.8;Theca cells: 100.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010361, HPA071185"	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	NA		170000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Cytokinetic bridge"	"CAB010361: AB_2268772, HPA071185: AB_2686356"	"unprognostic (1.08e-1)"	"prognostic favorable (6.28e-6)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (6.26e-5)"	"unprognostic (1.38e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.36e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (6.47e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.66e-2)"	"unprognostic (6.14e-3)"	62.7	126.5	46.6	27.6	47.6	18.9	53.9	39.9	64.2	53.2	29.5	59.0	20.9	56.9	28.5	41.8	53.7	14.2	204.8	49.2	53.3	35.4	78.4	46.1	15.9	56.8	54.5	94.1	34.0	21.6	71.2	17.3	55.3	41.2	13.0	25.2	42.3	20.8	310.9	42.3	36.3	21.8	40.7	71.6	40.2	57.2	50.3	18.2	39.6	122.1	13.4	50.6	44.2	46.6	37.5	16.3	40.3	74.4	36.2	30.8	9.9	30.5	23.6	32.7	27.5	21.6	15.0	13.8	26.2	49.2	22.9	25.4	26.7	26.6	32.3	23.1	17.7	27.7	20.6	24.4	36.8	21.9	33.5	33.8	18.1	30.0	11.1	26.6	29.7	19.0	29.1	47.3	36.7	48.1	46.3	31.9	21.5	38.7	45.0	38.0	47.8	36.7	41.7	13.5	36.5	24.2	34.2	31.3	23.8	18.1	37.2	26.5	37.7	71.7	20.3	100.7	39.6	31.9	24.9	23.6	49.6	28.0	32.7	0.1	1.5	0.2	0.8	2.7	0.3	0.8	0.3	0.5	1.1	0.5	0.5	0.7	3.2	0.4	2.5	0.6	0.3	0.6	46.6	47.6	39.9	64.2	49.2	53.3	56.8	54.5	55.3	40.7	50.3	46.6	39.5	6.4	3.4	9.4	7.0	8.8	6.8	6.4	2.2	42.2	19.2	19.0	116.8	22.8	4.7	14.7	27.1	6.9	9.0	24.6	7.9	12.4	32.4	11.7	22.9	26.7	17.5	2.5	16.9	19.1	5.7	22.6	8.6	12.9	0.0	15.9	26.4	39.7	34.5	3.3	21.6	11.8	2.0	49.4	50.8	15.7	49.0	37.1	14.2	9.4	37.8	26.1	9.2	10.1	10.7	15.6	11.6	51.9	3.3	6.4	20.7	11.8	7.0	23.9	19.7	23.3	23.5	26.4	6.9	10.1	11.2	8.1	10.0	100.6	14.4	6.6
PRKACG	PKACg	ENSG00000165059	"Protein kinase cAMP-activated catalytic subunit gamma"	P22612	9	69012504-69014113	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	152	"testis: 24.6"	"Group enriched"	"Detected in some"	27	"Early spermatids: 71.0;Late spermatids: 88.4;Spermatocytes: 41.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB004530, HPA071185"	Supported		Uncertain	"Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Cytokinetic bridge"	"CAB004530: AB_628137, HPA071185: AB_2686356"					"unprognostic (2.74e-1)"									"unprognostic (3.61e-2)"	"unprognostic (7.22e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PRKCH	"PKC-L, PKCL, PRKCL"	ENSG00000027075	"Protein kinase C eta"	P24723	14	61187559-61550976	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 128.4;Microglial cells: 267.9;NK-cells: 229.6;T-cells: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"gdT-cell: 116.5;MAIT T-cell: 91.3;memory CD4 T-cell: 88.0;memory CD8 T-cell: 137.0;naive CD4 T-cell: 106.9;naive CD8 T-cell: 105.5;NK-cell: 117.1;T-reg: 79.8"	"Group enriched"	"Detected in all"	14	"NK-cells: 117.1;T-cells: 137.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 81.8;HUVEC TERT2: 108.7;MOLT-4: 75.8;RT4: 46.4;TIME: 72.0"	"Group enriched"	"Detected in all"	6	"basal ganglia: 28.0;thalamus: 17.9"	"Low region specificity"	"Detected in all"			"HPA026294, HPA053709"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"HPA026294: AB_10603988, HPA053709: AB_2682237"	"unprognostic (1.42e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.55e-6)"	"unprognostic (1.14e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.98e-2)"	"unprognostic (4.73e-3)"	26.6	7.8	21.1	21.9	30.2	24.2	21.9	12.4	15.7	20.6	9.5	8.9	9.5	14.5	10.9	30.0	13.6	19.7	19.2	13.2	13.9	14.5	10.3	35.3	55.2	19.3	21.7	5.9	8.4	14.2	15.0	32.5	19.4	15.8	8.8	3.1	28.3	11.4	14.2	23.7	16.6	18.1	18.6	38.5	9.6	7.5	29.9	65.8	21.1	18.1	38.5	25.3	21.7	15.5	18.1	6.3	0.8	4.9	2.8	0.6	81.8	0.3	1.5	0.8	0.8	1.9	10.5	0.3	12.4	0.1	1.6	12.3	0.6	13.5	1.4	2.2	7.9	0.1	2.0	0.7	1.2	0.0	2.4	2.2	13.8	0.7	9.4	1.2	108.7	35.4	0.2	0.4	6.2	32.7	75.8	0.7	1.4	12.9	8.4	6.3	3.2	0.2	0.2	46.4	3.2	5.1	2.1	16.2	10.2	14.5	15.9	1.4	72.0	2.1	14.0	2.1	0.9	1.4	0.2	0.6	3.1	1.1	3.6	0.8	3.0	2.4	116.5	1.9	91.3	2.2	88.0	137.0	9.2	1.4	106.9	105.5	5.9	117.1	1.1	3.0	79.8	84.0	21.1	30.2	12.4	15.7	13.2	13.9	19.3	21.7	19.4	18.6	29.9	15.5	59.7	6.4	11.4	2.0	6.6	18.7	16.4	8.3	15.9	0.4	15.0	9.3	9.0	10.0	15.5	0.0	0.0	27.6	128.4	0.6	3.9	6.0	32.6	10.3	2.1	70.8	11.9	18.1	1.7	6.8	21.2	5.0	7.1	20.9	1.3	15.4	68.9	2.0	6.0	0.0	3.1	2.7	2.0	14.4	6.9	6.0	1.8	15.4	16.0	267.9	8.9	7.0	229.6	4.5	1.8	5.4	4.3	6.8	26.6	14.7	4.6	1.2	9.2	0.5	0.0	4.4	5.2	0.1	2.4	18.1	26.7	48.3	130.5	1.6	1.3	26.0
PRKD1	"PKC-mu, PKCM, PKD, PRKCM"	ENSG00000184304	"Protein kinase D1"	Q15139	14	29576479-30191898	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 362.1;Excitatory neurons: 147.4;Inhibitory neurons: 171.1;Microglial cells: 89.0;Oligodendrocyte precursor cells: 390.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 10.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 21.6;fHDF/TERT166: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018367, HPA029834"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	Cytosol	"CAB018367: AB_2253119, HPA029834: AB_10602821"	"unprognostic (5.35e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-3)"	"unprognostic (8.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.44e-5)"	"unprognostic (9.45e-4)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (3.89e-1)"	8.0	9.6	5.6	2.2	8.0	0.0	7.7	6.5	6.7	6.4	3.7	9.5	1.0	7.9	3.5	2.1	6.5	4.4	6.1	7.5	7.5	17.5	1.6	7.5	0.3	8.6	8.6	11.2	5.4	10.6	5.6	1.9	8.7	14.7	1.3	4.7	2.9	9.3	1.6	2.8	3.6	6.3	8.9	2.3	4.6	11.7	8.1	2.4	5.9	2.6	0.5	13.1	4.6	10.3	0.0	4.4	4.8	3.1	21.6	16.5	0.1	14.1	10.4	16.7	7.3	0.0	0.3	0.0	1.9	19.4	4.0	0.1	7.9	2.1	6.8	0.0	6.2	0.0	0.0	0.5	8.8	0.0	0.1	18.4	0.3	1.4	1.5	6.1	2.6	0.0	1.4	0.4	17.4	1.8	0.0	0.0	2.6	0.0	9.6	0.0	6.3	5.2	9.7	6.6	4.3	13.0	2.6	0.0	4.5	4.6	0.0	0.1	5.6	13.6	6.7	1.0	3.7	0.0	0.0	0.0	3.5	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	8.0	6.5	6.7	7.5	7.5	8.6	8.6	8.7	8.9	8.1	10.3	4.6	0.0	7.4	362.1	0.2	0.5	4.8	0.4	0.6	1.4	1.4	1.5	1.2	10.0	0.0	12.9	6.2	0.0	0.0	0.1	29.4	2.4	39.5	2.8	9.2	6.1	3.0	2.7	147.4	4.2	0.1	6.4	0.5	8.4	0.0	18.7	10.8	2.5	0.2	1.7	171.1	0.2	0.0	1.6	0.9	16.9	7.5	0.7	7.2	89.0	0.0	16.7	0.0	390.6	76.6	2.0	0.1	12.8	0.4	12.4	0.2	4.5	0.1	2.9	0.0	13.3	4.5	3.2	7.8	0.0	0.9	0.3	0.6	29.6	0.1	1.3
PRKDC	"DNA-PKC, DNA-PKcs, DNAPK, DNAPKc, DNPK1, HYRC, HYRC1, p350, p460, XRCC7"	ENSG00000253729	"Protein kinase, DNA-activated, catalytic subunit"	P78527	8	47773111-47960178	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, Ribosome biogenesis"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005167, HPA035174"	Supported		Enhanced	Nucleoplasm		NA	NA		250000	"Cluster 6: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"CAB005167: AB_2172845, HPA035174: AB_2674504"	"unprognostic (3.14e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (8.95e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.70e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.76e-3)"	"unprognostic (7.77e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.15e-2)"	17.3	16.8	8.6	14.1	10.7	19.2	16.1	9.8	11.9	18.2	10.8	16.2	7.0	20.1	8.0	24.0	18.3	7.4	16.7	10.6	9.3	14.8	14.0	14.8	17.9	10.4	10.0	19.8	18.0	14.0	16.3	10.9	9.8	13.5	11.6	23.8	16.0	9.2	26.4	19.8	17.2	12.1	10.6	18.8	16.6	18.3	9.6	27.8	13.4	15.0	17.1	18.7	17.5	14.3	123.5	103.4	98.4	93.9	59.9	63.0	41.6	51.2	49.9	70.3	68.9	68.0	39.6	117.1	43.1	63.3	52.3	68.5	131.3	70.2	109.3	26.3	81.8	230.2	92.1	83.7	25.8	88.6	46.0	45.9	22.5	111.3	115.3	27.1	73.4	79.5	156.6	48.0	78.8	57.7	125.8	72.3	108.6	85.6	31.2	60.8	77.3	41.2	35.5	104.4	49.2	62.5	158.1	50.6	51.1	60.2	72.6	60.1	86.2	91.5	78.0	73.0	104.2	41.3	56.7	162.8	51.7	97.9	75.6	11.4	8.1	4.1	8.7	6.8	11.0	13.1	10.8	9.2	6.5	16.7	11.2	10.3	7.7	12.8	13.7	15.3	8.3	2.9	8.6	10.7	9.8	11.9	10.6	9.3	10.4	10.0	9.8	10.6	9.6	14.3	73.4	38.5	36.1	56.8	67.9	38.4	48.3	59.7	77.4	103.4	63.1	64.0	82.1	22.8	44.1	42.3	125.1	61.1	81.9	17.5	17.6	41.9	29.0	66.0	166.5	59.7	25.8	147.6	85.5	36.0	60.6	73.2	55.0	72.6	45.6	105.1	32.5	41.2	35.9	104.3	77.1	31.2	38.7	45.5	20.1	15.5	56.8	54.6	19.6	61.8	63.6	73.1	57.7	82.0	76.0	34.9	16.6	69.6	69.3	57.1	13.2	23.5	50.1	111.6	52.6	91.2	69.3	100.7	106.3	85.3	40.6	33.0	71.0	143.2	55.2	36.4
PRKG1	"PGK, PKG, PKG1, PRKG1B, PRKGR1B"	ENSG00000185532	"Protein kinase cGMP-dependent 1"	Q13976	10	50990888-52298423	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 36.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 778.3;Excitatory neurons: 244.9;Inhibitory neurons: 473.0;Microglial cells: 188.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	36	"basophil: 7.3"	"Lineage enriched"	"Detected in single"	49	"granulocytes: 7.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.3;BJ hTERT+: 19.2;fHDF/TERT166: 16.1;U-138 MG: 11.2;U-87 MG: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007699, CAB009629"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"		"CAB009629: AB_2170663, HPA007699: AB_1079677"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.94e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.40e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.50e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.78e-4)"	7.0	8.3	6.4	2.7	7.2	0.6	3.1	1.4	6.9	10.3	12.4	5.5	2.4	10.3	3.5	5.2	5.2	7.0	14.1	6.6	10.7	3.8	1.7	6.8	1.2	5.1	4.6	4.2	1.7	9.6	1.3	10.1	3.2	6.4	5.3	3.6	4.0	8.1	25.8	1.0	3.4	14.6	5.3	2.5	3.3	1.8	12.2	1.5	7.0	36.1	0.9	5.4	4.2	2.7	0.1	0.2	1.7	14.3	6.5	6.0	0.1	5.4	19.2	2.1	2.6	0.1	0.9	0.3	0.0	16.1	2.0	0.1	0.0	0.1	1.7	0.0	5.0	1.0	0.3	0.0	5.5	0.0	0.1	8.1	0.1	4.8	0.1	0.6	0.0	0.0	0.0	0.1	5.3	0.1	0.0	0.0	4.1	0.0	2.5	0.0	3.9	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.1	2.0	0.1	0.0	0.0	11.2	1.9	5.9	3.7	1.5	0.8	0.0	10.0	0.0	2.5	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	6.4	7.2	1.4	6.9	6.6	10.7	5.1	4.6	3.2	5.3	12.2	2.7	10.5	16.0	10.8	778.3	0.3	0.9	1.7	0.0	7.4	5.9	2.8	9.4	31.4	0.0	0.0	3.7	0.0	1.0	0.3	2.9	0.0	2.4	56.0	0.4	14.7	7.1	0.0	3.4	244.9	3.6	1.2	24.2	0.5	0.5	4.5	0.1	5.0	0.0	0.4	0.0	473.0	4.2	0.0	0.0	2.2	53.0	32.6	5.3	3.6	188.3	0.0	23.6	0.0	24.6	8.0	4.8	14.1	39.5	0.1	0.5	3.2	0.2	0.9	1.3	39.5	3.9	69.9	0.9	0.9	1.6	0.6	2.2	0.2	7.9	3.6	1.0
PRKN	"AR-JP, PARK2, parkin, PDJ"	ENSG00000185345	"Parkin RBR E3 ubiquitin protein ligase"	O60260	6	161347417-162727775	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 28.3;tongue: 15.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 4.8;Distal tubular cells: 19.6;Proximal tubular cells: 6.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.3"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.0;HEL: 4.1;HSkMC: 1.7;Karpas-707: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016257, HPA036012"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"	Cytosol	"CAB016257: AB_628104, HPA036012: AB_2732471"	"unprognostic (9.23e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.85e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.16e-2)"	"prognostic favorable (6.75e-12)"	"unprognostic (9.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-1)"	3.4	3.3	4.1	0.1	3.6	0.3	1.9	0.4	5.7	1.3	0.6	2.7	1.2	1.6	1.2	3.2	1.2	1.5	9.1	4.6	1.8	5.2	1.2	1.0	0.5	1.0	1.9	2.8	1.2	2.3	1.8	0.4	1.6	1.2	0.6	1.5	1.3	1.4	28.3	2.0	1.0	1.2	1.0	1.0	1.9	5.3	1.9	0.5	1.3	15.9	0.3	2.5	1.0	2.4	0.0	0.0	0.3	2.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.5	4.1	0.1	0.6	0.3	0.0	0.0	1.7	0.0	0.0	0.2	0.3	0.0	0.2	0.2	2.2	0.0	0.2	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.7	0.0	0.0	0.5	1.0	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.7	1.7	0.3	2.2	0.8	0.1	1.3	0.6	0.8	0.9	0.7	1.6	1.8	1.8	0.5	0.6	0.4	0.0	0.1	0.8	4.1	3.6	0.4	5.7	4.6	1.8	1.0	1.9	1.6	1.0	1.9	2.4	2.3	9.6	4.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.1	1.5	0.0	0.0	1.8	1.8	0.0	0.5	0.4	0.0	19.6	1.1	0.0	3.4	1.8	0.7	0.0	0.0	0.0	2.2	0.1	1.8	0.0	3.2	2.5	3.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	6.8	1.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.4	3.7	0.0	0.0
PRKX	PKX1	ENSG00000183943	"Protein kinase X-linked"	P51817	X	3604340-3713649	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 33.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 108.3;Endometrial ciliated cells: 164.0;Glandular and luminal cells: 179.5;NK-cells: 139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 11.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015324	Supported		Supported	Nucleoplasm		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA015324: AB_1855715"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.15e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.70e-2)"	5.5	1.6	10.0	9.8	12.9	7.7	7.9	12.6	8.8	7.8	12.7	6.5	5.1	4.6	9.6	13.9	19.4	4.4	3.7	8.3	14.3	15.6	1.8	9.0	12.8	18.1	13.8	4.0	4.4	3.1	2.0	5.3	15.8	3.8	6.1	1.7	6.1	5.9	2.2	12.0	6.3	3.7	14.5	12.4	4.0	6.8	15.3	15.4	33.8	3.2	9.9	4.5	12.4	17.1	9.1	8.3	22.4	16.7	4.2	5.6	20.5	5.3	2.1	2.6	3.5	12.4	6.1	0.7	5.3	4.3	5.4	6.2	21.1	16.1	4.5	10.2	14.7	10.0	6.7	0.2	4.4	13.0	74.7	3.8	16.8	2.8	10.3	7.1	25.7	12.3	11.8	12.7	8.6	8.0	15.0	11.7	15.0	7.0	9.4	27.7	21.5	17.2	20.6	7.6	14.9	9.6	5.6	3.6	5.5	35.1	2.8	10.3	14.2	2.2	3.8	3.7	3.6	0.3	0.7	11.6	1.3	11.6	5.8	11.0	2.0	1.2	2.3	2.4	2.4	1.6	2.4	2.2	1.6	1.5	1.9	2.1	0.5	2.4	3.2	1.9	1.8	1.2	10.0	12.9	12.6	8.8	8.3	14.3	18.1	13.8	15.8	14.5	15.3	17.1	32.0	3.2	9.4	7.8	35.5	21.4	22.3	9.7	21.6	1.8	14.4	9.1	1.6	30.0	10.1	5.5	0.0	30.8	108.3	8.8	13.7	10.8	11.9	164.0	23.8	19.7	4.8	7.2	1.3	3.1	5.8	10.4	6.1	179.5	85.1	11.8	13.2	2.3	16.9	1.7	20.2	13.5	24.4	19.4	24.1	49.2	19.9	29.0	5.4	39.4	53.4	2.2	139.0	11.1	7.0	5.6	13.1	21.8	38.2	29.0	10.7	6.1	18.0	0.6	32.9	46.4	12.4	1.3	21.6	34.1	26.9	7.8	63.5	10.6	23.6	20.4
PRMT7	"FLJ10640, KIAA1933"	ENSG00000132600	"Protein arginine methyltransferase 7"	Q9NVM4	16	68310974-68358584	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044241	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA044241: AB_2678869"	"unprognostic (9.33e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.31e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.74e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.31e-1)"	9.7	11.9	8.1	6.2	8.3	4.7	10.5	8.4	10.2	9.8	12.0	10.8	3.2	9.4	3.3	7.5	10.7	4.3	13.2	8.3	8.3	8.6	10.2	5.9	9.4	8.9	8.4	12.1	9.7	4.8	11.1	6.3	8.8	10.5	3.0	4.6	10.0	7.0	21.8	9.8	8.8	4.5	8.3	9.7	8.8	9.8	8.4	14.4	8.6	13.5	5.8	9.7	8.3	8.4	18.1	24.7	13.2	36.1	7.1	7.0	50.8	13.8	6.8	19.5	15.6	79.4	16.1	42.4	29.8	14.0	8.4	22.6	20.4	13.8	12.6	12.7	24.5	8.6	30.8	36.8	7.8	24.3	15.8	11.3	4.9	15.2	14.0	9.3	11.8	18.7	28.1	0.8	10.3	28.2	25.8	36.3	25.3	16.5	18.8	43.7	19.3	25.7	10.7	17.7	19.8	13.2	53.5	16.2	15.7	11.9	25.2	22.2	16.0	14.7	12.9	19.9	17.6	9.6	22.5	41.6	17.1	23.4	16.8	12.3	8.2	7.1	17.4	10.6	20.2	10.9	11.6	14.9	11.8	12.8	16.7	15.4	0.8	21.4	9.5	32.9	14.7	14.3	8.1	8.3	8.4	10.2	8.3	8.3	8.9	8.4	8.8	8.3	8.4	8.4	7.1	19.2	10.6	16.6	12.1	6.9	8.9	12.8	9.1	21.2	10.8	8.8	13.3	8.6	10.0	9.2	54.2	25.4	12.6	28.3	5.9	12.3	4.4	12.9	8.7	7.6	13.2	7.8	25.0	16.1	8.4	10.5	23.4	5.9	7.0	24.9	6.8	8.4	12.2	30.3	25.9	32.4	10.2	7.7	20.6	4.3	11.8	6.2	8.8	12.2	9.1	9.7	13.4	18.6	20.4	23.6	29.8	13.2	6.9	6.7	24.7	7.7	14.5	18.2	13.1	9.9	8.6	6.9	19.3	6.1	6.0	11.6	16.5	10.0	24.1	12.7
PRNP	"AltPrP, CD230, CJD, GSS, PRIP, PRP"	ENSG00000171867	"Prion protein"	P04156	20	4686350-4701590	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell cycle, Growth arrest"	Prion	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 412.6;Basal squamous epithelial cells: 369.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	9	"basophil: 875.9"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 875.9"	"Cell line enhanced"	"Detected in many"		"WM-115: 1039.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042754, HPA043398"	Enhanced		Approved	"Nuclear membrane,Vesicles,Cytosol"		NA	Yes		5100000	"Cluster 38: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Nuclear membrane, Cytosol"	Vesicles	"HPA042754: AB_10964203, HPA043398: AB_2678461"	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.96e-4)"	"prognostic unfavorable (4.64e-4)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (7.41e-5)"	"unprognostic (7.60e-3)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.75e-2)"	"unprognostic (7.28e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.69e-2)"	87.0	92.4	283.8	52.4	308.4	83.7	106.7	255.1	385.9	135.4	415.8	184.2	37.1	125.5	59.1	79.2	79.9	110.1	197.5	315.6	244.8	132.8	79.7	79.2	59.8	262.8	260.8	163.7	41.5	62.8	83.8	66.9	270.1	146.1	70.5	178.6	60.3	148.2	64.0	95.4	47.4	140.8	265.0	75.2	61.6	68.1	302.5	47.9	89.1	74.0	60.0	124.9	83.4	292.8	226.4	141.6	41.7	64.2	329.6	199.9	36.6	363.4	527.6	175.5	177.7	50.0	171.5	40.9	79.2	727.9	391.8	508.8	45.9	498.3	326.2	31.8	39.0	0.2	19.6	193.8	402.0	72.8	16.5	177.5	711.9	701.8	583.9	257.0	152.8	28.6	22.8	142.9	205.1	45.7	28.8	46.2	33.1	99.8	266.4	33.9	110.0	38.3	88.7	40.3	49.2	7.0	98.9	144.3	554.1	56.4	30.2	38.8	224.5	282.9	127.1	158.6	296.1	63.1	129.5	132.9	226.8	51.9	1039.0	875.9	74.1	5.4	67.3	60.9	100.7	25.1	56.9	55.8	62.9	25.6	33.5	40.1	4.6	23.6	50.4	24.6	72.8	72.7	283.8	308.4	255.1	385.9	315.6	244.8	262.8	260.8	270.1	265.0	302.5	292.8	44.9	80.1	45.4	120.2	85.3	412.6	211.8	132.5	369.3	265.4	60.8	103.0	257.7	32.9	68.2	33.1	116.7	7.7	71.8	2.6	11.7	58.1	6.0	14.1	73.2	66.7	29.9	31.8	125.5	14.7	6.3	177.4	14.8	18.2	173.0	25.5	41.0	36.2	63.6	45.4	170.8	5.4	40.7	219.1	200.4	13.6	143.2	126.3	168.9	59.0	54.5	142.4	42.2	95.0	158.8	18.7	4.5	170.0	47.0	120.3	2.2	84.0	38.1	99.0	13.1	73.0	82.3	36.6	4.5	81.6	284.4	14.4	107.2	10.3	8.8	122.6
PRODH	"HSPOX2, PIG6, PRODH1, PRODH2, TP53I6"	ENSG00000100033	"Proline dehydrogenase 1"	O43272	22	18912777-18936553	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 49.2;skin 1: 39.8"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 183.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 91.3;RPTEC TERT1: 35.9"									HPA020361	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nucleoplasm, Vesicles"	"HPA020361: AB_10963116"	"unprognostic (2.46e-2)"	"prognostic favorable (1.54e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.94e-2)"	7.9	0.7	5.8	0.4	6.4	0.0	8.5	3.1	9.0	5.0	34.0	3.1	5.6	1.5	0.1	11.6	5.8	0.1	18.6	6.5	2.8	16.7	15.6	20.6	0.2	7.3	4.7	0.5	1.4	0.0	5.4	0.2	2.5	3.2	0.3	0.6	4.2	0.2	49.2	39.8	32.5	0.0	3.3	0.5	3.5	1.7	7.6	0.3	7.4	6.2	0.8	4.2	8.5	3.4	0.0	0.8	0.0	0.3	0.9	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.3	0.0	0.0	2.9	3.9	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.9	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.6	4.5	91.3	0.0	0.0	0.0	0.4	35.9	0.9	0.1	0.2	0.8	1.4	0.3	5.2	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.8	6.4	3.1	9.0	6.5	2.8	7.3	4.7	2.5	3.3	7.6	3.4	0.1	16.0	25.6	183.1	0.0	5.1	0.3	13.1	0.0	0.0	0.2	0.1	1.8	0.0	11.5	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.6	1.2	0.2	0.4	3.5	0.0	0.5	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	2.0	0.0	1.5	0.1	0.0	0.1	21.4	17.8	0.0	0.6	0.0	14.1	2.1	0.0	2.3	0.0	0.0	0.0	8.0	0.1	21.0	0.1	0.0	1.1	0.6	0.2	0.4	1.0	15.2	0.0	0.3	0.0	1.6	0.2
PROKR2	"dJ680N4.3, GPR73b, GPR73L1, GPRg2, KAL3, PKR2"	ENSG00000101292	"Prokineticin receptor 2"	Q8NFJ6	20	5299218-5316954	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.2;SH-SY5Y: 1.7"	"Region enhanced"	"Detected in many"		"olfactory bulb: 17.0"	"Low region specificity"	"Detected in all"			HPA047281	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA047281: AB_10960057"										"unprognostic (1.36e-1)"					"unprognostic (1.69e-1)"			0.0	0.0	1.3	0.1	1.4	0.8	0.1	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.5	0.1	2.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.2	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.7	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.3	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.1	0.3	0.2	0.2	1.0	0.1	0.1	0.4	0.2	0.0	1.3	1.4	0.2	0.9	1.2	0.2	0.1	2.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PROM1	"AC133, CD133, CORD12, MCDR2, PROML1, RP41, STGD4"	ENSG00000007062	"Prominin 1"	O43490	4	15963076-16084378	"CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cone-rod dystrophy, Disease variant, Retinitis pigmentosa, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 272.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 581.7;Respiratory ciliated cells: 144.8;Rod photoreceptor cells: 311.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 37.2;CACO-2: 70.6;CAPAN-2: 28.9;EFO-21: 62.2;NTERA-2: 97.4;RPTEC TERT1: 91.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA004922, CAB011525, HPA031053"	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB011525: AB_470302, HPA004922: AB_1846238, HPA031053: AB_2673713"	"unprognostic (6.33e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-2)"	"unprognostic (9.06e-2)"	"prognostic favorable (2.56e-5)"	"unprognostic (2.16e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.17e-1)"	0.3	0.3	4.1	6.2	3.0	4.0	27.7	2.7	3.5	44.9	2.0	30.7	12.4	6.0	4.3	5.1	5.4	30.9	6.7	3.3	2.8	20.9	1.8	3.1	0.0	3.8	4.3	0.1	14.4	0.0	0.1	30.1	3.6	2.8	16.7	272.9	57.9	7.1	1.0	0.9	22.9	3.5	2.8	0.2	24.8	8.0	5.0	0.1	4.8	0.0	0.1	4.2	0.2	3.1	0.0	0.0	37.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	70.6	28.9	0.6	62.2	0.0	0.0	0.1	7.3	0.0	0.1	0.3	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	97.4	0.0	0.0	1.4	0.1	0.0	91.1	0.1	12.0	3.6	0.0	2.4	1.9	3.5	0.6	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	3.0	2.7	3.5	3.3	2.8	3.8	4.3	3.6	2.8	5.0	3.1	0.2	3.2	4.8	1.3	0.3	0.0	0.1	7.2	0.0	14.8	38.2	30.0	8.6	31.5	29.9	82.8	581.7	0.6	1.0	39.3	0.0	64.1	31.4	71.1	1.7	5.1	44.4	2.1	0.9	15.5	0.1	4.4	31.6	14.8	0.0	3.8	0.7	0.1	0.1	10.1	5.4	15.0	34.6	0.0	0.0	44.3	3.1	0.7	0.0	27.2	0.6	47.5	0.0	45.8	1.2	38.2	28.3	6.4	0.4	1.5	18.8	3.6	144.8	311.3	0.0	0.8	3.1	2.1	1.0	0.7	0.0	0.1	0.7	0.3	26.0	4.1
PRPH2	"CACD2, rd2, RDS, RP7, TSPAN22"	ENSG00000112619	"Peripherin 2"	P23942	6	42696598-42722597	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Sensory transduction, Vision"		"Cone-rod dystrophy, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"retina: 641.4"	"Group enriched"	"Detected in some"	8	"Cone photoreceptor cells: 260.6;Rod photoreceptor cells: 482.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.0;ASC TERT1: 3.4;fHDF/TERT166: 5.3;HHSteC: 7.8;HSkMC: 6.0;LHCN-M2: 3.5"	"Region enriched"	"Detected in single"	7	"hippocampal formation: 2.4"	"Not detected"	"Not detected"			HPA029458	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA029458: AB_10602193"	"unprognostic (2.37e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.67e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.07e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.59e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.96e-3)"	1.1	0.8	2.1	0.5	1.5	0.0	0.5	0.4	1.8	2.0	0.1	2.2	0.4	2.1	1.8	0.7	1.3	1.1	1.5	3.1	2.1	1.4	0.2	1.5	0.1	0.9	1.0	3.1	2.3	4.3	2.5	0.9	1.2	1.5	0.8	641.4	0.7	1.1	13.2	0.3	1.4	1.9	0.4	0.8	1.2	3.7	2.7	0.2	4.1	2.9	0.1	1.2	1.1	1.2	0.0	0.0	0.0	0.0	3.0	3.4	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	7.8	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.2	0.0	0.1	0.0	2.1	1.5	0.4	1.8	3.1	2.1	0.9	1.0	1.2	0.4	2.7	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	39.3	0.1	0.0	0.9	0.0	0.1	0.0	260.6	0.1	0.0	0.0	3.9	0.3	0.2	0.1	0.9	2.3	0.0	0.0	2.3	0.2	0.0	1.3	0.0	0.1	0.0	0.2	0.4	0.2	0.0	11.8	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.9	0.0	42.6	1.0	0.5	0.6	0.5	0.0	1.9	0.0	0.2	0.0	0.2	0.0	482.7	0.0	0.9	0.8	2.3	0.5	0.1	0.3	0.1	0.0	1.3	0.0	0.1
PRPS1	"CMTX5, DFN2, DFNX1"	ENSG00000147224	"Phosphoribosyl pyrophosphate synthetase 1"	P60891	X	107628428-107651993	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Deafness, Disease variant, Gout, Mental retardation, Neurodegeneration, Neuropathy, Non-syndromic deafness, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043760, HPA051269"	Uncertain		Approved	Vesicles		NA	NA		320000	"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles		"HPA043760: AB_2678656, HPA051269: "	"unprognostic (4.47e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.30e-3)"	"unprognostic (2.56e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.25e-2)"	22.9	28.0	33.7	30.2	35.0	58.0	21.0	32.4	36.4	20.0	59.3	19.0	11.0	23.7	14.8	13.7	25.9	13.9	22.2	33.7	39.6	27.6	51.5	21.5	42.7	35.4	39.1	30.2	21.7	27.2	23.2	14.6	37.6	21.3	17.9	30.2	16.3	17.4	49.1	12.3	16.7	29.5	34.2	26.2	15.5	13.4	35.2	52.0	44.1	37.9	45.7	23.6	15.2	34.4	93.5	128.9	56.4	69.9	32.7	26.5	18.6	253.2	55.8	146.0	122.6	55.5	36.6	156.9	111.7	94.9	104.1	36.6	176.0	53.8	148.3	79.9	150.9	84.2	140.0	100.3	28.8	153.1	55.6	28.2	30.6	90.2	56.2	96.7	52.3	108.2	137.4	183.5	69.0	51.0	101.2	113.6	213.5	77.2	141.4	117.6	96.3	125.4	60.7	54.2	96.2	52.5	131.5	77.6	57.3	106.4	36.0	61.7	31.2	93.2	45.0	108.3	109.1	61.8	115.1	172.7	50.1	163.6	61.6	8.8	8.9	22.6	26.0	14.3	30.8	29.3	31.7	32.2	11.4	31.0	36.1	30.7	4.7	28.5	15.7	16.3	35.5	21.1	33.7	35.0	32.4	36.4	33.7	39.6	35.4	39.1	37.6	34.2	35.2	34.4	21.0	6.4	10.0	4.6	44.2	31.1	18.4	13.2	12.0	28.4	8.3	9.4	12.1	15.7	12.6	16.5	4.2	8.8	29.3	3.0	25.4	18.3	1.2	11.5	13.3	18.1	16.2	52.2	4.8	20.2	11.5	22.2	10.2	5.7	26.6	13.2	14.6	57.5	35.3	15.2	10.0	6.5	6.1	18.6	34.8	3.9	14.0	16.8	26.6	6.5	24.9	20.0	27.8	3.5	4.8	19.1	3.7	17.0	35.7	16.2	1.5	29.4	27.1	14.1	0.0	18.1	30.7	3.6	10.9	10.8	22.3	1.8	45.0	19.7	8.0	9.7
PRRT2	"DKFZp547J199, DSPB3, DYT10, EKD1, FICCA, FLJ25513, ICCA, IFITMD1, PKC"	ENSG00000167371	"Proline rich transmembrane protein 2"	Q7Z6L0	16	29811382-29815892	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Dystonia, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 124.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 82.3;Cone photoreceptor cells: 31.3;Leydig cells: 36.1;Peritubular cells: 40.3;Rod photoreceptor cells: 37.1"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"NK-cell: 3.2"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"AF22: 24.1;HeLa: 13.8;hTERT-RPE1: 14.0;REH: 17.6;U-138 MG: 14.5"									"HPA014447, HPA019203, HPA048045"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"		"HPA014447: AB_1855786, HPA019203: AB_2670097, HPA048045: "	"unprognostic (7.60e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.32e-3)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.43e-8)"	"unprognostic (1.22e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.44e-2)"	13.4	10.5	32.9	2.4	40.4	0.3	10.8	70.7	70.5	79.4	0.0	33.9	5.3	39.5	8.6	6.7	47.0	10.9	15.6	46.0	20.1	8.7	2.4	12.9	3.3	15.6	8.0	124.3	4.7	4.3	85.6	7.0	16.2	39.1	2.3	19.8	5.4	13.9	4.5	5.0	14.5	10.4	24.5	1.7	12.4	14.6	29.2	0.5	10.6	1.8	1.0	34.1	51.0	34.0	0.1	1.5	24.1	8.6	1.2	4.2	0.5	2.5	4.1	1.0	0.8	1.1	1.5	0.2	0.3	4.4	0.5	1.6	3.4	0.2	0.4	4.1	1.4	1.7	13.8	1.6	0.3	0.0	0.3	4.1	0.1	1.9	0.1	14.0	1.0	0.7	0.2	1.5	0.2	3.1	0.6	0.5	5.0	0.1	1.1	17.6	0.9	0.4	0.2	0.8	4.1	4.3	0.2	2.1	0.5	3.5	7.6	0.0	1.3	14.5	5.2	0.7	1.4	3.7	0.5	0.2	5.3	0.2	0.5	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.1	3.2	0.1	0.0	0.0	0.1	32.9	40.4	70.7	70.5	46.0	20.1	15.6	8.0	16.2	24.5	29.2	34.0	2.3	3.2	0.0	22.9	0.9	1.1	1.4	1.7	0.6	82.3	1.6	1.7	0.8	1.5	1.2	0.0	31.3	1.9	1.9	9.5	1.9	1.1	2.0	4.4	10.4	5.0	6.1	0.0	24.4	1.5	0.8	11.4	2.0	1.6	0.0	1.7	3.3	0.1	0.4	20.2	19.5	4.2	2.0	0.0	2.4	9.8	36.1	0.5	0.0	5.6	0.6	5.7	1.0	8.5	1.6	3.0	9.0	40.3	0.7	1.8	15.2	1.0	5.6	37.1	6.6	2.9	11.7	2.4	3.1	0.4	0.4	2.6	2.7	0.6	2.5	1.3
PRSS1	TRY1	ENSG00000204983	"Serine protease 1"	P07477	7	142749468-142753076	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1923	"pancreas: 341429.7"	"Cell type enriched"	"Detected in some"	28	"Exocrine glandular cells: 57138.3"	"Cancer enriched"	"Detected in many"	224	"pancreatic cancer: 1920.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"OE19: 10.6;RPMI-8226: 4.5;U-2 OS: 2.8"									"CAB025487, CAB025538, HPA062452, HPA063471"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		100000000000	"Cluster 35: T-regs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles	"Endoplasmic reticulum"	"CAB025487: , CAB025538: , HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.55e-5)"	"unprognostic (5.28e-1)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (6.41e-6)"				"unprognostic (8.26e-2)"		"prognostic favorable (7.05e-4)"	"unprognostic (1.35e-1)"			"unprognostic (3.93e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (3.12e-1)"	45.2	9.9	0.0	4.7	0.0	0.0	25.7	0.0	0.0	19.9	0.0	11.2	54.5	8.9	0.8	15.2	5.6	0.0	51.0	0.0	0.0	9.6	29.7	6.4	6.5	0.0	0.0	177.5	341429.7	0.1	10.3	13.9	0.0	15.2	0.0	0.0	44.2	4.2	8.9	12.1	12.7	0.0	0.0	13.4	77.1	6.9	0.0	0.0	6.4	0.0	0.0	4.7	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	100.7	0.0	0.1	0.0	3.6	0.0	0.0	0.0	57138.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	119.4	0.6	0.0	0.0	0.0	1985.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.2	0.2
PRSS12	"BSSP-3, MRT1"	ENSG00000164099	"Serine protease 12"	P56730	4	118280038-118353003	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Club cells: 34.3;Cytotrophoblasts: 48.0;Respiratory ciliated cells: 76.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 70.2;SH-SY5Y: 215.4;THP-1: 100.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035054	Uncertain		Approved	"Nucleoplasm,Actin filaments"	"Secreted - unknown location"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Actin filaments"	Nucleoplasm	"HPA035054: AB_10603990"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (2.66e-4)"	"prognostic favorable (1.03e-4)"	"unprognostic (4.21e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.83e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.09e-1)"	0.6	0.5	1.4	1.6	0.9	0.1	2.2	0.6	1.3	14.5	14.4	6.7	2.7	1.9	0.6	3.2	10.5	9.8	0.0	2.7	0.5	0.8	0.6	7.6	0.1	0.5	1.9	1.6	7.7	0.1	0.6	10.6	0.7	1.4	6.4	0.3	2.5	2.0	0.2	5.9	4.8	1.3	0.5	0.0	9.2	10.0	1.2	1.0	0.2	1.2	5.7	3.8	12.6	0.5	5.2	0.2	1.8	0.0	0.2	13.3	0.1	46.0	41.5	9.7	16.1	0.1	18.7	0.0	0.2	70.2	4.9	0.8	31.1	9.5	12.7	0.2	7.2	0.0	3.6	0.0	1.4	0.0	0.2	4.1	17.5	3.4	9.9	31.2	0.1	0.6	0.0	0.0	8.0	0.3	0.5	9.6	2.2	36.4	2.9	0.0	38.7	0.0	0.0	7.0	5.1	215.4	0.0	0.2	3.0	30.9	0.0	100.6	0.0	19.2	2.8	12.2	9.1	1.0	0.1	0.0	1.0	3.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	0.6	1.3	2.7	0.5	0.5	1.9	0.7	0.5	1.2	0.5	0.3	6.4	4.6	0.7	0.2	8.4	0.8	16.4	2.2	0.6	0.8	0.8	1.4	10.0	34.3	1.8	0.0	48.0	0.0	26.8	0.0	0.4	9.9	19.7	16.8	0.9	5.3	0.0	10.5	10.2	4.5	7.1	17.9	2.6	7.0	3.3	0.0	0.4	3.8	0.0	14.3	2.7	10.2	0.0	4.2	18.3	0.0	0.4	5.4	7.5	0.0	0.0	0.0	0.5	0.2	8.1	12.8	0.0	0.2	0.4	9.4	0.6	76.1	0.2	0.0	0.6	4.9	10.1	13.3	3.6	4.3	11.9	0.7	21.8	5.3	4.7
PRSS37		ENSG00000165076	"Serine protease 37"	A4D1T9	7	141836300-141841487	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	55	"testis: 41.3"	"Group enriched"	"Detected in some"	138	"Early spermatids: 612.8;Late spermatids: 325.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020541	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA020541: AB_1853004"	"unprognostic (4.70e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.69e-1)"		"unprognostic (2.41e-1)"			"unprognostic (3.21e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.30e-7)"	"unprognostic (1.42e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.72e-2)"		0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	41.3	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.7	0.2	0.2	0.1	0.3	0.2	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	612.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	325.7	2.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS56		ENSG00000237412	"Serine protease 56"	P0CW18	2	232520388-232525716	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 3.0;retina: 5.3;skeletal muscle: 9.7"	"Group enriched"	"Detected in some"	10	"Early spermatids: 29.0;Muller glia cells: 45.8"	"Group enriched"	"Detected in many"	4	"cervical cancer: 1.2;colorectal cancer: 2.5;endometrial cancer: 1.4;melanoma: 2.1;urothelial cancer: 4.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"Daudi: 1.0"	"Group enriched"	"Detected in some"	10	"basal ganglia: 1.8;olfactory bulb: 4.2"	"Region enhanced"	"Detected in many"		"olfactory bulb: 14.9"							NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"						"unprognostic (3.26e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.73e-3)"			"unprognostic (2.28e-1)"	"unprognostic (7.15e-2)"				"unprognostic (4.64e-2)"	"unprognostic (1.20e-1)"			0.0	0.0	0.4	0.0	1.2	0.0	0.0	1.6	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	2.9	1.3	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	5.3	0.0	0.0	9.7	0.0	0.0	0.0	1.1	0.0	0.0	0.8	1.4	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	1.6	3.0	0.1	3.0	2.9	1.3	3.0	1.1	1.4	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	45.8	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	3.6	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRTN3	"ACPA, AGP7, C-ANCA, MBT, P29, PR-3"	ENSG00000196415	"Proteinase 3"	P24158	19	840999-848175	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	55	"bone marrow: 2098.1"	"Cell type enriched"	"Detected in some"	17	"Erythroid cells: 26.5"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.0"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.0"	"Cell line enriched"	"Detected in some"	6	"THP-1: 2054.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005938, CAB017558"	Enhanced		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		390000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Vesicles	"CAB017558: AB_2172317, HPA005938: AB_1855764"	"unprognostic (2.81e-2)"			"unprognostic (2.10e-1)"	"unprognostic (3.83e-3)"		"unprognostic (4.20e-1)"	"unprognostic (3.31e-2)"		"unprognostic (3.34e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.67e-2)"	"unprognostic (8.62e-6)"	"unprognostic (5.31e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.14e-2)"		0.8	0.2	0.6	0.0	0.7	2098.1	0.4	0.2	1.3	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.0	1.6	0.6	0.4	0.3	2.8	11.7	0.4	0.3	0.4	0.1	0.1	0.2	1.3	0.6	0.4	0.3	0.0	0.0	1.6	0.0	0.3	1.3	0.0	0.0	0.2	38.2	0.1	0.2	0.6	7.1	0.4	0.0	0.0	0.0	0.1	0.4	1.2	0.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	343.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	2054.4	0.0	0.0	0.0	0.2	0.9	0.0	0.2	0.3	0.0	14.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	9.9	0.6	0.7	0.2	1.3	0.6	0.4	0.3	0.4	0.4	0.2	0.6	0.4	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.8	1.3	0.4	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	26.5	0.4	0.0	0.9	0.9	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	1.5	0.0	0.1	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.1
PRUNE1	"DRES-17, H-PRUNE, HTCD37, PRUNE"	ENSG00000143363	"Prune exopolyphosphatase 1"	Q86TP1	1	151008420-151035713	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 13.0;Breast glandular cells: 9.8;Breast myoepithelial cells: 8.9;Collecting duct cells: 11.0;Granulosa cells: 8.9;Proximal tubular cells: 8.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 169.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028411	Uncertain		Supported	Cytosol		NA	NA		41000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA028411: AB_10603229"	"unprognostic (6.24e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (6.91e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.12e-3)"	"unprognostic (7.05e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-1)"	10.1	9.5	12.2	7.7	12.1	4.4	14.9	16.1	15.1	15.0	12.4	14.8	12.5	14.8	15.6	12.4	16.0	9.2	33.4	12.4	12.6	18.8	14.3	10.8	10.8	12.0	12.5	17.2	10.7	20.9	12.6	7.1	11.9	12.2	14.5	10.8	13.2	14.4	29.4	11.5	12.0	14.1	11.9	11.2	11.2	18.3	12.8	16.2	32.5	21.4	12.6	13.7	11.9	13.5	11.0	11.6	20.2	19.3	24.3	6.6	10.9	5.1	11.2	18.7	16.4	14.1	13.0	22.2	21.7	6.9	5.5	15.5	19.9	13.4	14.6	24.5	22.6	26.6	11.8	20.4	13.5	17.5	13.0	8.4	24.7	10.2	9.5	15.4	9.2	29.4	21.1	18.3	8.9	26.2	27.2	14.1	18.7	39.7	15.0	24.2	12.8	21.5	13.4	14.9	28.7	23.5	17.5	23.5	16.1	28.3	32.6	25.7	6.3	6.6	7.8	7.5	8.1	44.1	40.0	169.1	6.5	13.0	16.9	19.1	8.1	17.8	16.4	7.8	19.8	14.4	18.1	18.6	11.9	15.4	21.7	17.5	18.6	18.8	12.2	6.4	18.5	22.3	12.2	12.1	16.1	15.1	12.4	12.6	12.0	12.5	11.9	11.9	12.8	13.5	4.5	6.4	13.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	9.8	8.9	0.0	0.0	3.1	11.0	0.0	4.1	3.2	0.0	0.0	6.0	0.0	4.3	7.8	2.1	0.0	0.0	0.0	5.7	4.8	2.5	0.0	6.4	0.0	8.9	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	5.6	0.0	0.0	1.0	0.0	0.0	8.9	2.9	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	5.1	2.8	4.8	0.0	0.0
PSAP	"GLBA, SAP1, SAP2"	ENSG00000197746	Prosaposin	P07602	10	71816298-71851325	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Lipid metabolism, Sphingolipid metabolism"		"Disease variant, Gangliosidosis, Gaucher disease, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 2792.8;Kupffer cells: 2427.0;Macrophages: 1916.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 11615.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 5104.0;hTERT-RPE1: 6978.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004426, CAB004647"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA		88000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"CAB004647: AB_425625, HPA004426: AB_1079701"	"unprognostic (4.43e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.64e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.62e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.06e-1)"	1068.6	1192.2	831.4	874.2	946.7	834.2	683.8	873.7	831.7	1073.9	1023.0	667.1	475.6	879.3	951.2	605.5	724.7	1115.6	1413.3	830.5	1081.8	860.4	906.4	1118.6	956.1	957.6	894.0	1106.9	544.7	1167.5	563.5	869.3	885.3	773.9	625.5	665.2	580.9	936.8	1409.5	544.4	487.7	1138.6	1025.9	1045.9	664.0	489.1	1048.8	672.3	875.9	987.5	560.4	941.2	578.3	1325.1	455.9	847.4	540.4	1121.0	5104.0	2910.1	1900.2	799.9	2368.3	620.8	735.9	795.4	1131.9	245.6	1608.1	1321.6	1038.9	964.1	207.5	659.1	434.8	481.4	381.8	288.9	352.3	459.6	1970.7	188.8	1596.0	1871.8	1479.1	625.7	1177.6	6978.9	1128.1	345.8	420.5	1158.1	777.0	294.9	843.8	290.1	249.5	575.4	404.0	172.9	301.3	696.7	730.3	764.4	584.4	515.8	751.1	2248.3	3122.2	700.4	454.4	431.1	1467.0	861.8	610.0	587.1	670.5	1289.0	1038.7	435.4	1375.5	374.4	650.0	863.2	10095.9	1127.5	424.2	11615.6	349.8	466.7	342.9	368.8	3481.1	425.5	370.1	350.6	2890.4	365.8	10148.2	1758.2	422.8	15009.0	831.4	946.7	873.7	831.7	830.5	1081.8	957.6	894.0	885.3	1025.9	1048.8	1325.1	263.2	253.2	339.0	136.8	173.9	228.3	253.4	487.0	108.1	193.8	254.6	158.7	664.1	253.1	318.9	476.3	127.2	891.6	260.2	434.8	70.5	1043.6	19.3	147.0	246.6	311.4	261.9	160.5	86.1	456.1	872.6	623.8	187.6	195.2	398.1	210.8	426.9	509.2	2792.8	333.1	93.7	242.2	343.8	2427.0	779.7	54.1	458.6	1916.9	663.5	105.9	1528.9	495.6	182.3	92.5	117.6	357.7	298.3	551.8	503.0	244.8	370.6	311.6	297.2	164.3	276.1	273.6	263.8	55.2	126.3	137.2	198.0	1073.2	138.9	624.1	228.3	223.9
PSAT1	PSA	ENSG00000135069	"Phosphoserine aminotransferase 1"	Q9Y617	9	78297125-78330093	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 175.0;liver: 267.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 115.5;Glandular and luminal cells: 145.9;Hepatocytes: 161.7;Proximal tubular cells: 304.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 15.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 15.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 1170.1;SK-MEL-30: 752.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014882, CAB040567, HPA042924"	Enhanced		Enhanced	Cytosol		NA	NA		2400000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"CAB014882: , CAB040567: , HPA042924: AB_2678223"	"unprognostic (8.26e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (5.62e-5)"	"unprognostic (4.05e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.86e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.00e-7)"	"unprognostic (3.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.71e-1)"	7.8	65.8	123.3	7.3	124.6	2.0	5.1	130.5	175.0	5.1	92.8	5.9	5.4	4.3	61.6	33.2	34.7	1.7	2.7	122.4	126.5	136.7	267.9	5.1	9.3	130.2	122.4	5.6	129.1	9.7	7.6	3.0	129.9	10.0	5.5	6.2	19.2	4.0	0.6	57.2	4.5	3.3	133.6	6.0	19.4	10.4	120.3	30.0	30.3	0.5	12.4	7.3	11.2	161.6	222.8	146.0	121.1	215.6	35.1	41.2	284.7	184.3	130.4	91.8	170.6	38.2	41.9	143.2	79.8	416.9	82.9	215.3	209.1	203.6	136.4	141.2	73.9	49.2	60.8	293.3	322.0	277.6	84.6	131.1	1170.1	122.0	322.9	22.6	85.0	548.3	53.8	358.2	77.1	83.2	95.8	44.3	278.2	415.1	158.4	46.5	78.6	173.4	126.6	50.9	54.9	127.0	51.1	87.7	752.3	75.9	42.0	344.1	19.9	23.2	73.5	85.9	151.5	242.0	242.7	0.8	268.9	215.6	112.1	0.0	0.0	0.0	5.2	0.0	5.9	3.1	5.0	7.0	0.3	1.3	8.1	7.5	0.3	0.0	0.1	0.0	15.1	3.3	123.3	124.6	130.5	175.0	122.4	126.5	130.2	122.4	129.9	133.6	120.3	161.6	0.4	0.0	0.0	70.2	11.0	41.9	8.8	18.9	115.5	0.9	1.8	3.9	0.6	1.5	4.7	11.0	0.0	32.0	2.2	2.0	62.6	11.5	1.7	77.7	10.3	3.7	3.6	29.9	7.3	48.4	13.7	4.2	6.6	145.9	0.0	0.5	3.6	161.7	5.3	5.0	6.0	4.8	18.3	4.4	2.9	3.8	5.0	3.4	19.6	5.6	3.8	26.7	0.0	48.2	78.8	22.7	0.1	1.9	29.1	16.0	0.3	304.1	3.8	1.1	0.0	33.5	14.3	1.6	3.7	35.5	50.7	9.3	8.6	68.2	4.2	11.8
PSEN1	"AD3, FAD, PS1, S182"	ENSG00000080815	"Presenilin 1"	P49768	14	73136418-73223691	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell adhesion, Notch signaling pathway"	"Hydrolase, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Oligodendrocytes: 395.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006844, HPA030760, HPA067496"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Nucleoplasm, Cell Junctions"	"CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853"	"unprognostic (1.67e-1)"	"unprognostic (4.79e-2)"	"unprognostic (7.39e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.84e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (1.65e-1)"	"unprognostic (8.99e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.52e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.85e-1)"	25.1	22.6	44.3	26.5	80.7	39.6	28.2	62.4	56.0	28.1	48.9	49.5	50.2	25.3	26.9	35.2	22.9	31.7	18.0	47.4	51.6	35.5	31.9	32.1	22.4	73.0	63.8	22.0	22.9	35.1	11.6	43.1	71.5	24.3	46.3	23.4	22.9	23.4	18.4	38.2	49.0	27.1	55.7	22.6	31.0	32.5	60.8	26.2	36.9	23.3	30.7	35.0	19.2	119.1	37.1	55.9	50.6	20.0	68.9	49.9	46.7	52.5	60.1	52.6	66.7	69.9	88.9	23.7	34.1	50.5	43.0	94.9	43.2	40.1	57.3	54.6	26.7	27.1	35.1	34.4	63.8	27.7	50.7	50.4	71.9	44.3	54.4	48.5	43.2	26.2	31.0	46.6	50.0	72.8	21.0	35.7	22.0	64.5	40.4	26.4	42.7	30.2	73.7	76.5	28.1	38.3	57.4	53.0	47.1	45.4	66.3	60.7	45.7	53.1	43.5	44.1	25.3	30.3	47.9	23.7	44.9	32.8	33.3	126.8	94.5	96.3	23.1	106.0	22.6	23.1	22.3	19.0	83.4	31.8	20.7	20.1	129.3	42.8	125.0	43.6	37.0	70.3	44.3	80.7	62.4	56.0	47.4	51.6	73.0	63.8	71.5	55.7	60.8	119.1	22.2	28.9	30.5	35.9	25.8	28.6	24.6	24.7	12.0	17.1	25.0	17.7	12.5	15.7	30.2	23.9	39.6	27.1	30.7	79.1	5.9	27.1	22.9	26.3	26.4	22.3	16.2	12.0	38.9	26.7	29.2	23.7	32.1	47.4	18.3	29.6	15.7	24.6	30.5	13.5	40.2	39.5	24.4	50.5	40.8	12.9	16.4	52.3	16.0	39.4	51.8	13.8	14.4	48.7	395.8	38.2	58.8	15.4	23.6	38.8	76.2	13.0	29.0	28.0	26.3	20.0	19.0	40.2	14.4	20.4	33.0	49.9	21.6	18.6	41.3	51.5
PSEN2	"AD3L, AD4, PS2, STM2"	ENSG00000143801	"Presenilin 2"	P49810	1	226870184-226927726	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Protease"	"Alzheimer disease, Amyloidosis, Cardiomyopathy, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ionocytes: 36.7;Syncytiotrophoblasts: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (3.40e-2)"	"unprognostic (4.73e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.86e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (8.25e-3)"	"unprognostic (8.53e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	11.2	19.8	9.7	7.5	9.8	1.6	10.6	12.5	10.7	9.7	10.7	15.2	10.5	15.9	9.0	10.3	13.4	8.3	14.0	9.4	10.6	13.5	12.6	11.5	8.0	9.8	10.9	12.8	45.5	18.1	17.1	9.0	10.8	14.9	8.1	7.4	13.0	13.6	26.5	10.1	13.8	10.4	8.5	15.6	11.5	13.5	10.7	3.3	9.5	16.7	5.0	13.5	9.7	9.7	14.1	24.5	7.2	21.9	10.0	3.5	10.2	12.4	26.5	16.9	12.9	13.8	21.5	1.0	17.0	16.8	10.5	7.9	12.1	11.9	6.7	13.6	20.7	8.7	10.5	12.0	15.4	7.5	15.7	9.1	13.9	18.9	10.4	11.2	6.9	0.7	18.1	6.4	10.0	14.7	0.4	8.2	20.5	22.0	16.0	0.4	22.6	26.4	15.9	13.4	11.3	18.3	9.7	30.6	51.6	18.4	26.5	13.1	8.5	11.2	8.9	9.9	15.2	25.6	45.0	0.9	21.5	2.5	15.7	37.4	8.7	18.4	4.5	9.7	5.1	7.4	1.5	4.6	11.4	3.1	0.7	2.0	1.6	20.0	30.2	0.8	2.4	5.2	9.7	9.8	12.5	10.7	9.4	10.6	9.8	10.9	10.8	8.5	10.7	9.7	11.0	16.0	10.8	2.6	3.9	1.7	4.5	4.0	1.8	6.2	6.6	4.1	12.9	15.7	4.7	5.5	0.0	15.9	1.3	5.9	1.9	13.0	2.5	4.5	3.0	10.0	6.0	6.1	4.2	18.0	4.1	5.9	7.7	5.2	14.5	10.1	19.2	8.4	17.2	16.8	4.5	5.1	36.7	7.2	6.5	1.3	7.2	8.2	33.8	5.6	18.9	21.2	2.1	2.5	1.5	15.2	7.8	13.2	9.9	5.3	13.8	7.2	4.9	5.8	6.6	9.4	10.6	1.5	6.1	3.8	1.8	45.8	2.9	6.6	4.3	4.6
PSMB4	"HN3, PROS26"	ENSG00000159377	"Proteasome 20S subunit beta 4"	P28070	1	151399560-151401937	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006700, HPA073499"	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA		12000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Mitochondria	"HPA006700: AB_1079704, HPA073499: "	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.74e-2)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.37e-3)"	"unprognostic (3.73e-1)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (2.90e-10)"	"unprognostic (5.33e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.85e-2)"	189.5	242.7	200.2	156.7	202.1	172.9	174.2	210.6	212.4	167.0	201.9	194.3	150.0	195.5	225.6	170.4	178.3	139.1	241.8	201.7	212.9	196.6	269.5	143.2	214.0	206.8	203.9	179.5	164.0	218.6	168.0	187.1	211.7	162.4	166.4	94.3	169.6	190.6	299.1	186.6	152.8	191.7	210.5	173.8	171.8	69.0	205.8	233.5	156.1	237.5	235.4	196.7	151.3	218.4	428.3	451.9	373.0	447.8	412.9	392.3	507.8	247.6	549.2	719.3	503.1	608.6	569.5	384.1	730.7	424.3	379.1	419.7	383.2	472.7	407.6	535.6	391.1	268.6	320.8	463.3	444.4	377.0	355.7	431.7	444.8	672.5	276.2	364.8	506.1	419.1	434.3	740.0	512.7	1174.2	463.5	452.0	952.8	638.6	576.2	433.8	266.9	688.2	594.4	354.2	408.6	488.0	283.6	626.5	879.8	459.1	564.1	594.6	320.7	310.4	326.1	333.8	557.0	726.9	902.5	769.1	459.5	337.8	667.8	291.8	343.4	227.0	265.0	342.2	314.8	293.6	303.7	301.0	421.7	257.5	260.4	272.8	251.5	347.3	270.5	468.1	405.1	395.2	200.2	202.1	210.6	212.4	201.7	212.9	206.8	203.9	211.7	210.5	205.8	218.4	72.2	153.8	127.4	10.1	82.2	76.6	81.9	131.5	82.0	56.3	62.0	71.6	128.0	68.6	123.2	71.7	16.7	209.8	79.7	87.8	103.7	127.9	16.0	118.1	107.5	97.7	66.4	87.1	10.4	195.8	146.7	91.9	47.4	110.0	111.1	81.1	92.8	151.7	125.0	48.8	11.5	80.5	89.5	108.1	88.8	15.6	104.4	89.4	96.0	12.2	186.2	89.5	64.9	6.6	14.7	131.7	75.0	105.3	89.1	75.5	117.5	148.9	141.5	62.8	65.7	86.0	127.5	54.5	49.7	80.0	75.9	267.3	80.2	124.5	96.0	89.1
PSPH	PSP	ENSG00000146733	"Phosphoserine phosphatase"	P78330	7	56011051-56051604	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 107.6;Early spermatids: 149.8;Late spermatids: 211.5;Proximal tubular cells: 91.7"	"Cancer enhanced"	"Detected in all"		"glioma: 41.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020376, HPA029515"	Approved		Approved	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA020376: AB_1855867, HPA029515: AB_10601492"	"prognostic unfavorable (2.30e-4)"	"unprognostic (7.80e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavorable (2.75e-5)"	"unprognostic (1.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.45e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (3.78e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.90e-3)"	"unprognostic (9.05e-3)"	4.7	9.4	11.0	3.7	12.4	3.7	3.9	11.8	10.8	4.7	13.3	4.8	4.2	4.9	5.2	8.7	16.1	5.9	8.1	11.0	11.0	10.0	6.8	3.5	5.1	12.3	12.9	8.2	6.7	6.6	9.4	3.7	11.7	6.4	4.4	4.4	4.5	6.4	4.6	4.2	4.1	5.1	12.2	3.9	6.2	7.1	12.1	5.8	7.0	6.0	5.9	5.2	5.7	16.1	130.1	37.6	23.1	93.0	18.9	25.3	16.7	32.5	18.5	18.7	32.7	34.7	23.5	62.9	21.0	29.4	44.5	26.9	52.6	26.9	19.0	48.1	27.9	17.9	11.1	62.2	44.4	18.6	26.8	31.8	50.2	27.7	32.6	25.1	17.7	61.2	44.4	42.4	26.4	17.3	27.7	48.3	38.0	47.5	52.1	35.9	14.4	39.8	17.2	6.8	43.6	49.8	23.5	14.9	68.9	20.9	44.8	41.4	14.5	15.1	24.8	45.5	30.3	26.9	53.0	72.8	21.9	39.9	49.7	2.5	6.2	5.9	3.1	4.4	2.3	5.4	3.0	3.8	9.6	6.1	4.5	4.1	2.9	4.7	7.1	9.3	4.0	4.8	11.0	12.4	11.8	10.8	11.0	11.0	12.3	12.9	11.7	12.2	12.1	16.1	2.1	3.2	1.5	11.4	5.2	6.8	16.9	20.5	8.6	5.2	8.3	5.8	13.1	11.5	11.4	5.5	2.1	12.8	4.5	2.4	107.6	8.6	149.8	62.9	5.4	4.2	4.8	7.2	9.3	8.0	7.5	9.9	3.1	9.4	1.3	16.5	5.0	9.8	9.5	1.7	9.8	5.0	4.1	4.4	5.8	211.5	8.4	4.3	7.2	0.0	5.7	46.8	2.1	7.1	13.8	7.1	3.5	6.0	10.1	6.5	3.1	91.7	28.3	3.1	13.1	5.1	20.0	30.1	22.5	7.6	8.5	4.7	3.9	16.1	7.3	7.7
PTCH1	"BCNS, NBCCS, PTCH"	ENSG00000185920	"Patched 1"	Q13635	9	95442980-95517057	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Cancer-related genes, Disease variant, Holoprosencephaly, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 26.7"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 237.5;Leydig cells: 191.0;Peritubular cells: 444.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 6.1"	"Lineage enriched"	"Detected in single"	9	"T-cells: 6.1"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 29.6;WM-115: 71.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013717, HPA075072"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"		"CAB013717: , HPA075072: AB_2686733"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.22e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.13e-6)"	"unprognostic (8.63e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.82e-1)"	3.0	3.5	9.5	4.0	11.6	0.7	2.8	24.6	5.6	26.7	2.7	11.3	8.1	15.6	2.7	2.9	7.1	8.1	2.9	4.7	17.8	4.6	2.2	5.5	2.2	16.0	12.7	5.0	6.4	2.5	2.1	3.8	8.0	6.8	12.3	8.3	7.5	4.0	3.0	3.2	11.6	2.4	7.0	3.3	12.5	14.5	24.0	2.1	4.7	4.8	3.0	7.2	2.9	4.5	10.1	4.7	20.3	12.9	3.0	5.0	11.4	1.9	1.7	2.2	1.4	4.9	4.8	8.0	3.3	3.8	4.4	22.3	11.7	1.6	1.4	7.9	7.8	0.0	4.8	2.3	2.7	0.2	4.2	4.7	2.4	2.2	1.4	4.3	4.2	3.5	7.3	9.1	1.0	1.9	0.1	3.2	29.6	7.2	1.8	0.0	15.5	4.2	1.6	1.5	13.8	7.0	7.1	6.8	2.9	18.8	1.8	2.1	1.1	2.6	12.9	13.6	1.5	18.0	16.8	5.3	3.8	3.9	71.0	0.0	0.0	0.0	6.1	0.0	3.3	0.7	1.1	2.5	0.0	0.2	1.9	2.2	0.0	0.3	0.0	0.0	1.2	1.7	9.5	11.6	24.6	5.6	4.7	17.8	16.0	12.7	8.0	7.0	24.0	4.5	6.0	0.0	6.4	49.0	3.0	4.0	2.7	3.0	4.6	20.3	3.5	4.6	5.9	25.8	2.7	0.0	41.7	3.0	11.8	2.0	5.9	3.5	88.4	12.2	89.8	5.4	21.7	0.4	15.2	4.2	1.9	27.2	1.1	11.0	1.3	2.6	6.4	2.9	0.8	20.2	10.7	11.0	4.1	0.9	1.2	237.5	191.0	1.4	12.4	4.7	0.8	55.6	54.6	39.7	20.5	2.4	3.1	444.5	3.1	4.9	3.1	1.6	5.5	13.4	39.5	4.8	9.4	4.4	35.5	3.0	4.4	1.4	6.5	71.7	4.7	1.4
PTCH2		ENSG00000117425	"Patched 2"	Q9Y6C5	1	44819844-44843253	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ovary: 24.6;parathyroid gland: 59.1;salivary gland: 75.2;testis: 25.6"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 107.8;Peritubular cells: 68.1;Plasma cells: 67.1;Theca cells: 138.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 9.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 11.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA046839			Supported	"Nucleoli,Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"	Nucleoli	"HPA046839: "	"unprognostic (6.54e-5)"	"unprognostic (1.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.89e-1)"	"unprognostic (7.42e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.67e-2)"	"prognostic favorable (5.74e-5)"	"unprognostic (2.92e-1)"	"unprognostic (5.74e-6)"	"unprognostic (1.55e-2)"	"unprognostic (4.86e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.81e-2)"	4.2	3.1	6.1	0.8	3.5	9.4	3.4	6.8	6.8	5.1	3.6	3.6	1.0	6.4	1.6	0.9	4.3	2.5	1.3	3.1	4.4	1.3	1.3	1.0	2.3	2.9	4.8	24.6	1.0	59.1	9.9	0.3	2.0	3.0	0.9	3.6	75.2	1.3	2.0	3.6	1.8	1.2	1.6	2.4	2.0	25.6	6.5	0.8	4.6	0.8	0.7	3.1	3.4	4.8	0.2	0.3	1.0	2.5	0.8	0.9	1.0	0.8	1.6	0.5	0.4	0.2	0.4	1.1	0.4	0.4	0.5	0.0	1.1	0.0	0.2	2.1	1.9	0.6	1.0	0.8	0.3	0.7	1.1	0.3	0.4	1.0	0.1	1.7	0.1	1.0	0.7	1.1	0.0	0.5	1.4	2.1	0.3	0.1	0.4	1.0	0.2	0.5	0.2	0.0	1.5	0.6	0.3	0.4	0.8	0.5	0.2	1.2	0.1	0.2	0.5	1.3	0.5	1.9	11.6	3.2	0.6	3.0	0.4	2.5	1.9	0.1	0.5	0.9	1.0	1.0	0.6	0.6	1.2	1.4	0.7	0.6	0.6	0.9	0.9	3.6	0.3	0.2	6.1	3.5	6.8	6.8	3.1	4.4	2.9	4.8	2.0	1.6	6.5	4.8	2.8	0.0	1.1	14.0	13.4	0.5	0.7	1.0	0.6	0.8	4.8	8.0	1.0	7.2	1.0	1.8	2.1	2.4	6.8	7.8	0.0	5.5	2.3	9.3	13.5	2.7	11.5	1.3	23.7	1.8	1.6	14.3	28.1	8.5	0.0	4.4	0.7	7.9	6.7	8.4	27.3	4.9	2.0	24.5	2.2	8.0	107.8	17.3	0.0	5.6	3.9	2.4	2.1	9.5	2.6	2.1	2.5	68.1	67.1	0.8	13.6	0.2	1.7	1.2	13.1	5.4	5.6	5.0	3.6	0.6	1.6	2.3	7.5	138.7	5.5	0.2
PTDSS1	"KIAA0024, PSS1, PSSA"	ENSG00000156471	"Phosphatidylserine synthase 1"	P48651	8	96261902-96336995	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016852	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Endoplasmic reticulum"	Nucleoplasm	"HPA016852: AB_1855878"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.89e-3)"	"unprognostic (7.48e-2)"	"unprognostic (5.68e-3)"	"prognostic unfavorable (1.08e-5)"	"prognostic unfavorable (9.83e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.55e-2)"	1.6	2.2	1.6	3.4	2.0	4.9	3.1	1.2	2.6	3.5	0.8	3.4	4.1	2.1	2.8	3.7	2.5	3.1	7.2	1.8	1.0	3.7	4.6	2.6	5.6	0.5	0.6	3.6	2.7	8.0	0.6	4.6	1.3	1.9	2.9	0.9	2.0	3.5	2.9	3.2	3.2	3.6	0.2	2.6	1.4	1.9	2.0	3.6	4.5	3.0	5.2	2.6	1.1	1.4	14.9	11.6	2.0	5.5	4.2	8.5	3.4	10.6	15.5	10.6	7.5	4.6	4.2	24.9	9.5	10.5	2.1	6.0	14.1	11.1	16.1	12.5	10.3	24.5	19.8	2.5	4.3	17.8	8.1	7.2	10.9	14.4	10.2	2.7	7.0	7.6	12.5	12.3	9.7	4.4	14.0	3.0	3.1	5.1	11.1	10.9	10.1	18.8	5.7	12.5	8.6	3.5	3.9	3.4	1.4	2.3	8.2	6.3	11.8	9.1	5.5	6.3	12.3	2.5	13.3	11.8	5.7	19.3	7.5	10.5	2.6	1.5	1.7	1.6	2.5	1.7	2.8	2.2	4.0	2.2	2.5	1.8	0.9	3.2	1.7	1.2	1.7	6.7	1.6	2.0	1.2	2.6	1.8	1.0	0.5	0.6	1.3	0.2	2.0	1.4	12.4	19.2	9.1	8.8	50.5	31.6	18.9	22.6	42.7	10.2	22.9	18.4	94.5	14.3	15.6	11.0	10.4	78.4	23.6	11.9	1.9	20.5	60.1	6.6	9.1	22.9	5.4	38.3	29.3	44.9	54.1	18.0	14.8	9.3	32.4	17.6	34.2	32.1	45.9	5.0	29.2	17.1	10.2	45.3	31.5	52.2	23.3	36.0	19.6	15.9	39.3	4.7	29.9	21.1	8.7	23.9	11.9	25.9	45.5	21.4	16.6	19.0	5.2	4.7	0.0	13.8	15.8	12.1	18.8	33.1	33.5	80.9	34.3	14.6	34.8	16.3
PTEN	"BZS, MHAM, MMAC1, PTEN1, TEP1"	ENSG00000171862	"Phosphatase and tensin homolog"	P60484	10	87863625-87971930	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Lipid metabolism, Neurogenesis"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 60.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB004076, HPA031335"	Approved		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"CAB004076: AB_390810, HPA031335: AB_2797221"	"unprognostic (8.72e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.41e-1)"	64.0	25.4	17.8	18.6	19.3	12.9	47.6	34.5	23.4	54.8	15.6	28.1	12.9	27.4	18.6	28.3	35.2	15.6	29.7	20.4	18.4	22.6	39.2	39.5	21.4	16.6	17.8	28.0	33.2	11.9	17.3	30.5	16.4	26.3	14.6	30.0	19.6	16.5	23.7	25.9	24.5	22.2	14.5	40.0	25.6	28.2	19.7	31.8	26.1	14.0	16.5	28.1	38.4	17.6	23.5	10.8	12.3	11.2	28.5	19.7	10.9	12.5	28.0	14.5	20.4	10.9	28.0	28.1	8.0	20.9	8.3	14.1	16.6	14.3	22.8	14.1	4.7	9.3	28.5	13.8	30.1	31.9	15.3	13.5	38.7	18.0	23.7	60.3	20.8	17.7	7.0	72.6	13.5	18.1	17.8	56.3	4.6	19.9	0.0	27.6	6.4	20.8	22.9	13.4	4.5	19.9	16.6	7.9	23.0	9.7	21.9	45.2	17.9	44.6	10.8	18.3	10.1	23.9	32.9	30.7	14.6	29.2	2.9	21.3	14.2	25.8	6.8	21.8	7.2	7.9	7.2	6.6	10.3	6.8	8.3	8.3	60.5	8.9	15.6	8.2	7.0	4.5	17.8	19.3	34.5	23.4	20.4	18.4	16.6	17.8	16.4	14.5	19.7	17.6	67.2	35.3	63.3	83.6	48.3	56.1	57.4	31.5	47.3	113.0	49.4	41.9	46.5	57.2	31.2	29.5	39.6	25.8	64.4	57.7	33.2	24.7	70.1	40.0	114.5	56.0	31.2	52.0	141.0	30.0	62.2	79.3	39.8	33.6	25.4	39.6	53.9	64.1	35.0	45.4	132.4	44.7	12.2	206.1	97.2	92.1	56.8	105.2	62.2	196.8	101.5	61.6	44.3	139.2	95.7	30.6	39.7	54.5	39.3	45.1	50.1	38.0	31.2	61.2	92.1	66.4	170.7	33.5	25.4	45.2	60.1	57.3	46.3	44.7	46.1	64.0
PTGDR	"DP, DP1, PTGDR1"	ENSG00000168229	"Prostaglandin D2 receptor"	Q13258	14	52267698-52276724	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Mast cell degranulation"	"G-protein coupled receptor, Receptor, Transducer"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 7.9;lymphoid tissue: 6.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 50.6;NK-cells: 187.4;T-cells: 31.4"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.0"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 68.0;NK-cell: 90.3"	"Group enriched"	"Detected in many"	33	"NK-cells: 90.3;T-cells: 68.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							HPA049668	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"			"HPA049668: "	"unprognostic (9.32e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.11e-3)"	"unprognostic (5.00e-2)"	"unprognostic (9.38e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.60e-8)"	"unprognostic (1.14e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.89e-2)"	2.0	0.5	0.2	2.1	1.7	1.4	1.2	0.8	0.7	2.1	2.6	5.6	0.7	1.5	1.0	0.4	1.3	1.6	1.9	0.1	0.3	0.5	1.1	1.7	3.2	2.4	0.6	0.8	0.3	0.4	2.1	0.2	0.4	0.8	7.9	0.0	1.1	0.4	0.6	0.6	1.4	0.8	1.5	6.3	1.3	0.2	0.4	0.9	1.1	0.4	1.1	0.9	1.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	68.0	0.0	33.5	0.1	9.0	40.9	0.1	0.0	1.4	22.5	2.3	90.3	0.4	0.2	0.2	12.9	0.2	1.7	0.8	0.7	0.1	0.3	2.4	0.6	0.4	1.5	0.4	0.1	2.9	3.2	0.0	0.0	0.9	0.5	0.0	0.0	0.6	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	50.6	3.2	0.0	0.0	0.0	0.2	0.1	2.0	1.2	2.7	0.2	0.0	0.0	1.5	1.1	0.1	1.3	0.2	2.2	0.5	0.1	0.0	0.2	7.5	0.0	1.9	0.4	0.0	0.0	4.6	1.8	1.0	0.4	0.0	187.4	0.0	0.1	0.0	2.8	0.0	4.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	5.5	0.0	0.0	0.1	0.1	0.0	31.4	2.2	14.6	0.0
PTK2	"FADK, FAK, FAK1, PPP1R71"	ENSG00000169398	"Protein tyrosine kinase 2"	Q05397	8	140657900-141002216	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 295.2;Excitatory neurons: 584.9;Oligodendrocyte precursor cells: 353.9;Oligodendrocytes: 791.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001842, CAB004036, HPA029671"	Approved		Supported	"Vesicles,Focal adhesion sites,Cytosol"		NA	Yes		25000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Focal adhesion sites"	"Vesicles, Cytosol"	"CAB004036: AB_2269034, HPA001842: AB_1855891, HPA029671: AB_10610288"	"prognostic unfavorable (3.21e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-2)"	51.0	40.4	83.8	19.5	115.1	6.7	42.1	62.4	99.9	40.3	51.0	37.2	25.8	37.3	49.7	25.6	34.0	32.1	36.9	84.5	77.3	42.6	30.1	39.4	25.3	79.1	87.6	33.7	32.1	53.1	21.3	74.2	81.0	34.0	35.3	35.5	39.9	41.6	38.7	29.6	29.5	37.6	67.6	22.8	32.8	38.9	86.7	11.9	38.7	39.4	25.8	43.9	34.0	154.5	52.6	81.9	111.0	40.3	45.8	48.8	71.6	50.8	70.0	46.3	45.3	35.9	42.1	31.7	111.7	65.3	65.0	60.3	66.1	116.0	69.6	0.3	30.8	70.1	44.3	50.0	62.5	0.1	31.8	33.4	55.8	58.0	81.0	121.5	139.0	44.0	72.0	0.8	62.9	91.0	0.9	0.7	43.2	113.2	90.3	46.8	60.9	1.5	97.7	117.3	43.9	54.8	79.0	25.0	52.0	97.2	59.2	1.2	84.9	45.2	85.5	54.0	58.1	0.0	0.6	3.4	58.7	0.6	62.9	1.6	3.3	0.0	0.2	1.4	0.0	5.3	0.6	0.0	4.5	6.3	4.4	1.6	1.3	4.7	0.8	6.1	0.2	3.9	83.8	115.1	62.4	99.9	84.5	77.3	79.1	87.6	81.0	67.6	86.7	154.5	71.3	32.1	33.1	295.2	20.6	33.3	70.1	36.3	64.9	55.2	29.3	23.5	29.6	32.9	32.1	55.2	60.5	37.0	8.0	23.1	23.5	27.2	68.4	29.3	43.3	54.3	25.8	8.4	584.9	23.3	53.7	37.2	37.8	46.5	9.5	84.7	37.5	15.7	8.1	67.3	263.6	23.0	30.5	15.2	15.9	38.8	23.9	19.4	24.9	159.3	3.9	40.9	0.0	353.9	791.4	43.1	23.5	21.8	1.7	82.4	29.3	25.6	33.7	55.0	98.6	32.7	128.4	88.9	65.5	42.8	25.9	33.2	3.4	67.0	24.1	87.3
PTPN11	"BPTP3, NS1, PTP2C, SH-PTP2, SHP-2, SHP2"	ENSG00000179295	"Protein tyrosine phosphatase non-receptor type 11"	Q06124	12	112418351-112509918	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005377	Approved		Supported	"Nucleoplasm,Nucleoli rim,Actin filaments,Cytosol"		NA	NA		74000	"Cluster 6: Non-specific - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Nucleoli rim"	"Actin filaments, Cytosol"	"CAB005377: AB_632401"	"unprognostic (2.18e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.80e-2)"	62.9	36.6	74.6	34.7	91.7	46.3	37.6	72.7	115.7	37.9	38.4	32.5	27.6	37.8	28.7	38.9	24.3	29.4	68.7	66.1	85.6	39.7	53.0	34.4	35.6	79.0	84.1	26.2	31.6	53.4	16.1	38.0	85.7	35.2	30.6	51.8	25.9	42.4	75.1	32.1	26.1	45.7	83.4	26.7	30.4	18.2	81.7	35.5	46.8	64.0	32.5	40.1	23.5	106.3	116.9	107.6	77.0	73.4	109.7	106.1	92.7	136.4	148.2	105.5	78.5	107.7	43.4	124.5	69.4	127.4	66.7	68.1	100.1	121.6	173.8	93.1	85.0	181.5	102.6	59.8	109.2	145.8	108.0	86.6	119.6	113.6	159.8	101.3	88.7	92.0	140.2	41.3	103.3	83.2	101.0	69.7	94.1	112.3	73.4	102.4	114.6	70.5	97.3	126.7	53.3	66.1	133.7	99.8	85.2	77.6	114.8	97.8	108.1	122.9	110.0	74.2	121.8	79.4	141.6	120.2	102.2	99.7	117.7	32.2	11.7	16.8	14.8	10.2	14.0	18.1	13.3	12.4	13.6	20.8	15.3	11.9	10.7	12.6	13.7	18.3	10.9	7.2	74.6	91.7	72.7	115.7	66.1	85.6	79.0	84.1	85.7	83.4	81.7	106.3	49.0	60.9	68.2	27.7	25.8	25.6	39.9	25.3	20.5	29.9	40.5	32.4	131.6	24.3	41.8	36.8	16.7	23.5	34.2	25.4	33.2	37.5	63.1	31.3	92.6	46.2	13.1	21.7	67.6	42.8	25.3	35.8	21.9	40.9	28.4	33.1	26.0	101.5	26.8	13.5	54.7	22.0	18.3	33.3	21.6	28.5	51.6	31.8	14.2	40.3	31.1	59.8	29.9	32.6	73.0	59.3	19.6	79.7	37.0	73.4	16.6	39.8	23.5	22.2	32.9	58.2	49.2	7.1	6.6	37.5	27.4	35.2	31.7	30.5	22.2	66.8
PTPN14	PEZ	ENSG00000152104	"Protein tyrosine phosphatase non-receptor type 14"	Q15678	1	214348700-214552449	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 91.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011469, HPA053864, CAB069441"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB011469: AB_299202, CAB069441: , HPA053864: AB_2682281"	"unprognostic (1.54e-1)"	"unprognostic (8.19e-2)"	"unprognostic (5.42e-5)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (7.43e-2)"	"unprognostic (8.34e-3)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-3)"	7.5	8.0	3.7	1.8	1.5	0.2	10.6	1.5	3.7	5.2	13.4	7.6	0.9	8.2	2.5	6.0	7.3	3.3	6.0	3.3	0.8	8.2	0.7	4.6	1.3	2.4	2.4	6.6	4.3	3.3	1.8	7.8	2.1	6.7	2.3	0.6	6.5	6.6	19.8	16.2	2.8	7.9	1.4	3.5	4.5	3.9	4.2	2.1	5.3	10.2	1.8	5.6	5.6	1.9	21.1	9.2	7.2	10.6	12.3	20.9	21.6	23.2	21.3	17.3	14.4	18.8	10.7	0.1	25.3	53.6	10.0	18.1	10.0	25.7	29.0	0.2	7.7	1.9	26.6	3.5	22.2	0.2	1.0	15.6	26.1	30.0	47.4	28.1	33.8	0.6	0.1	0.2	41.8	2.3	0.2	0.2	16.2	3.7	9.9	0.3	36.3	0.1	30.6	10.5	0.1	1.7	28.7	18.4	11.6	25.1	18.4	0.7	61.4	40.3	15.9	14.6	33.3	1.2	0.1	0.2	21.6	0.3	34.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.7	1.5	1.5	3.7	3.3	0.8	2.4	2.4	2.1	1.4	4.2	1.9	60.3	73.7	12.6	47.3	1.3	56.5	32.1	39.4	45.5	0.6	20.3	29.8	20.5	14.3	32.7	29.5	0.0	38.8	1.3	1.0	7.9	12.9	8.8	42.5	25.9	53.5	3.5	0.0	47.9	11.0	14.2	20.8	9.2	55.2	1.3	13.5	40.0	0.9	4.5	0.0	6.0	4.1	4.1	1.5	7.7	4.4	26.1	2.4	10.6	91.8	0.3	3.9	3.1	39.2	2.1	31.2	0.3	29.3	1.6	30.6	0.3	14.4	18.5	1.3	19.7	38.0	20.1	1.2	10.6	18.3	36.1	24.2	3.7	46.3	2.9	28.9
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase non-receptor type 22"	Q9Y2R2	1	113813811-113871753	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Immunity"	"Hydrolase, Protein phosphatase"	"Diabetes mellitus, Disease variant, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.0;lymphoid tissue: 20.3"	"Group enriched"	"Detected in many"	4	"B-cells: 67.4;dendritic cells: 176.0;NK-cells: 108.1;Plasma cells: 79.6;T-cells: 151.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 69.3;HL-60: 27.7;U-266/70: 29.2;U-698: 37.5;U-937: 28.4"	"Region enriched"	"Detected in single"	11	"cerebellum: 5.3"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Vesicles, Plasma membrane"	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	2.0	1.5	0.2	11.5	0.2	38.0	2.3	0.4	0.5	1.8	0.6	4.0	6.4	1.0	1.1	1.7	0.9	4.8	0.6	0.1	0.2	0.6	2.0	7.5	20.3	0.5	0.2	0.6	1.3	0.3	0.3	0.8	0.4	1.0	4.3	0.4	1.3	0.6	0.3	0.9	8.6	1.6	0.2	13.2	5.2	1.4	0.6	20.0	0.7	0.2	13.5	4.2	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.9	0.4	0.0	0.7	0.0	0.4	69.3	0.1	0.2	0.0	0.0	0.0	0.1	0.5	6.5	0.0	10.0	0.0	0.0	0.2	27.7	21.1	5.7	0.0	2.8	0.2	5.1	10.6	17.2	0.1	15.7	10.3	0.2	20.1	15.7	0.0	0.1	0.0	1.2	6.7	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.0	5.0	16.0	0.3	0.4	0.5	29.2	6.6	37.5	11.1	28.4	0.1	15.8	4.8	25.0	17.0	1.3	20.1	9.9	8.4	13.6	8.7	7.4	5.0	12.1	2.4	11.0	0.6	5.2	14.5	7.3	0.2	0.2	0.4	0.5	0.1	0.2	0.5	0.2	0.4	0.2	0.6	0.8	2.2	0.0	6.5	0.7	67.4	2.5	0.2	0.0	1.2	0.7	2.2	2.4	0.8	0.0	0.2	1.8	2.1	0.1	176.0	2.2	0.0	0.1	0.4	0.7	0.5	1.7	0.0	16.6	3.2	0.6	0.3	2.2	12.8	1.0	27.8	0.0	0.4	0.5	7.1	0.0	2.5	1.2	0.0	17.3	26.8	1.0	0.0	26.4	3.6	2.8	14.4	0.0	108.1	0.0	1.7	0.5	0.8	0.0	79.6	0.3	4.3	0.1	2.2	0.5	13.1	0.6	1.4	0.4	0.6	0.3	2.7	0.1	151.2	0.0	2.2	0.3
PTPN23	"DKFZP564F0923, HD-PTP, KIAA1471"	ENSG00000076201	"Protein tyrosine phosphatase non-receptor type 23"	Q9H3S7	3	47381011-47413435	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016845	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA016845: AB_1855926"	"unprognostic (1.17e-3)"	"unprognostic (8.68e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.07e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (3.05e-2)"	"unprognostic (4.40e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.68e-2)"	18.5	19.1	6.2	12.6	9.2	14.7	17.4	5.8	10.5	23.3	5.1	16.3	14.3	20.9	7.5	19.0	19.2	8.4	13.2	7.1	7.2	17.5	14.0	18.7	9.1	8.8	7.2	23.5	20.2	23.5	30.9	11.6	8.5	18.7	6.5	8.5	20.0	11.4	30.0	26.4	18.4	8.8	5.5	20.0	16.1	15.6	7.7	8.0	27.1	8.9	7.3	18.5	20.4	14.4	21.5	29.9	16.4	21.4	21.0	16.0	15.8	19.2	18.9	17.5	14.8	25.0	20.7	15.1	17.2	21.9	31.2	19.0	14.3	20.8	8.5	14.3	15.1	21.0	22.2	24.0	23.0	12.3	27.5	21.4	20.9	22.9	23.2	12.4	21.7	12.5	15.9	20.3	19.0	30.2	11.5	10.4	17.5	14.9	20.1	7.2	7.9	18.5	13.2	40.9	8.6	20.6	17.1	35.6	13.6	9.8	20.3	12.0	22.4	26.7	22.2	37.7	27.5	28.8	20.4	8.7	29.0	11.6	19.5	0.8	0.2	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.3	0.3	6.2	9.2	5.8	10.5	7.1	7.2	8.8	7.2	8.5	5.5	7.7	14.4	11.1	9.6	7.0	17.0	8.2	8.0	5.2	6.9	13.6	11.7	9.5	8.0	8.7	8.6	9.5	5.5	14.6	10.6	11.0	15.7	1.9	10.5	2.1	10.3	13.7	12.4	7.3	2.5	9.8	8.9	7.9	9.1	26.5	21.1	2.5	14.9	11.4	12.7	13.9	16.8	12.0	16.3	20.3	10.4	5.5	3.1	19.3	9.5	12.4	7.5	8.7	8.8	6.2	9.5	14.3	13.5	10.4	13.5	15.4	9.3	14.6	9.4	12.6	14.2	6.6	10.2	8.8	13.6	13.3	13.2	10.9	9.3	8.9	9.4	12.8	8.2
PTPRC	"CD45, GP180, LCA, T200"	ENSG00000081237	"Protein tyrosine phosphatase receptor type C"	P08575	1	198638457-198757476	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Hydrolase, Protein phosphatase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 208.6;lymphoid tissue: 329.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 525.2;dendritic cells: 1026.4;Macrophages: 534.1;monocytes: 554.9;NK-cells: 769.3;Plasma cells: 474.2;T-cells: 1049.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 209.9;HEL: 118.0;HL-60: 108.1;JURKAT: 266.4;MOLT-4: 161.1;THP-1: 87.0;U-266/70: 93.7;U-266/84: 91.2;U-698: 123.4;U-937: 94.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000052, HPA000440, CAB002800, CAB056154, CAB068221"	Enhanced		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		24000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.06e-2)"	32.8	11.6	3.8	248.5	3.3	208.6	13.9	4.4	4.3	14.9	6.9	26.4	27.4	11.3	5.6	15.1	8.4	45.7	7.3	3.5	5.6	7.0	29.6	68.6	329.9	12.9	8.6	5.7	5.6	4.0	2.9	23.5	11.5	11.6	30.5	2.0	13.8	6.6	4.6	5.7	42.9	25.3	7.9	202.5	37.9	5.5	6.9	306.9	7.0	7.6	251.2	62.1	5.2	14.7	0.4	0.0	0.2	0.2	0.0	0.0	0.8	0.3	0.3	0.1	0.0	0.0	0.1	209.9	0.3	0.7	0.2	0.3	0.0	0.2	0.4	0.6	0.0	118.0	0.2	0.1	0.0	108.1	0.7	0.0	0.0	0.3	0.0	0.4	0.5	266.4	2.4	3.3	0.3	0.1	161.1	65.0	0.5	0.2	0.2	4.6	0.4	0.3	0.1	0.1	1.2	1.8	0.1	0.4	0.5	0.2	0.3	87.0	1.3	0.0	0.8	0.8	0.4	93.7	91.2	123.4	0.1	94.5	0.4	226.1	480.0	521.4	634.4	885.8	541.8	249.0	437.0	618.1	385.8	245.8	489.8	494.1	844.3	506.9	1015.8	57.4	508.6	1340.6	3.8	3.3	4.4	4.3	3.5	5.6	12.9	8.6	11.5	7.9	6.9	14.7	12.6	44.8	62.3	0.7	525.2	15.8	0.9	0.0	4.0	0.3	6.0	9.3	4.6	5.7	14.2	1.8	0.0	0.6	1026.4	1.0	0.0	0.7	2.4	2.3	2.3	15.1	1.2	58.8	0.7	0.0	0.9	17.2	46.9	2.7	246.5	0.1	14.6	6.9	96.0	0.0	1.7	0.4	0.0	334.9	214.5	3.5	1.2	534.1	21.4	201.4	554.9	0.1	769.3	2.5	0.7	0.1	0.8	0.0	474.2	1.1	0.1	2.5	11.7	0.2	6.6	7.4	6.7	0.3	0.6	1.8	15.2	0.8	1049.1	5.4	0.9	0.8
PTPRF	LAR	ENSG00000142949	"Protein tyrosine phosphatase receptor type F"	P10586	1	43525187-43623666	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 259.9;Extravillous trophoblasts: 290.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 314.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012710	Uncertain		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		160000000		"Cluster 37: Intestine - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA012710: AB_1855933"	"unprognostic (8.20e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (4.59e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.68e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (7.03e-4)"	"unprognostic (2.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.58e-1)"	91.7	11.9	47.1	14.0	48.4	1.8	57.4	22.3	45.6	36.3	4.7	79.5	70.5	28.0	71.9	101.7	70.5	30.4	7.6	45.3	39.9	27.7	107.2	35.4	4.7	33.1	43.6	22.1	56.8	31.1	23.5	55.7	33.1	67.3	51.4	24.7	101.7	43.1	2.7	107.9	78.5	35.0	30.4	4.0	49.7	9.4	45.6	29.6	23.8	3.4	26.2	40.0	51.2	37.4	165.6	76.5	49.0	58.0	11.2	0.6	274.3	92.1	36.1	73.9	62.6	82.0	214.9	0.4	25.6	40.2	59.2	124.7	57.5	200.7	89.1	2.0	72.1	1.0	48.7	75.3	33.8	1.2	1.3	11.3	113.2	106.4	174.9	92.6	111.5	7.7	25.4	7.1	27.5	94.0	1.2	1.3	75.9	89.8	21.0	57.2	86.9	3.7	28.3	241.5	73.3	28.0	90.8	314.0	11.8	128.8	91.5	17.3	88.2	1.6	116.5	7.5	126.1	3.1	2.7	0.4	7.4	3.9	233.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.1	48.4	22.3	45.6	45.3	39.9	33.1	43.6	33.1	30.4	45.6	37.4	2.3	157.0	101.1	39.2	2.3	62.8	51.3	67.4	52.9	33.5	146.3	102.9	7.6	130.1	74.9	86.5	43.8	64.3	1.4	259.9	0.0	147.4	4.9	80.6	17.2	7.7	100.9	8.0	40.6	120.8	290.1	19.8	93.8	70.6	5.1	72.8	10.4	159.6	14.1	185.1	16.1	171.7	50.8	4.9	5.8	8.5	6.8	3.4	12.4	7.5	2.9	27.2	2.1	16.6	68.1	165.0	124.7	7.2	1.8	68.0	208.1	13.9	128.3	31.0	0.0	15.8	18.5	9.0	37.5	107.5	91.4	66.2	3.9	9.6	142.5	78.7
PTPRN2	"IA-2beta, ICAAR, KIAA0387, phogrin"	ENSG00000155093	"Protein tyrosine phosphatase receptor type N2"	Q92932	7	157539056-158587823	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Protein phosphatase, Receptor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9;pancreas: 98.1"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 131.1;Excitatory neurons: 439.6;Inhibitory neurons: 433.4;Oligodendrocyte precursor cells: 138.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 40.8"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 23.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 23.6"	"Cell line enhanced"	"Detected in many"		"AF22: 45.5;HDLM-2: 42.0;MOLT-4: 22.1;NB-4: 43.0;SCLC-21H: 23.8;SH-SY5Y: 25.4;U-87 MG: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006900, HPA007255, HPA026656"	Enhanced		Approved	Vesicles		NA	NA		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA006900: AB_1079715, HPA007255: , HPA026656: AB_1855912"	"unprognostic (2.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (9.37e-5)"	"unprognostic (7.12e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.16e-2)"	3.8	16.5	29.4	2.7	34.3	1.3	2.9	0.0	49.9	2.1	0.0	7.7	8.3	3.0	4.2	1.9	10.8	7.6	3.1	35.2	22.7	3.9	1.6	4.8	3.4	7.9	3.1	8.7	98.1	1.0	41.0	2.1	3.4	17.3	6.1	9.2	12.9	3.6	1.2	0.8	6.7	2.1	0.1	13.4	40.2	6.2	14.1	1.6	8.7	1.9	2.5	4.2	2.1	20.5	0.1	0.4	45.5	3.6	0.1	0.2	0.1	0.4	0.3	0.0	0.1	0.0	4.0	0.0	1.2	0.5	9.4	0.3	1.0	0.0	0.0	42.0	0.8	0.0	0.0	7.3	1.1	0.0	0.1	2.0	0.8	0.1	0.5	0.3	0.0	3.4	0.1	0.3	0.0	0.7	22.1	43.0	5.7	13.7	3.2	0.0	2.7	0.2	0.2	0.0	23.8	25.4	0.0	0.1	0.0	0.0	0.0	20.9	6.2	9.2	4.3	0.1	1.5	0.3	0.1	0.0	27.7	17.4	6.8	14.1	1.5	2.8	1.3	0.2	0.5	3.5	2.1	1.4	2.1	4.2	2.4	1.4	23.6	2.4	0.0	0.6	5.3	1.3	29.4	34.3	0.0	49.9	35.2	22.7	7.9	3.1	3.4	0.1	14.1	20.5	40.7	3.2	12.9	16.3	18.4	2.3	12.7	1.3	4.0	30.2	1.9	2.2	3.1	10.0	9.1	40.5	10.4	0.4	8.7	5.9	35.2	22.9	51.9	8.7	2.5	26.3	131.1	6.6	439.6	13.1	0.4	13.0	41.8	0.8	19.0	14.1	44.3	0.8	44.5	11.8	433.4	43.3	6.1	7.0	11.3	19.3	12.5	7.9	12.4	27.2	5.7	67.3	15.5	138.2	11.0	7.3	7.0	19.5	5.4	15.0	6.5	3.8	52.6	8.0	26.3	1.4	7.0	62.8	16.3	4.8	1.4	0.7	14.8	32.7	9.7	24.8
PTPRO	"GLEPP1, NPHS6, PTP-oc, PTP-U2, PTPU2"	ENSG00000151490	"Protein tyrosine phosphatase receptor type O"	Q16827	12	15322257-15602175	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 26.8;kidney: 36.3"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 193.6;Inhibitory neurons: 231.1;Oligodendrocyte precursor cells: 126.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 8.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 9.9;NTERA-2: 5.8;SH-SY5Y: 6.1;THP-1: 2.7"	"Region enhanced"	"Detected in all"		"olfactory bulb: 175.9"	"Low region specificity"	"Detected in all"			HPA034525	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA034525: AB_10669785"	"unprognostic (3.68e-2)"	"unprognostic (3.49e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.93e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	1.8	0.8	8.7	3.0	9.4	0.2	0.8	0.0	10.3	1.3	0.1	10.4	1.7	4.8	1.4	0.4	1.0	1.2	0.5	9.8	8.9	36.3	1.3	6.8	3.1	2.2	3.3	0.4	0.4	0.3	2.4	4.4	5.3	0.5	26.8	7.5	0.5	0.8	0.3	0.4	2.0	6.6	0.9	3.4	0.8	0.5	9.5	1.2	0.3	0.5	3.2	1.5	0.4	2.9	0.0	0.1	0.3	0.1	0.2	0.0	0.2	0.0	0.0	0.5	1.3	0.0	0.0	0.1	0.1	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	5.8	1.2	0.0	0.0	0.0	0.0	0.1	0.2	1.5	6.1	0.9	0.0	0.1	0.1	0.1	2.7	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.3	0.0	0.1	1.2	0.0	6.0	0.0	0.0	12.3	0.0	8.9	1.7	0.4	8.5	8.6	2.8	1.2	0.1	0.1	12.7	10.9	1.4	3.2	8.7	9.4	0.0	10.3	9.8	8.9	2.2	3.3	5.3	0.9	9.5	2.9	0.2	0.0	0.5	7.5	7.0	0.3	1.3	0.5	0.0	25.2	0.0	0.1	0.7	0.0	1.8	16.5	0.0	0.2	4.0	3.9	0.0	0.4	0.0	0.8	0.2	1.1	3.6	0.0	193.6	0.0	0.2	0.9	0.0	0.6	0.0	0.0	1.1	0.2	26.1	25.2	231.1	8.3	0.0	21.1	10.6	0.6	0.6	10.5	0.0	17.8	13.8	0.6	1.0	126.7	6.3	0.1	9.8	0.4	1.0	0.1	0.1	0.2	0.0	4.8	0.0	2.1	0.7	0.6	1.1	0.1	0.4	0.3	1.0	0.1	22.4	0.8
PTRH2	"BIT1, CFAP37, CGI-147, PTH2"	ENSG00000141378	"Peptidyl-tRNA hydrolase 2"	Q9Y3E5	17	59674636-59707626	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	Apoptosis	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012897	Supported		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA012897: AB_1855949"	"unprognostic (2.26e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (6.38e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.59e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.01e-8)"	"unprognostic (5.43e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.49e-2)"	20.8	25.9	24.3	17.3	25.1	14.5	27.6	25.0	31.9	19.7	23.6	24.1	15.3	18.8	48.5	18.1	18.4	18.2	14.5	25.1	26.1	18.5	45.7	14.7	19.0	25.9	26.1	16.9	19.5	18.6	14.1	18.6	26.7	20.7	27.5	10.2	15.9	18.6	25.0	15.7	13.2	22.9	24.8	17.5	16.1	19.5	24.9	17.3	16.2	20.9	24.1	44.0	11.8	27.4	75.9	142.9	44.3	40.8	84.8	72.6	47.4	70.6	63.8	60.7	89.0	94.1	57.7	54.1	105.0	60.9	101.1	73.3	98.4	93.8	89.4	104.2	133.2	96.7	72.3	176.2	129.4	86.0	52.5	82.0	120.9	93.9	108.5	42.8	102.5	37.4	111.3	58.2	92.4	187.9	74.2	71.2	38.0	194.5	113.4	39.1	74.8	80.7	103.7	109.2	57.9	74.2	36.7	39.6	91.5	50.7	93.1	61.1	67.2	77.8	77.8	47.1	77.9	73.6	91.9	82.3	50.7	54.4	60.4	6.1	69.0	2.9	22.7	67.4	30.9	43.1	26.3	25.7	50.0	33.1	37.4	27.0	29.0	34.8	86.0	59.4	34.0	37.9	24.3	25.1	25.0	31.9	25.1	26.1	25.9	26.1	26.7	24.8	24.9	27.4	21.4	16.0	13.6	5.5	18.7	36.7	50.1	48.1	27.9	4.1	17.1	22.4	15.4	11.5	51.6	11.0	4.2	26.8	13.0	8.9	11.7	27.2	22.1	23.4	33.1	22.5	6.7	17.9	9.8	25.6	25.0	29.7	17.3	24.1	22.8	12.8	12.8	31.5	16.9	8.4	9.1	10.3	22.4	9.7	17.2	12.0	17.4	14.6	14.2	2.8	11.4	7.2	13.4	7.5	11.5	28.8	12.3	9.8	24.8	35.1	10.0	16.5	33.3	3.4	13.1	25.4	32.2	33.4	13.3	21.3	35.7	31.7	12.6	22.4	16.7	37.5
PTS	PTPS	ENSG00000150787	"6-pyruvoyltetrahydropterin synthase"	Q03393	11	112226367-112269955	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Lyase	"Disease variant, Phenylketonuria"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001481	Uncertain		Approved	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA001481: AB_1079716"	"unprognostic (2.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.66e-3)"	"unprognostic (8.38e-3)"	"unprognostic (4.58e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.05e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.65e-1)"	11.7	63.0	17.6	10.2	18.7	22.7	20.5	20.2	27.6	17.5	20.2	18.9	15.0	13.6	29.7	29.0	11.7	20.6	8.8	16.5	25.1	44.7	68.9	7.8	10.5	23.1	26.1	9.9	15.0	29.0	32.8	18.0	24.6	21.1	21.5	19.0	17.5	16.4	18.5	17.0	16.1	13.0	19.7	7.7	27.4	10.3	20.5	4.4	23.2	10.9	12.4	21.7	19.2	21.6	24.5	24.2	33.4	12.9	23.9	26.8	35.4	78.3	38.8	45.5	48.5	57.0	26.1	28.5	53.5	51.6	60.8	38.0	47.5	54.8	50.6	19.7	28.8	7.5	44.6	55.8	70.9	18.4	4.0	47.8	77.1	43.9	53.0	36.5	35.2	24.6	24.9	16.8	30.1	29.8	14.8	23.8	23.1	54.2	48.3	9.4	6.3	37.6	101.2	38.8	32.2	32.5	41.1	43.8	26.0	109.0	32.3	15.2	40.2	42.5	43.0	49.7	60.7	9.9	20.8	69.4	29.3	19.4	44.1	1.1	0.4	0.4	1.2	0.7	1.3	1.5	1.7	1.8	0.7	1.6	1.1	1.5	0.2	1.5	2.0	2.0	1.9	0.7	17.6	18.7	20.2	27.6	16.5	25.1	23.1	26.1	24.6	19.7	20.5	21.6	43.7	19.2	26.5	13.1	28.6	122.6	80.4	146.2	59.2	17.4	69.4	69.0	95.0	47.1	85.7	55.2	0.0	56.7	41.4	80.0	211.3	91.9	5.5	66.4	37.0	42.8	80.0	23.2	16.8	78.9	120.7	47.9	37.8	72.6	20.8	45.1	34.6	123.6	36.9	10.1	25.4	73.1	150.5	21.4	38.1	7.6	14.6	28.4	26.6	15.0	26.1	48.5	22.6	17.6	36.1	114.4	74.4	25.9	33.0	91.9	58.3	151.0	80.8	18.3	26.3	22.7	70.8	23.3	92.6	65.4	131.1	70.3	28.5	59.6	44.4	114.9
PUS1		ENSG00000177192	"Pseudouridine synthase 1"	Q9Y606	12	131929200-131945896	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051636, HPA057593"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"		"HPA051636: AB_2681560, HPA057593: AB_2683479"	"unprognostic (2.72e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.69e-2)"	"unprognostic (8.12e-3)"	"unprognostic (8.07e-2)"	"unprognostic (4.57e-3)"	"unprognostic (7.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (3.49e-8)"	"unprognostic (1.80e-3)"	"unprognostic (8.06e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.56e-2)"	12.5	14.9	10.1	14.9	8.4	23.0	10.4	8.2	10.2	9.7	7.6	11.9	9.7	12.5	14.0	16.5	11.2	7.1	8.7	8.9	5.9	13.0	21.6	9.0	18.5	7.1	5.1	8.6	14.8	5.4	8.7	6.4	6.2	10.9	7.9	5.0	9.3	6.8	14.2	14.4	14.0	7.4	4.4	15.8	12.7	13.0	6.9	8.6	9.5	4.8	10.6	14.2	10.7	9.2	45.3	58.1	13.7	24.0	13.0	21.5	82.2	34.5	14.2	25.4	16.3	64.5	28.7	53.2	38.3	18.6	19.9	56.0	44.4	32.2	16.3	24.0	90.6	54.0	30.9	56.9	34.0	93.5	47.4	21.7	25.6	28.9	24.8	12.3	25.0	36.8	68.0	15.6	14.9	77.9	61.9	83.4	71.5	36.7	87.3	57.8	19.2	55.4	20.8	61.7	37.5	20.8	28.6	38.9	32.5	13.1	42.5	99.3	22.7	20.2	43.3	43.1	50.0	43.5	35.5	64.5	20.7	73.6	28.4	1.0	1.3	0.2	2.0	1.0	1.5	4.6	1.7	2.1	1.1	4.2	2.4	1.3	1.1	5.6	0.9	3.0	1.8	0.9	10.1	8.4	8.2	10.2	8.9	5.9	7.1	5.1	6.2	4.4	6.9	9.2	7.0	0.0	6.1	9.8	10.7	29.6	22.3	8.4	6.2	6.2	10.7	10.5	5.3	8.6	6.2	5.5	22.9	13.9	11.7	10.9	5.9	12.3	0.9	6.6	10.1	11.1	14.4	13.2	11.9	9.6	19.1	8.3	15.3	7.7	16.5	11.7	6.1	12.9	15.2	0.0	8.4	20.1	10.2	7.3	8.1	3.0	7.8	7.2	7.2	9.4	8.8	4.4	6.2	5.0	7.1	16.3	6.9	9.4	8.8	35.4	4.0	13.7	4.9	10.0	6.6	15.9	9.3	18.5	19.7	14.7	22.7	8.6	9.5	14.3	18.8	21.4
PUS3	FKSG32	ENSG00000110060	"Pseudouridine synthase 3"	Q9BZE2	11	125893485-125903221	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038040, HPA063802"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA038040: AB_10697092, HPA063802: AB_2685126"	"unprognostic (5.89e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (7.67e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.92e-3)"	"unprognostic (4.47e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.44e-1)"	8.3	8.4	7.1	8.2	7.8	3.3	9.4	8.4	11.6	7.7	6.7	8.5	10.9	7.8	9.7	9.0	7.4	6.5	7.1	7.1	8.7	9.0	33.2	6.1	9.2	7.8	7.8	7.3	17.8	7.0	8.5	6.7	7.3	8.7	7.9	8.4	7.7	5.4	15.0	9.5	6.8	9.7	7.0	7.6	10.1	7.2	8.5	11.0	9.3	15.2	10.5	10.1	6.3	7.6	6.5	7.9	23.2	24.9	24.3	29.7	11.0	21.1	17.0	11.6	13.2	24.0	23.2	31.4	33.3	9.2	17.1	22.5	37.6	19.7	11.5	28.2	18.2	31.2	9.5	18.6	24.6	20.5	9.2	23.1	23.4	13.7	29.8	16.2	21.0	23.5	34.0	16.1	13.0	4.0	23.7	23.6	19.8	47.0	15.8	4.8	20.5	18.4	20.3	9.5	27.1	25.7	13.1	21.4	11.7	16.5	43.2	13.8	15.3	24.0	10.1	11.9	17.3	12.4	20.1	33.6	6.7	31.9	17.1	14.2	10.5	9.9	13.4	10.8	15.3	13.3	13.1	12.8	9.2	14.8	17.0	16.0	4.2	14.9	14.0	8.0	15.0	8.3	7.1	7.8	8.4	11.6	7.1	8.7	7.8	7.8	7.3	7.0	8.5	7.6	8.5	9.6	11.5	3.6	9.5	12.9	12.2	10.6	8.0	9.3	7.3	9.4	5.4	11.5	13.6	5.5	29.2	9.7	7.4	3.6	5.9	17.8	7.7	4.4	8.9	10.5	4.8	14.5	2.9	27.2	12.7	6.1	9.2	4.4	12.7	6.1	10.4	33.0	8.2	5.0	3.4	4.6	10.2	5.0	2.9	6.3	7.8	5.5	1.8	1.9	9.9	9.8	6.2	2.5	3.8	15.0	3.9	7.9	6.7	9.1	10.2	16.9	6.2	10.9	6.6	9.9	10.1	7.8	7.2	6.7	11.8	14.0	7.9	12.8	6.5	10.9
PXDN	"D2S448, D2S448E, KIAA0230, MG50, PRG2, PXN"	ENSG00000130508	Peroxidasin	Q92626	2	1631887-1744852	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 79.1;Endometrial stromal cells: 99.4;Endothelial cells: 95.1;Hepatic stellate cells: 71.4;Skeletal myocytes: 120.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 323.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA012375	Approved				"Secreted to extracellular matrix"	NA	NA		9100000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA012375: AB_1855965"	"unprognostic (4.37e-2)"	"prognostic unfavorable (6.28e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (8.16e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.15e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.34e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.18e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.54e-3)"	59.5	5.5	4.1	24.3	3.5	0.9	33.7	1.9	4.1	18.2	27.5	36.1	7.9	32.8	4.0	4.9	18.0	22.7	22.7	3.1	7.7	9.0	12.4	27.6	5.0	4.2	6.2	32.7	3.8	3.0	11.7	33.4	4.7	17.5	8.7	5.2	13.6	11.1	7.7	6.9	16.3	61.8	2.6	10.0	13.2	6.4	5.2	2.1	8.4	11.5	2.1	33.8	13.5	3.4	39.9	13.9	72.0	0.1	198.3	180.9	54.6	231.4	182.3	99.0	107.9	0.1	0.5	0.0	323.8	230.3	4.5	8.3	0.3	142.3	125.5	0.6	2.4	0.0	139.3	0.0	196.4	0.6	0.0	200.7	41.0	112.2	83.8	299.5	247.0	35.9	0.1	0.0	142.6	23.6	6.8	8.0	58.3	0.0	52.3	13.2	250.8	0.6	115.9	0.1	0.2	131.9	0.2	73.6	0.4	142.9	27.0	0.9	242.4	162.8	79.7	6.2	180.7	0.2	205.4	1.0	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.1	3.5	1.9	4.1	3.1	7.7	4.2	6.2	4.7	2.6	5.2	3.4	79.1	6.4	2.3	2.6	0.4	2.9	2.8	12.8	0.6	2.5	17.5	14.1	5.8	17.2	7.0	1.8	0.0	0.6	0.2	0.3	0.0	10.4	33.4	4.2	99.4	95.1	1.8	0.0	6.6	0.0	11.3	45.2	0.0	3.4	1.3	43.7	71.4	1.8	1.9	0.0	7.3	1.3	20.3	5.7	4.4	40.7	26.8	0.7	7.2	8.4	0.6	10.0	1.0	55.8	0.7	0.5	0.1	15.1	0.0	14.0	0.0	0.2	6.7	0.8	46.0	120.1	51.1	22.0	16.0	0.5	2.8	1.4	1.0	33.3	0.5	1.4
PYCR1	P5C	ENSG00000183010	"Pyrroline-5-carboxylate reductase 1"	P32322	17	81932384-81942412	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis, Stress response"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 111.8;salivary gland: 121.1"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 63.8;Extravillous trophoblasts: 63.8;Intestinal goblet cells: 83.4;Prostatic glandular cells: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 4.2"	"Group enriched"	"Detected in many"	8	"B-cells: 4.2;dendritic cells: 1.9;T-cells: 1.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047660	Approved					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA047660: AB_2680115"	"unprognostic (1.12e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.04e-2)"	"unprognostic (7.27e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (2.80e-1)"	"unprognostic (9.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (3.02e-3)"	"unprognostic (7.12e-2)"	"prognostic unfavorable (7.33e-12)"	"unprognostic (7.98e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.92e-2)"	7.5	4.1	13.8	13.8	14.1	12.5	17.4	13.2	15.2	24.2	9.6	23.8	14.3	10.6	2.5	18.7	9.7	8.9	10.0	12.5	14.4	6.3	8.7	13.6	6.9	16.1	13.9	7.5	111.8	1.9	21.6	11.7	14.8	25.5	14.4	0.9	121.1	7.8	11.5	6.3	12.5	12.2	12.7	8.0	42.4	15.1	15.8	2.6	8.5	2.0	6.7	12.0	10.3	14.2	107.4	111.9	62.7	228.3	36.7	69.0	117.2	176.0	85.4	54.7	73.7	129.3	116.9	163.2	38.0	188.9	33.3	45.8	148.2	67.1	32.7	42.4	18.6	96.5	56.5	350.8	213.8	64.8	70.6	58.5	129.8	68.2	178.7	64.8	95.5	129.4	314.0	147.2	35.1	376.4	68.1	49.5	52.8	291.9	170.1	0.9	105.6	205.5	49.9	38.7	237.7	167.2	36.9	203.6	219.5	46.3	210.0	117.1	70.1	53.7	201.8	91.4	66.3	183.4	141.3	156.2	57.2	0.8	178.1	0.0	0.1	0.0	0.2	0.2	0.4	4.2	0.7	0.2	1.3	1.8	1.6	1.2	0.0	0.3	0.0	1.9	0.3	1.1	13.8	14.1	13.2	15.2	12.5	14.4	16.1	13.9	14.8	12.7	15.8	14.2	2.3	0.0	3.9	2.3	9.1	7.0	11.4	12.2	4.6	0.3	50.6	29.5	0.6	1.5	7.2	3.7	0.0	2.0	2.3	17.2	0.0	13.3	13.8	3.4	14.6	4.7	10.8	27.8	0.9	63.8	63.8	24.9	35.7	13.8	4.5	13.9	2.5	1.8	5.0	3.3	1.4	83.4	8.2	0.0	5.4	32.4	7.5	0.8	8.8	0.0	0.7	0.5	0.0	3.5	0.7	48.0	19.5	3.8	34.1	59.6	1.2	1.9	1.3	0.2	0.0	3.3	17.8	28.2	16.9	8.0	6.0	3.8	1.9	15.5	43.1	8.6
PYCR2	P5CR2	ENSG00000143811	"Pyrroline-5-carboxylate reductase 2"	Q96C36	1	225919877-225924340	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	Oxidoreductase	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA056873	Approved		Approved	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Mitochondria		"HPA056873: AB_2683263"	"unprognostic (1.11e-1)"	"unprognostic (8.08e-2)"	"prognostic unfavorable (5.02e-5)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.56e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.07e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (9.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.16e-3)"	38.0	71.7	53.2	35.8	62.4	47.3	35.8	68.1	54.2	46.4	51.8	39.6	22.3	48.5	26.4	32.3	44.7	22.4	62.3	50.4	61.3	40.2	40.3	38.2	47.2	69.0	61.2	47.9	47.2	42.0	57.0	28.5	66.0	39.6	18.3	34.0	39.6	40.9	66.8	28.3	34.4	25.7	68.6	49.5	38.9	34.4	59.2	43.9	30.0	49.1	33.9	50.3	33.3	72.5	72.6	59.6	35.0	59.1	38.8	40.0	73.2	74.8	46.3	49.7	44.1	77.2	58.3	126.1	156.6	55.0	39.1	81.6	50.5	58.6	28.3	154.6	107.5	120.6	60.2	81.5	59.8	107.9	189.1	38.8	72.3	56.1	64.1	44.1	47.8	103.7	178.4	81.6	50.9	60.5	135.8	120.9	196.0	112.8	80.4	120.2	79.0	263.6	65.2	58.3	44.0	56.7	62.4	48.7	161.0	27.9	62.3	202.0	40.3	38.4	46.5	82.9	104.4	129.9	156.2	127.4	60.7	80.6	109.3	38.4	19.6	39.6	45.5	29.2	47.8	34.4	43.8	42.4	31.3	41.9	74.9	62.4	13.3	67.9	26.3	59.2	44.0	45.1	53.2	62.4	68.1	54.2	50.4	61.3	69.0	61.2	66.0	68.6	59.2	72.5	28.0	19.2	22.8	11.4	31.6	14.8	64.6	53.4	8.0	15.6	24.3	21.2	47.6	20.0	24.8	35.0	14.6	90.6	39.1	12.9	49.0	50.0	8.2	92.8	25.6	26.7	26.5	58.7	4.6	34.0	46.3	23.7	10.2	31.8	38.7	74.9	21.0	16.6	40.0	13.5	5.8	17.8	57.0	20.4	19.8	8.8	38.2	31.5	33.8	8.4	46.4	46.9	46.4	5.5	29.3	29.1	15.8	37.6	23.1	42.1	18.3	35.8	55.4	42.7	26.3	19.8	24.4	40.1	46.2	9.4	12.8	41.7	34.9	44.9	16.1	40.4
PYGL	GSD6	ENSG00000100504	"Glycogen phosphorylase L"	P06737	14	50857891-50944483	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 145.6"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 151.2;Hofbauer cells: 177.6;Muller glia cells: 265.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 141.1;neutrophil: 153.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 279.1;HMC-1: 304.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000962, HPA004119"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		16000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane, Cytosol"		"HPA000962: AB_1079722, HPA004119: AB_1079723"	"unprognostic (2.70e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.55e-2)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (4.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.12e-3)"	110.1	21.0	5.9	24.1	6.6	108.9	36.4	5.0	8.4	33.6	10.4	19.0	3.7	20.7	6.4	55.8	19.1	13.0	14.9	5.2	6.2	10.2	145.6	26.1	6.3	10.7	17.6	18.2	5.7	21.1	7.5	49.3	8.7	13.0	24.0	78.2	26.8	29.7	5.1	37.0	8.4	26.7	8.6	49.4	9.6	5.2	9.0	4.8	10.2	5.8	6.8	41.7	38.1	10.3	145.7	40.8	10.1	64.3	47.0	56.2	114.5	28.6	24.1	77.4	117.3	107.4	18.3	0.1	54.4	171.7	91.2	279.1	107.0	144.8	132.0	0.5	46.8	28.0	60.5	82.4	83.8	106.9	304.4	119.4	56.8	104.1	43.6	75.4	69.3	0.8	11.6	0.5	55.4	144.7	0.4	141.7	39.3	12.8	152.0	2.7	36.2	6.1	104.7	95.1	4.5	4.4	131.0	43.3	1.7	38.6	20.6	200.4	3.2	29.7	49.6	56.0	92.9	1.2	0.3	0.5	27.3	107.7	15.9	50.2	55.9	141.1	0.0	24.2	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0	153.7	0.6	15.7	1.2	0.2	24.8	5.9	6.6	5.0	8.4	5.2	6.2	10.7	17.6	8.7	8.6	9.0	10.3	6.7	22.4	6.3	1.3	1.8	30.7	10.5	40.5	6.8	4.6	7.0	3.8	3.4	5.7	35.4	7.3	0.0	28.9	0.2	11.2	3.9	10.9	1.0	35.4	18.9	7.8	1.2	9.0	1.8	2.1	151.2	18.8	6.6	62.6	6.3	9.3	8.2	65.4	177.6	1.7	2.2	7.1	14.2	56.7	7.9	1.5	14.3	54.6	19.6	15.9	52.4	265.1	2.1	14.1	0.6	7.4	5.2	21.8	1.8	9.7	0.0	6.4	24.5	11.9	6.6	15.4	8.8	0.7	1.4	22.4	22.3	21.1	2.3	4.0	14.0	9.2
PYGM	GSD5	ENSG00000068976	"Glycogen phosphorylase, muscle associated"	P11217	11	64746389-64759974	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	65	"skeletal muscle: 8468.3;tongue: 3594.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 29.7;Cardiomyocytes: 47.5;Late spermatids: 49.2;Peritubular cells: 44.0;Skeletal myocytes: 64.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 8.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 8.1"	"Cell line enhanced"	"Detected in some"		"HSkMC: 3.7;NB-4: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056003	Enhanced					NA	NA		10000000	"Cluster 10: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"			"HPA056003: AB_2683006"	"unprognostic (3.33e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.87e-4)"	"unprognostic (1.95e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.33e-6)"	"unprognostic (3.37e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.68e-2)"	15.2	3.0	35.4	2.1	30.1	1.2	7.7	55.5	29.4	5.8	15.5	25.5	1.5	10.4	6.4	92.2	14.6	3.8	70.8	26.8	26.1	2.4	1.2	2.7	2.2	48.8	30.4	4.0	1.6	0.3	1.7	1.4	39.6	25.6	3.6	2.9	50.0	26.3	8468.3	4.2	7.0	14.7	44.9	3.3	6.9	6.7	47.3	1.3	5.2	3594.2	1.2	16.7	5.2	38.1	0.1	0.0	0.7	0.1	0.5	0.7	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.6	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.6	0.1	0.3	0.2	0.0	0.3	0.4	0.1	3.7	0.2	0.2	0.1	0.0	0.0	1.1	0.7	0.6	0.0	1.1	0.7	2.2	0.7	0.1	0.1	0.4	0.7	0.1	0.0	0.1	0.2	0.0	0.2	0.3	0.4	0.4	0.3	0.4	0.3	0.0	0.4	0.1	0.0	1.0	1.4	0.4	0.0	0.1	0.0	8.1	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.1	0.0	1.1	0.0	0.1	0.1	1.3	0.0	0.2	0.2	0.1	35.4	30.1	55.5	29.4	26.8	26.1	48.8	30.4	39.6	44.9	47.3	38.1	2.4	0.0	2.3	29.7	3.0	0.8	0.6	0.2	5.2	3.5	2.9	4.7	47.5	0.0	0.8	0.0	4.2	0.6	1.9	1.0	0.0	0.1	11.7	1.6	5.2	2.0	0.0	0.0	0.2	0.0	0.2	5.1	1.1	4.0	0.0	0.8	1.8	0.0	0.5	0.0	0.2	0.9	0.0	0.6	1.3	49.2	16.4	2.3	0.0	1.0	0.5	9.9	4.1	0.5	0.4	0.3	0.2	44.0	0.3	1.3	0.6	0.0	0.1	1.3	6.6	64.3	12.8	1.2	0.9	2.5	0.6	0.1	2.9	0.9	1.1	0.3
QARS1	QARS	ENSG00000172053	"Glutaminyl-tRNA synthetase 1"	P47897	3	49095932-49105130	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Epilepsy, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 55.5;Cytotrophoblasts: 193.9;Extravillous trophoblasts: 156.7;Hofbauer cells: 96.1;Syncytiotrophoblasts: 187.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036986, HPA036987"	Enhanced		Enhanced	Cytosol		No	No		58000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA036986: AB_10672344, HPA036987: AB_2675418"	"prognostic favorable (1.43e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.13e-3)"	"unprognostic (6.62e-3)"	"unprognostic (6.53e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.33e-1)"	"unprognostic (9.14e-2)"	"prognostic favorable (5.60e-6)"	"unprognostic (2.73e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.11e-1)"	61.1	58.8	20.0	57.2	21.3	96.6	89.5	23.5	18.5	58.3	34.2	104.8	101.6	45.5	58.5	102.5	71.0	48.3	72.0	18.4	21.1	57.1	51.1	52.3	75.8	23.8	21.0	69.0	73.9	78.1	33.0	76.7	23.0	60.4	121.0	21.4	103.2	61.1	156.1	105.0	84.6	60.2	22.7	60.1	75.0	30.0	23.0	92.3	53.2	146.2	118.8	72.8	58.1	24.6	95.9	97.8	128.0	197.4	146.4	180.8	159.2	90.5	188.2	160.5	152.9	123.0	113.5	257.1	61.4	136.7	95.3	119.9	166.3	137.8	111.4	78.2	148.0	206.4	156.0	216.1	91.2	187.2	130.9	184.8	123.1	127.4	108.1	175.3	184.7	144.6	95.3	112.4	118.0	89.2	130.7	154.9	116.1	159.0	122.9	76.0	123.7	200.6	108.5	163.9	48.7	161.6	85.4	211.0	147.8	122.7	184.4	205.5	137.6	82.8	127.3	131.7	117.9	111.9	176.5	142.9	88.4	156.3	60.3	30.7	84.3	25.8	44.5	104.1	57.4	62.2	54.1	47.0	127.0	49.9	46.6	49.0	8.0	71.8	94.5	57.4	82.1	81.2	20.0	21.3	23.5	18.5	18.4	21.1	23.8	21.0	23.0	22.7	23.0	24.6	15.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	0.0	0.0	0.0	0.0	193.9	11.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	156.7	14.7	0.0	0.0	0.0	0.0	0.0	0.0	96.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	187.0	2.0	0.0	0.0	0.0
QDPR	"DHPR, PKU2, SDR33C1"	ENSG00000151552	"Quinoid dihydropteridine reductase"	P09417	4	17460261-17512206	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Oxidoreductase	"Disease variant, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 752.2;choroid plexus: 301.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 337.6;Muller glia cells: 387.2;Oligodendrocytes: 481.3;Proximal tubular cells: 527.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058951, HPA065649"	Enhanced		Approved	Mitochondria		NA	NA		2500000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA058951: AB_2683861, HPA065649: AB_2685526"	"unprognostic (1.30e-2)"	"unprognostic (4.29e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.07e-1)"	"prognostic favorable (7.84e-6)"	"unprognostic (1.58e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.19e-1)"	66.6	74.3	515.1	10.2	720.1	15.1	26.4	696.9	571.9	15.8	301.8	21.2	25.6	16.5	40.1	15.6	17.3	17.7	43.4	457.6	578.5	110.1	197.2	23.3	11.9	663.0	752.2	18.3	28.8	49.9	32.7	11.8	688.6	28.7	17.0	40.1	36.3	19.5	108.6	16.2	23.9	17.9	524.9	14.3	23.7	12.4	602.6	13.6	22.1	61.2	13.3	14.5	15.1	663.7	33.1	62.5	30.2	35.8	66.1	32.3	41.5	43.2	22.3	47.5	41.6	52.2	46.4	12.2	28.0	30.3	50.8	18.4	40.3	58.4	33.7	35.3	7.3	34.8	33.4	128.3	37.3	46.2	2.9	40.8	35.6	31.6	40.3	25.9	24.5	33.2	37.0	29.0	50.6	19.2	65.0	77.8	44.8	36.7	45.4	27.0	21.0	52.2	48.2	17.5	47.1	64.3	31.9	6.7	156.6	35.0	15.7	19.0	37.7	23.6	41.1	26.5	38.2	43.1	67.7	85.3	52.0	43.1	41.7	0.3	38.9	3.0	31.3	61.3	29.8	18.6	33.1	32.3	48.3	18.3	37.4	32.6	1.1	29.8	48.4	115.1	20.3	34.4	515.1	720.1	696.9	571.9	457.6	578.5	663.0	752.2	688.6	524.9	602.6	663.7	20.3	28.9	31.5	10.7	14.8	20.0	21.3	32.2	18.8	36.2	37.6	28.3	74.4	50.1	19.5	38.6	8.4	69.6	22.8	13.7	109.5	41.1	1.0	11.8	19.1	17.2	174.3	30.1	23.1	23.4	34.2	27.1	27.5	17.8	25.4	42.3	20.7	337.6	80.3	82.4	21.9	31.1	34.6	38.1	23.9	4.8	22.7	32.2	152.9	12.2	23.4	387.2	16.5	15.1	481.3	16.9	11.6	38.0	23.6	23.2	41.4	527.2	6.2	31.4	26.3	27.5	25.4	3.3	58.9	29.7	16.1	18.3	18.5	90.0	35.7	17.3
QRSL1	"DKFZP564C1278, FLJ10989, FLJ12189, FLJ13447, GatA"	ENSG00000130348	"Glutaminyl-tRNA amidotransferase subunit QRSL1"	Q9H0R6	6	106629578-106668417	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"memory B-cell: 86.4;naive B-cell: 71.0"	"Lineage enriched"	"Detected in all"	7	"B-cells: 86.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029585, HPA029587"	Approved		Approved	Vesicles,Centrosome		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Vesicles	Centrosome	"HPA029585: AB_10599823, HPA029587: AB_10602311"	"unprognostic (1.86e-3)"	"unprognostic (5.58e-2)"	"unprognostic (6.19e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (8.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.46e-1)"	5.0	5.7	4.0	8.6	5.2	6.4	7.4	4.7	5.0	4.8	5.8	8.2	7.8	6.3	6.1	5.7	5.4	4.8	10.1	4.1	4.5	9.3	7.8	4.6	15.9	4.6	4.5	5.6	6.0	9.4	4.3	5.7	5.0	5.3	9.1	8.4	6.1	5.6	19.4	5.9	8.9	5.8	4.1	10.5	6.7	6.6	4.5	8.2	9.2	21.3	15.5	5.7	4.9	7.4	9.0	9.1	12.3	17.8	7.8	9.7	17.3	10.0	10.2	13.1	13.0	10.7	7.1	29.7	8.9	11.2	13.5	15.5	18.6	12.1	16.4	14.2	14.1	14.5	9.7	11.1	12.2	33.2	12.5	9.6	18.6	14.0	20.6	9.9	9.5	18.4	26.8	9.4	11.0	10.1	10.7	16.1	12.9	15.6	10.5	28.9	15.8	7.5	14.3	10.2	10.7	11.0	8.0	18.4	15.3	10.7	12.1	25.3	9.3	9.2	7.6	10.0	15.7	5.4	8.3	17.2	12.6	22.1	14.0	5.0	6.4	1.0	6.4	9.6	6.3	86.4	7.1	5.6	10.7	71.0	6.6	6.4	1.6	7.0	13.0	8.5	8.5	5.7	4.0	5.2	4.7	5.0	4.1	4.5	4.6	4.5	5.0	4.1	4.5	7.4	9.0	19.2	12.5	20.2	64.6	4.0	8.4	12.8	6.2	14.9	10.3	6.1	24.8	7.2	9.3	11.0	16.7	21.5	12.3	11.0	17.6	15.4	15.5	28.2	12.0	10.8	17.4	13.7	14.6	18.4	23.0	9.9	15.3	14.8	18.9	15.3	8.2	14.6	12.9	3.3	18.9	11.2	14.2	12.4	6.1	8.4	8.4	10.0	8.8	12.2	18.3	9.9	19.6	22.6	26.5	14.2	8.3	9.1	13.2	9.3	12.2	19.5	19.9	19.1	0.0	10.0	10.0	25.6	14.2	12.2	5.4	12.3	14.3	21.1	18.7	8.9
RAB27A	"GS2, HsT18676, RAB27, RAM"	ENSG00000069974	"RAB27A, member RAS oncogene family"	P51159	15	55202966-55319113	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	Exocytosis	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 119.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 147.1;Intestinal goblet cells: 252.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 261.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 208.7;K-562: 238.0;Karpas-707: 179.4;SK-MEL-30: 188.3;U-937: 185.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001333, CAB034046"	Enhanced					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 37: Intestine - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 27: Mucus-secreting cells - Mucin production"			"CAB034046: AB_2176724, HPA001333: AB_1079730"	"prognostic favorable (2.56e-4)"	"unprognostic (9.75e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.77e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (4.23e-2)"	"unprognostic (4.34e-1)"	"unprognostic (7.95e-3)"	"unprognostic (4.32e-1)"	17.5	27.8	3.5	40.2	3.9	100.2	13.9	4.4	4.4	12.9	5.6	53.0	30.0	12.8	5.0	20.6	12.3	17.6	7.7	3.4	6.7	19.2	43.6	42.4	46.0	5.8	5.0	8.0	29.2	11.4	31.4	17.6	5.9	61.2	66.1	4.2	18.3	11.8	3.2	12.8	40.9	25.8	5.0	30.8	119.9	10.0	5.9	19.3	30.5	7.0	46.2	37.5	13.9	5.7	23.0	10.0	9.7	11.3	8.3	38.8	9.5	29.4	32.5	19.2	26.4	7.0	15.6	0.9	22.3	16.0	38.9	16.0	15.7	27.0	18.3	84.9	9.7	5.4	37.6	18.1	56.0	208.7	26.5	34.3	44.2	29.0	71.6	80.7	46.9	26.4	238.0	179.4	20.7	27.7	1.5	57.6	3.6	38.9	14.7	32.4	27.3	50.3	28.7	17.7	14.9	7.1	31.4	15.2	188.3	24.3	13.3	162.2	25.3	52.5	20.3	33.1	33.6	72.0	88.2	6.0	70.2	185.1	19.0	261.3	72.4	99.8	59.2	30.1	58.2	8.0	28.6	61.9	39.0	13.4	13.9	37.4	114.9	34.1	24.0	2.1	36.2	48.9	3.5	3.9	4.4	4.4	3.4	6.7	5.8	5.0	5.9	5.0	5.9	5.7	27.5	76.9	147.1	12.7	18.6	14.1	25.7	19.2	6.2	3.0	16.3	18.3	7.4	15.7	50.1	11.0	2.1	6.3	81.0	18.5	13.7	24.6	2.8	10.1	15.6	32.1	74.3	12.8	12.5	87.6	18.7	16.9	93.3	16.7	31.7	8.8	41.7	41.7	15.6	0.0	12.2	252.0	12.2	33.3	15.2	2.2	7.5	31.1	71.2	10.3	71.9	2.4	104.0	10.1	7.1	62.9	15.9	13.9	38.6	32.3	14.6	6.7	31.3	4.4	19.7	9.4	15.8	9.3	4.6	7.1	15.5	7.5	81.4	4.6	18.4	23.4
RAB7A	"CMT2B, RAB7"	ENSG00000075785	"RAB7A, member RAS oncogene family"	P51149	3	128693669-128825942	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Host-virus interaction, Lipid degradation, Lipid metabolism, Protein transport, Transport"	Hydrolase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006964, CAB037131"	Supported		Supported	Lysosomes		NA	NA		5700000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Lysosomes		"CAB037131: AB_477460, HPA006964: AB_1856015"	"unprognostic (1.99e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (9.89e-6)"	"unprognostic (2.15e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (4.69e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.64e-3)"	170.6	157.1	120.1	101.4	132.2	99.9	149.5	133.4	159.4	138.3	123.7	128.9	108.3	137.4	143.0	188.2	110.1	109.7	186.8	128.9	138.4	131.8	145.2	152.9	108.8	138.8	142.0	122.7	88.6	155.9	101.5	117.5	139.4	101.3	126.0	103.8	133.3	63.9	332.4	164.9	116.8	124.0	135.9	123.0	114.9	61.5	140.3	124.6	122.5	249.7	136.6	144.4	143.4	159.0	280.2	95.5	146.0	78.3	300.6	94.0	126.0	252.8	183.9	164.4	158.8	170.1	179.2	134.2	163.2	236.2	289.9	163.4	175.2	248.6	99.2	149.4	111.7	294.3	83.6	165.8	303.0	269.4	182.5	243.7	104.0	176.7	204.4	220.7	89.2	114.4	143.4	148.0	108.1	213.1	176.8	294.6	121.4	294.8	144.8	140.2	130.7	170.4	85.7	205.4	105.8	138.5	142.1	194.7	405.4	174.9	180.3	254.8	202.9	192.7	98.0	325.7	125.9	184.4	187.0	192.0	312.7	212.1	235.5	194.9	176.8	213.6	92.1	192.3	92.3	93.2	97.4	94.5	200.0	85.8	94.8	93.6	374.2	128.8	204.0	81.8	120.7	201.3	120.1	132.2	133.4	159.4	128.9	138.4	138.8	142.0	139.4	135.9	140.3	159.0	154.4	89.8	81.8	66.9	109.9	296.7	331.2	218.1	104.7	66.0	112.8	73.0	110.7	90.1	129.4	132.4	18.8	230.0	92.3	222.1	240.7	259.6	11.2	90.8	90.8	165.3	96.9	111.3	83.9	198.9	283.4	172.5	79.0	142.4	146.2	46.5	142.8	127.9	403.9	74.0	82.5	122.8	219.7	208.6	379.9	19.6	133.6	242.8	339.7	99.3	220.9	154.6	121.5	80.9	111.4	303.7	185.0	157.2	79.9	279.2	172.7	332.3	118.7	37.6	138.1	107.7	160.5	116.4	100.4	122.8	308.0	497.9	107.7	109.6	103.5	324.6
RAC1	"p21-Rac1, Rac-1, TC-25"	ENSG00000136238	"Rac family small GTPase 1"	P63000	7	6374527-6403967	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 1980.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035994, HPA047820"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		3900000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 70: Brain - Nervous system development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"	Nucleoli	"CAB035994: , HPA047820: AB_2680167"	"unprognostic (8.66e-3)"	"unprognostic (2.47e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.88e-3)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (1.74e-5)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.72e-3)"	157.4	108.0	237.0	96.8	250.4	94.5	146.4	242.4	290.7	154.8	206.5	190.5	167.4	150.7	149.9	316.9	145.1	125.9	129.4	240.2	240.6	150.5	136.2	147.5	96.4	249.4	244.8	135.8	92.2	151.1	77.5	180.2	249.2	122.8	199.6	52.2	137.9	145.0	179.5	189.2	161.9	179.3	260.2	96.6	160.6	51.6	241.1	115.3	127.2	141.1	169.6	205.3	188.6	262.9	519.9	230.9	233.0	255.1	270.1	341.8	138.6	284.9	348.0	371.6	375.8	227.3	474.8	145.5	179.7	400.9	384.2	359.4	251.5	345.9	471.9	68.3	207.8	146.6	171.7	166.5	323.7	134.0	114.6	229.7	302.8	268.4	297.6	281.7	333.4	141.3	266.2	111.7	406.4	377.3	74.0	312.4	419.1	261.9	272.3	129.2	236.9	214.6	481.7	322.7	175.8	295.9	201.7	726.1	241.4	264.7	409.6	396.3	341.8	242.4	364.3	300.7	334.5	84.1	99.5	135.4	223.9	250.9	470.6	31.0	117.3	63.0	23.8	83.0	15.1	46.8	26.8	30.9	112.8	49.9	33.0	21.8	168.6	26.1	83.5	64.5	46.1	47.0	237.0	250.4	242.4	290.7	240.2	240.6	249.4	244.8	249.2	260.2	241.1	262.9	755.4	147.4	123.6	28.7	155.9	934.1	981.6	232.1	429.2	90.4	485.3	593.8	200.6	484.7	164.8	356.8	25.0	802.8	224.1	920.9	536.1	183.5	77.6	388.7	362.9	641.2	336.7	313.3	43.3	174.2	1064.1	415.9	305.3	422.8	130.9	325.4	580.8	367.1	832.0	146.4	35.3	632.9	179.0	811.3	1066.7	58.8	476.3	705.7	458.9	66.5	607.2	341.1	191.6	23.1	56.7	299.1	754.4	472.8	212.2	1495.5	816.4	832.0	214.1	64.2	479.9	346.6	466.6	216.6	373.1	774.5	1148.6	845.4	180.0	353.6	573.7	1980.7
RAC3		ENSG00000169750	"Rac family small GTPase 3"	P60763	17	82031678-82034204	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 45.0;Extravillous trophoblasts: 152.1;Spermatogonia: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"CACO-2: 230.8;HEK 293: 274.7;NB-4: 156.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047820	Uncertain					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA047820: AB_2680167"	"unprognostic (3.48e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (6.21e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (4.69e-4)"	"unprognostic (1.25e-3)"	12.3	5.0	22.8	1.8	20.8	7.7	13.7	26.3	29.5	5.3	9.3	4.8	3.4	2.8	7.3	10.9	3.8	3.0	3.0	19.7	24.5	9.4	20.7	4.0	1.7	23.3	22.3	4.8	4.7	9.3	22.8	5.6	27.0	11.1	1.4	2.8	18.1	4.2	0.8	12.4	3.7	1.3	15.3	1.9	11.8	28.1	26.5	2.2	9.8	0.2	1.5	3.1	7.6	20.6	11.1	15.1	45.6	63.1	9.7	18.2	50.5	7.8	7.2	26.1	22.3	230.8	21.4	5.8	11.5	4.8	1.7	15.6	43.0	17.8	4.1	3.6	274.7	64.6	20.2	16.7	47.0	28.0	12.2	27.5	13.0	3.5	12.0	19.5	60.3	33.8	103.1	30.2	10.8	35.6	7.3	156.4	61.4	39.2	27.6	47.6	4.5	27.7	20.0	5.4	109.8	111.5	4.1	57.2	55.7	16.1	58.6	40.7	21.6	10.8	9.8	5.5	12.1	14.6	9.9	4.4	6.6	17.3	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	22.8	20.8	26.3	29.5	19.7	24.5	23.3	22.3	27.0	15.3	26.5	20.6	1.6	0.0	0.0	2.3	0.9	8.7	16.3	12.2	19.9	5.3	36.9	45.0	0.2	4.3	3.6	5.5	0.0	30.0	1.8	3.3	21.5	9.8	19.1	5.9	5.4	2.3	3.0	6.9	5.2	3.3	152.1	10.7	8.2	12.6	4.5	17.8	1.4	11.3	9.7	6.7	8.3	5.1	22.4	0.0	2.6	16.6	5.6	0.9	14.2	0.0	2.0	6.0	0.0	3.5	2.0	5.5	2.4	1.9	2.6	16.4	4.2	26.0	2.4	7.3	0.0	0.8	5.3	2.2	58.0	15.8	7.5	14.1	3.1	8.6	5.2	8.4
RAG1	"MGC43321, RNF74"	ENSG00000166349	"Recombination activating 1"	P15918	11	36510709-36593156	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA recombination, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Multifunctional enzyme, Nuclease, Transferase"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	92	"lymphoid tissue: 395.0"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.9;Hepatic stellate cells: 8.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MOLT-4: 283.5;REH: 266.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA043939			Supported	Nucleoplasm		NA	NA				"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA043939: AB_2732512"	"unprognostic (7.35e-2)"	"unprognostic (1.57e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.98e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-9)"	"unprognostic (2.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.53e-4)"	"unprognostic (1.53e-1)"	0.4	0.5	0.1	0.2	0.1	4.3	0.2	0.1	0.2	0.4	0.2	0.4	0.8	0.2	0.8	0.1	0.3	0.4	0.3	0.1	0.1	1.3	0.8	0.6	0.1	0.1	0.1	0.3	0.3	0.6	0.1	0.6	0.1	0.3	0.3	0.6	0.4	0.3	0.1	0.1	1.0	0.1	0.1	2.6	0.5	0.3	0.1	395.0	2.4	0.3	0.6	0.3	0.1	0.1	0.4	0.0	0.5	0.1	0.2	0.6	0.0	0.3	0.3	0.1	0.5	0.0	0.4	0.5	0.0	0.0	0.1	0.2	0.0	0.4	0.4	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.3	0.4	0.0	0.3	0.2	0.5	54.0	0.2	0.0	0.5	0.0	283.5	0.0	2.2	0.2	0.0	266.4	0.0	1.3	0.9	0.0	0.1	0.3	0.1	0.7	0.1	1.2	1.0	0.1	1.0	0.2	0.2	0.2	0.1	2.3	1.9	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.5	0.0	0.0	0.0	0.1	0.1	1.4	0.7	0.0	1.0	1.0	0.8	0.9	0.0	0.4	1.8	0.0	0.2	0.5	1.3	3.9	0.8	2.3	0.3	0.3	1.6	0.0	0.4	1.8	0.5	0.1	0.7	0.0	0.4	0.0	0.3	8.2	2.1	0.4	0.0	1.7	0.8	0.0	0.6	0.7	1.7	0.0	0.1	0.0	1.0	1.1	0.5	2.1	1.0	1.3	1.1	0.4	0.0	0.0	0.5	3.0	2.9	0.4	0.9	0.0	0.2	0.7	1.0	1.0	0.2	0.4	0.4	0.4	0.5	0.6	0.6
RANBP2	"ADANE, ANE1, NUP358"	ENSG00000153201	"RAN binding protein 2"	P49792	2	108719482-108785809	"Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway"	"RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA		160000	"Cluster 38: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear membrane"	"Nucleoplasm, Vesicles"	"CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: AB_2671385, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (2.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.53e-1)"	20.3	24.3	8.6	16.3	11.6	42.1	19.7	14.4	17.1	18.1	20.3	15.6	13.4	17.7	20.5	14.3	14.6	13.7	14.9	11.8	9.4	18.1	17.4	14.0	18.6	9.2	8.1	24.4	20.2	30.1	21.5	16.5	9.5	20.9	15.2	26.5	16.4	17.2	30.3	17.2	13.4	15.2	8.6	15.0	17.6	21.3	8.2	23.3	28.4	23.6	18.0	16.9	12.1	12.2	40.5	24.2	34.1	31.0	38.7	34.5	32.9	35.5	28.0	28.7	25.1	60.7	18.9	63.2	26.8	37.2	35.3	33.1	58.9	36.9	41.5	38.9	28.5	65.9	30.3	43.2	22.5	77.9	21.3	29.1	27.5	44.9	34.7	28.3	44.5	27.1	71.9	34.0	38.4	22.3	34.8	31.6	43.0	20.3	28.7	32.3	52.3	30.7	25.3	49.6	49.4	22.6	31.5	26.7	34.7	20.4	17.2	35.4	53.5	29.8	39.6	21.2	40.2	27.9	44.4	55.8	23.1	34.4	23.5	5.4	2.6	2.7	3.7	1.7	4.1	2.7	3.0	3.4	2.2	2.7	2.9	3.3	3.9	2.2	3.6	2.6	2.7	1.4	8.6	11.6	14.4	17.1	11.8	9.4	9.2	8.1	9.5	8.6	8.2	12.2	54.5	76.9	85.3	48.6	91.5	55.7	34.5	39.1	61.5	51.2	34.1	25.8	103.9	38.6	63.0	58.8	73.0	28.8	96.1	28.9	1.9	34.7	77.3	83.6	65.3	55.7	106.4	50.5	125.5	50.9	17.5	56.5	68.3	142.1	84.9	52.2	31.4	56.6	47.9	32.0	92.2	59.5	44.7	44.9	80.7	32.9	38.5	114.0	48.0	55.3	57.0	20.0	34.0	44.2	80.0	41.5	29.9	56.1	118.4	44.1	28.8	15.6	67.0	40.5	46.0	56.9	59.0	78.3	65.4	53.3	67.8	40.6	104.8	25.3	38.3	38.7
RARS1	"DALRD1, RARS"	ENSG00000113643	"Arginyl-tRNA synthetase 1"	P54136	5	168486451-168519301	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 50.8;Cytotrophoblasts: 104.2;Extravillous trophoblasts: 96.8;Hofbauer cells: 57.2;Syncytiotrophoblasts: 84.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003979, HPA004130"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		74000	"Cluster 27: Non-specific - Gene expression"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA003979: AB_1856083, HPA004130: AB_1856084"	"unprognostic (1.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.59e-5)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (3.26e-3)"	"unprognostic (5.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.33e-2)"	27.5	25.6	12.7	31.5	12.3	12.8	36.3	19.6	15.6	22.9	9.4	37.6	54.8	26.7	33.5	38.2	25.8	23.4	29.5	12.8	11.2	33.2	43.5	22.0	31.0	9.0	10.7	23.0	34.4	32.7	16.6	36.5	9.8	27.9	43.0	17.2	32.9	23.5	31.1	41.8	48.7	32.8	5.4	21.8	32.8	23.2	12.1	23.5	30.2	34.6	40.6	41.1	25.2	21.4	100.2	115.6	82.5	94.2	113.4	128.9	143.9	143.4	122.3	145.7	168.7	198.4	105.6	104.3	114.2	137.2	149.3	93.9	111.0	192.7	188.5	110.1	76.5	71.2	103.1	126.5	96.8	169.2	72.6	99.7	100.8	159.0	76.0	89.3	118.5	56.4	107.7	51.9	158.1	92.4	70.7	68.7	138.1	86.7	77.8	30.3	122.0	99.7	129.7	110.8	79.6	97.7	109.1	124.7	152.7	101.1	113.4	69.9	118.7	104.7	96.3	81.9	169.4	51.8	100.3	105.7	114.3	118.0	101.9	5.2	21.5	8.2	17.4	27.3	20.2	15.5	17.2	18.8	32.1	9.5	21.2	22.6	5.8	26.6	26.7	14.7	19.3	18.2	12.7	12.3	19.6	15.6	12.8	11.2	9.0	10.7	9.8	5.4	12.1	21.4	10.8	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.8	0.0	0.0	0.0	0.0	104.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	96.8	12.8	0.0	0.0	0.0	0.0	0.0	0.0	57.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	84.3	1.4	0.0	0.0	0.0
RARS2	"DALRD2, dJ382I10.6, MGC14993, MGC23778, PRO1992, RARSL"	ENSG00000146282	"Arginyl-tRNA synthetase 2, mitochondrial"	Q5T160	6	87513938-87589987	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039987, HPA042645"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA039987: AB_2676786, HPA042645: AB_2678097"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.98e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.08e-3)"	"unprognostic (8.28e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.16e-3)"	24.0	39.6	10.8	15.8	11.8	19.3	21.3	14.7	11.6	21.5	19.2	20.8	17.8	21.8	18.6	17.7	19.7	19.0	22.7	10.4	11.4	20.5	27.9	18.3	16.8	11.5	11.6	18.5	24.0	21.4	17.5	22.2	11.8	18.8	22.7	25.9	20.8	13.6	22.5	18.5	22.6	21.5	11.0	18.5	19.2	25.3	12.5	18.5	20.6	19.3	19.0	20.6	18.2	15.5	19.8	19.1	45.1	49.8	44.6	47.5	31.9	46.6	54.2	30.8	38.6	36.6	21.6	25.0	26.9	47.4	32.0	26.7	37.9	25.8	43.2	18.0	36.0	25.7	24.4	58.7	56.1	30.7	21.3	48.9	24.6	26.4	33.1	44.5	41.0	25.7	59.6	24.4	46.8	35.2	10.0	32.8	29.2	42.3	20.0	19.9	45.9	22.2	38.5	40.1	40.8	54.7	24.8	12.1	33.1	38.2	22.5	45.8	28.1	21.2	16.8	22.8	38.4	25.6	45.1	21.1	32.2	31.8	36.6	18.8	17.8	22.7	16.1	18.6	19.0	15.1	20.4	15.1	15.6	16.2	19.9	16.9	11.9	18.6	20.7	17.9	27.9	15.4	10.8	11.8	14.7	11.6	10.4	11.4	11.5	11.6	11.8	11.0	12.5	15.5	34.4	19.2	15.6	30.0	21.2	17.3	35.4	51.3	12.5	13.9	17.3	16.8	19.9	10.0	37.8	11.0	20.9	31.0	18.1	14.6	45.0	32.9	95.3	23.5	29.3	22.8	9.0	7.4	46.8	46.9	45.5	28.3	12.8	20.3	18.3	27.9	23.6	15.5	20.5	6.7	59.0	23.5	44.7	13.5	14.1	50.6	25.4	15.0	19.6	38.4	22.6	13.6	19.6	56.3	63.9	37.6	21.2	24.0	20.7	30.8	57.2	32.9	24.2	20.3	26.3	18.9	30.0	61.8	33.7	14.1	18.0	39.5	20.6	51.4	27.0	33.9
RBCK1	"C20orf18, HOIL1, RBCK2, RNF54, UBCE7IP3, XAP4, ZRANB4"	ENSG00000125826	"RANBP2-type and C3HC4-type zinc finger containing 1"	Q9BYM8	20	407498-432139	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 255.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (1.94e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.15e-2)"	"unprognostic (7.89e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (7.41e-9)"	"unprognostic (5.87e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.39e-3)"	41.3	68.6	20.4	28.8	23.3	25.7	38.6	26.6	32.3	48.5	16.9	50.2	34.6	47.0	13.9	55.0	44.7	19.4	41.3	20.2	20.8	52.5	108.9	47.7	28.1	27.9	22.1	53.5	55.3	30.1	64.1	22.8	23.9	56.0	17.7	12.2	41.9	26.3	38.6	43.0	56.8	19.2	20.3	66.2	50.3	34.8	22.0	43.7	46.7	18.2	18.0	45.6	46.8	27.6	64.0	88.4	21.9	37.2	44.3	54.7	44.9	34.2	55.0	56.2	73.4	53.7	74.1	29.2	51.3	70.7	103.5	62.7	29.4	151.0	19.0	21.7	29.8	30.2	23.9	140.9	185.3	28.4	21.5	83.1	255.7	43.0	173.2	68.2	50.8	109.8	29.6	55.0	40.7	33.2	61.5	69.9	18.4	77.4	73.0	40.3	21.8	37.3	72.7	57.5	41.3	35.9	24.1	122.4	140.7	25.0	73.3	64.2	31.0	54.5	27.0	33.2	46.5	44.4	61.6	35.6	24.5	61.4	39.0	56.5	48.8	85.4	61.9	71.3	43.5	48.1	48.0	63.1	43.6	46.8	38.7	45.2	135.6	52.4	83.9	72.1	55.7	52.7	20.4	23.3	26.6	32.3	20.2	20.8	27.9	22.1	23.9	20.3	22.0	27.6	69.4	32.1	39.8	40.8	54.4	44.5	77.1	96.2	49.5	15.3	65.4	66.7	19.9	64.3	48.2	57.0	16.7	88.7	72.6	111.4	62.6	111.7	58.9	40.4	45.3	59.3	61.7	43.8	15.8	116.2	102.4	52.3	50.0	54.3	43.8	62.9	57.1	139.3	66.8	16.8	17.8	122.8	46.8	69.8	44.2	163.3	65.9	57.2	42.7	23.4	69.1	45.1	106.1	22.1	24.3	108.5	161.0	47.8	30.5	98.8	185.2	74.5	39.0	29.0	46.0	56.9	51.9	32.6	29.3	69.0	40.2	94.7	71.0	110.6	74.2	120.3
RBM8A	"BOV-1A, BOV-1B, BOV-1C, RBM8, RBM8B, Y14, ZNRP"	ENSG00000265241	"RNA binding motif protein 8A"	Q9Y5S9	1	145917714-145927678	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 735.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018403	Supported		Supported	"Nuclear speckles"		NA	NA		100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"		"HPA018403: AB_1858908"	"unprognostic (3.81e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.79e-3)"	"unprognostic (7.27e-3)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (3.30e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-3)"	86.1	74.9	37.2	105.4	39.1	214.7	82.3	38.7	43.0	69.6	35.6	70.5	70.1	67.7	49.3	163.6	62.2	58.0	73.0	36.8	41.7	81.6	77.5	72.8	126.4	39.7	39.8	72.0	59.9	78.4	65.8	85.3	40.8	66.4	56.4	45.0	79.2	48.2	214.9	92.0	69.2	57.7	42.1	81.6	67.5	71.3	40.0	120.7	68.8	100.1	123.7	112.8	80.4	43.9	377.0	300.7	268.8	215.7	94.6	92.2	330.0	224.3	150.7	315.0	230.1	400.0	277.4	342.0	344.9	155.3	166.5	252.5	289.3	245.3	257.0	305.6	275.7	264.2	229.2	299.8	133.6	446.6	222.6	102.2	180.8	283.0	300.3	137.4	238.1	291.9	405.2	314.7	246.2	1033.8	452.3	352.2	463.7	323.9	518.4	394.4	234.6	341.2	203.2	355.6	274.6	335.7	334.5	169.7	316.5	231.0	318.0	534.3	247.3	252.3	324.0	250.9	626.0	352.2	603.4	502.6	226.4	264.9	223.2	464.6	316.5	513.6	337.2	363.9	322.1	444.3	317.6	346.4	318.0	389.6	296.1	328.3	363.7	389.8	361.3	498.4	386.3	582.7	37.2	39.1	38.7	43.0	36.8	41.7	39.7	39.8	40.8	42.1	40.0	43.9	289.1	70.5	132.4	8.1	251.0	332.9	396.7	475.4	244.2	66.3	168.5	184.7	78.0	98.7	262.8	88.3	54.2	376.2	276.0	125.3	187.9	224.1	243.7	148.0	134.3	206.0	158.9	149.2	10.8	223.2	506.3	174.1	80.5	152.8	244.0	136.8	120.3	124.4	204.3	35.3	9.1	127.6	313.3	100.3	265.2	54.4	102.2	170.7	208.1	9.4	197.7	120.3	165.8	6.0	16.1	245.4	159.8	85.4	174.9	259.6	119.5	204.1	195.1	86.3	98.6	213.7	208.1	212.0	168.9	208.1	318.0	735.5	282.1	139.7	141.7	393.0
RBP3	"D10S64, D10S65, D10S66, RP66"	ENSG00000265203	"Retinol binding protein 3"	P10745	10	47348363-47357881	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"	Transport		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	335	"retina: 542.3"	"Group enriched"	"Detected in some"	11	"Cone photoreceptor cells: 2070.4;Rod photoreceptor cells: 1610.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 1.3"	"Low region specificity"	"Detected in many"			"HPA041301, HPA044239"	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA041301: AB_2677398, HPA044239: AB_2678868"	"unprognostic (3.48e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.36e-2)"		"unprognostic (4.02e-2)"	"unprognostic (1.40e-1)"		"unprognostic (1.58e-2)"		"unprognostic (5.09e-2)"	"unprognostic (5.14e-3)"			"unprognostic (7.44e-2)"	"unprognostic (1.23e-1)"		"unprognostic (4.68e-3)"	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.1	0.3	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.6	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	542.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.3	1.2	1.6	0.5	0.3	0.6	0.1	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.7	0.0	0.0	0.5	0.0	0.0	0.0	2070.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	43.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	148.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1610.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RDH11	"ARSDR1, MDT1, SDR7C1"	ENSG00000072042	"Retinol dehydrogenase 11"	Q8TC12	14	67676800-67695793	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Cataract, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 582.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 241.8;Muller glia cells: 299.7;Prostatic glandular cells: 285.7"	"Cancer enriched"	"Detected in all"	13	"prostate cancer: 286.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB046011	Enhanced				"Intracellular and membrane"	NA	NA		340000	"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 5: Muller glia cells - Visual perception"			"CAB046011: AB_11129613"	"unprognostic (1.38e-1)"	"unprognostic (6.86e-3)"	"unprognostic (1.77e-1)"	"prognostic favorable (2.62e-4)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (9.29e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (1.30e-7)"	"unprognostic (1.65e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.74e-2)"	23.6	59.5	39.3	24.5	43.2	13.9	28.7	50.2	54.4	32.6	35.9	29.2	34.1	33.2	86.0	34.6	23.5	42.7	17.6	40.4	47.2	106.0	153.1	34.9	20.4	49.2	47.7	28.9	42.6	79.8	23.4	21.9	49.3	582.0	31.4	73.9	44.2	34.4	8.3	31.4	23.9	43.6	49.8	22.2	31.9	28.4	46.1	30.7	61.7	13.5	26.2	34.3	30.3	58.4	183.7	81.9	71.3	82.0	111.5	100.4	59.3	68.0	134.2	83.7	150.9	68.6	216.7	31.7	51.2	64.6	104.8	142.5	104.0	150.8	113.7	63.0	42.6	65.1	40.7	69.0	106.9	24.3	46.0	94.4	98.0	109.3	92.0	63.9	97.4	87.0	52.1	101.1	77.2	97.5	72.2	38.8	40.4	49.7	92.8	53.6	87.4	45.8	194.1	93.0	73.8	62.0	71.2	89.7	99.1	58.2	100.7	38.3	74.2	89.5	101.1	38.9	49.5	47.5	40.0	40.7	115.8	66.0	74.3	282.4	71.1	104.0	62.3	57.7	68.2	39.0	67.7	61.5	51.3	45.5	67.3	64.8	11.0	56.3	65.4	59.1	65.1	115.8	39.3	43.2	50.2	54.4	40.4	47.2	49.2	47.7	49.3	49.8	46.1	58.4	27.0	25.6	66.0	38.2	29.2	11.5	40.0	77.9	16.5	53.5	45.4	24.5	20.4	68.6	59.9	47.8	50.1	24.9	32.4	26.8	7.9	92.5	2.5	21.9	50.9	39.3	43.3	29.2	33.3	84.0	38.1	37.5	19.9	38.2	29.2	46.3	47.8	241.8	35.8	79.1	37.6	28.9	89.5	42.4	15.4	6.1	43.2	35.9	35.6	17.8	39.8	299.7	37.0	70.4	43.4	61.2	36.7	56.1	27.3	285.7	17.5	56.0	23.9	97.0	46.0	29.7	38.7	25.8	24.0	20.2	19.2	63.5	29.8	66.7	25.3	46.1
RDH12	"FLJ30273, LCA13, RP53, SDR7C2"	ENSG00000139988	"Retinol dehydrogenase 12"	Q96NR8	14	67701886-67734451	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Oxidoreductase	"Disease variant, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"retina: 222.7;skin 1: 63.8"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 146.0;Rod photoreceptor cells: 453.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"				"unprognostic (4.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.72e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.83e-2)"	"unprognostic (3.58e-1)"	"unprognostic (3.92e-1)"	0.1	4.1	1.3	0.1	1.0	0.1	2.2	1.0	1.4	11.0	0.4	0.0	0.3	0.0	8.7	22.1	0.5	17.6	0.0	0.9	1.2	13.6	3.8	0.1	0.0	1.2	2.3	0.0	3.2	0.0	0.9	0.1	1.2	0.5	0.0	222.7	1.7	0.1	0.1	63.8	0.1	0.0	0.6	0.0	12.4	0.1	4.6	0.4	1.2	0.0	1.6	0.0	23.6	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.0	1.0	1.4	0.9	1.2	1.2	2.3	1.2	0.6	4.6	1.1	0.0	0.0	0.0	0.7	0.0	4.7	0.3	0.0	0.6	39.8	0.1	0.1	0.0	20.0	0.3	1.8	146.0	0.0	0.0	0.1	0.0	0.7	0.2	1.8	1.1	2.2	0.0	0.0	1.2	1.7	0.0	0.4	14.3	1.7	0.0	0.0	0.0	5.7	0.2	20.2	0.9	0.0	0.0	0.6	0.9	0.0	0.3	0.2	1.8	1.0	0.0	53.0	0.0	1.5	0.2	1.5	2.6	0.0	0.0	0.3	0.1	12.5	0.2	453.2	0.0	0.0	0.2	0.0	0.1	4.7	38.6	0.0	0.1	0.1	0.1	0.3
RDH5	"HSD17B9, RDH1, SDR9C5"	ENSG00000135437	"Retinol dehydrogenase 5"	Q92781	12	55720367-55724705	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sensory transduction, Steroid metabolism, Vision"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 94.5;liver: 58.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Proximal enterocytes: 49.9;Rod photoreceptor cells: 62.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 28.5;ASC TERT1: 24.3;hTEC/SVTERT24-B: 15.3;hTERT-RPE1: 24.5;LHCN-M2: 15.4;U-87 MG: 26.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063345			Uncertain	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA063345: AB_2684992"	"unprognostic (1.04e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.63e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.12e-3)"	"unprognostic (3.27e-2)"	94.5	1.8	2.2	4.1	2.5	1.0	34.2	2.2	2.6	2.5	3.5	13.6	18.5	4.2	7.8	3.1	4.6	4.2	9.2	2.0	2.2	9.0	58.9	1.9	1.8	2.7	2.5	2.1	3.5	0.3	1.7	0.6	2.4	4.4	4.4	3.2	3.3	2.2	6.1	2.7	15.5	19.5	2.5	2.2	5.9	2.4	2.8	0.9	2.7	7.6	0.7	5.5	2.2	3.4	0.7	1.4	0.8	0.5	28.5	24.3	0.6	3.8	4.2	0.7	1.4	0.5	7.9	1.0	0.7	2.1	0.2	0.3	0.3	0.1	0.6	1.0	1.3	0.1	2.0	2.1	0.8	0.1	0.3	10.5	1.0	15.3	0.1	24.5	0.3	0.5	0.2	1.3	15.4	0.7	0.4	0.2	0.3	3.7	2.3	0.6	0.4	0.5	0.2	0.8	0.2	1.1	0.2	0.5	3.4	0.2	0.7	0.6	0.5	1.5	1.5	1.1	0.9	1.1	0.5	0.2	26.7	0.4	0.3	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.2	0.5	0.2	0.0	0.2	0.0	0.2	0.3	0.2	0.5	0.0	0.0	2.2	2.5	2.2	2.6	2.0	2.2	2.7	2.5	2.4	2.5	2.8	3.4	2.5	9.6	2.2	0.0	4.6	1.9	4.5	3.9	0.6	24.3	2.7	5.0	3.9	10.0	2.4	1.8	62.6	2.2	5.3	23.5	1.9	2.1	0.8	1.8	2.9	3.7	11.5	0.0	0.0	2.6	1.2	3.9	11.2	1.5	0.0	4.9	3.6	18.4	0.6	16.8	0.0	10.3	0.0	4.5	7.9	2.3	13.4	2.3	5.4	0.0	4.7	8.2	12.3	0.0	0.0	3.6	18.6	6.8	0.7	3.2	49.9	13.0	4.7	62.9	13.1	14.0	9.3	3.9	6.4	0.8	1.7	1.5	4.8	5.3	15.9	3.1
RECQL4	RecQ4	ENSG00000160957	"RecQ like helicase 4"	O94761	8	144511288-144517845	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase"	"Cancer-related genes, Cataract, Craniosynostosis, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.4;testis: 22.4"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 23.5;Spermatogonia: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"CAB017800, HPA025821"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 32: T-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB017800: , HPA025821: AB_1856168"	"unprognostic (5.92e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.17e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (1.12e-2)"	"unprognostic (4.12e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.12e-3)"	"unprognostic (8.82e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.34e-1)"	1.7	1.8	3.0	5.8	3.7	25.4	2.0	7.7	7.0	2.9	0.1	4.7	6.0	2.5	0.4	13.3	2.1	2.1	1.8	2.6	1.6	2.5	2.7	2.3	6.8	6.9	2.3	2.7	3.1	0.7	3.1	2.5	7.4	8.6	1.6	1.5	5.8	0.8	2.5	10.1	5.2	1.0	1.7	6.5	3.2	22.4	4.1	7.4	3.4	0.5	2.5	2.5	3.1	3.6	33.7	58.8	27.0	57.1	1.6	2.6	47.1	33.2	5.9	24.2	20.2	58.4	48.4	22.8	21.5	5.6	14.2	40.1	18.0	14.2	6.6	40.3	68.6	82.4	118.5	44.3	0.5	21.2	65.7	3.3	2.1	27.1	5.5	3.4	6.8	45.4	83.3	28.9	8.5	104.1	77.3	56.9	18.8	27.8	69.5	80.0	21.2	37.9	6.7	35.8	52.9	32.0	45.2	37.3	12.1	7.4	45.5	45.7	9.2	38.9	117.4	47.3	62.6	16.0	18.1	39.3	22.4	64.6	39.9	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.7	7.7	7.0	2.6	1.6	6.9	2.3	7.4	1.7	4.1	3.6	0.7	0.0	0.0	2.0	2.2	1.5	0.7	0.9	1.2	2.7	3.7	2.7	1.8	1.5	0.5	0.0	4.2	3.9	1.0	5.9	0.0	0.5	3.9	2.1	0.9	0.7	0.0	6.1	2.0	0.4	8.1	1.8	4.6	2.0	0.0	8.8	0.0	0.7	3.6	0.0	1.6	4.1	0.0	0.6	1.1	7.4	1.2	1.0	0.0	0.0	0.3	0.3	1.0	0.0	0.8	0.3	0.2	1.5	9.1	0.7	0.7	0.5	0.7	1.7	0.0	1.4	1.2	23.5	20.6	6.6	1.0	1.5	1.2	0.5	7.0	0.7
RETREG1	"FAM134B, FLJ20152, JK1"	ENSG00000154153	"Reticulophagy regulator 1"	Q9H6L5	5	16473038-16617038	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Autophagy		"Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 91.4;skeletal muscle: 141.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Cytotrophoblasts: 53.7;Exocrine glandular cells: 59.3;Glandular and luminal cells: 197.7;Pancreatic endocrine cells: 51.5;Proximal tubular cells: 152.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 28.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.3;T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.0;GAMG: 20.3;HSkMC: 28.8;MOLT-4: 20.4;RPTEC TERT1: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012077			Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum"		"HPA012077: AB_2668621"	"unprognostic (1.63e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (5.25e-10)"	"unprognostic (3.75e-1)"	"unprognostic (9.96e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.58e-1)"	15.6	3.5	20.6	6.6	26.4	2.0	13.6	23.9	33.2	13.2	21.6	24.6	12.6	4.0	5.2	3.6	7.5	13.4	91.4	19.4	22.1	61.0	44.2	9.3	6.4	27.2	25.2	2.1	37.7	30.1	9.9	13.2	27.8	11.1	32.4	7.5	5.2	5.0	141.8	10.0	25.6	2.6	23.6	2.3	10.9	12.3	25.0	20.6	6.7	81.9	4.3	2.3	5.2	37.6	1.3	0.5	0.1	3.5	26.0	3.2	15.1	0.1	3.5	3.1	4.1	2.3	0.1	0.3	2.4	0.0	20.3	3.9	7.8	0.8	1.0	4.1	3.4	0.0	10.6	0.0	0.1	5.3	0.0	28.8	11.7	0.6	3.1	7.5	0.0	15.4	0.0	0.1	1.2	1.0	20.4	0.1	0.8	3.4	0.6	3.2	0.0	1.2	26.2	0.9	17.4	2.0	1.0	1.1	13.1	1.9	5.9	2.4	0.0	2.4	0.2	6.4	3.1	0.7	0.0	0.0	14.9	18.0	6.5	2.3	0.1	0.0	0.2	0.0	0.6	0.0	0.6	0.3	0.0	0.3	1.7	1.0	0.9	0.0	0.0	0.0	0.8	0.2	20.6	26.4	23.9	33.2	19.4	22.1	27.2	25.2	27.8	23.6	25.0	37.6	4.2	73.7	8.6	0.0	3.4	0.0	0.0	0.0	0.0	0.0	33.3	19.0	0.0	0.0	9.9	44.1	0.0	53.7	2.2	0.0	17.6	31.1	0.0	33.5	45.2	1.2	0.0	0.0	0.0	59.3	2.0	7.8	0.0	197.7	1.3	3.3	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	51.5	0.0	0.0	0.8	0.0	0.0	152.8	19.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	10.9	8.1	0.3	0.0	0.0
RFT1	CDG1N	ENSG00000163933	"RFT1 homolog"	Q96AA3	3	53088483-53130453	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060327, HPA069022"	Approved		Approved	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA060327: AB_2684253, HPA069022: AB_2732126"	"unprognostic (5.74e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.35e-3)"	"unprognostic (5.16e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.81e-2)"	"unprognostic (9.26e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.54e-2)"	11.8	12.5	5.7	14.5	6.2	8.3	12.5	5.5	6.6	9.0	4.9	11.8	10.3	9.1	13.0	12.1	12.4	10.5	9.0	6.1	5.3	8.7	14.0	9.2	16.7	5.6	5.2	12.5	22.3	15.6	6.2	13.8	5.9	9.3	13.2	4.3	18.0	10.4	5.1	9.9	10.5	11.2	5.5	9.9	10.4	13.5	5.4	14.2	14.6	6.7	15.8	12.6	8.8	8.0	39.1	36.3	24.3	39.0	27.9	29.5	50.6	34.8	32.3	59.2	53.7	35.9	74.6	51.0	21.3	33.5	55.6	40.7	55.4	56.8	51.9	48.4	24.5	50.6	24.8	36.0	48.8	46.7	28.4	31.4	46.8	79.6	57.1	26.2	37.9	52.7	27.1	45.2	39.4	39.6	44.2	27.3	48.8	67.5	47.3	18.1	23.5	77.5	32.8	26.1	13.8	18.7	43.0	30.9	31.2	26.2	23.3	65.5	25.5	54.3	35.2	37.7	69.1	28.6	37.1	38.4	38.9	58.8	58.3	50.2	40.2	18.4	22.2	40.5	22.5	21.2	20.6	22.9	42.9	35.5	23.7	23.7	13.4	23.1	29.4	48.9	20.1	25.7	5.7	6.2	5.5	6.6	6.1	5.3	5.6	5.2	5.9	5.5	5.4	8.0	6.0	3.2	3.7	8.8	8.7	5.0	10.8	18.3	5.2	4.6	7.6	5.5	7.4	11.5	12.6	9.2	4.2	39.4	6.0	5.1	1.9	17.4	1.9	5.6	9.5	8.1	2.4	17.7	9.4	21.1	33.1	9.2	4.1	5.7	2.5	17.8	10.4	10.7	22.0	5.0	8.9	6.4	10.2	9.9	5.0	2.3	8.7	9.8	7.2	9.4	11.7	5.8	3.1	7.5	11.3	12.2	8.8	6.0	19.3	9.1	5.7	5.6	8.3	6.4	0.0	7.0	8.7	10.1	8.9	8.0	4.3	24.2	7.7	22.0	11.7	8.1
RFWD3	"FANCW, FLJ10520, RNF201"	ENSG00000168411	"Ring finger and WD repeat domain 3"	Q6PCD5	16	74621399-74666877	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 47.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048258, HPA075649"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 42: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA048258: AB_2680332, HPA075649: AB_2686761"	"unprognostic (4.79e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.35e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.31e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.29e-1)"	5.2	3.9	2.5	9.9	3.5	47.7	7.6	4.0	3.2	6.4	4.4	8.0	6.5	6.2	5.3	9.4	6.8	6.5	2.9	2.3	2.9	6.7	5.8	6.1	15.4	3.3	3.1	7.0	10.2	6.8	3.8	8.0	3.2	4.9	9.3	6.2	5.8	5.1	3.3	12.6	6.1	6.1	2.8	8.1	6.2	25.2	3.4	27.1	6.6	2.7	16.7	7.2	6.8	4.7	46.1	57.5	42.6	31.2	8.8	11.9	47.8	40.5	30.9	63.0	54.5	75.4	46.8	63.6	32.1	31.8	31.6	53.9	70.3	42.1	76.9	20.0	42.1	56.3	46.0	43.0	7.6	57.3	56.3	8.6	13.2	79.6	48.7	16.3	27.3	53.2	86.7	27.7	48.1	72.8	84.0	52.2	84.0	26.8	27.7	128.7	28.8	55.9	22.7	47.8	31.5	33.6	65.2	22.8	28.8	38.2	41.7	48.4	26.7	46.0	43.9	26.2	51.4	37.4	75.1	188.3	32.8	43.5	57.0	12.1	4.4	6.5	5.5	4.1	6.1	4.9	4.5	5.1	4.6	5.4	6.7	4.8	4.9	6.2	7.7	3.5	7.2	4.4	2.5	3.5	4.0	3.2	2.3	2.9	3.3	3.1	3.2	2.8	3.4	4.7	6.0	0.0	5.9	4.2	13.2	10.8	6.8	4.0	10.2	6.6	8.4	8.3	3.9	2.8	5.4	1.8	10.4	12.1	15.3	7.6	11.7	6.2	5.4	6.9	5.7	7.2	9.5	22.5	8.9	7.6	8.3	5.9	5.1	6.6	4.5	13.5	11.7	7.4	8.9	3.3	7.1	9.7	2.0	12.2	6.0	6.3	3.7	7.8	16.0	15.0	7.6	3.0	10.3	6.6	15.2	10.0	2.7	4.1	11.6	12.7	4.3	4.6	5.9	6.7	6.6	6.4	5.6	48.5	31.7	9.5	9.2	7.5	10.6	3.6	9.5	11.4
RGR	RP44	ENSG00000148604	"Retinal G protein coupled receptor"	P47804	10	84230666-84259960	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"retina: 139.0"	"Cell type enriched"	"Detected in some"	29	"Muller glia cells: 1475.8"	"Cancer enriched"	"Detected in single"	4	"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"midbrain: 23.4;olfactory bulb: 49.7;thalamus: 27.3"	HPA059149			Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Plasma membrane, Cytosol"	"HPA059149: "	"unprognostic (9.28e-2)"		"unprognostic (1.05e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.53e-2)"				"unprognostic (4.57e-2)"	"unprognostic (1.57e-1)"				"unprognostic (1.59e-1)"	"unprognostic (1.97e-1)"			0.2	0.0	11.9	0.0	11.9	0.0	0.1	4.4	14.6	0.0	14.4	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.5	7.4	8.5	0.0	0.0	0.2	0.0	5.2	8.2	0.0	0.0	0.0	0.4	0.0	5.4	0.0	0.0	139.0	0.1	0.0	0.0	0.1	0.1	0.0	3.1	0.0	0.2	0.9	10.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	11.9	4.4	14.6	7.4	8.5	5.2	8.2	5.4	3.1	10.1	6.2	0.0	0.0	0.0	6.8	0.0	0.0	0.1	0.0	0.0	20.6	0.1	0.1	0.4	0.0	0.0	0.0	31.3	0.0	0.0	0.1	0.0	0.0	8.6	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	10.6	0.3	0.0	0.0	0.0	0.0	1475.8	0.0	2.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.6	0.0	2.8	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RHAG	"CD241, RH50A, SLC42A1"	ENSG00000112077	"Rh associated glycoprotein"	Q02094	6	49605175-49636839	"CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"		"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"bone marrow: 119.6"	"Cell type enriched"	"Detected in some"	170	"Erythroid cells: 494.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	202	"HEL: 506.0;K-562: 491.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA046051, HPA055331"	Approved		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Endoplasmic reticulum"		"HPA046051: , HPA055331: AB_2682785"					"unprognostic (8.16e-2)"						"unprognostic (6.86e-2)"	"unprognostic (1.25e-3)"		"unprognostic (1.65e-1)"				0.2	0.0	0.0	0.0	0.0	119.6	0.0	0.0	0.0	0.7	0.0	0.5	0.1	0.1	0.0	0.1	0.2	0.0	2.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.2	0.2	0.0	0.2	0.6	0.0	0.1	0.4	0.0	0.0	1.7	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	506.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	491.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.4	0.4	0.1	0.3	0.0	494.2	0.2	0.2	0.6	0.3	0.0	0.6	2.5	0.0	1.1	0.1	0.5	0.0	0.1	0.0	0.0	0.6	0.3	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.4	0.1	0.0	0.0
RHBDF2	"FLJ22341, iRhom2, RHBDL5, RHBDL6, TOC, TOCG"	ENSG00000129667	"Rhomboid 5 homolog 2"	Q6PJF5	17	76470891-76501790	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Growth factor binding"	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 58.4;Kupffer cells: 57.3;NK-cells: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 75.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA018080	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 57: B-cells - Immune response"			"HPA018080: AB_2178634"	"unprognostic (1.19e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.11e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-3)"	"unprognostic (9.79e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (3.96e-11)"	"unprognostic (5.24e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.14e-1)"	18.3	10.1	9.4	31.2	8.6	29.7	13.6	11.7	11.0	8.8	11.6	9.0	6.5	7.4	1.6	23.9	10.1	10.3	10.3	9.7	12.1	10.9	6.3	24.8	27.6	26.6	17.2	8.0	19.5	3.1	5.3	9.7	22.4	9.1	4.4	2.9	11.6	2.6	13.5	29.1	26.6	6.4	20.9	42.2	10.5	3.0	30.0	6.5	12.3	3.1	21.3	11.0	15.7	28.8	38.3	43.3	1.3	10.7	0.4	1.1	30.1	8.6	26.9	6.7	9.1	13.3	45.0	41.5	28.6	10.9	39.0	29.9	7.3	40.8	6.2	7.1	13.6	2.8	3.5	21.8	25.6	1.8	5.9	4.5	20.2	18.1	20.7	15.4	20.3	5.9	4.3	18.3	4.6	30.7	4.3	4.7	6.7	25.7	26.1	10.3	0.4	75.3	17.8	14.0	9.2	12.6	9.9	28.7	38.7	8.5	24.7	11.4	32.4	0.6	14.4	0.7	11.0	44.3	22.6	33.7	24.3	11.2	27.1	6.3	13.4	4.3	8.0	13.1	5.5	12.7	2.1	5.8	6.5	7.4	1.5	3.6	10.2	4.9	12.2	10.0	1.1	8.8	9.4	8.6	11.7	11.0	9.7	12.1	26.6	17.2	22.4	20.9	30.0	28.8	22.3	6.4	6.9	2.3	58.4	17.6	15.3	35.0	8.0	4.2	4.7	5.5	3.3	18.6	19.2	3.7	2.1	1.0	47.1	2.0	0.0	21.3	0.5	4.2	0.8	15.3	1.8	1.3	0.6	9.8	2.2	4.7	7.7	6.6	0.0	15.4	7.9	3.4	37.6	0.0	0.5	4.1	6.1	57.3	42.7	0.7	0.9	48.8	10.6	38.4	40.1	1.1	64.9	1.0	0.1	14.2	4.8	0.4	36.5	20.4	1.9	1.8	16.2	1.4	6.6	3.6	3.2	0.7	7.1	9.9	29.3	1.6	22.3	2.8	7.8	20.4
RHCE	"CD240CE, RH"	ENSG00000188672	"Rh blood group CcEe antigens"	P18577	1	25362249-25430192	"Blood group antigen proteins, CD markers, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"bone marrow: 48.5"	"Cell type enriched"	"Detected in some"	67	"Erythroid cells: 511.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HEL: 81.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "	"unprognostic (1.37e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.91e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.61e-2)"	"unprognostic (5.77e-5)"	"unprognostic (1.38e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.15e-3)"	"unprognostic (1.63e-1)"	0.3	0.6	1.5	0.1	1.9	48.5	0.3	1.6	3.3	0.3	1.2	0.2	0.2	0.2	4.2	0.6	1.0	0.3	1.2	1.5	1.4	0.4	1.7	0.4	0.5	1.9	1.6	0.5	1.2	0.1	3.4	1.1	1.9	1.0	0.3	2.2	5.5	0.2	1.5	0.6	0.1	0.0	1.5	1.1	0.4	2.2	1.6	0.8	0.6	0.9	0.3	0.1	0.5	2.2	0.2	0.1	0.2	0.5	0.9	0.6	0.1	0.3	0.3	0.4	0.1	0.1	1.5	0.7	1.1	1.0	0.1	0.3	0.0	0.2	0.2	0.4	0.1	81.3	0.0	0.0	1.1	0.0	0.6	1.9	1.5	0.6	0.5	0.0	0.0	0.6	17.5	0.4	0.5	0.8	0.0	0.6	1.7	0.7	0.5	0.2	0.2	2.6	0.0	0.0	0.7	0.8	0.3	0.3	1.0	0.8	0.5	0.0	0.1	0.2	0.0	0.9	0.0	5.1	1.4	1.0	2.9	0.9	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.5	1.9	1.6	3.3	1.5	1.4	1.9	1.6	1.9	1.5	1.6	2.2	0.8	0.0	0.0	5.5	0.8	0.5	0.5	0.3	0.6	4.2	1.1	2.5	0.7	1.5	0.2	0.0	0.0	0.8	1.2	0.5	0.0	0.3	1.1	1.2	0.7	0.4	0.0	511.8	2.9	0.2	0.7	0.4	3.6	0.8	4.5	0.6	0.0	0.7	0.2	6.7	2.3	0.0	0.0	0.6	0.4	0.5	0.6	1.7	0.0	0.0	0.0	4.7	1.0	2.0	2.7	0.5	0.0	0.7	3.0	0.3	0.1	0.0	0.9	2.4	6.6	0.5	0.5	3.0	7.6	0.6	1.4	0.8	0.8	0.7	0.3	0.7
RHO	"CSNBAD1, OPN2, RP4"	ENSG00000163914	Rhodopsin	P08100	3	129528639-129535344	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Congenital stationary night blindness, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5994	"retina: 4062.1"	"Cell type enriched"	"Detected in some"	7	"Rod photoreceptor cells: 4509.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	4	"hippocampal formation: 9.7"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.1"	"HPA013440, CAB022486, CAB034887, CAB034888"	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"CAB022486: , CAB034887: AB_785511, CAB034888: AB_785512, HPA013440: AB_2668844"	"unprognostic (4.32e-2)"			"unprognostic (1.21e-1)"	"unprognostic (1.68e-1)"		"unprognostic (1.83e-1)"	"unprognostic (2.87e-1)"		"unprognostic (1.94e-1)"			"unprognostic (9.19e-11)"	"unprognostic (4.24e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.91e-1)"		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4062.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	369.9	0.0	0.0	0.6	0.0	0.0	0.0	454.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	26.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	218.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	590.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4509.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RHOA	"ARH12, ARHA, Rho12, RHOH12"	ENSG00000067560	"Ras homolog family member A"	P61586	3	49359139-49412998	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle, Cell division, Host-virus interaction"	Hydrolase	"Cancer-related genes, Disease variant, Ectodermal dysplasia, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005052	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		1500000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"CAB005052: AB_562216"	"unprognostic (1.50e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (8.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.44e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (3.21e-6)"	"unprognostic (5.14e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.52e-2)"	452.4	315.0	234.6	357.9	258.6	473.4	360.0	257.1	274.1	310.4	237.4	351.9	274.6	293.8	298.6	362.6	269.2	267.1	269.6	220.8	271.2	286.9	274.5	430.9	396.3	282.9	245.8	297.2	225.3	269.4	164.3	396.8	287.2	244.5	369.3	113.3	238.0	315.6	331.0	281.3	281.0	416.9	259.3	329.1	292.1	154.1	257.5	387.7	326.3	298.5	454.9	358.2	273.6	292.5	470.4	406.1	500.9	512.7	569.9	858.9	370.8	930.1	735.7	790.3	722.4	347.6	527.4	721.8	251.6	1404.1	448.8	259.5	560.4	630.6	817.6	505.7	323.3	678.8	488.0	416.0	604.2	647.9	472.8	668.2	437.8	643.2	508.1	799.7	1038.0	391.9	361.1	437.9	967.5	254.3	717.3	739.0	441.4	548.2	497.1	325.5	451.4	610.5	701.9	559.6	167.7	387.3	599.0	464.5	495.4	499.4	301.7	819.6	972.1	558.4	483.2	737.2	725.7	388.0	775.6	754.8	567.9	691.6	678.3	716.9	1105.5	1160.5	480.1	1358.8	423.8	432.7	415.6	479.6	806.9	379.3	314.5	397.1	1282.7	440.9	1398.1	645.5	554.9	1884.8	234.6	258.6	257.1	274.1	220.8	271.2	282.9	245.8	287.2	259.3	257.5	292.5	502.8	387.8	265.2	20.5	374.6	270.9	260.0	236.1	251.6	47.1	239.4	223.1	141.1	178.7	220.9	180.3	6.2	355.8	373.1	447.2	340.4	339.5	48.2	174.2	243.7	413.8	234.4	319.3	26.1	347.8	709.8	386.2	313.9	201.0	257.3	141.6	312.7	173.2	760.0	82.4	27.0	344.9	191.2	771.9	495.8	55.6	335.2	683.7	327.3	52.5	710.0	219.9	389.3	24.6	51.4	398.0	354.6	407.7	375.7	334.1	341.3	350.8	201.1	40.8	276.1	354.1	450.1	264.4	253.6	390.8	279.6	525.2	359.5	299.1	347.7	371.4
RIPK1	RIP	ENSG00000137275	"Receptor interacting serine/threonine kinase 1"	Q13546	6	3063824-3115187	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Inflammatory response, Necrosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010302, HPA015257"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"CAB010302: AB_2178118, HPA015257: AB_1856294"	"unprognostic (1.24e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.29e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.44e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.38e-2)"	"prognostic favorable (6.71e-4)"	18.5	12.0	1.9	9.3	1.9	0.5	16.2	1.8	3.8	12.8	2.4	17.5	12.3	14.5	5.3	17.6	12.8	10.6	11.8	1.8	1.9	13.7	23.6	13.5	10.1	2.2	1.9	8.5	17.4	12.2	12.3	10.9	2.0	13.7	13.0	2.4	16.4	8.9	11.7	20.7	19.9	11.9	2.0	19.4	16.5	5.3	2.0	11.9	14.4	5.0	13.0	15.5	13.7	1.9	14.4	9.8	12.9	12.4	27.6	19.2	5.5	21.4	30.8	22.8	26.7	12.4	8.0	13.8	20.9	30.1	23.2	14.3	17.9	17.2	24.3	27.8	9.4	16.7	4.5	6.9	17.2	15.6	20.1	24.8	15.1	20.4	15.3	17.6	20.6	6.2	19.4	4.6	22.0	17.8	10.7	7.7	8.8	17.4	12.7	11.8	10.9	14.5	17.3	27.2	11.3	12.2	14.7	7.8	22.4	26.0	15.2	8.7	25.1	20.6	12.1	8.2	16.4	9.8	15.3	13.5	8.9	7.0	27.7	0.1	0.4	0.9	0.6	0.9	1.0	0.3	0.9	1.7	1.0	1.2	0.7	0.7	0.0	1.5	0.5	0.5	1.7	0.8	1.9	1.9	1.8	3.8	1.8	1.9	2.2	1.9	2.0	2.0	2.0	1.9	28.6	6.4	12.0	17.3	14.7	11.0	10.3	6.6	16.5	4.4	14.7	17.8	8.6	17.2	16.7	9.2	12.5	8.9	21.9	27.1	5.9	9.4	2.0	10.5	14.0	16.7	6.6	7.2	23.1	12.9	7.7	18.3	27.0	13.4	10.8	8.7	10.0	14.6	11.6	5.0	26.7	17.7	4.1	6.7	11.1	0.8	6.8	15.3	3.6	11.2	13.8	6.6	12.3	14.6	16.2	13.8	11.7	6.0	22.3	11.3	12.7	8.7	17.4	21.4	19.7	32.5	17.9	1.2	2.8	20.5	9.9	11.9	20.8	10.6	11.3	14.5
RIPK4	"ANKK2, ANKRD3, DIK, PKK, RIP4"	ENSG00000183421	"Receptor interacting serine/threonine kinase 4"	P57078	21	41739369-41767089	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 72.2"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 52.3;Endometrial ciliated cells: 76.5;Gastric mucus-secreting cells: 61.2;Glandular and luminal cells: 174.2;Squamous epithelial cells: 71.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 32.2;GAMG: 41.2;HaCaT: 47.5;hTCEpi: 31.4;RPTEC TERT1: 28.3;RT4: 30.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA030942	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA030942: AB_2732462"	"unprognostic (8.93e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.32e-3)"	"unprognostic (7.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (6.22e-5)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (9.98e-2)"	"prognostic favorable (6.52e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.78e-2)"	1.6	0.0	0.1	0.4	0.0	0.6	4.3	0.0	0.1	11.8	3.7	3.1	9.7	1.1	2.4	72.2	5.8	5.2	1.5	0.1	0.1	11.5	19.1	4.2	0.1	0.3	0.6	0.1	14.3	7.4	10.8	2.3	0.1	10.7	2.0	0.6	14.8	9.8	0.0	21.5	13.6	0.1	0.1	0.0	15.5	2.0	0.1	7.8	7.9	0.0	5.2	6.3	22.3	0.1	14.3	9.0	0.0	0.0	0.0	0.0	13.7	0.1	0.1	0.2	0.2	23.5	32.2	0.0	13.3	2.9	41.2	47.5	0.7	19.2	0.0	0.0	9.4	0.0	6.9	8.8	0.0	0.0	0.0	0.0	31.4	0.2	4.2	0.0	0.0	14.3	0.0	0.0	0.0	10.3	2.0	0.0	0.8	9.3	26.1	0.0	0.0	2.3	28.3	30.8	4.5	0.3	15.5	15.7	15.1	1.3	9.6	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	4.2	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.6	0.1	0.1	0.1	0.1	0.1	28.9	9.1	0.0	0.1	15.8	27.4	24.0	52.3	0.0	13.0	12.4	1.1	17.2	28.0	3.7	0.0	8.3	0.3	22.8	9.8	12.4	1.5	76.5	16.9	0.9	22.7	0.0	0.0	10.4	5.1	0.6	61.2	174.2	2.5	0.0	0.0	17.0	1.0	0.0	0.0	14.2	16.2	0.6	1.4	1.6	0.0	0.9	7.2	0.0	0.0	0.4	0.0	0.0	0.0	19.0	11.8	0.0	0.0	24.0	26.5	13.5	22.2	0.9	0.0	0.0	1.3	1.4	2.5	71.2	15.2	2.5	1.5	0.0	11.2	24.1
RIT1	"MGC125864, MGC125865, RIBB, RIT, ROC1"	ENSG00000143622	"Ras like without CAAX 1"	Q92963	1	155897808-155911404	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 80.7"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 107.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053249	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"			"HPA053249: AB_2682089"	"unprognostic (1.84e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.27e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (8.64e-6)"	"unprognostic (3.80e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.19e-2)"	"unprognostic (9.22e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.33e-3)"	19.8	13.8	10.7	22.9	12.1	80.7	13.3	12.0	13.0	16.6	12.1	14.0	12.7	14.8	15.4	37.3	10.8	18.5	15.7	10.3	11.8	25.1	12.2	22.7	18.3	13.5	12.7	12.8	13.8	16.5	11.0	23.0	13.3	13.8	14.3	16.0	14.4	18.0	10.8	12.8	12.5	21.3	11.6	21.7	19.7	12.2	12.8	21.5	13.4	16.5	23.6	23.6	21.9	13.3	21.0	22.9	42.3	21.7	21.5	26.6	12.0	37.2	37.4	35.2	35.4	24.1	40.0	9.6	50.0	43.9	25.3	24.7	32.0	18.5	29.4	12.9	16.4	21.0	24.4	15.6	55.7	22.5	37.9	37.1	22.5	40.9	27.4	47.7	48.7	19.7	21.0	26.3	54.3	27.3	30.7	14.9	23.0	36.2	13.9	24.0	33.3	19.6	29.9	44.2	19.7	30.7	27.1	51.1	34.8	76.9	37.3	29.4	62.5	31.7	22.3	27.3	30.7	31.1	30.9	38.8	33.9	22.8	43.0	22.8	41.0	46.9	19.5	25.5	15.6	16.9	16.8	18.5	31.1	17.1	20.2	18.1	106.3	28.8	29.3	12.5	23.8	30.0	10.7	12.1	12.0	13.0	10.3	11.8	13.5	12.7	13.3	11.6	12.8	13.3	45.8	48.1	23.9	12.4	22.4	28.9	36.5	43.7	21.6	8.1	17.4	12.3	14.2	8.6	40.4	18.4	10.4	14.5	41.8	14.1	21.5	39.4	10.4	20.4	25.7	50.5	12.6	16.4	5.1	23.4	16.8	20.8	13.3	32.5	14.0	15.2	24.7	7.0	50.7	6.7	5.3	11.5	42.7	45.6	107.9	10.3	7.2	62.6	33.8	11.2	79.2	25.9	16.5	8.5	8.1	28.3	15.4	15.8	13.4	48.8	15.4	70.6	21.9	11.9	26.3	18.2	26.1	12.7	23.2	26.0	30.7	33.5	32.7	20.7	10.0	79.2
RLIM	"MGC15161, NY-REN-43, RNF12"	ENSG00000131263	"Ring finger protein, LIM domain interacting"	Q9NVW2	X	74582976-74614624	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018895	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA018895: AB_1856323"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (1.20e-1)"	11.3	11.8	10.6	10.4	11.7	41.2	10.5	5.9	9.9	10.0	10.0	6.8	5.9	9.5	5.6	8.7	8.4	9.6	8.8	11.2	15.1	10.0	8.3	12.1	8.9	8.5	10.3	10.6	7.5	11.7	10.3	9.8	10.3	9.8	6.6	10.7	7.4	7.1	9.6	9.4	6.1	9.3	7.3	9.3	7.4	6.5	12.6	11.0	11.7	8.6	9.5	8.5	8.0	8.2	23.7	24.2	22.8	18.7	20.1	22.5	22.4	22.4	26.0	19.9	24.4	18.9	24.4	12.8	25.4	28.6	26.7	19.9	45.9	26.7	30.1	11.7	23.9	22.7	43.2	10.7	17.4	34.6	38.6	21.7	14.4	28.2	46.5	15.6	23.3	20.9	19.9	22.9	24.6	18.1	26.0	16.8	35.0	12.9	22.5	24.3	48.0	21.5	16.1	28.6	16.4	19.5	42.3	19.0	24.5	20.4	11.2	24.9	31.0	23.4	23.1	24.8	19.6	12.0	24.6	20.3	25.5	33.1	23.2	22.8	6.0	5.9	3.1	7.5	3.1	3.0	3.9	3.8	4.9	3.3	4.2	3.8	11.5	5.3	5.6	2.6	4.8	3.2	10.6	11.7	5.9	9.9	11.2	15.1	8.5	10.3	10.3	7.3	12.6	8.2	44.8	16.0	17.0	13.4	22.4	35.8	29.6	16.1	23.3	13.8	18.3	13.5	30.5	18.6	20.4	25.8	14.6	16.3	27.6	10.3	11.7	13.7	7.9	32.3	35.3	30.1	23.2	12.8	19.2	10.7	21.5	27.7	27.0	41.0	38.0	24.6	21.0	14.8	18.2	21.9	18.9	10.6	10.2	20.7	34.1	4.4	9.9	29.1	17.8	15.9	12.7	13.2	12.3	11.1	16.4	14.8	8.5	18.8	16.3	25.5	6.8	12.0	25.2	14.6	6.6	31.1	24.1	9.7	18.2	21.6	38.8	26.3	22.0	19.0	11.4	37.2
RNASEH1		ENSG00000171865	"Ribonuclease H1"	O60930	2	3541430-3558333	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Disease variant, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA034817, HPA043037"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA034817: , HPA043037: AB_2678280"	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.81e-3)"	"unprognostic (4.32e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (7.83e-6)"	"unprognostic (9.43e-2)"	"unprognostic (8.46e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.23e-3)"	10.6	8.7	9.7	9.5	10.6	11.4	9.7	8.2	12.3	8.5	6.8	7.8	7.2	11.7	11.3	9.6	7.8	7.5	13.0	11.1	11.2	7.1	8.1	7.9	10.2	10.1	9.1	8.2	8.7	9.1	3.3	7.9	10.1	9.3	9.5	8.7	7.7	11.8	15.3	9.9	7.8	13.3	9.2	9.0	6.9	7.0	11.7	10.3	9.5	15.0	10.9	8.5	4.7	10.5	11.9	21.4	22.1	22.5	24.9	23.2	17.2	29.0	30.6	24.8	16.5	19.4	13.0	33.6	13.7	31.5	18.8	14.7	32.6	23.2	30.9	12.4	17.5	33.1	18.9	27.5	35.5	42.0	23.3	23.5	24.9	24.2	29.3	18.5	21.5	54.8	33.0	19.4	31.1	9.3	32.7	27.3	34.7	20.6	17.0	26.9	32.0	34.3	21.0	19.7	33.3	48.9	17.8	15.9	27.5	16.7	10.3	22.9	24.8	24.1	11.5	24.7	40.7	36.1	37.5	43.9	43.2	35.1	37.5	0.1	0.6	1.3	1.3	1.2	2.2	1.1	1.0	1.7	0.7	0.6	1.0	2.1	0.5	0.4	1.2	1.5	0.4	0.7	9.7	10.6	8.2	12.3	11.1	11.2	10.1	9.1	10.1	9.2	11.7	10.5	15.6	22.4	6.9	9.1	30.7	7.5	26.1	21.0	13.6	25.7	14.9	12.6	25.9	11.5	14.7	3.7	20.9	32.7	25.4	14.4	37.2	44.3	5.1	9.6	20.8	20.1	15.0	13.5	11.8	48.7	44.3	20.2	17.9	11.0	27.3	17.9	16.8	18.0	30.8	35.3	10.7	16.4	14.2	18.8	8.9	3.4	13.7	16.2	10.6	10.3	32.3	17.5	30.9	7.5	9.8	48.3	9.9	26.4	41.7	50.2	16.6	28.6	14.1	18.8	19.7	23.6	23.4	21.0	27.5	17.8	12.1	36.5	18.9	27.7	15.9	37.9
RNASEH2A	"AGS4, RNASEHI, RNHIA, RNHL"	ENSG00000104889	"Ribonuclease H2 subunit A"	O75792	19	12806584-12813640	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 62.3;Extravillous trophoblasts: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042692			Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA042692: AB_10793981"	"unprognostic (6.74e-2)"	"prognostic favorable (1.18e-4)"	"prognostic favorable (6.18e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (8.48e-2)"	"unprognostic (9.33e-2)"	"prognostic favorable (1.22e-4)"	"unprognostic (3.80e-3)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (6.29e-6)"	"unprognostic (3.40e-3)"	"unprognostic (4.35e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.60e-2)"	8.9	6.8	7.0	11.8	7.2	28.0	9.0	10.4	9.1	10.8	6.2	10.5	10.3	8.5	4.9	18.3	10.6	4.9	7.6	7.2	6.1	7.4	6.9	7.3	17.1	7.3	6.5	8.9	9.2	5.3	5.4	10.4	7.4	6.0	10.7	8.4	8.6	5.0	8.9	13.9	10.0	8.2	6.0	14.5	9.4	19.8	6.8	24.4	7.5	6.6	18.7	8.2	10.8	9.5	130.0	103.8	94.8	75.7	12.3	23.4	76.2	68.4	40.0	126.3	136.0	76.2	58.7	126.9	106.2	36.6	59.6	79.4	82.6	89.2	83.5	82.7	118.1	67.7	112.9	89.9	7.1	70.6	60.5	10.4	19.7	110.7	43.9	21.4	47.3	114.8	91.2	46.8	82.0	251.4	132.8	83.0	56.4	79.1	167.4	146.1	102.0	113.7	39.6	63.8	119.8	76.7	67.0	39.8	46.7	39.8	76.1	78.4	29.3	129.2	55.7	197.0	126.1	97.6	130.3	108.5	77.4	129.4	105.5	9.4	19.1	17.2	23.9	27.6	23.3	36.8	19.6	22.5	19.0	36.3	15.9	19.6	4.4	44.8	27.7	21.0	25.8	19.1	7.0	7.2	10.4	9.1	7.2	6.1	7.3	6.5	7.4	6.0	6.8	9.5	5.3	0.0	2.6	1.3	15.3	14.0	15.7	22.9	6.8	16.2	2.8	11.7	2.7	12.8	7.6	0.0	4.2	62.3	9.1	11.3	0.0	5.4	16.1	0.8	1.6	9.0	8.4	38.7	2.2	6.0	117.4	10.3	10.7	1.1	3.8	2.5	11.7	4.4	48.9	8.4	3.0	13.9	22.4	9.1	13.2	18.8	8.4	9.3	12.4	1.9	8.5	10.4	14.4	1.0	2.4	2.1	6.8	4.9	33.0	5.3	6.2	1.0	9.5	13.9	6.6	15.6	9.8	51.2	44.9	23.8	13.2	22.7	10.2	0.8	24.8	16.1
RNASEL	"PRCA1, RNS4"	ENSG00000135828	"Ribonuclease L"	Q05823	1	182573634-182589256	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense"	"Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002633, CAB010906"	Approved		Supported	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB010906: AB_477444, HPA002633: AB_1856314"	"unprognostic (3.46e-2)"	"unprognostic (9.10e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.81e-1)"	5.6	6.4	3.2	8.8	3.5	3.6	5.9	3.4	3.9	6.6	3.7	8.1	7.0	6.5	9.6	6.2	5.2	6.9	3.4	2.9	3.4	6.2	3.5	6.9	9.6	3.4	3.5	11.3	3.1	7.9	5.4	6.9	3.6	7.2	9.0	5.7	5.0	8.3	2.0	5.4	8.0	7.1	2.8	8.9	7.8	2.2	3.6	8.0	9.1	4.5	9.9	6.0	6.3	3.3	2.6	3.6	1.5	0.6	7.9	13.7	2.8	4.9	6.1	4.9	4.5	2.1	5.6	5.6	8.4	5.6	2.2	4.7	3.6	5.1	1.9	4.5	3.1	6.6	1.3	0.3	4.1	12.4	12.5	9.8	11.4	2.6	0.7	3.1	2.1	8.2	2.4	4.2	4.3	3.8	3.6	5.1	1.2	8.4	1.0	5.3	1.2	2.9	5.2	3.4	0.7	0.2	4.4	5.3	4.3	3.9	5.4	13.6	2.8	2.5	2.0	2.7	2.7	3.7	1.3	0.7	4.0	7.5	3.8	41.7	14.8	53.1	9.4	15.8	12.4	10.3	11.1	10.1	12.4	7.9	17.3	12.8	55.3	10.9	30.3	14.7	10.0	10.5	3.2	3.5	3.4	3.9	2.9	3.4	3.4	3.5	3.6	2.8	3.6	3.3	4.5	6.4	4.2	5.2	6.5	1.0	2.9	4.9	1.2	4.3	2.8	2.4	1.3	1.5	9.0	3.7	4.2	4.2	8.2	14.8	7.9	6.7	0.0	2.5	9.6	5.1	2.4	4.8	4.2	1.8	3.7	6.4	7.7	3.4	5.7	5.5	3.9	1.6	6.2	1.7	6.6	9.3	8.2	9.7	1.2	0.8	2.8	5.8	0.0	1.9	7.3	8.7	5.2	6.0	3.6	2.2	3.2	6.4	2.7	3.5	7.2	7.3	9.1	6.1	19.7	5.8	5.2	0.4	0.9	4.5	1.0	2.6	7.5	12.1	4.0	4.6
RNASET2	"bA514O12.3, FLJ10907, RNASE6PL"	ENSG00000026297	"Ribonuclease T2"	O00584	6	166922113-166957191	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Endonuclease, Hydrolase, Lyase, Nuclease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 490.2;Glandular and luminal cells: 761.3;Hofbauer cells: 382.2;Kupffer cells: 484.7;Macrophages: 418.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 497.9"									"HPA029013, HPA066509"	Approved				"Secreted to blood"	NA	NA		15000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"HPA029013: AB_10602922, HPA066509: AB_2685682"	"unprognostic (4.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.13e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (1.70e-14)"	"unprognostic (5.03e-2)"	"unprognostic (7.34e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.01e-2)"	34.9	35.0	50.1	68.6	50.4	124.3	50.2	52.2	65.9	161.5	52.3	74.0	57.6	49.1	140.7	24.8	134.6	69.6	19.8	49.5	53.5	31.2	52.4	47.2	117.4	68.2	54.3	36.2	144.7	40.7	26.3	43.5	66.2	51.9	89.9	8.3	112.8	94.1	7.3	25.4	65.4	27.8	61.9	195.1	72.9	13.3	59.1	43.8	76.7	12.1	86.9	54.9	32.2	79.8	12.8	14.2	12.6	37.8	57.0	40.6	8.4	15.8	21.2	7.3	7.4	33.7	19.9	11.1	149.8	41.3	16.7	41.0	20.8	18.6	4.3	15.9	35.1	10.2	20.6	84.6	19.1	152.7	37.3	23.9	33.6	4.3	2.7	30.4	10.1	21.7	20.9	94.5	10.9	44.9	12.6	109.5	6.4	140.0	13.0	25.0	16.6	131.7	136.3	9.9	4.4	28.7	32.0	100.4	8.3	22.3	13.1	497.9	19.3	14.9	9.8	43.7	13.5	15.0	19.5	1.4	32.3	149.2	10.3	116.9	185.6	674.8	29.1	277.0	53.4	136.7	159.9	72.3	226.4	119.6	128.4	41.4	438.9	30.7	368.8	369.3	90.8	179.8	50.1	50.4	52.2	65.9	49.5	53.5	68.2	54.3	66.2	61.9	59.1	79.8	21.8	19.2	29.3	10.1	270.1	43.3	116.4	45.1	72.3	10.5	97.0	95.1	9.5	47.1	28.0	38.6	0.0	63.4	286.8	133.7	23.5	59.2	10.3	490.2	78.9	44.9	75.4	27.6	13.6	27.4	58.8	45.8	80.0	761.3	71.7	38.6	19.2	20.0	382.2	13.5	37.1	204.0	24.4	484.7	187.7	11.3	35.4	418.2	58.7	113.4	146.1	24.4	64.9	14.6	1.7	74.1	324.8	29.3	158.6	61.2	178.5	19.6	19.0	7.1	26.3	31.9	18.6	10.0	23.1	58.3	34.5	27.8	149.2	15.3	193.0	103.9
RNF113A	"Cwc24, RNF113, ZNF183"	ENSG00000125352	"Ring finger protein 113A"	O15541	X	119870475-119871733	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000160, HPA076658"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA000160: AB_1079821, HPA076658: AB_2732319"	"unprognostic (2.85e-1)"	"unprognostic (4.38e-3)"	"unprognostic (5.55e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.02e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (7.93e-4)"	"unprognostic (7.99e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.91e-2)"	"prognostic favorable (6.23e-4)"	11.0	9.6	11.5	13.0	12.1	35.3	10.2	13.0	14.4	10.5	11.3	11.4	13.2	9.8	9.6	11.3	10.2	8.2	12.7	11.7	13.9	9.2	17.7	11.0	24.7	12.7	13.0	13.4	19.1	9.2	10.0	9.0	13.1	8.9	9.5	15.6	14.4	8.8	12.3	17.1	17.5	7.5	11.9	24.3	12.1	3.4	13.1	24.7	9.9	10.6	19.0	10.8	10.3	12.6	16.9	22.9	11.0	17.7	20.7	14.9	22.3	14.8	25.0	17.6	21.0	19.7	14.1	28.0	28.1	13.8	25.1	20.4	24.4	19.1	13.1	21.9	18.0	17.0	25.8	23.5	28.3	33.7	28.3	18.4	20.6	17.7	26.0	20.7	17.1	19.4	12.2	38.4	17.3	47.5	23.5	39.9	16.1	29.5	32.8	21.7	23.2	45.3	18.5	20.6	14.7	12.9	23.1	35.5	33.1	12.9	8.7	32.9	13.1	18.6	6.6	26.7	29.7	43.2	36.0	27.9	16.8	44.1	12.3	96.4	59.5	109.5	73.9	60.3	74.4	83.6	78.3	79.0	63.4	88.6	81.3	73.1	27.5	65.9	72.6	53.3	96.6	73.6	11.5	12.1	13.0	14.4	11.7	13.9	12.7	13.0	13.1	11.9	13.1	12.6	14.8	9.6	14.8	2.6	42.8	24.3	17.2	26.6	30.7	11.5	13.6	21.1	8.9	18.6	21.4	14.7	14.6	18.5	51.6	10.8	9.8	18.3	0.5	13.1	18.8	17.4	4.2	10.3	3.0	16.8	37.6	15.2	16.3	16.5	26.5	14.4	18.2	13.1	24.4	13.5	4.1	16.8	14.2	17.6	23.1	1.4	12.2	17.0	26.6	5.6	17.2	16.5	39.1	2.0	6.2	15.5	17.8	9.8	59.6	12.3	34.9	25.1	19.6	17.7	6.6	8.3	19.3	2.9	5.8	20.9	24.4	26.4	50.2	15.9	15.5	14.3
RNF125	FLJ20456	ENSG00000101695	"Ring finger protein 125"	Q96EQ8	18	32018825-32073219	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 169.6;Early spermatids: 90.7;NK-cells: 160.6;Oligodendrocytes: 64.3;T-cells: 114.8"	"Cancer enhanced"	"Detected in all"		"testis cancer: 8.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 51.5;SK-MEL-30: 13.2;U-937: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041514	Uncertain		Supported	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"	Nucleoli	"HPA041514: AB_10795596"	"unprognostic (2.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.93e-1)"	"unprognostic (5.03e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.30e-3)"	"unprognostic (6.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.07e-3)"	10.2	1.3	2.0	5.2	3.7	18.4	6.3	2.7	2.7	3.9	1.6	5.0	10.5	2.9	0.5	2.5	3.4	3.3	2.6	1.9	2.3	1.0	12.5	4.7	7.0	3.6	3.2	1.4	3.1	1.7	0.3	3.7	3.4	1.8	6.4	0.3	2.2	1.4	2.3	4.9	11.3	3.3	2.6	5.9	3.4	1.0	3.8	5.3	1.4	2.9	4.0	3.0	1.7	6.2	1.2	0.1	0.2	0.4	0.5	0.8	1.0	0.1	0.0	0.0	0.0	0.1	2.5	0.1	1.2	0.1	0.4	0.9	1.6	1.2	0.2	6.6	2.6	0.3	0.4	0.3	0.1	8.9	51.5	1.6	2.4	0.0	2.8	0.3	0.4	2.7	0.1	1.9	0.1	2.0	2.3	8.2	4.2	8.9	1.5	9.2	0.6	0.2	0.5	0.5	0.9	0.3	0.2	0.1	13.2	1.6	1.3	4.2	0.2	0.1	0.7	0.1	0.1	5.9	0.2	0.1	0.6	11.5	6.9	13.3	4.5	4.5	15.0	2.5	9.9	2.5	12.0	12.8	4.2	2.3	9.5	12.3	1.9	15.5	2.8	4.3	13.7	6.9	2.0	3.7	2.7	2.7	1.9	2.3	3.6	3.2	3.4	2.6	3.8	6.2	62.2	3.2	5.8	3.3	16.3	9.8	3.1	1.0	14.2	0.8	5.3	3.7	2.1	4.3	3.8	12.9	0.0	0.4	169.6	24.6	1.9	1.0	90.7	4.9	2.1	28.4	1.2	15.8	2.7	1.8	0.1	5.3	8.6	13.4	18.9	0.2	12.5	25.1	10.5	0.0	3.0	8.3	0.0	19.2	12.6	17.4	2.8	18.4	1.8	30.9	23.8	0.7	160.6	3.5	64.3	1.1	4.5	0.0	49.9	2.7	41.4	4.5	1.7	0.9	0.0	3.2	3.2	0.5	1.8	5.8	6.8	0.8	114.8	0.2	14.7	2.4
RNF13	RZF	ENSG00000082996	"Ring finger protein 13"	O43567	3	149812770-149962139	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 591.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 462.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064784	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	Cytosol	"HPA064784: AB_2685350"	"unprognostic (1.27e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.64e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.00e-8)"	"unprognostic (2.95e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.79e-1)"	48.2	41.2	58.1	40.4	95.2	19.9	53.9	88.1	91.5	33.6	63.7	35.0	28.9	33.3	57.2	32.6	30.2	40.6	34.4	55.0	77.3	67.9	73.8	64.1	38.0	101.8	83.9	35.6	36.1	52.3	18.3	64.1	100.8	46.6	37.1	40.4	75.5	39.3	36.5	32.5	30.5	36.9	85.6	53.0	34.3	25.2	75.9	32.0	64.0	42.6	33.2	42.3	28.9	131.0	60.6	39.4	24.4	29.0	92.2	55.2	40.3	32.2	86.2	32.3	47.4	33.4	84.4	26.6	48.7	42.0	58.7	58.0	37.5	41.5	42.9	34.1	24.6	35.8	17.3	31.2	61.5	35.0	41.8	59.9	73.1	26.5	71.8	37.3	37.0	24.9	10.1	49.7	28.0	34.5	26.2	18.8	16.8	58.6	29.1	19.0	26.7	108.5	54.2	29.6	12.6	37.6	28.5	39.9	110.3	19.2	79.2	34.0	37.8	40.8	16.5	45.6	23.4	89.9	61.9	51.5	35.9	30.1	23.6	98.2	130.1	106.5	37.4	153.8	48.8	51.9	41.5	44.8	93.1	48.4	38.0	42.4	462.3	46.3	207.8	68.3	48.7	104.5	58.1	95.2	88.1	91.5	55.0	77.3	101.8	83.9	100.8	85.6	75.9	131.0	100.9	109.0	72.3	78.7	55.3	73.5	68.2	84.3	74.0	44.5	54.5	51.1	27.3	48.6	68.1	47.8	29.2	101.2	61.9	30.2	43.0	63.0	2.5	32.5	34.5	69.4	20.3	32.4	122.1	70.6	83.5	84.8	31.6	39.7	60.8	14.6	80.3	53.7	201.2	21.9	98.8	27.7	67.1	183.9	173.7	6.7	76.1	177.6	103.2	92.8	93.5	98.5	38.1	115.6	591.2	58.7	33.6	88.0	62.4	71.9	38.5	71.5	40.4	37.2	92.1	76.3	55.5	23.6	32.5	52.3	72.5	52.5	49.8	38.2	27.7	55.8
RNF139	"HRCA1, RCA1, TRC8"	ENSG00000170881	"Ring finger protein 139"	Q8WU17	8	124474880-124488618	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Ubl conjugation pathway"	"Receptor, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 93.2"	"Group enriched"	"Detected in all"	10	"Early spermatids: 810.1;Late spermatids: 992.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001202	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 34: Spermatids - Unknown function"			"HPA001202: AB_1079824"	"unprognostic (3.28e-3)"	"unprognostic (2.92e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.71e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.45e-1)"	23.5	20.8	10.0	15.9	11.1	93.2	18.9	14.8	12.7	16.6	11.2	15.6	9.2	20.2	13.6	16.5	16.7	16.8	15.3	11.0	11.0	15.3	26.1	16.6	17.3	11.0	10.8	23.6	14.4	11.8	10.2	19.4	11.0	14.9	14.8	12.4	16.5	13.3	20.3	17.2	14.2	20.3	11.8	13.9	13.9	68.7	11.7	19.3	16.3	22.6	14.8	16.7	12.4	15.0	26.6	17.1	21.6	20.3	43.2	34.1	16.6	23.5	44.4	18.6	24.7	10.9	21.6	27.5	27.8	31.7	14.3	19.7	18.3	28.4	28.9	37.6	24.5	41.1	11.9	22.9	33.3	19.6	23.2	30.5	41.0	20.5	55.9	27.1	26.2	26.8	29.1	41.3	22.2	70.2	32.9	13.6	14.3	52.6	25.6	13.2	14.9	27.0	35.3	34.4	9.4	22.3	31.0	76.5	33.4	16.5	35.7	20.7	20.6	13.9	29.7	22.2	26.3	32.9	40.9	28.6	19.9	31.7	13.9	2.7	6.2	10.1	8.7	4.1	11.0	7.9	7.8	10.5	8.4	7.1	8.1	8.4	8.5	7.2	11.4	4.0	11.4	6.7	10.0	11.1	14.8	12.7	11.0	11.0	11.0	10.8	11.0	11.8	11.7	15.0	21.1	3.2	8.4	11.8	66.2	66.2	62.1	27.2	58.6	14.5	31.6	19.7	16.2	34.3	18.5	22.0	6.2	42.3	58.5	22.5	11.7	19.9	810.1	31.3	22.6	24.9	21.7	27.1	12.9	18.0	55.9	40.1	23.4	37.1	20.3	23.2	22.9	31.8	25.0	16.8	12.8	18.5	10.2	33.7	74.4	992.2	29.5	43.4	35.6	12.2	26.5	21.3	26.8	8.5	18.5	22.5	11.4	27.1	35.4	41.1	17.0	16.9	20.1	22.7	19.7	39.7	49.2	62.3	24.3	46.7	70.5	75.5	83.5	22.6	18.2	55.5
RNF146	"dactylidin, dJ351K20.1, DKFZp434O1427"	ENSG00000118518	"Ring finger protein 146"	Q9NTX7	6	127266682-127288567	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027158, HPA027209"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA027158: AB_10600772, HPA027209: AB_10602312"	"unprognostic (8.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.74e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (2.65e-2)"	"prognostic favorable (7.32e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.15e-2)"	52.9	37.0	49.5	32.4	56.0	10.6	42.7	79.4	61.2	48.1	36.2	40.5	21.9	57.4	60.8	25.3	42.4	38.6	46.9	50.7	51.6	37.1	31.8	38.7	35.1	53.2	52.1	49.5	23.3	40.0	33.3	51.8	56.8	31.7	30.9	48.1	31.2	34.5	114.9	29.5	31.1	45.9	55.2	47.1	29.9	31.3	52.5	24.3	47.1	91.5	33.3	36.9	34.3	61.5	13.2	16.2	60.3	53.6	54.7	54.3	22.2	43.5	69.0	22.8	32.4	21.3	19.3	23.6	30.3	35.7	36.2	16.4	18.1	20.4	32.9	27.6	16.0	30.3	21.8	30.0	54.0	18.0	20.6	47.6	42.1	26.1	51.1	52.5	40.6	23.2	33.0	22.5	50.7	25.2	17.9	32.0	22.1	8.1	17.1	22.6	15.7	12.1	32.4	14.3	36.0	36.6	17.1	23.6	27.7	35.5	16.1	60.8	48.3	39.7	13.1	41.8	31.7	32.3	22.0	15.6	30.5	31.0	38.5	27.5	30.0	26.6	14.3	32.4	14.7	17.4	12.2	16.3	22.8	17.9	11.0	15.5	37.0	19.8	40.1	11.7	15.0	16.1	49.5	56.0	79.4	61.2	50.7	51.6	53.2	52.1	56.8	55.2	52.5	61.5	24.6	35.3	29.3	35.6	23.7	17.7	14.3	15.1	18.8	34.7	16.9	14.7	38.9	31.5	16.7	9.2	4.2	29.0	14.7	13.5	41.1	28.0	52.5	15.7	29.5	30.5	20.4	12.8	53.5	15.8	27.2	50.6	7.1	11.5	22.2	28.1	31.4	30.5	26.3	30.3	54.5	12.1	38.7	68.4	24.6	45.4	69.6	29.9	46.2	42.2	31.1	41.1	28.8	56.3	76.5	18.0	17.0	66.5	9.3	26.3	15.7	51.7	23.9	20.9	32.9	36.2	31.9	41.7	24.9	15.0	20.0	38.4	20.8	36.0	10.9	25.9
RNF168	FLJ35794	ENSG00000163961	"Ring finger protein 168"	Q8IYW5	3	196468783-196503768	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 199.9;Late spermatids: 459.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046109			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA046109: AB_2679540"	"unprognostic (6.15e-3)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.11e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (6.81e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (4.83e-3)"	"unprognostic (2.80e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.65e-2)"	8.6	4.8	3.9	6.0	4.2	20.6	6.8	5.9	4.3	9.3	4.4	6.1	6.1	6.0	4.0	7.9	5.9	4.5	6.8	3.2	6.3	4.7	10.4	8.1	7.2	6.1	5.2	7.4	4.8	4.0	3.5	5.4	6.5	5.3	5.7	4.9	5.8	4.1	13.1	11.5	5.6	5.3	4.9	6.8	5.8	10.7	6.0	7.7	4.9	8.3	8.7	6.7	9.3	6.0	21.6	8.5	14.8	19.5	13.6	9.8	21.1	12.9	8.1	8.5	13.3	16.6	10.4	22.7	29.1	10.8	11.9	21.3	21.0	15.4	13.0	10.9	10.3	43.0	22.2	20.7	7.0	13.3	10.3	9.8	5.8	13.3	11.7	6.0	12.6	18.4	13.1	23.1	8.7	36.4	44.6	7.8	17.6	11.6	10.8	19.7	17.2	18.4	7.2	29.2	12.3	12.4	14.6	17.7	11.1	10.9	26.8	11.7	12.4	14.6	11.4	15.7	17.2	19.6	19.7	33.2	14.3	15.8	11.9	30.0	7.3	8.8	12.2	8.0	10.9	6.3	10.1	8.8	6.6	6.6	8.8	9.4	8.0	8.7	12.2	6.2	7.0	7.5	3.9	4.2	5.9	4.3	3.2	6.3	6.1	5.2	6.5	4.9	6.0	6.0	34.4	16.0	37.5	16.0	37.7	100.1	49.8	30.8	52.3	36.0	17.3	15.0	21.7	12.8	20.0	14.7	60.5	14.6	76.4	25.3	17.6	14.0	199.9	17.0	20.8	33.3	14.4	14.1	33.5	8.9	26.6	27.9	23.9	24.0	50.1	24.0	24.3	25.9	17.9	15.2	36.0	18.5	28.5	32.4	98.8	459.7	20.2	33.9	26.6	28.1	38.2	12.7	42.2	25.1	27.4	10.5	17.3	20.7	37.9	27.7	11.4	10.3	17.1	39.8	13.1	23.6	25.7	13.8	54.9	55.5	126.6	10.7	63.7	20.3	22.4	50.3
RNF170	"ADSA, DKFZP564A022, SNAX1"	ENSG00000120925	"Ring finger protein 170"	Q96K19	8	42849637-42897290	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050931, HPA054621"	Uncertain					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"			"HPA050931: AB_2681279, HPA054621: AB_2682545"	"unprognostic (3.06e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.54e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.61e-3)"	"unprognostic (4.13e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.13e-1)"	9.3	11.7	14.5	7.5	15.6	2.4	12.7	16.3	16.8	7.9	11.5	11.1	10.3	9.5	14.9	14.2	9.3	9.2	7.7	14.1	15.8	16.4	19.7	9.3	9.4	15.9	15.5	12.3	8.1	13.5	9.5	19.2	16.2	11.0	11.3	35.6	11.0	10.6	11.9	15.1	11.4	7.6	15.0	9.1	10.7	5.9	15.6	6.1	28.8	9.2	9.9	7.6	8.5	18.3	11.4	18.1	18.2	9.2	29.4	29.7	10.8	13.3	18.1	12.3	13.2	8.5	36.0	13.6	15.7	12.8	22.1	9.6	9.6	13.2	10.8	9.4	10.4	15.9	8.5	9.3	16.1	2.0	10.9	26.0	20.4	9.3	18.8	16.0	13.3	15.0	14.6	15.8	19.9	3.4	17.0	9.5	8.6	24.1	6.5	8.7	24.2	7.7	19.6	10.8	4.7	14.3	12.8	8.9	23.0	17.7	23.1	9.5	19.5	13.2	5.8	17.8	4.3	25.2	26.4	15.7	18.2	6.7	13.6	1.4	5.7	2.1	2.9	5.7	4.2	6.6	4.8	5.3	8.8	3.9	5.6	4.1	0.6	4.9	5.5	8.9	6.7	4.5	14.5	15.6	16.3	16.8	14.1	15.8	15.9	15.5	16.2	15.0	15.6	18.3	13.5	48.1	20.5	41.1	16.1	7.6	13.1	22.3	5.7	44.8	14.9	9.5	11.5	15.7	29.2	23.9	89.6	41.6	9.8	22.1	17.6	21.6	1.7	16.0	14.5	15.2	13.1	5.5	36.7	27.8	19.4	20.0	11.2	13.3	9.5	25.5	21.8	21.7	22.9	21.9	43.7	15.3	20.3	18.5	9.2	2.4	15.2	15.4	8.8	15.9	21.9	31.8	30.9	36.2	75.9	32.2	18.4	20.7	10.7	9.6	34.5	22.1	33.3	72.1	13.1	23.9	12.1	14.9	19.3	12.5	11.5	31.2	12.8	25.7	16.6	12.2
RNF213	"ALO17, C17orf27, KIAA1554, KIAA1618, MYMY2, NET57"	ENSG00000173821	"Ring finger protein 213"	Q63HN8	17	80260866-80398786	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Ubl conjugation pathway"	"Hydrolase, Transferase"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 396.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 90.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003347, HPA026790"	Approved		Supported	Cytosol		NA	NA		3500	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA003347: AB_1079204, HPA026790: AB_10602296"	"unprognostic (8.98e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.97e-3)"	"prognostic unfavorable (4.65e-5)"	"unprognostic (7.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-3)"	"unprognostic (8.92e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.56e-2)"	7.4	9.9	6.8	18.6	12.9	25.6	7.0	9.0	11.3	8.0	13.0	9.0	8.7	7.8	8.7	7.1	8.6	10.7	6.5	5.1	6.9	10.5	6.2	13.2	17.9	23.5	11.4	9.0	7.8	34.2	6.6	10.0	18.3	7.1	7.8	12.0	10.8	6.8	6.6	8.8	10.6	9.1	13.8	18.7	11.1	3.4	16.5	20.2	11.0	7.6	14.5	11.0	7.1	17.3	40.1	69.7	6.9	4.9	24.4	37.0	5.1	9.9	21.4	43.7	37.1	7.5	18.1	2.6	8.3	20.8	46.6	22.7	9.3	12.9	14.7	90.8	4.3	6.3	29.9	13.3	10.5	6.7	6.2	20.5	8.6	24.6	10.6	13.7	34.3	28.3	11.8	14.5	16.5	9.7	26.7	2.8	5.1	7.5	16.0	18.0	15.9	3.1	12.1	34.1	6.6	9.2	24.1	50.3	17.3	15.3	11.6	8.2	44.5	24.2	19.0	14.4	10.3	6.3	6.3	7.0	18.2	7.6	8.9	19.5	20.8	10.4	26.2	18.5	17.5	15.3	18.6	21.6	5.4	15.5	14.6	18.2	84.5	26.1	17.1	32.0	15.4	4.8	6.8	12.9	9.0	11.3	5.1	6.9	23.5	11.4	18.3	13.8	16.5	17.3	76.1	89.8	56.9	56.8	89.9	35.8	37.2	39.2	43.3	21.2	59.9	41.7	32.6	75.8	50.3	101.2	50.1	21.0	240.8	117.4	13.7	120.3	1.4	58.7	58.9	90.7	46.0	30.3	23.6	162.4	31.5	50.8	158.0	93.4	46.7	140.7	74.3	56.4	98.0	23.5	15.5	68.2	32.6	136.5	94.9	3.7	60.9	128.9	30.2	87.1	194.6	26.1	396.5	32.2	70.4	166.1	76.2	51.6	167.6	100.8	116.3	92.2	66.2	68.5	65.7	52.3	53.7	1.4	8.2	43.0	34.4	21.8	211.6	84.7	54.9	66.5
RNF216	"TRIAD3, UBCE7IP1, ZIN"	ENSG00000011275	"Ring finger protein 216"	Q9NWF9	7	5620047-5781696	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease variant, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.5;Late spermatids: 257.6;Spermatocytes: 159.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018955, HPA021123"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA018955: AB_1858500, HPA021123: AB_1858501"	"unprognostic (3.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (6.24e-5)"	"unprognostic (2.88e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-3)"	14.3	12.3	14.3	12.8	15.9	15.6	13.1	12.6	14.6	13.2	10.0	25.5	8.1	21.9	8.2	12.3	15.8	8.7	21.7	13.8	17.5	10.0	10.1	12.8	17.0	14.9	15.4	16.5	14.9	13.9	15.4	7.7	14.8	14.6	5.8	7.2	11.4	13.7	19.6	13.3	17.9	15.0	12.8	19.2	14.6	30.1	16.2	12.8	12.7	11.9	11.5	16.4	10.9	14.3	22.0	23.6	17.0	32.8	21.6	14.6	11.5	20.7	19.3	17.6	15.8	16.7	12.3	17.3	11.4	22.0	38.7	17.1	13.6	15.3	10.3	11.4	19.3	12.5	13.6	18.0	27.7	19.5	25.3	21.4	20.4	16.2	14.6	18.4	15.0	19.2	28.4	12.9	18.9	35.2	8.8	44.7	25.7	13.1	20.0	26.1	23.4	12.2	13.9	13.9	14.1	25.3	11.8	33.9	13.2	15.3	14.2	28.2	20.5	24.9	39.9	25.2	22.8	11.4	9.0	16.0	19.6	21.7	37.4	3.5	7.7	24.2	10.1	8.3	9.4	8.3	9.3	8.7	6.3	8.8	10.9	11.3	13.2	12.7	8.7	7.1	8.3	6.9	14.3	15.9	12.6	14.6	13.8	17.5	14.9	15.4	14.8	12.8	16.2	14.3	33.4	6.4	23.9	34.9	33.6	16.6	20.8	11.9	15.9	36.4	16.1	17.8	33.3	8.6	13.6	12.9	52.1	14.1	47.7	10.3	25.4	17.6	145.5	14.6	33.7	29.7	6.0	8.8	50.2	13.7	12.9	26.7	16.3	16.9	19.6	34.0	26.4	15.1	22.9	28.6	61.7	15.4	6.1	23.0	29.3	257.6	37.3	23.1	12.4	49.6	37.0	30.2	56.7	46.3	64.2	15.6	7.0	30.1	20.3	24.2	13.0	14.9	13.7	48.5	26.3	46.0	30.0	159.8	124.2	12.9	16.2	15.2	40.2	22.8	11.8	15.2
RNF43	"DKFZp781H0392, FLJ20315, URCC"	ENSG00000108375	"Ring finger protein 43"	Q68DV7	17	58353676-58417595	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Developmental protein, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.7"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 67.7;Intestinal goblet cells: 41.6;Undifferentiated cells: 63.6"	"Cancer enriched"	"Detected in many"	4	"colorectal cancer: 41.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 17.0;CACO-2: 24.7;Hep G2: 49.4;OE19: 54.7"									HPA008079	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA008079: AB_1856371"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.79e-1)"	"prognostic favorable (6.04e-9)"	"unprognostic (3.61e-3)"	"unprognostic (2.56e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.04e-2)"	0.2	10.9	1.7	2.0	3.1	0.7	5.5	9.6	2.7	2.6	1.5	13.4	22.7	1.7	4.4	10.4	4.8	2.7	2.7	2.0	1.3	6.1	9.1	3.6	0.4	1.8	3.4	0.9	8.2	5.2	4.3	4.8	1.9	9.4	19.3	1.2	9.3	4.8	0.3	11.3	16.9	0.6	1.4	0.5	5.8	3.4	2.3	3.7	1.9	0.0	1.5	2.1	5.2	1.4	1.1	17.0	2.7	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	24.7	8.2	0.0	8.5	0.0	1.9	4.6	0.6	6.8	0.0	8.6	11.3	1.9	0.8	49.4	0.0	0.2	0.1	0.0	13.4	0.0	2.1	0.0	0.0	0.2	0.2	0.4	0.0	0.2	0.1	0.2	0.4	54.7	1.0	0.3	0.0	2.2	5.9	9.0	1.6	0.1	1.6	0.7	0.5	5.4	2.0	0.1	0.0	0.0	1.8	0.0	0.0	0.6	1.4	0.1	0.3	0.0	3.8	0.1	0.0	0.0	0.2	0.0	0.3	0.2	0.1	0.3	0.0	0.1	0.2	0.1	0.1	0.3	0.0	0.0	0.2	0.0	1.7	3.1	9.6	2.7	2.0	1.3	1.8	3.4	1.9	1.4	2.3	1.4	0.3	3.2	8.9	29.0	2.5	9.6	17.5	14.1	67.7	2.5	17.3	13.6	4.0	17.2	5.8	18.4	2.1	26.0	2.2	33.0	15.6	5.3	1.2	14.6	1.1	1.8	15.5	0.8	1.8	2.7	3.1	0.7	9.7	12.7	0.0	7.2	0.7	11.9	2.6	5.0	1.3	41.6	12.2	0.8	0.9	1.5	0.3	1.3	14.2	4.7	2.8	12.0	10.3	0.0	0.7	6.2	21.1	0.4	1.0	9.9	28.7	2.9	5.6	2.8	0.0	0.5	1.1	1.0	0.8	28.4	6.1	5.9	3.1	0.4	63.6	6.3
RNF6	DKFZp686P0776	ENSG00000127870	"Ring finger protein 6"	Q9Y252	13	26132115-26222314	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 99.1;Late spermatids: 191.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039343, HPA040048"	Approved		Supported	"Nuclear membrane"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear membrane"		"HPA039343: AB_2676456, HPA040048: AB_10672969"	"unprognostic (3.22e-1)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.63e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.21e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.84e-1)"	"unprognostic (7.70e-2)"	"unprognostic (8.47e-2)"	18.9	17.3	12.4	18.7	13.3	32.5	17.9	13.4	18.4	13.4	13.5	18.4	17.5	12.4	13.7	18.5	14.5	13.7	13.7	13.9	11.7	18.2	16.6	16.2	22.4	10.4	13.5	11.5	14.1	22.3	10.7	19.9	11.5	16.0	18.5	26.6	13.5	13.9	21.2	17.3	18.8	15.7	10.8	19.7	17.2	33.6	13.7	25.3	17.5	15.3	23.8	18.3	10.1	11.5	33.3	28.9	10.7	15.8	36.3	28.2	23.9	56.3	45.2	35.4	24.9	36.4	41.8	59.5	27.3	53.5	31.5	43.7	30.2	45.3	58.4	57.7	19.2	64.8	23.9	31.3	56.6	68.7	65.4	26.8	86.1	39.8	84.2	34.3	36.0	25.5	25.6	0.1	55.3	30.0	38.5	39.8	8.7	59.5	19.8	30.4	41.5	23.7	43.6	43.3	19.3	11.9	29.9	54.0	54.1	24.8	20.7	66.3	47.6	30.4	18.6	41.1	40.5	14.8	14.9	34.9	27.8	38.4	40.7	46.6	14.5	34.7	15.6	18.4	17.1	18.6	17.1	17.7	17.6	12.5	16.8	14.8	9.7	20.0	23.3	9.1	19.2	14.2	12.4	13.3	13.4	18.4	13.9	11.7	10.4	13.5	11.5	10.8	13.7	11.5	20.9	22.4	19.8	6.8	26.5	30.5	12.7	17.5	14.8	22.2	15.1	10.5	13.5	5.7	19.7	7.3	25.0	20.2	31.6	24.8	33.2	15.1	99.1	37.4	16.9	23.0	11.4	24.8	14.4	15.4	21.8	16.1	17.3	19.9	26.6	12.1	17.5	12.3	17.5	30.3	17.2	15.5	24.4	22.4	19.9	191.0	14.6	23.0	14.2	12.2	21.6	24.9	29.9	11.6	16.2	24.4	20.1	11.3	18.0	22.0	15.8	21.4	40.1	43.2	26.3	21.6	14.5	83.5	29.1	19.2	29.1	42.1	26.2	17.1	12.6	23.5
ROR1	NTRKR1	ENSG00000185483	"Receptor tyrosine kinase like orphan receptor 1"	Q01973	1	63774017-64181498	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Kinase, Receptor, Transferase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 26.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 51.3;Astrocytes: 81.0;Inhibitory neurons: 69.7;Microglial cells: 36.5;Oligodendrocytes: 109.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 40.5;ASC TERT1: 50.3;CACO-2: 36.8;HHSteC: 38.3;HSkMC: 41.6;NTERA-2: 43.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"	NA	NA		7700000	"Cluster 40: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (5.15e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.11e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.87e-2)"	"unprognostic (5.15e-2)"	4.4	1.1	0.6	2.2	1.4	0.4	3.7	3.0	0.8	7.5	4.6	4.5	2.2	7.1	1.4	5.2	2.5	5.2	7.5	0.7	0.6	2.3	0.5	7.0	1.2	0.7	0.9	8.3	5.5	26.9	0.5	3.1	0.5	5.4	4.0	1.5	1.2	6.4	2.3	2.3	1.7	7.7	0.3	3.2	6.4	1.5	1.2	2.5	1.4	1.6	1.1	4.2	2.3	1.1	15.5	12.2	5.9	0.8	40.5	50.3	4.0	2.9	8.3	1.6	4.3	36.8	4.9	0.3	6.6	7.2	2.9	3.2	0.1	2.9	1.1	0.0	3.7	0.0	1.6	0.5	38.3	0.0	0.0	41.6	10.9	21.7	25.2	8.4	0.7	0.5	0.0	0.3	11.0	0.2	0.2	0.1	43.0	11.3	6.1	0.2	0.2	9.8	8.7	0.3	3.4	13.6	0.8	0.2	6.4	19.9	0.1	0.0	8.4	3.3	5.7	23.0	6.2	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.6	1.4	3.0	0.8	0.7	0.6	0.7	0.9	0.5	0.3	1.2	1.1	1.1	51.3	10.5	81.0	1.8	3.8	2.2	0.5	29.0	4.7	3.0	2.0	11.4	1.5	1.3	1.8	0.0	0.2	0.1	1.3	0.0	5.6	9.6	1.2	9.2	1.8	21.5	0.0	11.6	15.2	1.0	14.5	16.8	1.9	0.0	1.1	0.7	0.0	7.6	0.0	69.7	2.2	2.0	0.6	4.9	8.1	27.7	0.5	3.6	36.5	0.0	5.3	0.0	3.5	109.9	15.3	0.8	14.7	0.1	1.4	0.0	3.4	0.8	0.3	6.6	6.8	8.5	1.4	1.8	11.5	4.5	0.3	0.2	0.3	3.3	0.8
ROR2	"BDB, BDB1, NTRKR2"	ENSG00000169071	"Receptor tyrosine kinase like orphan receptor 2"	Q01974	9	91563091-91950228	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 18.4;Endometrial stromal cells: 19.3;Fibroblasts: 14.4;Inhibitory neurons: 18.6;Microglial cells: 15.9;Oligodendrocyte precursor cells: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"AF22: 24.5;HHSteC: 63.1;HSkMC: 52.2;U-266/70: 38.3;U-266/84: 27.5"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"cerebellum: 7.2;spinal cord: 3.7"	HPA021868	Uncertain					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA021868: AB_1856406"	"unprognostic (9.38e-3)"	"unprognostic (4.69e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.48e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (9.86e-7)"	"unprognostic (2.16e-3)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (4.28e-8)"	"unprognostic (1.25e-2)"	6.9	5.7	0.8	3.9	0.6	0.1	4.4	0.4	0.5	18.7	28.2	32.7	2.2	23.7	1.5	8.2	11.6	8.6	11.1	1.4	0.8	1.4	0.5	5.5	0.5	1.7	2.1	13.9	1.6	16.6	1.6	3.5	0.9	13.9	2.2	1.0	1.6	13.3	0.3	4.2	7.7	11.0	1.2	3.3	12.8	3.4	1.2	3.0	5.6	0.7	1.0	17.5	10.6	0.7	0.0	0.2	24.5	0.0	5.3	0.5	6.8	0.4	6.3	4.0	7.8	0.0	0.0	0.0	0.1	0.8	3.9	0.2	5.2	0.0	1.7	0.0	4.2	0.0	18.3	0.0	63.1	0.0	0.0	52.2	0.0	5.6	0.0	0.0	0.0	0.2	14.7	0.0	0.0	0.4	0.1	3.6	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	7.2	0.6	0.0	0.0	5.0	14.8	0.0	0.0	0.0	4.8	2.0	0.0	38.3	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.4	0.5	1.4	0.8	1.7	2.1	0.9	1.2	1.2	0.7	0.3	0.0	0.0	1.6	0.1	3.1	11.3	0.9	1.2	1.4	3.7	3.0	8.2	1.5	0.2	0.0	0.0	0.4	0.0	0.5	0.0	2.5	4.5	18.4	19.3	1.4	3.0	0.0	1.4	1.5	0.2	14.4	2.6	7.5	1.3	0.1	0.4	0.0	0.8	0.0	18.6	2.8	0.0	0.0	4.8	8.6	5.9	0.4	5.4	15.9	1.6	7.4	0.0	27.6	0.4	0.6	1.6	9.1	0.1	8.6	0.0	0.0	0.2	0.5	6.6	0.0	2.9	2.3	14.3	0.1	2.3	0.4	0.7	0.4	0.8	5.3
RPIA		ENSG00000153574	"Ribose 5-phosphate isomerase A"	P49247	2	88691673-88750929	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 89.6"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 234.3;Erythroid cells: 167.9;Syncytiotrophoblasts: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042620, HPA057954"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA		2500000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA042620: AB_10793980, HPA057954: AB_2683563"	"unprognostic (3.35e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.31e-1)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-3)"	"unprognostic (8.70e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (8.53e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-2)"	"unprognostic (8.79e-3)"	17.2	11.0	7.4	19.6	7.6	89.6	16.0	8.3	8.9	13.4	8.0	22.7	22.1	13.2	9.5	24.1	14.6	11.7	16.0	7.3	8.2	10.6	7.8	12.2	28.0	7.8	7.5	13.7	17.9	7.4	8.2	33.8	7.5	8.9	23.0	4.1	15.9	8.1	29.9	11.9	18.9	12.5	7.8	19.2	18.9	9.6	8.0	40.4	9.7	17.1	32.4	16.5	12.5	7.9	29.7	17.0	33.7	26.9	23.4	23.9	73.8	16.1	15.1	26.1	17.8	61.1	38.2	150.1	34.3	18.7	35.8	17.7	42.4	13.5	40.9	71.9	55.3	60.2	11.0	60.7	23.7	111.5	42.4	22.1	11.2	23.3	35.9	13.0	37.4	78.7	65.7	25.3	24.8	46.5	123.4	97.2	30.7	97.6	27.7	63.5	40.1	36.8	21.7	47.1	24.0	27.4	19.4	24.8	39.3	18.3	13.5	45.3	21.4	15.5	40.7	51.2	46.7	19.7	17.2	149.3	15.9	99.4	22.5	10.6	16.0	36.4	16.9	16.7	21.4	31.4	23.5	25.1	22.7	23.5	33.4	27.8	3.9	21.9	21.9	10.9	22.0	20.6	7.4	7.6	8.3	8.9	7.3	8.2	7.8	7.5	7.5	7.8	8.0	7.9	38.9	12.8	13.2	4.6	43.2	37.3	21.3	31.2	21.6	8.7	22.2	18.2	13.7	14.3	22.7	20.2	2.1	234.3	37.1	20.6	9.8	21.7	8.1	28.0	23.3	35.0	19.2	167.9	13.3	34.2	98.9	23.5	31.1	43.2	21.6	30.7	24.3	7.1	43.8	13.5	15.7	26.9	26.4	23.1	33.9	4.0	19.9	23.7	40.9	11.2	32.4	5.2	60.8	13.6	13.3	22.8	28.1	18.8	35.8	41.7	20.6	18.7	10.1	4.8	19.7	19.8	18.0	28.4	33.4	37.6	40.9	225.6	38.8	37.8	58.5	43.7
RPS6KA3	"CLS, HU-3, MRX19, RSK2"	ENSG00000177189	"Ribosomal protein S6 kinase A3"	P51812	X	20149911-20267519	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 236.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003221, CAB003853, CAB013520"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553"	"unprognostic (1.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-1)"	21.1	18.8	6.9	33.7	10.2	16.2	14.8	12.7	12.8	16.1	8.5	32.8	24.1	17.5	8.5	18.7	15.1	26.9	21.1	8.7	9.4	19.5	45.0	32.3	31.3	8.4	10.0	10.6	17.2	59.4	5.9	19.5	8.5	19.9	31.8	15.7	13.2	18.0	51.8	15.0	27.6	27.8	8.7	29.2	21.1	5.5	10.6	32.9	21.2	40.3	32.6	34.2	8.5	8.0	44.9	77.0	28.4	14.8	27.1	47.3	8.6	38.0	57.4	27.8	37.7	87.7	56.2	29.3	12.8	40.0	40.5	30.9	32.8	32.2	51.1	24.8	26.1	34.6	46.2	236.8	27.7	67.8	34.2	30.3	25.1	43.5	54.4	24.3	101.9	30.4	23.1	81.0	29.4	21.2	44.2	20.7	20.6	57.8	45.9	23.3	60.0	33.8	23.9	36.9	13.1	12.8	51.1	15.3	54.4	35.3	0.1	20.0	57.3	30.1	20.8	96.3	21.7	64.3	42.1	32.1	56.9	33.1	72.6	11.9	3.8	7.9	4.7	5.3	8.3	2.4	5.4	5.2	5.6	3.2	3.7	4.5	5.8	6.6	6.0	6.7	2.9	2.2	6.9	10.2	12.7	12.8	8.7	9.4	8.4	10.0	8.5	8.7	10.6	8.0	60.6	44.8	67.5	31.6	34.8	54.4	37.0	21.2	10.2	37.8	20.4	10.8	22.9	34.3	41.1	16.5	22.9	4.0	70.0	63.5	3.9	26.3	0.4	10.8	24.0	61.1	25.0	19.1	142.2	30.5	6.7	31.6	24.5	26.1	44.3	8.3	34.6	65.4	22.6	13.5	108.4	59.1	28.5	40.8	104.3	1.5	13.1	62.6	37.4	126.5	53.7	27.5	46.4	116.6	27.0	37.4	57.9	21.1	25.5	56.6	33.5	25.1	23.3	9.7	19.7	41.5	21.3	6.4	8.7	13.8	55.5	3.6	66.0	14.2	61.1	63.8
RS1	"RS, XLRS1"	ENSG00000102104	"Retinoschisin 1"	O15537	X	18639688-18672108	"Disease related genes, Human disease related genes, Potential drug targets, Predicted secreted proteins, Transporters"	"Cell adhesion, Sensory transduction, Vision"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	207	"retina: 213.7"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 160.6;Rod photoreceptor cells: 162.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059546	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA059546: AB_2684058"	"unprognostic (8.31e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.80e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.14e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.04e-4)"	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	213.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.3	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	6.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	1.9	0.0	0.0	0.0	160.6	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	162.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0
RTEL1	"bK3184A7.3, C20orf41, DKFZP434C013, KIAA1088, NHL, RTEL"	ENSG00000258366	"Regulator of telomere elongation helicase 1"	Q9NZ71	20	63657810-63696253	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"B-cells: 1.0;Erythroid cells: 3.8;Gastric mucus-secreting cells: 3.1;Plasma cells: 3.0;Squamous epithelial cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA020622, HPA067329, HPA078328"			Approved	"Nuclear speckles,Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles, Nuclear bodies"		"HPA020622: AB_2732425, HPA067329: AB_2685823, HPA078328: AB_2732380"	"unprognostic (3.63e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.27e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.59e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.30e-2)"	"unprognostic (9.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.50e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.84e-2)"	4.9	7.0	1.3	6.1	1.6	8.2	5.2	5.7	4.7	6.8	0.5	8.5	4.8	10.0	3.0	4.6	6.2	3.0	3.9	1.2	0.9	4.1	4.8	6.0	4.2	2.9	0.6	6.4	8.6	2.8	12.2	4.2	1.8	6.7	2.1	2.5	6.3	4.5	5.4	4.5	5.8	3.1	0.2	6.1	6.6	7.6	1.2	4.8	7.8	2.3	2.4	6.5	6.0	1.5	8.3	11.7	7.9	15.5	1.6	1.7	14.5	16.8	4.5	26.0	6.6	22.2	7.0	11.0	8.6	5.2	9.8	15.3	5.5	11.1	6.1	5.5	11.0	13.8	21.2	21.5	5.7	13.4	24.1	2.2	6.0	6.4	7.9	4.9	9.0	19.6	17.4	10.4	5.8	8.7	21.3	17.5	7.8	7.1	22.3	17.2	7.4	11.6	4.1	9.7	15.7	9.3	9.3	27.5	2.2	3.6	7.2	15.2	12.1	29.4	9.5	10.1	13.2	9.4	4.2	7.1	7.1	9.5	10.4	0.0	1.0	0.0	0.9	1.1	0.5	0.3	0.5	0.6	1.3	0.5	0.9	0.4	0.0	0.1	1.0	1.1	0.5	0.8	1.3	1.6	5.7	4.7	1.2	0.9	2.9	0.6	1.8	0.2	1.2	1.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.6	0.0	3.8	0.0	0.0	0.0	0.4	3.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	0.0	1.1	0.1	0.0	0.7	0.0	0.0	0.0
RXFP2	"GPR106, GREAT, INSL3R, LGR8, RXFPR2"	ENSG00000133105	"Relaxin family peptide receptor 2"	Q8WXD0	13	31739526-31803389	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	7	"Early spermatids: 8.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	10	"classical monocyte: 1.7"	"Lineage enriched"	"Detected in single"	18	"monocytes: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"basal ganglia: 2.6"							NA	NA			"Cluster 25: Monocytes - Inflammatory response"			"Cluster 23: Spermatids - Flagellum & Golgi organization"																			"unprognostic (1.77e-2)"		0.1	0.5	0.0	0.0	0.7	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.2	0.3	0.2	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
S1PR2	"AGR16, DFNB68, EDG5, Gpcr13, H218"	ENSG00000267534	"Sphingosine-1-phosphate receptor 2"	O95136	19	10221433-10231331	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 92.9;Early spermatids: 92.3;Late spermatids: 184.9;Syncytiotrophoblasts: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 45.0"	"Group enriched"	"Detected in many"	8	"granulocytes: 45.0;T-cells: 12.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 29.4;Daudi: 54.1;U-266/70: 38.9;U-698: 57.3;WM-115: 38.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014255, HPA014307"	Approved		Uncertain	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	"Nuclear speckles"	"HPA014255: , HPA014307: AB_1847989"	"unprognostic (5.38e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.05e-3)"	"unprognostic (8.50e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (4.91e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.09e-2)"	7.7	2.5	1.9	6.4	1.8	1.2	5.5	1.7	1.8	10.4	1.9	4.8	1.8	8.3	2.7	3.3	8.4	6.2	6.6	1.6	2.0	3.1	5.6	13.7	10.9	2.8	1.9	5.6	2.9	2.5	3.0	18.5	2.2	6.9	2.4	1.2	4.1	2.3	0.8	5.4	4.8	4.2	2.0	1.9	4.3	13.2	2.1	1.4	3.4	1.3	10.9	8.3	7.0	2.9	3.0	0.4	3.4	6.9	18.2	22.2	29.4	4.4	8.9	1.9	4.1	1.9	1.7	54.1	5.1	8.2	2.3	1.7	1.2	2.1	1.3	5.5	2.7	1.2	1.2	1.3	6.1	1.4	1.1	12.2	1.1	3.8	1.3	5.3	0.2	2.6	1.3	11.1	1.3	2.5	0.6	2.5	3.4	0.9	1.7	3.8	1.4	2.0	1.6	2.5	2.4	4.7	2.5	1.5	3.8	2.6	1.2	1.3	0.4	6.9	2.2	15.9	1.3	38.9	19.6	57.3	2.6	2.7	38.6	45.0	2.8	0.6	7.2	2.4	8.9	0.3	9.2	7.0	2.6	0.5	3.7	3.8	0.7	3.6	1.0	0.4	12.4	2.0	1.9	1.8	1.7	1.8	1.6	2.0	2.8	1.9	2.2	2.0	2.1	2.9	2.0	0.0	1.1	0.3	2.0	0.0	4.6	0.0	1.2	0.6	8.3	4.6	0.6	2.8	0.6	1.8	2.1	92.9	5.4	0.0	0.0	3.6	92.3	8.6	21.5	2.0	2.4	0.0	0.3	3.3	18.1	17.7	0.0	18.1	0.0	2.0	3.9	7.6	13.2	0.0	0.9	0.5	0.0	3.1	0.0	184.9	22.1	7.2	0.0	0.0	4.0	7.1	3.1	6.6	0.5	2.7	0.3	13.2	2.6	4.9	0.0	0.9	0.0	0.5	13.1	2.0	4.6	1.5	1.2	2.0	0.0	68.4	4.2	1.1	0.2	4.1
SARDH	"DMGDHL1, SDH"	ENSG00000123453	"Sarcosine dehydrogenase"	Q9UL12	9	133663560-133739955	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"epididymis: 47.9;liver: 114.4;pancreas: 43.2"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 120.6"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 18.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 3.3;naive CD4 T-cell: 6.7;T-reg: 8.8"	"Lineage enriched"	"Detected in single"	16	"T-cells: 8.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.4;Hep G2: 31.1;MOLT-4: 22.5;RH-30: 18.5;RPMI-8226: 39.1;SH-SY5Y: 14.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA057267, HPA058086"	Approved		Approved	Mitochondria		NA	NA		230000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA057267: AB_2683388, HPA058086: AB_2683601"	"unprognostic (3.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.48e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.30e-2)"	1.1	2.2	3.6	2.5	3.5	0.9	0.8	1.9	3.9	2.6	0.7	1.1	1.8	2.0	47.9	0.6	1.9	1.3	2.4	3.3	3.5	12.0	114.4	2.6	4.1	4.4	3.1	3.0	43.2	2.1	4.1	0.9	3.4	2.3	0.4	0.6	5.3	1.8	0.6	0.4	1.3	0.9	2.9	1.3	3.0	0.7	4.2	4.3	1.6	0.3	2.4	1.1	1.0	3.1	0.0	0.1	1.4	17.4	0.1	0.5	2.3	0.1	0.7	0.9	1.1	0.3	0.2	0.0	2.4	0.3	2.2	0.1	0.0	0.3	0.7	0.0	0.3	2.5	0.0	31.1	1.9	0.1	0.3	4.2	0.0	2.0	0.1	0.4	0.2	13.1	0.1	0.4	11.1	3.2	22.5	2.4	2.8	1.7	0.2	1.6	18.5	39.1	0.0	0.1	1.7	14.7	0.0	0.4	3.9	0.8	2.4	0.2	0.1	3.3	3.0	0.3	0.0	0.3	0.0	1.3	2.1	1.4	0.1	0.3	0.1	0.1	0.3	0.0	0.8	0.0	3.3	0.8	0.0	0.3	6.7	1.2	0.5	0.1	0.0	0.3	8.8	1.4	3.6	3.5	1.9	3.9	3.3	3.5	4.4	3.1	3.4	2.9	4.2	3.1	0.1	0.0	1.9	6.8	0.4	0.3	0.4	0.0	1.2	0.1	0.2	0.8	0.8	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.0	0.8	1.2	5.7	1.5	1.1	0.1	2.3	0.0	0.3	1.3	0.8	2.9	120.6	0.1	0.0	0.7	0.0	0.0	1.6	0.6	0.8	4.7	0.2	0.0	1.9	0.0	4.2	1.0	0.5	0.3	0.1	0.0	3.0	0.7	0.3	0.0	21.3	0.0	0.3	0.0	1.6	3.5	0.1	0.8	0.0	0.1	0.0	4.2	1.6	0.0	0.2
SARS1	"SARS, SERS"	ENSG00000031698	"Seryl-tRNA synthetase 1"	P49591	1	109213918-109238182	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"Aminoacyl-tRNA synthetase, DNA-binding, Ligase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 98.8;Cytotrophoblasts: 186.0;Extravillous trophoblasts: 147.6;Hofbauer cells: 88.1;Syncytiotrophoblasts: 188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016939, HPA064668"	Approved		Enhanced	Cytosol		NA	NA		330000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA016939: AB_1856585, HPA064668: AB_2685316"	"unprognostic (4.92e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.78e-2)"	"prognostic favorable (9.47e-4)"	"prognostic unfavorable (5.75e-4)"	"prognostic unfavorable (6.13e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.45e-3)"	86.9	89.4	78.6	55.9	78.6	35.7	80.5	77.2	98.1	79.3	57.4	89.1	63.6	85.8	64.2	97.1	71.5	53.6	96.0	81.9	92.6	77.4	102.4	102.3	60.9	88.3	81.1	78.5	150.1	102.1	88.6	76.2	91.1	66.2	74.8	68.0	86.1	73.9	113.3	111.9	69.9	79.3	72.9	64.5	112.4	46.3	78.1	66.7	139.8	87.9	76.4	88.3	82.1	90.9	208.5	82.1	152.3	230.3	224.2	201.4	261.6	213.1	222.1	183.7	227.1	161.4	62.7	224.1	107.7	307.2	102.8	111.6	241.1	305.9	212.4	159.0	150.4	86.6	96.3	118.4	448.1	110.5	93.7	249.4	526.5	217.1	467.7	155.9	221.9	279.5	201.9	273.2	181.3	205.8	124.8	57.5	63.4	125.6	193.5	101.1	192.5	102.6	139.9	111.0	210.0	111.2	102.5	164.7	601.4	114.9	93.5	131.2	174.5	108.3	135.0	155.5	151.8	205.6	89.6	183.7	341.3	119.8	376.7	191.5	193.9	219.6	228.6	212.2	240.0	235.8	238.2	227.3	198.8	252.4	246.4	229.4	89.7	193.5	226.6	128.2	300.9	460.5	78.6	78.6	77.2	98.1	81.9	92.6	88.3	81.1	91.1	72.9	78.1	90.9	30.6	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.8	0.0	0.0	0.0	0.0	186.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	147.6	23.9	0.0	0.0	0.0	0.0	0.0	0.0	88.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	188.4	5.9	0.0	0.0	0.0
SARS2	"FLJ20450, mtSerRS, SARS, SARSM, SerRSmt, SERS, SYS"	ENSG00000104835	"Seryl-tRNA synthetase 2, mitochondrial"	Q9NP81	19	38915266-38930763	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.1;Late spermatids: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA052730, HPA056957"	Approved		Uncertain	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"	Vesicles	"HPA052730: AB_2681929, HPA056957: AB_2683286"	"unprognostic (3.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.62e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.62e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.69e-2)"	7.3	17.3	4.2	7.2	4.7	9.3	8.2	4.4	6.8	9.7	3.6	10.1	9.3	9.3	2.8	14.3	8.5	5.9	12.4	4.7	4.4	14.6	18.7	6.6	9.8	5.0	4.4	9.8	15.9	7.8	11.9	7.6	5.3	12.2	5.3	2.3	11.3	6.2	16.4	12.3	10.2	5.1	4.2	12.0	11.9	10.7	4.4	7.5	14.4	11.5	6.6	9.4	9.6	5.4	17.6	47.3	15.5	10.7	5.8	13.3	23.7	10.7	12.6	23.1	17.7	36.0	18.4	17.2	16.3	12.5	9.7	13.9	14.7	29.2	5.3	12.7	24.4	33.7	17.7	32.0	15.4	29.1	31.9	20.7	13.5	14.5	7.6	9.5	14.2	26.3	29.9	14.2	10.6	28.4	21.4	20.7	18.5	21.6	8.5	31.2	16.4	18.6	20.5	36.2	29.1	18.1	14.2	32.7	8.9	4.6	21.8	19.1	11.4	13.7	17.7	11.7	15.1	11.0	7.1	13.2	10.9	18.5	13.8	0.0	8.0	1.0	14.2	14.4	11.5	12.0	10.7	14.7	25.2	10.7	7.5	8.6	0.5	14.0	13.7	9.9	13.4	8.9	4.2	4.7	4.4	6.8	4.7	4.4	5.0	4.4	5.3	4.2	4.4	5.4	2.7	6.4	7.9	6.2	8.4	4.2	3.8	8.3	3.4	8.0	7.0	5.3	8.1	7.2	6.8	5.5	8.4	40.1	5.6	8.9	15.6	15.5	15.7	3.6	3.6	3.8	11.4	13.2	6.8	12.7	23.0	4.8	9.7	3.9	5.7	7.4	6.1	10.1	12.9	5.0	6.7	9.2	10.2	6.7	4.2	56.9	4.7	4.8	3.6	1.9	7.7	3.1	5.2	1.5	3.1	8.4	5.6	4.9	10.1	2.6	7.4	10.3	5.1	13.4	0.0	2.7	4.2	1.9	8.2	12.8	4.1	29.1	7.4	10.6	17.8	3.2
SAT1	"SAT, SSAT"	ENSG00000130066	"Spermidine/spermine N1-acetyltransferase 1"	P21673	X	23783173-23786226	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 8151.3;Langerhans cells: 13855.3;Prostatic glandular cells: 7419.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 3422.0;non-classical monocyte: 2519.0"	"Group enriched"	"Detected in all"	9	"granulocytes: 3422.0;monocytes: 2519.0"	"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 551.5;hTERT-HME1: 821.9;RPTEC TERT1: 694.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB047343, HPA055312, CAB069914"	Supported					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB047343: , CAB069914: AB_830224, HPA055312: AB_2682781"	"unprognostic (4.19e-2)"	"unprognostic (3.92e-2)"	"unprognostic (6.41e-2)"	"prognostic favorable (2.87e-4)"	"unprognostic (8.58e-2)"	"unprognostic (7.90e-3)"	"unprognostic (8.52e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.38e-3)"	"unprognostic (2.23e-1)"	"unprognostic (7.58e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.97e-3)"	"unprognostic (1.65e-1)"	843.8	307.2	171.6	568.4	175.0	1484.9	454.0	167.0	279.5	337.8	219.7	339.0	630.9	319.0	170.8	407.4	322.7	600.8	604.4	171.8	202.0	739.5	885.0	1252.9	431.3	186.2	178.6	197.9	229.3	268.7	548.5	603.5	188.6	413.1	364.3	108.3	786.6	342.2	66.2	200.1	509.5	175.4	185.5	706.6	562.6	116.2	197.7	231.8	757.0	79.0	333.4	536.2	241.6	206.6	62.2	123.1	30.8	48.3	256.0	103.8	83.6	89.2	149.8	21.7	50.2	59.0	179.3	102.7	160.0	21.1	172.4	91.9	16.4	551.5	78.8	34.1	74.3	49.9	60.0	503.5	327.5	48.8	46.1	216.2	412.0	169.0	821.9	197.2	181.5	16.4	21.4	88.4	63.8	59.1	35.9	219.1	20.6	455.2	56.3	30.0	19.8	126.1	694.6	126.0	8.7	8.9	91.2	204.8	179.2	222.3	31.5	10.7	68.9	175.6	8.9	106.6	44.7	37.1	9.6	23.1	104.8	28.8	34.2	557.6	720.4	478.9	66.0	1930.3	41.6	125.3	77.4	53.8	324.8	79.1	45.9	53.3	3422.0	33.8	2519.0	161.2	231.5	742.5	171.6	175.0	167.0	279.5	171.8	202.0	186.2	178.6	188.6	185.5	197.7	206.6	798.0	734.0	1585.4	98.9	875.4	2435.0	3753.4	8151.3	1203.6	54.9	895.9	574.4	454.2	574.7	5509.5	829.4	116.7	853.1	409.5	1249.8	1189.5	5869.5	17.3	3940.5	859.6	1554.6	526.9	195.2	40.3	3065.2	1643.7	1211.3	1347.1	5651.2	870.6	110.6	558.3	994.1	2115.2	72.3	77.6	852.3	3733.2	4693.0	13855.3	55.2	165.3	5207.7	3922.0	213.6	5274.6	501.9	189.5	90.5	14.2	2774.1	1293.8	92.2	1091.8	7419.8	1851.7	2065.2	4274.2	114.4	151.2	765.7	857.5	31.6	14.7	1022.4	1468.3	2880.9	899.3	260.2	804.4	6549.5
SC5D	SC5DL	ENSG00000109929	Sterol-C5-desaturase	O75845	11	121292681-121313410	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 393.6"	"Cell type enhanced"	"Detected in all"		"Hepatic stellate cells: 141.0;Hepatocytes: 307.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066283, HPA070248"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Nucleoplasm, Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"HPA066283: AB_2685648, HPA070248: AB_2686240"	"unprognostic (4.78e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.98e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (2.79e-2)"	"unprognostic (7.96e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (4.29e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.98e-1)"	28.6	35.3	18.4	12.6	20.4	5.7	56.6	37.1	29.3	20.7	17.6	23.2	48.2	15.1	73.2	39.6	16.5	18.2	22.0	19.9	29.9	49.1	393.6	24.6	13.5	42.9	28.0	16.9	21.5	48.6	15.6	14.7	39.1	101.4	19.9	29.5	22.4	56.6	7.7	13.8	24.7	16.2	32.2	8.8	21.7	24.3	24.6	13.5	23.9	13.0	19.5	21.5	27.1	36.5	26.5	14.3	184.8	39.5	72.1	59.9	27.8	27.8	53.5	18.2	32.4	83.1	95.9	25.4	89.0	32.3	156.6	100.8	59.2	70.9	18.1	12.5	80.0	34.6	73.4	64.4	57.9	24.8	12.5	51.0	57.4	60.4	60.2	15.6	29.8	22.8	25.0	34.6	89.0	27.4	9.4	29.2	59.8	74.4	39.7	13.2	51.0	21.6	133.6	116.5	51.1	28.8	73.4	14.6	38.0	125.4	62.2	38.6	58.3	19.0	29.7	32.5	14.0	6.4	11.2	33.3	7.0	49.5	33.5	7.8	3.7	1.0	3.5	4.9	5.9	4.4	4.7	4.2	6.5	4.1	6.8	6.7	0.3	5.3	3.6	7.7	5.5	2.6	18.4	20.4	37.1	29.3	19.9	29.9	42.9	28.0	39.1	32.2	24.6	36.5	10.4	19.2	31.9	23.8	62.6	9.7	49.9	48.9	14.8	26.8	33.7	12.4	20.8	18.6	40.8	20.2	31.3	15.9	47.5	26.4	5.9	24.1	3.0	11.5	8.8	15.7	14.4	18.1	29.6	28.9	16.7	16.3	18.3	19.6	17.7	11.1	141.0	307.1	21.0	23.5	29.4	15.3	59.0	22.1	17.0	1.3	19.3	17.6	19.6	20.6	15.6	38.7	13.4	27.6	34.0	19.3	18.8	17.0	20.9	50.1	24.1	15.8	18.7	28.3	13.1	12.9	14.7	6.7	12.7	36.2	15.5	18.6	56.5	42.8	13.3	54.4
SCARB2	"CD36L2, HLGP85, LIMP-2, LIMPII, SR-BII"	ENSG00000138760	"Scavenger receptor class B member 2"	Q14108	4	76158737-76234536	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 12.5;classical monocyte: 14.1;intermediate monocyte: 26.0;myeloid DC: 8.2;non-classical monocyte: 24.9;plasmacytoid DC: 28.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 28.9;granulocytes: 12.5;monocytes: 26.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 499.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015415, HPA018014"	Supported		Approved	Cytosol		NA	NA		9200	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 35: Glandular cells - Unknown function"	Cytosol		"CAB015415: AB_831511, HPA018014: AB_1852881"	"prognostic unfavorable (2.82e-5)"	"unprognostic (2.73e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.12e-3)"	"unprognostic (2.08e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.89e-2)"	60.6	24.0	33.5	27.7	63.5	7.3	56.7	58.9	38.9	60.8	18.9	61.6	39.2	44.1	58.4	33.9	45.4	60.0	61.6	29.6	48.6	46.8	89.9	77.1	20.2	62.2	49.6	58.9	58.9	63.6	11.1	80.2	62.5	72.3	64.0	53.2	80.5	55.4	89.8	26.0	49.1	57.8	60.1	47.0	60.7	19.4	50.7	21.3	65.9	81.3	20.6	65.3	25.1	92.9	39.8	38.4	48.9	97.1	499.7	242.0	35.8	131.5	250.2	114.0	178.2	72.5	112.3	0.0	85.1	262.3	109.6	28.3	28.3	78.9	96.0	138.8	30.1	3.2	32.9	25.3	129.9	19.0	12.1	186.9	72.3	117.3	54.5	268.9	200.6	10.0	15.6	188.6	159.2	58.2	1.6	4.0	9.7	120.3	23.6	23.3	82.7	42.0	64.4	43.6	101.3	110.2	104.7	61.3	115.5	49.3	34.6	17.1	131.3	125.9	48.5	104.7	47.5	167.6	98.8	0.2	158.1	22.2	170.9	12.5	14.1	3.1	2.8	26.0	2.6	3.8	1.9	1.5	8.2	3.0	2.6	4.3	1.9	1.1	24.9	28.9	3.0	6.1	33.5	63.5	58.9	38.9	29.6	48.6	62.2	49.6	62.5	60.1	50.7	92.9	89.0	176.3	52.4	47.3	20.1	24.0	90.5	64.8	34.1	109.6	69.7	36.4	53.0	87.2	52.1	99.3	60.5	35.3	43.6	109.0	7.9	119.9	7.1	50.3	74.0	69.9	102.4	28.6	57.4	72.9	47.5	108.3	40.8	88.8	3.8	84.8	79.6	108.7	143.4	60.6	55.4	77.1	44.7	165.7	27.5	5.6	45.4	76.2	67.6	38.4	43.5	87.2	6.2	106.1	201.1	78.0	68.3	66.5	82.2	133.5	103.2	27.6	54.4	81.7	92.1	91.0	68.1	18.2	16.5	34.8	33.8	59.4	16.3	56.5	55.3	93.4
SCP2		ENSG00000116171	"Sterol carrier protein 2"	P22307	1	52927276-53051698	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid transport, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1116.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1240.7;Proximal enterocytes: 769.0;Proximal tubular cells: 881.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027101, HPA027135, HPA027317"	Supported		Supported	Nucleoplasm,Peroxisomes		NA	NA		640000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"	Peroxisomes	Nucleoplasm	"HPA027101: AB_1856634, HPA027135: AB_1856633, HPA027317: AB_10610422"	"unprognostic (7.51e-2)"	"unprognostic (5.23e-2)"	"prognostic favorable (7.05e-5)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.53e-2)"	"unprognostic (6.16e-2)"	"prognostic favorable (7.85e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-2)"	203.7	125.5	68.5	92.7	71.6	111.2	196.6	74.2	90.1	153.8	79.2	256.7	336.3	94.6	165.5	140.2	119.7	144.6	162.4	65.8	76.1	319.8	1116.8	140.6	106.0	75.4	72.3	94.5	119.2	130.9	64.7	79.0	77.9	150.9	270.5	76.6	114.0	97.3	142.0	130.6	305.7	112.9	75.6	83.9	234.4	63.4	74.7	131.9	140.9	152.8	125.5	139.2	76.9	78.9	120.6	64.8	85.5	157.9	273.6	232.6	92.7	140.0	208.9	90.1	129.2	58.7	127.5	114.7	147.6	206.6	105.3	82.5	59.6	131.0	136.5	168.2	86.4	123.4	88.8	122.1	182.0	179.9	197.5	190.2	175.0	107.1	52.9	196.2	260.0	132.6	111.5	58.2	184.7	70.1	200.7	155.2	94.6	304.4	126.0	101.9	150.9	158.3	252.2	192.2	70.9	85.3	122.0	246.3	121.6	189.6	125.9	201.4	203.8	122.4	63.4	213.2	114.9	95.9	131.0	134.2	159.0	175.7	113.8	285.6	193.7	286.0	185.9	208.8	152.1	150.8	144.9	184.6	230.5	132.6	120.8	171.4	29.4	176.8	204.2	150.9	195.2	289.5	68.5	71.6	74.2	90.1	65.8	76.1	75.4	72.3	77.9	75.6	74.7	78.9	167.0	134.6	198.4	52.2	91.1	150.4	123.8	222.2	110.4	37.5	189.8	86.0	157.4	258.7	166.2	185.8	31.3	182.7	128.3	512.7	473.5	168.1	57.4	150.4	81.6	126.8	235.1	93.4	45.0	162.4	156.5	124.3	180.4	125.3	138.4	54.0	146.7	1240.7	203.5	42.1	54.4	462.7	250.3	230.1	173.1	51.4	184.2	148.8	192.1	42.2	154.6	132.0	181.3	48.2	44.3	157.4	503.4	171.9	76.6	118.1	769.0	881.0	178.2	34.1	78.9	72.0	110.6	20.4	19.4	150.0	170.8	133.9	132.9	110.3	336.4	187.8
SCYL1	"GKLP, HT019, MGC78454, NKTL, NTKL, P105, TAPK, TEIF, TRAP"	ENSG00000142186	"SCY1 like pseudokinase 1"	Q96KG9	11	65525077-65538704	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"ER-Golgi transport, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"	"Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 138.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015015	Uncertain		Supported	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA015015: AB_1856643"	"unprognostic (5.56e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.41e-1)"	"unprognostic (4.29e-1)"	"unprognostic (7.86e-3)"	"unprognostic (6.49e-3)"	"unprognostic (4.27e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.29e-3)"	43.4	69.3	36.6	26.4	37.4	32.8	41.1	33.1	53.9	46.8	37.1	46.7	28.0	49.4	32.5	40.0	44.0	26.3	59.7	39.2	34.1	45.7	83.2	42.4	30.7	36.0	35.2	52.4	61.6	35.5	44.7	34.6	35.5	47.3	17.2	12.4	48.5	33.7	104.5	44.5	39.6	27.5	30.9	46.4	50.0	50.6	37.7	23.4	48.8	51.6	21.8	47.8	39.5	39.0	55.0	45.9	36.6	50.9	65.4	56.6	50.0	66.6	89.4	77.7	60.4	66.9	32.2	39.2	65.7	86.9	66.2	49.1	38.7	50.1	27.0	46.6	49.7	46.4	50.8	78.3	92.8	30.8	64.0	79.1	48.6	66.9	49.4	54.2	51.6	39.7	49.2	53.8	49.0	118.9	41.4	70.4	35.3	36.9	63.4	41.4	28.5	72.5	48.1	48.4	33.7	35.7	41.2	89.6	74.5	22.4	88.8	38.4	51.4	61.3	41.0	100.7	40.1	73.8	55.8	41.4	71.0	25.3	43.7	2.9	21.1	28.4	20.7	20.0	16.6	14.0	19.6	20.9	23.5	14.3	15.2	15.0	41.9	18.2	13.6	17.0	14.4	19.8	36.6	37.4	33.1	53.9	39.2	34.1	36.0	35.2	35.5	30.9	37.7	39.0	22.7	19.2	16.7	11.4	25.7	21.9	29.8	30.9	25.0	25.4	29.9	20.1	5.8	21.5	26.0	20.2	12.5	64.6	18.5	47.4	37.2	37.5	25.7	17.3	22.7	23.7	30.5	22.3	14.6	43.4	70.0	34.1	38.2	25.4	25.4	34.0	22.1	35.0	38.1	16.8	12.8	39.9	28.5	19.2	24.3	25.2	45.7	24.5	30.2	11.2	34.3	26.6	21.6	6.6	10.5	36.4	31.4	45.5	53.4	44.8	50.8	37.2	15.3	22.0	13.1	24.4	33.8	39.5	21.8	27.5	23.2	138.6	23.2	44.3	36.2	38.5
SCYL2	"CVAK104, KIAA1360"	ENSG00000136021	"SCY1 like pseudokinase 2"	Q6P3W7	12	100267140-100341715	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021050	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"			"HPA021050: AB_1846175"	"unprognostic (7.01e-3)"	"unprognostic (3.04e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.01e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.27e-2)"	"unprognostic (8.19e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.93e-2)"	"unprognostic (4.44e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.18e-1)"	13.4	13.4	6.2	16.4	7.3	21.5	16.8	9.9	8.2	14.0	7.6	22.9	20.2	14.5	20.9	22.1	10.9	16.2	14.9	7.6	8.6	21.2	28.7	17.2	15.0	5.6	5.4	8.8	17.9	20.9	12.9	21.0	6.3	17.0	26.9	16.7	15.7	15.9	15.6	13.7	17.0	17.4	6.3	14.7	16.4	14.6	7.5	19.0	15.6	19.1	19.8	21.5	11.5	7.2	37.7	29.0	45.8	37.7	28.8	31.1	43.2	38.0	42.8	34.8	29.6	28.1	19.4	23.4	17.7	46.9	23.7	32.1	36.4	27.8	40.6	36.5	24.2	76.0	18.5	20.3	25.7	36.2	72.8	23.1	42.5	39.5	44.9	41.3	44.4	26.0	40.8	19.7	37.4	29.2	29.2	31.7	28.6	21.7	32.6	23.4	33.6	22.7	31.6	61.1	28.3	25.3	43.0	44.2	36.2	48.2	64.9	27.8	41.7	29.7	17.2	27.8	24.8	22.6	32.1	28.3	14.6	24.6	34.4	12.3	5.2	10.0	4.0	6.5	5.1	3.3	4.2	3.8	6.6	2.3	4.5	4.9	6.7	8.6	5.7	2.0	6.2	4.0	6.2	7.3	9.9	8.2	7.6	8.6	5.6	5.4	6.3	6.3	7.5	7.2	24.4	16.0	35.2	37.9	20.4	35.9	21.3	17.4	33.0	16.8	29.6	17.1	30.1	7.2	26.8	20.2	27.1	31.3	22.7	44.1	5.9	16.8	8.5	24.4	19.1	24.8	21.7	28.6	50.3	21.7	22.2	20.2	37.8	31.2	27.9	15.1	16.4	37.1	25.1	15.2	54.1	30.6	12.2	34.6	47.4	4.7	13.4	29.2	16.0	44.0	27.5	10.9	17.5	64.3	47.2	24.0	32.1	15.4	22.2	36.8	16.2	26.3	18.3	16.2	0.0	13.1	20.9	24.9	12.0	36.8	34.7	59.4	22.6	19.2	33.6	52.8
SDHB	"SDH, SDH1"	ENSG00000117118	"Succinate dehydrogenase complex iron sulfur subunit B"	P21912	1	17018722-17054032	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 491.5;tongue: 580.6"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 405.5;Proximal tubular cells: 449.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002868, CAB009822, CAB068233, CAB068234, CAB068235"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"	"Intracellular and membrane"	NA	NA		7900	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Plasma membrane"	"CAB009822: AB_2183458, CAB068233: AB_2665638, CAB068234: AB_2665639, CAB068235: AB_2665640, HPA002868: AB_1079889"	"unprognostic (1.06e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (2.93e-7)"	"unprognostic (1.46e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.82e-2)"	85.8	95.7	68.0	59.0	72.2	94.6	68.7	80.6	84.3	56.8	81.1	134.3	163.0	56.0	71.0	77.4	59.8	48.0	302.8	69.9	76.9	228.0	336.1	56.1	75.3	74.8	71.4	44.4	80.3	144.3	42.8	57.6	73.8	55.7	132.4	62.9	74.0	60.5	491.5	55.6	121.9	70.4	73.9	60.5	92.8	64.4	74.9	62.7	64.3	580.6	84.2	71.3	52.0	78.9	157.3	152.7	72.2	107.8	141.6	135.2	95.9	122.4	145.2	254.3	227.7	216.8	183.1	206.8	159.3	156.4	176.1	180.1	290.7	226.8	284.8	128.7	280.6	183.4	149.2	168.2	172.8	276.0	135.6	140.4	154.9	224.5	370.1	138.7	183.6	176.5	165.2	236.9	179.6	129.5	182.4	175.1	70.4	224.6	302.6	146.1	142.5	265.4	252.4	88.7	157.5	86.0	172.3	216.3	392.3	76.4	131.1	169.1	94.9	115.8	131.0	206.4	176.0	98.9	133.3	198.6	170.4	438.5	128.3	68.7	149.8	149.5	71.4	206.5	70.7	89.9	81.0	77.5	186.8	81.1	73.5	74.8	174.3	85.3	185.7	89.3	113.8	116.1	68.0	72.2	80.6	84.3	69.9	76.9	74.8	71.4	73.8	73.9	74.9	78.9	48.2	64.1	47.4	20.9	57.4	52.1	93.3	199.8	40.5	31.5	45.2	49.4	405.5	101.5	97.0	47.8	14.6	107.1	48.3	176.1	354.1	134.3	220.3	48.7	38.2	54.7	48.6	77.3	27.7	149.2	142.2	62.0	46.9	45.5	66.6	39.9	46.8	226.0	177.4	37.0	32.1	103.1	116.0	88.7	67.9	30.5	57.8	78.4	64.0	29.0	123.1	78.3	48.4	15.6	24.6	111.5	218.3	67.7	62.2	74.4	300.5	449.0	79.8	53.8	39.5	57.1	191.6	148.9	71.5	72.9	54.6	121.8	46.8	69.3	162.0	110.9
SDHC	"CYB560, cybL, PGL3"	ENSG00000143252	"Succinate dehydrogenase complex subunit C"	Q99643	1	161314381-161363206	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 776.7;Proximal tubular cells: 916.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.48e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (2.20e-4)"	"unprognostic (9.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.19e-3)"	"unprognostic (3.77e-1)"	128.9	143.7	73.7	64.1	79.7	60.5	100.3	84.5	85.1	78.7	92.9	118.9	127.8	70.9	76.0	109.7	98.6	63.3	154.1	68.4	83.4	285.7	319.4	65.5	74.7	78.8	79.1	69.2	62.5	173.6	52.4	73.1	76.7	77.3	132.2	84.3	74.8	84.7	277.4	69.8	101.4	101.4	85.1	62.8	89.9	52.7	84.8	93.1	89.5	288.4	105.1	88.4	61.3	85.6	161.1	129.7	157.5	147.7	248.3	213.3	196.3	150.9	190.3	180.3	137.3	185.4	208.7	53.7	190.6	214.8	121.6	178.5	244.3	214.2	193.2	185.6	205.6	110.2	106.6	196.7	126.9	193.8	109.1	211.5	181.7	174.3	119.4	167.9	177.5	164.0	178.9	43.8	266.3	167.0	152.4	112.5	145.4	376.3	123.7	131.6	151.0	217.1	330.3	167.8	118.3	180.7	211.0	385.1	225.4	207.9	342.1	259.3	133.5	103.7	125.1	127.9	147.3	173.3	287.8	269.4	140.3	139.2	193.6	88.6	111.0	65.7	76.6	99.6	79.6	68.6	66.2	75.4	136.1	65.7	71.2	71.0	52.0	66.9	87.5	100.6	78.3	130.0	73.7	79.7	84.5	85.1	68.4	83.4	78.8	79.1	76.7	85.1	84.8	85.6	50.9	44.8	59.4	14.7	70.1	61.8	151.2	342.6	59.7	74.9	81.4	58.3	94.0	131.5	163.5	150.8	64.6	248.0	65.5	95.9	776.7	218.4	18.6	87.1	63.8	80.7	66.8	81.4	19.3	145.2	248.5	79.8	79.5	62.6	58.3	66.6	83.2	249.1	237.3	72.3	27.4	103.4	215.7	100.6	74.4	34.7	102.9	94.6	129.9	9.4	176.1	107.8	107.1	17.6	24.5	142.7	89.5	109.1	71.9	100.2	139.1	916.5	177.9	69.3	52.6	74.5	94.4	115.3	114.4	111.2	76.4	307.6	72.0	215.7	154.2	155.0
SEC31A	"ABP125, ABP130, KIAA0905, SEC31L1"	ENSG00000138674	"SEC31 homolog A, COPII coat complex component"	O94979	4	82818509-82901166	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005457	Approved		Supported	Vesicles,Cytosol		NA	NA		40000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Cytosol"		"HPA005457: AB_1079896"	"unprognostic (3.50e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (6.14e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.69e-4)"	98.7	103.3	52.2	78.4	54.3	119.4	111.4	62.4	70.1	145.5	94.9	107.1	124.2	119.7	162.1	92.6	90.9	122.1	110.7	54.0	61.4	133.6	174.8	96.2	88.2	58.4	58.7	152.8	192.6	116.4	108.4	143.2	58.7	113.4	127.2	87.9	134.0	111.3	96.8	107.8	111.0	131.5	50.9	76.5	110.1	77.8	54.4	93.8	168.0	85.6	102.1	113.1	94.1	63.9	146.2	65.2	183.6	130.4	318.9	394.5	133.3	264.8	295.4	146.0	179.2	113.2	182.3	188.3	113.7	532.2	84.6	68.1	183.3	176.2	200.4	193.4	72.7	115.3	110.5	302.1	316.4	124.4	140.7	380.5	217.7	223.5	254.3	251.2	240.5	83.8	178.4	181.1	264.2	128.6	164.9	99.6	126.1	154.0	58.3	121.2	100.1	140.3	237.2	83.0	118.6	131.2	105.7	180.7	174.9	184.8	142.1	137.8	248.2	190.7	98.9	169.0	168.8	135.1	62.4	256.7	190.6	147.8	224.2	84.3	66.9	51.2	65.1	74.0	80.5	60.0	57.6	64.3	73.3	50.0	56.9	54.6	19.2	89.9	83.1	61.1	52.7	71.8	52.2	54.3	62.4	70.1	54.0	61.4	58.4	58.7	58.7	50.9	54.4	63.9	62.6	105.8	85.3	50.9	58.1	60.5	60.5	64.1	56.9	52.3	54.5	43.7	85.5	51.5	109.8	47.8	54.2	57.3	61.0	62.8	27.4	65.8	30.6	90.1	164.6	65.0	38.3	41.2	61.0	71.2	85.3	125.2	100.9	119.7	75.2	241.0	65.0	94.0	45.9	42.1	60.0	99.4	50.8	51.2	55.3	19.3	139.1	63.8	51.6	67.5	60.4	36.5	38.1	74.9	72.6	67.5	46.3	126.0	152.2	76.3	121.0	65.9	100.5	66.9	52.6	86.5	98.9	30.3	34.6	62.2	74.2	81.5	55.4	78.9	54.9	101.1
SEC61A1		ENSG00000058262	"SEC61 translocon subunit alpha 1"	P61619	3	128051641-128071683	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"	Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022076			Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"		"CAB022076: "	"unprognostic (1.84e-1)"	"unprognostic (8.00e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (7.82e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.07e-6)"	"unprognostic (2.84e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (6.84e-9)"	"unprognostic (2.73e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.51e-2)"	82.1	100.7	31.3	88.3	33.4	79.5	75.3	33.5	34.7	144.5	52.4	90.7	81.9	88.9	128.9	88.7	78.1	81.7	74.2	32.3	39.6	64.6	134.8	93.3	60.2	40.9	37.6	67.3	272.1	111.7	93.5	112.8	36.0	90.0	90.0	37.0	176.3	97.0	70.5	66.9	75.8	110.7	36.6	73.7	105.5	38.8	46.6	61.4	104.8	59.3	80.6	97.0	68.7	35.8	272.8	136.5	132.0	240.3	367.9	317.3	256.9	426.9	470.8	349.0	371.2	259.1	186.9	184.7	259.5	534.8	266.2	232.6	209.0	291.3	334.2	168.1	126.2	213.5	143.5	273.6	542.9	264.1	225.9	348.1	345.4	329.3	422.4	265.0	314.3	122.2	136.9	415.3	412.8	237.7	135.1	87.5	184.6	231.6	202.8	144.2	125.5	349.8	181.4	229.3	155.8	162.4	216.0	193.5	270.7	152.0	184.2	215.1	327.3	278.3	164.7	333.7	201.4	386.6	210.6	265.8	456.3	166.2	369.1	160.3	88.6	67.0	89.0	79.6	120.0	43.8	62.9	78.2	82.6	26.1	38.8	46.2	22.5	65.0	84.2	114.0	45.1	116.9	31.3	33.4	33.5	34.7	32.3	39.6	40.9	37.6	36.0	36.6	46.6	35.8	31.9	32.1	33.1	18.6	46.6	37.0	25.7	44.4	30.7	17.0	63.5	41.3	15.0	37.1	43.3	49.7	35.5	64.3	59.2	107.2	3.9	81.0	42.2	28.2	72.9	45.9	73.6	19.5	12.6	154.5	136.3	57.4	77.5	68.6	26.0	55.6	49.6	118.2	75.9	26.9	18.5	150.8	38.7	34.8	32.1	25.7	41.0	38.2	33.8	26.2	32.1	22.4	28.8	19.1	17.2	104.9	50.2	43.6	192.8	69.6	63.5	26.8	31.0	15.5	32.9	25.6	47.2	12.3	18.4	42.5	29.5	127.9	32.4	52.6	100.4	44.6
SEC63	"DNAJC23, ERdj2, PRO2507, SEC63L"	ENSG00000025796	"SEC63 homolog, protein translocation regulator"	Q9UGP8	6	107867756-107958208	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Transport"	Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 354.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053295, HPA060535"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA053295: AB_2682105, HPA060535: AB_2684312"	"prognostic unfavorable (3.32e-4)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.51e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (6.16e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.41e-2)"	27.5	33.0	11.6	22.0	14.3	32.9	23.3	14.4	12.9	30.2	25.7	19.2	16.8	25.2	29.6	19.5	21.8	22.0	19.0	12.4	15.3	20.0	46.6	21.7	16.7	13.3	12.0	40.4	61.2	31.7	14.4	20.9	14.2	27.7	18.6	21.2	77.8	23.3	14.3	15.5	18.0	22.2	12.3	16.1	23.1	33.0	12.1	22.6	52.1	14.1	17.3	21.8	14.0	17.7	28.5	17.1	46.0	57.6	47.1	55.2	41.4	59.2	65.0	27.8	39.2	30.8	34.6	52.8	49.4	53.7	34.4	40.9	32.3	38.3	42.5	63.8	35.7	57.2	25.2	31.6	73.2	65.9	32.5	43.5	61.4	44.5	97.6	50.0	39.3	31.7	48.5	82.8	57.7	22.7	20.6	29.5	36.4	30.0	18.1	65.2	54.4	43.7	33.5	37.1	40.3	45.7	32.9	48.8	59.1	31.2	34.9	95.8	42.5	41.6	25.8	42.2	46.6	31.4	25.0	52.9	45.9	56.4	48.7	5.6	5.2	5.0	4.8	4.7	7.5	4.4	3.9	3.9	5.4	4.0	4.3	3.4	1.7	7.1	9.8	6.9	2.2	3.5	11.6	14.3	14.4	12.9	12.4	15.3	13.3	12.0	14.2	12.3	12.1	17.7	55.6	118.6	143.3	38.2	64.4	85.0	70.5	90.9	42.7	57.7	67.8	54.2	78.8	81.5	125.5	53.3	39.6	80.8	71.6	39.2	11.7	86.0	40.3	48.7	102.8	61.6	53.5	31.5	52.5	125.4	96.4	107.1	46.9	54.8	68.9	84.8	59.6	126.7	62.7	47.1	50.8	80.0	83.4	56.7	78.9	23.9	106.2	54.8	80.0	42.2	54.3	61.0	59.8	60.3	64.8	81.9	53.5	118.8	144.6	91.1	37.2	38.4	116.7	49.9	46.0	108.2	77.2	143.1	75.0	44.7	80.0	91.0	52.3	354.8	60.8	73.8
SELENBP1	"hSBP, hSP56, LPSB"	ENSG00000143416	"Selenium binding protein 1"	Q13228	1	151364304-151372707	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein transport, Transport"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 509.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 525.6;Distal enterocytes: 1056.9;Erythroid cells: 590.9;Hepatocytes: 501.5;Paneth cells: 451.4;Undifferentiated cells: 452.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 2.4"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 2.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 144.9;HEL: 120.5;HSkMC: 75.9;OE19: 92.8;SK-BR-3: 274.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005741, CAB008366, HPA011731"	Enhanced		Supported	Nucleoli		NA	NA		59000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli		"CAB008366: AB_592677, HPA005741: AB_1856662, HPA011731: AB_1856663"	"unprognostic (1.51e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.52e-3)"	"unprognostic (6.25e-3)"	"unprognostic (6.28e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.86e-3)"	128.3	18.7	49.8	24.9	53.0	95.9	76.3	45.5	54.8	57.0	47.4	509.3	74.7	31.3	43.4	31.8	132.7	52.2	69.1	47.1	48.2	77.2	261.7	181.0	10.9	47.8	51.0	49.4	29.0	11.9	15.0	20.4	46.5	44.2	471.7	3.9	61.6	48.8	72.9	25.2	94.2	49.5	46.9	51.1	126.4	6.1	51.0	7.1	115.1	138.1	6.8	58.3	29.3	45.7	0.0	17.2	31.9	1.8	144.9	59.1	8.4	5.9	2.6	3.1	6.5	18.1	5.4	0.0	30.7	10.7	0.0	0.4	0.0	0.4	2.8	0.1	14.8	120.5	53.1	28.9	30.5	0.2	0.0	75.9	1.0	5.3	0.1	0.4	19.0	0.0	12.4	0.0	8.0	13.2	0.0	0.0	26.6	92.8	32.2	0.1	1.7	0.7	7.1	0.0	0.4	0.7	0.5	274.4	0.0	25.1	49.4	1.8	1.8	0.0	1.1	16.8	0.1	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	49.8	53.0	45.5	54.8	47.1	48.2	47.8	51.0	46.5	46.9	51.0	45.7	36.6	294.9	525.6	38.2	4.0	10.8	27.7	56.4	30.7	0.3	73.0	59.9	135.7	75.8	123.9	5.5	0.0	2.4	1.9	1056.9	115.4	17.1	0.7	30.9	14.9	27.5	155.0	590.9	0.1	9.1	2.1	85.2	163.6	14.1	27.3	10.9	26.0	501.5	15.3	0.0	0.1	137.2	79.3	39.6	12.4	4.2	66.5	3.9	33.8	13.1	0.2	37.4	0.0	0.0	2.0	6.5	451.4	80.9	0.8	25.6	251.0	148.3	101.5	1.4	52.6	15.6	102.3	0.1	0.3	22.7	9.9	4.0	5.7	30.5	452.4	71.0
SELENOI	"EPT1, KIAA1724, SELI, SEPI"	ENSG00000138018	"Selenoprotein I"	Q9C0D9	2	26308547-26395891	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 22.0;Endometrial ciliated cells: 16.3;Glandular and luminal cells: 15.3;Pancreatic endocrine cells: 13.6;Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064125	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA064125: "	"unprognostic (6.29e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.05e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.00e-3)"	"unprognostic (7.79e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.65e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.42e-2)"	3.6	6.4	7.9	5.5	8.4	12.1	8.1	11.2	10.6	5.4	5.0	8.6	12.3	4.1	5.4	11.1	3.5	4.0	3.9	10.3	9.3	7.9	23.2	4.4	5.7	6.8	7.3	3.5	9.0	17.2	4.5	4.7	8.6	6.2	8.7	9.3	6.2	4.2	7.0	18.3	18.4	3.7	9.7	4.3	7.1	4.4	7.2	6.3	7.1	6.6	6.1	7.5	7.1	10.0	42.7	25.7	20.9	21.0	12.8	10.2	32.0	20.3	9.2	10.0	10.2	54.5	26.6	49.5	24.2	9.5	21.4	34.1	32.4	17.9	14.4	13.7	15.4	31.3	17.5	32.3	12.2	41.9	9.7	8.1	15.6	22.3	21.9	6.1	9.4	17.6	35.9	16.6	13.5	18.4	25.1	20.7	26.8	21.6	17.4	22.6	49.2	25.0	19.3	32.4	45.7	19.4	17.3	36.2	16.4	17.3	17.4	12.4	15.1	17.1	22.0	22.7	31.7	22.6	60.8	65.8	17.5	25.4	15.6	0.0	0.7	0.0	0.9	1.0	0.9	2.5	0.9	1.2	0.7	1.0	1.2	2.0	0.2	0.9	0.9	1.3	1.8	0.4	7.9	8.4	11.2	10.6	10.3	9.3	6.8	7.3	8.6	9.7	7.2	10.0	9.1	12.8	8.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	12.2	7.1	0.0	0.0	3.1	22.0	0.0	6.1	11.7	0.0	0.0	10.4	0.0	16.3	12.8	3.7	0.0	0.0	0.0	10.4	6.2	2.9	0.0	15.3	1.3	8.6	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	13.6	0.0	0.0	3.9	0.0	0.0	5.6	2.2	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	16.6	4.7	11.5	0.0	0.0
SELENOT	SELT	ENSG00000198843	"Selenoprotein T"	P62341	3	150602875-150630445	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 215.1;Extravillous trophoblasts: 230.6;Hofbauer cells: 238.8;Pancreatic endocrine cells: 206.0;Proximal tubular cells: 176.8;Syncytiotrophoblasts: 489.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039780	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA039780: AB_10805594"	"unprognostic (1.13e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.79e-3)"	"unprognostic (6.30e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.08e-3)"	"unprognostic (4.91e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.41e-2)"	49.2	73.5	44.0	56.4	47.2	100.0	47.8	49.8	58.9	44.0	44.8	49.1	51.2	39.2	62.7	41.0	49.1	38.9	51.9	46.0	52.2	75.4	72.4	51.0	80.5	46.9	46.9	36.0	45.4	84.2	45.6	60.6	49.9	49.5	56.6	69.7	45.5	48.8	44.9	28.3	50.3	54.1	50.5	46.4	45.1	39.7	47.7	58.3	67.2	54.0	73.2	63.4	32.0	53.9	232.1	94.9	57.1	51.8	86.7	84.0	111.3	174.3	127.3	120.7	79.6	145.9	129.1	125.6	192.2	128.7	107.5	76.1	89.6	110.3	177.7	124.8	77.3	130.9	48.4	68.1	94.6	77.1	102.5	74.1	86.5	107.6	92.1	86.7	132.2	58.2	31.0	359.9	173.4	137.6	107.5	46.1	65.4	134.2	99.0	79.0	73.8	215.4	102.6	132.7	64.2	39.8	106.4	64.4	74.8	71.2	133.6	96.2	125.7	65.1	41.1	121.1	172.6	261.3	151.4	176.1	88.8	142.1	56.9	218.1	163.8	142.5	133.7	138.4	148.5	119.6	111.3	125.4	126.5	102.3	87.4	110.1	198.8	106.3	155.7	90.7	132.3	324.7	44.0	47.2	49.8	58.9	46.0	52.2	46.9	46.9	49.9	50.5	47.7	53.9	80.6	60.9	67.9	0.0	53.4	0.0	0.0	0.0	0.0	0.0	97.2	66.5	0.0	0.0	29.1	108.5	0.0	215.1	114.7	0.0	97.8	166.8	0.0	63.9	46.8	35.5	0.0	0.0	0.0	135.0	230.6	30.9	0.0	64.7	45.4	31.5	0.0	0.0	238.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.5	0.0	0.0	123.5	0.0	0.0	0.0	0.0	206.0	0.0	0.0	21.0	0.0	0.0	176.8	32.8	0.0	0.0	0.0	37.1	0.0	0.0	0.0	0.0	489.3	48.1	63.4	0.0	0.0
SEPSECS	"SLA, SLA/LP"	ENSG00000109618	"Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase"	Q9HD40	4	25120014-25160550	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"RNA-binding, Transferase, tRNA-binding"	"Disease variant, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 26.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070409			Approved	Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 16: U-266 - Nucleosome"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Vesicles		"HPA070409: AB_2686265"	"unprognostic (1.83e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.37e-3)"	"unprognostic (5.86e-2)"	"unprognostic (9.63e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.82e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.56e-2)"	"unprognostic (4.45e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.13e-3)"	4.7	3.5	2.1	1.7	2.1	0.7	4.4	2.0	3.0	4.2	1.6	5.3	4.8	3.8	2.6	3.2	3.8	2.5	2.7	2.0	2.1	8.2	26.1	3.9	2.1	2.2	2.0	4.9	7.4	3.3	3.0	2.8	2.1	3.4	2.7	1.5	3.9	2.0	3.4	5.2	7.6	1.3	2.0	5.6	5.0	4.0	2.1	5.2	4.8	2.6	2.0	3.8	3.5	2.3	1.7	1.0	3.0	1.3	3.9	4.9	2.5	1.1	1.9	2.6	2.3	0.6	2.6	2.9	1.4	1.0	2.6	1.3	3.5	1.2	2.0	1.9	1.3	2.5	1.0	1.8	4.0	2.0	3.3	4.0	4.2	1.0	3.7	3.1	2.5	4.3	7.0	2.5	1.6	0.7	4.4	6.2	2.1	1.8	2.5	1.3	4.3	1.7	3.7	0.7	1.6	2.4	1.3	1.4	4.7	1.9	1.5	5.5	1.0	1.4	0.7	0.7	1.7	2.3	6.2	1.6	1.4	5.4	1.8	0.0	0.2	0.1	0.1	0.6	0.2	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	2.1	2.1	2.0	3.0	2.0	2.1	2.2	2.0	2.1	2.0	2.1	2.3	5.7	0.0	7.2	9.4	6.6	2.4	1.7	3.9	2.8	3.0	5.5	4.3	5.3	22.8	4.3	16.5	0.0	5.5	4.1	10.2	7.9	5.4	30.0	7.3	6.2	6.1	6.1	8.2	5.3	4.7	3.5	4.8	8.2	5.4	3.8	7.9	6.1	42.6	6.1	5.0	7.2	7.7	4.1	8.1	4.5	18.1	3.4	6.6	3.6	14.0	8.0	3.2	4.1	16.1	18.5	5.4	6.0	6.4	6.9	2.7	20.0	20.9	10.2	2.4	0.0	4.9	4.4	26.0	18.3	5.3	3.3	5.9	6.2	7.6	7.8	1.1
SETD1A	"KIAA0339, KMT2F, Set1"	ENSG00000099381	"SET domain containing 1A, histone lysine methyltransferase"	O15047	16	30957754-30984664	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA020646, HPA058376"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA020646: AB_1856752, HPA058376: AB_2683695"	"unprognostic (8.62e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (5.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.18e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.94e-1)"	10.2	10.0	6.0	7.3	5.5	20.1	10.0	8.4	8.3	11.0	3.0	13.0	6.6	13.0	2.8	9.0	10.5	4.1	8.5	5.5	5.5	8.4	10.4	8.2	8.6	5.6	5.4	12.4	10.6	8.0	11.9	5.0	5.4	10.2	3.3	3.1	9.3	6.1	15.1	12.3	10.5	6.3	4.1	11.8	10.0	20.8	6.0	10.0	11.8	7.1	5.1	10.2	9.3	6.9	13.1	24.4	15.9	19.4	8.7	6.3	18.0	13.6	10.6	11.9	10.1	20.2	12.8	34.2	15.2	13.0	12.0	16.4	15.0	14.6	9.3	18.5	56.1	16.0	47.1	23.2	8.9	26.6	26.2	11.0	11.3	17.1	10.8	9.2	9.3	19.5	32.3	19.0	6.4	27.2	32.3	27.7	23.4	9.0	15.4	48.7	15.9	21.9	7.6	13.9	17.6	18.1	18.7	15.1	10.8	8.7	16.2	22.1	12.8	17.7	17.1	11.6	14.9	28.0	36.2	32.4	14.3	22.9	13.5	0.0	0.1	0.6	0.2	0.3	0.3	0.0	0.2	0.2	0.1	0.5	0.1	0.2	0.0	0.2	0.1	0.6	0.1	0.2	6.0	5.5	8.4	8.3	5.5	5.5	5.6	5.4	5.4	4.1	6.0	6.9	7.8	3.2	9.2	9.1	8.8	15.7	5.1	3.8	15.4	8.1	9.5	8.3	3.9	5.7	4.0	7.3	6.2	4.6	11.4	6.8	0.0	4.2	3.1	6.1	8.2	9.9	10.3	6.7	6.4	4.2	3.7	7.8	6.1	8.6	3.8	9.5	7.5	9.1	6.5	13.5	6.1	7.9	2.0	4.7	7.1	2.9	9.9	5.5	8.8	6.5	4.7	4.8	7.2	2.5	5.7	5.4	4.8	11.7	7.9	8.3	5.1	2.8	4.0	5.2	6.6	10.8	7.8	17.5	23.3	15.7	12.9	2.9	8.6	10.3	6.9	4.8
SETD2	"FLJ23184, HIF-1, HYPB, KIAA1732, KMT3A"	ENSG00000181555	"SET domain containing 2, histone lysine methyltransferase"	Q9BYW2	3	47016429-47164113	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Differentiation, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Methyltransferase, Transferase"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042451	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Cytosol	"HPA042451: AB_10806239"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.84e-2)"	"prognostic favorable (7.99e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.79e-2)"	"unprognostic (5.43e-2)"	9.9	6.5	8.2	10.7	10.5	23.8	10.3	24.1	8.3	12.6	10.8	9.7	9.1	13.3	6.1	9.8	11.0	8.5	7.2	6.2	6.7	10.8	10.0	9.4	13.5	8.3	8.5	15.3	13.3	16.2	2.2	11.4	8.4	10.2	11.0	10.6	9.6	9.7	11.1	9.0	10.3	11.9	8.1	11.4	10.7	13.1	7.9	19.2	15.5	14.5	13.3	9.8	4.0	12.8	21.1	13.2	25.4	14.5	15.3	18.9	11.3	17.9	17.0	20.8	19.9	15.4	13.8	43.5	11.6	25.5	20.0	12.4	29.5	17.6	27.6	27.5	12.2	47.3	24.8	12.4	11.7	34.1	26.5	15.2	17.3	20.7	24.6	15.3	20.1	22.8	29.9	16.6	17.8	9.5	26.7	8.5	20.6	9.4	15.4	17.5	25.6	23.2	12.4	26.6	10.9	17.6	29.5	11.8	12.0	17.2	12.9	27.5	26.7	24.6	18.1	21.5	29.9	22.0	25.4	43.7	14.2	19.6	14.6	1.3	1.2	2.9	2.0	1.1	1.1	2.2	1.2	1.6	1.4	2.5	1.7	1.6	3.3	3.6	1.1	1.5	0.6	0.6	8.2	10.5	24.1	8.3	6.2	6.7	8.3	8.5	8.4	8.1	7.9	12.8	50.5	48.1	58.8	115.9	58.3	33.3	22.6	15.6	54.1	40.5	31.0	29.1	67.2	27.1	53.2	11.0	41.7	20.3	58.2	32.6	11.7	20.9	26.1	62.8	63.0	41.2	22.1	38.9	131.4	22.4	12.7	39.2	56.6	66.2	58.8	68.9	23.6	29.8	16.8	26.9	129.4	28.2	14.2	28.8	26.5	35.1	30.4	42.7	17.8	148.9	37.9	22.7	43.3	113.1	143.2	23.7	22.3	33.1	54.0	31.2	24.6	11.5	49.7	39.9	13.1	56.1	42.6	71.0	29.3	60.2	35.7	18.5	65.3	57.1	29.5	34.7
SETD5	FLJ10707	ENSG00000168137	"SET domain containing 5"	Q9C0A6	3	9397615-9479240	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Autism, Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 263.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017093, HPA035574"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"CAB017093: , HPA035574: AB_2674681"	"unprognostic (6.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (6.21e-4)"	"unprognostic (5.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (6.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.15e-3)"	24.9	28.1	22.3	19.3	22.0	14.9	25.4	33.7	24.9	29.5	20.9	30.5	15.2	27.6	30.2	25.0	30.2	18.8	23.0	23.5	22.3	18.3	27.6	33.5	23.1	20.5	20.3	33.2	28.5	18.0	26.5	24.0	21.1	25.6	20.9	33.9	28.3	20.4	23.9	32.8	25.6	23.2	18.6	26.1	23.9	17.8	22.2	25.5	30.5	21.5	26.7	26.5	28.1	24.2	25.3	28.6	57.8	27.0	36.5	33.6	138.5	24.9	30.2	31.6	35.4	29.1	30.2	53.5	14.3	33.4	29.8	20.0	50.6	29.8	35.5	38.4	27.6	50.6	56.4	29.8	36.7	42.0	31.9	35.0	52.2	49.3	55.1	37.3	35.7	35.6	50.0	40.0	32.6	36.4	35.7	38.1	42.2	19.5	23.9	37.7	47.6	26.2	29.6	37.7	22.3	34.6	34.2	29.8	22.6	52.6	39.7	30.8	41.6	35.3	41.6	21.0	28.9	27.4	34.2	83.6	26.9	30.4	33.2	0.4	0.4	0.2	0.9	0.2	0.8	0.7	0.6	0.7	0.3	0.7	0.5	0.5	1.1	1.1	0.2	0.8	0.1	0.1	22.3	22.0	33.7	24.9	23.5	22.3	20.5	20.3	21.1	18.6	22.2	24.2	51.5	41.7	50.6	136.1	53.6	93.9	54.4	28.5	86.6	110.6	45.1	26.2	25.5	41.5	50.0	42.3	114.7	38.9	50.4	39.1	3.9	37.3	7.9	45.9	60.3	62.5	62.4	34.3	175.0	34.0	41.3	62.2	45.9	49.4	48.1	60.6	63.1	50.1	24.4	55.5	188.5	51.9	26.4	32.4	70.7	11.7	66.8	30.8	44.4	108.7	39.7	33.4	39.1	263.9	131.7	44.2	46.2	53.8	67.7	88.2	39.4	12.8	52.9	60.9	13.1	65.3	52.8	50.6	37.8	75.2	91.5	57.3	49.6	56.2	47.8	84.2
SFXN4	SLC56A4	ENSG00000183605	"Sideroflexin 4"	Q6P4A7	10	119140767-119165714	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018028, HPA020872"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"	Vesicles	"HPA018028: AB_1856792, HPA020872: AB_1856793"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.84e-2)"	"unprognostic (4.56e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.70e-3)"	"unprognostic (4.22e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.07e-3)"	13.3	35.9	9.9	10.1	12.5	16.4	14.1	12.8	13.6	14.2	17.0	21.9	20.4	11.1	13.5	19.1	14.3	8.6	33.1	10.2	12.4	24.5	36.4	8.5	14.4	11.3	12.5	16.0	33.7	23.1	21.5	8.8	11.6	18.8	22.7	5.7	27.8	13.2	51.4	11.5	17.3	12.2	10.6	20.9	17.3	11.9	11.3	11.0	24.7	59.3	17.8	16.4	13.8	12.5	26.2	27.6	8.7	41.8	10.4	19.7	33.0	16.3	19.8	21.0	21.8	45.9	43.2	62.6	15.6	14.9	22.4	48.2	57.5	36.3	24.3	33.1	65.7	28.7	18.4	47.3	37.1	49.7	28.8	21.1	34.4	22.0	63.8	19.5	25.0	46.5	45.2	17.5	13.6	29.6	53.8	60.4	11.8	50.2	32.5	51.7	27.1	49.0	24.3	17.3	25.2	13.9	10.8	42.2	61.9	11.1	26.0	28.4	11.5	10.6	21.9	19.8	37.6	42.6	53.0	56.3	16.2	72.6	7.2	2.5	18.1	1.9	6.5	19.5	10.8	12.5	7.9	7.1	21.2	7.0	12.1	9.8	2.2	7.3	15.9	10.6	6.0	11.1	9.9	12.5	12.8	13.6	10.2	12.4	11.3	12.5	11.6	10.6	11.3	12.5	8.0	6.4	5.6	29.0	16.9	12.0	25.8	39.9	23.3	7.9	17.8	18.2	36.2	12.8	19.1	14.7	2.1	37.6	6.2	13.2	58.7	28.4	27.4	7.6	8.9	8.4	18.0	33.6	22.3	23.8	25.8	12.4	14.3	7.9	5.7	28.5	7.1	31.5	29.2	6.7	29.1	24.7	30.5	17.6	5.0	69.3	8.7	13.1	12.4	8.4	11.3	7.7	10.3	22.1	19.5	17.6	12.1	13.5	31.9	28.0	29.8	65.6	13.5	11.3	6.6	22.3	10.6	27.7	15.2	26.9	9.1	21.9	9.2	44.5	45.8	20.5
SGMS2	"MGC26963, SMS2"	ENSG00000164023	"Sphingomyelin synthase 2"	Q8NHU3	4	107824563-107915047	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 126.6;Basal prostatic cells: 167.4;Endometrial ciliated cells: 172.1;Glandular and luminal cells: 147.8;Urothelial cells: 159.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 3.7;eosinophil: 2.4;intermediate monocyte: 1.5;myeloid DC: 4.2;non-classical monocyte: 1.4"	"Group enriched"	"Detected in many"	35	"dendritic cells: 4.2;granulocytes: 2.4;monocytes: 3.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015076	Supported					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA015076: AB_1857298"	"unprognostic (7.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.88e-3)"	"unprognostic (9.53e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.82e-3)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.37e-4)"	"unprognostic (6.18e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.22e-3)"	8.6	3.0	5.2	9.0	15.3	4.6	5.2	10.1	7.8	12.7	36.7	12.3	19.5	8.8	4.6	16.4	12.5	39.6	9.1	3.3	6.5	14.5	20.4	27.8	1.1	13.9	14.3	1.1	11.7	3.6	4.7	5.1	13.0	9.6	10.6	0.8	9.2	4.6	2.5	3.6	16.5	29.1	10.2	1.1	13.8	9.6	10.6	0.8	18.0	3.4	2.9	13.9	4.2	21.6	20.8	7.7	1.1	5.8	12.9	29.9	0.4	25.0	18.8	11.6	12.1	3.5	42.1	1.5	9.7	40.0	10.1	7.6	14.5	22.1	20.7	5.9	5.7	0.9	16.5	1.2	14.8	14.2	0.1	10.4	15.1	22.7	27.4	24.2	26.1	0.3	0.2	0.5	18.6	6.9	0.5	0.1	0.7	12.1	8.6	0.5	9.9	2.9	30.7	10.0	2.0	0.1	19.1	26.9	3.3	3.0	14.5	0.4	44.7	13.9	21.9	20.1	11.7	1.4	0.5	0.8	18.7	3.4	5.9	0.0	3.7	2.4	0.0	1.5	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	1.0	5.2	15.3	10.1	7.8	3.3	6.5	13.9	14.3	13.0	10.2	10.6	21.6	3.4	86.6	126.6	7.2	1.0	56.0	167.4	12.8	18.2	0.5	20.9	10.4	17.8	28.6	88.0	16.5	0.0	1.0	2.9	32.3	3.9	19.8	71.4	172.1	13.5	10.7	8.9	0.0	8.0	19.5	0.9	26.6	58.1	147.8	10.1	2.8	11.4	25.0	5.5	1.7	10.0	26.0	14.2	22.1	43.0	11.1	2.5	28.2	8.8	1.9	23.3	0.2	2.1	0.5	18.5	37.9	60.5	0.4	0.4	96.9	33.5	12.4	104.0	0.1	0.0	46.1	22.0	0.9	3.1	38.1	72.9	13.8	3.3	0.1	21.8	159.7
SGPL1	SPL	ENSG00000166224	"Sphingosine-1-phosphate lyase 1"	O95470	10	70815948-70881184	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 112.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021125, HPA023086"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum"		"HPA021125: AB_1856803, HPA023086: AB_1856804"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.21e-2)"	"unprognostic (4.68e-3)"	12.0	12.7	15.8	18.0	17.4	6.8	13.0	15.2	16.3	17.6	11.0	16.7	16.0	14.4	18.8	27.9	15.3	12.6	6.4	14.7	16.4	15.5	22.9	10.7	18.1	18.6	16.7	9.0	18.5	21.0	9.4	10.0	17.4	17.5	17.9	10.8	14.3	12.4	9.6	30.4	22.8	13.9	17.4	16.1	12.3	14.0	17.7	17.9	20.1	6.0	20.1	25.0	14.7	19.8	26.9	35.2	33.2	38.1	8.9	11.5	22.1	15.5	16.4	16.5	21.4	38.4	57.8	24.2	18.0	15.8	15.9	44.1	28.8	31.0	23.5	39.1	15.6	2.5	17.5	46.2	33.6	10.6	20.9	21.8	51.4	22.1	57.6	34.6	10.4	22.3	7.2	20.4	23.6	29.6	13.2	7.1	15.0	35.4	19.5	16.6	25.2	9.1	26.3	112.1	22.6	27.5	30.9	46.6	28.5	25.9	24.3	7.5	20.3	14.8	38.7	11.6	30.1	8.4	12.6	11.0	14.7	19.3	10.7	1.1	18.2	14.0	18.0	34.6	16.5	7.2	11.5	14.7	16.2	8.7	8.5	13.5	15.0	18.8	44.9	8.9	11.8	12.4	15.8	17.4	15.2	16.3	14.7	16.4	18.6	16.7	17.4	17.4	17.7	19.8	3.8	16.0	6.4	32.3	11.0	12.2	17.8	21.4	8.0	6.3	15.8	9.8	6.3	27.1	23.2	46.0	20.9	7.3	16.0	41.5	3.9	36.2	2.9	30.2	13.3	7.3	25.1	4.4	48.7	37.6	13.8	10.1	6.6	46.1	14.7	23.1	7.1	44.5	27.6	15.2	38.8	21.2	22.4	43.1	16.1	5.2	11.5	25.7	7.2	35.6	22.7	9.8	25.7	41.7	43.8	55.6	18.8	20.3	5.9	26.0	53.5	12.0	26.6	9.7	6.6	13.3	19.0	20.0	34.0	15.9	22.7	6.3	11.1	18.2	20.9	25.3
SGSH	"HSS, MPS3A, SFMD"	ENSG00000181523	"N-sulfoglucosamine sulfohydrolase"	P51688	17	80206716-80220923	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 62.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023436, HPA023451"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"			"HPA023436: AB_1856806, HPA023451: AB_1856807"	"unprognostic (4.33e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.39e-3)"	"prognostic unfavorable (7.71e-4)"	"prognostic favorable (2.72e-4)"	"unprognostic (6.08e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (3.10e-4)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (7.50e-2)"	"unprognostic (3.68e-2)"	16.6	45.9	1.7	12.2	2.3	3.6	17.2	0.7	5.2	13.5	8.8	14.8	12.7	17.2	4.6	11.0	16.0	10.6	9.9	2.0	5.4	15.7	9.5	18.1	13.4	4.4	7.6	12.3	20.4	16.0	17.0	12.4	4.2	19.7	6.5	2.8	21.8	11.1	7.0	18.9	16.7	10.6	2.5	28.4	17.8	3.9	5.3	4.2	21.2	4.6	6.9	15.5	11.5	1.8	2.6	7.9	9.8	15.6	22.5	20.2	10.4	16.0	40.4	27.7	24.2	9.0	9.5	0.1	25.7	24.9	13.2	9.9	6.2	11.7	4.7	5.3	9.6	0.0	22.3	25.0	62.2	0.0	5.9	33.9	12.0	9.9	10.5	5.8	50.7	4.7	7.1	26.2	17.9	16.2	0.3	0.2	3.3	10.0	13.2	1.4	3.7	21.1	20.2	18.5	2.0	11.7	18.4	44.1	10.6	4.9	32.8	0.5	32.5	31.9	7.0	11.4	7.4	26.1	3.6	3.9	13.6	0.0	16.3	0.0	20.6	0.0	12.1	8.0	16.0	3.5	10.5	11.3	20.4	3.8	8.2	6.7	2.1	9.3	8.0	1.5	13.5	12.7	1.7	2.3	0.7	5.2	2.0	5.4	4.4	7.6	4.2	2.5	5.3	1.8	7.5	3.2	10.8	4.2	5.5	5.1	3.7	5.9	5.7	3.7	9.3	9.3	1.7	5.7	7.3	7.3	8.4	18.2	5.2	12.0	0.0	8.9	0.2	5.3	9.2	10.1	3.0	2.7	2.6	15.9	8.7	10.1	17.9	10.0	0.0	13.6	9.7	4.5	17.7	0.0	3.4	9.3	4.1	18.2	7.6	0.5	11.5	13.0	1.8	2.8	8.4	4.1	6.2	4.5	1.7	6.8	6.0	14.3	5.5	5.5	8.1	4.9	3.8	3.9	13.1	4.0	5.3	0.3	0.5	6.4	5.5	27.0	7.2	32.0	8.0	2.9
SHPK	"CARKL, SHK"	ENSG00000197417	Sedoheptulokinase	Q9UHJ6	17	3608240-3636250	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 19.1;Proximal enterocytes: 18.9;Rod photoreceptor cells: 18.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024361, HPA064939"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA		350000	"Cluster 40: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nuclear speckles"		"HPA024361: AB_1846030, HPA064939: AB_2685388"	"unprognostic (1.75e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	7.4	9.9	3.5	3.9	5.0	4.8	6.9	4.1	4.4	9.8	3.1	6.4	13.5	4.8	2.9	9.4	6.2	3.6	4.5	3.4	3.5	10.2	23.3	4.7	3.9	3.9	4.8	7.5	10.9	8.6	4.5	6.2	4.2	5.7	6.0	7.1	7.0	5.4	3.3	9.7	11.5	3.5	3.0	4.4	8.4	4.2	4.3	4.5	5.5	3.3	5.3	5.6	7.8	8.7	6.7	13.5	14.0	9.1	5.7	5.7	7.8	4.4	4.0	8.5	5.0	23.3	6.2	7.9	9.5	8.6	7.9	12.8	18.8	14.3	6.1	12.8	18.3	8.6	11.6	17.0	6.9	7.6	11.8	9.7	6.8	9.4	6.3	7.2	16.1	6.2	11.6	9.8	8.3	12.0	9.8	5.9	7.0	15.3	8.9	13.3	7.3	12.6	12.0	8.5	4.1	10.7	16.2	14.7	4.6	8.4	13.2	4.4	11.6	12.8	6.1	12.5	10.9	3.3	4.5	5.2	13.9	6.7	6.7	1.5	2.2	2.5	1.9	2.3	2.0	2.1	1.8	1.6	3.0	1.5	3.0	1.9	0.4	3.2	1.8	3.2	1.6	2.5	3.5	5.0	4.1	4.4	3.4	3.5	3.9	4.8	4.2	3.0	4.3	8.7	2.6	0.0	3.2	11.1	2.0	0.0	1.0	0.1	3.4	5.9	3.2	2.3	1.0	4.3	0.8	5.5	16.7	10.0	1.1	9.2	1.9	3.3	0.5	2.6	2.5	2.9	3.5	5.2	4.5	4.7	10.1	3.3	4.6	2.9	0.0	5.0	3.6	19.1	8.4	15.2	5.3	6.0	0.0	2.2	0.4	0.4	4.1	2.2	0.0	8.4	2.7	2.5	1.0	4.0	8.2	5.3	6.7	2.6	2.0	2.2	18.9	8.5	1.0	18.2	0.0	4.8	1.8	0.6	1.2	3.0	0.4	5.6	2.1	16.9	6.5	1.8
SIAE	"CSE-C, LSE, MGC87009, YSG2"	ENSG00000110013	"Sialic acid acetylesterase"	Q9HAT2	11	124633113-124695707	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Serine esterase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 104.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 58.0;Cardiomyocytes: 59.5;Distal enterocytes: 102.4;Paneth cells: 53.0;Proximal enterocytes: 51.6;Undifferentiated cells: 63.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 88.6;ASC TERT1: 91.3;HSkMC: 98.9;OE19: 97.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038052, HPA038053"	Approved				"Intracellular and membrane"	NA	NA		2200000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA038052: AB_10671518, HPA038053: AB_10673039"	"unprognostic (9.97e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-3)"	"prognostic favorable (4.66e-5)"	"unprognostic (3.30e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.90e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.45e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (4.42e-11)"	"unprognostic (7.24e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.92e-2)"	18.7	17.3	16.8	11.8	21.6	3.7	15.9	26.9	19.8	13.0	38.9	97.8	34.3	7.1	34.3	13.6	19.3	16.7	43.8	16.1	27.1	62.1	43.4	20.6	5.8	25.3	23.7	5.7	17.3	45.3	14.4	11.8	24.7	20.4	104.4	6.2	18.4	15.3	26.7	13.0	35.8	10.4	23.0	9.1	19.0	10.3	24.9	3.7	54.0	33.3	6.7	16.8	7.8	26.3	8.9	14.0	8.0	34.6	88.6	91.3	20.9	16.8	24.0	4.3	2.6	10.9	61.4	5.5	24.2	21.5	9.4	17.3	12.8	18.7	4.2	26.0	3.9	8.6	3.7	11.1	41.8	0.7	7.2	98.9	24.9	11.4	17.3	58.5	30.6	11.0	7.1	37.5	14.8	16.5	0.2	0.6	5.0	97.7	28.5	3.2	0.2	8.4	51.4	12.1	2.4	5.1	46.5	18.6	8.0	24.0	36.8	3.2	34.1	23.6	4.3	26.5	4.0	9.4	7.5	0.7	8.3	4.6	9.8	7.6	2.9	0.1	0.4	2.1	0.3	0.5	1.3	0.6	1.9	0.7	1.7	1.1	0.5	0.2	3.7	0.5	0.6	1.8	16.8	21.6	26.9	19.8	16.1	27.1	25.3	23.7	24.7	23.0	24.9	26.3	4.2	19.2	58.0	11.8	2.4	3.2	6.3	6.7	7.4	6.5	10.1	4.3	59.5	12.8	9.4	36.8	0.0	7.6	0.6	102.4	9.8	15.2	14.0	9.1	9.3	6.9	14.5	5.2	15.0	3.8	8.8	7.5	12.8	14.0	1.3	3.9	8.9	30.0	4.5	5.0	9.1	31.0	4.1	3.5	1.6	12.0	3.1	4.3	3.6	6.5	4.5	1.9	1.0	8.0	6.7	5.2	53.0	1.2	3.9	7.4	51.6	26.2	11.9	1.8	0.0	4.9	7.9	14.8	9.6	12.2	5.3	6.7	2.0	8.9	63.6	7.1
SIK1	"msk, SNF1LK"	ENSG00000142178	"Salt inducible kinase 1"	P57059	21	43414483-43427131	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Cell cycle, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 88.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 302.0;Basal respiratory cells: 123.5;Langerhans cells: 141.9;Suprabasal keratinocytes: 422.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 35.3;HeLa: 63.1;hTCEpi: 45.4;LHCN-M2: 45.5;U-266/84: 37.7"	"Low region specificity"	"Detected in all"							"CAB023801, HPA038211, HPA078064"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 61: Skin - Cornification"	"Cluster 20: HeLa - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm	Vesicles	"CAB023801: , HPA038211: AB_2675894, HPA078064: "	"unprognostic (4.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.00e-1)"	"unprognostic (5.02e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.30e-3)"	"unprognostic (2.35e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.89e-1)"	"unprognostic (9.94e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.82e-1)"	24.5	8.3	0.7	6.2	0.4	10.5	19.5	0.5	1.8	17.5	0.8	7.0	0.4	4.4	0.0	18.5	18.6	15.1	16.0	0.3	1.1	5.1	20.9	12.7	4.3	1.0	1.0	26.9	11.8	5.9	12.5	12.5	0.8	9.2	0.7	8.5	12.1	13.3	13.0	88.0	5.4	5.3	0.0	7.2	12.2	3.0	0.7	11.0	6.2	1.3	4.6	16.9	14.4	0.5	1.2	3.4	4.3	0.1	0.3	1.6	1.7	2.0	0.7	3.5	2.7	5.1	0.1	5.4	1.5	0.4	19.8	23.6	3.5	35.3	2.0	0.3	1.1	1.6	63.1	2.0	4.8	1.7	0.2	2.1	45.4	0.9	10.7	20.7	0.7	0.1	0.2	0.2	45.5	0.3	0.9	3.9	1.9	0.0	3.4	0.1	0.8	5.7	4.0	13.3	0.1	0.0	24.2	4.0	0.8	0.7	2.3	0.6	8.1	0.9	4.2	0.4	0.1	9.5	37.7	1.0	10.0	4.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.4	0.5	1.8	0.3	1.1	1.0	1.0	0.8	0.0	0.7	0.5	23.7	28.9	77.3	0.0	18.4	302.0	0.8	123.5	26.7	0.3	8.6	6.3	11.7	7.2	68.4	12.9	0.0	0.8	13.4	16.4	0.0	3.2	0.0	23.2	4.8	18.4	27.6	0.0	0.0	2.1	1.3	11.1	15.3	29.1	19.6	2.3	4.2	7.7	1.7	0.0	0.0	16.5	85.5	3.8	141.9	0.1	0.0	10.1	96.0	0.0	1.6	1.3	0.0	0.0	0.0	7.3	24.3	0.0	36.3	0.5	23.8	0.2	50.7	0.2	0.0	2.4	27.4	0.1	0.4	35.1	422.7	2.5	16.4	0.8	20.3	1.2
SIK3	"FLJ12240, KIAA0999, L19, QSK"	ENSG00000160584	"SIK family kinase 3"	Q9Y2K2	11	116843402-117098437	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 375.5;Excitatory neurons: 384.4;Inhibitory neurons: 399.6;Oligodendrocyte precursor cells: 457.9;Oligodendrocytes: 1679.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045245, HPA048161"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA045245: AB_2679270, HPA048161: AB_2680293"	"unprognostic (3.19e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.78e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.12e-5)"	"unprognostic (1.82e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-2)"	10.1	7.2	19.3	11.4	36.6	12.7	9.2	15.0	34.3	9.6	0.0	11.7	8.5	12.6	7.2	10.4	12.4	9.8	12.8	19.7	19.4	10.3	13.8	9.7	9.9	22.0	23.1	16.5	15.4	17.7	10.0	12.1	22.5	8.2	8.8	19.1	9.8	11.3	19.5	7.5	8.7	14.1	11.5	11.8	9.7	21.4	36.1	12.3	17.1	14.4	10.4	10.1	7.5	41.1	11.8	8.9	13.9	14.7	11.7	12.6	22.2	8.8	15.7	6.8	7.6	21.8	13.3	13.9	14.0	16.3	15.0	18.1	11.6	12.7	9.4	38.5	7.4	31.2	9.7	13.6	10.9	11.2	11.8	13.9	7.2	14.5	23.3	8.7	9.2	9.0	15.2	10.1	9.4	4.0	10.2	12.1	7.7	8.0	6.6	12.9	8.0	11.1	9.3	2.2	13.5	10.8	23.7	10.3	4.4	10.5	6.8	11.8	10.6	8.3	10.4	14.0	8.9	7.1	5.6	17.5	7.7	18.2	11.4	2.0	0.4	0.0	0.3	0.5	0.5	0.1	0.3	0.1	0.6	1.0	0.0	0.0	0.9	0.6	1.5	0.0	0.0	0.2	19.3	36.6	15.0	34.3	19.7	19.4	22.0	23.1	22.5	11.5	36.1	41.1	25.8	9.6	22.1	375.5	34.9	26.5	26.0	6.8	7.4	42.6	26.1	21.5	22.2	10.0	12.4	5.5	112.6	8.7	47.3	12.5	5.9	7.6	89.2	64.4	27.9	20.4	17.3	12.4	384.4	7.3	2.8	22.1	12.8	71.5	17.2	37.4	17.2	26.3	7.7	47.1	399.6	11.1	6.1	21.7	45.1	214.9	10.2	31.4	16.0	161.1	25.6	36.3	12.3	457.9	1679.9	9.2	8.2	14.3	28.1	22.0	9.7	6.9	20.5	63.9	0.0	35.0	23.2	18.0	14.8	7.4	24.3	29.7	44.2	14.8	11.4	30.0
SLC10A7	"C4orf13, DKFZp313H0531, DKFZp566M114, DKFZp779O2438, MGC25043"	ENSG00000120519	"Solute carrier family 10 member 7"	Q0GE19	4	146253975-146521964	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 44.4;Microglial cells: 50.6;Oligodendrocyte precursor cells: 62.4;Oligodendrocytes: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039996	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA039996: AB_10673266"	"unprognostic (9.44e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.39e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.55e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.43e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.69e-2)"	"unprognostic (9.57e-2)"	5.4	4.6	2.6	4.9	4.0	6.0	6.0	3.2	2.6	7.2	1.7	7.0	4.6	4.9	12.0	5.8	4.4	5.6	2.9	2.9	3.6	3.8	7.2	5.9	5.6	4.6	3.8	5.6	6.5	3.7	3.6	8.9	4.9	6.3	9.2	3.9	6.9	3.3	2.2	3.7	5.4	5.9	3.8	5.3	9.7	3.4	3.5	6.5	7.0	3.2	5.9	4.7	4.8	5.1	5.2	1.7	12.2	5.0	8.6	10.3	5.8	6.3	8.2	5.7	5.8	4.7	21.6	9.6	4.4	6.9	3.6	5.2	7.2	8.6	6.8	11.1	3.5	11.8	4.2	8.5	5.5	20.5	18.3	4.9	6.8	6.9	8.7	3.1	10.2	10.2	13.2	25.6	4.3	3.6	15.6	5.2	2.2	11.4	8.6	8.6	8.9	13.7	4.0	3.8	3.7	3.1	4.3	12.8	5.3	6.4	7.5	8.1	5.8	5.1	5.4	7.8	4.4	20.7	24.9	13.4	7.0	8.2	7.4	10.9	3.0	4.5	3.7	4.8	3.8	3.9	3.7	3.3	4.0	2.8	3.5	3.4	0.3	5.1	3.9	2.7	4.9	2.2	2.6	4.0	3.2	2.6	2.9	3.6	4.6	3.8	4.9	3.8	3.5	5.1	10.8	3.2	3.9	44.4	7.9	3.3	4.2	2.0	2.8	6.8	5.2	3.7	2.1	8.6	3.2	1.8	4.2	6.4	8.2	6.2	1.9	4.0	2.3	4.8	6.2	5.4	4.8	9.9	34.3	5.1	13.2	6.1	11.2	6.0	22.9	5.8	8.9	10.3	5.8	8.4	37.1	14.7	2.0	7.3	3.1	1.2	7.5	6.1	0.0	50.6	4.9	3.4	6.2	62.4	82.0	3.6	3.4	4.9	15.8	3.3	4.2	1.9	7.3	11.8	0.0	4.0	5.5	7.0	4.5	5.2	4.8	6.2	8.6	2.3	7.6	4.1
SLC11A2	"DCT1, DMT1, NRAMP2"	ENSG00000110911	"Solute carrier family 11 member 2"	P49281	12	50979401-51028566	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032139, HPA032140"	Uncertain		Supported	Mitochondria		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"HPA032139: AB_10964213, HPA032140: AB_10962932"	"unprognostic (4.40e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.07e-6)"	"unprognostic (1.06e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.24e-1)"	12.1	17.0	12.8	14.0	21.6	15.9	30.3	19.6	18.1	29.3	12.7	16.4	53.8	15.7	17.6	23.9	21.4	17.7	14.7	13.2	16.5	22.5	25.6	23.2	10.3	22.8	18.3	12.8	22.6	42.5	10.9	23.7	22.9	24.4	16.2	23.1	31.2	19.3	18.4	20.3	13.8	15.3	19.1	8.7	17.8	13.3	18.5	19.2	41.6	20.3	17.2	20.4	13.9	31.1	19.0	22.4	31.4	28.7	33.5	28.6	106.3	19.7	73.9	19.0	21.8	30.6	35.3	11.8	38.8	22.8	35.7	25.3	26.6	19.2	21.9	17.1	17.4	27.4	29.2	35.5	35.7	19.0	54.5	31.6	24.3	32.7	35.1	45.6	22.8	23.6	24.4	5.6	22.4	21.7	21.8	12.9	46.6	19.8	15.5	14.7	28.6	21.1	23.4	27.7	21.6	19.0	16.3	47.1	20.9	36.2	50.8	12.6	26.8	19.2	15.8	21.5	10.9	14.1	20.4	4.7	54.1	10.2	8.3	0.6	4.7	1.9	4.2	6.8	3.7	2.6	3.3	4.3	7.0	3.3	4.6	4.3	2.3	6.0	4.8	2.9	2.9	3.4	12.8	21.6	19.6	18.1	13.2	16.5	22.8	18.3	22.9	19.1	18.5	31.1	9.8	38.5	46.1	32.7	6.9	15.4	24.8	84.0	22.2	26.6	37.6	18.5	15.5	25.8	69.4	57.0	18.8	27.0	11.9	14.0	3.9	30.6	1.5	31.7	11.6	13.1	16.4	64.8	33.6	28.3	22.5	17.3	15.3	43.6	71.4	20.1	11.4	41.3	35.2	28.6	38.1	14.3	42.7	16.9	25.4	1.7	9.6	30.1	26.6	26.2	15.7	26.5	6.2	51.8	94.5	20.6	15.0	8.6	8.2	47.8	13.2	9.0	109.6	17.8	6.6	14.2	13.2	9.0	12.2	14.3	13.4	19.4	10.7	10.4	15.0	23.1
SLC12A6	"ACCPN, KCC3"	ENSG00000140199	"Solute carrier family 12 member 6"	Q9UHW9	15	34229784-34338060	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"		Neuropathy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 15.2;neutrophil: 23.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 23.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034563	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 57: B-cells - Immune response"	"Vesicles, Cytosol"		"HPA034563: AB_10603887"	"unprognostic (3.53e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.60e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.83e-1)"	"prognostic favorable (3.33e-6)"	"unprognostic (2.39e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.41e-1)"	6.4	4.0	5.9	11.5	7.4	26.8	5.5	7.2	7.9	11.9	2.5	5.5	7.3	5.2	7.0	18.8	4.6	5.2	7.3	6.5	7.3	15.9	3.9	9.1	10.1	8.9	7.3	4.2	3.5	3.1	5.6	4.3	9.3	3.5	6.1	31.1	6.4	3.8	10.6	7.6	9.1	4.9	6.6	12.9	6.7	25.9	7.7	15.5	9.0	10.9	11.6	8.3	17.6	8.4	4.4	5.2	3.1	4.7	10.0	11.4	2.4	5.9	15.1	4.9	7.1	3.1	7.2	3.1	5.9	7.2	4.3	44.0	7.9	5.3	5.8	1.2	5.1	24.6	14.0	7.0	6.4	14.5	24.6	6.9	9.1	14.1	29.1	10.9	14.9	6.8	5.4	6.8	6.7	1.6	1.6	11.0	2.4	3.8	5.7	7.1	5.5	3.3	5.5	11.2	7.2	5.0	7.1	0.2	1.5	7.1	2.8	4.8	9.4	5.9	4.2	21.0	1.4	6.4	6.8	1.9	6.6	10.5	2.2	15.2	1.4	2.6	0.6	1.8	0.4	1.4	0.9	0.9	0.9	2.4	1.6	1.4	23.4	0.7	0.8	1.0	3.2	1.0	5.9	7.4	7.2	7.9	6.5	7.3	8.9	7.3	9.3	6.6	7.7	8.4	16.4	22.4	21.0	30.0	32.0	1.1	4.5	1.5	7.4	15.3	5.2	4.3	8.7	5.7	4.2	5.5	85.5	3.2	11.5	8.6	0.0	5.6	15.6	9.8	7.4	17.7	6.7	35.9	47.7	4.7	1.6	7.0	17.9	22.4	5.1	8.4	16.1	7.5	13.2	8.4	52.0	7.0	2.0	37.1	3.8	8.3	8.1	25.6	0.0	50.6	34.5	8.7	15.5	40.7	58.4	13.1	9.7	8.6	29.9	6.5	18.3	16.4	4.2	56.6	19.7	7.0	4.0	39.9	21.2	14.8	0.9	1.1	18.0	4.1	7.4	43.6
SLC12A8	CCC9	ENSG00000221955	"Solute carrier family 12 member 8"	A0AV02	3	125082636-125212864	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 22.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 23.9;Excitatory neurons: 38.4;granulocytes: 17.8;Inhibitory neurons: 27.8;Intestinal goblet cells: 36.6;Oligodendrocyte precursor cells: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.6;HHSteC: 33.6;OE19: 27.6;U-2197: 67.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031123	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm		"HPA031123: AB_2301872"	"unprognostic (4.74e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.35e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.13e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.78e-2)"	1.5	1.1	2.9	1.2	3.2	0.0	2.3	1.0	3.1	1.4	11.7	3.5	5.6	0.6	3.6	4.1	2.0	8.3	0.6	3.4	2.4	3.2	6.8	2.2	0.6	1.6	2.0	0.3	10.0	4.3	2.2	2.7	1.9	2.8	4.2	0.1	11.9	0.6	0.1	1.3	3.6	0.7	1.0	0.3	4.1	2.3	2.0	0.5	22.9	0.0	0.9	2.1	2.2	2.0	14.7	0.0	2.7	0.0	3.3	4.6	6.7	0.8	2.0	0.9	1.7	19.6	6.8	0.0	1.9	5.6	2.8	8.5	0.0	0.0	0.5	0.0	0.0	0.0	7.2	0.0	33.6	0.0	1.0	8.7	8.3	1.9	0.9	16.3	0.0	0.0	0.0	0.6	1.3	3.9	0.0	0.0	9.3	27.6	0.7	0.0	0.2	0.0	6.8	1.3	4.2	0.0	7.0	8.4	0.1	0.9	15.6	0.4	0.2	0.2	1.3	67.9	0.0	0.1	1.9	5.0	3.3	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.2	1.0	3.1	3.4	2.4	1.6	2.0	1.9	1.0	2.0	2.0	0.2	0.0	0.5	7.2	0.1	1.0	1.3	3.3	3.4	0.0	5.6	4.3	1.1	2.8	2.5	23.9	0.0	0.5	0.1	1.6	0.0	3.9	0.3	0.8	1.4	0.3	5.4	0.0	38.4	3.5	6.5	2.1	7.7	2.7	17.8	1.8	0.0	9.4	0.9	0.0	27.8	36.6	0.0	0.0	0.7	0.5	0.0	0.5	0.0	7.5	2.1	0.0	1.0	31.7	2.0	2.9	3.4	0.0	0.2	6.2	2.6	1.5	0.4	0.0	0.0	0.2	0.7	0.6	0.4	4.3	0.3	3.0	0.8	0.1	5.6	1.0
SLC13A3	"NADC3, SDCT2"	ENSG00000158296	"Solute carrier family 13 member 3"	Q8WWT9	20	46557823-46684467	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"kidney: 407.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.8;Cytotrophoblasts: 106.6;Excitatory neurons: 65.0;Oligodendrocytes: 178.1;Proximal tubular cells: 245.9;Syncytiotrophoblasts: 79.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.1;EFO-21: 18.8;Hep G2: 56.1;HHSteC: 18.4;K-562: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014333, HPA014353, HPA014736"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA014333: AB_2732407, HPA014353: AB_1856968, HPA014736: AB_1856970"	"unprognostic (1.07e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	1.3	2.4	12.5	0.7	22.8	0.2	1.9	16.5	16.1	2.0	4.9	0.8	0.3	1.8	1.0	0.9	2.4	1.9	1.0	10.1	16.2	407.6	21.7	1.4	0.6	18.3	19.5	4.5	9.0	0.2	2.6	43.2	19.0	6.3	0.5	1.1	4.9	0.8	1.0	2.2	0.4	1.9	12.5	0.6	4.7	8.7	19.9	1.1	1.4	0.3	0.7	1.8	1.4	37.4	0.1	0.0	1.6	5.6	8.3	7.7	16.1	3.5	2.0	1.9	1.4	0.0	0.1	0.2	18.8	0.2	0.1	2.1	0.1	2.6	4.5	0.0	0.6	6.8	0.4	56.1	18.4	0.1	4.8	10.5	7.5	10.9	5.4	5.4	0.0	0.0	15.3	0.3	0.0	0.6	0.1	0.7	10.3	0.2	0.0	0.2	0.0	0.1	1.2	0.4	0.7	0.2	0.0	4.0	0.8	1.0	2.9	0.3	0.2	0.1	4.0	8.7	0.1	0.5	1.2	0.1	0.6	0.0	0.4	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.5	0.0	0.0	12.5	22.8	16.5	16.1	10.1	16.2	18.3	19.5	19.0	12.5	19.9	37.4	0.3	0.0	2.2	53.8	3.8	1.3	1.0	0.8	6.2	0.7	1.2	1.7	1.7	0.0	0.5	7.3	0.0	106.6	0.0	0.1	15.6	0.2	23.3	0.5	2.0	0.6	0.0	0.0	65.0	0.9	7.1	2.3	3.1	0.8	0.0	3.0	0.4	17.5	9.5	0.0	40.3	0.0	0.0	0.3	0.7	27.8	3.1	2.0	0.0	11.2	0.0	0.4	0.0	24.1	178.1	0.9	0.0	0.4	1.2	3.5	0.0	245.9	6.4	0.2	0.0	0.4	1.0	6.6	1.2	1.2	0.6	79.4	1.5	2.2	0.0	0.6
SLC13A5	"INDY, NACT"	ENSG00000141485	"Solute carrier family 13 member 5"	Q86YT5	17	6684719-6713377	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 414.0"	"Cell type enriched"	"Detected in some"	15	"Hepatocytes: 381.0"	"Cancer enriched"	"Detected in some"	15	"liver cancer: 27.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	79	"Hep G2: 58.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044343	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044343: AB_10961771"	"unprognostic (8.46e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.78e-11)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.04e-1)"	0.3	2.7	4.8	0.0	7.0	0.0	0.3	4.8	8.0	0.3	2.7	0.0	0.0	0.3	0.0	1.1	2.1	0.0	0.1	5.3	7.9	0.7	414.0	0.0	0.2	6.8	6.1	0.6	0.3	0.0	0.8	0.0	5.4	0.0	0.0	1.7	38.0	0.0	0.0	0.1	0.0	0.0	4.8	3.3	0.0	2.3	8.4	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	58.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	7.0	4.8	8.0	5.3	7.9	6.8	6.1	5.4	4.8	8.4	3.9	0.4	0.0	0.0	24.8	4.8	0.5	0.6	0.6	1.2	0.6	0.1	0.1	0.9	7.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	1.9	0.0	24.0	0.3	0.5	0.1	0.4	0.0	0.1	0.0	0.9	16.8	381.0	0.0	0.0	0.2	0.0	0.0	23.2	1.1	0.4	0.6	0.3	0.0	1.9	0.0	7.0	0.0	1.5	0.1	16.9	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.6	0.0	0.5	0.5	2.4	2.8	1.2	0.4	0.1	1.0	7.8	0.0	0.3
SLC16A1	"MCT, MCT1"	ENSG00000155380	"Solute carrier family 16 member 1"	P53985	1	112911847-112957593	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 158.4;Granulosa cells: 322.8;Muller glia cells: 184.8;Rod photoreceptor cells: 277.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 6.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003324, CAB017489, HPA071055, CAB079035"	Enhanced	Supported	Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cell Junctions"		"CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: AB_2686337"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (1.53e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavorable (4.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (1.30e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-3)"	20.7	10.4	35.7	11.8	36.1	4.3	7.5	37.8	99.4	7.1	37.8	46.8	32.5	28.6	22.8	15.3	13.1	14.8	67.9	33.5	35.2	11.4	55.6	4.9	9.5	38.6	35.9	7.9	2.0	10.0	5.2	34.0	37.0	14.4	35.3	68.9	3.5	11.2	67.5	13.0	16.6	39.2	37.0	6.6	26.6	29.8	38.3	11.7	8.6	59.6	11.6	11.9	7.1	38.2	111.1	24.0	86.9	74.3	61.9	52.1	272.7	64.6	51.1	52.0	80.9	85.4	67.1	113.8	82.3	61.6	32.6	113.1	126.3	124.8	96.8	75.6	105.2	108.9	63.4	112.9	104.6	123.2	9.9	72.2	144.6	75.7	146.4	79.2	131.4	53.8	131.3	78.0	61.9	19.9	70.2	70.1	271.4	36.7	74.5	67.9	130.7	92.8	67.3	1.9	86.9	46.5	121.8	3.8	97.5	130.0	3.7	48.9	80.9	45.4	72.0	89.3	93.1	39.7	33.9	116.7	137.1	78.5	56.0	0.0	1.4	0.0	1.5	1.6	1.7	0.9	1.8	2.0	2.5	0.3	0.8	1.5	0.1	0.6	0.3	0.2	6.1	0.8	35.7	36.1	37.8	99.4	33.5	35.2	38.6	35.9	37.0	37.0	38.3	38.2	15.1	0.0	2.6	8.5	16.5	89.3	6.5	39.9	87.6	16.9	16.5	9.9	126.3	10.0	5.7	0.0	158.4	77.4	20.3	99.8	0.0	2.5	107.2	14.3	70.7	22.8	3.5	20.2	9.8	3.3	67.6	32.8	67.2	35.8	8.9	322.8	6.4	37.5	15.4	20.2	11.6	17.3	20.3	9.0	15.7	118.3	11.8	12.8	39.2	20.6	4.3	184.8	0.0	9.0	23.8	7.4	7.7	7.5	25.5	16.5	9.3	10.8	3.9	277.5	0.0	38.2	22.1	45.3	23.6	29.6	39.5	46.0	20.9	49.6	23.3	1.3
SLC16A11	"FLJ90193, MCT11"	ENSG00000174326	"Solute carrier family 16 member 11"	Q8NCK7	17	7041621-7044092	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid metabolism, Symport, Transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 13.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Muller glia cells: 32.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 12.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	8	"B-cells: 1.0;T-cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 18: Non-specific - Mitochondria"		"Cluster 5: Muller glia cells - Visual perception"				"unprognostic (4.65e-4)"	"unprognostic (9.40e-3)"	"unprognostic (6.10e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.97e-5)"	"unprognostic (5.22e-3)"	"prognostic favorable (2.56e-4)"	"unprognostic (2.22e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.58e-1)"	"prognostic favorable (1.45e-5)"	"unprognostic (1.30e-2)"	"prognostic favorable (3.19e-7)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.83e-2)"	1.5	0.7	1.4	0.3	1.4	0.0	3.7	2.2	1.9	1.9	7.1	1.3	0.4	1.3	1.4	2.3	12.8	0.4	3.0	1.4	2.0	4.7	9.6	2.8	0.4	1.6	1.8	2.6	4.0	5.4	4.8	0.0	2.0	3.1	0.0	0.2	10.4	1.9	0.5	6.0	1.8	0.0	2.1	1.8	1.3	0.8	1.1	0.2	13.5	0.1	0.2	0.9	1.8	1.8	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.9	0.6	0.3	1.4	0.0	1.0	0.7	1.3	0.0	0.1	0.0	0.0	0.0	0.2	1.4	1.4	2.2	1.9	1.4	2.0	1.6	1.8	2.0	2.1	1.1	1.8	9.8	12.8	8.4	2.6	5.9	1.8	5.4	4.0	4.6	0.4	7.0	8.8	2.6	8.6	8.3	7.3	0.0	0.0	3.0	0.2	1.9	3.9	0.3	0.4	0.1	4.0	9.6	0.0	0.6	1.3	0.0	1.7	0.0	0.2	0.0	0.0	1.4	5.0	0.0	0.0	0.3	1.2	6.1	0.3	0.4	0.7	6.8	0.4	3.6	0.0	0.4	32.0	9.2	2.0	0.1	0.1	0.1	4.9	1.1	3.1	0.0	1.5	6.5	1.9	0.0	1.2	1.3	1.5	1.2	5.9	3.1	0.1	3.9	0.4	1.4	7.9
SLC16A12	MCT12	ENSG00000152779	"Solute carrier family 16 member 12"	Q6ZSM3	10	89430299-89556641	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"		Cataract	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"choroid plexus: 92.2;epididymis: 51.8;kidney: 85.2;pancreas: 25.3"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 18.1;Leydig cells: 27.1;Peritubular cells: 26.7;Proximal tubular cells: 69.2"	"Cancer enriched"	"Detected in many"	10	"renal cancer: 18.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC TERT1: 23.0;HSkMC: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037587			Approved	Mitochondria		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA037587: AB_2732475"	"unprognostic (5.38e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.51e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.60e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (4.50e-12)"	"unprognostic (3.84e-2)"	"unprognostic (7.91e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.84e-3)"	1.8	2.5	0.8	0.1	1.1	0.0	1.9	1.0	2.7	9.2	92.2	0.8	0.1	1.4	51.8	0.3	4.1	0.1	4.9	2.9	0.3	85.2	2.0	2.5	0.1	0.5	1.6	1.3	25.3	0.1	3.4	11.6	0.6	0.6	0.2	0.0	0.4	14.1	1.6	0.5	0.3	0.3	1.2	0.0	1.0	3.3	1.0	0.4	6.2	2.5	0.0	0.4	0.7	0.6	0.2	0.0	0.0	0.0	3.0	23.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.5	0.0	3.7	0.0	0.0	8.2	0.2	1.2	1.5	2.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	2.8	0.0	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	1.1	1.0	2.7	2.9	0.3	0.5	1.6	0.6	1.2	1.0	0.6	0.8	3.2	3.9	3.3	0.6	0.0	2.2	0.1	0.0	0.1	4.6	0.1	3.3	1.5	2.9	14.7	0.0	16.4	0.1	0.0	15.6	0.0	8.3	11.5	0.8	1.3	18.1	0.0	0.3	4.1	1.1	2.2	0.0	1.0	1.3	0.0	0.4	2.2	1.2	3.3	0.4	0.2	0.0	0.0	0.9	4.8	27.1	1.0	0.0	11.2	0.1	0.0	0.0	0.0	0.4	2.1	0.1	26.7	0.0	0.7	0.0	69.2	6.2	0.6	13.1	3.4	7.8	0.2	0.5	0.0	0.3	9.0	0.9	0.1	0.0	1.8
SLC16A13	MCT13	ENSG00000174327	"Solute carrier family 16 member 13"	Q7RTY0	17	7036015-7040117	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 36.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 8.2;NK-cells: 6.2;Squamous epithelial cells: 7.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 22.8;GAMG: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065245			Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"	Cytosol	"HPA065245: AB_2685443"	"unprognostic (5.61e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (2.44e-2)"	"unprognostic (7.31e-3)"	"unprognostic (9.70e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.14e-1)"	1.4	1.0	1.1	2.1	0.8	0.4	1.4	1.8	1.1	1.8	1.0	2.2	9.2	0.8	1.3	5.3	1.8	3.7	1.6	0.9	1.0	6.8	36.1	2.4	2.8	1.2	1.2	0.5	1.2	2.9	0.8	1.5	1.0	1.4	1.6	0.3	3.3	0.8	0.4	5.3	5.5	0.9	0.9	3.5	1.9	0.5	1.0	1.8	3.3	0.2	2.5	1.2	2.6	0.8	13.1	22.8	5.3	3.2	3.2	1.8	2.2	1.3	3.3	2.9	6.5	7.4	14.3	8.3	2.2	2.1	26.2	20.1	4.1	7.0	1.2	10.3	2.9	3.4	1.8	18.0	3.6	1.2	7.6	2.1	7.8	4.3	3.5	3.9	11.9	7.4	4.0	2.3	3.1	6.5	5.1	2.1	2.2	6.6	1.8	2.4	1.8	1.4	2.7	3.6	0.2	1.4	4.0	2.2	1.8	7.8	6.1	1.8	4.5	1.8	4.1	3.0	1.9	4.0	8.9	0.5	5.4	3.0	0.8	0.0	0.8	1.0	1.2	0.8	0.9	1.1	1.0	1.5	0.8	2.5	1.1	1.1	0.9	1.2	0.9	1.1	1.2	0.5	1.1	0.8	1.8	1.1	0.9	1.0	1.2	1.2	1.0	0.9	1.0	0.8	2.3	0.0	1.5	0.7	5.1	0.5	0.9	1.3	4.0	0.4	1.6	0.9	0.4	1.5	0.8	5.5	0.0	1.9	2.4	1.1	0.0	1.0	0.0	0.5	0.5	2.8	0.0	0.4	1.8	0.2	0.4	0.6	4.1	0.7	3.8	1.1	2.2	8.2	0.5	3.3	1.1	1.2	2.0	0.6	3.1	0.0	0.9	1.6	0.0	1.0	1.4	0.9	6.2	0.5	0.0	0.5	0.1	0.0	2.9	0.9	2.4	1.9	1.4	0.5	0.0	0.3	1.1	0.0	0.0	7.4	1.6	2.5	4.7	0.5	1.0	1.0
SLC16A2	"AHDS, DXS128, MCT7, MCT8, MRX22, XPCT"	ENSG00000147100	"Solute carrier family 16 member 2"	P36021	X	74421493-74533917	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 40.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.2;Hepatocytes: 63.7;Inhibitory neurons: 21.6;Oligodendrocyte precursor cells: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 83.9;GAMG: 70.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072719			Approved	"Plasma membrane"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA072719: AB_2686552"	"prognostic unfavorable (8.88e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavorable (3.16e-4)"	13.8	24.7	4.6	4.8	5.8	0.0	5.4	1.7	5.7	9.4	1.2	7.0	3.3	10.3	1.7	2.9	9.3	6.0	10.4	7.7	4.9	7.9	40.7	7.5	0.9	5.6	3.9	12.8	5.5	11.7	9.8	9.2	1.8	6.2	1.8	1.1	5.0	5.8	2.7	2.5	3.1	6.9	3.5	1.2	4.7	0.9	8.1	5.7	12.6	3.7	1.8	6.6	6.2	3.0	8.4	10.4	7.2	43.1	20.8	11.1	0.0	83.9	29.7	38.2	20.6	0.1	0.9	0.0	1.3	37.5	70.8	1.7	1.1	40.2	22.1	6.1	3.6	0.0	0.0	0.0	1.5	0.0	0.0	16.5	9.5	19.3	23.3	14.6	0.1	0.1	0.0	0.0	9.1	0.0	0.5	2.7	27.2	0.0	7.8	17.4	19.9	0.0	18.0	0.1	1.9	12.0	9.6	50.2	0.3	2.5	0.6	1.1	0.0	32.5	8.8	35.7	41.9	0.0	0.0	0.0	34.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	5.8	1.7	5.7	7.7	4.9	5.6	3.9	1.8	3.5	8.1	3.0	5.6	0.0	0.6	22.2	0.2	0.8	4.3	2.4	0.6	5.7	4.3	3.4	4.5	8.6	2.9	3.7	0.0	5.7	0.1	0.0	3.9	4.3	0.1	0.3	9.8	6.1	8.4	0.0	14.5	2.4	4.9	11.8	0.5	0.5	2.5	1.7	3.6	63.7	1.0	3.3	21.6	0.3	0.0	1.3	0.8	1.2	15.2	0.1	3.6	15.9	0.6	6.2	0.0	23.1	7.1	4.6	0.0	20.7	0.1	5.1	0.4	4.7	2.4	1.5	13.1	9.7	5.6	0.1	0.1	0.9	1.3	2.1	0.4	1.4	0.2	4.9
SLC17A5	"AST, ISSD, NSD, SD, SIALIN, SIASD, SLD"	ENSG00000119899	"Solute carrier family 17 member 5"	Q9NRA2	6	73593379-73653992	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"parathyroid gland: 310.5"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"thyroid cancer: 47.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 99.9;ASC TERT1: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044479			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Cytosol"		"HPA044479: "	"unprognostic (6.48e-3)"	"unprognostic (7.95e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-3)"	"unprognostic (4.44e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.09e-1)"	10.4	10.5	5.9	6.4	6.0	6.8	13.8	6.2	7.0	10.7	5.9	20.4	16.4	9.4	44.6	8.4	5.3	10.4	8.5	6.5	8.5	31.9	17.6	13.2	5.3	6.5	7.0	4.0	11.6	310.5	9.9	21.7	7.8	16.8	22.1	18.3	30.3	14.7	5.4	7.1	21.1	10.6	5.7	7.0	14.4	6.1	7.1	4.5	43.5	6.2	5.6	12.6	6.3	7.6	7.4	9.9	9.7	15.6	99.9	74.2	12.8	23.8	59.4	6.3	22.0	6.6	17.6	6.8	11.2	32.9	14.8	12.6	13.7	5.9	11.2	4.8	15.5	2.8	5.1	15.4	19.4	5.6	10.8	34.2	8.8	14.2	9.7	26.4	16.2	9.0	7.1	7.2	22.3	4.9	2.3	3.3	7.1	30.9	5.7	5.0	12.1	28.5	16.0	20.2	3.8	6.7	4.8	14.0	14.4	14.0	6.3	34.1	23.5	3.0	2.8	12.1	5.7	20.4	30.6	1.9	10.5	11.6	9.0	13.3	7.9	3.3	6.0	7.4	5.8	3.9	6.6	5.8	7.6	2.4	5.4	6.0	5.7	8.9	4.8	5.5	6.6	4.9	5.9	6.0	6.2	7.0	6.5	8.5	6.5	7.0	7.8	5.7	7.1	7.6	8.8	22.4	20.7	16.3	8.2	9.6	13.2	13.7	5.7	8.2	22.6	5.5	6.8	18.6	17.4	51.5	29.2	19.4	11.0	46.4	3.9	14.2	36.6	16.6	7.8	13.8	12.1	3.8	47.7	13.7	13.5	25.8	14.8	19.6	14.5	3.2	23.9	32.9	64.6	0.0	46.8	47.7	20.3	24.8	22.7	48.3	7.5	25.4	10.6	14.0	11.2	8.3	13.4	17.6	16.3	19.2	17.5	11.3	20.6	29.1	23.9	36.3	21.5	28.9	0.0	10.5	9.1	8.4	3.6	10.2	11.2	22.8	11.0	2.9	19.2	30.7
SLC17A8	"DFNA25, VGLUT3"	ENSG00000179520	"Solute carrier family 17 member 8"	Q8NDX2	12	100357074-100422055	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Hearing, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 11.3;intestine: 5.2"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 13.3;Proximal enterocytes: 43.1"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Group enriched"	"Detected in many"	5	"basal ganglia: 11.3;midbrain: 8.3;pons: 6.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			CAB079058		Supported				NA	NA				"Cluster 45: Intestine - Brush border"		"Cluster 45: Enterocytes - Digestion"			"CAB079058: "	"unprognostic (4.52e-3)"			"unprognostic (2.18e-1)"	"unprognostic (8.56e-2)"		"unprognostic (1.32e-3)"	"unprognostic (3.65e-1)"		"unprognostic (7.67e-2)"	"unprognostic (1.25e-1)"		"unprognostic (1.71e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.55e-1)"			0.0	0.0	0.4	0.0	11.3	0.0	0.0	0.0	1.6	0.0	0.7	0.4	0.7	0.1	0.0	0.0	0.3	0.0	0.0	0.4	1.3	0.0	0.5	0.0	0.0	0.4	8.3	0.0	0.0	0.0	0.0	0.3	6.5	0.0	0.3	1.2	0.0	0.0	0.0	0.0	5.2	0.0	0.2	0.0	0.0	0.1	1.6	1.4	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.3	0.0	1.6	0.4	1.3	0.4	8.3	6.5	0.2	1.6	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	13.3	0.1	0.1	0.0	0.0	0.4	0.0	3.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	6.6	1.1	0.0	3.2	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	1.5	0.2	0.0	1.7	0.0	0.0	0.0	43.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0
SLC17A9	"C20orf59, FLJ23412, VNUT"	ENSG00000101194	"Solute carrier family 17 member 9"	Q9BYT1	20	62952707-62969585	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Exocytosis, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 43.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 18.2;Gastric mucus-secreting cells: 29.0;Hepatocytes: 48.8;Hofbauer cells: 18.0;Intestinal goblet cells: 19.7;Plasma cells: 38.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 4.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 35.7;CACO-2: 32.9;Hep G2: 69.5;NB-4: 39.0;RPMI-8226: 36.1;U-937: 43.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA047470			Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA047470: AB_2680060"	"unprognostic (2.65e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.33e-3)"	"unprognostic (5.33e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (2.78e-15)"	"unprognostic (6.06e-3)"	"unprognostic (5.51e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.06e-1)"	1.3	1.0	0.3	5.8	0.5	11.4	1.3	0.7	0.7	1.9	0.7	3.7	5.5	1.5	0.2	0.8	1.9	1.3	1.3	0.6	0.8	0.9	43.0	3.5	5.2	1.2	0.9	1.7	1.4	0.0	2.2	1.7	1.3	1.3	3.1	0.0	4.0	0.6	1.0	0.7	4.2	1.4	0.9	11.1	9.5	0.4	1.2	0.7	1.2	0.1	4.2	2.7	1.7	2.0	0.0	0.0	0.0	0.2	0.3	3.1	0.1	35.7	10.0	11.4	18.0	32.9	0.0	25.9	0.0	28.3	0.0	0.0	5.0	0.0	2.8	0.0	0.0	11.5	0.9	69.5	7.7	20.9	0.0	2.5	0.0	13.6	0.0	0.0	7.6	0.1	0.1	14.6	0.0	0.0	0.9	39.0	0.0	12.9	0.2	26.9	0.0	36.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	19.4	2.6	0.0	0.0	1.2	0.0	5.0	0.3	14.2	0.0	43.8	0.0	0.0	0.9	0.0	0.7	1.7	0.5	2.2	0.0	0.4	2.6	1.7	0.0	0.3	0.0	4.9	0.3	0.0	0.1	0.7	0.3	0.5	0.7	0.7	0.6	0.8	1.2	0.9	1.3	0.9	1.2	2.0	1.1	0.0	1.1	0.0	18.2	0.9	0.2	0.3	0.0	0.4	1.0	1.0	1.3	12.8	1.0	0.0	0.0	0.3	5.5	6.4	0.0	0.3	0.7	2.6	7.3	1.4	3.0	1.7	0.7	0.4	0.9	4.0	29.0	2.5	5.1	2.4	1.4	48.8	18.0	0.0	0.4	19.7	0.0	5.1	12.4	0.6	1.2	7.2	5.4	2.8	1.3	0.1	4.1	1.0	0.1	1.7	3.1	0.7	38.6	0.6	0.2	0.4	0.8	0.1	0.0	1.6	4.2	0.4	1.0	0.0	1.1	0.8	3.6	3.8	9.3	0.6
SLC18A3	VACHT	ENSG00000187714	"Solute carrier family 18 member A3"	Q16572	10	49610310-49612720	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"brain: 25.6"	"Cell type enriched"	"Detected in some"	4	"Fibroblasts: 7.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 7.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"spinal cord: 78.1"	CAB079011		Supported				NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"CAB079011: "				"unprognostic (2.14e-4)"	"unprognostic (1.55e-1)"			"unprognostic (1.01e-1)"		"unprognostic (9.39e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-1)"		"unprognostic (5.85e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.16e-1)"		0.0	0.0	0.7	0.3	2.0	0.0	0.0	0.0	19.7	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	18.9	8.0	0.0	0.0	0.0	1.2	0.4	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	3.6	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	6.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	7.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.0	0.0	19.7	0.1	4.9	18.9	8.0	25.6	3.6	0.7	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0
SLC19A2	"THTR1, TRMA"	ENSG00000117479	"Solute carrier family 19 member 2"	O60779	1	169463909-169485944	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 124.1;tongue: 84.9"	"Cell type enhanced"	"Detected in many"		"Skeletal myocytes: 84.5;Syncytiotrophoblasts: 156.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006119, HPA016599"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA006119: AB_1079996, HPA016599: AB_1857005"	"prognostic favorable (8.41e-4)"	"unprognostic (8.82e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.29e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (4.45e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (2.70e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-2)"	42.2	17.8	3.0	8.3	3.1	8.7	20.9	5.1	4.2	10.5	9.3	11.8	3.5	8.6	6.1	11.3	21.3	25.8	31.2	4.0	3.6	13.0	37.1	19.5	2.6	4.9	3.7	20.5	22.2	24.8	19.0	18.1	4.0	10.5	4.3	7.5	12.5	3.8	124.1	16.5	11.4	6.1	3.7	2.8	19.2	7.8	4.2	4.1	15.7	84.9	2.8	18.1	12.9	3.5	7.4	5.1	11.4	9.0	34.4	12.7	25.0	5.8	4.3	4.6	6.5	20.9	7.6	6.5	6.4	3.9	8.5	7.7	13.9	8.5	5.1	18.8	13.0	6.2	16.7	19.3	18.7	15.8	5.9	15.0	12.2	7.4	18.8	6.4	7.0	11.3	25.3	4.1	7.9	5.0	8.2	7.1	25.8	14.1	7.7	0.0	24.6	7.5	12.2	15.5	9.9	13.3	8.0	13.6	29.2	12.8	8.5	10.1	5.8	5.5	7.7	6.9	11.4	5.6	5.6	2.1	8.1	6.0	7.4	0.0	0.6	1.1	0.3	0.2	1.1	0.4	0.4	0.7	0.7	0.4	1.0	1.0	0.4	0.9	2.0	0.2	0.3	0.2	3.0	3.1	5.1	4.2	4.0	3.6	4.9	3.7	4.0	3.7	4.2	3.5	13.6	9.6	19.3	11.8	7.3	29.6	16.5	4.4	43.9	5.3	34.1	13.6	27.7	7.2	11.4	5.5	2.1	26.9	11.3	10.6	0.0	7.4	4.3	22.6	9.7	3.7	9.0	5.2	15.6	5.3	4.5	52.7	49.5	42.7	10.2	4.1	1.1	29.8	7.0	6.7	22.8	6.4	12.2	2.9	8.8	2.7	6.8	18.3	21.4	7.5	1.0	2.5	2.1	16.1	3.3	9.6	5.4	4.9	14.0	16.5	5.6	2.0	12.7	5.1	0.0	84.5	14.2	6.7	4.1	35.2	50.4	156.4	7.5	3.1	6.7	28.9
SLC19A3	THTR2	ENSG00000135917	"Solute carrier family 19 member 3"	Q9BZV2	2	227683763-227718028	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 46.7;breast: 28.4;placenta: 24.1"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 65.4;Syncytiotrophoblasts: 160.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 6.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 13.9;BEWO: 6.2;CACO-2: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038898	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA038898: AB_10673481"	"unprognostic (3.37e-2)"	"unprognostic (3.59e-5)"	"unprognostic (1.95e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.12e-3)"	"unprognostic (7.28e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.71e-2)"	"unprognostic (7.01e-3)"	46.7	0.6	5.0	1.9	3.3	1.2	28.4	4.7	4.3	0.5	1.0	2.6	9.1	0.5	0.1	0.7	0.5	5.7	0.7	3.4	4.4	2.2	13.8	4.1	0.8	5.2	4.2	0.9	1.7	0.1	0.1	24.1	5.4	0.3	1.8	2.2	1.1	0.1	0.9	1.6	5.6	0.4	4.4	0.5	0.5	0.5	5.7	0.2	0.4	0.8	0.4	1.0	0.4	4.0	0.3	0.9	0.2	0.8	13.9	0.3	6.2	0.1	0.2	0.2	0.6	20.2	0.4	0.2	0.1	0.1	4.6	0.4	0.6	0.5	0.8	0.0	1.0	0.1	1.1	0.8	1.8	0.2	0.1	3.4	0.4	0.1	0.8	0.3	0.0	0.3	0.1	0.6	0.0	1.6	0.1	0.5	3.0	0.7	0.1	0.3	0.1	0.2	0.2	0.2	0.9	0.1	0.3	1.9	0.5	2.6	0.2	0.2	0.6	0.4	0.4	4.1	0.4	0.1	0.1	0.6	1.4	0.2	0.5	6.8	0.8	1.0	0.4	0.6	0.3	0.8	0.4	0.4	0.2	1.3	0.5	0.5	3.3	2.2	0.7	1.0	0.2	0.3	5.0	3.3	4.7	4.3	3.4	4.4	5.2	4.2	5.4	4.4	5.7	4.0	0.2	9.6	5.1	2.3	0.0	0.0	0.5	0.0	0.6	5.3	0.2	0.1	0.4	5.7	0.0	1.8	0.0	65.4	0.1	5.7	1.9	4.4	0.3	0.1	0.0	2.6	1.2	0.0	0.4	0.0	7.4	3.2	0.0	0.1	0.0	0.3	0.0	13.1	5.1	0.0	0.9	1.6	0.0	0.6	0.0	0.7	0.3	0.9	0.0	25.3	0.0	0.8	0.0	4.5	0.3	0.4	1.0	0.0	0.1	0.4	9.3	3.0	0.0	0.2	0.0	1.7	1.6	0.0	0.3	0.0	0.0	160.6	0.2	0.1	6.5	0.4
SLC1A1	"EAAC1, EAAT3"	ENSG00000106688	"Solute carrier family 1 member 1"	P43005	9	4490468-4587469	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 45.0;intestine: 64.7;kidney: 51.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 163.5;Glandular and luminal cells: 98.7;Hepatocytes: 68.4;Microglial cells: 67.5;Oligodendrocyte precursor cells: 161.4;Proximal enterocytes: 110.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 29.1;HDLM-2: 70.9;HUVEC TERT2: 32.5;RPTEC TERT1: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062356	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA062356: "	"unprognostic (1.28e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.25e-2)"	"prognostic favorable (2.86e-8)"	"unprognostic (2.68e-1)"	"unprognostic (9.49e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.64e-1)"	4.6	1.7	13.2	2.3	15.4	0.1	4.1	9.5	14.8	5.8	12.9	12.4	34.8	3.7	45.0	2.3	2.6	25.5	2.8	16.5	12.6	51.0	41.2	20.9	2.6	10.8	13.0	0.6	2.1	0.3	6.8	8.1	13.6	6.3	10.2	6.0	4.8	3.2	1.4	1.5	64.7	3.2	10.9	0.4	5.2	0.8	13.9	0.4	29.5	1.3	8.2	5.6	1.5	10.1	0.1	2.0	1.6	9.5	24.3	29.1	8.3	10.4	21.4	3.2	3.1	17.2	0.5	13.7	0.6	5.4	3.9	0.0	3.6	5.7	2.9	70.9	4.5	0.0	13.6	0.1	0.8	0.9	0.0	2.0	0.2	12.1	0.0	1.6	32.5	0.2	0.0	0.0	2.2	0.3	0.0	0.3	4.2	10.5	1.8	0.0	0.0	0.2	66.4	6.1	2.2	2.0	0.8	3.8	0.0	7.7	1.4	0.5	17.6	4.9	0.4	9.5	3.0	0.1	0.1	0.0	23.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	13.2	15.4	9.5	14.8	16.5	12.6	10.8	13.0	13.6	10.9	13.9	10.1	12.2	163.5	3.2	4.2	0.4	0.0	1.1	0.6	4.6	3.9	2.0	0.8	2.3	28.6	6.1	0.0	0.0	0.1	0.0	52.4	3.9	8.1	4.3	10.7	13.3	10.6	0.0	0.0	48.4	0.8	0.0	1.8	2.0	98.7	0.0	0.6	2.5	68.4	0.1	0.0	50.3	10.1	0.0	1.3	0.3	11.2	0.3	1.1	0.0	67.5	0.0	0.8	0.0	161.4	3.5	9.3	10.6	0.0	0.0	2.4	110.6	43.1	3.3	1.1	0.0	0.5	3.1	0.1	0.2	1.0	0.6	0.1	1.4	0.4	8.5	1.8
SLC1A2	"EAAT2, GLT-1"	ENSG00000110436	"Solute carrier family 1 member 2"	P43004	11	35251205-35420063	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 782.3;choroid plexus: 202.7"	"Cell type enriched"	"Detected in many"	7	"Astrocytes: 4607.2"	"Cancer enriched"	"Detected in some"	5	"glioma: 28.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.1;BJ hTERT+: 2.4;fHDF/TERT166: 1.7;Hep G2: 2.9;NTERA-2: 3.1;SCLC-21H: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002574, HPA009172, HPA067499"	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB002574: AB_564087, HPA009172: AB_1849764, HPA067499: "	"unprognostic (8.00e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.35e-1)"	"unprognostic (8.33e-4)"	"unprognostic (6.34e-2)"	"unprognostic (8.06e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.49e-2)"	0.6	4.6	546.9	0.6	731.2	0.4	3.8	388.1	782.3	1.2	202.7	0.2	0.5	1.0	0.3	0.2	0.3	0.2	0.9	631.1	432.5	0.2	34.9	0.6	1.9	450.6	533.6	0.1	9.5	0.1	2.6	1.1	384.2	0.3	0.1	60.1	4.6	0.1	0.3	1.3	0.2	0.3	409.7	0.5	2.1	1.7	498.7	0.2	0.3	0.5	1.6	0.3	0.6	453.4	0.0	0.1	0.5	0.0	0.2	2.1	0.0	0.5	2.4	0.1	0.1	0.0	0.0	0.0	0.0	1.7	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.3	2.9	0.1	0.3	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.2	0.0	1.1	0.0	0.1	0.5	0.0	0.3	0.1	0.1	0.2	0.0	0.3	0.0	0.0	0.5	0.0	0.1	1.3	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.5	0.2	0.1	0.1	0.1	0.1	546.9	731.2	388.1	782.3	631.1	432.5	450.6	533.6	384.2	409.7	498.7	453.4	0.4	3.2	4.8	4607.2	0.4	2.9	0.0	0.0	0.0	109.9	8.1	2.4	3.1	0.0	0.0	0.0	148.0	25.6	0.3	0.1	0.0	0.1	96.6	1.8	11.7	1.6	0.0	0.0	83.7	3.4	1.0	3.1	1.1	1.5	0.0	0.7	0.0	6.7	3.3	6.7	81.5	0.0	0.0	0.0	3.0	97.9	0.0	0.6	1.8	194.9	31.6	10.1	0.0	634.9	12.3	0.4	0.0	0.0	0.1	0.3	0.0	0.1	0.8	161.2	0.0	0.3	1.8	0.5	1.3	0.0	1.1	269.4	0.2	0.0	0.0	0.1
SLC1A3	"EA6, EAAT1, GLAST"	ENSG00000079215	"Solute carrier family 1 member 3"	P43003	5	36596588-36688334	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	10	"brain: 776.8;choroid plexus: 400.6;retina: 221.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1735.2;Microglial cells: 332.6;Muller glia cells: 472.6;Oligodendrocyte precursor cells: 237.7;Oligodendrocytes: 249.0"	"Cancer enriched"	"Detected in all"	21	"glioma: 168.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"classical monocyte: 1.5;intermediate monocyte: 1.2;myeloid DC: 1.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.6;monocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 50.0;CACO-2: 112.6;HaCaT: 71.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002573, HPA037467, HPA037468"	Enhanced	Supported	Approved	Nucleoli,Vesicles		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Vesicles"		"CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.17e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	30.7	16.4	500.4	7.4	544.2	3.3	17.7	549.4	776.8	8.7	400.6	3.0	0.5	1.6	1.1	10.5	6.0	8.0	45.4	514.6	502.5	2.2	3.8	10.2	17.4	477.6	510.1	12.6	5.0	2.2	18.1	20.3	502.4	3.2	1.1	221.1	4.7	4.7	14.1	6.0	3.2	4.1	495.4	9.3	2.2	1.2	532.8	3.6	3.4	9.2	5.4	7.0	5.3	494.9	1.3	0.2	50.0	5.3	5.9	14.3	37.7	0.3	0.0	2.4	4.9	112.6	5.6	0.0	27.8	2.3	1.0	71.4	16.9	9.1	2.2	1.8	33.0	0.0	0.5	0.0	2.5	1.3	0.6	26.9	34.5	14.4	5.3	1.8	0.0	1.1	0.0	0.2	8.7	0.2	0.1	0.1	6.0	0.1	5.9	0.0	0.5	0.0	0.1	3.1	4.7	0.0	5.1	14.6	2.1	24.4	0.2	3.1	0.0	6.2	10.3	0.1	20.7	0.0	0.0	0.3	21.7	37.7	12.6	0.0	1.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	500.4	544.2	549.4	776.8	514.6	502.5	477.6	510.1	502.4	495.4	532.8	494.9	1.1	3.2	0.5	1735.2	0.7	10.7	14.3	19.0	83.1	7.1	3.7	3.4	36.0	0.0	3.1	0.0	2.1	32.9	0.1	0.0	0.0	0.8	0.7	16.3	1.2	8.9	0.0	0.8	2.6	0.0	15.9	7.8	2.0	11.7	0.0	0.2	1.1	0.5	41.2	3.3	4.7	0.0	0.0	77.6	5.9	4.1	4.4	59.6	7.2	332.6	3.3	472.6	0.0	237.7	249.0	0.3	0.0	0.0	0.7	5.2	0.0	0.0	5.3	19.1	6.6	2.6	3.1	0.3	0.3	32.7	7.1	9.2	1.0	20.7	0.0	3.6
SLC1A4	"ASCT1, SATT"	ENSG00000115902	"Solute carrier family 1 member 4"	P43007	2	64988477-65023865	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 59.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 69.9;Granulosa cells: 49.2;Melanocytes: 85.4;Plasma cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 294.5;U-266/70: 132.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034963, HPA034964"	Approved		Enhanced	Centrosome		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Centrosome		"HPA034963: AB_2797223, HPA034964: AB_2674386"	"unprognostic (7.61e-2)"	"prognostic favorable (3.59e-4)"	"unprognostic (2.49e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (4.23e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (6.37e-3)"	"unprognostic (4.14e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.98e-2)"	4.3	26.4	49.1	9.1	46.8	13.4	13.6	32.1	48.6	14.0	18.0	9.4	6.1	12.8	8.2	7.5	4.8	3.9	6.2	43.4	56.6	1.9	9.0	4.9	10.7	37.2	43.1	13.2	29.6	5.5	13.7	6.6	52.1	9.6	8.4	19.3	7.5	7.1	40.1	18.6	5.6	12.3	29.5	7.5	8.1	11.7	59.9	20.5	5.7	17.0	19.0	4.8	6.2	30.3	15.3	11.6	6.6	34.9	14.7	9.5	9.4	28.5	14.0	11.7	19.8	3.2	2.2	49.7	6.5	44.8	14.7	43.2	13.7	3.6	12.0	20.1	5.4	26.0	13.1	30.9	31.0	43.8	23.1	4.4	73.8	15.8	24.2	3.9	7.3	49.1	20.7	122.0	8.4	13.5	37.7	29.1	4.7	20.1	13.9	13.5	1.9	125.5	4.9	7.7	29.3	14.1	17.9	16.1	294.5	3.0	19.3	47.8	1.6	16.0	19.0	31.2	17.5	132.8	71.2	118.8	23.6	86.5	86.2	0.0	2.1	1.8	0.9	4.8	1.2	0.9	0.9	1.5	3.9	0.3	0.0	0.8	0.0	5.1	9.4	7.2	3.5	1.4	49.1	46.8	32.1	48.6	43.4	56.6	37.2	43.1	52.1	29.5	59.9	30.3	3.6	0.0	2.7	69.9	13.6	20.0	2.1	6.7	46.1	6.3	21.0	7.1	5.5	1.5	1.7	1.8	33.3	2.4	20.2	2.9	0.0	2.0	32.4	5.4	8.2	5.3	8.4	6.1	20.6	9.3	1.3	4.0	5.1	5.6	7.0	49.2	7.5	13.1	17.7	6.7	25.5	9.0	6.1	6.8	11.8	47.5	11.1	11.1	85.4	8.4	5.1	14.6	2.1	5.0	3.9	7.1	0.8	29.7	65.7	2.6	0.4	1.5	5.4	17.7	0.0	5.1	7.3	2.0	0.9	5.9	6.1	2.5	10.9	0.4	5.8	1.0
SLC20A2	"Glvr-2, GLVR2, MLVAR, PiT-2, Ram-1"	ENSG00000168575	"Solute carrier family 20 member 2"	Q08357	8	42416475-42541926	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction, Ion transport, Phosphate transport, Sodium transport, Symport, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 130.6;skeletal muscle: 131.2"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 250.2;Oligodendrocytes: 151.7;Urothelial cells: 170.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 132.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026540	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA026540: AB_1855408"	"prognostic unfavorable (7.67e-4)"	"unprognostic (3.22e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.43e-2)"	"prognostic favorable (1.01e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.86e-2)"	"unprognostic (4.95e-2)"	11.9	8.0	33.4	9.8	45.3	3.0	12.1	55.4	37.1	15.8	130.6	22.8	46.7	18.5	9.9	32.7	24.5	15.1	63.2	30.1	48.7	17.5	39.7	15.1	6.5	46.5	56.5	8.1	51.6	15.0	10.5	13.5	47.5	13.6	19.0	7.5	87.9	17.6	131.2	23.3	18.8	17.9	42.7	7.4	15.1	15.9	67.8	11.9	82.8	57.6	9.1	22.0	21.7	52.8	52.7	14.3	19.0	16.0	10.4	8.8	41.1	46.9	80.8	23.9	58.7	38.9	132.9	17.4	53.6	42.1	13.5	81.1	11.4	45.2	41.6	4.3	8.7	27.8	4.8	22.0	14.9	9.9	12.3	9.5	40.2	24.7	22.7	16.7	12.0	13.7	27.2	14.0	47.3	14.4	18.1	16.1	19.2	50.5	8.8	14.9	20.9	18.5	21.4	47.5	5.1	19.2	12.8	21.8	12.8	15.0	17.5	17.3	34.9	50.0	17.4	12.3	25.7	9.0	22.2	12.6	15.8	19.5	28.3	3.2	2.2	0.2	3.6	1.6	4.3	2.1	4.0	3.5	3.7	2.1	4.8	3.7	0.8	6.8	1.3	2.0	4.1	3.1	33.4	45.3	55.4	37.1	30.1	48.7	46.5	56.5	47.5	42.7	67.8	52.8	11.1	28.9	18.6	51.6	9.1	98.9	250.2	22.7	96.2	13.4	21.7	14.9	60.2	14.3	21.7	16.5	16.7	23.9	14.3	76.2	13.7	29.6	10.4	79.9	15.8	18.9	12.0	6.9	88.9	31.4	23.7	15.8	15.8	61.2	3.8	17.1	6.4	30.7	10.2	6.7	88.4	11.5	18.3	7.7	12.2	10.0	7.2	10.2	10.6	78.7	7.3	14.4	14.4	63.3	151.7	47.4	35.8	11.7	8.6	76.6	20.0	7.3	57.6	10.2	6.6	22.9	28.3	5.2	7.2	73.9	74.3	25.4	14.2	23.7	12.5	170.3
SLC22A18	"BWR1A, BWSCR1A, IMPT1, ITM, ORCTL2, SLC22A1L, TSSC5"	ENSG00000110628	"Solute carrier family 22 member 18"	Q96BI1	11	2899721-2925246	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 42.3;liver: 45.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 368.4;Late spermatids: 499.1;Paneth cells: 385.7;Proximal enterocytes: 730.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 33.4;Karpas-707: 29.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA067812, HPA071461"	Enhanced					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"			"HPA067812: AB_2685902, HPA071461: AB_2686401"	"unprognostic (1.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.80e-1)"	"unprognostic (7.75e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.67e-1)"	"unprognostic (8.25e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.48e-2)"	"unprognostic (9.35e-2)"	"unprognostic (8.60e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.51e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.82e-1)"	6.9	3.0	0.1	2.1	0.1	1.5	6.7	0.0	1.2	6.5	0.8	27.8	42.3	6.8	0.2	13.3	8.2	4.0	16.7	0.1	1.0	16.7	45.2	6.8	2.3	0.6	0.5	4.8	6.4	1.7	3.2	5.4	0.4	8.0	4.2	0.0	10.3	2.8	1.7	16.1	28.0	0.9	0.2	9.1	11.3	2.1	1.0	0.7	12.0	0.0	1.1	6.5	9.7	0.8	2.3	14.1	0.0	7.2	1.3	2.0	5.8	4.4	7.4	2.5	4.2	8.0	33.4	1.0	14.1	5.8	5.6	7.3	0.4	0.7	0.5	6.8	1.3	0.3	3.3	7.4	13.5	0.1	6.2	5.7	1.3	2.1	0.4	2.2	0.0	4.5	0.3	29.1	1.4	6.8	0.2	0.8	0.7	10.6	3.3	2.6	0.0	4.7	1.1	4.2	0.3	2.5	1.8	17.6	15.7	0.1	3.6	3.8	0.5	1.9	4.2	6.1	0.3	5.5	1.4	0.3	7.7	3.9	7.5	32.1	28.7	27.4	6.8	28.2	3.7	4.2	5.1	4.8	17.9	3.0	2.7	4.0	42.3	6.3	22.9	13.2	9.4	13.5	0.1	0.1	0.0	1.2	0.1	1.0	0.6	0.5	0.4	0.2	1.0	0.8	1.6	6.4	9.6	1.6	5.6	7.4	22.5	48.8	14.2	1.2	16.8	11.0	11.2	54.3	29.0	27.6	0.0	102.6	9.0	368.4	7.9	31.4	161.7	9.3	5.3	2.7	19.8	1.3	3.0	8.7	20.9	9.4	47.9	14.1	15.9	7.6	6.4	158.6	46.3	0.0	0.6	93.2	52.9	33.0	16.7	499.1	10.5	23.5	19.6	4.7	18.8	6.9	10.3	0.5	1.6	22.5	385.7	7.5	3.1	10.2	730.9	122.1	26.6	1.1	0.0	2.7	11.2	5.8	4.1	19.2	8.8	181.3	13.7	7.3	121.3	20.3
SLC22A5	"CDSP, OCTN2, SCD"	ENSG00000197375	"Solute carrier family 22 member 5"	O76082	5	132369710-132395613	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 56.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 63.9;Proximal enterocytes: 56.2"	"Cancer enhanced"	"Detected in all"		"renal cancer: 8.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 34.7;SiHa: 37.8"	"Low region specificity"	"Detected in some"							HPA063062			Approved	Mitochondria		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA063062: AB_2684934"	"unprognostic (3.88e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.19e-2)"	"prognostic favorable (2.87e-5)"	"unprognostic (5.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.09e-2)"	"prognostic favorable (7.36e-4)"	"unprognostic (3.53e-2)"	"prognostic favorable (8.36e-4)"	"unprognostic (1.12e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.17e-2)"	5.3	6.6	7.5	2.0	7.9	0.9	4.9	7.8	7.8	5.0	14.4	12.4	13.7	4.0	11.1	3.9	8.4	4.1	14.2	7.3	8.0	26.7	7.8	3.2	1.2	7.8	7.8	5.6	8.2	17.9	11.0	4.2	7.4	9.1	9.4	3.7	6.4	11.2	56.1	6.0	16.9	2.5	7.5	2.5	6.0	3.8	8.0	2.1	5.4	22.3	1.8	5.0	5.0	7.8	6.1	14.4	0.9	11.3	4.4	2.1	19.3	2.7	2.9	4.5	6.2	10.7	12.2	2.9	6.0	2.6	13.1	14.3	9.4	7.0	5.3	3.6	11.6	1.5	34.7	4.9	7.3	2.4	2.4	2.0	12.9	3.1	15.8	7.6	1.2	5.2	6.8	1.8	4.4	10.4	3.6	2.4	1.0	10.5	6.2	1.3	0.0	15.9	13.5	15.2	4.8	3.3	37.8	28.9	7.6	2.9	13.5	3.1	0.7	0.7	3.9	9.5	3.3	6.0	12.8	0.1	2.9	5.9	2.7	0.0	2.0	0.0	1.1	1.0	1.2	0.6	1.1	1.4	3.1	0.6	1.1	1.4	0.2	0.8	0.3	0.2	2.1	1.0	7.5	7.9	7.8	7.8	7.3	8.0	7.8	7.8	7.4	7.5	8.0	7.8	3.0	9.6	8.2	23.5	3.8	7.6	7.5	4.7	13.1	6.7	16.9	5.3	5.6	21.5	5.5	16.5	12.5	23.6	3.2	63.9	1.9	9.8	2.0	13.7	10.3	2.6	7.2	1.7	11.9	5.2	5.5	5.6	16.3	26.6	0.0	6.1	2.9	8.6	4.2	10.1	11.1	14.3	8.2	6.7	1.6	2.8	6.5	5.9	5.4	17.8	1.3	9.4	0.0	7.1	4.2	6.4	26.3	4.1	4.8	14.2	56.2	22.2	9.4	7.1	0.0	17.7	3.8	8.4	2.8	9.6	6.3	8.2	4.0	0.3	18.0	9.0
SLC24A1	"CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX"	ENSG00000074621	"Solute carrier family 24 member 1"	O60721	15	65611366-65660995	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sensory transduction, Symport, Transport, Vision"		"Congenital stationary night blindness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	34	"retina: 193.5"	"Cell type enriched"	"Detected in many"	11	"Rod photoreceptor cells: 338.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA039370	Enhanced		Approved	Microtubules		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 79: Retina - Phototransduction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	Microtubules		"HPA039370: AB_10960279"	"unprognostic (9.47e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.39e-3)"	"unprognostic (4.64e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.91e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (8.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.96e-2)"	4.0	3.0	2.4	1.9	2.2	1.8	4.9	5.7	2.7	4.8	2.5	2.6	2.2	3.8	4.7	2.4	5.1	3.8	1.6	2.1	2.1	5.1	2.9	3.1	3.3	2.3	2.3	5.4	2.9	3.8	2.7	3.6	2.3	3.2	2.4	193.5	2.6	3.1	1.0	5.1	3.0	2.9	2.3	3.9	2.5	4.1	2.1	2.4	5.1	1.3	1.8	3.0	3.2	2.5	1.5	3.0	3.2	2.9	4.7	7.9	4.0	3.7	4.2	3.7	2.4	1.4	6.5	2.1	12.4	3.7	1.3	4.1	3.9	4.2	2.1	2.2	2.8	4.6	2.5	6.8	6.8	3.1	6.0	6.7	5.9	2.1	12.3	5.1	6.4	4.8	5.0	7.0	6.0	6.4	2.0	2.8	4.1	13.5	1.2	2.0	1.0	1.4	5.6	6.0	1.5	2.1	1.0	2.8	8.0	4.4	6.0	4.2	9.3	3.7	3.7	1.4	2.6	2.8	5.5	2.4	3.9	6.4	3.1	2.6	0.4	0.7	0.4	0.4	0.5	0.4	0.4	0.4	0.3	1.0	0.3	0.4	0.6	0.8	0.2	0.8	0.1	0.1	2.4	2.2	5.7	2.7	2.1	2.1	2.3	2.3	2.3	2.3	2.1	2.5	4.0	6.4	5.1	5.2	3.4	1.5	1.4	1.2	1.8	29.8	3.5	2.8	2.3	0.0	3.8	0.0	27.1	4.2	1.6	2.9	0.0	1.5	1.6	6.3	5.4	15.6	1.8	1.7	2.2	1.3	2.7	2.6	4.1	7.9	2.5	4.7	3.6	1.4	1.9	20.2	2.0	2.5	2.0	3.1	1.6	2.5	3.1	2.7	1.8	4.7	1.2	26.1	2.1	3.0	1.4	2.6	0.5	2.2	3.3	1.4	2.6	0.7	4.1	338.3	0.0	3.4	2.5	20.3	10.1	2.9	1.0	2.5	2.5	8.3	2.6	0.9
SLC24A4	NCKX4	ENSG00000140090	"Solute carrier family 24 member 4"	Q8NFF2	14	92322581-92501481	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Olfaction, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"choroid plexus: 92.6"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 251.6;Cone photoreceptor cells: 200.1"	"Group enriched"	"Detected in some"	5	"glioma: 0.5;melanoma: 0.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 11.1;intermediate monocyte: 14.7;non-classical monocyte: 11.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 14.7"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063206			Approved	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"		"HPA063206: "	"unprognostic (1.53e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.58e-2)"	0.5	0.2	7.1	1.4	10.3	3.5	0.1	17.5	8.1	0.2	92.6	0.2	0.2	0.1	0.1	0.2	0.2	0.6	0.2	7.2	5.3	0.0	0.1	0.8	1.2	22.7	14.1	0.2	0.1	0.0	1.4	0.3	19.1	0.2	0.2	12.3	0.1	0.3	0.8	0.1	0.3	0.4	14.7	2.7	0.1	1.1	16.5	0.4	0.1	1.0	0.4	0.3	0.2	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	11.1	0.0	0.0	14.7	0.2	0.0	0.0	0.0	3.0	0.1	0.0	0.0	1.5	0.1	11.6	0.5	0.0	2.7	7.1	10.3	17.5	8.1	7.2	5.3	22.7	14.1	19.1	14.7	16.5	12.9	0.8	0.0	1.9	47.0	0.4	0.0	0.1	0.0	0.0	251.6	0.3	0.1	1.8	0.0	0.0	0.0	200.1	0.0	0.1	0.0	0.0	0.0	4.0	0.5	0.1	0.9	0.0	0.8	19.9	0.0	0.1	0.5	0.0	0.8	0.0	0.0	1.1	0.0	4.0	0.0	28.5	0.0	0.0	22.2	1.8	5.6	0.3	16.6	0.0	2.8	44.3	4.1	1.0	10.1	1.3	0.1	0.0	0.4	0.1	0.2	0.0	0.2	0.7	10.6	0.0	9.9	0.2	0.1	1.6	0.0	0.0	0.3	0.3	0.0	0.0	0.1
SLC24A5	"JSX, OCA6"	ENSG00000188467	"Solute carrier family 24 member 5"	Q71RS6	15	48120990-48142672	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport"		Albinism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 8.2"	"Group enriched"	"Detected in some"	7	"Early spermatids: 20.7;Melanocytes: 76.5"	"Cancer enriched"	"Detected in single"	162	"melanoma: 8.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	800	"SK-MEL-30: 251.8"	"Group enriched"	"Detected in some"	5	"hippocampal formation: 3.0;pons and medulla: 4.1;thalamus: 1.5"	"Low region specificity"	"Detected in all"									NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 29: Early spermatids - Spermatogenesis"								"unprognostic (3.47e-2)"				"unprognostic (1.80e-1)"	"unprognostic (1.35e-1)"			"unprognostic (1.92e-3)"					0.0	0.0	0.3	0.0	0.3	0.0	0.2	0.3	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.1	1.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	251.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.2	0.1	0.5	0.1	0.9	0.2	0.0	0.9	0.2	0.3	0.0	0.5	0.7	0.2	2.4	0.0	0.0	0.0	6.4	0.0	0.1	0.3	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	20.7	1.5	0.1	0.1	0.0	0.4	2.9	0.0	0.0	0.5	0.0	0.9	0.0	0.1	0.0	0.0	0.1	5.0	2.7	0.0	0.0	0.0	0.7	6.6	0.0	0.0	76.5	1.0	0.0	0.9	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	4.6	0.0	0.1	0.1	0.1	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0
SLC25A1	"CTP, SLC20A3"	ENSG00000100075	"Solute carrier family 25 member 1"	P53007	22	19175581-19178739	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 197.7"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 221.1;Proximal enterocytes: 304.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 101.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (2.12e-1)"	"unprognostic (3.98e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.72e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.46e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.03e-2)"	113.3	76.3	45.8	22.3	46.9	14.2	90.3	49.5	58.6	43.5	47.6	63.9	114.1	40.0	16.2	59.2	34.7	21.5	27.3	41.5	65.8	86.8	197.7	33.6	21.4	61.0	58.3	43.6	54.8	33.1	39.3	27.4	73.0	53.9	33.9	5.6	39.5	30.0	17.3	49.1	92.4	21.0	49.4	31.4	52.9	36.3	51.8	16.3	46.1	7.7	25.5	43.9	40.8	55.2	111.9	114.3	85.9	73.6	209.1	102.5	91.2	77.5	96.9	65.7	90.4	136.4	77.2	66.9	38.8	110.5	70.5	95.4	82.9	138.1	37.2	59.6	164.1	35.5	97.7	278.4	148.2	67.3	107.5	145.1	81.7	75.7	58.4	73.3	62.8	53.4	184.6	61.9	74.7	288.1	37.0	80.8	57.5	173.5	70.0	70.4	44.6	29.9	196.2	135.8	55.5	71.2	83.1	163.0	48.6	52.6	122.6	171.7	63.6	80.3	69.3	62.0	53.2	78.2	39.9	35.4	82.5	31.5	41.4	11.6	15.7	101.9	16.6	17.9	10.6	33.3	18.7	18.2	13.7	43.5	16.7	14.3	8.1	13.7	23.8	10.5	19.6	10.6	45.8	46.9	49.5	58.6	41.5	65.8	61.0	58.3	73.0	49.4	51.8	55.2	18.5	9.6	18.9	10.7	35.0	22.0	27.2	21.6	31.9	7.8	44.2	41.9	7.2	38.6	17.0	33.1	2.1	135.6	18.4	178.6	50.9	33.5	30.5	41.4	37.0	16.8	41.0	21.7	5.2	45.6	139.5	27.1	50.4	83.7	2.5	67.5	21.4	221.1	47.5	13.5	6.1	107.3	28.5	30.5	18.2	98.8	28.9	32.6	28.4	2.8	29.6	27.7	16.5	3.0	10.1	39.7	128.1	29.3	38.7	28.7	304.3	127.3	11.1	4.2	13.1	14.5	37.8	15.3	29.5	60.5	30.4	127.7	24.6	55.7	108.3	30.4
SLC25A11	"OGC, SLC20A4"	ENSG00000108528	"Solute carrier family 25 member 11"	Q02978	17	4937130-4940053	"Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 233.6;skeletal muscle: 314.5;tongue: 450.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021167	Approved					NA	NA		25000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA021167: AB_1857021"	"unprognostic (8.58e-2)"	"unprognostic (4.06e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.86e-1)"	"unprognostic (9.48e-2)"	"prognostic favorable (6.41e-6)"	"unprognostic (2.84e-1)"	"prognostic favorable (2.84e-9)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.09e-1)"	35.6	52.5	69.2	33.8	70.7	31.7	32.0	77.7	79.8	35.3	70.8	46.7	47.5	36.7	22.1	50.5	41.6	30.7	233.6	76.8	73.6	66.6	66.7	30.0	40.7	69.2	72.7	30.7	27.9	70.8	36.4	27.6	69.6	34.0	36.1	23.2	41.6	38.4	314.5	48.7	40.2	33.4	70.2	37.5	39.9	10.9	77.0	45.1	38.5	450.4	33.9	38.5	33.3	71.5	51.1	134.6	67.3	66.3	64.7	39.9	47.3	56.2	57.2	96.2	79.3	85.1	24.7	78.3	74.5	55.3	46.8	99.6	88.1	101.5	37.8	99.6	113.8	86.4	70.9	74.5	66.0	37.6	100.7	57.7	65.1	85.4	71.7	46.7	67.8	83.2	38.7	74.1	82.7	91.2	121.6	38.3	35.6	56.1	89.6	108.6	41.4	71.0	74.8	52.6	59.9	62.1	70.9	79.0	65.2	33.6	73.3	58.7	46.0	43.0	28.1	58.8	109.7	39.3	25.4	30.7	84.8	62.6	108.4	126.0	170.3	132.3	98.8	176.8	90.8	87.5	75.1	87.8	160.4	74.3	74.1	81.2	111.8	151.6	165.1	107.0	97.3	186.2	69.2	70.7	77.7	79.8	76.8	73.6	69.2	72.7	69.6	70.2	77.0	71.5	39.7	25.6	23.3	12.7	32.9	38.1	47.1	92.7	25.6	60.3	47.5	51.3	150.6	51.5	40.0	66.2	16.7	132.2	39.0	67.0	185.9	60.7	15.2	30.3	29.7	41.0	27.6	50.3	8.0	53.6	138.7	40.2	30.5	28.2	39.3	45.6	33.5	61.5	109.1	47.1	10.5	51.6	99.7	45.3	44.4	19.6	30.4	56.2	51.6	9.4	106.9	59.2	47.4	9.5	10.4	47.4	58.7	38.4	45.8	43.1	99.9	202.5	26.5	56.0	52.6	43.1	48.4	15.1	31.3	46.9	44.3	102.5	38.4	57.5	88.3	42.1
SLC25A12	Aralar	ENSG00000115840	"Solute carrier family 25 member 12"	O75746	2	171783405-171999859	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 97.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 97.7;Excitatory neurons: 148.5;Inhibitory neurons: 175.2;Oligodendrocyte precursor cells: 111.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035333, HPA035334"	Enhanced		Uncertain	"Nuclear speckles,Cytosol"		NA	NA		9100	"Cluster 32: T-cells - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"	Cytosol	"HPA035333: AB_10603028, HPA035334: AB_2674577"	"unprognostic (3.24e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (7.86e-4)"	"unprognostic (2.65e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.21e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.91e-8)"	"unprognostic (8.64e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.70e-1)"	11.1	11.5	8.5	4.0	9.0	2.8	11.6	9.3	12.3	11.5	6.1	25.2	2.2	13.4	4.3	12.7	11.7	3.7	62.7	8.9	9.0	13.4	1.8	7.1	4.4	6.9	6.7	14.5	3.9	12.0	17.1	3.2	6.8	13.7	6.1	15.8	16.8	9.5	97.0	14.5	10.7	8.5	5.8	8.9	16.4	6.1	7.4	5.6	15.1	51.1	5.2	16.2	12.4	8.4	4.9	3.0	4.2	8.0	9.5	11.7	0.0	5.3	11.2	7.7	7.3	2.2	3.2	14.5	2.6	7.5	4.3	4.3	7.9	8.5	10.7	6.3	10.4	6.9	4.4	5.5	3.8	14.8	4.9	12.6	7.0	11.0	2.3	4.1	8.0	7.0	5.0	5.2	4.4	3.2	9.7	6.5	3.0	3.8	4.7	9.6	4.7	7.4	8.0	4.5	5.1	1.6	2.6	8.5	4.0	2.5	2.8	3.1	6.4	6.2	2.0	6.0	3.2	8.8	4.2	13.6	9.1	7.5	2.9	0.0	0.4	0.1	1.0	0.4	0.8	0.7	0.5	0.9	0.4	0.5	0.9	1.5	0.0	0.9	0.7	0.1	0.7	0.4	8.5	9.0	9.3	12.3	8.9	9.0	6.9	6.7	6.8	5.8	7.4	8.4	9.8	0.0	9.8	71.2	11.3	6.9	10.2	13.2	19.9	25.5	9.3	11.8	97.7	0.0	18.4	18.4	25.0	7.5	10.7	11.6	19.6	1.7	3.2	5.0	10.3	8.7	14.4	6.9	148.5	3.3	1.8	15.1	12.8	6.1	10.8	7.3	7.9	0.6	4.5	37.0	175.2	6.1	16.2	8.4	5.4	2.1	12.5	7.2	16.0	25.3	9.7	19.8	5.2	111.6	44.1	2.0	4.7	24.5	19.5	4.6	4.1	13.2	11.2	25.5	13.1	12.5	16.6	7.8	9.1	16.8	7.7	1.2	15.0	11.0	7.6	8.3
SLC25A13	"ARALAR2, CITRIN, CTLN2"	ENSG00000004864	"Solute carrier family 25 member 13"	Q9UJS0	7	96120220-96322147	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 150.1"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 153.4;Oligodendrocytes: 439.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018997	Enhanced		Supported	Mitochondria		NA	NA		21000	"Cluster 14: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA018997: AB_1857023"	"unprognostic (3.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (9.14e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.32e-1)"	"unprognostic (7.09e-2)"	9.2	14.3	7.0	8.9	13.7	8.0	10.3	13.7	10.0	8.0	15.1	16.3	16.0	7.6	10.2	9.6	9.5	9.9	6.6	6.7	9.9	32.3	150.1	7.9	7.1	13.6	12.2	7.8	9.6	13.8	8.3	16.1	13.0	8.2	17.8	19.4	7.7	12.5	7.0	12.3	13.4	6.7	10.1	10.0	14.4	7.4	11.3	3.9	13.7	3.3	8.7	11.0	7.6	20.2	45.3	39.2	44.2	15.5	7.5	6.0	61.8	11.2	8.5	26.5	26.7	70.7	41.2	20.2	51.9	7.2	57.8	26.3	50.1	16.2	31.0	8.0	33.0	23.0	34.4	55.4	17.4	29.5	17.4	15.8	16.9	22.7	20.4	10.1	31.0	3.0	65.9	7.6	13.0	49.6	0.1	27.6	78.0	47.8	24.0	11.6	26.3	46.8	63.7	42.1	21.1	69.0	38.8	81.1	67.3	72.9	24.2	22.4	18.2	19.6	43.6	46.8	34.5	15.2	40.8	12.7	24.1	28.0	32.9	0.4	3.1	2.2	1.4	4.5	1.5	2.4	1.1	1.3	6.1	1.2	0.7	0.9	0.6	2.0	5.1	3.1	1.2	1.4	7.0	13.7	13.7	10.0	6.7	9.9	13.6	12.2	13.0	10.1	11.3	20.2	31.5	9.6	12.6	60.7	19.7	7.4	8.5	8.6	16.5	36.5	13.6	17.1	8.3	27.1	9.2	18.4	54.2	29.2	8.9	32.1	27.4	19.8	11.0	44.0	23.2	20.7	37.8	15.3	26.6	19.1	26.5	18.8	44.4	34.2	14.5	30.4	11.7	153.4	23.2	10.1	43.7	22.3	12.2	23.8	10.0	11.1	13.1	21.5	21.4	82.4	13.2	17.6	8.2	53.3	439.6	22.6	23.7	15.8	12.7	14.9	27.1	74.9	14.2	47.3	13.1	19.0	16.9	7.0	14.5	25.4	8.0	20.0	7.9	21.6	25.5	15.4
SLC25A15	"D13S327, HHH, ORC1, ORNT1"	ENSG00000102743	"Solute carrier family 25 member 15"	Q9Y619	13	40789412-40812460	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 37.6;liver: 88.3;pancreas: 52.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 44.5;Hepatocytes: 39.8;Proximal enterocytes: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042146	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA042146: AB_2677874"	"unprognostic (4.17e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.85e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.37e-2)"	"prognostic favorable (1.74e-4)"	"unprognostic (4.04e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (5.46e-4)"	2.3	1.4	2.0	4.1	2.2	5.6	4.6	2.3	2.5	2.1	2.3	5.9	37.6	3.1	1.1	3.2	2.6	5.0	2.8	1.9	2.6	5.6	88.3	2.3	4.8	2.6	2.3	2.9	52.1	3.4	1.3	2.8	2.5	2.8	6.5	2.8	3.4	1.8	5.9	3.7	26.7	3.4	2.1	2.5	5.5	9.4	2.4	5.3	17.3	6.0	5.3	2.6	1.6	2.9	7.4	14.7	16.5	21.3	6.5	8.2	17.3	5.6	2.9	6.8	3.9	17.6	15.2	48.0	6.4	10.3	12.7	12.6	26.6	15.5	7.0	11.9	12.4	37.0	8.6	26.6	12.7	15.0	5.3	9.0	8.6	9.6	21.9	4.6	11.2	23.8	18.1	7.8	11.8	28.2	10.2	9.9	33.2	32.7	7.9	25.5	12.0	10.6	11.7	7.0	7.7	20.1	10.2	18.4	10.1	11.5	13.6	23.2	8.4	8.4	12.1	12.7	17.0	8.9	9.6	27.9	8.4	11.4	16.4	1.3	0.5	0.1	1.6	0.9	1.0	0.6	1.0	1.1	1.1	0.7	1.0	2.0	0.7	1.4	0.5	0.5	0.9	0.5	2.0	2.2	2.3	2.5	1.9	2.6	2.6	2.3	2.5	2.1	2.4	2.9	0.3	3.2	0.5	3.9	1.3	0.3	1.0	0.8	2.2	1.4	2.1	1.4	1.1	1.5	0.2	0.0	0.0	2.2	1.3	0.6	7.9	2.1	4.6	1.2	2.1	0.9	1.2	9.0	2.4	4.3	44.5	1.0	1.5	2.1	0.0	1.5	0.7	39.8	1.7	0.0	4.3	0.6	2.0	1.6	0.3	6.8	0.6	1.0	1.8	1.0	0.0	0.4	2.1	5.0	1.4	1.7	2.7	0.0	6.2	1.6	19.0	4.3	0.1	1.9	0.0	1.0	1.1	5.4	9.3	2.1	0.1	1.5	3.2	4.3	3.5	0.8
SLC25A19	"DNC, MCPHA, MUP1, TPC"	ENSG00000125454	"Solute carrier family 25 member 19"	Q9HC21	17	75272981-75289510	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 82.2;Langerhans cells: 160.3;Spermatocytes: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021936			Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA021936: "	"unprognostic (2.28e-1)"	"unprognostic (7.05e-3)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (6.71e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.71e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.13e-1)"	10.9	31.2	11.6	16.0	12.4	8.0	6.4	13.1	13.3	7.3	12.4	9.8	9.4	6.7	2.4	8.6	6.3	6.2	10.6	11.7	12.6	10.9	8.8	11.7	22.9	14.9	12.6	6.2	8.8	8.1	4.8	12.1	13.2	6.1	8.8	3.1	6.2	3.7	14.5	4.9	8.5	7.1	13.0	14.6	10.9	33.0	14.7	8.6	6.0	16.7	18.8	11.5	5.7	14.7	28.3	34.8	6.2	18.4	13.6	7.0	20.0	18.1	7.0	20.3	20.5	59.8	17.4	89.8	12.8	6.4	17.7	24.7	43.5	20.9	25.3	26.5	70.5	41.1	40.4	58.4	11.5	58.7	44.9	6.1	11.6	31.5	25.2	4.7	33.9	44.9	51.0	41.9	6.5	59.3	61.8	59.3	13.5	55.3	67.8	47.4	19.8	85.1	14.1	19.7	60.7	15.3	19.3	51.4	22.2	10.2	32.1	47.3	12.0	12.1	24.1	23.5	49.0	102.7	53.4	95.8	9.5	66.9	15.5	0.3	21.0	2.3	16.2	25.2	16.6	36.3	12.7	15.4	24.9	29.7	14.2	14.7	1.7	10.0	14.8	31.0	17.7	14.5	11.6	12.4	13.1	13.3	11.7	12.6	14.9	12.6	13.2	13.0	14.7	14.7	5.1	6.4	6.7	3.3	27.6	15.2	10.8	6.0	2.8	1.2	5.4	7.5	0.6	2.8	6.1	7.3	2.1	7.5	13.3	8.6	23.5	6.5	18.0	5.6	8.7	6.7	3.0	11.1	3.1	5.3	82.2	8.6	9.7	3.5	11.4	2.7	2.5	2.9	44.1	3.3	3.5	6.2	4.1	9.5	160.3	24.1	3.1	31.5	24.9	4.7	38.8	1.6	11.3	2.0	2.4	5.1	8.6	3.4	26.5	14.1	6.5	6.4	3.9	6.0	6.6	5.9	10.0	79.6	11.9	7.9	12.9	8.9	12.5	11.4	11.0	9.7
SLC25A20	"CAC, CACT"	ENSG00000178537	"Solute carrier family 25 member 20"	O43772	3	48856926-48898904	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 42.2;Hepatocytes: 64.2;Proximal enterocytes: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 96.1;RPMI-8226: 138.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016862, HPA029863"	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Mitochondria, Cytosol"		"HPA016862: AB_1857028, HPA029863: AB_10602893"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.96e-3)"	"unprognostic (4.06e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.71e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.12e-1)"	"unprognostic (4.22e-2)"	"unprognostic (3.49e-2)"	20.7	29.9	16.3	11.9	18.2	10.7	17.9	18.6	16.4	8.3	15.3	26.5	65.6	10.4	4.6	9.1	12.8	15.7	62.8	15.5	17.9	25.6	148.3	15.6	14.6	17.7	17.4	5.9	30.4	17.3	11.6	7.3	17.8	11.7	23.5	4.5	19.9	9.0	66.5	10.4	52.7	15.1	17.4	20.6	21.0	9.1	17.5	17.3	11.4	61.1	16.1	11.3	8.4	18.4	4.1	12.8	9.7	13.8	30.1	11.8	1.9	22.3	11.8	15.2	15.8	16.3	19.1	19.0	15.6	35.1	18.7	4.1	24.5	9.8	11.6	47.9	11.8	26.4	19.2	20.4	14.0	27.8	48.1	14.9	11.2	20.6	3.8	6.1	20.2	28.1	24.1	96.1	20.2	10.9	30.4	13.7	5.1	22.9	27.6	10.6	5.9	138.4	16.4	10.1	3.9	13.6	20.7	0.2	11.4	13.6	30.5	12.9	16.6	17.2	3.2	25.5	16.4	35.6	27.0	21.8	24.5	19.5	23.3	60.8	101.1	215.2	97.4	79.7	62.2	36.8	53.1	71.2	97.5	33.0	41.2	69.1	48.6	64.6	83.7	120.5	60.7	112.3	16.3	18.2	18.6	16.4	15.5	17.9	17.7	17.4	17.8	17.4	17.5	18.4	7.5	6.4	2.7	13.1	7.0	1.8	2.5	4.6	3.4	1.1	4.0	3.6	42.2	4.3	4.4	0.0	6.2	2.3	13.6	28.4	3.9	3.5	1.3	2.3	4.6	5.5	7.3	16.4	2.2	4.3	2.3	6.1	9.2	2.1	1.3	3.8	7.5	64.2	16.9	0.0	3.8	12.7	2.0	13.4	4.5	1.8	10.5	10.0	1.8	1.0	31.3	2.9	32.0	1.0	6.0	3.7	16.4	12.4	12.6	3.9	51.8	16.7	5.9	1.3	0.0	5.4	5.3	8.3	7.1	4.1	1.3	1.2	14.4	27.7	16.6	2.9
SLC25A21	"ODC, ODC1"	ENSG00000183032	"Solute carrier family 25 member 21"	Q9BQT8	14	36677921-37172606	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 6.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 27.8;Excitatory neurons: 14.1;Exocrine glandular cells: 10.0;Inhibitory neurons: 10.4;Oligodendrocyte precursor cells: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"K-562: 26.4;Karpas-707: 54.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000662	Uncertain					NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA000662: AB_1080000"	"unprognostic (6.81e-3)"	"unprognostic (6.98e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-4)"	"unprognostic (9.09e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.07e-1)"	0.9	1.2	0.2	0.3	0.3	6.3	0.5	0.3	0.3	0.6	0.1	0.6	0.7	1.3	0.2	1.2	0.7	0.6	1.3	0.2	0.4	1.6	0.4	0.5	0.1	0.4	0.3	2.0	2.8	0.9	0.3	0.1	0.4	1.6	0.3	1.0	1.6	0.4	0.7	0.3	1.2	0.7	0.4	0.5	0.8	3.9	0.3	0.3	1.5	0.9	0.1	0.6	0.3	0.5	1.3	1.0	0.4	3.2	0.1	1.0	0.0	0.3	0.8	1.7	0.7	0.2	0.9	0.1	1.4	0.4	0.0	1.0	0.0	0.7	0.6	0.8	9.5	0.9	0.8	0.8	1.0	0.0	0.0	0.7	1.1	0.0	0.5	0.9	3.9	0.0	26.4	54.4	0.8	2.7	0.0	0.0	2.1	0.0	4.1	0.0	0.0	0.0	0.8	3.9	2.6	0.0	2.6	0.2	1.3	0.4	2.9	0.0	1.9	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.3	0.2	0.4	0.4	0.3	0.4	0.4	0.3	0.5	0.3	0.0	0.0	2.3	0.2	1.0	1.8	1.8	6.8	0.1	1.0	0.9	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.1	1.9	0.9	1.4	0.1	1.0	0.7	1.8	27.8	14.1	10.0	0.0	0.9	0.0	0.2	0.0	0.4	0.7	0.3	0.2	1.7	10.4	0.5	2.0	0.0	0.4	1.4	1.5	0.1	0.0	4.7	0.0	4.3	0.0	11.6	5.2	3.7	0.0	0.7	0.0	2.7	0.1	4.2	0.4	1.5	0.0	1.1	1.1	3.1	3.6	3.6	0.9	0.0	0.1	1.9	1.0	0.6
SLC25A22	"EIEE3, FLJ13044, GC1, NET44"	ENSG00000177542	"Solute carrier family 25 member 22"	Q9H936	11	790475-798281	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.1;pancreas: 83.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 143.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014662	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria	Nucleoplasm	"HPA014662: AB_10600808"	"unprognostic (1.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (8.67e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.61e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	15.8	13.6	49.1	11.0	59.8	7.5	11.2	17.9	83.1	9.0	0.0	10.0	12.9	9.6	2.1	15.2	10.4	4.1	7.7	74.2	7.9	15.1	40.2	15.1	10.1	24.5	11.1	12.7	83.4	4.0	48.7	5.0	25.4	13.9	3.0	16.1	14.4	4.3	2.0	14.2	12.2	3.7	2.4	13.9	13.5	19.1	19.1	6.3	9.4	0.5	6.2	10.3	10.3	40.2	56.2	35.7	20.4	18.6	8.3	14.8	19.4	26.3	21.3	28.0	17.7	34.9	37.1	16.8	19.2	21.6	31.9	48.8	22.4	31.1	6.3	31.9	41.4	15.4	18.2	21.9	35.8	24.7	25.0	14.9	18.6	21.4	22.6	8.8	13.0	19.3	31.8	25.3	12.7	33.9	26.3	23.5	44.8	33.9	53.7	30.9	11.2	38.9	16.8	9.2	100.3	45.3	15.0	35.9	18.7	3.1	17.4	12.5	13.0	32.1	21.5	14.8	25.0	22.1	14.3	21.5	37.8	22.2	19.3	0.0	1.6	2.5	3.7	3.3	2.2	1.3	2.3	3.9	1.8	1.0	1.3	2.3	0.9	2.0	3.4	0.5	1.3	1.6	49.1	59.8	17.9	83.1	74.2	7.9	24.5	11.1	25.4	2.4	19.1	40.2	5.7	6.4	8.6	7.8	8.4	12.6	8.7	9.5	9.1	143.2	9.1	7.5	2.5	8.6	5.0	9.2	33.3	7.1	8.8	3.9	3.9	22.0	12.4	9.5	9.0	7.0	13.1	2.5	11.8	19.3	10.3	5.1	12.8	11.2	2.5	7.2	3.3	17.6	4.3	43.7	10.0	7.6	2.0	2.8	4.6	7.7	4.7	4.1	3.6	3.7	6.6	16.0	13.4	2.5	1.4	14.1	7.8	4.9	13.7	23.8	13.0	7.1	5.8	32.0	0.0	2.8	6.7	1.8	10.4	7.4	13.4	3.1	8.2	13.7	5.9	8.8
SLC25A24	"APC1, DKFZp586G0123"	ENSG00000085491	"Solute carrier family 25 member 24"	Q6NUK1	1	108134043-108200849	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 126.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028519, HPA063636"	Enhanced		Enhanced	Mitochondria		NA	NA		19000	"Cluster 7: Monocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA028519: AB_10603890, HPA063636: AB_2685068"	"unprognostic (1.94e-2)"	"unprognostic (7.30e-3)"	"prognostic favorable (1.01e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.54e-4)"	"unprognostic (1.51e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-3)"	"unprognostic (6.18e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.29e-1)"	10.0	6.2	0.8	5.3	0.7	3.8	8.2	0.6	1.3	12.5	0.8	13.5	11.4	6.6	3.2	6.0	6.7	6.8	4.9	0.7	0.8	6.3	1.6	9.1	5.1	0.8	0.7	5.9	4.2	8.2	2.8	9.4	0.9	4.0	16.0	6.7	6.7	4.6	3.7	4.3	12.3	8.7	0.6	5.7	6.9	3.2	1.0	5.0	7.1	4.5	4.9	10.1	7.0	0.7	38.2	8.9	28.8	8.6	17.9	23.4	11.4	13.0	17.0	25.1	27.4	11.3	12.9	0.0	10.3	28.7	10.9	14.1	7.9	24.0	35.1	7.9	4.4	2.4	13.4	5.2	14.9	6.1	4.9	17.6	17.0	15.0	18.5	16.8	19.6	5.7	6.2	13.0	32.2	28.7	3.7	1.4	14.3	17.3	8.1	5.7	33.9	12.6	16.9	22.8	5.0	8.7	17.4	14.9	17.5	27.5	13.3	10.7	10.5	13.8	6.2	23.2	15.0	3.0	2.3	0.0	5.0	11.8	8.2	0.4	0.5	0.4	0.3	0.5	0.3	0.1	0.2	0.2	0.4	0.4	0.1	0.3	0.1	0.2	0.7	0.3	0.4	0.1	0.8	0.7	0.6	1.3	0.7	0.8	0.8	0.7	0.9	0.6	1.0	0.7	33.9	54.5	27.8	5.5	24.2	15.6	20.4	20.6	17.1	14.7	25.5	16.8	15.5	17.2	33.5	18.4	8.4	7.1	16.3	126.7	21.5	31.2	3.2	62.0	46.7	28.6	18.1	6.7	18.0	36.9	60.2	23.2	40.2	61.7	22.2	20.9	29.6	1.2	54.1	10.1	14.9	43.2	18.3	51.8	32.8	2.9	19.6	50.0	23.2	16.9	44.7	12.7	11.3	14.6	20.8	67.6	51.2	18.0	9.7	14.3	54.4	24.9	55.2	33.9	52.6	27.2	26.5	6.2	2.4	24.8	14.9	6.2	23.9	41.8	59.1	33.8
SLC25A26		ENSG00000144741	"Solute carrier family 25 member 26"	Q70HW3	3	66133610-66388116	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026887	Supported		Supported	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA026887: AB_2189921"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.83e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.43e-2)"	"prognostic favorable (1.73e-5)"	"unprognostic (4.73e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-1)"	15.8	16.0	9.6	5.6	9.9	12.9	15.0	8.7	11.0	12.7	6.8	18.1	7.8	13.3	9.4	15.9	12.7	7.8	28.3	10.1	8.7	18.5	25.9	11.6	10.7	9.1	9.3	16.5	15.5	14.9	10.2	7.7	9.2	13.5	9.5	8.5	16.1	9.0	42.4	22.0	13.3	7.8	9.3	13.5	17.4	14.3	11.1	8.6	15.8	21.0	9.6	17.5	14.1	11.3	10.7	10.4	6.5	12.4	13.9	13.1	13.9	9.0	15.7	10.7	10.2	13.5	13.9	12.3	5.5	15.1	14.3	7.6	7.3	15.8	11.7	11.5	16.8	16.3	8.1	19.2	14.7	22.5	13.4	17.7	29.6	8.4	21.3	11.2	8.9	21.5	9.2	12.8	12.9	12.5	9.9	28.3	20.8	23.2	6.8	10.0	11.7	19.4	10.1	8.3	5.4	14.6	12.4	11.8	21.4	10.9	9.8	19.7	10.4	12.7	11.0	15.9	16.6	21.1	30.6	15.1	17.4	21.1	14.7	1.8	9.9	6.1	15.4	10.8	14.5	19.3	16.9	16.4	18.3	16.2	20.5	17.5	0.9	18.1	6.7	17.5	17.7	13.4	9.6	9.9	8.7	11.0	10.1	8.7	9.1	9.3	9.2	9.3	11.1	11.3	11.6	32.1	22.2	22.9	29.5	35.8	38.6	45.7	28.5	17.7	36.1	34.0	106.9	30.0	25.0	18.4	12.5	36.8	27.3	14.1	35.2	28.8	33.3	17.2	13.6	20.5	18.6	9.2	55.5	45.1	44.6	26.1	17.3	19.1	19.6	21.1	13.2	39.1	30.3	11.8	51.4	29.2	28.5	22.3	26.5	28.6	16.1	15.8	37.4	31.9	21.4	26.5	32.0	32.2	63.9	27.6	20.8	21.8	18.7	49.1	30.8	57.7	16.2	24.5	19.7	31.7	22.1	29.4	32.9	28.2	36.8	32.7	39.6	22.3	33.3	37.8
SLC25A3	PHC	ENSG00000075415	"Solute carrier family 25 member 3"	Q00325	12	98593591-98606379	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1537.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1748.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045709			Supported	Mitochondria		NA	NA		83000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA045709: AB_10965843"	"unprognostic (1.16e-2)"	"unprognostic (4.68e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.56e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.25e-3)"	"unprognostic (9.41e-2)"	"unprognostic (4.98e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (8.11e-7)"	"unprognostic (3.45e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.72e-2)"	300.9	550.7	131.2	184.7	136.0	209.2	267.5	159.3	146.5	224.3	209.3	418.9	396.4	283.5	226.1	437.7	248.9	136.2	1237.8	132.6	160.4	419.8	370.1	255.7	201.7	148.9	149.6	290.2	392.2	499.7	216.9	192.4	153.0	209.9	347.6	167.2	302.7	220.9	1537.4	275.7	321.2	257.4	150.4	235.1	423.5	90.8	159.0	205.7	225.1	1233.2	312.8	294.7	264.6	135.4	731.4	447.1	620.0	509.6	534.1	891.5	1005.3	622.8	724.1	704.3	573.4	787.6	316.4	1003.2	376.9	633.0	320.3	573.7	616.9	741.3	680.6	402.9	651.8	589.5	297.4	563.3	683.0	665.7	416.6	857.3	616.8	494.2	681.2	994.3	990.8	488.8	654.9	240.5	782.7	436.5	642.5	724.2	605.4	540.6	988.5	703.0	730.3	1075.0	858.8	559.6	355.5	506.1	740.1	565.5	1009.8	504.4	771.0	676.3	782.0	371.2	390.0	442.8	603.4	486.5	648.5	678.1	295.6	368.3	494.9	184.7	408.9	223.2	244.7	520.2	285.6	298.5	270.8	271.4	534.7	222.6	281.3	269.8	166.6	288.5	545.2	321.7	377.4	637.0	131.2	136.0	159.3	146.5	132.6	160.4	148.9	149.6	153.0	150.4	159.0	135.4	319.2	214.7	294.8	46.0	392.2	376.0	590.6	751.4	495.1	223.1	442.5	549.3	1748.6	370.3	384.5	215.2	79.2	785.9	480.8	727.5	874.6	512.1	41.7	217.9	275.3	328.6	312.4	413.5	44.9	879.5	946.2	393.1	390.4	288.7	210.4	477.9	278.1	416.3	589.4	292.7	49.7	470.7	370.2	467.9	280.7	29.0	255.1	449.1	437.6	34.7	593.5	317.3	294.5	32.2	42.2	632.9	602.7	256.5	442.7	652.4	945.5	1029.4	201.1	230.2	302.4	470.5	733.5	126.1	169.9	796.6	362.4	814.7	356.3	536.0	729.1	769.9
SLC25A32	MFTC	ENSG00000164933	"Solute carrier family 25 member 32"	Q9H2D1	8	103398635-103415189	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024763, HPA047402"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA024763: , HPA047402: AB_2680032"	"unprognostic (2.45e-3)"	"unprognostic (8.19e-2)"	"unprognostic (3.87e-3)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.06e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (9.47e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (1.53e-6)"	"unprognostic (7.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.49e-2)"	13.5	7.2	3.1	12.5	3.9	14.6	11.2	4.1	4.8	8.6	2.9	7.7	6.8	10.7	7.5	7.3	9.3	11.5	9.7	4.1	4.5	9.6	17.9	8.5	16.9	4.7	4.6	9.6	8.5	8.8	11.3	10.1	4.6	8.0	7.7	1.4	6.4	7.5	9.6	6.9	7.6	10.9	4.6	12.7	7.0	6.4	4.0	8.7	7.1	9.2	12.8	15.0	7.0	5.3	33.7	11.5	10.5	18.3	21.3	23.3	10.3	27.4	39.9	30.6	31.4	14.0	19.6	73.8	25.8	29.5	17.7	20.4	22.5	22.5	47.0	45.5	16.1	53.5	8.5	18.3	37.4	26.5	23.1	23.1	17.9	34.5	51.2	8.6	32.5	19.4	33.9	25.9	30.5	13.5	45.0	21.6	17.1	39.3	23.6	33.6	16.3	50.8	20.8	12.7	28.0	17.2	13.6	22.3	48.9	10.5	19.3	18.5	22.6	36.7	24.9	44.2	36.2	19.2	19.7	76.8	31.0	38.1	27.5	0.6	3.3	1.6	6.0	3.7	7.3	7.0	6.4	6.9	4.1	4.8	6.5	6.7	0.8	5.2	4.3	3.5	5.5	5.7	3.1	3.9	4.1	4.8	4.1	4.5	4.7	4.6	4.6	4.6	4.0	5.3	28.9	3.2	3.3	10.1	46.9	23.1	16.7	6.9	32.5	9.4	10.3	6.7	10.4	11.5	5.4	5.5	6.2	11.9	20.9	4.1	7.9	9.8	4.8	8.3	14.0	22.2	11.4	16.2	30.3	9.4	13.6	19.6	27.0	9.1	8.9	8.0	20.0	15.2	10.2	8.4	25.8	7.1	8.2	7.3	11.6	4.7	9.3	16.2	10.6	24.4	9.9	7.6	15.5	25.6	46.6	10.0	3.1	8.6	56.3	14.4	4.1	9.5	2.6	8.1	19.7	13.5	14.7	22.9	17.1	32.6	25.9	14.0	27.7	9.5	7.5	15.1
SLC25A38	FLJ20551	ENSG00000144659	"Solute carrier family 25 member 38"	Q96DW6	3	39383370-39397351	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041027	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA041027: AB_10794403"	"unprognostic (3.82e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.54e-2)"	"prognostic favorable (1.58e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.06e-1)"	"prognostic favorable (7.29e-4)"	19.1	35.4	22.2	18.8	23.3	70.0	21.0	25.9	26.8	23.8	33.6	28.1	25.3	27.3	27.6	14.5	27.3	19.4	20.7	22.9	26.3	28.7	58.0	21.0	36.2	24.2	24.1	44.1	45.6	38.7	30.7	15.4	25.3	29.2	36.9	23.0	22.5	23.9	48.2	16.7	25.2	20.3	22.6	27.2	33.8	18.7	26.0	33.6	52.0	35.7	35.4	27.8	19.1	23.3	24.3	38.3	24.3	41.2	56.4	46.4	30.8	33.6	46.1	48.3	43.7	26.3	5.6	67.8	19.6	31.6	40.7	18.4	55.2	40.1	36.0	43.6	45.0	52.0	33.5	40.2	75.6	37.7	33.9	58.8	46.1	46.2	93.2	44.6	31.5	52.8	47.7	40.6	36.4	35.2	44.7	67.0	66.2	35.9	44.3	16.2	26.4	47.7	37.5	45.4	24.3	31.1	11.9	65.9	34.0	44.5	33.5	35.0	26.9	38.3	26.4	56.2	48.9	54.7	93.1	41.9	29.3	48.3	24.7	30.7	9.6	18.1	38.8	5.7	44.7	50.8	39.1	43.3	14.9	37.8	41.7	40.5	1.0	57.0	8.4	18.5	55.3	29.2	22.2	23.3	25.9	26.8	22.9	26.3	24.2	24.1	25.3	22.6	26.0	23.3	10.4	22.4	27.4	8.5	35.6	11.5	13.0	12.5	28.5	13.2	26.1	22.6	16.8	22.8	9.6	27.6	6.2	35.2	33.1	21.9	21.5	15.7	6.5	26.6	16.3	11.1	12.6	73.7	8.9	16.9	32.6	13.7	16.8	38.5	22.2	24.0	9.7	27.0	15.2	5.0	10.1	25.6	12.2	7.0	13.7	12.9	15.5	9.8	12.4	1.9	11.2	18.9	29.9	7.1	6.2	13.4	22.2	13.5	23.3	17.7	23.1	31.3	12.3	12.6	6.6	15.2	14.9	11.0	7.8	19.4	10.2	19.4	36.6	32.8	26.7	8.4
SLC25A42	MGC26694	ENSG00000181035	"Solute carrier family 25 member 42"	Q86VD7	19	19063994-19113030	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 82.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 67.7;Hepatocytes: 52.1;Proximal tubular cells: 39.6;Rod photoreceptor cells: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.7;MAIT T-cell: 1.4;memory B-cell: 3.3;memory CD4 T-cell: 1.5;memory CD8 T-cell: 2.4;naive B-cell: 3.2;naive CD4 T-cell: 1.0;naive CD8 T-cell: 1.4;NK-cell: 1.8;T-reg: 1.7"	"Group enriched"	"Detected in many"	6	"B-cells: 3.3;NK-cells: 1.8;T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"K-562: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049449	Approved		Supported	Mitochondria		Yes	No			"Cluster 43: B-cells - Humoral immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"HPA049449: AB_2680772"	"unprognostic (2.27e-1)"	"prognostic favorable (5.04e-4)"	"unprognostic (5.79e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.27e-3)"	"prognostic favorable (4.11e-4)"	"unprognostic (6.89e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.29e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.03e-2)"	8.5	7.5	17.2	4.3	16.9	8.3	7.9	14.5	18.3	13.1	16.7	8.4	5.1	10.1	3.7	5.2	12.5	3.5	15.8	17.9	16.9	34.1	82.0	6.6	9.0	14.9	15.2	16.9	11.3	6.0	14.4	2.6	14.7	9.9	2.4	8.4	9.2	5.2	46.5	6.7	9.3	4.9	13.9	12.7	8.3	7.0	18.0	8.1	25.6	32.6	7.5	9.6	9.1	13.9	7.3	1.0	1.8	3.2	6.8	5.6	2.8	3.5	5.2	5.3	6.0	1.4	14.3	5.2	8.0	3.3	5.3	1.3	3.7	2.9	3.0	1.3	7.0	1.8	2.0	11.8	5.4	0.8	3.6	5.6	2.0	4.0	2.4	4.3	2.4	16.8	20.9	9.2	2.8	6.6	9.0	8.4	1.0	2.0	7.4	6.8	3.2	10.2	2.1	1.3	2.0	1.5	3.7	0.1	1.6	2.4	6.5	4.1	2.2	3.9	2.2	8.2	3.4	10.7	6.2	4.1	4.1	11.2	2.0	0.0	0.1	0.1	2.7	0.3	1.4	3.3	1.5	2.4	0.2	3.2	1.0	1.4	0.0	1.8	0.3	0.4	1.7	0.9	17.2	16.9	14.5	18.3	17.9	16.9	14.9	15.2	14.7	13.9	18.0	13.9	4.6	0.0	13.1	12.4	14.2	3.2	2.8	3.3	2.8	67.7	5.9	6.6	9.7	5.7	4.1	9.2	18.8	7.7	16.5	3.1	13.7	1.5	1.2	2.5	5.4	4.1	8.4	13.7	18.6	3.1	3.8	5.1	4.1	3.6	3.8	8.3	5.3	52.1	1.8	3.3	25.0	3.8	6.1	0.6	1.9	1.6	5.0	1.4	3.6	6.5	1.3	12.5	32.0	16.1	8.6	2.5	4.6	6.4	16.4	2.4	9.2	39.6	3.0	41.4	6.6	9.6	5.8	10.6	7.6	0.9	2.8	4.7	10.9	8.0	3.1	1.7
SLC25A46		ENSG00000164209	"Solute carrier family 25 member 46"	Q96AG3	5	110738136-110765161	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 238.9;Late spermatids: 448.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039601, HPA071582"	Approved		Supported	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA039601: AB_2676592, HPA071582: AB_2686422"	"unprognostic (1.86e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (1.98e-1)"	22.9	15.9	10.4	19.9	11.8	17.6	16.4	12.7	16.7	18.5	7.8	22.1	23.8	14.7	10.5	21.2	10.7	15.8	31.1	12.2	12.2	29.7	30.0	16.7	22.5	12.4	10.2	11.7	15.4	20.6	4.9	17.0	13.2	15.7	21.6	18.8	13.3	16.0	55.8	14.9	20.9	20.8	10.3	15.7	20.1	21.9	11.2	24.8	19.8	60.2	26.8	19.0	6.6	14.1	36.2	27.7	25.7	20.7	65.2	60.2	9.9	44.3	55.9	47.5	59.3	37.6	28.7	96.8	44.8	50.1	61.9	29.6	41.0	71.2	54.3	61.8	20.8	40.1	35.2	25.6	53.1	37.3	40.2	49.9	25.4	55.5	39.6	29.5	31.9	37.2	31.4	56.4	54.1	27.3	54.0	17.2	18.1	25.7	24.7	26.0	57.0	71.5	35.1	39.2	46.7	33.5	37.7	29.7	49.7	23.7	30.9	35.3	42.5	43.6	21.0	40.7	54.4	111.8	76.2	68.4	48.0	43.8	24.0	29.2	16.0	13.2	12.3	19.0	12.5	14.4	13.7	12.9	17.0	14.5	14.5	14.8	6.6	20.9	17.7	11.1	18.2	17.4	10.4	11.8	12.7	16.7	12.2	12.2	12.4	10.2	13.2	10.3	11.2	14.1	21.3	22.4	24.8	40.8	26.7	22.9	9.1	16.0	31.9	16.8	15.7	10.8	63.5	11.5	12.9	20.2	22.9	21.7	18.0	34.8	19.6	18.1	238.9	10.4	20.1	18.9	23.4	29.9	73.3	25.6	18.2	22.6	34.7	12.1	19.0	16.2	26.7	43.9	27.2	18.5	63.9	28.3	32.6	26.1	21.0	448.2	21.1	23.9	30.2	31.9	28.1	21.9	17.5	49.8	91.8	18.9	22.8	22.2	73.8	8.0	26.5	41.7	14.9	14.1	19.7	18.5	22.6	23.3	14.2	30.0	26.9	20.5	23.9	22.7	24.0	6.8
SLC26A1	"EDM4, SAT-1"	ENSG00000145217	"Solute carrier family 26 member 1"	Q9H2B4	4	979073-993440	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 16.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 6.2;Excitatory neurons: 4.4;Hepatocytes: 10.4;Inhibitory neurons: 4.4;Oligodendrocyte precursor cells: 5.5;Proximal enterocytes: 6.4;Proximal tubular cells: 9.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 13.8;HMC-1: 8.7;T-47d: 9.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA041654	Uncertain		Approved	Microtubules		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Microtubules		"HPA041654: AB_10796350"	"unprognostic (1.96e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.67e-4)"	"unprognostic (5.13e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-3)"	1.8	7.0	2.5	1.5	2.5	1.4	2.7	5.4	3.3	2.9	0.1	2.2	5.2	2.1	0.2	1.6	2.1	1.2	1.2	2.9	2.0	5.8	16.8	2.0	1.5	3.9	2.5	2.5	3.3	0.1	3.3	0.3	3.2	3.0	0.1	0.6	3.2	0.1	1.4	2.5	4.5	0.0	1.0	2.4	3.1	1.2	2.0	0.1	3.2	0.3	0.1	1.8	1.9	2.6	1.3	2.1	0.0	1.6	0.1	0.4	4.1	1.7	0.1	0.0	0.0	4.6	2.7	0.7	2.4	0.0	1.6	1.3	0.1	0.0	0.0	2.7	0.8	3.0	3.3	13.8	0.1	2.1	8.7	0.5	0.2	0.1	0.0	1.0	0.3	2.6	3.3	0.0	0.3	2.8	1.4	3.5	0.8	1.6	7.2	6.9	0.0	0.3	0.7	4.5	0.2	1.2	0.4	0.2	1.2	0.3	9.1	1.3	2.0	4.4	0.9	4.8	1.3	6.5	3.2	1.0	1.4	4.1	2.1	5.4	0.3	0.2	0.2	0.1	0.3	0.2	0.5	0.4	0.1	0.0	0.3	0.7	0.0	0.6	0.1	0.1	0.8	0.3	2.5	2.5	5.4	3.3	2.9	2.0	3.9	2.5	3.2	1.0	2.0	2.6	0.3	0.0	1.1	6.2	0.2	0.0	0.2	0.3	0.0	0.0	0.8	0.8	1.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	1.9	0.1	0.0	0.7	0.3	0.3	0.0	0.0	4.4	0.4	3.6	0.3	0.5	0.8	1.3	0.8	1.4	10.4	0.7	0.0	4.4	0.8	0.0	0.3	0.0	0.0	0.9	0.4	1.8	1.0	0.3	0.3	0.0	5.5	1.7	0.4	1.3	0.4	0.1	0.2	6.4	9.7	0.0	0.3	0.0	0.4	0.3	0.1	0.1	0.2	0.1	0.8	0.5	0.6	0.7	0.1
SLC26A2	"DTD, DTDST"	ENSG00000155850	"Solute carrier family 26 member 2"	P50443	5	149960758-149993455	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"intestine: 212.0"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 2026.2;Glandular and luminal cells: 684.5;Syncytiotrophoblasts: 808.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"EFO-21: 66.1;RPTEC TERT1: 151.7;TIME: 80.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041957, HPA058090"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 37: Intestine - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA041957: AB_10795646, HPA058090: AB_2683602"	"unprognostic (6.64e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.03e-2)"	"prognostic favorable (7.29e-4)"	"unprognostic (2.59e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (2.59e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.06e-1)"	5.2	30.7	2.2	7.8	2.3	2.5	9.2	9.5	3.8	6.3	4.0	212.0	12.9	9.3	22.8	10.7	5.0	5.5	2.8	2.2	3.5	4.9	1.7	7.3	4.0	3.8	3.4	4.8	3.4	37.7	7.1	34.0	3.5	12.2	189.6	20.8	35.8	18.4	3.9	7.8	16.1	9.3	3.8	3.7	3.3	4.2	3.9	4.2	4.5	3.7	5.9	4.7	3.0	3.4	9.5	8.6	10.5	17.3	12.6	8.8	2.5	8.9	8.0	7.0	8.5	44.7	5.1	7.4	66.1	9.5	16.8	6.8	10.0	20.5	12.4	6.0	6.4	9.3	6.7	5.2	9.4	17.3	15.2	9.8	11.8	11.7	15.2	17.3	16.8	9.0	2.4	7.1	29.6	3.0	6.6	9.1	3.2	3.2	13.5	9.5	16.3	3.9	151.7	41.6	3.2	8.1	15.6	3.6	27.2	8.1	7.3	10.0	80.4	16.0	11.8	14.2	10.7	5.2	7.3	4.3	14.7	20.6	23.5	4.9	0.5	0.3	0.9	0.3	1.1	0.5	0.5	0.8	0.7	0.5	0.8	0.9	0.3	1.1	1.6	0.7	1.1	0.5	2.2	2.3	9.5	3.8	2.2	3.5	3.8	3.4	3.5	3.8	3.9	3.4	47.4	44.8	11.3	3.3	8.5	4.6	13.2	22.9	7.4	17.1	23.8	14.6	7.8	7.2	24.2	33.1	16.7	219.2	11.5	2026.2	1.9	6.1	32.7	237.0	92.3	29.8	21.1	16.6	5.4	9.9	7.7	21.5	5.1	684.5	90.0	29.6	17.2	2.0	30.4	6.7	7.9	52.5	20.3	15.3	11.8	15.7	17.4	17.4	90.7	17.8	19.6	15.2	15.5	16.6	6.0	12.1	177.4	12.4	15.2	15.1	91.7	5.1	26.6	84.5	0.0	18.7	13.9	8.7	11.4	73.9	5.1	808.9	14.0	26.3	208.9	5.5
SLC26A3	"CLD, DRA"	ENSG00000091138	"Solute carrier family 26 member 3"	P40879	7	107765467-107803225	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 1120.4"	"Cell type enriched"	"Detected in some"	4	"Distal enterocytes: 2328.4"	"Cancer enriched"	"Detected in many"	14	"colorectal cancer: 52.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPMI-8226: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036055	Approved					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA036055: AB_10602401"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.85e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.58e-3)"	1.1	0.0	0.0	19.7	0.0	0.0	59.5	0.2	0.1	0.3	0.0	1120.4	576.9	0.9	15.3	0.5	0.8	17.8	0.0	0.0	0.0	0.8	0.5	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.1	878.8	0.1	0.0	129.9	0.0	0.1	118.5	15.0	0.0	0.0	1.3	0.9	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	165.9	4.2	0.0	0.3	0.0	0.0	0.0	51.4	41.7	0.3	34.3	0.0	0.0	0.0	0.0	0.0	2328.4	0.0	0.0	6.4	1.8	0.1	0.3	14.3	0.0	110.2	0.0	0.0	0.1	0.0	0.2	26.7	0.2	0.0	0.1	0.0	0.0	114.3	32.5	0.0	0.0	0.0	0.6	0.3	0.1	0.0	89.9	0.0	0.0	0.0	101.6	182.1	0.0	503.4	0.0	0.0	0.3	388.9	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	2.2	0.0	86.0	0.1
SLC26A4	"DFNB4, PDS"	ENSG00000091137	"Solute carrier family 26 member 4"	O43511	7	107660828-107717809	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"thyroid gland: 263.7"	"Cell type enhanced"	"Detected in many"		"Club cells: 19.0;Excitatory neurons: 29.3;Inhibitory neurons: 53.9;Ionocytes: 54.9;Prostatic glandular cells: 17.3;Urothelial cells: 19.9"	"Cancer enriched"	"Detected in some"	8	"thyroid cancer: 37.6"	"Group enriched"	"Detected in many"	88	"amygdala: 4.0;basal ganglia: 10.2;cerebral cortex: 11.8;hippocampal formation: 8.8"	"Immune cell enriched"	"Detected in single"	8	"naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.6;hTERT-RPE1: 3.7;LHCN-M2: 2.1"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 9.7"	"Region enhanced"	"Detected in some"		"hippocampal formation: 4.8"	HPA042860	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA042860: AB_10796680"	"unprognostic (1.19e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.39e-1)"	0.4	0.1	4.0	0.1	10.2	0.0	0.8	0.0	11.8	1.4	0.0	0.2	0.1	0.5	0.1	0.1	0.3	0.4	0.6	8.8	0.0	6.4	0.1	0.5	0.4	0.0	0.0	0.3	0.3	3.9	0.3	0.3	0.0	3.8	0.2	0.1	0.4	0.2	0.5	0.2	0.1	0.3	0.0	0.1	0.7	0.6	0.0	0.2	263.7	0.1	0.2	1.5	0.3	0.0	0.3	0.1	0.2	0.0	0.3	0.6	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.1	0.2	0.0	0.0	1.6	0.4	0.0	0.1	0.1	0.1	0.1	0.5	0.0	0.4	0.2	0.0	3.7	0.0	0.3	0.0	0.1	2.1	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.3	0.3	0.2	0.1	1.3	0.3	0.3	0.1	0.3	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	10.2	0.0	11.8	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.2	7.7	2.6	0.2	1.7	0.7	6.5	0.0	6.6	3.2	1.8	0.6	0.0	19.0	0.0	2.1	0.3	0.4	0.4	0.0	0.2	3.9	0.3	0.5	4.9	7.3	0.0	29.3	0.0	0.1	1.5	0.0	1.8	5.1	0.2	1.1	0.2	0.3	1.7	53.9	0.0	54.9	0.6	2.0	2.7	0.9	0.7	7.2	3.7	0.7	1.2	1.0	1.5	1.6	0.1	0.1	1.2	0.0	17.3	0.0	0.1	15.2	1.8	0.0	2.9	1.6	2.0	0.4	0.1	1.4	0.0	1.7	0.2	0.5	19.9
SLC26A5	"DFNB61, PRES"	ENSG00000170615	"Solute carrier family 26 member 5"	P58743	7	103352730-103446207	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell shape, Hearing"	"Motor protein"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Astrocytes: 5.5;Excitatory neurons: 4.1;Gastric mucus-secreting cells: 7.1;Hepatic stellate cells: 5.3;Inhibitory neurons: 3.5;Microglial cells: 6.5;Oligodendrocytes: 4.2"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"basal ganglia: 10.4"							NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (3.86e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.38e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.56e-4)"	"unprognostic (4.21e-3)"	"unprognostic (8.92e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.67e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.69e-3)"	0.1	0.1	0.3	0.0	0.3	0.0	0.7	2.2	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.4	0.1	0.4	0.5	0.0	0.2	0.3	0.0	0.0	0.3	0.4	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.6	0.2	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.2	0.2	0.1	0.4	0.4	0.5	0.3	0.4	0.3	0.5	0.3	6.4	2.6	5.5	0.2	0.3	0.0	0.0	0.0	0.2	0.3	0.1	0.7	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.4	0.2	0.5	0.0	0.0	4.1	0.0	0.0	2.2	7.1	0.2	0.0	0.0	5.3	0.0	0.0	0.0	3.5	0.0	0.0	0.3	0.3	0.0	0.3	0.0	0.0	6.5	0.0	0.3	0.0	2.0	4.2	0.3	0.0	0.0	0.0	0.8	0.0	0.0	2.2	1.2	0.0	0.2	0.1	0.3	0.5	0.0	0.3	0.0	0.6	0.0	0.0	0.6
SLC26A8		ENSG00000112053	"Solute carrier family 26 member 8"	Q96RN1	6	35943516-36024868	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Differentiation, Ion transport, Meiosis, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 44.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 54.1;Excitatory neurons: 15.8;Inhibitory neurons: 12.1;Late spermatids: 12.0;Spermatocytes: 64.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	11	"neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA038081	Enhanced					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA038081: AB_10670653"	"unprognostic (8.18e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.93e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.78e-1)"	"unprognostic (4.63e-6)"	"unprognostic (7.14e-2)"	"unprognostic (4.24e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.24e-8)"	0.2	0.1	0.6	0.3	0.5	4.8	0.1	0.8	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	1.1	0.0	0.1	0.3	0.0	0.9	0.6	0.0	0.1	0.0	0.2	0.1	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.3	1.0	0.0	44.0	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.6	0.5	0.8	0.8	0.4	1.1	0.9	0.6	1.1	0.3	0.9	0.2	0.1	3.2	1.1	2.0	0.0	0.4	0.4	0.1	0.0	0.3	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	54.1	0.4	0.2	0.3	0.0	0.0	15.8	0.0	0.0	0.3	0.0	0.8	0.0	0.1	0.4	0.8	0.1	0.0	12.1	0.0	0.0	1.2	0.4	12.0	0.9	0.5	1.8	1.0	0.9	0.0	0.0	0.5	1.0	0.1	0.0	0.4	0.1	0.4	0.3	0.1	0.3	0.3	0.0	0.7	0.1	64.8	0.8	0.0	0.1	0.3	0.3	0.0	0.0	0.2
SLC27A4	"ACSVL4, FATP4"	ENSG00000167114	"Solute carrier family 27 member 4"	Q6P1M0	9	128340527-128361470	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 53.7;Proximal enterocytes: 100.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007293, CAB009771"	Approved		Approved	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"CAB009771: AB_2270540, HPA007293: AB_1857062"	"unprognostic (7.25e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.92e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.31e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.07e-2)"	"prognostic favorable (2.61e-5)"	"unprognostic (7.29e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.45e-2)"	"unprognostic (8.01e-3)"	11.4	14.7	22.5	8.5	23.7	2.7	11.6	25.4	30.3	17.2	12.4	22.8	66.9	14.4	6.3	61.8	10.4	7.3	20.4	22.7	25.9	28.8	40.0	11.8	6.4	29.4	23.9	8.3	21.6	15.5	12.1	5.6	28.8	13.1	9.4	6.8	16.4	7.5	16.1	41.8	41.1	9.3	19.7	11.6	16.4	25.8	27.1	5.8	15.5	6.2	9.6	15.5	23.5	24.1	20.8	41.8	21.1	28.1	31.5	9.8	23.3	16.7	11.7	20.3	14.5	30.1	20.7	19.1	13.5	19.8	24.8	70.6	25.5	20.7	6.7	19.5	37.2	11.4	35.6	28.5	17.1	21.0	17.8	12.7	29.6	21.2	17.0	9.4	23.1	26.3	27.5	13.7	20.2	56.2	26.0	22.7	9.2	51.6	63.0	30.4	19.6	36.4	38.1	32.0	34.8	19.2	27.6	57.0	20.3	11.3	26.7	8.8	32.4	23.7	22.9	26.6	22.0	11.4	17.4	6.5	24.3	13.0	27.7	0.0	2.5	1.7	4.7	3.3	3.4	2.1	2.9	3.6	4.4	0.9	2.3	2.4	1.0	1.4	4.3	3.9	2.2	2.4	22.5	23.7	25.4	30.3	22.7	25.9	29.4	23.9	28.8	19.7	27.1	24.1	4.7	0.0	1.1	12.7	2.0	2.8	1.4	4.0	1.2	9.6	5.8	3.0	5.2	7.2	2.8	9.2	12.5	6.1	2.1	53.7	1.9	13.1	4.8	3.6	5.2	5.3	13.1	4.0	27.7	16.0	6.8	3.5	14.3	9.3	8.9	5.9	3.6	20.1	11.3	8.4	29.2	18.6	8.2	6.1	1.9	5.4	1.2	5.4	1.8	15.9	10.0	5.0	6.2	8.5	26.4	26.4	30.0	4.1	3.2	3.2	100.6	9.7	1.8	7.8	6.6	4.4	4.4	11.8	7.9	11.9	6.1	5.2	2.4	7.9	25.7	2.8
SLC28A1	CNT1	ENSG00000156222	"Solute carrier family 28 member 1"	O00337	15	84884654-84945798	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"intestine: 49.1;kidney: 48.2;liver: 111.3"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 38.6;Hofbauer cells: 54.3;Proximal enterocytes: 86.9;Proximal tubular cells: 93.4"	"Group enriched"	"Detected in some"	63	"liver cancer: 10.9;renal cancer: 33.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA019551, HPA056247"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Nuclear speckles, Cytosol"	"HPA019551: AB_2670187, HPA056247: "	"unprognostic (3.81e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.42e-2)"	"unprognostic (7.72e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.55e-1)"	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.1	0.3	0.0	0.0	37.9	0.0	0.5	0.1	0.7	0.2	1.0	0.1	0.3	48.2	111.3	0.0	0.2	0.9	0.3	0.0	0.0	0.2	0.2	1.2	0.7	0.0	0.0	0.0	0.1	0.0	1.5	0.0	49.1	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.3	0.9	0.3	0.7	0.4	0.2	0.6	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.3	2.2	4.3	0.6	7.3	0.0	0.5	0.0	0.0	11.7	3.0	0.0	0.4	0.1	0.1	0.0	0.0	0.5	0.0	0.5	0.4	0.0	0.6	0.0	0.0	0.4	38.6	54.3	0.0	0.5	2.8	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.5	1.1	0.3	2.5	0.0	0.0	0.0	86.9	93.4	1.4	0.0	0.0	2.6	0.2	0.0	0.0	0.0	0.0	0.8	0.4	0.3	1.5	0.1
SLC29A3	"ENT3, FLJ11160"	ENSG00000198246	"Solute carrier family 29 member 3"	Q9BZD2	10	71319259-71381423	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 46.1;Extravillous trophoblasts: 45.3;Hofbauer cells: 34.7;Syncytiotrophoblasts: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 31.8;Hep G2: 35.9;RT4: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046085, HPA054976, HPA057905"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Vesicles"		"HPA046085: AB_2679531, HPA054976: AB_2682659, HPA057905: AB_2683550"	"unprognostic (1.73e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (6.07e-6)"	"unprognostic (1.28e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (3.43e-3)"	4.7	2.6	3.1	4.1	3.9	1.1	4.8	3.7	3.7	7.3	2.7	4.4	2.1	6.8	2.5	2.2	5.8	4.4	2.4	3.0	3.6	2.5	9.4	6.7	7.1	4.7	3.7	9.7	5.2	3.5	1.7	11.2	4.2	5.1	3.5	0.3	4.9	2.9	1.4	2.6	3.7	5.1	4.2	6.5	6.1	3.7	4.4	3.7	3.8	0.6	3.8	9.8	4.4	5.0	2.1	12.3	1.8	7.8	6.8	5.3	31.8	2.3	2.2	0.7	0.4	13.8	8.8	7.4	6.4	4.7	3.2	18.3	5.7	2.9	0.1	5.6	5.6	2.2	1.0	35.9	3.3	1.8	4.5	5.2	12.9	0.3	0.6	1.5	3.2	8.5	6.5	6.8	0.9	19.1	4.2	3.8	4.2	19.2	4.5	5.7	0.6	5.9	2.3	29.5	8.5	9.6	6.4	20.3	1.7	5.2	3.2	4.0	5.2	0.2	3.8	2.3	0.1	1.8	3.1	4.0	7.6	24.0	1.3	4.2	19.3	2.2	5.4	15.3	4.6	4.9	4.5	5.1	29.1	1.9	3.5	5.0	1.5	9.4	10.3	20.2	5.5	9.5	3.1	3.9	3.7	3.7	3.0	3.6	4.7	3.7	4.2	4.2	4.4	5.0	2.0	3.2	1.1	2.0	3.1	0.3	1.5	4.0	1.8	2.3	2.7	3.8	0.8	1.5	3.8	0.0	0.0	46.1	6.3	2.6	0.0	6.1	3.6	1.8	3.2	1.8	1.8	4.2	2.4	8.9	45.3	4.7	7.1	2.4	2.5	10.2	3.3	5.4	34.7	0.0	1.3	2.5	8.2	11.8	4.4	15.2	2.8	10.9	1.8	16.9	8.5	3.0	3.1	2.5	2.7	7.9	13.1	1.5	6.0	3.2	0.1	2.0	2.6	0.4	0.0	0.2	2.5	0.6	5.0	0.7	0.0	31.7	2.9	10.0	2.5	1.7
SLC2A1	"CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR"	ENSG00000117394	"Solute carrier family 2 member 1"	P11166	1	42925353-42958893	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Cancer-related genes, Cataract, Disease variant, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 98.7;skin 1: 79.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 833.8;Erythroid cells: 520.4;Extravillous trophoblasts: 536.4;Syncytiotrophoblasts: 2482.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 241.0;CACO-2: 219.9;Hep G2: 157.4"	"Low region specificity"	"Detected in all"							"CAB002759, HPA031345, HPA058494"	Enhanced	Supported	Enhanced	"Plasma membrane"		No	No		2000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"CAB002759: , HPA031345: AB_2673835, HPA058494: AB_2683734"	"unprognostic (3.60e-2)"	"unprognostic (5.85e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (3.65e-8)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (4.55e-9)"	"unprognostic (1.11e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.05e-4)"	6.9	3.6	24.1	2.5	26.1	41.6	7.8	33.7	27.7	28.6	43.6	6.1	0.4	5.1	1.4	54.1	8.2	1.7	10.0	20.6	28.5	14.2	1.7	3.3	1.0	31.9	29.3	5.5	2.1	4.5	4.8	98.7	34.5	6.0	1.0	24.6	17.6	5.1	2.0	79.8	4.6	0.4	24.7	7.5	8.4	2.1	41.2	1.0	3.0	1.5	2.1	19.3	54.2	29.4	60.5	52.9	66.3	6.2	3.5	1.2	241.0	47.8	36.9	15.5	27.8	219.9	96.3	22.2	138.9	6.0	26.5	43.6	12.5	52.3	14.8	16.4	10.3	29.8	20.9	157.4	12.9	16.8	8.1	3.3	21.3	18.3	20.5	96.7	2.9	12.8	81.2	1.5	11.7	46.6	7.4	11.7	35.1	22.1	17.9	8.4	20.6	23.3	21.7	17.9	27.0	23.8	47.7	95.6	11.0	70.0	3.8	16.9	14.9	25.6	28.6	6.1	83.8	5.3	6.5	11.5	57.1	8.2	25.5	0.5	0.1	1.2	10.6	0.3	8.5	10.9	5.1	6.7	3.7	8.3	3.8	4.8	0.2	4.3	0.1	18.4	6.2	4.0	24.1	26.1	33.7	27.7	20.6	28.5	31.9	29.3	34.5	24.7	41.2	29.4	3.1	0.0	1.8	12.7	25.4	286.1	48.8	286.3	66.0	15.8	41.4	21.8	26.7	20.0	159.3	27.6	66.7	833.8	33.5	53.1	5.9	53.2	4.0	112.1	46.0	100.5	18.4	520.4	2.8	11.7	536.4	25.9	11.7	118.9	6.3	6.8	2.2	2.1	84.8	5.0	3.2	22.4	65.1	1.6	34.2	0.3	7.8	5.0	21.4	71.2	36.0	350.1	18.6	8.0	9.9	120.3	51.9	14.7	11.6	31.2	1.9	2.2	118.1	32.1	0.0	9.8	32.1	0.1	2.4	99.1	238.3	2482.5	20.8	5.5	11.8	105.8
SLC2A10	GLUT10	ENSG00000197496	"Solute carrier family 2 member 10"	O95528	20	46709649-46736347	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 43.6;Intestinal goblet cells: 56.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	75	"basophil: 20.9"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 20.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 45.8;HSkMC: 56.6;OE19: 49.8;SK-MEL-30: 60.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041015, HPA055673"	Approved		Supported	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"HPA041015: AB_2677252, HPA055673: AB_2682879"	"unprognostic (8.94e-3)"	"unprognostic (2.62e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.06e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.00e-1)"	"unprognostic (5.96e-2)"	7.0	5.9	4.0	3.5	4.1	1.2	15.3	3.4	3.9	19.4	18.9	12.7	5.4	7.9	8.7	5.1	9.9	10.3	5.2	3.8	3.7	3.5	41.4	6.9	1.7	5.2	4.7	9.9	17.4	19.5	6.3	11.6	4.0	31.3	16.0	1.6	24.0	9.9	1.5	3.6	5.3	8.5	3.8	2.6	22.8	2.6	4.0	1.6	19.5	2.7	2.1	9.3	8.4	3.4	0.0	0.1	11.3	11.7	45.8	38.9	34.2	22.2	30.2	10.1	12.0	0.9	38.9	0.0	16.3	40.6	0.0	0.2	0.0	1.1	4.8	0.0	0.3	3.3	0.0	18.6	32.2	0.0	0.0	56.6	1.0	6.2	0.0	11.8	4.2	0.0	0.2	0.1	17.5	41.3	0.0	1.2	4.3	49.8	2.9	0.0	1.6	0.1	0.0	10.6	0.0	1.8	4.3	7.2	60.3	8.1	5.4	9.2	2.6	21.7	9.1	17.2	2.9	0.3	0.1	0.0	0.1	0.0	4.6	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	4.0	4.1	3.4	3.9	3.8	3.7	5.2	4.7	4.0	3.8	4.0	3.4	4.2	6.4	6.3	12.4	0.8	0.6	6.1	7.8	5.2	0.0	29.6	14.4	6.4	7.2	15.8	1.8	0.0	2.7	0.4	11.4	0.0	7.4	0.2	3.2	17.8	4.6	3.6	6.1	0.1	5.6	16.3	16.7	23.4	4.0	6.3	10.7	8.6	43.6	1.1	0.0	0.4	56.6	12.2	1.9	1.3	1.6	26.4	0.4	1.8	2.8	0.0	5.5	0.0	10.1	0.3	5.1	10.3	17.3	2.8	23.9	1.7	0.8	27.5	0.5	13.1	5.1	6.3	0.8	0.3	4.2	1.0	2.1	0.5	3.6	14.6	10.9
SLC2A2	GLUT2	ENSG00000163581	"Solute carrier family 2 member 2"	P11168	3	170996347-171026743	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 836.1"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 457.6"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 105.2"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	55	"CACO-2: 7.7;Hep G2: 27.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010444, HPA028997"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"CAB010444: AB_641068, HPA028997: AB_2672860"			"unprognostic (9.56e-2)"		"unprognostic (1.24e-1)"		"prognostic favorable (2.63e-5)"				"unprognostic (3.10e-1)"		"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.31e-2)"			0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.2	0.4	0.0	0.2	0.0	66.1	0.0	0.0	0.0	0.0	5.2	0.0	0.3	0.3	30.8	836.1	0.0	0.0	0.5	0.4	0.0	2.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	27.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.2	0.4	0.3	0.3	0.5	0.4	0.8	0.4	0.4	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	90.1	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.2	6.7	0.0	0.0	0.1	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	457.6	0.0	0.0	0.1	3.0	0.0	10.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	2.5	0.0	0.0	0.0	105.4	63.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.8	0.0
SLC2A4	GLUT4	ENSG00000181856	"Solute carrier family 2 member 4"	P14672	17	7281718-7288257	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 98.8;skeletal muscle: 223.6"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 135.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"Hep G2: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			CAB016544	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB016544: AB_629533"	"unprognostic (2.53e-1)"	"unprognostic (7.40e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.12e-4)"	"unprognostic (2.40e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.23e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.07e-2)"	16.9	5.2	1.4	0.2	1.7	1.1	11.2	0.9	1.5	9.2	0.9	53.1	0.8	9.3	1.2	5.9	11.3	0.7	98.8	1.3	1.1	2.6	3.7	2.1	0.2	1.0	1.5	3.2	0.8	3.4	4.4	0.6	1.2	9.9	1.1	0.4	6.3	3.3	223.6	4.1	9.7	4.3	1.0	0.3	11.7	3.3	1.3	0.1	4.5	63.2	0.0	27.0	5.6	1.1	0.0	0.0	0.4	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	1.7	0.9	1.5	1.3	1.1	1.0	1.5	1.2	1.0	1.3	1.1	1.7	0.0	0.0	1.0	0.0	1.8	0.9	0.3	2.2	0.1	1.5	1.3	135.2	0.0	0.2	0.0	0.0	0.3	0.0	1.0	7.9	0.1	16.6	0.2	0.1	3.7	0.0	10.7	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.3	1.8	2.8	0.1	0.0	0.0	0.8	0.0	0.3	0.3	4.8	0.0	0.1	7.2	1.0	0.0	6.0	0.0	0.0	0.0	0.1	1.2	8.6	0.0	0.8	0.8	0.3	0.4	0.4	32.9	7.0	19.8	1.7	2.2	0.5	1.1	1.0	0.1	0.5	1.0	0.7
SLC2A9	"Glut9, GLUTX, URATv1"	ENSG00000109667	"Solute carrier family 2 member 9"	Q9NRM0	4	9771153-10054936	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 29.3;liver: 21.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 27.4;Proximal tubular cells: 72.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 36.9;myeloid DC: 30.5"	"Group enriched"	"Detected in many"	30	"dendritic cells: 30.5;monocytes: 36.9"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 48.1;Hep G2: 23.6;hTCEpi: 19.9;THP-1: 20.5;U-937: 13.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA066229, HPA075669"	Enhanced					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA066229: AB_2685639, HPA075669: "	"unprognostic (3.21e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.56e-2)"	"unprognostic (8.94e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (1.32e-11)"	"unprognostic (1.01e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.20e-1)"	1.6	2.6	1.0	2.0	1.2	2.1	4.2	1.3	1.2	2.5	2.7	1.8	10.7	1.4	2.4	5.2	3.5	2.4	2.3	1.1	1.6	29.3	21.4	4.2	2.0	2.3	1.5	1.6	1.0	2.4	1.4	7.6	2.0	3.5	1.6	1.2	16.6	18.8	0.5	2.2	8.4	2.0	1.8	1.8	1.0	0.7	2.0	4.2	2.7	0.5	1.4	6.4	4.0	3.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.1	0.0	0.3	2.4	0.0	3.5	0.7	0.0	7.3	0.0	48.1	0.0	8.2	0.3	0.0	0.0	23.6	1.6	0.1	6.3	3.4	19.9	0.0	4.8	0.0	0.1	0.8	0.0	0.1	0.1	0.0	0.3	2.4	0.0	0.4	0.1	1.5	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	20.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.5	0.1	0.0	36.9	0.9	0.3	7.6	0.3	0.3	0.3	0.1	30.5	0.1	0.2	0.1	1.1	0.2	0.9	12.2	0.2	9.1	1.0	1.2	1.3	1.2	1.1	1.6	2.3	1.5	2.0	1.8	2.0	3.0	1.4	0.0	0.0	8.1	1.3	0.9	13.4	27.4	6.2	0.0	4.6	6.1	2.4	0.0	5.7	3.7	2.1	18.7	0.5	1.7	3.9	0.5	5.1	4.1	2.1	1.5	0.0	1.3	4.4	1.1	1.8	1.6	1.1	11.5	1.3	0.5	2.2	5.2	10.3	0.0	5.6	0.9	10.2	8.7	3.7	3.4	0.0	8.8	0.0	15.9	4.4	1.2	1.0	10.6	1.1	0.6	0.5	0.4	0.3	2.0	8.1	72.6	3.0	0.4	0.0	4.6	1.6	1.1	1.9	5.4	0.6	8.5	0.9	0.7	2.5	7.7
SLC30A10	"DKFZp547M236, ZnT-10, ZNT8, ZRC1"	ENSG00000196660	"Solute carrier family 30 member 10"	Q6XR72	1	219685427-219958647	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant, Dystonia, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 23.9;liver: 33.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 20.2;Distal enterocytes: 44.3;Early spermatids: 38.3;Hepatocytes: 21.1;Late spermatids: 36.1;Paneth cells: 14.4;Proximal enterocytes: 13.6"	"Cancer enriched"	"Detected in some"	14	"liver cancer: 7.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.0;HEL: 1.5;K-562: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064547	Enhanced					NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA064547: AB_2732715"	"unprognostic (7.88e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.96e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.10e-3)"	"unprognostic (4.47e-7)"	"unprognostic (3.16e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.19e-3)"	"unprognostic (5.72e-2)"	0.0	0.0	6.0	0.0	6.1	0.3	0.0	4.4	7.6	0.0	7.4	3.8	23.9	0.0	0.0	0.0	0.0	0.4	0.0	5.9	5.7	0.0	33.5	0.0	0.0	5.4	5.9	0.2	0.0	0.0	0.0	0.0	5.6	0.1	5.0	0.4	0.0	0.0	0.7	0.1	8.9	0.0	4.5	0.0	0.0	0.7	6.5	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.3	0.3	0.3	0.2	0.1	0.1	6.0	6.1	4.4	7.6	5.9	5.7	5.4	5.9	5.6	4.5	6.5	4.7	0.0	0.0	0.0	20.2	0.2	0.3	0.0	0.2	0.0	0.3	0.2	0.0	1.2	1.5	0.1	0.0	0.0	0.1	0.0	44.3	0.0	0.2	38.3	0.0	0.0	1.0	0.0	2.7	4.3	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.4	21.1	0.1	0.0	4.3	0.6	0.0	0.6	0.3	36.1	1.2	0.0	1.8	9.4	0.0	3.1	0.0	3.0	3.3	0.0	14.4	1.5	0.0	0.0	13.6	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.9	0.0	0.1	0.3	0.0	1.3	0.8	0.0
SLC30A2	ZNT2	ENSG00000158014	"Solute carrier family 30 member 2"	Q9BRI3	1	26037252-26046118	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pancreas: 99.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 31.0;Endometrial ciliated cells: 30.5;Glandular and luminal cells: 93.7;Proximal tubular cells: 36.2;Syncytiotrophoblasts: 85.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 19.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 2.1;RPTEC TERT1: 4.5;WM-115: 3.5"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 1.2"	"Not detected"	"Not detected"			HPA017979			Approved	Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA017979: AB_1857085"	"unprognostic (4.87e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.86e-6)"	"unprognostic (9.38e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.01e-2)"	0.1	1.2	0.4	0.3	0.5	0.6	1.1	1.9	1.0	0.2	0.3	0.5	0.5	0.5	0.3	0.1	0.4	6.7	6.3	0.4	0.3	20.2	0.1	0.2	0.2	0.2	0.0	0.1	99.8	2.2	0.0	4.5	0.1	0.2	0.1	0.5	1.6	2.3	3.8	1.0	0.8	0.1	0.0	0.3	0.3	0.2	0.6	0.0	19.8	0.7	0.1	0.5	0.0	0.2	0.1	0.1	0.0	0.4	0.1	0.0	2.1	0.1	0.1	0.0	0.0	0.3	0.4	0.1	0.4	0.0	0.1	0.3	0.1	0.2	0.0	0.3	0.1	0.2	0.2	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.7	0.0	0.3	0.2	0.3	0.3	0.2	0.0	0.1	0.3	0.3	4.5	0.1	0.4	0.1	0.3	0.5	0.1	0.7	0.3	0.1	0.2	0.2	0.5	0.2	0.1	0.3	0.2	0.3	0.2	0.2	3.5	0.9	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.6	0.3	0.1	0.2	0.1	0.0	0.4	0.5	1.9	1.0	0.4	0.3	0.2	0.0	0.1	0.0	0.6	0.2	0.2	3.2	3.0	0.0	0.6	0.4	0.7	0.0	0.0	4.5	9.1	0.4	13.9	8.6	0.0	9.2	0.0	31.0	0.1	0.5	5.9	11.5	0.0	30.5	9.7	1.0	0.0	0.0	0.0	21.1	2.8	0.5	0.0	93.7	4.5	0.1	0.0	0.0	3.6	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.3	0.9	3.6	0.0	1.0	0.7	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.6	3.9	36.2	0.0	2.3	6.6	2.1	1.0	0.2	0.4	0.0	0.9	85.1	0.9	0.1	1.1	0.7
SLC30A9	"C4orf1, GAC63, HUEL, ZNT9"	ENSG00000014824	"Solute carrier family 30 member 9"	Q6PML9	4	41990502-42090461	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transcription, Transcription regulation, Transport, Zinc transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004014	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA004014: AB_1080005"	"unprognostic (4.26e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (2.86e-14)"	"unprognostic (4.67e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.39e-2)"	8.8	15.4	11.4	6.9	12.4	5.8	13.8	12.0	16.1	11.8	12.2	13.4	12.6	10.3	16.0	9.3	9.9	8.6	21.1	12.8	11.9	30.5	14.2	8.9	7.4	11.1	11.3	11.1	12.9	22.7	14.6	9.4	11.6	13.6	13.9	19.8	12.2	10.0	14.7	9.6	11.6	8.5	10.9	7.9	12.9	6.8	11.5	9.1	17.3	20.5	7.8	9.5	8.0	11.7	12.7	6.2	20.3	23.2	15.3	21.3	11.4	17.3	20.8	14.8	17.5	6.4	16.2	13.0	12.2	20.0	19.1	6.3	17.3	14.3	21.1	4.4	10.2	14.9	10.7	10.9	27.1	20.8	10.3	17.0	14.4	12.7	16.5	23.8	16.3	12.9	20.4	6.0	26.2	6.1	12.0	19.6	15.6	19.7	8.5	5.9	18.4	10.8	30.2	10.6	22.5	25.3	12.3	13.5	15.9	14.3	17.2	15.5	17.7	17.4	10.1	17.6	20.3	11.9	9.5	12.3	23.8	17.4	15.5	3.1	1.8	1.0	1.2	2.3	1.3	1.3	1.3	1.5	2.5	1.1	1.7	1.4	0.8	2.1	1.9	1.8	1.6	1.4	11.4	12.4	12.0	16.1	12.8	11.9	11.1	11.3	11.6	10.9	11.5	11.7	19.7	48.1	44.5	48.3	26.5	15.2	22.8	24.7	24.5	34.9	30.3	16.9	90.7	32.9	33.8	38.6	25.0	44.4	11.4	33.8	103.7	35.9	7.1	27.3	29.2	22.1	33.5	32.2	70.0	36.4	34.0	27.7	37.8	26.8	34.2	33.3	21.4	25.4	24.2	50.5	74.7	36.7	30.5	22.2	21.1	8.7	20.8	23.8	24.9	43.1	28.0	29.7	9.2	63.3	84.7	34.3	17.4	22.6	35.8	27.1	25.5	111.7	43.6	39.3	6.6	29.3	28.1	16.1	18.0	40.8	22.7	49.4	21.2	44.8	38.3	24.2
SLC33A1	"ACATN, AT-1, AT1, SPG42"	ENSG00000169359	"Solute carrier family 33 member 1"	O00400	3	155821024-155854456	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Cataract, Deafness, Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042430	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Vesicles, Cytosol"		"HPA042430: AB_10806238"	"unprognostic (5.12e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.57e-2)"	"unprognostic (5.65e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.73e-2)"	"unprognostic (5.74e-2)"	8.8	11.0	3.9	4.9	4.8	2.9	8.4	4.6	4.7	12.3	9.2	7.2	6.9	8.8	12.9	8.0	9.5	7.8	7.6	4.6	5.3	10.4	17.2	8.4	5.0	4.4	4.2	8.0	30.9	11.6	5.9	6.6	4.6	8.3	6.4	6.8	11.2	11.0	4.7	6.4	7.7	7.1	5.2	5.8	8.8	5.4	5.2	7.1	18.8	4.8	6.2	6.8	7.9	7.3	18.9	17.7	7.3	8.3	24.4	23.5	12.9	13.1	21.2	19.8	18.7	8.5	22.0	9.9	24.1	13.1	19.8	17.1	14.3	15.2	20.8	16.5	13.3	11.3	6.5	15.8	41.5	13.3	8.9	18.4	26.7	9.7	49.5	20.5	19.8	12.4	8.6	27.8	14.3	14.3	5.0	3.7	6.8	17.7	14.9	5.6	8.1	29.1	9.7	11.8	7.9	5.9	11.1	24.5	21.4	11.3	8.1	11.2	21.4	10.1	4.9	17.9	13.1	33.2	14.4	12.3	14.6	8.8	14.0	12.7	8.4	6.2	8.9	6.3	9.6	5.4	6.0	6.8	10.4	3.5	5.4	5.5	1.7	6.6	6.5	16.1	5.7	5.9	3.9	4.8	4.6	4.7	4.6	5.3	4.4	4.2	4.6	5.2	5.2	7.3	9.0	22.4	25.0	16.0	14.8	8.9	11.7	20.8	18.2	17.5	16.0	9.0	23.8	18.6	21.5	11.0	27.1	18.2	21.1	14.2	5.9	15.3	13.7	11.2	20.3	13.7	12.5	8.4	17.9	15.4	28.3	19.7	20.9	16.6	12.0	12.8	16.4	64.3	19.5	18.5	17.4	18.1	12.2	14.7	15.8	13.2	18.6	15.2	12.4	10.3	19.0	15.4	12.3	11.1	20.8	14.4	5.3	21.4	33.3	19.5	18.9	17.1	23.4	23.0	13.1	16.0	16.0	19.5	9.2	12.2	9.5	37.6	15.3	10.2	13.9	10.9
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"kidney: 155.4"	"Cell type enriched"	"Detected in some"	14	"Proximal tubular cells: 143.2"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HEL: 2.4;U-937: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles, Plasma membrane"	"Nucleoplasm, Mitotic spindle, Cytosol"	"HPA051255: AB_2681409, HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	7.3	0.0	0.0	0.2	0.0	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	143.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.1
SLC34A2	NAPI-3B	ENSG00000157765	"Solute carrier family 34 member 2"	O95436	4	25648011-25678748	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lung: 753.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 477.5;Alveolar cells type 2: 1315.9;Club cells: 179.9;Glandular and luminal cells: 241.3;Respiratory ciliated cells: 217.0"	"Group enriched"	"Detected in many"	4	"lung cancer: 252.6;ovarian cancer: 191.7;thyroid cancer: 585.2"	"Region enriched"	"Detected in single"	6	"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	82	"BEWO: 32.2;EFO-21: 121.0;RPTEC TERT1: 86.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037989, HPA066474"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA037989: AB_10670536, HPA066474: "	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.25e-2)"	"unprognostic (7.33e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.60e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.93e-1)"	0.4	0.8	0.0	0.3	0.0	0.0	19.1	2.1	0.2	66.6	6.9	0.1	16.4	34.6	0.1	1.5	69.8	9.0	0.2	0.1	0.0	16.7	1.2	753.0	0.1	0.0	0.0	1.3	7.3	0.0	2.1	4.8	0.1	1.0	0.0	0.5	90.2	16.8	0.1	2.6	4.3	0.2	0.0	0.7	2.5	2.7	0.3	2.1	33.6	0.0	7.4	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	32.2	0.0	0.0	0.0	0.0	0.2	0.1	0.2	121.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.4	0.1	0.0	0.2	0.1	0.1	86.8	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.5	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	477.5	1315.9	0.0	0.1	0.0	0.1	79.1	0.0	0.0	41.5	7.5	0.8	34.3	179.9	20.2	0.0	1.4	0.0	0.0	5.9	72.2	5.4	78.6	30.3	2.5	0.0	0.0	0.1	8.5	0.0	2.6	0.0	241.3	29.0	0.0	0.0	0.0	0.2	0.0	0.1	1.2	26.4	0.0	0.0	20.8	1.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	2.5	0.0	0.0	11.8	13.6	3.4	217.0	0.0	0.0	0.0	5.8	2.1	0.1	0.0	0.0	0.3	4.8	0.0	1.8	4.0
SLC34A3	"FLJ38680, NPTIIc"	ENSG00000198569	"Solute carrier family 34 member 3"	Q8N130	9	137230757-137236555	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 9.7;kidney: 13.6"	"Group enriched"	"Detected in some"	9	"Proximal enterocytes: 83.7;Proximal tubular cells: 40.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.0;HDLM-2: 2.8;HeLa: 3.3;MCF7: 7.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA023776	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA023776: AB_1857102"	"unprognostic (2.69e-1)"	"unprognostic (4.16e-1)"	"unprognostic (9.08e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.12e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.20e-1)"	0.0	0.1	0.1	0.1	0.3	0.3	0.0	0.0	0.5	0.2	0.0	0.1	0.5	0.2	0.0	2.9	0.4	0.5	0.2	0.2	0.2	13.6	0.0	0.3	0.2	1.8	2.0	0.0	0.6	0.0	1.2	0.0	0.5	0.3	0.0	0.2	1.6	0.0	0.1	0.4	9.7	0.0	0.5	0.2	0.4	0.4	0.8	0.0	0.3	0.0	0.0	0.1	0.5	1.1	0.6	1.2	0.7	1.5	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.5	4.0	0.5	0.1	0.0	0.1	1.8	0.0	0.0	0.1	2.8	0.3	0.1	3.3	1.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.5	0.0	0.2	0.3	0.6	0.0	7.6	0.0	0.1	0.3	0.7	0.8	0.9	0.5	0.0	0.0	0.6	0.0	1.3	0.4	0.9	0.2	0.6	2.2	0.0	0.3	0.3	0.3	1.5	0.1	0.7	0.3	0.3	0.7	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.2	0.2	1.8	2.0	0.5	0.5	0.8	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	83.7	40.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0
SLC35A1	"CMPST, hCST"	ENSG00000164414	"Solute carrier family 35 member A1"	P78382	6	87470623-87512336	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 103.0;Inhibitory neurons: 87.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"				"unprognostic (3.04e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.26e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavorable (2.70e-6)"	"unprognostic (2.85e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.04e-1)"	16.4	24.0	24.6	15.6	25.4	11.2	30.9	28.3	31.6	27.8	28.5	39.6	18.8	24.9	22.1	13.9	20.2	19.5	16.0	26.0	25.5	21.2	32.9	37.6	17.9	24.3	24.1	23.1	15.8	23.7	18.9	19.7	24.4	36.8	47.6	14.4	31.6	16.5	13.8	24.9	21.5	22.0	24.5	19.0	29.2	13.2	24.9	16.3	16.9	15.7	16.3	21.5	16.7	25.4	4.8	11.5	20.4	24.1	54.4	49.3	16.4	13.9	12.2	11.4	15.6	9.9	86.0	17.6	16.8	17.3	31.7	18.5	24.8	11.3	14.6	25.3	18.4	20.0	14.7	17.8	35.7	26.3	13.3	25.3	26.6	13.5	26.1	26.8	27.5	25.5	26.1	28.4	17.0	44.6	7.3	39.6	11.0	60.4	18.6	22.4	19.9	19.0	35.6	20.4	13.3	14.6	25.7	47.4	23.2	23.3	42.2	53.0	26.0	16.4	11.1	18.2	11.3	21.1	32.7	6.5	13.7	46.2	23.7	52.1	54.1	22.8	17.5	42.8	27.1	17.8	18.7	21.5	46.9	16.7	23.7	22.3	13.2	17.5	44.2	17.3	26.8	36.9	24.6	25.4	28.3	31.6	26.0	25.5	24.3	24.1	24.4	24.5	24.9	25.4	14.7	44.8	33.6	19.2	11.7	14.8	18.1	37.1	18.8	6.2	23.6	16.6	6.2	20.0	25.5	16.5	12.5	25.0	16.1	27.1	7.9	10.1	10.6	6.3	9.9	15.8	15.0	8.2	103.0	8.9	19.7	19.2	13.3	6.8	21.6	14.2	42.8	20.7	15.6	11.8	87.2	73.5	48.8	28.2	11.1	7.1	16.4	15.8	21.4	24.4	27.4	17.3	16.5	42.3	26.9	11.5	19.0	19.2	9.4	17.5	14.5	11.3	25.4	7.0	19.7	8.9	16.9	9.6	14.2	9.0	14.8	27.5	14.9	12.5	32.7	8.9
SLC35A2	"UGALT, UGAT, UGT, UGT1, UGT2, UGTL"	ENSG00000102100	"Solute carrier family 35 member A2"	P78381	X	48903180-48911958	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036087	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"		"HPA036087: AB_10604093"	"prognostic unfavorable (3.16e-4)"	"unprognostic (3.34e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.15e-3)"	"unprognostic (4.25e-3)"	"prognostic unfavorable (9.64e-5)"	"unprognostic (3.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-3)"	"unprognostic (9.58e-2)"	"unprognostic (3.16e-2)"	"prognostic favorable (8.23e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.13e-2)"	15.8	20.5	13.7	12.7	14.3	15.9	14.9	14.3	14.8	18.7	19.4	29.3	17.3	13.1	28.4	24.7	32.6	15.2	15.0	14.5	15.8	19.8	31.8	18.2	11.4	14.6	15.0	9.3	30.0	24.7	21.3	19.9	15.4	17.1	28.2	3.1	23.8	14.8	14.0	21.9	18.0	11.7	14.4	14.7	25.0	7.1	15.9	11.8	15.4	7.2	14.7	19.8	15.4	15.9	48.8	55.2	18.8	27.3	36.5	31.6	29.7	49.7	54.1	51.3	59.9	64.0	84.5	18.8	22.2	54.2	64.4	67.0	51.7	40.0	39.7	27.9	34.0	20.5	33.1	49.6	47.8	38.7	40.9	35.7	69.9	48.6	39.8	28.9	30.6	25.9	38.7	29.8	37.6	47.1	20.5	35.0	39.7	55.3	67.7	22.3	35.5	61.1	44.4	39.1	21.8	36.1	52.9	54.5	28.7	35.1	80.8	30.7	28.2	30.3	30.6	55.4	27.5	45.1	32.8	19.6	38.4	34.1	40.3	18.1	22.3	40.0	15.3	23.4	15.8	10.7	12.6	13.9	27.7	9.9	8.3	14.6	24.2	13.8	17.5	27.7	13.1	11.9	13.7	14.3	14.3	14.8	14.5	15.8	14.6	15.0	15.4	14.4	15.9	15.9	16.2	9.6	17.0	3.3	13.1	14.1	11.7	29.0	2.8	4.5	26.5	10.9	5.2	10.0	23.5	16.5	0.0	31.0	15.6	24.1	3.9	27.4	3.3	24.2	12.0	13.5	12.7	19.0	2.6	32.3	30.6	14.0	18.8	16.8	2.5	8.0	11.0	15.6	23.4	6.7	2.5	31.5	28.5	10.1	14.5	1.3	9.9	12.3	10.6	4.7	21.9	9.4	8.2	4.5	4.4	27.1	19.7	10.9	19.3	18.7	17.8	10.5	50.5	5.7	6.6	9.7	19.4	10.3	6.8	10.9	17.5	48.0	13.8	12.2	21.7	23.4
SLC35A3		ENSG00000117620	"Solute carrier family 35 member A3"	Q9Y2D2	1	99969351-100035634	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Autism spectrum disorder, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 211.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015253	Uncertain					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA015253: AB_1857106"	"unprognostic (1.05e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.57e-3)"	"unprognostic (5.89e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.34e-2)"	11.6	7.3	4.3	10.4	5.1	11.4	18.3	6.6	5.8	19.1	10.0	53.3	49.7	9.6	11.4	14.4	13.1	13.5	5.5	4.1	4.7	21.3	37.3	11.5	8.0	4.7	4.6	8.1	11.5	19.8	4.8	10.2	5.1	23.0	53.8	6.9	22.0	11.6	4.9	10.8	41.4	8.8	4.5	7.9	33.4	2.8	4.9	18.9	24.9	6.1	8.9	10.5	10.2	6.3	28.3	7.6	6.7	7.1	14.8	12.9	26.7	24.5	14.8	9.4	13.6	4.9	15.1	15.1	30.0	14.3	13.3	16.0	12.7	11.0	21.6	18.7	9.4	13.7	10.7	11.8	9.2	22.1	1.6	6.8	12.1	11.5	22.2	11.3	11.1	11.9	23.0	21.9	19.3	7.1	14.6	11.4	8.2	16.0	24.9	4.5	20.4	9.4	17.1	16.0	8.6	4.8	17.0	32.3	13.7	6.2	19.7	16.6	13.0	14.3	13.0	32.0	13.3	12.9	16.2	11.2	23.0	13.5	6.1	4.4	2.1	1.1	2.2	2.1	2.5	2.5	2.2	2.6	1.7	1.8	2.7	2.3	0.6	4.3	1.7	5.0	2.8	1.9	4.3	5.1	6.6	5.8	4.1	4.7	4.7	4.6	5.1	4.5	4.9	6.3	23.5	80.1	28.6	12.4	17.8	25.0	21.6	30.5	18.8	15.7	33.9	15.4	8.8	27.1	50.5	55.2	20.9	19.4	51.4	211.0	7.9	18.1	4.4	49.4	22.4	20.5	19.8	9.7	24.4	15.3	30.5	17.0	43.3	46.3	17.1	19.5	20.7	49.3	14.2	10.1	26.6	110.6	22.4	17.8	17.1	2.1	13.4	14.2	8.8	23.4	18.0	19.0	14.4	30.2	46.7	21.7	82.8	13.2	25.6	43.3	112.4	25.3	92.6	25.1	6.6	14.4	17.7	16.2	8.3	21.2	29.7	23.3	23.8	12.8	116.4	48.4
SLC35C1	"FLJ11320, FUCT1"	ENSG00000181830	"Solute carrier family 35 member C1"	Q96A29	11	45804072-45813016	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 84.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 50.6;Distal enterocytes: 54.6;Pancreatic endocrine cells: 50.6;Paneth cells: 54.0;Proximal enterocytes: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064001	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"		"HPA064001: AB_2685171"	"unprognostic (2.62e-2)"	"unprognostic (5.16e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (8.22e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.64e-4)"	"unprognostic (2.30e-2)"	28.2	7.3	6.6	10.7	6.3	2.4	19.8	7.0	7.0	9.6	6.1	19.8	24.4	8.8	2.3	41.5	7.3	12.2	9.0	6.2	7.2	7.0	84.5	10.2	6.6	8.2	7.9	6.3	13.4	5.6	10.4	15.0	7.7	9.9	14.3	1.6	26.1	5.9	6.8	5.1	24.1	9.9	6.5	8.4	18.5	5.2	8.8	4.5	6.6	6.9	10.0	13.8	14.9	6.3	10.3	25.8	6.3	16.3	19.9	19.8	19.5	22.1	20.1	13.3	14.4	10.7	15.2	10.4	9.9	27.3	19.4	26.0	13.4	13.6	6.5	24.8	14.5	5.9	20.4	20.6	42.6	11.4	16.2	23.8	16.3	9.2	11.1	16.2	17.6	10.3	13.3	13.8	14.4	21.8	5.9	9.0	27.5	39.9	34.6	7.2	10.5	21.5	15.1	25.4	6.0	8.6	16.6	16.3	9.5	6.6	13.7	6.0	25.7	25.0	14.7	46.1	15.6	9.8	26.9	4.9	18.5	14.4	14.2	9.7	11.6	12.5	11.0	11.9	12.3	5.0	18.0	14.7	9.6	3.7	9.3	8.0	1.8	5.6	8.7	8.2	13.0	10.1	6.6	6.3	7.0	7.0	6.2	7.2	8.2	7.9	7.7	6.5	8.8	6.3	5.5	0.0	11.2	2.6	6.2	3.6	8.9	12.7	3.4	1.9	11.1	3.0	50.6	22.8	26.7	5.5	2.1	13.8	6.4	54.6	0.0	18.4	4.9	7.3	6.7	10.6	9.6	3.6	2.0	41.9	14.0	10.5	23.4	11.4	2.5	5.2	6.8	42.2	14.7	3.3	2.1	40.6	4.1	9.3	4.8	6.0	6.5	6.3	1.8	2.8	9.5	2.8	7.2	1.0	2.1	50.6	54.0	5.7	13.6	11.8	58.0	4.7	11.4	1.1	0.0	3.6	9.7	4.0	4.3	12.7	2.4	15.3	6.5	5.7	26.4	20.1
SLC35D1	"KIAA0260, UGTREL7"	ENSG00000116704	"Solute carrier family 35 member D1"	Q9NTN3	1	66999350-67054148	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 75.6;Early spermatids: 73.5;Hepatocytes: 114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (6.91e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.63e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (2.12e-3)"	"unprognostic (6.39e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.20e-1)"	4.9	6.6	4.0	7.8	4.6	8.9	5.2	4.1	4.2	7.6	9.9	26.0	15.9	5.7	4.9	5.3	5.0	6.4	3.7	3.8	4.2	12.5	74.7	3.7	7.5	4.7	6.1	7.8	7.5	8.1	5.6	9.5	4.8	7.2	26.8	12.3	4.4	5.7	7.5	9.8	16.3	6.9	4.0	4.2	12.9	6.2	5.8	10.1	6.4	5.0	8.6	7.3	6.8	7.0	8.3	4.7	14.2	12.0	14.4	16.6	16.8	18.4	24.1	13.1	9.1	10.2	2.0	25.7	7.9	14.6	15.4	12.5	9.9	11.6	16.4	25.8	4.6	19.2	9.8	20.2	12.1	22.0	12.2	16.3	25.4	15.4	10.9	21.0	5.1	10.6	11.8	13.3	32.0	2.8	13.6	6.8	5.9	22.5	6.4	10.4	29.3	2.9	6.0	15.6	1.7	6.3	27.8	8.5	11.9	7.9	7.0	16.2	5.6	24.2	5.7	15.0	17.9	27.6	15.4	14.1	17.2	3.3	10.4	8.5	0.9	2.6	2.0	0.7	2.4	1.3	1.5	1.6	1.1	0.9	2.1	2.0	0.2	3.5	1.7	0.6	2.8	0.9	4.0	4.6	4.1	4.2	3.8	4.2	4.7	6.1	4.8	4.0	5.8	7.0	4.9	6.4	2.2	34.6	12.8	5.5	5.9	9.4	13.1	6.9	7.5	4.8	3.1	20.0	4.6	5.5	12.5	40.5	18.3	75.6	0.0	3.1	73.5	6.3	10.9	4.3	15.0	9.1	22.8	9.6	5.7	8.3	14.8	8.7	4.5	13.2	7.5	114.3	6.9	6.7	28.2	18.9	2.0	8.8	4.6	13.7	6.2	5.5	1.8	23.4	3.1	17.8	9.2	37.7	51.2	8.3	20.8	4.5	9.3	5.8	24.9	10.6	7.5	9.4	0.0	8.6	7.5	7.7	6.4	8.2	7.7	16.3	12.8	11.3	21.7	8.8
SLC36A2	"PAT2, TRAMD1, tramdorin"	ENSG00000186335	"Solute carrier family 36 member 2"	Q495M3	5	151314972-151347590	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	60	"kidney: 67.6;skeletal muscle: 80.2;tongue: 29.8"	"Cell type enriched"	"Detected in some"	8	"Proximal tubular cells: 53.0"	"Cancer enriched"	"Detected in single"	9	"renal cancer: 0.5"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA044002, HPA062229"	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA044002: AB_10964214, HPA062229: AB_2684717"	"unprognostic (3.47e-1)"	"unprognostic (3.40e-1)"		"unprognostic (2.26e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.38e-3)"	"unprognostic (4.66e-3)"	"unprognostic (3.03e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.89e-2)"	0.2	0.1	0.2	0.1	0.1	0.3	0.1	0.8	0.6	0.0	0.1	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.2	0.1	0.0	67.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.2	0.9	0.0	80.2	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	29.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.3	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.4	0.2	0.2	1.1	0.4	0.1	0.4	0.1	0.1	0.2	0.1	0.8	0.6	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	5.9	0.0	6.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.0	0.0	0.0	0.0	1.8	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1
SLC38A8		ENSG00000166558	"Solute carrier family 38 member 8"	A6NNN8	16	84009667-84042795	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"brain: 3.9"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 16.1"	"Cancer enriched"	"Detected in single"	14	"melanoma: 6.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"									NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (9.69e-2)"	"unprognostic (6.16e-2)"		"unprognostic (8.00e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.16e-2)"		"unprognostic (3.54e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.45e-1)"			0.0	0.1	3.7	0.0	3.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	1.0	0.8	0.0	0.1	0.0	0.0	1.1	1.6	0.0	0.2	0.1	0.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.4	3.0	0.5	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.9	0.0	1.3	1.0	0.8	1.1	1.6	0.9	0.6	3.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	1.4	0.0	0.0	0.0	0.0	16.1	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC39A13	FLJ25785	ENSG00000165915	"Solute carrier family 39 member 13"	Q96H72	11	47407132-47416496	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	13	"Early spermatids: 298.2;Late spermatids: 905.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043971	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA043971: AB_10959744"	"unprognostic (7.84e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (1.18e-1)"	"unprognostic (8.56e-3)"	"unprognostic (3.81e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (2.73e-5)"	"unprognostic (1.39e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (1.96e-4)"	"unprognostic (3.16e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.12e-1)"	40.9	42.4	28.3	24.2	31.4	8.3	37.5	30.6	36.3	51.1	30.4	53.4	14.0	77.9	8.8	21.8	48.1	20.2	59.5	26.0	27.3	80.4	26.7	61.4	18.2	33.0	29.7	50.9	42.3	27.2	51.3	40.6	30.4	52.7	6.8	11.0	31.3	26.2	31.4	32.4	31.8	26.6	26.8	36.5	41.2	73.4	35.0	12.3	46.8	12.6	8.7	45.6	37.4	28.5	23.3	20.4	23.5	26.7	56.3	78.2	6.8	89.7	66.2	50.4	57.0	8.1	15.7	8.8	22.9	69.6	49.6	38.3	7.1	61.7	13.9	25.7	25.9	4.7	52.7	16.7	84.3	8.1	11.0	65.4	43.4	31.9	26.1	62.9	53.4	16.9	4.5	19.6	54.8	20.7	17.4	11.5	11.0	19.8	28.2	20.6	33.6	8.9	86.1	11.1	19.9	37.0	26.9	49.1	26.2	8.7	32.8	11.7	76.0	76.6	34.6	88.1	42.7	14.9	5.2	4.1	85.2	11.2	57.3	2.1	3.6	3.2	12.4	13.3	8.5	4.1	8.2	8.9	4.6	5.1	7.5	6.4	6.6	7.4	15.3	4.9	4.5	5.9	28.3	31.4	30.6	36.3	26.0	27.3	33.0	29.7	30.4	26.8	35.0	28.5	20.0	9.6	6.4	18.6	6.7	18.2	18.3	23.0	17.1	24.0	11.5	15.6	18.3	15.7	8.0	29.5	12.5	11.1	11.6	3.4	9.8	32.9	298.2	6.5	20.3	20.9	9.6	4.4	9.6	20.7	16.4	37.8	6.6	13.1	5.7	15.4	21.8	6.2	18.9	32.0	11.7	7.9	14.2	5.3	12.2	905.5	32.9	9.3	19.6	4.7	26.6	16.7	11.3	8.0	10.1	35.5	8.3	40.3	8.1	23.5	8.2	8.8	4.5	17.0	46.0	16.1	36.2	12.7	6.4	2.4	4.1	19.6	9.6	36.7	5.7	8.3
SLC39A14	"KIAA0062, NET34, ZIP14"	ENSG00000104635	"Solute carrier family 39 member 14"	Q15043	8	22367278-22434129	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant, Dystonia, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 551.3;pancreas: 252.7"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 266.7;Hepatocytes: 611.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 321.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016508, HPA056732"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane"		NA	NA		1100000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum, Golgi apparatus, Plasma membrane"		"HPA016508: AB_1857148, HPA056732: "	"unprognostic (1.67e-1)"	"unprognostic (6.67e-3)"	"prognostic favorable (5.00e-5)"	"unprognostic (9.83e-3)"	"unprognostic (9.21e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.66e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.79e-7)"	"unprognostic (4.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.11e-3)"	63.5	72.4	13.0	35.5	11.0	1.4	39.8	11.9	13.1	17.3	39.7	48.2	142.2	30.2	6.2	11.6	25.9	32.0	76.7	14.5	22.9	30.8	551.3	23.9	7.6	43.0	30.4	27.7	252.7	12.9	21.5	19.0	25.7	22.3	50.3	18.6	21.8	18.7	43.0	20.0	84.9	33.0	13.3	8.1	80.5	26.5	25.3	6.0	87.7	17.4	6.9	56.0	14.5	14.8	51.8	68.3	18.4	37.6	65.1	54.7	40.1	72.8	321.0	111.3	173.5	226.9	47.9	51.1	39.9	86.1	288.9	55.6	92.8	91.1	181.9	53.1	49.2	40.8	51.0	230.7	154.3	28.5	43.2	58.4	72.6	198.0	136.9	56.3	50.5	36.5	36.2	51.2	57.3	24.0	43.4	18.2	113.4	81.9	49.8	60.1	34.9	110.8	40.8	22.3	31.3	48.7	74.3	31.3	151.4	39.7	25.1	39.4	28.0	137.3	69.2	87.4	75.7	29.2	28.7	66.9	194.3	37.7	81.9	0.0	0.4	2.1	6.7	0.1	7.2	4.0	3.8	5.0	1.5	1.9	4.3	5.9	0.1	2.7	0.1	0.7	3.4	3.4	13.0	11.0	11.9	13.1	14.5	22.9	43.0	30.4	25.7	13.3	25.3	14.8	12.4	3.2	7.7	11.4	9.1	33.3	11.5	10.8	18.8	7.8	20.3	16.6	66.6	41.5	3.8	7.3	2.1	0.4	3.6	91.6	1.9	47.6	0.5	136.1	58.3	32.2	33.4	10.5	26.2	74.7	2.7	58.8	47.9	266.7	0.0	20.8	29.6	611.4	1.8	48.8	24.6	60.6	6.1	15.4	25.8	3.2	23.9	2.9	44.4	6.5	2.7	5.2	2.1	9.0	3.9	47.3	39.1	41.8	13.5	26.5	75.6	24.6	1.1	8.2	0.0	47.1	32.2	0.7	3.0	4.1	21.0	0.5	7.4	14.7	43.5	9.4
SLC39A4	"AEZ, AWMS2, ZIP4"	ENSG00000147804	"Solute carrier family 39 member 4"	Q6P5W5	8	144409742-144416844	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 88.1"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 406.4;Proximal tubular cells: 230.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"CAPAN-2: 36.4;Hep G2: 97.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (2.59e-1)"	"unprognostic (2.35e-3)"	"unprognostic (9.16e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (9.04e-4)"	"unprognostic (2.78e-2)"	"unprognostic (3.97e-1)"	"unprognostic (9.04e-3)"	"unprognostic (1.87e-1)"	0.1	0.2	0.1	1.4	0.2	0.5	0.3	0.0	0.7	0.7	0.0	33.1	88.1	0.4	0.1	0.2	0.9	0.5	0.0	0.2	0.0	18.4	1.3	3.1	0.1	0.0	0.0	3.3	1.4	0.0	0.2	1.0	0.0	1.3	0.5	0.0	1.2	0.3	0.0	0.5	74.9	0.1	0.0	0.7	2.9	1.3	0.0	0.0	3.9	0.0	0.0	0.6	0.6	0.0	2.3	0.2	0.0	0.1	0.0	0.0	2.5	0.1	0.0	0.0	0.0	2.1	36.4	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	6.4	0.8	1.6	0.6	97.4	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.5	2.2	0.0	1.7	0.0	0.4	0.1	0.5	0.1	0.4	0.0	1.1	0.0	0.4	0.9	1.9	0.2	0.4	0.1	0.4	1.7	0.1	0.0	0.1	0.2	0.0	0.0	0.9	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	19.2	24.8	0.3	21.3	18.7	36.6	46.9	38.7	0.2	45.0	50.3	7.4	20.0	24.1	42.3	0.0	17.0	15.4	112.8	50.9	40.0	1.4	41.8	12.9	10.9	42.6	26.3	1.0	42.9	69.7	16.8	29.6	51.9	37.4	8.5	8.9	27.4	32.1	3.3	0.2	95.0	30.5	18.2	21.0	2.0	8.1	23.5	21.4	0.0	25.9	11.3	23.7	0.0	0.1	75.6	135.0	6.4	31.9	60.8	406.4	230.3	26.9	1.0	6.6	7.5	11.1	2.9	33.1	46.4	30.0	11.2	15.4	23.2	98.2	46.3
SLC39A5		ENSG00000139540	"Solute carrier family 39 member 5"	Q6ZMH5	12	56230049-56237846	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"intestine: 237.4;kidney: 110.0;liver: 171.1;pancreas: 306.8"	"Cell type enriched"	"Detected in some"	4	"Proximal enterocytes: 798.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 30.6;liver cancer: 36.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	53	"CACO-2: 39.9;Hep G2: 58.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.1"	"Not detected"	"Not detected"			HPA018423			Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Vesicles	Nucleoplasm	"HPA018423: AB_1857154"	"unprognostic (5.94e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.93e-3)"	"prognostic favorable (5.05e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-4)"	0.3	0.1	0.2	5.5	0.2	0.1	0.3	0.5	0.4	0.3	0.2	73.7	237.4	0.4	0.0	0.1	0.3	6.5	0.2	0.1	0.1	110.0	171.1	0.2	0.4	0.2	0.1	0.4	306.8	0.0	0.2	0.1	0.1	0.3	45.9	6.4	0.1	0.3	0.1	0.3	219.0	2.6	0.1	0.3	1.4	0.2	0.1	0.0	0.3	0.2	0.0	0.2	0.2	0.1	0.0	0.3	0.1	0.2	0.2	0.3	0.5	0.0	0.0	0.1	0.0	39.9	0.4	0.1	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.6	0.1	0.2	0.2	58.5	0.2	0.1	0.2	0.2	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.2	0.0	0.8	0.0	0.9	0.1	0.2	0.2	0.3	0.5	0.1	0.3	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.4	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.4	0.6	0.1	0.0	0.0	0.9	0.1	0.3	0.2	15.7	0.0	3.7	116.7	0.0	0.0	171.9	19.6	0.3	0.6	0.0	0.1	0.2	25.3	2.7	0.2	20.6	0.0	0.1	0.0	0.0	0.0	0.0	2.2	138.9	0.1	0.0	0.2	112.7	0.0	1.6	1.2	1.4	0.0	1.3	0.0	0.0	0.6	0.6	0.0	0.0	0.1	7.4	192.8	0.0	0.0	0.1	798.4	169.9	0.0	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.8	0.0	168.7	0.0
SLC39A8	BIGM103	ENSG00000138821	"Solute carrier family 39 member 8"	Q9C0K1	4	102251041-102431258	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 171.1"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 778.8;Alveolar cells type 2: 305.6;Extravillous trophoblasts: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 158.9;HL-60: 120.9;Karpas-707: 171.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038832, HPA038833"	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"			"HPA038832: AB_2676226, HPA038833: AB_10670910"	"prognostic favorable (6.69e-4)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.34e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.50e-2)"	"unprognostic (9.59e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.20e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.78e-2)"	"prognostic favorable (6.34e-6)"	"unprognostic (3.25e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.13e-3)"	45.5	3.5	9.6	28.9	10.7	36.5	18.1	10.2	12.1	84.7	9.9	37.8	6.7	11.0	5.7	3.0	11.9	7.8	30.4	8.3	10.5	18.3	40.0	171.1	13.3	14.6	10.7	14.0	54.5	42.0	8.0	13.0	14.4	8.4	43.0	6.4	89.3	6.6	1.1	9.4	7.3	9.1	14.2	6.7	7.8	2.6	13.5	14.4	12.3	2.0	12.3	20.8	6.8	11.6	20.2	19.5	4.4	0.1	15.8	35.4	10.1	2.2	158.9	5.8	9.3	0.9	72.5	19.3	21.0	0.6	20.0	1.4	13.5	4.4	3.4	34.1	39.5	51.0	37.5	0.3	6.3	120.9	16.8	19.1	5.0	3.1	9.1	15.4	2.1	47.1	51.6	171.2	30.7	13.4	43.7	55.9	13.0	26.8	19.0	11.0	0.2	63.8	33.3	7.4	5.6	14.0	55.0	1.0	5.3	3.8	13.4	44.4	11.3	19.3	7.3	39.1	31.6	76.3	34.1	90.4	31.0	77.4	18.2	0.0	1.8	1.4	6.3	1.1	10.9	1.8	11.7	10.0	3.3	3.9	8.6	5.9	0.1	13.7	0.4	1.2	5.0	4.2	9.6	10.7	10.2	12.1	8.3	10.5	14.6	10.7	14.4	14.2	13.5	11.6	16.1	778.8	305.6	15.7	14.5	11.7	9.2	35.9	5.2	2.6	42.8	13.1	21.3	4.3	23.9	5.5	4.2	19.2	14.9	20.3	11.7	1.8	0.7	17.7	5.2	19.8	24.0	46.7	6.6	32.7	217.5	17.4	4.1	40.9	3.8	32.4	5.7	26.1	42.9	3.3	1.5	74.1	6.1	29.8	79.0	0.7	1.2	28.9	28.4	60.9	10.8	5.2	9.2	5.0	1.7	11.8	26.2	1.2	56.0	9.6	2.1	17.7	2.9	1.6	6.6	2.6	8.8	2.3	6.0	2.1	7.0	60.6	23.6	31.0	64.3	6.8
SLC3A1	"ATR1, CSNU1, D2H, NBAT, RBAT"	ENSG00000138079	"Solute carrier family 3 member 1"	Q07837	2	44275458-44321494	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 136.2;kidney: 649.3;pancreas: 217.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 74.4;Glandular and luminal cells: 128.9;Proximal enterocytes: 258.9;Proximal tubular cells: 363.0"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 61.9"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	22	"RPTEC TERT1: 106.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038360, HPA071102"	Enhanced		Approved	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Nuclear bodies"	"HPA038360: AB_2675975, HPA071102: AB_2732171"	"unprognostic (1.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.90e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (3.67e-7)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.58e-4)"	0.5	0.3	1.2	1.1	1.7	0.6	0.4	6.8	3.4	1.0	0.1	22.4	113.9	1.4	1.9	0.2	0.6	51.5	0.4	1.6	1.3	649.3	36.6	0.4	0.4	0.6	0.6	0.5	217.5	0.0	0.5	0.1	0.7	1.0	22.7	3.5	0.3	0.3	1.0	0.6	136.2	0.5	0.0	0.5	0.9	1.7	1.0	0.0	0.4	0.1	0.1	0.3	0.3	1.7	0.0	1.0	0.0	0.2	0.2	0.1	0.3	0.1	0.0	0.0	0.1	4.9	0.0	0.1	4.3	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.4	0.2	0.0	0.0	0.4	0.1	1.2	0.5	0.1	0.1	0.2	106.1	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.1	0.4	0.2	0.3	0.1	0.3	0.2	0.4	0.3	0.3	0.7	0.3	0.4	0.5	0.6	0.3	0.1	1.0	0.6	0.7	0.4	0.4	0.1	0.3	0.2	0.1	1.2	1.7	6.8	3.4	1.6	1.3	0.6	0.6	0.7	0.0	1.0	1.7	0.2	3.2	1.5	0.3	6.1	0.0	0.3	0.0	0.0	12.1	0.2	0.0	0.4	74.4	0.0	42.3	10.4	0.1	0.8	18.2	62.6	37.0	12.4	62.2	14.4	0.6	0.0	0.0	9.1	13.8	0.0	0.9	1.1	128.9	0.0	0.1	0.4	4.6	0.1	21.9	9.0	8.4	0.0	0.0	0.0	8.5	1.2	3.2	0.0	1.0	1.6	1.0	1.0	3.0	3.7	4.8	18.6	0.4	1.5	1.1	258.9	363.0	0.0	11.2	0.0	2.6	1.2	0.8	0.4	0.7	0.1	0.1	2.8	0.2	15.7	1.2
SLC40A1	"FPN1, HFE4, IREG1, MTP1, SLC11A3"	ENSG00000138449	"Solute carrier family 40 member 1"	Q9NP59	2	189560590-189583758	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 489.8;Kupffer cells: 1340.2;Syncytiotrophoblasts: 2463.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 326.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 509.0;CACO-2: 123.1;HEL: 430.0;HMC-1: 110.5;T-47d: 207.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065634	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA065634: AB_2685524"	"unprognostic (1.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.22e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.44e-2)"	"prognostic favorable (8.55e-5)"	"unprognostic (4.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.11e-2)"	59.6	333.5	9.3	52.6	11.9	45.8	97.7	9.6	9.8	156.3	10.4	124.7	289.3	95.4	61.6	30.5	214.2	148.7	52.6	7.2	12.0	79.9	251.5	122.9	172.6	15.6	15.7	317.2	53.2	91.8	19.0	250.1	12.8	39.5	130.8	29.5	58.7	53.1	64.2	12.2	127.9	69.3	15.5	368.1	96.8	33.2	13.9	62.6	68.0	60.3	59.1	53.1	21.8	11.3	0.0	7.4	0.6	0.0	509.0	3.3	25.4	0.2	6.6	1.9	3.1	123.1	0.4	0.2	1.0	0.2	1.4	0.4	2.4	0.3	1.6	0.3	1.7	430.0	1.7	45.8	1.9	1.5	110.5	35.9	0.2	1.2	0.0	11.7	13.0	16.4	44.6	1.1	6.3	0.0	18.2	28.8	1.5	92.7	1.7	0.2	5.0	2.5	5.3	18.1	1.0	5.4	0.8	35.4	0.0	39.5	207.6	6.2	0.3	0.8	11.7	0.5	0.1	1.1	0.2	0.3	0.1	0.2	0.1	129.8	101.5	172.1	2.2	23.7	3.2	0.2	54.4	4.9	115.6	0.7	80.2	17.8	326.2	4.6	2.6	18.8	5.3	105.8	9.3	11.9	9.6	9.8	7.2	12.0	15.6	15.7	12.8	15.5	13.9	11.3	44.2	125.0	40.3	3.6	12.0	9.2	51.3	10.5	19.9	4.8	83.8	30.0	48.0	138.7	31.6	33.1	4.2	489.8	5.7	328.9	49.0	54.7	10.5	39.6	38.2	39.8	18.6	253.7	0.3	71.8	20.3	81.9	76.5	129.5	9.5	12.8	245.9	259.7	86.4	6.7	6.8	60.8	6.1	1340.2	26.8	9.2	121.2	172.7	8.8	34.7	41.7	17.5	2.1	14.6	0.2	71.5	86.2	58.6	4.1	26.2	163.0	150.0	34.4	48.4	65.7	13.7	49.1	7.4	3.9	12.5	8.1	2463.5	11.9	84.8	48.9	27.7
SLC44A1	"CD92, CDW92, CHTL1, CTL1"	ENSG00000070214	"Solute carrier family 44 member 1"	Q8WWI5	9	105244622-105439171	"CD markers, Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 284.9"	"Cell type enriched"	"Detected in all"	8	"Oligodendrocytes: 2444.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 285.9;ASC TERT1: 224.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064714, HPA074007"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		99000	"Cluster 24: B-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria	Nucleoplasm	"HPA064714: AB_2685334, HPA074007: "	"unprognostic (3.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.54e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.20e-2)"	"prognostic favorable (1.85e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-2)"	16.9	13.3	112.9	12.9	204.4	11.4	26.2	166.7	138.7	16.7	79.4	50.2	22.6	15.9	32.4	18.4	15.2	20.2	12.7	116.2	136.1	21.8	38.0	18.4	9.7	204.3	167.7	14.1	15.1	23.2	5.3	23.3	205.5	11.8	49.0	14.1	9.6	25.0	9.4	21.5	27.0	17.3	161.1	9.5	35.2	3.5	150.8	13.6	43.6	20.2	15.5	21.8	15.6	284.9	29.0	23.8	6.4	7.9	285.9	224.1	20.3	23.9	61.7	15.1	20.2	25.6	74.8	38.4	12.0	90.2	17.1	56.1	19.3	34.4	25.7	34.0	15.7	47.8	15.8	32.0	19.3	9.6	23.7	125.3	27.6	29.0	26.1	38.8	48.6	19.7	1.4	77.1	17.3	40.8	38.8	10.9	35.9	51.1	22.9	8.0	24.7	29.3	20.9	66.6	30.6	12.0	33.4	36.5	33.3	37.8	36.2	28.7	41.9	15.1	13.5	16.5	17.7	59.1	41.7	28.4	29.2	20.6	20.2	1.7	3.3	0.7	0.7	1.2	0.4	1.1	0.7	0.4	2.2	2.0	0.8	0.3	0.5	5.3	0.7	0.8	0.8	0.9	112.9	204.4	166.7	138.7	116.2	136.1	204.3	167.7	205.5	161.1	150.8	284.9	48.6	35.3	26.5	83.2	22.2	70.6	36.0	28.3	75.1	10.3	76.9	27.2	10.1	67.2	19.9	106.7	235.6	53.3	7.6	296.5	3.9	17.5	2.9	59.2	40.3	45.2	157.2	20.4	174.2	36.5	12.1	64.0	84.1	175.2	100.1	16.7	48.9	170.0	21.3	6.7	108.1	160.0	14.2	46.5	46.5	6.1	110.0	48.6	74.7	81.5	91.0	9.0	13.4	257.3	2444.2	36.9	161.2	79.7	162.9	23.8	95.4	27.1	31.4	53.3	39.5	43.8	34.9	2.3	4.4	86.9	74.3	70.6	20.3	12.1	199.1	34.8
SLC44A4	"C6orf29, CTL4, DFNA72, FLJ14491, NG22, TPPT"	ENSG00000204385	"Solute carrier family 44 member 4"	Q53GD3	6	31863192-31879046	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 132.0;prostate: 83.0;stomach 1: 83.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 546.0;Exocrine glandular cells: 213.4;Intestinal goblet cells: 327.8;Paneth cells: 299.3;Proximal enterocytes: 267.7;Respiratory ciliated cells: 406.7;Undifferentiated cells: 259.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 222.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"OE19: 14.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046977, HPA054176"	Enhanced					NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA046977: AB_2679887, HPA054176: AB_2682404"	"unprognostic (5.84e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.86e-3)"	"unprognostic (4.85e-3)"	"unprognostic (2.75e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (2.65e-3)"	"unprognostic (2.44e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.06e-6)"	"unprognostic (1.37e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (6.06e-4)"	0.8	8.2	0.0	2.5	0.0	1.0	5.3	0.0	0.0	22.4	0.0	132.0	100.8	5.9	2.5	2.0	46.9	18.8	0.0	0.0	0.0	32.1	0.4	14.9	0.1	0.3	0.1	1.6	8.9	0.0	16.1	3.5	0.1	83.0	30.3	0.0	42.6	3.9	0.0	1.1	86.8	2.9	0.0	1.6	83.4	0.7	0.0	0.2	1.9	0.0	0.7	11.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	14.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	3.7	22.4	36.0	0.0	3.8	0.5	23.0	71.4	0.6	0.3	14.6	6.1	0.4	38.6	180.2	66.2	0.0	0.3	0.5	546.0	3.9	111.2	2.3	127.4	8.9	6.2	46.7	0.0	0.1	213.4	0.5	2.4	208.5	67.5	2.5	1.1	0.4	0.0	0.5	0.0	0.1	327.8	91.6	0.0	0.0	3.2	1.5	2.5	0.0	0.0	1.6	0.7	0.0	0.0	0.0	184.0	299.3	0.4	0.3	142.0	267.7	61.5	406.7	0.6	0.0	0.8	11.9	0.2	0.2	0.5	0.4	0.7	2.3	5.5	259.6	139.4
SLC45A1	DNB5	ENSG00000162426	"Solute carrier family 45 member 1"	Q9Y2W3	1	8318114-8344167	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Symport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 10.0;Horizontal cells: 10.1;Inhibitory neurons: 11.1"	"Cancer enhanced"	"Detected in many"		"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"non-classical monocyte: 3.9"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.7;GAMG: 2.7;HHSteC: 4.9;U-87 MG: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078818	Enhanced					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA078818: "	"unprognostic (1.77e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.32e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.18e-1)"	"unprognostic (5.67e-2)"	"unprognostic (8.53e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-3)"	2.2	1.8	3.4	0.5	3.3	0.0	2.1	2.6	5.6	3.5	1.9	4.0	0.5	5.1	0.8	0.9	4.3	1.1	1.9	3.4	3.7	4.2	0.2	0.9	0.4	5.0	3.3	3.0	1.0	1.1	6.7	0.3	6.0	2.9	0.3	1.6	0.9	2.1	1.2	0.8	1.9	1.1	1.1	1.4	1.7	1.4	3.9	0.1	1.4	1.3	0.1	3.0	2.6	2.9	0.0	1.8	0.3	0.8	3.7	2.6	0.0	0.1	0.8	0.2	0.5	0.0	0.2	0.0	0.2	0.5	2.7	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.1	0.0	4.9	0.0	1.4	1.2	0.1	0.6	0.0	0.9	0.4	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.9	0.0	1.2	0.0	0.8	0.0	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.0	0.3	1.5	0.2	0.0	0.0	0.0	6.5	0.0	0.1	0.0	0.1	0.0	0.6	0.6	0.8	0.3	0.4	0.4	0.1	0.0	0.2	0.3	0.0	0.0	3.9	0.0	0.3	0.4	3.4	3.3	2.6	5.6	3.4	3.7	5.0	3.3	6.0	1.1	3.9	2.9	6.3	0.0	0.0	5.2	0.6	0.4	1.8	0.8	0.6	7.0	0.3	0.0	1.4	0.0	0.1	1.8	4.2	0.1	0.2	0.0	0.0	0.6	2.5	0.6	2.4	2.9	0.0	0.0	10.0	0.2	0.0	3.1	0.0	0.9	0.0	1.6	1.1	0.0	0.1	10.1	11.1	0.2	0.0	0.3	1.5	5.4	3.4	0.7	0.0	0.0	0.0	6.1	0.0	5.0	4.4	0.1	0.0	5.7	0.3	0.9	0.0	0.5	0.1	5.0	6.6	2.7	2.5	0.6	0.5	0.0	0.3	0.0	1.0	1.4	0.1	0.4
SLC45A2	"AIM-1, MATP, OCA4"	ENSG00000164175	"Solute carrier family 45 member 2"	Q9UMX9	5	33944623-33984693	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Melanin biosynthesis, Sensory transduction, Vision"		"Albinism, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 1.2;skin 1: 1.0;testis: 1.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.1;Excitatory neurons: 4.1;Inhibitory neurons: 5.4;Late spermatids: 5.1;Melanocytes: 12.4;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 4.7"	"Cancer enriched"	"Detected in some"	18	"melanoma: 47.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	28	"SK-MEL-30: 60.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (2.97e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.34e-3)"	"unprognostic (4.06e-2)"	"unprognostic (8.45e-2)"	"unprognostic (7.39e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.50e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.39e-1)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.4	1.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.4	0.0	0.0	0.1	1.0	0.0	0.0	0.1	0.0	0.2	1.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	60.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.3	0.1	0.1	0.2	0.1	0.2	0.4	0.1	0.0	0.0	1.0	0.0	0.6	0.1	0.0	0.0	0.6	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.1	0.3	0.1	0.3	0.0	0.0	4.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.4	5.1	0.0	0.0	12.4	0.0	0.0	0.1	0.0	2.5	4.7	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.1	0.1	0.0
SLC46A1	"HCP1, MGC9564, PCFT"	ENSG00000076351	"Solute carrier family 46 member 1"	Q96NT5	17	28394642-28407197	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 93.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 26.6;Hepatocytes: 27.8;Hofbauer cells: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"CACO-2: 205.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011614	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"		"CAB011614: AB_2270597"	"unprognostic (1.10e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.59e-2)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (9.11e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.04e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.10e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.04e-1)"	6.7	24.8	8.1	5.7	10.6	3.4	5.7	14.7	9.2	5.6	26.7	5.7	93.9	4.6	8.5	2.4	13.4	4.6	4.6	8.0	8.4	7.5	27.3	6.9	5.5	11.2	9.7	8.7	11.2	15.0	15.5	8.2	10.4	7.4	5.6	8.7	12.5	9.0	3.6	2.3	40.5	5.5	9.8	11.1	5.5	3.1	10.0	23.4	6.4	2.8	2.1	5.0	2.6	12.1	5.4	22.5	7.4	12.2	5.9	1.3	22.9	6.3	4.6	5.1	5.7	205.4	6.4	0.4	3.6	3.4	14.8	17.3	8.4	14.1	4.3	13.1	19.6	0.2	14.0	17.6	2.1	0.1	10.1	2.8	25.3	5.3	15.8	7.1	0.4	1.8	8.9	1.2	0.9	7.2	0.1	0.6	4.4	5.2	2.9	0.3	6.0	2.7	4.0	11.8	19.4	10.2	43.6	20.1	2.4	10.1	15.6	3.4	0.6	0.8	8.6	1.2	6.6	9.0	11.1	0.3	1.2	1.3	4.7	5.2	0.9	0.6	0.4	3.0	0.7	1.6	0.4	0.3	1.4	0.8	0.5	0.8	1.0	1.6	2.6	0.5	0.9	0.5	8.1	10.6	14.7	9.2	8.0	8.4	11.2	9.7	10.4	9.8	10.0	12.1	1.2	12.8	5.3	7.5	1.0	0.4	1.9	2.8	4.0	26.6	5.1	6.1	2.3	17.2	2.2	7.3	4.2	20.8	0.2	3.7	0.0	3.5	3.6	18.2	1.8	1.9	1.2	0.4	2.8	4.6	9.7	3.6	3.1	1.5	1.3	4.2	1.8	27.8	25.7	20.2	4.6	2.4	0.0	21.5	1.0	19.5	4.1	8.0	0.0	5.6	2.0	2.2	0.0	8.0	6.9	3.8	3.6	3.4	3.0	2.6	3.9	4.6	4.3	6.0	6.6	3.7	1.4	0.3	0.3	1.2	0.3	4.4	0.6	5.8	1.3	1.6
SLC49A4	"DIRC2, FLJ14784, RCC4"	ENSG00000138463	"Solute carrier family 49 member 4"	Q96SL1	3	122795069-122881139	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 44.0;Extravillous trophoblasts: 61.2;Syncytiotrophoblasts: 226.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072579			Supported	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"HPA072579: AB_2686536"	"unprognostic (1.40e-1)"	"unprognostic (8.53e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (9.74e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.87e-1)"	"prognostic favorable (8.81e-11)"	"unprognostic (2.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.13e-2)"	4.4	5.0	4.9	2.7	5.1	5.9	3.1	4.9	5.3	3.0	6.2	4.1	1.9	2.6	3.8	5.6	3.1	3.7	6.4	5.7	5.9	4.6	3.5	5.2	2.0	4.8	5.6	2.2	6.5	12.7	2.4	7.6	5.6	4.9	4.5	5.7	3.7	3.6	15.9	6.6	2.6	2.7	5.2	2.8	3.1	2.5	5.6	1.9	5.2	14.0	2.5	4.0	2.6	5.9	7.4	6.1	5.9	3.3	7.5	6.1	19.6	3.1	6.7	4.9	5.0	14.4	8.0	1.0	3.9	3.5	10.9	10.5	4.3	5.6	4.7	1.6	3.2	1.2	3.3	6.2	5.5	0.7	0.7	5.0	15.0	3.5	5.9	7.6	5.6	2.0	0.7	1.3	6.3	3.3	0.9	0.8	5.3	2.5	9.8	2.0	13.3	1.5	7.0	8.4	6.1	4.6	9.1	4.1	8.4	3.7	4.8	1.6	8.0	7.6	2.8	4.6	2.6	1.3	1.2	0.4	3.8	1.3	4.2	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.9	0.0	0.2	0.0	0.0	0.0	4.9	5.1	4.9	5.3	5.7	5.9	4.8	5.6	5.6	5.2	5.6	5.9	3.5	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	44.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	61.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	226.6	0.4	0.0	0.0	0.0
SLC4A1	"AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR"	ENSG00000004939	"Solute carrier family 4 member 1 (Diego blood group)"	P02730	17	44248390-44268141	"Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"	"Blood group antigen"	"Disease variant, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"bone marrow: 407.2"	"Cell type enriched"	"Detected in some"	80	"Erythroid cells: 1629.2"	"Cancer enriched"	"Detected in single"	91	"renal cancer: 16.3"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.0;neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"K-562: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015584, CAB034438, HPA063911"	Enhanced					NA	NA		22000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB034438: AB_2123479, HPA015584: AB_1844824, HPA063911: AB_2685151"	"unprognostic (1.36e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.93e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.13e-1)"	0.5	0.3	0.7	0.3	0.7	407.2	0.2	2.2	1.4	0.1	1.7	0.2	0.3	0.1	0.3	0.3	0.1	0.3	0.9	0.6	0.5	72.1	2.2	1.8	0.4	0.8	0.6	0.1	0.2	0.0	0.6	10.9	0.9	0.1	0.1	0.7	0.4	0.1	2.2	0.5	0.2	0.0	0.3	12.8	0.3	0.3	1.1	0.7	0.3	1.5	0.1	0.1	0.1	1.7	0.2	0.0	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.2	0.4	0.4	0.0	0.2	0.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.8	0.2	0.2	0.1	0.6	0.0	0.3	0.1	0.1	0.4	0.2	0.3	0.3	0.1	0.1	0.6	0.6	0.1	0.3	0.3	0.2	0.2	0.1	0.2	0.1	0.4	0.5	0.2	3.0	0.3	0.5	0.2	0.3	0.2	0.3	0.2	0.2	0.1	0.5	0.2	0.2	2.7	1.1	0.4	0.3	0.1	0.2	0.7	0.7	2.2	1.4	0.6	0.5	0.8	0.6	0.9	0.3	1.1	1.7	0.8	6.4	0.6	0.3	2.0	0.0	1.3	0.0	0.0	0.4	1.0	1.1	0.7	0.0	0.6	20.2	0.0	0.4	0.1	0.2	3.9	0.1	0.8	0.2	0.4	0.7	0.0	1629.2	0.2	0.0	1.6	0.5	0.0	0.5	0.0	0.1	0.7	0.9	1.4	0.0	0.2	0.1	0.0	1.0	0.0	0.0	0.0	1.9	0.0	1.0	0.6	0.2	2.1	0.0	0.0	0.0	0.0	0.4	0.3	0.9	0.2	0.4	0.0	0.2	0.0	1.2	0.2	0.7	0.5	0.0	0.0	0.8	1.5	0.7	0.1	0.6
SLC4A11	"BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1"	ENSG00000088836	"Solute carrier family 4 member 11"	Q8NBS3	20	3227417-3239559	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Symport, Transport"		"Corneal dystrophy, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 51.3;salivary gland: 54.0;thyroid gland: 60.9"	"Cell type enhanced"	"Detected in many"		"Club cells: 25.5;Collecting duct cells: 112.2;Ionocytes: 79.3;Respiratory ciliated cells: 48.1;Sertoli cells: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 70.6;Hep G2: 43.0;RT4: 30.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA018120, HPA058377"	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Vesicles	"HPA018120: AB_1857186, HPA058377: "	"unprognostic (2.33e-1)"	"prognostic favorable (9.03e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.52e-2)"	"unprognostic (9.66e-3)"	"unprognostic (3.73e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (6.21e-6)"	"unprognostic (7.37e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-3)"	2.4	6.9	4.5	0.7	3.5	0.4	3.4	2.3	3.1	10.9	5.6	0.4	0.1	0.5	2.6	16.5	1.7	1.1	0.8	2.9	1.4	51.3	0.2	2.0	1.4	2.0	2.3	0.2	0.5	0.6	4.3	0.2	2.6	5.4	0.3	0.4	54.0	7.0	5.2	12.8	0.6	0.3	0.8	0.7	2.5	5.9	4.3	1.0	60.9	0.1	1.8	3.4	5.8	1.9	11.0	15.5	1.8	7.9	5.1	1.3	21.1	5.4	3.4	2.8	1.6	1.1	14.1	0.0	6.1	1.9	6.6	70.6	8.3	16.8	0.5	0.1	3.2	0.7	7.5	43.0	3.2	4.0	13.6	0.7	6.8	3.4	3.2	2.3	7.0	9.8	1.6	9.7	2.9	7.2	0.5	0.4	12.1	13.6	20.7	2.6	10.3	3.5	16.9	30.7	0.9	4.9	2.7	17.5	0.3	5.4	6.7	7.0	12.1	2.1	7.0	0.5	2.7	0.4	0.6	0.1	0.1	2.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	4.5	3.5	2.3	3.1	2.9	1.4	2.0	2.3	2.6	0.8	4.3	1.9	0.8	0.0	0.0	1.6	0.0	0.8	2.2	16.3	8.0	0.2	4.9	4.4	1.1	0.0	25.5	112.2	0.0	0.1	0.6	0.8	0.0	0.7	5.8	2.3	0.6	0.7	0.0	0.0	0.3	0.5	0.1	0.3	5.1	4.2	0.0	0.2	1.1	0.0	0.4	0.0	0.1	0.2	79.3	0.3	0.0	2.2	0.0	0.5	0.0	0.0	0.6	0.1	0.0	0.0	0.3	3.0	1.3	0.4	0.0	3.7	0.0	0.5	48.1	0.2	26.3	0.6	5.8	3.0	4.7	3.3	0.4	0.0	0.2	0.1	0.2	5.7
SLC4A4	"hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5"	ENSG00000080493	"Solute carrier family 4 member 4"	Q9Y6R1	4	71062667-71572087	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 119.5;pancreas: 260.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 819.1;Cholangiocytes: 133.0;Distal enterocytes: 282.9;Ductal cells: 129.2;Proximal tubular cells: 211.0"	"Group enriched"	"Detected in many"	5	"glioma: 23.9;pancreatic cancer: 22.5;prostate cancer: 47.4;renal cancer: 19.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 13.0;fHDF/TERT166: 6.1;HBF TERT88: 5.7;hTERT-RPE1: 6.0;RPTEC TERT1: 15.4;U-138 MG: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022493, HPA035628, HPA035629, HPA079220"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB022493: , HPA035628: AB_2674708, HPA035629: AB_2674709, HPA079220: "	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (7.69e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (7.00e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.04e-1)"	5.1	0.7	30.0	2.2	43.6	0.5	1.0	47.0	32.5	11.5	0.0	41.1	54.3	0.4	0.3	1.2	0.9	29.4	6.2	21.5	37.9	119.5	21.7	6.9	0.2	38.6	28.0	0.8	260.3	17.2	5.8	2.7	24.8	34.7	41.2	5.1	2.5	1.1	2.2	0.1	14.6	1.7	38.2	0.8	18.6	0.5	38.5	3.5	22.0	3.5	0.0	4.5	0.4	33.2	0.0	3.5	1.0	0.0	0.0	0.0	0.1	13.0	1.9	2.2	1.6	0.0	0.1	0.0	0.1	6.1	0.5	0.0	0.2	0.0	5.7	0.0	1.7	0.9	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	6.0	0.0	0.7	0.0	0.5	1.2	0.0	4.8	0.2	0.1	0.2	0.0	0.0	0.0	0.9	15.4	4.1	0.9	0.1	0.0	0.0	0.2	1.3	0.0	0.0	0.0	7.7	0.7	5.5	0.6	0.0	0.0	0.0	5.1	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	30.0	43.6	47.0	32.5	21.5	37.9	38.6	28.0	24.8	38.2	38.5	33.2	1.5	3.2	37.1	819.1	2.2	0.0	4.3	3.2	0.6	3.2	0.9	0.3	24.0	133.0	31.1	25.8	0.0	0.3	7.2	282.9	15.6	129.2	11.5	2.8	0.5	1.3	8.5	4.0	51.4	24.2	0.1	4.9	33.1	5.8	1.3	0.6	3.9	35.8	0.2	0.0	93.4	65.6	2.0	0.6	0.2	1.5	0.0	2.3	1.8	34.7	1.0	3.9	1.0	29.1	3.7	16.2	60.8	0.0	1.7	40.8	31.8	211.0	10.4	1.5	6.6	1.0	6.2	0.1	1.0	5.5	0.0	0.3	6.8	2.4	68.1	12.3
SLC52A3	"bA371L19.1, C20orf54, hRFT2, RFVT3"	ENSG00000101276	"Solute carrier family 52 member 3"	Q9NQ40	20	760080-776015	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.2;testis: 40.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 23.9;Cytotrophoblasts: 32.8;Distal enterocytes: 18.8;Glandular and luminal cells: 21.3;Paneth cells: 21.7;Proximal enterocytes: 35.5;Syncytiotrophoblasts: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.1"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 42.1;OE19: 31.8;RT4: 12.3;SK-BR-3: 15.4;T-47d: 20.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049391, HPA059078"	Approved					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA049391: AB_2680743, HPA059078: AB_2732630"	"unprognostic (4.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.03e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.43e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.36e-2)"	"unprognostic (4.39e-3)"	"unprognostic (4.82e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (5.51e-6)"	"unprognostic (3.04e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-1)"	2.1	0.2	11.0	1.5	8.9	0.4	2.6	9.5	11.4	2.3	5.5	11.5	14.4	2.0	2.0	4.9	1.8	2.6	5.7	9.0	11.1	9.4	0.1	1.2	0.4	12.9	9.8	0.9	1.6	0.2	0.3	4.3	12.3	8.0	7.1	0.6	6.1	4.0	0.6	1.8	19.2	1.7	9.8	0.2	5.6	40.1	12.5	0.1	0.5	0.9	0.8	4.9	2.5	9.7	6.6	2.2	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	4.6	42.1	0.0	7.0	0.0	0.6	6.9	0.0	6.0	0.0	0.0	0.0	0.8	0.7	0.3	0.0	0.0	0.3	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.6	31.8	4.5	0.0	0.0	1.1	0.0	12.3	0.1	0.2	7.2	15.4	0.1	0.8	20.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	2.1	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.1	0.0	0.4	0.2	0.3	0.8	0.5	0.1	0.3	0.1	0.2	11.0	8.9	9.5	11.4	9.0	11.1	12.9	9.8	12.3	9.8	12.5	9.7	3.8	9.6	3.1	0.0	0.1	0.6	2.2	5.3	1.8	0.4	3.2	2.4	0.7	4.3	5.3	23.9	2.1	32.8	0.0	18.8	1.9	6.6	1.1	8.9	1.1	10.8	0.0	0.0	0.1	2.0	0.9	0.4	4.6	21.3	0.0	5.9	0.0	0.0	2.6	0.0	0.0	6.0	6.1	0.0	1.3	3.2	0.9	0.2	1.8	2.8	0.0	0.0	0.0	0.0	0.0	5.2	21.7	0.4	0.1	4.3	35.5	0.1	2.4	0.1	0.0	0.4	0.6	0.6	0.8	2.3	1.1	52.1	0.2	1.3	10.8	5.8
SLC5A1	"D22S675, NAGT, SGLT1"	ENSG00000100170	"Solute carrier family 5 member 1"	P13866	22	32043261-32113029	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 528.1"	"Cell type enriched"	"Detected in many"	6	"Proximal enterocytes: 768.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 20.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"OE19: 34.2"	"Region enriched"	"Detected in single"	26	"cerebellum: 7.6"	"Low region specificity"	"Detected in many"			"CAB015467, HPA051805, HPA055106"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Golgi apparatus"	"Nuclear membrane, Cytosol"	"CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.59e-4)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.53e-2)"	"prognostic favorable (6.97e-7)"	"unprognostic (4.68e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.45e-2)"	0.1	0.0	0.1	4.2	0.1	0.0	9.7	0.2	0.1	12.3	0.0	10.7	528.1	0.5	3.5	5.1	1.1	26.9	75.2	0.1	0.0	6.6	1.7	2.1	0.3	0.1	0.0	0.0	1.6	0.3	1.0	0.0	0.1	3.0	9.7	0.2	19.0	2.4	0.3	13.5	302.4	0.7	0.0	2.9	7.2	2.3	0.5	0.1	0.0	0.0	4.0	0.0	6.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	34.2	0.0	0.0	0.0	2.1	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.2	0.1	0.0	0.0	0.3	0.2	0.6	1.7	4.2	0.0	0.0	11.6	6.5	115.2	115.8	8.2	0.0	0.0	0.0	0.2	19.8	0.0	3.0	38.4	2.4	1.4	1.0	25.4	0.0	0.4	1.4	0.0	1.4	5.6	10.3	0.0	0.0	0.0	0.3	0.0	0.0	0.3	34.1	0.0	0.0	0.0	71.3	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	32.6	1.5	0.0	17.6	768.7	6.4	2.0	0.0	0.0	0.0	0.7	10.1	4.2	2.0	5.5	0.0	0.1	0.1	41.2	6.7
SLC5A7	"CHT1, hCHT"	ENSG00000115665	"Solute carrier family 5 member 7"	Q9GZV3	2	107986523-108013994	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport"		"Congenital myasthenic syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 32.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Club cells: 3.1;Respiratory ciliated cells: 1.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"RT4: 3.6;SCLC-21H: 1.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 23.1;hypothalamus: 9.0;midbrain: 9.4;pons and medulla: 14.4;thalamus: 6.2"	"Group enriched"	"Detected in many"	6	"basal ganglia: 20.4;pons: 26.5;spinal cord: 46.7"	HPA046105			Approved	"Nuclear bodies,Cell Junctions,Intermediate filaments"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cell Junctions, Intermediate filaments"	"Nuclear bodies"	"HPA046105: "	"unprognostic (2.98e-1)"		"unprognostic (1.01e-1)"					"unprognostic (1.29e-3)"			"unprognostic (7.10e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.05e-2)"	"unprognostic (9.78e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.61e-2)"	0.1	0.7	1.1	0.5	3.0	0.0	0.1	0.0	10.3	0.7	1.0	2.6	0.7	0.1	0.1	0.3	0.1	0.1	0.3	0.2	5.3	0.3	0.0	0.2	0.0	20.2	21.2	0.2	0.1	0.0	0.0	0.0	32.9	0.3	0.7	0.9	0.3	1.1	0.0	0.0	0.8	0.7	2.8	0.0	0.5	0.1	1.6	0.0	1.2	0.1	0.0	1.3	0.6	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.0	0.0	10.3	0.2	5.3	20.2	21.2	32.9	2.8	1.6	7.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3
SLC6A14		ENSG00000268104	"Solute carrier family 6 member 14"	Q9UN76	X	116436606-116461458	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		Obesity	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 16.0;salivary gland: 20.6"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 115.7;Basal respiratory cells: 94.9;Club cells: 225.6;Pancreatic endocrine cells: 170.4;Respiratory ciliated cells: 58.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.7;Hep G2: 3.4;OE19: 1.2"									HPA003193	Uncertain		Approved	Vesicles		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA003193: AB_2190122"	"unprognostic (3.06e-2)"	"unprognostic (3.55e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (9.74e-4)"	"unprognostic (1.34e-2)"		"unprognostic (3.89e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	0.0	0.0	0.1	2.2	0.0	0.1	7.7	0.3	0.1	7.0	0.0	1.4	0.9	0.2	0.0	2.3	0.2	0.8	0.0	0.1	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	1.0	0.7	0.0	20.6	1.3	0.0	3.2	0.6	0.1	0.0	0.0	3.8	0.1	0.0	0.0	0.0	0.0	1.1	1.6	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	22.4	115.7	0.0	0.1	0.1	0.3	94.9	0.0	0.0	17.6	11.6	0.2	0.0	225.6	0.0	0.0	0.0	0.1	18.1	0.0	17.6	0.1	0.2	0.0	0.5	2.4	0.0	0.0	32.0	0.0	1.0	10.7	0.4	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.1	0.0	0.0	0.1	0.0	0.5	16.0	0.0	0.0	0.0	0.0	0.0	0.0	170.4	10.2	0.0	0.0	10.5	0.2	0.0	58.1	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.4	0.0	0.4	0.0	8.9	23.4
SLC6A17		ENSG00000197106	"Solute carrier family 6 member 17"	Q9H1V8	1	110150494-110202202	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 52.9;pituitary gland: 25.3"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 60.6;Inhibitory neurons: 59.4"	"Cancer enriched"	"Detected in some"	9	"melanoma: 17.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008043, HPA008044"	Enhanced		Approved	Mitochondria		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA008043: , HPA008044: AB_1857192"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-3)"	"unprognostic (5.52e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.11e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.68e-3)"	0.4	5.9	21.6	0.2	26.3	0.1	0.3	1.2	52.9	0.1	0.0	0.3	0.0	0.1	1.0	0.4	0.1	0.1	0.1	20.1	9.6	1.3	0.0	0.1	0.0	13.7	8.2	0.0	1.4	8.8	25.3	0.8	10.5	0.1	0.1	6.0	0.6	0.1	0.1	6.2	0.1	0.1	0.0	0.0	0.7	1.8	24.8	0.0	0.3	0.1	0.0	0.1	0.1	15.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	5.5	0.5	2.1	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.0	1.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.8	6.2	1.9	36.0	1.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	7.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	26.3	1.2	52.9	20.1	9.6	13.7	8.2	10.5	0.0	24.8	15.7	0.0	0.0	0.0	2.6	0.0	0.5	0.0	0.1	0.0	5.1	0.2	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.9	0.0	1.2	0.0	0.0	0.5	0.0	0.0	60.6	0.0	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	59.4	0.0	4.1	0.0	0.0	0.7	0.0	0.0	10.6	3.7	0.0	0.7	0.0	4.5	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.7	0.4	0.0	1.8	0.0	0.4	0.1	0.0	0.0	0.0	0.0
SLC6A18	"FLJ31236, Xtrp2"	ENSG00000164363	"Solute carrier family 6 member 18"	Q96N87	5	1225381-1246189	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	76	"kidney: 8.2"	"Cell type enriched"	"Detected in some"	7	"Proximal tubular cells: 55.6"	"Cancer enriched"	"Detected in single"	44	"renal cancer: 4.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011885	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA011885: AB_1857198"			"unprognostic (2.02e-1)"										"unprognostic (5.69e-3)"	"unprognostic (2.90e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	55.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0
SLC6A19		ENSG00000174358	"Solute carrier family 6 member 19"	Q695T7	5	1201595-1225111	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	35	"intestine: 142.4;kidney: 88.7"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 561.5"	"Group enriched"	"Detected in many"	4	"renal cancer: 7.9;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 14.3;HEL: 18.3;OE19: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037415, HPA043207"	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 45: Enterocytes - Digestion"			"HPA037415: AB_10672346, HPA043207: AB_2678363"			"unprognostic (1.26e-1)"				"unprognostic (1.01e-3)"				"unprognostic (6.04e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (4.14e-6)"	"unprognostic (1.37e-1)"	"unprognostic (7.36e-2)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	139.7	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	88.7	0.9	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	5.6	0.0	0.0	0.0	0.0	0.0	142.4	0.3	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.4	0.0	5.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	64.3	0.6	1.8	0.0	0.0	0.0	104.4	1.9	0.1	0.1	0.0	0.0	0.1	4.8	2.7	0.0	0.0	14.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	561.5	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	8.7	0.0
SLC6A20	"IMINO, SIT1, XT3, Xtrp3"	ENSG00000163817	"Solute carrier family 6 member 20"	Q9NP91	3	45755449-45796536	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"choroid plexus: 59.2;intestine: 24.2"	"Cell type enriched"	"Detected in some"	4	"Proximal enterocytes: 74.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 4.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.7;OE19: 3.9;SuSa: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (1.57e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.26e-2)"	"unprognostic (4.33e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.55e-5)"	"unprognostic (2.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.09e-2)"	0.2	0.1	0.4	0.7	1.7	0.4	0.4	1.8	4.7	1.3	59.2	0.5	24.2	0.8	0.1	0.1	0.2	6.9	0.2	2.0	0.2	1.9	0.1	1.9	0.3	0.3	0.3	0.1	3.0	0.1	1.3	0.1	0.4	0.4	0.2	0.5	0.7	0.1	0.8	0.7	17.6	0.3	0.3	0.1	5.2	0.4	0.7	0.9	0.1	0.5	0.1	0.0	0.1	0.6	0.1	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.7	0.1	0.5	0.0	0.2	1.7	0.0	0.0	0.1	0.0	0.1	0.2	0.7	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.2	0.2	0.1	0.4	3.9	0.1	0.2	0.0	0.2	0.1	0.1	0.1	0.2	0.8	0.1	0.0	1.1	0.1	0.0	0.0	0.2	0.2	0.2	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	1.7	1.8	4.7	2.0	0.2	0.3	0.3	0.4	0.3	0.7	0.6	0.1	0.0	5.0	0.0	0.1	0.5	0.6	0.6	0.0	0.3	0.7	0.4	1.2	17.2	2.7	0.0	0.0	0.1	0.2	3.5	0.0	13.7	0.6	1.7	0.5	0.1	0.0	0.0	1.4	0.2	0.1	0.7	17.9	2.1	0.0	0.2	0.4	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	9.4	1.2	1.2	0.4	2.3	74.7	3.5	1.4	0.3	0.0	0.6	0.3	0.2	0.2	0.0	0.3	0.0	0.3	0.1	7.0	4.2
SLC6A5	"GLYT2, NET1"	ENSG00000165970	"Solute carrier family 6 member 5"	Q9Y345	11	20599594-20659285	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	23	"brain: 22.2"	"Group enriched"	"Detected in some"	39	"Early spermatids: 20.6;Late spermatids: 66.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"medulla oblongata: 22.2;pons: 20.0;spinal cord: 7.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	9	"pons and medulla: 49.3"	"Group enriched"	"Detected in many"	8	"medulla oblongata: 30.5;spinal cord: 18.3"	CAB079052		Supported				NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 31: Spermatids - Spermatogenesis"			"CAB079052: "					"unprognostic (6.94e-2)"	"unprognostic (2.28e-1)"									"unprognostic (4.75e-2)"			0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	22.2	1.3	0.0	0.0	0.0	0.6	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.3	0.2	0.2	0.0	22.2	1.3	20.0	7.6	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	66.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC6A6	TAUT	ENSG00000131389	"Solute carrier family 6 member 6"	P31641	3	14402576-14489349	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 68.5"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 571.3;Rod photoreceptor cells: 547.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 59.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 59.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 66.6;RPTEC TERT1: 111.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015028, HPA016488"	Enhanced		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Cell Junctions, Cytosol"		"HPA015028: AB_1857200, HPA016488: AB_1857202"	"unprognostic (8.25e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.63e-2)"	"prognostic favorable (5.22e-5)"	"prognostic unfavorable (5.75e-8)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.81e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.90e-1)"	10.9	25.6	1.7	8.4	6.9	54.7	8.5	5.0	7.7	11.3	0.0	3.9	0.9	10.4	0.0	6.7	6.7	9.4	24.4	3.5	3.8	12.2	1.5	20.5	7.5	9.6	6.6	28.9	2.3	2.5	7.4	7.9	6.7	4.3	2.4	68.5	17.1	7.2	30.9	18.3	17.1	6.9	1.7	15.6	9.4	3.7	11.0	4.5	9.3	8.7	9.1	8.1	6.1	6.8	4.1	18.4	4.6	10.1	11.6	5.7	15.9	4.3	26.4	8.4	6.2	8.8	5.6	12.6	4.5	10.9	11.7	4.3	4.5	10.1	16.5	3.7	9.7	8.8	66.6	24.2	0.0	3.7	22.3	1.9	2.6	7.8	1.6	7.7	14.5	6.2	10.1	3.5	18.6	8.1	9.4	20.3	6.1	7.1	10.8	6.1	7.3	24.9	111.8	28.5	7.2	4.6	3.1	3.2	0.6	36.8	11.5	4.5	15.3	9.7	3.9	5.2	6.2	3.9	6.0	7.1	19.3	6.6	23.2	5.6	9.2	8.6	2.5	7.3	1.3	4.0	2.7	3.0	2.8	2.1	0.5	0.6	59.2	1.8	9.4	1.4	8.7	4.6	1.7	6.9	5.0	7.7	3.5	3.8	9.6	6.6	6.7	1.7	11.0	6.8	42.7	6.4	21.5	1.3	16.4	49.3	17.1	51.5	43.9	126.1	9.5	6.9	4.2	7.2	52.8	20.2	571.3	3.0	14.5	0.5	0.0	12.0	19.6	82.1	23.0	29.4	14.4	9.4	17.4	8.2	15.8	13.5	29.0	126.9	13.3	2.5	11.7	0.6	27.2	10.1	18.5	3.5	46.8	60.1	59.5	16.6	17.4	58.8	17.8	32.8	110.9	30.8	10.3	3.0	23.9	31.1	12.6	17.3	13.3	17.6	51.3	23.3	69.5	547.8	0.0	11.4	8.3	0.4	1.3	15.7	23.9	5.1	25.5	46.8	3.6	16.8
SLC6A9	GLYT1	ENSG00000196517	"Solute carrier family 6 member 9"	P48067	1	43991500-44031467	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 72.4;skin 1: 46.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.7;Distal enterocytes: 17.8;Erythroid cells: 33.1;Ionocytes: 20.3"	"Cancer enhanced"	"Detected in all"		"glioma: 18.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 62.3;hTCEpi: 106.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013977	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA013977: AB_1849835"	"unprognostic (2.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (5.36e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.20e-2)"	3.9	31.0	21.7	4.9	45.5	10.8	4.6	53.2	24.2	12.1	6.3	11.0	2.3	7.4	1.1	23.1	9.5	4.8	2.1	16.1	31.3	4.3	2.3	11.6	1.1	66.3	43.5	2.9	8.2	2.8	1.7	1.4	63.6	3.9	6.3	17.2	11.5	5.5	1.1	46.6	6.0	9.1	45.6	1.9	7.4	1.1	45.9	1.4	5.3	0.6	4.3	12.3	25.1	72.4	19.7	13.7	7.1	18.0	11.2	3.7	15.6	14.7	41.0	24.3	30.1	4.8	7.5	0.3	1.6	42.9	0.0	62.3	11.0	12.5	5.0	0.1	1.8	17.1	33.9	5.8	50.3	3.8	0.7	11.3	106.6	11.9	28.5	15.3	0.6	12.3	13.0	48.5	1.0	10.4	2.9	0.1	5.4	7.4	19.1	2.2	0.0	22.9	2.3	2.2	4.4	4.2	7.4	35.3	7.0	1.7	9.1	10.3	0.2	2.8	11.0	2.4	8.0	53.1	39.2	4.4	9.2	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	45.5	53.2	24.2	16.1	31.3	66.3	43.5	63.6	45.6	45.9	72.4	1.5	0.0	2.0	5.9	1.1	7.5	0.9	3.2	8.0	30.7	2.2	0.9	0.7	4.3	2.2	1.8	16.7	0.5	0.5	17.8	0.0	3.7	5.9	4.8	0.4	0.7	0.0	33.1	2.2	8.9	1.0	0.9	1.5	2.7	0.0	0.0	0.0	0.3	0.3	1.7	1.5	2.7	20.3	0.0	1.0	0.8	1.5	0.1	3.6	0.0	1.0	1.2	0.0	3.0	16.4	4.2	3.0	1.5	1.3	2.0	9.1	1.1	12.5	11.1	6.6	0.1	10.0	0.1	0.4	8.9	12.9	0.5	0.3	1.2	2.6	3.2
SLC7A14	"KIAA1613, PPP1R142"	ENSG00000013293	"Solute carrier family 7 member 14"	Q8TBB6	3	170459548-170586075	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 15.9;pituitary gland: 7.3;retina: 6.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 28.4;Excitatory neurons: 61.9;Horizontal cells: 28.6;Inhibitory neurons: 90.2;Oligodendrocytes: 67.4"	"Group enriched"	"Detected in some"	11	"glioma: 0.8;pancreatic cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 3.2;SCLC-21H: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045929	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA045929: AB_2679501"	"unprognostic (1.00e-1)"		"unprognostic (9.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.68e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.03e-6)"	"unprognostic (1.54e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.24e-3)"	0.0	2.3	8.9	0.4	8.1	0.1	0.0	5.5	8.8	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	7.9	15.9	0.1	0.0	0.0	0.0	15.6	6.4	0.1	0.7	0.0	7.3	0.0	14.9	0.1	0.4	6.1	0.0	0.0	0.1	0.1	0.3	0.1	4.0	0.0	0.2	0.1	8.9	0.0	0.0	0.0	0.0	0.0	0.1	7.7	0.0	0.0	0.1	0.0	0.5	0.9	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.9	8.1	5.5	8.8	7.9	15.9	15.6	6.4	14.9	4.0	8.9	7.7	0.8	3.2	2.2	4.6	0.1	0.4	0.3	0.1	0.0	28.4	0.1	0.0	1.0	0.0	2.5	0.0	2.1	0.1	0.1	0.0	0.0	0.0	0.6	0.2	0.2	0.5	1.8	0.0	61.9	0.0	0.1	0.4	0.0	0.1	2.5	0.1	0.4	0.9	0.0	28.6	90.2	0.1	0.0	0.0	1.2	0.6	2.1	0.4	3.6	6.5	0.0	1.8	0.0	9.5	67.4	0.1	1.2	2.6	0.1	0.3	0.1	0.2	3.0	4.3	0.0	0.7	0.5	0.0	0.2	0.0	0.6	0.0	0.4	0.1	0.0	0.2
SLC7A9	CSNU3	ENSG00000021488	"Solute carrier family 7 member 9"	P82251	19	32830509-32869767	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 124.6;kidney: 68.2"	"Cell type enriched"	"Detected in some"	7	"Proximal enterocytes: 772.0"	"Group enriched"	"Detected in some"	7	"liver cancer: 6.6;renal cancer: 5.2;stomach cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"BEWO: 3.4;CACO-2: 8.2;Hep G2: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042591	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"HPA042591: AB_10962500"	"unprognostic (4.12e-2)"	"unprognostic (5.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.69e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (5.10e-5)"	0.2	0.1	0.7	0.1	0.7	0.0	0.3	0.7	0.9	0.8	0.6	0.8	78.3	0.4	1.4	0.2	0.5	0.2	0.1	0.7	0.7	68.2	17.3	0.2	0.1	0.7	0.7	0.6	0.3	0.0	0.7	0.1	0.7	1.0	0.2	1.0	0.2	0.2	0.0	0.3	124.6	0.2	0.6	0.3	0.2	0.4	0.7	0.2	0.8	0.0	0.0	0.3	0.5	0.7	0.0	0.1	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.7	0.9	0.7	0.7	0.7	0.7	0.7	0.6	0.7	0.7	0.1	0.0	0.0	2.3	0.5	0.0	0.1	0.0	0.0	1.3	0.2	0.6	0.4	0.0	0.0	5.5	4.2	0.2	0.1	0.0	1.9	0.1	1.6	0.3	0.2	0.1	0.0	0.0	3.1	7.2	8.8	0.2	0.0	0.2	0.0	0.4	0.0	12.2	0.2	0.0	3.0	18.2	0.0	0.0	0.0	0.1	0.6	0.5	0.0	2.8	0.0	0.2	0.0	0.0	1.7	0.6	27.5	0.0	0.0	0.0	772.0	97.8	1.8	1.2	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.1	11.7	0.0
SLC9A1	"APNH, NHE1, PPP1R143"	ENSG00000090020	"Solute carrier family 9 member A1"	P19634	1	27098809-27166981	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"Deafness, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 76.5;stomach 1: 65.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 81.5;Gastric mucus-secreting cells: 160.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022371, HPA048532, HPA052891"	Enhanced		Supported	"Plasma membrane"		NA	NA		21000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB022371: , HPA048532: AB_2680431, HPA052891: AB_2681981"	"unprognostic (6.18e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.70e-2)"	"unprognostic (4.33e-3)"	"unprognostic (3.18e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (3.44e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-2)"	9.6	10.7	6.1	10.4	14.7	11.5	9.0	2.8	10.8	10.9	0.2	18.6	29.3	10.9	8.0	11.0	7.6	16.9	13.7	2.3	5.3	5.8	2.4	13.2	7.0	13.8	4.7	7.0	8.6	20.7	8.2	21.9	11.2	9.0	13.6	4.5	76.5	19.4	4.6	10.5	19.0	10.7	0.5	11.6	65.9	10.1	10.4	6.3	9.5	4.9	6.7	15.1	9.2	2.4	32.3	10.7	9.9	10.1	21.8	15.7	60.8	25.9	38.5	21.7	23.5	13.0	20.0	14.4	21.9	33.4	10.5	38.9	9.8	62.4	13.4	17.4	9.4	21.9	7.1	5.5	66.1	13.1	16.0	19.7	29.5	36.5	50.7	15.8	36.3	9.8	6.3	13.4	32.3	18.7	6.8	6.4	14.0	38.2	21.9	11.8	9.0	6.7	10.9	46.3	11.4	3.7	21.5	28.4	12.6	10.0	13.3	7.9	39.9	23.0	9.4	21.7	14.5	12.6	8.6	4.3	24.6	14.1	13.5	0.0	0.6	0.6	0.7	0.3	1.5	0.1	0.8	0.7	0.2	0.3	0.5	0.6	2.0	0.1	0.6	0.0	0.3	0.8	6.1	14.7	2.8	10.8	2.3	5.3	13.8	4.7	11.2	0.5	10.4	2.4	13.5	6.4	14.8	6.5	7.9	31.2	17.9	14.6	13.1	7.4	21.7	23.2	13.5	7.2	8.3	11.0	0.0	40.3	11.9	81.5	0.0	9.1	26.5	13.8	15.9	9.7	12.5	0.4	14.1	12.5	19.4	12.7	160.0	26.5	27.3	7.5	6.8	1.2	12.9	20.2	14.1	15.0	4.1	5.7	5.1	14.4	9.3	12.7	7.2	8.4	4.3	8.2	12.3	4.0	4.6	28.1	43.1	13.2	4.8	9.6	38.9	1.2	5.9	3.8	6.6	20.8	9.8	3.6	4.4	15.0	25.1	52.9	9.8	4.8	18.3	18.3
SLC9A3R1	"EBP50, NHERF, NHERF1"	ENSG00000109062	"SLC9A3 regulator 1"	O14745	17	74748628-74769353	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Wnt signaling pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 352.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 295.8;Proximal enterocytes: 536.9;Proximal tubular cells: 433.0;Squamous epithelial cells: 303.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 572.4;SK-BR-3: 450.7;T-47d: 873.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001962, HPA009672, HPA027247"	Enhanced		Approved	"Vesicles,Plasma membrane,Centriolar satellite"		NA	Yes		940000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	"Vesicles, Centriolar satellite"	"CAB001962: , HPA009672: AB_1857215, HPA027247: AB_10601162"	"unprognostic (1.29e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (9.83e-5)"	"unprognostic (7.41e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.81e-3)"	"unprognostic (5.53e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.08e-2)"	27.0	146.3	98.9	43.7	103.0	115.7	64.1	105.6	118.1	58.3	127.5	85.1	257.8	22.6	26.0	352.8	89.7	96.6	24.3	98.3	91.0	203.5	269.2	26.5	67.9	100.2	97.6	11.1	85.4	110.3	20.8	33.6	95.6	43.9	59.3	13.0	192.2	71.1	5.2	51.1	274.4	11.6	92.2	61.1	78.2	22.5	102.0	57.7	21.4	10.0	89.2	25.7	103.3	106.1	102.1	82.6	40.4	42.1	23.9	17.5	179.9	24.1	22.4	60.3	58.2	259.6	59.6	22.2	23.9	51.4	32.3	142.2	69.8	46.4	28.3	25.9	66.2	167.4	210.9	350.8	48.6	110.3	108.9	14.4	25.6	48.0	20.6	124.9	50.2	65.8	54.0	115.9	93.8	572.4	262.5	246.7	36.1	286.3	47.6	28.0	45.4	100.6	83.5	71.7	34.6	45.3	25.2	450.7	51.9	110.4	873.8	87.3	17.0	18.7	53.5	43.8	40.2	200.0	98.9	40.9	30.2	145.4	11.2	581.6	91.9	440.8	421.5	133.0	279.8	58.6	255.5	360.4	87.8	52.1	147.5	266.1	318.8	308.8	172.1	90.8	309.0	345.9	98.9	103.0	105.6	118.1	98.3	91.0	100.2	97.6	95.6	92.2	102.0	106.1	12.3	6.4	17.2	29.0	41.8	46.1	21.4	128.7	50.1	2.2	135.3	78.7	17.8	163.0	120.8	31.3	4.2	74.5	122.9	295.8	66.5	194.9	15.8	61.8	7.8	12.0	18.7	24.8	0.4	99.0	56.6	24.7	45.3	85.0	25.3	7.3	7.9	190.6	85.4	5.0	0.5	58.0	105.8	25.7	18.8	9.9	8.7	43.5	28.4	3.7	27.0	86.2	203.9	5.0	11.4	76.5	143.8	41.8	151.1	27.5	536.9	433.0	76.0	5.0	6.6	27.6	20.0	22.5	19.5	303.4	57.4	111.5	126.1	17.1	57.1	34.6
SLC9A6	"KIAA0267, NHE6"	ENSG00000198689	"Solute carrier family 9 member A6"	Q92581	X	135973841-136047269	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 40.3;Horizontal cells: 48.8;Inhibitory neurons: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059445, HPA059590"	Enhanced		Supported	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"HPA059445: AB_2684021, HPA059590: AB_2684075"	"unprognostic (1.35e-1)"	"unprognostic (8.28e-3)"	"unprognostic (4.36e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.06e-2)"	5.1	6.3	11.6	5.6	11.9	4.6	3.3	1.2	15.7	5.6	0.0	6.0	8.5	6.4	3.3	6.3	5.7	5.5	8.6	12.7	19.0	6.9	4.5	6.7	5.7	7.8	4.4	8.0	3.8	10.4	2.2	4.7	8.9	4.0	6.1	14.4	4.1	4.9	7.5	4.7	7.8	7.4	3.4	5.7	5.8	5.8	15.3	5.6	6.7	7.1	6.6	5.6	1.6	4.2	20.0	10.5	9.1	3.8	14.8	14.2	17.3	15.9	16.9	13.3	27.9	9.2	15.5	14.8	35.2	18.4	19.8	11.6	14.3	14.0	19.1	11.7	12.9	4.0	15.3	5.3	7.9	11.6	13.3	7.7	11.6	22.0	10.8	9.4	11.2	12.5	7.5	20.5	14.9	8.7	15.5	3.4	6.0	7.1	14.0	10.4	16.0	15.2	9.4	9.8	9.5	7.2	11.4	1.2	8.9	8.8	4.5	8.7	16.4	16.5	10.9	24.5	20.7	9.6	23.8	12.7	10.0	19.4	9.4	2.0	5.0	3.0	6.4	7.0	11.1	4.1	7.1	5.9	5.8	2.6	7.6	5.7	2.0	5.1	6.0	3.5	6.9	5.4	11.6	11.9	1.2	15.7	12.7	19.0	7.8	4.4	8.9	3.4	15.3	4.2	4.3	3.2	5.4	22.9	5.9	7.5	1.4	6.2	7.4	14.2	2.7	3.4	11.2	12.8	4.0	12.9	8.4	2.5	6.1	8.9	0.0	4.3	0.8	4.2	4.1	4.9	10.7	5.0	40.3	6.0	2.4	5.1	8.6	6.8	1.3	4.6	8.2	9.6	9.9	48.8	42.0	4.0	8.2	13.0	7.0	1.4	5.6	9.8	8.8	15.9	8.2	12.9	4.1	19.6	22.7	6.1	6.0	4.5	3.8	2.0	10.3	6.0	3.1	7.8	0.0	5.1	8.4	9.0	11.9	7.0	6.8	2.9	8.9	3.1	6.0	3.1
SLC9A7	NHE7	ENSG00000065923	"Solute carrier family 9 member A7"	Q96T83	X	46599251-46759118	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Potassium transport, Sodium transport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 41.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.3;Inhibitory neurons: 66.8;Oligodendrocyte precursor cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048938, HPA075385"	Approved		Supported	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA048938: AB_2680565, HPA075385: AB_2686747"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (8.58e-4)"	"prognostic unfavorable (8.14e-4)"	"unprognostic (2.16e-2)"	"unprognostic (2.73e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.08e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	0.5	5.0	9.1	2.4	41.6	3.6	5.8	6.3	14.6	1.2	0.5	0.6	1.2	0.8	2.6	1.9	1.7	1.6	1.1	8.6	17.0	2.6	3.1	1.3	6.3	13.9	7.5	4.3	3.4	8.9	9.2	1.1	14.2	4.6	0.9	4.9	6.0	2.0	5.7	2.1	2.2	0.7	6.7	3.7	6.3	0.8	14.5	3.2	4.3	2.5	6.3	1.8	1.3	5.1	10.4	7.7	1.1	3.3	1.2	7.4	4.3	9.6	12.0	5.7	4.5	7.9	10.9	22.7	2.9	15.6	11.0	4.6	7.4	10.9	10.3	11.9	3.9	2.3	3.1	3.3	4.6	1.0	17.9	4.6	1.4	16.1	10.6	26.8	8.2	7.7	0.2	0.3	7.9	15.7	2.6	1.2	5.3	5.0	9.2	10.0	0.4	0.2	4.4	11.4	8.2	1.0	4.9	7.3	2.1	9.2	9.7	0.4	0.4	12.0	4.0	1.8	5.7	2.3	0.5	11.2	17.1	0.1	4.0	0.5	0.2	0.1	0.1	0.2	0.1	1.7	0.2	0.1	1.1	1.7	0.1	0.1	0.8	0.5	0.2	2.8	0.3	0.2	9.1	41.6	6.3	14.6	8.6	17.0	13.9	7.5	14.2	6.7	14.5	5.1	0.5	3.2	8.2	11.4	21.0	0.6	10.1	0.9	1.2	13.0	16.9	8.6	5.7	1.5	2.6	16.5	4.2	7.9	24.4	0.3	0.0	17.6	0.0	1.8	2.0	1.5	2.4	5.5	43.3	14.2	0.7	2.7	13.3	1.7	0.0	4.5	0.7	6.5	6.4	13.5	66.8	2.0	0.0	6.3	8.4	0.6	0.9	9.2	1.8	3.7	8.0	6.1	1.0	69.9	1.6	16.4	0.1	0.4	2.8	21.0	0.1	2.1	0.1	3.5	6.6	12.1	1.9	0.0	1.6	4.2	1.0	7.3	2.9	1.3	0.9	11.5
SLC9A9	"FLJ35613, NHE9"	ENSG00000181804	"Solute carrier family 9 member A9"	Q8IVB4	3	143265222-143848485	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Astrocytes: 149.8;Inhibitory neurons: 159.5;Microglial cells: 396.3;Oligodendrocyte precursor cells: 272.9;Oligodendrocytes: 431.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.3;ASC TERT1: 24.9;HSkMC: 17.6;Karpas-707: 62.8;RPMI-8226: 30.4;U-266/70: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058234	Approved					NA	NA		280000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA058234: AB_2683648"	"unprognostic (8.22e-2)"	"unprognostic (6.88e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (8.18e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.35e-3)"	"unprognostic (7.73e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (5.57e-7)"	"unprognostic (5.01e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.28e-2)"	12.8	5.1	9.7	8.8	14.4	2.0	5.3	12.5	11.3	6.9	6.9	7.3	3.0	4.2	3.7	12.8	6.8	9.6	5.4	9.9	16.3	2.3	7.1	5.9	14.7	20.4	13.5	7.9	1.0	3.0	3.4	15.9	19.5	8.8	5.8	1.3	4.5	8.5	2.1	7.7	7.0	8.0	14.4	13.1	5.0	1.8	13.8	15.5	3.5	5.0	13.5	11.4	7.7	18.2	0.5	0.5	0.8	1.0	19.3	24.9	0.3	1.0	6.6	0.5	3.1	0.0	0.2	3.0	0.2	2.9	1.5	0.7	0.9	1.9	0.8	12.8	0.2	1.6	0.4	0.0	2.2	0.8	1.3	17.6	5.2	0.7	0.9	1.1	0.3	2.3	0.0	62.8	4.2	0.0	1.5	0.0	0.2	0.0	0.5	2.6	0.1	30.4	0.0	0.5	0.4	0.0	1.5	0.0	0.0	0.4	0.2	0.6	0.0	2.4	0.6	2.8	1.4	29.1	0.1	0.1	4.3	0.4	1.2	0.2	6.2	0.7	4.7	10.6	4.0	3.3	4.9	7.5	8.4	3.7	2.7	4.0	0.5	4.2	9.0	0.6	9.3	4.8	9.7	14.4	12.5	11.3	9.9	16.3	20.4	13.5	19.5	14.4	13.8	18.2	4.5	0.0	1.1	149.8	13.2	3.7	10.4	8.7	22.8	0.2	0.6	1.3	1.5	0.0	3.4	3.7	2.1	0.5	10.4	0.0	0.0	1.0	4.8	0.8	10.1	4.4	0.0	9.9	25.6	0.2	0.5	26.5	7.1	0.8	0.0	0.7	21.8	0.0	55.4	0.0	159.5	0.0	6.1	30.5	9.9	4.4	9.3	31.0	7.2	396.3	24.3	2.8	13.4	272.9	431.8	0.8	0.1	7.2	10.9	11.1	0.0	0.4	1.6	0.1	0.0	18.0	7.0	0.3	0.4	23.9	5.1	1.1	19.7	3.7	0.1	3.9
SLCO1B1	"LST-1, OATP-C, OATP1B1, SLC21A6"	ENSG00000134538	"Solute carrier organic anion transporter family member 1B1"	Q9Y6L6	12	21131194-21239796	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	614	"liver: 537.2"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 83.1"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 52.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.1;NTERA-2: 1.3;RPMI-8226: 1.8;SuSa: 2.2"									"HPA050892, HPA073093"	Supported		Supported	"Plasma membrane"		NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA050892: AB_2681265, HPA073093: "			"unprognostic (5.45e-1)"			"unprognostic (1.82e-4)"	"unprognostic (2.43e-3)"	"unprognostic (1.96e-3)"		"unprognostic (1.80e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.82e-2)"		"unprognostic (5.63e-2)"	"unprognostic (3.86e-2)"		"unprognostic (3.49e-1)"	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	537.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	83.1	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SLCO1B3	"OATP1B3, OATP8, SLC21A8"	ENSG00000111700	"Solute carrier organic anion transporter family member 1B3"	Q9NPD5	12	20810702-20916911	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 265.1"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 203.4"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 65.3;A549: 17.5;CAPAN-2: 12.6;GAMG: 13.6;HeLa: 14.2;PC-3: 17.3;U-2 OS: 14.7"									"HPA004943, HPA050892"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA004943: AB_1854758, HPA050892: AB_2681265"		"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.95e-2)"		"unprognostic (1.63e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.09e-2)"		"unprognostic (3.08e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.37e-2)"		"unprognostic (1.50e-1)"	"unprognostic (6.61e-3)"		"unprognostic (2.36e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	13.0	16.2	0.3	0.2	0.1	0.4	0.3	0.0	0.3	0.0	0.5	0.0	0.0	265.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	65.3	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	12.6	0.0	4.3	0.0	13.6	0.1	0.0	0.5	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	14.7	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	203.4	0.0	0.0	0.5	0.0	0.0	1.6	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.2
SLCO2A1	"MATR1, OATP2A1, PGT, SLC21A2"	ENSG00000174640	"Solute carrier organic anion transporter family member 2A1"	Q92959	3	133932701-134052184	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 123.7"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 47.1;Endothelial cells: 65.2;Hepatic stellate cells: 146.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"EFO-21: 90.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA013742	Enhanced					NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA013742: AB_2668877"	"unprognostic (4.39e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (9.69e-4)"	"unprognostic (8.53e-2)"	"unprognostic (2.32e-3)"	"prognostic favorable (9.24e-5)"	"unprognostic (1.92e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.87e-2)"	"unprognostic (5.63e-3)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.07e-2)"	30.4	42.5	1.6	16.8	1.6	0.0	18.1	1.3	2.7	30.9	9.1	24.7	10.2	46.3	6.1	18.8	28.3	18.8	26.4	1.5	1.6	52.8	2.4	123.7	9.2	2.0	1.6	5.2	20.8	28.7	15.8	23.4	2.2	36.5	18.0	0.0	20.8	84.7	2.1	13.5	29.3	33.5	1.9	24.2	23.6	1.3	2.3	8.4	89.3	3.4	9.6	21.3	20.3	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.5	4.3	0.5	0.0	0.1	0.1	0.0	90.6	0.9	0.0	11.2	0.1	0.0	0.1	0.1	0.1	0.0	5.8	0.0	2.4	0.0	0.0	3.4	0.2	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.6	6.0	0.0	0.0	0.0	0.0	8.7	0.0	0.1	0.0	4.6	1.5	0.0	3.7	0.1	0.0	22.1	0.0	4.5	0.1	0.4	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	1.6	1.3	2.7	1.5	1.6	2.0	1.6	2.2	1.9	2.3	1.7	19.8	0.0	2.5	0.0	2.1	5.1	9.1	0.5	8.6	0.0	0.8	3.9	4.6	1.5	1.6	3.7	0.0	1.5	0.0	47.1	0.0	2.8	1.0	0.9	0.2	65.2	1.2	0.0	8.1	3.3	4.0	8.7	18.8	1.6	1.3	0.1	146.7	0.6	0.2	0.0	1.7	4.1	0.0	2.2	0.4	0.8	0.3	0.7	0.0	2.8	0.0	0.0	0.0	0.0	0.1	14.0	15.8	0.0	0.0	1.5	3.2	2.1	0.8	0.0	0.0	0.4	1.1	0.4	0.2	2.0	1.7	0.8	1.1	0.1	0.6	2.2
SLURP1	"ANUP, ARS, ArsB, LY6-MT, LY6LS, MDM"	ENSG00000126233	"Secreted LY6/PLAUR domain containing 1"	P55000	8	142740949-142742406	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Cytokine	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 1039.2;skin 1: 858.5"	"Group enriched"	"Detected in some"	16	"Squamous epithelial cells: 20.8;Suprabasal keratinocytes: 65.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 66.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.3;MCF7: 1.5;RT4: 1.1;T-47d: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA050967	Approved				"Secreted in other tissues"	NA	NA		7700000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA050967: AB_2681293"	"unprognostic (1.22e-2)"	"unprognostic (5.08e-2)"		"unprognostic (1.16e-2)"		"unprognostic (1.42e-2)"		"unprognostic (1.84e-1)"	"unprognostic (7.32e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-4)"	"unprognostic (1.58e-1)"		"unprognostic (2.98e-1)"			"unprognostic (1.43e-1)"	0.9	0.6	0.1	0.0	0.0	0.0	11.3	0.7	0.5	105.0	0.0	0.3	0.0	0.2	0.0	1039.2	0.2	0.2	0.4	0.1	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.2	0.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	70.1	0.0	1.4	858.5	0.3	0.0	0.0	0.2	0.8	0.3	0.1	0.9	0.2	0.0	17.4	0.3	206.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.6	0.0	0.0	1.8	1.5	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	20.8	65.8	0.0	0.0	0.0	0.0	0.8
SMARCAD1	"DKFZP762K2015, ETL1, KIAA1122"	ENSG00000163104	"SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1"	Q9H4L7	4	94207611-94291292	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 86.5;Inhibitory neurons: 82.5;Oligodendrocyte precursor cells: 86.5;Oligodendrocytes: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016737	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA016737: AB_1857271"	"unprognostic (5.01e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.41e-3)"	"unprognostic (9.08e-3)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (2.45e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.20e-3)"	10.0	9.5	7.1	11.2	7.8	7.5	15.2	12.0	8.5	10.6	7.5	9.4	9.7	14.5	12.6	10.5	10.7	10.3	7.6	7.3	8.6	11.7	9.8	9.7	16.0	7.2	7.4	14.2	8.7	11.7	11.0	14.1	7.7	11.1	12.3	14.6	8.9	10.0	7.3	20.8	9.5	11.8	7.7	11.9	10.8	12.2	8.2	18.6	15.0	6.8	14.2	11.2	9.7	9.9	15.0	18.6	59.1	38.1	16.5	26.6	30.1	26.8	24.3	21.8	20.3	18.2	23.7	37.8	17.7	23.1	19.8	12.9	42.3	22.4	30.7	29.8	18.7	27.5	20.5	27.2	24.4	41.2	28.9	27.8	17.8	27.3	34.9	27.0	33.7	33.3	46.7	15.5	32.4	12.3	69.1	21.3	40.1	19.1	9.4	40.1	33.6	19.6	24.6	18.4	33.8	49.9	20.1	32.8	28.6	36.7	17.1	26.9	32.3	27.6	29.9	17.1	20.3	21.8	34.8	45.1	25.7	21.2	34.8	2.7	1.3	0.2	2.3	1.7	2.5	2.9	2.6	2.6	2.4	2.4	2.8	3.3	0.0	4.5	1.7	2.1	2.3	1.3	7.1	7.8	12.0	8.5	7.3	8.6	7.2	7.4	7.7	7.7	8.2	9.9	19.0	12.8	11.3	56.2	16.7	11.7	6.5	12.8	25.6	20.9	15.5	13.2	12.7	4.3	24.7	9.2	16.7	13.5	20.1	7.1	1.9	12.4	2.1	27.6	32.3	17.8	9.0	25.5	86.5	10.0	11.8	19.9	17.9	17.9	24.0	29.5	13.2	13.5	10.8	18.5	82.5	12.9	14.2	14.6	5.4	3.1	14.3	13.7	3.6	47.8	12.6	8.1	17.5	86.5	99.5	15.0	6.3	18.4	16.4	7.7	4.4	15.5	26.8	18.8	6.6	21.1	16.2	25.9	34.8	18.7	9.7	9.6	17.3	26.2	12.6	5.8
SMPD1	ASM	ENSG00000166311	"Sphingomyelin phosphodiesterase 1"	P17405	11	6390440-6394998	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"	"Disease variant, Neurodegeneration, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 131.3;Late spermatids: 200.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 139.1;fHDF/TERT166: 144.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		2700000	"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (8.76e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.28e-3)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (9.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.90e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (4.35e-2)"	"prognostic favorable (4.57e-6)"	"unprognostic (4.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.71e-1)"	21.8	36.5	38.8	13.9	44.7	7.3	20.1	45.1	43.0	21.2	33.9	25.3	16.8	20.9	14.4	20.6	14.6	21.5	55.8	39.1	43.0	73.7	95.3	31.3	14.6	42.7	42.6	17.9	32.8	34.2	41.9	21.6	43.3	29.4	14.9	8.5	29.0	20.0	37.9	37.9	23.8	17.6	40.9	21.1	25.4	14.0	47.5	17.8	34.0	29.4	11.0	23.6	21.0	46.8	16.4	13.1	10.1	26.5	139.1	72.2	17.1	60.4	95.0	27.7	33.0	22.0	11.9	4.7	27.4	144.0	59.3	7.4	8.4	12.7	13.0	21.0	9.6	5.1	19.5	6.0	62.3	3.7	37.4	96.0	23.4	25.9	17.7	100.9	61.6	1.7	9.1	30.5	58.9	17.0	0.1	6.5	3.9	23.2	22.3	1.2	5.5	7.0	23.9	6.2	17.0	9.7	27.6	19.5	38.5	12.9	7.3	7.0	53.9	103.0	10.9	59.1	15.4	37.6	44.0	3.5	93.7	10.8	47.1	1.9	2.5	3.4	6.4	2.1	5.0	1.5	5.5	5.0	1.3	3.1	10.0	10.1	2.5	6.6	0.6	1.7	4.7	3.2	38.8	44.7	45.1	43.0	39.1	43.0	42.7	42.6	43.3	40.9	47.5	46.8	14.1	25.6	14.4	10.7	12.2	7.9	22.8	15.3	6.8	12.6	13.7	9.0	37.7	24.3	12.8	25.8	25.0	38.8	11.5	131.3	11.7	53.4	50.0	6.2	13.0	18.6	23.8	9.9	5.8	38.2	14.4	31.4	15.8	21.0	10.8	9.4	26.7	88.5	34.1	20.2	5.5	20.3	24.4	15.5	6.2	200.7	11.5	15.8	55.2	4.7	7.8	16.4	36.0	6.6	15.5	24.7	83.1	13.5	23.1	26.0	51.7	75.1	2.4	5.2	0.0	8.9	17.1	1.4	3.1	7.5	8.0	34.3	23.3	10.2	18.0	15.4
SMPD4	"FLJ20297, FLJ20756, KIAA1418, NET13, nSMase-3, NSMASE3"	ENSG00000136699	"Sphingomyelin phosphodiesterase 4"	Q9NXE4	2	130151392-130182750	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046279, HPA049426"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nuclear membrane"	Cytosol	"HPA046279: AB_2679611, HPA049426: AB_2680762"	"unprognostic (5.02e-2)"	"unprognostic (9.61e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (7.47e-5)"	"unprognostic (1.69e-1)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (3.27e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.73e-4)"	"prognostic unfavorable (8.16e-8)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.09e-1)"	9.9	10.8	4.2	11.1	4.9	25.4	10.9	5.3	6.2	15.5	3.1	12.1	9.5	15.5	5.0	13.8	15.9	9.2	11.7	4.0	7.0	8.6	9.2	10.6	15.7	7.5	5.0	14.6	13.3	15.2	22.7	14.9	6.3	11.8	11.1	4.7	12.9	11.7	13.3	13.5	11.5	12.9	2.4	11.2	10.3	17.7	6.0	19.8	16.0	12.0	15.7	11.8	12.3	10.0	89.1	41.5	46.2	39.2	29.1	21.8	58.7	41.5	42.0	76.3	62.8	119.2	47.0	56.2	41.2	49.9	36.3	43.8	64.0	64.4	40.4	72.7	61.2	60.5	36.2	90.1	31.2	68.5	34.7	25.6	39.4	77.0	27.2	21.1	44.9	51.4	82.2	40.8	40.7	44.3	72.2	32.0	77.0	40.1	56.4	74.3	44.2	59.0	27.0	38.6	66.8	36.3	42.8	54.5	22.7	24.9	37.8	34.8	32.8	57.0	49.3	33.0	49.4	34.3	44.0	79.2	51.4	38.7	44.0	1.8	9.2	14.8	12.9	11.2	14.3	8.9	9.6	11.6	9.6	9.1	9.0	10.5	4.3	12.1	8.1	6.0	9.2	10.4	4.2	4.9	5.3	6.2	4.0	7.0	7.5	5.0	6.3	2.4	6.0	10.0	17.4	3.2	11.3	4.9	20.8	15.0	9.1	8.8	12.0	19.8	21.5	23.0	3.9	5.7	8.0	7.3	12.5	23.8	16.4	7.9	9.8	9.2	22.7	16.0	19.7	12.0	13.1	21.2	6.9	12.2	26.5	12.2	18.8	26.3	6.3	29.0	10.4	17.3	14.1	15.2	6.7	12.8	4.1	13.2	7.7	41.7	14.6	10.2	16.0	1.0	8.8	9.9	11.3	7.5	10.4	11.8	10.5	18.4	27.0	9.4	7.7	5.9	9.9	16.0	0.0	14.1	12.8	25.0	25.6	18.7	20.6	15.6	15.6	16.0	15.2	9.6
SNCA	"NACP, PARK1, PARK4, PD1"	ENSG00000145335	"Synuclein alpha"	P37840	4	89700345-89838315	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Alzheimer disease, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"bone marrow: 273.6;brain: 128.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 1225.0;Excitatory neurons: 251.5;Melanocytes: 352.2;Oligodendrocytes: 195.4"	"Cancer enriched"	"Detected in many"	8	"melanoma: 37.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 102.9"	"Group enriched"	"Detected in all"	4	"dendritic cells: 102.9;granulocytes: 51.5;monocytes: 66.9"	"Cell line enhanced"	"Detected in many"		"HEL: 221.5;HUVEC TERT2: 269.8;RT4: 137.3;SK-MEL-30: 271.6;TIME: 311.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005459, CAB010877"	Enhanced				"Intracellular and membrane"	NA	NA		28000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB010877: AB_261518, HPA005459: AB_2667324"	"unprognostic (4.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-4)"	"unprognostic (7.48e-3)"	16.0	9.9	91.5	10.0	112.2	273.6	7.8	47.2	128.2	26.1	16.1	28.5	3.3	34.3	3.4	8.5	11.2	5.4	20.9	115.2	69.1	12.4	2.9	16.6	2.2	97.5	88.3	29.3	2.2	1.1	28.7	28.3	89.9	17.3	6.9	20.3	15.9	9.7	1.2	16.4	8.6	33.3	36.0	15.2	6.4	3.2	76.2	5.3	10.2	8.5	4.8	9.3	23.2	107.0	0.5	1.0	40.1	0.0	0.7	0.0	0.6	0.4	44.5	1.6	3.0	0.0	0.0	0.2	12.0	0.0	0.0	9.3	53.6	97.7	1.5	0.0	22.6	221.5	115.4	0.5	84.2	0.0	1.4	2.1	38.2	0.0	109.5	117.3	269.8	2.2	2.0	0.6	0.2	0.0	2.1	0.3	10.6	0.2	4.8	0.0	15.8	0.0	0.3	137.3	23.2	15.6	0.2	0.3	271.6	29.0	0.0	0.4	311.4	1.3	8.0	0.1	0.8	0.2	0.2	0.1	8.8	0.2	87.4	51.5	66.9	0.1	0.3	27.7	0.1	4.2	1.9	0.3	84.6	1.7	1.0	0.5	11.1	17.3	8.2	102.9	0.0	63.7	91.5	112.2	47.2	128.2	115.2	69.1	97.5	88.3	89.9	36.0	76.2	107.0	1.8	0.0	0.6	40.1	2.6	76.6	16.3	173.4	101.3	10.4	0.9	14.4	13.4	0.0	21.5	11.0	0.0	10.1	10.1	0.1	1.9	0.0	0.6	0.3	1.1	19.4	1.8	1225.0	251.5	0.2	1.9	32.7	0.0	0.3	0.0	23.9	7.5	0.8	62.3	10.1	53.8	0.0	44.7	17.2	64.2	1.5	2.1	100.7	352.2	76.8	24.4	19.4	4.1	95.5	195.4	0.2	0.0	0.0	0.5	11.3	0.0	2.0	6.6	7.4	13.1	0.5	5.3	19.6	16.9	4.5	22.6	3.4	3.8	43.6	0.0	3.4
SNRNP200	"ASCC3L1, BRR2, HELIC2, KIAA0788, RP33, U5-200KD"	ENSG00000144028	"Small nuclear ribonucleoprotein U5 subunit 200"	O75643	2	96274338-96321271	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029321	Approved		Supported	Nucleoplasm		NA	NA		78000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA029321: AB_10604096"	"unprognostic (2.63e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	26.5	21.8	11.2	38.1	11.3	58.8	38.6	16.9	12.1	31.9	25.5	29.6	29.4	41.0	20.2	29.5	39.8	25.8	26.9	9.9	11.1	28.8	29.3	29.3	43.2	13.1	10.3	53.2	34.3	52.4	19.7	39.2	12.0	31.6	34.6	67.6	35.1	33.0	47.4	30.8	30.3	38.5	12.2	36.5	30.6	40.4	9.8	73.5	37.4	38.7	52.3	30.1	21.6	14.6	97.8	107.7	144.1	106.1	63.1	57.1	131.5	67.3	80.6	119.5	112.9	197.3	69.3	169.3	101.3	83.3	178.9	74.9	264.4	88.8	130.8	94.3	139.4	221.6	169.8	106.7	40.9	171.2	92.4	58.1	53.7	133.2	112.0	61.3	97.3	98.3	198.2	112.3	68.3	82.3	158.8	49.4	182.8	77.9	102.4	185.0	139.3	107.4	43.8	145.4	159.8	150.5	107.7	88.7	65.4	165.0	86.4	100.5	86.2	98.3	117.2	101.3	96.2	101.0	134.0	207.6	66.2	109.0	106.2	16.7	4.7	6.0	7.9	5.0	8.9	5.7	6.0	9.5	5.6	6.1	5.2	7.1	4.7	7.3	6.1	5.8	6.8	5.5	11.2	11.3	16.9	12.1	9.9	11.1	13.1	10.3	12.0	12.2	9.8	14.6	47.3	44.8	53.9	21.9	57.4	29.6	27.2	35.5	38.1	79.3	40.2	42.4	35.2	54.3	46.2	51.5	104.3	43.2	64.2	43.4	5.9	42.6	29.3	42.4	48.7	44.8	46.7	54.1	21.2	46.7	36.1	37.9	52.0	48.8	25.3	79.0	40.4	49.4	35.1	87.5	21.1	40.6	34.6	31.9	33.2	18.2	57.5	35.2	17.8	16.9	45.2	79.1	73.2	17.1	16.7	46.1	30.7	55.3	68.3	34.8	47.3	17.9	50.7	135.2	65.7	54.7	45.5	77.6	56.0	38.7	33.0	44.6	71.6	53.3	49.4	30.3
SNX3	Grd19	ENSG00000112335	"Sorting nexin 3"	O60493	6	108211222-108261246	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		Microphthalmia	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		270000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"				"prognostic unfavorable (4.37e-5)"	"unprognostic (1.70e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.74e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.67e-1)"	224.3	220.8	217.3	131.3	220.4	296.3	182.6	216.5	304.6	169.5	208.3	167.6	119.4	137.9	152.8	172.4	144.5	132.0	266.6	224.3	219.6	168.6	199.0	147.3	184.0	214.2	219.8	187.5	123.6	124.4	95.4	199.3	215.8	104.6	112.9	88.3	134.5	119.4	323.0	129.0	125.2	157.0	221.1	145.1	122.0	109.8	218.9	123.4	123.2	285.3	163.6	166.5	147.8	234.9	164.9	98.2	94.9	314.3	505.0	377.9	147.6	241.3	240.3	187.5	231.2	155.0	118.8	138.5	232.8	315.3	328.8	128.6	212.5	207.9	254.6	161.2	136.7	268.1	110.2	182.6	272.9	183.9	175.3	324.4	279.9	180.1	202.1	296.9	312.9	131.0	261.6	161.1	263.1	156.6	70.4	403.7	80.1	199.1	166.2	76.2	229.7	145.4	300.0	225.1	111.0	154.9	155.5	197.7	260.4	212.2	100.6	623.8	235.8	161.0	108.2	218.0	319.7	65.0	90.7	148.9	284.2	332.5	197.2	118.5	75.9	169.1	37.4	70.5	48.2	215.3	43.8	39.5	109.8	181.6	44.6	37.0	48.4	64.5	68.6	132.1	48.8	70.4	217.3	220.4	216.5	304.6	224.3	219.6	214.2	219.8	215.8	221.1	218.9	234.9	329.6	105.8	70.0	39.2	332.6	378.9	328.7	264.3	231.1	44.6	254.0	244.3	395.2	161.5	160.3	191.3	16.7	685.3	219.3	199.1	643.7	307.1	387.8	144.6	161.1	352.6	128.0	611.8	55.7	253.8	581.2	323.0	101.9	120.0	167.1	127.2	275.9	240.6	974.2	43.7	43.1	154.7	189.2	451.6	786.3	496.6	288.6	415.7	368.2	31.9	409.1	325.7	209.1	27.2	39.7	260.1	200.9	266.7	187.1	247.7	321.4	697.8	198.8	53.7	256.4	186.0	304.1	316.5	173.3	354.5	440.8	618.3	181.0	259.4	180.6	337.9
SOD1	"ALS, ALS1, IPOA"	ENSG00000142168	"Superoxide dismutase 1"	P00441	21	31659666-31668931	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1645.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 3357.9;Proximal tubular cells: 3285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001401, CAB008670"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA	44900000	50000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 15: Liver - Metabolism"	"Cluster 16: U-266 - Nucleosome"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB008670: AB_1623312, HPA001401: AB_1080132"	"unprognostic (1.73e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.43e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.34e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.28e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.26e-2)"	257.6	597.1	558.0	118.4	577.4	166.4	233.5	605.2	805.1	206.6	586.6	251.0	360.3	179.5	228.4	221.1	197.1	206.0	477.3	575.1	619.9	483.2	1645.6	153.9	169.6	619.8	604.6	302.1	117.1	210.6	236.7	155.8	653.1	203.9	180.5	248.6	160.5	204.2	428.0	152.1	266.7	136.6	588.1	147.5	210.4	132.1	585.8	165.7	197.4	355.9	151.7	232.1	220.6	634.7	526.8	451.4	309.2	312.8	407.3	282.1	257.8	430.2	258.0	291.3	217.4	593.6	326.0	628.2	441.2	405.8	517.7	186.1	453.3	320.6	239.9	463.3	540.0	1008.2	579.5	866.3	267.4	451.7	363.1	294.8	240.6	406.5	225.2	327.9	331.2	469.0	704.4	773.2	357.4	860.0	489.0	454.5	466.1	830.0	475.4	413.0	622.0	981.4	579.4	320.5	335.9	281.4	805.1	419.4	438.3	279.2	484.3	393.4	387.4	222.9	489.2	304.7	322.0	583.4	1374.2	741.8	455.7	654.3	301.9	204.2	159.7	194.0	313.4	234.0	365.3	427.1	509.2	402.4	212.8	310.1	521.8	412.1	37.8	241.4	465.4	240.6	746.0	474.5	558.0	577.4	605.2	805.1	575.1	619.9	619.8	604.6	653.1	588.1	585.8	634.7	319.8	294.9	175.1	38.2	248.1	491.4	672.7	479.2	319.8	226.6	264.1	352.9	721.0	527.6	294.7	391.8	47.9	703.4	250.2	703.5	1631.7	426.3	277.0	410.7	241.2	261.0	288.4	898.8	39.7	807.3	574.9	365.8	198.8	216.3	220.0	278.9	318.1	3357.9	363.3	282.7	45.5	402.7	366.2	220.0	318.5	952.2	521.9	224.2	419.8	29.0	313.1	598.5	239.0	28.6	68.7	322.8	600.9	528.1	178.2	567.0	1158.3	3285.9	638.3	216.5	440.4	313.6	404.5	211.7	506.3	379.9	349.8	725.9	423.1	470.3	593.6	497.7
SOD2	GClnc1	ENSG00000112096	"Superoxide dismutase 2"	P04179	6	159669069-159762529	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 1083.7;skeletal muscle: 3230.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2508.2;Prostatic glandular cells: 3524.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	10	"neutrophil: 4470.5"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 4470.5"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1611.9;GAMG: 614.3;HSkMC: 688.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001814, CAB002013"	Supported		Enhanced	Mitochondria		NA	NA		55000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB002013: , HPA001814: AB_1080134"	"unprognostic (2.47e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.14e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (8.12e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.82e-1)"	324.8	245.9	66.8	522.8	43.2	1083.7	169.0	37.8	125.8	92.6	99.7	126.4	60.5	105.4	7.2	136.5	118.5	121.8	178.5	37.0	101.0	252.4	459.8	266.5	64.8	250.0	96.1	55.8	212.3	69.1	42.7	62.9	192.9	130.8	37.9	25.1	328.8	43.9	3230.1	90.0	83.7	108.4	62.5	81.4	120.4	39.6	153.1	38.2	67.2	312.6	65.0	514.9	97.9	85.4	35.8	46.3	37.3	85.1	229.0	378.7	20.5	52.7	1611.9	57.7	131.1	91.3	19.4	70.7	144.5	54.1	614.3	58.9	39.1	42.5	42.4	71.2	87.2	74.5	71.8	152.3	169.5	74.0	31.9	688.9	68.5	180.9	133.6	40.7	30.0	44.9	106.7	82.2	55.4	37.6	60.3	46.6	63.3	41.5	55.4	79.6	50.3	63.9	106.2	56.6	71.5	29.5	105.1	52.4	21.4	14.1	33.1	33.7	30.4	168.6	62.1	92.5	87.9	37.8	100.2	86.5	186.7	57.4	23.6	146.3	364.4	181.1	38.8	273.9	43.4	43.4	54.9	38.5	105.2	38.3	45.0	36.9	4470.5	19.1	445.3	14.8	87.9	340.0	66.8	43.2	37.8	125.8	37.0	101.0	250.0	96.1	192.9	62.5	153.1	85.4	303.2	201.9	746.1	13.4	99.0	684.7	1144.9	2508.2	114.4	45.6	150.2	96.6	0.0	287.4	613.3	237.3	45.9	18.3	43.8	153.9	86.1	1400.2	318.2	281.7	649.8	593.0	79.6	101.2	31.1	1389.7	51.2	1098.4	103.5	1080.1	112.3	23.1	58.9	395.0	292.0	32.0	30.1	92.7	339.7	333.3	1425.8	111.5	58.1	1031.2	521.2	15.9	339.9	50.4	35.0	8.5	12.2	581.6	111.3	65.1	101.2	3524.0	128.6	530.1	269.6	61.8	39.5	1164.0	407.3	91.7	51.4	258.7	681.8	27.2	119.4	38.3	148.1	1195.7
SON	"BASS1, C21orf50, DBP-5, FLJ21099, FLJ33914, KIAA1019, NREBP"	ENSG00000159140	"SON DNA and RNA binding protein"	P18583	21	33543038-33577481	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023535, HPA031755, HPA031756"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear speckles"		"HPA023535: AB_1857362, HPA031755: AB_2674029, HPA031756: AB_2674030"	"unprognostic (1.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.54e-1)"	69.1	62.5	45.6	57.8	52.1	161.9	65.0	56.4	58.6	59.4	71.9	64.1	44.9	66.9	61.5	60.7	68.5	43.2	60.3	43.7	45.7	49.4	60.3	65.2	81.0	49.8	46.8	76.7	63.4	92.8	63.9	60.9	51.3	61.2	56.4	91.8	64.3	52.6	89.4	64.1	67.8	51.1	47.6	71.5	66.8	48.0	47.8	92.8	64.4	53.8	76.2	62.9	55.9	65.8	105.7	59.7	126.1	72.7	108.1	98.3	89.2	77.2	88.1	73.0	69.6	89.5	75.2	163.8	45.9	114.8	86.6	76.4	152.4	113.0	109.7	85.4	77.9	220.0	78.2	111.3	79.3	215.0	110.8	100.6	128.7	88.0	124.5	91.3	110.1	91.2	172.9	150.9	101.1	101.6	121.0	112.9	136.0	108.5	60.7	121.5	133.8	118.1	109.7	102.1	84.1	77.6	124.2	100.3	91.3	103.6	93.6	128.3	116.0	83.4	73.1	66.6	87.0	144.8	143.2	193.9	84.7	172.3	78.9	33.7	20.3	28.7	20.7	18.4	20.8	30.4	22.9	22.1	15.8	28.2	22.7	22.3	37.4	22.3	24.5	38.5	22.1	15.8	45.6	52.1	56.4	58.6	43.7	45.7	49.8	46.8	51.3	47.6	47.8	65.8	374.1	410.3	298.2	201.4	355.2	433.1	312.2	310.6	250.4	389.7	213.1	219.2	351.5	320.3	298.0	301.6	221.0	224.1	423.2	276.8	193.7	209.7	97.0	296.9	412.2	342.1	186.8	375.8	93.1	207.3	164.7	333.4	208.0	335.8	418.2	216.1	304.8	344.6	170.1	455.9	105.8	256.0	219.7	237.2	307.4	66.0	393.9	261.0	218.7	146.1	256.8	335.7	347.1	131.7	162.3	190.0	217.2	393.4	294.4	250.7	198.0	225.7	288.3	372.0	381.3	505.0	399.2	470.1	334.6	197.8	394.2	327.1	378.2	183.2	246.3	226.5
SORD		ENSG00000140263	"Sorbitol dehydrogenase"	Q00796	15	45023147-45077185	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 163.8;liver: 247.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 138.7;Hepatocytes: 649.4;Prostatic glandular cells: 218.8;Proximal tubular cells: 270.2"	"Group enriched"	"Detected in all"	4	"liver cancer: 30.3;prostate cancer: 72.5;thyroid cancer: 30.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"basophil: 86.3;eosinophil: 55.9"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 86.3"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040260, HPA040621"	Enhanced		Approved	Cytosol		NA	NA		2800000	"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA040260: AB_10794872, HPA040621: AB_10795384"	"unprognostic (8.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.90e-2)"	"prognostic favorable (6.14e-5)"	"unprognostic (3.33e-3)"	"unprognostic (1.67e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.56e-1)"	2.0	15.7	4.9	3.1	3.8	2.8	53.8	7.4	8.4	163.8	1.9	5.3	7.5	4.3	6.9	10.2	6.7	8.2	5.6	5.0	4.5	50.3	247.0	3.2	2.6	4.3	3.7	2.4	5.7	4.4	3.1	2.5	4.0	87.9	7.8	4.8	5.3	27.0	2.2	16.6	7.2	3.5	4.2	2.3	9.2	12.2	3.9	3.7	89.4	2.8	3.4	9.1	6.9	6.3	12.3	12.2	4.7	20.8	4.4	5.3	5.9	1.8	3.5	12.2	7.0	12.2	5.8	2.7	8.0	5.4	4.1	17.6	19.9	19.1	9.2	29.9	12.3	13.5	12.1	50.3	0.2	18.0	25.5	6.7	18.0	6.6	9.5	5.4	12.5	15.1	11.7	10.6	14.9	8.1	18.4	38.3	39.0	29.4	13.8	0.9	16.6	6.4	16.8	12.1	25.1	12.2	2.1	57.3	5.9	5.2	16.4	22.5	4.7	3.5	38.0	1.6	5.8	8.7	4.5	4.4	14.2	18.6	10.6	86.3	1.7	55.9	1.6	1.5	1.7	5.4	1.3	1.6	1.7	6.9	1.6	1.4	3.8	1.1	2.1	2.4	2.5	2.0	4.9	3.8	7.4	8.4	5.0	4.5	4.3	3.7	4.0	4.2	3.9	6.3	3.9	0.0	3.1	5.5	11.9	7.8	26.5	14.8	17.6	10.8	24.7	17.5	3.2	25.8	28.1	33.1	0.0	1.3	2.3	15.0	29.4	68.2	31.7	40.2	17.4	4.9	84.8	37.5	4.8	138.7	5.1	7.5	31.1	43.7	8.8	11.5	15.7	649.4	16.0	3.3	5.4	32.5	22.4	24.2	6.4	24.1	3.7	12.2	16.0	1.0	13.3	9.0	2.1	7.1	8.9	89.0	18.1	6.0	7.9	218.8	8.0	270.2	42.5	4.7	0.0	8.9	8.9	7.4	2.8	35.1	20.3	1.0	6.5	15.3	39.4	131.2
SORL1	"C11orf32, gp250, LR11, LRP9, SorLA, SorLA-1"	ENSG00000137642	"Sortilin related receptor 1"	Q92673	11	121452314-121633763	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Transport"	Receptor	"Alzheimer disease, Amyloidosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 79.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 387.8;Excitatory neurons: 247.4;Microglial cells: 404.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 125.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 125.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 142.8;Daudi: 68.7;OE19: 93.5;RT4: 102.1;U-698: 139.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011500, HPA031321"	Uncertain				"Secreted to blood"	NA	NA		79000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB011500: AB_443414, HPA031321: AB_2673826"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.08e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.80e-7)"	"unprognostic (2.48e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.21e-2)"	7.0	6.1	29.1	24.4	39.1	47.4	13.9	49.5	35.5	44.4	0.0	17.3	11.6	5.4	8.9	5.4	40.1	7.3	2.4	33.8	39.7	19.0	58.2	10.4	21.1	40.3	46.8	9.0	8.0	10.4	16.8	2.3	47.0	20.8	16.9	20.3	21.8	25.4	1.7	3.4	18.1	4.5	45.3	21.8	10.3	5.1	38.8	17.0	13.5	4.0	23.0	15.7	6.6	79.1	1.3	8.1	7.3	1.1	0.0	0.0	7.4	0.4	2.4	0.3	0.0	11.9	142.8	68.7	8.5	1.8	10.5	47.4	9.1	7.0	0.1	0.0	2.6	0.0	10.3	16.8	0.1	29.6	0.1	0.0	7.6	0.0	25.8	4.0	0.0	8.7	0.0	0.7	0.0	9.7	7.1	15.3	8.8	93.5	10.8	7.7	0.4	1.6	15.8	102.1	5.1	1.5	15.2	21.5	0.0	16.0	21.0	9.5	0.3	0.1	4.9	1.0	0.0	0.0	0.0	139.8	0.1	38.6	0.4	44.3	15.9	59.1	22.1	6.9	29.3	1.9	24.6	20.0	6.6	5.1	23.1	20.8	125.7	20.9	9.4	16.4	19.3	21.2	29.1	39.1	49.5	35.5	33.8	39.7	40.3	46.8	47.0	45.3	38.8	79.1	1.6	6.4	23.3	160.9	20.7	4.5	42.3	23.3	18.2	68.8	44.5	22.0	12.3	18.6	36.8	79.1	387.8	0.4	130.1	132.1	0.0	10.3	1.2	21.6	2.9	10.3	6.1	8.8	247.4	0.7	0.7	5.8	14.3	24.7	12.0	20.6	34.6	114.5	39.1	50.5	80.1	54.6	40.7	62.4	16.9	5.0	77.9	67.0	3.6	404.7	97.5	28.0	146.2	74.9	86.0	6.4	81.1	57.9	28.6	36.1	168.6	1.0	15.6	31.2	0.0	19.5	10.3	2.9	18.8	20.8	2.4	0.4	60.2	32.7	42.2	33.4
SORT1	"Gp95, NT3"	ENSG00000134243	"Sortilin 1"	Q99523	1	109309568-109397918	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Endocytosis, Osteogenesis, Transport"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 285.6"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 447.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 9.2;non-classical monocyte: 10.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006889, CAB011498"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA	7170000	110000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB011498: AB_2192606, HPA006889: AB_1080056"	"unprognostic (2.10e-2)"	"unprognostic (7.46e-2)"	"prognostic favorable (7.74e-6)"	"unprognostic (4.12e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (3.34e-3)"	"unprognostic (4.27e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.95e-1)"	"unprognostic (4.46e-3)"	48.2	11.3	71.0	12.0	168.3	21.4	25.1	124.3	114.2	17.7	21.5	29.5	22.1	24.7	139.8	41.5	27.5	17.8	64.7	131.8	90.0	38.7	6.5	37.4	2.8	151.9	133.8	6.1	17.5	46.5	11.3	44.8	153.1	18.3	26.9	40.0	25.2	44.0	85.0	19.0	21.9	27.8	102.8	10.2	18.2	43.5	118.0	6.4	42.7	71.8	10.3	16.9	18.0	285.6	38.8	15.3	37.5	45.8	107.0	21.2	107.3	28.2	44.9	27.2	29.0	39.8	14.0	0.3	35.2	11.9	19.9	9.4	44.7	22.3	38.9	1.1	21.2	10.7	23.5	43.1	41.8	0.2	33.5	53.2	3.6	33.3	7.3	72.6	4.2	31.7	81.3	4.0	38.7	41.1	27.9	0.8	14.1	17.5	6.3	30.7	87.9	18.9	52.0	27.8	38.3	21.8	16.6	109.3	120.6	53.1	46.1	6.7	1.1	5.8	21.7	1.0	47.6	37.0	32.2	0.3	9.8	0.3	24.3	0.0	7.1	2.5	0.0	9.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.8	0.4	10.8	1.6	0.0	2.0	71.0	168.3	124.3	114.2	131.8	90.0	151.9	133.8	153.1	102.8	118.0	285.6	10.6	38.5	47.9	54.5	1.9	1.3	4.7	6.7	1.2	14.9	27.5	14.2	98.9	27.1	20.3	75.4	35.5	30.6	3.2	70.2	5.9	23.9	65.1	33.2	5.2	15.9	16.8	4.0	87.9	23.7	30.2	9.8	16.8	34.9	7.6	10.4	7.9	22.1	30.1	13.5	56.7	27.7	6.1	38.7	9.9	79.7	8.7	34.6	21.4	78.7	37.7	21.7	0.0	48.7	447.8	25.6	23.2	49.7	1.5	7.1	64.0	13.1	29.6	50.7	32.9	25.1	53.6	46.3	21.6	9.3	1.8	36.8	2.1	1.8	28.3	10.8
SPAST	"ADPSP, FSP2, KIAA1083, SPG4"	ENSG00000021574	Spastin	Q9UBP0	2	32063556-32157637	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Differentiation, Neurogenesis"	"Allosteric enzyme, Developmental protein, Isomerase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 55.2;Oligodendrocyte precursor cells: 59.3;Oligodendrocytes: 62.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017311	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA017311: AB_1857415"	"unprognostic (1.89e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.26e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (5.71e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.13e-1)"	5.8	5.9	9.0	7.2	12.7	9.9	6.2	10.8	12.9	8.6	1.6	7.1	7.4	7.7	5.0	6.9	6.5	6.5	3.9	9.0	10.6	5.9	9.6	6.3	9.7	10.8	11.2	9.1	5.3	6.2	4.4	6.8	10.5	6.3	7.5	6.9	4.2	5.3	7.8	7.4	8.0	7.3	11.6	7.0	6.3	9.8	10.7	14.1	8.5	10.0	9.2	7.3	4.4	13.9	17.5	12.2	19.7	19.5	12.0	14.2	17.8	9.4	13.7	9.7	8.6	16.9	14.8	30.2	8.5	13.1	14.2	12.0	19.5	9.6	11.9	20.7	11.8	33.3	6.0	20.5	11.0	23.2	22.4	7.9	12.3	12.4	11.6	11.7	21.5	9.6	27.6	10.0	10.7	7.4	37.8	19.4	20.5	19.2	7.1	19.8	27.9	19.5	13.0	10.7	27.9	29.9	16.0	13.2	15.9	16.0	8.7	15.8	18.8	10.6	16.2	9.5	11.1	14.7	29.7	23.8	11.6	19.9	13.0	1.8	3.5	3.8	1.8	4.9	2.5	2.4	2.8	2.9	3.9	1.9	2.9	3.0	5.3	3.9	3.8	1.7	4.2	2.5	9.0	12.7	10.8	12.9	9.0	10.6	10.8	11.2	10.5	11.6	10.7	13.9	15.0	9.6	4.4	26.4	12.2	9.6	5.9	7.9	11.4	15.4	11.7	6.9	8.0	8.6	7.9	5.5	22.9	9.6	21.4	11.4	0.0	6.6	4.4	16.9	11.8	11.3	10.8	10.3	38.9	8.0	7.4	8.1	9.7	13.7	10.1	16.7	7.9	12.0	9.7	10.1	55.2	10.8	10.2	17.5	9.9	8.5	8.7	17.6	1.8	36.5	21.1	7.9	18.6	59.3	62.7	10.4	9.8	10.1	12.5	8.7	10.9	7.0	13.0	14.1	0.0	11.9	11.9	16.7	21.2	11.7	13.1	8.1	13.3	10.9	10.4	7.2
SPATA5	"AFG2, SPAF"	ENSG00000145375	"Spermatogenesis associated 5"	Q8NB90	4	122923070-123319433	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Chaperone, Developmental protein, Hydrolase"	"Deafness, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 207.9;Inhibitory neurons: 59.0;Microglial cells: 104.0;Oligodendrocyte precursor cells: 79.9;Oligodendrocytes: 91.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036450, HPA036451"	Approved		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol		"HPA036450: AB_2675131, HPA036451: AB_10670107"	"unprognostic (4.28e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.65e-4)"	"unprognostic (1.95e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.43e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.68e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.79e-1)"	1.3	0.8	0.8	0.9	1.1	1.4	1.6	2.3	1.0	1.3	1.2	1.0	0.6	1.3	0.8	1.0	1.0	0.8	0.9	0.6	1.2	1.1	1.1	0.9	1.2	1.2	1.1	1.2	0.8	1.5	0.7	1.4	1.2	1.1	1.2	2.2	1.0	1.1	1.3	1.2	0.7	1.3	1.0	1.3	2.3	3.6	1.0	2.0	1.5	1.2	1.2	1.0	1.1	1.3	2.3	3.2	2.9	7.1	2.4	1.7	1.9	4.0	1.6	3.3	3.3	1.5	3.2	3.7	2.4	2.4	2.4	2.0	5.0	2.2	5.6	6.2	0.9	3.8	5.7	2.5	1.1	5.2	4.0	1.2	1.1	3.8	3.3	1.7	3.4	2.4	7.7	6.2	4.6	2.4	10.1	3.2	2.1	3.6	1.3	3.3	7.2	2.4	1.9	1.9	4.8	3.1	3.2	2.3	1.7	4.2	2.2	2.0	2.6	6.9	5.2	4.6	4.2	3.9	5.0	3.3	3.3	4.4	6.2	0.5	0.2	0.2	0.6	0.6	0.4	0.5	0.5	0.5	0.1	0.5	0.5	0.5	0.3	0.5	0.2	0.7	0.3	0.2	0.8	1.1	2.3	1.0	0.6	1.2	1.2	1.1	1.2	1.0	1.0	1.3	10.7	16.0	5.0	34.6	9.1	5.1	5.6	2.6	6.2	6.2	4.2	3.2	4.3	11.5	7.4	1.8	14.6	5.1	6.7	2.9	0.0	3.1	207.9	4.5	9.6	8.5	2.4	11.2	48.8	3.6	4.3	5.1	14.3	5.2	5.1	8.6	4.2	3.2	3.5	3.3	59.0	2.6	0.0	4.1	5.3	25.0	7.2	5.3	0.0	104.0	1.8	4.0	4.1	79.9	91.4	4.2	2.1	4.5	10.6	3.9	1.5	3.1	6.4	11.3	0.0	12.5	6.6	14.7	10.6	5.0	5.4	2.2	9.9	4.7	4.1	3.0
SPEG	"APEG1, BPEG, KIAA1297, MGC12676, MYLK6, SPEGalpha, SPEGbeta"	ENSG00000072195	"Striated muscle enriched protein kinase"	Q15772	2	219434843-219493629	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 174.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 45.7;Cardiomyocytes: 61.5;Late spermatids: 39.6;Sertoli cells: 46.0;Smooth muscle cells: 32.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 45.9;U-87 MG: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018904	Enhanced		Approved	Vesicles		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA018904: AB_1844924"	"unprognostic (3.70e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.45e-4)"	"unprognostic (2.04e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.92e-3)"	"unprognostic (2.29e-2)"	"unprognostic (8.66e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.47e-9)"	"unprognostic (1.14e-1)"	"unprognostic (7.01e-2)"	"unprognostic (5.95e-4)"	"unprognostic (1.28e-3)"	16.1	6.8	16.8	7.7	18.7	0.0	15.3	15.5	20.7	75.5	9.7	174.8	5.3	89.5	6.2	15.6	70.0	7.3	48.5	19.8	14.5	4.1	1.3	8.7	0.6	16.1	15.8	21.9	3.4	4.4	34.3	4.5	14.6	58.8	3.8	1.0	10.0	25.5	118.0	7.8	31.9	23.1	15.3	2.4	48.1	5.4	15.3	0.5	5.9	21.7	0.2	87.7	42.1	15.6	6.1	0.5	3.1	4.9	1.6	4.7	1.8	13.1	8.5	8.6	6.4	4.5	1.9	0.0	4.5	9.7	4.3	7.2	2.5	3.1	3.4	0.0	1.7	0.0	6.1	0.3	2.1	0.0	0.5	13.2	4.6	7.8	1.9	45.9	0.0	3.2	3.5	0.0	6.1	1.6	0.1	18.8	6.5	0.0	2.4	2.8	7.0	1.1	8.5	0.0	3.4	15.1	0.6	0.0	0.3	14.3	0.3	0.2	0.0	20.6	21.3	2.4	21.1	0.4	0.0	0.2	23.3	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	18.7	15.5	20.7	19.8	14.5	16.1	15.8	14.6	15.3	15.3	15.6	2.4	0.0	2.2	45.7	0.4	3.2	6.0	1.3	2.8	5.3	10.3	14.6	61.5	4.3	0.1	1.8	2.1	0.6	1.4	4.1	0.0	1.5	21.8	0.9	3.6	2.2	6.7	2.7	20.5	1.2	0.9	10.0	3.6	1.3	0.0	1.0	5.7	3.1	1.1	5.0	20.9	4.1	0.0	5.6	1.9	39.6	10.5	1.6	3.6	4.7	1.4	8.4	0.0	5.0	1.0	0.2	3.2	18.8	0.9	6.5	8.5	4.3	0.1	0.9	46.0	17.1	32.4	11.6	3.7	0.2	1.4	1.4	1.2	0.4	3.5	5.3
SPG7	"CAR, CMAR, SPG5C"	ENSG00000197912	"SPG7 matrix AAA peptidase subunit, paraplegin"	Q9UQ90	16	89490719-89557766	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 52: Non-specific - Transcription"				"unprognostic (1.42e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.12e-2)"	"prognostic favorable (2.22e-4)"	"unprognostic (4.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.33e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (3.56e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.71e-1)"	"prognostic favorable (4.25e-4)"	29.8	44.8	19.3	7.0	18.8	8.2	27.9	21.3	28.6	31.5	18.5	33.3	9.9	31.8	4.0	28.2	26.4	6.8	52.3	19.4	18.3	32.4	47.0	24.9	8.9	19.7	18.6	39.0	31.9	13.8	38.7	5.9	20.3	31.2	8.1	9.9	29.0	9.7	56.7	31.3	35.5	9.0	16.9	34.1	31.1	31.9	18.7	10.5	53.1	31.0	8.0	30.1	26.9	20.0	11.5	28.3	17.3	26.6	33.2	24.2	10.9	27.3	24.6	21.0	10.4	23.0	22.3	16.5	32.5	20.1	16.2	30.5	21.5	24.4	14.7	11.7	25.3	11.4	12.0	43.4	16.2	5.5	10.3	15.2	20.1	12.8	14.1	27.9	25.6	22.0	23.1	5.5	21.7	21.0	14.4	22.5	21.9	23.8	21.4	31.8	26.2	10.8	15.9	17.3	16.4	10.5	44.9	8.3	9.5	15.2	22.6	17.0	33.7	13.9	17.2	12.0	12.2	13.7	19.8	12.8	17.7	19.8	17.7	4.5	2.5	3.9	2.7	2.4	2.6	1.6	1.7	1.3	2.8	3.4	3.1	2.0	2.9	3.7	1.7	2.3	1.8	1.0	19.3	18.8	21.3	28.6	19.4	18.3	19.7	18.6	20.3	16.9	18.7	20.0	53.9	48.1	49.4	39.2	45.6	15.9	27.9	30.1	44.9	57.8	31.2	37.2	45.8	22.8	41.5	35.0	95.9	39.9	47.6	42.3	19.6	40.0	66.0	50.5	41.7	49.9	37.2	27.3	58.5	25.8	28.8	35.9	67.2	54.1	21.5	95.3	51.0	38.1	32.2	40.4	53.1	43.8	30.5	34.8	21.8	22.1	42.9	35.2	21.4	35.6	42.6	30.5	51.5	87.0	46.2	39.5	39.5	33.4	43.5	29.5	68.2	23.8	37.7	73.7	6.6	36.9	36.2	57.5	36.5	36.7	18.0	25.9	45.5	68.3	51.0	28.7
SPHK2		ENSG00000063176	"Sphingosine kinase 2"	Q9NRA0	19	48619291-48630717	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 68.5;Cone photoreceptor cells: 77.2;Rod photoreceptor cells: 79.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 64.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049062			Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 24: NB-4 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA049062: "	"unprognostic (5.33e-2)"	"unprognostic (4.11e-2)"	"unprognostic (9.61e-2)"	"prognostic unfavorable (5.19e-4)"	"unprognostic (2.10e-1)"	"unprognostic (7.19e-3)"	"unprognostic (3.04e-1)"	"unprognostic (4.45e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (9.30e-4)"	"unprognostic (1.25e-1)"	"prognostic favorable (2.59e-5)"	"unprognostic (1.18e-2)"	"unprognostic (9.97e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.06e-2)"	9.4	10.5	18.9	6.8	20.6	3.4	9.6	23.5	29.3	9.4	9.1	16.5	22.1	12.0	2.1	9.2	11.6	3.1	7.3	25.9	19.4	23.1	31.8	8.5	5.9	36.0	30.5	15.5	8.9	7.4	16.5	2.2	37.2	13.3	3.6	3.2	7.6	4.4	7.8	4.8	18.9	2.6	21.2	11.4	14.8	24.1	30.6	5.3	16.0	3.1	3.1	10.7	7.3	26.1	8.4	22.3	8.2	15.3	8.5	3.6	16.3	8.5	6.8	9.3	11.1	39.8	10.4	15.0	5.9	5.3	5.6	6.4	7.5	6.9	1.3	17.5	19.4	16.9	11.5	13.7	13.5	11.1	17.3	6.5	3.6	6.5	4.4	4.4	5.2	20.9	11.7	12.5	4.7	8.3	27.2	64.7	11.2	6.0	10.7	23.3	6.5	10.0	4.3	5.3	29.3	23.1	8.3	12.7	8.3	4.5	7.1	6.9	8.5	13.6	7.7	10.9	17.1	24.5	31.0	16.4	7.9	12.2	12.6	11.7	6.2	2.9	4.3	7.1	4.0	5.0	3.4	4.2	5.5	8.6	4.8	4.8	2.4	5.6	6.2	5.4	3.7	3.5	18.9	20.6	23.5	29.3	25.9	19.4	36.0	30.5	37.2	21.2	30.6	26.1	3.7	6.4	7.7	8.5	13.3	3.3	5.7	5.6	4.6	68.5	6.8	6.5	1.5	12.8	6.2	11.0	77.2	6.8	13.6	20.6	1.9	6.2	11.0	6.2	6.1	6.5	16.2	2.1	9.1	5.0	6.3	5.3	15.3	6.9	4.5	14.5	6.4	19.8	8.3	45.4	11.2	11.3	4.1	12.3	7.3	18.4	16.4	6.5	3.6	6.5	11.4	20.8	33.0	6.0	11.9	6.8	16.7	12.8	7.1	6.2	44.2	18.6	4.9	79.9	6.6	6.3	5.4	18.1	6.3	7.3	2.8	4.5	12.3	8.9	17.3	4.3
SPNS2	SLC62A2	ENSG00000183018	"Sphingolipid transporter 2"	Q8IVW8	17	4498881-4539035	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.7;Endothelial cells: 34.5;Microglial cells: 37.5;Oligodendrocytes: 97.8;Urothelial cells: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 31.0;RPTEC TERT1: 161.7;SK-BR-3: 76.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068717	Uncertain					NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA068717: AB_2686021"	"unprognostic (3.03e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.10e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.89e-2)"	17.3	2.6	13.1	5.2	14.0	7.9	14.7	13.1	18.2	14.6	0.1	6.5	12.2	8.6	0.6	51.0	7.8	12.1	10.7	14.1	12.1	28.6	3.8	28.3	4.9	26.4	16.2	1.8	10.0	1.1	2.1	7.9	28.9	5.3	2.1	0.6	16.5	2.0	4.4	24.8	10.8	4.8	13.9	11.4	21.0	1.3	15.5	1.7	8.5	3.9	13.3	6.6	22.6	25.1	9.7	1.2	0.0	0.2	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.5	8.1	0.5	11.8	0.0	0.1	0.5	0.0	0.7	0.0	0.1	0.2	0.6	0.2	0.0	0.1	3.0	0.0	0.0	0.2	0.0	0.0	0.0	4.2	4.7	0.0	0.0	0.0	3.8	0.2	17.0	0.1	17.6	0.3	0.8	0.0	0.3	161.7	0.5	5.4	0.2	0.0	76.7	0.0	5.1	2.7	7.5	0.2	0.2	0.7	0.3	0.1	0.3	0.3	0.1	0.0	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.1	14.0	13.1	18.2	14.1	12.1	26.4	16.2	28.9	13.9	15.5	25.1	32.7	6.4	10.6	1.6	0.2	1.8	0.4	2.1	0.0	1.2	4.3	3.6	1.2	22.8	16.2	22.0	0.0	1.3	0.2	2.8	1.9	16.7	0.2	0.5	1.0	34.5	0.0	3.2	23.4	3.0	30.5	1.7	26.0	2.8	0.0	0.0	12.5	6.7	1.1	6.7	26.2	12.7	2.0	0.3	1.6	0.2	0.6	1.9	1.8	37.5	0.0	0.4	0.0	3.5	97.8	18.6	0.0	0.4	1.2	11.7	1.9	24.3	16.9	1.1	0.0	1.4	3.1	0.6	0.5	0.6	2.4	1.9	1.6	0.1	1.1	39.8
SPR	SDR38C1	ENSG00000116096	"Sepiapterin reductase"	P35270	2	72887382-72892158	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 85.3;Exocrine glandular cells: 81.1;Proximal tubular cells: 91.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 8.3;intermediate monocyte: 2.4;myeloid DC: 8.9"	"Group enriched"	"Detected in many"	11	"dendritic cells: 8.9;monocytes: 8.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039505	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		180000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"HPA039505: AB_10795466"	"unprognostic (4.09e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.50e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.95e-1)"	25.9	50.8	26.0	7.6	27.2	0.6	20.0	27.2	61.4	14.5	39.6	36.4	23.4	13.4	36.9	19.7	26.3	11.9	44.4	26.8	30.0	44.2	99.8	15.9	3.2	27.9	31.5	12.2	63.5	38.4	10.9	6.8	29.8	26.2	32.5	3.1	31.2	16.7	43.9	9.1	22.0	11.5	27.9	9.6	42.1	7.3	28.5	2.4	20.5	25.4	5.1	25.2	13.7	28.0	47.5	130.9	0.6	20.0	51.2	18.5	31.8	21.4	31.8	16.0	15.0	84.0	48.0	34.5	25.4	26.1	80.6	43.9	58.1	35.1	13.3	10.0	43.7	51.7	30.8	87.4	19.1	8.2	13.6	16.7	38.7	17.6	19.7	32.7	42.6	25.4	54.0	6.8	21.4	100.5	3.3	31.1	10.9	139.9	118.7	0.0	82.8	20.3	85.8	73.4	8.0	14.6	39.6	89.7	31.0	16.9	40.4	9.9	52.8	17.4	42.2	30.5	38.7	7.2	16.9	2.3	25.0	17.6	31.0	0.0	8.3	0.7	0.3	2.4	0.3	0.0	0.1	0.1	8.9	0.0	0.1	0.3	0.0	0.0	0.9	0.9	0.0	2.4	26.0	27.2	27.2	61.4	26.8	30.0	27.9	31.5	29.8	27.9	28.5	28.0	13.8	12.8	7.3	0.3	1.1	8.4	23.0	14.8	20.5	0.7	22.2	16.5	46.2	38.6	10.8	42.3	0.0	18.1	0.4	85.3	21.5	56.9	0.3	12.5	4.2	16.7	11.4	6.6	0.7	81.1	10.6	13.9	26.0	6.7	4.5	8.4	17.2	62.9	42.1	1.7	0.4	39.6	12.2	6.0	7.4	1.5	9.3	9.7	14.2	1.9	20.8	13.8	0.0	0.0	0.3	43.3	50.4	5.7	1.4	33.9	71.0	91.6	11.2	0.7	6.6	8.3	8.6	0.4	10.2	17.8	6.5	4.4	1.9	8.7	57.8	15.6
SPTLC1	"hLCB1, HSAN1, HSN1, LCB1, SPTI"	ENSG00000090054	"Serine palmitoyltransferase long chain base subunit 1"	O15269	9	92000087-92115413	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010860, CAB018747, HPA063907"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"		"CAB018747: AB_2195864, HPA010860: AB_1080086, HPA063907: AB_2685148"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.37e-2)"	"prognostic favorable (1.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.49e-1)"	35.6	32.6	24.0	27.3	27.0	23.3	44.1	26.0	34.2	43.1	28.6	42.3	34.7	40.4	41.3	54.3	36.7	34.1	21.5	24.3	26.6	42.8	23.4	33.6	25.7	27.8	27.5	43.8	26.5	48.0	17.3	42.4	28.0	32.9	44.1	19.8	31.3	28.1	14.2	41.3	37.9	31.4	27.9	26.3	37.1	26.5	25.6	25.9	53.0	18.6	34.4	37.2	34.7	31.6	73.0	48.8	46.8	41.6	120.0	92.0	78.4	74.7	94.2	65.3	66.3	31.5	150.7	38.6	45.1	93.9	78.3	198.4	49.7	68.1	73.0	39.8	36.1	36.7	32.7	51.7	80.5	65.5	49.9	82.6	92.6	68.0	74.8	72.3	62.5	43.5	83.8	46.6	91.1	69.6	34.7	47.6	67.5	97.4	57.9	39.4	58.7	33.3	84.1	37.9	35.0	37.2	104.4	81.1	61.3	62.4	39.2	54.2	72.3	58.8	48.0	73.9	56.8	33.2	44.4	23.9	74.2	39.3	79.4	32.4	33.1	20.2	16.7	36.1	17.0	15.4	18.0	17.4	30.6	15.5	21.4	16.6	33.3	18.5	34.2	18.4	25.7	25.5	24.0	27.0	26.0	34.2	24.3	26.6	27.8	27.5	28.0	27.9	25.6	31.6	40.7	38.5	38.3	27.7	22.1	10.6	13.6	14.5	26.2	6.9	33.2	20.6	4.1	4.3	25.9	36.8	14.6	12.7	24.4	8.0	9.8	53.4	94.8	34.7	42.5	23.1	2.4	7.2	35.3	56.4	15.6	32.3	13.7	47.4	24.6	26.9	6.1	4.3	11.0	6.7	32.5	7.2	12.2	5.7	10.3	26.1	6.2	24.6	12.4	20.6	22.0	13.7	7.2	36.7	52.1	60.8	7.1	6.0	26.2	9.8	11.7	28.5	28.0	8.7	13.1	12.1	23.5	35.3	25.9	27.6	9.1	21.8	21.9	33.2	6.9	14.5
SPTLC2	"hLCB2a, KIAA0526, LCB2, LCB2A"	ENSG00000100596	"Serine palmitoyltransferase long chain base subunit 2"	O15270	14	77505997-77616637	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 164.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (3.16e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.09e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (6.69e-8)"	"unprognostic (1.29e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.32e-1)"	17.6	12.2	14.6	12.6	26.7	33.7	18.3	24.0	19.4	15.2	9.9	18.5	14.5	10.5	7.6	22.8	14.2	11.8	6.7	15.3	18.1	17.6	7.7	13.1	12.0	30.7	21.5	10.4	5.7	10.7	6.2	20.4	31.5	8.4	19.8	14.2	13.7	8.8	3.9	12.2	17.4	11.6	25.3	19.6	20.4	5.0	21.7	10.3	10.9	6.1	13.3	15.0	10.8	52.7	28.9	18.5	14.1	15.5	14.3	17.8	23.7	41.7	30.8	28.2	29.3	23.7	62.3	28.8	10.4	42.7	14.5	34.7	38.1	23.7	42.5	12.6	11.0	82.5	13.4	14.3	12.1	8.4	25.8	11.7	11.4	18.4	20.4	16.3	40.6	19.4	16.2	13.5	16.2	24.9	22.2	28.7	9.2	45.4	16.8	23.5	14.3	10.0	32.9	63.4	13.6	17.1	15.0	50.3	15.8	24.7	61.8	15.3	25.9	25.7	18.2	9.6	9.7	7.6	13.4	19.1	17.3	29.4	14.8	18.3	31.3	27.1	6.1	24.2	5.7	6.7	5.1	6.8	31.2	7.9	3.5	5.8	19.1	17.7	31.8	11.1	6.0	13.4	14.6	26.7	24.0	19.4	15.3	18.1	30.7	21.5	31.5	25.3	21.7	52.7	125.1	28.9	27.3	24.8	27.3	32.4	28.3	27.0	15.4	15.7	24.3	18.4	8.9	15.7	30.7	47.8	35.5	11.9	28.3	37.6	1.9	24.0	1.6	44.1	36.0	53.1	13.2	51.3	31.2	16.1	12.3	18.9	43.3	36.0	51.3	37.2	68.2	7.2	25.1	5.0	29.5	39.3	20.3	75.9	19.8	1.7	14.6	66.2	19.6	83.4	51.3	8.8	32.0	59.3	164.0	35.0	30.4	15.8	11.0	27.0	28.4	8.8	33.5	20.0	32.9	10.5	25.5	7.3	19.0	37.7	29.1	6.6	23.3	14.6	33.0	60.0
SRD5A3	"FLJ13352, SRD5A2L, SRD5A2L1"	ENSG00000128039	"Steroid 5 alpha-reductase 3"	Q9H8P0	4	55346213-55373100	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Cataract, Congenital disorder of glycosylation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 245.5;Club cells: 245.2;Pancreatic endocrine cells: 155.5;Respiratory ciliated cells: 195.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 79.6"					"Low region specificity"	"Detected in all"			HPA027006	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane, Cytosol"		"HPA027006: AB_1857469"	"unprognostic (1.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.02e-2)"	"prognostic favorable (9.39e-4)"	"unprognostic (1.50e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (9.31e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.85e-10)"	"unprognostic (4.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.52e-2)"	12.5	12.0	10.4	2.5	11.5	3.7	12.2	11.0	12.4	12.9	9.2	7.3	3.8	6.8	4.2	26.1	5.6	10.3	9.3	10.7	10.1	9.6	14.5	10.5	2.5	11.0	11.2	3.1	20.2	7.0	5.9	4.0	10.8	7.4	4.1	1.5	16.4	2.9	6.3	15.4	7.0	2.6	10.9	6.8	9.7	3.3	10.9	6.0	7.6	5.4	6.0	10.0	14.7	12.7	9.7	4.3	10.3	10.1	29.4	20.4	5.6	10.4	9.3	2.4	5.4	6.5	19.5	21.2	11.7	11.0	11.1	7.0	5.3	7.9	3.9	6.6	17.1	12.3	5.2	15.8	9.2	23.7	6.1	17.6	14.5	5.4	5.3	7.8	14.4	38.5	21.2	47.7	21.1	10.8	36.0	10.3	13.0	53.2	9.3	11.4	3.3	14.0	12.8	7.9	16.0	9.1	10.7	79.6	8.3	9.0	9.4	17.9	8.3	25.0	4.7	2.0	8.1	28.6	15.8	7.9	34.1	29.5	25.9	25.6	35.8	11.7	16.1	56.5	18.6	12.5	12.0	15.2	30.2	12.7	10.2	14.4	1.8	8.6	59.5	61.7	12.5	23.1	10.4	11.5	11.0	12.4	10.7	10.1	11.0	11.2	10.8	10.9	10.9	12.7	25.4	9.6	15.9	4.6	7.8	13.6	13.3	245.5	5.2	4.9	43.8	29.3	5.3	34.3	245.2	5.5	4.2	27.0	21.2	12.2	3.9	93.4	3.2	51.2	31.0	19.6	12.0	14.9	11.1	105.4	106.0	16.2	13.3	105.9	14.0	6.7	17.5	18.6	63.4	10.1	17.1	22.6	57.0	32.4	34.1	0.5	1.8	27.6	24.9	4.7	31.3	21.9	18.6	8.5	23.4	155.5	10.0	5.7	16.8	17.5	9.4	18.4	195.0	3.9	13.1	13.3	28.2	3.5	20.1	32.7	29.7	7.5	7.2	15.4	23.3	108.6
SRP54		ENSG00000100883	"Signal recognition particle 54"	P61011	14	34981957-35029686	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Hydrolase, Ribonucleoprotein, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 327.3;Late spermatids: 901.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048977, HPA062044"	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA048977: AB_2680583, HPA062044: AB_2684668"	"unprognostic (1.22e-3)"	"unprognostic (6.04e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.50e-3)"	22.8	33.1	17.1	30.2	18.1	17.4	28.7	19.3	22.5	32.5	20.9	28.1	25.8	23.3	35.8	28.5	22.0	23.2	32.1	17.6	21.3	35.3	61.9	25.0	34.6	19.8	19.2	22.7	55.0	39.7	36.2	29.5	20.5	31.2	29.5	24.2	60.3	28.7	39.8	26.1	26.8	23.5	20.0	28.4	30.4	44.0	18.1	35.5	30.9	33.7	42.6	34.8	23.1	21.4	59.3	66.9	56.7	54.9	62.8	61.3	67.8	83.2	78.3	87.3	107.0	71.3	62.8	75.8	77.5	81.4	75.8	56.1	79.0	66.7	125.6	87.5	37.8	70.9	54.6	184.6	92.7	70.5	65.4	51.5	64.8	63.5	102.3	66.1	88.8	64.9	61.7	82.7	93.1	98.8	81.9	42.4	45.0	96.1	61.3	58.5	72.2	67.4	104.9	89.3	48.9	59.4	59.3	76.7	74.6	71.4	99.4	49.7	66.6	48.7	51.0	62.8	57.1	73.2	108.3	101.1	36.8	45.9	63.5	23.8	27.4	39.2	31.0	35.0	39.6	25.6	31.4	34.0	32.8	25.8	28.7	28.3	27.1	42.1	47.0	21.9	48.2	30.5	17.1	18.1	19.3	22.5	17.6	21.3	19.8	19.2	20.5	20.0	18.1	21.4	40.8	12.8	49.3	25.5	63.2	40.0	56.0	74.6	37.5	37.5	40.7	29.0	41.0	34.3	81.2	40.5	58.4	67.3	59.6	39.4	64.6	73.2	327.3	53.1	43.9	40.7	44.9	36.2	25.4	79.8	75.6	45.8	38.7	64.3	47.5	37.3	36.4	110.0	49.7	26.9	26.8	48.7	87.5	39.0	43.6	901.8	38.5	47.4	28.4	24.4	56.1	44.3	41.2	27.6	54.6	55.1	34.0	37.6	133.1	60.7	39.0	79.2	93.0	50.1	26.3	38.3	46.1	95.4	76.0	36.0	50.3	94.0	64.7	43.0	31.6	64.5
SRP72		ENSG00000174780	"Signal recognition particle 72"	O76094	4	56467617-56503681	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Ribonucleoprotein	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034621	Approved					NA	NA		23000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA034621: AB_10601593"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.76e-2)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-2)"	"unprognostic (4.09e-3)"	"unprognostic (4.60e-3)"	"unprognostic (9.63e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.35e-1)"	37.7	31.6	13.9	41.2	15.0	73.5	49.8	15.1	18.1	41.4	20.5	39.1	29.3	40.8	29.5	42.3	33.0	33.5	25.2	14.2	19.1	33.4	45.4	32.1	49.5	14.9	18.8	45.0	47.7	43.4	16.4	48.3	16.8	31.1	41.1	27.3	43.8	32.7	33.3	34.3	31.6	44.6	15.9	39.1	33.6	27.2	14.9	52.8	54.3	35.7	55.6	46.6	23.7	18.6	109.1	82.0	101.6	98.7	63.2	90.0	98.0	157.2	125.0	129.3	102.7	91.2	120.5	167.6	105.6	132.2	68.2	61.1	126.9	133.4	152.3	44.3	74.0	146.4	90.3	86.0	115.7	284.4	116.3	85.8	175.9	138.0	243.3	112.1	117.1	126.4	216.1	157.0	124.9	84.2	168.6	73.9	88.2	135.1	86.1	149.2	81.9	127.0	88.5	101.7	62.9	104.5	99.8	193.4	88.5	81.3	77.0	102.3	142.7	106.8	143.3	110.4	165.2	111.8	56.9	181.2	114.9	148.3	132.2	43.0	64.3	38.7	50.4	70.8	65.1	52.8	50.9	51.1	82.1	48.5	49.4	49.9	8.4	59.5	57.5	61.4	60.8	58.7	13.9	15.0	15.1	18.1	14.2	19.1	14.9	18.8	16.8	15.9	14.9	18.6	78.5	73.7	72.5	17.0	84.7	97.3	93.7	103.5	47.3	61.6	65.8	80.4	45.2	54.3	87.9	27.6	18.8	120.8	97.0	30.5	66.5	121.1	86.3	38.9	87.2	83.7	53.2	113.8	30.2	131.2	197.3	84.0	39.3	73.3	101.9	94.5	63.9	80.1	100.4	57.2	32.4	94.8	69.2	109.4	78.9	116.1	65.3	83.4	58.7	28.1	122.4	54.5	72.1	29.1	35.6	111.8	48.7	66.5	156.6	131.7	43.5	71.1	54.6	37.7	39.5	92.9	106.7	48.2	86.5	73.2	100.9	166.5	71.1	111.0	89.0	115.2
ST14	"HAI, MT-SP1, PRSS14, SNC19, TMPRSS14"	ENSG00000149418	"ST14 transmembrane serine protease matriptase"	Q9Y5Y6	11	130159782-130210362	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 144.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 489.4;Paneth cells: 327.2;Proximal enterocytes: 251.9;Undifferentiated cells: 216.9;Urothelial cells: 286.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"thalamus: 10.0"	"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 25.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 25.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 224.2;CAPAN-2: 443.0;HaCaT: 311.4;OE19: 240.4;RPMI-8226: 301.2;SK-BR-3: 203.1;T-47d: 308.3;U-698: 218.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA047014, HPA056258"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		1100000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA047014: AB_2679902, HPA056258: "	"unprognostic (1.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.25e-1)"	"prognostic favorable (5.03e-11)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.60e-2)"	4.3	3.9	0.8	26.7	1.2	4.3	17.7	1.8	2.9	18.6	1.2	124.7	130.7	5.7	21.8	104.5	37.1	32.6	0.9	0.9	1.1	43.2	6.3	18.5	11.9	1.8	1.7	0.6	59.2	36.5	19.1	15.1	3.1	23.1	60.1	0.0	58.7	23.6	0.3	50.2	144.8	5.4	1.1	9.1	64.9	1.0	10.0	10.5	28.6	0.0	20.9	34.8	42.5	2.7	167.2	0.2	0.0	0.6	0.0	0.0	86.4	0.0	0.0	0.0	0.0	224.2	443.0	163.6	16.7	0.0	0.1	311.4	0.0	99.3	0.0	0.1	0.2	0.1	0.1	0.9	0.0	22.0	0.8	0.0	49.3	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	128.5	0.3	1.1	1.7	240.4	0.9	0.2	0.0	301.2	28.8	134.2	17.8	0.4	1.5	203.1	0.4	1.6	308.3	32.0	0.1	0.4	2.7	0.7	0.7	0.2	0.3	218.5	0.3	50.4	0.5	0.0	3.6	3.4	0.0	2.2	0.1	5.0	0.0	0.0	6.2	3.6	0.0	0.0	0.5	0.0	0.3	25.0	0.0	1.2	0.8	1.2	1.8	2.9	0.9	1.1	1.8	1.7	3.1	1.1	10.0	2.7	0.2	32.1	28.6	0.0	18.2	40.9	51.5	45.2	26.2	0.0	36.5	21.5	1.2	77.2	61.6	62.5	0.0	45.6	26.1	489.4	3.9	115.8	37.8	43.9	5.7	1.7	123.4	0.8	1.0	91.8	14.6	3.2	112.1	79.6	11.4	0.2	0.4	2.1	58.1	0.0	0.4	201.0	148.5	22.7	13.2	13.9	1.8	28.0	7.2	0.0	13.6	0.0	1.0	0.0	0.1	153.4	327.2	0.7	5.9	108.7	251.9	10.0	76.4	0.0	6.6	0.0	4.9	0.2	0.3	61.3	43.9	39.7	2.9	0.0	216.9	286.8
ST3GAL3	"MRT12, SIAT6"	ENSG00000126091	"ST3 beta-galactoside alpha-2,3-sialyltransferase 3"	Q11203	1	43705824-43931165	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.0;tongue: 82.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 59.7;Excitatory neurons: 94.4;Granulosa cells: 52.5;Inhibitory neurons: 120.1;Microglial cells: 57.1;Oligodendrocyte precursor cells: 66.9;Oligodendrocytes: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051102	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA051102: AB_2681344"	"unprognostic (8.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.01e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.38e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.68e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.35e-1)"	"unprognostic (6.60e-2)"	12.9	14.7	28.5	5.0	27.3	11.0	11.0	30.8	32.5	14.6	22.8	19.4	2.6	16.7	9.8	8.3	12.8	6.9	26.1	27.2	29.4	9.9	13.5	8.7	6.1	27.9	29.0	14.9	8.0	6.7	17.8	6.5	29.2	13.2	4.4	24.5	8.3	13.3	88.0	7.0	6.6	13.1	23.2	7.6	9.6	22.6	30.8	4.9	8.4	82.9	3.7	16.7	10.1	28.1	4.3	2.7	23.4	11.0	17.4	21.9	3.0	15.5	30.8	14.1	13.7	2.6	6.6	7.0	8.6	19.0	7.7	3.8	2.8	10.2	15.7	8.7	5.8	15.0	10.6	7.5	14.7	6.6	7.1	12.1	7.4	9.7	21.3	26.1	12.1	18.4	8.8	13.1	25.3	2.7	7.0	11.7	9.2	1.0	8.1	11.4	3.3	6.1	11.0	2.4	9.3	13.8	5.5	2.5	14.1	9.6	3.5	30.3	10.4	8.3	3.9	13.3	15.4	10.4	6.1	6.9	11.7	15.7	15.3	1.7	2.1	1.2	3.3	1.1	2.9	2.2	2.1	2.5	1.5	2.8	3.5	2.6	2.4	2.2	1.9	3.3	2.9	3.3	28.5	27.3	30.8	32.5	27.2	29.4	27.9	29.0	29.2	23.2	30.8	28.1	6.7	6.4	19.3	59.7	6.6	3.3	3.0	4.1	5.7	9.4	4.6	3.3	34.5	1.5	3.8	3.7	0.0	3.1	2.7	2.2	5.9	2.6	19.4	2.4	6.6	7.6	2.4	8.4	94.4	2.4	1.6	9.0	1.5	2.8	24.1	52.5	4.6	8.6	3.1	18.5	120.1	1.4	4.1	2.2	3.1	14.5	3.7	4.5	3.6	57.1	3.6	6.1	5.2	66.9	66.2	2.7	0.2	11.7	4.2	2.2	0.1	6.3	4.9	17.8	19.7	5.8	9.8	8.5	5.1	2.7	1.3	1.0	6.0	15.7	1.7	10.0
ST3GAL5	"SIAT9, SIATGM3S, ST3GalV"	ENSG00000115525	"ST3 beta-galactoside alpha-2,3-sialyltransferase 5"	Q9UNP4	2	85837120-85905199	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 47.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 112.8;Oligodendrocyte precursor cells: 94.0;Oligodendrocytes: 108.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 41.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 54.4;RT4: 47.0;SK-MEL-30: 40.8;U-266/84: 42.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034708, HPA040425, HPA068928"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"HPA034708: AB_10601594, HPA040425: AB_2676978, HPA068928: AB_2686060"	"unprognostic (7.90e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-2)"	"unprognostic (5.03e-3)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.25e-7)"	"unprognostic (2.22e-1)"	"unprognostic (5.74e-2)"	"prognostic favorable (4.99e-4)"	"prognostic favorable (4.48e-4)"	17.5	47.4	17.1	4.6	26.9	2.3	8.5	16.4	20.1	5.4	7.9	5.0	1.0	9.9	0.9	2.7	10.4	8.1	4.2	16.0	24.7	2.8	9.8	14.6	9.1	24.7	22.6	10.1	3.9	0.4	12.8	17.7	23.1	6.7	2.6	31.0	7.1	0.5	12.4	6.1	6.9	3.5	20.6	20.0	5.6	10.8	23.6	5.0	27.9	3.5	4.4	20.8	5.9	41.6	0.3	27.0	2.5	54.4	22.0	11.8	8.0	5.9	18.0	5.6	5.0	0.5	19.6	0.7	0.2	10.2	2.5	1.0	3.6	6.4	7.0	0.2	3.2	0.6	1.1	1.0	17.6	0.4	7.8	6.9	0.8	2.1	0.8	10.1	13.7	7.4	0.8	30.2	18.3	1.8	1.9	3.1	0.2	9.6	0.0	3.5	17.0	11.0	2.9	47.0	3.8	3.8	0.2	0.1	40.8	5.4	0.2	1.1	4.5	0.1	2.7	0.1	0.4	30.0	42.5	0.5	4.2	5.6	27.7	0.6	0.8	0.1	0.6	3.0	0.8	1.1	0.3	0.4	0.5	0.7	0.3	0.3	0.6	0.6	2.4	0.2	0.1	0.3	17.1	26.9	16.4	20.1	16.0	24.7	24.7	22.6	23.1	20.6	23.6	41.6	8.5	86.6	112.8	37.5	29.1	5.6	27.6	20.5	1.2	56.6	3.1	2.3	1.9	40.0	33.9	3.7	58.4	0.4	48.3	0.2	3.9	12.0	12.3	9.0	27.8	8.1	6.7	0.4	46.9	16.6	1.1	21.7	6.1	8.5	34.8	35.2	29.6	21.1	35.6	72.3	60.2	0.1	12.2	45.4	18.1	12.0	8.1	24.9	32.0	45.9	20.1	56.0	12.3	94.0	108.4	6.2	0.1	1.9	19.5	6.8	0.0	3.7	10.7	45.2	0.0	21.3	5.0	8.4	16.1	0.2	3.8	0.3	28.9	6.3	0.1	8.3
STAMBP	AMSH	ENSG00000124356	"STAM binding protein"	O95630	2	73828916-73873659	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"LHCN-M2: 1108.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035800, HPA035801"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		18000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA035800: AB_10670591, HPA035801: AB_2732470"	"unprognostic (1.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (6.13e-2)"	"unprognostic (2.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.89e-1)"	15.6	11.6	21.7	14.6	30.6	13.3	20.2	29.7	23.8	19.3	19.3	21.5	20.7	20.6	15.5	25.4	18.3	16.9	22.3	20.6	24.5	21.9	19.0	15.7	19.3	31.3	28.0	17.7	12.2	24.3	9.3	17.3	30.4	22.1	23.2	14.6	21.5	15.6	37.4	16.7	20.4	21.3	27.9	14.9	18.2	15.8	27.1	23.2	22.6	42.8	21.6	16.8	16.0	38.6	39.0	44.0	34.0	31.6	31.1	37.2	39.1	23.3	31.7	42.1	40.3	73.7	35.9	32.2	35.8	19.8	55.7	30.0	36.6	81.7	47.6	56.6	41.3	43.3	29.1	58.1	43.4	35.8	50.0	30.1	57.6	49.6	70.7	53.5	25.1	43.7	47.9	47.8	1108.9	46.8	55.9	32.4	54.9	55.1	22.7	38.6	89.4	46.1	45.2	43.0	62.0	45.8	28.4	34.6	49.1	36.4	32.3	21.4	22.0	37.5	44.5	22.9	41.9	44.8	46.9	24.9	46.4	38.1	44.7	30.7	18.9	34.2	15.9	21.4	17.2	21.5	18.3	15.6	19.9	19.3	18.9	14.4	27.6	22.3	19.9	19.5	25.8	14.9	21.7	30.6	29.7	23.8	20.6	24.5	31.3	28.0	30.4	27.9	27.1	38.6	22.1	19.2	17.7	22.9	21.5	16.3	28.9	61.7	31.3	22.3	28.8	27.7	41.1	28.6	34.4	25.8	12.5	43.0	27.4	48.7	49.0	37.9	80.8	35.6	37.3	21.4	10.3	34.9	18.5	36.3	32.5	26.0	18.8	45.8	52.6	21.2	17.5	41.1	33.0	26.9	22.1	36.4	40.7	27.7	16.2	125.0	32.6	25.2	7.2	16.9	34.1	24.9	25.7	26.2	67.2	44.5	41.8	34.6	21.5	40.9	57.2	68.8	24.5	21.0	39.5	28.2	27.2	33.1	44.2	44.5	21.6	44.5	21.4	27.5	34.3	27.1
STEAP3	"dudlin-2, STMP3, TSAP6"	ENSG00000115107	"STEAP3 metalloreductase"	Q658P3	2	119223831-119265652	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, Cell cycle, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 189.5;parathyroid gland: 78.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 33.3;Exocrine glandular cells: 36.2;Hepatocytes: 91.6;Respiratory ciliated cells: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.4;intermediate monocyte: 2.7;myeloid DC: 4.1;NK-cell: 1.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.1;monocytes: 2.7;NK-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 149.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA050510	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	Nucleoli	"HPA050510: AB_2681151"	"unprognostic (6.51e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.94e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.08e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.82e-1)"	"unprognostic (4.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.82e-2)"	9.1	6.3	4.3	3.9	3.7	16.9	14.5	7.1	4.6	16.7	10.6	9.5	22.1	3.6	5.3	15.8	7.7	2.3	9.5	7.0	7.5	6.9	189.5	9.1	0.9	14.4	9.4	4.4	27.1	78.9	13.8	11.3	12.8	11.8	6.9	0.7	34.3	7.5	29.9	9.0	10.9	3.1	7.6	1.8	22.5	1.9	7.2	2.2	5.4	12.5	3.1	7.0	7.2	12.7	21.8	25.6	0.0	8.7	12.1	112.9	22.1	6.8	7.4	13.1	11.8	19.5	29.0	0.1	49.9	38.5	94.1	35.9	11.1	22.4	14.9	0.1	35.9	42.1	22.2	38.8	30.0	10.5	7.7	67.3	38.7	78.0	27.7	89.8	11.4	0.0	20.9	4.2	37.6	20.6	0.1	6.2	34.2	33.3	52.7	0.2	14.7	18.5	16.2	54.1	41.9	7.7	18.8	64.1	4.9	4.9	12.7	13.7	49.6	81.2	46.8	17.4	37.4	0.1	0.1	0.2	149.1	26.2	17.2	0.0	2.4	0.4	0.1	2.7	0.0	0.4	0.0	0.0	4.1	0.1	0.0	0.0	0.0	1.3	0.4	0.2	0.0	1.0	4.3	3.7	7.1	4.6	7.0	7.5	14.4	9.4	12.8	7.6	7.2	12.7	9.1	0.0	7.9	2.3	1.0	2.0	7.4	11.9	8.0	0.6	15.5	10.7	6.2	2.8	16.2	0.0	0.0	33.3	0.2	12.2	0.0	8.1	0.2	8.1	1.9	6.2	1.8	29.5	1.3	36.2	4.1	3.6	23.4	5.7	3.8	3.5	1.4	91.6	10.9	0.0	1.0	6.0	8.2	5.9	3.8	0.7	1.8	6.1	0.0	1.9	1.4	0.1	0.0	0.5	0.0	20.8	7.7	7.5	0.1	8.3	11.8	1.5	36.1	0.1	6.6	4.1	3.3	0.6	0.2	19.5	1.4	23.7	0.4	13.1	11.6	8.9
STIM1	"D11S4896E, GOK"	ENSG00000167323	"Stromal interaction molecule 1"	Q13586	11	3854527-4093210	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011088, HPA012123, CAB037128, CAB037288"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		1900000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"		"CAB037128: AB_1079007, CAB037288: AB_1079008, HPA011088: AB_1849884, HPA012123: AB_1849882"	"unprognostic (2.06e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.39e-2)"	40.6	18.4	32.9	22.3	31.5	46.4	33.1	18.1	34.5	40.4	30.5	33.7	18.1	39.3	18.2	65.6	39.0	25.1	24.0	30.5	23.1	20.0	38.0	26.8	29.8	17.4	22.9	41.2	30.1	43.7	18.0	17.5	18.9	26.0	24.6	11.4	61.1	24.3	111.9	47.1	31.3	34.3	18.6	31.5	32.2	25.4	26.9	68.6	40.9	49.7	29.7	32.2	40.4	22.4	42.4	48.5	14.1	23.5	60.9	55.4	22.2	31.1	31.0	22.6	28.5	24.3	13.8	44.7	35.4	46.2	50.9	74.3	20.1	21.5	19.3	36.7	30.5	70.1	19.2	36.0	53.0	58.9	40.1	56.8	53.2	32.0	90.7	28.2	31.7	59.6	44.2	80.1	24.7	9.8	55.8	20.7	5.4	23.3	18.1	13.8	22.1	41.7	38.2	23.7	3.4	14.2	51.2	33.5	19.2	22.5	12.7	32.4	34.0	40.2	13.8	42.2	25.1	88.0	71.9	22.5	33.4	24.0	26.0	16.6	11.2	20.0	17.8	14.8	14.5	7.9	13.1	19.5	9.6	11.4	14.8	13.3	16.7	20.8	25.5	8.3	14.7	17.1	32.9	31.5	18.1	34.5	30.5	23.1	17.4	22.9	18.9	18.6	26.9	22.4	20.1	16.0	8.2	53.8	22.2	16.4	7.4	9.5	17.6	5.3	16.5	13.2	4.6	18.6	10.5	5.5	14.6	27.3	35.2	27.9	1.9	12.4	4.9	17.5	35.5	12.6	9.1	18.1	63.5	14.5	13.5	20.2	10.7	24.0	29.8	4.7	20.3	32.6	15.7	16.8	56.3	13.0	12.2	22.2	15.2	9.2	27.4	18.7	17.8	57.1	11.0	16.5	36.0	77.4	5.1	12.3	6.7	11.3	14.8	11.2	7.9	3.6	14.2	3.9	26.3	17.1	18.4	21.4	13.5	50.6	22.3	17.4	28.5	1.6	11.8	11.9
STK10	"LOK, PRO2729"	ENSG00000072786	"Serine/threonine kinase 10"	O94804	5	172042079-172188224	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 76.5;lymphoid tissue: 45.2"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 107.7;Kupffer cells: 91.4;NK-cells: 171.0;T-cells: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 143.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015083, CAB020840"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		16000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Plasma membrane"		"CAB020840: , HPA015083: AB_2669151"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (2.88e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.25e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	14.9	5.7	3.1	37.1	3.6	76.5	11.4	18.4	5.6	4.5	3.5	8.5	8.4	4.9	1.7	5.6	4.7	13.2	7.6	3.1	4.0	5.9	6.2	18.4	44.1	6.2	4.4	2.5	7.2	3.1	4.1	17.2	5.8	4.4	6.9	1.2	4.7	3.5	5.0	14.2	16.0	7.8	5.4	45.2	11.1	14.0	6.4	20.6	5.3	5.5	25.0	14.9	5.2	7.0	22.2	20.2	12.7	18.8	14.7	18.1	31.5	28.4	24.0	20.2	18.9	10.6	28.6	26.8	14.6	35.6	42.3	25.4	5.7	35.1	13.5	35.0	9.3	32.1	8.2	6.1	20.2	32.7	36.4	17.4	7.5	27.4	23.1	7.5	18.3	10.4	3.0	36.2	14.7	35.7	23.5	73.4	5.0	11.3	16.1	38.2	9.9	17.7	8.2	27.6	8.3	10.2	16.4	22.5	77.9	15.6	8.2	68.7	24.8	22.3	11.3	15.8	15.5	30.2	48.4	17.1	29.4	49.8	143.3	16.7	26.5	23.4	36.5	46.3	26.9	10.0	19.3	26.3	22.5	8.1	11.0	20.0	48.9	16.9	71.8	7.1	26.7	44.0	3.1	3.6	18.4	5.6	3.1	4.0	6.2	4.4	5.8	5.4	6.4	7.0	35.8	3.2	11.2	1.6	40.5	6.6	8.4	7.2	5.7	4.3	3.3	3.7	3.8	5.7	6.1	1.8	6.2	4.1	107.7	11.8	1.9	4.5	2.5	3.5	4.6	23.9	12.0	11.8	8.5	6.2	27.2	9.3	20.9	7.1	28.4	3.6	18.2	2.3	36.3	47.1	7.9	19.9	2.0	91.4	43.8	3.2	2.8	61.3	8.8	32.8	49.8	2.1	171.0	10.1	14.4	10.7	11.8	1.5	42.8	11.7	6.5	2.0	6.1	2.2	13.1	5.1	10.2	5.3	7.8	2.6	4.1	5.1	81.4	11.4	5.3	10.7
STK11	"LKB1, PJS"	ENSG00000118046	"Serine/threonine kinase 11"	Q15831	19	1177558-1228431	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Autophagy, Cell cycle, Differentiation, DNA damage, Spermatogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.9;Late spermatids: 338.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016231, HPA017254, CAB022105, HPA067481"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB016231: AB_627890, CAB022105: , HPA017254: AB_1852924, HPA067481: AB_2685847"	"unprognostic (8.60e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.00e-2)"	"prognostic favorable (3.69e-5)"	"unprognostic (2.04e-2)"	"prognostic favorable (1.96e-4)"	"unprognostic (9.11e-3)"	"unprognostic (3.19e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.95e-3)"	"unprognostic (7.70e-3)"	"unprognostic (3.54e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.12e-3)"	32.1	44.2	18.8	18.2	15.5	34.1	32.3	24.8	23.5	35.4	24.7	38.7	25.6	33.6	5.5	39.7	34.9	11.8	48.4	18.3	14.7	36.4	45.5	30.5	20.5	19.2	19.4	37.9	34.2	16.1	36.8	12.6	15.2	39.3	7.7	5.7	29.7	16.1	108.2	40.2	37.7	9.6	16.3	48.3	38.1	102.4	17.6	15.0	34.3	27.7	12.9	34.4	35.0	14.9	50.0	25.8	19.9	35.9	18.6	17.0	35.5	24.0	27.7	25.1	25.4	22.5	37.1	31.9	24.8	27.8	11.2	32.3	20.1	41.9	8.2	60.2	37.8	34.8	1.7	26.4	38.1	36.6	53.5	30.5	28.9	19.4	29.2	22.3	25.2	28.1	63.1	51.1	13.9	39.3	31.9	27.7	33.0	19.6	25.1	50.0	20.0	36.1	21.1	39.7	39.8	26.6	0.0	19.7	24.2	11.4	30.3	55.2	33.7	24.6	25.0	45.2	38.7	85.3	38.1	25.7	22.6	48.1	25.5	1.7	3.3	3.9	0.4	5.5	0.3	2.3	0.8	1.4	1.6	0.7	0.7	0.6	9.9	1.4	5.7	0.8	0.6	0.5	18.8	15.5	24.8	23.5	18.3	14.7	19.2	19.4	15.2	16.3	17.6	14.9	24.5	6.4	13.7	12.7	10.5	16.7	7.4	9.5	9.6	25.5	22.0	18.4	13.7	15.7	9.0	23.9	18.8	7.5	20.1	44.4	7.9	9.4	154.9	18.0	18.1	15.7	15.0	27.3	7.9	14.0	5.3	13.2	21.9	17.8	2.5	80.3	15.4	31.6	15.2	18.5	8.5	33.1	6.1	18.3	26.4	338.7	24.5	20.7	16.0	11.2	20.4	21.2	9.2	9.0	6.5	16.7	29.3	20.7	10.2	15.1	27.5	11.0	9.3	21.0	13.1	21.5	23.7	85.5	20.1	14.6	15.5	8.8	16.6	45.2	35.4	12.6
STK19	"D6S60, G11, RP1"	ENSG00000204344	"Serine/threonine kinase 19"	P49842	6	31971091-31982821	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in all"	4	"Proximal tubular cells: 348.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.4;HEL: 1.5;HL-60: 1.6;REH: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031511, HPA068559"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 72: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA031511: AB_2673915, HPA068559: AB_2686004"	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.95e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.10e-1)"	1.5	3.6	0.1	0.2	0.1	0.0	1.3	0.4	0.9	2.1	0.0	2.5	0.0	1.4	0.3	1.9	1.0	0.1	1.2	0.0	0.0	1.5	2.2	1.3	0.0	0.0	0.0	1.1	1.1	0.2	1.4	0.4	0.1	2.1	0.0	0.2	0.9	0.1	1.3	2.5	0.7	0.0	0.0	1.2	1.3	1.5	0.1	0.1	1.2	0.0	0.1	2.0	1.5	0.4	0.0	0.1	0.0	0.4	1.1	0.7	0.0	0.3	0.1	0.2	0.4	0.0	0.7	0.6	0.3	0.5	0.0	0.6	0.0	0.2	0.3	1.4	0.4	1.5	0.3	0.0	0.5	1.6	0.0	0.6	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	1.1	0.4	0.0	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.9	0.0	0.7	0.2	0.0	0.0	1.1	0.0	0.1	0.3	0.2	0.6	0.2	0.0	0.8	0.2	0.3	0.1	0.1	0.3	0.4	0.4	0.0	0.1	0.1	0.1	0.4	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	21.2	9.6	21.5	13.7	16.4	13.0	14.0	23.0	13.6	11.8	26.6	27.6	8.1	18.6	24.6	22.0	20.9	37.2	22.4	13.8	39.2	26.3	85.8	27.8	31.8	20.6	19.3	4.6	8.7	28.3	20.0	23.3	19.4	20.7	9.5	20.1	14.3	21.1	19.3	10.1	8.0	17.3	18.3	8.8	10.0	76.0	20.2	18.3	17.8	11.2	12.5	30.2	13.4	4.5	6.5	23.6	16.4	18.4	11.9	13.2	15.0	348.9	41.8	21.9	32.9	19.6	21.1	39.5	21.0	17.9	18.2	49.7	19.8	45.1	13.1	11.8
STK4	"KRS2, MST1, YSK3"	ENSG00000101109	"Serine/threonine kinase 4"	Q13043	20	44966479-45080021	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.7"	"Cell type enhanced"	"Detected in all"		"B-cells: 372.8;dendritic cells: 341.8;Langerhans cells: 606.9;monocytes: 367.5;Plasma cells: 336.2;T-cells: 414.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004038, HPA015270"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		45000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB004038: AB_2144632, HPA015270: AB_1854150"	"unprognostic (2.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.83e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (5.70e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.18e-2)"	10.0	8.5	6.9	33.8	8.0	57.7	9.1	6.2	10.8	7.9	9.9	11.1	10.2	8.5	7.6	9.1	6.2	11.7	4.6	7.2	8.7	6.0	9.2	15.9	43.1	8.7	7.6	7.0	6.0	5.9	4.1	10.4	9.2	6.7	13.0	7.3	7.4	8.0	3.3	11.2	13.5	9.3	8.3	30.4	12.7	9.7	7.5	33.1	7.6	4.9	41.7	15.0	6.9	10.3	27.8	18.7	23.3	16.1	13.5	16.9	16.0	23.6	35.7	39.4	35.6	52.7	14.6	66.6	20.4	16.9	33.4	28.5	24.3	31.8	49.7	30.8	13.8	48.6	27.8	36.8	23.8	63.5	66.4	13.8	25.6	36.7	39.6	19.4	14.6	44.6	23.5	37.0	19.9	21.7	47.6	42.3	13.9	17.7	12.5	30.2	25.2	31.2	14.4	18.7	10.9	13.2	35.6	20.0	27.0	17.2	18.3	39.1	18.7	29.2	28.6	34.4	27.8	48.4	41.7	73.2	28.6	29.5	22.0	80.6	19.7	54.8	34.4	19.9	34.3	26.2	32.2	32.0	18.4	26.9	33.1	28.0	101.8	28.5	38.0	10.0	34.3	22.3	6.9	8.0	6.2	10.8	7.2	8.7	8.7	7.6	9.2	8.3	7.5	10.3	26.2	16.0	24.6	18.9	372.8	55.7	49.3	33.8	28.5	27.3	22.9	17.4	7.6	14.3	25.2	42.3	52.1	24.1	341.8	23.7	9.8	16.3	5.9	19.1	25.1	32.1	25.7	46.3	76.7	17.6	30.3	29.7	34.1	25.1	133.6	114.0	26.0	22.0	61.1	43.7	38.2	20.7	28.5	109.3	606.9	5.0	22.7	154.4	133.4	85.3	367.5	20.2	278.1	34.2	48.1	21.6	27.9	17.0	336.2	32.6	23.2	13.4	26.1	69.9	13.1	25.5	29.2	44.2	42.4	20.9	53.0	19.4	414.5	48.1	19.5	45.5
STRA6	FLJ12541	ENSG00000137868	"Signaling receptor and transporter of retinol STRA6"	Q9BX79	15	74179466-74212267	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 24.5"	"Cell type enhanced"	"Detected in many"		"Club cells: 17.6;Endometrial stromal cells: 43.1;Extravillous trophoblasts: 12.1;Fibroblasts: 16.1;Proximal tubular cells: 10.3;Syncytiotrophoblasts: 26.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 33.7;CAPAN-2: 94.5;SH-SY5Y: 59.2;WM-115: 142.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040839	Approved					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA040839: AB_10794881"	"unprognostic (1.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.09e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.67e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.89e-1)"	"unprognostic (7.91e-13)"	"unprognostic (2.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.91e-1)"	0.1	1.0	0.1	0.3	0.0	0.0	0.9	0.0	0.4	24.5	0.4	0.1	0.0	4.3	0.5	1.1	3.6	0.3	0.1	0.1	0.1	4.3	0.0	0.2	0.8	0.1	0.0	0.6	0.1	0.0	5.5	7.6	0.0	5.2	0.0	0.0	0.7	1.4	0.0	0.3	0.2	0.2	0.1	0.1	0.0	3.1	0.3	0.2	0.1	0.1	0.5	1.3	2.4	0.0	0.5	33.7	1.9	0.1	0.0	0.0	6.0	1.0	0.2	0.0	0.0	11.7	94.5	0.0	22.1	0.1	0.7	3.4	1.8	0.0	0.0	0.0	0.2	3.0	1.3	2.5	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.4	6.1	0.6	2.9	0.1	0.0	0.4	0.0	0.0	0.0	2.9	17.4	59.2	0.0	3.6	0.0	3.6	0.2	0.1	0.0	0.2	7.3	0.6	1.6	0.1	0.2	0.0	0.6	0.0	142.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	1.0	9.7	0.0	0.0	0.2	0.3	1.0	0.0	17.6	0.0	0.0	4.2	0.0	0.0	1.9	0.3	1.7	2.1	43.1	1.3	0.0	0.0	0.1	0.0	12.1	16.1	0.0	1.8	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	2.0	0.0	0.8	0.8	6.8	0.4	1.8	1.9	0.1	0.0	0.0	0.0	0.0	4.7	0.0	4.1	0.0	0.4	0.0	10.3	6.6	0.0	0.0	1.3	4.7	0.5	0.5	0.0	0.0	26.4	0.3	0.1	0.0	1.3
STRADA	"LYK5, NY-BR-96, Stlk, STRAD"	ENSG00000266173	"STE20 related adaptor alpha"	Q7RTN6	17	63682336-63741986	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.0;Excitatory neurons: 49.1;Inhibitory neurons: 47.5;Oligodendrocyte precursor cells: 33.2;Oligodendrocytes: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031637	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA031637: AB_10601718"	"unprognostic (1.59e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.59e-3)"	"unprognostic (5.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (7.56e-5)"	"unprognostic (6.79e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"prognostic favorable (5.34e-5)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (6.08e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"prognostic favorable (6.43e-4)"	21.3	28.3	32.2	12.7	32.9	18.3	19.6	31.9	35.8	23.9	30.0	23.0	8.8	20.5	18.2	21.1	23.0	13.4	23.1	32.9	32.6	27.8	23.0	19.0	20.3	34.3	31.8	24.7	17.7	19.1	26.4	13.4	32.6	22.5	11.6	13.9	15.6	14.3	14.6	20.8	19.4	17.2	31.0	32.0	20.5	49.0	32.4	20.1	20.0	10.1	20.4	22.6	20.0	32.8	12.7	37.5	31.9	32.3	30.8	22.8	12.4	23.8	21.6	33.6	29.8	9.9	14.4	19.5	14.4	20.3	16.7	10.5	21.4	23.1	33.0	21.5	20.7	38.4	25.9	23.7	21.8	36.7	26.5	23.9	19.4	38.2	22.1	22.3	37.6	30.0	24.9	20.0	32.2	23.6	43.4	25.0	16.0	10.7	21.2	27.9	50.8	23.8	30.2	24.9	36.0	39.4	16.3	26.3	26.1	32.9	19.7	26.4	30.5	31.7	22.5	25.8	20.0	19.9	22.9	24.3	23.4	21.8	25.7	19.2	9.5	8.8	9.6	6.9	8.8	10.3	8.7	10.7	15.8	7.5	8.5	7.6	10.8	16.8	10.7	13.3	7.3	8.0	32.2	32.9	31.9	35.8	32.9	32.6	34.3	31.8	32.6	31.0	32.4	32.8	6.4	9.6	7.3	48.0	12.5	0.0	0.1	0.5	6.2	2.1	3.6	3.4	0.5	0.0	2.9	9.2	0.0	2.1	9.3	1.2	0.0	7.0	1.1	8.6	9.4	3.7	0.0	3.4	49.1	2.8	0.9	4.7	6.1	7.2	2.5	12.7	0.7	0.1	1.5	1.7	47.5	2.2	2.0	1.3	1.4	2.2	0.6	6.7	0.0	27.2	17.9	1.2	5.2	33.2	71.4	4.8	2.0	1.5	10.2	0.4	1.9	2.0	2.5	3.7	0.0	2.0	4.1	3.1	1.2	4.7	0.4	2.5	9.1	9.3	2.0	0.2
STS	"ARSC, ARSC1"	ENSG00000101846	"Steroid sulfatase"	P08842	X	7147237-7804358	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Pregnancy, Steroid metabolism"	Hydrolase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 26.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 41.8;Excitatory neurons: 32.2;Inhibitory neurons: 39.3;Syncytiotrophoblasts: 94.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 48.5;RPMI-8226: 69.8;U-266/70: 110.2;U-698: 47.2"					"Low region specificity"	"Detected in all"			HPA002904	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA002904: AB_1080116"	"unprognostic (1.09e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.23e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (4.05e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.34e-1)"	18.2	4.6	3.7	4.5	4.8	2.1	5.8	4.0	12.1	5.6	1.3	6.8	2.8	4.3	2.4	3.1	4.8	7.3	6.6	4.2	3.7	4.8	8.7	8.7	4.1	5.8	6.1	4.7	3.0	2.8	1.2	26.6	5.5	5.2	5.9	6.1	3.1	5.6	5.2	4.9	3.2	6.8	1.3	4.7	12.0	2.4	12.1	4.4	3.9	6.6	3.6	9.4	3.9	7.8	11.5	3.7	7.5	3.0	48.5	24.9	37.5	22.3	7.8	5.8	5.3	19.2	11.2	21.4	5.0	15.5	5.0	3.0	5.4	3.9	5.8	3.3	8.6	1.8	12.7	5.7	2.7	3.8	11.5	8.3	0.7	3.8	2.3	4.0	8.8	2.0	1.4	23.5	15.2	2.9	2.2	3.1	3.3	0.2	4.8	3.9	4.8	69.8	14.2	16.0	5.6	4.8	4.7	8.3	3.0	11.8	3.8	1.6	15.8	22.5	2.2	30.0	4.4	110.2	0.8	47.2	5.9	3.0	6.5	0.9	1.7	0.4	0.4	2.0	0.2	0.4	0.2	0.2	0.9	0.7	0.1	0.3	1.3	0.7	1.3	0.3	0.3	0.6	3.7	4.8	4.0	12.1	4.2	3.7	5.8	6.1	5.5	1.3	12.1	7.8	10.2	12.8	2.2	10.4	1.8	0.9	1.8	2.9	0.6	3.5	3.3	1.5	7.5	1.5	8.5	1.8	0.0	41.8	1.6	16.7	0.0	8.6	0.3	4.5	4.5	4.2	3.6	3.2	32.2	19.9	18.9	6.1	5.1	5.2	7.0	6.7	3.6	8.2	7.7	1.7	39.3	4.6	10.2	7.5	1.7	0.4	2.8	2.8	1.8	10.3	4.7	2.6	0.0	19.1	12.1	10.2	6.5	6.8	1.9	7.8	4.6	3.0	7.5	0.8	0.0	17.5	5.7	0.5	1.7	0.4	1.0	94.0	1.0	4.0	4.3	8.9
STT3A	"ITM1, MGC9042, STT3-A, TMC"	ENSG00000134910	"STT3 oligosaccharyltransferase complex catalytic subunit A"	P46977	11	125591712-125625215	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 391.8"	"Cell type enhanced"	"Detected in all"		"Plasma cells: 91.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030735	Approved					NA	NA		23000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA030735: AB_10603342"	"unprognostic (8.25e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.02e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (8.40e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.82e-2)"	38.5	39.2	14.6	44.6	17.7	31.8	55.8	17.9	16.9	84.9	29.8	54.0	42.2	60.8	140.4	30.2	56.3	39.5	38.5	15.0	20.1	45.8	69.0	39.0	32.9	19.4	18.4	68.0	69.0	391.8	29.0	63.8	19.6	56.2	59.5	40.0	80.1	77.2	18.4	31.6	42.1	58.9	17.5	34.4	51.4	44.5	17.5	34.8	83.9	24.4	48.8	50.4	33.3	23.1	113.1	99.5	123.7	173.6	230.1	176.4	133.8	198.5	238.5	158.6	196.6	304.2	294.3	143.6	236.2	297.3	222.4	202.7	173.5	176.2	208.5	114.8	90.0	341.0	63.7	215.1	254.4	208.4	153.6	138.4	125.8	219.5	424.5	186.1	182.2	63.9	147.1	210.6	205.4	82.7	84.4	65.6	78.6	221.8	106.0	98.9	107.1	221.5	173.7	170.1	77.5	66.2	142.9	229.3	72.5	144.9	267.8	148.1	164.5	227.7	82.0	97.6	159.7	66.3	82.4	109.6	87.4	206.3	184.7	96.2	46.7	36.6	56.1	45.4	77.9	42.8	53.7	52.0	65.2	32.1	37.1	44.4	15.7	52.8	41.8	158.3	44.0	47.5	14.6	17.7	17.9	16.9	15.0	20.1	19.4	18.4	19.6	17.5	17.5	23.1	17.4	28.9	25.0	6.8	20.8	16.2	14.3	40.3	12.5	11.6	15.2	9.8	23.3	27.1	29.1	16.5	20.9	45.4	21.7	16.1	1.9	30.1	10.6	22.9	51.0	17.3	15.6	19.6	7.6	27.2	73.4	33.0	26.0	57.0	17.1	29.0	32.2	38.5	30.7	1.7	8.9	37.3	20.3	23.6	31.9	5.4	21.5	17.3	24.9	9.4	12.6	13.2	11.3	11.6	10.9	28.6	12.2	18.8	91.9	19.3	15.6	13.6	23.6	15.1	19.7	23.1	32.8	33.5	13.1	21.9	14.8	45.6	14.6	22.3	26.9	13.9
STT3B	"FLJ90106, SIMP, STT3-B"	ENSG00000163527	"STT3 oligosaccharyltransferase complex catalytic subunit B"	Q8TCJ2	3	31532638-31637616	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 264.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036448, HPA036646"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		17000	"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA036448: AB_2675129, HPA036646: AB_10673472"	"unprognostic (2.17e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (7.91e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.02e-1)"	42.8	59.9	21.1	52.2	29.5	63.7	57.1	23.3	27.0	62.1	30.9	59.7	47.9	51.8	90.3	44.8	45.3	60.2	49.4	22.6	30.7	49.6	74.8	49.3	59.9	24.3	23.1	105.5	45.7	76.6	24.8	60.3	23.9	56.3	61.4	38.6	49.9	51.3	62.1	44.7	49.1	57.7	25.4	44.2	55.1	94.3	26.1	71.8	80.7	57.8	58.8	56.6	32.1	27.6	77.9	128.0	115.4	121.7	142.0	142.3	249.7	142.3	124.9	104.2	119.9	117.7	164.5	134.0	67.8	130.0	85.8	63.9	108.1	123.5	135.9	377.1	70.2	115.0	120.7	126.4	109.4	252.0	131.1	109.8	129.7	148.8	186.7	160.7	107.1	168.3	62.8	209.6	144.0	44.4	246.8	154.8	92.9	129.6	70.7	252.3	62.6	196.0	122.0	110.7	48.7	59.4	141.3	207.2	84.5	98.3	93.4	132.8	209.3	139.8	88.6	139.7	127.3	129.0	166.4	111.4	126.9	170.0	117.6	2.1	3.3	6.2	3.1	3.9	5.0	2.4	5.6	4.4	2.9	2.7	5.3	4.3	1.2	6.1	2.9	5.5	3.0	2.0	21.1	29.5	23.3	27.0	22.6	30.7	24.3	23.1	23.9	25.4	26.1	27.6	32.1	86.6	57.7	34.6	69.6	68.1	58.4	34.1	74.6	51.0	57.2	29.5	71.1	54.3	76.0	44.1	68.8	67.3	65.3	41.8	13.7	34.1	162.8	25.0	65.9	42.0	45.1	50.9	61.5	45.3	100.5	49.6	45.3	43.5	31.1	43.6	37.9	68.2	54.8	45.4	59.4	57.5	36.7	58.0	76.0	264.9	36.4	71.5	51.6	53.4	49.1	34.2	56.7	60.3	73.3	36.5	50.0	32.7	144.2	74.1	50.5	31.5	42.2	37.4	26.3	39.0	53.3	90.9	55.2	65.0	61.8	95.4	78.3	68.4	66.1	69.4
STUB1	"CHIP, HSPABP2, NY-CO-7, SDCCAG7, UBOX1"	ENSG00000103266	"STIP1 homology and U-box containing protein 1"	Q9UNE7	16	680224-682870	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037202, CAB037209, HPA041222, HPA043531"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"CAB037202: AB_1840759, CAB037209: AB_1840757, HPA041222: AB_2677368, HPA043531: AB_2678533"	"unprognostic (5.70e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.77e-2)"	"prognostic favorable (6.49e-9)"	"unprognostic (9.67e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.30e-1)"	80.2	126.3	185.5	35.6	186.9	48.9	76.0	183.8	242.7	74.8	173.1	100.3	50.7	67.0	60.3	86.8	65.3	42.1	151.1	187.3	185.3	91.4	100.7	65.0	52.5	188.2	184.2	65.7	93.7	90.6	93.7	23.9	187.9	80.2	32.6	33.2	86.6	53.5	201.8	111.7	63.1	40.1	180.6	70.0	86.2	45.1	193.5	42.3	72.9	125.2	38.2	80.7	69.1	188.0	81.6	107.6	59.4	108.0	123.4	102.5	43.8	112.8	95.1	100.9	90.5	131.0	97.1	83.0	78.2	147.5	69.1	69.7	73.0	137.3	42.9	93.6	318.8	53.4	154.1	104.7	183.7	85.9	96.4	141.1	134.3	118.2	71.4	76.3	106.2	72.3	87.1	119.2	149.3	318.4	90.1	85.4	76.4	107.1	127.5	143.5	46.8	200.6	132.5	72.6	121.1	103.4	89.4	165.8	137.1	35.9	114.1	147.8	108.7	104.3	99.8	94.3	125.9	137.6	150.2	132.3	83.8	73.9	122.0	17.7	13.6	21.7	15.7	12.9	14.5	19.6	13.5	13.8	12.1	21.0	12.8	11.6	13.4	11.2	13.9	20.7	13.2	7.2	185.5	186.9	183.8	242.7	187.3	185.3	188.2	184.2	187.9	180.6	193.5	188.0	96.2	38.5	27.9	24.5	88.9	114.7	107.2	63.9	83.1	93.3	137.1	158.7	1.0	104.4	52.4	130.6	52.1	80.1	101.4	142.7	285.7	139.6	8.6	82.8	69.6	71.6	76.0	68.5	23.2	169.7	93.8	85.7	68.3	65.0	21.0	97.9	80.3	122.1	113.1	84.1	21.1	101.4	85.5	69.4	94.9	16.7	109.0	79.0	117.4	15.0	154.4	184.3	110.2	14.1	24.8	190.2	110.8	112.1	108.6	160.8	165.5	324.1	61.2	83.9	72.3	82.3	129.7	50.4	62.4	107.0	120.5	100.7	96.2	132.5	109.3	118.8
STXBP1	"hUNC18, MUNC18-1, rbSec1, UNC18"	ENSG00000136854	"Syntaxin binding protein 1"	P61764	9	127579370-127696027	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 174.5;pituitary gland: 66.4;retina: 214.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 131.0;Cone photoreceptor cells: 156.4;Excitatory neurons: 243.2;Inhibitory neurons: 157.5;Rod photoreceptor cells: 155.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 39.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 174.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 144.1;SK-MEL-30: 131.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008209, HPA023483, CAB034434"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		29000	"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"CAB034434: AB_2196699, HPA008209: AB_1857624, HPA023483: AB_1857625"	"unprognostic (2.32e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.85e-2)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.47e-4)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.87e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.08e-3)"	"prognostic favorable (9.81e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.51e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.36e-3)"	27.5	28.8	22.8	7.8	33.2	1.1	21.0	38.6	174.5	21.8	0.0	15.9	5.5	24.1	7.1	10.4	32.3	11.4	24.0	48.3	12.2	14.1	3.1	32.1	6.0	48.7	0.0	25.2	24.8	15.0	66.4	14.1	33.1	10.5	8.4	214.2	15.6	10.4	9.0	11.4	9.3	21.0	0.0	10.4	13.3	9.1	6.8	5.8	20.1	9.2	7.0	15.4	16.4	27.2	13.2	27.1	25.5	28.8	56.6	48.3	23.2	45.0	22.9	26.6	23.3	1.5	15.4	13.1	24.2	29.7	74.2	4.7	22.6	28.1	32.7	29.8	15.4	17.1	69.7	4.9	28.5	1.8	14.6	36.6	15.4	70.0	33.7	42.6	32.2	43.4	17.8	19.6	45.5	24.5	12.5	5.2	21.5	21.4	35.9	7.5	12.1	31.3	22.0	0.6	144.1	69.9	72.9	37.2	131.9	22.5	5.8	5.6	47.5	30.0	15.1	59.9	17.4	40.2	73.2	17.4	59.2	18.9	28.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.9	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.2	22.8	33.2	38.6	174.5	48.3	12.2	48.7	0.0	33.1	0.0	6.8	27.2	24.3	25.6	70.7	34.0	1.2	11.6	10.1	8.4	12.5	131.0	10.5	8.0	15.2	1.5	9.2	3.7	156.4	2.7	1.1	0.5	7.9	13.1	2.2	8.3	14.7	28.9	45.6	4.0	243.2	8.4	5.9	18.7	3.1	7.0	5.1	5.0	26.7	1.4	4.4	84.1	157.5	10.2	8.2	2.5	5.6	2.2	20.5	3.0	10.6	45.0	0.6	27.0	0.0	61.3	39.0	5.3	0.0	44.4	1.6	10.8	0.1	8.9	15.9	155.6	13.1	9.5	11.2	40.6	16.9	2.9	7.5	24.5	2.3	17.7	0.9	7.1
SUCLA2	LINC00444	ENSG00000136143	"Succinate-CoA ligase ADP-forming subunit beta"	Q9P2R7	13	47745736-48037968	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 232.2;tongue: 271.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 256.2;Late spermatids: 314.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039435, HPA039536, HPA061528"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA039435: AB_10673144, HPA039536: AB_2676561, HPA061528: AB_2684553"	"unprognostic (5.66e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (7.59e-14)"	"unprognostic (3.53e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.22e-4)"	53.9	40.6	28.4	20.2	30.8	13.6	38.7	36.6	39.2	32.4	33.6	37.1	58.2	27.2	24.8	33.1	24.7	20.3	100.2	30.7	38.2	77.5	29.0	18.2	22.0	30.6	30.0	30.9	25.4	71.2	20.4	28.1	32.3	35.8	36.3	44.2	33.9	31.3	232.2	20.5	44.7	33.1	30.6	19.9	29.7	17.9	33.8	30.7	36.4	271.9	23.9	26.0	25.3	35.1	44.9	49.5	60.6	37.1	68.4	51.3	38.9	64.8	72.4	66.9	44.5	91.3	47.9	61.3	49.3	63.9	39.9	60.0	81.9	61.9	81.6	59.8	75.9	69.2	45.8	58.0	47.6	69.9	38.9	48.4	71.2	45.3	52.6	54.4	49.0	70.7	47.7	21.1	65.8	31.4	73.1	80.8	64.4	150.2	64.7	60.9	55.4	49.3	94.4	41.9	34.7	41.2	54.5	49.3	39.1	66.5	43.8	60.8	39.0	36.2	24.1	53.0	45.7	23.0	37.4	72.7	22.8	50.9	54.8	12.6	50.2	27.8	34.4	53.7	41.9	34.6	38.0	42.2	62.5	33.1	47.7	47.5	8.8	51.8	46.1	49.8	46.6	36.5	28.4	30.8	36.6	39.2	30.7	38.2	30.6	30.0	32.3	30.6	33.8	35.1	20.8	25.6	16.8	17.6	20.1	32.4	37.7	57.5	21.1	44.8	28.9	26.5	148.8	17.2	40.2	31.3	12.5	48.7	18.1	29.1	164.4	32.3	256.2	50.9	32.0	22.0	19.2	21.0	37.0	17.8	42.7	37.7	19.9	52.6	33.7	25.2	16.1	14.7	29.9	45.4	39.0	19.5	71.2	16.7	20.4	314.2	37.0	21.7	42.7	21.5	24.9	43.3	13.4	26.2	38.2	20.2	30.6	46.3	22.1	35.9	62.3	127.4	29.9	42.4	39.5	33.3	50.0	36.3	29.0	22.8	31.7	52.1	19.7	47.3	30.4	39.0
SUCLG1		ENSG00000163541	"Succinate-CoA ligase GDP/ADP-forming subunit alpha"	P53597	2	84423528-84460045	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 554.0"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 935.2;Proximal enterocytes: 647.5;Proximal tubular cells: 2949.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036683, HPA036684"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Intracellular and membrane"	NA	NA		350000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Plasma membrane, Cytosol"	"HPA036683: AB_10671708, HPA036684: AB_2675248"	"unprognostic (6.84e-3)"	"unprognostic (7.16e-3)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (2.21e-8)"	"unprognostic (4.94e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	118.7	73.3	70.6	43.1	73.2	48.2	80.0	76.2	92.5	49.9	91.1	156.9	231.1	42.4	78.8	86.9	54.6	41.9	258.1	71.1	74.5	554.0	193.0	41.6	47.8	71.7	70.2	45.7	93.6	244.2	46.8	48.8	72.9	54.3	165.9	38.4	120.6	66.6	274.1	55.4	195.4	63.5	73.8	39.6	81.1	36.9	73.3	61.7	97.6	368.1	63.1	66.4	58.5	76.9	90.2	94.9	73.8	91.1	137.8	91.2	127.7	98.4	85.2	126.0	91.2	224.5	72.0	122.4	67.0	119.8	100.2	126.8	156.7	118.4	149.8	119.3	141.4	105.9	75.4	129.2	116.0	110.6	82.7	109.1	95.6	106.3	143.7	76.7	115.1	97.9	110.1	98.1	117.5	137.4	158.2	101.1	39.4	334.1	170.0	98.3	172.6	134.5	172.2	106.4	89.8	49.3	78.9	163.7	162.3	69.0	99.8	85.4	93.1	96.6	94.6	119.9	124.9	84.2	131.0	107.8	113.9	150.4	88.0	101.6	91.0	80.8	79.0	110.2	88.5	70.2	72.0	88.4	115.4	55.4	79.1	84.3	49.7	102.3	114.3	63.2	107.7	142.7	70.6	73.2	76.2	92.5	71.1	74.5	71.7	70.2	72.9	73.8	73.3	76.9	52.7	64.1	96.5	32.7	61.0	35.4	108.9	129.6	44.3	33.3	105.0	109.1	408.6	131.5	115.2	141.6	22.9	232.3	49.9	218.1	935.2	131.8	49.2	67.1	56.9	57.0	106.3	68.4	45.8	113.2	129.3	69.8	79.5	80.8	91.3	46.0	57.5	210.0	131.7	45.4	43.5	202.1	105.8	71.3	46.0	35.9	54.7	82.2	119.2	16.9	89.8	68.2	58.7	28.1	46.2	67.1	215.4	74.1	57.1	64.2	647.5	2949.2	83.7	36.1	52.6	61.1	98.3	138.9	54.4	111.3	41.3	188.4	64.4	90.7	388.7	111.0
SUGCT	"C7orf10, DERP13, FLJ11808, ORF19"	ENSG00000175600	"Succinyl-CoA:glutarate-CoA transferase"	Q9HAC7	7	40135005-40860763	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 44.4;liver: 28.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 76.0;Inhibitory neurons: 38.5;Oligodendrocyte precursor cells: 58.3;Proximal tubular cells: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 43.9;LHCN-M2: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026698, HPA026704, HPA026705"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA026698: AB_10600191, HPA026704: AB_10600230, HPA026705: AB_10601003"	"unprognostic (4.66e-3)"	"unprognostic (3.45e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.32e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.27e-3)"	"unprognostic (7.65e-2)"	"prognostic favorable (3.93e-7)"	"unprognostic (2.62e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.41e-3)"	"prognostic unfavorable (2.53e-4)"	2.4	9.0	1.7	0.9	1.8	0.1	2.3	1.7	2.2	2.2	4.4	4.5	0.7	2.2	1.0	2.1	1.7	2.8	3.9	1.7	2.0	44.4	28.4	0.6	0.8	2.0	2.1	4.1	2.3	4.1	0.9	0.6	1.9	2.0	2.4	2.0	1.4	1.8	10.3	0.9	5.3	2.2	1.8	0.8	1.0	2.8	1.8	0.8	1.8	8.2	1.0	2.0	1.6	1.8	0.8	0.1	4.8	3.4	5.0	11.5	1.8	2.5	4.6	3.2	3.8	2.0	1.0	3.1	1.2	3.5	3.4	0.2	1.4	43.9	5.3	0.0	2.1	2.8	0.3	7.3	6.2	0.4	0.3	14.6	9.7	3.7	2.2	6.9	0.9	1.2	3.9	0.3	26.2	0.0	0.1	0.4	8.1	0.1	3.7	2.9	0.4	0.0	7.4	0.0	0.3	2.7	4.0	1.8	5.8	7.9	0.1	0.7	3.7	14.6	4.2	0.2	1.0	0.3	0.0	0.2	2.8	1.2	3.3	0.0	0.0	0.1	0.2	0.0	0.4	0.5	0.7	0.3	0.0	0.3	1.4	0.9	0.3	0.0	0.0	0.0	0.0	0.2	1.7	1.8	1.7	2.2	1.7	2.0	2.0	2.1	1.9	1.8	1.8	1.8	0.6	3.2	0.5	76.0	1.9	2.0	2.1	26.0	10.2	1.0	1.3	23.0	5.1	1.5	4.4	1.8	8.4	1.5	0.0	10.1	17.6	1.2	31.0	0.9	2.5	0.7	3.6	0.4	19.8	0.8	2.4	3.5	0.0	1.3	0.0	2.2	0.0	21.1	0.3	0.0	38.5	1.5	0.0	1.3	1.0	16.7	6.2	0.7	3.6	14.0	0.1	5.3	0.0	58.3	22.8	0.6	5.6	3.0	0.1	0.8	13.9	81.6	0.8	4.5	6.6	1.4	15.3	2.7	3.1	3.2	0.6	0.8	0.7	7.4	5.3	0.7
SULT2B1	HSST2	ENSG00000088002	"Sulfotransferase family 2B member 1"	O00204	19	48552172-48599425	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 286.0;skin 1: 186.5;vagina: 145.9"	"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 62.3;Proximal enterocytes: 75.9;Squamous epithelial cells: 56.0;Suprabasal keratinocytes: 137.4;Urothelial cells: 114.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 74.2;MCF7: 46.8;OE19: 122.9;T-47d: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041724, HPA043539, HPA076510"	Enhanced		Enhanced	Vesicles,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Cytosol	"HPA041724: AB_2677638, HPA043539: AB_2678540, HPA076510: "	"unprognostic (6.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.28e-3)"	"unprognostic (8.74e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (7.96e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.77e-2)"	0.3	0.2	0.5	0.4	0.4	0.1	11.5	0.6	0.8	74.4	0.4	0.8	9.3	0.5	6.8	286.0	1.2	2.7	0.2	0.5	0.5	13.0	0.3	9.4	0.0	0.5	0.7	0.1	0.7	7.9	0.4	1.5	0.5	22.6	0.2	0.0	53.6	3.7	0.4	186.5	18.2	0.1	0.4	0.1	3.5	0.5	0.9	0.4	1.9	0.0	28.3	0.7	145.9	0.5	12.6	15.8	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.9	74.2	0.1	0.1	0.0	0.7	3.9	0.1	0.3	0.0	0.5	0.4	0.0	0.5	0.5	0.0	0.0	7.2	0.2	2.1	0.0	0.0	0.1	0.0	0.8	0.1	0.1	0.0	46.8	0.0	0.5	0.0	122.9	0.0	0.1	0.0	0.1	0.0	3.5	0.2	0.1	0.0	6.2	0.3	0.0	36.7	0.1	0.2	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.4	0.3	0.5	0.1	0.0	0.3	0.2	0.6	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.1	0.2	0.5	0.4	0.6	0.8	0.5	0.5	0.5	0.7	0.5	0.4	0.9	0.5	0.4	19.2	0.5	1.0	0.0	24.1	30.5	11.6	0.0	0.0	16.8	12.4	0.6	5.7	40.2	9.2	0.0	3.2	0.0	4.4	0.0	12.2	0.0	15.7	1.4	0.9	4.8	0.0	1.0	1.2	3.1	1.2	2.6	17.5	0.0	0.1	0.0	0.3	0.7	0.0	0.9	12.6	24.4	0.0	4.8	0.9	0.3	0.4	12.4	1.0	0.0	1.6	0.0	0.5	0.8	18.5	7.9	0.0	0.0	62.3	75.9	1.3	6.7	0.6	0.0	0.1	2.2	0.2	11.1	56.0	137.4	1.9	0.6	2.0	9.2	114.6
SUMF1	"FGE, UNQ3037"	ENSG00000144455	"Sulfatase modifying factor 1"	Q8NBK3	3	3700814-4467273	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 116.4;hTERT-RPE1: 117.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038025	Uncertain				"Intracellular and membrane"	NA	NA		2800000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"HPA038025: AB_10675624"	"unprognostic (5.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.99e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.79e-7)"	"unprognostic (5.12e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.86e-2)"	20.7	19.5	10.4	13.1	12.0	10.2	29.2	10.9	12.2	21.3	15.6	23.9	13.3	15.8	26.8	28.7	25.6	19.7	12.5	10.2	12.2	39.3	27.4	23.0	12.6	12.2	11.7	17.4	18.9	46.8	14.5	18.8	11.4	22.1	29.6	3.4	22.8	17.7	4.3	20.3	14.1	20.5	11.4	16.8	23.8	5.1	13.1	10.6	28.4	7.6	13.4	20.0	18.5	13.1	25.0	20.6	11.4	6.3	116.4	61.3	21.9	34.4	53.9	16.2	18.2	9.6	78.9	3.7	20.3	63.0	24.3	13.3	5.0	39.0	25.2	12.0	10.1	5.4	18.9	26.2	30.0	6.1	14.4	56.6	43.2	18.2	5.3	117.9	44.8	8.9	9.1	8.4	45.8	40.2	3.4	9.1	12.0	22.8	23.4	6.3	17.0	16.0	86.6	28.0	2.2	12.6	24.6	56.8	20.4	19.5	75.7	15.6	41.4	32.5	4.2	25.3	21.0	10.4	22.8	1.7	63.2	13.5	24.7	66.1	100.5	35.6	38.9	81.8	35.2	26.6	31.2	32.9	86.6	30.7	39.4	32.0	36.2	42.0	78.2	45.9	16.9	90.2	10.4	12.0	10.9	12.2	10.2	12.2	12.2	11.7	11.4	11.4	13.1	13.1	12.8	19.2	20.1	36.9	13.8	12.7	18.8	32.9	21.1	5.6	29.5	23.2	5.5	18.6	16.7	38.6	6.2	29.8	9.7	16.5	11.7	39.3	26.1	14.2	14.1	13.7	8.4	11.1	53.2	19.1	23.3	25.8	21.4	21.9	17.1	10.4	17.5	18.7	28.2	3.3	57.0	19.7	4.1	37.1	12.0	10.7	16.4	24.3	19.6	62.8	43.9	6.8	11.3	56.8	85.5	14.0	16.4	17.3	11.5	13.7	10.5	23.8	19.4	6.2	6.6	21.2	16.5	4.8	5.1	25.9	11.8	24.4	11.6	11.1	25.6	18.3
SUOX		ENSG00000139531	"Sulfite oxidase"	P51687	12	55997180-56006641	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 49.6;Proximal tubular cells: 35.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 72.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038208, HPA038209"	Approved					NA	NA		44000	"Cluster 52: Eosinophils - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA038208: AB_2675892, HPA038209: AB_10672738"	"unprognostic (1.72e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.71e-3)"	"unprognostic (2.86e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.74e-2)"	"prognostic favorable (6.28e-4)"	"unprognostic (6.95e-2)"	"prognostic favorable (4.77e-7)"	"unprognostic (1.65e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (8.32e-5)"	19.2	35.2	19.3	9.5	20.2	12.8	18.2	21.0	22.6	16.7	22.2	20.6	19.3	17.6	33.0	21.5	22.9	16.7	29.4	19.6	19.9	40.8	72.3	15.6	8.3	20.7	20.0	22.1	17.4	48.6	16.6	11.5	20.6	25.2	17.1	13.8	20.2	24.5	45.6	10.4	15.6	17.4	20.1	13.6	21.3	8.3	21.7	6.7	18.2	28.8	12.0	21.2	14.3	24.0	10.2	29.8	18.5	30.2	29.6	12.2	40.1	11.5	12.5	15.4	11.1	28.8	22.1	1.2	19.8	14.0	10.6	13.2	13.7	14.5	8.2	45.8	9.0	15.7	19.4	34.9	10.9	0.2	25.9	19.0	5.5	13.1	6.8	23.0	38.9	1.6	28.2	19.0	16.2	25.1	0.4	10.0	9.9	15.6	21.4	13.6	7.7	22.4	17.8	20.4	9.2	12.3	21.1	42.6	17.4	17.2	72.2	14.9	20.6	8.5	10.4	10.8	8.2	22.0	21.3	1.6	13.7	10.2	12.7	11.1	12.6	29.6	0.2	18.7	0.1	2.5	1.2	0.0	16.1	0.3	0.9	0.2	5.1	16.5	16.2	0.5	7.9	11.8	19.3	20.2	21.0	22.6	19.6	19.9	20.7	20.0	20.6	20.1	21.7	24.0	4.5	9.6	10.9	10.7	1.1	1.3	3.8	6.7	6.2	5.1	9.1	6.1	21.7	11.5	12.8	14.7	6.2	29.7	0.9	7.7	17.6	5.6	0.7	7.7	6.7	7.1	6.0	6.5	4.1	6.3	19.1	6.4	6.6	12.4	4.5	6.6	8.9	49.6	10.5	10.1	4.4	6.0	4.1	8.9	4.0	0.9	4.4	4.3	1.8	5.6	10.0	8.5	2.1	5.5	6.2	5.3	7.4	9.1	3.2	3.1	7.9	35.8	6.1	8.4	6.6	8.4	5.4	2.4	1.4	6.8	2.3	30.8	1.6	6.7	7.7	3.0
SYNJ1	"INPP5G, PARK20"	ENSG00000159082	"Synaptojanin 1"	O43426	21	32628759-32728040	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, RNA-binding"	"Disease variant, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.9;retina: 48.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 110.9;Inhibitory neurons: 91.5;Oligodendrocytes: 61.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011916	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"	Centrosome	"HPA011916: AB_1857692"	"unprognostic (6.84e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (4.43e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.36e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.92e-1)"	7.6	6.9	15.0	5.3	22.8	23.8	6.5	1.1	45.9	6.2	3.5	5.6	4.0	5.1	5.1	4.6	5.0	5.2	6.4	22.1	9.8	7.4	5.7	8.0	6.3	19.5	5.6	4.8	4.8	8.4	13.8	9.8	14.8	4.5	5.4	48.4	4.7	3.7	7.7	5.1	6.3	4.9	0.0	7.9	5.0	10.2	8.7	7.1	7.3	6.4	4.8	5.5	5.4	25.9	5.5	2.9	5.0	5.7	8.9	7.1	10.3	11.3	6.2	6.8	5.7	6.1	2.6	2.0	3.8	6.9	8.9	5.0	8.9	6.8	8.4	6.8	8.1	13.8	8.7	3.5	4.8	5.6	11.7	4.1	4.9	12.0	6.1	5.8	10.8	7.3	10.6	11.6	9.0	5.5	5.5	5.1	3.4	6.4	6.0	6.1	11.1	7.4	7.5	4.3	5.6	4.5	14.0	8.4	5.6	6.9	7.8	7.2	11.2	10.0	5.3	8.2	6.4	6.0	7.8	4.4	8.0	10.7	8.7	3.4	2.9	6.9	1.2	5.2	2.0	0.1	1.9	2.0	2.5	0.3	2.2	2.2	9.1	0.5	4.7	1.4	2.6	1.1	15.0	22.8	1.1	45.9	22.1	9.8	19.5	5.6	14.8	0.0	8.7	25.9	10.2	6.4	5.4	22.9	3.9	4.8	1.9	3.1	8.0	24.8	3.8	2.5	10.0	2.8	4.0	1.8	45.9	17.7	7.0	4.8	5.9	2.0	19.9	2.4	4.7	11.9	3.0	5.0	110.9	1.3	9.8	5.3	4.1	3.6	3.8	2.2	11.0	4.2	10.1	10.1	91.5	2.0	0.0	18.6	5.7	11.3	2.8	15.7	1.8	31.9	6.5	21.8	4.1	49.3	61.0	2.8	5.3	4.5	8.6	2.7	6.2	6.5	4.6	45.4	6.6	6.1	5.8	22.1	13.3	6.7	3.3	38.0	9.9	2.8	5.4	4.3
SYP	MRX96	ENSG00000102003	Synaptophysin	P08247	X	49187815-49200199	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 259.4;pituitary gland: 106.8;retina: 316.3"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 529.2;Cone photoreceptor cells: 546.3;Rod photoreceptor cells: 594.4"	"Group enriched"	"Detected in many"	6	"glioma: 12.8;pancreatic cancer: 5.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"K-562: 20.3;SCLC-21H: 102.6;SH-SY5Y: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000076, HPA002858, CAB055505, CAB078999, HPA079659"	Enhanced	Supported				NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB000076: AB_2315411, CAB055505: AB_564017, CAB078999: , HPA002858: AB_1080153, HPA079659: "	"unprognostic (2.08e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.37e-3)"	"unprognostic (4.37e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.46e-5)"	"unprognostic (8.52e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.44e-3)"	"unprognostic (8.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.94e-1)"	2.6	40.1	115.7	3.6	132.0	0.8	1.9	26.0	259.4	1.8	0.0	7.4	12.4	1.5	2.0	1.2	1.7	0.8	3.1	144.0	137.9	5.0	0.8	3.0	0.9	89.5	25.8	1.7	7.6	3.3	106.8	0.8	76.2	1.6	3.9	316.3	1.3	1.1	1.9	1.8	13.9	1.9	4.7	2.0	5.3	1.7	86.0	4.2	2.3	1.4	0.7	1.5	2.2	116.9	0.9	3.9	2.9	5.8	3.2	0.5	0.4	0.2	0.1	0.7	0.8	3.6	2.1	3.2	0.5	0.1	4.4	2.9	3.1	0.4	0.7	6.5	3.5	4.9	1.4	1.1	0.1	0.6	10.5	0.4	0.1	0.5	0.7	0.4	0.3	2.7	20.3	7.6	0.6	1.1	1.7	0.4	9.6	2.5	0.8	0.6	0.6	1.5	0.2	0.4	102.6	36.8	1.1	0.4	1.5	0.9	1.9	1.8	0.6	0.6	3.2	1.0	0.4	0.5	6.7	0.8	1.7	1.3	3.2	0.7	0.2	0.1	0.0	0.2	0.1	0.2	0.1	0.2	0.1	0.4	0.1	0.1	1.9	0.2	0.1	0.6	0.1	0.0	115.7	132.0	26.0	259.4	144.0	137.9	89.5	25.8	76.2	4.7	86.0	116.9	7.5	0.0	3.9	24.2	6.3	2.5	2.8	1.0	1.2	529.2	5.8	8.1	1.8	2.8	2.9	9.2	546.3	1.1	1.9	11.3	0.0	0.9	10.3	1.4	3.1	6.5	116.4	0.4	115.1	2.6	0.6	3.7	10.2	3.1	8.8	3.4	6.1	1.2	1.2	122.8	118.4	37.7	10.2	1.9	4.9	12.6	4.1	3.6	3.6	17.8	2.7	54.4	3.1	28.1	33.7	1.2	2.1	3.8	1.5	1.5	16.3	0.9	4.6	594.4	6.6	5.4	7.8	2.4	2.8	3.4	2.6	1.4	3.5	41.3	10.8	1.0
SYT1	"P65, SVP65, SYT"	ENSG00000067715	"Synaptotagmin 1"	P21579	12	78863993-79452008	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"brain: 403.3;retina: 197.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 1287.6;Cone photoreceptor cells: 894.5;Excitatory neurons: 3753.2;Inhibitory neurons: 2910.4;Rod photoreceptor cells: 905.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"amygdala: 113.1;basal ganglia: 153.7;cerebral cortex: 403.3;hippocampal formation: 134.2;white matter: 146.0"	"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.0;naive B-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 39.4;hTERT-RPE1: 37.1;LHCN-M2: 31.9;SH-SY5Y: 30.9;WM-115: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008394, HPA064788"	Enhanced	Supported				NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA008394: AB_1857696, HPA064788: AB_2685351"	"unprognostic (1.02e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.77e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.68e-5)"	"unprognostic (2.78e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.14e-3)"	"unprognostic (3.05e-8)"	"unprognostic (2.89e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	0.5	21.7	113.1	2.2	153.7	0.6	0.7	19.7	403.3	1.4	0.0	4.4	1.5	9.9	0.7	0.7	0.8	1.3	0.2	134.2	2.0	1.9	1.9	0.9	0.3	0.0	0.0	5.2	0.3	0.0	6.4	2.6	3.0	6.6	2.8	197.7	0.2	5.5	0.2	0.2	3.4	25.2	0.0	2.6	1.3	0.7	12.5	0.5	0.3	0.5	0.3	1.6	2.5	146.0	0.0	19.2	14.2	0.0	1.4	4.0	0.0	1.4	1.7	1.0	1.1	1.0	0.5	0.0	2.8	0.2	5.0	0.6	0.3	2.2	1.6	0.3	0.7	1.0	0.5	0.0	3.6	0.0	0.3	1.1	1.4	5.2	39.4	37.1	13.6	0.7	0.7	2.2	31.9	3.1	1.8	0.0	10.3	2.1	5.3	0.0	14.3	0.0	0.0	5.5	18.8	30.9	0.0	2.4	0.3	9.5	6.8	0.0	5.4	2.0	0.7	0.0	6.2	3.4	8.0	0.1	4.5	0.0	29.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.1	153.7	19.7	403.3	134.2	2.0	0.0	0.0	3.0	0.0	12.5	146.0	2.2	0.0	0.6	124.7	9.0	0.9	0.1	0.0	0.0	1287.6	0.2	3.4	0.6	0.0	1.3	0.0	894.5	5.6	0.1	0.1	0.0	0.0	1.4	0.6	20.2	10.4	96.9	1.3	3753.2	0.2	2.2	5.9	0.0	0.7	0.0	0.7	1.8	0.1	13.9	62.2	2910.4	0.1	0.0	4.7	7.2	2.9	69.3	1.6	1.8	137.7	0.0	337.7	0.0	126.2	105.1	0.1	7.6	4.5	8.5	11.5	0.1	0.1	0.0	905.8	0.0	0.0	6.7	1.5	5.7	0.2	0.6	5.9	0.4	1.8	0.1	0.3
SYVN1	"DER3, HRD1"	ENSG00000162298	"Synoviolin 1"	Q86TM6	11	65121780-65134532	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Stress response, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 72.9;Plasma cells: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 205.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005480, HPA024300, CAB037030"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Endoplasmic reticulum, Plasma membrane"	"CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (7.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.89e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.16e-1)"	29.2	40.3	19.3	37.1	25.6	31.0	27.6	23.2	21.4	30.7	26.7	29.2	26.1	29.1	38.8	28.4	30.6	19.7	25.3	18.6	21.2	24.5	117.5	27.0	60.9	27.9	25.6	30.9	90.9	35.0	38.2	26.2	24.6	28.5	29.0	18.7	55.9	30.3	34.2	29.3	39.4	25.9	22.8	51.2	39.4	24.3	23.4	18.3	43.4	19.0	81.1	25.8	24.8	25.9	32.4	40.6	24.0	32.5	59.8	33.8	23.8	32.8	33.5	40.9	28.8	22.2	55.0	181.0	43.8	42.4	53.8	48.8	26.4	33.3	33.6	28.4	20.0	28.6	46.8	50.2	72.3	43.3	49.6	43.3	59.0	36.1	81.0	36.4	27.0	19.0	36.4	90.1	24.3	47.9	19.1	31.2	26.1	33.6	28.0	31.9	20.3	74.0	25.7	31.5	15.6	32.0	30.4	74.1	53.3	21.0	55.4	28.2	25.9	28.3	18.6	51.2	22.4	178.1	134.2	205.9	38.1	21.8	32.3	16.8	7.4	14.0	7.4	4.7	6.5	21.9	5.2	6.9	4.4	22.6	3.7	3.9	7.0	3.5	4.7	18.4	5.3	6.6	19.3	25.6	23.2	21.4	18.6	21.2	27.9	25.6	24.6	22.8	23.4	25.9	11.5	16.0	21.4	11.1	43.5	17.6	6.9	13.8	12.0	10.7	21.0	15.5	4.0	22.8	20.8	11.0	33.3	14.5	16.4	23.1	1.9	13.6	6.6	14.2	16.2	11.3	8.4	13.2	9.6	18.9	16.5	14.2	17.9	22.1	1.3	10.1	15.0	72.9	15.1	13.5	9.5	33.6	16.2	15.3	13.2	4.1	20.5	10.8	12.4	9.4	10.5	11.0	13.4	13.0	15.8	18.2	11.7	13.2	90.5	14.9	14.0	7.7	15.1	18.7	13.1	11.9	10.7	19.3	13.2	9.7	16.1	42.8	11.7	13.6	18.6	13.8
TACR3	"NK3R, NKR, TAC3R"	ENSG00000169836	"Tachykinin receptor 3"	P29371	4	103586031-103719985	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.4;retina: 2.7;urinary bladder: 1.9"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 13.1;Excitatory neurons: 6.7;Extravillous trophoblasts: 4.5;Oligodendrocytes: 10.5;Skeletal myocytes: 11.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons: 8.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"BEWO: 7.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA009418	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"			"HPA009418: AB_1857727"	"unprognostic (3.81e-2)"				"unprognostic (2.92e-1)"	"unprognostic (2.29e-1)"		"unprognostic (3.50e-1)"		"unprognostic (3.21e-1)"				"unprognostic (5.52e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.72e-2)"	0.0	0.0	2.7	0.0	0.3	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.4	0.2	0.0	0.1	0.0	1.4	1.5	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	1.9	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.1	0.4	0.3	2.4	1.4	1.5	8.4	1.7	0.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	6.7	0.0	4.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	1.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	11.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAF1	"BA2R, CCG1, CCGS, DYT3, DYT3/TAF1, KAT4, NSCL2, TAF2A, TAFII250"	ENSG00000147133	"TATA-box binding protein associated factor 1"	P21675	X	71366264-71532374	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Dystonia, Mental retardation, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA001075, CAB016283"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB016283: AB_671202, HPA001075: AB_1080179"	"unprognostic (2.95e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (6.54e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (6.03e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.56e-2)"	10.9	8.6	10.3	11.4	12.7	12.8	12.3	13.7	11.1	11.1	10.2	10.0	6.6	13.8	12.9	7.5	11.1	7.8	7.0	9.3	14.1	7.5	7.8	9.1	14.1	11.5	11.3	14.4	9.8	12.2	8.4	10.0	10.9	10.0	10.0	27.3	7.7	10.1	10.5	13.3	9.3	10.9	8.2	15.4	10.6	7.2	12.5	14.8	12.7	10.3	12.4	9.2	8.6	16.8	18.6	15.9	18.2	12.4	14.6	23.2	11.0	13.3	12.1	13.7	11.1	12.3	11.3	17.6	11.5	14.9	12.3	17.5	24.1	11.0	17.0	11.2	21.9	20.1	22.1	13.1	11.1	39.7	19.4	14.1	11.3	14.2	27.2	12.8	14.7	13.2	28.2	41.1	14.4	14.5	22.4	25.4	20.9	23.5	20.8	19.8	35.8	21.6	11.1	25.0	9.0	14.5	37.7	13.6	18.7	14.3	9.6	22.9	18.6	16.5	14.2	13.4	9.7	17.5	17.4	21.4	9.0	33.2	12.5	1.6	1.4	0.7	1.4	0.9	1.3	1.0	1.4	1.4	1.5	1.5	1.6	1.8	1.8	1.5	1.6	1.4	1.0	0.7	10.3	12.7	13.7	11.1	9.3	14.1	11.5	11.3	10.9	8.2	12.5	16.8	26.7	32.1	26.7	44.7	21.2	11.9	8.9	10.4	18.2	37.5	12.5	13.3	17.2	10.0	23.9	3.7	81.3	8.6	21.5	7.8	1.9	6.3	2.5	17.0	23.4	24.6	11.4	28.6	54.3	7.0	5.9	17.6	12.2	18.9	23.4	23.9	18.9	12.6	8.8	16.8	52.2	14.6	6.1	16.2	20.0	2.6	22.1	20.4	5.4	47.8	23.9	17.0	29.9	49.3	79.1	7.6	13.3	22.2	18.7	11.2	13.4	5.2	14.8	67.9	0.0	27.4	18.0	9.3	10.7	17.8	17.3	5.7	23.8	25.9	13.6	9.6
TALDO1		ENSG00000177156	"Transaldolase 1"	P37837	11	747415-765012	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pentose shunt"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 820.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 2870.4;neutrophil: 3726.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048089			Approved	Nucleoplasm,Cytosol		NA	NA		29000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	Cytosol	"HPA048089: AB_2680260"	"unprognostic (5.29e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.97e-2)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.78e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.97e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.16e-3)"	139.5	80.7	108.0	121.8	128.8	464.8	121.0	129.3	119.3	101.9	105.2	99.6	116.0	68.4	66.4	330.6	79.1	100.0	95.5	108.0	113.8	111.6	136.2	109.1	107.8	135.8	119.3	77.0	107.5	49.3	53.0	88.0	130.0	91.9	78.4	34.2	132.8	60.1	120.7	132.7	101.0	60.8	124.0	152.6	132.5	40.4	120.1	109.9	140.3	107.1	115.8	160.8	142.1	148.2	331.0	405.5	115.4	218.1	235.8	136.5	338.0	242.2	313.8	238.2	194.5	176.6	694.8	179.5	323.1	324.7	181.9	345.5	185.6	263.5	122.8	238.9	372.5	310.9	146.0	616.4	250.3	498.4	449.0	112.0	210.6	159.6	129.0	170.4	331.6	224.0	413.5	294.3	224.5	318.0	296.4	601.2	183.9	478.9	326.0	243.5	131.5	656.4	437.9	185.4	284.2	100.1	224.9	466.1	243.3	102.4	220.0	383.9	434.1	107.9	99.5	86.0	232.9	122.9	132.1	223.5	238.5	440.5	444.7	1456.7	1203.5	2870.4	94.1	432.7	102.3	145.5	125.7	115.5	654.2	127.2	100.9	94.9	3726.6	112.2	457.8	267.0	192.7	1066.0	108.0	128.8	129.3	119.3	108.0	113.8	135.8	119.3	130.0	124.0	120.1	148.2	90.2	141.1	117.2	10.7	91.1	73.5	199.8	354.0	61.5	50.3	113.0	122.2	46.4	100.1	253.4	150.8	14.6	419.8	83.8	151.0	250.5	230.4	82.1	156.5	85.4	85.6	101.5	507.0	13.1	272.1	427.6	97.3	144.3	216.7	161.4	86.0	93.5	149.7	418.3	50.5	11.6	186.0	268.5	271.8	169.4	21.2	117.8	352.8	140.5	7.5	820.0	142.1	84.5	10.6	54.8	257.6	200.3	104.2	129.4	361.9	197.7	309.1	232.6	61.7	72.3	59.6	115.0	143.2	140.6	257.6	83.1	526.6	86.8	77.5	215.1	342.6
TAP1	"ABCB2, D6S114E, PSF1, RING4"	ENSG00000168394	"Transporter 1, ATP binding cassette subfamily B member"	Q03518	6	32845209-32853816	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 126.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009516, HPA072354"	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum, Centriolar satellite"		"CAB009516: AB_2303048, HPA072354: AB_2686513"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.56e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (3.02e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (6.58e-5)"	"unprognostic (2.07e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	28.4	24.9	16.1	50.1	16.2	13.7	20.7	15.8	20.3	21.6	16.2	30.3	36.0	20.5	2.5	31.6	17.8	12.7	25.4	14.7	16.2	21.8	19.3	52.7	50.0	24.0	16.1	12.1	14.5	7.0	11.6	12.1	21.2	21.9	12.5	1.7	25.9	7.0	16.3	51.2	42.6	11.5	18.6	73.0	33.4	11.5	19.4	25.5	17.0	7.4	21.3	23.9	24.4	17.4	22.9	13.7	0.1	16.1	8.8	11.4	126.2	8.1	34.3	59.3	86.5	2.0	27.3	41.8	25.0	12.6	48.9	45.8	4.5	20.6	5.3	81.0	6.1	26.5	4.1	10.8	42.3	0.1	17.5	15.0	17.9	17.1	10.4	8.6	15.4	8.4	1.9	55.0	10.6	10.5	17.7	27.4	0.8	3.1	11.1	47.6	5.2	32.8	25.0	10.5	0.2	1.2	6.7	38.0	33.4	1.7	30.9	37.4	9.7	21.5	8.1	53.1	11.4	59.9	82.6	12.6	16.6	16.6	16.4	176.8	99.5	270.1	155.8	101.6	133.8	137.3	125.2	153.7	95.0	107.5	120.9	124.6	295.6	132.9	94.6	94.8	213.8	221.2	16.1	16.2	15.8	20.3	14.7	16.2	24.0	16.1	21.2	18.6	19.4	17.4	72.1	25.6	24.0	9.1	62.1	74.7	47.1	54.5	27.3	4.8	21.5	15.9	7.3	24.3	33.1	5.5	0.0	5.6	108.0	78.8	5.9	81.6	0.5	31.3	39.3	63.6	16.8	12.6	1.1	75.3	95.0	26.9	42.8	77.9	26.6	13.8	27.1	11.1	45.9	15.2	1.9	55.9	57.0	31.9	90.6	0.3	13.1	43.9	23.2	16.9	115.9	25.1	149.3	12.1	3.6	91.3	38.8	10.5	84.8	70.2	84.6	6.9	29.4	2.8	6.6	18.1	27.8	1.0	1.3	20.4	76.4	4.8	92.3	18.2	54.5	52.1
TAP2	"ABCB3, D6S217E, PSF2, RING11"	ENSG00000204267	"Transporter 2, ATP binding cassette subfamily B member"	Q03519	6	32821833-32838770	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"monocytes: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 61.4;U-251 MG: 52.0"									HPA001312	Approved		Supported	"Nuclear speckles,Endoplasmic reticulum"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum"	"Nuclear speckles"	"HPA001312: AB_1080206"	"unprognostic (2.95e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (5.22e-8)"	"unprognostic (5.32e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.71e-2)"	17.1	11.7	1.0	4.3	1.0	8.8	14.7	0.8	1.2	16.3	0.5	14.6	10.2	13.7	1.1	26.0	11.9	1.1	14.4	1.2	2.0	12.4	11.5	25.7	7.9	1.6	1.1	9.2	9.0	3.7	8.2	3.1	1.5	9.9	5.5	2.5	11.2	2.1	8.6	14.5	25.2	4.1	0.8	29.8	11.4	2.5	1.8	9.7	12.3	5.8	8.1	10.6	17.2	1.7	4.4	2.0	0.5	5.0	6.1	6.5	0.0	2.3	3.3	13.1	17.7	3.9	41.0	36.5	7.5	9.1	37.1	38.8	15.8	61.4	6.9	43.8	1.9	20.3	11.6	1.3	8.5	0.0	29.5	0.6	2.6	10.3	24.8	0.0	12.1	0.0	20.0	12.2	0.4	1.6	5.8	2.4	0.5	0.0	11.7	25.8	0.0	12.8	10.9	1.1	0.0	0.0	16.0	37.3	4.1	1.0	7.4	1.9	5.7	25.7	6.9	3.9	52.0	17.9	31.4	33.3	19.5	25.7	10.9	1.8	1.3	1.6	3.0	3.2	1.7	0.4	0.8	1.7	0.8	0.3	0.6	0.7	3.8	1.9	2.8	1.3	1.2	0.8	1.0	1.0	0.8	1.2	1.2	2.0	1.6	1.1	1.5	0.8	1.8	1.7	48.2	0.0	7.5	7.5	20.7	0.0	15.6	0.0	3.4	5.0	9.2	8.0	3.5	4.3	3.7	14.7	2.1	1.9	37.9	21.0	1.9	34.1	0.1	18.0	19.4	32.0	3.6	4.0	6.6	33.4	45.8	8.0	10.7	41.9	5.1	8.7	16.4	8.3	23.9	18.5	14.6	14.9	0.0	18.9	0.0	0.0	5.6	20.3	0.0	14.0	69.3	17.7	47.4	10.6	6.5	35.1	12.6	6.0	18.0	29.7	55.9	4.8	1.5	5.8	0.0	8.6	10.3	0.7	2.5	11.1	0.0	1.6	24.0	20.3	14.3	16.7
TAPBP	TAPA	ENSG00000231925	"TAP binding protein"	O15533	6	33299694-33314387	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 168.7;Karpas-707: 140.8;U-266/70: 140.5"	"Low region specificity"	"Detected in all"							HPA007066	Approved					NA	NA		20000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"			"HPA007066: AB_1857769"	"prognostic favorable (2.76e-4)"	"unprognostic (1.43e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.21e-2)"	"prognostic favorable (6.29e-4)"	"unprognostic (1.67e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.54e-3)"	47.3	73.1	2.4	28.5	4.8	25.0	43.1	1.9	2.8	40.1	1.2	66.7	52.3	38.2	13.3	57.3	43.8	10.5	63.7	2.9	1.8	67.4	107.5	82.1	21.2	2.7	3.2	33.3	48.2	14.9	38.8	18.7	2.0	64.3	19.6	4.1	61.9	17.2	26.7	54.0	81.9	23.1	1.9	129.0	52.1	16.2	2.0	24.4	59.1	6.5	36.7	45.0	43.4	2.4	3.3	1.2	6.3	26.1	20.3	25.6	92.9	18.5	88.1	42.5	57.1	0.1	168.7	48.1	38.1	41.3	92.2	2.9	0.3	30.3	15.8	125.5	4.1	19.1	9.9	24.8	0.2	20.4	63.0	51.7	20.6	0.8	8.2	37.8	0.4	16.0	1.5	140.8	14.7	19.6	51.9	44.1	0.5	0.0	6.3	2.8	0.4	1.3	35.5	1.2	8.6	0.6	0.6	2.4	23.7	3.7	1.4	0.9	45.5	89.4	18.6	1.3	2.0	140.5	117.4	46.2	58.6	38.8	58.8	159.7	87.9	172.1	137.3	121.6	117.0	97.1	99.7	114.3	90.0	86.0	76.2	109.9	151.3	159.6	139.0	102.9	85.9	150.5	2.4	4.8	1.9	2.8	2.9	1.8	2.7	3.2	2.0	1.9	2.0	2.4	116.8	125.0	102.1	22.5	186.6	77.0	93.3	148.2	66.6	34.7	82.0	64.1	73.9	84.4	105.8	71.7	33.3	46.9	223.7	259.6	13.7	256.4	1.9	64.0	52.4	99.1	84.6	58.0	25.9	282.9	85.9	63.9	105.5	78.4	91.9	65.9	75.0	143.7	119.7	20.2	15.0	174.6	83.4	124.3	128.0	9.2	33.2	131.9	119.2	30.9	229.3	34.7	195.7	23.6	8.7	215.5	172.4	32.0	194.9	130.4	283.2	33.1	113.3	30.4	32.9	39.3	57.6	1.2	0.6	53.6	56.3	49.1	163.7	66.4	162.3	141.0
TARS1	TARS	ENSG00000113407	"Threonyl-tRNA synthetase 1"	P26639	5	33440696-33468091	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 63.4;Cytotrophoblasts: 36.6;dendritic cells: 15.9;Extravillous trophoblasts: 42.1;Hofbauer cells: 32.1;Syncytiotrophoblasts: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037425	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		580000	"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Actin filaments"	"HPA037425: AB_10672279"	"prognostic unfavorable (6.14e-5)"	"unprognostic (5.13e-2)"	"unprognostic (9.04e-2)"	"prognostic unfavorable (5.17e-4)"	"unprognostic (9.10e-2)"	"unprognostic (1.07e-3)"	"prognostic unfavorable (9.88e-7)"	"unprognostic (1.43e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.25e-2)"	29.0	32.2	13.7	33.8	16.2	45.0	26.8	20.0	20.1	24.0	17.1	42.6	30.7	24.7	35.8	40.9	17.4	19.9	38.7	13.8	17.9	32.4	68.6	24.1	29.9	22.4	18.5	17.9	68.1	33.8	9.9	37.1	18.3	27.6	42.8	40.7	36.8	26.4	38.4	19.1	29.8	37.2	18.4	21.7	40.0	18.7	18.3	31.7	37.6	28.4	40.1	42.9	10.8	22.6	253.0	136.1	132.7	189.5	80.2	129.9	230.1	237.5	172.9	152.5	163.7	176.6	128.7	96.0	84.8	176.5	271.8	151.1	261.1	207.1	267.4	158.9	140.5	151.1	332.9	108.5	256.7	225.6	141.0	133.7	287.7	217.5	273.9	102.4	144.3	191.8	236.3	204.6	191.5	105.7	166.3	104.7	159.2	181.5	168.4	137.1	237.9	123.4	170.8	119.8	81.0	102.7	245.6	175.8	195.5	103.8	85.9	236.3	123.0	132.8	211.9	102.5	196.3	135.4	258.4	132.6	156.2	302.6	148.3	34.2	22.0	22.6	27.4	24.5	27.6	28.7	25.2	26.6	32.6	23.9	21.5	27.5	2.6	46.2	18.3	18.3	24.2	20.6	13.7	16.2	20.0	20.1	13.8	17.9	22.4	18.5	18.3	18.4	18.3	22.6	12.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.4	0.0	0.0	0.0	0.0	36.6	15.9	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	42.1	11.7	0.0	0.0	0.0	0.0	0.0	0.0	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	52.1	2.6	0.0	0.0	0.0
TARS2	"FLJ12528, TARSL1"	ENSG00000143374	"Threonyl-tRNA synthetase 2, mitochondrial"	Q9BW92	1	150487364-150507609	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028626	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA028626: AB_10601719"	"unprognostic (2.48e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.75e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.55e-2)"	9.8	16.5	11.8	10.6	11.4	10.0	10.3	11.2	12.5	9.5	10.9	10.3	8.9	8.9	13.0	13.4	11.7	7.7	20.3	11.3	11.5	14.3	25.3	8.6	14.7	12.0	11.5	11.7	8.4	17.7	9.3	8.9	12.7	8.7	11.3	14.7	9.7	9.3	31.9	11.8	9.6	10.0	10.4	12.5	12.0	11.0	11.9	12.6	11.2	31.1	15.4	9.6	9.4	12.8	33.5	27.4	18.1	27.4	19.9	18.2	34.1	15.9	17.2	30.7	30.8	22.4	30.3	48.0	34.2	12.0	21.1	33.8	44.2	36.8	23.5	29.2	38.4	22.7	25.2	22.7	19.7	31.4	33.4	16.2	30.2	23.4	31.6	19.9	20.1	26.4	40.3	32.6	21.8	40.4	27.0	26.0	22.3	46.0	40.2	27.5	23.0	59.8	20.9	15.7	25.5	29.8	24.1	52.5	38.7	25.4	42.3	48.9	11.9	17.8	18.8	14.9	27.2	31.2	39.6	36.2	26.6	36.3	17.6	30.5	15.4	30.5	21.0	27.0	21.3	28.7	20.5	21.2	25.0	25.3	19.6	20.7	2.4	33.2	29.3	16.7	31.4	18.3	11.8	11.4	11.2	12.5	11.3	11.5	12.0	11.5	12.7	10.4	11.9	12.8	6.3	3.2	12.8	6.2	13.2	3.3	5.6	10.4	5.2	15.3	6.2	4.6	22.3	11.5	11.9	7.3	20.9	24.5	8.8	8.2	11.7	11.5	1.6	9.6	12.8	7.4	4.2	11.1	9.3	9.8	14.3	8.4	13.3	11.7	22.2	11.0	6.8	22.6	13.2	15.2	9.1	12.6	6.1	7.7	5.2	2.5	8.4	8.8	3.6	2.8	12.5	7.6	9.2	6.0	9.9	11.9	3.5	7.2	9.9	4.5	8.5	8.8	9.4	16.8	6.6	10.3	8.3	18.2	12.3	7.4	4.0	14.1	10.6	15.8	12.6	4.8
TAT		ENSG00000198650	"Tyrosine aminotransferase"	P17735	16	71565660-71577092	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Aminotransferase, Transferase"	"Disease variant, Mental retardation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"liver: 1272.2"	"Cell type enriched"	"Detected in some"	43	"Hepatocytes: 4164.8"	"Cancer enriched"	"Detected in some"	10	"liver cancer: 152.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (3.66e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.01e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-2)"	0.1	0.0	0.0	0.1	0.0	0.1	58.9	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.4	1272.2	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.6	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.8	0.1	1.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.7	6.7	0.0	0.1	0.0	0.0	0.6	95.3	18.7	0.5	72.9	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.3	1.0	0.3	0.0	3.1	0.0	45.5	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.1	49.6	4164.8	0.0	0.0	0.0	0.0	0.0	72.3	0.0	0.7	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	2.7	0.2	0.3	1.0	0.0	0.0	0.1	1.3	1.3	0.0	0.0	0.0	3.9	0.0	0.1	0.0
TBC1D4	"AS160, DKFZp779C0666, KIAA0603"	ENSG00000136111	"TBC1 domain family member 4"	O60343	13	75283503-75482169	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		"GTPase activation"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.8"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 157.7;Microglial cells: 307.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 25.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 84.7;HUVEC TERT2: 61.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040145, HPA059885"	Approved		Supported	Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA040145: AB_2676860, HPA059885: AB_2684152"	"unprognostic (5.44e-3)"	"unprognostic (5.23e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.54e-3)"	"unprognostic (1.25e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.87e-1)"	"unprognostic (5.02e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (1.07e-11)"	"unprognostic (6.40e-2)"	"unprognostic (3.16e-1)"	"unprognostic (8.88e-2)"	"unprognostic (3.45e-1)"	14.8	70.6	13.2	15.7	12.5	3.4	20.1	12.5	15.1	10.0	7.1	8.7	4.6	8.5	18.4	9.4	10.7	14.1	33.8	10.5	13.8	25.2	11.7	11.9	34.2	15.9	12.0	44.8	15.0	22.1	5.3	20.7	16.7	12.3	10.4	1.6	27.6	4.3	82.8	21.4	10.3	10.2	12.0	21.0	11.0	5.3	20.0	10.7	24.3	54.9	32.6	8.4	9.2	10.5	12.9	14.9	9.2	0.6	21.3	22.8	12.0	11.0	5.8	8.7	9.6	84.7	15.5	2.7	2.4	15.7	4.2	12.0	23.4	11.0	9.0	42.6	24.3	41.5	19.8	25.9	5.4	20.0	0.5	25.0	19.7	9.7	22.4	14.9	61.6	46.0	12.0	1.3	10.0	6.2	29.4	3.6	12.9	24.7	8.8	26.4	8.7	15.2	8.5	9.3	16.9	5.2	4.8	14.6	8.0	4.8	5.0	0.7	26.2	9.8	12.1	5.2	13.0	0.7	0.1	0.3	17.4	18.5	14.7	5.0	0.4	0.0	0.7	0.1	0.0	0.6	11.2	2.5	0.6	0.5	10.4	4.9	0.5	0.5	0.1	9.9	25.0	2.3	13.2	12.5	12.5	15.1	10.5	13.8	15.9	12.0	16.7	12.0	20.0	10.5	17.8	6.4	29.1	32.3	2.6	36.2	10.0	2.0	19.9	1.6	33.1	41.1	81.4	10.0	6.1	14.7	0.0	10.8	32.4	8.0	15.6	12.3	25.5	14.3	17.7	32.6	21.0	5.0	78.0	7.4	9.7	17.3	7.1	8.7	5.1	81.5	26.0	19.4	26.6	1.7	157.7	10.7	24.4	24.8	25.8	5.2	3.7	12.9	21.4	307.3	33.6	0.4	1.0	40.7	5.1	4.9	2.9	7.2	2.1	16.4	3.4	10.8	3.9	0.6	6.6	24.8	21.6	2.4	7.7	24.2	44.2	4.9	25.2	8.1	15.5	10.6
TBCK	"HSPC302, MGC16169"	ENSG00000145348	"TBC1 domain containing kinase"	Q8TEA7	4	106041599-106316683	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 134.8;Excitatory neurons: 196.6;Inhibitory neurons: 221.1;Microglial cells: 128.4;Oligodendrocyte precursor cells: 147.2;Oligodendrocytes: 188.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 44.0;BJ hTERT+ SV40 Large T+ RasG12V: 81.7;HBF TERT88: 59.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039951, HPA051611"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA039951: AB_10795300, HPA051611: AB_2681550"	"unprognostic (1.65e-1)"	"unprognostic (2.60e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.81e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.20e-4)"	"unprognostic (8.17e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.29e-1)"	7.4	5.2	5.6	3.0	5.3	1.3	3.4	11.0	6.1	4.5	8.3	3.2	2.3	4.3	6.0	4.2	5.3	5.6	2.8	6.1	7.0	6.3	4.4	4.1	3.0	5.2	5.3	6.4	5.8	4.8	3.9	5.5	6.0	4.7	3.1	7.6	3.6	6.0	1.6	4.1	3.3	4.7	3.5	3.6	3.5	6.1	6.9	4.7	5.5	4.3	2.6	5.2	3.0	10.1	1.4	5.9	9.0	2.7	36.7	19.1	1.1	8.1	8.9	44.0	81.7	10.9	6.4	2.3	13.0	28.0	7.0	5.4	5.7	8.1	59.3	5.1	1.8	14.1	4.5	10.3	9.7	2.7	6.3	20.9	5.9	4.1	7.1	14.5	11.1	6.0	7.2	3.8	10.2	7.7	5.2	3.7	2.0	14.4	2.0	4.1	3.7	6.8	11.1	9.0	4.4	4.1	8.2	4.0	5.6	7.6	4.8	8.5	8.3	7.7	4.3	2.4	4.4	2.5	6.1	6.8	10.1	5.6	5.0	14.1	5.1	5.1	4.7	5.7	5.6	4.8	4.9	6.4	4.8	7.9	5.6	5.2	0.4	5.2	3.8	4.4	5.5	4.0	5.6	5.3	11.0	6.1	6.1	7.0	5.2	5.3	6.0	3.5	6.9	10.1	7.7	19.2	25.2	134.8	13.9	2.3	6.4	9.0	17.1	20.7	8.2	6.9	8.2	5.7	15.5	14.7	20.9	11.5	9.0	3.5	3.9	4.3	45.7	10.2	15.9	8.9	5.4	9.2	196.6	0.9	6.6	12.5	15.3	21.1	11.4	21.5	8.6	4.6	6.8	11.8	221.1	5.7	10.2	6.2	1.6	28.2	11.1	7.7	5.4	128.4	4.6	8.1	10.3	147.2	188.8	2.2	8.0	12.8	10.4	4.3	4.8	8.0	11.9	15.3	0.0	10.6	9.6	14.5	8.2	14.2	2.4	7.4	10.6	13.9	5.5	4.5
TBK1	NAK	ENSG00000183735	"TANK binding kinase 1"	Q9UHD2	12	64452090-64502114	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Disease variant, Glaucoma, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045797, HPA060211"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA045797: AB_2679457, HPA060211: AB_2684222"	"unprognostic (4.73e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (4.35e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.26e-2)"	"unprognostic (9.56e-3)"	11.6	15.3	6.0	10.1	6.1	16.9	11.4	5.6	6.9	10.6	5.3	10.5	15.1	11.0	6.7	11.3	9.5	10.1	9.4	5.8	5.6	11.8	17.4	12.9	14.6	6.5	6.9	9.6	7.5	11.6	9.8	13.7	6.1	10.6	8.5	6.3	10.2	9.0	18.4	8.6	11.4	10.8	5.3	13.4	10.2	23.5	6.7	6.8	8.5	14.9	12.9	16.0	10.2	7.1	23.3	24.2	11.1	10.6	24.7	26.1	29.0	22.9	37.6	22.5	21.1	14.9	12.4	31.5	21.4	26.8	34.4	19.0	19.4	20.0	26.4	29.5	17.1	33.0	15.3	19.1	30.2	35.2	36.4	18.5	19.1	23.1	23.6	42.3	32.4	11.0	27.9	38.7	31.6	27.0	0.9	17.0	29.9	22.9	13.8	14.9	15.3	31.8	25.1	36.9	9.8	14.7	33.3	36.0	23.5	23.5	33.1	24.9	25.9	20.2	18.1	14.9	24.0	25.4	54.3	30.3	28.1	18.6	26.1	41.8	10.1	24.3	13.9	17.7	16.3	12.8	10.1	15.2	12.2	10.1	2.8	8.7	17.8	26.6	15.5	2.1	13.6	10.0	6.0	6.1	5.6	6.9	5.8	5.6	6.5	6.9	6.1	5.3	6.7	7.1	23.7	19.2	20.5	28.4	21.6	11.0	25.7	20.1	15.4	17.0	14.9	9.1	10.9	8.6	23.4	22.0	10.4	28.8	30.0	14.1	11.7	19.3	34.5	19.2	17.9	28.6	17.3	18.3	50.5	23.6	32.6	21.3	15.3	30.2	43.1	17.5	16.8	17.1	20.2	18.5	42.2	10.5	12.2	23.0	30.2	29.2	19.3	31.1	14.2	46.9	31.4	12.7	33.0	39.2	52.3	16.9	10.9	20.7	25.6	43.7	13.6	12.3	20.8	16.3	26.3	22.4	18.7	68.9	12.7	14.0	14.9	92.6	27.1	11.5	10.1	41.6
TDO2	"TDO, TPH2"	ENSG00000151790	"Tryptophan 2,3-dioxygenase"	P48775	4	155854738-155920406	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"liver: 797.8"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1174.2"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 35.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 9.6;HDLM-2: 22.0;U-87 MG: 11.3"	"Group enriched"	"Detected in some"	7	"cerebellum: 6.3;hippocampal formation: 5.3;white matter: 1.9"	"Low region specificity"	"Detected in all"			HPA039611	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"HPA039611: "	"unprognostic (1.10e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-8)"	"unprognostic (7.99e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.95e-2)"	0.3	1.6	0.3	16.8	0.5	0.0	0.1	0.2	1.2	0.2	0.2	1.2	3.5	0.4	0.6	0.7	0.3	1.9	0.0	0.5	0.3	0.6	797.8	3.2	3.1	0.2	1.1	0.1	0.3	0.1	4.0	0.6	0.2	0.2	1.4	0.0	0.4	0.2	0.2	0.0	5.9	2.5	0.3	1.9	1.6	0.4	0.3	0.2	0.2	0.0	2.6	7.6	0.1	0.7	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	9.6	0.0	0.2	0.0	0.1	0.0	0.0	22.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	1.1	0.0	0.0	0.0	0.9	0.0	0.0	0.1	3.5	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	1.6	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	1.2	0.4	0.5	0.0	3.4	0.0	0.0	11.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.2	1.2	0.5	0.3	0.2	1.1	0.2	0.3	0.3	0.7	0.8	0.0	0.0	0.7	2.7	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.6	158.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.5	0.1	1.1	2.4	0.0	32.0	4.1	0.0	0.0	1.7	3.6	0.1	0.0	0.0	29.6	1174.2	0.9	0.0	0.4	0.0	0.0	31.7	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.6	0.0	11.3	0.4	1.1	0.0	0.0	0.3	2.3	0.3	0.0	0.1
TDRD9	"C14orf75, DKFZp434N0820, FLJ36164, NET54"	ENSG00000156414	"Tudor domain containing 9"	Q8NDG6	14	103928456-104052667	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"parathyroid gland: 30.6;testis: 40.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 43.2;Spermatocytes: 63.2;Spermatogonia: 38.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"classical monocyte: 1.6"	"Lineage enriched"	"Detected in single"	6	"monocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 24.4;HeLa: 21.5;HMC-1: 94.2;RPTEC TERT1: 25.5;SK-MEL-30: 13.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"				"unprognostic (3.71e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.13e-4)"	"unprognostic (1.60e-2)"	"unprognostic (4.57e-3)"	"unprognostic (8.97e-2)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (2.41e-2)"	0.4	0.5	0.9	0.6	0.8	1.7	0.5	1.3	0.9	0.4	1.2	0.3	0.1	0.4	0.4	0.2	0.9	0.9	0.6	0.8	0.8	2.1	0.3	1.0	0.5	1.7	1.0	0.2	0.5	30.6	1.0	0.5	2.0	0.3	0.2	3.5	0.3	0.5	0.1	0.1	0.3	0.5	1.1	3.0	0.8	40.7	1.1	0.3	5.4	0.5	0.5	0.4	0.2	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	21.5	0.0	0.0	0.0	94.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	25.5	0.0	8.7	0.0	0.0	0.6	13.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.8	1.3	0.9	0.8	0.8	1.7	1.0	2.0	1.1	1.1	1.3	0.9	6.4	2.0	2.3	0.0	0.0	0.1	0.1	0.0	4.3	1.0	0.4	12.4	0.0	0.7	0.0	4.2	0.0	0.5	0.0	1.9	0.6	13.1	43.2	1.5	0.9	0.0	1.3	9.1	0.0	0.0	0.7	0.0	3.7	0.0	0.3	0.4	0.1	1.9	6.7	4.6	0.0	2.0	1.8	0.0	7.3	0.9	1.5	0.0	2.8	2.9	0.6	0.0	1.0	4.6	0.5	0.0	2.2	0.3	0.5	0.0	2.5	0.2	2.3	6.6	0.9	0.8	63.2	38.6	0.0	0.0	0.0	0.3	11.7	0.0	0.1
TECR	"GPSN2, MRT14, SC2, TER"	ENSG00000099797	"Trans-2,3-enoyl-CoA reductase"	Q9NZ01	19	14517085-14565980	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Oxidoreductase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1013.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029780, HPA056488"	Supported		Supported	"Endoplasmic reticulum"		NA	NA		10000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"HPA029780: AB_10603348, HPA056488: AB_2683149"	"unprognostic (9.73e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.53e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (2.60e-4)"	102.7	162.6	189.0	43.1	201.7	74.2	100.4	220.8	237.5	156.8	216.5	78.5	106.1	53.2	103.2	373.2	87.1	49.7	78.4	180.1	200.0	112.2	133.9	67.8	55.7	209.6	191.2	80.9	105.5	306.1	78.7	68.0	212.2	85.7	59.3	82.8	222.3	83.5	366.3	263.5	95.9	36.7	207.6	75.4	81.7	182.7	199.9	65.8	92.7	209.6	85.3	51.6	185.9	230.2	220.5	162.1	149.5	169.6	214.7	97.2	156.9	62.8	175.2	196.3	242.9	225.3	246.2	113.8	127.4	134.2	152.4	328.8	158.1	254.3	84.0	192.3	165.9	193.7	225.4	254.6	129.7	139.5	143.7	144.9	201.8	174.3	96.1	98.4	93.7	169.2	128.9	391.5	104.0	289.3	170.1	248.3	155.6	556.1	227.6	154.4	96.1	521.1	275.1	115.8	183.2	113.0	103.1	278.4	139.6	77.2	151.3	274.4	55.2	160.5	66.8	141.0	212.6	118.4	119.8	122.7	163.8	212.6	162.2	55.6	72.7	52.5	137.8	106.4	148.8	100.1	180.1	159.1	124.2	99.1	207.1	164.5	32.7	183.7	83.9	137.1	290.1	170.9	189.0	201.7	220.8	237.5	180.1	200.0	209.6	191.2	212.2	207.6	199.9	230.2	60.4	73.7	71.1	47.7	87.6	169.5	227.5	297.9	125.7	90.8	161.1	155.6	52.9	120.1	221.5	165.5	123.0	509.5	88.1	159.2	56.7	166.2	443.9	102.2	40.1	64.7	100.0	80.1	15.3	225.1	525.5	81.8	89.7	64.2	36.1	90.1	73.2	143.1	188.0	112.7	19.2	144.0	199.4	113.8	99.3	1013.1	72.7	77.8	163.7	18.7	61.6	577.9	103.0	12.5	46.5	104.8	128.2	60.2	206.1	110.2	343.2	202.9	213.1	177.5	65.7	68.4	286.7	215.0	134.2	255.3	239.7	486.2	117.7	116.0	216.2	196.5
TERT	"EST2, hEST2, TCS1, TP2, TRT"	ENSG00000164362	"Telomerase reverse transcriptase"	O14746	5	1253147-1295068	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"DNA-binding, Nucleotidyltransferase, Ribonucleoprotein, RNA-directed DNA polymerase, Transferase"	"Cancer-related genes, Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.4;Intestinal goblet cells: 1.0;Plasma cells: 2.8;Spermatocytes: 1.5;Spermatogonia: 4.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 438.0;fHDF/TERT166: 429.4;HBEC3-KT: 929.2;hTEC/SVTERT24-B: 560.1;LHCN-M2: 252.2;TIME: 799.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA054641, HPA065897"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA					"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA054641: AB_2682554, HPA065897: AB_2685576"	"unprognostic (1.21e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-1)"	"unprognostic (9.16e-4)"	"unprognostic (8.84e-11)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-1)"		"unprognostic (3.35e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	213.2	438.0	3.2	0.0	173.9	31.7	59.4	0.3	0.1	3.0	0.2	429.4	0.1	0.1	1.0	929.2	29.1	0.0	1.7	0.1	0.0	0.4	0.1	0.5	1.2	0.0	22.9	560.1	6.8	1.3	1.5	1.8	2.9	0.2	252.2	0.4	0.2	9.4	2.9	0.1	1.3	2.1	0.0	5.4	23.9	0.5	0.2	2.1	0.1	0.0	0.2	0.0	0.1	0.3	799.9	0.0	0.0	0.0	0.0	0.9	0.5	0.7	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	4.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0
TET1	"bA119F7.1, CXXC6, KIAA1676, LCX"	ENSG00000138336	"Tet methylcytosine dioxygenase 1"	Q8NFU7	10	68560337-68694487	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 54.5;Extravillous trophoblasts: 79.9;Oligodendrocyte precursor cells: 44.7;Oligodendrocytes: 45.3;Theca cells: 43.7"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 10.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.7;HAP1: 20.4;K-562: 12.0;NTERA-2: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019032, HPA057273"			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nuclear membrane"	"HPA019032: AB_1847363, HPA057273: AB_2683391"	"unprognostic (1.60e-1)"	"unprognostic (8.30e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.88e-4)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.52e-3)"	0.4	0.2	0.6	0.2	1.2	0.3	0.4	4.9	0.7	0.7	0.8	0.4	0.1	0.9	0.6	0.2	0.5	0.3	0.3	0.3	0.9	0.3	0.2	0.2	0.3	0.9	1.3	0.8	0.2	0.7	0.3	1.2	1.1	0.6	0.3	1.5	1.0	0.3	0.9	0.3	0.2	0.5	1.0	0.3	0.4	0.2	1.1	2.0	0.5	0.3	0.3	0.2	0.4	2.2	0.7	0.8	8.0	9.0	0.8	0.7	17.7	0.4	1.0	0.7	1.2	5.5	0.3	0.0	0.3	0.8	0.1	0.0	20.4	0.0	0.8	0.3	3.3	2.1	0.0	4.9	1.2	1.9	1.0	1.0	0.1	0.5	0.1	1.6	0.1	3.5	12.0	1.4	0.7	0.6	3.3	1.4	11.9	0.0	1.1	3.2	2.5	0.2	0.4	0.8	2.2	3.5	0.4	0.5	1.6	7.9	1.0	1.5	0.3	0.7	1.6	0.0	0.6	0.5	0.6	3.2	0.2	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.4	0.3	0.1	0.2	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.2	0.5	0.0	0.6	1.2	4.9	0.7	0.3	0.9	0.9	1.3	1.1	1.0	1.1	2.2	6.3	3.2	6.2	54.5	2.5	1.1	1.8	0.4	5.2	2.5	7.0	9.5	7.2	1.5	2.6	0.0	10.4	21.0	3.0	0.2	0.0	2.7	0.8	3.6	34.2	4.8	13.8	2.5	15.6	0.4	79.9	15.4	1.5	2.9	0.0	13.6	5.7	2.5	3.9	35.3	20.6	0.3	4.1	0.0	0.3	1.7	25.7	0.8	1.8	12.2	0.4	16.1	5.2	44.7	45.3	0.6	0.0	20.7	7.3	1.4	0.0	0.9	0.8	12.5	6.6	21.9	10.7	0.5	1.5	0.8	1.1	27.9	2.6	43.7	0.6	0.4
TET2	"FLJ20032, KIAA1546"	ENSG00000168769	"Tet methylcytosine dioxygenase 2"	Q6N021	4	105145875-105279816	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 112.6;Oligodendrocytes: 128.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 55.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 55.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043135	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA043135: AB_10794177"	"unprognostic (6.83e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.70e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.15e-2)"	"unprognostic (7.84e-2)"	4.3	3.1	2.9	10.1	4.4	22.4	5.4	2.5	2.7	6.3	5.8	5.2	6.1	7.2	6.0	7.7	4.9	5.0	3.3	2.1	4.6	4.1	4.2	5.4	5.6	5.3	4.4	4.3	3.7	4.6	1.8	10.2	5.3	4.4	5.9	6.6	4.7	3.3	2.8	11.0	6.0	5.7	2.9	7.2	5.3	1.3	4.1	5.4	4.2	5.2	7.0	5.5	4.5	5.6	5.1	3.1	10.9	11.1	2.1	3.7	4.2	3.1	4.8	4.8	4.7	3.1	6.4	0.5	4.0	4.0	2.1	4.9	9.3	6.1	5.3	6.7	2.9	7.0	6.5	1.6	4.9	15.5	11.8	3.8	7.9	4.5	5.6	8.6	6.4	4.1	7.7	13.6	4.4	3.1	2.5	4.7	2.5	6.2	2.2	8.4	4.7	1.0	4.7	9.4	7.5	5.9	4.2	9.1	0.8	5.9	4.5	11.8	9.1	7.8	6.7	2.1	5.3	9.5	6.8	6.8	4.8	3.8	7.2	30.1	13.6	14.7	3.9	10.4	1.6	5.3	2.3	2.2	10.2	6.3	1.9	2.9	55.5	5.9	13.6	8.9	3.1	3.3	2.9	4.4	2.5	2.7	2.1	4.6	5.3	4.4	5.3	2.9	4.1	5.6	24.5	25.6	29.1	58.8	28.3	14.4	11.0	14.2	12.5	22.8	15.6	13.6	27.9	5.7	23.9	9.2	16.7	23.1	34.1	19.0	7.9	7.0	0.4	22.1	38.3	20.3	23.3	10.9	48.4	7.5	5.7	18.0	21.4	33.2	27.8	15.5	13.6	8.5	14.5	35.3	89.7	15.8	32.6	48.8	93.3	0.9	8.1	98.3	5.4	90.9	48.1	5.8	34.0	112.6	128.3	8.2	18.7	7.2	22.5	12.1	16.3	2.8	22.3	24.3	13.1	47.0	21.7	0.2	1.3	28.4	35.9	34.2	18.9	24.7	14.0	27.5
TET3	"hCG_40738, MGC22014"	ENSG00000187605	"Tet methylcytosine dioxygenase 3"	O43151	2	73984910-74108176	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Chromatin regulator, Developmental protein, Dioxygenase, DNA-binding, Oxidoreductase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.7;skin 1: 16.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 88.5;Oligodendrocytes: 86.7;Suprabasal keratinocytes: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050845	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Vesicles, Cytosol"	"HPA050845: AB_2681256"	"unprognostic (1.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.83e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (2.05e-1)"	"unprognostic (5.30e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.10e-1)"	2.2	1.6	3.7	5.2	2.4	19.7	3.0	6.3	13.7	2.5	0.0	4.1	5.4	2.0	1.4	7.6	1.9	2.5	1.2	9.3	1.7	1.6	3.9	4.1	3.7	2.0	1.5	1.5	2.6	2.0	1.5	4.6	2.2	2.5	4.3	3.6	4.2	1.1	1.2	16.2	6.0	2.1	0.6	3.8	4.3	1.6	2.7	5.8	2.3	1.3	4.1	3.4	4.0	5.8	9.0	8.0	14.5	8.9	1.2	1.3	26.4	1.8	2.4	3.4	2.7	16.6	8.1	14.9	3.5	2.4	1.6	9.4	13.0	5.2	3.6	6.7	5.2	19.2	7.0	5.6	5.1	20.2	11.3	2.0	13.3	4.2	9.9	4.3	5.3	10.3	13.4	4.8	2.0	14.6	10.0	13.0	8.1	7.7	2.7	15.4	9.1	5.2	3.8	16.5	18.1	15.5	4.0	10.3	4.9	5.7	6.6	16.1	6.7	3.7	15.4	1.8	6.8	4.2	2.0	12.7	2.4	13.9	4.9	0.1	0.4	0.2	0.0	0.4	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.1	0.1	0.2	0.1	0.2	3.7	2.4	6.3	13.7	9.3	1.7	2.0	1.5	2.2	0.6	2.7	5.8	4.2	6.4	9.0	31.3	6.4	49.5	3.5	4.2	14.8	16.3	8.0	5.8	2.9	2.8	8.0	1.8	20.9	7.0	7.3	10.5	0.0	3.5	4.7	18.8	11.9	6.6	6.0	24.8	88.5	4.4	30.1	3.4	13.7	29.6	2.5	6.2	3.6	6.1	10.1	10.1	45.7	8.0	8.2	26.9	23.2	0.8	0.6	26.9	10.6	54.4	27.1	1.5	2.1	41.7	86.7	6.2	7.7	3.0	4.8	6.2	10.3	1.5	11.9	8.6	0.0	3.8	7.7	0.5	2.6	24.4	68.2	2.5	5.5	2.3	6.9	7.0
TEX14	CT113	ENSG00000121101	"Testis expressed 14, intercellular bridge forming factor"	Q8IWB6	17	58556678-58692055	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 27.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 23.3;Spermatocytes: 56.4;Spermatogonia: 16.2"	"Cancer enhanced"	"Detected in some"		"breast cancer: 0.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.3;Karpas-707: 7.9;MCF7: 3.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA030620, HPA077020"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	"Vesicles, Plasma membrane"	"HPA030620: AB_10601598, HPA077020: AB_2732327"	"unprognostic (1.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.67e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.76e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.00e-3)"	"unprognostic (5.88e-2)"	0.1	0.1	0.5	0.1	0.6	1.7	0.2	1.1	0.6	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.5	0.4	0.2	0.2	0.1	0.5	0.5	0.3	0.1	0.0	0.2	0.1	0.5	0.2	0.0	1.1	0.1	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.1	27.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.1	1.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.2	0.0	0.1	6.3	0.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	7.9	0.0	3.3	0.3	0.0	0.4	0.1	0.1	0.3	0.2	1.2	0.0	0.1	0.9	0.1	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.3	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	1.1	0.6	0.4	0.5	0.5	0.5	0.5	0.5	0.5	0.8	4.4	0.0	0.0	2.9	5.7	0.9	1.8	0.7	2.8	0.6	4.7	7.2	1.3	5.7	1.5	1.8	0.0	1.6	0.7	0.1	0.0	0.0	23.3	0.4	0.2	1.5	0.0	0.0	2.2	0.0	1.0	0.7	0.5	1.8	1.3	0.2	1.4	0.8	3.7	0.0	2.2	0.5	2.0	0.6	2.3	6.4	0.3	4.6	3.6	2.8	0.0	0.6	1.0	1.0	3.0	0.1	0.0	0.4	4.3	0.7	0.0	0.1	0.2	1.3	0.0	1.2	1.5	56.4	16.2	1.7	0.1	1.1	0.7	0.0	0.0	0.4
TGDS	"SDR2E1, TDPGD"	ENSG00000088451	"TDP-glucose 4,6-dehydratase"	O95455	13	94574054-94596242	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 75.2;U-698: 97.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039927, HPA040857"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	No			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA039927: AB_10795238, HPA040857: AB_10794867"	"unprognostic (4.07e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (5.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.09e-1)"	10.4	9.4	5.3	8.2	5.5	6.0	12.4	5.6	8.2	10.4	6.3	8.0	10.2	8.0	11.8	6.9	9.2	6.8	5.4	4.9	5.6	10.9	30.0	7.1	12.9	5.6	5.4	12.1	10.0	8.1	8.4	10.1	5.9	7.9	9.5	6.9	7.7	7.6	4.1	7.5	9.2	6.7	5.6	9.2	9.1	6.0	5.3	14.1	13.3	4.3	11.0	9.1	6.4	6.6	16.7	7.2	11.6	10.6	17.2	13.5	14.1	15.3	14.9	14.2	13.4	18.9	15.9	26.0	14.8	10.9	8.8	10.4	20.1	11.9	14.9	20.3	7.7	20.7	8.1	18.1	21.0	75.2	13.8	14.9	9.5	8.0	22.8	11.1	13.2	18.9	21.3	8.9	13.3	10.8	20.6	38.4	15.2	26.8	8.3	17.1	11.4	15.9	18.3	7.4	15.9	8.9	11.6	24.2	43.5	19.1	10.2	39.8	12.2	5.6	14.5	8.6	12.6	20.0	11.4	97.5	14.9	26.5	15.5	14.7	5.5	10.8	9.6	6.6	14.9	9.5	11.6	10.7	8.7	7.1	16.8	12.5	1.6	12.1	8.3	7.6	13.8	6.9	5.3	5.5	5.6	8.2	4.9	5.6	5.6	5.4	5.9	5.6	5.3	6.6	7.4	12.8	6.8	8.1	12.8	2.4	9.2	15.9	6.8	4.3	7.8	7.9	5.2	8.6	11.9	7.3	2.1	15.7	12.5	5.8	9.8	11.9	1.2	10.4	8.9	7.0	5.4	3.4	7.7	9.1	17.7	12.9	6.1	6.0	11.4	7.7	7.9	21.4	11.2	1.7	6.7	7.7	8.2	8.8	7.2	1.0	14.3	7.5	8.8	8.4	11.1	7.0	7.2	12.1	10.4	8.9	6.6	8.2	10.7	10.9	10.0	17.6	15.9	4.7	26.3	6.7	8.1	11.9	12.3	8.5	3.7	10.4	11.0	9.2	9.1	9.7
TGFBR1	"ACVRLK4, ALK-5, ALK5, ESS1, MSSE, TBR-i, TBRI"	ENSG00000106799	"Transforming growth factor beta receptor 1"	P36897	9	99104038-99154192	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 128.4;Late spermatids: 101.7;Microglial cells: 116.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 253.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002441, CAB031481, HPA056473"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane"		"CAB002441: AB_564029, CAB031481: AB_2202455, HPA056473: AB_2683144"	"unprognostic (2.58e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.80e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.14e-2)"	15.9	9.9	9.8	18.2	9.3	33.7	15.4	13.2	8.9	19.4	11.8	18.8	11.7	20.6	8.8	15.0	8.5	21.7	8.2	6.8	11.3	22.6	14.8	16.3	13.8	18.4	14.5	13.0	8.3	8.5	7.6	48.8	20.0	17.1	13.4	4.7	8.3	16.8	8.7	6.2	9.3	33.0	18.0	16.5	18.4	18.3	17.5	11.2	11.2	13.2	13.6	22.5	8.4	27.9	13.7	19.5	115.5	36.1	26.2	19.3	17.4	44.1	47.8	40.7	44.9	19.9	9.3	29.7	13.4	34.6	32.1	30.4	39.6	34.1	54.0	77.1	12.3	43.9	20.7	17.8	43.2	27.2	102.8	40.2	35.4	62.8	29.5	25.2	7.4	10.9	62.4	12.1	55.4	20.3	4.0	31.0	24.7	12.2	11.5	11.0	253.1	12.5	9.9	3.8	31.1	36.2	34.3	150.2	46.4	47.3	28.1	36.6	13.6	29.8	25.5	129.3	27.3	12.1	13.4	20.0	62.5	45.9	26.2	16.2	2.4	9.5	7.8	1.6	6.7	1.6	3.3	5.8	2.0	1.2	3.2	6.2	4.9	4.3	2.0	1.4	2.4	2.2	9.8	9.3	13.2	8.9	6.8	11.3	18.4	14.5	20.0	18.0	17.5	27.9	13.5	6.4	8.8	18.9	18.9	23.6	7.4	19.9	44.3	8.0	18.9	11.7	7.6	4.3	12.8	60.7	0.0	23.0	37.3	5.0	0.0	18.8	128.4	6.4	22.7	17.6	9.6	7.4	14.2	31.2	6.7	36.0	9.2	9.3	29.9	19.5	6.4	12.7	49.4	0.0	8.6	7.3	8.2	32.4	52.5	101.7	9.6	39.7	35.6	116.2	24.3	3.1	35.0	45.8	21.1	33.8	4.2	13.5	11.9	18.4	3.6	13.8	5.0	2.0	32.9	21.8	20.9	11.0	12.7	25.6	16.2	19.4	25.4	7.6	8.3	11.5
TGM1	"ICR2, LI, LI1, TGASE, TGK"	ENSG00000092295	"Transglutaminase 1"	P22735	14	24249114-24264432	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Keratinization	"Acyltransferase, Transferase"	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"esophagus: 713.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Basal respiratory cells: 63.6;Club cells: 18.8;Distal tubular cells: 29.4;Squamous epithelial cells: 34.7"	"Group enriched"	"Detected in many"	4	"cervical cancer: 30.8;head and neck cancer: 78.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.5;HaCaT: 24.2;HeLa: 16.2;MCF7: 17.5;SK-BR-3: 21.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015159, HPA040171, HPA070372"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		530000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Vesicles, Plasma membrane"		"CAB015159: AB_2202870, HPA040171: AB_2676869, HPA070372: "	"unprognostic (2.95e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.94e-7)"	"unprognostic (7.11e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.86e-2)"	25.7	1.3	0.6	0.9	0.8	0.7	2.2	3.7	2.0	78.7	0.8	1.4	0.8	1.0	1.6	713.5	4.4	0.6	5.1	0.5	0.6	2.5	1.7	5.3	1.5	1.5	0.9	3.0	3.2	0.2	3.3	1.2	1.4	4.1	0.9	1.7	89.7	4.4	1.1	73.2	1.9	0.5	0.4	2.6	1.8	2.9	0.9	1.3	2.7	0.3	40.4	1.3	144.2	0.9	1.1	2.0	1.1	1.0	0.0	0.8	17.5	0.4	0.2	1.0	1.6	1.2	1.7	1.0	2.3	1.3	0.3	24.2	2.8	2.0	0.6	2.0	3.3	1.4	16.2	5.7	0.8	0.9	1.5	1.5	9.3	0.5	2.0	0.5	0.7	3.4	1.0	1.0	0.7	17.5	0.7	1.9	0.3	1.1	2.2	1.1	0.1	1.1	0.6	2.1	1.2	1.6	0.2	21.7	0.1	1.4	1.5	1.1	0.8	1.1	4.8	2.0	0.9	1.5	1.8	0.3	0.4	2.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	3.7	2.0	0.5	0.6	1.5	0.9	1.4	0.4	0.9	0.9	0.2	12.8	1.1	2.0	0.0	0.3	4.6	63.6	4.0	0.9	1.1	0.8	0.8	5.7	18.8	0.0	0.0	1.4	0.3	0.2	29.4	2.0	0.1	0.3	0.2	0.2	0.0	0.0	1.5	0.9	0.8	3.9	0.0	0.6	4.5	0.7	0.0	0.2	0.4	0.0	1.7	0.1	6.1	0.6	0.3	0.0	0.6	0.4	0.0	1.0	0.4	0.2	0.0	1.0	1.0	2.6	0.0	0.4	0.1	7.4	0.1	0.2	2.1	0.6	0.0	0.1	1.0	0.0	0.6	34.7	1.8	1.2	0.6	1.2	0.3	6.2
TGM2	TGC	ENSG00000198959	"Transglutaminase 2"	P21980	20	38127385-38166578	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Acyltransferase, Hydrolase, Protease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 432.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 204.5;Cytotrophoblasts: 311.1;Ductal cells: 226.7;Endometrial stromal cells: 459.1;Hepatic stellate cells: 408.0;Hepatocytes: 205.7;Pancreatic endocrine cells: 326.5;Syncytiotrophoblasts: 374.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 1546.7;EFO-21: 505.5;hTERT-RPE1: 994.3;HUVEC TERT2: 695.3;TIME: 924.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002598, HPA021019, HPA029518"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	Yes	No		1700000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol	"Plasma membrane"	"CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133"	"unprognostic (7.80e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.29e-2)"	"unprognostic (9.78e-3)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (6.99e-2)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.70e-2)"	"unprognostic (6.40e-2)"	105.9	45.1	23.0	68.4	22.3	3.2	30.3	22.9	29.5	432.0	53.0	30.6	29.8	266.3	28.3	37.3	217.7	127.7	394.9	21.4	23.0	76.7	244.1	288.5	18.0	25.4	22.5	40.6	25.6	19.3	95.9	234.3	26.0	88.7	20.8	2.1	9.8	56.6	63.9	4.0	63.7	159.0	24.4	32.7	62.3	3.9	30.6	15.4	36.3	33.4	10.3	154.2	87.8	24.8	65.0	47.5	0.2	1.8	47.3	5.1	24.0	95.5	45.2	0.7	1.8	78.4	1546.7	0.1	505.5	1.0	105.4	1.7	0.1	221.7	3.4	0.7	0.2	10.3	2.6	35.0	191.9	0.0	0.5	5.2	0.4	40.2	0.3	994.3	695.3	0.0	21.4	0.1	16.0	0.3	0.0	0.6	0.8	0.9	4.6	0.0	0.1	0.3	69.0	0.0	0.0	1.3	224.4	0.2	7.6	31.6	2.2	0.6	924.2	1.6	57.6	7.8	46.3	0.0	0.6	0.8	60.7	0.1	18.4	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	22.3	22.9	29.5	21.4	23.0	25.4	22.5	26.0	24.4	30.6	24.8	58.0	9.6	18.3	0.0	7.4	0.5	10.4	41.0	0.6	0.0	8.5	8.8	204.5	31.5	55.3	14.7	2.1	311.1	0.1	11.7	3.9	226.7	3.2	16.7	459.1	183.8	0.0	74.5	0.1	145.7	38.6	37.7	0.5	13.1	2.5	2.8	408.0	205.7	54.4	0.0	0.1	1.8	6.1	23.7	2.1	5.0	1.2	35.5	0.0	28.1	6.5	0.4	0.0	0.0	0.3	326.5	1.1	6.0	0.0	68.6	63.0	27.6	23.6	0.5	0.0	5.2	49.1	0.4	4.0	0.9	0.0	374.2	3.9	2.1	3.3	26.4
TGM3	TGE	ENSG00000125780	"Transglutaminase 3"	Q08188	20	2296001-2341079	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Keratinization	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"esophagus: 1838.1"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 46.2;Squamous epithelial cells: 22.5"	"Cancer enriched"	"Detected in many"	9	"head and neck cancer: 81.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	295	"neutrophil: 30.3"	"Lineage enriched"	"Detected in single"	303	"granulocytes: 30.3"	"Cell line enriched"	"Detected in single"	14	"EFO-21: 5.2"									HPA004728	Approved					NA	NA		14000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA004728: AB_1080360"	"unprognostic (7.14e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.23e-3)"	"unprognostic (4.27e-2)"	"unprognostic (4.20e-2)"	"unprognostic (8.62e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.78e-8)"	"unprognostic (1.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.67e-2)"	0.6	0.3	0.2	0.2	0.0	1.4	3.9	0.0	0.1	54.3	0.0	0.3	0.0	0.2	0.8	1838.1	1.4	2.2	0.4	0.2	0.0	0.2	0.8	0.5	0.0	0.1	0.3	0.3	1.1	0.0	1.6	0.1	0.1	0.6	0.8	0.0	229.3	0.0	0.4	83.1	0.4	0.0	0.1	0.4	2.2	2.0	0.0	0.1	0.1	0.0	142.9	0.3	31.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	1.9	4.0	0.1	0.1	46.2	0.0	0.4	0.0	0.0	0.3	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.2	3.7	0.0	0.0	0.3	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.2	0.0	0.0	0.0	0.1	1.2	0.5	22.5	8.2	0.0	0.0	0.1	0.3	0.2
TGM5	"TGMX, TGX"	ENSG00000104055	"Transglutaminase 5"	O43548	15	43232590-43266928	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 12.0;skin 1: 39.3"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 2.6;Club cells: 4.3;Early spermatids: 3.2;Late spermatids: 4.0;Suprabasal keratinocytes: 6.7;Urothelial cells: 12.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HEL: 16.6"	"Region enriched"	"Detected in single"	12	"cerebellum: 2.6"	"Low region specificity"	"Detected in many"									NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 36: HEL - Hemostasis"	"Cluster 22: Epithelial cell types - Mixed function"				"unprognostic (3.17e-2)"	"unprognostic (1.03e-2)"		"unprognostic (5.92e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.24e-2)"		"unprognostic (1.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.44e-15)"	"unprognostic (1.94e-1)"	"unprognostic (3.14e-1)"	"unprognostic (7.22e-3)"	"unprognostic (5.71e-2)"	0.8	0.0	0.0	0.0	0.0	0.2	1.7	0.2	0.0	3.9	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.2	1.0	0.0	0.0	4.3	1.2	0.3	39.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.3	0.5	7.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.3	0.0	0.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.2	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	2.6	1.5	0.0	0.0	1.0	0.5	0.2	0.0	4.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.2	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	4.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.2	0.8	6.7	1.9	0.0	0.0	0.0	12.1
TGM6	"dJ734P14.3, SCA35, TGM3L, TGY"	ENSG00000166948	"Transglutaminase 6"	O95932	20	2380901-2432753	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"cerebellum: 1.0"	HPA059196	Uncertain					NA	NA									"HPA059196: AB_2683943"						"unprognostic (1.18e-1)"						"unprognostic (2.84e-2)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
THG1L	"FLJ11601, FLJ20546, hTHG1, ICF45, IHG-1"	ENSG00000113272	"TRNA-histidine guanylyltransferase 1 like"	Q9NWX6	5	157731420-157741449	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Nucleotidyltransferase, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035877, HPA035878"	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"			"HPA035877: AB_10669979, HPA035878: AB_10672993"	"unprognostic (4.30e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.37e-2)"	"unprognostic (5.74e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.05e-1)"	"prognostic unfavorable (3.93e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.69e-1)"	3.8	4.9	2.3	4.0	2.5	5.9	5.3	2.7	2.7	5.2	2.2	6.9	5.5	6.8	5.9	5.0	6.4	4.7	3.4	2.2	2.7	3.5	5.1	3.0	5.4	2.6	2.4	7.6	4.7	3.1	3.2	4.3	2.6	4.0	7.7	3.4	3.1	5.3	3.9	5.4	4.9	5.7	2.1	4.1	5.4	4.9	2.6	5.3	6.7	2.8	6.0	6.4	4.6	3.0	8.8	15.4	7.2	13.8	6.7	19.6	5.5	6.8	12.6	13.7	18.1	21.4	8.7	21.8	5.7	6.0	8.3	9.1	9.0	13.1	15.2	8.9	12.0	7.7	10.2	9.1	7.6	16.6	8.0	17.8	15.4	12.1	16.6	13.0	5.1	3.4	13.8	6.9	8.2	12.1	2.0	11.3	6.9	3.9	14.8	3.3	13.8	12.6	8.5	11.0	9.1	12.8	5.5	8.2	11.3	5.2	13.9	9.5	5.8	10.9	7.2	9.2	18.5	6.0	7.1	14.0	4.8	15.9	6.9	3.9	7.8	0.1	3.3	8.7	3.9	5.7	4.3	3.4	7.0	4.6	6.3	5.3	0.7	6.7	8.7	4.5	5.0	3.9	2.3	2.5	2.7	2.7	2.2	2.7	2.6	2.4	2.6	2.1	2.6	3.0	6.0	3.2	8.6	1.3	14.7	20.6	27.7	27.1	27.9	2.6	14.2	15.4	6.2	11.5	11.5	3.7	4.2	17.6	10.2	6.9	9.8	17.1	19.2	8.8	20.8	9.0	7.2	23.5	1.8	26.4	12.8	15.4	12.2	7.2	2.5	17.3	6.8	8.6	19.1	0.0	1.4	14.3	8.2	15.7	17.9	8.6	14.3	16.2	5.4	1.9	21.2	2.0	7.2	0.5	1.9	12.1	19.6	15.4	13.7	21.2	9.7	14.7	5.8	4.6	6.6	17.1	12.4	19.8	8.9	24.0	15.3	13.8	11.2	38.0	24.1	28.4
TKFC	"DAK, DKFZP586B1621, NET45"	ENSG00000149476	"Triokinase and FMN cyclase"	Q3LXA3	11	61333220-61353295	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Lyase, Multifunctional enzyme, Transferase"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 192.8;liver: 115.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 115.9;Proximal enterocytes: 415.8;Proximal tubular cells: 91.2;Theca cells: 93.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 133.2;RPMI-8226: 140.7;T-47d: 135.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039486, HPA048186"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		6800000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Cytosol	Nucleoplasm	"HPA039486: AB_10795402, HPA048186: AB_2680305"	"unprognostic (4.00e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.42e-2)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (8.38e-5)"	"unprognostic (2.07e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.02e-1)"	9.5	82.8	5.9	9.4	6.0	16.6	12.1	5.8	6.6	9.5	5.7	12.5	192.8	11.0	7.6	16.3	15.4	9.2	7.6	6.4	5.1	45.5	115.8	9.0	13.6	6.8	6.3	10.3	24.0	6.7	14.0	6.1	6.2	12.2	5.7	5.6	16.2	8.9	10.9	17.8	138.0	5.2	6.5	13.0	16.6	28.2	6.0	7.5	14.7	5.6	8.0	10.9	11.0	7.2	19.9	51.3	8.5	30.0	10.7	11.4	24.2	11.7	12.4	10.4	6.9	23.1	47.1	25.0	39.3	8.5	11.0	27.7	16.3	21.8	3.5	42.5	21.7	15.7	26.2	133.2	17.9	13.4	25.0	18.2	14.5	9.9	35.4	9.4	10.7	17.1	27.2	46.7	7.9	91.8	11.9	11.9	23.8	19.2	33.8	20.0	13.8	140.7	17.1	35.0	33.0	29.6	21.0	36.4	19.3	6.0	135.4	9.2	13.0	21.0	21.6	16.6	7.0	85.8	76.5	22.9	21.3	12.3	19.7	2.6	13.4	6.5	7.1	7.8	9.6	10.3	8.3	7.1	21.2	9.7	5.8	6.2	1.2	6.5	6.5	10.1	12.9	9.7	5.9	6.0	5.8	6.6	6.4	5.1	6.8	6.3	6.2	6.5	6.0	7.2	8.0	0.0	14.5	0.0	9.5	0.0	13.8	0.0	11.4	12.8	19.1	16.0	3.8	11.5	6.8	14.7	14.6	31.2	8.3	4.8	29.4	19.6	16.2	16.4	6.6	8.0	13.3	7.8	0.0	14.6	6.2	11.2	20.4	12.1	7.6	10.8	7.5	115.9	17.1	8.4	0.0	31.6	0.0	17.2	0.0	12.0	15.2	8.2	0.0	0.0	21.2	10.0	9.2	0.0	0.0	11.2	32.9	22.6	11.0	11.1	415.8	91.2	10.9	17.8	6.6	4.7	3.6	37.5	14.1	12.6	0.0	15.2	6.5	93.6	47.6	13.4
TKT		ENSG00000163931	Transketolase	P29401	3	53224712-53256052	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 667.0"	"Cell type enhanced"	"Detected in all"		"Kupffer cells: 696.7;monocytes: 624.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 447.9;eosinophil: 274.4;intermediate monocyte: 199.0;myeloid DC: 203.8;neutrophil: 375.3;non-classical monocyte: 242.6"	"Group enriched"	"Detected in all"	9	"dendritic cells: 203.8;granulocytes: 375.3;monocytes: 447.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029480, HPA029481"	Enhanced		Enhanced	Nucleoplasm		NA	NA		150000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA029480: AB_10599307, HPA029481: AB_10601895"	"unprognostic (5.05e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (7.21e-6)"	"unprognostic (6.78e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.90e-3)"	152.2	93.2	78.0	66.2	80.0	667.0	71.9	93.2	82.3	59.7	60.5	73.2	84.2	44.7	19.2	168.5	53.7	97.2	27.4	72.3	96.9	68.2	58.1	93.4	69.2	89.2	89.9	87.7	154.0	41.4	45.6	61.2	93.8	48.8	48.8	21.7	54.9	50.9	12.8	47.0	58.1	51.6	77.4	99.8	66.1	20.2	87.9	82.9	116.1	15.2	67.4	130.9	85.5	97.2	313.0	1542.9	216.0	241.5	470.8	570.8	439.5	206.2	353.8	348.8	330.8	430.1	779.3	388.5	96.8	302.9	673.3	438.3	377.9	775.8	102.4	131.0	210.3	259.6	1022.2	655.2	573.9	321.4	168.1	416.0	437.5	418.5	213.7	949.2	444.9	323.8	188.3	164.7	144.5	381.6	338.6	358.1	737.1	603.0	367.9	201.1	98.5	726.2	550.3	520.2	139.6	103.7	383.4	605.3	365.1	656.7	188.8	437.4	335.9	107.2	164.2	320.0	401.9	94.5	190.3	235.7	234.4	321.0	203.8	51.5	447.9	274.4	17.8	199.0	22.8	39.7	25.8	20.6	203.8	21.1	26.6	20.7	375.3	30.8	242.6	34.4	36.7	312.4	78.0	80.0	93.2	82.3	72.3	96.9	89.2	89.9	93.8	77.4	87.9	97.2	79.5	134.6	125.6	46.7	92.1	79.4	384.6	325.3	287.4	41.0	99.3	80.5	14.9	75.8	149.5	62.5	29.2	349.0	69.7	139.1	80.3	197.7	6.5	87.4	79.6	81.8	52.6	150.3	16.9	269.8	249.8	80.2	168.7	95.5	62.7	123.6	75.0	83.4	256.0	37.0	23.9	149.6	142.4	696.7	110.5	8.9	157.2	333.3	76.5	17.8	624.4	88.8	46.4	17.1	39.3	193.6	81.4	106.8	109.4	337.7	141.5	219.1	99.2	46.3	52.6	35.9	102.1	16.8	30.6	409.3	67.1	413.6	78.8	427.2	276.7	413.6
TLK2	"MGC44450, PKU-ALPHA"	ENSG00000146872	"Tousled like kinase 2"	Q86UE8	17	62458658-62615481	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (2.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.53e-3)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (4.53e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.82e-2)"	"unprognostic (4.78e-2)"	"unprognostic (5.32e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.88e-1)"	"unprognostic (7.30e-2)"	19.9	16.9	7.5	21.1	14.9	36.1	11.8	19.8	12.0	12.4	9.5	21.7	20.5	22.9	8.7	23.6	13.2	20.9	22.6	9.8	17.5	15.2	12.5	16.2	25.5	18.1	14.2	21.6	18.0	16.0	9.8	17.4	14.4	16.0	14.8	43.4	16.5	11.4	32.4	23.7	20.5	16.1	10.0	21.4	18.6	52.1	12.8	23.2	30.0	21.8	17.2	19.1	10.9	25.5	40.9	36.9	62.2	66.4	20.3	26.0	36.6	44.1	34.4	51.7	46.6	39.0	35.7	79.0	22.0	29.2	45.1	27.2	45.1	19.0	48.9	42.3	36.1	54.2	33.6	39.2	36.2	57.9	33.1	22.7	25.4	34.7	41.7	31.2	25.9	44.9	54.4	36.0	28.3	89.2	82.7	22.0	39.8	24.4	30.9	55.9	81.8	25.7	24.9	40.7	66.9	90.6	37.6	25.5	57.1	52.0	43.2	51.8	34.9	71.2	66.9	32.5	50.6	40.1	54.5	72.3	29.4	29.1	38.2	2.5	1.4	4.9	1.2	1.2	1.3	2.2	2.1	1.5	1.3	2.2	1.7	2.3	2.8	3.9	1.3	1.9	2.8	0.9	7.5	14.9	19.8	12.0	9.8	17.5	18.1	14.2	14.4	10.0	12.8	25.5	27.5	32.1	26.7	33.6	22.1	22.7	14.4	9.6	9.1	62.2	17.3	14.0	27.3	11.5	11.6	14.7	83.4	11.5	29.5	19.9	11.7	10.3	107.7	28.7	34.4	22.3	18.0	23.6	37.7	10.0	12.0	19.0	10.7	36.4	20.8	27.7	13.6	10.3	12.5	28.6	37.2	16.0	14.2	18.2	19.7	173.0	21.1	22.0	17.8	37.5	15.1	22.4	15.5	45.8	67.1	15.7	21.8	17.7	24.5	21.2	14.8	7.3	27.2	84.5	6.6	30.0	21.9	81.7	38.0	18.7	21.9	15.2	21.4	30.8	15.8	21.3
TM4SF20	"FLJ22800, TCCE518"	ENSG00000168955	"Transmembrane 4 L six family member 20"	Q53R12	2	227362038-227381995	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"intestine: 266.6"	"Cell type enriched"	"Detected in some"	4	"Proximal enterocytes: 703.0"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8"	"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.6;RPMI-8226: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051838, HPA063184, HPA065531"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Focal adhesion sites"		"HPA051838: AB_2681631, HPA063184: AB_2684958, HPA065531: AB_2685506"	"unprognostic (4.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.75e-2)"		"unprognostic (4.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.04e-3)"		0.1	0.1	0.2	0.3	0.2	0.2	0.0	1.2	0.4	0.0	0.4	3.1	266.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	3.9	0.3	0.0	0.0	0.0	0.3	144.5	1.6	0.0	0.1	0.5	3.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.1	0.2	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.7	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.2	1.2	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	48.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	21.4	0.0	0.0	0.0	77.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.0	0.5	0.0	157.9	0.7	0.0	0.0	703.0	0.0	0.0	0.3	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	18.8	0.0
TMC1	"DFNA36, DFNB11, DFNB7"	ENSG00000165091	"Transmembrane channel like 1"	Q8TDI8	9	72521608-72838297	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Hearing, Ion transport, Transport"	"Ion channel"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"cervix: 1.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 19.2;Early spermatids: 7.9;Endometrial stromal cells: 5.5;Microglial cells: 5.6;Urothelial cells: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;HAP1: 5.2;NTERA-2: 1.9;SuSa: 1.0;U-266/70: 1.3;U-266/84: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (6.36e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.19e-3)"	"unprognostic (3.97e-1)"	"unprognostic (5.67e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.31e-1)"	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.5	0.5	1.0	0.1	0.0	0.0	0.1	0.8	0.1	0.1	0.0	0.0	0.4	0.6	0.7	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.4	0.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.5	0.5	0.4	0.6	0.6	0.6	0.6	0.5	0.4	0.7	1.3	0.0	0.0	19.2	0.0	0.3	2.9	0.1	0.6	0.2	0.1	0.1	0.4	0.0	0.0	1.8	0.0	4.0	0.1	0.4	0.0	0.2	7.9	1.4	5.5	1.2	0.0	0.0	1.5	0.6	2.8	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	1.2	0.0	0.0	0.0	0.0	2.6	0.3	0.1	0.0	5.6	0.6	1.1	0.0	1.5	1.3	0.5	2.2	0.0	0.0	3.1	0.0	3.0	0.0	0.0	0.0	0.3	0.2	1.8	3.1	0.5	0.0	2.6	0.1	0.5	0.0	6.8
TMC6	"EVER1, EVIN1, LAK-4P, TNRC6C-AS1"	ENSG00000141524	"Transmembrane channel like 6"	Q7Z403	17	78107397-78132407	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 110.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 108.7;SK-BR-3: 121.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051430	Uncertain					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA051430: AB_2681483"	"unprognostic (6.34e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (5.36e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.10e-2)"	"prognostic favorable (3.20e-4)"	29.5	6.8	19.2	45.4	50.5	72.7	25.2	43.4	33.5	11.3	5.2	23.5	21.7	7.6	1.0	25.4	14.1	9.7	35.9	19.3	26.4	20.6	9.1	40.3	69.7	59.3	49.7	3.8	14.6	3.1	5.6	8.8	55.9	20.2	6.6	0.6	29.3	7.9	3.5	17.9	50.6	3.5	35.8	110.5	14.6	2.6	48.4	26.3	12.9	1.8	32.4	14.6	18.4	81.9	17.9	14.0	7.5	6.0	0.0	0.0	15.2	0.0	0.0	0.2	0.2	25.2	19.2	19.7	23.7	0.0	6.3	31.0	1.0	5.9	0.0	2.0	11.3	41.3	4.2	31.0	1.9	38.3	67.0	1.1	16.2	0.0	1.3	0.2	14.7	9.2	108.7	73.3	0.0	36.1	18.9	65.4	5.9	32.9	4.9	8.4	0.6	58.9	11.4	65.1	1.9	4.9	5.7	121.0	33.2	9.7	68.7	57.6	5.2	0.0	8.7	0.1	0.3	57.6	27.3	13.2	0.0	60.4	1.0	17.7	11.6	23.2	56.2	38.3	49.0	28.5	41.7	46.2	18.6	21.7	36.5	39.6	15.3	35.8	63.5	5.7	38.0	33.5	19.2	50.5	43.4	33.5	19.3	26.4	59.3	49.7	55.9	35.8	48.4	81.9	43.8	41.7	29.6	8.1	69.5	11.1	21.0	22.3	7.4	3.2	17.4	6.5	14.7	10.0	41.5	16.5	0.0	1.2	79.8	25.0	0.0	41.2	0.3	5.1	1.6	19.7	9.1	28.4	0.2	23.1	26.4	4.6	10.2	8.0	40.5	0.7	23.6	2.2	67.0	1.7	0.2	14.0	40.7	66.2	29.9	1.2	9.6	44.7	14.2	20.6	62.0	7.5	85.5	1.5	50.8	40.5	53.7	1.2	62.6	31.5	20.3	2.0	20.3	1.8	13.1	4.6	13.5	0.5	2.2	8.4	10.2	3.7	83.7	2.5	30.3	37.4
TMC8	"EVER2, EVIN2"	ENSG00000167895	"Transmembrane channel like 8"	Q8IU68	17	78130770-78142968	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 91.8;intestine: 54.6;lymphoid tissue: 117.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 44.9;dendritic cells: 52.3;granulocytes: 41.2;Langerhans cells: 44.6;NK-cells: 85.5;T-cells: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 46.3;HL-60: 63.0;HMC-1: 119.9;Karpas-707: 103.9;RPMI-8226: 66.6;U-266/70: 49.3;U-937: 51.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047387, HPA054429"	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"HPA047387: , HPA054429: AB_2682485"	"unprognostic (8.54e-3)"	"prognostic favorable (8.45e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.59e-1)"	"prognostic favorable (4.19e-5)"	"unprognostic (6.38e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.27e-1)"	"prognostic unfavorable (1.96e-7)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	7.8	3.0	3.6	56.0	4.4	91.8	3.7	3.7	5.1	3.7	3.5	8.2	10.3	2.5	0.7	4.8	4.0	7.4	2.7	3.6	4.8	5.2	7.1	18.4	100.5	5.8	4.7	1.3	2.0	0.5	2.2	3.9	5.6	4.9	4.5	0.1	5.8	1.3	1.8	3.6	54.6	2.4	5.0	117.0	10.4	1.2	7.8	60.1	6.4	0.9	46.7	6.4	5.0	7.2	0.5	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.3	46.3	2.0	0.0	0.1	3.4	0.0	0.1	0.0	0.0	0.1	16.4	0.1	0.8	0.0	63.0	119.9	0.0	0.0	0.0	0.0	0.0	0.0	22.1	4.0	103.9	0.0	1.3	20.9	2.8	0.2	3.5	0.5	1.4	0.3	66.6	0.0	0.2	0.0	0.1	0.0	2.2	0.6	0.1	6.9	12.7	0.1	0.0	0.1	0.1	0.0	49.3	2.0	4.6	0.1	51.9	0.1	2.6	2.0	6.6	13.4	3.4	9.7	5.5	10.8	13.3	2.3	4.8	9.4	8.6	3.3	7.5	7.9	2.1	6.5	5.5	3.6	4.4	3.7	5.1	3.6	4.8	5.8	4.7	5.6	5.0	7.8	7.2	3.6	3.2	10.2	1.0	44.9	5.4	10.4	4.9	4.6	0.2	1.2	1.5	1.9	1.5	6.5	0.0	0.0	0.4	52.3	3.7	0.0	1.0	0.7	1.0	0.6	3.2	1.2	17.1	0.4	1.3	1.4	2.3	2.0	1.8	41.2	0.1	5.7	0.5	30.5	0.0	0.4	1.4	14.2	28.2	44.6	0.5	0.0	22.0	7.2	24.4	30.2	0.2	85.5	1.0	2.7	0.6	3.6	0.4	20.2	2.9	0.9	0.4	2.1	0.2	0.0	0.3	2.0	0.4	0.6	8.4	4.5	0.5	68.6	2.7	7.0	10.7
TMCO1	"HP10122, TMCC4"	ENSG00000143183	"Transmembrane and coiled-coil domains 1"	Q9UM00	1	165724293-165827755	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease variant, Glaucoma, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054768, HPA078775"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"		"HPA054768: AB_2682597, HPA078775: "	"unprognostic (1.22e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (5.17e-7)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (5.92e-2)"	"unprognostic (4.16e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.80e-2)"	67.5	92.5	46.4	51.6	50.2	48.4	91.1	53.8	63.5	74.0	72.2	127.0	115.7	55.9	111.5	58.5	65.9	80.1	56.4	46.4	55.6	110.3	162.5	55.0	62.4	54.1	55.5	59.5	73.5	143.6	33.8	57.4	55.0	79.6	128.7	74.3	77.8	69.9	48.7	39.3	108.9	61.4	56.6	46.5	80.7	75.4	49.8	89.3	103.8	48.0	70.8	97.7	29.1	60.6	158.4	172.1	132.2	77.9	243.9	120.7	126.9	259.4	191.7	156.0	162.1	249.9	229.2	99.1	267.4	195.9	67.1	214.7	171.8	140.3	175.1	252.0	164.2	121.1	180.3	158.7	195.1	216.6	154.1	159.0	173.9	179.5	142.6	148.4	117.1	122.6	329.7	186.0	227.3	123.1	172.1	160.6	169.4	527.6	197.3	125.0	143.4	256.1	204.7	198.4	133.5	235.4	201.3	209.2	170.9	195.0	277.1	275.7	121.5	138.9	116.5	123.8	248.3	357.4	521.1	346.5	111.4	139.7	187.4	213.3	172.2	172.9	159.7	169.4	170.4	151.8	168.7	173.1	135.5	132.6	134.3	156.5	132.1	156.6	201.7	243.8	207.1	290.3	46.4	50.2	53.8	63.5	46.4	55.6	54.1	55.5	55.0	56.6	49.8	60.6	124.0	96.1	70.7	23.8	95.6	84.8	89.8	264.5	75.1	79.1	142.9	135.9	62.6	224.4	181.1	213.3	68.8	136.1	138.9	371.5	43.0	202.3	82.2	131.4	147.9	92.7	88.6	75.5	20.7	191.7	148.4	113.1	64.2	154.7	76.5	71.9	106.7	326.0	140.9	75.7	24.9	137.0	227.9	106.4	76.0	151.6	123.6	92.7	99.6	16.9	78.9	236.7	152.4	25.6	23.3	227.0	215.7	129.4	153.5	73.6	290.0	151.5	175.2	75.9	124.9	67.7	101.7	232.1	87.7	89.4	92.9	111.4	109.2	117.6	143.6	94.5
TMEM106B	"FLJ11273, MGC33727"	ENSG00000106460	"Transmembrane protein 106B"	Q9NUM4	7	12211270-12243367	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Amyotrophic lateral sclerosis, Disease variant, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058342	Approved		Supported	Endosomes,Lysosomes		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 33: Fibroblasts - ECM organization"	"Endosomes, Lysosomes"		"HPA058342: AB_2683684"	"unprognostic (5.29e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.50e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.52e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.70e-1)"	9.9	26.1	6.0	7.1	8.5	7.2	10.9	10.7	9.1	13.1	7.6	12.6	8.6	14.7	12.2	10.3	11.2	9.1	11.4	6.3	7.0	17.8	18.8	7.7	7.9	7.4	7.4	12.0	10.1	12.7	9.9	14.0	8.1	14.6	11.5	14.6	13.1	13.9	14.7	9.0	10.2	12.7	10.5	8.4	8.9	7.0	7.4	6.7	16.0	12.2	6.8	10.7	10.2	14.5	13.9	26.3	14.8	24.2	26.3	21.3	11.5	19.7	33.3	12.6	12.7	8.6	42.1	3.7	21.2	23.5	30.0	14.6	11.9	12.5	10.5	7.2	11.5	5.5	14.5	8.3	20.8	20.5	8.6	22.1	14.1	9.9	19.2	57.5	16.0	10.2	16.1	11.1	14.9	4.4	3.9	8.6	17.4	17.5	13.9	11.1	10.9	10.1	23.5	12.4	15.4	21.4	18.8	15.4	16.7	20.0	13.9	10.0	18.9	14.0	20.3	14.1	16.2	15.0	28.6	5.9	19.6	6.7	35.2	11.6	4.3	5.3	9.1	5.2	12.8	6.1	10.6	10.6	2.9	7.8	17.3	13.2	2.8	14.4	7.9	0.9	10.3	6.8	6.0	8.5	10.7	9.1	6.3	7.0	7.4	7.4	8.1	10.5	7.4	14.5	45.0	73.7	40.3	41.1	34.3	36.8	42.6	38.5	62.6	55.0	46.0	30.4	46.0	38.6	49.3	66.2	45.9	54.0	18.9	53.6	17.6	115.4	5.0	29.2	56.3	34.6	57.6	24.4	60.1	58.7	36.0	65.8	36.7	37.8	14.5	53.8	41.7	85.1	33.3	65.6	78.6	37.9	57.0	29.2	23.9	4.3	49.0	23.9	37.4	28.1	19.1	95.2	39.1	66.9	82.3	75.3	53.4	60.9	39.9	85.0	57.1	67.7	47.4	51.8	32.9	49.5	41.6	40.1	31.6	56.4	43.3	135.6	41.1	70.7	47.2	81.9
TMEM126A	"DKFZp586C1924, OPA7"	ENSG00000171202	"Transmembrane protein 126A"	Q9H061	11	85647967-85656547	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046648	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"HPA046648: AB_2679737"	"unprognostic (3.79e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.08e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (8.60e-5)"	"unprognostic (8.25e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.17e-1)"	31.9	28.0	40.3	23.1	41.5	43.8	33.5	41.4	52.3	21.8	39.5	28.0	32.6	20.0	31.2	27.2	19.8	19.9	82.1	41.4	42.3	33.1	49.0	20.5	27.3	40.7	40.6	21.0	33.9	26.3	22.2	22.8	41.5	23.5	29.3	23.9	31.3	19.5	81.6	19.4	26.0	27.6	41.1	21.0	32.8	38.5	41.4	24.2	26.6	98.7	27.8	30.5	20.1	42.4	46.7	53.2	50.9	33.0	67.2	66.7	38.0	55.9	60.1	82.3	77.6	65.9	67.5	25.4	61.3	69.2	32.0	48.9	53.8	59.5	70.7	72.5	31.0	72.5	56.9	73.7	82.4	89.0	54.8	58.0	65.8	73.1	78.0	43.5	71.6	72.2	51.1	39.0	86.2	57.5	48.6	112.3	48.1	175.1	68.4	48.3	49.5	79.2	54.5	57.0	34.3	34.7	49.4	72.9	44.7	44.5	88.1	64.4	42.8	70.4	52.7	134.6	65.3	27.5	54.4	70.4	37.0	63.6	85.2	6.6	23.9	11.6	21.2	28.1	26.0	29.8	26.4	23.8	32.9	27.3	24.4	24.1	1.9	15.1	23.4	24.7	26.4	18.7	40.3	41.5	41.4	52.3	41.4	42.3	40.7	40.6	41.5	41.1	41.4	42.4	40.5	28.9	24.3	12.7	39.6	31.7	55.3	87.9	29.6	14.8	45.8	62.1	110.8	28.6	57.5	38.6	6.2	67.8	38.5	23.6	146.8	51.0	147.8	26.8	32.8	36.7	21.7	46.1	8.6	93.2	73.3	40.8	23.4	24.2	37.4	33.6	26.7	68.5	94.6	8.4	9.0	46.6	40.7	54.4	43.3	80.6	29.5	48.4	33.8	5.6	66.3	35.1	38.1	8.5	11.8	64.5	34.8	26.7	45.4	73.4	61.8	109.4	39.7	21.9	19.7	40.0	40.9	119.0	57.9	49.4	42.1	52.9	42.1	42.2	57.1	71.2
TMEM126B	HT007	ENSG00000171204	"Transmembrane protein 126B"	Q8IUX1	11	85628573-85636539	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Chaperone	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014480, HPA019186"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA014480: AB_1858083, HPA019186: AB_1858084"	"unprognostic (1.11e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.67e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.70e-3)"	"unprognostic (4.42e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.50e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.66e-2)"	16.1	16.7	29.2	13.0	29.4	6.5	19.3	28.9	38.9	18.2	25.9	21.4	19.6	19.3	30.7	14.3	15.8	17.3	24.7	30.4	31.7	15.3	17.2	15.8	18.7	29.7	30.0	16.4	15.9	11.0	20.8	13.3	30.9	17.0	17.6	18.6	15.7	14.1	16.2	13.8	19.8	21.4	30.1	16.5	17.6	10.9	30.2	16.0	16.8	20.1	17.5	18.6	14.8	32.3	37.9	29.8	33.1	16.0	60.2	49.6	10.6	33.1	36.1	25.6	38.1	84.8	37.1	39.9	72.2	27.1	28.6	45.0	53.2	33.0	23.8	56.5	49.7	30.1	49.1	36.1	35.6	75.4	34.7	37.9	38.3	38.6	47.0	41.1	38.6	49.5	72.5	31.2	58.8	47.9	29.4	91.3	36.1	129.6	50.1	25.0	25.4	33.6	49.5	42.1	30.8	19.1	31.2	24.9	31.9	42.5	50.1	45.4	20.5	38.2	26.5	96.9	35.4	14.6	91.1	47.7	19.4	60.4	20.6	21.5	15.6	7.9	19.0	18.2	24.8	18.3	23.4	23.5	20.1	17.7	23.3	23.4	5.9	23.4	14.5	18.4	25.9	15.9	29.2	29.4	28.9	38.9	30.4	31.7	29.7	30.0	30.9	30.1	30.2	32.3	44.9	22.4	40.7	16.6	34.6	26.1	32.2	80.8	22.8	32.5	36.8	31.1	87.3	54.3	57.2	40.5	14.6	41.0	54.2	33.6	168.3	76.0	5.4	27.2	39.2	46.1	34.6	34.5	19.3	49.0	54.5	45.1	15.8	25.8	42.5	27.8	42.5	43.6	84.1	23.5	20.1	41.3	81.4	47.4	44.6	8.3	66.5	43.5	72.9	9.4	48.8	79.0	80.3	20.6	29.7	51.5	52.8	88.4	22.4	35.3	56.5	162.9	51.3	31.2	39.5	30.0	43.8	34.4	46.8	23.1	36.9	25.2	49.7	45.4	52.0	45.4
TMEM132E	DFNB99	ENSG00000181291	"Transmembrane protein 132E"	Q6IEE7	17	34579487-34639318	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 17.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 4.1;Inhibitory neurons: 6.4;Oligodendrocyte precursor cells: 13.0;Proximal tubular cells: 11.5"	"Cancer enriched"	"Detected in some"	4	"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070608	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		170000	"Cluster 40: NK-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Golgi apparatus"	"Nuclear bodies, Cytosol"	"HPA070608: AB_2686286"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.29e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.71e-2)"	0.3	0.1	4.6	0.0	3.0	0.0	0.1	6.1	6.4	0.4	0.0	0.1	1.2	0.1	0.0	0.1	0.1	0.1	0.5	2.6	6.2	3.6	0.4	0.1	0.1	17.9	5.1	0.2	0.0	0.0	0.1	0.1	10.2	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.7	0.1	8.7	0.3	0.1	1.9	6.5	0.0	0.2	0.0	0.1	0.1	0.2	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	4.3	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	4.6	3.0	6.1	6.4	2.6	6.2	17.9	5.1	10.2	8.7	6.5	11.1	0.1	0.0	0.0	2.6	0.1	0.3	0.0	0.0	0.0	1.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	6.4	0.0	0.0	1.9	0.7	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.1	0.0	0.2	0.5	1.2	2.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TMEM165	"GDT1, TMPT27, TPARL"	ENSG00000134851	"Transmembrane protein 165"	Q9HC07	4	55395957-55453397	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 1021.6;Urothelial cells: 601.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038299, HPA062424"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"		"HPA038299: AB_10675793, HPA062424: AB_2732682"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-3)"	"unprognostic (3.46e-3)"	"unprognostic (7.07e-3)"	"unprognostic (5.97e-2)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (2.08e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.18e-8)"	"unprognostic (9.05e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.18e-2)"	53.4	61.3	39.2	42.6	75.1	11.3	35.2	62.0	70.8	45.9	36.0	32.4	32.0	34.0	31.1	55.8	31.6	46.0	37.3	40.8	51.1	41.6	19.3	52.7	32.6	84.8	72.0	22.3	40.1	32.3	24.0	60.5	78.9	37.8	33.3	15.0	40.4	30.6	17.1	26.2	27.9	40.0	54.5	37.0	39.2	13.7	65.8	24.0	37.8	17.2	42.5	78.8	42.7	117.4	74.6	30.4	47.1	50.2	143.5	105.4	50.0	138.6	212.7	98.0	106.7	34.2	108.3	76.9	98.3	85.9	56.2	53.8	50.0	56.8	98.9	43.8	46.4	66.0	50.1	66.6	89.1	92.1	75.1	109.1	72.7	55.9	37.3	82.4	113.2	25.6	112.8	47.8	116.5	54.5	73.0	76.5	51.7	97.8	70.6	52.0	35.5	42.1	148.6	70.2	48.3	64.7	69.8	261.0	85.8	46.3	41.2	65.3	98.3	83.1	49.6	37.0	102.5	44.4	38.5	48.3	98.9	77.2	67.9	23.7	40.4	26.0	15.2	35.7	17.0	19.0	14.3	17.8	36.5	11.5	12.1	14.4	28.6	18.1	35.9	28.4	18.3	30.2	39.2	75.1	62.0	70.8	40.8	51.1	84.8	72.0	78.9	54.5	65.8	117.4	119.6	54.5	52.4	42.7	87.9	245.1	277.8	295.0	147.4	50.6	85.8	42.7	32.2	71.4	214.9	79.1	81.3	112.5	97.7	42.4	17.6	171.1	32.1	123.6	99.1	108.0	50.4	79.1	58.2	163.5	157.2	110.4	76.0	173.8	21.0	57.6	113.8	18.4	105.7	28.6	71.5	69.4	77.3	97.9	145.7	24.7	58.7	109.5	88.9	59.0	117.5	53.2	123.6	71.4	1021.6	248.0	48.6	63.6	117.1	239.3	51.3	50.0	125.2	91.9	98.6	92.2	129.0	37.8	24.6	169.4	268.8	80.6	81.6	90.6	61.6	601.6
TMEM175	MGC4618	ENSG00000127419	"Transmembrane protein 175"	Q9BSA9	4	932387-958656	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057160	Approved		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nuclear membrane"		"HPA057160: AB_2683356"	"unprognostic (3.84e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.61e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (4.71e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.51e-3)"	17.5	28.2	13.0	8.1	13.3	12.9	17.5	15.7	24.6	14.7	12.2	15.5	8.9	17.3	6.0	14.2	14.9	10.0	19.6	12.9	13.1	16.4	33.5	16.1	16.1	14.6	13.1	12.2	23.3	9.2	30.9	7.4	14.5	19.0	3.6	10.2	21.4	8.7	19.7	17.0	17.5	6.4	11.4	26.1	19.3	13.2	12.7	8.9	21.0	4.5	6.1	16.1	13.5	13.5	4.9	9.5	5.1	7.0	23.7	12.3	11.8	13.0	8.6	7.3	10.8	4.2	20.5	4.0	7.5	12.8	12.8	8.4	4.7	9.5	3.1	9.2	11.9	8.3	14.9	4.3	13.7	4.6	14.8	17.5	11.3	6.4	4.3	5.1	4.6	8.1	8.2	30.0	6.4	16.2	11.3	17.4	3.2	5.8	24.8	7.5	3.1	11.5	7.0	5.0	14.0	12.9	8.6	5.5	7.8	2.5	24.3	11.3	6.6	13.7	3.0	16.8	9.1	23.0	5.9	7.4	13.2	9.4	11.3	36.8	32.2	27.2	20.6	41.1	13.3	19.4	17.3	15.5	29.4	21.6	12.6	17.6	27.8	17.0	39.7	47.1	18.5	21.2	13.0	13.3	15.7	24.6	12.9	13.1	14.6	13.1	14.5	11.4	12.7	13.5	17.0	12.8	8.9	26.8	20.7	6.2	8.1	21.0	12.5	26.8	15.2	14.4	10.4	8.6	17.1	14.7	4.2	24.1	19.2	13.7	1.9	8.8	6.1	11.6	12.2	10.2	16.2	3.0	42.8	11.4	10.1	16.6	17.9	11.3	7.0	10.8	10.8	24.5	15.2	47.1	37.8	9.6	34.6	14.5	9.1	4.0	12.5	15.8	19.6	15.0	9.6	38.6	15.5	25.1	29.1	7.9	16.1	16.1	16.7	6.1	16.6	8.0	13.6	28.7	13.1	10.1	12.3	24.0	14.1	12.3	7.7	18.9	15.3	29.2	7.6	8.4
TMEM199	"C17orf32, MGC45714, VMA12, VPH2"	ENSG00000244045	"Transmembrane protein 199"	Q8N511	17	28357642-28363683	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027051	Uncertain					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"			"HPA027051: AB_10600915"	"unprognostic (3.01e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (9.98e-2)"	"unprognostic (4.60e-2)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.67e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.38e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.51e-3)"	"unprognostic (5.95e-2)"	8.3	11.9	9.2	10.3	10.4	13.3	8.6	10.1	13.0	9.1	9.6	9.0	7.4	9.5	9.6	10.6	8.0	6.2	9.3	9.5	10.5	12.9	14.4	8.5	12.7	10.2	10.1	8.0	8.9	15.5	11.7	9.5	10.1	9.8	7.9	13.9	9.5	6.8	7.2	11.6	9.0	6.2	9.5	13.2	8.9	7.8	10.4	12.8	10.8	7.5	11.2	8.8	8.8	12.0	12.2	20.4	19.6	16.7	7.9	6.8	16.5	14.8	9.5	20.6	18.5	48.9	9.6	17.6	14.8	11.0	26.4	20.6	21.8	13.9	18.0	32.8	19.6	13.0	17.7	23.6	15.9	18.7	22.0	9.7	12.6	19.6	13.0	12.2	10.2	16.1	21.6	21.8	15.4	24.1	21.3	25.6	16.2	21.0	13.9	17.2	24.4	16.3	15.5	20.2	24.8	26.0	17.8	45.6	27.1	20.1	28.7	16.9	14.0	17.4	13.5	15.0	25.3	29.3	38.9	16.2	21.6	11.4	22.2	28.5	24.2	20.0	15.1	25.2	16.6	17.1	13.1	13.4	20.0	16.0	16.4	14.5	18.9	15.6	23.0	14.0	14.9	19.1	9.2	10.4	10.1	13.0	9.5	10.5	10.2	10.1	10.1	9.5	10.4	12.0	12.4	32.1	8.6	8.8	21.0	5.7	10.5	34.3	15.4	13.8	14.3	14.4	5.6	12.8	23.5	9.2	8.4	40.2	15.5	21.1	43.0	40.2	3.7	12.0	11.4	14.6	15.6	12.2	11.0	31.4	38.1	10.6	7.7	10.9	7.6	11.9	17.5	26.8	51.3	11.8	10.5	15.7	32.6	22.9	9.5	4.5	11.5	22.4	21.4	6.5	45.0	19.1	25.7	7.5	13.7	35.4	19.4	6.4	15.1	13.1	20.3	54.0	15.1	14.0	13.1	8.6	14.2	26.5	35.4	14.0	8.8	48.4	15.2	14.7	13.0	11.4
TMEM237	"ALS2CR4, JBTS14"	ENSG00000155755	"Transmembrane protein 237"	Q96Q45	2	201620184-201643570	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cilium biogenesis/degradation"		"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"retina: 89.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 81.7;Rod photoreceptor cells: 160.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052596, HPA054732"	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 79: Retina - Phototransduction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA052596: AB_2681879, HPA054732: AB_2682587"	"unprognostic (1.70e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (1.73e-1)"	"unprognostic (4.06e-1)"	"unprognostic (8.30e-6)"	"unprognostic (4.15e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.62e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (7.96e-6)"	"unprognostic (1.32e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-1)"	4.1	15.1	6.3	1.7	6.5	2.3	11.0	7.1	7.8	5.0	6.0	3.0	0.8	6.0	4.6	6.0	5.8	4.1	7.7	6.8	6.7	5.4	1.9	5.1	2.3	6.9	6.9	8.4	1.9	5.0	3.0	5.2	7.2	7.8	3.7	89.3	5.1	4.8	7.7	18.5	1.8	5.8	7.1	1.4	2.2	3.0	6.4	7.0	4.6	9.2	3.1	4.1	3.4	6.8	3.7	7.2	32.3	16.4	7.8	10.1	3.1	22.6	9.9	14.7	28.4	5.9	5.3	3.7	6.9	21.9	12.7	6.8	5.6	24.4	27.1	6.9	20.6	10.7	21.4	19.4	15.1	10.4	2.1	9.0	5.0	20.4	5.1	24.8	25.5	23.4	7.8	13.0	29.8	5.2	29.7	16.3	32.7	1.9	23.8	43.9	30.8	7.6	12.2	9.7	33.7	47.4	21.4	8.4	12.6	20.3	12.5	18.7	6.8	26.8	7.3	8.6	9.5	6.0	14.9	11.4	22.7	9.7	17.0	0.0	0.0	0.0	1.0	1.1	0.9	0.7	1.0	1.6	1.3	0.1	1.1	1.4	0.0	0.9	0.7	0.3	1.8	0.5	6.3	6.5	7.1	7.8	6.8	6.7	6.9	6.9	7.2	7.1	6.4	6.8	6.8	6.4	9.6	12.4	1.6	71.2	81.7	46.7	50.7	33.3	17.1	41.4	20.2	2.8	18.9	18.4	41.7	21.0	3.1	0.6	13.7	11.1	8.9	16.3	10.9	11.6	4.8	8.6	16.5	7.6	26.8	25.8	3.1	7.7	5.1	19.9	10.4	2.7	9.4	32.0	15.3	4.5	18.3	2.2	12.2	7.0	21.8	2.9	12.4	4.7	5.7	38.5	0.0	14.1	10.8	6.5	1.9	21.4	3.0	36.9	0.7	3.9	19.8	160.3	6.6	33.2	20.6	33.3	22.0	30.0	45.3	15.1	4.2	39.8	5.3	29.2
TMEM38B	"bA219P18.1, C9orf87, D4Ertd89e, FLJ10493, TRIC-B"	ENSG00000095209	"Transmembrane protein 38B"	Q9NVV0	9	105694541-105776629	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 77.4;tongue: 62.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 267.0;Late spermatids: 488.4;Spermatocytes: 157.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018465	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA018465: AB_1858116"	"unprognostic (3.34e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.80e-2)"	"prognostic favorable (7.96e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.89e-3)"	"unprognostic (9.98e-2)"	7.6	14.0	6.2	7.1	11.6	19.1	4.7	19.5	9.2	7.6	6.3	12.5	6.4	8.3	17.3	7.2	7.2	6.8	30.7	7.4	12.9	29.2	15.3	5.7	8.1	8.3	8.4	18.3	4.9	9.2	5.8	4.6	10.6	8.0	11.8	10.4	4.0	6.8	77.4	6.0	10.7	8.1	5.9	6.3	6.7	28.6	9.0	4.9	28.8	62.1	5.1	5.0	4.0	19.6	16.7	25.6	19.6	30.9	110.5	24.3	40.8	23.4	15.3	22.6	23.3	40.0	22.5	38.4	11.8	8.5	36.4	11.6	28.4	13.5	24.4	29.0	37.8	15.8	16.2	24.7	15.1	48.1	32.7	23.0	11.8	15.5	21.6	7.1	9.1	26.6	84.3	33.2	14.0	46.4	33.6	14.5	15.1	48.7	27.1	22.3	61.4	18.4	10.3	13.2	34.1	8.3	24.2	39.4	17.9	13.0	49.2	33.5	4.9	20.5	20.2	78.9	24.7	40.7	109.8	19.1	38.2	52.2	41.7	15.6	20.2	53.8	13.2	29.6	17.7	56.6	18.3	15.8	23.3	56.6	38.9	24.9	3.1	28.2	26.8	51.7	18.0	24.2	6.2	11.6	19.5	9.2	7.4	12.9	8.3	8.4	10.6	5.9	9.0	19.6	9.2	0.0	2.7	7.5	27.8	30.3	24.9	6.2	15.9	12.9	8.9	3.9	55.5	15.7	8.4	25.8	29.2	12.0	16.4	19.1	66.5	8.9	267.0	2.2	7.2	9.9	31.8	7.2	12.4	6.9	19.0	24.2	9.2	3.0	15.8	11.3	3.6	24.4	30.9	11.8	28.6	12.9	18.3	7.9	33.2	488.4	85.1	21.4	32.0	6.5	18.3	30.6	3.1	65.4	30.6	6.3	12.2	44.8	20.2	55.1	10.9	47.0	7.6	12.3	118.3	18.2	58.1	157.8	47.6	13.0	32.7	21.2	13.8	39.7	19.0	20.2
TMEM67	"JBTS6, MGC26979, MKS3, NPHP11"	ENSG00000164953	"Transmembrane protein 67"	Q5HYA8	8	93754844-93819234	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Deafness, Disease variant, Joubert syndrome, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 66.7;Excitatory neurons: 59.8;Respiratory ciliated cells: 95.8;Rod photoreceptor cells: 83.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (1.57e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.07e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.25e-5)"	"unprognostic (2.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (8.41e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.01e-1)"	2.4	2.5	1.7	1.3	2.7	1.4	3.5	2.8	2.7	3.6	10.3	2.1	1.4	4.2	6.3	1.8	13.3	2.8	5.0	2.5	3.0	3.1	1.2	3.6	1.4	6.5	6.8	4.2	2.6	4.7	5.8	2.1	3.1	2.8	2.2	6.1	1.9	3.2	1.2	3.7	1.3	2.4	3.5	1.9	2.0	6.8	3.1	1.4	6.0	0.6	1.7	2.5	2.2	3.9	5.8	3.7	5.2	4.1	4.4	9.8	3.1	3.3	5.4	3.8	7.5	2.1	13.0	1.5	6.9	3.6	6.9	5.9	1.9	3.3	5.6	1.1	4.3	3.6	4.8	1.8	4.0	2.7	1.5	4.2	3.0	6.8	3.0	7.1	4.0	6.1	2.5	0.9	4.0	1.4	4.5	2.0	4.3	2.3	3.4	1.6	1.7	0.0	4.7	2.5	3.4	5.7	3.3	0.9	5.6	4.6	6.8	1.4	2.1	4.1	1.7	5.7	3.0	1.8	5.5	1.6	7.4	0.8	3.9	1.7	0.5	0.2	1.5	0.2	1.2	0.7	1.3	1.3	1.0	1.5	1.5	1.5	0.5	1.8	0.2	1.1	0.3	0.5	1.7	2.7	2.8	2.7	2.5	3.0	6.5	6.8	3.1	3.5	3.1	3.9	5.0	12.8	8.7	27.4	6.3	2.8	5.6	12.2	2.2	14.6	6.0	5.6	31.9	5.7	12.5	20.2	66.7	3.4	5.6	1.2	0.0	6.4	24.5	50.9	15.1	6.8	9.0	4.6	59.8	2.7	5.6	9.8	4.1	4.9	5.1	16.1	10.0	1.6	2.2	23.5	34.2	2.4	8.2	2.9	2.6	7.7	16.1	1.8	1.8	13.1	1.5	9.3	3.1	17.6	3.4	2.1	0.5	10.5	2.7	2.1	0.4	3.9	95.8	83.2	6.6	18.9	6.9	47.6	16.5	2.6	1.4	2.3	5.6	13.7	2.8	1.6
TMEM70	FLJ20533	ENSG00000175606	"Transmembrane protein 70"	Q9BUB7	8	73972437-73982783	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 100.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 78.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023187, CAB034226"	Approved		Supported	Nucleoplasm,Mitochondria		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Mitochondria	Nucleoplasm	"CAB034226: AB_2205189, HPA023187: AB_2671101"	"unprognostic (2.26e-3)"	"unprognostic (4.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.37e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.65e-3)"	"unprognostic (6.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.70e-2)"	18.1	18.2	9.2	9.8	9.7	10.4	11.3	10.5	12.3	8.0	9.5	12.6	5.8	8.9	10.6	9.3	11.3	8.9	19.3	10.3	10.2	12.0	24.4	9.0	10.1	9.6	9.1	10.5	25.0	8.3	7.6	10.3	10.1	7.4	9.7	6.1	9.9	5.9	100.7	7.7	9.5	9.1	9.5	9.6	17.8	9.8	9.5	11.0	6.0	20.5	10.3	11.3	7.4	10.1	21.2	16.4	13.1	13.8	14.9	12.7	13.6	17.6	15.8	19.4	15.3	15.8	11.9	28.4	15.0	12.0	16.4	19.1	24.9	16.8	21.4	18.9	17.5	28.3	10.0	21.2	14.7	15.5	14.5	11.8	15.3	12.2	6.4	7.3	16.4	14.2	22.0	13.5	20.5	15.9	35.8	29.6	12.3	26.6	20.6	25.4	12.8	24.2	20.5	20.0	29.7	13.1	11.0	78.0	23.3	10.2	16.0	14.1	10.6	11.1	13.7	20.7	16.9	19.9	18.7	28.1	16.4	12.1	12.5	6.3	9.1	6.7	8.0	10.2	9.1	17.7	9.0	9.3	9.6	10.9	10.3	9.6	6.7	5.8	7.9	11.0	7.9	12.0	9.2	9.7	10.5	12.3	10.3	10.2	9.6	9.1	10.1	9.5	9.5	10.1	136.2	16.0	30.1	5.5	37.1	67.3	43.7	54.8	24.5	23.9	26.2	22.2	46.3	14.3	35.7	22.0	8.4	71.2	48.1	69.0	66.5	36.6	20.3	40.8	26.2	96.4	13.8	26.5	12.8	63.5	59.6	50.2	17.3	17.1	39.9	17.0	28.5	50.3	132.4	10.1	11.4	31.7	42.7	70.0	74.5	12.1	29.8	73.2	40.9	5.6	38.9	23.1	22.6	3.5	8.1	43.6	37.9	29.0	68.6	42.1	28.8	75.4	58.7	17.5	39.5	61.9	40.8	70.6	29.5	21.5	59.7	70.3	39.8	52.6	34.1	26.2
TMEM94	KIAA0195	ENSG00000177728	"Transmembrane protein 94"	Q12767	17	75441159-75500452	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 43.0;Granulosa cells: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008423, HPA050660"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA008423: AB_1852283, HPA050660: AB_2681207"	"unprognostic (4.05e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.27e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (9.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.96e-2)"	21.3	55.9	50.3	13.9	46.4	18.4	21.7	27.7	54.9	21.9	30.5	25.1	18.8	24.4	5.4	21.1	30.7	15.8	27.8	40.7	31.5	29.7	20.2	25.6	14.1	40.1	36.8	27.7	23.7	20.3	30.1	14.2	30.5	19.9	13.6	27.7	21.1	13.2	63.4	22.9	28.2	10.7	34.8	29.7	25.0	27.1	47.1	18.0	27.4	25.8	8.6	20.5	15.3	35.8	15.3	40.7	33.6	52.6	16.1	18.8	45.6	9.2	20.0	15.4	15.4	13.7	22.6	20.6	30.3	15.9	23.6	19.9	15.8	25.6	8.8	19.4	23.1	22.0	18.4	22.9	21.2	23.7	45.2	30.9	14.5	15.0	13.4	13.9	28.1	18.3	22.6	24.4	20.7	19.1	53.3	18.8	14.4	19.3	16.2	36.2	37.2	19.2	16.0	40.7	28.1	30.5	10.2	47.4	28.7	25.3	29.8	29.3	16.0	16.5	19.0	16.5	13.8	53.2	17.2	12.2	17.2	23.8	20.8	0.1	2.6	3.0	3.5	1.6	2.6	1.0	1.6	2.5	2.5	2.5	1.3	2.2	0.7	2.4	1.4	3.3	2.1	2.9	50.3	46.4	27.7	54.9	40.7	31.5	40.1	36.8	30.5	34.8	47.1	35.8	12.8	12.8	11.1	0.0	5.8	0.0	3.3	0.0	6.2	43.0	10.9	9.1	0.0	12.8	6.2	9.2	31.3	16.1	8.8	18.0	0.0	8.1	4.7	10.1	6.8	8.2	7.3	10.7	0.0	9.5	11.0	4.4	28.1	8.6	6.3	41.5	13.9	8.9	15.4	20.2	0.0	10.5	0.0	12.4	0.0	1.9	6.8	8.9	0.0	0.0	5.6	15.2	4.1	0.0	0.0	6.0	9.1	9.1	8.1	3.3	19.6	3.4	2.9	33.6	6.6	7.5	6.0	14.9	8.8	9.7	0.0	20.1	6.9	19.0	9.3	3.1
TMIE	DFNB6	ENSG00000181585	"Transmembrane inner ear"	Q8NEW7	3	46694528-46710886	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.6;choroid plexus: 10.5;pituitary gland: 9.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.8;Spermatocytes: 2.6;Spermatogonia: 3.2"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.1;EFO-21: 2.7;JURKAT: 10.7;SH-SY5Y: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038298	Uncertain		Uncertain	Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Cytosol"		"HPA038298: AB_10675792"	"unprognostic (6.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.40e-3)"	"unprognostic (3.94e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.29e-2)"	"unprognostic (6.78e-2)"	0.7	6.2	14.2	0.5	14.1	0.0	0.4	14.0	18.0	0.7	10.5	1.0	0.4	0.5	0.7	1.5	0.6	0.2	0.7	14.1	19.3	2.3	0.8	1.0	0.8	19.6	15.7	1.5	0.2	0.1	9.9	0.4	19.2	0.5	0.3	0.7	0.5	1.0	3.6	0.7	0.5	0.4	16.0	0.7	0.3	1.5	18.7	0.5	0.9	1.2	0.8	0.6	0.9	14.9	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.1	0.0	2.7	0.0	0.5	0.1	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.0	0.0	1.8	0.0	1.2	0.0	0.5	10.7	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.7	0.1	1.2	0.0	0.3	0.1	0.1	0.3	2.3	0.3	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.1	0.0	2.4	0.4	0.0	0.0	0.0	0.0	0.4	0.4	14.2	14.1	14.0	18.0	14.1	19.3	19.6	15.7	19.2	16.0	18.7	14.9	1.9	0.0	0.0	0.3	0.0	0.8	0.2	0.5	0.0	3.8	0.2	0.6	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.9	0.4	0.5	0.2	0.0	0.7	0.0	0.0	1.7	0.4	0.1	0.4	0.0	0.1	0.0	0.1	0.4	0.1	0.6	0.0	0.8	0.0	0.0	0.0	0.4	1.5	0.6	0.3	0.0	1.9	0.1	1.4	0.0	0.0	0.3	1.2	0.0	0.4	0.0	0.3	0.0	0.0	0.6	0.5	0.0	1.1	1.0	2.6	3.2	0.0	0.9	0.1	0.2	0.1	0.0	0.2
TMLHE	"BBOX2, FLJ10727, TMLH, XAP130"	ENSG00000185973	"Trimethyllysine hydroxylase, epsilon"	Q9NVH6	X	155489011-155719098	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carnitine biosynthesis"	"Dioxygenase, Oxidoreductase"	"Autism, Autism spectrum disorder, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 51.5;Oligodendrocyte precursor cells: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA034589, HPA040331"	Approved		Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 68: Oligodendrocytes - Mixed function"	Mitochondria		"HPA034589: AB_10670571, HPA040331: AB_2676929"	"unprognostic (1.98e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.10e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.20e-3)"	"unprognostic (6.97e-2)"	"prognostic favorable (3.68e-6)"	"unprognostic (1.69e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.75e-2)"	11.7	10.2	7.1	6.6	7.4	8.4	11.3	9.0	8.0	11.3	8.1	11.6	11.8	9.4	10.4	10.3	9.9	8.0	25.3	6.7	7.7	16.7	18.8	5.6	7.0	8.5	8.2	12.0	9.5	18.9	5.4	8.4	8.5	6.6	12.5	10.9	12.7	9.7	32.0	5.9	11.2	12.3	8.3	8.7	9.1	2.9	7.3	8.9	10.5	33.4	7.6	8.2	6.6	9.8	25.0	11.9	9.8	28.6	11.8	18.1	0.0	9.9	14.6	12.3	32.4	8.7	13.9	0.0	38.9	17.6	28.2	13.4	21.2	9.7	13.9	10.3	14.3	11.3	19.5	10.2	16.4	10.5	7.6	19.5	20.0	13.6	20.8	18.2	19.5	15.5	15.8	9.0	20.5	9.3	12.8	11.8	3.0	21.6	0.1	12.7	15.5	9.4	15.0	8.5	9.2	13.7	9.3	0.5	11.2	10.5	10.6	11.9	16.5	10.3	9.7	20.4	12.4	11.0	12.6	9.6	12.4	16.4	9.6	3.4	12.6	14.7	4.6	14.9	3.5	8.1	5.0	3.9	13.1	10.6	6.5	5.7	18.2	6.2	21.5	6.1	5.5	5.8	7.1	7.4	9.0	8.0	6.7	7.7	8.5	8.2	8.5	8.3	7.3	9.8	6.7	0.0	2.3	27.1	10.1	5.2	12.1	14.4	9.6	4.0	5.2	7.5	7.2	7.2	9.7	9.2	0.0	8.8	6.5	7.9	23.5	10.7	0.0	6.8	7.4	6.2	6.1	14.3	22.2	7.6	6.8	10.2	9.2	7.3	10.1	8.1	4.2	12.0	12.4	0.0	29.5	7.3	4.1	16.1	10.4	0.5	8.4	12.1	12.4	51.5	13.1	7.6	10.3	47.7	25.5	8.5	7.3	5.7	5.6	4.3	17.4	17.0	9.5	5.4	0.0	5.9	9.5	0.3	2.5	7.6	4.1	6.7	8.0	10.5	6.5	11.0
TMPRSS15	"ENTK, MGC133046, PRSS7"	ENSG00000154646	"Transmembrane serine protease 15"	P98073	21	18269116-18485879	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	512	"intestine: 979.8"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 28.0"	"Group enriched"	"Detected in some"	12	"liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"U-138 MG: 50.8;U-87 MG: 141.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"olfactory bulb: 5.0;spinal cord: 1.8"	"HPA015611, HPA034857, HPA072934"	Enhanced		Approved	"Plasma membrane"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA015611: AB_1855791, HPA034857: , HPA072934: AB_2732214"					"unprognostic (9.26e-2)"	"unprognostic (4.14e-1)"		"unprognostic (3.52e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.70e-2)"		"unprognostic (6.35e-2)"	"unprognostic (5.92e-2)"			0.0	0.0	0.9	0.2	0.7	0.0	0.0	1.9	1.7	0.0	0.0	0.2	979.8	0.2	0.0	0.1	0.0	0.1	0.1	0.7	0.6	0.0	0.0	0.0	0.7	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	21.8	0.0	0.0	0.0	0.4	1.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.3	0.0	4.6	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.8	0.0	0.3	0.0	0.9	0.0	0.2	141.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.7	1.9	1.7	0.7	0.6	0.2	0.6	0.1	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	4.0	0.0
TMPRSS3	"DFNB10, DFNB8"	ENSG00000160183	"Transmembrane serine protease 3"	P57727	21	42371887-42396091	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 23.7;stomach 1: 14.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 17.7;Cholangiocytes: 24.3;Ductal cells: 16.1;Endometrial ciliated cells: 17.1;Gastric mucus-secreting cells: 23.4;Ionocytes: 16.2;Muller glia cells: 20.4;Respiratory ciliated cells: 39.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 16.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 3.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 3.1"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 274.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 16: U-266 - Nucleosome"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"unprognostic (8.47e-3)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (3.64e-4)"	"unprognostic (2.85e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.17e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.66e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.33e-1)"	0.5	0.3	3.8	0.2	4.0	0.1	8.7	4.0	3.7	6.3	2.0	0.2	1.3	0.7	0.0	0.2	23.7	8.6	0.0	3.4	4.1	2.4	0.5	3.4	0.5	4.9	4.7	0.0	3.0	0.0	1.5	0.2	3.7	0.4	0.1	3.9	9.2	0.4	0.1	0.1	1.1	0.0	3.5	0.4	14.5	0.0	4.7	0.9	2.9	0.0	0.4	1.0	0.0	2.7	4.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	32.9	0.0	66.2	26.5	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.6	0.0	14.0	0.0	1.5	3.5	0.0	0.0	1.0	0.4	0.0	0.0	0.0	2.8	1.5	0.0	0.0	33.9	1.6	0.0	0.0	3.2	0.3	0.1	0.0	1.7	0.0	0.2	0.7	274.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	3.1	0.0	1.7	1.8	0.0	0.0	0.3	0.9	0.3	0.0	0.5	0.0	0.8	0.5	3.8	4.0	4.0	3.7	3.4	4.1	4.9	4.7	3.7	3.5	4.7	2.7	0.1	12.8	3.7	2.3	0.4	0.3	2.3	8.1	0.0	0.2	17.7	9.9	0.6	24.3	10.8	7.3	0.0	0.0	0.1	1.4	5.9	16.1	1.4	17.1	0.4	0.2	0.0	2.7	0.0	13.8	0.1	1.3	23.4	5.2	0.0	0.2	0.4	0.0	0.1	0.0	0.0	2.0	16.2	0.0	0.5	0.6	0.3	0.3	0.0	0.0	0.0	20.4	0.0	0.0	0.1	11.8	1.4	0.0	0.4	2.4	2.9	0.0	39.8	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	1.4	0.1	2.5	5.0
TMPRSS5	"MGC141886, MGC148044"	ENSG00000166682	"Transmembrane serine protease 5"	Q9H3S3	11	113687547-113706373	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.6;choroid plexus: 20.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 26.4;Excitatory neurons: 5.4;Horizontal cells: 5.0;Oligodendrocytes: 15.5"	"Cancer enhanced"	"Detected in some"		"glioma: 5.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.0;CAPAN-2: 3.2;OE19: 2.0;WM-115: 2.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010992			Approved	Nucleoplasm		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA010992: AB_1858152"	"unprognostic (1.53e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.08e-1)"	"unprognostic (5.19e-3)"	"unprognostic (8.49e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.04e-3)"	1.3	0.5	28.1	0.2	34.7	1.4	2.0	24.9	39.0	0.8	20.8	0.7	0.1	0.5	0.2	0.5	0.7	0.7	1.0	28.2	27.0	1.0	1.0	0.7	0.2	34.0	29.8	0.6	0.5	0.0	1.6	0.2	33.1	0.8	0.3	1.1	9.6	0.3	2.6	2.1	0.7	0.3	28.5	0.8	0.8	2.1	32.1	0.3	0.6	0.5	0.3	0.7	1.0	50.6	0.2	0.3	2.0	1.1	0.2	0.1	0.3	0.5	0.2	0.3	0.4	1.1	3.2	0.1	1.4	0.2	0.3	0.4	0.1	0.2	0.1	0.2	0.6	0.4	0.3	0.0	0.1	0.5	0.4	0.2	0.2	0.2	0.5	0.2	0.3	0.7	0.4	0.2	0.4	0.0	0.4	0.6	0.2	2.0	0.1	0.4	0.2	0.0	0.3	0.2	0.3	0.4	0.2	0.0	1.6	0.2	0.2	0.2	0.2	0.4	0.7	0.3	0.3	0.2	0.1	0.0	0.1	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	34.7	24.9	39.0	28.2	27.0	34.0	29.8	33.1	28.5	32.1	50.6	0.2	0.0	0.0	26.4	0.2	0.3	0.2	0.0	0.0	0.5	1.0	0.9	0.5	0.0	0.1	1.8	2.1	0.0	0.2	0.2	0.0	0.3	0.1	0.3	0.2	0.3	0.0	1.3	5.4	0.9	0.0	0.3	0.0	0.4	0.0	0.4	0.4	0.2	0.1	5.0	2.8	0.0	0.0	0.0	0.3	0.3	0.3	0.1	0.0	2.8	0.1	3.2	0.0	3.5	15.5	0.6	0.0	0.0	0.3	0.2	0.0	0.0	0.1	1.3	0.0	0.5	0.1	1.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.2
TMPRSS6	"FLJ30744, MT2"	ENSG00000187045	"Transmembrane serine protease 6"	Q8IU80	22	37065436-37109713	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"liver: 128.4"	"Group enriched"	"Detected in some"	11	"Early spermatids: 61.0;Hepatocytes: 99.9;Late spermatids: 143.9"	"Group enriched"	"Detected in many"	14	"liver cancer: 51.3;thyroid cancer: 14.1"	"Group enriched"	"Detected in some"	4	"basal ganglia: 4.4;thalamus: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Hep G2: 5.0;SCLC-21H: 8.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 3.3"							NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (3.93e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.29e-5)"	"unprognostic (7.95e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (8.16e-6)"	"unprognostic (2.44e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.15e-7)"	"unprognostic (2.38e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.86e-5)"	0.1	0.1	0.2	0.2	4.4	0.2	0.4	0.1	0.6	0.1	0.0	0.6	2.2	0.1	0.8	0.2	0.5	0.9	0.0	0.2	0.2	0.1	128.4	0.7	0.3	0.2	0.4	0.1	1.3	0.0	13.0	0.7	0.2	0.2	0.5	0.1	0.0	0.0	0.0	2.2	1.0	0.0	0.0	0.2	3.6	7.7	1.3	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.5	0.2	0.1	5.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.9	0.0	0.0	0.2	0.1	0.1	0.3	0.1	0.2	0.0	0.0	8.1	0.3	0.1	0.6	0.0	0.1	0.1	0.0	0.4	0.3	1.0	0.1	0.0	1.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.4	0.1	0.6	0.2	0.2	0.2	0.4	0.2	0.0	1.3	0.1	0.0	0.0	0.0	0.3	0.6	0.5	0.0	0.0	0.0	0.0	0.6	0.3	0.5	2.8	0.0	0.0	0.0	0.0	0.1	8.8	0.0	0.2	61.0	0.0	0.0	0.3	5.3	8.0	0.1	0.0	2.6	0.0	2.6	0.0	0.0	0.0	2.5	99.9	0.1	0.0	0.1	1.5	0.0	3.2	0.0	143.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.1	0.3	0.3	0.1	0.6	0.0
TMTC3	"FLJ90492, SMILE"	ENSG00000139324	"Transmembrane O-mannosyltransferase targeting cadherins 3"	Q6ZXV5	12	88142296-88199887	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Transferase	"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ionocytes: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038550	Approved					NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA038550: AB_10672715"	"unprognostic (1.05e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.44e-1)"	"unprognostic (8.07e-3)"	"unprognostic (2.56e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	5.9	4.4	3.6	3.8	3.8	1.7	6.7	5.8	4.7	5.6	2.1	4.5	5.4	6.4	5.2	9.1	3.9	5.7	3.8	3.9	4.6	8.1	9.0	5.2	2.9	3.4	3.9	5.3	3.2	6.2	2.8	10.2	4.1	7.4	4.7	7.9	3.8	6.3	1.7	12.5	4.4	9.2	3.2	3.9	3.8	4.1	3.6	4.0	6.3	4.3	4.5	6.8	4.7	4.1	13.2	14.0	12.6	11.9	28.8	25.4	22.5	28.1	26.6	15.8	16.9	20.3	9.2	4.1	5.0	25.8	9.6	28.9	13.5	22.4	26.5	2.4	10.2	4.0	9.5	9.3	15.0	4.3	2.5	21.7	12.0	30.5	12.0	16.2	24.9	3.4	8.9	1.4	17.8	7.9	3.0	5.5	9.7	5.0	7.3	2.6	27.4	4.1	13.7	21.3	10.7	10.6	22.8	16.1	7.3	13.3	25.9	4.3	26.4	21.8	12.0	19.4	13.7	4.5	6.3	4.7	6.8	5.0	16.5	7.4	1.3	2.3	1.8	1.1	2.2	2.3	2.0	1.4	0.9	1.8	2.4	2.0	1.3	1.2	1.6	0.9	1.7	0.7	3.6	3.8	5.8	4.7	3.9	4.6	3.4	3.9	4.1	3.2	3.6	4.1	15.9	12.8	8.2	19.6	6.9	34.2	24.4	29.1	24.5	12.5	11.4	8.1	11.1	5.7	20.0	7.3	27.1	29.6	3.5	6.7	3.9	14.5	26.8	23.7	22.2	16.9	3.6	9.5	51.6	10.8	18.2	23.8	8.6	21.9	9.5	12.4	15.7	19.2	8.2	13.5	46.8	5.9	75.3	5.9	6.0	18.2	20.2	3.7	8.8	20.6	2.8	8.3	2.1	28.1	42.4	12.4	4.9	19.5	4.6	18.0	7.3	13.9	34.9	23.4	19.7	17.1	22.3	12.0	8.7	32.6	40.5	17.8	5.2	14.1	7.1	14.4
TMX2	"PDIA12, TXNDC14"	ENSG00000213593	"Thioredoxin related transmembrane protein 2"	Q9Y320	11	57712593-57740973	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Lissencephaly, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040282, HPA063763"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"		"HPA040282: AB_10697715, HPA063763: AB_2685116"	"unprognostic (3.66e-3)"	"unprognostic (6.96e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.73e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.64e-4)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (4.48e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.26e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (1.55e-5)"	"unprognostic (5.88e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (3.37e-4)"	52.9	75.1	77.7	37.3	83.0	27.0	50.5	87.4	101.9	43.6	103.3	70.0	56.4	39.4	58.2	62.8	42.7	33.2	71.5	75.0	84.1	78.7	83.4	45.0	31.5	81.7	81.5	40.9	57.7	84.9	43.1	44.0	83.5	50.1	80.8	64.7	49.6	53.8	44.7	45.1	58.3	43.1	84.3	44.9	60.9	30.6	85.5	34.9	57.1	41.3	47.6	48.2	43.8	90.6	122.7	141.4	78.5	143.4	144.8	77.2	86.6	144.2	111.8	140.0	117.9	135.3	205.6	115.1	156.6	116.3	207.1	220.0	203.5	115.4	146.3	83.3	88.9	110.2	105.7	136.8	119.3	156.6	145.5	94.8	166.5	154.8	243.2	76.3	80.6	95.3	194.4	130.9	157.7	62.7	93.0	177.1	153.8	227.7	191.5	124.7	97.9	242.5	174.4	136.4	90.3	129.3	110.2	255.7	168.3	76.7	228.5	102.2	66.7	130.5	84.8	176.1	152.1	127.9	269.5	115.3	146.6	109.3	198.3	37.8	41.5	40.0	34.6	72.4	44.0	36.8	34.4	40.9	40.6	34.9	43.1	43.8	11.2	37.8	86.0	49.7	32.0	45.0	77.7	83.0	87.4	101.9	75.0	84.1	81.7	81.5	83.5	84.3	85.5	90.6	37.9	38.5	34.0	0.0	32.0	32.1	44.9	108.2	19.9	43.4	35.8	28.1	42.6	30.0	60.8	49.7	31.3	108.0	29.9	39.5	43.0	72.4	2.0	19.6	27.4	36.8	28.8	37.6	0.0	43.5	85.6	38.6	23.0	20.7	43.1	29.9	31.8	48.7	62.0	30.3	0.0	49.6	81.4	30.8	21.4	3.6	48.7	31.9	48.0	0.0	37.8	91.1	19.6	0.0	0.0	54.5	32.0	43.6	32.5	49.0	51.4	41.1	37.4	66.7	39.5	36.3	34.5	60.7	62.2	33.6	32.7	99.6	26.6	46.6	75.2	43.6
TNFAIP3	"A20, OTUD7C"	ENSG00000118503	"TNF alpha induced protein 3"	P21580	6	137867214-137883312	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Ubl conjugation pathway"	"DNA-binding, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 519.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 774.9;Endometrial ciliated cells: 605.2;Glandular and luminal cells: 1498.3;Macrophages: 596.6;Suprabasal keratinocytes: 745.7;T-cells: 624.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 106.5;Karpas-707: 161.3;REH: 151.5;U-266/84: 131.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002116	Approved		Approved	Centrosome,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Centrosome, Cytosol"		"HPA002116: AB_1858162"	"unprognostic (5.50e-3)"	"unprognostic (9.98e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.01e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.01e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (6.06e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	57.0	15.6	4.4	114.6	3.8	519.5	23.3	2.9	23.9	27.5	12.0	22.6	21.4	31.3	5.2	26.6	23.4	47.8	23.0	3.2	2.8	13.8	27.4	56.2	76.8	6.1	3.9	73.2	25.8	25.8	7.5	28.9	6.7	17.3	24.7	19.1	16.1	10.3	8.6	50.5	30.7	33.5	6.6	46.1	22.8	8.3	9.5	71.1	11.7	3.8	55.7	171.1	14.6	6.2	32.6	4.8	1.8	2.8	10.1	16.9	7.8	18.8	67.6	4.8	5.7	34.9	8.8	7.3	43.1	20.0	106.5	22.6	1.1	50.4	8.9	46.8	2.2	7.5	19.8	21.1	11.2	10.3	12.8	15.6	7.3	56.4	53.6	5.6	2.9	21.2	17.4	161.3	8.4	1.8	56.2	41.4	1.5	2.1	1.4	151.5	39.4	6.1	14.8	15.1	0.7	0.3	3.6	5.3	16.9	7.0	3.4	11.7	14.8	46.9	6.8	46.0	9.6	48.7	131.4	14.0	16.9	13.1	6.1	7.3	12.6	9.6	19.6	9.3	27.9	7.4	19.4	18.0	14.3	7.8	13.1	10.1	13.6	11.1	5.1	26.2	19.2	14.8	4.4	3.8	2.9	23.9	3.2	2.8	6.1	3.9	6.7	6.6	9.5	6.2	71.8	38.5	76.3	2.0	94.5	774.9	150.2	102.1	384.7	1.1	29.0	42.3	4.6	25.8	53.7	0.0	29.2	8.1	395.5	53.9	1.9	60.0	2.6	605.2	365.9	114.8	11.9	5.2	0.1	26.9	104.8	110.1	111.1	1498.3	255.9	2.3	48.5	13.5	45.7	0.0	0.3	38.6	67.1	125.2	461.8	3.2	6.8	596.6	129.9	8.4	59.1	1.7	14.4	2.0	0.3	30.5	29.5	6.0	331.4	170.2	37.3	3.1	84.3	13.3	6.6	29.0	94.9	2.7	2.2	367.9	745.7	23.1	624.2	14.9	20.9	78.1
TNIK	KIAA0551	ENSG00000154310	"TRAF2 and NCK interacting kinase"	Q9UKE5	3	171058414-171460408	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1074.4;Excitatory neurons: 248.4;Inhibitory neurons: 360.8;Oligodendrocyte precursor cells: 374.5;Oligodendrocytes: 205.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 65.2;HMC-1: 71.3;WM-115: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012128, HPA012297"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		160000	"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA012128: AB_1858226, HPA012297: AB_1858225"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.97e-2)"	1.4	4.4	25.7	6.2	33.7	4.4	2.1	4.1	17.5	1.3	0.0	8.2	21.0	3.4	0.9	4.1	2.8	5.1	9.4	20.8	15.7	3.8	3.1	8.9	6.7	25.5	18.7	1.5	3.7	0.5	8.4	1.9	6.3	3.5	6.7	19.4	1.9	4.6	23.2	1.0	21.3	4.3	19.0	4.5	7.0	7.7	20.1	7.0	6.3	23.6	5.3	4.8	2.1	10.7	0.9	1.2	43.4	4.7	0.8	0.1	10.4	9.3	2.5	7.3	4.8	41.5	16.9	0.0	3.4	9.0	6.9	14.1	6.3	2.6	7.3	0.3	9.8	65.2	3.7	0.0	19.0	13.0	71.3	6.1	5.9	4.3	0.9	15.7	43.6	10.5	23.3	0.1	1.1	1.1	4.1	13.5	18.2	30.6	17.9	0.0	11.8	16.6	12.0	0.1	2.1	2.3	5.8	0.4	9.6	4.1	20.4	2.9	0.5	0.0	7.9	20.5	7.1	0.1	0.0	0.1	1.8	13.8	52.1	4.6	0.1	10.5	3.5	0.0	4.4	0.0	4.2	3.2	0.0	0.2	5.8	3.1	0.1	2.4	0.1	0.0	5.3	1.0	25.7	33.7	4.1	17.5	20.8	15.7	25.5	18.7	6.3	19.0	20.1	10.7	0.7	6.4	50.4	1074.4	4.9	2.5	1.6	1.3	9.1	19.2	8.4	6.5	28.6	21.5	7.1	9.2	14.6	6.3	32.5	19.6	5.9	12.1	48.6	1.1	2.5	1.6	13.2	13.5	248.4	7.7	1.3	9.1	21.4	0.3	83.5	0.4	2.5	8.1	2.9	0.0	360.8	10.3	0.0	6.5	1.9	38.0	2.5	10.4	1.8	57.1	1.6	65.0	51.5	374.5	205.5	7.1	21.6	6.4	11.7	0.7	56.2	17.3	1.8	28.7	0.0	12.4	6.2	3.1	1.0	10.3	1.6	2.5	47.4	9.9	16.6	3.2
TNNI3K	CARK	ENSG00000116783	"TNNI3 interacting kinase"	Q59H18	1	74235387-74544428	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"heart muscle: 58.7"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 27.0;Early spermatids: 32.0;Late spermatids: 6.6;Proximal tubular cells: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CAPAN-2: 1.0"															NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (1.04e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.66e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.59e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.20e-1)"	"unprognostic (8.80e-2)"	"unprognostic (8.77e-2)"	1.8	1.4	3.6	0.3	3.6	0.1	1.4	4.9	7.2	1.0	2.0	2.0	0.4	1.3	2.5	0.6	1.5	0.4	58.7	3.7	3.9	3.4	0.4	0.9	0.4	3.3	3.2	1.5	0.4	0.7	2.3	0.0	3.6	1.1	0.5	5.2	0.8	0.4	1.5	1.6	0.8	0.9	3.5	1.4	1.1	4.0	3.5	0.4	1.0	0.6	0.5	1.4	0.9	4.8	0.0	0.1	0.2	0.0	0.1	0.4	0.0	0.0	0.3	0.0	0.2	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.6	3.6	4.9	7.2	3.7	3.9	3.3	3.2	3.6	3.5	3.5	4.8	0.1	0.0	0.0	0.0	0.0	0.9	0.1	0.2	0.0	1.2	0.2	0.3	27.0	0.0	0.1	1.8	0.0	0.0	0.0	0.1	1.9	0.1	32.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	6.6	0.9	0.2	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	8.0	0.1	0.5	0.0	0.6	0.8	0.5	1.4	0.0	0.3	0.1	0.1	0.0	0.0	0.2
TOP3A	"TOP3, ZGRF7"	ENSG00000177302	"DNA topoisomerase III alpha"	Q13472	17	18271428-18315007	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, Disease variant, Dwarfism, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002449	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"			"CAB002449: AB_564037"	"unprognostic (5.49e-2)"	"unprognostic (9.04e-2)"	"unprognostic (8.99e-2)"	"unprognostic (7.24e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.33e-3)"	"unprognostic (6.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.39e-4)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (5.58e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.53e-2)"	"unprognostic (5.05e-2)"	"unprognostic (6.05e-2)"	9.4	8.0	1.9	3.3	1.8	5.7	8.6	3.1	2.6	8.6	2.1	7.8	2.3	8.4	1.6	8.6	8.5	2.1	6.0	1.8	1.8	7.0	11.2	7.7	3.6	1.7	1.6	7.5	7.7	2.6	8.9	2.5	1.7	7.7	2.4	2.1	8.1	1.7	10.0	11.3	8.2	2.6	1.4	11.4	7.6	11.7	2.0	4.2	6.7	2.5	3.3	8.5	7.8	2.0	9.3	14.2	9.4	11.1	3.8	4.6	10.9	9.4	4.9	14.2	12.8	22.4	3.4	13.7	6.0	6.5	6.6	11.7	12.6	6.7	11.5	11.6	11.4	13.1	15.2	7.9	4.3	5.8	11.9	2.9	4.6	15.0	8.7	2.9	7.3	11.5	11.3	5.7	6.1	6.4	15.2	5.9	8.7	13.8	6.8	17.4	22.6	14.8	3.2	8.1	7.7	13.6	12.6	8.3	8.4	24.5	16.1	6.5	6.5	10.6	8.1	18.2	15.4	5.8	13.7	10.4	6.6	8.0	10.5	1.1	3.1	3.4	1.8	2.7	1.3	0.7	1.3	1.6	1.3	0.8	1.1	1.2	4.2	2.2	1.5	1.2	1.2	2.0	1.9	1.8	3.1	2.6	1.8	1.8	1.7	1.6	1.7	1.4	2.0	2.0	5.3	6.4	4.8	6.5	9.7	2.0	4.5	4.5	6.8	20.8	6.2	3.9	3.1	5.7	7.4	11.0	39.6	7.4	11.8	4.6	3.9	4.2	7.2	5.0	8.7	6.2	0.0	9.9	16.4	3.7	6.9	6.3	6.6	6.3	5.1	12.1	6.4	7.0	5.4	21.9	17.2	4.2	4.1	12.4	6.3	7.9	8.1	11.6	1.8	12.2	13.9	6.4	15.5	11.6	11.2	3.6	2.8	6.4	12.0	5.8	3.8	2.1	6.5	22.2	13.1	9.3	6.6	26.7	25.5	5.2	3.4	4.4	9.0	13.1	5.9	5.0
TOPORS	"LUN, RP31, TP53BPL"	ENSG00000197579	"TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase"	Q9NS56	9	32540544-32552586	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 169.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 67.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 67.6"	"Cell line enhanced"	"Detected in all"		"HEL: 90.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060640, HPA065661"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA060640: AB_2684334, HPA065661: AB_2685527"	"unprognostic (1.75e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (7.07e-4)"	"unprognostic (2.70e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (6.64e-6)"	"unprognostic (1.22e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.92e-1)"	9.8	9.8	5.4	8.4	6.3	25.2	12.4	10.5	8.5	10.3	7.3	9.2	8.3	11.4	10.0	9.9	7.6	8.7	6.8	5.4	6.6	13.2	16.2	9.3	9.3	6.1	6.1	15.3	8.6	14.0	6.9	10.0	6.2	11.2	9.3	11.5	7.6	9.3	7.2	9.6	8.8	11.2	5.9	10.5	8.9	14.8	6.6	14.5	14.1	10.4	10.1	10.3	7.2	8.3	16.6	15.1	20.4	17.9	24.4	21.8	12.9	20.7	19.5	16.9	19.5	9.5	8.3	26.8	11.7	20.8	14.8	10.9	24.2	23.5	23.6	22.5	13.3	90.8	25.2	11.9	15.1	26.1	24.0	17.9	25.8	24.4	17.1	20.9	20.8	20.1	16.1	13.6	27.9	8.9	23.5	47.6	27.2	12.3	15.2	23.9	18.1	12.2	22.5	17.2	10.1	16.1	20.7	11.2	13.8	22.9	11.3	14.7	22.0	18.4	18.6	9.6	15.5	9.5	16.2	28.5	17.0	14.8	8.4	38.8	10.0	21.3	9.6	9.8	10.3	9.4	10.4	11.4	10.2	10.8	13.9	13.8	67.6	15.0	13.6	8.2	13.5	7.3	5.4	6.3	10.5	8.5	5.4	6.6	6.1	6.1	6.2	5.9	6.6	8.3	69.2	54.5	32.0	10.7	49.1	47.2	45.3	33.7	61.5	46.8	32.7	28.6	18.4	25.8	37.0	25.8	37.5	31.9	63.4	26.3	19.6	25.1	169.9	36.2	38.1	48.8	45.9	66.5	14.5	18.4	16.9	42.0	25.0	45.5	41.8	43.6	26.4	24.3	17.7	55.5	15.5	22.9	44.7	19.1	35.3	21.8	33.2	31.8	19.6	7.5	30.4	43.5	36.0	13.0	22.4	21.1	24.3	32.7	39.5	39.0	24.3	22.7	22.3	42.0	19.7	54.0	48.2	54.4	53.7	39.0	47.6	50.8	55.4	43.1	24.0	49.8
TP53	"LFS1, p53"	ENSG00000141510	"Tumor protein p53"	P04637	17	7661779-7687538	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Host-virus interaction, Necrosis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002973, CAB039238, CAB039239, HPA051244, HPA063532, CAB072876, CAB079965"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	"Mitochondria, Cytosol"	"CAB002973: AB_2206626, CAB039238: , CAB039239: , CAB072876: AB_2665731, CAB079965: , HPA051244: AB_2681403, HPA063532: "	"unprognostic (2.29e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.26e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (9.95e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (1.86e-3)"	"unprognostic (7.89e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.08e-1)"	19.3	13.8	10.4	27.1	12.6	19.6	22.5	10.4	16.5	19.9	10.3	29.0	18.9	24.5	12.8	28.8	31.3	13.2	11.1	10.1	11.4	14.9	16.5	15.1	34.6	18.7	13.6	27.3	18.3	9.4	7.3	23.5	12.5	17.7	27.5	4.1	18.9	15.3	12.3	37.4	20.4	24.6	12.6	31.1	22.6	10.4	12.3	47.2	17.4	6.1	45.4	20.8	19.9	13.3	81.5	145.3	81.1	57.3	37.3	43.9	82.8	28.4	66.1	78.5	100.2	4.2	40.6	190.5	126.9	58.7	77.6	174.9	119.7	80.4	72.8	42.7	76.5	77.6	76.8	70.9	111.5	1.6	37.0	55.7	93.0	38.9	106.5	45.6	79.4	24.7	3.8	6.9	41.5	145.1	130.0	96.3	80.2	10.4	2.4	252.2	56.1	66.2	59.4	87.3	46.0	80.5	94.1	62.6	24.3	39.4	109.2	7.4	100.7	91.6	30.2	1.0	48.3	47.6	37.9	82.5	23.6	9.7	80.1	1.2	21.2	3.4	13.0	21.7	15.9	21.5	13.3	14.6	30.3	19.1	13.7	15.4	2.4	17.5	19.3	27.3	17.3	14.7	10.4	12.6	10.4	16.5	10.1	11.4	18.7	13.6	12.5	12.6	12.3	13.3	21.1	9.6	12.8	16.3	26.0	28.7	14.5	24.6	24.5	2.6	36.1	30.4	2.5	18.6	15.4	20.2	0.0	36.9	24.7	16.9	9.8	24.8	12.8	11.5	29.0	24.5	30.7	21.7	2.1	18.1	39.6	17.0	11.2	19.5	1.3	31.7	22.1	18.0	24.2	0.0	3.2	43.0	18.3	27.8	20.1	3.8	23.0	19.3	12.4	7.5	31.9	4.9	25.7	9.0	8.0	15.8	16.4	17.0	7.8	15.7	10.3	10.1	8.8	2.6	13.1	25.9	20.6	0.5	4.9	28.7	32.8	22.4	16.5	27.4	54.1	11.5
TP53RK	"BUD32, C20orf64, dJ101A2.2, Nori-2p, prpk, TPRKB"	ENSG00000172315	"TP53 regulating kinase"	Q96S44	20	46684365-46689444	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 214.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 212.4;SK-MEL-30: 90.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004688, HPA015837"	Approved					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"CAB004688: AB_426116, HPA015837: AB_1855776"	"unprognostic (9.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (9.76e-2)"	"prognostic unfavorable (6.70e-5)"	"unprognostic (4.41e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (6.27e-5)"	"unprognostic (9.16e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.74e-2)"	6.5	7.7	6.0	7.3	5.3	6.3	8.9	4.7	6.1	6.9	2.6	6.5	4.8	7.0	4.6	8.8	6.3	5.7	5.1	5.0	6.1	6.8	7.0	5.7	11.2	5.1	5.3	6.2	5.4	7.4	6.2	6.0	5.0	7.9	6.0	6.4	7.1	6.1	6.7	9.6	5.9	6.8	4.8	7.0	7.0	12.1	6.9	13.2	8.0	5.3	11.9	10.6	6.8	6.5	12.7	8.7	17.9	15.9	18.5	15.1	16.6	17.7	16.3	22.7	16.4	24.7	8.0	32.2	26.1	14.6	20.3	19.6	23.1	20.3	19.6	7.9	12.0	31.0	8.4	22.4	24.3	20.2	212.4	20.3	24.2	15.8	15.4	10.6	15.3	12.7	21.5	13.1	19.6	19.1	31.0	35.5	14.6	18.1	29.8	17.9	16.2	19.1	15.2	14.1	21.6	11.5	21.3	42.1	90.7	9.3	15.4	21.8	15.7	26.3	15.5	17.5	19.8	14.5	19.6	24.7	15.2	15.2	12.6	36.6	16.1	28.4	16.9	15.8	19.5	19.9	18.2	19.4	16.7	19.3	19.9	17.1	2.7	22.5	14.6	25.4	25.5	17.4	6.0	5.3	4.7	6.1	5.0	6.1	5.1	5.3	5.0	4.8	6.9	6.5	12.6	9.6	13.1	5.2	14.3	50.7	54.8	45.9	39.9	9.4	22.8	21.2	7.0	18.6	27.7	9.2	12.5	42.6	23.9	10.4	27.4	28.9	214.7	13.3	25.6	17.5	13.1	16.2	5.0	23.8	73.6	29.1	23.4	14.2	22.9	14.6	11.0	12.2	25.8	15.2	4.7	16.5	32.6	14.4	28.5	49.9	22.1	13.1	37.4	4.7	17.9	8.1	21.6	6.0	6.0	34.7	4.9	16.1	8.4	62.6	15.5	31.1	18.0	10.4	6.6	8.8	26.1	87.6	15.6	35.2	61.8	88.7	19.4	26.8	13.1	59.9
TPI1		ENSG00000111669	"Triosephosphate isomerase 1"	P60174	12	6867119-6870948	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Glycolysis"	"Isomerase, Lyase"	"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 2470.8;tongue: 2005.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050924, HPA053568"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA		170000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Vesicles	"HPA050924: AB_2681276, HPA053568: AB_2682193"	"unprognostic (2.85e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (4.14e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (7.04e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	340.4	588.6	446.2	269.7	480.2	334.8	274.5	476.5	541.9	314.1	446.9	425.6	421.0	240.5	220.2	764.4	248.2	216.8	819.8	481.0	462.0	609.0	536.1	308.6	253.9	459.2	460.4	269.9	238.1	496.4	236.8	287.2	467.2	272.1	435.3	625.0	377.6	273.3	2470.8	410.1	404.5	301.5	429.7	291.4	329.0	239.8	503.5	200.3	269.1	2005.8	410.4	363.8	440.6	454.4	1556.8	1350.5	706.1	1094.6	666.5	696.6	1236.3	1097.5	1184.9	1999.1	2407.5	1409.9	823.0	903.4	212.7	1069.7	1042.4	748.8	1671.0	1812.3	2189.4	1196.4	1265.1	1172.0	924.4	926.2	496.8	1351.5	924.0	764.0	739.7	1537.8	1305.0	2816.1	1233.3	451.0	615.0	336.5	1554.5	1130.0	709.6	1119.5	1741.0	1302.3	855.9	413.5	1156.1	930.7	1261.4	1061.1	497.2	830.0	953.3	977.8	542.7	1452.6	224.4	1003.2	778.2	1068.0	914.6	703.1	1631.7	653.4	285.7	1327.8	2153.1	821.2	784.9	1708.8	2304.1	2375.2	824.6	2402.3	845.7	863.3	820.0	808.0	2656.1	800.9	570.5	703.0	934.3	1387.7	2165.7	482.0	1106.3	4679.5	446.2	480.2	476.5	541.9	481.0	462.0	459.2	460.4	467.2	429.7	503.5	454.4	311.5	134.6	204.2	34.6	290.6	684.8	553.8	1756.4	414.9	284.6	294.3	303.3	552.5	391.7	673.0	389.9	110.5	1017.0	278.2	850.3	1508.5	1361.5	203.0	280.8	307.0	352.0	425.5	243.3	38.4	786.5	1824.0	386.5	408.3	343.9	362.8	364.8	276.6	547.3	937.3	297.8	33.7	567.2	1151.5	386.7	750.4	683.5	279.0	482.8	674.1	18.7	1129.8	739.6	312.0	17.1	26.7	1081.5	889.4	263.3	427.9	556.2	1595.9	1642.7	401.2	298.0	197.2	270.5	551.3	14.9	79.0	690.4	615.9	1530.4	352.9	869.2	827.0	652.5
TPP1	"CLN2, LPIC, SCAR7, TPP-1"	ENSG00000166340	"Tripeptidyl peptidase 1"	O14773	11	6612768-6619448	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant, Epilepsy, Neurodegeneration, Neuronal ceroid lipofuscinosis, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 261.6;Kupffer cells: 376.5;Macrophages: 219.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037709, HPA044868"	Enhanced				"Intracellular and membrane"	NA	NA		9500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA037709: AB_10672913, HPA044868: AB_2679122"	"unprognostic (8.27e-3)"	"unprognostic (5.85e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.34e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (4.31e-4)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (3.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-2)"	74.7	145.9	71.0	74.6	81.0	111.7	44.3	80.3	81.4	53.8	120.1	59.1	59.9	74.0	43.1	39.5	47.1	65.1	56.3	70.6	78.4	71.6	92.7	81.5	77.7	85.2	82.6	49.7	36.2	54.2	63.6	94.2	81.0	38.9	59.7	48.5	42.5	57.5	31.4	39.5	73.3	92.0	74.7	135.0	48.4	20.0	83.3	47.4	45.7	39.0	60.9	68.4	42.8	90.4	26.1	48.1	25.9	50.5	309.9	160.1	21.8	50.9	220.7	36.9	62.0	20.1	122.5	37.4	32.6	136.6	220.2	85.8	48.3	68.7	57.9	37.3	27.6	32.2	23.8	54.9	210.9	45.8	182.6	231.8	104.5	45.9	102.6	240.4	158.8	32.9	59.8	124.6	110.4	30.2	16.6	52.4	18.0	61.5	57.1	36.1	21.6	77.0	62.8	38.2	4.5	20.4	52.6	44.6	91.0	76.5	30.8	79.7	188.0	119.7	33.1	101.1	19.8	92.3	95.3	14.0	139.8	101.7	64.5	67.0	167.1	38.2	39.9	171.2	30.0	35.1	31.4	41.0	185.9	37.0	20.1	27.2	27.5	29.1	125.1	93.1	60.3	138.8	71.0	81.0	80.3	81.4	70.6	78.4	85.2	82.6	81.0	74.7	83.3	90.4	32.0	25.6	37.3	31.6	53.0	23.7	28.4	29.8	13.1	24.8	21.1	23.9	41.8	50.1	26.8	16.5	12.5	35.4	71.0	55.2	5.9	42.2	11.8	13.3	30.2	40.7	16.7	37.5	12.5	13.4	45.3	40.3	16.3	24.8	62.2	25.6	75.7	81.0	261.6	15.2	12.4	31.3	26.4	376.5	126.5	11.2	27.1	219.8	90.7	15.9	156.0	37.9	49.4	8.0	21.9	17.4	44.1	26.4	26.4	23.5	99.7	51.6	14.5	23.8	6.6	19.0	20.3	0.8	1.1	27.6	20.0	88.0	42.2	24.6	32.5	26.5
TPR		ENSG00000047410	"Translocated promoter region, nuclear basket protein"	P12270	1	186311652-186375693	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 772.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019661, HPA019663, HPA024336"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA		30000000	"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear membrane"		"HPA019661: AB_1858215, HPA019663: AB_1858216, HPA024336: AB_1858217"	"unprognostic (4.51e-2)"	"unprognostic (9.87e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.88e-3)"	"prognostic favorable (4.71e-4)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.31e-3)"	"unprognostic (3.75e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	19.8	14.5	12.2	23.4	14.1	28.9	19.7	14.4	10.9	17.6	18.4	17.6	15.5	20.3	19.7	14.8	15.0	16.1	17.1	9.5	12.9	16.0	15.4	18.0	26.0	13.6	12.0	23.1	15.5	34.2	13.4	26.7	13.8	17.2	20.0	19.8	15.8	17.6	20.4	24.2	19.3	17.6	12.2	22.9	19.1	43.8	13.3	31.0	22.7	22.3	26.0	19.6	14.5	15.1	55.9	46.7	68.2	39.8	53.4	47.4	73.2	62.0	41.2	42.8	40.4	70.5	45.9	64.0	47.1	42.1	29.4	70.9	51.9	42.4	52.1	51.8	58.6	86.8	78.3	49.7	28.7	93.1	53.5	36.4	25.0	64.4	49.4	39.3	51.3	36.5	106.0	57.3	45.8	47.5	46.2	24.5	76.1	49.9	16.0	54.3	54.3	56.5	34.8	65.0	37.7	59.5	72.9	47.1	37.6	92.5	53.1	58.0	73.0	42.5	40.6	47.7	76.6	63.2	77.6	57.0	27.5	45.8	38.7	121.4	34.1	69.0	43.8	30.0	37.7	48.9	38.6	36.8	20.6	55.4	47.3	32.8	145.7	33.0	50.4	58.7	49.1	17.3	12.2	14.1	14.4	10.9	9.5	12.9	13.6	12.0	13.8	12.2	13.3	15.1	126.4	218.0	119.6	43.1	122.9	101.2	105.5	98.6	114.9	89.8	65.8	79.8	180.0	54.3	110.0	58.8	79.2	136.9	136.8	51.2	23.5	107.1	199.3	129.1	151.7	123.8	67.7	102.4	42.5	74.7	99.9	126.5	80.5	134.4	81.0	134.2	74.6	40.8	72.8	99.3	42.6	61.9	93.6	64.2	79.3	50.4	125.6	92.6	55.2	39.4	137.3	101.1	139.0	48.2	62.8	90.1	56.7	117.4	113.7	95.1	52.4	27.7	120.9	111.4	131.5	172.5	152.1	772.9	250.4	85.6	99.2	150.8	145.8	160.0	77.7	96.0
TPSAB1	"TPS1, TPS2, TPSB1"	ENSG00000172236	"Tryptase alpha/beta 1"	Q15661	16	1240379-1242554	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	13	"granulocytes: 5873.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	893	"basophil: 89.3"	"Lineage enriched"	"Detected in single"	893	"granulocytes: 89.3"	"Cell line enriched"	"Detected in some"	166	"HMC-1: 3813.2"									"CAB016369, CAB022175, HPA049153, HPA049554"	Supported				"Secreted to blood"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"CAB016369: AB_628406, CAB022175: , HPA049153: AB_2680656, HPA049554: AB_2680815"	"unprognostic (2.06e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.64e-2)"	"unprognostic (9.31e-3)"	"prognostic favorable (9.62e-6)"	"unprognostic (1.02e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.36e-2)"	96.6	2.9	0.3	23.6	0.5	2.4	47.2	0.3	0.9	53.7	0.9	83.0	71.6	73.3	6.0	64.3	26.6	129.7	14.7	0.4	0.4	13.9	12.2	128.5	21.3	0.4	0.3	3.2	18.9	2.3	3.5	1.2	0.6	65.9	34.6	0.0	60.2	22.5	10.1	122.7	148.7	17.9	0.4	5.9	104.0	8.9	0.4	14.2	4.7	13.0	13.2	113.5	52.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	1.3	3813.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.3	2.1	6.1	0.5	0.4	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.1	1.1	0.0	0.0	2.8	22.9	2.0	89.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.5	0.3	0.9	0.4	0.4	0.4	0.3	0.6	0.4	0.4	0.3	0.0	25.6	135.5	0.0	2.9	18.6	5.1	0.0	1.2	0.0	0.9	0.1	0.3	0.0	8.1	0.0	0.0	0.0	0.2	0.9	0.0	1.2	0.3	0.0	0.0	4.1	0.0	3.8	0.0	0.0	0.2	7.6	0.5	0.0	5873.9	0.0	0.0	0.3	5.2	0.0	0.0	0.0	0.0	0.3	25.6	0.2	0.0	7.7	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	11.7	4.0	0.4	0.1	5.1	0.0	0.0	0.3	3.2	0.0	0.1	0.1	9.9	0.3	440.9	0.0	0.5	5.6
TRAF3	"CAP-1, CD40bp, CRAF1, LAP1, RNF118"	ENSG00000131323	"TNF receptor associated factor 3"	Q13114	14	102777449-102911500	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Immunity, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002933	Uncertain					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA002933: AB_1080352"	"unprognostic (4.06e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.49e-3)"	"unprognostic (5.25e-2)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (1.31e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.42e-5)"	"unprognostic (1.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.12e-1)"	6.6	4.2	8.3	18.8	8.7	20.5	4.8	6.3	14.5	3.9	7.6	7.9	7.7	5.8	2.3	6.6	6.8	6.2	6.3	15.6	12.1	5.4	6.4	7.3	20.9	9.8	9.9	3.3	4.5	7.2	8.4	3.9	9.5	5.0	6.3	4.4	4.8	5.7	5.6	6.8	10.7	6.4	8.1	12.0	6.7	10.7	12.8	9.4	6.1	3.3	15.9	8.8	4.7	8.0	25.3	26.4	14.8	9.7	7.5	11.4	23.4	19.1	19.0	19.1	16.7	13.3	36.7	18.6	22.5	19.2	25.8	14.9	20.4	20.4	19.1	50.2	13.9	18.2	11.7	10.3	12.0	21.4	54.5	11.4	13.9	13.1	18.3	10.9	13.9	27.8	18.2	57.4	11.8	23.6	46.2	12.6	8.0	10.7	19.2	25.5	19.8	11.7	16.8	29.3	38.3	13.8	19.8	14.1	13.0	6.6	13.1	24.2	29.9	18.0	14.8	48.0	27.8	42.2	51.7	36.0	20.5	10.8	21.8	3.3	5.1	1.8	2.9	4.0	2.4	10.0	4.2	2.6	3.6	9.5	3.0	2.1	3.8	2.4	2.5	5.9	3.8	5.0	8.3	8.7	6.3	14.5	15.6	12.1	9.8	9.9	9.5	8.1	12.8	8.0	4.2	6.4	8.9	54.5	43.3	12.2	20.4	20.0	18.2	42.6	9.1	6.9	8.0	10.0	13.8	0.0	6.2	5.3	12.8	14.9	3.9	15.8	9.7	20.2	13.5	8.6	17.4	2.1	108.3	17.8	11.7	11.2	8.6	12.2	8.2	3.5	1.4	5.3	12.9	15.2	63.1	15.8	10.2	8.7	29.5	7.6	1.8	20.3	17.8	23.4	18.1	5.4	8.2	63.8	43.6	22.6	5.9	6.4	42.1	28.8	16.9	8.3	19.2	11.0	0.0	12.2	8.4	14.2	33.2	12.7	12.6	3.4	21.9	1.5	11.3	24.9
TRAF3IP2	"ACT1, C6orf2, C6orf4, C6orf5, C6orf6, CIKS, DKFZP586G0522"	ENSG00000056972	"TRAF3 interacting protein 2"	O43734	6	111555381-111606906	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Inflammatory response, Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 61.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 149.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA036352	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"	Vesicles	"HPA036352: AB_10672085"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (1.79e-1)"	"prognostic favorable (4.73e-5)"	"unprognostic (2.81e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (5.16e-5)"	"unprognostic (1.11e-1)"	"unprognostic (4.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.31e-1)"	19.7	16.3	24.8	19.5	24.8	32.4	19.9	24.3	29.4	24.9	23.7	34.0	28.6	36.2	47.2	26.5	34.7	14.2	8.3	24.4	26.0	9.3	8.6	17.5	16.3	27.2	28.2	13.9	21.6	13.6	9.3	14.2	25.6	19.2	26.4	5.9	25.3	30.8	11.4	35.0	25.1	22.1	21.7	6.8	35.5	3.0	28.7	21.0	14.8	14.8	22.5	26.5	18.1	22.9	32.2	11.0	6.8	15.7	35.9	39.0	15.6	39.8	62.2	9.9	14.1	8.7	14.1	6.2	13.2	33.5	35.5	58.2	8.0	86.2	18.4	43.2	11.6	12.7	10.6	11.9	13.9	6.9	22.6	47.1	57.5	29.9	110.1	24.9	20.0	15.2	13.6	1.9	13.2	22.0	51.2	19.4	9.0	30.6	8.8	53.3	12.4	2.7	29.5	52.4	27.3	6.9	12.1	71.8	47.8	12.7	31.6	18.0	9.2	19.2	7.6	149.7	35.5	0.8	12.4	16.8	45.8	10.8	50.1	25.8	2.5	5.3	3.8	0.8	12.7	6.4	7.6	5.6	2.6	8.6	7.6	7.4	3.5	5.7	0.3	0.8	17.9	3.1	24.8	24.8	24.3	29.4	24.4	26.0	27.2	28.2	25.6	21.7	28.7	22.9	24.7	3.2	13.8	26.1	10.8	30.1	61.5	46.3	11.4	7.5	8.3	8.6	4.9	7.2	21.6	3.7	12.5	19.3	3.8	30.0	5.9	35.4	0.1	20.9	14.5	18.3	13.2	5.2	5.9	31.9	28.8	14.4	18.3	32.7	20.2	7.7	3.9	5.5	6.0	6.7	10.8	16.9	16.2	1.3	10.7	0.5	7.2	5.8	12.4	7.5	6.2	14.2	8.2	19.6	6.6	20.2	26.3	7.5	4.5	42.9	18.5	5.9	18.3	5.5	0.0	14.7	10.5	0.8	2.1	16.2	24.6	20.9	7.9	4.6	21.9	45.0
TRAF7	"DKFZp586I021, MGC7807, RFWD1, RNF119"	ENSG00000131653	"TNF receptor associated factor 7"	Q6Q0C0	16	2155698-2178129	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041229	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Plasma membrane"	"HPA041229: AB_10794194"	"unprognostic (1.94e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.77e-3)"	"unprognostic (7.08e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.23e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (8.48e-2)"	29.1	29.4	16.5	24.4	15.1	35.0	28.2	18.2	23.0	32.1	17.0	38.0	40.0	31.2	11.6	54.6	30.4	22.2	21.3	17.9	14.6	28.1	51.5	33.2	22.9	17.8	15.3	23.5	37.4	14.6	32.1	20.6	14.8	27.0	17.4	8.5	34.7	16.5	30.4	47.7	35.2	18.8	14.2	34.5	35.6	14.8	17.7	19.1	25.6	9.9	18.6	34.5	34.8	14.3	57.7	72.2	40.3	72.5	40.8	76.5	47.4	43.4	53.9	49.9	44.6	88.2	72.1	36.6	50.2	55.4	31.8	65.9	38.1	76.8	18.8	58.3	48.8	52.4	98.5	68.3	53.8	56.3	72.7	76.2	62.8	48.1	62.6	41.0	97.4	70.6	57.1	47.9	48.2	131.1	58.3	65.2	79.7	78.7	34.8	107.4	66.7	74.2	40.2	30.4	80.9	67.2	36.3	68.5	48.6	20.9	78.1	68.2	74.3	60.2	83.9	56.7	48.2	69.2	55.0	48.4	34.4	35.9	47.8	4.0	9.1	7.3	4.5	12.4	4.3	5.5	4.4	4.7	11.2	3.9	3.1	3.8	6.2	2.9	8.9	5.3	6.5	5.3	16.5	15.1	18.2	23.0	17.9	14.6	17.8	15.3	14.8	14.2	17.7	14.3	18.9	0.0	9.2	12.4	18.2	28.8	21.1	34.2	22.8	15.9	31.6	27.9	4.9	21.5	20.8	14.7	6.2	23.5	17.4	56.4	17.6	39.0	5.0	23.6	34.6	26.5	34.0	33.6	8.9	59.0	36.3	19.0	38.7	27.9	9.5	22.1	26.0	32.3	42.2	37.0	8.2	38.7	34.6	41.8	21.3	13.1	24.8	26.8	10.6	8.4	33.9	12.6	6.2	6.6	4.9	53.0	43.6	22.2	24.0	33.8	80.0	29.2	19.7	10.9	6.6	11.9	18.3	8.5	25.3	50.7	32.5	26.7	16.0	29.0	42.5	38.5
TRAIP	"RNF206, TRIP"	ENSG00000183763	"TRAF interacting protein"	Q9BWF2	3	49828601-49856574	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 8.2;Spermatocytes: 15.6;Spermatogonia: 9.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 10.8"	"HPA036261, HPA036262"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"HPA036261: AB_10673348, HPA036262: AB_2675029"	"unprognostic (5.30e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.68e-3)"	"prognostic unfavorable (8.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.24e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.01e-5)"	"unprognostic (5.84e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	1.5	1.0	1.6	1.8	2.5	6.8	1.9	0.7	1.8	2.0	0.4	2.3	1.5	1.7	1.4	2.9	1.8	1.0	0.9	1.6	0.9	0.8	0.8	0.9	4.6	0.6	0.6	2.1	1.0	0.8	1.2	1.6	0.7	1.4	2.9	2.3	1.2	0.9	2.0	4.2	2.0	2.1	0.6	1.9	1.2	7.9	1.3	5.3	1.4	1.2	4.4	1.3	1.9	0.9	10.4	12.4	17.4	17.6	1.6	2.4	14.4	12.4	5.8	25.3	24.0	15.2	11.6	25.5	8.5	7.1	17.7	13.4	18.5	14.0	18.8	14.7	12.2	19.2	16.3	13.6	0.7	15.8	15.4	1.6	2.0	20.4	10.7	3.0	6.7	22.3	14.0	17.8	11.4	15.1	26.5	20.1	14.0	12.3	20.3	14.4	11.7	14.8	4.6	14.2	8.4	14.4	13.6	11.3	8.8	12.4	10.2	22.4	5.2	16.1	19.0	22.5	24.4	13.0	33.7	27.3	8.1	21.2	14.6	0.0	0.6	0.3	0.9	0.3	0.9	2.9	0.5	2.1	0.6	1.5	0.7	1.1	0.1	1.2	1.3	0.7	0.3	0.6	1.6	2.5	0.7	1.8	1.6	0.9	0.6	0.6	0.7	0.6	1.3	0.9	0.6	3.2	0.6	1.0	1.8	1.1	0.6	1.5	2.2	2.8	1.2	1.4	2.6	0.0	0.3	3.7	0.0	4.2	1.2	1.8	0.0	2.0	4.3	0.6	0.9	0.8	0.0	3.8	1.4	1.0	8.2	2.0	1.5	0.9	0.0	5.7	1.1	0.7	3.5	0.0	0.9	2.0	0.0	0.8	0.4	4.8	2.5	0.7	1.8	1.0	1.8	1.7	0.0	0.5	0.6	1.1	0.3	1.2	4.3	0.8	0.9	0.3	0.5	3.3	0.0	1.4	1.7	15.6	9.1	2.3	0.3	1.0	1.2	1.2	4.6	0.2
TRDN	TRISK	ENSG00000186439	Triadin	Q13061	6	123216339-123637093	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 421.6;skeletal muscle: 1944.1;tongue: 1018.2"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 1145.1;Muller glia cells: 765.7;Skeletal myocytes: 398.6"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 2.2;prostate cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.9"	"Region enriched"	"Detected in some"	10	"olfactory bulb: 11.0"	"Region enriched"	"Detected in some"	23	"olfactory bulb: 28.9"	"HPA038226, HPA058226"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA038226: AB_10795574, HPA058226: AB_2683643"	"unprognostic (1.05e-2)"			"unprognostic (1.99e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.06e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.55e-2)"		"unprognostic (3.97e-2)"	16.3	2.6	4.2	0.0	3.7	0.0	2.0	4.0	5.8	0.7	3.1	0.4	0.0	1.7	10.4	18.5	12.5	0.2	421.6	3.0	12.5	0.4	0.1	0.4	0.1	6.7	7.0	1.3	0.1	0.0	15.3	0.2	7.9	17.0	0.3	83.5	13.1	0.9	1944.1	0.6	0.2	1.0	9.2	0.1	0.1	5.1	10.2	0.3	0.3	1018.2	0.1	0.0	0.6	6.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.7	4.0	5.8	3.0	12.5	6.7	7.0	7.9	9.2	10.2	6.3	0.3	0.0	0.0	4.2	0.0	0.0	0.5	0.0	0.0	7.9	0.0	0.3	1145.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	68.0	0.0	0.0	6.0	0.0	0.0	1.1	0.0	0.0	38.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.4	35.5	13.1	0.5	1.8	0.0	0.0	765.7	0.0	3.0	3.2	0.0	0.0	11.3	0.0	0.0	0.0	0.2	0.0	21.8	0.0	398.6	7.1	1.3	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TREH	"MGC129621, TRE, TREA"	ENSG00000118094	Trehalase	O43280	11	118657316-118679690	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 66.3"	"Group enriched"	"Detected in some"	5	"Late spermatids: 315.7;Proximal enterocytes: 186.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039913, HPA042045"	Enhanced		Approved	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		12000000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	Cytosol	Vesicles	"HPA039913: AB_10674988, HPA042045: AB_2677817"	"unprognostic (1.29e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.22e-4)"	"unprognostic (2.52e-1)"	"unprognostic (9.83e-2)"	"prognostic favorable (3.76e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (2.09e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-1)"	0.7	0.2	1.6	0.3	3.7	0.0	0.4	0.6	3.8	0.3	0.0	1.6	60.0	0.4	0.6	1.6	0.3	2.6	1.0	1.1	2.7	13.4	6.1	0.2	0.1	2.1	2.0	0.2	1.8	0.0	0.3	0.1	1.9	0.5	1.3	0.0	0.2	0.0	0.0	0.1	66.3	0.1	0.6	0.1	1.7	1.8	2.5	0.0	0.4	0.0	0.0	0.4	0.3	6.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.5	0.0	0.4	0.0	0.2	0.0	0.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.7	0.6	3.8	1.1	2.7	2.1	2.0	1.9	0.6	2.5	6.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.3	0.3	1.5	0.0	1.8	0.0	0.1	0.0	2.3	7.9	0.2	45.6	0.8	1.6	0.1	3.0	0.0	0.1	2.5	0.0	0.3	4.6	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	7.0	0.0	0.0	0.4	315.7	2.1	0.1	0.0	0.0	0.0	0.0	0.0	1.5	5.3	0.9	6.3	1.9	0.1	0.3	186.3	32.8	0.0	0.0	0.0	0.3	0.2	1.7	0.8	2.1	0.0	0.0	0.1	0.0	3.7	0.0
TREX1	"AGS1, DRN3"	ENSG00000213689	"Three prime repair exonuclease 1"	Q9NSU2	3	48465811-48467645	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Exonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease variant, Neurodegeneration, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 53.6;Club cells: 24.5;Ionocytes: 40.7;Langerhans cells: 22.6;Melanocytes: 24.9;Respiratory ciliated cells: 29.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 67.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035437, HPA046721"	Supported		Supported	Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"HPA035437: AB_10672092, HPA046721: AB_2732531"																		9.9	14.3	32.7	16.5	33.4	28.7	12.2	33.2	42.1	13.8	39.8	12.4	11.1	7.7	11.4	19.2	15.5	13.8	10.7	33.0	32.7	12.2	12.8	13.8	26.6	33.0	34.2	7.4	13.1	11.3	20.6	8.4	34.3	16.6	9.9	1.9	36.5	15.4	9.7	26.4	12.0	7.0	33.8	25.0	13.7	4.0	33.5	18.1	8.4	13.8	18.1	13.1	10.4	33.7	19.2	18.1	13.3	10.3	18.1	17.5	0.0	6.7	29.5	46.9	67.5	0.3	21.8	23.8	11.7	24.4	44.8	21.4	0.9	27.2	6.7	19.9	1.6	13.5	58.1	0.5	20.1	12.8	9.3	16.2	2.5	25.9	9.8	9.8	20.4	16.9	0.0	32.6	20.7	0.4	17.3	8.6	0.1	11.0	11.2	14.4	4.9	43.2	13.4	3.8	0.1	8.1	21.8	29.6	15.4	0.9	0.8	20.3	22.2	8.5	9.2	21.8	14.2	26.4	16.9	10.4	21.5	25.4	7.5	7.7	142.3	11.0	32.6	119.2	18.7	86.8	43.0	31.4	125.9	87.5	40.3	33.8	82.2	30.9	94.6	99.1	43.3	78.6	32.7	33.4	33.2	42.1	33.0	32.7	33.0	34.2	34.3	33.8	33.5	33.7	0.0	0.0	0.5	6.8	2.1	9.1	0.0	53.6	0.6	0.0	0.0	0.0	6.3	0.0	24.5	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	4.6	0.0	1.7	2.3	0.0	0.0	4.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.8	40.7	0.0	22.6	0.0	0.0	2.0	24.9	5.6	0.0	0.0	0.0	1.0	5.9	0.0	1.1	0.0	3.9	0.0	0.0	0.0	29.9	0.0	0.0	0.0	4.2	0.0	0.0	2.7	13.9	0.0	2.6	0.0	1.5	0.0
TRIM2	"CMT2R, KIAA0517, RNF86"	ENSG00000109654	"Tripartite motif containing 2"	Q9C040	4	153152163-153339319	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 116.2"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1132.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 47.0;SK-MEL-30: 46.8"									"HPA035853, HPA035854"	Supported		Uncertain	Centrosome		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 45: Intestine - Brush border"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Centrosome		"HPA035853: AB_10669533, HPA035854: AB_10669659"	"unprognostic (8.94e-2)"	"unprognostic (7.89e-2)"	"unprognostic (6.21e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.30e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.42e-2)"	"prognostic favorable (6.58e-14)"	"unprognostic (5.89e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.19e-2)"	"unprognostic (4.13e-2)"	5.8	11.8	29.5	4.8	64.4	0.1	11.8	38.6	46.2	23.6	0.0	21.6	17.4	9.9	8.0	10.7	15.2	12.6	8.4	48.0	34.8	24.2	7.9	7.2	2.2	40.1	33.2	12.8	12.7	1.0	21.6	2.5	56.3	13.1	19.3	19.4	42.9	13.4	2.1	7.1	17.3	7.0	35.3	10.6	27.4	1.9	37.9	2.9	50.6	3.0	3.9	12.0	11.5	116.2	10.2	0.2	47.0	24.2	22.0	27.2	0.5	12.7	15.4	3.6	4.5	4.1	0.2	0.1	7.7	21.7	8.5	6.4	24.7	4.7	3.2	0.0	5.4	0.1	4.6	0.5	24.7	0.1	0.1	13.5	2.3	5.4	4.7	12.9	3.4	0.4	0.2	0.0	4.9	0.4	2.4	0.1	37.4	27.5	8.8	1.0	9.4	0.0	37.0	11.8	14.5	27.3	4.4	2.7	46.8	6.9	1.7	0.5	2.8	12.7	3.0	10.8	3.9	0.0	0.0	0.1	20.9	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.1	29.5	64.4	38.6	46.2	48.0	34.8	40.1	33.2	56.3	35.3	37.9	116.2	11.2	6.4	33.7	189.0	2.6	7.0	15.3	40.2	9.1	67.7	40.5	29.1	39.6	17.2	82.1	58.8	29.2	2.0	0.7	59.4	101.8	9.6	3.3	113.3	16.3	17.3	62.3	0.4	266.4	26.1	0.5	22.0	80.0	95.6	1.3	4.8	21.0	12.4	1.4	111.0	211.2	64.1	54.9	0.8	7.7	2.4	29.5	2.2	64.0	21.5	3.2	86.9	0.0	237.2	1132.8	22.5	41.4	32.7	1.5	17.8	62.9	14.7	106.0	23.4	26.3	14.7	16.2	0.4	1.3	5.0	4.0	0.7	2.8	8.7	90.8	33.7
TRIM24	"hTIF1, RNF82, TIF1, Tif1a"	ENSG00000122779	"Tripartite motif containing 24"	O15164	7	138460259-138589996	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"AF22: 146.5;HMC-1: 196.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043495, HPA061717"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA043495: AB_10962915, HPA061717: AB_2684592"	"unprognostic (2.40e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.94e-4)"	"prognostic favorable (6.57e-4)"	"unprognostic (4.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.54e-2)"	"unprognostic (6.34e-2)"	7.5	25.7	6.0	6.9	6.8	10.6	9.1	5.8	7.0	6.4	5.2	8.1	10.0	8.8	8.4	9.0	5.7	5.3	10.4	6.0	7.1	8.0	23.1	11.4	8.0	6.8	6.4	30.0	10.8	14.2	3.8	12.3	6.3	11.7	9.2	12.2	8.3	5.2	13.9	8.6	9.7	7.6	6.2	7.2	11.6	27.3	8.2	17.3	9.1	16.4	7.8	7.5	6.1	9.0	15.0	18.1	146.5	42.7	9.6	8.9	11.4	13.7	14.4	10.5	10.2	28.7	13.6	28.7	13.2	13.2	21.5	7.9	71.9	11.4	15.4	22.1	17.7	63.1	13.1	88.9	13.1	49.8	196.8	7.9	11.8	8.8	13.9	7.3	25.0	15.4	72.6	17.1	12.7	29.2	85.2	44.8	56.3	77.6	16.0	66.5	17.3	24.2	23.6	43.9	30.3	68.8	25.5	22.6	7.5	50.6	15.5	32.3	10.7	12.1	9.9	21.4	19.1	15.6	18.2	47.8	20.1	32.1	18.0	0.3	0.6	1.0	0.5	0.6	0.1	0.2	0.4	0.3	0.5	0.3	0.4	0.5	0.9	0.6	0.3	0.3	0.7	0.2	6.0	6.8	5.8	7.0	6.0	7.1	6.8	6.4	6.3	6.2	8.2	9.0	29.0	51.3	46.9	26.1	9.5	13.9	13.4	13.8	10.8	13.6	14.7	14.4	39.7	20.0	18.8	7.3	16.7	28.4	14.9	12.2	5.9	7.1	70.4	16.7	22.9	18.9	10.1	31.3	27.9	12.4	15.2	16.0	20.4	25.2	40.4	85.2	14.3	31.9	10.3	40.4	46.6	10.9	14.2	9.5	14.9	38.7	14.0	13.8	14.2	21.5	12.2	23.3	9.2	64.3	67.1	9.5	9.5	16.1	13.7	12.2	6.8	10.6	14.5	22.4	13.1	21.5	17.6	72.8	14.7	22.2	11.8	22.2	15.8	34.6	19.4	12.8
TRIM27	"RFP, RNF76"	ENSG00000204713	"Tripartite motif containing 27"	P14373	6	28903002-28923988	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transport, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 49.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048684, HPA053408"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA048684: AB_2680493, HPA053408: AB_2682139"	"unprognostic (1.57e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.76e-3)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (3.50e-6)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (2.71e-4)"	23.8	28.1	1.8	7.2	1.7	1.1	23.3	1.1	2.6	33.0	2.2	23.0	8.7	24.5	0.0	20.5	31.0	0.5	24.3	1.6	1.3	32.7	59.5	26.8	2.2	2.2	2.1	30.8	53.0	0.6	33.8	4.5	1.8	35.1	0.6	0.1	25.8	6.5	21.2	17.6	26.8	2.3	1.5	45.8	27.3	14.4	2.0	0.9	26.3	0.0	1.0	28.7	22.6	2.0	2.4	8.2	1.2	21.7	2.8	6.2	0.3	16.1	0.8	5.1	6.2	6.1	1.7	1.6	1.1	4.8	1.3	17.5	4.0	9.2	0.5	1.3	2.6	20.3	2.5	9.3	4.3	2.0	5.7	0.1	1.0	4.1	1.3	0.6	4.5	5.8	2.1	12.1	1.3	4.9	11.1	0.9	0.0	3.4	13.5	20.1	4.6	49.7	3.9	2.3	4.9	18.7	19.9	11.6	4.1	0.6	11.6	12.2	13.1	6.3	9.3	14.7	5.1	31.7	2.7	17.9	6.8	24.8	20.0	5.2	4.4	2.5	7.0	12.5	11.3	7.0	10.6	5.5	8.5	1.8	4.1	7.6	2.7	6.4	7.0	5.6	5.2	9.9	1.8	1.7	1.1	2.6	1.6	1.3	2.2	2.1	1.8	1.5	2.0	2.0	21.4	16.0	24.8	11.8	32.2	28.4	41.9	27.4	33.6	11.7	32.2	24.6	18.3	24.3	24.0	29.5	16.7	46.4	25.4	15.9	21.5	39.5	12.9	27.1	27.0	32.0	27.6	24.6	13.5	43.4	55.5	25.5	26.5	27.2	21.5	36.9	27.8	42.1	41.1	8.4	13.4	38.5	26.4	28.3	23.5	6.8	23.9	29.0	8.8	16.9	46.5	10.4	29.9	19.1	19.7	48.9	18.7	18.4	51.2	53.3	19.3	27.6	23.9	13.6	19.7	14.8	31.0	8.0	16.1	25.8	19.6	45.6	28.9	43.7	28.3	30.9
TRIM32	"BBS11, HT2A, LGMD2H, TATIP"	ENSG00000119401	"Tripartite motif containing 32"	Q13049	9	116687305-116701300	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Limb-girdle muscular dystrophy, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050060	Approved		Approved	"Intermediate filaments"		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Intermediate filaments"		"HPA050060: AB_2681000"	"unprognostic (2.47e-2)"	"unprognostic (7.06e-3)"	"unprognostic (5.50e-2)"	"unprognostic (3.63e-1)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (4.53e-4)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (2.41e-3)"	"unprognostic (2.92e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.03e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.64e-3)"	"unprognostic (9.77e-2)"	6.7	7.2	4.6	5.4	4.5	1.0	6.8	16.4	5.4	10.1	15.2	6.0	5.9	10.6	6.5	7.4	13.1	6.4	7.9	4.7	6.1	5.2	3.8	5.5	8.1	3.6	2.8	10.1	6.2	8.6	3.5	6.1	3.9	6.9	6.2	7.2	5.2	7.3	18.6	4.6	7.2	10.7	2.1	6.2	5.4	5.2	4.5	7.5	6.3	12.5	7.4	7.6	5.7	3.4	10.9	24.5	14.3	15.7	28.3	20.1	10.8	19.9	21.7	22.1	18.4	16.4	11.7	11.3	8.6	30.7	16.5	22.8	17.5	22.4	20.0	9.9	8.5	6.1	15.4	10.2	14.7	4.1	19.1	17.4	19.7	21.0	12.3	24.4	14.6	12.4	8.6	9.3	26.3	13.9	11.0	0.1	13.0	26.2	14.6	12.7	38.2	7.4	9.0	25.1	14.2	7.2	15.7	10.8	11.4	14.3	29.8	4.0	18.2	20.4	16.2	15.3	15.2	15.1	4.3	17.7	17.0	2.7	20.5	0.0	1.7	0.0	10.9	3.3	8.4	7.3	9.5	8.7	2.3	5.1	9.6	9.8	0.3	7.0	3.0	4.3	20.9	6.0	4.6	4.5	16.4	5.4	4.7	6.1	3.6	2.8	3.9	2.1	4.5	3.4	2.5	6.4	0.6	5.5	4.3	4.2	6.3	9.3	5.7	11.7	3.1	3.7	7.6	7.2	7.3	9.2	0.0	6.7	2.1	1.7	1.9	8.5	3.5	7.1	10.7	3.6	4.2	0.4	7.6	8.0	3.6	6.1	3.6	2.3	2.5	4.5	2.9	4.1	7.2	1.7	10.1	4.0	8.2	2.4	4.7	2.1	5.3	2.2	1.8	1.9	0.8	4.0	3.1	6.6	5.1	5.0	2.6	12.0	3.1	2.8	10.6	3.1	10.8	4.8	0.0	6.0	6.6	17.7	13.1	5.6	3.7	7.4	4.7	5.0	5.3	4.8
TRIM33	"FLJ11429, KIAA1113, PTC7, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA"	ENSG00000197323	"Tripartite motif containing 33"	Q9UPN9	1	114392790-114511203	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 237.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 13.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 115.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004345	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	Vesicles	Nucleoplasm	"HPA004345: AB_1858287"	"unprognostic (8.90e-2)"	"unprognostic (5.86e-2)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.09e-2)"	"unprognostic (8.42e-3)"	"prognostic favorable (8.93e-4)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-1)"	9.3	8.1	10.1	10.7	11.3	25.4	13.5	18.3	16.9	12.5	8.2	9.5	8.8	15.2	29.8	11.7	9.1	10.9	8.9	11.5	9.9	13.5	12.2	10.9	13.3	8.0	9.1	14.4	12.2	15.3	7.3	16.0	8.2	12.6	10.1	18.8	10.7	11.0	8.8	14.8	8.9	11.8	8.1	12.7	11.2	25.3	9.5	17.8	14.2	10.7	12.8	11.5	9.8	11.3	30.9	16.3	30.1	22.6	12.5	13.1	51.0	15.4	16.3	20.9	22.1	18.5	12.8	32.8	15.5	18.1	13.6	17.4	27.6	18.0	28.6	24.9	16.4	31.6	21.7	21.6	13.8	40.3	25.3	12.5	12.9	24.9	25.2	16.0	17.8	27.3	40.1	22.5	20.2	115.4	40.9	17.0	40.7	11.7	16.3	34.8	45.9	10.8	14.9	47.7	20.8	21.9	29.2	34.7	27.4	19.3	15.8	21.7	20.1	14.5	23.4	33.8	21.7	15.7	15.6	33.4	20.4	23.0	42.0	13.2	1.2	6.1	2.5	1.5	2.2	3.0	2.6	2.7	1.5	1.4	2.0	3.1	3.6	4.1	2.4	3.0	1.6	0.8	10.1	11.3	18.3	16.9	11.5	9.9	8.0	9.1	8.2	8.1	9.5	11.3	31.0	19.2	33.3	70.5	35.4	52.8	28.9	28.6	25.6	75.6	35.9	23.9	29.2	30.0	32.3	55.2	98.0	64.9	53.9	33.3	1.9	21.0	237.3	50.4	37.5	33.2	52.1	37.9	120.7	23.6	34.0	28.7	30.1	90.0	37.4	55.6	40.7	44.3	29.6	26.9	108.5	30.4	30.5	50.3	47.9	97.9	49.0	37.2	19.6	79.6	42.9	31.5	54.6	116.6	101.8	31.4	34.9	36.9	31.6	47.3	26.6	17.3	31.4	58.3	32.9	38.3	32.5	60.0	31.9	31.2	55.4	87.7	42.8	48.1	31.2	55.3
TRIM36	"HAPRIN, RBCC728, RNF98"	ENSG00000152503	"Tripartite motif containing 36"	Q9NQ86	5	115124762-115180546	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"retina: 44.2;testis: 174.3"	"Group enriched"	"Detected in many"	26	"Early spermatids: 2120.7;Late spermatids: 4980.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 9.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 5.8;non-classical monocyte: 6.5"	"Group enriched"	"Detected in many"	48	"dendritic cells: 5.8;granulocytes: 3.2;monocytes: 6.5"	"Cell line enhanced"	"Detected in many"		"RH-30: 24.5;SCLC-21H: 28.3;SH-SY5Y: 19.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061321			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA061321: AB_2684479"	"unprognostic (6.36e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.33e-6)"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.82e-13)"	"unprognostic (4.95e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.80e-3)"	0.5	1.3	13.2	1.6	16.7	0.5	4.4	3.9	14.2	2.4	8.7	7.5	14.1	0.9	0.6	0.3	2.2	0.5	0.2	16.1	15.7	0.3	0.4	1.8	0.3	17.0	10.5	4.7	1.6	0.2	13.4	1.1	16.1	10.0	7.5	44.2	0.5	0.6	0.2	0.6	13.8	0.8	10.2	0.5	4.6	174.3	12.7	0.7	0.2	0.4	0.4	0.4	1.3	20.0	3.6	0.9	1.6	8.4	0.2	0.1	2.0	0.7	2.8	1.5	1.7	1.2	1.7	0.0	1.4	0.1	11.9	1.1	7.9	1.5	1.1	0.6	2.7	6.0	3.3	1.7	0.3	6.0	4.8	0.1	1.4	0.7	2.0	1.9	0.1	11.2	0.2	7.9	2.3	4.6	1.6	5.4	6.7	0.6	3.8	1.3	24.5	1.9	0.9	0.1	28.3	19.6	5.3	0.5	3.2	0.8	5.8	7.4	0.7	2.3	1.8	1.7	2.7	1.2	0.8	0.0	2.5	3.4	1.1	0.0	1.2	3.2	0.0	1.3	0.0	0.0	0.0	0.0	5.8	0.1	0.0	0.0	0.3	0.0	6.5	1.2	0.0	0.6	13.2	16.7	3.9	14.2	16.1	15.7	17.0	10.5	16.1	10.2	12.7	20.0	0.4	0.0	3.4	1.0	0.1	2.3	0.6	0.2	0.6	5.0	14.8	9.3	2.3	0.0	0.5	1.8	56.3	0.0	1.8	27.6	0.0	0.4	2120.7	3.3	0.3	2.0	3.5	0.0	39.7	1.8	0.5	1.4	6.6	1.1	1.3	0.1	0.4	0.0	2.8	5.0	14.0	15.8	2.0	1.9	18.1	4980.3	14.9	6.0	8.8	29.0	3.4	6.9	0.0	2.5	53.4	1.5	20.4	12.8	0.1	12.1	28.2	0.2	5.0	76.8	6.6	2.0	2.3	136.2	26.9	1.2	1.3	0.3	0.7	0.1	8.8	0.2
TRIM37	"KIAA0898, MUL, POB1, TEF3"	ENSG00000108395	"Tripartite motif containing 37"	O94972	17	58982638-59106921	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Ubl conjugation pathway"	"Repressor, Transferase"	"Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 62.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 129.2;Excitatory neurons: 96.7;Inhibitory neurons: 105.2;Late spermatids: 88.8;Spermatocytes: 133.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 30.4"	"Group enriched"	"Detected in all"	5	"granulocytes: 30.4;T-cells: 8.3"	"Cell line enriched"	"Detected in all"	4	"MCF7: 242.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021911	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA021911: AB_10964487"	"unprognostic (4.07e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.99e-6)"	"unprognostic (7.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.46e-1)"	"unprognostic (4.27e-2)"	"unprognostic (3.04e-2)"	8.8	12.3	16.2	9.5	19.3	6.8	8.2	24.8	31.4	7.9	5.2	9.0	6.7	8.8	10.7	8.4	9.7	8.9	11.5	19.5	13.8	7.6	8.2	8.9	9.0	21.4	15.2	6.1	7.7	8.6	10.3	9.4	23.0	9.4	7.0	32.9	5.8	9.2	11.1	7.4	6.2	10.8	9.4	8.6	6.5	62.3	18.2	12.1	13.3	12.7	8.4	9.0	6.5	18.7	21.4	33.3	21.9	27.5	20.5	19.0	35.3	24.0	36.9	25.3	41.4	19.6	14.4	21.1	36.1	25.3	43.3	19.0	31.5	17.7	40.5	41.8	30.4	32.6	28.9	27.1	36.1	16.8	15.8	15.4	16.1	32.5	40.8	25.8	33.0	19.1	25.4	29.7	24.9	242.4	34.0	9.5	31.5	28.9	22.0	15.0	57.1	13.7	24.0	29.7	51.7	29.9	24.8	10.2	23.2	26.4	30.4	7.8	25.9	39.5	47.6	36.5	27.6	30.5	48.5	18.5	26.8	17.5	18.7	30.4	3.7	4.5	7.2	2.7	6.7	3.6	4.7	4.6	4.0	3.9	4.0	5.4	5.3	3.4	2.8	3.0	8.3	3.1	16.2	19.3	24.8	31.4	19.5	13.8	21.4	15.2	23.0	9.4	18.2	18.7	10.3	9.6	11.0	44.4	13.2	7.9	6.0	6.5	15.4	19.7	13.2	12.2	24.1	7.2	15.6	9.2	33.3	15.1	7.8	12.0	3.9	10.3	129.2	30.8	13.8	13.7	12.0	12.8	96.7	5.6	10.6	14.0	11.7	13.5	10.8	18.0	12.1	18.9	8.7	45.4	105.2	7.2	16.2	9.1	6.9	88.8	9.9	9.3	12.4	18.7	7.2	19.9	5.2	36.2	43.5	10.2	11.3	17.7	15.1	9.9	3.3	9.7	29.1	38.8	13.1	10.9	17.3	133.1	45.0	14.0	6.3	17.8	14.7	19.7	9.1	6.8
TRIM71	"LIN-41, LIN41"	ENSG00000206557	"Tripartite motif containing 71"	Q2Q1W2	3	32817997-32897824	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"RNA-mediated gene silencing, Ubl conjugation pathway"	"Developmental protein, RNA-binding, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 4.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Extravillous trophoblasts: 15.6;Inhibitory neurons: 4.5;Oligodendrocyte precursor cells: 4.5;Spermatogonia: 13.7"	"Cancer enriched"	"Detected in some"	28	"testis cancer: 28.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 31.4;BEWO: 94.5;Hep G2: 63.8;NTERA-2: 84.3;SuSa: 76.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA038141, HPA038142"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Actin filaments, Focal adhesion sites"		"HPA038141: AB_2675857, HPA038142: AB_10697240"	"unprognostic (2.93e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.36e-6)"	"unprognostic (3.92e-2)"	"unprognostic (9.27e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.65e-2)"	0.0	0.0	1.0	0.0	1.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.8	0.9	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	31.4	0.0	0.0	0.0	94.5	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	1.6	0.0	63.8	0.0	1.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.4	0.0	0.0	0.6	6.9	84.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	76.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.0	0.8	0.9	0.8	0.1	0.1	0.1	0.0	0.8	0.2	0.0	9.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	2.7	0.0	1.8	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.2	0.0	0.0	3.1	0.0	15.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	4.5	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	1.0	0.1	0.0	0.0	4.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	3.6	0.7	0.5	0.0	0.0	0.1	0.3	13.7	0.0	0.0	4.0	0.1	0.0	0.0	0.0
TRIO	ARHGEF23	ENSG00000038382	"Trio Rho guanine nucleotide exchange factor"	O75962	5	14143342-14532128	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 205.7;Excitatory neurons: 400.9;Inhibitory neurons: 443.4;Microglial cells: 308.2;Oligodendrocyte precursor cells: 476.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 215.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008157, HPA064664"	Supported		Approved	Vesicles,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Vesicles	"HPA008157: AB_1858327, HPA064664: AB_2685315"	"unprognostic (6.65e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (9.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.55e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.23e-1)"	35.3	20.5	31.7	11.6	33.3	5.5	31.8	32.2	38.6	23.4	34.5	36.6	6.8	38.9	15.5	14.5	21.2	18.8	31.9	37.2	33.6	24.9	22.1	25.7	10.2	28.1	28.1	52.8	20.6	9.1	28.9	11.6	26.6	28.2	13.6	10.2	17.4	11.1	20.9	18.7	27.8	19.2	26.4	38.9	22.9	17.2	31.4	13.3	17.0	17.4	10.6	27.1	20.5	27.2	43.7	15.9	37.2	18.0	78.6	101.0	41.3	40.4	49.2	32.6	36.9	10.3	17.4	10.4	28.0	56.6	79.6	13.0	6.5	19.4	66.6	25.8	8.0	5.5	46.1	13.2	40.0	13.9	14.8	47.6	19.9	114.4	36.4	30.3	28.8	6.8	1.4	6.8	78.7	8.3	0.1	9.5	9.3	4.8	13.7	9.9	22.9	34.2	31.6	20.5	17.1	67.5	34.3	9.0	18.9	47.1	5.3	2.0	66.4	61.4	38.3	44.7	48.4	0.3	2.2	12.9	215.1	8.8	14.8	0.1	0.5	0.0	0.0	0.7	0.1	0.7	0.0	0.0	0.5	1.8	0.0	0.0	0.0	1.6	0.6	1.1	0.3	0.1	31.7	33.3	32.2	38.6	37.2	33.6	28.1	28.1	26.6	26.4	31.4	27.2	33.0	19.2	25.9	205.7	16.6	16.4	13.0	15.6	17.1	30.5	21.9	15.0	19.3	10.0	21.0	11.0	14.6	9.7	5.6	24.8	0.0	21.2	2.9	11.7	24.8	28.7	18.0	6.5	400.9	14.2	22.0	38.9	7.7	34.2	17.7	17.2	14.6	17.1	14.2	28.6	443.4	20.6	14.2	15.4	22.1	6.6	78.6	20.2	5.4	308.2	12.1	7.3	2.1	476.5	80.4	38.5	14.9	42.9	29.2	52.8	9.2	5.4	18.3	2.7	6.6	27.5	20.0	3.5	6.2	7.2	13.8	8.2	3.8	11.7	19.4	20.3
TRIP12	"KIAA0045, TRIPC, ULF"	ENSG00000153827	"Thyroid hormone receptor interactor 12"	Q14669	2	229763837-229923239	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 251.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036835, HPA045893"	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA036835: AB_2675340, HPA045893: AB_2679486"	"unprognostic (1.22e-1)"	"unprognostic (4.87e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.33e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (3.37e-3)"	"unprognostic (3.49e-3)"	"unprognostic (4.87e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.01e-2)"	48.2	32.3	20.2	47.1	26.7	53.9	33.6	20.2	31.4	34.8	15.7	40.8	25.6	30.8	33.4	47.6	28.1	33.9	41.5	16.0	25.4	41.3	42.8	33.3	48.2	20.7	20.8	32.7	29.3	45.0	24.8	44.6	22.1	39.9	33.9	34.8	30.2	33.0	81.7	29.3	27.6	38.2	17.9	41.1	39.1	127.7	21.5	60.3	44.5	59.0	56.3	46.3	26.5	30.0	97.1	100.7	96.2	79.0	94.9	106.2	88.3	144.5	103.0	106.9	118.7	80.5	75.3	37.8	96.2	135.6	129.5	76.3	140.5	105.9	159.3	132.4	52.9	264.1	84.4	78.3	76.4	195.8	163.2	88.1	80.3	174.9	108.5	74.9	145.1	88.2	188.2	38.2	122.5	72.5	105.3	68.5	77.0	50.3	47.7	94.8	189.8	33.6	75.7	156.4	94.4	67.5	1.6	51.9	97.7	85.1	48.2	118.3	188.8	133.9	94.7	84.9	115.5	66.4	79.3	119.0	103.8	77.0	116.6	34.0	14.2	23.6	12.9	16.2	13.1	9.6	12.0	12.7	13.4	8.9	9.5	9.7	36.0	13.9	18.7	12.6	19.5	9.8	20.2	26.7	20.2	31.4	16.0	25.4	20.7	20.8	22.1	17.9	21.5	30.0	78.3	89.8	51.2	85.8	43.4	31.0	32.8	36.3	25.6	31.2	41.2	29.8	91.0	34.3	52.8	31.3	52.1	27.0	60.8	57.3	15.6	37.5	119.5	63.5	65.2	59.3	18.6	40.2	147.6	45.1	25.1	43.7	56.6	73.5	39.2	53.1	50.0	54.3	35.1	42.1	130.3	32.5	30.5	89.6	32.2	102.1	34.8	70.8	26.6	122.7	63.9	25.8	56.7	127.2	251.3	57.8	35.0	45.5	52.1	44.7	25.7	34.5	73.1	32.1	19.7	57.5	45.0	137.2	59.3	43.1	36.2	42.4	47.0	60.2	31.9	54.5
TRIT1	"FLJ20061, IPT"	ENSG00000043514	"TRNA isopentenyltransferase 1"	Q9H3H1	1	39838110-39883511	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Transferase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024174, HPA027330"	Approved		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA024174: AB_1858346, HPA027330: "	"unprognostic (4.61e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.38e-3)"	"prognostic unfavorable (8.80e-4)"	"unprognostic (4.00e-2)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (5.34e-6)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.68e-3)"	"prognostic unfavorable (7.08e-8)"	"unprognostic (6.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.90e-2)"	9.0	9.9	13.1	7.0	13.1	5.6	12.9	14.7	16.1	15.6	12.8	13.6	6.3	14.7	15.3	18.5	13.1	6.0	15.2	13.1	14.0	15.3	13.0	9.2	8.4	12.1	12.1	14.3	21.5	9.7	16.7	11.8	12.6	19.9	10.5	14.7	13.6	10.9	9.5	21.6	11.1	10.0	12.0	12.6	12.0	11.9	13.9	11.8	16.8	4.4	9.9	15.3	16.8	14.3	20.5	9.4	23.0	18.4	10.6	16.5	29.8	11.1	17.3	22.0	21.8	20.0	20.6	11.5	17.4	11.3	12.2	18.9	29.4	22.7	29.7	17.0	15.6	25.6	22.8	13.5	21.8	21.0	14.4	13.3	21.3	25.0	26.9	25.9	18.0	27.1	31.7	14.1	13.8	11.5	14.3	30.7	31.6	17.4	6.2	21.1	21.6	23.3	21.1	27.3	21.9	16.6	15.2	10.3	17.7	23.0	12.5	37.5	11.0	12.8	18.2	21.1	21.3	19.4	13.2	22.5	14.2	24.6	12.1	0.0	5.4	0.6	2.0	3.9	3.7	2.9	1.8	2.2	10.4	2.2	1.9	2.7	0.2	2.0	5.3	10.1	2.3	2.4	13.1	13.1	14.7	16.1	13.1	14.0	12.1	12.1	12.6	12.0	13.9	14.3	4.9	22.4	7.8	16.6	8.0	14.8	17.1	14.4	10.2	4.6	7.8	9.1	10.8	5.7	11.7	7.3	2.1	34.1	10.3	2.9	7.9	12.2	5.9	13.5	10.8	6.2	10.2	13.3	31.3	9.3	32.8	9.6	3.1	6.1	2.5	9.4	8.9	7.0	8.2	15.2	26.6	8.8	16.2	5.9	5.1	3.1	9.6	7.3	5.4	26.2	12.3	4.9	3.1	34.7	31.3	9.5	5.8	11.3	3.3	8.8	4.5	9.2	25.7	7.3	0.0	8.8	6.9	24.9	16.2	13.2	17.0	16.6	6.1	10.7	9.0	11.2
TRMT1	"FLJ20244, TRM1"	ENSG00000104907	"TRNA methyltransferase 1"	Q9NXH9	19	13104902-13117567	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041130, HPA041380"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041130: AB_10803995, HPA041380: AB_10793873"	"unprognostic (2.10e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (8.74e-3)"	"prognostic unfavorable (9.87e-7)"	"unprognostic (1.19e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.49e-2)"	22.0	19.8	16.5	16.2	15.3	21.1	21.0	14.7	22.1	24.3	14.8	20.0	11.8	22.9	6.3	22.3	23.6	8.9	17.3	15.5	14.7	18.0	22.1	17.3	23.2	16.0	14.8	28.7	25.4	10.0	17.2	11.3	16.8	23.0	10.9	6.5	17.0	11.4	28.8	23.4	21.7	12.5	14.2	30.6	18.9	16.8	16.2	11.6	19.2	10.5	15.9	22.3	22.2	17.6	38.6	25.3	26.9	46.0	26.7	34.1	38.7	42.1	20.9	45.3	39.1	27.4	30.8	47.7	53.6	22.9	23.7	34.8	45.2	37.3	20.9	31.3	62.8	38.0	68.7	46.5	48.7	77.2	43.1	48.4	48.4	47.3	44.1	28.9	33.8	35.2	83.7	14.9	28.6	42.6	31.7	83.3	64.0	24.2	57.5	52.5	34.6	65.8	28.3	38.2	63.5	28.9	26.2	53.7	44.8	19.4	21.0	42.8	38.2	65.1	25.5	39.8	75.1	25.6	53.4	44.1	30.3	80.7	34.7	1.8	18.9	0.6	8.9	15.0	8.6	12.4	9.6	8.6	18.2	12.9	11.1	8.5	3.7	5.6	9.9	10.6	6.9	10.7	16.5	15.3	14.7	22.1	15.5	14.7	16.0	14.8	16.8	14.2	16.2	17.6	15.5	12.8	13.1	8.5	47.5	24.0	27.0	16.8	22.8	8.9	16.6	20.2	8.3	11.5	9.6	12.9	2.1	21.7	19.6	16.6	5.9	17.3	22.4	7.9	11.7	17.6	7.2	13.0	12.0	14.9	22.6	14.3	17.9	9.8	29.8	19.7	6.1	10.8	47.7	8.4	9.1	14.1	4.1	80.0	51.0	47.9	14.0	57.4	17.8	10.3	64.8	6.1	12.3	2.5	7.5	12.8	6.8	12.8	24.2	29.0	7.8	14.2	9.2	12.6	13.1	17.5	16.1	21.1	20.0	20.7	20.6	15.5	24.4	14.6	22.5	20.3
TRMT10A	"MGC27034, RG9MTD2, TRM10"	ENSG00000145331	"TRNA methyltransferase 10A"	Q8TBZ6	4	99546709-99564039	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Diabetes mellitus, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 99.5;Spermatogonia: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047601, HPA058241"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli, Actin filaments"	Cytosol	"HPA047601: AB_2680099, HPA058241: AB_2683651"	"unprognostic (5.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (1.68e-2)"	4.3	3.7	2.0	3.1	2.6	2.2	4.4	2.6	2.9	1.9	1.5	3.6	4.3	2.7	3.9	3.6	5.8	3.4	2.3	1.8	2.5	4.9	9.8	2.4	4.4	2.6	2.5	3.3	5.9	3.7	2.3	3.7	2.9	4.1	3.6	2.8	3.9	2.2	3.9	3.7	4.5	2.7	2.7	3.5	4.4	9.9	2.4	4.3	6.1	2.7	4.4	2.9	2.0	4.3	8.2	5.4	10.1	5.7	6.0	8.4	7.8	9.6	3.7	5.8	4.1	4.9	9.4	10.9	3.7	5.6	5.9	4.4	10.9	5.1	8.6	13.7	5.4	8.0	4.4	7.6	5.5	19.6	7.8	5.4	14.4	5.7	14.0	3.0	6.4	10.0	17.5	9.4	4.5	9.4	16.4	3.5	6.5	13.8	5.0	9.5	10.2	7.2	8.5	6.8	6.3	5.8	5.3	28.3	9.9	8.5	9.3	7.8	4.9	6.9	7.2	5.5	11.1	7.0	12.4	10.0	4.9	10.9	4.7	2.7	3.9	2.1	1.8	3.8	1.7	3.5	3.3	3.3	5.2	5.8	3.5	3.2	4.9	3.3	3.4	3.0	3.9	1.9	2.0	2.6	2.6	2.9	1.8	2.5	2.6	2.5	2.9	2.7	2.4	4.3	7.2	3.2	10.3	8.8	8.7	8.2	5.6	8.4	10.2	4.3	12.1	8.6	6.4	11.5	6.6	11.0	4.2	16.8	6.1	10.6	43.0	13.8	46.8	33.5	12.1	7.2	7.2	2.1	5.3	19.3	16.4	6.9	8.6	21.6	8.2	11.0	8.2	32.6	8.5	5.0	4.6	11.1	12.2	8.1	4.1	17.0	6.5	5.0	5.4	1.9	8.4	8.7	5.2	3.5	19.7	14.1	11.0	7.5	10.4	4.8	19.0	31.9	20.6	5.9	13.1	5.7	8.1	99.5	55.0	10.2	9.5	17.5	5.5	8.1	10.6	6.6
TRMT10C	"FLJ20432, MRPP1, RG9MTD1"	ENSG00000174173	"TRNA methyltransferase 10C, mitochondrial RNase P subunit"	Q7L0Y3	3	101561868-101566446	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036671	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria	Nucleoplasm	"HPA036671: AB_10602085"	"unprognostic (7.42e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.08e-3)"	"unprognostic (4.47e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.55e-2)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (1.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.42e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (3.32e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	16.6	17.4	6.9	14.8	7.9	18.2	20.8	9.1	9.7	12.2	8.5	15.4	12.7	14.1	13.4	18.9	14.5	11.4	21.6	7.8	7.9	19.2	25.2	10.3	20.5	7.4	7.4	15.7	10.4	15.6	6.4	14.0	7.9	11.9	14.7	7.8	13.0	9.9	27.6	12.7	13.1	16.0	7.4	12.5	12.1	11.8	7.5	17.5	15.4	30.2	20.7	26.6	8.6	7.5	58.9	28.2	36.6	37.1	33.0	28.0	34.1	34.2	33.3	43.6	48.5	43.2	38.6	121.3	43.4	21.6	35.4	57.9	71.5	52.5	59.7	43.8	35.3	81.6	20.5	31.6	25.4	72.5	33.1	32.9	53.3	38.3	35.4	23.2	43.1	45.4	70.3	26.3	47.6	40.4	58.2	52.9	68.2	75.9	60.4	42.9	29.8	54.3	56.2	49.0	90.9	51.8	26.7	56.0	78.1	31.9	74.0	78.9	28.7	23.6	45.0	15.8	36.5	30.4	59.4	117.5	40.0	51.5	36.2	56.6	18.2	12.8	21.1	24.7	29.8	35.7	26.2	25.1	22.7	34.2	35.0	33.2	8.1	21.4	27.4	25.8	26.2	19.5	6.9	7.9	9.1	9.7	7.8	7.9	7.4	7.4	7.9	7.4	7.5	7.5	33.3	22.4	24.0	4.9	47.9	94.3	153.4	106.8	63.7	30.6	39.9	52.7	51.5	21.5	69.2	29.5	14.6	65.7	50.3	21.5	52.8	48.5	49.7	54.7	54.0	39.5	35.8	65.0	8.8	33.8	47.0	38.8	28.1	63.5	46.3	47.3	31.4	56.9	31.1	21.9	8.5	31.5	69.2	27.3	31.9	13.7	37.3	23.7	14.2	1.9	42.1	29.8	37.0	6.6	7.6	37.2	17.9	37.6	21.5	85.3	17.3	72.0	53.3	33.9	32.9	58.1	41.3	77.7	55.0	55.2	105.0	65.5	46.4	57.1	47.0	127.4
TRMT5	"KIAA1393, TRM5"	ENSG00000126814	"TRNA methyltransferase 5"	Q32P41	14	60971441-60981170	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 221.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000943	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA000943: AB_1080388"	"unprognostic (1.58e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.11e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.82e-3)"	"unprognostic (4.50e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-1)"	7.3	5.5	3.5	4.4	3.8	4.8	9.8	6.0	4.1	6.5	3.1	6.7	5.7	7.0	7.8	7.6	7.4	5.1	4.2	3.4	4.6	6.9	6.8	5.0	6.0	2.5	3.4	9.9	6.7	10.5	3.5	7.0	2.8	6.9	6.0	5.2	7.6	4.8	7.5	6.7	4.5	7.0	3.1	4.7	5.8	17.3	4.0	6.1	7.2	7.2	5.8	6.7	3.9	3.8	49.7	12.5	17.9	25.0	15.5	23.6	19.4	18.2	14.0	19.1	15.2	9.8	28.7	25.2	19.9	13.3	14.3	22.3	22.9	26.4	25.0	25.3	11.5	18.6	8.1	10.2	25.1	33.2	9.9	18.3	25.1	17.4	25.4	17.0	17.0	21.6	24.5	8.8	28.3	18.7	17.1	16.8	16.4	19.4	20.3	5.4	41.5	21.4	16.3	16.7	22.1	21.6	20.2	20.1	16.6	15.4	33.5	19.7	16.1	22.1	26.7	15.7	17.5	5.3	10.8	11.6	15.6	7.2	21.0	0.1	3.2	0.7	2.4	5.5	3.3	4.9	3.4	3.5	3.0	4.1	3.8	3.4	0.3	1.4	5.9	5.2	4.5	2.5	3.5	3.8	6.0	4.1	3.4	4.6	2.5	3.4	2.8	3.1	4.0	3.8	7.0	6.4	10.9	3.9	4.5	6.4	19.5	15.9	9.6	5.7	6.3	10.0	8.0	1.5	19.6	11.0	4.2	12.8	5.7	3.2	1.9	7.7	221.8	8.2	17.4	9.2	5.4	10.7	5.4	7.5	12.4	12.4	9.7	8.1	6.3	12.1	8.6	7.0	10.9	3.3	6.7	8.3	8.2	6.2	7.6	50.2	11.1	6.0	7.2	3.7	4.1	12.2	1.0	9.0	6.3	8.2	4.8	7.5	4.7	8.2	3.9	11.1	14.9	5.4	13.1	14.7	9.5	23.3	12.6	11.1	4.3	19.2	5.2	14.4	7.6	10.6
TRMU	"FLJ10140, MTO2, MTU1, TRMT"	ENSG00000100416	"TRNA mitochondrial 2-thiouridylase"	O75648	22	46330875-46357340	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"RNA-binding, Transferase, tRNA-binding"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000824, HPA035273, HPA043300"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA000824: AB_2732393, HPA035273: AB_10602901, HPA043300: AB_2678415"	"unprognostic (2.96e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.52e-3)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (4.72e-2)"	"unprognostic (7.14e-2)"	"unprognostic (7.89e-2)"	"prognostic favorable (6.86e-4)"	"unprognostic (4.74e-3)"	"prognostic unfavorable (5.63e-6)"	"unprognostic (7.26e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.44e-3)"	4.2	7.5	7.7	2.3	7.8	2.9	4.0	8.3	9.6	4.3	8.3	4.5	4.7	3.6	7.5	5.6	3.4	2.6	11.2	7.6	8.5	9.1	8.8	3.5	5.0	8.5	8.6	4.0	10.2	8.0	5.3	4.1	8.5	4.4	4.1	2.8	5.5	4.7	6.9	4.8	4.0	3.9	7.9	4.2	4.3	2.3	8.5	3.0	4.6	8.4	4.3	4.2	4.1	7.8	17.8	16.0	6.6	15.1	12.2	8.6	16.6	18.1	12.6	24.9	19.2	22.7	4.5	11.5	12.5	16.2	10.9	15.3	28.5	16.0	21.1	7.5	38.4	13.6	25.0	27.1	10.4	26.5	9.0	8.2	17.6	25.8	8.1	10.3	16.2	5.8	19.3	2.7	15.3	19.1	10.4	21.5	25.5	10.6	27.5	12.2	14.4	21.2	12.5	12.1	15.9	19.0	16.0	18.5	31.7	8.2	10.7	10.9	11.9	11.1	19.8	15.8	20.7	6.5	7.8	12.6	15.7	19.1	22.8	0.0	6.2	3.8	9.4	9.0	8.3	5.4	8.2	8.9	7.1	5.5	7.3	6.9	1.3	8.0	9.8	5.8	11.0	5.9	7.7	7.8	8.3	9.6	7.6	8.5	8.5	8.6	8.5	7.9	8.5	7.8	12.7	9.6	6.1	22.9	13.2	6.2	10.8	16.8	7.4	26.4	10.6	11.8	14.7	10.0	10.7	11.0	16.7	24.9	16.1	14.1	27.4	20.1	1.6	6.3	10.2	14.5	12.5	14.3	19.4	19.6	21.0	11.9	21.9	6.6	9.5	26.8	13.9	16.8	15.9	13.5	18.0	12.3	10.2	9.9	4.0	3.3	15.2	8.8	8.8	5.6	14.9	11.9	20.6	10.1	14.6	19.5	9.9	17.0	13.8	14.2	15.3	27.9	10.2	26.4	6.6	7.6	14.4	18.5	12.9	9.6	9.7	15.3	13.1	21.0	19.3	9.9
TRNT1	"CCA1, CGI-47, MtCCA"	ENSG00000072756	"TRNA nucleotidyl transferase 1"	Q96Q11	3	3126933-3150879	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036938	Uncertain		Supported	Mitochondria		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA036938: AB_10670566"	"unprognostic (6.39e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.02e-1)"	9.7	10.0	7.2	8.9	7.2	3.5	8.5	7.9	8.0	7.8	7.0	8.1	4.4	8.8	5.5	9.4	7.6	8.3	8.4	7.4	7.2	17.2	10.0	8.4	9.7	7.1	7.3	8.3	8.4	8.3	10.3	10.5	7.1	11.3	7.6	4.0	7.7	6.3	9.3	6.4	7.9	8.3	7.3	10.7	9.1	6.5	7.4	9.8	11.3	7.6	10.9	13.1	7.9	8.0	20.0	29.6	18.2	9.8	24.1	21.5	20.5	19.9	17.4	21.6	20.9	25.0	20.9	35.6	12.8	22.4	32.0	12.6	24.6	18.6	26.5	24.6	13.3	28.7	25.3	24.9	31.4	32.2	20.8	17.9	25.0	20.2	6.8	15.0	21.0	24.1	25.1	9.8	35.9	37.2	22.0	21.4	15.2	29.2	19.0	20.5	28.1	32.5	26.1	25.8	10.8	15.9	31.6	20.6	18.5	26.3	18.7	16.3	14.8	22.8	18.7	23.6	25.7	12.6	31.4	43.4	17.2	27.6	25.0	49.4	12.4	36.4	16.4	18.1	16.0	25.8	20.8	18.1	16.8	15.7	22.7	20.1	16.6	19.8	19.0	15.6	18.6	11.2	7.2	7.2	7.9	8.0	7.4	7.2	7.1	7.3	7.1	7.3	7.4	8.0	20.7	16.0	13.4	15.3	30.2	14.8	29.0	19.9	24.5	13.5	12.1	11.0	14.3	2.8	16.3	18.4	14.6	25.8	23.5	10.6	45.0	19.1	2.3	15.8	19.0	21.1	8.4	16.6	23.8	9.9	17.8	19.9	23.4	12.0	22.8	20.7	12.5	9.2	13.3	10.1	27.0	10.7	16.2	11.0	13.3	2.9	10.8	13.3	7.2	23.4	20.3	17.1	18.6	23.6	34.7	10.6	9.2	8.6	30.7	30.9	11.0	32.7	11.4	15.7	0.0	14.9	17.4	20.8	17.9	23.4	13.1	28.3	22.0	24.7	13.5	23.9
TRPC3		ENSG00000138741	"Transient receptor potential cation channel subfamily C member 3"	Q13507	4	121874481-121952060	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.4;pituitary gland: 7.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 18.1;Inhibitory neurons: 82.7;Oligodendrocyte precursor cells: 33.7;Rod photoreceptor cells: 32.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 2.3;Karpas-707: 2.6;U-2 OS: 1.5;U-251 MG: 1.5"	"Region enhanced"	"Detected in all"		"cerebellum: 57.8"	"Low region specificity"	"Detected in many"									NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.12e-3)"	"unprognostic (9.80e-2)"	"unprognostic (4.80e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.42e-3)"	0.3	0.0	2.3	0.1	4.0	0.0	0.2	4.6	5.8	0.8	0.1	0.2	0.1	0.4	0.2	0.0	0.5	0.8	0.2	0.8	3.2	0.1	0.1	0.9	0.1	10.4	2.8	0.1	0.0	0.2	7.4	1.1	2.2	0.2	0.1	3.9	0.1	0.6	0.4	0.1	0.5	2.6	1.6	0.2	0.2	0.4	4.6	0.0	0.1	0.2	0.0	1.7	0.7	1.7	0.0	0.0	0.8	0.1	0.1	0.1	0.0	0.4	0.4	0.7	0.2	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.4	0.0	0.1	0.0	1.3	2.3	0.2	0.0	0.1	0.7	0.3	0.2	0.0	0.0	0.0	1.1	0.0	0.1	0.0	2.6	0.5	0.1	0.8	0.0	0.4	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.1	1.2	1.5	0.1	1.5	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.3	4.0	4.6	5.8	0.8	3.2	10.4	2.8	2.2	1.6	4.6	1.7	0.5	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.8	0.0	0.0	0.0	8.4	0.0	0.5	0.0	0.0	0.0	2.3	0.0	0.3	0.2	0.0	0.0	18.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	82.7	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.1	4.6	0.0	33.7	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	32.0	0.0	0.3	1.4	0.5	0.8	0.0	0.0	0.0	0.5	0.5	0.0	0.1
TRPC6	"FSGS2, TRP6"	ENSG00000137672	"Transient receptor potential cation channel subfamily C member 6"	Q9Y210	11	101451564-101872562	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 13.3;placenta: 20.8"	"Cell type enhanced"	"Detected in many"		"Club cells: 10.5;Excitatory neurons: 19.3;Inhibitory neurons: 47.2;Microglial cells: 12.2;Smooth muscle cells: 20.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"A549: 4.9;ASC diff: 8.8;BJ hTERT+: 4.9;HEL: 4.8;RPTEC TERT1: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045098	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA045098: AB_10959600"	"unprognostic (1.45e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.71e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.47e-4)"	"unprognostic (1.99e-3)"	"unprognostic (4.88e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.32e-2)"	4.3	0.5	1.2	0.7	1.5	0.2	3.3	0.6	1.3	3.4	5.8	2.8	1.2	4.8	1.6	5.7	5.4	2.3	0.5	1.5	1.9	1.4	0.1	13.3	1.1	1.8	3.4	1.2	0.7	0.9	0.2	20.8	1.2	2.2	1.6	0.3	0.9	5.4	0.4	1.9	1.2	4.0	1.6	2.2	1.6	0.6	2.0	0.2	9.4	1.0	0.8	1.8	2.0	1.2	0.0	4.9	0.2	0.0	8.8	2.1	0.0	3.2	4.9	0.7	0.1	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	4.8	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	1.2	1.5	0.6	1.3	1.5	1.9	1.8	3.4	1.2	1.6	2.0	1.2	3.4	0.0	2.6	2.0	0.0	2.3	1.9	0.0	0.0	1.4	0.4	2.9	0.7	0.0	10.5	3.7	0.0	1.3	0.0	0.1	0.0	0.0	1.0	3.0	4.0	1.6	0.0	0.0	19.3	0.2	0.0	3.1	0.0	8.0	0.0	0.1	0.0	0.0	0.3	0.0	47.2	0.0	0.0	0.0	5.3	0.5	6.2	1.8	1.8	12.2	0.1	0.0	0.0	2.0	0.3	0.0	5.1	0.7	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.3	20.2	0.1	0.7	0.1	3.4	0.4	0.1	2.1	0.0	1.5
TRPM1	"CSNB1C, LTRPC1, MLSN1"	ENSG00000134160	"Transient receptor potential cation channel subfamily M member 1"	Q7Z4N2	15	31001061-31161273	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"retina: 9.4;skin 1: 4.1"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 627.4;Melanocytes: 158.3"	"Cancer enriched"	"Detected in single"	179	"melanoma: 14.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	112	"SK-MEL-30: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014779, HPA071139"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Centriolar satellite"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 56: Bipolar cells - Visual perception"	"Centriolar satellite"	"Golgi apparatus, Plasma membrane"	"HPA014779: AB_2669090, HPA071139: "	"unprognostic (5.28e-2)"	"unprognostic (1.35e-1)"		"unprognostic (9.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.84e-2)"	"unprognostic (6.20e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.63e-2)"	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	9.4	0.1	0.0	0.0	4.1	0.0	0.0	0.5	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.1	0.2	0.2	0.4	0.3	0.5	0.3	0.5	0.0	0.0	0.0	0.7	0.0	4.2	0.0	0.0	0.0	627.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	50.5	0.1	0.1	1.7	0.0	0.0	0.9	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	13.5	0.8	0.0	0.0	0.0	1.0	6.3	0.0	0.0	158.3	0.0	0.0	11.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	22.2	0.0	0.1	0.1	10.1	4.4	1.8	1.0	1.0	0.0	0.0	0.0	0.1
TRPM4	FLJ20041	ENSG00000130529	"Transient receptor potential cation channel subfamily M member 4"	Q8TD43	19	49157741-49211836	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 179.2;Hepatocytes: 81.7;Intestinal goblet cells: 114.8;Paneth cells: 77.1;Undifferentiated cells: 88.9"	"Cancer enriched"	"Detected in all"	4	"prostate cancer: 85.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 3.3;granulocytes: 2.8;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"OE19: 32.7;RT4: 60.8;SK-BR-3: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA041169	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA041169: AB_2677343"	"unprognostic (8.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.86e-2)"	"prognostic favorable (2.88e-7)"	"unprognostic (1.62e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.53e-7)"	"unprognostic (8.46e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.00e-2)"	10.8	6.1	5.8	6.1	5.4	4.6	13.5	8.5	7.0	11.5	4.8	46.1	25.3	9.9	2.5	13.1	9.2	7.4	23.0	5.9	4.5	22.8	15.4	16.0	1.8	6.2	7.4	3.3	10.1	3.7	5.6	5.3	6.9	35.7	12.9	1.3	27.3	6.2	14.0	26.6	22.9	3.4	4.2	5.5	20.6	5.4	6.6	1.0	17.3	5.3	1.9	13.7	14.4	5.1	11.9	9.0	2.1	9.5	7.7	6.6	6.6	10.0	6.0	2.7	3.7	6.1	18.7	0.4	2.7	6.8	3.6	15.7	1.3	3.0	1.0	0.2	3.4	1.9	4.0	3.7	6.6	0.3	11.7	9.3	13.6	5.3	2.6	3.3	4.6	1.0	4.9	2.1	6.9	17.4	0.8	0.9	1.0	32.7	13.3	4.1	2.0	0.6	4.6	60.8	0.8	2.2	4.1	38.6	2.2	0.7	22.6	3.7	11.8	14.4	7.8	7.9	0.2	3.9	4.3	0.4	7.9	7.4	5.3	2.2	4.3	0.7	0.3	2.5	0.2	0.5	0.2	0.2	3.3	0.5	0.3	0.3	2.8	0.5	1.0	3.1	0.2	1.4	5.8	5.4	8.5	7.0	5.9	4.5	6.2	7.4	6.9	4.2	6.6	5.1	12.8	32.1	2.6	9.8	3.5	12.5	15.3	9.9	9.1	2.0	19.0	14.6	16.7	17.2	12.3	14.7	0.0	6.6	0.2	179.2	19.6	7.9	2.9	17.5	8.2	11.7	21.7	0.0	5.4	18.5	6.8	6.0	71.4	36.2	5.7	2.9	11.4	81.7	19.9	0.0	8.5	114.8	14.2	9.8	19.0	3.1	6.8	8.5	39.2	9.4	12.8	6.7	0.0	3.5	0.9	32.9	77.1	7.2	7.6	35.5	55.3	3.8	8.9	2.6	32.9	2.2	8.5	6.1	15.7	8.4	11.5	3.4	1.9	4.1	88.9	33.1
TRPM6	"CHAK2, FLJ22628, HOMG, HSH"	ENSG00000119121	"Transient receptor potential cation channel subfamily M member 6"	Q9BX84	9	74722495-74888094	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 6.6;intestine: 16.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 128.9;Glandular and luminal cells: 36.5;Microglial cells: 39.4;Oligodendrocytes: 81.1;Proximal enterocytes: 23.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 23.1;neutrophil: 7.5"	"Lineage enriched"	"Detected in single"	41	"granulocytes: 23.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.8;HeLa: 2.4;Karpas-707: 1.3;RT4: 3.8;U-266/70: 1.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (3.95e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.80e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.72e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.10e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-2)"	0.6	0.0	2.1	0.6	3.5	2.6	0.6	3.0	2.4	0.3	0.2	13.2	7.0	0.3	0.2	0.3	0.2	0.3	0.2	1.6	2.8	1.9	0.1	0.3	0.3	4.2	3.4	0.0	0.1	1.4	0.5	0.3	4.1	0.5	16.6	0.4	0.3	0.1	0.1	0.7	7.9	0.5	2.7	0.5	0.2	1.4	3.1	0.4	0.2	0.1	0.3	0.4	0.3	6.6	0.0	0.8	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	1.0	0.1	0.3	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.1	0.1	2.4	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.5	0.1	0.0	1.4	0.0	0.1	0.0	0.1	0.1	23.1	0.1	2.4	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	7.5	0.5	0.2	0.3	0.0	0.1	2.1	3.5	3.0	2.4	1.6	2.8	4.2	3.4	4.1	2.7	3.1	6.6	3.3	0.0	1.7	1.0	0.3	0.1	1.9	0.3	2.2	0.3	0.2	0.4	0.9	0.0	1.3	3.7	0.0	0.2	0.2	128.9	0.0	0.0	4.0	11.3	3.4	3.2	3.6	0.0	1.3	0.0	0.1	0.3	0.0	36.5	0.0	0.1	3.3	0.1	0.0	0.0	0.5	3.0	0.0	0.3	0.6	0.9	0.0	0.4	0.0	39.4	0.0	0.3	0.0	0.5	81.1	0.0	13.8	0.4	0.1	1.3	23.3	0.0	0.8	2.7	0.0	0.7	0.4	1.6	2.4	0.5	1.0	0.1	0.5	0.2	7.5	0.8
TRPM7	"CHAK1, LTRPC7, TRP-PLIK"	ENSG00000092439	"Transient receptor potential cation channel subfamily M member 7"	Q96QT4	15	50552473-50686797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Necrosis, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 108.9"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 122.2;Oligodendrocytes: 109.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 122.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035522, HPA052173"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA035522: , HPA052173: AB_2681749"	"unprognostic (3.14e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.59e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.97e-1)"	11.5	9.6	4.3	13.3	6.5	21.4	13.6	15.4	6.7	10.3	29.3	13.8	14.4	12.7	14.6	8.6	9.4	11.1	15.5	4.8	3.5	22.9	25.3	11.6	16.6	4.9	3.9	16.4	12.2	108.9	5.3	13.3	5.9	10.9	14.4	10.5	10.9	10.6	7.8	16.6	13.1	11.4	3.2	12.2	13.6	9.9	6.4	15.5	17.3	9.1	14.4	11.4	8.1	10.4	21.4	21.0	17.2	19.1	48.5	36.2	20.9	26.4	36.7	16.5	21.6	29.1	11.6	46.4	12.7	30.8	42.5	35.1	23.3	19.5	23.4	26.0	13.7	37.1	31.5	15.4	44.0	38.8	27.6	33.9	22.4	18.8	35.0	24.0	13.5	28.8	42.6	34.5	30.4	33.7	25.1	18.8	13.0	29.4	12.8	27.2	23.7	22.7	23.0	49.9	14.2	18.1	18.2	28.7	35.8	30.1	18.0	41.6	20.7	26.1	12.4	122.4	30.8	23.3	54.9	44.0	28.4	77.5	24.8	1.8	1.3	1.6	2.5	1.3	2.9	2.2	1.8	1.7	1.5	2.3	1.6	1.9	1.7	2.4	1.4	1.9	2.0	0.8	4.3	6.5	15.4	6.7	4.8	3.5	4.9	3.9	5.9	3.2	6.4	10.4	23.9	19.2	31.3	73.1	36.4	31.6	17.2	11.0	44.9	21.9	18.8	11.9	25.9	21.5	8.2	12.9	12.5	23.0	38.4	17.0	3.9	11.7	33.3	21.6	27.1	19.7	18.5	29.6	122.2	12.7	9.4	26.1	37.8	23.1	17.7	26.0	14.6	43.9	14.6	21.9	92.7	19.5	6.1	22.4	19.8	26.0	26.4	26.5	19.6	66.5	24.2	8.5	29.9	80.9	109.1	15.5	13.9	20.3	33.2	24.9	23.4	11.0	19.3	22.6	13.1	30.0	22.0	23.1	23.6	25.7	24.2	16.3	34.5	22.2	20.4	11.1
TRPV4	"CMT2C, OTRPC4, TRP12, VR-OAC, VRL-2, VROAC"	ENSG00000111199	"Transient receptor potential cation channel subfamily V member 4"	Q9HBA0	12	109783087-109833406	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Charcot-Marie-Tooth disease, Disease variant, Dwarfism, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 50.8;salivary gland: 19.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 17.1;Cholangiocytes: 20.0;Cytotrophoblasts: 20.0;Kupffer cells: 19.6;Respiratory ciliated cells: 28.2;Syncytiotrophoblasts: 21.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	5	"hippocampal formation: 4.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 7.9;BJ hTERT+: 9.5;EFO-21: 7.2;HaCaT: 14.2;HUVEC TERT2: 8.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA007150	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA007150: AB_1080393"	"unprognostic (2.98e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.20e-3)"	"unprognostic (6.25e-3)"	"unprognostic (1.09e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (4.12e-5)"	"unprognostic (1.20e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-2)"	1.0	0.8	0.2	0.9	0.3	0.1	1.9	0.7	0.5	2.0	50.8	0.4	0.7	0.6	0.4	10.3	4.7	1.4	0.8	4.2	0.2	14.7	8.6	2.2	0.8	0.5	0.4	0.3	4.4	0.3	2.1	5.2	0.3	6.8	0.3	0.0	19.2	0.8	0.1	7.5	0.4	0.7	0.2	2.8	0.7	0.8	0.8	0.1	0.9	0.0	0.9	1.8	2.2	0.4	2.4	0.2	0.0	0.0	2.0	1.2	7.9	4.2	9.5	1.2	0.3	0.0	6.4	0.0	7.2	5.8	0.0	14.2	1.0	0.0	0.4	0.0	1.8	0.0	0.1	3.7	0.6	0.0	0.0	3.4	2.0	2.7	0.0	0.6	8.7	0.0	0.5	0.0	0.4	5.3	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.0	0.0	4.9	0.0	0.0	0.3	0.6	2.6	3.5	1.1	0.2	4.5	0.0	2.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	5.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.7	0.5	4.2	0.2	0.5	0.4	0.3	0.2	0.8	0.4	0.1	0.0	0.0	0.0	0.7	3.3	8.1	17.1	7.4	0.0	5.1	5.5	1.0	20.0	12.0	11.0	0.0	20.0	0.4	0.0	3.9	2.5	0.2	3.2	1.0	1.4	0.0	0.0	0.3	9.3	5.3	1.2	2.0	1.2	0.0	0.9	0.7	7.7	4.0	0.0	0.4	0.0	6.1	19.6	0.7	0.2	0.9	2.6	7.2	1.9	0.8	0.0	0.0	1.0	0.3	2.0	0.0	0.0	0.0	4.6	0.0	12.5	28.2	0.0	0.0	0.1	1.1	0.3	1.1	4.5	3.8	21.1	0.3	0.2	0.0	3.3
TRPV6	"CaT1, ECAC2"	ENSG00000165125	"Transient receptor potential cation channel subfamily V member 6"	Q9H1D0	7	142871208-142885745	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 38.3;prostate: 23.5;salivary gland: 69.3"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 18.6;Collecting duct cells: 27.6;Cytotrophoblasts: 17.0;Ductal cells: 80.1;Early spermatids: 25.9;Late spermatids: 37.3"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 16.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.6;HaCaT: 18.0;RT4: 30.7;SK-BR-3: 23.5;T-47d: 52.8"	"Low region specificity"	"Detected in single"							HPA062864	Approved					NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 6: T47d - Mammary gland"	"Cluster 1: Pancreatic cells - Digestion"			"HPA062864: AB_2684885"	"unprognostic (9.85e-2)"	"unprognostic (1.60e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.49e-2)"	"unprognostic (9.39e-3)"	"unprognostic (1.69e-1)"	"unprognostic (7.17e-3)"	"unprognostic (3.53e-2)"	0.0	0.0	0.5	0.0	0.6	0.1	4.2	0.6	1.1	0.5	0.6	0.1	8.1	0.1	0.3	2.7	0.2	8.2	0.1	0.5	0.6	5.2	0.9	0.2	0.0	0.6	0.6	0.0	38.3	1.5	0.5	11.9	0.8	23.5	0.0	0.0	69.3	1.6	0.0	6.4	2.2	0.0	0.6	0.0	4.5	1.2	0.6	0.0	1.8	0.0	0.2	0.4	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	1.9	0.1	0.0	23.5	0.6	0.9	52.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.6	1.1	0.5	0.6	0.6	0.6	0.8	0.6	0.6	0.6	0.0	3.2	0.0	0.0	0.0	0.5	1.1	0.2	5.2	0.6	2.4	2.0	1.9	18.6	1.4	27.6	0.0	17.0	0.1	0.1	0.0	80.1	25.9	0.7	0.2	0.2	0.0	0.0	0.1	3.3	0.8	0.2	3.6	1.6	0.0	0.0	0.4	0.0	1.6	3.3	0.1	0.3	0.0	0.0	0.0	37.3	0.9	0.2	0.0	0.0	2.0	0.7	0.0	0.0	6.8	8.9	0.1	0.0	0.0	10.6	0.1	0.3	0.7	0.2	0.0	1.0	0.3	0.3	0.4	4.3	1.8	6.0	0.0	0.0	0.2	3.1
TSEN2	"MGC2776, SEN2, SEN2L"	ENSG00000154743	"TRNA splicing endonuclease subunit 2"	Q8NCE0	3	12484421-12541549	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 43.8;Excitatory neurons: 42.8;Inhibitory neurons: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027120, HPA027125, HPA027268"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Centrosome, Cytosol"	"HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347"	"unprognostic (5.58e-2)"	"unprognostic (4.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (1.42e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.90e-2)"	"unprognostic (6.06e-2)"	"prognostic favorable (3.49e-4)"	8.9	9.4	3.4	1.1	3.9	0.3	8.9	4.4	4.8	11.5	3.7	11.5	1.4	10.9	2.6	8.6	12.0	1.8	15.5	3.5	3.7	10.2	8.5	6.0	2.2	3.6	3.5	14.2	12.1	3.2	10.9	0.9	3.6	10.0	2.3	3.4	6.7	3.2	15.9	8.3	6.9	3.2	3.3	6.6	9.7	6.7	3.9	2.6	9.0	3.8	2.2	11.5	9.7	3.8	6.2	11.8	5.5	7.4	6.3	7.7	7.6	5.8	4.3	6.6	5.1	4.2	5.2	5.5	3.3	4.0	5.8	5.8	7.8	9.4	5.4	5.5	9.8	5.1	9.1	5.7	5.4	9.3	2.1	4.9	11.2	10.1	9.7	3.3	4.7	8.8	10.7	3.4	6.5	11.9	9.6	6.1	6.5	10.5	13.5	4.6	2.3	13.5	9.9	4.8	1.5	4.5	6.7	5.0	4.8	3.1	10.1	5.1	4.5	4.2	3.9	4.7	9.7	3.1	8.6	6.2	5.6	11.8	5.4	0.6	1.9	0.0	2.7	1.6	4.4	3.7	4.6	3.8	2.3	3.2	6.2	5.1	0.4	2.5	1.7	3.4	1.6	2.6	3.4	3.9	4.4	4.8	3.5	3.7	3.6	3.5	3.6	3.3	3.9	3.8	5.5	3.2	3.3	26.1	8.9	2.9	11.2	5.6	13.1	28.1	3.7	4.3	7.0	10.0	3.8	11.0	43.8	8.8	2.6	9.2	1.9	6.2	1.6	7.1	7.4	6.2	4.2	8.4	42.8	4.2	4.3	5.7	13.7	3.7	5.1	17.7	3.6	5.0	4.6	10.1	46.4	5.2	4.1	3.5	1.7	2.8	9.0	3.6	3.6	16.9	2.4	8.0	6.2	19.1	31.8	4.5	5.0	10.1	3.8	6.2	2.3	6.9	11.1	34.1	6.6	7.9	6.3	14.0	23.0	7.1	4.8	1.9	4.6	15.3	8.4	8.0
TSEN34	"LENG5, SEN34, SEN34L"	ENSG00000170892	"TRNA splicing endonuclease subunit 34"	Q9BSV6	19	54189938-54194536	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Disease variant, Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 5.0;eosinophil: 1.9;neutrophil: 4.8"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 5.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041111, HPA048208"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA041111: AB_10794263, HPA048208: AB_2680313"	"unprognostic (3.24e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (1.44e-7)"	"unprognostic (2.38e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.04e-3)"	"unprognostic (8.98e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.12e-1)"	28.5	68.2	2.2	1.3	1.8	1.3	29.5	2.4	2.4	38.8	1.8	34.7	1.1	37.1	1.9	41.0	37.8	1.5	26.3	2.1	1.7	39.1	41.3	31.5	1.3	2.2	1.7	47.9	43.0	1.8	36.0	1.3	2.0	36.2	1.3	2.0	34.0	1.9	26.7	40.5	27.7	1.2	1.3	44.1	34.3	45.0	1.7	0.5	30.9	1.8	0.7	38.9	34.2	2.2	3.3	1.7	2.5	3.1	1.3	2.0	3.9	0.6	1.0	0.9	1.7	2.1	1.1	1.1	0.0	0.9	2.5	2.5	2.6	2.3	1.4	1.1	6.2	1.0	1.1	2.0	0.5	1.1	1.1	1.9	1.1	2.0	1.3	0.9	1.3	0.0	1.7	0.9	2.4	1.4	0.4	0.2	1.5	2.9	1.1	1.4	2.6	0.7	3.4	2.4	0.1	1.7	0.0	3.5	3.0	2.5	2.6	3.1	1.1	0.2	2.8	2.7	3.4	1.4	1.9	0.9	2.6	1.3	1.2	5.0	0.6	1.9	0.2	0.5	0.4	0.1	0.3	0.1	0.3	0.4	0.4	0.2	4.8	0.0	0.3	0.4	0.0	0.2	2.2	1.8	2.4	2.4	2.1	1.7	2.2	1.7	2.0	1.3	1.7	2.2	33.1	12.8	27.7	6.8	28.2	73.5	92.0	137.7	67.2	35.4	62.9	60.8	11.8	52.9	60.9	44.1	29.2	102.5	45.4	58.8	95.9	68.7	24.0	39.4	37.0	32.5	76.8	13.7	3.8	59.7	98.2	47.5	19.9	35.3	26.6	47.7	35.7	40.6	57.8	16.8	4.9	103.7	122.1	37.0	53.6	17.2	67.7	45.0	46.2	1.0	51.8	81.9	18.6	6.0	5.9	50.4	55.9	66.5	27.6	79.8	57.8	110.5	70.0	48.9	59.2	38.7	60.8	40.1	77.2	56.7	70.2	111.0	32.8	100.3	66.5	62.3
TSPAN12	"NET-2, TM4SF12"	ENSG00000106025	"Tetraspanin 12"	O95859	7	120787320-120858402	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Angiogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 91.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 118.6;Collecting duct cells: 103.0;Distal tubular cells: 189.8;Glandular and luminal cells: 87.5;Proximal tubular cells: 111.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 44.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 53.0;HUVEC TERT2: 58.3;RH-30: 52.2;RPTEC TERT1: 90.5;RT4: 65.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051570, HPA058244"	Uncertain		Approved	Vesicles,Microtubules		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Microtubules	Vesicles	"HPA051570: , HPA058244: AB_2683652"	"unprognostic (2.40e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.97e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.43e-1)"	11.9	65.9	4.1	5.3	4.4	0.4	8.7	5.2	5.2	21.4	2.8	24.0	39.4	10.5	14.9	5.0	10.9	20.4	47.7	3.3	4.7	91.6	35.8	45.8	4.5	8.0	6.2	1.7	17.4	10.7	7.5	20.3	5.2	6.8	20.4	1.8	46.8	22.4	3.3	1.6	42.0	11.9	4.6	28.2	22.1	3.9	8.1	2.7	23.4	5.5	4.3	17.5	4.0	3.6	0.0	1.4	15.1	0.2	3.1	1.0	14.7	0.3	0.6	1.2	5.0	2.5	4.0	0.0	10.4	0.4	1.8	0.2	7.7	1.6	1.9	0.0	53.0	2.8	14.5	2.2	8.1	0.1	2.5	0.3	0.0	0.4	0.3	2.1	58.3	0.0	0.7	1.8	6.8	2.0	0.2	0.4	24.5	11.1	9.4	0.1	52.2	2.0	90.5	65.4	12.5	7.4	0.7	1.3	0.0	20.0	8.0	1.9	2.5	12.3	3.8	0.1	6.5	15.8	0.0	0.2	1.7	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	4.4	5.2	5.2	3.3	4.7	8.0	6.2	5.2	4.6	8.1	3.6	40.0	118.6	45.0	18.6	1.7	2.5	20.3	1.8	14.8	0.0	19.4	3.8	62.5	64.3	19.9	103.0	0.0	40.5	0.0	18.0	189.8	6.8	0.6	63.4	9.0	38.0	9.6	2.7	1.8	7.2	53.5	10.0	14.8	87.5	2.5	1.8	18.2	32.9	4.1	0.0	2.9	16.9	6.1	0.8	3.6	1.5	4.1	1.5	5.4	3.7	0.0	0.5	0.0	10.1	0.4	4.7	30.5	0.7	2.2	9.1	68.3	111.1	5.7	0.1	0.0	11.6	16.6	0.6	8.9	13.8	2.0	24.2	1.9	9.6	35.5	28.3
TSPAN7	"A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2"	ENSG00000156298	"Tetraspanin 7"	P41732	X	38561542-38688920	"CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 542.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 274.9;Excitatory neurons: 215.6;Hepatic stellate cells: 407.3;Inhibitory neurons: 249.8;Oligodendrocyte precursor cells: 353.4"	"Cancer enhanced"	"Detected in all"		"glioma: 71.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 109.5;JURKAT: 380.9;MOLT-4: 239.7;SCLC-21H: 129.0;U-266/70: 163.2"	"Low region specificity"	"Detected in all"							"HPA003140, CAB062566, CAB068245"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB062566: AB_2665608, CAB068245: AB_2665609, HPA003140: AB_1078454"	"unprognostic (1.12e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (5.06e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.88e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.54e-1)"	"prognostic favorable (5.48e-7)"	"unprognostic (5.65e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-3)"	56.1	125.6	355.5	17.2	433.8	1.3	33.5	369.5	542.1	42.6	271.3	68.1	36.3	43.8	37.6	33.6	36.5	25.8	70.3	413.7	334.3	56.2	45.0	67.4	41.1	290.3	298.8	19.6	19.8	13.9	28.0	25.1	283.6	18.8	64.6	286.9	12.5	26.8	153.9	19.4	34.0	51.1	291.7	96.3	14.5	4.8	331.7	15.7	51.3	232.3	28.9	29.7	16.9	384.6	0.1	0.0	2.9	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	3.8	1.6	0.0	109.5	14.9	0.5	0.0	67.2	0.0	0.1	1.2	1.5	0.0	0.0	0.0	0.0	0.0	380.9	0.0	0.4	1.7	0.4	239.7	0.0	11.2	0.1	0.0	14.6	4.6	0.0	11.0	1.4	129.0	14.4	0.0	0.0	4.3	6.5	0.0	0.3	0.0	0.1	3.1	0.1	1.0	163.2	54.8	0.0	5.4	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	355.5	433.8	369.5	542.1	413.7	334.3	290.3	298.8	283.6	291.7	331.7	384.6	116.1	12.8	23.8	274.9	1.1	10.6	2.7	6.3	6.2	92.0	1.0	3.8	34.1	1.5	4.6	11.0	43.8	0.4	0.2	69.1	23.5	0.4	0.0	2.1	1.6	153.3	18.7	5.3	215.6	0.6	0.4	14.0	4.6	5.6	10.1	108.1	407.3	4.8	45.1	97.6	249.8	23.5	0.0	15.0	10.0	1.9	0.6	1.5	14.2	46.9	0.0	102.3	0.0	353.4	50.6	0.9	21.9	3.0	1.5	2.4	40.3	9.8	1.2	107.4	59.2	26.5	11.7	0.6	3.3	9.9	6.5	0.8	2.6	27.0	35.7	0.9
TTBK2	"KIAA0847, SCA11"	ENSG00000128881	"Tau tubulin kinase 2"	Q6IQ55	15	42738730-42920809	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 33.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 153.8;Inhibitory neurons: 185.1;Late spermatids: 146.2;Oligodendrocytes: 125.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018113, HPA049866"	Approved		Uncertain	"Intermediate filaments"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Intermediate filaments"		"HPA018113: AB_1858421, HPA049866: AB_2680923"	"unprognostic (2.15e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.30e-2)"	"unprognostic (7.73e-2)"	"unprognostic (4.26e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.78e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	5.3	4.2	7.7	3.0	9.9	5.2	4.4	11.3	20.0	6.0	2.1	6.7	1.6	5.3	3.9	2.6	5.5	3.7	7.2	6.9	13.9	3.4	3.1	4.8	3.4	17.4	9.1	6.4	2.5	4.6	5.6	4.0	18.9	4.7	3.0	17.7	3.2	3.8	10.4	3.1	3.9	5.0	6.3	4.3	3.4	33.4	16.9	5.2	3.8	6.3	3.1	5.3	4.7	13.8	5.7	3.8	8.4	4.2	6.5	6.6	1.8	4.6	7.4	4.5	6.9	4.3	1.3	3.3	6.1	4.7	9.2	3.9	8.1	6.7	6.8	13.0	3.6	4.8	6.9	1.6	5.0	6.7	7.8	4.7	6.5	3.9	21.1	9.9	5.2	5.1	7.0	4.9	4.5	0.9	4.1	4.3	2.3	1.7	3.8	7.2	9.1	1.7	5.8	4.0	6.6	6.5	12.6	0.9	2.5	5.8	2.6	8.7	5.8	5.1	4.7	5.7	6.0	7.1	11.3	5.5	3.9	5.8	3.0	0.1	0.5	0.2	0.2	0.3	0.5	0.3	0.2	0.2	0.1	0.3	0.3	0.2	0.2	0.4	0.2	0.2	0.1	0.1	7.7	9.9	11.3	20.0	6.9	13.9	17.4	9.1	18.9	6.3	16.9	13.8	16.2	6.4	11.8	75.7	11.5	10.7	12.1	11.8	26.2	36.3	9.6	7.6	17.6	12.8	10.0	9.2	37.5	4.1	9.1	3.9	0.0	5.7	80.5	24.9	11.7	17.0	14.3	17.4	153.8	4.3	3.2	15.5	4.6	4.6	19.0	16.2	17.5	9.8	7.4	45.4	185.1	5.1	2.0	16.0	25.9	146.2	16.8	16.4	12.4	69.3	16.9	16.5	6.2	97.5	125.6	7.5	2.6	20.3	6.6	12.4	5.5	5.5	40.5	39.4	13.1	24.6	16.3	34.5	10.1	12.5	9.2	3.1	13.4	11.3	5.3	7.4
TTN	"CMD1G, CMH9, CMPD4, FLJ32040, LGMD2J, MYLK5, TMD"	ENSG00000155657	Titin	Q8WZ42	2	178525989-178830802	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 167.2;skeletal muscle: 920.6;tongue: 369.5"	"Cell type enriched"	"Detected in many"	16	"Cardiomyocytes: 24394.9"	"Cancer enriched"	"Detected in single"	4	"head and neck cancer: 1.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RH-30: 1.9"	"Not detected"	"Not detected"							"HPA007042, CAB022682, HPA030048"	Enhanced					NA	NA		16000000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB022682: , HPA007042: AB_1080292, HPA030048: AB_2732451"	"unprognostic (1.00e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.49e-4)"	"unprognostic (1.99e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.34e-2)"	0.6	0.4	2.7	0.5	2.4	4.3	0.5	2.8	4.9	0.3	0.0	0.4	0.4	0.4	0.2	2.7	0.3	0.7	167.2	1.9	3.4	0.2	0.3	1.2	1.4	11.2	4.4	0.7	1.7	0.0	0.8	0.5	6.6	2.7	0.0	1.9	7.0	0.0	920.6	0.8	0.6	0.0	3.2	0.7	0.4	1.6	4.8	0.7	0.6	369.5	0.4	0.2	0.3	5.3	0.3	0.1	0.7	0.4	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.7	0.1	1.0	0.2	0.0	0.7	0.7	0.0	0.0	0.0	1.0	0.8	1.5	1.3	0.4	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.7	0.6	0.7	0.9	0.5	0.1	0.2	0.7	1.0	0.2	0.1	0.7	0.5	1.9	0.6	0.0	0.2	0.4	0.7	0.1	0.5	0.0	0.6	0.3	1.0	0.7	0.0	0.0	0.3	0.2	1.4	0.2	1.4	0.0	0.5	0.3	1.8	0.2	0.5	0.4	0.2	0.1	6.1	0.9	0.7	0.1	5.7	2.0	2.6	1.0	3.6	0.2	0.2	6.0	0.1	2.7	2.4	2.8	4.9	1.9	3.4	11.2	4.4	6.6	3.2	4.8	5.3	10.9	16.0	173.4	43.8	32.1	0.9	1.6	0.0	2.8	102.7	1.7	0.5	24394.9	30.0	6.2	0.0	20.9	0.7	6.8	0.1	1.9	14.1	43.2	3.4	6.8	99.1	4.2	3.0	25.1	28.3	0.3	502.5	3.6	7.2	10.1	0.7	2.5	0.6	0.3	16.8	31.3	0.1	0.0	0.8	0.8	6.4	1.2	26.2	0.0	25.3	0.6	12.0	2.1	11.6	4.9	0.5	0.1	4.5	10.6	0.2	0.3	0.4	2.9	27.8	0.0	1466.9	104.7	9.3	1.5	2.3	0.1	0.4	24.3	2.8	0.5	0.1
TUSC3	"MagT2, MGC13453, MRT22, MRT7, N33, OST3A, SLC58A2"	ENSG00000104723	"Tumor suppressor candidate 3"	Q13454	8	15417215-15766649	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 472.9;Extravillous trophoblasts: 321.8;Syncytiotrophoblasts: 783.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049851, HPA049974"	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA049851: AB_2680913, HPA049974: AB_2680976"	"unprognostic (3.31e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.46e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.02e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.81e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.99e-3)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.86e-4)"	"unprognostic (1.55e-1)"	23.3	68.8	18.7	8.4	18.4	0.1	28.3	22.3	17.1	25.0	46.6	14.5	9.3	31.9	100.8	11.8	57.6	16.7	34.9	17.1	48.2	25.2	6.9	18.4	6.8	8.9	11.6	73.6	35.0	54.0	69.6	80.5	8.9	46.4	15.5	40.9	12.1	29.7	4.5	8.2	8.2	32.5	7.7	5.3	10.8	23.2	21.0	7.5	9.5	5.7	5.6	34.0	13.0	8.0	52.1	38.4	104.3	96.7	125.2	126.7	0.2	74.9	168.8	85.2	139.3	0.1	0.1	0.7	24.5	105.9	92.4	39.3	37.5	76.1	116.0	0.1	49.8	0.0	30.1	6.0	51.9	0.2	5.6	111.8	22.8	121.0	43.1	113.7	6.9	15.9	70.9	15.6	123.2	41.2	20.6	0.4	49.2	0.0	33.5	24.8	88.7	0.3	108.3	127.1	40.7	74.6	0.0	40.6	56.5	76.2	49.8	0.2	29.0	71.9	71.3	31.3	36.5	0.0	10.0	0.4	1.2	0.0	102.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	18.4	22.3	17.1	17.1	48.2	8.9	11.6	8.9	7.7	21.0	8.0	88.6	0.0	10.3	13.4	0.6	9.9	61.1	123.5	63.7	50.4	40.0	52.1	47.5	18.6	47.0	79.1	8.4	472.9	0.9	2.1	17.6	179.0	11.5	100.8	48.6	36.2	95.7	0.0	141.0	12.2	321.8	53.4	7.7	35.0	1.3	39.3	7.5	0.0	41.8	32.0	155.3	26.3	95.6	0.0	6.3	7.6	34.8	1.5	24.9	24.4	1.6	35.9	0.0	61.3	3.9	23.8	4.1	23.0	2.6	63.8	0.0	23.7	172.4	28.1	39.5	2.0	49.7	60.9	47.4	26.2	4.1	783.8	1.6	46.6	7.8	51.4
TWNK	"C10orf2, FLJ21832, IOSCA, PEO, PEO1, TWINKLE, TWINL"	ENSG00000107815	"Twinkle mtDNA helicase"	Q96RR1	10	100987367-100994403	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA replication"	"Helicase, Hydrolase"	"Deafness, Disease variant, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 6.8;Breast myoepithelial cells: 6.6;Ductal cells: 5.4;Endometrial stromal cells: 7.2;Granulosa cells: 7.1;Theca cells: 9.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002532	Uncertain					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA002532: AB_1078311"	"unprognostic (8.10e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.82e-3)"	"unprognostic (7.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.95e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.46e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.45e-1)"	4.9	7.0	3.7	5.5	3.7	3.0	7.5	3.6	3.5	3.8	3.2	4.4	3.3	4.6	5.3	5.5	6.6	2.6	5.0	3.4	3.6	5.9	6.0	2.1	6.1	3.9	4.0	5.1	5.2	4.8	2.4	3.8	3.8	4.0	4.8	1.6	4.0	3.4	11.6	5.5	3.8	4.5	3.7	4.6	3.9	8.3	4.0	8.1	4.1	12.6	8.3	6.6	3.5	3.5	15.5	32.0	12.5	39.7	11.1	7.2	14.7	11.4	14.8	17.3	16.6	52.6	13.1	55.4	21.1	7.0	10.4	25.0	52.2	27.7	21.1	25.5	31.0	42.1	17.4	40.2	19.1	54.8	16.7	14.9	30.7	25.5	77.6	15.8	10.6	26.3	45.9	15.0	12.3	21.2	37.0	18.8	35.8	28.2	25.9	35.5	27.5	33.2	10.7	15.4	20.1	38.5	12.0	16.0	37.8	13.8	20.9	16.0	12.4	8.6	17.4	10.6	32.5	28.0	31.3	46.0	10.6	47.8	9.8	1.2	0.6	0.1	1.2	0.5	3.7	2.4	1.8	2.7	1.2	2.1	2.0	2.2	0.0	2.5	0.8	1.3	0.4	1.4	3.7	3.7	3.6	3.5	3.4	3.6	3.9	4.0	3.8	3.7	4.0	3.5	3.5	0.0	2.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	6.8	6.6	0.0	0.0	3.1	1.8	0.0	4.2	1.9	0.0	3.9	5.4	0.0	2.3	7.2	2.0	0.0	0.0	0.0	3.0	3.7	1.3	0.0	2.8	1.3	7.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.6	1.1	9.1	0.0	0.0
TXNRD2	"SELZ, TR, TR3, TRXR2"	ENSG00000184470	"Thioredoxin reductase 2"	Q9NNW7	22	19875517-19941820	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2 OS: 139.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002007, HPA003323"	Supported		Approved	Mitochondria,Cytosol		NA	NA		2800000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Mitochondria, Cytosol"		"CAB002007: , HPA003323: AB_1080396"	"unprognostic (3.17e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.30e-1)"	"unprognostic (9.71e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.10e-7)"	"unprognostic (2.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	10.5	44.4	11.9	8.9	12.0	14.5	12.3	18.1	19.3	11.7	21.2	14.9	10.3	10.6	6.2	10.2	10.6	6.2	30.0	12.9	11.9	24.8	65.4	13.6	9.1	11.8	12.1	16.5	15.9	13.5	14.4	9.8	11.5	26.8	4.6	4.4	15.4	8.2	23.0	10.9	12.0	5.1	11.3	16.9	26.4	14.6	12.4	4.9	15.2	16.1	6.1	11.8	10.4	11.8	19.4	39.2	3.5	14.9	6.9	9.6	8.8	18.8	21.1	31.8	23.4	36.7	19.4	10.9	43.2	19.0	32.7	33.2	17.8	25.2	12.1	21.6	46.5	18.8	34.4	22.4	12.9	21.1	8.4	9.2	18.5	16.2	13.8	12.9	91.3	2.2	106.4	17.4	24.8	47.1	7.2	30.1	17.7	46.9	27.6	10.5	85.2	10.0	19.3	21.0	19.1	16.4	32.0	39.9	21.8	5.8	33.7	27.6	52.2	23.0	139.5	19.8	38.4	17.6	14.0	6.9	22.4	15.5	30.3	2.7	10.5	5.8	3.5	8.2	2.6	3.9	3.0	3.2	7.8	2.6	3.9	3.2	0.9	3.8	7.9	2.9	2.1	4.6	11.9	12.0	18.1	19.3	12.9	11.9	11.8	12.1	11.5	11.3	12.4	11.8	5.6	16.0	23.6	11.1	10.3	4.2	23.1	15.1	3.4	22.1	11.4	9.1	16.7	15.7	15.7	20.2	10.4	60.7	8.8	14.7	58.7	22.0	26.4	9.8	8.4	14.4	1.2	33.1	9.2	32.0	24.3	12.4	23.4	10.0	1.3	27.6	8.9	49.5	25.9	10.1	8.5	16.9	20.3	22.0	7.8	18.2	15.5	14.6	5.4	10.3	27.2	18.7	10.3	8.5	7.2	22.3	13.9	9.1	12.2	17.8	15.6	52.0	16.6	11.0	6.6	11.3	13.3	10.9	14.0	6.4	5.3	42.0	11.4	36.4	16.4	15.7
TYK2	JTK1	ENSG00000105397	"Tyrosine kinase 2"	P29597	19	10350529-10380572	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 52.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 206.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005157	Uncertain		Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"HPA005157: AB_1858480"	"unprognostic (1.60e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.67e-2)"	"prognostic favorable (9.62e-4)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.05e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (1.02e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (2.10e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-1)"	"prognostic favorable (4.16e-4)"	53.0	60.5	69.9	37.0	71.9	82.6	52.5	70.7	82.3	55.8	72.2	51.5	29.4	44.8	22.6	46.2	49.0	26.2	65.0	69.6	68.8	77.3	111.2	72.6	51.5	75.1	71.4	56.4	65.1	28.6	66.2	20.1	71.5	64.5	25.7	25.2	50.8	20.6	41.3	51.1	73.9	23.5	70.2	140.8	54.6	16.6	71.8	54.4	60.2	33.7	51.8	49.3	46.0	76.4	29.1	41.1	24.1	38.0	31.9	44.2	23.5	38.9	39.1	48.1	52.2	31.5	18.7	44.5	44.5	43.4	32.8	28.4	29.4	45.5	24.2	78.0	45.5	81.4	90.5	80.2	49.4	34.4	89.4	43.2	31.3	54.5	32.2	29.9	46.5	56.6	35.0	116.1	42.3	90.1	50.7	206.9	7.7	28.4	71.8	49.9	21.1	45.1	40.0	90.1	22.4	28.0	37.6	38.6	28.1	18.4	21.5	57.2	41.1	61.7	22.7	74.1	45.9	97.2	81.4	40.2	32.4	70.8	36.6	9.8	20.8	27.2	12.8	15.2	7.9	7.5	7.6	11.6	23.5	8.0	5.0	7.1	33.0	8.6	15.7	13.0	10.1	13.0	69.9	71.9	70.7	82.3	69.6	68.8	75.1	71.4	71.5	70.2	71.8	76.4	18.6	12.8	17.9	13.1	17.5	6.6	5.4	7.6	13.1	9.2	10.3	11.0	25.7	11.5	11.1	9.2	4.2	7.0	23.2	14.6	52.8	7.6	2.1	10.2	12.6	12.8	4.8	8.6	10.4	11.1	9.7	11.1	27.0	12.0	19.6	17.1	15.4	27.1	14.6	0.0	9.2	8.7	8.2	28.2	14.6	8.8	7.5	30.8	16.0	12.2	25.3	8.7	17.5	11.1	11.1	11.8	12.9	9.8	19.5	5.9	12.1	29.0	11.2	11.0	0.0	10.5	12.6	1.5	4.5	8.8	7.2	6.7	19.4	13.6	11.1	6.3
TYROBP	"DAP12, KARAP, PLO-SL, PLOSL"	ENSG00000011600	"Transmembrane immune signaling adaptor TYROBP"	O43914	19	35904401-35908295	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 596.8;lymphoid tissue: 423.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 3777.1;Kupffer cells: 3698.1;Langerhans cells: 1990.8;Macrophages: 2837.1;monocytes: 3371.2;NK-cells: 1772.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 6415.4"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"HMC-1: 678.1;THP-1: 390.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009493, HPA041899"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB009493: AB_638987, HPA041899: AB_10795266"	"unprognostic (7.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.39e-2)"	126.3	76.1	55.8	234.3	54.3	596.8	59.1	58.6	116.8	44.3	61.4	62.0	70.6	25.9	15.0	28.1	43.7	105.0	39.7	53.0	66.4	34.4	85.5	261.5	161.0	81.7	64.0	18.3	24.7	22.0	27.0	124.7	74.8	31.7	49.8	3.9	38.3	26.7	10.6	21.5	78.8	68.0	74.1	423.3	43.1	15.0	74.0	52.5	21.9	31.6	36.6	131.7	21.5	114.4	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	56.7	0.0	0.0	0.5	33.2	678.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	49.1	0.3	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.3	0.5	0.0	0.0	0.2	0.9	0.0	390.6	0.0	0.0	0.3	0.8	0.1	0.4	0.1	1.0	0.1	10.8	0.1	974.2	4983.5	2573.9	468.0	3367.8	246.5	22.4	9.5	64.2	1912.0	8.4	11.7	51.2	6415.4	1664.1	3413.8	1653.1	9.5	5260.2	55.8	54.3	58.6	116.8	53.0	66.4	81.7	64.0	74.8	74.1	74.0	114.4	24.5	57.7	168.4	0.0	50.9	55.2	2.0	0.0	1.2	0.1	11.5	43.3	6.8	34.3	43.4	20.2	0.0	19.8	987.6	1.7	1.9	2.1	3.9	1.3	1.4	47.1	0.0	87.8	0.1	5.8	28.0	24.9	5.6	1.5	753.7	0.3	73.2	25.0	3777.1	0.0	0.1	0.2	0.0	3698.1	1990.8	11.6	9.3	2837.1	56.9	18.7	3371.2	0.6	1772.4	0.0	0.1	1.3	2.3	1.2	19.4	1.5	0.5	8.9	20.5	1.8	78.9	5.3	10.0	0.9	3.0	4.9	44.6	38.9	236.5	0.1	0.5	1.8
UBA1	"A1S9T, CFAP124, GXP1, POC20, UBE1, UBE1X"	ENSG00000130985	"Ubiquitin like modifier activating enzyme 1"	P22314	X	47190861-47215128	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase	"Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000289, HPA001506, CAB019435, CAB073410"	Approved		Supported	Nucleoplasm		NA	NA		14000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB019435: AB_2211440, CAB073410: , HPA000289: AB_1080443, HPA001506: AB_2756305"	"unprognostic (7.18e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (6.10e-5)"	"unprognostic (7.22e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.17e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.38e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.21e-2)"	98.4	157.9	102.9	98.3	113.2	94.3	98.6	103.4	115.5	127.9	133.9	101.1	71.3	127.1	64.3	155.3	119.3	64.9	117.4	106.2	102.0	131.2	114.7	109.5	105.0	106.9	104.2	136.5	89.0	107.5	135.2	67.4	109.3	103.2	68.5	95.6	119.5	78.9	201.1	119.5	100.4	117.4	94.4	131.9	98.6	98.7	110.0	119.7	160.1	114.1	110.8	101.1	124.8	121.3	269.1	273.2	307.7	471.9	207.4	186.8	135.0	175.1	187.1	248.6	200.5	219.3	201.3	201.6	111.8	357.0	361.5	254.9	392.9	375.7	180.9	163.4	391.7	126.1	295.2	180.0	145.1	215.2	258.8	177.4	193.2	362.7	279.4	176.7	330.2	236.1	138.9	173.7	250.4	343.4	203.3	188.5	329.6	163.2	417.1	233.1	215.3	343.7	198.7	287.0	197.4	148.1	520.8	250.9	116.9	329.9	349.5	130.3	241.6	183.1	210.7	266.4	166.1	117.6	132.8	286.3	189.4	150.8	224.9	31.0	39.7	40.7	39.4	51.1	34.0	39.8	31.8	35.0	43.2	29.9	24.7	31.1	44.8	38.1	49.7	29.3	40.3	39.9	102.9	113.2	103.4	115.5	106.2	102.0	106.9	104.2	109.3	94.4	110.0	121.3	37.2	51.3	34.7	45.1	37.1	33.6	38.6	55.7	26.2	24.9	48.3	39.6	51.4	51.5	50.0	82.8	16.7	46.3	34.2	133.1	35.2	77.5	29.6	84.9	56.3	40.9	57.5	33.2	27.1	90.8	68.7	45.0	74.9	97.5	18.3	60.3	43.5	51.2	60.0	11.8	35.5	78.6	30.5	49.0	37.8	61.6	42.3	51.4	19.6	31.9	57.7	20.7	13.4	32.2	46.5	147.9	74.7	65.8	44.0	55.2	82.2	61.6	56.4	25.1	39.5	38.8	56.6	10.5	34.0	51.3	42.1	71.1	34.6	56.8	68.2	55.4
UBE2A	"HHR6A, HR6A, RAD6A, UBC2"	ENSG00000077721	"Ubiquitin conjugating enzyme E2 A"	P49459	X	119574536-119591083	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 508.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: AB_2667061, HPA051765: AB_2681597, HPA065898: AB_2685577"	"unprognostic (2.27e-3)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.12e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.07e-4)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.54e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (2.20e-6)"	"unprognostic (9.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.92e-2)"	40.0	27.4	30.1	39.1	30.6	29.8	29.4	34.1	38.8	34.1	27.1	52.3	37.5	32.0	38.2	53.4	27.3	32.6	63.2	29.6	32.2	41.0	30.1	32.9	46.9	34.4	32.5	20.1	29.2	39.2	18.9	56.8	34.4	31.0	45.0	27.1	30.9	33.0	71.9	30.7	39.1	43.0	32.1	26.8	30.5	17.6	32.1	46.1	30.5	55.0	50.4	46.9	32.8	35.1	129.5	104.1	60.8	54.1	103.0	125.6	63.9	122.6	106.3	141.8	130.3	50.8	84.0	96.4	126.4	133.9	240.6	86.4	86.3	65.7	128.6	142.3	60.6	42.7	71.9	47.1	96.6	105.9	72.1	86.9	90.1	134.0	58.3	98.1	99.4	86.5	57.0	83.6	160.1	134.5	166.6	99.9	106.3	125.7	126.9	84.2	64.0	91.6	113.1	76.6	48.9	51.3	171.2	75.0	93.7	73.2	65.8	92.6	101.5	92.4	42.0	184.3	142.5	83.6	147.1	92.4	99.1	136.3	74.6	46.8	58.5	92.5	43.0	92.1	34.8	52.6	37.9	38.5	74.6	48.7	23.7	33.9	78.0	35.0	101.1	58.5	56.8	51.1	30.1	30.6	34.1	38.8	29.6	32.2	34.4	32.5	34.4	32.1	32.1	35.1	67.5	102.5	40.9	12.7	79.1	124.8	91.6	129.4	51.8	17.2	60.7	43.9	66.7	44.3	80.7	40.5	31.3	179.8	93.0	168.6	101.8	95.4	51.7	75.6	55.3	62.9	45.5	70.4	9.9	102.1	176.2	67.7	37.8	63.0	57.0	35.7	46.4	35.5	131.3	8.4	9.4	49.7	103.7	59.1	183.9	15.3	37.0	97.3	83.6	15.9	129.0	49.8	41.2	14.6	18.0	137.6	132.5	40.6	92.2	98.2	85.6	125.2	107.7	35.0	46.0	56.3	101.1	44.1	32.1	74.6	127.9	508.5	94.8	36.6	54.5	120.3
UBE2QL1	FLJ25076	ENSG00000215218	"Ubiquitin conjugating enzyme E2 Q family like 1"	A1L167	5	6448859-6496723	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.1;heart muscle: 16.8;retina: 28.3;skeletal muscle: 54.5;tongue: 13.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.0;Cardiomyocytes: 27.6;Excitatory neurons: 47.8;Granulosa cells: 45.5;Horizontal cells: 45.4;Inhibitory neurons: 35.3;Rod photoreceptor cells: 63.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 5.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 29.7;PC-3: 24.6;SCLC-21H: 23.1;U-266/70: 54.4;U-266/84: 52.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057414			Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Plasma membrane"	"HPA057414: "	"unprognostic (1.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.15e-3)"	"unprognostic (8.41e-2)"	"prognostic favorable (6.81e-8)"	"unprognostic (3.18e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.41e-2)"	1.2	1.4	14.3	0.4	14.6	0.0	1.1	16.5	26.1	2.1	1.8	5.3	0.3	0.8	1.0	0.4	0.7	0.4	16.8	17.9	11.4	3.4	1.2	0.1	0.1	12.0	7.9	2.6	0.6	0.1	3.2	0.0	11.6	3.5	0.3	28.3	0.8	5.5	54.5	1.5	1.4	0.7	5.6	0.2	2.9	0.7	10.1	0.3	1.2	13.9	0.2	0.3	1.3	17.7	0.1	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	29.7	0.0	5.3	0.0	0.0	0.3	0.0	24.6	0.1	0.0	11.5	0.0	0.0	23.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	54.4	52.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	14.6	16.5	26.1	17.9	11.4	12.0	7.9	11.6	5.6	10.1	17.7	0.2	0.0	0.0	5.5	0.3	1.3	0.5	0.5	0.0	30.0	0.4	1.0	27.6	0.0	0.0	0.0	6.2	0.0	0.0	0.0	5.9	0.0	0.0	0.2	0.4	1.0	5.4	0.0	47.8	0.2	0.0	3.6	1.1	0.1	0.0	45.5	0.0	1.0	0.1	45.4	35.3	0.0	0.0	0.3	0.3	0.3	4.1	0.1	0.0	2.8	0.0	9.4	0.0	12.1	5.4	0.1	0.0	6.8	1.8	0.9	0.0	0.2	0.0	63.6	0.0	3.2	1.4	0.1	0.3	0.0	0.1	0.0	0.0	0.5	0.0	0.0
UBE2T	"FANCT, HSPC150"	ENSG00000077152	"Ubiquitin conjugating enzyme E2 T"	Q9NPD8	1	202331657-202341980	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 74.5;Erythroid cells: 134.3;Extravillous trophoblasts: 103.4;Spermatocytes: 114.1;Spermatogonia: 113.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002831			Approved	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoli	Nucleoplasm	"HPA002831: AB_1080445"	"unprognostic (2.38e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.27e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (4.79e-6)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"prognostic favorable (6.90e-6)"	"unprognostic (6.28e-3)"	"unprognostic (2.85e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (5.37e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.86e-2)"	2.3	3.7	6.6	10.4	6.5	28.7	4.5	5.8	13.7	4.1	5.0	13.1	8.7	4.5	4.4	10.6	3.3	2.5	11.3	6.8	7.4	3.5	3.2	3.0	19.0	6.5	6.6	1.0	0.7	4.4	3.0	10.1	6.9	2.1	15.5	2.5	2.7	3.1	17.2	5.3	8.2	9.4	6.0	6.2	4.7	19.3	6.7	47.1	2.9	13.0	18.6	6.3	5.0	6.1	123.3	111.6	167.1	79.8	15.4	27.9	94.2	130.2	72.8	146.0	102.6	79.9	147.1	140.4	50.0	47.0	108.4	98.6	154.1	76.7	131.2	128.1	87.2	85.6	54.0	93.8	6.9	105.2	102.0	9.8	18.1	114.0	47.2	34.3	85.8	157.4	111.0	114.0	116.4	113.3	190.8	135.1	65.4	126.9	57.4	145.0	176.2	122.9	57.1	58.1	131.3	132.8	90.2	112.1	44.8	49.8	117.1	64.6	41.8	65.7	104.6	116.1	159.6	57.8	120.1	182.9	64.5	107.0	139.1	0.0	0.7	1.7	3.3	2.3	2.5	8.5	4.5	3.3	1.7	6.6	6.4	7.1	0.0	1.2	8.9	3.4	10.8	2.4	6.6	6.5	5.8	13.7	6.8	7.4	6.5	6.6	6.9	6.0	6.7	6.1	1.9	0.0	2.2	1.3	13.3	14.3	10.4	29.9	2.8	6.4	6.3	8.6	12.8	0.0	12.1	5.5	0.0	74.5	5.4	10.1	5.9	10.9	24.4	15.7	7.6	5.3	1.2	134.3	8.3	7.5	103.4	11.8	10.7	6.7	8.8	32.2	3.9	2.4	27.7	10.1	6.1	14.4	32.6	1.9	5.4	8.2	3.1	5.8	3.6	1.9	2.6	1.6	0.0	1.0	1.4	10.3	2.9	4.1	32.1	5.2	3.3	12.2	16.2	1.2	6.6	0.8	11.3	114.1	113.1	15.5	10.9	22.4	9.3	12.1	30.5	11.3
UBE3A	"ANCR, AS, E6-AP, EPVE6AP, FLJ26981, HPVE6A"	ENSG00000114062	"Ubiquitin protein ligase E3A"	Q05086	15	25333728-25439051	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009723, HPA039410, HPA040380"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB009723: AB_639982, HPA039410: AB_10671997, HPA040380: AB_2676952"	"unprognostic (7.95e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.17e-2)"	29.1	29.0	28.0	27.6	30.3	32.4	32.6	42.8	41.7	33.5	14.0	33.5	22.9	32.9	29.5	32.9	29.9	24.5	40.6	31.0	28.2	32.6	42.2	24.9	33.3	22.3	23.6	37.1	27.2	38.4	15.3	28.4	24.0	31.8	28.9	32.8	23.3	28.4	109.2	26.8	29.5	30.9	19.9	26.9	26.1	45.6	28.1	41.7	41.5	92.0	34.2	32.8	20.0	29.2	55.9	33.6	77.7	46.1	45.0	56.4	38.4	84.8	54.8	59.9	55.6	76.0	27.6	103.4	61.2	68.2	57.8	51.2	106.8	62.2	75.2	54.1	32.7	85.8	49.0	43.1	65.5	107.0	60.2	60.6	56.2	58.3	71.6	60.0	47.6	87.0	89.0	71.1	95.1	32.3	84.0	29.1	50.3	62.1	46.6	88.6	117.8	45.6	51.7	91.1	80.0	59.6	72.1	72.1	102.1	51.3	57.9	56.7	59.2	102.1	84.7	52.1	64.5	77.5	103.4	139.5	60.4	56.6	55.3	14.4	12.7	17.2	17.0	11.2	19.9	17.3	18.5	20.8	16.7	22.8	20.8	18.7	2.2	29.6	22.3	15.2	15.8	9.7	28.0	30.3	42.8	41.7	31.0	28.2	22.3	23.6	24.0	19.9	28.1	29.2	56.6	96.1	80.5	112.6	74.7	71.1	83.8	40.6	84.2	82.7	59.5	42.3	175.3	42.9	58.7	38.6	56.3	52.3	74.3	43.3	19.6	51.6	139.4	53.6	75.2	58.7	68.7	64.3	187.7	49.6	49.6	64.1	52.5	63.8	62.8	84.1	44.3	58.6	46.0	80.8	196.3	55.0	12.2	60.9	41.1	61.6	56.8	64.4	53.4	87.1	53.3	54.5	54.6	126.2	124.4	59.8	41.5	64.7	95.7	102.8	51.4	50.3	59.4	59.2	78.9	119.0	80.5	146.1	88.3	78.3	90.6	74.0	63.3	65.7	52.6	98.6
UBE3B		ENSG00000151148	"Ubiquitin protein ligase E3B"	Q7Z3V4	12	109477402-109536705	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041012	Approved		Approved	"Nuclear speckles,Mitochondria"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 51: Myeloid cells - Hemostasis"	"Nuclear speckles"	Mitochondria	"HPA041012: AB_10964435"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.37e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.46e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (2.49e-5)"	"unprognostic (3.35e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-1)"	13.8	16.5	14.4	10.7	16.1	9.2	13.7	13.3	15.6	14.4	16.5	17.8	12.9	14.1	13.4	18.6	16.2	12.1	26.2	14.4	12.4	16.7	16.0	13.6	12.6	13.7	14.6	15.8	14.3	22.6	13.6	13.1	14.8	15.4	18.1	14.9	14.4	14.1	34.0	19.2	15.8	14.7	12.5	15.8	16.5	12.9	16.1	12.6	18.2	29.7	13.5	17.0	14.5	20.3	17.1	26.4	20.4	14.8	33.9	27.1	17.9	22.1	25.1	26.2	17.4	28.0	17.1	10.6	16.0	36.3	22.5	21.5	20.9	28.3	25.1	23.4	14.7	20.3	17.6	25.5	21.7	16.7	16.2	31.0	25.8	25.4	30.2	39.5	28.7	24.8	22.7	9.7	30.2	26.6	11.5	24.2	21.0	19.1	31.6	18.8	19.2	20.9	22.4	30.2	19.1	34.9	25.8	34.6	17.3	23.7	35.3	17.6	26.5	32.3	9.2	16.8	16.0	21.8	19.4	18.6	32.1	13.7	27.4	22.9	12.9	12.8	12.6	14.5	12.4	13.6	12.1	9.0	12.4	10.0	10.0	13.3	16.1	13.1	12.0	11.4	16.2	10.7	14.4	16.1	13.3	15.6	14.4	12.4	13.7	14.6	14.8	12.5	16.1	20.3	11.9	12.8	15.1	34.0	9.7	5.1	11.8	13.9	6.8	19.3	14.4	12.8	35.4	11.5	17.1	16.5	33.3	17.9	12.8	21.0	11.7	17.7	15.7	12.6	12.5	14.2	9.0	13.0	24.5	15.3	11.5	11.1	18.8	12.2	9.5	20.0	11.7	18.8	12.5	21.9	23.6	15.9	18.3	19.2	6.1	32.0	12.5	14.2	10.6	13.1	17.7	13.6	32.0	21.1	38.3	25.3	13.7	9.8	15.6	17.2	19.6	19.9	18.4	25.0	6.6	9.4	13.0	10.4	13.2	13.4	7.2	23.7	10.7	17.7	16.8	18.4
UBQLN4	"A1U, C1orf6, UBIN"	ENSG00000160803	"Ubiquilin 4"	Q9NRR5	1	156035299-156053798	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair"		"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 9.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061797	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA061797: AB_2684613"	"unprognostic (3.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.65e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.57e-1)"	18.9	19.4	39.9	14.6	47.9	9.1	19.1	34.3	52.5	31.6	27.3	24.5	13.6	24.3	15.3	33.7	26.7	11.5	26.7	40.8	40.2	25.7	31.7	20.8	15.0	38.1	38.3	21.1	32.2	25.6	11.3	15.5	37.7	25.4	15.5	18.3	23.3	19.6	59.7	27.0	18.8	22.9	37.1	20.2	28.2	19.8	40.0	14.1	17.7	39.5	17.0	26.1	26.0	39.8	45.9	54.1	50.8	50.1	34.1	21.0	50.0	37.8	20.7	37.2	27.8	49.0	40.5	77.7	33.9	34.7	20.1	50.2	51.8	40.8	35.2	65.9	54.9	42.8	31.5	47.7	21.9	46.4	77.3	15.9	51.6	51.3	41.5	32.6	44.8	24.4	81.4	42.1	34.0	56.3	51.4	46.5	69.8	117.2	49.8	64.8	37.4	76.9	30.2	45.7	37.3	108.0	38.0	93.2	38.7	49.0	90.1	50.4	43.7	34.3	44.9	35.3	41.4	92.7	79.4	83.2	21.0	45.9	49.1	9.7	0.7	0.4	1.5	0.7	1.9	1.1	1.1	1.6	0.5	0.8	0.8	1.2	0.0	1.2	0.1	1.2	1.0	0.7	39.9	47.9	34.3	52.5	40.8	40.2	38.1	38.3	37.7	37.1	40.0	39.8	8.6	6.4	5.3	9.8	8.4	13.4	9.4	9.1	18.2	6.8	17.2	9.9	4.3	17.2	8.5	23.9	6.2	8.1	8.1	9.6	3.9	11.6	0.8	5.0	10.2	9.3	10.7	6.3	5.9	10.9	9.1	7.4	7.1	8.9	1.3	13.4	11.7	22.7	9.9	6.7	6.6	10.8	8.2	8.4	7.2	4.9	6.5	8.3	17.8	9.4	15.6	7.3	5.2	4.5	9.2	13.1	6.9	9.1	13.0	25.3	8.2	12.1	5.4	6.0	0.0	10.7	7.8	4.9	5.6	21.0	14.6	8.2	7.7	4.8	15.0	14.3
UBR1		ENSG00000159459	"Ubiquitin protein ligase E3 component n-recognin 1"	Q8IWV7	15	42942897-43106113	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 108.9;Inhibitory neurons: 108.8;Oligodendrocyte precursor cells: 102.1;Oligodendrocytes: 127.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038838, HPA038839"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Cytosol"	"HPA038838: AB_10673120, HPA038839: "	"unprognostic (1.07e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.89e-1)"	9.1	7.9	12.5	8.8	29.4	24.9	9.3	11.7	17.4	9.9	4.8	8.6	7.8	10.7	7.4	5.8	8.0	8.6	13.7	11.6	31.5	9.2	7.1	8.6	10.9	24.2	18.3	7.7	9.5	14.3	6.6	10.5	21.6	10.0	8.0	14.3	6.3	10.5	12.0	5.6	7.8	9.6	8.5	9.5	7.2	10.1	21.2	13.3	12.6	14.0	8.7	9.1	5.8	48.6	7.4	10.2	11.6	9.6	17.1	14.7	10.7	17.6	19.4	15.9	19.2	13.3	5.5	8.6	10.1	18.4	18.9	12.4	17.1	15.5	18.1	18.0	8.4	33.1	20.4	6.3	12.3	23.0	14.4	15.3	8.4	18.8	14.8	14.6	17.0	16.7	19.6	12.3	18.7	4.5	12.7	6.8	6.5	18.9	10.6	16.4	15.7	6.4	14.9	16.6	12.0	10.3	22.7	12.0	7.7	13.1	10.9	12.2	24.3	17.9	11.1	16.7	18.0	14.6	26.4	23.6	12.2	14.6	16.6	3.7	1.5	2.5	2.4	1.8	2.9	1.9	2.6	2.9	1.4	2.3	2.6	3.2	2.9	3.2	1.7	2.2	1.9	0.9	12.5	29.4	11.7	17.4	11.6	31.5	24.2	18.3	21.6	8.5	21.2	48.6	46.4	48.1	30.7	73.1	28.9	10.6	11.6	9.3	17.1	27.5	15.4	10.8	28.0	12.8	19.1	9.2	27.1	14.7	35.8	12.8	0.0	10.8	16.8	13.4	27.4	24.5	14.4	23.8	108.9	14.4	7.7	25.6	20.9	18.2	28.5	22.8	17.2	9.9	8.1	32.0	108.8	10.9	14.2	16.4	10.6	16.9	16.1	17.1	8.8	73.1	15.6	13.5	23.7	102.1	127.6	10.3	8.2	20.7	33.2	7.7	12.3	9.2	15.7	38.8	13.1	34.7	36.5	27.0	17.8	8.6	7.2	36.9	31.4	16.5	10.6	9.8
UCHL1	"PARK5, PGP9.5, Uch-L1"	ENSG00000154277	"Ubiquitin C-terminal hydrolase L1"	P09936	4	41256413-41268455	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 692.7;pituitary gland: 285.4"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 115.8;Distal tubular cells: 258.2;Excitatory neurons: 147.1;Horizontal cells: 146.4;Inhibitory neurons: 118.4;Spermatogonia: 88.4"	"Cancer enhanced"	"Detected in all"		"glioma: 129.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 1142.2;SCLC-21H: 1160.6;U-251 MG: 1162.6;U-266/84: 1138.4;U-87 MG: 1209.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002580, HPA005993, CAB079024"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA		500000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560"	"unprognostic (1.54e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.77e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.12e-3)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.93e-4)"	30.1	104.4	211.4	19.2	188.8	0.6	13.6	83.4	342.7	18.9	0.0	49.0	9.0	13.2	3.3	3.3	9.7	12.3	26.9	229.7	692.7	62.7	1.6	8.2	12.9	255.7	205.2	35.6	11.6	0.6	285.4	2.5	446.7	12.3	6.9	38.3	3.7	5.8	27.5	4.7	18.9	9.2	122.2	2.7	14.5	16.5	150.3	4.1	9.8	7.7	7.3	31.7	29.1	231.2	3.3	712.8	146.8	0.4	18.9	19.7	0.4	681.4	352.8	236.0	243.4	149.0	0.9	0.0	1142.2	384.4	356.7	1.1	262.8	0.6	116.4	1.5	97.0	0.0	6.9	0.2	529.3	0.1	1.2	127.4	3.0	197.9	0.0	413.7	2.0	0.0	0.0	2.3	122.6	0.6	1.0	12.3	435.3	0.0	714.1	0.1	297.2	0.7	386.3	0.3	1160.6	765.7	5.1	2.8	1.8	165.4	0.8	5.0	3.3	16.8	5.2	0.4	1162.6	583.1	1138.4	3.1	1209.3	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	211.4	188.8	83.4	342.7	229.7	692.7	255.7	205.2	446.7	122.2	150.3	231.2	0.8	0.0	3.1	29.0	2.1	1.7	1.1	1.5	1.2	25.6	0.3	0.6	3.1	0.0	3.5	115.8	8.4	3.6	0.0	0.1	258.2	4.3	3.5	0.9	9.8	3.9	4.2	0.8	147.1	0.8	0.8	35.4	1.1	0.5	2.5	46.3	8.9	0.6	4.7	146.4	118.4	0.0	4.1	0.6	3.4	6.0	37.0	2.3	3.6	35.6	0.6	21.6	0.0	55.8	54.6	3.0	0.0	17.3	9.2	3.7	0.0	17.1	7.4	61.3	0.0	3.6	35.7	10.4	88.4	0.3	1.6	1.5	1.3	20.0	0.2	1.0
UCP3	SLC25A9	ENSG00000175564	"Uncoupling protein 3"	P55916	11	74000277-74009085	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	80	"skeletal muscle: 393.2;tongue: 263.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 15.4;Late spermatids: 14.0;NK-cells: 6.2;Skeletal myocytes: 6.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"HDLM-2: 15.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB010771, HPA072225"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB010771: AB_261839, HPA072225: AB_2686498"	"unprognostic (3.76e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.25e-6)"	"unprognostic (2.68e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.50e-4)"	1.2	1.7	2.5	1.3	2.6	2.2	1.3	3.9	3.0	1.4	2.3	1.7	0.7	1.4	2.0	2.9	1.5	0.8	2.4	2.7	2.1	1.7	1.3	1.4	1.3	2.4	2.1	1.1	1.1	0.9	2.7	0.5	2.3	1.8	0.7	4.0	3.7	0.7	393.2	1.4	1.7	0.8	1.8	3.1	1.2	3.9	2.4	1.6	2.6	263.1	0.7	1.4	0.9	2.8	0.2	1.8	1.7	1.5	0.7	0.3	0.3	0.5	0.4	0.4	0.2	0.4	0.4	0.9	0.2	0.3	0.2	1.9	0.7	0.3	0.7	15.8	0.5	0.3	2.4	0.2	0.5	1.1	1.4	0.4	1.1	1.1	0.1	0.3	0.5	0.9	0.4	1.2	0.6	1.0	0.7	1.4	0.9	1.4	1.1	1.4	3.6	0.5	0.9	0.5	0.9	1.0	0.4	0.7	0.6	0.3	0.2	1.0	0.3	0.2	1.1	0.6	1.1	1.4	1.5	0.7	0.2	1.0	0.5	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.3	0.3	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	2.5	2.6	3.9	3.0	2.7	2.1	2.4	2.1	2.3	1.8	2.4	2.8	0.8	0.0	0.0	1.6	0.8	0.1	0.1	0.5	0.6	2.3	1.0	1.1	0.7	0.0	1.1	0.0	0.0	0.3	2.0	0.3	0.0	0.3	15.4	1.2	1.1	0.6	0.0	0.4	1.6	0.5	0.2	0.4	0.0	0.8	0.0	0.7	1.1	0.3	0.7	0.0	1.6	0.5	2.0	0.8	0.0	14.0	0.0	0.6	0.0	1.0	0.7	0.8	6.2	0.5	0.6	0.4	0.1	0.7	0.5	0.2	0.3	0.1	3.0	2.1	0.0	6.5	0.5	1.5	0.8	0.4	0.3	0.3	1.5	0.3	0.6	0.1
UFSP2	"C4orf20, FLJ11200"	ENSG00000109775	"UFM1 specific peptidase 2"	Q9NUQ7	4	185399537-185425979	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 190.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039985, HPA043298"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA039985: AB_10794206, HPA043298: AB_10795037"	"unprognostic (8.87e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.19e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.07e-8)"	"unprognostic (1.92e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.36e-3)"	"unprognostic (6.70e-3)"	21.2	24.9	19.9	9.5	21.7	5.7	24.3	25.2	24.1	21.6	29.6	19.5	13.0	19.9	28.1	25.8	17.7	15.6	32.1	20.4	21.9	37.3	24.1	17.1	11.9	20.4	20.2	31.4	19.7	23.8	10.0	14.0	20.9	19.8	15.3	56.4	20.3	19.2	48.5	21.6	12.0	20.2	20.7	14.5	17.5	21.0	21.3	14.3	25.9	40.6	16.1	16.2	10.1	25.3	17.5	11.9	28.8	24.3	25.8	25.6	15.3	20.3	20.5	19.3	19.3	18.4	23.2	17.9	9.0	19.7	14.7	16.1	20.4	32.2	17.4	21.8	12.4	11.8	13.0	23.3	30.2	15.3	12.3	14.7	26.8	16.5	16.7	26.7	35.7	21.9	24.8	34.3	28.2	16.3	22.0	16.4	8.7	11.8	16.7	20.2	11.5	20.4	31.9	11.4	18.6	14.8	11.3	25.6	23.1	17.6	15.4	13.6	27.3	9.5	16.8	7.5	17.2	34.6	14.8	9.5	30.5	11.0	25.3	10.8	12.3	7.6	21.2	10.4	25.7	22.0	21.7	24.1	14.1	15.4	23.2	22.9	0.7	21.5	11.1	19.9	20.6	12.5	19.9	21.7	25.2	24.1	20.4	21.9	20.4	20.2	20.9	20.7	21.3	25.3	33.8	6.4	23.9	14.7	30.1	22.0	28.7	35.1	33.0	47.6	20.9	25.5	27.0	15.7	31.1	20.2	66.7	26.0	23.4	8.3	111.6	28.3	190.5	16.4	28.9	24.1	19.3	24.0	12.2	33.1	29.7	34.2	20.4	19.2	29.7	21.9	21.8	17.3	27.2	18.5	17.8	18.6	28.5	22.1	18.8	52.9	35.4	18.5	35.6	12.2	17.3	71.8	21.6	23.6	33.2	19.7	14.6	42.2	53.0	15.4	22.2	100.9	23.7	87.9	65.7	31.8	38.9	89.3	56.7	22.6	18.9	41.9	27.1	35.6	14.8	19.6
UGDH		ENSG00000109814	"UDP-glucose 6-dehydrogenase"	O60701	4	39498755-39528311	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Allosteric enzyme, Oxidoreductase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 137.7"	"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 345.5;Hepatocytes: 231.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 509.6;Hep G2: 595.9;U-2197: 375.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034444, HPA036656, HPA036657"	Enhanced		Supported	Nucleoplasm		Yes	No		1300000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.96e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-3)"	"unprognostic (6.86e-2)"	"prognostic unfavorable (5.51e-10)"	"unprognostic (2.48e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	48.5	27.8	6.2	29.5	7.3	2.4	32.0	9.4	9.2	31.5	18.1	96.5	45.3	29.1	10.6	34.1	29.6	40.5	16.0	5.9	8.3	37.5	137.7	19.0	13.3	7.4	7.7	30.0	33.7	23.1	7.8	38.4	8.0	35.6	73.3	14.3	16.8	14.0	6.7	9.9	41.1	23.5	7.6	11.5	47.4	6.8	8.4	10.3	27.8	9.5	14.5	54.4	17.1	9.7	36.0	509.6	58.4	76.2	181.5	185.3	51.3	102.7	113.8	94.5	84.8	76.2	115.5	25.4	63.0	133.3	94.5	33.5	56.0	29.5	95.8	32.1	13.0	26.2	65.4	595.9	72.7	34.1	25.3	64.4	14.9	160.2	49.8	78.9	59.3	20.9	34.1	17.3	67.9	89.8	29.4	34.4	53.1	194.0	46.4	48.3	95.0	22.0	53.7	120.0	31.2	46.7	69.2	37.9	45.3	41.4	21.0	27.0	85.9	97.9	49.1	375.8	54.2	42.1	33.3	23.3	86.9	25.8	56.6	30.0	20.9	19.7	23.2	18.4	37.8	18.8	18.8	24.9	19.0	18.4	16.1	19.4	3.8	42.3	11.2	22.5	13.5	18.8	6.2	7.3	9.4	9.2	5.9	8.3	7.4	7.7	8.0	7.6	8.4	9.7	19.1	25.6	27.6	4.6	14.1	116.1	73.4	19.5	43.9	7.5	115.8	62.0	8.9	24.3	25.4	20.2	14.6	21.3	12.9	207.8	70.5	54.7	1.1	78.3	53.8	25.4	113.3	9.1	10.6	345.5	78.8	145.7	184.0	64.8	35.5	11.1	20.7	231.3	17.8	10.1	12.6	114.5	12.2	20.2	33.3	1.6	33.2	12.7	30.2	7.5	19.9	7.3	9.2	46.3	12.8	195.8	112.2	29.0	21.3	127.3	81.4	79.6	65.7	9.2	32.9	39.0	57.5	6.5	5.5	102.2	40.1	29.0	11.7	12.4	152.4	86.4
UGP2	"SVUGP2, UGP1, UGPP1"	ENSG00000169764	"UDP-glucose pyrophosphorylase 2"	Q16851	2	63840952-63891562	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 858.6;tongue: 756.1"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 849.9;Hepatocytes: 559.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 417.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034696, HPA034697, HPA064836"	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria		NA	NA		13000000	"Cluster 38: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"	"Centrosome, Mitochondria"	Nucleoplasm	"HPA034696: AB_10670171, HPA034697: AB_2674287, HPA064836: AB_2685365"	"unprognostic (1.00e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.50e-5)"	"unprognostic (2.20e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.44e-2)"	267.3	72.0	79.8	65.8	89.3	40.1	119.7	72.7	109.8	65.9	78.8	177.9	66.0	75.2	50.6	97.5	68.9	60.7	232.5	87.9	81.4	105.4	858.6	65.4	65.7	77.7	77.0	47.0	74.4	113.3	49.8	137.8	77.6	57.4	159.3	36.8	92.9	66.2	498.0	59.1	67.6	78.5	73.2	50.8	69.5	38.3	83.3	106.2	64.5	756.1	73.7	88.4	63.7	91.8	122.3	77.6	63.1	42.0	176.1	222.4	220.6	129.1	116.1	82.7	89.4	170.0	104.5	149.5	48.3	165.6	79.9	57.4	73.4	102.6	137.0	99.2	35.7	86.5	50.4	117.9	87.0	79.1	73.9	148.1	175.8	76.1	80.3	108.4	119.4	38.9	48.2	58.1	327.8	56.7	104.6	75.2	122.9	207.7	50.1	80.4	117.9	84.5	147.4	77.7	36.5	29.6	103.3	149.8	64.3	162.6	51.7	59.2	144.3	84.4	125.9	113.8	90.5	101.3	51.4	174.9	99.2	122.7	225.7	417.1	33.0	53.1	48.0	40.7	51.8	33.0	53.6	50.1	27.9	31.8	57.6	53.6	45.4	70.0	39.5	29.7	127.2	62.0	79.8	89.3	72.7	109.8	87.9	81.4	77.7	77.0	77.6	73.2	83.3	91.8	73.4	28.9	54.0	107.4	65.3	75.8	87.8	245.9	34.7	49.6	360.6	87.1	264.3	104.4	171.6	47.8	64.6	414.3	81.1	849.9	242.6	140.6	91.5	53.0	106.3	69.8	44.5	56.0	86.1	103.6	445.5	159.3	79.0	49.5	67.8	42.4	63.5	559.4	120.9	87.5	78.4	179.8	144.5	102.4	90.2	86.1	79.2	89.1	96.0	62.8	139.7	58.8	154.5	37.2	79.3	91.6	313.9	77.5	60.7	81.2	176.2	284.4	139.3	57.3	72.3	50.5	129.2	84.9	54.9	50.9	57.8	472.8	143.1	90.6	189.5	109.1
UGT1A1	"GNT1, UGT1, UGT1A"	ENSG00000241635	"UDP glucuronosyltransferase family 1 member A1"	P22309	2	233760270-233773300	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"intestine: 201.2;liver: 322.4"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 105.0"	"Cancer enriched"	"Detected in some"	19	"liver cancer: 16.4"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 14.0;OE19: 64.5;RT4: 34.7"	"Not detected"	"Not detected"													NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"						"unprognostic (7.28e-2)"			"unprognostic (2.49e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.69e-2)"			"unprognostic (4.17e-3)"	"unprognostic (6.31e-3)"	"unprognostic (1.94e-5)"	"unprognostic (2.78e-3)"			"unprognostic (2.99e-4)"	0.1	0.1	0.6	0.2	0.5	0.5	0.2	1.5	0.8	0.1	0.2	3.0	201.2	0.2	0.4	3.5	0.1	1.0	0.2	0.4	0.8	4.0	322.4	0.2	0.3	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.2	2.4	0.9	0.5	0.3	0.1	1.8	79.2	0.1	0.0	0.2	2.4	0.6	0.3	0.1	0.2	0.1	0.3	10.0	0.9	0.6	0.3	1.1	0.2	0.2	0.1	0.1	0.6	0.0	0.0	0.0	0.1	5.4	0.3	0.2	2.5	0.1	0.1	14.0	0.0	0.2	0.0	0.2	0.1	0.1	0.6	1.6	0.0	0.5	0.2	0.2	0.6	0.0	0.0	0.1	0.0	0.3	0.2	0.6	0.0	0.8	0.1	0.3	0.5	64.5	6.5	0.1	0.1	0.6	0.0	34.7	0.2	0.4	2.6	0.4	0.0	0.2	0.2	0.0	0.1	0.2	0.1	0.3	0.0	0.2	0.2	0.1	0.7	0.4	0.2	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	1.4	0.3	0.1	0.1	0.1	0.0	0.6	0.5	1.5	0.8	0.4	0.8	0.2	0.2	0.2	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.6	0.0	0.0	0.0	0.0	0.0	3.7	1.8	0.0	0.0	0.0	1.8	0.0	0.1	2.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.1	105.0	0.0	0.0	0.0	0.4	0.0	2.4	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.1	6.9	14.6	2.2	1.5	0.0	0.0	0.4	0.1	0.2	0.1	1.5	0.0	0.0	0.1	0.0	0.7	7.3
UHRF1	"FLJ21925, ICBP90, Np95, RNF106, TDRD22"	ENSG00000276043	"Ubiquitin like with PHD and ring finger domains 1"	Q96T88	19	4903080-4962154	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 27.0;lymphoid tissue: 67.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 49.7;Plasma cells: 21.0;Squamous epithelial cells: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.8;T-cells: 2.3"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 450.9;REH: 1004.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA049408, HPA055446"	Enhanced		Supported	Nucleoplasm		No	Yes			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA049408: AB_2756317, HPA055446: AB_2732597"	"unprognostic (3.83e-2)"	"unprognostic (6.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (6.81e-4)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (4.52e-5)"	"unprognostic (2.33e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	1.0	0.9	2.1	9.6	2.7	27.0	1.7	2.1	2.3	1.6	1.8	2.9	3.7	1.0	0.1	6.5	0.4	0.8	0.5	2.0	2.2	0.6	0.9	1.3	15.8	2.8	2.8	0.3	0.6	0.2	0.2	2.1	2.7	0.6	2.6	0.4	1.5	0.2	1.2	3.4	3.9	1.9	1.9	3.7	3.3	5.2	3.5	67.2	0.3	0.3	10.3	1.6	2.5	4.6	111.3	78.7	116.6	83.4	3.3	13.3	18.5	88.3	42.0	89.9	86.8	94.6	54.9	62.7	21.1	39.4	32.7	54.1	81.2	47.7	63.0	102.7	92.2	54.3	74.3	102.4	1.3	135.1	78.9	6.5	3.5	48.9	12.6	14.1	27.2	97.2	79.3	70.5	54.5	86.7	450.9	82.5	52.5	40.0	84.3	1004.5	259.7	45.4	24.9	80.1	86.0	68.5	69.2	37.7	12.1	18.8	68.2	127.6	34.2	94.6	76.7	124.3	108.3	29.8	33.1	183.5	54.8	129.7	123.3	0.3	0.2	0.1	0.6	0.0	0.0	0.2	0.8	1.0	1.3	0.1	0.2	0.8	0.8	0.5	0.2	4.8	2.3	0.6	2.1	2.7	2.1	2.3	2.0	2.2	2.8	2.8	2.7	1.9	3.5	4.6	0.2	0.0	0.0	1.6	2.1	0.0	0.8	0.0	3.4	2.5	4.4	2.8	4.3	1.5	0.6	0.0	0.0	6.6	6.9	2.6	0.0	2.2	2.9	1.3	1.8	2.2	0.0	49.7	0.4	0.4	7.8	4.7	8.6	2.4	0.0	10.4	0.4	0.7	8.9	3.3	0.4	2.3	0.0	1.9	0.0	1.8	0.6	3.8	0.0	0.0	2.0	0.6	1.0	3.0	1.3	4.2	1.9	0.4	21.0	0.6	1.4	0.2	0.7	0.7	0.0	1.2	6.1	6.1	11.9	15.8	0.0	1.4	3.7	1.5	8.3	1.3
UHRF2	"MGC33463, NIRF, RNF107, TDRD23, URF2"	ENSG00000147854	"Ubiquitin like with PHD and ring finger domains 2"	Q96PU4	9	6413151-6507054	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 78.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026633, HPA026697"			Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA026633: AB_2732431, HPA026697: AB_2732432"	"unprognostic (1.08e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.14e-2)"	"unprognostic (6.21e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.50e-1)"	10.0	8.1	8.2	9.9	10.3	44.6	9.7	14.9	10.4	12.9	10.4	11.6	6.2	12.9	10.0	8.3	9.9	7.9	7.2	8.7	9.2	8.1	7.9	7.8	17.3	9.4	8.6	12.4	10.7	9.7	5.4	12.1	9.4	15.3	9.2	9.2	8.5	12.6	11.0	7.7	8.5	14.0	8.8	10.4	8.3	8.4	10.0	21.2	8.1	11.9	16.6	11.4	10.1	14.3	18.1	18.8	26.7	11.9	21.4	30.7	20.5	43.9	23.4	23.7	41.2	12.4	12.0	26.9	9.2	19.2	21.8	11.9	24.6	22.5	36.0	53.6	14.9	46.3	36.2	19.7	17.8	19.3	16.1	13.5	14.1	18.4	44.5	44.4	93.2	25.4	5.1	24.0	56.0	5.9	37.0	79.2	10.8	24.8	14.8	43.1	12.4	8.7	17.2	11.3	24.8	9.4	16.6	11.0	25.6	32.1	14.0	41.9	78.6	25.2	10.0	11.0	34.4	7.2	23.2	30.4	12.4	18.2	10.2	4.0	0.5	2.7	1.2	0.5	0.8	1.8	1.8	1.0	0.3	2.9	1.0	1.2	0.5	0.6	0.9	1.2	1.9	0.6	8.2	10.3	14.9	10.4	8.7	9.2	9.4	8.6	9.4	8.8	10.0	14.3	27.5	6.4	14.4	24.2	33.9	21.5	10.2	6.2	12.0	22.0	13.8	13.1	59.0	4.3	8.4	12.9	31.3	13.2	31.3	9.1	1.9	5.2	23.6	12.8	22.9	24.1	7.1	34.9	44.2	4.0	9.9	16.0	20.9	24.5	17.7	27.8	12.8	14.6	10.7	28.6	53.3	14.8	4.1	12.6	9.3	8.1	19.3	15.6	21.4	51.5	12.5	6.4	16.5	46.8	78.6	6.2	14.4	14.7	30.1	16.0	10.2	7.3	6.3	34.8	13.1	14.4	18.8	46.2	23.4	16.1	19.0	5.9	29.0	13.7	12.6	9.8
ULK4	"FAM7C1, FLJ20574, REC01035"	ENSG00000168038	"Unc-51 like kinase 4"	Q96C45	3	41246599-41962130	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 352.3;Excitatory neurons: 108.6;Inhibitory neurons: 99.2;Late spermatids: 405.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017930	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA017930: AB_1858615"	"unprognostic (3.16e-2)"	"unprognostic (2.98e-3)"	"unprognostic (9.72e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.75e-3)"	"unprognostic (3.43e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.12e-2)"	2.7	3.1	1.6	2.9	2.1	8.5	2.5	0.4	1.7	8.5	16.9	1.6	1.2	6.6	4.5	1.5	9.0	1.9	8.6	2.3	2.5	3.9	2.1	3.5	3.0	6.9	7.6	2.1	2.0	8.0	2.9	2.7	3.9	2.2	1.7	6.0	1.7	2.4	0.4	2.1	2.0	3.5	5.6	2.0	2.4	23.4	2.5	3.0	4.9	0.4	2.7	1.9	3.7	2.1	8.3	2.9	2.8	3.8	1.1	1.7	4.8	2.7	2.7	3.2	3.0	1.0	2.3	9.5	1.6	6.3	3.5	4.1	3.7	2.1	2.9	1.5	1.0	2.1	5.7	3.3	4.1	6.5	1.8	1.6	2.3	16.1	3.2	4.4	2.2	6.4	2.1	7.5	2.3	6.4	8.1	4.9	3.4	2.1	3.4	1.7	9.1	4.5	7.2	7.6	1.6	10.3	3.1	1.3	2.8	1.8	3.1	2.0	6.6	2.0	2.4	14.2	2.5	4.5	9.0	3.9	11.5	6.3	2.5	3.7	3.7	4.0	5.0	4.3	4.1	3.7	5.3	4.5	3.3	4.7	4.0	5.7	6.6	1.8	2.3	3.3	7.7	3.0	1.6	2.1	0.4	1.7	2.3	2.5	6.9	7.6	3.9	5.6	2.5	2.1	6.4	9.6	6.9	84.9	11.2	2.0	3.0	4.0	5.2	5.6	5.7	4.6	14.8	4.3	5.1	3.7	54.2	3.1	9.9	2.0	0.0	3.4	352.3	45.3	27.4	6.0	1.8	2.1	108.6	2.4	4.1	8.7	10.2	7.5	1.3	49.6	1.8	6.6	7.3	11.8	99.2	1.2	2.0	3.1	4.0	405.2	6.5	6.9	0.0	80.6	5.9	10.4	3.1	49.8	62.0	3.0	0.7	4.1	5.1	0.9	1.1	5.9	47.3	26.7	6.6	4.4	10.5	38.9	9.6	3.3	3.7	4.2	10.8	3.6	1.9	1.2
UMPS		ENSG00000114491	"Uridine monophosphate synthetase"	P11172	3	124730433-124749273	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Decarboxylase, Glycosyltransferase, Lyase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 109.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036178, HPA036179"	Uncertain		Approved	Cytosol		NA	NA		9200	"Cluster 26: Non-specific - Mitochondria"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA036178: AB_10673002, HPA036179: AB_10673615"	"unprognostic (6.41e-2)"	"unprognostic (6.70e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.51e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.31e-1)"	1.3	1.4	2.5	1.2	2.5	1.3	1.8	2.8	2.9	1.0	1.1	2.3	2.0	1.3	1.0	2.0	1.8	0.7	0.8	2.6	1.8	1.8	2.6	0.9	1.4	2.8	2.1	1.9	2.1	1.5	0.8	0.7	2.3	1.4	1.6	1.8	1.3	0.7	3.1	2.3	2.1	1.1	2.0	2.6	1.8	0.9	2.3	1.8	1.1	0.7	1.7	0.8	1.0	3.5	1.4	4.4	5.1	2.1	2.9	3.4	5.4	7.9	2.4	3.1	2.6	3.8	2.1	4.0	8.2	3.0	7.9	9.0	7.1	2.4	5.0	4.4	4.2	8.2	3.0	2.7	2.6	8.7	6.0	3.8	2.3	1.8	3.9	1.9	1.2	8.2	3.7	1.9	2.3	3.5	10.8	1.7	12.1	3.9	2.7	7.4	6.0	3.3	2.4	2.5	4.0	2.6	11.3	4.2	4.3	3.7	4.1	3.1	15.4	2.5	5.2	7.4	3.2	8.0	12.5	12.1	2.8	3.4	2.6	5.9	10.3	5.5	14.0	11.3	12.4	17.0	9.2	12.1	14.6	24.3	13.9	10.8	0.7	12.8	9.3	11.0	12.4	11.9	2.5	2.5	2.8	2.9	2.6	1.8	2.8	2.1	2.3	2.0	2.3	3.5	9.6	6.4	11.5	6.5	11.2	15.8	24.5	41.3	18.8	8.3	8.9	12.3	6.2	20.0	22.8	9.2	4.2	66.8	13.2	9.0	29.4	29.8	3.2	10.9	18.2	15.2	9.6	16.2	11.0	30.5	35.0	12.7	14.3	12.1	12.0	22.8	7.9	31.4	22.0	5.0	12.0	10.3	20.3	7.0	5.9	4.4	13.7	8.3	3.6	10.3	18.0	11.0	13.4	15.6	12.2	23.4	8.6	13.9	10.4	14.6	14.0	25.9	22.1	9.1	13.1	13.3	17.1	23.2	32.1	20.6	19.0	109.2	11.0	29.5	17.8	21.1
UNC80	"C2orf21, FLJ33496, KIAA1843, UNC-80"	ENSG00000144406	"Unc-80 homolog, NALCN channel complex subunit"	Q8N2C7	2	209771832-209999300	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 21.0;pituitary gland: 13.6;retina: 18.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 117.7;Excitatory neurons: 432.0;Inhibitory neurons: 354.7;Oligodendrocyte precursor cells: 290.5"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8;prostate cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 2.5;SCLC-21H: 4.0;SH-SY5Y: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042472, HPA050959"	Enhanced		Approved	"Nuclear bodies,Vesicles"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear bodies"	Vesicles	"HPA042472: AB_10965318, HPA050959: "	"unprognostic (7.91e-3)"	"unprognostic (2.25e-4)"	"unprognostic (1.44e-2)"	"unprognostic (3.20e-4)"	"unprognostic (1.92e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.31e-3)"	"unprognostic (5.36e-2)"	"unprognostic (5.16e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.24e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.40e-3)"	0.0	3.9	6.4	0.0	9.9	0.0	0.0	15.6	21.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.4	1.1	0.0	6.9	4.9	0.1	0.0	0.1	0.0	6.7	1.5	0.5	1.0	0.2	13.6	0.0	5.8	0.9	0.1	18.9	0.1	0.2	0.0	0.1	0.1	0.2	1.1	0.2	0.4	3.5	2.6	0.1	0.3	0.0	0.0	0.2	0.0	5.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.0	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	9.9	15.6	21.0	6.9	4.9	6.7	1.5	5.8	1.1	2.6	5.0	0.2	0.0	1.1	49.0	0.0	0.8	0.3	1.9	0.0	117.7	0.2	0.1	2.1	0.0	0.7	0.0	66.7	0.0	0.0	0.0	0.0	0.0	31.9	1.1	1.7	0.5	0.0	0.0	432.0	0.0	0.0	1.1	0.0	0.1	1.3	0.6	0.0	0.0	0.1	52.2	354.7	0.0	0.0	0.0	0.0	10.5	0.9	0.3	0.0	10.3	0.0	26.6	0.0	290.5	12.8	0.1	0.0	1.9	0.0	1.2	0.0	0.2	0.8	75.6	0.0	0.2	0.1	7.5	3.8	0.0	0.1	0.0	0.0	15.1	0.0	0.3
UNC93B1	UNC93	ENSG00000110057	"Unc-93 homolog B1, TLR signaling regulator"	Q9H1C4	11	67991100-68004982	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 76.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 96.2;Kupffer cells: 78.3;Macrophages: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 14.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 128.9;RPMI-8226: 368.2;SK-BR-3: 95.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038716, HPA038717, HPA042803"	Approved		Approved	Nucleoplasm		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"HPA038716: AB_2676169, HPA038717: AB_10674836, HPA042803: AB_2678176"	"unprognostic (3.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.36e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (4.76e-2)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.05e-3)"	"unprognostic (5.23e-3)"	18.7	17.7	4.9	19.9	5.6	19.9	15.4	5.0	7.5	19.0	6.4	20.2	22.5	7.7	0.8	20.5	15.7	9.8	7.3	4.9	5.0	16.4	15.3	29.5	29.5	10.7	6.5	6.2	17.1	2.6	6.7	6.4	8.1	16.4	3.1	0.1	27.9	8.8	3.5	16.3	35.8	3.1	7.9	76.7	20.6	1.7	6.8	3.5	14.8	1.5	7.3	20.6	15.0	10.2	18.9	34.1	2.5	13.8	7.2	2.7	28.2	8.3	7.7	13.0	11.8	2.8	128.9	40.9	30.8	4.0	11.0	44.9	1.0	7.0	0.4	14.1	9.3	4.2	11.1	6.4	11.2	30.0	22.7	6.0	7.6	3.8	1.5	5.0	2.6	6.4	3.0	19.3	2.0	18.7	0.2	23.9	6.2	46.8	16.7	24.5	0.0	368.2	11.8	10.7	3.9	5.5	14.0	95.6	19.3	1.0	35.4	39.0	9.2	8.6	12.2	12.8	0.8	13.2	18.8	7.0	16.0	30.7	10.5	0.1	3.8	6.6	0.1	7.2	0.2	2.5	0.2	0.2	5.1	2.7	0.0	0.0	3.2	2.1	7.7	14.8	0.0	1.2	4.9	5.6	5.0	7.5	4.9	5.0	10.7	6.5	8.1	7.9	6.8	10.2	12.5	9.6	9.1	4.6	45.3	4.0	21.9	12.5	9.1	0.0	16.4	13.1	1.8	40.0	21.0	16.5	0.0	10.3	63.3	23.2	1.9	36.8	0.8	32.0	5.9	10.0	4.2	3.0	1.1	23.4	47.8	8.0	20.9	17.2	7.0	9.3	10.0	5.4	96.2	5.0	0.1	17.2	14.2	78.3	28.4	0.1	4.4	85.3	23.2	13.1	57.5	4.7	8.2	0.0	0.7	49.7	25.6	4.1	33.8	27.0	31.7	6.9	57.3	0.5	0.0	8.3	9.8	0.2	1.1	12.9	6.5	7.3	10.5	2.1	23.1	37.7
UNG	"DGU, HIGM4, UDG, UNG1, UNG2"	ENSG00000076248	"Uracil DNA glycosylase"	P13051	12	109097597-109110992	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 64.9;Spermatogonia: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011605	Uncertain		Approved	Cytosol		NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"CAB011605: AB_778737"	"unprognostic (4.38e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.64e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (5.68e-3)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (4.66e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.57e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.89e-2)"	19.8	56.7	32.4	14.7	32.4	16.0	23.1	30.1	34.8	16.6	27.7	28.0	17.1	14.5	12.7	29.7	15.6	10.4	21.1	29.2	34.9	27.5	32.2	9.6	18.0	32.2	31.4	15.7	12.4	33.2	10.9	17.8	34.1	13.6	29.3	6.8	17.7	17.6	43.0	32.7	18.8	14.5	31.6	16.1	17.7	24.3	33.5	22.8	22.2	33.5	27.0	13.5	20.1	30.8	77.1	77.5	72.8	66.6	118.6	33.8	69.5	44.4	30.1	68.6	52.3	61.7	51.6	100.3	65.1	40.2	35.9	47.6	81.4	46.0	66.4	85.6	150.9	98.1	41.1	105.5	17.7	147.6	58.2	30.7	41.6	33.0	18.3	54.6	50.4	117.8	80.9	32.5	47.0	96.2	136.8	173.6	130.0	124.2	117.7	123.9	109.8	85.9	43.4	95.6	103.3	57.4	79.6	67.8	39.5	94.2	126.2	68.2	26.0	59.1	52.7	39.3	62.5	62.6	145.0	190.5	44.8	97.7	73.8	12.9	2.7	5.0	22.4	5.3	31.6	16.0	25.5	25.6	6.8	17.2	16.4	18.4	0.0	16.5	5.5	4.9	25.5	14.4	32.4	32.4	30.1	34.8	29.2	34.9	32.2	31.4	34.1	31.6	33.5	30.8	26.6	0.0	4.8	16.0	9.2	18.0	11.0	13.2	25.0	2.6	21.7	14.1	12.4	7.2	5.0	42.3	4.2	64.9	12.5	14.7	19.6	14.4	3.4	7.6	15.0	17.7	8.4	32.4	7.0	6.2	38.1	12.6	14.3	9.9	7.6	24.8	20.3	20.8	18.3	5.0	6.2	21.4	10.2	3.8	5.4	4.2	14.0	5.5	14.2	6.5	3.8	15.8	7.2	6.6	4.0	5.0	10.3	14.7	16.7	6.8	9.3	20.2	3.2	3.5	6.6	10.2	11.5	21.9	74.6	37.8	20.9	20.4	15.3	25.7	40.4	9.7
UPB1	BUP1	ENSG00000100024	"Beta-ureidopropionase 1"	Q9UBR1	22	24494107-24528390	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 216.0"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 146.5;Proximal tubular cells: 68.5"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 25.4"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.8"	"Group enriched"	"Detected in some"	14	"basophil: 2.1;neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 2.1"	"Cell line enriched"	"Detected in single"	7	"CACO-2: 3.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA000728, HPA076321"	Enhanced					NA	NA		1400000	"Cluster 17: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA000728: AB_1080471, HPA076321: "	"unprognostic (7.27e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.09e-4)"	"prognostic favorable (2.30e-7)"	"unprognostic (8.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.89e-6)"	"unprognostic (3.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.63e-3)"	0.2	0.2	0.2	0.2	0.6	2.0	0.1	0.7	1.8	0.2	0.2	0.2	1.2	0.2	0.2	0.1	0.3	0.1	1.9	0.2	0.0	25.7	216.0	0.8	0.2	0.1	0.1	0.2	0.1	0.0	0.4	0.0	0.4	0.3	0.1	1.1	0.1	0.1	0.5	0.9	0.4	0.1	0.0	0.8	0.2	3.0	0.4	0.6	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.4	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.7	1.8	0.2	0.0	0.1	0.1	0.4	0.0	0.4	0.1	0.8	0.0	2.0	0.3	0.6	0.6	1.3	0.1	0.0	4.0	0.3	0.3	2.4	4.3	0.0	1.8	10.4	0.1	0.1	0.0	11.7	0.1	1.2	0.2	0.6	1.9	2.4	5.3	0.7	0.4	0.1	1.4	0.0	0.5	0.0	0.6	3.6	146.5	0.1	0.0	1.2	0.0	0.0	5.1	2.7	1.4	0.3	1.0	0.0	0.0	21.3	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.7	1.2	0.0	68.5	0.0	1.8	0.0	2.7	3.7	12.8	6.8	0.0	1.1	0.3	0.9	0.2	0.1	1.1
UPK3A	UPK3	ENSG00000100373	"Uroplakin 3A"	O75631	22	45284949-45295874	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"prostate: 21.3;skeletal muscle: 35.0;urinary bladder: 48.0"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 15.0;monocytes: 22.6;Prostatic glandular cells: 54.1;Proximal enterocytes: 29.8;Urothelial cells: 24.5"	"Group enriched"	"Detected in many"	6	"prostate cancer: 35.3;urothelial cancer: 78.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 86.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 86.6;monocytes: 32.0"	"Group enriched"	"Detected in some"	5	"Hep G2: 29.9;RT4: 48.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA018407, HPA018415"	Enhanced		Uncertain	"Nuclear membrane,Nuclear bodies"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	"Nuclear membrane"	"Nuclear bodies"	"HPA018407: AB_1858641, HPA018415: AB_1858640"	"unprognostic (1.27e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.98e-5)"	"unprognostic (1.69e-2)"	"unprognostic (4.82e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-5)"	"unprognostic (2.01e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.05e-3)"	0.2	0.1	0.1	0.5	0.1	1.5	0.2	0.1	0.4	0.0	0.3	1.0	0.0	0.1	0.1	0.3	0.3	0.9	0.1	0.1	0.2	0.1	0.0	0.2	0.9	0.2	0.1	0.1	0.2	4.9	0.7	0.0	0.2	21.3	0.7	0.0	2.8	0.2	35.0	0.0	1.3	0.1	0.1	1.1	0.1	0.1	0.1	0.7	2.3	4.5	0.8	48.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	4.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	4.6	0.0	0.1	0.0	0.2	0.0	48.9	0.1	0.0	0.2	0.8	0.0	0.0	0.1	5.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	21.2	0.0	0.0	25.8	0.0	1.2	0.0	0.1	86.6	0.5	0.0	0.0	3.6	0.4	32.0	32.9	0.0	7.4	0.1	0.1	0.1	0.4	0.1	0.2	0.2	0.1	0.2	0.1	0.1	0.3	0.2	0.0	0.0	0.7	1.2	0.1	15.0	0.1	0.0	0.1	4.6	3.6	0.2	2.8	0.1	0.0	0.0	0.0	4.0	3.3	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.1	3.5	0.0	4.8	8.7	1.7	0.3	6.4	0.0	0.0	22.6	0.8	2.1	0.0	0.0	0.0	9.3	0.0	0.1	54.1	29.8	0.0	0.1	0.0	0.0	1.6	0.5	0.0	0.4	0.0	0.4	0.1	0.2	0.0	4.4	24.5
UQCRC2	"QCR2, UQCR2"	ENSG00000140740	"Ubiquinol-cytochrome c reductase core protein 2"	P22695	16	21953288-21983660	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 722.2;tongue: 933.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 556.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007998, HPA019146"	Enhanced		Enhanced	Mitochondria		NA	NA		180000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA007998: AB_1858648, HPA019146: AB_1858649"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (6.58e-9)"	"unprognostic (2.33e-1)"	"unprognostic (9.78e-3)"	"unprognostic (4.67e-3)"	"unprognostic (7.36e-2)"	158.8	117.7	69.0	103.1	71.2	127.7	108.4	75.5	90.0	90.8	113.9	259.8	292.5	98.2	72.7	157.4	109.7	99.5	559.4	72.4	73.7	240.0	245.1	75.4	120.0	74.1	69.5	114.5	89.7	257.2	39.8	96.5	72.7	95.6	262.8	142.3	133.8	104.3	722.2	85.4	233.6	121.2	65.8	80.9	153.2	55.8	76.5	131.3	107.9	933.2	149.3	153.6	59.8	73.3	173.9	193.1	116.5	66.4	154.3	186.8	169.1	163.8	160.6	177.5	174.5	347.9	177.7	338.9	144.3	170.4	129.8	324.6	222.3	212.7	193.7	151.4	178.4	185.9	166.1	494.3	164.6	249.1	501.2	232.3	229.4	130.3	186.2	169.4	248.1	224.1	217.9	159.1	177.2	230.6	288.6	175.0	124.6	261.1	148.8	310.9	263.6	390.0	285.8	214.6	154.4	114.9	237.2	318.6	190.3	151.6	354.4	264.1	179.3	103.3	98.1	104.0	148.0	126.3	87.2	302.7	188.7	239.8	126.4	80.1	128.7	71.4	80.0	147.8	103.3	96.0	98.3	89.3	153.9	77.9	106.8	97.6	45.9	101.8	148.1	67.6	134.8	157.3	69.0	71.2	75.5	90.0	72.4	73.7	74.1	69.5	72.7	65.8	76.5	73.3	105.5	64.1	52.5	81.9	81.1	90.6	190.8	444.0	74.6	109.1	91.7	79.6	556.2	84.4	194.9	71.7	87.6	238.3	82.6	233.4	455.9	124.5	88.0	72.0	55.7	91.3	113.8	92.4	65.0	109.6	157.6	89.0	144.3	65.8	92.6	99.6	84.3	122.3	195.5	69.0	74.0	224.4	238.0	145.1	100.6	89.9	68.3	104.6	131.6	27.2	162.1	108.0	91.6	60.3	50.7	97.2	214.0	97.0	72.9	114.4	378.0	306.9	110.2	152.6	78.9	94.1	109.5	68.9	56.7	132.0	88.4	278.3	91.3	170.2	358.7	204.3
UQCRFS1	"RIP1, RIS1, RISP, UQCR5"	ENSG00000169021	"Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1"	P47985	19	29205320-29213151	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 231.6;tongue: 285.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1474.9;Distal tubular cells: 1035.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041863, HPA050339"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA041863: AB_10794638, HPA050339: AB_2681095"	"unprognostic (4.00e-2)"	"unprognostic (2.23e-3)"	"prognostic favorable (3.29e-4)"	"unprognostic (7.91e-3)"	"unprognostic (3.93e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.92e-9)"	"unprognostic (6.11e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.92e-2)"	28.7	50.1	25.6	17.4	26.7	52.8	24.7	29.4	31.1	18.3	33.6	49.0	43.2	19.2	23.1	33.2	19.3	13.2	138.3	27.2	28.4	62.5	50.9	17.6	17.2	27.0	27.4	15.4	29.4	47.3	19.9	17.3	26.1	18.8	52.6	26.6	26.7	21.9	231.6	27.9	34.0	24.8	26.4	21.1	39.3	25.9	29.3	26.0	16.8	285.9	25.9	25.7	20.3	26.0	63.0	103.7	37.7	34.1	60.6	45.9	41.8	47.8	49.7	64.7	71.1	63.3	37.7	56.7	49.2	54.4	52.7	64.8	83.4	56.9	77.6	38.7	83.2	80.2	39.2	58.1	51.3	77.2	67.5	55.5	60.4	44.2	66.9	38.0	52.4	69.0	58.0	34.5	70.2	58.0	54.5	57.6	39.6	132.2	39.7	48.9	50.3	43.1	80.9	74.4	45.8	22.4	43.5	84.9	58.2	42.0	39.6	63.4	33.4	43.5	66.4	30.2	50.4	16.4	33.3	52.5	38.4	66.4	31.7	51.4	90.7	43.8	50.0	90.9	50.3	54.8	53.2	51.9	106.6	48.0	56.1	53.6	27.3	49.2	78.3	59.3	68.4	166.2	25.6	26.7	29.4	31.1	27.2	28.4	27.0	27.4	26.1	26.4	29.3	26.0	69.7	54.5	46.6	16.6	104.9	147.6	279.7	466.7	105.9	71.8	119.5	128.4	1474.9	161.5	201.4	114.0	16.7	282.0	116.8	321.6	1035.0	245.2	258.4	106.1	66.8	106.8	160.0	147.9	18.1	235.1	271.7	126.7	139.7	88.5	90.7	114.2	83.9	272.1	266.1	52.2	19.2	293.6	317.3	160.6	109.6	146.0	92.2	136.6	165.4	13.1	206.6	124.6	132.8	19.6	15.8	205.0	225.8	81.6	159.4	257.3	338.6	758.4	132.4	84.1	98.6	107.5	131.0	348.8	80.5	203.9	160.3	381.9	109.5	209.1	407.4	372.1
UROC1	"FLJ31300, HMFN0320"	ENSG00000159650	"Urocanate hydratase 1"	Q96N76	3	126481166-126517773	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	336	"liver: 116.6"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 62.2"	"Cancer enriched"	"Detected in single"	100	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"NB-4: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069863	Enhanced					NA	NA		670000		"Cluster 62: Liver - Hemostasis"	"Cluster 24: NB-4 - Immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA069863: AB_2732143"	"unprognostic (1.28e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.71e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.65e-5)"	"unprognostic (3.97e-2)"	"unprognostic (2.66e-1)"		"unprognostic (5.52e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	116.6	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	13.5	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.1	3.3	62.2	0.3	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
UROD		ENSG00000126088	"Uroporphyrinogen decarboxylase"	P06132	1	45010950-45015575	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Decarboxylase, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Erythroid cells: 806.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 420.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027468, HPA028668, HPA030350"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		2600000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"HPA027468: AB_1858654, HPA028668: AB_10603458, HPA030350: AB_2673440"	"unprognostic (5.90e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.73e-2)"	"unprognostic (8.12e-2)"	51.7	120.1	72.0	25.5	73.9	199.0	48.2	72.0	79.3	40.8	77.2	49.3	29.2	46.9	54.7	34.2	49.2	30.8	70.6	73.1	74.5	58.0	100.9	34.8	35.2	72.1	73.4	51.1	45.1	115.0	42.6	39.4	73.6	35.1	30.1	24.7	61.4	44.2	75.9	31.7	30.7	54.7	72.9	37.8	38.5	44.8	73.6	44.0	54.0	83.8	36.1	40.3	32.7	73.8	66.0	42.5	67.0	89.1	113.4	107.7	31.8	87.4	209.8	163.9	125.2	59.9	32.3	46.4	82.3	122.8	116.3	31.1	127.2	153.6	116.9	42.9	133.4	245.4	95.4	200.7	132.4	79.0	42.6	115.1	97.6	154.1	132.3	121.8	208.9	92.9	420.8	48.5	157.6	53.5	49.9	62.9	104.1	51.5	145.9	76.5	96.5	69.9	141.7	54.4	73.9	57.3	89.1	63.9	134.3	73.7	50.8	77.6	137.5	96.9	71.6	34.2	130.5	49.4	60.1	38.1	141.0	117.6	47.2	72.3	111.9	65.5	57.4	81.5	58.8	84.9	69.2	56.7	149.7	81.9	63.6	58.0	20.1	87.4	50.9	102.3	88.7	122.1	72.0	73.9	72.0	79.3	73.1	74.5	72.1	73.4	73.6	72.9	73.6	73.8	25.8	44.8	38.0	7.8	25.4	22.9	35.8	101.4	43.9	27.3	31.0	37.1	74.4	41.5	45.3	27.6	16.7	98.6	22.1	21.4	90.1	73.5	8.1	20.3	30.7	42.7	18.0	806.8	9.4	63.7	54.6	57.1	17.3	21.2	52.6	20.4	38.6	98.5	101.8	13.5	6.7	20.2	73.2	37.9	29.4	16.2	79.6	38.5	48.0	5.6	103.6	89.7	24.7	7.1	7.3	51.2	23.7	56.1	36.8	15.9	32.7	134.5	32.9	25.3	39.5	29.4	75.0	37.3	42.3	31.6	24.7	49.8	23.3	72.7	20.9	29.1
UROS		ENSG00000188690	"Uroporphyrinogen III synthase"	P10746	10	125784980-125823258	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 231.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044038	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		69000	"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	Cytosol	"HPA044038: AB_10966692"	"unprognostic (8.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-1)"	27.9	41.3	54.1	13.4	55.3	67.5	26.9	40.6	64.5	15.9	33.0	29.9	20.9	21.4	56.9	24.9	19.3	15.6	73.2	56.3	45.8	40.7	59.7	20.5	18.8	41.6	48.1	22.5	32.9	30.0	29.9	11.3	43.5	27.4	16.5	26.2	29.6	19.1	83.8	23.0	24.2	18.1	40.2	28.0	29.6	31.2	51.8	18.6	32.5	80.0	19.1	27.3	17.0	47.8	45.5	56.3	29.8	74.9	38.5	42.2	51.9	51.4	94.5	39.0	34.6	22.9	54.0	58.4	24.7	72.9	24.3	23.5	18.5	43.1	31.3	78.1	39.9	125.3	27.9	40.1	67.3	50.7	29.7	59.3	20.7	25.8	66.0	47.5	34.4	48.5	24.4	54.1	63.5	65.2	51.2	72.8	37.7	31.8	54.0	33.1	34.1	37.3	53.9	28.2	26.2	46.8	51.6	41.8	80.7	30.8	40.4	59.1	33.8	52.3	19.6	38.1	48.2	50.7	36.8	40.6	75.6	23.1	26.3	4.9	31.9	4.6	30.1	33.1	33.9	30.1	29.3	38.6	53.5	37.5	38.1	29.6	2.1	53.6	31.9	25.3	29.8	38.1	54.1	55.3	40.6	64.5	56.3	45.8	41.6	48.1	43.5	40.2	51.8	47.8	19.0	19.2	23.1	20.5	34.3	9.3	12.0	31.8	9.6	49.3	36.2	39.5	70.5	40.0	28.6	36.8	45.9	60.8	36.3	19.1	101.8	59.7	57.0	11.2	25.5	22.2	14.5	231.5	23.9	59.6	47.4	33.3	23.9	16.9	11.4	112.3	28.2	53.4	79.3	47.1	25.2	25.6	40.7	47.8	20.8	123.7	35.8	31.6	62.2	9.4	58.7	77.0	69.0	13.6	29.6	42.7	15.8	40.6	46.9	27.3	52.9	142.6	20.4	42.3	6.6	22.8	36.7	55.7	100.9	28.5	12.8	20.0	37.8	55.0	38.8	21.3
USP16	Ubp-M	ENSG00000156256	"Ubiquitin specific peptidase 16"	Q9Y5T5	21	29024629-29054488	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 514.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021140	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA021140: AB_1858668"	"unprognostic (6.06e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.73e-2)"	"unprognostic (8.65e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.54e-1)"	27.0	23.0	18.8	23.4	23.2	29.3	27.4	21.3	20.4	22.7	19.1	24.6	25.1	25.2	25.2	25.2	19.9	20.4	29.3	17.5	20.5	22.1	30.7	20.9	27.9	20.5	20.8	22.3	26.0	34.3	16.7	24.2	21.7	25.7	26.4	42.3	24.7	23.6	34.7	19.9	22.8	22.6	20.2	21.9	23.4	25.7	20.3	30.0	33.8	37.5	32.3	27.1	14.1	27.5	59.9	23.4	36.5	33.0	25.4	41.5	34.2	56.9	37.9	38.5	36.4	29.5	38.3	60.5	16.8	54.8	58.7	26.5	45.6	41.5	50.1	58.6	48.4	80.9	27.3	33.1	37.6	80.3	43.0	35.9	42.9	50.3	46.4	28.7	37.5	33.9	67.7	103.8	45.3	27.3	49.7	29.3	39.2	48.4	29.9	33.0	89.7	69.6	31.7	42.5	39.4	41.9	36.8	58.1	51.1	24.9	40.2	54.2	38.0	44.8	55.7	41.8	59.3	87.8	129.3	62.5	46.8	57.3	45.6	37.4	24.1	33.6	36.3	24.9	28.6	40.7	34.1	33.6	23.1	46.0	36.9	35.8	23.5	31.5	34.0	36.2	38.9	17.2	18.8	23.2	21.3	20.4	17.5	20.5	20.5	20.8	21.7	20.2	20.3	27.5	60.3	86.6	91.9	27.4	114.4	57.2	132.5	68.9	55.2	161.0	65.8	58.7	84.2	64.3	83.1	53.3	89.6	81.7	108.2	90.2	133.1	77.9	514.9	85.9	82.6	55.0	82.6	40.8	18.2	119.9	79.7	68.3	55.0	107.7	141.8	61.5	45.7	86.2	59.9	72.3	27.6	100.4	44.7	62.0	53.1	117.0	87.7	69.4	62.2	25.3	117.3	94.1	96.8	28.1	47.3	94.0	99.2	86.9	106.8	100.1	74.8	91.8	94.1	183.5	59.2	133.4	83.2	100.4	82.4	68.4	64.4	162.0	105.3	72.8	90.6	141.9
USP18		ENSG00000184979	"Ubiquitin specific peptidase 18"	Q9UMW8	22	18150170-18177397	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 46.9;Extravillous trophoblasts: 31.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 181.8;BJ hTERT+ SV40 Large T+ RasG12V: 196.2"									HPA044768	Uncertain		Supported	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	Vesicles	"HPA044768: AB_10963697"	"unprognostic (2.06e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.40e-2)"	"unprognostic (5.42e-2)"	"unprognostic (3.29e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.29e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.28e-2)"	"unprognostic (8.38e-2)"	10.8	5.0	3.6	5.1	3.8	8.1	8.3	3.3	4.5	4.0	4.0	5.0	6.0	3.2	7.8	4.0	7.3	6.6	4.4	3.7	3.9	5.9	23.6	7.9	9.2	5.1	3.9	2.9	4.2	3.6	5.7	5.7	4.2	5.3	4.4	0.7	14.0	2.5	3.8	3.4	6.7	4.0	7.0	11.0	7.2	9.7	4.1	15.0	7.3	5.5	6.5	4.0	3.6	3.7	14.4	14.6	4.2	18.2	18.2	13.5	18.4	7.3	17.5	181.8	196.2	2.2	20.1	0.2	10.8	4.0	57.5	4.9	21.6	6.4	6.2	64.4	29.4	28.3	1.9	27.0	2.1	6.9	25.7	6.0	2.5	12.8	0.0	1.0	40.8	20.6	1.4	1.7	1.8	24.9	33.4	16.7	12.7	15.6	11.0	13.1	28.4	0.0	3.6	12.4	15.2	11.9	8.8	15.0	71.9	16.3	9.9	6.6	66.7	1.3	3.5	4.1	7.5	3.4	45.4	0.2	16.3	17.1	10.5	3.2	3.9	8.3	8.5	11.0	10.7	5.3	7.2	11.1	1.8	3.4	8.2	9.6	0.7	13.3	8.6	3.3	13.1	5.3	3.6	3.8	3.3	4.5	3.7	3.9	5.1	3.9	4.2	7.0	4.1	3.7	9.7	9.6	4.8	0.7	2.5	1.7	4.5	5.7	2.2	0.2	8.4	8.3	1.4	8.6	6.9	0.0	0.0	4.6	3.0	6.2	46.9	5.9	1.6	20.1	2.5	8.4	3.0	1.3	0.5	11.1	31.9	7.1	4.1	6.3	0.0	8.5	11.0	5.5	8.7	0.0	0.6	3.5	6.1	6.3	0.8	1.7	3.7	3.8	3.6	0.0	1.6	5.1	8.2	2.0	0.3	13.4	3.2	7.2	2.3	2.5	5.4	8.0	12.2	0.3	6.6	8.0	2.5	10.9	1.0	4.0	1.0	1.5	5.0	5.5	2.8	2.9
USP27X	USP27	ENSG00000273820	"Ubiquitin specific peptidase 27 X-linked"	A6NNY8	X	49879484-49882558	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Alveolar cells type 2: 15.5;Bipolar cells: 15.8;Cytotrophoblasts: 44.5;Syncytiotrophoblasts: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SuSa: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077264			Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA077264: AB_2686831"	"unprognostic (4.12e-2)"	"unprognostic (9.58e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.14e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.31e-2)"	"prognostic favorable (9.31e-4)"	"unprognostic (5.37e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.58e-1)"	1.6	2.5	6.0	1.3	6.2	0.5	2.0	8.0	5.8	3.0	3.1	3.2	1.0	3.9	2.9	1.6	3.5	1.6	1.8	5.3	14.4	2.7	1.8	2.7	1.7	4.9	8.4	6.3	2.6	3.0	7.3	11.7	5.9	3.0	1.4	3.8	1.6	2.8	4.4	2.1	2.1	2.8	3.6	1.8	2.4	1.3	10.5	2.6	2.4	2.1	1.7	3.0	2.2	4.4	1.6	3.8	4.2	4.8	3.8	3.1	3.6	1.6	2.6	1.8	1.4	6.9	1.6	0.9	1.6	4.2	6.0	2.6	6.0	4.0	2.6	2.0	3.1	1.6	1.1	6.2	2.6	0.5	3.4	4.4	2.7	2.6	2.6	4.4	2.5	4.2	3.4	1.5	2.9	3.7	2.5	1.2	4.8	2.7	2.7	2.7	3.7	0.3	2.9	1.4	1.1	3.2	3.4	3.0	4.0	12.9	3.5	1.1	1.9	2.1	4.3	3.8	0.7	1.6	0.4	0.6	2.5	1.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	6.2	8.0	5.8	5.3	14.4	4.9	8.4	5.9	3.6	10.5	4.4	3.5	19.2	15.5	0.7	2.5	2.9	4.5	0.3	2.2	15.8	1.9	2.7	2.6	0.0	7.5	0.0	0.0	44.5	1.4	1.7	5.9	1.5	0.1	2.1	4.1	5.2	4.2	0.0	2.9	0.7	3.6	2.7	1.1	2.1	2.5	4.0	2.5	1.9	4.0	5.0	3.3	1.3	0.0	0.6	1.0	0.3	2.1	1.2	0.0	0.0	1.5	8.3	0.0	3.5	0.8	1.2	0.5	3.4	0.5	3.3	0.5	2.9	13.2	2.5	6.6	2.5	2.6	0.2	1.3	0.9	2.3	26.1	2.0	8.8	1.6	1.7
USP45	MGC14793	ENSG00000123552	"Ubiquitin specific peptidase 45"	Q70EL2	6	99432325-99521728	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"brain: 53.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 47.1;Inhibitory neurons: 44.4;Oligodendrocytes: 39.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 53.5"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029602, HPA029604"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA029602: AB_10600418, HPA029604: AB_10602283"	"unprognostic (7.81e-3)"	"unprognostic (3.10e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.77e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.91e-2)"	6.1	4.4	5.2	4.9	5.8	4.4	4.6	53.5	9.4	4.3	3.8	5.3	7.3	5.1	4.8	5.3	4.0	6.2	6.2	5.8	6.3	6.3	4.2	3.7	7.4	6.0	7.7	4.5	4.0	4.5	3.6	5.2	8.2	5.1	6.7	6.7	4.0	4.2	6.0	6.3	5.8	4.5	5.3	4.6	4.4	3.3	6.2	3.1	5.3	5.5	5.2	4.3	3.8	9.0	5.9	4.0	8.1	11.2	14.3	13.5	8.7	10.3	11.1	10.1	14.7	8.2	6.4	15.2	7.3	10.3	11.9	7.7	12.1	9.8	13.9	12.2	12.0	15.2	8.4	6.7	11.4	14.2	8.3	15.3	7.6	9.2	15.5	10.7	15.4	13.8	37.2	14.8	9.6	5.5	4.5	13.3	12.8	9.1	8.9	6.8	5.9	8.9	13.8	6.8	11.3	9.2	7.0	9.1	7.8	10.0	4.9	6.8	15.5	5.5	7.1	8.1	15.5	6.3	6.2	29.1	9.8	13.1	10.1	2.9	1.4	0.4	3.2	0.8	4.2	5.3	2.7	4.0	2.4	6.7	1.9	1.9	0.3	1.9	2.0	3.6	2.6	1.0	5.2	5.8	53.5	9.4	5.8	6.3	6.0	7.7	8.2	5.3	6.2	9.0	13.3	3.2	5.8	22.5	13.3	2.3	9.6	6.8	4.6	10.3	4.4	4.6	9.4	4.3	4.7	3.7	18.8	6.4	7.3	5.9	5.9	4.3	15.7	10.1	10.3	7.6	2.4	4.2	47.1	2.5	6.6	7.1	9.7	4.3	2.5	5.8	6.8	4.5	4.0	10.1	44.4	2.9	10.2	4.8	2.6	10.2	13.1	4.6	3.6	22.5	10.0	5.4	2.1	32.6	39.4	5.0	3.1	8.6	6.5	8.6	8.3	15.8	10.4	7.4	0.0	6.3	6.7	1.9	7.5	5.2	2.8	7.4	7.1	5.8	7.3	6.9
USP6	"HRP1, Tre-2, TRE17, Tre2, TRESMCR"	ENSG00000129204	"Ubiquitin specific peptidase 6"	P35125	17	5116032-5175034	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Calmodulin-binding, Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 19.6;testis: 13.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 24.4;Spermatocytes: 26.9"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 2.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046969			Uncertain	Vesicles		NA	NA				"Cluster 23: Testis - Cell cycle regulation"		"Cluster 37: Myocytes - Muscle contraction"	Vesicles		"HPA046969: "	"unprognostic (3.89e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.32e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.91e-4)"	"unprognostic (6.28e-3)"	"unprognostic (3.24e-4)"	"unprognostic (3.75e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.09e-4)"	0.4	0.3	0.2	0.2	0.5	0.1	0.7	0.3	0.6	1.4	1.5	0.8	0.0	0.9	0.7	0.2	0.5	0.5	0.4	0.4	0.3	0.6	0.1	0.4	0.3	0.7	0.2	2.6	0.3	0.0	0.6	0.5	0.6	0.6	0.3	2.5	0.5	0.4	19.6	0.6	0.3	0.9	0.2	0.4	0.2	13.4	0.5	0.0	0.9	0.6	0.2	0.3	0.5	0.9	0.1	0.1	0.3	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.2	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.4	0.3	0.1	0.1	0.0	0.3	0.2	0.0	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.5	0.3	0.6	0.4	0.3	0.7	0.2	0.6	0.2	0.5	0.9	2.0	6.4	10.8	0.0	0.4	10.8	1.0	1.1	0.0	8.5	4.0	3.8	1.6	5.7	3.5	3.7	12.5	0.6	1.0	0.1	3.9	0.0	24.4	1.1	2.1	3.0	0.0	5.3	1.2	0.0	0.8	1.8	0.0	1.4	0.0	1.2	3.6	3.2	2.7	1.7	1.0	0.0	0.0	5.4	6.4	13.5	1.8	3.1	3.6	2.8	3.2	5.1	0.0	0.0	2.9	0.1	0.1	2.6	0.1	2.1	0.0	3.2	4.0	12.3	6.6	5.9	1.7	26.9	11.5	0.0	10.4	0.7	1.1	0.9	0.2	1.1
USP8	"HumORF8, KIAA0055, SPG59, UBPY"	ENSG00000138592	"Ubiquitin specific peptidase 8"	P40818	15	50424380-50514421	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050215	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Cytosol	"HPA050215: AB_2681054"	"unprognostic (5.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (4.89e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.58e-1)"	20.3	18.8	11.5	21.1	11.0	27.6	19.6	14.4	13.3	20.5	18.1	21.5	26.7	19.1	10.4	20.7	18.5	16.4	15.1	9.1	14.6	27.0	28.1	19.5	19.0	14.1	13.1	19.9	17.4	45.1	10.6	20.3	12.5	17.0	20.8	22.2	19.8	17.2	17.6	14.2	24.4	18.4	11.5	18.7	22.5	32.0	13.6	20.9	25.4	22.7	24.3	20.0	12.6	13.2	30.6	35.8	23.7	41.1	32.3	44.3	31.0	45.7	43.9	35.7	40.4	19.5	17.7	28.8	35.0	43.5	46.6	57.8	28.8	28.3	39.9	27.2	19.3	52.9	31.9	27.3	35.9	34.3	34.4	32.4	36.2	26.0	55.8	37.0	36.3	23.3	28.4	36.8	32.9	45.9	26.6	12.0	28.5	32.6	17.1	24.1	39.1	45.8	29.5	61.3	29.1	23.8	42.5	55.9	57.4	48.9	35.8	36.9	45.0	41.1	24.1	122.7	52.7	28.5	69.8	32.4	30.6	65.6	40.1	114.6	27.7	50.1	21.4	26.1	22.1	37.3	22.9	23.3	22.7	34.3	24.0	21.2	47.9	22.1	35.0	20.5	20.0	16.0	11.5	11.0	14.4	13.3	9.1	14.6	14.1	13.1	12.5	11.5	13.6	13.2	63.5	96.1	130.8	36.2	101.8	28.9	40.7	47.3	35.9	54.5	41.7	40.0	69.8	51.5	72.7	47.8	68.8	59.0	92.7	79.5	25.4	53.7	153.7	91.5	79.7	53.8	53.3	36.8	41.0	51.3	45.4	55.8	58.1	65.6	86.7	48.5	51.0	56.6	45.4	33.7	44.3	68.7	36.7	73.2	38.2	28.4	53.7	77.6	40.9	46.9	85.3	45.5	72.1	34.7	46.1	57.3	58.2	61.7	87.1	51.0	88.9	49.9	114.9	74.2	46.0	108.2	56.2	140.5	54.8	39.6	41.5	105.2	72.6	77.1	64.8	55.3
USP9X	"DFFRX, FAF, MRX99"	ENSG00000124486	"Ubiquitin specific peptidase 9 X-linked"	Q93008	X	41085445-41236579	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, Chromosome partition, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011618, HPA047417, CAB070164"	Approved		Uncertain	Vesicles		NA	NA		24000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Vesicles		"CAB011618: AB_470860, CAB070164: AB_10011071, HPA047417: "	"unprognostic (5.42e-3)"	"unprognostic (6.42e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.99e-2)"	"unprognostic (4.76e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.33e-1)"	16.4	16.8	11.9	14.3	13.9	18.2	14.2	12.7	12.8	15.3	14.3	14.8	13.6	15.4	14.9	14.1	16.0	13.0	15.3	14.3	13.2	17.8	33.9	14.4	15.8	12.2	13.1	13.4	16.0	30.0	10.2	18.4	13.8	12.3	13.7	22.0	11.5	15.3	39.1	13.8	14.3	16.3	12.5	13.3	13.8	17.5	12.8	18.8	19.5	28.4	16.2	15.0	12.6	16.4	38.6	44.2	39.1	40.2	33.0	32.7	8.8	21.5	28.8	23.8	27.5	21.1	16.9	25.7	11.5	48.5	71.3	25.3	67.1	39.7	39.7	32.0	50.5	29.3	41.3	19.9	27.6	26.4	21.0	29.3	17.9	56.4	53.4	35.5	37.2	17.1	36.0	20.3	38.6	29.1	18.8	12.7	42.6	14.1	24.7	20.3	51.8	16.9	24.7	30.7	22.2	20.8	89.0	26.7	26.0	69.8	24.3	16.2	40.2	36.6	27.6	34.6	24.0	19.1	22.3	30.9	26.4	12.1	18.5	1.7	2.3	3.0	2.5	1.9	3.6	2.8	3.0	2.7	2.6	2.1	3.0	2.8	6.4	2.5	2.5	2.1	2.8	1.5	11.9	13.9	12.7	12.8	14.3	13.2	12.2	13.1	13.8	12.5	12.8	16.4	38.1	41.7	35.1	48.0	42.6	48.3	30.8	29.6	55.2	38.1	41.3	29.5	83.5	54.3	37.9	27.6	37.5	39.6	46.3	58.5	7.9	28.4	14.9	85.5	56.9	43.6	26.9	41.0	84.9	26.5	25.4	41.4	41.8	136.9	25.9	58.3	45.7	62.8	32.6	37.0	86.0	39.1	18.3	47.8	42.1	15.4	33.2	55.5	33.8	67.5	44.6	31.3	30.9	74.9	108.0	32.6	40.1	49.2	38.8	35.6	47.7	21.5	35.8	31.2	32.9	70.6	48.3	86.4	82.9	55.2	55.3	46.7	42.4	45.8	38.0	40.2
USP9Y	"AZFA, DFFRY"	ENSG00000114374	"Ubiquitin specific peptidase 9 Y-linked"	O00507	Y	12537650-12860839	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Excitatory neurons: 89.5;Inhibitory neurons: 69.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 21.5;RT4: 17.4"	"Not detected"	"Not detected"							HPA057687			Uncertain	Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA057687: "			"unprognostic (2.63e-1)"		"unprognostic (8.97e-2)"	"unprognostic (1.10e-5)"	"unprognostic (8.46e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.41e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.42e-1)"	3.6	5.2	1.3	1.7	1.4	2.6	3.3	2.8	5.2	0.0	2.5	4.5	1.7	0.0	7.2	5.2	0.0	4.6	5.5	1.3	1.4	7.1	3.0	5.2	2.2	1.2	1.1	0.0	6.0	3.5	8.8	2.3	1.3	9.7	4.9	12.9	4.9	7.0	5.2	3.2	4.4	0.0	1.0	5.1	3.9	4.2	1.4	0.0	5.7	9.7	5.6	4.5	0.0	2.4	0.0	4.7	0.0	0.0	0.0	0.0	5.3	14.2	14.6	7.2	8.5	0.0	0.0	7.7	0.0	12.2	0.0	0.0	0.0	0.0	8.6	8.1	0.0	7.3	0.0	9.5	5.8	0.0	0.0	9.7	8.9	0.0	0.0	0.0	0.0	3.0	0.0	0.0	12.2	0.0	9.8	0.0	4.6	0.0	0.0	0.0	3.5	2.1	21.5	17.4	7.2	0.0	0.0	0.0	4.4	12.5	0.0	0.2	10.6	9.5	0.0	0.0	7.0	0.0	9.7	15.1	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.4	0.7	0.5	0.1	0.7	0.8	0.5	0.0	0.1	0.0	0.6	0.6	0.0	1.3	1.4	2.8	5.2	1.3	1.4	1.2	1.1	1.3	1.0	1.4	2.4	0.0	25.6	23.5	29.4	11.0	11.7	8.5	9.5	18.2	23.6	0.0	0.0	26.5	7.2	12.6	20.2	64.6	6.3	5.3	0.3	1.9	6.9	0.5	0.0	0.0	5.8	0.0	5.9	89.5	0.0	1.7	8.1	6.6	0.0	2.5	0.0	6.1	2.3	3.1	26.9	69.5	1.1	8.2	5.6	9.3	1.1	12.5	3.6	3.6	31.9	3.6	8.8	14.4	28.6	17.4	2.3	0.0	15.4	4.1	13.2	0.7	6.3	19.9	23.1	0.0	5.2	4.4	2.8	2.6	20.6	11.6	3.4	14.7	0.0	1.5	11.9
VANGL1	STB2	ENSG00000173218	"VANGL planar cell polarity protein 1"	Q8TAA9	1	115641970-115698224	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 6.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.3;NK-cells: 6.2;T-cells: 3.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025235, CAB076375"	Approved		Approved	"Plasma membrane"		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB076375: AB_2665604, HPA025235: AB_1858718"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (7.53e-4)"	"unprognostic (9.94e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.18e-3)"	"unprognostic (5.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (6.43e-3)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-3)"	"unprognostic (9.06e-3)"	4.9	3.9	2.1	3.8	1.2	2.5	3.2	0.8	1.1	9.1	3.0	6.8	3.8	5.5	4.9	10.4	12.0	3.8	5.4	1.3	1.3	5.3	3.0	4.1	2.1	1.2	3.0	4.4	5.0	5.2	0.5	3.6	1.7	4.4	6.4	1.6	6.4	4.5	0.9	6.8	3.9	7.3	1.2	2.2	5.5	5.0	6.5	7.3	7.6	2.4	2.5	6.4	4.4	1.0	49.6	20.7	6.6	8.9	24.1	21.5	13.1	18.8	13.5	24.1	19.1	12.0	24.1	0.0	31.5	21.9	22.7	60.9	11.2	33.3	15.8	57.9	13.7	27.4	18.4	9.8	8.8	8.2	11.4	11.4	23.1	17.2	18.2	12.8	24.1	45.9	16.8	14.8	24.5	65.7	41.0	3.4	16.7	28.8	19.5	0.1	19.1	14.3	11.0	32.8	5.9	8.0	33.9	22.2	15.4	12.4	11.3	8.8	26.2	16.5	25.7	36.3	34.6	2.1	2.3	0.2	22.3	14.3	41.1	0.0	0.5	0.0	1.9	0.3	0.5	0.2	1.2	1.9	2.3	0.0	0.4	2.0	0.0	6.2	0.5	2.0	3.0	1.0	2.1	1.2	0.8	1.1	1.3	1.3	1.2	3.0	1.7	1.2	6.5	1.0	9.2	3.2	3.2	5.5	0.5	7.4	7.4	16.8	11.4	5.2	4.6	4.6	7.9	2.8	9.6	9.2	39.6	5.0	3.4	11.2	0.0	15.7	6.1	25.1	7.7	10.5	6.7	13.2	0.9	13.8	7.3	10.1	8.2	17.0	0.0	5.1	28.9	2.5	4.3	0.0	0.7	8.6	10.2	1.9	1.4	3.0	5.9	2.9	0.0	4.7	11.1	4.7	9.2	2.0	0.1	20.8	6.1	8.2	1.8	8.3	2.6	5.6	12.8	0.9	6.6	4.3	8.5	5.5	7.0	20.0	6.5	0.4	3.1	3.2	10.3	6.5
VAPB	"ALS8, VAP-B, VAP-C"	ENSG00000124164	"VAMP associated protein B and C"	O95292	20	58389229-58451101	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Unfolded protein response"		"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013144, CAB013722"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA		240000	"Cluster 32: T-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"		"CAB013722: , HPA013144: AB_1858717"	"unprognostic (3.28e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (1.08e-8)"	"unprognostic (1.05e-1)"	"unprognostic (5.31e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.99e-2)"	15.7	36.4	32.1	11.2	30.4	4.2	14.2	29.6	30.1	13.7	20.3	24.2	19.6	16.4	10.3	19.3	14.9	9.7	29.4	28.8	33.5	24.8	35.0	14.1	9.6	34.6	34.0	17.9	18.9	27.9	21.0	9.2	36.2	17.8	9.9	14.3	16.2	12.3	46.4	13.0	18.2	11.6	36.4	15.0	19.0	8.8	37.0	12.2	23.3	39.6	6.7	18.1	12.9	31.5	31.0	30.4	33.6	18.0	30.3	12.5	29.5	27.0	11.2	41.0	20.1	123.0	29.0	27.2	37.7	18.3	32.3	57.6	27.1	38.9	24.6	12.8	20.2	16.5	32.2	38.9	30.2	15.5	19.8	28.9	44.4	22.8	18.7	19.8	20.5	26.7	39.5	14.9	20.0	96.7	24.5	30.6	17.7	60.2	40.0	24.2	31.3	18.0	31.6	40.7	47.1	32.6	44.7	117.0	48.0	18.4	48.0	23.2	28.6	65.8	31.9	33.3	36.9	19.9	23.1	31.4	55.7	16.8	33.8	2.1	2.3	3.1	3.9	2.4	4.5	2.8	4.6	3.2	2.3	2.3	3.3	4.8	3.7	3.7	3.0	2.3	2.7	2.6	32.1	30.4	29.6	30.1	28.8	33.5	34.6	34.0	36.2	36.4	37.0	31.5	22.5	44.8	26.8	31.6	18.7	11.7	13.5	17.2	23.9	29.7	23.6	21.1	46.5	24.3	16.6	31.3	29.2	34.8	20.7	28.6	35.2	35.1	5.0	18.2	20.9	23.2	21.7	18.7	34.3	30.5	50.3	24.0	20.4	16.0	9.5	23.3	15.7	40.3	16.1	35.3	34.7	23.4	22.4	18.5	10.0	6.1	18.6	17.3	14.2	40.3	22.8	34.3	20.6	35.2	43.7	37.5	22.4	25.2	14.0	17.7	38.9	42.9	19.1	29.7	13.1	22.2	26.0	22.0	29.4	18.2	10.5	44.5	20.5	37.4	27.6	16.6
VARS1	"VARS, VARS2"	ENSG00000204394	"Valyl-tRNA synthetase 1"	P26640	6	31777518-31795752	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 10.1;Cytotrophoblasts: 23.2;Extravillous trophoblasts: 48.3;Hofbauer cells: 30.7;Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"U-266/84: 140.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046710	Approved		Enhanced	Cytosol		NA	NA		110000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA046710: AB_2679765"	"unprognostic (1.86e-2)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.86e-4)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (3.20e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.59e-1)"	22.2	24.6	2.0	6.6	1.6	3.2	21.9	0.4	2.4	20.1	0.0	21.0	5.6	29.4	0.9	32.5	22.1	1.1	20.0	0.7	2.3	19.2	29.3	19.8	3.0	2.4	1.9	19.7	37.3	2.5	33.6	2.2	2.2	17.6	1.7	1.3	20.6	1.2	58.2	34.3	21.9	3.5	0.8	30.0	23.3	63.6	2.6	3.0	18.5	3.1	2.8	23.5	20.7	1.5	36.2	11.6	12.4	36.9	9.1	8.5	84.0	52.2	10.8	25.2	13.3	11.5	9.9	58.3	60.2	18.4	18.9	22.0	33.5	32.4	8.8	46.0	74.0	31.7	18.4	21.3	18.3	75.7	60.6	12.5	8.2	14.8	16.5	6.2	13.5	22.9	92.2	48.8	12.7	13.2	51.0	16.2	35.0	11.9	32.5	55.5	20.5	132.7	13.0	12.4	42.1	26.2	12.0	31.0	19.5	5.8	23.2	34.0	31.2	24.2	37.8	28.2	72.5	87.9	140.4	44.1	14.6	31.1	29.0	0.0	0.3	0.1	0.2	0.3	0.3	0.5	0.3	0.3	0.5	0.3	0.3	0.1	0.1	0.5	0.3	0.6	0.1	0.5	2.0	1.6	0.4	2.4	0.7	2.3	2.4	1.9	2.2	0.8	2.6	1.5	4.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	23.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	48.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	16.6	0.4	0.0	0.0	0.0
VARS2	"DKFZP434L1435, G7a, KIAA1885, VARS2L, VARSL"	ENSG00000137411	"Valyl-tRNA synthetase 2, mitochondrial"	Q5ST30	6	30914205-30926459	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062449, HPA070267"	Approved		Approved	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA062449: AB_2684766, HPA070267: AB_2686245"	"unprognostic (1.74e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.50e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.43e-2)"	10.2	14.4	1.3	2.1	1.5	1.9	9.7	1.5	1.6	12.5	0.4	10.5	1.2	10.4	1.5	22.5	10.1	0.2	11.1	1.4	1.3	12.5	18.9	10.5	3.1	1.3	1.6	15.3	14.0	2.3	17.1	0.9	1.4	10.2	2.2	1.4	10.9	1.1	20.9	10.1	12.8	0.7	1.2	13.4	11.7	11.8	1.3	4.1	15.0	0.2	2.3	10.5	13.2	1.3	13.8	9.6	5.5	23.1	4.9	4.4	0.7	2.2	1.9	2.5	1.6	12.6	8.9	11.9	7.5	3.0	9.4	0.0	21.3	0.0	2.4	4.6	15.7	13.2	10.2	0.9	6.7	2.3	0.3	6.2	8.1	5.9	1.3	0.9	1.3	19.5	0.1	10.5	5.4	0.0	4.6	0.0	1.7	0.0	1.2	9.1	0.0	10.3	18.3	0.0	8.5	0.2	0.2	6.6	5.4	5.0	16.3	7.4	2.2	14.2	1.4	1.0	0.1	10.0	17.1	18.8	0.0	0.6	8.7	0.0	0.0	0.0	0.3	0.1	0.4	0.3	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.3	0.2	0.1	1.3	1.5	1.5	1.6	1.4	1.3	1.3	1.6	1.4	1.2	1.3	1.3	3.0	6.4	12.5	14.7	8.0	4.0	4.9	4.7	4.0	6.6	6.4	3.7	11.6	8.6	5.5	9.2	0.0	8.7	4.1	10.1	1.9	6.7	1.5	7.7	5.2	3.9	13.1	3.4	8.3	7.1	9.6	4.8	11.7	8.6	12.7	12.9	7.5	22.5	9.2	8.4	9.1	8.4	2.0	6.9	3.5	1.6	4.1	5.1	1.8	3.7	7.9	2.8	4.1	8.0	7.2	8.9	4.7	4.1	12.3	2.3	12.4	12.5	8.9	6.0	0.0	2.9	3.7	10.4	8.0	9.0	4.1	3.4	4.8	6.9	10.9	3.8
VCP	"CDC48, IBMPFD, p97, TERA"	ENSG00000165280	"Valosin containing protein"	P55072	9	35053928-35072668	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway"	Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 540.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005593, HPA012728, HPA012814"	Supported		Enhanced	Nucleoplasm,Cytosol		No	No		34000000	"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Cytosol"		"CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.15e-2)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.78e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.24e-1)"	"prognostic favorable (9.63e-7)"	"unprognostic (1.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (9.11e-2)"	59.8	88.4	56.8	33.7	59.0	52.0	54.2	58.9	58.0	57.8	72.0	51.8	33.8	59.0	51.6	84.9	49.4	35.3	117.5	60.4	66.2	59.1	87.5	57.2	42.5	64.4	62.0	46.1	61.2	65.7	57.3	46.0	68.2	54.5	36.5	26.3	63.2	58.9	176.0	64.0	51.8	42.5	62.3	64.1	62.5	45.1	63.7	59.6	49.7	135.3	53.3	57.9	55.3	69.8	167.6	223.8	124.6	57.5	187.4	135.3	98.3	153.8	215.0	244.1	197.6	160.0	60.1	140.8	137.2	242.9	173.1	69.5	253.1	230.7	227.6	146.2	126.0	95.3	216.5	238.0	146.5	92.4	106.2	148.5	136.4	239.2	115.6	104.4	276.2	56.3	97.6	71.4	219.2	154.7	114.3	234.9	152.2	82.7	219.1	80.7	111.8	72.8	204.1	175.7	65.7	84.1	100.4	81.2	45.1	152.2	71.5	60.3	215.5	77.5	112.5	63.7	118.6	41.9	116.5	104.3	139.5	67.0	105.4	142.0	62.7	75.0	58.8	70.0	62.4	59.2	59.0	65.6	75.3	53.0	42.3	44.4	71.1	67.1	80.4	49.8	91.2	111.8	56.8	59.0	58.9	58.0	60.4	66.2	64.4	62.0	68.2	62.3	63.7	69.8	86.5	80.1	73.7	22.9	124.3	77.0	120.8	147.6	111.5	86.6	66.0	47.2	220.4	47.1	115.1	55.2	118.9	276.8	91.0	111.9	74.3	188.6	43.6	97.8	85.6	127.7	84.2	137.0	27.4	187.5	164.7	109.7	133.5	105.8	62.1	106.2	111.0	126.0	133.1	74.0	27.7	108.3	89.5	57.9	65.6	47.0	83.9	81.5	76.5	16.9	159.6	88.7	54.6	18.6	31.4	247.9	69.0	86.9	267.6	118.3	77.2	113.4	102.5	90.0	138.1	74.1	154.9	144.5	118.7	126.2	90.6	540.6	105.4	129.6	96.4	135.6
VEGFC	"VEGF-C, VRP"	ENSG00000150630	"Vascular endothelial growth factor C"	P49767	4	176683538-176792922	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 39.3;Endothelial cells: 22.0;Leydig cells: 13.7;Microglial cells: 36.5"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 22.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 146.5;HBF TERT88: 114.4;hTEC/SVTERT24-B: 116.5;LHCN-M2: 129.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 7.0"						"Secreted to blood"	NA	NA	383000	340000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (4.18e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (7.88e-5)"	"unprognostic (4.53e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (1.89e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.22e-1)"	25.0	6.9	2.6	4.2	2.5	0.2	16.7	2.7	2.8	9.7	2.1	4.7	2.4	7.3	1.8	4.0	8.5	6.8	12.7	2.4	2.4	6.7	4.2	16.8	8.0	3.1	2.8	5.9	1.8	2.7	1.5	19.3	2.9	5.1	3.3	1.2	7.4	5.0	3.1	5.1	6.8	6.6	2.6	3.9	3.2	1.4	3.7	1.1	27.7	4.1	3.4	10.3	7.6	2.5	5.9	2.8	1.8	0.0	25.5	25.3	0.0	146.5	87.3	79.2	62.5	0.0	0.7	0.0	0.0	82.7	33.1	4.4	1.3	54.8	114.4	0.1	2.8	0.0	3.8	0.0	13.9	0.0	0.0	27.0	2.5	116.5	80.5	79.3	49.7	0.0	0.0	0.0	129.9	2.1	0.0	0.0	1.3	0.0	47.1	0.0	8.4	0.0	0.0	3.3	0.0	0.0	2.3	3.3	0.1	0.7	0.7	0.2	24.2	83.6	9.2	20.8	42.1	0.2	0.0	0.0	34.9	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	2.5	2.7	2.8	2.4	2.4	3.1	2.8	2.9	2.6	3.7	2.5	39.3	3.2	0.0	10.1	0.1	2.4	1.3	3.2	0.0	1.0	3.2	1.7	1.5	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.5	3.1	8.3	10.9	22.0	0.0	0.0	2.0	0.0	0.0	9.1	0.0	11.0	0.0	8.5	10.0	0.0	0.3	1.7	2.0	0.0	4.1	0.3	2.2	1.2	13.7	0.4	3.6	36.5	0.0	3.4	0.0	1.5	0.6	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.4	0.2	0.0	1.9	11.7	0.2	2.0	0.3	2.0	0.0	0.2	1.9	0.0	3.6
VPS13A	"CHAC, KIAA0986"	ENSG00000197969	"Vacuolar protein sorting 13 homolog A"	Q96RL7	9	77177445-77421537	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 228.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021652, HPA021662"	Supported					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA021652: AB_1858759, HPA021662: AB_1858760"	"unprognostic (1.52e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.49e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.68e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.69e-3)"	"unprognostic (9.67e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.96e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.70e-2)"	5.1	7.6	2.6	7.1	4.8	17.6	7.3	11.2	9.6	4.4	3.6	9.4	16.3	6.0	8.0	7.6	4.7	9.0	9.5	6.0	0.1	9.9	7.4	6.3	8.8	0.5	0.1	3.6	8.8	9.3	6.5	3.6	0.3	6.7	11.4	7.2	8.0	6.6	14.6	15.6	13.8	7.2	0.0	10.6	12.3	16.8	0.2	10.3	8.5	9.8	7.6	6.4	6.2	3.1	21.0	10.4	9.1	7.9	8.5	7.4	13.7	11.4	10.3	9.8	11.1	4.2	9.3	16.4	5.2	10.6	11.9	27.9	13.7	11.3	17.4	15.5	11.0	21.7	21.3	10.3	8.3	28.3	13.9	4.7	16.6	14.5	17.7	17.3	14.1	15.7	14.3	17.4	6.0	9.8	21.7	9.7	10.2	11.9	8.3	15.7	17.4	6.8	14.1	20.2	13.3	13.3	14.3	9.2	6.3	16.6	6.3	6.3	18.6	10.4	11.3	14.4	14.6	9.7	9.6	8.4	10.8	13.2	4.2	3.8	0.2	2.0	1.2	0.1	1.2	0.9	0.9	0.9	0.1	1.2	0.7	0.8	0.2	1.2	0.1	2.2	0.7	0.2	2.6	4.8	11.2	9.6	6.0	0.1	0.5	0.1	0.3	0.0	0.2	3.1	29.7	64.1	46.5	48.3	32.2	33.0	26.6	28.0	27.3	29.1	25.4	22.1	87.2	27.1	41.2	29.5	58.4	15.2	42.3	78.9	3.9	18.2	90.5	33.8	28.2	38.6	87.8	48.4	228.3	18.4	4.8	18.9	86.6	42.6	19.0	32.4	37.5	34.1	8.6	11.8	101.1	47.4	30.5	10.6	14.4	55.0	13.7	13.3	23.2	43.1	11.9	16.4	41.2	72.4	23.0	46.2	42.9	15.8	42.7	31.0	98.5	21.7	38.9	18.2	32.9	33.1	30.5	74.3	64.5	36.6	31.3	8.9	43.2	38.0	39.8	25.7
VPS35	"FLJ10752, MEM3, PARK17"	ENSG00000069329	"VPS35 retromer complex component"	Q96QK1	16	46656132-46689518	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"		"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040802	Supported		Supported	Endosomes,Lysosomes		NA	NA		500000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Endosomes, Lysosomes"		"HPA040802: AB_2677142"	"unprognostic (1.11e-2)"	"unprognostic (8.70e-2)"	"prognostic favorable (7.74e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.67e-3)"	"prognostic unfavorable (2.10e-6)"	"unprognostic (5.32e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.49e-1)"	"prognostic favorable (9.75e-5)"	"unprognostic (3.68e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.89e-3)"	5.4	4.2	2.9	3.0	3.0	9.5	4.6	2.6	3.2	4.2	2.8	4.2	1.9	4.3	1.9	4.7	4.0	1.4	6.1	3.0	2.5	3.7	1.7	4.1	2.9	3.0	2.4	4.7	4.4	5.2	3.3	2.1	3.2	3.0	1.8	4.1	4.5	2.4	4.6	6.1	4.9	1.7	2.1	4.2	4.5	2.7	2.8	3.9	2.7	2.7	1.8	4.5	4.2	3.4	3.2	5.0	4.1	2.8	6.5	7.3	2.1	3.8	5.4	6.4	3.7	4.3	2.7	4.2	2.3	6.5	3.3	3.9	7.5	7.5	9.1	1.6	6.4	3.9	3.8	3.0	5.4	5.2	5.8	5.8	5.5	7.3	4.5	6.3	6.6	6.0	3.1	1.8	6.5	2.9	4.0	5.0	1.4	3.0	6.6	5.4	5.4	5.2	5.2	4.4	1.8	2.1	4.1	3.2	1.8	4.5	1.9	2.6	3.9	1.9	1.9	4.3	2.7	2.3	3.2	4.9	3.4	4.0	1.3	1.8	1.3	1.3	0.7	1.7	0.7	0.8	0.7	0.6	1.5	1.0	1.0	0.7	1.5	0.8	2.3	0.6	1.1	1.1	2.9	3.0	2.6	3.2	3.0	2.5	3.0	2.4	3.2	2.1	2.8	3.4	65.9	51.3	59.4	20.5	84.3	72.5	80.0	98.6	72.8	56.5	77.9	75.9	102.9	57.2	83.4	68.0	60.5	134.5	44.9	65.9	54.8	111.7	111.2	136.4	92.3	63.3	80.8	52.6	43.1	72.5	102.2	70.1	88.7	88.4	72.2	211.1	54.7	40.2	123.4	45.4	42.5	79.7	107.8	108.3	87.9	32.4	77.9	113.6	46.2	30.0	153.0	71.4	45.3	28.6	31.3	101.1	101.9	72.2	41.7	77.0	164.6	103.7	188.9	82.6	46.0	57.5	88.9	207.9	118.0	101.5	87.7	113.1	51.5	95.9	97.6	84.5
VRK1		ENSG00000100749	"VRK serine/threonine kinase 1"	Q99986	14	96797304-96954846	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 50.4;testis: 37.1"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 198.9;Spermatogonia: 110.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000660, HPA017929"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA000660: AB_1080579, HPA017929: AB_1858770"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (4.20e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-1)"	5.9	5.2	5.9	12.8	7.1	50.4	11.5	6.0	7.9	5.2	4.3	10.8	6.5	6.5	6.9	8.9	9.2	4.4	5.2	5.9	5.1	4.9	5.5	4.9	27.1	5.3	5.5	6.0	3.2	5.4	3.1	7.6	5.4	5.0	12.3	4.4	4.3	5.0	4.7	7.4	7.2	6.7	4.8	11.3	6.5	37.1	5.9	35.5	5.9	4.6	27.9	7.7	5.4	7.0	52.4	27.0	78.5	30.2	9.2	14.9	44.8	42.8	34.4	67.1	65.4	36.0	54.7	139.2	22.4	24.3	39.2	56.5	75.5	54.4	90.5	73.4	36.4	90.5	18.7	39.3	10.2	168.5	49.2	8.5	9.7	50.4	32.6	12.8	47.0	104.8	76.6	79.0	56.9	65.5	137.1	76.5	47.8	39.9	59.3	124.5	134.2	48.6	32.3	59.3	53.2	28.0	34.2	36.4	30.8	36.0	39.3	66.6	24.4	27.9	22.8	47.7	37.3	37.7	53.5	124.8	44.7	74.6	34.8	42.7	12.3	26.2	21.5	15.5	29.0	31.3	24.9	26.4	15.7	32.7	27.1	27.3	6.5	45.6	15.2	21.4	34.9	19.4	5.9	7.1	6.0	7.9	5.9	5.1	5.3	5.5	5.4	4.8	5.9	7.0	15.3	3.2	4.6	6.8	30.6	16.8	13.8	23.3	6.2	12.4	9.3	11.3	11.8	12.8	16.7	14.7	8.4	34.8	24.8	6.3	11.7	13.5	21.3	21.1	8.3	12.4	3.0	76.2	42.0	19.4	48.3	11.4	14.8	10.8	28.5	20.0	7.1	3.3	19.2	10.1	36.2	10.4	20.3	11.8	14.9	11.5	5.6	12.0	12.4	19.7	14.2	6.2	27.8	12.1	19.8	10.3	2.2	9.8	25.4	6.1	3.0	11.2	37.6	9.6	19.7	14.3	15.1	198.9	110.9	14.1	13.9	15.1	26.8	9.2	18.1	10.4
WARS1	"IFI53, IFP53, WARS"	ENSG00000140105	"Tryptophanyl-tRNA synthetase 1"	P23381	14	100333790-100376805	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 324.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 66.4;Cytotrophoblasts: 16.5;Endothelial cells: 38.5;Hofbauer cells: 43.1;Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 1345.3;non-classical monocyte: 1608.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 908.5;SK-MEL-30: 1012.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005573, HPA018944"	Enhanced		Enhanced	Cytosol		No	No		49000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA005573: AB_2667366, HPA018944: AB_2669986"	"unprognostic (5.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.26e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (4.84e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.92e-3)"	100.7	67.9	40.3	185.6	44.4	70.5	65.4	40.1	45.5	35.9	45.2	67.8	44.8	39.6	70.3	54.4	50.8	48.7	157.6	44.2	56.0	83.6	47.9	207.5	139.0	72.0	52.6	21.2	47.5	39.2	63.4	324.4	65.3	49.1	72.0	37.8	49.5	38.3	74.7	28.4	67.7	76.2	47.6	110.6	70.1	67.7	55.0	61.7	159.9	67.0	86.2	107.7	30.7	44.9	91.2	85.7	54.6	319.1	78.7	110.7	87.3	117.4	220.7	232.1	301.4	57.4	80.2	101.7	105.5	277.4	59.7	151.1	158.8	130.3	153.1	154.4	48.3	64.1	60.9	72.3	908.5	184.9	101.6	126.9	186.9	141.3	290.1	74.5	225.0	66.1	202.8	255.0	107.5	178.0	64.3	87.1	55.4	94.1	152.2	51.4	86.5	64.9	119.3	80.8	145.7	84.9	69.4	58.7	1012.4	70.5	153.6	234.7	153.1	25.7	58.9	269.2	61.3	446.4	277.1	191.9	295.0	144.2	205.5	96.5	471.7	610.4	41.5	1345.3	38.4	71.4	34.5	38.4	337.9	68.0	24.8	28.6	170.9	44.5	1608.2	54.7	44.8	672.7	40.3	44.4	40.1	45.5	44.2	56.0	72.0	52.6	65.3	47.6	55.0	44.9	66.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	16.5	3.7	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	11.5	5.5	0.0	0.0	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	16.6	0.5	0.0	0.0	0.0
WARS2	mtTrpRS	ENSG00000116874	"Tryptophanyl tRNA synthetase 2, mitochondrial"	Q9UGM6	1	119031216-119140654	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028007, HPA069692"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA028007: , HPA069692: AB_2686172"	"unprognostic (1.00e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.05e-2)"	"unprognostic (7.73e-3)"	"unprognostic (3.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.76e-3)"	"prognostic favorable (1.45e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.88e-3)"	"unprognostic (4.71e-2)"	7.3	8.8	2.4	4.1	2.4	1.9	9.4	2.4	3.0	6.9	6.5	7.3	7.7	6.3	3.8	6.1	9.4	4.9	7.9	2.3	2.6	9.6	6.1	5.0	4.7	2.4	2.4	8.2	8.9	10.2	3.8	6.3	2.4	5.7	8.0	6.0	5.4	3.5	6.3	5.2	5.1	5.2	2.4	3.0	7.2	4.6	2.3	4.6	6.8	6.5	5.1	6.8	5.6	2.8	12.8	5.0	7.5	7.9	9.6	21.6	7.6	7.0	10.5	7.6	9.1	14.4	5.6	19.0	11.4	12.0	4.2	8.2	13.9	12.6	11.7	9.8	16.6	8.9	12.8	13.9	19.6	14.8	4.8	16.1	9.7	11.1	20.2	10.0	11.7	7.9	14.1	13.4	14.4	15.7	8.9	8.6	9.9	9.8	10.6	6.3	24.9	9.9	20.9	17.5	10.7	6.6	11.3	15.4	16.7	13.1	6.9	11.1	8.8	7.8	9.2	15.2	13.8	6.4	4.6	8.3	9.6	12.1	14.7	0.0	5.0	0.3	3.4	3.6	5.0	4.6	3.6	4.5	6.7	6.2	4.2	4.2	0.2	4.2	2.2	3.2	4.5	3.4	2.4	2.4	2.4	3.0	2.3	2.6	2.4	2.4	2.4	2.4	2.3	2.8	7.2	9.6	12.3	22.5	10.4	9.6	17.6	14.7	14.2	6.7	13.1	11.3	10.6	5.7	11.2	11.0	6.2	16.9	7.0	6.5	17.6	9.8	57.7	15.2	8.6	7.5	6.7	18.9	15.5	11.9	15.3	15.5	17.9	13.8	8.8	9.7	2.2	7.5	9.5	6.7	21.4	10.2	14.2	10.0	6.9	31.8	9.9	8.2	10.6	11.2	13.0	5.0	3.1	12.1	18.2	8.7	6.1	8.2	9.1	13.1	7.5	18.8	14.7	8.2	6.6	12.0	10.1	5.4	6.1	19.8	10.7	20.0	10.2	19.6	15.8	14.4
WASHC4	"KIAA1033, SWIP"	ENSG00000136051	"WASH complex subunit 4"	Q2M389	12	105107324-105169130	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 44.1;Endometrial stromal cells: 48.3;Hofbauer cells: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045666, HPA046737"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA045666: AB_2679411, HPA046737: AB_2679778"	"unprognostic (2.68e-2)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (4.85e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.41e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.86e-2)"	22.4	21.1	9.4	30.9	13.8	23.8	20.8	13.8	12.2	20.7	11.8	16.1	15.3	20.1	19.9	15.1	13.1	22.6	14.3	9.1	13.8	23.5	29.7	20.2	44.0	17.8	13.0	22.8	18.3	20.4	8.5	30.5	18.4	19.2	18.4	15.4	16.1	15.8	12.2	31.2	18.4	19.8	15.2	32.9	17.9	12.1	14.5	18.0	22.1	14.2	39.5	17.6	12.6	22.1	24.0	28.2	24.6	18.2	56.3	56.6	29.5	36.5	41.5	41.7	38.0	20.2	13.5	53.4	19.8	61.0	26.5	21.9	21.5	22.3	33.5	19.2	15.3	11.1	25.6	16.8	38.4	30.9	20.5	45.7	25.7	37.3	30.4	45.1	68.7	18.1	22.1	18.6	45.9	12.1	17.1	32.6	30.1	16.8	23.5	32.7	32.8	16.6	55.6	27.5	15.4	19.0	37.7	26.4	37.9	31.0	19.6	32.9	84.1	49.8	13.6	32.1	23.9	23.3	23.9	42.7	35.4	26.1	51.4	21.3	15.1	9.2	3.0	18.4	4.4	16.2	4.7	4.1	11.9	12.9	4.9	4.7	16.7	8.0	34.2	5.8	3.5	6.9	9.4	13.8	13.8	12.2	9.1	13.8	17.8	13.0	18.4	15.2	14.5	22.1	37.5	35.3	24.3	0.0	25.3	0.0	0.0	0.0	0.0	0.0	16.4	11.0	0.0	0.0	11.8	44.1	0.0	24.1	17.5	0.0	19.6	25.8	0.0	23.8	48.3	18.0	0.0	0.0	0.0	22.1	28.0	14.6	0.0	31.7	26.5	30.7	0.0	0.0	51.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.3	0.0	0.0	26.9	0.0	0.0	0.0	0.0	24.2	0.0	0.0	5.2	0.0	0.0	41.8	17.5	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	32.0	8.9	29.1	0.0	0.0
WEE2	"FLJ16107, WEE1B"	ENSG00000214102	"WEE2 oocyte meiosis inhibiting kinase"	P0C1S8	7	141708353-141731271	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Meiosis	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Distal tubular cells: 1.9;Proximal tubular cells: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA027418, HPA054280"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA					"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA027418: AB_10603144, HPA054280: "	"unprognostic (6.35e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.88e-3)"	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.4	0.3	0.0	0.0	0.3	0.0	0.1	0.4	0.1	0.1	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.2	0.6	0.1	0.0	0.2	0.1	0.2	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WFS1	"DFNA14, DFNA38, DFNA6, DIDMOAD, WFS"	ENSG00000109501	"Wolframin ER transmembrane glycoprotein"	O76024	4	6269849-6303265	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cataract, Deafness, Diabetes insipidus, Diabetes mellitus, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 131.4;Extravillous trophoblasts: 120.2;Granulosa cells: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 100.4;Hep G2: 83.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029128	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"			"HPA029128: AB_10603460"	"unprognostic (4.27e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.13e-6)"	"unprognostic (7.35e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.97e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.33e-3)"	"unprognostic (6.20e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (3.64e-2)"	39.4	20.2	43.7	6.8	71.2	0.7	36.0	34.3	47.2	51.9	34.5	44.8	12.2	75.4	14.0	11.3	58.6	12.4	64.3	35.9	36.8	16.8	17.1	43.8	5.9	34.4	43.7	87.1	20.1	7.2	50.2	16.6	36.6	34.6	3.4	6.9	14.6	36.3	16.0	26.8	22.0	17.0	33.7	29.3	29.1	31.8	44.1	2.9	48.1	7.5	2.3	57.8	29.1	32.1	14.1	35.3	9.1	33.9	37.2	10.2	100.4	23.0	32.7	15.8	14.6	24.8	37.2	5.5	34.3	26.3	74.8	8.0	6.8	14.2	6.4	5.7	14.1	0.0	11.0	83.0	34.5	0.0	1.1	33.7	18.8	15.0	13.6	12.3	25.3	2.5	0.6	24.3	9.7	28.0	1.1	0.3	13.5	20.3	38.0	3.4	9.6	7.5	6.7	52.4	6.1	15.4	12.2	17.4	13.1	9.6	31.5	0.3	19.9	19.8	22.8	19.1	14.8	26.0	10.1	0.5	23.9	0.2	18.3	0.0	0.7	0.0	2.7	0.9	3.9	2.4	1.3	2.1	0.2	1.2	1.3	1.5	0.0	1.5	1.1	0.4	0.8	1.4	43.7	71.2	34.3	47.2	35.9	36.8	34.4	43.7	36.6	33.7	44.1	32.1	38.4	131.4	12.4	40.5	3.6	2.4	1.9	2.5	2.2	4.9	9.7	6.0	42.5	5.7	5.7	25.8	0.0	22.2	1.0	2.0	0.0	5.5	10.3	18.1	12.6	21.1	33.5	0.0	2.7	4.4	120.2	15.4	13.3	25.5	1.3	71.4	21.4	10.7	19.0	3.3	4.7	5.7	4.1	1.3	2.4	19.1	40.0	2.5	12.4	12.2	0.7	31.7	0.0	9.5	2.4	10.9	1.6	57.9	19.0	4.7	3.7	3.7	12.1	5.0	13.1	3.6	15.1	10.8	14.6	2.2	3.4	39.7	1.6	11.0	4.7	2.1
WNK1	"HSAN2, HSN2, PPP1R167, PRKWNK1"	ENSG00000060237	"WNK lysine deficient protein kinase 1"	Q9H4A3	12	752579-911452	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Protein kinase inhibitor, Serine/threonine-protein kinase, Transferase"	"Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 293.0"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 336.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046541, HPA059157"	Enhanced		Supported	Cytosol		NA	NA		92000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA046541: AB_2679690, HPA059157: AB_2683935"	"unprognostic (1.40e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.67e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.30e-2)"	56.7	20.6	190.8	36.4	236.8	54.2	33.5	179.4	166.1	32.8	110.8	22.8	14.4	26.7	30.4	72.1	29.4	27.1	63.8	132.3	161.1	84.0	31.6	44.6	39.2	232.3	238.4	30.1	22.5	51.1	17.0	36.0	217.0	29.7	24.2	87.4	24.0	33.4	79.7	52.0	17.4	36.1	225.4	30.2	27.6	48.3	238.0	61.3	27.7	79.8	46.9	35.8	43.8	293.0	53.9	97.5	131.8	11.3	88.1	80.0	52.2	48.3	61.6	58.2	51.3	59.4	55.7	71.0	16.8	107.8	73.5	39.8	93.8	56.7	84.3	124.7	51.4	169.4	122.2	46.1	66.7	86.9	68.2	64.0	82.1	97.6	164.4	61.6	73.4	68.0	76.4	158.2	77.8	54.1	154.6	15.6	105.8	47.8	24.3	78.0	138.8	20.8	80.6	96.8	35.1	40.7	121.8	82.9	33.6	183.3	86.8	97.2	78.3	67.1	77.3	86.2	70.8	23.8	43.1	103.8	59.4	44.6	53.2	0.7	1.8	1.6	1.9	2.1	1.9	1.7	1.9	2.1	1.4	1.2	1.2	1.9	5.6	1.4	4.7	1.2	3.4	1.6	190.8	236.8	179.4	166.1	132.3	161.1	232.3	238.4	217.0	225.4	238.0	293.0	261.1	102.5	141.6	77.1	65.3	112.8	42.3	38.3	85.4	87.9	50.6	39.5	241.6	50.1	47.1	90.1	150.1	32.5	83.0	27.8	86.1	28.0	29.7	63.0	68.6	106.7	58.7	304.2	182.3	24.4	32.9	58.3	37.2	70.2	52.6	46.2	52.5	71.7	57.3	84.1	165.0	26.3	16.2	121.4	80.8	21.2	61.8	96.7	37.4	114.3	95.7	64.0	61.8	126.7	336.4	41.7	34.8	55.7	76.5	59.0	24.2	21.8	64.6	96.1	13.1	69.6	63.8	186.5	74.6	147.2	136.0	28.5	112.9	33.2	25.8	55.2
WNK4	PRKWNK4	ENSG00000126562	"WNK lysine deficient protein kinase 4"	Q96J92	17	42780610-42797066	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 11.0;kidney: 37.6;prostate: 11.6"	"Cell type enriched"	"Detected in some"	4	"Distal tubular cells: 160.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 32.6;K-562: 36.8;TIME: 34.1;WM-115: 23.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016500	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA016500: AB_10962984"	"unprognostic (6.34e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.08e-3)"	"unprognostic (4.33e-3)"	"unprognostic (7.70e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.99e-2)"	1.3	0.0	0.7	1.1	0.9	0.0	2.8	0.8	3.3	0.6	0.3	9.8	1.9	0.2	0.7	8.9	0.4	0.0	0.1	1.7	1.1	37.6	0.2	0.1	0.1	1.1	0.7	4.3	0.2	0.0	1.2	0.0	0.7	11.6	11.0	0.6	1.8	1.1	0.0	0.5	3.7	0.4	0.6	0.1	3.4	0.2	1.0	0.0	0.0	0.3	0.1	0.2	0.4	1.0	2.1	1.2	0.6	0.0	0.7	0.2	4.8	11.9	4.8	4.5	1.3	0.7	1.0	0.6	6.8	32.6	1.2	0.0	0.2	0.3	8.6	0.6	1.8	0.1	0.0	4.7	7.4	0.3	0.7	3.9	1.4	6.4	2.1	2.1	0.3	0.4	36.8	1.3	0.0	1.0	0.0	1.1	0.3	2.0	8.2	0.6	1.2	0.0	0.0	0.5	0.0	0.2	0.1	0.2	1.7	4.1	2.4	2.7	34.1	0.3	3.1	0.5	0.4	6.2	5.3	1.2	0.0	2.1	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.8	3.3	1.7	1.1	1.1	0.7	0.7	0.6	1.0	1.0	0.2	0.0	0.6	0.0	0.5	0.0	0.2	0.0	0.6	0.2	7.1	4.1	1.0	1.5	0.6	7.3	0.0	0.0	0.3	8.0	160.4	0.0	0.0	5.1	1.1	0.2	13.1	0.0	0.2	0.2	0.2	0.1	3.1	6.7	4.5	0.1	0.7	0.0	0.0	0.0	0.2	40.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.2	0.4	0.0	3.6	0.9	1.0	2.9	0.5	0.0	0.2	0.5	0.8	0.8	12.1	0.4	0.0	0.2	0.0	13.1	0.3
WRN	"RECQ3, RECQL2"	ENSG00000165392	"WRN RecQ like helicase"	Q14191	8	31033788-31176138	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Exonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 74.7;Early spermatids: 116.3;Oligodendrocytes: 88.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028661	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA028661: AB_10602255"	"unprognostic (8.73e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.66e-1)"	3.0	3.6	1.7	3.2	1.7	8.2	4.8	4.1	2.4	3.0	2.6	3.5	1.5	6.4	3.2	2.7	2.9	2.4	1.7	1.6	1.7	2.1	2.5	2.4	2.5	1.8	2.1	5.2	2.6	2.0	2.1	3.6	1.8	3.5	2.9	4.4	3.5	2.6	2.1	4.1	2.5	4.2	1.2	3.1	2.3	3.0	1.9	3.2	3.2	2.2	3.0	2.6	2.3	3.1	4.4	5.9	10.8	5.3	6.7	9.8	5.0	4.7	4.9	6.4	6.6	2.7	1.5	10.0	4.6	4.3	4.4	2.4	6.4	3.8	9.7	3.3	4.3	9.6	4.9	4.4	5.4	8.7	4.3	7.1	3.7	3.6	6.2	3.9	7.7	6.1	14.5	5.0	6.8	2.0	17.5	6.6	7.7	5.1	3.2	7.5	7.5	6.7	2.9	4.4	3.3	5.2	6.9	2.7	3.8	4.9	2.9	5.3	9.1	6.2	3.8	3.1	4.9	1.4	3.0	14.6	5.5	3.8	4.2	0.8	0.2	0.3	0.3	0.1	0.4	0.5	0.5	0.3	0.2	0.5	0.3	0.4	0.3	1.1	0.1	0.1	0.3	0.1	1.7	1.7	4.1	2.4	1.6	1.7	1.8	2.1	1.8	1.2	1.9	3.1	17.5	9.6	10.6	74.7	15.1	13.5	11.7	5.3	18.8	14.5	14.7	10.5	7.5	15.7	8.8	16.5	22.9	7.1	18.0	5.3	1.9	6.7	116.3	15.8	32.3	12.5	2.4	49.2	59.7	9.8	5.7	15.2	21.9	17.1	2.5	18.5	7.1	9.7	5.3	15.2	54.9	13.8	8.2	5.3	6.6	12.8	19.0	7.8	10.6	51.5	6.9	14.3	4.1	61.3	88.6	9.1	4.2	14.3	16.6	15.3	3.9	2.7	10.0	19.8	6.6	20.2	15.3	10.9	19.2	10.1	10.2	5.6	13.0	15.2	7.7	11.0
XK	"Kx, NA, NAC, X1k, XKR1"	ENSG00000047597	"X-linked Kx blood group"	P51811	X	37685791-37732130	"Blood group antigen proteins, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"	"Blood group antigen"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.2;intestine: 12.2;stomach 1: 11.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 26.7;Erythroid cells: 63.5;Gastric mucus-secreting cells: 17.9;Proximal enterocytes: 21.5;Undifferentiated cells: 14.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 6.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	53	"basophil: 10.2;eosinophil: 5.8"	"Lineage enriched"	"Detected in single"	102	"granulocytes: 10.2"	"Cell line enhanced"	"Detected in many"		"HEL: 44.4;HL-60: 23.2;K-562: 29.1;NB-4: 21.1;RPMI-8226: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019036	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria	"Nucleoplasm, Vesicles"	"HPA019036: AB_1846286"	"unprognostic (2.37e-2)"	"unprognostic (7.13e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.97e-2)"	"unprognostic (4.56e-1)"	"unprognostic (3.59e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (5.90e-2)"	"unprognostic (4.44e-8)"	"unprognostic (1.74e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.43e-1)"	0.2	2.1	2.5	1.4	2.5	14.2	0.7	2.3	3.0	1.2	0.2	12.2	10.8	0.7	0.5	2.0	3.8	0.9	4.3	3.2	4.9	0.9	0.8	1.0	0.2	1.6	0.9	0.7	4.9	0.7	1.3	0.7	2.0	1.5	11.2	2.1	1.2	0.9	5.4	0.7	10.6	1.8	0.5	0.5	11.5	1.4	2.8	0.2	0.9	5.8	0.5	1.1	0.8	1.4	17.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	14.7	0.3	0.0	0.8	2.7	15.4	0.1	0.0	0.0	4.2	44.4	2.4	0.0	0.0	23.2	3.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	29.1	10.9	0.1	1.7	0.2	21.1	5.5	0.7	5.6	0.0	0.0	20.2	0.0	1.1	4.1	0.1	0.8	1.4	0.1	0.9	2.1	5.6	0.0	0.0	0.8	0.0	2.4	9.3	16.5	0.0	0.2	12.1	0.1	10.2	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	2.5	2.5	2.3	3.0	3.2	4.9	1.6	0.9	2.0	0.5	2.8	1.4	0.0	0.0	1.1	2.6	0.8	0.4	0.4	0.1	1.2	0.7	1.1	0.8	7.9	0.0	0.1	0.0	6.2	0.3	0.1	26.7	0.0	0.0	1.2	4.0	0.1	0.3	6.1	63.5	11.0	3.1	0.1	0.6	17.9	0.9	0.0	0.1	0.0	0.9	0.1	3.3	12.6	10.9	2.0	0.3	0.0	0.4	0.0	0.2	1.8	1.9	0.0	0.0	0.0	4.5	1.2	1.1	9.2	0.7	2.2	0.9	21.5	0.1	1.7	1.4	0.0	0.7	1.3	10.2	6.1	3.8	1.1	0.0	0.3	0.1	14.7	1.5
XPNPEP2		ENSG00000122121	"X-prolyl aminopeptidase 2"	O43895	X	129738949-129769536	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 166.6;kidney: 156.0"	"Cell type enriched"	"Detected in some"	6	"Proximal enterocytes: 475.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 4.3;intermediate monocyte: 1.4;MAIT T-cell: 1.2;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.8;naive CD8 T-cell: 2.0;non-classical monocyte: 2.8;T-reg: 1.4"	"Group enriched"	"Detected in many"	7	"monocytes: 2.8;T-cells: 4.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.2;ASC TERT1: 40.1;HSkMC: 21.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000339, CAB025136, CAB025269, HPA064568"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		13000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"		"CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: "	"unprognostic (7.95e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-3)"	7.5	0.9	0.1	3.7	0.1	0.2	3.0	0.1	0.1	3.7	0.1	5.5	99.0	2.4	0.1	2.2	6.3	4.3	5.3	0.1	0.1	156.0	23.1	2.1	0.5	0.2	0.1	1.8	0.3	0.3	0.1	1.2	0.1	1.8	6.3	0.0	1.5	0.4	0.5	4.4	166.6	6.0	0.1	0.3	3.4	0.1	0.1	1.0	1.4	2.4	0.4	7.8	4.0	0.1	0.0	0.0	0.5	0.0	8.2	40.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	4.3	1.4	1.2	0.0	1.3	2.8	0.2	0.2	0.4	2.0	0.1	0.0	2.8	0.4	1.4	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.8	0.0	0.2	0.5	11.4	5.9	0.0	0.0	0.0	0.1	0.3	1.2	0.0	0.2	0.0	0.0	10.0	1.1	0.0	0.0	0.0	0.4	18.5	0.8	0.0	0.3	12.8	0.0	1.0	3.6	0.0	0.0	1.0	1.8	1.0	0.0	0.0	3.1	0.0	0.1	0.0	21.0	0.0	0.1	0.0	475.9	75.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	1.0	1.2	0.9	0.0	8.4	0.0
XPNPEP3	"APP3, ICP55, NPHPL1"	ENSG00000196236	"X-prolyl aminopeptidase 3"	Q9NQH7	22	40857077-40932815	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 232.9;Late spermatids: 306.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000527	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Mitochondria	Cytosol	"HPA000527: AB_1079266"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.77e-2)"	"unprognostic (3.22e-3)"	"unprognostic (5.03e-3)"	"unprognostic (6.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.69e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.24e-1)"	2.7	4.9	6.4	1.3	6.3	1.6	2.6	8.3	7.8	2.9	7.1	2.5	14.6	4.7	5.0	2.8	3.7	4.4	5.3	7.8	6.1	3.7	8.2	2.4	2.5	7.2	6.6	3.8	3.6	2.1	3.7	1.5	6.6	2.8	2.2	4.4	3.4	2.5	5.5	5.5	10.1	2.4	5.6	2.8	2.8	3.7	6.7	5.9	3.2	3.5	1.9	3.7	2.8	9.0	2.7	4.1	2.5	5.5	6.3	4.6	2.1	3.3	2.5	1.7	1.7	3.1	1.6	5.2	1.8	6.5	7.8	7.3	4.7	2.4	2.7	3.5	9.7	3.3	9.7	7.5	3.2	6.0	0.5	4.0	3.9	5.7	3.3	2.7	3.3	3.8	2.9	4.8	4.3	4.1	3.1	3.2	1.5	5.0	8.3	3.9	3.3	3.0	5.9	3.6	2.3	1.9	3.9	4.8	3.3	2.6	6.1	2.7	3.2	3.6	3.4	3.4	2.1	4.7	4.0	7.4	5.6	8.5	2.5	2.8	2.5	2.9	2.1	2.5	1.0	3.7	1.2	1.2	1.9	1.9	2.4	1.9	3.6	0.7	6.9	3.8	1.9	2.8	6.4	6.3	8.3	7.8	7.8	6.1	7.2	6.6	6.6	5.6	6.7	9.0	9.6	6.4	17.6	32.0	12.7	13.3	8.0	15.6	9.6	16.0	12.9	13.2	22.5	15.7	14.0	9.2	18.8	21.7	11.0	6.2	15.6	12.2	232.9	37.5	16.6	11.7	13.8	12.0	22.0	17.1	18.7	13.1	12.2	12.0	14.0	17.8	10.8	36.0	14.7	16.8	24.0	9.5	12.2	12.6	15.7	306.8	19.9	11.9	17.8	18.7	7.8	13.0	9.2	19.6	42.3	10.4	9.5	15.4	11.8	7.8	3.5	25.3	38.5	19.8	32.9	14.0	12.7	65.6	34.2	12.2	16.3	20.0	11.0	19.5	8.7	7.6
XYLT1	"PXYLT1, XT-I"	ENSG00000103489	"Xylosyltransferase 1"	Q86Y38	16	17101769-17470960	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"		"Glycosyltransferase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Oligodendrocyte precursor cells: 1194.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.0"	"Lineage enriched"	"Detected in single"	4	"monocytes: 2.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 55.1;ASC TERT1: 34.0;U-2197: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007478, HPA007966"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to blood"	NA	NA		150000	"Cluster 14: Monocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 18: U-2197 - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	"Endoplasmic reticulum"	"HPA007478: AB_1080616, HPA007966: AB_1080618"	"unprognostic (1.82e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	6.4	6.2	6.2	4.9	8.0	7.2	4.5	2.3	6.3	7.8	8.5	8.8	4.3	7.9	1.0	5.1	3.7	2.3	4.2	8.8	3.6	1.0	0.3	3.5	5.1	3.7	4.3	5.3	2.8	0.9	0.6	6.0	4.2	2.7	5.2	8.3	2.5	4.5	1.1	5.0	5.3	5.7	1.6	5.4	3.4	2.3	3.6	4.1	2.2	1.2	4.3	4.3	4.6	4.6	0.0	0.3	8.0	0.1	55.1	34.0	9.6	25.6	12.9	2.7	1.0	0.3	0.6	6.1	0.0	31.3	0.9	0.6	0.0	5.1	4.5	12.1	0.6	8.0	0.0	0.0	0.6	11.5	10.2	12.6	0.7	15.0	2.4	4.6	0.0	0.3	0.0	23.8	2.8	0.8	0.1	12.4	8.5	4.4	0.0	3.5	0.0	1.2	0.0	11.5	2.0	15.2	1.9	7.9	1.4	5.9	1.9	7.2	0.0	24.6	2.9	57.2	0.0	26.4	1.4	11.6	28.9	12.8	22.4	0.3	0.2	0.4	0.2	1.2	0.3	0.1	0.1	0.1	0.4	0.3	0.2	0.1	0.1	0.4	2.0	0.1	0.3	0.2	6.2	8.0	2.3	6.3	8.8	3.6	3.7	4.3	4.2	1.6	3.6	4.6	1.0	3.2	2.5	45.4	9.2	7.9	1.6	0.0	1.2	12.9	3.8	3.7	3.4	0.0	0.7	0.0	98.0	12.7	12.4	9.1	0.0	1.5	0.5	0.5	24.7	2.9	12.6	7.4	172.8	1.6	20.1	12.2	2.6	0.8	2.5	6.4	1.4	0.2	3.5	0.0	72.8	4.3	4.1	9.7	27.6	0.8	12.8	8.5	3.6	29.0	6.1	1.9	11.3	1194.8	63.0	4.0	7.4	50.0	6.2	5.3	6.1	0.2	0.0	4.4	6.6	7.9	5.9	0.3	1.6	4.1	18.5	13.1	7.7	8.1	6.9	6.4
XYLT2	"PXYLT2, XT-II"	ENSG00000015532	"Xylosyltransferase 2"	Q9H1B5	17	50346126-50363138	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"stomach 1: 86.7"	"Group enriched"	"Detected in many"	6	"Early spermatids: 316.4;Late spermatids: 91.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		1100000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 4: Stomach - Digestion"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"				"unprognostic (1.52e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.29e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.63e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.68e-2)"	7.4	9.7	4.9	6.6	5.2	4.5	8.1	8.0	8.2	12.3	8.7	10.0	9.6	11.4	5.3	8.4	11.8	6.6	9.1	5.6	3.0	8.9	7.5	7.3	9.3	4.1	5.6	13.6	12.9	9.4	6.4	8.6	3.8	13.6	3.6	4.5	12.2	10.1	5.8	15.3	8.7	5.2	2.5	10.1	86.7	6.7	7.0	8.6	9.3	2.4	4.0	12.0	10.9	5.3	21.1	26.2	7.0	5.9	9.7	9.4	18.4	19.3	17.4	17.2	19.1	28.3	15.5	10.9	47.6	17.3	14.9	15.8	2.4	27.0	3.7	54.3	18.5	24.6	8.6	12.4	13.3	7.8	12.5	12.8	16.4	13.6	6.3	16.9	14.9	9.4	4.4	8.8	11.3	27.5	14.4	10.7	6.5	14.0	18.0	7.2	20.4	9.0	9.5	10.8	3.6	9.0	12.9	11.9	20.3	8.0	57.4	7.5	17.4	38.4	19.2	20.9	17.3	48.0	23.6	3.9	40.4	12.3	10.6	3.7	2.0	1.5	2.7	1.2	2.7	1.3	2.7	3.6	2.4	2.2	2.7	2.5	1.9	3.6	1.1	1.6	2.5	2.9	4.9	5.2	8.0	8.2	5.6	3.0	4.1	5.6	3.8	2.5	7.0	5.3	7.5	9.6	6.1	13.1	3.9	5.7	3.2	7.3	5.7	8.3	3.9	5.7	8.4	10.0	4.4	1.8	29.2	7.0	3.8	7.5	0.0	7.1	316.4	4.6	6.7	6.8	10.8	0.8	4.9	6.2	5.4	9.1	17.3	6.8	1.3	9.6	10.4	8.0	3.6	6.7	7.2	9.4	2.0	6.0	1.4	91.4	12.5	3.8	7.2	6.5	2.7	5.9	5.2	6.6	4.7	6.8	3.5	17.3	4.7	2.0	4.6	2.8	3.2	6.1	26.3	6.9	6.7	2.4	4.3	3.4	3.1	1.5	4.8	5.3	11.1	1.4
YARS1	"tyrRS, YARS, YRS, YTS"	ENSG00000134684	"Tyrosyl-tRNA synthetase 1"	P54577	1	32775237-32817380	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 17.5;Cytotrophoblasts: 41.8;Extravillous trophoblasts: 48.1;Hofbauer cells: 41.0;Syncytiotrophoblasts: 37.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017936, HPA018950, HPA018954"	Enhanced		Enhanced	Cytosol		No	No		1400000	"Cluster 48: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA017936: AB_1858916, HPA018950: AB_1858919, HPA018954: AB_1858915"	"unprognostic (4.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.38e-3)"	"prognostic unfavorable (6.97e-11)"	"unprognostic (5.05e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (1.02e-11)"	"unprognostic (3.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (6.57e-4)"	24.9	40.3	39.9	35.0	51.2	19.9	21.3	38.1	60.4	20.5	30.1	27.5	26.0	16.9	25.0	34.4	21.6	15.3	22.4	42.1	46.6	20.6	47.7	27.8	38.2	37.5	38.4	15.1	85.6	34.1	14.8	26.2	42.3	18.8	32.4	38.0	29.6	29.0	31.9	26.0	21.6	35.4	38.5	22.0	40.8	31.2	44.2	34.6	42.3	36.6	50.0	34.6	14.0	49.6	157.1	92.1	86.1	194.5	111.2	117.7	91.7	151.0	136.7	133.2	165.0	116.6	103.0	287.5	63.1	173.2	112.7	90.8	269.0	204.4	198.9	122.6	113.9	254.2	117.2	114.2	383.4	202.9	147.3	129.0	252.3	212.7	544.2	98.3	140.9	245.8	291.8	268.7	117.8	107.8	233.0	159.3	149.1	185.3	134.5	198.3	75.2	234.9	109.8	76.5	149.5	94.2	89.0	102.7	300.8	99.2	95.2	247.5	103.6	73.6	135.7	152.1	135.7	242.8	265.2	255.7	184.8	297.7	203.6	56.1	33.3	17.8	59.0	35.2	58.4	23.8	35.4	55.1	45.8	20.3	25.2	39.0	6.9	98.1	35.0	26.9	40.9	51.5	39.9	51.2	38.1	60.4	42.1	46.6	37.5	38.4	42.3	38.5	44.2	49.6	7.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	41.8	11.6	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	48.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	37.6	1.4	0.0	0.0	0.0
YARS2	"CGI-04, FLJ13995, mt-TyrRS"	ENSG00000139131	"Tyrosyl-tRNA synthetase 2"	Q9Y2Z4	12	32727490-32755897	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038721, HPA057610, HPA074097"	Uncertain		Supported	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	"Nuclear bodies"	"HPA038721: AB_10674837, HPA057610: AB_2683483, HPA074097: AB_2686660"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.99e-3)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (1.41e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.39e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.71e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.09e-1)"	6.1	6.0	4.1	6.5	3.8	7.8	6.6	4.3	4.5	5.9	3.9	5.8	4.8	5.8	5.0	7.1	5.2	4.4	6.2	3.9	3.3	4.8	6.0	4.3	8.1	3.7	3.0	6.1	5.8	6.5	3.7	7.8	4.3	4.6	6.4	4.6	8.1	4.5	7.3	5.4	5.2	5.3	3.1	6.1	5.8	4.6	3.2	7.9	4.6	8.5	8.3	7.4	5.1	4.3	19.8	23.3	13.3	15.8	14.3	16.6	42.0	14.8	15.0	17.9	17.4	58.8	24.6	35.4	23.6	15.0	25.8	24.9	26.7	38.9	20.0	15.5	41.8	23.6	16.4	33.0	20.6	25.3	13.2	15.6	24.4	16.9	30.5	23.0	28.5	18.4	33.7	15.9	19.1	16.1	18.9	30.4	73.5	13.0	28.2	21.0	28.4	21.1	22.9	27.8	20.5	10.0	22.7	19.5	14.7	51.5	36.5	22.7	19.5	16.9	17.7	27.8	25.3	9.4	10.7	37.0	15.7	18.6	14.3	10.2	6.1	3.7	8.4	8.0	8.8	7.3	8.8	8.7	8.5	9.6	9.0	10.5	1.0	11.9	9.6	8.2	8.4	5.1	4.1	3.8	4.3	4.5	3.9	3.3	3.7	3.0	4.3	3.1	3.2	4.3	14.5	6.4	4.4	25.5	16.1	10.1	20.1	27.0	14.2	16.8	11.4	8.4	7.7	1.5	15.1	11.0	20.9	34.7	15.9	5.4	7.9	19.9	6.5	19.7	17.7	10.2	7.2	21.2	22.2	16.5	36.9	12.5	6.6	24.6	7.0	18.9	6.8	5.6	20.1	15.2	31.2	7.3	16.2	9.3	6.0	4.6	10.5	10.4	5.4	18.7	16.0	12.3	16.5	26.7	44.1	14.2	7.6	8.6	9.3	13.9	7.9	11.5	9.0	19.9	13.1	10.5	19.1	6.3	12.8	12.9	8.4	17.9	13.9	24.3	12.8	12.6
YME1L1	YME1L	ENSG00000136758	"YME1 like 1 ATPase"	Q96TA2	10	27110111-27155266	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA066953	Approved		Supported	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	"Nuclear bodies"	"HPA066953: AB_2685753"	"unprognostic (2.28e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (8.25e-6)"	"unprognostic (7.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.09e-2)"	48.8	52.6	17.7	51.7	18.4	95.1	47.5	23.3	21.7	52.4	36.4	52.2	46.0	50.3	53.3	59.1	43.7	46.0	61.4	17.8	22.7	54.0	65.5	39.8	56.6	18.2	22.1	50.8	52.0	54.5	33.3	61.1	19.9	48.4	52.4	42.0	44.7	44.5	111.4	40.1	46.3	49.2	16.6	46.4	48.8	51.2	19.7	65.9	62.2	97.7	62.5	56.8	35.0	24.4	146.6	105.3	125.5	62.0	118.3	123.9	100.7	143.3	79.7	139.7	157.6	143.3	171.9	152.1	90.8	154.8	100.5	135.6	152.8	122.6	152.9	143.4	89.0	144.4	91.0	98.3	124.6	100.4	114.5	104.7	143.3	123.4	121.6	122.5	146.7	138.8	173.8	150.5	154.4	95.1	189.1	53.7	97.4	119.3	49.4	160.4	199.7	143.0	107.7	68.2	95.6	121.9	138.4	105.2	138.9	102.8	101.5	115.1	146.9	83.4	117.3	140.8	126.7	75.1	121.9	196.1	119.4	178.8	65.8	195.0	146.4	165.4	147.5	128.5	149.4	143.0	142.4	138.8	121.9	149.7	129.3	136.8	204.0	135.6	143.1	222.6	156.7	155.5	17.7	18.4	23.3	21.7	17.8	22.7	18.2	22.1	19.9	16.6	19.7	24.4	105.4	67.3	81.8	40.5	108.3	70.1	96.7	55.6	92.2	53.1	76.8	90.9	103.6	32.9	66.4	29.5	83.4	61.2	121.0	179.4	15.6	52.2	62.3	141.4	152.5	86.1	50.3	63.1	67.0	48.6	74.4	101.1	136.6	224.3	110.8	75.0	58.5	70.0	73.2	50.5	68.1	121.2	32.6	98.9	133.2	27.0	57.8	125.4	56.9	41.2	63.7	63.8	47.4	66.9	75.2	66.8	109.3	43.2	93.8	83.7	156.5	47.3	70.1	65.7	72.3	156.6	94.5	143.4	57.4	92.5	64.9	94.8	122.1	102.2	104.4	75.0
ZAP70	"SRK, STD, ZAP-70"	ENSG00000115085	"Zeta chain of T cell receptor associated protein kinase 70"	P43403	2	97713576-97739862	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.8;lymphoid tissue: 79.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 101.0;NK-cells: 155.5;T-cells: 105.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	41	"gdT-cell: 137.4;MAIT T-cell: 93.2;memory CD4 T-cell: 71.7;memory CD8 T-cell: 108.3;naive CD4 T-cell: 50.8;naive CD8 T-cell: 79.8;NK-cell: 112.2;T-reg: 80.1"	"Group enriched"	"Detected in many"	56	"NK-cells: 112.2;T-cells: 137.4"	"Group enriched"	"Detected in some"	11	"JURKAT: 121.0;MOLT-4: 183.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002625, HPA003134"	Enhanced					NA	NA		14000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB002625: , HPA003134: AB_1080629"	"unprognostic (4.11e-3)"	"prognostic favorable (6.89e-5)"	"unprognostic (3.82e-3)"	"prognostic favorable (9.66e-8)"	"unprognostic (5.78e-2)"	"prognostic favorable (3.93e-6)"	"unprognostic (2.30e-3)"	"unprognostic (1.09e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.23e-3)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (3.02e-8)"	"unprognostic (1.29e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.40e-2)"	"unprognostic (5.83e-3)"	3.3	1.3	0.5	28.0	0.6	24.8	1.9	0.5	0.9	1.7	0.7	4.0	5.8	1.4	0.5	2.3	2.2	5.4	1.4	0.5	0.7	2.8	3.9	8.7	57.0	0.8	1.3	0.8	1.0	0.4	1.1	0.9	0.7	2.5	1.5	0.0	2.3	0.8	2.0	2.4	18.5	0.5	0.6	35.5	6.7	2.7	1.2	79.9	3.5	2.8	17.7	4.9	2.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	121.0	0.0	0.7	0.0	0.0	183.4	0.5	0.1	0.0	0.0	7.2	0.1	9.1	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	14.1	0.1	0.0	0.0	0.3	0.3	0.5	137.4	0.4	93.2	0.2	71.7	108.3	0.3	1.6	50.8	79.8	2.2	112.2	1.0	0.9	80.1	64.2	0.5	0.6	0.5	0.9	0.5	0.7	0.8	1.3	0.7	0.6	1.2	0.6	0.8	9.6	13.6	0.3	3.9	1.5	0.0	0.0	0.0	0.0	0.8	0.5	3.0	0.0	0.0	0.0	0.0	0.1	101.0	0.2	1.9	0.2	1.0	1.6	0.5	0.8	0.0	8.8	0.2	0.0	0.0	1.8	4.6	0.4	2.5	0.1	2.5	0.7	2.2	0.0	0.2	0.0	0.0	2.8	2.2	0.7	0.0	3.4	1.8	2.8	5.0	0.0	155.5	0.0	0.1	0.0	0.0	0.0	28.0	0.1	0.0	0.5	0.0	0.0	0.0	14.3	0.6	1.3	2.1	0.2	1.4	0.0	105.6	0.1	0.1	0.2
ZDHHC15	"DHHC15, FLJ31812, MRX91"	ENSG00000102383	"Zinc finger DHHC-type palmitoyltransferase 15"	Q96MV8	X	75368427-75523502	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.2;Inhibitory neurons: 17.7;Oligodendrocyte precursor cells: 17.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 3.2;K-562: 2.1;LHCN-M2: 2.2;MOLT-4: 2.4;NTERA-2: 2.0;RH-30: 3.1;RPTEC TERT1: 1.7;SH-SY5Y: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003618, HPA064901"	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"	Cytosol	"HPA003618: AB_2217686, HPA064901: "	"unprognostic (8.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.62e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.00e-4)"	"unprognostic (1.96e-2)"	"unprognostic (3.19e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.78e-13)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.67e-4)"	0.8	1.5	1.7	0.3	1.7	0.1	1.6	1.8	1.5	1.6	1.3	1.0	0.2	1.9	1.0	0.8	1.2	0.8	1.7	1.5	2.5	1.5	0.2	1.2	0.3	2.2	2.2	2.5	1.1	1.1	1.1	0.0	2.0	1.1	0.5	1.9	4.5	1.1	0.3	0.7	0.3	1.5	1.8	0.8	0.4	0.6	3.0	0.8	2.0	0.5	0.2	0.7	0.8	2.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	2.1	0.0	2.2	0.0	2.4	0.0	2.0	0.0	0.0	0.0	3.1	0.0	1.7	0.0	0.8	2.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.5	0.0	0.4	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.7	1.8	1.5	1.5	2.5	2.2	2.2	2.0	1.8	3.0	2.0	2.9	6.4	3.1	8.5	0.1	4.0	1.6	0.0	3.4	4.2	2.0	1.5	9.5	1.5	1.3	5.5	4.2	0.0	0.3	0.0	0.0	0.7	0.0	0.2	2.9	3.5	1.8	0.4	18.2	0.7	0.0	3.5	0.0	0.3	1.3	2.5	2.2	0.1	0.1	0.0	17.7	0.0	0.0	0.0	4.4	0.2	0.9	0.1	0.0	5.6	0.0	2.2	1.0	17.1	9.1	0.2	0.0	3.8	0.0	0.7	0.0	1.0	0.0	2.3	6.6	5.4	2.5	0.2	0.7	2.2	3.7	0.0	0.5	2.3	0.0	0.6
ZDHHC9	"CGI-89, CXorf11, DHHC9, ZDHHC10, ZNF379, ZNF380"	ENSG00000188706	"Zinc finger DHHC-type palmitoyltransferase 9"	Q9Y397	X	129803288-129843909	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 66.0;Oligodendrocytes: 118.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031814	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 45: Intestine - Brush border"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum, Golgi apparatus"	Cytosol	"HPA031814: AB_10610700"	"prognostic unfavorable (9.77e-5)"	"prognostic unfavorable (4.64e-5)"	"unprognostic (2.83e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (4.01e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.11e-2)"	28.2	12.0	39.2	10.2	66.6	5.4	24.3	46.5	52.5	19.1	23.3	22.0	31.6	11.8	11.7	15.6	12.1	15.3	15.5	39.2	49.0	37.1	40.1	26.7	3.3	60.5	58.2	11.2	25.9	25.2	11.4	17.2	52.5	18.8	24.9	6.0	21.1	11.3	13.4	35.3	34.0	15.3	44.8	3.9	19.5	4.1	57.8	3.6	13.8	11.3	6.6	23.8	14.5	78.6	45.9	23.8	33.2	67.5	112.4	87.7	27.0	44.3	50.6	20.9	26.0	37.6	58.4	1.6	73.7	47.6	54.0	30.4	38.0	44.6	30.0	2.6	23.7	9.2	24.0	50.1	44.4	6.1	15.7	96.0	71.1	34.0	50.1	36.5	39.9	15.0	10.1	17.6	34.0	40.0	8.8	11.4	18.0	102.3	40.4	8.2	21.4	27.1	30.1	25.2	26.3	22.0	12.7	64.7	20.5	38.9	27.6	10.1	32.8	21.1	7.3	50.0	36.3	16.5	12.7	5.5	37.9	25.1	10.8	0.0	2.2	1.8	3.0	2.0	3.7	2.7	3.6	2.9	2.4	1.5	4.5	2.6	0.0	2.5	5.2	5.1	1.8	2.1	39.2	66.6	46.5	52.5	39.2	49.0	60.5	58.2	52.5	44.8	57.8	78.6	66.0	22.4	28.6	4.6	2.8	18.6	12.4	12.8	13.1	9.1	16.8	15.1	4.6	17.2	15.9	46.0	2.1	5.6	2.7	20.1	3.9	18.6	1.8	23.8	16.9	16.6	18.0	4.2	10.5	19.8	19.1	32.7	18.3	59.7	2.5	11.5	7.9	43.7	4.9	1.7	11.8	23.2	10.2	3.5	12.2	2.0	12.2	3.9	10.6	7.5	0.3	1.5	1.0	9.5	118.2	33.5	14.6	7.5	7.7	39.1	51.0	25.8	7.2	2.8	0.0	9.5	11.1	8.4	8.7	16.9	19.2	10.3	5.1	7.5	27.2	22.1
ZFYVE27	"FLJ32919, SPG33"	ENSG00000155256	"Zinc finger FYVE-type containing 27"	Q5T4F4	10	97737121-97760907	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037523, HPA069876"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles"	Cytosol	"HPA037523: AB_10672351, HPA069876: AB_2686218"	"unprognostic (2.21e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (3.12e-1)"	"unprognostic (3.42e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.05e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.38e-3)"	"prognostic favorable (7.54e-4)"	"unprognostic (4.18e-2)"	"unprognostic (1.26e-2)"	"prognostic favorable (7.80e-4)"	14.4	27.9	33.1	12.9	32.1	23.2	15.8	29.2	35.9	20.6	34.8	25.6	24.8	16.5	22.9	16.5	20.3	12.1	17.8	35.5	33.6	28.3	32.6	17.7	16.1	32.6	31.4	25.9	23.7	19.2	38.3	9.5	33.2	22.0	16.3	28.4	18.9	10.3	12.8	18.2	30.6	8.5	29.1	29.1	19.8	23.0	33.5	12.7	20.4	5.9	13.1	16.8	17.0	32.4	17.7	21.4	12.6	28.1	14.1	9.8	17.2	17.7	18.5	20.3	19.7	19.1	35.9	27.2	19.8	12.8	25.9	38.8	18.4	17.2	10.6	28.3	18.6	12.9	23.1	18.1	18.1	20.9	24.9	16.0	20.4	19.9	15.2	32.4	11.5	22.5	19.6	17.9	15.3	13.8	16.9	39.4	10.3	15.3	16.4	19.2	12.7	13.0	19.5	10.8	10.1	19.7	11.9	9.9	47.2	11.5	21.8	20.5	12.4	10.2	11.9	15.6	34.2	20.6	18.6	14.3	25.3	26.5	11.9	4.8	5.8	9.3	9.6	6.2	8.2	7.1	6.6	7.9	5.4	6.7	7.5	8.3	8.2	6.8	9.2	5.6	9.5	8.3	33.1	32.1	29.2	35.9	35.5	33.6	32.6	31.4	33.2	29.1	33.5	32.4	10.0	3.2	11.4	14.0	22.1	8.2	12.8	11.3	18.8	29.9	11.1	8.9	7.2	14.3	9.7	14.7	58.4	7.4	21.2	33.9	7.9	14.9	5.2	14.3	7.8	11.0	20.3	14.3	33.6	16.0	5.7	10.1	19.4	11.4	14.0	17.3	10.8	10.9	8.2	37.0	35.2	15.6	14.2	8.8	5.7	1.5	9.6	11.0	10.6	16.9	11.2	14.8	15.5	12.5	20.2	13.9	26.1	9.1	13.4	13.8	35.5	8.6	16.6	43.7	19.7	6.7	9.9	8.9	7.6	10.4	5.5	13.5	17.9	10.9	14.7	17.7
ZMPSTE24	"FACE-1, HGPS, PRO1, STE24, Ste24p"	ENSG00000084073	"Zinc metallopeptidase STE24"	O75844	1	40258041-40294180	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006988	Approved					NA	NA		50000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"			"HPA006988: AB_1080659"	"unprognostic (6.32e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.75e-3)"	"unprognostic (4.63e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (5.73e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.84e-3)"	"unprognostic (4.78e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (2.71e-2)"	20.5	24.6	16.3	19.9	16.7	5.6	25.5	18.1	22.9	26.2	21.9	28.5	22.2	26.7	27.4	21.7	18.8	25.7	20.6	16.1	18.8	46.0	38.4	21.7	16.8	17.4	17.7	14.3	17.4	53.3	10.2	22.1	18.5	26.3	33.1	10.9	19.6	23.8	16.3	16.3	23.4	32.2	18.7	13.7	21.3	11.0	17.7	15.5	27.5	18.1	23.0	29.4	16.2	18.9	69.3	38.4	35.6	26.1	90.3	71.3	67.0	64.0	60.6	81.7	73.9	35.4	118.8	62.7	41.1	92.1	29.9	71.0	78.4	67.9	97.9	54.4	39.8	59.9	36.0	44.5	45.4	99.3	68.8	45.5	67.4	64.7	28.4	45.4	58.3	27.3	63.0	60.6	80.1	30.2	60.7	28.3	70.0	47.2	42.2	52.2	60.2	77.6	75.2	58.0	38.0	44.6	60.9	155.6	85.9	56.3	55.2	249.1	46.4	68.6	52.5	56.0	78.0	37.1	106.2	49.6	75.6	64.6	79.1	18.9	21.4	14.0	17.6	27.2	22.5	15.0	19.4	19.4	29.4	11.4	16.7	22.9	8.5	29.6	24.3	18.4	24.6	22.7	16.3	16.7	18.1	22.9	16.1	18.8	17.4	17.7	18.5	18.7	17.7	18.9	28.9	38.5	24.1	19.2	20.1	32.0	24.2	41.4	33.0	6.6	35.9	19.0	25.5	54.3	43.0	73.5	0.0	41.4	22.1	44.3	31.3	58.9	3.5	30.7	32.6	31.2	27.6	18.1	16.6	36.9	38.3	36.0	21.9	40.0	21.0	16.6	27.5	64.4	34.0	10.1	13.9	31.0	54.9	33.9	24.5	2.2	28.6	28.6	24.9	11.2	30.5	29.3	19.6	17.6	20.2	44.0	29.3	32.7	31.1	37.7	31.7	42.6	64.2	7.7	0.0	26.8	41.2	7.8	6.4	31.5	27.1	39.0	23.1	28.9	35.6	24.5